FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Piane, GM
   Smith, TC
AF Piane, Gina M.
   Smith, Tyler C.
TI Building an Evidence Base for the Co-Occurrence of Chronic Disease and
   Psychiatric Distress and Impairment
SO PREVENTING CHRONIC DISEASE
LA English
DT Article
ID NATIONAL-COMORBIDITY-SURVEY; MENTAL-HEALTH-SERVICES; DSM-IV DISORDERS;
   SURVEY REPLICATION; UNITED-STATES; PRIMARY-CARE; PREVALENCE; LIFETIME;
   POPULATION; DEPLOYMENT
AB Introduction Mental disorders and chronic diseases have been reported to independently affect half of the US population. The objective of this study was to evaluate the comorbid nature of these conditions.
   Methods We analyzed data from 39,954 participants from the 2009 California Health Interview Survey who reported both psychological distress and impairment, on the basis of the Kessler 6 and the Sheehan Disability Scale, and 1 or more of 4 chronic diseases (type 2 diabetes, high blood pressure, asthma, heart disease). Weighted and nonweighted multivariable logistic regression were used to investigate the association between psychological distress and impairment and chronic disease, after adjusting for sex, age, race, current smoking, binge drinking in the previous year, moderate physical activity, and body mass index.
   Results After controlling for covariates in the model, we found a significant dose-response relationship between reported chronic diseases and psychiatric distress and impairment that ranged from 1.50 for 1 reported chronic disease to 4.68 for 4 reported chronic diseases.
   Conclusion The growing chronic disease burden should be understood clinically in the context of mental health conditions. Further research is needed to identify ways to integrate mental health and chronic disease prevention in primary care.
C1 [Piane, Gina M.] Natl Univ, Sch Hlth & Human Serv, Dept Community Hlth, San Diego, CA 92123 USA.
   [Smith, Tyler C.] Natl Univ, San Diego, CA 92123 USA.
RP Piane, GM (reprint author), Natl Univ, Sch Hlth & Human Serv, Dept Community Hlth, 3678 Aero Court, San Diego, CA 92123 USA.
EM GPiane@nu.edu
CR [Anonymous], 2009, LANCET, V373, P185, DOI 10.1016/S0140-6736(09)60048-9
   [Anonymous], 2011, CAL HLTH INT SURV 20
   Boyko EJ, 2010, DIABETES CARE, V33, P1771, DOI 10.2337/dc10-0296
   Breslau J, 2005, PSYCHOL MED, V35, P317, DOI 10.1017/S0033291704003514
   *COMM CROSS QUAL C, 2006, AD MENT HLTH ADD DIS
   Committee on Quality of Care in America, 2001, CROSSING QUALITY CHA
   Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581
   Fabricatore AN, 2004, CLIN DERMATOL, V22, P332, DOI 10.1016/j.clindermatol.2004.01.006
   Granado NS, 2009, HYPERTENSION, V54, P966, DOI 10.1161/HYPERTENSIONAHA.109.132555
   Hambrick JP, 2004, J ANXIETY DISORD, V18, P825, DOI 10.1016/j.janxdis.2003.10.004
   Johnson-Lawrence V, 2012, PSYCHIAT SERV, V63, P1137, DOI 10.1176/appi.ps.201100365
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012
   Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617
   Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593
   KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8
   Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095
   Kim G, 2012, INT J GERIATR PSYCH, V27, P1070, DOI 10.1002/gps.2825
   King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414
   Kung Hsiang-Ching, 2008, Natl Vital Stat Rep, V56, P1
   Mascie-Taylor CGN, 2003, SCIENCE, V302, P1921, DOI 10.1126/science.1092488
   Pfeiffer PN, 2011, PSYCHIAT SERV, V62, P422, DOI 10.1176/ps.62.4.pss6204_0422
   Pratt KM, 2012, PROF PSYCHOL-RES PR, V43, P281, DOI 10.1037/a0028122
   Reeves William C., 2011, Morbidity and Mortality Weekly Report, V60, P1
   Remington Patrick L, 2011, MMWR Suppl, V60, P70
   Satcher D, 2010, PREV CHRONIC DIS, V7
   Scott KM, 2008, INT J OBESITY, V32, P192, DOI 10.1038/sj.ijo.0803701
   Seelig AD, 2010, SLEEP, V33, P1615, DOI 10.1093/sleep/33.12.1615
   Sheehan DV, 1983, ANXIETY DIS
   Zivin K, 2010, MED CARE, V48, P843, DOI 10.1097/MLR.0b013e3181e5792b
NR 30
TC 5
Z9 5
U1 0
U2 4
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1545-1151
J9 PREV CHRONIC DIS
JI Prev. Chronic Dis.
PD OCT
PY 2014
VL 11
AR E188
DI 10.5888/pcd11.140211
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA AR3XM
UT WOS:000343522500017
PM 25340360
OA Green Published, Bronze
DA 2019-01-08
ER

PT J
AU Jansen, HJ
   Vervoort, GMM
   De Haan, AFJ
   Netten, PM
   de Grauw, WJ
   Tack, CJ
AF Jansen, Henry J.
   Vervoort, Gerald M. M.
   De Haan, Anton F. J.
   Netten, Paetrick M.
   de Grauw, Wim J.
   Tack, Cees J.
TI Diabetes-Related Distress, Insulin Dose, and Age Contribute to
   Insulin-Associated Weight Gain in Patients With Type 2 Diabetes: Results
   of a Prospective Study
SO DIABETES CARE
LA English
DT Article
ID PREDICTING BODY DENSITY; PROBLEM AREAS; GENERALIZED EQUATIONS;
   DEPRESSIVE SYMPTOMS; EMOTIONAL DISTRESS; MELLITUS; METFORMIN; VALIDITY;
   THERAPY
AB OBJECTIVE
   The determinants of insulin-associated weight gain in type 2 diabetes mellitus (T2DM) are partly unknown. Therefore, we conducted a prospective study to identify predictors of insulin-associated weight gain.
   RESEARCH DESIGN AND METHODS
   In patients with T2DM, we assessed physical activity by accelerometry and measured diabetes-related distress by questionnaires before and 6 and 12 months after starting insulin therapy. Glycemic control (HbA(1c)) and insulin dose were monitored.
   RESULTS
   After 12 months of insulin therapy, mean body weight had increased by 3.0 +/- 2.5 kg (P < 0.001). The drop in HbA(1c) was correlated with insulin-associated weight gain. With the use of a multiple linear regression model, a cluster of variables was identified that significantly related to weight gain. Diabetes-related distress, initial insulin dose, and the increase of insulin dose during the course of the study as well as age appeared to be important predictors of weight gain after initiation of insulin therapy. Physical activity (measured as MET) decreased from 1.40 +/- 0.04 at baseline to 1.32 +/- 0.04 MET (P < 0.05) but was not significantly related to weight changes.
   CONCLUSIONS
   Diabetes-related distress, initial and titration of insulin dose, and age all significantly predict insulin-associated weight gain. After the initiation of insulin therapy, physical activity decreased significantly, but this did not determine weight gain over the first 12 months. Our study findings may have clinical implications.
C1 [Jansen, Henry J.; Vervoort, Gerald M. M.; Tack, Cees J.] Radboud Univ Nijmegen Med Ctr, Dept Internal Med, Nijmegen, Netherlands.
   [De Haan, Anton F. J.] Radboud Univ Nijmegen, Dept Hlth Evidence, Biostat Grp, Nijmegen, Netherlands.
   [Netten, Paetrick M.] Jeroen Bosch Hosp, Dept Internal Med, Shertogenbosch, Netherlands.
   [de Grauw, Wim J.] Radboud Univ Nijmegen Med Ctr, Dept Primary & Community Care, Nijmegen, Netherlands.
   [de Grauw, Wim J.] Family Practice Berghem, Berghem, Netherlands.
RP Jansen, HJ (reprint author), Radboud Univ Nijmegen Med Ctr, Dept Internal Med, Nijmegen, Netherlands.
EM h.jansen@jbz.nl
RI de Haan, Antonius/L-4344-2015; Tack, Cees/A-2368-2014; Vervoort,
   G.M.M./L-4718-2015; Grauw, W.J.C./L-4334-2015
CR Balkau B, 2014, DIABETES CARE, V37, P2108, DOI 10.2337/dc13-3010
   Bouma M, 2006, Ned Tijdschr Geneeskd, V150, P2251
   Brumpton B, 2013, INT J OBESITY, V37, P1268, DOI 10.1038/ijo.2012.204
   DEFRONZO RA, 1981, INT J OBESITY, V5, P93
   Ekelund U, 2005, AM J CLIN NUTR, V81, P964
   Forman-Hoffman VL, 2007, J GERONTOL B-PSYCHOL, V62, pS43, DOI 10.1093/geronb/62.1.S43
   Fruin ML, 2004, MED SCI SPORT EXER, V36, P1063, DOI 10.1249/01.MSS.0000128144.91337.38
   Heller S, 2004, DIABETES RES CLIN PR, V65, pS23, DOI 10.1016/j.diabres.2004.07.005
   Holman RR, 2007, NEW ENGL J MED, V357, P1716, DOI 10.1056/NEJMoa075392
   Hosoya T, 2012, INTERNAL MED, V51, P263, DOI 10.2169/internalmedicine.51.5768
   JACKSON AS, 1978, BRIT J NUTR, V40, P497, DOI 10.1079/BJN19780152
   JACKSON AS, 1980, MED SCI SPORT EXER, V12, P175
   Jansen HJ, 2011, ENDOCRINE, V39, P190, DOI 10.1007/s12020-010-9423-4
   Jansen HJ, 2010, NETH J MED, V68, P359
   Miller ST, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-70
   Rotella F, 2013, DIABETES RES CLIN PR, V99, P98, DOI 10.1016/j.diabres.2012.11.022
   Ryan M, 2008, DIABETES CARE, V31, P448, DOI 10.2337/dc07-1171
   Salle A, 2005, BRIT J NUTR, V94, P931, DOI 10.1079/BJN20051592
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   St-Arnaud-McKenzie D, 2010, J GERONTOL A-BIOL, V65, P1362, DOI 10.1093/gerona/glq150
   Thompson F. E, 2008, NUTR PREVENTION TREA, V2, P3
   Turner RC, 1999, JAMA-J AM MED ASSOC, V281, P2005, DOI 10.1001/jama.281.21.2005
   Verbeke G, 1997, LINEAR MIXED MODELS
   Welch G, 2003, DIABETIC MED, V20, P69, DOI 10.1046/j.1464-5491.2003.00832.x
   Westenbrink S, 2012, NEVO KWALITEISHANDBO, P1
   Wolfe R R, 2000, Curr Opin Clin Nutr Metab Care, V3, P67, DOI 10.1097/00075197-200001000-00011
   Yki-Jarvinen H, 2006, DIABETOLOGIA, V49, P442, DOI 10.1007/s00125-005-0132-0
NR 27
TC 15
Z9 16
U1 1
U2 6
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
EI 1935-5548
J9 DIABETES CARE
JI Diabetes Care
PD OCT
PY 2014
VL 37
IS 10
BP 2710
EP 2717
DI 10.2337/dc13-1205
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AR4UM
UT WOS:000343582400023
PM 25011948
OA Bronze
DA 2019-01-08
ER

PT J
AU Reeve, R
   Church, J
   Haas, M
   Bradford, W
   Viney, R
AF Reeve, Rebecca
   Church, Jody
   Haas, Marion
   Bradford, Wylie
   Viney, Rosalie
TI Factors that drive the gap in diabetes rates between Aboriginal and
   non-Aboriginal people in non-remote NSW
SO AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH
LA English
DT Article
DE Aboriginal; diabetes; non-remote; risk factors
ID ANTHROPOMETRIC INDEXES; AUSTRALIANS; POPULATIONS; PREVALENCE; RISK
AB Objective: To identify factors underpinning the gap in diabetes rates between Aboriginal and non-Aboriginal people in non-remote NSW. This will indicate appropriate target areas for policy and for monitoring progress towards reducing the gap.
   Methods: Data from the 2004-05 National Health Survey and National Aboriginal and Torres Strait Islander Health Survey were used to estimate differences in self-reported diabetes rates and risk/prevention factors between Aboriginal and non-Aboriginal people in non-remote NSW. Logistic regression models were used to investigate the contribution of each factor to predicting the probability of diabetes.
   Results: Risk factors for diabetes are more prevalent and diabetes rates 2.5 to 4 times higher in Aboriginal compared to non-Aboriginal adults in non-remote NSW. The odds of (known) diabetes for both groups are significantly higher for older people, those with low levels of education and those who are overweight or obese. In the Aboriginal sample, the odds of diabetes are significantly higher for people reporting forced removal of their relatives.
   Conclusions: Differences in BMI and education appear to be driving the diabetes gap, together with onset at younger ages in the Aboriginal population. Psychological distress, indicated by removal of relatives, may contribute to increased risk of diabetes in the Aboriginal population.
   Implications: The results imply that improved nutrition and exercise, capacity to access and act upon health care information and early intervention are required to reduce the diabetes gap. Current strategies appear to be appropriately aligned with the evidence; however, further research is required to determine whether implementation methods are effective.
C1 [Reeve, Rebecca; Church, Jody; Haas, Marion; Viney, Rosalie] Univ Technol Sydney, Ctr Hlth Econ Res & Evaluat, Broadway, NSW 2007, Australia.
   [Bradford, Wylie] Macquarie Univ, N Ryde, NSW 2109, Australia.
RP Reeve, R (reprint author), Univ Technol Sydney, Ctr Hlth Econ Res & Evaluat, POB 123, Broadway, NSW 2007, Australia.
EM rebecca.reeve@chere.uts.edu.au
RI Haas, Marion/H-2732-2017
OI Bradford, Wylie/0000-0002-7478-2290; Reeve, Rebecca/0000-0003-1022-8052
FU UTS Faculty of Business Research Grant; National Health and Medical
   Research Council [571926]
FX This study was approved by the ethics committees of the University of
   Technology, Sydney and the Aboriginal Health and Medical Research
   Council. We are grateful for advice provided by the study's Aboriginal
   Reference Group, in particular Debra Fernando and Wylie Bradford (who is
   also a co-author of the paper), and for comments from Richard Norman and
   Patsy Kenny on a previous draft and the anonymous reviewers. The work
   was supported by a UTS Faculty of Business Research Grant and a National
   Health and Medical Research Council Capacity Building Grant (571926).
CR Aboriginal and Torres Strait Islander Healing Foundation Development Team, 2009, AB TORR STRAIT ISL H
   Aboriginal Health and Medical Research Council of NSW, 2009, 10 OUT 10 DEADL HLTH
   Australian Bureau of Statistics, 2010, 4720 0 NAT AB TORR S
   Australian Bureau of Statistics, 2006, 4715 0 55 002 NAT AB
   Australian Bureau of Statistics, 2008, 4820 0 55 001 DIAB A
   Australian Bureau of Statistics, 2006, 4715 0 NAT AB TORR S
   Australian Bureau of Statistics, 2006, 2039 0 55 001 SOC IN
   Australian Indigenous HealthInfoNet, 2007, REV DIAB IND PEOPL
   Australian Institute of Health and Welfare, 2009, MEAS SOC EM WELLB AB
   Bombay A, 2009, INT J INDIG HEALTH, V5, P6
   Brunner E, 2006, SOCIAL DETERMINANTS, P6
   Cunningham J, 2008, ETHNIC HEALTH, V13, P23, DOI 10.1080/13557850701803130
   Cunningham J, 2010, AUST NZ J PUBL HEAL, V34, pS18, DOI 10.1111/j.1753-6405.2010.00547.x
   Daniel M, 1999, DIABETES CARE, V22, P1993, DOI 10.2337/diacare.22.12.1993
   Daniel M, 2002, DIABETES RES CLIN PR, V57, P23, DOI 10.1016/S0168-8227(02)00006-2
   Dea K, 2008, DIABETES RES CLIN PR, V80, P483
   Diabetes Australia, 2010, CAUS TYP 2 DIAB
   Gracey M, 2007, ASIA PAC J CLIN NUTR, V16, P688
   Kelly K., 2009, 10 COOP RES CTR AB H
   Kennedy B, 2004, P 12 BIENN C POP SOC
   Li M, 2010, DIABETES RES CLIN PR, V87, P401, DOI 10.1016/j.diabres.2009.12.004
   Lloyd C, 2005, DIABETES SPECTR, V18, P121, DOI [DOI 10.2337/DIASPECT.18.2.121, 10.2337/diaspect.18.2.121]
   MCCARTY DJ, 1996, RISE RISE DIABETES A
   Minges KE, 2011, DIABETES RES CLIN PR, V93, P139, DOI 10.1016/j.diabres.2011.06.012
   National Health and Medical Research Centre, 2001, NAT EV BAS GUID MA 2
   NSW Health, 2012, NSW STAT KNOCK CHALL
   NSW Health, 2008, NAT PARTN AGR CLOS G
   Nutbeam D, 1993, NATL ACTION PLAN DIA
   Rowley KG, 1997, CLIN EXP PHARMACOL P, V24, P776, DOI 10.1111/j.1440-1681.1997.tb02131.x
   Silburn S. R., 2006, FAMILY MATTERS, V75, P10
   Wang Z, 2004, INT J OBESITY, V28, P1580, DOI 10.1038/sj.ijo.0802771
   Wang ZM, 2007, EUR J CARDIOV PREV R, V14, P172, DOI 10.1097/01.hjr.0000220580.34763.fb
   World Health Organization (WHO), 2000, WHO TECH REP SER, V894, P1
NR 33
TC 1
Z9 1
U1 1
U2 11
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1326-0200
EI 1753-6405
J9 AUST NZ J PUBL HEAL
JI Aust. N. Z. Publ. Health
PD OCT
PY 2014
VL 38
IS 5
SI SI
BP 459
EP 465
DI 10.1111/1753-6405.12211
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA AQ4KL
UT WOS:000342765100014
PM 25168646
DA 2019-01-08
ER

PT J
AU Loprinzi, PD
   Codey, K
AF Loprinzi, Paul D.
   Codey, Kathleen
TI Influence of visual acuity on anxiety, panic and depression disorders
   among young and middle age adults in the United States
SO JOURNAL OF AFFECTIVE DISORDERS
LA English
DT Article
DE Epidemiology; Psychological distress; Vision
ID PHYSICAL-ACTIVITY; OLDER-ADULTS; VISION; IMPAIRMENT; SYMPTOMS; LIFE
AB Background: Previous research, albeit limited, has demonstrated an association of visual acuity with depression and anxiety. However, these studies are limited in that they have focused on older adults, used a convenient sample, and/or used a subjective assessment of visual function. As a result, the purpose of this study was to examine the association of objectively-measured visual acuity with depression and anxiety (and panic disorder) among a national sample of young- and middle-age U.S. adults (20-39 years).
   Methods: Using data from the 2003-2004 NI-LANES (n=602), the presence of anxiety, depression, and panic disorders was assessed from a diagnostic interview. Visual acuity was assessed from a vision exam using the Nidek Auto Lensmeter Model (LM-990A) and expressed as LogMAR units.
   Results: After adjusting for age, gender, race-ethnicity, body mass index, mean arterial pressure, cotinine, diabetes, and physical activity, visual acuity was not associated with panic disorder (p=0.71) or depression disorder (p=0.20), but for every 0.1 LogMAR Unit change in vision, participants had a 14% (OR=1.14; p=0.04) higher odds of having an anxiety disorder.
   Limitations: The main limitation of this study was the cross-sectional design.
   Conclusion: Young- and middle-age U.S. adults with worse visual function are at increased odds of having an anxiety disorder. Strategies to prevent and treat anxiety among those with worse visual function are needed. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Loprinzi, Paul D.; Codey, Kathleen] Bellarmine Univ, Donna & Allan Lansing Sch Nursing & Hlth Sci, Louisville, KY 40205 USA.
RP Loprinzi, PD (reprint author), Bellarmine Univ, Donna & Allan Lansing Sch Nursing & Hlth Sci, Louisville, KY 40205 USA.
EM ploprinzi@bellarmine.edu
CR Bernabei V, 2011, AGING MENT HEALTH, V15, P467, DOI 10.1080/13607863.2011.562483
   Boerner K, 2004, J GERONTOL B-PSYCHOL, V59, pP35, DOI 10.1093/geronb/59.1.P35
   Bull FC, 2009, J PHYS ACT HEALTH, V6, P790, DOI 10.1123/jpah.6.6.790
   Crewe JM, 2011, CLIN EXP OPHTHALMOL, V39, P336, DOI 10.1111/j.1442-9071.2010.02466.x
   de Mello MT, 2013, J AFFECT DISORDERS, V149, P241, DOI 10.1016/j.jad.2013.01.035
   Grue EV, 2009, SCAND J CARING SCI, V23, P635, DOI 10.1111/j.1471-6712.2008.00654.x
   Han JN, 1996, J PSYCHOSOM RES, V41, P481, DOI 10.1016/S0022-3999(96)00220-6
   Hassan SE, 2002, OPTOMETRY VISION SCI, V79, P697, DOI 10.1097/00006324-200211000-00007
   Holladay JT, 1997, J REFRACT SURG, V13, P388
   Karlsson JS, 1998, J VISUAL IMPAIR BLIN, V92, P483
   Kempen GIJM, 2012, QUAL LIFE RES, V21, P1405, DOI 10.1007/s11136-011-0061-y
   Kulaksizoglu IB, 2007, CNS DRUGS, V21, P473, DOI 10.2165/00023210-200721060-00004
   LACEY JI, 1954, SCIENCE, V120, P1045, DOI 10.1126/science.120.3130.1045
   Loprinzi P.D., 2014, J PHYS ACT IN PRESS
   Loprinzi P.D., 2014, AM J HLTH P IN PRESS
   Loprinzi PD, 2013, MAYO CLIN PROC, V88, P690, DOI 10.1016/j.mayocp.2013.04.008
   Monteso P, 2012, J PSYCHIATR MENT HLT, V19, P426, DOI 10.1111/j.1365-2850.2011.01798.x
   National Health and Nutrition Examination Survey, 2006, COMP INT DIAGN INT
   Richman J, 2010, ARCH OPHTHALMOL-CHIC, V128, P1576, DOI 10.1001/archophthalmol.2010.275
   Robertson N, 2006, DIABETIC MED, V23, P1110, DOI 10.1111/j.1464-5491.2006.01970.x
   Scilley K, 2002, OPHTHALMOLOGY, V109, P1235, DOI 10.1016/S0161-6420(02)01060-6
   Velayudhan A, 2010, Ind Psychiatry J, V19, P41, DOI 10.4103/0972-6748.77636
   Vitale S, 2006, JAMA-J AM MED ASSOC, V295, P2158, DOI 10.1001/jama.295.18.2158
NR 23
TC 9
Z9 9
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-0327
EI 1573-2517
J9 J AFFECT DISORDERS
JI J. Affect. Disord.
PD OCT 1
PY 2014
VL 167
BP 8
EP 11
DI 10.1016/j.jad.2014.05.052
PG 4
WC Clinical Neurology; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA AO4UA
UT WOS:000341335700002
PM 25082107
DA 2019-01-08
ER

PT J
AU Persson, M
   Fadl, H
AF Persson, M.
   Fadl, H.
TI Perinatal outcome in relation to fetal sex in offspring to mothers with
   pre-gestational and gestational diabetes-a population-based study
SO DIABETIC MEDICINE
LA English
DT Article
ID RESPIRATORY-DISTRESS SYNDROME; CONGENITAL-ANOMALIES; NEONATAL OUTCOMES;
   PREGNANCY; WOMEN; MELLITUS; MALFORMATIONS; INFANTS; GLUCOSE; EMBRYOS
AB Aim The objective of the present study was to investigate if perinatal outcome differs with fetal sex in pregnancies with maternal Type 1 diabetes, Type 2 diabetes or gestational diabetes.
   Methods This was a population-based cohort study, with data from the Medical Birth Registry in Sweden throughout the period 1998-2007. Singleton pregnancies with maternal Type 1 diabetes (n = 4092), Type 2 diabetes (n = 412) and gestational diabetes (n = 8602) were identified based on the International Classification of Diseases, 10th edition code. For comparison, 905 565 pregnancies without diabetes were included. The primary outcome was a composite outcome, consisting of any of the following diagnoses: perinatal mortality rate, major malformation, preterm delivery, acute respiratory disorders and neonatal hypoglycaemia. Logistic regression was used to obtain odds ratios for adverse outcomes in male offspring within the diabetic and reference cohorts, respectively.
   Results In pregnancies with diabetes, maternal characteristics did not differ with fetal sex, except for a higher rate of Caesarean delivery in male offspring of women with Type 1 diabetes. Male infants to mothers with Type 1 diabetes and gestational diabetes had significantly increased odds of respiratory disorders [adjusted odds ratio (confidence interval) Type 1 diabetes: 1.50 (1.12-2.02); gestational diabetes: 1.81 (1.27-2.57)]. Male infants to mothers with gestational diabetes also had significantly increased odds of major malformations [adjusted odds ratio: 1.44 (1.07-1.93)]. In offspring of mothers with Type 2 diabetes, odds ratios of most outcomes were higher in male infants; however, not significantly different from female infants. In pregnancies without diabetes, male infants had significantly higher odds of all adverse outcomes, except perinatal mortality rate.
   Conclusion The risk of adverse perinatal outcome in offspring of mothers with Type 1 diabetes and gestational diabetes did not differ by sex, except for a higher risk in male infants for respiratory disorders. The risk of major malformations was also significantly increased in male offspring to mothers with gestational diabetes. In offspring of mothers with Type 2 diabetes, no significant differences between sexes were found.
C1 [Persson, M.] Karolinska Inst, Karolinska Univ Hosp, Dept Med, Clin Epidemiol Unit, Stockholm, Sweden.
   [Fadl, H.] Univ Orebro, Dept Obstet & Gynecol, Sch Hlth & Med Sci, SE-70182 Orebro, Sweden.
RP Persson, M (reprint author), Karolinska Inst, Karolinska Univ Hosp, Dept Med, Clin Epidemiol Unit, Stockholm, Sweden.
EM Martina.Persson@ki.se
FU Stockholm City Council
FX This work was supported by unrestricted grants from the Stockholm City
   Council.
CR Anderberg E, 2007, ACTA OBSTET GYN SCAN, V86, P1432, DOI 10.1080/00016340701532444
   [Anonymous], 2003, SUMM CONT QUAL
   Bracero LA, 1996, GYNECOL OBSTET INVES, V41, P10, DOI 10.1159/000292026
   Chaabane S, 2013, CURR DRUG SAF, V8, P128, DOI 10.2174/15748863112079990011
   Di Renzo GC, 2007, GENDER MED, V4, P19, DOI 10.1016/S1550-8579(07)80004-0
   Eidem I, 2010, ACTA OBSTET GYN SCAN, V89, P1403, DOI 10.3109/00016349.2010.518594
   ERIKSSON UJ, 1993, DIABETES, V42, P411, DOI 10.2337/diabetes.42.3.411
   Evers IM, 2009, DIABETES CARE, V32, P1194, DOI 10.2337/dc09-0367
   Fadl HE, 2010, DIABETIC MED, V27, P436, DOI 10.1111/j.1464-5491.2010.02978.x
   Garcia-Patterson A, 2011, DIABETIC MED, V28, P436, DOI 10.1111/j.1464-5491.2011.03227.x
   Ghidini A, 2005, BJOG-INT J OBSTET GY, V112, P140, DOI 10.1111/j.1471-0528.2004.00308.x
   GREENOUGH A, 1987, ACTA PAEDIATR SCAND, V76, P54, DOI 10.1111/j.1651-2227.1987.tb10414.x
   HANSON U, 1990, DIABETOLOGIA, V33, P100, DOI 10.1007/BF00401047
   Hogberg U, 1997, ACTA OBSTET GYN SCAN, V76, P907, DOI 10.3109/00016349709034900
   Jensen DM, 2004, DIABETES CARE, V27, P2819, DOI 10.2337/diacare.27.12.2819
   KHOURY MJ, 1985, AM J OBSTET GYNECOL, V151, P777, DOI 10.1016/0002-9378(85)90518-6
   Kraemer S, 2000, BRIT MED J, V321, P1609, DOI 10.1136/bmj.321.7276.1609
   Lisi A, 2005, AM J MED GENET A, V134A, P49, DOI 10.1002/ajmg.a.30514
   Newham JJ, 2013, DIABETIC MED, V30, P1442, DOI 10.1111/dme.12293
   OLVER RE, 1977, J PHYSL, V273, P58
   Ostlund I, 2004, ACTA OBSTET GYN SCAN, V83, P46, DOI 10.1111/j.1600-0412.2004.00267.x
   PAPAGEORGIOU AN, 1981, PEDIATRICS, V67, P614
   Perez-Crespo M, 2005, MOL REPROD DEV, V72, P502, DOI 10.1002/mrd.20366
   Persson B, 2005, FRONT DIABETES, V17, P288
   Persson M, 2012, BJOG-INT J OBSTET GY, V119, P565, DOI 10.1111/j.1471-0528.2012.03277.x
   Persson M, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000601
   Persson M, 2009, DIABETES CARE, V32, P2005, DOI 10.2337/dc09-0656
   Tennant PWG, 2011, BIRTH DEFECTS RES A, V91, P894, DOI 10.1002/bdra.22846
   TIFFIN GJ, 1991, J REPROD FERTIL, V93, P125
   Tundidor D, 2012, GENDER MED, V9, P411, DOI 10.1016/j.genm.2012.09.002
   Vatten LJ, 2004, EARLY HUM DEV, V76, P47, DOI 10.1016/j.earlhumdev.2003.10.006
NR 31
TC 13
Z9 13
U1 0
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD SEP
PY 2014
VL 31
IS 9
BP 1047
EP 1054
DI 10.1111/dme.12479
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AS1AN
UT WOS:000344008700006
PM 24773081
DA 2019-01-08
ER

PT J
AU Tovote, KA
   Fleer, J
   Snippe, E
   Peeters, ACTM
   Emmelkamp, PMG
   Sanderman, R
   Links, TP
   Schroevers, MJ
AF Tovote, K. Annika
   Fleer, Joke
   Snippe, Evelien
   Peeters, Anita C. T. M.
   Emmelkamp, Paul M. G.
   Sanderman, Robbert
   Links, Thera P.
   Schroevers, Maya J.
TI Individual Mindfulness-Based Cognitive Therapy and Cognitive Behavior
   Therapy for Treating Depressive Symptoms in Patients With Diabetes:
   Results of a Randomized Controlled Trial
SO DIABETES CARE
LA English
DT Article
ID PRIMARY-CARE PATIENTS; TREATMENT PREFERENCES; MENTAL-HEALTH;
   METAANALYSIS; INTERVENTION; OUTPATIENTS; DISTRESS; MELLITUS; ANXIETY;
   FUTURE
AB OBJECTIVE
   Depression is a common comorbidity of diabetes, undesirably affecting patients' physical and mental functioning. Psychological interventions are effective treatments for depression in the general population as well as in patients with a chronic disease. The aim of this study was to assess the efficacy of individual mindfulness-based cognitive therapy (MBCT) and individual cognitive behavior therapy (CBT) in comparison with awaiting-list control condition for treating depressive symptoms in adults with type 1 or type 2 diabetes.
   RESEARCH DESIGN AND METHODS
   In this randomized controlled trial, 94 outpatients with diabetes and comorbid depressive symptoms (i.e., Beck Depression Inventory-II [ BDI-II] >= 14) were randomized to MBCT (n = 31), CBT (n = 32), or waiting list (n = 31). All participants completed written questionnaires and interviews at pre- and postmeasurement (3 months later). Primary outcome measure was severity of depressive symptoms (BDI-II and Toronto Hamilton Depression Rating Scale). Anxiety (Generalized Anxiety Disorder 7), well-being (Well-Being Index), diabetes-related distress (Problem Areas In Diabetes), and HbA(1c) levels were assessed as secondary outcomes.
   RESULTS
   Results showed that participants receiving MBCT and CBT reported significantly greater reductions in depressive symptoms compared with patients in the waiting-list control condition (respectively, P = 0.004 and P < 0.001; d = 0.80 and 1.00; clinically relevant improvement 26% and 29% vs. 4%). Both interventions also had significant positive effects on anxiety, well-being, and diabetes-related distress. No significant effect was found on HbA(1c) values.
   CONCLUSIONS
   Both individual MBCT and CBT are effective in improving a range of psychological symptoms in individuals with type 1 and type 2 diabetes.
C1 [Tovote, K. Annika; Fleer, Joke; Snippe, Evelien; Sanderman, Robbert; Schroevers, Maya J.] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Psychol, Groningen, Netherlands.
   [Peeters, Anita C. T. M.] Hosp Rivierenland Tiel, Dept Internal Med, Tiel, Netherlands.
   [Emmelkamp, Paul M. G.] Univ Amsterdam, Dept Clin Psychol, NL-1018 WB Amsterdam, Netherlands.
   [Emmelkamp, Paul M. G.] King Abdulaziz Univ, Ctr Social & Humanities Res, Jeddah 21413, Saudi Arabia.
   [Sanderman, Robbert] Univ Twente, Dept Psychol Hlth & Technol, NL-7500 AE Enschede, Netherlands.
   [Links, Thera P.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands.
RP Schroevers, MJ (reprint author), Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Psychol, Groningen, Netherlands.
EM m.j.schroevers@umcg.nl
RI Emmelkamp, Paul/G-3274-2011
OI Emmelkamp, Paul/0000-0001-6066-5512
FU University of Groningen
FX This study was financed by the University of Groningen.
CR Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Bech P., 2004, QUALITY LIFE NEWSLET, V32, P15
   Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13
   Beck AT, 1979, COGNITIVE THERAPY DE
   Beltman MW, 2010, BRIT J PSYCHIAT, V197, P11, DOI 10.1192/bjp.bp.109.064675
   Butler AC, 2006, CLIN PSYCHOL REV, V26, P17, DOI 10.1016/j.cpr.2005.07.003
   Chiesa A, 2011, PSYCHIAT RES, V187, P441, DOI 10.1016/j.psychres.2010.08.011
   Coelho HF, 2007, J CONSULT CLIN PSYCH, V75, P1000, DOI 10.1037/0022-006X.75.6.1000
   Cohen J, 1977, STAT POWER ANAL BEHA
   Cohen J, 2003, METHODOLOGICAL ISSUE, P427
   Dwight-Johnson M, 2000, J GEN INTERN MED, V15, P527, DOI 10.1046/j.1525-1497.2000.08035.x
   Egede LE, 2010, DIABETES RES CLIN PR, V87, P302, DOI 10.1016/j.diabres.2010.01.024
   Galante J, 2013, J RES NURS, V18, P133, DOI 10.1177/1744987112466087
   Griffiths K, 2009, J HEALTH PSYCHOL, V14, P675, DOI 10.1177/1359105309104911
   Harkness E, 2010, DIABETES CARE, V33, P926, DOI 10.2337/dc09-1519
   Hofmann SG, 2010, J CONSULT CLIN PSYCH, V78, P169, DOI 10.1037/a0018555
   JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037//0022-006X.59.1.12
   Kabat-Zinn J, 2003, CLIN PSYCHOL-SCI PR, V10, P144, DOI 10.1093/clipsy/bpg016
   Katon WJ, 2008, AM J MED, V121, P8, DOI 10.1016/j.amjmed.2008.09.008
   Khoury B, 2013, CLIN PSYCHOL REV, V33, P763, DOI 10.1016/j.cpr.2013.05.005
   Lamers F, 2010, PSYCHOTHER PSYCHOSOM, V79, P217, DOI 10.1159/000313690
   Lang AJ, 2005, J BEHAV MED, V28, P581, DOI 10.1007/s10865-005-9019-2
   Lau MA, 2012, MINDFULNESS, V3, P318, DOI 10.1007/s12671-012-0108-3
   Lustman PJ, 1998, ANN INTERN MED, V129, P613, DOI 10.7326/0003-4819-129-8-199810150-00005
   Manicavasgar V, 2011, J AFFECT DISORDERS, V130, P138, DOI 10.1016/j.jad.2010.09.027
   McIntyre RS, 2005, CAN MED ASSOC J, V173, P1327, DOI 10.1503/cmaj.050786
   Penckofer SM, 2012, ANN BEHAV MED, V44, P192, DOI 10.1007/s12160-012-9377-2
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Safren SA, 2014, DIABETES CARE, V37, P625, DOI [10.2337/dc13-0816, 10.2337/dc16-er06]
   Schroevers MJ, 2013, MINDFULNESS     0814
   Segal Z., 2002, MINDFULNESS BASED CO
   Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092
   Strong V, 2008, LANCET, V372, P40, DOI 10.1016/S0140-6736(08)60991-5
   Swift JK, 2011, J CLIN PSYCHOL, V67, P155, DOI 10.1002/jclp.20759
   Tolin DF, 2010, CLIN PSYCHOL REV, V30, P710, DOI 10.1016/j.cpr.2010.05.003
   Tovote K Annika, 2013, BMC Psychol, V1, P17, DOI 10.1186/2050-7283-1-17
   van Bastelaar KMP, 2011, DIABETES CARE, V34, P320, DOI 10.2337/dc10-1248
   Van der Feltz-Cornelis CM, 2010, GEN HOSP PSYCHIAT, V32, P380, DOI 10.1016/j.genhosppsych.2010.03.011
   van Son J, 2013, DIABETES CARE, V36, P823, DOI 10.2337/dc12-1477
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
NR 40
TC 46
Z9 49
U1 4
U2 77
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
EI 1935-5548
J9 DIABETES CARE
JI Diabetes Care
PD SEP
PY 2014
VL 37
IS 9
BP 2427
EP 2434
DI 10.2337/dc13-2918
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AN8HX
UT WOS:000340846300014
PM 24898301
OA Bronze
DA 2019-01-08
ER

PT J
AU Hayashino, Y
   Mashitani, T
   Tsujii, S
   Ishii, H
AF Hayashino, Yasuaki
   Mashitani, Tsuyoshi
   Tsujii, Satoru
   Ishii, Hitoshi
CA Diabet Distress Care Registry
TI Elevated Levels of hs-CRP Are Associated With High Prevalence of
   Depression in Japanese Patients With Type 2 Diabetes: The Diabetes
   Distress and Care Registry at Tenri (DDCRT 6)
SO DIABETES CARE
LA English
DT Article
ID C-REACTIVE PROTEIN; RANDOMIZED CONTROLLED-TRIALS; GLYCEMIC CONTROL;
   METAANALYSIS; INFLAMMATION; ADULTS; RISK; SYMPTOMS; CYTOKINE; EXERCISE
AB OBJECTIVE
   Because of the absence of data on the direct association between inflammation and depression in patients with diabetes, we examined the association between hs-CRP levels and the high prevalence of depression in adult patients with type 2 diabetes.
   RESEARCH DESIGN AND METHODS
   Cross-sectional data were obtained from 3,573 patients with type 2 diabetes recruited from a Japanese diabetes registry. A multiple logistic regression analysis adjusted for potential confounders was used to assess independent associations between hs-CRP levels and major depression, as defined by the Patient Health Questionnaire-9.
   RESULTS
   Mean age, BMI, and HbA(1c) levels were 66.0 years, 24.6 kg/m(2), and 7.4% (57.8 mmol/mol), respectively, and 122 patients (3.4%) suffered from major depression. In the age-and sex-adjusted model, the odds ratio (OR) for major depression was 1.86 (95% CI 1.01-3.42; P = 0.045) in the highest CRP quintile compared with that in the 3rd CRP quintile; however, this association disappeared after adjustment for other possible confounders (OR 1.58 [95% CI 0.85-2.94]; P = 0.148). Among patients with a BMI of >= 25 kg/m(2), a significant association was observed between the highest hs-CRP quintile and major depression (multivariable-adjusted OR 2.69 [95% CI 1.09-7.08]; P = 0.032).
   CONCLUSIONS
   We observed a significant positive association between high hs-CRP levels and depression in patients with diabetes who had a high BMI.
C1 [Hayashino, Yasuaki; Mashitani, Tsuyoshi; Tsujii, Satoru; Ishii, Hitoshi; Diabet Distress Care Registry] Tenri Hosp, Dept Endocrinol, Tenri, Nara 632, Japan.
RP Hayashino, Y (reprint author), Tenri Hosp, Dept Endocrinol, Tenri, Nara 632, Japan.
EM hayasino-y@umin.net
OI Tsujii, Satoru/0000-0002-1834-6515; Hayashino,
   Yasuaki/0000-0002-2932-8478
FU Manpei Suzuki Diabetes Foundation; JSPS KAKENHI [25460641]
FX This study was partially supported by the Manpei Suzuki Diabetes
   Foundation and JSPS KAKENHI (grant 25460641).
CR Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Bertoni AG, 2010, DIABETES CARE, V33, P804, DOI 10.2337/dc09-1679
   Brummett BH, 2010, PSYCHOSOM MED, V72, P333, DOI 10.1097/PSY.0b013e3181d2f104
   Champaneri S, 2010, CURR DIABETES REP, V10, P396, DOI 10.1007/s11892-010-0148-9
   Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB
   Dantzer R, 2007, BRAIN BEHAV IMMUN, V21, P153, DOI 10.1016/j.bbi.2006.09.006
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   Dentino AN, 1999, J AM GERIATR SOC, V47, P6, DOI 10.1111/j.1532-5415.1999.tb01894.x
   DOSEMECI M, 1990, AM J EPIDEMIOL, V132, P746, DOI 10.1093/oxfordjournals.aje.a115716
   Doyle TA, 2013, J PSYCHOSOM RES, V75, P419, DOI 10.1016/j.jpsychores.2013.08.006
   Elovainio M, 2009, PSYCHOSOM MED, V71, P423, DOI 10.1097/PSY.0b013e31819e333a
   Gellis ZD, 2012, AM J CARDIOL, V110, P1219, DOI 10.1016/j.amjcard.2012.06.021
   Gimeno D, 2009, PSYCHOL MED, V39, P413, DOI 10.1017/S0033291708003723
   Golden SH, 2008, JAMA-J AM MED ASSOC, V299, P2751, DOI 10.1001/jama.299.23.2751
   Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341
   Hayashino Y, 2014, METABOLISM, V63, P431, DOI 10.1016/j.metabol.2013.08.018
   Hayashino Y, 2012, DIABETES RES CLIN PR, V98, P349, DOI 10.1016/j.diabres.2012.10.004
   Hayashino Y, 2012, DIABETES RES CLIN PR, V97, P405, DOI 10.1016/j.diabres.2012.04.005
   Hood KK, 2012, DIABETES CARE, V35, P2443, DOI 10.2337/dc11-2329
   HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183
   Kobrosly R, 2010, NEUROTOXICOLOGY, V31, P126, DOI 10.1016/j.neuro.2009.10.005
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Maes M, 1999, NEUROPSYCHOBIOLOGY, V39, P1, DOI 10.1159/000026552
   Mashitani T, 2013, DIABETES RES CLIN PR, V100, P189, DOI 10.1016/j.diabres.2013.03.006
   NHS National Institute for Health and Clinical Excellence (NICE), 2004, TYP 1 DIAB DIAGN MAN, V15
   Pickup JC, 2004, DIABETES CARE, V27, P813, DOI 10.2337/diacare.27.3.813
   Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327
   Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006
   Reichenberg A, 2001, ARCH GEN PSYCHIAT, V58, P445, DOI 10.1001/archpsyc.58.5.445
   Schellenberg ES, 2013, ANN INTERN MED, V159, P543, DOI 10.7326/0003-4819-159-8-201310150-00007
   Seino Y, 2010, J DIABETES INVEST, V1, P212, DOI 10.1111/j.2040-1124.2010.00074.x
   SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624
   Spitzer RL, 1986, BIOMETRICS RES DEV, P4
   Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812
   Stewart JC, 2009, BRAIN BEHAV IMMUN, V23, P936, DOI 10.1016/j.bbi.2009.04.011
   Tsujii S, 2012, DIABETIC MED, V29, P1451, DOI 10.1111/j.1464-5491.2012.03647.x
   Umpierre D, 2011, JAMA-J AM MED ASSOC, V305, P1790, DOI 10.1001/jama.2011.576
   van Dooren FEP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057058
   van Steenbergen-Weijenburg KM, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-235
   Wang X, 2013, DIABETES CARE, V36, P166, DOI 10.2337/dc12-0702
   Williams LS, 2005, STROKE, V36, P635, DOI 10.1161/01.STR.0000155688.18207.33
NR 41
TC 19
Z9 19
U1 1
U2 8
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
EI 1935-5548
J9 DIABETES CARE
JI Diabetes Care
PD SEP
PY 2014
VL 37
IS 9
BP 2459
EP 2465
DI 10.2337/dc13-2312
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AN8HX
UT WOS:000340846300018
PM 24969579
OA Bronze
DA 2019-01-08
ER

PT J
AU Stuckey, HL
   Mullan-Jensen, CB
   Reach, G
   Burns, KK
   Piana, N
   Vallis, M
   Wens, J
   Willaing, I
   Skovlund, SE
   Peyrot, M
AF Stuckey, Heather L.
   Mullan-Jensen, Christine B.
   Reach, Gerard
   Burns, Katharina Kovacs
   Piana, Natalia
   Vallis, Michael
   Wens, Johan
   Willaing, Ingrid
   Skovlund, Soren E.
   Peyrot, Mark
TI Personal Accounts of the Negative and Adaptive Psychosocial Experiences
   of People With Diabetes in the Second Diabetes Attitudes, Wishes and
   Needs (DAWN2) Study
SO DIABETES CARE
LA English
DT Article
ID RANDOMIZED-CONTROLLED-TRIAL; GLYCEMIC CONTROL; PSYCHOLOGICAL DISTRESS;
   CARE; DEPRESSION; OUTCOMES; HEALTH; MANAGEMENT; MELLITUS; INTERVENTION
AB OBJECTIVE
   To identify the psychosocial experiences of diabetes, including negative accounts of diabetes and adaptive ways of coping from the perspective of the person with diabetes.
   RESEARCH DESIGN AND METHODS
   Participants were 8,596 adults (1,368 with type 1 diabetes and 7,228 with type 2 diabetes) in the second Diabetes Attitudes, Wishes and Needs (DAWN2) study. Qualitative data were responses to open-ended survey questions about successes, challenges, and wishes for improvement in living with diabetes and about impactful experiences. Emergent coding developed with multinational collaborators identified thematic content about psychosocial aspects. The kappa measure of interrater reliability was 0.72.
   RESULTS
   Analysis identified two negative psychosocial themes: 1) anxiety/fear, worry about hypoglycemia and complications of diabetes, depression, and negative moods/hopelessness and 2) discrimination at work and public misunderstanding about diabetes. Two psychosocial themes demonstrated adaptive ways of coping with diabetes: 1) having a positive outlook and sense of resilience in the midst of having diabetes and 2) receiving psychosocial support through caring and compassionate family, friends, health care professionals, and other people with diabetes.
   CONCLUSIONS
   The personal accounts give insight into the psychosocial experiences and coping strategies of people with diabetes and can inform efforts to meet those needs and capitalize on strengths.
C1 [Stuckey, Heather L.] Penn State Univ, Dept Med, Coll Med, Hershey, PA 17033 USA.
   [Mullan-Jensen, Christine B.; Skovlund, Soren E.] Novo Nordisk AS, Publ Hlth Evidence & Insights, Global Publ Affairs, Copenhagen, Denmark.
   [Reach, Gerard] Univ Paris 13, Sorbonne Paris Cite, Dept Endocrinol Diabet & Metab Dis, Avicenne Hosp, Bobigny, France.
   [Reach, Gerard] Univ Paris 13, Sorbonne Paris Cite, Ctr Rech Nutr Humaine Ile De France, Bobigny, France.
   [Burns, Katharina Kovacs] Univ Alberta, Edmonton Clin Hlth Acad, Interdisciplinary Hlth Res Acad, Edmonton, AB, Canada.
   [Piana, Natalia] Univ Perugia, Hlth Lifestyle Inst, Ctr Univ Ric Interdipartimentale Attivita Motoria, I-06100 Perugia, Italy.
   [Vallis, Michael] Dalhousie Univ, Dept Family Med, Halifax, NS, Canada.
   [Vallis, Michael] Dalhousie Univ, Dept Psychiat, Halifax, NS, Canada.
   [Wens, Johan] Univ Antwerp, Dept Med & Hlth Sci Primary & Interdisciplinary C, B-2020 Antwerp, Belgium.
   [Willaing, Ingrid] Steno Diabet Ctr, Steno Hlth Promot Ctr, DK-2820 Gentofte, Denmark.
   [Peyrot, Mark] Loyola Univ Maryland, Dept Sociol, Baltimore, MD USA.
RP Stuckey, HL (reprint author), Penn State Univ, Dept Med, Coll Med, Hershey, PA 17033 USA.
EM hstuckey@hmc.psu.edu
OI Vallis, Michael/0000-0002-0165-5936; Wens, Johan/0000-0002-0229-9064;
   Willaing, Ingrid/0000-0002-3082-8816
FU Novo Nordisk; Novo Nordisk A/S; Eli Lilly; Sanofi; Merck Serono;
   Novartis; Bristol-Myers Squibb; Janssen; Abbott; LifeScan; Roche
   Diagnostics; Bayer Diagnostics; Dexcom; AbbVie; Pfizer; BD; Merck;
   Bayer; Bristol-Myers Squibb-Amylin; Roche-Genentech; Tethys
FX Novo Nordisk funded the DAWN2 study. H. L. S. received funding from Novo
   Nordisk for her role in developing the coding scheme and
   training/supervising the coders. C.B.M.-J.'s salary is paid by Novo
   Nordisk A/S. G.R. has received travel reimbursement from Novo Nordisk to
   attend the International DAWN2 Publication Planning Committee meetings;
   received speaking fees from Novo Nordisk, Eli Lilly, Sanofi, Merck
   Serono, Novartis, Bristol-Myers Squibb, Janssen, Abbott, LifeScan, Roche
   Diagnostics, Bayer Diagnostics, and Dexcom; and acted as an advisory
   board member for LifeScan. K. K. B. has received travel reimbursement
   from Novo Nordisk to attend the International DAWN2 Publication Planning
   Committee meetings. M. V. has research funding from AbbVie and Pfizer
   and receives speaking fees from Novo Nordisk, AbbVie, Sanofi, BD, Merck,
   and Bayer. J.W. has acted as an advisory board member for Eli Lilly,
   Bristol-Myers Squibb, AstraZeneca, and Novo Nordisk. I. W. is employed
   by Steno Diabetes Center A/S, a research hospital working in the Danish
   National Health Service and owned by Novo Nordisk A/S. S. E. S. is an
   employee of Novo Nordisk A/S. M. P. has recently received research
   grants and/or consulting fees from Bristol-Myers Squibb-Amylin, Eli
   Lilly, Novo Nordisk, Roche-Genentech, and Tethys; has received speaking
   honoraria from Novo Nordisk; has participated in advisory panels for
   Novo Nordisk and Roche; and has received financial support from Novo
   Nordisk for his participation as principal investigator for the DAWN2
   study. No other potential conflicts of interest relevant to this article
   were reported.
CR Ando M, 2005, PSYCHOL REP, V96, P129
   Assal J P, 1981, Journ Annu Diabetol Hotel Dieu, P223
   Bogner HR, 2012, ANN FAM MED, V10, P15, DOI 10.1370/afm.1344
   Brands AMA, 2007, J INT NEUROPSYCH SOC, V13, P288, DOI 10.1017/S1355617707070312
   Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI DOI 10.1191/1478088706QP0630A
   Chen SM, 2012, INT J NURS STUD, V49, P637, DOI 10.1016/j.ijnurstu.2011.11.011
   Egede LE, 2012, CURR PSYCHIAT REP, V14, P15, DOI 10.1007/s11920-011-0240-0
   Fisher EB, 2012, J AFFECT DISORDERS, V142, pS56, DOI 10.1016/S0165-0327(12)70009-5
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Fortmann AL, 2011, HEALTH PSYCHOL, V30, P251, DOI 10.1037/a0022850
   Gask L, 2011, CHRONIC ILLN, V7, P239, DOI 10.1177/1742395311403636
   Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341
   Hojat M, 2011, ACAD MED, V86, P359, DOI 10.1097/ACM.0b013e3182086fe1
   Karlsen B, 2012, J ADV NURS, V68, P391, DOI 10.1111/j.1365-2648.2011.05751.x
   Kim SS, 2004, EVAL HEALTH PROF, V27, P237, DOI 10.1177/0163278704267037
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Leventhal H, 1997, TREATMENT COMPLIANCE, P21
   Lustman PJ, 2005, J DIABETES COMPLICAT, V19, P113, DOI 10.1016/j.jdiacomp.2004.01.002
   Mirzaei M, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-251
   Mosnier-Pudar H, 2009, DIABETES METAB, V35, P220, DOI 10.1016/j.diabet.2009.02.001
   Nicolucci A, 2013, DIABETIC MED, V30, P767, DOI 10.1111/dme.12245
   Peyrot M, 2006, DIABETES CARE, V29, P1256, DOI 10.2337/dc05-2444
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   Peyrot M, 2013, DIABETES RES CLIN PR, V99, P174, DOI 10.1016/j.diabres.2012.11.016
   Polonsky William H, 2002, Curr Diab Rep, V2, P153, DOI 10.1007/s11892-002-0075-5
   Porojan M, 2009, Rom J Intern Med, V47, P409
   Robertson SM, 2012, PSYCHOSOMATICS, V53, P1, DOI 10.1016/j.psym.2011.09.008
   Rubin RR, 2006, DIABETES CARE, V29, P1249, DOI 10.2337/dc05-2494
   Saatci E, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-67
   Schunk M, 2012, DIABETIC MED, V29, P646, DOI 10.1111/j.1464-5491.2011.03465.x
   Shubrook JH, 2011, J AM OSTEOPATH ASSOC, V111, P531
   Sultan S, 2003, DIABETES METAB, V29, pS21
   Sultan S, 2011, PSYCHOL HEALTH, V26, P101, DOI 10.1080/08870441003703226
   Tuncay T, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-79
   Weinger K, 2011, ARCH INTERN MED, V171, P1990, DOI 10.1001/archinternmed.2011.502
NR 35
TC 35
Z9 35
U1 0
U2 27
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
EI 1935-5548
J9 DIABETES CARE
JI Diabetes Care
PD SEP
PY 2014
VL 37
IS 9
BP 2466
EP 2474
DI 10.2337/dc13-2536
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AN8HX
UT WOS:000340846300019
PM 24973437
OA Bronze
DA 2019-01-08
ER

PT J
AU Strandberg, RB
   Graue, M
   Wentzel-Larsen, T
   Peyrot, M
   Rokne, B
AF Strandberg, Ragnhild Bjarkoy
   Graue, Mark
   Wentzel-Larsen, Tore
   Peyrot, Mark
   Rokne, Berk
TI Relationships of diabetes-specific emotional distress, depression,
   anxiety, and overall well-being with HbA(1c) in adult persons with type
   1 diabetes
SO JOURNAL OF PSYCHOSOMATIC RESEARCH
LA English
DT Article
DE Depression; Anxiety; Diabetes-specific emotional distress; HbA(1c); Type
   1 diabetes
ID PROBLEM AREAS; HOSPITAL ANXIETY; GLYCEMIC CONTROL; SELF-CARE; CLINICAL
   DEPRESSION; NEEDS 2ND; SCALE; VALIDITY; HEALTH; ASSOCIATION
AB Objective: Emotional problems are common in adults with diabetes, and knowledge about how different indicators of emotional problems are related with glycemic control is required. The aim was to examine the relationships of diabetes-specific emotional distress, depression, anxiety, and overall well-being with glycosylated hemoglobin (HbA(1c)).
   Methods: Of the 319 adults with type 1 diabetes attending the endocrinology outpatient clinic at a university hospital in Norway, 235 (74%) completed the Diabetes Distress Scale, the Problem Areas in Diabetes Survey, the Hospital Anxiety and Depression Scale, and the World Health Organization-Five Well-Being Index. Blood samples were taken at the time of data collection to determine HbA(1c). Regression analyses examined associations of diabetes-specific emotional distress, anxiety, depression, and overall well-being with HbA(1c). The relationship between diabetes-specific emotional distress and HbA(1c) was tested for nonlinearity.
   Results: Diabetes-specific emotional distress was related to glycemic control (DDS total: unstandardized coefficient = 0.038, P < .001; PAID total: coefficient = 0.021, P = .007), but depression, anxiety, and overall well-being were not. On the DDS, only regimen-related distress was independently related to HbA(1c) (coefficient = 0.056, P < .001). A difference of 0.5 standard deviation of baseline regimen distress is associated with a difference of 0.6 in HbA(1c). No significant nonlineatity was detected in the relationship between diabetes-specific distress and HbA(1c).
   Conclusions: To stimulate adequate care strategies, health personnel should acknowledge depression and diabetes-specific emotional distress as different conditions in clinical consultations. Addressing diabetes-specific emotional distress, in particular regimen distress, in clinical consultation might improve glycemic control. 2014 The Authors. Published by Elsevier Inc.
C1 [Strandberg, Ragnhild Bjarkoy; Graue, Mark] Bergen Univ Coll, Ctr Evidence Based Practice, N-5020 Bergen, Norway.
   [Strandberg, Ragnhild Bjarkoy; Rokne, Berk] Univ Bergen, Fac Med & Dent, Dept Global Publ Hlth & Primary Care, N-5020 Bergen, Norway.
   [Graue, Mark] Haukeland Hosp, Dept Paediat, N-5021 Bergen, Norway.
   [Wentzel-Larsen, Tore] Norwegian Ctr Violence & Traumat Stress Studies, Oslo, Norway.
   [Wentzel-Larsen, Tore] Ctr Child & Adolescent Mental Hlth, Oslo, Norway.
   [Wentzel-Larsen, Tore] Haukeland Hosp, Clin Res Ctr, Oslo, Norway.
   [Peyrot, Mark] Loyola Univ, Dept Sociol, Baltimore, MD USA.
   [Rokne, Berk] Haukeland Hosp, Dept Res & Dev, Oslo, Norway.
RP Strandberg, RB (reprint author), Bergen Univ Coll, Ctr Evidence Based Practice, POB 7030, N-5020 Bergen, Norway.
EM rob@hib.no
CR A. American Diabetes, 2013, DIABETES CARE, V36, P1033, DOI DOI 10.2337/DC12-2625
   Aikens JE, 2012, DIABETES CARE, V35, P2472, DOI 10.2337/dc12-0181
   Ali MK, 2013, NEW ENGL J MED, V368, P1613, DOI 10.1056/NEJMsa1213829
   American Diabetes Association, 2014, DIABETES CARE S1, V37, pS14, DOI DOI 10.2337/DC14-S014
   ATKINSON MA, 1994, NEW ENGL J MED, V331, P1428
   Atkinson MA, 2014, LANCET, V383, P69, DOI 10.1016/S0140-6736(13)60591-7
   Bech P, 2003, INT J METH PSYCH RES, V12, P85, DOI 10.1002/mpr.145
   Beverly EA, 2012, DIABETES CARE, V35, P1466, DOI [10.2337/dc11-2422, 10.2337/dc12-0661]
   Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3
   Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933
   Cohen J., 1969, STAT POWER ANAL BEHA
   Cooper John G, 2013, Tidsskr Nor Laegeforen, V133, P2257, DOI 10.4045/tidsskr.13.0153
   Coyne JC, 2012, J PSYCHOSOM RES, V72, P173, DOI 10.1016/j.jpsychores.2011.12.003
   de Wit M, 2007, DIABETES CARE, V30, P2003, DOI 10.2337/dc07-0447
   Doyle F, 2012, J PSYCHOSOM RES, V73, P74, DOI 10.1016/j.jpsychores.2012.04.003
   Fayers P. M., 2000, QUALITY LIFE ASSESSM
   Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Gonzalez JS, 2008, DIABETOLOGIA, V51, P1822, DOI 10.1007/s00125-008-1113-x
   Gonzalez JS, 2011, DIABETES CARE, V34, P236, DOI 10.2337/dc10-1970
   Graue M, 2012, INT J NURS STUD, V49, P174, DOI 10.1016/j.ijnurstu.2011.08.007
   Harrell F, 2001, REGRESSION MODELING
   Hendrieckx C, 2014, DIABETES RES CLIN PR, V103, P430, DOI 10.1016/j.diabres.2013.12.005
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   Hessler D, 2014, DIABETES CARE, V37, P617, DOI 10.2337/dc13-0762
   Holt RIG, 2013, DIABETIC MED, V30, P789, DOI 10.1111/dme.12242
   Hudson JL, 2014, J PSYCHOSOM RES, V76, P265, DOI 10.1016/j.jpsychores.2014.02.004
   Joensen LE, 2013, DIABETIC MED, V30, P1132, DOI 10.1111/dme.12241
   Lloyd CE, 2010, DIABETIC MED, V27, P234, DOI 10.1111/j.1464-5491.2009.02896.x
   Moskowitz JT, 2008, HEALTH PSYCHOL, V27, pS73, DOI 10.1037/0278-6133.27.1.S73
   Mykletun A, 2001, BRIT J PSYCHIAT, V179, P540, DOI 10.1192/bjp.179.6.540
   Nicolucci A, 2013, DIABETIC MED, V30, P767, DOI 10.1111/dme.12245
   Peyrot M, 1999, J HEALTH SOC BEHAV, V40, P141, DOI 10.2307/2676370
   Peyrot M, 2008, DIABETES TECHNOL THE, V10, P461, DOI 10.1089/dia.2008.0031
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Pouwer F, 2006, PATIENT EDUC COUNS, V60, P235, DOI 10.1016/j.pec.2005.01.009
   Reddy J, 2013, PSYCHOSOMATICS, V54, P44, DOI 10.1016/j.psym.2012.08.004
   Robertson SM, 2012, PSYCHOSOMATICS, V53, P1, DOI 10.1016/j.psym.2011.09.008
   Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O
   Snaith R Philip, 2003, Health Qual Life Outcomes, V1, P29, DOI 10.1186/1477-7525-1-29
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Snoek FJ, 2012, DIABETES CARE, V35, P2128, DOI 10.2337/dc11-1326
   The Diabetes Control and Complications Trial Research Group, 1993, NEW ENGL J MED, V329, P977, DOI [10.1056/NEJM199309303291401, DOI 10.1056/NEJM199309303291401]
   WATSON D, 1995, J ABNORM PSYCHOL, V104, P3, DOI 10.1037/0021-843X.104.1.3
   Welch G, 2003, DIABETIC MED, V20, P69, DOI 10.1046/j.1464-5491.2003.00832.x
   Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047
   Wilkinson A, 2014, INT J NURS STUD, V51, P111, DOI 10.1016/j.ijnurstu.2013.01.006
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
NR 52
TC 54
Z9 55
U1 0
U2 30
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0022-3999
EI 1879-1360
J9 J PSYCHOSOM RES
JI J. Psychosomat. Res.
PD SEP
PY 2014
VL 77
IS 3
BP 174
EP 179
DI 10.1016/j.jpsychores.2014.06.015
PG 6
WC Psychiatry
SC Psychiatry
GA AO2DU
UT WOS:000341126500003
PM 25149027
OA Other Gold, Green Published
DA 2019-01-08
ER

PT J
AU Jokela, M
   Hakulinen, C
   Singh-Manoux, A
   Kivimaki, M
AF Jokela, M.
   Hakulinen, C.
   Singh-Manoux, A.
   Kivimaeki, M.
TI Personality change associated with chronic diseases: pooled analysis of
   four prospective cohort studies
SO PSYCHOLOGICAL MEDICINE
LA English
DT Article
DE Chronic disease; longitudinal studies; meta-analyses; morbidity;
   personality development
ID MENTAL-HEALTH; LIFE-SPAN; PSYCHOLOGICAL ADJUSTMENT; POSTTRAUMATIC
   GROWTH; HEART-DISEASE; METAANALYSIS; MORTALITY; CONSCIENTIOUSNESS;
   SATISFACTION; DEPRESSION
AB Background. Common chronic conditions, such as heart disease and cancer, are associated with increased psychological distress, functional limitations and shortened life expectancy, but whether these diseases alter aspects of personality remains unclear.
   Method. To examine whether the onset of heart disease, stroke, diabetes, cancer, hypertension, arthritis and respiratory disease is associated with subsequent changes in personality traits of the five-factor model, we pooled data from the Health and Retirement Study, the Midlife in the United States Survey, and the graduate and sibling samples of the Wisconsin Longitudinal Study for an individual-participant meta-analysis (total n=17 493; mean age at baseline 55.8 years).
   Results. After adjustment for age, we observed consistent decreases in extraversion [-0.25 T-scores per one disease; 95% confidence interval (CI) -0.40 to -0.10], emotional stability (-0.40, 95% CI -0.61 to -0.19), conscientiousness (-0.44, 95% CI -0.57 to -0.30) and openness to experience (-0.25, 95% CI -0.37 to -0.13) but not in agreeableness (-0.05, 95% CI -0.19 to 0.08) after the onset of chronic diseases. The onset of each additional chronic disease accelerated the average age-related personality change by 2.5 years in decreasing extraversion, 5.5 years in decreasing conscientiousness, and 1.6 years in decreasing openness to experience, and attenuated the increasing levels of emotional stability by 1.9 years. Co-morbid conditions were associated with larger changes than single diseases, suggesting a dose-response association between morbidity and personality change.
   Conclusions. These results support the hypothesis that chronic diseases influence personality development in adulthood.
C1 [Jokela, M.; Hakulinen, C.] Univ Helsinki, Inst Behav Sci, FIN-00014 Helsinki, Finland.
   [Jokela, M.] Univ Cambridge, Dept Psychol, Cambridge, England.
   [Singh-Manoux, A.; Kivimaeki, M.] UCL, Res Dept Epidemiol & Publ Hlth, London, England.
   [Singh-Manoux, A.] INSERM, U1018, Ctr Res Epidemiol & Populat Hlth, Villejuif, France.
RP Jokela, M (reprint author), Univ Helsinki, Inst Behav Sci, Siltavuorenpenger 1A,POB 9, FIN-00014 Helsinki, Finland.
EM markus.jokela@helsinki.fi
RI Singh-Manoux, Archana/F-6804-2013; Jokela, Markus/A-4669-2009
OI Singh-Manoux, Archana/0000-0002-1244-5037; Jokela,
   Markus/0000-0003-0117-0012; Kivimaki, Mika/0000-0002-4699-5627;
   Hakulinen, Christian/0000-0001-8629-9960
FU National Institute on Aging [AG-9775, AG-21079]; Vilas Estate Trust;
   National Science Foundation; Spencer Foundation; Graduate School of the
   University of Wisconsin-Madison; Academy of Finland [124322, 124271,
   132944]; Medical Research Council [MRC K013351]; US National Institutes
   of Health (NIH) [R01HL036310, R01AG034454]; Finnish Work Environment
   Fund; Research Foundation of the University of Helsinki; Finnish
   Cultural Foundation; National Institute on Aging, NIH [R01AG034454,
   R01AG013196]; Economic and Social Research Council [ES/J023299/1];
   Medical Research Council [MR/K013351/1]
FX The authors wish to gratefully thank the original collectors of the
   data, and the ESDS (Economic and Social Data Service;
   http://www.esds.ac.uk/) and the Inter-university Consortium for
   Political and Social Research (http://www.icpsr.umich.edu) for making
   the data available. The research uses data from the Wisconsin
   Longitudinal Study (WLS) of the University of Wisconsin-Madison. Since
   1991, the WLS has been supported principally by the National Institute
   on Aging (AG-9775 and AG-21079), with additional support from the Vilas
   Estate Trust, the National Science Foundation, the Spencer Foundation
   and the Graduate School of the University of Wisconsin-Madison. A public
   use file of data from the WLS is available from the Wisconsin
   Longitudinal Study, University of Wisconsin-Madison, 1180 Observatory
   Drive, Madison, Wisconsin 53706 (and
   http://www.ssc.wisc.edu/wlsresearch/data/). The interpretations,
   opinions and inferences based on the data are solely the responsibility
   of the authors.; This research was supported by the Academy of Finland
   (grant no. 124322, 124271 and 132944); the Medical Research Council (MRC
   K013351); the US National Institutes of Health (NIH) (R01HL036310;
   R01AG034454); and the Finnish Work Environment Fund. C. H. was
   financially supported by the Research Foundation of the University of
   Helsinki and the Finnish Cultural Foundation; A. S.-M. was supported by
   the National Institute on Aging, NIH (R01AG013196; R01AG034454). M. K.
   is an Economic and Social Research Council Professor.
CR Affleck G, 2001, J CONSULT CLIN PSYCH, V69, P587, DOI 10.1037//0022-006X.69.4.587
   Baird BM, 2010, SOC INDIC RES, V99, P183, DOI 10.1007/s11205-010-9584-9
   Barskova T, 2009, DISABIL REHABIL, V31, P1709, DOI 10.1080/09638280902738441
   Bogg T, 2004, PSYCHOL BULL, V130, P887, DOI 10.1037/0033-2909-130.6.887
   Bostock L, 2009, J CLIN PSYCHOL MED S, V16, P281, DOI 10.1007/s10880-009-9175-6
   Carver CS, 2010, ANNU REV PSYCHOL, V61, P679, DOI 10.1146/annurev.psych.093008.100352
   Cho HJ, 2013, PSYCHOL MED, V43, P1773, DOI 10.1017/S0033291712002437
   Clark AE, 2008, ECON J, V118, pF222, DOI 10.1111/j.1468-0297.2008.02150.x
   Crimmins EM, 2004, ANNU REV PUBL HEALTH, V25, P79, DOI 10.1146/annurev.publhealth.25.102802.124401
   Davydov DM, 2010, CLIN PSYCHOL REV, V30, P479, DOI 10.1016/j.cpr.2010.03.003
   de Ridder D, 2008, LANCET, V372, P246, DOI 10.1016/S0140-6736(08)61078-8
   Evers AWM, 2011, NAT REV RHEUMATOL, V7, P409, DOI 10.1038/nrrheum.2011.80
   Franzen-Dahlin A, 2006, SCAND J CARING SCI, V20, P412, DOI 10.1111/j.1471-6712.2006.00422.x
   Gao SJ, 2000, AM J GERIAT PSYCHIAT, V8, P209, DOI 10.1176/appi.ajgp.8.3.209
   Go AS, 2013, CIRCULATION, V127, P143, DOI 10.1161/CIR.0b013e318282ab8f
   Headey B, 2010, SOC INDIC RES, V97, P7, DOI 10.1007/s11205-009-9559-x
   Hulbert-Williams N, 2012, PSYCHO-ONCOLOGY, V21, P857, DOI 10.1002/pon.1980
   Jokela M, 2014, MOL PSYCHIATR, V19, P910, DOI 10.1038/mp.2013.162
   Jokela M, 2013, PSYCHOL MED, V43, P2037, DOI 10.1017/S0033291712003042
   Jokela M, 2013, OBES REV, V14, P315, DOI 10.1111/obr.12007
   Jokela M, 2014, HEALTH PSYCHOL, V33, P1618, DOI 10.1037/hea0000003
   Jokela M, 2013, AM J EPIDEMIOL, V178, P667, DOI 10.1093/aje/kwt170
   Juster FT, 1995, J HUM RESOUR, V30, pS7, DOI 10.2307/146277
   KATZ PP, 1995, ARTHRITIS RHEUM, V38, P49, DOI 10.1002/art.1780380108
   Kivimaki M, 2014, MOL PSYCHIATR, V19, P149, DOI 10.1038/mp.2013.35
   Lucas RE, 2011, J PERS SOC PSYCHOL, V101, P847, DOI 10.1037/a0024298
   Martin LR, 2007, HEALTH PSYCHOL, V26, P428, DOI 10.1037/0278-6133.26.4.428
   McCathie HCF, 2002, EUR RESPIR J, V19, P47, DOI 10.1183/09031936.02.00240702
   MENDELSOHN GA, 1995, J PERS, V63, P233, DOI 10.1111/j.1467-6494.1995.tb00809.x
   NELSON L, 1993, NEUROPSYCHOLOGY, V7, P553
   Obonsawin MC, 2007, J NEUROL NEUROSUR PS, V78, P1239, DOI 10.1136/jnnp.2004.052654
   Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100
   Penley JA, 2002, J BEHAV MED, V25, P551, DOI 10.1023/A:1020641400589
   Powdthavee N, 2009, SOC SCI MED, V69, P1834, DOI 10.1016/j.socscimed.2009.09.023
   Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0
   Raison CL, 2013, MOL PSYCHIATR, V18, P15, DOI 10.1038/mp.2012.2
   Reich M, 2008, CURR OPIN ONCOL, V20, P353, DOI 10.1097/CCO.0b013e3282fc734b
   Remer-Osborn J, 1998, TOP STROKE REHABIL, V5, P45
   Roberts BW, 2006, PSYCHOL BULL, V132, P1, DOI 10.1037/0033-2909.132.1.1
   Robins Wahlin T-B, 2010, INT J GERIATR PSYCH, V26, P1019
   Saulsman LM, 2004, CLIN PSYCHOL REV, V23, P1055, DOI 10.1016/j.cpr.2002.09.001
   Sharpe L, 2006, SOC SCI MED, V62, P1153, DOI 10.1016/j.socscimed.2005.07.010
   Sheikh AI, 2004, J CLIN PSYCHOL MED S, V11, P265, DOI 10.1023/B:JOCS.0000045346.76242.73
   Stanton AL, 2007, ANNU REV PSYCHOL, V58, P565, DOI 10.1146/annurev.psych.58.110405.085615
   Stone J, 2004, J NEUROL NEUROSUR PS, V75, P1708, DOI 10.1136/jnnp.2004.037887
   Strong K, 2005, LANCET, V366, P1578, DOI 10.1016/S0140-6736(05)67341-2
   Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X
   WOLLMERING E, 2007, WISCONSIN LONGITUDIN
   Wortman J, 2012, PSYCHOL AGING, V27, P867, DOI 10.1037/a0029322
   Wu S, 2001, J HEALTH ECON, V20, P495, DOI 10.1016/S0167-6296(01)00084-4
NR 50
TC 48
Z9 48
U1 0
U2 50
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0033-2917
EI 1469-8978
J9 PSYCHOL MED
JI Psychol. Med.
PD SEP
PY 2014
VL 44
IS 12
BP 2629
EP 2640
DI 10.1017/S0033291714000257
PG 12
WC Psychology, Clinical; Psychiatry; Psychology
SC Psychology; Psychiatry
GA AN2GV
UT WOS:000340403400016
PM 25055176
DA 2019-01-08
ER

PT J
AU Bani-Issa, W
   Almomani, F
   Eldeirawi, K
AF Bani-Issa, Wegdan
   Almomani, Fidaa
   Eldeirawi, Kamal
TI Urinary incontinence among adult women with diabetes in Jordan:
   epidemiology, correlates and perceived impact on emotional and social
   well-being
SO JOURNAL OF CLINICAL NURSING
LA English
DT Article
DE correlates; diabetes; impact on emotional and social well-being; stress
   incontinence; urge incontinence; women's health
ID QUALITY-OF-LIFE; RISK-FACTORS; PREVALENCE; HEALTH
AB Aims and objectives. To assess the epidemiology and correlates of urinary incontinence and its perceived impact on the emotional and social well-being of Jordanian women.
   Background. Diabetes is a chronic disease with rising prevalence in women worldwide. Although urinary incontinence is a complication of diabetes, it is not commonly assessed with limited nurses' knowledge available on its prevalence, correlates and its perceived impact on lives of women.
   Design. A cross-sectional survey design using probability sampling approach was used to collect information on incontinence.
   Methods. A total of 1011 adult women, 20-65 years old, attending primary healthcare centres in Jordan were interviewed using a standardised incontinence questionnaire. Questionnaire included items to assess the perceived impact of incontinence on social and emotional well-being of women. The study outcome included weekly or more any, stress and urge incontinence.
   Results. Of 435 (43%) diabetic and 576 (57%) nondiabetic women, a total of 676 (66.8%) women reported incontinence. The prevalence of weekly or more any, urge and stress incontinence was significantly higher in diabetic than in nondiabetic women, 31.5, 13.8 and 20% versus 18.2, 5.9 and 14.2%, respectively. After adjusting for age, body mass index, parity and history of urinary tract infections, in multiple logistic regression analyses, diabetes was significantly associated with any (OR: 1.99; 95% CI: 1.44-2.74) urge (OR: 2.23; 95% CI: 1.38-3.61) and stress incontinence (OR: 1.54; CI: 1.07-2.22). Obesity and age were found to be significant correlates for urge incontinence in diabetics. Women with incontinence perceived incontinence as bothersome condition with negative impact on social well-being.
   Conclusions. Incontinence is a common and distressing problem in diabetic women, especially for those who are older and obese. Prospective cohort studies are needed to assess how nurse-led interventions may impact the negative consequences of incontinence on women well-being.
   Relevance to clinical practice. Nurses are in the right position to assess urinary incontinence in diabetic women. Proper communications, culturally sensitive screening and tailored interventions may assist nurses in providing care and support to alleviate the impact of incontinence on women well-being.
C1 [Bani-Issa, Wegdan] Univ Sharjah, Dept Nursing, Coll Hlth Sci, Sharjah, U Arab Emirates.
   [Almomani, Fidaa] Jordan Univ Sci & Technol, Fac Appl Med Sci, Dept Allied Hlth & Occupat Therapy, Irbid, Jordan.
   [Eldeirawi, Kamal] Univ Illinois, Coll Nursing, Dept Hlth Syst Sci, Chicago, IL USA.
RP Bani-Issa, W (reprint author), Univ Sharjah, Dept Nursing, Coll Hlth Sci, POB 27272, Sharjah, U Arab Emirates.
EM wbaniissa@sharjah.ac.ae
OI Baniissa, Wegdan/0000-0001-8551-9052
FU Jordan University of Science and Technology Jordan [20120064]
FX This research received a grant from Jordan University of Science and
   Technology Jordan: Grant number 20120064. The grant covered expenses
   associated with data collection process and data analysis and
   interpretation.
CR Abrams P, 2003, UROLOGY, V61, P37, DOI 10.1016/S0090-4295(02)02243-4
   Albers-Heitner CP, 2011, SCAND J CARING SCI, V25, P303, DOI 10.1111/j.1471-6712.2010.00827.x
   Alnsour M, 2012, PREVENTING CHRONIC D, V9, P1
   Altaweel W, 2012, NEUROUROL URODYNAM, V31, P642, DOI 10.1002/nau.22201
   American Diabetes Association, 2012, STAND MED CAR DIAB
   Andersson G, 2010, J TRANSCULT NURS, V20, P296
   Brown J, 2006, DIABETES SELF MANAGE
   Brown JS, 2009, J UROLOGY, V181, P13, DOI 10.1016/j.juro.2008.10.078
   Brown JS, 2006, DIABETES CARE, V29, P1307, DOI 10.2337/dc05-2463
   Brown JS, 2006, DIABETES CARE, V29, P385, DOI 10.2337/diacare.29.02.06.dc05-1781
   Brown JS, 2005, DIABETES CARE, V28, P177, DOI 10.2337/diacare.28.1.177
   Danforth N, 2009, J UROLOGY, V181, P193
   Department of Statistics [Jordan] and ICF Macro, 2010, JORD POP FAM HLTH SU
   Ebbesen H, 2007, ACTA OBESTETRIC GYNO, V86, P1256
   Gil KM, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-8
   Hanzaree Zahirah, 2010, Nurs Stand, V25, P41
   Howard Faith, 2010, Br J Nurs, V19, P748
   International Diabetes Federation (IDF), 2012, DIAB GLOB BURD
   Izci Y, 2009, INT UROGYNECOL J, V20, P947, DOI 10.1007/s00192-009-0888-8
   Jackson SL, 2005, DIABETES CARE, V28, P1730, DOI 10.2337/diacare.28.7.1730
   Lewis M, 2005, AM J OBSTET GYNECOL, V193, P2154
   Lifford KL, 2005, J AM GERIATR SOC, V53, P1851, DOI 10.1111/j.1532-5415.2005.53565.x
   McCleary-Sills J, 2012, WOMENS DEMAND REPROD
   National Health and Nutrition Examination Survey (NHANES), 2008, DOC COD FREQ KIDN CO
   National Heart Lung and Blood Institute, 2012, CALC YOUR BODY MASS
   National Institute of Health (NIH), 2012, UR INC NEUR DIS NICE
   National Kidney and Urologic Diseases Information Clearinghouse, 2010, UR INC WOM
   Nazarko L, 2010, BRIT J HEALTHCARE AS, V4, P353
   Nazarko Linda, 2013, Br J Community Nurs, V18, P62
   Nojomi M, 2008, J RES MED SCI, V13, P22
   Phalen S, 2009, J UROLOGY S, V182, pS14
   Phalen S, 2009, DIABETES CARE, V32, P1391
   Polit DF, 2010, ESSENTIALS NURSING R
   Rizk D E, 1999, Int Urogynecol J Pelvic Floor Dysfunct, V10, P160, DOI 10.1007/s001920050038
   Rohr G, 2005, SCAND J PRIM HEALTH, V23, P203, DOI 10.1080/02813430500362803
   Shakhatreh FMN, 2005, SAUDI MED J, V26, P830
   Thuroff JW, 2011, EUR UROL, V59, P387, DOI 10.1016/j.eururo.2010.11.021
   World Health Organization, 2011, NONC DIS COUNTRY PRO
   Yuan HB, 2010, HEALTH SOC CARE COMM, V18, P82, DOI 10.1111/j.1365-2524.2009.00876.x
NR 39
TC 5
Z9 5
U1 1
U2 3
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0962-1067
EI 1365-2702
J9 J CLIN NURS
JI J. Clin. Nurs.
PD SEP
PY 2014
VL 23
IS 17-18
BP 2451
EP 2460
DI 10.1111/jocn.12392
PG 10
WC Nursing
SC Nursing
GA AL9AI
UT WOS:000339431300009
PM 24112089
DA 2019-01-08
ER

PT J
AU Mackey, ER
   Struemph, K
   Powell, PW
   Chen, R
   Streisand, R
   Holmes, CS
AF Mackey, Eleanor R.
   Struemph, Kari
   Powell, Priscilla W.
   Chen, Rusan
   Streisand, Randi
   Holmes, Clarissa S.
TI Maternal Depressive Symptoms and Disease Care Status in Youth With Type
   1 Diabetes
SO HEALTH PSYCHOLOGY
LA English
DT Article
DE diabetes; maternal depression; adolescents; disease care; adherence
ID METABOLIC-CONTROL; GLYCEMIC CONTROL; FAMILY CONFLICT; PSYCHOLOGICAL
   DISTRESS; REGIMEN ADHERENCE; RISK-FACTORS; FIT INDEXES; ADOLESCENTS;
   MANAGEMENT; CHILDREN
AB Objective: The current study assessed relations among maternal depressive symptoms, poorer youth diabetes adherence, and glycemic control. Specifically, hypothesized mediating links of lowered expectations of parental involvement, less parental monitoring, and more conflict were examined. Method: Participants included 225 mothers and their young adolescents, aged 11-14 years (M = 12.73 years, SD = 1.2) diagnosed with T1D. Maternal depressive symptoms and outcome expectancies for maternal involvement were evaluated with self-report questionnaires. Multisource, parent/youth, and multimethod assessment of adherence, parental monitoring, and conflict were evaluated during a baseline assessment from a larger randomized clinical trial. Results: The first hypothesized structural equation model demonstrated a good fit and indicated that more maternal depressive symptoms were directly associated with less parental monitoring and more conflict, which in turn each were associated with poorer adherence and glycemic control. Although higher involvement expectancies were associated with more monitoring and less conflict, they were not associated with other model variables. A second alternative model also fit the data well; poorer youth adherence was associated with more conflict that in turn related to maternal depressive symptoms. Conclusions: Two models were tested by which maternal depressive symptoms and poorer youth adherence were interrelated via less monitoring and more conflict. Follow-up longitudinal evaluation can best characterize the full extent of these relations.
C1 [Mackey, Eleanor R.; Streisand, Randi] Childrens Natl Hlth Syst, Washington, DC USA.
   [Struemph, Kari; Powell, Priscilla W.; Holmes, Clarissa S.] VA Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA.
   [Chen, Rusan] Georgetown Univ, Ctr New Designs Learning & Scholarship, Washington, DC 20057 USA.
   [Holmes, Clarissa S.] Georgetown Univ, Washington, DC 20057 USA.
RP Holmes, CS (reprint author), VA Commonwealth Univ, 806 West Franklin St,POB 842018, Richmond, VA 23284 USA.
EM cholmes@richmond.edu
OI Mackey, Eleanor/0000-0001-8490-6798
FU NIH/NIDDK [5R01DK070917-04]
FX This work was supported by NIH/NIDDK 5R01DK070917-04 awarded to CH. The
   authors gratefully acknowledge the assistance of Elizabeth Robinson with
   manuscript preparations.
CR Anderson BJ, 2009, FAM SYST HEALTH, V27, P141, DOI 10.1037/a0015759
   Anderson BJ, 2002, DIABETIC MED, V19, P635, DOI 10.1046/j.1464-5491.2002.00752.x
   Bandura A., 1997, SELF EFFICACY EXERCI
   Beck AT, 1996, MANUAL BECK DEPRESSI
   Center for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET
   Collins LM, 2001, PSYCHOL METHODS, V6, P330, DOI 10.1037//1082-989X.6.4.330
   Cunningham NR, 2011, J PEDIATR PSYCHOL, V36, P196, DOI 10.1093/jpepsy/jsq071
   Driscoll KA, 2010, J PEDIATR PSYCHOL, V35, P814, DOI 10.1093/jpepsy/jsp138
   Dubowitz H, 2007, PEDIATRICS, V119, P435, DOI 10.1542/peds.2006-2010
   Eckshtain D, 2010, J PEDIATR PSYCHOL, V35, P426, DOI 10.1093/jpepsy/jsp068
   Ellis DH, 2008, FORTUNE, V157, P42
   Ellis DA, 2007, J PEDIATR PSYCHOL, V32, P907, DOI 10.1093/jpepsy/jsm009
   Ertel KA, 2011, J WOMENS HEALTH, V20, P1609, DOI 10.1089/jwh.2010.2657
   Helgeson VS, 2009, J PEDIATR PSYCHOL, V34, P254, DOI 10.1093/jpepsy/jsn079
   Hilliard ME, 2013, HEALTH PSYCHOL, V32, P388, DOI 10.1037/a0027811
   Hollingshead A. A., 1975, 4 FACTOR INDEX UNPUB
   Holmes CS, 2006, J PEDIATR PSYCHOL, V31, P770, DOI 10.1093/jpepsy/jsj083
   Hood KK, 2007, DIABETES CARE, V30, P1764, DOI 10.2337/dc06-2358
   Horsch A, 2007, J TRAUMA STRESS, V20, P881, DOI 10.1002/jts.20247
   Horwitz SM, 2007, J WOMENS HEALTH, V16, P678, DOI 10.1089/jwh.2006.0185
   Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118
   Hu LT, 1998, PSYCHOL METHODS, V3, P424, DOI 10.1037//1082-989X.3.4.424
   Iannotti RJ, 2006, J DEV BEHAV PEDIATR, V27, P98, DOI 10.1097/00004703-200604000-00003
   Iannotti RJ, 2006, DIABETES CARE, V29, P2263, DOI 10.2337/dc06-0685
   Jaser SS, 2010, J PEDIATR PSYCHOL, V35, P738, DOI 10.1093/jpepsy/jsp098
   JOHNSON SB, 1986, HEALTH PSYCHOL, V5, P545, DOI 10.1037/0278-6133.5.6.545
   Kline R. B., 2011, PRINCIPLES PRACTICE
   MacCallum RC, 2000, ANNU REV PSYCHOL, V51, P201, DOI 10.1146/annurev.psych.51.1.201
   Moos R. H., 2002, FAMILY ENV SCALE MAN
   Muthen B, 1998, MPLUS USERS GUIDE
   Quittner AL, 2008, J PEDIATR PSYCHOL, V33, P916, DOI 10.1093/jpepsy/jsm064
   Schilling Lynne S, 2006, J Pediatr Nurs, V21, P412, DOI 10.1016/j.pedn.2006.01.034
   Swift EE, 2006, ANN BEHAV MED, V32, P39, DOI 10.1207/s15324796abm3201_5
   Wiebe DJ, 2011, J PEDIATR PSYCHOL, V36, P837, DOI 10.1093/jpepsy/jsr002
   Williams LB, 2009, DIABETIC MED, V26, P908, DOI 10.1111/j.1464-5491.2009.02794.x
   Wissow LS, 2008, PEDIATRICS, V121, P266, DOI 10.1542/peds.2007-0418
   WYSOCKI T, 1992, DIABETES CARE, V15, P43, DOI 10.2337/diacare.15.1.43
   Wysocki T, 2006, J PEDIATR PSYCHOL, V31, P928, DOI 10.1093/jpepsy/jsj098
NR 38
TC 9
Z9 9
U1 0
U2 20
PU AMER PSYCHOLOGICAL ASSOC
PI WASHINGTON
PA 750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA
SN 0278-6133
EI 1930-7810
J9 HEALTH PSYCHOL
JI Health Psychol.
PD AUG
PY 2014
VL 33
IS 8
BP 783
EP 791
DI 10.1037/hea0000066
PG 9
WC Psychology, Clinical; Psychology
SC Psychology
GA AS3HA
UT WOS:000344167100004
PM 24799001
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Johnson, MD
   Anderson, JR
   Walker, A
   Wilcox, A
   Lewis, VL
   Robbins, DC
AF Johnson, Matthew D.
   Anderson, Jared R.
   Walker, Ann
   Wilcox, Allison
   Lewis, Virginia L.
   Robbins, David C.
TI Spousal Protective Buffering and Type 2 Diabetes Outcomes
SO HEALTH PSYCHOLOGY
LA English
DT Article
DE couple coping; dietary adherence; exercise; illness appraisal; type 2
   diabetes
ID CHRONIC ILLNESS; SELF-CARE; SUPPORT; QUESTIONNAIRE; SATISFACTION;
   BEHAVIORS; DISTRESS
AB Objective: Guided by the developmental-contextual model of couples coping with chronic illness (Berg & Upchurch, 2007), the purpose of this study is to explore moderated associations between spousal protective buffering and illness outcomes for partners diagnosed with type 2 diabetes (dietary adherence, frequency of exercise, and HbA(1c) level). Patient diabetes appraisals (distress, control, self-efficacy, and consequences) were explored as potential moderators. Methods: Participants were 117 married couples in which one member had been diagnosed with type 2 diabetes. Data were gathered from spouses and patients through a survey instrument and analyzed with path analysis. Results: Protective buffering was associated with fewer days of exercise when patients reported low diabetes distress and diabetes consequences. Additionally, protective buffering was associated with higher HbA1c when patients reported high diabetes control. Conclusions: Protective buffering did not exhibit a uniform association with the type 2 diabetes outcomes. Rather, the association between spousal protective buffering and patient illness adjustment was dependent on patient appraisal of the illness. These findings contribute a nuanced addition to the literature documenting the role of couple coping in chronic illness management and also provide impetus for further, longitudinal investigation of the ways healthy spouses cope with partner illness.
C1 [Johnson, Matthew D.] Univ Alberta, Dept Human Ecol, Edmonton, AB T6G 2N1, Canada.
   [Anderson, Jared R.] Kansas State Univ, Sch Family Studies & Human Serv, Manhattan, KS 66506 USA.
   [Walker, Ann; Wilcox, Allison; Lewis, Virginia L.; Robbins, David C.] Univ Kansas Med Ctr, KU Diabet Inst, Kansas City, KS USA.
RP Johnson, MD (reprint author), Univ Alberta, 302 Human Ecol Bldg, Edmonton, AB T6G 2N1, Canada.
EM matt.johnson@ualberta.ca
CR Berg CA, 2007, PSYCHOL BULL, V133, P920, DOI 10.1037/0033-2909.133.6.920
   Buunk A. P., 1996, GEDRAG GEZONDHEID, V24, P304
   Coyne JC, 1994, J FAMILY PSYCHOL, V8, P43, DOI DOI 10.1037/0893-3200.8.1.43
   De Ridder DTD, 2005, PSYCHOL HEALTH, V20, P497, DOI 10.1080/14768320500098699
   Franks MM, 2012, AGING MENT HEALTH, V16, P902, DOI 10.1080/13607863.2012.674486
   Hagedoorn M, 2000, HEALTH PSYCHOL, V19, P274, DOI 10.1037//0278-6133.19.3.274
   King DK, 2010, DIABETES CARE, V33, P751, DOI 10.2337/dc09-1746
   Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494
   Muthen L. K., 1998, MPLUS USERS GUIDE
   Nouwen A, 2011, HEALTH PSYCHOL, V30, P771, DOI 10.1037/a0024500
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Preacher KJ, 2006, J EDUC BEHAV STAT, V31, P437, DOI 10.3102/10769986031004437
   Rosland AM, 2012, J BEHAV MED, V35, P221, DOI 10.1007/s10865-011-9354-4
   Schokker MC, 2010, J FAM PSYCHOL, V24, P578, DOI 10.1037/a0021009
   Talbot F, 1997, J BEHAV MED, V20, P291, DOI 10.1023/A:1025508928696
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
NR 16
TC 7
Z9 7
U1 0
U2 11
PU AMER PSYCHOLOGICAL ASSOC
PI WASHINGTON
PA 750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA
SN 0278-6133
EI 1930-7810
J9 HEALTH PSYCHOL
JI Health Psychol.
PD AUG
PY 2014
VL 33
IS 8
BP 841
EP 844
DI 10.1037/hea0000054
PG 4
WC Psychology, Clinical; Psychology
SC Psychology
GA AS3HA
UT WOS:000344167100010
PM 24447192
DA 2019-01-08
ER

PT J
AU Staniute, M
   Bunevicius, A
   Brozaitiene, J
   Bunevicius, R
AF Staniute, Margarita
   Bunevicius, Adomas
   Brozaitiene, Julija
   Bunevicius, Robertas
TI Relationship of health-related quality of life with fatigue and exercise
   capacity in patients with coronary artery disease
SO EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING
LA English
DT Article
DE Health-related quality of life; fatigue; exercise capacity; coronary
   artery disease
ID CHRONIC HEART-FAILURE; MYOCARDIAL-INFARCTION; ANXIETY DISORDERS;
   DEPRESSION; ASSOCIATION; PERSONALITY; ANGINA; OUTPATIENTS; PREDICTOR;
   SYMPTOMS
AB Objective: The study objective was to evaluate the relationship of health-related quality of life (HRQoL) with fatigue and exercise capacity in coronary artery disease (CAD) patients.
   Methods: A total of 1072 consecutive CAD patients on admission to a cardiac rehabilitation program were evaluated for HRQoL (36-item Short Form Medical Outcome Questionnaire; SF-36), body mass index, clinical characteristics (New York Heart Association (NYHA) class, angina pectoris class, coronary interventions, treatment with beta blockers, hypertension and diabetes), symptoms of depression and anxiety (Hospital Anxiety and Depression Scale), fatigue (Multidimensional Fatigue Inventory-20; MFI-20), and exercise capacity (bicycle ergometer test).
   Results: In univariate regression analyses lower scores on all SF-36 domains were associated with greater scores on all MFI-20 subscales. Exercise capacity was associated with all SF-36 domains, except for social functioning and mental health domains. In multivariate regression analyses, after adjusting for age, gender, body mass index, NYHA class, angina pectoris class, hypertension, diabetes, coronary interventions, treatment with betablockers, and symptoms of depression and anxiety, greater limitation due to physical and due to emotional problems, poor social functioning, decreased energy/vitality, worse general health perception, reduced mental component summary and lower global SF-36 score were independently associated with higher MFI-20 general fatigue score. Reduced physical functioning, greater pain, and reduced physical component summary SF-36 scores were associated with greater MFI-20 physical fatigue score. Lower SF-36 mental health score was associated, with greater MFI-20 mental fatigue score.
   Conclusion: In CAD patients undergoing rehabilitation, poor HRQoL is associated with greater fatigue and decreased exercise capacity independently from mental distress and CAD severity score.
C1 [Staniute, Margarita; Bunevicius, Adomas; Brozaitiene, Julija; Bunevicius, Robertas] Lithuanian Univ Hlth Sci, Behav Med Inst, LT-00135 Palanga, Lithuania.
RP Staniute, M (reprint author), Lithuanian Univ Hlth Sci, Behav Med Inst, Vyduno 4, LT-00135 Palanga, Lithuania.
EM mstaniute@ktl.mii.lt
OI Bunevicius, Adomas/0000-0003-0446-6898
FU Research Council of Lithuania [LIG-04/2011]
FX This research was funded by a grant (No. LIG-04/2011) from the Research
   Council of Lithuania.
CR Alsen P, 2010, J CARDIOVASC NURS, V25, pE1, DOI 10.1097/JCN.0b013e3181c6dcfd
   Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0
   Bunevicius A, 2007, DEPRESS ANXIETY, V24, P455, DOI 10.1002/da.20274
   Bunevicius A, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-37
   Bunevicius A, 2012, PSYCHOSOM MED, V74, P848, DOI 10.1097/PSY.0b013e318268e7f0
   Bunevicius A, 2012, J PSYCHOSOM RES, V72, P22, DOI 10.1016/j.jpsychores.2011.10.006
   Bunevicius A, 2011, GEN HOSP PSYCHIAT, V33, P527, DOI 10.1016/j.genhosppsych.2011.06.009
   Bunevicius A, 2011, AM HEART J, V162, P310, DOI 10.1016/j.ahj.2011.05.003
   Bunevicius R, 2013, INT J CARDIOL, V164, P246, DOI 10.1016/j.ijcard.2012.06.076
   Buneviciute J, 2013, J HEALTH PSYCHOL, V18, P1493, DOI 10.1177/1359105312465909
   CAMPEAU L, 1976, CIRCULATION, V54, P522, DOI 10.1161/circ.54.3.947585
   Chen LH, 2010, J CLIN NURS, V19, P1588, DOI 10.1111/j.1365-2702.2010.03218.x
   Deaton C, 2011, EUR J CARDIOVASC NUR, V10, P75, DOI 10.1016/j.ejcnurse.2010.08.007
   Evangelista Lorraine S, 2008, Prog Cardiovasc Nurs, V23, P12, DOI 10.1111/j.1751-7117.2008.07275.x
   Fini A, 2009, REV LAT-AM ENFERM, V17, P557, DOI 10.1590/S0104-11692009000400019
   Fletcher GF, 2001, CIRCULATION, V104, P1694, DOI 10.1161/hc3901.095960
   Flynn KE, 2012, AM HEART J, V163, P88, DOI 10.1016/j.ahj.2011.09.027
   Johnson NP, 2008, AM J CARDIOL, V102, P1028, DOI 10.1016/j.amjcard.2008.06.017
   Juenger J, 2002, HEART, V87, P235, DOI 10.1136/heart.87.3.235
   Kent LK, 2009, HARVARD REV PSYCHIAT, V17, P377, DOI 10.3109/10673220903463333
   Kimble LP, 2011, J ADV NURS, V67, P1000, DOI 10.1111/j.1365-2648.2010.05564.x
   Lavoie KL, 2004, AM HEART J, V148, P621, DOI 10.1016/j.ahj.2004.04.009
   MARK DB, 1991, NEW ENGL J MED, V325, P849, DOI 10.1056/NEJM199109193251204
   Middel B, 2011, J EVAL CLIN PRACT, V17, P452, DOI 10.1111/j.1365-2753.2010.01449.x
   Myers J, 2006, J CARD FAIL, V12, P439, DOI 10.1016/j.cardfail.2006.04.004
   Peric VM, 2006, ANN THORAC SURG, V81, P2115, DOI 10.1016/j.athoracsur.2006.01.033
   Saeed T., 2011, Eastern Mediterranean Health Journal, V17, P46
   Sarkar U, 2007, PSYCHOSOM MED, V69, P306, DOI 10.1097/PSY.0b013e3180514d57
   Silverman MN, 2010, PM&R, V2, P338, DOI 10.1016/j.pmrj.2010.04.008
   SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O
   Smith ORF, 2008, EUR J CARDIOV PREV R, V15, P583, DOI 10.1097/HJR.0b013e3283083e17
   Smith ORF, 2010, EUR J HEART FAIL, V12, P841, DOI 10.1093/eurjhf/hfq075
   Smith ORF, 2009, J PSYCHOSOM RES, V66, P195, DOI 10.1016/j.jpsychores.2008.10.021
   Stafford L, 2007, J PSYCHOSOM RES, V62, P401, DOI 10.1016/j.jpsychores.2006.12.009
   Staniute M, 2013, J CARDIOVASC NURS, V28, P83, DOI 10.1097/JCN.0b013e318233e69d
   The Criteria Committee of the New York Heart Association, 1994, NOM CRIT DIAGN DIS H, P253
   Thombs BD, 2006, J GEN INTERN MED, V21, P30, DOI 10.1111/j.1525-1497.2005.00269x
   WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
NR 39
TC 13
Z9 13
U1 2
U2 26
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1474-5151
EI 1873-1953
J9 EUR J CARDIOVASC NUR
JI Eur. J. Cardiovasc. Nurs.
PD AUG
PY 2014
VL 13
IS 4
BP 338
EP 344
DI 10.1177/1474515113496942
PG 7
WC Cardiac & Cardiovascular Systems; Nursing
SC Cardiovascular System & Cardiology; Nursing
GA AQ1YB
UT WOS:000342579700007
PM 23818215
DA 2019-01-08
ER

PT J
AU Martyn-Nemeth, P
   Quinn, L
   Hacker, E
   Park, H
   Kujath, AS
AF Martyn-Nemeth, Pamela
   Quinn, Laurie
   Hacker, Eileen
   Park, Hanjong
   Kujath, Amber S.
TI Diabetes distress may adversely affect the eating styles of women with
   type 1 diabetes
SO ACTA DIABETOLOGICA
LA English
DT Article
DE Diabetes mellitus type 1; Diabetes distress; Eating style; Fear of
   hypoglycemia
ID BEHAVIOR; QUESTIONNAIRE; HYPOGLYCEMIA; SCALE
AB The aim of this study was to determine the relationships among diabetes distress, fear of hypoglycemia, and eating styles in women with type 1 diabetes (T1DM). Fifteen women (mean age 37 +/- A 13.5 years) with T1DM completed surveys measuring diabetes distress, fear of hypoglycemia (FOH), and eating style. Height, weight, and A1C were obtained, and open-ended comments regarding hypoglycemic concerns and experiences were recorded. Diabetes distress was positively associated with A1C (r = .655, p = .008). High levels of external (73 %), emotional (47 %), and restrained (53 %) eating styles were reported. Emotional and external eating styles were positively associated with diabetes distress (r = .575 and r = .622; p < .05). Those with poorer glycemic control (A1C > 7 %; 53 mmol/mol) had higher levels of restrained eating behavior (F = 10.69, p = .006) and greater interpersonal distress (F = 5.916, p = .03) than those with better glycemic control (A1C < 7 %; 53 mmol/mol). A nonlinear relationship was identified between interpersonal distress and FOH (behavior subscale, p = .0383) indicating that fewer behavioral approaches were employed to avoid hypoglycemia at higher distress levels. The women in this sample were emotionally burdened by their disease. Distress was associated with eating styles linked with overeating and poor glycemic control. High levels of emotional and external eating styles may have important clinical implications for those with T1DM.
C1 [Martyn-Nemeth, Pamela; Quinn, Laurie; Hacker, Eileen; Park, Hanjong] Univ Illinois, Coll Nursing, Dept Biobehav Hlth Sci, Chicago, IL 60607 USA.
   [Kujath, Amber S.] Rush Univ, Coll Nursing, Dept Adult Hlth & Gerontol Nursing, Chicago, IL 60612 USA.
RP Martyn-Nemeth, P (reprint author), Univ Illinois, Coll Nursing, Dept Biobehav Hlth Sci, Chicago, IL 60607 USA.
EM pmartyn@uic.edu
OI Park, HanJong/0000-0003-0896-654X
FU UIC Center for Reducing Risks in Vulnerable Populations [NIH P30 NR
   09-014-04]; UIC College of Nursing Internal Research Support Program
   (IRSP)
FX This study was supported in part by the UIC Center for Reducing Risks in
   Vulnerable Populations Grant NIH P30 NR 09-014-04 and by the UIC College
   of Nursing Internal Research Support Program (IRSP). The authors wish to
   acknowledge Dr. Chang Park for statistical consultation. The authors
   thank Kevin Grandfield, Publication Manager for the UIC Department of
   Biobehavioral Health Science for editorial assistance.
CR Adam TC, 2007, PHYSIOL BEHAV, V91, P449, DOI 10.1016/j.physbeh.2007.04.011
   Anderbro T, 2010, DIABETIC MED, V27, P1151, DOI 10.1111/j.1464-5491.2010.03078.x
   Cryer PE, 2002, DIABETOLOGIA, V45, P937, DOI 10.1007/s00125-002-0822-9
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Gonder-Frederick LA, 2011, DIABETES CARE, V34, P801, DOI 10.2337/dc10-1343
   Lloyd CE, 2010, DIABETIC MED, V27, P234, DOI 10.1111/j.1464-5491.2009.02896.x
   Ouwens MA, 2003, APPETITE, V40, P291, DOI 10.1016/S0195-6663(03)00006-0
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Solli O, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-18
   van de Laar FA, 2006, DIABETIC MED, V23, P788, DOI 10.1111/j.1464-5491.2006.01885.x
   VANSTRIEN T, 1986, INT J EAT DISORDER, V5, P295, DOI 10.1002/1098-108X(198602)5:2<295::AID-EAT2260050209>3.0.CO;2-T
   WARDLE J, 1987, J PSYCHOSOM RES, V31, P161, DOI 10.1016/0022-3999(87)90072-9
NR 13
TC 14
Z9 14
U1 0
U2 11
PU SPRINGER-VERLAG ITALIA SRL
PI MILAN
PA VIA DECEMBRIO, 28, MILAN, 20137, ITALY
SN 0940-5429
EI 1432-5233
J9 ACTA DIABETOL
JI Acta Diabetol.
PD AUG
PY 2014
VL 51
IS 4
BP 683
EP 686
DI 10.1007/s00592-014-0575-1
PG 4
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AN3RW
UT WOS:000340507200023
PM 24615054
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Virtanen, M
   Ferrie, JE
   Tabak, AG
   Akbaraly, TN
   Vahtera, J
   Singh-Manoux, A
   Kivimaki, M
AF Virtanen, Marianna
   Ferrie, Jane E.
   Tabak, Adam G.
   Akbaraly, Tasnime N.
   Vahtera, Jussi
   Singh-Manoux, Archana
   Kivimaeki, Mika
TI Psychological Distress and Incidence of Type 2 Diabetes in High-Risk and
   Low-Risk Populations: The Whitehall II Cohort Study
SO DIABETES CARE
LA English
DT Article
ID WORK-RELATED STRESS; PSYCHOSOCIAL FACTORS; MELLITUS; DEPRESSION;
   METAANALYSIS; ASSOCIATION; DIAGNOSIS; OBESITY; WOMEN; MEN
AB OBJECTIVE
   We examined whether psychological distress predicts incident type 2 diabetes and if the association differs between populations at higher or lower risk of type 2 diabetes.
   RESEARCH DESIGN AND METHODS
   This was a prospective cohort of 5,932 diabetes-free adults (4,189 men and 1,743 women, mean age 54.6 years) with three 5-year data cycles (1991-2009): a total of 13,207 person-observations. Participants were classified into four groups according to their prediabetes status and Framingham Offspring Type 2 Diabetes Risk Score: normoglycemia with a risk score of 0-9, normoglycemia with a risk score of 10-19, prediabetes with a risk score of 10-19, and prediabetes with a risk score of >19. Psychological distress was assessed by the General Health Questionnaire. Incident type 2 diabetes was ascertained by 2-h oral glucose tolerance test, doctor diagnosis, or use of antihyperglycemic medication at the 5-year follow-up for each data cycle. Adjustments were made for age, sex, ethnicity, socioeconomic status, antidepressant use, smoking, and physical activity.
   RESULTS
   Among participants with normoglycemia and among those with prediabetes combined with a low risk score, psychological distress did not predict type 2 diabetes. Diabetes incidence in these groups varied between 1.6 and 15.6%. Among participants with prediabetes and a high risk score, 40.9% of those with psychological distress compared with 28.5% of those without distress developed diabetes during the follow-up. The corresponding adjusted odds ratio for psychological distress was 2.07 (95% CI 1.19-3.62).
   CONCLUSIONS
   These data suggest that psychological distress is associated with an accelerated progression to manifest diabetes in a subpopulation with advanced prediabetes.
C1 [Virtanen, Marianna; Vahtera, Jussi] Finnish Inst Occupat Hlth, Helsinki, Finland.
   [Ferrie, Jane E.; Tabak, Adam G.; Singh-Manoux, Archana; Kivimaeki, Mika] UCL, Dept Epidemiol & Publ Hlth, London, England.
   [Ferrie, Jane E.] Univ Bristol, Sch Community & Social Med, Bristol, Avon, England.
   [Tabak, Adam G.] Semmelweis Univ, Fac Med, Dept Med 1, H-1085 Budapest, Hungary.
   [Akbaraly, Tasnime N.] INSERM, U1061, Montpellier, France.
   [Vahtera, Jussi] Univ Turku, Turku, Finland.
   [Vahtera, Jussi] Turku Univ Hosp, FIN-20520 Turku, Finland.
   [Singh-Manoux, Archana] INSERM, U1018, Paris, France.
RP Virtanen, M (reprint author), Finnish Inst Occupat Hlth, Helsinki, Finland.
EM marianna.virtanen@ttl.fi
RI Singh-Manoux, Archana/F-6804-2013; AKBARALY, Tasnime/H-1389-2018
OI Singh-Manoux, Archana/0000-0002-1244-5037; AKBARALY,
   Tasnime/0000-0002-2150-4190; Vahtera, Jussi/0000-0002-6036-061X;
   Kivimaki, Mika/0000-0002-4699-5627; Tabak, Adam/0000-0002-6234-3936
FU Medical Research Council [K013351]; British Heart Foundation; National
   Heart, Lung, and Blood Institute; National Institutes of Health (NIH)
   [R01-HL-036310]; National Institute on Aging, NIH [R01-AG-013196,
   R01-AG-034454]; Academy of Finland [258598, 265174]; National Excellence
   Program [TAMOP 4.2.4.A/1-11-1-2012-0001]; European Union; European
   Social Fund; National Heart, Lung, and Blood Institute [R01-HL-036310];
   Languedoc-Roussillon Region (Chercheur d'Avenir Grant); NIH
   [R01-HL-036310, R01-AG-034454]; professorial fellowship from the
   Economic and Social Research Council; British Heart Foundation
   [RG/13/2/30098]; Economic and Social Research Council [ES/J023299/1];
   Medical Research Council [MR/K013351/1]
FX The Whitehall II Study is supported by grants from the Medical Research
   Council (K013351); the British Heart Foundation; the National Heart,
   Lung, and Blood Institute; National Institutes of Health (NIH)
   (R01-HL-036310); and the National Institute on Aging, NIH (R01-AG-013196
   and R01-AG-034454). M.V. is supported by the Academy of Finland (258598
   and 265174); A.G.T. by the TAMOP 4.2.4.A/1-11-1-2012-0001 National
   Excellence Program (a research fellowship cofinanced by the European
   Union and the European Social Fund); T.N.A. by the National Heart, Lung,
   and Blood Institute (R01-HL-036310) and by the Languedoc-Roussillon
   Region (Chercheur d'Avenir Grant 2011); and A.S.-M. by the National
   Institute on Aging, NIH (R01-AG-013196 and R01-AG-034454). M.K. is
   supported by the Medical Research Council (K013351), the NIH
   (R01-HL-036310 and R01-AG-034454), and a professorial fellowship from
   the Economic and Social Research Council.
CR Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
   *AM DIAB ASS, 2010, DIABETES CARE S1, V33, pS62, DOI DOI 10.2337/DC10-S062
   Aroda VR, 2008, J CLIN ENDOCR METAB, V93, P3259, DOI 10.1210/jc.2008-1091
   Brotman DJ, 2007, LANCET, V370, P1089, DOI 10.1016/S0140-6736(07)61305-1
   Brunner EJ, 1997, DIABETOLOGIA, V40, P1341, DOI 10.1007/s001250050830
   Brunner EJ, 2013, NAT REV ENDOCRINOL, V9, P449, DOI 10.1038/nrendo.2013.124
   Chida Y, 2008, DIABETOLOGIA, V51, P2168, DOI 10.1007/s00125-008-1154-1
   Cosgrove MP, 2012, OCCUP MED-OXFORD, V62, P167, DOI 10.1093/occmed/kqs002
   Eriksson AK, 2013, DIABETES CARE, V36, P2683, DOI 10.2337/dc12-1738
   Fonseca VA, 2007, CLIN CORNERSTONE, V8, P19
   Fonseca Vivian A, 2007, Clin Cornerstone, V8, P10
   Goldberg D, 1972, DETECTION PSYCHIAT I
   Golden SH, 2008, JAMA-J AM MED ASSOC, V299, P2751, DOI 10.1001/jama.299.23.2751
   Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341
   Head J, 2013, PSYCHOL MED, V43, P2649, DOI 10.1017/S0033291713000342
   Heraclides A, 2009, DIABETES CARE, V32, P2230, DOI 10.2337/dc09-0132
   Heraclides AM, 2012, OBESITY, V20, P428, DOI 10.1038/oby.2011.95
   Kawakami N, 1999, J EPIDEMIOL COMMUN H, V53, P359, DOI 10.1136/jech.53.6.359
   Knol MJ, 2006, DIABETOLOGIA, V49, P837, DOI 10.1007/s00125-006-0159-x
   Kumari M, 2004, ARCH INTERN MED, V164, P1873, DOI 10.1001/archinte.164.17.1873
   Lindstrom J, 2010, HORM METAB RES, V42, pS37, DOI 10.1055/s-0029-1240975
   Marmot M, 2005, INT J EPIDEMIOL, V34, P251, DOI 10.1093/ije/dyh372
   McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307
   Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985
   Mommersteeg PMC, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1109
   Norberg M, 2007, DIABETES RES CLIN PR, V76, P368, DOI 10.1016/j.diabres.2006.09.002
   Pouwer F, 2010, DISCOV MED, V9, P112
   Ryden L, 2013, EUR HEART J, V34, P3035, DOI 10.1093/eurheartj/eht108
   Stringhini S, 2010, JAMA-J AM MED ASSOC, V303, P1159, DOI 10.1001/jama.2010.297
   Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9
   Tabak AG, 2009, LANCET, V373, P2215, DOI 10.1016/S0140-6736(09)60619-X
   Toshihiro M, 2008, DIABETIC MED, V25, P1211, DOI 10.1111/j.1464-5491.2008.02566.x
   Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068
NR 33
TC 22
Z9 22
U1 0
U2 20
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
EI 1935-5548
J9 DIABETES CARE
JI Diabetes Care
PD AUG
PY 2014
VL 37
IS 8
BP 2091
EP 2097
DI 10.2337/dc13-2725
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AN3MI
UT WOS:000340491800020
PM 24784831
OA Green Published, Bronze
DA 2019-01-08
ER

PT J
AU Korda, RJ
   Paige, E
   Yiengprugsawan, V
   Latz, I
   Friel, S
AF Korda, Rosemary J.
   Paige, Ellie
   Yiengprugsawan, Vasoontara
   Latz, Isabel
   Friel, Sharon
TI Income-related inequalities in chronic conditions, physical functioning
   and psychological distress among older people in Australia:
   cross-sectional findings from the 45 and up study
SO BMC PUBLIC HEALTH
LA English
DT Article
ID SOCIOECONOMIC INEQUALITIES; HEALTH INEQUALITIES; DISABILITY FINDINGS;
   PREVALENCE; ENGLAND; COHORT; LEVEL; RISK; AGE; PARTICIPANTS
AB Background: The burden of chronic disease continues to rise as populations age. There is relatively little published on the socioeconomic distribution of this burden in older people. This study quantifies absolute and relative income-related inequalities in prevalence of chronic diseases, severe physical functioning limitation and high psychological distress in mid-age and older people in Australia.
   Methods: Cross-sectional study of 208,450 participants in the 45 and Up Study, a population-based cohort of men and women aged 45-106 years from New South Wales, Australia. Chronic conditions included self-reported heart disease, diabetes, Parkinson's disease, cancer and osteoarthritis; physical functioning limitation (severe/not) was measured using Medical Outcomes Study measures and psychological distress (high/not) using the Kessler Psychological Distress Scale. For each outcome, prevalence was estimated in relation to annual household income (6 categories). Prevalence differences (PDs) and ratios (PRs) were generated, comparing the lowest income category (<$20,000) to the highest (>=$70,000), using Poisson regression with robust standard errors, weighted for age, sex and region of residence. Analyses were stratified by age group (45-64, 65-79 and >= 80 years) and sex and adjusted for age and country of birth.
   Results: With few exceptions, there were income gradients in the prevalence of chronic conditions among all age-sex groups, with prevalence decreasing with increasing income. Of the chronic diseases, PDs were highest for diabetes (ranging between 5.69% and 10.36% across age-sex groups) and in women, also for osteoarthritis (5.72% to 8.14%); PRs were highest for osteoarthritis in men aged 45-64 years (4.01), otherwise they were highest for diabetes (1.78 to 3.43). Inequalities were very high for both physical functioning limitation and psychological distress, particularly among those aged 45-64 (PDs between 18.67% and 29.23% and PRs between 4.63 and 16.51). Absolute and relative inequalities tended to decrease with age, but remained relatively high for diabetes and physical functioning in the elderly (>= 80 years).
   Conclusions: Significant inequalities in the prevalence of chronic conditions, physical functioning and psychological distress persist into old age. The additional health burden placed on those who are already disadvantaged is likely to become an increasingly important issue in an ageing population.
C1 [Korda, Rosemary J.; Paige, Ellie; Yiengprugsawan, Vasoontara; Friel, Sharon] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia.
   [Latz, Isabel] Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90024 USA.
RP Korda, RJ (reprint author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, GPO Box 4, Canberra, ACT 0200, Australia.
EM Rosemary.Korda@anu.edu.au
OI Yiengprugsawan, Vasoontara/0000-0001-9101-4704; Friel,
   Sharon/0000-0002-8345-5435
CR ABS (Australian Bureau of Statistics), 2008, POP PROJ AUSTR 2006
   Australian Bureau of Statistics, 2006, 2039 0 INF PAP INTR
   Australian Bureau of Statistics, 2006, 2006 CENS DAT CANB A
   Australian Institute of Health and Welfare, 2012, AUSTR HLTH 2012
   Australian Institute of Health and Welfare, 2012, 4817055001 AUSTR I H
   Avendano M, 2008, STROKE, V39, P1533, DOI 10.1161/STROKEAHA.107.490383
   Banks E, 2008, INT J EPIDEMIOL, V37, P941, DOI 10.1093/ije/dym184
   Banks E, 2011, PUBLIC HEALTH NUTR, V14, P34, DOI 10.1017/S1368980010000674
   Banks E, 2010, MED J AUSTRALIA, V193, pS62
   Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0
   Beckett M, 2000, J HEALTH SOC BEHAV, V41, P106, DOI 10.2307/2676363
   Berkman CS, 1998, J AGING HEALTH, V10, P81, DOI 10.1177/089826439801000105
   BOULT C, 1994, J GERONTOL, V49, pM28, DOI 10.1093/geronj/49.1.M28
   Breeze E, 2001, AM J PUBLIC HEALTH, V91, P277, DOI 10.2105/AJPH.91.2.277
   Byles JE, 2013, DEPRESS ANXIETY
   Chittleborough CR, 2011, INT J PUBLIC HEALTH, V56, P71, DOI 10.1007/s00038-010-0197-5
   COAG Reform Council, 2013, HEALTHC 2011 12 COMP
   Dalstra JAA, 2005, INT J EPIDEMIOL, V34, P316, DOI 10.1093/ije/dyh386
   Di Cesare M, 2013, LANCET, V381, P585, DOI 10.1016/S0140-6736(12)61851-0
   Espelt A, 2013, GAC SANIT, V27, P494, DOI 10.1016/j.gaceta.2013.03.002
   Lima-Costa MF, 2012, AM J PUBLIC HEALTH, V102, P1535, DOI 10.2105/AJPH.2012.300765
   Glover J, 2004, AUSTR NZ HLTH POLICY, V1, P8, DOI DOI 10.1186/1743-8462-1-8
   Holden L, 2010, AUST NZ J PUBL HEAL, V34, P304, DOI 10.1111/j.1753-6405.2010.00531.x
   Huisman M, 2003, SOC SCI MED, V57, P861, DOI 10.1016/S0277-9536(02)00454-9
   Institute for Health Metrics and Evaluation, 2013, SEATTL IHME
   Jan S, 2012, MED J AUSTRALIA, V196, P29, DOI 10.5694/mja11.11105
   Kempen GIJM, 1997, AM J PUBLIC HEALTH, V87, P38, DOI 10.2105/AJPH.87.1.38
   Korda RJ, 2012, MED J AUSTRALIA, V197, P631, DOI 10.5694/mja12.11035
   Korda RJ, 2009, AUST NZ J PUBL HEAL, V33, P458, DOI 10.1111/j.1753-6405.2009.00430.x
   Koster A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-244
   Mackenbach JP, 2011, J EPIDEMIOL COMMUN H, V65, P412, DOI 10.1136/jech.2010.112680
   Marmot M, 2002, HEALTH AFFAIR, V21, P31, DOI 10.1377/hlthaff.21.2.31
   McMunn A, 2009, AGE AGEING, V38, P181, DOI 10.1093/ageing/afn236
   Mealing NM, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-26
   Mishra GD, 2004, SOC SCI MED, V58, P1585, DOI 10.1016/S0277-9536(03)00368-X
   Nagel G, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-384
   Ponsonby AL, 1996, AUST NZ J PUBL HEAL, V20, P54, DOI 10.1111/j.1467-842X.1996.tb01336.x
   Rai D, 2013, BRIT J PSYCHIAT, V202, P195, DOI 10.1192/bjp.bp.112.112482
   Ramsay SE, 2008, ANN EPIDEMIOL, V18, P896, DOI 10.1016/j.annepidem.2008.09.006
   Savva GM, 2013, J AM GERIATR SOC, V61, pS291, DOI 10.1111/jgs.12196
   Stringhini S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000419
   Sulander T, 2006, INT J EPIDEMIOL, V35, P1255, DOI 10.1093/ije/dyl183
   Taylor M, 2009, COMMUN SER, P76
   Thorslund M, 1994, J Aging Health, V6, P51, DOI 10.1177/089826439400600104
   Tsimbos C, 2010, INT J PUBLIC HEALTH, V55, P5, DOI 10.1007/s00038-009-0083-1
   Turrell G, 2006, HLTH INEQUALITIES AU, V2
   Ware JE, SF 36 HLTH SURV UPD
   WHO, 2008, CLOS GAP GEN HLTH EQ
   Wilson KCM, 1999, BRIT J PSYCHIAT, V175, P549, DOI 10.1192/bjp.175.6.549
   Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090
NR 50
TC 13
Z9 13
U1 1
U2 18
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD JUL 22
PY 2014
VL 14
AR 741
DI 10.1186/1471-2458-14-741
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA AP0EF
UT WOS:000341733400001
PM 25048295
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Perera, J
   Kirthinanda, DS
   Wijeratne, S
   Wickramarachchi, TK
AF Perera, Jennifer
   Kirthinanda, Dinoo S.
   Wijeratne, Sujani
   Wickramarachchi, Thanuja K.
TI Descriptive cross sectional study on prevalence, perceptions,
   predisposing factors and health seeking behaviour of women with stress
   urinary incontinence
SO BMC WOMENS HEALTH
LA English
DT Article
DE Stress urinary incontinence; Prevalence; Risk factors; Health seeking
   behaviour
ID MIDDLE-AGED WOMEN; KNOWLEDGE; DISTRESS; YOUNG
AB Background: Stress urinary incontinence (SUI) leads to considerable physical and psychological morbidity. The highest prevalence reported was found in Caucasian Americans (range 23% -67%) and the lowest in Singaporean females (4.8%). The study assessed the prevalence, perceptions, predisposing factors and health seeking behaviour of women with SUI in an Asian setting which may have different sociocultural implications.
   Methods: 400 consecutive women > 20 years of age attending the outpatient department of a tertiary care hospital in Sri Lanka, for non-urinary conditions were studied over a 3 week period using an interviewer administered questionnaire. SUI was diagnosed on clinical history alone when leakage of urine occurred either with coughing, sneezing, walking or lifting heavy objects. The severity was graded using the Finnish Gynaecological Society's Urinary Incontinence Severity Score (UISS). Data were analysed using SPSS version 20. Odds ratios were calculated using univariate and multivariate analysis.
   Results: Ninety three (23.33%) had SUI and only 12 (12.9%) had sought treatment. The prevalence among women > 50 years of age was 34.71% (n = 121) compared to 18.28% (n = 279) in those = 50 years. 25 (26.88%) had mild SUI, 66 (70.97%) moderate and 2 (2.15%) severe as per UISS. SUI was perceived as an illness by 210 (52.5%). SUI was significantly associated with pregnancy, parity, vaginal delivery, complicated labour, diabetes mellitus, chronic cough, constipation and faecal incontinence (p < 0.05). Among those affected main reasons for not seeking medical advice included; being embarrassed (n = 27, 33.33%), not knowing that it is remediable (n = 23, 28.40%), perceiving SUI to be a normal consequence of childbirth (n = 19, 23.46%) and having to attend to needs of the family (n = 12, 14.81%). None who had been pregnant (n = 313) had received advice on postnatal pelvic floor exercises. SUI interfered with social activities (71;76.34%), sexual function (21; 22.58%) and resulted in despair (67; 72.09%). It was associated with clinically diagnosed candidiasis (50; 53.76%) and soreness in the perineal region (49; 52.69%).
   Conclusions: SUI is a common and neglected gynaecological problem with poor healthcare seeking behaviour. Community based education may help to minimize the occurrence and improve the quality of life of those affected.
C1 [Perera, Jennifer; Kirthinanda, Dinoo S.; Wijeratne, Sujani; Wickramarachchi, Thanuja K.] Univ Colombo, Fac Med, Dept Microbiol, Colombo, Sri Lanka.
RP Perera, J (reprint author), Univ Colombo, Fac Med, Dept Microbiol, POB 271, Colombo, Sri Lanka.
EM jennifer_perera55@yahoo.com
CR Abrams P, 2003, UROLOGY, V61, P37, DOI 10.1016/S0090-4295(02)02243-4
   CHAN CJ, 1991, AGE AGEING, V20, P262
   Ebbesen MH, 2007, ACTA OBSTET GYN SCAN, V86, P1256, DOI 10.1080/00016340701625347
   EL-Hefnawy AS, 2011, MATURITAS, V68, P374, DOI 10.1016/j.maturitas.2011.01.005
   FOLDSPANG A, 1992, J EPIDEMIOL COMMUN H, V46, P595, DOI 10.1136/jech.46.6.595
   Fultz NH, 2000, J AGING HEALTH, V12, P459, DOI 10.1177/089826430001200401
   Gleason JL, 2013, INT UROGYNECOL J, V24, P295, DOI 10.1007/s00192-012-1829-5
   Gomman H M, 2001, J Egypt Public Health Assoc, V76, P313
   Hahnestad YS, 2004, BRIT MED J, V329, P889, DOI 10.1136/bmj.329.7471.889
   Hannestad YS, 2000, J CLIN EPIDEMIOL, V53, P1150, DOI 10.1016/S0895-4356(00)00232-8
   Hemachandra NN, 2009, SOC SCI MED, V69, P1395, DOI 10.1016/j.socscimed.2009.08.019
   HOLST K, 1988, NEW ZEAL MED J, V101, P756
   Hunskaar S, 2000, INT UROGYNECOL J, V11, P301, DOI 10.1007/s001920070021
   Kirss F, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-524
   Knarr J, 2010, JCOM, V17, P519
   Makinen J, 1992, FINN MED J, V47, P2373
   MITTENESS LS, 1990, J AM GERIATR SOC, V38, P374, DOI 10.1111/j.1532-5415.1990.tb03525.x
   Mouritsen L, 1998, ACTA OBSTET GYN SCAN, V77, P361
   NORTON PA, 1988, BRIT MED J, V297, P1187, DOI 10.1136/bmj.297.6657.1187
   Novielli Karen D., 2003, International Urology and Nephrology, V35, P423, DOI 10.1023/B:UROL.0000022868.73066.9a
   Peyrat L, 2002, BJU INT, V89, P61, DOI 10.1046/j.1464-410X.2002.02546.x
   REKERS H, 1992, EUR J OBSTET GYN R B, V43, P229, DOI 10.1016/0028-2243(92)90178-2
   Reymert Jannike, 1994, Scandinavian Journal of Primary Health Care, V12, P180, DOI 10.3109/02813439409003696
   Samuelsson E, 2000, ACTA OBSTET GYN SCAN, V79, P208, DOI 10.1034/j.1600-0412.2000.079003208.x
   Shaw C, 2006, BJU INT, V97, P752, DOI 10.1111/j.1464-410X.2006.06071.x
   SHUMAKER SA, 1994, QUAL LIFE RES, V3, P291, DOI 10.1007/BF00451721
   St John W, 2013, J WOUND OSTOMY CONT, V40, P524, DOI 10.1097/WON.0b013e3182a2198a
   Swanson JG, 2005, CAN FAM PHYSICIAN, V51, P85
   Thomas S, 2000, Nurs Stand, V14, P43
   Wan XJ, 2014, J CLIN NURS, V23, P2170, DOI 10.1111/jocn.12482
   Whitford HM, 2007, MIDWIFERY, V23, P204, DOI 10.1016/j.midw.2006.06.006
NR 31
TC 18
Z9 19
U1 2
U2 23
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1472-6874
J9 BMC WOMENS HEALTH
JI BMC Womens Health
PD JUL 2
PY 2014
VL 14
AR 78
DI 10.1186/1472-6874-14-78
PG 7
WC Public, Environmental & Occupational Health; Obstetrics & Gynecology
SC Public, Environmental & Occupational Health; Obstetrics & Gynecology
GA AL2MU
UT WOS:000338960500001
PM 24985068
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Kapoor, S
   Thorn, BE
AF Kapoor, S.
   Thorn, B. E.
TI Healthcare use and prescription of opioids in rural residents with pain
SO RURAL AND REMOTE HEALTH
LA English
DT Article
DE chronic pain; depression; healthcare utilization; psychosocial factors;
   USA
ID LOW-BACK-PAIN; INDUCED HYPERALGESIA; CHRONIC DISEASE; NONMEDICAL USE;
   MENTAL-HEALTH; MEDICAL USE; THERAPY; VALIDATION; DEPRESSION; ABUSE
AB Introduction: Chronic pain is a major public health problem. Increased healthcare utilization by individuals with pain puts enormous burden on financial and health resources. There is extremely limited understanding of psychosocial factors that affect healthcare use and prescription of opioids in individuals who experience heightened healthcare disparities associated with being African-American, having low income, and with rural residency. Health disparities research indicates that rural residency and low socioeconomic status are associated with greater self-reported pain levels. It is logical to expect then that this would be associated with increased needs for health services. However, at the same time, these very variables function as barriers in accessing health care. This disparity between greater need and limited access in turn creates greater distress. Further complicating the picture is the rapidly emerging concern about the misuse of prescription opioids in rural areas. As a result, empirical inquiry has started focusing on the variables influencing the likelihood of receiving opioid prescriptions in rural areas. The understanding of psychosocial factors affecting healthcare use and prescription of opioids in individuals who experience heightened healthcare disparities associated with being African-American, low-income, and living in rural areas remains extremely limited. The primary aim of this study was to examine the demographic and psychosocial variables that affect health services use in a rural, low-income population with chronic pain. Secondarily, the influence of these same variables on receiving prescription for opioids was examined.
   Methods: Healthcare use during a 3 month period, prescription analgesics, as well as medical comorbidities were obtained from the medical records of 64 patients with chronic pain. The participants were enrolling in an upcoming psychosocial intervention offered at two rural federally qualified health centers in a south-eastern state in the USA. For the present study, these participants consented to have their medical records reviewed for the 3 months prior to beginning the intervention protocol. Additionally, the pre-treatment (baseline) assessments were used in the present analyses. Demographic information, including age, sex, and education level, as well as measures of pain intensity, depressive symptoms, pain-related disability, and pain catastrophizing were collected.
   Results: The participants were rural residents in medically underserved counties, primarily female (73.4%) and African-American (67.2%), and approximately 77% reported annual household income of less than $13,000. A majority had medical comorbidities, including diabetes mellitus (46.89%), cardiovascular disorders (29.7%), chronic renal disorder (14.1%), and asthma (6.3%). Approximately 30% had a diagnosis of depression. Demographic variables such as age, sex, and ethnicity did not influence the healthcare use or prescription of opioids. Depressive symptoms uniquely influenced health services use, with higher scores predicting greater health services utilization. In addition, those with a diagnosis of depression (per medical records) and those with a higher number of medical comorbidities were more likely to receive prescription opioids.
   Conclusions: This study adds to the current understanding of the factors affecting healthcare use and prescription of opioids in low-income individuals living in rural areas with chronic pain receiving treatment at federally qualified health centers. Since healthcare use was predicted by depressive symptoms and the prescription of opioids by a clinical diagnosis of depression, screening for depression is advised as part of the standard care of patients with pain, ideally with follow-up assessments and treatment of depression as necessary. Furthermore, making psychosocial interventions more available at rural healthcare centers may help in lowering psychological distress, which may have the ultimate effect of reducing opioid prescriptions for this subset of patients.
C1 [Kapoor, S.; Thorn, B. E.] Univ Alabama, Tuscaloosa, AL 35487 USA.
RP Kapoor, S (reprint author), Univ Alabama, Tuscaloosa, AL 35487 USA.
FU National Institute of Nursing Research; National Institute of Mental
   Health [NR010112]
FX This research was supported by the National Institute of Nursing
   Research and the National Institute of Mental Health, NR010112. The
   authors have no conflicts of interest to report. The authors thank all
   of the patients and medical staff who made this research possible. The
   authors also acknowledge Drs Jennifer Gardner and Melissa Day for their
   earlier contributions to this research project.
CR Adam P, 2012, JOURNAL OF RURAL HEA, V29, P205
   Andersen T. E., 2011, SOCIAL SCIENCE AND M, V74, P1461
   [Anonymous], 2009, CALL REV CHRON PAIN
   Ballantyne JC, 2003, NEW ENGL J MED, V349, P1943, DOI 10.1056/NEJMra025411
   Becker A, 2010, SPINE, V35, P1714, DOI 10.1097/BRS.0b013e3181cd656f
   Bennett MI, 2005, J PAIN, V6, P149, DOI 10.1016/j.jpain.2004.11.007
   Blanchard EB, 1985, MANAGEMENT OF CHRONI
   Blyth FM, 2004, PAIN, V111, P51, DOI 10.1016/j.pain.2004.05.020
   Board on Health Sciences Policy, 2011, RELIEVING PAIN IN AM
   Breckenridge J, 2003, J PAIN, V4, P344, DOI 10.1016/S1526-5900(03)00638-2
   Cicero TJ, 2007, PHARMACOEPIDEM DR S, V16, P827, DOI 10.1002/pds.1452
   Cimmino MA, 2011, BEST PRACT RES CL RH, V25, P173, DOI 10.1016/j.berh.2010.01.012
   Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129
   Cranford JA, 2013, ADDICT BEHAV, V38, P2768, DOI 10.1016/j.addbeh.2013.06.015
   Dhalla IA, 2011, BRITISH MEDICAL JOUR, V343, P1
   Dobscha SK, 2013, CLIN J PAIN, V29, P102, DOI 10.1097/AJP.0b013e3182490bdb
   Ehde D, 2005, EDUCATION INTERVENTI
   Elliott AM, 1999, LANCET, V354, P1248, DOI 10.1016/S0140-6736(99)03057-3
   Engel CC, 1996, PAIN, V65, P197, DOI 10.1016/0304-3959(95)00164-6
   Grabe HJ, 2009, SOC PSYCH PSYCH EPID, V44, P835, DOI 10.1007/s00127-009-0005-9
   Grattan A, 2012, ANN FAM MED, V10, P304, DOI 10.1370/afm.1371
   Griffiths C, 2007, BRIT MED J, V334, P1254, DOI 10.1136/bmj.39227.698785.47
   Groenewald C, 2013, J PAIN, V14, pS39, DOI 10.1016/j.jpain.2013.01.452
   Hoffman Pamela K, 2002, J Community Health Nurs, V19, P213, DOI 10.1207/153276502320948445
   Hojsted J, 2013, PAIN, V154, P2677, DOI 10.1016/j.pain.2013.07.046
   Johnson JL, 2013, CEPHALALGIA, V33, P52, DOI 10.1177/0333102412467512
   Kalso E, 2012, ABC OF PAIN, V218, P103
   Katz C, 2013, DRUG ALCOHOL DEPEN, V132, P107, DOI 10.1016/j.drugalcdep.2013.01.010
   Kissin I, 2013, J PAIN RES, V6, P513, DOI [10.2147/JPR.S47182, 10.2147/JPR.S47162]
   Kuhajda MC, 2010, TRANSLATIONAL BEHAVI, V1, P216
   Larrison CR, 2011, PSYCHIAT SERV, V62, P1255, DOI 10.1176/ps.62.11.pss6211_1255
   Laxmaiah M, 2012, PAIN PHYSICIAN, V15, pES9
   Lee JL, 2013, HEALTH PSYCHOL, V32, P320, DOI 10.1037/a0027806
   Lee M, 2011, PAIN PHYSICIAN, V14, P145
   Leo RJ, 2013, ESSENTIALS OF PALLIA
   McCabe SE, 2013, PAIN, V154, P708, DOI 10.1016/j.pain.2013.01.011
   Merrill JO, 2012, GEN HOSP PSYCHIAT, V34, P581, DOI 10.1016/j.genhosppsych.2012.06.018
   Miller D, 2004, J WOMENS HEALTH, V13, P217, DOI 10.1089/154099904322966209
   Nelson JA, 2010, HOME HLTH CARE MAN P, V22, P339, DOI 10.1177/1084822309353552
   Okie S, 2010, NEW ENGL J MED, V363, P1981, DOI 10.1056/NEJMp1011512
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Rost K, 2002, MED CARE RES REV, V59, P231, DOI 10.1177/1077558702059003001
   Stroud MW, 2004, J PAIN, V5, P257, DOI 10.1016/j.jpain.2004.04.002
   Sullivan MD, 2013, PAIN, V154, pS94, DOI 10.1016/j.pain.2013.09.009
   Sullivan MD, 2005, PAIN, V119, P95, DOI 10.1016/j.pain.2005.09.020
   Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524
   Tan G, 2004, J PAIN, V5, P133, DOI 10.1016/j.jpain.2003.12.005
   Thorn BE, 2011, PAIN, V152, P2710, DOI 10.1016/j.pain.2011.07.007
   Toblin RL, 2011, PAIN, V152, P1249, DOI 10.1016/j.pain.2010.12.036
   Tollefson Joanne, 2006, Aust J Rural Health, V14, P134, DOI 10.1111/j.1440-1584.2006.00780.x
   Trevino CM, 2013, J PAIN, V14, P424, DOI 10.1016/j.jpain.2012.12.016
   Turk D, 2002, CLINICAL JOURNAL OF, V18, P257
   TURK DC, 1994, BEHAV RES THER, V32, P9, DOI 10.1016/0005-7967(94)90078-7
NR 53
TC 4
Z9 4
U1 0
U2 14
PU AUSTRALIAN RURAL HEALTH EDUC NETWORK
PI DEAKIN WEST
PA PO BOX 242, DEAKIN WEST, ACT 2600, AUSTRALIA
SN 1445-6354
J9 RURAL REMOTE HEALTH
JI Rural Remote Health
PD JUL-SEP
PY 2014
VL 14
IS 3
AR 2879
PG 12
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA AR3WZ
UT WOS:000343521000039
PM 25204693
DA 2019-01-08
ER

PT J
AU Selvarajah, D
   Cash, T
   Sankar, A
   Thomas, L
   Davies, J
   Cachia, E
   Gandhi, R
   Wilkinson, ID
   Wilkinson, N
   Emery, CJ
   Tesfaye, S
AF Selvarajah, Dinesh
   Cash, Thomas
   Sankar, Adhithya
   Thomas, Lloyd
   Davies, Jennifer
   Cachia, Elaine
   Gandhi, Rajiv
   Wilkinson, Iain D.
   Wilkinson, Nicholas
   Emery, Celia J.
   Tesfaye, Solomon
TI The contributors of emotional distress in painful diabetic neuropathy
SO DIABETES & VASCULAR DISEASE RESEARCH
LA English
DT Article
DE Painful diabetic neuropathy; emotional distress; depression; anxiety
ID LOW-BACK-PAIN; PERIPHERAL NEUROPATHY; PRIMARY-CARE; DEPRESSION SCALE;
   HOSPITAL ANXIETY; VALIDATION; PREDICTORS; DISABILITY; DULOXETINE;
   COMMUNITY
AB Aims: To examine the contribution of demographic, social, clinical and psychological factors to emotional distress in patients with painful diabetic neuropathy (DN).
   Methods: In total, 142 patients with confirmed painful DN underwent detailed clinical and self-assessment measures (Neuropathic Pain Scale, Hospital Anxiety and Depression Scale, Pain Acceptance Questionnaire and Pain Catastrophizing Scale).
   Results: The prevalence of emotional distress was 51.4% in this cohort. Age, sex, marital status, employment history, pain intensity, duration of diabetes and the presence of diabetic and non-diabetic complications were significantly correlated to anxiety and depressive symptom scores. Multiple regression analysis confirmed that the presence of catastrophic thinking was an independent contributor to greater symptoms of anxiety and depression. Being young, single and unemployed significantly contributed to greater anxiety symptoms. Pain-related restriction of quality of life was associated with greater depression symptom scores.
   Conclusions: This study found a high prevalence of emotional distress in patients with painful DN. It highlights that the differing independent contributors to anxiety and depressive symptoms are based on an individual's circumstances and experience. We conclude by highlighting the importance of adopting a holistic approach to pain management, incorporating interventions to increase psychological flexibility alongside conventional pharmacological treatments to improve emotional distress in painful DN.
C1 [Selvarajah, Dinesh; Cash, Thomas; Sankar, Adhithya; Thomas, Lloyd; Davies, Jennifer; Cachia, Elaine; Wilkinson, Iain D.] Univ Sheffield, Sch Med, Dept Human Metab, Sheffield S10 2JF, S Yorkshire, England.
   [Gandhi, Rajiv; Emery, Celia J.; Tesfaye, Solomon] Sheffield Teaching Hosp NHS Fdn Trust, Royal Hallamshire Hosp, Diabet Res Dept, Sheffield, S Yorkshire, England.
   [Wilkinson, Nicholas] Sheffield Hlth & Social Care NHS Fdn Trust, Improving Access Psychol Therapies Sheffield IAPT, Sheffield, S Yorkshire, England.
RP Selvarajah, D (reprint author), Univ Sheffield, Sch Med, Dept Human Metab, Beech Hill Rd, Sheffield S10 2JF, S Yorkshire, England.
EM d.selvarajah@sheffield.ac.uk
OI Tesfaye, Solomon/0000-0003-1190-1472; Wilkinson,
   Iain/0000-0003-2703-6890
FU Diabetes UK; Juvenile Diabetes Research Foundation grant
FX This research was supported by a Diabetes UK and Juvenile Diabetes
   Research Foundation grant.
CR Abbott CA, 2002, DIABETIC MED, V19, P377, DOI 10.1046/j.1464-5491.2002.00698.x
   Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433
   BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037//0022-3514.51.6.1173
   Boothby J, 1999, PSYCHOSOCIAL FACTORS, P334
   Collins MM, 2009, DIABETIC MED, V26, P153, DOI 10.1111/j.1464-5491.2008.02648.x
   Daousi C, 2004, DIABETIC MED, V21, P976, DOI 10.1111/j.1464-5491.2004.01271.x
   Davies M, 2006, DIABETES CARE, V29, P1518, DOI 10.2337/dc05-2228
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   Fishbain DA, 2008, CURR MED RES OPIN, V24, P3105, DOI 10.1185/03007990802429627 
   Galer BS, 2000, DIABETES RES CLIN PR, V47, P123, DOI 10.1016/S0168-8227(99)00112-6
   Galer BS, 1997, NEUROLOGY, V48, P332, DOI 10.1212/WNL.48.2.332
   Gore M, 2011, PAIN PRACT, V11, P167, DOI 10.1111/j.1533-2500.2010.00415.x
   Gureje O, 1998, JAMA-J AM MED ASSOC, V280, P147, DOI 10.1001/jama.280.2.147
   Herrmann C, 1997, J PSYCHOSOM RES, V42, P17, DOI 10.1016/S0022-3999(96)00216-4
   Index of Multiple Deprivation (IMD), 2004, WHICH IS US QUAL LIF
   Jensen Troels S, 2006, Diab Vasc Dis Res, V3, P108, DOI 10.3132/dvdr.2006.013
   Kleinbaum D., 2007, APPL REGRESSION ANAL
   McCracken LM, 2004, PAIN, V107, P159, DOI 10.1016/j.pain.2003.10.012
   McWilliams LA, 2003, PAIN, V106, P127, DOI 10.1016/S0304-3959(03)00301-4
   Means-Christensen AJ, 2008, DEPRESS ANXIETY, V25, P593, DOI 10.1002/da.20342
   Mrtikainen P, 2002, INT J EPIDEMIOL, V31, P1091
   Ohayon MM, 2010, J PSYCHIATR RES, V44, P454, DOI 10.1016/j.jpsychires.2009.10.013
   Rosemann T, 2007, ARTHRIT RHEUM-ARTHR, V57, P415, DOI 10.1002/art.22624
   Selvarajah D, 2010, DIABETES CARE, V33, P128, DOI 10.2337/dc09-1029
   Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524
   Sullivan MJL, 2005, PAIN, V113, P310, DOI 10.1016/j.pain.2004.11.003
   Tesfaye S, 2010, DIABETES CARE, V33, P2285, DOI 10.2337/dc10-1303
   Thorn BE, 2002, COGN BEHAV PRACT, V9, P127, DOI 10.1016/S1077-7229(02)80006-2
   Tsai PF, 2005, J ADV NURS, V51, P158, DOI 10.1111/j.1365-2648.2005.03481.x
   Turk DC, 1996, BIOPSYCHOSOCIAL PERS, P3
   Turk DC, 2010, MAYO CLIN PROC, V85, pS42, DOI 10.4065/mcp.2009.0648
   Turner JA, 2000, PAIN, V85, P115, DOI 10.1016/S0304-3959(99)00259-6
   Vinik Etta J, 2005, Diabetes Technol Ther, V7, P497, DOI 10.1089/dia.2005.7.497
   VLAEYEN JWS, 1995, PAIN, V62, P363, DOI 10.1016/0304-3959(94)00279-N
   Vlaeyen JWS, 1999, PAIN, V82, P297, DOI 10.1016/S0304-3959(99)00054-8
   Williamson GM, 1998, REHABIL PSYCHOL, V43, P327
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
NR 37
TC 17
Z9 17
U1 0
U2 12
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1479-1641
EI 1752-8984
J9 DIABETES VASC DIS RE
JI Diabetes Vasc. Dis. Res.
PD JUL
PY 2014
VL 11
IS 4
BP 218
EP 225
DI 10.1177/1479164114522135
PG 8
WC Endocrinology & Metabolism; Peripheral Vascular Disease
SC Endocrinology & Metabolism; Cardiovascular System & Cardiology
GA AN6RW
UT WOS:000340725200001
PM 24821753
DA 2019-01-08
ER

PT J
AU Abdallah, M
   Raza, R
   Abdallah, T
   McCord, D
   Khoueiry, G
AF Abdallah, Mokhtar
   Raza, Rehan
   Abdallah, Tarek
   McCord, Donald
   Khoueiry, Georges
TI A rare case of silent transmural myocardial infarction with diffuse ST
   elevations complicated by concomitant severe hyperkalemia
SO HEART & LUNG
LA English
DT Article
DE Hyperkalemia; ST elevation; Myocardial infarction
ID DIABETIC-KETOACIDOSIS; SEGMENT ELEVATION; PSEUDOINFARCTION PATTERN;
   CORONARY STENOSES; ISCHEMIA; OUTCOMES
AB It is well described that certain group of patients do not display the typical symptoms of myocardial infarction (MI). Elderly patients, diabetics and those with previous coronary artery bypass graft surgery are at high risk for silent MI. The diagnosis of Acute MI in the emergency room (ER) is mainly based on the electrocardiogram (EKG) findings of ST elevations or new onset left bundle branch block which is supported by the clinical presentation and positive biomarkers when present. The diagnoses can sometimes become challenging when the patient is asymptomatic and has coincidental finding of hyperkalemia with diffuse ST segment elevations simulating that seen with electrolyte disturbance. Despite the well known pseudoinfarction pattern of hyperkalemia, acute MI should be ruled out first. A high index of suspicion is needed, especially in high risk patients. We think that in rare clinical situation when the diagnosis is in doubt, MI should be ruled out, as time has a high impact on patient mortality. An urgent bedside echocardiogram is very beneficial in excluding regional wall motion abnormalities and preventing any delay in destination therapy for transmural MI. We present a 67 years old female with history of diabetes and chronic kidney disease sent by her nephrologist to the ER for severe hyperkalemia (Potassium 7.2 milliequivalent/L). She was found to have ST elevations on EKG despite having no chest pain or distress. On cardiac catheterization she had a total occlusion of the proximal left circumflex artery, with a filling defect consistent with large thrombus. (C) 2014 Elsevier Inc. All rights reserved.
C1 [McCord, Donald; Khoueiry, Georges] SIUH, Dept Med, Div Cardiol, New York, NY USA.
   [Abdallah, Mokhtar; Raza, Rehan] SIUH, Dept Med, New York, NY USA.
   [Abdallah, Tarek] SIUH, Dept Med, Div Pulm, New York, NY USA.
RP Khoueiry, G (reprint author), Dartmouth Hitchcock Med Ctr, 1 Med Ctr Dr, Lebanon, NH 03756 USA.
EM Khoueiry_gm@hotmail.com
CR Cho JY, 2012, AM J CARDIOL, V109, P337, DOI 10.1016/j.amjcard.2011.09.017
   Cosson E, 2003, DIABETES CARE, V26, P1313, DOI 10.2337/diacare.26.4.1313
   Cosson E, 2003, DIABETES METAB, V29, P470, DOI 10.1016/S1262-3636(07)70060-5
   Erne P, 2007, JAMA-J AM MED ASSOC, V297, P1985, DOI 10.1001/jama.297.18.1985
   Gibson CM, 2001, CIRCULATION, V104, P2632, DOI 10.1161/circ.104.22.2632
   KAMIMURA M, 1992, HOSP PRACT, V27, P28
   LEVINE HD, 1956, CIRCULATION, V13, P29, DOI 10.1161/01.CIR.13.1.29
   Moulik PK, 2002, BRIT MED J, V325, P1346, DOI 10.1136/bmj.325.7376.1346
   Sims DB, 2005, CIRCULATION, V111, pE295, DOI 10.1161/01.CIR.0000165127.41028.D1
   Sweterlitsch EM, 1996, AM HEART J, V132, P1086, DOI 10.1016/S0002-8703(96)90037-X
   Wang K, 2003, NEW ENGL J MED, V349, P2128, DOI 10.1056/NEJMra022580
   Wang KY, 2004, NEW ENGL J MED, V351, P593, DOI 10.1056/NEJMicm970566
NR 12
TC 1
Z9 1
U1 0
U2 2
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0147-9563
EI 1527-3288
J9 HEART LUNG
JI Heart Lung
PD JUL-AUG
PY 2014
VL 43
IS 4
BP 286
EP 288
DI 10.1016/j.hrtlng.2014.04.017
PG 3
WC Cardiac & Cardiovascular Systems; Nursing; Respiratory System
SC Cardiovascular System & Cardiology; Nursing; Respiratory System
GA AL2RJ
UT WOS:000338972500007
PM 24856226
DA 2019-01-08
ER

PT J
AU Baumeister, H
   Nowoczin, L
   Lin, J
   Seifferth, H
   Seufert, J
   Laubner, K
   Ebert, DD
AF Baumeister, H.
   Nowoczin, L.
   Lin, J.
   Seifferth, H.
   Seufert, J.
   Laubner, K.
   Ebert, D. D.
TI Impact of an acceptance facilitating intervention on diabetes patients'
   acceptance of Internet-based interventions for depression: A randomized
   controlled trial
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Diabetes; Depression; Psychotherapy; Acceptance; E-health
ID COMORBID MENTAL-DISORDERS; PSYCHOLOGICAL TREATMENTS;
   INFORMATION-TECHNOLOGY; HEALTH; METAANALYSIS; CARE; ADULTS;
   ACCEPTABILITY; POPULATION; INTENTION
AB Aims: To (1) determine diabetes patients' acceptance of Internet-based interventions (IBIs) for depression, to (2) examine the effectiveness of an acceptance facilitating intervention (AFI) and to (3) explore subgroup specific effects.
   Methods: 141 diabetes patients from two inpatient rehabilitation units and one outpatient clinic in Germany were randomly allocated to an intervention (IG) and a no-intervention control group (CG). The IG received an AFI consisting of a personal information session before filling-out a questionnaire on patients' acceptance of IBIs, predictors of acceptance (performance expectancy, effort expectancy, social influence, facilitating conditions, and Internet anxiety) as well as sociodemographic, depression-related and diabetes-related variables. The CG filled out the questionnaire immediately. Patients' acceptance of IBIs was measured with a four-item scale (sum-score ranging from 4 to 20).
   Results: The CG showed a low (50.7%) to medium (40.8%) acceptance with only 8.5% of all diabetes patients reporting a high acceptance of IBIs for depression. The AFI had no significant effect on acceptance (IG: M = 10.55, SD = 4.69, n = 70; KG: M = 9.65, SD = 4.27, n = 71; d = 0.20 [95%-CI: -0.13; 0.53]) and the predictors of acceptance. Yet, subgroup analyses yielded a trend for depressed, diabetes-related distressed, female and younger (<59) participants and for those who do not frequently use the Internet to profit from the AFI.
   Conclusion: Diabetes patients show a rather low acceptance toward IBIs for depression. Findings indicate that the AFI is likely to be effective in the subgroup of depressed, diabetes-related distressed, female or younger diabetes patients, but not in the whole target population. Hence, AFIs might need to be tailored to the specific needs of subpopulations. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
C1 [Baumeister, H.; Nowoczin, L.; Lin, J.; Seifferth, H.] Univ Freiburg, Inst Psychol, Dept Rehabil Psychol & Psychotherapy, D-79085 Freiburg, Germany.
   [Baumeister, H.; Lin, J.] Univ Freiburg, Fac Med, D-79085 Freiburg, Germany.
   [Seufert, J.; Laubner, K.] Univ Med Ctr Freiburg, Freiburg, Germany.
   [Ebert, D. D.] Leuphana Univ, Div Hlth Trainings Online, Luneburg, Germany.
   [Ebert, D. D.] Univ Marburg, Dept Psychol Clin Psychol & Psychotherapy, D-35032 Marburg, Germany.
RP Baumeister, H (reprint author), Univ Freiburg, Inst Psychol, Dept Rehabil Psychol & Psychotherapy, Engelbergerstr 41, D-79085 Freiburg, Germany.
EM baumeister@psychologie.uni-freiburg.de
FU German statutory pension insurance scheme
FX This study was partly funded by the German statutory pension insurance
   scheme (project: Internet-based health interventions: state of research
   and implementation possibilities for the medical rehabilitation).
CR Andrews G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013196
   Baumeister H, CLIN J PAIN IN PRESS
   Baumeister H, 2012, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858
   Baumeister H, 2008, KLIN VERHALTENSMED R, V82, P254
   Baumeister H, 2007, SOC PSYCH PSYCH EPID, V42, P537, DOI 10.1007/s00127-007-0204-1
   Baumeister H, 2012, CURR OPIN PSYCHIATR, V25, P405, DOI 10.1097/YCO.0b013e3283556c63
   Baumeister H, 2012, J AFFECT DISORDERS, V139, P240, DOI 10.1016/j.jad.2011.05.025
   Baumeister H, 2011, PSYCHOTHER PSYCHOSOM, V80, P275, DOI 10.1159/000323404
   Baumeister H, 2010, J CLIN EPIDEMIOL, V63, P558, DOI 10.1016/j.jclinepi.2009.08.009
   Bennett GG, 2009, ANNU REV PUBL HEALTH, V30, P273, DOI 10.1146/annurev.publhealth.031308.100235
   Bhattacherjee A, 2009, BEHAV INFORM TECHNOL, V28, P389, DOI 10.1080/01449290802121230
   Blankers M, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1448
   Brouwer W, 2009, HEALTH EDUC, V109, P460, DOI 10.1108/09654280911001149
   Brouwer W, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.956
   Celik V, 2013, COMPUT EDUC, V60, P148, DOI 10.1016/j.compedu.2012.06.008
   Corrigan P. W., 2002, AM J PSYCHIAT REHABI, V6, P312, DOI [10.1080/10973430208408441, DOI 10.1080/10973430208408441]
   Cranen K, 2012, HEALTH EXPECT, V15, P339, DOI 10.1111/j.1369-7625.2011.00668.x
   Crutzen R, 2011, HEALTH EDUC BEHAV, V38, P49, DOI 10.1177/1090198110372878
   Dattakumar Ambica, 2012, Stud Health Technol Inform, V178, P33
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   Donkin L, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1772
   Gun SY, 2011, AUSTRALAS PSYCHIATRY, V19, P259, DOI 10.3109/10398562.2011.562295
   Haase R, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.2133
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   Holden RJ, 2010, J BIOMED INFORM, V43, P159, DOI 10.1016/j.jbi.2009.07.002
   Hutter N, 2010, DIABETOLOGIA, V53, P2470, DOI 10.1007/s00125-010-1873-y
   Jimison Holly, 2008, Evid Rep Technol Assess (Full Rep), P1
   Kaltenthaler E, 2008, PSYCHOL MED, V38, P1521, DOI 10.1017/S0033291707002607
   Kim J, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.2143
   Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026
   Lin EHB, 2008, J PSYCHOSOM RES, V65, P571, DOI 10.1016/j.jpsychores.2008.06.007
   Lin J, 2013, REHABILITATION, V52, P155, DOI 10.1055/s-0033-1343491
   Mitchell N, 2007, BEHAV COGN PSYCHOTH, V35, P421, DOI 10.1017/S1352465807003700
   Mohr DC, 2010, ANN BEHAV MED, V40, P89, DOI 10.1007/s12160-010-9203-7
   Moxham C, 2012, HEALTH SERV MANAG RE, V25, P129, DOI 10.1258/hsmr.2012.012018
   NICE, DEPR AD CHRON PHYS H
   Nijland N, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1603
   Nobis S, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-306
   Nowoczin L., 2013, AKZEPTANZ INTERNETBA
   Or CKL, 2011, J AM MED INFORM ASSN, V18, P51, DOI 10.1136/jamia.2010.007336
   Park M, 2013, GEN HOSP PSYCHIAT, V35, P217, DOI 10.1016/j.genhosppsych.2013.01.006
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Richards D, 2012, CLIN PSYCHOL REV, V32, P329, DOI 10.1016/j.cpr.2012.02.004
   Smith KLW, 2013, HEALTH N Y, V5, P1561, DOI DOI 10.4236/HEALTH.2013.510212
   Taiwo Ayankunle Adegbite, 2013, Journal of Theoretical and Applied Information Technology, V49, P48
   Thoolen B, 2007, DIABETES EDUCATOR, V33, P465, DOI 10.1177/0145721707301491
   van Bastelaar KMP, 2011, DIABETES CARE, V34, P320, DOI 10.2337/dc10-1248
   van Gemert-Pijnen JEWC, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1672
   Venkatesh V, 2003, MIS QUART, V27, P425
   Waller R, 2009, PSYCHOL MED, V39, P705, DOI 10.1017/S0033291708004224
   Wilson EV, 2004, J AM MED INFORM ASSN, V11, P241, DOI 10.1197/jamia.1475
   Wootton BM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020548
NR 52
TC 30
Z9 31
U1 0
U2 25
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
EI 1872-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD JUL
PY 2014
VL 105
IS 1
BP 30
EP 39
DI 10.1016/j.diabres.2014.04.031
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AK8YT
UT WOS:000338715400007
PM 24862240
DA 2019-01-08
ER

PT J
AU Hernandez, R
   Ruggiero, L
   Riley, BB
   Wang, YM
   Chavez, N
   Quinn, LT
   Gerber, BS
   Choi, YK
AF Hernandez, Rosalba
   Ruggiero, Laurie
   Riley, Barth B.
   Wang, Yamin
   Chavez, Noel
   Quinn, Lauretta T.
   Gerber, Ben S.
   Choi, Young-Ku
TI Correlates of Self-Care in Low-Income African American and Latino
   Patients With Diabetes
SO HEALTH PSYCHOLOGY
LA English
DT Article
DE diabetes self-care; minorities; biopsychosocial factors; correlates;
   Type 2 diabetes
ID GLYCEMIC CONTROL; RACIAL/ETHNIC DIFFERENCES; PHYSICAL-ACTIVITY;
   BLOOD-GLUCOSE; UNITED-STATES; ETHNIC-GROUPS; MANAGEMENT; ADHERENCE;
   ASSOCIATION; DISPARITIES
AB Objective: This study aimed to examine diabetes self-care (DSC) patterns in low-income African American and Latino patients with Type 2 diabetes, and identify patient-related, biomedical/disease-related, and psychosocial correlates of DSC. Method: We performed cross-sectional analysis of survey data from African Americans and Latinos aged >= 18 years with Type 2 diabetes (n = 250) participating in a diabetes self-management intervention at 4 primary care clinics. The Summary of Diabetes Self-Care Activities captured the subcomponents of healthy eating, physical activity, blood sugar testing, foot care, and smoking. Correlates included patient-related attributes, biomedical/disease-related factors, and psychosocial constructs, with their multivariable influence assessed with a 3-step model building procedure using regression techniques. Results: Baseline characteristics were as follows: mean age of 53 years (SD = 12.4); 69% female; 53% African American; 74% with incomes below $20,000; and 60% with less than a high school education. DSC performance levels were highest for foot care (4.5/7 days) and lowest for physical activity (2.5/7 days). Across racial/ethnic subgroups, diabetes-related distress was the strongest correlate for DSC when measured as a composite score. Psychosocial factors accounted for 14% to 33% of variance in self-care areas for both racial/ethnic groups. Patient characteristics were more salient correlates in Hispanic/Latinos when examining the self-care subscales, particularly those requiring monetary resources. Conclusions: Important information is provided on specific DSC patterns in a sample of ethnic/racial minorities with Type 2 diabetes. Significant correlates found may help with identification and intervention of patients who may benefit from strategies to increase self-care adherence.
C1 [Hernandez, Rosalba] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA.
   [Hernandez, Rosalba; Ruggiero, Laurie; Wang, Yamin; Chavez, Noel; Gerber, Ben S.] Univ Illinois, Sch Publ Hlth, Inst Hlth Res & Policy & Community Hlth Sci, Chicago, IL USA.
   [Riley, Barth B.] Univ Illinois, Coll Nursing, Dept Hlth Syst Sci, Chicago, IL USA.
   [Quinn, Lauretta T.] Univ Illinois, Coll Nursing, Dept Biobehav Hlth Sci, Chicago, IL USA.
   [Gerber, Ben S.] Jesse Brown VA Med Ctr, Chicago, IL USA.
   [Choi, Young-Ku] Univ Illinois, Sch Publ Hlth, Inst Hlth Res & Policy & Epidemiol & Biostat, Chicago, IL USA.
RP Hernandez, R (reprint author), Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, 680 N Lake Shore Dr, Chicago, IL 60611 USA.
EM rosalba.hernandez@northwestern.edu
OI Gerber, Ben/0000-0003-4367-6396
FU National Institute of Nursing Research [5RO1 NR010313]; National
   Institute of Health (NIH) [5T32 HL069771-10]
FX Research reported in this publication was supported by the National
   Institute of Nursing Research under Award Number 5RO1 NR010313 (Laurie
   Ruggiero, Principal Investigator). Rosalba Hernandez was supported by
   the National Institute of Health (NIH) under Award Number 5T32
   HL069771-10 (Martha L. Daviglus, Principal Investigator). The content
   and views expressed in this article are those of the authors and do not
   necessarily reflect the position or policy of the National Institute of
   Nursing Research, the Department of Veterans Affairs, the United States
   government, or the National Institutes of Health. Rosalba Hernandez
   researched data, wrote, and reviewed/edited the manuscript. Laurie
   Ruggiero contributed to conceptualization of study, interpretation of
   data, discussion, and reviewed/edited the manuscript. Barth B. Riley and
   Young-Ku Choi researched data, contributed to the design of analytical
   methods, and reviewed/edited the manuscript. Yamin Wang conducted the
   data analysis and reviewed/edited the manuscript. Noel Chavez, Lauretta
   T. Quinn, and Ben S. Gerber contributed to conceptualization of study,
   provided recommendations on study methods, and reviewed/edited the
   manuscript. Rosalba Hernandez, Laurie Ruggiero, and Yamin Wang had full
   access to the data and serve as guarantors, taking responsibility for
   the integrity of the data and accuracy of data analysis. The authors
   would like to thank all members of the research team and the
   administrators, staff, and patients of Access Community Health Network
   for their efforts and support of this project.
CR Anderson RM, 2003, DIABETES CARE, V26, P1641, DOI 10.2337/diacare.26.5.1641-a
   Asche C, 2011, CLIN THER, V33, P74, DOI 10.1016/j.clinthera.2011.01.019
   Belza Basia, 2004, Prev Chronic Dis, V1, pA09
   Boule NG, 2001, JAMA-J AM MED ASSOC, V286, P1218, DOI 10.1001/jama.286.10.1218
   Centers for Disease Control and Prevention, 2005, TRENDS LEIS TIM PHYS, V54, P991
   Choi S, 2011, ETHNIC DIS, V21, P183
   Concha JB, 2009, DIABETES EDUCATOR, V35, P941, DOI 10.1177/0145721709344125
   Delamater AM, 2006, CLIN DIABETES, V24, P71, DOI [10.2337/diaclin.24.2.71, DOI 10.2337/DIACLIN.24.2.71]
   Dunn MZ, 2008, J TRANSCULT NURS, V19, P40, DOI 10.1177/1043659607309138
   Federal Interagency Forum on Aging-Related Statics, 2010, OLD AM 2010 KEY IND
   Harris MI, 1998, DIABETES CARE, V21, pC11, DOI 10.2337/diacare.21.3.C11
   Hayes C, 2008, J AM DIET ASSOC, V108, pS19, DOI 10.1016/j.jada.2008.01.016
   HILL AB, 1965, P ROY SOC MED, V58, P295
   Huang ES, 2009, DIABETES CARE, V32, P311, DOI 10.2337/dc08-1307
   Jette AM, 1998, GERONTOLOGIST, V38, P412, DOI 10.1093/geront/38.4.412
   Kirk JK, 2007, ETHNIC DIS, V17, P135
   Levine DA, 2009, ETHNIC DIS, V19, P97
   Little R.J.A, 1987, STAT ANAL MISSING DA
   Lynch EB, 2012, HEALTH EDUC RES, V27, P814, DOI 10.1093/her/cys058
   Mier Nelda, 2007, Prev Chronic Dis, V4, pA24
   National Glycohemoglobin Standardization Program, 2013, HARM HEM ALC TEST
   Norris SL, 2002, DIABETES CARE, V25, P1159, DOI 10.2337/diacare.25.7.1159
   Nwasuruba C, 2007, J GEN INTERN MED, V22, P115, DOI 10.1007/s11606-007-0120-9
   Orzech KM, 2013, HEALTH EDUC BEHAV, V40, P56, DOI 10.1177/1090198112436970
   Parada H, 2012, DIABETES EDUCATOR, V38, P552, DOI 10.1177/0145721712445215
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Ruggiero L, 1997, DIABETES CARE, V20, P568, DOI 10.2337/diacare.20.4.568
   Sallis JF, 2000, MED SCI SPORT EXER, V32, P1598
   Schectman JM, 2002, DIABETES CARE, V25, P1015, DOI 10.2337/diacare.25.6.1015
   Sigal RJ, 2006, DIABETES CARE, V29, P1433, DOI 10.2337/dc06-9910
   Snowling NJ, 2006, DIABETES CARE, V29, P2518, DOI 10.2337/dc06-1317
   St John A, 2006, CLIN CHIM ACTA, V365, P257, DOI 10.1016/j.cca.2005.09.003
   Thackeray R, 2004, DIABETES EDUCATOR, V30, P665, DOI 10.1177/014572170403000418
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Trief PM, 2013, ETHNIC HEALTH, V18, P83, DOI 10.1080/13557858.2012.700915
   Vincent D, 2008, NURS RES, V57, P101, DOI 10.1097/01.NNR.0000313484.18670.ab
   WILSON W, 1986, DIABETES CARE, V9, P614, DOI 10.2337/diacare.9.6.614
NR 37
TC 5
Z9 5
U1 1
U2 27
PU AMER PSYCHOLOGICAL ASSOC
PI WASHINGTON
PA 750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA
SN 0278-6133
EI 1930-7810
J9 HEALTH PSYCHOL
JI Health Psychol.
PD JUL
PY 2014
VL 33
IS 7
BP 597
EP 607
DI 10.1037/hea0000043
PG 11
WC Psychology, Clinical; Psychology
SC Psychology
GA AK5CS
UT WOS:000338442500003
PM 24364373
OA Green Accepted
DA 2019-01-08
ER

PT J
AU van Son, J
   Nyklicek, I
   Pop, VJ
   Blonk, MC
   Erdtsieck, RJ
   Pouwer, F
AF van Son, Jenny
   Nyklicek, Ivan
   Pop, Victor J.
   Blonk, Marion C.
   Erdtsieck, Ronald J.
   Pouwer, Francois
TI Mindfulness-based cognitive therapy for people with diabetes and
   emotional problems: Long-term follow-up findings from the DiaMind
   randomized controlled trial
SO JOURNAL OF PSYCHOSOMATIC RESEARCH
LA English
DT Article
DE Anxiety; Comorbidity; Diabetes; Depressive symptoms; Mindfulness-based
   cognitive therapy; Randomized controlled trial
ID QUALITY-OF-LIFE; DEPRESSION; DISTRESS; INTERVENTION; ANXIETY; ADULTS;
   OUTPATIENTS; PREVALENCE; MELLITUS.; SYMPTOMS
AB Objective: The DiaMind trial showed beneficial immediate effects of mindfulness-based cognitive therapy (MBCT) on emotional distress, but not on diabetes distress and HbA(1c). The aim of the present report was to examine if the effects would be sustained after six month follow-up.
   Methods: In the DiaMind trial, 139 outpatients with diabetes (type-I or type-II) and a lowered level of emotional well-being were randomized into MBCT (n = 70) or a waiting list with treatment as usual (TAU: n = 69). Primary outcomes were perceived stress, anxiety and depressive symptoms, and diabetes distress. Secondary outcomes were, among others, health status, and glycemic control (HbA(1c)).
   Results: Compared to TAU, MBCT showed sustained reductions at follow-up in perceived stress (p < .001, d = .76), anxiety (p < .001, assessed by HADS d = .83; assessed by POMS d = .92), and HADS depressive symptoms (p = .004, d = .51), but not POMS depressive symptoms when using Bonferroni correction for multiple testing (p = .016, d = .48). No significant between-group effect was found on diabetes distress and HbA(1c).
   Conclusion: This study showed sustained benefits of MBCT six months after the intervention on emotional distress in people with diabetes and a lowered level of emotional well-being. (C) 2014 Elsevier Inc. All rights reserved.
C1 [van Son, Jenny; Nyklicek, Ivan; Pop, Victor J.; Pouwer, Francois] Tilburg Univ, Dept Med & Clin Psychol, Ctr Res Psychol Somat Dis CoRPS, NL-5000 LE Tilburg, Netherlands.
   [Blonk, Marion C.] Catharina Hosp, Dept Internal Med, Eindhoven, Netherlands.
   [Erdtsieck, Ronald J.] Maxima Med Ctr, Dept Internal Med, Eindhoven, Netherlands.
RP Nyklicek, I (reprint author), POB 90153, NL-5000 LE Tilburg, Netherlands.
EM I.Nyklicek@tilburguniversity.edu
FU Dutch Diabetes Research Foundation (Diabetesfonds) [2008.13.005]
FX The study is supported by a grant from the Dutch Diabetes Research
   Foundation (Diabetesfonds) (project number 2008.13.005, awarded to Dr I.
   Nyklicek).
CR American Diabetes Association, 2013, DIABETES CARE, V36, pS11
   Baer RA, 2006, ASSESSMENT, V13, P27, DOI 10.1177/1073191105283504
   Baumeister H, 2012, COCHRANE DB SYST REV, V12
   Branstrom R, 2012, INT J BEHAV MED, V19, P535, DOI 10.1007/s12529-011-9192-3
   Cohen J, 1977, STAT POWER ANAL BEHA
   Cohen S, 1988, SOC PSYCHOL HEALTH, V1, P31
   Egede LE, 2005, DIABETES CARE, V28, P1339, DOI 10.2337/diacare.28.6.1339
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Franck E, 2008, PSYCHOL BELG, V48, P25, DOI 10.5334/pb-48-1-25
   Gregg JA, 2007, J CONSULT CLIN PSYCH, V75, P336, DOI 10.1037/0022-006X.75.2.336
   Grigsby AB, 2002, J PSYCHOSOM RES, V53, P1053, DOI 10.1016/S0022-3999(02)00417-8
   Hartmann M, 2012, DIABETES CARE, V35, P945, DOI 10.2337/dc11-1343
   Hofmann SG, 2010, J CONSULT CLIN PSYCH, V78, P169, DOI 10.1037/a0018555
   Jenkinson C, 1997, J PUBLIC HEALTH MED, V19, P179, DOI 10.1093/oxfordjournals.pubmed.a024606
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Makine C, 2009, DIABETIC MED, V26, P28, DOI 10.1111/j.1464-5491.2008.02606.x
   Mirowsky J, 2002, J HEALTH SOC BEHAV, V43, P152, DOI 10.2307/3090194
   Morone NE, 2008, PAIN, V134, P310, DOI 10.1016/j.pain.2007.04.038
   Pbert L, 2012, THORAX, V67, P769, DOI 10.1136/thoraxjnl-2011-200253
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Pouwer F, 2010, DIABETIC MED, V27, P217, DOI 10.1111/j.1464-5491.2009.02903.x
   Schram MT, 2009, CURR DIABETES REV, V5, P112, DOI 10.2174/157339909788166828
   Segal Z., 2002, MINDFULNESS BASED CO
   van Dooren FEP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057058
   van Son J, 2013, DIABETES CARE, V36, P823, DOI 10.2337/dc12-1477
   van Son J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-131
   Vollestad J, 2011, BEHAV RES THER, V49, P281, DOI 10.1016/j.brat.2011.01.007
   Wald F., 1990, NED T PSYCHOL, V45, P86
   Zangi HA, 2012, ANN RHEUM DIS, V71, P911, DOI 10.1136/annrheumdis-2011-200351
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
NR 30
TC 25
Z9 25
U1 4
U2 56
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0022-3999
EI 1879-1360
J9 J PSYCHOSOM RES
JI J. Psychosomat. Res.
PD JUL
PY 2014
VL 77
IS 1
BP 81
EP 84
DI 10.1016/j.jpsychores.2014.03.013
PG 4
WC Psychiatry
SC Psychiatry
GA AJ4KK
UT WOS:000337645000013
PM 24913347
OA Bronze
DA 2019-01-08
ER

PT J
AU Fisher, L
   Gonzalez, JS
   Polonsky, WH
AF Fisher, L.
   Gonzalez, J. S.
   Polonsky, W. H.
TI The confusing tale of depression and distress in patients with diabetes:
   a call for greater clarity and precision
SO DIABETIC MEDICINE
LA English
DT Review
ID GLYCEMIC CONTROL; SELF-CARE; BIDIRECTIONAL ASSOCIATION; MEDICATION
   ADHERENCE; CLINICAL DEPRESSION; MAJOR DEPRESSION; CONTROLLED-TRIAL;
   METAANALYSIS; MANAGEMENT; SYMPTOMS
AB Studies have identified significant linkages between depression and diabetes, with depression associated with poor self-management behaviour, poor clinical outcomes and high rates of mortality. However, findings are not consistent across studies, yielding confusing and contradictory results about these relationships. We suggest that there has been a failure to define and measure depression' in a consistent manner. Because the diagnosis of depression is symptom-based only, without reference to source or content, the context of diabetes is not considered when addressing the emotional distress experienced by individuals struggling with diabetes. To reduce this confusion, we suggest that an underlying construct of emotional distress' be considered as a core construct to link diabetes-related distress, subclinical depression, elevated depression symptoms and major depressive disorder (MDD). We view emotional distress as a single, continuous dimension that has two primary characteristics: content and severity; that the primary content of emotional distress among these individuals include diabetes and its management, other life stresses and other contributors; and that both the content and severity of distress be addressed directly in clinical care. We suggest further that all patients, even those whose emotional distress rises to the level of MDD or anxiety disorders, can benefit from consideration of the content of distress to direct care effectively, and we suggest strategies for integrating the emotional side of diabetes into regular diabetes care. This approach can reduce confusion between depression and distress so that appropriate and targeted patient-centred interventions can occur.
C1 [Fisher, L.] Univ Calif San Francisco, San Francisco, CA 94143 USA.
   [Gonzalez, J. S.] Yeshiva Univ, Ferkauf Grad Sch Psychol, Bronx, NY USA.
   [Gonzalez, J. S.] Albert Einstein Coll Med, Bronx, NY 10467 USA.
   [Polonsky, W. H.] Univ Calif San Diego, San Diego, CA 92103 USA.
   [Polonsky, W. H.] Behav Diabet Inst, San Diego, CA USA.
RP Fisher, L (reprint author), Univ Calif San Francisco, San Francisco, CA 94143 USA.
EM fisherl@fcm.ucsf.edu
FU National Institutes of Health (NIH) [DK061937, DK094863, DK020541,
   DK098742]
FX This article was supported in part by National Institutes of Health
   (NIH) grants DK061937, DK094863, DK020541 and DK098742.
CR Aikens JE, 2012, DIABETES CARE, V35, P2472, DOI 10.2337/dc12-0181
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Black SA, 2003, DIABETES CARE, V26, P2822, DOI 10.2337/diacare.26.10.2822
   Bogner HR, 2012, ANN FAM MED, V10, P15, DOI 10.1370/afm.1344
   Chan JCN, 2009, DIABETES CARE, V32, P227, DOI 10.2337/dc08-0435
   Cole J, 2008, BRIT J PSYCHIAT, V192, P83, DOI 10.1192/bjp.bp.107.039826
   COYNE JC, 1994, PSYCHOL BULL, V116, P29, DOI 10.1037/0033-2909.116.1.29
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   Esbitt S. A., 2013, SCREENING DEPRESSION
   Fisher EB, 2012, J AFFECT DISORDERS, V142S1, P556
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2011, PATIENT EDUC COUNS, V86, P372
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2013, DIABETES CARE, V36, P2551, DOI 10.2337/dc12-2493
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Gask L, 2011, CHRONIC ILLN, V7, P239, DOI 10.1177/1742395311403636
   Georgiades A, 2007, PSYCHOSOM MED, V69, P235, DOI 10.1097/PSY.0b013e318042588d
   Goldberg D, 2011, WORLD PSYCHIATRY, V10, P226
   Golden SH, 2008, JAMA-J AM MED ASSOC, V299, P2751, DOI 10.1001/jama.299.23.2751
   Gonzalez JS, 2008, DIABETIC MED, V25, P1102, DOI 10.1111/j.1464-5491.2008.02535.x
   Gonzalez JS, 2010, DIABETOLOGIA, V53, P2241, DOI 10.1007/s00125-010-1821-x
   Gonzalez JS, 2007, DIABETES CARE, V30, P2222, DOI 10.2337/dc07-0158
   Gonzalez JS, 2011, DIABETES CARE, V34, P236, DOI 10.2337/dc10-1970
   Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341
   Katon W, 2010, DEPRESSION DIABETES
   Katon WJ, 2010, NEW ENGL J MED, V363, P2622
   Li C, 2008, DIABETIC MED, V25, P878, DOI 10.1111/j.1464-5491.2008.02477.x
   Lin EHB, 2006, ANN FAM MED, V4, P46, DOI 10.1370/afm.423
   Lustman PJ, 2000, DIABETES CARE, V23, P618, DOI 10.2337/diacare.23.5.618
   Mezuk B, 2013, HEALTH PSYCHOL, V32, P254, DOI 10.1037/a0029014
   Nouwen A, 2011, DIABETES CARE, V34, P752, DOI 10.2337/dc10-1414
   Pan A, 2010, ARCH INTERN MED, V170, P1884, DOI 10.1001/archinternmed.2010.356
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Pouwer F, 2003, DIABETOLOGIA, V46, P892, DOI 10.1007/s00125-003-1124-6
   Radloff LS, 1977, APPL PSYCH MEAS, V1, P385, DOI DOI 10.1177/014662167700100306
   Roy T, 2012, DIABETIC MED, V29, P164, DOI 10.1111/j.1464-5491.2011.03401.x
   Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737
   Sullivan MD, 2012, DIABETES CARE, V35, P1708, DOI 10.2337/dc11-1791
   Tanenbaum ML, 2012, DIABETES EDUCATOR, V38, P695, DOI 10.1177/0145721712452795
   Trief PM, 2007, DIABETES CARE, V30, P1266, DOI 10.2337/dc06-2476
   Twist K, 2013, PSYCHOSOM MED, V75, P803
   WAKEFIELD JC, 1992, AM PSYCHOL, V47, P373, DOI 10.1037//0003-066X.47.3.373
   Wakefield JC, 2013, WORLD PSYCHIATRY, V12, P44, DOI 10.1002/wps.20015
   Wakefield JC, 2012, COMPR PSYCHIAT, V53, P130, DOI 10.1016/j.comppsych.2011.03.001
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   Williams JW, 2004, ANN INTERN MED, V140, P1015, DOI 10.7326/0003-4819-140-12-200406150-00012
   Wittchen HU, 1994, J PSYCHIATR RES, V28, P57
NR 48
TC 123
Z9 125
U1 6
U2 44
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD JUL
PY 2014
VL 31
IS 7
BP 764
EP 772
DI 10.1111/dme.12428
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AJ4DL
UT WOS:000337621100004
PM 24606397
OA Green Accepted
HC Y
HP N
DA 2019-01-08
ER

PT J
AU Pengpid, S
   Peltzer, K
   Skaal, L
AF Pengpid, Supa
   Peltzer, Karl
   Skaal, Linda
TI Efficacy of a church-based lifestyle intervention programme to control
   high normal blood pressure and/or high normal blood glucose in church
   members: a randomized controlled trial in Pretoria, South Africa
SO BMC PUBLIC HEALTH
LA English
DT Article
ID DIABETES PREVENTION PROGRAM; NEW-ZEALAND; RISK; HEALTH; TRANSLATION
AB Background: In persons 15 years and above in South Africa the prevalence of pre-diabetes and diabetes has been estimated at 9.1% and 9.6%, respectively, and the prevalence of systolic prehypertension and hypertension, 38.2% and 24.6%, respectively. Elevated blood glucose and elevated blood pressure are prototype of preventable chronic cardiovascular disease risk factors. Lifestyle interventions have been shown to control high normal blood pressure and/or high normal blood glucose.
   Methods/Design: This study proposes to evaluate the efficacy of a community (church)-based lifestyle intervention programme to control high normal blood pressure and/or high normal blood glucose in church members in a randomized controlled trial in Gauteng, South Africa. The objectives are to: (1) measure non-communicable diseases profile, including hypertension and diabetes, health behaviours, weight management and psychological distress of church members; (2) measure the reduction of blood glucose and blood pressure levels after the intervention; (3) prevent the development of impaired glucose tolerance; (4) compare health behaviours, weight management and psychological distress, blood glucose and blood pressure levels between intervention and control groups, and within group during 6, 12, 24 and 36 months during and post intervention. The study will use a group-randomized design, recruiting 300 church members from 12 churches. Churches will be randomly assigned to experimental and control conditions.
   Discussion: Lifestyle interventions may prevent from the development of high blood pressure and/or diabetes. The findings will impact public health and will enable the health ministry to formulate policy related to lifestyle interventions to control blood pressure and glucose.
C1 [Pengpid, Supa] Univ Limpopo, Dept Res Dev & Innovat, ZA-0727 Sovenga, Turfloop, South Africa.
   [Pengpid, Supa; Peltzer, Karl] Mahidol Univ, ASEAN Inst Hlth Dev, Phutthamonthon 73170, Nakhonpathom, Thailand.
   [Peltzer, Karl] Univ Limpopo, Dept Psychol, Sovenga, Turfloop, South Africa.
   [Peltzer, Karl] Human Sci Res Council, HIV AIDS TB & STIs HAST, ZA-0001 Pretoria, South Africa.
   [Skaal, Linda] Univ Limpopo, Dept Publ Hlth, ZA-0727 Sovenga, Turfloop, South Africa.
RP Pengpid, S (reprint author), Univ Limpopo, Dept Res Dev & Innovat, ZA-0727 Sovenga, Turfloop, South Africa.
EM supaprom@yahoo.com
FU Directorate General for Development Cooperation (DGDC) through the
   Flemish Interuniversity Council (VLIR-UOS)
FX The trial is funded by the Directorate General for Development
   Cooperation (DGDC) through the Flemish Interuniversity Council
   (VLIR-UOS). Brian Oldenburg and Pelvikki Absetz are thanked for their
   input in the development of previous versions of the protocol. We also
   acknowledge input from Pindile Mntla, Busi Ntuli-Ngcobo, Mashudu Manafe,
   Christophe De Block, Marc Van Sprundel.
CR Absetz P, 2011, GOAL LIFESTYLE IMPLE
   Ackermann RT, 2008, AM J PREV MED, V35, P357, DOI 10.1016/j.amepre.2008.06.035
   Adams G, 2004, J CLIN EPIDEMIOL, V57, P785, DOI 10.1016/j.jclinepi.2003.12.013
   Anderson A, 2002, INT REV MISSION, V91, P523
   Anderson A, 2000, ZION PENTECOST SPIRI
   Anderson Allan H, 1992, THESIS U S AFRICA
   [Anonymous], 2001, SAJCN, V14
   Boltri JM, 2011, J NATL MED ASSOC, V103, P194, DOI 10.1016/S0027-9684(15)30301-1
   Brown N, 2012, DIABETES RES CLIN PR, V98, P369, DOI 10.1016/j.diabres.2012.09.005
   Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702
   Dagogo-Jack S, 2010, MED PRIN PRACT, V19, P167, DOI 10.1159/000285280
   Egan BM, 2010, CARDIOL CLIN, V28, P561, DOI 10.1016/j.ccl.2010.07.008
   Funk KL, 2008, HEALTH PROMOT PRACT, V9, P271, DOI 10.1177/1524839906289035
   Glasgow RE, 2003, AM J PUBLIC HEALTH, V93, P1261, DOI 10.2105/AJPH.93.8.1261
   Hedayati SS, 2011, KIDNEY INT, V79, P1061, DOI 10.1038/ki.2011.46
   Knowler WC, 2002, NEW ENGL J MED, V346, P393
   Lambert E. V., 2001, SAJCN - South African Journal of Clinical Nutrition, V14, pS12
   Lancaster KJ, 2014, AM HEART J, V167, P301, DOI 10.1016/j.ahj.2013.10.026
   Lien LF, 2007, HYPERTENSION, V50, P609, DOI 10.1161/HYPERTENSIONAHA.107.089458
   Lindstrom J, 2013, DIABETOLOGIA, V56, P284, DOI 10.1007/s00125-012-2752-5
   Makrilakis K, 2011, DIABETES METAB, V37, P144, DOI 10.1016/j.diabet.2010.09.006
   Marquez-Celedonio FG, 2009, REV ESP CARDIOL, V62, P86, DOI 10.1016/S0300-8932(09)70025-9
   Maruthur NM, 2009, CIRCULATION, V119, P2026, DOI 10.1161/CIRCULATIONAHA.108.809491
   NATHAN DM, 1997, LANCET S1, V350, pS14, DOI DOI 10.1016/S0140-6736(97)90021-0
   Oettingen G., 2000, INT J EDUC RES, V33, P705, DOI DOI 10.1016/S0883-0355(00)00046-X
   Oexmann Mary Joan, 2000, Ethnicity and Disease, V10, P17
   Orozco LJ, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003054.pub3
   Papadopoulos DP, 2008, HYPERTENS RES, V31, P1681, DOI 10.1291/hypres.31.1681
   Peltzer K, 1999, J RELIG AFR, V29, P387
   Petrella RJ, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-45
   Schulz KF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000251
   Schwarzer R, 1995, SELF EFFICACY CHANGI, P259, DOI DOI 10.1017/CBO9780511527692.011
   Seedat Y K, 2011, S Afr Med J, V102, P57
   Shisana O LD, 2013, SANHANES 1 TEAM S AF
   Simmons D, 1998, DIABETIC MED, V15, P136, DOI 10.1002/(SICI)1096-9136(199802)15:2<136::AID-DIA530>3.3.CO;2-G
   Simmons D, 2004, DIABETIC MED, V21, P122, DOI 10.1111/j.1464-5491.2004.01020.x
   Thomas GN, 2010, CURR DIABETES REV, V6, P378, DOI 10.2174/157339910793499092
   Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801
   Uutela A, 2004, J HEALTH PSYCHOL, V9, P73, DOI 10.1177/1359105304036103
   WHO, 2011, HYP FACT SHEET
   Yoon U, 2012, METABOLISM
NR 41
TC 4
Z9 4
U1 2
U2 23
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD JUN 6
PY 2014
VL 14
AR 568
DI 10.1186/1471-2458-14-568
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA AL2OF
UT WOS:000338964200004
PM 24906450
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Kopf, S
   Oikonomou, D
   Hartmann, M
   Feier, F
   Faude-Lang, V
   Morcos, M
   Haring, HU
   Herzog, W
   Bierhaus, A
   Humpert, PM
   Nawroth, PP
AF Kopf, S.
   Oikonomou, D.
   Hartmann, M.
   Feier, F.
   Faude-Lang, V.
   Morcos, M.
   Haering, H. -U.
   Herzog, W.
   Bierhaus, A.
   Humpert, P. M.
   Nawroth, P. P.
TI Effects of Stress Reduction on Cardiovascular Risk Factors in Type 2
   Diabetes Patients with Early Kidney Disease - Results of a Randomized
   Controlled Trial (HEIDIS)
SO EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
LA English
DT Article
DE type 2 diabetes; psychosocial stress; MBSR; diabetic kidney disease;
   cardiovascular risk
ID CORONARY-HEART-DISEASE; BLOOD-GLUCOSE CONTROL; LONG-TERM; CAROTID
   ATHEROSCLEROSIS; MYOCARDIAL-INFARCTION; PSYCHOSOCIAL STRESS; EMOTIONAL
   DISTRESS; GLYCEMIC CONTROL; MINDFULNESS; MORTALITY
AB Objective: Current guidelines for the treatment of type 2 diabetes focus on pharmacological treatment of glucose and cardio-vascular risk factors. The aim of this prospective randomized controlled intervention study was to examine the effects of a psychosocial intervention on clinical endpoints and risk factors in patients with type 2 diabetes and early diabetic kidney disease.
   Methods: 110 patients were randomized to receive an 8-week mindfulness-based stress reduction (MBSR) training (n = 53) compared to standard care (n = 57). The study was carried out open-labelled and randomization was performed computer-generated in a 1:1 ratio. Primary outcome of the study was the change in urinary albumin excretion (albumin-creatinine-ratio, ACR); secondary outcomes were metabolic parameters, intima media thickness (IMT), psychosocial parameters and cardiovascular events.
   Results: 89 patients (42 in control group and 47 in intervention group) were analysed after 3 years of follow-up. After 1 year, the intervention group showed a reduction of ACR from 44 [16/80] to 39 [20/71] mg/g, while controls increased from 47 [16/120] to 59 [19/128] mg/g (p = 0.05). Parallel to the reduction of stress levels after 1 year, the intervention-group additionally showed reduced catecholamine levels (p < 0.05), improved 24 h-mean arterial (p < 0.05) and maximum systolic blood pressure (p < 0.01), as well as a reduction in IMT (p < 0.01). However, these effects were lost after 2 and 3 years of follow-up.
   Conclusions: This is the first study to show that a psychosocial intervention improves cardiovascular risk factors in high risk type 2 diabetes patients.
C1 [Kopf, S.; Oikonomou, D.; Feier, F.; Morcos, M.; Bierhaus, A.; Humpert, P. M.; Nawroth, P. P.] Heidelberg Univ, Dept Med & Clin Chem 1, D-69120 Heidelberg, Germany.
   [Hartmann, M.; Faude-Lang, V.; Herzog, W.] Heidelberg Univ, Dept Med & Psychosomat 2, D-69120 Heidelberg, Germany.
   [Faude-Lang, V.] Univ Hamburg Eppendorf, Dept Psychosomat Med & Psychotherapy, Hamburg, Germany.
   [Morcos, M.; Humpert, P. M.] Stoffwechselzentrum Rhein Pfalz, Mannheim, Germany.
   [Haering, H. -U.] Univ Tubingen, Dept Med & Clin Chem 4, Tubingen, Germany.
RP Kopf, S (reprint author), Heidelberg Univ, Dept Med & Clin Chem 1, Neuenheimer Feld 410, D-69120 Heidelberg, Germany.
EM Stefan.Kopf@med.uni-heidelberg.de
FU Manfred Lautenschlager Foundation; Dietmar Hopp Foundation; Deutsches
   Zentrum fur Diabetesforschund (DZD); Institute for Diabetes Research and
   Metabolic Diseases; Federal Ministry of Education and Research (BMBF)
FX This study was supported by the Manfred Lautenschlager Foundation and
   Dietmar Hopp Foundation (both to P. Nawroth) and the Deutsches Zentrum
   fur Diabetesforschund (DZD) in cooperation with the Institute for
   Diabetes Research and Metabolic Diseases (to H-U. Haring, University of
   Tubingen, Germany). The Manfred Lautenschlager Foundation is a privately
   sourced foundation to this project. The funding was used to support
   physicians and study nurses as well as laboratory materials. The Dietmar
   Hopp Foundation is a privately sourced foundation supporting part of
   this study with laboratory materials. The Deutsches Zentrum fur
   Diabetesforschung is funded by the Federal Ministry of Education and
   Research (BMBF). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR ADAMS DO, 1994, PSYCHOSOM MED, V56, P316, DOI 10.1097/00006842-199407000-00007
   Berry JD, 2012, NEW ENGL J MED, V366, P321, DOI 10.1056/NEJMoa1012848
   Bierhaus A, 2006, ANESTHESIOL CLIN N A, V24, P325, DOI 10.1016/j.atc.2006.01.001
   Bierhaus A, 2003, P NATL ACAD SCI USA, V100, P1920, DOI 10.1073/pnas.0438019100
   Blumenthal JA, 2005, JAMA-J AM MED ASSOC, V293, P1626, DOI 10.1001/jama.293.13.1626
   Brand S, 2012, NEUROPSYCHOBIOLOGY, V65, P109, DOI 10.1159/000330362
   Cao JJ, 2008, ATHEROSCLEROSIS, V197, P806, DOI 10.1016/j.atherosclerosis.2007.07.029
   Castillo-Richmond A, 2000, STROKE, V31, P568, DOI 10.1161/01.STR.31.3.568
   Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5
   Crouse JR, 2007, JAMA-J AM MED ASSOC, V297, P1344, DOI 10.1001/jama.297.12.1344
   Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804
   de Groot E, 1998, J AM COLL CARDIOL, V31, P1561, DOI 10.1016/S0735-1097(98)00170-3
   Denollet J, 2001, CIRCULATION, V104, P2018, DOI 10.1161/hc4201.097940
   Deutsche Diabetes Gesellschaft. (DDG), 2006, GUID DIAGN TREATM FO
   Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431
   Eurich DT, 2004, DIABETES CARE, V27, P1330, DOI 10.2337/diacare.27.6.1330
   Faude-Lang V, 2010, PSYCHOTHER PSYCH MED, V60, P185, DOI 10.1055/s-0030-1248420
   Fields JZ, 2002, AM J CARDIOL, V89, P952, DOI 10.1016/S0002-9149(02)02245-2
   Fujihara K, 2012, EXP CLIN ENDOCR DIAB, V120, P560, DOI 10.1055/s-0032-1314873
   Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245
   Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743
   Goldstein David S, 2008, Endocr Regul, V42, P111
   Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404
   Hamer M, 2008, J AM COLL CARDIOL, V52, P2156, DOI 10.1016/j.jacc.2008.08.057
   Hartmann M, 2012, DIABETES CARE, V35, P945, DOI 10.2337/dc11-1343
   Hu ZW, 1999, J PHARMACOL EXP THER, V290, P28
   Humpert PM, 2007, HORM METAB RES, V39, P899, DOI 10.1055/s-2007-993155
   Kabat-Zinn J., 1990, FULL CATASTROPHE LIV
   Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006
   Lin EHB, 2010, DIABETES CARE, V33, P264, DOI 10.2337/dc09-1068
   Lowe B, 2004, J AFFECT DISORDERS, V78, P131, DOI 10.1016/S0165-0327(02)00237-9
   Ludwig DS, 2008, JAMA-J AM MED ASSOC, V300, P1350, DOI 10.1001/jama.300.11.1350
   McEwen BS, 2000, NEUROPSYCHOPHARMACOL, V22, P108, DOI 10.1016/S0893-133X(99)00129-3
   Nawroth PP, 2010, EXP CLIN ENDOCR DIAB, V118, P1, DOI 10.1055/s-0029-1246117
   Ninomiya T, 2009, J AM SOC NEPHROL, V20, P1813, DOI 10.1681/ASN.2008121270
   Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489
   Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987
   Rosenkranz MA, 2013, BRAIN BEHAV IMMUN, V27, P174, DOI 10.1016/j.bbi.2012.10.013
   Rosenzweig S, 2010, J PSYCHOSOM RES, V68, P29, DOI 10.1016/j.jpsychores.2009.03.010
   Rozanski A, 1999, CIRCULATION, V99, P2192, DOI 10.1161/01.CIR.99.16.2192
   RUBIN RR, 1992, DIABETES CARE, V15, P1640, DOI 10.2337/diacare.15.11.1640
   Samann A, 2012, EXP CLIN ENDOCR DIAB, V120, P335, DOI 10.1055/s-0031-1299705
   Surwit RS, 2002, DIABETES CARE, V25, P30, DOI 10.2337/diacare.25.1.30
   Thayer JF, 2010, INT J CARDIOL, V141, P122, DOI 10.1016/j.ijcard.2009.09.543
   van Son J, 2013, DIABETES CARE, V36, P823, DOI 10.2337/dc12-1477
   von Eynatten M, 2009, DIABETES, V58, P2093, DOI 10.2337/db09-0204
   Walton KG, 2002, BEHAV MED, V28, P106, DOI 10.1080/08964280209596049
   Ward D, 2002, J VASC RES, V39, P1, DOI 10.1159/000048988
   Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292
   Yang Z, 2013, EXP CLIN ENDOCR DIAB, V121, P372, DOI 10.1055/s-0033-1341520
   Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9
   1998, LANCET, V352, P854
   2000, LANCET, V355, P253
NR 53
TC 12
Z9 12
U1 5
U2 31
PU JOHANN AMBROSIUS BARTH VERLAG MEDIZINVERLAGE HEIDELBERG GMBH
PI STUTTGART
PA RUEDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 0947-7349
EI 1439-3646
J9 EXP CLIN ENDOCR DIAB
JI Exp. Clin. Endocrinol. Diabet.
PD JUN
PY 2014
VL 122
IS 6
BP 341
EP 349
DI 10.1055/s-0034-1372583
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AW4RQ
UT WOS:000346268700005
PM 24798861
DA 2019-01-08
ER

PT J
AU Byles, JE
   Robinson, I
   Banks, E
   Gibson, R
   Leigh, L
   Rodgers, B
   Curryer, C
   Jorm, L
AF Byles, Julie E.
   Robinson, Ian
   Banks, Emily
   Gibson, Richard
   Leigh, Lucy
   Rodgers, Bryan
   Curryer, Cassie
   Jorm, Louisa
TI PSYCHOLOGICAL DISTRESS AND COMORBID PHYSICAL CONDITIONS: DISEASE OR
   DISABILITY?
SO DEPRESSION AND ANXIETY
LA English
DT Article
DE psychological distress; mental health; comorbidity; chronic disease;
   socioeconomic factors; patient care planning; disability
ID PERCEIVED SOCIAL SUPPORT; COMMUNITY-HEALTH SURVEY; FUNCTIONAL
   DISABILITY; DEPRESSIVE SYMPTOMS; INTERVIEW SURVEY; HEART-DISEASE;
   RISK-FACTOR; US ADULTS; LATE-LIFE; ILLNESS
AB Background: The relationship between comorbidity and psychological distress is well documented, however the mechanism of this association is unclear. We aim to assess the extent to which the association between common chronic conditions and high scores on the Kessler Psychological Distress Scale (K10) measure of psychological distress vary according to comorbid conditions, disability, and sociodemographic circumstances. Methods: Analysis of self-reported cross-sectional data from the New South Wales 45 and Up Study, Australia, for 236,508 participants aged 45 years and over, using logistic regression modeling. Results: Self-reported heart attack/angina, other heart disease, stroke, and diabetes were all significantly associated with higher risk of high/very high K10 scores. These associations were attenuated, but remained statistically significant, when comorbidity, disability, and sociodemographic factors were added to the model. Men reporting needing help for daily tasks were nine times as likely to report high/very high K10 scores as those without this need, and women reporting needing help were seven times more likely to have high/very high K10 scores. Conclusions: Heart attack/angina, other heart disease, stroke, and diabetes are all significantly associated with psychological distress. However, these effects are partly explained by other comorbid conditions, limitations on physical functioning, and sociodemographic factors. These findings highlight the importance of developing public health policies that encompass psychological, physiological, and social domains, and provide crucial insights for clinicians in identifying and supporting those people at risk of psychological distress. Depression and Anxiety 31: 524-532, 2014. (C) 2013 Wiley Periodicals, Inc.
C1 [Byles, Julie E.; Gibson, Richard; Leigh, Lucy; Curryer, Cassie] Univ Newcastle, Res Ctr Gender Hlth & Ageing, Fac Hlth & Med, Newcastle, NSW 2308, Australia.
   [Byles, Julie E.] Univ Newcastle, World Hlth Org WHO Collaborating Ctr Internatl Lo, Newcastle, NSW 2308, Australia.
   [Byles, Julie E.] HMRI, Publ Hlth Capac Bldg Grp, Newcastle, NSW, Australia.
   [Byles, Julie E.] AAG, Melbourne, Vic, Australia.
   [Robinson, Ian] Univ Newcastle, Acad & Global Relat Div, Newcastle, NSW 2308, Australia.
   [Banks, Emily; Jorm, Louisa] Univ Technol Sydney, Sax Inst, Sydney, NSW 2007, Australia.
   [Banks, Emily] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia.
   [Rodgers, Bryan] Australian Natl Univ, Australian Demog & Social Res Inst, Canberra, ACT, Australia.
   [Rodgers, Bryan] Australian Natl Univ, Coll Arts & Social Sci, Canberra, ACT, Australia.
   [Jorm, Louisa] Univ Western Sydney, Dept Populat Hlth, Sydney, NSW, Australia.
RP Byles, JE (reprint author), Univ Newcastle, Res Ctr Gender Hlth & Ageing, Fac Hlth & Med, HMRI Bldg, Newcastle, NSW 2308, Australia.
EM julie.byles@newcastle.edu.au
RI Byles, Julie/C-5062-2008
OI Byles, Julie/0000-0002-3984-6877
CR AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359
   Australian Bureau of Statistics, 2009, NAT HLTH SURV 2007 2
   Australian Bureau of Statistics, 2008, NAT SURV MENT HLTH W
   Balon R, 2006, DEPRESS ANXIETY, V23, P377, DOI 10.1002/da.20217
   Bambara JK, 2011, DISABIL REHABIL, V33, P1, DOI 10.3109/09638288.2010.481026
   Banks E, 2001, J Epidemiol Biostat, V6, P357
   Banks E, 2010, MED J AUSTRALIA, V193, P62
   Banks E, 2008, INT J EPIDEMIOL, V37, P941, DOI 10.1093/ije/dym184
   Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2
   Cairney J, 2007, CAN J PSYCHIAT, V52, P111, DOI 10.1177/070674370705200209
   Carney RA, 2002, STROKE, V33, P5, DOI 10.1161/str.33.1.5
   Centre for Epidemiology and Research, 2009, 2008 REP AD HLTH NEW
   Cunningham J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-95
   Department of Health and Ageing, 2001, DEP HLTH AG OCC PAP, V14
   Drapeau A., 2012, MENTAL ILLNESSES UND, P105, DOI DOI 10.5772/1235
   Dunlop DD, 2004, MED CARE, V42, P502, DOI 10.1097/01.mlr.0000127997.51128.81
   Egede LE, 2012, CURR PSYCHIAT REP, V14, P15, DOI 10.1007/s11920-011-0240-0
   Fenton WS, 2006, CURR OPIN PSYCHIATR, V19, P421, DOI 10.1097/01.yco.0000228765.33356.9f
   Fortin M, 2006, ANN FAM MED, V4, P417, DOI 10.1370/afm.528
   Greenbaum JN, 2012, J ARTHROPLASTY, V27, P1310, DOI 10.1016/j.arth.2011.10.031
   Hagger MS, 2003, PSYCHOL HEALTH, V18, P141, DOI 10.1080/088704403100081321
   Hamer M, 2008, J AM COLL CARDIOL, V52, P2156, DOI 10.1016/j.jacc.2008.08.057
   Hamer M, 2009, J PSYCHOSOM RES, V66, P255, DOI 10.1016/j.jpsychores.2008.11.002
   Holden L, 2010, AUST NZ J PUBL HEAL, V34, P304, DOI 10.1111/j.1753-6405.2010.00531.x
   Hough E S, 1999, Health Care Women Int, V20, P349
   Huang CQ, 2010, AGEING RES REV, V9, P131, DOI 10.1016/j.arr.2009.05.005
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Leventhal H, 1998, PSYCHOL HEALTH, V13, P717, DOI 10.1080/08870449808407425
   Leventhal H, 2012, SELF REGULATION HLTH, P42
   Lewis G, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5177
   May M, 2002, STROKE, V33, P7, DOI 10.1161/hs0102.100529
   Mirowsky J, 2002, J HEALTH SOC BEHAV, V43, P152, DOI 10.2307/3090194
   Mommersteeg PMC, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1109
   Moon L, 2006, SOCIOECONOMIC INEQUA
   Moore JL, 2009, EPILEPSIA, V50, P1077, DOI 10.1111/j.1528-1167.2008.01996.x
   Ormel J, 2002, J GERONTOL B-PSYCHOL, V57, pP338, DOI 10.1093/geronb/57.4.P338
   Quail JM, 2011, CAN J AGING, V30, P591, DOI 10.1017/S0714980811000493
   Rasul F, 2005, J EPIDEMIOL COMMUN H, V59, P140, DOI 10.1136/jech.2004.019786
   Ridner SH, 2004, J ADV NURS, V45, P536, DOI 10.1046/j.1365-2648.2003.02938.x
   Russ TC, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4933
   Schmitz N, 2008, J PSYCHOSOM RES, V65, P165, DOI 10.1016/j.jpsychores.2008.03.004
   Schmitz N, 2009, PSYCHOSOMATICS, V50, P42, DOI 10.1176/appi.psy.50.1.42
   Serrano CV, 2011, VASC HEALTH RISK MAN, V7, P159, DOI 10.2147/VHRM.S10783
   Shih M, 2006, J GEN INTERN MED, V21, P1160, DOI 10.1111/j.1525-1497.2006.00573.x
   Strine TW, 2005, EPILEPSIA, V46, P1133, DOI 10.1111/j.1528-1167.2005.01605.x
   Valderas JM, 2009, ANN FAM MED, V7, P357, DOI 10.1370/afm.983
   WARE JE, 1994, SF 36 PHYSL MENTAL H
   Yang Y, 2006, J HEALTH SOC BEHAV, V47, P355, DOI 10.1177/002214650604700404
   Zeiss AM, 1996, PSYCHOL AGING, V11, P572, DOI 10.1037/0882-7974.11.4.572
NR 49
TC 16
Z9 16
U1 0
U2 16
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1091-4269
EI 1520-6394
J9 DEPRESS ANXIETY
JI Depress. Anxiety
PD JUN
PY 2014
VL 31
IS 6
BP 524
EP 532
DI 10.1002/da.22162
PG 9
WC Psychology, Clinical; Psychiatry; Psychology
SC Psychology; Psychiatry
GA AL3XZ
UT WOS:000339066600008
PM 23922120
DA 2019-01-08
ER

PT J
AU Sorkin, DH
   Mavandadi, S
   Rook, KS
   Biegler, KA
   Kilgore, D
   Dow, E
   Ngo-Metzger, Q
AF Sorkin, Dara H.
   Mavandadi, Shahrzad
   Rook, Karen S.
   Biegler, Kelly A.
   Kilgore, David
   Dow, Emily
   Ngo-Metzger, Quyen
TI Dyadic Collaboration in Shared Health Behavior Change: The Effects of a
   Randomized Trial to Test a Lifestyle Intervention for High-Risk Latinas
SO HEALTH PSYCHOLOGY
LA English
DT Article
DE dyadic behavioral lifestyle intervention; social support and social
   control; type 2 diabetes control and prevention; weight loss; Hispanic;
   Latina
ID DIABETES PREVENTION PROGRAM; WEIGHT-LOSS INTERVENTION; MEXICAN-AMERICAN
   WOMEN; SOCIAL SUPPORT; PHYSICAL-ACTIVITY; CHRONIC ILLNESS; PSYCHOLOGICAL
   DISTRESS; GLYCEMIC LOAD; US ADULTS; FAMILY
AB Objective: This study sought to evaluate the feasibility of a pilot, dyad-based lifestyle intervention, the Unidas por la Vida program, for improving weight loss and dietary intake among high-risk Mexican American mothers who have Type 2 diabetes and their overweight/obese adult daughters. Method: Mother-daughter dyads (N = 89) were recruited from two federally qualified health centers and randomly assigned to either the Unidas intervention or to the control condition. The 16-week Unidas intervention consisted of the following: (a) four group meetings, (b) eight home visits, and (c) booster telephone calls by a lifestyle community coach. The control condition consisted of educational materials mailed to participants' homes. Participants completed surveys at T1 (baseline) and T2 (16 weeks) that assessed various demographic, social network involvement, and dietary variables. Results: Unidas participants lost significantly more weight at T2 (p < .003) compared with the control participants. Furthermore, intervention participants also were more likely to be eating foods with lower glycemic load (p < .001) and less saturated fat (p = .004) at T2. Unidas participants also reported a significant increase in health-related social support and social control (persuasion control only) and a decrease in undermining. Conclusions: The Unidas program promoted weight loss and improved dietary intake, as well as changes in diet-related involvement of participants' social networks. The results from this study demonstrate that interventions that draw upon multiple people who share a health-risk have the potential to foster significant changes in lifestyle behaviors and in social network members' health-related involvement. Future research that builds on these findings is needed to elucidate the specific dyadic and social network processes that may drive health behavior change.
C1 [Sorkin, Dara H.; Biegler, Kelly A.] Univ Calif Irvine, Div Gen Internal Med, Irvine, CA USA.
   [Sorkin, Dara H.; Biegler, Kelly A.] Univ Calif Irvine, Primary Care & Hlth Policy Res Inst, Irvine, CA USA.
   [Mavandadi, Shahrzad] Univ Penn, Perelman Sch Med, Philadelphia VA Med Center;, Mental Illness Res Educ & Clin Ctr,Dept Psychiat, Philadelphia, PA 19104 USA.
   [Rook, Karen S.] Univ Calif Irvine, Dept Psychol & Social Behav, Irvine, CA USA.
   [Kilgore, David; Dow, Emily] Univ Calif Irvine, Div Family Med, Irvine, CA USA.
   [Ngo-Metzger, Quyen] Agcy Healthcare Res & Qual, Ctr Primary Care Prevent & Clin Partnership, US Prevent Serv Task Force Program, US Dept Hlth & Human Serv, Rockville, MD USA.
RP Sorkin, DH (reprint author), UCI Hlth Policy Res Inst, Suite 110, Irvine, CA 92617 USA.
EM dsorkin@uci.edu
FU National Center for Research Resources; National Center for Advancing
   Translational Sciences, National Institutes of Health [UL1 TR000153,
   R34DK083500, K01DK078939]
FX We thank Carolina Vilchis and Grada Christensen for their contributions.
   We would also like to thank Karen McGlinn, Executive Director, Share Our
   Selves Medical Clinic, for her unwavering support. The project described
   was supported by the National Center for Research Resources and the
   National Center for Advancing Translational Sciences, National
   Institutes of Health, through Grants UL1 TR000153, R34DK083500, and
   K01DK078939. The views expressed in this publication are solely the
   opinions of the authors and do not necessarily reflect the official
   policies of U.S. Department of Veterans Affairs, Department of Health
   and Human Services, the National Institutes of Health, or the Agency for
   Healthcare Research and Quality, nor does mention of the department or
   agency names imply endorsement by the U.S. government.
CR American Diabetes Association, 2013, CREAT YOUR PLAT
   August KJ, 2010, SOC SCI MED, V71, P1831, DOI 10.1016/j.socscimed.2010.08.022
   Berg Judith A, 2002, Health Care Women Int, V23, P894, DOI 10.1080/07399330290112399
   Berkman LF, 2000, SOC WORK HEALTH CARE, V31, P3, DOI 10.1300/J010v31n02_02
   Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4
   Bishop J, 2013, FAM COMMUNITY HEALTH, V36, P158, DOI 10.1097/FCH.0b013e318282b2d3
   BLOCK G, 1986, AM J EPIDEMIOL, V124, P453, DOI 10.1093/oxfordjournals.aje.a114416
   Block G, 2000, AM J PREV MED, V18, P284, DOI 10.1016/S0749-3797(00)00119-7
   Block G., 2006, PREVENTING CHRONIC D, V3, P1
   Campbell L, 2002, PERS RELATIONSHIP, V9, P327, DOI 10.1111/1475-6811.00023
   Center for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET
   Chang VW, 2003, AM J PREV MED, V24, P332, DOI 10.1016/S0749-3797(03)00020-5
   Cleland V, 2013, OBES REV, V14, P197, DOI 10.1111/j.1467-789X.2012.01058.x
   Coleman KJ, 2010, DIABETES EDUCATOR, V36, P784, DOI 10.1177/0145721710377360
   Corsino L, 2012, ETHNIC DIS, V22, P51
   COUSINS JH, 1992, PUBLIC HEALTH REP, V107, P549
   Everson-Hock ES, 2013, PREV MED, V56, P265, DOI 10.1016/j.ypmed.2013.02.023
   Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39
   Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014
   Franks MM, 2006, J FAM PSYCHOL, V20, P311, DOI 10.1037/0893-3200.20.2.311
   Gallant MP, 2003, HEALTH EDUC BEHAV, V30, P170, DOI 10.1177/1090198102251030
   Garcia-Maas L D, 1999, J Transcult Nurs, V10, P213, DOI 10.1177/104365969901000312
   Gonder-Frederick LA, 2002, J CONSULT CLIN PSYCH, V70, P611, DOI 10.1037//0022-006X.70.3.611
   Gorin AA, 2008, INT J OBESITY, V32, P1678, DOI 10.1038/ijo.2008.150
   Greaves CJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-119
   Henry SL, 2013, J HEALTH PSYCHOL, V18, P1550, DOI 10.1177/1359105312465913
   Herman WH, 2003, DIABETES CARE, V26, P36
   Hogan BE, 2002, CLIN PSYCHOL REV, V22, P381, DOI 10.1016/S0272-7358(01)00102-7
   Johnson M, 2013, DIABETIC MED, V30, P3, DOI 10.1111/dme.12018
   Kenny D. A., 2006, DYADIC DATA ANAL
   Knowler WC, 2002, NEW ENGL J MED, V346, P393
   Lewis MA, 1999, HEALTH PSYCHOL, V18, P63, DOI 10.1037/0278-6133.18.1.63
   Lindberg NM, 2013, J OBES, DOI 10.1155/2013/542736
   Lindberg NM, 2012, J IMMIGR MINOR HEALT, V14, P1030, DOI 10.1007/s10903-012-9616-4
   Livesey G, 2013, AM J CLIN NUTR, V97, P584, DOI 10.3945/ajcn.112.041467
   Marquez B, 2013, J ACAD NUTR DIET, V113, P680, DOI 10.1016/j.jand.2013.01.020
   Martire LM, 2004, HEALTH PSYCHOL, V23, P599, DOI 10.1037/0278-6133.23.6.599
   Martire LM, 2013, ANN BEHAV MED, V45, P213, DOI 10.1007/s12160-012-9442-x
   McLean N, 2003, INT J OBESITY, V27, P987, DOI 10.1038/sj.ijo.0802383
   Melanson KJ, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-57
   Narayan KMV, 2007, DIABETES CARE, V30, P1562, DOI 10.2337/dc06-2544
   O'Brien MJ, 2013, DIABETES CARE, V36, P355, DOI 10.2337/dc12-0548
   Perez LG, 2013, AM J PREV MED, V44, P550, DOI 10.1016/j.amepre.2013.01.016
   Ritzwoller DP, 2013, J GEN INTERN MED, V28, P1581, DOI 10.1007/s11606-013-2492-3
   ROOK KS, 1990, PSYCHOL AGING, V5, P327, DOI 10.1037/0882-7974.5.3.327
   Rook KS., 2011, HDB STRESS SCI BIOL, P123
   ROSENTHAL B, 1980, INT J OBESITY, V4, P165
   SALLIS JF, 1987, PREV MED, V16, P825, DOI 10.1016/0091-7435(87)90022-3
   Seeman TE, 2000, AM J HEALTH PROMOT, V14, P362, DOI 10.4278/0890-1171-14.6.362
   Sorkin DH, 2013, J HEALTH CARE POOR U, V24, P116, DOI 10.1353/hpu.2013.0103
   Stephens MAP, 2013, HEALTH PSYCHOL, V32, P1029, DOI 10.1037/a0030018
   Stephens MAP, 2009, HEALTH PSYCHOL, V28, P48, DOI 10.1037/a0012385
   TEUFELSHONE NI, 2005, PREVENTING CHRONIC D, V2, P1
   Tucker JS, 2006, HEALTH PSYCHOL, V25, P715, DOI 10.1037/0278-6133.25.6.715
   Tucker JS, 2006, PERS SOC PSYCHOL B, V32, P1143, DOI 10.1177/0146167206289728
   US Department of Health and Human Services, WHAT AR FED QUAL HLT
   Waters LA, 2011, J PHYS ACT HEALTH, V8, P85, DOI 10.1123/jpah.8.1.85
   Willett W, 2002, AM J CLIN NUTR, V76, p274S
NR 58
TC 30
Z9 30
U1 2
U2 28
PU AMER PSYCHOLOGICAL ASSOC
PI WASHINGTON
PA 750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA
SN 0278-6133
EI 1930-7810
J9 HEALTH PSYCHOL
JI Health Psychol.
PD JUN
PY 2014
VL 33
IS 6
SI SI
BP 566
EP 575
DI 10.1037/hea0000063
PG 10
WC Psychology, Clinical; Psychology
SC Psychology
GA AK5CQ
UT WOS:000338442300008
PM 24884910
OA Green Published
DA 2019-01-08
ER

PT J
AU Schrepf, A
   Markon, K
   Lutgendorf, SK
AF Schrepf, Andrew
   Markon, Kristian
   Lutgendorf, Susan K.
TI From Childhood Trauma to Elevated C-Reactive Protein in Adulthood: The
   Role of Anxiety and Emotional Eating
SO PSYCHOSOMATIC MEDICINE
LA English
DT Article
DE C-reactive protein; inflammation; emotional eating; childhood trauma;
   anxiety; stress; cardiovascular disease
ID RISK-FACTORS; PSYCHOMETRIC PROPERTIES; PSYCHOLOGICAL STRESS;
   GENDER-DIFFERENCES; SEXUAL-ABUSE; LIFE-SPAN; DRUG-USE; DEPRESSION;
   INFLAMMATION; OBESITY
AB Objective: Childhood trauma is known to be related to inflammatory processes in adulthood, but underlying psychological/behavioral mechanisms have not been fully characterized. To investigate associations between childhood trauma and inflammation (indexed by C-reactive protein [CRP]), we used a structural equation modeling approach on a subsample of the Midlife in the United States biomarker project. Methods: Participants included 687 men and women without history of cancer, diabetes, cardiovascular disease, or strokewho completed a physical examination and extensive questionnaires and provided blood. To test for sex differences, we held as many parameters invariant across sexes as possible while still retaining good model fit. Results: Tests of direct and indirect effects revealed that childhood trauma was significantly associated with elevated CRP, via elevated body mass index (BMI; p < .001). This relationship was mediated by a broad latent measure of distress, which was associated with using food as a coping mechanism. Men and women differed in reported levels of physical abuse, sexual abuse, and physical neglect. Compared with men, women showed a stronger association between BMI and CRP, whereas men had a stronger association between use of food to cope and elevated BMI. Conclusions: Our results are consistent with a model in which childhood trauma is associated with elevated CRP, a relationship associated with stress reactivity and compensatory emotional eating. Men and women may experience trauma in qualitatively distinct patterns but share many vulnerabilities, which can lead to elevated health risks. Emotional eating may be an important target for intervention in this population.
C1 [Schrepf, Andrew; Markon, Kristian; Lutgendorf, Susan K.] Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA.
   [Lutgendorf, Susan K.] Univ Iowa, Dept Obstet & Gynecol, Iowa City, IA 52242 USA.
   [Lutgendorf, Susan K.] Univ Iowa, Dept Urol, Iowa City, IA 52242 USA.
   [Lutgendorf, Susan K.] Univ Iowa, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA.
RP Lutgendorf, SK (reprint author), Univ Iowa, Dept Psychol, E11 Seashore Hall, Iowa City, IA 52242 USA.
EM susan-lutgendorf@uiowa.edu
FU National Institutes of Health [CA140933]; National Institute on Aging
   [P01-AG020166]; John D. and Catherine T. MacArthur Foundation Research
   Network on Successful Midlife Development
FX This manuscript was supported, in part, by the National Institutes of
   Health (Grant CA140933; awarded to S. L.) and by the National Institute
   on Aging (Grant P01-AG020166). The original study was supported, in
   part, by the John D. and Catherine T. MacArthur Foundation Research
   Network on Successful Midlife Development. The authors have no conflicts
   of interest.
CR Allen B, 2007, J TRAUMA STRESS, V20, P587, DOI 10.1002/jts.20195
   Anda RF, 2006, EUR ARCH PSY CLIN N, V256, P174, DOI 10.1007/s00406-005-0624-4
   Bader K, 2007, J SLEEP RES, V16, P285, DOI 10.1111/j.1365-2869.2007.00608.x
   Bernstein D, 1998, MANUAL CHILDHOOD TRA
   Bornstein SR, 2006, MOL PSYCHIATR, V11, P892, DOI 10.1038/sj.mp.4001873
   Briere J, 2003, CHILD ABUSE NEGLECT, V27, P1205, DOI 10.1016/j.chiabu.2003.09.008
   Calabro P, 2005, J AM COLL CARDIOL, V46, P1112, DOI 10.1016/j.jacc.2005.06.017
   Carpenter LL, 2011, PSYCHOPHARMACOLOGY, V214, P367, DOI 10.1007/s00213-010-2007-4
   Center for Disease Control, 2013, ADV CHILDH EXP ACE S
   Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5
   COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404
   Copeland WE, 2012, PSYCHOL MED, V42, P2641, DOI 10.1017/S0033291712000554
   Cortes AM, 2005, CHILD ABUSE NEGLECT, V29, P905, DOI 10.1016/j.chiabu.2004.12.010
   D'Argenio A, 2009, PHYSIOL BEHAV, V98, P543, DOI 10.1016/j.physbeh.2009.08.010
   Danese A, 2014, MOL PSYCHIATR, V19, P544, DOI 10.1038/mp.2013.54
   Danese A, 2009, ARCH PEDIAT ADOL MED, V163, P1135, DOI 10.1001/archpediatrics.2009.214
   Dannlowski U, 2012, BIOL PSYCHIAT, V71, P286, DOI 10.1016/j.biopsych.2011.10.021
   de Beurs E, 1999, PSYCHOL MED, V29, P583, DOI 10.1017/S0033291799008351
   DeSantis SM, 2011, DEPRESS ANXIETY, V28, P383, DOI 10.1002/da.20795
   Fagundes CP, 2013, BRAIN BEHAV IMMUN, V27, P8, DOI 10.1016/j.bbi.2012.06.014
   FAMULARO R, 1992, J AM ACAD CHILD PSY, V31, P863, DOI 10.1097/00004583-199209000-00013
   Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8
   FINKELHOR D, 1990, CHILD ABUSE NEGLECT, V14, P19, DOI 10.1016/0145-2134(90)90077-7
   Fresco DM, 2001, PSYCHOL MED, V31, P1025
   Geliebter Allan, 2003, Eat Behav, V3, P341, DOI 10.1016/S1471-0153(02)00100-9
   Goossens L, 2009, EUR EAT DISORD REV, V17, P68, DOI 10.1002/erv.892
   Greenfield EA, 2009, SOC SCI MED, V68, P791, DOI 10.1016/j.socscimed.2008.12.004
   Gunstad J, 2006, PSYCHIAT RES, V142, P31, DOI 10.1016/j.psychres.2005.11.007
   Harrington M, 2011, CAN J PSYCHIAT, V56, P686, DOI 10.1177/070674371105601107
   Heffner JL, 2011, AM J ADDICTION, V20, P307, DOI 10.1111/j.1521-0391.2011.00141.x
   Heim C, 2001, BIOL PSYCHIAT, V49, P1023, DOI 10.1016/S0006-3223(01)01157-X
   Heim C, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.041.2009
   Kenardy Justin, 2003, Eat Behav, V4, P149, DOI 10.1016/S1471-0153(03)00019-9
   Khera A, 2009, J CLIN ENDOCR METAB, V94, P3251, DOI 10.1210/jc.2008-2406
   Kiecolt-Glaser JK, 2011, PSYCHOSOM MED, V73, P16, DOI 10.1097/PSY.0b013e31820573b6
   Klaassens ER, 2009, PROG NEURO-PSYCHOPH, V33, P889, DOI 10.1016/j.pnpbp.2009.04.011
   Kling KC, 1997, PSYCHOL AGING, V12, P288, DOI 10.1037/0882-7974.12.2.288
   Koenig W, 1999, CIRCULATION, V99, P237, DOI 10.1161/01.CIR.99.2.237
   Love GD, 2010, J AGING HEALTH, V22, P1059, DOI 10.1177/0898264310374355
   McCauley J, 1997, JAMA-J AM MED ASSOC, V277, P1362, DOI 10.1001/jama.277.17.1362
   Merikangas KR, 1998, ADDICT BEHAV, V23, P893, DOI 10.1016/S0306-4603(98)00076-8
   Midei AJ, 2011, OBES REV, V12, pe159, DOI 10.1111/j.1467-789X.2010.00823.x
   Miller GE, 2012, BIOL PSYCHIAT, V72, P34, DOI 10.1016/j.biopsych.2012.02.034
   Miller GE, 2011, PSYCHOL BULL, V137, P959, DOI 10.1037/a0024768
   Miller GE, 2010, PSYCHOL SCI, V21, P848, DOI 10.1177/0956797610370161
   Morozink JA, 2010, HEALTH PSYCHOL, V29, P626, DOI 10.1037/a0021360
   Oliver G, 2000, PSYCHOSOM MED, V62, P853, DOI 10.1097/00006842-200011000-00016
   Otte C, 2005, BIOL PSYCHIAT, V57, P27, DOI 10.1016/j.biopsych.2004.10.009
   Pasquali R, 2006, ANN NY ACAD SCI, V1083, P111, DOI 10.1196/annals.1367.009
   Patton GC, 1998, AM J PUBLIC HEALTH, V88, P1518, DOI 10.2105/AJPH.88.10.1518
   Pervanidou P, 2012, METABOLISM, V61, P611, DOI 10.1016/j.metabol.2011.10.005
   PLINER P, 1990, PERS SOC PSYCHOL B, V16, P263, DOI 10.1177/0146167290162007
   Ridker PM, 1998, CIRCULATION, V98, P731, DOI 10.1161/01.CIR.98.8.731
   Rodgers CS, 2004, CHILD ABUSE NEGLECT, V28, P575, DOI 10.1016/j.chiabu.2004.01.002
   Rooks C, 2012, PSYCHOSOM MED, V74, P146, DOI 10.1097/PSY.0b013e318240a7d8
   Scher CD, 2001, J TRAUMA STRESS, V14, P843, DOI 10.1023/A:1013058625719
   Slopen N, 2010, PSYCHOSOM MED, V72, P694, DOI 10.1097/PSY.0b013e3181e9c16f
   Strine TW, 2005, SOC PSYCH PSYCH EPID, V40, P432, DOI 10.1007/s00127-005-0914-1
   Torres SJ, 2007, NUTRITION, V23, P887, DOI 10.1016/j.nut.2007.08.008
   Tsenkova V, 2013, APPETITE, V69, P151, DOI 10.1016/j.appet.2013.05.020
   VANSTRIEN T, 1986, INT J OBESITY, V10, P29
   Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131
   Vythilingam M, 2002, AM J PSYCHIAT, V159, P2072, DOI 10.1176/appi.ajp.159.12.2072
   Waller G, 1998, INT J EAT DISORDER, V23, P419, DOI 10.1002/(SICI)1098-108X(199805)23:4<419::AID-EAT9>3.0.CO;2-L
   WATSON D, 1995, J ABNORM PSYCHOL, V104, P3, DOI 10.1037/0021-843X.104.1.3
NR 65
TC 14
Z9 14
U1 2
U2 33
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0033-3174
EI 1534-7796
J9 PSYCHOSOM MED
JI Psychosom. Med.
PD JUN
PY 2014
VL 76
IS 5
BP 327
EP 336
DI 10.1097/PSY.0000000000000072
PG 10
WC Psychiatry; Psychology; Psychology, Multidisciplinary
SC Psychiatry; Psychology
GA AK0TQ
UT WOS:000338128800002
PM 24933013
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Tang, TS
   Funnell, M
   Sinco, B
   Piatt, G
   Palmisano, G
   Spencer, MS
   Kieffer, EC
   Heisler, M
AF Tang, Tricia S.
   Funnell, Martha
   Sinco, Brandy
   Piatt, Gretchen
   Palmisano, Gloria
   Spencer, Michael S.
   Kieffer, Edith C.
   Heisler, Michele
TI Comparative Effectiveness of Peer Leaders and Community Health Workers
   in Diabetes Self-management Support: Results of a Randomized Controlled
   Trial
SO DIABETES CARE
LA English
DT Article
ID LIFE-STYLE INTERVENTION; MEXICAN-AMERICANS; LATINO ADULTS;
   AFRICAN-AMERICAN; GLYCEMIC CONTROL; EDUCATION; OUTCOMES; PROGRAM;
   PARTNERSHIPS; METAANALYSIS
AB OBJECTIVE
   To compare a peer leader (PL) versus a community health worker (CHW) telephone outreach intervention in sustaining improvements in HbA(1c) over 12 months after a 6-month diabetes self-management education (DSME) program.
   RESEARCH DESIGN AND METHODS
   One hundred and sixteen Latino adults with type 2 diabetes were recruited from a federally qualified health center and randomized to 1) a 6-month DSME program followed by 12 months of weekly group sessions delivered by PLs with telephone outreach to those unable to attend or 2) a 6-month DSME program followed by 12 months of monthly telephone outreach delivered by CHWs. The primary outcome was HbA(1c). Secondary outcomes were cardiovascular disease risk factors, diabetes distress, and diabetes social support. Assessments were conducted at baseline, 6, 12, and 18 months.
   RESULTS
   After DSME, the PL group achieved a reduction in mean HbA(1c) (8.2-7.5% or 66-58 mmol/mol, P < 0.0001) that was maintained at 18 months (-0.6% or -6.6 mmol/mol from baseline [P = 0.009]). The CHW group also showed a reduction in HbA(1c) (7.8 vs. 7.3% or 62 vs. 56 mmol/mol, P = 0.0004) post-6 month DSME; however, it was attenuated at 18 months (-0.3% or -3.3 mmol/mol from baseline, within-group P = 0.234). Only the PL group maintained improvements achieved in blood pressure at 18 months. At the 18-month follow-up, both groups maintained improvements in waist circumference, diabetes support, and diabetes distress, with no significant differences between groups.
   CONCLUSIONS
   Both low-cost maintenance programs led by either a PL or a CHW maintained improvements in key patient-reported diabetes outcomes, but the PL intervention may have additional benefit in sustaining clinical improvements beyond 12 months.
C1 [Tang, Tricia S.] Univ British Columbia, Dept Med, Vancouver, BC, Canada.
   [Funnell, Martha; Piatt, Gretchen] Univ Michigan, Dept Med Educ, Ann Arbor, MI 48109 USA.
   [Sinco, Brandy; Spencer, Michael S.; Kieffer, Edith C.] Univ Michigan, Sch Social Work, Ann Arbor, MI 48109 USA.
   [Palmisano, Gloria] Community Hlth & Social Serv Ctr, Detroit, MI USA.
   [Heisler, Michele] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.
   [Heisler, Michele] Ann Arbor VA Ctr Clin Management Res, Ann Arbor, MI USA.
RP Tang, TS (reprint author), Univ British Columbia, Dept Med, Vancouver, BC, Canada.
EM tricia.tang@vch.ca
RI Albertin, Paloma/X-1093-2018; Heisler, Michele/B-5774-2015
OI Heisler, Michele/0000-0002-6889-2063
FU American Academy of Family Physicians Foundation [P30DK092926]; National
   Institute of Diabetes and Digestive and Kidney Diseases
   [R18DK0785501A1]; Centers for Disease Control and Prevention
   [U50/CCU417409]
FX This research was supported by a Peers for Progress grant from the
   American Academy of Family Physicians Foundation (grant P30DK092926)
   (Michigan Center for Diabetes Translational Research), by the National
   Institute of Diabetes and Digestive and Kidney Diseases (grant
   R18DK0785501A1), and by the Centers for Disease Control and Prevention
   (cooperative agreement no. U50/CCU417409). The funding sources had no
   role in the study design; data collection; administration of the
   interventions; analysis, interpretation, or reporting of data; or
   decision to submit the findings for publication.
CR ANDERSON RM, 2002, PRACTICAL PSYCHOL DI, P3
   Arsie MP, 2000, ACTA DIABETOL, V37, P1, DOI 10.1007/s005920070028
   Baig AA, 2012, DIABETES EDUCATOR, V38, P733, DOI 10.1177/0145721712455700
   Barrera M, 2002, AM J COMMUN PSYCHOL, V30, P637, DOI 10.1023/A:1016369114780
   Brown HS, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.120074
   Brown SA, 2005, DIABETES CARE, V28, P527, DOI 10.2337/diacare.28.3.527
   Brown SA, 2002, DIABETES CARE, V25, P259, DOI 10.2337/diacare.25.2.259
   Diggle P, 2002, ANAL LONGITUDINAL DA
   Emmons KM, 2001, AM J PREV MED, V20, P68, DOI 10.1016/S0749-3797(00)00254-3
   Feathers JT, 2007, DIABETES EDUCATOR, V33, P509, DOI 10.1177/0145721707301371
   Feathers JT, 2005, AM J PUBLIC HEALTH, V95, P1552, DOI 10.2105/AJPH.2005.066134
   Fedder DO, 2003, ETHNIC DIS, V13, P22
   Funnel MM, 2004, MED MANAGEMENT TYPE, P124
   Gary TL, 2003, DIABETES EDUCATOR, V29, P488, DOI 10.1177/014572170302900313
   Glasgow RE, 2012, PATIENT EDUC COUNS, V87, P81, DOI 10.1016/j.pec.2011.07.024
   Haas L, 2012, DIABETES CARE, V35, P2393, DOI 10.2337/dc12-1707
   Heisler M, 2009, AM J PREV MED, V37, pS270, DOI 10.1016/j.amepre.2009.08.016
   Israel B. A., 2005, METHODS COMMUNITY BA
   Lawlor MS, 2013, AM J PREV MED, V44, pS381, DOI 10.1016/j.amepre.2012.12.016
   LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13
   Lorig K, 2008, DIABETES CARE, V31, P408, DOI 10.2337/dc07-1313
   Norris SL, 2002, DIABETES CARE, V25, P1159, DOI 10.2337/diacare.25.7.1159
   Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561
   Philis-Tsimikas A, 2011, DIABETES CARE, V34, P1926, DOI 10.2337/dc10-2081
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   ROGERS EJ, 1993, CLIN CHEM, V39, P860
   Rosal MC, 2011, DIABETES CARE, V34, P838, DOI 10.2337/dc10-1981
   Rothschild SK, 2012, CONTEMP CLIN TRIALS, V33, P369, DOI 10.1016/j.cct.2011.10.013
   Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232
   Shah M, 2013, CURR DIABETES REP, V13, P163, DOI 10.1007/s11892-012-0359-3
   Siminerio L, 2013, DIABETES EDUCATOR, V39, P705, DOI 10.1177/0145721713492570
   Sixta CS, 2008, DIABETES EDUCATOR, V34, P299, DOI 10.1177/0145721708314490
   Spencer MS, 2011, AM J PUBLIC HEALTH, V101, P2253, DOI 10.2105/AJPH.2010.300106
   Steed L, 2003, PATIENT EDUC COUNS, V51, P5, DOI 10.1016/S0738-3991(02)00213-6
   Tang TS, 2012, DIABETES RES CLIN PR, V95, P85, DOI 10.1016/j.diabres.2011.04.003
   Tang TS, 2011, PATIENT EDUC COUNS, V85, P160, DOI 10.1016/j.pec.2010.12.013
   Trento M, 2002, DIABETOLOGIA, V45, P1231, DOI 10.1007/s00125-002-0904-8
   Turner RC, 1998, LANCET, V352, P837
   United States Census Bureau, 2010, AM FACTFINDER
   West B. T., 2007, LINEAR MIXED MODELS
NR 40
TC 55
Z9 56
U1 2
U2 28
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
EI 1935-5548
J9 DIABETES CARE
JI Diabetes Care
PD JUN
PY 2014
VL 37
IS 6
BP 1525
EP 1534
DI 10.2337/dc13-2161
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AJ5RX
UT WOS:000337746100026
PM 24722495
OA Green Published, Other Gold
DA 2019-01-08
ER

PT J
AU Shim, U
   Oh, JY
   Lee, H
   Sung, YA
   Kim, HN
   Kim, HL
AF Shim, Unjin
   Oh, Jee-Young
   Lee, Hyejin
   Sung, Yeon-Ah
   Kim, Han-Na
   Kim, Hyung-Lae
TI Association between extraversion personality and abnormal glucose
   regulation in young Korean women
SO ACTA DIABETOLOGICA
LA English
DT Article
DE Five-factor model; Extraversion personality; Abnormal glucose regulation
ID ALL-CAUSE MORTALITY; GLYCEMIC CONTROL; OLDER-ADULTS; STRESS RESPONSES;
   SEX-DIFFERENCES; 5-FACTOR MODEL; METAANALYSIS; POPULATION; OPENNESS;
   ABILITY
AB Depression and psychological distress are known to be associated with diabetes development as well as the disease progression including glycemic control and chronic complication, but relationship of personality with diabetes is controversial. We examined whether personality trait and the presence of abnormal glucose regulation (AGR; diabetes and pre-diabetes) are associated in young women. A total of 1,617 young women aged 19-39 years without previously diagnosed diabetes were participated voluntarily. Personality trait was assessed by self-reported questionnaire using the five-factor model (neuroticism, extraversion, openness to experience, agreeableness and conscientiousness) consisting of five-point scale ranging from 'strongly disagreeable' to 'strongly agreeable.' Glucose tolerance status was assessed by standard 75-g oral glucose tolerance test. One hundred and eleven women were newly diagnosed with AGR (6.9 %). Among five factors, only extraversion trait was significantly associated with AGR. Multiple linear regression analysis showed significant negative association between extraversion trait and 2-h post-load glucose after adjustment for age, BMI, systolic blood pressure, triglycerides, HDL cholesterol and family history of diabetes (beta = -0.16, P = 0.026). Multiple logistic regression showed extraversion trait having a significant association with the presence of AGR after adjustment for the same covariates (OR 0.97, 95 % CI 0.95-0.99, P = 0.011). The frequency of AGR was significantly increased according to the decrease in extraversion score (P for trend with exact test = 0.047). In conclusion, extraversion may be an important personality trait having a beneficial effect on decreasing the risk of AGR.
C1 [Shim, Unjin] Ewha Womans Univ, Dept Internal Med, Seoul Seonam Hosp, Med Ctr, Seoul, South Korea.
   [Oh, Jee-Young; Lee, Hyejin; Sung, Yeon-Ah] Ewha Womans Univ, Mokdong Hosp, Sch Med, Dept Internal Med, Seoul 158710, South Korea.
   [Kim, Han-Na; Kim, Hyung-Lae] Ewha Womans Univ, Sch Med, Dept Biochem, Seoul, South Korea.
RP Oh, JY (reprint author), Ewha Womans Univ, Mokdong Hosp, Sch Med, Dept Internal Med, 911-1 Mokdong, Seoul 158710, South Korea.
EM jyoh@ewha.ac.kr
FU Ewha Global Top5 Grant of Ewha Womans University; Basic Science Research
   Program through the National Research Foundation of Korea (NRF) -
   Ministry of Education, Science, and Technology [2010-0026606]
FX This work was supported by the Ewha Global Top5 Grant 2013 of Ewha
   Womans University and the Basic Science Research Program through the
   National Research Foundation of Korea (NRF), funded by the Ministry of
   Education, Science, and Technology (2010-0026606).
CR Ahn CK, 1997, KOREAN J COUNSELING, V9, P443
   American Diabetes Association: Diagnosis and classification of diabetes mellitus, 2012, DIABETES CARE S1, V35, pS64, DOI [10.2337/dc12-s064, DOI 10.2337/DC12-S064]
   Anderson RJ, 2002, INT J PSYCHIAT MED, V32, P235, DOI 10.2190/KLGD-4H8D-4RYL-TWQ8
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Barrett-Connor E, 2013, BEST PRACT RES CL EN, V27, P481, DOI 10.1016/j.beem.2013.05.013
   Barrick MR, 1998, J APPL PSYCHOL, V83, P377, DOI 10.1037/0021-9010.83.3.377
   Bogg T, 2004, PSYCHOL BULL, V130, P887, DOI 10.1037/0033-2909-130.6.887
   Chan O, 2003, Minerva Endocrinol, V28, P87
   Costa PT, 1992, REVISED NEO PERSONAL
   Eriksson AK, 2012, DIABETES RES CLIN PR, V95, P145, DOI 10.1016/j.diabres.2011.10.003
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Golden SH, 2006, PSYCHONEUROENDOCRINO, V31, P325, DOI 10.1016/j.psyneuen.2005.08.008
   Hill PL, 2011, HEALTH PSYCHOL, V30, P797, DOI 10.1037/a0023860
   Hogan MJ, 2012, PSYCHOL AGING, V27, P849, DOI 10.1037/a0029066
   Iwasa H, 2008, AM J GERIAT PSYCHIAT, V16, P399, DOI 10.1097/JGP.0b013e3181662ac9
   Jokela M, 2013, OBES REV, V14, P315, DOI 10.1111/obr.12007
   Jokela M, 2013, HLTH PSYCHOL
   Jonassaint CR, 2009, INT J PSYCHOPHYSIOL, V74, P274, DOI 10.1016/j.ijpsycho.2009.09.012
   Kiecolt-Glaser JK, 2003, P NATL ACAD SCI USA, V100, P9090, DOI 10.1073/pnas.1531903100
   Kim DJ, 2011, DIABETES METAB J, V35, P303, DOI 10.4093/dmj.2011.35.4.303
   Lane JD, 2000, DIABETES CARE, V23, P1321, DOI 10.2337/diacare.23.9.1321
   Lebovitz HE, 1999, CLIN CHEM, V45, P1339
   Rhee J, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-16
   Robertson SM, 2012, PSYCHOSOMATICS, V53, P1, DOI 10.1016/j.psym.2011.09.008
   Rosmond R, 2003, MED SCI MONITOR, V9, P35
   Rostambeigi N, 2010, DIABETES RES CLIN PR, V88, P117, DOI 10.1016/j.diabres.2009.12.025
   Schneider TR, 2012, STRESS HEALTH, V28, P102, DOI 10.1002/smi.1409
   Skinner TC, 2002, HEALTH PSYCHOL, V21, P61, DOI 10.1037//0278-6133.21.1.61
   Stilley CS, 2004, ANN BEHAV MED, V27, P117, DOI 10.1207/s15324796abm2702_6
   Suarez EC, 2006, HEALTH PSYCHOL, V25, P484, DOI 10.1037/0278-6133.25.4.484
   Sutin AR, 2010, BIOL PSYCHOL, V84, P186, DOI 10.1016/j.biopsycho.2010.01.012
   Ter Horst GJ, 2009, PHYSIOL BEHAV, V97, P239, DOI 10.1016/j.physbeh.2009.02.036
   Terracciano A, 2009, PSYCHOSOM MED, V71, P682, DOI 10.1097/PSY.0b013e3181a2925b
   Terry DP, 2013, J CLIN EXP NEUROPSYC, V35, P509, DOI 10.1080/13803395.2013.795932
   Tornroos M, 2013, J OCCUP HEALTH PSYCH, V18, P492, DOI 10.1037/a0033987
   Vollrath ME, 2007, DIABETIC MED, V24, P1028, DOI 10.1111/j.1464-5491.2007.02215.x
   Waller D, 2013, DIABETES CARE, V36, P2968, DOI 10.2337/dc12-1743
   Weiss A, 2005, PSYCHOSOM MED, V67, P724, DOI 10.1097/01.psy.0000181272.58103.18
   Wilson RS, 2005, PSYCHOSOM MED, V67, P841, DOI 10.1097/01.psy.0000190615.20656.83
   Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a
NR 40
TC 2
Z9 2
U1 0
U2 11
PU SPRINGER-VERLAG ITALIA SRL
PI MILAN
PA VIA DECEMBRIO, 28, MILAN, 20137, ITALY
SN 0940-5429
EI 1432-5233
J9 ACTA DIABETOL
JI Acta Diabetol.
PD JUN
PY 2014
VL 51
IS 3
BP 421
EP 427
DI 10.1007/s00592-013-0529-z
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AH8PL
UT WOS:000336400100010
PM 24212719
DA 2019-01-08
ER

PT J
AU Fisher, L
   Hessler, D
   Masharani, U
   Strycker, L
AF Fisher, L.
   Hessler, D.
   Masharani, U.
   Strycker, L.
TI Impact of baseline patient characteristics on interventions to reduce
   diabetes distress: the role of personal conscientiousness and diabetes
   self-efficacy
SO DIABETIC MEDICINE
LA English
DT Article
ID PRIMARY-CARE PATIENTS; OLDER-ADULTS; SCALE; DEPRESSION; OUTCOMES;
   THERAPY
AB AimsTo improve patient-centred care by determining the impact of baseline levels of conscientiousness and diabetes self-efficacy on the outcomes of efficacious interventions to reduce diabetes distress and improve disease management.
   MethodsAdults with Type 2 diabetes with diabetes distress and self-care problems (N=392) were randomized to one of three distress reduction interventions: computer-assisted self-management; computer-assisted self-management plus problem-solving therapy; and health education. The baseline assessment included conscientiousness and self-efficacy, demographics, diabetes status, regimen distress, emotional burden, medication adherence, diet and physical activity. Changes in regimen distress, emotional burden and self-care between baseline and 12months were recorded and ancova models assessed how conscientiousness and self-efficacy qualified the significant improvements in distress and management outcomes.
   ResultsParticipants with high baseline conscientiousness displayed significantly larger improvements in medication adherence and emotional burden than participants with low baseline conscientiousness. Participants with high baseline self-efficacy showed greater improvements in diet, physical activity and regimen distress than participants with low baseline self-efficacy. The impact of conscientiousness and self-efficacy were independent of each other and occurred across all three intervention groups. A significant interaction indicated that those with both high self-efficacy and high conscientiousness at baseline had the biggest improvement in physical activity by 12months.
   ConclusionsBoth broad personal traits and disease-specific expectations qualify the outcomes of efficacious interventions. These findings reinforce the need to change from a one-size-fits-all approach to diabetes interventions to an approach that crafts clinical interventions in ways that fit the personal traits and skills of individual people.
   What's new?
   <list list-type="bulleted" id="dme12403-list-0001"> The traits and beliefs that people with diabetes bring with them to clinical interventions influence the outcomes of interventions, even those previously shown to be efficacious. Conscientiousness, a personal trait, and diabetes self-efficacy, a set of beliefs and expectations about management, are independent predictors of the success of interventions to improve management and reduce distress.
C1 [Fisher, L.; Hessler, D.] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA.
   [Masharani, U.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA.
   [Strycker, L.] Oregon Res Inst, Eugene, OR 97403 USA.
RP Fisher, L (reprint author), Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA.
EM fisherl@fcm.ucsf.edu
FU National Institute of Diabetes, Digestive and Kidney Disease [DK 061937]
FX This research was funded by the National Institute of Diabetes,
   Digestive and Kidney Disease (DK 061937).
CR Allan JL, 2013, ANN BEHAV MED, V46, P114, DOI 10.1007/s12160-013-9483-9
   Arean P, 2008, GERONTOLOGIST, V48, P311, DOI 10.1093/geront/48.3.311
   Bandura A., 1986, SOCIAL FDN THOUGHT A
   Benet-Martinez V, 1998, J PERS SOC PSYCHOL, V75, P729, DOI 10.1037//0022-3514.75.3.729
   Bogg T, 2013, ANN BEHAV MED, V45, P278, DOI 10.1007/s12160-012-9454-6
   Chapman BP, 2013, AM J GERIAT PSYCHIAT, V21, P737, DOI 10.1016/j.jagp.2012.11.013
   Chiolero A, 2009, FRONTIERS PUBLIC HLT, V1, P8
   Costa Jr P. T., 1992, NEO PERSONALITY INVE
   Duncan T., 2006, INTRO LATENT VARIABL
   Fisher L, 2009, DIABETIC MED, V26, P622, DOI 10.1111/j.1464-5491.2009.02730.x
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Fisher L, 2013, DIABETES CARE, V36, P2551, DOI 10.2337/dc12-2493
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Fry PS, 2009, J HEALTH PSYCHOL, V14, P513, DOI 10.1177/1359105309103571
   Gao J, 2013, BMC FAM PRAC, V24, P500
   Glasgow RE, 2010, J GEN INTERN MED, V25, P1315, DOI 10.1007/s11606-010-1480-0
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Krousel-Wood M, 2005, J MED SCI, V330, P182
   Lorig K, 1996, OUTCOME MEASURES HLT
   Masharani U, 2007, DIABETES DEMYSTIFIED
   Nezu AM, 2004, BEHAV THER, V35, P1, DOI 10.1016/S0005-7894(04)80002-9
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Schafer J., 1999, NORM USERS GUIDE VER
   Stewart AL, 2001, MED SCI SPORT EXER, V33, P1126
   Thompson F. E., 1998, European Journal of Clinical Nutrition, V52, pS63
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Triad Group, 2010, DIABETES CARE, V33, P940
   Tsjii S., 2012, DIABETIC MED, V29, P1451
   Vollrath ME, 2007, DIABETIC MED, V24, P1028, DOI 10.1111/j.1464-5491.2007.02215.x
NR 30
TC 11
Z9 13
U1 4
U2 29
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD JUN
PY 2014
VL 31
IS 6
BP 739
EP 746
DI 10.1111/dme.12403
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AH2KD
UT WOS:000335949000017
PM 24494593
OA Green Accepted
DA 2019-01-08
ER

PT J
AU van der Pols-Vijlbrief, R
   Dekker, JM
   Stehouwer, CD
   de Boer, MR
   Nijpels, G
   Snoek, FJ
   Adriaanse, MC
AF van der Pols-Vijlbrief, R.
   Dekker, J. M.
   Stehouwer, C. D.
   de Boer, M. R.
   Nijpels, G.
   Snoek, F. J.
   Adriaanse, M. C.
TI Symptom burden and its association with change in glucose metabolism
   status over a 7-year period: the Hoorn Study
SO DIABETIC MEDICINE
LA English
DT Article
ID QUALITY-OF-LIFE; PATIENT-REPORTED OUTCOMES; DIABETES-MELLITUS;
   POPULATION; PARTICIPANTS; PREVALENCE; DIAGNOSIS; DISTRESS
AB Aims To study symptom burden among older people and its associations with change in glucose metabolism status over a 7-year period.
   Methods We conducted a prospective population-based cohort study among 397 older people. We used the revised Diabetes Symptom Checklist to assess symptom burden. Glucose metabolism status was determined using an oral glucose tolerance test. Analyses were adjusted for multiple confounders, including cardiovascular risk and risk of depression (Center for Epidemiological Studies Depression Scale score 16).
   Results Revised Diabetes Symptom Checklist total scores (range 0-100) increased slightly over time among people with normal glucose metabolism (mean difference 1.04; P = 0.04) and those with impaired glucose metabolism (1.96; P = 0.01), but not among people with Type 2 diabetes (0.46; P = 0.55). These associations between symptom burden and glucose status were attenuated after full adjustment for multiple confounders and remained statistically significant for those with impaired glucose status. Linear mixed models showed significant mean differences in revised Diabetes Symptom Checklist total scores over time when comparing people with Type 2 diabetes with those with normal or impaired glucose metabolism, but not when comparing subjects with impaired vs normal glucose metabolism; these results did not alter after full adjustment.
   Conclusions Symptom burden increased gradually over time in the people with impaired glucose metabolism and those with normal glucose metabolism, but not in patients with Type 2 diabetes over a 7-year follow-up period.
   What's new?
   This is the first study investigating diabetes-related symptom burden among older people and its associations with a change in glucose metabolism status over a 7-year period. The results indicate that symptom burden increases gradually over time among the participants with impaired glucose and those with normal glucose status, but not among patients with Type 2 diabetes. Prospective studies are needed in larger populations, including data on comorbidities and information about diabetes treatment, given the potential of treatment to reduce diabetes complications and subsequent symptom burden .
C1 [van der Pols-Vijlbrief, R.; de Boer, M. R.; Adriaanse, M. C.] Vrije Univ Amsterdam, Fac Earth & Life Sci, Dept Hlth Sci, Amsterdam, Netherlands.
   [van der Pols-Vijlbrief, R.; Dekker, J. M.; de Boer, M. R.; Nijpels, G.; Snoek, F. J.; Adriaanse, M. C.] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands.
   [Dekker, J. M.; de Boer, M. R.] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands.
   [Dekker, J. M.; Nijpels, G.] Vrije Univ Amsterdam Med Ctr, Dept Gen Practice, Amsterdam, Netherlands.
   [Stehouwer, C. D.] Maastricht Univ Med Ctr, Dept Internal Med, Maastricht, Netherlands.
   [Stehouwer, C. D.] Maastricht Univ Med Ctr, Cardiovasc Res Inst, Maastricht, Netherlands.
   [Snoek, F. J.] Vrije Univ Amsterdam Med Ctr, Dept Med Psychol, Amsterdam, Netherlands.
RP van der Pols-Vijlbrief, R (reprint author), Vrije Univ Amsterdam, Fac Earth & Life Sci, Dept Hlth Sci, Amsterdam, Netherlands.
EM rachel.vijlbrief@vu.nl
OI de Boer, Michiel/0000-0001-9240-0199
FU Dutch Diabetes Research Foundation [2009.13.011]
FX The present study was funded by the Dutch Diabetes Research Foundation
   in the 'Stem van de Patient programme', project number: 2009.13.011.
CR Adriaanse MC, 2008, DIABETES CARE, V31, P2268, DOI 10.2337/dc08-1074
   Adriaanse MC, 2005, QUAL LIFE RES, V14, P1501, DOI 10.1007/s11136-004-0028-3
   Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
   Ali MK, 2012, DIABETIC MED, V29, pE67, DOI 10.1111/j.1464-5491.2011.03532.x
   Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS55, DOI 10.2337/dc08-S055
   Arbuckle RA, 2009, VALUE HEALTH, V12, P1168, DOI 10.1111/j.1524-4733.2009.00571.x
   Black SA, 2002, AM J PUBLIC HEALTH, V92, P543, DOI 10.2105/AJPH.92.4.543
   Campbell RK, 2009, J AM PHARM ASSOC, V49, pS3, DOI 10.1331/JAPhA.2009.09077
   de Vegt F, 2001, JAMA-J AM MED ASSOC, V285, P2109, DOI 10.1001/jama.285.16.2109
   Dueck AC, 2007, VALUE HEALTH, V10, pS64, DOI 10.1111/j.1524-4733.2007.00268.x
   Florez H, 2010, POSTGRAD MED, V122, P112, DOI 10.3810/pgm.2010.03.2128
   Gavin JR, 1999, DIABETES CARE, V22, pS5
   Hajos TRS, 2012, QUAL LIFE RES, V21, P1359, DOI 10.1007/s11136-011-0051-0
   Henry RMA, 2003, CIRCULATION, V107, P2089, DOI 10.1161/01.CIR.0000065222.34933.FC
   Koopman RJ, 2005, ANN FAM MED, V3, P60, DOI 10.1370/afm.214
   MOOY JM, 1995, DIABETES CARE, V18, P1270, DOI 10.2337/diacare.18.9.1270
   Petrie KJ, 2003, J PSYCHOSOM RES, V54, P401, DOI 10.1016/S0022-3999(02)00461-0
   Peyrot M, 2011, DIABETES TECHNOL THE, V13, P471, DOI 10.1089/dia.2010.0167
   Pischke CR, 2006, AM J CARDIOL, V97, P1267, DOI 10.1016/j.amjcard.2005.11.051
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O
   Schram MT, 2009, CURR DIABETES REV, V5, P112, DOI 10.2174/157339909788166828
   Shafer AB, 2006, J CLIN PSYCHOL, V62, P123, DOI 10.1002/jclp.20213
   Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047
NR 24
TC 1
Z9 1
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD JUN
PY 2014
VL 31
IS 6
BP 747
EP 753
DI 10.1111/dme.12406
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AH2KD
UT WOS:000335949000018
PM 24494697
DA 2019-01-08
ER

PT J
AU Lacey, CJ
   Salzberg, MR
   D'Souza, WJ
AF Lacey, Cameron J.
   Salzberg, Michael R.
   D'Souza, Wendyl J.
TI Risk factors for psychological distress in community-treated epilepsy
SO EPILEPSY & BEHAVIOR
LA English
DT Article
DE Epilepsy; Psychiatric comorbidity; Community; Risk factors
ID PSYCHIATRIC COMORBIDITY; ANTIEPILEPTIC DRUGS; DEPRESSION; ADULTS;
   POPULATION; ANXIETY; PREDICTORS; DIAGNOSES; STRESS
AB The study aimed to determine risk factors for psychological distress in a community-treated sample of patients with epilepsy. This study investigated the Tasmanian Epilepsy Register participants. Participants included were as follows: aged 13 years and over, able to complete the individual computer-assisted participant interview, and diagnosed with epilepsy following an epilepsy specialist review of the diagnostic epilepsy interview, which was interpreted using standardized diagnostic guidelines. Psychological distress was assessed with the Kessler-10 questionnaire. Risk factors were grouped into four domains: sociodemographic factors, disease-related factors, psychological factors, and treatment-related factors. High or very high levels of psychological distress were reported by 22% of the participants, with 7.8% having very high distress. The regression model showed that psychological distress was significantly associated with female gender (F = 18.1, p < 0.001), diabetes mellitus (F= 8.7, p = 0.003), intellectual disability (F= 7.1, p = 0.06), and not receiving phenytoin (F= 5.1, p = 0.02). While the model was significant (F = 5.78, p < 0.001), only 11% of the variance of the K-10 score was explained by these factors (adjusted R-squared = 0.11). This study identifies female gender and comorbid medical conditions as risk factors for psychological distress and the use of phenytoin as a protective factor. The few factors identified and the limited variance explained suggest that a focus on epilepsy-related variables is unlikely to explain key influences underlying psychiatric comorbidity in patients with epilepsy. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Lacey, Cameron J.; Salzberg, Michael R.] Univ Melbourne, St Vincents Hosp Melbourne, Dept Psychiat, Melbourne, Vic 3065, Australia.
   [Lacey, Cameron J.; D'Souza, Wendyl J.] Univ Melbourne, St Vincents Hosp Melbourne, Dept Med, Fitzroy, Vic 3065, Australia.
RP Lacey, CJ (reprint author), Univ Otago, Dept Psychol Med, POB 4345, Christchurch, New Zealand.
EM cameron.lacey@otago.ac.nz
OI D'Souza, Wendyl/0000-0002-1750-5131
FU Lundbeck Neuropsychiatry Research Fellowship; Menzies Research Institute
   NHMRC Capacity Building Grant; NHMRC Health Professional Fellowship; The
   Booth Estate Launceston; The Royal Hobart Hospital Research Foundation;
   GSK Neurology; Clifford Craig Medical Research Trust, North West
   Tasmania
FX Cameron Lacey has received support from a Lundbeck Neuropsychiatry
   Research Fellowship. Wendyl D'Souza has received support from a Menzies
   Research Institute NHMRC Capacity Building Grant and an NHMRC Health
   Professional Fellowship. The Tasmanian Epilepsy Register was supported
   by The Booth Estate Launceston, The Royal Hobart Hospital Research
   Foundation, GSK Neurology, and the Clifford Craig Medical Research
   Trust, North West Tasmania. We also thank our research assistant Pam
   McDonald for her considerable efforts in participant liaison, data
   processing, and management.
CR Adams SJ, 2008, BRIT J PSYCHIAT, V192, P464, DOI 10.1192/bjp.bp.107.046664
   Australian Bureau of Statistics, 2012, INF PAP US KESSL PSY
   BABOR TF, 2001, WHOMSDMSB016A
   Barry JJ, 2008, EPILEPSY BEHAV, V13, pS1, DOI 10.1016/j.yebeh.20008.04.005
   Brummett BH, 2007, PSYCHOSOM MED, V69, P621, DOI 10.1097/PSY.0b013e31814b8de6
   Christensen J, 2007, LANCET NEUROL, V6, P693, DOI 10.1016/S1474-4422(07)70175-8
   Clarke DM, 2009, MED J AUSTRALIA, V190, pS54
   Cook MJ, 2013, LANCET NEUROL, V12, P563, DOI 10.1016/S1474-4422(13)70075-9
   Cramer JA, 2003, EPILEPSIA, V44, P1578, DOI 10.1111/j.0013-9580.2003.28403.x
   D'Souza WJ, 2010, EPILEPSY RES, V91, P20, DOI 10.1016/j.eplepsyres.2010.06.003
   D'Souza WJ, 2008, EPIDEMIOLOGY EPILEPS
   Ettinger A, 2004, NEUROLOGY, V63, P1008, DOI 10.1212/01.WNL.0000138430.11829.61
   Ettinger AB, 2006, PSYCHIAT ISSUES EPIL
   Ettinger AB, 2006, NEUROLOGY, V67, P1916, DOI 10.1212/01.wnl.0000247045.85646.c0
   Foulds J, 2013, INT J ALCOHOL DRUG R, V2, P59, DOI 10.7895/ijadr.v2i1.73
   Gaitatzis A, 2004, ACTA NEUROL SCAND, V110, P207, DOI 10.1111/j.1600-0404.2004.00324.x
   Goodwin R, 2006, AM PSYCHIAT PUBLISHI, P33
   Hermann BP, 2000, EPILEPSIA S2, V41, P31
   Hitiris N, 2007, EPILEPSY RES, V75, P192, DOI 10.1016/j.eplepsyres.2007.06.003
   Hoppe C, 2011, NAT REV NEUROL, V7, P462, DOI 10.1038/nrneurol.2011.104
   Kanner AM, 2009, NEUROLOGY, V72, P793, DOI 10.1212/01.wnl.0000343850.85763.9c
   Karouni M, 2010, EUR J CLIN PHARMACOL, V66, P1151, DOI 10.1007/s00228-010-0861-y
   Kendler KS, 2002, AM J PSYCHIAT, V159, P1133, DOI 10.1176/appi.ajp.159.7.1133
   Kessler RC, 2012, MOL PSYCHIATR, V17, P748, DOI 10.1038/mp.2011.56
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Lacey CJ, 2009, EPILEPSIA, V50, P1991, DOI 10.1111/j.1528-1167.2009.02165.x
   Mensah SA, 2006, EPILEPSY BEHAV, V8, P213, DOI 10.1016/j.yebeh.2005.09.014
   OTTMAN R, 1990, EPILEPSIA, V31, P110, DOI 10.1111/j.1528-1157.1990.tb05368.x
   Ottman R, 2011, EPILEPSIA, V52, P308, DOI 10.1111/j.1528-1167.2010.02927.x
   Petrovski S, 2010, NEUROLOGY, V75, P1015, DOI 10.1212/WNL.0b013e3181f25b16
   REUTENS DC, 1992, EPILEPSIA, V33, P1065, DOI 10.1111/j.1528-1157.1992.tb01760.x
   RUTGERS MJ, 1986, EPILEPSIA, V27, P734, DOI 10.1111/j.1528-1157.1986.tb03603.x
   Statistics ABo, 2001, INF PAP CENS POP HOU
   Stefanello S, 2010, EPILEPSIA, V51, P1120, DOI 10.1111/j.1528-1167.2009.02386.x
   Taylor RS, 2011, EPILEPSIA, V52, P2168, DOI 10.1111/j.1528-1167.2011.03213.x
   Thapar A, 2009, EPILEPSY BEHAV, V14, P134, DOI 10.1016/j.yebeh.2008.09.004
   Trewin D, 2005, AUSTR STANDARD GEOGR
   VICTOROFF J, 1994, NEUROPSY NEUROPSY BE, V7, P87
   Vink D, 2008, J AFFECT DISORDERS, V106, P29, DOI 10.1016/j.jad.2007.06.005
   Weintraub D, 2007, EPILEPSY BEHAV, V10, P105, DOI 10.1016/j.yebeh.2006.08.008
NR 40
TC 5
Z9 5
U1 0
U2 6
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1525-5050
EI 1525-5069
J9 EPILEPSY BEHAV
JI Epilepsy Behav.
PD JUN
PY 2014
VL 35
BP 1
EP 5
DI 10.1016/j.yebeh.2014.03.025
PG 5
WC Behavioral Sciences; Clinical Neurology; Psychiatry
SC Behavioral Sciences; Neurosciences & Neurology; Psychiatry
GA AH8YQ
UT WOS:000336424500001
PM 24785427
DA 2019-01-08
ER

PT J
AU De Smedt, D
   Clays, E
   Annemans, L
   Pardaens, S
   Kotseva, K
   De Bacquer, D
AF De Smedt, Delphine
   Clays, Els
   Annemans, Lieven
   Pardaens, Sofie
   Kotseva, Kornelia
   De Bacquer, Dirk
TI Risk factor awareness in a coronary population and the association with
   health-related quality of life outcomes
SO INTERNATIONAL JOURNAL OF PUBLIC HEALTH
LA English
DT Article
DE Coronary heart disease; Awareness; Health-related quality of life
ID ACUTE MYOCARDIAL-INFARCTION; HEART-DISEASE PATIENTS; HYPERTENSION;
   MORTALITY; KNOWLEDGE; PREVALENCE; PERCEPTION; DEPRESSION; ADHERENCE
AB The purpose of this study was to investigate the risk factor level awareness in coronary patients and to assess its associations with health-related quality of life (HRQoL)/psychological distress.
   Data on 8,743 coronary patients from 22 European countries, interviewed and examined at least 6 months after their acute event was available.
   81.7 % of patients indicated to be aware of their own blood pressure level, whereas only 46.6 % of patients indicated to be aware of their cholesterol level. Furthermore, 43.7 % of patients were aware of their blood glucose level, whereas in diabetes patients blood glucose level awareness reached 81.8 %. Risk factor level awareness was significantly associated with HRQoL/psychological distress, with patients being unaware of their risk factor levels having worse outcomes. The relationship between awareness and HRQoL/psychological distress seemed to be partly mediated by the attempt of patients to adopt a healthier behaviour.
   Health care workers should be encouraged to inform their patients about the importance of their coronary risk factors, the actual level and their personal target.
C1 [De Smedt, Delphine; Clays, Els; Annemans, Lieven; De Bacquer, Dirk] Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium.
   [Annemans, Lieven] Vrije Univ Brussel, Fac Med & Pharm, Brussels, Belgium.
   [Annemans, Lieven] I CHER Interuniv Ctr Hlth Econ, Ghent, Belgium.
   [Pardaens, Sofie] Univ Ghent, Dept Internal Med, B-9000 Ghent, Belgium.
   [Kotseva, Kornelia] Univ London Imperial Coll Sci Technol & Med, Dept Cardiovasc Med, Natl Heart & Lung Inst, London, England.
RP De Smedt, D (reprint author), Univ Ghent, Dept Publ Hlth, Pintelaan 185,Blok A-2, B-9000 Ghent, Belgium.
EM delphine.desmedt@ugent.be
FU AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Pfizer;
   Sanofi-Aventis; Servier; Merck/Schering-Plough; Novartis
FX The EUROASPIRE survey was supported by the aid of unrestricted
   educational grants, which were given to the European Society of
   Cardiology by the following companies: main sponsors: AstraZeneca,
   Bristol-Myers Squibb, GlaxoSmithKline, Pfizer, Sanofi-Aventis, and
   Servier; sponsors: Merck/Schering-Plough and Novartis.
CR Alm-Roijer Carin, 2004, Eur J Cardiovasc Nurs, V3, P321
   Alves E, 2012, INT J PUBLIC HEALTH, V57, P837, DOI 10.1007/s00038-012-0340-6
   Baroletti S, 2010, CIRCULATION, V121, P1455, DOI 10.1161/CIRCULATIONAHA.109.904003
   BRODY DS, 1989, J GEN INTERN MED, V4, P506, DOI 10.1007/BF02599549
   Calvillo J, 2015, HEALTH EXPECT, V18, P643, DOI 10.1111/hex.12089
   Cheng S, 2005, J HUM HYPERTENS, V19, P769, DOI 10.1038/sj.jhh.1001895
   Cheng Susan, 2005, Prev Cardiol, V8, P11, DOI 10.1111/j.1520-037X.2005.3939.x
   De Smedt D, 2014, EUR J PREV CARDIOL, V21, P796, DOI 10.1177/2047487312473846
   De Smedt D, 2013, INT J CARDIOL, V167, P2294, DOI 10.1016/j.ijcard.2012.06.025
   French DP, 2005, BRIT J HEALTH PSYCH, V10, P167, DOI 10.1348/13590705X26722
   Grover SA, 2007, ARCH INTERN MED, V167, P2296, DOI 10.1001/archinte.167.21.2296
   Karthik Shishir, 2006, Interact Cardiovasc Thorac Surg, V5, P268, DOI 10.1510/icvts.2005.120956
   Korhonen PE, 2011, J HYPERTENS, V29, P2070, DOI 10.1097/HJH.0b013e32834bbca7
   Kotseva K, 2009, EUR J CARDIOV PREV R, V16, P121, DOI 10.1097/HJR.0b013e3283294b1d
   Kurdyak PA, 2011, J EVAL CLIN PRACT, V17, P444, DOI 10.1111/j.1365-2753.2010.01446.x
   Lau-Walker MO, 2009, J CLIN NURS, V18, P63, DOI 10.1111/j.1365-2702.2008.02386.x
   Leynen F, 2006, EUR J CARDIOV PREV R, V13, P261, DOI 10.1097/01.hjr.0000194420.62379.de
   Ludt S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029334
   Macedo ME, 2005, J HYPERTENS, V23, P1661, DOI 10.1097/01.hjh.0000179908.51187.de
   Mena-Martin FJ, 2003, J HYPERTENS, V21, P1283, DOI 10.1097/01.hjh.0000059086.43904.17
   Nash IS, 2003, ARCH INTERN MED, V163, P1597, DOI 10.1001/archinte.163.13.1597
   Perk J, 2012, EUR HEART J, V33, P1635, DOI 10.1093/eurheartj/ehs092
   Rabin R, 2013, USER GUIDE BASIC INF
   Rasmussen JN, 2007, JAMA-J AM MED ASSOC, V297, P177, DOI 10.1001/jama.297.2.177
   Redfern J, 2007, MED J AUSTRALIA, V186, P21
   Small N, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-263
   Spertus JA, 2002, CIRCULATION, V106, P43, DOI 10.1161/01.CIR.0000020688.24874.90
   Stafford L, 2009, J PSYCHOSOM RES, V66, P211, DOI 10.1016/j.jpsychores.2008.09.005
   Thombs BD, 2008, EUR J CARDIOV PREV R, V15, P479, DOI 10.1097/HJR.0b013e328300b717
   Ware J., 2002, SCORE VERSION 2 SF 1
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
NR 31
TC 1
Z9 1
U1 0
U2 4
PU SPRINGER BASEL AG
PI BASEL
PA PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND
SN 1661-8556
EI 1661-8564
J9 INT J PUBLIC HEALTH
JI Int. J. Public Health
PD JUN
PY 2014
VL 59
IS 3
BP 475
EP 483
DI 10.1007/s00038-014-0551-0
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA AH3NP
UT WOS:000336031100007
PM 24770848
DA 2019-01-08
ER

PT J
AU Bergmann, N
   Gyntelberg, F
   Faber, J
AF Bergmann, N.
   Gyntelberg, F.
   Faber, J.
TI The appraisal of chronic stress and the development of the metabolic
   syndrome: a systematic review of prospective cohort studies
SO ENDOCRINE CONNECTIONS
LA English
DT Review
DE metabolic syndrome; adiposity; hypertension; dyslipidemia; type 2
   diabetes mellitus; psychological stress; job stress
AB Chronic psychosocial stress has been proposed as a risk factor for the development of the metabolic syndrome (MES). This review gives a systematic overview of prospective cohort studies investigating chronic psychosocial stress as a risk factor for incident MES and the individual elements of MES. Thirty-nine studies were included. An association between chronic psychosocial stress and the development of MES was generally supported. Regarding the four elements of MES: i) weight gain: the prospective studies supported etiological roles for relationship stress, perceived stress, and distress, while the studies on work-related stress (WS) showed conflicting results; ii) dyslipidemi: too few studies on psychosocial stress as a risk factor for dyslipidemia were available to draw a conclusion; however, a trend toward a positive association was present; iii) type 2 diabetes mellitus (DM2): prospective studies supported perceived stress and distress as risk factors for the development of DM2 among men, but not among women, while WS was generally not supported as a risk factor among neither men nor women; iv) hypertension: marital stress and perceived stress might have an influence on blood pressure (BP), while no association was found regarding distress. Evaluating WS the results were equivocal and indicated that different types of WS affected the BP differently between men and women. In conclusion, a longitudinal association between chronic psychosocial stress and the development of MES seems present. However, the number of studies with sufficient quality is limited and the design of the studies is substantially heterogeneous.
C1 [Bergmann, N.; Faber, J.] Herlev Univ Hosp, Dept Med O, Endocrine Unit, DK-2730 Herlev, Denmark.
   [Gyntelberg, F.] Natl Res Ctr Working Environm, Copenhagen, Denmark.
   [Faber, J.] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark.
RP Bergmann, N (reprint author), Herlev Univ Hosp, Dept Med O, Endocrine Unit, DK-2730 Herlev, Denmark.
EM n.c.bergmann@hotmail.com
OI Bergmann, natasha/0000-0002-6797-8041
CR Allard KO, 2011, J OCCUP ENVIRON MED, V53, P1364, DOI 10.1097/JOM.0b013e3182363bda
   Baker B, 2000, ARCH INTERN MED, V160, P3453, DOI 10.1001/archinte.160.22.3453
   Bech P., 2012, CLIN PSYCHOMETRICS
   Berset M, 2011, SCAND J WORK ENV HEA, V37, P45, DOI 10.5271/sjweh.3089
   Bjorntorp P, 1999, DIABETES-METAB RES, V15, P427
   Block JP, 2009, AM J EPIDEMIOL, V170, P181, DOI 10.1093/aje/kwp104
   Brunner EJ, 2007, AM J EPIDEMIOL, V165, P828, DOI 10.1093/aje/kwk058
   Brunner EJ, 2013, NAT REV ENDOCRINOL, V9, P449, DOI 10.1038/nrendo.2013.124
   Chandola T, 2006, BRIT MED J, V332, P521, DOI 10.1136/bmj.38693.435301.80
   Choi B, 2014, J INTERN MED, V275, P438, DOI 10.1111/joim.12173
   COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404
   Cosgrove MP, 2012, OCCUP MED-OXFORD, V62, P167, DOI 10.1093/occmed/kqs002
   Dweck JS, 2014, APPETITE, V72, P106, DOI 10.1016/j.appet.2013.10.001
   Edwards EM, 2012, J OCCUP ENVIRON MED, V54, P1447, DOI 10.1097/JOM.0b013e3182783f27
   Eek F, 2009, SCAND J PUBLIC HEALT, V37, P532, DOI 10.1177/1403494809104359
   Eriksson AK, 2008, DIABETIC MED, V25, P834, DOI 10.1111/j.1464-5491.2008.02463.x
   Eriksson AK, 2013, DIABETES CARE, V36, P2683, DOI 10.2337/dc12-1738
   Fauvel JP, 2003, HYPERTENSION, V42, P1112, DOI 10.1161/01.HYP.0000102862.93418.EE
   Fowler-Brown AG, 2009, OBESITY, V17, P2106, DOI 10.1038/oby.2009.130
   Gerace TA, 1996, PREV MED, V25, P593, DOI 10.1006/pmed.1996.0094
   Gilbert-Ouimet M, 2012, J PSYCHOSOM RES, V72, P26, DOI 10.1016/j.jpsychores.2011.07.002
   Gilbert-Ouimet M, 2014, SCAND J WORK ENV HEA, V40, P109, DOI 10.5271/sjweh.3390
   Gimeno D, 2010, OCCUP ENVIRON MED, V67, P256, DOI 10.1136/oem.2009.047324
   Goldberg DP, 1988, USERSS GUIDE GEN HLT
   Goldstein DS, 2002, STRESS, V5, P54, DOI 10.1080/10253890290012345
   Goodwin JE, 2012, PEDIATR NEPHROL, V27, P1059, DOI 10.1007/s00467-011-1928-4
   Guimont C, 2006, AM J PUBLIC HEALTH, V96, P1436, DOI 10.2105/AJPH.2004.057679
   Heraclides AM, 2012, OBESITY, V20, P428, DOI 10.1038/oby.2011.95
   Heslop P, 2002, SOC SCI MED, V54, P1589, DOI 10.1016/S0277-9536(01)00138-1
   Holmes ME, 2010, OBES REV, V11, P492, DOI 10.1111/j.1467-789X.2009.00680.x
   Ishizaki M, 2008, SCAND J WORK ENV HEA, V34, P288, DOI 10.5271/sjweh.1267
   Karasek R, 1998, J Occup Health Psychol, V3, P322, DOI 10.1037/1076-8998.3.4.322
   Kato M, 2009, ENDOCR J, V56, P459, DOI 10.1507/endocrj.K09E-003
   Kawakami N, 1999, J EPIDEMIOL COMMUN H, V53, P359, DOI 10.1136/jech.53.6.359
   Kivimaki M, 2006, INT J OBESITY, V30, P982, DOI 10.1038/sj.ijo.0803229
   Kivimaki M, 2002, BRIT MED J, V325, P857, DOI 10.1136/bmj.325.7369.857
   Kivimaki M, 2007, AM J HYPERTENS, V20, P1146, DOI 10.1016/j.amjhyper.2007.06.006
   Korkeila M, 1998, INT J OBESITY, V22, P949, DOI 10.1038/sj.ijo.0800694
   Kouvonen A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-24
   Kouvonen A, 2011, AM J PUBLIC HEALTH, V101, P1474, DOI 10.2105/AJPH.2010.300115
   Kroenke CH, 2007, AM J EPIDEMIOL, V165, P175, DOI 10.1093/aje/kwj355
   Kumari M, 2004, ARCH INTERN MED, V164, P1873, DOI 10.1001/archinte.164.17.1873
   Lallukka T, 2008, EUR J EPIDEMIOL, V23, P303, DOI 10.1007/s10654-008-9233-7
   Landsbergis P, 2000, OCCUP MED, V15, P163
   Landsbergis PA, 2013, AM J PUBLIC HEALTH, V103, pE61, DOI 10.2105/AJPH.2012.301153
   Levenstein S, 2001, ARCH INTERN MED, V161, P1341, DOI 10.1001/archinte.161.10.1341
   Liberati A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2700
   Macfarlane DP, 2008, J ENDOCRINOL, V197, P189, DOI 10.1677/JOE-08-0054
   Magee CA, 2010, J OCCUP ENVIRON MED, V52, P977, DOI 10.1097/JOM.0b013e3181f26e72
   Markovitz JH, 2004, ANN BEHAV MED, V28, P4, DOI 10.1207/s15324796abm2801_2
   Matud MP, 2004, PERS INDIV DIFFER, V37, P1401, DOI 10.1016/j.paid.2004.01.010
   Mente A, 2010, J AM COLL CARDIOL, V55, P2390, DOI 10.1016/j.jacc.2009.12.053
   Mommersteeg PMC, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1109
   Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034
   Myers MG, 1999, AM J HYPERTENS, V12, P1149, DOI 10.1016/S0895-7061(99)00199-5
   NIAURA R, 1992, BIOL PSYCHOL, V34, P1, DOI 10.1016/0301-0511(92)90022-M
   Novak M, 2013, DIABETIC MED, V30, pE8, DOI 10.1111/dme.12037
   Nyberg ST, 2012, J INTERN MED, V272, P65, DOI 10.1111/j.1365-2796.2011.02482.x
   Ohlin B, 2007, J HYPERTENS, V25, P525
   Oksanen T, 2012, J HYPERTENS, V30, P1129, DOI 10.1097/HJH.0b013e32835377ed
   Pouwer F, 2010, DISCOV MED, V9, P112
   Puustinen PJ, 2011, PSYCHOSOM MED, V73, P158, DOI 10.1097/PSY.0b013e3182037315
   Quist HG, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-43
   Raikkonen K, 2007, DIABETES CARE, V30, P872, DOI 10.2337/dc06-1857
   Rod NH, 2009, J INTERN MED, V266, P467, DOI 10.1111/j.1365-2796.2009.02124.x
   Roos E, 2013, ARCH ENVIRON OCCUP H, V68, P166, DOI 10.1080/19338244.2012.686931
   Rosmond R, 2005, PSYCHONEUROENDOCRINO, V30, P1, DOI 10.1016/j.psyneuen.2004.05.007
   Schnall PL, 1998, PSYCHOSOM MED, V60, P697, DOI 10.1097/00006842-199811000-00007
   Schubert C, 2009, BIOL PSYCHOL, V80, P325, DOI 10.1016/j.biopsycho.2008.11.005
   Siegrist J, 2004, SOC SCI MED, V58, P1483, DOI 10.1016/S0277-9536(03)00351-4
   Smith PM, 2012, OCCUP MED-OXFORD, V62, P413, DOI 10.1093/occmed/kqs128
   Sparrenberger F, 2009, J HUM HYPERTENS, V23, P12, DOI 10.1038/jhh.2008.74
   Tobe SW, 2007, AM J HYPERTENS, V20, P148, DOI 10.1016/j.amjhyper.2006.07.011
   Toker S, 2012, J OCCUP HEALTH PSYCH, V17, P259, DOI 10.1037/a0028401
   Toshihiro M, 2008, DIABETIC MED, V25, P1211, DOI 10.1111/j.1464-5491.2008.02566.x
   Troxel WM, 2005, ARCH INTERN MED, V165, P1022, DOI 10.1001/archinte.165.9.1022
   van Holland BJ, 2012, INT ARCH OCC ENV HEA, V85, P849, DOI 10.1007/s00420-011-0727-3
   Wardle J, 2011, OBESITY, V19, P771, DOI 10.1038/oby.2010.241
   Whisman MA, 2012, HEALTH PSYCHOL, V31, P80, DOI 10.1037/a0025671
   Williams ED, 2013, ANN BEHAV MED, V46, P62, DOI 10.1007/s12160-013-9473-y
   Zellner DA, 2006, PHYSIOL BEHAV, V87, P789, DOI 10.1016/j.physbeh.2006.01.014
NR 81
TC 58
Z9 58
U1 4
U2 15
PU BIOSCIENTIFICA LTD
PI BRISTOL
PA EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4JT,
   ENGLAND
SN 2049-3614
J9 ENDOCR CONNECT
JI Endocr. Connect.
PD JUN 1
PY 2014
VL 3
IS 2
BP R55
EP R80
DI 10.1530/EC-14-0031
PG 26
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA V44UM
UT WOS:000209773900003
PM 24743684
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Molina, Y
   Lehavot, K
   Beadnell, B
   Simoni, J
AF Molina, Yamile
   Lehavot, Keren
   Beadnell, Blair
   Simoni, Jane
TI Racial Disparities in Health Behaviors and Conditions Among Lesbian and
   Bisexual Women: The Role of Internalized Stigma
SO LGBT HEALTH
LA English
DT Article
DE bisexual; health disparities; lesbian/gay; physical health;
   race/ethnicity; women
ID FEMINIST IDENTITY DEVELOPMENT; ACTIVITY QUESTIONNAIRE IPAQ; BODY-FAT
   DISTRIBUTION; SEXUAL ORIENTATION; AFRICAN-AMERICAN; PHYSICAL-ACTIVITY;
   US ADULTS; GAY MEN; PSYCHOLOGICAL DISTRESS; VEGETABLE INTAKE
AB There are documented disparities in physical health behaviors and conditions, such as physical activity and obesity, with regard to both race/ethnicity and sexual orientation. However, physical health disparities for lesbian and bisexual (LB) women who are also racial minorities are relatively unexplored. Minority stressors, such as internalized stigma, may account for disparities in such multiply marginalized populations. We sought to (1) characterize inequalities among non-Hispanic white and African American LB women and (2) examine the roles of internalized sexism and homophobia in disparities. Data on health behaviors (diet, physical activity); physical health (hypertension, diabetes, overweight/obesity); internalized sexism; and internalized homophobia were collected via a web-based survey. Recruitment ads were sent electronically to over 200 listservs, online groups, and organizations serving the lesbian, gay, and bisexual community in all 50 U.S. states. The analytic sample consisted of 954 white and 75 African American LB women. African American participants were more likely than white participants to report low fruit/vegetable intake and physical activity, a higher body mass index, and a history of diabetes and hypertension. There were no racial differences in internalized homophobia, but African American women reported higher levels of internalized sexism. Internalized sexism partially mediated racial disparities in physical activity and diabetes, but not in the other outcomes. Findings suggest that African American LB women may be at greater risk than their white counterparts for poor health and that internalized sexism may be a mediator of racial differences for certain behaviors and conditions.
C1 [Molina, Yamile] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA.
   [Molina, Yamile] Univ Illinois, Epidemiol & Biostat Div, Chicago, IL USA.
   [Molina, Yamile] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA.
   [Lehavot, Keren] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA.
   [Beadnell, Blair] Univ Washington, Sch Social Work, Seattle, WA 98195 USA.
   [Simoni, Jane] Univ Washington, Dept Psychol, Seattle, WA 98195 USA.
   [Lehavot, Keren] VA Puget Sound Hlth Care Syst, Seattle, WA USA.
RP Molina, Y (reprint author), Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave N,M3-B232, Seattle, WA 98109 USA.
EM ymolina@fhcrc.org
OI Simoni, Jane/0000-0002-8711-1576
FU Centers for Disease Control Grant for Public Health Research
   Dissertation [R36 CD000996]; National Cancer Institute Supplement to
   Promote Diversity in Health-Related Research [P50CA148143];
   Biobehavioral Cancer Prevention and Control Training Program at the
   University of Washington [R25CA92408]
FX This research was supported by a Centers for Disease Control Grant for
   Public Health Research Dissertation (R36 CD000996) award to K.L.
   Manuscript preparation was supported by funding to Y.M. through a
   National Cancer Institute Supplement to Promote Diversity in
   Health-Related Research (P50CA148143) and a postdoctoral fellowship
   through the Biobehavioral Cancer Prevention and Control Training Program
   at the University of Washington (R25CA92408).
CR Aaron DJ, 2001, AM J PUBLIC HEALTH, V91, P972, DOI 10.2105/AJPH.91.6.972
   Acevedo-Garcia D, 2003, AM J PUBLIC HEALTH, V93, P214
   Adler NE, 2008, ANNU REV PUBL HEALTH, V29, P235, DOI 10.1146/annurev.publhealth.29.020907.090852
   Amadio DM, 2006, ADDICT BEHAV, V31, P1153, DOI 10.1016/j.addbeh.2005.08.013
   [Anonymous], 2010, BIENN REP DIR NAT I
   Baker AH, 2003, APPETITE, V40, P269, DOI 10.1016/S0195-6663(03)00014-X
   Balsam KF, 2011, CULT DIVERS ETHN MIN, V17, P163, DOI 10.1037/a0023244
   Bird CE, 1999, SOC SCI MED, V48, P745, DOI 10.1016/S0277-9536(98)00402-X
   Block G, 2000, AM J PREV MED, V18, P284, DOI 10.1016/S0749-3797(00)00119-7
   Borrell C, 2010, J WOMENS HEALTH, V19, P741, DOI 10.1089/jwh.2009.1594
   Bowen DJ, 2008, OBESITY, V16, P221, DOI 10.1038/oby.2007.34
   Brancati FL, 2000, JAMA-J AM MED ASSOC, V283, P2253, DOI 10.1001/jama.283.17.2253
   Braveman P, 2006, ANNU REV PUBL HEALTH, V27, P167, DOI 10.1146/annurev.publhealth.27.021405.102103
   Bridges SK, 2003, J MULTICULT COUNS D, V31, P113, DOI 10.1002/j.2161-1912.2003.tb00537.x
   Burgess D., 2007, J LGBT HLTH RES, V3, P1, DOI DOI 10.1080/15574090802226626
   Butler C, 2002, J NATL MED ASSOC, V94, P143
   Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501
   Case P, 2004, J WOMENS HEALTH, V13, P1033, DOI 10.1089/jwh.2004.13.1033
   Chambers EC, 2004, J NATL MED ASSOC, V96, P1594
   Conron KJ, 2010, AM J PUBLIC HEALTH, V100, P1953, DOI 10.2105/AJPH.2009.174169
   Dilley JA, 2010, AM J PUBLIC HEALTH, V100, P460, DOI 10.2105/AJPH.2007.130336
   Dube EM, 1999, DEV PSYCHOL, V35, P1389, DOI 10.1037//0012-1649.35.6.1389
   Fischer AR, 2000, PSYCHOL WOMEN QUART, V24, P15, DOI 10.1111/j.1471-6402.2000.tb01018.x
   Gorman BK, 2006, J HEALTH SOC BEHAV, V47, P95, DOI 10.1177/002214650604700201
   Greene B, 1997, J Lesbian Stud, V1, P109, DOI 10.1300/J155v01n01_09
   Hagstromer M, 2006, PUBLIC HEALTH NUTR, V9, P755, DOI 10.1079/PHN2005898
   Hallal PC, 2004, MED SCI SPORT EXER, V36, P556, DOI 10.1249/01.MSS.0000117161.66394.07
   Hancock A. -M., 2004, POLITICS DISGUST PUB
   Hatzenbuehler ML, 2010, AM J PUBLIC HEALTH, V100, P452, DOI 10.2105/AJPH.2009.168815
   Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360
   Herek GM, 1998, J GAY LESBIAN MED AS, V2, P17, DOI DOI 10.1016/0145-2134(92)90011-F
   Herek GM, 2002, HEALTH PSYCHOL, V22, P595
   Hertz RP, 2005, ARCH INTERN MED, V165, P2098, DOI 10.1001/archinte.165.18.2098
   Hill SA, 2002, SEX ROLES, V47, P493, DOI 10.1023/A:1022026303937
   Institute of Medicine (US) Committee on Lesbian Gay Bisexual and Transgender Health Issues and Research Gaps and Opportunities, 2011, HLTH LESB GAY BISEX
   Jones CP, 2000, AM J PUBLIC HEALTH, V90, P1212, DOI 10.2105/AJPH.90.8.1212
   Kant AK, 2007, AM J PREV MED, V32, P264, DOI 10.1016/j.amepre.2006.12.011
   Katznelson Ira, 2005, AFFIRMATIVE ACTION W
   Kertzner RM, 2009, AM J ORTHOPSYCHIAT, V79, P500, DOI 10.1037/a0016848
   Keyhani S, 2008, HYPERTENSION, V51, P1149, DOI 10.1161/HYPERTENSIONAHA.107.107342
   Kirkpatrick SI, 2012, J ACAD NUTR DIET, V112, P624, DOI 10.1016/j.jand.2011.11.012
   Krane V, 2004, SEX ROLES, V50, P315, DOI 10.1023/B:SERS.0000018888.48437.4f
   Krieger N, 2004, EPIDEMIOL REV, V26, P92, DOI 10.1093/epirev/mxh009
   Krieger N, 1997, ANNU REV PUBL HEALTH, V18, P341, DOI 10.1146/annurev.publhealth.18.1.341
   Laditka SB, 2002, J WOMEN AGING, V14, P163, DOI 10.1300/J074v14n01_11
   LaVeist T. A., 2002, RACE ETHNICITY HLTH
   Lehman P., 2000, THESIS FLORIDA I TEC
   Lewis RJ, 2003, J SOC CLIN PSYCHOL, V22, P716, DOI 10.1521/jscp.22.6.716.22932
   LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958
   Mak WWS, 2007, SOC SCI MED, V65, P245, DOI 10.1016/j.socscimed.2007.03.015
   Martin J. L., 1992, SUMMARY MEASUR UNPUB
   Massey D., 2007, CATEGORICALLY UNEQUA
   Mays VM, 2002, AM J PUBLIC HEALTH, V92, P632, DOI 10.2105/AJPH.92.4.632
   McCollum Marianne, 2005, Gend Med, V2, P246, DOI 10.1016/S1550-8579(05)80054-3
   McKay Becky, 2011, Medical Reference Services Quarterly, V30, P393, DOI 10.1080/02763869.2011.608971
   Mensah GA, 2005, CIRCULATION, V111, P1233, DOI 10.1161/01.CIR.0000158136.76824.04
   MEYER IH, 1995, J HEALTH SOC BEHAV, V36, P38, DOI 10.2307/2137286
   Moradi B, 2002, COUNS PSYCHOL, V30, P66, DOI 10.1177/0011000002301004
   Moradi B, 2010, COUNS PSYCHOL, V38, P397, DOI 10.1177/0011000009335263
   National Heart Lung and Blood institute National Institute of Diabetes and Digestive and Kidney Diseases (U.S.), 1998, CLIN GUID ID EV TREA
   Ogden CL, 2009, AM J CLIN NUTR, V89, P1001, DOI 10.3945/ajcn.2009.27592
   Packard GM, 2002, AM NIGHTMARE HIST JI
   Piggot M, 2004, THESIS SWINBURNE U T
   Preacher KJ, 2008, BEHAV RES MET, V40, P87
   Ransdell LB, 1998, MED SCI SPORT EXER, V30, P1608, DOI 10.1097/00005768-199811000-00009
   Roberts SA, 2003, WOMEN HEALTH ISS, V13, P167, DOI 10.1016/S1049-3867(03)00041-0
   Sartore ML, 2009, QUEST, V61, P289, DOI 10.1080/00336297.2009.10483617
   SCHAFER JL, 2002, PSYCHOL METHODS, V7, P142, DOI DOI 10.1037/1082-989X.7.2.147
   Sekayi D, 2003, J NEGRO EDUC, V72, P467, DOI DOI 10.2307/3211197
   Szymanski DA, 2005, J COUNS DEV, V83, P355, DOI 10.1002/j.1556-6678.2005.tb00355.x
   Szymanski DM, 2008, COUNS PSYCHOL, V36, P525, DOI 10.1177/0011000007309489
   Szymanski DM, 2009, J COUNS PSYCHOL, V56, P110, DOI 10.1037/a0013317
   Szymanski DM, 2005, COUNS PSYCHOL, V33, P729, DOI 10.1177/0011000005278408
   Thomas AJ, 2008, CULT DIVERS ETHN MIN, V14, P307, DOI 10.1037/1099-9809.14.4.307
   Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3
   Tull ES, 2005, J NATL MED ASSOC, V97, P206
   Tull ES, 2007, ETHNIC DIS, V17, P731
   U. S. Department of Health and Human Services, 2011, HLTH PEOPL 2020 OBJ
   Valanis BG, 2000, ARCH FAM MED, V9, P843, DOI 10.1001/archfami.9.9.843
   Veenstra G, 2013, SOC SCI MED, V89, P16, DOI 10.1016/j.socscimed.2013.04.014
   Watters JL, 2007, PUBLIC HEALTH NUTR, V10, P701, DOI 10.1017/S1368980007662284
   West CM, 1995, PSYCHOTHER, V32, P458, DOI 10.1037/0033-3204.32.3.458
   Whitson HE, 2010, J GERONTOL A-BIOL, V65, P1325, DOI 10.1093/gerona/glq139
   Williams DR, 2009, J BEHAV MED, V32, P20, DOI 10.1007/s10865-008-9185-0
   Williams DR, 2005, HEALTH AFFAIR, V24, P325, DOI 10.1377/hlthaff.24.2.325
   Williams DR, 2002, AM J PUBLIC HEALTH, V92, P588, DOI 10.2105/AJPH.92.4.588
   Wilson P.A., 2007, HLTH SEXUAL MINORITI, P607
   Wolin KY, 2008, J PHYS ACT HEALTH, V5, P746, DOI 10.1123/jpah.5.5.746
   Zhang Q, 2009, ETHNIC HEALTH, V14, P439, DOI 10.1080/13557850802699155
NR 89
TC 10
Z9 10
U1 3
U2 11
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2325-8292
EI 2325-8306
J9 LGBT HEALTH
JI LGBT Health
PD JUN
PY 2014
VL 1
IS 2
BP 131
EP 139
DI 10.1089/lgbt.2013.0007
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA CR9PV
UT WOS:000361689800012
PM 25364769
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Pandit, AU
   Bailey, SC
   Curtis, LM
   Seligman, HK
   Davis, TC
   Parker, RM
   Schillinger, D
   DeWalt, D
   Fleming, D
   Mohr, DC
   Wolf, MS
AF Pandit, Anjali U.
   Bailey, Stacy C.
   Curtis, Laura M.
   Seligman, Hilary K.
   Davis, Terry C.
   Parker, Ruth M.
   Schillinger, Dean
   DeWalt, Darren
   Fleming, David
   Mohr, David C.
   Wolf, Michael S.
TI Disease-related distress, self-care and clinical outcomes among
   low-income patients with diabetes
SO JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH
LA English
DT Article
ID DEPRESSION; HEALTH; ADHERENCE; SCALE
AB Background The purpose of this study is to determine the prevalence of diabetes distress and its relationship with health behaviours and clinical outcomes in low-income patients.
   Methods Secondary analyses were conducted using baseline data from a clinical trial evaluating a diabetes self-management intervention. Interviews were conducted with 666 participants receiving care at nine safety net clinics in Missouri. Distress was measured using the Diabetes Distress Scale, and outcomes included medication adherence, physical activity, nutrition and clinical biomarkers (haemoglobin A1C (HbA1C), blood pressure, low-density lipoprotein (LDL) cholesterol).
   Results In a sample of 666 participants, 14.1% and 27.3% of patients were identified as highly and moderately distressed, respectively, with higher rates among younger, female and lower income patients. When compared with moderately and no distress groups, highly distressed patients were less adherent to medications (20.7% vs 29.9% vs 39.4%, p<0.001) and had higher HbA1C values (9.3% (SD=2.0) vs 8.2% (SD=1.8) vs 7.8% (SD=1.7), p<0.001), diastolic blood pressure (81.8 (SD=9.4) vs 80.2 (9.7) vs 78.9 (SD=8.8), p=0.02) and LDL cholesterol (104.6 (SD=42.4) vs 97.2 (34.3) vs 95.5 (37.9)) In multivariable analyses, high and moderate distress were associated with lower medication adherence (OR=0.44; 0.27 to 0.23, p=0.001) and (OR=0.58; 0.42 to 0.79; p=0.001), respectively, and higher HbA1C in only the highly distressed group (B=1.3; 0.81 to 1.85; p<0.001) compared with the no distress group.
   Conclusions Diabetes distress is prevalent and linked to poorer adherence to health behaviours and glycemic control in a sample of patients receiving care from low-income clinics.
C1 [Pandit, Anjali U.; Bailey, Stacy C.; Curtis, Laura M.; Wolf, Michael S.] Feinberg Sch Med, Hlth Literacy & Learning Program, Dept Gen Internal Med, Chicago, IL USA.
   [Seligman, Hilary K.; Schillinger, Dean] Univ Calif San Francisco, Div Gen Internal Med, San Francisco, CA 94143 USA.
   [Davis, Terry C.] Louisiana State Univ, Hlth Sci Ctr, Dept Med & Pediat, Shreveport, LA 71105 USA.
   [Parker, Ruth M.] Emory Univ, Sch Med, Div Gen Med, Atlanta, GA USA.
   [DeWalt, Darren] Univ N Carolina, Sch Med, Div Gen Internal Med, Chapel Hill, NC USA.
   [Fleming, David] Univ Missouri, Sch Med, Dept Med, Columbia, MO 65212 USA.
   [Mohr, David C.] Northwestern Univ, Dept Prevent Med, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA.
RP Pandit, AU (reprint author), Northwestern Univ, Div Gen Internal Med, Hlth Literacy & Learning Program HeLP, Feinberg Sch Med, 750 N Lake Shore,Dr 10th Floor, Chicago, IL 60611 USA.
EM a-pandit@northwestern.edu
OI DeWalt, Darren/0000-0003-2270-751X; Mohr, David/0000-0002-5443-7596;
   Curtis, Laura/0000-0003-2380-2201
FU Missouri Foundation for Health
FX This paper was supported by the Missouri Foundation for Health.
CR American Association for Public Opinion, 2004, STAND DEF FIN DISP C
   Bailey Stacy Cooper, 2009, Med Care, V47, P707, DOI 10.1097/MLR.0b013e318195fd02
   Baker DW, 1999, PATIENT EDUC COUNS, V38, P33, DOI 10.1016/S0738-3991(98)00116-5
   Bener A, 2011, ONCOL REV, V5, P5, DOI 10.1007/s12156-010-0061-0
   Centers for Disease Control and Prevention, 2006, BEH RISK FACT SURV F
   Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278
   Fisher L, 2009, DIABETIC MED, V26, P622, DOI 10.1111/j.1464-5491.2009.02730.x
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Hays RD, 2009, QUAL LIFE RES, V18, P873, DOI 10.1007/s11136-009-9496-9
   Jimenez-Garcia R, 2012, PRIM CARE DIABETES, V6, P149, DOI 10.1016/j.pcd.2011.10.002
   Lopez-Quintero C, 2010, J AM DIET ASSOC, V110, pS62, DOI 10.1016/j.jada.2010.03.009
   MacKinnon DP, 2009, CURR DIR PSYCHOL SCI, V18, P16, DOI 10.1111/j.1467-8721.2009.01598.x
   MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007
   Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Slean GR, 2012, MED CARE, V50, pS69, DOI 10.1097/MLR.0b013e3182641127
   Tol A, 2012, J DIABETES METAB DIS, V11, DOI 10.1186/2251-6581-11-20
   U.S. Preventive Services Task Force, 2010, 1005145 US PREV SERV
   Wolf MS, 2011, ARCH INTERN MED, V171, P300, DOI 10.1001/archinternmed.2011.39
NR 21
TC 29
Z9 29
U1 6
U2 28
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0143-005X
EI 1470-2738
J9 J EPIDEMIOL COMMUN H
JI J. Epidemiol. Community Health
PD JUN
PY 2014
VL 68
IS 6
BP 557
EP 564
DI 10.1136/jech-2013-203063
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA AG4AV
UT WOS:000335362000012
PM 24489044
DA 2019-01-08
ER

PT J
AU Salam, RA
   Das, JK
   Bhutta, ZA
AF Salam, Rehana A.
   Das, Jai K.
   Bhutta, Zulfiqar A.
TI Impact of intrauterine growth restriction on long-term health
SO CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
LA English
DT Review
DE catch-up growth; intrauterine growth restriction; metabolic diseases;
   prenatal programming
ID FOR-GESTATIONAL-AGE; INSULIN-RESISTANCE; FETAL-GROWTH; METABOLIC
   SYNDROME; POSTNATAL LIFE; CHILDREN BORN; PRETERM BIRTH; LEPTIN LEVELS;
   RETARDATION; IUGR
AB Purpose of reviewIntrauterine growth restriction (IUGR) is responsible for the higher rates of fetal, perinatal, and neonatal morbidity and mortality. This review details the IUGR risk factors, its short and long-term sequel, the mechanism underlying the long-term consequences, and the strategies to tackle IUGR burden.Recent findingsShort-term consequences of IUGR involve metabolic, thermal, and hematological disturbances leading to morbidities. Long term consequences due to changes in the fetal nutritional environment is associated with increased risk of developing metabolic syndrome and cardiovascular disease, systolic hypertension, obesity, insulin resistance, and diabetes type II in adulthood. There are no effective therapies to reverse IUGR, and antenatal management is aimed at determining the ideal time and mode of delivery. In order to prevent complications associated with IUGR, it is important to first detect the condition and institute appropriate surveillance to assess fetal well-being coupled with suitable intervention in case of fetal distress.SummaryReliable prediction of IUGR may be achieved by combining clinical risk factors with Doppler abnormalities, fetal growth, and biomarkers. If this can be achieved, there is potential to reduce future perinatal morbidity, mortality and long-term consequences, but steps geared toward the prevention of IUGR are of unparalleled importance.
C1 [Salam, Rehana A.; Das, Jai K.; Bhutta, Zulfiqar A.] Aga Khan Univ, Div Woman & Child Hlth, Karachi 74800, Pakistan.
   [Bhutta, Zulfiqar A.] Hosp Sick Children, Program Global Pediat Res, Toronto, ON M5G 1X8, Canada.
RP Bhutta, ZA (reprint author), Aga Khan Univ, Ctr Excellence Women & Child Hlth, Karachi 74800, Pakistan.
EM zulfiqar.bhutta@aku.edu
CR Abitbol CL, 2012, NAT REV NEPHROL, V8, P265, DOI 10.1038/nrneph.2012.38
   Arcangeli T, 2012, ULTRASOUND OBST GYN, V40, P267, DOI 10.1002/uog.11112
   Bacchetta J, 2008, ARCH PEDIATRIE, V15, P1212, DOI 10.1016/j.arcped.2008.04.013
   Bacchetta J, 2009, KIDNEY INT, V76, P445, DOI 10.1038/ki.2009.201
   Baschat AA, 2011, ULTRASOUND OBST GYN, V37, P501, DOI 10.1002/uog.9008
   Bjarnegard N, 2013, ULTRASOUND OBST GYN, V41, P177, DOI 10.1002/uog.12314
   Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X
   Boiko J, 2005, INT J OBESITY, V29, P565, DOI 10.1038/sj.ijo.0802901
   Briana DD, 2009, EUR J ENDOCRINOL, V160, P337, DOI 10.1530/EJE-08-0621
   Chan PYL, 2010, INT J PEDIAT, V2010, P1
   Cianfarani S, 2012, INT J OBESITY, V36, P1270, DOI 10.1038/ijo.2012.54
   Conde-Agudelo A, 2013, BJOG-INT J OBSTET GY, V120, P681, DOI 10.1111/1471-0528.12172
   Crume T. L., 2013, OBESITY, V22, P608
   Dessi A, 2012, J MATERN-FETAL NEO M, V25, P13, DOI 10.3109/14767058.2012.714639
   Fowden AL, 2005, EARLY HUM DEV, V81, P723, DOI 10.1016/j.earlhumdev.2005.06.007
   Fowden AL, 2004, REPRODUCTION, V127, P515, DOI 10.1530/rep.1.00033
   Gatford KL, 2013, CLIN OBSTET GYNECOL, V56, P520, DOI 10.1097/GRF.0b013e31829e5b29
   Gerhardt A, 2013, J THROMB THROMBOLYS, V37, P107
   Geva R, 2006, PEDIATRICS, V118, P91, DOI 10.1542/peds.2005-2343
   Grivell R, 2009, BEST PRACT RES CL OB, V23, P795, DOI 10.1016/j.bpobgyn.2009.06.004
   Ibanez L, 2008, J CLIN ENDOCR METAB, V93, P2079, DOI 10.1210/jc.2007-2850
   Imdad A, 2011, BMC PUBLIC HEALTH, V11, pS22, DOI DOI 10.1186/1471-2458-11-S3-S20.PUBMED:21501438
   Jaquet D, 2005, DIABETOLOGIA, V48, P849, DOI 10.1007/s00125-005-1724-4
   Jaquet D, 2000, J CLIN ENDOCR METAB, V85, P1401, DOI 10.1210/jc.85.4.1401
   Javaid MK, 2005, CALCIFIED TISSUE INT, V76, P341, DOI 10.1007/s00223-004-1128-3
   Kallen B, 2013, EUR RESPIR J, V41, P671, DOI 10.1183/09031936.00041912
   Koklu E, 2007, PEDIATR RES, V62, P704, DOI 10.1203/PDR.0b013e318157caaa
   Lindqvist PG, 2005, ULTRASOUND OBST GYN, V25, P258, DOI 10.1002/uog.1806
   Longo S, 2013, J MATERN-FETAL NEO M, V26, P222, DOI 10.3109/14767058.2012.715006
   Lopez-Bermejo A, 2006, CLIN ENDOCRINOL, V64, P479, DOI 10.1111/j.1365-2265.2006.02496.x
   Mandruzzato G, 2008, J PERINAT MED, V36, P277, DOI 10.1515/JPM.2008.050
   Martinez-Cordero C, 2006, ARCH MED RES, V37, P490, DOI 10.1016/j.arcmed.2005.11.004
   McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003
   McMillen IC, 2004, P NUTR SOC, V63, P405, DOI 10.1079/PNS2004370
   Miller J, 2008, SEMIN PERINATOL, V32, P274, DOI 10.1053/j.semperi.2008.04.010
   Neitzke U, 2008, PLACENTA, V29, P246, DOI 10.1016/j.placenta.2007.11.014
   Ong KK, 2004, EUR J ENDOCRINOL, V151, pU131, DOI 10.1530/eje.0.151U131
   Phillips DIW, 2001, CLIN EXP PHARMACOL P, V28, P967, DOI 10.1046/j.1440-1681.2001.03558.x
   Pike K, 2012, SEM FET NEON MED
   Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2
   Roberts DJ, 2008, J CLIN PATHOL, V61, P1254, DOI 10.1136/jcp.2008.055236
   Rosenberg A, 2008, SEM PER
   Saenger P, 2007, ENDOCR REV, V28, P219, DOI 10.1210/er.2006-0039
   Salam RA, 2013, EXPERT REV OBSTET GY, V8, P559
   Schreuder M, 2006, CLIN COURSE PEDIAT I, P112
   Singh S, 2013, INT J REPROD CONTRAC, V2, P566
   Smith GCS, 2007, LANCET, V370, P1715, DOI 10.1016/S0140-6736(07)61723-1
   Srinivas SK, 2009, J PERINATOL, V29, P680, DOI 10.1038/jp.2009.83
   Stocker CJ, 2005, P NUTR SOC, V64, P143, DOI 10.1079/PNS2005417
   Suhag A, 2013, CURR OBSTET GYNECOL, V2, P1
   Sukrat B, 2013, BIOMED RES INT, V2013, P1
   Teeninga N, 2008, NEPHROL DIAL TRANSPL, V23, P1615, DOI 10.1093/ndt/gfm829
   Tinnion R, 2013, ARCH DIS CHILD, DOI 10.1136/archdischild-2013-304615
   Valuniene M, 2007, MED LITH, V43, P784
   Von Beckerath A-K, 2012, AM J OBSTET GYNECOL, V208, P130
   Wojcik W, 2013, PSYCHOL MED, V43, P1, DOI 10.1017/S0033291712000682
   Yajnik CS, 2002, J CLIN ENDOCR METAB, V87, P5575, DOI 10.1210/jc.2002-020434
   Yuen BSJ, 2003, FASEB J, V17, P1102, DOI 10.1096/fj.02-0756fje
   Zanardo V, 2013, HYPERTENS RES, V36, P440, DOI 10.1038/hr.2012.219
NR 59
TC 47
Z9 52
U1 0
U2 20
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1363-1950
EI 1473-6519
J9 CURR OPIN CLIN NUTR
JI Curr. Opin. Clin. Nutr. Metab. Care
PD MAY
PY 2014
VL 17
IS 3
BP 249
EP 254
DI 10.1097/MCO.0000000000000051
PG 6
WC Endocrinology & Metabolism; Nutrition & Dietetics
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA AG5FM
UT WOS:000335444900008
PM 24613859
DA 2019-01-08
ER

PT J
AU Elgart, JF
   Caporale, JE
   Asteazaran, S
   De La Fuente, JL
   Camilluci, C
   Brown, JB
   Gonzalez, CD
   Gagliardino, JJ
AF Elgart, Jorge F.
   Caporale, Joaquin E.
   Asteazaran, Santiago
   De La Fuente, Jorge L.
   Camilluci, Cecilia
   Brown, Jonathan B.
   Gonzalez, Claudio D.
   Gagliardino, Juan J.
TI Association between socioeconomic status, type 2 diabetes and its
   chronic complications in Argentina
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Socioeconomic status; Type 2 diabetes; Chronic complications; Diabetes
   costs in Argentina
ID GLUCOSE CONTROL; MARITAL-STATUS; HEALTH; CARE; IMPACT; POPULATION;
   PREVALENCE; MELLITUS; DISEASE; COSTS
AB Aim: To compare the socioeconomic status (SES) of people with type 2 diabetes (T2DM) in Argentina (Cordoba) with and without major chronic complications of diabetes, with that recorded in persons without diabetes matched by age and gender.
   Methods: For this descriptive and analytic case-control study, potential candidates were identified from the electronic records of one institution of the Social Security System of the city of Cordoba. We identified and recruited 387 persons each with T2DM with or without chronic complications and 774 gender-and age-matched persons without T2DM (recruitment rate, 83%). Data were obtained by telephone interviews and supplemented with data from the institution's records. Group comparisons were performed with parametric or non-parametric tests as appropriate. We used ordinary least squares to regress household income and the difference between income and household expenses on diabetes status, age, sex, education and body mass index.
   Results: Persons with T2DM, particularly those with complications, reported fewer years of general education (13.6 +/- 4.2 years vs. 12.2 +/- 4.4 years), a lower percentage of full time jobs (43.0% vs. 26.9%), lower salaries and monthly household income among those with full-time jobs (> 5000 ARG$: 52.6% vs. 24.5%), and a higher propensity to spend more money than they earned (expenditure/income ratio >= 1: 10.2% vs. 16.0%). The percentage of unmarried people was also higher among people with type 2 diabetes (7.0% vs. 10.9%).
   Conclusion: T2DM and the development of its complications are each positively associated with lower SES and greater economic distress in Argentina. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
C1 [Elgart, Jorge F.; Caporale, Joaquin E.; Asteazaran, Santiago; Brown, Jonathan B.; Gagliardino, Juan J.] Natl Univ La Plata, Natl Res Council, PAHO WHO Collaborating Ctr Diabet, CENEXA Ctr Expt & Appl Endocrinol,Sch Med, RA-1900 La Plata, Argentina.
   [De La Fuente, Jorge L.; Camilluci, Cecilia] Hosp Privado, Ctr Med Cordoba, Cordoba, Argentina.
   [Gonzalez, Claudio D.] Univ Buenos Aires, Sch Med, Dept Pharmacol, RA-1053 Buenos Aires, DF, Argentina.
RP Elgart, JF (reprint author), CENEXA UNLP CONICET LA PLATA, Fac Ciencias Med UNLP, 60 & 120, RA-1900 La Plata, Argentina.
EM jelgart@cenexa.org
OI Gonzalez, Claudio/0000-0002-3772-8850; Elgart, Jorge/0000-0002-6101-1219
FU Novo Nordisk International
FX This study was partially supported with an unrestricted grant provided
   by Novo Nordisk International. The authors thank the authorities at
   Hospital Privado - Centro Medico de Cordoba, Argentina, Enzo Rucci for
   informatic support and Adriana Di Maggio for careful manuscript editing
   prior to submission.
CR ADVANCE Collaborative Group, 2008, NEW ENGL J MED, V358, P2560, DOI [10.1056/NEJMoa0802987, DOI 10.1056/NEJM0A0802987]
   Agardh E, 2011, INT J EPIDEMIOL, V40, P804, DOI 10.1093/ije/dyr029
   American Diabetes Association, DIABETES CARE
   [Anonymous], 2008, DIABETES EDUCATOR, V34, P451, DOI 10.1177/0145721708316627
   Artazcoz L, GAC SANIT
   August KJ, 2010, SOC SCI MED, V71, P1831, DOI 10.1016/j.socscimed.2010.08.022
   Brown AF, 2004, EPIDEMIOL REV, V26, P63, DOI 10.1093/epirev/mxh002
   Chaikiat A, 2012, HEALTH PLACE, V18, P877, DOI 10.1016/j.healthplace.2012.03.003
   Chen RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050957
   Cohen S, 2004, AM PSYCHOL, V59, P676, DOI 10.1037/0003-066X.59.8.676
   Commendatore V, 2013, INT J CLIN PRACT, V67, P1261, DOI 10.1111/ijcp.12208
   Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431
   Elovainio M, 2011, AM J EPIDEMIOL, V174, P779, DOI 10.1093/aje/kwr149
   Fano V, 2013, EUR J PUBLIC HLT JAN
   Ferrante D, 2011, REV ARGENT SALUD PUB, V2, P34
   Fletcher J, 2008, J HEALTH ECON, V27, P794, DOI 10.1016/j.jhealeco.2007.10.010
   Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778
   Gagliardino JJ, 2013, DIABETIC MED, V30, P1102, DOI 10.1111/dme.12230
   Gagliardino JJ, 2012, DIABETES METAB, V38, P128, DOI 10.1016/j.diabet.2011.09.002
   Gagliardino JJ, PAN AM J PUBLIC HLTH
   Guariguata L, 2013, DIABETES RES CLIN PR
   Hex N, 2012, DIABETIC MED, V29, P855, DOI 10.1111/j.1464-5491.2012.03698.x
   Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470
   Hsu CC, 2012, DIABETES CARE, V35, P2286, DOI 10.2337/dc11-2052
   International Diabetes Federation, 2010, DIAB SOC EC IMP STUD
   Johnson NJ, 2000, ANN EPIDEMIOL, V10, P224, DOI 10.1016/S1047-2797(99)00052-6
   Gagliardino JJ, 2013, DIABETES-METAB RES, V29, P152, DOI 10.1002/dmrr.2368
   Kanjilal S, 1971, ARCH INTERN MED
   Larranaga I, 2005, DIABETIC MED, V22, P1047, DOI 10.1111/j.1464-5491.2005.01598.x
   Lavigne JE, 2003, PHARMACOECONOMICS, V21, P1123, DOI 10.2165/00019053-200321150-00006
   Li YP, 2010, DIABETES, V59, P2400, DOI 10.2337/db10-0385
   Maier W, 2013, DIABETIC MED, V30, pE78, DOI 10.1111/dme.12062
   Morsanutto A, 2006, J DIABETES COMPLICAT, V20, P163, DOI 10.1016/j.jdiacomp.2005.06.011
   OLIVERA EM, 1991, DIABETES CARE, V14, P593, DOI 10.2337/diacare.14.7.593
   Pan American Health Organization/World Health Organization (PAHO/WHO), 2012, HLTH SIT AM BAS IND
   Shaw K, 2011, DIABETES EDUCATOR, V37, P813, DOI 10.1177/0145721711424618
   Shen J, 2012, CARDIOL RES PRACT, DOI 10.1155/2012/178675
   Trento M, 2004, DIABETES CARE, V27, P670, DOI 10.2337/diacare.27.3.670
   UK Prospective Diabetes Study Group, BMJ
   Venermo M., 2013, BMJ OPEN, V8, P3
   Williams R, 2002, DIABETOLOGIA, V45, pS13, DOI 10.1007/s00125-002-0859-9
   Wilper AP, 2008, ANN INTERN MED, V149, P170, DOI 10.7326/0003-4819-149-3-200808050-00006
   Wolf G, 2011, NEPHROL DIAL TRANSPL, V26, P4017, DOI 10.1093/ndt/gfr185
   Zhang H, 2013, DIABETIC MED, V30, pE157, DOI 10.1111/dme.12156
   Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a
NR 45
TC 7
Z9 7
U1 0
U2 18
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
EI 1872-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD MAY
PY 2014
VL 104
IS 2
BP 241
EP 247
DI 10.1016/j.diabres.2014.02.010
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AF6SV
UT WOS:000334845800013
PM 24629409
DA 2019-01-08
ER

PT J
AU Zdunczyk, B
   Sendela, J
   Szypowska, A
AF Zdunczyk, Beata
   Sendela, Joanna
   Szypowska, Agnieszka
TI High prevalence of depressive symptoms in wellcontrolled adolescents
   with type 1 diabetes treated with continuous subcutaneous insulin
   infusion
SO DIABETES-METABOLISM RESEARCH AND REVIEWS
LA English
DT Article
DE quality of life; glycated haemoglobin; insulin pump; depression;
   adolescent
ID QUALITY-OF-LIFE; GLYCEMIC CONTROL; CHILDRENS DEPRESSION;
   METABOLIC-CONTROL; FAMILY CONFLICT; MEDIATING ROLE; MANAGEMENT; YOUTH;
   INVENTORY; STRESS
AB BackgroundResearchers report co-morbid depressive symptoms in children with poorly controlled type 1 diabetes (T1D). However, excellent diabetes control may be associated with emotional distress as well. The aim of this study was to evaluate the prevalence of depressive symptoms in T1D children with HbA(1c) <7.5% and 7.5% treated with insulin pump.
   MethodsA total of 372 children (186 girls) with a mean age of 14.22.0years and mean diabetes duration of 5.33.5years were included. All subjects were treated for T1D for a minimum of 1year. Children filled out a Polish version of the Children's Depression Inventory (CDI) and answered questions in the Quality of Life Questionnaire. Statistical analysis was made using Student's t-test, Mann-Whitney U-test, Fisher's exact test and Spearman's rank correlation.
   ResultsEighteen per cent (31/177) of participants with HbA(1c) <7.5% and 21% (41/195) with HbA(1c) 7.5% reported depressive symptoms (CDI scores 13). Adolescents with HbA(1c) <7.5% and CDI13 had higher total insulin dose (p=0.039) and longer diabetes duration (p=0.043) than subjects with CDI<13. There was no difference in prevalence of depressive symptoms among patients with HbA(1c) 7.5% and HbA(1c) <7.5% (odds ratio [1.25 95% confidence interval (CI) 0.75-2.11], p=0.432). In both groups, adolescents with CDI13 had worse quality of life than those with CDI<13 (p<0.0001).
   ConclusionsIn both groups, one in five adolescents with either good or poor glycemic control had depressive symptoms compared with <7% in subjects without diabetes. Long-lasting T1D significantly increased the risk of depressive symptoms in well-controlled youth. Depressive symptoms strongly affected the quality of life regardless of diabetes control. Copyright (c) 2013 John Wiley & Sons, Ltd.
C1 [Zdunczyk, Beata; Sendela, Joanna; Szypowska, Agnieszka] Med Univ Warsaw, Dept Pediat, PL-01184 Warsaw, Poland.
RP Szypowska, A (reprint author), Med Univ Warsaw, Dept Pediat, Dzialdowska 1, PL-01184 Warsaw, Poland.
EM agnieszka.szypowska@gmail.com
FU Medical University of Warsaw
FX We declare that we have no conflict of interest. The study was fully
   sponsored by the Medical University of Warsaw.
CR Alsaleh FM, 2012, J CLIN PHARM THER, V37, P140, DOI 10.1111/j.1365-2710.2011.01283.x
   Berg CA, 2011, J PEDIATR PSYCHOL, V36, P329, DOI 10.1093/jpepsy/jsq088
   Bot M, 2013, DIABETIC MED, V30, pE115, DOI 10.1111/dme.12082
   Colton PA, 2013, PEDIATR DIABETES, V14, P372, DOI 10.1111/pedi.12016
   de Ornelas Maia AC, 2013, CLIN PRACT EPIDEMIOL, V12, P136
   de Wit M, 2011, PEDIATR DIABETES, V12, P172, DOI 10.1111/j.1399-5448.2010.00673.x
   Diabet Control Complications Trial Res Grp, 1996, DIABETES CARE, V19, P195
   Gonder-Frederick Linda, 2011, Diabetes Manag (Lond), V1, P627
   Goossens L, 2010, EUR CHILD ADOLES PSY, V19, P587, DOI 10.1007/s00787-010-0089-5
   Grey M, 2002, J PSYCHOSOM RES, V53, P907, DOI 10.1016/S0022-3999(02)00312-4
   Hains AA, 2006, DIABETES CARE, V29, P818, DOI 10.2337/diacare.29.04.06.dc05-1828
   Hassan K, 2006, J PEDIATR-US, V149, P526, DOI 10.1016/j.jpeds.2006.05.039
   Helgeson VS, 2012, J PEDIATR PSYCHOL, V37, P467, DOI 10.1093/jpepsy/jsr110
   Hood KK, 2006, DIABETES CARE, V29, P1389, DOI 10.2337/dc06-0087
   Ingersoll G M, 1991, Diabetes Educ, V17, P114, DOI 10.1177/014572179101700219
   Johnson B, 2013, DIABETIC MED, V30, P199, DOI 10.1111/j.1464-5491.2012.03721.x
   Kakleas K, 2009, DIABETES METAB, V35, P339, DOI 10.1016/j.diabet.2009.05.002
   Korbel CD, 2007, CHILD HEALTH CARE, V36, P83, DOI 10.1080/02739610701316936
   Kordonouri O, 2011, DIABETES RES CLIN PR, V93, pS118, DOI 10.1016/S0168-8227(11)70027-4
   Kovac M, 2003, CHILDRENS DEPRESSION
   KOVACS M, 1985, PSYCHOPHARMACOL BULL, V21, P995
   Laffel LMB, 2003, DIABETES CARE, V26, P3067, DOI 10.2337/diacare.26.11.3067
   Massengale Jill, 2005, Issues Ment Health Nurs, V26, P137, DOI 10.1080/01612840590901590
   Matziou V, 2011, J DIABETES, V3, P82, DOI 10.1111/j.1753-0407.2010.00106.x
   Rewers M, 2009, PEDIATR DIABETES, V10, P71, DOI 10.1111/j.1399-5448.2009.00582.x
   Santiprabhob J, 2012, SE ASIAN J TROP MED, V43, P172
   Seiffge-Krenke I, 2003, J ADOLESCENT HEALTH, V33, P180, DOI 10.1016/S1054-139X(02)00707-3
   SMUCKER MR, 1986, J ABNORM CHILD PSYCH, V14, P25, DOI 10.1007/BF00917219
   Timbremont B, 2004, J CLIN CHILD ADOLESC, V33, P149, DOI 10.1207/S15374424JCCP3301_14
   Weissberg-Benchell J, 2009, J PEDIATR PSYCHOL, V34, P977, DOI 10.1093/jpepsy/jsp003
   Williams LB, 2009, DIABETIC MED, V26, P908, DOI 10.1111/j.1464-5491.2009.02794.x
NR 31
TC 8
Z9 8
U1 0
U2 14
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1520-7560
J9 DIABETES-METAB RES
JI Diabetes-Metab. Res. Rev.
PD MAY
PY 2014
VL 30
IS 4
BP 333
EP 338
DI 10.1002/dmrr.2499
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AE4BE
UT WOS:000333922200009
PM 24323887
DA 2019-01-08
ER

PT J
AU Papathanasiou, A
   Koutsovasilis, A
   Shea, S
   Philalithis, A
   Papavasiliou, S
   Melidonis, A
   Lionis, C
AF Papathanasiou, A.
   Koutsovasilis, A.
   Shea, S.
   Philalithis, A.
   Papavasiliou, S.
   Melidonis, A.
   Lionis, C.
TI The Problem Areas in Diabetes ( PAID) scale: psychometric evaluation
   survey in a Greek sample with type 2 diabetes
SO JOURNAL OF PSYCHIATRIC AND MENTAL HEALTH NURSING
LA English
DT Article
DE diabetes mellitus; Problem Areas in Diabetes scale; quality of life
ID QUALITY-OF-LIFE; SF-36 HEALTH SURVEY; EMOTIONAL DISTRESS; OUTCOME
   MEASURES; PREVALENCE; MELLITUS; VERSION; RESPONSIVENESS; PROJECTIONS;
   VALIDATION
AB Accessible summary<list list-type="custom">
   center dot Several instruments have been developed for the assessment of emotional distress in patients with diabetes. The Problem Areas in Diabetes Scale (PAID) is a brief self-report scale that evaluates diabetes-related distress.
   center dot There is a lack of validated instruments for the evaluation of psychological aspects in patients with diabetes in Greek language.
   center dot The current study was conducted to translate and adapt the PAID scale in Greek language and to evaluate the psychometric properties in two different study populations of patients with diabetes.
   AbstractThe aim of this study was to translate the Problem Areas in Diabetes (PAID) scale into Greek, adapt it culturally to Greece and determine its psychometric properties. The translation process included two forward translations, reconciliation, backward translation and pre-testing steps. The validation incorporated the exploration of internal consistency (Cronbach's alpha), test-retest reliability (interclass correlation coefficient), construct validity (exploratory factor analysis) and responsiveness (Spearman correlation coefficient). Participants included 101 consecutive patients from a rural primary healthcare centre and 101 patients from an urban hospital. All patients completed the PAID scale and the Short Form-36 (SF-36) version 2. Internal consistency considered good (Cronbach's alpha=0.948). Interclass correlation coefficient was 0.942 (95% CI 0.915-0.961). Factor analysis yielded three factors: Diabetes-related emotional problems' (51.79% variance, Cronbach's alpha=0.910), Food-related problems' (9.55% variance, Cronbach's alpha=0.824) and Social support-related problems' (5.96% variance, Cronbach's alpha=0.704). Scree plot test and conceptual congruency of items supported a three-factor solution. Total PAID showed a negative correlation with both SF-36 mental component summary (r=-0.733, P<0.0001) and SF-36 physical component summary (r=-0.594, P<0.0001). Our findings indicate that the Greek version of the PAID questionnaire is reliable and valid for patients with diabetes mellitus in Greece.
C1 [Papathanasiou, A.] Hlth Med Ctr Stylida, Lamia, Greece.
   [Papathanasiou, A.; Koutsovasilis, A.; Melidonis, A.] Tzaneio Gen Hosp Piraeus, Ctr Diabet, Piraeus, Greece.
   [Shea, S.] Univ Crete, Fac Med, Clin Social & Family Med, Iraklion, Greece.
   [Papathanasiou, A.; Philalithis, A.; Lionis, C.] Univ Crete, Sch Med, Clin Social & Family Med, Iraklion, Greece.
   [Papavasiliou, S.] Univ Hosp Heraklion, Dept Endocrinol Diabet Mellitus & Dis Metab, Iraklion, Greece.
RP Papathanasiou, A (reprint author), Rue Beau Sejour 14, CH-1003 Lausanne, Switzerland.
EM ath_papathanasiou@yahoo.com
CR Alonso J, 2004, QUAL LIFE RES, V13, P283, DOI 10.1023/B:QURE.0000018472.46236.05
   Amsberg S, 2008, INT J NURS STUD, V45, P1319, DOI 10.1016/j.ijnurstu.2007.09.010
   Anagnostopoulos F, 2005, QUAL LIFE RES, V14, P1959, DOI 10.1007/s11136-005-3866-8
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Anderson RM, 1997, DIABETES CARE, V20, P299, DOI 10.2337/diacare.20.3.299
   Bowling A, 2002, RES METHODS HLTH INV
   Bradley C, 2002, DIABETES METAB RES, V18, pS64, DOI 10.1002/dmrr.279
   de Vet HCW, 2001, INT J TECHNOL ASSESS, V17, P479
   Delahanty LM, 2007, DIABETIC MED, V24, P48, DOI 10.1111/j.1464-5491.2007.02028.x
   DeVellis RF, 1991, SCALE DEV THEORY APP
   Fisher EB, 2007, DIABETES EDUCATOR, V33, P1080, DOI 10.1177/0145721707309808
   Garratt AM, 2002, DIABETIC MED, V19, P1, DOI 10.1046/j.1464-5491.2002.00650.x
   GLASGOW RE, 1992, DIABETES CARE, V15, P1423, DOI 10.2337/diacare.15.10.1423
   Glasgow RE, 1997, DIABETES CARE, V20, P562, DOI 10.2337/diacare.20.4.562
   Gonder-Frederick LA, 2002, J CONSULT CLIN PSYCH, V70, P611, DOI 10.1037//0022-006X.70.3.611
   Gross CC, 2007, DIABETES RES CLIN PR, V76, P455, DOI 10.1016/j.diabres.2006.09.022
   Ishii H. W. G., 1999, DIABETES S1, V48, pA139
   JACOBSON AM, 1997, SEMIN CLIN NEUROPSYC, V2, P82
   KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116
   King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414
   Lionis C, 2008, Prim Care Diabetes, V2, P97, DOI 10.1016/j.pcd.2008.03.003
   Lionis C, 2001, DIABETIC MED, V18, P768, DOI 10.1046/j.1464-5491.2001.00526.x
   Lionis CD, 1996, FAM PRACT, V13, P18, DOI 10.1093/fampra/13.1.18
   Medical Outcomes Trust, 1997, MED OUTCOMES TRUST B, V5, P3
   Miller S. T., 2008, BMC PUBLIC HEALTH, V8, P70
   Papathanasiou A, 2005, ARCH HELL MED, V22, P336
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Polonsky WH, 2000, DIABETES SPECTRUM, V13, P36
   Rubin R, 2000, DIABETES SPECTR, V13, P21
   Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O
   Rubin RR, 2001, J CLIN PSYCHOL, V57, P457, DOI 10.1002/jclp.1041
   Sen S. S., 1999, AM J HEALTH-SYST PH, V56, P1965
   Sen S. S., 1999, AM J HEALTH-SYST PH, V56, P1971
   Sigurdardottir AK, 2008, INT J NURS STUD, V45, P526, DOI 10.1016/j.ijnurstu.2006.10.008
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Spencer MS, 2006, J HEALTH CARE POOR U, V17, P88, DOI 10.1353/hpu.2006.0095
   WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002
   Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008
   Watkins K, 2004, PHARMACOECONOMICS, V22, P1109, DOI 10.2165/00019053-200422170-00002
   Welch G, 2003, DIABETIC MED, V20, P69, DOI 10.1046/j.1464-5491.2003.00832.x
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047
   World Health Organization, 1999, DEF DIAGN CLASS DI 1
NR 44
TC 5
Z9 8
U1 0
U2 18
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1351-0126
EI 1365-2850
J9 J PSYCHIATR MENT HLT
JI J. Psychiatr. Ment. Health Nurs.
PD MAY
PY 2014
VL 21
IS 4
BP 345
EP 353
DI 10.1111/j.1365-2850.2012.01875.x
PG 9
WC Nursing; Psychiatry
SC Nursing; Psychiatry
GA AD8TL
UT WOS:000333538400008
PM 22340071
DA 2019-01-08
ER

PT J
AU Dalsgaard, EM
   Vestergaard, M
   Skriver, MV
   Maindal, HT
   Lauritzen, T
   Borch-Johnsen, K
   Witte, D
   Sandbaek, A
AF Dalsgaard, Else-Marie
   Vestergaard, Mogens
   Skriver, Mette V.
   Maindal, Helle T.
   Lauritzen, Torsten
   Borch-Johnsen, Knut
   Witte, Daniel
   Sandbaek, Annelli
TI Psychological distress, cardiovascular complications and mortality among
   people with screen-detected type 2 diabetes: follow-up of the
   ADDITION-Denmark trial
SO DIABETOLOGIA
LA English
DT Article
DE All-cause mortality; Cardiovascular risk factors.; Complications;
   General practice; Mental health; Morbidity; Type 2 diabetes mellitus
ID ALL-CAUSE MORTALITY; GLYCEMIC CONTROL; MENTAL-HEALTH; GENERAL-PRACTICE;
   DEPRESSION; RISK; METAANALYSIS; ASSOCIATION; MELLITUS; OUTCOMES
AB Aim/hypothesis The aim of this study was to examine the association between psychological distress and the risk of cardiovascular disease (CVD) events and all-cause mortality in patients with screen-detected type 2 diabetes mellitus. In addition, we explored whether or not metabolic control and medication adherence could explain part of this association.
   Methods A follow-up study was performed including 1,533 patients aged 40-69 years with screen-detected type 2 diabetes mellitus identified in general practice during 2001-2006 in the Denmark arm of the ADDITION (Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care) study. Mental health was measured at baseline with the Mental Health Inventory 5 (MHI-5). Psychological distress was defined as an MHI-5 score of <= 68 (18.2% of the population). CVD risk factors were measured at baseline and repeated at the follow-up examination. Information on death, hospital discharge diagnosis, and antihypertensive and lipid-lowering drug treatment was obtained from national registers. Cox proportional regression was used to estimate HRs for the association between psychological distress, CVD events and all-cause mortality. Age- and sex-adjusted risk difference analyses were performed to estimate differences in meeting treatment targets.
   Results Patients with psychological distress had a 1.8-fold higher mortality rate (HR 1.76, 95% CI 1.23, 2.53) and a 1.7-fold higher risk of having a CVD event (HR: 1.69, 95% CI 1.05, 2.70) compared with those with an MHI-5 score of > 68. Overall, psychological distress was not associated with the ability to meet treatment targets for HbA(1c) levels, cholesterol levels or BP, or to redeem antihypertensive or lipid-lowering drug treatment.
   Conslusions/interpretation In people detected and treated early in the diabetes disease trajectory, those with psychological distress at the time of diagnosis had a higher risk of CVD events and death than those without psychological distress.
C1 [Dalsgaard, Else-Marie; Vestergaard, Mogens; Lauritzen, Torsten; Sandbaek, Annelli] Aarhus Univ, Dept Publ Hlth, Sect Gen Practice, DK-8000 Aarhus, Denmark.
   [Vestergaard, Mogens] Aarhus Univ, Res Unit Gen Practice, DK-8000 Aarhus, Denmark.
   [Skriver, Mette V.; Maindal, Helle T.] Aarhus Univ, Sect Hlth Promot & Hlth Serv, Dept Publ Hlth, DK-8000 Aarhus, Denmark.
   [Borch-Johnsen, Knut] Holbaek Cent Hosp, Holbaek, Region Zealand, Denmark.
   [Witte, Daniel] Ctr Rech Publ Sante, Strassen, Luxembourg.
RP Dalsgaard, EM (reprint author), Aarhus Univ, Dept Publ Hlth, Sect Gen Practice, Bartholins Alle 2, DK-8000 Aarhus, Denmark.
EM emdl@alm.au.dk
RI Vestergaard, Mogens/M-9333-2014; Maindal, Helle Terkildsen/N-8916-2016;
   Witte, Daniel/C-1722-2008
OI Vestergaard, Mogens/0000-0001-8830-2174; Maindal, Helle
   Terkildsen/0000-0003-0525-7254; Witte, Daniel/0000-0002-0769-2922;
   Dalsgaard, Else-Marie/0000-0003-2115-7480; Skriver,
   Mette/0000-0002-7017-8221
FU National Health Services in the county of Copenhagen in Denmark;
   National Health Services in the county of Aarhus in Denmark; National
   Health Services in the county of Ringkobing in Denmark; National Health
   Services in the county of Ribe Denmark; Danish Council for Strategic
   Research; Danish Research Foundation for General Practice; Novo Nordisk
   Foundation; Danish Centre for Evaluation and Health Technology
   Assessment; Danish Fund of the National Board of Health; Danish Medical
   Research Council; Aarhus University Research Foundation; Novo Nordisk
   AS; Novo Nordisk Scandinavia AB; Novo Nordisk UK; ASTRA Denmark; Pfizer
   Denmark; Glaxo SmithKline; Pharma Denmark; Servier Denmark A/S; HemoCue
   Denmark A/S
FX ADDITION-Denmark was supported by the National Health Services in the
   counties of Copenhagen, Aarhus, Ringkobing, Ribe and South Jutland in
   Denmark, The Danish Council for Strategic Research, the Danish Research
   Foundation for General Practice, Novo Nordisk Foundation, the Danish
   Centre for Evaluation and Health Technology Assessment, the Danish Fund
   of the National Board of Health, the Danish Medical Research Council,
   and the Aarhus University Research Foundation. The trial has been given
   unrestricted grants from Novo Nordisk AS, Novo Nordisk Scandinavia AB,
   Novo Nordisk UK, ASTRA Denmark, Pfizer Denmark, Glaxo SmithKline Pharma
   Denmark, Servier Denmark A/S and HemoCue Denmark A/S. Parts of the
   grants from Novo Nordisk Foundation and Novo Nordisk were transferred to
   the other centres.
CR Adriaanse MC, 2005, QUAL LIFE RES, V14, P1501, DOI 10.1007/s11136-004-0028-3
   Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
   Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x
   [Anonymous], 1991, IDA INT DAT ARB HOV
   Arroyo C, 2004, DIABETES CARE, V27, P129, DOI 10.2337/diacare.27.1.129
   Bek T, 2009, ACTA OPHTHALMOL, V87, P270, DOI 10.1111/j.1755-3768.2008.01207.x
   BERWICK DM, 1991, MED CARE, V29, P169, DOI 10.1097/00005650-199102000-00008
   CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8
   Christensen J, 2004, DIABETOLOGIA, V47, P1566, DOI 10.1007/s00125-004-1496-2
   Dalsgaard EM, 2009, DIABETIC MED, V26, P518, DOI 10.1111/j.1464-5491.2009.02715.x
   de Jonge P, 2010, NEUROSCI BIOBEHAV R, V35, P84, DOI 10.1016/j.neubiorev.2009.11.025
   Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341
   Griffin SJ, 2011, LANCET, V378, P156, DOI 10.1016/S0140-6736(11)60698-3
   Hamer M, 2008, J AM COLL CARDIOL, V52, P2156, DOI 10.1016/j.jacc.2008.08.057
   Hamer M, 2010, PSYCHOSOM MED, V72, P882, DOI 10.1097/PSY.0b013e3181f6696e
   Katon W, 2009, PSYCHOSOM MED, V71, P965, DOI 10.1097/PSY.0b013e3181bd8f55
   Kelly MJ, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-10
   Khalil CA, 2012, EUR J PREV CARDIOL, V19, P374, DOI 10.1177/1741826711409324
   Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717
   Lauritzen T, 2000, INT J OBESITY, V24, pS6, DOI 10.1038/sj.ijo.0801420
   Lauritzen T, 2012, PRIM CARE DIABETES, V6, P193, DOI 10.1016/j.pcd.2012.04.005
   Lin EHB, 2009, ANN FAM MED, V7, P414, DOI 10.1370/afm.998
   Lustman PJ, 2005, J DIABETES COMPLICAT, V19, P113, DOI 10.1016/j.jdiacomp.2004.01.002
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482
   MCHORNEY CA, 1995, MED CARE, V33, P15, DOI 10.1097/00005650-199501000-00002
   Meijer A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-130
   Pan A, 2011, ARCH GEN PSYCHIAT, V68, P42, DOI 10.1001/archgenpsychiatry.2010.176
   Pan A, 2010, ARCH INTERN MED, V170, P1884, DOI 10.1001/archinternmed.2010.356
   Park M, 2013, GEN HOSP PSYCHIAT, V35, P217, DOI 10.1016/j.genhosppsych.2013.01.006
   Park P, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-350
   Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965
   Pouwer F, 2010, DIABETIC MED, V27, P217, DOI 10.1111/j.1464-5491.2009.02903.x
   Pouwer F, 2013, ENDOCRIN METAB CLIN, V42, P529, DOI 10.1016/j.ecl.2013.05.002
   Rumpf HJ, 2001, PSYCHIAT RES, V105, P243, DOI 10.1016/S0165-1781(01)00329-8
   Russ TC, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4933
   Sandbaek A, 2008, DIABETOLOGIA, V51, P1127, DOI 10.1007/s00125-008-1013-0
   Simmons RK, 2012, LANCET, V380, P1741, DOI 10.1016/S0140-6736(12)61422-6
   Smith KJ, 2013, J PSYCHOSOM RES, V74, P89, DOI 10.1016/j.jpsychores.2012.11.013
   Spijkerman AMW, 2002, DIABETES CARE, V25, P1784, DOI 10.2337/diacare.25.10.1784
   Sullivan MD, 2012, DIABETES CARE, V35, P1708, DOI 10.2337/dc11-1791
   Surtees PG, 2008, NEUROLOGY, V70, P788, DOI 10.1212/01.wnl.0000304109.18563.81
   van Dooren FEP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057058
   Ware JE, 1998, J CLIN EPIDEMIOL, V51, P903, DOI 10.1016/S0895-4356(98)00081-X
   WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002
NR 45
TC 12
Z9 12
U1 1
U2 21
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0012-186X
EI 1432-0428
J9 DIABETOLOGIA
JI Diabetologia
PD APR
PY 2014
VL 57
IS 4
BP 710
EP 717
DI 10.1007/s00125-014-3165-4
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AC5ZX
UT WOS:000332600700009
PM 24442448
DA 2019-01-08
ER

PT J
AU Zoffmann, V
   Vistisen, D
   Due-Christensen, M
AF Zoffmann, V.
   Vistisen, D.
   Due-Christensen, M.
TI A cross-sectional study of glycaemic control, complications and
   psychosocial functioning among 18- to 35-year-old adults with Type 1
   diabetes
SO DIABETIC MEDICINE
LA English
DT Article
ID YOUNG-ADULTS; SELF-DETERMINATION; CARE; EXPERIENCES; TRANSITION;
   DEPRESSION; DISTRESS; DISEASE; LIFE
AB Aims
   To describe the level of glycaemic control, complications and psychosocial functioning and the relationships between these variables in the under-researched group of younger adults with Type1 diabetes.
   Methods
   Local electronic health records provided data on age, gender, disease duration, HbA(1c) and complications for 710 younger adults (18-35years) with Type1 diabetes. A questionnaire with wide-ranging psychometric scales was used to measure various aspects of psychosocial functioning: the burden of diabetes-related problems, well-being, self-esteem, perceived competence in managing diabetes, perceived autonomy support from health professionals and self-management motivations. Furthermore, patients reported weekly self-monitored blood glucose measurements and insulin administration. Associations between HbA(1c), complication and psychosocial indicators were tested using linear and logistic regression models, adjusted stepwise for confounders, including age, gender, diabetes duration, continuous subcutaneous insulin infusion, smoking and BMI.
   Results
   In total, 406 (57%) participants responded. The responders had a mean age of 27.1 (5.1) years, a mean diabetes duration of 13.5 (7.9) years and an HbA(1c) of 66mmol/mol (8.2%), with similar values for both genders (P=0.87). Complications were observed among women more commonly than among men (31.6 vs. 18.8%, P<0.01), and high distress levels were more prevalent among women compared with men (51.2 vs. 31.9%, P<0.0001). Except for perceived autonomy support, the psychosocial variables were all associated with HbA(1c) (P<0.001).
   Conclusions
   The high prevalence of poor glycaemic control, early complications and psychosocial distress require health-promoting interventions tailored to the interrelated clinical and psychosocial needs of younger adults with Type1 diabetes.
C1 [Zoffmann, V.; Due-Christensen, M.] Steno Diabet Ctr, Patient Care Ctr, DK-2820 Gentofte, Denmark.
   [Zoffmann, V.] Oslo Univ Hosp, NKLMS, Oslo, Norway.
   [Vistisen, D.] Steno Diabet Ctr, DK-2820 Gentofte, Denmark.
RP Zoffmann, V (reprint author), Steno Diabet Ctr, Patient Care Ctr, DK-2820 Gentofte, Denmark.
EM vzof@steno.dk
OI Vistisen, Dorte/0000-0001-5045-5351; Due-Christensen,
   Mette/0000-0003-2604-3730
FU Steno Diabetes Center
FX This study was supported by grants from the Steno Diabetes Center.
CR BENJAMINI Y, 1995, J R STAT SOC B, V57, P289
   Bowman GS, 2001, J ADV NURS, V34, P256, DOI 10.1046/j.1365-2648.2001.01752.x
   Brierley S, 2012, DIABETIC MED, V29, P677, DOI 10.1111/j.1464-5491.2012.03601.x
   Bryden KS, 2003, DIABETES CARE, V26, P1052, DOI 10.2337/diacare.26.4.1052
   Costacou T, 2011, AM J KIDNEY DIS, V58, P565, DOI 10.1053/j.ajkd.2011.05.025
   DeVries JH, 2004, DIABETIC MED, V21, P1263, DOI 10.1111/j.1464-5491.2004.01386.x
   Due-Christensen M, 2012, DIABETIC MED, V29, P251, DOI 10.1111/j.1464-5491.2011.03521.x
   Franciosi M, 2013, NUTR METAB CARDIOVAS, V23, P606, DOI 10.1016/j.numecd.2012.03.002
   Franconi Flavia, 2012, Endocrine Metabolic & Immune Disorders-Drug Targets, V12, P179
   Garvey KC, 2012, DIABETES CARE, V35, P1716, DOI 10.2337/dc11-2434
   Gonzalez JS, 2011, DIABETES CARE, V34, P236, DOI 10.2337/dc10-1970
   Hansen MV, 2009, DIABETES RES CLIN PR, V85, P183, DOI 10.1016/j.diabres.2009.04.022
   Harjutsalo V, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5364
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   Hislop AL, 2008, DIABETIC MED, V25, P91, DOI 10.1111/j.1464-5491.2007.02310.x
   Holmes-Walker DJ, 2007, DIABETIC MED, V24, P764, DOI 10.1111/j.1464-5491.2007.02152.x
   JACOBSON AM, 1991, DIABETES CARE, V14, P599, DOI 10.2337/diacare.14.7.599
   Kipps S, 2002, DIABETIC MED, V19, P649, DOI 10.1046/j.1464-5491.2002.00757.x
   Levesque CS, 2007, HEALTH EDUC RES, V22, P691, DOI 10.1093/her/cyl148
   Markowitz JT, 2012, DIABETIC MED, V29, P522, DOI 10.1111/j.1464-5491.2011.03537.x
   Marrero DG, 2013, DIABETES CARE, V36, P463, DOI 10.2337/dc12-2305
   Peveler RC, 2005, DIABETES CARE, V28, P84, DOI 10.2337/diacare.28.1.84
   Ryan RM, 2006, J PERS, V74, P1557, DOI 10.1111/j.1467-6494.2006.00420.x
   Saunders SA, 2004, QJM-INT J MED, V97, P575, DOI 10.1093/qjmed/hch098
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Williams GC, 2000, SELF DETERMINATION H
   Wisman PP, 2012, EUR J VASC ENDOVASC, V43, P441, DOI 10.1016/j.ejvs.2012.01.006
   Zoffmann V, 2005, QUAL HEALTH RES, V15, P750, DOI 10.1177/1049732304273888
   Zoffmann V, 2006, PATIENT EDUC COUNS, V64, P78, DOI 10.1016/j.pec.2005.11.017
   Zoffmann V, 2012, QUAL HEALTH RES, V22, P103, DOI 10.1177/1049732311420735
NR 30
TC 17
Z9 17
U1 0
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD APR
PY 2014
VL 31
IS 4
BP 493
EP 499
DI 10.1111/dme.12363
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AC8BQ
UT WOS:000332758400019
PM 24236961
DA 2019-01-08
ER

PT J
AU Lee, HY
   Hahm, MI
   Lee, SG
AF Lee, Hoo-Yeon
   Hahm, Myung-Il
   Lee, Sang Gyu
TI Risk of suicidal ideation in diabetes varies by diabetes regimen,
   diabetes duration, and HbA1c level
SO JOURNAL OF PSYCHOSOMATIC RESEARCH
LA English
DT Article
DE Suicidal ideation; Diabetes; Depression; Insulin; HbA1c
ID SOUTH-KOREA; DEPRESSIVE SYMPTOMS; PHYSICAL ILLNESS; GLYCEMIC CONTROL;
   ECONOMIC-CRISIS; ADULTS; ASSOCIATION; PREVALENCE; JAPAN; AGE
AB Objective: To investigate patient subgroups based on the clinical characteristics of diabetes to evaluate risk factors for suicidal ideation using a large population-based sample in South Korea.
   Methods: Data from the Fifth Korea National Health and Nutrition Examination Survey, a cross-sectional, nationally representative survey, were analyzed. The participants were 9159 subjects aged >= 40 years. We defined patients with diabetes based on self-reported physician-diagnosed diabetes. We evaluated clinical risk factors for suicidal ideation according to diabetes regimen, diabetes duration, and glycated hemoglobin (HbA1c) level compared with no diabetes. Given the complex sample design and unequal weights, we analyzed weighted percentages and used survey logistic regression.
   Results: Diabetes per se was not associated with suicidal ideation. However, suicidal ideation was significantly more prevalent among patients who had injected insulin, had a duration of diabetes >= 5 years and had HbA1c levels >= 6.5 compared with those without diabetes. Depressive symptoms were the most prominent predictor of suicidal ideation.
   Conclusions: Insulin therapy, diabetes of long duration, and unsatisfactory glycemic control were identified as risk factors for suicidal ideation; thus, patients with these characteristics warrant special attention. Our findings suggest the need to integrate efforts to manage emotional distress into diabetes care. (C) 2014 Elsevier Inc All rights reserved.
C1 [Lee, Hoo-Yeon] Dankook Univ, Coll Med, Dept Social Med, Cheonan Si 330714, Choongnam, South Korea.
   [Hahm, Myung-Il] Soonchunhyang Univ, Coll Med Sci, Dept Hlth Adm & Management, Asan 336745, Choongnam, South Korea.
   [Lee, Sang Gyu] Yonsei Univ, Grad Sch Publ Hlth, Seoul 120749, South Korea.
RP Lee, SG (reprint author), Yonsei Univ, Grad Sch Publ Hlth, 50 Yonsei Ro, Seoul 120749, South Korea.
EM LEEVAN@yuhs.ac
FU Dankook University
FX The present research was conducted by the research fund of Dankook
   University in 2012.
CR Aikens JE, 2008, DIABETIC MED, V25, P1324, DOI 10.1111/j.1464-5491.2008.02590.x
   Aikens JE, 2009, DIABETES CARE, V32, P1177, DOI 10.2337/dc09-0071
   Berge LI, 2012, DIABETIC MED, V29, P509, DOI 10.1111/j.1464-5491.2011.03530.x
   Bogner HR, 2007, DIABETES CARE, V30, P3005, DOI 10.2337/dc07-0974
   Bot M, 2013, DIABETIC MED, V30, pE115, DOI 10.1111/dme.12082
   Chang SS, 2009, SOC SCI MED, V68, P1322, DOI 10.1016/j.socscimed.2009.01.010
   Chen YY, 2012, EPIDEMIOL REV, V34, P129, DOI 10.1093/epirev/mxr025
   Chin YR, 2011, INT J PUBLIC HEALTH, V56, P429, DOI 10.1007/s00038-011-0245-9
   Crump C, 2013, PSYCHOL MED, P1
   Maia ACCD, 2012, COMPR PSYCHIAT, V53, P1169, DOI 10.1016/j.comppsych.2012.03.011
   Dombrovski AY, 2008, AM J GERIAT PSYCHIAT, V16, P905, DOI 10.1097/JGP.0b013e3181860034
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Gallo JJ, 2013, BMJ-BRIT MED J, P346
   Golden SH, 2007, PSYCHOSOM MED, V69, P529, DOI 10.1097/PSY.0b013e3180f61c5c
   Gonzalez JS, 2011, DIABETES CARE, V34, P236, DOI 10.2337/dc10-1970
   Han S, 2013, J PUBLIC HEALTH-UK, V35, P228, DOI 10.1093/pubmed/fds097
   Han SJ, 2013, DIABETES RES CLIN PR, V101, pE14, DOI 10.1016/j.diabres.2013.06.012
   Harrison KE, 2010, INT PSYCHOGERIATR, V22, P445, DOI 10.1017/S1041610209991463
   Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X
   Holt RIG, 2009, DIABETIC MED, V26, P641, DOI 10.1111/j.1464-5491.2009.02742.x
   Hong JH, 2011, WORLD PSYCHIATRY, V10, P40
   Kageyama T, 2012, PSYCHIAT CLIN NEUROS, V66, P105, DOI 10.1111/j.1440-1819.2011.02313.x
   Kim MH, 2010, SOC SCI MED, V70, P1254, DOI 10.1016/j.socscimed.2010.01.004
   Kim SY, 2011, CRISIS, V32, P5, DOI 10.1027/0227-5910/a000046
   Kim Yangho, 2013, J Prev Med Public Health, V46, P96, DOI 10.3961/jpmph.2013.46.2.96
   Kim YR, 2011, INT PSYCHOGERIATR, V23, P979, DOI 10.1017/S1041610211000263
   Ko SH, 2011, DIABETES METAB J, V35, P431, DOI 10.4093/dmj.2011.35.5.431
   Korea Centers for Disease Control and Prevention, 2012, 5 KOR NAT HLTH NUTR
   Kposowa AJ, 2000, J EPIDEMIOL COMMUN H, V54, P254, DOI 10.1136/jech.54.4.254
   Lee HY, 2013, PSYCHIAT RES, V210, P323, DOI 10.1016/j.psychres.2013.05.012
   Levy TB, 2011, ARCH GERONTOL GERIAT, V52, P115, DOI 10.1016/j.archger.2010.02.012
   Li CY, 2008, DIABETES CARE, V31, P105, DOI 10.2337/dc07-1154
   Lofman S, 2012, J PSYCHOSOM RES, V73, P268, DOI 10.1016/j.jpsychores.2012.08.002
   Moon SS, 2012, INT J SOC PSYCHIATR, V58, P657, DOI 10.1177/0020764011433626
   Myers AK, 2013, PSYCHONEUROENDOCRINO, V38, P2810, DOI 10.1016/j.psyneuen.2013.06.013
   O'Connor E, 2013, ANN INTERN MED, V158, P741, DOI 10.7326/0003-4819-158-10-201305210-00642
   Park SM, 2010, J PSYCHOSOM RES, V69, P389, DOI 10.1016/j.jpsychores.2010.03.002
   Purselle DC, 2009, PSYCHIAT RES, V167, P258, DOI 10.1016/j.psychres.2008.02.003
   Quan H, 2002, SOC PSYCH PSYCH EPID, V37, P190, DOI 10.1007/s001270200014
   Taylor P, 2003, AGEING SOC, V23, P25, DOI 10.1017/S0144686X02001022
   Tektonidou MG, 2011, ARTHRIT CARE RES, V63, P1322, DOI 10.1002/acr.20516
   Trento M, 2012, ACTA DIABETOL, V49, P199, DOI 10.1007/s00592-011-0275-z
   van Bastelaar KMP, 2011, DIABETES CARE, V34, P320, DOI 10.2337/dc10-1248
NR 43
TC 6
Z9 6
U1 1
U2 9
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0022-3999
EI 1879-1360
J9 J PSYCHOSOM RES
JI J. Psychosomat. Res.
PD APR
PY 2014
VL 76
IS 4
BP 275
EP 279
DI 10.1016/j.jpsychores2014.02.003
PG 5
WC Psychiatry
SC Psychiatry
GA AD6NX
UT WOS:000333378600002
PM 24630176
DA 2019-01-08
ER

PT J
AU de Vries, L
   van der Heijden, AAWA
   van 't Riet, E
   Baan, CA
   Kostense, PJ
   Rijken, M
   Rutten, GEHM
   Nijpels, G
AF de Vries, Lianne
   van der Heijden, Amber A. W. A.
   van 't Riet, Esther
   Baan, Caroline A.
   Kostense, Piet J.
   Rijken, Mieke
   Rutten, Guy E. H. M.
   Nijpels, Giel
TI Peer support to decrease diabetes-related distress in patients with type
   2 diabetes mellitus: design of a randomised controlled trial
SO BMC ENDOCRINE DISORDERS
LA English
DT Article
DE Peer support; Diabetes mellitus type 2; Distress; Randomised controlled
   trial
ID SELF-MANAGEMENT; SOCIAL SUPPORT; PROBLEM AREAS; CARE; SCALE; OUTCOMES
AB Background: Many type 2 diabetes mellitus patients face difficulties self-managing their illness, which can lead to high levels of diabetes-related distress. Diabetes distress may be decreased by peer support, as peers understand and have dealt with similar problems, and can help motivate each other. A recent systematic review concluded that evidence of benefits of peer support in patients with type 2 diabetes mellitus is too inconsistent due to weak theoretical foundation of the interventions. This study describes the design of a trial evaluating the effectiveness of a group-based, peer support programme with a strong theoretical foundation on diabetes-related distress in type 2 diabetes patients.
   Methods: This is a parallel group randomised controlled trial of a six session group-based peer support intervention, delivered by peer leaders and group psychotherapists, compared with one educational meeting on diabetes. At least 152 patients with a type 2 diabetes duration of three years or more and between 50 and 70 years of age, recruited via their general practitioner, will be randomised to receive the peer support intervention or one educational meeting. The intervention is developed in line with three key stages of research development of the Medical Research Council framework. The primary outcome measure for this study is diabetes-related distress. Secondary outcomes include self-management behaviour, well-being and health-related quality of life. Perceived social support is a process measure. Outcomes will be measured one month before, and 6, and 12 months after the intervention by means of self-reported questionnaires. Analysis will be on an intention-to-treat basis.
   Discussion: This article contains a description of the design of a study that will investigate the effect of a group-based, peer support intervention on diabetes-related distress in type 2 diabetes patients. The intervention was developed in recognition of the limited evidence, and the importance of a theoretical foundation and its implementation. Findings will contribute to knowledge in the field of peer support and patient-important outcomes in type 2 diabetes patients.
C1 [de Vries, Lianne; van der Heijden, Amber A. W. A.; Nijpels, Giel] Vrije Univ Amsterdam, Med Ctr, Dept Gen Practice & Elderly Care Med, Amsterdam, Netherlands.
   [van 't Riet, Esther; Kostense, Piet J.] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands.
   [de Vries, Lianne; van der Heijden, Amber A. W. A.; van 't Riet, Esther; Kostense, Piet J.; Nijpels, Giel] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands.
   [Baan, Caroline A.] Natl Inst Publ Hlth & Environm, RIVM, NL-3720 BA Bilthoven, Netherlands.
   [Rijken, Mieke] NIVEL, Netherlands Inst Hlth Serv Res, Utrecht, Netherlands.
   [Rutten, Guy E. H. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.
RP de Vries, L (reprint author), Vrije Univ Amsterdam, Med Ctr, Dept Gen Practice & Elderly Care Med, Amsterdam, Netherlands.
EM li.devries@vumc.nl
FU Dutch Diabetes Research Foundation
FX This study is funded by the Dutch Diabetes Research Foundation.
CR Barrera M, 2002, AM J COMMUN PSYCHOL, V30, P637, DOI 10.1023/A:1016369114780
   Bech P, 1996, PSYCHOTHER PSYCHOSOM, V65, P183, DOI 10.1159/000289073
   Boothrovd R. I., 2010, FAM PRACT S1, V27, pi62
   Brownson CA, 2009, PATIENT, V2, P5, DOI 10.2165/01312067-200902010-00002
   Burleson B. R., 1994, COMMUNICATION SOCIAL, pxi
   Carper MM, 2013, J BEHAV MED, P1
   Cleveringa FGW, 2010, DIABETIC MED, V27, P442, DOI 10.1111/j.1464-5491.2010.02968.x
   Dale JR, 2012, DIABETIC MED, V29, P1361, DOI 10.1111/j.1464-5491.2012.03749.x
   Dennis CL, 2003, INT J NURS STUD, V40, P321, DOI 10.1016/S0020-7489(02)00092-5
   Fisher L, 2013, DIABETES CARE, V36, P2551, DOI 10.2337/dc12-2493
   Heisler M., 2006, BUILDING PEER SUPPOR
   Heisler M., 2007, DIABETES SPECTRUM, V20, P214, DOI DOI 10.2337/DIASPECT.20.4.214
   Heisler M, 2010, ANN INTERN MED, V153, P507, DOI 10.7326/0003-4819-153-8-201010190-00007
   Heisler M, 2010, FAM PRACT, V27, pI23, DOI 10.1093/fampra/cmp003
   Medical Research Council, 2000, FRAM DEV EV RCTS COM, P18
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   van Dam HA, 2005, PATIENT EDUC COUNS, V59, P1, DOI 10.1016/j.pec.2004.11.001
   Vinicor F, 1998, DIABETES CARE, V21, pC15, DOI 10.2337/diacare.21.3.C15
   Welch G, 2003, DIABETIC MED, V20, P69, DOI 10.1046/j.1464-5491.2003.00832.x
   Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029
   Wills T. A., 2000, SOCIAL SUPPORT MEASU, P86
NR 23
TC 8
Z9 8
U1 2
U2 23
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1472-6823
J9 BMC ENDOCR DISORD
JI BMC Endocr. Disord.
PD MAR 4
PY 2014
VL 14
AR 21
DI 10.1186/1472-6823-14-21
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AF3QW
UT WOS:000334628200002
PM 24593296
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Kulzer, B
   Seitz, L
   Kern, W
AF Kulzer, B.
   Seitz, L.
   Kern, W.
TI Real-world Patient-reported Rates of Non-severe Hypoglycaemic Events in
   Germany
SO EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
LA English
DT Article
DE hypoglycaemia; insulin therapy; diabetes-related distress; hypoglycaemia
   awareness
ID DIABETES MANAGEMENT; TYPE-1; FREQUENCY; RISK; AWARENESS; PRODUCTIVITY;
   EDUCATION; IMPACT
AB Aims: Hypoglycaemia is a common side effect of insulin therapy in diabetes patients, with negative physical and emotional impacts. Despite this, there are few studies investigating the frequency of non-severe hypoglycaemic events from the perspective of patients in the real-world setting. We investigated self-reported NSHE frequency and levels of hypoglycaemia awareness in Germany.
   Methods: Respondents > 15 years with Type 1 or insulin-treated Type 2 diabetes (receiving basal only, basal-bolus or other insulin regimens) were recruited using online panels to complete <= 4 questionnaires. Questionnaires collected demographics, non-severe hypoglycaemic event rates and patient-reported level of hypoglycaemia awareness. Non-severe hypoglycaemic event rates are reported as respondent-week records and calculated using data from all respondents completing at least one questionnaire.
   Results: A total of 1 771 respondent-week records were obtained from 614 participants. Mean non-severe hypoglycaemic event rates per respondent-week were 1.6 for Type 1 and 0.6-0.8 for Type 2, with estimated annual rates of 83 and 31-42 respectively. Two-thirds of Type 1 (65 %) and Type 2 (61-72 %) respondents reported impaired levels of awareness or unawareness of hypoglycaemic events (inability or impaired ability to recognise the symptoms of hypoglycaemia). Respon dents' self-reported hypoglycaemia-awareness was significantly associated with the proportion of asymptomatic non-severe hypoglycaemic events; respondents classified as being unaware of hypoglycaemia had a higher proportion of asymptomatic non-severe hypoglycaemic events than aware respondents.
   Conclusion: Non-severe hypoglycaemic events are common in people with Type 1 or insulin-treated Type 2 diabetes in the real-world setting in Germany but may still be underestimated due to an inability to recognise the symptoms of hypoglycaemia.
C1 [Kulzer, B.] Forschungsinst Diabet Akad, Bad Mergentheim, Germany.
   [Seitz, L.] Novo Nordisk Pharma GmbH, D-55127 Mainz, Germany.
   [Kern, W.] Endokrinologikum, Ulm, Germany.
RP Seitz, L (reprint author), Novo Nordisk Pharma GmbH, Brucknerstr 1, D-55127 Mainz, Germany.
EM lsiz@novonordisk.com
CR Akram K, 2006, DIABETIC MED, V23, P750, DOI 10.1111/j.1464-5491.2006.01880.x
   Brod M, 2011, VALUE HEALTH, V14, P665, DOI 10.1016/j.jval.2011.02.001
   Childs BP, 2005, DIABETES CARE, V28, P1245
   (CHMP) CfMPfHU, 2012, GUID CLIN INV MED PR
   CLARKE WL, 1995, DIABETES CARE, V18, P517, DOI 10.2337/diacare.18.4.517
   Davis RE, 2005, CURR MED RES OPIN, V21, P1477, DOI 10.1185/030079905X61929
   Donnelly LA, 2005, DIABETIC MED, V22, P749, DOI 10.1111/j.1464-5491.2005.01501.x
   EphMRA, 1997, COD COND
   ESOMAR, 2007, ICC ESOMAR INT COD M
   GOLD AE, 1994, DIABETES CARE, V17, P697, DOI 10.2337/diacare.17.7.697
   Heller SR, 2007, DIABETOLOGIA, V50, P1140, DOI 10.1007/s00125-007-0599-y
   Hoi-Hansen T, 2010, J DIABETES COMPLICAT, V24, P392, DOI 10.1016/j.jdiacomp.2009.07.006
   IDF Clinical Guidelines Task Force, 2012, GLOB GUID TYP 2 DIAB
   Internet World Stats, 2012, INT PEN RAT
   Janssen MMJ, 2000, DIABETES METAB RES, V16, P157, DOI 10.1002/1520-7560(0000)9999:9999<::AID-DMRR104>3.0.CO;2-U
   Kristensen PL, 2012, DIABETES RES CLIN PR, V96, P17, DOI 10.1016/j.diabres.2011.10.046
   Kulzer B, 2013, DIABETOL STOFFWECHS, V8, P107, DOI 10.1055/s-0033-1335312
   Leiter LA, 2005, CAN J DIABETES, V29, P1
   Lundkvist Jonas, 2005, Eur J Health Econ, V6, P197, DOI 10.1007/s10198-005-0276-3
   Miller CD, 2001, ARCH INTERN MED, V161, P1653, DOI 10.1001/archinte.161.13.1653
   Ostenson CG, 2014, DIABETIC MED, V31, P92, DOI 10.1111/dme.12261
   Pedersen-Bjergaard U, 2004, DIABETES-METAB RES, V20, P479, DOI 10.1002/dmrr.482
   Pedersen-Bjergaard U, 2003, DIABETES-METAB RES, V19, P232, DOI 10.1002/dmrr.377
   PRAMMING S, 1991, DIABETIC MED, V8, P217, DOI 10.1111/j.1464-5491.1991.tb01575.x
   Rathmann W, 2013, DTSCH ARZTEBL INT, V110, P331, DOI 10.3238/arztebl.2013.0331
   The DCCT Research Group, 1997, DIABETES, V46, P271, DOI 10.2337/diabetes. 46.2.271
   Turner RC, 1998, LANCET, V352, P837
   Wild D, 2007, PATIENT EDUC COUNS, V68, P10, DOI 10.1016/j.pec.2007.05.003
NR 28
TC 13
Z9 13
U1 0
U2 0
PU JOHANN AMBROSIUS BARTH VERLAG MEDIZINVERLAGE HEIDELBERG GMBH
PI STUTTGART
PA RUEDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 0947-7349
EI 1439-3646
J9 EXP CLIN ENDOCR DIAB
JI Exp. Clin. Endocrinol. Diabet.
PD MAR
PY 2014
VL 122
IS 3
BP 167
EP 172
DI 10.1055/s-0033-1363688
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AY2FF
UT WOS:000347403300240
PM 24643694
DA 2019-01-08
ER

PT J
AU Hessler, D
   Fisher, L
   Glasgow, RE
   Strycker, LA
   Dickinson, LM
   Arean, PA
   Masharani, U
AF Hessler, Danielle
   Fisher, Lawrence
   Glasgow, Russell E.
   Strycker, Lisa A.
   Dickinson, L. Miriam
   Arean, Patricia A.
   Masharani, Umesh
TI Reductions in Regimen Distress Are Associated With Improved Management
   and Glycemic Control Over Time
SO DIABETES CARE
LA English
DT Article
ID DIABETES DISTRESS; DEPRESSIVE SYMPTOMS; CLINICAL DEPRESSION; OLDER
   ADULTS; OUTCOMES; METAANALYSIS; ADHERENCE; STRESS; THERAPY; HUMANS
AB OBJECTIVECross-sectional and longitudinal associations among regimen distress (RD), self-management, and glycemic control were undertaken to explore mechanisms of operation among these variables.RESEARCH DESIGN AND METHODSIn a behavioral randomized control trial (RCT) to reduce RD, 392 adults with type 2 diabetes were assessed for RD, diet, exercise, medication adherence, and HbA(1c) at baseline and at 4 and 12 months. Associations among RD, self-management, and HbA(1c) were examined in cross-sectional analyses at baseline, in prospective analyses using baseline values to predict change over time, and in time-varying analyses.RESULTSAt baseline, greater RD and poorer medication adherence were independently associated with higher HbA(1c) (P = 0.05 and P < 0.001, respectively), and greater RD was associated with poorer medication adherence (P = 0.03). No consistent pattern of significant prospective associations was found. Significant time-varying findings showed that decreases in RD were associated with improvements in medication adherence (P < 0.01), physical activity (P < 0.001), and HbA(1c) (P = 0.02) over time following intervention. Changes in self-management were not associated with changes in HbA(1c) over time.CONCLUSIONSIn the context of an RCT to reduce distress, RD, self-management, and HbA(1c) were interrelated in cross-sectional and time-varying analyses. Decreases in RD were associated with improvements in both self-management and HbA(1c) over 12 months. Findings point to the complex and likely multifaceted pathways of association among these key constructs, with results indicating significant linkages between RD and both self-management and glycemic control over time.
C1 [Hessler, Danielle; Fisher, Lawrence; Arean, Patricia A.; Masharani, Umesh] Univ Calif San Francisco, San Francisco, CA 94143 USA.
   [Glasgow, Russell E.] NCI, Div Canc Control & Populat Sci, Rockville, MD USA.
   [Strycker, Lisa A.] Oregon Res Inst, Eugene, OR 97403 USA.
   [Dickinson, L. Miriam] Univ Colorado, Aurora, CO USA.
RP Hessler, D (reprint author), Univ Calif San Francisco, San Francisco, CA 94143 USA.
EM hesslerd@fcm.ucsf.edu
FU National Institute of Diabetes and Digestive and Kidney Diseases
   [DK-061937]
FX This research was funded by National Institute of Diabetes and Digestive
   and Kidney Diseases grant DK-061937.
CR Aikens JE, 2012, DIABETES CARE, V35, P2472, DOI 10.2337/dc12-0181
   Arean P, 2008, GERONTOLOGIST, V48, P311, DOI 10.1093/geront/48.3.311
   Bocchieri LE, 2002, J PSYCHOSOM RES, V52, P155, DOI 10.1016/S0022-3999(01)00241-0
   Chapman B. P., 2006, J GERONTOL B-PSYCHOL, V61, P362
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2013, DIABETES CARE, V36, P2551, DOI 10.2337/dc12-2493
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Glasgow RE, 2011, J MED INTERNET RES, V13, P70, DOI 10.2196/jmir.1391
   Glasgow RE, 2010, J GEN INTERN MED, V25, P1315, DOI 10.1007/s11606-010-1480-0
   Golden SH, 2008, JAMA-J AM MED ASSOC, V299, P2751, DOI 10.1001/jama.299.23.2751
   Gonzalez JS, 2011, DIABETES CARE, V34, P236, DOI 10.2337/dc10-1970
   Goodwin RD, 2006, J HEALTH PSYCHOL, V11, P643, DOI 10.1177/1359105306066610
   HANSON CL, 1987, DIABETES CARE, V10, P752, DOI 10.2337/diacare.10.6.752
   Harada ND, 2001, MED SCI SPORT EXER, V33, P962, DOI 10.1097/00005768-200106000-00016
   Hedeker D, 2006, LONGITUDINAL DATA AN, P69
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Krousel-Wood M, 2005, AM J MED SCI, V330, P128, DOI 10.1097/00000441-200509000-00006
   Lloyd C, 2005, DIABETES SPECTR, V18, P121, DOI [DOI 10.2337/DIASPECT.18.2.121, 10.2337/diaspect.18.2.121]
   Masharani U, 2007, DIABETES DEMYSTIFIED
   Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985
   Miller GE, 2007, PSYCHOL BULL, V133, P25, DOI 10.1037/0033-2909.133.1.25
   Neuhaus JM, 1998, BIOMETRICS, V54, P638, DOI 10.2307/3109770
   Nezu AM, 2004, BEHAV THER, V35, P1, DOI 10.1016/S0005-7894(04)80002-9
   NORM, 1999, NORM MULT IMP INC MU
   Peyrot M, 1999, J HEALTH SOC BEHAV, V40, P141, DOI 10.2307/2676370
   Peyrot MF, 2001, DIABETES CARE, V24, P1703, DOI 10.2337/diacare.24.10.1703
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Rhee MK, 2005, DIABETES EDUCATOR, V31, P240, DOI 10.1177/0145721705274927
   Skaff MM, 2009, HEALTH PSYCHOL, V28, P265, DOI 10.1037/a0014429
   Steptoe A, 2007, BRAIN BEHAV IMMUN, V21, P901, DOI 10.1016/j.bbi.2007.03.011
   Stewart AL, 2001, MED SCI SPORT EXER, V33, P1126
   Thompson F. E., 1998, European Journal of Clinical Nutrition, V52, pS63
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Tsujii S, 2012, DIABETIC MED, V29, P1451, DOI 10.1111/j.1464-5491.2012.03647.x
   Umpierre D, 2011, JAMA-J AM MED ASSOC, V305, P1790, DOI 10.1001/jama.2011.576
   Zwarenstein M, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2390
NR 38
TC 36
Z9 39
U1 0
U2 11
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
EI 1935-5548
J9 DIABETES CARE
JI Diabetes Care
PD MAR
PY 2014
VL 37
IS 3
BP 617
EP 624
DI 10.2337/dc13-0762
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AB3RT
UT WOS:000331708600014
PM 24170750
OA Green Published, Other Gold
DA 2019-01-08
ER

PT J
AU Hendrieckx, C
   Halliday, JA
   Bowden, JP
   Colman, PG
   Cohen, N
   Jenkins, A
   Speight, J
AF Hendrieckx, C.
   Halliday, J. A.
   Bowden, J. P.
   Colman, P. G.
   Cohen, N.
   Jenkins, A.
   Speight, J.
TI Severe hypoglycaemia and its association with psychological well-being
   in Australian adults with type 1 diabetes attending specialist tertiary
   clinics
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Type 1 diabetes; Severe hypoglycaemia; Impaired awareness of
   hypoglycaemia; Well-being; Fear of hypoglycaemia
ID IMPAIRED AWARENESS; MANAGEMENT; FEAR; EDUCATION; IMPACT; LIFE
AB Aim: To investigate severe hypoglycaemia (SH) in adults with type 1 diabetes and its associations with impaired awareness of hypoglycaemia (IAH), clinical, psychological and sociodemographic factors.
   Methods: Attendees of three specialist diabetes clinics in Melbourne, Australia completed questions about frequency of SH in the past six months; impaired awareness of hypoglycaemia (Gold score); and measures of general emotional well-being (WHO-5), diabetes-specific positive well-being (subscale of W-BQ28), diabetes-related distress (PAID) and fear of hypoglycaemia (HFS).
   Results: Of 422 participants (mean +/- SD age 37.5 +/- 15.0 years; 54% women), 78 (18.5%) reported at least one SH event and 86 (20.5%) had IAH. SH and IAH frequencies were similar at all clinics. In total, 194 SH events were reported, with 10 people experiencing 40% of events. Compared with those without SH, participants with SH had longer diabetes duration, were younger at diabetes onset and more likely to have IAH (p < 0.01). Those with SH had greater fear of hypoglycaemia and diabetes-related distress, poorer general emotional well-being, and lower diabetes-specific positive well-being, (p < 0.01). There were no associations with age, gender, insulin regimen or HbA1c.
   Conclusions: This study has identified that SH and IAH in Australian adults with type 1 diabetes exist at similar levels to those reported in US and European research. SH was significantly associated with IAH and fear of hypoglycaemia.
   Assessment of hypoglycaemia, IAH and psychological well-being as part of a routine diabetes clinic visit was well accepted by attendees and enabled identification of those who may benefit from medical, educational or therapeutic interventions. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
C1 [Hendrieckx, C.; Halliday, J. A.; Speight, J.] Diabet Australia Vic, Australian Ctr Behav Res Diabet, Melbourne, Vic, Australia.
   [Hendrieckx, C.; Halliday, J. A.; Speight, J.] Deakin Univ, Sch Psychol, Ctr Mental Hlth & Well Being Res, Burwood, Vic, Australia.
   [Bowden, J. P.; Colman, P. G.] Royal Melbourne Hosp, Dept Endocrinol & Diabet, Melbourne, Vic, Australia.
   [Cohen, N.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia.
   [Jenkins, A.] Univ Melbourne, St Vincents Hosp, Dept Med, Melbourne, Vic, Australia.
   [Speight, J.] AHP Res, Hornchurch, Essex, England.
RP Hendrieckx, C (reprint author), Australian Ctr Behav Res Diabet, 570 Elizabeth St, Melbourne, Vic 3000, Australia.
EM chendrieckx@acbrd.org.au
RI Jenkins, Alicia/N-2482-2015
OI Cohen, Neale/0000-0002-4441-9511; Speight, Jane/0000-0002-1204-6896
FU Diabetes Australia-Vic; Deakin University
FX We thank Elizabeth Maclean for data collection at Baker IDI, Daniel
   Calandro for data collection assistance at SVH, Lucy Morrish for data
   collection assistance at RMH, and Laura Smith and Anna Scovelle for
   biomedical data input and quality control of the survey data. We thank
   the participants for their contribution to this project. We also thank
   Diabetes Australia-Vic and Deakin University for their financial
   support.
CR Anderbro T, 2010, DIABETIC MED, V27, P1151, DOI 10.1111/j.1464-5491.2010.03078.x
   Barendse S, 2012, DIABETIC MED, V29, P293, DOI 10.1111/j.1464-5491.2011.03416.x
   Bech P., 2004, QUALITY LIFE NEWSLET, V32, P15
   Bohme P, 2013, DIABETES METAB, V39, P63, DOI 10.1016/j.diabet.2012.10.006
   Choudhary P, 2011, POSTGRAD MED J, V87, P298, DOI 10.1136/pgmj.2008.068197
   Cox D, 2008, DIABETES CARE, V31, P1527, DOI 10.2337/dc07-1956
   COX DJ, 1987, DIABETES CARE, V10, P617, DOI 10.2337/diacare.10.5.617
   Cox DJ, 2001, DIABETES CARE, V24, P637, DOI 10.2337/diacare.24.4.637
   Cryer PE, 2002, DIABETOLOGIA, V45, P937, DOI 10.1007/s00125-002-0822-9
   Cryer PE, 2009, J CLIN ENDOCR METAB, V94, P709, DOI 10.1210/jc.2008-1410
   Frier BM, 2008, DIABETES-METAB RES, V24, P87, DOI 10.1002/dmrr.796
   Geddes J, 2008, DIABETIC MED, V25, P501, DOI 10.1111/j.1464-5491.2008.02413.x
   GOLD AE, 1994, DIABETES CARE, V17, P697, DOI 10.2337/diacare.17.7.697
   Gonder-Frederick LA, 2011, DIABETES CARE, V34, P801, DOI 10.2337/dc10-1343
   Graveling Alex J, 2009, Prim Care Diabetes, V3, P131, DOI 10.1016/j.pcd.2009.08.007
   Heller SR, 2007, DIABETOLOGIA, V50, P1140, DOI 10.1007/s00125-007-0599-y
   Hendrieckx C, 2012, ANN SCI M AUSTR DIAB, Va274, P159
   Hermanns N, 2007, DIABETES-METAB RES, V23, P528, DOI 10.1002/dmrr.710
   Hermanns Norbert, 2010, Diabetes Care, V33, pe36, DOI 10.2337/dc09-1656
   Jorgensen HV, 2003, DIABETES CARE, V26, P1106, DOI 10.2337/diacare.26.4.1106
   Kristensen PL, 2012, DIABETES RES CLIN PR, V96, P17, DOI 10.1016/j.diabres.2011.10.046
   Leiter LA, 2005, CAN J DIABETES, V29, P186
   Little S, 2012, BMC ENDOCR DISORD, V12, DOI 10.1186/1472-6823-12-33
   Misso ML, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005103.pub2
   O'Connell SM, 2011, DIABETES CARE, V34, P2379, DOI 10.2337/dc11-0748
   Pedersen-Bjergaard U, 2003, DIABETES-METAB RES, V19, P232, DOI 10.1002/dmrr.377
   Snoek FJ, 2011, DIABETES CARE, V34, P601, DOI 10.2337/dc10-1552
   Speight J, 2000, P BRIT PSYCHOL SOC, V8, P21
   Speight J, 2011, DIABETES MILES AUSTR
   Tu E, 2010, INT J CARDIOL, V138, P91, DOI 10.1016/j.ijcard.2008.06.021
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   Wild D, 2007, PATIENT EDUC COUNS, V68, P10, DOI 10.1016/j.pec.2007.05.003
NR 32
TC 35
Z9 37
U1 0
U2 11
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
EI 1872-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD MAR
PY 2014
VL 103
IS 3
BP 430
EP 436
DI 10.1016/j.diabres.2013.12.005
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AF3AC
UT WOS:000334582700028
PM 24513121
DA 2019-01-08
ER

PT J
AU Aikens, JE
   Zivin, K
   Trivedi, R
   Piette, JD
AF Aikens, James E.
   Zivin, Kara
   Trivedi, Ranak
   Piette, John D.
TI Diabetes self-management support using mHealth and enhanced informal
   caregiving
SO JOURNAL OF DIABETES AND ITS COMPLICATIONS
LA English
DT Article
DE Diabetes; mHealth; Primary care; Care management
ID MEDICATION ADHERENCE; PREDICTIVE-VALIDITY; HEALTH LITERACY; QUESTIONS;
   DISTRESS; MELLITUS; OUTCOMES; FAMILY; SCALE
AB Objective: To characterize diabetes patient engagement and clinician notifications for an mHealth interactive voice response (IVR) service.
   Design: Observational study.
   Methods: For three to six months, VA patients with diabetes received weekly IVR calls assessing health status and self-care along with tailored education. Patients could enroll with an informal caregiver who received suggestions on self-management support. Notifications were issued to clinicians when patients reported significant problems.
   Results: Patients (n = 303) participated for a total of 5684 patient-weeks, during which 84% of calls were completed. The odds of call completion decreased over time (AOR = 0.96, p < 0.001), and were lower among unmarried patients (AOR = 0.67, p = 0.038) and those who had difficulties with health literacy (AOR = 0.67, p = 0.039), diabetes-related distress (AOR = 0.30, p = 0.018), or medication nonadherence (AOR = 0.57, p = 0.002). Twenty-one clinician notifications were triggered per 100 patient-weeks. The odds of notification were higher during the early weeks of the program (AOR = 0.95, p < 0.001) and among patients who were older (AOR = 1.03, p = 0.004) or more physically impaired (AOR = 0.97, p < 0.001).
   Conclusions: By providing information that is reliable, valid, and actionable, IVR-based mHealth services may increase access to between-visit monitoring and diabetes self-management support. The system detects abnormal glycemia and blood pressure levels that might otherwise go unreported, although thresholds for clinician notifications might require adjustment to avoid overloading clinicians. Patient engagement might be enhanced by addressing health literacy and psychological distress. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Aikens, James E.] Univ Michigan, Dept Family Med, Ann Arbor, MI 48104 USA.
   [Zivin, Kara] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA.
   [Zivin, Kara; Piette, John D.] Ann Arbor Dept Vet Affairs Ctr Clin Management Re, Ann Arbor, MI USA.
   [Zivin, Kara] Univ Michigan, Inst Social Res, Ann Arbor, MI USA.
   [Trivedi, Ranak] VA Palo Alto Hlth Care Syst, Ctr Innovat Implementat, Palo Alto, CA USA.
   [Trivedi, Ranak] Stanford Univ, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA.
   [Piette, John D.] Univ Michigan, Sch Publ Hlth, Dept Hlth Behav & Hlth Educ, Ann Arbor, MI 48109 USA.
RP Aikens, JE (reprint author), Univ Michigan, Dept Family Med, 1018 Fuller St, Ann Arbor, MI 48104 USA.
EM aikensj@umich.edu
OI Zivin, Kara/0000-0001-8246-6864
FU VA Career Development Awards [CD2 07-206-1, CDA-09-206]; Michigan
   Diabetes Translational Research Center [P30DK092926]; National Institute
   of Diabetes and Digestive and Kidney Diseases [R18DK088294]
FX JDP is a VA Senior Research Career Scientist. KZ and RT are supported by
   VA Career Development Awards (grant # CD2 07-206-1 to K.Z. and grant #
   CDA-09-206 to R.T.). Other financial support came from the Michigan
   Diabetes Translational Research Center (grant # P30DK092926) and grant #
   R18DK088294 from the National Institute of Diabetes and Digestive and
   Kidney Diseases. The views expressed in this manuscript are those of the
   authors and do not necessarily represent the opinions of the Department
   of Veterans Affairs.
CR Aikens JE, 2012, DIABETES CARE, V35, P2472, DOI 10.2337/dc12-0181
   Aikens JE, 2009, DIABETES CARE, V32, P19, DOI 10.2337/dc08-1533
   Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
   Anderson Robert M, 2009, Ther Patient Educ, V1, P3
   Armour TA, 2005, DIABETIC MED, V22, P1295, DOI 10.1111/j.1464-5491.2005.01618.x
   Attkisson C C, 1982, Eval Program Plann, V5, P233, DOI 10.1016/0149-7189(82)90074-X
   Chew LD, 2004, FAM MED, V36, P588
   Chew LD, 2008, J GEN INTERN MED, V23, P561, DOI 10.1007/s11606-008-0520-5
   Irwin M, 1999, ARCH INTERN MED, V159, P1701, DOI 10.1001/archinte.159.15.1701
   Kawachi I, 2001, J URBAN HEALTH, V78, P458, DOI 10.1093/jurban/78.3.458
   Kohout F J, 1993, J Aging Health, V5, P179, DOI 10.1177/089826439300500202
   MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007
   Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x
   Piette J. D., 2013, J MED INTERNET RES, V15
   Piette JD, 1997, DIABETES EDUCATOR, V23, P672, DOI 10.1177/014572179702300607
   Piette JD, MED CARE IN PRESS
   Piette JD, 2007, DIABETES CARE, V30, P2425, DOI 10.2337/dc07-1046
   Piette JD, 2013, MED CARE, V51, P216, DOI 10.1097/MLR.0b013e318277ebf8
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Robles TF, 2003, PHYSIOL BEHAV, V79, P409, DOI 10.1016/S0031-9384(03)00160-4
   Rosland AM, 2013, FAM SYST HEALTH, V31, P119, DOI 10.1037/a0031535
   Schwartz S, 1998, Health Manag Technol, V19, P41
   StataCorp, 2011, STAT STAT SOFTW REL
   Talley RC, 2007, AM J PUBLIC HEALTH, V97, P224, DOI 10.2105/AJPH.2004.059337
   Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003
NR 25
TC 22
Z9 25
U1 1
U2 26
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1056-8727
EI 1873-460X
J9 J DIABETES COMPLICAT
JI J. Diabetes Complications
PD MAR-APR
PY 2014
VL 28
IS 2
BP 171
EP 176
DI 10.1016/j.jdiacomp.2013.11.008
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AD8VD
UT WOS:000333542900014
PM 24374137
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Karlsen, B
   Bru, E
AF Karlsen, Bjorg
   Bru, Edvin
TI The relationship between diabetes-related distress and clinical
   variables and perceived support among adults with type 2 diabetes: A
   prospective study
SO INTERNATIONAL JOURNAL OF NURSING STUDIES
LA English
DT Article
DE Adults with type 2 diabetes; Clinical variables; Diabetes-related
   distress; Healthcare professionals; Prospective longitudinal study;
   Social support
ID SOCIAL SUPPORT; EMOTIONAL DISTRESS; PROBLEM AREAS; GLYCEMIC CONTROL;
   SCALE; DEPRESSION; MANAGEMENT; VALIDITY; PAID; PERSPECTIVES
AB Background: Diabetes-related distress is a prevalent emotional state experienced among people living with type 2 diabetes. It has predominantly been studied in relation to diabetes management and metabolic control and to some extent in relation to perceived social support. Little is known about the relative prospective contribution of clinical variables and perceived support on diabetes-related distress.
   Objective: To investigate the predictive influence of clinical variables and perceived support from health care professionals and family on diabetes-related distress.
   Design: The study has a prospective, longitudinal design.
   Settings: The participants were recruited from seven general practitioners in the south western part of Norway and from members of the Norwegian Diabetes Association.
   Participants: The sample comprised 296 people with type 2 diabetes. Inclusion criteria were: adults (30-70 years) diagnosed with type 2 diabetes who were willing and able to complete a questionnaire written in Norwegian.
   Methods: Data were collected by postal questionnaires assessing perceived support from health care professionals and family and diabetes-related distress measured by the Problem Areas in Diabetes Scale at two time points separated by an interval of one year (October 2008 and 2009). Clinical data were collected by self-report. The follow-up group, for which both assessment data were available, constituted our sample comprising 296 adults.
   Results: Descriptive results and findings from correlations and prospective multivariate associations indicate small changes in diabetes-related distress over a period of one year. In total, multiple regression analyses showed that clinical variables were very weak predictors of diabetes-related distress, whereas perceived social support emerged as statistically significant although a moderate predictor of distress. Among the support variables, only 'constructive support from health care professionals' and 'non-supportive family behaviour' accounted for changes in diabetes-related distress.
   Conclusions: Findings suggest that diabetes-related distress among adults with type 2 diabetes is relatively stable over time and may be difficult to alter. Health care professionals should therefore be aware that stimulating people to change is challenging and complex. Moreover, they should devote more attention to non-clinical factors such as social support when addressing diabetes-related distress. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Karlsen, Bjorg; Bru, Edvin] Univ Stavanger, Fac Social Sci, Dept Hlth Studies, N-4036 Stavanger, Norway.
   [Bru, Edvin] Univ Stavanger, Norwegian Ctr Learning Environm & Behav Res Educ, N-4036 Stavanger, Norway.
RP Karlsen, B (reprint author), Univ Stavanger, Fac Social Sci, Dept Hlth Studies, N-4036 Stavanger, Norway.
EM bjorg.karlsen@uis.no
OI Bru, Edvin/0000-0003-2004-6957
FU Norwegian Diabetes Association
FX The study was supported by grants from the Norwegian Diabetes
   Association.
CR Birkeland K. I., 2009, NASJONALE KLIN RETNI
   CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267
   Caspi A, 2005, ANNU REV PSYCHOL, V56, P453, DOI 10.1146/annurev.psych.55.090902.141913
   COBB S, 1976, PSYCHOSOM MED, V38, P300, DOI 10.1097/00006842-197609000-00003
   COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037//0033-2909.98.2.310
   COLEMAN JS, 1988, AM J SOCIOL, V94, pS95, DOI 10.1086/228943
   Costa P. T., 1996, HDB COPING THEORY RE, P44
   COX DJ, 1992, J CONSULT CLIN PSYCH, V60, P628, DOI 10.1037//0022-006X.60.4.628
   de Groot Mary, 2010, Diabetes Spectr, V23, P15, DOI 10.2337/diaspect.23.1.15
   DECI EL, 1991, EDUC PSYCHOL-US, V26, P325, DOI 10.1207/s15326985ep2603&4_6
   Delahanty LM, 2007, DIABETIC MED, V24, P48, DOI 10.1111/j.1464-5491.2007.02028.x
   Fisher L, 2009, DIABETIC MED, V26, P622, DOI 10.1111/j.1464-5491.2009.02730.x
   Fisher L, 2001, DIABETES CARE, V24, P1751, DOI 10.2337/diacare.24.10.1751
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Ford ME, 1998, J NATL MED ASSOC, V90, P425
   Graue M, 2012, INT J NURS STUD, V49, P174, DOI 10.1016/j.ijnurstu.2011.08.007
   Hewitt PL, 1996, HDB COPING THEORY RE, P410
   Hunt LM, 1998, WESTERN J NURS RES, V20, P656, DOI 10.1177/019394599802000602
   Jenum Anne Karen, 2008, Prim Care Diabetes, V2, P203, DOI 10.1016/j.pcd.2008.06.003
   Karlsen B., 2004, PSYCHOL HEALTH MED, V9, P53
   Karlsen B, 2012, J ADV NURS, V68, P391, DOI 10.1111/j.1365-2648.2011.05751.x
   Kunitz SJ, 2004, BRIT MED BULL, V69, P61, DOI 10.1093/bmb/ldh015
   Lazarus R. S, 1984, STRESS APPRAISAL COP
   Livneh H., 2007, COPING CHRONIC ILLNE
   Lloyd C, 2005, DIABETES SPECTR, V18, P121, DOI [DOI 10.2337/DIASPECT.18.2.121, 10.2337/diaspect.18.2.121]
   Norusis M. J., 2011, PASW STAT 18 GUID DA
   Oftedal B, 2011, J NURSING HEALTHCARE, V3, P12
   Papelbaum M, 2010, DIABETES RES CLIN PR, V89, P227, DOI 10.1016/j.diabres.2010.05.024
   Pedhazur E. J., 1982, MULTIPLE REGRESSIONS
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Sacco WP, 2006, INTERPERSONAL, COGNITIVE, AND SOCIAL NATURE OF DEPRESSION, P101
   Sacco WP, 1999, INTERACTIONAL NATURE OF DEPRESSION, P329, DOI 10.1037/10311-012
   SCHAFER LC, 1986, DIABETES CARE, V9, P179, DOI 10.2337/diacare.9.2.179
   Schreurs KMG, 1997, CLIN PSYCHOL REV, V17, P89, DOI 10.1016/S0272-7358(96)00050-5
   Sigurdardottir AK, 2008, INT J NURS STUD, V45, P526, DOI 10.1016/j.ijnurstu.2006.10.008
   Skinner Chas T., 2000, PSYCHOL DIABETES CAR
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Stene Lars Christian, 2004, Tidsskr Nor Laegeforen, V124, P1511
   STEWART M, 2000, CHRONIC CONDITIONS C
   Tang TS, 2008, DIABETES EDUCATOR, V34, P266, DOI 10.1177/0145721708315680
   Taylor S, 2006, HLTH PSYCHOL
   Thorne SE, 2001, PATIENT EDUC COUNS, V42, P81, DOI 10.1016/S0738-3991(00)00095-1
   Trief PM, 1998, DIABETES CARE, V21, P241, DOI 10.2337/diacare.21.2.241
   Welch G, 2003, DIABETIC MED, V20, P69, DOI 10.1046/j.1464-5491.2003.00832.x
   Welch G, 2007, ETHNIC DIS, V17, P541
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   Yang J, 2009, J CLIN NURS, V18, P1295, DOI 10.1111/j.1365-2702.2008.02703.x
NR 49
TC 18
Z9 20
U1 0
U2 29
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0020-7489
EI 1873-491X
J9 INT J NURS STUD
JI Int. J. Nurs. Stud.
PD MAR
PY 2014
VL 51
IS 3
BP 438
EP 447
DI 10.1016/j.ijnurstu.2013.06.016
PG 10
WC Nursing
SC Nursing
GA AC8YB
UT WOS:000332819900012
PM 23891535
DA 2019-01-08
ER

PT J
AU Rassart, J
   Luyckx, K
   Moons, P
   Weets, I
AF Rassart, Jessica
   Luyckx, Koen
   Moons, Philip
   Weets, Ilse
TI Personality and self-esteem in emerging adults with Type 1 diabetes
SO JOURNAL OF PSYCHOSOMATIC RESEARCH
LA English
DT Article
DE Big Five; Diabetes Type 1; Insulin pump; Personality; Self-esteem; Sex
   differences
ID QUALITY-OF-LIFE; GENDER-DIFFERENCES; GLYCEMIC CONTROL; YOUNG-ADULTS;
   PSYCHOLOGICAL ADJUSTMENT; CHRONIC ILLNESS; HEALTH-STATUS; ADOLESCENTS;
   CARE; DEPRESSION
AB Objective: The present study examined (1) mean-level differences in self-esteem and Big Five personality traits between individuals with and without diabetes; and (2) demographic, clinical, and psychological correlates of patients' self-esteem and Big Five.
   Research design and methods: A total of 478 emerging adults with Type 1 diabetes (18-35 years old) were selected from the Belgian Diabetes Registry and completed questionnaires on personality, self-esteem, and diabetes-related distress. The control group consisted of 341 healthy participants who were matched (1:1) on sex and age with the patient group.
   Results: First, mean-level differences between patients and controls differed according to patients' sex and illness duration. Women with diabetes reported lower self-esteem and were less extraverted and emotionally stable as compared to female controls. In contrast, men with diabetes reported higher self-esteem and were more agreeable but less emotionally stable as compared to male controls. Furthermore, whereas both patients with shorter and longer illness duration were less extraverted and emotionally stable as compared to controls, only patients with longer illness duration reported heightened agreeableness. Second, self-esteem and Big Five were found to relate to patients' sex and (to a lesser extent) age and illness duration. Finally, patients reporting elevated diabetes-related distress reported lower self-esteem, and were less agreeable and emotionally stable as compared to patients not reporting such distress.
   Conclusions: Patients' personality and self-esteem might be important targets for future prevention and intervention efforts. The present findings can assist healthcare professionals in identifying those patients who might benefit the most from such programs. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Rassart, Jessica; Luyckx, Koen; Moons, Philip] Katholieke Univ Leuven, B-3000 Louvain, Belgium.
   [Moons, Philip] Katholieke Univ Leuven Hosp, Louvain, Belgium.
   [Moons, Philip] Copenhagen Univ Hosp, Ctr Heart, Copenhagen, Denmark.
   [Weets, Ilse] Free Univ Brussels, Brussels, Belgium.
RP Rassart, J (reprint author), Katholieke Univ Leuven, Dept Psychol, Tiensestr 102, B-3000 Louvain, Belgium.
EM Jessica.Rassart@ppw.kuleuven.be
OI Moons, Philip/0000-0002-8609-4516
CR Abraido-Lanza AF, 1997, AM J COMMUN PSYCHOL, V25, P601, DOI 10.1023/A:1024682800238
   Arnett JJ, 2000, AM PSYCHOL, V55, P469, DOI 10.1037/0003-066X.55.5.469
   Auryan S, 2008, DIABETES OBES METAB, V10, P1135, DOI 10.1111/j.1463-1326.2008.00896.x
   Austin S, 2011, J HEALTH PSYCHOL, V16, P917, DOI 10.1177/1359105310396392
   Boeger A, 1996, Z KINDER JUG-PSYCH, V24, P231
   Branje SJT, 2004, J PERS SOC PSYCHOL, V86, P615, DOI 10.1037/0022-3514.86.4.615
   Brickman AL, 1996, PSYCHOSOMATICS, V37, P459, DOI 10.1016/S0033-3182(96)71534-7
   Bryden KS, 2003, DIABETES CARE, V26, P1052, DOI 10.2337/diacare.26.4.1052
   Bury M, 1982, Sociol Health Illn, V4, P167, DOI 10.1111/1467-9566.ep11339939
   Chapman B. P., DEV PSYCHOL IN PRESS
   Costa PT, 1992, REVISED NEO PERSONAL
   Daneman D., 2002, Diabetes Spectrum, V15, P83, DOI 10.2337/diaspect.15.2.83
   Enzlin P, 2002, PATIENT EDUC COUNS, V48, P139, DOI 10.1016/S0738-3991(02)00009-5
   Erol RY, 2011, J PERS SOC PSYCHOL, V101, P607, DOI 10.1037/a0024299
   Ferro MA, 2013, HEALTH PSYCHOL, V32, P839, DOI 10.1037/a0031861
   Friedman HS, 2008, BRAIN BEHAV IMMUN, V22, P668, DOI 10.1016/j.bbi.2007.09.004
   Fritschi C, 2010, J PSYCHOSOM RES, V69, P33, DOI 10.1016/j.jpsychores.2010.01.021
   Gendelman N, 2009, DIABETES CARE, V32, P575, DOI 10.2337/dc08-1835
   HAUSER ST, 1983, ARCH GEN PSYCHIAT, V40, P325
   Helgeson VS, 2007, J PEDIATR PSYCHOL, V32, P794, DOI 10.1093/jpepsy/jsm020
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   Hirose M, 2012, CURR DIABETES REP, V12, P711, DOI 10.1007/s11892-012-0313-4
   Hocking MC, 2005, CLIN CHILD FAM PSYCH, V8, P221, DOI 10.1007/s10567-005-6667-2
   Johnston-Brooks CH, 2002, PSYCHOSOM MED, V64, P43, DOI 10.1097/00006842-200201000-00007
   Jylha P, 2006, DEPRESS ANXIETY, V23, P281, DOI 10.1002/da.20167
   Korbel CD, 2007, CHILD HEALTH CARE, V36, P83, DOI 10.1080/02739610701316936
   Lawson VL, 2010, BRIT J HEALTH PSYCH, V15, P623, DOI 10.1348/135910709X478664
   Linley PA, 2004, J TRAUMA STRESS, V17, P11, DOI 10.1023/B:JOTS.0000014671.27856.7e
   Lorig KR, 2001, MED CARE, V39, P1217, DOI 10.1097/00005650-200111000-00008
   Luyckx K, 2009, DIABETES CARE, V32, P797, DOI 10.2337/dc08-1990
   McAdams D.P., 2009, ANNU REV CLIN PSYCHO, V61, P517
   McCrae R. R., 1999, HDB PERSONALITY THEO, P139
   Pek Hatice, 2002, J Pediatr Nurs, V17, P279, DOI 10.1053/jpdn.2002.126710
   Peters A, 2011, DIABETES CARE, V34, P2477, DOI 10.2337/dc11-1723
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Rassart J, 2013, PSYCHOL HEALTH, V28, P319, DOI 10.1080/08870446.2012.729836
   Roberts B. W., 2008, HDB PERSONALITY THEO, P375
   Rosenberg M, 1965, SOC ADOLESCENT SELF
   Sawyer SM, 2003, J PAEDIATR CHILD H, V39, P2, DOI 10.1046/j.1440-1754.2003.00081.x
   Schneider S, 2007, DIABETES CARE, V30, P1107, DOI 10.2337/dc06-2197
   Seiffge-Krenke I., 2001, DIABETIC ADOLESCENTS
   SEIGEL WM, 1990, J ADOLESCENT HEALTH, V11, P501, DOI 10.1016/0197-0070(90)90110-N
   Sparud-Lundin C, 2010, J ADV NURS, V66, P128, DOI 10.1111/j.1365-2648.2009.05166.x
   Specht J, 2011, J PERS SOC PSYCHOL, V101, P862, DOI 10.1037/a0024950
   Spijkerman AMW, 2002, EUR J CLIN INVEST, V32, P924, DOI 10.1046/j.1365-2362.2002.01090.x
   Stahl A, 2011, DIABETOLOGIA, V54, pS41
   Tackett JL, 2006, CLIN PSYCHOL REV, V26, P584, DOI 10.1016/j.cpr.2006.04.003
   Tamres LK, 2002, PERS SOC PSYCHOL REV, V6, P2, DOI 10.1207/S15327957PSPR0601_1
   Tang TZ, 2009, ARCH GEN PSYCHIAT, V66, P1322, DOI 10.1001/archgenpsychiatry.2009.166
   Taylor MD, 2003, DIABETIC MED, V20, P135, DOI 10.1046/j.1464-5491.2003.00887.x
   THOMPSON RJ, 1994, J PEDIATR PSYCHOL, V19, P189, DOI 10.1093/jpepsy/19.2.189
   Unden AL, 2008, GENDER MED, V5, P162, DOI 10.1016/j.genm.2008.05.003
   van Bastelaar KMP, 2010, DIABETIC MED, V27, P798, DOI 10.1111/j.1464-5491.2010.03025.x
   Van De yen MOM, 2011, J PSYCHOSOM RES, V71, P166
   Vandewalle CL, 1997, DIABETES CARE, V20, P1556, DOI 10.2337/diacare.20.10.1556
   Varni JW, 2009, PEDIATR DIABETES, V10, P321, DOI 10.1111/j.1399-5448.2008.00482.x
   Vermulst A. A., 2005, QBF QUICK BIG 5 PERS
   Vlachioti E, 2010, J DIABETES, V2, P104, DOI 10.1111/j.1753-0407.2010.00067.x
   Vollrath ME, 2007, DIABETIC MED, V24, P1028, DOI 10.1111/j.1464-5491.2007.02215.x
   Weissberg-Benchell J, 2003, DIABETES CARE, V26, P1079, DOI 10.2337/diacare.26.4.1079
   Weissberg-Benchell J, 2007, DIABETES CARE, V30, P2441, DOI 10.2337/dc07-1249
   Wennick A, 2007, J ADV NURS, V60, P299, DOI 10.1111/j.1365-2648.2007.04411.x
   Wheeler K, 2012, J CHILD ADOL PS NURS, V25, P66, DOI 10.1111/j.1744-6171.2012.00329.x
   Williams SJ, 2000, SOCIOL HEALTH ILL, V22, P40, DOI 10.1111/1467-9566.00191
NR 64
TC 7
Z9 7
U1 4
U2 16
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0022-3999
EI 1879-1360
J9 J PSYCHOSOM RES
JI J. Psychosomat. Res.
PD FEB
PY 2014
VL 76
IS 2
BP 139
EP 145
DI 10.1016/j.jpsychores.2013.11.015
PG 7
WC Psychiatry
SC Psychiatry
GA AB2BJ
UT WOS:000331597700009
PM 24439690
DA 2019-01-08
ER

PT J
AU Nakaya, N
   Kogure, M
   Saito-Nakaya, K
   Tomata, Y
   Sone, T
   Kakizaki, M
   Tsuji, I
AF Nakaya, Naoki
   Kogure, Mana
   Saito-Nakaya, Kumi
   Tomata, Yasutake
   Sone, Toshimasa
   Kakizaki, Masako
   Tsuji, Ichiro
TI The association between self-reported history of physical diseases and
   psychological distress in a community-dwelling Japanese population: the
   Ohsaki Cohort 2006 Study
SO EUROPEAN JOURNAL OF PUBLIC HEALTH
LA English
DT Article
ID SOCIAL SUPPORT; SCREENING SCALES; DEPRESSION; METAANALYSIS; CANCER;
   QUESTIONNAIRE; DISABILITY; OUTCOMES; ILLNESS; DENMARK
AB Background: Patients with physical disease are known to suffer considerable psychological distress. Social support may confound the association between physical disease and psychological distress. Population-based epidemiological studies have not been conducted on the association between history of physical disease, psychological distress and social support. Methods: Using cross-sectional data from 2006, we studied 43 487 community-dwelling people aged epsilon 40 years living in Japan. We examined the association between 13 self-reported histories of physical disease and psychological distress evaluated using the Kessler 6-item psychological distress scale (K6), defined as epsilon 13 points out of 24. To investigate the association, we performed multiple logistic regression analyses adjusted for age, gender, social support and possible confounders. Social support, as the interaction between physical disease and psychological depression, was tested through the addition of cross-product terms to the multivariate-adjusted model. Results: The following histories of physical disease were found significantly and positively associated with psychological distress: cancer, diabetes mellitus, hyperlipidemia, hypertension, myocardial infarction, stroke, gastric or duodenal ulcer, liver disease, arthritis, osteoporosis, kidney disease and fall or fracture (odds ratio, 1.2-2.3). Social support did not modify the association between most histories of physical disease and psychological distress. Conclusions: Subjects with a history of physical disease were significantly and positively associated with psychological distress, and social support did not modify this association for most physical diseases. Even after patients have left hospital following treatment for physical disease, they require continuous monitoring for psychological distress by doctors and paramedics.
C1 [Nakaya, Naoki] Tohoku Univ, Tohoku Med Megabank Org, Dept Prevent Med & Epidemiol, Sendai, Miyagi 9808573, Japan.
   [Nakaya, Naoki; Kogure, Mana; Tomata, Yasutake; Sone, Toshimasa; Kakizaki, Masako; Tsuji, Ichiro] Tohoku Univ, Grad Sch Med, Dept Publ Hlth & Forens Med, Div Epidemiol, Sendai, Miyagi 9808573, Japan.
   [Nakaya, Naoki] Kamakura Womens Univ, Dept Nutr & Dietet, Fac Family & Consumer Sci, Kamakura, Kanagawa, Japan.
   [Saito-Nakaya, Kumi] Tohoku Univ, Grad Sch Med, Dept Behav Med, Sendai, Miyagi 9808573, Japan.
RP Nakaya, N (reprint author), Tohoku Univ, Tohoku Med Megabank Org, Dept Prevent Med & Epidemiol, 2-1 Seiryo, Sendai, Miyagi 9808573, Japan.
EM nakaya-thk@umin.ac.jp
OI Kakizaki, Masako/0000-0001-6030-8953
FU Japan Society for Challenging Exploratory Research [23650420]
FX Supported by grants from the Japan Society for Challenging Exploratory
   Research (No. 23650420).
CR Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   AROMAA A, 1994, ACTA PSYCHIAT SCAND, V89, P77, DOI 10.1111/j.1600-0447.1994.tb05807.x
   BARNETT PA, 1988, PSYCHOL BULL, V104, P97, DOI 10.1037/0033-2909.104.1.97
   Berkman L.F., 2000, SOCIAL EPIDEMIOLOGY
   Bower JE, 2000, J CLIN ONCOL, V18, P743, DOI 10.1200/JCO.2000.18.4.743
   Brummett BH, 2003, INT J BEHAV MED, V10, P239, DOI 10.1207/S15327558IJBM1003_04
   Ciesla JA, 2001, AM J PSYCHIAT, V158, P725, DOI 10.1176/appi.ajp.158.5.725
   Dalton SO, 2009, J CLIN ONCOL, V27, P1440, DOI 10.1200/JCO.2008.20.5526
   Dalton SO, 2008, EUR J CANCER, V44, P2074, DOI 10.1016/j.ejca.2008.06.018
   Dickens C, 2002, PSYCHOSOM MED, V64, P52, DOI 10.1097/00006842-200201000-00008
   Furukawa TA, 2003, PSYCHOL MED, V33, P357, DOI 10.1017/S0033291702006700
   Hammar N, 1998, OCCUP ENVIRON MED, V55, P548, DOI 10.1136/oem.55.8.548
   Hjollund NH, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-12
   Hozawa A, 2009, AM J CLIN NUTR, V90, P1390, DOI 10.3945/ajcn.2009.28214
   Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Koizumi Y, 2005, PSYCHIAT CLIN NEUROS, V59, P563, DOI 10.1111/j.1440-1819.2005.01415.x
   Kurimoto Ayumi, 2011, Nihon Ronen Igakkai Zasshi, V48, P149
   Kuriyama S, 2009, J EPIDEMIOL, V19, P294, DOI 10.2188/jea.JE20080076
   Lee SJ, 2007, AM J PUBLIC HEALTH, V97, P1820, DOI 10.2105/AJPH.2005.084871
   Lenze EJ, 2001, AM J GERIAT PSYCHIAT, V9, P113, DOI 10.1176/appi.ajgp.9.2.113
   Lett HS, 2005, PSYCHOSOM MED, V67, P869, DOI 10.1097/01.psy.0000188393.73571.0a
   MURAOKA Y, 1996, NIPPON RONEN SEISHIN, V7, P397
   Nausheen B, 2009, J PSYCHOSOM RES, V67, P403, DOI 10.1016/j.jpsychores.2008.12.012
   Ogawa K, 2003, PUBLIC HEALTH NUTR, V6, P147, DOI 10.1079/PHN2002411
   Oldehinkel AJ, 2011, NEUROSCI BIOBEHAV R, V35, P1757, DOI 10.1016/j.neubiorev.2010.10.013
   Picavet HSJ, 1997, AM J PUBLIC HEALTH, V87, P1680, DOI 10.2105/AJPH.87.10.1680
   SARASON IG, 1983, J PERS SOC PSYCHOL, V44, P127, DOI 10.1037/0022-3514.44.1.127
   STEWART AL, 1989, JAMA-J AM MED ASSOC, V262, P907, DOI 10.1001/jama.262.7.907
   Symister P, 2003, HEALTH PSYCHOL, V22, P123, DOI 10.1037/0278-6133.22.2.123
NR 30
TC 14
Z9 14
U1 0
U2 6
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1101-1262
EI 1464-360X
J9 EUR J PUBLIC HEALTH
JI Eur. J. Public Health
PD FEB
PY 2014
VL 24
IS 1
BP 45
EP 49
DI 10.1093/eurpub/ckt017
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA AA1EC
UT WOS:000330838200012
PM 23444426
OA Bronze
DA 2019-01-08
ER

PT J
AU Kasteleyn, MJ
   Gorter, KJ
   Stellato, RK
   Rijken, M
   Nijpels, G
   Rutten, GEHM
AF Kasteleyn, Marise J.
   Gorter, Kees J.
   Stellato, Rebecca K.
   Rijken, Mieke
   Nijpels, Giel
   Rutten, Guy E. H. M.
TI Tailored support for type 2 diabetes patients with an acute coronary
   event after discharge from hospital - design and development of a
   randomised controlled trial
SO DIABETOLOGY & METABOLIC SYNDROME
LA English
DT Article
DE Type 2 diabetes; Acute Coronary Event (ACE); Distress; Self-management;
   Self-efficacy; Quality of life; Depression; Primary care; Illness
   representations
ID QUALITY-OF-LIFE; ACUTE MYOCARDIAL-INFARCTION; CHANGING ILLNESS
   PERCEPTIONS; CARDIOVASCULAR-DISEASE RISK; CARDIAC REHABILITATION;
   EMOTIONAL DISTRESS; SELF-MANAGEMENT; ARTERY-DISEASE; HEALTH-STATUS;
   PROBLEM AREAS
AB Background: Type 2 diabetes mellitus patients with an acute coronary event (ACE) experience decreased quality of life and increased distress. According to the American Diabetes Association, discharge from the hospital is a time of increased distress for all patients. Tailored support specific to diabetes is scarce in that period. We developed an intervention based on Bandura's Social Cognitive Theory, Leventhal's Common Sense Model, and results of focus groups. The aim of this study is to evaluate the effectiveness of the intervention to reduce distress in type 2 diabetes patients who experienced a first ACE.
   Methods: Randomised controlled trial. Two hundred patients are recruited in thirteen hospitals. A diabetes nurse visits the patients in the intervention group (n = 100) at home within three weeks after discharge from hospital, and again after two weeks and two months. The control group (n = 100) receives a consultation by telephone. The primary outcome is diabetes-related distress, measured with the Problem Areas in Diabetes (PAID) questionnaire. Secondary outcomes are well-being, health status, anxiety, depression, HbA1c, blood pressure and lipids. Mediating variables are self-management, self-efficacy and illness representations. Outcomes are measured with questionnaires directly after discharge from hospital and five months later. Biomedical variables are obtained from the records from the primary care physician and the hospital. Differences between groups in change over time are analysed according to the intention-to-treat principle. The Holm-Bonferroni correction is used to adjust for multiplicity.
   Discussion: Type 2 diabetes patients who experience a first ACE need tailored support after discharge from the hospital. This trial will provide evidence on the effectiveness of a supportive intervention in reducing distress in these patients.
C1 [Kasteleyn, Marise J.; Gorter, Kees J.; Stellato, Rebecca K.; Rutten, Guy E. H. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands.
   [Rijken, Mieke] NIVEL, Netherlands Inst Hlth Serv Res, Utrecht, Netherlands.
   [Nijpels, Giel] Vrije Univ Amsterdam, Med Ctr, EMGO Inst, Amsterdam, Netherlands.
RP Kasteleyn, MJ (reprint author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, STR 6-131,POB 85500, NL-3508 GA Utrecht, Netherlands.
EM m.j.kasteleyn@umcutrecht.nl
OI Kasteleyn, Marise/0000-0001-7751-7516
FU Dutch Diabetes Research Foundation [2009.70]
FX This study is funded by the Dutch Diabetes Research Foundation (no:
   2009.70.). We would like to thank Professor K.C.B. Roes for his
   statistical support.
CR Aikens JE, 2012, DIABETES CARE, V35, P2472, DOI 10.2337/dc12-0181
   Bandura A, 1986, SELF EFFICACY SOCIAL
   Bech P, 1996, PSYCHOTHER PSYCHOSOM, V65, P183, DOI 10.1159/000289073
   Beck CA, 2001, AM HEART J, V142, P271, DOI 10.1067/mhj.2001.116758
   Beswick AD, 2005, J ADV NURS, V49, P538, DOI 10.1111/j.1365-2648.2004.03327.x
   Borm GF, 2007, J CLIN EPIDEMIOL, V60, P1234, DOI 10.1016/j.jclinepi.2007.02.006
   Boter H, 2003, BRIT MED J, V327, P284, DOI 10.1136/bmj.327.7409.284
   Buunk A. P., 1996, GEDRAG GEZONDHEID, V24, P304
   Chen SM, 2012, INT J NURS STUD, V49, P637, DOI 10.1016/j.ijnurstu.2011.11.011
   Coffey JT, 2002, DIABETES CARE, V25, P2238, DOI 10.2337/diacare.25.12.2238
   COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037//0033-2909.112.1.155
   de Raaij EJ, 2012, MANUAL THER, V17, P330, DOI 10.1016/j.math.2012.03.001
   De Ridder DTD, 2005, PSYCHOL HEALTH, V20, P497, DOI 10.1080/14768320500098699
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2013, DIABETES CARE, V36, P2551, DOI 10.2337/dc12-2493
   Fonda Stephanie J, 2009, J Diabetes Sci Technol, V3, P117
   Franklin K, 2004, ARCH INTERN MED, V164, P1457, DOI 10.1001/archinte.164.13.1457
   French DP, 2006, J PSYCHOSOM RES, V61, P757, DOI 10.1016/j.jpsychores.2006.07.029
   Gabbay RA, 2006, DIABETES RES CLIN PR, V71, P28, DOI 10.1016/j.diabres.2005.05.002
   Groenwold RHH, 2012, AM J EPIDEMIOL, V175, P210, DOI 10.1093/aje/kwr302
   Hagger MS, 2003, PSYCHOL HEALTH, V18, P141, DOI 10.1080/088704403100081321
   Hasdai D, 2002, EUR HEART J, V23, P1190, DOI 10.1053/euhj.2002.3193
   HOLM S, 1979, SCAND J STAT, V6, P65
   Hunt Caralise W, 2012, Home Healthc Nurse, V30, P255, DOI 10.1097/NHH.0b013e31824c28d2
   Huxley R, 2006, BMJ-BRIT MED J, V332, P73, DOI 10.1136/bmj.38678.389583.7C
   Keogh KM, 2011, AM J MANAG CARE, V17, P105
   Keogh KM, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-36
   Leventhal H, 2008, HDB PSYCHOL HLTH, VVI, P219
   Malmberg K, 2000, CIRCULATION, V102, P1014, DOI 10.1161/01.CIR.102.9.1014
   Marks R, 2005, HEALTH PROMOT PRACT, V6, P37, DOI 10.1177/1524839904266790
   Marks R, 2005, HEALTH PROMOT PRACT, V6, P148, DOI 10.1177/1524839904266792
   Mazzone T, 2008, LANCET, V371, P1800, DOI 10.1016/S0140-6736(08)60768-0
   Miketic JK, 2011, J CARDIOVASC NURS, V26, P210, DOI 10.1097/JCN.0b013e31820017dc
   Miller W. R., 2002, MOTIVATIONAL INTERVI
   Moss-Morris R, 2007, CLIN J PAIN, V23, P558, DOI 10.1097/AJP.0b013e318093fcab
   Nv Ven, 2003, DIABETES CARE, V26, P713
   Peterson Pamela N, 2006, BMC Cardiovasc Disord, V6, P41, DOI 10.1186/1471-2261-6-41
   Petrie KJ, 2007, CURR OPIN PSYCHIATR, V20, P163, DOI 10.1097/YCO.0b013e328014a871
   Petrie KJ, 2002, PSYCHOSOM MED, V64, P580, DOI 10.1097/00006842-200207000-00007
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Preis SR, 2009, CIRCULATION, V120, P212, DOI 10.1161/CIRCULATIONAHA.108.846519
   Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087
   Rollnick S., 2008, MOTIVATIONAL INTERVI
   Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O
   Ryden L, 2007, EUR HEART J, V28, P88, DOI [10.1093/eurheartj/ehl260, 10.1093/eurheartj/ehm124]
   Sarkar U, 2008, PATIENT EDUC COUNS, V70, P102, DOI 10.1016/j.pec.2007.09.008
   Schuz B, 2012, PSYCHOL HEALTH, V27, P13, DOI 10.1080/08870446.2010.541908
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Spinhoven P, 1997, PSYCHOL MED, V27, P363, DOI 10.1017/S0033291796004382
   STRECHER VJ, 1986, HEALTH EDUC QUART, V13, P73, DOI 10.1177/109019818601300108
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Trief P., 2003, FAMILIES SYSTEMS HLT, V21, P57, DOI [DOI 10.1037/H0089502, 10.1037/h0089502]
   Uchmanowicz I, 2013, ACTA DIABETOL, V50, P217, DOI 10.1007/s00592-011-0280-2
   van Jaarsveld CHM, 2001, J AM GERIATR SOC, V49, P1052, DOI 10.1046/j.1532-5415.2001.49208.x
   Vandelanotte C., 2005, J PHYS ACT HEALTH, V2, P63, DOI [10.1123/jpah.2.1.63, DOI 10.1123/JPAH.2.1.63]
   Verges B, 2004, DIABETIC MED, V21, P889, DOI 10.1111/j.1464-5491.2004.01262.x
   Vickers AJ, 2001, BMJ-BRIT MED J, V323, P1123, DOI 10.1136/bmj.323.7321.1123
   Watkins KW, 2000, DIABETES CARE, V23, P1511, DOI 10.2337/diacare.23.10.1511
   Welch G, 2003, DIABETIC MED, V20, P69, DOI 10.1046/j.1464-5491.2003.00832.x
   Welch G, 1994, HDB PSYCHOL DIABETES, P400
   Wermeling PR, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-121
   Zulman DM, 2012, PATIENT EDUC COUNS, V87, P74, DOI 10.1016/j.pec.2011.07.013
NR 62
TC 4
Z9 4
U1 1
U2 16
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1758-5996
J9 DIABETOL METAB SYNDR
JI Diabetol. Metab. Syndr.
PD JAN 18
PY 2014
VL 6
AR 5
DI 10.1186/1758-5996-6-5
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AB9FP
UT WOS:000332096400001
PM 24438342
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Dismuke, CE
   Hernandez-Tejada, MA
   Egede, LE
AF Dismuke, Clara E.
   Hernandez-Tejada, Melba A.
   Egede, Leonard E.
TI RELATIONSHIP OF SERIOUS PSYCHOLOGICAL DISTRESS TO QUALITY OF LIFE IN
   ADULTS WITH DIABETES
SO INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE
LA English
DT Article
DE serious psychological distress; quality of life; diabetes; SF-12
ID FACTOR SURVEILLANCE SYSTEM; MAJOR DEPRESSIVE DISORDER; US ADULTS;
   UNITED-STATES; RISK-FACTORS; PREVALENCE; VALIDITY; SCALES
AB Objective: To examine the association between serious psychological distress (SPD) and the Physical and Mental Health components of Quality of Life (QOL) while controlling for depression in a national sample of adults with diabetes. Methods: SPD was assessed in 1,659 adults with diabetes who participated in the 2007 Medical Care Expenditure Survey (MEPS). SPD was measured by the 6-item Kessler scale. Depression was assessed with the PHQ-2 screen. Quality of life was measured with the physical (PCS) and mental (MCS) components of the SF-12. We used multiple linear regression to assess the relationship between SPD and quality of life while controlling for relevant covariates and depression screen results to assess the independent effect of SPD on QOL above and beyond the effect of depression. Results: Among US adults with diabetes, 9% had SPD and 15.4% screened positive for depression. Among those with SPD, 85.8% had depression and among those with depression, 50.5% had SPD. In the adjusted model for socio-demographic factors and comorbidities, SPD was significantly associated with lower PCS scores (-5.51 95% CI -7.55; -3.45) and MCS scores (-18.99 95% CI -20.81; -17.18). In the adjusted model that also controlled for depression, SPD was still significantly associated with lower PCS scores (-3.03 95% CI -5.63; -0.43) and MCS scores (-9.46 95% CI -11.67; -7.24). Conclusions: Among U.S. adults, SPD is associated with significantly diminished QOL above and beyond the effects of depression. Targeted interventions to mitigate the adverse effects of SPD are needed, independent of programs to address depression.
C1 [Dismuke, Clara E.; Egede, Leonard E.] Ralph H Johnson VA Med Ctr, Charleston, SC USA.
   [Dismuke, Clara E.; Hernandez-Tejada, Melba A.; Egede, Leonard E.] Med Univ S Carolina, Charleston, SC 29425 USA.
RP Egede, LE (reprint author), Med Univ S Carolina, Ctr Hlth Dispar Res, 135 Rutledge Ave,Room 280G,POB 250593, Charleston, SC 29425 USA.
EM egedel@musc.edu
FU National Institute for Diabetes, Digestive and Kidney Diseases [K24
   DK093699]
FX Dr. Egede is supported by grant #K24 DK093699 funded by the National
   Institute for Diabetes, Digestive and Kidney Diseases. The manuscript
   represents the views of the authors and not those of the VA or NIH. Dr.
   Leonard E. Egede is the guarantor of this work and, as such, had full
   access to all the data in the study and takes responsibility for the
   integrity of the data and the accuracy of the data analysis.
CR [Anonymous], MED EXP PAN SURV 200
   BRUCE ML, 1994, SOC PSYCH PSYCH EPID, V29, P165
   Center for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET
   Croft JB, 2009, INT J PUBLIC HEALTH, V54, P4, DOI 10.1007/s00038-009-0017-y
   Egede L., 2004, MED CLIN N AM, V90, P627
   Egede LE, 2011, CURRENT PSYCHIAT REP, V14, P15
   Egede LE, 2007, GEN HOSP PSYCHIAT, V29, P409, DOI 10.1016/j.genhosppsych.2007.06.002
   Egede LE, 2010, GEN HOSP PSYCHIAT, V32, P563, DOI 10.1016/j.genhosppsych.2010.08.002
   Egede LE, 2010, DIABETES RES CLIN PR, V87, P302, DOI 10.1016/j.diabres.2010.01.024
   Elliott JO, 2009, SEIZURE-EUR J EPILEP, V18, P332, DOI 10.1016/j.seizure.2008.11.003
   Gonzalez JS, 2011, DIABETES CARE, V34, P236, DOI 10.2337/dc10-1970
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C
   Li C, 2007, DIABETES CARE, V33, P1061, DOI DOI 10.2337/DC09-1515]
   Li CY, 2009, INT J PUBLIC HEALTH, V54, P43, DOI 10.1007/s00038-009-0006-1
   Lincoln KD, 2011, RES SOCIAL WORK PRAC, V21, P278, DOI 10.1177/1049731510386122
   McGuire LC, 2009, INT J PUBLIC HEALTH, V54, P84, DOI 10.1007/s00038-009-0011-4
   McKnight-Eily LR, 2009, INT J PUBLIC HEALTH, V54, P111, DOI 10.1007/s00038-009-0015-0
   Okoro CA, 2009, INT J PUBLIC HEALTH, V54, P52, DOI 10.1007/s00038-009-0077-z
   Oraka E, 2010, CHEST, V137, P609, DOI 10.1378/chest.09-1777
   Pearson WS, 2009, INT J PUBLIC HEALTH, V54, P23, DOI 10.1007/s00038-009-0003-4
   Penninx BWJH, 1998, J NATL CANCER I, V90, P1888, DOI 10.1093/jnci/90.24.1888
   Pratt Laura A, 2007, Adv Data, P1
   Rubin R, 2000, DIABETES SPECTR, V13, P21
   Shih M, 2008, QUAL LIFE RES, V17, P521, DOI 10.1007/s11136-008-9330-9
   Shih M, 2006, J GEN INTERN MED, V21, P1160, DOI 10.1111/j.1525-1497.2006.00573.x
   Shin JK, 2012, DIABETES RES CLIN PR, V95, P406, DOI 10.1016/j.diabres.2011.10.043
   Strine TW, 2009, INT J PUBLIC HEALTH, V54, P9, DOI 10.1007/s00038-009-0001-6
   Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003
NR 29
TC 5
Z9 5
U1 0
U2 6
PU BAYWOOD PUBL CO INC
PI AMITYVILLE
PA 26 AUSTIN AVE, PO BOX 337, AMITYVILLE, NY 11701 USA
SN 0091-2174
EI 1541-3527
J9 INT J PSYCHIAT MED
JI Int. J. Psychiatr. Med.
PY 2014
VL 48
IS 2
BP 135
EP 146
DI 10.2190/PM.48.2.f
PG 12
WC Psychiatry
SC Psychiatry
GA AU5XU
UT WOS:000345677700006
PM 25377154
DA 2019-01-08
ER

PT J
AU Kofahl, C
   Dogan, M
   Dogan, G
   Mnich, E
   von dem Knesebeck, O
AF Kofahl, Christopher
   Dogan, Mustafa
   Dogan, Gulsun
   Mnich, Eva
   von dem Knesebeck, Olaf
TI Quality of life of Turkish type 2 diabetics in Germany and Turkey - a
   comparison between Hamburg and Istanbul
SO ETHNICITY & HEALTH
LA English
DT Article
DE quality of life; WHOQOL; migrants; diabetes; Turkey; Germany; SES;
   education; environment; IADL; functional limitations; social support;
   cross-sectional comparative study
ID PSYCHOMETRIC PROPERTIES; PSYCHOLOGICAL DISTRESS; CARE SERVICES; HEALTH;
   IMMIGRANTS; MIGRANTS; MELLITUS; SWEDEN; WHOQOL; DETERMINANTS
AB Objectives. The analyses address the following research questions: (1) Do Turkish diabetics in Germany and Turkey differ in terms of quality of life? (2) If yes, can these differences (in part) be explained by social factors (age, gender, education, household size), functional limitations and availability of support? (3) Are social factors, functional limitations and availability of support differently associated with quality of life among Turkish diabetics in Germany and Turkey?
   Design. For this comparative cross-sectional study, 111 patients with type 2 diabetes were personally interviewed in Istanbul (Turkey) and 294 Turkish patients in Hamburg (Germany). For quality of life measurement we have used the Turkish version of the WHOQOL-Bref-26. Sociodemographics included age, sex, education and householdsize. Health related functional limitations were assessed on the basis of an index of (instrumental) activities of daily living including the availability of help. Statistical analyses were conducted on group comparisons with Chi-square-and T-tests as well as linear regressions.
   Results. There are no significant differences between Turkish diabetics in Germany and Turkey in the physical and the psychological dimensions of the WHOQOL-Bref. However, in the WHOQOL-domains 'social QoL' and ` environmental QoL' Turkish diabetics living in Hamburg have a significantly better quality of life than their counterparts in Istanbul. These differences cannot be explained by individual sociodemographic factors, functional limitations and availability of support. Furthermore, we found much stronger positive associations between education and quality of life in Istanbul than in Hamburg.
   Conclusion. Beyond strong similarities between the two samples in sociodemographics, physical and mental health the social and environmental quality of life was significantly assessed better by the Turkish diabetics living in Hamburg. This is most likely an effect of public investment in social security, infrastructure and health care which is also influencing the decision as to where to spend life in retirement.
C1 [Kofahl, Christopher; Mnich, Eva; von dem Knesebeck, Olaf] Univ Med Ctr Hamburg Eppendorf, Dept Med Sociol, Hamburg, Germany.
   [Dogan, Mustafa; Dogan, Gulsun] Afyon Kocatepe Univ, Tip Fak, Guz Hastaliklari Anabilim Dali, Afyon, Turkey.
RP Kofahl, C (reprint author), Univ Med Ctr Hamburg Eppendorf, Dept Med Sociol, Hamburg, Germany.
EM kofahl@uke.de
FU German Federal Ministry of Education and Research [01GX0749]; project
   'Health literacy of Turkish immigrants with diabetes 2 related to course
   of disease, health care, socioeconomic status and integration'
   [02/2008-09/2011]
FX The study in Hamburg was undertaken as part of the project 'Health
   literacy of Turkish immigrants with diabetes 2 related to course of
   disease, health care, socioeconomic status and integration'
   (02/2008-09/2011). The project was funded by the German Federal Ministry
   of Education and Research [01GX0749]. We also like to thank the two
   anonymous reviewers for their engaged comments and helpful advice in the
   progress of this paper.
CR Akbiyik DI, 2008, EUR PSYCHIAT, V23, pS4, DOI 10.1016/S0924-9338(08)70055-5
   BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037//0022-3514.51.6.1173
   Baykara-Krumme H, 2006, ALTWERDEN DEUTSCHLAN, P447
   Bayram N, 2007, QUAL LIFE RES, V16, P1319, DOI 10.1007/s11136-007-9249-6
   Bien B, 2013, EUR J PUBLIC HEALTH, V23, P1032, DOI 10.1093/eurpub/cks190
   Bradley DE, 2010, J AGING HEALTH, V22, P882, DOI 10.1177/0898264310368430
   Chu Nancy, 2010, J Cult Divers, V17, P105
   DESTATIS, 2012, BEV ERW BEV MIGR ERG, V2.2
   DESTATIS, 2013, DESTATIS FACHSERIE
   Di Rosa M, 2011, GEROPSYCH, V24, P5, DOI 10.1024/1662-9647/a000031
   Dundar P., 2002, HIPPOKRATIA, V6, P37
   Eisenman DP, 2003, JAMA-J AM MED ASSOC, V290, P627, DOI 10.1001/jama.290.5.627
   Eser E., 1999, PSIKIYATRI PSIKOLOJI, V7, P23
   Fassaert T, 2011, INT J SOC PSYCHIATR, V57, P132, DOI 10.1177/0020764009103647
   Harper A, 1998, PSYCHOL MED, V28, P551
   Hohne A., 2008, ETABLIERUNG WEITEREN, V55, P103
   Kocken PL, 2008, PATIENT EDUC COUNS, V70, P25, DOI 10.1016/j.pec.2007.09.016
   Kofahl C, 2013, GESUNDHEITSWESEN, V75, P803, DOI 10.1055/s-0033-1334936
   Koochek A, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-60
   Laube H, 2001, DIABETES STOFFWECH H, V10, P51
   Gonzalez-Castro JL, 2011, INT J SOC PSYCHIATR, V57, P30, DOI 10.1177/0020764010347336
   Mladovsky P, 2012, HEALTH POLICY, V105, P1, DOI 10.1016/j.healthpol.2012.01.007
   Nielsen SS, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-210
   Norredam M, 2010, EUR J PUBLIC HEALTH, V20, P555, DOI 10.1093/eurpub/ckp195
   Ozcan V., 2006, LEBENSSITUATION GESU, P7
   Parmakerli-Czemmel B, 2007, DIABETOL STOFFWECHS, V2, P46, DOI 10.1055/s-2007-960524
   Power M, 1998, SOC SCI MED, V46, P1569
   Satman I, 2002, DIABETES CARE, V25, P1551, DOI 10.2337/diacare.25.9.1551
   Sin MK, 2011, J GERONTOL NURS, V37, P43, DOI 10.3928/00989134-20100930-02
   Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00
   Sujoldzic A, 2006, COLLEGIUM ANTROPOL, V30, P703
   Taloyan M, 2008, NORD J PSYCHIAT, V62, P392, DOI 10.1080/08039480801984263
   Tinghog P, 2010, INT J SOC PSYCHIATR, V56, P74, DOI 10.1177/0020764008096163
   Wandell PE, 2003, DIABETES METAB, V29, P435, DOI 10.1016/S1262-3636(07)70057-5
   WHO, 1948, OFF REC WHO
NR 35
TC 4
Z9 4
U1 1
U2 13
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1355-7858
EI 1465-3419
J9 ETHNIC HEALTH
JI Ethn. Health
PY 2014
VL 19
IS 6
BP 617
EP 630
DI 10.1080/13557858.2014.885932
PG 14
WC Ethnic Studies; Public, Environmental & Occupational Health
SC Ethnic Studies; Public, Environmental & Occupational Health
GA AP7VH
UT WOS:000342285000003
PM 24517236
DA 2019-01-08
ER

PT J
AU Brewer, C
   de Jong, C
   Williams, J
AF Brewer, Colin
   de Jong, Catherine
   Williams, Jonathan
TI Rapid opiate detoxification and antagonist induction under general
   anaesthesia or intravenous sedation is humane, sometimes essential and
   should always be an option. Three illustrative case reports involving
   diabetes and epilepsy and a review of the literature
SO JOURNAL OF PSYCHOPHARMACOLOGY
LA English
DT Review
DE Naltrexone; heroin; opiate; detoxification; antagonist; sedation;
   anaesthesia; diabetes; epilepsy; withdrawal
ID RANDOMIZED CONTROLLED-TRIAL; NALTREXONE-ACCELERATED DETOXIFICATION;
   ULTRARAPID OPIOID DETOXIFICATION; ABSTINENCE RATES; HEROIN-ADDICTS;
   PRECIPITATED WITHDRAWAL; MAINTENANCE TREATMENT; DEPENDENCE; METHADONE;
   MORTALITY
AB When abstinence is an appropriate goal, controlled studies and systematic reviews confirm that rapid, antagonist-precipitated opiate withdrawal procedures are the most effective and cost effective methods of initiating abstinence, and naltrexone (NTX) maintenance. While 'rapid' withdrawal, better conceptualised as Rapid Antagonist Induction (RAI), can often be humanely achieved with modest sedation levels, we present three case histories to support our argument that for some patients, general anaesthesia (GA), or techniques of intravenous sedation (IVS) that approach GA, are essential for safety and success. This includes patients with intercurrent disease (e.g. epilepsy or insulin-dependent diabetes) but also those with severe withdrawal phobia after previous distressing experiences. We discuss the history of the procedure. The dangers of RAI under GA or IVS in experienced hands have been exaggerated and the appropriate expertise should be more easily available. Patients and clinicians readily accept risks of major surgery for the excessive intake of food that causes most obesity. Similar risk-acceptance exists in cosmetic surgery and obstetrics. The increasing use and effectiveness of long-acting implants or depot-injections of NTX for relapse-prevention have largely solved compliance problems that undermined the potential of oral NTX. Their ability to prevent opiate overdose in abstinent, non-tolerant patients also strengthens arguments both for offering RAI as a therapeutic option and for reducing psychological, professional and practical barriers to using it.
C1 [Brewer, Colin] Stapleford Ctr, London SW1W 9NP, England.
   [Williams, Jonathan] Brighton & Sussex Univ Hosp, Brighton, E Sussex, England.
RP Brewer, C (reprint author), Stapleford Ctr, 25a Eccleston St, London SW1W 9NP, England.
EM brewerismo@gmail.com
CR Ali R, 2003, DRUG ALCOHOL REV, V22, P425, DOI 10.1080/09595230310001613949
   Arbous MS, 2005, ANESTHESIOLOGY, V102, P257, DOI 10.1097/00000542-200502000-00005
   Armstrong J, 2003, ACAD EMERG MED, V10, P860, DOI 10.1197/aemj.10.8.860
   Arnold-Reed Diane E, 2005, J Opioid Manag, V1, P17
   Bainbridge D, 2012, LANCET, V380, P1075, DOI 10.1016/S0140-6736(12)60990-8
   Ballantyne GH, 2008, OBES SURG, V18, P660, DOI 10.1007/s11695-007-9357-y
   Beaini AY, 2000, ADDICT BIOL, V5, P451, DOI 10.1111/j.1369-1600.2000.tb00215.x
   Bell JR, 1999, MED J AUSTRALIA, V171, P26
   BLACHLY P, 1975, DEV FIELD DRUG ABUSE, P327
   BREWER C, 1988, BRIT J PSYCHIAT, V153, P340, DOI 10.1192/bjp.153.3.340
   Brewer C, 1997, ADDICT BIOL, V2, P291, DOI 10.1080/13556219772589
   Brewer C, 1998, LANCET, V351, P218, DOI 10.1016/S0140-6736(05)78171-X
   Brewer C, 2000, CNS DRUGS, V14, P329, DOI 10.2165/00023210-200014050-00001
   Brewer C, 1999, REV ESP DROGODEPENDE, V24, P426
   Brewer C, 2009, CONT NEUROSCIENCE SE
   Brewer C, 2003, ADICCIONES, V4, P299
   Brewer C, 1989, WELLINGTON HOSP  JUL, P4
   Carreno J. E., 1997, ACT 24 JORN NAC SOC, P607
   Carreno JE, 2002, ADDICT BIOL, V7, P243, DOI 10.1080/135562102200120479
   Carreno JE, 2003, ADDICT BIOL, V8, P429, DOI 10.1080/13556210310001646402
   Chan K Y, 1996, J Clin Forensic Med, V3, P87, DOI 10.1016/S1353-1131(96)90012-7
   CHARNEY DS, 1982, ARCH GEN PSYCHIAT, V39, P1327
   Collins ED, 2005, JAMA-J AM MED ASSOC, V294, P903, DOI 10.1001/jama.294.8.903
   Cornish JW, 1997, J SUBST ABUSE TREAT, V14, P529, DOI 10.1016/S0740-5472(97)00020-2
   Currie J, 2000, RAPID INDUCTION ONTO
   Day E, 2011, J SUBST ABUSE TREAT, V40, P56, DOI 10.1016/j.jsat.2010.08.007
   De Jong CAJ, 2005, ADDICTION, V100, P206, DOI 10.1111/j.1360-0443.2004.00959.x
   de Jong CJ, 2006, JAMA-J AM MED ASSOC, V295, P887, DOI 10.1001/jama.295.8.887-a
   De Jong CJ, 2005, ADDICTION, V100, P1742, DOI 10.1111/j.1360-0443.2005.01267.x
   De Jong CAJ, 2007, AM J ADDICTION, V16, P124, DOI 10.1080/10550490601184472
   Digiusto E, 2004, ADDICTION, V99, P450, DOI 10.1111/j.1360-0443.2004.00654.x
   Eklund C, 1996, WITHDRAWAL METHADONE, P9
   Escalante-Tattersfield T, 2008, SURG OBES RELAT DIS, V4, P126, DOI 10.1016/j.soard.2007.12.015
   FISHBAIN DA, 1988, J CLIN PSYCHOPHARM, V8, P441, DOI 10.1097/00004714-198812000-00018
   Floch-Tudal C, 2000, ANN MED INTERNE, V151, pB30
   Foster J, 2003, ADDICT BIOL, V8, P211, DOI 10.1080/1355621031000117446
   Foster J, 1999, ADDICT BIOL, V4, P232
   GERRA G, 1995, J SUBST ABUSE TREAT, V12, P35, DOI 10.1016/0740-5472(94)00077-8
   GOLZ J, 2000, SUCHTTHERAPIE, V1, P166
   GOSSOP M, 1991, BRIT J PSYCHIAT, V158, P697, DOI 10.1192/bjp.158.5.697
   Gossop M, 2000, BRIT J PSYCHIAT, V177, P262, DOI 10.1192/bjp.177.3.262
   Gowing L, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002022.pub3
   Greenberg M, 2000, J ADDICT DIS, V19, P53, DOI 10.1300/J069v19n04_05
   Hamilton RJ, 2002, ACAD EMERG MED, V9, P63, DOI 10.1111/j.1553-2712.2002.tb01169.x
   Hankins GDV, 2006, SEMIN PERINATOL, V30, P276, DOI 10.1053/j.semperi.2006.07.009
   Home Office Drug Strategy, 2010, RED DEM RESTR SUPPL
   Horspool MJ, 2008, EUR ADDICT RES, V14, P179, DOI 10.1159/000141641
   Hulse GK, 2009, ARCH GEN PSYCHIAT, V66, P1108, DOI 10.1001/archgenpsychiatry.2009.130
   Hulse GK, 2005, DRUG ALCOHOL DEPEN, V79, P351, DOI 10.1016/j.drugalcdep.2005.02.009
   Hulse GK, 2004, ADDICT BIOL, V9, P59, DOI 10.1080/13556210410001674103
   Hulse GK, 2003, ADDICT BIOL, V8, P337, DOI 10.1080/13556210310001602257
   Jorgensen CH, 2011, ALCOHOL CLIN EXP RES, V35, P1749, DOI 10.1111/j.1530-0277.2011.01523.x
   KOSTEN TA, 1989, AM J DRUG ALCOHOL AB, V15, P237, DOI 10.3109/00952998908993405
   Krabbe PFM, 2003, ADDICT BIOL, V8, P351, DOI 10.1080/13556210310001602275
   Krupitsky EM, 2004, J SUBST ABUSE TREAT, V26, P285, DOI 10.1016/j.jsat.2004.02.002
   Krupitsky E, 2012, ARCH GEN PSYCHIAT, V69, P973, DOI 10.1001/archgenpsychiatry.2012.1a
   Kunoe N, 2009, BRIT J PSYCHIAT, V194, P541, DOI 10.1192/bjp.bp.108.055319
   Laheij RJF, 2000, JAMA-J AM MED ASSOC, V283, P1143, DOI 10.1001/jama.283.9.1143
   LEGARDA JJ, 1994, DRUG ALCOHOL DEPEN, V35, P91, DOI 10.1016/0376-8716(94)90115-5
   Li G, 2009, ANESTHESIOLOGY, V110, P759, DOI 10.1097/ALN.0b013e31819b5bdc
   LOIMER N, 1989, J PSYCHIAT RES, V23, P81, DOI 10.1016/0022-3956(89)90020-4
   Madlung-Kratzer E, 2009, ADDICTION, V104, P1549, DOI 10.1111/j.1360-0443.2009.02653.x
   McGregor C, 2002, DRUG ALCOHOL DEPEN, V68, P5, DOI 10.1016/S0376-8716(02)00077-7
   McKeganey N, 2004, DRUG-EDUC PREV POLIC, V11, P423, DOI 10.1080/09687630410001723229
   MILBY JB, 1986, AM J PSYCHIAT, V143, P739
   MUNOZ E, 1988, PLAST RECONSTR SURG, V82, P116, DOI 10.1097/00006534-198882010-00021
   National Institute for Clinical Excellence. (NICE), 2008, DRUG MIS OP DET NICE, P122
   Oliver P, 2005, ADDICTION, V100, P560, DOI 10.1111/j.1360-0443.2005.01020.x
   Pfab R, 1999, J TOXICOL-CLIN TOXIC, V37, P43, DOI 10.1081/CLT-100102407
   RESNICK RB, 1977, CLIN PHARMACOL THER, V21, P409
   SENFT RA, 1991, J SUBST ABUSE TREAT, V8, P257, DOI 10.1016/0740-5472(91)90048-F
   Seoane A, 1997, BRIT J PSYCHIAT, V171, P340, DOI 10.1192/bjp.171.4.340
   Shanahan MD, 2005, ADDICT BEHAV, V20
   Sigmon SC, 2012, AM J DRUG ALCOHOL AB, V38, P187, DOI 10.3109/00952990.2011.653426
   Stella L, 2005, LIFE SCI, V77, P2717, DOI 10.1016/j.lfs.2005.05.036
   Strang J, 2005, BRIT J GEN PRACT, V55, P444
   Strang J, 2003, BRIT MED J, V326, P959, DOI 10.1136/bmj.326.7396.959
   Tait RJ, 2008, J SUBST ABUSE TREAT, V35, P116, DOI 10.1016/j.jsat.2007.08.014
   Waal Helge, 2003, Tidsskr Nor Laegeforen, V123, P1660
   Weiss RD, 2011, ARCH GEN PSYCHIAT, V68, P1238, DOI 10.1001/archgenpsychiatry.2011.121
NR 80
TC 0
Z9 0
U1 1
U2 2
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0269-8811
EI 1461-7285
J9 J PSYCHOPHARMACOL
JI J. Psychopharmacol.
PD JAN
PY 2014
VL 28
IS 1
BP 67
EP 75
DI 10.1177/0269881113504835
PG 9
WC Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry
SC Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry
GA AJ8RJ
UT WOS:000337974400009
PM 24043724
DA 2019-01-08
ER

PT J
AU Wycherley, TP
   Clifton, PM
   Noakes, M
   Brinkworth, GD
AF Wycherley, Thomas Philip
   Clifton, Peter Marshall
   Noakes, Manny
   Brinkworth, Grant David
TI Weight loss on a structured hypocaloric diet with or without exercise
   improves emotional distress and quality of life in overweight and obese
   patients with type 2 diabetes
SO JOURNAL OF DIABETES INVESTIGATION
LA English
DT Article
DE Lifestyle intervention; Well-being; Caloric restriction
ID HIGH-PROTEIN DIET; LOW-CARBOHYDRATE; BODY-COMPOSITION; MELLITUS; IMPACT
AB Aims/IntroductionTo evaluate the effects of a caloric restricted weight loss program with or without supervised resistance exercise training (EX) on diabetes-related emotional distress and quality of life (QOL) in overweight and obese patients with type2 diabetes.
   Materials and MethodsIn a parallel design, 106 men and women with type2 diabetes were randomized to a prescriptive 16-week caloric restricted diet (D; 6,000-7,000kJ/day), with (n=65) or without (n=41) EX (three times per week). Bodyweight, glycated hemoglobin, diabetes-specific emotional distress (Problem Areas in Diabetes [PAID] questionnaire) and QOL (Diabetes-39 [D-39] questionnaire) was assessed pre- and post-intervention.
   ResultsA total of 84 participants completed the study (D n=33, D+EX n=51). Weight loss was significantly greater in D+EX compared with D (-11.45.8 vs -8.8 +/- 5.8kg, P=0.04 timexdiet). Overall, there were significant improvements in glycated hemoglobin, PAID total score and the D-39 dimensions of diabetes control', anxiety and worry', sexual functioning', energy and mobility', overall rating of QOL' and severity of diabetes' (P0.01 for time). The D-39 dimension, social burden', did not change (P=0.07 for time). There was no difference between groups in the response for any of these variables (P0.10).
   ConclusionA structured caloric restricted diet with or without EX improves emotional distress and QOL in overweight and obese patients with type 2 diabetes. This trial was registered with Australian New Zealand Clinical Trials Registry (; ACTR No: ACTRN12608000206325).
C1 [Wycherley, Thomas Philip] Univ S Australia, Div Hlth Sci, Sansom Inst Hlth Res, Adelaide, SA 5001, Australia.
   [Clifton, Peter Marshall] Baker IDI Heart & Diabet Inst, Adelaide, SA, Australia.
   [Noakes, Manny; Brinkworth, Grant David] Commonwealth Sci & Ind Res Org, Anim Food & Hlth Sci, Preventat Hlth Flagship, Adelaide, SA, Australia.
RP Brinkworth, GD (reprint author), Commonwealth Sci & Ind Res Org, Anim Food & Hlth Sci, Preventat Hlth Flagship, Adelaide, SA, Australia.
EM grant.brinkworth@csiro.au
RI Biguzzi, Felipe/E-4724-2015; noakes, manny/H-2813-2013; Clifton,
   Peter/F-4446-2013
OI Clifton, Peter/0000-0002-6411-626X; Brinkworth,
   Grant/0000-0001-9017-8395
FU Heart Foundation; Diabetes Australia Research Trust
FX This work was supported with project grants from the Heart Foundation
   and the Diabetes Australia Research Trust. George Weston Foods donated
   food for this study. None of the funding agencies played a role in the
   conception, design or conduct of the study, collection, management,
   analysis and interpretation of the data; or preparation, review and
   approval of the manuscript.
CR Boyer JG, 1997, MED CARE, V35, P440, DOI 10.1097/00005650-199705000-00003
   Bradley C, 2002, DIABETES METAB RES, V18, pS64, DOI 10.1002/dmrr.279
   Colberg Sheri R, 2010, Diabetes Care, V33, pe147, DOI 10.2337/dc10-9990
   Davis NJ, 2012, DIABETES EDUCATOR, V38, P250, DOI 10.1177/0145721711436132
   Fine JT, 1999, JAMA-J AM MED ASSOC, V282, P2136, DOI 10.1001/jama.282.22.2136
   Fontaine KR, 1999, QUAL LIFE RES, V8, P275, DOI 10.1023/A:1008835602894
   Garratt AM, 2002, DIABETIC MED, V19, P1, DOI 10.1046/j.1464-5491.2002.00650.x
   Gillison FB, 2009, SOC SCI MED, V68, P1700, DOI 10.1016/j.socscimed.2009.02.028
   Halyburton AK, 2007, AM J CLIN NUTR, V86, P580
   Huang IC, 2008, VALUE HEALTH, V11, P450, DOI 10.1111/j.1524-4733.2007.00261.x
   KAPLAN RM, 1987, J GEN INTERN MED, V2, P220, DOI 10.1007/BF02596443
   Kaukua JK, 2004, INT J OBESITY, V28, P600, DOI 10.1038/sj.ijo.0802591
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O
   Scully D, 1998, BRIT J SPORT MED, V32, P111, DOI 10.1136/bjsm.32.2.111
   Thomson RL, 2010, FERTIL STERIL, V94, P1812, DOI 10.1016/j.fertnstert.2009.11.001
   Wadden TA, 1996, AM J CLIN NUTR, V63, P461, DOI 10.1093/ajcn/63.3.461
   Watkins K, 2004, PHARMACOECONOMICS, V22, P1109, DOI 10.2165/00019053-200422170-00002
   Welch G, 2003, DIABETIC MED, V20, P69, DOI 10.1046/j.1464-5491.2003.00832.x
   Williamson DA, 2009, ARCH INTERN MED, V169, P163, DOI 10.1001/archinternmed.2008.544
   Wycherley TP, 2010, DIABETES OBES METAB, V12, P1097, DOI 10.1111/j.1463-1326.2010.01307.x
   Wycherley TP, 2010, DIABETES CARE, V33, P969, DOI 10.2337/dc09-1974
NR 22
TC 11
Z9 12
U1 1
U2 16
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2040-1124
J9 J DIABETES INVEST
JI J. Diabetes Investig.
PD JAN
PY 2014
VL 5
IS 1
BP 94
EP 98
DI 10.1111/jdi.12120
PG 5
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AA6HC
UT WOS:000331198400017
PM 24843744
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Miller, JL
   Linville, TD
   Dykens, EM
AF Miller, Jennifer L.
   Linville, Tiffany D.
   Dykens, Elisabeth M.
TI Effects of metformin in children and adolescents with Prader-Willi
   syndrome and early-onset morbid obesity: a pilot study
SO JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM
LA English
DT Article
DE metformin; obesity; Prader-Willi syndrome
ID BODY-MASS INDEX; INSULIN SENSITIVITY; METABOLIC SYNDROME; SYNDROME PWS;
   DIABETES-MELLITUS; BRAIN; RESISTANCE; HYPERPHAGIA; DYSFUNCTION;
   PREVENTION
AB Prader-Willi syndrome (PWS) is one of the most commonly recognized causes of early-onset childhood obesity. Individuals with PWS have significant hyperphagia and decreased recognition of satiety. The exact etiology of the hyperphagia remains unknown and, therefore, untreatable. We conducted a pilot, open-label study of response to metformin in 21 children with PWS and six with early morbid obesity (EMO). Participants had significant insulin resistance and glucose intolerance on oral glucose tolerance testing (OGTT) and were started on metformin for these biochemical findings. We administered the Hyperphagia Questionnaire to parents of patients before and after starting metformin treatment. Both the PWS and EMO groups showed significant improvements in food-related distress, anxiety, and ability to be redirected away from food on the Hyperphagia Questionnaire. In the PWS group, improvements were predominantly seen in females. Within the PWS group, responders to metformin had higher 2-h glucose levels on OGTT (7.48 mmol/L vs. 4.235 mmol/L; p=0.003) and higher fasting insulin levels (116 pmol/L vs. 53.5 pmol/L; p=0.04). Additionally, parents of 5/13 individuals with PWS and 5/6 with EMO reported that their child was able to feel full while on metformin (for many this was the first time they had ever described a feeling of fullness). Metformin may improve sense of satiety and decrease anxiety about food in some individuals with PWS and EMO. Positive response to metformin may depend on the degree of hyperinsulinism and glucose intolerance. Nonetheless, the results of this pilot study bear further investigation.
C1 [Miller, Jennifer L.] Univ Florida, Dept Pediat, Div Endocrinol, Gainesville, FL 32610 USA.
   [Linville, Tiffany D.] Univ Florida, Dept Pediat, Gainesville, FL USA.
   [Dykens, Elisabeth M.] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA.
RP Miller, JL (reprint author), Univ Florida, Dept Pediat, Div Endocrinol, Gainesville, FL 32610 USA.
EM millejl@peds.ufl.edu
FU NIDDK NIH HHS [K23 DK081203]
CR Adam CL, 2010, INT J OBESITY, V34, P980, DOI 10.1038/ijo.2010.28
   Adler-Wailes DC, 2013, J CLIN ENDOCR METAB, V98, P1676, DOI 10.1210/jc.2012-3817
   Aubert G, 2011, METABOLISM, V60, P327, DOI 10.1016/j.metabol.2010.02.007
   Banks WA, 2012, ENDOCRINOLOGY, V153, P4111, DOI 10.1210/en.2012-1435
   Bizzarri C, 2010, EUR J ENDOCRINOL, V162, P499, DOI 10.1530/EJE-09-1033
   Butler MG, 2008, AM J MED GENET A, V146A, P854, DOI 10.1002/ajmg.a.32249
   Cassidy SB, 2009, EUR J HUM GENET, V17, P3, DOI 10.1038/ejhg.2008.165
   Chan NN, 1998, J ROY SOC MED, V91, P598, DOI 10.1177/014107689809101116
   Davies W, 2008, FRONT NEUROENDOCRIN, V29, P413, DOI 10.1016/j.yfrne.2007.12.001
   Debette S, 2010, ANN NEUROL, V68, P136, DOI 10.1002/ana.22062
   Dykens EM, 2007, OBESITY, V15, P1816, DOI 10.1038/oby.2007.216
   Freemark M, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.4.e55
   Garfield AS, 2012, ENDOCRINOLOGY, V153, P4600, DOI 10.1210/en.2012-1282
   Goldstone AP, 2006, PROG BRAIN RES, V153, P57, DOI 10.1016/S0079-6123(06)53033-1
   Haqq AM, 2008, CLIN ENDOCRINOL, V69, P911, DOI 10.1111/j.1365-2265.2008.03385.x
   Haqq AM, 2007, CLIN ENDOCRINOL, V67, P944, DOI 10.1111/j.1365-2265.2007.02991.x
   Haqq AM, 2011, J CLIN ENDOCR METAB, V96, pE225, DOI 10.1210/jc.2010-1733
   Hirsch HJ, 2009, J CLIN ENDOCR METAB, V94, P2262, DOI 10.1210/jc.2008-2760
   Holsen LM, 2012, INT J OBESITY, V36, P638, DOI 10.1038/ijo.2011.204
   Holsen LM, 2009, INT J OBESITY, V33, P273, DOI 10.1038/ijo.2008.255
   Holsen LM, 2006, OBESITY, V14, P1028, DOI 10.1038/oby.2006.118
   Karmi A, 2010, DIABETES, V59, P2171, DOI 10.2337/db09-0138
   Kennedy L, 2006, INT J OBESITY, V30, P382, DOI 10.1038/sj.ijo.0803115
   Kim F, 2008, ARTERIOSCL THROM VAS, V28, P1982, DOI 10.1161/ATVBAHA.108.169722
   Li JJ, 2012, PHARMACOL BIOCHEM BE, V101, P564, DOI 10.1016/j.pbb.2012.03.002
   Luchsinger JA, 2010, J ALZHEIMERS DIS, V20, P723, DOI 10.3233/JAD-2010-091687
   Lv WS, 2012, BRAIN RES, V1444, P11, DOI 10.1016/j.brainres.2012.01.028
   McNeilly AD, 2011, BEHAV BRAIN RES, V217, P134, DOI 10.1016/j.bbr.2010.10.017
   Miller J, 2006, J PEDIATR-US, V149, P192, DOI 10.1016/j.jpeds.2006.04.013
   Miller JL, 2007, J NEUROL NEUROSUR PS, V78, P615, DOI 10.1136/jnnp.2006.099044
   Newall H, 2012, INT CLIN PSYCHOPHARM, V27, P69, DOI 10.1097/YIC.0b013e32834d0a5b
   PIMENTEL GD, 2012, METABOLISM, V62, P171
   Proto C, 2007, METABOLISM, V56, P1076, DOI 10.1016/j.metabol.2007.03.016
   Ring LE, 2010, J CLIN INVEST, V120, P2931, DOI 10.1172/JCI41985
   Roth CL, 2010, J PEDIATR ENDOCR MET, V23, P1299, DOI 10.1515/jpem.2010.204
   Schmidt F, 2012, EXP CLIN ENDOCR DIAB, V120, P579, DOI 10.1055/s-0032-1306330
   Schrander-Stumpel CTRM, 2004, AM J MED GENET A, V124A, P333, DOI 10.1002/ajmg.a.20371
   Segura B, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-64
   Stark R, 2013, MOL CELL ENDOCRINOL, V366, P215, DOI 10.1016/j.mce.2012.06.012
   Thompson JA, 2011, SEMIN REPROD MED, V29, P211, DOI 10.1055/s-0031-1275522
   Viollet B, 2011, HANDB EXP PHARMACOL, V203, P303, DOI 10.1007/978-3-642-17214-4_13
   Yau PL, 2010, DIABETOLOGIA, V53, P2298, DOI 10.1007/s00125-010-1857-y
   Yau PL, 2012, PEDIATRICS, V130, pE856, DOI 10.1542/peds.2012-0324
   Zhang YY, 2012, MOL CELL BIOCHEM, V368, P69, DOI 10.1007/s11010-012-1344-5
NR 44
TC 8
Z9 9
U1 3
U2 24
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0334-018X
EI 2191-0251
J9 J PEDIATR ENDOCR MET
JI J. Pediatr. Endocrinol. Metab.
PD JAN
PY 2014
VL 27
IS 1-2
BP 23
EP 29
DI 10.1515/jpem-2013-0116
PG 7
WC Endocrinology & Metabolism; Pediatrics
SC Endocrinology & Metabolism; Pediatrics
GA 296EW
UT WOS:000330168900006
PM 23893676
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Rogers, EA
   Hessler, DM
   Bodenheimer, TS
   Ghorob, A
   Vittinghoff, E
   Thom, DH
AF Rogers, Elizabeth A.
   Hessler, Danielle M.
   Bodenheimer, Thomas S.
   Ghorob, Amireh
   Vittinghoff, Eric
   Thom, David H.
TI Diabetes Peer Coaching Do "Better Patients" Make Better Coaches?
SO DIABETES EDUCATOR
LA English
DT Article
ID RANDOMIZED CONTROLLED-TRIAL; SELF-MANAGEMENT; SCREENING INSTRUMENT;
   GLYCEMIC CONTROL; DISTRESS SCALE; RISK-FACTORS; ADHERENCE; SUPPORT; CARE
AB Purpose The purpose of this study was to identify characteristics of peer coaches associated with improvement in diabetes control among low-income patients with type 2 diabetes.
   Methods Low-income patients with type 2 diabetes who spoke English or Spanish from 6 urban clinics in San Francisco, California, were invited to participate in the study. Twenty participants received training and provided peer coaching to 109 patients over a 6-month peer coaching intervention. Primary outcome was average change in patient glycosylated hemoglobin (A1C). Characteristics of peer coaches included age, gender, years with diabetes, A1C, body mass index (BMI), levels of diabetes-related distress, self-efficacy in diabetes self-management, and depression.
   Results Patient improvement in A1C was associated with having a coach with a lower sense of self-efficacy in diabetes management (P < .001), higher level of diabetes-related distress (P = .01), and lower depression score (P = .03).
   Conclusions Coach characteristics are associated with patient success in improving A1C. Better levels of coach diabetes self-efficacy and distress were not helpful and, in fact, were associated with less improvement in patient A1C, suggesting that some coach uncertainty about his or her own diabetes might foster improved patient self-management. These coach characteristics should be considered when recruiting peer coaches.
C1 [Rogers, Elizabeth A.] Univ Calif San Francisco, Div Gen Internal Med, San Francisco, CA 94143 USA.
   [Rogers, Elizabeth A.] Univ Calif San Francisco, Div Gen Pediat, San Francisco, CA 94143 USA.
   [Rogers, Elizabeth A.] Univ Minnesota, Div Gen Internal Med, Minneapolis, MN 55414 USA.
   [Rogers, Elizabeth A.] Div Gen Pediat & Adolescent Hlth, Minneapolis, MN USA.
   [Hessler, Danielle M.; Bodenheimer, Thomas S.; Ghorob, Amireh; Thom, David H.] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA.
   [Vittinghoff, Eric] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.
RP Rogers, EA (reprint author), Univ Minnesota, Div Gen Internal Med, Appl Clin Res Program, Room 166,717 Delaware St SE, Minneapolis, MN 55414 USA.
EM earogers@umn.edu
RI Rogers, Elizabeth/I-2042-2015
OI Rogers, Elizabeth/0000-0002-4819-7178
FU American Academy of Family Physicians; NRSA [T32 HP19025]
FX The randomized controlled trial generating the cohort in this study was
   funded by the American Academy of Family Physicians. At the time of the
   study, E. Rogers was a UCSF primary care research fellow funded by NRSA
   grant T32 HP19025.
CR Bodenheimer T, 2007, JAMA-J AM MED ASSOC, V298, P2048, DOI 10.1001/jama.298.16.jrr70000
   Center for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET
   Clark SE., 2001, PEER VERSUS COPING M
   CUNNINGHAM CE, 1993, J CONSULT CLIN PSYCH, V61, P871, DOI 10.1037//0022-006X.61.5.871
   Dale JR, 2012, DIABETIC MED, V29, P1361, DOI 10.1111/j.1464-5491.2012.03749.x
   Fernandez A, 2011, J GEN INTERN MED, V26, P170, DOI 10.1007/s11606-010-1507-6
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Ghorob A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-208
   Heisler M, 2010, ANN INTERN MED, V153, P507, DOI 10.7326/0003-4819-153-8-201010190-00007
   Gagliardino JJ, 2013, DIABETES-METAB RES, V29, P152, DOI 10.1002/dmrr.2368
   Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026
   Long JA, 2012, ANN INTERN MED, V156, P416, DOI 10.7326/0003-4819-156-6-201203200-00004
   Lorig K, 2008, DIABETES CARE, V31, P408, DOI 10.2337/dc07-1313
   Philis-Tsimikas A, 2011, DIABETES CARE, V34, P1926, DOI 10.2337/dc10-2081
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   SCHUNK DH, 1991, EDUC PSYCHOL, V26, P207, DOI 10.1207/s15326985ep2603&4_2
   Thom DH, 2013, ANN FAM MED, V11, P137, DOI 10.1370/afm.1443
   Thornton RLJ, 2011, PATIENT EDUC COUNS, V85, pE201, DOI 10.1016/j.pec.2011.07.015
   Traylor AH, 2010, DIABETES CARE, V33, P520, DOI 10.2337/dc09-0760
   van der Wulp I, 2012, DIABETIC MED, V29, pe390, DOI 10.1111/j.1464-5491.2012.03629.x
   van Steenbergen-Weijenburg KM, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-235
   Wallston KA, 2007, J BEHAV MED, V30, P395, DOI 10.1007/s10865-007-9110-y
   Wu CJ, 2012, INT NURS REV, V59, P345, DOI 10.1111/j.1466-7657.2012.00998.x
NR 24
TC 10
Z9 10
U1 0
U2 12
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0145-7217
EI 1554-6063
J9 DIABETES EDUCATOR
JI Diabetes Educ.
PD JAN
PY 2014
VL 40
IS 1
BP 107
EP 115
DI 10.1177/0145721713513178
PG 9
WC Endocrinology & Metabolism; Public, Environmental & Occupational Health
SC Endocrinology & Metabolism; Public, Environmental & Occupational Health
GA 291YU
UT WOS:000329869600009
PM 24258250
DA 2019-01-08
ER

PT J
AU Goedendorp, MM
   Tack, CJ
   Steggink, E
   Bloot, L
   Bazelmans, E
   Knoop, H
AF Goedendorp, Martine M.
   Tack, Cees J.
   Steggink, Elles
   Bloot, Lotte
   Bazelmans, Ellen
   Knoop, Hans
TI Chronic Fatigue in Type 1 Diabetes: Highly Prevalent but Not Explained
   by Hyperglycemia or Glucose Variability
SO DIABETES CARE
LA English
DT Article
ID RANDOMIZED CONTROLLED-TRIAL; COGNITIVE-BEHAVIOR THERAPY;
   RHEUMATOID-ARTHRITIS; SYMPTOM CHECKLIST; PHYSICAL-ACTIVITY;
   SELF-MANAGEMENT; BREAST-CANCER; PRIMARY-CARE; DEPRESSION; DISTRESS
AB OBJECTIVEFatigue is a classical symptom of hyperglycemia, but the relationship between chronic fatigue and diabetes has not been systematically studied. We investigated prevalence, impact, and potential determinants of chronic fatigue in patients with type 1 diabetes mellitus (T1DM).RESEARCH DESIGN AND METHODSOut of 324 randomly selected T1DM outpatients, 214 participated in this cross-sectional observational study. Participants were compared with age- and sex-matched population-based controls. Chronic fatigue, functional impairments, current health status, comorbidity, diabetes-related factors, and fatigue-related cognitions and behaviors were assessed with questionnaires, and HbA(1c) values and comorbidity were assessed with medical records. Sixty-six patients underwent continuous glucose monitoring combined with an electronic fatigue diary for 5 days. Acute fatigue and four glucose parameters were determined: mean, variability, and relative time spent in hypoglycemia and hyperglycemia.RESULTST1DM patients were significantly more often chronically fatigued (40%; 95% CI 34-47%) compared with matched controls (7%; 95% CI 3-10%; P < 0.001). Chronically fatigued patients had significantly more functional impairments. Fatigue was the most troublesome symptom. Age, depression, pain, sleeping problems, low self-efficacy concerning fatigue, and physical inactivity were significantly associated with chronic fatigue. Chronically fatigued patients spent slightly less time in hypoglycemia (proportion 0.07 0.06 vs. 0.12 +/- 0.10; P = 0.025). Glucose parameters were not related to acute fatigue.CONCLUSIONSChronic fatigue is highly prevalent and clinically relevant in T1DM. Its significant relationship with cognitive behavioral variables and weak association with blood glucose levels suggests that behavioral interventions could be helpful in managing chronic fatigue in T1DM.
C1 [Goedendorp, Martine M.; Bloot, Lotte; Knoop, Hans] Radboud Univ Nijmegen, Med Ctr, Expert Ctr Chron Fatigue, NL-6525 ED Nijmegen, Netherlands.
   [Tack, Cees J.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands.
   [Steggink, Elles] Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands.
   [Bazelmans, Ellen] Radboud Univ Nijmegen, Med Ctr, Dept Med Psychol, NL-6525 ED Nijmegen, Netherlands.
RP Knoop, H (reprint author), Radboud Univ Nijmegen, Med Ctr, Expert Ctr Chron Fatigue, NL-6525 ED Nijmegen, Netherlands.
EM hans.knoop@radboudumc.nl
RI Tack, Cees/A-2368-2014; Knoop, Hans/D-3264-2009
OI Knoop, Hans/0000-0001-7763-3517
FU Dutch Diabetes Research Foundation
FX This study was supported by the Dutch Diabetes Research Foundation.
CR Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3
   Alberts M, 1997, Ned Tijdschr Geneeskd, V141, P1526
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Arbuckle RA, 2009, VALUE HEALTH, V12, P1168, DOI 10.1111/j.1524-4733.2009.00571.x
   Beck AT, 1997, BEHAV RES THER, V35, P785, DOI 10.1016/S0005-7967(97)00025-9
   Beck AT, 1997, ASSESSMENT, V4, P211, DOI 10.1177/107319119700400301
   BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001
   CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8
   Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB
   Drivsholm T, 2005, DIABETOLOGIA, V48, P210, DOI 10.1007/s00125-004-1625-y
   Fritschi C, 2010, J PSYCHOSOM RES, V69, P33, DOI 10.1016/j.jpsychores.2010.01.021
   FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009
   Goedendorp MM, 2010, ONCOLOGIST, V15, P1122, DOI 10.1634/theoncologist.2010-0092
   GROOTENHUIS PA, 1994, DIABETIC MED, V11, P253, DOI 10.1111/j.1464-5491.1994.tb00268.x
   Hewlett S, 2011, RHEUMATOLOGY, V50, P1004, DOI 10.1093/rheumatology/keq282
   Hewlett S, 2011, ANN RHEUM DIS, V70, P1060, DOI 10.1136/ard.2010.144691
   Jacobsen PB, 2004, J CONSULT CLIN PSYCH, V72, P355, DOI 10.1037/0022-006X.72.2.355
   Jacobsen PB, 1999, CANC RES THER CONTRO, V8, P155
   Kalkman JS, 2007, J PSYCHOSOM RES, V62, P571, DOI 10.1016/j.jpsychores.2006.11.014
   Kalkman JS, 2005, J NEUROL NEUROSUR PS, V76, P1406, DOI 10.1136/jnnp.2004.050005
   King P, 1998, DIABETES CARE, V21, P341, DOI 10.2337/diacare.21.3.341
   Lasselin J, 2012, PSYCHONEUROENDOCRINO, V37, P1468, DOI 10.1016/j.psyneuen.2012.01.016
   MONTOYE HJ, 1983, MED SCI SPORT EXER, V15, P403
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Prins JB, 2001, LANCET, V357, P841, DOI 10.1016/S0140-6736(00)04198-2
   RAY C, 1993, SOC SCI MED, V37, P385, DOI 10.1016/0277-9536(93)90268-9
   Reeves WC, 2003, BMC HEALTH SERV RES, V3, DOI 10.1186/1472-6963-3-25
   Repping-Wuts H, 2007, J CLIN NURS, V16, P377, DOI 10.1111/j.1365-2702.2007.02082.x
   Servaes P, 2002, ANN ONCOL, V13, P589, DOI 10.1093/annonc/mdf082
   Siegelaar SE, 2010, ENDOCR REV, V31, P171, DOI 10.1210/er.2009-0021
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Sommerfield AJ, 2004, DIABETES CARE, V27, P2335, DOI 10.2337/diacare.27.10.2335
   van der Ven NCW, 2003, DIABETES CARE, V26, P713, DOI 10.2337/diacare.26.3.713
   van Hoogmoed D, 2010, RHEUMATOLOGY, V49, P1294, DOI 10.1093/rheumatology/keq043
   Vercoulen JHMM, 1996, ARCH NEUROL-CHICAGO, V53, P642, DOI 10.1001/archneur.1996.00550070080014
   VERCOULEN JHMM, 1994, J PSYCHOSOM RES, V38, P383, DOI 10.1016/0022-3999(94)90099-X
   Vercoulen JHMM, 1999, GEDRAGSTHERAPIE, V32, P131
   Warren RE, 2003, DIABETES-METAB RES, V19, P408, DOI 10.1002/dmrr.396
   Weijman I, 2005, DIABETES RES CLIN PR, V68, P56, DOI 10.1016/j.diabres.2004.08.004
NR 39
TC 29
Z9 29
U1 4
U2 34
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
EI 1935-5548
J9 DIABETES CARE
JI Diabetes Care
PD JAN
PY 2014
VL 37
IS 1
BP 73
EP 80
DI 10.2337/dc13-0515
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 275KV
UT WOS:000328676000024
PM 23949561
OA Other Gold
DA 2019-01-08
ER

PT J
AU Hajos, TRS
   Polonsky, WH
   Pouwer, F
   Gonder-Frederick, L
   Snoek, FJ
AF Hajos, Tibor R. S.
   Polonsky, William H.
   Pouwer, Frans
   Gonder-Frederick, Linda
   Snoek, Frank J.
TI Toward Defining a Cutoff Score for Elevated Fear of Hypoglycemia on the
   Hypoglycemia Fear Survey Worry Subscale in Patients With Type 2 Diabetes
SO DIABETES CARE
LA English
DT Article
ID QUALITY-OF-LIFE; HEALTH-RELATED QUALITY; GLYCEMIC CONTROL; DISTRESS;
   MELLITUS; MANAGEMENT; SCALE; STATE; CARE
AB OBJECTIVETo determine a cutoff score for clinically meaningful fear of hypoglycemia (FoH) on the Hypoglycemia Fear Survey Worry subscale (HFS-W).RESEARCH DESIGN AND METHODSData on the HFS-W, history of hypoglycemia, emotional well-being (World Health Organization-5 well-being index), and distress about diabetes symptoms (Diabetes Symptom Checklist-Revised) were available from Dutch patients with type 2 diabetes who were treated with oral medication or insulin (n = 1,530). Four criteria were applied to define a threshold for clinically meaningful FoH: 1) modal score distribution (MD criterion), 2) scores 2 SDs above the mean (SD criterion), 3) concurrent validity with severe hypoglycemia and suboptimal well-being (CV criterion), and 4) an elevated score (3) on more than one HFS-W item (elevated item endorsement [EI criterion]). Associations between the outcomes of these approaches and a history of severe hypoglycemia and suboptimal well-being were studied.RESULTSOf the 1,530 patients, 19% had a HFS-W score of 0 (MD criterion), and 5% reported elevated FoH (HFS-W mean + 2 SD; SD criterion). Patients with severe hypoglycemia reported higher HFS-W scores than those without (25 20 vs. 15 +/- 17; P < 0.001). Patients with suboptimal well-being reported higher HFS-W scores than those with satisfactory well-being (20 +/- 18 vs. 13 +/- 15; P < 0.001, CV criterion). Elevated FoH (defined by the EI criterion) was seen in 26% of patients. The SD and EI criteria were the strongest associated with history of severe hypoglycemia. The EI criterion was the strongest associated with suboptimal well-being.CONCLUSIONSAlthough no definite cutoff score has been determined, the EI criterion may be most indicative of clinically relevant FoH in this exploratory study. Further testing of the clinical relevance of this criterion is needed.
C1 [Hajos, Tibor R. S.; Snoek, Frank J.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst, Diabet Psychol Res Grp,Dept Med Psychol, Amsterdam, Netherlands.
   [Polonsky, William H.] Behav Diabet Inst, San Diego, CA USA.
   [Pouwer, Frans] Tilburg Univ, Ctr Res Psychol Somat Dis CoRPS, NL-5000 LE Tilburg, Netherlands.
   [Gonder-Frederick, Linda] Univ Virginia, Behav Med Ctr, Charlottesville, VA USA.
RP Snoek, FJ (reprint author), Vrije Univ Amsterdam, Med Ctr, EMGO Inst, Diabet Psychol Res Grp,Dept Med Psychol, Amsterdam, Netherlands.
EM fj.snoek@vumc.nl
FU EMGO+ Institute, Amsterdam
FX This work was financially supported by a travel grant from the EMGO+
   Institute, Amsterdam.
CR Amiel SA, 2008, DIABETIC MED, V25, P245, DOI 10.1111/j.1464-5491.2007.02341.x
   Arbuckle RA, 2009, VALUE HEALTH, V12, P1168, DOI 10.1111/j.1524-4733.2009.00571.x
   Barendse S, 2012, DIABETIC MED, V29, P293, DOI 10.1111/j.1464-5491.2011.03416.x
   Bech P, 2003, INT J METH PSYCH RES, V12, P85, DOI 10.1002/mpr.145
   COX DJ, 1987, DIABETES CARE, V10, P617, DOI 10.2337/diacare.10.5.617
   Cryer PE, 2003, DIABETES CARE, V26, P1902, DOI 10.2337/diacare.26.6.1902
   Cryer PE, 1999, DIABETES-METAB RES, V15, P42, DOI 10.1002/(SICI)1520-7560(199901/02)15:1<42::AID-DMRR1>3.0.CO;2-B
   Gold AE, 1997, DIABETIC MED, V14, P309
   Gonder-Frederick LA, 2011, DIABETES CARE, V34, P801, DOI 10.2337/dc10-1343
   Hajos TRS, 2013, DIABETIC MED, V30, pE63, DOI 10.1111/dme.12040
   Hajos TRS, 2012, QUAL LIFE RES, V21, P1359, DOI 10.1007/s11136-011-0051-0
   Hajos TRS, 2011, DIABETIC MED, V28, P1096, DOI 10.1111/j.1464-5491.2011.03329.x
   Heller SR, 2007, DIABETOLOGIA, V50, P1140, DOI 10.1007/s00125-007-0599-y
   Makoul G, 2007, PATIENT EDUC COUNS, V67, P333, DOI 10.1016/j.pec.2007.05.005
   Marrett Elizabeth, 2011, BMC Res Notes, V4, P251, DOI 10.1186/1756-0500-4-251
   Nixon R, 2011, DIABETES TECHNOL THE, V13, P93, DOI 10.1089/dia.2010.0192
   Pedersen-Bjergaard U, 2003, DIABETES-METAB RES, V19, P232, DOI 10.1002/dmrr.377
   POLONSKY WH, 1992, HEALTH PSYCHOL, V11, P199, DOI 10.1037/0278-6133.11.3.199
   Rubin DB, 1987, MULTIPLE IMPUTATION
   Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147
   Sheu WHH, 2012, DIABETES RES CLIN PR, V96, P141, DOI 10.1016/j.diabres.2011.12.027
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Snoek FJ, 1996, GEDRAG GEZOND, V5, P287
   Stargardt T, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-91
   ter Braak EWMT, 2000, DIABETES CARE, V23, P1467, DOI 10.2337/diacare.23.10.1467
   Wild D, 2007, PATIENT EDUC COUNS, V68, P10, DOI 10.1016/j.pec.2007.05.003
NR 26
TC 17
Z9 17
U1 0
U2 11
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
EI 1935-5548
J9 DIABETES CARE
JI Diabetes Care
PD JAN
PY 2014
VL 37
IS 1
BP 102
EP 108
DI 10.2337/dc13-0971
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 275KV
UT WOS:000328676000028
PM 23990513
OA Other Gold
DA 2019-01-08
ER

PT J
AU Mashitani, T
   Hayashino, Y
   Okamura, S
   Tsujii, S
   Ishii, H
AF Mashitani, Tsuyoshi
   Hayashino, Yasuaki
   Okamura, Shintarou
   Tsujii, Satoru
   Ishii, Hitoshi
TI Correlations Between Serum Bilirubin Levels and Diabetic Nephropathy
   Progression Among Japanese Type 2 Diabetic Patients: A Prospective
   Cohort Study (Diabetes Distress and Care Registry at Tenri [DDCRT 5])
SO DIABETES CARE
LA English
DT Article
ID CARDIOVASCULAR-DISEASE; OXIDATIVE STRESS; GLYCEMIC CONTROL;
   GILBERT-SYNDROME; KIDNEY-FUNCTION; HEART-DISEASE; ALBUMINURIA; RISK;
   COMPLICATIONS; ASSOCIATION
AB OBJECTIVETo assess the correlations between serum bilirubin levels and diabetic nephropathy development and progression in type 2 diabetic patients.RESEARCH DESIGN AND METHODSLongitudinal data were obtained from 2,511 type 2 diabetic patients registered in a Japanese diabetes registry. To assess the independent correlations between serum bilirubin levels and either the development or progression of diabetic nephropathy, we used logistic regression analysis adjusted for potential confounders.RESULTSThe median follow-up period was 503.4 days (range 238-777). The mean patient age, BMI, and HbA(1c) level was 65.2 years, 24.7 kg/m(2), and 7.5% (58.5 mmol/mol), respectively. Baseline serum bilirubin levels were significantly associated with the urinary albumin-creatinine ratio at baseline (P < 0.001) and 1 year after registration (P < 0.001). Multivariable adjusted odds ratios for progression from microalbuminuria to macroalbuminuria for the second, third, and fourth quartile of serum bilirubin levels were 0.89 (95% CI 0.49-1.58), 0.93 (0.47-1.83), and 0.33 (0.13-0.84), respectively, showing a statistically significant linear trend across categories (P = 0.032). However, this trend disappeared after adjustment for hemoglobin levels.CONCLUSIONSSerum bilirubin levels were associated with diabetic nephropathy progression in type 2 diabetic patients independent of possible confounders. Serum bilirubin levels might be the link in the correlation between hemoglobin levels and nephropathy progression.
C1 [Mashitani, Tsuyoshi; Hayashino, Yasuaki; Okamura, Shintarou; Tsujii, Satoru; Ishii, Hitoshi] Tenri Hosp, Diabet Distress & Care Registry, Tenri Study Grp, Dept Endocrinol, Tenri, Nara 632, Japan.
RP Mashitani, T (reprint author), Tenri Hosp, Diabet Distress & Care Registry, Tenri Study Grp, Dept Endocrinol, Tenri, Nara 632, Japan.
EM mashiyan@gmail.com
OI Hayashino, Yasuaki/0000-0002-2932-8478; Tsujii,
   Satoru/0000-0002-1834-6515
FU Manpei Suzuki Diabetes Foundation; Japan Society for the Promotion of
   Science KAKENHI [25460641]
FX This study was partially supported by the Manpei Suzuki Diabetes
   Foundation and Japan Society for the Promotion of Science KAKENHI (Grant
   25460641, Grant-in-Aid for Scientific Research).
CR Adler AI, 2003, KIDNEY INT, V63, P225, DOI 10.1046/j.1523-1755.2003.00712.x
   [Anonymous], 2008, KIDNEY INT, V74, P1197
   Babazono T, 2006, DIABETOLOGIA, V49, P1387, DOI 10.1007/s00125-006-0247-y
   BAYNES JW, 1991, DIABETES, V40, P405, DOI 10.2337/diabetes.40.4.405
   Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161
   Caramori ML, 2000, DIABETES, V49, P1399, DOI 10.2337/diabetes.49.9.1399
   Djousse L, 2001, AM J CARDIOL, V87, P1196, DOI 10.1016/S0002-9149(01)01494-1
   Djousse L, 2001, AM J CARDIOL, V87, pA7
   Djousse L, 2001, AM J CARDIOL, V87, pA4
   DOSEMECI M, 1990, AM J EPIDEMIOL, V132, P746, DOI 10.1093/oxfordjournals.aje.a115716
   Endler G, 2003, CLIN CHEM, V49, P1201, DOI 10.1373/49.7.1201
   Fujii M, 2010, KIDNEY INT, V78, P905, DOI 10.1038/ki.2010.265
   Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421
   Hayashino Y, 2012, DIABETES RES CLIN PR, V97, P405, DOI 10.1016/j.diabres.2012.04.005
   Inoguchi T, 2007, JAMA-J AM MED ASSOC, V298, P1398, DOI 10.1001/jama.298.12.1398-b
   Katayama S, 2011, DIABETOLOGIA, V54, P1025, DOI 10.1007/s00125-010-2025-0
   Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303
   Lin JP, 2006, CIRCULATION, V114, P1476, DOI 10.1161/CIRCULATIONAHA.106.633206
   Madsen-Bouterse SA, 2008, REV ENDOCR METAB DIS, V9, P315, DOI 10.1007/s11154-008-9090-4
   Makino H, 2007, DIABETES CARE, V30, P1577, DOI 10.2337/dc06-1998
   Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034
   Molitch Mark E, 2004, Diabetes Care, V27 Suppl 1, pS79
   Riphagen IJ, 2012, AM SOC NEPHR 45 ANN
   Ritz E, 1999, NEW ENGL J MED, V341, P1127, DOI 10.1056/NEJM199910073411506
   Sahai A, 1999, KIDNEY INT, V56, P1277, DOI 10.1046/j.1523-1755.1999.00703.x
   Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x
   STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864
   Targher G, 2009, CLIN CHEM LAB MED, V47, P1055, DOI 10.1515/CCLM.2009.244
   Tsujii S, 2012, DIABETIC MED, V29, P1451, DOI 10.1111/j.1464-5491.2012.03647.x
   Vitek L, 2002, ATHEROSCLEROSIS, V160, P449, DOI 10.1016/S0021-9150(01)00601-3
   Weir MR, 2007, CLIN J AM SOC NEPHRO, V2, P581, DOI 10.2215/CJN.03190906
   Yasuda M, 2011, OPHTHALMOLOGY, V118, P1423, DOI 10.1016/j.ophtha.2010.12.009
NR 32
TC 25
Z9 28
U1 0
U2 7
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
EI 1935-5548
J9 DIABETES CARE
JI Diabetes Care
PD JAN
PY 2014
VL 37
IS 1
BP 252
EP 258
DI 10.2337/dc13-0407
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 275KV
UT WOS:000328676000047
PM 24009299
OA Other Gold
DA 2019-01-08
ER

PT J
AU Hermanns, N
   Kulzer, B
   Ehrmann, D
   Bergis-Jurgan, N
   Haak, T
AF Hermanns, Norbert
   Kulzer, Bernhard
   Ehrmann, Dominic
   Bergis-Jurgan, Nikola
   Haak, Thomas
TI The effect of a diabetes education programme (PRIMAS) for people with
   type 1 diabetes: Results of a randomized trial
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Type 1 diabetes; Diabetes self-management education; Diabetes education
   programme; Intensive insulin treatment
ID SELF-MANAGEMENT EDUCATION; INSULIN-TREATMENT; HYPOGLYCEMIA; MELLITUS;
   SCALE; METAANALYSIS; DISTRESS; THERAPY; DISEASE; ADULTS
AB Objective: In a randomized, multi-centre trial, the efficacy of a self-management-oriented education programme (PRIMAS) for people with type 1 diabetes was compared with an established education programme as control group (CG). Primary outcome was the effect on glycaemic control in a 6-month follow-up. Secondary outcomes were the impact on emotional aspects, self-management related aspects and hypoglycaemia problems.
   Methods: The study was conducted in an outpatient setting. 160 participants were randomized. Baseline characteristics in PRIMAS and CG were similar (age 45.1 +/- 13.5 vs. 45.9 +/- 13.1 years, p = .716; diabetes duration 18.8 +/- 12.3 vs. 19.8 +/- 13.4 years, p = .615; BMI 26.5 +/- 4.6 vs. 27.5 +/- 5.0 kg/m(2), p = .236; HbA1c 8.3 +/- 1.1 vs. 8.1 +/- 1.0%, p = .236).
   Results: At follow-up there was a significant 0.4 percentage points greater reduction of HbA1c in PRIMAS compared to CG (Delta -0.4 +/- 1.0% vs. Delta 0.0 +/- 0.6%; p = .012). Also, diabetes-related distress (Delta -0.3 +/- 0.7 vs. -0.1 +/- 0.4, p = .032) and dissatisfaction with diabetes treatment (Delta -3.3 +/- 6.9 vs. -1.9 +/- 5.6, p = .024) decreased more in PRIMAS. Diabetes empowerment (Delta 2.6 +/- 5.9 vs. 0.8 +/- 5.1, p = .037) and diabetes self-efficacy (Delta 1.4 +/- 3.6 vs. 0.2 +/- 4.0, p = .013) increased in PRIMAS. Incidence of severe hypoglycemia, hypoglycemia awareness, diabetes knowledge, and self-care behaviour improved in both groups with no significant differences between groups.
   Conclusion: PRIMAS is more effective in lowering HbA1c than a previously established education programmes and also showed superiority in reducing diabetes-related distress and increasing diabetes empowerment, diabetes self-efficacy and satisfaction with insulin therapy. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
C1 [Hermanns, Norbert; Kulzer, Bernhard; Ehrmann, Dominic; Bergis-Jurgan, Nikola; Haak, Thomas] Res Inst Diabet Acad Mergentheim FIDAM, D-97980 Bad Mergentheim, Germany.
   [Hermanns, Norbert; Kulzer, Bernhard] Otto Friedrich Univ Bamberg, D-96047 Bamberg, Germany.
   [Hermanns, Norbert; Kulzer, Bernhard; Haak, Thomas] Diabet Ctr Mergentheim, D-97980 Bad Mergentheim, Germany.
RP Hermanns, N (reprint author), Theodor Klotzbuecher Str 12, D-97980 Bad Mergentheim, Germany.
EM hermanns@diabetes-zentrum.de
OI Ehrmann, Dominic/0000-0002-5794-5596
FU Berlin Chemie AG/Menarini Diagnostics, Germany
FX The development and evaluation was supported by an unrestricted grant of
   Berlin Chemie AG/Menarini Diagnostics, Germany. The funders had no role
   in the conceptualisation of PRIMAS, study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Anderson R, 2000, NAT HIST, V109, P23
   Bohm BO, 2012, THERAPIE DIABETES ME
   Bragd J, 2003, DIABETIC MED, V20, P216, DOI 10.1046/j.1464-5491.2003.00902.x
   Centers for Disease Control and Prevention (CDC), NAT DIAB FACTSH
   CLARKE WL, 1995, DIABETES CARE, V18, P517, DOI 10.2337/diacare.18.4.517
   DAFNE Study Group, 2002, BMJ-BRIT MED J, V325, DOI DOI 10.1136/BMJ.325.7367.746
   Davies MJ, 2008, BRIT MED J, V336, P491, DOI 10.1136/bmj.39474.922025.BE
   *DIAB CONTR COMPL, 1997, DIABETES, V46, P271, DOI DOI 10.2337/DIABETES.46.2.271
   Ehrmann D, 2011, DIABETOL STOFFWECHS, V6, P62
   Ellis SE, 2004, PATIENT EDUC COUNS, V52, P97, DOI 10.1016/S0738-3991(03)00016-8
   Funnell MM, 2011, DIABETES CARE, V34, pS89, DOI 10.2337/dc11-S089
   Hautzinger M, 1993, ALLGEMEINE DEPRESSIO
   Hermanns N, 2007, DIABETES-METAB RES, V23, P528, DOI 10.1002/dmrr.710
   Hopkins D, 2012, DIABETES CARE, V35, P1638, DOI 10.2337/dc11-1579
   IDF Clinical Guidelines Task Force, 2005, GLOB GUID TYP 2 DIAB
   Institute for Clinical Excellence, 2003, GUID US PAT DEUC MOD
   International Diabetes Federation, IDF DIABETES ATLAS
   Jorgens V, 2009, BEHANDLUNGS SCHULUNG, V5
   Kempe J, 2002, DIABETES STOFFWECH H, V11, P144
   KULZER B, 1995, VERHALTENSTHERAPIE, V5, pA72
   MUHLHAUSER I, 1983, DIABETOLOGIA, V25, P470
   MUHLHAUSER I, 1987, DIABETOLOGIA, V30, P681, DOI 10.1007/BF00296989
   Nathan DM, 2005, NEW ENGL J MED, V353, P2643
   Norris SL, 2002, DIABETES CARE, V25, P1159, DOI 10.2337/diacare.25.7.1159
   PIEBER TR, 1995, DIABETES CARE, V18, P625, DOI 10.2337/diacare.18.5.625
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Pouwer F, 2003, DIABETOLOGIA, V46, P892, DOI 10.1007/s00125-003-1124-6
   REICHARD P, 1991, J INTERN MED, V230, P101, DOI 10.1111/j.1365-2796.1991.tb00415.x
   Roy T, 2012, J AFFECT DISORDERS, V142, P8
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   The Diabetes Control and Complications Trial Research Group, 1993, NEW ENGL J MED, V329, P977, DOI [10.1056/NEJM199309303291401, DOI 10.1056/NEJM199309303291401]
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
NR 32
TC 33
Z9 33
U1 0
U2 16
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
EI 1872-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD DEC
PY 2013
VL 102
IS 3
BP 149
EP 157
DI 10.1016/j.diabres.2013.10.009
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 272UX
UT WOS:000328488100003
PM 24210673
DA 2019-01-08
ER

PT J
AU Pasek, RC
   Gannon, M
AF Pasek, Raymond C.
   Gannon, Maureen
TI Advancements and challenges in generating accurate animal models of
   gestational diabetes mellitus
SO AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
LA English
DT Review
DE gestational diabetes mellitus; pregnancy; beta-cell; hyperplasia;
   hypertrophy; glucose-stimulated insulin secretion
ID PANCREATIC BETA-CELL; INSULIN-SECRETION; GROWTH-HORMONE;
   TRANSCRIPTION-FACTOR-7-LIKE-2 TCF7L2; TRANSCRIPTION FACTOR; PROLACTIN
   RECEPTOR; GENE POLYMORPHISMS; EMBRYO DEVELOPMENT; GLUCOSE-TOLERANCE;
   HUMAN-PREGNANCY
AB The maintenance of glucose homeostasis during pregnancy is critical to the health and well-being of both the mother and the developing fetus. Strikingly, approximately 7% of human pregnancies are characterized by insufficient insulin production or signaling, resulting in gestational diabetes mellitus (GDM). In addition to the acute health concerns of hyperglycemia, women diagnosed with GDM during pregnancy have an increased incidence of complications during pregnancy as well as an increased risk of developing type 2 diabetes (T2D) later in life. Furthermore, children born to mothers diagnosed with GDM have increased incidence of perinatal complications, including hypoglycemia, respiratory distress syndrome, and macrosomia, as well as an increased risk of being obese or developing T2D as adults. No single environmental or genetic factor is solely responsible for the disease; instead, a variety of risk factors, including weight, ethnicity, genetics, and family history, contribute to the likelihood of developing GDM, making the generation of animal models that fully recapitulate the disease difficult. Here, we discuss and critique the various animal models that have been generated to better understand the etiology of diabetes during pregnancy and its physiological impacts on both the mother and the fetus. Strategies utilized are diverse in nature and include the use of surgical manipulation, pharmacological treatment, nutritional manipulation, and genetic approaches in a variety of animal models. Continued development of animal models of GDM is essential for understanding the consequences of this disease as well as providing insights into potential treatments and preventative measures.
C1 [Gannon, Maureen] Tennessee Valley Healthcare Syst, Dept Vet Affairs, Nashville, TN USA.
   [Pasek, Raymond C.; Gannon, Maureen] Vanderbilt Univ, Dept Med, Med Ctr, Div Diabet Endocrinol & Metab, Nashville, TN 37232 USA.
   [Gannon, Maureen] Vanderbilt Univ, Dept Cell & Dev Biol, Med Ctr, Nashville, TN 37232 USA.
   [Gannon, Maureen] Vanderbilt Univ, Dept Mol Physiol & Biophys, Med Ctr, Nashville, TN 37232 USA.
RP Gannon, M (reprint author), Vanderbilt Univ, Dept Med, Med Ctr, 2213 Garland Ave,MRB 4 7435, Nashville, TN 37232 USA.
EM Maureen.gannon@vanderbilt.edu
OI Pasek, Raymond/0000-0002-1817-8697
FU Vanderbilt Molecular Endocrinology Training Program [5 T32 DK-07563];
   Veterans Administration [1BX000990-01A1]; Juvenile Diabetes Research
   Foundation [1-2011-592]
FX R. C. Pasek was supported by the Vanderbilt Molecular Endocrinology
   Training Program (Grant 5 T32 DK-07563). M. Gannon was supported by a
   grant from the Veterans Administration (1BX000990-01A1) and the Juvenile
   Diabetes Research Foundation (1-2011-592).
CR Aerts L, 1998, DIABETES RES CLIN PR, V41, P9, DOI 10.1016/S0168-8227(98)00063-1
   American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS88
   ARISON RN, 1967, DIABETES, V16, P51, DOI 10.2337/diab.16.1.51
   Brelje TC, 2004, ENDOCRINOLOGY, V145, P4162, DOI 10.1210/en.2004-0201
   BRUCKMANN G, 1947, J BIOL CHEM, V168, P241
   Butler AE, 2010, DIABETOLOGIA, V53, P2167, DOI 10.1007/s00125-010-1809-6
   Cardinal JW, 1998, ENDOCRINOLOGY, V139, P2885, DOI 10.1210/en.139.6.2885
   Carlson AJ, 1911, AM J PHYSIOL, V27, P323
   Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5
   Cheung NW, 2003, DIABETES CARE, V26, P2005, DOI 10.2337/diacare.26.7.2005
   COHEN G, 1974, J BIOL CHEM, V249, P2447
   Cuthbert FP, 1936, AM J PHYSIOL, V115, P480
   Cypryk Katarzyna, 2008, Endokrynol Pol, V59, P393
   Demirci C, 2012, DIABETES, V61, P1143, DOI 10.2337/db11-1154
   DIAMOND MP, 1989, J REPROD FERTIL, V86, P1
   DICKINSON JE, 1990, AM J OBSTET GYNECOL, V163, P1831, DOI 10.1016/0002-9378(90)90759-Z
   DICKINSON JE, 1991, AM J OBSTET GYNECOL, V165, P1673, DOI 10.1016/0002-9378(91)90013-H
   DOOLEY SL, 1991, DIABETES, V40, P25, DOI 10.2337/diab.40.2.S25
   Dunn JS, 1943, LANCET, V1, P484
   EZEKWE MO, 1984, J ANIM SCI, V59, P974
   Ford SP, 2009, AM J PHYSIOL-REG I, V297, pR835, DOI 10.1152/ajpregu.00072.2009
   Frias JL, 2007, AM J MED GENET A, V143A, P2904, DOI 10.1002/ajmg.a.32071
   Fujinaka Y, 2007, J BIOL CHEM, V282, P30707, DOI 10.1074/jbc.M702607200
   GAUGUIER D, 1990, DIABETES, V39, P734, DOI 10.2337/diabetes.39.6.734
   GEWOLB IH, 1982, PEDIATR RES, V16, P869, DOI 10.1203/00006450-198210000-00013
   Giachini FRC, 2008, J ANAT, V212, P31, DOI 10.1111/j.1469-7580.2007.00839.x
   GILLMAN J, 1958, BRIT MED J, V2, P1260, DOI 10.1136/bmj.2.5107.1260
   Gilmartin Amanda Bird Hoffert, 2008, Rev Obstet Gynecol, V1, P129
   Gloyn AL, 2006, HUM MUTAT, V27, P220, DOI 10.1002/humu.20292
   GORUS FK, 1982, BIOCHEM J, V208, P513, DOI 10.1042/bj2080513
   GRIFFITHS M, 1948, AUST J EXP BIOL MED, V26, P339, DOI 10.1038/icb.1948.35
   Gupta RK, 2007, GENE DEV, V21, P756, DOI 10.1101/gad.1535507
   Gupta RK, 2005, J CLIN INVEST, V115, P1006, DOI 10.1172/JCI22365
   Harder T, 2001, GYNECOL OBSTET INVES, V51, P160, DOI 10.1159/000052916
   Higashide S, 1992, Nihon Geka Hokan, V61, P311
   HOFTIEZER V, 1973, DIABETOLOGIA, V9, P178, DOI 10.1007/BF01219780
   Holemans K, 2004, AM J OBSTET GYNECOL, V190, P858, DOI 10.1016/j.ajog.2003.09.025
   Huang C, 2009, ENDOCRINOLOGY, V150, P1618, DOI 10.1210/en.2008-1003
   HUMMEL KP, 1966, SCIENCE, V153, P1127, DOI 10.1126/science.153.3740.1127
   JARRETT I. G., 1956, AUSTRALIAN JOUR EXPTL BIOL AND MED SCI, V34, P133, DOI 10.1038/icb.1956.16
   JAWERBAUM A, 1993, PROSTAGLANDINS, V45, P487, DOI 10.1016/0090-6980(93)90124-P
   Johansson M, 2006, ENDOCRINOLOGY, V147, P2315, DOI 10.1210/en.2005-0997
   JONES N, 1957, Proc Soc Study Fertil, V9, P51
   Karnik SK, 2007, SCIENCE, V318, P806, DOI 10.1126/science.1146812
   Karnik SK, 2005, P NATL ACAD SCI USA, V102, P14659, DOI 10.1073/pnas.0503484102
   KATO R, 1970, JPN J PHARMACOL, V20, P554, DOI 10.1254/jjp.20.554
   KAUFMANN RC, 1981, AM J OBSTET GYNECOL, V141, P479, DOI 10.1016/S0002-9378(15)33263-4
   Kelly PA, 2002, MOL CELL ENDOCRINOL, V197, P127, DOI 10.1016/S0303-7207(02)00286-1
   KEMNITZ JW, 1984, DIABETOLOGIA, V26, P60
   Kilpatrick DC, 2002, BBA-GEN SUBJECTS, V1572, P401, DOI 10.1016/S0304-4165(02)00321-5
   Kim H, 2010, NAT MED, V16, P804, DOI 10.1038/nm.2173
   Kim S. Y., 2004, PREV CHRONIC DIS, V9, pE88
   Kivimaki M, 2010, DIABETES CARE, V33, P2611, DOI 10.2337/dc10.1187
   Kobayashi K, 2004, ARTIF ORGANS, V28, P1035, DOI 10.1111/j.1525-1594.2004.00002.x
   Le TN, 2013, GENET TEST MOL BIOMA, V17, P567, DOI 10.1089/gtmb.2013.0009
   LENICH CM, 1991, J LIPID RES, V32, P431
   LENZEN S, 1988, DIABETOLOGIA, V31, P337, DOI 10.1007/BF02341500
   Liang CY, 2010, METABOLISM, V59, P943, DOI 10.1016/j.metabol.2009.10.015
   Long H, 2013, CURR DIABETES REP, V13, P43, DOI 10.1007/s11892-012-0330-3
   Lopez-Soldado Iliana, 2003, Exp Diabesity Res, V4, P107, DOI 10.1155/EDR.2003.107
   Markowitz J, 1927, AM J PHYSIOL, V79, P553
   MARTIN ME, 1995, BIOSCIENCE REP, V15, P15, DOI 10.1007/BF01200211
   Megia A, 2004, J CLIN ENDOCR METAB, V89, P5081, DOI 10.1210/jc.2004-0211
   Metzger BE, 1998, DIABETES CARE, V21, pB161
   Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848
   MIODOVNIK M, 1989, AM J OBSTET GYNECOL, V160, P1239, DOI 10.1016/0002-9378(89)90203-2
   Miura A, 2006, J BIOL CHEM, V281, P5246, DOI 10.1074/jbc.M507496200
   Moehn S, 2012, J NUTR, V142, p2231S, DOI 10.3945/jn.112.159061
   Moore MC, 2011, J APPL PHYSIOL, V110, P458, DOI 10.1152/japplphysiol.00768.2010
   Morisset J, 2000, PANCREAS, V21, P321, DOI 10.1097/00006676-200010000-00015
   Murata M, 1999, BIOCHEM PHARMACOL, V57, P881, DOI 10.1016/S0006-2952(98)00370-0
   Nebigil CG, 2000, P NATL ACAD SCI USA, V97, P9508, DOI 10.1073/pnas.97.17.9508
   OSULLIVAN JB, 1973, AM J OBSTET GYNECOL, V116, P895
   Pan A, 2012, DIABETOLOGIA, V55, P63, DOI 10.1007/s00125-011-2268-4
   PANG K, 1994, P NATL ACAD SCI USA, V91, P9559, DOI 10.1073/pnas.91.20.9559
   PARSONS JA, 1995, ENDOCRINOLOGY, V136, P2013, DOI 10.1210/en.136.5.2013
   PARSONS JA, 1992, ENDOCRINOLOGY, V130, P1459, DOI 10.1210/en.130.3.1459
   Perera HK, 2006, GENE EXPR PATTERNS, V6, P971, DOI 10.1016/j.modgep.2006.04.001
   Perkins JM, 2007, CLIN DIABETES, V25, P57, DOI DOI 10.2337/DIACLIN.25.2.57
   PHELPS RL, 1981, AM J OBSTET GYNECOL, V140, P730, DOI 10.1016/0002-9378(81)90731-6
   Plank JL, 2011, ENDOCRINOLOGY, V152, P4589, DOI 10.1210/en.2010-1462
   RAMSAY TG, 1994, AM J PHYSIOL-REG I, V267, pR1391
   REYNOLDS WA, 1974, DIABETES, V23, P777, DOI 10.2337/diab.23.9.777
   Rieck S, 2010, TRENDS ENDOCRIN MET, V21, P151, DOI 10.1016/j.tem.2009.11.001
   Robitaille J, 2008, GENET MED, V10, P240, DOI 10.1097/GIM.0b013e31816b10
   ROSSINI AA, 1978, ENDOCRINOLOGY, V103, P1518, DOI 10.1210/endo-103-4-1518
   RYAN EA, 1993, DIABETES, V42, P316, DOI 10.2337/diabetes.42.2.316
   Savitz DA, 2008, BJOG-INT J OBSTET GY, V115, P969, DOI 10.1111/j.1471-0528.2008.01763.x
   SCHEIN PS, 1974, CANCER, V34, P993, DOI 10.1002/1097-0142(197410)34:4<993::AID-CNCR2820340404>3.0.CO;2-T
   SCHEIN PS, 1968, CANCER RES, V28, P1501
   SCHNEDL WJ, 1994, DIABETES, V43, P1326, DOI 10.2337/diabetes.43.11.1326
   Schraenen A, 2010, DIABETOLOGIA, V53, P2589, DOI 10.1007/s00125-010-1913-7
   Segar EM, 2009, CLIN SCI, V117, P129, DOI 10.1042/CS20080550
   Shaat N, 2007, DIABETOLOGIA, V50, P972, DOI 10.1007/s00125-007-0623-2
   Shaat N, 2006, DIABETOLOGIA, V49, P1545, DOI 10.1007/s00125-006-0258-8
   Shaat N, 2005, DIABETOLOGIA, V48, P2544, DOI 10.1007/s00125-005-0035-0
   Sharma A, 1999, DIABETES, V48, P507, DOI 10.2337/diabetes.48.3.507
   Sivan Eyal, 2003, Curr Diab Rep, V3, P319, DOI 10.1007/s11892-003-0024-y
   Szkudelski T, 2001, PHYSIOL RES, V50, P537
   Tein MSC, 1998, EXP PHYSIOL, V83, P165, DOI 10.1113/expphysiol.1998.sp004099
   TSAI MY, 1982, BIOCHIM BIOPHYS ACTA, V712, P395, DOI 10.1016/0005-2760(82)90358-7
   VANASSCHE FA, 1978, BRIT J OBSTET GYNAEC, V85, P818
   VERCHEVAL M, 1990, DIABETOLOGIA, V33, P187, DOI 10.1007/BF00404794
   Waguri M, 1997, DIABETES, V46, P1281, DOI 10.2337/diabetes.46.8.1281
   Wang RN, 1996, DIABETOLOGIA, V39, P548, DOI 10.1007/s001250050477
   Watanabe RM, 2007, DIABETES, V56, P1481, DOI 10.2337/db06-1682
   Weinhaus AJ, 2007, J ENDOCRINOL, V193, P367, DOI 10.1677/JOE-07-0043
   Xavier GD, 2012, DIABETOLOGIA, V55, P2667, DOI 10.1007/s00125-012-2600-7
   Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0
   Yamashita H, 2003, PEDIATR RES, V53, P411, DOI 10.1203/01.PDR.0000049667.58071.7D
   Yamashita H, 2001, ENDOCRINOLOGY, V142, P2888, DOI 10.1210/en.142.7.2888
   Zabihi S, 2008, TOXICOL SCI, V105, P166, DOI 10.1093/toxsci/kfn101
   Zhang HJ, 2006, MOL ENDOCRINOL, V20, P1853, DOI 10.1210/me.2006-0056
   Zhang H, 2010, DIABETES, V59, P143, DOI 10.2337/db09-0050
NR 114
TC 18
Z9 19
U1 0
U2 24
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0193-1849
EI 1522-1555
J9 AM J PHYSIOL-ENDOC M
JI Am. J. Physiol.-Endocrinol. Metab.
PD DEC
PY 2013
VL 305
IS 11
BP E1327
EP E1338
DI 10.1152/ajpendo.00425.2013
PG 12
WC Endocrinology & Metabolism; Physiology
SC Endocrinology & Metabolism; Physiology
GA 268IX
UT WOS:000328164700001
PM 24085033
OA Green Published
DA 2019-01-08
ER

PT J
AU Singh, H
   Murphy, HR
   Hendrieckx, C
   Ritterband, L
   Speight, J
AF Singh, Harsimran
   Murphy, Helen R.
   Hendrieckx, Christel
   Ritterband, Lee
   Speight, Jane
TI The Challenges and Future Considerations Regarding Pregnancy-Related
   Outcomes in Women with Pre-Existing Diabetes
SO CURRENT DIABETES REPORTS
LA English
DT Article
DE Pregnancy; Pre-existing diabetes; Congenital malformations;
   Preconception counseling; Gestational; Prepregnancy care; Contraception;
   Glycemic control; High-risk pregnancy; Distress; Fetal outcomes;
   Stillbirth; Neonatal death; Newborn; Motherhood
ID PRE-CONCEPTION CARE; PRECONCEPTION CARE; PREPREGNANCY CARE;
   CONGENITAL-MALFORMATIONS; METABOLIC-CONTROL; GLYCEMIC CONTROL; TYPE-1;
   MELLITUS; RISK; HYPOGLYCEMIA
AB Ineffective management of blood glucose levels during preconception and pregnancy has been associated with severe maternal and fetal complications in women with pre-existing diabetes. Studies have demonstrated that preconception counseling and pre-pregnancy care can dramatically reduce these risks. However, pregnancy-related outcomes in women with diabetes continue to be less than ideal. This review highlights and discusses a variety of patient, provider, and organizational factors that can contribute to these suboptimal outcomes. Based on the findings of studies reviewed and authors' clinical and research experiences, recommendations have been proposed focusing on various aspects of care provided, including improved accessibility to effective preconception and pregnancy-related care and better organized clinic consultations that are sensitive to women's diabetes and pregnancy needs.
C1 [Singh, Harsimran; Ritterband, Lee] Univ Virginia, Sch Med, Dept Psychiat & Neurobehav Sci, Div Behav Hlth & Technol, Charlottesville, VA 22903 USA.
   [Murphy, Helen R.] Addenbrookes Hosp, Metab Res Labs, Cambridge CB2 0QQ, England.
   [Murphy, Helen R.] Addenbrookes Hosp, NIHR Cambridge Biomed Ctr, Inst Metab Sci, Cambridge CB2 0QQ, England.
   [Hendrieckx, Christel; Speight, Jane] Australian Ctr Behav Res Diabet, Diabet Australia Vic, Melbourne, Vic 3000, Australia.
   [Hendrieckx, Christel; Speight, Jane] Deakin Univ, Ctr Mental Hlth & Wellbeing Res, Sch Psychol, Burwood, Australia.
   [Speight, Jane] AHP Res, Uxbridge, Middx, England.
RP Singh, H (reprint author), Univ Virginia, Sch Med, Dept Psychiat & Neurobehav Sci, Div Behav Hlth & Technol, 310 Old Ivy Way,Suite 102, Charlottesville, VA 22903 USA.
EM hs9dc@virginia.edu; hm386@medschl.cam.ac.uk; chendrieckx@acbrd.org.au;
   lr5b@virginia.edu; jspeight@acbrd.org.au
RI Ritterband, Lee/G-7810-2011
OI Ritterband, Lee/0000-0001-7624-5213; Speight, Jane/0000-0002-1204-6896
FU National Institute for Health Research; NIH/NIDDK; National Institute
   for Health Research [PDF/01/036, CDF-2013-06-035]
FX Helen R. Murphy is funded by a research fellowship supported by the
   National Institute for Health Research. The views expressed in this
   publication are those of the authors and not necessarily those of the
   NHS, the National Institute for Health Research or the Department of
   Health. Lee Ritterband has been awarded an R21 grant by NIH/NIDDK to
   develop and test the feasibility of an Internet intervention to assist
   women with type 1 diabetes contemplating pregnancy better regulate their
   blood glucose levels in preparation for pregnancy. She is a part equity
   owner of BeHealth Solutions, LLC, a company who licenses software from
   UVA and makes this software and services for evidence-based clinical
   research and who are working to expand public access to proven eHealth
   interventions. This software includes a platform to build and host
   Internet interventions as well as 2 interventions developed by Dr.
   Ritterband and his team (1 for pediatric encopresis and 1 for adults
   with insomnia). Although none of this is explicitly discussed in this
   paper, within the Recommendation section, mention is made of accessing
   care via the Internet. Dr. Ritterband's wife, Dawn Ritterband, provides
   consultation to BeHealth Solutions, LLC.
CR *AM DIAB ASS, 2003, DIABETES CARE S1, V26, pS91
   American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS76
   American Diabetes Association, 2013, DIABETES CARE S1, V36, pS11, DOI DOI 10.2337/DC13-S011
   Balsells M, 2009, J CLIN ENDOCR METAB, V94, P4284, DOI 10.1210/jc.2009-1231
   Bell R, 2008, BJOG-INT J OBSTET GY, V115, P445, DOI 10.1111/j.1471-0528.2007.01644.x
   Bell R, 2012, DIABETOLOGIA
   Berg M, 2000, J PSYCHOSOM OBST GYN, V21, P39, DOI 10.3109/01674820009075607
   Berg M, 2009, BMC PREGNANCY CHILDB, V3, P27
   Berg Marie, 2003, J Perinat Educ, V12, P1
   Berg M, 2005, J PERINAT EDUC, V14, P23, DOI 10.1624/105812405X57552
   Bernasko J, 2004, OBSTET GYNECOL SURV, V59, P628, DOI 10.1097/00006254-200408000-00024
   Boulot P, 2003, DIABETES CARE, V26, P2990
   Brindley BG, 2004, GROWTH GENET HORM, V20, P49
   Casele HL, 1998, ARCH INTERN MED, V158, P1321, DOI 10.1001/archinte.158.12.1321
   Charron-Prochownik D, 2008, DIABETES CARE, V31, P1327, DOI 10.2337/dc07-1266
   CHEW EY, 1995, DIABETES CARE, V18, P631, DOI 10.2337/diacare.18.5.631
   Chuang CH, 2005, WOMEN HEALTH ISS, V15, P167, DOI 10.1016/j.whi.2005.04.002
   Colstrup M, 2013, J MATERN FETAL NEONA
   de Valk HW, 2011, BEST PRACT RES CL OB, V25, P65, DOI 10.1016/j.bpobgyn.2010.10.002
   Delamater AM, 2001, DIABETES CARE, V24, P1286, DOI 10.2337/diacare.24.7.1286
   Downs JS, 2010, DIABETES EDUCATOR, V36, P911, DOI 10.1177/0145721710383586
   Ekbom P, 2000, DIABETOLOGIA, V43, P927, DOI 10.1007/s001250051471
   Evers IM, 2002, DIABETES CARE, V25, P554, DOI 10.2337/diacare.25.3.554
   Evers IN, 2004, BRIT MED J, V328, P915, DOI 10.1136/bmj.38043.583160.EE
   Feig DS, 2002, LANCET, V359, P1690, DOI 10.1016/S0140-6736(02)08599-9
   Finer LB, 2006, PERSPECT SEX REPRO H, V38, P90, DOI 10.1363/3809006
   GARNER P, 1995, LANCET, V346, P157, DOI 10.1016/S0140-6736(95)91213-4
   Gupton A, 2001, J Obstet Gynecol Neonatal Nurs, V30, P192, DOI 10.1111/j.1552-6909.2001.tb01535.x
   Hatmaker DD, 1998, J PERINAT NEONAT NUR, V12, P1
   Holing EV, 1998, DIABETES CARE, V21, P889, DOI 10.2337/diacare.21.6.889
   JANZ NK, 1995, DIABETES CARE, V18, P157, DOI 10.2337/diacare.18.2.157
   Jensen DM, 2004, DIABETES CARE, V27, P2819, DOI 10.2337/diacare.27.12.2819
   Jovanovic L, 2001, DIABETES CARE, V24, P1130, DOI 10.2337/diacare.24.7.1130
   Kendrick JM, 2004, J PERINAT NEONAT NUR, V18, P14, DOI 10.1097/00005237-200401000-00003
   Kendrick JM, 2004, J PERINATAL NEONATAL, V18, P26
   Kim C, 2005, AM J OBSTET GYNECOL, V192, P227, DOI 10.1016/j.ajog.2004.06.105
   King R, 2009, MIDWIFERY, V25, P126, DOI 10.1016/j.midw.2007.01.016
   Kinsley B, 2007, CLIN THER, V29, pS153, DOI 10.1016/j.clinthera.2007.12.015
   Kitzmiller JL, 1996, DIABETES CARE, V19, P514, DOI 10.2337/diacare.19.5.514
   Kitzmiller JL, 2008, DIABETES CARE, V31, P1060, DOI 10.2337/dc08-9020
   Kitzmiller JL, 2010, BIRTH DEFECTS RES A, V88, P791, DOI 10.1002/bdra.20734
   Korenbrot Carol C, 2002, Matern Child Health J, V6, P75, DOI 10.1023/A:1015460106832
   Lain KY, 2007, CLIN OBSTET GYNECOL, V50, P938, DOI 10.1097/GRF.0b013e31815a5494
   Lambert K, 2013, DIABETES OBES METAB, DOI [10.1111/dom.12098, DOI 10.1111/D0M.12098]
   Langer N, 1998, J Matern Fetal Med, V7, P257, DOI 10.1002/(SICI)1520-6661(199811/12)7:6<257::AID-MFM1>3.0.CO;2-H
   Lapolla A, 2008, ACTA DIABETOL, V45, P61, DOI 10.1007/s00592-008-0024-0
   Lavender T, 2010, MIDWIFERY, V26, P589, DOI 10.1016/j.midw.2009.01.003
   Lee-Parritz A, 2012, OBSTET GYNECOL SURV, V67, P168, DOI 10.1097/OGX.0b013e31824bb538
   Lusignan S, 2005, BMC FAM PRACT, V22
   Macintosh MCM, 2006, BRIT MED J, V333, P177, DOI 10.1136/bmj.38856.692986.AE
   Makda SI, 2013, DIABETIC MED, V30, P457, DOI 10.1111/dme.12051
   McCorry NK, 2012, J MIDWIFERY WOM HEAL, V57, P396, DOI 10.1111/j.1542-2011.2011.00143.x
   Meltzer SJ, 2010, DIABETES CARE, V33, P2713, DOI [10.2337/dc10-1744, 10.2337/dc10.1744]
   Murphy HR, 2012, DIABETOLOGIA, V55, P282, DOI 10.1007/s00125-011-2363-6
   Murphy HR, 2011, DIABETIC MED, V28, P1060, DOI 10.1111/j.1464-5491.2011.03333.x
   Murphy HR, 2010, DIABETIC MED, V27, P92, DOI 10.1111/j.1464-5491.2009.02890.x
   Murphy HR, 2007, DIABETES CARE, V30, P2785, DOI 10.2337/dc0-0500
   Murphy HR, 2010, DIABETES CARE, V33, P2514, DOI 10.2337/dc10.1113
   Negrato CA, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-41
   Neithercott T., REAL LIFE STORIES DI
   Nielsen LR, 2008, DIABETES CARE, V31, P9, DOI 10.2337/dc07-1066
   Owens MD, 2006, MATERN CHILD HLTH J, V10, pS137, DOI 10.1007/s10995-006-0098-7
   Pearson DWM, 2007, BJOG-INT J OBSTET GY, V114, P104, DOI 10.1111/j.1471-0528.2006.01145.x
   Penney GC, 2003, BJOG-INT J OBSTET GY, V110, P315, DOI 10.1016/S1470-0328(03)02967-7
   Rasmussen B, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-54
   Ray JG, 2001, QJM-INT J MED, V94, P435, DOI 10.1093/qjmed/94.8.435
   Ringholm L, 2012, DIABETIC MED, V29, P558, DOI 10.1111/j.1464-5491.2012.03604.x
   Ringholm L, 2011, DIABETIC HYPOGLYCEMI, V3, P3
   Ritterband LM, 2003, PROF PSYCHOL-RES PR, V34, P527, DOI 10.1037/0735-7028.34.5.527
   Romano AM, 2007, J PERINAT EDUC, V16, P18, DOI 10.1624/105812407X244903
   ROSENN BM, 1995, OBSTET GYNECOL, V85, P417, DOI 10.1016/0029-7844(94)00415-A
   Rosenn BM, 1996, OBSTET GYNECOL, V87, P568, DOI 10.1016/0029-7844(95)00495-5
   Schwarz EB, 2012, J GEN INTERN MED, V27, P196, DOI 10.1007/s11606-011-1875-6
   Sparud-Lundin C, 2011, BMC MED INFORM DECIS, V7, P49
   Stenhouse E, 2011, MIDWIFERY, V27, P120, DOI 10.1016/j.midw.2009.06.004
   Temple R, 2010, BEST PRACT RES CL EN, V24, P591, DOI 10.1016/j.beem.2010.05.011
   Tripathi A, 2010, DIABETES CARE, V33, P586, DOI 10.2337/dc09-1585
   Trujillo AI, 2007, DIABETES SPECTRUM, V20, P94
   Vargas Roberto, 2010, Rev Obstet Gynecol, V3, P92
   Wahabi HA, 2010, BMC PREGNANCY CHILDB, V14, P63
   Zhu HD, 2012, AUST NZ J OBSTET GYN, V52, P593, DOI 10.1111/ajo.12010
   1990, DIABET MED, V7, P360
   1995, INT J GYNAECOL OBSTE, V50, P201
NR 83
TC 11
Z9 12
U1 2
U2 12
PU CURRENT MEDICINE GROUP
PI PHILADELPHIA
PA 400 MARKET STREET, STE 700, PHILADELPHIA, PA 19106 USA
SN 1534-4827
EI 1539-0829
J9 CURR DIABETES REP
JI Curr. Diabetes Rep.
PD DEC
PY 2013
VL 13
IS 6
BP 869
EP 876
DI 10.1007/s11892-013-0417-5
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 241SR
UT WOS:000326188500012
PM 24013963
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Lloyd, CE
   Gill, P
   Stone, M
AF Lloyd, Cathy E.
   Gill, Paramjit
   Stone, Margaret
TI Psychological Care in a National Health Service: Challenges for People
   with Diabetes
SO CURRENT DIABETES REPORTS
LA English
DT Article
DE Diabetes mellitus; Depression; Diabetes-related emotional distress;
   Primary care; Screening; Guidelines; Psychological care; National health
   service
ID COMORBID DEPRESSION; PREVALENCE; DISTRESS; TYPE-1; ADULTS
AB Recently, there has been a growing interest in psychological problems in people with diabetes and a concomitant increasing concern that these often go unreported and, thus, unidentified and treated. This has serious implications for both the self-management of diabetes and the individual's quality of life. In this review article we consider the question of screening for depression in people with diabetes within a national health service in the UK. The inadequacies of psychological care for patients with diabetes are discussed, in particular with regard to the importance of distinguishing between depressive symptoms and emotional distress related to having diabetes. Criteria for assessing the validity of screening for depression are discussed, together with national and international recommendations, with particular emphasis on current practice. The screening strategy currently recommended for implementation in primary care in the UK is outlined. The need for rigorous evaluation of screening initiatives is highlighted and a key conclusion is that case-finding alone is unlikely to be effective in terms of improving patient outcomes unless considered and applied in the context of overall case management. This review highlights the barriers and challenges to optimizing care for patients with co-morbid diabetes and depression, and outlines the therapies currently available in the UK, which might be disseminated in other countries.
C1 [Lloyd, Cathy E.] Open Univ, Fac Hlth & Social Care, Milton Keynes MK7 6AA, Bucks, England.
   [Gill, Paramjit] Univ Birmingham, Coll Med & Dent Sci, Sch Hlth & Populat Sci, Birmingham B15 2TT, W Midlands, England.
   [Stone, Margaret] Univ Leicester, Leicester Gen Hosp, Diabet Res Unit, Leicester LE5 4PW, Leics, England.
RP Lloyd, CE (reprint author), Open Univ, Fac Hlth & Social Care, Milton Keynes MK7 6AA, Bucks, England.
EM Cathy.Lloyd@open.ac.uk
OI Lloyd, Cathy/0000-0002-8863-3069
CR *AM DIAB ASS, 2011, DIABETES CARE S1, V34, pS11, DOI DOI 10.2337/DC11-S011
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Barnard KD, 2006, DIABETIC MED, V23, P445, DOI 10.1111/j.1464-5491.2006.01814.x
   BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5
   Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505
   Esbitt S. A., 2013, SCREENING DEPRESSION
   Hood K, 2013, SCREENING DEPRESSION
   *INT DIAB FED CLIN, 2005, GLOB GUID TYP 2 DIAB
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Lloyd CE, 2010, DIABETIC MED, V27, P234, DOI 10.1111/j.1464-5491.2009.02896.x
   Lloyd CE, 2010, DEPRESSION DIABETES
   Lloyd CE, 2013, SCREENING DEPRESSION
   Lustman PJ, 2000, DIABETES CARE, V23, P618, DOI 10.2337/diacare.23.5.618
   National Institute for Health and Care Excellence, NICE CLIN GUID 90 DE
   National Institute for Health and Care Excellence, 2009, CLIN GUID 90 DEPR TR
   National Institutes of Health and Clinical Excellence, 2011, QUAL STAND PROGR COS
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Pouwer F, 2006, PATIENT EDUC COUNS, V60, P235, DOI 10.1016/j.pec.2005.01.009
   Pouwer F, 2010, DIABETIC MED, V27, P217, DOI 10.1111/j.1464-5491.2009.02903.x
   Pouwer F, 2009, NAT REV ENDOCRINOL, V5, P665, DOI 10.1038/nrendo.2009.214
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737
NR 23
TC 2
Z9 2
U1 0
U2 6
PU CURRENT MEDICINE GROUP
PI PHILADELPHIA
PA 400 MARKET STREET, STE 700, PHILADELPHIA, PA 19106 USA
SN 1534-4827
EI 1539-0829
J9 CURR DIABETES REP
JI Curr. Diabetes Rep.
PD DEC
PY 2013
VL 13
IS 6
BP 894
EP 899
DI 10.1007/s11892-013-0416-6
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 241SR
UT WOS:000326188500015
PM 24013962
DA 2019-01-08
ER

PT J
AU Christodoulou, C
   Douzenis, A
   Mommersteeg, PMC
   Rallidis, L
   Poulios, A
   Efstathiou, V
   Bouras, G
   Varounis, C
   Korkoliakou, P
   Palios, J
   Kremastinos, DT
   Lykouras, L
AF Christodoulou, Christos
   Douzenis, Athanasios
   Mommersteeg, Paula M. C.
   Rallidis, Loukianos
   Poulios, Antonis
   Efstathiou, Vasiliki
   Bouras, Georgios
   Varounis, Christos
   Korkoliakou, Panagiota
   Palios, John
   Kremastinos, Dimitrios Th
   Lykouras, Lefteris
TI A case-control validation of Type D personality in Greek patients with
   stable coronary heart disease
SO ANNALS OF GENERAL PSYCHIATRY
LA English
DT Article
DE Coronary heart disease; Type D personality; DS14; Validity; HADS
ID D DISTRESSED PERSONALITY; UNHEALTHY LIFE-STYLE; D SCALE DS14;
   PSYCHOLOGICAL DISTRESS; MYOCARDIAL-INFARCTION; SOCIAL INHIBITION;
   CARDIAC PATIENTS; HEALTHY CONTROLS; RISK-FACTORS; PROGNOSIS
AB Background: Type D personality has been associated with a variety of emotional and social difficulties as well as with poor prognosis in patients with established coronary heart disease (CHD). We examined the psychometric properties and validity of the Type D Scale-14 (DS14) and the prevalence of Type D personality among Greek patients with CHD while taking into account demographic; clinical, such as diabetes mellitus, hypertension, and hypercholesterolemia; as well as psychological variables such as depression, anxiety, and psychological stress.
   Methods: Ninety-six patients with stable coronary heart disease and 80 healthy participants from the general population completed the Greek version of the DS14 and the Hospital Anxiety and Depression Scale (HADS).
   Results: Cronbach's a coefficient for the negative affectivity (NA) and social inhibition (SI) subscales was 0.83 and 0.72 for the CHD and 0.88 and 0.76 for the control group, respectively. Internal-structural validity was assessed by a factor analysis (two-factor solution), and the factor structure of the original DS14 was replicated. Using the standardized cutoff point of NA >= 10 and SI >= 10, instead of the median scores, in order to have compatible results with the majority of studies, the prevalence of Type D personality was 51% for the CHD patients and 13% for the control group. Higher NA and SI were connected with higher anxiety, depression, and total psychological stress. Finally, more patients with CHD and Type D personality than those without were diagnosed with type 2 diabetes; however, no differences were observed in hypertension or hypercholesterolemia.
   Conclusions: These results indicate that the Type D construct is reliable and valid in a Greek population. The prevalence of Type D personality was higher in patients with stable coronary heart disease than in people from the general population. The DS14 subscales were positively correlated with higher anxiety, depression, and total psychological stress. Regarding other CHD risk factors, only diabetes mellitus was found more frequently in CHD patients with Type D personality.
C1 [Christodoulou, Christos; Douzenis, Athanasios; Poulios, Antonis; Efstathiou, Vasiliki; Bouras, Georgios; Korkoliakou, Panagiota; Lykouras, Lefteris] Univ Athens, Sch Med, Dept Psychiat 2, Attikon Gen Hosp, Athens 12462, Greece.
   [Mommersteeg, Paula M. C.] Tilburg Univ, Dept Med & Clin Psychol, CoRPS Ctr Res Psychol Somat Dis, NL-5000 LE Tilburg, Netherlands.
   [Rallidis, Loukianos; Varounis, Christos; Palios, John; Kremastinos, Dimitrios Th] Univ Athens, Sch Med, Dept Cardiol 2, Attikon Gen Hosp, Athens 12462, Greece.
RP Christodoulou, C (reprint author), Univ Athens, Sch Med, Dept Psychiat 2, Attikon Gen Hosp, Athens 12462, Greece.
EM christo.christodoulou@gmail.com
RI Efstathiou, Vasiliki/I-3398-2014
OI Efstathiou, Vasiliki/0000-0003-2303-5997; , Douzenis/0000-0002-5321-7276
CR Albus C, 2004, EUR J CARDIOV PREV R, V11, P75, DOI 10.1097/01.hjr.0000116623.84388.6c
   Aquarius AE, 2005, AM J CARDIOL, V96, P996, DOI 10.1016/j.amjcard.2005.05.059
   Chida Y, 2009, J AM COLL CARDIOL, V53, P936, DOI 10.1016/j.jacc.2008.11.044
   Coyne J. C., 2011, PSYCHOSOM MED, V73, P563
   Denollet J, 2000, CIRCULATION, V102, P630, DOI 10.1161/01.CIR.102.6.630
   Denollet J, 2006, EUR HEART J, V27, P171, DOI 10.1093/eurheartj/ehi616
   Denollet J, 2005, PSYCHOSOM MED, V67, P89, DOI 10.1097/01.psy.0000149256.81953.49
   Denollet J, 2001, J PSYCHOSOM RES, V51, P465, DOI 10.1016/S0022-3999(01)00230-6
   Denollet J, 2000, J PSYCHOSOM RES, V49, P255, DOI 10.1016/S0022-3999(00)00177-X
   Denollet J, 1998, CIRCULATION, V97, P167, DOI 10.1161/01.CIR.97.2.167
   Denollet J, 1996, LANCET, V347, P417, DOI 10.1016/S0140-6736(96)90007-0
   Denollet J, 2010, CIRC-CARDIOVASC QUAL, V3, P546, DOI 10.1161/CIRCOUTCOMES.109.934406
   Frasure-Smith N, 2008, ARCH GEN PSYCHIAT, V65, P62, DOI 10.1001/archgenpsychiatry.2007.4
   Grande G, 2004, PSYCHOTHER PSYCH MED, V54, P413, DOI 10.1088/s-2004-828376
   Grande G, 2011, PSYCHOSOM MED, V73, P548, DOI 10.1097/PSY.0b013e318227a9bc
   Hemingway H, 1999, BMJ-BRIT MED J, V318, P1460, DOI 10.1136/bmj.318.7196.1460
   Kupper N, 2013, INT J CARDIOL, V166, P327, DOI 10.1016/j.ijcard.2011.10.084
   Lim HE, 2011, J KOREAN MED SCI, V26, P116, DOI 10.3346/jkms.2011.26.1.116
   Michopoulos Ioannis, 2008, Ann Gen Psychiatry, V7, P4, DOI 10.1186/1744-859X-7-4
   Mommersteeg PMC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-714
   Pedersen SS, 2004, J PSYCHOSOM RES, V57, P265, DOI 10.1016/S0022-3999(03)00614-7
   Pedersen SS, 2004, PSYCHOSOM MED, V66, P714, DOI 10.1097/01.psy.0000132874.82202.21
   Pedersen SS, 2004, J AM COLL CARDIOL, V44, P997, DOI 10.1016/j.jacc.2004.05.064
   Pelle AJ, 2010, CIRC-HEART FAIL, V3, P261, DOI 10.1161/CIRCHEARTFAILURE.109.871483
   Rallidis LS, 2011, EXPERT OPIN PHARMACO, V12, P1481, DOI 10.1517/14656566.2011.591379
   Rozanski A, 1999, CIRCULATION, V99, P2192, DOI 10.1161/01.CIR.99.16.2192
   Sogaro Elena, 2010, Monaldi Arch Chest Dis, V74, P181
   Spindler H, 2009, INT J BEHAV MED, V16, P98, DOI 10.1007/s12529-009-9037-5
   Svansdottir E, 2013, EUR J PREV CARDIOL, V20, P322, DOI 10.1177/2047487312441723
   Svansdottir E, 2012, J BEHAV MED, V35, P155, DOI 10.1007/s10865-011-9337-5
   Tziallas Dimitrios, 2011, BMC Res Notes, V4, P105, DOI 10.1186/1756-0500-4-105
   Whitehead DL, 2007, J PSYCHOSOM RES, V62, P419, DOI 10.1016/j.jpsychores.2006.11.005
   Williams L, 2008, J PSYCHOSOM RES, V64, P63, DOI 10.1016/j.jpsychores.2007.06.008
   Yu DSF, 2010, J PSYCHOSOM RES, V69, P111, DOI 10.1016/j.jpsychores.2010.01.014
   Yu XN, 2008, J PSYCHOSOM RES, V65, P595, DOI 10.1016/j.jpsychores.2008.06.009
   Zigmond AS, 1983, PSYCHIAT SCAND, V76, P361, DOI DOI 10.1111/J.1600-0447.1983.TB09716.X
NR 36
TC 6
Z9 6
U1 0
U2 9
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1744-859X
J9 ANN GEN PSYCHIATR
JI Ann. Gen. Psychiatr.
PD NOV 27
PY 2013
VL 12
AR 38
DI 10.1186/1744-859X-12-38
PG 7
WC Psychiatry
SC Psychiatry
GA 268ET
UT WOS:000328152600001
PM 24283252
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Nobis, S
   Lehr, D
   Ebert, DD
   Berking, M
   Heber, E
   Baumeister, H
   Becker, A
   Snoek, F
   Riper, H
AF Nobis, Stephanie
   Lehr, Dirk
   Ebert, David Daniel
   Berking, Matthias
   Heber, Elena
   Baumeister, Harald
   Becker, Annette
   Snoek, Frank
   Riper, Heleen
TI Efficacy and cost-effectiveness of a web-based intervention with mobile
   phone support to treat depressive symptoms in adults with diabetes
   mellitus type 1 and type 2: design of a randomised controlled trial
SO BMC PSYCHIATRY
LA English
DT Article
DE Diabetes; Depression; Guided web-based self-help; Internet; Randomised
   controlled trial; Efficacy; Cost-effectiveness
ID COGNITIVE-BEHAVIORAL THERAPY; EFFECTIVENESS ACCEPTABILITY CURVES;
   COMORBID MENTAL-DISORDERS; STATE WORRY QUESTIONNAIRE; SCALE-SHORT-FORM;
   SELF-HELP; PSYCHOLOGICAL TREATMENTS; CLINICAL-SIGNIFICANCE; PROBLEM
   DRINKING; GLYCEMIC CONTROL
AB Background: A diagnosis of diabetes mellitus types 1 or 2 doubles the odds of a comorbid depressive disorder. The combined diseases have a wide range of adverse outcomes, such as a lower quality of life, poorer diabetes outcomes and increased healthcare utilisation. Diabetes patients with depression can be treated effectively with psychotherapy, but access to psychological care is limited. In this study we will examine the efficacy and cost-effectiveness of a newly developed web-based intervention (GET. ON Mood Enhancer Diabetes) for people with diabetes and comorbid depressive symptoms.
   Methods/Design: A two-arm randomised controlled trial will be conducted. Adults with diabetes (type 1 or type 2) with increased depression scores (> 22 on the German version of the Center for Epidemiological Studies Depression Scale (CES-D)) will be included. Eligible participants will be recruited through advertisement in diabetes patient journals and via a large-scale German health insurance company. The participants will be randomly assigned to either a 6-week minimally guided web-based self-help program or an online psychoeducation program on depression. The study will include 260 participants, which will enable us to detect a statistically significant difference with a group effect size of d = 0.35 at a power of 80% and a significance level of p = 0.05. The primary outcome measure will be the level of depression as assessed by the CES-D. The secondary outcome measures will be: diabetes-specific emotional distress, glycaemic control, self-management behaviour and the participants' satisfaction with the intervention. Online self-assessments will be collected at baseline and after a 2 months period, with additional follow-up measurements 6 and 12 months after randomisation. The data will be analysed on an intention-to-treat basis and per protocol. In addition, we will conduct an economic evaluation from a societal perspective.
   Discussion: If this intervention is shown to be cost-effective, it has considerable potential for implementing psychological care for large numbers of people with diabetes and comorbid depression in routine practice and improve health outcomes.
C1 [Nobis, Stephanie; Lehr, Dirk; Ebert, David Daniel; Berking, Matthias; Heber, Elena; Riper, Heleen] Univ Luneburg, Div Online Hlth Training, D-21335 Luneburg, Germany.
   [Lehr, Dirk; Ebert, David Daniel; Berking, Matthias] Univ Marburg, Dept Clin Psychol & Psychotherapy, Marburg, Germany.
   [Baumeister, Harald] Univ Freiburg, D-79106 Freiburg, Germany.
   [Becker, Annette] Univ Marburg, Dept Gen Med Family Med, Marburg, Germany.
   [Snoek, Frank] Vrije Univ Amsterdam Med Ctr, Dept Med Psychol, Amsterdam, Netherlands.
   [Riper, Heleen] Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands.
   [Riper, Heleen] Vrije Univ Amsterdam Med Ctr, Inst Hlth & Care Res EMGO, Amsterdam, Netherlands.
RP Nobis, S (reprint author), Univ Luneburg, Div Online Hlth Training, D-21335 Luneburg, Germany.
EM nobis@inkubator.leuphana.de
RI Emchi, Karma/Q-1952-2016
OI Ebert, David Daniel/0000-0001-6820-0146
FU European Union [EFRE: CCI 2007DE161PR001]
FX We would like to acknowledge the European Union for funding this project
   (EFRE: CCI 2007DE161PR001) and the BARMER GEK for supporting the
   recruitment of this study.
CR Aguilera A, 2011, PROF PSYCHOL-RES PR, V42, P472, DOI 10.1037/a0025499
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Andersson G, 2008, BRIT J PSYCHIAT, V193, P270, DOI 10.1192/bjp.bp.108.054080
   Andersson Gerhard, 2009, Cognitive Behaviour Therapy, V38, P196, DOI 10.1080/16506070903318960
   Andrews G, 2001, AUST NZ J PUBL HEAL, V25, P494, DOI 10.1111/j.1467-842X.2001.tb00310.x
   Andrews G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013196
   [Anonymous], 1990, HLTH POLICY, V16, P199
   Attkisson C C, 1982, Eval Program Plann, V5, P233, DOI 10.1016/0149-7189(82)90074-X
   Baglioni C, 2011, J AFFECT DISORDERS, V135, P10, DOI 10.1016/j.jad.2011.01.011
   Barak A, 2008, J TECHNOL HUMAN SERV, V26, P109, DOI 10.1080/15228830802094429
   Barney LJ, 2006, AUST NZ J PSYCHIAT, V40, P51, DOI 10.1080/j.1440-1614.2006.01741.x
   Baumeister H, 2012, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858
   Baumeister H, 2011, PSYCHOTHER PSYCHOSOM, V80, P275, DOI 10.1159/000323404
   Berle D, 2011, CLIN PSYCHOL PSYCHOT, V18, P339, DOI 10.1002/cpp.724
   BLACK WC, 1990, MED DECIS MAKING, V10, P212, DOI 10.1177/0272989X9001000308
   Brazier J, 1998, J CLIN EPIDEMIOL, V51, P1115, DOI 10.1016/S0895-4356(98)00103-6
   Bundesarztekammer Kassenarztliche Bundesvereinigung Arbeitsgemeinschaft der Wissenschaftlichen Medizinische Fachgesellschaften, 2011, PAT NAT VERS UN DEPR
   Cepoiu M, 2008, J GEN INTERN MED, V23, P25, DOI 10.1007/s11606-007-0428-5
   Christensen H, 2006, PSYCHOL MED, V36, P1737, DOI 10.1017/S0033291706008695
   Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278
   Clarke G, 2005, J MED INTERNET RES, V7, DOI 10.2196/jmir.7.2.e16
   Cohen J, 1988, STAT POWER ANAL BEHA
   Coventry PA, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-10
   Cuijpers P, 2010, PSYCHOL MED, V40, P1943, DOI 10.1017/S0033291710000772
   Cuijpers P, 2007, CLIN PSYCHOL REV, V27, P318, DOI 10.1016/j.cpr.2006.11.001
   Cuijpers P, 2007, EUR PSYCHIAT, V22, P9, DOI 10.1016/j.eurpsy.2006.11.001
   D'Zurilla T. J., 1990, PSYCHOL ASSESSMENT, V2, P156, DOI DOI 10.1037/1040-3590.2.2.156
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   de Jongh T, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007459.pub2
   Delamater AM, 2006, CLIN DIABETES, V24, P71, DOI [10.2337/diaclin.24.2.71, DOI 10.2337/DIACLIN.24.2.71]
   DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101
   Dong C, 2004, INT J OBESITY, V28, P790, DOI 10.1038/sj.ijo.0802626
   Donker T, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-79
   Drummond MF, 2007, METHODS EC EVALUATIO
   Egede LE, 2010, DIABETES RES CLIN PR, V87, P302, DOI 10.1016/j.diabres.2010.01.024
   Ehrmann D, 2010, DIABETOL STOFFWECHS, V5, pFV14
   Elhai JD, 2008, PSYCHIAT RES, V159, P320, DOI 10.1016/j.psychres.2007.04.020
   Eysenbach G, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1923
   Fenwick E, 2004, HEALTH ECON, V13, P405, DOI 10.1002/hec.903
   Fenwick E, 2001, HEALTH ECON, V10, P779, DOI 10.1002/hec.635
   Ferrer-Roca O, 2004, J TELEMED TELECARE, V10, P282, DOI 10.1258/1357633042026341
   First M., 1996, USER GUIDE STRUCTURE
   FISCHER EH, 1970, J CONSULT CLIN PSYCH, V35, P79, DOI 10.1037/h0029636
   Fogg BJ, 2003, MORGAN KAUFMANN SERI
   Gahr A, 2011, DIABETOLOGIE STOFFWE, V6
   Ginter E, 2013, ADV EXP MED BIOL, V771, P42
   Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341
   Gregg JA, 2007, J CONSULT CLIN PSYCH, V75, P336, DOI 10.1037/0022-006X.75.2.336
   Hakkaart-Van Roijen L., 2002, MANUAL TRIMBOS IMTA
   Halle M, EVIDENZBASIERTE LEIT
   Harrison V, 2011, J MENT HEALTH, V20, P509, DOI 10.3109/09638237.2011.608746
   Hautzinger M, 2006, BDI 2 BECK DEPRESSIO
   Hautzinger M, 1993, ALLGEMEINE DEPRESSIO
   HERRMANN C, 1994, DIAGNOSTICA, V40, P143
   Hutter N, 2010, DIABETOLOGIA, V53, P2470, DOI 10.1007/s00125-010-1873-y
   International Diabetes Federation, 2012, IDF DIAB ATL
   JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037//0022-006X.59.1.12
   Kaltenthaler E, 2006, HEALTH TECHNOL ASSES, V10, P1, DOI 10.3310/hta10330
   Kanter JW, 2007, J PSYCHOPATHOL BEHAV, V29, P191, DOI 10.1007/s10862-006-9038-5
   Katon W, 2008, J GEN INTERN MED, V23, P1571, DOI 10.1007/s11606-008-0731-9
   Katon WJ, 2005, DIABETES CARE, V28, P2668, DOI 10.2337/diacare.28.11.2668
   Katon WJ, 2004, MED CARE, V42, P1222, DOI 10.1097/00005650-200412000-00009
   Kay-Lambkin FJ, 2009, ADDICTION, V104, P378, DOI 10.1111/j.1360-0443.2008.02444.x
   Krauth C, 2010, GESUNDH QUAL, V15, P251, DOI 10.1055/s-0029-1245680
   Ladwig I, VERHALTENST IN PRESS
   Lambert MJ, 2009, PSYCHOTHER RES, V19, P493, DOI 10.1080/10503300902849483
   Lehnert T, 2011, PSYCHIAT PRAX, V38, P369, DOI 10.1055/s-0031-1276934
   Leone T, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-39
   Little R J, 2002, STAT ANAL MISSING DA
   Lokkerbol J, 2013, AM J GERIAT IN PRESS
   Manos RC, 2011, BEHAV THER, V42, P726, DOI 10.1016/j.beth.2011.04.004
   Meyer B, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1151
   MEYER TJ, 1990, BEHAV RES THER, V28, P487, DOI 10.1016/0005-7967(90)90135-6
   Mitchell AJ, 2009, LANCET, V374, P609, DOI 10.1016/S0140-6736(09)60879-5
   Mitchell J., 2010, ELECT J APPL PSYCHOL, V6, P30, DOI DOI 10.7790/EJAP.V6I2.230
   Morin CM, 2006, SLEEP, V29, P1398, DOI 10.1093/sleep/29.11.1398
   Papelbaum M, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-26
   Peinemann F, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008216.pub4, 10.1371/journal.pmed.1000097, 10.1136/bmj.c869, 10.1136/bmj.b2535, 10.1016/j.jclinepi.2010.02.006, 10.1002/14651858.CD008242.pub3, 10.1016/j.jclinepi.2010.03.004]
   Petrak F, 2009, CURR OPIN PSYCHIATR, V22, P211, DOI 10.1097/YCO.0b013e3283207b45
   Piette JD, 2004, AM J MANAG CARE, V10, P152
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Prochaska JO, 1997, AM J HEALTH PROMOT, V12, P38, DOI 10.4278/0890-1171-12.1.38
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Riper H, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1691
   Riper H, 2009, ALCOHOL CLIN EXP RES, V33, P1401, DOI 10.1111/j.1530-0277.2009.00970.x
   Rohde P, 1997, AM J PSYCHIAT, V154, P1593, DOI 10.1176/ajp.154.11.1593
   Ruwaard J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040089
   Schafer JL, 2000, MONOGRAPHS STAT APPL, V72
   SCHMIDT J, 1989, PSYCHOTHER PSYCH MED, V39, P248
   Schmitt A, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-138
   Schram MT, 2009, CURR DIABETES REV, V5, P112, DOI 10.2174/157339909788166828
   Schulte D, 2005, Z KL PSYCH PSYCHOTH, V34, P176, DOI 10.1026/1616-3443.34.3.176
   Simon GE, 2005, GEN HOSP PSYCHIAT, V27, P344, DOI 10.1016/j.genhosppsych.2005.04.008
   Simon GE, 2007, ARCH GEN PSYCHIAT, V64, P65, DOI 10.1001/archpsyc.64.1.65
   Smit F, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1694
   Spek V, 2007, PSYCHOL MED, V37, P319, DOI 10.1017/S0033291706008944
   van Bastelaar K, 2011, PATIENT EDUC COUNS, V84, P49, DOI 10.1016/j.pec.2010.06.013
   van Bastelaar KM, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-9
   van Bastelaar KMP, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1657
   van Bastelaar KMP, 2011, DIABETES CARE, V34, P320, DOI 10.2337/dc10-1248
   van Eimeren B, 2012, 76 PROZENT DTSCH ONL
   Wangberg Silje C, 2008, Patient Prefer Adherence, V2, P57
   Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003
   Warmerdam L, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1436
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
NR 105
TC 17
Z9 17
U1 4
U2 49
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-244X
J9 BMC PSYCHIATRY
JI BMC Psychiatry
PD NOV 15
PY 2013
VL 13
AR 306
DI 10.1186/1471-244X-13-306
PG 10
WC Psychiatry
SC Psychiatry
GA 281YA
UT WOS:000329135700001
PM 24238346
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Hayashino, Y
   Tsujii, S
   Ishii, H
AF Hayashino, Y.
   Tsujii, S.
   Ishii, H.
CA Tenri Study Grp
TI High Frequency of Non-nocturnal Hypoglycemia was Associated with Poor
   Sleep Quality Measure by Pittsburg Sleep Quality Index in Patients with
   Diabetes Receiving Insulin Therapy: Diabetes Distress and Care Registry
   at Tenri (DDCRT 4)
SO EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
LA English
DT Article
DE diabetes; autoimmunity; hypoglycemia; sleep
ID YOUNG-CHILDREN; MELLITUS; DEPRESSION; DURATION; IMPACT
AB Aims: To investigate the temporal association between frequency of non-nocturnal hypoglycemia and sleep quality among patients with diabetes receiving insulin therapy.
   Methods: We used data from 1 513 patients with diabetes receiving insulin therapy. We estimated the relative risks (RR) of the frequency of non-nocturnal hypoglycemia for poor sleep quality measured by the Pittsburgh Sleep Quality Index.
   Results: The average age and HbA1c value of the patients were 63.7 years and 7.8%, respectively. Compared with poor sleep quality in patients without any type of non-nocturnal disabling hypoglycemia (NNDH), the multivariablea-djusted RR values for poor sleep quality were 1.30 (95 % confidence interval [CI], 1.06-1.61) and 1.37 (95 % CI, 0.96-1.95) in patients who experienced 1-4 and >= 5 episodes of NNDH, respectively (p = 0.004). Experiencing non-nocturnal severe hypoglycemia (NNSH) once in the past 90 days significantly increased the risk of poor sleep quality by 1.54 episodes (95 % CI, 1.16-2.05; p = 0.003). By adding the presence of depression as a variable to the multivariable-adjusted model, these associations were attenuated because we did not observe any significant association between NNDH and poor sleep quality (p = 0.178). However, a significant association between NNSH and poor sleep quality was observed (RR = 1.43; 95 % CI, 1.09-1.90; p = 0.011).
   Conclusions: A high frequency of non-nocturnal hypoglycemia was associated with poor sleep quality in patients with diabetes receiving insulin therapy. Our data also suggested that the association of NNDH, and not NNSH, was mediated by comorbid depression.
C1 [Hayashino, Y.; Tsujii, S.; Ishii, H.] Tenri Hosp, Dept Endocrinol, Tenri, Nara 6328552, Japan.
   [Tsujii, S.] Tenri Hosp, Ctr Diabet, Tenri, Nara 6328552, Japan.
RP Hayashino, Y (reprint author), Tenri Hosp, Dept Endocrinol, Mishima Cho 200, Tenri, Nara 6328552, Japan.
EM hayasino-y@umin.net
OI Hayashino, Yasuaki/0000-0002-2932-8478; Tsujii,
   Satoru/0000-0002-1834-6515
FU Manpei Suzuki Diabetes Foundation
FX The Manpei Suzuki Diabetes Foundation supported this study.
CR Ayas NT, 2003, DIABETES CARE, V26, P380, DOI 10.2337/diacare.26.2.380
   Batal O, 2011, LUNG, V189, P141, DOI 10.1007/s00408-010-9277-9
   Brod Meryl, 2012, J Med Econ, V15, P77, DOI 10.3111/13696998.2011.624144
   BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4
   CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112
   Doi Y, 1998, JAPANESE J PSYCHIAT, V13, P755
   Gottlieb DJ, 2005, ARCH INTERN MED, V165, P863, DOI 10.1001/archinte.165.8.863
   Green AJ, 2012, DIABETES RES CLIN PR, V96, P313, DOI 10.1016/j.diabres.2012.01.002
   Guillod L, 2007, DIABETES METAB, V33, P360, DOI 10.1016/j.diabet.2007.03.007
   Hayashino Y, 2012, DIABET MED
   HAYASHINO Y, 2012, DIABETES RES CLIN PR
   Jauch-Chara K, 2007, DIABETES, V56, P1938, DOI 10.2337/db07-0044
   Mashitani T, 2013, DIABETES RES CLIN PR, V100, P189, DOI 10.1016/j.diabres.2013.03.006
   Matyka KA, 2000, J PEDIATR-US, V137, P233, DOI 10.1067/mpd.2000.107186
   McHale M, 2008, PSYCHOSOM MED, V70, P869, DOI 10.1097/PSY.0b013e318186dea9
   Park MJ, 2012, METABOLISM, V61, P229, DOI 10.1016/j.metabol.2011.06.013
   Porter PA, 1997, J PEDIATR-US, V130, P366, DOI 10.1016/S0022-3476(97)70197-5
   Randloff LS, 1977, APPL PSYCH MEAS, V3, P385
   Resnick HE, 2003, DIABETES CARE, V26, P702, DOI 10.2337/diacare.26.3.702
   Rothman KJ, 1998, MODERN EPIDEMIOLOGY
   Schultes Bernd, 2007, PLoS Med, V4, pe69, DOI 10.1371/journal.pmed.0040069
   Skomro RP, 2001, SLEEP MED, V2, P417, DOI 10.1016/S1389-9457(01)00110-1
   Yaggi HK, 2006, DIABETES CARE, V29, P657, DOI 10.2337/diacare.29.03.06.dc05-0879
NR 23
TC 6
Z9 6
U1 0
U2 2
PU JOHANN AMBROSIUS BARTH VERLAG MEDIZINVERLAGE HEIDELBERG GMBH
PI STUTTGART
PA RUEDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 0947-7349
EI 1439-3646
J9 EXP CLIN ENDOCR DIAB
JI Exp. Clin. Endocrinol. Diabet.
PD NOV
PY 2013
VL 121
IS 10
BP 628
EP 634
DI 10.1055/s-0033-1355424
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 267TV
UT WOS:000328122000009
PM 24277485
DA 2019-01-08
ER

PT J
AU Jacob, MM
   Gonzales, KL
   Calhoun, D
   Beals, J
   Muller, CJ
   Goldberg, J
   Nelson, L
   Welty, TK
   Howard, BV
AF Jacob, Michelle M.
   Gonzales, Kelly L.
   Calhoun, Darren
   Beals, Janette
   Muller, Clemma Jacobsen
   Goldberg, Jack
   Nelson, Lonnie
   Welty, Thomas K.
   Howard, Barbara V.
TI Psychological trauma symptoms and Type 2 diabetes prevalence, glucose
   control, and treatment modality among American Indians in the Strong
   Heart Family Study
SO JOURNAL OF DIABETES AND ITS COMPLICATIONS
LA English
DT Article
DE Diabetes treatment modality; American Indians; Psychological trauma
   symptoms
ID HEALTH-CARE PROVIDERS; RESERVATION COMMUNITIES; CARDIOVASCULAR-DISEASE;
   DEPRESSIVE SYMPTOMS; EMOTIONAL DISTRESS; MENTAL-DISORDERS;
   STRESS-DISORDER; OLDER-ADULTS; ASSOCIATION; RISK
AB Aims: The aims of this paper are to examine the relationship between psychological trauma symptoms and Type 2 diabetes prevalence, glucose control, and treatment modality among 3776 American Indians in Phase V of the Strong Heart Family Study.
   Methods: This cross-sectional analysis measured psychological trauma symptoms using the National Anxiety Disorder Screening Day instrument, diabetes by American Diabetes Association criteria, and treatment modality by four categories: no medication, oral medication only, insulin only, or both oral medication and insulin. We used binary logistic regression to evaluate the association between psychological trauma symptoms and diabetes prevalence. We used ordinary least squares regression to evaluate the association between psychological trauma symptoms and glucose control. We used binary logistic regression to model the association of psychological trauma symptoms with treatment modality.
   Results: Neither diabetes prevalence (22%-31%; p = 0.19) nor control (8.0-8.6; p = 0.25) varied significantly by psychological trauma symptoms categories. However, diabetes treatment modality was associated with psychological trauma symptoms categories, as people with greater burden used either no medication, or both oral and insulin medications (odds ratio = 3.1, p < 0.001).
   Conclusions: The positive relationship between treatment modality and psychological trauma symptoms suggests future research investigate patient and provider treatment decision making. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Jacob, Michelle M.] Univ San Diego, Dept Ethn Studies, San Diego, CA 92110 USA.
   [Jacob, Michelle M.] Heritage Univ, Ctr Native Hlth & Culture, San Diego, CA 92110 USA.
   [Gonzales, Kelly L.] Portland State Univ, Coll Urban & Publ Affairs, Sch Community Hlth, Portland, OR 97201 USA.
   [Calhoun, Darren] MedStar Hlth Res Inst, Phoenix, AZ 85016 USA.
   [Beals, Janette] Univ Colorado, Ctr Amer Indian Hlth, Aurora, CO 80045 USA.
   [Beals, Janette] Univ Colorado, Ctr Alaska Native Hlth, Aurora, CO 80045 USA.
   [Muller, Clemma Jacobsen] Univ Washington, Seattle, WA 98101 USA.
   [Goldberg, Jack] Univ Washington, VET Registry, Seattle VA ERIC Res Prof Epidemiol, Seattle, WA 98101 USA.
   [Nelson, Lonnie] Univ Washington, Sch Publ Hlth, Dept Hlth Serv, Seattle, WA 98101 USA.
   [Welty, Thomas K.] Missouri Breaks Res Inc, Timber Lake, SD 57656 USA.
   [Howard, Barbara V.] MedStar Hlth Res Inst, Hyattsville, MD USA.
   [Howard, Barbara V.] Georgetown Univ, Ctr Translat Sci, Hyattsville, MD USA.
   [Howard, Barbara V.] Howard Univ, Ctr Translat Sci, Hyattsville, MD USA.
RP Jacob, MM (reprint author), Univ San Diego, Dept Ethn Studies, 5998 Alcala Pk,Maher 206, San Diego, CA 92110 USA.
EM mjacob@sandiego.edu
OI Muller, Clemma/0000-0001-5379-8747
FU Native Elder Research Center [AG015292]; Heritage University Center for
   Native Health & Culture Faculty Fellowship; National Heart, Lung and
   Blood Institute [U01HL-41642, U01HL-41652, U01HL-41654]
FX Native Elder Research Center AG015292; Heritage University Center for
   Native Health & Culture Faculty Fellowship.; National Heart, Lung and
   Blood Institute U01HL-41642, U01HL-41652 and U01HL-41654.
CR Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Beals J, 2005, ARCH GEN PSYCHIAT, V62, P99, DOI 10.1001/archpsyc.62.1.99
   Boyko EJ, 2010, DIABETES CARE, V33, P1771, DOI 10.2337/dc10-0296
   Calhoun D, 2009, J DIABETES COMPLICAT, V24, P217
   Centers for Disease Control and Prevention, 2007, NAT DIAB FACT SHEET
   Clar C, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14120
   Dedert EA, 2010, ANN BEHAV MED, V39, P61, DOI 10.1007/s12160-010-9165-9
   Delahanty LM, 2007, DIABETIC MED, V24, P48, DOI 10.1111/j.1464-5491.2007.02028.x
   Everson-Rose SA, 2004, DIABETES CARE, V27, P2856, DOI 10.2337/diacare.27.12.2856
   Garroutte EM, 2006, J GEN INTERN MED, V21, P111, DOI 10.1111/j.1525-1497.2006.00321.x
   Garroutte EM, 2004, SOC SCI MED, V59, P2233, DOI 10.1016/j.socscimed.2004.03.032
   Garroutte EM, 2008, SOC SCI MED, V67, P546, DOI 10.1016/j.socscimed.2008.04.015
   Goodwin RD, 2005, PREV MED, V40, P570, DOI 10.1016/j.ypmed.2004.07.013
   Jiang LH, 2008, DIABETES CARE, V31, P427, DOI 10.2337/dc07-2044
   Jiang L, 2007, DIABETES CARE, V30, P2228, DOI 10.2337/dc07-0097
   LEE ET, 1990, AM J EPIDEMIOL, V132, P1141, DOI 10.1093/oxfordjournals.aje.a115757
   Lin EHB, 2008, J PSYCHOSOM RES, V65, P571, DOI 10.1016/j.jpsychores.2008.06.007
   Lin PI, 2010, SCHIZOPHR RES, V123, P234, DOI 10.1016/j.schres.2010.08.022
   Lustman PJ, 2007, PSYCHOSOM MED, V69, P297, DOI 10.1097/PSY.0b013e318060cc2d
   Lustman PJ, 2002, J PSYCHOSOM RES, V53, P917, DOI 10.1016/S0022-3999(02)00416-6
   Marshall RD, 2001, AM J PSYCHIAT, V158, P1467, DOI 10.1176/appi.ajp.158.9.1467
   O'Connell J, 2010, DIABETES CARE, V33, P1463, DOI 10.2337/dc09-1652
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Ratanawongsa N, 2012, DIABETES EDUCATOR, V38, P94, DOI 10.1177/0145721711432649
   Ritsher JB, 2002, PSYCHIAT RES, V111, P199, DOI 10.1016/S0165-1781(02)00135-X
   Roubideaux Y., 2010, PRIORITIES REFORMING
   van Bastelaar KMP, 2010, DIABETIC MED, V27, P798, DOI 10.1111/j.1464-5491.2010.03025.x
   Wang H, 2010, DIABETES-METAB RES, V26, P378, DOI 10.1002/dmrr.1089
   WELTY TK, 1995, AM J EPIDEMIOL, V142, P269, DOI 10.1093/oxfordjournals.aje.a117633
NR 29
TC 5
Z9 5
U1 0
U2 12
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1056-8727
EI 1873-460X
J9 J DIABETES COMPLICAT
JI J. Diabetes Complications
PD NOV-DEC
PY 2013
VL 27
IS 6
BP 553
EP 557
DI 10.1016/j.jdiacomp.2013.07.008
PG 5
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 257UZ
UT WOS:000327414600004
PM 24051029
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Brumby, S
   Chandrasekara, A
   Kremer, P
   Torres, S
   McCoombe, S
   Lewandowski, P
AF Brumby, Susan
   Chandrasekara, Ananda
   Kremer, Peter
   Torres, Susan
   McCoombe, Scott
   Lewandowski, Paul
TI The effect of physical activity on psychological distress, cortisol and
   obesity: results of the farming fit intervention program
SO BMC PUBLIC HEALTH
LA English
DT Article
DE Obesity; Cortisol; Mental health; Rural; Farmer
ID METABOLIC SYNDROME; DEPRESSION; EXERCISE; STRESS
AB Background: Rural and regional Australians have a higher likelihood of mental illness throughout their lifetime than people living in major cities, although the underlying reasons are not yet well defined. Additionally, rural populations experience more lifestyle associated co-morbidities including obesity, diabetes and cardiovascular disease. Research conducted by the National Centre for Farmer Health between 2004 and 2009 revealed a positive correlation between obesity and psychological distress among the farming community. Chronic stress is known to overstimulate the regulation of the hypothalamic-pituitary-adrenal (HPA) axis and cortisol secretion which are associated with abdominal adiposity. Increasing physical activity may normalise cortisol secretion and thereby positively impact both physical and mental health. This paper assesses the effects of increasing physical activity on obesity, health behaviors and mental health in Victorian farming men and women.
   Methods: Farming Fit was a six month quasi-experimental (convenience sample) longitudinal design control-intervention study. Overweight or obese (BMI >= 25 kg/m(2)) farm men (n = 43) and women (n = 29) were recruited with demographic, health behaviors, anthropometric, blood pressure and biochemistry data collected at baseline and at a six months. Salivary cortisol and depression anxiety stress scale results were collected at baseline, three and six months. The intervention group (n = 37) received a personalized exercise program and regular phone coaching to promote physical activity. Results: The intervention group showed significant reductions in body weight and waist circumference.
   Results indicated that following the six month exercise program, the intervention group were 2.64 +/- 0.65 kg lighter (p < 0.001), had reduced waist circumference by 2.01 +/- 0.86 cm (p = 0.02) and BMI by 0.97 +/- 0.22 kg/m(2) (p < 0.001) relative to the control group.
   Conclusion: Increasing physical activity altered measures of obesity in farm men and women but did not affect mental health measures or cortisol secretion levels.
C1 [Brumby, Susan; Chandrasekara, Ananda; McCoombe, Scott] Western Dist Hlth Serv, Natl Ctr Farmer Hlth, Hamilton, Vic 3300, Australia.
   [Brumby, Susan; Chandrasekara, Ananda; McCoombe, Scott; Lewandowski, Paul] Deakin Univ, Sch Med, Geelong, Vic 3216, Australia.
   [Kremer, Peter] Deakin Univ, Sch Exercise & Nutr Sci, Geelong, Vic 3216, Australia.
   [Torres, Susan] Deakin Univ, Sch Exercise & Nutr Sci, Burwood, Vic 3125, Australia.
RP Brumby, S (reprint author), Western Dist Hlth Serv, Natl Ctr Farmer Hlth, POB 283, Hamilton, Vic 3300, Australia.
EM susan.brumby@deakin.edu.au
RI Mashamba-Thompson, Tivani/B-6087-2014
OI Kremer, Peter/0000-0003-2476-1958
FU beyondblue; Victorian Department of Primary Industries
FX We acknowledge the funding agencies involved in this study: beyondblue
   and the Victorian Department of Primary Industries. We would also like
   to thank and acknowledge the contributions of Jason Thomas, Hannah
   Simkin, Tracey Hatherell, Cate Mercer-Grant, Wayne Munro, April
   Brinkmann, Jo Williams, Bianca Todd, SFF health professionals and the
   farm men and women participating.
CR Alston M, 2004, AGR HUM VALUES, V21, P37, DOI 10.1023/B:AHUM.0000014019.84085.59
   *AUSTR BUR STAT, 2009, NAT HLTH SURV SUMM R, V2012
   Australian Bureau of Statistics, 2007, NAT SURV MENT HLTH W
   Australian Bureau of Statistics, 2010, CAUS DEATH AUSTR 200
   Australian Institute of Health and Welfare Australia's Health, 2010, 12 AIHW
   Bjorntorp P, 2000, BLOOD PRESSURE, V9, P71, DOI 10.1080/08037050050151762
   Booth ML, 2003, MED SCI SPORTS EXERC, V195, P3508
   Brumby S, 2009, RURAL REMOTE HEALTH, V9, P1
   BRUMBY S, 2012, 22 WORLD C GLOB WELL
   Brumby S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-362
   Brumby Susan, 2011, BMC Res Notes, V4, P89, DOI 10.1186/1756-0500-4-89
   Collins P, 2012, INT J ENV RES PUB HE, V9, P3030, DOI 10.3390/ijerph9093030
   Dallman MF, 2003, P NATL ACAD SCI USA, V100, P11696, DOI 10.1073/pnas.1934666100
   Dunbar JA, 2008, DIABETES CARE, V31, P2368, DOI 10.2337/dc08-0175
   EGGER G, 2005, PHYS ACTIVITY GUIDEL
   International Physical Activity Questionnaire, 2005, GUID DAT PROC AN INT
   Jones AP, 1998, J PUBLIC HEALTH MED, V20, P312, DOI 10.1093/oxfordjournals.pubmed.a024774
   Keppel G., 1991, DESIGN ANAL RES HDB
   LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U
   Lovibond SH, 1995, MANUAL DEPRESSION AN
   MACHADORODRIGUE.AM, 2012, URBAN RURAL CONTRAST
   Mathers CD, 2001, B WORLD HEALTH ORGAN, V79, P1076
   Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO
   SCHWARZ L, 1992, SPORTS MED, V13, P25, DOI 10.2165/00007256-199213010-00003
   Vaughan C, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-273
   Wu T, 2009, OBES REV, V10, P313, DOI 10.1111/j.1467-789X.2008.00547.x
NR 26
TC 7
Z9 7
U1 1
U2 37
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD OCT 28
PY 2013
VL 13
AR UNSP 1018
DI 10.1186/1471-2458-13-1018
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 284BH
UT WOS:000329290500002
PM 24165391
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Gucciardi, E
   Fortugno, M
   Senchuk, A
   Beanlands, H
   McCay, E
   Peel, EE
AF Gucciardi, Enza
   Fortugno, Mariella
   Senchuk, Andrea
   Beanlands, Heather
   McCay, Elizabeth
   Peel, Elizabeth E.
TI Self-monitoring of blood glucose in Black Caribbean and South Asian
   Canadians with non-insulin treated Type 2 diabetes mellitus: a
   qualitative study of patients' perspectives
SO BMC ENDOCRINE DISORDERS
LA English
DT Article
DE Self-monitoring of blood glucose; Diabetes mellitus; Caribbean; South
   Asian
ID GLYCEMIC CONTROL; HEALTH BELIEFS; TEST STRIPS; ORIGIN; METAANALYSIS;
   INDIVIDUALS; PERCEPTIONS; MANAGEMENT; PAKISTANI; EFFICACY
AB Background: To examine the views and current practice of SMBG among Black Caribbean and South Asian individuals with non-insulin treated Type 2 diabetes mellitus.
   Methods: Twelve participants completed semi-structured interviews that were guided by the Health Belief Model and analyzed using thematic network analysis.
   Results: The frequency of monitoring among participants varied from several times a day to once per week. Most participants expressed similar experiences regarding their views and practices of SMBG. Minor differences across gender and culture were observed. All participants understood the benefits, but not all viewed SMBG as beneficial to their personal diabetes management. SMBG can facilitate a better understanding and maintenance of self-care behaviours. However, it can trigger both positive and negative emotional responses, such as a sense of disappointment when high readings are not anticipated, resulting in emotional distress. Health care professionals play a key role in the way SMBG is perceived and used by patients.
   Conclusion: While the majority of participants value SMBG as a self-management tool, barriers exist that impede its practice, particularly its cost. How individuals cope with these barriers is integral to understanding why some patients adopt SMBG more than others.
C1 [Gucciardi, Enza; Fortugno, Mariella; Senchuk, Andrea] Ryerson Univ, Sch Nutr, Toronto, ON M5B 2K3, Canada.
   [Beanlands, Heather; McCay, Elizabeth] Ryerson Univ, Daphne Cockwell Sch Nursing, Toronto, ON M5B 2K3, Canada.
   [Peel, Elizabeth E.] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England.
RP Gucciardi, E (reprint author), Ryerson Univ, Sch Nutr, 350 Victoria St, Toronto, ON M5B 2K3, Canada.
EM egucciar@ryerson.ca
FU SSHRC Institutional Grant (SIG) Research, Ryerson University; Faculty of
   Community Services Seed Grant, Ryerson University
FX SSHRC Institutional Grant (SIG) Research, Ryerson University; Faculty of
   Community Services Seed Grant, Ryerson University.
CR Allemann S, 2009, CURR MED RES OPIN, V25, P2903, DOI 10.1185/03007990903364665
   [Anonymous], 2007, INT J TECHNOL ASSESS, V23, P146
   Attride-Stirling J, 2001, QUALITATIVE RES, V1, P385, DOI [DOI 10.1177/146879410100100307, 10.1177/146879410100100307]
   Barnett AH, 2008, DIABETES OBES METAB, V10, P1239, DOI 10.1111/j.1463-1326.2008.00894.x
   Bhopal R, 1999, BRIT MED J, V319, P215, DOI 10.1136/bmj.319.7204.215
   Cameron C, 2010, CAN J DIABETES, V34, P34, DOI 10.1016/S1499-2671(10)41008-4
   Cameron C, 2010, CAN MED ASSOC J, V182, P28, DOI 10.1503/cmaj.090765
   *CAN DIAB ASS, 2008, CAN J DIABETES S1, V32, P1
   Canadian Agency for Drugs and Technologies in Health, 2009, GAP AN KEY MESS PRES
   Canadian Diabetes Association, 2013, SELF MON BLOOD GLUC
   Canadian Optimal Medication Prescribing and Use Service, 2008, SYST REV US BLOOD GL
   Creatore MI, 2010, CAN MED ASSOC J, V182, P781, DOI 10.1503/cmaj.091551
   DiMatteo MR, 2007, MED CARE, V45, P521, DOI 10.1097/MLR.0b013e318032937e
   Ezenwaka CE, 2012, ARCH PHYSIOL BIOCHEM, V118, P16, DOI 10.3109/13813455.2011.625950
   Funnell MM, 2007, DIABETES EDUCATOR, V33, P1012, DOI 10.1177/0145721707308630
   Gerrald KR, 2010, CLIN DIABETES, V28, P121
   Gomersall T, 2011, QUAL HEALTH RES, V21, P853, DOI 10.1177/1049732311402096
   Gomes T, 2010, CAN MED ASSOC J, V182, P35, DOI 10.1503/cmaj.091017
   Harvey JN, 2009, DIABETIC MED, V26, P5, DOI 10.1111/j.1464-5491.2008.02628.x
   Hjelm KG, 2005, J ADV NURS, V50, P47, DOI 10.1111/j.1365-2648.2004.03348.x
   Karter AJ, 2000, DIABETES CARE, V23, P477, DOI 10.2337/diacare.23.4.477
   King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414
   Latter C, 2011, CAN J DIABETES, V35, P31, DOI 10.1016/S1499-2671(11)51006-8
   Lawton J, 2005, BRIT MED J, V330, P1247, DOI 10.1136/bmj.38460.642789.E0
   Malanda UL, 2012, COCHRANE DB SYST REV, V1, P1, DOI DOI 10.1002/14651858.CD005060
   McAndrew L, 2007, DIABETES EDUCATOR, V33, P991, DOI 10.1177/0145721707309807
   McGeoch G, 2007, DIABETES-METAB RES, V23, P423, DOI 10.1002/dmrr.749
   Miller D, 2011, CAN J DIABETES, V35, P317, DOI 10.1016/S1499-2671(11)54003-1
   Nyomba BLG, 2002, DIABETES CARE, V25, P1244, DOI 10.2337/diacare.25.7.1244-a
   O'Kane MJ, 2008, BRIT MED J, V336, P1174, DOI 10.1136/bmj.39534.571644.BE
   Peel E, 2004, BRIT J GEN PRACT, V54, P183
   Peel E, 2007, BRIT MED J, V335, P493, DOI 10.1136/bmj.39302.444572.DE
   Poolsup N, 2008, DIABETES TECHNOL THE, V10, pS51, DOI 10.1089/dia.2008.0001
   Rosenstock I. M., 1997, HLTH BEHAV HLTH ED T
   SMBG International Working Group, 2008, Diabetes Res Clin Pract, V82, pe15, DOI 10.1016/j.diabres.2008.08.021
   St John A, 2010, J DIABETES COMPLICAT, V24, P129, DOI 10.1016/j.jdiacomp.2009.01.002
   Tan MY, 2004, DIABETES RES CLIN PR, V66, P71, DOI 10.1016/j.diabres.2004.02.021
   The British Heart Foundation Statistics Website, 2008, ETHN DIFF PREV DIAB
   Towfigh A, 2008, AM J MANAG CARE, V14, P468
   Williams AS, 2004, DIABETES ACTION NETW, P19
   Woo V, 2010, CAN J DIABETES, V34, P19, DOI 10.1016/S1499-2671(10)41003-5
   Yi-Frazier JP, 2010, STRESS HEALTH, V26, P51, DOI 10.1002/smi.1258
NR 42
TC 7
Z9 7
U1 1
U2 19
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1472-6823
J9 BMC ENDOCR DISORD
JI BMC Endocr. Disord.
PD OCT 14
PY 2013
VL 13
AR 46
DI 10.1186/1472-6823-13-46
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 258GM
UT WOS:000327447300001
PM 24119213
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Stephens, MAP
   Franks, MM
   Rook, KS
   Iida, M
   Hemphill, RC
   Salem, JK
AF Stephens, Mary Ann Parris
   Franks, Melissa M.
   Rook, Karen S.
   Iida, Masumi
   Hemphill, Rachel C.
   Salem, James K.
TI Spouses' Attempts to Regulate Day-to-Day Dietary Adherence Among
   Patients With Type 2 Diabetes
SO HEALTH PSYCHOLOGY
LA English
DT Article
DE social support; social control; dietary adherence; daily diary
   assessments; married couples
ID ECOLOGICAL MOMENTARY ASSESSMENT; SOCIAL-CONTROL; HEALTH BEHAVIORS;
   PSYCHOLOGICAL DISTRESS; SELF-MANAGEMENT; CHRONIC ILLNESS; SUPPORT;
   MELLITUS; IMPACT; ADULTS
AB Objective: To investigate daily dietary adherence and diabetes-specific distress among older adults with type 2 diabetes mellitus (T2DM) as a function of spouses' diet-related support and diet-related control (persuasion and pressure) and whether these daily processes differ among couples who do and do not appraise responsibility for managing T2DM as shared. Methods: End-of-day diaries were completed by 126 couples in which one partner had T2DM (patient) and the other did not (spouse). Using electronic diary methods, each partner independently recorded data for 24 consecutive days (patients recorded their day's dietary adherence and diabetes-specific distress; spouses recorded their day's involvement in patients' dietary management). To assess dietary adherence, patients reported the extent to which they followed dietary recommendations that day with items from the Summary of Diabetes Self-Care Activities Measure. To assess diabetes-specific distress, patients reported the extent to which they worried about diabetes that day using items from the Problem Areas in Diabetes (PAID) scale. Results: Multilevel modeling revealed that, relative to the prior day, spouses' diet-related support was associated with increases in patients' adherence whereas diet-related persuasion and pressure were associated with decreases in adherence; spouses' pressure was associated with increases in patients' diabetes-specific distress. When partners appraised responsibility for managing T2DM as shared, support was associated with decreases in diabetes-specific distress; pressure was associated with decreases in adherence. Conclusions: Our findings offer insight into partners' day-to-day disease-related interactions and identify those that are likely to be beneficial versus detrimental for patients' physical and psychological health.
C1 [Stephens, Mary Ann Parris; Iida, Masumi; Hemphill, Rachel C.] Kent State Univ, Dept Psychol, Kent, OH 44242 USA.
   [Franks, Melissa M.] Purdue Univ, Dept Human Dev & Family Studies, W Lafayette, IN 47907 USA.
   [Rook, Karen S.] Univ Calif Irvine, Dept Psychol & Social Behav, Irvine, CA 92717 USA.
   [Salem, James K.] Summa Hlth Syst, Dept Diabet & Metab, Akron, OH USA.
RP Stephens, MAP (reprint author), Kent State Univ, Dept Psychol, POB 5190, Kent, OH 44242 USA.
EM mstephen@kent.edu
FU National Institute on Aging [R01 AG24833]
FX This research, entitled "Mind-Body Interactions in Management of Type 2
   Diabetes," was supported by grant R01 AG24833 from the National
   Institute on Aging.
CR Berg CA, 2007, PSYCHOL BULL, V133, P920, DOI 10.1037/0033-2909.133.6.920
   Berg CA, 2009, J FAM PSYCHOL, V23, P521, DOI 10.1037/a0015556
   Brehm S. S., 1981, PSYCHOL REACTANCE TH
   Cain AE, 2009, J PSYCHIATR RES, V43, P987, DOI 10.1016/j.jpsychires.2009.01.014
   Center for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET
   Centers for Disease Control and Prevention, 2010, DIAB SUCC OPP POP BA
   Clemes SA, 2009, MED SCI SPORT EXER, V41, P674, DOI 10.1249/MSS.0b013e31818cae32
   CONNELL CM, 1994, HEALTH PSYCHOL, V13, P263, DOI 10.1037//0278-6133.13.3.263
   Cranford JA, 2006, PERS SOC PSYCHOL B, V32, P917, DOI 10.1177/0146167206287721
   DiMatteo MR, 2004, HEALTH PSYCHOL, V23, P207, DOI 10.1037/0278-6133.23.2.207
   Dunbar-Jacob J, 2001, HANDBOOK OF HEALTH PSYCHOLOGY, P571
   Fekete E, 2009, PSYCHOL HEALTH, V24, P501, DOI 10.1080/08870440801894674
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Franks MM, 2006, J FAM PSYCHOL, V20, P311, DOI 10.1037/0893-3200.20.2.311
   Gallant MP, 2003, HEALTH EDUC BEHAV, V30, P170, DOI 10.1177/1090198102251030
   GARAYSEVILA ME, 1995, J DIABETES COMPLICAT, V9, P81, DOI 10.1016/1056-8727(94)00021-F
   GLASGOW RE, 1988, DIABETES CARE, V11, P377, DOI 10.2337/diacare.11.5.377
   Gonder-Frederick LA, 2002, J CONSULT CLIN PSYCH, V70, P611, DOI 10.1037//0022-006X.70.3.611
   GOODALL TA, 1991, HEALTH PSYCHOL, V10, P1, DOI 10.1037/0278-6133.10.1.1
   Green AJ, 2007, INT J CLIN PRACT, V61, P1791, DOI 10.1111/j.1742-1241.2007.01588.x
   HAMMOND GS, 1992, DIABETES CARE, V15, P469, DOI 10.2337/diacare.15.4.469
   Helgeson VS, 2004, J SOC PERS RELAT, V21, P53, DOI 10.1177/0265407504039840
   Iida M, 2010, PERS SOC PSYCHOL B, V36, P780, DOI 10.1177/0146167210369897
   KAPLAN RM, 1987, HEALTH PSYCHOL, V6, P387, DOI 10.1037/0278-6133.6.5.387
   Lewis MA, 1999, HEALTH PSYCHOL, V18, P63, DOI 10.1037/0278-6133.18.1.63
   Lewis MA, 2007, J APPL SOC PSYCHOL, V37, P298, DOI 10.1111/j.0021-9029.2007.00161.x
   LITTLEFIELD CH, 1990, HEALTH PSYCHOL, V9, P737, DOI 10.1037//0278-6133.9.6.737
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   ROOK KS, 1990, PSYCHOL AGING, V5, P327, DOI 10.1037/0882-7974.5.3.327
   Shiffman S, 2008, ANNU REV CLIN PSYCHO, V4, P1, DOI 10.1146/annurev.clinpsy.3.022806.091415
   Skinner TC, 2000, J PEDIATR PSYCHOL, V25, P257, DOI 10.1093/jpepsy/25.4.257
   Stephens MAP, 2010, FAM SYST HEALTH, V28, P199, DOI 10.1037/a0020513
   Stephens MAP, 2009, HEALTH PSYCHOL, V28, P48, DOI 10.1037/a0012385
   Thompson A, 1999, J MARRIAGE FAM, V61, P38, DOI 10.2307/353881
   Thorpe CT, 2008, J BEHAV MED, V31, P93, DOI 10.1007/s10865-007-9125-4
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Trief P., 2003, FAMILIES SYSTEMS HLT, V21, P57, DOI [DOI 10.1037/H0089502, 10.1037/h0089502]
   Tucker JS, 2006, HEALTH PSYCHOL, V25, P715, DOI 10.1037/0278-6133.25.6.715
   Tucker JS, 2001, J APPL SOC PSYCHOL, V31, P467, DOI 10.1111/j.1559-1816.2001.tb02051.x
   UMBERSON D, 1992, SOC SCI MED, V34, P907, DOI 10.1016/0277-9536(92)90259-S
   Westmaas JL, 2002, HEALTH PSYCHOL, V21, P368, DOI 10.1037//0278-6133.21.4.368
   Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047
   Williams K. E., 2002, PSYCHOL HEALTH MED, V7, P127, DOI [10.1080/13548500120116076, DOI 10.1080/13548500120116076]
   Woodcock A, 2001, PATIENT EDUC COUNS, V42, P257, DOI 10.1016/S0738-3991(00)00131-2
NR 44
TC 53
Z9 53
U1 0
U2 38
PU AMER PSYCHOLOGICAL ASSOC
PI WASHINGTON
PA 750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA
SN 0278-6133
EI 1930-7810
J9 HEALTH PSYCHOL
JI Health Psychol.
PD OCT
PY 2013
VL 32
IS 10
BP 1029
EP 1037
DI 10.1037/a0030018
PG 9
WC Psychology, Clinical; Psychology
SC Psychology
GA 232GW
UT WOS:000325481800001
PM 23025302
DA 2019-01-08
ER

PT J
AU Rasmussen, NH
   Smith, SA
   Maxson, JA
   Bernard, ME
   Cha, SS
   Agerter, DC
   Shah, ND
AF Rasmussen, Norman H.
   Smith, Steven A.
   Maxson, Julie A.
   Bernard, Matthew E.
   Cha, Stephen S.
   Agerter, David C.
   Shah, Nilay D.
TI Association of HbA(1c) with emotion regulation, intolerance of
   uncertainty, and purpose in life in type 2 diabetes mellitus
SO PRIMARY CARE DIABETES
LA English
DT Article
DE Emotion regulation; HbA(1c); Intolerance of uncertainty; Primary care;
   Purpose in life satisfaction
ID GLYCEMIC CONTROL; PRIMARY-CARE; VALIDATION; DEPRESSION; SCALE;
   INTERVENTIONS; METAANALYSIS; POPULATION; MORBIDITY; EVENTS
AB Background: The extant literature lacks breadth on psychological variables associated with health outcome for type 2 diabetes mellitus (T2DM). This investigation extends the scope of psychological information by reporting on previously unpublished factors.
   Objective: To investigate if intolerance of uncertainty, emotion regulation, or purpose in life differentiate T2DM adults with sustained high HbA(1c) (HH) vs. sustained acceptable HbA(1c) (AH).
   Subjects and methods: Cross-sectional observational study. Adult patients with diagnosed T2DM meeting inclusionary criteria for AR, HH, or a nondiabetic reference group (NDR) were randomly selected and invited to participate. Patients who consented and participated resulted in a final sample of 312 subgrouped as follows: HH (n = 108); AH (n = 98); and NDR (n = 106). Data sources included a survey, self-report questionnaires, and electronic medical record (EMR).
   Results: HH individuals with T2DM reported lower purpose in life satisfaction (p = 0.005) compared to the NDR group. The effect size for this finding is in the small-to-medium range using Cohen's guidelines for estimating clinical relevance. The HH-AH comparison on purpose in life was nonsignificant. The emotion regulation and intolerance of uncertainty comparisons across the three groups were not significant.
   Conclusions: The present study determined that lower purpose in life satisfaction is associated with higher HbA(1c). In a T2DM patient with sustained high HbA(1c), the primary care clinician is encouraged to consider screening for purpose in life satisfaction by asking a single question such as "Do the things you do in your life seem important and worthwhile?" The patient's response will assist the clinician in determining if meaning or purpose in life distress may be interferring with diabetes self-care. If this is the case, the clinician can shift the conversation to the value of behavioral and emotional health counseling. (C) 2013 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.
C1 [Rasmussen, Norman H.] Mayo Clin, Div Integrated Behav Healthcare, Dept Psychiat & Psychol, Rochester, MN 55905 USA.
   [Smith, Steven A.] Mayo Clin, Div Endocrinol Diabet Metab & Nutr, Rochester, MN 55905 USA.
   [Rasmussen, Norman H.; Maxson, Julie A.; Bernard, Matthew E.; Agerter, David C.] Mayo Clin, Dept Family Med, Rochester, MN 55905 USA.
   [Cha, Stephen S.] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN 55905 USA.
   [Shah, Nilay D.] Mayo Clin, Div Hlth Care Policy & Res, Rochester, MN 55905 USA.
RP Rasmussen, NH (reprint author), Mayo Clin, Div Integrated Behav Healthcare, Dept Family Med, 200 1st St SW, Rochester, MN 55905 USA.
EM rasmussen.norman@mayo.edu
FU Mayo Clinic Department of Family Medicine
FX Internal institutional discretionary research monies, allocated through
   the Mayo Clinic Department of Family Medicine, funded this study. Robert
   C. Colligan, PhD, Emeritus Member, Department of Psychiatry and
   Psychology, Mayo Clinic, made several suggestions that improved the
   clarity and scientific accuracy of the manuscript.
CR American Psychiatric Association, 1994, DIAGN STAT MAN MENT
   Angstman KB, 2012, J PRIM CARE COMMUNIT, V3, P155, DOI 10.1177/2150131911423824
   Arroll B, 2010, ANN FAM MED, V8, P348, DOI 10.1370/afm.1139
   Bloomgarden Zachary T, 2009, Diabetes Care, V32, pe141, DOI 10.2337/dc09-zb12
   Carleton RN, 2007, BEHAV RES THER, V45, P2307, DOI 10.1016/j.brat.2007.04.006
   Carleton RN, 2007, J ANXIETY DISORD, V21, P105, DOI 10.1016/j.janxdis.2006.03.014
   CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8
   Cherrington A, 2010, J BEHAV MED, V33, P81, DOI 10.1007/s10865-009-9233-4
   Ciechanowski PS, 2006, MED CARE, V44, P283, DOI 10.1097/01.mlr.0000199695.03840.0d
   Cohen J, 1988, STAT POWER ANAL BEHA
   Currie CJ, 2010, LANCET, V375, P481, DOI 10.1016/S0140-6736(09)61969-3
   de Groot Mary, 2010, Diabetes Spectr, V23, P15, DOI 10.2337/diaspect.23.1.15
   de Groot V, 2003, J CLIN EPIDEMIOL, V56, P221, DOI 10.1016/S0895-4356(02)00585-1
   Duangdao KM, 2008, J BEHAV MED, V31, P291, DOI 10.1007/s10865-008-9155-6
   Dugas MJ, 1997, COGNITIVE THER RES, V21, P593, DOI 10.1023/A:1021890322153
   Fowler GC, 2010, SOUTH MED J, V103, P911, DOI 10.1097/SMJ.0b013e3181eb34b2
   Garnefski N, 2001, PERS INDIV DIFFER, V30, P1311, DOI 10.1016/S0191-8869(00)00113-6
   Grant P, 2010, PRIM CARE DIABETES, V4, P69, DOI 10.1016/j.pcd.2010.02.001
   Gratz KL, 2004, J PSYCHOPATHOL BEHAV, V26, P41, DOI 10.1023/B:JOBA.0000007455.08539.94
   Hall PA, 2009, J PSYCHOSOM RES, V67, P297, DOI 10.1016/j.jpsychores.2009.05.015
   Huntley AL, 2012, ANN FAM MED, V10, P134, DOI 10.1370/afm.1363
   Imayama I, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-115
   Ismail K, 2004, LANCET, V363, P1589, DOI 10.1016/S0140-6736(04)16202-8
   Ismail K., 2009, PSYCHIATRY, V6, P203
   Katon WJ, 2008, AM J MED, V121, P8, DOI 10.1016/j.amjmed.2008.09.008
   KAZIS LE, 1989, MED CARE, V27, pS178, DOI 10.1097/00005650-198903001-00015
   Keshen Aaron, 2006, Am J Psychother, V60, P285
   Kraemer HC, 2001, AM J PSYCHIAT, V158, P848, DOI 10.1176/appi.ajp.158.987.848
   Martin A, 2006, GEN HOSP PSYCHIAT, V28, P71, DOI 10.1016/j.genhosppsych.2005.07.003
   Martins RK, 2009, CLIN PSYCHOL REV, V29, P283, DOI 10.1016/j.cpr.2009.02.001
   Nouwen A, 2011, HEALTH PSYCHOL, V30, P771, DOI 10.1037/a0024500
   Osborn CY, 2011, ANN BEHAV MED, V41, P300, DOI 10.1007/s12160-010-9241-1
   Padala PR, 2008, DIABETES RES CLIN PR, V79, P37, DOI 10.1016/j.diabres.2007.06.012
   Pani LN, 2008, DIABETES CARE, V31, P1991, DOI 10.2337/dc08-0577
   Peyrot M, 2007, DIABETES CARE, V30, P2433, DOI 10.2337/dc07-1222
   Rasmussen Norman H, 2010, Ment Health Fam Med, V7, P197
   Rasmussen Norman H, 2008, Ment Health Fam Med, V5, P139
   Reich JW, 2006, ARTHRIT RHEUM-ARTHR, V55, P86, DOI 10.1002/art.21700
   Renn BN, 2011, CLIN PSYCHOL REV, V31, P1239, DOI 10.1016/j.cpr.2011.08.001
   Ryder R., 1999, SPM HDB HLTH ASSESSM, P179
   Scheier MF, 2006, J BEHAV MED, V29, P291, DOI 10.1007/s10865-005-9044-1
   Seery MD, 2011, CURR DIR PSYCHOL SCI, V20, P390, DOI 10.1177/0963721411424740
   Weinger K, 2011, ARCH INTERN MED, V171, P1990, DOI 10.1001/archinternmed.2011.502
   Zoegemfiss K.Y., 2011, PATIENT, V4, P241
NR 44
TC 7
Z9 9
U1 2
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1751-9918
EI 1878-0210
J9 PRIM CARE DIABETES
JI Prim. Care Diabetes
PD OCT
PY 2013
VL 7
IS 3
BP 213
EP 221
DI 10.1016/j.pcd.2013.04.006
PG 9
WC Endocrinology & Metabolism; Primary Health Care
SC Endocrinology & Metabolism; General & Internal Medicine
GA 225LZ
UT WOS:000324965700006
PM 23685023
DA 2019-01-08
ER

PT J
AU Tanenbaum, ML
   Ritholz, MD
   Binko, DH
   Baek, RN
   Shreck, MSE
   Gonzalez, JS
AF Tanenbaum, Molly L.
   Ritholz, Marilyn D.
   Binko, Deborah H.
   Baek, Rachel N.
   Shreck, M. S. Erica
   Gonzalez, Jeffrey S.
TI Probing for depression and finding diabetes: a mixed-methods analysis of
   depression interviews with adults treated for type 2 diabetes
SO JOURNAL OF AFFECTIVE DISORDERS
LA English
DT Article
DE Diabetes; Depression; Diabetes-related distress; Screening; Comorbidity
ID MONTGOMERY-ASBERG DEPRESSION; COMORBID DEPRESSION; DISTRESS SCALE;
   SELF-CARE; METAANALYSIS; ASSOCIATION; SYMPTOMS; PEOPLE; TEMPERAMENT;
   PREVALENCE
AB Background: Depression has increased prevalence and consistently predicts poor health outcomes among patients with diabetes. The impact of stressors related to diabetes and its treatment on depression assessment is infrequently considered.
   Methods: We used mixed methods to evaluate depressive symptoms in adults with type 2 diabetes. We categorized responses related to diabetes and its treatment during interviews (n=70) using the Montgomery-Asberg Depression Rating Scale (MADRS) and administered questionnaires to measure diabetes related distress and depressive symptoms.
   Results: Participants (M age=56, SD=7; 67% female; 64% Black; 21% Latino) had mild depression on average (MADRS M=10, SD=9). Half of those with symptoms spontaneously mentioned diabetes context; 61% said diabetes contributed to their symptoms when questioned directly. Qualitative themes included: overlapping symptoms of diabetes and depression; burden of diabetes treatment; emotional impact of diabetes; and the bidirectional influence of depression and diabetes. Diabetes was mentioned more often at higher levels of depression severity (r=.38, p=.001). Higher HbA1c was associated with mentioning diabetes as a context for depressive symptoms (r=.32, p=.007). Insulin-users mentioned diabetes more often than those on oral medications only (p=.005).
   Limitations: MADRS is not a traditional qualitative interview so themes may not provide an exhaustive view of the role of diabetes context in depression assessment.
   Conclusions and clinical implications: The burden of type 2 diabetes and its treatment often provide an explanatory context for depressive symptoms assessed by structured clinical interviews, the gold standard of depression assessment. Diabetes context may influence accuracy of assessment and should inform intervention planning for those needing treatment. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Tanenbaum, Molly L.; Binko, Deborah H.; Baek, Rachel N.; Shreck, M. S. Erica; Gonzalez, Jeffrey S.] Yeshiva Univ, Ferkauf Grad Sch Psychol, Bronx, NY 10461 USA.
   [Ritholz, Marilyn D.] Joslin Diabet Ctr, Boston, MA 02215 USA.
   [Ritholz, Marilyn D.] Harvard Univ, Sch Med, Boston, MA USA.
   [Ritholz, Marilyn D.] Boston Childrens Hosp, Boston, MA USA.
   [Gonzalez, Jeffrey S.] Albert Einstein Coll Med, Diabet Res Ctr, Bronx, NY 10467 USA.
RP Gonzalez, JS (reprint author), Yeshiva Univ, Ferkauf Grad Sch Psychol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.
EM jeffrey.gonzalez@einstein.yu.edu
OI Tanenbaum, Molly/0000-0003-4222-4224
FU National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
   [DK-020541]
FX This study was partially supported by Grant DK-020541 from the National
   Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
CR Aikens JE, 2008, DIABETIC MED, V25, P1324, DOI 10.1111/j.1464-5491.2008.02590.x
   American Psychiatric Association, DIAGN STAT MAN MENT
   American Psychiatric Association, 2000, DIAGN STAT MAN MENT
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Beverly EA, 2012, J GEN INTERN MED, V27, P1180, DOI 10.1007/s11606-012-2070-0
   Beverly EA, 2011, DIABETES CARE, V34, P1086, DOI 10.2337/dc10-2298
   Black SA, 2003, DIABETES CARE, V26, P2822, DOI 10.2337/diacare.26.10.2822
   Cohen J, 1988, STAT POWER ANAL BEHA
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   Egede LE, 2005, DIABETES CARE, V28, P1339, DOI 10.2337/diacare.28.6.1339
   Egede LE, 2005, PSYCHOSOM MED, V67, P46, DOI 10.1097/01.psy.0000149260.82006.fb
   Fisher EB, 2012, J AFFECT DISORDERS, V142, pS56, DOI 10.1016/S0165-0327(12)70009-5
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Gask L, 2011, CHRONIC ILLN, V7, P239, DOI 10.1177/1742395311403636
   Gois C, 2012, J AFFECT DISORDERS, V143, P1, DOI 10.1016/j.jad.2012.05.028
   Gois C, 2012, J AFFECT DISORDERS, V142, pS67, DOI 10.1016/S0165-0327(12)70010-1
   Gois C, 2011, J AFFECT DISORDERS, V134, P52, DOI 10.1016/j.jad.2011.05.021
   Golden SH, 2008, JAMA-J AM MED ASSOC, V299, P2751, DOI 10.1001/jama.299.23.2751
   Gonzalez JS, 2008, DIABETOLOGIA, V51, P1822, DOI 10.1007/s00125-008-1113-x
   Gonzalez JS, 2007, DIABETES CARE, V30, P2222, DOI 10.2337/dc07-0158
   Gonzalez JS, 2011, DIABETES CARE, V34, P236, DOI 10.2337/dc10-1970
   Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341
   Holt RIG, 2012, J AFFECT DISORDERS, V142, pS72, DOI 10.1016/S0165-0327(12)70011-3
   Katon WJ, 2005, DIABETES CARE, V28, P2668, DOI 10.2337/diacare.28.11.2668
   Kim NS, 2012, MED DECIS MAKING, V32, P820, DOI 10.1177/0272989X12443417
   Knol MJ, 2007, PSYCHOSOM MED, V69, P300, DOI 10.1097/PSY.0b013e31805f48b9
   Kokanovic R., 2012, DEPRESSION AMBIVALEN
   Ludman EJ, 2004, GEN HOSP PSYCHIAT, V26, P430, DOI 10.1016/j.genhosppsych.2004.08.010
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   McPherson S, 2009, SOC SCI MED, V69, P1137, DOI 10.1016/j.socscimed.2009.05.032
   Mitchell AJ, 2011, J AFFECT DISORDERS, V130, P26, DOI 10.1016/j.jad.2010.07.028
   MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382
   Patton M.Q., 1999, HEALTH SERV RES, V34, P1139
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Pope C., 2000, QUALITATIVE RES HLTH
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Ritholz MD, 2011, CURR DIABETES REP, V11, P494, DOI 10.1007/s11892-011-0226-7
   Roy T, 2012, DIABETIC MED, V29, P164, DOI 10.1111/j.1464-5491.2011.03401.x
   Rubin RR, 2001, J CLIN PSYCHOL, V57, P457, DOI 10.1002/jclp.1041
   Russell Cynthia K, 2003, Evid Based Nurs, V6, P36
   Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi
   SNAITH RP, 1986, BRIT J PSYCHIAT, V148, P599, DOI 10.1192/bjp.148.5.599
   Svanborg P, 2001, J AFFECT DISORDERS, V64, P203, DOI 10.1016/S0165-0327(00)00242-1
   Tanenbaum ML, 2012, DIABETES EDUCATOR, V38, P695, DOI 10.1177/0145721712452795
   van den Boogaard TM, 2011, SOC SCI MED, V73, P1733, DOI 10.1016/j.socscimed.2011.09.027
   Vileikyte L, 2009, DIABETOLOGIA, V52, P1265, DOI 10.1007/s00125-009-1363-2
   Wittink MN, 2008, QUAL HEALTH RES, V18, P1174, DOI 10.1177/1049732308321737
NR 51
TC 5
Z9 5
U1 0
U2 23
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-0327
EI 1573-2517
J9 J AFFECT DISORDERS
JI J. Affect. Disord.
PD SEP 5
PY 2013
VL 150
IS 2
BP 533
EP 539
DI 10.1016/j.jad.2013.01.029
PG 7
WC Clinical Neurology; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 206YQ
UT WOS:000323563300051
PM 23453278
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Hsu, HC
   Chang, YH
   Lee, PJ
   Chen, SY
   Hsieh, CH
   Lee, YJ
   Wang, RH
AF Hsu, Hui-Chun
   Chang, Yu-Hung
   Lee, Pei-Ju
   Chen, Shi-Yu
   Hsieh, Chang-Hsun
   Lee, Yau-Jiunn
   Wang, Ruey-Hsia
TI Developing and Psychometric Testing of a Short-Form Problem Areas in
   Diabetes Scale in Chinese Patients
SO JOURNAL OF NURSING RESEARCH
LA English
DT Article
DE diabetes; Problem Areas in Diabetes; emotional distress
ID EMOTIONAL DISTRESS; DEPRESSION; VERSION; VALIDITY; CARE
AB Background: The 20-item Problem Areas in Diabetes (PAID) scale is widely used to measure diabetes-related emotional distress. The short-form PAID scale is helpful for the rapid screening of diabetes-related emotional distress in clinical settings.
   Purpose: This study developed and examined the psychometric properties of a short-form Chinese-version PAID (SFPAID- C) scale.
   Methods: The Chinese-version 20-item PAID (PAID-C) scale was administered to 855 patients with type 2 diabetes mellitus. Item analysis, exploratory factor analysis, and confirmatory factor analysis were then applied to develop the SF-PAID-C and evaluate its construct validity. The correlations between SFPAID- C and the latest HbA1c close to the measurement of PAID-C (baseline HbA1c) 3 months and 12 months later were used to examine the concurrent and predictive validity of the SF-PAID-C. Receiver operating characteristic curve analysis was used to examine the sensitivity and specificity of the SF-PAID-C. Cronbach's alpha was used to assess internal consistency. Test-retest on 24 patients was used to examine the stability of the SF-PAID-C.
   Results: An 8-item SF-PAID-C was developed. The SF-PAID-C significantly correlated with the PAID-C (r =.941, p < .001), baseline HbA1c (r = .148, p < .001), 3-month HbA1c (r = .147, p < .001), and 12-month HbA1c (r = .142, p < .001). The sensitivity and specificity of the SF-PAID-C were 93.2% and 94.2%, respectively. The Cronbach's alpha and test-retest reliability of the SF-PAID-C were .85 and.93, respectively.
   Conclusions/Implications for Practice: The SF-PAID-C is a reliable and valid scale that can be used to screen for diabetes-related emotional problem in Chinese patients with type 2 diabetes mellitus in clinical settings.
C1 [Hsu, Hui-Chun; Chang, Yu-Hung; Lee, Pei-Ju; Lee, Yau-Jiunn] Lees Endocrinol Clin, Pingtung, Taiwan.
   [Hsu, Hui-Chun] Kaohsiung Med Univ, Sch Nursing, Kaohsiung, Taiwan.
   [Chen, Shi-Yu; Hsieh, Chang-Hsun] Triserv Gen Hosp, Div Endocrinol & Metab, Taipei, Taiwan.
   [Wang, Ruey-Hsia] Kaohsiung Med Univ, Coll Nursing, Kaohsiung, Taiwan.
RP Wang, RH (reprint author), 100 Shih Chuan 1st Rd, Kaohsiung 80708, Taiwan.
EM wrhsia@kmu.edu.tw
RI Chang, Yu Hung/F-8176-2011
OI Chang, Yu Hung/0000-0001-6116-1893
CR Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011
   Amsberg S, 2008, INT J NURS STUD, V45, P1319, DOI 10.1016/j.ijnurstu.2007.09.010
   Bai YL, 2008, INT J NURS STUD, V45, P571, DOI 10.1016/.i.ijnurstu.2006.07.026
   Biggerstaff BJ, 2000, STAT MED, V19, P649, DOI 10.1002/(SICI)1097-0258(20000315)19:5<649::AID-SIM371>3.0.CO;2-H
   Chawla A, 2010, DIABETES EDUCATOR, V36, P337, DOI 10.1177/0145721709354607
   Cheng ST, 2006, INT J GERIATR PSYCH, V21, P333, DOI 10.1002/gps.1467
   Department of Health Executive Yuan Taiwan ROC, 2012, 2011 CAUS DEATH STAT
   Eigenmann CA, 2009, DIABETIC MED, V26, P425, DOI 10.1111/j.1464-5491.2009.02697.x
   Ely JJ, 2011, RURAL REMOTE HEALTH, V11
   Eom YS, 2011, DIABETES METAB J, V35, P182, DOI 10.4093/dmj.2011.35.2.182
   FERKETICH S, 1991, RES NURS HEALTH, V14, P165, DOI 10.1002/nur.4770140211
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118
   Huang MF, 2010, DIABETES CARE, V33, P38, DOI 10.2337/dc09-0768
   Karlsen B, 2012, J ADV NURS, V68, P391, DOI 10.1111/j.1365-2648.2011.05751.x
   Kline R. B., 2011, PRINCIPLES PRACTICE
   Lustman PJ, 1998, SEMIN CLIN NEUROPSYC, V3, P102
   McGuire BE, 2010, DIABETOLOGIA, V53, P66, DOI 10.1007/s00125-009-1559-5
   Nozaki T, 2009, BIOPSYCHOSOC MED, V3, DOI 10.1186/1751-0759-3-4
   Ogbera A, 2011, J DIABETES, V3, P348, DOI 10.1111/j.1753-0407.2011.00156.x
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   RINDSKOPF D, 1988, MULTIVAR BEHAV RES, V23, P51, DOI 10.1207/s15327906mbr2301_3
   Rosner B, 2006, FUNDAMENTALS BIOSTAT
   Sigurdardottir AK, 2008, INT J NURS STUD, V45, P526, DOI 10.1016/j.ijnurstu.2006.10.008
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Tien KJ, 2008, DIABETES RES CLIN PR, V79, P276, DOI 10.1016/j.diabres.2007.08.015
   Ullman JB, 2006, J PERS ASSESS, V87, P35, DOI 10.1207/s15327752jpa8701_03
   Wang RH, 2011, J ADV NURS, V67, P2658, DOI 10.1111/j.1365-2648.2011.05701.x
NR 28
TC 8
Z9 9
U1 0
U2 11
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1682-3141
J9 J NURS RES
JI J. Nurs. Res.
PD SEP
PY 2013
VL 21
IS 3
BP 212
EP 217
DI 10.1097/01.jnr.0000432048.31921.e2
PG 6
WC Nursing
SC Nursing
GA 300MY
UT WOS:000330469200009
PM 23958611
OA Bronze
DA 2019-01-08
ER

PT J
AU Wagner, JA
   Tennen, H
   Feinn, R
   Finan, PH
AF Wagner, Julie A.
   Tennen, Howard
   Feinn, Richard
   Finan, Patrick H.
TI RACIAL DISCRIMINATION AND METABOLIC CONTROL IN WOMEN WITH TYPE 2
   DIABETES
SO ETHNICITY & DISEASE
LA English
DT Article
DE Discrimination; Racism; Diabetes; Glycemic Control; Women
ID STRESSFUL LIFE EVENTS; PERCEIVED DISCRIMINATION; INSULIN-RESISTANCE;
   HEALTH; DEPRESSION; ASSOCIATION; EXPERIENCES; CARDIA; ADULTS; CARE
AB Purpose: We investigated whether self-reported racial discrimination was associated with insulin resistance (IR) and glycosylated hemoglobin (A1c) in women with type 2 diabetes in the United States, after controlling for covariates.
   Methods: Seventy-seven Black and White women with type 2 diabetes completed the Experiences of Discrimination Scale, which assesses self-reported lifetime frequency of racially motivated discrimination. Participants provided fasting blood samples for assessment of glucose and insulin for determination of IR and A1c. Covariates included age, education, waist circumference, diabetes distress, and stressful life events.
   Results: In unadjusted regression analysis discrimination was significantly associated with IR. There was a trend for a race by discrimination interaction, with a weaker effect for Blacks than Whites. Follow up analysis showed that discrimination was significantly associated with IR in both Blacks and Whites, even after adjustment, as was waist circumference. In unadjusted regression analysis, discrimination was significantly associated with A1c. There was a significant race by discrimination interaction. Follow up analysis showed that discrimination was not significantly associated with A1c among Blacks, but was among Whites, even after adjustment, as was diabetes distress and insulin use.
   Conclusions: Racial discrimination is associated with insulin resistance in Black and White women with diabetes, and with A1c in White women with diabetes.
C1 [Wagner, Julie A.; Tennen, Howard] Univ Connecticut, Ctr Hlth, Farmington, CT 06410 USA.
   [Finan, Patrick H.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.
RP Wagner, JA (reprint author), Univ Connecticut, Ctr Hlth, Div Behav Sci & Community Hlth MC3910, 263 Farmington Ave, Farmington, CT 06410 USA.
EM juwagner@uchc.edu
FU NIDDK [5R21DK074468]; University of Connecticut Health Center General
   Clinical Research Center [M01RR006192]
FX Supported by grants from NIDDK 5R21DK074468 and the University of
   Connecticut Health Center General Clinical Research Center (M01RR006192)
CR Aikens JE, 1997, DIABETES CARE, V20, P1111, DOI 10.2337/diacare.20.7.1111
   Bacha F, 2012, PEDIATR DIABETES, V13, P259, DOI 10.1111/j.1399-5448.2011.00820.x
   Barnes LL, 2008, AM J PUBLIC HEALTH, V98, P1241, DOI 10.2105/AJPH.2007.114397
   Borrell LN, 2013, ETHNIC HEALTH, V18, P227, DOI 10.1080/13557858.2012.713092
   Cunningham TJ, 2012, SOC SCI MED, V75, P922, DOI 10.1016/j.socscimed.2012.04.027
   De Vogli R, 2007, J PSYCHOSOM RES, V63, P413, DOI 10.1016/j.jpsychores.2007.04.006
   Donga E, 2010, J CLIN ENDOCR METAB, V95, P2963, DOI 10.1210/jc.2009-2430
   ESPOSITODELPUENTE A, 1994, INT J OBESITY, V18, P766
   Gibbons FX, 2012, J PERS SOC PSYCHOL, V102, P1089, DOI 10.1037/a0027404
   Grandner MA, 2012, BEHAV SLEEP MED, V10, P235, DOI 10.1080/15402002.2012.654548
   Hausmann LRM, 2008, MED CARE, V46, P905, DOI 10.1097/MLR.0b013e3181792562
   Helgeson VS, 2010, HEALTH PSYCHOL, V29, P153, DOI 10.1037/a0018163
   Hickson DA, 2012, ANN BEHAV MED, V43, P4, DOI 10.1007/s12160-011-9334-5
   HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4
   Jamieson JP, 2013, PSYCHOL SCI, V24, P131, DOI 10.1177/0956797612448194
   Johnson Portia, 2012, J Natl Black Nurses Assoc, V23, P34
   Kan C, 2013, DIABETES CARE, V36, P480, DOI 10.2337/dc12-1442
   Krieger N, 2005, SOC SCI MED, V61, P1576, DOI 10.1016/j.socscimed.2005.03.006
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Miyazaki Y, 2002, AM J PHYSIOL-ENDOC M, V283, P1135
   Pascoe AE, 2009, PSYCHOL BULL, V135, P531
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Pyykkonen AJ, 2010, DIABETES CARE, V33, P378, DOI 10.2337/dc09-1027
   SURWIT RS, 1992, DIABETES CARE, V15, P1413, DOI 10.2337/diacare.15.10.1413
   Wagner J, EXPOSURE DI IN PRESS
   Wagner J, 2007, DIABETES CARE, V30, P364, DOI 10.2337/dc06-1756
   Wagner JA, 2013, STRESS HEALTH, V29, P214, DOI 10.1002/smi.2449
   Wagner JA, 2011, J NATL MED ASSOC, V103, P224, DOI 10.1016/S0027-9684(15)30298-4
   Williams DR, 2012, AM J PUBLIC HEALTH, V102, P975, DOI 10.2105/AJPH.2012.300702
NR 30
TC 8
Z9 8
U1 0
U2 8
PU INT SOC HYPERTENSION BLACKS-ISHIB
PI ATLANTA
PA 100 AUBURN AVE NE STE 401, ATLANTA, GA 30303-2527 USA
SN 1049-510X
EI 1945-0826
J9 ETHNIC DIS
JI Ethn. Dis.
PD FAL
PY 2013
VL 23
IS 4
BP 421
EP 427
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 280HN
UT WOS:000329019400005
PM 24392603
DA 2019-01-08
ER

PT J
AU Joensen, LE
   Almdal, TP
   Willaing, I
AF Joensen, Lene E.
   Almdal, Thomas P.
   Willaing, Ingrid
TI Type 1 diabetes and living without a partner: Psychological and social
   aspects, self-management behaviour, and glycaemic control
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Type 1 diabetes; Cohabitation; Social support; Diabetes distress;
   Glycaemic control
ID QUALITY-OF-LIFE; MARITAL-STATUS; CHRONIC ILLNESS; EMOTIONAL DISTRESS;
   GENDER-DIFFERENCES; METABOLIC-CONTROL; HEALTH SURVEY; SCALE; MELLITUS;
   SUPPORT
AB Aims: (1) To investigate the association between cohabitation status and psychological aspects of living with diabetes (diabetes distress, diabetes empowerment, quality of life), self-management behaviours, and glycaemic control and (2) to explore whether potential associations are mediated by social support.
   Methods: Cross-sectional survey of 2419 adult outpatients with type 1 diabetes from a specialized diabetes clinic in Denmark. Stepwise multiple regression gender-stratified analyses assessed the association between cohabitation status and the variables of interest and the influence of social support.
   Results: Significant associations existed between living without a partner and low quality of life, low diabetes empowerment and HbA1c for both men and women. For women, living without a partner was significantly associated with higher diabetes distress and poor self-management behaviours. All associations were mediated by social support to varying degrees.
   Conclusions: Social network and social support are related to important diabetes outcomes in type 1 diabetes. Living without a partner indicates a need for support to prevent poorer diabetes outcomes. Women appear more susceptible to living without a partner in terms of psychosocial diabetes outcomes and glycaemic control. Generally, social support is a mediator in the association between cohabitation status and diabetes outcomes, but social support, as well as cohabitation status, are also independently associated with poorer diabetes outcomes. Assessment of cohabitation status as an indicator of psychosocial capabilities and glycaemic control may be useful in diabetes care and support. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
C1 [Joensen, Lene E.; Willaing, Ingrid] Steno Diabet Ctr, Steno Hlth Promot Ctr, DK-2820 Gentofte, Denmark.
   [Almdal, Thomas P.] Gentofte Univ Hosp, Gentofte, Denmark.
RP Joensen, LE (reprint author), Niels Steensens Vej 8, DK-2820 Gentofte, Denmark.
EM ljoe@steno.dk; almdal@dadlnet.dk; iwtp@steno.dk
OI Joensen, Lene Eide/0000-0002-4790-8759; Willaing,
   Ingrid/0000-0002-3082-8816
FU Novo Foundation; Novo Nordisk A/S
FX L.J. and I.W. are employed by Steno Diabetes Center A/S, a research
   hospital working in the Danish National Health Service and owned by Novo
   Nordisk A/S. Steno Diabetes Center receives part of its core funding
   from unrestricted grants from the Novo Foundation and Novo Nordisk A/S.
CR Anderson R, 2000, NAT HIST, V109, P23
   Anderson RM, 2003, DIABETES CARE, V26, P1641, DOI 10.2337/diacare.26.5.1641-a
   ANTONUCCI TC, 1987, SEX ROLES, V17, P737, DOI 10.1007/BF00287685
   August KJ, 2010, SOC SCI MED, V71, P1831, DOI 10.1016/j.socscimed.2010.08.022
   BERKMAN LF, 1979, AM J EPIDEMIOL, V109, P186, DOI 10.1093/oxfordjournals.aje.a112674
   Christensen AI, 2012, SCAND J PUBLIC HEALT, V40, P391, DOI 10.1177/1403494812451412
   de Oliveira IR, 2010, INT J NURS PRACT, V16, P106, DOI 10.1111/j.1440-172X.2009.01806.x
   Due P, 1999, SOC SCI MED, V48, P661, DOI 10.1016/S0277-9536(98)00381-5
   Eller M, 2008, INT J PUBLIC HEALTH, V53, P188, DOI 10.1007/s00038-008-7091-4
   Enzlin P, 2002, PATIENT EDUC COUNS, V48, P139, DOI 10.1016/S0738-3991(02)00009-5
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fitzgerald JT, 1996, EVAL HEALTH PROF, V19, P208, DOI 10.1177/016327879601900205
   Funnell MM, 2010, FAM PRACT, V27, pI17, DOI 10.1093/fampra/cmp027
   Gallant MP, 2003, HEALTH EDUC BEHAV, V30, P170, DOI 10.1177/1090198102251030
   Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7
   GOVE WR, 1983, J HEALTH SOC BEHAV, V24, P122, DOI 10.2307/2136639
   Harkness E, 2010, DIABETES CARE, V33, P926, DOI 10.2337/dc09-1519
   Hart HE, 2003, QUAL LIFE RES, V12, P1089, DOI 10.1023/A:1026197119569
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1126/science.3399889
   Joensen LE, 2013, DIABETIC MED, V30, P1132, DOI 10.1111/dme.12241
   LLOYD CE, 1993, DIABETES RES CLIN PR, V21, P187, DOI 10.1016/0168-8227(93)90068-G
   Lloyd CE, 1999, DIABETES RES CLIN PR, V44, P9, DOI 10.1016/S0168-8227(99)00004-2
   Manzoli L, 2007, SOC SCI MED, V64, P77, DOI 10.1016/j.socscimed.2006.08.031
   Metayer C, 1996, EUR J EPIDEMIOL, V12, P573, DOI 10.1007/BF00499455
   Nilsson PM, 2005, SCAND J PUBLIC HEALT, V33, P412, DOI 10.1080/14034940510005905
   PARKERSON GR, 1993, MED CARE, V31, P629, DOI 10.1097/00005650-199307000-00005
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   Peyrot M, 1999, J HEALTH SOC BEHAV, V40, P141, DOI 10.2307/2676370
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Rosland AM, 2012, J BEHAV MED, V35, P221, DOI 10.1007/s10865-011-9354-4
   Rothman JGS, 1998, MODERN EPIDEMIOLOGY, P115
   Schiotz ML, 2012, DIABETIC MED, V29, P654, DOI 10.1111/j.1464-5491.2011.03485.x
   Shaban C, 2009, DIABETES RES CLIN PR, V85, pE26, DOI 10.1016/j.diabres.2009.05.006
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Solli O, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-18
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   van Bastelaar KMP, 2010, DIABETIC MED, V27, P798, DOI 10.1111/j.1464-5491.2010.03025.x
   Weinger K, 2001, PATIENT EDUC COUNS, V42, P123, DOI 10.1016/S0738-3991(00)00098-7
   WIKBY A, 1991, DIABETES RES CLIN PR, V13, P53, DOI 10.1016/0168-8227(91)90033-A
   WIKBY A, 1993, QUAL LIFE RES, V2, P281, DOI 10.1007/BF00434799
   Wysocki Tim, 2006, Curr Diab Rep, V6, P117, DOI 10.1007/s11892-006-0022-y
   Zulman DM, 2012, PATIENT EDUC COUNS, V87, P74, DOI 10.1016/j.pec.2011.07.013
NR 44
TC 16
Z9 16
U1 1
U2 14
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
EI 1872-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD SEP
PY 2013
VL 101
IS 3
BP 278
EP 285
DI 10.1016/j.diabres.2013.07.001
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 231NW
UT WOS:000325424800009
PM 23891305
DA 2019-01-08
ER

PT J
AU Choi, SE
   Rush, EB
   Henry, SL
AF Choi, Sarah E.
   Rush, Elizabeth B.
   Henry, Shayna L.
TI Negative Emotions and Risk for Type 2 Diabetes Among Korean Immigrants
SO DIABETES EDUCATOR
LA English
DT Article
ID BODY-MASS INDEX; ASIAN-AMERICANS; WEIGHT-GAIN; DEPRESSION; PREVALENCE;
   ADULTS; POPULATIONS; DISTRESS; ANXIETY; OBESITY
AB Purpose The purpose of this study is to examine the relationship between negative emotions and bio-behavioral risk factors among Korean immigrants at risk for type 2 diabetes (T2DM).
   Methods Data were collected from 148 Korean immigrant adults who are at risk for T2DM as defined by having family history of T2DM in first-degree relatives, body mass index greater than 23, or history of gestational diabetes in women. Participants completed questionnaires and underwent biological measures. Negative emotions included feeling nervous, hopeless, restless, anxious, and stressed as well as depressive symptoms.
   Results High percentages of participants had T2DM risk factors including overweight, greater than normal waist to hip ratio, and blood glucose readings that are indicative of T2DM. Feeling stressed was the most commonly reported negative emotion (66%), followed by feeling anxious (51%), restless (38%), nervous (30%), and hopeless (13%). Experience of negative emotions was significantly related to behavioral risk factors; higher levels of experiencing negative emotions were related to increased soda intake and a decreased likelihood of doing at least 10 minutes of moderate exercise. Stress and anxiety were each negatively related to moderate exercise, and depressive symptoms were negatively related to both moderate and vigorous exercise. No significant relationship was found between negative emotions and biological risk factors.
   Conclusions Findings suggest that negative emotions, individually and taken together, may be related to T2DM risk behaviors in high-risk Korean immigrants. Behavioral interventions to prevent T2DM in this population should consider assessing and addressing negative emotions.
C1 [Choi, Sarah E.] Univ Calif Irvine, Coll Hlth Sci, Program Nursing Sci, Irvine, CA 92697 USA.
   [Rush, Elizabeth B.; Henry, Shayna L.] Univ Calif Irvine, Sch Social Ecol, Dept Psychol & Social Behav, Irvine, CA 92697 USA.
RP Choi, SE (reprint author), Univ Calif Irvine, Coll Hlth Sci, Program Nursing Sci, 100B Berk Hall, Irvine, CA 92697 USA.
EM sechoi@uci.edu
FU National Center for Research Resources; National Center for Advancing
   Translational Sciences, National Institute of Health [UL1 TR000153, 8KL2
   TR000147]
FX This study was supported by a grant from the National Center for
   Research Resources and the National Center for Advancing Translational
   Sciences, National Institute of Health, through Grant UL1 TR000153 and
   8KL2 TR000147 (Dr Choi).
CR Al-Amer RM, 2011, J DIABETES COMPLICAT, V25, P247, DOI 10.1016/j.jdiacomp.2011.03.001
   American Diabetes A, 2012, DIABETES CARE S1, V35, pS11, DOI DOI 10.2337/DC12-S011
   Bailey RC, 2013, DRUG ALCOHOL REV, V32, P162, DOI 10.1111/j.1465-3362.2012.00500.x
   Barba C, 2004, LANCET, V363, P157
   Barnes PM, 2008, HLTH CHARACTERISTICS, V394
   Barzi F, 2005, ANN EPIDEMIOL, V15, P405, DOI 10.1016/j.annepidem.2005.01.005
   Bouwman V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009971
   Breslau J, 2006, SOC PSYCH PSYCH EPID, V41, P943, DOI 10.1007/s00127-006-0119-2
   BRISLIN RW, 1970, J CROSS CULT PSYCHOL, V1, P185, DOI 10.1177/135910457000100301
   California Health Interview Survey, 2009, CHIS 2005 AD PUBL US
   Center for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET
   CHAN JM, 1994, DIABETES CARE, V17, P961, DOI 10.2337/diacare.17.9.961
   Cho MJ, 1998, PSYCHIAT RES, V81, P341, DOI 10.1016/S0165-1781(98)00122-X
   Cho MJ, 1998, J NERV MENT DIS, V186, P304, DOI 10.1097/00005053-199805000-00007
   Choi SE, 2011, J IMMIGR MINOR HEALT, V13, P803, DOI 10.1007/s10903-010-9397-6
   Choi SE, 2011, NURS RES, V60, P240, DOI 10.1097/NNR.0b013e31822232a0
   Clark J. L. D., 1988, STUDIES 2 LANGUAGE A, V10, P129, DOI [10.1017/S0272263100007270, DOI 10.1017/S0272263100007270]
   COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001
   Daniels MC, 2006, J APPL GERONTOL, V25, p60S, DOI 10.1177/0733464805285483
   *DPP RES GROUP, 2002, DIABETES CARE, V25, P2165, DOI DOI 10.2337/DIACARE.25.12.2165
   Engum A, 2007, J PSYCHOSOM RES, V62, P31, DOI 10.1016/j.jpsychores.2006.07.009
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Franks MM, 2012, AGING MENT HEALTH, V16, P902, DOI 10.1080/13607863.2012.674486
   Gaitan-Sierra C, 2011, HEALTH PSYCHOL, V30, P793, DOI 10.1037/a0025582
   Gonzalez JS, 2008, DIABETIC MED, V25, P1102, DOI 10.1111/j.1464-5491.2008.02535.x
   Han HR, 2002, NURS RES, V51, P309, DOI 10.1097/00006199-200209000-00007
   Hawkley LC, 2009, HEALTH PSYCHOL, V28, P354, DOI 10.1037/a0014400
   HURH WM, 1990, J NERV MENT DIS, V178, P703, DOI 10.1097/00005053-199011000-00006
   Huxley R, 2008, J HYPERTENS, V26, P169, DOI 10.1097/HJH.0b013e3282f16ad3
   Katon WJ, 2010, INT J GERIATR PSYCH, V25, P466, DOI 10.1002/gps.2363
   Kiecolt-Glaser JK, 2002, ANNU REV PSYCHOL, V53, P83, DOI 10.1146/annurev.psych.53.100901.135217
   Kim MT, 2005, ARCH PSYCHIAT NURS, V19, P217, DOI 10.1016/j.apnu.2005.07.004
   KUO WH, 1984, J NERV MENT DIS, V172, P449, DOI 10.1097/00005053-198408000-00002
   Lasser K, 2000, JAMA-J AM MED ASSOC, V284, P2606, DOI 10.1001/jama.284.20.2606
   Laugero KD, 2010, APPETITE, V56, P194
   McNeely MJ, 2004, DIABETES CARE, V27, P66, DOI 10.2337/diacare.27.1.66
   Noh S, 1998, CROSS CULTURAL RES J, V32, P358, DOI DOI 10.1177/106939719803200403
   Paddison CAM, 2011, BRIT J HEALTH PSYCH, V16, P213, DOI 10.1348/135910710X495366
   Park SY, 2008, ARCH PSYCHIAT NURS, V22, P12, DOI 10.1016/j.apnu.2007.06.011
   Perna FM, 2008, HEALTH PSYCHOL, V27, P275, DOI 10.1037/0278-6133.27.2.275
   Prochaska J, 2011, AM J LIFESTYLE MED, V5, P208, DOI DOI 10.1177/1559827610391883
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Rajpathak SN, 2010, ETHNIC DIS, V20, P225
   Schwerdtfeger A, 2010, J SPORT EXERCISE PSY, V32, P674, DOI 10.1123/jsep.32.5.674
   Sepulveda A, 2010, SPAN J PSYCHOL, V13, P364, DOI 10.1017/S1138741600003929
   Shai I, 2006, DIABETES CARE, V29, P1585, DOI 10.2337/dc06-0057
   Shin HS, 2007, INT J NURS STUD, V44, P415, DOI 10.1016/j.ijnurstu.2006.04.007
   Shiwaku K, 2005, DIABETES RES CLIN PR, V69, P52, DOI 10.1016/j.diabres.2004.11.001
   Simon GE, 2008, GEN HOSP PSYCHIAT, V30, P32, DOI 10.1016/j.genhosppsych.2007.09.001
   Skaff MM, 2009, HEALTH PSYCHOL, V28, P265, DOI 10.1037/a0014429
   Steptoe A, 2009, J PERS, V77, P1747, DOI 10.1111/j.1467-6494.2009.00599.x
   [U. S. Dietary Guidelines Advisory Committee U. S. Department of Agriculture U. S. Department of Health and Human Services], 2010, DIET GUID AM 2010
   Wismer B, 1999, KOREAN AM COMMUNITY
   Yeomans MR, 2009, APPETITE, V52, P290, DOI 10.1016/j.appet.2008.10.006
   Yun WJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-724
NR 56
TC 1
Z9 2
U1 0
U2 14
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0145-7217
J9 DIABETES EDUCATOR
JI Diabetes Educ.
PD SEP
PY 2013
VL 39
IS 5
BP 679
EP 688
DI 10.1177/0145721713492566
PG 10
WC Endocrinology & Metabolism; Public, Environmental & Occupational Health
SC Endocrinology & Metabolism; Public, Environmental & Occupational Health
GA 223TF
UT WOS:000324832200011
PM 23793726
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Siminerio, L
   Ruppert, KM
   Gabbay, RA
AF Siminerio, Linda
   Ruppert, Kristine M.
   Gabbay, Robert A.
TI Who Can Provide Diabetes Self-Management Support in Primary Care?
   Findings From a Randomized Controlled Trial
SO DIABETES EDUCATOR
LA English
DT Article
ID EMPOWERMENT; EDUCATION; ADULTS; SCALE
AB Purpose The purpose of this comparative effectiveness study is to compare diabetes self-management support (DSMS) approaches and determine who can be most effective in helping patients maintain/improve clinical outcomes, self-care behaviors, distress, and satisfaction following diabetes self-management education (DSME) delivered in primary care.
   Methods After receiving DSME, 141 participants were randomized to receive DSMS delivered by a trained supporter: educator, peer, practice staff, or usual education during a 6-month follow-up period. DSMS groups were compared to determine which supporter helped participants to maintain/improve A1C, blood pressure, lipids, weight, self-care, and distress. DSMS satisfaction was also examined.
   Results There was a significant improvement in A1C, empowerment, aspects of self-care, and distress following DSME at 6 weeks. Those in the educator DSMS group best sustained improved A1C while those in the other DSMS groups maintained glycemic improvements but began to show trends toward worsening. No significant differences or clear trends were seen in other clinical, behavioral, or psychosocial outcomes. The Program Reinforcement Impacts Self-Management (PRISM) study demonstrates that following DSME, participants maintained improved glycemia, lipid, weight, and self-care behaviors and reductions in distress throughout the delivery of DSMS interventions regardless of DSMS supporter. All of the participants reported satisfaction with DSMS.
   Conclusions These findings reaffirm the critical role of educators but suggest that others may serve as DSMS supporters. Results suggest that DSME delivered in primary care is effective and multiple DSMS agents are reasonable. As patient-centered self-management approaches are being explored in primary care, delivery of DSME and DSMS becomes paramount.
C1 [Siminerio, Linda] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15203 USA.
   [Ruppert, Kristine M.] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA 15203 USA.
   [Gabbay, Robert A.] Penn State Coll Med, Hershey, PA USA.
RP Siminerio, L (reprint author), Univ Pittsburgh, Dept Med, Quantum 1 Bldg,2 Hot Met St,2nd Fl,Rm 275, Pittsburgh, PA 15203 USA.
EM simineriol@upmc.edu
OI Ruppert, Kristine/0000-0002-3008-6584
FU Air Force Surgeon General's Office [FA7014-10-2-0005]
FX This research study is sponsored by the Air Force Surgeon General's
   Office under agreement number FA7014-10-2-0005. The views and
   conclusions contained herein are those of the authors and should not be
   interpreted as necessarily representing the official policies or
   endorsements, either expressed or implied, of the Air Force Surgeon
   General's Office or the US Government.
CR American Academy of Family Physicians American Academy of Paediatrics American College of Physicians American Osteopathic Association, 2007, JOINT PRINC PAT CTR
   Anderson R, 2000, NAT HIST, V109, P23
   ANDERSON RM, 1995, DIABETES CARE, V18, P943, DOI 10.2337/diacare.18.7.943
   Anderson RM, 2003, DIABETES CARE, V26, P1641, DOI 10.2337/diacare.26.5.1641-a
   Haas L, 2013, DIABETES CARE, V36, pS100, DOI 10.2337/dc13-S100
   Heisler M, 2010, ANN INTERN MED, V153, P507, DOI 10.7326/0003-4819-153-8-201010190-00007
   JANES GR, 1995, DIABETES AM, V95, P541
   Kocher R, 2010, ANN INTERN MED, V153, P536, DOI 10.7326/0003-4819-153-8-201010190-00274
   Lorig KR, 2001, MED CARE, V39, P1217, DOI 10.1097/00005650-200111000-00008
   National Committee for Quality Assurance, PHYS PRACT CONN PAT
   Norris SL, 2002, DIABETES CARE, V25, P1159, DOI 10.2337/diacare.25.7.1159
   Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561
   Peyrot M, 2007, DIABETES EDUCATOR, V33, P818, DOI 10.1177/0145721707307614
   Piette JD, 2001, DIABETES CARE, V24, P202, DOI 10.2337/diacare.24.2.202
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Tang T, 2011, DIABETES SPECTR, V24, P85, DOI DOI 10.2337/DIASPECT.24.2.85
   Tang Tricia S., 2011, PEER LEAD MAN
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Walker EA, 2011, DIABETES CARE, V34, P2, DOI 10.2337/dc10-1005
NR 19
TC 29
Z9 31
U1 1
U2 11
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0145-7217
J9 DIABETES EDUCATOR
JI Diabetes Educ.
PD SEP
PY 2013
VL 39
IS 5
BP 705
EP 713
DI 10.1177/0145721713492570
PG 9
WC Endocrinology & Metabolism; Public, Environmental & Occupational Health
SC Endocrinology & Metabolism; Public, Environmental & Occupational Health
GA 223TF
UT WOS:000324832200014
PM 23782622
DA 2019-01-08
ER

PT J
AU Pouwer, F
   Nefs, G
   Nouwen, A
AF Pouwer, Francois
   Nefs, Giesje
   Nouwen, Arie
TI Adverse Effects of Depression on Glycemic Control and Health Outcomes in
   People with Diabetes A Review
SO ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
LA English
DT Review
DE Type 1 diabetes; Type 2 diabetes; Depression; Mortality; Cardiovascular
   disease; Microvascular disease; Review
ID EDID RESEARCH CONSORTIUM; MINDFULNESS-BASED INTERVENTION;
   CORONARY-HEART-DISEASE; CO-MORBID DEPRESSION; EMOTIONAL DISTRESS;
   PROSPECTIVE COHORT; EUROPEAN DEPRESSION; INCREASED RISK; COMORBID
   DEPRESSION; INSULIN THERAPY
AB In the past decades, important advances have been achieved in the psychological aspects of diabetes. This article reviews the associations between diabetes, depression, and adverse health outcomes. The article provides an update on the literature regarding the prevalence of depression in diabetes, discusses the impact of depression on diabetes self-care and glycemic control in people with diabetes, and summarizes the results of longitudinal studies that have investigated depression as a risk factor for adverse health outcomes.
C1 [Pouwer, Francois; Nefs, Giesje] Tilburg Univ, Ctr Res Psychol Somat Dis CoRPS, Dept Med & Clin Psychol, NL-5000 LE Tilburg, Netherlands.
   [Nouwen, Arie] Middlesex Univ, Sch Hlth & Social Sci, London NW4 4BT, England.
RP Pouwer, F (reprint author), Tilburg Univ, Ctr Res Psychol Somat Dis CoRPS, Dept Med & Clin Psychol, Warandelaan 2,POB 90153, NL-5000 LE Tilburg, Netherlands.
EM f.pouwer@tilburguniversity.edu
RI Nefs, Giesje/C-9992-2018
CR Aikens JE, 2012, DIABETES CARE, V35, P2472, DOI 10.2337/dc12-0181
   Aikens JE, 2009, DIABETES CARE, V32, P1177, DOI 10.2337/dc09-0071
   American Psychiatric Association, 2000, DIAGN STAT MAN MENT
   Barnard KD, 2006, DIABETIC MED, V23, P445, DOI 10.1111/j.1464-5491.2006.01814.x
   Baumeister H, 2012, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858
   Bogner HR, 2007, DIABETES CARE, V30, P3005, DOI 10.2337/dc07-0974
   Bot M, 2013, DIABETIC MED, V30, pE115, DOI 10.1111/dme.12082
   Cappuccio FP, 2010, DIABETES CARE, V33, P414, DOI 10.2337/dc09-1124
   Champaneri S, 2010, CURR DIABETES REP, V10, P396, DOI 10.1007/s11892-010-0148-9
   Clouse RE, 2003, PSYCHOSOM MED, V65, P376, DOI 10.1097/01.PSY.0000041624.96580.1F
   Colton PA, 2013, PEDIATR DIABETES, V14, P372, DOI 10.1111/pedi.12016
   Cosgrove MP, 2008, OCCUP MED-OXFORD, V58, P7, DOI 10.1093/occmed/kqm105
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   de Jonge P, 2010, NEUROSCI BIOBEHAV R, V35, P84, DOI 10.1016/j.neubiorev.2009.11.025
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Gendelman N, 2009, DIABETES CARE, V32, P575, DOI 10.2337/dc08-1835
   Georgiades A, 2007, PSYCHOSOM MED, V69, P235, DOI 10.1097/PSY.0b013e318042588d
   Gonzalez JS, 2010, DIABETOLOGIA, V53, P2241, DOI 10.1007/s00125-010-1821-x
   Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341
   Gregg EW, 2000, DIABETES CARE, V23, P1272, DOI 10.2337/diacare.23.9.1272
   Howren MB, 2009, PSYCHOSOM MED, V71, P171, DOI 10.1097/PSY.0b013e3181907c1b
   Johnson B, 2013, DIABETIC MED, V30, P199, DOI 10.1111/j.1464-5491.2012.03721.x
   Katon W, 2012, ARCH GEN PSYCHIAT, V69, P410, DOI 10.1001/archgenpsychiatry.2011.154
   Katon W, 2009, PSYCHOSOM MED, V71, P965, DOI 10.1097/PSY.0b013e3181bd8f55
   Katon WJ, 2010, J GEN INTERN MED, V25, P423, DOI 10.1007/s11606-009-1248-6
   Knol MJ, 2006, DIABETOLOGIA, V49, P837, DOI 10.1007/s00125-006-0159-x
   Koopmans B, 2009, FAM PRACT, V26, P171, DOI 10.1093/fampra/cmp016
   Kop WJ, 2010, PSYCHOSOM MED, V72, P626, DOI 10.1097/PSY.0b013e3181eadd2b
   Korczak DJ, 2011, DIABETOLOGIA, V54, P2483, DOI 10.1007/s00125-011-2240-3
   Li J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043508
   Lin EHB, 2010, DIABETES CARE, V33, P264, DOI 10.2337/dc09-1068
   Lu FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004144
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   MacQueen G, 2011, MOL PSYCHIATR, V16, P252, DOI 10.1038/mp.2010.80
   Makine C, 2009, DIABETIC MED, V26, P28, DOI 10.1111/j.1464-5491.2008.02606.x
   Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985
   Mommersteeg PMC, 2013, DIABETIC MED, V30, pE208, DOI 10.1111/dme.12193
   Mommersteeg PMC, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1109
   Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9
   Nefs G, 2012, J PSYCHIATR RES, V46, P549, DOI 10.1016/j.jpsychires.2012.01.013
   Nouwen A, 2010, DIABETOLOGIA, V53, P2480, DOI 10.1007/s00125-010-1874-x
   Nouwen A, 2011, DIABETES CARE, V34, P752, DOI 10.2337/dc10-1414
   Novak M, 2013, DIABETIC MED, V30, pE8, DOI 10.1111/dme.12037
   Peyrot M, 2005, DIABETES CARE, V28, P2673, DOI 10.2337/diacare.28.11.2673
   Pouwer F, 2003, DIABETOLOGIA, V46, P892, DOI 10.1007/s00125-003-1124-6
   Pouwer F, 2005, DIABETIC MED, V22, P1465, DOI 10.1111/j.1464-5491.2005.01661.x
   Pouwer F, 2010, DIABETIC MED, V27, P217, DOI 10.1111/j.1464-5491.2009.02903.x
   Pouwer F, 2010, DISCOV MED, V9, P112
   Roglic G, 2005, DIABETES CARE, V28, P2130, DOI 10.2337/diacare.28.9.2130
   Rotella F, 2013, J CLIN PSYCHIAT, V74, P32, DOI 10.4088/JCP.12r07922
   Roy T, 2012, J AFFECT DISORDERS, V142, pS8, DOI 10.1016/S0165-0327(12)70004-6
   Scherrer JF, 2011, DIABETES CARE, V34, P1729, DOI 10.2337/dc11-0031
   Sieu N, 2011, GEN HOSP PSYCHIAT, V33, P429, DOI 10.1016/j.genhosppsych.2011.05.021
   Stuart MJ, 2012, NEUROSCI BIOBEHAV R, V36, P658, DOI 10.1016/j.neubiorev.2011.10.001
   Thombs Brett D, 2008, Diabetes Care, V31, pe55, DOI 10.2337/dc08-0446
   Turner RC, 1999, JAMA-J AM MED ASSOC, V281, P2005, DOI 10.1001/jama.281.21.2005
   van Bastelaar KMP, 2011, DIABETES CARE, V34, P320, DOI 10.2337/dc10-1248
   van Bastelaar KM, 2008, BMC PSYCHIATRY, V19, P9
   Van der Feltz-Cornelis CM, 2010, GEN HOSP PSYCHIAT, V32, P380, DOI 10.1016/j.genhosppsych.2010.03.011
   van Dooren FEP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057058
   van Son J, 2013, DIABETES CARE, V36, P823, DOI 10.2337/dc12-1477
   van Son J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-131
   Virk J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011523
   Wagner JA, 2012, INT J BEHAV MED, V19, P503, DOI 10.1007/s12529-011-9190-5
   Whooley MA, 2008, JAMA-J AM MED ASSOC, V300, P2379, DOI 10.1001/jama.2008.711
   Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047
   Williams LH, 2011, J DIABETES COMPLICAT, V25, P175, DOI 10.1016/j.jdiacomp.2010.07.002
   Williams LH, 2010, AM J MED, V123, P748, DOI 10.1016/j.amjmed.2010.01.023
   Williams R, 2002, DIABETOLOGIA, V45, pS13, DOI 10.1007/s00125-002-0859-9
   Willis T., PHARM RATIONALIS SIV
   Young V, 2013, DIABETIC MED, V30, P189, DOI 10.1111/j.1464-5491.2012.03771.x
NR 71
TC 43
Z9 44
U1 2
U2 35
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0889-8529
J9 ENDOCRIN METAB CLIN
JI Endocrinol. Metabol. Clin. North Amer.
PD SEP
PY 2013
VL 42
IS 3
BP 529
EP +
DI 10.1016/j.ecl.2013.05.002
PG 17
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 228MO
UT WOS:000325191100009
PM 24011885
DA 2019-01-08
ER

PT J
AU Fisher, L
   Hessler, D
   Glasgow, RE
   Arean, PA
   Masharani, U
   Naranjo, D
   Strycker, LA
AF Fisher, Lawrence
   Hessler, Danielle
   Glasgow, Russell E.
   Arean, Patricia A.
   Masharani, Umesh
   Naranjo, Diana
   Strycker, Lisa A.
TI REDEEM: A Pragmatic Trial to Reduce Diabetes Distress
SO DIABETES CARE
LA English
DT Article
ID RANDOMIZED CONTROLLED-TRIAL; MANAGEMENT SUPPORT PROGRAM;
   SELF-MANAGEMENT; GLYCEMIC CONTROL; DEPRESSIVE SYMPTOMS; INTERVENTION;
   OUTCOMES; SCALE; RECRUITMENT; THERAPY
AB OBJECTIVE To compare three interventions to reduce diabetes distress (DD) and improve self-management among non-clinically depressed adults with type 2 diabetes mellitus (T2DM).RESEARCH DESIGN AND METHODS In REDEEM, 392 adults with T2DM and DD were randomized to computer-assisted self-management (CASM), CASM plus DD-specific problem solving (CAPS), or a computer-administered minimal supportive intervention. Primary outcomes were Diabetes Distress Scale (DDS) total, the Emotional Burden (EB) and Regimen Distress (RD) DDS subscales, and diet, exercise, and medication adherence.RESULTS Significant and clinically meaningful reductions in DD (DDS, EB, and RD) and self-management behaviors occurred in all three conditions (P < 0.001), with no significant between-group differences. There was, however, a significant group x baseline distress interaction (P < 0.02), in which patients with high baseline RD in the CAPS condition displayed significantly larger RD reductions than those in the other two conditions. RD generated the most distress and displayed the greatest distress reduction as a result of intervention. The pace of DD reduction varied by patient age: older patients demonstrated significant reductions in DD early in the intervention, whereas younger adults displayed similar reductions later. Reductions in DD were accompanied by significant improvements in healthy eating, physical activity, and medication adherence, although not by change in HbA(1c).CONCLUSIONS DD is malleable and highly responsive to intervention. Interventions that enhance self-management also reduce DD significantly, but DD-specific interventions may be necessary for patients with high initial levels of DD. Future research should identify the minimal, most cost-effective interventions to reduce DD and improve self-management.
C1 [Fisher, Lawrence; Hessler, Danielle; Arean, Patricia A.; Masharani, Umesh; Naranjo, Diana] Univ Calif San Francisco, San Francisco, CA 94143 USA.
   [Glasgow, Russell E.] NCI, Div Canc Control & Populat Sci, Rockville, MD USA.
   [Strycker, Lisa A.] Oregon Res Inst, Eugene, OR 97403 USA.
RP Fisher, L (reprint author), Univ Calif San Francisco, San Francisco, CA 94143 USA.
EM fisherl@fcm.ucsf.edu
FU National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
   [DK061937]
FX This research was funded by National Institute of Diabetes and Digestive
   and Kidney Diseases (NIDDK) Grant DK061937.
CR Arean P, 2008, GERONTOLOGIST, V48, P311, DOI 10.1093/geront/48.3.311
   Fisher L, 2009, DIABETIC MED, V26, P622, DOI 10.1111/j.1464-5491.2009.02730.x
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Fisher L, 2012, PATIENT EDUC COUNS, V86, P372, DOI 10.1016/j.pec.2011.07.002
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Fredrickson BL, 2005, COGNITION EMOTION, V19, P313, DOI 10.1080/02699930441000238
   Gierisch JM, 2010, AM J PREV MED, V39, P334, DOI 10.1016/j.amepre.2010.05.020
   Glasgow RE, 2010, J INTERNET RES, V13, P9
   Glasgow RE, 2006, J CHRONIC ILLNESS, V2, P270
   Glasgow RE, 2012, PATIENT EDUC COUNS, V87, P81, DOI 10.1016/j.pec.2011.07.024
   Glasgow RE, 2010, J GEN INTERN MED, V25, P1315, DOI 10.1007/s11606-010-1480-0
   Glasgow RE, 2010, ANN BEHAV MED, V40, P40, DOI 10.1007/s12160-010-9189-1
   Glasgow RE, 2009, ANN BEHAV MED, V38, P46, DOI 10.1007/s12160-009-9134-3
   Gonzalez JS, 2011, DIABETES CARE, V34, P236, DOI 10.2337/dc10-1970
   Hartmann M, 2012, DIABETES CARE, V35, P945, DOI 10.2337/dc11-1343
   Hessler DM, 2011, PATIENT EDUC COUNS, V85, P154, DOI 10.1016/j.pec.2010.10.030
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Krousel-Wood M, 2005, J MED SCI, V330, P182
   Lazarus R. S, 1984, STRESS APPRAISAL COP
   Lorig K, 2008, DIABETES CARE, V31, P408, DOI 10.2337/dc07-1313
   Masharani U, 2007, DIABETES DE MYSTIFIE
   Moskowitz J. T., 2010, HDB ADULT RESILIENCE, P465
   Nezu AM, 2004, BEHAV THER, V35, P1, DOI 10.1016/S0005-7894(04)80002-9
   NEZU AM, 2006, PROMOTING TREATMENT, P135
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Reich JW, 2003, REV GEN PSYCHOL, V7, P66, DOI 10.1037/1089-2680.7.1.66
   Schafer JL, 1999, NORM USERS GUIDE MUL, P1
   Stewart AL, 2001, MED SCI SPORT EXER, V33, P1126
   Thompson F. E., 1998, European Journal of Clinical Nutrition, V52, pS63
   Toobert DJ, 2010, AM J HEALTH BEHAV, V34, P680
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Tsujii S, 2012, DIABETIC MED, V29, P1451, DOI 10.1111/j.1464-5491.2012.03647.x
   van Son J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-131
   Welch G, 2011, DIABETES RES CLIN PR, V91, P54, DOI 10.1016/j.diabres.2010.09.036
   Winkley K, 2006, BRIT MED J, V55, P1
   Zagarins SE, 2012, J BEHAV MED, V35, P299, DOI 10.1007/s10865-011-9359-z
   Zwarenstein M, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2390
NR 39
TC 84
Z9 87
U1 2
U2 22
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
J9 DIABETES CARE
JI Diabetes Care
PD SEP
PY 2013
VL 36
IS 9
BP 2551
EP 2558
DI 10.2337/dc12-2493
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 205CZ
UT WOS:000323420200038
PM 23735726
OA Other Gold, Green Published
DA 2019-01-08
ER

PT J
AU Eriksson, AK
   van den Donk, M
   Hilding, A
   Ostenson, CG
AF Eriksson, Anna-Karin
   van den Donk, Maureen
   Hilding, Agneta
   Ostenson, Claes-Goran
TI Work Stress, Sense of Coherence, and Risk of Type 2 Diabetes in a
   Prospective Study of Middle-Aged Swedish Men and Women
SO DIABETES CARE
LA English
DT Article
ID JOB DECISION LATITUDE; WHITE-COLLAR WORKERS; CARDIOVASCULAR-DISEASE;
   UNITED-STATES; HEALTH; POPULATION; MELLITUS; DEMANDS; GENDER; STRAIN
AB OBJECTIVE To investigate the prospective influence of work stress on type 2 diabetes (T2D).RESEARCH DESIGN AND METHODS This population-based cohort included 3,205 women and 2,227 men, aged 35-56 years, with baseline normal glucose tolerance measured with oral glucose tolerance test. At follow-up 8-10 years later, T2D was diagnosed in 60 women and 111 men. Work stress factors evaluated by questionnaire (i.e., demands, decision latitude, job strain, shift work, overtime work, and also sense of coherence) were studied in association with T2D. Odds ratios (ORs) and 95% CIs adjusted for age, education, BMI, physical activity, smoking, family history of diabetes, and psychological distress were calculated.RESULTS In women, low decision latitude was associated with T2D on its own (OR 2.4 [95% CI 1.1-5.2]) and combined with high demands: job strain (OR 4.2 [2.0-8.7]), adjusted for all available potential confounders. Also, shift work increased the risk of T2D in women (OR 2.2 [1.0-4.7]) when adjusted for age, education, and psychological distress, although this risk was diluted after multifactor adjustment (OR 1.9 [0.8-4.4]). In men, high work demands and high strain decreased the risk of T2D (OR 0.5 [0.3-0.9]) for both measures, as did an active job (high demands and high decision latitude, OR 0.4 [0.2-0.9]).CONCLUSIONS Work stress and shift work may contribute to the development of T2D in women. In men, the risk was decreased by high work demands, high strain, and an active job.
C1 [Eriksson, Anna-Karin] Karolinska Inst, Clin Epidemiol Unit, Dept Med, Stockholm, Sweden.
   [Eriksson, Anna-Karin; Hilding, Agneta; Ostenson, Claes-Goran] Karolinska Inst, Dept Mol Med & Surg, Endocrine & Diabet Unit, Stockholm, Sweden.
   [Eriksson, Anna-Karin] Karolinska Inst, Div Social Med, Dept Publ Hlth Sci, Stockholm, Sweden.
   [van den Donk, Maureen] Dutch Coll Gen Practitioners, Utrecht, Netherlands.
RP Eriksson, AK (reprint author), Karolinska Inst, Clin Epidemiol Unit, Dept Med, Stockholm, Sweden.
EM anna-karin.eriksson.2@ki.se
FU Stockholm County Council; Swedish Council of Working Life and Social
   Research; Novo Nordisk Scandinavia; Swedish Diabetes Association
FX This study was supported by grants from Stockholm County Council,
   Swedish Council of Working Life and Social Research, Novo Nordisk
   Scandinavia, and Swedish Diabetes Association. No other potential
   conflicts of interest relevant to this article were reported.
CR Agardh EE, 2003, DIABETES CARE, V26, P719, DOI 10.2337/diacare.26.3.719
   Antonovsky A, 1987, UNRAVELING MYSTERY H
   Belkic KL, 2004, SCAND J WORK ENV HEA, V30, P85, DOI 10.5271/sjweh.769
   Berntsson L, 2006, J EPIDEMIOL COMMUN H, V60, P1070, DOI 10.1136/jech.2005.042192
   Cosgrove MP, 2012, OCCUP MED-OXFORD, V62, P167, DOI 10.1093/occmed/kqs002
   Eriksson AK, 2008, DIABETIC MED, V25, P834, DOI 10.1111/j.1464-5491.2008.02463.x
   Eriksson AK, 2012, EUR J EPIDEMIOL, V27, P153, DOI 10.1007/s10654-011-9630-1
   Evertsson M, 2004, J MARRIAGE FAM, V66, P1272, DOI 10.1111/j.0022-2445.2004.00092.x
   FRANKENHAEUSER M, 1989, J ORGAN BEHAV, V10, P321, DOI 10.1002/job.4030100404
   Heraclides A, 2009, DIABETES CARE, V32, P2230, DOI 10.2337/dc09-0132
   KARASEK R, 1981, AM J PUBLIC HEALTH, V71, P694, DOI 10.2105/AJPH.71.7.694
   Karasek R, 1990, HLTH WORK STRESS PRO
   KARASEK RA, 1979, ADMIN SCI QUART, V24, P285, DOI 10.2307/2392498
   KARASEK RA, 1988, AM J PUBLIC HEALTH, V78, P910, DOI 10.2105/AJPH.78.8.910
   Kawakami N, 2004, DIABETES CARE, V27, P282, DOI 10.2337/diacare.27.1.282
   Kawakami N, 1999, J EPIDEMIOL COMMUN H, V53, P359, DOI 10.1136/jech.53.6.359
   KERSTEDT T, 2009, SLEEP MED CLIN, V4, P257, DOI DOI 10.1016/J.JSMC.2009.03.001
   Kivimaki M, 2011, PLOS MED, V8
   Knutsson A, 2003, OCCUP MED-OXFORD, V53, P103, DOI 10.1093/occmed/kqg048
   Kouvonen AM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-46
   Kroenke CH, 2007, AM J EPIDEMIOL, V165, P175, DOI 10.1093/aje/kwj355
   Kumari M, 2004, ARCH INTERN MED, V164, P1873, DOI 10.1001/archinte.164.17.1873
   LUNDBERG O, 1995, EUROPEAN J PUBLIC HL, V5, P56, DOI DOI 10.1093/EURPUB/5.1.56
   Lundberg U, 2005, PSYCHONEUROENDOCRINO, V30, P1017, DOI 10.1016/j.psyneuen.2005.03.014
   Lundberg U, 1999, J Occup Health Psychol, V4, P142, DOI 10.1037//1076-8998.4.2.142
   LUNDBERG U, 1994, SCAND J PSYCHOL, V35, P315, DOI 10.1111/j.1467-9450.1994.tb00956.x
   Mallon L, 2005, DIABETES CARE, V28, P2762, DOI 10.2337/diacare.28.11.2762
   Nakanishi N, 2001, OCCUP ENVIRON MED, V58, P569, DOI 10.1136/oem.58.9.569
   Norberg M, 2007, DIABETES RES CLIN PR, V76, P368, DOI 10.1016/j.diabres.2006.09.002
   Pan A., 2011, PLOS MED, V8
   Rosmond R, 2000, J INTERN MED, V247, P188, DOI 10.1046/j.1365-2796.2000.00603.x
   World Health Organization, 1999, DEF DIAGN CLASS DI 1
NR 32
TC 49
Z9 50
U1 0
U2 29
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
J9 DIABETES CARE
JI Diabetes Care
PD SEP
PY 2013
VL 36
IS 9
BP 2683
EP 2689
DI 10.2337/dc12-1738
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 205CZ
UT WOS:000323420200057
PM 23637356
OA Other Gold, Green Published
DA 2019-01-08
ER

PT J
AU Gabbay, RA
   Anel-Tiangco, RM
   Dellasega, C
   Mauger, DT
   Adelman, A
   Van Horn, DHA
AF Gabbay, Robert A.
   Anel-Tiangco, Raquel M.
   Dellasega, Cheryl
   Mauger, David T.
   Adelman, Alan
   Van Horn, Deborah H. A.
TI Diabetes nurse case management and motivational interviewing for change
   (DYNAMIC): Results of a 2-year randomized controlled pragmatic trial
SO JOURNAL OF DIABETES
LA English
DT Article
DE behavior change; motivational interviewing; nurse case management
ID GLYCEMIC CONTROL; SELF-MANAGEMENT; OLDER-ADULTS; PRIMARY-CARE;
   DOUBLE-BLIND; MELLITUS; DISEASE; SCALE; QUESTIONNAIRE; INTERVENTION
AB Background: The aim of the present study was to determine whether the addition of nurse case managers (NCMs) trained in motivational interviewing (MI) to usual care would result in improved outcomes in high-risk type 2 diabetes patients.
   Methods: A 2-year randomized controlled pragmatic trial randomized 545 patients to usual care control (n = 313) or those who received the intervention (n = 232) with additional practice-embedded NCM care, including MI-guided behavior change counseling. The NCMs received intensive MI training with ongoing fidelity assessment.
   Results: Systolic blood pressure (SBP) was better in the intervention than usual care group (131 +/- 15 vs. 135 +/- 18 mmHg, respectively; P < 0.05). Improvements were seen in both the control and intervention groups in terms of HbA1c (from 9.1% to 8.0% and from 8.8% to 7.8%, respectively), low-density lipoprotein (LDL; from 127 to 100 mg/dL and from 128 to 102 mg/dL, respectively), and diastolic blood pressure (from 78 to 74 mmHg and from 80 to 74 mmHg, respectively). Depression symptom scores were better in the intervention group. The reduction in diabetes-related distress approached statistical significance.
   Conclusions: The NCMs and MI improved SBP and complications screening. The large decrease in HbA1C and LDL in the control group may have obscured any further intervention effect. Although nurses prompted providers for medication titration, strategies to reduce provider clinical inertia may also be needed.
C1 [Gabbay, Robert A.] Penn State Hershey Diabet Inst, Hershey, PA USA.
   [Gabbay, Robert A.; Anel-Tiangco, Raquel M.] Penn State Milton S Hershey Med Ctr, Div Endocrinol Diabet & Metab, Hershey, PA USA.
   [Dellasega, Cheryl] Penn State Coll Med, Dept Humanities & Womens Studies, Hershey, PA 17033 USA.
   [Mauger, David T.] Penn State Coll Med, Dept Publ Hlth Sci, Hershey, PA 17033 USA.
   [Adelman, Alan] Penn State Hershey Med Grp Fishburn Rd, Hershey, PA USA.
   [Van Horn, Deborah H. A.] Van Horn Consulting, W Deptford, NJ USA.
RP Gabbay, RA (reprint author), Penn State Coll Med, Div Endocrinol Diabet & Metab, 500 Univ Dr,H044, Hershey, PA 17033 USA.
EM rgabbay@hmc.psu.edu
FU National Institutes of Health; National Institute of Diabetes and
   Digestive and Kidney Diseases [R18-DK067495]
FX This study was supported by a grant from the National Institutes of
   Health and National Institute of Diabetes and Digestive and Kidney
   Diseases (grant R18-DK067495). The authors thank Kendra DURDOCK, Nancy
   MARTINEZ-KING, and David GEORGE (Reading Hospital) for their
   contributions in conducting the study. R. A. G. is the guarantor of this
   work and, as such, had full access to all the data in the study and
   takes responsibility for the integrity of the data and the accuracy of
   the data analysis.
CR Anderson DR, 2010, J GEN INTERN MED, V25, P1116, DOI 10.1007/s11606-010-1419-5
   Bojadzievski, 2011, DIABETES CARE, V34, P1047
   Bradley C, 1999, DIABETES CARE, V22, P530, DOI 10.2337/diacare.22.3.530
   Bradley C, 1999, QUAL LIFE RES, V8, P79, DOI 10.1023/A:1026485130100
   Bricker PL, 2010, J CONTIN EDUC HEALTH, V30, P114, DOI 10.1002/chp.20067
   Brug J, 2007, J NUTR EDUC BEHAV, V39, P8, DOI 10.1016/j.jneb.2006.08.010
   Channon SJ, 2007, DIABETES CARE, V30, P1390, DOI 10.2337/dc06-2260
   Clark Marie, 2008, Prim Care Diabetes, V2, P113, DOI 10.1016/j.pcd.2008.04.004
   Davidson MB, 2003, DIABETES CARE, V26, P2281, DOI 10.2337/diacare.26.8.2281
   Dellasega C, 2012, DIABETES RES CLIN PR, V95, P37, DOI 10.1016/j.diabres.2011.08.011
   Echeverry D, 2009, DIABETES CARE, V32, P2156, DOI 10.2337/dc09-0785
   Ford ES, 2008, DIABETES CARE, V31, P102, DOI 10.2337/dc07-0565
   Fox KM, 2003, LANCET, V362, P782
   Gabbay RA, 2006, DIABETES RES CLIN PR, V71, P28, DOI 10.1016/j.diabres.2005.05.002
   Gerstein HC, 2000, LANCET, V355, P253
   Glettler E, 1996, J Case Manag, V5, P121
   Greaves CJ, 2008, BRIT J GEN PRACT, V58, P535, DOI 10.3399/bjgp08X319648
   Hampson SE, 2000, DIABETES CARE, V23, P943
   Hawkins SY, 2010, RES THEOR NURS PRACT, V24, P217, DOI 10.1891/1541-6577.24.4.217
   Katon WJ, 2003, NEW ENGL J MED, V363, P2611
   Khan L, 2009, DIABETES TECHNOL THE, V11, P255, DOI 10.1089/dia.2008.0057
   Lane C, 2005, PATIENT EDUC COUNS, V56, P166, DOI 10.1016/j.pec.2004.01.003
   Lewinsohn PM, 1997, PSYCHOL AGING, V12, P277, DOI 10.1037//0882-7974.12.2.277
   Lustman PJ, 2006, ARCH GEN PSYCHIAT, V63, P521, DOI 10.1001/archpsyc.63.5.521
   Martins RK, 2009, CLIN PSYCHOL REV, V29, P283, DOI 10.1016/j.cpr.2009.02.001
   Miller WR, 2001, BEHAV COGN PSYCHOTH, V29, P457, DOI 10.1017/S1352465801004064
   Minet LKR, 2011, DIABETOLOGIA, V54, P1620, DOI 10.1007/s00125-011-2120-x
   National Committee on Quality Assurance, 2008, STAND GUID PHYS PRAC
   Norris SL, 2002, AM J PREV MED, V22, P15, DOI 10.1016/S0749-3797(02)00423-3
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Renders CM, 2001, DIABETES CARE, V24, P1821, DOI 10.2337/diacare.24.10.1821
   Rollnick S., 2008, MOTIVATIONAL INTERVI
   Rubak S, 2005, BRIT J GEN PRACT, V55, P305
   Rubak S, 2011, SCAND J PRIM HEALTH, V29, P92, DOI 10.3109/02813432.2011.554271
   Shah BR, 2005, DIABETES CARE, V28, P600, DOI 10.2337/diacare.28.3.600
   Shojania KG, 2006, JAMA-J AM MED ASSOC, V296, P427, DOI 10.1001/jama.296.4.427
   Smith DE, 1997, DIABETES CARE, V20, P52, DOI 10.2337/diacare.20.1.52
   Viner RM, 2003, DIABETIC MED, V20, P739, DOI 10.1046/j.1464-5491.2003.00995.x
   Welch G, 2011, DIABETES RES CLIN PR, V91, P54, DOI 10.1016/j.diabres.2010.09.036
   Welch G, 2010, DIABETES RES CLIN PR, V88, P1, DOI 10.1016/j.diabres.2009.12.026
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
NR 41
TC 31
Z9 32
U1 5
U2 50
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1753-0393
J9 J DIABETES
JI J. Diabetes
PD SEP
PY 2013
VL 5
IS 3
BP 349
EP 357
DI 10.1111/1753-0407.12030
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 195NZ
UT WOS:000322711300020
PM 23368423
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Rees, G
   Lamoureux, EL
   Nicolaou, TE
   Hodgson, LAB
   Weinman, J
   Speight, J
AF Rees, G.
   Lamoureux, E. L.
   Nicolaou, T. E.
   Hodgson, L. A. B.
   Weinman, J.
   Speight, J.
TI Feedback of personal retinal images appears to have a motivational
   impact in people with non-proliferative diabetic retinopathy and
   suboptimal HbA(1c): findings of a pilot study
SO DIABETIC MEDICINE
LA English
DT Article
ID TRIAL; RISK; CARE
AB Aim To conduct a pilot study to explore the potential impact of visual feedback of personal retinal images on diabetes outcomes.
   Methods Twenty-five participants with non-proliferative diabetic retinopathy and suboptimal HbA(1c) (>53mmol/mol; >7%) were randomized to receive visual feedback of their own retinal images or to a control group. At baseline and 3-month follow-up, HbA(1c), standard measures of beliefs, diabetes-related distress and self-care activities were assessed.
   Results In unadjusted models, relative to controls, the intervention group showed significantly greater improvement in HbA(1c) at 3-month follow-up (-0.6% vs. +0.3%, P<0.01), as well as enhanced motivation to improve blood glucose management (P<0.05).
   Conclusions This small pilot study provides preliminary evidence that visual feedback of personal retinal images may offer a practical educational strategy for clinicians in eye care services to improve diabetes outcomes in non-target compliant patients. A fully powered randomized controlled trial is required to confirm these findings and determine the optimal use of feedback to produce sustained effects.
C1 [Rees, G.; Lamoureux, E. L.; Nicolaou, T. E.; Hodgson, L. A. B.] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic 3010, Australia.
   [Lamoureux, E. L.] Natl Univ Singapore, Singapore Eye Res Inst, Singapore 117548, Singapore.
   [Weinman, J.] Kings Coll London, Inst Psychiat, London, England.
   [Speight, J.] Diabet Australia Vic, Australian Ctr Behav Res Diabet, Melbourne, Vic, Australia.
   [Speight, J.] Deakin Univ, Sch Psychol, Ctr Mental Hlth & Wellbeing Res, Burwood, Vic, Australia.
RP Rees, G (reprint author), Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic 3010, Australia.
EM grees@unimelb.edu.au
OI Speight, Jane/0000-0002-1204-6896; Weinman, John
   Alfred/0000-0002-6786-0166
CR Broadbent E, 2006, J PSYCHOSOM RES, V60, P631, DOI 10.1016/j.jpsychores.2005.10.020
   *ETDRS, 1991, OPHTHALMOLOGY, V98, P786
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Funnel MM, 2009, DIABETES CARE, V32, pS87, DOI 10.2337/dc09-S087
   Hollands G. J., 2010, COCHRANE DATABASE SY, V2010, P1
   Lamoureux EL, 2012, CLIN EXP OPHTHALMOL, V40, P73, DOI 10.1111/j.1442-9071.2011.02697.x
   Milne S, 2000, J APPL SOC PSYCHOL, V30, P106, DOI 10.1111/j.1559-1816.2000.tb02308.x
   Nathan DM, 2008, ARCH OPHTHALMOL-CHIC, V126, P1707, DOI 10.1001/archopht.126.12.1707
   Scanlon PH, 2012, DIABETIC MED, V29, P836, DOI 10.1111/j.1464-5491.2012.03630.x
   Shahab L, 2011, HEALTH PSYCHOL, V30, P49, DOI 10.1037/a0021821
   Stratton IM, 2001, DIABETOLOGIA, V44, P156, DOI 10.1007/s001250051594
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
NR 12
TC 5
Z9 5
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
J9 DIABETIC MED
JI Diabetic Med.
PD SEP
PY 2013
VL 30
IS 9
BP 1122
EP 1125
DI 10.1111/dme.12192
PG 4
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 202DZ
UT WOS:000323195000017
PM 23601012
DA 2019-01-08
ER

PT J
AU Joensen, LE
   Tapager, I
   Willaing, I
AF Joensen, L. E.
   Tapager, I.
   Willaing, I.
TI Diabetes distress in Type1 diabetesa new measurement fit for purpose
SO DIABETIC MEDICINE
LA English
DT Article
ID QUALITY-OF-LIFE; PROBLEM-AREAS; EMOTIONAL DISTRESS; SCALE; HEALTH;
   DEPRESSION; VALIDITY; VERSION; QUESTIONNAIRES; RELIABILITY
AB Aims To examine and assess (1) the internal consistency and validity of a Danish translation of the Diabetes Distress Scale (DDS17) among adults with Type1 diabetes mellitus, (2) the properties of the brief version of DDS17 and (3) cut points for the DDS17.
   Methods Cross-sectional survey of 2419 adults with Type1 diabetes mellitus. Validated scales and questions measured diabetes distress (DDS17), diabetes empowerment (DES-SF), healthy diet, physical activity, self-rated health (SF-12) and quality of life (WHOQoL-BREF). An electronic patient record provided information about glycaemic control (HbA(1c)). We examined internal consistency, construct validity, subscale construction and cut points for determining clinically relevant diabetes distress, as well as two- and four-item brief versions of the DDS17.
   Results The DDS17 had a Cronbach's alpha of 0.92; subscale alphas were 0.83-0.89. A four-factor division into subscales was appropriate and the division corresponded closely to the four domains described in the development of the DDS17. The DDS17 correlated well with relevant measures; higher distress was correlated with low diabetes empowerment, low quality of life, unhealthy diet, not being physically active, poor glycaemic control and low scores on the mental component score of the SF-12. A two-item brief scale performed as well as a four-item version. The relationship between DDS17 and outcomes did not suggest distinct cut points for DDS17.
   Conclusions Our results provide support for the use of this Danish adaptation of the DDS17 for assessing psychosocial distress among adults with Type1 diabetes mellitus.
C1 [Joensen, L. E.; Willaing, I.] Steno Diabet Ctr, Steno Hlth Promot Ctr, DK-2820 Gentofte, Denmark.
   [Tapager, I.] Incentive, Holte, Denmark.
RP Joensen, LE (reprint author), Steno Diabet Ctr, Steno Hlth Promot Ctr, DK-2820 Gentofte, Denmark.
EM ljoe@steno.dk
OI Joensen, Lene Eide/0000-0002-4790-8759; Willaing,
   Ingrid/0000-0002-3082-8816
FU Novo Nordisk; Novo Nordisk Foundation; Capital Region of Denmark
FX The Steno Diabetes Center is an independent academic institution owned
   by Novo Nordisk and financed partly by Novo Nordisk, partly by the Novo
   Nordisk Foundation and partly by the Capital Region of Denmark.
CR Amsberg S, 2008, INT J NURS STUD, V45, P1319, DOI 10.1016/j.ijnurstu.2007.09.010
   Anderson R, 2000, NAT HIST, V109, P23
   Anderson RM, 2003, DIABETES CARE, V26, P1641, DOI 10.2337/diacare.26.5.1641-a
   Egede LE, 2012, CURR PSYCHIAT REP, V14, P15, DOI 10.1007/s11920-011-0240-0
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7
   Gonzalez JS, 2011, DIABETES CARE, V34, P236, DOI 10.2337/dc10-1970
   Graue M, 2012, INT J NURS STUD, V49, P174, DOI 10.1016/j.ijnurstu.2011.08.007
   Harper A, 1998, PSYCHOL MED, V28, P551
   Hatcher L, 1994, DEV MEASUREMENT MODE, P249
   Hatcher L, 1994, STEPS CONDUCTION EXP, P79
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   Huis In 't Veld EM, 2011, CARDIOVASC PSYCHIAT, V2011, DOI [10.1155/2011/315086, DOI 10.1155/2011/315086]
   Maindal HT, 2012, EUR J PUBLIC HEALTH, V22, P31, DOI 10.1093/eurpub/ckq188
   Papathanasiou A, 2012, J PSYCHIATR MENT HLT, DOI [10.1111/j.1356-2850.2012.01875.x, DOI 10.1111/J.1356-2850.2012.01875.X.[]
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Pouwer F, 2006, PATIENT EDUC COUNS, V60, P235, DOI 10.1016/j.pec.2005.01.009
   SAS/STAT, SAS STAT R 9 2 US GU
   Sigurdardottir AK, 2008, INT J NURS STUD, V45, P526, DOI 10.1016/j.ijnurstu.2006.10.008
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Snoek FJ, 2011, DIABETES CARE, V34, P601, DOI 10.2337/dc10-1552
   Streiner D, 2009, SELECTING ITEMS HLTH
   Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012
   Ting RZW, 2011, DIABETES CARE, V34, P1094, DOI 10.2337/dc10-1612
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Wang RH, 2011, J ADV NURS, V67, P2658, DOI 10.1111/j.1365-2648.2011.05701.x
NR 30
TC 25
Z9 28
U1 0
U2 13
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
J9 DIABETIC MED
JI Diabetic Med.
PD SEP
PY 2013
VL 30
IS 9
BP 1132
EP 1139
DI 10.1111/dme.12241
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 202DZ
UT WOS:000323195000019
PM 23701311
DA 2019-01-08
ER

PT J
AU Al-Nsour, M
   Zindah, M
   Belbeisi, A
   Rolle, IV
   Walke, H
   Strine, T
   Perry, GS
   Jarrar, B
   Mokdad, A
AF Al-Nsour, Mohannad
   Zindah, Meyasser
   Belbeisi, Adel
   Rolle, Italia V.
   Walke, Henry
   Strine, Tara
   Perry, Geraldine S.
   Jarrar, Bassam
   Mokdad, Ali
TI Frequent Mental Distress, Chronic Conditions, and Adverse Health
   Behaviors in the Behavioral Risk Factor Surveillance Survey, Jordan,
   2007
SO PREVENTING CHRONIC DISEASE
LA English
DT Article
ID QUALITY-OF-LIFE; HEART-DISEASE; ADULTS; DEPRESSION; ATTITUDES; OLDER
AB Introduction
   Recent evidence indicates that chronic diseases and mental illness are associated. In the Middle Eastern country of Jordan, chronic diseases and frequent mental distress (FMD) are increasing; however, the capacity for mental health care is limited. The objective of this study was to determine the association between FMD, chronic conditions, and adverse health behaviors in Jordan.
   Methods
   The third cycle of the Jordan Behavioral Risk Factor Surveillance Survey (2007) served as the data source for this study. The sample consisted of 3,612 noninstitutionalized Jordanian adults aged 18 years or older. Logistic regression was used to obtain odds ratios for the association between chronic conditions, health behaviors, and FMD adjusted for age, sex, marital status, education, income, and employment.
   Results
   In the adjusted models, people with hypertension (adjusted odds ratio [AOR], 2.0; 95% confidence interval [CI], 1.6 2.7), high cholesterol (AOR, 2.3; 95% CI, 1.6-3.2), diabetes (AOR, 1.6; 95% CI, 1.1-2.4), and asthma (AOR, 2.2; 95% CI, 1.5-3.1) and smokers (AOR, 1.5; 95% CI, 1.1-2.0) were more likely to have FMD than people without each of these conditions. Adults who reported vigorous physical activity were less likely to have FMD (AOR, 0.6; 95% CI, 0.4-0.9) than their less active counterparts.
   Conclusions
   In Jordan, FMD was associated with several chronic conditions. As a result, we suggest additional research to examine the complex relationship between FMD and chronic conditions. More doctors in the primary health care system should be trained in mental health.
C1 [Al-Nsour, Mohannad] Eastern Mediterranean Publ Hlth Network, Amman, Jordan.
   [Zindah, Meyasser; Belbeisi, Adel] Jordan Minist Hlth, Amman, Jordan.
   [Rolle, Italia V.; Walke, Henry; Strine, Tara; Perry, Geraldine S.; Jarrar, Bassam] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Mokdad, Ali] Univ Washington, Seattle, WA 98195 USA.
RP Al-Nsour, M (reprint author), Eastern Mediterranean Publ Hlth Network, Amman, Jordan.
EM mohannadnsour973@yahoo.com
CR Al-Krenawi A, 2004, INT J SOC PSYCHIATR, V50, P102, DOI 10.1177/0020764004040957
   Al-Krenawi A, 2000, COMMUNITY MENT HLT J, V36, P501, DOI 10.1023/A:1001963714338
   Al-Nsour M, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110077
   Al-Safi Saafan A, 2005, Eur J Cardiovasc Nurs, V4, P286, DOI 10.1016/j.ejcnurse.2005.03.004
   Bahou Y, 2004, East Mediterr Health J, V10, P138
   Belbeisi A., 2006, Morbidity and Mortality Weekly Report, V55, P653
   Belbeisi A, 2009, INT J PUBLIC HEALTH, V54, P106, DOI 10.1007/s00038-009-0014-1
   Caldwell JC, 2001, B WORLD HEALTH ORGAN, V79, P159
   Centers for Disease Control and Prevention, 2000, MEAS HLTH DAYS POP A
   Chapman Daniel P, 2005, Prev Chronic Dis, V2, pA14
   Cook J, 1998, JAMA-J AM MED ASSOC, V279, P1772
   Haddad LG, 2002, INT J NURS STUD, V39, P793, DOI 10.1016/S0020-7489(02)00016-0
   Hamid Hamada, 2004, Transcult Psychiatry, V41, P487, DOI 10.1177/1363461504047931
   Hammoudeh AJ, 2006, INT J CARDIOL, V110, P179, DOI 10.1002/j.ijcard.2005.08.005
   Jaddou HY, 2003, SAUDI MED J, V24, P472
   Khasawneh NF, 2005, SAUDI MED J, V26, P215
   Kulwicki A D, 2001, J Cult Divers, V8, P34
   Lopez AD, 1998, NAT MED, V4, P1241, DOI 10.1038/3218
   McGuire LC, 2007, AM J GERIAT PSYCHIAT, V15, P754, DOI 10.1097/JGP.0b013e3180986125
   Mohit A, 1999, East Mediterr Health J, V5, P231
   Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9
   Nasir LS, 2005, J AM BOARD FAM PRACT, V18, P125, DOI 10.3122/jabfm.18.2.125
   National Mental Health Team, 2010, NAT REP MENT HLTH SY
   Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0
   Rohrer J, 2007, J EVAL CLIN PRACT, V13, P435, DOI 10.1111/j.1365-2753.2006.00737.x
   Strine TW, 2005, AM J PREV MED, V28, P182, DOI 10.1016/j.ampre.2004.10.002
   Strine TW, 2004, PREV MED, V39, P191, DOI 10.1016/j.ypmed.2004.01.022
   Strine TW, 2004, CHEST, V126, P1849, DOI 10.1378/chest.126.6.1849
   World Health Organization, 2011, MENT HLTH ATL 2011
   Zahran H. S., 2004, Morbidity and Mortality Weekly Report, V53, P963
NR 30
TC 2
Z9 2
U1 0
U2 1
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1545-1151
J9 PREV CHRONIC DIS
JI Prev. Chronic Dis.
PD AUG
PY 2013
VL 10
AR UNSP 130030
DI 10.5888/pcd10.130030
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 285KJ
UT WOS:000329392600014
OA Green Published, Bronze
DA 2019-01-08
ER

PT J
AU Gariepy, G
   Smith, KJ
   Schmitz, N
AF Gariepy, Genevieve
   Smith, Kimberley J.
   Schmitz, Norbert
TI Diabetes distress and neighborhood characteristics in people with type 2
   diabetes
SO JOURNAL OF PSYCHOSOMATIC RESEARCH
LA English
DT Article
DE Diabetes; Diabetes, type 2; Distress; Stress; Neighborhood; Epidemiology
ID DEPRESSIVE SYMPTOMS; GLYCEMIC CONTROL; CLINICAL DEPRESSION;
   OLDER-ADULTS; HEALTH; DISORDER; ASSOCIATIONS; ENVIRONMENT; OUTCOMES;
   SMOKING
AB Objective: Diabetes-specific distress is an important psychological issue in people with diabetes. The neighborhood environment has the potential to be an important factor for diabetes distress. This study investigates the associations between neighborhood characteristics and diabetes distress in adults with type 2 diabetes.
   Methods: We used cross-sectional data from a community-based sample of 578 adults with type 2 diabetes from Quebec, Canada. Information on perceived neighborhood characteristics and diabetes distress was collected from phone interviews. We used factor analysis to combine questionnaire items into neighborhood factors. Information on neighborhood deprivation was derived from census data. We performed linear regressions for diabetes distress and specific domains of diabetes distress (emotional, regimen-related, physician-related and interpersonal distress), adjusting for individual-level variables.
   Results: Factorial analysis uncovered 3 important neighborhood constructs: perceived order (social and physical order), culture (social and cultural environment) and access (access to services and facilities). After adjusting for individual-level confounders, neighborhood order was significantly associated with diabetes distress and all specific domains of distress; neighborhood culture was specifically associated with regimen-related distress; and neighborhood access was specifically associated with physician-related distress. The objective measure of neighborhood material deprivation was associated with regimen-related distress.
   Conclusions: Neighborhood characteristics are associated with diabetes distress in people with type 2 diabetes. Clinicians should consider the neighborhood environment reported by their patients with diabetes when assessing and addressing diabetes-specific distress. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Gariepy, Genevieve; Schmitz, Norbert] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ H4H 1R3, Canada.
   [Gariepy, Genevieve; Smith, Kimberley J.; Schmitz, Norbert] Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada.
   [Smith, Kimberley J.; Schmitz, Norbert] McGill Univ, Dept Psychiat, Montreal, PQ H4H 1R3, Canada.
RP Gariepy, G (reprint author), McGill Univ, Douglas Mental Hlth Univ Inst, 6875 LaSalle Blvd, Montreal, PQ H4H 1R3, Canada.
EM genevieve.gariepy@mail.mcgill.ca
RI Schmitz, Norbert/A-5177-2010
OI Schmitz, Norbert/0000-0001-7777-6323; Smith,
   Kimberley/0000-0002-1323-627X; Gariepy, Genevieve/0000-0001-9209-4240
FU Canadian Institutes of Health; Canadian Diabetes Association
FX GG, KS and NS were supported by funding from the Canadian Institutes of
   Health. The Diabetes Health Study is funded by the Canadian Diabetes
   Association.
CR Aikens JE, 2012, DIABETES CARE, V35, P2472, DOI 10.2337/dc12-0181
   [Anonymous], 2008, CANADIAN J DIABETES
   Bandura A, 2004, HEALTH EDUC BEHAV, V31, P143, DOI 10.1177/1090198104263660
   Billimek J, 2012, J GEN INTERN MED, V27, P292, DOI 10.1007/s11606-011-1882-7
   Browne JL, 2013, DIABETIC MED, V30, P620, DOI 10.1111/dme.12078
   Casciano R, 2012, HEALTH PLACE, V18, P180, DOI 10.1016/j.healthplace.2011.09.002
   Chaikiat A, 2012, HEALTH PLACE, V18, P877, DOI 10.1016/j.healthplace.2012.03.003
   CURRY SJ, 1993, AM J PREV MED, V9, P78
   Deshpande AD, 2008, PHYS THER, V88, P1254, DOI 10.2522/ptj.20080020
   Echeverria SE, 2004, J URBAN HEALTH, V81, P682, DOI 10.1093/jurban/jth151
   Fiori KL, 2013, GERONTOLOGY, V59, P40, DOI 10.1159/000339747
   Fisher JTM L, 2009, DIABETIC MED, V26, P622
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Gary TL, 2008, DIABETES CARE, V31, P273, DOI 10.2337/dc07-1111
   Gary-Webb TL, 2011, BMC PUBLIC HEALTH, V11, P7
   Gonzalez JS, 2011, DIABETES CARE, V34, P236, DOI 10.2337/dc10-1970
   Hoehner CM, 2005, AM J PREV MED, V28, P105, DOI 10.1016/j.amepre.2004.10.023
   Karasek D, 2012, AM J PUBLIC HEALTH, V102, P343, DOI 10.2105/AJPH.2011.300364
   Kim J, 2010, SOC SCI RES, V39, P260, DOI 10.1016/j.ssresearch.2009.08.007
   Kneck A, 2012, J ADV NURS, V68, P2486, DOI 10.1111/j.1365-2648.2012.05947.x
   Mair C, 2008, J EPIDEMIOL COMMUN H, V62, P940, DOI 10.1136/jech.2007.066605
   Mair C, 2010, HEALTH PLACE, V16, P811, DOI 10.1016/j.healthplace.2010.04.006
   Mansfield ED, 2012, INT J BEHAV NUTR PHY, P9
   Martin KR, 2010, ARTHRIT CARE RES, V62, P1602, DOI 10.1002/acr.20267
   Mathew R., 2012, BMC FAM PRACT, V13
   Moore LV, 2012, AM J EPIDEMIOL, V175, P1037, DOI 10.1093/aje/kwr445
   Mujahid MS, 2007, AM J EPIDEMIOL
   Murrock CJ, 2013, WOMEN HEALTH, V53, P173, DOI 10.1080/03630242.2012.753979
   Owen N, 2004, AM J PREV MED, V27, P67, DOI 10.1016/j.amepre.2004.03.006
   Pampalon R., 2009, CHRONIC DIS CAN, V29, P174
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Ross CE, 1999, URBAN AFF REV, V34, P412, DOI 10.1177/10780879922184004
   Sampson RJ, 2004, SOC PSYCHOL QUART, V67, P319, DOI 10.1177/019027250406700401
   Schmitz MF, 2012, AGE AGEING, V41, P388, DOI 10.1093/ageing/afr163
   Schmitz N, 2009, DIABETES CARE, V32, P1998, DOI 10.2337/dc09-0838
   Stafford M, 2008, HEALTH PLACE, V14, P394, DOI 10.1016/j.healthplace.2007.08.006
   Steptoe A, 2001, ANN BEHAV MED, V23, P177, DOI 10.1207/S15324796ABM2303_5
   Tsujii S, 2012, DIABETIC MED, V29, P1451, DOI 10.1111/j.1464-5491.2012.03647.x
   Wen M, 2006, SOC SCI MED, V63, P2575, DOI 10.1016/j.socscimed.2006.06.025
   WETHINGTON E, 1986, J HEALTH SOC BEHAV, V27, P78, DOI 10.2307/2136504
   Wilkerson A, 2012, ENVIRON BEHAV, V44, P595, DOI 10.1177/0013916511402058
   Zagarins SE, 2012, J BEHAV MED, V35, P299, DOI 10.1007/s10865-011-9359-z
NR 46
TC 7
Z9 7
U1 1
U2 27
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0022-3999
J9 J PSYCHOSOM RES
JI J. Psychosomat. Res.
PD AUG
PY 2013
VL 75
IS 2
BP 147
EP 152
DI 10.1016/j.jpsychores.2013.05.009
PG 6
WC Psychiatry
SC Psychiatry
GA 204UQ
UT WOS:000323397100008
PM 23915771
DA 2019-01-08
ER

PT J
AU Wagner, JA
   Tennen, H
   Finan, PH
   Ghuman, N
   Burg, MM
AF Wagner, Julie A.
   Tennen, Howard
   Finan, Patrick H.
   Ghuman, Nimrta
   Burg, Matthew M.
TI Self-reported Racial Discrimination and Endothelial Reactivity to Acute
   Stress in Women
SO STRESS AND HEALTH
LA English
DT Article
DE endothelial function; racism; discrimination; diabetes; stress;
   reactivity
ID CORONARY-ARTERY-DISEASE; MENTAL STRESS; PERCEIVED DISCRIMINATION;
   SOCIOECONOMIC-STATUS; CARDIOVASCULAR REACTIVITY; ETHNIC DISCRIMINATION;
   HEALTH DISPARITIES; AFRICAN-AMERICANS; HEART-DISEASE; DYSFUNCTION
AB This study investigated the effect of self-reported racial discrimination on endothelial responses to acute laboratory mental stress among post-menopausal women. One-hundred thirteen women (n = 94 self-identified as White and n = 19 self-identified as racial/ethnic minority), 43% with type 2 diabetes, reported lifetime experiences of racial/ ethnic discrimination. Repeated assessments of flow-mediated dilation were performed at baseline, immediately after 5 min of mental arithmetic and at 20-min recovery. Both White and racial/ethnic minority women reported lifetime discrimination, with rates significantly higher among minorities. Self-reported lifetime discrimination was associated with attenuated flow-mediated dilation at recovery. Confounding variables, including clinical characteristics, mood, personality traits, other life stressors and general distress, did not better account for the effect of racial discrimination. Neither race/ethnicity nor diabetes status moderated the effect. The perceived stressfulness of the mental arithmetic was not associated with the endothelial response. In conclusion, self-reported lifetime discrimination is associated with attenuated endothelial recovery from acute mental stress. Elucidating the effects of discrimination and the biological mechanisms through which it affects the vasculature may suggest interventions to improve health. Copyright (C) 2012 John Wiley & Sons, Ltd.
C1 [Wagner, Julie A.] Univ Connecticut, Ctr Hlth, Div Behav Sci & Community Hlth, Farmington, CT 06030 USA.
   [Tennen, Howard] Univ Connecticut, Ctr Hlth, Dept Community Med, Farmington, CT 06030 USA.
   [Finan, Patrick H.] Johns Hopkins Univ, Baltimore, MD USA.
   [Ghuman, Nimrta] Univ Connecticut, Ctr Hlth, Calhoun Cardiol Ctr, Farmington, CT 06030 USA.
   [Burg, Matthew M.] Columbia Univ, Columbia, NY USA.
RP Wagner, JA (reprint author), Univ Connecticut, Ctr Hlth, Div Behav Sci & Community Hlth, 263 Farmington Ave, Farmington, CT 06030 USA.
EM juwagner@uchc.edu
FU University of Connecticut Center for Interdisciplinary Research in
   Women's Health; American Heart Association; American Diabetes
   Association; University of Connecticut Health Center General Clinical
   Research Center [M01RR006192]
FX This study was supported by grants from the University of Connecticut
   Center for Interdisciplinary Research in Women's Health, the American
   Heart Association, the American Diabetes Association and the University
   of Connecticut Health Center General Clinical Research Center
   (M01RR006192).
CR ANDRESEN EM, 1994, AM J PREV MED, V10, P77
   Blumenthal JA, 2005, JAMA-J AM MED ASSOC, V293, P1626, DOI 10.1001/jama.293.13.1626
   Borrell LN, 2006, SOC SCI MED, V63, P1415, DOI 10.1016/j.socscimed.2006.04.008
   Brion MJ, 2005, PSYCHOPHYSIOLOGY, V42, P282, DOI 10.1111/j.1469-8986.2005.00284.x
   Broudy R, 2007, J BEHAV MED, V30, P31, DOI 10.1007/s10865-006-9081-4
   Carlson ED, 2005, RES NURS HEALTH, V28, P306, DOI 10.1002/nur.20084
   Chan SY, 2003, J AM COLL CARDIOL, V42, P1037, DOI 10.1016/S0735-1097(03)00927-6
   Clark R, 2006, HEALTH PSYCHOL, V25, P20, DOI 10.1037/0278-6133.25.1.20
   COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404
   Cooper DC, 2010, ANN BEHAV MED, V39, P222, DOI 10.1007/s12160-010-9181-9
   Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6
   Costa P. T., 1992, NEO PI R PROFESSIONA
   Fogel J, 2003, PSYCHO-ONCOL, V12, P107, DOI 10.1002/pon.617
   Fujishiro K, 2009, SOC SCI MED, V68, P840, DOI 10.1016/j.socscimed.2008.12.007
   Ghiadoni L, 2000, CIRCULATION, V102, P2473, DOI 10.1161/01.CIR.102.20.2473
   Gottdiener JS, 2003, AM J CARDIOL, V92, P687, DOI 10.1016/S0002-9149(03)00823-3
   Gu K, 1999, JAMA-J AM MED ASSOC, V281, P1291, DOI 10.1001/jama.281.14.1291
   Hausmann LRM, 2008, MED CARE, V46, P905, DOI 10.1097/MLR.0b013e3181792562
   Hogue C. J. R., 2000, MINORITY HLTH AM FIN
   HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4
   Jackson JS, 1997, PERCEPTIONS DISCRIMI
   Jones Camara Phyllis, 2002, PHYLON, V50, P7, DOI DOI 10.2307/4149999
   Krieger N, 2005, SOC SCI MED, V61, P1576, DOI 10.1016/j.socscimed.2005.03.006
   Lepore SJ, 2006, ANN BEHAV MED, V31, P120, DOI 10.1207/s15324796abm3102_3
   Lewis TT, 2006, PSYCHOSOM MED, V68, P362, DOI 10.1097/01.psy.0000221360.94700.16
   Lewis TT, 2010, BRAIN BEHAV IMMUN, V24, P438, DOI 10.1016/j.bbi.2009.11.011
   McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307
   Merritt MM, 2006, HEALTH PSYCHOL, V25, P364, DOI 10.1037/0278-6133.25.3.364
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Richman LS, 2008, ANN BEHAV MED, V35, P105, DOI 10.1007/s12160-007-9013-8
   Richman LS, 2007, HEALTH PSYCHOL, V26, P675, DOI 10.1037/0278-6133.26.6.675
   ROSS R, 1986, NEW ENGL J MED, V314, P488, DOI 10.1056/NEJM198602203140806
   Salomon K, 2008, HEALTH PSYCHOL, V27, P473, DOI 10.1037/0278-6133.27.4.473
   Schwartz AR, 2003, PSYCHOSOM MED, V65, P22, DOI 10.1097/01.PSY.0000046075.79922.61
   Shavers VL, 2007, J NATL MED ASSOC, V99, P1013
   Soufer R, 1998, P NATL ACAD SCI USA, V95, P6454, DOI 10.1073/pnas.95.11.6454
   Szanton SL, 2011, INT J BEHAV MED
   Tomfohr L, 2010, PSYCHOSOM MED, V72, P266, DOI 10.1097/PSY.0b013e3181d0d8b2
   Wagner JA, 2006, PSYCHOSOM MED, V68, P80, DOI 10.1097/01.psy.0000195868.68122.9e
   Wagner J, 2007, DIABETES CARE, V30, P364, DOI 10.2337/dc06-1756
   Watson JM, 2002, J WOMEN HEALTH GEN-B, V11, P441, DOI 10.1089/15246090260137617
   WEISSMAN MM, 1977, AM J EPIDEMIOL, V106, P203, DOI 10.1093/oxfordjournals.aje.a112455
   White JB, 2004, ORGAN BEHAV HUM DEC, V94, P102, DOI 10.1016/j.obhdp.2004.03.005
   Williams DR, 2009, J BEHAV MED, V32, P20, DOI 10.1007/s10865-008-9185-0
   WILLIAMS DR, 1997, J HLTH PSYCHOL, V0002
   Zhang HR, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-011-0237-1
NR 46
TC 11
Z9 11
U1 0
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1532-3005
EI 1532-2998
J9 STRESS HEALTH
JI Stress Health
PD AUG
PY 2013
VL 29
IS 3
BP 214
EP 221
DI 10.1002/smi.2449
PG 8
WC Psychology, Applied; Psychiatry; Psychology
SC Psychology; Psychiatry
GA 193WJ
UT WOS:000322591900006
PM 22962001
DA 2019-01-08
ER

PT J
AU Chesla, CA
   Chun, KM
   Kwan, CML
   Mullan, JT
   Kwong, Y
   Hsu, L
   Huang, P
   Strycker, LA
   Shum, T
   To, D
   Kao, R
   Waters, CM
AF Chesla, Catherine A.
   Chun, Kevin M.
   Kwan, Christine M. L.
   Mullan, Joseph T.
   Kwong, Yulanda
   Hsu, Lydia
   Huang, Peggy
   Strycker, Lisa A.
   Shum, Tina
   To, Diana
   Kao, Rudy
   Waters, Catherine M.
TI Testing the efficacy of culturally adapted coping skills training for
   Chinese American immigrants with type 2 diabetes using community-based
   participatory research
SO RESEARCH IN NURSING & HEALTH
LA English
DT Article
DE Asian; Chinese; community-based participatory research; diabetes;
   distress; intervention; quality of life
ID QUALITY-OF-LIFE; SELF-MANAGEMENT EDUCATION; DISEASE MANAGEMENT; GLYCEMIC
   CONTROL; DEPRESSIVE SYMPTOMS; PACIFIC ISLANDERS; COLLEGE-STUDENTS;
   DISTRESS SCALE; METAANALYSIS; INTERVENTIONS
AB Chinese Americans demonstrate greater prevalence of diabetes than non-Hispanic whites and find standard diabetes care disregards their cultural health beliefs. Academic researchers and Chinatown agencies collaborated to culturally adapt and test an efficacious cognitive-behavioral intervention using community-based participatory research. Using a delayed-treatment repeated-measures design, 145 adult Chinese immigrants with Type 2 diabetes completed treatment. Immediate benefits of treatment were evident in the improvement (p<.05) in diabetes self-efficacy, diabetes knowledge, bicultural efficacy, family emotional and instrumental support, diabetes quality of life, and diabetes distress. Prolonged benefits were evident in all changed variables 2 months post-intervention. The CBPR approach enabled the development of a culturally acceptable, efficacious behavioral intervention, and provides a model for working with communities that demonstrate health disparities. (c) 2013 Wiley Periodicals, Inc. Res Nurs Health 36: 359-372, 2013
C1 [Chesla, Catherine A.; Kwan, Christine M. L.] Univ Calif San Francisco, Dept Family Hlth Care Nursing, San Francisco, CA 94143 USA.
   [Chun, Kevin M.] Univ San Francisco, Dept Psychol, San Francisco, CA 94117 USA.
   [Mullan, Joseph T.] Univ Calif San Francisco, Dept Social & Behav Sci, San Francisco, CA 94143 USA.
   [Kwong, Yulanda] Donaldina Cameron House, Social Serv Minist, San Francisco, CA USA.
   [Shum, Tina; To, Diana] Donaldina Cameron House, San Francisco, CA USA.
   [Hsu, Lydia] North East Med Serv, Hlth Counseling Serv Dept, San Francisco, CA USA.
   [Huang, Peggy] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA.
   [Strycker, Lisa A.] Oregon Res Inst, Eugene, OR 97403 USA.
   [Kao, Rudy] North East Med Serv, San Francisco, CA USA.
   [Waters, Catherine M.] Univ Calif San Francisco, Dept Community Hlth Syst, San Francisco, CA 94143 USA.
RP Chesla, CA (reprint author), Univ Calif San Francisco, Dept Family Hlth Care Nursing, 2 Koret Way,Box 0606, San Francisco, CA 94143 USA.
FU National Institute of Nursing Research [1R01NR010693]
FX This project was supported by the National Institute of Nursing Research
   (1R01NR010693). We thank the following organizations and individuals:
   Doreen Der-McLeod and Monica Walters of Donaldina Cameron House; Daniel
   Chan and Edna Tam of North East Medical Services; Anita Au-Yeung and
   Doris Hung of University of California San Francisco; Eunice Lew and all
   study participants; members of our Community Advisory Board. We thank
   Margaret Grey of Yale University for her ongoing consultation. An
   earlier version of this work was presented in the American Diabetes
   Association Convention in Philadelphia in 2012.
CR [Anonymous], 2009, SPSS STAT WIND VERS
   Bacallao Martica L, 2005, J Prim Prev, V26, P485, DOI 10.1007/s10935-005-0008-6
   Bandura A, 2004, HEALTH EDUC BEHAV, V31, P143, DOI 10.1177/1090198104263660
   Castro FG, 2010, ANNU REV CLIN PSYCHO, V6, P213, DOI 10.1146/annurev-clinpsy-033109-132032
   Chesla CA, 2004, DIABETES CARE, V27, P2850, DOI 10.2337/diacare.27.12.2850
   Chesla CA, 2009, DIABETES CARE, V32, P1812, DOI 10.2337/dc09-0278
   Chun KM, 2011, SOC SCI MED, V72, P256, DOI 10.1016/j.socscimed.2010.11.010
   Chun KM, 2004, PSYCHOL HEALTH, V19, P767, DOI 10.1080/08870440410001722958
   Cochran J, 2008, DIABETES EDUCATOR, V34, P815, DOI 10.1177/0145721708323640
   Coyne JC, 1994, J FAMILY PSYCHOL, V8, P43, DOI DOI 10.1037/0893-3200.8.1.43
   David EJR, 2009, J COUNS PSYCHOL, V56, P211, DOI 10.1037/a0015419
   Ellis SE, 2004, PATIENT EDUC COUNS, V52, P97, DOI 10.1016/S0738-3991(03)00016-8
   Fisher L, 2004, J FAM PSYCHOL, V18, P302, DOI 10.1037/0893-3200.18.2.302
   Fisher L, 2000, BEHAV MED, V26, P53, DOI 10.1080/08964280009595752
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Fitzgerald JT, 1998, DIABETES CARE, V21, P706, DOI 10.2337/diacare.21.5.706
   Fitzgerald JT, 1996, EVAL HEALTH PROF, V19, P209, DOI DOI 10.1177/016327879601900205
   Funnell MM, 2012, DIABETES CARE, V35, pS101, DOI [10.2337/dc12-s101, 10.2337/dc12-S089]
   Gary TL, 2003, DIABETES EDUCATOR, V29, P488, DOI 10.1177/014572170302900313
   Grey M, 2000, J PEDIATR-US, V137, P107, DOI 10.1067/mpd.2000.106568
   Grey M, 2011, NURS RES, V60, P173, DOI 10.1097/NNR.0b013e3182159c8f
   Grey M, 2009, RES NURS HEALTH, V32, P405, DOI 10.1002/nur.20336
   Grzywacz JG, 2006, HISPANIC J BEHAV SCI, V28, P404, DOI 10.1177/0739986306290645
   Guo XH, 2009, PSYCHOL ASSESSMENT, V21, P22, DOI 10.1037/a0014495
   Gupta LS, 2011, DIABETES CARE, V34, P1791, DOI 10.2337/dc11-0088
   Hodges J, 2007, BEHAV RES THER, V45, P901, DOI 10.1016/j.brat.2006.08.015
   Hox J. J., 2010, MULTILEVEL ANAL TECH
   Hsu WC, 2006, DIABETES CARE, V29, P415, DOI 10.2337/diacare.29.02.06.dc05-1915
   Huang MF, 2009, J NURS SCHOLARSHIP, V41, P385, DOI 10.1111/j.1547-5069.2009.01306.x
   Ismail K, 2004, LANCET, V363, P1589, DOI 10.1016/S0140-6736(04)16202-8
   Israel B. A., 2003, COMMUNITY BASED PART, P53
   Iwamasa G. Y, 2006, COGNITIVE BEHAV THER
   Jack Jr L., 2004, DIABETES MED, V22, P1295
   JACOBSON AM, 1994, DIABETES CARE, V17, P267, DOI 10.2337/diacare.17.4.267
   King GL, 2012, DIABETES CARE, V35, P1181, DOI 10.2337/dc12-0210
   Kwan CML, 2011, ASIAN AM J PSYCHOL, V2, P115, DOI 10.1037/a0024184
   LAFROMBOISE T, 1993, PSYCHOL BULL, V114, P395, DOI 10.1037/0033-2909.114.3.395
   LaFromboise TD, 2010, CULT DIVERS ETHN MIN, V16, P68, DOI 10.1037/a0016181
   McCoach DB, 2006, J EDUC PSYCHOL, V98, P14, DOI 10.1037/0022-0663.98.1.14
   Minet L, 2009, PATIENT EDUC COUNS, V80, P29
   Muller I, 2011, J TELEMED TELECARE, V17, P177, DOI 10.1258/jtt.2010.100709
   Nam S, 2012, J CARDIOVASC NURS, V27, P505, DOI 10.1097/JCN.0b013e31822375a5
   NICOS, 2004, CHIN COMM HLTH REP S
   Norris SL, 2002, DIABETES CARE, V25, P1159, DOI 10.2337/diacare.25.7.1159
   Plack K, 2010, CURR OPIN PSYCHIATR, V23, P131, DOI 10.1097/YCO.0b013e3283366555
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   RUBIN RR, 1991, DIABETES CARE, V14, P335, DOI 10.2337/diacare.14.4.335
   Saudek C. D., 2010, DIABETES ED, V19, DOI 2010.1177/014572179301900308
   Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147
   Sigurdardottir AK, 2007, PATIENT EDUC COUNS, V67, P21, DOI 10.1016/j.pec.2007.03.007
   Singer J. D., 2003, APPL LONGITUDINAL DA
   Smith TB, 2011, J CLIN PSYCHOL, V67, P166, DOI 10.1002/jclp.20757
   SUINN RM, 1987, EDUC PSYCHOL MEAS, V47, P401, DOI 10.1177/0013164487472012
   Trief PM, 2004, ANN BEHAV MED, V27, P148, DOI 10.1207/s15324796abm2703_2
   Tschann JM, 1999, J MARRIAGE FAM, V61, P269, DOI 10.2307/353747
   U. S. Census Bureau, 2010, AS PAC AM HER MONTH
   Wallerstein N., 2003, COMMUNITY BASED PART, P27
   Wang CY, 1999, DIABETES EDUCATOR, V25, P738, DOI 10.1177/014572179902500506
   Wei MF, 2010, J COUNS PSYCHOL, V57, P411, DOI 10.1037/a0020790
   Ying Y. W, 2009, HDB MENTAL HLTH ACCU, P45, DOI DOI 10.1007/978-1-60327-437-1_3
   Zhong XF, 2011, SE ASIAN J TROP MED, V42, P185
NR 63
TC 15
Z9 15
U1 3
U2 35
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0160-6891
J9 RES NURS HEALTH
JI Res. Nurs. Health
PD AUG
PY 2013
VL 36
IS 4
BP 359
EP 372
DI 10.1002/nur.21543
PG 14
WC Nursing
SC Nursing
GA 185XJ
UT WOS:000322003900005
PM 23606271
DA 2019-01-08
ER

PT J
AU Balfe, M
   Doyle, F
   Smith, D
   Sreenan, S
   Brugha, R
   Hevey, D
   Conroy, R
AF Balfe, Myles
   Doyle, Frank
   Smith, Diarmuid
   Sreenan, Seamus
   Brugha, Ruairi
   Hevey, David
   Conroy, Ronan
TI What's distressing about having type 1 diabetes? A qualitative study of
   young adults' perspectives
SO BMC ENDOCRINE DISORDERS
LA English
DT Article
DE Young adult; Distress; Qualitative; Type 1 diabetes; Emerging adulthood
ID PSYCHOLOGICAL DISTRESS; PSYCHIATRIC MORBIDITY; DEPRESSION; PREVALENCE;
   CARE; EXPLORATION; EXPERIENCES; TRANSITION; SUPPORT; ANXIETY
AB Background: Diabetes distress is a general term that refers to the emotional burdens, anxieties, frustrations, stressors and worries that stem from managing a severe, complex condition like Type 1 diabetes. To date there has been limited research on diabetes-related distress in younger people with Type 1 diabetes. This qualitative study aimed to identify causes of diabetes distress in a sample of young adults with Type 1 diabetes.
   Methods: Semi-structured interviews with 35 individuals with Type 1 diabetes (23-30 years of age).
   Results: This study found diabetes related-distress to be common in a sample of young adults with Type 1 diabetes in the second phase of young adulthood (23-30 years of age). Diabetes distress was triggered by multiple factors, the most common of which were: self-consciousness/stigma, day-to-day diabetes management difficulties, having to fight the healthcare system, concerns about the future and apprehension about pregnancy. A number of factors appeared to moderate distress in this group, including having opportunities to talk to healthcare professionals, attending diabetes education programmes and joining peer support groups. Young adults felt that having opportunities to talk to healthcare professionals about diabetes distress should be a component of standard diabetes care.
   Conclusions: Some aspects of living with diabetes frequently distress young adults with Type 1 diabetes who are in their twenties. Clinicians should facilitate young adults' attendance at diabetes education programmes, provide them with opportunities to talk about their diabetes-related frustrations and difficulties and, where possible, assist in the development of peer-support networks for young adults with diabetes.
C1 [Balfe, Myles; Brugha, Ruairi; Conroy, Ronan] Royal Coll Surgeons Ireland, Dept Epidemiol & Publ Hlth Med, Dublin 2, Ireland.
   [Balfe, Myles] Natl Univ Ireland Univ Coll Cork, Dept Sociol, Cork, Ireland.
   [Doyle, Frank] Royal Coll Surgeons Ireland, Dept Psychol, Dublin 2, Ireland.
   [Smith, Diarmuid] Beaumont Hosp, Dept Endocrinol, Dublin 9, Ireland.
   [Sreenan, Seamus] Connolly Hosp, Dept Endocrinol, Dublin, Ireland.
   [Hevey, David] Univ Dublin Trinity Coll, Dept Psychol, Dublin 2, Ireland.
RP Balfe, M (reprint author), Royal Coll Surgeons Ireland, Dept Epidemiol & Publ Hlth Med, Dublin 2, Ireland.
EM mylesbalfe@rcsi.ie
RI Doyle, Frank/C-2750-2012; Conroy, Ronan/C-6416-2008
OI Doyle, Frank/0000-0002-3785-7433; Conroy, Ronan/0000-0001-5983-8682;
   Hevey, David/0000-0003-2844-0449
FU Irish Health Research Board, Diabetes Ireland; MRCG
FX The authors would like to sincerely thank the Irish Health Research
   Board, Diabetes Ireland and the MRCG for funding this study, and the
   staff of Connolly and Beaumont Hospitals in Dublin for providing advice
   on various aspects of this project. They would like to thank the three
   article reviewers and the journal editorial staff for their extremely
   helpful and thorough feedback on the article. And finally they would
   like to thank the young adults who took part in the study.
CR Anderson B, 2010, DIABETES SPECTR, V23, P32
   Anderson BJ, 2004, PATIENT EDUC COUNS, V53, P347, DOI 10.1016/j.pec.2003.03.001
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Arnett JJ, 2000, YOUTH SOC, V31, P267, DOI 10.1177/0044118X00031003001
   Arnett JJ, 2000, AM PSYCHOL, V55, P469, DOI 10.1037/0003-066X.55.5.469
   Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI DOI 10.1191/1478088706QP0630A
   Bryden KS, 2003, DIABETES CARE, V26, P1052, DOI 10.2337/diacare.26.4.1052
   Bryden KS, 2001, DIABETES CARE, V24, P1536, DOI 10.2337/diacare.24.9.1536
   Cabassa LJ, 2008, SOC SCI MED, V66, P2413, DOI 10.1016/j.socscimed.2008.01.054
   Cameron F, 2010, DIABETES CARE, V33, P1470
   Cameron F, 2012, DIABETES MANAGE, V2, P1
   DAFNE Study Group, 2002, BMJ-BRIT MED J, V325, DOI DOI 10.1136/BMJ.325.7367.746
   Dantzer C, 2003, CLIN PSYCHOL REV, V23, P787, DOI 10.1016/S0272-7358(03)00069-2
   Duke D, 2011, AM J LIFESTYLE MED, V5, P85
   Egede LE, 2012, CURR PSYCHIAT REP, V14, P15, DOI 10.1007/s11920-011-0240-0
   Esbitt SA, 2013, SCREENING DEPRESSION, P27
   Farmer AJ, 2005, DIABETES CARE, V28, P2697, DOI 10.2337/diacare.28.11.2697
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Garvey K, 2011, DIABETES SPECTRUM, V24, P22, DOI [10.2337/diaspect.24.1.22, DOI 10.2337/DIASPECT.24.1.22]
   Gask L, 2011, CHRONIC ILLN, V7, P239, DOI 10.1177/1742395311403636
   Gendelman N, 2009, DIABETES CARE, V32, P575, DOI 10.2337/dc08-1835
   Gonzalez JS, 2011, DIABETES CARE, V34, P236, DOI 10.2337/dc10-1970
   Grigsby AB, 2002, J PSYCHOSOM RES, V53, P1053, DOI 10.1016/S0022-3999(02)00417-8
   Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903
   Haghighat R, 2001, BRIT J PSYCHIAT, V178, P207, DOI 10.1192/bjp.178.3.207
   Hillege S, 2011, ARCH PSY NURSING, V25, pe7
   Hislop AL, 2008, DIABETIC MED, V25, P91, DOI 10.1111/j.1464-5491.2007.02310.x
   Hood KK, 2006, DIABETES CARE, V29, P1389, DOI 10.2337/dc06-0087
   Insabella G, 2007, PEDIATR DIABETES, V8, P228, DOI 10.1111/j.1399-5448.2007.00266.x
   Iwasaki Y, 2005, SOC SCI MED, V60, P977, DOI 10.1016/j.socscimed.2004.06.032
   Kay C, 2009, J HEALTH PSYCHOL, V14, P242, DOI 10.1177/1359105308100208
   Kovacs M, 1997, DIABETES CARE, V20, P36, DOI 10.2337/diacare.20.1.36
   Lewis V, 2011, DIABETES SPECTRUM, V24, P4
   Markowitz JT, 2012, DIABETIC MED, V29, P522, DOI 10.1111/j.1464-5491.2011.03537.x
   Marshall MN, 1996, FAM PRACT, V13, P522, DOI 10.1093/fampra/13.6.522
   MAYOU R, 1991, PSYCHOL MED, V21, P639, DOI 10.1017/S0033291700022273
   McGuire BE, 2010, DIABETOLOGIA, V53, P66, DOI 10.1007/s00125-009-1559-5
   Monaghan M., 2010, Diabetes Spectrum, V23, P25, DOI 10.2337/diaspect.23.1.25
   Morse JM, 2000, QUAL HEALTH RES, V10, P3, DOI 10.1177/104973200129118183
   Northam EA, 2005, DIABETIC MED, V22, P152, DOI 10.1111/j.1464-5491.2004.01370.x
   Peters A, 2011, DIABETES CARE, V34, P2477, DOI 10.2337/dc11-1723
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Schabert J, 2013, PATIENT, V6, P1, DOI 10.1007/s40271-012-0001-0
   Scott L, 2005, CAN J DIABETES, V29, P203
   Steinsdottir F, 2012, LAEKNABLADID, V94, P823
   Watts S, 2010, PSYCHOL HEALTH, V25, P491, DOI 10.1080/08870440802688588
   Weissberg-Benchell J, 2007, DIABETES CARE, V30, P2441, DOI 10.2337/dc07-1249
   Wolpert HA, 2001, DIABETES CARE, V24, P1513, DOI 10.2337/diacare.24.9.1513
NR 48
TC 27
Z9 29
U1 1
U2 36
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1472-6823
J9 BMC ENDOCR DISORD
JI BMC Endocr. Disord.
PD JUL 25
PY 2013
VL 13
AR 25
DI 10.1186/1472-6823-13-25
PG 14
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 194AN
UT WOS:000322602700001
PM 23885644
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Gubhaju, L
   McNamara, BJ
   Banks, E
   Joshy, G
   Raphael, B
   Williamson, A
   Eades, SJ
AF Gubhaju, Lina
   McNamara, Bridgette J.
   Banks, Emily
   Joshy, Grace
   Raphael, Beverley
   Williamson, Anna
   Eades, Sandra J.
TI The overall health and risk factor profile of Australian Aboriginal and
   Torres Strait Islander participants from the 45 and up study
SO BMC PUBLIC HEALTH
LA English
DT Article
DE Aboriginal Australians; Torres Strait Islanders; 45 and Up study
ID COHORT
AB Background: Despite large disparities in health outcomes between Aboriginal and non-Aboriginal Australians, detailed evidence on the health and lifestyle characteristics of older Aboriginal Australians is lacking. The aim of this study is to quantify socio-demographic and health risk factors and mental and physical health status among Aboriginal participants from the 45 and Up Study and to compare these with non-Aboriginal participants from the study.
   Methods: The 45 and Up Study is a large-scale study of individuals aged 45 years and older from the general population of New South Wales, Australia responding to a baseline questionnaire distributed from 2006-2008. Odds ratios (OR) and 95% confidence intervals (CI) of self-reported responses from the baseline questionnaire for Aboriginal versus non-Aboriginal participants relating to socio-demographic factors, health risk factors, current and past medical and surgical history, physical disability, functional health limitations and levels of current psychological distress were calculated using unconditional logistic regression, with adjustments for age and sex.
   Results: Overall, 1939 of 266,661 45 and Up Study participants examined in this study identified as Aboriginal and/or Torres Strait Islander (0.7%). Compared to non-Aboriginal participants, Aboriginal participants were significantly more likely to be: younger (mean age 58 versus 63 years); without formal educational qualifications (age-and sex-adjusted OR = 6.2, 95% CI 5.3-7.3); of unemployed (3.7, 2.9-4.6) or disabled (4.6, 3.9-5.3) work status; and with a household income < $ 20,000/year versus >= $ 70,000/year (5.8, 5.0-6.9). Following additional adjustment for income and education, Aboriginal participants were significantly more likely than non-Aboriginal participants to: be current smokers (2.4, 2.0-2.8), be obese (2.1, 1.8-2.5), have ever been diagnosed with certain medical conditions (especially: diabetes [2.1, 1.8-2.4]; depression [1.6, 1.4-1.8] and stroke [1.8, 1.4-2.3]), have care-giving responsibilities (1.8, 1.5-2.2); have a major physical disability (2.6, 2.2-3.1); have severe physical functional limitation (2.9, 2.4-3.4) and have very high levels of psychological distress (2.4, 2.0-3.0).
   Conclusions: Aboriginal participants from the 45 and Up Study experience greater levels of disadvantage and have greater health needs (including physical disability and psychological distress) compared to non-Aboriginal participants. The study highlights the need to address the social determinants of health in Australia and to provide appropriate mental health services and disability support for older Aboriginal people.
C1 [Gubhaju, Lina; McNamara, Bridgette J.] Preventat Hlth, Baker IDI Heart & Diabet Inst, Melbourne, Vic 3004, Australia.
   [Banks, Emily; Joshy, Grace] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia.
   [Raphael, Beverley] Australian Natl Univ, Canberra, ACT 0200, Australia.
   [Banks, Emily; Williamson, Anna] Sax Inst, Sydney, NSW 1240, Australia.
   [Eades, Sandra J.] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia.
RP Eades, SJ (reprint author), Univ Sydney, Sch Publ Hlth, A27 Edward Ford Bldg, Sydney, NSW 2006, Australia.
EM Sandra.Eades@sydney.edu.au
OI Eades, Sandra/0000-0001-8629-3390
CR ABS, 2010, DEM SOC EC CHAR OV L
   ABS, 2006, INTR SOC IND
   AIHW, 2004, RUR REG REM HLTH GUI
   Andrews G, 2001, AUST NZ J PUBL HEAL, V25, P494, DOI 10.1111/j.1467-842X.2001.tb00310.x
   Australian Bureau of Statistics, 2006, NAT AB TORR STRAIT I
   Australian Bureau of Statistics [ABS], 2001, INF PAP US KESSL PSY
   Australian Institute of Health and Welfare (AIHW), 2011, HLTH WELF AUSTR AB T
   Australian Institute of Health and Welfare (AIHW), 2003, ACT AUSTR SURV GUID
   Banks E, 2008, INT J EPIDEMIOL, V37, P941, DOI 10.1093/ije/dym184
   Centre for Epidemiology and Research, 2010, 2006 2009 REP AD AB
   Cunningham J, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-8
   Hays R. D., 1995, USERS MANUAL MED OUT
   Investigators S, 2010, BMC PUBLIC HEALTH, V10, P287
   Mathews JD, 1998, MED J AUSTRALIA, V169, P625
   Mealing NM, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-26
   *NHMRC, 2003, DIET GUID AUSTR AD
   Ranzijn R, 2010, J HEALTH PSYCHOL, V15, P716, DOI 10.1177/1359105310368181
   Ross CE, 1996, J HEALTH SOC BEHAV, V37, P104, DOI 10.2307/2137234
   Sayers S, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-23
   Stewart A., 1992, MEASURING FUNCTIONIN
   SWAN P, 1995, WAYS FORWARD NATL AB
   Vos T, 2007, BURDEN DIS INJURY AB
   Vos T, 2009, INT J EPIDEMIOL, V38, P470, DOI 10.1093/ije/dyn240
   World Health Organization, 2000, WHO TECHN REP SER
NR 24
TC 16
Z9 16
U1 2
U2 24
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD JUL 17
PY 2013
VL 13
AR 661
DI 10.1186/1471-2458-13-661
PG 14
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 186GW
UT WOS:000322031100001
PM 23866062
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Beverly, EA
   Fitzgerald, SM
   Brooks, KM
   Hultgren, BA
   Ganda, OP
   Munshi, M
   Weinger, K
AF Beverly, Elizabeth A.
   Fitzgerald, Shane M.
   Brooks, Kelly M.
   Hultgren, Brittney A.
   Ganda, Om P.
   Munshi, Medha
   Weinger, Katie
TI Impact of Reinforcement of Diabetes Self-Care on Poorly Controlled
   Diabetes A Randomized Controlled Trial
SO DIABETES EDUCATOR
LA English
DT Article
ID QUALITY-OF-LIFE; GLYCEMIC CONTROL; COMPLICATIONS TRIAL; INTENSIVE
   TREATMENT; PROBLEM AREAS; ADULTS; INTERVENTIONS; IMPLEMENTATION;
   QUESTIONNAIRE; METAANALYSIS
AB Purpose The purpose of the study was to assess the value of reinforcing diabetes self-management for improving glycemia and self-care among adults with type 2 diabetes who had at least 3 hours of prior diabetes education.
   Methods In this randomized controlled trial, 134 participants (75% white, 51% female, 59 9 years old, 13 8 years with diabetes, A1C = 8.4% +/- 1.2%) were randomized to either a group map-based program (intervention) or group education on cholesterol and blood pressure (control). Participants were assessed for A1C levels, diabetes self-care behaviors (3-day pedometer readings, 6-minute walk test, blood glucose checks, frequency of self-care), and psychosocial factors (distress, frustration, quality of life) at baseline, 3, 6, and 12 months post intervention and health literacy at baseline.
   Results Groups did not differ on baseline characteristics including A1C levels, health literacy, or self-care; however, the intervention group had more years of education than controls. Intervention arm participants modestly improved A1C levels at 3 months post intervention but did not maintain that improvement at 6 and 12 months while control patients did not improve A1C levels at any time during follow-up. Importantly, frequency of self-reported self-care, diabetes quality of life, diabetes-related distress, and frustration with diabetes self-care improved in both groups over time.
   Conclusions Reinforcing self-care with diabetes education for patients who have not met glycemic targets helps improve A1C and could be considered a necessary component of ongoing diabetes care. The best method to accomplish reinforcement needs to be established.
C1 [Beverly, Elizabeth A.; Fitzgerald, Shane M.; Brooks, Kelly M.; Hultgren, Brittney A.; Ganda, Om P.; Munshi, Medha; Weinger, Katie] Joslin Diabet Ctr, Boston, MA 02215 USA.
   [Beverly, Elizabeth A.; Ganda, Om P.; Munshi, Medha; Weinger, Katie] Harvard Univ, Sch Med, Boston, MA USA.
RP Weinger, K (reprint author), Joslin Diabet Ctr, 1 Joslin Pl, Boston, MA 02215 USA.
EM Katie.Weinger@joslin.harvard.edu
RI Albertin, Paloma/X-1093-2018
FU American Diabetes Association (ADA) [7-08-CR-62]; Diabetes and
   Endocrinology Research Core NIH [P30 DK36836]; NIH [T32 DK007260]
FX This work was supported by the American Diabetes Association (ADA) grant
   7-08-CR-62, the Diabetes and Endocrinology Research Core NIH P30
   DK36836, and the NIH Training Grant No. T32 DK007260. Bayer HealthCare
   LLC (Tarrytown, New York) contributed glucose meters and test strips.
   ADA and these companies had no role in the conduct of the study or
   preparation of this manuscript..
CR AHERN J, 1993, DIABETES EDUCATOR, V19, P509, DOI 10.1177/014572179301900606
   Bradley C, 1994, HDB PSYCHOL DIABETES
   Conn VS, 2007, DIABETOLOGIA, V50, P913, DOI 10.1007/s00125-007-0625-0
   Davidson MB, 2002, DIABETES CARE, V25, P2116, DOI 10.2337/diacare.25.11.2116
   DCCT Res Grp, 1988, DIABETES CARE, V11, P725
   Deakin T, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003417.pub2
   Derogatis LR, 2000, BSI 18 BRIEF SYMPT I
   Dyer PH, 1998, DIABETIC MED, V15, P339, DOI 10.1002/(SICI)1096-9136(199804)15:4<339::AID-DIA577>3.0.CO;2-E
   Fitzmaurice G. M., 2011, APPL LONGITUDINAL AN
   Gafarian CT, 1999, DIABETES EDUCATOR, V25, P585, DOI 10.1177/014572179902500411
   Genuth S, 1999, DIABETES CARE, V22, P99
   HAMBURG BA, 1983, DIABETES CARE, V6, P409, DOI 10.2337/diacare.6.4.409
   Ismail K, 2004, LANCET, V363, P1589, DOI 10.1016/S0140-6736(04)16202-8
   JACOBSON AM, 1994, DIABETES CARE, V17, P267, DOI 10.2337/diacare.17.4.267
   JACOBSON AM, 1991, DIABETES CARE, V14, P599, DOI 10.2337/diacare.14.7.599
   Karter AJ, 2001, AM J MED, V111, P1, DOI 10.1016/S0002-9343(01)00742-2
   Khan H, 2011, PRIM CARE DIABETES, V5, P251, DOI 10.1016/j.pcd.2011.07.001
   Little R J, 2002, STAT ANAL MISSING DA
   Lorenz RA, 1996, DIABETES CARE, V19, P648, DOI 10.2337/diacare.19.6.648
   Maiorana A, 2002, DIABETES RES CLIN PR, V56, P115, DOI 10.1016/S0168-8227(01)00368-0
   Norris SL, 2002, DIABETES CARE, V25, P1159, DOI 10.2337/diacare.25.7.1159
   Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561
   NURSS JR, 2001, TEST FUNCTIONAL HLTH
   Peyrot M, 1999, J HEALTH SOC BEHAV, V40, P141, DOI 10.2307/2676370
   Pi-Sunyer FX, 1999, DIABETES CARE, V22, P191, DOI 10.2337/diacare.22.2.191
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Rubin RR, 2001, J CLIN PSYCHOL, V57, P457, DOI 10.1002/jclp.1041
   SHAMOON H, 1995, DIABETES CARE, V18, P361
   SHAMOON H, 1993, NEW ENGL J MED, V329, P977
   Sperl-Hillen J, 2011, ARCH INTERN MED, V171, P2001, DOI 10.1001/archinternmed.2011.507
   van der Ven NCW, 2003, DIABETES CARE, V26, P713, DOI 10.2337/diacare.26.3.713
   Wdowik MJ, 1997, DIABETES EDUCATOR, V23, P558, DOI 10.1177/014572179702300507
   Weinger K, 2005, DIABETES CARE, V28, P1346, DOI 10.2337/diacare.28.6.1346
   Weinger K, 2001, PATIENT EDUC COUNS, V42, P123, DOI 10.1016/S0738-3991(00)00098-7
   Weinger K, 2002, PRINCIPLES DIABETES, P639
   Weinger K, 2000, DIABETES S1, V48, pA318
   Weinger K, 2009, COMPLETE NURSES GUID
   Weinger K, 2011, ARCH INTERN MED, V171, P1990, DOI 10.1001/archinternmed.2011.502
   Welch G, 2003, DIABETIC MED, V20, P69, DOI 10.1046/j.1464-5491.2003.00832.x
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
NR 40
TC 17
Z9 17
U1 0
U2 10
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0145-7217
EI 1554-6063
J9 DIABETES EDUCATOR
JI Diabetes Educ.
PD JUL
PY 2013
VL 39
IS 4
BP 504
EP 514
DI 10.1177/0145721713486837
PG 11
WC Endocrinology & Metabolism; Public, Environmental & Occupational Health
SC Endocrinology & Metabolism; Public, Environmental & Occupational Health
GA 245EE
UT WOS:000326442300008
PM 23640303
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Ronda, MCM
   Dijkhorst-Oei, LT
   Gorter, KJ
   Beulens, JWJ
   Rutten, GEHM
AF Ronda, Maaike C. M.
   Dijkhorst-Oei, Lioe-Ting
   Gorter, Kees J.
   Beulens, Joline W. J.
   Rutten, Guy E. H. M.
TI Differences Between Diabetes Patients Who Are Interested or Not in the
   Use of a Patient Web Portal
SO DIABETES TECHNOLOGY & THERAPEUTICS
LA English
DT Article
ID PILOT RANDOMIZED-TRIAL; COLLABORATIVE CARE; DIGITAL DIVIDE; HEALTH
   RECORD; DISPARITIES; DISTRESS; VALIDITY; ADOPTION; OUTCOMES; OLDER
AB Objective: A patient Web portal allows patients to access their personal health record through the Internet. It may improve diabetes outcomes, but the adoption is unsatisfactory. We examined the differences between patients with and without a login in order to optimize its use.
   Patients and Methods: A survey was conducted among patients from 62 general practices and one outpatient clinic that all use a diabetes Web portal. Between November 2011 and March 2012 questionnaires were sent to 1,500 patients with and 3,000 patients without a login. Patient groups were stratified according to type of diabetes. Demographic and diabetes-related variables were analyzed with multivariable regression analysis.
   Results: The total response rate was 67%. Fewer than 50% of the patients did request a login. Among 128 patients with type 1 diabetes mellitus, those with a login (89.8%) were younger and more frequently treated by an internist. In 1,262 patients with type 2 diabetes mellitus, fewer patients had a log-in (41.0%), and the likelihood of having a login was independently associated with younger age, male gender, higher educational level, treatment by an internist, longer duration of diabetes, and polypharmacy (all P < 0.001).
   Conclusions: Patients with type 1 diabetes request a login more frequently than patients with type 2 diabetes, and patients with a login are strikingly different than patients without. The healthcare provider seems to play an important role in patients' Web utilization. Simply promoting use of electronic healthcare methods does not make sense. It is important to address disparities between patient groups to optimize the use of a Web portal.
C1 [Ronda, Maaike C. M.; Gorter, Kees J.; Beulens, Joline W. J.; Rutten, Guy E. H. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands.
   [Dijkhorst-Oei, Lioe-Ting] Meander Med Ctr, Amersfoort, Netherlands.
RP Ronda, MCM (reprint author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, STR 6-131,POB 85500, NL-3508 GA Utrecht, Netherlands.
EM m.c.m.ronda@umcutrecht.nl
RI Ronda, Maaike/L-2208-2014
OI Ronda, Maaike/0000-0002-6829-6982
FU Diabetes Fund; Netherlands Organization for Scientific Research in
   Diabetes [2010.13.1369]
FX This study was supported by The Diabetes Fund, The Netherlands
   Organization for Scientific Research in Diabetes (grant 2010.13.1369).
CR Ancker JS, 2011, J GEN INTERN MED, V26, P1117, DOI 10.1007/s11606-011-1749-y
   Andreassen HK, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-53
   Baan Caroline A, 2009, Ned Tijdschr Geneeskd, V153, pA580
   Bond GE, 2007, DIABETES TECHNOL THE, V9, P52, DOI 10.1089/dia.2006.0057
   Bradley C., 1994, HDB PSYCHOL DIABETES, P111
   Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6
   *CBS, US INF COMM TECHN IC
   Cho AH, 2010, TELEMED J E-HEALTH, V16, P595, DOI 10.1089/tmj.2009.0164
   Delbanco T, 2012, ANN INTERN MED, V157, P461, DOI 10.7326/0003-4819-157-7-201210020-00002
   Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014
   Fitzgerald JT, 1998, DIABETES CARE, V21, P706, DOI 10.2337/diacare.21.5.706
   Goel MS, 2011, J AM MED INFORM ASSN, V18, pI8, DOI 10.1136/amiajnl-2011-000473
   Goel MS, 2011, J GEN INTERN MED, V26, P1112, DOI 10.1007/s11606-011-1728-3
   Gorter KJ, 2011, PATIENT EDUC COUNS, V84, P56, DOI 10.1016/j.pec.2010.06.019
   Greenhalgh T, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5814
   Holbrook A, 2009, CAN MED ASSOC J, V181, P37, DOI 10.1503/cmaj.081272
   Lin CT, 2005, J MED INTERNET RES, V7, P13, DOI 10.2196/jmir.7.4.e47
   McCarrier KP, 2009, DIABETES TECHNOL THE, V11, P211, DOI 10.1089/dia.2008.0063
   McMahon GT, 2005, DIABETES CARE, V28, P1624, DOI 10.2337/diacare.28.7.1624
   Oh H, 2005, J MED INTERNET RES, V7
   Osborn CY, 2010, CURR DIABETES REP, V10, P422, DOI 10.1007/s11892-010-0151-1
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Ralston JD, 2009, DIABETES CARE, V32, P234, DOI 10.2337/dc08-1220
   Rubin DB, 1987, MULTIPLE IMPUTATION
   RUTTEN GEH, 2006, HUISARTS WET, V49, P137
   Sarkar U, 2011, J AM MED INFORM ASSN, V18, P318, DOI [10.1136/jamia.2010.006015, 10.1136/amiajnl.2010.006015]
   Sarkar U, 2010, J HEALTH COMMUN, V15, P183, DOI 10.1080/10810730.2010.499988
   *SCP, 2012, STAT
   Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007
   Shea S, 2009, J AM MED INFORM ASSN, V16, P446, DOI 10.1197/jamia.M3157
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   STUIJS JN, 2009, 260014001 RIJKS VOLK
   van der Bijl J, 1999, J ADV NURS, V30, P352, DOI 10.1046/j.1365-2648.1999.01077.x
   Weingart SN, 2006, J AM MED INFORM ASSN, V13, P91, DOI 10.1197/jamia.M1833
   Weppner WG, 2010, DIABETES CARE, V33, P2314, DOI 10.2337/dc10-1124
   Witry Matthew J, 2010, Perspect Health Inf Manag, V7, p1d
   Yamin CK, 2011, ARCH INTERN MED, V171, P568, DOI 10.1001/archinternmed.2011.34
NR 37
TC 13
Z9 13
U1 0
U2 11
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1520-9156
EI 1557-8593
J9 DIABETES TECHNOL THE
JI Diabetes Technol. Ther.
PD JUL
PY 2013
VL 15
IS 7
BP 556
EP 563
DI 10.1089/dia.2013.0023
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 180RD
UT WOS:000321611700006
PM 23777369
OA Green Published
DA 2019-01-08
ER

PT J
AU Nicolucci, A
   Burns, KK
   Holt, RIG
   Comaschi, M
   Hermanns, N
   Ishii, H
   Kokoszka, A
   Pouwer, F
   Skovlund, SE
   Stuckey, H
   Tarkun, I
   Vallis, M
   Wens, J
   Peyrot, M
AF Nicolucci, A.
   Burns, K. Kovacs
   Holt, R. I. G.
   Comaschi, M.
   Hermanns, N.
   Ishii, H.
   Kokoszka, A.
   Pouwer, F.
   Skovlund, S. E.
   Stuckey, H.
   Tarkun, I.
   Vallis, M.
   Wens, J.
   Peyrot, M.
CA DAWN2 Study Grp
TI Diabetes Attitudes, Wishes and Needs second study (DAWN2 (TM)):
   Cross-national benchmarking of diabetes-related psychosocial outcomes
   for people with diabetes
SO DIABETIC MEDICINE
LA English
DT Article
ID GLYCEMIC CONTROL; CARE; DISTRESS; BARRIERS; SUPPORT
AB Aims The second Diabetes Attitudes, Wishes and Needs (DAWN2) study aimed to assess psychosocial outcomes in people with diabetes across countries for benchmarking. Methods Surveys included new and adapted questions from validated questionnaires that assess health-related quality of life, self-management, attitudes/beliefs, social support and priorities for improving diabetes care. Questionnaires were conducted online, by telephone or in person. Results Participants were 8596 adults with diabetes across 17 countries. There were significant between-country differences for all benchmarking indicators; no one country's outcomes were consistently better or worse than others. The proportion with likely depression [WHO-5 Well-Being Index (WHO-5) score 28] was 13.8% (country range 6.5-24.1%). Diabetes-related distress [Problem Areas in Diabetes Scale5 (PAID-5) score 40] was reported by 44.6% of participants (17.2-67.6%). Overall quality of life was rated poor' or very poor' by 12.2% of participants (7.6-26.1%). Diabetes had a negative impact on all aspects investigated, ranging from 20.5% on relationship with family/friends to 62.2% on physical health. Approximately 40% of participants (18.6-64.9%) reported that their medication interfered with their ability to live a normal life. The availability of person-centred chronic illness care and support for active involvement was rated as low. Following self-care advice for medication and diet was most common, and least common for glucose monitoring and foot examination, with marked country variation. Only 48.8% of respondents had participated in diabetes educational programmes/activities to help manage their diabetes. Conclusions Cross-national benchmarking using psychometrically validated indicators can help identify areas for improvement and best practices to drive changes that improve outcomes for people with diabetes.
C1 [Nicolucci, A.] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, I-66030 Santa Maria Imbaro, Italy.
   [Burns, K. Kovacs] Univ Alberta, Edmonton Clin Hlth Acad, Edmonton, AB, Canada.
   [Holt, R. I. G.] Univ Southampton, Southampton, Hants, England.
   [Comaschi, M.] GVM Care & Res, Ist Clin Ligure Alta Specialita, Rapallo, Italy.
   [Hermanns, N.] Diabet Zentrum Mergentheim, Diabet Res Inst, Bad Mergentheim, Germany.
   [Ishii, H.] Tenri Hosp, Tenri, Nara 632, Japan.
   [Kokoszka, A.] Med Univ Warsaw, Warsaw, Poland.
   [Pouwer, F.] Tilburg Univ, NL-5000 LE Tilburg, Netherlands.
   [Skovlund, S. E.] Novo Nordisk AS, Copenhagen, Denmark.
   [Stuckey, H.] Penn State Coll Med, Hershey, PA USA.
   [Tarkun, I.] Kocaeli Univ, Kocaeli, Turkey.
   [Vallis, M.] Dalhousie Univ, Halifax, NS, Canada.
   [Wens, J.] Univ Antwerp, B-2020 Antwerp, Belgium.
   [Peyrot, M.] Loyola Univ Maryland, Baltimore, MD USA.
RP Nicolucci, A (reprint author), Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, I-66030 Santa Maria Imbaro, Italy.
EM nicolucci@negrisud.it
RI Wens, Johan/K-2705-2013; Kokoszka, Andrzej/O-7454-2018; Menendez Torre,
   Edelmiro/G-1547-2013
OI Wens, Johan/0000-0002-0229-9064; Kokoszka, Andrzej/0000-0003-4518-5494;
   Menendez Torre, Edelmiro/0000-0002-9548-7821; Vallis,
   Michael/0000-0002-0165-5936; Holt, Richard/0000-0001-8911-6744
FU Novo Nordisk A/S; Novo Nordisk
FX The DAWN2 study is funded by Novo Nordisk A/S. Medical writing and
   editorial support in the preparation of this manuscript, which was
   funded by Novo Nordisk A/S, was provided by Bioscript Medical Ltd. In
   collaboration with national, regional and global partners, including the
   International Diabetes Federation, International Alliance of Patients'
   Organizations and the international Steno Diabetes Center, the DAWN2
   survey working group, the DAWN2 International Publication Planning
   Committee (IPPC) and Harris Interactive, Novo Nordisk has assisted with
   the planning and designing of the DAWN2 study. Data collection was
   independently performed by Harris Interactive, who were funded by Novo
   Nordisk. Data analysis and publication preparation were performed by
   members of the DAWN2 IPPC and authors.
CR Anderson RM, 2010, PATIENT EDUC COUNS, V79, P277, DOI 10.1016/j.pec.2009.07.025
   [Anonymous], 2004, PRACT DIABETES INT, V21, P201
   Barnard KD, 2012, DIABETIC MED, V29, P1358, DOI 10.1111/j.1464-5491.2012.03727.x
   Beaser RS, 2011, ENDOCR PRACT, V17, P880, DOI 10.4158/EP10398.OR
   Beverly EA, 2011, DIABETES CARE, V34, P1086, DOI 10.2337/dc10-2298
   Crosson JC, 2010, J AM BOARD FAM MED, V23, P171, DOI 10.3122/jabfm.2010.02.090125
   De Berardis G, 2004, DIABETES CARE, V27, P398, DOI 10.2337/diacare.27.2.398
   de Wit M, 2007, DIABETES CARE, V30, P2003, DOI 10.2337/dc07-0447
   Fidler Carrie, 2011, J Med Econ, V14, P646, DOI 10.3111/13696998.2011.610852
   Funnell MM, 2006, CLIN DIABETES, V24, P154
   Holt RIG, 2013, DIABETIC MED, V30, P789, DOI 10.1111/dme.12242
   International Alliance of Patients Organizations (IAPO), 2012, PAT CTR HEALTHC IND
   Kaufman N, 2010, Int J Clin Pract Suppl, P41, DOI 10.1111/j.1742-1241.2009.02277.x
   Khan Mohammad A, 2011, Diabetes Ther, V2, P178, DOI 10.1007/s13300-011-0007-y
   Kim MY, 2012, DIABETES METAB J, V36, P452
   Mansell K, 2011, RES SOC ADMIN PHARM, V7, P396, DOI 10.1016/j.sapharm.2010.10.004
   Mayberry LS, 2012, DIABETES CARE, V35, P1239, DOI 10.2337/dc11-2103
   Mosnier-Pudar H, 2010, DIABETES METAB, V36, P476, DOI 10.1016/j.diabet.2010.08.004
   Mosnier-Pudar H, 2009, DIABETES METAB, V35, P220, DOI 10.1016/j.diabet.2009.02.001
   Nam S, 2011, DIABETES RES CLIN PR, V93, P1, DOI 10.1016/j.diabres.2011.02.002
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   Peyrot M, 2013, DIABETES RES CLIN PR, V99, P174, DOI 10.1016/j.diabres.2012.11.016
   Piya MK, 2010, BRIT J CLIN PHARMACO, V70, P631, DOI 10.1111/j.1365-2125.2010.03711.x
   Reddy J, 2013, PSYCHOSOMATICS, V54, P44, DOI 10.1016/j.psym.2012.08.004
   Singer J. D., 2003, APPL LONGITUDINAL DA
   Skovlund S. E., 2005, DIABETES SPECTRUM, V18, P136, DOI DOI 10.2337/DIASPECT.18.3.136
   Snijders T, 1999, MULTILEVEL ANAL INTR
   Zagarins SE, 2012, J BEHAV MED, V35, P299, DOI 10.1007/s10865-011-9359-z
NR 28
TC 215
Z9 227
U1 6
U2 58
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
J9 DIABETIC MED
JI Diabetic Med.
PD JUL
PY 2013
VL 30
IS 7
BP 767
EP 777
DI 10.1111/dme.12245
PG 11
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 169MR
UT WOS:000320784900002
PM 23711019
OA Bronze
HC Y
HP N
DA 2019-01-08
ER

PT J
AU Burns, KK
   Nicolucci, A
   Holt, RIG
   Willaing, I
   Hermanns, N
   Kalra, S
   Wens, J
   Pouwer, F
   Skovlund, SE
   Peyrot, M
AF Burns, K. Kovacs
   Nicolucci, A.
   Holt, R. I. G.
   Willaing, I.
   Hermanns, N.
   Kalra, S.
   Wens, J.
   Pouwer, F.
   Skovlund, S. E.
   Peyrot, M.
CA DAWN2 Study Grp
TI Diabetes Attitudes, Wishes and Needs second study (DAWN2 (TM)):
   Cross-national benchmarking indicators for family members living with
   people with diabetes
SO DIABETIC MEDICINE
LA English
DT Article
ID MELLITUS PATIENTS; TYPE-1; EXPERIENCE; PARENTS; SUPPORT; CARE;
   ADOLESCENTS; CHILDREN; OUTCOMES; FATHERS
AB Aims The second Diabetes Attitudes, Wishes and Needs (DAWN2) study examined the experiences of family members of people with diabetes for benchmarking and identifying unmet needs or areas for improvement to assist family members and those with diabetes to effectively self-manage. Methods In total, 2057 family members of people with diabetes participated in an online, telephone or in-person survey designed to assess the impact of diabetes on family life, family support for people with diabetes and educational and community support. Results Supporting a relative with diabetes was perceived as a burden by 35.3% (range across countries 10.6-61.7%) of respondents. Over half of respondents [51.4% (22.5-76.0%)] rated their quality of life as good' or very good'. However, distress about the person with diabetes was high, with 61.3% (31.5-86.4%) worried about hypoglycaemia. The impact of diabetes on aspects of life was felt by 51.8% (46.9-58.6%). The greatest negative effect was on emotional well-being [44.6% (31.8-63.0%)], although depression was less common [11.6% (4.2-20.0%)]. Many respondents did not know how to help the person with diabetes [37.1% (17.5-53.0%)] and wanted to be more involved in their care [39.4% (15.5-61.7%)]. Participation in diabetes educational programmes was low [23.1% (9.4-43.3%)], although most of those who participated found them helpful [72.1% (42.1-90.3%)]. Conclusions Diabetes has a negative impact on family members of people with diabetes. DAWN2 provides benchmarking indicators of family members' psychosocial needs that will help identify the support required for, and from, them to improve the lives of people with diabetes and their families.
C1 [Burns, K. Kovacs] Univ Alberta, Edmonton Clin Hlth Acad, Edmonton, AB, Canada.
   [Nicolucci, A.] Consorzio Mario Negri Sud, Chieti, Italy.
   [Holt, R. I. G.] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England.
   [Willaing, I.] Steno Diabet Ctr, DK-2820 Gentofte, Denmark.
   [Hermanns, N.] Diabet Zentrum Mergentheim, Diabet Res Inst, Bad Mergentheim, Germany.
   [Kalra, S.] Bharti Hosp, Karnal, India.
   [Kalra, S.] BRIDE, Karnal, India.
   [Wens, J.] Univ Antwerp, B-2020 Antwerp, Belgium.
   [Pouwer, F.] Tilburg Univ, NL-5000 LE Tilburg, Netherlands.
   [Skovlund, S. E.] Novo Nordisk AS, Copenhagen, Denmark.
   [Peyrot, M.] Loyola Univ Maryland, Baltimore, MD USA.
RP Burns, KK (reprint author), Univ Alberta, Edmonton Clin Hlth Acad, Edmonton, AB, Canada.
EM kathy.kovacsburns@ualberta.ca
RI Wens, Johan/K-2705-2013; Menendez Torre, Edelmiro/G-1547-2013; Kokoszka,
   Andrzej/O-7454-2018
OI Wens, Johan/0000-0002-0229-9064; Menendez Torre,
   Edelmiro/0000-0002-9548-7821; Kokoszka, Andrzej/0000-0003-4518-5494;
   Holt, Richard/0000-0001-8911-6744; Willaing, Ingrid/0000-0002-3082-8816
FU Novo Nordisk A/S; Novo Nordisk
FX The DAWN2 study is funded by Novo Nordisk A/S. Medical writing and
   editorial support in the preparation of this manuscript, which was
   funded by Novo Nordisk A/S, was provided by Bioscript Medical Ltd. In
   collaboration with national, regional and global partners, including the
   International Diabetes Federation, International Alliance of Patient
   Organizations and the international Steno Diabetes Center, the DAWN2
   survey working group, the DAWN2 International Publication Planning
   Committee (IPPC) and Harris Interactive, Novo Nordisk has assisted with
   the planning and designing of the DAWN2 study. Data collection was
   independently performed by Harris Interactive, who were funded by Novo
   Nordisk. Data analysis and publication preparation were performed by
   members of the DAWN2 IPPC and authors.
CR ANDERSON BJ, 1981, DIABETES CARE, V4, P586, DOI 10.2337/diacare.4.6.586
   Anderson RM, 2003, DIABETES CARE, V26, P1641, DOI 10.2337/diacare.26.5.1641-a
   [Anonymous], 2004, PRACT DIABETES INT, V21, P201
   Awadalla AW, 2006, J NATL MED ASSOC, V98, P727
   Barnard KD, 2012, DIABETIC MED, V29, P1358, DOI 10.1111/j.1464-5491.2012.03727.x
   Beverly EA, 2007, J PSYCHOSOC NURS, V45, P25
   Boman A, 2013, HEALTH SOC CARE COMM, V21, P263, DOI 10.1111/hsc.12013
   Cameron FJ, 2008, DIABETIC MED, V25, P463, DOI 10.1111/j.1464-5491.2008.02399.x
   De Berardis G, 2004, DIABETES CARE, V27, P398, DOI 10.2337/diacare.27.2.398
   Escudero-Carretero MJ, 2007, HEALTH EXPECT, V10, P337, DOI 10.1111/j.1369-7625.2007.00452.x
   Haugstvedt A, 2011, PEDIATR DIABETES, V12, P107, DOI 10.1111/j.1399-5448.2010.00661.x
   International Alliance of Patients Organizations (IAPO), 2012, PAT CTR HEALTHC IND
   International Diabetes Federation, 2004, DIABETES VOICE, V49, P1
   Knottnerus JA, 2012, J CLIN EPIDEMIOL, V65, P581, DOI 10.1016/j.jclinepi.2012.03.007
   Malerbi FEK, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-48
   Markowitz JT, 2012, DIABETIC MED, V29, P526, DOI 10.1111/j.1464-5491.2011.03434.x
   Mayberry LS, 2012, DIABETES CARE, V35, P1239, DOI 10.2337/dc11-2103
   Peyrot M, 2005, DIABETES CARE, V28, P2673, DOI 10.2337/diacare.28.11.2673
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   Peyrot M, 2013, DIABETES RES CLIN PR, V99, P174, DOI 10.1016/j.diabres.2012.11.016
   Rintala TM, 2013, J FAM NURS, V19, P3, DOI 10.1177/1074840712471899
   Rosland AM, 2010, CHRONIC ILLN, V6, P22, DOI 10.1177/1742395309354608
   Roy T, 2012, DIABETIC MED, V29, P164, DOI 10.1111/j.1464-5491.2011.03401.x
   Samuel-Hodge CD, 2013, J GEN INTERN MED, V28, P428, DOI 10.1007/s11606-012-2230-2
   Sinclair AJ, 2010, DIABETIC MED, V27, P1055, DOI 10.1111/j.1464-5491.2010.03066.x
   Singer J. D., 2003, APPL LONGITUDINAL DA
   Skovlund S. E., 2005, DIABETES SPECTRUM, V18, P136, DOI DOI 10.2337/DIASPECT.18.3.136
   Snijders T, 1999, MULTILEVEL ANAL INTR
   Snoek FJ, 2011, DIABETES CARE, V34, P601, DOI 10.2337/dc10-1552
   Stodberg R, 2007, J CLIN NURS, V16, P215, DOI 10.1111/j.1365-2702.2006.01797.x
   Whittemore R, 2012, DIABETES EDUCATOR, V38, P562, DOI 10.1177/0145721712445216
   World Health Organization (WHO), 2002, INN CAR CHRON COND B
NR 32
TC 67
Z9 68
U1 2
U2 17
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD JUL
PY 2013
VL 30
IS 7
BP 778
EP 788
DI 10.1111/dme.12239
PG 11
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 169MR
UT WOS:000320784900003
PM 23701236
OA Bronze
DA 2019-01-08
ER

PT J
AU Kibbey, KJ
   Speight, J
   Wong, JLA
   Smith, LA
   Teede, HJ
AF Kibbey, K. J.
   Speight, J.
   Wong, J. L. A.
   Smith, L. A.
   Teede, H. J.
TI Diabetes care provision: barriers, enablers and service needs of young
   adults with Type1 diabetes from a region of social disadvantage
SO DIABETIC MEDICINE
LA English
DT Article
ID ILLNESS PERCEPTION QUESTIONNAIRE; HOSPITAL ANXIETY; DEPRESSION SCALE;
   EATING BEHAVIORS; OUTCOMES; EXPERIENCES; PREVALENCE; DISTRESS; PEOPLE;
   ISSUES
AB Aims To determine the barriers to and enablers of engaging with specialist diabetes care and the service requirements of young adults with Type1 diabetes mellitus from a low socio-economic, multicultural region. Methods A cross-sectional survey targeted 357 young adults with Type1 diabetes, aged 18-30years. Participants completed questions about barriers/enablers to accessing diabetes care and service preferences, self-reported HbA1c, plus measures of diabetes-related distress (Problem Areas in Diabetes), depression/anxiety (Hospital Anxiety and Depression Scale), and illness perceptions (Brief Illness Perceptions Questionnaire). Results Eighty-six (24%) responses were received [55 (64%) female; mean +/- sd age 24 +/- 4years; diabetes duration 12 +/- 7years; HbA1c 68 +/- 16mmol/mol (8.4 +/- 1.5%)]. Logistical barriers to attending diabetes care were reported; for example, time constraints (30%), transportation (26%) and cost (21%). However, a previous unsatisfactory diabetes health experience' was cited as a barrier by 27%. Enablers were largely matched to overcoming these barriers. Over 90% preferred a multidisciplinary team environment, close to home, with after-hours appointment times. Forty per cent reported severe diabetes-related distress, 19% reported moderate-to-severe depressive symptoms and 50% reported moderate-to-severe anxiety. Conclusions Among these young adults with Type1 diabetes, glycaemic control was suboptimal and emotional distress common. They had identifiable logistical barriers to accessing and maintaining contact with diabetes care services, which can be addressed with flexible service provision. A substantial minority were discouraged by previous unsatisfactory experiences, suggesting health providers need to improve their interactions with young adults. This research will inform the design of life-stage-appropriate diabetes services targeting optimal engagement, access, attendance and ultimately improved healthcare outcomes in this vulnerable population.
C1 [Kibbey, K. J.; Wong, J. L. A.; Teede, H. J.] Southern Hlth, Diabet Unit, Melbourne, Vic, Australia.
   [Speight, J.; Smith, L. A.] Diabet Australia Vic, Australian Ctr Behav Res Diabet, Melbourne, Vic, Australia.
   [Speight, J.] Deakin Univ, Sch Psychol, Ctr Mental Hlth & Well Being Res, Burwood, Vic, Australia.
   [Smith, L. A.] Deakin Univ, Sch Psychol, Melbourne, Vic, Australia.
   [Wong, J. L. A.; Teede, H. J.] Monash Univ, Sch Publ Hlth & Preventat Med, Clayton, Vic 3800, Australia.
RP Teede, HJ (reprint author), Southern Hlth, Diabet Unit, Melbourne, Vic, Australia.
EM helena.teede@monash.edu
OI Speight, Jane/0000-0002-1204-6896; Teede, Helena/0000-0001-7609-577X
FU Novo Nordisk Regional Diabetes Support Scheme; Southern Health Diabetes
   Unit
FX This work was partially funded by a grant from the Novo Nordisk Regional
   Diabetes Support Scheme and by funds from the Southern Health Diabetes
   Unit.
CR Ambler GR, 2006, J PAEDIATR CHILD H, V42, P403, DOI 10.1111/j.1440-1754.2006.00889.x
   *AUSTR BUR STAT, 2006, HIGH YEAR SCH COMPL
   Australian Bureau of Statistics, 2011, HOUS US INF TECHN AU
   Bernstein CM, 2013, CLIN PEDIATR, V52, P10, DOI 10.1177/0009922812459950
   Broadbent E, 2006, J PSYCHOSOM RES, V60, P631, DOI 10.1016/j.jpsychores.2005.10.020
   Browne JL, 2013, DIABETIC MED, V30, P620, DOI 10.1111/dme.12078
   Craig M, 2011, NATL EVIDENCE BASED
   Crowley R, 2011, ARCH DIS CHILD, V96, P548, DOI 10.1136/adc.2010.202473
   Dovey-Pearce G, 2005, HEALTH SOC CARE COMM, V13, P409, DOI 10.1111/j.1365-2524.2005.00577.x
   Goyder EC, 2001, PUBLIC HEALTH, V115, P78, DOI 10.1038/sj.ph.1900730
   Greene A, 2009, PEDIATR DIABETES, V10, P50, DOI 10.1111/j.1399-5448.2009.00615.x
   Hargreaves Dougal S, 2011, J Clin Res Pediatr Endocrinol, V3, P43, DOI 10.4274/jcrpe.v3i2.10
   Herrmann C, 1997, J PSYCHOSOM RES, V42, P17, DOI 10.1016/S0022-3999(96)00216-4
   Ingerski LM, 2010, PEDIATR DIABETES, V11, P563, DOI 10.1111/j.1399-5448.2010.00645.x
   Kipps S, 2002, DIABETIC MED, V19, P649, DOI 10.1046/j.1464-5491.2002.00757.x
   Lloyd CE, 2000, DIABETIC MED, V17, P198, DOI 10.1046/j.1464-5491.2000.00260.x
   Maslakpak MH, 2010, SCAND J CARING SCI, V24, P463, DOI 10.1111/j.1471-6712.2009.00736.x
   Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494
   National Collaborating Centre for Women's and Children's Health National Collaborating Centre for Chronic Conditions, 2004, TYPE1 DIAB DIAGN MAN
   Neumark-Sztainer D, 2002, DIABETES CARE, V25, P1289, DOI 10.2337/diacare.25.8.1289
   Perry L, 2012, J CLIN NURS, V21, P1955, DOI 10.1111/j.1365-2702.2011.04012.x
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Quick VM, 2012, EAT BEHAV, V13, P207, DOI 10.1016/j.eatbeh.2012.02.003
   Scott L, 2005, CAN J DIABETES, V29, P203
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Snow R, 2012, DIABETIC MED, V29, P257, DOI 10.1111/j.1464-5491.2011.03447.x
   Speight J, 2011, DIABETES AUSTR LANGU
   Speight J, 2011, DIABETES MILES AUSTR
   Unger CC, 2011, RURAL REMOTE HEALTH, V11
   Wills CJ, 2003, BRIT MED J, V327, P260, DOI 10.1136/bmj.327.7409.260
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
NR 31
TC 14
Z9 14
U1 0
U2 10
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
J9 DIABETIC MED
JI Diabetic Med.
PD JUL
PY 2013
VL 30
IS 7
BP 878
EP 884
DI 10.1111/dme.12227
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 169MR
UT WOS:000320784900016
PM 23659590
DA 2019-01-08
ER

PT J
AU Kavanagh, K
   Flynn, DM
   Jenkins, KA
   Wilson, MD
   Chilton, FH
AF Kavanagh, K.
   Flynn, D. M.
   Jenkins, K. A.
   Wilson, M. D.
   Chilton, F. H.
TI Stearidonic and gamma-linolenic acids in echium oil improves glucose
   disposal in insulin resistant monkeys
SO PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
LA English
DT Article
DE Echium oil; Fish oil; Stearidonic acid; Polyunsaturated fatty acids;
   Gamma-Linolenic acid; Diabetes
ID N-3 FATTY-ACIDS; RESPIRATORY-DISTRESS-SYNDROME; EICOSAPENTAENOIC ACID;
   DOUBLE-BLIND; DIABETES-MELLITUS; CONTROLLED TRIAL; GENE-EXPRESSION;
   DIETARY-INTAKE; BORAGE OIL; ALPHA
AB Echium oil (EO) contains stearidonic acid (18:4), a n-3 polyunsaturated fatty acids (PUFAs), and gammalinolenic acids (18:3), a n-6 PUFA that can be converted to long chain (LC)-PUFAs. We aimed to compare a safflower oil (SO)-enriched diet to EO- and fish oil (FO)-enriched diets on circulating and tissue PUFAs levels and glycemic, inflammatory, and cardiovascular health biomarkers in insulin resistant African green monkeys. In a Latin-square cross-over study, eight monkeys consumed matched diets for 6 weeks with 3-week washout periods. Monkeys consuming FO had significantly higher levels of n-3 LC-PUFAs and EO supplementation resulted in higher levels of circulating n-3 LC-PUFAs and a significant increase in dihomo-gamma linolenic acid (DGLA) in red blood cells and muscle. Glucose disposal was improved after EO consumption. These data suggest that PUFAs in EO supplementation have the capacity to alter circulating, RBC and muscle LC-PUFA levels and improve glucose tolerance in insulin-resistant monkeys. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Kavanagh, K.; Flynn, D. M.; Jenkins, K. A.; Wilson, M. D.] Wake Forest Sch Med, Dept Pathol, Wake Forest, NC USA.
   [Chilton, F. H.] Wake Forest Sch Med, Dept Physiol & Pharmacol, Wake Forest, NC USA.
RP Kavanagh, K (reprint author), Wake Forest Univ Hlth Sci, Sect Comparat Med & Lipid Sci, Med Ctr Blvd, Winston Salem, NC 27127 USA.
EM kkavanag@wakehealth.edu
FU Wake Forest School of Medicine;  [P50 AT002782];  [P40 RR019963]; 
   [K01AG 033641];  [T32HL07115]
FX Sources of support: Grants P50 AT002782, P40 RR019963, K01AG 033641, and
   T32HL07115 as well as Wake Forest School of Medicine.
CR Abraham E, 1996, CRIT CARE MED, V24, P10, DOI 10.1097/00003246-199601000-00005
   Andreassi M, 1997, J INT MED RES, V25, P266, DOI 10.1177/030006059702500504
   ARISAKA M, 1991, PROSTAG LEUKOTR ESS, V43, P197, DOI 10.1016/0952-3278(91)90169-6
   Bosch J, 2012, NEW ENGL J MED, V367, P309, DOI 10.1056/NEJMoa1203859
   Brown AL, 2012, ARTERIOSCL THROM VAS, V32, P2122, DOI 10.1161/ATVBAHA.112.253435
   CHOPRA J, 1988, AM REV RESPIR DIS, V138, P915, DOI 10.1164/ajrccm/138.4.915
   Djousse L, 2011, AM J CLIN NUTR, V94, P527, DOI 10.3945/ajcn.111.013334
   Forrest LM, 2012, ATHEROSCLEROSIS, V220, P118, DOI 10.1016/j.atherosclerosis.2011.10.025
   Giacco R., NUTR METAB CARDIOVAS, V17, P572
   Henz BM, 1999, BRIT J DERMATOL, V140, P685
   Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665
   HOTAMISLIGIL GS, 1994, P NATL ACAD SCI USA, V91, P4854, DOI 10.1073/pnas.91.11.4854
   HUANG YS, 1991, BIOCHIM BIOPHYS ACTA, V1082, P319, DOI 10.1016/0005-2760(91)90208-Y
   Iggman D, 2010, DIABETOLOGIA, V53, P850, DOI 10.1007/s00125-010-1669-0
   James MJ, 2003, AM J CLIN NUTR, V77, P1140
   JONES DA, 1990, J BIOL CHEM, V265, P20166
   Kapoor R, 2006, CURR PHARM BIOTECHNO, V7, P531, DOI 10.2174/138920106779116874
   Karlstrom BE, 2011, AM J CLIN NUTR, V94, P26, DOI 10.3945/ajcn.110.006221
   Khamaisi M, 1999, ANTIOXID REDOX SIGN, V1, P523, DOI 10.1089/ars.1999.1.4-523
   Kitessa S.M., 2011, BR J NUTR, P1
   Knowler WC, 2002, NEW ENGL J MED, V346, P393
   Krachler B, 2008, NUTR METAB CARDIOVAS, V18, P503, DOI 10.1016/j.numecd.2007.04.005
   Lemke SL, 2010, AM J CLIN NUTR, V92, P766, DOI 10.3945/ajcn.2009.29072
   MANTZIORIS E, 1994, AM J CLIN NUTR, V59, P1304
   McAuley KA, 2002, DIABETES CARE, V25, P445, DOI 10.2337/diacare.25.3.445
   METCALFE LD, 1966, ANAL CHEM, V38, P514, DOI 10.1021/ac60235a044
   Meyer KA, 2001, DIABETES CARE, V24, P1528, DOI 10.2337/diacare.24.9.1528
   Montori VM, 2000, DIABETES CARE, V23, P1407, DOI 10.2337/diacare.23.9.1407
   Mori TA, 2003, FREE RADICAL BIO MED, V35, P772, DOI 10.1016/S0891-5849(03)00407-6
   Pacht ER, 2003, CRIT CARE MED, V31, P491, DOI 10.1097/01.CCM.0000049952.96496.3E
   Palombo JD, 1999, CRIT CARE MED, V27, P1908, DOI 10.1097/00003246-199909000-00032
   Sergeant S, 2012, BRIT J NUTR, V107, P547, DOI 10.1017/S0007114511003230
   Surette ME, 2004, J NUTR, V134, P1406
   Surette ME, 2003, CLIN THER, V25, P948, DOI 10.1016/S0149-2918(03)80116-9
   Takahashi Y, 2000, COMP BIOCHEM PHYS B, V127, P213, DOI 10.1016/S0305-0491(00)00254-6
   Takai S, 2009, J ATHEROSCLER THROMB, V16, P480, DOI 10.5551/jat.No430
   Villegas R, 2011, AM J CLIN NUTR, V94, P543, DOI 10.3945/ajcn.111.013193
   Weaver KL, 2009, J BIOL CHEM, V284, P15400, DOI 10.1074/jbc.M109.004861
   Whelan J, 2012, J NUTR, V142, p630S, DOI 10.3945/jn.111.149138
   Wu JHY, 2012, BRIT J NUTR, V107, pS214, DOI 10.1017/S0007114512001602
   YAMAZAKI K, 1992, BIOCHIM BIOPHYS ACTA, V1123, P18, DOI 10.1016/0005-2760(92)90166-S
   Zhang P, 2008, J NUTR BIOCHEM, V19, P655, DOI 10.1016/j.jnutbio.2007.08.005
   Zurier RB, 1996, ARTHRITIS RHEUM, V39, P1808, DOI 10.1002/art.1780391106
NR 43
TC 5
Z9 5
U1 0
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0952-3278
J9 PROSTAG LEUKOTR ESS
JI Prostaglandins Leukot. Essent. Fatty Acids
PD JUL
PY 2013
VL 89
IS 1
BP 39
EP 45
DI 10.1016/j.plefa.2013.04.003
PG 7
WC Biochemistry & Molecular Biology; Cell Biology; Endocrinology &
   Metabolism
SC Biochemistry & Molecular Biology; Cell Biology; Endocrinology &
   Metabolism
GA 173PO
UT WOS:000321091600005
PM 23664597
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Beverly, EA
   Fitzgerald, S
   Sitnikov, L
   Ganda, OP
   Caballero, AE
   Weinger, K
AF Beverly, Elizabeth A.
   Fitzgerald, Shane
   Sitnikov, Lilya
   Ganda, Om P.
   Caballero, A. Enrique
   Weinger, Katie
TI Do Older Adults Aged 60-75 Years Benefit From Diabetes Behavioral
   Interventions?
SO DIABETES CARE
LA English
DT Article
ID QUALITY-OF-LIFE; RANDOMIZED CONTROLLED-TRIALS; SELF-CARE; GLYCEMIC
   CONTROL; EDUCATIONAL INTERVENTIONS; META-ANALYSIS; MANAGEMENT; MELLITUS;
   METAANALYSIS; COMPLICATIONS
AB OBJECTIVE-In this secondary analysis, we examined whether older adults with diabetes (aged 60-75 years) could benefit from self-management interventions compared with younger adults. Seventy-one community-dwelling older adults and 151 younger adults were randomized to attend a structured behavioral group, an attention control group, or one-to-one education.
   RESEARCH DESIGN AND METHODS-We measured AlC, self-care (3-day pedometer readings, blood glucose checks, and frequency of self-care), and psychosocial factors (quality of life, diabetes distress, frustration with self-care, depression, self-efficacy, and coping styles) at baseline and 3, 6, and 12 months postintervention.
   RESULTS-Both older (age 67 +/- 5 years, AlC 8.7 +/- 0.8%, duration 20 +/- 12 years, 30% type 1 diabetes, 83% white, 41% female) and younger (age 47 +/- 9 years, AlC 9.2 +/- 1.2%, 18 +/- 12 years with diabetes, 59% type 1 diabetes, 82% white, 55% female) adults had improved AlC equally overtime. Importantly, older and younger adults in the group conditions improved more and maintained improvements at 12 months (older structured behavioral group change in AlC -0.72 +/- 1.4%, older control group -0.65 +/- 0.9%, younger behavioral group -0.55 +/- 1.2%, younger control group -0.43 +/- 1.7%). Furthermore, frequency of self-care, glucose checks, depressive symptoms, quality of life, distress, frustration with self-care, self-efficacy, and emotional coping improved in older and younger participants at follow-up.
   CONCLUSIONS-The findings suggest that, compared with younger adults, older adults receive equal glycemic benefit from participating in self-management interventions. Moreover, older adults showed the greatest glycemic improvement in the two group conditions. Clinicians can safely recommend group diabetes interventions to community-dwelling older adults with poor glycemic control.
C1 [Beverly, Elizabeth A.; Fitzgerald, Shane; Sitnikov, Lilya; Ganda, Om P.; Caballero, A. Enrique; Weinger, Katie] Joslin Diabet Ctr, Boston, MA 02215 USA.
   [Beverly, Elizabeth A.; Ganda, Om P.; Caballero, A. Enrique; Weinger, Katie] Harvard Univ, Sch Med, Boston, MA USA.
   [Sitnikov, Lilya] Univ Vermont, Burlington, VT USA.
RP Weinger, K (reprint author), Joslin Diabet Ctr, Boston, MA 02215 USA.
EM katie.weinger@joslin.harvard.edu
FU National Institutes of Health (NIH) [R01-DK-060115]; Diabetes and
   Endocrinology Research Core NIH [P30-DK-36836]; NIH [T32-DK-007260];
   Merck; Abbott; GlaxoSmithKline; Bristol-Myers Squibb; AstraZeneca;
   Daiichi-Sankyo
FX This work was supported by National Institutes of Health (NIH) Grant
   R01-DK-060115 (to K.W.), Diabetes and Endocrinology Research Core NIH
   Grant P30-DK-36836, and NIH Training Grant T32-DK-007260. The following
   companies contributed glucose meters and test strips: Abbott
   Laboratories (Abbott Park, IL), Life Scan (Milpitas, CA), and Roche
   Diagnostics (Indianapolis, IN). O.P.G. has provided consulting services
   to Abbott; received payment for lectures from Merck, Abbott,
   GlaxoSmithKline, Bristol-Myers Squibb, AstraZeneca, and Daiichi-Sankyo;
   and has stock options with Bristol-Myers Squibb. A.E.C. serves on the
   advisory panels of the following companies: Eli Lilly and Company;
   Amylin Pharmaceuticals, Inc.; Takeda Pharmaceuticals America, Inc;
   sanofi-aventis; and Daiichi-Sankyo. No other potential conflicts of
   interest relevant to this article were reported.
CR Blaum CS, 2002, J AM GERIATR SOC, V50, P581, DOI 10.1046/j.1532-5415.2002.50130.x
   Bradley C, 1994, HDB PSYCHOL DIABETES
   BROWN SA, 1988, NURS RES, V37, P223
   BROWN SA, 1990, PATIENT EDUC COUNS, V16, P189, DOI 10.1016/0738-3991(90)90070-2
   Center for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET
   Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278
   COONROD BA, 1994, DIABETES CARE, V17, P852, DOI 10.2337/diacare.17.8.852
   Deakin T, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003417.pub2
   Derogatis L. R., 2000, BSI 18 BRIEF SYMPTOM
   Espeland M, 2007, DIABETES CARE, V30, P1374
   Funnell MM, 2012, DIABETES CARE, V35, pS101, DOI [10.2337/dc12-s101, 10.2337/dc12-S089]
   GLASGOW RE, 1992, PATIENT EDUC COUNS, V19, P61, DOI 10.1016/0738-3991(92)90102-O
   Glasgow RE, 1997, DIABETES CARE, V20, P562, DOI 10.2337/diacare.20.4.562
   Ickowicz E, 2003, J AM GERIATR SOC, V51, pS265
   Ismail K, 2004, LANCET, V363, P1589, DOI 10.1016/S0140-6736(04)16202-8
   JACOBSON AM, 1994, DIABETES CARE, V17, P267, DOI 10.2337/diacare.17.4.267
   Kerr EA, 2007, J GEN INTERN MED, V22, P1635, DOI 10.1007/s11606-007-0313-2
   Krein SL, 2005, DIABETES CARE, V28, P65, DOI 10.2337/diacare.28.1.65
   Little R J, 2002, STAT ANAL MISSING DA
   Lundebjerg N, 2001, J AM GERIATR SOC, V49, P664
   Miller CK, 2002, PREV MED, V34, P252, DOI 10.1006/pmed.2001.0985
   Minet L, 2010, PATIENT EDUC COUNS, V80, P29, DOI 10.1016/j.pec.2009.09.033
   Munshi M, 2006, DIABETES CARE, V29, P1794, DOI 10.2337/dc06-0506
   PADGETT D, 1988, J CLIN EPIDEMIOL, V41, P1007, DOI 10.1016/0895-4356(88)90040-6
   Peyrot M, 1999, J HEALTH SOC BEHAV, V40, P141, DOI 10.2307/2676370
   PEYROT MF, 1992, DIABETES CARE, V15, P842, DOI 10.2337/diacare.15.7.842
   Piven M L, 2001, J Gerontol Nurs, V27, P8
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Schoenberg NE, 2001, J AGING HEALTH, V13, P443, DOI 10.1177/089826430101300401
   Stearne MR, 1998, BRIT MED J, V317, P720
   Stratton IM, 2000, BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405
   Suhl E, 2006, DIABETES SPECTR, V19, P234, DOI DOI 10.2337/DIASPECT.19.4.234
   UK Prospective Diabetes Study (UKPDS) Group, 1998, LANCET, V352, P837, DOI DOI 10.1016/S0140-6736(98)07019-6
   van der Ven NCW, 2003, DIABETES CARE, V26, P713, DOI 10.2337/diacare.26.3.713
   Weinger K, 2005, DIABETES CARE, V28, P1346, DOI 10.2337/diacare.28.6.1346
   Weinger K, 2001, PATIENT EDUC COUNS, V42, P123, DOI 10.1016/S0738-3991(00)00098-7
   Weinger K, 2006, DIABETES SPECTRUM, V19, P194
   Weinger K, 2011, ARCH INTERN MED, V171, P1990, DOI 10.1001/archinternmed.2011.502
   Welch G, 2003, DIABETIC MED, V20, P69, DOI 10.1046/j.1464-5491.2003.00832.x
   Zhang P, 2010, DIABETES RES CLIN PR, V87, P293, DOI 10.1016/j.diabres.2010.01.026
NR 40
TC 18
Z9 19
U1 2
U2 20
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
EI 1935-5548
J9 DIABETES CARE
JI Diabetes Care
PD JUN
PY 2013
VL 36
IS 6
BP 1501
EP 1506
DI 10.2337/dc12-2110
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 178UJ
UT WOS:000321472600012
PM 23315603
OA Green Published
DA 2019-01-08
ER

PT J
AU Sachdev, PS
   Levitan, C
   Crawford, J
   Sidhu, M
   Slavin, M
   Richmond, R
   Kochan, N
   Brodaty, H
   Wen, W
   Kang, K
   Mather, KA
AF Sachdev, Perminder S.
   Levitan, Charlene
   Crawford, John
   Sidhu, Mamta
   Slavin, Melissa
   Richmond, Robyn
   Kochan, Nicole
   Brodaty, Henry
   Wen, Wei
   Kang, Kristan
   Mather, Karen A.
CA Sydney Centenarian Study Team
TI The Sydney Centenarian Study: methodology and profile of centenarians
   and near-centenarians
SO INTERNATIONAL PSYCHOGERIATRICS
LA English
DT Article
DE centenarians; aging; longevity; dementia; MRI; methodology; genetics
ID ALZHEIMERS-DISEASE; BAYER-ACTIVITIES; DEMENTIA; SCALE; PREVALENCE; LIFE;
   AGE; QUESTIONNAIRE; LONGEVITY; STRENGTH
AB Background: The study of exceptionally long-living individuals can inform us about the determinants of successful aging. There are few population-based studies of centenarians and near-centenarians internationally, but none in Australia.
   Methods: Individuals 95 years and older were recruited from seven electoral districts in Sydney using the electoral roll, Medicare lists, and multiple other strategies to obtain a representative sample. Physical and mental health and cognitive status were assessed using standard instruments in multiple sessions, with assessments individually adapted. An informant was interviewed, and participants were invited to donate a blood sample, undergo an MRI scan, and enrol into the brain donation program.
   Results: Preliminary data on the first 200 participants are reported. Mean age was 97.4 years (range 95-106), with 29.5% being men, and 58.5% living in a private dwelling. Rates of heart disease and diabetes were lower than in octogenarians, but hearing and visual deficits were common. The mean mini-mental state examination (MMSE) score was 21.1, with men performing better. Rates of psychological distress were low and satisfaction with life high (mean 5.91 out of a maximum of 7); 54% scored <24 on MMSE; 39.5% were impaired on both MMSE and a functional measure; and 20% had previous diagnosis of dementia.
   Conclusions: This is a preliminary report describing the methodology of the study. It provides further evidence that dementia is not inevitable at this age and independent living is common. The study provides an excellent resource to determine the genetic and environmental contributions to long and successful cognitive aging.
C1 [Sachdev, Perminder S.; Levitan, Charlene; Crawford, John; Sidhu, Mamta; Slavin, Melissa; Kochan, Nicole; Brodaty, Henry; Wen, Wei; Kang, Kristan; Mather, Karen A.; Sydney Centenarian Study Team] Univ New S Wales, UNSW Med, Sch Psychiat, Brain & Ageing Res Program,Ctr Hlth Brain Ageing, Kensington, NSW 2052, Australia.
   [Sachdev, Perminder S.; Kochan, Nicole; Wen, Wei; Mather, Karen A.] Prince Wales Hosp, Inst Neuropsychiat, Randwick, NSW 2031, Australia.
   [Sachdev, Perminder S.; Slavin, Melissa; Brodaty, Henry] Univ New S Wales, Sch Psychiat, Primary Dementia Collaborat Res Ctr, UNSW Med, Kensington, NSW 2052, Australia.
   [Richmond, Robyn] Univ New S Wales, Sch Publ Hlth & Community Med, UNSW Med, Kensington, NSW 2052, Australia.
   [Brodaty, Henry] Prince Wales Hosp, Acad Dept Old Age Psychiat, Randwick, NSW 2031, Australia.
RP Sachdev, PS (reprint author), Prince Wales Hosp, UNSW Sch Psychiat, NPI, Euroa Ctr, Barker St, Randwick, NSW 2031, Australia.
EM p.sachdev@unsw.edu.au
RI Karen, Mather/O-9795-2016
OI Karen, Mather/0000-0003-4143-8941; Richmond, Robyn/0000-0003-2897-4109;
   Sachdev, Perminder/0000-0002-9595-3220
FU National Health & Medical Research Council of Australia [401184, 630593,
   568969]; University of New South Wales Gold Star Award
FX Many research assistants and administrative assistants contributed to
   data collection. DNA samples were extracted by Genetic Repositories
   Australia, an Enabling Facility, which is supported by a National Health
   & Medical Research Council of Australia grant no. 401184. The APOE
   genotyping was performed by Drs Arezoo Assareh and Karen A. Mather under
   the supervision of Professor Peter Schofield and Dr John Kwok at the
   Neuroscience Research Australia (NeuRA), Sydney, Australia. Angie
   Russell and Kate Crosbie assisted in manuscript preparation. We thank
   the participants for their enthusiastic support. This study was
   supported by the National Health & Medical Research Council of Australia
   (project grant ID 630593 and program grant ID 568969) and the University
   of New South Wales Gold Star Award to Melissa Slavin.
CR Australian Bureau of Statistics, 1991, CENS POP HOUS
   Australian Bureau of Statistics, 2001, CENS POP HOUS
   Australian Bureau of Statistics, 2006, CENS POP HOUS
   Benton AL, 1967, CORTEX, V3, P32, DOI DOI 10.1016/S0010-9452(67)80005-4
   Blansjaar BA, 2000, INT J GERIATR PSYCH, V15, P219, DOI 10.1002/(SICI)1099-1166(200003)15:3<219::AID-GPS97>3.0.CO;2-N
   BOHANNON RW, 1995, PERCEPT MOTOR SKILL, V80, P163, DOI 10.2466/pms.1995.80.1.163
   Brandt J, 2001, HOPKINS VERBAL LEARN
   Brodaty H, 2002, J AM GERIATR SOC, V50, P530, DOI 10.1046/j.1532-5415.2002.50122.x
   Cherbuin N, 2009, DEMENT GERIATR COGN, V28, P47, DOI 10.1159/000229025
   DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13
   Esiri MM, 2000, ANN NY ACAD SCI, V903, P239, DOI 10.1111/j.1749-6632.2000.tb06373.x
   Folquitto JC, 2007, REV BRAS PSIQUIATR, V29, P350, DOI 10.1590/S1516-44462006005000037
   Frederiksen H, 2006, ANN EPIDEMIOL, V16, P554, DOI 10.1016/j.annepidem.2005.10.006
   GARDNER RM, 1986, AM REV RESPIR DIS, V134, P625
   Gondo Y, 2008, ANNU REV GERONTOL GE, V27, P129
   Halliday G, 2002, ACTA NEUROPATHOL, V104, P72, DOI 10.1007/s00401-002-0529-5
   Hindmarch I, 1998, DEMENT GERIATR COGN, V9, P20, DOI 10.1159/000051195
   Jeune B, 2006, J GERONTOL A-BIOL, V61, P707, DOI 10.1093/gerona/61.7.707
   JORM AF, 1989, INT J GERIATR PSYCH, V4, P35, DOI 10.1002/gps.930040109
   Kaplan E, 2001, BOSTON NAMING TEST
   KATZ S, 1970, GERONTOLOGIST, V10, P20, DOI 10.1093/geront/10.1_Part_1.20
   LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179
   Maguire EA, 2003, BRAIN, V126, P1511, DOI 10.1093/brain/awg157
   Mathuranath PS, 2000, NEUROLOGY, V55, P1613
   MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a
   Nelson HE, 1991, NATL ADULT READING T
   Perls T, 2004, EXP GERONTOL, V39, P1587, DOI 10.1016/j.exger.2004.08.015
   PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x
   Richmond RL, 2008, MED J AUSTRALIA, V188, P720
   Ricker J. H., 1994, ASSESSMENT, V1, P51
   RITCHIE K, 1995, BRIT J PSYCHIAT, V166, P229, DOI 10.1192/bjp.166.2.229
   Robine JM, 2003, RES PERSPECT LONGEV, P145
   ROSEN WG, 1984, AM J PSYCHIAT, V141, P1356
   Sachdev PS, 2010, INT PSYCHOGERIATR, V22, P1248, DOI 10.1017/S1041610210001067
   Sachdev PS, 2012, ASIAN J GERONTOL GER, V7, P44
   Samuelsson SM, 1997, INT J AGING HUM DEV, V45, P223, DOI 10.2190/XKG9-YP7Y-QJTK-BGPG
   SHEIKH J I, 1986, Clinical Gerontologist, V5, P165
   Thomassen R, 1998, NEUROLOGY, V50, P283, DOI 10.1212/WNL.50.1.283
   Valenzuela MJ, 2007, PSYCHOL MED, V37, P1015, DOI 10.1017/S003329170600938X
   Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003
   Wechsler D., 1997, WECHSLER MEMORY SCAL
   Wechsler D., 1997, WECHSLER ADULT INTEL
   Wen W, 2009, HUM BRAIN MAPP, V30, P1155, DOI 10.1002/hbm.20586
   Willis S. L., 1993, TEST MANUAL EVERYDAY
   Wimo A, 2003, BRAIN AGING, V3, P48
NR 45
TC 17
Z9 19
U1 0
U2 19
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1041-6102
J9 INT PSYCHOGERIATR
JI Int. Psychogeriatr.
PD JUN
PY 2013
VL 25
IS 6
BP 993
EP 1005
DI 10.1017/S1041610213000197
PG 13
WC Psychology, Clinical; Geriatrics & Gerontology; Gerontology; Psychiatry;
   Psychology
SC Psychology; Geriatrics & Gerontology; Psychiatry
GA 175VH
UT WOS:000321261200015
PM 23510643
DA 2019-01-08
ER

PT J
AU Hodge, AM
   Flicker, L
   O'Dea, K
   English, DR
   Giles, GG
AF Hodge, Allison M.
   Flicker, Leon
   O'Dea, Kerin
   English, Dallas R.
   Giles, Graham G.
TI Diabetes and ageing in the Melbourne Collaborative Cohort Study (MCCS)
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Prospective study; Epidemiology; Type 2 diabetes; Healthy ageing
ID DEPRESSIVE SYMPTOMS; AGE 70; WOMEN; OLDER; POPULATION; SURVIVAL;
   MIDLIFE; SIZE; RISK; MEN
AB Aims: To examine the association between diabetes, and ageing 12 years later.
   Methods: Subjects reporting angina, cancer, heart attack or stroke at baseline (1990-1994) were excluded. Diabetes at baseline was identified by self-report or elevated plasma glucose (>= 7.0 mmol/l fasting or >= 11.1 mmol/l non-fasting). 6431 eligible men and women had survived to age 70 years at follow-up (2003-2007), and 5704 with complete data were included in these analyses. Those without ischemic heart disease, stroke, and cancer, no perceived major difficulty with physical functioning, and no evidence of psychological distress were considered to have aged successfully, irrespective of diabetes at follow-up (n = 1271). Logistic regression was used to examine the independent association between baseline diabetes and successful ageing.
   Results: At baseline 216 eligible people were identified with diabetes. This was inversely associated with successful ageing at follow-up independent of smoking, physical activity, alcohol use and obesity (OR 0.65, 95% 0.42-0.99), Of the people with diabetes at follow-up, only 12.5% did not have another condition characteristic of usual ageing, compared with 22.7% of people who did not have diabetes.
   Conclusions: Diabetes is strongly associated with factors characterising less successful ageing, suggesting that the impact of diabetes may be larger than currently estimated. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
C1 [Hodge, Allison M.; English, Dallas R.; Giles, Graham G.] Canc Council Victoria, Canc Epidemiol Ctr, Carlton, Vic 3053, Australia.
   [Flicker, Leon] Western Australian Inst Med Res, Western Australian Ctr Hlth & Ageing, Perth, WA, Australia.
   [Flicker, Leon] Univ Western Australia, Sch Med & Pharmacol, Nedlands, WA 6009, Australia.
   [Flicker, Leon] Royal Perth Hosp, Dept Geriatr Med, Perth, WA, Australia.
   [O'Dea, Kerin] Univ S Australia, Sansom Inst Hlth Res, Adelaide, SA 5001, Australia.
   [English, Dallas R.] Univ Melbourne, Ctr MEGA Epidemiol, Sch Populat Hlth, Melbourne, Vic 3010, Australia.
RP Hodge, AM (reprint author), Canc Council Victoria, Canc Epidemiol Ctr, 1 Rathdowne St, Carlton, Vic 3053, Australia.
EM allison.hodge@cancervic.org.au
RI O'Dea, Kerin/B-6916-2009
OI Giles, Graham/0000-0003-4946-9099; Hodge, Allison/0000-0001-5464-2197;
   English, Dallas/0000-0001-7828-8188
FU VicHealth; Cancer Council Victoria; National Health and Medical Research
   Council; NHMRC [520316]
FX This work was funded by VicHealth, The Cancer Council Victoria and the
   National Health and Medical Research Council. These funding sources had
   no input into study design, or collection, analysis and interpretation
   of the data.; AH was funded by NHMRC grant ID 520316.
CR AIHW, DIAB PREV AUSTR DET
   Australian Government, 2010, AUSTR 2050 FUT CHALL
   Begg S, 2007, BURDEN DIS INJURY AU
   Bouwman V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009971
   Collins MM, 2009, DIABETIC MED, V26, P153, DOI 10.1111/j.1464-5491.2008.02648.x
   Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7
   Giles G. G., 2002, Nutrition and lifestyle: opportunities for cancer prevention. European Conference on Nutrition and Cancer held in Lyon, France on 21-24 June, 2003, P69
   Glymour MM, 2008, MODERN EPIDEMIOLOGY, P183
   Golden SH, 2008, JAMA-J AM MED ASSOC, V299, P2751, DOI 10.1001/jama.299.23.2751
   Hodge A, 2010, AUSTR DIAB SOC AUSTR
   Hubbard RE, 2010, DIABETIC MED, V27, P603, DOI 10.1111/j.1464-5491.2010.02977.x
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Klijs B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025325
   Knol MJ, 2007, PSYCHOSOM MED, V69, P300, DOI 10.1097/PSY.0b013e31805f48b9
   Lu FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004144
   MacInnis RJ, 2004, CANCER EPIDEM BIOMAR, V13, P553
   Magliano DJ, 2009, AUST NZ J PUBL HEAL, V33, P540, DOI 10.1111/j.1753-6405.2009.00450.x
   Montross LP, 2006, AM J GERIAT PSYCHIAT, V14, P43, DOI 10.1097/01.JGP.0000192489.43179.31
   Nooyens ACJ, 2010, DIABETES CARE, V33, P1964, DOI 10.2337/dc09-2038
   Rowe JW, 1997, GERONTOLOGIST, V37, P433, DOI 10.1093/geront/37.4.433
   Strawbridge WJ, 2002, GERONTOLOGIST, V42, P727, DOI 10.1093/geront/42.6.727
   Sun Q, 2010, ARCH INTERN MED, V170, P194, DOI 10.1001/archinternmed.2009.503
   Sun Q, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3796
   van Dongen E, 2001, ARCH INTERN MED, V161
   Volpato S, 2010, CURR DIABETES REV, V6, P134, DOI 10.2174/157339910791162961
   WARE JE, 1995, MED CARE, V33, pAS264, DOI 10.1097/00005650-199501001-00005
   Yen CH, 2010, ARCH GERONTOL GERIAT, V50, pS53, DOI 10.1016/S0167-4943(10)70014-5
NR 27
TC 6
Z9 6
U1 0
U2 10
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD JUN
PY 2013
VL 100
IS 3
BP 398
EP 403
DI 10.1016/j.diabres.2013.03.024
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 166WV
UT WOS:000320591300019
PM 23582874
DA 2019-01-08
ER

PT J
AU Mashitani, T
   Hayashino, Y
   Okamura, S
   Kitatani, M
   Furuya, M
   Matsunaga, S
   Kuwata, H
   Tsujii, S
   Ishii, H
AF Mashitani, Tsuyoshi
   Hayashino, Yasuaki
   Okamura, Shintarou
   Kitatani, Masako
   Furuya, Miyuki
   Matsunaga, Satoshi
   Kuwata, Hirohito
   Tsujii, Satoru
   Ishii, Hitoshi
CA Tenri Study Grp
TI Patient-reported adherence to insulin regimen is associated with
   glycemic control among Japanese patients with type 2 diabetes: Diabetes
   Distress and Care Registry at Tenri (DDCRT 3)
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Type 2 diabetes; Insulin adherence; Number of injections; Glycemic
   control
ID MICROVASCULAR COMPLICATIONS; THERAPY; MELLITUS; WOMEN; BEHAVIORS;
   OMISSION; WELL
AB Aims: We investigated the association between self-reported adherence to an insulin regimen and glycemic control in Japanese patients with type 2 diabetes.
   Methods: Data from 1441 patients with type 2 diabetes who were treated with insulin were obtained from a diabetes registry in Japan. We obtained information on self-reported adherence to an insulin regimen. Relative risk regression analysis was employed to assess the independent association of various demographic factors with good glycemic control (HbA1c <7.0% [53 mmol/mol]) while adjusting for possible confounders.
   Results: The mean age, body mass index, and number of daily insulin injections of participants were 65.4 years, 24.7 kg/m(2), and 2.3, respectively. Of all patients, 70.6% reported high adherence to their insulin regimen. Compared with participants with higher adherence, the crude relative risk of good glycemic control was 0.82 (95% CI, 0.67-1.00) for those with middle adherence and 0.64 (95% CI, 0.31-1.31) for those with lower adherence (P = 0.029 for trend). Subgroup analysis confirmed this association in patients below 65 years old, but not in those 65 years old and over.
   Conclusions: A higher adherence to a daily insulin regimen was associated with a greater likelihood of good glycemic control in Japanese type 2 diabetes patients. This association was not seen in patients of 65 years old or over. Self-reported adherence to an insulin regimen may prove useful in titrating insulin dose in patients in the younger age group, but requires further investigation. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
C1 [Mashitani, Tsuyoshi; Hayashino, Yasuaki; Okamura, Shintarou; Kitatani, Masako; Furuya, Miyuki; Matsunaga, Satoshi; Kuwata, Hirohito; Tsujii, Satoru; Ishii, Hitoshi] Tenri Hosp, Dept Endocrinol, Tenri, Nara 6328552, Japan.
   [Tsujii, Satoru] Tenri Hosp, Ctr Diabet, Tenri, Nara 6328552, Japan.
RP Hayashino, Y (reprint author), Tenri Hosp, Dept Endocrinol, 200 Mishima Cho, Tenri, Nara 6328552, Japan.
EM hayasino-y@umin.net
OI Hayashino, Yasuaki/0000-0002-2932-8478; Tsujii,
   Satoru/0000-0002-1834-6515
FU Manpei Suzuki Diabetes Foundation
FX Grant support: The Manpei Suzuki Diabetes Foundation supported this
   study.
CR ANDERSON EJ, 1993, J AM DIET ASSOC, V93, P768, DOI 10.1016/0002-8223(93)91750-K
   Briesacher BA, 2008, PHARMACOTHERAPY, V28, P437, DOI 10.1592/phco.28.4.437
   Cramer JA, 2005, DIABETES CARE, V28, P78, DOI 10.2337/diacare.28.1.78
   Dhatt GS, 2005, CLIN CHIM ACTA, V358, P81, DOI 10.1016/j.cccn.2005.02.009
   Donnelly LA, 2007, QJM-INT J MED, V100, P345, DOI 10.1093/qjmed/hcm031
   GLASGOW RE, 1987, J CHRON DIS, V40, P399, DOI 10.1016/0021-9681(87)90173-1
   Goebel-Fabbri AE, 2008, DIABETES CARE, V31, P415, DOI 10.2337/dc07-2026
   Hayashino Y, 2012, DIABETES RES CLIN PR, V97, P405, DOI 10.1016/j.diabres.2012.04.005
   Mollema ED, 2001, J PSYCHOSOM RES, V51, P665, DOI 10.1016/S0022-3999(01)00229-X
   Morris AD, 1997, LANCET, V350, P1505, DOI 10.1016/S0140-6736(97)06234-X
   Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025
   OHKUBO Y, 1995, DIABETES RES CLIN PR, V28, P103, DOI 10.1016/0168-8227(95)01064-K
   Peyrot M, 2010, DIABETES CARE, V33, P240, DOI 10.2337/dc09-1348
   POLONSKY WH, 1994, DIABETES CARE, V17, P1178, DOI 10.2337/diacare.17.10.1178
   Rubin Richard R, 2005, Am J Med, V118 Suppl 5A, p27S
   Rubin RR, 2009, DIABETES EDUCATOR, V35, P1014, DOI 10.1177/0145721709345773
   Rydall AC, 1997, NEW ENGL J MED, V336, P1849, DOI 10.1056/NEJM199706263362601
   SCHAFER LC, 1986, DIABETES CARE, V9, P179, DOI 10.2337/diacare.9.2.179
   StataCorp, 2007, STAT 10 BAS REF MAN
   Tsujii S, 2012, DIABETIC MED, V29, P1451, DOI 10.1111/j.1464-5491.2012.03647.x
   UK Prospective Diabetes Study Group, 1995, DIABETES, V44, P1249
NR 21
TC 18
Z9 18
U1 1
U2 5
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD MAY
PY 2013
VL 100
IS 2
BP 189
EP 194
DI 10.1016/j.diabres.2013.03.006
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 166WR
UT WOS:000320590900014
PM 23522915
DA 2019-01-08
ER

PT J
AU Okumura, Y
   Ito, H
AF Okumura, Yasuyuki
   Ito, Hiroto
TI Out-of-pocket expenditure burdens in patients with cardiovascular
   conditions and psychological distress: a nationwide cross-sectional
   study
SO GENERAL HOSPITAL PSYCHIATRY
LA English
DT Article
DE Burden of disease; Resource allocation; Mental health policy; Equity in
   health
ID CORONARY-HEART-DISEASE; PHYSICAL CONDITIONS; MENTAL-HEALTH; RISK-FACTOR;
   REPRESENTATIVE SAMPLE; DEPRESSION; POPULATION; DISABILITY; JAPAN; CARE
AB Objectives: This study aimed to estimate the prevalence of psychological distress in individuals with and without cardiovascular risks and events [cardiovascular disease (CVD) conditions] and the incremental effects of psychological distress on the out-of-pocket health care expenditure burdens.
   Methods: We used data from the Comprehensive Survey of Living Conditions 2007, a nationally representative cross-sectional survey in Japan. Psychological distress assessed by the K6 scale, the presence of treated CVD conditions and out-of-pocket health care expenditures as a share of household consumption expenditures were self-reported by 20,763 individuals living alone and aged between 20 and 59 years.
   Results: Individuals with obesity [adjusted odds ratio (AOR), 4.3], stroke (AOR, 3.2), ischemic heart disease (AOR, 2.3), hyperlipidemia (AOR, 1.8) or diabetes (AOR, 1.7) were more likely than those without to have serious psychological distress (SPD). With the exception of ischemic heart disease, less than half of CVD patients comorbid with SPD received treatment for mental illness. Patients comorbid with SPD and obesity (AOR, 6.1), SPD and ischemic heart disease (AOR, 3.4), and SPD and hypertension (AOR, 2.6) had higher out-of-pocket burdens than patients with only CVD conditions.
   Conclusions: Our findings suggest the need for physicians to identify and manage SPD in patients with CVD conditions and for policymakers to find solutions to reduce the high out-of-pocket burdens among these patients. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Okumura, Yasuyuki; Ito, Hiroto] Natl Ctr Neurol & Psychiat, Dept Social Psychiat, Natl Inst Mental Hlth, Kodaira, Tokyo 1878553, Japan.
RP Okumura, Y (reprint author), Natl Ctr Neurol & Psychiat, Dept Social Psychiat, Natl Inst Mental Hlth, Kodaira, Tokyo 1878553, Japan.
EM yokumura@ncnp.go.jp
OI Okumura, Yasuyuki/0000-0001-5851-8919
FU Comprehensive Research on Disability Health and Welfare (Ministry of
   Health, Labour, and Welfare) [H21-KOKORO-IPPAN-007]
FX Funding for analyzing and writing this article was supported by
   Comprehensive Research on Disability Health and Welfare (Ministry of
   Health, Labour, and Welfare, H21-KOKORO-IPPAN-007).
CR Banthin JS, 2006, JAMA-J AM MED ASSOC, V296, P2712, DOI 10.1001/jama.296.22.2712
   Barth J, 2004, PSYCHOSOM MED, V66, P802, DOI 10.1097/01.psy.0000146332.53619.b2
   Blough DK, 2000, HLTH SERV OUTCOMES R, V1, P185, DOI DOI 10.1023/A:1012597123667
   Bureau Statistics, 2005, POP CENS JAP
   Bureau Statistics, 2007, POP CENS JAP
   Centres for Disease Control and Prevention, 2004, MMWR-MORBID MORTAL W, V53, P1089
   Chittleborough CR, 2011, INT J PUBLIC HEALTH, V56, P71, DOI 10.1007/s00038-010-0197-5
   Dobson A. J., 2008, INTRO GEN LINEAR MOD
   Fan AZ, 2009, INT J PUBLIC HEALTH, V54, P100, DOI 10.1007/s00038-009-1313-2
   Ferketich AK, 2005, EUR HEART J, V26, P1923, DOI 10.1093/eurheartj/ehi329
   Furukawa TA, 2008, INT J METH PSYCH RES, V17, P152, DOI 10.1002/mpr.257
   Gehi A, 2005, ARCH INTERN MED, V165, P2508, DOI 10.1001/archinte.165.21.2508
   Inoue A, 2010, J OCCUP HEALTH, V52, P227, DOI 10.1539/joh.O10002
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P1117, DOI 10.1001/archpsyc.60.11.1117
   Li CY, 2009, INT J PUBLIC HEALTH, V54, P43, DOI 10.1007/s00038-009-0006-1
   Lichtman JH, 2008, CIRCULATION, V118, P1768, DOI 10.1161/CIRCULATIONAHA.108.190769
   Long J. S., 1997, REGRESSION MODELS CA
   Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442
   Merikangas KR, 2007, ARCH GEN PSYCHIAT, V64, P1180, DOI 10.1001/archpsyc.64.10.1180
   Mitchell AJ, 2009, LANCET, V374, P609, DOI 10.1016/S0140-6736(09)60879-5
   Organisation for Economic Co-operation and Development, 2011, GOV GLANC 2011
   R Development Core Team, 2012, R LANG ENV STAT COMP
   Sareen J, 2006, ARCH INTERN MED, V166, P2109, DOI 10.1001/archinte.166.19.2109
   Schmitz N, 2007, PSYCHOSOM MED, V69, P332, DOI 10.1097/PSY.0b013e31804259e0
   Schwarz EB, 2009, OBSTET GYNECOL, V113, P974, DOI 10.1097/01.AOG.0000346884.67796.ca
   Scott KM, 2007, J AFFECT DISORDERS, V103, P113, DOI 10.1016/j.jad.2007.01.015
   Shibuya K, 2002, BRIT MED J, V324, P16, DOI 10.1136/bmj.324.7328.16
   Shibuya K, 2011, LANCET, V378, P1265, DOI 10.1016/S0140-6736(11)61098-2
   Shih M, 2008, QUAL LIFE RES, V17, P521, DOI 10.1007/s11136-008-9330-9
   Statistics and Information Department Minister's Secretariat Ministry of Health Labour and Welfare, 2009, COMPR SURV LIV COND
   Stein MB, 2006, PSYCHOL MED, V36, P587, DOI 10.1017/S0033291706007239
   Suliman S, J NERV MENT DIS, V198, P8
   Sullivan M, 2002, ARCH INTERN MED, V162, P1860, DOI 10.1001/archinte.162.16.1860
   Sullivan PW, 2007, OBESITY, V15, P3150, DOI 10.1038/oby.2007.375
   Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5
   Xu K, 2003, HOUSEHOLD HLTH SYSTE
   Zhao GX, 2009, INT J PUBLIC HEALTH, V54, P30, DOI 10.1007/s00038-009-0004-3
NR 38
TC 8
Z9 8
U1 0
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0163-8343
J9 GEN HOSP PSYCHIAT
JI Gen. Hosp. Psych.
PD MAY-JUN
PY 2013
VL 35
IS 3
BP 233
EP 238
DI 10.1016/j.genhosppsych.2012.12.013
PG 6
WC Psychiatry
SC Psychiatry
GA 145DZ
UT WOS:000318995800004
PM 23391611
DA 2019-01-08
ER

PT J
AU Van Haltren, K
   Malhotra, A
AF Van Haltren, Karen
   Malhotra, Atul
TI Characteristics of infants admitted with hypoglycemia to a neonatal unit
SO JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM
LA English
DT Article
DE diabetes; hypoglycemia; neonate
ID OUTCOMES; INJURY
AB Background: Neonatal hypoglycemia is a common symptom in early infant life. The currently available literature identifies the risk factors but not the degree to which each factor lends itself to the development or severity of an ensuing hypoglycemia.
   Methods: A retrospective electronic chart review of near-term and term infants (>35 weeks' gestation) admitted to a tertiary-level neonatal unit over 16 months was carried out from the initiation of electronic record keeping.
   Results: Ninety-five infants admitted with hypoglycemia to the unit were identified with complete records available. Fifty-eight percent of the infants were males, and the median gestation was 38 weeks. Twenty-two percent of the infants were premature, whereas 18% were macrosomic. Maternal diabetes was present in 27% infants. Comorbidities were common in this cohort, with approximately two-thirds of infants having multiple morbidities. The majority of which were jaundice and infection, whereas the minor ones were respiratory distress, initial lactic acidosis, feeding issues, and temperature instability.
   Conclusions: Neonatal hypoglycemia continues to be a significant morbidity in near-term and term infants. The presence of multiple morbidities is common in the setting of hypoglycemia and is the main determinant of the length of stay in the neonatal unit in this study population.
C1 [Malhotra, Atul] Monash Med Ctr, Melbourne, Vic 3168, Australia.
   [Van Haltren, Karen; Malhotra, Atul] Monash Univ, Dept Paediat, Melbourne, Vic 3004, Australia.
RP Malhotra, A (reprint author), Monash Med Ctr, 246 Clayton Rd, Melbourne, Vic 3168, Australia.
EM atul.malhotra@southernhealth.org.au
OI Malhotra, Atul/0000-0001-9664-4182
CR Adamkin DH, 2011, PEDIATRICS, V127, P575, DOI 10.1542/peds.2010-3851
   Burns CM, 2008, PEDIATRICS, V122, P65, DOI 10.1542/peds.2007-2822
   Cornblath M, 2000, PEDIATRICS, V105, P1141, DOI 10.1542/peds.105.5.1141
   Flores-le Roux JA, 2012, DIABETES RES CLIN PR, V97, P217, DOI 10.1016/j.diabres.2012.03.011
   Harris DL, 2012, J PEDIATR-US, V161, P787, DOI 10.1016/j.jpeds.2012.05.022
   Hay WW, 2009, J PEDIATR-US, V155, P612, DOI 10.1016/j.jpeds.2009.06.044
   Stanley CA, 1999, NEW ENGL J MED, V18, P127
   Tam EWY, 2008, PEDIATRICS, V122, P507, DOI 10.1542/peds.2007-2002
NR 8
TC 7
Z9 7
U1 0
U2 4
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0334-018X
J9 J PEDIATR ENDOCR MET
JI J. Pediatr. Endocrinol. Metab.
PD MAY
PY 2013
VL 26
IS 5-6
BP 525
EP 529
DI 10.1515/jpem-2013-0009
PG 5
WC Endocrinology & Metabolism; Pediatrics
SC Endocrinology & Metabolism; Pediatrics
GA 138HU
UT WOS:000318500400017
PM 23443262
DA 2019-01-08
ER

PT J
AU Negrato, CA
   Gomes, MB
AF Negrato, Carlos Antonio
   Gomes, Marilia Brito
TI RETRACTED: Historical facts of screening and diagnosing diabetes in
   pregnancy (Retracted article. See vol. 6, 59, 2014)
SO DIABETOLOGY & METABOLIC SYNDROME
LA English
DT Review; Retracted Publication
DE History of diabetes; Diabetes in pregnancy; Screening diabetes in
   pregnancy; Diagnosing diabetes in pregnancy
ID INTERNATIONAL WORKSHOP-CONFERENCE; CARBOHYDRATE-METABOLISM; PREDIABETIC
   STATE; GLUCOSE TOLERANCE; MELLITUS; RECOMMENDATIONS; HYPERGLYCEMIA;
   CRITERIA
AB Diabetes is the most common metabolic disorder affecting pregnancy. Its prevalence seems to be growing in parallel with the epidemics of overweight and obesity. Recognizing and treating diabetes or any degree of glucose intolerance in pregnancy results in lowering maternal and fetal complications. These patients present higher risk for excessive weight gain, preeclampsia, cesarean sections, a high risk of developing type 2 diabetes and cardiovascular disease in the future. Infants born to these mothers are at higher risk for macrosomia and birth trauma, and after delivery, these infants have a higher risk of developing hypoglycemia, hypocalcemia, hyperbilirubinemia, respiratory distress syndrome, polycythemia and subsequent obesity and type 2 diabetes. Despite several international workshops and a lot of research there is still no unique approach to diagnose and treat diabetes in pregnancy. Who, when and how to screen and diagnose diabetes in pregnancy has been debated in the literature for so many decades and this debate seems to be endless. We present the evolution that screening and diagnosing diabetes in pregnancy has had over time. Besides many evidence of the benefits these procedures bring, health care providers still often prefer to use alternate criteria for this purpose. The myriad of maternal and fetal complications that could be avoided with an appropriate and simple screening procedure are ignored. Robust clinical trials such as the Hyperglycemia and Adverse Pregnancy Outcomes (HAPO) study have shown how harmful can even slightly altered blood glucose levels be, but it has been found a resistance in the adoption of the new criteria proposed after this and other trials by many diabetes organizations. These organizations state that these new criteria would increase the incidence of diabetes in pregnancy, would imply in longer term follow-up of these patients and would pose an economic problem; they also state that alerting too many people in order to benefit a relatively few potential diabetics would arise psychologic ill-effects. We think that health care providers should look for an uniformity in the screening and diagnosing diabetes in pregnancy based on evidence based medicine and not on specialists consensus.
C1 [Negrato, Carlos Antonio] Baurus Diabet Assoc, Dept Internal Med, BR-17012433 Sao Paulo, Brazil.
   [Gomes, Marilia Brito] State Univ Hosp Rio de Janeiro, Dept Internal Med, Diabet Unit, Rio De Janeiro, Brazil.
RP Negrato, CA (reprint author), Baurus Diabet Assoc, Dept Internal Med, BR-17012433 Sao Paulo, Brazil.
EM carlosnegrato@uol.com.br
RI Negrato, Carlos/F-8363-2013
CR Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
   American Diabetes Association, 2009, DIABETES CARE, V32, P62
   American Diabetes Association (ADA), 2011, DIABETES CARE S1, V34, pS62, DOI DOI 10.2337/DC11-S062
   [Anonymous], 1985, Diabetes, V34 Suppl 2, P1
   [Anonymous], 1883, COMPT RENDUS SOC BIO, V5, P193
   Bennewitz HG, 1824, THESIS U BERLIN
   Brasil. Ministerio da Saude, 2010, GEST ALT RISC MAN TE, P302
   CARPENTER MW, 1982, AM J OBSTET GYNECOL, V144, P768, DOI 10.1016/0002-9378(82)90349-0
   CARRINGTON ER, 1957, OBSTET GYNECOL, V9, P664, DOI 10.1097/00006250-195706000-00008
   COLLIER E, 1991, DIABETES, V40, P197, DOI 10.2337/diabetes.40.2.197
   CONN JW, 1961, AM J MED, V31, P839, DOI 10.1016/0002-9343(61)90023-7
   Dubreuil G, 1920, COMPT RENDUS SOC BIO, V133, P1490
   Duncan JM, 1882, T OBSTET SOC LONDON, V24, P256
   FREINKEL N, 1980, DIABETES CARE, V3, P399, DOI 10.2337/diacare.3.3.399
   Graham G, 1924, Proc R Soc Med, V17, P102
   Hadden DR, 1975, CARBOHYD METABOL, P19
   HARRIS M, 1979, DIABETES, V28, P1039
   HOET JP, 1954, DIABETES, V3, P1
   Hofmeister Ztschr F, 1877, HOFMEISTER Z F, V1, P101
   JACKSON W. P. U., 1953, S AFRICAN MED JOUR, V27, P795
   JACKSON WPU, 1960, DIABETES, V9, P373, DOI 10.2337/diab.9.5.373
   Jovanovic L, 2001, JAMA-J AM MED ASSOC, V286, P2516, DOI 10.1001/jama.286.20.2516
   Knopp RH, 2002, DIABETES CARE, V25, P943, DOI 10.2337/diacare.25.5.943
   Lambie CG, 1926, J OBSTET GYN BR EMP, V33, P563
   Lecorche, 1885, ANN GYNECOL OBST, P257
   Lever JCW, 1847, GUYS HOSP REPORT, P3
   Mestman JH, 2002, ENDOCRINOLOGIST, V12, DOI 10.1097/00019616-200205000-00010
   Metzger BE, 1998, DIABETES CARE, V21, pB161
   Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943
   Metzger BE, 2007, DIABETES CARE, V30, pS251, DOI 10.2337/dc07-s225
   Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848
   MILLER HC, 1945, NEW ENGL J MED, V233, P376, DOI 10.1056/NEJM194509272331302
   MOSS JM, 1951, ANN INTERN MED, V34, P678, DOI 10.7326/0003-4819-34-3-678
   Negrato CA, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-27
   OSULLIVAN JB, 1964, DIABETES, V13, P278
   PEDERSEN J, 1956, LANCET, V270, P607
   Professional Practice Committee/American Diabetes Association, 2004, DIABETES CARE S1, V27, pS5
   Reichelt Angela J., 2002, Arq Bras Endocrinol Metab, V46, P574, DOI 10.1590/S0004-27302002000500012
   Reveno WS, 1923, JAMA-J AM MED ASSOC, V81, P2001
   Skipper E, 1933, Q J MED, V2, P353
   UNGER RH, 1958, DIABETES, V7, P455, DOI 10.2337/diab.7.6.455
   Von Noorden C, 1917, ZUCKERKRANKHEIT, V4
   Walker A, 1927, P ROY SOC MED, Vxxi, P13
   WHITE P, 1949, AM J MED, V7, P609, DOI 10.1016/0002-9343(49)90382-4
   WILKERSON HLC, 1957, DIABETES, V6, P324, DOI 10.2337/diab.6.4.324
   Williams JW, 1909, AM J MED SCI, V137, P1
NR 46
TC 6
Z9 7
U1 2
U2 17
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1758-5996
J9 DIABETOL METAB SYNDR
JI Diabetol. Metab. Syndr.
PD MAY 1
PY 2013
VL 5
AR 22
DI 10.1186/1758-5996-5-22
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 137EC
UT WOS:000318417100001
PM 23634949
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Wu, YP
   Hilliard, ME
   Rausch, J
   Dolan, LM
   Hood, KK
AF Wu, Y. P.
   Hilliard, M. E.
   Rausch, J.
   Dolan, L. M.
   Hood, K. K.
TI Family involvement with the diabetes regimen in young people: the role
   of adolescent depressive symptoms
SO DIABETIC MEDICINE
LA English
DT Article
ID GLYCEMIC CONTROL; HEALTH OUTCOMES; CHILDREN; ADHERENCE; RESPONSIBILITY;
   MANAGEMENT; MELLITUS; CARE; INTERVENTION; ASSOCIATION
AB Aims In young people with Type1 diabetes, depressive symptoms and shared responsibility for management of diabetes impact upon diabetes management and control. However, the simultaneous effects of both depressive symptoms and parental involvement on diabetes self-care and glycaemic control have not been examined. Thus, the aim of the current study was to examine the relationships between parental involvement and adolescent depressive symptoms in predicting blood glucose monitoring and glycaemic control. Methods One hundred and fifty young people with Type1 diabetes (mean age 15.3years) and their parents completed responsibility sharing and depressive symptom assessments, meter assessment of blood glucose monitoring and HbA1c at baseline and then 6, 12 and 18months. Results Parental involvement affected HbA1c through blood glucose monitoring only at low levels of adolescent depressive symptoms (score 6), which made up only 20% of the sample. In the presence of more depressive symptoms, parental involvement no longer was related to HbA1c through blood glucose monitoring. This was the relationship in the majority of the sample (80%). Conclusions While most young people in this sample are not showing evidence of high levels of depressive symptoms, even modest levels of distress interfere with parental involvement in diabetes management. By addressing adolescent depressive symptoms, interventions promoting parental involvement in these families may be more effective.
C1 [Wu, Y. P.; Hilliard, M. E.] Univ Cincinnati, Coll Med, Ctr Adherence Promot & Self Management, Cincinnati, OH USA.
   [Wu, Y. P.; Hilliard, M. E.; Rausch, J.] Univ Cincinnati, Coll Med, Cincinnati, OH USA.
   [Dolan, L. M.] Univ Cincinnati, Coll Med, Div Endocrinol, Cincinnati, OH USA.
   [Dolan, L. M.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA.
   [Hood, K. K.] Univ Calif San Francisco, Dept Pediat, Madison Clin Pediat Diabet, Div Endocrinol, San Francisco, CA 94143 USA.
RP Hood, KK (reprint author), Univ Calif San Francisco, Dept Pediat, Madison Clin Pediat Diabet, Div Endocrinol, San Francisco, CA 94143 USA.
EM hoodk@peds.ucsf.edu
RI Rausch, Joseph/E-8107-2018
OI Hilliard, Marisa/0000-0002-8813-629X
FU National Institutes of Health [K23, DK077340, T32HD068223]
FX This research was supported by a career development award from the
   National Institutes of Health to KKH (K23, DK077340) and a training
   grant from the National Institutes of Health supporting YPW
   (T32HD068223).
CR Anderson B, 1997, J PEDIATR-US, V130, P257, DOI 10.1016/S0022-3476(97)70352-4
   Anderson BJ, 2009, FAM SYST HEALTH, V27, P141, DOI 10.1037/a0015759
   ANDERSON BJ, 1990, J PEDIATR PSYCHOL, V15, P477, DOI 10.1093/jpepsy/15.4.477
   Berg CA, 2007, J PEDIATR PSYCHOL, V32, P995, DOI 10.1093/jpepsy/jsm043
   COLE DA, 1993, J FAMILY PSYCHOL, V7, P119, DOI DOI 10.1037/0893-3200.7.1.119
   Dantzer C, 2003, CLIN PSYCHOL REV, V23, P787, DOI 10.1016/S0272-7358(03)00069-2
   Dumenci L, 1996, MULTIVAR BEHAV RES, V31, P313, DOI 10.1207/s15327906mbr3103_3
   Ellis DA, 2007, J PEDIATR PSYCHOL, V32, P907, DOI 10.1093/jpepsy/jsm009
   Grey M, 2002, J PSYCHOSOM RES, V53, P907, DOI 10.1016/S0022-3999(02)00312-4
   Guilfoyle SM, 2011, PEDIATR DIABETES, V12, P560, DOI 10.1111/j.1399-5448.2010.00735.x
   Helgeson VS, 2008, J PEDIATR PSYCHOL, V33, P497, DOI 10.1093/jpepsy/jsm081
   Helgeson VS, 2011, PEDIATR DIABETES, V12, P25, DOI 10.1111/j.1399-5448.2010.00663.x
   Hilliard ME, 2011, DIABETES RES CLIN PR, V94, P39, DOI 10.1016/j.diabres.2011.05.027
   Hood KK, 2006, DIABETES CARE, V29, P1389, DOI 10.2337/dc06-0087
   Hood KK, 2007, DIABETES SPECTR, V20, P251
   JACOBSON AM, 1994, PSYCHOSOM MED, V56, P401, DOI 10.1097/00006842-199409000-00004
   Kovacs M., 1992, CHILDRENS DEPRESSION
   Kurt MD, 2002, CLIN PSYCHOL REV, V22, P247
   Laffel LMB, 2003, J PEDIATR-US, V142, P409, DOI 10.1067/mpd.2003.138
   LAGRECA AM, 1995, J PEDIATR PSYCHOL, V20, P449, DOI 10.1093/jpepsy/20.4.449
   McGrady Meghan E, 2010, Diabetes Res Clin Pract, V88, pe35, DOI 10.1016/j.diabres.2010.03.025
   McGrady ME, 2009, DIABETES CARE, V32, P804, DOI 10.2337/dc08-2111
   Morris AD, 1997, LANCET, V350, P1505, DOI 10.1016/S0140-6736(97)06234-X
   Nansel TR, 2009, PEDIATR DIABETES, V10, P105, DOI 10.1111/j.1399-5448.2008.00448.x
   Palmer DL, 2004, J PEDIATR PSYCHOL, V29, P35, DOI 10.1093/jpepsy/jsh005
   Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553
   Preacher KJ, 2007, MULTIVAR BEHAV RES, V42, P185, DOI 10.1080/00273170701341316
   Rausch JR, 2012, DIABETES CARE, V35, P1219, DOI 10.2337/dc11-2163
   Rice F, 2002, J CHILD PSYCHOL PSYC, V43, P65, DOI 10.1111/1469-7610.00004
   Sheeber L, 1997, J ABNORM CHILD PSYCH, V25, P333, DOI 10.1023/A:1025768504415
   Silverstein J, 2005, DIABETES CARE, V28, P186, DOI 10.2337/diacare.28.1.186
   SPSS I, 2009, SPSS 17
   Vesco AT, 2010, J PEDIATR PSYCHOL, V35, P1168, DOI 10.1093/jpepsy/jsq038
   Whittemore Robin, 2002, Pediatr Diabetes, V3, P135, DOI 10.1034/j.1399-5448.2002.30303.x
   Wysocki T, 2005, PEDIATR CLIN N AM, V52, P1755, DOI 10.1016/j.pcl.2005.07.003
NR 35
TC 8
Z9 8
U1 0
U2 14
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
J9 DIABETIC MED
JI Diabetic Med.
PD MAY
PY 2013
VL 30
IS 5
BP 596
EP 602
DI 10.1111/dme.12117
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 129SQ
UT WOS:000317863000019
PM 23320523
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Browne, JL
   Scibilia, R
   Speight, J
AF Browne, J. L.
   Scibilia, R.
   Speight, J.
TI The needs, concerns, and characteristics of younger Australian adults
   with Type 2 diabetes
SO DIABETIC MEDICINE
LA English
DT Article
ID IMPAIRED GLUCOSE-TOLERANCE; EMOTIONAL DISTRESS; SOCIAL STIGMA; PROBLEM
   AREAS; MELLITUS; COMPLICATIONS; MANAGEMENT; SCALE; ADOLESCENTS;
   EMPOWERMENT
AB Aims The mean age of onset of Type 2 diabetes mellitus is decreasing in Australia and internationally. We conducted an internet-based survey to improve our understanding of the emotional well-being and unmet needs of younger adults with Type 2 diabetes, and to inform service provision for this group. Methods A random sample of National Diabetes Services Scheme registrants (n=1,417) with Type 2 diabetes, aged 1839years, living in the Australian state of Victoria received an invitation to complete the online survey. The study was also advertised state-wide. The survey included validated scales (PAID-5: diabetes-related distress; WHO-5: general emotional well-being) and study-specific items. A total of 149 eligible respondents participated. Results Almost two-thirds (63%) of respondents reported severe-diabetes related distress; more than a quarter (27%) had impaired general emotional well-being. Most (82%) were overweight or obese (BMI25); most (77%) had at least one other co-morbidity. Lack of motivation, feeling burned out, and being time-poor were identified as top barriers to self-management. More than half (59%) of respondents had not participated in structured diabetes education. Respondents perceived that younger adults with Type 2 diabetes had different health-care needs than their older counterparts (68%), and that most Type 2 diabetes information/services were aimed at older adults (62%). Of a range of potential new services, respondents indicated greatest interest in an online forum specifically for younger adults with Type 2 diabetes. Conclusions Younger adults with Type 2 diabetes have impaired emotional well-being and physical health. Population-based research is needed to confirm the current findings, to further inform service delivery and optimise outcomes for this group.
C1 [Browne, J. L.; Speight, J.] Diabet Australia Vic, Australian Ctr Behav Res Diabet, Melbourne, Vic, Australia.
   [Browne, J. L.; Speight, J.] Deakin Univ, Ctr Mental Hlth & Wellbeing Res, Sch Psychol, Burwood, Vic, Australia.
   [Scibilia, R.] Diabet Australia Vic, Melbourne, Vic, Australia.
   [Speight, J.] AHP Res, Hornchurch, Essex, England.
RP Browne, JL (reprint author), Diabet Australia Vic, Australian Ctr Behav Res Diabet, Melbourne, Vic, Australia.
EM jbrowne@acbrd.org.au
OI Speight, Jane/0000-0002-1204-6896
FU Centre for Mental Health and Wellbeing Research at Deakin University;
   Diabetes Australia - Vic; Deakin University
FX The Australian Centre for Behavioural Research in Diabetes is a
   partnership for better health between Diabetes Australia - Vic and
   Deakin University. Both bodies provide core funding for the Centre,
   which enabled this work to be undertaken. The Centre for Mental Health
   and Wellbeing Research at Deakin University also provided a small grant
   to support this work.
CR Anderson RM, 2003, DIABETES CARE, V26, P1641, DOI 10.2337/diacare.26.5.1641-a
   *AUSTR BUR STAT, 2006, NAT AB TORR STRAIT I
   Bech P., 2004, QUALITY LIFE NEWSLET, V32, P15
   Benhalima K, 2011, PRIM CARE DIABETES, V5, P245, DOI 10.1016/j.pcd.2011.06.003
   Benhalima K, 2011, PRIM CARE DIABETES, V5, P57, DOI 10.1016/j.pcd.2010.08.001
   Berge LI, 2012, DIABETIC MED, V29, P509, DOI 10.1111/j.1464-5491.2011.03530.x
   Broadbent E, 2011, DIABETES CARE, V34, P338, DOI 10.2337/dc10-1779
   Delahanty LM, 2007, DIABETIC MED, V24, P48, DOI 10.1111/j.1464-5491.2007.02028.x
   Drivsholm T, 2005, DIABETOLOGIA, V48, P210, DOI 10.1007/s00125-004-1625-y
   Dunning T, 1999, J NURS HLTH CHRONIC, V16, P73, DOI DOI 10.1111/J.1752-9824.2009.01035.X
   Dunstan DW, 2002, DIABETES CARE, V25, P829, DOI 10.2337/diacare.25.5.829
   Feltbower RG, 2003, ARCH DIS CHILD, V88, P676, DOI 10.1136/adc.88.8.676
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   GLATTHAAR C, 1985, MED J AUSTRALIA, V143, P436
   Hessler DM, 2011, PATIENT EDUC COUNS, V85, P154, DOI 10.1016/j.pec.2010.10.030
   Hillier TA, 2003, DIABETES CARE, V26, P2999, DOI 10.2337/diacare.26.11.2999
   Koopman RJ, 2005, ANN FAM MED, V3, P60, DOI 10.1370/afm.214
   Lammi N, 2007, DIABETOLOGIA, V50, P1393, DOI 10.1007/s00125-007-0690-4
   McGrath NM, 1999, DIABETES RES CLIN PR, V43, P205, DOI 10.1016/S0168-8227(99)00003-0
   McGuire BE, 2010, DIABETOLOGIA, V53, P66, DOI 10.1007/s00125-009-1559-5
   Pinhas-Hamiel O, 2005, J PEDIATR-US, V146, P693, DOI 10.1016/j.jpeds.2004.12.042
   Rhodes ET, 2012, DIABETIC MED, V29, P453, DOI 10.1111/j.1464-5491.2011.03542.x
   Schabert J, 2013, PATIENT, V6, P1, DOI 10.1007/s40271-012-0001-0
   Scott Adrian, 2004, N Z Med J, V117, pU1219
   Senecal C, 2000, HEALTH PSYCHOL, V19, P452, DOI 10.1037//0278-6133.19.5.452
   Shah AS, 2011, DIABETOLOGIA, V54, P722, DOI 10.1007/s00125-010-1974-7
   Shiu ATY, 2003, J CLIN NURS, V12, P149, DOI 10.1046/j.1365-2702.2003.00735.x
   Sillars BA, 2010, INTERN MED J, V40, P850, DOI 10.1111/j.1445-5994.2010.02372.x
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Speight J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-120
   Urbina EM, 2009, CIRCULATION, V119, P2913, DOI 10.1161/CIRCULATIONAHA.108.830380
   van Dam HA, 2005, PATIENT EDUC COUNS, V59, P1, DOI 10.1016/j.pec.2004.11.001
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
NR 33
TC 24
Z9 25
U1 1
U2 26
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
J9 DIABETIC MED
JI Diabetic Med.
PD MAY
PY 2013
VL 30
IS 5
BP 620
EP 626
DI 10.1111/dme.12078
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 129SQ
UT WOS:000317863000023
PM 23181664
DA 2019-01-08
ER

PT J
AU Robertson, SM
   Amspoker, AB
   Cully, JA
   Ross, EL
   Naik, AD
AF Robertson, S. M.
   Amspoker, A. B.
   Cully, J. A.
   Ross, E. L.
   Naik, A. D.
TI Affective symptoms and change in diabetes self-efficacy and glycaemic
   control
SO DIABETIC MEDICINE
LA English
DT Article
ID DEPRESSION; STRESS; DISTRESS; ADULTS; TRIAL; CARE
AB Aims To examine the role of baseline depression, anxiety and stress symptoms on post-intervention diabetes self-efficacy and glycaemic control (HbA1c). Methods The current study analysed data from patients (n=85) with treated but uncontrolled Type2 diabetes who participated in a comparative effectiveness study of two diabetes self-management interventions. Hierarchical linear regression was used to examine the relationships between baseline affective symptoms and post-intervention diabetes self-efficacy and the moderating effects of baseline affective symptoms on the relationship between changes in diabetes self-efficacy and post-intervention HbA1c. Results Baseline depression was inversely associated with post-intervention diabetes self-efficacy (P=0.0001) after adjusting for baseline characteristics including diabetes self-efficacy. In contrast, normalmild levels of stress were associated with higher post-intervention diabetes self-efficacy (P=0.04). Anxiety and stress symptoms significantly and independently moderated the relationship between changes in diabetes self-efficacy and post-intervention HbA1c (P=0.02 and P=0.03, respectively). Further evaluation of these interactions demonstrated that changes in diabetes self-efficacy were associated with lower post-intervention HbA1c, but only among those with higher baseline affective symptoms. Conclusions We found a moderating effect across affective symptoms on the relationship between diabetes self-efficacy changes and post-intervention HbA1c in the context of a self-management intervention. Results suggest that patients with poorly controlled diabetes who have higher levels of depression, anxiety and stress symptoms may derive greater benefits from self-management interventions known to improve diabetes self-efficacy.
C1 [Robertson, S. M.; Amspoker, A. B.; Cully, J. A.; Ross, E. L.; Naik, A. D.] Univ Houston, Michael E DeBakey Vet Affairs Med Ctr, Houston Hlth Serv Res &Development Ctr Excellence, Houston, TX 77004 USA.
   [Robertson, S. M.; Amspoker, A. B.; Naik, A. D.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA.
   [Amspoker, A. B.; Cully, J. A.; Naik, A. D.] Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA.
   [Cully, J. A.; Naik, A. D.] Univ Houston, VA South Cent Mental Illness Res Educ & Clin Ctr, Houston, TX USA.
   [Ross, E. L.] Univ Houston, Dept Psychol, Houston, TX USA.
RP Robertson, SM (reprint author), Univ Houston, Michael E DeBakey Vet Affairs Med Ctr, Houston Hlth Serv Res &Development Ctr Excellence, Houston, TX 77004 USA.
EM smr1@bcm.tmc.edu
FU Agency for Healthcare Research and Quality; Centers for Research and
   Education on Therapeutics [U18HS016093]; Doris Duke Charitable
   Foundation; Veterans Affairs Office of Academic Affiliations; National
   Institute of Aging [5K23AG027144]
FX This manuscript is supported with resources and the use of facilities at
   the Houston Veterans Affairs Health Services Research and Development
   Center of Excellence (HEP90-020) at the Michael E. DeBakey Veterans
   Affairs Medical Center, Houston, TX. The parent study from which the
   data for the current analysis were derived was funded by the Agency for
   Healthcare Research and Quality, Centers for Research and Education on
   Therapeutics (U18HS016093) and a Doris Duke Charitable Foundation
   Clinical Scientist Development Award (Naik). SMR is a Veterans Affairs
   Health Services Research post-doc fellow supported by Veterans Affairs
   Office of Academic Affiliations. ADN received support from a National
   Institute of Aging Career Development Award (5K23AG027144).
CR Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x
   Bandura A., 1994, ENCY HUMAN BEHAV, V4, P71, DOI DOI 10.1002/9780470479216.C0RPSY0836
   Cherrington A, 2010, J BEHAV MED, V33, P81, DOI 10.1007/s10865-009-9233-4
   Cohen J., 2003, APPL MULTIPLE REGRES
   DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   GARMEZY N, 1984, CHILD DEV, V55, P97, DOI 10.2307/1129837
   Huang CJ, 2011, GEN HOSP PSYCHIAT, V33, P8, DOI 10.1016/j.genhosppsych.2010.10.008
   Kapson HS, 2010, BEHAV THER, V41, P447, DOI 10.1016/j.beth.2009.10.001
   Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955
   Krichbaum K, 2003, DIABETES ED, V29, P82
   LORIG K, 2001, PATIENT ED PRACTICAL
   LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U
   Marks R, 2005, HEALTH PROMOT PRACT, V6, P148, DOI 10.1177/1524839904266792
   Mishali M, 2011, FAM PRACT, V28, P82, DOI 10.1093/fampra/cmq086
   Naik AD, 2011, ARCH INTERN MED, V171, P453, DOI 10.1001/archinternmed.2011.70
   Nelson KM, 2007, J GEN INTERN MED, V22, P442, DOI 10.1007/s11606-006-0053-8
   PEYROT M, 1985, PSYCHOSOM MED, V47, P542, DOI 10.1097/00006842-198511000-00004
   Peyrot M, 1999, J HEALTH SOC BEHAV, V40, P141, DOI 10.2307/2676370
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Pouwer F, 2010, DISCOV MED, V9, P112
   Riazi A, 2004, DIABETES RES CLIN PR, V66, P237, DOI 10.1016/j.diabres.2004.04.001
   Robertson SM, 2012, PSYCHOSOMATICS, V53, P1, DOI 10.1016/j.psym.2011.09.008
   Rose V, 2009, PATIENT EDUC COUNS, V77, P260, DOI 10.1016/j.pec.2009.03.026
   Sacco WP, 2010, DIABETES RES CLIN PR, V90, P141, DOI 10.1016/j.diabres.2010.06.026
   Schneider S, 2010, J BEHAV MED, V33, P1, DOI 10.1007/s10865-009-9227-2
NR 27
TC 10
Z9 10
U1 2
U2 13
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD MAY
PY 2013
VL 30
IS 5
BP E189
EP E196
DI 10.1111/dme.12146
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 129SQ
UT WOS:000317863000006
PM 23350920
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Forlani, G
   Nuccitelli, C
   Caselli, C
   Moscatiello, S
   Mazzotti, A
   Centis, E
   Marchesini, G
AF Forlani, Gabriele
   Nuccitelli, Chiara
   Caselli, Chiara
   Moscatiello, Simona
   Mazzotti, Arianna
   Centis, Elena
   Marchesini, Giulio
TI A psychological support program for individuals with Type 1 diabetes
SO ACTA DIABETOLOGICA
LA English
DT Article
DE Anxiety; Depression; Locus of control; Quality of life; Type 1 diabetes;
   Well-being
ID QUALITY-OF-LIFE; DEPRESSIVE SYMPTOMS; COMORBID DEPRESSION;
   FOOT-SYNDROME; GROUP CARE; PREVALENCE; ADULTS; ANXIETY; LOCUS; MELLITUS
AB We aimed to test the effects of a psychological support program on the psychological distress, mood, and quality of life of well-educated individuals with type 1 diabetes. A newly developed support program was offered to 60 patients with type 1 diabetes on intensive insulin treatment, previously enrolled in group-care educational programs. Thirty-three subjects participated (experimental group, in groups of 8-12 subjects); 22, who postponed their entry, were used as controls. The program consisted of 7 weekly work sessions of 2 hours chaired by a psychologist and covered aspects of daily living with diabetes using role-playing, metaplan, and problem solving. At baseline and approximately 6 months later, all participants completed a battery of questionnaires, and the differences between the experimental and the control group were analyzed by repeated-measurements ANOVA. In response to the psychological support program, subjects in the experimental group reduced their depressive mood (Beck Depression Inventory and depression scales of the Psychological Well-Being Index) and anxiety (Self-rating Anxiety Scale), improved disease-specific quality of life (Symptom and Well-Being scales of the Well-Being Enquiry for Diabetes), increased their internal and decreased their external locus of control. These changes were accompanied by a 0.3% decrease in glycosylated hemoglobin, whereas no significant changes were observed in the control group (ANOVA, P = 0.032). These results underline the importance of psychological aspects in individuals with type 1 diabetes; treating the psychological aspects related to the disease may be as important as medical control in order to improve living with diabetes.
C1 [Forlani, Gabriele; Nuccitelli, Chiara; Caselli, Chiara; Moscatiello, Simona; Mazzotti, Arianna; Centis, Elena; Marchesini, Giulio] Alma Mater Studiorum Univ, Unit Metab Dis & Clin Dietet, S Orsola Malpighi Hosp, I-40138 Bologna, Italy.
RP Marchesini, G (reprint author), Alma Mater Studiorum Univ, Unit Metab Dis & Clin Dietet, S Orsola Malpighi Hosp, Via Massarenti 9, I-40138 Bologna, Italy.
EM giulio.marchesini@unibo.it
OI Marchesini, Giulio/0000-0003-2407-9860
FU Novo Nordisk
FX The psychological support program described in this article received the
   Italian DAWN award 2010 "Premio Roberto Sivieri", supported by Novo
   Nordisk.
CR Amsberg S, 2009, PATIENT EDUC COUNS, V77, P72, DOI 10.1016/j.pec.2009.01.015
   Anderson JA, 2003, COMMUNITY MENT HLT J, V39, P63, DOI 10.1023/A:1021225907821
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   BAGGIO A, 1997, INT J PAIN THERAPY, V7, P4
   Beck A, 1978, DEPRESSION INVENTORY
   BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561
   Collins MM, 2009, DIABETIC MED, V26, P153, DOI 10.1111/j.1464-5491.2008.02648.x
   Conti L., 2000, REPERTORIO SCALE VAL
   Dupuy HJ., 1984, ASSESSMENT QUALITY L, P170
   Eiber R, 1997, ENCEPHALE, V23, P351
   El Achhab Y, 2008, DIABETES RES CLIN PR, V80, P171, DOI 10.1016/j.diabres.2007.12.020
   Forlani G, 2006, J ENDOCRINOL INVEST, V29, P405, DOI 10.1007/BF03344123
   Gendelman N, 2009, DIABETES CARE, V32, P575, DOI 10.2337/dc08-1835
   GROSSI E, 2002, QUESTIONARIO PSYCHOL
   Hart HE, 2003, QUAL LIFE RES, V12, P1089, DOI 10.1023/A:1026197119569
   Hart HE, 2007, INDIAN J MED RES, V125, P203
   Hislop AL, 2008, DIABETIC MED, V25, P91, DOI 10.1111/j.1464-5491.2007.02310.x
   Li CY, 2008, DIABETES CARE, V31, P105, DOI 10.2337/dc07-1154
   Lin EHB, 2010, DIABETES CARE, V33, P264, DOI 10.2337/dc09-1068
   Lloyd CE, 2010, DIABETIC MED, V27, P234, DOI 10.1111/j.1464-5491.2009.02896.x
   Lloyd CE, 2000, DIABETIC MED, V17, P198, DOI 10.1046/j.1464-5491.2000.00260.x
   Lustman PJ, 1997, PSYCHOSOM MED, V59, P24, DOI 10.1097/00006842-199701000-00004
   LUSTMAN PJ, 1992, DIABETES CARE, V15, P1631, DOI 10.2337/diacare.15.11.1631
   Lustman PJ, 2002, PRACTICAL PSYCHOL DI, P219
   Manini R, 2007, NUTR METAB CARDIOVAS, V17, P493, DOI 10.1016/j.numecd.2006.07.001
   Mannucci E, 1996, DIABETES NUTR METAB, V9, P89
   PEYROT M, 1994, DIABETES CARE, V17, P994, DOI 10.2337/diacare.17.9.994
   Peyrot M, 2002, PRACTICAL PSYCHOL DI, P211
   Pouwer F, 2010, DIABETIC MED, V27, P217, DOI 10.1111/j.1464-5491.2009.02903.x
   Shaban C, 2009, DIABETES RES CLIN PR, V85, pe26
   Shaban MC, 2006, DIABETIC MED, V23, P1381, DOI 10.1111/j.1464-5491.2006.02012.x
   Shaw BF, 1985, HDB DEPRESSION TREAT, P372
   Simson U, 2008, DIABETIC MED, V25, P206, DOI 10.1111/j.1464-5491.2007.02370.x
   Simson U, 2008, PSYCHOTHER PSYCH MED, V58, P44, DOI 10.1055/s-2007-971001
   Trento M, 2008, DIABETIC MED, V25, P86, DOI 10.1111/j.1464-5491.2007.02319.x
   Trento M, 2006, DIABETES METAB, V32, P77, DOI 10.1016/S1262-3636(07)70250-1
   WALLSTON BS, 1978, HEALTH EDUC QUART, V6, P107, DOI 10.1177/109019817800600107
   Wild D, 2007, PATIENT EDUC COUNS, V68, P10, DOI 10.1016/j.pec.2007.05.003
   Zhang XP, 2007, MED CARE, V45, P820, DOI 10.1097/MLR.0b013e3180618b55
   ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371
NR 40
TC 4
Z9 4
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0940-5429
J9 ACTA DIABETOL
JI Acta Diabetol.
PD APR
PY 2013
VL 50
IS 2
BP 209
EP 216
DI 10.1007/s00592-011-0269-x
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 135LA
UT WOS:000318288400015
PM 21365339
DA 2019-01-08
ER

PT J
AU Jaremka, LM
   Lindgren, ME
   Kiecolt-Glaser, JK
AF Jaremka, Lisa M.
   Lindgren, Monica E.
   Kiecolt-Glaser, Janice K.
TI SYNERGISTIC RELATIONSHIPS AMONG STRESS, DEPRESSION, AND TROUBLED
   RELATIONSHIPS: INSIGHTS FROM PSYCHONEUROIMMUNOLOGY
SO DEPRESSION AND ANXIETY
LA English
DT Review
DE biological markers; depression; cognition; life events; stress;
   interpersonal relationships; psychoneuroimmunology; antidepressants
ID C-REACTIVE PROTEIN; CORONARY-HEART-DISEASE; RANDOMIZED CONTROLLED-TRIAL;
   GINGIVAL CREVICULAR FLUID; ACUTE MENTAL STRESS; SUPPLEMENTATION LOWERS
   INFLAMMATION; SOCIOECONOMIC-STATUS; PSYCHOLOGICAL STRESS; OLDER-ADULTS;
   CARDIOVASCULAR-DISEASE
AB Stress and depression consistently elevate inflammation and are often experienced simultaneously, which is exemplified by people in troubled relationships. Troubled relationships also elevate inflammation, which may be partially explained by their ability to engender high levels of stress and depression. People who are stressed, depressed, or in troubled relationships are also at greater risk for health problems than their less distressed counterparts. Inflammation, a risk factor for a variety of age-related diseases including cardiovascular disease, Type II diabetes, metabolic syndrome, and frailty, may be one key mechanistic pathway linking distress to poor health. Obesity may further broaden the health implications of stress and depression; people who are stressed or depressed are often overweight, and adipose tissue is a major source of proinflammatory cytokines. Stress, depression, and troubled relationships may have synergistic inflammatory effects: loneliness, subclinical depression, and major depression enhance inflammatory responses to an acute stressful event. The relationship between distress and inflammation is bidirectional; depression enhances inflammation and inflammation promotes depression. Interesting questions emerge from this literature. For instance, some stressors may be more potent than others and thus may be more strongly linked to inflammation. In addition, it is possible that psychological and interpersonal resources may buffer the negative inflammatory effects of stress. Understanding the links among stress, depression, troubled relationships, and inflammation is an exciting area of research that may provide mechanistic insight into the links between distress and poor health.
C1 [Jaremka, Lisa M.; Lindgren, Monica E.; Kiecolt-Glaser, Janice K.] Ohio State Univ, Inst Behav Med Res, Coll Med, Columbus, OH 43210 USA.
   [Kiecolt-Glaser, Janice K.] Ohio State Univ, Coll Med, Dept Psychiat, Columbus, OH 43210 USA.
RP Jaremka, LM (reprint author), Ohio State Univ, Inst Behav Med Res, Coll Med, 460 Med Ctr Dr, Columbus, OH 43210 USA.
EM lisa.jaremka@osumc.edu
RI Kiecolt-Glaser, Janice/A-3236-2009
OI Kiecolt-Glaser, Janice/0000-0003-4900-9578
FU American Cancer Society Postdoctoral Fellowship
   [121911-PF-12-040-01-CPPB]; Ohio State University Comprehensive Cancer
   Center Pelotonia Postdoctoral Fellowship; National Cancer Institute
   Research Supplement to Promote Diversity in Health-Related Research
   [CA126857]; NIH [CA126857, CA131029, CA154054, AG029562]
FX Contract grant sponsor: American Cancer Society Postdoctoral Fellowship;
   Contract grant number: 121911-PF-12-040-01-CPPB; Contract grant sponsor:
   Ohio State University Comprehensive Cancer Center Pelotonia Postdoctoral
   Fellowship; Contract grant sponsor: National Cancer Institute Research
   Supplement to Promote Diversity in Health-Related Research; Contract
   grant number: CA126857; Contract grant sponsor: NIH; Contract grant
   numbers: CA131029, CA126857, CA154054, and AG029562.
CR Aggarwal BB, 2006, BIOCHEM PHARMACOL, V72, P1605, DOI 10.1016/j.bcp.2006.06.029
   Alley DE, 2006, BRAIN BEHAV IMMUN, V20, P498, DOI 10.1016/j.bbi.2005.10.003
   Altemus M, 2001, J INVEST DERMATOL, V117, P309, DOI 10.1046/j.1523-1747.2001.01373.x
   Appelhans BM, 2012, J ACAD NUTR DIET, V112, P693, DOI 10.1016/j.jand.2012.02.006
   Appleton KM, 2010, AM J CLIN NUTR, V91, P757, DOI 10.3945/ajcn.2009.28313
   Baum A, 1999, ANN NY ACAD SCI, V896, P131, DOI 10.1111/j.1749-6632.1999.tb08111.x
   BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497
   Beach SRH, 1998, CLIN PSYCHOL REV, V18, P635, DOI 10.1016/S0272-7358(98)00023-3
   Benoit D, 2001, LIFE SCI, V68, P1641, DOI 10.1016/S0024-3205(01)00963-8
   Bierhaus A, 2003, P NATL ACAD SCI USA, V100, P1920, DOI 10.1073/pnas.0438019100
   Bjorntorp P, 2001, Obes Rev, V2, P73, DOI 10.1046/j.1467-789x.2001.00027.x
   BODNAR JC, 1994, PSYCHOL AGING, V9, P372
   Bremmer MA, 2008, J AFFECT DISORDERS, V106, P249, DOI 10.1016/j.jad.2007.07.002
   Brydon L, 2005, BRAIN BEHAV IMMUN, V19, P540, DOI 10.1016/j.bbi.2004.12.003
   Buske-Kirschbaum A, 2007, BRAIN BEHAV IMMUN, V21, P92, DOI 10.1016/j.bbi.2006.03.006
   Cacioppo JT, 2010, PSYCHOL AGING, V25, P453, DOI 10.1037/a0017216
   Capuron L, 2004, BIOL PSYCHIAT, V56, P819, DOI 10.1016/j.biopsych.2004.02.009
   Capuron L, 2002, NEUROPSYCHOPHARMACOL, V26, P643, DOI 10.1016/S0893-133X(01)00407-9
   Capuron L, 2009, J AFFECT DISORDERS, V119, P181, DOI 10.1016/j.jad.2009.02.017
   Carlson LE, 2003, PSYCHOSOM MED, V65, P571, DOI 10.1097/01.PSY.0000074003.35911.41
   Carroll JE, 2011, BRAIN BEHAV IMMUN, V25, P232, DOI 10.1016/j.bbi.2010.09.024
   Chandola T, 2008, EUR HEART J, V29, P640, DOI 10.1093/eurheartj/ehm584
   COHEN S, 1983, J APPL SOC PSYCHOL, V13, P99, DOI 10.1111/j.1559-1816.1983.tb02325.x
   COHEN S, 1991, NEW ENGL J MED, V325, P606, DOI 10.1056/NEJM199108293250903
   Cohen S, 2006, PSYCHOSOM MED, V68, P414, DOI 10.1097/01.psy.0000221236.37158.b9
   Cole SW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r189
   Corren J, 2011, CURR OPIN ALLERGY CL, V11, P565, DOI 10.1097/ACI.0b013e32834c3d30
   Creswell JD, 2012, BRAIN BEHAV IMMUN, V26, P1095, DOI 10.1016/j.bbi.2012.07.006
   Damjanovic AK, 2007, J IMMUNOL, V179, P4249, DOI 10.4049/jimmunol.179.6.4249
   Danner M, 2003, PSYCHOSOM MED, V65, P347, DOI 10.1097/01.PSY.0000041542.29808.01
   Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297
   Deinzer R, 2000, J CLIN PERIODONTOL, V27, P74, DOI 10.1034/j.1600-051x.2000.027001074.x
   Deinzer R, 1999, J CLIN PERIODONTOL, V26, P1, DOI 10.1034/j.1600-051X.1999.260101.x
   DellaGioia N, 2010, NEUROSCI BIOBEHAV R, V34, P130, DOI 10.1016/j.neubiorev.2009.07.014
   Dentino AN, 1999, J AM GERIATR SOC, V47, P6, DOI 10.1111/j.1532-5415.1999.tb01894.x
   DOBBIN JP, 1991, BRAIN BEHAV IMMUN, V5, P339, DOI 10.1016/0889-1591(91)90029-A
   Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033
   Eisenberger NI, 2010, BRAIN BEHAV IMMUN, V24, P558, DOI 10.1016/j.bbi.2009.12.009
   Ershler WB, 2000, ANNU REV MED, V51, P245, DOI 10.1146/annurev.med.51.1.245
   Fagundes CP, BRAIN BEHAV IN PRESS
   FITZGERALD JE, 1995, ORAL MICROBIOL IMMUN, V10, P297, DOI 10.1111/j.1399-302X.1995.tb00158.x
   Ford MB, 2010, J PERS SOC PSYCHOL, V98, P405, DOI 10.1037/a0017345
   Foster PS, 1996, J EXP MED, V183, P195, DOI 10.1084/jem.183.1.195
   Frasure-Smith N, 2007, BIOL PSYCHIAT, V62, P302, DOI 10.1016/j.biopsych.2006.09.029
   Giannopoulou C, 2003, J CLIN PERIODONTOL, V30, P145, DOI 10.1034/j.1600-051X.2003.300201.x
   Glaser R, 2003, ARCH GEN PSYCHIAT, V60, P1009, DOI 10.1001/archpsyc.60.10.1009
   Gleeson M, 2011, NAT REV IMMUNOL, V11, P607, DOI 10.1038/nri3041
   Goebel MU, 2000, PSYCHOSOM MED, V62, P591, DOI 10.1097/00006842-200007000-00019
   Gruenewald TL, 2009, SOC SCI MED, V69, P451, DOI 10.1016/j.socscimed.2009.05.018
   Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88
   Hackett RA, 2012, PSYCHONEUROENDOCRINO, V37, P1801, DOI 10.1016/j.psyneuen.2012.03.016
   Hammen C, 2005, ANNU REV CLIN PSYCHO, V1, P293, DOI 10.1146/annurev.clinpsy.1.102803.143938
   Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430
   Harris TB, 1999, AM J MED, V106, P506, DOI 10.1016/S0002-9343(99)00066-2
   Hawkley LC, 2010, ANN BEHAV MED, V40, P218, DOI 10.1007/s12160-010-9210-8
   Heffner KL, 2004, J BEHAV MED, V27, P233, DOI 10.1023/B:JOBM.0000028497.79129.ad
   Hemingway H, 2003, AM J CARDIOL, V92, P984, DOI 10.1016/S0002-9149(03)00985-8
   Herring MP, 2012, ARCH INTERN MED, V172, P101, DOI 10.1001/archinternmed.2011.696
   Hoffman BM, 2011, PSYCHOSOM MED, V73, P127, DOI 10.1097/PSY.0b013e31820433a5
   Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316
   Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485
   Howren MB, 2009, PSYCHOSOM MED, V71, P171, DOI 10.1097/PSY.0b013e3181907c1b
   Hugo FN, 2006, J PERIODONTOL, V77, P1008, DOI 10.1902/jop.2006.050037
   Irwin MR, 2008, BRAIN BEHAV IMMUN, V22, P129, DOI 10.1016/j.bbi.2007.07.013
   Irwin MR, 2007, BRAIN BEHAV IMMUN, V21, P374, DOI 10.1016/j.bbi.2007.01.010
   Jaremka LM, PSYCHOL SCI IN PRESS
   Jehn CF, 2006, CANCER, V107, P2723, DOI 10.1002/cncr22294
   Johannsen A, 2007, J PERIODONTAL RES, V42, P546, DOI 10.1111/j.1600-0765.2007.00980.x
   Johannsen A, 2006, J PERIODONTOL, V77, P1403, DOI 10.1902/jop.2006.050411
   Jones SA, 2001, FASEB J, V15, P43, DOI 10.1096/fj.99-1003rev
   Jousilahti P, 2003, J EPIDEMIOL COMMUN H, V57, P730, DOI 10.1136/jech.57.9.730
   Joynt KE, 2003, BIOL PSYCHIAT, V54, P248, DOI 10.1016/S0006-3223(03)00568-7
   Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7
   Kiecolt-Glaser JK, 2012, BRAIN BEHAV IMMUN, V26, P988, DOI 10.1016/j.bbi.2012.05.011
   Kiecolt-Glaser JK, 2011, BRAIN BEHAV IMMUN, V25, P1725, DOI 10.1016/j.bbi.2011.07.229
   Kiecolt-Glaser JK, 2010, NEUROSCI BIOBEHAV R, V35, P33, DOI 10.1016/j.neubiorev.2009.09.003
   Kiecolt-Glaser JK, 2010, PSYCHOSOM MED, V72, P365, DOI 10.1097/PSY.0b013e3181dbf489
   Kiecolt-Glaser JK, 2010, PSYCHOSOM MED, V72, P113, DOI 10.1097/PSY.0b013e3181cb9377
   Kiecolt-Glaser JK, 2005, ARCH GEN PSYCHIAT, V62, P1377, DOI 10.1001/archpsyc.62.12.1377
   Kiecolt-Glaser JK, 2001, PSYCHOL BULL, V127, P472, DOI 10.1037//0033-2909.127.4.472
   Kiecolt-Glaser JK, 2003, P NATL ACAD SCI USA, V100, P9090, DOI 10.1073/pnas.1531903100
   Kiecolt-Glaser JK, 2002, J PSYCHOSOM RES, V53, P873, DOI 10.1016/S0022-3999(02)00309-4
   Kiecolt-Glaser JK, 2002, ANNU REV PSYCHOL, V53, P83, DOI 10.1146/annurev.psych.53.100901.135217
   Kiecolt-Glaser JK, 2001, CURR DIR PSYCHOL SCI, V10, P18, DOI 10.1111/1467-8721.00105
   KIECOLTGLASER JK, 1991, PSYCHOSOM MED, V53, P345, DOI 10.1097/00006842-199107000-00001
   Kling MA, 2007, BIOL PSYCHIAT, V62, P309, DOI 10.1016/j.biopsych.2006.09.033
   Koster A, 2006, J GERONTOL A-BIOL, V61, P284, DOI 10.1093/gerona/61.3.284
   Kuper H, 2003, J EPIDEMIOL COMMUN H, V57, P147, DOI 10.1136/jech.57.2.147
   Lanquillon S, 2000, NEUROPSYCHOPHARMACOL, V22, P370, DOI 10.1016/S0893-133X(99)00134-7
   Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068
   LeResche L, 2002, PERIODONTOL 2000, V30, P91, DOI 10.1034/j.1600-0757.2002.03009.x
   Lin PY, 2007, J CLIN PSYCHIAT, V68, P1056, DOI 10.4088/JCP.v68n0712
   Loucks EB, 2006, AM J EPIDEMIOL, V163, P622, DOI 10.1093/aje/kwj076
   Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2
   Lutgendorf SK, 1999, J GERONTOL A-BIOL, V54, pM434, DOI 10.1093/gerona/54.9.M434
   Maes M, 2001, PSYCHOL MED, V31, P847, DOI 10.1017/S0033291701004007
   Maes M, 1998, CYTOKINE, V10, P313, DOI 10.1006/cyto.1997.0290
   MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224
   McDade TW, 2006, PSYCHOSOM MED, V68, P376, DOI 10.1097/01.psy.0000221371.43607.64
   McNutt MD, 2012, NEUROPSYCHOPHARMACOL, V37, P1444, DOI 10.1038/npp.2011.330
   Michelson D, 1996, NEW ENGL J MED, V335, P1176, DOI 10.1056/NEJM199610173351602
   Miller AH, 2010, BRAIN BEHAV IMMUN, V24, P1, DOI 10.1016/j.bbi.2009.09.009
   Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029
   Miller GE, 2005, AM J CARDIOL, V95, P317, DOI 10.1016/j.amjcard.2004.09.026
   Musselman DL, 2001, NEW ENGL J MED, V344, P961, DOI 10.1056/NEJM200103293441303
   Musselman DL, 2001, AM J PSYCHIAT, V158, P1252, DOI 10.1176/appi.ajp.158.8.1252
   O'Brien SM, 2006, BRIT J PSYCHIAT, V188, P449, DOI 10.1192/bjp.bp.105.011015
   Orth-Gomer K, 2000, JAMA-J AM MED ASSOC, V284, P3008, DOI 10.1001/jama.284.23.3008
   Owen N, 2003, BRAIN BEHAV IMMUN, V17, P286, DOI 10.1016/S0889-1591(03)00058-8
   Ozbay Fatih, 2008, Curr Psychiatry Rep, V10, P304, DOI 10.1007/s11920-008-0049-7
   Pace TWW, 2009, PSYCHONEUROENDOCRINO, V34, P87, DOI 10.1016/j.psyneuen.2008.08.011
   Paik IH, 2000, BEHAV MED, V26, P139, DOI 10.1080/08964280009595761
   Pan A, 2012, DIABETES CARE, V35, P1171, DOI 10.2337/dc11-2055
   Penninx BWJH, 2003, BIOL PSYCHIAT, V54, P566, DOI 10.1016/S0006-3223(03)01811-5
   Pollitt RA, 2008, J EPIDEMIOL COMMUN H, V62, P484, DOI 10.1136/jech.2006.054106
   Pratt LA, 1996, CIRCULATION, V94, P3123, DOI 10.1161/01.CIR.94.12.3123
   Ranjit N, 2007, CIRCULATION, V116, P2383, DOI 10.1161/CIRCULATIONAHA.107.706226
   Rector NA, 1997, PERS INDIV DIFFER, V23, P799, DOI 10.1016/S0191-8869(97)00095-0
   Reichenberg A, 2001, ARCH GEN PSYCHIAT, V58, P445, DOI 10.1001/archpsyc.58.5.445
   Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202
   Schulz R, 2000, ARCH INTERN MED, V160, P1761, DOI 10.1001/archinte.160.12.1761
   Shimbo D, 2006, HEART, V92, P1316, DOI 10.1136/hrt.2005.075861
   Song C, 1999, PSYCHIAT RES, V85, P293, DOI 10.1016/S0165-1781(99)00012-8
   Steptoe A, 1996, J PSYCHOSOM RES, V41, P171, DOI 10.1016/0022-3999(96)00095-5
   Steptoe A, 2002, BRAIN BEHAV IMMUN, V16, P774, DOI 10.1016/S0889-1591(02)00030-2
   Steptoe A, 2001, CLIN SCI, V101, P185, DOI 10.1042/CS20010038
   Stewart JC, 2009, BRAIN BEHAV IMMUN, V23, P936, DOI 10.1016/j.bbi.2009.04.011
   Strike PC, 2004, J PSYCHOSOM RES, V57, P189, DOI 10.1016/S0022-3999(03)00569-5
   Theorell T, 1998, AM J PUBLIC HEALTH, V88, P382, DOI 10.2105/AJPH.88.3.382
   Tiemeier H, 2003, EPIDEMIOLOGY, V14, P103, DOI 10.1097/00001648-200301000-00025
   Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937
   Trayhurn P, 2004, BRIT J NUTR, V92, P347, DOI 10.1079/BJN20041213
   Tyring S, 2006, LANCET, V367, P29, DOI 10.1016/S0140-6736(05)67763-X
   Uchino BN, 1996, PSYCHOL BULL, V119, P488, DOI 10.1037/0033-2909.119.3.488
   Vaccarino V, 2007, J AM COLL CARDIOL, V50, P2044, DOI 10.1016/j.jacc.2007.07.069
   Vitaliano PP, 2005, PSYCHOSOM MED, V67, P930, DOI 10.1097/01.psy.0000188485.65153.7b
   Vitaliano PP, 2002, PSYCHOSOM MED, V64, P418, DOI 10.1097/00006842-200205000-00006
   Vogelzangs N, 2008, ARCH GEN PSYCHIAT, V65, P1386, DOI 10.1001/archpsyc.65.12.1386
   von Kanel R, 2006, J AM GERIATR SOC, V54, P431, DOI 10.1111/j.1532-5415.2005.00642.x
   von Kanel R, 2006, BRAIN BEHAV IMMUN, V20, P40, DOI 10.1016/j.bbi.2005.03.013
   Weik U, 2008, PSYCHOSOM MED, V70, P906, DOI 10.1097/PSY.0b013e3181835bf3
   Whisman MA, 2003, TREATING DIFFICULT COUPLES: HELPING CLIENTS WITH COEXISTING MENTAL AND RELATIONSHIP DISORDERS, P3
   Whisman MA, 2010, HEALTH PSYCHOL, V29, P550, DOI 10.1037/a0020760
   Wirtz PH, 2007, BRAIN BEHAV IMMUN, V21, P851, DOI 10.1016/j.bbi.2007.02.003
   World Health Organisation, 2012, FACT SHEET OB OV
   Wright CE, 2005, BRAIN BEHAV IMMUN, V19, P345, DOI 10.1016/j.bbi.2004.10.003
NR 146
TC 46
Z9 48
U1 3
U2 73
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1091-4269
EI 1520-6394
J9 DEPRESS ANXIETY
JI Depress. Anxiety
PD APR
PY 2013
VL 30
IS 4
BP 288
EP 296
DI 10.1002/da.22078
PG 9
WC Psychology, Clinical; Psychiatry; Psychology
SC Psychology; Psychiatry
GA 126GJ
UT WOS:000317600800002
PM 23412999
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Willaing, I
   Rogvi, SA
   Bogelund, M
   Almdal, T
   Schiotz, M
AF Willaing, I.
   Rogvi, S. A.
   Bogelund, M.
   Almdal, T.
   Schiotz, M.
TI Recall of HbA(1c) and self-management behaviours, patient activation,
   perception of care and diabetes distress in Type2 diabetes
SO DIABETIC MEDICINE
LA English
DT Article
ID DANISH VERSION; SHORT-FORM; ADAPTATION; A1C
AB Aims The aim of this study was to investigate associations between HbA1c recall by patients with Type2 diabetes and self-management behaviours, patient activation, perception of care and diabetes distress. Methods In a cross-sectional survey, 993 patients with Type2 diabetes reported their latest HbA1c. Validated scales measured self-management behaviours, patient activation, perception of care and diabetes distress. Self-reported HbA1c was compared with latest measured HbA1c. Using logistic regressions, associations between HbA1c recall and the variables of interest were investigated. Results Sixty-four per cent of patients recalled their latest HbA1c. Poor HbA1c recall was significantly associated with unhealthy eating behaviour, low level of exercise, low level of patient activation, poor glycaemic control, not knowing target HbA1c level, low educational level and being female. There were no associations between recall of HbA1c and diabetes distress or perceived care. Conclusions Recall of HbA1c level may increase patient activation and health-promoting behaviours. However, low educational level may be a barrier for using HbA1c as a motivator for health-promoting behaviours. This study indicates a need for studies of causal relationships, as well as mechanisms and challenges in using patient awareness of HbA1c as a driver for health-promoting behaviours.
C1 [Willaing, I.; Rogvi, S. A.; Schiotz, M.] Steno Diabet Ctr, Steno Hlth Promot Ctr, DK-2820 Gentofte, Denmark.
   [Bogelund, M.] Incent Partners, Holte, Denmark.
   [Almdal, T.] Steno Diabet Ctr, Steno Patient Care Clin, DK-2820 Gentofte, Denmark.
RP Willaing, I (reprint author), Steno Diabet Ctr, Steno Hlth Promot Ctr, DK-2820 Gentofte, Denmark.
EM iwtp@steno.dk
OI Willaing, Ingrid/0000-0002-3082-8816
CR Beard E, 2010, PATIENT EDUC COUNS, V80, P227, DOI 10.1016/j.pec.2009.11.008
   BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170
   Gugiu PC, 2009, CHRONIC ILLN, V5, P268, DOI 10.1177/1742395309348072
   Guirguis LM, 2007, J AM PHARM ASSOC, V47, P29, DOI 10.1331/1544-3191.47.1.29.Guirguis
   Harwell TS, 2002, DIABETES EDUCATOR, V28, P99, DOI 10.1177/014572170202800111
   Heisler M, 2005, DIABETES CARE, V28, P816, DOI 10.2337/diacare.28.4.816
   Hibbard JH, 2005, HEALTH SERV RES, V40, P1918, DOI 10.1111/j.1475-6773.2005.00438.x
   Hibbard JH, 2007, HEALTH SERV RES, V42, P1443, DOI 10.1111/j.1475-6773.2006.00669.x
   *IDF CLIN GUID TAS, 2005, GLOB GUID TYP 2 DIAB
   Kumpatla Satyavani, 2010, Indian J Community Med, V35, P290, DOI 10.4103/0970-0218.66858
   Maindal HT, 2012, EUR J PUBLIC HEALTH, V22, P31, DOI 10.1093/eurpub/ckq188
   Maindal HT, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-209
   McGuire BE, 2009, DIABETOLOGIA, V53, P66
   Mosen DM, 2007, J AMBUL CARE MANAG, V30, P21
   Schiotz ML, 2012, DIABETIC MED, V29, P654, DOI 10.1111/j.1464-5491.2011.03485.x
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Williams G., 2004, HDB DIABETES
NR 17
TC 13
Z9 13
U1 1
U2 15
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
J9 DIABETIC MED
JI Diabetic Med.
PD APR
PY 2013
VL 30
IS 4
BP e139
EP e142
DI 10.1111/dme.12121
PG 4
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 110SG
UT WOS:000316465400003
PM 23331258
DA 2019-01-08
ER

PT J
AU Hermanns, N
   Caputo, S
   Dzida, G
   Khunti, K
   Meneghini, LF
   Snoek, F
AF Hermanns, Norbert
   Caputo, Salvatore
   Dzida, Grzegorz
   Khunti, Kamlesh
   Meneghini, Luigi F.
   Snoek, Frank
TI Screening, evaluation and management of depression in people with
   diabetes in primary care
SO PRIMARY CARE DIABETES
LA English
DT Review
DE Diabetes mellitus; Depression; Diabetes distress; Screening; Primary
   care; Cognitive behavioral therapy
ID PLACEBO-CONTROLLED TRIAL; CO-MORBID DEPRESSION; QUALITY-OF-LIFE;
   RANDOMIZED CONTROLLED-TRIAL; MAJOR DEPRESSION; GLYCEMIC CONTROL;
   SELF-CARE; COMORBID DEPRESSION; DOUBLE-BLIND; RISK-FACTOR
AB Family physicians are responsible for diagnosing and treating the majority of people with type 2 diabetes mellitus and co-morbid depression. As a result of the impact of co-morbid depression on patient self-care and treatment outcomes, screening for depression in the context of a structured approach to case management and patient follow up is recommended in people with diabetes and cardiovascular disease. This review summarizes the need for improved recognition and treatment of depression in diabetes; and makes expert recommendations with regard to integrating screening tools and therapies into a busy family or general medical practice setting. (C) 2012 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.
C1 [Hermanns, Norbert] FIDAM GmbH, Forschungsinst Diabet Akad Bad Mergentheim, Diabet Zentrum Mergentheim, D-97980 Bad Mergentheim, Germany.
   [Caputo, Salvatore] Univ Cattolica Sacro Cuore, Policlin Gemelli, Serv Diabetol, I-00168 Rome, Italy.
   [Dzida, Grzegorz] Med Univ Lublin, Dept Internal Dis, Lublin, Poland.
   [Khunti, Kamlesh] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England.
   [Meneghini, Luigi F.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA.
   [Snoek, Frank] Vrije Univ Amsterdam, Med Ctr, Dept Med Psychol, Diabet Psychol Res Grp, Amsterdam, Netherlands.
RP Hermanns, N (reprint author), FIDAM GmbH, Forschungsinst Diabet Akad Bad Mergentheim, Diabet Zentrum Mergentheim, Theodor Klotzbucher Str 12, D-97980 Bad Mergentheim, Germany.
EM hermanns@diabetes-zentrum.de
OI Meneghini, Luigi/0000-0003-4539-2725; Khunti,
   Kamlesh/0000-0003-2343-7099
FU Eli Lilly; Merck; MSD; Novo Nordisk; Sanofi Aventis; Takeda; Bioton;
   Servier; NIHR CLAHRC; Boehringer-Ingelheim; Mannkind; Pfizer; Astra
   Zeneca; Diabetes Research Foundation; Lifescan
FX SC has consulted for MSD and Novo Nordisk, and has received lecture fees
   from Eli Lilly, Merck, MSD, Novo Nordisk, Sanofi Aventis and Takeda. GD
   consults for Lifescan and Novo Nordisk; and has received-lecture fees
   from Bioton, Eli Lilly, Novo Nordisk, Sanofi Aventis and Servier. NH
   consults for Eli Lilly and Novo Nordisk; and has received lecture fees
   and grants/grants pending with Berlin Chemie and Eli Lilly. KK has
   received grants to his institution from NIHR CLAHRC, consults for
   Bristol Myers Squibb, Eli Lilly, MSD, Novo Nordisk and Roche, and has
   received lecture fees from Eli Lilly, MSD, Novartis, Novo Nordisk and
   Sanofi Aventis. LFM consults for Novo Nordisk and Sanofi Aventis, and
   has received grants of has grants pending from Boehringer-Ingelheim,
   Mannkind, and Pfizer. FS consults for Eli Lilly, Novo Nordisk and Roche;
   has grants/grants pending with Astra Zeneca, the Diabetes Research
   Foundation, Lifescan and Novo Nordisk; and has received lecture fees
   from Eli Lilly, Lifescan, Novartis and Novo Nordisk.
CR Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x
   Ali S, 2010, DIABETES-METAB RES, V26, P75, DOI 10.1002/dmrr.1065
   Anderson RJ, 2010, DIABETES CARE, V33, P485, DOI 10.2337/dc09-1466
   [Anonymous], 2005, BRIT J GEN PRACTICE, V55, P665
   Aujla N, 2010, DIABETIC MED, V27, P896, DOI 10.1111/j.1464-5491.2010.03042.x
   Barnard KD, 2006, DIABETIC MED, V23, P445, DOI 10.1111/j.1464-5491.2006.01814.x
   Bryan C, 2010, GEN HOSP PSYCHIAT, V32, P33, DOI 10.1016/j.genhosppsych.2009.07.009
   Carnethon MR, 2003, AM J EPIDEMIOL, V158, P416, DOI 10.1093/aje/kwg172
   Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278
   Ciechanowski PS, 2003, GEN HOSP PSYCHIAT, V25, P246, DOI 10.1016/S0163-8343(03)00055-0
   Croxford A.M., 2010, J UNDERGRADUATE RES, V3
   Cuijpers P, 2004, ACTA PSYCHIAT SCAND, V109, P325, DOI 10.1111/j.1600-0447.2004.00301.x
   Daly JM, 2009, J AM BOARD FAM MED, V22, P280, DOI 10.3122/jabfm.2009.03.080114
   Davies MJ, 2008, BRIT MED J, V336, P491, DOI 10.1136/bmj.39474.922025.BE
   de G.M., 2001, PSYCHOSOM MED, V63, P619
   de J.P., 2009, PSYCHOSOMATICS, V50, P227
   Delahanty LM, 2007, DIABETIC MED, V24, P48, DOI 10.1111/j.1464-5491.2007.02028.x
   Demakakos P, 2010, DIABETES CARE, V33, P792, DOI 10.2337/dc09-1663
   DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101
   Dirmaier J, 2010, PSYCHOTHER PSYCHOSOM, V79, P172, DOI 10.1159/000296135
   Echeverry D, 2009, DIABETES CARE, V32, P2156, DOI 10.2337/dc09-0785
   Egede LE, 2005, DIABETES CARE, V28, P1339, DOI 10.2337/diacare.28.6.1339
   Egede LE, 2004, DIABETES CARE, V27, P1751, DOI 10.2337/diacare.27.7.1751
   Egede LE, 2003, DIABETES CARE, V26, P104, DOI 10.2337/diacare.26.1.104
   Egede LE, 2002, DIABETES CARE, V25, P464, DOI 10.2337/diacare.25.3.464
   Egede LE, 2008, DIABETES TECHNOL THE, V10, P213, DOI 10.1089/dia.2007.0278
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Gallo JJ, 2005, AM J GERIAT PSYCHIAT, V13, P748, DOI 10.1176/appi.ajgp.13.9.748
   Gazmararian JA, 2009, DIABETES EDUCATOR, V35, P778, DOI 10.1177/0145721709338527
   Gill JM, 2008, INT J PSYCHIAT MED, V38, P203, DOI 10.2190/PM.38.2.g
   Goldberg D, 2001, BRIT MED J, V323, P948
   Golden SH, 2004, DIABETES CARE, V27, P429, DOI 10.2337/diacare.27.2.429
   Golden SH, 2008, JAMA-J AM MED ASSOC, V299, P2751, DOI 10.1001/jama.299.23.2751
   Goldney RD, 2004, DIABETES CARE, V27, P1066, DOI 10.2337/diacare.27.5.1066
   Gonzalez JS, 2007, DIABETES CARE, V30, P2222, DOI 10.2337/dc07-0158
   Gulseren L, 2005, ARCH MED RES, V36, P159, DOI 10.1016/j.arcmed.2004.12.018
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   Hermanns N, 2005, DIABETIC MED, V22, P293, DOI 10.1111/j.1464-5491.2005.01414.x
   Jacobson AM, 1997, QUAL LIFE RES, V6, P11
   Judd LL, 1997, J AFFECT DISORDERS, V45, P5, DOI 10.1016/S0165-0327(97)00055-4
   Kalsekar ID, 2006, ANN PHARMACOTHER, V40, P605, DOI 10.1345/aph.1G606
   Katon W, 2004, DIABETES CARE, V27, P914, DOI 10.2337/diacare.27.4.914
   Katon W, 2002, J PSYCHOSOM RES, V53, P859, DOI 10.1016/S0022-3999(02)00313-6
   Katon W, 2008, J GEN INTERN MED, V23, P1571, DOI 10.1007/s11606-008-0731-9
   Katon W, 2009, PSYCHOSOMATICS, V50, P570, DOI 10.1176/appi.psy.50.6.570
   Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955
   Katon WJ, 2005, DIABETES CARE, V28, P2668, DOI 10.2337/diacare.28.11.2668
   Katon WJ, 2004, MED CARE, V42, P1222, DOI 10.1097/00005650-200412000-00009
   Khunti K, 2000, J ROY SOC MED, V93, P183, DOI 10.1177/014107680009300407
   Knol MJ, 2006, DIABETOLOGIA, V49, P837, DOI 10.1007/s00125-006-0159-x
   Li CY, 2009, DIABETES RES CLIN PR, V83, P268, DOI 10.1016/j.diabres.2008.11.006
   Lin EHB, 2004, DIABETES CARE, V27, P2154, DOI 10.2337/diacare.27.9.2154
   Lin EHB, 2009, ANN FAM MED, V7, P414, DOI 10.1370/afm.998
   Lustman PJ, 2006, ARCH GEN PSYCHIAT, V63, P521, DOI 10.1001/archpsyc.63.5.521
   Lustman PJ, 1997, PSYCHOSOM MED, V59, P241, DOI 10.1097/00006842-199705000-00007
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Lustman PJ, 2000, DIABETES CARE, V23, P618, DOI 10.2337/diacare.23.5.618
   Lustman PJ, 1998, ANN INTERN MED, V129, P613, DOI 10.7326/0003-4819-129-8-199810150-00005
   McHale M, 2008, PSYCHOSOM MED, V70, P869, DOI 10.1097/PSY.0b013e318186dea9
   Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985
   Munoz RF, 2010, ANNU REV CLIN PSYCHO, V6, P181, DOI 10.1146/annurev-clinpsy-033109-132040
   Paile-Hyvarinen Maria, 2003, BMC Fam Pract, V4, P7, DOI 10.1186/1471-2296-4-7
   Pan A, 2010, ARCH INTERN MED, V170, P1884, DOI 10.1001/archinternmed.2010.356
   Simon GE, 2005, GEN HOSP PSYCHIAT, V27, P344, DOI 10.1016/j.genhosppsych.2005.04.008
   Snoek FJ, 2012, DIABETES CARE, V35, P2128, DOI 10.2337/dc11-1326
   Subramanian Deepak N, 2008, Qual Prim Care, V16, P341
   Thomas J, 2003, DIABETES CARE, V26, P2311, DOI 10.2337/diacare.26.8.2311
   Thoolen BJ, 2006, DIABETES CARE, V29, P2257, DOI 10.2337/dc06-0617
   Vamos EP, 2009, PSYCHOSOM MED, V71, P501, DOI 10.1097/PSY.0b013e3181a5a7ad
   van Bastelaar KM, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-9
   Van der Feltz-Cornelis CM, 2010, GEN HOSP PSYCHIAT, V32, P380, DOI 10.1016/j.genhosppsych.2010.03.011
   Vileikyte L, 2005, DIABETES CARE, V28, P2378, DOI 10.2337/diacare.28.10.2378
   Zhang XP, 2005, AM J EPIDEMIOL, V161, P652, DOI 10.1093/aje/kwi089
NR 74
TC 39
Z9 40
U1 1
U2 38
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1751-9918
J9 PRIM CARE DIABETES
JI Prim. Care Diabetes
PD APR
PY 2013
VL 7
IS 1
BP 1
EP 10
DI 10.1016/j.pcd.2012.11.002
PG 10
WC Endocrinology & Metabolism; Primary Health Care
SC Endocrinology & Metabolism; General & Internal Medicine
GA 113DR
UT WOS:000316647200001
PM 23280258
OA Other Gold
DA 2019-01-08
ER

PT J
AU van Son, J
   Nyklicek, I
   Pop, VJ
   Blonk, MC
   Erdtsieck, RJ
   Spooren, PF
   Toorians, AW
   Pouwer, F
AF van Son, Jenny
   Nyklicek, Ivan
   Pop, Victor J.
   Blonk, Marion C.
   Erdtsieck, Ronald J.
   Spooren, Pieter F.
   Toorians, Arno W.
   Pouwer, Francois
TI The Effects of a Mindfulness-Based Intervention on Emotional Distress,
   Quality of Life, and HbA(1c) in Outpatients With Diabetes (DiaMind)
SO DIABETES CARE
LA English
DT Article
ID STRESS-REDUCTION INTERVENTION; RANDOMIZED CONTROLLED-TRIALS; IMPROVE
   GLYCEMIC CONTROL; PSYCHOLOGICAL INTERVENTIONS; COGNITIVE THERAPY;
   DEPRESSION SCALE; HOSPITAL ANXIETY; ADULTS; METAANALYSIS; PREVALENCE
AB OBJECTIVE-Emotional distress is common in outpatients with diabetes, affecting; similar to 20-40% of the patients. The aim of this study was to determine the effectiveness of group therapy with Mindfulness-Based Cognitive Therapy (MBCT), relative to usual care, for patients with diabetes with regard to reducing emotional distress and improving health-related quality of life and glycemic control.
   RESEARCH DESIGN AND METHODS-In the present randomized controlled trial, 139 outpatients with diabetes (type 1 or type 2) and low levels of emotional well-being were randomized to MBCT (n = 70) or a waiting list group (n = 69). Primary outcomes were perceived stress (Perceived Stress Scale), anxiety and depressive symptoms (Hospital Anxiety and Depression Scale), mood (Profiles of Mood States), and diabetes-specific distress (Problem Areas In Diabetes). Secondary outcomes were health-related quality of life (12-Item Short-Form Health Survey), and glycemic control (HbA(1c)). Assessments were conducted at baseline and at 4 and 8 weeks of follow-up.
   RESULTS-Compared with control, MBCT was more effective in reducing stress (P < 0.001, Cohen d = 0.70), depressive symptoms (P = 0.006, d = 0.59), and anxiety (P = 0.019, d = 0.44). In addition, MBCT was more effective in improving quality of life (mental: P = 0.003, d = 0.55; physical: P = 0.032, d = 0.40). We found no significant effect on HbA1c or diabetes-specific distress, although patients with elevated diabetes distress in the MBCT group tended to show a decrease in diabetes distress (P = 0.07, d = 0.70) compared with the control group.
   CONCLUSIONS-Compared with usual care, MBCT resulted in a reduction of emotional distress and an increase in health-related quality of life in diabetic patients who had lower levels of emotional well-being. Diabetes Care 36:823-830, 2013
C1 [van Son, Jenny; Nyklicek, Ivan; Pop, Victor J.; Pouwer, Francois] Tilburg Univ, Dept Med & Clin Psychol, Ctr Res Psychol Somat Dis, NL-5000 LE Tilburg, Netherlands.
   [Blonk, Marion C.] Catharina Hosp, Dept Internal Med, Eindhoven, Netherlands.
   [Erdtsieck, Ronald J.] Maxima Med Ctr, Dept Internal Med, Eindhoven, Netherlands.
   [Spooren, Pieter F.] TweeSteden Hosp, Dept Internal Med, Tilburg, Netherlands.
   [Toorians, Arno W.] St Anna Hosp, Dept Internal Med, Geldrop, Netherlands.
RP Nyklicek, I (reprint author), Tilburg Univ, Dept Med & Clin Psychol, Ctr Res Psychol Somat Dis, NL-5000 LE Tilburg, Netherlands.
EM i.nyklicek@tilburguniversity.edu
FU Dutch Diabetes Research Foundation or "Diabetesfonds" [2008.13.005];
   Tilburg University, Center of Research on Psychology in Somatic diseases
FX The study is supported by grants from the Dutch Diabetes Research
   Foundation or "Diabetesfonds" (project number 2008.13.005, awarded to
   I.N.) and Tilburg University, Center of Research on Psychology in
   Somatic diseases.
CR Alam R, 2009, PATIENT EDUC COUNS, V75, P25, DOI 10.1016/j.pec.2008.08.026
   Bishop SR, 2004, CLIN PSYCHOL-SCI PR, V11, P230, DOI 10.1093/clipsy/bph077
   Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3
   Bogner HR, 2007, DIABETES CARE, V30, P3005, DOI 10.2337/dc07-0974
   Bohlmeijer E, 2010, J PSYCHOSOM RES, V68, P539, DOI 10.1016/j.jpsychores.2009.10.005
   Branstrom R, 2010, ANN BEHAV MED, V39, P151, DOI 10.1007/s12160-010-9168-6
   COHEN S, 1988, CLAR SYMP, P31
   Egede LE, 2005, DIABETES CARE, V28, P1339, DOI 10.2337/diacare.28.6.1339
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fjorback LO, 2011, ACTA PSYCHIAT SCAND, V124, P102, DOI 10.1111/j.1600-0447.2011.01704.x
   Foley E, 2010, J CONSULT CLIN PSYCH, V78, P72, DOI 10.1037/a0017566
   Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341
   Grigsby AB, 2002, J PSYCHOSOM RES, V53, P1053, DOI 10.1016/S0022-3999(02)00417-8
   Hartmann M, 2012, DIABETES CARE, V35, P945, DOI 10.2337/dc11-1343
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   Hofmann SG, 2010, J CONSULT CLIN PSYCH, V78, P169, DOI 10.1037/a0018555
   Ismail K, 2004, LANCET, V363, P1589, DOI 10.1016/S0140-6736(04)16202-8
   JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037//0022-006X.59.1.12
   Kabat-Zinn J., 1990, FULL CATASTROPHE LIV
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Makine C, 2009, DIABETIC MED, V26, P28, DOI 10.1111/j.1464-5491.2008.02606.x
   Mols F, 2009, QUAL LIFE RES, V18, P403, DOI 10.1007/s11136-009-9455-5
   Morone NE, 2008, PAIN, V134, P310, DOI 10.1016/j.pain.2007.04.038
   Nyklicek I, 2008, ANN BEHAV MED, V35, P331, DOI 10.1007/s12160-008-9030-2
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Pouwer F, 2006, PATIENT EDUC COUNS, V60, P235, DOI 10.1016/j.pec.2005.01.009
   Pouwer F, 2010, DIABETIC MED, V27, P217, DOI 10.1111/j.1464-5491.2009.02903.x
   Pouwer F, 2009, NAT REV ENDOCRINOL, V5, P665, DOI 10.1038/nrendo.2009.214
   Pradhan EK, 2007, ARTHRIT RHEUM-ARTHR, V57, P1134, DOI 10.1002/art.23010
   Rosenzweig S, 2007, ALTERN THER HEALTH M, V13, P36
   Schram MT, 2009, CURR DIABETES REV, V5, P112, DOI 10.2174/157339909788166828
   Segal Z., 2002, MINDFULNESS BASED CO
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   van Bastelaar KMP, 2011, DIABETES CARE, V34, P320, DOI 10.2337/dc10-1248
   Van der Feltz-Cornelis CM, 2010, GEN HOSP PSYCHIAT, V32, P380, DOI 10.1016/j.genhosppsych.2010.03.011
   van Son J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-131
   Wald F., 1990, NED T PSYCHOL, V45, P86
   Wang MY, 2008, J CLIN NURS, V17, P2524, DOI 10.1111/j.1365-2702.2008.02301.x
   Winkley K, 2006, BRIT MED J, V333, P65, DOI 10.1136/bmj.38874.652569.55
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
NR 40
TC 60
Z9 60
U1 2
U2 72
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
J9 DIABETES CARE
JI Diabetes Care
PD APR
PY 2013
VL 36
IS 4
BP 823
EP 830
DI 10.2337/dc12-1477
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 110RG
UT WOS:000316462400025
PM 23193218
OA Green Published, Other Gold
DA 2019-01-08
ER

PT J
AU D'Anna, R
   Scilipoti, A
   Giordano, D
   Caruso, C
   Cannata, ML
   Interdonato, ML
   Corrado, F
   Di Benedetto, A
AF D'Anna, Rosario
   Scilipoti, Angela
   Giordano, Domenico
   Caruso, Carmela
   Cannata, Maria Letizia
   Interdonato, Maria Lieta
   Corrado, Francesco
   Di Benedetto, Antonino
TI myo-Inositol Supplementation and Onset of Gestational Diabetes Mellitus
   in Pregnant Women With a Family History of Type 2 Diabetes A
   prospective, randomized, placebo-controlled study
SO DIABETES CARE
LA English
DT Article
ID POLYCYSTIC-OVARY-SYNDROME; METFORMIN; INOSITOL
AB OBJECTIVE-To check the hypothesis that myo-inositol supplementation may reduce gestational diabetesmellitus (GDM) onset in pregnant women with a family history of type 2 diabetes.
   RESEARCH DESIGN AND METHODS-A 2-year, prospective, randomized, open-label, placebo-controlled study was carried out in pregnant outpatients with a parent with type 2 diabetes who were treated from the end of the first trimester with 2 g myo-inositol plus 200 mu g folic acid twice a day (n = 110) and in the placebo group (n = 110), who were only treated with 200 mu g folic acid twice a day. The main outcome measure was the incidence of GDM in both groups. Secondary outcome measures were as follows: the incidence of fetal macrosomia (>4,000 g), gestational hypertension, preterm delivery, caesarean section, shoulder dystocia, neonatal hypoglycemia, and neonatal distress respiratory syndrome. GDM diagnosis was performed according to the International Association of the Diabetes and Pregnancy Study Groups (IADPSG) recommendations.
   RESULTS-Incidence of GDM was significantly reduced in the myo-inositol group compared with the placebo group: 6 vs. 15.3%, respectively (P = 0.04). In the myo-inositol group, a reduction of GDM risk occurrence was highlighted (odds ratio 0.35). A statistically significant reduction of fetal macrosomia in the myo-inositol group was also highlighted together with a significant reduction in mean fetal weight at delivery. In the other secondary outcome measures, there were no differences between groups.
   CONCLUSIONS-myo-Inositol supplementation in pregnant women with a family history of type 2 diabetes may reduce GDM incidence and the delivery of macrosomia fetuses. Diabetes Care 36:854-857, 2013
C1 [D'Anna, Rosario; Scilipoti, Angela; Giordano, Domenico; Caruso, Carmela; Cannata, Maria Letizia; Interdonato, Maria Lieta; Corrado, Francesco] Univ Messina, Dept Gynecol & Obstet Sci, Messina, Italy.
   [Di Benedetto, Antonino] Univ Messina, Dept Internal Med, Messina, Italy.
RP D'Anna, R (reprint author), Univ Messina, Dept Gynecol & Obstet Sci, Messina, Italy.
EM rosariodanna@tin.it
RI Di Benedetto, Antonino/H-9703-2012
OI Di Benedetto, Antonino/0000-0003-4093-5655
CR American College of Obstetricians and Gynecologists Committee on Practice Bulletins--Obstetrics, 2001, Obstet Gynecol, V98, P525
   Corrado F, 2011, DIABETIC MED, V28, P972, DOI 10.1111/j.1464-5491.2011.03284.x
   D'Anna R, 2012, GYNECOL ENDOCRINOL, V28, P440, DOI 10.3109/09513590.2011.633665
   Davey RX, 2001, MED J AUSTRALIA, V174, P118
   Genazzani AD, 2008, GYNECOL ENDOCRINOL, V24, P139, DOI 10.1080/09513590801893232
   Giordano D, 2011, MENOPAUSE, V18, P102, DOI 10.1097/gme.0b013e3181e8e1b1
   Glueck CJ, 2008, FERTIL STERIL, V89, P625, DOI 10.1016/j.fertnstert.2007.03.036
   Haffner SM, 1997, DIABETES CARE, V20, P1087, DOI 10.2337/diacare.20.7.1087
   Jenum AK, 2012, EUR J ENDOCRINOL, V166, P317, DOI 10.1530/EJE-11-0866
   Khattab S, 2011, GYNECOL ENDOCRINOL, V27, P789, DOI 10.3109/09513590.2010.540600
   Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943
   Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848
   Nestler JE, 1999, NEW ENGL J MED, V340, P1314, DOI 10.1056/NEJM199904293401703
   Santamaria A, 2012, CLIMACTERIC, V15, P490, DOI 10.3109/13697137.2011.631063
   Scioscia M, 2007, DIABETIC MED, V24, P1300, DOI 10.1111/j.1464-5491.2007.02267.x
   Vanky E, 2010, J CLIN ENDOCR METAB, V95, pE448, DOI 10.1210/jc.2010-0853
NR 16
TC 54
Z9 54
U1 0
U2 15
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
J9 DIABETES CARE
JI Diabetes Care
PD APR
PY 2013
VL 36
IS 4
BP 854
EP 857
DI 10.2337/dc12-1371
PG 4
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 110RG
UT WOS:000316462400029
PM 23340885
OA Green Published, Other Gold
DA 2019-01-08
ER

PT J
AU Law, GU
   Walsh, J
   Queralt, V
   Nouwen, A
AF Law, G. Urquhart
   Walsh, Jennifer
   Queralt, Victoria
   Nouwen, Arie
TI Adolescent and parent diabetes distress in type 1 diabetes: The role of
   self-efficacy, perceived consequences, family responsibility and
   adolescent-parent discrepancies
SO JOURNAL OF PSYCHOSOMATIC RESEARCH
LA English
DT Article
DE Adolescent; Distress; Parent; Responsibility; Self-efficacy; Type 1
   diabetes
ID QUALITY-OF-LIFE; ILLNESS REPRESENTATIONS; PSYCHOLOGICAL DISTRESS;
   METABOLIC-CONTROL; GLYCEMIC CONTROL; EMOTIONAL DISTRESS; YOUNG-ADULTS;
   MANAGEMENT; CARE; CHILDREN
AB Objective: To examine the association of adolescent and parent diabetes distress with perceived consequences, dietary self-efficacy, and discrepancies in diabetes family responsibility, in type 1 diabetes (T1D).
   Methods: 203 adolescents with T1D, aged 12-18, and their parents completed self-report questionnaires cross-sectionally.
   Results: Higher HbA1c, greater perceived negative consequences of diabetes, and reduced self-efficacy predicted adolescent diabetes distress. Higher HbA1c predicted parental diabetes distress, as did diabetes family responsibility disagreements when both family members claimed responsibility, and parents' perception of reduced adolescent self-efficacy.
   Conclusion: Dietary self-efficacy and perceived negative consequence's of diabetes are important factors to consider in assessing and managing adolescent diabetes distress. Perceptions of family responsibility for self-care tasks and parental confidence in adolescents' self-management have implications for parental diabetes distress. Clinical implications support long-held recommendations of taking a family-perspective of T1D care. (C) 2012 Elsevier Inc. All rights reserved.
C1 [Law, G. Urquhart; Walsh, Jennifer; Queralt, Victoria; Nouwen, Arie] Univ Birmingham, Birmingham B15 2TT, W Midlands, England.
RP Law, GU (reprint author), Univ Birmingham, Sch Psychol, Edgbaston B15 2TT, England.
EM g.u.law@bham.ac.uk
OI Walsh, Jennifer/0000-0002-7122-2650
CR Anderson BJ, 2009, FAM SYST HEALTH, V27, P141, DOI 10.1037/a0015759
   ANDERSON BJ, 1990, J PEDIATR PSYCHOL, V15, P477, DOI 10.1093/jpepsy/15.4.477
   Butler JM, 2009, J FAM PSYCHOL, V23, P611, DOI 10.1037/a0016141
   Butner J, 2009, DEV PSYCHOL, V45, P835, DOI 10.1037/a0015363
   Copp C, 1998, DIABETIC MED, V15, P119
   Cunningham NR, 2011, J PEDIATR PSYCHOL, V36, P196, DOI 10.1093/jpepsy/jsq071
   Dashiff C. J., 2003, J FAMILY NURSING, V9, P166, DOI DOI 10.1177/1074840703009002004
   de Wit M, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-10
   Dekovic M, 1997, J YOUTH ADOLESCENCE, V26, P253, DOI 10.1007/s10964-005-0001-7
   Delamater A, 2012, PEDIAT DIABETES, P1, DOI DOI 10.1111/11399-5448.2012.00894.X
   Eckshtain D, 2010, J PEDIATR PSYCHOL, V35, P426, DOI 10.1093/jpepsy/jsp068
   Edgar KA, 2003, J PEDIATR PSYCHOL, V28, P485, DOI 10.1093/jpepsy/jsg039
   Eiser JR, 2001, PSYCHOL HEALTH, V16, P99, DOI 10.1080/08870440108405492
   Graue M, 2003, ACTA PAEDIATR, V92, P1190, DOI 10.1080/08035250310005657
   Grey M, 1998, DIABETES CARE, V21, P909, DOI 10.2337/diacare.21.6.909
   Guo J, 2011, J ADV NURS, V67, P2294, DOI 10.1111/j.1365-2648.2011.05697.x
   Haugstvedt A, 2011, PEDIATR DIABETES, V12, P107, DOI 10.1111/j.1399-5448.2010.00661.x
   Hislop AL, 2008, DIABETIC MED, V25, P91, DOI 10.1111/j.1464-5491.2007.02310.x
   Iannotti RJ, 2006, J DEV BEHAV PEDIATR, V27, P98, DOI 10.1097/00004703-200604000-00003
   Ivey JB, 2009, J PEDIATR HEALTH CAR, V23, P10, DOI 10.1016/j.pedhc.2007.12.008
   Johnston-Brooks CH, 2002, PSYCHOSOM MED, V64, P43, DOI 10.1097/00006842-200201000-00007
   Law GU, 2002, J ADOLESCENT HEALTH, V31, P381, DOI 10.1016/S1054-139X(02)00397-X
   Leventhal H, 1980, MED PSYCHOL, P7
   Miller VA, 2003, J PEDIATR PSYCHOL, V28, P265, DOI 10.1093/jpepsy/jsg014
   Modi AC, 2012, PEDIATRICS, V129, pE473, DOI 10.1542/peds.2011-1635
   Nouwen A, 2009, PSYCHOL HEALTH, V24, P1071, DOI 10.1080/08870440802254597
   Ott J, 2000, CHILD HEALTH CARE, V29, P47, DOI 10.1207/S15326888CHC2901_4
   Patterson S, 2011, J MENT HEALTH, V20, P328, DOI 10.3109/09638237.2011.556163
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Pomerantz EM, 2001, DEV PSYCHOL, V37, P174, DOI 10.1037//0012-1649.37.2.174
   Schilling Lynne S, 2006, J Pediatr Nurs, V21, P412, DOI 10.1016/j.pedn.2006.01.034
   Senecal C, 2000, HEALTH PSYCHOL, V19, P452, DOI 10.1037//0278-6133.19.5.452
   Silverstein J, 2005, DIABETES CARE, V28, P186, DOI 10.2337/diacare.28.1.186
   Skinner TC, 2000, J PEDIATR PSYCHOL, V25, P257, DOI 10.1093/jpepsy/25.4.257
   Streisand R, 2005, J PEDIATR PSYCHOL, V30, P513, DOI 10.1093/jpepsy/jsi076
   Weissberg-Benchell J, 2011, PEDIATR DIABETES, V12, P341, DOI 10.1111/j.1399-5448.2010.00720.x
   Wiebe DJ, 2005, J PEDIATR PSYCHOL, V30, P167, DOI 10.1093/jpepsy/jsi004
   Williams LB, 2009, DIABETIC MED, V26, P908, DOI 10.1111/j.1464-5491.2009.02794.x
   Wysocki T, 2008, BEHAV THER, V39, P33, DOI 10.1016/j.beth.2007.04.001
NR 39
TC 18
Z9 19
U1 2
U2 44
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0022-3999
J9 J PSYCHOSOM RES
JI J. Psychosomat. Res.
PD APR
PY 2013
VL 74
IS 4
BP 334
EP 339
DI 10.1016/j.jpsychores.2012.12.009
PG 6
WC Psychiatry
SC Psychiatry
GA 112IT
UT WOS:000316586600011
PM 23497836
DA 2019-01-08
ER

PT J
AU Hendricks, M
   Monaghan, M
   Soutor, S
   Chen, RS
   Holmes, CS
AF Hendricks, Melissa
   Monaghan, Maureen
   Soutor, Sari
   Chen, Rusan
   Holmes, Clarissa S.
TI A Profile of Self-Care Behaviors in Emerging Adults With Type 1 Diabetes
SO DIABETES EDUCATOR
LA English
DT Article
ID QUALITY-OF-LIFE; GLYCEMIC CONTROL; YOUNG-ADULTS; PSYCHOLOGICAL
   ADJUSTMENT; TREATMENT ADHERENCE; INSULIN-TREATMENT; HEALTH-STATUS;
   CHILDREN; ADOLESCENTS; PREDICTORS
AB Purpose
   The purpose of this study is to characterize daily diabetes self-care behaviors and to evaluate associations among self-care behaviors, psychosocial adjustment, and glycemic control in an understudied sample of emerging adults with type 1 diabetes.
   Methods
   Forty-nine emerging adults (65% women; ages 18-26 years) completed 2 diabetes interviews to assess self-care behaviors and self-report measures of psychosocial adjustment. Glycemic control was assessed via hemoglobin A1C.
   Results
   Diabetes self-care behaviors varied widely and were largely suboptimal; only a small percentage of participants demonstrated self-care behaviors consistent with national and international recommendations. Psychosocial adjustment was within normal limits and was unrelated to frequency of self-care behaviors in this sample. Mean glycemic control (8.3%) was higher than the recommended A1C level (< 7.0%) for this age group. Use of intensive (eg, multiple daily injections or pump) insulin regimens was related to better glycemic control.
   Conclusions
   The majority of emerging adults in this sample did not engage in optimal daily diabetes self-care. Intensive insulin therapy was associated with better glycemic control without corresponding psychosocial distress. Diabetes care behaviors could be improved in this age group, and emerging adults may benefit from targeted education and behavioral support to enhance diabetes self-management and optimize health outcomes.
C1 [Hendricks, Melissa; Soutor, Sari; Holmes, Clarissa S.] Virginia Commonwealth Univ, Richmond, VA USA.
   [Monaghan, Maureen] Childrens Natl Med Ctr, Washington, DC 20010 USA.
   [Chen, Rusan; Holmes, Clarissa S.] Georgetown Univ, Washington, DC USA.
RP Hendricks, M (reprint author), Kennedy Krieger Inst, Dept Behav Psychol, 707 North Broadway, Baltimore, MD 21205 USA.
EM hendricksm@kennedykrieger.org
FU NIH/NIDDK [5R01DK070917-04]
FX This work was supported by NIH/NIDDK grant 5R01DK070917-04 awarded to
   principal investigator Clarissa S. Holmes.
CR *AM DIAB ASS, 2010, DIABETES CARE S1, V33, pS11, DOI DOI 10.2337/DC10-S011
   *AM DIAB ASS, 2004, DIABETES CARE S1, V27, pS58, DOI DOI 10.2337/DIACARE.27.2007.S58
   Anderson RJ, 2002, INT J PSYCHIAT MED, V32, P235, DOI 10.2190/KLGD-4H8D-4RYL-TWQ8
   [Anonymous], 2002, ALCNOW DISP HEM ALC
   Arnett JJ, 2000, AM PSYCHOL, V55, P469, DOI 10.1037/0003-066X.55.5.469
   Bangstad HJ, 2009, PEDIATR DIABETES, V10, P82, DOI 10.1111/j.1399-5448.2009.00578.x
   Barnard KD, 2007, DIABETIC MED, V24, P607, DOI 10.1111/j.1464-5491.2007.02120.x
   Bryden KS, 2003, DIABETES CARE, V26, P1052, DOI 10.2337/diacare.26.4.1052
   Bryden KS, 2001, DIABETES CARE, V24, P1536, DOI 10.2337/diacare.24.9.1536
   Chisholm V, 2007, J ADV NURS, V57, P482, DOI 10.1111/j.1365-2648.2006.04137.x
   Copeland WE, 2009, ARCH GEN PSYCHIAT, V66, P764, DOI 10.1001/archgenpsychiatry.2009.85
   DCCT Res Grp, 1988, DIABETES CARE, V11, P725
   DCCT Res Grp, 1994, J PEDIATR-US, V125, P177, DOI 10.1016/S0022-3476(94)70190-3
   DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017
   Ebbeling CB, 2007, JAMA-J AM MED ASSOC, V297, P2092, DOI 10.1001/jama.297.19.2092
   Ellis DA, 2005, PEDIATRICS, V116, pE826, DOI 10.1542/peds.2005-0638
   Hendricks MC, 2008, DIABETES, V57, pA524
   Hislop AL, 2008, DIABETIC MED, V25, P91, DOI 10.1111/j.1464-5491.2007.02310.x
   Hollingshead AB, 1975, 4 FACTOR INDEX SOCIA
   Holmes CS, 2006, J PEDIATR PSYCHOL, V31, P770, DOI 10.1093/jpepsy/jsj083
   Ingerski LM, 2010, PEDIATR DIABETES, V11, P563, DOI 10.1111/j.1399-5448.2010.00645.x
   Insabella G, 2007, PEDIATR DIABETES, V8, P228, DOI 10.1111/j.1399-5448.2007.00266.x
   Jacobson A, 1994, HDB PSYCHOL DIABETES, P64
   JACOBSON AM, 1994, DIABETES CARE, V17, P267, DOI 10.2337/diacare.17.4.267
   Jacobson AM, 1997, DIABETES CARE, V20, P811, DOI 10.2337/diacare.20.5.811
   Johns C, 2008, DIABETES EDUCATOR, V34, P874, DOI 10.1177/0145721708322857
   JOHNSON SB, 1986, HEALTH PSYCHOL, V5, P545, DOI 10.1037/0278-6133.5.6.545
   Liese AD, 2006, PEDIATRICS, V118, P1510, DOI 10.1542/peds.2006-0690
   Luyckx K, 2009, DIABETES CARE, V32, P797, DOI 10.2337/dc08-1990
   McNally K, 2010, DIABETES CARE, V33, P1159, DOI 10.2337/dc09-2116
   Northam EA, 2010, DIABETES CARE, V33, P1430, DOI 10.2337/dc09-2232
   Overby NC, 2008, PEDIATR DIABETES, V9, P393, DOI 10.1111/j.1399-5448.2008.00381.x
   Peters A, 2011, DIABETES CARE, V34, P2477, DOI 10.2337/dc11-1723
   Pettiti DB, 2009, J PEDIAT, V155, P668
   Ramchandani N, 2000, DIABETES EDUCATOR, V26, P656, DOI 10.1177/014572170002600413
   Rewers A, 2002, JAMA-J AM MED ASSOC, V287, P2511, DOI 10.1001/jama.287.19.2511
   Rewers M, 2009, PEDIATR DIABETES, V10, P71, DOI 10.1111/j.1399-5448.2009.00582.x
   Rohlfing CL, 2002, DIABETES CARE, V25, P275, DOI 10.2337/diacare.25.2.275
   Smart C, 2009, PEDIATR DIABETES, V10, P100, DOI 10.1111/j.1399-5448.2009.00572.x
   Streisand R, 2002, J PEDIATR PSYCHOL, V27, P759, DOI 10.1093/jpepsy/27.8.759
   Weissberg-Benchell J, 2007, DIABETES CARE, V30, P2441, DOI 10.2337/dc07-1249
   Wu YP, 2010, DIABETES RES CLIN PR, V89, P121, DOI 10.1016/j.diabres.2010.04.010
   WYSOCKI T, 1992, J DEV BEHAV PEDIATR, V13, P194
NR 43
TC 13
Z9 13
U1 0
U2 16
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0145-7217
EI 1554-6063
J9 DIABETES EDUCATOR
JI Diabetes Educ.
PD MAR-APR
PY 2013
VL 39
IS 2
BP 195
EP 203
DI 10.1177/0145721713475840
PG 9
WC Endocrinology & Metabolism; Public, Environmental & Occupational Health
SC Endocrinology & Metabolism; Public, Environmental & Occupational Health
GA 148DJ
UT WOS:000319222800005
PM 23396184
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Xaverius, PK
   Salas, J
AF Xaverius, Pamela K.
   Salas, Joanne
TI Surveillance of Preconception Health Indicators in Behavioral Risk
   Factor Surveillance System: Emerging Trends in the 21st Century
SO JOURNAL OF WOMENS HEALTH
LA English
DT Article
ID PREVENTIVE SERVICES; DIABETES-MELLITUS; CARE; WOMEN; ADULTS; BRFSS
AB Objectives: This article assesses emerging trends in the 21st century, if any, in preconception health indicators among women of reproductive age.
   Methods: This is a secondary analysis of cross-sectional data from the Behavioral Risk Factor Surveillance System (BRFSS), 2003-2010. Subjects were a sample of noninstitutionalized, 18-44-year-old, nonpregnant, women in the United States (n = 547,177) grouped into two categories, 2003-2006 (n = 275,630) and 2007-2010 (n = 271,547). Overall crude and adjusted prevalence odds ratios were calculated for preconception indicators before 2006 and after 2006.
   Results: Significant improvements were found for any and heavy alcohol use, smoking, social and emotional support, moderate/vigorous physical activity, and having had an influenza shot in the last year. In contrast, binge drinking, having a medical condition (i.e., diabetes, high blood pressure, asthma, or obesity), and self-reported health significantly worsened. No change was found for mental distress, HIV testing, and having a routine checkup.
   Conclusions: As the 21st century unfolds, emerging trends suggest that we need to focus on educating women, providers, and public health advocates about improved health before pregnancy, especially for women with chronic conditions and those who binge drink alcohol.
C1 [Xaverius, Pamela K.] St Louis Univ, Sch Publ Hlth, St Louis, MO 63104 USA.
   [Salas, Joanne] St Louis Univ, Sch Med, St Louis, MO 63104 USA.
RP Xaverius, PK (reprint author), St Louis Univ, Sch Publ Hlth, 3545 Lafayette,Room 474, St Louis, MO 63104 USA.
EM Pxaverius@slu.edu
OI Xaverius, Pamela/0000-0001-8824-2933
CR Ahluwalia IB, 2005, J WOMENS HEALTH, V14, P382, DOI 10.1089/jwh.2005.14.382
   *AM AC PED AM COLL, 2002, GUID PER CAR
   American College of Obstetricians and Gynecologists. Preconception Care Work Group, 2005, J OBSTET GYNECOL, V106, P665
   Atrash H, 2008, CURR OPIN OBSTET GYN, V20, P581, DOI 10.1097/GCO.0b013e328317a27c
   BLOOMBERG L, 1994, HEALTH EDUC QUART, V21, P447, DOI 10.1177/109019819402100407
   Centers for Disease Control and Prevention, 1993, MMWR-MORBID MORTAL W, V44, P219
   Centers for Disease Control and Prevention, 2007, BEH RISK FACT SURV S
   Council of State and Territorial Epidemiologists (CSTE), 2009, COR STAT PREC HLTH H
   Curtis M, 2006, MATERN CHILD HLTH J, V10, P553
   de Weerd S, 2002, OBSTET GYNECOL, V99, P45, DOI 10.1016/S0029-7844(01)01573-3
   Ettner SL, 1996, AM J PUBLIC HEALTH, V86, P1748, DOI 10.2105/AJPH.86.12.1748
   Guide to community preventive services, 2012, PROM PHYS ACT BEH SO
   Hayes D. K., 2011, PREV CHRONIC DIS, V8, P1
   Institute of Medicine Committee to Study the Prevention of Low Birth-weight (US), 1985, PREV LOW BIRTHW
   Jack B, 2008, WOMENS HLTH ISSUES S, V18S, pS18
   Johnson Kay, 2006, Morbidity and Mortality Weekly Report, V55, P1
   Kent H, 2008, J WOMENS HLTH ISS S6, V18, P567
   Kieffer EC, 2006, DIABETES CARE, V29, P1788, DOI 10.2337/dc06-0199
   LeBlanc ES, 2011, ANN INTERN MED, V155, P434, DOI 10.7326/0003-4819-155-7-201110040-00006
   Moos MK, 2010, J WOMENS HEALTH, V19, P561, DOI 10.1089/jwh.2009.1411
   Nelson DE, 2001, SOZ PRAVENTIV MED, V46, pS3
   O'Connor EA, 2009, ANN INTERN MED, V151, P793, DOI 10.7326/0003-4819-151-11-200912010-00007
   Pignone MP, 2001, AHRQ PUBLICATION
   Ranji UR, 2011, WOMENS HLTH CARE CHA
   Ray JG, 2001, QJM-INT J MED, V94, P435, DOI 10.1093/qjmed/94.8.435
   Strine TW, 2004, CHEST, V126, P1849, DOI 10.1378/chest.126.6.1849
   *TASK FORC COMM PR, 2002, AM J PREV MED, V22, P67, DOI DOI 10.1016/S0749-3797(02)00433-6
   Thompson BK, 2008, J WOMENS HEALTH, V17, P723, DOI 10.1089/jwh.2008.0870
   U.S. Department of Health Education and Welfare (PHS) HAS/BCHS, 1979, PRIM CAR EFF APPR CL
   *US DEP HHS, 1991, HLTH PEOPL 2000 NAT
   US Department of Health and Human Services, HLTH PEOPL 2020
   *US PREV SERV TASK, 2004, ANN INTERN MED, V140, P555
NR 32
TC 13
Z9 14
U1 0
U2 17
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1540-9996
J9 J WOMENS HEALTH
JI J. Womens Health
PD MAR
PY 2013
VL 22
IS 3
BP 203
EP 209
DI 10.1089/jwh.2012.3804
PG 7
WC Public, Environmental & Occupational Health; Medicine, General &
   Internal; Obstetrics & Gynecology; Women's Studies
SC Public, Environmental & Occupational Health; General & Internal
   Medicine; Obstetrics & Gynecology; Women's Studies
GA 105IU
UT WOS:000316061700126
PM 23428283
DA 2019-01-08
ER

PT J
AU Munshi, MN
   Segal, AR
   Suhl, E
   Ryan, C
   Sternthal, A
   Giusti, J
   Lee, Y
   Fitzgerald, S
   Staum, E
   Bonsignor, P
   DesRochers, L
   McCartney, R
   Weinger, K
AF Munshi, Medha N.
   Segal, Alissa R.
   Suhl, Emmy
   Ryan, Courtney
   Sternthal, Adrianne
   Giusti, Judy
   Lee, Yishan
   Fitzgerald, Shane
   Staum, Elizabeth
   Bonsignor, Patricia
   DesRochers, Laura
   McCartney, Richard
   Weinger, Katie
TI Assessment of Barriers to Improve Diabetes Management in Older Adults A
   randomized controlled study
SO DIABETES CARE
LA English
DT Article
ID DYSFUNCTION; MELLITUS; VALIDITY
AB OBJECTIVE-To evaluate whether assessment of barriers to self-care and strategies to cope with these barriers in older adults with diabetes is superior to usual care with attention control. The American Diabetes Association guidelines recommend the assessment of age-specific barriers. However, the effect of such strategy on outcomes is unknown.
   RESEARCH DESIGN AND METHODS-We randomized 100 subjects aged >= 69 years with poorly controlled diabetes (A1C >8%) in two groups. A geriatric diabetes team assessed barriers and developed strategies to help patients cope with barriers for an intervention group. The control group received equal amounts of attention time. The active intervention was performed for the first 6 months, followed by a "no-contact" period. Outcome measures included A1C, Tinetti test, 6-min walk test (6MWT), self-care frequency, and diabetes-related distress.
   RESULTS-We assessed 100 patients (age 75 +/- 5 years, duration 21 +/- 13 years, 68% type 2 diabetes, 89% on insulin) over 12 months. After the active period, A1C decreased by -0.45% in the intervention group vs. -0.31% in the control group. At 12 months, A1C decreased further in the intervention group by -0.21% vs. 0% in control group (linear mixed-model, P < 0.03). The intervention group showed additional benefits in scores on measures of self-care (Self-Care Inventory-R), gait and balance (Tinetti), and endurance (6MWT) compared with the control group. Diabetes-related distress improved in both groups.
   CONCLUSIONS-Only attention between clinic visits lowers diabetes-related distress in older adults. However, communication with an educator cognizant of patients' barriers improves glycemic control and self-care frequency, maintains functionality, and lowers distress in this population. Diabetes Care 36:543-549, 2013
C1 [Munshi, Medha N.; Segal, Alissa R.; Suhl, Emmy; Ryan, Courtney; Sternthal, Adrianne; Giusti, Judy; Lee, Yishan; Fitzgerald, Shane; Staum, Elizabeth; Bonsignor, Patricia; DesRochers, Laura; McCartney, Richard; Weinger, Katie] Joslin Diabet Ctr, Boston, MA 02215 USA.
   [Munshi, Medha N.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.
   [Munshi, Medha N.; Weinger, Katie] Harvard Univ, Sch Med, Boston, MA USA.
   [Segal, Alissa R.] Massachusetts Coll Pharm Hlth Sci, Boston, MA USA.
RP Munshi, MN (reprint author), Joslin Diabet Ctr, Boston, MA 02215 USA.
EM mmunshi@bidmc.harvard.edu
FU American Diabetes Association [1-07-CR-40]; U.S. Department of Defense
   Peer Reviewed Medical Research Program of the Office of the
   Congressionally Directed Medical Research Programs [W81XWH-07-1-0282];
   sanofi-aventis
FX The study was partly supported by a grant from a clinical research award
   from the American Diabetes Association, 1-07-CR-40 (M.N.M.), and partly
   from the U.S. Department of Defense Peer Reviewed Medical Research
   Program of the Office of the Congressionally Directed Medical Research
   Programs, W81XWH-07-1-0282 (M.N.M.).; M.N.M. received research funding
   from sanofi-aventis. No other potential conflicts of interest relevant
   to this article were reported.
CR Abrahams S, 2000, NEUROPSYCHOLOGIA, V38, P734, DOI 10.1016/S0028-3932(99)00146-3
   Anker SD, 2011, LANCET, V378, P731, DOI 10.1016/S0140-6736(11)61229-4
   [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc35-S011]
   Araki A, 2009, GERIATR GERONTOL INT, V9, P105, DOI 10.1111/j.1447-0594.2008.00495.x
   Bautmans Ivan, 2004, BMC Geriatr, V4, P6, DOI 10.1186/1471-2318-4-6
   Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278
   Drane DL, 2002, NEUROPSY NEUROPSY BE, V15, P39
   FILLENBAUM GG, 1981, J GERONTOL, V36, P428, DOI 10.1093/geronj/36.4.428
   Gregg EW, 2000, DIABETES CARE, V23, P1272, DOI 10.2337/diacare.23.9.1272
   Huang ES, 2005, J AM GERIATR SOC, V53, P306, DOI 10.1111/j.1532-5415.2005.53119.x
   Huang ES, 2009, AGING HLTH, V5, P207
   Ickowicz E, 2003, J AM GERIATR SOC, V51, pS265
   KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016
   LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179
   Montorio I, 1996, Int Psychogeriatr, V8, P103, DOI 10.1017/S1041610296002505
   Munshi M, 2006, DIABETES CARE, V29, P1794, DOI 10.2337/dc06-0506
   National Diabetes fact sheet, 2011, NAT DIAB FACT SHEET
   Nishiwaki Y, 2004, AM J EPIDEMIOL, V160, P797, DOI 10.1093/aje/kwh288
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   POSNER BM, 1993, AM J PUBLIC HEALTH, V83, P972, DOI 10.2105/AJPH.83.7.972
   Shea S, 2009, J AM MED INFORM ASSN, V16, P446, DOI 10.1197/jamia.M3157
   TINETTI ME, 1986, J AM GERIATR SOC, V34, P119, DOI 10.1111/j.1532-5415.1986.tb05480.x
   Weinger K, 2005, DIABETES CARE, V28, P1346, DOI 10.2337/diacare.28.6.1346
NR 23
TC 21
Z9 21
U1 0
U2 22
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
EI 1935-5548
J9 DIABETES CARE
JI Diabetes Care
PD MAR
PY 2013
VL 36
IS 3
BP 543
EP 549
DI 10.2337/dc12-1303
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 103OU
UT WOS:000315928700018
PM 23193208
OA Other Gold, Green Published
DA 2019-01-08
ER

PT J
AU Choi, SE
   Reed, PL
AF Choi, Sarah E.
   Reed, Preston L.
TI Contributors to Depressive Symptoms Among Korean Immigrants With Type 2
   Diabetes
SO NURSING RESEARCH
LA English
DT Article
DE depressive symptoms; gender differences; Korean immigrants;
   quality-of-life; type 2 diabetes
ID QUALITY-OF-LIFE; PSYCHOSOCIAL FACTORS; CHINESE PATIENTS; PREVALENCE;
   HEALTH; ADULTS; ASSOCIATION; ADHERENCE; AMERICANS; DISTRESS
AB Background: Patients with diabetes have a higher prevalence of depression than the general population. Korean immigrants with type 2 diabetes are understudied.
   Objectives: The aim of this study was to identify the prevalence and correlates of depressive symptoms in Korean immigrants.
   Methods: In this cross-sectional descriptive study, a community sample of 164 Korean immigrant adults with type 2 diabetes were assessed for depressive symptoms using the Center for Epidemiological Studies Depression scale. Predictors of depression were grouped into three categories: demographic (age, gender, education, English proficiency), clinical (duration of diabetes, comorbidities, insulin use), and psychosocial (general health, diabetes-related quality of life [QOL], family support).
   Results: Approximately 56% of participants had Center for Epidemiological Studies Depression Scale scores of >= 16. Higher levels of depression were associated with greater impact of diabetes on QOL (b = 5.68, p = .001), worse overall health (b = -0.09, p = .012), and less family support (b = 4.02, p = .042). The relationship between depression and diabetes impact on QOL was stronger for men than women (b = 6.67, p = .020).
   Discussion: Depressive symptoms are common among Korean immigrants with type 2 diabetes. Assessing diabetes-related QOL, general health, and family support may be of value in better understanding depressive symptoms among this population. Among Korean immigrant men with type 2 diabetes, specific attention should be paid to diabetes-related QOL.
C1 [Choi, Sarah E.] Univ Calif Irvine, Program Nursing Sci, Coll Hlth Sci, Irvine, CA 92697 USA.
   [Reed, Preston L.] Univ Calif Irvine, Dept Psychol & Social Behav, Irvine, CA 92697 USA.
RP Choi, SE (reprint author), Univ Calif Irvine, Program Nursing Sci, Coll Hlth Sci, 100B Berk Hall, Irvine, CA 92697 USA.
EM sechoi@uci.edu
FU National Center for Research Resources; National Center for Advancing
   Translational Sciences at the National Institutes of Health [UL1
   TR000153, KL2 TR000147]
FX This study was supported by a grant from the National Center for
   Research Resources and by the National Center for Advancing
   Translational Sciences at the National Institutes of Health through
   Grants UL1 TR000153 and KL2 TR000147 (Dr. Choi).
CR Ali S, 2010, DIABETES-METAB RES, V26, P75, DOI 10.1002/dmrr.1065
   Anderson RJ, 2000, DIABETES, V49, pA64
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Barnes P.M., 2008, ADV DATA, V394, P1
   Black SA, 2003, DIABETES CARE, V26, P2822, DOI 10.2337/diacare.26.10.2822
   BRISLIN RW, 1970, J CROSS CULT PSYCHOL, V1, P185, DOI 10.1177/135910457000100301
   Center for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET
   Cheng AY, 1999, DIABETES CARE, V22, P1216, DOI 10.2337/diacare.22.7.1216
   Choi S, 2008, DIABETES EDUCATOR, V34, P484, DOI 10.1177/0145721708316949
   Choi SE, 2011, J IMMIGR MINOR HEALT, V13, P803, DOI 10.1007/s10903-010-9397-6
   Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278
   Clark J. L. D., 1988, STUDIES 2 LANGUAGE A, V10, P129, DOI [10.1017/S0272263100007270, DOI 10.1017/S0272263100007270]
   DCCT Res Grp, 1988, DIABETES CARE, V11, P725
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2001, DIABETES CARE, V24, P1751, DOI 10.2337/diacare.24.10.1751
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   GLASGOW RE, 1988, DIABETES CARE, V11, P377, DOI 10.2337/diacare.11.5.377
   Gonzalez JS, 2007, DIABETES CARE, V30, P2222, DOI 10.2337/dc07-0158
   HURH WM, 1990, J NERV MENT DIS, V178, P703, DOI 10.1097/00005053-199011000-00006
   Katon W, 2004, DIABETES CARE, V27, P914, DOI 10.2337/diacare.27.4.914
   Kim MT, 2009, DIABETES EDUCATOR, V35, P986, DOI 10.1177/0145721709345774
   KUO WH, 1984, J NERV MENT DIS, V172, P449, DOI 10.1097/00005053-198408000-00002
   Lange LJ, 2005, J PSYCHOSOM RES, V58, P129, DOI 10.1016/j.jpsychores.2004.08.004
   Li CY, 2009, DIABETES RES CLIN PR, V83, P268, DOI 10.1016/j.diabres.2008.11.006
   Misra R, 2009, J DIABETES COMPLICAT, V23, P54, DOI 10.1016/j.jdiacomp.2007.11.003
   Nichols GA, 2003, DIABETES CARE, V26, P744, DOI 10.2337/diacare.26.3.744
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Shin HS, 2007, INT J NURS STUD, V44, P415, DOI 10.1016/j.ijnurstu.2006.04.007
   WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002
   Zhang CX, 2008, DIABETES RES CLIN PR, V79, P523, DOI 10.1016/j.diabres.2007.10.014
   Zhao W, 2006, PUBLIC HEALTH, V120, P696, DOI 10.1016/j.puhe.2006.04.012
NR 31
TC 2
Z9 2
U1 0
U2 10
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0029-6562
EI 1538-9847
J9 NURS RES
JI Nurs. Res.
PD MAR-APR
PY 2013
VL 62
IS 2
BP 115
EP 121
DI 10.1097/NNR.0b013e31827aec29
PG 7
WC Nursing
SC Nursing
GA 103WX
UT WOS:000315951300344
PM 23190692
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Aikens, JE
   Piette, JD
AF Aikens, J. E.
   Piette, J. D.
TI Longitudinal association between medication adherence and glycaemic
   control in Type2 diabetes
SO DIABETIC MEDICINE
LA English
DT Article
ID GLUCOSE CONTROL; CARE; OUTCOMES; HEALTH; DEPRESSION; CONCURRENT;
   METFORMIN; VALIDITY; PROGRAM; A1C
AB Aim Despite the widespread assumption that adherence drives glycaemic control, there is little published support for this in Type2 diabetes. The study objective was to determine whether self-reported medication adherence predicts future glycaemic control in Type2 diabetes, after accounting for baseline control. Methods Medication adherence (4-item Morisky scale), glycaemic control (HbA1c%), and other variables were assessed in 287 adult primary care patients prescribed oral medication (40% also on insulin) for Type2 diabetes. Glycaemic control was reassessed 6months later. Regression analyses examined concurrent and future glycaemic control as a function of baseline medication adherence after adjustment for baseline glycaemia and other potential confounders. Results Only half of patients reported high adherence. Cross-sectional adjusted analysis replicated prior reports of an adherence-HbA1c association (P=0.011). Even after adjusting for baseline HbA1c, each one-point increase in baseline Morisky total score was associated with a 1.8mmol/mol (or 0.16%) increase in HbA1c measured 6months later. Additionally, baseline endorsement of forgetting to take medication was associated with a 4.7mmol/mol (or 0.43%) increase in 6-month HbA1c (P=0.005). This effect persisted after adjusting for psychological distress and did not vary by key demographic and medical features. Conclusions Even after stringent adjustment for baseline glycaemic control, self-reported adherence to diabetes medication predicts long-term glycaemic control. The Morisky scale is an easy-to-use clinical tool to identify patients whose glycaemic control will subsequently worsen, regardless of age, gender and psychological distress.
C1 [Aikens, J. E.] Univ Michigan, Dept Family Med, Ann Arbor, MI 48109 USA.
   [Piette, J. D.] Univ Michigan, Dept Internal Med, Ann Arbor VA Ctr Clin Management Res, Ann Arbor, MI 48109 USA.
RP Aikens, JE (reprint author), Univ Michigan, Dept Family Med, Ann Arbor, MI 48109 USA.
EM aikensj@umich.edu
FU National Institute of Diabetes and Digestive and Kidney Diseases
   (NIDDK), National Institutes of Health (NIH) [R01 DK066016, P60DK020572]
FX This research was supported by National Institutes of Health (NIH) grant
   numbers R01 DK066016 and P60DK020572 (MDRTC), both from the National
   Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). JDP is
   a VA Senior Research Career Scientist.
CR Adams AS, 2008, DIABETES CARE, V31, P916, DOI 10.2337/dc07-1924
   Aikens J, 2012, DIABETES CARE
   Aikens JE, 2008, DIABETIC MED, V25, P1324, DOI 10.1111/j.1464-5491.2008.02590.x
   Aikens JE, 2009, DIABETES CARE, V32, P1177, DOI 10.2337/dc09-0071
   Aikens JE, 2005, ANN FAM MED, V3, P23, DOI 10.1370/afm.238
   Asche C, 2011, CLIN THER, V33, P74, DOI 10.1016/j.clinthera.2011.01.019
   Blonde L, 2003, DIABETES OBES METAB, V5, P424, DOI 10.1046/j.1463-1326.2003.00297.x
   Bosworth HB, 2011, AM HEART J, V162, P412, DOI 10.1016/j.ahj.2011.06.007
   Cass AR, 1999, INT J PSYCHIAT MED, V29, P293, DOI 10.2190/CPYJ-2HBF-RGCN-64V2
   Cramer JA, 2004, DIABETES CARE, V27, P1218, DOI 10.2337/diacare.27.5.1218
   Donnelly LA, 2007, QJM-INT J MED, V100, P345, DOI 10.1093/qjmed/hcm031
   Fitzgerald JT, 1996, EVAL HEALTH PROF, V19, P208, DOI 10.1177/016327879601900205
   Garber MC, 2004, MED CARE, V42, P649, DOI 10.1097/01.mlr.0000129496.05898.02
   George J, 2007, BRIT J CLIN PHARMACO, V63, P488, DOI 10.1111/j.1365-2125.2006.02800.x
   Granger BB, 2011, CURR OPIN CARDIOL, V26, P279, DOI 10.1097/HCO.0b013e328347c150
   Guillausseau PJ, 2003, DIABETES METAB, V29, P79, DOI 10.1016/S1262-3636(07)70011-3
   Heisler M, 2007, ARCH INTERN MED, V167, P1853, DOI 10.1001/archinte.167.17.1853
   Horswell RL, 2008, J HEALTH CARE POOR U, V19, P677, DOI 10.1353/hpu.0.0062
   Kindmalm L, 2007, ACTA DIABETOL, V44, P209, DOI 10.1007/s00592-007-0006-7
   Krapek K, 2004, ANN PHARMACOTHER, V38, P1357, DOI 10.1345/aph.1D612
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Krousel-Wood M, 2009, AM J MANAG CARE, V15, P59
   Lawrence DB, 2006, J MANAGE CARE PHARM, V12, P466
   MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007
   Parchman ML, 2007, DIABETES CARE, V30, P2849, DOI 10.2337/dc06-2516
   Piette JD, 2001, DIABETES CARE, V24, P202, DOI 10.2337/diacare.24.2.202
   Piette JD, 2004, MED CARE, V42, P102, DOI 10.1097/01.mlr.0000108742.26446.17
   Pladevall M, 2004, DIABETES CARE, V27, P2800, DOI 10.2337/diacare.27.12.2800
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Possidente CJ, 2005, AM J HEALTH-SYST PH, V62, P1311
   Rhee MK, 2005, DIABETES EDUCATOR, V31, P240, DOI 10.1177/0145721705274927
   Rozenfeld Y, 2008, AM J MANAG CARE, V14, P71
   Saini SD, 2009, AM J MANAG CARE, V15, pE22
   2002, FED REG, V67, P6931
NR 34
TC 47
Z9 49
U1 0
U2 21
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
J9 DIABETIC MED
JI Diabetic Med.
PD MAR
PY 2013
VL 30
IS 3
BP 338
EP 344
DI 10.1111/dme.12046
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 095MT
UT WOS:000315339300020
PM 23075262
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Peyrot, M
   Burns, KK
   Davies, M
   Forbes, A
   Hermanns, N
   Holt, R
   Kalra, S
   Nicolucci, A
   Pouwer, F
   Wens, J
   Willaing, I
   Skovlund, SE
AF Peyrot, Mark
   Burns, Katharina Kovacs
   Davies, Melanie
   Forbes, Angus
   Hermanns, Norbert
   Holt, Richard
   Kalra, Sanjay
   Nicolucci, Antonio
   Pouwer, Frans
   Wens, Johan
   Willaing, Ingrid
   Skovlund, Soren E.
CA Global DAWN2 Study Grp
TI Diabetes Attitudes Wishes and Needs 2 (DAWN2): A multinational,
   multi-stakeholder study of psychosocial issues in diabetes and
   person-centred diabetes care
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE People with diabetes; Family members; Healthcare providers; Survey;
   Person-centred care; Psychosocial; Self-management
ID SELF-MANAGEMENT EDUCATION; PATIENT ASSESSMENT; VALIDATION; HEALTH; SCALE
AB Aims: The Diabetes Attitudes Wishes and Needs 2 (DAWN2) study aims to provide a holistic assessment of diabetes care and management among people with diabetes (PWD), family members (FM), and healthcare professionals (HCPs) and explores potential drivers leading to active management.
   Methods: DAWN2 survey over 16,000 individuals (similar to 9000 PWD, similar to 2000 FM of PWD, and similar to 5000 HCPs) in 17 countries across 4 continents. Respondents complete a group-specific questionnaire; items are designed to allow cross-group comparisons on common topics. The questionnaires comprise elements from the original DAWN study (2001), as well as psychometrically validated instruments and novel questions developed for this study to assess self-management, attitudes/beliefs, disease impact/burden, psychosocial distress, health-related quality of life, healthcare provision/receipt, social support and priorities for improvement in the future. The questionnaires are completed predominantly online or by telephone interview, supplemented by face-to-face interviews in countries with low internet access. In each country, recruitment ensures representation of the diabetes population in terms of geographical distribution, age, gender, education and disease status.
   Discussion: DAWN2 aims to build on the original DAWN study to identify new avenues for improving diabetes care. This paper describes the study rationale, goals and methodology. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
C1 [Peyrot, Mark] Loyola Univ Maryland, Dept Sociol, Baltimore, MD 21210 USA.
   [Burns, Katharina Kovacs] Univ Alberta, Edmonton Clin Hlth Acad, Interdisciplinary Hlth Res Acad, Edmonton, AB, Canada.
   [Davies, Melanie] Univ Leicester, Dept Cardiovasc Sci, Leicester LE1 5WW, Leics, England.
   [Forbes, Angus] Kings Coll London, Florence Nightingale Sch Nursing & Midwifery, Dept Primary & Intermediate Care, London WC2R 2LS, England.
   [Hermanns, Norbert] Diabet Acad Mergentheim FIDAM, Res Inst, Bad Mergentheim, Germany.
   [Holt, Richard] Univ Southampton, Fac Med, Human Dev & Hlth Acad Unit, Southampton SO9 5NH, Hants, England.
   [Kalra, Sanjay] Bharti Hosp, Karnal 132001, Haryana, India.
   [Kalra, Sanjay] BRIDE, Karnal 132001, Haryana, India.
   [Nicolucci, Antonio] Consorzio Mario Negri Sud, Dept Clin Pharmacol & Epidemiol, Chieti, Italy.
   [Pouwer, Frans] Tilburg Univ, Dept Med & Clin Psychol, NL-5000 LE Tilburg, Netherlands.
   [Wens, Johan] Univ Antwerp, Dept Med & Hlth Sci, Primary & Interdisciplinary Care Antwerp, B-2020 Antwerp, Belgium.
   [Willaing, Ingrid] Steno Diabet Ctr, Steno Hlth Promot Ctr, DK-2820 Gentofte, Denmark.
   [Skovlund, Soren E.] Novo Nordisk AS, Patient Res Advocacy & Support, Copenhagen, Denmark.
RP Peyrot, M (reprint author), Loyola Univ Maryland, Dept Sociol, 4501 North Charles St, Baltimore, MD 21210 USA.
EM mpeyrot@loyola.edu
RI Wens, Johan/K-2705-2013
OI Wens, Johan/0000-0002-0229-9064; Willaing, Ingrid/0000-0002-3082-8816;
   Davies, Melanie/0000-0002-9987-9371; Holt, Richard/0000-0001-8911-6744;
   Forbes, Angus/0000-0003-3331-755X
FU Novartis; Novo Nordisk; Sanofi-Aventis; Lilly; Pfizer; Merck Sharp and
   Dohme; GlaxoSmithKline; Servier; Roche; Berlin Chemie; Eli Lilly;
   Bristol Myers Squibb-Astra Zeneca; Bayer; Amylin; Genentech; MannKind;
   Medtronic; Novo Nordisk A/S; National Institute for Health Research
   [RP-PG-0606-1272, RP-DG-1210-10183]
FX Melanie Davies has acted as consultant, advisory board member and
   speaker for Novartis, Novo Nordisk, SanofiAventis, Lilly, Merck Sharp
   and Dohme, and Roche, and as a speaker for Servier. She has received
   grants in support of investigator and investigator-initiated trials from
   Novartis, Novo Nordisk, Sanofi-Aventis, Lilly, Pfizer, Merck Sharp and
   Dohme, GlaxoSmithKline and Servier.; Norbert Hermanns is a member of the
   International DAWN2 Advisory Board. He has received research grants in
   the last year from Roche, Berlin Chemie, Eli Lilly and Sanofi Aventis.
   He also received speaking honoraria from Novo, Germany, Lilly, Berlin
   Chemie, Lifescan, Sanofi Aventis and Menarini Diagnostics.; Antonio
   Nicolucci has received research grants in the last year from Novo
   Nordisk, Eli Lilly, Sanofi Aventis, Merck Sharp and Dohme, Bristol Myers
   Squibb-Astra Zeneca and Bayer.; Mark Peyrot has recently received
   research grants and/ or consulting fees from Amylin, Genentech, Lilly,
   MannKind, Medtronic, and Novo Nordisk. He has received speaking
   honoraria from Novo Nordisk and has participated in advisory panels for
   Novo Nordisk and Roche. He has received financial support from Novo
   Nordisk for his participation as Principal Investigator for the DAWN2
   study.; The DAWN2 study is funded by Novo Nordisk A/S. Editorial
   assistance in the preparation of this manuscript, which was funded by
   Novo Nordisk A/S was provided by Dr. Mark Warren of Bioscript Stirling
   Ltd. The surveys were conducted by Harris Interactive Inc., an
   independent research organisation. The authors wish to acknowledge Anna
   Ginovker of Harris Interactive for directing the global fieldwork and
   Bioscript Stirling Ltd. for providing assistance with obtaining ethical
   approvals in several countries. Harris Interactive conducted the
   surveys, and provided expertise in designing the questionnaires and
   planning survey implementation, including sampling frames and
   strategies, questionnaire administration strategies, weighting criteria,
   etc.
CR American Diabetes Association, 2011, DIABETES CARE S1, V34
   Anderson R, 2000, NAT HIST, V109, P23
   Anderson RM, 2003, DIABETES CARE, V26, P1641, DOI 10.2337/diacare.26.5.1641-a
   [Anonymous], 2008, DIABETES EDUCATOR, V34, P451, DOI 10.1177/0145721708316627
   [Anonymous], 2011, QUAL STAND DIAB AD
   [Anonymous], 2011, CLIN GUID 87 TYP 2 D
   [Anonymous], 2011, IDF CHART RIGHTS RES
   [Anonymous], 2004, PRACT DIABETES INT, V21, P201
   [Anonymous], 2008, CLIN GUID 66 TYP 2 D
   [Anonymous], 2007, INT COD MARK SOC RES
   [Anonymous], 2011, COD STAND ETH SURV R
   Bech P, 1996, PSYCHOTHER PSYCHOSOM, V65, P183, DOI 10.1159/000289073
   Drab S, 2009, J AM PHARM ASSOC, V49, pE152, DOI 10.1331/JAPhA.2009.08181
   Funnell MM, 2007, DIABETES EDUCATOR, V33, P45, DOI 10.1177/0145721706298308
   Funnell MM, 2011, DIABETES CARE, V34, pS89, DOI 10.2337/dc11-S089
   Glasgow RE, 2005, DIABETES CARE, V28, P2655, DOI 10.2337/diacare.28.11.2655
   Glasgow RE, 2005, MED CARE, V43, P436, DOI 10.1097/01.mlr.0000160375.47920.8c
   Harkness E, 2010, DIABETES CARE, V33, P926, DOI 10.2337/dc09-1519
   Harper A, 1998, PSYCHOL MED, V28, P551
   International Diabetes Federation, 2004, DIABETES VOICE, V49, P1
   International Diabetes Federation Clinical Guidelines Task Force. Psychological care, 2005, PENT PROC EXTR ED DA, P19
   International Society for Pharmacoepidemiology, 2007, GUID GOOD PHARM PRAC
   Knottnerus JA, 2012, J CLIN EPIDEMIOL, V65, P581, DOI 10.1016/j.jclinepi.2012.03.007
   McGuire BE, 2010, DIABETOLOGIA, V53, P66, DOI 10.1007/s00125-009-1559-5
   National Collaborating Centre for Chronic Conditions, 2004, TYPE 1 DIAB AD NAT C
   National Collaborating Centre for Chronic Conditions (UK), 2008, TYP 2 DIAB NAT CLIN
   Parkin T, 2003, DIABETIC MED, V20, P909, DOI 10.1046/j.1464-5491.2003.01056.x
   Petrak F, 2005, CURR DIABETES REV, V1, P255, DOI 10.2174/157339905774574329
   Peyrot M, 2005, DIABETES CARE, V28, P2673, DOI 10.2337/diacare.28.11.2673
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   SCHAFER LC, 1986, DIABETES CARE, V9, P179, DOI 10.2337/diacare.9.2.179
   Skovlund S. E., 2005, DIABETES SPECTRUM, V18, P136, DOI DOI 10.2337/DIASPECT.18.3.136
   Szende A, 2007, EUROQOL GROUP MONOGR
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Uplinger N, 2009, DIABETES EDUCATOR, V35, P713, DOI 10.1177/0145721709340804
   Welch G, 2003, DIABETIC MED, V20, P69, DOI 10.1046/j.1464-5491.2003.00832.x
   Westberg SM, 2010, AM J PHARM EDUC, V74, DOI 10.5688/aj740349
   World Health Organization (WHO), 2002, INN CAR CHRON COND B
NR 39
TC 96
Z9 104
U1 0
U2 22
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
EI 1872-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD FEB
PY 2013
VL 99
IS 2
BP 174
EP 184
DI 10.1016/j.diabres.2012.11.016
PG 11
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 119UC
UT WOS:000317122400019
PM 23273515
OA Other Gold
DA 2019-01-08
ER

PT J
AU Gagliardino, JJ
   Arrechea, V
   Assad, D
   Gagliardino, GG
   Gonzalez, L
   Lucero, S
   Rizzuti, L
   Zufriategui, Z
   Clark, C
AF Jose Gagliardino, Juan
   Arrechea, Viviana
   Assad, Daniel
   Gagliardino, Gabriel G.
   Gonzalez, Lorena
   Lucero, Soledad
   Rizzuti, Liliana
   Zufriategui, Zulma
   Clark, Charles, Jr.
TI Type 2 diabetes patients educated by other patients perform at least as
   well as patients trained by professionals
SO DIABETES-METABOLISM RESEARCH AND REVIEWS
LA English
DT Article
DE peer support; diabetes education; type 2 diabetes management; quality of
   care; patient satisfaction; psychological impact
ID RANDOMIZED CONTROLLED-TRIAL; SELF-MANAGEMENT EDUCATION;
   ECONOMIC-ANALYSIS; GLUCOSE CONTROL; PEER SUPPORT; PROGRAM; CARE; ADULTS;
   INTERVENTIONS; DISTRESS
AB Background Diabetes education can improve the quality of care of people with diabetes, but many organizations are not equipped to manage its implementation. Involving people with diabetes in the education process can overcome the problem. Thus, we compared clinical, metabolic and psychological outcomes in people with type 2 diabetes 1year after attending a structured diabetes education programme implemented by professional educators versus the same programme implemented by trained peers with diabetes that also provided ongoing peer support. Methods People with type 2 diabetes (2575years) were randomly assigned to attend a 4-week structured diabetes education course delivered by professional educators (control) or previously trained peers (peer). Peers also received continuing psychological support, including examples on how to apply diabetes knowledge in daily life via weekly peer cellular phone calls and bimonthly face-to-face interviews in small groups (ten patients), using a structured questionnaire related to the patient's clinical, metabolic and psychological progress. Identical outcome data from both groups were used for follow-up. Results Both groups had a comparable positive effect on clinical, metabolic and psychological indicators immediately following the programme. Over the following year, peer-educated subjects had lower A1C and systolic blood pressure and showed higher adherence to physical activity and better control of hypoglycaemic episodes. Conclusion The non-inferiority of the peer outcomes and the mentioned improvements in this group suggest that volunteer trained peer educators and ongoing support can be successful. This approach provides an effective alternative method of education, especially in areas with limited availability of professionals and economic resources. Copyright (c) 2012 John Wiley & Sons, Ltd.
C1 [Jose Gagliardino, Juan; Gonzalez, Lorena; Clark, Charles, Jr.] UNLP, CENEXA Ctr Endocrinol Expt & Aplicada UNLPCONICET, Ctr Colaborador OPS OMS Diabet, Fac Ciencias Med, RA-1900 La Plata, Argentina.
   [Arrechea, Viviana; Assad, Daniel; Gagliardino, Gabriel G.; Lucero, Soledad; Rizzuti, Liliana; Zufriategui, Zulma] Ctr Educ Terapeut Bernardo A Houssay, La Plata, Argentina.
RP Gagliardino, JJ (reprint author), UNLP, Fac Ciencias Med, CENEXA UNLP CONICET LA PLATA, 60 Y 120, RA-1900 La Plata, Argentina.
EM cenexa@speedy.com.ar
FU American Academy of Family Physicians Foundation
FX This study was partially supported by a grant provided by the American
   Academy of Family Physicians Foundation for the Peers for Progress
   Program. JJG is member of the Research career of CONICET. VA, DA, GGG,
   SL, LR and ZZ are members of the Houssay Centre Education team. LG is a
   fellow from the National University of La Plata, CC Jr is a research
   advisor of CENEXA by this study. Thanks are due to A. Di Maggio for
   assistance in editing the manuscript.
CR Am Diabetes Assoc, 2006, DIABETES CARE, V29, pS4
   Anderson RM, 2005, ETHNIC DIS, V15, P671
   Baksi AK, 2008, DIABETIC MED, V25, P1076, DOI 10.1111/j.1464-5491.2008.02542.x
   Balducci S, 2012, DIABETES CARE, V35, P39, DOI 10.2337/dc11-1450
   Balducci S, 2010, ARCH INTERN MED, V170, P1794, DOI 10.1001/archinternmed.2010.380
   Barlow J, 2002, PATIENT EDUC COUNS, V48, P177, DOI 10.1016/S0738-3991(02)00032-0
   Beckles GLA, 1998, DIABETES CARE, V21, P1432, DOI 10.2337/diacare.21.9.1432
   Brown SA, 2005, DIABETES CARE, V28, P527, DOI 10.2337/diacare.28.3.527
   Clark CM, 2010, FAM PRACT, V27, pI3, DOI 10.1093/fampra/cmq001
   Cramer JA, 2004, DIABETES CARE, V27, P1218, DOI 10.2337/diacare.27.5.1218
   Duke SAS, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005268.pub2
   Fisher EB, 2010, FAM PRACT, V27, pI6, DOI 10.1093/fampra/cmp013
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Forkan R, 2006, PHYS THER, V86, P401
   Funnell MM, 2007, DIABETES CARE, V30, P1630, DOI 10.2337/dc07-9923
   Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778
   Gagliardino J J, 2001, Rev Panam Salud Publica, V10, P309, DOI 10.1590/S1020-49892001001100003
   Gagliardino JJ, 2006, DIABETES RES CLIN PR, V72, P284, DOI 10.1016/j.diabres.2006.02.004
   Gagliardino JJ, 2001, DIABETES CARE, V24, P1001, DOI 10.2337/diacare.24.6.1001
   Gary TL, 2003, DIABETES EDUCATOR, V29, P488, DOI 10.1177/014572170302900313
   Gonzalez JS, 2011, DIABETES CARE, V34, P236, DOI 10.2337/dc10-1970
   Gray A, 2000, BRIT MED J, V320, P1373, DOI 10.1136/bmj.320.7246.1373
   Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470
   Home P, 2006, DIABETIC MED, V23, P579
   Karwalajtys Tina, 2005, BMC Fam Pract, V6, P35, DOI 10.1186/1471-2296-6-35
   Karwalajtys T, 2009, J COMMUN HEALTH, V34, P336, DOI 10.1007/s10900-009-9149-5
   Klonoff DC, 2000, DIABETES CARE, V23, P390, DOI 10.2337/diacare.23.3.390
   Li CY, 2010, DIABETES CARE, V33, P1061, DOI 10.2337/dc09-1515
   LORIG K, 1985, ARTHRITIS RHEUM, V28, P680, DOI 10.1002/art.1780280612
   Lorig KR, 1999, MED CARE, V37, P5, DOI 10.1097/00005650-199901000-00003
   McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615
   Morsanutto A, 2006, J DIABETES COMPLICAT, V20, P163, DOI 10.1016/j.jdiacomp.2005.06.011
   Norris S, 2003, RACTICAL DIABETOLOGY, V22, P7
   Norris SL, 2002, DIABETES CARE, V25, P1159, DOI 10.2337/diacare.25.7.1159
   Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561
   Odegard PS, 2007, DIABETES EDUCATOR, V33, P1014, DOI 10.1177/0145721707308407
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   Polonsky WH, 2003, DIABETES CARE, V26, P3048, DOI 10.2337/diacare.26.11.3048
   Renders CM, 2003, DIABETIC MED, V20, P846, DOI 10.1046/j.1464-5491.2003.01009.x
   Renders CM, 2001, DIABETES CARE, V24, P1821, DOI 10.2337/diacare.24.10.1821
   Roter DL, 1998, MED CARE, V36, P1138, DOI 10.1097/00005650-199808000-00004
   Sherman BW, 2011, AM J MANAG CARE, V17, P729
   Snoek FJ, 2011, DIABETES CARE, V34, P601, DOI 10.2337/dc10-1552
   Stearne MR, 1998, BRIT MED J, V317, P703
   Trento M, 2004, DIABETES CARE, V27, P670, DOI 10.2337/diacare.27.3.670
   Williams R, 2002, DIABETOLOGIA, V45, pS13, DOI 10.1007/s00125-002-0859-9
   Zhang QY, 2011, AM J MANAG CARE, V17, P746
NR 50
TC 34
Z9 38
U1 4
U2 28
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1520-7560
J9 DIABETES-METAB RES
JI Diabetes-Metab. Res. Rev.
PD FEB
PY 2013
VL 29
IS 2
BP 152
EP 160
DI 10.1002/dmrr.2368
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 086CK
UT WOS:000314660400008
PM 23166062
DA 2019-01-08
ER

PT J
AU Rintala, TM
   Jaatinen, P
   Paavilainen, E
   Astedt-Kurki, P
AF Rintala, Tuula-Maria
   Jaatinen, Pia
   Paavilainen, Eija
   Astedt-Kurki, Paivi
TI Interrelation Between Adult Persons With Diabetes and Their Family: A
   Systematic Review of the Literature
SO JOURNAL OF FAMILY NURSING
LA English
DT Article
DE diabetes; diabetes self-management; adult person; family; family
   relationships; literature review
ID SELF-MANAGEMENT BEHAVIORS; SOCIAL-ENVIRONMENTAL SUPPORT; PARTNERS
   EXPRESSED EMOTION; EUROPEAN-AMERICAN PATIENTS; DISEASE MANAGEMENT;
   GLYCEMIC CONTROL; SPOUSAL SUPPORT; CARE BEHAVIORS; MARITAL RELATIONSHIP;
   AFRICAN-AMERICANS
AB Diabetes mellitus is a common chronic disease all over the world. Self-management plays a crucial role in diabetes management. The purpose of this systematic review was to summarize what is known about the interactions between adult persons with diabetes, their family, and diabetes self-management. MEDLINE, CINAHL, PSYCHINFO, LINDA, and MEDIC databases were searched for the years 2000 to 2011 and for English language articles, and the reference lists of the studies included were reviewed to capture additional studies. The findings indicate that family members have influence on the self-management of adult persons with diabetes. The support from family members plays a crucial role in maintaining lifestyle changes and optimizing diabetes management. Diabetes and its treatment also affect the life of family members in several ways, causing, for example, different types of psychological distress. More attention should be paid to family factors in diabetes management among adult persons.
C1 [Rintala, Tuula-Maria] Tampere Univ Appl Sci, Tampere, Finland.
   [Jaatinen, Pia] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland.
   [Rintala, Tuula-Maria; Paavilainen, Eija; Astedt-Kurki, Paivi] Univ Tampere, Sch Hlth Sci, FIN-33101 Tampere, Finland.
RP Rintala, TM (reprint author), Tampere Univ Appl Sci, Kuntokatu 4, Tampere, Finland.
EM tuula-maria.rintala@uta.fi
FU University of Tampere; Finnish Diabetes Association
FX The authors disclosed receipt of the following financial support for the
   research, authorship, and/or publication of this article: Financial
   support for this research was provided by the University of Tampere and
   the Finnish Diabetes Association.
CR Albright TL, 2001, FAM MED, V33, P354
   Aljasem LI, 2001, DIABETES EDUCATOR, V27, P393, DOI 10.1177/014572170102700309
   Anderson Barbara J, 2003, Curr Diab Rep, V3, P134, DOI 10.1007/s11892-003-0037-6
   Anderson RM, 2005, PATIENT EDUC COUNS, V57, P153, DOI 10.1016/j.pec.2004.05.008
   Armour TA, 2005, DIABETIC MED, V22, P1295, DOI 10.1111/j.1464-5491.2005.01618.x
   Awadalla AW, 2006, J NATL MED ASSOC, V98, P727
   Baanders AN, 2007, FAM COMMUNITY HEALTH, V30, P305, DOI 10.1097/01.FCH.0000290543.48576.cf
   Beverly EA, 2007, J PSYCHOSOC NURS, V45, P25
   Beverly EA, 2008, HEALTH EDUC BEHAV, V35, P707, DOI 10.1177/1090198107299787
   Beverly EA, 2010, HEALTH EDUC RES, V25, P211, DOI 10.1093/her/cyn032
   Cameron FJ, 2008, DIABETIC MED, V25, P463, DOI 10.1111/j.1464-5491.2008.02399.x
   Chesla CA, 2005, QUAL HEALTH RES, V15, P240, DOI 10.1177/1049732304272050
   Chesla CA, 2004, DIABETES CARE, V27, P2850, DOI 10.2337/diacare.27.12.2850
   Chesla CA, 2003, FAM PROCESS, V42, P375, DOI 10.1111/j.1545-5300.2003.00375.x
   Chesla CA, 2010, J FAM NURS, V16, P355, DOI 10.1177/1074840710383145
   Chesla CA, 2009, DIABETES CARE, V32, P1812, DOI 10.2337/dc09-0278
   Chlebowy DO, 2006, DIABETES EDUCATOR, V32, P777, DOI 10.1177/0145721706291760
   Chlebowy DO, 2010, DIABETES EDUCATOR, V36, P897, DOI 10.1177/0145721710385579
   Choi SE, 2009, DIABETES EDUCATOR, V35, P978, DOI 10.1177/0145721709349220
   De Ridder DTD, 2005, PSYCHOL HEALTH, V20, P497, DOI 10.1080/14768320500098699
   Denham SA, 2007, FAMILIES SYSTEMS HLT, V25, P36, DOI DOI 10.1037/1091-7527.25.1.36
   Egede LE, 2010, DIABETES EDUCATOR, V36, P276, DOI 10.1177/0145721710361389
   Fisher L, 2004, J FAM PSYCHOL, V18, P302, DOI 10.1037/0893-3200.18.2.302
   Fisher L, 2002, DIABETES CARE, V25, P1564, DOI 10.2337/diacare.25.9.1564
   Fisher L, 2000, DIABETES CARE, V23, P267, DOI 10.2337/diacare.23.3.267
   Fisher L, 2000, FAM PROCESS, V39, P403, DOI 10.1111/j.1545-5300.2000.39402.x
   Fortmann AL, 2011, HEALTH PSYCHOL, V30, P251, DOI 10.1037/a0022850
   Funnell MM, 2004, CLIN DIABETES, V22, P123, DOI DOI 10.2337/DIACLIN.22.3.123
   Gavin JR, 2010, DIABETES EDUCATOR, V36, p26S, DOI 10.1177/0145721710369637
   Gerstle JF, 2001, J AM DIET ASSOC, V101, P918, DOI 10.1016/S0002-8223(01)00227-9
   Gherman A, 2011, DIABETES EDUCATOR, V37, P392, DOI 10.1177/0145721711403012
   Hagedoorn M, 2006, DIABETIC MED, V23, P271, DOI 10.1111/j.1464-5491.2006.01794.x
   Hill-Briggs F, 2007, DIABETES EDUCATOR, V33, P1032, DOI 10.1177/0145721707308412
   Jones RA, 2008, DIABETES EDUCATOR, V34, P318, DOI 10.1177/0145721708314485
   Jorgensen HV, 2003, DIABETES CARE, V26, P1106, DOI 10.2337/diacare.26.4.1106
   Kang CM, 2010, INT J NURS STUD, V47, P1363, DOI 10.1016/j.ijnurstu.2010.03.009
   Keogh KM, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-36
   King DK, 2010, DIABETES CARE, V33, P751, DOI 10.2337/dc09-1746
   Leonard BJ, 2005, J FAM NURS, V11, P102, DOI 10.1177/1074840705275152
   Lohri-Posey B, 2006, FAM COMMUNITY HEALTH, V29, P214, DOI 10.1097/00003727-200607000-00008
   Magarey J M, 2001, Int J Nurs Pract, V7, P376
   Manoogian MM, 2010, J FAM COMMUN, V10, P40, DOI 10.1080/15267430903385826
   McBroom LA, 2009, DIABETES EDUCATOR, V35, P428, DOI 10.1177/0145721709332814
   McGowan J, 2005, J MED LIBR ASSOC, V93, P74
   Minet L, 2010, PATIENT EDUC COUNS, V80, P29, DOI 10.1016/j.pec.2009.09.033
   Nardacci EA, 2010, DIABETES EDUCATOR, V36, p4S, DOI 10.1177/0145721710362798
   Needleman IG, 2002, J CLIN PERIODONTOL, V29, P6, DOI 10.1034/j.1600-051X.29.s3.15.x
   Norris SL, 2002, DIABETES CARE, V25, P1159, DOI 10.2337/diacare.25.7.1159
   Paddison C, 2010, EUR DIABETES NURS, V7, P29, DOI DOI 10.1002/EDN.152
   Rees CA, 2010, DIABETES EDUCATOR, V36, P435, DOI 10.1177/0145721710364419
   Rosland AM, 2008, J GEN INTERN MED, V23, P1992, DOI 10.1007/s11606-008-0814-7
   Sabone MB, 2008, J FAM NURS, V14, P363, DOI 10.1177/1074840708323047
   Searle A, 2007, J PSYCHOSOM RES, V63, P175, DOI 10.1016/j.jpyschores.2007.02.006
   Song M, 2010, J CARDIOVASC NURS, V25, P93, DOI 10.1097/JCN.0b013e3181c5a364
   Stephens MAP, 2010, FAM SYST HEALTH, V28, P199, DOI 10.1037/a0020513
   Stodberg R, 2007, J CLIN NURS, V16, P215, DOI 10.1111/j.1365-2702.2006.01797.x
   Tang TS, 2008, DIABETES EDUCATOR, V34, P266, DOI 10.1177/0145721708315680
   Toljamo M, 2001, J CLIN NURS, V10, P618, DOI 10.1046/j.1365-2702.2001.00520.x
   Trief P., 2003, FAMILIES SYSTEMS HLT, V21, P57, DOI [DOI 10.1037/H0089502, 10.1037/h0089502]
   Trief P. M., 2006, FAMILIES SYSTEMS HLT, V24, P318, DOI [10.1037/1091-7527.24.3.318, DOI 10.1037/1091-7527.24.3.318]
   Trief PM, 2004, ANN BEHAV MED, V27, P148, DOI 10.1207/s15324796abm2703_2
   Trief PM, 2002, DIABETES CARE, V25, P1154, DOI 10.2337/diacare.25.7.1154
   Trief PM, 2001, DIABETES CARE, V24, P1384, DOI 10.2337/diacare.24.8.1384
   van Dam HA, 2005, PATIENT EDUC COUNS, V59, P1, DOI 10.1016/j.pec.2004.11.001
   Watanabe K, 2010, INTERNAL MED, V49, P983, DOI 10.2169/internalmedicine.49.3230
   Wearden AJ, 2000, J PSYCHOSOM RES, V49, P125, DOI 10.1016/S0022-3999(00)00141-0
   Wearden AJ, 2006, BRIT J HEALTH PSYCH, V11, P1, DOI 10.1348/135910705X73676
   Weiler DM, 2009, DIABETES EDUCATOR, V35, P285, DOI 10.1177/0145721708329545
   Wen LK, 2004, DIABETES EDUCATOR, V30, P980, DOI 10.1177/014572170403000619
   White P, 2007, DIABETIC MED, V24, P796, DOI 10.1111/j.1464-5491.2007.02271.x
   White P, 2009, DIABETES EDUCATOR, V35, P810, DOI 10.1177/0145721709340930
   Williams K. E., 2002, PSYCHOL HEALTH MED, V7, P127, DOI [10.1080/13548500120116076, DOI 10.1080/13548500120116076]
NR 72
TC 46
Z9 46
U1 0
U2 26
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1074-8407
EI 1552-549X
J9 J FAM NURS
JI J. Fam. Nurs.
PD FEB
PY 2013
VL 19
IS 1
BP 3
EP 28
DI 10.1177/1074840712471899
PG 26
WC Family Studies; Nursing
SC Family Studies; Nursing
GA 076XV
UT WOS:000313993400001
PM 23288886
DA 2019-01-08
ER

PT J
AU Hajos, TRS
   Pouwer, F
   Skovlund, SE
   Den Oudsten, BL
   Geelhoed-Duijvestijn, PHLM
   Tack, CJ
   Snoek, FJ
AF Hajos, T. R. S.
   Pouwer, F.
   Skovlund, S. E.
   Den Oudsten, B. L.
   Geelhoed-Duijvestijn, P. H. L. M.
   Tack, C. J.
   Snoek, F. J.
TI Psychometric and screening properties of the WHO-5 well-being index in
   adult outpatients with Type 1 or Type 2 diabetes mellitus
SO DIABETIC MEDICINE
LA English
DT Article
ID PATIENT HEALTH QUESTIONNAIRE; QUALITY-OF-LIFE; COMORBID DEPRESSION;
   VALIDITY; METAANALYSIS; PREVALENCE; VALIDATION; DISTRESS; CLINICS; PHQ-9
AB Objective The 5-item World Health Organization well-being index is a commonly used measure of emotional well-being, but research on psychometric properties in outpatients with diabetes is scarce. We examined psychometric and screening properties for depression of this index in a large sample of Dutch outpatients with diabetes. Methods Patients with Type 1 (n = 384) and Type 2 (n = 549) diabetes from three outpatient clinics completed the WHO-5 index, the nine-item Patient Health Questionnaire, the Problem Areas in Diabetes survey and the Short Form-12 health survey. Internal consistency of the WHO-5 index was determined by Cronbach's alpha. The factor structure was tested by confirmatory factor analysis. Concurrent validity was assessed by correlations with the Patient Health Questionnaire, Problem Areas in Diabetes and the Short Form-12 mental component scores. Sensitivity and specificity of the WHO-5 index as depression screener were tested against two existing Patient Health Questionnaire cut-off scores for depression using receiver operating characteristic curves. Results A one-factor structure of the WHO-5 index was verified by confirmatory factor analysis for patients with Type 1 and Type 2 diabetes. Moderate to strong correlations were observed between the WHO-5 index and the Patient Health Questionnaire scores, the Problem Areas in Diabetes scores and the Short Form-12 mental component scores (r = 0.550.69, P < 0.001). Receiver operating characteristic curves showed that a WHO-5 index cut-off of < 50 performed best as an indication for likely depression, with sensitivity compared with a Patient Health Questionnaire score = 10 and = 12 of 79% and 88%, respectively, and specificity of 88% and 76%, respectively. Conclusions The WHO-5 index is a short, psychometrically sound measure of emotional well-being that appears suitable for use as screening test for likely depression in outpatients with Type 1 and Type 2 diabetes.
C1 [Hajos, T. R. S.; Snoek, F. J.] Vrije Univ Amsterdam Med Ctr, EMGO Inst, Dept Med Psychol, Diabet Psychol Res Grp, Amsterdam, Netherlands.
   [Pouwer, F.; Den Oudsten, B. L.] Tilburg Univ, Dept Med Psychol & Neuropsychol, CoRPS Ctr Res Psychol Somat Dis, NL-5000 LE Tilburg, Netherlands.
   [Skovlund, S. E.] Novo Nordisk AS, DAWN Diabet Attitudes Wishes & Needs Programme, DK-2880 Bagsvaerd, Denmark.
   [Den Oudsten, B. L.] St Elizabeth Hosp, Dept Educ & Res, Tilburg, Netherlands.
   [Geelhoed-Duijvestijn, P. H. L. M.] Haaglanden Med Ctr, Dept Internal Med, The Hague, Netherlands.
   [Tack, C. J.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands.
RP Hajos, TRS (reprint author), Vrije Univ Amsterdam Med Ctr, EMGO Inst, Dept Med Psychol, Diabet Psychol Res Grp, Amsterdam, Netherlands.
EM t.hajos@vumc.nl
RI Tack, Cees/A-2368-2014
CR *AM DIAB ASS, 2010, DIABETES CARE S1, V33, pS11, DOI DOI 10.2337/DC10-S011
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Awata S, 2007, PSYCHIAT CLIN NEUROS, V61, P112, DOI 10.1111/j.1440-1819.2007.01619.x
   Barnard KD, 2006, DIABETIC MED, V23, P445, DOI 10.1111/j.1464-5491.2006.01814.x
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   de Vet HC, 2011, MEASUREMENT MED, P150
   de Wit M, 2007, DIABETES CARE, V30, P2003, DOI 10.2337/dc07-0447
   Egede LE, 2010, DIABETES TECHNOL THE, V12, P257, DOI 10.1089/dia.2009.0143
   Gilbody S, 2007, J GEN INTERN MED, V22, P1596, DOI 10.1007/s11606-007-0333-y
   Herzog W, 2009, STRUCT EQU MODELING, V16, P1, DOI 10.1080/10705510802561279
   Home P, 2006, DIABETIC MED, V23, P579
   Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Lowe B, 2004, J AFFECT DISORDERS, V78, P131, DOI 10.1016/S0165-0327(02)00237-9
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Pouwer F, 2006, PATIENT EDUC COUNS, V60, P235, DOI 10.1016/j.pec.2005.01.009
   Pouwer F, 2011, DIABETOLOGIA, V54, P741, DOI 10.1007/s00125-010-2033-0
   Pouwer F, 2010, DIABETIC MED, V27, P217, DOI 10.1111/j.1464-5491.2009.02903.x
   Pouwer F, 2009, NAT REV ENDOCRINOL, V5, P665, DOI 10.1038/nrendo.2009.214
   Roy T, 2012, DIABETIC MED, V29, P164, DOI 10.1111/j.1464-5491.2011.03401.x
   Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Snoek FJ, 2011, DIABETES CARE, V34, P601, DOI 10.2337/dc10-1552
   Streiner DL, 2008, HLTH MEASUREMENT SCA
   van Steenbergen-Weijenburg KM, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-235
   WHO, 1998, WELLB MEAS HLTH CAR
   Wittkampf KA, 2007, GEN HOSP PSYCHIAT, V29, P388, DOI 10.1016/j.genhosppsych.2007.06.004
NR 27
TC 50
Z9 55
U1 1
U2 20
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
J9 DIABETIC MED
JI Diabetic Med.
PD FEB
PY 2013
VL 30
IS 2
BP E63
EP E69
DI 10.1111/dme.12040
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 075HV
UT WOS:000313876500005
PM 23072401
DA 2019-01-08
ER

PT J
AU Sabourin, BC
   Pursley, S
AF Sabourin, Brigitte C.
   Pursley, Shannon
TI Psychosocial Issues in Diabetes Self-Management: Strategies for
   Healthcare Providers
SO CANADIAN JOURNAL OF DIABETES
LA English
DT Article
DE behaviour modification; emotion management; motivational enhancement;
   psychosocial; type 2 diabetes
ID RANDOMIZED CONTROLLED-TRIALS; COMORBID DEPRESSION; BEHAVIORAL-CHANGE;
   GLYCEMIC CONTROL; INTERVENTIONS; MELLITUS; HYPOGLYCEMIA; METAANALYSIS;
   ADULTS; FEAR
AB Education and training for diabetes mellitus self-management is widely available and an essential part of many diabetes centres. Nonetheless, the majority of individuals with diabetes do not adhere to optimal self-management recommendations. It is believed that psychosocial issues play an important role in individuals' ability to undertake the extensive behavioural demands involved in managing diabetes. The goal of the present article is to provide an overview of psychosocial issues and suggest strategies for healthcare providers in supporting patients with the challenges of diabetes self-management. First, motivational enhancement strategies have the potential to augment patients' own motivation to engage in health behaviours. Second, behavior modification principles can increase patients' self-efficacy and their experiences of success. Third, managing distressing emotions, including anxiety, depression, distress specifically related to diabetes care, and fear of hypoglycemia, can facilitate motivation and ability to undertake diabetes self-management efforts. Recognizing and addressing psychosocial challenges allows healthcare providers to better support their patients in the demanding tasks of diabetes self-management. (C) 2013 Canadian Diabetes Association
C1 [Sabourin, Brigitte C.] Dalhousie Univ, Queen Elizabeth II Hlth Sci Ctr, Halifax, NS, Canada.
   [Pursley, Shannon] Burlington Psychol & Counselling Serv, Burlington, ON, Canada.
   [Pursley, Shannon] Grandview Med Ctr, Cambridge, ON, Canada.
   [Pursley, Shannon] Waterloo Wellington Self Management Program, Cambridge, ON, Canada.
RP Sabourin, BC (reprint author), Capital Dist Hlth Author, QEII Psychol, Room 4055,Abbie J Lane Bldg,5909 Vet Mem Lane, Halifax, NS B3H 2E2, Canada.
EM brigitte.sabourin@dal.ca
OI Sabourin, Brigitte/0000-0001-7600-9974
CR Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191
   Boyle S, 2004, BEHAV RES THER, V42, P357, DOI 10.1016/j.brat.2003.11.006
   Canadian Diabetes Association Clinical Practice Guidelines Committee: Canadian, 2008, CAN J DIABETES S1, V32, pS1, DOI DOI 10.1503/CMAJ.080554
   COX DJ, 1987, DIABETES CARE, V10, P617, DOI 10.2337/diacare.10.5.617
   COX DJ, 1990, DIABETES CARE, V13, P458, DOI 10.2337/diacare.13.4.458
   Deakin T, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003417.pub2
   Egede LE, 2002, DIABETES CARE, V25, P464, DOI 10.2337/diacare.25.3.464
   Elliott TR, 2001, J CLIN PSYCHOL MED S, V8, P283, DOI 10.1023/A:1011920914079
   Fisher L, 2007, DIABETES CARE, V30, P2746, DOI 10.2337/dc07-1166
   Funnell MM, 2004, CLIN DIABETES, V22, P123, DOI DOI 10.2337/DIACLIN.22.3.123
   Glasgow RE, 1999, DIABETES CARE, V22, P832, DOI 10.2337/diacare.22.5.832
   Grigsby AB, 2002, J PSYCHOSOM RES, V53, P1053, DOI 10.1016/S0022-3999(02)00417-8
   Ismail K, 2004, LANCET, V363, P1589, DOI 10.1016/S0140-6736(04)16202-8
   Lehrer P. M., 2007, PRINCIPLES PRACTICES
   Locke EA, 2002, AM PSYCHOL, V57, P705, DOI 10.1037//0003-066X.57.9.705
   LUSTMAN PJ, 1992, DIABETES CARE, V15, P1631, DOI 10.2337/diacare.15.11.1631
   Lustman PJ, 1998, ANN INTERN MED, V129, P613, DOI 10.7326/0003-4819-129-8-199810150-00005
   Malemute CL, 2011, DIABETES EDUCATOR, V37, P549, DOI 10.1177/0145721711410718
   Markowitz SM, 2011, PSYCHOSOMATICS, V52, P1, DOI 10.1016/j.psym.2010.11.007
   Miller W. R., 2002, MOTIVATIONAL INTERVI
   Minet L, 2010, PATIENT EDUC COUNS, V80, P29, DOI 10.1016/j.pec.2009.09.033
   Nezu AM, 2004, BEHAV THER, V35, P1, DOI 10.1016/S0005-7894(04)80002-9
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   Peyrot M, 2007, DIABETES CARE, V30, P2433, DOI 10.2337/dc07-1222
   POLONSKY WH, 1992, HEALTH PSYCHOL, V11, P199, DOI 10.1037/0278-6133.11.3.199
   Rubin RR, 2001, J CLIN PSYCHOL, V57, P457, DOI 10.1002/jclp.1041
   Sabourin BC, 2011, CAN J DIABETES, V35, P287, DOI 10.1016/S1499-2671(11)53013-8
   Shiu ATY, 2002, J ADV NURS, V39, P155
   Sultan S, 2001, J HEALTH PSYCHOL, V6, P731, DOI 10.1177/135910530100600616
   SURWIT RS, 1992, DIABETES CARE, V15, P1413, DOI 10.2337/diacare.15.10.1413
   Thoolen BJ, 2009, PSYCHOL HEALTH, V24, P237, DOI 10.1080/08870440701864504
   Vallis M., 2010, FAM MED FOR VANC OCT
   Vallis TM, 2001, CAN J DIABETES, V25, P31
   Wild D, 2007, PATIENT EDUC COUNS, V68, P10, DOI 10.1016/j.pec.2007.05.003
   Zhang XP, 2007, MED CARE, V45, P820, DOI 10.1097/MLR.0b013e3180618b55
NR 36
TC 4
Z9 6
U1 2
U2 14
PU CANADIAN DIABETES ASSOC
PI TORONTO
PA 1400-522 UNIVERSITY AVE, TORONTO, ONTARIO M5G 2R5, CANADA
SN 1499-2671
J9 CAN J DIABETES
JI Can. J. Diabetes
PD FEB
PY 2013
VL 37
IS 1
BP 36
EP 40
DI 10.1016/j.jcjd.2013.01.002
PG 5
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AL8SE
UT WOS:000339408500007
PM 24070746
DA 2019-01-08
ER

PT J
AU Liu, Y
   Croft, JB
   Wheaton, AG
   Perry, GS
   Chapman, DP
   Strine, TW
   McKnight-Eily, LR
   Presley-Cantrell, L
AF Liu, Yong
   Croft, Janet B.
   Wheaton, Anne G.
   Perry, Geraldine S.
   Chapman, Daniel P.
   Strine, Tara W.
   McKnight-Eily, Lela R.
   Presley-Cantrell, Letitia
TI Association between perceived insufficient sleep, frequent mental
   distress, obesity and chronic diseases among US adults, 2009 behavioral
   risk factor surveillance system
SO BMC PUBLIC HEALTH
LA English
DT Article
DE Insufficient sleep; Chronic disease; Population-based study
ID CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; DURATION; POPULATION;
   HYPERTENSION; DEPRIVATION; DEPRESSION; ANXIETY; HEALTH; ASTHMA
AB Background: Although evidence suggests that poor sleep is associated with chronic disease, little research has been conducted to assess the relationships between insufficient sleep, frequent mental distress (FMD >= 14 days during the past 30 days), obesity, and chronic disease including diabetes mellitus, coronary heart disease, stroke, high blood pressure, asthma, and arthritis.
   Methods: Data from 375,653 US adults aged >= 18 years in the 2009 Behavioral Risk Factor Surveillance System were used to assess the relationships between insufficient sleep and chronic disease. The relationships were further examined using a multivariate logistic regression model after controlling for age, sex, race/ethnicity, education, and potential mediators (FMD and obesity).
   Results: The overall prevalence of insufficient sleep during the past 30 days was 10.4% for all 30 days, 17.0% for 14-29 days, 42.0% for 1-13 days, and 30.6% for zero day. The positive relationships between insufficient sleep and each of the six chronic disease were significant (p < 0.0001) after adjustment for covariates and were modestly attenuated but not fully explained by FMD. The relationships between insufficient sleep and both diabetes and high blood pressure were also modestly attenuated but not fully explained by obesity.
   Conclusions: Assessment of sleep quantity and quality and additional efforts to encourage optimal sleep and sleep health should be considered in routine medical examinations. Ongoing research designed to test treatments for obesity, mental distress, or various chronic diseases should also consider assessing the impact of these treatments on sleep health.
C1 [Liu, Yong; Croft, Janet B.; Wheaton, Anne G.; Perry, Geraldine S.; Chapman, Daniel P.; McKnight-Eily, Lela R.; Presley-Cantrell, Letitia] Ctr Dis Control & Prevent CDC, Div Populat Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA.
   [Strine, Tara W.] Ctr Dis Control & Prevent CDC, Div Behav Surveillance, Off Surveillance Epidemiol & Lab Serv, Atlanta, GA 30345 USA.
RP Liu, Y (reprint author), Ctr Dis Control & Prevent CDC, Div Populat Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Highway NE,Mail Stop K-67, Atlanta, GA 30341 USA.
EM ikd8@cdc.gov
CR Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P1175
   Arora VM, 2007, ARCH INTERN MED, V167, P1738, DOI 10.1001/archinte.167.16.1738
   Axon RN, 2010, AM J HYPERTENS, V23, P30, DOI 10.1038/ajh.2009.199
   Ayas NT, 2003, DIABETES CARE, V26, P380, DOI 10.2337/diacare.26.2.380
   Ayas NT, 2003, ARCH INTERN MED, V163, P205, DOI 10.1001/archinte.163.2.205
   BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037//0022-3514.51.6.1173
   BOWLIN SJ, 1993, J CLIN EPIDEMIOL, V46, P561, DOI 10.1016/0895-4356(93)90129-O
   CATTERALL JR, 1986, THORAX, V41, P676, DOI 10.1136/thx.41.9.676
   Centers for Disease Control and Prevention (CDC), 2009, BEH RISK FACT SURV S
   Daniel LC, 2012, ANN ALLERG ASTHMA IM, V109, P41, DOI 10.1016/j.anai.2012.05.015
   Davidson K, 2000, ARCH INTERN MED, V160, P1495, DOI 10.1001/archinte.160.10.1495
   Engum A, 2007, J PSYCHOSOM RES, V62, P31, DOI 10.1016/j.jpsychores.2006.07.009
   Gangwisch JE, 2006, HYPERTENSION, V47, P833, DOI 10.1161/01.HYP.0000217362.34748.e0
   Gangwisch JE, 2005, SLEEP, V28, P1289, DOI 10.1093/sleep/28.10.1289
   Gottlieb DJ, 2005, ARCH INTERN MED, V165, P863, DOI 10.1001/archinte.165.8.863
   Grandner MA, 2011, J PUBLIC HEALTH-HEID, V19, P463, DOI 10.1007/s10389-011-0398-2
   Haghighatdoost F, 2012, NUTRITION, V28, P1146, DOI 10.1016/j.nut.2012.04.015
   Hamer M, 2008, J AM COLL CARDIOL, V52, P2156, DOI 10.1016/j.jacc.2008.08.057
   Hanson MD, 2008, J PEDIATR PSYCHOL, V33, P312, DOI 10.1093/jpepsy/jsm120
   HUNG J, 1990, LANCET, V336, P261, DOI 10.1016/0140-6736(90)91799-G
   *I MED, 2006, SLEEP DIS SLEEP DEPR
   Irwin MR, 2012, SLEEP, V35, P537, DOI 10.5665/sleep.1742
   JACKSON C, 1992, AM J PUBLIC HEALTH, V82, P412, DOI 10.2105/AJPH.82.3.412
   Kopec JA, 2004, CAN J PUBLIC HEALTH, V95, P361
   Kripke DF, 2002, ARCH GEN PSYCHIAT, V59, P131, DOI 10.1001/archpsyc.59.2.131
   Lavie P, 2000, BRIT MED J, V320, P479, DOI 10.1136/bmj.320.7233.479
   Leander M, 2009, RESP MED, V103, P194, DOI 10.1016/j.rmed.2008.09.015
   Luckhaupt Sara E., 2012, Morbidity and Mortality Weekly Report, V61, P281
   Malhotra A, 2009, PROG CARDIOVASC DIS, V51, P279, DOI 10.1016/j.pcad.2008.10.004
   Mallon L, 2005, DIABETES CARE, V28, P2762, DOI 10.2337/diacare.28.11.2762
   McKnight-Eily L. R., 2008, Morbidity and Mortality Weekly Report, V57, P200
   Merikanto I, 2012, CHRONOBIOL INT, V29, P311, DOI 10.3109/07420528.2012.655870
   Mezick EJ, 2011, SLEEP MED REV, V15, P51, DOI 10.1016/j.smrv.2010.03.001
   Mokdad Ali H, 2003, MMWR Recomm Rep, V52, P1
   MOLDOFSKY H, 1976, PSYCHOSOM MED, V38, P35, DOI 10.1097/00006842-197601000-00006
   Moriarty David G, 2003, Health Qual Life Outcomes, V1, P37, DOI 10.1186/1477-7525-1-37
   *NAT HEART LUNG BL, 1998, NIH PUBL
   Nelson D.E., 2001, INT J PUBLIC HEALTH, V46, P1, DOI DOI 10.1186/1471-2288-13-49
   Patel SR, 2006, AM J EPIDEMIOL, V164, P947, DOI 10.1093/aje/kwj280
   Patel SR, 2004, SLEEP, V27, P440, DOI 10.1093/sleep/27.3.440
   Prasanna SJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0009016, 10.1371/journal.pone.0014189]
   Rothman K. J., 2008, MODERN EPIDEMIOLOGY, P51
   Sabanayagam C, 2011, SLEEP MED, V12, P7, DOI 10.1016/j.sleep.2010.09.002
   Shahar E, 2001, AM J RESP CRIT CARE, V163, P19, DOI 10.1164/ajrccm.163.1.2001008
   Shen BJ, 2008, J AM COLL CARDIOL, V51, P113, DOI 10.1016/j.jacc.2007.09.033
   Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8
   Strine TW, 2005, SLEEP MED, V6, P23, DOI 10.1016/j.sleep.2004.06.003
   Taheri S, 2006, ARCH DIS CHILD, V91, P881, DOI 10.1136/adc.2005.093013
   van de Mheen HD, 1998, SOCIOL HEALTH ILL, V20, P754, DOI 10.1111/1467-9566.00128
   van den Berg JF, 2009, J CLIN PSYCHIAT, V70, P1105, DOI 10.4088/JCP.08m04448
   van Mill JG, 2010, J CLIN PSYCHIAT, V71, P239, DOI 10.4088/JCP.09m05218gry
   Vishnu A, 2011, INT J ENDOCRINOL, DOI 10.1155/2011/789358
   Yaggi HK, 2005, NEW ENGL J MED, V353, P2034, DOI 10.1056/NEJMoa043104
NR 53
TC 44
Z9 45
U1 0
U2 28
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD JAN 29
PY 2013
VL 13
AR 84
DI 10.1186/1471-2458-13-84
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 082LE
UT WOS:000314392500001
PM 23360346
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Hung, CH
   Tzeng, JI
   Chang, CN
   Chen, YW
   Cho, CY
   Wang, JJ
AF Hung, Ching-Hsia
   Tzeng, Jann-Inn
   Chang, Che-Ning
   Chen, Yu-Wen
   Cho, Chia-Ying
   Wang, Jhi-Joung
TI Treadmill Exercise Preconditioning Attenuates Lung Damage Caused by
   Systemic Endotoxemia in Type 1 Diabetic Rats
SO JOURNAL OF DIABETES RESEARCH
LA English
DT Article
ID RESPIRATORY-DISTRESS-SYNDROME; PROTEIN RESPONSE; CONSCIOUS RATS; SHOCK;
   INJURY; INSULIN; MELLITUS; INTERLEUKIN-6; HYPERTHERMIA; PRETREATMENT
AB Endotoxemia induces a series of inflammatory responses that may result in lung injury. However, heat shock protein72 (HSP72) has the potential to protect the lungs from damage. The objective of this study was to determine whether prior exercise conditioning could increase the expression of HSP72 in the lungs and attenuate lung damage in diabetic rats receiving lipopolysaccharide (LPS). Streptozotocin was used to induce diabetes in adult male Wistar rats. Rats were randomly assigned to sedentary or exercise groups. Rats in the exercise condition ran on a treadmill 5 days/week, 30-60 min/day, with an intensity of 1.0 mile/hour over a 3-week period. Rats received an intravenous infusion of LPS after 24 hrs from the last training session. Elevated lavage tumor necrosis factor-alpha (TNF-alpha) level in response to LPS was more marked in diabetic rats. HSP72 expression in lungs was significantly increased after exercise conditioning, but less pronounced in diabetic rats. After administration of LPS, exercised rats displayed higher survival rate as well as decreased lavage TNF-alpha level and lung edema in comparison to sedentary rats. Our findings suggest that exercise conditioning could attenuate the occurrence of inflammatory responses and lung damage, thereby reducing mortality rate in diabetic rats during endotoxemia.
C1 [Hung, Ching-Hsia; Chang, Che-Ning; Cho, Chia-Ying] Natl Cheng Kung Univ, Dept Phys Therapy, Tainan 701, Taiwan.
   [Tzeng, Jann-Inn] Chia Nan Univ Pharm & Sci, Dept Food Sci & Technol, Tainan 717, Taiwan.
   [Tzeng, Jann-Inn] Chi Mei Med Ctr, Dept Anesthesiol, Tainan 710, Taiwan.
   [Chen, Yu-Wen] China Med Univ, Dept Phys Therapy, Taichung 404, Taiwan.
   [Wang, Jhi-Joung] Chi Mei Med Ctr, Dept Med Res, Tainan 710, Taiwan.
RP Chen, YW (reprint author), China Med Univ, Dept Phys Therapy, Taichung 404, Taiwan.
EM cywhwok@mail.cmu.edu.tw
FU National Science Council of Taiwan [NSC 95-2314-B-006-072-MY3, NSC
   101-2314-B-006-037-MY3]
FX Financial support for this study was provided by the National Science
   Council of Taiwan (NSC 95-2314-B-006-072-MY3 and NSC
   101-2314-B-006-037-MY3).
CR Atalay M, 2004, J APPL PHYSIOL, V97, P605, DOI 10.1152/japplphysiol.01183.2003
   Bannerman DD, 2003, AM J PHYSIOL-LUNG C, V284, pL899, DOI 10.1152/ajplung.00338.2002
   BOCZKOWSKI J, 1988, AM REV RESPIR DIS, V138, P260, DOI 10.1164/ajrccm/138.2.260
   CARROLL P, 1982, DIABETES CARE, V5, P574, DOI 10.2337/diacare.5.6.574
   Chang SL, 1999, DIABETOLOGIA, V42, P250, DOI 10.1007/s001250051146
   Chatterjee S, 2007, J SURG RES, V140, P99, DOI 10.1016/j.jss.2006.09.002
   Chen HI, 2007, MED SCI SPORT EXER, V39, P435, DOI 10.1249/mss.0b013e31802d11c8
   Chen YW, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2006.033829
   Dekker MJ, 2007, METABOLISM, V56, P332, DOI 10.1016/j.metabol.2006.10.015
   Demirel HA, 1998, MED SCI SPORT EXER, V30, P1211, DOI 10.1097/00005768-199808000-00005
   ENSOR JE, 1994, AM J PHYSIOL, V266, pC967
   Fakioglu H, 2004, PHARMACOL RES, V49, P45, DOI 10.1016/j.phrs.2003.03.001
   Freudenberg MA, 2008, IMMUNOBIOLOGY, V213, P193, DOI 10.1016/j.imbio.2007.11.008
   Ganter MT, 2006, AM J PHYSIOL-LUNG C, V291, pL354, DOI 10.1152/ajplung.00405.2005
   Geerlings SE, 1999, FEMS IMMUNOL MED MIC, V26, P259, DOI 10.1111/j.1574-695X.1999.tb01397.x
   GLASS EJ, 1987, DIABETOLOGIA, V30, P228, DOI 10.1007/BF00270420
   Goldhammer E, 2005, INT J CARDIOL, V100, P93, DOI 10.1016/j.ijcard.2004.08.073
   Hawkins LD, 2004, CURR TOP MED CHEM, V4, P1147, DOI 10.2174/1568026043388123
   HILLERDAL G, 1982, ACTA MED SCAND, V211, P221
   Honiden S, 2009, CRIT CARE MED, V37, P2455, DOI 10.1097/CCM.0b013e3181a0fea5
   Hung CH, 2005, SHOCK, V23, P426, DOI 10.1097/01.shk.0000159557.95285.96
   Hung CH, 2004, NEUROSCI LETT, V364, P63, DOI 10.1016/j.neulet.2004.02.074
   Hung CH, 2008, APPL PHYSIOL NUTR ME, V33, P976, DOI 10.1139/H08-081
   Koh Y, 2001, INFLAMMATION, V25, P187, DOI 10.1023/A:1011040515262
   Kregel KC, 2002, J APPL PHYSIOL, V92, P2177, DOI 10.1152/japplphysiol.01267.2001
   Lepock JR, 2003, INT J HYPERTHER, V19, P252, DOI 10.1080/0265673031000065042
   Martins JD, 2006, SHOCK, V25, P260, DOI 10.1097/01.shk.0000194042.18699.b4
   Mehanna A, 2007, LIFE SCI, V81, P1301, DOI 10.1016/j.lfs.2007.09.006
   Okamoto H, 1998, STROKE, V29, P1209, DOI 10.1161/01.STR.29.6.1209
   Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004
   Rojas M, 2005, AM J PHYSIOL-LUNG C, V288, pL333, DOI 10.1152/ajplung.00334.2004
   Rusko H, 1987, J SPORT SCI, V5, P273, DOI 10.1080/02640418708729782
   Shimada H, 2006, SHOCK, V26, P311, DOI 10.1097/01.shk.0000224960.17274.6f.
   Takao Y, 2005, ANESTH ANALG, V100, P810, DOI 10.1213/01.ANE.0000144775.19385.8C
   Tang GJ, 1998, CRIT CARE MED, V26, P1558, DOI 10.1097/00003246-199809000-00024
   Van Molle W, 2002, IMMUNITY, V16, P685, DOI 10.1016/S1074-7613(02)00310-2
   Wong HR, 1997, SHOCK, V8, P213, DOI 10.1097/00024382-199709000-00010
   Yang CH, 2009, RESUSCITATION, V80, P1204, DOI 10.1016/j.resuscitation.2009.06.017
NR 38
TC 6
Z9 6
U1 0
U2 5
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 2314-6745
EI 2314-6753
J9 J DIABETES RES
JI J. Diabetes Res.
PY 2013
AR 527090
DI 10.1155/2013/527090
PG 10
WC Endocrinology & Metabolism; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Research & Experimental Medicine
GA 276VZ
UT WOS:000328779100001
PM 24392457
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Zhang, J
   Xu, CP
   Wu, HX
   Xue, XJ
   Xu, ZJ
   Li, Y
   Gao, Q
   Liu, QZ
AF Zhang, Jie
   Xu, Cui-ping
   Wu, Hong-xia
   Xue, Xiu-juan
   Xu, Ze-jun
   Li, Yan
   Gao, Qing
   Liu, Qing-zhi
TI Comparative study of the influence of diabetes distress and depression
   on treatment adherence in Chinese patients with type 2 diabetes: a
   cross-sectional survey in the People's Republic of China
SO NEUROPSYCHIATRIC DISEASE AND TREATMENT
LA English
DT Article
DE distress; depression; type 2 diabetes; treatment; adherence; People's
   Republic of China
ID CLINICAL DEPRESSION; EMOTIONAL-PROBLEMS; GLYCEMIC CONTROL; SCALE;
   ADULTS; PREVALENCE; SYMPTOMS; ANXIETY; IMPACT
AB Background: The purpose of this study was to explore diabetes-related distress and depression and their influence on treatment adherence in Chinese patients with type 2 diabetes.
   Methods: We surveyed 200 type 2 diabetic patients from two public hospitals using the Diabetes Distress Scale (DDS), Zung Self-rating Depression Scale, and Revised Treatment Adherence in Diabetes Questionnaire (RADQ). A multiple regression model was used to explore the relationship between diabetes distress, depression, and treatment adherence.
   Results: In the 200 eligible patients, the incidence of depression and diabetes distress was approximately 24% and 64%, respectively. The mean score on the RADQ was 23.0 +/- 6.0. Multiple regression analysis showed that DDS scores (beta = 5.34, P = 0.000), age (beta = 0.15, P = 0.014), and family history (beta = 3.2, P = 0.016) had a positive correlation with depression. DDS scores (beta = -2.30, P = 0.000) and treatment methods (beta = -0.93, P = 0.012) were risk factors for poor treatment adherence, whereas age (beta = 0.089, P = 0.000) and cohabitation (beta = 0.93, P = 0.012) increased treatment adherence. The independent-samples t-test showed that depression also affected treatment adherence (t = 2.53, P < 0.05).
   Conclusion: These findings suggest that the DDS is a predictor of depression and that diabetes distress plays a more important part than depression in treatment adherence. Screening for diabetes distress may be useful for primary prevention of psychologic problems; however, some form of specialized psychologic intervention should be incorporated to promote patient adherence with treatment.
C1 [Zhang, Jie] Shandong Med Coll, Jinan, Peoples R China.
   [Xu, Cui-ping; Wu, Hong-xia; Xue, Xiu-juan; Gao, Qing] Shandong Univ, Qianfoshan Hosp, Jinan 250100, Shandong, Peoples R China.
   [Xu, Ze-jun] Sichuan Prov Peoples Hosp, Chengdu, Sichuan, Peoples R China.
   [Li, Yan] Shandong Univ Tradit Chinese Med, Jinan, Shandong, Peoples R China.
   [Liu, Qing-zhi] Shandong Univ, QiLu Hosp, Jinan 250100, Shandong, Peoples R China.
RP Xu, CP (reprint author), Shandong Univ, Qianfoshan Hosp, Jinan 250100, Shandong, Peoples R China.
EM xucuiping775@sohu.com
FU Qianfoshan Hospital, Shandong Province
FX This study was supported by a grant from Qianfoshan Hospital, Shandong
   Province. The authors thank the endocrinology nurses for their help with
   data collection and Professor Ju Liu for assistance with preparation of
   the manuscript.
CR Barefoot JC, 2000, PSYCHOSOM MED, V62, P790, DOI 10.1097/00006842-200011000-00008
   Chen ZH, 2000, ACAD J KUNMING MED C, V4, P67
   Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278
   Egede LE, 2012, CURR PSYCHIAT REP, V14, P15, DOI 10.1007/s11920-011-0240-0
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   GAVARD JA, 1993, DIABETES CARE, V16, P1167, DOI 10.2337/diacare.16.8.1167
   Gonzalez JS, 2007, DIABETES CARE, V30, P2222, DOI 10.2337/dc07-0158
   Graue M, 2012, INT J NURS STUD, V49, P174, DOI 10.1016/j.ijnurstu.2011.08.007
   Grigsby AB, 2002, J PSYCHOSOM RES, V53, P1053, DOI 10.1016/S0022-3999(02)00417-8
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   Kalsekar ID, 2006, ANN PHARMACOTHER, V40, P605, DOI 10.1345/aph.1G606
   Kokoszka A, 2009, EUR PSYCHIAT, V24, P425, DOI 10.1016/j.eurpsy.2009.04.002
   Nichols GA, 2003, DIABETES CARE, V26, P744, DOI 10.2337/diacare.26.3.744
   Odusan O, 2012, Afr J Med Med Sci, V41, P141
   Passik SD, 2000, PSYCHOSOMATICS, V41, P121, DOI 10.1176/appi.psy.41.2.121
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Pouwer F, 2005, DIABETES RES CLIN PR, V70, P166, DOI 10.1016/j.diabres.2005.03.031
   Ting RZW, 2011, DIABETES CARE, V34, P1094, DOI 10.2337/dc10-1612
   Yang Q., 2010, J NURSING CHINA, V17, P8
   Zagarins SE, 2012, J BEHAV MED, V35, P299, DOI 10.1007/s10865-011-9359-z
   ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63
NR 26
TC 18
Z9 19
U1 0
U2 16
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1176-6328
J9 NEUROPSYCH DIS TREAT
JI Neuropsychiatr. Dis. Treat.
PY 2013
VL 9
BP 1289
EP 1294
DI 10.2147/NDT.S49798
PG 6
WC Clinical Neurology; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 208SN
UT WOS:000323699900001
PM 24039431
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Wang, L
   Wang, KS
AF Wang, Liang
   Wang, Ke-Sheng
TI Age Differences in the Associations of Behavioral and Psychosocial
   Factors with Stroke
SO NEUROEPIDEMIOLOGY
LA English
DT Article
DE Stroke; Risk factor; Age difference; Severe psychological distress;
   Smoking; Physical activity
ID AMERICAN-HEART-ASSOCIATION; BLACK-WHITE DIFFERENCES; SERIOUS
   MENTAL-ILLNESS; RISK-FACTORS; PSYCHOLOGICAL DISTRESS; PHYSICAL-ACTIVITY;
   1ST-EVER STROKE; ISCHEMIC-STROKE; SEX-DIFFERENCES; DISEASE
AB Background: Stroke remains a major public health burden. Few studies have focused on the age differences in the associations of behavioral and psychosocial factors with stroke while no study focusing on the effect of severe psychological distress (SPD) on stroke has been conducted. The aim of this study was to examine the age differences in these risk factors for stroke as young (18-44 years), middle aged (45 64 years), and elderly (65 years or older). Methods: A total of 1,258 adults with stroke and 39,985 controls were selected from the 2005 California Health Interview Survey. Multiple logistic regression analyses were used to estimate the associations of the factors with stroke at different ages. Results: The prevalence of SPD was 10% in cases and 3.6% in controls, respectively. Overall, current smoking, lack of physical activity, alcohol consumption, SPD, type II diabetes, male, older age, and unemployment were all associated with a higher prevalence of stroke. Practically, we found that smoking and SPD were associated with the prevalence of stroke in young adults, lack of physical activity was associated with the prevalence of stroke in middle-aged adults, and lack of physical activity and SPD were associated with the prevalence of stroke in the elderly. Conclusions: Appropriate intervention for reducing stroke and eliminating its disparities may be developed separately at each age. Copyright (C) 2013 S. Karger AG, Basel
C1 [Wang, Liang; Wang, Ke-Sheng] E Tennessee State Univ, Dept Biostat & Epidemiol, Coll Publ Hlth, Johnson City, TN 37614 USA.
RP Wang, L (reprint author), E Tennessee State Univ, Dept Biostat & Epidemiol, POB 70259, Johnson City, TN 37614 USA.
EM wangl2@etsu.edu
CR [Anonymous], 1996, 1995 HEART STROK FAC
   Baggaley RF, 2007, TROP MED INT HEALTH, V12, P1225, DOI 10.1111/j.1365-3156.2007.01906.x
   Brown RD, 1996, STROKE, V27, P373
   Carney RA, 2002, STROKE, V33, P5, DOI 10.1161/str.33.1.5
   Carson AP, 2009, ANN EPIDEMIOL, V19, P630, DOI 10.1016/j.annepidem.2009.04.008
   Centers for Disease Control and Prevention (CDC), VIT STAT PUBL US DAT
   Engstad T, 2000, STROKE, V31, P1602, DOI 10.1161/01.STR.31.7.1602
   GILES WH, 1995, ARCH INTERN MED, V155, P1319, DOI 10.1001/archinte.155.12.1319
   GILLUM RF, 1988, STROKE, V19, P1
   Gillum RF, 1999, AM J EPIDEMIOL, V150, P1266
   Hamer M, 2012, CAN MED ASSOC J, V184, P1461, DOI 10.1503/cmaj.111719
   Hankey GJ, 1998, STROKE, V29, P2491, DOI 10.1161/01.STR.29.12.2491
   Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5
   House A, 2001, STROKE, V32, P696, DOI 10.1161/01.STR.32.3.696
   HOWARD G, 1994, STROKE, V25, P2120, DOI 10.1161/01.STR.25.11.2120
   Jonas BS, 2000, PSYCHOSOM MED, V62, P463, DOI 10.1097/00006842-200007000-00001
   Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Kissela B, 2004, STROKE, V35, P426, DOI 10.1161/01.STR.0000110982.74967.39
   KITTNER SJ, 1990, JAMA-J AM MED ASSOC, V264, P1267, DOI 10.1001/jama.264.10.1267
   Lee CD, 2003, STROKE, V34, P2475, DOI 10.1161/01.STR.0000091843.02517.9D
   Liao YL, 2009, STROKE, V40, P3336, DOI 10.1161/STROKEAHA.109.561688
   Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667
   Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703
   Lofmark U, 2007, NEUROEPIDEMIOLOGY, V28, P135, DOI 10.1159/000102141
   Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442
   Myint PK, 2008, EUR J CARDIOV PREV R, V15, P663, DOI 10.1097/HJR.0b013e32830fe465
   Nelson DE, 2001, SOZ PRAVENTIV MED, V46, pS3
   OMAHONY PG, 1995, STROKE, V26, P1334, DOI 10.1161/01.STR.26.8.1334
   Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO
   PLEIS JR, 2007, VITAL HLTH STAT, V10, P1
   Reeves MJ, 2008, LANCET NEUROL, V7, P915, DOI 10.1016/S1474-4422(08)70193-5
   Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046
   Sacco RL, 1998, AM J EPIDEMIOL, V147, P259
   Schiller JS, 2012, VITAL HLTH STAT, V10, P1
   Simons LA, 1998, STROKE, V29, P1341, DOI 10.1161/01.STR.29.7.1341
   Sims NR, 2010, BBA-MOL BASIS DIS, V1802, P80, DOI 10.1016/j.bbadis.2009.09.003
   Suadicani P, 2011, J OCCUP ENVIRON MED, V53, P1388, DOI 10.1097/JOM.0b013e31823c149d
   Swartz JA, 2006, J SUBST ABUSE TREAT, V31, P287, DOI 10.1016/j.jsat.2006.04.009
   Tsadok MA, 2012, JAMA-J AM MED ASSOC, V307, P1952, DOI 10.1001/jama.2012.3490
   Tuttolomondo A, 2008, NUTR METAB CARDIOVAS, V18, P152, DOI 10.1016/j.numecd.2007.02.003
   Wendel-Vos GCW, 2004, INT J EPIDEMIOL, V33, P787, DOI 10.1093/ije/dyh168
   You JS, 2008, STROKE, V39, pE42, DOI 10.1161/STROKEAHA.107.506717
   Zhang Y, 2008, CIRCULATION, V118, P1577, DOI 10.1161/CIRCULATIONAHA.108.772285
NR 44
TC 1
Z9 2
U1 0
U2 3
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0251-5350
J9 NEUROEPIDEMIOLOGY
JI Neuroepidemiology
PY 2013
VL 41
IS 2
BP 94
EP 100
DI 10.1159/000350018
PG 7
WC Public, Environmental & Occupational Health; Clinical Neurology
SC Public, Environmental & Occupational Health; Neurosciences & Neurology
GA 198RQ
UT WOS:000322940400004
PM 23774713
DA 2019-01-08
ER

PT J
AU Saydah, SH
   Imperatore, G
   Beckles, GL
AF Saydah, Sharon H.
   Imperatore, Giuseppina
   Beckles, Gloria L.
TI Socioeconomic Status and Mortality Contribution of health care access
   and psychological distress among US adults with diagnosed diabetes
SO DIABETES CARE
LA English
DT Article
ID ALL-CAUSE MORTALITY; EDUCATIONAL-LEVEL; RISK-FACTORS; LIFE-COURSE;
   FOLLOW-UP; POSITION; INEQUALITIES; ASSOCIATION; DEPRESSION; BEHAVIORS
AB OBJECTIVE-Although several studies have examined the association between socioeconomic status (SES) and mortality in the general population, few have investigated this relationship among people with diabetes. This study sought to determine how risk of mortality associated with measures of SES among adults with diagnosed diabetes is mitigated by association with demographics, comorbidities, diabetes treatment, psychological distress, or health care access and utilization.
   RESEARCH DESIGN AND METHODS-The study included 6,177 adults aged 25 years or older with diagnosed diabetes who participated in the National Health Interview Surveys (1997-2003) linked to mortality data (follow-up through 2006). SES was measured by education attained, financial wealth (either stocks/dividends or home ownership), and income-to-poverty ratio.
   RESULTS-In unadjusted analysis, risk of death was significantly greater for people with lower levels of education and income-to-poverty ratio than for those at the highest levels. After adjusting for demographics, comorbidities, diabetes treatment and duration, health care access, and psychological distress variables, the association with greater risk of death remained significant only for people with the lowest level of education (relative hazard 1.52 [95% CI 1.04-2.23]). After multivariate adjustment, the risk of death was significantly greater for people without certain measures of financial wealth (e. g., stocks, home ownership) (1.56 [1.07-2.27]) than for those with them.
   CONCLUSIONS-The findings suggest that after adjustments for demographics, health care access, and psychological distress, the level of education attained and financial wealth remain strong predictors of mortality risk among adults with diabetes. Diabetes Care 36: 49-55, 2013
C1 [Saydah, Sharon H.; Imperatore, Giuseppina; Beckles, Gloria L.] Ctr Dis Control & Prevent, Div Diabet Translat, Atlanta, GA 30329 USA.
RP Saydah, SH (reprint author), Ctr Dis Control & Prevent, Div Diabet Translat, Atlanta, GA 30329 USA.
EM ssaydah@cdc.gov
CR Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879
   Brown AF, 2004, EPIDEMIOL REV, V26, P63, DOI 10.1093/epirev/mxh002
   Centers for Disease Control and Prevention National Center for Health Statistics, 2000, DES EST NAT HLTH INT
   Chaturvedi N, 1998, BRIT MED J, V316, P100
   Cubbin C, 2011, AM J HEALTH BEHAV, V35, P28
   Dalaker J, 2009, CURRENT POPULATION R
   Dowd JB, 2011, INT J EPIDEMIOL, V40, P183, DOI 10.1093/ije/dyq189
   Dray-Spira R, 2010, DIABETES CARE, V33, P1200, DOI 10.2337/dc09-2094
   Egede LE, 2005, DIABETES CARE, V28, P1339, DOI 10.2337/diacare.28.6.1339
   Galobardes B, 2006, J EPIDEMIOL COMMUN H, V60, P95, DOI 10.1136/jech.2004.028092
   Galobardes B, 2006, J EPIDEMIOL COMMUN H, V60, P7, DOI 10.1136/jech.2004.023531
   Gnavi R, 2004, INT J EPIDEMIOL, V33, P864, DOI 10.1093/ije/dyh089
   Hajat A, 2011, AM J EPIDEMIOL, V173, P192, DOI 10.1093/aje/kwq348
   HUIE SAB, 2003, SOCIAL SCI Q, V84, P667, DOI DOI 10.1111/1540-6237.8403011
   Katon W, 2008, J GEN INTERN MED, V23, P1571, DOI 10.1007/s11606-008-0731-9
   Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184
   Krieger N, 1997, ANNU REV PUBL HEALTH, V18, P341, DOI 10.1146/annurev.publhealth.18.1.341
   Laaksonen M, 2008, EUR J PUBLIC HEALTH, V18, P38, DOI 10.1093/eurpub/ckm051
   Lantz PM, 2010, SOC SCI MED, V70, P1558, DOI 10.1016/j.socscimed.2010.02.003
   Lawlor DA, 2007, DIABETIC MED, V24, P892, DOI 10.1111/j.1464-5491.2007.02187.x
   Lee ET, 2003, PARAMETRIC METHODS C, P246
   Lipscombe LL, 2010, CAN MED ASSOC J, V182, pE1, DOI 10.1503/cmaj.090495
   Lorant V, 2003, AM J EPIDEMIOL, V157, P98, DOI 10.1093/aje/kwf182
   Macintyre S, 2003, J PUBLIC HEALTH MED, V25, P288, DOI 10.1093/pubmed/fdg089
   Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519
   McEwen LN, 2007, DIABETES CARE, V30, P1736, DOI 10.2337/dc07-0305
   Miech RA, 2009, AM J PREV MED, V36, P126, DOI 10.1016/j.amepre.2008.09.041
   National Center for Health Statistics Office of Analysis and Epidemiology The National Health Interview Survey, 1986, LINK MORT FIL 1986 2
   Pollack CE, 2007, AM J PREV MED, V33, P250, DOI 10.1016/j.amerpe.2007.04.033
   Saydah S, 2010, PUBLIC HEALTH REP, V125, P377, DOI 10.1177/003335491012500306
   Schenker N., 2008, MULTIPLE IMPUTATION
   Secrest AM, 2011, ANN EPIDEMIOL, V21, P367, DOI 10.1016/j.annepidem.2011.02.011
   Smith GD, 1997, BMJ-BRIT MED J, V314, P547, DOI 10.1136/bmj.314.7080.547
   Smith JP, 1999, J ECON PERSPECT, V13, P144
   Stringhini S, 2010, JAMA-J AM MED ASSOC, V303, P1159, DOI 10.1001/jama.2010.297
   Turrell G, 2007, J EPIDEMIOL COMMUN H, V61, P723, DOI 10.1136/jech.2007.050609
   van Oort FVA, 2005, J EPIDEMIOL COMMUN H, V59, P214, DOI 10.1136/jech.2003.016493
   Walker JJ, 2011, DIABETES CARE, V34, P1127, DOI 10.2337/dc10-1862
   Weng C, 2000, DIABETIC MED, V17, P612, DOI 10.1046/j.1464-5491.2000.00352.x
   Zhang XP, 2005, AM J EPIDEMIOL, V161, P652, DOI 10.1093/aje/kwi089
NR 40
TC 47
Z9 47
U1 0
U2 11
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
J9 DIABETES CARE
JI Diabetes Care
PD JAN
PY 2013
VL 36
IS 1
BP 49
EP 55
DI 10.2337/dc11-1864
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 083LP
UT WOS:000314465700030
PM 22933434
OA Green Published, Other Gold
DA 2019-01-08
ER

PT J
AU Rodriguez-Penney, AT
   Iudicello, JE
   Riggs, PK
   Doyle, K
   Ellis, RJ
   Letendre, SL
   Grant, I
   Woods, SP
AF Rodriguez-Penney, Alan T.
   Iudicello, Jennifer E.
   Riggs, Patricia K.
   Doyle, Katie
   Ellis, Ronald J.
   Letendre, Scott L.
   Grant, Igor
   Woods, Steven Paul
CA HIV Neurobehav Res Program
TI Co-Morbidities in Persons Infected with HIV: Increased Burden with Older
   Age and Negative Effects on Health-Related Quality of Life
SO AIDS PATIENT CARE AND STDS
LA English
DT Article
ID ACTIVE ANTIRETROVIRAL THERAPY; COMORBIDITY INDEX; NEUROCOGNITIVE
   IMPAIRMENT; MEDICAL COMORBIDITIES; METABOLIC SYNDROME; AIDS; COHORT;
   ADULTS; RISK; IMPACT
AB This study sought to determine the synergistic effects of age and HIV infection on medical co-morbidity burden, along with its clinical correlates and impact on health-related quality of life (HRQoL) across the lifespan in HIV. Participants included 262 individuals across four groups stratified by age (<= 40 and 50 years) and HIV serostatus. Medical co-morbidity burden was assessed using a modified version of the Charlson Co-morbidity Index (CCI). Multiple regression accounting for potentially confounding demographic, psychiatric, and medical factors revealed an interaction between age and HIV infection on the CCI, with the highest medical co-morbidity burden in the older HIV + cohort. Nearly half of the older HIV + group had at least one major medical co-morbidity, with the most prevalent being diabetes (17.8%), syndromic neurocognitive impairment (15.4%), and malignancy (12.2%). Affective distress and detectable plasma viral load were significantly associated with the CCI in the younger and older HIV-infected groups, respectively. Greater co-morbidity burden was uniquely associated with lower physical HRQoL across the lifespan. These findings highlight the prevalence and clinical impact of co-morbidities in older HIV-infected adults and underscore the importance of early detection and treatment efforts that might enhance HIV disease outcomes.
C1 [Rodriguez-Penney, Alan T.] Univ Puerto Rico, Sch Med, San Juan, PR 00936 USA.
   [Iudicello, Jennifer E.; Riggs, Patricia K.; Doyle, Katie; Grant, Igor] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA.
   [Ellis, Ronald J.] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA.
   [Letendre, Scott L.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA.
RP Woods, SP (reprint author), Univ Calif San Diego, Dept Psychiat 8231, 220 Dickinson St,Suite B, San Diego, CA 92103 USA.
EM spwoods@ucsd.edu
OI Ellis, Ronald/0000-0003-4931-752X
FU National Institutes of Health [R01-MH73419, T32-DA31098, P30-MH62512,
   T35-AG026757, L30-DA034362]
FX The San Diego HIV Neurobehavioral Research Program (HNRP) group is
   affiliated with the University of California, San Diego, the Naval
   Hospital, San Diego, and the Veterans Affairs San Diego Healthcare
   System, and includes: Director: Igor Grant, MD; Co-Directors: J. Hampton
   Atkinson, MD, Ronald J. Ellis, MD, PhD, and J. Allen McCutchan, MD;
   Center Manager: Thomas D. Marcotte, PhD; Jennifer Marquie-Beck, MPH;
   Melanie Sherman; Neuromedical Component: Ronald J. Ellis, MD, PhD
   (P.I.), J. Allen McCutchan, MD, Scott Letendre, MD, Edmund Capparelli,
   PharmD, Rachel Schrier, PhD, Terry Alexander, RN, Debra Rosario, MPH,
   Shannon LeBlanc; Neurobehavioral Component: Robert K. Heaton, PhD
   (P.I.), Steven Paul Woods, PsyD, MarianaCherner, PhD, David J. Moore,
   PhD, Matthew Dawson; Neuroimaging Component: Terry Jernigan, PhD (P.I.),
   Christine Fennema-Notestine, PhD, Sarah L. Archibald, MA, John
   Hesselink, MD, Jacopo Annese, PhD, Michael J. Taylor, PhD; Neurobiology
   Component: Eliezer Masliah, MD (P.I.), Cristian Achim, MD, PhD, Ian
   Everall, FRCPsych, FRCPath, PhD (Consultant); Neurovirology Component:
   Douglas Richman, MD, (P.I.), David M. Smith, MD; International
   Component: J. Allen McCutchan, MD, (P.I.); Developmental Component:
   Cristian Achim, MD, PhD; (P.I.), Stuart Lipton, MD, PhD; Participant
   Accrual and Retention Unit: J. Hampton Atkinson, MD (P.I.); Data
   Management Unit: Anthony C. Gamst, PhD (P.I.), Clint Cushman (Data
   Systems Manager); Statistics Unit: Ian Abramson, PhD (P.I.), Florin
   Vaida, PhD, Reena Deutsch, PhD, Anya Umlauf, MS. The authors thank
   Marizela Cameron, Erica Weber, and Nichole Duarte for their assistance
   with study management. This research was supported by National
   Institutes of Health grants R01-MH73419 and T32-DA31098 to Dr. Woods,
   P30-MH62512 to Dr. Grant, T35-AG026757 to Dr. Dilip Jeste, and
   L30-DA034362 to Dr. Iudicello.
CR Alencastro PR, 2011, AIDS PATIENT CARE ST, V25, P627, DOI 10.1089/apc.2010.0360
   American Psychiatric Association, 1994, DIAGN STAT MAN MENT
   Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b
   Backus LI, 2011, AIDS PATIENT CARE ST, V25, P203, DOI 10.1089/apc.2010.0379
   Bamford LP, 2010, AIDS, V24, P928, DOI 10.1097/QAD.0b013e328337b116
   Barclay TR, 2007, HEALTH PSYCHOL, V26, P40, DOI 10.1037/0278-6133.26.1.40
   Bing EG, 2000, QUAL LIFE RES, V9, P55, DOI 10.1023/A:1008919227665
   Blanco JR, 2010, AIDS REV, V12, P218
   Campsmith Michael L, 2003, Health Qual Life Outcomes, V1, P12, DOI 10.1186/1477-7525-1-12
   Cederfjall C, 2001, AIDS PATIENT CARE ST, V15, P31, DOI 10.1089/108729101460083
   Center for Disease Control and Prevention, 2009, HIV SURV REP 2008
   Center for Disease Control and Prevention, 2011, HIV SURV REP 2010
   CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8
   Deeks SG, 2009, BRIT MED J, V338, DOI 10.1136/bmj.a3172
   DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8
   Doyle K, 2012, AIDS BEHAV, V16, P2309, DOI 10.1007/s10461-011-0121-x
   Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4
   Ellis RJ, 1997, ARCH NEUROL-CHICAGO, V54, P416, DOI 10.1001/archneur.1997.00550160054016
   Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993
   GARDNER ID, 1980, REV INFECT DIS, V2, P801
   Goulet JL, 2007, CLIN INFECT DIS, V45, P1593, DOI 10.1086/523577
   Grabar S, 2004, AIDS, V18, P2029, DOI 10.1097/00002030-200410210-00007
   Grinspoon S, 2005, NEW ENGL J MED, V352, P48, DOI 10.1056/NEJMra041811
   Grunfeld C, 2009, AIDS, V23, P1841, DOI 10.1097/QAD.0b013e32832d3b85
   Guaraldi G, 2011, CLIN INFECT DIS, V53, P1120, DOI 10.1093/cid/cir627
   Hall SF, 2006, J CLIN EPIDEMIOL, V59, P849, DOI 10.1016/j.jclinepi.2005.11.013
   Hasse B, 2011, CLIN INFECT DIS, V53, P1130, DOI 10.1093/cid/cir626
   Health and Human Services Agency, 2012, HIV AIDS EP REP 2012
   Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727
   Heaton RK, 2004, J INT NEUROPSYCH SOC, V10, P317, DOI 10.1017/S1355617704102130
   Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1
   Hernandez MD, 2011, CURR OPIN HIV AIDS, V6, P478, DOI 10.1097/COH.0b013e32834bd365
   High KP, 2012, JAIDS-J ACQ IMM DEF, V60, pS1, DOI 10.1097/QAI.0b013e31825a3668
   Hinkin CH, 2008, J ADDICT DIS, V27, P11, DOI 10.1300/J069v27n02_02
   Holzemer WL, 1998, J ADV NURS, V28, P622, DOI 10.1046/j.1365-2648.1998.00800.x
   Hughes AK, 2011, AIDS PATIENT CARE ST, V25, P539, DOI 10.1089/apc.2011.0026
   Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683
   Iudicello JE, 2012, J CLIN EXP NEUROPSYC, V34, P476, DOI 10.1080/13803395.2011.651103
   Jia HG, 2004, AIDS PATIENT CARE ST, V18, P594, DOI 10.1089/1087291042404666
   Kamat R, 2012, ARCH CLIN NEUROPSYCH, V27, P520, DOI 10.1093/arclin/acs055
   Kilbourne AM, 2001, J CLIN EPIDEMIOL, V54, pS22, DOI 10.1016/S0895-4356(01)00443-7
   LAMPING DL, 1994, PSYCHOL HEALTH, V9, P31, DOI 10.1080/08870449408407458
   LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179
   Lohse N, 2011, JAIDS-J ACQ IMM DEF, V57, P334, DOI 10.1097/QAI.0b013e31821d34ed
   McCutchan JA, 2012, NEUROLOGY, V78, P485, DOI 10.1212/WNL.0b013e3182478d64
   McNair D. M, 1981, PROFILE MOOD STATES
   Mocroft A, 2010, JAIDS-J ACQ IMM DEF, V55, P262, DOI 10.1097/QAI.0b013e3181e9be6b
   Monroe AK, 2011, JAIDS-J ACQ IMM DEF, V58, P458, DOI 10.1097/QAI.0b013e31823801c4
   Morgan EE, 2012, JAIDS-J ACQ IMM DEF, V61, P341, DOI 10.1097/QAI.0b013e31826bfc53
   Neidig Judith L, 2003, J Assoc Nurses AIDS Care, V14, P30, DOI 10.1177/1055329002250992
   Nokes KM, 2011, J ASSOC NURSE AIDS C, V22, P186, DOI 10.1016/j.jana.2010.10.006
   OKeefe EA, 1996, QUAL LIFE RES, V5, P275, DOI 10.1007/BF00434749
   Oursler KK, 2006, AIDS PATIENT CARE ST, V20, P782, DOI 10.1089/apc.2006.20.782
   Oursler KK, 2011, AIDS PATIENT CARE ST, V25, P13, DOI 10.1089/apc.2010.0242
   Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16
   Peters L, 2011, ANTIVIR THER, V16, P667, DOI 10.3851/IMP1815
   PHILLIPS AN, 1991, J ACQ IMMUN DEF SYND, V4, P970
   Reekie J, 2010, CANCER-AM CANCER SOC, V116, P5306, DOI 10.1002/cncr.25311
   Schuster Randi Melissa, 2012, Neurobehav HIV Med, V2012, P15
   Skiest DJ, 1996, AM J MED, V101, P605, DOI 10.1016/S0002-9343(96)00329-4
   Sorensen K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-80
   Tate D, 2003, AIDS PATIENT CARE ST, V17, P115, DOI 10.1089/108729103763807936
   Thames AD, 2011, J CLIN EXP NEUROPSYC, V33, P200, DOI 10.1080/13803395.2010.499357
   Tozzi V, 2005, AIDS RES HUM RETROV, V21, P706, DOI 10.1089/aid.2005.21.706
   Tumbarello M, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-46
   Valcour V, 2004, NEUROLOGY, V63, P822, DOI 10.1212/01.WNL.0000134665.58343.8D
   Vance D, 2011, J NEUROSCI NURS, V43, P215, DOI 10.1097/JNN.0b013e3182212a04
   Wechsler D., 2001, WECHSLER TEST ADULT
   Weiss JJ, 2010, AIDS PATIENT CARE ST, V24, P39, DOI 10.1089/apc.2009.0152
   *WHO, 1998, COMP INT DIAGN INT C
   Woods SP, 2004, J CLIN EXP NEUROPSYC, V26, P759, DOI 10.1080/13803390490509565
   Woods SP, 2006, J CLIN EXP NEUROPSYC, V28, P1030, DOI 10.1080/13803390500350985
   Woods SP, 2008, NEUROPSYCHOLOGY, V22, P110, DOI 10.1037/0894-4105.22.1.110
   Woods SP, 2010, J CLIN EXP NEUROPSYC, V32, P398, DOI 10.1080/13803390903130737
   Zavascki AP, 2007, J CLIN EPIDEMIOL, V60, P867, DOI 10.1016/j.jclinepi.2006.11.004
   Zisook S, 1998, J CLIN PSYCHIAT, V59, P217, DOI 10.4088/JCP.v59n0502
NR 76
TC 108
Z9 109
U1 1
U2 21
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1087-2914
EI 1557-7449
J9 AIDS PATIENT CARE ST
JI Aids Patient Care STDS
PD JAN
PY 2013
VL 27
IS 1
BP 5
EP 16
DI 10.1089/apc.2012.0329
PG 12
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA 071HX
UT WOS:000313583400002
PM 23305257
OA Green Published
HC Y
HP N
DA 2019-01-08
ER

PT J
AU Faria, M
   Pavin, EJ
   Parisi, MCR
   Lorena, SLS
   Brunetto, SQ
   Ramos, CD
   Pavan, CR
   Mesquita, MA
AF Faria, Mariza
   Pavin, Elizabeth Joao
   Ribeiro Parisi, Maria Candida
   Silva Lorena, Sonia Leticia
   Brunetto, Sergio Quirino
   Ramos, Celso Dario
   Pavan, Celia Regina
   Mesquita, Maria Aparecida
TI Delayed Small Intestinal Transit in Patients with Long-Standing Type 1
   Diabetes Mellitus: Investigation of the Relationships with Clinical
   Features, Gastric Emptying, Psychological Distress, and Nutritional
   Parameters
SO DIABETES TECHNOLOGY & THERAPEUTICS
LA English
DT Article
ID SMALL-BOWEL TRANSIT; BACTERIAL OVERGROWTH; OROCECAL TRANSIT;
   GASTROINTESTINAL MOTILITY; AUTONOMIC NEUROPATHY; FUNCTIONAL DYSPEPSIA;
   GUT TRANSIT; ANXIETY; DISORDERS; SYMPTOMS
AB Background: Studies on small intestinal transit in type 1 diabetes mellitus have reported contradictory results. This study assessed the orocecal transit time (OCTT) in a group of patients with type 1 diabetes mellitus and its relationships with gastrointestinal symptoms, glycemic control, chronic complications of diabetes, anthropometric indices, gastric emptying, small intestinal bacterial overgrowth (SIBO), and psychological distress.
   Subjects and Methods: Twenty-eight patients with long-standing (> 10 years) type 1 diabetes mellitus (22 women, six men; mean age, 39 +/- 9 years) participated in the study. The lactulose hydrogen breath test was used to determine OCTT and the occurrence of SIBO. The presence of anxiety and depression was assessed by the Hospital Anxiety and Depression scale. Gastric emptying was measured by scintigraphy. Anthropometric indices included body mass index, percentage body fat, midarm circumference, and arm muscle area.
   Results: There was a statistically significant increase in OCTT values in diabetes patients (79 +/- 41 min) in comparison with controls (54 +/- 17 min) (P = 0.01). Individual analysis showed that OCTT was above the upper limit (mean + 2 SD) in 30.8% of patients. All anthropometric parameters were significantly decreased (P < 0.05) in patients with prolonged OCTT in comparison with those with normal OCTT. In contrast, there was no statistically significant association between prolonged OCTT and gastrointestinal symptoms, peripheral neuropathy, diabetic retinopathy, glycated hemoglobin, delayed gastric emptying, SIBO, anxiety, or depression.
   Conclusions: Small bowel transit may be delayed in about one-third of patients with long-standing type 1 diabetes mellitus. This abnormality seems to have a negative effect on nutritional status in these patients.
C1 [Faria, Mariza; Silva Lorena, Sonia Leticia; Pavan, Celia Regina; Mesquita, Maria Aparecida] Univ Estadual Campinas, Div Gastroenterol, Sao Paulo, Brazil.
   [Pavin, Elizabeth Joao; Ribeiro Parisi, Maria Candida] Univ Estadual Campinas, Div Endocrinol, Dept Clin Med, Fac Med Sci, Sao Paulo, Brazil.
   [Brunetto, Sergio Quirino; Ramos, Celso Dario] Univ Estadual Campinas, Nucl Med Serv, Dept Radiol, Sao Paulo, Brazil.
RP Mesquita, MA (reprint author), Univ Estadual Campinas, Dept Clin Med, Disciplina Gastroenterol, Rua Tessalia Vieira de Camargo,126 Cidade Univ Ze, BR-13083887 Campinas, SP, Brazil.
EM mesquita@fcm.unicamp.br
RI 5, INCT/H-4505-2013; Diabetes, Inct/I-2186-2013
CR BASILISCO G, 1989, DIGEST DIS SCI, V34, P509, DOI 10.1007/BF01536325
   Botega NJ, 1995, REV SAUDE PUBL, V29, P355, DOI 10.1590/S0034-89101995000500004
   Cuoco L, 2002, HEPATO-GASTROENTEROL, V49, P1582
   DEBOER SY, 1993, DIGEST DIS SCI, V38, P2228, DOI 10.1007/BF01299901
   DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060
   FOLWACZNY C, 1995, Z GASTROENTEROL, V33, P517
   Frisancho AR, 1990, ANTHROPOMETRIC STAND
   Ghoshal UC, 2011, J NEUROGASTROENTEROL, V17, P312, DOI 10.5056/jnm.2011.17.3.312
   Gorard DA, 1996, GUT, V39, P551, DOI 10.1136/gut.39.4.551
   Grigsby AB, 2002, J PSYCHOSOM RES, V53, P1053, DOI 10.1016/S0022-3999(02)00417-8
   GURNEY JM, 1973, AM J CLIN NUTR, V26, P912
   IBER FL, 1993, DIGEST DIS SCI, V38, P45, DOI 10.1007/BF01296772
   Zhao JB, 2006, WORLD J GASTROENTERO, V12, P2846, DOI 10.3748/wjg.v12.i18.2846
   Kuo P, 2007, DRUGS, V67, P1671, DOI 10.2165/00003495-200767120-00003
   Lewis SJ, 1997, SCAND J GASTROENTERO, V32, P920, DOI 10.3109/00365529709011203
   Lloyd CE, 2000, DIABETIC MED, V17, P198, DOI 10.1046/j.1464-5491.2000.00260.x
   Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061
   Lorena SLS, 2002, J CLIN GASTROENTEROL, V35, P21, DOI 10.1097/01.MCG.0000017334.66204.F3
   Lorena SLS, 2004, J CLIN GASTROENTEROL, V38, P230, DOI 10.1097/00004836-200403000-00007
   MADSEN JL, 1992, DIGEST DIS SCI, V37, P1548
   Ojetti V, 2009, EUR REV MED PHARMACO, V13, P419
   Park, 2005, OBES RES, V13, P491
   Punkkinen J, 2008, DIABETIC MED, V25, P570, DOI 10.1111/j.1464-5491.2008.02428.x
   Rana SV, 2008, SCAND J GASTROENTERO, V43, P1030, DOI 10.1080/00365520801947074
   Rana S, 2011, DIABETES TECHNOL THE, V13, P1115, DOI 10.1089/dia.2011.0078
   Rayner CK, 2001, DIABETES CARE, V24, P371, DOI 10.2337/diacare.24.2.371
   Read NW, 1991, GASTROINTESTINAL TRA, P97
   RosaeSilva L, 1996, GUT, V39, P748, DOI 10.1136/gut.39.5.748
   Russo A, 1996, DIABETOLOGIA, V39, P984
   Sadik R, 2004, AM J GASTROENTEROL, V99, P2429, DOI 10.1111/j.1572-0241.2004.40406.x
   Sadik R, 2003, SCAND J GASTROENTERO, V38, P36, DOI 10.1080/00365520310000410
   SARNO S, 1993, ITAL J GASTROENTEROL, V25, P490
   SCARPELLO JHB, 1976, BRIT MED J, V2, P1225, DOI 10.1136/bmj.2.6046.1225
   Schvarcz E, 1996, DIABETIC MED, V13, P478
   Shakil A, 2008, AM FAM PHYSICIAN, V77, P1697
   SPENGLER U, 1989, PANCREAS, V4, P65, DOI 10.1097/00006676-198902000-00010
   Toeller M, 2001, INT J OBESITY, V25, P1815, DOI 10.1038/sj.ijo.0801816
   WERTH B, 1992, GUT, V33, P1199, DOI 10.1136/gut.33.9.1199
   World Health Organization, 1998, OB PREV MAN GLOB EP
   Xing JH, 2004, OBES RES, V12, P1723, DOI 10.1038/oby.2004.213
NR 40
TC 10
Z9 10
U1 0
U2 5
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1520-9156
J9 DIABETES TECHNOL THE
JI Diabetes Technol. Ther.
PD JAN
PY 2013
VL 15
IS 1
BP 32
EP 38
DI 10.1089/dia.2012.0158
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 069FL
UT WOS:000313420600006
PM 23126582
DA 2019-01-08
ER

PT J
AU Smith, KJ
   Gariepy, G
   Pedneault, M
   Beland, M
   Clyde, M
   Schmitz, N
AF Smith, Kimberley J.
   Gariepy, Genevieve
   Pedneault, Maxime
   Beland, Melanie
   Clyde, Matthew
   Schmitz, Norbert
TI Exploring the Association of Psychological Status with Self-Rated
   Diabetes Control: Results from the Montreal Evaluation of Diabetes
   Treatment Study
SO PSYCHOSOMATICS
LA English
DT Article
ID DISTRESS SCALE; DEPRESSION; ANXIETY; METAANALYSIS; POPULATION; PHQ-9
AB Aims: There is an increasing interest in single-item self-rated indicators of perceived health and control status in people with chronic illnesses such as diabetes. However, self-rated measures can be associated with indicators of psychological status. The aim of this paper is to explore the association of anxiety, depression, and diabetes distress with self-rated diabetes control. Methods: Telephone interviews were conducted with 1,787 people with type 2 diabetes taking oral hypoglycemic medication. Diabetes control, health behaviors, and outcomes, anxiety, depression, and diabetes distress were assessed by standardized questionnaires. Self-reported diabetes control was modeled using logistic regression. Results: The best fit logistic regression model for self-rated poor diabetes control was a model that incorporated diabetes distress. When adjusted for age, sex, and all other health behaviors and outcomes, poor diabetes control was most associated with diabetes distress, physical inactivity, being overweight, and poor eating habits. Conclusions: Results from this study indicate that poor self-rated diabetes control shares the strongest associations with diabetes-specific distress along with perceptions of diabetes-specific healthcare behaviors and outcomes. (Psychosomatics 2013; 54:35-43)
C1 [Smith, Kimberley J.; Pedneault, Maxime; Beland, Melanie; Clyde, Matthew; Schmitz, Norbert] McGill Univ, Dept Psychiat, Montreal, PQ H4H 1R3, Canada.
   [Smith, Kimberley J.; Gariepy, Genevieve; Pedneault, Maxime; Beland, Melanie; Clyde, Matthew; Schmitz, Norbert] McGill Univ, Douglas Mental Hlth Univ Inst, Montreal, PQ H4H 1R3, Canada.
   [Gariepy, Genevieve; Schmitz, Norbert] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ H4H 1R3, Canada.
   [Schmitz, Norbert] Montreal Diabet Res Ctr, Montreal, PQ, Canada.
RP Smith, KJ (reprint author), McGill Univ, Douglas Mental Hlth Univ Inst, Montreal, PQ H4H 1R3, Canada.
EM lcimberly.smith@douglas.mcgill.ca
RI Schmitz, Norbert/A-5177-2010
OI Schmitz, Norbert/0000-0001-7777-6323; Gariepy,
   Genevieve/0000-0001-9209-4240; Smith, Kimberley/0000-0002-1323-627X
FU Canadian Institutes of Health Research (CIHR); BIP; Regie de l'assurance
   maladies du Quebec (RAMQ)
FX The authors extend their thanks to the Canadian Institutes of Health
   Research (CIHR) for funding this study. They thank the BIP and Regie de
   l'assurance maladies du Quebec (RAMQ) for their support of this
   research. They also thank all the study collaborators and all the
   participants who kindly gave their time to help us with our research.
CR Brez S, 2008, CAN J DIABETES, V32, pS32
   Fincke BG, 2005, J AMBUL CARE MANAG, V28, P262
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2009, DIABETIC MED, V26, P622, DOI 10.1111/j.1464-5491.2009.02730.x
   Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341
   Hayashino Y, 2012, DIABET MED
   Katon W, 2007, GEN HOSP PSYCHIAT, V29, P147, DOI 10.1016/j.genhosppsych.2006.11.005
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Lange LJ, 2005, J PSYCHOSOM RES, V58, P129, DOI 10.1016/j.jpsychores.2004.08.004
   Leyva B, 2011, ETHNIC DIS, V21, P322
   Lin EHB, 2010, DIABETES CARE, V33, P264, DOI 10.2337/dc09-1068
   Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093
   Manea L, 2012, CAN MED ASSOC J, V184, pE191, DOI 10.1503/cmaj.110829
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Schmitz N, 2011, PSYCHOSOMATICS, V52, P167, DOI 10.1016/j.psym.2010.11.020
   Schmitz N, 2009, DIABETES CARE, V32, P1998, DOI 10.2337/dc09-0838
   Scott KM, 2007, J AFFECT DISORDERS, V103, P113, DOI 10.1016/j.jad.2007.01.015
   Smith KJ, 2012, DIABETES RES CLIN PR, V95, P162, DOI 10.1016/j.diabres.2011.10.019
   Stankovic Z, 2011, PSYCHIAT DANUB, V23, P34
   Statistics Canada, 2003, CANADIAN COMMUNITY H
   Wennberg P, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000760
   Wu SFV, 2011, INT J NURS STUD, V48, P1376, DOI 10.1016/j.ijnurstu.2011.04.008
   Zagarins SE, 2012, J BEHAV MED, V35, P299, DOI 10.1007/s10865-011-9359-z
   Zulman DM, 2012, PATIENT EDUC COUNS, V87, P74, DOI 10.1016/j.pec.2011.07.013
NR 26
TC 15
Z9 16
U1 1
U2 21
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0033-3182
J9 PSYCHOSOMATICS
JI Psychosomatics
PD JAN-FEB
PY 2013
VL 54
IS 1
BP 35
EP 43
DI 10.1016/j.psym.2012.08.002
PG 9
WC Psychiatry; Psychology
SC Psychiatry; Psychology
GA 071QS
UT WOS:000313609900005
PM 23295005
DA 2019-01-08
ER

PT J
AU Reddy, J
   Wilhelm, K
   Campbell, L
AF Reddy, Jaya
   Wilhelm, Kay
   Campbell, Lesley
TI Putting PAID to Diabetes-Related Distress: The Potential Utility of the
   Problem Areas in Diabetes (PAID) Scale in Patients with Diabetes
SO PSYCHOSOMATICS
LA English
DT Article
ID DEPRESSIVE SYMPTOMS; EMOTIONAL-PROBLEMS; GLYCEMIC CONTROL; PRIMARY-CARE;
   SELF-CARE; ADULTS; QUESTIONNAIRE; EXPECTATIONS; VALIDATION; DISORDERS
AB Introduction: Distress and depression are commonly reported negative affects in people with diabetes (PWD), and may influence glycemic control. 'Distress' can be measured as general or diabetes-related. 'Depression' is considered through symptom severity or episodes of depressive disorder, both potentially derived by the Patient Health Questionnaire (PHQ-9). While current depressive disorder is found to affect the course of diabetes mellitus (DM), past depressive disorder may have a similar impact. Objectives: To test the relationships between DM-distress (measured by the Problem Areas in Diabetes instrument [PAID]) and glycemic control, while considering the effects of general distress; depression severity; and both current and previous depressive disorder. Methods: In a diabetic service, 184 type 1 (n = 51) and type 2 (n = 133) PWD completed the PAID, PHQ-9 depression scale from the Patient Health Questionnaire, Kessler-10 psychological distress (K10), and Short-Form Survey (SF-12) instruments. Glycosylated hemoglobin (HbA1c) levels measured on the day of recruitment were recorded from the case notes. Results: DM-related distress correlated positively with HbA1c, PHQ-9 depression, K10, and SF-12 MCS (mental component summary) scores, (all p < 0.01); and negatively with age(p < 0.01). Regression analysis revealed a significant association between PAID with PHQ-9 depression scores (p < 0.01) and with HbA1c (p < 0.01). PWD with past depressive disorder had higher PAID scores than those without (p < 0.05), and this was significant even after controlling for current depression scores (p < 0.05). Conclusions: In PWD, DM-specific distress measured by the PAID correlated significantly with impaired glycemic control. Both past and current depressions are independently associated with DM-distress. The PAID is discussed as a potential screening tool. (Psychosomatics 2013; 54:44-51)
C1 [Reddy, Jaya; Wilhelm, Kay] Univ New S Wales, Sch Psychiat, Fac Med, Randwick, NSW 2031, Australia.
   [Reddy, Jaya; Wilhelm, Kay] Univ New S Wales, Black Dog Inst, Randwick, NSW 2031, Australia.
   [Reddy, Jaya; Wilhelm, Kay] St Vincents Hosp, St Vincents Urban Mental Hlth Res Inst, Sydney, NSW 2010, Australia.
   [Reddy, Jaya] Univ Kebangsaan Malaysia, Dept Psychiat, Kuala Lumpur, Malaysia.
   [Campbell, Lesley] St Vincents Hosp, Diabet Serv, Sydney, NSW 2010, Australia.
   [Campbell, Lesley] Univ New S Wales, Sch Med, Fac Med, Sydney, NSW 2052, Australia.
RP Reddy, J (reprint author), St Vincents Hosp, St Vincents Urban Mental Hlth Res Inst, Faces St, Sydney, NSW 2010, Australia.
EM jreddy68@yahoo.com
FU NHMRC [222708, 230802, 157209, 510137]; Centre for Mental Health, NSW
   Department of Health
FX The study was supported by NHMRC Program grants 222708, 230802, 157209,
   and 510137; an Infrastructure Grant from the Centre for Mental Health,
   NSW Department of Health. The authors thank the Diabetes Services at St.
   Vincent's and Prince of Wales Hospitals for access to their patients,
   and the patients themselves, for their time, interest, and provision of
   material.
CR Chawla A, 2010, DIABETES EDUCATOR, V36, P337, DOI 10.1177/0145721709354607
   Delahanty LM, 2007, DIABETIC MED, V24, P48, DOI 10.1111/j.1464-5491.2007.02028.x
   Diez-Quevedo C, 2001, PSYCHOSOM MED, V63, P679, DOI 10.1097/00006842-200107000-00021
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Gonzalez JS, 2008, DIABETOLOGIA, V51, P1822, DOI 10.1007/s00125-008-1113-x
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   Jackson JL, 2001, ANN INTERN MED, V134, P889, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00013
   Karlsen B, 2004, PATIENT EDUC COUNS, V53, P299, DOI 10.1016/j.pec.2003.10.008
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006
   Lloyd CE, 2010, DIABETIC MED, V27, P234, DOI 10.1111/j.1464-5491.2009.02896.x
   Lustman PJ, 1997, GEN HOSP PSYCHIAT, V19, P138, DOI 10.1016/S0163-8343(96)00170-3
   Nakahara R, 2006, PSYCHOSOMATICS, V47, P240, DOI 10.1176/appi.psy.47.3.240
   Nozaki T, 2009, BIOPSYCHOSOC MED, V3, DOI 10.1186/1751-0759-3-4
   Perini SJ, 2006, J AFFECT DISORDERS, V90, P123, DOI 10.1016/j.jad.2005.10.011
   Peyrot M, 1999, DIABETES CARE, V22, P448, DOI 10.2337/diacare.22.3.448
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Pouwer F, 2005, DIABETES RES CLIN PR, V70, P166, DOI 10.1016/j.diabres.2005.03.031
   Rao JK, 2000, ARCH FAM MED, V9, P1148, DOI 10.1001/archfami.9.10.1148
   Reddy JP, 2011, THESIS
   Rubin RR, 2001, J CLIN PSYCHOL, V57, P457, DOI 10.1002/jclp.1041
   Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737
   Surwit Richard S., 1993, Annals of Behavioral Medicine, V15, P227
   Wagner JA, 2007, DIABETIC MED, V24, P211, DOI 10.1111/j.1464-5491.2007.02044.x
   Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003
   Welch G, 2003, DIABETIC MED, V20, P69, DOI 10.1046/j.1464-5491.2003.00832.x
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   Wilhelm K, 2004, PSYCHOSOMATICS, V45, P461, DOI 10.1176/appi.psy.45.6.461
   Yi JP, 2008, INT J BEHAV MED, V15, P167, DOI 10.1080/10705500802219481
NR 32
TC 27
Z9 29
U1 2
U2 23
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0033-3182
J9 PSYCHOSOMATICS
JI Psychosomatics
PD JAN-FEB
PY 2013
VL 54
IS 1
BP 44
EP 51
DI 10.1016/j.psym.2012.08.004
PG 8
WC Psychiatry; Psychology
SC Psychiatry; Psychology
GA 071QS
UT WOS:000313609900006
PM 23295006
DA 2019-01-08
ER

PT J
AU Hilliard, ME
   Wu, YP
   Rausch, J
   Dolan, LM
   Hood, KK
AF Hilliard, Marisa E.
   Wu, Yelena P.
   Rausch, Joseph
   Dolan, Lawrence M.
   Hood, Korey K.
TI Predictors of Deteriorations in Diabetes Management and Control in
   Adolescents With Type 1 Diabetes
SO JOURNAL OF ADOLESCENT HEALTH
LA English
DT Article
DE Type 1 diabetes; Depression; Distress; Family conflict; Blood glucose
   monitoring; Glycemic control
ID GLYCEMIC CONTROL; FAMILY CONFLICT; DEPRESSIVE SYMPTOMS; ADHERENCE;
   CHILDREN; IMPACT; TRAJECTORIES; ASSOCIATION; STATEMENT; ADULTHOOD
AB Purpose: Deteriorating type 1 diabetes management and control are common among adolescents; however, clinical evidence suggests that individual trajectories can vary. The aim of this study was to examine patterns and predictors of blood glucose monitoring (BGM) frequency and glycemic control (hemoglobin A1c).
   Methods: Prospective data analysis spanning 18-24 months was conducted with 150 adolescent-parent pairs. Latent group-based trajectory modeling identified subgroups and determined medical, demographic, psychological, and family predictors of subgroup membership.
   Results: Three subgroups emerged, representing diabetes management and control that are "meeting treatment targets" (40%; A1c at baseline = 7.4%, BGM frequency at baseline = 4.8 checks/day) and two levels "not meeting targets":"normatively similar" youth (40%; A1c = 9.2%, BGM frequency = 2.8 checks/day), and "high-risk" youth (20%; A1c = 11.2%, BGM frequency = 2.9 checks/day). Subgroup membership was maintained over 18-24 months. There was minimal change across time, although only one-third of adolescents met treatment targets. Older age, longer diabetes duration, ethnic minority status, unmarried caregiver status, insulin delivery via injections versus continuous subcutaneous insulin infusion, greater depressive symptoms, negative affect about BGM, and diabetes-specific family conflict each predicted membership in a subgroup with poorer diabetes management and control.
   Conclusions: Among the nearly two-thirds of adolescents with management and control that do not meet treatment targets, modifiable and nonmodifiable factors may signal the need for prevention or intervention. Demographic and medical factors may call for proactive efforts to prevent deterioration, and psychological symptoms and family conflict signal opportunities for clinical intervention to promote improved diabetes management and control in adolescence. (C) 2013 Society for Adolescent Health and Medicine. All rights reserved.
C1 [Hood, Korey K.] Univ Calif San Francisco, Madison Clin Pediat Diabet, Div Endocrinol, Dept Pediat, San Francisco, CA 94143 USA.
   [Hilliard, Marisa E.] Johns Hopkins Univ, Sch Med, Johns Hopkins Adherence Res Ctr, Dept Med, Baltimore, MD USA.
   [Wu, Yelena P.; Rausch, Joseph] Cincinnati Childrens Hosp, Med Ctr, Ctr Promot Treatment Adherence & Self Management, Div Behav Med & Clin Psychol, Cincinnati, OH USA.
   [Rausch, Joseph; Dolan, Lawrence M.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA.
   [Dolan, Lawrence M.] Cincinnati Childrens Hosp, Med Ctr, Div Endocrinol, Cincinnati, OH USA.
RP Hood, KK (reprint author), Univ Calif San Francisco, Madison Clin Pediat Diabet, Div Endocrinol, Dept Pediat, 400 Parnassus Ave,4th Floor,UCSF Mail Box 0318, San Francisco, CA 94143 USA.
EM hoodk@peds.ucsf.edu
RI Rausch, Joseph/E-8107-2018
OI Hilliard, Marisa/0000-0002-8813-629X
FU National Institutes of Health [K23, DK077340]
FX This research was supported by a career development award from the
   National Institutes of Health to K.K.H. (K23, DK077340).
CR AMIEL SA, 1986, NEW ENGL J MED, V315, P215, DOI 10.1056/NEJM198607243150402
   Anderson B. J., 2004, DIABETES SPECTRUM, V17, P22, DOI [DOI 10.2337/DIASPECT.17.1.22, 10.2337/diaspect.17.1.22]
   Anderson BJ, 2002, DIABETIC MED, V19, P635, DOI 10.1046/j.1464-5491.2002.00752.x
   Anderson BJ, 1999, DIABETES CARE, V22, P713, DOI 10.2337/diacare.22.5.713
   Barnard KD, 2008, PRACT DIABETES INT, V25, P194
   Bryden KS, 2001, DIABETES CARE, V24, P1536, DOI 10.2337/diacare.24.9.1536
   Butler DA, 2008, PEDIATR DIABETES, V9, P373, DOI 10.1111/j.1399-5448.2008.00370.x
   David-Ferdon C, 2008, J CLIN CHILD ADOLESC, V37, P62, DOI 10.1080/15374410701817865
   Genuth S, 2001, J PEDIATR-US, V139, P804, DOI 10.1067/mpd.2001.118887
   Graffy J, 2009, PRIM HEALTH CARE RES, V10, P210
   Grey M, 2002, J PSYCHOSOM RES, V53, P907, DOI 10.1016/S0022-3999(02)00312-4
   Helgeson VS, 2011, PEDIATR DIABETES, V12, P25, DOI 10.1111/j.1399-5448.2010.00663.x
   Helgeson VS, 2010, J PEDIATR PSYCHOL, V35, P1161, DOI 10.1093/jpepsy/jsq011
   Helgeson VS, 2009, J PEDIATR PSYCHOL, V34, P254, DOI 10.1093/jpepsy/jsn079
   Hood KK, 2004, DIABETES CARE, V27, P2610, DOI 10.2337/diacare.27.11.2610
   Hood KK, 2007, DIABETES CARE, V30, P1764, DOI 10.2337/dc06-2358
   Hood KK, 2011, PEDIATR DIABETES, V12, P718, DOI 10.1111/j.1399-5448.2011.00771.x
   Hood KK, 2009, PEDIATRICS, V124, pE1171, DOI 10.1542/peds.2009-0207
   JACOBSON AM, 1994, PSYCHOSOM MED, V56, P401, DOI 10.1097/00006842-199409000-00004
   JOHNSON SB, 1992, J PEDIATR PSYCHOL, V17, P537, DOI 10.1093/jpepsy/17.5.537
   Kazak AE, 2006, FAM SYST HEALTH, V24, P381, DOI DOI 10.1037/1091-7527.24.4.381
   KOVACS M, 1992, J AM ACAD CHILD PSY, V31, P1112, DOI 10.1097/00004583-199211000-00020
   KOVACS M, 1985, PSYCHOPHARMACOL BULL, V21, P995
   Kovacs M, 1997, DIABETES CARE, V20, P45, DOI 10.2337/diacare.20.1.45
   Lustman PJ, 2002, J PSYCHOSOM RES, V53, P917, DOI 10.1016/S0022-3999(02)00416-6
   Luyckx K, 2009, DIABETES CARE, V32, P797, DOI 10.2337/dc08-1990
   McGrady ME, 2009, DIABETES CARE, V32, P804, DOI 10.2337/dc08-2111
   Moreland EC, 2006, ARCH INTERN MED, V166, P689, DOI 10.1001/archinte.166.6.689
   Muthen L. K., 1998, MPLUS USERS GUIDE
   Nagin D, 2005, GROUP BASED MODELING
   Patino AM, 2005, J PEDIATR PSYCHOL, V30, P503, DOI 10.1093/jpepsy.jsi075
   Petitti DB, 2009, J PEDIATR-US, V155, P668, DOI 10.1016/j.jpeds.2009.05.025
   Phillip M, 2007, DIABETES CARE, V30, P1653, DOI 10.2337/dc07-9922
   Rohan JM, 2011, PEDIATR DIABETES, V12, P611, DOI 10.1111/j.1399-5448.2010.00752.x
   Silverstein J, 2005, DIABETES CARE, V28, P186, DOI 10.2337/diacare.28.1.186
   Swift EE, 2006, ANN BEHAV MED, V32, P39, DOI 10.1207/s15324796abm3201_5
   Wagner EH, 2001, JAMA-J AM MED ASSOC, V285, P182, DOI 10.1001/jama.285.2.182
   Wysocki T, 2007, DIABETES CARE, V30, P555, DOI 10.2337/dc06-1613
NR 38
TC 73
Z9 73
U1 1
U2 41
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1054-139X
EI 1879-1972
J9 J ADOLESCENT HEALTH
JI J. Adolesc. Health
PD JAN
PY 2013
VL 52
IS 1
BP 28
EP 34
DI 10.1016/j.jadohealth.2012.05.009
PG 7
WC Psychology, Developmental; Public, Environmental & Occupational Health;
   Pediatrics
SC Psychology; Public, Environmental & Occupational Health; Pediatrics
GA 061LU
UT WOS:000312850500004
PM 23260831
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Fleer, J
   Tovote, KA
   Keers, JC
   Links, TP
   Sanderman, R
   Coyne, JC
   Schroevers, MJ
AF Fleer, J.
   Tovote, K. A.
   Keers, J. C.
   Links, T. P.
   Sanderman, R.
   Coyne, J. C.
   Schroevers, M. J.
TI Screening for depression and diabetes-related distress in a diabetes
   outpatient clinic
SO DIABETIC MEDICINE
LA English
DT Article
ID PLACEBO-CONTROLLED TRIAL; CO-MORBID DEPRESSION; GLYCEMIC CONTROL;
   PROBLEM AREAS; DOUBLE-BLIND; PREVALENCE; ADULTS; SCALE; DISORDERS;
   SERVICES
AB Aims To investigate: (1) the willingness of patients with diabetes to participate in a screening programme; (2) the extent to which patients with diabetes who screen positive endorse need for psychosocial care; (3) the rate of referral to psychosocial care during screening vs. usual care. Methods Four hundred and ninety-nine patients with diabetes were invited to complete the Center for Epidemiologic Studies Depression and the Problem Areas in Diabetes questionnaires. Patients screening positive on either instrument were invited for an interview. One year after screening was withdrawn, rates of referral to psychosocial care were assessed from physician reports of patient referrals. Results In total, 349/499 (70%) patients with diabetes completed the questionnaire. Patients who did not take up the screening were younger, smoked more often and had higher HbA1c values. No-shows for clinical appointments accounted for 74% of non-participation. Of the 104 (30% of 349) patients screening positive, 45 accepted an invitation for an interview. Finally, 36/104 (35%) would like a referral for psychological care. Seven per cent of patients were referred to psychological care during screening compared with 1% when screening was withdrawn. Conclusions Results raise questions as to whether screening is the most efficient way to identify patients with psychological problems. Many patients did not take up the screening, especially those with low adherence to diabetes care in general. Furthermore, few patients screening positive wanted to be referred. Screening should be evaluated in the context of consideration of alternative ways to identify at-risk patients, including providing resources to deal with patients with already known adjustment and adherence problems. Diabet. Med. 30, 88-94 (2013)
C1 [Fleer, J.; Tovote, K. A.; Sanderman, R.; Coyne, J. C.; Schroevers, M. J.] Univ Groningen, Dept Hlth Sci, Sect Hlth Psychol, Groningen, Netherlands.
   [Fleer, J.; Tovote, K. A.; Keers, J. C.; Links, T. P.; Sanderman, R.; Coyne, J. C.; Schroevers, M. J.] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands.
   [Keers, J. C.; Links, T. P.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands.
   [Keers, J. C.] Martini Hosp Groningen, Res Inst, Groningen, Netherlands.
   [Coyne, J. C.] Univ Penn, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 19104 USA.
RP Fleer, J (reprint author), Univ Groningen, Dept Hlth Sci, Sect Hlth Psychol, Groningen, Netherlands.
EM j.fleer@umcg.nl
FU Dutch Diabetes Foundation [2006.13.007]
FX This study was supported by the Dutch Diabetes Foundation (2006.13.007).
CR Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x
   Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS13, DOI 10.2337/dc09-S013
   Barnard KD, 2006, DIABETIC MED, V23, P445, DOI 10.1111/j.1464-5491.2006.01814.x
   Beekman ATF, 1997, PSYCHOL MED, V27, P231, DOI 10.1017/S0033291796003510
   Bot M, 2010, DIABETIC MED, V27, P1295, DOI 10.1111/j.1464-5491.2010.03119.x
   Brown JSL, 2004, BRIT J PSYCHIAT, V185, P511, DOI 10.1192/bjp.185.6.511
   de Wit M, 2010, PEDIATR DIABETES, V11, P175, DOI 10.1111/j.1399-5448.2009.00543.x
   FECHNERBATES S, 1994, J CONSULT CLIN PSYCH, V62, P550, DOI 10.1037//0022-006X.62.3.550
   Forsell Y, 2006, PSYCHIAT SERV, V57, P114, DOI 10.1176/appi.ps.57.1.114
   Garssen B, 2008, PSYCHO-ONCOLOGY, V17, P726, DOI 10.1002/pon.1362
   Garssen B, 2010, J NATL CANCER I, V102, P507, DOI 10.1093/jnci/djq047
   Gilbody S, 2010, SCREENING DEPRESSION, P335
   Gottlieb SS, 2004, J AM COLL CARDIOL, V43, P1542, DOI 10.1016/j.jacc.2003.10.064
   Holland W, 2005, SCREENING DIS PREVEN
   International Diabetes Federation, 2005, GLOB GUID TYP 2 DIAB
   Katon WJ, 2004, ARCH GEN PSYCHIAT, V61, P1042, DOI 10.1001/archpsyc.61.10.1042
   Korhonen T, 2007, PSYCHOL MED, V37, P705, DOI 10.1017/S0033291706009639
   Li CY, 2010, DIABETES CARE, V33, P1061, DOI 10.2337/dc09-1515
   Lustman PJ, 1997, PSYCHOSOM MED, V59, P241, DOI 10.1097/00006842-199705000-00007
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Lustman PJ, 2000, DIABETES CARE, V23, P618, DOI 10.2337/diacare.23.5.618
   Lustman PJ, 1998, ANN INTERN MED, V129, P613, DOI 10.7326/0003-4819-129-8-199810150-00005
   Luttik MLA, 2011, EUR J CARDIOVASC NUR, V10, P228, DOI 10.1016/j.ejcnurse.2010.08.005
   Nefs G, 2012, DIABETOLOGIA, V55, P608, DOI 10.1007/s00125-011-2411-2
   Palmer SC, 2012, CANCER-AM CANCER SOC, V118, P2735, DOI 10.1002/cncr.26603
   PEYROT M, 1994, DIABETES EDUCATOR, V20, P143, DOI 10.1177/014572179402000210
   Pouwer F, 2006, PATIENT EDUC COUNS, V60, P235, DOI 10.1016/j.pec.2005.01.009
   Pouwer F, 2011, DIABETOLOGIA, V54, P741, DOI 10.1007/s00125-010-2033-0
   Pouwer F, 2009, NAT REV ENDOCRINOL, V5, P665, DOI 10.1038/nrendo.2009.214
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Roy T, 2012, DIABETIC MED, V29, P164, DOI 10.1111/j.1464-5491.2011.03401.x
   Rubin R. R., 1993, DIABETES ED, V19, P210, DOI [DOI 10.1177/014572179301900308, 10.1177/014572179301900308]
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Snoek FJ, 2011, DIABETES CARE, V34, P601, DOI 10.2337/dc10-1552
   Tuinman MA, 2008, CANCER-AM CANCER SOC, V113, P870, DOI 10.1002/cncr.23622
   van Scheppingen C, 2011, PSYCHO-ONCOLOGY, V20, P655, DOI 10.1002/pon.1939
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
NR 37
TC 19
Z9 19
U1 0
U2 22
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD JAN
PY 2013
VL 30
IS 1
BP 88
EP 94
DI 10.1111/dme.12001
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 057GD
UT WOS:000312550100017
PM 22924587
DA 2019-01-08
ER

PT J
AU Pouwer, F
   Wijnhoven, HAH
   Ujcic-Voortman, JK
   de Wit, M
   Schram, MT
   Baan, CA
   Snoek, FJ
AF Pouwer, F.
   Wijnhoven, H. A. H.
   Ujcic-Voortman, J. K.
   de Wit, M.
   Schram, M. T.
   Baan, C. A.
   Snoek, F. J.
TI Ethnic aspects of emotional distress in patients with diabetes - the
   Amsterdam Health Monitor Study
SO DIABETIC MEDICINE
LA English
DT Article
ID CO-MORBID DEPRESSION; PSYCHOLOGICAL DISTRESS; RISK-FACTORS; PREVALENCE;
   METAANALYSIS; NETHERLANDS; MELLITUS; ANXIETY; MOROCCAN; TURKISH
AB Aims Depression and anxiety are relatively common in patients with diabetes, but it is unclear whether migrant patients with diabetes are at increased risk for emotional distress. We determined levels of emotional distress in patients with diabetes with a Turkish, Moroccan or Dutch ethnic background and compare distress levels with healthy control subjects. Among patients with diabetes, we examined demographic and clinical correlates of higher levels of emotional distress. Methods Cross-sectional data were collected within the framework of the population-based Amsterdam Health Monitor Survey. Adult participants were interviewed to assess demographics, presence of chronic disease(s) and ethnic background. Emotional distress was determined with the Kessler psychological distress scale. Blood was drawn to determine HbA1c, glucose, HDL and total cholesterol. Anthropometrics and blood pressure were assessed during a medical examination. Results The total sample comprised of 1736 participants. The prevalence of emotional distress was significantly higher in participants with diabetes (31%) compared with healthy participants (19%). Increased levels of emotional distress were reported by 38% of the Turkish, 35% of the native Dutch and 29% of the Moroccan patients with diabetes. Among patients with diabetes, the presence of two or more co-morbid chronic diseases was most strongly associated with higher levels of emotional distress, whereas glycaemic control, cholesterol, blood pressure or waist circumference were not. Conclusions Emotional distress affects approximately one third of adult patients with diabetes living in Amsterdam. Having multiple co-morbid diseases seems related to more emotional distress among these patients, while ethnicity and diabetes-related characteristics are not. Diabet. Med. 30, e25-e31 (2013)
C1 [Pouwer, F.] Tilburg Univ, Ctr Res Psychol Somat Dis, Dept Med & Clin Psychol, NL-5000 LE Tilburg, Netherlands.
   [Wijnhoven, H. A. H.] Vrije Univ Amsterdam, Dept Hlth Sci, Amsterdam, Netherlands.
   [Wijnhoven, H. A. H.; Baan, C. A.; Snoek, F. J.] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands.
   [Ujcic-Voortman, J. K.; de Wit, M.] Amsterdam Publ Hlth Serv GGD, Amsterdam, Netherlands.
   [Schram, M. T.] Maastricht Univ, Dept Internal Med, Med Ctr, Maastricht, Netherlands.
   [Schram, M. T.; Baan, C. A.] Ctr Prevent & Hlth Serv Res, Natl Inst Publ Hlth & Environm, Bilthoven, Netherlands.
   [Snoek, F. J.] Vrije Univ Amsterdam, Dept Med Psychol, Med Ctr, Amsterdam, Netherlands.
RP Pouwer, F (reprint author), Tilburg Univ, Ctr Res Psychol Somat Dis, Dept Med & Clin Psychol, NL-5000 LE Tilburg, Netherlands.
EM f.pouwer@tilburguniversity.edu
CR Adriaanse MC, 2008, DIABETIC MED, V25, P843, DOI 10.1111/j.1464-5491.2008.02464.x
   Agyemang C, 2006, J HYPERTENS, V24, P2169, DOI 10.1097/01.hjh.0000249693.73618.c9
   Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x
   Barnard KD, 2006, DIABETIC MED, V23, P445, DOI 10.1111/j.1464-5491.2006.01814.x
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   Fassaert T, 2009, INT J METH PSYCH RES, V18, P159, DOI 10.1002/mpr.288
   Fassaert T, 2010, GEN HOSP PSYCHIAT, V32, P368, DOI 10.1016/j.genhosppsych.2010.04.010
   Grigsby AB, 2002, J PSYCHOSOM RES, V53, P1053, DOI 10.1016/S0022-3999(02)00417-8
   Home P, 2006, DIABETIC MED, V23, P579
   Ismail K, 2007, DIABETES CARE, V30, P1473, DOI 10.2337/dc06-2313
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Knol MJ, 2007, PSYCHOSOM MED, V69, P300, DOI 10.1097/PSY.0b013e31805f48b9
   Koopmans B, 2009, DIABETOLOGIA, V52, P2056, DOI 10.1007/s00125-009-1460-2
   Koyvess-Masfety V, 2000, CAN J PSYCHIAT, V2005, P926
   Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985
   Nefs G, 2012, DIABETOLOGIA, V55, P608, DOI 10.1007/s00125-011-2411-2
   Nicolaas Han, BUITENLANDSE MIGRATI
   Nouwen A, 2010, DIABETOLOGIA, V53, P2480, DOI 10.1007/s00125-010-1874-x
   Pouwer F, 2003, DIABETOLOGIA, V46, P892, DOI 10.1007/s00125-003-1124-6
   Pouwer F, 2006, PATIENT EDUC COUNS, V60, P235, DOI 10.1016/j.pec.2005.01.009
   Pouwer F, 2010, DIABETIC MED, V27, P217, DOI 10.1111/j.1464-5491.2009.02903.x
   Pouwer F, 2001, DIABETES CARE, V24, P1929, DOI 10.2337/diacare.24.11.1929
   Pouwer F, 2009, NAT REV ENDOCRINOL, V5, P665, DOI 10.1038/nrendo.2009.214
   Pouwer F, 2010, DISCOV MED, V9, P112
   Schram MT, 2009, CURR DIABETES REV, V5, P112, DOI 10.2174/157339909788166828
   Shankman SA, 2003, CLIN PSYCHOL REV, V23, P605, DOI 10.1016/S0272-7358(03)00038-2
   Snoek FJ, 2011, DIABETES CARE, V34, P601, DOI 10.2337/dc10-1552
   Uittewaal PJM, 2004, PREV MED, V39, P1068
   Ujcic-Voortman JK, 2009, EUR J PUBLIC HEALTH, V19, P511, DOI 10.1093/eurpub/ckp096
   van der Wurff FB, 2004, J AFFECT DISORDERS, V83, P33, DOI 10.1016/j.jad.2004.04.009
NR 30
TC 7
Z9 7
U1 0
U2 18
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD JAN
PY 2013
VL 30
IS 1
BP E25
EP E31
DI 10.1111/dme.12031
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 057GD
UT WOS:000312550100004
PM 23072362
DA 2019-01-08
ER

PT J
AU Kay, W
   Inika, G
   Jaya, R
   Phillip, M
   Lesley, C
   Carol, DS
   Kerrie, P
   Peter, S
AF Kay, Wilhelm
   Inika, Gillis
   Jaya, Reddy
   Phillip B, Mitchell
   Lesley, Campbell
   Carol, Dobson-Stone
   Kerrie, Pierce
   Peter R, Schofield
TI Association between serotonin transporter promoter polymorphisms and
   psychological distress in a diabetic population
SO PSYCHIATRY RESEARCH
LA English
DT Article
DE Serotonin transporter; SLC6A4; 5-HTTLPR; rs25531; Anxiety; Depression
ID DEPRESSIVE SYMPTOMS; GENE POLYMORPHISM; LIFE EVENTS; 5-HTTLPR;
   METAANALYSIS; PREVALENCE; STRESS; MODERATION; MELLITUS; DISEASE
AB Investigations into serotonin transporter and anxiety and depression have shown an association between stress, depression onset and genotype. We investigated the relationship between 5-HTTLPR genotype and depression and anxiety in a population with diabetes mellitus, a condition associated with high rates of stress and depression. Participants were classified according to 'S' and 'L' alleles as well as the modification of the single nucleotide polymorphism (SNP) rs25531. The 5-HTTLPR low-expression genotype group (S or L-G allele carriers) had significantly higher psychological distress (K10) scores (N=234, P=0.047). Subsequent analysis revealed that the effect of genotype was related to anxiety symptoms rather than depression symptoms. Furthermore, the main effect of genotype was not observed when the modification of the SNP polymorphism was not taken into account. Findings suggest that 5-HTTLPR/rs25531 genotype is associated with psychological distress in a sample of subjects with diabetes. Crown Copyright (C) 2012 Published by Elsevier Ireland Ltd. All rights reserved.
C1 [Kay, Wilhelm; Inika, Gillis; Jaya, Reddy; Phillip B, Mitchell] Univ New S Wales, Fac Med, Sch Psychiat, Randwick, NSW 2031, Australia.
   [Kay, Wilhelm; Inika, Gillis; Jaya, Reddy; Phillip B, Mitchell] Univ New S Wales, Black Dog Inst, Randwick, NSW 2031, Australia.
   [Kay, Wilhelm; Jaya, Reddy] St Vincents Hosp, Urban Mental Hlth & Wellbeing Inst, Sydney, NSW 2010, Australia.
   [Jaya, Reddy] Univ Kebangsaan Malaysia, Dept Psychiat, Kuala Lumpur, Malaysia.
   [Lesley, Campbell] Univ New S Wales, Fac Med, Sch Med, Sydney, NSW 2052, Australia.
   [Carol, Dobson-Stone; Kerrie, Pierce; Peter R, Schofield] Neurosci Res Inst, Randwick, NSW 2031, Australia.
   [Carol, Dobson-Stone; Peter R, Schofield] Univ New S Wales, Sch Med Sci, Sydney, NSW 2052, Australia.
RP Kay, W (reprint author), Univ NSW, Sch Psychiat, St Vincents Hosp, OBrien Ctr, Level 4,390 Victoria St, Darlinghurst, NSW 2010, Australia.
EM kwilhelm@stvincents.com.au
RI Pierce, Kerrie/O-7300-2018
OI Pierce, Kerrie/0000-0003-0636-4836; Schofield,
   Peter/0000-0003-2967-9662; Mitchell, Philip/0000-0002-7954-5235
FU NHMRC [222708]; ARC [DP0774248]; Centre for Mental Health, NSW
   Department of Health;  [510216]
FX Adam Finch, Liesbeth Geerligs, Elaine Royal, Lucinda Wedgwood, Tara
   Showyin and Jennifer Siegel were involved in data collection. Funding
   from the NHMRC Programme Grant no. 222708, the Project Grant no. 510216,
   the ARC Discovery Project Grant no. DP0774248, and an Infrastructure
   Grant from the Centre for Mental Health, NSW Department of Health. We
   thank Kevin Bird and Dusan Hadzi-Pavlovic for statistical input and
   advice; the Diabetes Services at St Vincent's and Prince of Wales
   Hospitals, Sydney for access to their patients and the patients
   themselves, for their time, interest and provision of material for
   genotyping.
CR Aikens JE, 2009, DIABETES CARE, V32, P1177, DOI 10.2337/dc09-0071
   Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Andrews G, 2001, AUST NZ J PUBL HEAL, V25, P494, DOI 10.1111/j.1467-842X.2001.tb00310.x
   Aujla N, 2010, DIABETIC MED, V27, P896, DOI 10.1111/j.1464-5491.2010.03042.x
   Bull SJ, 2009, MOL PSYCHIATR, V14, P1095, DOI 10.1038/mp.2008.48
   Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968
   Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452
   Costa PT, 1992, REVISED NEO PERSONAL
   DOHRENWEND BP, 1980, ARCH GEN PSYCHIAT, V37, P1229
   Gonda X, 2007, PSYCHIAT RES, V149, P261, DOI 10.1016/j.psychres.2006.05.014
   Grabe HJ, 2005, MOL PSYCHIATR, V10, P220, DOI 10.1038/sj.mp.4001555
   Grafe K, 2004, DIAGNOSTICA, V50, P171, DOI 10.1026/0012-1924.50.4.171
   Grigsby AB, 2002, J PSYCHOSOM RES, V53, P1053, DOI 10.1016/S0022-3999(02)00417-8
   Hu XZ, 2006, AM J HUM GENET, V78, P815, DOI 10.1086/503850
   Karg K, 2011, ARCH GEN PSYCHIAT, V68, P444, DOI 10.1001/archgenpsychiatry.2010.189
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Knol MJ, 2006, DIABETOLOGIA, V49, P837, DOI 10.1007/s00125-006-0159-x
   Kohen R, 2008, ARCH GEN PSYCHIAT, V65, P1296, DOI 10.1001/archpsyc.65.11.1296
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   LENZE EJ, 2005, AM J GERIATR PSYCHIA, V13, P428
   Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527
   Link B. G., 1980, MENTAL ILLNESS US EP, P114
   Miyata S, 2007, BRAIN RES, V1147, P233, DOI 10.1016/j.brainres.2007.02.001
   Mossner R, 2001, MOL PSYCHIATR, V6, P350, DOI 10.1038/sj.mp.4000849
   Munafo MR, 2009, BIOL PSYCHIAT, V65, P211, DOI 10.1016/j.biopsych.2008.06.009
   Nakamura M, 2000, MOL PSYCHIATR, V5, P32, DOI 10.1038/sj.mp.4000698
   Nakatani D, 2005, AM HEART J, V150, P652, DOI 10.1016/j.ahj.2005.03.062
   Otte C, 2007, AM J PSYCHIAT, V164, P1379, DOI 10.1176/appi.apj.2007.06.06101617
   Pan A, 2008, J AFFECT DISORDERS, V109, P75, DOI 10.1016/j.jad.2007.11.002
   Petrisic MS, 1997, J NEUROCHEM, V68, P2435
   Ramasubbu R, 2006, J NEUROPSYCH CLIN N, V18, P96, DOI 10.1176/appi.neuropsych.18.1.96
   Risch N, 2009, JAMA-J AM MED ASSOC, V301, P2462, DOI 10.1001/jama.2009.878
   Rutter M, 2010, DEPRESS ANXIETY, V27, P1, DOI 10.1002/da.20641
   Skinner TC, 2010, DIABETIC MED, V27, P965, DOI 10.1111/j.1464-5491.2010.03028.x
   Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737
   Szily E, 2008, J NEURAL TRANSM, V115, P819, DOI 10.1007/s00702-008-0029-4
   Uher R, 2008, MOL PSYCHIATR, V13, P131, DOI 10.1038/sj.mp.4002067
   Wendland JR, 2006, MOL PSYCHIATR, V11, P224, DOI 10.1038/sj.mp.4001789
   Wilhelm K, 2006, BRIT J PSYCHIAT, V188, P210, DOI 10.1192/bjp.bp.105.009522
NR 40
TC 5
Z9 6
U1 0
U2 16
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0165-1781
J9 PSYCHIAT RES
JI Psychiatry Res.
PD DEC 30
PY 2012
VL 200
IS 2-3
BP 343
EP 348
DI 10.1016/j.psychres.2012.07.008
PG 6
WC Psychiatry
SC Psychiatry
GA 073TF
UT WOS:000313764700044
PM 22921508
DA 2019-01-08
ER

PT J
AU Mommersteeg, PMC
   Herr, R
   Zijlstra, WP
   Schneider, S
   Pouwer, F
AF Mommersteeg, Paula M. C.
   Herr, Raphael
   Zijlstra, Wobbe P.
   Schneider, Sven
   Pouwer, Francois
TI Higher levels of psychological distress are associated with a higher
   risk of incident diabetes during 18 year follow-up: results from the
   British household panel survey
SO BMC PUBLIC HEALTH
LA English
DT Article
DE Type 2 diabetes; Psychological distress; Prospective; Risk factor;
   British household panel survey
ID PHYSICAL-ACTIVITY; DEPRESSIVE SYMPTOMS; HEART-DISEASE; TYPE-2; MELLITUS;
   ADULTS; CARE; METAANALYSIS; MORTALITY; JAPANESE
AB Background: Reviews have shown that depression is a risk factor for the development of type 2 diabetes. However, there is limited evidence for general psychological distress to be associated with incident diabetes. The aim of the present study was to test whether persons who report higher levels of psychological distress are at increased risk to develop type 2 diabetes during 18 years follow up, adjusted for confounders.
   Methods: A prospective analysis using data from 9,514 participants (41 years, SD=14; 44% men) of the British Household Panel Survey. The General Health Questionnaire 12 item version was used to assess general psychological distress, diabetes was measured by means of self-report. Cox proportional hazards regression models were used to calculate the multivariate-adjusted hazard ratio (HR) of incident diabetes during 18 years follow up, comparing participants with low versus high psychological distress at baseline (1991).
   Results: A total of 472 participants developed diabetes 18 year follow up. Those with a high level of psychological distress had a 33% higher hazard of developing diabetes (HR=1.33, 95% CI 1.10-1.61), relative to those with a low level of psychological distress, adjusted for age, sex, education level and household income. After further adjustment for differences in level of energy, health status, health problems and activity level, higher psychological distress was no longer associated with incident diabetes (HR=1.10, 95% CI 0.91-1.34).
   Conclusions: Higher levels of psychological distress are a risk factor for the development of diabetes during an 18 year follow up period. This association may be potentially mediated by low energy level and impaired health status.
C1 [Mommersteeg, Paula M. C.; Zijlstra, Wobbe P.; Pouwer, Francois] Tilburg Univ, Dept Med & Clin Psychol, Ctr Res Psychol Somat Dis, CoRPS, NL-5000 LE Tilburg, Netherlands.
   [Herr, Raphael; Schneider, Sven] Med Fac Mannheim, Mannheim Inst Publ Hlth Social & Prevent Med, MIPH, Mannheim, Germany.
   [Zijlstra, Wobbe P.] Tilburg Univ, Dept Methodol & Stat, NL-5000 LE Tilburg, Netherlands.
RP Mommersteeg, PMC (reprint author), Tilburg Univ, Dept Med & Clin Psychol, Ctr Res Psychol Somat Dis, CoRPS, NL-5000 LE Tilburg, Netherlands.
EM P.M.C.Mommersteeg@tilburguniversity.edu
FU Roche Diagnostics Deutschland GmbH, Mannheim, Germany
FX SvS was supported by a small grant from Roche Diagnostics Deutschland
   GmbH, Mannheim, Germany, for a study on gestational diabetes. All other
   authors: Nothing to declare.
CR Barr-Anderson DJ, 2011, AM J PREV MED, V40, P76, DOI 10.1016/j.amepre.2010.09.033
   Brice J, 2010, BRIT HOUSEHOLD PANEL, VA
   Champaneri S, 2010, CURR DIABETES REP, V10, P396, DOI 10.1007/s11892-010-0148-9
   Dandona P, 2005, CIRCULATION, V111, P1448, DOI 10.1161/01.CIR.0000158483.13093.9D
   Fisher L, 2011, CURR MED RES OPIN, V27, P39, DOI 10.1185/03007995.2011.619176
   Gillett M, 2012, DIABETIC MED
   Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242
   Golden SH, 2006, PSYCHONEUROENDOCRINO, V31, P325, DOI 10.1016/j.psyneuen.2005.08.008
   Hahn D, 2006, PSYCHOSOC MED, V3, P9
   Hamer M, 2010, PSYCHOSOM MED, V72, P882, DOI 10.1097/PSY.0b013e3181f6696e
   Hankins M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-355
   Home P, 2006, DIABETIC MED, V23, P579
   Institute for Social and Economic Research British Household Panel Survey, 2010, WAV 1 18 1991 2009 C
   Kato M, 2009, ENDOCR J, V56, P459, DOI 10.1507/endocrj.K09E-003
   Klein M, 2005, SURVIVAL ANAL SELF L
   Knol MJ, 2006, DIABETOLOGIA, V49, P837, DOI 10.1007/s00125-006-0159-x
   Koopmans B, 2009, FAM PRACT, V26, P171, DOI 10.1093/fampra/cmp016
   Kriegsman DMW, 1996, J CLIN EPIDEMIOL, V49, P1407, DOI 10.1016/S0895-4356(96)00274-0
   Kumari M, 2004, ARCH INTERN MED, V164, P1873, DOI 10.1001/archinte.164.17.1873
   Lysy Z, 2008, DIABETIC MED, V25, P1133, DOI 10.1111/j.1464-5491.2008.02545.x
   Gonzalez ELM, 2009, J EPIDEMIOL COMMUN H, V63, P332, DOI 10.1136/jech.2008.080382
   Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985
   Orozco LJ, 2008, COCHRANE DB SYST REV, V3, DOI DOI 10.02/1461051858
   Pouwer F, 2011, DIABETOLOGIA, V54, P741, DOI 10.1007/s00125-010-2033-0
   Pouwer F, 2010, DISCOV MED, V9, P112
   Ridner SH, 2004, J ADV NURS, V45, P536, DOI 10.1046/j.1365-2648.2003.02938.x
   Rod NH, 2009, J INTERN MED, V266, P467, DOI 10.1111/j.1365-2796.2009.02124.x
   Sawatzky R, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-68
   Shirom A, 2010, PSYCHOSOM MED, V72, P727, DOI 10.1097/PSY.0b013e3181eeb643
   Toshihiro M, 2008, DIABETIC MED, V25, P1211, DOI 10.1111/j.1464-5491.2008.02566.x
   van der Heijden MMP, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-331
   Whooley MA, 2008, JAMA-J AM MED ASSOC, V300, P2379, DOI 10.1001/jama.2008.711
   Willis T, 1675, PHARM RATIONALIS SIV
   Yates T, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-46
NR 34
TC 20
Z9 20
U1 1
U2 23
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD DEC 23
PY 2012
VL 12
AR 1109
DI 10.1186/1471-2458-12-1109
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 074RT
UT WOS:000313831600001
PM 23259455
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Gois, C
   Akiskal, H
   Akiskal, K
   Figueira, ML
AF Gois, Carlos
   Akiskal, Hagop
   Akiskal, Kareen
   Luisa Figueira, M.
TI Depressive temperament, distress, psychological adjustment and
   depressive symptoms in type 2 diabetes
SO JOURNAL OF AFFECTIVE DISORDERS
LA English
DT Review
DE Depressive temperament; Depression; TEMPS-A; Type 2 diabetes; Diabetes
   distress; Metabolic control
ID SELF-REPORTED DISTRESS; GLYCEMIC CONTROL; ANXIETY DISORDERS;
   BIDIRECTIONAL ASSOCIATION; RISK-FACTOR; ADULTS; METAANALYSIS;
   PERSONALITY; WOMEN; VALIDATION
AB Major depression, depressive symptoms, distress with diabetes and psychological adjustment to type 2 diabetes (T2DM) are somehow overlapping constructs with shared covariance. Nevertheless, diabetes distress remains the most prevalent long-lasting factor associated with hyperglycemia in T2DM. This ought to be taken on account when treatment is planned, namely when one is looking for metabolic control and emotional distress integrative care. Temperament or other long-term individual characteristics may support the interplay of distress, psychological adjustment and depressive states in T2DM. Depressive temperament may constitute a vulnerability factor to behavioral or biological T2DM outcome or even a potential risk factor to T2DM later incidence. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Gois, Carlos; Luisa Figueira, M.] Univ Lisbon, Hosp Santa Maria, Fac Med, Dept Psychiat, P-1600 Lisbon, Portugal.
   [Akiskal, Hagop; Akiskal, Kareen] Univ Calif San Diego, La Jolla, CA 92093 USA.
   [Akiskal, Hagop; Akiskal, Kareen] Int Mood Ctr, La Jolla, CA USA.
RP Gois, C (reprint author), Univ Lisbon, Hosp Santa Maria, Fac Med, Dept Psychiat, Av Prof Egas Moniz, P-1600 Lisbon, Portugal.
EM carlosgois13@gmail.com
OI Gois, Carlos/0000-0003-4346-4844
CR Akiskal HS, 2005, J AFFECT DISORDERS, V85, P3, DOI 10.1016/j.jad.2004.12.001
   AKISKAL HS, 1983, J AFFECT DISORDERS, V40, P801
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Arroyo C, 2004, DIABETES CARE, V27, P129, DOI 10.2337/diacare.27.1.129
   Brown LC, 2006, CAN MED ASSOC J, V175, P42, DOI 10.1503/cmaj.051429
   Carnethon MR, 2003, AM J EPIDEMIOL, V158, P416, DOI 10.1093/aje/kwg172
   Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278
   CLARK LA, 1994, J ABNORM PSYCHOL, V103, P103, DOI 10.1037/0021-843X.103.1.103
   COYNE JC, 1994, PSYCHOL BULL, V116, P29, DOI 10.1037/0033-2909.116.1.29
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   de Ridder D, 2008, LANCET, V372, P246, DOI 10.1016/S0140-6736(08)61078-8
   Delahanty LM, 2007, DIABETIC MED, V24, P48, DOI 10.1111/j.1464-5491.2007.02028.x
   Demakakos P, 2010, DIABETES CARE, V33, P792, DOI 10.2337/dc09-1663
   Eaton WW, 1996, DIABETES CARE, V19, P1097, DOI 10.2337/diacare.19.10.1097
   Engum A, 2005, DIABETES CARE, V28, P1904, DOI 10.2337/diacare.28.8.1904
   FECHNERBATES S, 1994, J CONSULT CLIN PSYCH, V62, P550, DOI 10.1037//0022-006X.62.3.550
   Figueira ML, 2008, J AFFECT DISORDERS, V111, P193, DOI 10.1016/j.jad.2008.03.001
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2001, DIABETES CARE, V24, P1751, DOI 10.2337/diacare.24.10.1751
   Fisher L., 2009, DIABETIC MED, V29, P622
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Gois C.J., 2010, ACTA DIABETOLOGY
   Gois C, 2011, J AFFECT DISORDERS, V134, P52, DOI 10.1016/j.jad.2011.05.021
   Golden SH, 2008, JAMA-J AM MED ASSOC, V299, P2751, DOI 10.1001/jama.299.23.2751
   Gonzalez J.S., 2007, DIABETES CARE, V30, P222
   Gonzalez J.S., 2011, DIABETES CARE, V4, P236
   Ismail K, 2007, DIABETES CARE, V30, P1473, DOI 10.2337/dc06-2313
   Katon Wayne J, 2011, Dialogues Clin Neurosci, V13, P7
   Kawakami N, 1999, DIABETES CARE, V22, P1071, DOI 10.2337/diacare.22.7.1071
   KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P853
   Knol MJ, 2006, DIABETOLOGIA, V49, P837, DOI 10.1007/s00125-006-0159-x
   Lane JD, 2000, DIABETES CARE, V23, P1321, DOI 10.2337/diacare.23.9.1321
   Lin EHB, 2004, DIABETES CARE, V27, P2154, DOI 10.2337/diacare.27.9.2154
   LUSTMAN PJ, 1991, PSYCHOSOM MED, V53, P305, DOI 10.1097/00006842-199105000-00004
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985
   Mezuk B, 2008, AM J PUBLIC HEALTH, V98, P1480, DOI 10.2105/AJPH.2007.126441
   Nakahara R, 2006, PSYCHOSOMATICS, V47, P240, DOI 10.1176/appi.psy.47.3.240
   Nichols GA, 2000, DIABETES CARE, V23, P273, DOI 10.2337/diacare.23.3.273
   Pan A, 2010, ARCH INTERN MED, V170, P1884, DOI 10.1001/archinternmed.2010.356
   Power F., 2005, DIABETES RES CLIN PR, V70, P166
   Richardson LK, 2008, GEN HOSP PSYCHIAT, V30, P509, DOI 10.1016/j.genhosppsych.2008.07.001
   Rihmer Z, 2010, CURR OPIN PSYCHIATR, V23, P12, DOI 10.1097/YCO.0b013e32833299d4
   Rubin R.R., 2006, CLIN DIABETES, V21, P269
   Sharpe L, 2006, SOC SCI MED, V62, P1153, DOI 10.1016/j.socscimed.2005.07.010
   Stanton A.L., 2007, ANNU REV PSYCHOL, V58, P656
   Tomassini A, 2009, INT J PSYCHIAT CLIN, V13, P31, DOI 10.1080/13651500802369482
   Watson D, 2005, J RES PERS, V39, P46, DOI 10.1016/j.jrp.2004.09.006
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
NR 49
TC 6
Z9 6
U1 1
U2 30
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-0327
J9 J AFFECT DISORDERS
JI J. Affect. Disord.
PD DEC 20
PY 2012
VL 143
IS 1-3
BP 1
EP 4
DI 10.1016/j.jad.2012.05.028
PG 4
WC Clinical Neurology; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 038ZY
UT WOS:000311213800001
PM 22901331
DA 2019-01-08
ER

PT J
AU Schrier, AC
   Ujcic-Voortman, JK
   de Wit, MAS
   Verhoeff, AP
   Kupka, R
   Dekker, J
   Beekman, ATF
AF Schrier, Agnes C.
   Ujcic-Voortman, Joanne K.
   de Wit, Matty A. S.
   Verhoeff, Arnoud P.
   Kupka, Ralph
   Dekker, Jack
   Beekman, Aartjan T. F.
TI Ethnic differences in the association between cardiovascular risk
   factors and psychological distress in a population study in the
   Netherlands
SO BMC PUBLIC HEALTH
LA English
DT Article
DE Obesity; Cardiovascular; Depression; Ethnicity; Epidemiology
ID MAJOR DEPRESSIVE DISORDER; METABOLIC SYNDROME; GENERAL-POPULATION;
   ANXIETY DISORDERS; SCREENING SCALES; NATIVE DUTCH; FOLLOW-UP; OBESITY;
   SYMPTOMS; TURKISH
AB Background: There is growing body of evidence of an association between cardiovascular risk factors and depressive and anxiety symptoms. The purpose of this study was to investigate whether these associations are similar in ethnic minority groups.
   Methods: A random urban population sample, aged 18+, stratified by ethnicity (484 native Dutch subjects, 383 Turkish-Dutch subjects, and 316 Moroccan-Dutch subjects), in Amsterdam, the Netherlands, was interviewed with the Kessler Psychological Distress scale (K10) in combination with measurements of several cardiovascular risk factors. The association of psychological distress (defined as a K10 score above cut-off of 20) with cardiovascular risk factors (obesity, abdominal obesity, hypertension, hypercholesterolemia, low HDL cholesterol levels or diabetes), ethnicity and their interaction was analyzed using logistic regression analyses, stratified by gender and adjusted for age.
   Results: Cardiovascular risk factors were not significantly associated with psychological distress in any of the gender/ethnic groups, with the exception of a positive association of obesity and hypertension with psychological distress in native Dutch women and a negative association of hypertension and psychological distress in Turkish men. Interaction terms of cardiovascular risk factors and ethnicity were approaching significance only in the association of obesity with the K10 in women.
   Conclusion: In this cross-sectional multi-ethnic adult population sample the majority of the investigated cardiovascular risk factors were not associated with psychological distress. The association of obesity with psychological distress varies by gender and ethnicity. Our findings indicate that the prevention of obesity and psychological distress calls for an integrated approach in native Dutch women, but not necessarily in Turkish-Dutch and Moroccan-Dutch women, in whom these problems may be targeted separately.
C1 [Schrier, Agnes C.; Kupka, Ralph] Altrecht Inst Mental Hlth Care, Utrecht, Netherlands.
   [Ujcic-Voortman, Joanne K.; de Wit, Matty A. S.; Verhoeff, Arnoud P.] Publ Hlth Serv Amsterdam, Dept Epidemiol, Amsterdam, Netherlands.
   [Verhoeff, Arnoud P.] Univ Amsterdam, Dept Sociol & Anthropol, Amsterdam, Netherlands.
   [Kupka, Ralph; Beekman, Aartjan T. F.] Vrije Univ Amsterdam, Med Ctr, Dept Psychiat, Amsterdam, Netherlands.
   [Dekker, Jack] Vrije Univ Amsterdam, Med Ctr, Dept Clin Psychol, Amsterdam, Netherlands.
   [Dekker, Jack; Beekman, Aartjan T. F.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands.
RP Schrier, AC (reprint author), Altrecht Inst Mental Hlth Care, Utrecht, Netherlands.
EM a.schrier@altrecht.nl
RI Verhoeff, Arnoud/F-7924-2013
FU Municipality of Amsterdam; National Institute of Public Health;
   Environment in the Netherlands; Public Health Service Amsterdam;
   Altrecht Institute for Mental Health
FX The data collection of the study was financed by the Municipality of
   Amsterdam and the National Institute of Public Health and the
   Environment in the Netherlands. The data analyses built on the work of
   Mrs. Joanne Ujcic-Voortman, who is financed by the Public Health Service
   Amsterdam. Mrs. A. C. Schrier was supported by Altrecht Institute for
   Mental Health during data analysis and writing of the manuscript.
CR Agyemang C, 2006, J HYPERTENS, V24, P2169, DOI 10.1097/01.hjh.0000249693.73618.c9
   Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8
   Alonso J, 2004, INT J METH PSYCH RES, V18, P159
   Andrews G, 2001, AUST NZ J PUBL HEAL, V25, P494, DOI 10.1111/j.1467-842X.2001.tb00310.x
   Beydoun MA, 2010, J AFFECT DISORDERS, V123, P52, DOI 10.1016/j.jad.2009.09.021
   Carpenter KM, 2000, AM J PUBLIC HEALTH, V90, P251, DOI 10.2105/AJPH.90.2.251
   CBO Dutch Institute for Healthcare Improvement, 2006, DUTCH GUID CARD RISK
   de Wit L, 2010, PSYCHIAT RES, V178, P230, DOI 10.1016/j.psychres.2009.04.015
   de Wit MAS, 2008, SOC PSYCH PSYCH EPID, V43, P905, DOI 10.1007/s00127-008-0382-5
   Delaney JAC, 2010, HYPERTENSION, V55, P408, DOI 10.1161/HYPERTENSIONAHA.109.139824
   Donker T, 2010, PSYCHIAT RES, V176, P45, DOI 10.1016/j.psychres.2009.01.012
   Dortland AKBV, 2010, ACTA PSYCHIAT SCAND, V122, P30, DOI 10.1111/j.1600-0447.2010.01565.x
   Dortland AKBV, 2010, J CLIN PSYCHIAT, V71, P729, DOI 10.4088/JCP.08m04865blu
   Fassaert T, 2008, INT J METH PSYCH RES, V18, P159
   Gavin AR, 2010, PUBLIC HEALTH REP, V125, P698, DOI 10.1177/003335491012500512
   Grabe S, 2006, PSYCHOL BULL, V132, P622, DOI 10.1037/0033-2909.132.4.622
   Heo M, 2006, INT J OBESITY, V30, P513, DOI 10.1038/sj.ijo.0803122
   Hildrum B, 2009, ACTA PSYCHIAT SCAND, V120, P14, DOI 10.1111/j.1600-0447.2008.01315.x
   Jackson JS, 2010, AM J PUBLIC HEALTH, V100, P933, DOI 10.2105/AJPH.2008.143446
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Keyes KM, 2011, SOC SCI MED, V72, P650, DOI 10.1016/j.socscimed.2010.12.005
   Kinder LS, 2004, PSYCHOSOM MED, V66, P316, DOI 10.1097/01.psy.0000124755.91880.f4
   Koponen H, 2008, J CLIN PSYCHIAT, V69, P178, DOI 10.4088/JCP.v69n0202
   Levecque K, 2007, J AFFECT DISORDERS, V97, P229, DOI 10.1016/j.jad.2006.06.022
   Luppino FS, 2011, PSYCHOSOM MED, V73, P257, DOI 10.1097/PSY.0b013e31820a59c0
   Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2
   Marijnissen RM, 2010, J AM GERIATR SOC, V59, P67
   Nicolaou M, 2008, PUBLIC HEALTH NUTR, V11, P1332, DOI 10.1017/S1368980008002966
   Ozmen D, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-80
   Simon GE, 2006, ARCH GEN PSYCHIAT, V63, P824, DOI 10.1001/archpsyc.63.7.824
   Skilton MR, 2007, BIOL PSYCHIAT, V62, P1251, DOI 10.1016/j.biopsych.2007.01.012
   Slot J, 2006, MEASUREMENT ACTUAL Q
   Tedders SH, 2011, J AFFECT DISORDERS, V135, P115, DOI 10.1016/j.jad.2011.06.045
   Toker S, 2008, DEPRESS ANXIETY, V25, P661, DOI 10.1002/da.20379
   Ujcic-Voortman JK, 2011, OBESITY FACTS, V4, P53, DOI 10.1159/000324555
   Ujcic-Voortman JK, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-740
   Ujcic-Voortman JK, 2009, EUR J PUBLIC HEALTH, V19, P511, DOI 10.1093/eurpub/ckp096
   Vogelzangs N, 2007, J GERONTOL A-BIOL, V62, P563, DOI 10.1093/gerona/62.5.563
   Vogelzangs N, 2010, J CLIN PSYCHIAT, V71, P391, DOI 10.4088/JCP.08m04743blu
   Vogelzangs N, 2008, ARCH GEN PSYCHIAT, V65, P1386, DOI 10.1001/archpsyc.65.12.1386
   World Health Organization, 2000, 903 WHO
NR 41
TC 2
Z9 2
U1 1
U2 9
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD DEC 18
PY 2012
VL 12
AR 1090
DI 10.1186/1471-2458-12-1090
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 077OB
UT WOS:000314035900001
PM 23249268
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Mendenhall, E
   Shivashankar, R
   Tandon, N
   Ali, MK
   Narayan, KMV
   Prabhakaran, D
AF Mendenhall, Emily
   Shivashankar, Roopa
   Tandon, Nikhil
   Ali, Mohammed K.
   Narayan, K. M. Venkat
   Prabhakaran, Dorairaj
TI Stress and diabetes in socioeconomic context: A qualitative study of
   urban Indians
SO SOCIAL SCIENCE & MEDICINE
LA English
DT Article
DE Social distress; Depression; Type 2 diabetes; Qualitative interviews;
   Urban health; India
ID PRIMARY-CARE; DEVELOPING-COUNTRIES; CARDIOVASCULAR RISK; RURAL
   EPIDEMIOLOGY; ANXIETY DISORDERS; DEPRESSION; PREVALENCE; MELLITUS;
   PERSPECTIVES; METAANALYSIS
AB Type 2 diabetes has escalated in urban India in the past two decades. Historically a disease of the affluent, recent epidemiological evidence indicates rising diabetes incidence and prevalence in urban India's middle class and working poor. Although there is substantial qualitative data about people with diabetes from high-income countries, scant resources provide insight into diabetes experiences among those in India, and lower-income groups specifically. In this article, we use individual-level analysis of illness narratives to understand how people experience and understand diabetes across income groups in Delhi, India. We conducted in-depth qualitative interviews and administered the Hopkins Symptoms Check-List (HSCL-25) to evaluate depression among 59 people with diabetes in northeast Delhi between December 2011 and February 2012. We analyzed their responses to: 1) what caused your diabetes?: 2) what do you find most stressful in your daily life?: and 3) where do you seek diabetes care? We found few people held diabetes beliefs that were congruent with socio-spiritual or biomedical explanatory models, and higher income participants commonly cited "tension" as a contributor to diabetes. Stress associated with children's futures, financial security, and family dynamics were most commonly reported, but how these subjective stresses were realized in people's lives varied across income groups. Depression was most common among the poorest income group (55%) but was also reported among middle- (38%) and high-income (29%) participants. One-quarter of respondents reported diabetes distress, but only those from the low-income community reported co-occurring depression and these respondents often revealed poor access to diabetes care. These data suggest that lower-income populations not only have higher rates of depression but also may be more likely to delay health care and therefore develop diabetes complications. This research has many implications for public health care in India as diabetes prevalence shifts to affect lower income groups who concurrently experience higher rates of depression and poorer access to medical care. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Mendenhall, Emily] Univ Witwatersrand, Fac Hlth Sci, MRC Wits Dev Pathways Hlth Res Unit, ZA-2198 Johannesburg, South Africa.
   [Mendenhall, Emily; Shivashankar, Roopa; Tandon, Nikhil; Ali, Mohammed K.; Narayan, K. M. Venkat; Prabhakaran, Dorairaj] Publ Hlth Fdn India, COE CARRS, New Delhi, India.
   [Shivashankar, Roopa; Prabhakaran, Dorairaj] Ctr Chron Dis Control, New Delhi, India.
   [Tandon, Nikhil] All Indian Inst Med Res, New Delhi, India.
   [Ali, Mohammed K.; Narayan, K. M. Venkat] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.
RP Mendenhall, E (reprint author), Univ Witwatersrand, Fac Hlth Sci, MRC Wits Dev Pathways Hlth Res Unit, ZA-2198 Johannesburg, South Africa.
EM emily.mendenhall@gmail.com
RI Narayan, K.M. Venkat/J-9819-2012
OI Narayan, K.M. Venkat/0000-0001-8621-5405; Prabhakaran,
   Dorairaj/0000-0002-3172-834X; Mendenhall, Emily/0000-0002-5826-1321
FU Fogarty International Center of the National Institutes of Health
   through the International Clinical Research Fellows Program at
   Vanderbilt University [R24 TW007988]; American Relief and Recovery Act;
   Fogarty International Center [D43 HD065249]; Eunice Kennedy Shriver
   National Institute of Child Health & Human Development
FX We are grateful to the study participants who shared their time and
   personal experiences with us. Planning this study would have been
   difficult without the guidance from Lesley Jo Weaver regarding
   qualitative diabetes research in Delhi, and conducting the study would
   have been impossible without the hard work of Sneha Sharma and Allam
   Ashraf. Thank you to John Millhauser and Sara Lewis for reviewing the
   manuscript. The first author (EM) was supported by the Fogarty
   International Center of the National Institutes of Health through the
   International Clinical Research Fellows Program at Vanderbilt University
   (R24 TW007988) and the American Relief and Recovery Act. The second
   author (RS) was supported by a National Institutes of Health D43
   Fellowship (D43 HD065249) from the Fogarty International Center and the
   Eunice Kennedy Shriver National Institute of Child Health & Human
   Development.
CR Ajay VS, 2008, DIABETIC MED, V25, P1187, DOI 10.1111/j.1464-5491.2008.02554.x
   Bernard H. R., 1988, RES METHODS CULTURAL
   Brown RA, 2009, ANN HUM BIOL, V36, P248, DOI 10.1080/03014460902832942
   Chokkanathan S, 2009, SOC SCI MED, V68, P243, DOI [10.1016/j.socscimed.2008.10.008, 10.1016/j.socscimed.2008.40.008]
   DALAL AK, 2000, PSYCHOL DEV SOC, V12, P67, DOI DOI 10.1177/097133360001200105
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   de Groot M, 2006, DIABETES CARE, V29, P549, DOI 10.2337/diacare.29.03.06.dc05-1396
   Deepa Mohan, 2011, J Diabetes Sci Technol, V5, P918
   Ebrahim S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000268
   Egede LE, 2010, DIABETES RES CLIN PR, V87, P302, DOI 10.1016/j.diabres.2010.01.024
   Finkler K, 2004, SOC SCI MED, V59, P2037, DOI 10.1016/j.socscimed.2004.03.008
   Golden SH, 2008, JAMA-J AM MED ASSOC, V299, P2751, DOI 10.1001/jama.299.23.2751
   Golden SH, 2007, PSYCHOSOM MED, V69, P529, DOI 10.1097/PSY.0b013e3180f61c5c
   Gupta R, 2007, BR J DIABETES VASC D, V7, P12, DOI DOI 10.1177/14746514070070010301)
   Hunt LM, 1998, SOC SCI MED, V46, P959, DOI 10.1016/S0277-9536(97)10014-4
   Katon W, 2010, CONTEMP CLIN TRIALS, V31, P312, DOI 10.1016/j.cct.2010.03.009
   Kielmann Karina, 2002, Med Anthropol, V21, P157, DOI 10.1080/01459740212903
   Kirmayer L. J., 1998, PSYCHOSOM MED, V3, P343
   Kleinman A., 1980, PATIENTS HEALERS CON
   Knol MJ, 2006, DIABETOLOGIA, V49, P837, DOI 10.1007/s00125-006-0159-x
   Lieberman LS, 2003, ANNU REV NUTR, V23, P345, DOI 10.1146/annurev.nutr.23.011702.073212
   Lin EHB, 2009, ANN FAM MED, V7, P414, DOI 10.1370/afm.998
   Loewe R, 1998, SOC SCI MED, V47, P1267, DOI 10.1016/S0277-9536(98)00192-0
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   McDade TW, 2002, MED ANTHROPOL Q, V16, P123, DOI 10.1525/maq.2002.16.2.123
   McGarvey S. T., 1989, HUMAN POPULATION BIO, P263
   Mendenhall E, 2012, DIABETIC MED, V29, pE308, DOI 10.1111/j.1464-5491.2012.03708.x
   Mendenhall E, 2010, MED ANTHROPOL Q, V24, P220, DOI 10.1111/j.1548-1387.2010.01098.x
   Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985
   Mollica RF, 2004, MEASURING TRAUMA MEA
   Nair M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-701
   Nunnally JC, 1994, PSYCHOMETRIC THEORY
   Patel V, 1998, BRIT J PSYCHIAT, V172, P533, DOI 10.1192/bjp.172.6.533
   Patel V, 2003, B WORLD HEALTH ORGAN, V81, P609
   Patel V, 2011, BRIT J PSYCHIAT, V199, P459, DOI 10.1192/bjp.bp.111.092155
   Patel V, 2011, LANCET, V377, P413, DOI 10.1016/S0140-6736(10)61188-9
   Patel V, 2010, LANCET, V376, P2086, DOI 10.1016/S0140-6736(10)61508-5
   Poongothai S, 2010, DIABETES TECHNOL THE, V12, P989, DOI 10.1089/dia.2010.0081
   Poongothai S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007185
   Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x
   Poss J, 2002, MED ANTHROPOL Q, V16, P360, DOI 10.1525/maq.2002.16.3.360
   Rai M, 2009, INT J DIABETES DEV C, V29, P129, DOI 10.4103/0973-3930.54290
   Ramachandram A, 2007, EPIDEMIOLOGY DIABETE
   Raval A, 2010, INDIAN J MED RES, V132, P195
   Reddy KS, 2007, P NATL ACAD SCI USA, V104, P16263, DOI 10.1073/pnas.0700933104
   Renders CM, 2001, DIABETES CARE, V24, P1821, DOI 10.2337/diacare.24.10.1821
   Sarkar S, 2008, STRESS HEALTH, V24, P23, DOI 10.1002/smi.1159
   Shobhana R, 2003, J Assoc Physicians India, V51, P363
   Sridhar G, 2000, DIABETES RES CLIN PR, V50, P981
   Sridhar GR, 2007, DIABETES METAB SYND, V1, P181, DOI 10.1016/j.dsx.2007.05.006
   Sridhar GR, 2002, CURR SCI INDIA, V83, P1556
   Weaver LJ, 2011, ETHOS, V39, P211, DOI 10.1111/j.1548-1352.2011.01185.x
   Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a
NR 53
TC 27
Z9 27
U1 0
U2 42
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0277-9536
J9 SOC SCI MED
JI Soc. Sci. Med.
PD DEC
PY 2012
VL 75
IS 12
BP 2522
EP 2529
DI 10.1016/j.socscimed.2012.09.040
PG 8
WC Public, Environmental & Occupational Health; Social Sciences, Biomedical
SC Public, Environmental & Occupational Health; Biomedical Social Sciences
GA 060DX
UT WOS:000312757800058
PM 23111063
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Yorgason, JB
   Roper, SO
   Sandberg, JG
   Berg, CA
AF Yorgason, Jeremy B.
   Roper, Susanne O.
   Sandberg, Jonathan G.
   Berg, Cynthia A.
TI Stress Spillover of Health Symptoms From Healthy Spouses to Patient
   Spouses in Older Married Couples Managing Both Diabetes and
   Osteoarthritis
SO FAMILIES SYSTEMS & HEALTH
LA English
DT Article
DE health; coping with illness/disability; marriage; comorbid illnesses
ID STAGE RENAL-DISEASE; QUALITY-OF-LIFE; MARITAL SATISFACTION; CHRONIC
   ILLNESS; FAMILY PROCESS; DIARY METHODS; CROSSOVER; SUPPORT; ASSOCIATION;
   DISTRESS
AB Many studies examining illness within marriage have investigated how illness in one spouse influences the other spouse. In later-life marriages, where both spouses are more likely to have health challenges, there is an increased likelihood that health symptoms from both spouses affect each other. In the current study we examined how health symptoms in a "healthy" spouse may exacerbate health problems in a partner (the patient) who is managing multiple chronic illnesses. Surveys were collected across 14 days from 27 later-life couples where patients had both diabetes and osteoarthritis. Results indicated that higher healthy spouse symptoms were generally associated with higher patient symptoms, suggesting a spillover effect. Spouse reports of positive and negative mood were inversely linked with patient health outcomes. Spouse reports of higher positive marital interactions were surprisingly linked with higher patients' arthritis activity and activity limitations, possibly indicating a compensatory effect where marital interactions increase with symptoms. Daily spouse reports of positive marital interactions and mood were linked with patient health outcomes even after the spillover of health symptoms was taken into account.
C1 [Yorgason, Jeremy B.; Roper, Susanne O.; Sandberg, Jonathan G.] Brigham Young Univ, Sch Family Life, Provo, UT 84602 USA.
   [Berg, Cynthia A.] Univ Utah, Dept Psychol, Salt Lake City, UT 84112 USA.
RP Yorgason, JB (reprint author), Brigham Young Univ, Sch Family Life, 2079 JFSB, Provo, UT 84602 USA.
EM Jeremy_yorgason@byu.edu
OI Yorgason, Jeremy/0000-0002-4208-7306
FU Marjorie Pay Hinckley Chair; Family Studies Center; Gerontology Center
   at Brigham Young University
FX Funding for this study was provided by the Marjorie Pay Hinckley Chair,
   the Family Studies Center, and the Gerontology Center at Brigham Young
   University. We express appreciation to the couples who participated in
   this study, and to the students who assisted with data collection.
CR Administration on Aging (AoA), 2009, PROF OLD AM 2009
   Bayliss Elizabeth A, 2003, Ann Fam Med, V1, P15, DOI 10.1370/afm.4
   Berg CA, 2008, PSYCHOL AGING, V23, P505, DOI 10.1037/a0012687
   Berg CA, 2007, PSYCHOL BULL, V133, P920, DOI 10.1037/0033-2909.133.6.920
   Bigatti SM, 2002, HEALTH PSYCHOL, V21, P157, DOI 10.1037//0278-6133.21.2.157
   Bolger N, 2003, ANNU REV PSYCHOL, V54, P579, DOI 10.1146/annurev.psych.54.101601.145030
   Bookwala J, 1996, PSYCHOL AGING, V11, P582, DOI 10.1037//0882-7974.11.4.582
   BOOTH A, 1994, J MARRIAGE FAM, V56, P218, DOI 10.2307/352716
   Burgener S, 2002, ALZ DIS ASSOC DIS, V16, P88, DOI 10.1097/01.WAD.0000015567.76518.5C
   Center on an Aging Society, 2003, MULT CHRON COND CHAL
   COYNE JC, 1991, J PERS SOC PSYCHOL, V61, P404, DOI 10.1037/0022-3514.61.3.404
   Gleason MEJ, 2008, J PERS SOC PSYCHOL, V94, P824, DOI 10.1037/0022-3514.94.5.824
   Gunthert K. C., 2012, HDB RES METHODS STUD
   Hays R D, 1993, Health Econ, V2, P217, DOI 10.1002/hec.4730020305
   Henry NJM, 2007, PSYCHOL AGING, V22, P428, DOI 10.1037/0882.7974.22.3.428
   Iida M, 2010, PERS SOC PSYCHOL B, V36, P780, DOI 10.1177/0146167210369897
   LARSEN RJ, 1991, J PERS, V59, P387, DOI 10.1111/j.1467-6494.1991.tb00254.x
   Larson RW, 1999, J MARRIAGE FAM, V61, P5, DOI 10.2307/353879
   Laurenceau JP, 2005, J FAM PSYCHOL, V19, P86, DOI 10.1037/0893-3200.19.1.86
   Lawrence RC, 1998, ARTHRITIS RHEUM-US, V41, P778, DOI 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V
   Neff LA, 2005, J PERS SOC PSYCHOL, V88, P480, DOI 10.1037/0022-3514.88.3.480
   Newton-John TRO, 2002, PAIN REV, V9, P7, DOI 10.1191/0968130202pr186ra
   PASTOR PN, 2002, CHARTBOOK TRENDS HLT
   Piazza JR, 2007, J GERONTOL B-PSYCHOL, V62, pP313, DOI 10.1093/geronb/62.6.P313
   Pruchno R, 2009, J GERONTOL B-PSYCHOL, V64, P212, DOI 10.1093/geronb/gbp006
   REISS D, 1986, ARCH GEN PSYCHIAT, V43, P795
   REVENSON TA, 2005, COUPLES COPING STRES, P137, DOI DOI 10.1037/11031-007
   Scheibe S, 2010, J GERONTOL B-PSYCHOL, V65, P135, DOI 10.1093/geronb/gbp132
   SHAVELSON RJ, 1991, GEN THEORY PRIMER
   Stephens MAP, 2006, REHABIL PSYCHOL, V51, P3, DOI 10.1037/0090-5550.51.1.3
   Story TN, 2007, PSYCHOL AGING, V22, P719, DOI 10.1037/0882-7974.22.4.719
   Turner-Musa J, 1999, SOC SCI MED, V48, P1333, DOI 10.1016/S0277-9536(98)00437-7
   WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063
   Westman M, 2001, HUM RELAT, V54, P717, DOI 10.1177/0018726701546002
   Westman M, 1998, HUM RELAT, V51, P137, DOI 10.1177/001872679805100202
   Westman M, 2008, J OCCUP HEALTH PSYCH, V13, P168, DOI 10.1037/1076-8998.13.2.168
   Whittemore R, 2003, DIABETES EDUCATOR, V29, P847, DOI 10.1177/014572170302900514
   Wray LA, 2006, J GERONTOL B-PSYCHOL, V61, pS290, DOI 10.1093/geronb/61.6.S290
   Xu JQ, 2010, NATL VITAL STAT REPO, V58
   Yorgason JB, 2008, RES AGING, V30, P623, DOI 10.1177/0164027508322570
   Yorgason JB, 2006, FAM RELAT, V55, P613, DOI 10.1111/j.1741-3729.2006.00430.x
   Yorgason JB, 2010, FAM SYST HEALTH, V28, P30, DOI 10.1037/a0019396
NR 42
TC 9
Z9 9
U1 1
U2 16
PU EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC
PI WASHINGTON
PA 750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA
SN 1091-7527
J9 FAM SYST HEALTH
JI Fam. Syst. Health
PD DEC
PY 2012
VL 30
IS 4
BP 330
EP 343
DI 10.1037/a0030670
PG 14
WC Health Care Sciences & Services; Family Studies; Public, Environmental &
   Occupational Health
SC Health Care Sciences & Services; Family Studies; Public, Environmental &
   Occupational Health
GA 062LC
UT WOS:000312920300006
PM 23148979
DA 2019-01-08
ER

PT J
AU Sato, M
   Yamazaki, Y
AF Sato, Miho
   Yamazaki, Yoshihiko
TI Work-related factors associated with self-care and psychological health
   among people with type 2 diabetes in Japan
SO NURSING & HEALTH SCIENCES
LA English
DT Article
DE employment; Japanese; psychological health; self-care; shift work; type
   2 diabetes
ID CHRONIC ILLNESS; SOCIAL SUPPORT; MANAGEMENT; DEPRESSION; DISTRESS;
   BEHAVIORS; EFFICACY; MELLITUS; ANXIETY; ADULTS
AB This study on individuals with type 2 diabetes living in Japan aimed to examine work-related factors that influence self-care and psychological health among people. A cross-sectional survey was conducted among 121 working adults with type 2 diabetes. A self-report questionnaire assessed demographics, work characteristics, self-disclosure of diabetes, support in the workplace, work-related difficulties due to diabetes, and workplace conformity. Dietary self-care, exercise, depression, and emotional distress were also evaluated. The results indicated statistically significant influence of working night shifts, self-disclosure of diabetes, and workplace conformity on dietary self-care. Work-related difficulties due to diabetes had negative effects on depression and emotional distress, and job control and support in the workplace were found to be correlated with emotional distress. These findings suggest that work-related factors have an impact on some forms of self-care activities and psychological health and that it is important to increase understanding of these issues and provide appropriate support for workers through education and counseling and adjustments in the workplace.
C1 [Sato, Miho] Hokkaido Univ, Dept Fundamental Nursing, Fac Hlth Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan.
   [Yamazaki, Yoshihiko] Univ Tokyo, Dept Hlth Sociol, Grad Sch Hlth Sci & Nursing, Tokyo, Japan.
RP Sato, M (reprint author), Hokkaido Univ, Dept Fundamental Nursing, Fac Hlth Sci, Kita Ku, Kita 12,Nishi 5, Sapporo, Hokkaido 0600812, Japan.
EM m_sato@med.hokudai.ac.jp
RI Sato, Miho/D-8722-2012
FU Japan Society for the Promotion of Science
FX This study was conducted with research support from Young Scientists
   (B), from the Japan Society for the Promotion of Science Grants-in-Aid
   for Scientific Research, fiscal year 2007-2008. The authors would like
   to thank the study's participants for their involvement in this research
   project. We also wish to express our appreciation to the members of the
   Department of Health Sociology, University of Tokyo, Japan, for their
   support.
CR Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Atkinson G, 2008, SPORTS MED, V38, P671, DOI 10.2165/00007256-200838080-00005
   Daitoku Masuko, 2006, Journal of the Japan Diabetes Society, V49, P1
   Delahanty LM, 2007, DIABETIC MED, V24, P48, DOI 10.1111/j.1464-5491.2007.02028.x
   Detaille SI, 2006, PATIENT EDUC COUNS, V64, P183, DOI 10.1016/j.pec.2005.12.015
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2009, DIABETIC MED, V26, P622, DOI 10.1111/j.1464-5491.2009.02730.x
   Glasgow RE, 1999, ANN BEHAV MED, V21, P159, DOI 10.1007/BF02908297
   Gotay CC, 2004, HEALTH PLACE, V10, P153, DOI 10.1016/S1353-8292(03)00055-8
   Harvey JN, 2009, DIABETIC MED, V26, P5, DOI 10.1111/j.1464-5491.2008.02628.x
   Hatta H, 1998, SHINSHIN IGAKU, V38, P310
   ISHIYAMA FI, 1994, INT J ADV COUNS, V17, P167, DOI 10.1007/BF01407732
   Kusuba Y, 2000, J JAPAN ACAD DIAB ED, V4, P32
   Ministry of Health Labor and Welfare (MHLW), 2007, OV NAT HLTH NUTR SUR
   Ministry of Labour, 1999, SAG KANR SHIKK NO YO, P351
   Morimoto A., 2010, JMAJ - Japan Medical Association Journal, V53, P36
   Mulcahy K, 2003, DIABETES EDUCATOR, V29, P804
   Munir F, 2005, SOC SCI MED, V60, P1397, DOI 10.1016/j.socscimed.2004.07.012
   PADGETT DL, 1996, DIABETES SPECTRUM, V9, P13
   Rosland AM, 2008, J GEN INTERN MED, V23, P1992, DOI 10.1007/s11606-008-0814-7
   Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O
   Sacco WP, 2006, J BEHAV MED, V29, P523, DOI 10.1007/s1086-006-9072-5
   Sarkar U, 2006, DIABETES CARE, V29, P823, DOI 10.2337/diacare.29.04.06.dc05-1615
   Sharoni SKA, 2012, NURS HEALTH SCI, V14, P38, DOI 10.1111/j.1442-2018.2011.00658.x
   Sugimoto H, 2005, J JPN SOC HLTH ED PR, V13, P11
   Tellez-Zenteno JF, 2002, ARCH MED RES, V33, P53, DOI 10.1016/S0188-4409(01)00349-6
   Tokyo Metropolitan Government Institution of Labor, 1993, TYUS DANS NO SYOK SE, P77
   TOOBERT DJ, 1991, J BEHAV MED, V14, P71, DOI 10.1007/BF00844769
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Trief PM, 1999, DIABETES CARE, V22, P569, DOI 10.2337/diacare.22.4.569
   Uehata T, 1991, 1 I IND MED, P38
   van Hooff MLM, 2011, WORK STRESS, V25, P55, DOI 10.1080/02678373.2011.570941
   Weijman I, 2005, PATIENT EDUC COUNS, V59, P87, DOI 10.1016/j.pec.2004.10.004
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
NR 34
TC 5
Z9 5
U1 1
U2 20
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1441-0745
J9 NURS HEALTH SCI
JI Nurs. Health Sci.
PD DEC
PY 2012
VL 14
IS 4
SI SI
BP 520
EP 527
DI 10.1111/j.1442-2018.2012.00729.x
PG 8
WC Nursing
SC Nursing
GA 045IL
UT WOS:000311689100015
PM 22957813
DA 2019-01-08
ER

PT J
AU Jortberg, BT
   Miller, BF
   Gabbay, RA
   Sparling, K
   Dickinson, WP
AF Jortberg, Bonnie T.
   Miller, Benjamin F.
   Gabbay, Robert A.
   Sparling, Kerri
   Dickinson, W. Perry
TI Patient-Centered Medical Home: How It Affects Psychosocial Outcomes for
   Diabetes
SO CURRENT DIABETES REPORTS
LA English
DT Article
DE Patient-centered medical home; Diabetes; Psychosocial outcomes; Mental
   health; Behavioral health; Team approach; Care management; Care
   coordination; Payment reform
ID MENTAL-HEALTH-CARE; UNITED-STATES; DISORDERS; DISTRESS; DEPRESSION;
   SERVICES; DELIVERY; SYSTEM; COST; TIME
AB Fragmentation of the current U.S. health care system and the increased prevalence of chronic diseases in the U.S. have led to the recognition that new models of care are needed. Chronic disease management, including diabetes, is often accompanied by a myriad of associated psychosocial issues that need to be addressed as part of a comprehensive treatment plan. Diabetes care should be aligned with comprehensive whole-person health care. The patient-centered medical home (PCMH) has emerged as a model for enhanced primary care that focuses on comprehensive integrated care. PCMH demonstration projects have shown improvements in quality of care, patient experience, care coordination, access to care, and quality measures for diabetes. Key PCMH transformative features associated with psychosocial issues related to diabetes reviewed in this article include integration of mental and behavioral health, care management/coordination, payment reform, advanced access, and putting the patient at the center of health care. This article also reviews the evidence supporting comprehensive and integrated care for addressing psychosocial issues associated with diabetes in the medical home.
C1 [Jortberg, Bonnie T.; Miller, Benjamin F.; Dickinson, W. Perry] Univ Colorado, Sch Med, Dept Family Med, Aurora, CO 80045 USA.
   [Gabbay, Robert A.] Penn State Coll Med, Div Endocrinol Diabet & Metab, Penn State Inst Diabet, Hershey, PA 17036 USA.
   [Sparling, Kerri] Patient Advocate, Coventry, RI 02816 USA.
RP Jortberg, BT (reprint author), Univ Colorado, Sch Med, Dept Family Med, Mail Stop F496,AO1,12631 E 17th Ave,Room 3519, Aurora, CO 80045 USA.
EM bonnie.jortberg@ucdenver.edu; Benjamin.miller@ucdenver.edu;
   rgabbay@psu.edu; kerri@sixuntilme.com; perry.dickinson@ucdenver.edu
OI Miller, Benjamin/0000-0003-1647-0122
FU Animas Corporation; Juvenile Diabetes Research Foundation; NIDDK
FX Conflicts of interest: B. T. Jortberg, none; B. F. Miller, none; R. A.
   Gabbay, none. K. Sparling: has been a consultant for Animas Corporation
   and Lifespan Corporation; has received honoraria (contracted speaker)
   and consulting fees (TV commercial) from Animas Corporation; has
   received payment for development of educational presentations, including
   service on speakers' bureaus from the Juvenile Diabetes Research
   Foundation; has received travel/accommodations expenses covered or
   reimbursed from Animas Corporation and Juvenile Diabetes Research
   Foundation; is a columnist for Web page for dLIFE, diatribe, Juvenile
   Diabetes Research Foundation, and Animas Corporation (columnist for Web
   page and videos); has been a consultant in documentary for Novo Nordisk;
   has contract writing for WEGOHealth and CVS; has speaking engagements
   for Johnson & Johnson; and has been a consultant for Roche. W. P.
   Dickinson has received grant support from NIDDK.
CR American Academy of Family Physicians (AAFP) American Academy of Pediatrics ( AAP) American College of Physicians (ACP) American Osteopathic Association (AOA), 2007, JOINT PRINC PAT CTR
   Blount A., 2003, FAMILIES SYSTEMS HLT, V21, P121, DOI DOI 10.1037/1091-7527.21.2.121
   Blumenthal D, 2010, NEW ENGL J MED, V362, P382, DOI 10.1056/NEJMp0912825
   Bojadzievski T, 2011, DIABETES CARE, V34, P1047, DOI 10.2337/dc10-1671
   Butler M, 2008, AHRQ PUBLICATION, V09-E003
   Ciechanowski P, 2010, DIABETES CARE, V33, P539, DOI 10.2337/dc09-1298
   Coleman K, 2009, HEALTH AFFAIR, V28, P75, DOI 10.1377/hlthaff.28.1.75
   Collins C, 2010, EVOLVING MODELS BEHA
   Crabtree Benjamin F, 2010, Ann Fam Med, V8 Suppl 1, pS80, DOI 10.1370/afm.1107
   Craven MA, 2006, CAN J PSYCHIAT, V51, p7S
   Cunningham PJ, 2009, HEALTH AFFAIR, V28, pW490, DOI 10.1377/hlthaff.28.3.w490
   DEGRUY F, 1996, PRIMARY CARE AM HLTH
   Delamater AM, 2001, DIABETES CARE, V24, P1286, DOI 10.2337/diacare.24.7.1286
   Delamater AM, 2006, CLIN DIABETES, V24, P71, DOI [10.2337/diaclin.24.2.71, DOI 10.2337/DIACLIN.24.2.71]
   Dickinson WP, 2010, FAM SYST HEALTH, V28, P348, DOI 10.1037/a0021866
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   FRIES JF, 1993, NEW ENGL J MED, V329, P321, DOI 10.1056/NEJM199307293290506
   Glasgow RE, 2001, DIABETES SPECTRUM, V14, P33, DOI DOI 10.2337/DIASPECT.14.1.33
   Glasgow RE, 2012, HEALTH AFFAIR, V31, P497, DOI 10.1377/hlthaff.2010.1295
   Golden SH, 2008, JAMA-J AM MED ASSOC, V299, P2751, DOI 10.1001/jama.299.23.2751
   Gonder-Frederick LA, 2002, J CONSULT CLIN PSYCH, V70, P611, DOI 10.1037//0022-006X.70.3.611
   Goodson JD, 2010, ANN INTERN MED, V152, P742, DOI 10.7326/0003-4819-152-11-201006010-00249
   Green CA, 2010, ADM POLICY MENT HLTH, V37, P327, DOI 10.1007/s10488-009-0239-6
   Grumbach K, 2012, OUTCOMES IMPLEMENTIN
   Institute of Medicine, 2006, COMM CROSS QUAL CHAS
   Institute of Medicine, 2001, CROSS QUAL CHASM NEW
   Kathol RG, 2010, PSYCHOSOM MED, V72, P511, DOI 10.1097/PSY.0b013e3181e2c4a0
   Kessler RC, 2005, NEW ENGL J MED, V352, P2515, DOI 10.1056/NEJMsa043266
   Leff B, 2009, AM J MANAG CARE, V15, P555
   Lowes L, 2005, J ADV NURS, V50, P253, DOI 10.1111/j.1365-2648.2005.03388.x
   Lustman P, 1995, PSYCHOSOCIAL ASPECTS
   Mauch D., 2008, HHS PUB
   McCarthy D, 2008, N DAKOTA EXPERIENCE
   McClellan M, 2010, HEALTH AFFAIR, V29, P982, DOI 10.1377/hlthaff.2010.0194
   Miller BF, 2011, BRIT J GEN PRACT, V61, P471, DOI 10.3399/bjgp11X583470
   Miller BF, 2011, FAM SYST HEALTH, V29, P144, DOI 10.1037/a0023993
   Miller BF, 2011, AHRQ PUBLICATION
   Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9
   Nutting PA, 2011, HEALTH AFFAIR, V30, P439, DOI 10.1377/hlthaff.2010.0159
   Office of the Congressional Budget, 2004, AN LIT DIS MAN PROGR
   Paulus RA, 2008, HEALTH AFFAIR, V27, P1235, DOI 10.1377/hlthaff.27.5.1235
   Peek C. J., 2008, COLLABORATIVE MED CA
   Petterson SM, 2008, AM FAM PHYSICIAN, V77, P757
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   REGIER DA, 1993, ARCH GEN PSYCHIAT, V50, P85
   Reid RJ, 2010, HEALTH AFFAIR, V29, P835, DOI 10.1377/hlthaff.2010.0158
   Reid RJ, 2009, AM J MANAG CARE, V15, pE71
   Shahady EJ, 2011, J PARTICIPATORY 0404, V4, pe18
   Shojania KG, 2006, JAMA-J AM MED ASSOC, V296, P427, DOI 10.1001/jama.296.4.427
   Sia C, 2004, PEDIATRICS, V113, P1473
   Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x
   Steiner BD, 2008, ANN FAM MED, V6, P361, DOI 10.1370/afm.866
   Tapp H, 2012, J AM BOARD FAM MED, V25, P245, DOI 10.3122/jabfm.2012.02.110243
   Tsai AC, 2005, AM J MANAG CARE, V11, P478
   Unutzer Jurgen, 2012, Am J Public Health, V102, pe41, DOI 10.2105/AJPH.2011.300555
   Wang PS, 2005, ARCH GEN PSYCHIAT, V62, P629, DOI 10.1001/archpsyc.62.6.629
   Weber V, 2008, J GEN INTERN MED, V23, P379, DOI 10.1007/s11606-007-0439-2
   Williams JW, 2012, AHRQ PUBLICATION
   Yarnall KSH, 2003, AM J PUBLIC HEALTH, V93, P635, DOI 10.2105/AJPH.93.4.635
NR 60
TC 17
Z9 17
U1 0
U2 13
PU CURRENT MEDICINE GROUP
PI PHILADELPHIA
PA 400 MARKET STREET, STE 700, PHILADELPHIA, PA 19106 USA
SN 1534-4827
EI 1539-0829
J9 CURR DIABETES REP
JI Curr. Diabetes Rep.
PD DEC
PY 2012
VL 12
IS 6
BP 721
EP 728
DI 10.1007/s11892-012-0316-1
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 032HP
UT WOS:000310706500011
PM 22961115
DA 2019-01-08
ER

PT J
AU Naranjo, D
   Hessler, DM
   Deol, R
   Chesla, CA
AF Naranjo, Diana
   Hessler, Danielle M.
   Deol, Rupinder
   Chesla, Catherine A.
TI Health and Psychosocial Outcomes in US Adult Patients with Diabetes from
   Diverse Ethnicities
SO CURRENT DIABETES REPORTS
LA English
DT Article
DE Diabetes; Psychosocial; Health; Distress; Depression; Culture;
   Diversity; Ethnicity; African American; Latino; Asian; American Indian
ID OLDER MEXICAN-AMERICANS; NUTRITION EXAMINATION SURVEY; IMPAIRED
   GLUCOSE-TOLERANCE; URBAN AFRICAN-AMERICANS; 3RD NATIONAL-HEALTH; STAGE
   RENAL-DISEASE; QUALITY-OF-CARE; GLYCEMIC CONTROL; DEPRESSIVE SYMPTOMS;
   UNITED-STATES
AB Within the United States, diabetes is a serious public health concern and patients with diabetes are more likely to experience clinical depression, psychological distress, and depressive symptoms than those without. Negative psychosocial factors are associated with poorer diabetes management and glycemic control. Overall, both the rates of diabetes and related psychological distress are greater for persons of diverse ethnicities than for non-Latino whites, and have reached epidemic proportions in certain groups. The following article will provide an overview across ethnicities of the rates of diabetes, health outcomes, psychosocial outcomes, and unique cultural and linguistic challenges that contribute to disparities within US diabetes patients of diverse ethnicities. Using this information, our hope is that health care practitioners and researchers alike can better respond to the psychosocial needs of ethnically diverse patients.
C1 [Naranjo, Diana] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA.
   [Hessler, Danielle M.] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA.
   [Deol, Rupinder; Chesla, Catherine A.] Univ Calif San Francisco, Dept Family Hlth Care Nursing, San Francisco, CA 94143 USA.
RP Naranjo, D (reprint author), Univ Calif San Francisco, Dept Pediat, 400 Parnassus Ave,4th Floor,MailBox 0318, San Francisco, CA 94143 USA.
EM NaranjoD@peds.ucsf.edu
CR Anderson RJ, 2000, DIABETES, V49, pA64
   Baines D., 1992, HLTH BEHAV RES MINOR, P230
   Barnes Patricia M, 2008, Adv Data, P1
   Bell RA, 2005, DIABETES CARE, V28, P823, DOI 10.2337/diacare.28.4.823
   Black SA, 1999, AM J PUBLIC HEALTH, V89, P546, DOI 10.2105/AJPH.89.4.546
   Black SA, 1998, J GERONTOL A-BIOL, V53, pM188, DOI 10.1093/gerona/53A.3.M188
   Black SA, 2002, AM J PUBLIC HEALTH, V92, P543, DOI 10.2105/AJPH.92.4.543
   Blazer DG, 2002, J PSYCHOSOM RES, V53, P913, DOI 10.1016/S0022-3999(02)00314-8
   Braginsky Nafanua, 2011, Hawaii Med J, V70, P196
   Brown AF, 2005, DIABETES CARE, V28, P2864, DOI 10.2337/diacare.28.12.2864
   Brown SA, 2000, DIABETES EDUCATOR, V26, P425, DOI 10.1177/014572170002600310
   Caban A, 2006, DIABETES EDUCATOR, V32, P584, DOI 10.1177/0145721706290435
   Carter JS, 1996, DIABETES CARE, V19, P764, DOI 10.2337/diacare.19.7.764
   Carter JS, 1996, ANN INTERN MED, V125, P221, DOI 10.7326/0003-4819-125-3-199608010-00011
   Carter-Edwards L, 2004, DIABETES EDUCATOR, V30, P493, DOI 10.1177/014572170403000321
   CDC, 2011, PREV DIAB HISP 6 US
   CDC NCHS, 2000, STAT CFDCAPANCFH
   Centers for Disease Control and Prevention (CDC), 2011, NAT DIAB FACT SHEET
   Chesla CA, 2000, DIABETES CARE, V23, P1780, DOI 10.2337/diacare.23.12.1780
   Chesla CA, 2005, QUAL HEALTH RES, V15, P240, DOI 10.1177/1049732304272050
   Chesla CA, 2004, DIABETES CARE, V27, P2850, DOI 10.2337/diacare.27.12.2850
   Chesla CA, 2009, DIABETES CARE, V32, P1812, DOI 10.2337/dc09-0278
   Chun KM, 2011, SOC SCI MED, V72, P256, DOI 10.1016/j.socscimed.2010.11.010
   Chun KM, 2004, PSYCHOL HEALTH, V19, P767, DOI 10.1080/08870440410001722958
   Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278
   Concha JB, 2009, DIABETES EDUCATOR, V35, P941, DOI 10.1177/0145721709344125
   COWIE CC, 1989, NEW ENGL J MED, V321, P1074, DOI 10.1056/NEJM198910193211603
   Davidson Mayer B., 2001, Ethnicity and Disease, V11, P148
   de Groot M, 2006, DIABETES CARE, V29, P549, DOI 10.2337/diacare.29.03.06.dc05-1396
   De Groot M, 2001, DIABETES CARE, V24, P407, DOI 10.2337/diacare.24.2.407
   Deshpande AD, 2008, PHYS THER, V88, P1254, DOI 10.2522/ptj.20080020
   Devlin H, 2006, HEALTH PROMOT PRACT, V7, P47, DOI 10.1177/1524839905275395
   DHHS, 2000, HLTH PEOPL 2010 OBJ
   Egede LE, 2006, DIABETES CARE, V29, P131, DOI 10.2337/diacare.29.1.131
   Egede LE, 2002, DIABETES EDUCATOR, V28, P258, DOI 10.1177/014572170202800211
   El-Kebbi IM, 2003, ARCH INTERN MED, V163, P69, DOI 10.1001/archinte.163.1.69
   Everson SA, 2002, J PSYCHOSOM RES, V53, P891, DOI 10.1016/S0022-3999(02)00303-3
   Eyler AA, 1999, SOC SCI MED, V49, P781, DOI 10.1016/S0277-9536(99)00137-9
   Fernandez A, 2004, J GEN INTERN MED, V19, P167, DOI 10.1111/j.1525-1497.2004.30266.x
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2001, DIABETES CARE, V24, P1751, DOI 10.2337/diacare.24.10.1751
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Gamble VN, 1997, AM J PUBLIC HEALTH, V87, P1773, DOI 10.2105/AJPH.87.11.1773
   Garduno-Diaz SD, 2012, DIABETES-METAB RES, V28, P6, DOI 10.1002/dmrr.1219
   Gleeson-Kreig J, 2002, PUBLIC HEALTH NURS, V19, P215, DOI 10.1046/j.0737-1209.2002.19310.x
   Golden SH, 2008, JAMA-J AM MED ASSOC, V299, P2751, DOI 10.1001/jama.299.23.2751
   Gonzalez HM, 2001, J AM GERIATR SOC, V49, P948, DOI 10.1046/j.1532-5415.2001.49186.x
   Gross R, 2005, J GEN INTERN MED, V20, P460, DOI 10.1111/j.1525-1497.2005.30003.x
   Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518
   Hausmann LRM, 2010, PATIENT PREFER ADHER, V4, P291, DOI 10.2147/PPA.S12353
   Hennessy CH, 1999, DIABETES EDUCATOR, V25, P747, DOI 10.1177/014572179902500507
   Hessler DM, 2012, J HEALTH PSYCHOL, V17, P535, DOI 10.1177/1359105311422120
   Hessler DM, 2010, PATIENT EDUC COUNS, V85, P154
   Hill-Briggs F, 2002, J GEN INTERN MED, V17, P412, DOI 10.1046/j.1525-1497.2002.11002.x
   Hoeman SP, 1996, WESTERN J NURS RES, V18, P518, DOI 10.1177/019394599601800504
   Hsu WC, 2006, DIABETES CARE, V29, P415, DOI 10.2337/diacare.29.02.06.dc05-1915
   Ingram M, 2007, DIABETES EDUCATOR, V33, p172S, DOI 10.1177/0145721707304170
   Jacobs EA, 2006, J GEN INTERN MED, V21, P642, DOI 10.1111/j.1525-1497.2006.00485.x
   Jiang LH, 2008, DIABETES CARE, V31, P427, DOI 10.2337/dc07-2044
   Jiang LH, 2009, QUAL LIFE RES, V18, P709, DOI 10.1007/s11136-009-9495-x
   Johnson JA, 1996, MED CARE, V34, P97, DOI 10.1097/00005650-199602000-00001
   Katon W, 2009, PSYCHOSOM MED, V71, P965, DOI 10.1097/PSY.0b013e3181bd8f55
   Katon WJ, 2005, DIABETES CARE, V28, P2668, DOI 10.2337/diacare.28.11.2668
   Katon WJ, 2005, ARCH GEN PSYCHIAT, V62, P1313, DOI 10.1001/archpsyc.62.12.1313
   KENNY SJ, 1995, DIABETES AM, P47
   King GL, 2012, DIABETES CARE, V35, P1181, DOI 10.2337/dc12-0210
   KING H, 1993, DIABETES CARE, V16, P157, DOI 10.2337/diacare.16.1.157
   Kirk JK, 2006, DIABETES CARE, V29, P2130, DOI 10.2337/dc05-1973
   KISSEBAH AH, 1982, J CLIN ENDOCR METAB, V54, P254, DOI 10.1210/jcem-54-2-254
   KNOWLER WC, 1993, DIABETES CARE, V16, P216, DOI 10.2337/diacare.16.1.216
   Kogan SM, 2007, ETHNIC DIS, V17, P106
   Kozak DL, 1997, OMEGA-J DEATH DYING, V35, P347, DOI 10.2190/C47K-EGNU-DC36-97DG
   Lanting LC, 2005, DIABETES CARE, V28, P2280, DOI 10.2337/diacare.28.9.2280
   Lawton J, 2007, SOCIOL HEALTH ILL, V29, P891, DOI 10.1111/j.1467-9566.2007.01036.x
   Lee CMY, 2007, ASIA PAC J CLIN NUTR, V16, P187
   Lee ET, 2000, DIABETES CARE, V23, P181, DOI 10.2337/diacare.23.2.181
   Lee S, 2006, DIABETES RES CLIN PR, V74, P282, DOI 10.1016/j.diabres.2006.03.026
   Li CY, 2008, DIABETES CARE, V31, P105, DOI 10.2337/dc07-1154
   Lujan J, 2007, DIABETES EDUCATOR, V33, P660, DOI 10.1177/0145721707304080
   Lynch EB, 2012, HEALTH EDUC RES, V27, P814, DOI 10.1093/her/cys058
   Macaden L, 2006, INT J OLDER PEOPLE N, V1, P177, DOI 10.1111/j.1748-3743.2006.00026.x
   Mau MK, 2003, J NATL MED ASSOC, V95, P955
   McBean AM, 2004, DIABETES CARE, V27, P2317, DOI 10.2337/diacare.27.10.2317
   Meetoo Danny, 2005, Br J Nurs, V14, P154
   Melkus GD, 2009, DIABETES EDUCATOR, V35, P293, DOI 10.1177/0145721708327532
   Miller P, 1987, Am Indian Alsk Native Ment Health Res, V1, P24
   Moffet HH, 2009, INT J EPIDEMIOL, V38, P38, DOI 10.1093/ije/dyn040
   MUNETA B, 1993, DIABETES CARE, V16, P346, DOI 10.2337/diacare.16.1.346
   Munoz RF, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1463
   Naranjo D, 2012, J IMMIGRANT HLTH, DOI [10.1007/s10903-012-9689-0, DOI 10.1007/S10903-012-9689-0]
   Naranjo DM, 2011, ANN FAM MED, V9, P115, DOI 10.1370/afm.1212
   Narayan KMV, 2003, JAMA-J AM MED ASSOC, V290, P1884, DOI 10.1001/jama.290.14.1884
   Naylor J L, 2003, Int J Circumpolar Health, V62, P363
   NEWMAN JM, 1993, DIABETES CARE, V16, P297, DOI 10.2337/diacare.16.1.297
   Novins DK, 2004, MED CARE, V42, P670, DOI 10.1097/01.mlr.0000129902.29132.a6
   O'Connell J, 2010, DIABETES CARE, V33, P1463, DOI 10.2337/dc09-1652
   Oza-Frank R, 2009, DIABETES CARE, V32, P1644, DOI 10.2337/dc09-0573
   Peek ME, 2007, MED CARE RES REV, V64, p101S, DOI 10.1177/1077558707305409
   Perez-Stable EJ, 1997, MED CARE, V35, P1212, DOI 10.1097/00005650-199712000-00005
   Pieroni A, 2007, J ETHNOPHARMACOL, V113, P100, DOI 10.1016/j.jep.2007.05.009
   Piette JD, 2000, MED CARE, V38, P218, DOI 10.1097/00005650-200002000-00011
   Pistulka GM, 2012, QUAL HEALTH RES, V22, P825, DOI 10.1177/1049732312438778
   RALEIGH VS, 1997, HLTH TRENDS, V28, P122
   Robbins JM, 2000, J EPIDEMIOL COMMUN H, V54, P839, DOI 10.1136/jech.54.11.839
   Sahota PKC, 2008, J CLIN PSYCHIAT, V69, P800, DOI 10.4088/JCP.v69n0513
   Samuel-Hodge CD, 2000, DIABETES CARE, V23, P928, DOI 10.2337/diacare.23.7.928
   Schenker Y, 2010, PATIENT EDUC COUNS, V81, P222, DOI 10.1016/j.pec.2010.02.005
   SORLIE PD, 1993, JAMA-J AM MED ASSOC, V270, P2464, DOI 10.1001/jama.270.20.2464
   Spencer MS, 2006, J HEALTH CARE POOR U, V17, P88, DOI 10.1353/hpu.2006.0095
   Stone M, 2005, FAM PRACT, V22, P647, DOI 10.1093/fampra/cmi069
   Talbot F, 2000, DIABETES CARE, V23, P1556, DOI 10.2337/diacare.23.10.1556
   Taylor Christopher, 2004, Prev Chronic Dis, V1, pA06
   Teufel-Shone Nicolette I, 2005, Prev Chronic Dis, V2, pA20
   Tillman L. C., 2002, ED RES, V31, P3, DOI DOI 10.3102/0013189X031009003
   Timmins CL, 2002, J MIDWIFERY WOM HEAL, V47, P80, DOI 10.1016/S1526-9523(02)00218-0
   Tuomilehto J, 2003, DIABETES CARE, V26, P1770
   Turner RC, 1998, LANCET, V352, P854
   Wagner J, 2007, DIABETES RES CLIN PR, V75, P119, DOI 10.1016/j.diabres.2006.05.004
   Wagner J, 2007, DIABETES CARE, V30, P364, DOI 10.2337/dc06-1756
   Wang CY, 2005, NURS RES, V54, P347, DOI 10.1097/00006199-200509000-00009
   Washington Gail, 2009, J Health Hum Serv Adm, V32, P305
   Wen LK, 2004, DIABETES EDUCATOR, V30, P980, DOI 10.1177/014572170403000619
   Young BA, 2003, DIABETES CARE, V26, P2392, DOI 10.2337/diacare.26.8.2392
NR 124
TC 14
Z9 14
U1 0
U2 16
PU CURRENT MEDICINE GROUP
PI PHILADELPHIA
PA 400 MARKET STREET, STE 700, PHILADELPHIA, PA 19106 USA
SN 1534-4827
J9 CURR DIABETES REP
JI Curr. Diabetes Rep.
PD DEC
PY 2012
VL 12
IS 6
BP 729
EP 738
DI 10.1007/s11892-012-0319-y
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 032HP
UT WOS:000310706500012
PM 22961116
DA 2019-01-08
ER

PT J
AU Aikens, JE
AF Aikens, James E.
TI Prospective Associations Between Emotional Distress and Poor Outcomes in
   Type 2 Diabetes
SO DIABETES CARE
LA English
DT Article
ID QUALITY-OF-LIFE; HEALTH-RISK BEHAVIORS; PRIMARY-CARE PATIENTS; GLYCEMIC
   CONTROL; SELF-CARE; DEPRESSIVE SYMPTOMS; MEDICATION ADHERENCE; CLINICAL
   DEPRESSION; MULTIPLE-SCLEROSIS; VALIDITY
AB OBJECTIVE-Cross-sectional studies link both depressive symptoms (DS) and diabetes-related distress (DRD) to diabetes self-management and/or glycemic control. However, longitudinal studies of these variables are rare, and their results are somewhat conflicting. The study objective was to compare DS and DRD as longitudinal predictors of medication adherence, self-care behavior, and glycemic control in type 2 diabetes.
   RESEARCH DESIGN AND METHODS-Primary care patients with type 2 diabetes reported DS, DRD, and other variables at baseline were studied. Medication adherence, self-care behaviors (diet, physical activity, and glucose testing), and glycemic control (HbA(1c)) were assessed 6 months later (n = 253). Cross-sectional and longitudinal regression analyses were used to model behavioral and medical outcomes as a function of baseline confounders, DS, and DRD.
   RESULTS-Adjusted cross-sectional and longitudinal analyses yielded very similar results. In the latter, only DS were significantly associated with future diet behavior (P = 0.049), physical activity (P = 0.001), and glucose testing (P = 0.018). In contrast, only DRD predicted future glycemic control (P < 0.001) and medication adherence (P = 0.011).
   CONCLUSIONS-Distress-outcome associations seem to vary by type of distress under consideration. Only DS predicts future lifestyle-oriented self-management behaviors. In contrast, only DRD predicts glycemic control, perhaps by decreasing medication adherence. Clinical assessment and intervention should encompass both types of distress, unless the goal is to narrowly target a highly specific outcome.
C1 Univ Michigan, Dept Family Med, Ann Arbor, MI 48109 USA.
RP Aikens, JE (reprint author), Univ Michigan, Dept Family Med, Ann Arbor, MI 48109 USA.
EM aikensj@umich.edu
FU National Institutes of Health from the National Institute of Diabetes
   and Digestive and Kidney Diseases [R01-DK-066016, P60-DK-020572]
FX This research was supported by National Institutes of Health grants
   R01-DK-066016 and P60-DK-020572 (to Michigan Diabetes Research and
   Training Center), both from the National Institute of Diabetes and
   Digestive and Kidney Diseases.
CR Aikens JE, 2008, DIABETIC MED, V25, P1324, DOI 10.1111/j.1464-5491.2008.02590.x
   Aikens JE, 2009, DIABETES CARE, V32, P1177, DOI 10.2337/dc09-0071
   Aikens JE, 2005, ANN FAM MED, V3, P23, DOI 10.1370/afm.238
   Campayo A, 2011, CURR PSYCHIAT REP, V13, P26, DOI 10.1007/s11920-010-0165-z
   Cass AR, 1999, INT J PSYCHIAT MED, V29, P293, DOI 10.2190/CPYJ-2HBF-RGCN-64V2
   Delahanty LM, 2007, DIABETIC MED, V24, P48, DOI 10.1111/j.1464-5491.2007.02028.x
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Fitzgerald JT, 1996, EVAL HEALTH PROF, V19, P208, DOI 10.1177/016327879601900205
   Golden-Kreutz DM, 2004, PSYCHO-ONCOLOGY, V13, P211, DOI 10.1002/pon.736
   Gonzalez JS, 2008, DIABETIC MED, V25, P1102, DOI 10.1111/j.1464-5491.2008.02535.x
   Gonzalez JS, 2008, DIABETOLOGIA, V51, P1822, DOI 10.1007/s00125-008-1113-x
   Gonzalez JS, 2011, DIABETES CARE, V34, P236, DOI 10.2337/dc10-1970
   Graue M, 2012, INT J NURS STUD, V49, P174, DOI 10.1016/j.ijnurstu.2011.08.007
   Janssens ACJW, 2004, J CLIN EPIDEMIOL, V57, P180, DOI 10.1016/S0895-4356(03)00260-9
   Janssens ACJW, 2003, ACTA NEUROL SCAND, V108, P389, DOI 10.1034/j.1600-0404.2003.00166.x
   Kandasamy A, 2011, INDIAN J CANCER, V48, P55, DOI 10.4103/0019-509X.75828
   Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955
   Katon WJ, 2010, INT J GERIATR PSYCH, V25, P466, DOI 10.1002/gps.2363
   Krapek K, 2004, ANN PHARMACOTHER, V38, P1357, DOI 10.1345/aph.1D612
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Lustman PJ, 2005, J DIABETES COMPLICAT, V19, P113, DOI 10.1016/j.jdiacomp.2004.01.002
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Mann DM, 2009, J BEHAV MED, V32, P278, DOI 10.1007/s10865-009-9202-y
   Markowitz SM, 2011, PSYCHOSOMATICS, V52, P1, DOI 10.1016/j.psym.2010.11.007
   MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007
   Nouwen A, 2010, DIABETOLOGIA, V53, P2480, DOI 10.1007/s00125-010-1874-x
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Strine TW, 2005, AM J PUBLIC HEALTH, V95, P2042, DOI 10.2105/AJPH.2005.066225
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   van Bastelaar KMP, 2010, DIABETIC MED, V27, P798, DOI 10.1111/j.1464-5491.2010.03025.x
   van Bastelaar K, 2011, PATIENT EDUC COUNS, V84, P49, DOI 10.1016/j.pec.2010.06.013
   Wang RH, 2011, J ADV NURS, V67, P2658, DOI 10.1111/j.1365-2648.2011.05701.x
   Weinger K, 2005, DIABETES CARE, V28, P1346, DOI 10.2337/diacare.28.6.1346
   2002, FED REG, V67, P6931
NR 37
TC 86
Z9 86
U1 1
U2 33
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
J9 DIABETES CARE
JI Diabetes Care
PD DEC
PY 2012
VL 35
IS 12
BP 2472
EP 2478
DI 10.2337/dc12-0181
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 041UF
UT WOS:000311426000027
PM 23033244
OA Other Gold, Green Published
DA 2019-01-08
ER

PT J
AU Byrne, M
   Newell, J
   Coffey, N
   O' Hara, MC
   Cooke, D
   Dinneen, SF
AF Byrne, M.
   Newell, J.
   Coffey, N.
   O' Hara, M. C.
   Cooke, D.
   Dinneen, S. F.
TI Predictors of quality of life gains among people with type 1 diabetes
   participating in the Dose Adjustment for Normal Eating (DAFNE)
   structured education programme
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Diabetes mellitus type 1; Quality of life; Predictors; Self-management
   programmes; DSQOLS
ID PROBLEM AREAS; MULTIPLE IMPUTATION; HOSPITAL ANXIETY; DEPRESSION SCALE;
   MANAGEMENT; HEALTH; DISTRESS; VALIDITY; OUTCOMES; FREEDOM
AB Aims: To examine predictors of quality of life gains among people with type 1 diabetes following the Dose Adjustment for Normal Eating (DAFNE) self-management training programme.
   Methods: Clinical and questionnaire data were collected from 437 patients from 6 hospital centres before, and 18 months post-DAFNE intervention. Glycated haemoglobin (HbA(1c)), weight, height, and blood pressure levels were recorded by clinicians during clinic appointments. Questionnaires included the Diabetes-Specific Quality of Life Scale (DSQOLS), the Problem Areas in Diabetes Scale (PAID) and the Hospital Anxiety and Depression Scale (HADS). Basic demographics were recorded at baseline. Linear mixed models were fitted to identify predictors of change in quality of life at an 18 month follow-up assessment.
   Results: Patients with high levels of diabetes-related distress experienced greatest improvement in DSQOLS quality of life scores (p = 0.001). Patients with poor glycaemic control (higher levels of HbA(1c); p = 0.03) and those with high levels of anxiety (p = 0.001) experienced the greatest reductions in diabetes-related distress.
   Conclusions: Patients with higher baseline levels of anxiety, higher levels of diabetes-related distress and higher baseline levels of HbA(1c) are most likely to experience quality of life gain from participation in self-management programmes such as DAFNE. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
C1 [Byrne, M.] Natl Univ Ireland, Sch Psychol, Galway, Ireland.
   [Newell, J.] Natl Univ Ireland, HRB Clin Res Facil, Galway, Ireland.
   [Newell, J.; Coffey, N.] Natl Univ Ireland, Sch Math Stat & Appl Math, Galway, Ireland.
   [O' Hara, M. C.; Dinneen, S. F.] Natl Univ Ireland, Sch Med, Galway, Ireland.
   [Cooke, D.] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England.
RP Byrne, M (reprint author), Natl Univ Ireland, Sch Psychol, Galway, Ireland.
EM molly.byrne@nuigalway.ie
RI Bargary, Norma/J-7728-2013
OI Bargary, Norma/0000-0003-4372-0019; Byrne, Molly/0000-0001-8900-4320;
   Newell, John/0000-0001-7685-6655; Dinneen, Sean/0000-0002-6636-0493
FU Health Research Board through a health services research award
   [HS-2005-25]
FX This study was supported by the Health Research Board through a health
   services research award (HS-2005-25).
CR Amiel S, 2002, BRIT MED J, V325, P746
   Barnard J, 1999, BIOMETRIKA, V86, P948, DOI 10.1093/biomet/86.4.948
   Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3
   Bott U, 1998, DIABETES CARE, V21, P757, DOI 10.2337/diacare.21.5.757
   Cochran J, 2008, DIABETES EDUCATOR, V34, P815, DOI 10.1177/0145721708323640
   Colagiuri R, 2009, DIABETIC MED, V26, P442, DOI 10.1111/j.1464-5491.2009.02700.x
   Debaty I, 2008, DIABETES METAB, V34, P507, DOI 10.1016/j.diabet.2008.03.007
   Dinneen SF, 2009, TRIALS, V10, DOI [10.1186/745-6215-10-88, DOI 10.1186/745-6215-10-88]
   Glasgow RE, 1997, DIABETES CARE, V20, P562, DOI 10.2337/diacare.20.4.562
   Hart HE, 2005, QUAL LIFE RES, V14, P1, DOI 10.1007/s11136-004-0782-2
   Hlatky MA, 2010, AM HEART J, V159, DOI 10.1016/j.ahj.2009.11.004
   King G, 2001, AM POLIT SCI REV, V95, P49
   Maddigan SL, 2005, QUAL LIFE RES, V14, P1311, DOI 10.1007/s11136-004-6640-4
   McGuire BE, 2010, DIABETOLOGIA, V53, P66, DOI 10.1007/s00125-009-1559-5
   Oliver L, 2009, PRACT DIAB INT, V26, P371, DOI DOI 10.1002/PDI.1424
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Redekop WK, 2002, DIABETES CARE, V25, P458, DOI 10.2337/diacare.25.3.458
   Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O
   Rubin RR, 2001, J CLIN PSYCHOL, V57, P457, DOI 10.1002/jclp.1041
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Speight J, 2010, DIABETES RES CLIN PR, V89, P22, DOI 10.1016/j.diabres.2010.03.017
   Tuncay T, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-79
   Welch G, 2003, DIABETIC MED, V20, P69, DOI 10.1046/j.1464-5491.2003.00832.x
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
NR 26
TC 15
Z9 16
U1 0
U2 20
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD NOV
PY 2012
VL 98
IS 2
BP 243
EP 248
DI 10.1016/j.diabres.2012.09.017
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 049CA
UT WOS:000311958400011
PM 23018180
DA 2019-01-08
ER

PT J
AU Hughes, LC
   Keith, SE
   Byars, A
   Wiginton, KL
AF Hughes, Lynne C.
   Keith, Susan E.
   Byars, Allyn
   Wiginton, Kristin L.
TI Cognitive Mapping in Persons Newly Diagnosed With Type 2 Diabetes
SO DIABETES EDUCATOR
LA English
DT Article
ID EMOTIONAL DISTRESS; SELF-MANAGEMENT; ADHERENCE; ILLNESS; EXPERIENCES;
   DEPRESSION; ATTITUDES; BELIEFS; WOMEN
AB Purpose
   The purpose of this study was to determine the issues and perceptions of persons newly diagnosed (within last 3 months) with type 2 diabetes.
   Methods
   In this qualitative study, 16 adults newly diagnosed with type 2 diabetes were recruited, who completed a demographic, lifestyle, and diabetes management questionnaire and then were interviewed using cognitive mapping. Participants were asked to write words or phrases that came to mind when thinking about living with diabetes. From these words, common concepts were identified, grouped into clusters, and reduced into categories. Associations were sought between demographics and categories.
   Results
   A total of 260 Post-It notes were written, from which 123 concepts were identified and grouped into 24 clusters. The most frequent concept was eat, and the 3 most frequent clusters were food, negative emotions, and diabetes and its complications. The 9 categories, in order of frequency, were as follows: (1) need to (self-management), (2) concerns, (3) "I'm sick", (4) emotional distress, (5) loss, (6) the no's (limitations), (7) fears and complications, (8) have to (medical management), and (9) coping. Persons with a college education and a later interview date since diagnosis were associated with the concepts in the need to and have to categories. Concepts in the I'm sick category were associated with lower income and Hispanic ethnicity.
   Conclusions
   Diabetes educators should consider this holistic representation of the issues and perceptions reflected in the common concepts, clusters, and categories expressed by persons newly diagnosed with diabetes.
C1 [Hughes, Lynne C.] Rocky Mt Univ Hlth Profess, Provo, UT USA.
   [Keith, Susan E.; Byars, Allyn] Angelo State Univ, San Angelo, TX 76909 USA.
   [Wiginton, Kristin L.] Texas Womans Univ, Denton, TX 76204 USA.
RP Hughes, LC (reprint author), Univ Incarnate Word, Sch Phys Therapy, 4301 Broadway,CPO 412, San Antonio, TX 78209 USA.
EM lchpt@yahoo.com
RI Albertin, Paloma/X-1093-2018
CR American Association of Diabetes Educators, 2007, DIABETES ED, V33, P45
   Beeney LJ, 1996, PATIENT EDUC COUNS, V29, P109, DOI 10.1016/0738-3991(96)00939-1
   Briesacher BA, 2008, PHARMACOTHERAPY, V28, P437, DOI 10.1592/phco.28.4.437
   CABAN A, 2008, DIABETES SPECTRUM, V21, P120, DOI DOI 10.2337/DIASPECT.21.2.120
   Center for Disease Control and Prevention, 2011, NATIONAL DIABETES FA
   Dansereau DF, 2002, J SUBST ABUSE TREAT, V22, P219, DOI 10.1016/S0740-5472(02)00235-0
   Everett J, 1998, J DIABETES NURS, V2, P170
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   FITZGERALD JT, 1995, DIABETES EDUCATOR, V21, P523, DOI 10.1177/014572179502100605
   Gillibrand W, 2001, J ADV NURS, V34, P501, DOI 10.1046/j.1365-2648.2001.01779.x
   Grams GD, 1996, CAN MED ASSOC J, V155, P1563
   Haynes RB, 2002, JAMA-J AM MED ASSOC, V288, P2880, DOI 10.1001/jama.288.22.2880
   Heuer L, 2006, J COMMUN HEALTH NURS, V23, P49, DOI 10.1207/s15327655jchn2301_5
   IRVINE AA, 1989, PATIENT EDUC COUNS, V13, P3, DOI 10.1016/0738-3991(89)90065-7
   Koch T, 2000, J CLIN NURS, V9, P247, DOI 10.1046/j.1365-2702.2000.00341.x
   Koch T, 1999, J CLIN NURS, V8, P712, DOI 10.1046/j.1365-2702.1999.00320.x
   Kralik D, 2001, J ADV NURS, V33, P594, DOI 10.1046/j.1365-2648.2001.01704.x
   Krug L M, 1991, Diabetes Educ, V17, P185, DOI 10.1177/014572179101700314
   Lohri-Posey B, 2006, FAM COMMUNITY HEALTH, V29, P214, DOI 10.1097/00003727-200607000-00008
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   McCord E C, 1995, Fam Med, V27, P267
   Mier N, 2007, PREV CHRONIC DIS
   Nathan DM, 2008, DIABETES CARE, V31, P1473, DOI 10.2337/dc08-0545
   Oomen JS, 1999, DIABETES EDUCATOR, V25, P220, DOI 10.1177/014572179902500207
   Peel E, 2004, PATIENT EDUC COUNS, V53, P269, DOI 10.1016/j.pec.2003.07.010
   Penckofer S, 2007, DIABETES EDUCATOR, V33, P680, DOI 10.1177/0145721707304079
   Quackenbush PA, 1996, DIABETES EDUCATOR, V22, P231, DOI 10.1177/014572179602200306
   Satterfield DL, 2003, J PUBLIC HEALTH MAN, pS56
   Shenolikar RA, 2006, J NATL MED ASSOC, V98, P1071
   Shewchuk RM, 2004, AM J HEALTH BEHAV, V28, P43, DOI 10.5993/AJHB.28.1.5
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Spencer MS, 2006, J HEALTH CARE POOR U, V17, P88, DOI 10.1353/hpu.2006.0095
   SWIFT CS, 1995, DIABETES EDUCATOR, V21, P533, DOI 10.1177/014572179502100607
   US Census Bureau, MEAN EARNINGS BY HIG
   von Goeler DS, 2003, DIABETES EDUCATOR, V29, P663, DOI 10.1177/014572170302900412
   WIERENGA ME, 1994, DIABETES EDUCATOR, V20, P138, DOI 10.1177/014572179402000209
   Wiginton KL, 1999, HEALTH EDUC BEHAV, V26, P443, DOI 10.1177/109019819902600403
   Wiginton KL, 1997, J AM COLL HEALTH, V45, P175, DOI 10.1080/07448481.1997.9936879
NR 39
TC 0
Z9 0
U1 1
U2 13
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0145-7217
J9 DIABETES EDUCATOR
JI Diabetes Educ.
PD NOV-DEC
PY 2012
VL 38
IS 6
BP 845
EP 854
DI 10.1177/0145721712460100
PG 10
WC Endocrinology & Metabolism; Public, Environmental & Occupational Health
SC Endocrinology & Metabolism; Public, Environmental & Occupational Health
GA 038WQ
UT WOS:000311205200008
PM 22986638
DA 2019-01-08
ER

PT J
AU Snoek, FJ
   Kersch, NYA
   Eldrup, E
   Harman-Boehm, I
   Hermanns, N
   Kokoszka, A
   Matthews, DR
   McGuire, BE
   Pibernik-Okanovic, M
   Singer, J
   de Wit, M
   Skovlund, SE
AF Snoek, Frank J.
   Kersch, Nancy Y. A.
   Eldrup, Ebbe
   Harman-Boehm, Ilana
   Hermanns, Norbert
   Kokoszka, Andrzej
   Matthews, David R.
   McGuire, Brian E.
   Pibernik-Okanovic, Mirjana
   Singer, Joelle
   de Wit, Maartje
   Skovlund, Soren E.
TI Monitoring of Individual Needs in Diabetes (MIND)-2 Follow-up data from
   the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) MIND
   study
SO DIABETES CARE
LA English
DT Article
ID RANDOMIZED CONTROLLED-TRIAL; QUALITY-OF-LIFE; CARE; DEPRESSION;
   VALIDITY; METAANALYSIS; DISTRESS; ADULTS; SCALE
AB OBJECTIVE-To test the effects of implementing computer-assisted Monitoring of Individual Needs in Diabetes (MIND) in routine diabetes care on psychological status and glycemic control, identify predictors of poor psychological outcomes, and evaluate care providers' experiences.
   RESEARCH DESIGN AND METHODS-The MIND procedure was implemented as part of the annual review in diabetes clinics across eight countries in a prospective observational study with a 1-year follow-up. MIND encompasses well-being (World Health Organization Five Well-Being Index [WHO-5]), diabetes-related distress (Problem Areas in Diabetes [PAID]), a Life Event Inventory, and the patient's agenda for their consultation. Medical data and agreed case- management actions were retrieved from the charts.
   RESULTS-Of the total 1,567 patients, 891 patients (57%) were monitored at a 1-year follow-up. Twenty-eight percent of the patients screened positive for depression and/or diabetes distress at baseline and considered cases, 17% of whom were receiving psychological care. Cases were significantly more often female and had type 2 diabetes and worse glycemic control compared with noncases. Clinically relevant improvements in WHO-5 and PAID were observed over time in cases, irrespective of referral (effects sizes 0.59 and 0.48, respectively; P < 0.0001). Glycemic control did not change. Female sex, life events, and concomitant chronic diseases were predictors of poor psychological outcomes. MIND was well received by patients and staff.
   CONCLUSIONS-MIND appears suitable for screening and discussion of emotional distress as part of the annual review. Broader dissemination in diabetes care is recommendable, but sustainability will depend on reimbursement and availability of support services.
C1 [Snoek, Frank J.; Kersch, Nancy Y. A.; de Wit, Maartje] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands.
   [Eldrup, Ebbe] Steno Diabet Ctr, Copenhagen, Denmark.
   [Harman-Boehm, Ilana] Soroka Univ, Med Ctr, Beer Sheva, Israel.
   [Hermanns, Norbert] Mergentheim Diabet Zentrum, Mergentheim, Germany.
   [Kokoszka, Andrzej] Med Univ Warsaw, Dept Psychiat, Warsaw, Poland.
   [Kokoszka, Andrzej] Diabet Outpatients Clin Ochota, Warsaw, Poland.
   [Matthews, David R.] Oxford Ctr Diabet Endocrinol & Metab, Oxford, England.
   [McGuire, Brian E.] Natl Univ Ireland, Sch Psychol, Galway, Ireland.
   [McGuire, Brian E.] Univ Coll Hosp, Galway, Ireland.
   [Pibernik-Okanovic, Mirjana] Vuk Vrhovac Univ Clin, Zagreb, Croatia.
   [Singer, Joelle] Rabin Med Ctr, Petah Tiqwa, Israel.
   [Skovlund, Soren E.] Diabet Attitudes Wishes & Needs Program, Bagsvaerd, Denmark.
RP Snoek, FJ (reprint author), Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands.
EM fj.snoek@vumc.nl
RI Kokoszka, Andrzej/O-7454-2018
OI Kokoszka, Andrzej/0000-0003-4518-5494
FU Novo Nordisk; National Institute for Health Research [NF-SI-0508-10272]
FX This study was supported by an unrestricted research grant from Novo
   Nordisk. No other potential conflicts of interest relevant to this
   article were reported.
CR Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x
   American Diabetes Association, 2006, DIABETES CARE S1, V29, pS4
   Awata S, 2007, PSYCHIAT CLIN NEUROS, V61, P112, DOI 10.1111/j.1440-1819.2007.01619.x
   Bower P, 2005, BRIT J PSYCHIAT, V186, P11, DOI 10.1192/bjp.186.1.11
   Cohen J, 1988, STAT POWER ANAL BEHA
   de Wit M, 2010, PEDIATR DIABETES, V11, P175, DOI 10.1111/j.1399-5448.2009.00543.x
   De Wit M, 2008, DIABETES CARE, V31, P1521, DOI 10.2337/dc08-0394
   Gilbody S, 2006, BRIT MED J, V332, P1027, DOI 10.1136/bmj.332.7548.1027
   HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4
   Home P, 2006, DIABETIC MED, V23, P579
   Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955
   Li CY, 2010, DIABETES CARE, V33, P1061, DOI 10.2337/dc09-1515
   Lowe B, 2004, J AFFECT DISORDERS, V78, P131, DOI 10.1016/S0165-0327(02)00237-9
   McGuire BE, 2010, DIABETOLOGIA, V53, P66, DOI 10.1007/s00125-009-1559-5
   Nefs G, 2012, DIABETOLOGIA, V55, P608, DOI 10.1007/s00125-011-2411-2
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   Pouwer F, 2011, DIABETOLOGIA, V54, P741, DOI 10.1007/s00125-010-2033-0
   Pouwer F, 2001, DIABETES CARE, V24, P1929, DOI 10.2337/diacare.24.11.1929
   Rogers E. M., 1995, DIFFUSION INNOVATION
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Snoek FJ, 2011, DIABETES CARE, V34, P601, DOI 10.2337/dc10-1552
   van Bastelaar KMP, 2011, DIABETES CARE, V34, P320, DOI 10.2337/dc10-1248
   Winkley K, 2006, BRIT MED J, V333, P65, DOI 10.1136/bmj.38874.652569.55
NR 23
TC 21
Z9 21
U1 2
U2 20
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
J9 DIABETES CARE
JI Diabetes Care
PD NOV
PY 2012
VL 35
IS 11
BP 2128
EP 2132
DI 10.2337/dc11-1326
PG 5
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 041TM
UT WOS:000311424100009
PM 22837364
OA Other Gold, Green Published
DA 2019-01-08
ER

PT J
AU McMahon, GT
   Fonda, SJ
   Gomes, HE
   Alexis, G
   Conlin, PR
AF McMahon, Graham T.
   Fonda, Stephanie J.
   Gomes, Helen E.
   Alexis, George
   Conlin, Paul R.
TI A Randomized Comparison of Online- and Telephone-Based Care Management
   with Internet Training Alone in Adult Patients with Poorly Controlled
   Type 2 Diabetes
SO DIABETES TECHNOLOGY & THERAPEUTICS
LA English
DT Article
ID NURSE CASE-MANAGEMENT; CONTROLLED-TRIAL; GLYCEMIC CONTROL; PROBLEM
   AREAS; HEALTH; VETERANS; QUALITY; INTERVENTIONS; EDUCATION; MELLITUS
AB Aims: Care management may improve the quality of diabetes care by enhancing contact between high-risk patients and their providers. This prospective, longitudinal, randomized trial sought to investigate whether telephone or online care management improves diabetes-related outcomes over time compared with usual care supplemented with Internet access and training.
   Subjects and Methods: One hundred fifty-one adult subjects with type 2 diabetes mellitus and an elevated hemoglobin A1c (A1c) level (>= 8.5%) were randomly assigned to online care management (n = 51), telephone-based care management (n = 51), or Web training (n = 49) groups. Online and telephone participants interacted with a care manager through a diabetes education and care management Web site and by telephone, respectively. The Web training group was provided with online diabetes self-management resources but no care management support. The primary outcome measure was A1c measured every 3 months for a year.
   Results: A1c declined significantly and substantially in all groups over 12 months. A1c declined linearly at a rate of 0.32% (P < 0.0001) per quarter for the online group, 0.36% (P < 0.0001) for the telephone group, and 0.41% for the Web training group (P < 0.0001). The rate of change over time did not differ significantly among groups. The groups converged at 12 months with average absolute A1c difference of -1.5%. The number of interactions with care providers was not significantly associated with the change in A1c. Blood pressure, weight, lipid levels, and diabetes distress did not differ among groups over time.
   Conclusions: Online, telephone-based care management, and Web training for diabetes patients with elevated A1c were each associated with a substantial improvement in A1c over a 1-year period. Internet access and training alone may be as effective as care management in patients with poorly controlled diabetes.
C1 [McMahon, Graham T.; Conlin, Paul R.] Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA.
   [McMahon, Graham T.; Fonda, Stephanie J.; Gomes, Helen E.; Alexis, George; Conlin, Paul R.] Vet Affairs Boston Healthcare Syst, Med Serv, Boston, MA USA.
   [McMahon, Graham T.; Conlin, Paul R.] Harvard Univ, Sch Med, Boston, MA USA.
RP McMahon, GT (reprint author), Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, 221 Longwood Ave,RF-291, Boston, MA 02115 USA.
EM gmcmahon@partners.org
RI McMahon, Graham/D-3740-2009
OI McMahon, Graham/0000-0003-4288-6535
FU VA Health Services Research and Development [TEL-02-100]; National
   Institutes of Health [K24 DK063214]; Department of the Army Cooperative
   Agreement [DAMD 17-98-2-8017]
FX The authors would like to acknowledge the generous participation of
   patients and the collaborative support of providers within the VA Boston
   Healthcare System. The study was supported by grants from VA Health
   Services Research and Development (TEL-02-100), National Institutes of
   Health (K24 DK063214), and the Department of the Army Cooperative
   Agreement (DAMD 17-98-2-8017).
CR [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc35-S011]
   Aubert RE, 1998, ANN INTERN MED, V129, P605, DOI 10.7326/0003-4819-129-8-199810150-00004
   Heisler M, 2010, ANN INTERN MED, V153, P507, DOI 10.7326/0003-4819-153-8-201010190-00007
   Ishani A, 2011, DIABETES CARE, V34, P1689, DOI 10.2337/dc10-2121
   Izquierdo RE, 2003, DIABETES CARE, V26, P1002, DOI 10.2337/diacare.26.4.1002
   Kaufman N, 2010, Int J Clin Pract Suppl, P41, DOI 10.1111/j.1742-1241.2009.02277.x
   Kaufman Neal D, 2011, J Diabetes Sci Technol, V5, P798
   Klonoff DC, 2000, DIABETES CARE, V23, P390, DOI 10.2337/diacare.23.3.390
   Kok PE, 2011, J CLIN NURS, V20, P2997, DOI 10.1111/j.1365-2702.2011.03743.x
   Krein SL, 2004, AM J MED, V116, P732, DOI 10.1016/j.amjmed.2003.11.028
   Lorig K, 2010, DIABETES CARE, V33, P1275, DOI 10.2337/dc09-2153
   Lynch CP, 2010, DIABETES TECHNOL THE, V12, P427, DOI 10.1089/dia.2009.0171
   McMahon GT, 2005, DIABETES CARE, V28, P1624, DOI 10.2337/diacare.28.7.1624
   Piette JD, 2001, DIABETES CARE, V24, P202, DOI 10.2337/diacare.24.2.202
   Polonsky WH, 2003, DIABETES CARE, V26, P3048, DOI 10.2337/diacare.26.11.3048
   Raji A, 2002, ARCH INTERN MED, V162, P1301, DOI 10.1001/archinte.162.11.1301
   Ramadas A, 2011, INT J MED INFORM, V80, P389, DOI 10.1016/j.ijmedinf.2011.02.002
   Samoocha David, 2010, J Med Internet Res, V12, pe23, DOI 10.2196/jmir.1286
   Shea S, 2009, J AM MED INFORM ASSN, V16, P446, DOI 10.1197/jamia.M3157
   Shojania KG, 2006, JAMA-J AM MED ASSOC, V296, P427, DOI 10.1001/jama.296.4.427
   Sidorov J, 2002, DIABETES CARE, V25, P684, DOI 10.2337/diacare.25.4.684
   Solomon M, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1924
   Steffens B, 2000, AM J MANAG CARE, V6, pS697
   Trivedi AN, 2011, MED CARE, V49, P560, DOI 10.1097/MLR.0b013e31820fb0f6
   Vouri SM, 2011, J MANAGE CARE PHARM, V17, P304, DOI 10.18553/jmcp.2011.17.4.304
   Wakefield BJ, 2011, TELEMED E-HEALTH, V17, P254, DOI 10.1089/tmj.2010.0176
   Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3
   Welch G, 2003, DIABETIC MED, V20, P69, DOI 10.1046/j.1464-5491.2003.00832.x
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   Zhang P, 2010, DIABETES RES CLIN PR, V87, P293, DOI 10.1016/j.diabres.2010.01.026
NR 30
TC 17
Z9 18
U1 2
U2 18
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1520-9156
EI 1557-8593
J9 DIABETES TECHNOL THE
JI Diabetes Technol. Ther.
PD NOV
PY 2012
VL 14
IS 11
BP 1060
EP 1067
DI 10.1089/dia.2012.0137
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 030LX
UT WOS:000310573300015
PM 22953754
OA Green Published
DA 2019-01-08
ER

PT J
AU Tsujii, S
   Hayashino, Y
   Ishii, H
AF Tsujii, S.
   Hayashino, Y.
   Ishii, H.
CA Tenri Study Grp
TI Diabetes distress, but not depressive symptoms, is associated with
   glycaemic control among Japanese patients with Type 2 diabetes: Diabetes
   Distress and Care Registry at Tenri (DDCRT 1)
SO DIABETIC MEDICINE
LA English
DT Article
ID PROBLEM AREAS; COMORBID DEPRESSION; EMOTIONAL DISTRESS; ADULTS;
   MELLITUS; SCALE
AB Aims To investigate the association between glycaemic control, diabetes distress and depressive symptoms among Japanese patients with Type 2 diabetes. Methods Cross-sectional data from 3305 patients with Type 2 diabetes were obtained from a baseline assessment of a diabetes registry at a general hospital in Japan. The Centre for Epidemiologic Studies Depression scale and Problem Areas in Diabetes scale were used to measure depressive symptoms and diabetes-related distress, respectively. Modified Poisson regression analysis was used to estimate the relative risks for poor glycaemic control across the quartiles of Centre for Epidemiologic Studies Depression scale and Problem Areas in Diabetes scale scores. Results The average age of the participants was 64.9 years and the average HbA1c level was 58.1 mmol/mol (7.5%). Clinically significant levels of depressive symptoms (Centre for Epidemiologic Studies Depression scale scores = 16) were reported by 27.8% of participants. These scores significantly correlated with Problem Areas in Diabetes scale scores (r = 0.4354, P < 0.0001). Diabetes distress, but not depressive symptoms, was significantly associated with higher HbA1c levels. The relative risks for poor glycaemic control (HbA1c= 64 mmol/mol; 8.0%), when adjusted for age, sex, BMI, type of diabetes therapy and duration of diabetes, was 67% higher among patients with Problem Areas in Diabetes scale scores in the highest quartile (= 26.25) compared with those in the lowest quartile (03.75). Conclusion A significant association between glycaemic control and diabetes-related distress, but not depressive symptoms, was observed in Japanese patients with Type 2 diabetes.
C1 [Tsujii, S.] Tenri Hosp, Ctr Diabet, Tenri, Nara 632, Japan.
   [Hayashino, Y.] Kyoto Univ, Sch Med, Dept Epidemiol & Healthcare Res, Kyoto 606, Japan.
   [Ishii, H.] Tenri Hosp, Dept Endocrinol, Tenri, Nara 632, Japan.
RP Tsujii, S (reprint author), Tenri Hosp, Ctr Diabet, Tenri, Nara 632, Japan.
EM stsujii@tenriyorozu.jp
OI Hayashino, Yasuaki/0000-0002-2932-8478; Tsujii,
   Satoru/0000-0002-1834-6515
FU Manpei Suzuki Diabetes Foundation
FX The Manpei Suzuki Diabetes Foundation supported this study. The funding
   source had no role in the design and conduct of the study, the
   collection, analysis and interpretation of the data, or in the
   preparation, review or approval of the manuscript.
CR Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Dhatt GS, 2005, CLIN CHIM ACTA, V358, P81, DOI 10.1016/j.cccn.2005.02.009
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Georgiades A, 2007, PSYCHOSOM MED, V69, P235, DOI 10.1097/PSY.0b013e318042588d
   Golden SH, 2008, JAMA-J AM MED ASSOC, V299, P2751, DOI 10.1001/jama.299.23.2751
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   Huang MF, 2010, DIABETES CARE, V33, P38, DOI 10.2337/dc09-0768
   Ishii H, 1999, DIABETES S, V48
   Katon WJ, 2005, DIABETES CARE, V28, P2668, DOI 10.2337/diacare.28.11.2668
   Lloyd CE, 2010, DIABETIC MED, V27, P234, DOI 10.1111/j.1464-5491.2009.02896.x
   McHale M, 2008, PSYCHOSOM MED, V70, P869, DOI 10.1097/PSY.0b013e318186dea9
   Nichols GA, 2000, DIABETES CARE, V23, P273, DOI 10.2337/diacare.23.3.273
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Randloff LA, 1977, APPL PSYCH MEAS, V1, P385
   Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   van Bastelaar KMP, 2010, DIABETIC MED, V27, P798, DOI 10.1111/j.1464-5491.2010.03025.x
   Welch G, 2003, DIABETIC MED, V20, P69, DOI 10.1046/j.1464-5491.2003.00832.x
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090
NR 21
TC 33
Z9 34
U1 1
U2 18
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
J9 DIABETIC MED
JI Diabetic Med.
PD NOV
PY 2012
VL 29
IS 11
BP 1451
EP 1455
DI 10.1111/j.1464-5491.2012.03647.x
PG 5
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 017QE
UT WOS:000309604600021
PM 22416679
DA 2019-01-08
ER

PT J
AU Nefs, G
   Bot, M
   Browne, JL
   Speight, J
   Pouwer, F
AF Nefs, Giesje
   Bot, Mariska
   Browne, Jessica L.
   Speight, Jane
   Pouwer, Francois
TI Diabetes MILES - The Netherlands: rationale, design and sample
   characteristics of a national survey examining the psychosocial aspects
   of living with diabetes in Dutch adults
SO BMC PUBLIC HEALTH
LA English
DT Article
DE Diabetes; Psychology; Self-care; Well-being; National survey
ID QUALITY-OF-LIFE; D DISTRESSED PERSONALITY; POOR GLYCEMIC CONTROL; SEXUAL
   DYSFUNCTION; SOCIAL SUPPORT; SELF-CARE; PSYCHOMETRIC PROPERTIES;
   NEGATIVE AFFECTIVITY; COMORBID DEPRESSION; PROBLEM AREAS
AB Background: As the number of people with diabetes is increasing rapidly worldwide, a more thorough understanding of the psychosocial aspects of living with this condition has become an important health care priority. While our knowledge has grown substantially over the past two decades with respect to the physical, emotional and social difficulties that people with diabetes may encounter, many important issues remain to be elucidated. Under the umbrella of the Diabetes MILES (Management and Impact for Long-term Empowerment and Success) Study International Collaborative, Diabetes MILES - The Netherlands aims to examine how Dutch adults with diabetes manage their condition and how it affects their lives. Topics of special interest in Diabetes MILES The Netherlands include subtypes of depression, Type D personality, mindfulness, sleep and sexual functioning.
   Methods/design: Diabetes MILES - The Netherlands was designed as a national online observational study among adults with diabetes. In addition to a main set of self-report measures, the survey consisted of five complementary modules to which participants were allocated randomly. From September to October 2011, a total of 3,960 individuals with diabetes (40% type 1, 53% type 2) completed the battery of questionnaires covering a broad range of topics, including general health, self-management, emotional well-being and contact with health care providers. People with self-reported type 1 diabetes (specifically those on insulin pump therapy) were over-represented, as were those using insulin among respondents with self-reported type 2 diabetes. People from ethnic minorities were under-represented. The sex distribution was fairly equal in the total sample, participants spanned a broad age range (19-90 years), and diabetes duration ranged from recent diagnosis to living with the condition for over fifty years.
   Discussion: The Diabetes MILES Study enables detailed investigation of the psychosocial aspects of living with diabetes and an opportunity to put these findings in an international context. With several papers planned resulting from a pooled Australian-Dutch dataset and data collections planned in other countries, the Diabetes MILES Study International Collaborative will contribute substantially to identifying potentially unmet needs of those living with diabetes and to inform clinical research and care across the globe.
C1 [Nefs, Giesje; Bot, Mariska; Pouwer, Francois] Tilburg Univ, Dept Med & Clin Psychol, Ctr Res Psychol Somat Dis CoRPS, NL-5000 LE Tilburg, Netherlands.
   [Bot, Mariska] Vrije Univ Amsterdam, Med Ctr, Dept Psychiat, Amsterdam, Netherlands.
   [Bot, Mariska] GGZ Geest, Amsterdam, Netherlands.
   [Browne, Jessica L.; Speight, Jane] Diabet Australia Vic, Australian Ctr Behav Res Diabet, Melbourne, Vic, Australia.
   [Browne, Jessica L.; Speight, Jane] Deakin Univ, Sch Psychol, Ctr Mental Hlth & Wellbeing Res, Burwood, Vic, Australia.
   [Speight, Jane] AHP Res, Hornchurch, Essex, England.
RP Pouwer, F (reprint author), Tilburg Univ, Dept Med & Clin Psychol, Ctr Res Psychol Somat Dis CoRPS, POB 90153, NL-5000 LE Tilburg, Netherlands.
EM f.pouwer@uvt.nl
RI Nefs, Giesje/C-9992-2018
OI Speight, Jane/0000-0002-1204-6896
FU Dutch Association for Diabetes Research (Nederlandse Vereniging voor
   Diabetes Onderzoek)/Lilly Diabetes
FX This study was supported by the Prof. dr. J. Terpstra Young Investigator
   Award 2010 from the Dutch Association for Diabetes Research (Nederlandse
   Vereniging voor Diabetes Onderzoek)/Lilly Diabetes to GN. The funding
   source had no role in the design, data collection, analysis or
   interpretation of the study, or in the decision to submit the manuscript
   for publication. In particular, we thank all people with diabetes who
   participated in Diabetes MILES - The Netherlands. We also thank the
   Dutch Diabetes Association and the Dutch Diabetes Research Foundation
   for their kind and very valuable assistance in the recruitment of
   participants. We gratefully acknowledge the technical support of SpITs,
   the IT service of the School of Social and Behavioural Sciences of
   Tilburg University that hosted both the web application and the website.
   Finally, we thank Dr Christel Hendrieckx and Elizabeth Holmes-Truscott
   of The Australian Centre for Behavioural Research in Diabetes and prof.
   dr. Johannes Ruige of Ghent University for their expert advice during
   the data cleaning process.
CR Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Barone MTU, 2011, DIABETES RES CLIN PR, V91, P129, DOI 10.1016/j.diabres.2010.07.011
   Bhasin S, 2007, LANCET, V369, P597, DOI 10.1016/S0140-6736(07)60280-3
   Black SA, 2003, DIABETES CARE, V26, P2822, DOI 10.2337/diacare.26.10.2822
   Bohlmeijer E, 2011, ASSESSMENT, V18, P308, DOI 10.1177/1073191111408231
   Bradley C, 1999, QUAL LIFE RES, V8, P79, DOI 10.1023/A:1026485130100
   Broadbent E, 2006, J PSYCHOSOM RES, V60, P631, DOI 10.1016/j.jpsychores.2005.10.020
   BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4
   Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB
   Daneman D, 2006, LANCET, V367, P847, DOI 10.1016/S0140-6736(06)68341-4
   de Jonge P, 2011, J PSYCHOSOM RES, V71, P59, DOI 10.1016/j.jpsychores.2010.12.013
   Denollet J, 2008, J INTERN MED, V263, P203, DOI 10.1111/j.1365-2796.2007.01870.x
   Denollet J, 2005, PSYCHOSOM MED, V67, P89, DOI 10.1097/01.psy.0000149256.81953.49
   Denollet J, 2010, CIRC-CARDIOVASC QUAL, V3, P546, DOI 10.1161/CIRCOUTCOMES.109.934406
   Diabetes Fonds, 2011, DIAB CIJF
   DiMatteo MR, 2004, HEALTH PSYCHOL, V23, P207, DOI 10.1037/0278-6133.23.2.207
   Egede LE, 2005, DIABETES CARE, V28, P1339, DOI 10.2337/diacare.28.6.1339
   Egede LE, 2002, DIABETES CARE, V25, P464, DOI 10.2337/diacare.25.3.464
   Einvik G, 2011, EUR J CARDIOV PREV R, V18, P504, DOI 10.1177/1741826710389383
   Frasure-Smith N, 2010, POSTGRAD MED J, V86, P193, DOI 10.1136/hrt.2009.186957
   Funnell MM, 2004, CLIN DIABETES, V22, P123, DOI DOI 10.2337/DIACLIN.22.3.123
   Giraldi A, 2010, J SEX RES, V47, P199, DOI 10.1080/00224491003632834
   Glasgow RE, 1999, DIABETES CARE, V22, P832, DOI 10.2337/diacare.22.5.832
   Gonder-Frederick LA, 2011, DIABETES CARE, V34, P801, DOI 10.2337/dc10-1343
   Gonzalez JS, 2007, DIABETES CARE, V30, P2222, DOI 10.2337/dc07-0158
   Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341
   Gregg EW, 2000, DIABETES CARE, V23, P1272, DOI 10.2337/diacare.23.9.1272
   Gregg JA, 2007, J CONSULT CLIN PSYCH, V75, P336, DOI 10.1037/0022-006X.75.2.336
   Grigsby AB, 2002, J PSYCHOSOM RES, V53, P1053, DOI 10.1016/S0022-3999(02)00417-8
   Hausteiner C, 2010, PSYCHOSOM MED, V72, P163, DOI 10.1097/PSY.0b013e3181cb8bae
   Heine RJ, 2004, HDB DIABETES MELLITU
   Hirschfeld RMA, 2000, AM J PSYCHIAT, V157, P1873, DOI 10.1176/appi.ajp.157.11.1873
   International Diabetes Federation, 2011, IDF DIAB ATL
   JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Lamers SMA, 2011, J CLIN PSYCHOL, V67, P99, DOI 10.1002/jclp.20741
   Lin EH, 2009, DIABETES CARE, V33, P264
   Ludwig DS, 2008, JAMA-J AM MED ASSOC, V300, P1350, DOI 10.1001/jama.300.11.1350
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Malavige LS, 2009, J SEX MED, V6, P1232, DOI 10.1111/j.1743-6109.2008.01168.x
   Marshall SM, 2006, BRIT MED J, V333, P475, DOI 10.1136/bmj.38922.650521.80
   Matza LS, 2009, ANN PHARMACOTHER, V43, P1621, DOI 10.1345/aph.1M174
   Michielsen HJ, 2004, EUR J PSYCHOL ASSESS, V20, P39, DOI 10.1027//1015-5759.20.1.39
   Mols F, 2010, GEN HOSP PSYCHIAT, V32, P66, DOI 10.1016/j.genhosppsych.2009.09.010
   Mommersteeg PMC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-714
   Nefs G, 2012, J PSYCHIATR RES, V46, P549, DOI 10.1016/j.jpsychires.2012.01.013
   Nefs G, 2012, J PSYCHOSOM RES, V72, P251, DOI 10.1016/j.jpsychores.2012.01.006
   Pelle AJ, 2010, INT J CARDIOL, V142, P65, DOI 10.1016/j.ijcard.2008.12.086
   Penson DF, 2009, J SEX MED, V6, P1969, DOI 10.1111/j.1743-6109.2009.01292.x
   Peyrot M, 2005, DIABETES CARE, V28, P2673, DOI 10.2337/diacare.28.11.2673
   Poortvliet MC, 2007, DIABETES NEDERLAND O
   Resnick HE, 2003, DIABETES CARE, V26, P702, DOI 10.2337/diacare.26.3.702
   Roglic G, 2005, DIABETES CARE, V28, P2130, DOI 10.2337/diacare.28.9.2130
   Rosenzweig S, 2007, ALTERN THER HEALTH M, V13, P36
   Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O
   RUSH AJ, 1986, PSYCHIAT RES, V18, P65
   Skomro RP, 2001, SLEEP MED, V2, P417, DOI 10.1016/S1389-9457(01)00110-1
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Snoek FJ, 2011, DIABETES CARE, V34, P601, DOI 10.2337/dc10-1552
   Snoek FJ, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-69
   SPANIER GB, 1976, J MARRIAGE FAM, V38, P15, DOI 10.2307/350547
   Speight J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-120
   Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092
   Statline-Centraal Bureau voor de Statistiek, 2011, ICT GEBR PERS NAAR P
   Tao B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011501
   The Diabetes Control and Complications Trial Research Group, 1993, N ENGL J MED, V329, P977
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   van der Ven NCW, 2005, PATIENT EDUC COUNS, V56, P313, DOI 10.1016/j.pec.2004.03.005
   VANSTRIEN T, 1986, INT J EAT DISORDER, V5, P295, DOI 10.1002/1098-108X(198602)5:2<295::AID-EAT2260050209>3.0.CO;2-T
   Vileikyte L, 2003, DIABETES CARE, V26, P2549, DOI 10.2337/diacare.26.9.2549
   Weinger K, 2005, DIABETES CARE, V28, P1346, DOI 10.2337/diacare.28.6.1346
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047
   Williams L, 2008, J PSYCHOSOM RES, V64, P63, DOI 10.1016/j.jpsychores.2007.06.008
   Williams L, 2011, PSYCHOL HEALTH, V26, P703, DOI 10.1080/08870446.2010.488265
   Williams R, 2002, DIABETOLOGIA, V45, pS13, DOI 10.1007/s00125-002-0859-9
   ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2
   Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a
   1998, LANCET, V352, P837
   1998, BMJ, V317, P703
NR 80
TC 13
Z9 13
U1 2
U2 25
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD OCT 30
PY 2012
VL 12
AR 925
DI 10.1186/1471-2458-12-925
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 082CM
UT WOS:000314369300001
PM 23110382
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Hajos, TRS
   Pouwer, F
   de Grooth, R
   Holleman, F
   Twisk, JWR
   Diamant, M
   Snoek, FJ
AF Hajos, T. R. S.
   Pouwer, F.
   de Grooth, R.
   Holleman, F.
   Twisk, J. W. R.
   Diamant, M.
   Snoek, F. J.
TI The longitudinal association between glycaemic control and
   health-related quality of life following insulin therapy optimisation in
   type 2 diabetes patients. A prospective observational study in secondary
   care
SO QUALITY OF LIFE RESEARCH
LA English
DT Article
DE Type 2 diabetes mellitus; Insulin glargine; Glycaemic control; Quality
   of life; Emotional well-being
ID SYMPTOM CHECKLIST; CONTROLLED TRIAL; MELLITUS; COMPLICATIONS;
   HYPOGLYCEMIA; DEPRESSION; MANAGEMENT; DISTRESS; RISK
AB Purpose To test whether improvement in glycosylated haemoglobin (HbA(1c)) as a marker of glycaemic control, following intensifying insulin therapy, is associated with improvements in HRQoL.
   Methods Dutch sub-optimally controlled (HbA(1c) > 7%) type 2 diabetes patients (N = 447, mean age 59 +/- 11) initiated insulin glargine therapy. Data were collected at baseline, 3 and 6 months, and included HbA1c and measures of HRQoL: diabetes symptom distress (Diabetes Symptom Checklist-revised; DSC-r), fear of hypoglycaemia (Hypoglycaemia Fear Survey; HFS-w) and emotional well-being (WHO-5 wellbeing index).
   Results HbA(1c) decreased from 8.8 +/- 1.4% to 8.0 +/- 1.2% and 7.7 +/- 1.3% at 3 and 6 months follow-up, respectively (P < 0.001), DSC-r score improved from 17.7 +/- 14.7 to 14.3 +/- 13.3 and 13.6 +/- 13.3 (P < 0.001). HFS-w score did not significantly change. WHO-5 score increased from 56 +/- 23 to 62 +/- 23 and 65 +/- 22 P < 0.001). A modest, significant association was found between HbA(1c) and WHO-5 score (B = -1.8, 95% CI: -2.7 to -0.8) and HbA1c and DSC-r score (B = 1.0, 95% CI: 0.4 to 1.6). No such association was found for HFS-w score.
   Conclusions An association between improvement in HbA(1c) by means of optimising insulin therapy and improvement in HRQoL in type 2 diabetes patients has been observed. A weak, yet significant longitudinal association was found between improved HbA(1c) and emotional well-being and diabetes symptom distress.
C1 [Hajos, T. R. S.; Snoek, F. J.] VU Univ Med Ctr VUMC, Dept Med Psychol, Amsterdam, Netherlands.
   [Hajos, T. R. S.; Twisk, J. W. R.; Snoek, F. J.] Vrije Univ Amsterdam Med Ctr, EMGO Res Inst, NL-1081 BT Amsterdam, Netherlands.
   [Pouwer, F.] Tilburg Univ, Ctr Res Psychol Somat Dis CoRPS, NL-5000 LE Tilburg, Netherlands.
   [de Grooth, R.] Sanofi Aventis, Gouda, Netherlands.
   [Holleman, F.] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands.
   [Twisk, J. W. R.] Vrije Univ Amsterdam Med Ctr, Dept Clin Epidemiol & Biostat, NL-1081 BT Amsterdam, Netherlands.
   [Diamant, M.] Vrije Univ Amsterdam Med Ctr, Ctr Diabet, Dept Internal Med, NL-1081 BT Amsterdam, Netherlands.
RP Hajos, TRS (reprint author), Vrije Univ Amsterdam Med Ctr, EMGO Res Inst, Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.
EM t.hajos@vumc.nl
FU Sanofi-Aventis
FX This study was financially supported by an unrestricted grant of
   Sanofi-Aventis.
CR Amiel S, 2002, BRIT MED J, V325, P746
   Arbuckle R. A., 2009, VALUE HLTH
   Arbuckle RA, 2009, VALUE HEALTH, V12, P1168, DOI 10.1111/j.1524-4733.2009.00571.x
   Bech P, 2003, INT J METH PSYCH RES, V12, P85, DOI 10.1002/mpr.145
   COX DJ, 1987, DIABETES CARE, V10, P617, DOI 10.2337/diacare.10.5.617
   de Sonnaville JJJ, 1998, DIABETES CARE, V21, P919, DOI 10.2337/diacare.21.6.919
   Dluhy RG, 2008, NEW ENGL J MED, V358, P2630, DOI 10.1056/NEJMe0804182
   GOLDSTEIN DE, 1995, DIABETES CARE, V18, P896, DOI 10.2337/diacare.18.6.896
   Gonder-Frederick LA, 1997, SEMIN CLIN NEUROPSYC, V2, P57
   GROOTENHUIS PA, 1994, DIABETIC MED, V11, P253, DOI 10.1111/j.1464-5491.1994.tb00268.x
   Heisler M, 2005, DIABETES CARE, V28, P816, DOI 10.2337/diacare.28.4.816
   Heller SR, 2007, DIABETOLOGIA, V50, P1140, DOI 10.1007/s00125-007-0599-y
   Horvath K, 2007, COCHRANE DB SYST REV
   Hunt SM, 1997, QUAL LIFE RES, V6, P205
   King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414
   Lloyd A, 2001, Value Health, V4, P392, DOI 10.1046/j.1524-4733.2001.45029.x
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Pouwer F, 2001, DIABETIC MED, V18, P595, DOI 10.1046/j.1464-5491.2001.00499.x
   Rubin DB, 1987, MULTIPLE IMPUTATION
   Rubin Richard R, 2010, Pediatr Endocrinol Rev, V7 Suppl 3, P405
   Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O
   Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147
   Swinnen SG, 2010, DIABETES CARE, V33, P1176, DOI 10.2337/dc09-2294
   Testa MA, 1998, JAMA-J AM MED ASSOC, V280, P1490, DOI 10.1001/jama.280.17.1490
   Turner R, 1996, ANN INTERN MED, V124, P136, DOI 10.7326/0003-4819-124-1_Part_2-199601011-00011
   Turner RC, 1998, LANCET, V352, P837
   UK Prospective Diabetes Study Group, 1999, DIABETES CARE, V22, P1125, DOI DOI 10.2337/DIACARE.22.7.1125
   VanderDoes FEE, 1996, DIABETES CARE, V19, P204, DOI 10.2337/diacare.19.3.204
   WEINBERGER M, 1994, MED CARE, V32, P1173, DOI 10.1097/00005650-199412000-00002
   2010, DIABETES CARE S1, V33, pS11
NR 30
TC 16
Z9 17
U1 0
U2 2
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0962-9343
J9 QUAL LIFE RES
JI Qual. Life Res.
PD OCT
PY 2012
VL 21
IS 8
BP 1359
EP 1365
DI 10.1007/s11136-011-0051-0
PG 7
WC Health Care Sciences & Services; Health Policy & Services; Public,
   Environmental & Occupational Health
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA 089LR
UT WOS:000314912500006
PM 22065281
OA Other Gold, Green Published
DA 2019-01-08
ER

PT J
AU Chan, HL
   Lin, CK
   Chau, YL
   Chang, CM
AF Chan, Hsiang-Lin
   Lin, Chih-Kuang
   Chau, Yeuk-Lun
   Chang, Chia-Ming
TI The impact of depression on self-care activities and health care
   utilization among people with diabetes in Taiwan
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Diabetes; Depression; Self-care; Health care utilization
ID COMPLICATIONS; SYMPTOMS; METAANALYSIS; INDIVIDUALS; ASSOCIATION;
   DISTRESS; ASIA
AB Using cross-sectional analyses of a nationally representative community sample (n = 1260), we found that in people with diabetes, depression was associated with lower rates of reducing or quitting smoking and alcohol, less exercise, less regular lifestyle, but more health care utilization and a higher rate of foot care. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
C1 Chang Gung Mem Hosp, Dept Psychiat, Linkou, Taiwan.
   Chang Gung Univ, Coll Med, Tao Yuan, Taiwan.
RP Chang, CM (reprint author), Chang Gung Mem Hosp, Dept Psychiat, 5 Fusing St, Gueishan Township 333, Taoyuan County, Taiwan.
EM cmchang58@yahoo.com.tw
FU  [CMRPG370411]
FX This study was supported by a grant from CMRPG370411 to CM Chang. We
   thank the Bureau of Health Promotion for providing HPKAP data for
   analysis.
CR Bogner HR, 2007, DIABETES CARE, V30, P3005, DOI 10.2337/dc07-0974
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   Egede LE, 2004, DIABETES CARE, V27, P1751, DOI 10.2337/diacare.27.7.1751
   Egede LE, 2009, GEN HOSP PSYCHIAT, V31, P422, DOI 10.1016/j.genhosppsych.2009.06.007
   Gonzalez JS, 2008, DIABETOLOGIA, V51, P1822, DOI 10.1007/s00125-008-1113-x
   Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341
   Katon WJ, 2005, DIABETES CARE, V28, P2668, DOI 10.2337/diacare.28.11.2668
   Lee S, 2006, DIABETES RES CLIN PR, V74, P282, DOI 10.1016/j.diabres.2006.03.026
   Lee Y, 2000, Chang Gung Med J, V23, P688
   Lin EHB, 2004, DIABETES CARE, V27, P2154, DOI 10.2337/diacare.27.9.2154
   Lin EHB, 2010, DIABETES CARE, V33, P264, DOI 10.2337/dc09-1068
   Lloyd CE, 2010, DIABETIC MED, V27, P234, DOI 10.1111/j.1464-5491.2009.02896.x
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Mohamed M, 2008, CURR MED RES OPIN, V24, P507, DOI 10.1185/030079908X261131 
   Papelbaum M, 2010, DIABETES RES CLIN PR, V89, P227, DOI 10.1016/j.diabres.2010.05.024
   Simon GE, 2005, GEN HOSP PSYCHIAT, V27, P344, DOI 10.1016/j.genhosppsych.2005.04.008
   Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1
   Yoshida S, 2009, PSYCHIAT CLIN NEUROS, V63, P65, DOI 10.1111/j.1440-1819.2008.01889.x
NR 18
TC 6
Z9 6
U1 0
U2 3
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD OCT
PY 2012
VL 98
IS 1
BP E4
EP E7
DI 10.1016/j.diabres.2012.06.003
PG 4
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 036KZ
UT WOS:000311026100002
PM 22749685
DA 2019-01-08
ER

PT J
AU Testa, MA
   Gill, J
   Su, M
   Turner, RR
   Blonde, L
   Simonson, DC
AF Testa, Marcia A.
   Gill, Jasvinder
   Su, Max
   Turner, Ralph R.
   Blonde, Lawrence
   Simonson, Donald C.
TI Comparative Effectiveness of Basal-Bolus Versus Premix Analog Insulin on
   Glycemic Variability and Patient-Centered Outcomes during Insulin
   Intensification in Type 1 and Type 2 Diabetes: A Randomized, Controlled,
   Crossover Trial
SO JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
LA English
DT Article
ID QUALITY-OF-LIFE; MULTIPLE DAILY INJECTIONS; GLUCOSE VARIABILITY;
   PLASMA-GLUCOSE; ANTIHYPERTENSIVE THERAPY; HYPERTENSIVE PATIENTS;
   CLINICAL-TRIAL; BLOOD-GLUCOSE; MELLITUS; ASSOCIATION
AB Context: In patients with diabetes, intraday glucose variability might predict health outcomes independently from glycosylated hemoglobin (HbA(1c)).
   Objective: Our objective was to evaluate patient satisfaction (PS), quality of life (QoL), glycemic control, and variability during insulin intensification to HbA(1c) below 7.0%.
   Patients, Design, and Setting: Eighty-two type 1 and 306 insulin-treated type 2 diabetes patients (47% male; age 54 +/- 11 yr; HbA(1c) = 7.8 +/- 0.7%) participated in this multicenter, randomized, crossover trial at 52 U.S. centers.
   Interventions: Interventions included insulin glargine plus premeal glulisine (n = 192) vs. twice-daily premix 75/25 or 70/30 analog insulin (n = 196) for 12 wk and crossed to the alternate arm for 12 wk.
   Main Outcome Measures: Main outcome measures included PS and QoL questionnaires, 3-d continuous glucose monitoring (CGM), and HbA(1c) every 4-8 wk.
   Results: Mean +/- SE HbA(1c) change was -0.39 +/- 0.09% for glargine-glulisine and -0.05 +/- 0.09% for premix (P < 0.0001). The PS net benefit scale (0-100) improved from 51.1 to 60.5 +/- 1.2 for glargine-glulisine and worsened to 45.4 +/- 1.2 for premix (P < 0.0001). The PS regimen acceptance scale was comparable (P = 0.33). Overall QoL favored glargine-glulisine (P < 0.001), as did perceived health (P < 0.0001), symptom distress (P < 0.0001), general health perceptions (P < 0.01), and psychosocial (P < 0.02). CGM daily glucose mean, daily glucose SD (glycemic variability), and percent time over 140 mg/dl were lower for glargine-glulisine by 13.1 +/- 2.7 mg/dl, 5.9 +/- 1.4 mg/dl, and 7.3 +/- 1.6%, respectively (all P < 0.0001), with no difference in CGM percent time below 70 mg/dl (P = 0.09). Symptomatic hypoglycemia rates were comparable. HbA(1c), mean CGM daily glucose, and glycemic variability were independent predictors of PS net benefit.
   Conclusions: Patient satisfaction was impacted more positively by improved QoL, reduced glucose variability, and better glycemic control with a basal-bolus regimen than negatively by the burden of additional injections, thereby facilitating insulin intensification and the ability to achieve HbA(1c) below 7.0%. (J Clin Endocrinol Metab 97: 3504-3514, 2012)
C1 [Testa, Marcia A.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.
   [Simonson, Donald C.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA.
   [Gill, Jasvinder] Sanofi Aventis US, Bridgewater, NJ 08807 USA.
   [Su, Max; Turner, Ralph R.] Phase V Technol, Wellesley Hills, MA 02481 USA.
   [Blonde, Lawrence] Ochsner Med Ctr, Dept Endocrinol Diabet & Metab Dis, Ochsner Diabet Clin Res Unit, New Orleans, LA 70121 USA.
RP Testa, MA (reprint author), Harvard Univ, Sch Publ Hlth, Dept Biostat, 655 Huntington Ave, Boston, MA 02115 USA.
EM testa@hsph.harvard.edu
FU sanofi-aventis, U.S.; sanofi-aventis; Amylin Pharmaceuticals; Boehringer
   Ingelheim; Eli Lilly and Co.; AstraZeneca LP; Bristol-Myers Squibb Co.;
   Daiichi-Sankyo; GlaxoSmithKline; Lifescan; Mann-Kind Corp.; Merck Co.;
   Novartis Pharmaceuticals Corp.; Novo Nordisk; Pfizer; Roche
   Pharmaceuticals; Harvard School of Public Health
FX The clinical trial was funded by sanofi-aventis, U.S., which had no role
   in the data collection, management, analysis, and manuscript preparation
   except for the contributions of one of the co-authors, J.G., who is an
   employee of sanofi-aventis and also served as the clinical trial medical
   monitor.; L.B. has received consulting fees and research grants from
   sanofi-aventis, in addition to consulting and research grants from
   Amylin Pharmaceuticals, Boehringer Ingelheim, Eli Lilly and Co.,
   AstraZeneca LP, Bristol-Myers Squibb Co., Daiichi-Sankyo,
   GlaxoSmithKline, Lifescan, Mann-Kind Corp., Merck & Co., Novartis
   Pharmaceuticals Corp., Novo Nordisk, Pfizer, and Roche Pharmaceuticals.
   M.A.T., M.S., R.R.T., and D.C.S. have nothing to declare. The survey
   design and statistical analyses were supported by unrestricted funds
   from the Harvard School of Public Health.
CR *AM DIAB ASS, 2010, DIABETES CARE S1, V33, pS11, DOI DOI 10.2337/DC10-S011
   Anderson R. B., 1994, DRUG INF J, V28, P89
   ANDERSON RB, 1995, DRUG INF J, V29, pS1689
   Blonde L, 2009, DIABETES OBES METAB, V11, P623, DOI 10.1111/j.1463-1326.2009.01060.x
   Bode BW, 2007, CLIN THER, V29, pS135, DOI 10.1016/j.clinthera.2007.12.013
   Borg R, 2011, DIABETOLOGIA, V54, P69, DOI 10.1007/s00125-010-1918-2
   Cameron Fergus J, 2010, Pediatr Endocrinol Rev, V7 Suppl 3, P432
   Danne T, 2009, DIABETOLOGIA, V52, P1496, DOI 10.1007/s00125-009-1408-6
   Herman WH, 2005, DIABETES CARE, V28, P1568, DOI 10.2337/diacare.28.7.1568
   Hermanns N, 2007, DIABETOLOGIA, V50, P930, DOI 10.1007/s00125-007-0643-y
   Hirsch IB, 2005, J DIABETES COMPLICAT, V19, P178, DOI 10.1016/j.jdiacomp.2004.10.001
   Johnson EL, 2010, J FAM PRACTICE, V59, pE1
   Kilpatrick ES, 2007, DIABETOLOGIA, V50, P2553, DOI 10.1007/s00125-007-0820-z
   McDonnell CM, 2007, DIABETES CARE, V30, P2211, DOI 10.2337/dc07-0328
   Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681, DOI 10.1001/jama.295.14.1681
   Raskin P, 2003, DIABETES CARE, V26, P2598, DOI 10.2337/diacare.26.9.2598
   Riddle MC, 2003, DIABETES CARE, V26, P3080, DOI 10.2337/diacare.26.11.3080
   Rodbard D, 2009, DIABETES TECHNOL THE, V11, P551, DOI 10.1089/dia.2009.0015
   Rodbard D, 2009, DIABETES TECHNOL THE, V11, pS55, DOI 10.1089/dia.2008.0132
   Rodbard HW, 2009, ENDOCR PRACT, V15, P540, DOI 10.4158/EP.15.6.540
   SHAMOON H, 1993, NEW ENGL J MED, V329, P977
   Stratton IM, 2000, BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405
   Temelkova-Kurktschiev TS, 2000, DIABETES CARE, V23, P1830, DOI 10.2337/diacare.23.12.1830
   Testa M, 2003, DIABETES S1, V52, pA420
   Testa M, 2000, DIABETES SPECTRUM, V13, P29
   Testa M A, 2000, Med Care, V38, pII166
   Testa MA, 1998, DIABETES CARE, V21, pC44, DOI 10.2337/diacare.21.3.C44
   Testa MA, 2000, DIABETES, V49, pA73
   TESTA MA, 1991, AM J HYPERTENS, V4, P363, DOI 10.1093/ajh/4.4.363
   TESTA MA, 1993, NEW ENGL J MED, V328, P907, DOI 10.1056/NEJM199304013281302
   Testa MA, 1998, JAMA-J AM MED ASSOC, V280, P1490, DOI 10.1001/jama.280.17.1490
   Testa MA, 1998, J HYPERTENS, V16, P1839, DOI 10.1097/00004872-199816120-00018
   Testa MA, 1996, NEW ENGL J MED, V334, P835, DOI 10.1056/NEJM199603283341306
   TESTA MA, 1988, POSTGRAD MED J, V64, P50
   Testa MA, 2007, DIABETES CARE, V30, P1399, DOI 10.2337/dc06-1497
   TURNER RC, 1995, DIABETES, V44, P1249
   Wei M, 2000, CIRCULATION, V101, P2047, DOI 10.1161/01.CIR.101.17.2047
   Weintrob N, 2003, PEDIATRICS, V112, P559, DOI 10.1542/peds.112.3.559
   Zambanini A, 1999, DIABETES RES CLIN PR, V46, P239, DOI 10.1016/S0168-8227(99)00099-6
NR 39
TC 25
Z9 25
U1 0
U2 3
PU ENDOCRINE SOC
PI CHEVY CHASE
PA 8401 CONNECTICUT AVE, SUITE 900, CHEVY CHASE, MD 20815-5817 USA
SN 0021-972X
J9 J CLIN ENDOCR METAB
JI J. Clin. Endocrinol. Metab.
PD OCT 1
PY 2012
VL 97
IS 10
BP 3504
EP 3514
DI 10.1210/jc.2012-1763
PG 11
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 018MH
UT WOS:000309664400044
PM 22851487
OA Bronze
DA 2019-01-08
ER

PT J
AU Atlantis, E
AF Atlantis, Evan
TI Excess burden of type 1 and type 2 diabetes due to psychopathology
SO JOURNAL OF AFFECTIVE DISORDERS
LA English
DT Article
DE Diabetes; Psychological distress; Depression; Anxiety; Antidepressants;
   Anti-anxiety medications
ID CO-MORBID DEPRESSION; PSYCHOLOGICAL DISTRESS; COMORBID DEPRESSION;
   PROSPECTIVE COHORT; HEALTH-CARE; PREVALENCE; ANTIDEPRESSANTS;
   METAANALYSIS; MELLITUS; TRENDS
AB Background: Whether the prevalence of type 1 or 2 diabetes is rising among people with psychopathology is uncertain. This study investigates changes in the prevalence of type 1 and type 2 diabetes associated with psychopathology in the adult Australian population from 2001 to 2008.
   Methods: Data analysed were from 48,359 participants aged >= 25 years from the 2001, 2004-05 or 2007-08 National Health Surveys. Lifetime diagnosis of type 1 and type 2 diabetes was determined by self-report. Psychopathology status was determined with the 10-item Kessler Psychological Distress Scale (using scores >= 30), contemporaneous use of antidepressants or anti-anxiety medications, or both.
   Results: Overall, the prevalence of type 1 diabetes remained stable whereas the prevalence of type 2 diabetes increased by 36% between 2001 and 2008. On average, odds ratios with 95% confidence intervals (95% CI) for type 1 and type 2 diabetes ranged from 1.43 (0.98, 2.10) to 2.44 (1.63, 3.64) and 1.32 (1.13, 1.53) to 1.67 (1.39, 2.02) for people with compared to those without psychopathology by any definition independent of socio-demographic covariates, consistently over the 8-year period. After further adjustments for lifestyle covariates, the strength of these odds ratios were attenuated and ranged from 1.32 (0.90, 1.95) to 2.24 (1.49, 3.36) and 1.16 (0.99, 1.36) to 1.51 (1.24, 1.83) for type 1 and type 2 diabetes.
   Limitations: Data were self-report from serial surveys.
   Conclusions: The prevalence of both type 1 and type 2 diabetes was consistently higher for people with psychopathology from 2001 to 2008. Clinicians should consider routinely screening patients with diabetes for psychopathology and vice versa, as well as lifestyle risk factors, to inform practice for more effective management and prevention planning. (C) 2012 Elsevier B. V. All rights reserved.
C1 [Atlantis, Evan] Univ Western Sydney, Family & Community Hlth Res Grp, Sch Nursing & Midwifery, Penrith, NSW 2751, Australia.
   [Atlantis, Evan] Univ Adelaide, Sch Med, Adelaide, SA, Australia.
RP Atlantis, E (reprint author), Univ Western Sydney, Family & Community Hlth Res Grp, Sch Nursing & Midwifery, Bldg 17,Room 17-1-14,Campbelltown Campus,Locked B, Penrith, NSW 2751, Australia.
EM e.atlantis@uws.edu.au
CR Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x
   American Diabetes Association, 2011, DIABETES CARE S1, V34, pS62, DOI [10.2337/dc11-S062, DOI 10.2337/DC11-S062]
   Andrews G, 2001, AUST NZ J PUBL HEAL, V25, P494, DOI 10.1111/j.1467-842X.2001.tb00310.x
   Atlantis E, 2008, INT J OBESITY, V32, P715, DOI 10.1038/sj.ijo.0803762
   Atlantis E, 2009, OBES REV, V10, P543, DOI 10.1111/j.1467-789X.2009.00590.x
   Atlantis E, 2012, SOC PSYCH PSYCH EPID, V47, P871, DOI 10.1007/s00127-011-0394-4
   Atlantis E, 2012, AUST NZ J PSYCHIAT, V46, P445, DOI 10.1177/0004867411433218
   Atlantis E, 2012, SOC PSYCH PSYCH EPID, V47, P615, DOI 10.1007/s00127-011-0365-9
   Atlantis E, 2010, INT J GERIATR PSYCH, V25, P688, DOI 10.1002/gps.2409
   Atlantis E, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3868
   Australian Bureau of Statistics A National Health Survey, 2001, 990 AUSTR BUR STAT A
   Australian Bureau of Statistics B National Health Survey, 2005, 1778 AUSTR BUR STAT
   Australian Bureau of Statistics C National Health Survey, 2007, 4324 AUSTR BUR STAT
   Australian Institute of Health and Welfare, 2009, AUSTR I HLTH WELF DI
   Barbui C, 1999, SOC PSYCH PSYCH EPID, V34, P152, DOI 10.1007/s001270050127
   Barnard KD, 2006, DIABETIC MED, V23, P445, DOI 10.1111/j.1464-5491.2006.01814.x
   Barr ELM, 2007, CIRCULATION, V116, P151, DOI 10.1161/CIRCULATIONAHA.106.685628
   Brhlikova P, 2011, J ROY SOC MED, V104, P25, DOI 10.1258/jrsm.2010.100080
   Chiu CJ, 2010, SOC PSYCH PSYCH EPID, V45, P67, DOI 10.1007/s00127-009-0043-3
   Coles-Rutishauser I., 2001, EVALUATION SHORT DIE
   Davydow DS, 2011, PSYCHOSOMATICS, V52, P117, DOI 10.1016/j.psym.2010.12.020
   Glasziou P, 2008, BRIT MED J, V336, P1472, DOI 10.1136/bmj.39590.732037.47
   Goldney RD, 2010, AUST NZ J PSYCHIAT, V44, P901, DOI 10.3109/00048674.2010.490520
   Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341
   GREY M, 1995, DIABETES CARE, V18, P1330, DOI 10.2337/diacare.18.10.1330
   Harman JS, 2009, PSYCHIAT SERV, V60, P611, DOI 10.1176/appi.ps.60.5.611
   Hilliard ME, 2011, DIABETES RES CLIN PR, V94, P39, DOI 10.1016/j.diabres.2011.05.027
   Hutter N, 2010, DIABETOLOGIA, V53, P2470, DOI 10.1007/s00125-010-1873-y
   International Diabetes Federation, 2011, IDF DIAB ATL
   Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Kovacs M, 1997, DIABETES CARE, V20, P45, DOI 10.2337/diacare.20.1.45
   Lin EHB, 2010, DIABETES CARE, V33, P264, DOI 10.2337/dc09-1068
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Manderbacka K, 2011, PHARMACOEPIDEM DR S, V20, P338, DOI 10.1002/pds.2072
   Mant A, 2004, MED J AUSTRALIA, V181, pS21
   McFall M, 2010, JAMA-J AM MED ASSOC, V304, P2485, DOI 10.1001/jama.2010.1769
   Meijer WEE, 2004, EUR J CLIN PHARMACOL, V60, P57, DOI 10.1007/s00228-004-0726-3
   Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985
   Moore M, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3999
   Northam EA, 2005, DIABETIC MED, V22, P152, DOI 10.1111/j.1464-5491.2004.01370.x
   Nouwen A, 2010, DIABETOLOGIA, V53, P2480, DOI 10.1007/s00125-010-1874-x
   Petersen M, 2008, DIABETES CARE, V31, P596, DOI 10.2337/dc08-9017
   Pouwer F, 2010, DIABETIC MED, V27, P217, DOI 10.1111/j.1464-5491.2009.02903.x
   Schram MT, 2009, CURR DIABETES REV, V5, P112, DOI 10.2174/157339909788166828
   Simon GE, 2010, GEN HOSP PSYCHIAT, V32, P583, DOI 10.1016/j.genhosppsych.2010.09.010
   Stewart SM, 2005, PEDIATRICS, V115, P1315, DOI 10.1542/peds.2004-1717
   Van der Feltz-Cornelis CM, 2010, GEN HOSP PSYCHIAT, V32, P380, DOI 10.1016/j.genhosppsych.2010.03.011
   Wilkins Tricia Lee, 2011, Int Clin Psychopharmacol, V26, P159, DOI 10.1097/YIC.0b013e328342ce31
   World Health Organization, 2008, GLOB BURD DIS 2004 U
NR 50
TC 7
Z9 7
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-0327
J9 J AFFECT DISORDERS
JI J. Affect. Disord.
PD OCT
PY 2012
VL 142
SU S
BP S36
EP S41
DI 10.1016/S0165-0327(12)70007-1
PG 6
WC Clinical Neurology; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 017GJ
UT WOS:000309577800006
PM 23062855
DA 2019-01-08
ER

PT J
AU Rogvi, S
   Tapager, I
   Almdal, TP
   Schiotz, ML
   Willaing, I
AF Rogvi, S.
   Tapager, I.
   Almdal, T. P.
   Schiotz, M. L.
   Willaing, I.
TI Patient factors and glycaemic control - associations and explanatory
   power
SO DIABETIC MEDICINE
LA English
DT Article
ID DIABETIC-PATIENTS; CHRONIC ILLNESS; PRIMARY-CARE; DANISH VERSION;
   KNOWLEDGE; ADAPTATION; MANAGEMENT; PREDICTORS; ACTIVATION; OUTCOMES
AB Diabet. Med. 29, e382e389 (2012) Abstract Aims To investigate the association between glycaemic control and patient socio-demographics, activation level, diabetes-related distress, assessment of care, knowledge of target HbA1c, and self-management behaviours, and to determine to what extent these factors explain the variance in HbA1c in a large Danish population of patients with Type 2 diabetes. Methods Cross-sectional survey and record review of 2045 patients from a specialist diabetes clinic. Validated scales measured patient activation, self-management behaviours, diabetes-related emotional distress, and perceived care. The electronic patient record provided information about HbA1c, medication, body mass index, and duration of diabetes. Data were analysed using multiple linear regression models with stepwise addition of covariates. Results The response rate was 54% (n = 1081). Good glycaemic control was significantly associated with older age, higher education, higher patient activation, lower diabetes-related emotional distress, better diet and exercise behaviours, lower body mass index, shorter duration of disease and knowledge of HbA1c targets (P < 0.05 for all). Patient socio-demographics, behaviour; perceptions of care and diabetes distress accounted for 14% of the total variance in HbA1c levels (P = 0.0134), but the variance explained was higher for respondents treated with medications other than insulin. Conclusions Our study emphasizes the complex relationships between patient activation, distress and behaviour, specific treatment modalities and glycaemic control. Knowledge of treatment goals, achieving patient activation in coping with diabetes, and lowering disease-related emotional stress are important patient education goals. However, the large unexplained component of HbA1c variance highlights the need for more research to understand the mechanisms of glycaemic control.
C1 [Rogvi, S.; Schiotz, M. L.; Willaing, I.] Steno Diabet Ctr, Steno Hlth Promot Ctr, DK-2820 Gentofte, Denmark.
   [Tapager, I.] Incent Partners, Holte, Denmark.
   [Almdal, T. P.] Steno Diabet Ctr, Steno Patient Care Clin, DK-2820 Gentofte, Denmark.
RP Willaing, I (reprint author), Steno Diabet Ctr, Steno Hlth Promot Ctr, DK-2820 Gentofte, Denmark.
EM iwtp@steno.dk
CR *AM DIAB ASS, 2011, DIABETES CARE S1, V34, pS11, DOI DOI 10.2337/DC11-S011
   Bains SS, 2011, DIABETES TECHNOL THE, V13, P335, DOI 10.1089/dia.2010.0160
   Bebb C, 2005, DIABETIC MED, V22, P1364, DOI 10.1111/j.1464-5491.2005.01662.x
   Benoit SR, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-36
   Berikai P, 2007, DIABETES CARE, V30, P1587, DOI 10.2337/dc06-2026
   BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170
   Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775
   Chiu C, 2010, PREVENTING CHRONIC D, V7, P1
   Daly JM, 2009, J AM BOARD FAM MED, V22, P280, DOI 10.3122/jabfm.2009.03.080114
   Delahanty LM, 2007, DIABETIC MED, V24, P48, DOI 10.1111/j.1464-5491.2007.02028.x
   Glasgow RE, 2005, DIABETES CARE, V28, P2655, DOI 10.2337/diacare.28.11.2655
   Gugiu PC, 2009, CHRONIC ILLN, V5, P268, DOI 10.1177/1742395309348072
   He X, 2007, INT NURS REV, V54, P280, DOI 10.1111/j.1466-7657.2007.00570.x
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   Hibbard JH, 2004, HEALTH SERV RES, V39, P1005, DOI 10.1111/j.1475-6773.2004.00269.x
   Hojat M, 2011, ACAD MED, V86, P359, DOI 10.1097/ACM.0b013e3182086fe1
   Huang ES, 2011, DIABETES CARE, V34, P1329, DOI 10.2337/dc10-2377
   Khattab M, 2010, J DIABETES COMPLICAT, V24, P84, DOI 10.1016/j.jdiacomp.2008.12.008
   Maindal HT, 2012, EUR J PUBLIC HEALTH, V22, P31, DOI 10.1093/eurpub/ckq188
   Maindal HT, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-209
   McGuire BE, 2009, DIABETOLOGIA, V53, P66
   Nichols GA, 2000, DIABETES CARE, V23, P273, DOI 10.2337/diacare.23.3.273
   Ozcelik F, 2010, POL ARCH MED WEWN, V120, P399
   Papelbaum M, 2010, DIABETES RES CLIN PR, V89, P227, DOI 10.1016/j.diabres.2010.05.024
   Remmers C, 2009, J AMBUL CARE MANAG, V32, P320, DOI 10.1097/JAC.0b013e3181ba6e77
   Rhee MK, 2005, DIABETES EDUCATOR, V31, P240, DOI 10.1177/0145721705274927
   Schiotz M, 2012, PATIENT EDUC COUNS, V87, P217, DOI 10.1016/j.pec.2011.09.003
   Schmittdiel J, 2008, J GEN INTERN MED, V23, P77, DOI 10.1007/s11606-007-0452-5
   Snoek FJ, 2011, DIABETES CARE, V34, P601, DOI 10.2337/dc10-1552
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
NR 30
TC 31
Z9 32
U1 0
U2 16
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
J9 DIABETIC MED
JI Diabetic Med.
PD OCT
PY 2012
VL 29
IS 10
BP e382
EP e389
DI 10.1111/j.1464-5491.2012.03703.x
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 008MF
UT WOS:000308960400005
PM 22540962
DA 2019-01-08
ER

PT J
AU van der Wulp, I
   de Leeuw, JRJ
   Gorter, KJ
   Rutten, GEHM
AF van der Wulp, I.
   de Leeuw, J. R. J.
   Gorter, K. J.
   Rutten, G. E. H. M.
TI Effectiveness of peer-led self-management coaching for patients recently
   diagnosed with Type 2 diabetes mellitus in primary care: a randomized
   controlled trial
SO DIABETIC MEDICINE
LA English
DT Article
ID QUALITY-OF-LIFE; MARITAL RELATIONSHIP; CHRONIC ILLNESS; PROBLEM AREAS;
   SCALE; INTERVENTION; ADAPTATION; DISTRESS; VALIDITY; PROGRAM
AB Diabet. Med. 29, e390e397 (2012) Summary Aims To study the effectiveness of a peer-led self-management coaching intervention in recently diagnosed patients with Type 2 diabetes. Methods Randomized controlled trial of recently diagnosed patients with Type 2 diabetes from 54 participating general practices. The intervention group received three home visits by an experienced peer (expert patient) who adhered to the recommended treatment and lifestyle guidelines. Together with their expert patient, participants set feasible goals and these were evaluated in the next visit. Participants in the control group received care as usual. At baseline, 3 months and 6 months post-intervention, participants completed a questionnaire measuring changes in self-efficacy, coping, physical activity, dietary habits, psychological well-being, depressive symptoms and diabetes related distress. Results In total, 327 patients were eligible for inclusion in the study of which 133 consented to participate. In participating patients, self-efficacy, coping and saturated fat intake improved significantly over time. Analyses of participants with low self-efficacy at baseline (25th percentile: 44) revealed a significant time X group difference, F = 3.71; P = 0.03. Participants who reported low psychological well-being at baseline increased substantially throughout the study (F = 23.84; P < 0.01) but no significant time X group differences were found. Conclusions A peer-led self-management coaching programme for recently diagnosed patients with Type 2 diabetes improved self-efficacy of patients experiencing low self-efficacy shortly after diagnosis.
C1 [van der Wulp, I.; de Leeuw, J. R. J.; Gorter, K. J.; Rutten, G. E. H. M.] UMC Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.
RP van der Wulp, I (reprint author), UMC Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.
EM i.vanderwulp-2@umcutrecht.nl
FU Dutch Diabetes Research Foundation [2005.13.017]
FX We thank all patients and expert patients for participating in this
   study. This study was supported by a grant of the Dutch Diabetes
   Research Foundation, grant number: 2005.13.017.
CR Bandura A., 1986, SOCIAL FDN THOUGHT A, P391
   Barlow J, 2002, PATIENT EDUC COUNS, V48, P177, DOI 10.1016/S0738-3991(02)00032-0
   Cade JE, 2009, DIABETIC MED, V26, P1048, DOI 10.1111/j.1464-5491.2009.02808.x
   Chaveepojnkamjorn W, 2009, SE ASIAN J TROP MED, V40, P169
   Dale J, 2009, PATIENT EDUC COUNS, V75, P91, DOI 10.1016/j.pec.2008.09.014
   Dennis CL, 2003, INT J NURS STUD, V40, P321, DOI 10.1016/S0020-7489(02)00092-5
   Field A, 2005, DISCOVERING STAT USI, P428
   Glasgow RE, 2003, PREV MED, V36, P410, DOI 10.1016/S0091-7435(02)00056-7
   Heijmans M, 1999, PSYCHOL HEALTH, V14, P451, DOI 10.1080/08870449908407340
   Kalo I, 2003, DIABETOLOGIA, V46, pA88
   Kotani Kazuhiko, 2004, Aust J Rural Health, V12, P251, DOI 10.1111/j.1440-1854.2004.00626.x
   Lorig K, 2009, DIABETES EDUCATOR, V35, P641, DOI 10.1177/0145721709335006
   Newman S, 2004, LANCET, V364, P1523, DOI 10.1016/S0140-6736(04)17277-2
   Paul GM, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-45
   Pieper B A, 1990, Diabetes Educ, V16, P108, DOI 10.1177/014572179001600206
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   RUTTEN GEH, 2006, HUISARTS WET, V49, P137
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Thoolen B., 2008, HLTH PSYCHOL REV, V2, P65, DOI [10.1080/17437190802311361, DOI 10.1080/17437190802311361]
   Thoolen B, 2007, DIABETES CARE, V30, P2832, DOI 10.2337/dc07-0777
   Trief PM, 2002, DIABETES CARE, V25, P1154, DOI 10.2337/diacare.25.7.1154
   Trief PM, 2001, DIABETES CARE, V24, P1384, DOI 10.2337/diacare.24.8.1384
   van Assema P, 2001, J HUM NUTR DIET, V14, P377, DOI 10.1046/j.1365-277X.2001.00310.x
   van Assema P, 1992, Eur J Cancer Prev, V1, P375, DOI 10.1097/00008469-199208000-00006
   van der Bijl J, 1999, J ADV NURS, V30, P352, DOI 10.1046/j.1365-2648.1999.01077.x
   VanWormer JJ, 2004, DIABETES EDUCATOR, V30, P404, DOI 10.1177/014572170403000309
   WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4
   Welch G, 1994, HDB PSYCHOL DIABETES, P391
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   WHO Collaborating Center for Mental Health, WHO 5 WELL BEING IND
NR 31
TC 27
Z9 27
U1 0
U2 28
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD OCT
PY 2012
VL 29
IS 10
BP e390
EP e397
DI 10.1111/j.1464-5491.2012.03629.x
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 008MF
UT WOS:000308960400006
PM 22414198
DA 2019-01-08
ER

PT J
AU Slean, GR
   Jacobs, EA
   Lahiff, M
   Fisher, L
   Fernandez, A
AF Slean, Geraldine Rosaura
   Jacobs, Elizabeth A.
   Lahiff, Maureen
   Fisher, Lawrence
   Fernandez, Alicia
TI Aspects of Culturally Competent Care are Associated With Less Emotional
   Burden Among Patients With Diabetes
SO MEDICAL CARE
LA English
DT Article
DE emotional burden; diabetes distress; doctor-patient relationship;
   doctor-patient communication; culturally competent care; trust;
   minority; Hispanic/Latino; African American
ID DEPRESSIVE SYMPTOMS; DISTRESS; COMMUNICATION; RACE/ETHNICITY; LANGUAGE
AB Background: Diabetes distress is associated with poor diabetes self-management and worse clinical outcomes. Whether there is an association between patient experience of health care and degree of emotional burden (EB) of diabetes distress is not known.
   Objective: To investigate whether aspects of culturally competent care are associated with the EB of diabetes distress.
   Design: Cross-sectional survey consisting of face-to-face interviews.
   Subjects: A total of 502 ethnically diverse patients with diabetes receiving care in safety-net clinics in 2 cities.
   Measures: The main outcome measure was high EB on the Diabetes Distress Scale (mean score >= 3). The predictors were 3 domains (Doctor Communication-Positive Behaviors, Trust, and Doctor Communication-Health Promotion) of the Consumer Assessment of Healthcare Providers and Systems-Cultural Competence (Consumer Assessments of Healthcare Providers and Systems' Cultural Competence Item Set) instrument.
   Results: Of 502 patients, 263 (52%) reported high EB. In adjusted logistic regressions controlling for sociodemographic and clinical factors, patient report of optimal Doctor Communication-Positive Behaviors (adjusted odds ratio, 0.46; 95% confidence interval, 0.39-0.54), and optimal Trust (adjusted odds ratio, 0.65; 95% confidence interval, 0.54-0.78) were associated with lower EB. Doctor Communication-Health Promotion Communication was not associated with EB.
   Discussion: Patient report of better doctor communication behavior and higher trust in physician are inversely associated with high EB among patients with diabetes. Further research should determine whether interventions improving patient physician communication and trust can lower the EB of diabetes.
C1 [Slean, Geraldine Rosaura] Univ Calif San Francisco, Joint Med Program, San Francisco, CA 94143 USA.
   [Slean, Geraldine Rosaura] Univ Calif Berkeley, Joint Med Program, Berkeley, CA 94720 USA.
   [Jacobs, Elizabeth A.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Madison, WI 53706 USA.
   [Jacobs, Elizabeth A.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Populat Hlth Sci, Madison, WI 53706 USA.
   [Lahiff, Maureen] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.
   [Fisher, Lawrence] Univ Calif San Francisco, Dept Family & Community Med & Psychiat, San Francisco, CA 94143 USA.
   [Fernandez, Alicia] Univ Calif San Francisco, Dept Internal Med, San Francisco Gen Hosp, San Francisco, CA 94143 USA.
RP Fernandez, A (reprint author), Univ Calif San Francisco, Dept Internal Med, San Francisco Gen Hosp, POB 1364, San Francisco, CA 94143 USA.
EM afernandez@medsfgh.ucsf.edu
OI Slean, Geraldine/0000-0003-2859-5723
FU Russell Sage Foundation; Commonwealth Fund; Arnold P. Gold Foundation;
   UCSF Dean's Summer Research Fellowship Program; UCB-UCSF Smith Thesis
   Research Fellowship Program
FX Supported by Russell Sage Foundation, Commonwealth Fund, Arnold P. Gold
   Foundation, UCSF Dean's Summer Research Fellowship Program, and UCB-UCSF
   Smith Thesis Research Fellowship Program.
CR Aikens JE, 2005, DIABETES EDUCATOR, V31, P681, DOI 10.1177/0145721705280829
   Doescher MP, 2000, ARCH FAM MED, V9, P1156, DOI 10.1001/archfami.9.10.1156
   Fernandez A, 2004, J GEN INTERN MED, V19, P167, DOI 10.1111/j.1525-1497.2004.30266.x
   Fernandez A, 2011, J GEN INTERN MED, V26, P170, DOI 10.1007/s11606-010-1507-6
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2009, DIABETIC MED, V26, P622, DOI 10.1111/j.1464-5491.2009.02730.x
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Johnson RL, 2004, AM J PUBLIC HEALTH, V94, P2084, DOI 10.2105/AJPH.94.12.2084
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   Morales LS, 1999, J GEN INTERN MED, V14, P409, DOI 10.1046/j.1525-1497.1999.06198.x
   National Quality Forum (NQF), 2009, COMPR FRAM PREF PRAC
   Peek ME, 2009, J GEN INTERN MED, V24, P1135, DOI 10.1007/s11606-009-1047-0
   Pibernik-Okanovic M, 2008, DIABETIC MED, V25, P1252, DOI 10.1111/j.1464-5491.2008.02553.x
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Pouwer F, 2005, DIABETES RES CLIN PR, V70, P166, DOI 10.1016/j.diabres.2005.03.031
   Pouwer F, 2009, NAT REV ENDOCRINOL, V5, P665, DOI 10.1038/nrendo.2009.214
   Rabi DM, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-124
   Rivadeneyra R, 2000, AM J MED, V108, P470, DOI 10.1016/S0002-9343(99)00445-3
   Schenker Y, 2010, PATIENT EDUC COUNS, V81, P222, DOI 10.1016/j.pec.2010.02.005
   Schenker Y, 2009, J GEN INTERN MED, V24, P550, DOI 10.1007/s11606-009-0937-5
   Spencer MS, 2006, J HEALTH CARE POOR U, V17, P88, DOI 10.1353/hpu.2006.0095
   Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737
   Stern RJ, 2012, MED CARE, V50, pS49, DOI 10.1097/MLR.0b013e31826410fb
   Swenson SL, 2008, MED CARE, V46, P257, DOI 10.1097/MLR.0b013e31816080e9
   Weech-Maldonado R, 2003, HEALTH SERV RES, V38, P789, DOI 10.1111/1475-6773.00147
   Weech-Maldonado R, 2012, MED CARE, V50, pS22, DOI 10.1097/MLR.0b013e318263134b
   Zweifler J, 2010, INT J EQUITY HEALTH, V9, DOI 10.1186/1475-9276-9-4
NR 29
TC 12
Z9 12
U1 0
U2 15
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0025-7079
J9 MED CARE
JI Med. Care
PD SEP
PY 2012
VL 50
IS 9
SU 2
BP S69
EP S73
DI 10.1097/MLR.0b013e3182641127
PG 5
WC Health Care Sciences & Services; Health Policy & Services; Public,
   Environmental & Occupational Health
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA 080IO
UT WOS:000314235300011
PM 22895234
OA Bronze
DA 2019-01-08
ER

PT J
AU Cleator, J
   Abbott, J
   Judd, P
   Sutton, C
   Wilding, JPH
AF Cleator, J.
   Abbott, J.
   Judd, P.
   Sutton, C.
   Wilding, J. P. H.
TI Night eating syndrome: implications for severe obesity
SO NUTRITION & DIABETES
LA English
DT Review
DE obesity; night eating; sleep; circadian rhythm
ID OBSTRUCTIVE SLEEP-APNEA; BODY-MASS INDEX; WEIGHT-LOSS;
   GENERAL-POPULATION; BARIATRIC SURGERY; METABOLIC SYNDROME;
   BULIMIA-NERVOSA; MORBIDLY OBESE; ENERGY-INTAKE; FOOD-INTAKE
AB Night eating syndrome (NES) was first identified in 1955 by Stunkard, a psychiatrist specialising in eating disorders (ED). Over the last 20 years considerable progress has been made in defining NES as a significant clinical entity in its own right and it has now been accepted for inclusion in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) due for publication in 2013. NES is considered a dysfunction of circadian rhythm with a disassociation between eating and sleeping. Core criteria include a daily pattern of eating with a significantly increased intake in the evening and/or night time, as manifested by one or both of the following: at least 25% of food intake is consumed after the evening meal or at least two episodes of nocturnal eating per week. An important recent addition to core criteria includes the presence of significant distress and/or impairment in functioning. Stunkard's team recommend further investigation on the pathogenesis of NES, in particular its relationship with traumatic life events, psychiatric comorbidity, the age of onset of NES and course of NES over time. The relationship between NES and other ED also requires further clarification as night-eaters exhibit some features of other ED; previous guidance to separate NES from other ED may have hindered earlier characterisation of NES. Evidence from European and American studies suggests NES features strongly in populations with severe obesity. The complex interplay between depression, impaired sleep and obesity-related comorbidity in severely obese individuals makes understanding NES in this context even more difficult. This review examines evidence to date on the characterisation of NES and concludes by examining the applicability of current NES criteria to individuals with severe obesity. Nutrition and Diabetes (2012) 2, e44; doi:10.1038/nutd.2012.16; published online 10 September 2012
C1 [Cleator, J.; Wilding, J. P. H.] Univ Liverpool, Dept Obes & Endocrinol, Liverpool L69 3BX, Merseyside, England.
   [Abbott, J.] Univ Cent Lancashire, Sch Psychol, Preston PR1 2HE, Lancs, England.
   [Judd, P.; Sutton, C.] Univ Cent Lancashire, Sch Hlth, Preston PR1 2HE, Lancs, England.
RP Cleator, J (reprint author), Univ Manchester, Sch Nursing Midwifery & Social Work, Jean McFarlane Bldg,Oxford Rd, Manchester M13 9PL, Lancs, England.
EM jacqueline.cleator@manchester.ac.uk
RI Wilding, John/A-7106-2008
OI Wilding, John/0000-0003-2839-8404; Sutton, Chris/0000-0002-6406-1318;
   Cleator, Jacqueline/0000-0002-0313-101X
FU Roche Products Limited
FX Professor Wilding received an educational grant from Roche Products
   Limited to support the study fees of Jacqueline Cleator while she
   conducted research into NES at the University of Liverpool, UK.
   Professors Abbott and Judd and Dr Sutton have no relevant conflict of
   interest to declare.
CR Adami GF, 2002, NUTRITION, V18, P587, DOI 10.1016/S0899-9007(02)00761-X
   Adami GF, 1999, INT J EAT DISORDER, V25, P335, DOI 10.1002/(SICI)1098-108X(199904)25:3<335::AID-EAT12>3.0.CO;2-1
   Allison K. C., 2004, OVERCOMING NIGHT EAT
   Allison KC, 2005, J CLIN ENDOCR METAB, V90, P6214, DOI 10.1210/jc.2005-1018
   Allison KC, 2005, J CONSULT CLIN PSYCH, V73, P1107, DOI 10.1037/0022-006X.73.6.1107
   Allison Kelly C, 2008, Eat Behav, V9, P62, DOI 10.1016/j.eatbeh.2007.03.007
   Allison KC, 2007, BEHAV RES THER, V45, P2874, DOI 10.1016/j.brat.2007.05.007
   Allison Kelly C, 2010, Am J Psychother, V64, P91
   Allison KC, 2010, INT J EAT DISORDER, V43, P241, DOI 10.1002/eat.20693
   Allison Kelly C, 2008, Eat Behav, V9, P398, DOI 10.1016/j.eatbeh.2008.04.004
   Allison KC, 2006, OBESITY, V14, p77S, DOI 10.1038/oby.2006.286
   Andersen GS, 2004, INT J OBESITY, V28, P1338, DOI 10.1038/sj.ijo.0802731
   Aronoff NJ, 2001, J AM DIET ASSOC, V101, P102, DOI 10.1016/S0002-8223(01)00022-0
   Atlantis E, 2008, INT J OBESITY, V32, P881, DOI 10.1038/ijo.2008.54
   Birketvedt GS, 1999, JAMA-J AM MED ASSOC, V282, P657, DOI 10.1001/jama.282.7.657
   Birketvedt GS, 2002, AM J PHYSIOL-ENDOC M, V282, pE366, DOI 10.1152/ajpendo.00251.2001
   Bixler EO, 2005, J CLIN ENDOCR METAB, V90, P4510, DOI 10.1210/jc.2005-0035
   Blaine B, 2008, J HEALTH PSYCHOL, V13, P1190, DOI 10.1177/1359105308095977
   Boston RC, 2008, AM J CLIN NUTR, V87, P1672
   Bower B, 2010, J SLEEP RES, V19, P323, DOI 10.1111/j.1365-2869.2009.00816.x
   Busetto L, 2005, OBES SURG, V15, P195, DOI 10.1381/0960892053268327
   Calugi S, 2009, INT J OBESITY, V33, P899, DOI 10.1038/ijo.2009.105
   Ceru-Bjork C, 2001, INT J OBESITY, V25, P365, DOI 10.1038/sj.ijo.0801552
   Chaput JP, 2005, PHYSIOL BEHAV, V86, P224, DOI 10.1016/j.physbeh.2005.07.014
   Cizza G, 2005, SLEEP, V28, P1217, DOI 10.1093/sleep/28.10.1217
   Colles SL, 2007, INT J OBESITY, V31, P1722, DOI 10.1038/sj.ijo.0803664
   Colles SL, 2008, OBESITY, V16, P615, DOI 10.1038/oby.2007.101
   Colles SL, 2008, OBESITY, V16, P608, DOI 10.1038/oby.2007.99
   Cooper-Kazaz R, 2012, J CLIN PSYCHOPHARM, V32, P143, DOI 10.1097/JCP.0b013e31823f9051
   Coughlin SR, 2004, EUR HEART J, V25, P735, DOI 10.1016/j.ehj.2004.02.021
   Dalgleish T, 2001, PERS INDIV DIFFER, V31, P453, DOI 10.1016/S0191-8869(00)00150-1
   Dalle GR, 2011, INT J EAT DISORDER, V44, P150, DOI DOI 10.1002/EAT.20786
   de Zwaan M, 2006, INT J EAT DISORDER, V39, P224, DOI 10.1002/eat.20246
   Devlin MJ, 2004, OBES SURG, V14, P1252, DOI 10.1381/0960892042386940
   Dixon JB, 2003, ARCH INTERN MED, V163, P2058, DOI 10.1001/archinte.163.17.2058
   Drevets WC, 2001, CURR OPIN NEUROBIOL, V11, P240, DOI 10.1016/S0959-4388(00)00203-8
   EHLERS CL, 1988, ARCH GEN PSYCHIAT, V45, P948
   FAIRBURN CG, 1990, AM J PSYCHIAT, V147, P401
   Friedman S, 2004, CAN J PSYCHIAT, V49, P790
   Friedman S, 2006, APPETITE, V47, P119, DOI 10.1016/j.appet.2006.03.159
   Gangwisch JE, 2005, SLEEP, V28, P1289, DOI 10.1093/sleep/28.10.1289
   Garaulet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017435
   Geliebter A, 2002, APPETITE, V39, P175, DOI 10.1006/appe.2001.0472
   Gluck ME, 2001, OBES RES, V9, P264, DOI 10.1038/oby.2001.31
   Goel N, 2009, J BIOL RHYTHM, V24, P85, DOI 10.1177/0748730408328914
   Goldschmidt AB, 2008, INT J EAT DISORDER, V41, P153, DOI 10.1002/eat.20481
   Goncalves MD, 2009, EUR EAT DISORD REV, V17, P184, DOI 10.1002/erv.918
   GREENO CG, 1995, INT J EAT DISORDER, V18, P343, DOI 10.1002/1098-108X(199512)18:4<343::AID-EAT2260180407>3.0.CO;2-P
   Grilo CM, 2004, BEHAV RES THER, V42, P397, DOI 10.1016/S0005-7967(03)00148-7
   Hasler G, 2004, SLEEP, V27, P661, DOI 10.1093/sleep/27.4.661
   HEALEY ES, 1981, PSYCHOSOM MED, V43, P439
   Hildebrandt T, 2006, EUR EAT DISORD REV, V14, P17, DOI 10.1002/erv.667
   Huang CJ, 2010, INT J OBESITY, V34, P720, DOI 10.1038/ijo.2009.285
   International Classification of Sleep Disorders, 2005, DIAGN COD MAN
   Jennings JR, 2007, SLEEP, V30, P219, DOI 10.1093/sleep/30.2.219
   Karp JF, 2005, J CLIN PSYCHIAT, V66, P591, DOI 10.4088/JCP.v66n0508
   Knutson KL, 2006, ARCH INTERN MED, V166, P1768, DOI 10.1001/archinte.166.16.1768
   Kretsch MJ, 1999, J AM DIET ASSOC, V99, P300, DOI 10.1016/S0002-8223(99)00078-4
   KULDAU JM, 1986, INT J EAT DISORDER, V5, P143, DOI 10.1002/1098-108X(198601)5:1<143::AID-EAT2260050114>3.0.CO;2-T
   Lamerz A, 2005, J CHILD PSYCHOL PSYC, V46, P385, DOI 10.1111/j.1469-7610.2004.00363.x
   Latner JD, 2007, BEHAV RES THER, V45, P2203, DOI 10.1016/j.brat.2006.12.002
   Latner JD, 2004, OBES RES, V12, P956, DOI 10.1038/oby.2004.117
   Leskela US, 2004, J NERV MENT DIS, V192, P373, DOI 10.1097/01.nmd.0000126705.15497.c9
   LICHTMAN SW, 1992, NEW ENGL J MED, V327, P1893, DOI 10.1056/NEJM199212313272701
   Lundgren JD, 2006, AM J PSYCHIAT, V163, P156, DOI 10.1176/appi.ajp.163.1.156
   Lundgren JD, 2008, PSYCHIAT RES-NEUROIM, V162, P214, DOI 10.1016/j.pscychresns.2007.07.006
   Lundgren JD, 2006, INT J EAT DISORDER, V39, P516, DOI 10.1002/eat.20269
   Lundgren JD, 2011, PSYCHIAT RES, V186, P103, DOI 10.1016/j.psychres.2010.08.008
   Lundgren JD, 2010, PSYCHIAT RES, V175, P233, DOI 10.1016/j.psychres.2008.10.027
   Lundgren Jennifer D, 2008, Eat Behav, V9, P343, DOI 10.1016/j.eatbeh.2007.12.004
   Marshall HM, 2004, INT J EAT DISORDER, V35, P217, DOI 10.1002/eat.10241
   Miyaoka T, 2003, INT CLIN PSYCHOPHARM, V18, P175, DOI 10.1097/01.yic.0000068440.56680.8e
   Morse SA, 2006, DIABETES CARE, V29, P1800, DOI 10.2337/dc06-0315
   Napolitano MA, 2001, INT J EAT DISORDER, V30, P193, DOI 10.1002/eat.1072
   Nordin M, 2005, J OCCUP HEALTH PSYCH, V10, P54, DOI 10.1037/1076-8998.10.1.54
   O'Brien Bridget, 2005, Ir Med J, V98, P250
   O'Reardon JP, 2006, AM J PSYCHIAT, V163, P893, DOI 10.1176/appi.ajp.163.5.893
   O'Reardon JP, 2004, OBES RES, V12, P1789, DOI 10.1038/oby.2004.222
   O'Reardon JP, 2004, INT J EAT DISORDER, V35, P16, DOI 10.1002/eat.10224
   Olbrich K, 2009, EUR EAT DISORD REV, V17, P120, DOI 10.1002/erv.908
   Palmese LB, 2011, SCHIZOPHR RES, V133, P238, DOI 10.1016/j.schres.2011.07.030
   Patel SR, 2008, INT J OBESITY, V32, P1825, DOI 10.1038/ijo.2008.198
   Pawlow LA, 2003, INT J OBESITY, V27, P970, DOI 10.1038/sj.ijo.0802320
   Powers PS, 1999, INT J EAT DISORDER, V25, P293, DOI 10.1002/(SICI)1098-108X(199904)25:3<293::AID-EAT7>3.0.CO;2-G
   RAND CSW, 1993, INT J OBESITY, V17, P657
   RAND CSW, 1986, INT J EAT DISORDER, V5, P75, DOI 10.1002/1098-108X(198601)5:1<75::AID-EAT2260050107>3.0.CO;2-V
   Rand CSW, 1997, INT J EAT DISORDER, V22, P65
   Rogers NL, 2006, SLEEP, V29, P814, DOI 10.1093/sleep/29.6.814
   Root TL, 2010, EAT BEHAV, V11, P92, DOI 10.1016/j.eatbeh.2009.10.004
   Rosmond R, 2004, MED HYPOTHESES, V62, P976, DOI 10.1016/j.mehy.2003.12.030
   Sassaroli Sandra, 2009, Eat Disord, V17, P140, DOI 10.1080/10640260802714597
   SPAGGIARI MC, 1994, SLEEP, V17, P339, DOI 10.1093/sleep/17.4.339
   Striegel-Moore RH, 2006, OBESITY, V14, P139, DOI 10.1038/oby.2006.17
   Striegel-Moore RH, 2005, INT J EAT DISORDER, V37, P200, DOI 10.1002/eat.20128
   Striegel-Moore RH, 2008, INT J EAT DISORDER, V41, P411, DOI 10.1002/eat.20514
   Striegel-Moore RH, 2010, INT J EAT DISORDER, V43, P520, DOI 10.1002/eat.20735
   Stunkard A, 2010, EAT WEIGHT DISORD-ST, V15, pE2, DOI 10.1007/BF03325274
   Stunkard A, 1996, INT J OBESITY, V20, P1
   STUNKARD AJ, 1955, AM J MED, V19, P78, DOI 10.1016/0002-9343(55)90276-X
   Stunkard AJ, 2003, INT J OBESITY, V27, P1, DOI 10.1038/sj.ijo.0802186
   Stunkard A, 2008, AM J PSYCHIAT, V165, P424, DOI 10.1176/appi.ajp.2007.07081351
   Taheri S, 2006, ARCH DIS CHILD, V91, P881, DOI 10.1136/adc.2005.093013
   Taheri S, 2004, PLOS MED, V1, P210, DOI 10.1371/journal.pmed.0010062
   Takeda Eiji, 2004, J Med Invest, V51, P139, DOI 10.2152/jmi.51.139
   Telch CF, 1998, INT J EAT DISORDER, V24, P313, DOI 10.1002/(SICI)1098-108X(199811)24:3<313::AID-EAT9>3.0.CO;2-P
   Tholin S, 2009, OBESITY, V17, P1050, DOI 10.1038/oby.2008.676
   Tzischinsky O, 2004, EUR EAT DISORD REV, V12, P101, DOI 10.1002/erv.538
   Vetrugno R, 2006, SLEEP, V29, P949, DOI 10.1093/sleep/29.7.949
   Vorona RD, 2005, ARCH INTERN MED, V165, P25, DOI 10.1001/archinte.165.1.25
   Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301
   Winkelman JW, 2003, SLEEP MED, V4, P243, DOI 10.1016/S1389-9457(03)00060-1
   Youngstedt SD, 2004, SLEEP MED REV, V8, P159, DOI 10.1016/j.smrv.2003.10.002
NR 112
TC 22
Z9 22
U1 0
U2 23
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2044-4052
J9 NUTR DIABETES
JI Nutr. Diabetes
PD SEP
PY 2012
VL 2
AR e44
DI 10.1038/nutd.2012.16
PG 10
WC Endocrinology & Metabolism; Nutrition & Dietetics
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 084GW
UT WOS:000314527700002
PM 23446659
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Fritschi, C
   Quinn, L
   Hacker, ED
   Penckofer, SM
   Wang, E
   Foreman, M
   Ferrans, CE
AF Fritschi, Cynthia
   Quinn, Laurie
   Hacker, Eileen D.
   Penckofer, Sue M.
   Wang, Edward
   Foreman, Marquis
   Ferrans, Carol E.
TI Fatigue in Women With Type 2 Diabetes
SO DIABETES EDUCATOR
LA English
DT Article
ID PHYSICAL-ACTIVITY; GLYCEMIC CONTROL; AFRICAN-AMERICANS; BLOOD-PRESSURE;
   SYMPTOMS; GLUCOSE; ADULTS; PEOPLE; SAMPLE; RISK
AB Purpose
   The purpose of this study was to explore the relationship between fatigue and physiological, psychological, and lifestyle phenomena in women with type 2 diabetes (T2DM) in order to establish the magnitude and correlates of fatigue in women with T2DM and explore the interrelationships between fatigue and specific diabetes-related factors that may be associated with increased levels of fatigue. These factors included physiological factors (glucose control, diabetes symptoms), psychological factors (diabetes emotional distress, depressive symptoms in general), and lifestyle factors (body mass index, physical activity).
   Methods
   A cross-sectional, descriptive design was used. Women who reported conditions known to cause fatigue were excluded. Physiological measures included fasting blood glucose (FBG), hemoglobin A1C (A1C), glucose variability, and body mass index (BMI). Women completed questionnaires about health, fatigue levels, diabetes symptoms, diabetes emotional distress, depressive symptoms, physical activity, and current diabetes self-care practices. A subset of the women wore a Medtronic Gold CGM sensor for 3 days for assessment of glucose variability.
   Results
   Eighty-three women aged 40 to 65 years with T2DM completed the study. Fatigue was significantly related to diabetes symptoms, diabetes emotional distress, depressive symptoms, higher BMI, and reduced physical activity. There was no relationship between fatigue and FBG or A1C. The strongest explanatory factors for fatigue were diabetes symptoms, depressive symptoms, and BMI, which accounted for 48% of the variance in fatigue scores. Glucose variability was not significantly associated with fatigue in these women.
   Conclusions
   Fatigue is a persistent clinical complaint among women with T2DM and may signal the presence of physiological, psychological, and lifestyle-related phenomena that could undermine diabetes health outcomes.
C1 [Fritschi, Cynthia; Quinn, Laurie; Hacker, Eileen D.; Wang, Edward; Ferrans, Carol E.] Univ Illinois, Coll Nursing, Dept Biobehav Hlth Sci, Chicago, IL 60612 USA.
   [Penckofer, Sue M.] Loyola Univ, Marcella Niehoff Sch Nursing, Chicago, IL 60611 USA.
   [Foreman, Marquis] Rush Univ, Coll Nursing, Chicago, IL 60612 USA.
RP Fritschi, C (reprint author), Univ Illinois, Coll Nursing, Dept Biobehav Hlth Sci, MC 802,845 S Damen Ave, Chicago, IL 60612 USA.
EM Fritschi@uic.edu
OI Fritschi, Cynthia/0000-0001-5447-8315
FU National Institutes of Health/National Institute for Nursing research
   [F31 NR009751]
FX This work was supported in part by the National Institutes of
   Health/National Institute for Nursing research F31 NR009751. The authors
   thank Kevin Grandfield, Publication Manager for the UIC Department of
   Biobehavioral Health Science, for editorial assistance.
CR Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS55, DOI 10.2337/dc08-S055
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Bonora E, 2001, DIABETES CARE, V24, P2023, DOI 10.2337/diacare.24.12.2023
   Bonora E, 2001, DIABETOLOGIA, V44, P2107, DOI 10.1007/s001250100020
   Bulpitt CJ, 1998, DIABETES CARE, V21, P111, DOI 10.2337/diacare.21.1.111
   Casalenuovo GA, 2002, FATIGUE DIABETES MEL
   Cavelti-Weder Claudia, 2011, Diabetes Care, V34, pe158, DOI 10.2337/dc11-1196
   Colberg SR, 2010, MED SCI SPORT EXER, V42, P2282, DOI 10.1249/MSS.0b013e3181eeb61c
   de Sonnaville JJJ, 1998, DIABETES CARE, V21, P919, DOI 10.2337/diacare.21.6.919
   Deshpande AD, 2005, DIABETES CARE, V28, P1012, DOI 10.2337/diacare.28.5.1012
   Drivsholm T, 2005, DIABETOLOGIA, V48, P210, DOI 10.1007/s00125-004-1625-y
   Fritschi C, 2010, J PSYCHOSOM RES, V69, P33, DOI 10.1016/j.jpsychores.2010.01.021
   Fritschi C, 2010, DIABETES EDUCATOR, V36, P250, DOI 10.1177/0145721709355835
   GROOTENHUIS PA, 1994, DIABETIC MED, V11, P253, DOI 10.1111/j.1464-5491.1994.tb00268.x
   Gross T M, 2000, Diabetes Technol Ther, V2 Suppl 1, pS19
   Hays LM, 1999, DIABETES CARE, V22, P706, DOI 10.2337/diacare.22.5.706
   Hume C, 2010, DIABETES EDUCATOR, V36, P495, DOI 10.1177/0145721710368326
   Kennedy G, 2005, FREE RADICAL BIO MED, V39, P584, DOI 10.1016/j.freeradbiomed.2005-04.020
   Kovatchev B., 2003, Journal of Applied Research, V3, P449
   Lim K, 2005, PREV MED, V40, P33, DOI 10.1016/j.ypmed.2004.04.046
   Lim WJ, 2005, ARCH INTERN MED, V165, P910, DOI 10.1001/archinte.165.8.910
   Lin Jin-Mann S, 2009, Popul Health Metr, V7, P18, DOI 10.1186/1478-7954-7-18
   McArdle W. D., 2001, EXERCISE PHYSL, P752
   McDonnell C M, 2005, Diabetes Technol Ther, V7, P253, DOI 10.1089/dia.2005.7.253
   McNair D, 1992, MANUAL PROFILE MOOD
   Morrato EH, 2007, DIABETES CARE, V30, P203, DOI 10.2337/dc06-1128
   Nielsen ABS, 2011, SCAND J PRIM HEALTH, V29, P157, DOI 10.3109/02813432.2011.585542
   Pearte CA, 2004, ETHNIC DIS, V14, P198
   Plotnikoff RC, 2006, MED SCI SPORT EXER, V38, P1526, DOI 10.1249/01.mss.0000228937.86539.95
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Puetz TW, 2006, SPORTS MED, V36, P767, DOI 10.2165/00007256-200636090-00004
   REGENSTEINER JG, 1995, MED SCI SPORT EXER, V27, P874
   Resnick HE, 2006, J CLIN SLEEP MED, V2, P163
   Sachedina N, 2003, DIABETIC MED, V20, P1012, DOI 10.1046/j.1464-5491.2003.01037.x
   Sallis JF, 1999, RES Q EXERCISE SPORT, V70, P127, DOI 10.1080/02701367.1999.10608030
   SALLIS JF, 1985, AM J EPIDEMIOL, V121, P91, DOI 10.1093/oxfordjournals.aje.a113987
   Schwarz R, 2003, ONKOLOGIE, V26, P140, DOI 10.1159/000069834
   SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O
   Sommerfield AJ, 2004, DIABETES CARE, V27, P2335, DOI 10.2337/diacare.27.10.2335
   St John A, 2006, CLIN CHIM ACTA, V365, P257, DOI 10.1016/j.cca.2005.09.003
   STEWART AL, 1994, J CLIN EPIDEMIOL, V47, P719, DOI 10.1016/0895-4356(94)90169-4
   Tamborlane WV, 2005, PEDIATR DIABETES, V6, P13
   Theorell-Haglow J, 2006, SLEEP, V29, P751, DOI 10.1093/sleep/29.6.751
   Thomas LE, 2008, DIABETES TECHNOL THE, V10, P102, DOI 10.1089/dia.2007.0244
   Thomas N, 2004, POSTGRAD MED J, V80, P287, DOI 10.1136/pgmj.2003.010553
   Van der Does FEE, 1998, DIABETES CARE, V21, P2085, DOI 10.2337/diacare.21.12.2085
   VanderDoes FEE, 1996, DIABETES CARE, V19, P204, DOI 10.2337/diacare.19.3.204
   Warren RE, 2003, DIABETES-METAB RES, V19, P408, DOI 10.1002/dmrr.396
   Weijman I, 2004, J OCCUP ENVIRON MED, V46, P828, DOI 10.1097/01.jom.0000135605.62330.ca
   Weijman I, 2003, OCCUP ENVIRON MED, V60, P93
   Wenzel J, 2005, DIABETES EDUCATOR, V31, P98, DOI 10.1177/0145721704273242
   Wijeratne C, 2007, J PSYCHOSOM RES, V62, P153, DOI 10.1016/j.jpsychores.2006.09.011
   Wood FG, 2004, J ADV NURS, V45, P190, DOI 10.1046/j.1365-2648.2003.02880.x
NR 53
TC 18
Z9 18
U1 0
U2 11
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0145-7217
EI 1554-6063
J9 DIABETES EDUCATOR
JI Diabetes Educ.
PD SEP-OCT
PY 2012
VL 38
IS 5
BP 662
EP 672
DI 10.1177/0145721712450925
PG 11
WC Endocrinology & Metabolism; Public, Environmental & Occupational Health
SC Endocrinology & Metabolism; Public, Environmental & Occupational Health
GA 038WM
UT WOS:000311204800006
PM 22713262
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Cha, E
   Clark, PC
   Reilly, CM
   Higgins, M
   Lobb, M
   Smith, AL
   Dunbar, SB
AF Cha, EunSeok
   Clark, Patricia C.
   Reilly, Carolyn Miller
   Higgins, Melinda
   Lobb, Maureen
   Smith, Andrew L.
   Dunbar, Sandra B.
TI Educational Needs for Improving Self-Care in Heart Failure Patients With
   Diabetes
SO DIABETES EDUCATOR
LA English
DT Article
ID 6-MINUTE WALK; HYPERTENSION; DEPRESSION; MELLITUS; OUTCOMES;
   DYSFUNCTION; MECHANISMS; MANAGEMENT; MORBIDITY; MORTALITY
AB Purpose
   To explore the need for self-monitoring and self-care education in heart failure patients with diabetes (HF-DM patients) by describing cognitive and affective factors to provide guidance in developing effective self-management education.
   Methods
   A cross-sectional correlation design was employed using baseline patient data from a study testing a 12-week patient and family dyad intervention to improve dietary and medication-taking self-management behaviors in HF patients. Data from 116 participants recruited from metropolitan Atlanta area were used. Demographic and comorbidities, physical function, psychological distress, relationship with health care provider, self-efficacy (medication taking and low sodium diet), and behavioral outcomes (medications, dietary habits) were assessed. Descriptive statistics and a series of chi-square tests, t tests, or Mann-Whitney tests were performed to compare HF patients with and without DM.
   Results
   HF-DM patients were older and heavier, had more comorbidities, and took more daily medications than HF patients. High self-efficacy on medication and low-sodium diet was reported in both groups with no significant difference. Although HF-DM patients took more daily medications than HF, both groups exhibited high HF medication-taking behaviors. The HF-DM patients consumed significantly lower total sugar than HF patients but clinically higher levels of sodium.
   Conclusions
   Diabetes educators need to be aware of potential conflicts of treatment regimens to manage 2 chronic diseases. Special and integrated diabetes self-management education programs that incorporate principles of HF self-management should be developed to improve self-management behavior in HF-DM patients.
C1 [Cha, EunSeok; Reilly, Carolyn Miller; Higgins, Melinda; Lobb, Maureen; Dunbar, Sandra B.] Emory Univ, Nell Hodgson Woodruff Sch Nursing, Atlanta, GA 30322 USA.
   [Clark, Patricia C.] Georgia State Univ, Byrdine F Lewis Sch Nursing & Hlth Profess, Atlanta, GA 30303 USA.
   [Smith, Andrew L.] Emory Univ, Sch Med, Atlanta, GA USA.
RP Cha, E (reprint author), Emory Univ, Nell Hodgson Woodruff Sch Nursing, 1520 Clifton Rd NE, Atlanta, GA 30322 USA.
EM echa5@emory.edu
RI Higgins, Melinda/B-6459-2013; Albertin, Paloma/X-1093-2018
OI Higgins, Melinda/0000-0001-6579-5885; Reilly,
   Carolyn/0000-0003-1641-1747; cha, eunseok/0000-0001-6115-567X
FU Family Partnership Intervention for Heart Failure [R01 R08800]; National
   Institute of Nursing Research [NIH 07/01/04-11/30/09]; PHS grant from
   the General Clinical Research Center program, National Institutes of
   Health, National Center for Research Resources [M01 RR0039]; PHS Grant
   from the Clinical and Translational Science Award program, National
   Institutes of Health, National Center for Research Resources [UL1
   RR025008]; Nitromed; Atlanta Veteran's Administration Medical Center
FX This study was supported by A Family Partnership Intervention for Heart
   Failure (R01 R08800), National Institute of Nursing Research, NIH
   07/01/04-11/30/09, PI: S. Dunbar. The study was supported in part by PHS
   grant M01 RR0039 from the General Clinical Research Center program,
   National Institutes of Health, National Center for Research Resources,
   and by PHS Grant UL1 RR025008 from the Clinical and Translational
   Science Award program, National Institutes of Health, National Center
   for Research Resources. The study was supported by Nitromed through an
   unrestricted educational grant. We also acknowledge the Atlanta
   Veteran's Administration Medical Center for their support.
CR Aguilar D, 2009, J AM COLL CARDIOL, V54, P422, DOI 10.1016/j.jacc.2009.04.049
   *AM DIAB ASS, 2011, DIABETES CARE S1, V34, pS11, DOI DOI 10.2337/DC11-S011
   American Diabetes Association, TOTAL PREVALENCE OF
   American Heart Association, DIET AND LIFESTYLE R
   ANDREN L, 1989, AM J MED, V87, pS39, DOI 10.1016/0002-9343(89)90494-4
   Ashrafian H, 2007, CIRCULATION, V116, P434, DOI 10.1161/CIRCULATIONAHA.107.702795
   Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13
   BITTNER V, 1993, JAMA-J AM MED ASSOC, V270, P1702, DOI 10.1001/jama.270.14.1702
   Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775
   Boyle JP, 2010, POPULATION HLTH METR, V8
   Brunzell JD, 2008, DIABETES CARE, V31, P811, DOI 10.2337/dc08-9018
   Center for Disease Control and Prevention, 2009, OVERWEIGHT AND OBESI
   CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8
   Doran GT, 1981, MANAG REV, V71, P35
   Dunbar SB, 2008, J CARDIOVASC NURS, V23, P258, DOI 10.1097/01.JCN.0000305093.20012.b8
   Fujita T, 2007, NEPHROL DIAL TRANSPL, V22, P3102, DOI 10.1093/ndt/gfm409
   Gerstein HC, 2011, NEW ENGL J MED, V364, P818, DOI 10.1056/NEJMoa1006524
   Giamouzis G, 2010, J CARD FAIL, V16, P207, DOI 10.1016/j.cardfail.2009.12.007
   Greenberg BH, 2007, AM HEART J, V154, DOI 10.1016/j.ahj.2007.05.001
   Greenberg BH, 2007, AM HEART J, V154, P277
   Gress TW, 2000, NEW ENGL J MED, V342, P905, DOI 10.1056/NEJM200003303421301
   GUTIERREZ RC, 1999, CAN J CARDIOVASC NUR, V10, P29
   GUYATT GH, 1984, THORAX, V39, P818, DOI 10.1136/thx.39.11.818
   HealthyPeople. Gov, 2017, HLTH PEOPL 2020
   Hill J. M., 2011, THESIS
   Hunt SA, 2009, CIRCULATION, V119, pE391, DOI 10.1161/CIRCULATIONAHA.109.192065
   Kamalesh M, 2005, INT J CARDIOL, V99, P125, DOI 10.1016/j.ijcard.2004.05.049
   Koelling TM, 2005, CIRCULATION, V111, P179, DOI 10.1161/01.CIR.0000151811.53450.B8
   Lin EHB, 2006, ANN FAM MED, V4, P46, DOI 10.1370/afm.423
   Lorig K, 2006, LIVING A HEALTHY LIF
   Masoudi FA, 2007, AM J CARDIOL, V99, p113B, DOI 10.1016/j.amjcard.2006.11.013
   McCance K, 2010, PATHOPHYSIOLOGY THE
   Melander O, 2000, HYPERTENSION, V35, P827, DOI 10.1161/01.HYP.35.3.827
   Morgan AL, 2006, J CARD FAIL, V12, P54, DOI 10.1016/j.cardfail.2005.08.004
   *NAT CTR HLTH STAT, 2007, HEALTH
   Nichols GA, 2004, DIABETES CARE, V27, P1879, DOI 10.2337/diacare.27.8.1879
   Orzano AJ, 2004, J AM BOARD FAM PRACT, V17, P359, DOI 10.3122/jabfm.17.5.359
   Reilly CM, 2009, J CARDIOVASC NURS, V24, P500, DOI 10.1097/JCN.0b013e3181aff0b0
   Resnick B, 2004, MIDDLE RANGE THEORIE, P183
   Riegel B, 2002, PATIENT EDUC COUNS, V46, P287, DOI 10.1016/S0738-3991(01)00165-3
   Shah MR, 2001, AM J CARDIOL, V88, P987, DOI 10.1016/S0002-9149(01)01975-0
   Tahrani AA, 2007, BRIT MED J, V335, P508, DOI 10.1136/bmj.39255.669444.AE
   Tang WHW, 2007, DIABETES OBES METAB, V9, P447, DOI 10.1111/j.1463-1326.2006.00616.x
   U. S. Department of Agriculture U. S. Department of Health and Human Services, 2010, DIETARY GUIDELINES F
   Williams GC, 1996, J PERS SOC PSYCHOL, V70, P767, DOI 10.1037/0022-3514.70.4.767
   Williams GC, 1998, DIABETES CARE, V21, P1644, DOI 10.2337/diacare.21.10.1644
NR 46
TC 10
Z9 10
U1 0
U2 23
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0145-7217
J9 DIABETES EDUCATOR
JI Diabetes Educ.
PD SEP-OCT
PY 2012
VL 38
IS 5
BP 673
EP 684
DI 10.1177/0145721712450923
PG 12
WC Endocrinology & Metabolism; Public, Environmental & Occupational Health
SC Endocrinology & Metabolism; Public, Environmental & Occupational Health
GA 038WM
UT WOS:000311204800007
PM 22722611
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Tanenbaum, ML
   Gonzalez, JS
AF Tanenbaum, Molly L.
   Gonzalez, Jeffrey S.
TI The Influence of Diabetes on a Clinician-Rated Assessment of Depression
   in Adults With Type 1 Diabetes
SO DIABETES EDUCATOR
LA English
DT Article
ID MONTGOMERY-ASBERG DEPRESSION; CO-MORBID DEPRESSION; QUALITATIVE
   RESEARCH; COMORBID DEPRESSION; PROSPECTIVE COHORT; FOOT ULCERS;
   PREVALENCE; DISTRESS; METAANALYSIS; ASSOCIATION
AB Purpose
   The purpose of the study was to examine the role of diabetes and diabetes-related distress within clinician-administered depression interviews of adults with type 1 diabetes.
   Methods
   This mixed-methods study coded responses to a structured clinical interview of depressive symptom severity administered to adults with type 1 diabetes (n = 34; 65% female; 56% white, 38% African American, 27% Hispanic). Pearson correlations and t tests assessed relationships between interview-based and self-reported ratings of diabetes-related distress and depression.
   Results
   Among participants endorsing depressive symptoms in the interview, 73% mentioned diabetes as a contributing factor. Themes emerged relating to (1) a link between diabetes symptoms and distress, including problems with appetite, sleep, concentration, and social relationships; (2) overlapping symptoms between diabetes and depression; and (3) the perceived interconnectedness of mood and blood glucose levels. Clinician-assessed depression ratings were strongly associated with self-reported ratings of depression and self-reported diabetes-related distress. Interview-based diabetes-related distress was significantly associated with self-reported diabetes-related distress. Those with a diagnosis of major depressive disorder (44%) reported more diabetes-related distress.
   Conclusions
   Results suggest that diabetes may influence the evaluation of depression, even in standardized clinical interviews administered by trained professionals, the gold standard of assessment. Findings highlight a need for improved conceptualization and measurement of distress in individuals with diabetes to distinguish between symptoms caused by illness burden and those indicating a psychiatric disorder.
C1 [Tanenbaum, Molly L.; Gonzalez, Jeffrey S.] Yeshiva Univ, Ferkauf Grad Sch Psychol, Bronx, NY 10461 USA.
   [Gonzalez, Jeffrey S.] Albert Einstein Coll Med, Diabet Res Ctr, Bronx, NY 10467 USA.
RP Gonzalez, JS (reprint author), Yeshiva Univ, Ferkauf Grad Sch Psychol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.
EM jeffrey.gonzalez@einstein.yu.edu
FU Einstein Diabetes Research Center; NIDDK [DK020541]
FX This project was supported by a pilot and feasibility grant awarded to
   JSG by the Einstein Diabetes Research Center (supported by NIDDK
   DK020541). We are grateful to Persis Commissariat, BA, and Sabrina A.
   Esbitt, MA, for assisting with analyzing the qualitative data for this
   project.
CR Aikens JE, 2008, DIABETIC MED, V25, P1324, DOI 10.1111/j.1464-5491.2008.02590.x
   Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x
   Ali S, 2009, POSTGRAD MED J, V85, P238, DOI 10.1136/pgmj.2008.074641
   American Psychiatric Association, 2000, DIAGN STAT MAN MENT
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Anderson RM, 1998, DIABETES CARE, V21, P1387, DOI 10.2337/diacare.21.9.1387
   Barnard KD, 2006, DIABETIC MED, V23, P445, DOI 10.1111/j.1464-5491.2006.01814.x
   Black SA, 2003, DIABETES CARE, V26, P2822, DOI 10.2337/diacare.26.10.2822
   Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI DOI 10.1191/1478088706QP0630A
   Cabassa LJ, 2008, SOC SCI MED, V66, P2413, DOI 10.1016/j.socscimed.2008.01.054
   Castro FG, 2010, J MIX METHOD RES, V4, P342, DOI 10.1177/1558689810382916
   Cohen J, 1988, STAT POWER ANAL BEHA
   COYNE JC, 1994, PSYCHOL BULL, V116, P29, DOI 10.1037/0033-2909.116.1.29
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   Egede LE, 2005, DIABETES CARE, V28, P1339, DOI 10.2337/diacare.28.6.1339
   Egede LE, 2005, PSYCHOSOM MED, V67, P46, DOI 10.1097/01.psy.0000149260.82006.fb
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Folkman S, 2004, ANNU REV PSYCHOL, V55, P745, DOI 10.1146/annurev.psych.55.090902.141456
   Gask L, 2011, CHRONIC ILLN, V7, P239, DOI 10.1177/1742395311403636
   Gonzalez JS, 2010, DIABETOLOGIA, V53, P2241, DOI 10.1007/s00125-010-1821-x
   Gonzalez JS, 2007, DIABETES CARE, V30, P2222, DOI 10.2337/dc07-0158
   Gonzalez JS, 2011, DIABETES CARE, V34, P236, DOI 10.2337/dc10-1970
   Gonzalez Jeffrey S, 2010, Epidemiol Psichiatr Soc, V19, P110
   Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341
   Katon WJ, 2005, DIABETES CARE, V28, P2668, DOI 10.2337/diacare.28.11.2668
   Kim NS, MED DECIS MAKING
   Lin EHB, 2010, DIABETES CARE, V33, P264, DOI 10.2337/dc09-1068
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Markowitz SM, 2011, PSYCHOSOMATICS, V52, P1, DOI 10.1016/j.psym.2010.11.007
   MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Ritholz MD, 2011, CURR DIABETES REP, V11, P494, DOI 10.1007/s11892-011-0226-7
   Roy T, 2012, DIABETIC MED, V29, P164, DOI 10.1111/j.1464-5491.2011.03401.x
   Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi
   SNAITH RP, 1986, BRIT J PSYCHIAT, V148, P599, DOI 10.1192/bjp.148.5.599
   Svanborg P, 2001, J AFFECT DISORDERS, V64, P203, DOI 10.1016/S0165-0327(00)00242-1
   Vileikyte L, 2005, DIABETES CARE, V28, P2378, DOI 10.2337/diacare.28.10.2378
   Vileikyte L, 2009, DIABETOLOGIA, V52, P1265, DOI 10.1007/s00125-009-1363-2
   Williams LH, 2010, AM J MED, V123, P748, DOI 10.1016/j.amjmed.2010.01.023
   Yoshikawa H, 2008, DEV PSYCHOL, V44, P344, DOI 10.1037/0012-1649.44.2.344
   Zhang XP, 2005, AM J EPIDEMIOL, V161, P652, DOI 10.1093/aje/kwi089
NR 45
TC 9
Z9 9
U1 0
U2 11
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0145-7217
J9 DIABETES EDUCATOR
JI Diabetes Educ.
PD SEP-OCT
PY 2012
VL 38
IS 5
BP 695
EP 704
DI 10.1177/0145721712452795
PG 10
WC Endocrinology & Metabolism; Public, Environmental & Occupational Health
SC Endocrinology & Metabolism; Public, Environmental & Occupational Health
GA 038WM
UT WOS:000311204800009
PM 22814358
DA 2019-01-08
ER

PT J
AU Hayashino, Y
   Okamura, S
   Matsunaga, S
   Tsujii, S
   Ishii, H
AF Hayashino, Yasuaki
   Okamura, Shintaro
   Matsunaga, Satoshi
   Tsujii, Satoru
   Ishii, Hitoshi
CA Tenri Cohort Study Grp
TI The association between Problem Areas in Diabetes Scale scores and
   glycemic control is modified by types of diabetes therapy: Diabetes
   Distress and Care Registry in Tenri (DDCRT 2)
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Diabetes distress; Glycemic control; Diabetes registry
ID QUALITY-OF-LIFE; MELLITUS; ADULTS
AB Aim: To evaluate the joint association of Problem Areas in Diabetes (PAID) Scale scores and glycemic control with diabetes therapy.
   Methods: We used 3479 patients' data with type 1 and type 2. Modified Poisson regression analysis was used to estimate relative risks (RRs) for poor glycemic control (HbA1c >= 7.0%) across quartiles of PAID scores.
   Results: Compared with the 1st quartile of PAID score, multivariable-adjusted RRs for poor glycemic control were 0.99 (95% CI, 0.87-1.11), 1.05 (95% CI, 0.93-1.18), and 1.12 (95% CI, 1.00-1.27), respectively, for 2nd to 4th quartiles, and we observed significant trend (p for trend = 0.03). We observed significant interaction of PAID score and HbA1c with diabetes therapy (p = 0.0469). In patients receiving diet only therapy, the RRs for poor glycemic control were 1.38 (95% CI, 0.93-2.05), 1.18 (95% CI, 0.51-5.13), and 1.81 (95% CI, 1.16-2.79), respectively for 2nd to 4th quartiles of PAID score compared with the 1st quartile (p for trend = 0.025); while we did not observe significant association between PAID and poor glycemic control in patients receiving medication therapy.
   Conclusions: Diabetes distress measured by PAID survey was associated with poor glycemic control, and this association was modified by diabetes therapy. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
C1 [Hayashino, Yasuaki] Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Healthcare Epidemiol, Sakyo Ku, Kyoto 6068501, Japan.
   [Okamura, Shintaro; Matsunaga, Satoshi; Ishii, Hitoshi] Tenri Hosp, Dept Endocrinol, Tenri, Nara 632, Japan.
   [Tsujii, Satoru] Tenri Hosp, Ctr Diabet, Tenri, Nara 632, Japan.
RP Hayashino, Y (reprint author), Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Healthcare Epidemiol, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.
EM hayasino-y@umin.net
OI Tsujii, Satoru/0000-0002-1834-6515; Hayashino,
   Yasuaki/0000-0002-2932-8478
FU Manpei Suzuki Diabetes Foundation
FX This study was supported by the Manpei Suzuki Diabetes Foundation. The
   funding source had no role in the design and conduct of the study; in
   the collection, analysis, and interpretation of the data; or in the
   preparation, review, or approval of the manuscript.
CR American Diabetes Association, 2011, DIABETES CARE S1, V35, pS4
   Dhatt GS, 2005, CLIN CHIM ACTA, V358, P81, DOI 10.1016/j.cccn.2005.02.009
   Hajos TR, 2011, QUAL LIFE RES
   Huang MF, 2010, DIABETES CARE, V33, P38, DOI 10.2337/dc09-0768
   Ishii H., 2000, Journal of the Japan Diabetes Society, V43, P13
   McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074
   Nichols GA, 2000, DIABETES CARE, V23, P273, DOI 10.2337/diacare.23.3.273
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Testa MA, 1998, JAMA-J AM MED ASSOC, V280, P1490, DOI 10.1001/jama.280.17.1490
   UK Prospective Diabetes Study Group, 1999, DIABETES CARE, V22, P1125, DOI DOI 10.2337/DIACARE.22.7.1125
   VanderDoes FEE, 1996, DIABETES CARE, V19, P204, DOI 10.2337/diacare.19.3.204
   WEINBERGER M, 1994, MED CARE, V32, P1173, DOI 10.1097/00005650-199412000-00002
   Weinger K, 2005, DIABETES CARE, V28, P1346, DOI 10.2337/diacare.28.6.1346
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090
NR 15
TC 16
Z9 16
U1 0
U2 5
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD SEP
PY 2012
VL 97
IS 3
BP 405
EP 410
DI 10.1016/j.diabres.2012.04.005
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 013FU
UT WOS:000309292100012
PM 22554998
DA 2019-01-08
ER

PT J
AU Speight, J
   Conn, J
   Dunning, T
   Skinner, TC
AF Speight, J.
   Conn, J.
   Dunning, T.
   Skinner, T. C.
CA Diabet Australia
TI Diabetes Australia position statement. A new language for diabetes:
   Improving communications with and about people with diabetes
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Language; Diabetes; Communication; Adherence; Control
ID SELF-MANAGEMENT; CHRONIC ILLNESS; CARE; TYPE-2; ADHERENCE; OUTCOMES;
   RECOMMENDATIONS; EXPERIENCES; SUPPORT; TRIAL
AB Diabetes is the fastest growing chronic condition in Australia, affecting 1.7 million Australians, requiring daily self-care, and known to reduce quantity and quality of life. On average, people with diabetes experience greater emotional distress than those without diabetes. One source of distress can be the language used to refer to diabetes, its management and the person with diabetes. The way verbal and written language is used reflects and shapes people's thoughts, beliefs and behaviours. Language has the power to persuade, change or reinforce beliefs and stereotypes - for better or worse. Words do more than reflect people's reality: they create reality and affect how people view the world and their diabetes. Language needs to engage people with diabetes and support their self-care efforts. Importantly, language that de-motivates or induces fear, guilt or distress needs to be avoided and countered. Diabetes Australia believes optimal communication increases the motivation, health and well-being of people with diabetes, and that careless or negative language can be de-motivating, is often inaccurate, and can be harmful. Diabetes Australia developed this position statement to encourage greater awareness of the language surrounding diabetes and provide recommendations for more careful and positive language use. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
C1 [Speight, J.] Australian Ctr Behav Res Diabet, Melbourne, Vic 3000, Australia.
   [Speight, J.] Deakin Univ, Sch Psychol, Ctr Mental Hlth & Wellbeing Res, Burwood, Australia.
   [Speight, J.] AHP Res, Uxbridge, Middx, England.
   [Conn, J.] Royal Melbourne Hosp, Dept Endocrinol & Diabet, Parkville, Vic 3050, Australia.
   [Dunning, T.] Deakin Univ, Fac Hlth, Sch Nursing, Geelong, Vic 3217, Australia.
   [Dunning, T.] Geelong Hosp, Geelong, Vic, Australia.
   [Skinner, T. C.] Univ Tasmania, Rural Clin Sch, Burnie, Tas 7320, Australia.
RP Speight, J (reprint author), Australian Ctr Behav Res Diabet, 570 Elizabeth St, Melbourne, Vic 3000, Australia.
EM jspeight@acbrd.org.au
OI Skinner, Timothy/0000-0002-0018-6963; Speight, Jane/0000-0002-1204-6896
FU Australian Centre for Behavioural Research in Diabetes
FX We thank Elizabeth Holmes-Truscott and Jennifer Halliday (The Australian
   Centre for Behavioural Research in Diabetes) for their support of the
   Working Group. We thank Dr Jessica Browne, Virginia Hagger, Dr Christel
   Hendrieckx and Renza Scibilia for their valuable comments on an earlier
   draft.
CR Anderson RM, 2000, DIABETES EDUCATOR, V26, P597, DOI 10.1177/014572170002600405
   Bissell P, 2004, SOC SCI MED, V58, P851, DOI 10.1016/S0277-9536(03)00259-4
   Boroditsky L, 2003, ENCY COGNITIVE SCI, P917, DOI DOI 10.1002/0470018860.500567
   Broom D, 2004, SOC SCI MED, V58, P2371, DOI 10.1016/j.socscimed.2003.09.002
   Fisher EB, 2012, HEALTH AFFAIR, V31, P130, DOI 10.1377/hlthaff.2011.0914
   Fleischman S, 1999, J MED HUMANITIES, V20, P3
   Funnell MM, 2000, JAMA-J AM MED ASSOC, V284, P1709, DOI 10.1001/jama.284.13.1709
   Gallivan J, 2007, SOC MARK Q, V13, P65, DOI 10.1080/15245000701678453
   Glasgow RE, 1999, DIABETES CARE, V22, P2090, DOI 10.2337/diacare.22.12.2090
   Greenfield C, 2011, AUST J RURAL HEALTH, V19, P15, DOI 10.1111/j.1440-1584.2010.01171.x
   HARDIN C, 1993, SOC COGNITION, V11, P277, DOI 10.1521/soco.1993.11.3.277
   Hawthorne K, 2011, DIABETIC MED, V28, P1103, DOI 10.1111/j.1464-5491.2011.03292.x
   Hayashino Y, 2011, EXP CLIN ENDOCR DIAB, V119, P276, DOI 10.1055/s-0030-1265213
   Heisler M, 2003, J GEN INTERN MED, V18, P893, DOI 10.1046/j.1525-1497.2003.21132.x
   Heisler M, 2002, J GEN INTERN MED, V17, P243, DOI 10.1046/j.1525-1497.2002.10905.x
   Khan H, 2011, PRIM CARE DIABETES, V5, P251, DOI 10.1016/j.pcd.2011.07.001
   Khattab M, 2010, J DIABETES COMPLICAT, V24, P84, DOI 10.1016/j.jdiacomp.2008.12.008
   Kollias Anastasios, 2009, Prim Care Diabetes, V3, P249, DOI 10.1016/j.pcd.2009.08.001
   Murphy HR, 2010, DIABETIC MED, V27, P92, DOI 10.1111/j.1464-5491.2009.02890.x
   Paterson B, 2001, J ADV NURS, V34, P574, DOI 10.1046/j.1365-2648.2001.01786.x
   Polonsky WH, 2005, DIABETES CARE, V28, P2543, DOI 10.2337/diacare.28.10.2543
   Roberson MH, 1992, QUALITATIVE HLTH RES, V2, P7
   Schillinger D, 2009, DIABETES CARE, V32, P559, DOI 10.2337/dc08-0787
   SHERBOURNE CD, 1992, J BEHAV MED, V15, P447, DOI 10.1007/BF00844941
   Singh H, 2010, DIABETES, V59
   Snow R, 2012, DIABETIC MED, V29, P257, DOI 10.1111/j.1464-5491.2011.03447.x
   Street RL, 2009, PATIENT EDUC COUNS, V74, P295, DOI 10.1016/j.pec.2008.11.015
   Stuckey HL, 2010, QUAL HEALTH RES, V20, P42, DOI 10.1177/1049732309355286
   Swift PGF, 2010, PEDIATR DIABETES, V11, P271, DOI 10.1111/j.1399-5448.2009.00596.x
   Thorne SE, 2000, INT J NURS STUD, V37, P303, DOI 10.1016/S0020-7489(00)00007-9
   Turner RC, 1998, LANCET, V352, P837
   Wild D, 2007, PATIENT EDUC COUNS, V68, P10, DOI 10.1016/j.pec.2007.05.003
   Zhao G, 2008, DIABETIC MED, V25, P221, DOI 10.1111/j.1464-5491.2007.02332.x
NR 33
TC 16
Z9 17
U1 0
U2 11
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD SEP
PY 2012
VL 97
IS 3
BP 425
EP 431
DI 10.1016/j.diabres.2012.03.015
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 013FU
UT WOS:000309292100015
PM 22513346
DA 2019-01-08
ER

PT J
AU Munshi, MN
   Hayes, M
   Iwata, I
   Lee, Y
   Weinger, K
AF Munshi, M. N.
   Hayes, M.
   Iwata, I.
   Lee, Y.
   Weinger, K.
TI Which aspects of executive dysfunction influence ability to manage
   diabetes in older adults?
SO DIABETIC MEDICINE
LA English
DT Article
DE cognition; diabetes; elderly
ID COGNITIVE IMPAIRMENT; DYSEXECUTIVE SYMPTOMS; MELLITUS; TRAIL;
   QUESTIONNAIRE; DECLINE; SAMPLE; WOMEN
AB Diabet. Med. 29, 1171-1177 (2012) Abstract Aims To examine whether different aspects of executive function as measured by different assessment tools are associated with glycaemic control and other clinical characteristics in older adults with Type 2 diabetes. Methods We performed a cross-sectional study of older adults aged >= 70 years with Type 2 diabetes at a tertiary care diabetes centre. The Dysexecutive Questionnaire was used to measure self-reported executive dysfunction. Objective tests of executive functions included a modified clock drawing test (Clock-in-a-Box), Trail Making Tests (parts A and B) and verbal fluency. Demographic and clinical information was collected using questionnaires and surveys. Glycaemic control was measured by HbA1c. Results We evaluated 145 patients [average age 77 +/- 5 years, diabetes duration 15 +/- 11 years, mean HbA1c 56 +/- 11 mmol/mol (7.3 +/- 1.1%)]. Poor performances on objective tests (low scores on Clock-in-a-Box and verbal fluency; and high scores on Trail Making Tests A and B) but not on the subjective test (the Dysexecutive Questionnaire), were associated with poor glycaemic control (r = -0.23, P < 0.005; r = -0.17, P < 0.04; r = 0.20, P < 0.01, r = 0.22, P < 0.008, r = -0.07, P < 0.42, respectively). In a multiple regression model (r2 = 0.39), high Dysexecutive Questionnaire scores were associated with higher diabetes-related distress (P < 0.0004), depressive symptoms (P < 0.004), number of falls (P < 0.009), fear of falling (P < 0.01), less years of education (P < 0.0007) and fewer medications (P < 0.001). Conclusions On the one hand, in older adults, executive dysfunction detected by objective tests is associated with poor glycaemic control and may be considered before prescribing complex treatment regimens. On the other hand, self-reported executive dysfunction is associated with risk and fear of falls, and more affective symptoms, which may indicate higher awareness of subtle deficits.
C1 [Munshi, M. N.; Lee, Y.; Weinger, K.] Joslin Diabet Ctr, Boston, MA 02215 USA.
   [Munshi, M. N.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.
   [Munshi, M. N.; Weinger, K.] Harvard Univ, Sch Med, Boston, MA USA.
   [Hayes, M.] Univ Calif San Francisco, San Francisco, CA 94143 USA.
   [Iwata, I.] Duke Univ, Med Ctr, Durham, NC USA.
RP Munshi, MN (reprint author), 1 Joslin Pl, Boston, MA 02215 USA.
EM medha.munshi@joslin.harvard.edu
FU American Diabetes Association [1-07-CR-40]; Department of Defense PRMRP
   of the Office of the Congressionally Directed Medical Research Programs
   [W81XWH-07-1-0282]; Joslin Diabetes Center Clinical Research Center
FX The study was partly supported by a grant from a clinical research award
   from American Diabetes Association, 1-07-CR-40 (MM), Department of
   Defense PRMRP of the Office of the Congressionally Directed Medical
   Research Programs, W81XWH-07-1-0282 (MM), and the Joslin Diabetes Center
   Clinical Research Center.
CR Abbatecola AM, 2004, J AM GERIATR SOC, V52, P1713, DOI 10.1111/j.1532-5415.2004.52466.x
   Abrahams S, 2000, NEUROPSYCHOLOGIA, V38, P734, DOI 10.1016/S0028-3932(99)00146-3
   Amieva H, 2003, BRAIN COGNITION, V53, P129, DOI 10.1016/S0278-2626(03)00094-0
   Arvanitakis Z, 2004, ARCH NEUROL-CHICAGO, V61, P661, DOI 10.1001/archneur.61.5.661
   Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547
   Chan RCK, 2001, BRIT J PSYCHOL, V92, P551, DOI 10.1348/000712601162338
   Chaytor N, 2007, BRAIN INJURY, V21, P615, DOI 10.1080/02699050701426949
   CORRIGAN JD, 1987, J CLIN PSYCHOL, V43, P402, DOI 10.1002/1097-4679(198707)43:4<402::AID-JCLP2270430411>3.0.CO;2-E
   Drane DL, 2002, NEUROPSY NEUROPSY BE, V15, P39
   Fontbonne A, 2001, DIABETES CARE, V24, P366, DOI 10.2337/diacare.24.2.366
   Gerstorf D, 2008, AGING NEUROPSYCHOL C, V15, P424, DOI 10.1080/13825580701640374
   Grande L., 2005, J INT NEUROPSYCH SOC, V11, P9
   Gregg EW, 2000, ARCH INTERN MED, V160, P174, DOI 10.1001/archinte.160.2.174
   Ickowicz E, 2003, J AM GERIATR SOC, V51, pS265
   KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016
   LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179
   Mitchell RLC, 2007, NEUROPSYCHOLOGIA, V45, P617, DOI 10.1016/j.neuropsychologia.2006.06.030
   Montorio I, 1996, Int Psychogeriatr, V8, P103, DOI 10.1017/S1041610296002505
   Munshi M, 2006, DIABETES CARE, V29, P1794, DOI 10.2337/dc06-0506
   Nguyen HT, 2010, J AM GERIATR SOC, V58, P1123, DOI 10.1111/j.1532-5415.2010.02857.x
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   SCHMIDT R, 1992, ARCH NEUROL-CHICAGO, V49, P825, DOI 10.1001/archneur.1992.00530320049011
   Sinclair AJ, 2000, DIABETES RES CLIN PR, V50, P203, DOI 10.1016/S0168-8227(00)00195-9
   Spreen O, 1991, COMPENDIUM NEUROPSYC
   Stewart R, 1999, DIABETIC MED, V16, P93, DOI 10.1046/j.1464-5491.1999.00027.x
   Thabit H, 2009, DIABETES RES CLIN PR, V86, P208, DOI 10.1016/j.diabres.2009.09.004
   Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8
   van Harten B, 2007, EUR NEUROL, V57, P70, DOI 10.1159/000098054
   Yaffe K, 2004, NEUROLOGY, V63, P658, DOI 10.1212/01.WNL.0000134666.64593.BA
NR 29
TC 13
Z9 17
U1 0
U2 17
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD SEP
PY 2012
VL 29
IS 9
BP 1171
EP 1177
DI 10.1111/j.1464-5491.2012.03606.x
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 988EC
UT WOS:000307470200029
PM 22340082
DA 2019-01-08
ER

PT J
AU Tanda, R
   Salsberry, PJ
AF Tanda, Rika
   Salsberry, Pamela J.
TI Integrating Risks for Type 2 Diabetes Across Childhood: A Life Course
   Perspective
SO JOURNAL OF PEDIATRIC NURSING-NURSING CARE OF CHILDREN & FAMILIES
LA English
DT Article
DE Type 2 diabetes; Childhood obesity; Life course model; Cumulative risks
ID INTRAUTERINE GROWTH RESTRICTION; BODY-MASS INDEX; INSULIN-RESISTANCE;
   SOCIOECONOMIC-STATUS; BIRTH-WEIGHT; OVERWEIGHT ADOLESCENTS;
   PSYCHOLOGICAL DISTRESS; DEVELOPMENTAL ORIGINS; PROSPECTIVE COHORT;
   METABOLIC SYNDROME
AB Type 2 diabetes (T2DM) emerged among children, due in large measure to a strong physiological link between increased weight states and T2DM. In this article, cumulative risk factors for T2DM across childhood and its underlying mechanisms are reviewed. The points of intervention for T2DM should occur throughout childhood. The use of Halfon and Hochstein's framework enables practitioners and researchers in the nursing field to better understand a child's individual risk for T2DM. Only with this long view will prevention and interventions be successful in stemming the tide of the "twin epidemic" threatening children worldwide. (C) 2012 Elsevier Inc. All rights reserved.
C1 [Tanda, Rika; Salsberry, Pamela J.] Ohio State Univ, Coll Nursing, Columbus, OH 43210 USA.
RP Tanda, R (reprint author), Ohio State Univ, Coll Nursing, Columbus, OH 43210 USA.
EM tanda.3@buckeyemail.osu.edu
CR Armstrong J, 2002, LANCET, V359, P2003, DOI 10.1016/S0140-6736(02)08837-2
   Baker Elizabeth A, 2006, Prev Chronic Dis, V3, pA76
   BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171
   Bell JF, 2008, AM J PREV MED, V35, P547, DOI 10.1016/j.amepre.2008.07.006
   Bender BG, 2007, PEDIATRICS, V120, P805, DOI 10.1542/peds.2007-0500
   Bertram CE, 2002, REPRODUCTION, V124, P459, DOI 10.1530/rep.0.1240459
   Black PH, 2006, MED HYPOTHESES, V67, P879, DOI 10.1016/j.mehy.2006.04.008
   Bohringer A, 2008, PSYCHONEUROENDOCRINO, V33, P1394, DOI 10.1016/j.psyneuen.2008.08.002
   Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808
   Brufani C, 2009, EUR J ENDOCRINOL, V160, P769, DOI 10.1530/EJE-08-0878
   Cottrell EC, 2008, PHYSIOL BEHAV, V94, P17, DOI 10.1016/j.physbeh.2007.11.017
   Dabelea D, 2007, JAMA-J AM MED ASSOC, V297, P2716
   Danielzik S, 2004, INT J OBESITY, V28, P1494, DOI 10.1038/sj.ijo.0802756
   Davison KK, 2005, J PEDIATR-US, V147, P436, DOI 10.1016/j.jpeds.2005.05.002
   De Boo HA, 2006, AUST NZ J OBSTET GYN, V46, P4, DOI 10.1111/j.1479-828X.2006.00506.x
   Devaskar SU, 2007, REV ENDOCR METAB DIS, V8, P105, DOI 10.1007/s11154-007-9050-4
   Diego MA, 2006, PSYCHOSOM MED, V68, P747, DOI 10.1097/01.psy.0000238212.21598.7b
   Doyle AC, 2007, OBESITY, V15, P145, DOI 10.1038/oby.2007.515
   Elenkov IJ, 2008, NEUROCHEM INT, V52, P40, DOI 10.1016/j.neuint.2007.06.037
   FEMANDEZTWINN DS, 2006, PHYSIOL BEHAV, V88, P234
   Franco M, 2008, AM J PREV MED, V35, P561, DOI 10.1016/j.amepre.2008.07.003
   Gibson LY, 2007, MED J AUSTRALIA, V186, P591
   Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473
   Goran MI, 2001, DIABETES, V50, P2444, DOI 10.2337/diabetes.50.11.2444
   Goran MI, 2006, INT J PEDIATR OBES, V1, P139, DOI 10.1080/17477160600780423
   Gordon-Larsen P, 2006, PEDIATRICS, V117, P417, DOI 10.1542/peds.2005-0058
   Gray L, 2008, EUR J PUBLIC HEALTH, V18, P616, DOI 10.1093/eurpub/ckn044
   HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248
   Halfon N, 2002, MILBANK Q, V80, P433, DOI 10.1111/1468-0009.00019
   Halfon N., 2005, ZERO 3
   Harshaw C, 2008, DEV REV, V28, P541, DOI 10.1016/j.dr.2008.08.001
   Hemphill E, 2008, AM J HEALTH PROMOT, V22, P426, DOI 10.4278/ajhp.22.6.426
   Ievers-Landis CE, 2008, J DEV BEHAV PEDIATR, V29, P243, DOI 10.1097/DBP.0b013e31816d923d
   Jenkins SK, 2005, COMPR CHILD ADOLES N, V28, P175, DOI 10.1080/01460860500227580
   Kajantie E, 2008, HORM-INT J ENDOCRINO, V7, P101, DOI 10.1007/BF03401501
   Kaplowitz PB, 2008, PEDIATRICS, V121, pS208, DOI 10.1542/peds.2007-1813F
   Khashan AS, 2008, PSYCHOSOM MED, V70, P688, DOI 10.1097/PSY.0b013e318177940d
   Lee JM, 2008, ARCH PEDIAT ADOL MED, V162, P682, DOI 10.1001/archpedi.162.7.682
   Lesage J, 2004, J ENDOCRINOL, V181, P291, DOI 10.1677/joe.0.1810291
   Li FZ, 2009, AM J HEALTH PROMOT, V23, P203, DOI 10.4278/ajhp.071214133
   Li J, 2008, ACTA PAEDIATR, V97, P221, DOI 10.1111/j.1651-2227.2007.00602.x
   Libbey HP, 2008, OBESITY, V16, pS24, DOI 10.1038/oby.2008.455
   Liese AD, 2006, PEDIATRICS, V118, P1510, DOI 10.1542/peds.2006-0690
   Lillycrop KA, 2005, J NUTR, V135, P1382
   Lobel M, 2008, HEALTH PSYCHOL, V27, P604, DOI 10.1037/a0013242
   Lumeng JC, 2007, PEDIATRICS, V120, P1020, DOI 10.1542/peds.2006-3295
   Lutfiyya MN, 2008, J AM BOARD FAM MED, V21, P191, DOI 10.3122/jabfm.2008.03.070207
   Maffeis C, 2008, J CLIN ENDOCR METAB, V93, P2122, DOI 10.1210/jc.2007-2089
   Martyn-Nemeth P, 2009, RES NURS HEALTH, V32, P96, DOI 10.1002/nur.20304
   Mayer-Davis EJ, 2008, J AM DIET ASSOC, V108, pS45, DOI 10.1016/j.jada.2008.01.018
   Mayer-Davis EJ, 2008, DIABETES CARE, V31, P470, DOI 10.2337/dc071321
   Miralles O, 2006, OBESITY, V14, P1371, DOI 10.1038/oby.2006.155
   Moran A, 2008, CIRCULATION, V117, P2361, DOI 10.1161/CIRCULATIONAHA.107.704569
   O'Regan D, 2004, AM J PHYSIOL-ENDOC M, V287, pE863, DOI 10.1152/ajpendo.00137.2004
   Ogden CL, 2002, JAMA-J AM MED ASSOC, V288, P1728, DOI 10.1001/jama.288.14.1728
   Ogden CL, 2008, JAMA-J AM MED ASSOC, V299, P2401, DOI 10.1001/jama.299.20.2401
   Owen CG, 2006, AM J CLIN NUTR, V84, P1043
   Park JH, 2008, J CLIN INVEST, V118, P2316, DOI [10.1172/JC133655, 10.1172/JCI33655]
   Precht DH, 2007, ACTA OBSTET GYN SCAN, V86, P266, DOI 10.1080/00016340601088406
   Reagan LP, 2007, CURR OPIN PHARMACOL, V7, P633, DOI 10.1016/j.coph.2007.10.012
   Salsberry PJ, 2005, PEDIATRICS, V116, P1329, DOI 10.1542/peds.2004-2583
   Sharma AJ, 2008, AM J EPIDEMIOL, V168, P995, DOI 10.1093/aje/kwn223
   Sherwood NE, 2009, PREV CHRONIC DIS, V6, DOI 10.1177/1479972308095936
   Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104
   Smyth S, 2006, NAT MED, V12, P75, DOI 10.1038/nm0106-75
   Spence JC, 2008, INT J PEDIATR OBES, V3, P109, DOI 10.1080/17477160701875007
   Swallen KC, 2005, PEDIATRICS, V115, P340, DOI 10.1542/peds.2004-0678
   Swanson JM, 2009, SEMIN REPROD MED, V27, P391, DOI 10.1055/s-0029-1237427
   Taksali SE, 2008, DIABETES, V57, P367, DOI 10.2337/db07-0932
   Taveras EM, 2008, J ALLERGY CLIN IMMUN, V121, P1161, DOI 10.1016/j.jaci.2008.03.021
   Taveras EM, 2004, PEDIATRICS, V114, pE577, DOI 10.1542/peds.2004-0801
   Taylor SE, 2007, ANNU REV CLIN PSYCHO, V3, P377, DOI 10.1146/annurev.clinpsy.3.022806.091520
   Teegarden SL, 2008, PHYSIOL BEHAV, V93, P713, DOI 10.1016/j.physbeh.2007.11.030
   Tsiotra PC, 2006, ANN NY ACAD SCI, V1083, P63, DOI 10.1196/annals.1367.007
   Valsamakis G, 2006, ANN NY ACAD SCI, V1092, P138, DOI 10.1196/annals.1365.012
   van Dijk CE, 2009, PEDIATRICS, V123, P102, DOI 10.1542/peds.2007-3382
   Vickers MH, 2005, ENDOCRINOLOGY, V146, P4211, DOI 10.1210/en.2005-0581
   Voss LD, 2008, CHILD CARE HLTH DEV, V34, P470, DOI 10.1111/j.1365-2214.2008.00827.x
   Weiss R, 2005, DIABETES CARE, V28, P902, DOI 10.2337/diacare.28.4.902
   Weyermann M, 2007, EPIDEMIOLOGY, V18, P722, DOI 10.1097/EDE.0b013e3181567ed4
   *WHO, 2007, PREV EXC BOD WEIGHT
   Woo JG, 2008, PEDIATRICS, V121, pE458, DOI 10.1542/peds.2007-1446
   Xekouki P, 2007, OBESITY, V15, P860, DOI 10.1038/oby.2007.600
   Zeller MH, 2007, OBESITY, V15, P126, DOI 10.1038/oby.2007.517
NR 84
TC 4
Z9 4
U1 0
U2 19
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0882-5963
J9 J PEDIATR NURS
JI J. Pediatr. Nurs.
PD AUG
PY 2012
VL 27
IS 4
BP 310
EP 318
DI 10.1016/j.pedn.2011.03.014
PG 9
WC Nursing; Pediatrics
SC Nursing; Pediatrics
GA 045OO
UT WOS:000311706400006
PM 22703677
DA 2019-01-08
ER

PT J
AU Hopkins, D
   Lawrence, I
   Mansell, P
   Thompson, G
   Amiel, S
   Campbell, M
   Heller, S
AF Hopkins, David
   Lawrence, Ian
   Mansell, Peter
   Thompson, Gillian
   Amiel, Stephanie
   Campbell, Michael
   Heller, Simon
TI Improved Biomedical and Psychological Outcomes 1 Year After Structured
   Education in Flexible Insulin Therapy for People With Type 1 Diabetes
   The U.K. DAFNE experience
SO DIABETES CARE
LA English
DT Article
ID ENABLE DIETARY FREEDOM; SEVERE HYPOGLYCEMIA; HOSPITAL ANXIETY;
   DEPRESSION SCALE; PREVALENCE; SYMPTOMS; DISTRESS; VALIDITY; PROGRAM;
   IDDM
AB OBJECTIVE-DAFNE (Dose Adjustment For Normal Eating), a structured education program in flexible insulin therapy, has been widely adopted in the U.K. after validation in a randomized trial. To determine benefits in routine practice, we collected biomedical and psychological data from all participants attending during a 12-month period.
   RESEARCH DESIGN AND METHODS-HbA(1c), weight, self-reported hypoglycemia awareness, severe hypoglycemia frequency, PAID (Problem Areas In Diabetes), HADS (Hospital Anxiety and Depression Scale), and EuroQol Group 5-Dimension Self-Report Questionnaire scores were recorded prior to DAFNE and after 1 year.
   RESULTS-Complete baseline and follow-up HbA(1c) data were available for 639 (54.9%) of 1,1.63 attendees. HbA(1c) fell from 8.51 +/- 1.41 (mean +/- SD) to 8.24 +/- 1.29% (difference 0.27 [95% CI 0.16-0.38]; P < 0.001), with a greater mean fall of 0.44% from baseline HbA(1c) >8.5%. Severe hypoglycemia rate fell from 1.7 +/- 8.5 to 0.6 +/- 3.7 episodes per person per year (1.1 [0.7-1.4]) and hypoglycemia recognition improved in 43% of those reporting unawareness. Baseline psychological distress was evident, with a PAID score of 25.2 and HADS scores of 5.3 (anxiety) and 4.8 (depression), falling to 16.7 (8.5 [6.6-10.4]), 4.6 (0.7 [0.4-1.0]), and 4.2 (0.6 [0.3-0.8]), respectively (all P < 0.001 at 1 year). Clinically relevant anxiety and depression (HADS >= 8) fell from 24.4 to 18.0% and 20.9 to 15.5%, respectively.
   CONCLUTIONS-A structured education program delivered in routine clinical practice not only improves HbA(1c) while reducing severe hypoglycemia rate and restoring hypoglycemia awareness but also reduces psychological distress and improves perceived well-being.
C1 [Hopkins, David] Kings Coll Hosp Natl Hlth Serv Fdn Trust, Dept Diabet Med, London, England.
   [Lawrence, Ian] Univ Hosp Leicester Natl Hlth Serv Trust, Dept Diabet, Leicester, Leics, England.
   [Mansell, Peter] Univ Nottingham, Sch Biomed Sci, Nottingham NG7 2RD, England.
   [Thompson, Gillian] Northumbria Healthcare Fdn Trust, Cent DAFNE Off, Northumbria, England.
   [Amiel, Stephanie] Kings Coll London, Sch Med, Diabetes Res Grp, London WC2R 2LS, England.
   [Campbell, Michael] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England.
   [Heller, Simon] Univ Sheffield, Acad Unit Diabet Endocrinol & Metab, Sheffield, S Yorkshire, England.
RP Hopkins, D (reprint author), Kings Coll Hosp Natl Hlth Serv Fdn Trust, Dept Diabet Med, London, England.
EM dhopkins3@nhs.net
OI Campbell, Michael/0000-0003-3529-2739; Heller, Simon/0000-0002-2425-9565
FU U.K. National Institute for Health Research; U.K. DAFNE Collaborative;
   National Institute for Health Research [RP-PG-0606-1184]
FX This study forms part of a broader program of research entitled
   "Improving Management of Type 1 Diabetes in the U.K.: The DAFNE Program
   as a Research Test Bed" funded by the U.K. National Institute for Health
   Research. G.T. is employed as the national director of the DAFNE program
   and funded by the U.K. DAFNE Collaborative.
CR Amiel S, 2002, BRIT MED J, V325, P746
   Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3
   Bott S, 1997, DIABETOLOGIA, V40, P926, DOI 10.1007/s001250050769
   Bradley C, 2001, LANCET, V357, P7, DOI 10.1016/S0140-6736(00)03562-5
   Campbell MJ, 2007, MED STAT TXB HLTH SC, P278
   CRANSTON I, 1994, LANCET, V344, P283, DOI 10.1016/S0140-6736(94)91336-6
   DAGOGOJACK S, 1994, DIABETES, V43, P1426, DOI 10.2337/diabetes.43.12.1426
   FANELLI CG, 1993, DIABETES, V42, P1683, DOI 10.2337/diabetes.42.11.1683
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   Lloyd CE, 2000, DIABETIC MED, V17, P198, DOI 10.1046/j.1464-5491.2000.00260.x
   MUHLHAUSER I, 1983, DIABETOLOGIA, V25, P470
   PIEBER TR, 1995, DIABETES CARE, V18, P625, DOI 10.2337/diacare.18.5.625
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Samann A, 2005, DIABETOLOGIA, V48, P1965, DOI 10.1007/s00125-005-1905-1
   Shaban MC, 2006, DIABETIC MED, V23, P1381, DOI 10.1111/j.1464-5491.2006.02012.x
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   The EuroQol Group, 1990, HLTH POLICY, V16, P199, DOI DOI 10.1016/0168-8510(90)90421-9
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
NR 18
TC 91
Z9 93
U1 0
U2 14
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
J9 DIABETES CARE
JI Diabetes Care
PD AUG
PY 2012
VL 35
IS 8
BP 1638
EP 1642
DI 10.2337/dc11-1579
PG 5
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 980KD
UT WOS:000306891200003
PM 22619082
OA Other Gold, Green Published
DA 2019-01-08
ER

PT J
AU Webb, RT
   Kontopantelis, E
   Doran, T
   Qin, P
   Creed, F
   Kapur, N
AF Webb, Roger T.
   Kontopantelis, Evangelos
   Doran, Tim
   Qin, Ping
   Creed, Francis
   Kapur, Nav
TI Risk of self-harm in physically ill patients in UK primary care
SO JOURNAL OF PSYCHOSOMATIC RESEARCH
LA English
DT Article
DE Self-harm; Suicidal behaviour; Physical illness; Depression; Primary
   care; Epidemiology
ID PRACTICE RESEARCH DATABASE; SUICIDAL-BEHAVIOR; MEDICAL ILLNESS;
   ASSOCIATION; COHORT; IDEATION; EPILEPSY; DISEASES; LIFE
AB Objective: To examine self-harm risk across the adult age range in patients diagnosed with various physical illnesses using the General Practice Research Database - a broadly representative sample of all people registered with a family practice in the United Kingdom.
   Methods: We conducted a large nested case-control study sampled from the whole primary care cohort. During 2001-2008 we studied 2306 cases of self-harm and 46,120 age and gender-matched controls without such an episode recorded. Relative risks were estimated against reference patients with none of the examined physical illnesses. Additionally, we assessed confounding by recorded depression, effect modification by gender and multi-morbidity effects.
   Results: Risk was significantly elevated in relation to any of the physical illnesses (male OR 1.35, 95% CI 1.18-1.54; female OR 1.62,95% CI 1.40-1.86). For both genders combined, risk was raised with each specific illness. Effects sizes were consistently larger in women. Adjustment for recorded depression explained much of the elevated risk, but not so in women with asthma, back pain, diabetes, epilepsy or hypertension. Raised risk was seen in younger adults and during middle age, but not among older people. There was a dose-response relationship with increasing number of physical illnesses, and in women this was independent of depression.
   Conclusion: Heightened risk was seen with a variety of physical illnesses. The findings indicate a need for tackling psychological distress and reducing self-harm risk in physically ill patients who attend primary healthcare services for non-psychiatric reasons, particularly so for women and younger and middle aged adults. (c) 2012 Elsevier Inc. All rights reserved.
C1 [Webb, Roger T.; Kapur, Nav] Univ Manchester, Ctr Suicide Prevent, Ctr Mental Hlth & Risk, Manchester M13 9PL, Lancs, England.
   [Kontopantelis, Evangelos; Doran, Tim] Univ Manchester, Hlth Sci Primary Care Res Grp, Manchester M13 9PL, Lancs, England.
   [Qin, Ping] Univ Aarhus, Natl Ctr Register Based Res, DK-8000 Aarhus C, Denmark.
   [Creed, Francis] Univ Manchester, Mental Hlth & Neurodegenerat Res Grp, Manchester M13 9PL, Lancs, England.
RP Webb, RT (reprint author), Univ Manchester, Ctr Suicide Prevent, Ctr Mental Hlth & Risk, Room 2-311,Jean McFarlane Bldg,Oxford Rd, Manchester M13 9PL, Lancs, England.
EM roger.webb@manchester.ac.uk
RI Research Datalink, Clinical Practice/H-2477-2013; CPRD, CPRD/B-9594-2017
OI Kontopantelis, Evangelos/0000-0001-6450-5815; Webb,
   Roger/0000-0001-8532-2647
FU National Institute for Health Research [CDF-2011-04-016]; Department of
   Health [CDF-2011-04-016]; Medical Research Council [MC_PC_13042,
   MR/K006665/1]
CR ASHLEY MJ, 1977, ARCH INTERN MED, V137, P883, DOI 10.1001/archinte.137.7.883
   Barry D, 1996, STAT MED, V15, P2603
   Bergen H, 2010, BRIT J PSYCHIAT, V197, P493, DOI 10.1192/bjp.bp.110.077651
   Brady J, 2006, ALCOHOL ALCOHOLISM, V41, P473, DOI 10.1093/alcalc/agl060
   Christensen J, 2007, LANCET NEUROL, V6, P693, DOI 10.1016/S1474-4422(07)70175-8
   Clayton D., 1993, STAT MODELS EPIDEMIO
   Conwell Y, 2002, BIOL PSYCHIAT, V52, P193, DOI 10.1016/S0006-3223(02)01347-1
   Cooper J, 2005, AM J PSYCHIAT, V162, P297, DOI 10.1176/appi.ajp.162.2.297
   Cukrowicz KC, 2011, PSYCHOL AGING, V26, P331, DOI 10.1037/a0021836
   Dennis M, 2009, SOC PSYCH PSYCH EPID, V44, P608, DOI 10.1007/s00127-008-0474-2
   Doran T, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3590
   Druss B, 2000, ARCH INTERN MED, V160, P1522, DOI 10.1001/archinte.160.10.1522
   Goodwin RD, 2003, SOC SCI MED, V56, P1783, DOI 10.1016/S0277-9536(02)00174-0
   Grabbe L, 1997, AM J PUBLIC HEALTH, V87, P434, DOI 10.2105/AJPH.87.3.434
   Hammad TA, 2008, PHARMACOEPIDEM DR S, V17, P1197, DOI 10.1002/pds.1672
   Haw C, 2005, SOC PSYCH PSYCH EPID, V40, P964, DOI 10.1007/s00127-005-0981-3
   Hawton K, 2008, SUICIDE LIFE-THREAT, V38, P650, DOI 10.1521/suli.2008.38.6.650
   Hendin H, 1999, J CLIN PSYCHIAT, V60, P46
   Hennessy S, 1999, AM J EPIDEMIOL, V149, P195
   Ilgen MA, 2010, SUICIDE LIFE-THREAT, V40, P597, DOI 10.1521/suli.2010.40.6.597
   Juurlink DN, 2004, ARCH INTERN MED, V164, P1179, DOI 10.1001/archinte.164.11.1179
   Kaplan MS, 2007, AM J ORTHOPSYCHIAT, V77, P56, DOI 10.1037/0002-9432.77.1.56
   Khan NF, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X483562
   Khan NF, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-1
   LUBIN JH, 1984, BIOMETRICS, V40, P63, DOI 10.2307/2530744
   MacLean J, 2011, J AFFECT DISORDERS, V130, P245, DOI 10.1016/j.jad.2010.10.028
   Marusic A, 2006, SUICIDE LIFE-THREAT, V36, P323, DOI 10.1521/suli.2006.36.3.323
   McCormick A, 1995, MORBIDITY STAT GEN P, V3
   Nilsson L, 1997, EPILEPSIA, V38, P1062, DOI 10.1111/j.1528-1157.1997.tb01194.x
   Quan H, 2002, SOC PSYCH PSYCH EPID, V37, P190, DOI 10.1007/s001270200014
   RIFKIN A, 1992, POSTGRAD MED, V92, P147
   Scott KM, 2010, PSYCHOSOM MED, V72, P712, DOI 10.1097/PSY.0b013e3181e3333d
   Venkoba Rao A, 1990, Crisis, V11, P48
   Viilo KM, 2005, PSYCHOSOM MED, V67, P241, DOI 10.1097/01.psy.0000151488.71789.7f
   Waern M, 2002, BMJ-BRIT MED J, V324, P1355, DOI 10.1136/bmj.324.7350.1355
   Walley T, 1997, LANCET, V350, P1097, DOI 10.1016/S0140-6736(97)04248-7
   Webb RT, 2012, ARCH GEN PSYCHIAT, V69, P256, DOI 10.1001/archgenpsychiatry.2011.1561
NR 37
TC 13
Z9 13
U1 0
U2 11
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0022-3999
EI 1879-1360
J9 J PSYCHOSOM RES
JI J. Psychosomat. Res.
PD AUG
PY 2012
VL 73
IS 2
BP 92
EP 97
DI 10.1016/j.jpsychores.2012.05.010
PG 6
WC Psychiatry
SC Psychiatry
GA 977BZ
UT WOS:000306632700003
PM 22789410
DA 2019-01-08
ER

PT J
AU Wermeling, PR
   van den Donk, M
   Gorter, KJ
   Beulens, JWJ
   Rutten, GEHM
AF Wermeling, Paulien R.
   van den Donk, Maureen
   Gorter, Kees J.
   Beulens, Joline W. J.
   Rutten, Guy E. H. M.
TI Frequency of Monitoring Diabetes in Primary Care: What Do
   Well-Controlled Patients Prefer?
SO CANADIAN JOURNAL OF DIABETES
LA English
DT Article
DE diabetes mellitus type 2; general practitioners; monitoring frequency;
   patient preference; primary health care
AB Objective: To describe the preferences and the associated patients' characteristics of well-controlled type 2 diabetes patients for the diabetes monitoring frequency in primary care.
   Methods: Cross-sectional study with 233 participating general practitioners across the Netherlands. Eligible patients were between 40 and 80 years, diagnosed with type 2 diabetes for more than 1 year not on insulin, and with glycated hemoglobin (A1C) <= 7.5%, systolic blood pressure <= 145 mm Hg and total cholesterol <= 5.2 mmol/L. Participants were asked whether they had a preference for 3-monthly or 6-monthly monitoring or no preference.
   Results: From 2215 patients, 747 patients (33.7%) preferred 3-monthly and 677 (30.6%) 6-monthly monitoring by either the general practitioner or the practice nurse. The former group consisted of less smokers, felt less healthy, reported more diabetes-related distress, had the highest reported frequency of hyperglycemic episodes and used more oral blood glucose lowering drugs compared to the other patients. Those preferring 6-monthly monitoring were least satisfied with diabetes treatment, reported the lowest frequency of hyperglycemic episodes and used less oral blood glucose lowering drugs compared to the other patients.
   Conclusion: A preference for more frequent monitoring was associated with a worse disease status, whereas a preference for less frequent monitoring tended to be associated with the opposite. Patients seem to have logical preferences that need to be accounted for in diabetes care. (C) 2012 Canadian Diabetes Association
C1 [Wermeling, Paulien R.; van den Donk, Maureen; Gorter, Kees J.; Beulens, Joline W. J.; Rutten, Guy E. H. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands.
RP Wermeling, PR (reprint author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, STR 6-131,POB 85500, NL-3508 GA Utrecht, Netherlands.
EM P.Wermeling@umcutrecht.nl
FU ZonMw, the Netherlands organisation for health research and development
   [80-82310-98-09058]
FX This study was supported by ZonMw, the Netherlands organisation for
   health research and development (grant 80-82310-98-09058).
CR *AM DIAB ASS, 2011, DIABETES CARE S1, V34, pS11, DOI DOI 10.2337/DC11-S011
   Bradley C., 1994, HDB PSYCHOL DIABETES, P111
   Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6
   Burgers JS, 2002, DIABETES CARE, V25, P1933, DOI 10.2337/diacare.25.11.1933
   Canadian Diabetes Association Clinical Practice Guidelines Expert Committee, 2008, CAN J DIABETES, V32, pS32
   Cleveringa FGW, 2010, DIABETIC MED, V27, P442, DOI 10.1111/j.1464-5491.2010.02968.x
   Cleveringa FGW, 2008, DIABETES CARE, V31, P2273, DOI 10.2337/dc08-0312
   Coulter A, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4989
   DeSalvo KB, 2003, INT J QUAL HEALTH C, V15, P399, DOI 10.1093/intqhc/mzg067
   Gorter KJ, 2010, DIABETIC MED, V27, P85, DOI 10.1111/j.1464-5491.2009.02886.x
   Gorter KJ, 2010, PATIENT EDUC COUNS, V84, P56
   Griffin SJ, 2011, LANCET, V378, P156, DOI 10.1016/S0140-6736(11)60698-3
   Hakkaart-van Roijen L., 2007, MANUAL SHORT FORM HL
   Joosten EAG, 2008, PSYCHOTHER PSYCHOSOM, V77, P219, DOI 10.1159/000126073
   Kleefstra N, 2010, NETH J MED, V68, P311
   Lamers LM, 2006, HEALTH ECON, V15, P1121, DOI 10.1002/hec.1124
   Parchman ML, 2010, ANN FAM MED, V8, P410, DOI 10.1370/afm.1161
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Rijksinstituut voor Volksgezondheid en Milieu (RIVM), 2012, DRIE JAAR INT BEK DI
   Rubin DB, 1987, MULTIPLE IMPUTATION
   RUTTEN GEH, 2006, HUISARTS WET, V49, P137
   Say R, 2006, PATIENT EDUC COUNS, V60, P102, DOI 10.1016/j.pec.2005.02.003
   Schwartz LM, 1999, J GEN INTERN MED, V14, P230, DOI 10.1046/j.1525-1497.1999.00322.x
   Statistics Netherlands (CBS), 2000, STAND ALL IND 10 24, V10, P24
   Stone MA, 2010, DIABETES RES CLIN PR, V87, P252, DOI 10.1016/j.diabres.2009.10.020
   Underwood M, 2008, BMJ-BRIT MED J, V336, P138, DOI 10.1136/bmj.39399.656331.25
   van Bruggen R, 2008, BR J GEN PRACT, V58, P339
   van den Donk M, 2010, QUAL LIFE RES, V19, P509, DOI 10.1007/s11136-010-9604-x
   WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002
   Welch HG, 1999, J GEN INTERN MED, V14, P223, DOI 10.1046/j.1525-1497.1999.00321.x
   Wendel-Vos GCW, 2003, J CLIN EPIDEMIOL, V56, P1163, DOI 10.1016/S0895-4356(03)00220-8
   Wermeling PR, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-35
NR 32
TC 2
Z9 2
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1499-2671
J9 CAN J DIABETES
JI Can. J. Diabetes
PD AUG
PY 2012
VL 36
IS 4
BP 187
EP 192
DI 10.1016/j.jcjd.2012.07.012
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA V33EQ
UT WOS:000209002500012
DA 2019-01-08
ER

PT J
AU Vallis, M
AF Vallis, Michael
TI A New Dawn for Diabetes in Canada
SO CANADIAN JOURNAL OF DIABETES
LA English
DT Article
DE depression; diabetes distress; knowledge translation; psychosocial
AB This paper is intended to highlight the need for diabetes healthcare professionals to better address psychosocial issues in diabetes by summarizing selective evidence that identifies the important psychosocial needs and issues of those living with diabetes. The main purpose of this paper is to draw the attention of Canadian diabetes professionals to a specific international psychosocial initiative called the Diabetes Attitudes, Wishes and Needs (DAWN) program. The DAWN program began with the DAWN study, a large-scale psychosocial study conducted at an international level but not including Canada. This is a relevant study for 2 reasons. First, the results of DAWN can guide Canadian diabetes healthcare providers by virtue of the fact that multiple knowledge translation tools have been developed and can be directly accessed by Canadian providers. Second, DAWN2, a follow-up study, has recently been launched and Canada is one of 18 participating countries. Increasing the awareness of Canadian diabetes healthcare providers about the results of DAWN and the launch of DAWN2 can further advance knowledge translation for the management of psychosocial factors in diabetes. (C) 2012 Canadian Diabetes Association
C1 [Vallis, Michael] Capital Hlth, Diabet Management Ctr, Halifax, NS, Canada.
   [Vallis, Michael] Dalhousie Univ, Halifax, NS, Canada.
RP Vallis, M (reprint author), Diabet Management Ctr, 7071 Bayers Rd,Suite 165, Halifax, NS B3L 2C2, Canada.
EM tvallis@dal.ca
OI Vallis, Michael/0000-0002-0165-5936
FU Novo Nordisk
FX MV is the Canadian lead, and sits on the Global Advisory Board of the
   Novo Nordisk funded DAWN2 study. In this capacity he receives honoraria
   and travel expenses to present at professional venues regarding the DAWN
   studies. No funding was provided for the preparation of this paper.
CR Alberti G, 2002, PRACT DIABETES INT, V19, P22, DOI DOI 10.1002/PDI.305/PDF
   Crosson JC, 2010, J AM BOARD FAM MED, V23, P171, DOI 10.3122/jabfm.2010.02.090125
   Crow S, 2001, INT J EAT DISORDER, V30, P222, DOI 10.1002/eat.1077
   de Wit M, 2012, PEDIAT DIABETES
   Egede LE, 2005, DIABETES CARE, V28, P1339, DOI 10.2337/diacare.28.6.1339
   Egede LE, 2004, DIABETES CARE, V27, P421, DOI 10.2337/diacare.27.2.421
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2009, DIABETES CARE, V33, P23
   Fisher L, 2007, DIABETES CARE, V30, P2746, DOI 10.2337/dc07-1166
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Glasgow RE, 1999, DIABETES CARE, V22, P832, DOI 10.2337/diacare.22.5.832
   Grigsby AB, 2004, J PSYCHOSOM RES, V27, P1053
   Group DS, 2006, PRACT DIABETES INT, V23, P313
   Group DS, 2002, PRACT DIABETES INT, V19, P187
   Group DS, 2004, PRACT DIABETES INT, V21, P201
   Jones JM, 2000, BMJ-BRIT MED J, V320, P1563, DOI 10.1136/bmj.320.7249.1563
   Lipscombe LL, 2007, LANCET, V369, P750, DOI 10.1016/S0140-6736(07)60361-4
   Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985
   Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9
   Petrak F, 2005, CURR DIABETES REV, V1, P255, DOI 10.2174/157339905774574329
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Skovlund S. E., 2005, DIABETES SPECTRUM, V18, P136, DOI DOI 10.2337/DIASPECT.18.3.136
   Snoek FJ, 2011, DIABETES CARE, V34, P601, DOI 10.2337/dc10-1552
   Soewondo P, 2010, MED J INDONES, V19, P235
   van Bastelaar KMP, 2011, DIABETES CARE, V34, P320, DOI 10.2337/dc10-1248
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
NR 29
TC 1
Z9 1
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1499-2671
J9 CAN J DIABETES
JI Can. J. Diabetes
PD AUG
PY 2012
VL 36
IS 4
BP 210
EP 213
DI 10.1016/j.jcjd.2012.06.006
PG 4
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA V33EQ
UT WOS:000209002500016
DA 2019-01-08
ER

PT J
AU Gill, RG
   Bishop, NH
AF Gill, Ronald G.
   Bishop, Nicholas H.
TI Clinical islet transplantation: where immunity and metabolism intersect?
SO CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY
LA English
DT Review
DE autoimmunity; islet transplantation; metabolism; type 1 diabetes
ID PROLONGS ALLOGRAFT SURVIVAL; TYPE-1 DIABETIC-PATIENTS; EARLY GRAFT
   FAILURE; BETA-CELL FUNCTION; AMYLOID DEPOSITION; IMMUNOSUPPRESSIVE
   REGIMEN; PANCREATIC-ISLETS; THERAPY; BLOCKADE; MICE
AB Purpose of review
   The dramatic results of the Edmonton Protocol in 2000 triggered tremendous excitement over the application of pancreatic islet transplantation as a viable approach to achieving consistent insulin independence in type 1 diabetic patients. However, this optimism in the field was tempered by follow-up studies showing frequent attrition of graft function commonly requiring a return to exogenous insulin therapy within 1-3 years after transplant. The purpose of this review is to put these initial studies in perspective and to highlight progress and challenges in this important field.
   Recent findings
   Recent clinical and experimental findings demonstrate a progressive improvement in the function and durability of islet allografts. Induction therapies targeting T lymphocytes and costimulatory pathways have been highly effective at promoting islet transplant function. It is also apparent that islet injury associated with metabolic distress provides a nonimmune barrier to islet transplant outcomes.
   Summary
   Newer therapeutic interventions show great promise for attenuating the adaptive immune response to islet allografts. Also, clarifying the mechanisms of metabolic-related tissue distress may provide additional potential targets for improving islet graft outcomes.
C1 [Gill, Ronald G.] Univ Colorado, Dept Surg & Immunol, Colorado Ctr Transplantat Care Res & Educ CCTCARE, Aurora, CO 80045 USA.
RP Gill, RG (reprint author), Univ Colorado, Dept Surg & Immunol, Colorado Ctr Transplantat Care Res & Educ CCTCARE, 1775 Aurora Ct,Box F-528, Aurora, CO 80045 USA.
EM Ronald.Gill@ucdenver.edu
FU Juvenile Diabetes Research Foundation [4-2008-812]
FX This work was supported in part by Juvenile Diabetes Research Foundation
   grant 4-2008-812.
CR Ablamunits V, 2012, DIABETES, V61, P145, DOI 10.2337/db11-1033
   Badell IR, 2012, AM J TRANSPLANT, V12, P126, DOI 10.1111/j.1600-6143.2011.03736.x
   Badell IR, 2010, J CLIN INVEST, V120, P4520, DOI 10.1172/JCI43895
   Badell IR, 2012, AM J TRANSPLANT
   Bellin MD, 2011, TRANSPLANTATION, V91, P376
   Bussiere CT, 2006, DIABETOLOGIA, V49, P2341, DOI 10.1007/s00125-006-0374-5
   Cai K, 2011, DIABETOLOGIA, V54, P617, DOI 10.1007/s00125-010-1972-9
   Cantaluppi V, 2006, AM J TRANSPLANT, V6, P2601, DOI 10.1111/j.1600-6143.2006.01534.x
   Cantley J, 2010, DIABETES OBES METAB, V12, P159, DOI 10.1111/j.1463-1326.2010.01276.x
   Davalli AM, 1996, DIABETES, V45, P1161, DOI 10.2337/diabetes.45.9.1161
   Donath MY, 2008, DIABETES CARE, V31, pS161, DOI 10.2337/dc08-s243
   Emamaullee JA, 2006, DIABETES, V55, P1907, DOI 10.2337/db05-1254
   Gao Q, 2010, AM J TRANSPLANT, V10, P1588, DOI 10.1111/j.1600-6143.2010.03151.x
   Grossman EJ, 2010, PLOS ONE, V5, pe8759
   Hering BJ, 2004, AM J TRANSPLANT, V4, P390, DOI 10.1046/j.1600-6143.2003.00351.x
   Hull RL, 2004, J CLIN ENDOCR METAB, V89, P3629, DOI 10.1210/jc.2004-0405
   Huurman VAL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002435
   Johansson H, 2006, AM J TRANSPLANT, V6, P305, DOI 10.1111/j.1600-6143.2005.01186.x
   Koulmanda M, 2012, AM J TRANSPLANT
   Kruger B, 2010, EUR J IMMUNOL, V40, P2914, DOI 10.1002/eji.201040601
   Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213
   Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935
   Matsuoka N, 2010, J CLIN INVEST, V120, P735, DOI 10.1172/JCI41360
   McCall M, 2012, AM J TRANSPLANT, V12, P322, DOI 10.1111/j.1600-6143.2011.03796.x
   Nicolls MR, 2000, J IMMUNOL, V164, P3627, DOI 10.4049/jimmunol.164.7.3627
   Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959
   Ozmen L, 2002, DIABETES, V51, P1779, DOI 10.2337/diabetes.51.6.1779
   Posselt AM, 2010, AM J TRANSPLANT, V10, P1870, DOI 10.1111/j.1600-6143.2010.03073.x
   Posselt AM, 2010, TRANSPLANTATION, V90, P1595, DOI 10.1097/TP.0b013e3181fe1377
   Potter KJ, 2010, P NATL ACAD SCI USA, V107, P4305, DOI 10.1073/pnas.0909024107
   Roelen DL, 2009, CLIN EXP IMMUNOL, V156, P141, DOI 10.1111/j.1365-2249.2008.03812.x
   Roep BO, 1999, DIABETES, V48, P484, DOI 10.2337/diabetes.48.3.484
   Ryan EA, 2002, DIABETES, V51, P2148, DOI 10.2337/diabetes.51.7.2148
   Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060
   Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267
   Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401
   Steer SA, 2006, PLOS MED, V3, P253, DOI 10.1371/journal.pmed.0030017
   Sutherland DER, 2010, TRANSPLANTATION, V86, P1799
   Tanemura M, 2011, AM J TRANSPLANT, V12, P102
   Turgeon NA, 2010, AM J TRANSPLANT, V10, P2082, DOI 10.1111/j.1600-6143.2010.03212.x
   Udayasankar J, 2009, DIABETOLOGIA, V52, P145, DOI 10.1007/s00125-008-1185-7
   Westermark GT, 2008, NEW ENGL J MED, V359, P977, DOI 10.1056/NEJMc0802893
   Westermark GT, 2012, TRANSPLANTATION, V93, P219, DOI 10.1097/TP.0b013e31823e46ef
   Westwell-Roper C, 2011, J IMMUNOL, V187, P2755, DOI 10.4049/jimmunol.1002854
   Zhang N, 2006, DIABETES, V55, P2429, DOI 10.2337/db06-0173
   Zheng XX, 2003, IMMUNITY, V19, P503, DOI 10.1016/S1074-7613(03)00259-0
NR 46
TC 8
Z9 8
U1 0
U2 6
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1752-296X
J9 CURR OPIN ENDOCRINOL
JI Curr. Opin. Endocrinol. Diabetes Obes.
PD AUG
PY 2012
VL 19
IS 4
BP 249
EP 254
DI 10.1097/MED.0b013e328355a2ec
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 970FX
UT WOS:000306114600001
PM 22647539
DA 2019-01-08
ER

PT J
AU Roberts, MH
   Mapel, DW
AF Roberts, Melissa H.
   Mapel, Douglas W.
TI Limited Lung Function: Impact of Reduced Peak Expiratory Flow on Health
   Status, Health-Care Utilization, and Expected Survival in Older Adults
SO AMERICAN JOURNAL OF EPIDEMIOLOGY
LA English
DT Article
DE aged; health services; mortality; peak expiratory flow rate; respiratory
   function tests
ID OBSTRUCTIVE PULMONARY-DISEASE; ELDERLY POPULATION; COGNITIVE FUNCTION;
   MORTALITY; SPIROMETRY; PREDICTOR; QUALITY; SAMPLE; PERFORMANCE;
   DISABILITY
AB The authors examined whether peak expiratory flow (PEF) is a valid measure of health status in older adults. Survey and test data from the 2006 and 2008 cycles of the Health and Retirement Study, a longitudinal study of US adults over age 50 years (with biennial surveys initiated in 1992), were used to develop predicted PEF regression models and to examine relations between low PEF values and other clinical factors. Low PEF (80 of predicted value) was prevalent among persons with chronic conditions, including frequent pain, obstructive lung disease, heart disease, diabetes, and psychological distress. Persons with higher physical disability scores had substantially higher adjusted odds of having low PEF, on par with those for conditions known to be associated with poor health (cancer, heart disease, and stroke). In a multivariate regression model for difficulty with mobility, PEF remained an independent factor (odds ratio (OR) 1.69, 95 confidence interval (CI): 1.53, 1.86). Persons with low PEF in 2006 were more likely to be hospitalized (OR 1.26, 95 CI: 1.10, 1.43) within the subsequent 2 years and to estimate their chances of surviving for 10 or more years at less than 50 (OR 1.69, 95 CI: 1.24, 2.30). PEF is a valid measure of health status in older persons, and low PEF is an independent predictor of hospitalization and poor subjective mortality assessment.
C1 [Roberts, Melissa H.; Mapel, Douglas W.] LCF Res, Albuquerque, NM 87106 USA.
RP Roberts, MH (reprint author), LCF Res, 2309 Renard Pl SE,Suite 103, Albuquerque, NM 87106 USA.
EM melissa.roberts@lcfresearch.org
FU National Institute on Aging [U01AG009740]
FX The Health and Retirement Study was sponsored by the National Institute
   on Aging (grant U01AG009740). No financial support was received for the
   current analysis.
CR Allen S, 2008, CLIN RESPIR J, V2, P208, DOI 10.1111/j.1752-699X.2008.00063.x
   [Anonymous], 2007, NIH PUBL
   Bellia V, 2003, EUR RESPIR J, V21, p21S, DOI 10.1183/09031936.03.00402303
   Bellia V, 2000, AM J RESP CRIT CARE, V161, P1094, DOI 10.1164/ajrccm.161.4.9810093
   CARVALHAESNETO N, 1995, AM J RESP CRIT CARE, V152, P1611, DOI 10.1164/ajrccm.152.5.7582303
   COOK NR, 1995, J GERONTOL A-BIOL, V50, pM317, DOI 10.1093/gerona/50A.6.M317
   COOK NR, 1991, AM J EPIDEMIOL, V133, P784, DOI 10.1093/oxfordjournals.aje.a115957
   COOK NR, 1989, AM J EPIDEMIOL, V130, P66, DOI 10.1093/oxfordjournals.aje.a115324
   Cooper R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4467
   Coultas DB, 2001, AM J RESP CRIT CARE, V164, P372, DOI 10.1164/ajrccm.164.3.2004029
   Eisner MD, 2008, AM J EPIDEMIOL, V167, P1090, DOI 10.1093/aje/kwn025
   Fonda SJ, 2004, DOCUMENTATION PHYS F
   Fragoso CAV, 2008, J AM GERIATR SOC, V56, P1014, DOI 10.1111/j.1532-5415.2008.01687.x
   Fragoso CAV, 2007, J GERONTOL A-BIOL, V62, P1147
   Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108
   Hansen EF, 2001, AM J RESP CRIT CARE, V163, P690, DOI 10.1164/ajrccm.163.3.2006120
   Hegewald MJ, 2007, CHEST, V131, P1494, DOI 10.1378/chest.06-2707
   Hurd MD, 2002, ECON J, V112, P966, DOI 10.1111/1468-0297.00065
   Klein BEK, 2001, DIABETES CARE, V24, P1967, DOI 10.2337/diacare.24.11.1967
   Klein R, 2005, AM J OPHTHALMOL, V140, P129, DOI 10.1016/j.ajo.2004.12.049
   Miller MR, 2009, RESP MED, V103, P442, DOI 10.1016/j.rmed.2008.09.016
   Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805
   Newman AB, 2006, JAMA-J AM MED ASSOC, V295, P2018, DOI 10.1001/jama.295.17.2018
   NUNN AJ, 1989, BRIT MED J, V298, P1068, DOI 10.1136/bmj.298.6680.1068
   Pezzoli L, 2003, AGE AGEING, V32, P43, DOI 10.1093/ageing/32.1.43
   Quanjer PH, 1997, EUR RESPIR J, V10, pS2
   Salm M, 2010, CAN J ECON, V43, P1040, DOI 10.1111/j.1540-5982.2010.01605.x
   Schunemann HJ, 2000, CHEST, V118, P656, DOI 10.1378/chest.118.3.656
   Sin DD, 2005, CHEST, V127, P1952, DOI 10.1378/chest.127.6.1952
   Steffick D. E., 2000, DOCUMENTATION AFFECT
   Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923
   Tilvis R, 1997, BRIT MED J, V314, P605, DOI 10.1136/bmj.314.7080.605
   TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124
   Young RP, 2007, EUR RESPIR J, V30, P616, DOI 10.1183/09031936.00021707
NR 34
TC 16
Z9 16
U1 0
U2 5
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0002-9262
J9 AM J EPIDEMIOL
JI Am. J. Epidemiol.
PD JUL 15
PY 2012
VL 176
IS 2
BP 127
EP 134
DI 10.1093/aje/kwr503
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 974CD
UT WOS:000306406500007
PM 22759722
OA Bronze, Green Published
DA 2019-01-08
ER

PT J
AU Whittemore, R
   Jaser, S
   Chao, A
   Jang, M
   Grey, M
AF Whittemore, Robin
   Jaser, Sarah
   Chao, Ariana
   Jang, Myoungock
   Grey, Margaret
TI Psychological Experience of Parents of Children With Type 1 Diabetes A
   Systematic Mixed-Studies Review
SO DIABETES EDUCATOR
LA English
DT Review
ID POSTTRAUMATIC-STRESS-DISORDER; YOUNG-CHILDREN; GLYCEMIC CONTROL;
   PSYCHOSOCIAL ADJUSTMENT; DEPRESSIVE SYMPTOMS; METABOLIC-CONTROL;
   CONTROLLED-TRIAL; FAMILY; MELLITUS; MOTHERS
AB Purpose
   The purpose of this review is to describe the prevalence of psychological distress in parents of children with type 1 diabetes (T1DM), the relationship between parental psychological distress and health outcomes, and parents' psychological experience of having a child with T1DM. Clinical and research implications are presented.
   Method
   A systematic mixed-studies review was undertaken to review the quantitative and qualitative research on the parental experience of having a child with T1DM. A total of 34 articles met the inclusion criteria and were included in the review.
   Results
   The prevalence of parental psychological distress across all studies ranged from 10% to 74%, with an average of 33.5% of parents reporting distress at diagnosis and 19% of parents reporting distress 1 to 4 years after diagnosis. Parental psychological distress in parents of children with T1DM, regardless of how it was defined, was associated with higher child self-report of stress and depressive symptoms, more problematic child behavior, and lower child self-report of quality of life. Parental psychological distress also had negative effects on diabetes management. Themes of the qualitative synthesis indicated that parents perceived T1DM as a difficult diagnosis that contributed to significant family disruption. Adjustment occurred over time; however, ongoing stress was experienced.
   Conclusions
   Screening for psychological distress in parents of children with T1DM is indicated, and preventive interventions are needed.
C1 [Whittemore, Robin; Jaser, Sarah; Chao, Ariana; Jang, Myoungock; Grey, Margaret] Yale Univ, Sch Nursing, New Haven, CT 06536 USA.
RP Whittemore, R (reprint author), Yale Univ, Sch Nursing, 100 Church St S, New Haven, CT 06536 USA.
EM robin.whittemore@yale.edu
FU  [NIH/NR04009];  [RC1NR011594]
FX Special acknowledgements to Heather Jacobs for her assistance in the
   preparation of this manuscript. Funding sources: NIH/NR04009;
   RC1NR011594.
CR ANDERSON BJ, 1991, ADVANCES IN CHILD HEALTH PSYCHOLOGY, P167
   Anderson BJ, 1999, DIABETES CARE, V22, P713, DOI 10.2337/diacare.22.5.713
   Armour TA, 2005, DIABETIC MED, V22, P1295, DOI 10.1111/j.1464-5491.2005.01618.x
   Auslander W F, 1993, Health Soc Work, V18, P101
   Beardslee WR, 1998, J AM ACAD CHILD PSY, V37, P1134, DOI 10.1097/00004583-199811000-00012
   Bowes S, 2009, J ADV NURS, V65, P992, DOI 10.1111/j.1365-2648.2009.04963.x
   Buckloh LM, 2008, DIABETES CARE, V31, P1516, DOI 10.2337/dc07-2349
   CADMAN D, 1991, PEDIATRICS, V87, P884
   Cameron FJ, 2007, DIABETES CARE, V30, P2716, DOI 10.2337/dc07-0603
   Cameron LD, 2007, J PEDIATR PSYCHOL, V32, P733, DOI 10.1093/jpepsy/jslo53
   Chaney JM, 1997, J PEDIATR PSYCHOL, V22, P229
   Eckshtain D, 2010, J PEDIATR PSYCHOL, V35, P426, DOI 10.1093/jpepsy/jsp068
   Edmonds-Myles S, 2010, DIABETES EDUCATOR, V36, P318, DOI 10.1177/0145721709349219
   Ellis DA, 2007, J CONSULT CLIN PSYCH, V75, P168, DOI 10.1037/0022-006X.75.1.168
   Faulkner M S, 1996, J Pediatr Nurs, V11, P82, DOI 10.1016/S0882-5963(96)80065-0
   Forsander GA, 2000, ACTA PAEDIATR, V89, P1462, DOI 10.1080/080352500456651
   Golderberg D., 1988, USERS GUIDE GEN HLTH
   Grey M, 2009, RES NURS HEALTH, V32, P405, DOI 10.1002/nur.20336
   HATTON DL, 1995, J ADV NURS, V22, P569, DOI 10.1046/j.1365-2648.1995.22030569.x
   Hilliard ME, 2011, CHILD CARE HLTH DEV, V37, P224, DOI 10.1111/j.1365-2214.2010.01162.x
   Hoff A. L., 2005, FAMILIES SYSTEMS HLT, V23, P329, DOI DOI 10.1037/1091-7527.23.3.329
   Jaser SS, 2008, J PEDIATR PSYCHOL, V33, P509, DOI 10.1093/jpepsy/jsm104
   Jaser SS, 2010, J PEDIATR PSYCHOL, V35, P738, DOI 10.1093/jpepsy/jsp098
   Jaser SS, 2009, CHILD HEALTH CARE, V38, P91, DOI 10.1080/02739610902813229
   Kerr LK, 2001, WESTERN J MED, V175, P349, DOI 10.1136/ewjm.175.5.349
   KOVACS M, 1990, J CONSULT CLIN PSYCH, V58, P189, DOI 10.1037//0022-006X.58.2.189
   Laffel LMB, 2003, J PEDIATR-US, V142, P409, DOI 10.1067/mpd.2003.138
   Landolt MA, 2005, J AM ACAD CHILD PSY, V44, P682, DOI 10.1097/01-chi.0000161645.98022.35
   Landolt MA, 2002, J PEDIATR PSYCHOL, V27, P647, DOI 10.1093/jpepsy/27.7.647
   Lowes L, 2005, J ADV NURS, V50, P253, DOI 10.1111/j.1365-2648.2005.03388.x
   Lowes L, 2004, DIABETIC MED, V21, P531, DOI 10.1111/j.1464-5491.2004.01193.x
   Marshall M, 2009, J CLIN NURS, V18, P1703, DOI 10.1111/j.1365-2702.2008.02737.x
   McBroom LA, 2009, DIABETES EDUCATOR, V35, P428, DOI 10.1177/0145721709332814
   Mellin AE, 2004, J PEDIATR PSYCHOL, V29, P221, DOI 10.1093/jpepsy/jsh023
   Miles M., 1994, QUALITATIVE DATA ANA
   Mitchell SJ, 2009, FAM SYST HEALTH, V27, P314, DOI 10.1037/a0018191
   Monaghan MC, 2009, FAM SYST HEALTH, V27, P28, DOI 10.1037/a0014770
   Mullins LL, 2004, CHILD HEALTH CARE, V33, P21, DOI 10.1207/s15326888chc3301_2
   Northam E, 1996, J PEDIATR PSYCHOL, V21, P699, DOI 10.1093/jpepsy/21.5.699
   Olson AL, 2006, PEDIATRICS, V118, P207, DOI 10.1542/peds.2005-2346
   Pai ALH, 2008, J PEDIATR PSYCHOL, V33, P50, DOI 10.1093/jpepsy/jsm053
   Pluye P, 2009, INT J NURS STUD, V46, P529, DOI 10.1016/j.ijnurstu.2009.01.009
   Powers SW, 2002, DIABETES CARE, V25, P313, DOI 10.2337/diacare.25.2.313
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Rodrigue J R, 1994, Child Health Care, V23, P181, DOI 10.1207/s15326888chc2303_3
   Seppanen S M, 1999, Nurs Health Sci, V1, P63, DOI 10.1046/j.1442-2018.1999.00009.x
   Smaldone A, 2011, J PEDIATR HEALTH CAR, V25, P87, DOI 10.1016/j.pedhc.2009.09.003
   Spielberger C. D., 1983, MANUAL STATE TRAIT A
   Stallwood Lynda, 2005, J Pediatr Health Care, V19, P293, DOI 10.1016/j.pedhc.2005.04.003
   Streisand R, 2005, J PEDIATR PSYCHOL, V30, P513, DOI 10.1093/jpepsy/jsi076
   Streisand R, 2001, J PEDIATR PSYCHOL, V26, P155, DOI 10.1093/jpepsy/26.3.155
   Streisand R, 2008, PATIENT EDUC COUNS, V73, P333, DOI 10.1016/j.pec.2008.06.014
   Sullivan-Bolyai S, 2006, MCN-AM J MATERN-CHIL, V31, P24, DOI 10.1097/00005721-200601000-00007
   Sullivan-Bolyai S, 2004, DIABETES EDUCATOR, V30, P476, DOI 10.1177/014572170403000319
   Sullivan-Bolyai S, 2003, J Pediatr Nurs, V18, P21, DOI 10.1053/jpdn.2003.4
   Sullivan-Bolyai Susan, 2002, J Spec Pediatr Nurs, V7, P93, DOI 10.1111/j.1744-6155.2002.tb00158.x
   Sullivan-Bolyai S, 2010, DIABETES EDUCATOR, V36, P88, DOI 10.1177/0145721709352384
   Viner R, 1996, ARCH DIS CHILD, V74, P418, DOI 10.1136/adc.74.5.418
   Weinzimer SA, 2006, CLIN DIABETES, P505
   Wennick A, 2006, J FAM NURS, V12, P368, DOI 10.1177/1074840706296724
   Whittemore R, 2005, J ADV NURS, V52, P546, DOI 10.1111/j.1365-2648.2005.03621.x
   Wood JJ, 2003, J CHILD PSYCHOL PSYC, V44, P134, DOI 10.1111/1469-7610.00106
   Wysocki T, 2000, J PEDIATR PSYCHOL, V25, P23, DOI 10.1093/jpepsy/25.1.23
NR 63
TC 83
Z9 86
U1 4
U2 38
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0145-7217
J9 DIABETES EDUCATOR
JI Diabetes Educ.
PD JUL-AUG
PY 2012
VL 38
IS 4
BP 562
EP 579
DI 10.1177/0145721712445216
PG 18
WC Endocrinology & Metabolism; Public, Environmental & Occupational Health
SC Endocrinology & Metabolism; Public, Environmental & Occupational Health
GA 976AX
UT WOS:000306554000010
PM 22581804
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Tsai, CH
   Wu, JS
   Chang, YF
   Lu, FH
   Yang, YC
   Chang, CJ
AF Tsai, Chung-Hung
   Wu, Jin-Shang
   Chang, Yin-Fan
   Lu, Feng-Hwa
   Yang, Yi-Ching
   Chang, Chih-Jen
TI The relationship between psychiatric symptoms and glycemic status in a
   Chinese population
SO JOURNAL OF PSYCHIATRIC RESEARCH
LA English
DT Article
DE Brief symptoms rating scale; Depression; Anxiety; Diabetes mellitus;
   Pre-diabetes; Hyperglycemia
ID TYPE-2 DIABETES-MELLITUS; DEPRESSIVE SYMPTOMS; INSULIN-RESISTANCE;
   RISK-FACTOR; BIDIRECTIONAL ASSOCIATION; GLUCOSE-METABOLISM; FASTING
   GLUCOSE; SLEEP DURATION; WOMEN; HOSTILITY
AB With the exception of depression and anxiety, there has been no study designed to evaluate the association between other psychiatric symptoms and Type 2 diabetes.
   The aim of this study was to investigate the relationship between different psychiatric symptoms and diabetes as well as pre-diabetes (Pre-DM) in a Chinese population. Totally, 9561 participants without a history of diabetes, depression, psychosis, use of hypnotics, and abnormal thyroid function were enrolled. Psychiatric symptoms were measured by Brief Symptoms Rating Scale questionnaire, which consists of three global indices [General Severity Index (GSI), Total Number of Positive Symptoms (PST), and Positive Symptom Distress Index (PSDI)] and ten subscales, including somatization, obsession, interpersonal sensitivity, depression, anxiety, hostility, phobia, paranoid ideation, psychoticism and additional symptoms. Different glycemic statuses included normal glucose tolerance (NGT), Pre-DM, and newly-diagnosed diabetes (NDD) group. GSI, somatization, hostility, phobia, psychoticism, and additional symptoms were the factors positively associated with NDD as well as pre-DM in an age-adjusted model. After adjustments for age, gender, body mass index, educational level, hypertension, plasma triglycerides and creatinine, smoking, alcohol use, regular exercise, marital status, and family history of diabetes mellitus, the following psychiatric symptoms were independently related to both NDD and pre-DM: GSI, PST, somatization, obsession, interpersonal sensitivity, depression, anxiety, hostility, phobia, psychoticism, and additional symptoms. In addition to depression and anxiety, global indices of psychiatric symptoms and other subscales, including somatization, obsession, interpersonal sensitivity, hostility, phobia, psychoticism and additional symptoms, may have an impact on both diabetes and Pre-DM. (C) 2012 Elsevier Ltd. All rights reserved.
C1 [Tsai, Chung-Hung; Wu, Jin-Shang; Chang, Yin-Fan; Lu, Feng-Hwa; Yang, Yi-Ching; Chang, Chih-Jen] Natl Cheng Kung Univ Hosp, Dept Family Med, Tainan 70428, Taiwan.
   [Wu, Jin-Shang; Lu, Feng-Hwa; Yang, Yi-Ching; Chang, Chih-Jen] Natl Cheng Kung Univ, Coll Med, Dept Family Med, Tainan 70101, Taiwan.
RP Yang, YC (reprint author), Natl Cheng Kung Univ Hosp, Dept Family Med, 138 Sheng Li Rd, Tainan 70428, Taiwan.
EM yiching@mail.ncku.edu.tw; em75210@email.nck.edu.tw
OI Yang, Yi-Ching/0000-0003-1391-8040
FU Department of Family Medicine, National Cheng-Kung University Hospital
   [NCKUHFM-100-003]
FX This study was supported by the grants from Department of Family
   Medicine, National Cheng-Kung University Hospital (NCKUHFM-100-003).
CR *AM DIAB ASS, 2009, DIABETES CARE S1, V32, pS13, DOI DOI 10.2337/DC09-S013
   Appels A, 2000, PSYCHOSOM MED, V62, P601, DOI 10.1097/00006842-200009000-00001
   Arroyo C, 2004, DIABETES CARE, V27, P129, DOI 10.2337/diacare.27.1.129
   Aujla N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007755
   Ayas NT, 2003, DIABETES CARE, V26, P380, DOI 10.2337/diacare.26.2.380
   Bjorntorp P, 2001, SCAND CARDIOVASC J, V35, P172, DOI 10.1080/140174301750305045
   Bouwman V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009971
   Brown ES, 2004, BIOL PSYCHIAT, V55, P1, DOI 10.1016/S0006-3223(03)00473-6
   Campayo A, 2010, AM J PSYCHIAT, V167, P580, DOI 10.1176/appi.ajp.2009.09010038
   Carnethon MR, 2007, ARCH INTERN MED, V167, P802, DOI 10.1001/archinte.167.8.802
   Carnethon MR, 2003, AM J EPIDEMIOL, V158, P416, DOI 10.1093/aje/kwg172
   de Vegt F, 1999, DIABETOLOGIA, V42, P926, DOI 10.1007/s001250051249
   Eaton WW, 1996, DIABETES CARE, V19, P1097, DOI 10.2337/diacare.19.10.1097
   Engum A, 2007, J PSYCHOSOM RES, V62, P31, DOI 10.1016/j.jpsychores.2006.07.009
   Eriksson AK, 2008, DIABETIC MED, V25, P834, DOI 10.1111/j.1464-5491.2008.02463.x
   Everson-Rose SA, 2004, DIABETES CARE, V27, P2856, DOI 10.2337/diacare.27.12.2856
   Georgiades A, 2009, PSYCHOSOM MED, V71, P642, DOI 10.1097/PSY.0b013e3181acee3a
   Golden SH, 2004, DIABETES CARE, V27, P429, DOI 10.2337/diacare.27.2.429
   Golden SH, 2008, JAMA-J AM MED ASSOC, V299, P2751, DOI 10.1001/jama.299.23.2751
   Gonzalez JS, 2007, DIABETES CARE, V30, P2222, DOI 10.2337/dc07-0158
   Grigsby AB, 2002, J PSYCHOSOM RES, V53, P1053, DOI 10.1016/S0022-3999(02)00417-8
   Haupt DW, 2001, J CLIN PSYCHIAT, V62, P15
   Haupt DW, 2001, J CLIN PSYCHIAT S27, V62, P40
   Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485
   Huxley R, 2006, BMJ-BRIT MED J, V332, P73, DOI 10.1136/bmj.38678.389583.7C
   Jiang LH, 2008, DIABETES CARE, V31, P427, DOI 10.2337/dc07-2044
   Kato M, 2009, ENDOCR J, V56, P459, DOI 10.1507/endocrj.K09E-003
   KAWAKAMI N, 1995, IND HEALTH, V33, P153, DOI 10.2486/indhealth.33.153
   Kawakami N, 1999, DIABETES CARE, V22, P1071, DOI 10.2337/diacare.22.7.1071
   Kivimaki M, 2010, DIABETES CARE, V33, P2611, DOI 10.2337/dc10.1187
   Knol MJ, 2006, DIABETOLOGIA, V49, P837, DOI 10.1007/s00125-006-0159-x
   Kumari M, 2004, ARCH INTERN MED, V164, P1873, DOI 10.1001/archinte.164.17.1873
   Lee M B, 1990, J Formos Med Assoc, V89, P1081
   Lin LS, 1995, CHINESE PSYCHIAT, V9, P65
   Mallon L, 2005, DIABETES CARE, V28, P2762, DOI 10.2337/diacare.28.11.2762
   Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985
   Narita K, 2008, PSYCHONEUROENDOCRINO, V33, P305, DOI 10.1016/j.psyneuen.2007.11.013
   Olson MM, 2010, INT J PSYCHIAT MED, V40, P289, DOI 10.2190/PM.40.3.e
   Palinkas LA, 2004, DIABETIC MED, V21, P1185, DOI 10.1111/j.1464-5491.2004.01315.x
   Pan A, 2010, ARCH INTERN MED, V170, P1884, DOI 10.1001/archinternmed.2010.356
   Pouwer F, 2010, DISCOV MED, V9, P112
   Powers A. C., 2001, HARRISONS PRINCIPLES, P2109
   Raikkonen K, 1996, METABOLISM, V45, P1533, DOI 10.1016/S0026-0495(96)90184-5
   Rief W, 1998, PSYCHOSOM MED, V60, P198, DOI 10.1097/00006842-199803000-00016
   Rod NH, 2009, J INTERN MED, V266, P467, DOI 10.1111/j.1365-2796.2009.02124.x
   Rosmond Roland, 2003, Med Sci Monit, V9, pRA35
   SCHERWITZ LW, 1992, AM J EPIDEMIOL, V136, P136, DOI 10.1093/oxfordjournals.aje.a116480
   Shen BJ, 2008, DIABETES CARE, V31, P1293, DOI 10.2337/dc07-1945
   Smith TW, 2001, HANDBOOK OF HEALTH PSYCHOLOGY, P139
   Surwit RS, 2002, DIABETES CARE, V25, P835, DOI 10.2337/diacare.25.5.835
   van den Akker M, 2004, ACTA PSYCHIAT SCAND, V110, P178
   Young EA, 2004, BIOL PSYCHIAT, V56, P113, DOI 10.1016/j.biopsych.2004.03.017
   Zhang JP, 2006, PSYCHOSOM MED, V68, P718, DOI 10.1097/01.psy.0000228343.89466.11
NR 53
TC 2
Z9 3
U1 1
U2 13
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0022-3956
EI 1879-1379
J9 J PSYCHIATR RES
JI J. Psychiatr. Res.
PD JUL
PY 2012
VL 46
IS 7
BP 927
EP 932
DI 10.1016/j.jpsychires.2012.04.003
PG 6
WC Psychiatry
SC Psychiatry
GA 975UD
UT WOS:000306536100013
PM 22608774
DA 2019-01-08
ER

PT J
AU Mols, F
   Oerlemans, S
   Denollet, J
   Roukema, JA
   van de Poll-Franse, LV
AF Mols, Floortje
   Oerlemans, Simone
   Denollet, Johan
   Roukema, Jan-Anne
   van de Poll-Franse, Lonneke V.
TI Type D personality is associated with increased comorbidity burden and
   health care utilization among 3080 cancer survivors
SO GENERAL HOSPITAL PSYCHIATRY
LA English
DT Article
DE Cancer; Comorbidity; Health care utilization; Type D personality
ID QUALITY-OF-LIFE; CORONARY-HEART-DISEASE; MYOCARDIAL-INFARCTION;
   DISTRESSED PERSONALITY; DEPRESSION; QUESTIONNAIRE; MECHANISMS;
   POPULATION; MORTALITY; SYMPTOMS
AB Objective: Cancer survivors often report comorbid diseases, but there are individual differences in risk. Type D personality is a general propensity to psychological distress that is related to poor cardiovascular outcomes. In this study, we examined whether type D was also related to comorbidity burden and health care utilization among cancer survivors.
   Methods: Individuals diagnosed with endometrial cancer or colorectal cancer between 1998 and 2007, or with lymphoma or multiple myeloma between 1999 and 2008 as registered in the Eindhoven Cancer Registry, received the Self-Administered Comorbidity Questionnaire, questions on health care utilization and the Type D personality scale; 69% (n=3080) responded.
   Results: Nineteen percent of survivors had a type D personality. Over a 12-month period, type D survivors significantly more often reported osteoarthritis, back pain, and depression than non type D survivors. Also, type D survivors more often reported to feel bothered by high blood pressure, osteoarthritis, heart disease, depression, diabetes and lung disease during daily activities. Type D survivors more often visited their general practitioner than non type D survivors (P<.001), also in relation to cancer (0 visits: 54% vs. 60%; 1-5: 28% vs. 22%; >5: 9% vs. 5%; P<.001), as well as their specialist (0 visits: 6% vs. 7%; 1-5 visits: 59% vs. 64%; >5 visits: 30% vs. 23%; P<.01).
   Conclusion: Type D personality is a vulnerability factor that may help to identify subgroups of cancer survivors who are at an increased risk for comorbidity burden and increased health care utilization. (C) 2012 Elsevier Inc. All rights reserved.
C1 [Mols, Floortje; Oerlemans, Simone; Denollet, Johan; Roukema, Jan-Anne; van de Poll-Franse, Lonneke V.] Tilburg Univ, Dept Med Psychol & Neuropsychol, CoRPS Ctr Res Psychol Somat Dis, NL-5000 LE Tilburg, Netherlands.
   [Mols, Floortje; Oerlemans, Simone; van de Poll-Franse, Lonneke V.] Eindhoven Canc Registry, Ctr Comprehens Canc S, Eindhoven, Netherlands.
   [Roukema, Jan-Anne] St Elizabeth Hosp, Dept Surg, Tilburg, Netherlands.
RP Mols, F (reprint author), Tilburg Univ, Dept Med Psychol & Neuropsychol, CoRPS Ctr Res Psychol Somat Dis, POB 90153, NL-5000 LE Tilburg, Netherlands.
EM F.Mols@uvt.nl
FU Netherlands Organization for Scientific Research (The Hague, The
   Netherlands) [451-10-041]; Netherlands Organization for Scientific
   Research [480-08-009]
FX The present research was supported by a VENI grant (#451-10-041) from
   the Netherlands Organization for Scientific Research (The Hague, The
   Netherlands) awarded to Floortje Mols. The data collection of this study
   was funded by an Investment Subsidy (#480-08-009) of the Netherlands
   Organization for Scientific Research awarded to Lonneke van de
   Poll-Franse for setting up the PROFILES registry. These funding agencies
   had no further role in study design; in the collection, analysis and
   interpretation of data; in the writing of the report; and in the
   decision to submit the article for publication.
CR Aquarius AE, 2005, AM J CARDIOL, V96, P996, DOI 10.1016/j.amjcard.2005.05.059
   Babyak MA, 2004, PSYCHOSOM MED, V66, P411, DOI 10.1097/01.psy.0000127692.23278.a9
   Bartels H, 2009, OTOL NEUROT IN PRESS
   Brostrom A, 2007, J SLEEP RES, V16, P439, DOI 10.1111/j.1365-2869.2007.00620.x
   Chapman BP, 2007, EUR J PERSONALITY, V21, P911, DOI 10.1002/per.645
   COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319
   de Valck CFJ, 2007, AUDIOLOGICAL MED, V5, P169
   DENOLLET J, 1995, PSYCHOSOM MED, V57, P582, DOI 10.1097/00006842-199511000-00011
   Denollet J, 2000, CIRCULATION, V102, P630, DOI 10.1161/01.CIR.102.6.630
   Denollet J, 2005, PSYCHOSOM MED, V67, P89, DOI 10.1097/01.psy.0000149256.81953.49
   Denollet J, 2009, PSYCHOL MED, V39, P749, DOI 10.1017/S0033291708004157
   Denollet J, 1996, LANCET, V347, P417, DOI 10.1016/S0140-6736(96)90007-0
   Doyle F, 2011, GEN HOSP PSYCHIAT, V33, P224, DOI 10.1016/j.genhosppsych.2011.03.008
   Ganz PA, 2003, EUR J CANCER, V39, P2136, DOI 10.1016/S0959-8049(03)00489-1
   Janssen-Heijnen MLG LW, 2005, RESULTS 50 YEARS CAN
   Jellesma FC, 2008, J DEV BEHAV PEDIAT
   Katz JN, 1996, MED CARE, V34, P73, DOI 10.1097/00005650-199601000-00006
   Kupper N, 2007, J PERS ASSESS, V89, P265, DOI 10.1080/00223890701629797
   Lang K, 2009, BMC HEALTH SERV RES, V9, P227
   Li X, 2011, ANN ONCOL
   LINET MS, 1989, J CLIN EPIDEMIOL, V42, P1207, DOI 10.1016/0895-4356(89)90119-4
   Louwman WJ, 2010, BRIT J CANCER, V103, P1742, DOI 10.1038/sj.bjc.6605949
   Martens EJ, 2008, PSYCHOL MED, V38, P257, DOI 10.1017/S0033291707001377
   Meulenbroek LFP, 2010, J PSYCHOSOM RES, V68, P379, DOI 10.1016/j.jpsychores.2009.10.002
   Mols F, 2011, J AFFECT DISORD
   Mols F, 2007, INT J CANCER, V121, P871, DOI 10.1002/ijc.22739
   Mols F, 2012, J AFFECT DISORDERS, V136, P26, DOI 10.1016/j.jad.2011.08.034
   Mols F, 2010, EUR J CANCER, V46, P573, DOI 10.1016/j.ejca.2009.09.016
   Mols F, 2010, GEN HOSP PSYCHIAT, V32, P66, DOI 10.1016/j.genhosppsych.2009.09.010
   Mols F, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-9
   Pedersen SS, 2004, J PSYCHOSOM RES, V57, P265, DOI 10.1016/S0022-3999(03)00614-7
   Pedersen SS, 2003, EUR J CARDIOV PREV R, V10, P241, DOI 10.1097/01.hjr.0000085246.65733.06
   Pedersen SS, 2006, AM HEART J, V151, p367e1
   Pedersen SS, 2011, AM J CARDIOL, V108, P69, DOI 10.1016/j.amjcard.2011.02.344
   Pelle AJ, 2009, INT J CARDIOL
   Sangha O, 2003, ARTHRIT RHEUM-ARTHR, V49, P156, DOI 10.1002/art.10993
   Schiffer AA, 2007, HEART, V93, P814, DOI 10.1136/hrt.2006.102822
   Shun SC, 2011, ONCOL NURS FORUM, V38, P378, DOI 10.1188/11.ONF.E221-E228
   *SIGN KANK, 2004, KANK NED TRENDS PROG
   Thomas G, 2006, FOLIA PHONIATR LOGO, V58, P250, DOI 10.1159/000093182
   UICC, 1992, TNM ATL ILL GUID TNM, P141
   van de Poll-Franse LV, 2011, EUR J CANC
   van Duijn C, 2002, MAANDSTATISTIEK BEVO, V50, P32
   Williams L, 2008, J PSYCHOSOM RES, V64, P63, DOI 10.1016/j.jpsychores.2007.06.008
   Williams L, 2011, J PSYCHOSOM RES, V70, P141, DOI 10.1016/j.jpsychores.2010.07.015
NR 45
TC 22
Z9 22
U1 0
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0163-8343
J9 GEN HOSP PSYCHIAT
JI Gen. Hosp. Psych.
PD JUL-AUG
PY 2012
VL 34
IS 4
BP 352
EP 359
DI 10.1016/j.genhosppsych.2012.01.014
PG 8
WC Psychiatry
SC Psychiatry
GA 972TI
UT WOS:000306302700005
PM 22459997
OA Bronze
DA 2019-01-08
ER

PT J
AU Beverly, EA
   Ganda, OP
   Ritholz, MD
   Lee, Y
   Brooks, KM
   Lewis-Schroeder, NF
   Hirose, M
   Weinger, K
AF Beverly, Elizabeth A.
   Ganda, Om P.
   Ritholz, Marilyn D.
   Lee, Yishan
   Brooks, Kelly M.
   Lewis-Schroeder, Nina F.
   Hirose, Masakazu
   Weinger, Katie
TI Look Who's (Not) Talking Diabetic patients' willingness to discuss
   self-care with physicians
SO DIABETES CARE
LA English
DT Article
ID QUALITY-OF-LIFE; GLYCEMIC CONTROL; PROVIDER COMMUNICATION; DEPRESSIVE
   SYMPTOMS; HEALTH-CARE; ADULTS; COMPLICATIONS; MANAGEMENT; METAANALYSIS;
   PREVALENCE
AB OBJECTIVE-Nearly one-half of diabetic patients have glycated hemoglobin A(1c) (HbA(1c)) levels above recommended targets. Effective physician patient communication improves glycemia and diabetes self-care; however, communication gaps may exist that prevent patients from discussing self-care problems with treatment providers.
   RESEARCH DESIGN AND METHODS-We assessed diabetic patients' (n = 316, 85% white, 51% female, 71% type 2 diabetes, 59 +/- 11 years old, 16 +/- 3 years education, 19 +/- 13 years diabetes duration, and HbA(1c) = 7.9 +/- 1.4%) HbA(1c), frequency of self-care, diabetes-related distress, depressive and anxiety symptoms, coping styles, diabetes quality of life, and self-care communication in the treatment relationship. Multivariate logistic regression models examined the main and interaction effects of health and psychosocial factors associated with patients' reluctance to discuss self-care.
   RESULTS-Patients reported positive relationships with their doctors and valued honest communication; however, 30% of patients were reluctant to discuss self-care. Reluctant patients reported less frequent self-care (P = 0.05), lower diabetes quality of life (P = 0.002), and more diabetes-related distress (P = 0.001), depressive symptoms (P < 0.001), and anxiety symptoms (P = 0.001). Patients who reported elevated depressive symptoms, although not necessarily major depression, were more likely to be reluctant to discuss self-care (odds ratio [OR] 1.66 for 10-point change in t score; P < 0.001), whereas patients who were older (OR 0.78 for 10-year change; P = 0.05) and those who used more self-controlled coping styles (OR 0.78 for 10-point change; P = 0.007) were less likely to be reluctant.
   CONCLUSIONS-Awareness of elevated depressive symptoms is important in clinical practice given that these patients may be more reluctant to discuss self-care. Interventions and evidence-based approaches are needed to improve both depressive symptoms and physician-patient communication about self-care.
C1 [Beverly, Elizabeth A.; Ganda, Om P.; Ritholz, Marilyn D.; Lee, Yishan; Brooks, Kelly M.; Lewis-Schroeder, Nina F.; Hirose, Masakazu; Weinger, Katie] Joslin Diabet Ctr, Boston, MA 02215 USA.
   [Beverly, Elizabeth A.; Ganda, Om P.; Ritholz, Marilyn D.; Lewis-Schroeder, Nina F.; Hirose, Masakazu; Weinger, Katie] Harvard Univ, Sch Med, Boston, MA USA.
   [Ritholz, Marilyn D.] Childrens Hosp, Boston, MA 02115 USA.
RP Weinger, K (reprint author), Joslin Diabet Ctr, Boston, MA 02215 USA.
EM katie.weinger@joslin.harvard.edu
FU Kathleen P. Welsh Fund; National Institutes of Health (NIH) Grant
   [R01-DK-60115]; American Diabetes Association Grant [7-08-CR-62];
   Diabetes and Endocrinology Research Core NIH [P30-DK-36836]; NIH
   Training Grant [T32-DK-007260]; Merck; Abbott; GlaxoSmithKline;
   Bristol-Myers Squibb; AstraZeneca; Daiichi Sankyo
FX This work was supported by the Kathleen P. Welsh Fund, National
   Institutes of Health (NIH) Grant R01-DK-60115, American Diabetes
   Association Grant 7-08-CR-62, the Diabetes and Endocrinology Research
   Core NIH P30-DK-36836, and NIH Training Grant T32-DK-007260.; O.P.G. has
   provided consulting services to Abbott; received payment for lectures
   from Merck, Abbott, GlaxoSmithKline, Bristol-Myers Squibb, AstraZeneca,
   and Daiichi Sankyo; and has stock options with BMS. No other potential
   conflicts of interest relevant to this article were reported.
CR Aikens JE, 2005, DIABETES EDUCATOR, V31, P681, DOI 10.1177/0145721705280829
   *AM DIAB ASS, 2011, DIABETES CARE S1, V34, pS11, DOI DOI 10.2337/DC11-S011
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Bastiaens H, 2007, PATIENT EDUC COUNS, V68, P33, DOI 10.1016/j.pec.2007.03.025
   Beck A. T., 1976, COGNITIVE THERAPY EM
   Bennett IM, 2009, ARCH WOMEN MENT HLTH, V12, P301, DOI 10.1007/s00737-009-0103-4
   Berry LL, 2008, ANN FAM MED, V6, P6, DOI 10.1370/afm.757
   Blaum CS, 2002, J AM GERIATR SOC, V50, P581, DOI 10.1046/j.1532-5415.2002.50130.x
   Bradley C, 1994, HDB PSYCHOL DIABETES, P65
   Bundesmann R, 2011, PATIENT EDUC COUNS, V85, P143, DOI 10.1016/j.pec.2010.09.025
   Burns DD, 1980, FEELING GOOD NEW MOO
   Ciechanowski P, 2006, SOC SCI MED, V63, P3067, DOI 10.1016/j.socscimed.2006.08.002
   Derogatis L. R., 2000, BSI 18 BRIEF SYMPTOM
   Fisher E. B., 2007, DIABETES ED, V33, P1104
   Fisher EB, 2007, DIABETES EDUCATOR, V33, P1080, DOI 10.1177/0145721707309808
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341
   Heisler M, 2007, J GERONTOL A-BIOL, V62, P1435, DOI 10.1093/gerona/62.12.1435
   Hoerger TJ, 2008, DIABETES CARE, V31, P81, DOI 10.2337/dc07-1.572
   JACOBSON AM, 1994, DIABETES CARE, V17, P267, DOI 10.2337/diacare.17.4.267
   Kokanovic R, 2007, J GEN INTERN MED, V22, P459, DOI 10.1007/s11606-007-0143-2
   Lin EHB, 2004, DIABETES CARE, V27, P2154, DOI 10.2337/diacare.27.9.2154
   Lin EHB, 2009, ANN FAM MED, V7, P414, DOI 10.1370/afm.998
   Lin EHB, 2010, DIABETES CARE, V33, P264, DOI 10.2337/dc09-1068
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Nathan DM, 2005, NEW ENGL J MED, V353, P2643
   Peters S, 2009, J GEN INTERN MED, V24, P443, DOI 10.1007/s11606-008-0872-x
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   Peyrot M, 1999, J HEALTH SOC BEHAV, V40, P141, DOI 10.2307/2676370
   Piette JD, 2003, J GEN INTERN MED, V18, P624, DOI 10.1046/j.1525-1497.2003.31968.x
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Ritholz MD, 2011, DIABETES EDUCATOR, V37, P794, DOI 10.1177/0145721711423320
   Rogers AE, 2000, BRIT MED J, V321, P605, DOI 10.1136/bmj.321.7261.605
   Schenker Y, 2009, J GEN INTERN MED, V24, P550, DOI 10.1007/s11606-009-0937-5
   SHAMOON H, 1993, NEW ENGL J MED, V329, P977
   Speight J, 2009, DIABETIC MED, V26, P315, DOI 10.1111/j.1464-5491.2009.02682.x
   Swenson SL, 2008, MED CARE, V46, P257, DOI 10.1097/MLR.0b013e31816080e9
   Turner RC, 1998, LANCET, V352, P837
   Weinger K, 2005, DIABETES CARE, V28, P1346, DOI 10.2337/diacare.28.6.1346
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269
NR 41
TC 40
Z9 42
U1 0
U2 15
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
J9 DIABETES CARE
JI Diabetes Care
PD JUL
PY 2012
VL 35
IS 7
BP 1466
EP 1472
DI 10.2337/dc11-2422
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 962MJ
UT WOS:000305548900012
PM 22826455
OA Green Published, Other Gold
DA 2019-01-08
ER

PT J
AU Denny, CH
   Floyd, RL
   Green, PP
   Hayes, DK
AF Denny, Clark H.
   Floyd, R. Louise
   Green, Patricia P.
   Hayes, Donald K.
TI Racial and Ethnic Disparities in Preconception Risk Factors and
   Preconception Care
SO JOURNAL OF WOMENS HEALTH
LA English
DT Article
ID PREGESTATIONAL DIABETES-MELLITUS; FREQUENT MENTAL DISTRESS; RANDOMIZED
   CONTROLLED-TRIAL; UNITED-STATES; BIRTH OUTCOMES; HEALTH-CARE; PERINATAL
   OUTCOMES; PREGNANCY OUTCOMES; REPRODUCTIVE-AGE; PRETERM BIRTH
AB Objective: At-risk drinking, cigarette smoking, obesity, diabetes, and frequent mental distress, as well as their co-occurrence in childbearing aged women, are risk factors for adverse pregnancy outcomes. This study estimated the prevalence of these five risk factors individually and in combination among nonpregnant women aged 18-44 years by demographic and psychosocial characteristics, with a focus on racial and ethnic disparities.
   Methods: Data from the 2008 Behavioral Risk Factor Surveillance System (BRFSS) on nonpregnant women aged 18-44 years (n = 54,612) were used to estimate the prevalences of five risk factors, pairs of co-occurring risk factors, and multiple risk factors for poor pregnancy outcomes.
   Results: The majority of women had at least one risk factor, and 18.7% had two or more risk factors. Having two or more risk factors was highest among women who were American Indian and Alaska Native (34.4%), had less than a high school education (28.7%), were unable to work (50.1%), were unmarried (23.3%), and reported sometimes, rarely, or never receiving sufficient social and emotional support (32.8%). The most prevalent pair of co-occurring risk factors was at-risk drinking and smoking (5.7%).
   Conclusions: The high proportion of women of childbearing age with preconception risk factors highlights the need for preconception care. The common occurrence of multiple risk factors suggests the importance of developing screening tools and interventions that address risk factors that can lead to poor pregnancy outcomes. Increased attention should be given to high-risk subgroups.
C1 [Denny, Clark H.; Floyd, R. Louise; Green, Patricia P.] Ctr Dis Control & Prevent, Fetal Alcohol Syndrome Prevent Team, Div Birth Defects & Dev Disabil, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
   [Hayes, Donald K.] Ctr Dis Control & Prevent, Appl Sci Branch, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
RP Denny, CH (reprint author), Ctr Dis Control & Prevent, Fetal Alcohol Syndrome Prevent Team, Div Birth Defects & Dev Disabil, Natl Ctr Birth Defects & Dev Disabil, 1600 Clifton Rd NE,Mailstop E-86, Atlanta, GA 30333 USA.
EM cdenny@cdc.gov
CR Ahluwalia IB, 2005, J WOMENS HEALTH, V14, P382, DOI 10.1089/jwh.2005.14.382
   Ahluwalia IB, 2004, OBSTET GYNECOL, V104, P477, DOI 10.1097/01.AOG.0000137920.58741.26
   Alder J, 2007, J MATERN-FETAL NEO M, V20, P189, DOI 10.1080/14767050701209560
   Alexander GR, 2008, MATERN CHILD HLTH J, V12, pS5, DOI 10.1007/s10995-007-0295-z
   Allaire AD, 1998, EUR J OBSTET GYN R B, V78, P163, DOI 10.1016/S0301-2115(98)00062-1
   American Academy of Pediatrics, 2000, PEDIATRICS, V106, P358
   American Diabetes Association, 2011, DIABETES CARE S1, V34, pS11, DOI DOI 10.2337/DC11-S011
   Anderson JE, 2006, MATERN CHILD HLTH J, V10, pS101, DOI 10.1007/s10995-006-0093-z
   Andresen EM, 2001, QUAL LIFE RES, V10, P609, DOI 10.1023/A:1013187903591
   Atrash H, 2008, CURR OPIN OBSTET GYN, V20, P581, DOI 10.1097/GCO.0b013e328317a27c
   Atrash HK, 2006, MATERN CHILD HLTH J, V10, pS3, DOI 10.1007/s10995-006-0100-4
   Berg C J, 2001, Matern Child Health J, V5, P75, DOI 10.1023/A:1011344914802
   Blumberg Stephen J, 2011, Natl Health Stat Report, P1
   Castor ML, 2006, AM J PUBLIC HEALTH, V96, P1478, DOI 10.2105/AJPH.2004.053942
   *CDC, 2002, MMWR-MORBID MORTAL W, V51, P1
   Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V47, P326
   Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1227
   Committee on Obstetric Practice, 2009, Obstet Gynecol, V113, P1419, DOI 10.1097/AOG.0b013e3181ac06b6
   Correa A, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.028
   Cowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062
   Delnevo CD, 2008, AM J EPIDEMIOL, V167, P15, DOI 10.1093/aje/kwm313
   Dominguez TP, 2008, HEALTH PSYCHOL, V27, P194, DOI 10.1037/0278-6133.27.2.194
   Dorfman S. F., 2008, TREATING TOBACCO USE
   Elsinga J, 2008, WOMEN HEALTH ISS, V18, pS117, DOI 10.1016/j.whi.2008.09.003
   Finer LB, 2006, PERSPECT SEX REPRO H, V38, P90, DOI 10.1363/3809006
   Floyd RL, 2007, AM J PREV MED, V32, P1, DOI 10.1016/j.amepre.2006.08.028
   Floyd RL, 1999, AM J PREV MED, V17, P101, DOI 10.1016/S0749-3797(99)00059-8
   Galindo A, 2006, J PERINAT MED, V34, P323, DOI 10.1515/JPM.2006.052
   Gennaro S, 2003, JOGNN, V32, P668, DOI 10.1177/0884217503257484
   Giscombe CL, 2005, PSYCHOL BULL, V131, P662, DOI 10.1037/0033-2909.131.5.662
   Glynn LM, 2007, PEPTIDES, V28, P1155, DOI 10.1016/j.peptides.2007.04.005
   Harelick L, 2011, WOMEN HEALTH ISS, V21, P272, DOI 10.1016/j.whi.2011.03.006
   Heron Melonie, 2009, Natl Vital Stat Rep, V57, P1
   Hessol NA, 2005, PEDIATRICS, V115, pE44, DOI 10.1542/peds.2004-0478
   Hessol NA, 1998, OBSTET GYNECOL, V92, P814, DOI 10.1016/S0029-7844(98)00310-X
   Holtzman D, 2004, COMMUNITY-BASED HEALTH RESEARCH: ISSUES AND METHODS, P115
   Hulsey T M, 2001, J Obstet Gynecol Neonatal Nurs, V30, P275, DOI 10.1111/j.1552-6909.2001.tb01545.x
   Jack BW, 2008, AM J OBSTET GYNECOL, V199, pS266, DOI 10.1016/j.ajog.2008.07.067
   Johnson Kay, 2006, Morbidity and Mortality Weekly Report, V55, P1
   Kanny D, 2010, JAMA-J AM MED ASSOC, V304, P2474
   Keppel KG, 2007, AM J EPIDEMIOL, V166, P97, DOI 10.1093/aje/kwm044
   Livingood WC, 2010, MATERN CHILD HLTH J, V14, P382, DOI 10.1007/s10995-009-0471-4
   Lu Michael C, 2003, Matern Child Health J, V7, P13, DOI 10.1023/A:1022537516969
   Lu MC, 2010, ETHNIC DIS, V20, P62
   Mateja WA, 2012, J WOMENS HEALTH, V21, P26, DOI 10.1089/jwh.2010.2582
   Mathews T J, 2010, Natl Vital Stat Rep, V58, P1
   Merrill RM, 2009, PREV CHRONIC DIS, V6
   Mokdad Ali H, 2003, MMWR Recomm Rep, V52, P1
   Moore LL, 2000, EPIDEMIOLOGY, V11, P689, DOI 10.1097/00001648-200011000-00013
   Moos MK, 2008, AM J OBSTET GYNECOL, V199, pS280, DOI 10.1016/j.ajog.2008.08.060
   Moriarty David G, 2003, Health Qual Life Outcomes, V1, P37, DOI 10.1186/1477-7525-1-37
   Moriarty DG, 2009, AM J PREV MED, V36, P497, DOI 10.1016/j.amepre.2009.01.038
   National Research Council and Institute of Medicine Board on Children Youth and Families, 2007, INFL PREGN WEIGHT MA
   Nelson DE, 2010, ADDICTION, V105, P1589, DOI 10.1111/j.1360-0443.2010.03007.x
   Nelson DE, 2001, SOZ PRAVENTIV MED, V46, pS3
   Newschaffer CJ, 1998, VALIDATION BEHAV RIS
   Okoro C, 2007, OCCUP MED-OXFORD, V57, P217, DOI 10.1093/occmed/kql177
   PAGEL MD, 1990, SOC SCI MED, V30, P597, DOI 10.1016/0277-9536(90)90158-O
   Posner SF, 2006, MATERN CHILD HLTH J, V10, pS197, DOI 10.1007/s10995-006-0107-x
   Ramos RG, 2008, AM J PUBLIC HEALTH, V98, P1122, DOI 10.2105/AJPH.2007.120055
   Rao AK, 2006, AM J OBSTET GYNECOL, V195, P834, DOI 10.1016/j.ajog.2006.06.079
   Rosenbaum S, 2008, WOMEN HEALTH ISS, V18, pS26, DOI 10.1016/j.whi.2008.07.013
   Salihu Hamisu M, 2003, Matern Child Health J, V7, P219, DOI 10.1023/A:1027319517405
   Sanders Lorraine B, 2009, Policy Polit Nurs Pract, V10, P129, DOI 10.1177/1527154409338494
   Sarwer DB, 2006, J WOMENS HEALTH, V15, P720, DOI 10.1089/jwh.2006.15.720
   Schempf AH, 2007, AM J PUBLIC HEALTH, V97, P1255, DOI 10.2105/AJPH.2006.093708
   Sheffield JS, 2002, OBSTET GYNECOL, V100, P925, DOI 10.1016/S0029-7844(02)02242-1
   Sibai BM, 2000, AM J OBSTET GYNECOL, V182, P364, DOI 10.1016/S0002-9378(00)70225-0
   Sibai BM, 2000, AM J OBSTET GYNECOL, V183, P1520, DOI 10.1067/mob.2000.107621
   Siega-Riz AM, 2006, MATERN CHILD HLTH J, V10, pS153, DOI 10.1007/s10995-006-0115-x
   Spring B, 2004, J CONSULT CLIN PSYCH, V72, P785, DOI 10.1037/0022-006X.72.5.785
   STEER RA, 1992, J CLIN EPIDEMIOL, V45, P1093, DOI 10.1016/0895-4356(92)90149-H
   Strine TW, 2004, AM J PREV MED, V26, P213, DOI 10.1016/j.amepre.2003.11.002
   Toet J, 2006, QUAL LIFE RES, V15, P179, DOI 10.1007/s11136-005-8484-y
   Tsai J, 2010, PREV SCI, V11, P197, DOI 10.1007/s11121-009-0158-5
   Tucker MJ, 2007, AM J PUBLIC HEALTH, V97, P247, DOI 10.2105/AJPH.2005.072975
   Weisman CS, 2011, WOMEN HEALTH ISS, V21, P265, DOI 10.1016/j.whi.2011.03.007
   Xaverius PK, 2009, J WOMENS HEALTH, V18, P49, DOI 10.1089/jwh.2007.0629
NR 78
TC 18
Z9 18
U1 1
U2 25
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1540-9996
EI 1931-843X
J9 J WOMENS HEALTH
JI J. Womens Health
PD JUL
PY 2012
VL 21
IS 7
BP 720
EP 729
DI 10.1089/jwh.2011.3259
PG 10
WC Public, Environmental & Occupational Health; Medicine, General &
   Internal; Obstetrics & Gynecology; Women's Studies
SC Public, Environmental & Occupational Health; General & Internal
   Medicine; Obstetrics & Gynecology; Women's Studies
GA 969SP
UT WOS:000306078900004
PM 22559934
DA 2019-01-08
ER

PT J
AU Ali, MK
   Feeney, P
   Hire, D
   Simmons, DL
   O'Connor, PJ
   Ganz-Lord, F
   Goff, D
   Zhang, P
   Anderson, RT
   Narayan, KMV
   Sullivan, MD
AF Ali, M. K.
   Feeney, P.
   Hire, D.
   Simmons, D. L.
   O'Connor, P. J.
   Ganz-Lord, F.
   Goff, D., Jr.
   Zhang, P.
   Anderson, R. T.
   Narayan, K. M. V.
   Sullivan, M. D.
TI Glycaemia and correlates of patient-reported outcomes in ACCORD trial
   participants
SO DIABETIC MEDICINE
LA English
DT Article
DE ACCORD study; cardiovascular disease; health-related quality of life;
   patient-reported outcomes; Type 2 diabetes
ID QUALITY-OF-LIFE; RANDOMIZED CONTROLLED-TRIAL; TYPE-2 DIABETES-MELLITUS;
   TREATMENT SATISFACTION; HEALTH; ADULTS; CARE
AB Diabet. Med. 29, e67e74 (2012) Abstract Aims Post-hoc evaluation of relationships between first-year change in glycaemic control (HbA1c) and change in patient-reported outcomes among ACCORD health-related quality of life (HRQoL) substudy participants. Methods Data from 2053 glycaemia-trial subjects were analysed. We assessed physical and mental health status (36-Item Short Form Health Survey, Version-2), symptom count and severity (Diabetes Symptoms Distress Checklist) and treatment satisfaction (Diabetes Treatment Satisfaction Questionnaire). Linear mixed models were used to test relationships between 1-year changes in HbA1c and patient reported outcomes sequentially adjusting for correlates (baseline characteristics, baseline patient reported outcomes, treatment assignment, frequency of clinical contact and post-randomization weight change plus new complications). Results Poorer baseline control of HbA1c and cardiovascular disease risk factors predicted greater one-year improvements in treatment satisfaction. Similarly, poorer baseline patient reported outcome scores all individually predicted greater 1-year improvement in that same outcome. Accounting for baseline and post-randomization characteristics and treatment arm, 1-year change in HbA1c was unrelated to changes in overall physical or mental health; however, every one percentage-point (10.9 mmol/mol) reduction in HbA1c was associated with lower symptom count (beta = 0.599; P = 0.012), lower symptom distress (beta = 0.051; P = 0.001), and higher treatment satisfaction (beta = -2.514; P < 0.001). Conclusions Independent of all relevant covariates, better glycaemic control over 1 year was associated with reduced patient-reported diabetes symptoms and symptom distress, and increased treatment satisfaction, but not overall physical and mental health. Further investigation is required to understand the specific psychosocial mechanisms that affect how patients value health and treatments.
C1 [Ali, M. K.; Narayan, K. M. V.] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.
   [Feeney, P.; Hire, D.; Sullivan, M. D.] Wake Forest Univ Hlth Sci, Winston Salem, NC USA.
   [Feeney, P.] Stat Collaborat Inc, Washington, DC USA.
   [Simmons, D. L.] Cent Arkansas Vet Healthcare Syst, Little Rock, AR USA.
   [Simmons, D. L.] Univ Arkansas Med Sci, Little Rock, AR 72205 USA.
   [O'Connor, P. J.] Hlth Partners Res Fdn, Minneapolis, MN USA.
   [Ganz-Lord, F.] Cornell Univ, Weill Cornell Med Coll, Ithaca, NY 14853 USA.
   [Goff, D., Jr.] Wake Forest Univ, Sch Med, Winston Salem, NC 27109 USA.
   [Zhang, P.] US Ctr Dis Control, Atlanta, GA USA.
   [Anderson, R. T.] Penn State Univ, Coll Med, Hershey, PA USA.
   [Sullivan, M. D.] Univ Washington, Sch Med, Seattle, WA USA.
RP Ali, MK (reprint author), Emory Univ, Rollins Sch Publ Hlth, 1518 Clifton Rd NE,CNR 7th Floor, Atlanta, GA 30322 USA.
EM mkali@emory.edu
RI Narayan, K.M. Venkat/J-9819-2012
OI Narayan, K.M. Venkat/0000-0001-8621-5405
CR Adriaanse MC, 2008, DIABETES CARE, V31, P2268, DOI 10.2337/dc08-1074
   ANDERSON RM, 1995, DIABETES CARE, V18, P943, DOI 10.2337/diacare.18.7.943
   Anderson RT, 2011, DIABETES CARE, V34, P807, DOI 10.2337/dc10-1926
   Buse JB, 2007, AM J CARDIOL, V99, p21I, DOI 10.1016/j.amjcard.2007.03.003
   De Wit M, 2008, DIABETES CARE, V31, P1521, DOI 10.2337/dc08-0394
   Diabet Control Complications Trial Res Grp, 1996, DIABETES CARE, V19, P195
   Fincke BG, 2005, J AMBUL CARE MANAG, V28, P262
   Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743
   Glasgow RE, 1997, DIABETES CARE, V20, P562, DOI 10.2337/diacare.20.4.562
   Goddijn PPM, 1999, DIABETIC MED, V16, P23, DOI 10.1046/j.1464-5491.1999.00002.x
   Gore M, 2005, J PAIN SYMPTOM MANAG, V30, P374, DOI 10.1016/j.jpainsymman.2005.04.009
   Hermansen K, 2007, DRUG SAFETY, V30, P1127, DOI 10.2165/00002018-200730120-00005
   Janssen PGH, 2009, BRIT J GEN PRACT, V59, P43, DOI 10.3399/bjgp09X394851
   Nicolucci A, 2009, NUTR METAB CARDIOVAS, V19, P45, DOI 10.1016/j.numecd.2007.12.005
   PEYROT M, 1994, DIABETES CARE, V17, P994, DOI 10.2337/diacare.17.9.994
   Peyrot M, 2009, DIABETES CARE, V32, P1411, DOI 10.2337/dc08-2256
   Pitale S, 2005, J DIABETES COMPLICAT, V19, P207, DOI 10.1016/j.jdiacomp.2004.12.002
   Pouwer F, 2001, DIABETES CARE, V24, P1929, DOI 10.2337/diacare.24.11.1929
   Redekop WK, 2002, DIABETES CARE, V25, P458, DOI 10.2337/diacare.25.3.458
   Rejeski WJ, 2006, OBESITY, V14, P870, DOI 10.1038/oby.2006.101
   Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O
   Speight J, 2009, DIABETIC MED, V26, P315, DOI 10.1111/j.1464-5491.2009.02682.x
   Sullivan MD, 2007, AM J CARDIOL, V99, p90I, DOI 10.1016/j.amjcard.2007.03.027
   Tabaei BP, 2004, QUAL LIFE RES, V13, P1153, DOI 10.1023/B:QURE.0000031336.81580.52
   Testa MA, 1998, JAMA-J AM MED ASSOC, V280, P1490, DOI 10.1001/jama.280.17.1490
   Testa MA, 1996, NEW ENGL J MED, V334, P835, DOI 10.1056/NEJM199603283341306
   UK Prospective Diabetes Study Grp, 1999, DIABETES CARE, V22, P1125
   Unden AL, 2008, GENDER MED, V5, P162, DOI 10.1016/j.genm.2008.05.003
   VanderDoes FEE, 1996, DIABETES CARE, V19, P204, DOI 10.2337/diacare.19.3.204
   WEINBERGER M, 1994, MED CARE, V32, P1173, DOI 10.1097/00005650-199412000-00002
   Wexler DJ, 2006, DIABETOLOGIA, V49, P1489, DOI 10.1007/s00125-006-0249-9
NR 31
TC 10
Z9 10
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD JUL
PY 2012
VL 29
IS 7
BP E67
EP E74
DI 10.1111/j.1464-5491.2011.03532.x
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 961IQ
UT WOS:000305458500010
PM 22141437
DA 2019-01-08
ER

PT J
AU Jimenez-Garcia, R
   Huedo, MAM
   Hernandez-Barrera, V
   de Andres, AL
   Martinez, D
   Jimenez-Trujillo, I
   Carrasco-Garrido, P
AF Jimenez-Garcia, Rodrigo
   Martinez Huedo, Maria Angeles
   Hernandez-Barrera, Valentin
   Lopez de Andres, Ana
   Martinez, David
   Jimenez-Trujillo, Isabel
   Carrasco-Garrido, Pilar
TI Psychological distress and mental disorders among Spanish diabetic
   adults: A case-control study
SO PRIMARY CARE DIABETES
LA English
DT Article
DE Anxiety; Depression; Diabetes; Mental disorders; Psychological distress
ID QUALITY-OF-LIFE; COMORBID DEPRESSION; US ADULTS; HEALTH; CARE;
   DISABILITY; MELLITUS; ANXIETY; PREVALENCE; ATTITUDES
AB Aim: To compare the prevalence of psychological distress and mental disorders between diabetes and non-diabetes sufferers and to identify associated factors.
   Methods: Case-control study based on data from the 2006 to 2007 Spanish National Health Survey. We identified 2193 type 2 diabetic adults. Non-diabetic controls were 1:1 matched by age-and-sex. The presence of a mental disorder was considered if subjects answered yes to the questions: "Have you suffered depression and/or anxiety over the previous 12 months? AND "Has your medical doctor confirmed the diagnosis?". The 12-item General Health Questionnaire was used to measure psychological distress. Independent covariables included socio-demographics and heath related variables.
   Results: Prevalence of mental disorders was 18.6% among diabetics and 16.4% among controls (adjusted OR 1.17 CI 95% 1.01-1.38). 26% of diabetes and 18.9% of the non-diabetic suffered psychological distress (adjusted OR 1.51 CI 95% 1.25-1.83). Among diabetics variables associated with suffering a mental disorder and psychological distress were: female sex, younger age, worse self rated health, comorbidity, GP visit in the last 4 weeks and ER attendance in last year.
   Conclusions: Diabetic adults have significantly higher prevalence of diagnosed mental disorders and psychological distress than non-diabetic subjects. Programs targeted at preventing, monitoring and controlling these mental health problems at primary care should be implemented. (C) 2011 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.
C1 [Jimenez-Garcia, Rodrigo; Martinez Huedo, Maria Angeles; Hernandez-Barrera, Valentin; Lopez de Andres, Ana; Jimenez-Trujillo, Isabel; Carrasco-Garrido, Pilar] Univ Rey Juan Carlos, Prevent Med & Publ Hlth Teaching & Res Unit, Dept Hlth Sci, Madrid, Spain.
   [Martinez, David] Univ Complutense, Dept Prevent Med, E-28040 Madrid, Spain.
RP Jimenez-Garcia, R (reprint author), Fac Ciencias Salud, Unidad Med Preventiva, Avda Atenas S-N, Madrid 28922, Spain.
EM rodrigo.jimenez@urjc.es
FU ISCIII [ETES: PI09/90515]
FX The work was supported by a Grant from the ISCIII (ETES: PI09/90515).
CR American Diabetes Association, 2009, DIABETES CARE S1, V32, pS26
   Anderson RJ, 2002, INT J PSYCHIAT MED, V32, P235, DOI 10.2190/KLGD-4H8D-4RYL-TWQ8
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Badia X, 1999, MED CLIN-BARCELONA, V112, P79
   CALLAHAN CM, 1992, J GEN INTERN MED, V7, P26, DOI 10.1007/BF02599097
   Collins MM, 2009, DIABETIC MED, V26, P153, DOI 10.1111/j.1464-5491.2008.02648.x
   Das-Munshi J, 2007, PSYCHOSOM MED, V69, P543, DOI 10.1097/PSY.0b013e3180cc3062
   de Jonge P, 2006, DIABETOLOGIA, V49, P2627, DOI 10.1007/s00125-006-0442-x
   Egede LE, 2004, DIABETES CARE, V27, P421, DOI 10.2337/diacare.27.2.421
   Egede LE, 2002, DIABETES CARE, V25, P464, DOI 10.2337/diacare.25.3.464
   Egede LE, 2009, GEN HOSP PSYCHIAT, V31, P422, DOI 10.1016/j.genhosppsych.2009.06.007
   Faresjo T, 2010, INT J ENV RES PUB HE, V7, P325, DOI 10.3390/ijerph7010325
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Frayne SM, 2005, ARCH INTERN MED, V165, P2631, DOI 10.1001/archinte.165.22.2631
   Gispert R, 2003, SOC PSYCH PSYCH EPID, V38, P677, DOI 10.1007/s00127-003-0692-6
   Goldberg D., 1988, USERS GUIDE GEN HLTH
   Grigsby AB, 2002, J PSYCHOSOM RES, V53, P1053, DOI 10.1016/S0022-3999(02)00417-8
   Hervas A, 2007, AN SIST SANIT NAVAR, V30, P45, DOI 10.4321/s1137-66272007000100005
   Huerta JM, 2009, REV ESP CARDIOL, V62, P143, DOI 10.1016/S0300-8932(09)70156-3
   *INE, ENC NAC SAL ESP 2006
   Katon WJ, 2008, AM J MED, V121, P8, DOI 10.1016/j.amjmed.2008.09.008
   Kruse J, 2003, DIABETES CARE, V26, P1841, DOI 10.2337/diacare.26.6.1841
   Li C, 2008, DIABETIC MED, V25, P878, DOI 10.1111/j.1464-5491.2008.02477.x
   Lin EHB, 2004, DIABETES CARE, V27, P2154, DOI 10.2337/diacare.27.9.2154
   Lin EHB, 2008, J PSYCHOSOM RES, V65, P571, DOI 10.1016/j.jpsychores.2008.06.007
   MUNOZ PE, 1979, ARCH NEUROBIOL, V42, P139
   Petersen M, 2008, DIABETES CARE, V31, P596, DOI 10.2337/dc08-9017
   Ruiz-Ramos Miguel, 2006, Gac Sanit, V20 Suppl 1, P15, DOI 10.1157/13086022
   Sanchez-Lopez Mdel P, 2008, PSICOTHEMA, V20, P839
   Sanchez-Villegas A., 2008, BMC PSYCHIATRY, V17, P38
   Schieman S, 2002, J AGING HEALTH, V14, P260, DOI 10.1177/089826430201400205
   Shao WA, 1997, J FAM PRACTICE, V44, P161
   Snoek FJ, 2002, DIABETIC MED, V19, P265, DOI 10.1046/j.1464-5491.2002.00678.x
   Sturmer T, 2000, J Epidemiol Biostat, V5, P125
   Unden AL, 2008, GENDER MED, V5, P162, DOI 10.1016/j.genm.2008.05.003
   Von Korff M, 2005, PSYCHOSOM MED, V67, P233, DOI 10.1097/01.psy.0000155662.82621.50
NR 36
TC 8
Z9 8
U1 4
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1751-9918
J9 PRIM CARE DIABETES
JI Prim. Care Diabetes
PD JUL
PY 2012
VL 6
IS 2
BP 149
EP 156
DI 10.1016/j.pcd.2011.10.002
PG 8
WC Endocrinology & Metabolism; Primary Health Care
SC Endocrinology & Metabolism; General & Internal Medicine
GA 960HJ
UT WOS:000305378300009
PM 22047940
DA 2019-01-08
ER

PT J
AU Franks, MM
   Sahin, ZS
   Seidel, AJ
   Shields, CG
   Oates, SK
   Boushey, CJ
AF Franks, Melissa M.
   Sahin, Z. Seda
   Seidel, Amber J.
   Shields, Cleveland G.
   Oates, Shannon K.
   Boushey, Carol J.
TI Table for Two: Diabetes Distress and Diet-Related Interactions of
   Married Patients With Diabetes and Their Spouses
SO FAMILIES SYSTEMS & HEALTH
LA English
DT Article
DE marriage; shared meals; diabetes distress
ID SOCIAL-CONTROL; SELF-CARE; CHRONIC ILLNESS; MEDICATION ADHERENCE;
   EMOTIONAL DISTRESS; EATING PATTERNS; OLDER PATIENTS; MARITAL-STATUS;
   TYPE-2; HEALTH
AB In adjusting to chronic illness, patients often negotiate new or altered daily routines within a dynamic family context. Yet, the responses of family members to the disease and its management are understudied. The authors investigated patients with Type 2 diabetes and their spouses (N = 55 couples) and examined the association of diet-related interactions (i.e., diet-related support, diet-related pressure, and frequency of sharing meals together) with each partner's adjustment to the illness context (i.e., diabetes distress). All spouses (100%) reported providing some type of diet-related support to their partners with diabetes in the past month, and many reported exerting pressure to improve their partners' diet choices (60%). In addition, many couples (64%) indicated that they frequently shared meals together in the past month. For spouses, their provision of diet-related pressure was associated (positively) with their diabetes distress. Frequently sharing meals was associated with less diabetes distress among patients, even after controlling for their glycemic control and diet adherence. Findings reveal that spouses of patients with diabetes are actively involved in illness management with their partners, and these activities are associated with their own diabetes distress and with that of their ill partners.
C1 [Franks, Melissa M.; Sahin, Z. Seda; Seidel, Amber J.; Shields, Cleveland G.] Purdue Univ, Dept Human Dev & Family Studies, W Lafayette, IN 47906 USA.
   [Oates, Shannon K.] Indiana Univ Hlth Arnett, Div Endocrinol & Metab, Lafayette, IN USA.
   [Boushey, Carol J.] Univ Hawaii, Ctr Canc, Program Epidemiol, Honolulu, HI 96822 USA.
RP Franks, MM (reprint author), Purdue Univ, Dept Human Dev & Family Studies, W Lafayette, IN 47906 USA.
EM mmfranks@purdue.edu
OI Shields, Cleveland/0000-0003-3709-6969
FU Regenstrief Center for Healthcare Engineering; Purdue Research
   Foundation; Purdue University
FX Support for this project was provided by the Regenstrief Center for
   Healthcare Engineering, Purdue Research Foundation, and Agricultural
   Research Programs, Purdue University.
CR American Diabetes Association, 2008, DIABETES CARE, V31, pS61, DOI DOI 10.2337/DC08-5061
   Anderson B. J., 1993, DEV ASPECTS HLTH COM, P77
   [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc35-S011]
   August KJ, 2011, J HEALTH PSYCHOL, V16, P1109, DOI 10.1177/1359105311401670
   August KJ, 2010, SOC SCI MED, V71, P1831, DOI 10.1016/j.socscimed.2010.08.022
   Berg CA, 2007, PSYCHOL BULL, V133, P920, DOI 10.1037/0033-2909.133.6.920
   Beverly EA, 2008, HEALTH EDUC BEHAV, V35, P707, DOI 10.1177/1090198107299787
   Center for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET
   Delahanty LM, 2007, DIABETIC MED, V24, P48, DOI 10.1111/j.1464-5491.2007.02028.x
   Delormier T, 2009, SOCIOL HEALTH ILL, V31, P215, DOI 10.1111/j.1467-9566.2008.01128.x
   Fiese BH, 2006, NEW DIR CHILD ADOLES, V111, P67, DOI 10.1002/cad.155
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2002, DIABETES CARE, V25, P1564, DOI 10.2337/diacare.25.9.1564
   Fisher L, 2009, DIABETIC MED, V26, P622, DOI 10.1111/j.1464-5491.2009.02730.x
   Fisher L, 2000, J FAM PRACTICE, V49, P561
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Franks M. M., 2010, 63 ANN M GER SOC AM
   Franks MM, 2010, FAM RELAT, V59, P599, DOI 10.1111/j.1741-3729.2010.00626.x
   Franks MM, 2006, J FAM PSYCHOL, V20, P311, DOI 10.1037/0893-3200.20.2.311
   Fulikerson JA, 2008, J AM DIET ASSOC, V108, P706, DOI 10.1016/j.jada.2008.01.005
   Fulkerson JA, 2007, J CONSULT CLIN PSYCH, V75, P181, DOI 10.1037/0022-006X.75.1.181
   Gillman MW, 2000, ARCH FAM MED, V9, P235, DOI 10.1001/archfami.9.3.235
   Gonder-Frederick LA, 2002, J CONSULT CLIN PSYCH, V70, P611, DOI 10.1037//0022-006X.70.3.611
   Gonzalez JS, 2007, DIABETES CARE, V30, P2222, DOI 10.2337/dc07-0158
   Halter J. B., 1999, DIABETES MELLITUS IN, P991
   Huang ES, 2005, J AM GERIATR SOC, V53, P306, DOI 10.1111/j.1532-5415.2005.53119.x
   Lin EHB, 2004, DIABETES CARE, V27, P2154, DOI 10.2337/diacare.27.9.2154
   Magkos F, 2009, ANNU REV NUTR, V29, P223, DOI 10.1146/annurev-nutr-080508-141200
   Miller D, 2005, J NUTR EDUC BEHAV, V37, P226, DOI 10.1016/S1499-4046(06)60276-5
   NORTON R, 1983, J MARRIAGE FAM, V45, P141, DOI 10.2307/351302
   Paisley J, 2008, J NUTR EDUC BEHAV, V40, P80, DOI 10.1016/j.jneb.2007.04.374
   Penckofer S, 2007, DIABETES EDUCATOR, V33, P680, DOI 10.1177/0145721707304079
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Rook KS, 2011, J SOC PERS RELAT, V28, P772, DOI 10.1177/0265407510391335
   Savoca M, 2001, J NUTR EDUC, V33, P224, DOI 10.1016/S1499-4046(06)60035-3
   Schafer RB, 1999, SOC SCI MED, V48, P787, DOI 10.1016/S0277-9536(98)00377-3
   Shaw BA, 2006, J COMMUN HEALTH, V31, P393, DOI 10.1007/s10900-006-9018-4
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Stephens MAP, 2010, FAM SYST HEALTH, V28, P199, DOI 10.1037/a0020513
   Stephens MAP, 2009, HEALTH PSYCHOL, V28, P48, DOI 10.1037/a0012385
   Tang TS, 2008, DIABETES EDUCATOR, V34, P266, DOI 10.1177/0145721708315680
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Trief P., 2003, FAMILIES SYSTEMS HLT, V21, P57, DOI [DOI 10.1037/H0089502, 10.1037/h0089502]
   Trief P. M., 2006, FAMILIES SYSTEMS HLT, V24, P318, DOI [10.1037/1091-7527.24.3.318, DOI 10.1037/1091-7527.24.3.318]
   Tucker JS, 2001, J APPL SOC PSYCHOL, V31, P467, DOI 10.1111/j.1559-1816.2001.tb02051.x
   UMBERSON D, 1992, SOC SCI MED, V34, P907, DOI 10.1016/0277-9536(92)90259-S
   Wansink B, 2007, ENVIRON BEHAV, V39, P106, DOI 10.1177/0013916506295573
NR 49
TC 18
Z9 18
U1 0
U2 18
PU EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC
PI WASHINGTON
PA 750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA
SN 1091-7527
EI 1939-0602
J9 FAM SYST HEALTH
JI Fam. Syst. Health
PD JUN
PY 2012
VL 30
IS 2
BP 154
EP 165
DI 10.1037/a0028614
PG 12
WC Health Care Sciences & Services; Family Studies; Public, Environmental &
   Occupational Health
SC Health Care Sciences & Services; Family Studies; Public, Environmental &
   Occupational Health
GA 962NG
UT WOS:000305551200006
PM 22709327
DA 2019-01-08
ER

PT J
AU Nadimpalli, SB
   Hutchinson, MK
AF Nadimpalli, Sarah B.
   Hutchinson, M. Katherine
TI An Integrative Review of Relationships Between Discrimination and Asian
   American Health
SO JOURNAL OF NURSING SCHOLARSHIP
LA English
DT Article
DE Nursing; discrimination; racism; health outcomes; Asian American; health
   disparities
ID MEXICAN-ORIGIN ADULTS; RACIAL-DISCRIMINATION; PERCEIVED DISCRIMINATION;
   ETHNIC-IDENTITY; UNITED-STATES; PSYCHOLOGICAL DISTRESS; DEPRESSIVE
   SYMPTOMS; FILIPINO AMERICANS; KOREAN IMMIGRANTS; PHYSICAL HEALTH
AB Purpose: Many ethnic minorities in the United States experience disproportionate rates of adverse health outcomes or health disparities. Factors such as socioeconomic status do not fully explain how these disparities are generated and maintained. Research has demonstrated that chronic experiences of discrimination are harmful to the health of African Americans and Latinos. However, there is a dearth of research examining Asian Americans experiences with discrimination and health disparities. The purpose of this integrative review was to summarize the current literature examining discrimination and the mental and physical health of Asian Americans. Design and Methods: Combinations of search terms related to discrimination, health, and Asian Americans were used to search five electronic databases. Inclusion criteria were primary research studies, published in English between 1980 and 2011, Asian American adults, and discrimination examined in relationship to a physical or mental health outcome. The search initially yielded 489 results; 14 quantitative studies met inclusion criteria. Findings and Conclusions: Quantitative studies in this review revealed several significant associations between discrimination and health outcomes in Asian Americans. Discrimination was significantly associated with depressive symptoms in seven studies. Three studies found associations between discrimination and physical health, including cardiovascular disease, respiratory conditions, obesity, and diabetes. Although the literature was limited by self-reported data, cross-sectional designs, and inconsistent definitions and measurement of discrimination, the findings suggest that discrimination is a significant contributor to poorer health and health disparities for Asian Americans. The findings clearly demonstrate the need for further nursing research in this area to inform evidence-based practice and social policy. Clinical Relevance: Patient care providers can recognize discrimination as a significant stressor or purveyor of illness and explore ways to facilitate coping and resilience with their Asian American patients. Community-based participatory research approaches can be implemented by clinicians, academicians, and Asian American community partners to address the issue of discrimination and Asian American health outcomes.
C1 [Nadimpalli, Sarah B.; Hutchinson, M. Katherine] NYU, Coll Nursing, New York, NY 10003 USA.
RP Nadimpalli, SB (reprint author), NYU, Coll Nursing, 726 Broadway,10th Floor, New York, NY 10003 USA.
EM sb3354@nyu.edu
OI Hutchinson, M.Katherine/0000-0001-8270-9491
CR Bernstein KS, 2011, COMMUNITY MENT HLT J, V47, P24, DOI 10.1007/s10597-009-9261-0
   Creswell J, 2009, RES DESIGN QUALITATI
   de Castro AB, 2008, AM J PUBLIC HEALTH, V98, P520, DOI 10.2105/AJPH.2007.110163
   Finch BK, 2000, J HEALTH SOC BEHAV, V41, P295, DOI 10.2307/2676322
   Flores E, 2008, HISPANIC J BEHAV SCI, V30, P401, DOI 10.1177/0739986308323056
   Gee GC, 2006, AM J PUBLIC HEALTH, V96, P677, DOI 10.2105/AJPH.2004.060442
   Gee GC, 2002, AM J PUBLIC HEALTH, V92, P615, DOI 10.2105/AJPH.92.4.615
   Gee GC, 2008, AM J PUBLIC HEALTH, V98, P493, DOI 10.2105/AJPH.2007.114025
   Gee GC, 2007, AM J PUBLIC HEALTH, V97, P1275, DOI 10.2105/AJPH.2006.091827
   Gee GC, 2007, SOC SCI MED, V64, P1984, DOI 10.1016/j.socscimed.2007.02.013
   Hahm HC, 2010, WOMEN HEALTH ISS, V20, P350, DOI 10.1016/j.whi.2010.05.002
   Jones CP, 2000, AM J PUBLIC HEALTH, V90, P1212, DOI 10.2105/AJPH.90.8.1212
   Krieger N, 1996, AM J PUBLIC HEALTH, V86, P1370, DOI 10.2105/AJPH.86.10.1370
   Krieger N, 1999, INT J HEALTH SERV, V29, P295, DOI 10.2190/M11W-VWXE-KQM9-G97Q
   Lam BT, 2007, AM J ORTHOPSYCHIAT, V77, P370, DOI 10.1037/0002-9432.77.3.370
   Lee MY, 2004, J MARITAL FAM THER, V30, P497, DOI 10.1111/j.1752-0606.2004.tb01258.x
   Lee RM, 2005, J COUNS PSYCHOL, V52, P36, DOI 10.1037/0022-0167-52.1.36
   Mossakowski KN, 2003, J HEALTH SOC BEHAV, V44, P318, DOI 10.2307/1519782
   Mossakowski KN, 2007, SOC PSYCHOL QUART, V70, P290, DOI 10.1177/019027250707000307
   New York City Commission on Human Rights, 2003, DISCR MUSL AR S AS N
   Oh YJ, 2002, J SOC PSYCHOL, V142, P511, DOI 10.1080/00224540209603915
   Okihiro G, 2001, COLUMBIA GUIDE ASIAN
   Paradies Y, 2006, INT J EPIDEMIOL, V35, P888, DOI 10.1093/ije/dyl056
   Piette JD, 2006, PATIENT EDUC COUNS, V60, P41, DOI 10.1016/j.pec.2004.12.001
   Polit D. F., 2012, NURSING RES GENERATI
   Ryan AM, 2006, J HEALTH CARE POOR U, V17, P116, DOI 10.1353/hpu.2006.0079
   Trinh-Shevrin C., 2009, ASIAN AM COMMUNITIES, P162
   U.S. Census Bureau, 2005, AM COMM SURV 2004
   U. S. Department of Health and Human Services, 2001, MENT HLTH CULT RAC E
   US Bureau of the Census, 2007, AM COMM AS 2004
   US Department of Health and Human Services, 1999, MENT HLTH REP SURG G
   von Elm E, 2007, PLOS MED, V4, P1623, DOI 10.1371/journal.pmed.0040296
   Whittemore R, 2005, J ADV NURS, V52, P546, DOI 10.1111/j.1365-2648.2005.03621.x
   Williams D R, 1997, J Health Psychol, V2, P335, DOI 10.1177/135910539700200305
   World Health Organization, 1998, HLTH PROM GLOSS
   Yip T, 2008, DEV PSYCHOL, V44, P787, DOI 10.1037/0012-1649.44.3.787
   Yoo HC, 2009, SOC SCI MED, V68, P726, DOI 10.1016/j.socscimed.2008.11.013
NR 37
TC 17
Z9 18
U1 2
U2 30
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1527-6546
EI 1547-5069
J9 J NURS SCHOLARSHIP
JI J. Nurs. Scholarsh.
PD JUN
PY 2012
VL 44
IS 2
BP 127
EP 135
DI 10.1111/j.1547-5069.2012.01448.x
PG 9
WC Nursing
SC Nursing
GA 950PD
UT WOS:000304660300004
PM 22551064
DA 2019-01-08
ER

PT J
AU Brumby, S
   Chandrasekara, A
   McCoombe, S
   Kremer, P
   Lewandowski, P
AF Brumby, Susan
   Chandrasekara, Ananda
   McCoombe, Scott
   Kremer, Peter
   Lewandowski, Paul
TI Cardiovascular risk factors and psychological distress in Australian
   farming communities
SO AUSTRALIAN JOURNAL OF RURAL HEALTH
LA English
DT Article
DE obesity; mental health; farmer; cardiovascular disease
ID METABOLIC SYNDROME; PHYSICAL-ACTIVITY; LIFE-STYLE; OBESITY; DISEASE;
   POPULATION; OVERWEIGHT; FARMERS; BURDEN; HEALTH
AB Objective: To examine the prevalence of cardiovascular disease (CVD) risk factors, psychological distress and associations between physical and mental health parameters within a cohort of the Australian farming community. Design: Cross-sectional descriptive study. Setting: Farming communities across Australia. Participants: Data of men (n = 957) and women (n = 835) farmers from 97 locations across Australia were stratified into categories based on National Cholesterol Education Program guidelines. Main outcome measure(s): Prevalence of and interrelationship between overweight, obesity, dyslipidaemia, hypertension, diabetes risk and psychological distress. Results: There was a higher prevalence of overweight (42.5%, 95% confidence interval (CI), 34.250.8), obesity (21.8%, 95% CI, 18.325.3), abdominal adiposity (38.4% 95% CI, 24.552.5), hypertension (54.0%, 95% CI, 34.473.5) and diabetes risk (25.3%, 95% CI, 17.736.7) in the farming cohort compared with national data. There was also a positive significant association between the prevalence of psychological distress and obesity, abdominal adiposity, body fat percentage and metabolic syndrome in older (age = 50 years) participants. Conclusions: This study group of farming men and women exhibited an increased prevalence of CVD risk factors and co-morbidities. The findings indicate a positive association between psychological distress and risk for developing CVD, particularly in the older farmers. If the younger cohort were to maintain elevated rates of psychological distress, then it is foreseeable that the next generation of farmers could experience poorer physical health than their predecessors.
C1 [Brumby, Susan; Chandrasekara, Ananda; McCoombe, Scott] Natl Ctr Farmer Hlth, Western Dist Hlth Serv, Hamilton, Vic 3300, Australia.
   [Brumby, Susan; Chandrasekara, Ananda; McCoombe, Scott; Lewandowski, Paul] Deakin Univ, Sch Med, Geelong, Vic 3217, Australia.
   [Kremer, Peter] Deakin Univ, Sch Psychol, Geelong, Vic 3217, Australia.
RP Brumby, S (reprint author), Natl Ctr Farmer Hlth, Western Dist Hlth Serv, Hamilton, Vic 3300, Australia.
EM susan.brumby@wdhs.net
OI Chandrasekara, Ananda/0000-0003-0947-6083; Kremer,
   Peter/0000-0003-2476-1958
CR Alston M, 2004, AGR HUM VALUES, V21, P37, DOI 10.1023/B:AHUM.0000014019.84085.59
   Australian Bureau of Statistics, 2011, AUSTR DEM STAT 3101
   Australian Government Department of Agriculture Fisheries and Forestry, 2008, NAT RUR ADV COUNC AN
   Australian Institute of Health and Welfare, 2008, DIAB AUSTR FACTS 200, P58
   Bjorntorp P, 2007, BR J NUTR S1, V83, P49
   BRACKBILL RM, 1994, AM J EPIDEMIOL, V139, P1055, DOI 10.1093/oxfordjournals.aje.a116949
   Brumby SA, 2009, RURAL REMOTE HEALTH, V9
   Brumby S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-362
   Brumby Susan, 2011, BMC Res Notes, V4, P89, DOI 10.1186/1756-0500-4-89
   CAMACHO TC, 1991, AM J EPIDEMIOL, V134, P220, DOI 10.1093/oxfordjournals.aje.a116074
   Cameron AJ, 2003, MED J AUSTRALIA, V178, P427
   Dallman MF, 2003, P NATL ACAD SCI USA, V100, P11696, DOI 10.1073/pnas.1934666100
   Department for Environment Food and Rural Affairs, 2009, SERV CORD OR PROGR S, P48
   Dunstan D, 2001, DIABESITY ASS DISORD
   Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6
   Frager L, 2000, HLTH SAFETY AUSTR FA
   Janus ED, 2007, MED J AUSTRALIA, V187, P147
   JOHNSON JV, 1989, SCAND J WORK ENV HEA, V15, P271, DOI 10.5271/sjweh.1852
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Kousar R, 2008, METABOLISM, V57, P1502, DOI 10.1016/j.metabol.2008.06.003
   Lorenzo C, 2007, DIABETES CARE, V30, P8, DOI 10.2337/dc06-1414
   Mathers CD, 2001, B WORLD HEALTH ORGAN, V79, P1076
   Miller K, 2008, AUST J RURAL HEALTH, V16, P327, DOI 10.1111/j.1440-1584.2008.01011.x
   Rautiainen Risto H, 2005, J Agromedicine, V10, P21
   SCHWARZ L, 1992, SPORTS MED, V13, P25, DOI 10.2165/00007256-199213010-00003
NR 25
TC 11
Z9 12
U1 0
U2 20
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1038-5282
J9 AUST J RURAL HEALTH
JI Aust. J. Rural Health
PD JUN
PY 2012
VL 20
IS 3
BP 131
EP 137
DI 10.1111/j.1440-1584.2012.01273.x
PG 7
WC Public, Environmental & Occupational Health; Nursing
SC Public, Environmental & Occupational Health; Nursing
GA 946XH
UT WOS:000304390300007
PM 22620477
DA 2019-01-08
ER

PT J
AU Woudenberg, YJC
   Lucas, C
   Latour, C
   Reimer, WJMSO
AF Woudenberg, Y. J. C.
   Lucas, C.
   Latour, C.
   Reimer, W. J. M. Scholte Op
TI Acceptance of insulin therapy: a long shot? Psychological insulin
   resistance in primary care
SO DIABETIC MEDICINE
LA English
DT Article
DE insulin therapy; primary care; psychology; Type 2 diabetes
ID NATIONAL DIABETES ATTITUDES; NEEDS DAWN; COMPLICATIONS; DEPRESSION;
   APPRAISAL; DISTRESS; BARRIERS; WISHES
AB Diabet. Med. 29, 796802 (2012) Abstract Aim To explore which factors are associated with psychological insulin resistance in insulin-naive patients with Type 2 diabetes in primary care. Methods A sample of 101 insulin-naive patients with Type 2 diabetes completed self-administered questionnaires including demographic and clinical characteristics, the Insulin Treatment Appraisal Scale and the Center for Epidemiological Studies Depression scale. Psychological insulin resistance was denoted by negative appraisal of insulin (Insulin Treatment Appraisal Scale). Results Thirty-nine per cent of the sample were unwilling to accept insulin therapy. Unwilling participants perceived taking insulin more often as a failure to control their diabetes with tablets or lifestyle compared with willing participants (59 vs. 33%), unwilling participants were more reluctant to accept the responsibilities of everyday management of insulin therapy (49 vs. 24%). Multiple linear regression analysis revealed that depression and objection to lifelong insulin therapy were independently associated with psychological insulin resistance. Conclusions In this study in primary care, depression and objection to lifelong insulin therapy are associated with psychological insulin resistance. Analysis of the objection to the indefiniteness of insulin therapy showed a sense of limitation of daily life and loss of independence that should not be underestimated. Insulin should be offered as a means to improve health as this might facilitate the acceptance of insulin therapy.
C1 [Latour, C.; Reimer, W. J. M. Scholte Op] Amsterdam Univ Appl Sci, Sch Nursing, NL-1000 CN Amsterdam, Netherlands.
   [Woudenberg, Y. J. C.] Univ Amsterdam, Med Ctr Oost, Amsterdam, Netherlands.
   [Lucas, C.] Univ Amsterdam, Dept Clin Epidemiol Biostat & Bioinformat, Amsterdam, Netherlands.
   [Lucas, C.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands.
RP Reimer, WJMSO (reprint author), Amsterdam Univ Appl Sci, Sch Nursing, Room C211,POB 2557, NL-1000 CN Amsterdam, Netherlands.
EM w.j.m.scholte.op.reimer@hva.nl
CR Bogatean MP, 2004, PRACT DIABETES INT, V21, P247, DOI DOI 10.1002/PDI.670
   Brod M, 2009, QUAL LIFE RES, V18, P23, DOI 10.1007/s11136-008-9419-1
   Brunton Stephen A, 2006, Clin Cornerstone, V8 Suppl 2, pS19, DOI 10.1016/S1098-3597(06)80012-8
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Heijmans M, 2010, ONTWIKKELING ZORG CH
   Larkin ME, 2008, DIABETES EDUCATOR, V34, P511, DOI 10.1177/0145721708317869
   Makine C, 2009, DIABETIC MED, V26, P28, DOI 10.1111/j.1464-5491.2008.02606.x
   Meulepas MA, 2007, FAM PRACT, V24, P20, DOI 10.1093/fampra/cml055
   Morris JE, 2005, PRACTICAL DIABETES I, V22, P239, DOI DOI 10.1002/PDI.829
   Noordman J, 2008, INZET DOKTERSASSISTE
   Peyrot M, 2005, DIABETES CARE, V28, P2673, DOI 10.2337/diacare.28.11.2673
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   Polonsky WH, 2005, DIABETES CARE, V28, P2543, DOI 10.2337/diacare.28.10.2543
   Polonsky W, 2007, DIABETES EDUCATOR, V33, p241S, DOI 10.1177/0145721707305701
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Rubino A, 2007, DIABETIC MED, V24, P1412, DOI 10.1111/j.1464-5491.2007.02279.x
   Snoek FJ, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-69
   Steyerberg EW, 2009, CLIN PREDICTION MODE, P207
   Stratton IM, 2000, BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405
   ten Brinke R, 2008, PRIM CARE DIABETES, V2, P45, DOI 10.1016/j.pcd.2007.12.004
   Turner RC, 1998, LANCET, V352, P837
   Yu PC, 2010, DIABETES RES CLIN PR, V89, P1, DOI 10.1016/j.diabres.2009.12.009
NR 22
TC 23
Z9 23
U1 2
U2 8
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
J9 DIABETIC MED
JI Diabetic Med.
PD JUN
PY 2012
VL 29
IS 6
BP 796
EP 802
DI 10.1111/j.1464-5491.2011.03552.x
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 942YN
UT WOS:000304087700018
PM 22150962
DA 2019-01-08
ER

PT J
AU Atlantis, E
   Sullivan, T
   Sartorius, N
   Almeida, OP
AF Atlantis, Evan
   Sullivan, Thomas
   Sartorius, Norman
   Almeida, Osvaldo P.
TI Changes in the prevalence of psychological distress and use of
   antidepressants or anti-anxiety medications associated with comorbid
   chronic diseases in the adult Australian population, 2001-2008
SO AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
LA English
DT Article
DE Psychological distress; depression; anxiety; antidepressants;
   anti-anxiety medications; chronic disease; trends
ID COMMUNITY SAMPLE; MAJOR DEPRESSION; NATIONAL TRENDS; HEALTH; DISORDERS;
   EFFICACY; PEOPLE; PUBLICATION; DISABILITY; WEIGHT
AB Objective: To investigate changes in the prevalence of psychological distress and use of antidepressants or anti-anxiety medications associated with comorbid chronic diseases in the adult Australian population from 2001 to 2008.
   Methods: Participants were 48,359 adults aged >= 25 years from the 2001, 2004-05 or 2007-08 Australian National Health Surveys. Clinically significant psychological distress was determined with the 10-item Kessler Psychological Distress Scale (using scores >= 30). Contemporaneous use of antidepressants or anti-anxiety medications and the presence of chronic diseases including diabetes, cardiovascular disease, cancer, asthma and arthritis were by self-report.
   Results: Overall, the prevalence of psychological distress was relatively stable (3.9 vs. 3.7%) between 2001 and 2008, but increased from 5.9 to 7.0% and 4.6 to 5.0% for people with diabetes and cardiovascular disease. In contrast, the use of antidepressants or anti-anxiety medications decreased from 7.3 to 4.8% across all disease categories. On average, the odds of psychological distress and use of antidepressants or anti-anxiety medications was 1.15 to 1.59-fold and 1.10 to 1.64-fold higher, respectively, for all chronic diseases after adjustments for socio-demographic and lifestyle variables. After further adjustment for all chronic disease predictors fitted jointly, these associations decreased in strength (percentage change in the log odds ratio) by 14 to 98%. Each additional chronic disease increased the odds of both psychological distress (1.34-fold higher) and use of antidepressants or anti-anxiety medications (1.40-fold higher) in a dose response manner.
   Conclusions: Although the prevalence of psychological distress changed little for adult Australians between 2001 and 2008, it increased for people with diabetes and cardiovascular disease. Conversely, the reported use of antidepressants or anti-anxiety medications progressively decreased for people with, and without, chronic diseases. Overall, there was a persistently higher psychopathology burden associated with each and increasing number of comorbid chronic diseases.
C1 [Atlantis, Evan] Univ Adelaide, Sch Med, Adelaide, SA 5000, Australia.
   [Atlantis, Evan] Royal Adelaide Hosp, Inst Med & Vet Sci, SA Hlth, Govt S Australia, Adelaide, SA 5000, Australia.
   [Sullivan, Thomas] Univ Adelaide, Data Management & Anal Ctr, Discipline Publ Hlth, Adelaide, SA 5000, Australia.
   [Sartorius, Norman] Assoc Improvement Mental Hlth Programmes, Geneva, Switzerland.
   [Almeida, Osvaldo P.] Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA 6009, Australia.
   [Almeida, Osvaldo P.] Univ Western Australia, Western Australian Ctr Hlth & Ageing, Med Res Ctr, Perth, WA 6009, Australia.
   [Almeida, Osvaldo P.] Royal Perth Hosp, Dept Psychiat, Perth, WA, Australia.
RP Atlantis, E (reprint author), Univ Adelaide, Sch Med, Adelaide, SA 5000, Australia.
EM evan.atlantis@adelaide.edu.au
RI Almeida, Osvaldo/A-4925-2008
OI Almeida, Osvaldo/0000-0002-8689-6199; Atlantis,
   Evan/0000-0001-5877-6141; Sullivan, Thomas/0000-0002-6930-5406
CR Andrews G, 2001, AUST NZ J PUBL HEAL, V25, P494, DOI 10.1111/j.1467-842X.2001.tb00310.x
   Atlantis E, 2008, INT J OBESITY, V32, P715, DOI 10.1038/sj.ijo.0803762
   Atlantis E, 2009, OBES REV, V10, P543, DOI 10.1111/j.1467-789X.2009.00590.x
   Atlantis E, 2011, SOCIAL PSYCHIAT PSYC
   Atlantis E, 2011, SOC PSYCH PSYCH EPID, V46, P1303, DOI 10.1007/s00127-010-0302-3
   Australian Bureau of Statistics, 1778 AUSTR BUR STAT
   Australian Bureau of Statistics, 2008, 2007 NAT SURV MENT H
   Australian Bureau of Statistics, 4324 AUSTR BUR STAT
   Australian Bureau of Statistics, 990 AUSTR BUR STAT
   Australian Bureau of Statistics, 1998, AUSTR MEAS 1995
   Barbui C, 1999, SOC PSYCH PSYCH EPID, V34, P152, DOI 10.1007/s001270050127
   Brhlikova P, 2011, J ROY SOC MED, V104, P25, DOI 10.1258/jrsm.2010.100080
   Britt HC, 2008, MED J AUSTRALIA, V189, P72
   Caughey GE, 2010, AGE AGEING, V39, P488, DOI 10.1093/ageing/afq055
   Clarke DM, 2009, MED J AUSTRALIA, V190, pS54
   Coles-Rutishauser I., 2001, EVALUATION SHORT DIE
   Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X
   Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3
   DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101
   Dunstan D, 2001, DIABESITY ASS DISORD
   Egede LE, 2007, GEN HOSP PSYCHIAT, V29, P409, DOI 10.1016/j.genhosppsych.2007.06.002
   Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7
   Fletcher JR, 2008, MED J AUSTRALIA, V188, pS107
   Goldney RD, 2010, AUST NZ J PSYCHIAT, V44, P901, DOI 10.3109/00048674.2010.490520
   Grayson DA, 2000, J GERONTOL B-PSYCHOL, V55, pP273, DOI 10.1093/geronb/55.5.P273
   Gunn J, 2010, SOCIAL PSYCHIAT PSYC, V47, P175
   Harman JS, 2009, PSYCHIAT SERV, V60, P611, DOI 10.1176/appi.ps.60.5.611
   Harris MG, 2011, AUST NZ J PSYCHIAT, V45, P249, DOI 10.3109/00048674.2010.531459
   Holden L, 2010, AUST NZ J PUBL HEAL, V34, P304, DOI 10.1111/j.1753-6405.2010.00531.x
   Hollingworth SA, 2010, AUST NZ J PSYCHIAT, V44, P513, DOI 10.3109/00048670903555138
   Katon W, 2007, GEN HOSP PSYCHIAT, V29, P147, DOI 10.1016/j.genhosppsych.2006.11.005
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045
   Kosidou K, 2010, ACTA PSYCHIAT SCAND, V122, P47, DOI 10.1111/j.1600-0447.2009.01487.x
   Licht CMM, 2008, ARCH GEN PSYCHIAT, V65, P1358, DOI 10.1001/archpsyc.65.12.1358
   Mant A, 2004, MED J AUSTRALIA, V181, pS21
   Mathew SJ, 2009, AM J PSYCHIAT, V166, P140, DOI 10.1176/appi.ajp.2008.08071102
   Meijer WEE, 2004, EUR J CLIN PHARMACOL, V60, P57, DOI 10.1007/s00228-004-0726-3
   Moore M, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3999
   Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9
   Olfson M, 2004, J CLIN PSYCHIAT, V65, P1166, DOI 10.4088/JCP.v65n0903
   Olfson M, 2008, ARCH GEN PSYCHIAT, V65, P94, DOI 10.1001/archgenpsychiatry.2007.5
   Taylor D, 2011, BRIT J PSYCHIAT, V198, P179, DOI 10.1192/bjp.bp.110.077610
   Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779
   Uijen Annemarie A, 2008, Eur J Gen Pract, V14 Suppl 1, P28, DOI 10.1080/13814780802436093
   World Health Organization, 2008, GLOB BURD DIS 2004 U
NR 46
TC 21
Z9 21
U1 0
U2 4
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0004-8674
J9 AUST NZ J PSYCHIAT
JI Aust. N. Z. J. Psych.
PD MAY
PY 2012
VL 46
IS 5
BP 445
EP 456
DI 10.1177/0004867411433218
PG 12
WC Psychiatry
SC Psychiatry
GA 944EI
UT WOS:000304181700008
PM 22535293
DA 2019-01-08
ER

PT J
AU Carcone, AI
   Ellis, DA
   Naar-King, S
AF Carcone, April Idalski
   Ellis, Deborah A.
   Naar-King, Sylvie
TI Linking Caregiver Strain to Diabetes Illness Management and Health
   Outcomes in a Sample of Adolescents in Chronically Poor Metabolic
   Control
SO JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS
LA English
DT Article
DE caregiver strain; caregiver mental health symptoms; adherence; metabolic
   control; diabetes
ID SOCIAL SUPPORT; GLYCEMIC CONTROL; PSYCHOLOGICAL DISTRESS; SELF-CARE;
   FAMILY CAREGIVERS; PARENTAL BURDEN; MEDIATING ROLE; CHILDREN; YOUTH;
   QUESTIONNAIRE
AB Objective: This study examined a multivariate model of the relationship between caregiver strain and adolescent diabetes illness outcomes in a sample of caregivers of adolescents in chronically poor metabolic control (hemoglobin A(1c) >= 8.0% at enrollment and for previous 12 mo). Caregiver mental health symptoms were hypothesized to mediate the relationship between caregiver strain and adolescent illness management behavior and metabolic control. Caregivers' perceptions of social support and their level of responsibility for diabetes care tasks were hypothesized to be directly related to caregiver strain and indirectly to caregiver mental health symptoms. Methods: One hundred forty-six caregiver-adolescent dyads completed baseline measures of caregiver strain, responsibility for diabetes care, social support, mental health symptoms, and illness management behavior. Adolescent metabolic control was also assessed. Results: Findings from structural equation modeling suggested that caregiver strain was directly and positively associated with caregiver mental health symptoms which mediated the relationship to adolescent diabetes management behavior and metabolic control. Caregivers' responsibility for diabetes care tasks was directly related to caregiver strain and indirectly to caregiver mental health, but caregivers' perception of social support was not. Conclusions: These findings suggest that caregiver strain is an important dimension of the caregiving context of diabetes. Clinicians and researchers should consider how caregiving strain, responsibility for illness management, and mental health symptoms might be impacting children's diabetes care behavior and diabetes health when working with and designing interventions for adolescents with diabetes. (J Dev Behav Pediatr 33:343-351, 2012)
C1 [Carcone, April Idalski; Ellis, Deborah A.; Naar-King, Sylvie] Wayne State Univ, Pediat Prevent Res Ctr, Carman & Ann Adams Dept Pediat, Detroit, MI 48202 USA.
RP Carcone, AI (reprint author), Wayne State Univ, Pediat Prevent Res Ctr, Carman & Ann Adams Dept Pediat, 4707 St Antoine St,Suite W534,Bin 502, Detroit, MI 48202 USA.
EM acarcone@med.wayne.edu
OI Idalski Carcone, April/0000-0002-4731-1995
FU National Institute of Diabetes, Digestive and Kidney Diseases [R01
   DK59067]
FX This project was supported by grant #R01 DK59067 from the National
   Institute of Diabetes, Digestive and Kidney Diseases.
CR AMIEL SA, 1986, NEW ENGL J MED, V315, P215, DOI 10.1056/NEJM198607243150402
   ANDERSON BJ, 1990, J PEDIATR PSYCHOL, V15, P477, DOI 10.1093/jpepsy/15.4.477
   Angold A, 1998, AM J PUBLIC HEALTH, V88, P75, DOI 10.2105/AJPH.88.1.75
   [Anonymous], 2010, IBM SPSS AM COMP PRO
   Arbuckle J., 2009, AMOS 18 USERS GUIDE
   BAILLIE V, 1988, NURS RES, V37, P217
   BARRERA M, 1986, AM J COMMUN PSYCHOL, V14, P413, DOI 10.1007/BF00922627
   Bearman KJ, 2002, J PEDIATR PSYCHOL, V27, P417, DOI 10.1093/jpepsy/27.5.417
   Brannan A. M., 2001, J CHILD FAM STUD, V10, P405, DOI DOI 10.1023/A:1016705306848
   Brannan AM, 1997, J EMOT BEHAV DISORD, V5, P212, DOI 10.1177/106342669700500404
   Brannan AM, 2003, J EMOT BEHAV DISORD, V11, P77, DOI 10.1177/106342660301100202
   Bussing R, 2003, J AM ACAD CHILD PSY, V42, P842, DOI 10.1097/01.CHI.0000046876.27264.BF
   Bussing R, 2003, J AM ACAD CHILD PSY, V42, P184, DOI 10.1097/01.CHI.0000037011.34553.A9
   Butler DA, 2008, PEDIATR DIABETES, V9, P373, DOI 10.1111/j.1399-5448.2008.00370.x
   Calderon C, 2011, J PEDIATR PSYCHOL, V36, P188, DOI 10.1093/jpepsy/jsq069
   Canning RD, 1996, J PEDIATR PSYCHOL, V21, P735, DOI 10.1093/jpepsy/21.5.735
   Carcone AI, 2011, J DEV BEHAV PEDIATR, V32, P581, DOI 10.1097/DBP.0b013e31822c1a27
   Cooper C, 2003, J AM ACAD CHILD PSY, V42, P1370, DOI 10.1097/01.CHI.0000085751.71002.48
   Cunningham NR, 2011, J PEDIATR PSYCHOL, V36, P196, DOI 10.1093/jpepsy/jsq071
   Dashiff C. J., 2003, J FAMILY NURSING, V9, P166, DOI DOI 10.1177/1074840703009002004
   DCCT Res Grp, 1994, J PEDIATR-US, V125, P177, DOI 10.1016/S0022-3476(94)70190-3
   DELAMATER AM, 1991, DIABETES CARE, V14, P20, DOI 10.2337/diacare.14.1.20
   Derogatis LR, 2004, BSI 18 MANUAL
   Diabetes Technologies Inc, 2004, LAB TEST KIT ACCUBAS
   Dovey-Pearce G, 2007, BRIT J HEALTH PSYCH, V12, P75, DOI 10.1348/135910706X98317
   Forsander G, 1998, ACTA PAEDIATR, V87, P857, DOI 10.1080/080352598750013635
   FREY MA, 1989, ADV NURS SCI, V12, P67, DOI 10.1097/00012272-198910000-00009
   Frey MA, 2004, DIABETES EDUCATOR, V30, P647, DOI 10.1177/014572170403000416
   Haller MJ, 2004, J PEDIATR-US, V144, P660, DOI 10.1016/j.jpeds.2003.12.042
   Heflinger C. A., 2004, J FAMILY SOCIAL WORK, V8, P27, DOI DOI 10.1300/J039V08N01_
   IBM Corporation, 2011, IBM SPSS STAT COMP P
   Johnson SB, 2000, J PEDIATR PSYCHOL, V25, P171, DOI 10.1093/jpepsy/25.3.171
   Johnson SB, 1990, NEUROPSYCHOLOGICAL B, P30
   Kang E. J., 2005, J CHILD FAM STUD, V14, P43, DOI DOI 10.1007/S10826-005-1112-1
   Kline R. B., 2005, PRINCIPLES PRACTICE
   La Greca AM, 2002, J PEDIATR PSYCHOL, V27, P665, DOI 10.1093/jpepsy/27.8.665
   Lee JM, 2006, DIABETES CARE, V29, P420, DOI 10.2337/diacare.29.02.06.dc05-2182
   Leishman JM, 2010, INDIVIDUAL FAMILY PR
   Levine BS, 2001, J PEDIATR-US, V139, P197, DOI 10.1067/mpd.2001.116283
   Luescher JL, 1999, J CHILD NEUROL, V14, P642, DOI 10.1177/088307389901401004
   McCabe Kristen M, 2003, Ment Health Serv Res, V5, P137, DOI 10.1023/A:1024439317884
   MONTGOMERY RJV, 1985, FAM RELAT, V34, P19, DOI 10.2307/583753
   Moran A, 1999, DIABETES, V48, P2039, DOI 10.2337/diabetes.48.10.2039
   Morris AD, 1997, LANCET, V350, P1505, DOI 10.1016/S0140-6736(97)06234-X
   Mullins LL, 2011, J PEDIATR PSYCHOL, V36, P249, DOI 10.1093/jpepsy/jsq080
   Oh H, 2009, INT J DISABIL DEV ED, V56, P149, DOI 10.1080/10349120902868624
   Palmer DL, 2004, J PEDIATR PSYCHOL, V29, P35, DOI 10.1093/jpepsy/jsh005
   Patterson JM, 1997, J DEV BEHAV PEDIATR, V18, P383, DOI 10.1097/00004703-199712000-00003
   Quittner AL, 2008, J PEDIATR PSYCHOL, V33, P916, DOI 10.1093/jpepsy/jsm064
   Raina P, 2005, PEDIATRICS, V115, pE626, DOI 10.1542/peds.2004-1689
   Ratner PA, 1998, ADV DESIGN NURSING R
   Sales E, 2004, SOC WORK RES, V28, P211, DOI 10.1093/swr/28.4.211
   Schilling LS, 2002, DIABETES EDUCATOR, V28, P796, DOI 10.1177/014572170202800520
   Schoeder C. E., 2007, J CHILD FAM STUD, V16, P888, DOI DOI 10.1007/S10826-007-9133-6
   Schreiber JB, 2006, J EDUC RES, V99, P323, DOI 10.3200/JOER.99.6.323-338
   Seiffge-Krenke I, 2003, J ADOLESCENT HEALTH, V33, P180, DOI 10.1016/S1054-139X(02)00707-3
   Serr J, 2007, 18 INT NURS RES C FO
   Silverstein J, 2005, DIABETES CARE, V28, P186, DOI 10.2337/diacare.28.1.186
   Thomas AM, 1997, J PEDIATR PSYCHOL, V22, P541, DOI 10.1093/jpepsy/22.4.541
   THOMPSON EH, 1993, J GERONTOL, V48, pS245, DOI 10.1093/geronj/48.5.S245
   Varekamp I, 1990, FAM SYST MED, V8, P291
   Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110
   WEISSBERGBENCHELL J, 1995, DIABETES CARE, V18, P77, DOI 10.2337/diacare.18.1.77
   Wysocki T, 1996, DIABETES CARE, V19, P119, DOI 10.2337/diacare.19.2.119
   WYSOCKI T, 1992, J DEV BEHAV PEDIATR, V13, P194
   Wysocki Tim, 2006, Curr Diab Rep, V6, P117, DOI 10.1007/s11892-006-0022-y
NR 66
TC 8
Z9 8
U1 0
U2 13
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0196-206X
EI 1536-7312
J9 J DEV BEHAV PEDIATR
JI J. Dev. Behav. Pediatr.
PD MAY
PY 2012
VL 33
IS 4
BP 343
EP 351
DI 10.1097/DBP.0b013e31824eaac8
PG 9
WC Behavioral Sciences; Psychology, Developmental; Pediatrics
SC Behavioral Sciences; Psychology; Pediatrics
GA 939PQ
UT WOS:000303825200008
PM 22566030
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Hartmann, M
   Kopf, S
   Kircher, C
   Faude-Lang, V
   Djuric, Z
   Augstein, F
   Friederich, HC
   Kieser, M
   Bierhaus, A
   Humpert, PM
   Herzog, W
   Nawroth, PP
AF Hartmann, Mechthild
   Kopf, Stefan
   Kircher, Claudia
   Faude-Lang, Verena
   Djuric, Zdenka
   Augstein, Florian
   Friederich, Hans-Christoph
   Kieser, Meinhard
   Bierhaus, Angelika
   Humpert, Per M.
   Herzog, Wolfgang
   Nawroth, Peter P.
TI Sustained Effects of a Mindfulness-Based Stress-Reduction Intervention
   in Type 2 Diabetic Patients Design and first results of a randomized
   controlled trial (the Heidelberger Diabetes and Stress-Study)
SO DIABETES CARE
LA English
DT Article
ID METAANALYSIS; DEPRESSION; COMPLICATIONS; ACCEPTANCE
AB OBJECTIVE-To determine whether a mindfulness-based stress reduction (MBSR) intervention is effective for reducing psychosocial distress (i.e., depression, psychosocial stress) and the progression of nephropathy (i.e., albuminuria) and for improving the subjective health status of patients with type 2 diabetes.
   RESEARCH DESIGN AND METHODS-Patients with type 2 diabetes and microalbuminuria were randomized to a mindfulness-based intervention (n = 53) or a treatment-as-usual control (n = 57) group. The study is designed to investigate long-term outcomes over a period of 5 years. We present data up to the first year of follow-up (FU).
   RESULTS-At FU, the MBSR group showed lower levels of depression (d = 0.71) and improved health status (d = 0.54) compared with the control group. No significant differences in albuminuria were found. Per-protocol analysis also showed higher stress reduction in the intervention group (d = 0.64).
   CONCLUSIONS-MBSR intervention achieved a prolonged reduction in psychosocial distress. The effects on albuminuria will be followed up further.
C1 [Hartmann, Mechthild; Faude-Lang, Verena; Friederich, Hans-Christoph; Herzog, Wolfgang] Heidelberg Univ, Dept Med & Psychosomat 2, Heidelberg, Germany.
   [Kopf, Stefan; Kircher, Claudia; Djuric, Zdenka; Augstein, Florian; Bierhaus, Angelika; Humpert, Per M.; Nawroth, Peter P.] Heidelberg Univ, Dept Med & Clin Chem 1, Heidelberg, Germany.
   [Faude-Lang, Verena] Univ Hamburg Eppendorf, Dept Psychosomat Med & Psychotherapy, Hamburg, Germany.
   [Kieser, Meinhard] Heidelberg Univ, Inst Med Biometry, Heidelberg, Germany.
RP Hartmann, M (reprint author), Heidelberg Univ, Dept Med & Psychosomat 2, Heidelberg, Germany.
EM mechthild.hartmann@med.uni-heidelberg.de
FU Lautenschlager Stiftung; European Foundation for the Study of Diabetes
FX This study was supported by the Lautenschlager Stiftung (to P.P.N.) and
   the European Foundation for the Study of Diabetes (to A.B.).
CR Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Bierhaus A, 2003, P NATL ACAD SCI USA, V100, P1920, DOI 10.1073/pnas.0438019100
   Bierhaus A, 2009, DIABETOLOGIA, V52, P2251, DOI 10.1007/s00125-009-1458-9
   Bohlmeijer E, 2010, J PSYCHOSOM RES, V68, P539, DOI 10.1016/j.jpsychores.2009.10.005
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   Faude-Lang V, 2010, PSYCHOTHER PSYCH MED, V60, P185, DOI 10.1055/s-0030-1248420
   Gregg JA, 2007, J CONSULT CLIN PSYCH, V75, P336, DOI 10.1037/0022-006X.75.2.336
   Grossman P, 2004, J PSYCHOSOM RES, V57, P35, DOI 10.1016/S0022-3999(03)00573-7
   Kabat-Zinn J, 1990, FULL CATASTROPHY LIV
   Lin EHB, 2010, DIABETES CARE, V33, P264, DOI 10.2337/dc09-1068
   Pouwer F, 2010, DISCOV MED, V9, P112
   Rosenzweig S, 2007, ALTERN THER HEALTH M, V13, P36
   Spitzer RL, 2000, AM J OBSTET GYNECOL, V183, P759, DOI 10.1067/mob.2000.106580
   Ware JE, 1998, J CLIN EPIDEMIOL, V51, P1167, DOI 10.1016/S0895-4356(98)00108-5
NR 14
TC 55
Z9 60
U1 3
U2 42
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
EI 1935-5548
J9 DIABETES CARE
JI Diabetes Care
PD MAY
PY 2012
VL 35
IS 5
BP 945
EP 947
DI 10.2337/dc11-1343
PG 3
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 931KN
UT WOS:000303218900003
PM 22338101
OA Green Published, Other Gold
DA 2019-01-08
ER

PT J
AU Schiotz, ML
   Bogelund, M
   Almdal, T
   Jensen, BB
   Willaing, I
AF Schiotz, M. L.
   Bogelund, M.
   Almdal, T.
   Jensen, B. B.
   Willaing, I.
TI Social support and self-management behaviour among patients with Type 2
   diabetes
SO DIABETIC MEDICINE
LA English
DT Article
DE diabetes; psychosocial problems; self-management; social network
ID CHRONIC ILLNESS; ACTIVATION; FAMILY; CARE; ASSOCIATION; OUTCOMES;
   NETWORK
AB Aims To investigate the relationship between structural and functional social support and patient activation, diabetes-related emotional distress, perceived diabetes care, self-management behaviour and HbA1c levels among patients with Type 2 diabetes. Methods Self-administered questionnaires were collected from 2572 patients with Type 2 diabetes. After adjusting for gender, age and education, Tobit and logistic regression models were used to examine associations between social network and patient activation, psychosocial problems, self-management behaviours and HbA1c levels. Results Frequent contact with friends was associated with more positive scores for activation, fewer psychosocial problems, more positive assessment of care and health-promoting self-management behaviours such as frequent exercising and frequent foot examinations. Frequent contact with family was associated with more positive assessments of care. Living with a partner was associated with lower prevalence of smoking, a higher frequency of foot examinations and higher HbA1c levels. A poor functional social network, measured as perceived lack of help in the event of severe illness, was associated with low patient activation, greater emotional distress, negative assessment of care, less health-promoting eating habits and less frequent foot examinations. Conclusions Good social support is significantly associated with health-promoting behaviours and well-being among patients with Type 2 diabetes. However, HbA1c levels are higher for cohabitant persons, indicating barriers for social support. Intervention research is needed to investigate the causal relationship between social networks and health-promoting behaviours. This knowledge should be used in clinical practice when targeting and designing education, support and care for patients with Type 2 diabetes.
C1 [Schiotz, M. L.; Almdal, T.; Jensen, B. B.; Willaing, I.] Steno Diabet Ctr, Steno Hlth Promot Ctr, DK-2820 Gentofte, Denmark.
   [Bogelund, M.] Incent Partners, Holte, Denmark.
RP Willaing, I (reprint author), Steno Diabet Ctr, Steno Hlth Promot Ctr, Niels Steensens Vej 8, DK-2820 Gentofte, Denmark.
EM iwtp@steno.dk
OI Jensen, Bjarne Bruun/0000-0002-3403-8475; Willaing,
   Ingrid/0000-0002-3082-8816
CR Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775
   Due P, 1999, SOC SCI MED, V48, P661, DOI 10.1016/S0277-9536(98)00381-5
   Funnell MM, 2008, DIABETES CARE, V31, pS97, DOI 10.2337/dc08-S097
   Gallant MP, 2007, RES AGING, V29, P375, DOI 10.1177/0164027507303169
   Gallant MP, 2003, HEALTH EDUC BEHAV, V30, P170, DOI 10.1177/1090198102251030
   Glasgow RE, 2005, DIABETES CARE, V28, P2655, DOI 10.2337/diacare.28.11.2655
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   Hibbard JH, 2004, HEALTH SERV RES, V39, P1005, DOI 10.1111/j.1475-6773.2004.00269.x
   Hibbard JH, 2007, HEALTH SERV RES, V42, P1443, DOI 10.1111/j.1475-6773.2006.00669.x
   Hibbard JH, 2007, J AMBUL CARE MANAG, V30, P2
   IDF Clinical Guidelines Task Force, 2005, GLOB GUID TYP 2 DIAB
   Jones RA, 2008, DIABETES EDUCATOR, V34, P318, DOI 10.1177/0145721708314485
   KAPLAN RM, 1987, HEALTH PSYCHOL, V6, P387, DOI 10.1037/0278-6133.6.5.387
   LEVY RL, 1983, SOC SCI MED, V17, P1329, DOI 10.1016/0277-9536(83)90192-2
   Maindal HT, 2012, EUR J PUBLIC HEALTH, V22, P31, DOI 10.1093/eurpub/ckq188
   Maindal HT, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-209
   McGuire BE, 2009, DIABETOLOGIA, V53, P66
   Mosen DM, 2007, J AMBUL CARE MANAG, V30, P21
   Nathan DM, 2008, DIABETES CARE, V31, P173, DOI 10.2337/dc08-9016
   NICE, 2008, IMPL NICE GUID COMM
   Rosland AM, 2010, CHRONIC ILLN, V6, P22, DOI 10.1177/1742395309354608
   Rosland AM, 2008, J GEN INTERN MED, V23, P1992, DOI 10.1007/s11606-008-0814-7
   SHERBOURNE CD, 1992, J BEHAV MED, V15, P447, DOI 10.1007/BF00844941
   Snoek FJ, 2011, DIABETES CARE, V34, P601, DOI 10.2337/dc10-1552
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Wooldridge JM, 2006, INTRO ECONOMETRICS M, P595
NR 26
TC 47
Z9 48
U1 1
U2 42
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0742-3071
J9 DIABETIC MED
JI Diabetic Med.
PD MAY
PY 2012
VL 29
IS 5
BP 654
EP 661
DI 10.1111/j.1464-5491.2011.03485.x
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 927LJ
UT WOS:000302908600016
PM 21992512
DA 2019-01-08
ER

PT J
AU Keen, AJA
   Duncan, E
   McKillop-Smith, A
   Evans, ND
   Gold, AE
AF Keen, A. J. A.
   Duncan, E.
   McKillop-Smith, A.
   Evans, N. D.
   Gold, A. E.
TI Dose Adjustment for Normal Eating (DAFNE) in routine clinical practice:
   who benefits?
SO DIABETIC MEDICINE
LA English
DT Article
DE education; patient education; Type 1 diabetes
ID HOSPITAL ANXIETY; DEPRESSION SCALE
AB Aims To explore the effectiveness of Dose Adjustment for Normal Eating in routine clinical practice in the UK. Methods Participants were 124 adults with Type 1 diabetes who had completed a Dose Adjustment for Normal Eating course. Data were collected before the course and again 1 year later on a variety of biological, psychological and social measures. Results There were a range of significant benefits consistent with Dose Adjustment for Normal Eating aims, including: better control among those with baseline HbA1c= 81 mmol/mol (9.6%) (z = -2.8, P = 0.004); reduced number of participants reporting severe hypoglycaemia (chi(2) = 4.27, P = 0.039); total eradication of diabetic ketoacidosis (chi(2) = 4.17, P = 0.041) and lower diabetes-related distress (z = -4.5, P < 0.001). The most deprived of the clinic population were significantly under-represented (chi(2) = 17.8, P = 0.001) and the levels of clinical depression were unusually low. Conclusions These results indicate that Dose Adjustment for Normal Eating delivered in routine clinical practice is associated with a range of benefits and that certain clinical and psychosocial characteristics are associated with better outcomes.
C1 [Keen, A. J. A.; McKillop-Smith, A.; Evans, N. D.; Gold, A. E.] Univ Aberdeen, Ctr Diabet, NHS Grampian, Aberdeen, Scotland.
   [Duncan, E.] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen, Scotland.
RP Keen, AJA (reprint author), Woolmanhill Hosp, Ctr Diabet, Aberdeen AB25 1LD, Scotland.
EM a.keen@nhs.net
CR Barnard KD, 2006, DIABETIC MED, V23, P445, DOI 10.1111/j.1464-5491.2006.01814.x
   Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3
   BLAND JM, 1994, BRIT MED J, V308, P1499, DOI 10.1136/bmj.308.6942.1499
   Collins MM, 2009, DIABETIC MED, V26, P153, DOI 10.1111/j.1464-5491.2008.02648.x
   DAFNE Study Group, BR MED J, V325, P746
   Department of Health, 2010, GEN MOD LONG TERM CO
   Department of Health, 2005, SELF CAR REAL CHOIC
   Department of Health, 2005, SUPP PEOPL LONG TERM
   Glasgow RE, 2007, ANNU REV PUBL HEALTH, V28, P413, DOI 10.1146/annurev.publhealth.28.021406.144145
   Heller SR, 2009, BR J DIABETES VASC D, V9, P269
   Hermanns N, 2006, DIABETOLOGIA, V49, P468
   Jorde R, 2000, DIABETIC MED, V17, P451, DOI 10.1046/j.1464-5491.2000.00295.x
   Newman S, 2004, LANCET, V364, P1523, DOI 10.1016/S0140-6736(04)17277-2
   Oliver L, 2009, PRACT DIAB INT, V26, P371, DOI DOI 10.1002/PDI.1424
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Redman BK, 2007, CHRONIC ILLN, V3, P88, DOI 10.1177/1742395307079196
   Rijken M, 2008, CARING PEOPLE CHRONI, V6, P116
   Speight J, 2010, DIABETES RES CLIN PR, V89, P22, DOI 10.1016/j.diabres.2010.03.017
   The EuroQol Group, 1990, HLTH POLICY, V16, P199, DOI DOI 10.1016/0168-8510(90)90421-9
   Warsi A, 2004, ARCH INTERN MED, V164, P1641, DOI 10.1001/archinte.164.15.1641
   WHO, 2008, 2008 2013 ACT PLAN G
   Yach D, 2004, JAMA-J AM MED ASSOC, V291, P2616, DOI 10.1001/jama.291.21.2616
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
NR 23
TC 13
Z9 13
U1 0
U2 5
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0742-3071
J9 DIABETIC MED
JI Diabetic Med.
PD MAY
PY 2012
VL 29
IS 5
BP 670
EP 676
DI 10.1111/j.1464-5491.2011.03479.x
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 927LJ
UT WOS:000302908600018
PM 21988559
DA 2019-01-08
ER

PT J
AU Zulman, DM
   Rosland, AM
   Choi, H
   Langa, KM
   Heisler, M
AF Zulman, Donna M.
   Rosland, Ann-Marie
   Choi, HwaJung
   Langa, Kenneth M.
   Heisler, Michele
TI The influence of diabetes psychosocial attributes and self-management
   practices on change in diabetes status
SO PATIENT EDUCATION AND COUNSELING
LA English
DT Article
DE Diabetes; Self-management; Self-efficacy; Diabetes distress
ID BLOOD-GLUCOSE CONTROL; GLYCEMIC CONTROL; CONTROLLED-TRIAL; PROBLEM
   AREAS; CARE; COMPLICATIONS; KNOWLEDGE; EFFICACY; HEALTH; BEHAVIORS
AB Objective: To examine the influence of diabetes psychosocial attributes and self-management on glycemic control and diabetes status change.
   Methods: Using data from the Health and Retirement Study, a nationally representative longitudinal study of U.S. adults >51 years, we examined cross-sectional relationships among diabetes psychosocial attributes (self-efficacy, risk awareness, care understanding, prioritization of diabetes, and emotional distress), self-management ratings, and glycemic control. We then explored whether self-management ratings and psychosocial attributes in 2003 predicted change in diabetes status in 2004.
   Results: In multivariate analyses (N = 1834), all diabetes psychosocial attributes were associated with self-management ratings, with self-efficacy and diabetes distress having the strongest relationships (adj coeff = 8.1, p < 0.01 and -4.1, p < 0.01, respectively). Lower self-management ratings in 2003 were associated cross-sectionally with higher hemoglobin A1C (adj coeff = 0.16, p < 0.01), and with perceived worsening diabetes status in 2004 (adj OR = 1.36, p < 0.05), with much of this latter relationship explained by diabetes distress.
   Conclusion: Psychosocial attributes, most notably diabetes-related emotional distress, contribute to difficulty with diabetes self-management, poor glycemic control, and worsening diabetes status over time.
   Practice implications: Self-management and adherence interventions should target psychosocial attributes such as disease-related emotional distress. Published by Elsevier Ireland Ltd.
C1 [Zulman, Donna M.] VA Palo Alto Hlth Care Syst, Ctr Hlth Care Evaluat, Menlo Pk, CA 94025 USA.
   [Zulman, Donna M.] Stanford Univ, Dept Internal Med, Div Gen Med Disciplines, Stanford, CA 94305 USA.
   [Rosland, Ann-Marie; Choi, HwaJung; Langa, Kenneth M.; Heisler, Michele] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.
   [Rosland, Ann-Marie; Langa, Kenneth M.; Heisler, Michele] Hlth Serv Res & Dev Ctr Excellence, Dept Vet Affairs, Ann Arbor, MI USA.
   [Choi, HwaJung; Heisler, Michele] Univ Michigan, Robert Wood Johnson Fdn, Clin Scholars Program, Ann Arbor, MI 48109 USA.
   [Heisler, Michele] Univ Michigan, Sch Publ Hlth, Dept Hlth Behav & Hlth Educ, Ann Arbor, MI 48109 USA.
RP Zulman, DM (reprint author), VA Palo Alto Hlth Care Syst, Ctr Hlth Care Evaluat, 795 Willow Rd,152-MPD, Menlo Pk, CA 94025 USA.
EM dzulman@stanford.edu
RI Northe, Hilda/I-1916-2012; Heisler, Michele/B-5774-2015; Rosland,
   Annmarie/B-7750-2016
OI Northe, Hilda/0000-0002-8873-5014; Heisler, Michele/0000-0002-6889-2063;
   
FU The National Institute on Aging (NIA) [U01 AG09740]; Robert Wood Johnson
   Foundation
FX The National Institute on Aging (NIA) provided funding for the Health
   and Retirement Study (HRS) (U01 AG09740), data from which were used for
   this analysis. The HRS is performed at the Institute for Social
   Research, University of Michigan. Dr. Zulman was supported by the Robert
   Wood Johnson Foundation Clinical Scholars Program and an associated VA
   Advanced Fellowship.
CR ANDERSON RM, 1995, DIABETES CARE, V18, P943, DOI 10.2337/diacare.18.7.943
   Anderson Robert M, 2009, Ther Patient Educ, V1, P3
   DeSalvo KB, 2006, QUAL LIFE RES, V15, P191, DOI 10.1007/s11136-005-0887-2
   Egede LE, 2005, CURR DIABETES REV, V1, P235, DOI 10.2174/157339905774574356
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Fitzgerald JT, 1996, EVAL HEALTH PROF, V19, P208, DOI 10.1177/016327879601900205
   Fonda Stephanie J, 2009, J Diabetes Sci Technol, V3, P117
   Hayward RA, 1997, JAMA-J AM MED ASSOC, V278, P1663, DOI 10.1001/jama.278.20.1663
   Heisler M, 2003, DIABETES CARE, V26, P738, DOI 10.2337/diacare.26.3.738
   Heisler M, 2002, J GEN INTERN MED, V17, P243, DOI 10.1046/j.1525-1497.2002.10905.x
   Heisler M, 2007, ARCH INTERN MED, V167, P1853, DOI 10.1001/archinte.167.17.1853
   Hurley A C, 1992, Diabetes Educ, V18, P146, DOI 10.1177/014572179201800208
   Jones H, 2003, DIABETES CARE, V26, P732, DOI 10.2337/diacare.26.3.732
   Karter AJ, 2001, AM J MED, V111, P1, DOI 10.1016/S0002-9343(01)00742-2
   Kerr EA, 2007, J GEN INTERN MED, V22, P1635, DOI 10.1007/s11606-007-0313-2
   King DK, 2010, DIABETES CARE, V33, P751, DOI 10.2337/dc09-1746
   Kingery P M, 1989, Health Educ, V20, P13
   Klungel OH, 2008, PRIM CARE DIABETES, V2, P25, DOI 10.1016/j.pcd.2008.01.003
   Lorig KR, 2006, MED CARE, V44, P964, DOI 10.1097/01.mlr.0000233678.80203.c1
   Maddigan SL, 2004, DIABETES CARE, V27, P1306, DOI 10.2337/diacare.27.6.1306
   McPherson ML, 2008, RES SOC ADM PHARM, V4, P37, DOI 10.1016/j.sapharm.2007.01.002
   National Institute on Aging, 2011, HLTH RET STUD LONG S
   Nelson KM, 2007, J GEN INTERN MED, V22, P442, DOI 10.1007/s11606-006-0053-8
   Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561
   Panja S, 2005, J INVEST MED, V53, P264, DOI 10.2310/6650.2005.53509
   Persell SD, 2004, PREV MED, V39, P746, DOI 10.1016/j.ypmed.2004.02.045
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Sarkar U, 2006, DIABETES CARE, V29, P823, DOI 10.2337/diacare.29.04.06.dc05-1615
   Scollan-Koliopoulos M, 2010, DIABETES EDUCATOR, V36, P473, DOI 10.1177/0145721710362108
   SHAMOON H, 1993, NEW ENGL J MED, V329, P977
   Sousa Valmi D, 2005, Res Theory Nurs Pract, V19, P217, DOI 10.1891/rtnp.2005.19.3.217
   Steffic D, 2000, DOCUMENTATION AFFECT
   Stolar M, 2010, AM J MED, V123, pS3, DOI 10.1016/j.amjmed.2009.12.004
   Trief PM, 2009, AGE AGEING, V38, P219, DOI 10.1093/ageing/afn299
   Turner RC, 1998, LANCET, V352, P837
   Weinger K, 2005, DIABETES CARE, V28, P1346, DOI 10.2337/diacare.28.6.1346
   Welch G, 2003, DIABETIC MED, V20, P69, DOI 10.1046/j.1464-5491.2003.00832.x
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
NR 40
TC 26
Z9 27
U1 1
U2 10
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0738-3991
J9 PATIENT EDUC COUNS
JI Patient Educ. Couns.
PD APR
PY 2012
VL 87
IS 1
BP 74
EP 80
DI 10.1016/j.pec.2011.07.013
PG 7
WC Public, Environmental & Occupational Health; Social Sciences,
   Interdisciplinary
SC Public, Environmental & Occupational Health; Social Sciences - Other
   Topics
GA 930YX
UT WOS:000303182000013
PM 21840149
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Dennedy, MC
   Avalos, G
   O'Reilly, MW
   O'Sullivan, EP
   Gaffney, G
   Dunne, F
AF Dennedy, Michael Conall
   Avalos, Gloria
   O'Reilly, Michael W.
   O'Sullivan, Eoin P.
   Gaffney, Geraldine
   Dunne, Fidelma
TI ATLANTIC-DIP: Raised Maternal Body Mass Index (BMI) Adversely Affects
   Maternal and Fetal Outcomes in Glucose-Tolerant Women According to
   International Association of Diabetes and Pregnancy Study Groups
   (IADPSG) Criteria
SO JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
LA English
DT Article
ID WEIGHT-GAIN; SHORT-TERM; OBESITY; IMPACT; METAANALYSIS; PREVALENCE;
   MELLITUS
AB Context: Raised maternal body mass index (BMI) in association with hyperglycemia is associated with adverse pregnancy outcome. The contribution of raised BMI as an independent risk factor for adverse pregnancy outcome is of growing concern and increasing prevalence.
   Objective: The aim of this study was to investigate the effects of raised maternal BMI on pregnancy outcome in glucose-tolerant women using the International Association of Diabetes and Pregnancy Study Groups criteria.
   Participants and Setting: We studied a cohort of glucose-tolerant, pregnant women (n = 3656) who were attending antenatal obstetric clinics and were recruited to a universal screening program for gestational diabetes under the ATLANTIC-DIP partnership.
   Design: We conducted a prospective observational study of pregnancy outcome. Maternal outcomes include glucose, delivery mode, pregnancy-induced hypertension, preeclampsia, antepartum hemorrhage, and postpartum hemorrhage. Fetal outcomes included birth weight, congenital malformation, fetal death, neonatal jaundice, hypoglycemia, and respiratory distress.
   Results: Increasing maternal BMI was associated with adverse pregnancy outcomes: higher cesarean section rates, preeclampsia, pregnancy-induced hypertension, increased birth weight, and congenital malformation. The association of glucose with adverse pregnancy outcome was weak and did not interact with raised BMI. A BMI threshold of 28 kg/m(2) was associated with a significant rise in adverse pregnancy outcome.
   Conclusions: Raised maternal BMI, within the overweight range, is associated with adverse pregnancy outcomes. These adverse effects of BMI occur independently of maternal glucose. It is apparent that pregnancy unmasks an underlying unhealthy metabolic milieu in obese and overweight women. (J Clin Endocrinol Metab 97: E608-E612, 2012)
C1 [Dennedy, Michael Conall] Natl Univ Ireland, Dept Med, Inst Clin Sci, Dept Endocrinol, Galway, Ireland.
   [Gaffney, Geraldine] Natl Univ Ireland, Dept Obstet & Gynecol, Galway, Ireland.
RP Dennedy, MC (reprint author), Natl Univ Ireland, Dept Med, Inst Clin Sci, Dept Endocrinol, Galway, Ireland.
EM cdennedy@me.com
OI O'Reilly, Michael/0000-0002-9108-9105; Dennedy,
   Michael/0000-0001-9325-6520
FU Health Research Board of Ireland
FX This work was supported by the Health Research Board of Ireland.
CR Catalano PM, 2006, BJOG-INT J OBSTET GY, V113, P1126, DOI 10.1111/j.1471-0528.2006.00989.x
   Dennedy MC, 2010, BEST PRACT RES CL EN, V24, P573, DOI 10.1016/j.beem.2010.06.001
   Fitzsimons KJ, 2010, SEMIN FETAL NEONAT M, V15, P100, DOI 10.1016/j.siny.2009.09.004
   Heslehurst N, 2008, OBES REV, V9, P635, DOI 10.1111/j.1467-789X.2008.00511.x
   Heslehurst N, 2007, BJOG-INT J OBSTET GY, V114, P334, DOI 10.1111/j.1471-0528.2006.01230.x
   Heslehurst N, 2007, BJOG-INT J OBSTET GY, V114, P187, DOI 10.1111/j.1471-0528.2006.01180.x
   Huda SS, 2010, SEMIN FETAL NEONAT M, V15, P70, DOI 10.1016/j.siny.2009.09.006
   Jensen DM, 2005, DIABETES CARE, V28, P2118, DOI 10.2337/diacare.28.9.2118
   Jensen DM, 2003, AM J OBSTET GYNECOL, V189, P239, DOI 10.1067/mob.2003.441
   Lederman SA, 1997, OBSTET GYNECOL, V90, P483, DOI 10.1016/S0029-7844(97)00355-4
   Lewis G, 2007, SAVING MOTHERS LIVES
   Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943
   Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848
   Modder J., 2010, CMACE RCOG JOINT GUI
   National Institute for Health and Clinical Excellence, 2010, DIET INT PHYS ACT IN
   O'Reilly MW, 2011, EUR J ENDOCRINOL, V165, P953, DOI 10.1530/EJE-11-0663
   O'Sullivan EP, 2011, DIABETOLOGIA, V54, P1670, DOI 10.1007/s00125-011-2150-4
   Owens LA, 2010, DIABETES CARE, V33, P577, DOI 10.2337/dc09-0911
   PEDERSEN J, 1952, Ugeskr Laeger, V114, P685
   Stothard KJ, 2009, JAMA-J AM MED ASSOC, V301, P636, DOI 10.1001/jama.2009.113
NR 20
TC 30
Z9 31
U1 0
U2 3
PU ENDOCRINE SOC
PI CHEVY CHASE
PA 8401 CONNECTICUT AVE, SUITE 900, CHEVY CHASE, MD 20815-5817 USA
SN 0021-972X
J9 J CLIN ENDOCR METAB
JI J. Clin. Endocrinol. Metab.
PD APR
PY 2012
VL 97
IS 4
BP E608
EP E612
DI 10.1210/jc.2011-2674
PG 5
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 925US
UT WOS:000302787800012
PM 22319044
OA Bronze
DA 2019-01-08
ER

PT J
AU Nefs, G
   Pouwer, F
   Pop, V
   Denollet, J
AF Nefs, Giesje
   Pouwer, Francois
   Pop, Victor
   Denollet, Johan
TI Type D (distressed) personality in primary care patients with type 2
   diabetes: Validation and clinical correlates of the DS14 assessment
SO JOURNAL OF PSYCHOSOMATIC RESEARCH
LA English
DT Article
DE Clinical care; Personality; Psychology; Type 2 diabetes; Validation
ID CORONARY-HEART-DISEASE; NEGATIVE AFFECTIVITY; SOCIAL INHIBITION;
   CARDIOVASCULAR-DISEASE; DEPRESSION SCALE; RISK-FACTORS; ANXIETY;
   PREVALENCE; MECHANISMS; OUTCOMES
AB Objective: In cardiovascular research, Type D personality (high negative affectivity and social inhibition) has been associated with a more than 3-fold increased risk of adverse health outcomes. This study examined the validity and clinical correlates of the Type D construct as assessed by the Type D Scale-14 (DS14) in type 2 diabetes patients.
   Methods: 1553 primary care patients with type 2 diabetes were assessed for demographic, clinical, lifestyle and psychological characteristics in 2007. A subgroup (n=1012) completed the DS14 again 1 year later.
   Results: The two-factor model of the Type D construct was confirmed in exploratory and confirmatory factor analyses; results were stable across gender. The Negative Affectivity (NA) and Social Inhibition (SI) subscales had adequate reliability in both men and women, as measured by Cronbach's alpha (NA=0.87, SI=0.83), lambda2 (NA=0.87/0.88, SI=0.84), corrected item-total correlations (NA 0.47-0.77, SI 0.34-0.72) and mean inter-item correlations (NA=0.50/0.51, SI=0.42). One year test-retest reliability using intraclass correlation coefficients was 0.64/0.63 for NA and 0.73/0.65 for SI. Type D and non-Type D patients did not differ in vascular history or physiological risk factors, but Type D women had a more sedentary lifestyle (p=.003). Type D patients experienced less social support and more stressful life events, loneliness, and more depressed mood, anhedonia and anxiety (p<.001 for most variables). These differences were clinically significant (Cohen's d>0.60 for most variables).
   Conclusion: Type D personality can be reliably assessed in primary care patients with type 2 diabetes, and is associated with increased loneliness, stress and emotional distress in these patients. (C) 2012 Elsevier Inc. All rights reserved.
C1 [Nefs, Giesje; Pouwer, Francois; Pop, Victor; Denollet, Johan] Tilburg Univ, Ctr Res Psychol Somat Dis CoRPS, Dept Med Psychol & Neuropsychol, NL-5000 LE Tilburg, Netherlands.
RP Denollet, J (reprint author), Tilburg Univ, Ctr Res Psychol Somat Dis CoRPS, Dept Med Psychol & Neuropsychol, POB 90153, NL-5000 LE Tilburg, Netherlands.
EM denollet@uvt.nl
RI Nefs, Giesje/C-9992-2018
FU Netherlands Organisation for Health Research and Development;
   Netherlands Organisation for Scientific Research (The Hague, The
   Netherlands)
FX This study was supported by a ZonMW grant from the Netherlands
   Organisation for Health Research and Development and by a Vici grant
   from the Netherlands Organisation for Scientific Research (The Hague,
   The Netherlands). The funding sources had no role in the design, data
   collection, analysis or interpretation of the study, or in the decision
   to submit the article for publication. G.N; F.P., V.P. and J.D. wrote
   the manuscript, researched data, reviewed/edited the manuscript and
   contributed to the discussion.
CR Bergvik S, 2010, SCAND J PSYCHOL, V51, P334, DOI 10.1111/j.1467-9450.2009.00793.x
   Black SA, 2003, DIABETES CARE, V26, P2822, DOI 10.2337/diacare.26.10.2822
   Brown T. A., 2006, CONFIRMATORY FACTOR
   Denollet J, 2006, EUR HEART J, V27, P171, DOI 10.1093/eurheartj/ehi616
   Denollet J, 2005, PSYCHOSOM MED, V67, P89, DOI 10.1097/01.psy.0000149256.81953.49
   Denollet J, 2010, CIRC-CARDIOVASC QUAL, V3, P546, DOI 10.1161/CIRCOUTCOMES.109.934406
   Einvik G, 2011, EUR J CARDIOV PREV R, V18, P504, DOI 10.1177/1741826710389383
   Emons WHM, 2007, J PSYCHOSOM RES, V63, P27, DOI 10.1016/j.jphyschores.2007.03.010
   Hausteiner C, 2010, PSYCHOSOM MED, V72, P163, DOI 10.1097/PSY.0b013e3181cb8bae
   Kubzansky LD, 2006, ANN BEHAV MED, V31, P21, DOI 10.1207/s15324796abm3101_5
   Kupper N, 2007, J PERS ASSESS, V89, P265, DOI 10.1080/00223890701629797
   Lin EHB, 2010, DIABETES CARE, V33, P264, DOI 10.2337/dc09-1068
   Marshall SM, 2006, BRIT MED J, V333, P475, DOI 10.1136/bmj.38922.650521.80
   Martens EJ, 2007, J PSYCHOSOM RES, V63, P545, DOI 10.1016/j.jpsychores.2007.06.005
   McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037//1082-989X.1.1.30
   Mols F, 2010, GEN HOSP PSYCHIAT, V32, P66, DOI 10.1016/j.genhosppsych.2009.09.010
   Mols F, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-9
   Mommersteeg PMC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-714
   Nefs G, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-388
   OHARA MW, 1986, ARCH GEN PSYCHIAT, V43, P569
   Pedersen SS, 2007, EUR J CARDIOV PREV R, V14, P135, DOI 10.1097/HJR.0b013e328045c282
   Pedersen SS, 2009, INT J BEHAV MED, V16, P108, DOI 10.1007/s12529-008-9022-4
   Pelle AJ, 2010, INT J CARDIOL, V142, P65, DOI 10.1016/j.ijcard.2008.12.086
   POP VJ, 1992, J AFFECT DISORDERS, V26, P105, DOI 10.1016/0165-0327(92)90041-4
   Pouwer F, 2009, NAT REV ENDOCRINOL, V5, P665, DOI 10.1038/nrendo.2009.214
   Roest AM, 2010, PSYCHOSOM MED, V72, P563, DOI 10.1097/PSY.0b013e3181dbff97
   Roest AM, 2010, J AM COLL CARDIOL, V56, P38, DOI 10.1016/j.jacc.2010.03.034
   Simson U, 2008, PSYCHOTHER PSYCH MED, V58, P44, DOI 10.1055/s-2007-971001
   Smith LL, 1998, J PERS SOC PSYCHOL, V75, P1350, DOI 10.1037/0022-3514.75.5.1350
   Spindler H, 2009, INT J BEHAV MED, V16, P98, DOI 10.1007/s12529-009-9037-5
   Streiner DL, 2008, HLTH MEASUREMENT SCA
   Svansdottir E, 2012, J BEHAV MED, V35, P155, DOI 10.1007/s10865-011-9337-5
   Tuohy A, 2008, BRIT J CLIN PSYCHOL, V47, P153, DOI 10.1348/014466507X238608
   Van der Kooy K, 2007, INT J GERIATR PSYCH, V22, P613, DOI 10.1002/gps.1723
   Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1
   Williams L, 2008, J PSYCHOSOM RES, V64, P63, DOI 10.1016/j.jpsychores.2007.06.008
   Williams L, 2011, PSYCHOL HEALTH, V26, P703, DOI 10.1080/08870446.2010.488265
   Yu DSF, 2010, J PSYCHOSOM RES, V69, P111, DOI 10.1016/j.jpsychores.2010.01.014
NR 38
TC 19
Z9 20
U1 1
U2 13
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0022-3999
EI 1879-1360
J9 J PSYCHOSOM RES
JI J. Psychosomat. Res.
PD APR
PY 2012
VL 72
IS 4
BP 251
EP 257
DI 10.1016/j.jpsychores.2012.01.006
PG 7
WC Psychiatry
SC Psychiatry
GA 910FG
UT WOS:000301622000002
PM 22405217
DA 2019-01-08
ER

PT J
AU Atlantis, E
   Shi, ZM
   Penninx, BJWH
   Wittert, GA
   Taylor, A
   Almeida, OP
AF Atlantis, Evan
   Shi, Zumin
   Penninx, Brenda J. W. H.
   Wittert, Gary A.
   Taylor, Anne
   Almeida, Osvaldo P.
TI Chronic medical conditions mediate the association between depression
   and cardiovascular disease mortality
SO SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY
LA English
DT Article
DE Depressive symptoms; Chronic diseases; Comorbidity; High blood pressure;
   Diabetes; Heart disease; Death
ID CORONARY-HEART-DISEASE; HEALTHY AGING MELSHA; NATIONAL DEATH INDEX;
   SCALE CES-D; MYOCARDIAL-INFARCTION; PSYCHOLOGICAL DISTRESS;
   OLDER-ADULTS; ENDOTHELIAL FUNCTION; PHYSICAL ILLNESS; RANDOMIZED-TRIAL
AB To determine whether chronic medical conditions mediate the association between depression and cardiovascular disease (CVD) mortality.
   Data analyzed were from 6,394 subjects aged 25-74 years who participated in extensive health examinations in the NHEFS conducted between 1971 and 1975 and follow-up studies to 1992. CVD mortality was the endpoint. Depression predictors were clinically significant depressive symptoms at baseline by the GWB-D, and/or at 1982-1984 by the CES-D ('baseline', 'new', or 'twice' depression). Chronic conditions were prevalent/incident high blood pressure, diabetes, and non-fatal CVD by examination and/or self-report. Mediation effects were assessed by stepwise adjustments of covariates and additive interactions in competing risks regression models (accounting for other mortality causes) and logit models.
   Baseline, new, and twice depression were significant predictors of CVD mortality in competing-risks models adjusted for demographics (HRs 1.3, 1.4, and 2.0), but effects were progressively weakened and became non-significant after adjustment for lifestyle factors, prevalent and incident medical conditions, respectively. CVD mortality risk was 80% higher for depression plus incident non-fatal CVD than without (HR 4.0 vs. 3.2, additive interaction), and mediation effects of depression via chronic medical conditions (particularly via incident non-fatal CVD) increased the risk by 2-11% in logit models, independent of all covariates.
   Several levels of evidence suggest that the association between depression and CVD mortality is partially mediated by prevalent/incident chronic medical conditions, as well as unhealthy lifestyle behaviors. Patients presenting with clinically significant depressive symptoms, particularly if persistent, should be assessed for both chronic conditions and lifestyle risk factors.
C1 [Atlantis, Evan; Wittert, Gary A.] Govt S Australia, S Australia Hlth, Royal Adelaide Hosp, Inst Med & Vet Sci, Adelaide, SA, Australia.
   [Atlantis, Evan; Wittert, Gary A.] Univ Adelaide, Sch Med, Freemasons Fdn Ctr Mens Hlth, Adelaide, SA, Australia.
   [Wittert, Gary A.] Univ Adelaide, Sch Med, Ctr Clin Res Excellence Nutr Physiol Intervent &, Adelaide, SA, Australia.
   [Penninx, Brenda J. W. H.] Vrije Univ Amsterdam Med Ctr, Dept Psychiat, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands.
   [Almeida, Osvaldo P.] Univ Western Australia, Sch Psychiat & Clin Neurosci, Western Australian Ctr Hlth & Ageing, Med Res Ctr, Perth, WA 6009, Australia.
   [Almeida, Osvaldo P.] Royal Perth Hosp, Dept Psychiat, Perth, WA, Australia.
RP Atlantis, E (reprint author), Govt S Australia, S Australia Hlth, Royal Adelaide Hosp, Inst Med & Vet Sci, Adelaide, SA, Australia.
EM evan.atlantis@adelaide.edu.au
RI Taylor, Anne/F-5708-2010; Almeida, Osvaldo/A-4925-2008; Shi,
   Zumin/A-1093-2009; Atlantis, Evan/D-8338-2012
OI Taylor, Anne/0000-0002-4422-7974; Almeida, Osvaldo/0000-0002-8689-6199;
   Shi, Zumin/0000-0002-3099-3299; Atlantis, Evan/0000-0001-5877-6141
CR Akbaraly TN, 2009, BRIT J PSYCHIAT, V195, P408, DOI 10.1192/bjp.bp.108.058925
   Atlantis E, 2011, SOC PSYCH PSYCH EPID, V46, P1303, DOI 10.1007/s00127-010-0302-3
   Atlantis E, 2011, INT J GERIATR PSYCH, V26, P341, DOI 10.1002/gps.2532
   Atlantis E, 2010, INT J GERIATR PSYCH, V25, P688, DOI 10.1002/gps.2409
   Bao AM, 2008, BRAIN RES REV, V57, P531, DOI 10.1016/j.brainresrev.2007.04.005
   Barton DA, 2007, J HYPERTENS, V25, P2117, DOI 10.1097/HJH.0b013e32829baae7
   Beekman ATF, 1997, PSYCHOL MED, V27, P231, DOI 10.1017/S0033291796003510
   Berkman LF, 2003, JAMA-J AM MED ASSOC, V289, P3106
   Buis ML, 2010, STATA J, V10, P11, DOI 10.1177/1536867X1001000104
   Campayo A, 2010, AM J PSYCHIAT, V167, P580, DOI 10.1176/appi.ajp.2009.09010038
   Centers for Disease Control and Prevention, 2009, NAT HLTH NUTR EX SUR
   Dahl CAF, 2010, SOC PSYCH PSYCH EPID, V45, P309, DOI 10.1007/s00127-009-0069-6
   de Jonge P, 2007, AM J PSYCHIAT, V164, P1371, DOI 10.1176/appi.apj.2007.06091492
   Fazio A F, 1977, Vital Health Stat 2, P1
   Ferketich AK, 2000, ARCH INTERN MED, V160, P1261, DOI 10.1001/archinte.160.9.1261
   Gallo JJ, 2007, ANN INTERN MED, V146, P689, DOI 10.7326/0003-4819-146-10-200705150-00002
   Gunn JM, 2012, SOC PSYCH PSYCH EPID, V47, P175, DOI 10.1007/s00127-010-0330-z
   Haukkala A, 2009, ANN EPIDEMIOL, V19, P623, DOI 10.1016/j.annepidem.2009.01.010
   Howren MB, 2009, PSYCHOSOM MED, V71, P171, DOI 10.1097/PSY.0b013e3181907c1b
   Lewinsohn PM, 1997, PSYCHOL AGING, V12, P277, DOI 10.1037//0882-7974.12.2.277
   Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667
   Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2
   Mapppsy LKR, 2008, DIABETES CARE, V31, P880, DOI 10.2337/dc07-2215
   Marzari C, 2005, J GERONTOL A-BIOL, V60, P85, DOI 10.1093/gerona/60.1.85
   Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985
   Musselman DL, 2000, ARCH GEN PSYCHIAT, V57, P875, DOI 10.1001/archpsyc.57.9.875
   Nabi H, 2008, ARTERIOSCL THROM VAS, V28, P1398, DOI 10.1161/ATVBAHA.108.167239
   Nicholson A, 2005, PSYCHOSOM MED, V67, P522, DOI 10.1097/01.psy.0000171159.86446.9e
   Nicholson A, 2006, EUR HEART J, V27, P2763, DOI 10.1093/eurheartj/ehl338
   Parker G, 2009, BRIT J PSYCHIAT, V194, P1, DOI 10.1192/bjp.bp.108.054767
   Pasco JA, 2008, BRIT J PSYCHIAT, V193, P322, DOI 10.1192/bip.bp.107.046706
   Patten SB, 2009, GEN HOSP PSYCHIAT, V31, P571, DOI 10.1016/j.genhosppsych.2009.08.001
   Patton GC, 1998, AM J PUBLIC HEALTH, V88, P1518, DOI 10.2105/AJPH.88.10.1518
   Penninx BWJH, 2001, ARCH GEN PSYCHIAT, V58, P221, DOI 10.1001/archpsyc.58.3.221
   Pizzi C, 2009, CLIN PHARMACOL THER, V86, P527, DOI 10.1038/clpt.2009.121
   Pizzi C, 2008, EUR HEART J, V29, P1110, DOI 10.1093/eurheartj/ehn137
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Rasul F, 2007, PSYCHOL MED, V37, P1305, DOI 10.1017/S0033291707000402
   Rasul F, 2005, J EPIDEMIOL COMMUN H, V59, P140, DOI 10.1136/jech.2004.019786
   RICHEDWARDS JW, 1994, AM J EPIDEMIOL, V140, P1016, DOI 10.1093/oxfordjournals.aje.a117191
   Sauer WH, 2003, CIRCULATION, V108, P32, DOI 10.1161/01.CIR.0000079172.43229.CD
   STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804
   Strawbridge WJ, 2002, AM J EPIDEMIOL, V156, P328, DOI 10.1093/aje/kwf047
   Thombs BD, 2008, JAMA-J AM MED ASSOC, V300, P2161, DOI 10.1001/jama.2008.667
   Thurston RC, 2006, PSYCHOSOM MED, V68, P25, DOI 10.1097/01.psy.0000195883.68888.68
   Van der Kooy K, 2007, INT J GERIATR PSYCH, V22, P613, DOI 10.1002/gps.1723
   Whooley MA, 2008, JAMA-J AM MED ASSOC, V300, P2379, DOI 10.1001/jama.2008.711
   Wouts L, 2008, ARCH GEN PSYCHIAT, V65, P596, DOI 10.1001/archpsyc.65.5.596
   Ziegelstein RC, 2000, ARCH INTERN MED, V160, P1818, DOI 10.1001/archinte.160.12.1818
   ZONDERMAN AB, 1989, JAMA-J AM MED ASSOC, V262, P1191, DOI 10.1001/jama.262.9.1191
NR 50
TC 18
Z9 18
U1 0
U2 15
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0933-7954
EI 1433-9285
J9 SOC PSYCH PSYCH EPID
JI Soc. Psychiatry Psychiatr. Epidemiol.
PD APR
PY 2012
VL 47
IS 4
BP 615
EP 625
DI 10.1007/s00127-011-0365-9
PG 11
WC Psychiatry
SC Psychiatry
GA 912HI
UT WOS:000301786400012
PM 21384119
DA 2019-01-08
ER

PT J
AU Eriksson, AK
   Ekbom, A
   Hilding, A
   Ostenson, CG
AF Eriksson, Anna-Karin
   Ekbom, Anders
   Hilding, Agneta
   Ostenson, Claes-Goran
TI The influence of non-response in a population-based cohort study on type
   2 diabetes evaluated by the Swedish Prescribed Drug Register
SO EUROPEAN JOURNAL OF EPIDEMIOLOGY
LA English
DT Article
DE Cohort; Lifestyle; Non-participation; Screening; Selection bias; Type 2
   diabetes
ID MIDDLE-AGED MEN; SCREENING-PROGRAM; FAMILY-HISTORY; GLUCOSE; SWEDEN;
   WOMEN; LIFE; PRESCRIPTION; PREVALENCE; ATTENDANCE
AB Bias due to non-response in observational studies may lead to false risk estimates. We evaluated potential selective non-response in Stockholm Diabetes Prevention Program (SDPP) using a population-based drug register. A cohort of 12,952 men and 19,416 women, aged 35-56 years, was screened for diabetes and family history of diabetes (FHD). Response rate: 79% in men and 85% in women. Of the 4,209 men and 6,916 women that were invited, 70 and 68% participated in a baseline health examination including oral glucose tolerance test. A follow-up was performed in 79% of male and 70% of female baseline participants. We used data from the prescription register to estimate absolute risks and ORs for drug-treated diabetes in the non-response/non-participation groups. At both screening and baseline steps absolute risks of drug-treated diabetes were equal in non-participants and participants. Adjusted ORs were 0.9-1.0. At follow-up, absolute risks were higher among non-participants than participants, men 6.2/4.4% and women 2.6/1.6%, adjusted ORs 1.4 (0.9-2.3) and 1.5 (0.9-2.4), suggesting selective non-participation. Further analyses of FHD, smoking, physical activity, socioeconomic position and psychological distress demonstrated no previous false risk estimates for type 2 diabetes. However, for body mass index, there were indications of overestimation in women. We conclude that bias from non-response was not present at screening or baseline steps, suggesting that diabetes prevalence and risks may be estimated from a population-based cohort study with high attendance rate such as the SDPP. However, follow-up data should be treated with some caution, since the sample may have become biased.
C1 [Eriksson, Anna-Karin; Ekbom, Anders] Karolinska Univ Hosp, Dept Med, Clin Epidemiol Unit, Karolinska Inst, S-17176 Stockholm, Sweden.
   [Hilding, Agneta; Ostenson, Claes-Goran] Karolinska Inst, Dept Mol Med & Surg, Endocrine & Diabet Unit, Stockholm, Sweden.
RP Eriksson, AK (reprint author), Karolinska Univ Hosp, Dept Med, Clin Epidemiol Unit, Karolinska Inst, T2 Eugeniahemmet, S-17176 Stockholm, Sweden.
EM anna-karin.eriksson@karolinska.se
FU Stockholm County Council; Swedish Council of Working Life and Social
   Research; Novo Nordisk Scandinavia
FX This study was supported by grants from Stockholm County Council,
   Swedish Council of Working Life and Social Research, and Novo Nordisk
   Scandinavia. The authors thank the nurses, technicians and other staff
   members at the health-care centres and the laboratory who carried out
   the oral glucose tolerance tests and other measurements.
CR Agardh EE, 2007, INT J EPIDEMIOL, V36, P84, DOI 10.1093/ije/dyl269
   Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
   BERGMAN U, 1984, ACTA MED SCAND, P15
   Carlsson S, 1999, DIABETES CARE, V22, P1043, DOI 10.2337/diacare.22.7.1043
   Cowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062
   Dalsgaard EM, 2009, DIABETIC MED, V26, P518, DOI 10.1111/j.1464-5491.2009.02715.x
   Eriksson AK, 2008, DIABETIC MED, V25, P834, DOI 10.1111/j.1464-5491.2008.02463.x
   FORREST RD, 1990, J INTERN MED, V228, P267, DOI 10.1111/j.1365-2796.1990.tb00230.x
   Hilding A, 2006, DIABETOLOGIA, V49, P2589, DOI 10.1007/s00125-006-0402-5
   Juel K, 2008, J PUBLIC HEALTH-UK, V30, P111, DOI 10.1093/pubmed/fdm072
   Lagerlund M, 2000, EUR J CANCER PREV, V9, P25, DOI 10.1097/00008469-200002000-00004
   Larsen IK, 2006, EUR J CANCER PREV, V15, P10, DOI 10.1097/01.cej.0000186636.27496.bb
   Rodvall Y, 2005, EUR J CANCER PREV, V14, P459, DOI 10.1097/01.cej.0000178078.21910.da
   Rothman KJ, 2008, MODERN EPIDEMIOLOGY
   Sargeant LA, 2010, DIABETIC MED, V27, P995, DOI 10.1111/j.1464-5491.2010.03056.x
   Stalhammar J, 2001, SCAND J PRIM HEALTH, V19, P163
   Statistics Sweden, 2005, SWED SOC CLASS
   WALINDER O, 1986, UPSALA J MED SCI, V91, P89, DOI 10.3109/03009738609178494
   Wandell PE, 1997, EUR J CLIN PHARMACOL, V52, P249, DOI 10.1007/s002280050285
   Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294
NR 20
TC 7
Z9 7
U1 0
U2 2
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0393-2990
J9 EUR J EPIDEMIOL
JI Eur. J. Epidemiol.
PD MAR
PY 2012
VL 27
IS 3
BP 153
EP 162
DI 10.1007/s10654-011-9630-1
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 958EH
UT WOS:000305218800001
PM 22089424
DA 2019-01-08
ER

PT J
AU Dalfra, MG
   Nicolucci, A
   Bisson, T
   Bonsembiante, B
   Lapolla, A
AF Dalfra, M. G.
   Nicolucci, A.
   Bisson, T.
   Bonsembiante, B.
   Lapolla, A.
CA QLISG
TI Quality of life in pregnancy and post-partum: a study in diabetic
   patients
SO QUALITY OF LIFE RESEARCH
LA English
DT Article
DE Quality of life; Pregnancy; Gestational diabetes; Type 1 diabetes
   mellitus; Insulin therapy
ID EMOTIONAL ADJUSTMENT; DEPRESSION; MELLITUS; EXPERIENCES; DIAGNOSIS;
   SYMPTOMS; IMPACT
AB Purpose We evaluated quality of life in pregnant women with diabetes followed up at Italian diabetes clinics.
   Methods A total of 245 pregnant women (30 type 1 diabetes mellitus (T1DM), 176 gestational diabetes (GDM) and 39 controls) were asked to fill in a questionnaire including the SF-36 Health Survey and the Center for Epidemiological Studies-Depression (CES-D) Scale in third trimester of pregnancy and after delivery. GDM and T1DM also completed two diabetes-specific questionnaires (Diabetes-related stress and Diabetes health distress). Quality of life scores were compared between the groups with the Mann-Whitney U-test, mean changes in scores (after delivery to 3rd trimester) were compared between groups by ANCOVA.
   Results Regarding the SF-36 scores in the third trimester of pregnancy, T1DM and GDM women had a better Standardised Physical Component score than controls (P < 0.0001, P = 0.009, respectively). GDM and T1DM pregnant women scored significantly lower for general health perception than controls (P = 0.009 and P = 0.001, respectively). T1DM patients had lower Standardised Mental Component scores than controls (P = 0.03). Compared with the third trimester of pregnancy, the severity of depressive symptoms increased significantly after delivery in both diabetic groups, but not in controls (P < 0.0001). Scores improved in all SF-36 areas in healthy and GDM women, while they all became worse in the T1DM group.
   Conclusions Pregnancy is associated with a perception of poor general health in women with both T1DM and GDM. After delivery, significantly worse depressive symptoms were documented in both groups, while a generally worse physical and psychological well-being was only identified in women with T1DM. These findings have important implications for pregnancy follow-up.
C1 [Dalfra, M. G.; Bisson, T.; Bonsembiante, B.; Lapolla, A.] Univ Padua, DPT Sci Med & Chirurg, I-35128 Padua, Italy.
   [Nicolucci, A.] Consorzio Mario Negri Sud, DPT Farmacol Clin & Epidemiol, Chieti, Italy.
RP Lapolla, A (reprint author), Univ Padua, DPT Sci Med & Chirurg, Via Giustiniani 2, I-35128 Padua, Italy.
EM annunziata.lapolla@unipd.it
OI VITACOLONNA, Ester/0000-0003-1756-661X
CR American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS76
   Apolone G, 1998, J CLIN EPIDEMIOL, V51, P1025, DOI 10.1016/S0895-4356(98)00094-8
   Bradley C, 2002, DIABETES METAB RES, V18, pS64, DOI 10.1002/dmrr.279
   CARPENTER MW, 1982, AM J OBSTET GYNECOL, V144, P768, DOI 10.1016/0002-9378(82)90349-0
   Chida Y, 2008, DIABETOLOGIA, V51, P2168, DOI 10.1007/s00125-008-1154-1
   COMSTOCK GW, 1976, PSYCHOL MED, V6, P551
   De Berardis G, 2002, DIABETES CARE, V25, P284, DOI 10.2337/diacare.25.2.284
   DUNN SM, 1986, DIABETES CARE, V9, P480, DOI 10.2337/diacare.9.5.480
   Franciosi M, 2001, DIABETES CARE, V24, P1870, DOI 10.2337/diacare.24.11.1870
   GREENFIELD S, 1994, DIABETES CARE, V17, P32
   Halkoaho A, 2010, EUR J OBSTET GYN R B, V148, P40, DOI 10.1016/j.ejogrb.2009.09.025
   Horwitz SM, 2007, J WOMENS HEALTH, V16, P678, DOI 10.1089/jwh.2006.0185
   Kamysheva E, 2008, BODY IMAGE, V5, P152, DOI 10.1016/j.bodyim.2007.12.005
   Kim C, 2005, J WOMENS HEALTH, V14, P729, DOI 10.1089/jwh.2005.14.729
   Kim C, 2002, DIABETES CARE, V25, P1862, DOI 10.2337/diacare.25.10.1862
   Lacasse A, 2008, BJOG-INT J OBSTET GY, V115, P1484, DOI 10.1111/j.1471-0528.2008.01891.x
   Langer N, 2000, DIABETES EDUCATOR, V26, P667, DOI 10.1177/014572170002600414
   LANGER N, 1994, OBSTET GYNECOL, V84, P329
   Metzger BE, 2007, DIABETES CARE, V30, pS251, DOI 10.2337/dc07-s225
   Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Rumbold AR, 2002, AUST NZ J OBSTET GYN, V42, P131, DOI 10.1111/j.0004-8666.2002.00131.x
   Samsa G, 1999, PHARMACOECONOMICS, V15, P141, DOI 10.2165/00019053-199915020-00003
   SPIRITO A, 1989, OBSTET GYNECOL, V73, P562
   Ware JE, 1993, SF 36 HLTH SURVEY MA
   Ware JE, 1994, SF 36 PHYS MENTAL HL
NR 26
TC 34
Z9 35
U1 0
U2 12
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0962-9343
J9 QUAL LIFE RES
JI Qual. Life Res.
PD MAR
PY 2012
VL 21
IS 2
BP 291
EP 298
DI 10.1007/s11136-011-9940-5
PG 8
WC Health Care Sciences & Services; Health Policy & Services; Public,
   Environmental & Occupational Health
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA 933YX
UT WOS:000303404500011
PM 21633879
DA 2019-01-08
ER

PT J
AU Fisher, L
   Hessler, D
   Naranjo, D
   Polonsky, W
AF Fisher, Lawrence
   Hessler, Danielle
   Naranjo, Diana
   Polonsky, William
TI AASAP: A program to increase recruitment and retention in clinical
   trials
SO PATIENT EDUCATION AND COUNSELING
LA English
DT Article
DE Recruitment; Clinical trials; Retention; Diabetes
ID SOCIAL-EXCHANGE; FOLLOW-UP; ATTRITION; RATES
AB Objective: To evaluate a theory based, subject-centered, staff/subject communication program, AASAP (anticipate, acknowledge, standardize, accept, plan), to increase recruitment and retention in RCTs.
   Methods: AASAP was evaluated with logistical regression by comparing rates of recruitment (at telephone screening, baseline assessment, initial intervention) and intervention retention (over 16 weeks) before (-AASAP) and after (+AASAP) it was introduced to a 3-arm RCT to reduce disease distress among highly distressed subjects with type 2 diabetes.
   Results: Included were 250 subjects in -AASAP and 338 in +AASAP. Significant improvement in recruitment occurred at each of the 3 recruitment stages: agreed at screening (OR = 2.52; p < 0.001), attended baseline assessment (OR = 1.91; p < 0.001), attended initial intervention (OR = 1.46; p < 0.03). Higher education and shorter diabetes duration predicted better recruitment in -AASAP (OR = 2.23: p < 0.001). but not in +AASAP. AASAP also improved intervention retention over 16 weeks (OR = 3.46; p < 0.05).
   Conclusion: AASAP is a structured program of subject/staff communication that helps improve external validity by enhancing both subject recruitment and retention. Practical implications: AASAP can be taught to non-professional staff and can be adapted to a variety of health settings. It can also be used by clinicians to engage patients in programs of ongoing care. Published by Elsevier Ireland Ltd.
C1 [Fisher, Lawrence; Hessler, Danielle; Naranjo, Diana] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA.
   [Polonsky, William] Univ Calif San Diego, Behav Diabet Inst, San Diego, CA 92103 USA.
RP Hessler, D (reprint author), Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA.
EM fisherl@fcm.ucsf.edu; hesslerd@fcm.ucsf.edu
FU National Institute of Diabetes, Digestive and Kidney Disease [DK61937-7]
FX This research was funded by Grant DK61937-7 from the National Institute
   of Diabetes, Digestive and Kidney Disease. The following medical groups
   and education centers collaborated in this research: Alta Bates Diabetes
   Education Center, Brown and Toland Medical Group, California Pacific
   Diabetes Education Center, Hill Physicians Medical Group, University of
   California, San Francisco Hospital and Clinics.
CR Bonell C, 2006, BRIT MED J, V333, P346, DOI 10.1136/bmj.333.7563.346
   Bornhoft G., 2006, BIOMED CENTRAL MED R, V6, P1
   EMERSON RM, 1976, ANNU REV SOCIOL, V2, P335, DOI 10.1146/annurev.so.02.080176.002003
   FREEDMAN DS, 1980, SOCIOL METHOD RES, V9, P87, DOI 10.1177/004912418000900104
   Froelicher Erika Sivarajan, 2003, J Cardiopulm Rehabil, V23, P269, DOI 10.1097/00008483-200307000-00004
   Glasgow RE, 1996, DIABETES EDUCATOR, V22, P573, DOI 10.1177/014572179602200605
   Gross D, 2001, RES NURS HEALTH, V24, P530, DOI 10.1002/nur.10010
   Homans G. C., 1961, SOCIAL BEHAV ITS ELE
   Lawler EJ, 2001, AM J SOCIOL, V107, P321, DOI 10.1086/324071
   LeBlanc P, 2010, NURS RES, V17, P74
   Marcellus Lenora, 2004, Can J Nurs Res, V36, P82
   Meyers K, 2003, DRUG ALCOHOL DEPEN, V69, P73, DOI 10.1016/S0376-8716(02)00252-1
   Miller W. R., 2002, MOTIVATIONAL INTERVI
   POLIT DF, 1995, NURSING RES PRINCIPL
   Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8
   Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147
   Scott CK, 2004, DRUG ALCOHOL DEPEN, V74, P21, DOI 10.1016/j.drugalcdep.2003.11.007
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Woolard RH, 2004, ACAD EMERG MED, V11, P859, DOI 10.1197/j.aem.2003.09.021
NR 19
TC 20
Z9 20
U1 1
U2 6
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0738-3991
J9 PATIENT EDUC COUNS
JI Patient Educ. Couns.
PD MAR
PY 2012
VL 86
IS 3
BP 372
EP 377
DI 10.1016/j.pec.2011.07.002
PG 6
WC Public, Environmental & Occupational Health; Social Sciences,
   Interdisciplinary
SC Public, Environmental & Occupational Health; Social Sciences - Other
   Topics
GA 924EA
UT WOS:000302672700016
PM 21831557
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Schmidt, CA
   Bernaix, LW
   Chiappetta, M
   Carroll, E
   Beland, A
AF Schmidt, Cynthia A.
   Bernaix, Laura W.
   Chiappetta, Maria
   Carroll, Emily
   Beland, Ann
TI In-Hospital Survival Skills Training for Type 1 Diabetes: Perceptions OF
   Children AND Parents
SO MCN-THE AMERICAN JOURNAL OF MATERNAL-CHILD NURSING
LA English
DT Article
DE Children; Diabetes education; Parents; Type 1 diabetes; Self-care skills
ID QUALITATIVE DESCRIPTION; EDUCATION; CARE
AB Purpose: When a child is diagnosed with type 1 diabetes, parents and/or children must gain significant knowledge and learn specific skills to maintain health. Children in the United States who experience diabetic ketoacidosis (DKA) at the time of diagnosis typically spend 3 days in the hospital learning these life-saving skills. The purpose of this study was to gain knowledge concerning children's and parents' perceptions of this hospitalization period and of the initial education and support received from nurses.
   Study Design and Methods: The study used qualitative descriptive methods. A child interview guide and written parent survey were used to elicit children's and parents' perceptions. Two outside experts reviewed these tools. Twenty children aged 8 to 15 years along with 25 parents participated. Reductionistic and constructionistic steps were used to analyze the qualitative data.
   Results: During this hospitalization, children were most disturbed by the invasiveness of the required interventions while parents reported significant emotional distress related to the diagnosis. Children and parents alike felt the Survival Skills Training they received was effective. Education involving demonstration and return demonstration, supervision of skill performance, positive feedback from nurses about skill performance, and reassurance for long-term quality of life were nurse behaviors found to be helpful.
   Clinical Implications: Implications for care include age-appropriate information in a variety of formats, minimizing the invasive nature of the treatment, providing opportunities for demonstration/return demonstration of skills, providing positive support and reassurance, and delivering concentrated instruction related to carbohydrate counting.
C1 [Schmidt, Cynthia A.; Bernaix, Laura W.] So Illinois Univ, Edwardsville, IL 62026 USA.
   [Chiappetta, Maria; Beland, Ann] Childrens Mem Med Ctr, Chicago, IL USA.
   [Carroll, Emily] Hlth Finders Collaborat, Northfield, MN USA.
RP Schmidt, CA (reprint author), So Illinois Univ, Edwardsville, IL 62026 USA.
EM caschmi@siue.edu
FU Children's Memorial Medical Center, Chicago, IL through the Shaw Faculty
FX This study was funded through the Shaw Faculty Collaborative Research
   Grant program awarded by Children's Memorial Medical Center, Chicago,
   IL.
CR *AM DIAB ASS, 1996, DIABETES CARE, V19, pS50, DOI DOI 10.1002/14651858.CD004099.PUB2
   Beck JK, 2004, PEDIATRICS, V113, pE47, DOI 10.1542/peds.113.1.e47
   Clar C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004099.pub2
   FIELD P, 1985, NURSING RES APPL QUA
   Fisher MJ, 2011, J PEDIATR NURS, V26, P58, DOI 10.1016/j.pedn.2009.12.071
   Habich Michele, 2006, Pediatr Nurs, V32, P113
   Howe CJ, 2011, MCN-AM J MATERN-CHIL, V36, P25, DOI 10.1097/NMC.0b013e3181fc6093
   Insel R., 2011, PREVENTION TYPE 1 DI
   Jonsson L, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-36
   Juvenile Diabetes Research Foundation, 2012, DIAB FACTS
   KAZAK AE, 1996, FAMILIES SYSTEMS HLT, V14, P365, DOI DOI 10.1037/H0089795
   Knafl K A, 1988, West J Nurs Res, V10, P195, DOI 10.1177/019394598801000207
   Kortesluoma RL, 2003, J ADV NURS, V42, P434, DOI 10.1046/j.1365-2648.2003.02643.x
   Krahenbuhl S, 2006, CHILD CARE HLTH DEV, V32, P321, DOI 10.1111/j.1365-2214.2006.00608.x
   Rennick Janet E, 2004, Pediatr Crit Care Med, V5, P358, DOI 10.1097/01.PCC.0000128603.20501.0D
   Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G
   Sandelowski M, 2001, RES NURS HEALTH, V24, P230, DOI 10.1002/nur.1025
   Sandelowski M, 2010, RES NURS HEALTH, V33, P77, DOI 10.1002/nur.20362
   Silverstein J, 2005, DIABETES CARE, V28, P186, DOI 10.2337/diacare.28.1.186
   Smaldone A, 2011, J PEDIATR HEALTH CAR, V25, P87, DOI 10.1016/j.pedhc.2009.09.003
   Streisand R, 2008, PATIENT EDUC COUNS, V73, P333, DOI 10.1016/j.pec.2008.06.014
   Svoren BM, 2003, PEDIATRICS, V112, P914, DOI 10.1542/peds.112.4.914
   Swift PGF, 2007, PEDIATR DIABETES, V8, P103, DOI 10.1111/j.1399-5448.2007.00232.x
   Wanzer MB, 2004, HEALTH COMMUN, V16, P363, DOI 10.1207/S15327027HC1603_6
NR 24
TC 3
Z9 4
U1 0
U2 17
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0361-929X
EI 1539-0683
J9 MCN-AM J MATERN-CHIL
JI MCN-Am. J. Matern.-Child Nurs.
PD MAR-APR
PY 2012
VL 37
IS 2
BP 88
EP 94
DI 10.1097/NMC.0b013e318244febc
PG 7
WC Nursing
SC Nursing
GA 906BE
UT WOS:000301319100005
PM 22357069
DA 2019-01-08
ER

PT J
AU Striegel, RH
   Bedrosian, R
   Wang, C
   Schwartz, S
AF Striegel, Ruth H.
   Bedrosian, Richard
   Wang, Chun
   Schwartz, Steven
TI Why Men Should Be Included in Research on Binge Eating: Results from a
   Comparison of Psychosocial Impairment in Men and Women
SO INTERNATIONAL JOURNAL OF EATING DISORDERS
LA English
DT Article
DE eating disorders; binge eating; obesity; metabolic syndrome; work
   productivity impairment; psychosocial impairment
ID GUIDED SELF-HELP; DISORDER SYMPTOMS; COMMUNITY SAMPLE; YOUNG-ADULTS;
   COMORBIDITY; PREVALENCE; VALIDITY; REPLICATION; DEPRESSION; OVERWEIGHT
AB Objective: Prevalence of binge eating has been shown to be as common in men as in women, yet few studies have included men. Men are especially underrepresented in treatment studies, raising the question of whether men who binge eat experience less distress or impairment than women. This study compared demographic and clinical correlates of binge eating in a large employee sample of men and women.
   Method: Cross-sectional data from 21,743 men and 24,608 women who participated in a health risk self assessment screening were used. Group differences in obesity, hypertension, dyslipidemia, Type 2 diabetes, depression, stress, sleep, sick days, work impairment, and non-work activity impairment were tested using chi-square tests (categorical variables) and independent sample t-tests (continuous variables).
   Results: Effect size estimates indicate that men (n = 1,630) and women (n = 2,754) who binge eat experience comparable levels of clinical impairment. They also report substantially greater impairment when compared with men and women who do not binge eat.
   Discussion: The underrepresentation of men in treatment-seeking samples does not appear to reflect lower levels of impairment in men versus women. Efforts are needed to raise awareness of the clinical significance of binge eating in men so that this group can receive appropriate screening and treatment services. (C) 2011 by Wiley Periodicals, Inc.
C1 [Striegel, Ruth H.] Wesleyan Univ, Dept Psychol, Middletown, CT 06459 USA.
   [Bedrosian, Richard; Wang, Chun; Schwartz, Steven] HealthMedia Inc, Ann Arbor, MI USA.
RP Striegel, RH (reprint author), Wesleyan Univ, Dept Psychol, 207 High St, Middletown, CT 06459 USA.
EM rstriegel@wesleyan.edu
FU HealthMedia, Inc.
FX Dr. Striegel-Moore was compensated by HealthMedia, Inc. for her work on
   this study. Drs. Bedrosian, Wang, and Schwartz are employees of
   HealthMedia, Inc.
CR Bedrosian RC, 2011, INT J EAT DISORDER, V44, P639, DOI 10.1002/eat.20844
   Brownley KA, 2007, INT J EAT DISORDER, V40, P337, DOI 10.1002/eat.20370
   COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404
   DeBar LL, 2011, PSYCHIAT SERV, V62, P367, DOI 10.1176/ps.62.4.pss6204_0367
   Debar LL, 2009, CONTEMP CLIN TRIALS, V30, P326, DOI 10.1016/j.cct.2009.02.007
   Dickerson JF, 2011, INT J EAT DISORDER, V44, P524, DOI 10.1002/eat.20842
   Grilo CM, 2009, INT J EAT DISORDER, V42, P228, DOI 10.1002/eat.20599
   Hudson JI, 2007, BIOL PSYCHIAT, V61, P348, DOI 10.1016/j.biopsych.2006.03.040
   Hudson JI, 2010, AM J CLIN NUTR, V91, P1568, DOI 10.3945/ajcn.2010.29203
   Kraemer HC, 2003, J AM ACAD CHILD PSY, V42, P1524, DOI 10.1097/01.chi.0000091507.46853.d1
   Lewinsohn PM, 2002, INT J EAT DISORDER, V32, P426, DOI 10.1002/eat.10103
   Marcus MD, 2009, INT J EAT DISORDER, V42, P739, DOI 10.1002/eat.20725
   Mond JM, 2007, INT J EAT DISORDER, V40, P391, DOI 10.1002/eat.20380
   Mond JM, 2009, OBESITY, V17, P1627, DOI 10.1038/oby.2009.27
   Mond JM, 2009, J WOMENS HEALTH, V18, P1081, DOI 10.1089/jwh.2008.1174
   Perez M, 2011, OBESITY SILVER SPRIN
   RADLOFF LS, 1979, J ABNORM PSYCHOL, V88, P174, DOI 10.1037//0021-843X.88.2.174
   REILLY MC, 1993, PHARMACOECONOMICS, V4, P353, DOI 10.2165/00019053-199304050-00006
   Roberto CA, 2010, INT J EAT DISORDER, V43, P724, DOI 10.1002/eat.20770
   Smith DE, 1998, ANN BEHAV MED, V20, P227, DOI 10.1007/BF02884965
   Striegel-Moore RH, 2000, INT J EAT DISORDER, V27, P381
   Striegel-Moore RH, 2010, J CONSULT CLIN PSYCH, V78, P312, DOI 10.1037/a0018915
   Striegel-Moore RH, 2009, INT J EAT DISORDER, V42, P471, DOI 10.1002/eat.20625
   Wilson GT, 2010, ARCH GEN PSYCHIAT, V67, P94, DOI 10.1001/archgenpsychiatry.2009.170
   Wilson GT, 2009, INT J EAT DISORDER, V42, P603, DOI 10.1002/eat.20726
   Wolfe BE, 2009, INT J EAT DISORDER, V42, P674, DOI 10.1002/eat.20728
   Wonderlich SA, 2009, INT J EAT DISORDER, V42, P687, DOI 10.1002/eat.20719
NR 27
TC 74
Z9 75
U1 0
U2 24
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0276-3478
J9 INT J EAT DISORDER
JI Int. J. Eating Disord.
PD MAR
PY 2012
VL 45
IS 2
BP 233
EP 240
DI 10.1002/eat.20962
PG 8
WC Psychology, Clinical; Nutrition & Dietetics; Psychiatry; Psychology
SC Psychology; Nutrition & Dietetics; Psychiatry
GA 904WB
UT WOS:000301228500009
PM 22031213
DA 2019-01-08
ER

PT J
AU Shin, JK
   Chiu, YL
   Choi, S
   Cho, S
   Bang, H
AF Shin, Jinah K.
   Chiu, Ya-Lin
   Choi, Sarah
   Cho, Soyeon
   Bang, Heejung
TI Serious psychological distress, health risk behaviors, and diabetes care
   among adults with type 2 diabetes: The California Health Interview
   Survey 2007
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Diabetes care; Health risk behaviors; Physical activity; Serious
   psychological distress; Smoking cigarettes; Type 2 diabetes
ID POOR GLYCEMIC CONTROL; DEPRESSIVE SYMPTOMS; SELF-CARE; METAANALYSIS;
   PREVALENCE; ADHERENCE; MORTALITY; MELLITUS; SMOKING; ASSOCIATION
AB Aims: To examine the association between type 2 diabetes and serious psychological distress (SPD) and to assess if SPD was an independent risk factor for health risk behaviors and diabetes care among adults with diabetes.
   Methods: Cross-sectional analysis was performed using the 2007 California Health Interview Survey with adults in California. Multiple logistic models were used to examine the associations between the multiple risk and outcome factors.
   Results: Of the participants, 6.9% of adults had diagnoses of type 2 diabetes. SPD was present in 7.0% of adults with diabetes but only in 3.5% of adults without diabetes. Multiple logistic regression analysis revealed that participants with diabetes were significantly more likely than those without diabetes to experience SPD (OR = 1.81; 95% CI = [1.3-2.5], p = 0.0002), adjusting for other factors. In addition, participants with diabetes and SPD were more likely to report insufficient physical activity and more current cigarette smoking than participants without SPD. SPD among participants with diabetes, however, did not significantly affect good diabetes care.
   Conclusions: The findings suggest that adults with diabetes are more likely to experience SPD than adults without diabetes. Further research is needed to explore the underlying mechanisms for this association among adults with both diabetes and SPD. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
C1 [Shin, Jinah K.] Elmhurst Hosp Ctr, Dept Psychiat, Elmhurst, NY 11373 USA.
   [Chiu, Ya-Lin] Cornell Univ, Weill Med Coll, Dept Publ Hlth, Div Biostat & Epidemiol, New York, NY 10065 USA.
   [Choi, Sarah] Univ Calif Irvine, Nursing Sci Coll Hlth Sci, Irvine, CA 92697 USA.
   [Cho, Soyeon] CUNY NYC Coll Technol, Human Serv Dept, Brookyn, NY 11201 USA.
   [Bang, Heejung] Univ Calif Davis, Dept Publ Hlth Sci, Div Biostat, Davis, CA USA.
RP Shin, JK (reprint author), Elmhurst Hosp, Dept Psychiat, New York, NY 11373 USA.
EM JSHIN124@HOTMAIL.COM; yac2003@med.cornell.edu; sechoi@uci.edu;
   scho@city-tech.cuny.edu; hbang@ucdavis.edu
CR Al-Delaimy WK, 2002, ARCH INTERN MED, V162, P273, DOI 10.1001/archinte.162.3.273
   Al-Delaimy WK, 2001, DIABETES CARE, V24, P2043, DOI 10.2337/diacare.24.12.2043
   *AM DIAB ASS, 2011, DIABETES CARE S1, V34, pS11, DOI DOI 10.2337/DC11-S011
   Anderson RJ, 2002, INT J PSYCHIAT MED, V32, P235, DOI 10.2190/KLGD-4H8D-4RYL-TWQ8
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   [Anonymous], 2003, MMWR MORB MORTAL WKL, V53, P1089
   California Health Interview Survey, 1 CHIS UCLA CTR HLTH
   Center for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET
   Choi SE, 2011, J IMMIGR MINOR HEALT, V13, P803, DOI 10.1007/s10903-010-9397-6
   Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278
   Cosgrove MP, 2008, OCCUP MED-OXFORD, V58, P7, DOI 10.1093/occmed/kqm105
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   Golden SH, 2008, JAMA-J AM MED ASSOC, V299, P2751, DOI 10.1001/jama.299.23.2751
   Grigsby AB, 2002, J PSYCHOSOM RES, V53, P1053, DOI 10.1016/S0022-3999(02)00417-8
   Hamer M, 2010, PSYCHOSOM MED, V72, P882, DOI 10.1097/PSY.0b013e3181f6696e
   Ismail K, 2007, DIABETES CARE, V30, P1473, DOI 10.2337/dc06-2313
   Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Knol MJ, 2006, DIABETOLOGIA, V49, P837, DOI 10.1007/s00125-006-0159-x
   Korff MV, 2005, PSYCHOSOM MED, V67, P233
   Laaksonen DE, 2005, DIABETES, V54, P158, DOI 10.2337/diabetes.54.1.158
   Li CY, 2009, INT J PUBLIC HEALTH, V54, P43, DOI 10.1007/s00038-009-0006-1
   Lin EHB, 2004, DIABETES CARE, V27, P2154, DOI 10.2337/diacare.27.9.2154
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985
   Narayan KMV, 2006, DIABETES CARE, V29, P2114, DOI 10.2337/dc06-1136
   Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561
   O'Connor PJ, 2009, ANN FAM MED, V7, P328, DOI 10.1370/afm.964
   Park H, 2004, J CLIN EPIDEMIOL, V57, P978, DOI 10.1016/j.jclinepi.2004.01.015
   Shih M, 2008, QUAL LIFE RES, V17, P521, DOI 10.1007/s11136-008-9330-9
   Solberg LI, 2004, ANN FAM MED, V2, P26, DOI 10.1370/afm.36
   Spangler JG, 2001, ADDICT BEHAV, V26, P21, DOI 10.1016/S0306-4603(00)00077-0
   Thiebaut ACM, 2007, ANN INTERN MED, V146, P65, DOI 10.7326/0003-4819-146-1-200701020-00012
   Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047
NR 34
TC 13
Z9 14
U1 0
U2 12
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD MAR
PY 2012
VL 95
IS 3
BP 406
EP 414
DI 10.1016/j.diabres.2011.10.043
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 897HG
UT WOS:000300638200022
PM 22169109
DA 2019-01-08
ER

PT J
AU Guilfoyle, SM
   Denson, LA
   Baldassano, RN
   Hommel, KA
AF Guilfoyle, S. M.
   Denson, L. A.
   Baldassano, R. N.
   Hommel, K. A.
TI Paediatric parenting stress in inflammatory bowel disease: application
   of the Pediatric Inventory for Parents
SO CHILD CARE HEALTH AND DEVELOPMENT
LA English
DT Article
DE adolescence; inflammatory bowel disease; parenting distress; Pediatric
   Inventory for Parents; sociodemographics
ID QUALITY-OF-LIFE; ULCERATIVE-COLITIS; CROHNS-DISEASE; MEDICATION
   ADHERENCE; ACTIVITY INDEX; CHILDREN; ADOLESCENTS; HEALTH; OUTCOMES;
   THERAPY
AB Background The psychosocial functioning of caregivers of adolescents managing inflammatory bowel disease (IBD) has been understudied; yet, poor caregiver functioning can place youth at risk for compromised disease management. The current study addressed this limitation by examining a sample of caregivers of adolescents with IBD. Study aims included (1) documenting rates of paediatric parenting stress; (2) identifying associated sociodemographic predictors of parenting stress; and (3) comparing previously published rates of parenting stress to those within other paediatric chronic conditions, including cancer, type 1 diabetes, obesity, sickle cell disease, bladder exstrophy.
   Methods Caregivers of adolescents with an IBD diagnosis (Mage = 15.4 +/- 1.4, 44.4% female, 88.7% Caucasian) and receiving tertiary care within a gastroenterology clinic (n = 62) completed the Pediatric Inventory for Parents (PIP) as a measure of paediatric parenting stress with frequency and difficulty as PIP subscales. Paediatric gastroenterologists provided disease severity assessments.
   Results Adolescents with IBD were experiencing relatively mild disease activity. Bivariate correlations revealed that PIP-difficulty was positively associated with Crohn's disease severity (r = 0.38, P < 0.01). Caregiver age was negatively associated with the frequency of parenting stress total (r = -0.25, P = 0.05) and communication scores (r = -0.25, P < 0.05). The frequency and difficulty of parenting stressors within the IBD sample were similar to rates within type 1 diabetes, but were significantly lower than rates identified in other paediatric chronic conditions.
   Conclusions Caregivers of adolescents with IBD seem to experience low rates of parenting stress when their adolescents are receiving outpatient care and during phases of IBD relative inactivity. The sociodemographic characteristics of IBD families (i. e. primarily Caucasian, well-educated and higher socio-economic status) likely encourage greater access to financial and psychosocial resources, which may aid in promoting more optimal stress management.
C1 [Guilfoyle, S. M.; Hommel, K. A.] Cincinnati Childrens Hosp, Div Behav Med & Clin Psychol, Ctr Promot Treatment Adherence & Self Management, Med Ctr, Cincinnati, OH 45229 USA.
   [Denson, L. A.] Cincinnati Childrens Hosp, Div Gastroenterol Hepatol & Nutr, Med Ctr, Cincinnati, OH 45229 USA.
   [Denson, L. A.; Hommel, K. A.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA.
   [Baldassano, R. N.] Childrens Hosp Philadelphia, Div Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA.
   [Baldassano, R. N.] Univ Penn Sch Med, Dept Paediat, Philadelphia, PA USA.
RP Hommel, KA (reprint author), Cincinnati Childrens Hosp, Div Behav Med & Clin Psychol, Ctr Promot Treatment Adherence & Self Management, Med Ctr, 3333 Burnet Ave,MLC 7039, Cincinnati, OH 45229 USA.
EM kevin.hommel@cchmc.org
FU NIDDK [K23 DK079037]; PHS [P30 DK 078392]; Procter and Gamble
   Pharmaceuticals; Prometheus Laboratories, Inc.; USPHS from the General
   Clinical Research Centers, National Center for Research Resources, NIH
   [M01 RR 08084]
FX Research is supported in part by NIDDK K23 DK079037, PHS Grant P30 DK
   078392, Procter and Gamble Pharmaceuticals, Prometheus Laboratories,
   Inc., USPHS Grant # M01 RR 08084 from the General Clinical Research
   Centers Program, National Center for Research Resources, NIH.
CR Benchimol E. I., 2010, INFLAMMATOR IN PRESS, DOI [10.1002/ibd.21349, DOI 10.1002/IBD.21349]
   Blanchard JF, 2001, AM J EPIDEMIOL, V154, P328, DOI 10.1093/aje/154.4.328
   BURKE PM, 1994, CHILD PSYCHIAT HUM D, V25, P45, DOI 10.1007/BF02251099
   COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037//0033-2909.112.1.155
   ENGSTROM I, 1991, J AM ACAD CHILD PSY, V30, P904, DOI 10.1097/00004583-199111000-00007
   Engstrom I, 1999, J PEDIATR GASTR NUTR, V28, pS28, DOI 10.1097/00005176-199904001-00004
   Fanjiang G, 2007, J PEDIATR GASTR NUTR, V44, P312, DOI 10.1097/MPG.0b013e31802e98d4
   Fredericks EM, 2007, AM J TRANSPLANT, V7, P1974, DOI 10.1111/j.1600-6143.2007.01878.x
   GITLIN K, 1991, ADVANCES IN CHILD HEALTH PSYCHOLOGY, P54
   Greenley RN, 2009, J PEDIATR PSYCHOL, V34, P129, DOI 10.1093/jpepsy/jsn056
   Hollingshead A. A., 1975, 4 FACTOR INDEX UNPUB
   Hommel KA, 2008, J PEDIATR PSYCHOL, V33, P867, DOI 10.1093/jpepsy/jsn022
   Hyams J, 2005, J PEDIATR GASTR NUTR, V41, P416, DOI 10.1097/01.mpg.0000183350.46795.42
   HYAMS JS, 1991, J PEDIATR GASTR NUTR, V12, P439, DOI 10.1097/00005176-199105000-00005
   Kappelman MD, 2007, CLIN GASTROENTEROL H, V5, P1424, DOI 10.1016/j.cgh.2007.07.012
   LICHTIGER S, 1994, NEW ENGL J MED, V330, P1841, DOI 10.1056/NEJM199406303302601
   Logan DE, 2002, J PEDIATR PSYCHOL, V27, P475, DOI 10.1093/jpepsy/27.5.475
   Mackner LM, 2005, INFLAMM BOWEL DIS, V11, P1006, DOI 10.1097/01.MIB.0000186409.15392.54
   Mackner LM, 2005, AM J GASTROENTEROL, V100, P1386, DOI 10.1111/j.1572-0241.2005.41428.x
   Mednick L, 2009, J UROLOGY, V181, P1312, DOI 10.1016/j.juro.2008.10.051
   Mullins L, 2000, INT J REHABILITATION, V5, P177, DOI DOI 10.1023/A:1012999205376
   Ohleyer Vanessa, 2007, J Child Health Care, V11, P132, DOI 10.1177/1367493507076065
   Quittner A. L., 2003, HDB PEDIAT PSYCHOL, V3, P696
   Streisand R, 2005, J PEDIATR PSYCHOL, V30, P513, DOI 10.1093/jpepsy/jsi076
   Streisand R, 2001, J PEDIATR PSYCHOL, V26, P155, DOI 10.1093/jpepsy/26.3.155
   van der Zaag-Loonen HJ, 2004, QUAL LIFE RES, V13, P1011, DOI 10.1023/B:QURE.0000025598.89003.0c
NR 26
TC 12
Z9 12
U1 1
U2 7
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0305-1862
J9 CHILD CARE HLTH DEV
JI Child Care Health Dev.
PD MAR
PY 2012
VL 38
IS 2
BP 273
EP 279
DI 10.1111/j.1365-2214.2010.01200.x
PG 7
WC Psychology, Developmental; Pediatrics
SC Psychology; Pediatrics
GA 885JV
UT WOS:000299776100015
PM 21299591
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Paradies, YC
   Cunningham, J
AF Paradies, Yin C.
   Cunningham, Joan
TI The DRUID study: racism and self-assessed health status in an indigenous
   population
SO BMC PUBLIC HEALTH
LA English
DT Article
ID AMERICAN YOUNG-ADULTS; BODY-MASS INDEX; PERCEIVED DISCRIMINATION;
   DEPRESSIVE SYMPTOMS; MENTAL-HEALTH; ASIAN-AMERICANS; SUBSTANCE USE;
   RACIAL/ETHNIC DISCRIMINATION; PSYCHOLOGICAL DISTRESS; ETHNIC
   DISCRIMINATION
AB Background: There is now considerable evidence from around the world that racism is associated with both mental and physical ill-health. However, little is known about the mediating factors between racism and ill-health. This paper investigates relationships between racism and self-assessed mental and physical health among Indigenous Australians as well as potential mediators of these relationships.
   Methods: A total of 164 adults in the Darwin Region Urban Indigenous Diabetes (DRUID) study completed a validated instrument assessing interpersonal racism and a separate item on discrimination-related stress. Self-assessed health status was measured using the SF-12. Stress, optimism, lack of control, social connections, cultural identity and reactions/responses to interpersonal racism were considered as mediators and moderators of the relationship between racism/discrimination and self-assessed health status.
   Results: After adjusting for socio-demographic factors, interpersonal racism was significantly associated with the SF-12 mental (but not the physical) health component. Stress, lack of control and feeling powerless as a reaction to racism emerged as significant mediators of the relationship between racism and general mental health. Similar findings emerged for discrimination-related stress.
   Conclusions: Racism/discrimination is significantly associated with poor general mental health among this indigenous population. The mediating factors between racism and mental health identified in this study suggest new approaches to ameliorating the detrimental effects of racism on health. In particular, the importance of reducing racism-related stress, enhancing general levels of mastery, and minimising negative social connections in order to ameliorate the negative consequences of racism.
C1 [Paradies, Yin C.] Univ Melbourne, McCaughey Ctr, Melbourne Sch Populat Hlth, Melbourne, Vic, Australia.
   [Cunningham, Joan] Univ Melbourne, Sch Populat Hlth, Melbourne, Vic, Australia.
   [Cunningham, Joan] Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT 0909, Australia.
RP Paradies, YC (reprint author), Univ Melbourne, McCaughey Ctr, Melbourne Sch Populat Hlth, Melbourne, Vic, Australia.
EM yinp@unimelb.edu.au
RI Cunningham, Joan/E-6339-2012
OI Cunningham, Joan/0000-0002-1012-0909; Paradies, Yin/0000-0001-9927-7074
FU DRUID; Indigenous Steering Group; National Health and Medical Research
   Council (NHMRC) [236207, 283310, 545200]; Australian Government
   Department of Employment and Workplace Relations; Clive and Vera
   Ramaciotti Foundation; Vincent Fairfax Family Foundation; International
   Diabetes Institute; Bayer HealthCare; University of Melbourne
FX The authors gratefully acknowledge the support of DRUID study
   participants, study staff, members of the Indigenous Steering Group, and
   partner organisations. The DRUID Study was funded by the National Health
   and Medical Research Council (NHMRC Project Grant #236207), with
   additional support from the Australian Government Department of
   Employment and Workplace Relations, the Clive and Vera Ramaciotti
   Foundation, the Vincent Fairfax Family Foundation, the International
   Diabetes Institute (AusDiab Partnership), and Bayer HealthCare. The
   DRUID Study is an in-kind project of the Cooperative Research Centre for
   Aboriginal Health (CRCAH). Ms Hannah Reich provided research assistance
   in the drafting of this manuscript. The first author was supported by a
   University of Melbourne McKenzie fellowship. The second author was
   supported by an NHMRC Career Development Award (#283310) and an NHMRC
   Research Fellowship (#545200).
CR Alvarez AN, 2010, J COUNS PSYCHOL, V57, P167, DOI 10.1037/a0019091
   [Anonymous], 4704 0 HLTH WELFARE
   Barnes LL, 2008, AM J PUBLIC HEALTH, V98, P1241, DOI 10.2105/AJPH.2007.114397
   Bennett GG, 2005, AM J PUBLIC HEALTH, V95, P238, DOI 10.2105/AJPH.2004.037812
   Bennett GG, 2004, AM BEHAV SCI, V47, P963, DOI 10.1177/0002764203261070
   Berman G, 2010, ETHNIC RACIAL STUD, V33, P214, DOI 10.1080/01419870802302272
   Borrell LN, 2006, SOC SCI MED, V63, P1415, DOI 10.1016/j.socscimed.2006.04.008
   Brondolo E, 2010, HDB STRESS SCI
   Brondolo E, 2011, AM J HYPERTENSION
   Brondolo E, 2009, J BEHAV MED, V32, P64, DOI 10.1007/s10865-008-9193-0
   Broudy R, 2007, J BEHAV MED, V30, P31, DOI 10.1007/s10865-006-9081-4
   Caputo RK, 2003, SOC WORK HEALTH CARE, V37, P17, DOI 10.1300/J0101v37n02_02
   Carver CS, CLIN PSYCHOL REV
   Chae DH, 2008, AM J PUBLIC HEALTH, V98, P485, DOI 10.2105/AJPH.2006.102012
   Chandola T, 2004, SOC SCI MED, V58, P1501, DOI 10.1016/S0277-9536(03)00352-6
   Chen CY, 2009, CURR OPIN PSYCHIATR, V22, P287, DOI 10.1097/YCO.0b013e32832a2349
   Choi Y, 2006, AM J ORTHOPSYCHIAT, V76, P86, DOI 10.1037/0002-9432.76.1.86
   Cunningham J, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-8
   Deardorff J, 2003, J ABNORM CHILD PSYCH, V31, P205, DOI 10.1023/A:1022582410183
   DeMaris A, 2002, SOCIOL METHOD RES, V31, P27, DOI 10.1177/0049124102031001002
   DeSalvo KB, 2006, J GEN INTERN MED, V21, P267, DOI 10.1111/j.1525-1497.2005.0291.x
   DeSantis AS, 2007, J ADOLESCENT HEALTH, V41, P3, DOI 10.1016/j.jadohealth.2007.03.006
   Din-Dzietham R, 2004, SOC SCI MED, V58, P449, DOI 10.1016/S0277-9536(03)00211-9
   Ender P, 2010, CAN I PERFORM MEDIAT
   Franzini L, 2004, SOC SCI MED, V59, P1629, DOI 10.1016/j.socscimed.2004.02.014
   Fritz MS, 2007, PSYCHOL SCI, V18, P233, DOI 10.1111/j.1467-9280.2007.01882.x
   Gallaher G, 2009, BOOK OUR OWN BACKYAR
   Gee GC, 2002, AM J PUBLIC HEALTH, V92, P615, DOI 10.2105/AJPH.92.4.615
   Gee G, 2009, SOC SCI MED, V68, P1676, DOI 10.1016/j.socscimed.2009.02.002
   Gee GC, 2008, AM J PUBLIC HEALTH, V98, P493, DOI 10.2105/AJPH.2007.114025
   Gee GC, 2007, AM J PUBLIC HEALTH, V97, P933, DOI 10.2105/AJPH.2005.075739
   Gibbons FX, 2007, DRUG ALCOHOL DEPEN, V88, pS27, DOI 10.1016/j.drugalcdep.2006.12.015
   Gibbons FX, 2004, J PERS SOC PSYCHOL, V86, P517, DOI 10.1037/0022-3514.86.4.517
   Gill SC, 2007, PSYCHIAT RES, V152, P63, DOI 10.1016/j.psychres.2006.11.005
   Griffin JM, 2002, SOC SCI MED, V54, P783, DOI 10.1016/S0277-9536(01)00109-5
   Guthrie BJ, 2002, NURS RES, V51, P183, DOI 10.1097/00006199-200205000-00007
   Hagenaars AK, 1994, BOOK POVERTY STAT LA
   Hair F. J., 2006, MULTIVARIATE DATA AN
   Harrell CJP, 2011, DU BOIS REV, V8, P143, DOI 10.1017/S1742058X11000178
   Harris R, 2006, SOC SCI MED, V63, P1428, DOI 10.1016/j.socscimed.2006.04.009
   Heim D, J CROSS CULTURAL PSY
   Banks KH, 2007, J BLACK PSYCHOL, V33, P331, DOI 10.1177/0095798407302540
   Hunte HER, 2011, AM J EPIDEMIOL, V2011, P1
   Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359
   Jane-Llopis E, 2006, DRUG ALCOHOL REV, V25, P515, DOI 10.1080/09595230600944461
   Juang LP, 2009, J PRIM PREV, V30, P475, DOI 10.1007/s10935-009-0177-9
   Kaiser CR, 2006, LAW SOCIAL INQUIRY, V31, P801, DOI 10.1111/j.1747-4469.2006.00036.x
   Krieger N, 1999, INT J HEALTH SERV, V29, P295, DOI 10.2190/M11W-VWXE-KQM9-G97Q
   Krieger N, 2010, AM J PUBLIC HEALTH, V100, P1485, DOI 10.2105/AJPH.2009.159517
   Landrine Hope, 2000, Ethnicity and Disease, V10, P195
   Larson A, 2007, AUST NZ J PUBL HEAL, V31, P322, DOI 10.1111/j.1753-6405.2007.00079.x
   Lewis TT, 2011, AM J EPIDEMIOL, V2011, P1
   Lewis TT, 2011, BOOK DO CHRONIC EXPE
   Liang CTH, 2007, J COUNS PSYCHOL, V54, P132, DOI 10.1037/0022-0167.542.132
   Manson S, 1995, BOOK INDIAN SERVICES
   MCCLELLAND GH, 1993, PSYCHOL BULL, V114, P376, DOI 10.1037//0033-2909.114.2.376
   Mellor D, 2001, J ETHN MIGR STUD, V27, P473, DOI DOI 10.1080/13691830124387
   Moradi B, 2004, J COUNS PSYCHOL, V51, P418, DOI 10.1037/0022-0167.51.4.418
   Mossakowski KN, 2003, J HEALTH SOC BEHAV, V44, P318, DOI 10.2307/1519782
   Nolh S, 2007, AM J PUBLIC HEALTH, V97, P1269, DOI 10.2105/AJPH.2005.085316
   Okamoto J, 2009, AM J HEALTH BEHAV, V33, P718
   Ong AD, 2008, J SOC CLIN PSYCHOL, V27, P105, DOI 10.1521/jscp.2008.27.2.105
   Ong AD, 2009, J PERS SOC PSYCHOL, V96, P1259, DOI 10.1037/a0015335
   Operario D, 2004, PSYCHOL HEALTH, V19, P237, DOI 10.1080/08870440310001638098
   Otiniano AD, 2011, BOOK DISCRIMINATION
   Paradies Y., 2008, INT ENCY PUBLIC HLTH, V5, P474
   Paradies Y, SOCIAL PSYCHIAT PSYC
   Paradies Y, 2009, BOOK BUILDING OUR ST
   Paradies Y., 2009, YOUTH IDENTITY MIGRA, P207
   Paradies Y, 2008, BOOK IMPACT RACISM I
   Paradies Y, 2010, INT J PSYCHOL RES, V5
   Paradies Y, 2008, INT J EQUITY HLTH, V7
   Paradies Y, 2006, INT J EPIDEMIOL, V35, P888, DOI 10.1093/ije/dyl056
   Paradies Y, 2009, ETHNIC RACIAL STUD, V32, P548, DOI 10.1080/01419870802065234
   Pascoe EA, 2009, PSYCHOL BULL, V135, P531, DOI 10.1037/a0016059
   Piette JD, 2006, PATIENT EDUC COUNS, V60, P41, DOI 10.1016/j.pec.2004.12.001
   Pituch KA, 2008, MULTIVAR BEHAV RES, V43, P237, DOI 10.1080/00273170802034844
   Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879
   Priest N, 2012, J EPIDEMIOL COMMUN H
   Priest N, J EPIDEMIOL COMMUN H
   Priest NC, 2011, MED J AUSTRALIA, V194, P546
   Richman LS, 2008, ANN BEHAV MED, V35, P105, DOI 10.1007/s12160-007-9013-8
   Rodriguez MS, 2004, EFFECTS PERCEIVED DI
   Sanders-Phillips K, 2009, CLIN CHILD FAM PSYCH, V12, P174, DOI 10.1007/s10567-009-0053-4
   SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063
   Sechrist GB, 2004, J PERS SOC PSYCHOL, V87, P111, DOI 10.1037/0022-3514.87.1.111
   Sellers RM, 2003, J HEALTH SOC BEHAV, V44, P302, DOI 10.2307/1519781
   Sellers SL, 2006, HLTH ED BEHAV
   Shelton RC, 2009, ETHNIC DIS, V19, P251
   Shorey HS, 2002, HISPANIC J BEHAV SCI, V24, P3, DOI 10.1177/0739986302024001001
   Sibthorpe B, 2001, AM J PUBLIC HEALTH, V91, P1660, DOI 10.2105/AJPH.91.10.1660
   Sohn L, 2008, MIL MED, V173, P331, DOI 10.7205/MILMED.173.4.331
   Spatz C, 2008, RES METHODS IDEAS TE
   Steering Committee for the Review of Government Service P, 2009, BOOK OV IND DIS KEY
   Steffen PR, 2006, ETHNIC DIS, V16, P16
   Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393
   Thomas KS, 2006, HEALTH PSYCHOL, V25, P635, DOI 10.1037/0278-6133.25.5.635
   Todorova ILG, 2010, SOCIOL HEALTH ILL, V32, P843, DOI 10.1111/j.1467-9566.2010.01257.x
   Tull ES, 2005, J NATL MED ASSOC, V97, P206
   Ware JE, 2002, BOOK SCORE VERSION S
   Williams DR, 2009, J BEHAV MED, V32, P20, DOI 10.1007/s10865-008-9185-0
   Yoo HC, 2009, SOC SCI MED, V68, P726, DOI 10.1016/j.socscimed.2008.11.013
   ZUBRICK SR, 2005, BOOK W AUSTR ABORIGI
NR 103
TC 19
Z9 19
U1 0
U2 18
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD FEB 14
PY 2012
VL 12
AR 131
DI 10.1186/1471-2458-12-131
PG 12
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 908YU
UT WOS:000301529800001
PM 22333047
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Speight, J
   Browne, JL
   Holmes-Truscott, E
   Hendrieckx, C
   Pouwer, F
AF Speight, Jane
   Browne, Jessica L.
   Holmes-Truscott, Elizabeth
   Hendrieckx, Christel
   Pouwer, Frans
TI Diabetes MILES-Australia (management and impact for long-term
   empowerment and success): methods and sample characteristics of a
   national survey of the psychological aspects of living with type 1 or
   type 2 diabetes in Australian adults
SO BMC PUBLIC HEALTH
LA English
DT Article
DE Diabetes; Psychology; National survey; Self-care; Quality of life;
   Diabetes-related distress; Depression
ID QUALITY-OF-LIFE; CO-MORBID DEPRESSION; SOCIAL SUPPORT; NEEDS DAWN;
   SELF-CARE; PREVALENCE; DISTRESS; ILLNESS; QUESTIONNAIRE; VALIDATION
AB Background: Successful management of diabetes requires attention to the behavioural, psychological and social aspects of this progressive condition. The Diabetes MILES (Management and Impact for Long-term Empowerment and Success) Study is an international collaborative. Diabetes MILES-Australia, the first Diabetes MILES initiative to be undertaken, was a national survey of adults living with type 1 or type 2 diabetes in Australia. The aim of this study was to gather data that will provide insights into how Australians manage their diabetes, the support they receive and the impact of diabetes on their lives, as well as to use the data to validate new diabetes outcome measures.
   Methods/design: The survey was designed to include a core set of self-report measures, as well as modules specific to diabetes type or management regimens. Other measures or items were included in only half of the surveys. Cognitive debriefing interviews with 20 participants ensured the survey content was relevant and easily understood. In July 2011, the survey was posted to 15,000 adults (aged 18-70 years) with type 1 or type 2 diabetes selected randomly from the National Diabetes Services Scheme (NDSS) database. An online version of the survey was advertised nationally. A total of 3,338 eligible Australians took part; most (70.4%) completed the postal survey. Respondents of both diabetes types and genders, and of all ages, were adequately represented in both the postal and online survey sub-samples. More people with type 2 diabetes than type 1 diabetes took part in Diabetes MILES-Australia (58.8% versus 41.2%). Most respondents spoke English as their main language, were married/in a de facto relationship, had at least a high school education, were occupied in paid work, had an annual household income > $AUS40,000, and lived in metropolitan areas.
   Discussion: A potential limitation of the study is the under-representation of respondents from culturally and linguistically diverse backgrounds (including Aboriginal and Torres Strait Islander origin). Diabetes MILES-Australia represents a major achievement in the study of diabetes in Australia, where for the first time, the focus is on psychosocial and behavioural aspects of this condition at a national level.
C1 [Speight, Jane; Browne, Jessica L.; Holmes-Truscott, Elizabeth; Hendrieckx, Christel] Australian Ctr Behav Res Diabet, Melbourne, Vic 3000, Australia.
   [Speight, Jane; Browne, Jessica L.; Holmes-Truscott, Elizabeth; Hendrieckx, Christel] Deakin Univ, Sch Psychol, Ctr Mental Hlth & Wellbeing Res, Burwood, Vic 3125, Australia.
   [Speight, Jane] AHP Res, Hornchurch, Essex, England.
   [Pouwer, Frans] Tilburg Univ, Ctr Res Psychol Somat Dis CoRPS FSW, NL-5037 AB Tilburg, Netherlands.
RP Speight, J (reprint author), Australian Ctr Behav Res Diabet, 570 Elizabeth St, Melbourne, Vic 3000, Australia.
EM jspeight@acbrd.org.au
OI Holmes-Truscott, Elizabeth/0000-0001-9139-4663; Speight,
   Jane/0000-0002-1204-6896
FU Diabetes Australia-Vic; Deakin University; sanofi aventis; National
   Diabetes Services Scheme (NDSS) Strategic Development Grant
FX The Diabetes MILES-Australia 2011 Survey was funded by a National
   Diabetes Services Scheme (NDSS) Strategic Development Grant. The NDSS is
   an initiative of the Australia Government administered by Diabetes
   Australia.; This funding supported the part-time employment of F HT and
   JB as well as the conduct of the data collection (including
   distribution, return and scanning of postal surveys; the development of
   the online survey).; The contributions of JS and CH were supported by
   the core funding provided by Diabetes Australia-Vic and Deakin
   University to The Australian Centre for Behavioural Research in
   Diabetes. In addition, Diabetes MILES-Australia received sponsorship
   from sanofi aventis to support the development of the study website
   http://www.diabetesMILES.org and miscellaneous activities.; We thank the
   many people with diabetes who took part in the cognitive debriefing
   interviews and the Diabetes MILES-Australia 2011 Survey.; We acknowledge
   the Diabetes MILES-Australia Reference Group for their generous advice
   throughout the study and for their continued collaboration on the
   dissemination of findings. We thank Jennifer Halliday and Jasmin
   Schabert from The Australian Centre for Behavioural Research in Diabetes
   for their contributions to the cognitive debriefing interviews and
   processing of return postal surveys. We also thank Luke Barisic from the
   School of Psychology, Deakin University for programming the online
   survey. Finally, we thank the Diabetes Australia-Vic mailroom
   coordinators and volunteers for kindly undertaking the survey packaging
   and distribution.
CR Alberti G, 2002, PRACT DIABETES INT, V19, P22, DOI DOI 10.1002/PDI.305/PDF
   Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x
   Amiel S, 2002, BRIT MED J, V325, P746
   Anderson RM, 2003, DIABETES CARE, V26, P1641, DOI 10.2337/diacare.26.5.1641-a
   Anderson RM, 2010, PATIENT EDUC COUNS, V79, P277, DOI 10.1016/j.pec.2009.07.025
   Australian Bureau of Statistics (ABS), 2008, MIGR, P09
   Australian Institute of Health and Welfare (AIHW), 1999, NAT HLTH DAT DICT VE
   Barnard KD, 2006, DIABETIC MED, V23, P445, DOI 10.1111/j.1464-5491.2006.01814.x
   Bech P., 2004, QUALITY LIFE NEWSLET, V32, P15
   Bradley C, 2002, DIABETES METAB RES, V18, pS64, DOI 10.1002/dmrr.279
   Broadbent E, 2006, J PSYCHOSOM RES, V60, P631, DOI 10.1016/j.jpsychores.2005.10.020
   Broadbent E, 2011, DIABETES CARE, V34, P338, DOI 10.2337/dc10-1779
   COX DJ, 1987, DIABETES CARE, V10, P617, DOI 10.2337/diacare.10.5.617
   Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB
   David M, 2011, BMJ OPEN, V1, P1
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   de Ridder D, 2004, J PSYCHOSOM RES, V56, P341, DOI 10.1016/S0022-3999(03)00034-5
   Donald M, 2011, BMC PUBLIC HLTH
   Dunstan DW, 2002, DIABETES CARE, V25, P829, DOI 10.2337/diacare.25.5.829
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Funnell MM, 2004, CLIN DIABETES, V22, P123, DOI DOI 10.2337/DIACLIN.22.3.123
   Gale EAM, 2009, DIABETOLOGIA, V52, P559, DOI 10.1007/s00125-009-1275-1
   GOLD AE, 1994, DIABETES CARE, V17, P697, DOI 10.2337/diacare.17.7.697
   Herdman M, QUALITY LIFE RES
   Horne R, 1999, J PSYCHOSOM RES, V47, P555, DOI 10.1016/S0022-3999(99)00057-4
   Horne R, 1999, PSYCHOL HEALTH, V14, P1, DOI 10.1080/08870449908407311
   International Wellbeing Group, 2006, PERS WELLB INDEX
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   LEMPERS JD, 1989, CHILD DEV, V60, P25, DOI 10.1111/j.1467-8624.1989.tb02692.x
   McCormack LA, 2008, DIABETES EDUCATOR, V34, P707, DOI 10.1177/0145721708321021
   Paddison C, 2010, EUR DIABETES NURS, V7, P29, DOI DOI 10.1002/EDN.152
   Peyrot M, 2005, DIABETES CARE, V28, P2673, DOI 10.2337/diacare.28.11.2673
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Rosenberg M., 1965, SOC ADOLESCENT CHILD
   Rubin RR, 2006, DIABETES CARE, V29, P1249, DOI 10.2337/dc05-2494
   Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O
   SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063
   Schwarzer R, 1995, MEASURES HLTH PSYCHO, P35, DOI DOI 10.1037/T00393-000
   Skinner TC, 2000, J PEDIATR PSYCHOL, V25, P257, DOI 10.1093/jpepsy/25.4.257
   Skovlund S. E., 2005, DIABETES SPECTRUM, V18, P136, DOI DOI 10.2337/DIASPECT.18.3.136
   Snoek FJ, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-69
   Speight J, 2010, DIABETES RES CLIN PR, V89, P22, DOI 10.1016/j.diabres.2010.03.017
   Speight J, 2010, DIABETIC MED, V27, P3
   Speight J, 2000, P BRIT PSYCHOL SOC, V8, P21
   Speight J, 2010, DIABETES        0303
   Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092
   Tang TS, 2008, DIABETES EDUCATOR, V34, P266, DOI 10.1177/0145721708315680
   van Dam HA, 2005, PATIENT EDUC COUNS, V59, P1, DOI 10.1016/j.pec.2004.11.001
   Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047
   Wilson P, 2010, BMJ, V340, pc3228
   World Health Organization, 1983, HLTH ED SELF CAR POS
   Yi JP, 2008, BRIT J HEALTH PSYCH, V13, P311, DOI 10.1348/135910707X186994
   Zimmet PZ, 1999, DIABETOLOGIA, V42, P499, DOI 10.1007/s001250051188
NR 55
TC 34
Z9 34
U1 1
U2 22
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD FEB 12
PY 2012
VL 12
AR 120
DI 10.1186/1471-2458-12-120
PG 13
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 921HV
UT WOS:000302469600001
PM 22325032
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Hermanns, N
   Kulzer, B
   Maier, B
   Mahr, M
   Haak, T
AF Hermanns, Norbert
   Kulzer, Bernhard
   Maier, Berthold
   Mahr, Marina
   Haak, Thomas
TI The effect of an education programme (MEDIAS 2 ICT) involving intensive
   insulin treatment for people with type 2 diabetes
SO PATIENT EDUCATION AND COUNSELING
LA English
DT Article
DE Type 2 diabetes; Diabetes education; Self-management; Intensive insulin
   treatment
ID EMOTIONAL DISTRESS; PROBLEM AREAS; MANAGEMENT; METAANALYSIS; ADULTS;
   SCALE; DEPRESSION; DISEASE; RISK
AB Objective: In a randomized, multi-centre trial, the effect of an education programme (MEDIAS 2 ICT) involving intensive insulin treatment for people with type 2 diabetes was compared with an established education programme as an active comparator condition (ACC).
   Methods: We investigated whether MEDIAS 2 ICT was non-inferior to ACC in overall glycaemic control. Secondary outcomes were the diabetes-related distress, diabetes knowledge, quality of life, self-care behavior, lipids, blood pressure and weight.
   Results: 186 subjects were randomized. After a six month follow-up the mean HbA1c decrease was 0.37% (from 8.2 +/- 1.1% to 7.8 +/- 1.5%) in the ACC and 0.63% (from 8.5 +/- 1.5% to 7.9 +/- 1.2%) in MEDIAS 2 ICT. The mean difference between both groups was -0.26% (95% CI -0.63 to -0.14) in favor of MEDIAS 2 ICT. This result was within the predefined limit for non-inferiority. Diabetes-related distress was significantly more reduced in MEDIAS 2 ICT (-3.4 +/- 7.1) than in ACC (0.4 +/- 9.0; p = 0.31).
   Conclusion: MEDIAS 2 ICT is as effective in lowering HbA1c as previously established education programmes, but showed superiority in reducing diabetes-related distress.
   Practical implications: MEDIAS 2 ICT provides an alternative for education of people with type 2 diabetes treated by multiple injection therapy. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
C1 [Hermanns, Norbert; Kulzer, Bernhard; Maier, Berthold; Mahr, Marina; Haak, Thomas] Diabet Acad Mergentheim FIDAM, Res Inst, Bad Mergentheim, Germany.
RP Hermanns, N (reprint author), Theodor Klotzbuecher Str 12, D-97980 Bad Mergentheim, Germany.
EM hermanns@diabetes-zentrum.de
RI Albertin, Paloma/X-1093-2018
FU Lilly, Germany
FX The conduct of this study was supported by an unrestricted grant from
   Lilly, Germany.
CR Berger M, 1987, BEHANDLUNGS SCHULUNG
   Bretzel RG, 2008, LANCET, V371, P1073, DOI 10.1016/S0140-6736(08)60485-7
   BULLINGER M, 1995, SOC SCI MED, V41, P1359, DOI 10.1016/0277-9536(95)00115-N
   Chodosh J, 2005, ANN INTERN MED, V143, P427, DOI 10.7326/0003-4819-143-6-200509200-00007
   Cochran J, 2008, DIABETES EDUCATOR, V34, P815, DOI 10.1177/0145721708323640
   CURRIE CJ, 2009, DIABETOLOGIA
   Deakin T, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003417.pub2
   Delahanty LM, 2007, DIABETIC MED, V24, P48, DOI 10.1111/j.1464-5491.2007.02028.x
   Ellis SE, 2004, PATIENT EDUC COUNS, V52, P97, DOI 10.1016/S0738-3991(03)00016-8
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Grusser M, 2009, BEHANDLUNGS SCHULUNG
   Hermanns N, 2005, DIABETIC MED, V22, P293, DOI 10.1111/j.1464-5491.2005.01414.x
   Holman RR, 2009, NEW ENGL J MED, V361, P1736, DOI 10.1056/NEJMoa0905479
   Kalfhaus J, 2000, DIABETES METAB, V26, P197
   McCall WA, 1930, MEASUREMENT
   Norris SL, 2002, AM J PREV MED, V22, P15, DOI 10.1016/S0749-3797(02)00423-3
   Norris SL, 2002, DIABETES CARE, V25, P1159, DOI 10.2337/diacare.25.7.1159
   Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561
   Peyrot M, 1999, DIABETES CARE, V22, P448, DOI 10.2337/diacare.22.3.448
   Peyrot M, 1997, DIABETES CARE, V20, P585, DOI 10.2337/diacare.20.4.585
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   SAWICKI PT, 1995, DIABETIC MED, V12, P893, DOI 10.1111/j.1464-5491.1995.tb00392.x
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Turner RC, 1998, LANCET, V352, P837
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
NR 26
TC 18
Z9 21
U1 0
U2 11
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0738-3991
J9 PATIENT EDUC COUNS
JI Patient Educ. Couns.
PD FEB
PY 2012
VL 86
IS 2
BP 226
EP 232
DI 10.1016/j.pec.2011.05.017
PG 7
WC Public, Environmental & Occupational Health; Social Sciences,
   Interdisciplinary
SC Public, Environmental & Occupational Health; Social Sciences - Other
   Topics
GA 904QN
UT WOS:000301213100014
PM 21715124
DA 2019-01-08
ER

PT J
AU Graue, M
   Haugstvedt, A
   Wentzel-Larsen, T
   Iversen, MM
   Karlsen, B
   Rokne, B
AF Graue, Marit
   Haugstvedt, Anne
   Wentzel-Larsen, Tore
   Iversen, Marjolein M.
   Karlsen, Bjorg
   Rokne, Berit
TI Diabetes-related emotional distress in adults: Reliability and validity
   of the Norwegian versions of the Problem Areas in Diabetes Scale (PAID)
   and the Diabetes Distress Scale (DDS)
SO INTERNATIONAL JOURNAL OF NURSING STUDIES
LA English
DT Article
DE Diabetes; Psychological factors; Psychosocial aspects; Psychometrics;
   Reliability; Validity
ID PERFORMANCE-MEASURES; HOSPITAL ANXIETY; DEPRESSION; QUALITY; MANAGEMENT;
   CARE
AB Background: Regular assessment of diabetes-related emotional distress is recommended to identify high-risk people with diabetes and to further prevent negative effects on self-management. Nevertheless, psychological problems are greatly under diagnosed. Translating and testing instruments for psychosocial assessment across languages, countries and cultures allow for further research collaboration and enhance the prospect of improving treatment and care.
   Objectives: To examine the psychometric properties of the Norwegian versions of the Problem Areas in Diabetes Scale and the Diabetes Distress Scale.
   Design: Cross-sectional survey design.
   Settings: A sample comprising adults with diabetes (response rate 71%) completed the Problem Areas in Diabetes Scale and the Diabetes Distress Scale, which were translated into Norwegian with standard forward-backwards translation.
   Participants: The study included 292 participants with type 1 (80%) and type 2 diabetes (20%) aged 18-69 years, 58% males, mean diabetes duration 17.3 years (11.6), mean HbA(1c) 8.2% (1.6).
   Methods: We used exploratory factor analysis with principal axis factoring and varimax rotation to investigate the factor structure and performed confirmatory factor analysis to test the best fit of a priori-defined models. Convergent and discriminate validity were examined using the Short Form-36 Health Survey, Hospital Anxiety and Depression Scale and demographic and disease-related clinical variables. We explored reliability by internal consistency and test-retest analysis.
   Results: Exploratory factor analysis supported a four-factor model for the Diabetes Distress Scale. Confirmatory factor analysis indicated that the data and the hypothesized model for the Diabetes Distress Scale fit acceptably but not for the Problem Areas in Diabetes Scale. Greater distress assessed with both instruments correlated moderately with lower health-related quality of life and greater anxiety and depression. The instruments discriminated between those having additional health conditions or disabilities, foot problems or neuropathy. Women and participants with higher HbA(1c) levels reported significantly higher diabetes-related emotional distress.
   Conclusions: The Norwegian versions of the Problem Areas in Diabetes Scale and the Diabetes Distress Scale have satisfactory psychometric properties and can be used to map diabetes-related emotional distress for diagnostic or clinical use. The Diabetes Distress Scale also contributes to identifying sub-domains of distress and seems promising for use in clinical trials. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Graue, Marit; Haugstvedt, Anne; Iversen, Marjolein M.] Bergen Univ Coll, Dept Nursing, N-5020 Bergen, Norway.
   [Graue, Marit] Haukeland Hosp, Childrens Clin, N-5021 Bergen, Norway.
   [Haugstvedt, Anne; Rokne, Berit] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Bergen, Norway.
   [Wentzel-Larsen, Tore] Haukeland Hosp, Clin Res Ctr, N-5021 Bergen, Norway.
   [Iversen, Marjolein M.] Stavanger Univ Hosp, Endocrinol Sect, Dept Med, Stavanger, Norway.
   [Karlsen, Bjorg] Univ Stavanger, Dept Hlth Studies, Stavanger, Norway.
   [Rokne, Berit] Haukeland Hosp, Dept Res & Dev, N-5021 Bergen, Norway.
RP Graue, M (reprint author), Bergen Univ Coll, Dept Nursing, Postbox 7030, N-5020 Bergen, Norway.
EM marit.graue@hib.no
FU Bergen University College; Western Norway Health Authority Trust; Bergen
   University College, University of Bergen; Stavanger University
FX Bergen University College and the Western Norway Health Authority Trust
   kindly supported this research. We thank the patients for participating
   and nurses at the endocrinology outpatient clinic, Ingvild Hernar, Kari
   Horn, Elisabeth Iversen, Befit M. Tarlebo and Elin Irrborg, for
   enthusiastic participating in data collection.; This study was supported
   by the Bergen University College, University of Bergen and Stavanger
   University as part of the research group DIABEST.
CR Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3
   Chawla A, 2010, DIABETES EDUCATOR, V36, P337, DOI 10.1177/0145721709354607
   Collins MM, 2009, DIABETIC MED, V26, P153, DOI 10.1111/j.1464-5491.2008.02648.x
   Cooper JG, 2009, DIABETES CARE, V32, P81, DOI 10.2337/dc08-0605
   Eeg-Olofsson K, 2007, DIABETES CARE, V30, P496, DOI 10.2337/dc06-1406
   Fayers P, 2007, ASSESSMENT ANAL INTE
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2009, DIABETIC MED, V26, P622, DOI 10.1111/j.1464-5491.2009.02730.x
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Glasgow RE, 2008, DIABETES CARE, V31, P1046, DOI 10.2337/dc07-1845
   Goldney RD, 2004, DIABETES CARE, V27, P1066, DOI 10.2337/diacare.27.5.1066
   GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   Huang MF, 2010, DIABETES CARE, V33, P38, DOI 10.2337/dc09-0768
   IDF, 2006, DIABETIC MED, V23, P579
   Kartal A, 2011, INT J NURS STUD, V48, P227, DOI 10.1016/j.ijnurstu.2010.07.004
   Lloyd CE, 2010, DIABETIC MED, V27, P234, DOI 10.1111/j.1464-5491.2009.02896.x
   Lloyd CE, 2003, DIABETES-METAB RES, V19, P401, DOI 10.1002/dmrr.394
   Loge JH, 1998, J CLIN EPIDEMIOL, V51, P1069, DOI 10.1016/S0895-4356(98)00098-5
   O'Connor PJ, 2011, DIABETES CARE, V34, P1651, DOI 10.2337/dc11-0735
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   Peyrot M, 2007, DIABETES CARE, V30, P2433, DOI 10.2337/dc07-1222
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Pouwer F, 2006, PATIENT EDUC COUNS, V60, P235, DOI 10.1016/j.pec.2005.01.009
   Sigurdardottir AK, 2008, INT J NURS STUD, V45, P526, DOI 10.1016/j.ijnurstu.2006.10.008
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Ware J.E., 2000, SF36 HLTH SURVEY MAN
   Welch G, 2003, DIABETIC MED, V20, P69, DOI 10.1046/j.1464-5491.2003.00832.x
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
NR 32
TC 32
Z9 37
U1 1
U2 25
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0020-7489
EI 1873-491X
J9 INT J NURS STUD
JI Int. J. Nurs. Stud.
PD FEB
PY 2012
VL 49
IS 2
BP 174
EP 182
DI 10.1016/j.ijnurstu.2011.08.007
PG 9
WC Nursing
SC Nursing
GA 900AV
UT WOS:000300859900007
PM 21924422
DA 2019-01-08
ER

PT J
AU Seligman, HK
   Jacobs, EA
   Lopez, A
   Tschann, J
   Fernandez, A
AF Seligman, Hilary K.
   Jacobs, Elizabeth A.
   Lopez, Andrea
   Tschann, Jeanne
   Fernandez, Alicia
TI Food Insecurity and Glycemic Control Among Low-Income Patients With Type
   2 Diabetes
SO DIABETES CARE
LA English
DT Article
ID NUTRITION EXAMINATION SURVEY; NATIONAL-HEALTH; MEDICATION ADHERENCE;
   SELF-MANAGEMENT; CHRONIC DISEASE; HUNGER; DISTRESS; ADULTS; WOMEN;
   HYPOGLYCEMIA
AB OBJECTIVE-To determine whether food insecurity-the inability to reliably afford safe and nutritious food-is associated with poor glycemic control and whether this association is mediated by difficulty following a healthy diet, diabetes self-efficacy, or emotional distress related to diabetes.
   RESEARCH DESIGN AND METHODS-We used multivariable regression models to examine the association between food insecurity and poor glycemic control using a cross-sectional survey and chart review of 711 patients with diabetes in safety net health clinics. We then examined whether difficulty following a diabetic diet, self-efficacy, or emotional distress related to diabetes mediated the relationship between food insecurity and glycemic control.
   RESULTS-The food insecurity prevalence in our sample was 46%. Food-insecure participants were significantly more likely than food-secure participants to have poor glycemic control, as defined by hemoglobin A(1c) >= 8.5% (42 vs. 33%; adjusted odds ratio 1.48 [95% CI 1.07-2.04]). Food-insecure participants were more likely to report difficulty affording a diabetic diet (64 vs. 49%, P < 0.001). They also reported lower diabetes-specific self-efficacy (P < 0.001) and higher emotional distress related to diabetes (P < 0.001). Difficulty following a healthy diet and emotional distress partially mediated the association between food insecurity and glycemic control.
   CONCLUSIONS-Food insecurity is an independent risk factor for poor glycemic control in the safety net setting. This risk may be partially attributable to increased difficulty following a diabetes-appropriate diet and increased emotional distress regarding capacity for successful diabetes self-management. Screening patients with diabetes for food insecurity may be appropriate, particularly in the safety net setting.
C1 [Seligman, Hilary K.; Lopez, Andrea; Fernandez, Alicia] Univ Calif San Francisco, Div Gen Internal Med, San Francisco Gen Hosp, San Francisco, CA 94143 USA.
   [Seligman, Hilary K.; Lopez, Andrea] Univ Calif San Francisco, San Francisco Gen Hosp, Ctr Vulnerable Populat, San Francisco, CA USA.
   [Jacobs, Elizabeth A.] Univ Wisconsin, Sch Med & Publ Hlth, Div Gen Med, Madison, WI USA.
   [Jacobs, Elizabeth A.] Univ Wisconsin, Sch Med & Publ Hlth, Hlth Innovat Program, Madison, WI USA.
   [Tschann, Jeanne] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA.
RP Seligman, HK (reprint author), Univ Calif San Francisco, Div Gen Internal Med, San Francisco Gen Hosp, San Francisco, CA 94143 USA.
EM hseligman@medsfgh.ucsf.edu
OI Lopez, Andrea/0000-0002-9488-4622
FU Russell Sage Foundation; The Commonwealth Fund; National Institutes of
   Health (NIH)/National Center for Research Resources (NCRR)/Office of the
   Director, University of California, San Francisco (UCSF)-Clinical &
   Translational Science Institute (CTSI) [KL2 RR024130]; Arnold P. Gold
   Foundation
FX This project was supported by funding from the Russell Sage Foundation
   and The Commonwealth Fund. H.K.S. received additional support from the
   National Institutes of Health (NIH)/National Center for Research
   Resources (NCRR)/Office of the Director, University of California, San
   Francisco (UCSF)-Clinical & Translational Science Institute (CTSI) Grant
   KL2 RR024130. A.F. received additional support from an Arnold P. Gold
   Foundation Professorship. The contents of the project are solely the
   responsibility of the authors and do not necessarily represent the
   official views of the NIH.
CR Adams EJ, 2003, J NUTR, V133, P1070
   Adriaanse MC, 2008, DIABETES CARE, V31, P2268, DOI 10.2337/dc08-1074
   Agardh E, 2011, INT J EPIDEMIOL, V40, P804, DOI 10.1093/ije/dyr029
   ANDERSON SA, 1990, J NUTR, V120, P1559, DOI 10.1093/jn/120.suppl_11.1555
   Bhattacharya J, 2004, J HEALTH ECON, V23, P839, DOI 10.1016/j.jhealeco.2003.12.008
   Bickel G, 2000, GUIDE MEASURING HOUS
   Coleman-Jensen A, HOUSEHOLD FOOD SECUR
   Dixon LB, 2001, J NUTR, V131, P1232
   Drewnowski A, 2005, J NUTR, V135, P900
   Drewnowski A, 2004, AM J PUBLIC HEALTH, V94, P1555, DOI 10.2105/AJPH.94.9.1555
   DREWNOWSKI A, 2005, AM J CLIN NUTR S, V82, P265
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Hager ER, 2010, PEDIATRICS, V126, pE26, DOI 10.1542/peds.2009-3146
   Hurley A C, 1992, Diabetes Educ, V18, P146, DOI 10.1177/014572179201800208
   Kaiser LL, 2004, AM J CLIN NUTR, V80, P1372
   Karter AJ, 2002, JAMA-J AM MED ASSOC, V287, P2519, DOI 10.1001/jama.287.19.2519
   Kendall A, 1996, J AM DIET ASSOC, V96, P1019, DOI 10.1016/S0002-8223(96)00271-4
   Krapek K, 2004, ANN PHARMACOTHER, V38, P1357, DOI 10.1345/aph.1D612
   Lee JS, 2001, J NUTR, V131, P1503
   Lorig K, 1996, OUTCOME MEASURES HLT
   MacKinnon DP, 2002, PSYCHOL METHODS, V7, P83, DOI 10.1037//1082-989X.7.1.83
   Marjerrison S, 2011, J PEDIATR-US, V158, P607, DOI 10.1016/j.jpeds.2010.10.003
   Minnesota Department of Health. Optimal diabetes care, 2011, OPT DIAB CAR 2011 DA
   MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007
   National Committee for Quality Assurance (NCQA), 2009, 2009 HEDIS PERF MEAS
   National Quality Forum (NQF), HEM A1C MAN
   Olson CM, 1999, J NUTR, V129, p521S, DOI 10.1093/jn/129.2.521S
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Robbins JM, 2001, AM J PUBLIC HEALTH, V91, P76
   Sarkar U, 2006, DIABETES CARE, V29, P823, DOI 10.2337/diacare.29.04.06.dc05-1615
   Seligman HK, 2007, J GEN INTERN MED, V22, P1018, DOI 10.1007/s11606-007-0192-6
   Seligman HK, 2011, ARCH INTERN MED, V171, P1204, DOI 10.1001/archinternmed.2011.287
   Seligman HK, 2010, J HEALTH CARE POOR U, V21, P1227, DOI 10.1353/hpu.2010.0921
   Seligman HK, 2010, NEW ENGL J MED, V363, P6, DOI 10.1056/NEJMp1000072
   Seligman HK, 2010, J NUTR, V140, P304, DOI 10.3945/jn.109.112573
   Tarasuk VS, 1999, J NUTR, V129, P672
   Tarasuk VS, 2001, J NUTR, V131, P2670
   Wilde PE, 2000, AM J AGR ECON, V82, P200, DOI 10.1111/0002-9092.00016
   Wolfe WS, 1998, J AGING HEALTH, V10, P327, DOI 10.1177/089826439801000304
NR 40
TC 100
Z9 104
U1 0
U2 24
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
J9 DIABETES CARE
JI Diabetes Care
PD FEB
PY 2012
VL 35
IS 2
BP 233
EP 238
DI 10.2337/dc11-1627
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 886LN
UT WOS:000299856000008
PM 22210570
OA Green Published, Other Gold
DA 2019-01-08
ER

PT J
AU Fisher, L
   Hessler, DM
   Polonsky, WH
   Mullan, J
AF Fisher, Lawrence
   Hessler, Danielle M.
   Polonsky, William H.
   Mullan, Joseph
TI When Is Diabetes Distress Clinically Meaningful? Establishing cut points
   for the Diabetes Distress Scale
SO DIABETES CARE
LA English
DT Article
ID DEPRESSION; ADULTS; CARE
AB OBJECTIVE-To identify the pattern of relationships between the 17-item Diabetes Distress Scale (DDS17) and diabetes variables to establish scale cut points for high distress among patients with type 2 diabetes.
   RESEARCH DESIGN AND METHODS-Recruited were 506 study 1 and 392 study 2 adults with type 2 diabetes from community medical groups. Multiple regression equations associated the DDS17, a 17-item scale that yields a mean-item score, with HbA(1c), diabetes self-efficacy, diet, and physical activity. Associations also were undertaken for the two-item DDS (DDS2) screener. Analyses included control variables, linear, and quadratic (curvilinear) DDS terms.
   RESULTS-Significant quadratic effects occurred between the DDS17 and each diabetes variable, with increases in distress associated with poorer outcomes: study 1 HbA(1c) (P < 0.02), self-efficacy (P < 0.001), diet (P < 0.001), physical activity (P < 0.04); study 2 HbA(1c) (P < 0.03), self-efficacy (P < 0.004), diet (P < 0.04), physical activity (P = NS). Substantive curvilinear associations with all four variables in both studies began at unexpectedly low levels of DDS17: the slope increased linearly between scores 1 and 2, was more muted between 2 and 3, and reached a maximum between 3 and 4. This suggested three patient subgroups: little or no distress, <2.0; moderate distress, 2.0-2.9; high distress, >= 3.0. Parallel findings occurred for the DDS2.
   CONCLUSIONS-In two samples of type 2 diabetic patients we found a consistent pattern of curvilinear relationships between the DDS and HbA(1c), diabetes self-efficacy, diet, and physical activity. The shape of these relationships suggests cut points for three patient groups: little or no, moderate, and high distress.
C1 [Fisher, Lawrence; Hessler, Danielle M.] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA.
   [Polonsky, William H.] Behav Diabet Inst, San Diego, CA USA.
   [Mullan, Joseph] Univ Calif San Francisco, Sch Nursing, San Francisco, CA 94143 USA.
RP Fisher, L (reprint author), Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA.
EM fisherl@fcm.ucsf.edu
FU National Institute of Diabetes and Digestive and Kidney Diseases
   [DK062732, DK061937]
FX This research was supported by grants DK062732 and DK061937 from the
   National Institute of Diabetes and Digestive and Kidney Diseases.
CR Ammerman A, 2004, STARTING CONVERSATIO
   Coyne JC, 1992, FAMILY HLTH PSYCHOL, P94
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2009, DIABETIC MED, V26, P622, DOI 10.1111/j.1464-5491.2009.02730.x
   Fisher L, 2000, DIABETES CARE, V23, P267, DOI 10.2337/diacare.23.3.267
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Glasgow RE, 2011, J MED INTERNET RES, V13, P70, DOI 10.2196/jmir.1391
   Gonzalez JS, 2011, DIABETES CARE, V34, P236, DOI 10.2337/dc10-1970
   Hessler DM, 2011, WHY DO YOUNGER ADULT
   Lorig K, 1996, OUTCOME MEASURES HLT
   Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004
   O'Brien SM, 2004, BIOMETRICS, V60, P504, DOI 10.1111/j.0006-341X.2004.00196.x
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737
   Stewart AL, 2001, MED SCI SPORT EXER, V33, P1126
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Williams B., 2006, FINDING OPTIMAL CUTP
   WITTCHEN HU, 1994, J PSYCHIAT RES, V28, P57, DOI 10.1016/0022-3956(94)90036-1
NR 20
TC 146
Z9 153
U1 1
U2 28
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
J9 DIABETES CARE
JI Diabetes Care
PD FEB
PY 2012
VL 35
IS 2
BP 259
EP 264
DI 10.2337/dc11-1572
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 886LN
UT WOS:000299856000013
PM 22228744
OA Other Gold, Green Published
DA 2019-01-08
ER

PT J
AU Kaas, A
   Andersen, MLM
   Fredheim, S
   Hougaard, P
   Buschard, K
   Petersen, JS
   de Beaufort, C
   Robertson, KJ
   Hansen, L
   Mortensen, HB
   Nielsen, LB
AF Kaas, Anne
   Andersen, Marie Louise Max
   Fredheim, Siri
   Hougaard, Philip
   Buschard, Karsten
   Petersen, Jacob Steen
   de Beaufort, Carine
   Robertson, Kenneth J.
   Hansen, Lars
   Mortensen, Henrik B.
   Nielsen, Lotte B.
CA Hvidoere Study Grp Childhood Diabe
TI Proinsulin, GLP-1, and glucagon are associated with partial remission in
   children and adolescents with newly diagnosed type 1 diabetes
SO PEDIATRIC DIABETES
LA English
DT Article
DE GLP-1; glucagon; proinsulin; type 1 diabetes; remission phase
ID BETA-CELL FUNCTION; INSULIN AUTOANTIBODIES; GLYCEMIC CONTROL; PEPTIDE
   RATIO; MELLITUS; RELEASE; NIDDM; PERSPECTIVES; ANTIBODIES; SECRETION
AB Objective: Proinsulin is a marker of beta-cell distress and dysfunction in type 2 diabetes and transplanted islets. Proinsulin levels are elevated in patients newly diagnosed with type 1 diabetes. Our aim was to assess the relationship between proinsulin, insulin dose-adjusted haemoglobin A1c (IDAA1C), glucagon-like peptide-1 (GLP-1), glucagon, and remission status the first year after diagnosis of type 1 diabetes.
   Methods: Juvenile patients (n = 275) were followed 1, 6, and 12 months after diagnosis. At each visit, partial remission was defined as IDAA1C = 9%. The patients had a liquid meal test at the 1-, 6-, and 12-month visits, which included measurement of C-peptide, proinsulin, GLP-1, glucagon, and insulin antibodies (IA).
   Results: Patients in remission at 6 and 12 months had significantly higher levels of proinsulin compared to non-remitting patients (p < 0.0001, p = 0.0002). An inverse association between proinsulin and IDAA1C was found at 1 and 6 months (p = 0.0008, p = 0.0022). Proinsulin was positively associated with C-peptide (p < 0.0001) and IA (p = 0.0024, p = 0.0068, p < 0.0001) at 1, 6, and 12 months. Glucagon (p < 0.0001 and p < 0.02) as well as GLP-1 (p = 0.0001 and p = 0.002) were significantly lower in remitters than in non-remitters at 6 and 12 months. Proinsulin associated positively with GLP-1 at 1 month (p = 0.004) and negatively at 6 (p = 0.002) and 12 months (p = 0.0002).
   Conclusions: In type 1 diabetes, patients in partial remission have higher levels of proinsulin together with lower levels of GLP-1 and glucagon compared to patients not in remission. In new onset type 1 diabetes proinsulin level may be a sign of better residual beta-cell function.
C1 Glostrup Univ Hosp, Dept Paediat, DK-2600 Glostrup, Denmark.
   [Kaas, Anne; Andersen, Marie Louise Max; Fredheim, Siri; Hansen, Lars; Mortensen, Henrik B.; Nielsen, Lotte B.] Glostrup Herlev Univ Hosp, Dept Paediat, Copenhagen, Denmark.
   [Hougaard, Philip] Univ So Denmark, Dept Stat, Odense, Denmark.
   [Buschard, Karsten] Rigshosp, Bartholin Inst, DK-2100 Copenhagen, Denmark.
   [Petersen, Jacob Steen] Novo Nordisk AS, Malov, Denmark.
   [de Beaufort, Carine] Ctr Hosp Luxembourg, Clin Pediat, Luxembourg, Luxembourg.
   [Robertson, Kenneth J.] Royal Hosp Sick Children, Dept Paediat, Glasgow G3 8SJ, Lanark, Scotland.
RP Kaas, A (reprint author), Glostrup Univ Hosp, Dept Paediat, Res Pk, DK-2600 Glostrup, Denmark.
EM annekaas@dadlnet.dk
OI Mortensen, Henrik Bindesbol/0000-0001-9231-8363; Buschard,
   Karsten/0000-0002-0126-7423
CR Arai T, 2010, CLIN IMMUNOL, V136, P74, DOI 10.1016/j.clim.2010.02.016
   Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0
   Blandino-Rosano M, 2008, J MOL ENDOCRINOL, V41, P35, DOI 10.1677/JME-07-0154
   BOHMER K, 1991, DIABETOLOGIA, V34, P830, DOI 10.1007/BF00408359
   Bosi E, 2010, J CLIN ENDOCR METAB, V95, P2607, DOI 10.1210/jc.2009-2741
   Creutzfeldt WOC, 1996, DIABETES CARE, V19, P580, DOI 10.2337/diacare.19.6.580
   DCCT Res Grp, 1987, J CLIN ENDOCR METAB, V65, P30
   Dromey JA, 2011, J AUTOIMMUN, V36, P47, DOI 10.1016/j.jaut.2010.10.005
   Forst T, 2011, DIABETES OBES METAB, V13, P542, DOI 10.1111/j.1463-1326.2011.01386.x
   Holst JJ, 2006, DIABETOLOGIA, V49, P253, DOI 10.1007/s00125-005-0107-1
   HOLST JJ, 1982, BIOCHEM J, V207, P381, DOI 10.1042/bj2070381
   Hostens K, 1999, J CLIN INVEST, V104, P67, DOI 10.1172/JCI6438
   Kaas A, 2010, CLIN EXP IMMUNOL, V161, P444, DOI 10.1111/j.1365-2249.2010.04193.x
   Kahn SE, 1997, DIABETES, V46, P1725, DOI 10.2337/diabetes.46.11.1725
   Kawamori D, 2009, ISLETS, V1, P276, DOI 10.4161/isl.1.3.9967
   Kielgast U, 2009, CURR DIABETES REV, V5, P266, DOI 10.2174/157339909789804413
   Klimek AM, 2009, AM J TRANSPLANT, V9, P2119, DOI 10.1111/j.1600-6143.2009.02740.x
   LEAHY JL, 1991, DIABETES, V40, P985, DOI 10.2337/diabetes.40.8.985
   LUDVIGSSON J, 1982, ACTA DIABETOL LAT, V19, P351, DOI 10.1007/BF02629258
   Madsbad S, 2011, DIABETES OBES METAB, V13, P394, DOI 10.1111/j.1463-1326.2011.01357.x
   Mortensen HB, 2010, PEDIATR DIABETES, V11, P218, DOI 10.1111/j.1399-5448.2009.00566.x
   Mortensen HB, 2009, DIABETES CARE, V32, P1384, DOI 10.2337/dc08-1987
   MULLER WA, 1971, J CLIN INVEST, V50, P1992, DOI 10.1172/JCI106691
   ORSKOV C, 1994, DIABETES, V43, P535, DOI 10.2337/diabetes.43.4.535
   Porksen S, 2007, J CLIN ENDOCR METAB, V92, P2910, DOI 10.1210/jc.2007-0244
   PORTE D, 1989, DIABETES, V38, P1333, DOI 10.2337/diabetes.38.11.1333
   Pratley RE, 2008, DIABETES OBES METAB, V10, P931, DOI 10.1111/j.1463-1326.2007.00835.x
   Roder ME, 1998, J CLIN ENDOCR METAB, V83, P604, DOI 10.1210/jc.83.2.604
   Scholin A, 2011, DIABETIC MED, V28, P156, DOI 10.1111/j.1464-5491.2010.03191.x
   Snorgaard O, 1996, DIABETES CARE, V19, P146, DOI 10.2337/diacare.19.2.146
   SPINAS GA, 1992, DIABETES CARE, V15, P632, DOI 10.2337/diacare.15.5.632
NR 31
TC 9
Z9 10
U1 0
U2 8
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1399-543X
EI 1399-5448
J9 PEDIATR DIABETES
JI Pediatr. Diabetes
PD FEB
PY 2012
VL 13
IS 1
BP 51
EP 58
DI 10.1111/j.1399-5448.2011.00812.x
PG 8
WC Endocrinology & Metabolism; Pediatrics
SC Endocrinology & Metabolism; Pediatrics
GA 882FY
UT WOS:000299549900009
PM 22118630
OA Green Published
DA 2019-01-08
ER

PT J
AU Egede, LE
   Dismuke, CE
AF Egede, Leonard E.
   Dismuke, Clara E.
TI Serious Psychological Distress and Diabetes: A Review of the Literature
SO CURRENT PSYCHIATRY REPORTS
LA English
DT Review
DE Kessler; Psychological distress; Serious psychological distress;
   Diabetes; Depression; Schizophrenia; Post-traumatic stress disorder;
   PTSD; Diabetes distress; Anxiety
ID CORONARY-HEART-DISEASE; MAJOR DEPRESSION; GLYCEMIC CONTROL; MEDICATION
   ADHERENCE; COMORBID DEPRESSION; GENERAL-POPULATION; PROSPECTIVE COHORT;
   MENTAL-ILLNESS; HEALTH-CARE; LOW-INCOME
AB With the development of a measure of serious psychological distress (SPD) in 2002, more attention is being paid to the association of SPD with diabetes outcomes and processes of care. We review the literature on the relationship between SPD and diabetes processes of care and outcomes, as well as the literature on the relationship between specific mental health diagnoses and diabetes processes of care and outcomes during the 2010 to 2011 period. There is an extensive literature on the association of mental health diagnoses with diabetes outcomes, especially for depression. Because the Kessler scale measures a much broader range of mental health issues than any specific DSM-IV/Structured Clinical Interview for DSM Disorders diagnosis and is designed to assess SPD at the population level, additional research needs to be conducted both in clinical settings and using large administrative datasets to examine the association between SPD and diabetes outcomes and processes of care.
C1 [Egede, Leonard E.; Dismuke, Clara E.] Ralph H Johnson Vet Affairs Med Ctr, Ctr Dis Prevent & Hlth Intervent Diverse Populat, Charleston, SC 29425 USA.
   [Egede, Leonard E.; Dismuke, Clara E.] Med Univ S Carolina, Ctr Hlth Dispar Res, Charleston, SC 29425 USA.
RP Egede, LE (reprint author), Ralph H Johnson Vet Affairs Med Ctr, Ctr Dis Prevent & Hlth Intervent Diverse Populat, 135 Rutledge Ave,Room 280H,POB 250593, Charleston, SC 29425 USA.
EM egedel@musc.edu
FU Center for Disease Prevention and Health Interventions for Diverse
   Populations HSRD [REA 08-261]
FX The authors acknowledge and appreciate the resources provided by the
   Center for Disease Prevention and Health Interventions for Diverse
   Populations HSR&D program (grant REA 08-261) and the Ralph H. Johnson
   Veterans Affairs Medical Center. The views expressed in this article are
   those of the authors and do not necessarily represent the views of the
   Department of Veterans Affairs.
CR Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x
   Arnaud B, 2010, ALCOHOL CLIN EXP RES, V34, P1235, DOI 10.1111/j.1530-0277.2010.01201.x
   Auila N, 2011, DIABETIC MED, V28, P785
   Becker T, 2011, DIABETES CARE, V34, P398, DOI 10.2337/dc10-1139
   Boyko EJ, 2010, DIABETES CARE, V33, P1771, DOI 10.2337/dc10-0296
   Bresee L, 2011, EUR PSYCHIAT, V33, P327
   Bryan C, 2010, DIABETES CARE, V33, P1034
   Campayo A, 2011, CURR PSYCHIAT REP, V13, P26, DOI 10.1007/s11920-010-0165-z
   Centres for Disease Control and Prevention, 2004, MMWR-MORBID MORTAL W, V53, P1089
   Clouse RE, 2003, PSYCHOSOM MED, V65, P376, DOI 10.1097/01.PSY.0000041624.96580.1F
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   Dismuke CE, 2011, GEN HOSP PSYCHIAT, V33, P311, DOI 10.1016/j.genhosppsych.2011.03.014
   Dismuke CE, 2010, GEN HOSP PSYCHIAT, V32, P484, DOI 10.1016/j.genhosppsych.2010.06.004
   Dunbar JA, 2008, DIABETES CARE, V31, P2368, DOI 10.2337/dc08-0175
   Egede LE, 2005, DIABETES CARE, V28, P1339, DOI 10.2337/diacare.28.6.1339
   Egede LE, 2004, DIABETES CARE, V27, P1751, DOI 10.2337/diacare.27.7.1751
   Egede LE, 2004, DIABETES CARE, V27, P421, DOI 10.2337/diacare.27.2.421
   Egede LE, 2002, DIABETES CARE, V25, P464, DOI 10.2337/diacare.25.3.464
   Egede LE, 2005, CURR DIABETES REV, V1, P235, DOI 10.2174/157339905774574356
   Egede LE, 2010, GEN HOSP PSYCHIAT, V32, P563, DOI 10.1016/j.genhosppsych.2010.08.002
   Egede LE, 2010, DIABETES RES CLIN PR, V87, P302, DOI 10.1016/j.diabres.2010.01.024
   Egede LE, 2010, DIABETES EDUCATOR, V36, P276, DOI 10.1177/0145721710361389
   Ell K, 2011, GEN HOSP PSYCHIAT
   Ell K, 2010, DIABETES CARE, V33, P706, DOI 10.2337/dc09-1711
   Eren I, 2008, DEPRESS ANXIETY, V25, P98, DOI 10.1002/da.20288
   Finkelstein EA, 2003, DIABETES CARE, V26, P415, DOI 10.2337/diacare.26.2.415
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Gonzalez JS, 2007, DIABETES CARE, V30, P2222, DOI 10.2337/dc07-0158
   Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341
   Heckbert SR, 2010, J GEN INTERN MED, V25, P524, DOI 10.1007/s11606-010-1272-6
   Hsu JH, 2011, CAN J PSYCHIAT, V56, P19, DOI 10.1177/070674371105600105
   Katon W, 2008, J GEN INTERN MED, V23, P1571, DOI 10.1007/s11606-008-0731-9
   Katon WJ, 2010, J GEN INTERN MED, V25, P423, DOI 10.1007/s11606-009-1248-6
   Kessler R.C., 2010, INT J METHODS PSY S1, P4
   Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Kessler RC, 2006, B WORLD HEALTH ORGAN, V84, P930, DOI 10.2471/BLT.06.033019
   Kreyenbuhl J, 2010, SCHIZOPHRENIA BULL, V36, P428, DOI 10.1093/schbul/sbn106
   Krieger N, 2011, AM J PUBLIC HEALTH, V101, P1704, DOI 10.2105/AJPH.2011.300168
   Labad J, 2010, DIABETOLOGIA, V53, P467, DOI 10.1007/s00125-009-1628-9
   Le Trong K, 2006, Cost Eff Resour Alloc, V4, P18, DOI 10.1186/1478-7547-4-18
   Li CY, 2010, DIABETES CARE, V33, P1061, DOI 10.2337/dc09-1515
   Li CY, 2009, INT J PUBLIC HEALTH, V54, P43, DOI 10.1007/s00038-009-0006-1
   Lin EHB, 2004, DIABETES CARE, V27, P2154, DOI 10.2337/diacare.27.9.2154
   Lin EHB, 2010, DIABETES CARE, V33, P264, DOI 10.2337/dc09-1068
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   McDade-Montez E, 2011, ANN BEHAV MED
   McMillan KA, 2010, J CLIN PSYCHIAT, V71, P1168, DOI 10.4088/JCP.08m04986gry
   Miller SA, 2011, GEN HOSP PSYCHIAT, V33, P116, DOI 10.1016/j.genhosppsych.2010.12.005
   Mitchell CM, 2011, PSYCHOL ASSESSMENT, V23, P752, DOI 10.1037/a0023288
   Nouwen A, 2011, DIABETES CARE, V34, P752, DOI 10.2337/dc10-1414
   Osborn CY, 2010, DIABETES CARE, V33, P1050, DOI 10.2337/dc09-1929
   Pan A, 2010, ARCH INTERN MED, V22, P1884
   Pan A, 2011, ARCH GEN PSYCHIAT, V68, P42, DOI 10.1001/archgenpsychiatry.2010.176
   Pirraglia PA, 2011, AM J MANAG CARE, V17, P319
   Richardson LK, 2008, GEN HOSP PSYCHIAT, V30, P509, DOI 10.1016/j.genhosppsych.2008.07.001
   Schoepf D, 2011, EUR PSYCHIAT
   Scott-Tilley D, 2010, PERSPECT PSYCHIATR C, V46, P26, DOI 10.1111/j.1744-6163.2009.00235.x
   Sorkin DH, 2011, DIABETES CARE, V34, P598, DOI 10.2337/dc10-1825
   Ting RZW, 2011, DIABETES CARE, V34, P1094, DOI 10.2337/dc10-1612
   Trento M, 2011, ACTA DIABETOL
   Williams SL, 2010, INT J PSYCHIAT MED, V40, P233, DOI 10.2190/PM.40.3.a
   ZAGARINS SE, 2011, J BEHAV MED
NR 65
TC 51
Z9 51
U1 0
U2 36
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1523-3812
J9 CURR PSYCHIAT REP
JI Curr. Psychiatry Rep.
PD FEB
PY 2012
VL 14
IS 1
BP 15
EP 22
DI 10.1007/s11920-011-0240-0
PG 8
WC Psychiatry
SC Psychiatry
GA 876FJ
UT WOS:000299092700003
PM 22002804
DA 2019-01-08
ER

PT J
AU Due-Christensen, M
   Zoffmann, V
   Hommel, E
   Lau, M
AF Due-Christensen, M.
   Zoffmann, V.
   Hommel, E.
   Lau, M.
TI Can sharing experiences in groups reduce the burden of living with
   diabetes, regardless of glycaemic control?
SO DIABETIC MEDICINE
LA English
DT Article
DE diabetes-related distress; good and poor metabolic control;
   psychosocial; support groups
ID RANDOMIZED CONTROLLED-TRIAL; OF-THE-LITERATURE; PSYCHOSOCIAL
   INTERVENTIONS; TYPE-1; QUESTIONNAIRES; METAANALYSIS; DEPRESSION;
   MANAGEMENT; DISTRESS; IMPROVE
AB Aims To test whether patients with Type 1 diabetes would join support groups and benefit by improving psychosocial functioning, regardless of their HbA1c levels. Methods A pre-post test with follow-up after 6 and 12 months was conducted as a concurrent mixed-method study. The convenience sample included patients with Type 1 diabetes aged = 21 years, having been diagnosed = 1 year earlier. Primary outcome was diabetes-related distress (using the Problem Areas in Diabetes scale). Secondary outcomes were psychological distress and depressive symptoms (Symptom Check List -90-R/Global Severity Index and depression subscale), well-being (World Health Organization 5) and HbA1c. Results Equal numbers of patients with HbA1c above and below 64 mmol/mol (8%) joined the support groups (n = 54). Focus group interviews revealed that major benefits were feeling less alone and being intuitively understood among peers. The patients perceived the support groups as a safe environment for sharing experiences. Problem Areas in Diabetes, Global Severity Index and depression subscale scores were significantly reduced post-intervention and maintained at 1-year follow-up. Well-being increased insignificantly. HbA1c was unchanged. Conclusions Support groups are able to reduce diabetes-related and psychological distress 1 year after the intervention for patients with both good and poor glycaemic control displaying high levels of distress. Although patients with severely high levels of diabetes-related distress might need more extensive therapeutic interventions to further reduce their level of distress. Further, interventions that target specific self-management problems are needed for patients with poor glycaemic control to help them accomplish lower levels of HbA1c. Moreover, healthcare providers must be aware that patients with good glycaemic control might have an unacknowledged psychosocial burden of living with the illness.
C1 [Due-Christensen, M.; Zoffmann, V.; Hommel, E.] Steno Diabet Ctr, DK-2820 Gentofte, Denmark.
   [Lau, M.] Stolpegaard Psychotherapy Ctr, Gentofte, Denmark.
RP Due-Christensen, M (reprint author), Steno Diabet Ctr, Niels Steensens Vej 2, DK-2820 Gentofte, Denmark.
EM mtdc@steno.dk
OI Due-Christensen, Mette/0000-0003-2604-3730; Zoffmann,
   Vibeke/0000-0003-0571-5331; Hommel, Eva/0000-0001-7570-5919
FU Steno Diabetes Center
FX This study was supported by grants from the Steno Diabetes Center. We
   acknowledge all patients for their participation.
CR ANDERSON RM, 1995, DIABETES CARE, V18, P943, DOI 10.2337/diacare.18.7.943
   Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI DOI 10.1191/1478088706QP0630A
   Creswell J. W., 2003, RES DESIGN QUALITATI, P208
   de Wit M, 2007, DIABETES CARE, V30, P2003, DOI 10.2337/dc07-0447
   Derogatis L., 1994, SCL 90 R SYMPTOM CHE
   DeVries JH, 2004, DIABETIC MED, V21, P1263, DOI 10.1111/j.1464-5491.2004.01386.x
   Fisher EB, 2007, DIABETES EDUCATOR, V33, P1080, DOI 10.1177/0145721707309808
   Grigsby AB, 2002, J PSYCHOSOM RES, V53, P1053, DOI 10.1016/S0022-3999(02)00417-8
   Harkness E, 2010, DIABETES CARE, V33, P926, DOI 10.2337/dc09-1519
   Hartemann-Heurtier A, 2001, DIABETES METAB, V27, P553
   Heisler M., 2007, DIABETES SPECTRUM, V20, P214, DOI DOI 10.2337/DIASPECT.20.4.214
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   Hernandez C A, 1996, Can J Nurs Res, V28, P37
   Hill-Briggs F, 2007, DIABETES EDUCATOR, V33, P1032, DOI 10.1177/0145721707308412
   Kazdin A. E., 1994, HDB PSYCHOTHERAPY BE, P19
   Lowe B, 2004, J AFFECT DISORDERS, V78, P131, DOI 10.1016/S0165-0327(02)00237-9
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Olsen LR, 2004, ACTA PSYCHIAT SCAND, V110, P225, DOI 10.1111/j.1600-0447.2004.00399.x
   Peyrot M, 2007, DIABETES CARE, V30, P2433, DOI 10.2337/dc07-1222
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68
   Skinner TC, 2005, PSYCHOL DIABETES CAR, P141
   Snoek FJ, 2011, DIABETES CARE, V34, P601, DOI 10.2337/dc10-1552
   van Bastelaar KMP, 2010, DIABETIC MED, V27, P798, DOI 10.1111/j.1464-5491.2010.03025.x
   van der Ven NCW, 2005, DIABETIC MED, V22, P1619
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   Winkley K, 2006, BRIT MED J, V333, P65, DOI 10.1136/bmj.38874.652569.55
   Zoffmann V, 2006, PATIENT EDUC COUNS, V64, P78, DOI 10.1016/j.pec.2005.11.017
NR 28
TC 20
Z9 21
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD FEB
PY 2012
VL 29
IS 2
BP 251
EP 256
DI 10.1111/j.1464-5491.2011.03521.x
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 874TK
UT WOS:000298980800015
PM 22061095
DA 2019-01-08
ER

PT J
AU Karlsen, B
   Oftedal, B
   Bru, E
AF Karlsen, Bjorg
   Oftedal, Bjorg
   Bru, Edvin
TI The relationship between clinical indicators, coping styles, perceived
   support and diabetes-related distress among adults with type 2 diabetes
SO JOURNAL OF ADVANCED NURSING
LA English
DT Article
DE clinical indicators; diabetes-related distress; healthcare providers;
   social support; type 2 diabetes
ID PROBLEM AREAS; EMOTIONAL DISTRESS; GLYCEMIC CONTROL; DEPRESSION; SCALE;
   ADJUSTMENT; VALIDITY; DUTCH
AB Aim: This article is a report of a cross-sectional study examining the degree to which clinical indicators, coping styles and perceived support from healthcare professionals and family are related to diabetes-related distress. Background: Many people with type 2 diabetes experience high levels of distress stemming from concerns and worries associated with their disease. Diabetes-related distress has predominantly been studied in relation to diabetes management and metabolic control, and to some extent in relation to coping styles and perceived social support. To date, little is known about the relative contribution of clinical indicators, coping styles and perceptions of social support to perceived distress among people with type 2 diabetes. Methods: A sample comprising 425 Norwegian adults, aged 3070, with type 2 diabetes, completed questionnaires assessing coping styles, perceived social support from health professionals and family and diabetes-related distress assessed by the Problem Areas in Diabetes Scale. Demographical and clinical data were collected by self-report. Data were collected in October 2008. Findings: Results from the regression analyses showed a greater variance in emotional distress accounted for by coping styles (21.3%) and perceived support (19.7%) than by clinical indicators (5.8%). Conclusion: Findings may indicate that healthcare providers should pay more attention to non-clinical factors such as coping styles and social support, when addressing diabetes-related distress. They should also be aware that interventions based on psychosocial approaches may primarily influence distress, and not necessarily metabolic control.
C1 [Karlsen, Bjorg; Oftedal, Bjorg] Univ Stavanger, Fac Social Sci, Dept Hlth Studies, Stavanger, Norway.
   [Bru, Edvin] Univ Stavanger, Ctr Behav Res, Stavanger, Norway.
RP Karlsen, B (reprint author), Univ Stavanger, Fac Social Sci, Dept Hlth Studies, Stavanger, Norway.
EM bjorg.karlsen@uis.no
OI Bru, Edvin/0000-0003-2004-6957
FU Norwegian Diabetes Association
FX The study was supported by grants from the Norwegian Diabetes
   Association.
CR Bouchard G, 2004, EUR J PERSONALITY, V18, P221, DOI 10.1002/per.512
   Bru E., 2002, PSYCHOL HEALTH MED, V7, P245, DOI DOI 10.1080/13548500220139403
   CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267
   Chang EC, 2007, PERS INDIV DIFFER, V43, P1149, DOI 10.1016/j.paid.2007.03.007
   Costa P. T., 1996, HDB COPING THEORY RE, P44
   COX DJ, 1992, J CONSULT CLIN PSYCH, V60, P628, DOI 10.1037//0022-006X.60.4.628
   de Groot Mary, 2010, Diabetes Spectr, V23, P15, DOI 10.2337/diaspect.23.1.15
   de Ridder D, 2001, CLIN PSYCHOL REV, V21, P205, DOI 10.1016/S0272-7358(99)00046-X
   DECI EL, 1991, EDUC PSYCHOL-US, V26, P325, DOI 10.1207/s15326985ep2603&4_6
   Delahanty LM, 2007, DIABETIC MED, V24, P48, DOI 10.1111/j.1464-5491.2007.02028.x
   DeRidder D, 1997, PSYCHOL HEALTH, V12, P417, DOI 10.1080/08870449708406717
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2009, DIABETIC MED, V26, P622, DOI 10.1111/j.1464-5491.2009.02730.x
   Fisher L, 2001, DIABETES CARE, V24, P1751, DOI 10.2337/diacare.24.10.1751
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Folkman S, 2004, ANNU REV PSYCHOL, V55, P745, DOI 10.1146/annurev.psych.55.090902.141456
   Folkman S., 1988, MANUAL WAYS COPING Q
   Ford ME, 1998, J NATL MED ASSOC, V90, P425
   Hewitt PL, 1996, HDB COPING THEORY RE, P410
   Karlsen B., 2004, PSYCHOL HEALTH MED, V9, P53
   Kosciulek John F., 2007, COPING CHRONIC ILLNE, P73
   Lazarus R., 1991, EMOTION ADAPTATION
   Lazarus R. S, 1984, STRESS APPRAISAL COP
   Lloyd C, 2005, DIABETES SPECTR, V18, P121, DOI [DOI 10.2337/DIASPECT.18.2.121, 10.2337/diaspect.18.2.121]
   Macrodimitris SD, 2001, HEALTH PSYCHOL, V20, P208, DOI 10.1037//0278-6133.20.3.208
   Maes S., 1996, HDB COPING THEORY RE, P221
   Moos RH, 2003, J CLIN PSYCHOL, V59, P1257, DOI 10.1002/jclp.10218
   Papelbaum M, 2010, DIABETES RES CLIN PR, V89, P227, DOI 10.1016/j.diabres.2010.05.024
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Pouwer F, 2005, DIABETES RES CLIN PR, V70, P166, DOI 10.1016/j.diabres.2005.03.031
   Sacco WP, 2006, INTERPERSONAL, COGNITIVE, AND SOCIAL NATURE OF DEPRESSION, P101
   Sacco WP, 1999, INTERACTIONAL NATURE OF DEPRESSION, P329, DOI 10.1037/10311-012
   SCHAFER LC, 1986, DIABETES CARE, V9, P179, DOI 10.2337/diacare.9.2.179
   Sigurdardottir AK, 2008, INT J NURS STUD, V45, P526, DOI 10.1016/j.ijnurstu.2006.10.008
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   STEWART M, 2000, CHRONIC CONDITIONS C
   Taylor S, 2006, HLTH PSYCHOL
   Thorne SE, 2001, PATIENT EDUC COUNS, V42, P81, DOI 10.1016/S0738-3991(00)00095-1
   Trief PM, 1998, DIABETES CARE, V21, P241, DOI 10.2337/diacare.21.2.241
   Welch G, 2003, DIABETIC MED, V20, P69, DOI 10.1046/j.1464-5491.2003.00832.x
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   Yang J, 2009, J CLIN NURS, V18, P1295, DOI 10.1111/j.1365-2702.2008.02703.x
NR 44
TC 43
Z9 46
U1 1
U2 16
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0309-2402
EI 1365-2648
J9 J ADV NURS
JI J. Adv. Nurs.
PD FEB
PY 2012
VL 68
IS 2
BP 391
EP 401
DI 10.1111/j.1365-2648.2011.05751.x
PG 11
WC Nursing
SC Nursing
GA 874UW
UT WOS:000298984600015
PM 21707728
DA 2019-01-08
ER

PT J
AU Hay, WW
AF Hay, William W., Jr.
TI Care of the Infant of the Diabetic Mother
SO CURRENT DIABETES REPORTS
LA English
DT Article
DE Gestational diabetes; Infant of diabetic mother; Large for gestational
   age; Pregnancy; Hypoglycemia; Hyperbilirubinemia; Hypocalcemia;
   Hypomagnesemia; Polycythemia; Hyperviscosity; Continuous glucose
   monitoring; Intrauterine growth restriction; Preterm birth; Caudal
   regression syndrome
ID LOW-BIRTH-WEIGHT; NEONATAL HYPOGLYCEMIA; NEWBORN-INFANTS;
   IRON-DEFICIENCY; HIGH GLUCOSE; GESTATIONAL-AGE; PREGNANT-WOMEN; TERM
   INFANTS; FETAL; MELLITUS
AB Gestational diabetes mellitus (GDM) from all causes of diabetes is the most common medical complication of pregnancy and is increasing in incidence, particularly as type 2 diabetes continues to increase worldwide. Despite advances in perinatal care, infants of diabetic mothers (IDMs) remain at risk for a multitude of physiologic, metabolic, and congenital complications such as preterm birth, macrosomia, asphyxia, respiratory distress, hypoglycemia, hypocalcemia, hyperbilirubinemia, polycythemia and hyperviscosity, hypertrophic cardiomyopathy, and congenital anomalies, particularly of the central nervous system. Overt type 1 diabetes around conception produces marked risk of embryopathy (neural tube defects, cardiac defects, caudal regression syndrome), whereas later in gestation, severe and unstable type 1 maternal diabetes carries a higher risk of intrauterine growth restriction, asphyxia, and fetal death. IDMs born to mothers with type 2 diabetes are more commonly obese (macrosomic) with milder conditions of the common problems found in IDMs. IDMs from all causes of GDM also are predisposed to later-life risk of obesity, diabetes, and cardiovascular disease. Care of the IDM neonate needs to focus on ensuring adequate cardiorespiratory adaptation at birth, possible birth injuries, maintenance of normal glucose metabolism, and close observation for polycythemia, hyperbilirubinemia, and feeding intolerance.
C1 Univ Colorado, Sch Med, Perinatal Res Ctr, Aurora, CO 80045 USA.
RP Hay, WW (reprint author), Univ Colorado, Sch Med, Perinatal Res Ctr, Anschutz Med Campus,F441,13243 E 23rd Ave, Aurora, CO 80045 USA.
EM bill.hay@ucdenver.edu
CR Ahlsson FSE, 2007, PEDIATRICS, V120, P958, DOI 10.1542/peds.2007-0165
   Ahmed MU, 1997, BIOCHEM J, V324, P565, DOI 10.1042/bj3240565
   *AM DIAB ASS, 2005, DIABETES CARE S1, V28, pS4, DOI DOI 10.2337/DIACARE
   Banerjee S, 2003, MAGNESIUM RES, V16, P127
   Baptiste-Roberts K, 2011, MATERN CHILD HLTH J, DOI 10.007/s10995-011-0756-2
   BARD H, 1985, PEDIATRICS, V75, P1143
   BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095
   Barnes-Powell LL, 2007, NEONATAL NETW, V26, P283, DOI 10.1891/0730-0832.26.5.283
   Beard J, 2003, J NUTR, V133, P1174
   Beardsall K, 2005, ARCH DIS CHILD-FETAL, V90, pF307, DOI 10.1136/adc.2004.051979
   Beardsall K, 2008, NEW ENGL J MED, V359, P1873, DOI 10.1056/NEJMoa0803725
   Boluyt N, 2006, PEDIATRICS, V117, P2231, DOI 10.1542/peds.2005-1919
   Bromiker R, 2006, J PEDIATR-US, V149, P640, DOI 10.1016/j.jpeds.2006.07.034
   Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615
   Burguet A, 2010, DIABETES METAB, V36, P682, DOI 10.1016/j.diabet.2010.11.018
   Carver TD, 1996, AM J PHYSIOL-ENDOC M, V271, pE865
   CASSON F, 1997, BRIT MED J, V315, P275
   Catalano PM, 2007, OBSTET GYNECOL, V109, P419, DOI 10.1097/01.AOG.0000253311.44696.85
   Cetin H, 2011, J INT MED RES, V39, P815, DOI 10.1177/147323001103900314
   Chu SY, 2007, DIABETES CARE, V30, P2070, DOI 10.2337/dc06-2559a
   Clark RJ, 2003, J BIOL CHEM, V278, P44230, DOI 10.1074/jbc.M303810200
   Coetzee E J, 2000, Semin Neonatol, V5, P221, DOI 10.1053/siny.2000.0010
   Connor JR, 1996, GLIA, V17, P83, DOI 10.1002/(SICI)1098-1136(199606)17:2<83::AID-GLIA1>3.0.CO;2-7
   Cordero L, 1998, ARCH PEDIAT ADOL MED, V152, P249
   Cornblath M, 2000, PEDIATRICS, V105, P1141, DOI 10.1542/peds.105.5.1141
   COWETT RM, 1982, PEDIATR CLIN N AM, V29, P1213
   COWETT RM, 2002, NEOREVIEWS, V3, pE173, DOI DOI 10.1542/NEO.3-9-E173
   Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973
   CRUIKSHANK DP, 1983, AM J OBSTET GYNECOL, V135, P1010
   Dabelea D, 2007, DIABETES CARE, V30, pS169, DOI 10.2337/dc07-s211
   De Leon DD, 2007, NAT CLIN PRACT ENDOC, V3, P57, DOI 10.1038/ncpendmet0368
   DEMARINI S, 1994, OBSTET GYNECOL, V83, P918, DOI 10.1097/00006250-199406000-00003
   deReginer RA, 2000, J PEDIATR-US, V137, P777, DOI 10.1067/mpd.2000.109149
   DEUNGRIA M, 2003, PEDIATR RES, V133, P1174
   Di Cianni G, 2005, DIABETIC MED, V22, P21, DOI 10.1111/j.1464-5491.2004.01336.x
   Doblado Manuel, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P488, DOI 10.1097/MED.0b013e3282f1cb92
   Du XL, 2003, J CLIN INVEST, V112, P1049, DOI 10.1172/JCI200318127
   Eidelman AI, 2002, SEMIN PERINATOL, V26, P232, DOI 10.1053/sper.2002.34215
   ELIXHAUSER A, 1993, DIABETES CARE, V16, P1146, DOI 10.2337/diacare.16.8.1146
   Ellis H, 2009, J PEDIATR SURG, V44, P2343, DOI 10.1016/j.jpedsurg.2009.07.054
   GABBAY KH, 1966, SCIENCE, V151, P209, DOI 10.1126/science.151.3707.209
   Gewolb IH, 1996, EXP LUNG RES, V22, P201, DOI 10.3109/01902149609050847
   GEWOLB IH, 1995, LAB INVEST, V73, P59
   Gewolb IH, 1997, EXP LUNG RES, V23, P245, DOI 10.3109/01902149709087370
   Gustafsson J, 2009, INDIAN J MED RES, V130, P618
   Harris DL, 2010, J PEDIATR-US, V157, P198, DOI 10.1016/j.jpeds.2010.02.003
   Hay WW, 2010, J PEDIATR-US, V157, P180, DOI 10.1016/j.jpeds.2010.04.007
   Hay WW, 2006, J PHYSIOL-LONDON, V572, P17, DOI 10.1113/jphysiol.2006.105072
   HAY WW, 2008, NUTR PEDIAT BASIC SC, P311
   HAY WW, 2003, TXB DIABETES PREGNAN, P201
   HECK IJ, 1987, J PEDIAT, V110, P119
   IKEDA H, 2011, MOL CELL BIOL, V3, P1054
   Ikeda K, 1996, BIOCHEMISTRY-US, V35, P8075, DOI 10.1021/bi9530550
   Jensen DM, 2004, DIABETES CARE, V27, P2819, DOI 10.2337/diacare.27.12.2819
   KAISER N, 1993, DIABETES, V42, P80, DOI 10.2337/diabetes.42.1.80
   Kalhan SC, 2002, NEONATAL PERINATAL M, P1357
   KELLY DP, 1994, NEW ENGL J MED, V330, P913
   Kitajima M, 2001, OBSTET GYNECOL, V97, P776, DOI 10.1016/S0029-7844(01)01328-X
   KNOPP RH, 1992, DIABETES CARE, V15, P1605, DOI 10.2337/diacare.15.11.1605
   Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9
   Koya D, 1998, DIABETES, V47, P859, DOI 10.2337/diabetes.47.6.859
   LILIEN LD, 1980, J PEDIATR-US, V97, P295, DOI 10.1016/S0022-3476(80)80499-9
   Lisowski LA, 2010, HERZ, V35, P19, DOI 10.1007/s00059-010-3244-3
   Lozoff B, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.4.e51
   MANCOJOHNSON MJ, 1994, PEDIATR RES, V36, P293, DOI 10.1203/00006450-199409000-00005
   MCLELLAN AC, 1994, CLIN SCI, V87, P21, DOI 10.1042/cs0870021
   Meissner T, 1997, EUR J PEDIATR, V156, P754, DOI 10.1007/s004310050706
   Meur S, 2007, PAEDIAT CHILD HLTH, V17, P217, DOI DOI 10.1016/J.PAED.2007.03.004
   MIMOUNI F, 1990, AM J PERINAT, V7, P203, DOI 10.1055/s-2007-999481
   MIMOUNI F, 1988, J PEDIATR-US, V113, P345, DOI 10.1016/S0022-3476(88)80282-8
   Mongiovi M, 2010, CURR PHARM DESIGN, V16, P2929, DOI 10.2174/138161210793176428
   MORRIS MA, 1985, AM J OBSTET GYNECOL, V153, P651, DOI 10.1016/S0002-9378(85)80253-2
   Nold JL, 2004, PEDIATR CLIN N AM, V51, P619, DOI 10.1016/j.pcl.2004.01.003
   Ouzilleau C, 2003, CAN MED ASSOC J, V168, P403
   Persson B, 2009, SEMIN FETAL NEONAT M, V14, P106, DOI 10.1016/j.siny.2009.01.003
   PETRY CD, 1994, AM J PHYSIOL-ENDOC M, V267, pE507
   Platas II, 2009, NEONATOLOGY, V95, P217, DOI 10.1159/000165980
   Ralser Markus, 2007, J Biol, V6, P10, DOI 10.1186/jbiol61
   Rao R, 1999, J NUTR, V129, P199
   Rayani HH, 1999, EXP LUNG RES, V25, P69, DOI 10.1080/019021499270439
   Regnault TRH, 2006, NEONATAL NUTRITION AND METABOLISM, 2ND EDITION, P32, DOI 10.1017/CBO9780511544712.004
   Rolo LC, 2011, ARQ BRAS CARDIOL, V96, P386, DOI 10.1590/S0066-782X2011005000036
   Rozance PJ, 2006, BIOL NEONATE, V90, P74, DOI 10.1159/000091948
   Rozance PJ, 2010, EARLY HUM DEV, V86, P275, DOI 10.1016/j.earlhumdev.2010.05.002
   Salhab WA, 2004, PEDIATRICS, V114, P361, DOI 10.1542/peds.114.2.361
   Schaefer-Graf UM, 2008, DIABETES CARE, V31, P1858, DOI 10.2337/dc08-0039
   Schwartz R, 2000, SEMIN PERINATOL, V24, P120, DOI 10.1053/sp.2000.6363
   Son GH, 2010, ACTA OBSTET GYN SCAN, V89, P700, DOI 10.3109/00016341003605677
   SUGAHARA K, 1994, AM J RESP CELL MOL, V11, P397, DOI 10.1165/ajrcmb.11.4.7917308
   Sunehag A, 1997, PEDIATR RES, V42, P492, DOI 10.1203/00006450-199710000-00012
   Thorn SR, 2011, SEMIN REPROD MED, V29, P225, DOI 10.1055/s-0031-1275516
   Thorn SR, 2009, ENDOCRINOLOGY, V150, P3021, DOI 10.1210/en.2008-1789
   Verhaeghe J, 2011, METABOLISM, V60, P71, DOI 10.1016/j.metabol.2010.04.013
   VISSER GHA, 2008, TXB DIABETES PREGNAN
   Volpe JJ, 2001, NEUROLOGY NEWBORN, P178
   Wagner RK, 1999, OBSTET GYN CLIN N AM, V26, P371, DOI 10.1016/S0889-8545(05)70080-2
   WARDPLATT M, 2005, SEMIN FETAL NEONAT M, V10, P341
   WARSHAW JB, 2006, OSKIS PEDIAT PRINCIP, P423
   Weindling MA, 2009, SEMIN FETAL NEONAT M, V14, P111
   WIDNESS JA, 1981, J CLIN INVEST, V67, P637, DOI 10.1172/JCI110078
   WIDNESS JA, 1989, ENDOCRINE DISORDERS, P273
   Yan SF, 2003, CIRC RES, V93, P1159, DOI 10.1161/01.RES.0000103862.26506.3D
   Yang J, 2006, OBSTET GYNECOL, V108, P644, DOI 10.1097/01.AOG.0000231688.08263.47
   2011, DIABETES, V60, P1849
   2011, PEDIATRICS, V127, P575
   2007, CONFIDENTIAL ENQUIRY
NR 106
TC 49
Z9 50
U1 1
U2 23
PU CURRENT MEDICINE GROUP
PI PHILADELPHIA
PA 400 MARKET STREET, STE 700, PHILADELPHIA, PA 19106 USA
SN 1534-4827
J9 CURR DIABETES REP
JI Curr. Diabetes Rep.
PD FEB
PY 2012
VL 12
IS 1
BP 4
EP 15
DI 10.1007/s11892-011-0243-6
PG 12
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 874AD
UT WOS:000298926500002
PM 22094826
DA 2019-01-08
ER

PT J
AU Curcio, R
   Alexandre, NMC
   Torres, HD
   Lima, MHM
AF Curcio, Raquel
   Costa Alexandre, Neuza Maria
   Torres, Heloisa de Carvalho
   Melo Lima, Maria Helena
TI Translation and adaptation of the "Diabetes Distress Scale - DDS" in
   Brazilian culture
SO ACTA PAULISTA DE ENFERMAGEM
LA English
DT Article
DE Diabetes mellitus; Quality of life; Validation studies; Translating
ID QUALITY-OF-LIFE; GLYCEMIC CONTROL; SELF-CARE; HEALTH; DEPRESSION;
   VALIDITY
AB Objective: To translate and adapt the Diabetes Distress Scale for the Brazilian culture. Methods: The process followed international standards for adaptation of an instrument: translation, back translation and evaluation by a panel of judges, and pretest. Results: The stages of translation and back translation were performed successfully, and the evaluation of the synthesis version by the expert panel resulted in modification of items, ensuring the equivalence between the original and translated versions. During the pretest, there were reformulations of some items, making them clearer and easier to understand. Conclusion: The Brazilian version of the Diabetes Distress Scale received satisfactory results with respect to the process of translation and cultural adaptation.
C1 [Curcio, Raquel] State Univ Campinas UNICAMP, Campinas, SP, Brazil.
   [Costa Alexandre, Neuza Maria; Melo Lima, Maria Helena] State Univ Campinas UNICAMP, Fac Med Sci, Dept Nursing, Campinas, SP, Brazil.
   [Torres, Heloisa de Carvalho] Univ Fed Minas Gerais, Sch Nursing, Dept Appl Nursing, Belo Horizonte, MG, Brazil.
RP Lima, MHM (reprint author), Rua Tessalia Vieira de Camargo 126,Caixa Postal 6, BR-13083887 Campinas, SP, Brazil.
EM melolima@fcm.unicamp.br
RI Lima, Maria Helena/C-5389-2018; Lima, Maria Helena/E-9595-2012
OI Lima, Maria Helena/0000-0001-6521-8324; Lima, Maria
   Helena/0000-0001-6521-8324
CR Alexandre Neusa Maria Costa, 2002, Rev Panam Salud Publica, V11, P109, DOI 10.1590/S1020-49892002000200007
   Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014
   Curcio R, 2011, REV ELETRONICA ENFER, V13, P331
   El Achhab Y, 2008, DIABETES RES CLIN PR, V80, P171, DOI 10.1016/j.diabres.2007.12.020
   Fisher L, 2009, DIABETIC MED, V26, P622, DOI 10.1111/j.1464-5491.2009.02730.x
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Gonzalez JS, 2007, DIABETES CARE, V30, P2222, DOI 10.2337/dc07-0158
   Graue M, 2012, INT J NURS STUD, V49, P174, DOI 10.1016/j.ijnurstu.2011.08.007
   GUILLEMIN F, 1995, SCAND J RHEUMATOL, V24, P61, DOI 10.3109/03009749509099285
   Herschbach P, 2005, J PSYCHOSOM RES, V58, P505, DOI 10.1016/j.jpsychores.2005.02.007
   Home P, 2006, DIABETIC MED, V23, P579
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Moreira RO, 2003, ARQ BRAS ENDOCRINOL, V47, P19
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Ting RZW, 2011, DIABETES CARE, V34, P1094, DOI 10.2337/dc10-1612
   Torres HD, 2011, ACTA PAUL ENFERM, V24, P514, DOI 10.1590/S0103-21002011000400011
   Wexler DJ, 2006, DIABETOLOGIA, V49, P1489, DOI 10.1007/s00125-006-0249-9
   Wynd CA, 2003, WESTERN J NURS RES, V25, P508, DOI 10.1177/0193945903252998
NR 20
TC 4
Z9 4
U1 0
U2 6
PU UNIV FED SAO PAULO, DEPT ENFERMAGEN
PI SAO PAULO
PA RUA NAPOLEAO DE BARROS, 754 VILA CLEMENTINO, SAO PAULO, CEP04024-002,
   BRAZIL
SN 0103-2100
J9 ACTA PAUL ENFERM
JI Acta Paul. Enferm.
PY 2012
VL 25
IS 5
BP 762
EP 767
DI 10.1590/S0103-21002012005000025
PG 6
WC Nursing
SC Nursing
GA 170TF
UT WOS:000320875900018
OA DOAJ Gold
DA 2019-01-08
ER

PT J
AU Grzywacz, JG
   Arcury, TA
   Saldana, S
   Kirk, JK
   Bell, RA
   Ip, E
   Quandt, SA
AF Grzywacz, Joseph G.
   Arcury, Thomas A.
   Saldana, Santiago
   Kirk, Julienne K.
   Bell, Ronny A.
   Ip, Edward
   Quandt, Sara A.
TI Social Control in Older Adults' Diabetes Self Management and Well-Being
SO BEHAVIORAL MEDICINE
LA English
DT Article
DE depressive symptoms; diabetes management; ethnicity; social control
ID PSYCHOLOGICAL DISTRESS; HEALTH BEHAVIORS; MARITAL-STATUS; INTEGRATION;
   GENDER; TYPE-1
AB The "dual effects" hypothesis argues that social control can be effective in promoting positive health-related behavior change, but it can also jeopardize the targeted individual's well-being. This hypothesis is tested using hemoglobin A1C as an objective indicator of behavioral compliance with diabetes self-management behavior and depressive symptoms. Differences in the effects of social control on A1C and depressive symptoms by sex and ethnicity are tested. Cross-sectional data were obtained from a multi-ethnic sample of older adults with diabetes (N = 593). Greater social control was associated with poorer rather than better odds of achieving glucose control, and with greater depressive symptoms. There was no evidence that social control has differential effects on either glucose control or depressive symptoms by sex or ethnicity. Active use of social control attempts by family members and friends, especially if they are coercive or punitive in nature, are likely counterproductive for maintaining the physical and mental health of older adults with diabetes.
C1 [Quandt, Sara A.] Wake Forest Sch Med, Dept Epidemiol & Prevent, Winston Salem, NC 27157 USA.
RP Quandt, SA (reprint author), Wake Forest Sch Med, Dept Epidemiol & Prevent, Med Ctr Blvd, Winston Salem, NC 27157 USA.
EM squandt@wakehealth.edu
OI Grzywacz, Joseph/0000-0002-2308-7781
FU National Institute of Aging [R01 AG17587]
FX This research was supported by a grant from the National Institute of
   Aging (R01 AG17587).
CR Aiken L. S, 1991, MULTIPLE REGRESSION
   American Diabetes Association, 2011, Diabetes Care, V34 Suppl 1, pS11, DOI 10.2337/dc11-S011
   Arcury T. A., J APPL GERO IN PRESS
   Arcury TA, 1999, HUM ORGAN, V58, P128, DOI 10.17730/humo.58.2.t5g838w7u1761868
   August KJ, 2010, SOC SCI MED, V71, P1831, DOI 10.1016/j.socscimed.2010.08.022
   Barnes LL, 2004, J GERONTOL B-PSYCHOL, V59, pS146, DOI 10.1093/geronb/59.3.S146
   Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4
   Bode Bruce W, 2007, J Diabetes Sci Technol, V1, P405
   de Leon CFM, 2001, J GERONTOL B-PSYCHOL, V56, pS179, DOI 10.1093/geronb/56.3.S179
   HUGHES M, 1981, AM J SOCIOL, V87, P48, DOI 10.1086/227419
   Kramer CK, 2011, DIABETES CARE, V34, P1238, DOI 10.2337/dc11-0079
   KRAUSE N, 1993, SOC SCI MED, V36, P1429, DOI 10.1016/0277-9536(93)90385-H
   Lewis MA, 1999, HEALTH PSYCHOL, V18, P63, DOI 10.1037/0278-6133.18.1.63
   Lewis MA, 2004, J SOC PERS RELAT, V21, P669, DOI 10.1177/0265404045893
   NATHAN DM, 1993, NEW ENGL J MED, V328, P1676, DOI 10.1056/NEJM199306103282306
   Quandt SA, 2006, J GERONTOL A-BIOL, V61, P394, DOI 10.1093/gerona/61.4.394
   Quandt SA, 2001, J APPL GERONTOL, V20, P356, DOI 10.1177/073346480102000307
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   ROOK KS, 1990, PSYCHOL AGING, V5, P327, DOI 10.1037/0882-7974.5.3.327
   Stephens MAP, 2010, FAM SYST HEALTH, V28, P199, DOI 10.1037/a0020513
   Thorpe CT, 2008, J BEHAV MED, V31, P93, DOI 10.1007/s10865-007-9125-4
   Tucker JS, 2006, HEALTH PSYCHOL, V25, P715, DOI 10.1037/0278-6133.25.6.715
   Tucker JS, 2004, J GERONTOL B-PSYCHOL, V59, pP147, DOI 10.1093/geronb/59.4.P147
   UMBERSON D, 1987, J HEALTH SOC BEHAV, V28, P306, DOI 10.2307/2136848
   UMBERSON D, 1992, SOC SCI MED, V34, P907, DOI 10.1016/0277-9536(92)90259-S
   WEISSMAN MM, 1977, AM J EPIDEMIOL, V106, P203, DOI 10.1093/oxfordjournals.aje.a112455
NR 26
TC 9
Z9 10
U1 0
U2 12
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0896-4289
EI 1940-4026
J9 BEHAV MED
JI Behav. Med.
PY 2012
VL 38
IS 4
BP 115
EP 120
DI 10.1080/08964289.2012.693976
PG 6
WC Behavioral Sciences; Psychiatry
SC Behavioral Sciences; Psychiatry
GA 030ZO
UT WOS:000310608900001
PM 23121208
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Al-Nsour, M
   Zindah, M
   Belbeisi, A
   Hadaddin, R
   Brown, DW
   Walke, H
AF Al-Nsour, Mohannad
   Zindah, Meyasser
   Belbeisi, Adel
   Hadaddin, Raja
   Brown, David W.
   Walke, Henry
TI Prevalence of Selected Chronic, Noncommunicable Disease Risk Factors in
   Jordan: Results of the 2007 Jordan Behavioral Risk Factor Surveillance
   Survey
SO PREVENTING CHRONIC DISEASE
LA English
DT Article
ID DIABETES-MELLITUS; WEIGHT-GAIN; PREVENTION
AB Introduction
   Noncommunicable diseases (NCDs) are the leading cause of illness and death in Jordan. Since 2002, the Jordan Ministry of Health, in cooperation with the World Health Organization and the Centers for Disease Control and Prevention, established the Jordan Behavioral Risk Factor Surveillance Survey to collect information on many of the behaviors and conditions related to NCDs. The objectives of this study were to describe the prevalence of selected NCD risk factors and the relationship between body mass index and selected health conditions among a nationally representative sample of Jordanian adults aged 18 years or older.
   Methods
   We used a multistage sampling design to select 3,688 households, from which we randomly selected and interviewed 1 adult aged 18 years or older. A total of 3,654 adults completed the survey. We randomly selected a subsample of 889 interviewed adults and invited them to visit local health clinics for a medical evaluation; we obtained measurements, including fasting blood glucose and blood lipids, from 765 adults. Data were collected between June 1, 2007, and August 23, 2007.
   Results
   Nearly one-third of participants smoked cigarettes, 18% reported having been diagnosed with high blood pressure, and 10% reported frequent mental distress. Compared with survey participants who did not participate in the medical evaluation, those who participated were more likely to self-report high blood pressure, high blood cholesterol, and diabetes and report lower levels of health-related quality of life. Among participants of the medical evaluation, an estimated 11% reported they had been diagnosed with diabetes by a health professional, and 19% were diagnosed with diabetes according to laboratory testing. Approximately one-third of participants of the medical evaluation were either overweight (30%) or obese (36%). In the fully adjusted model, obese participants of the medical evaluation were nearly 3 times as likely to have high blood pressure and more than 2 times as likely to have high blood cholesterol as normal-weight participants.
   Conclusion
   Diabetes, high blood pressure, high cholesterol, and obesity are a public health concern in Jordan. Adequate and continuous monitoring of NCD risk factors in Jordan is needed, and the surveillance findings should be used in health promotion and disease prevention activities.
C1 [Al-Nsour, Mohannad; Zindah, Meyasser; Belbeisi, Adel; Hadaddin, Raja] Minist Hlth, Amman 11196, Jordan.
   [Brown, David W.] Brown Consulting Grp, Charlotte, NC USA.
   [Walke, Henry] Ctr Dis Control & Prevent, Atlanta, GA USA.
RP Al-Nsour, M (reprint author), Minist Hlth, Dahiyat Al Rasheed Alwifaq St,Bldg 94,1st Floor,O, Amman 11196, Jordan.
EM mohannadnsour973@yahoo.com
CR Belbeisi A., 2006, Morbidity and Mortality Weekly Report, V55, P653
   Belbeisi A, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-18
   Belbeisi A, 2009, INT J PUBLIC HEALTH, V54, P106, DOI 10.1007/s00038-009-0014-1
   Brown DW, 2009, PREV CHRONIC DIS, V6
   Centers for Disease Control and Prevention, 2000, MEAS HLTH DAYS POP A
   Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P1042
   COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001
   Directorate of Information Studies and Research, 2008, MORT JORD 2005
   ERIKSSON KF, 1991, DIABETOLOGIA, V34, P891, DOI 10.1007/BF00400196
   HANSON RL, 1995, DIABETES, V44, P261, DOI 10.2337/diabetes.44.3.261
   Jordan Cancer Registry, 2009, CANC INC JORD 2006
   Jordan Department of Statistics, 2007, POP FAM HLTH SURV 20
   Mokdad AH, 2007, ETHN DIS S3, V17, pS3
   Nelson DE, 2001, SOZ PRAVENTIV MED, V46, pS3
   Ounpuu S, 2001, Chronic Dis Can, V22, P93
   PISUNYER FX, 1993, ANN INTERN MED, V119, P655, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00006
   ROWLAND ML, 1990, AM J CLIN NUTR, V52, P1125
   Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801
   World Health Organization, PROJ MORT BURD DIS 2
   Zindah M, 2008, PREV CHRONIC DIS, V5
NR 20
TC 13
Z9 13
U1 0
U2 7
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1545-1151
J9 PREV CHRONIC DIS
JI Prev. Chronic Dis.
PD JAN
PY 2012
VL 9
AR 110077
DI 10.5888/pcd9.110077
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 977GI
UT WOS:000306644300025
PM 22172192
OA Green Published
DA 2019-01-08
ER

PT J
AU Franks, MM
   Hemphill, RC
   Seidel, AJ
   Stephens, MAP
   Rook, KS
   Salem, JK
AF Franks, Melissa M.
   Hemphill, Rachel C.
   Seidel, Amber J.
   Stephens, Mary Ann Parris
   Rook, Karen S.
   Salem, James K.
TI Setbacks in diet adherence and emotional distress: A study of older
   patients with type 2 diabetes and their spouses
SO AGING & MENTAL HEALTH
LA English
DT Article
DE chronic illness management; diabetes distress; depressive symptoms
ID DEPRESSIVE SYMPTOMS; CHRONIC ILLNESS; SOCIAL-CONTROL; LIFE-STYLE;
   SELF-CARE; ADULTS; MELLITUS; SCALE; MANAGEMENT; BEHAVIORS
AB Objectives: We investigated patients' difficulties in managing their diet (i.e. diet setbacks) and associations with change in disease-specific and general emotional distress (diabetes distress and depressive symptoms) among patients with type 2 diabetes and their spouses.
   Method: Data for this study were collected in couples' homes (N = 115 couples) using structured interviews and self-administered questionnaires at three time points: baseline (T1), six months after baseline (T2) and 12 months after baseline (T3).
   Results: Patients' diet setbacks were associated with an increase in their diabetes distress in the shorter-term (over six months). Patients' diet setbacks were not associated with longer-term change in diabetes distress or with change in depressive symptoms at either time point (six months or one year). In contrast, spouses' perceptions of patients' diet setbacks were associated with increases in their own diabetes distress at both time points (over six months and one year), and also with an increase in their depressive symptoms in the longer-term (over one year).
   Conclusion: Findings reveal detrimental consequences of patients' diet nonadherence for emotional well-being that extend to the well-being of their spouses.
C1 [Franks, Melissa M.; Seidel, Amber J.] Purdue Univ, Dept Human Dev & Family Studies, W Lafayette, IN 47907 USA.
   [Hemphill, Rachel C.; Stephens, Mary Ann Parris] Kent State Univ, Dept Psychol, Kent, OH 44242 USA.
   [Rook, Karen S.] Univ Calif Irvine, Dept Psychol & Social Behav, Irvine, CA USA.
   [Salem, James K.] SUMMA Hlth Syst, Akron, OH USA.
RP Franks, MM (reprint author), Purdue Univ, Dept Human Dev & Family Studies, W Lafayette, IN 47907 USA.
EM mmfranks@purdue.edu
FU National Institute on Aging [R01 AG24833]
FX This research, entitled 'Mind-Body Interactions in Management of Type 2
   Diabetes' was supported by grant R01 AG24833 from the National Institute
   on Aging.
CR August KJ, 2010, SOC SCI MED, V71, P1831, DOI 10.1016/j.socscimed.2010.08.022
   Bell RA, 2010, AM J HEALTH BEHAV, V34, P36
   Berg CA, 2007, PSYCHOL BULL, V133, P920, DOI 10.1037/0033-2909.133.6.920
   Beverly EA, 2008, HEALTH EDUC BEHAV, V35, P707, DOI 10.1177/1090198107299787
   Center for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET
   Delahanty LM, 2007, DIABETIC MED, V24, P48, DOI 10.1111/j.1464-5491.2007.02028.x
   Engum A, 2005, DIABETES CARE, V28, P1904, DOI 10.2337/diacare.28.8.1904
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2002, DIABETES CARE, V25, P1564, DOI 10.2337/diacare.25.9.1564
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Franks M.M., 2010, SOCIAL SUPPORT SOCIA
   Franks MM, 2010, FAM RELAT, V59, P599, DOI 10.1111/j.1741-3729.2010.00626.x
   Gonder-Frederick LA, 2002, J CONSULT CLIN PSYCH, V70, P611, DOI 10.1037//0022-006X.70.3.611
   Halter JB, 1999, PROCESSING OF MEDICAL INFORMATION IN AGING PATIENTS, P23
   Huang ES, 2009, DIABETES CARE, V32, P2225, DOI 10.2337/dc09-0459
   Huang ES, 2005, J AM GERIATR SOC, V53, P306, DOI 10.1111/j.1532-5415.2005.53119.x
   Kenny D. A., 2006, DYADIC DATA ANAL
   Lin EHB, 2004, DIABETES CARE, V27, P2154, DOI 10.2337/diacare.27.9.2154
   Murata GH, 2004, CLIN ENDOCRINOL, V60, P451, DOI 10.1111/j.1365-2265.2004.02001.x
   Nothwehr F, 2000, PREV MED, V30, P407, DOI 10.1006/pmed.2000.0658
   Nouwen A, 2010, DIABETOLOGIA, V53, P2480, DOI 10.1007/s00125-010-1874-x
   Penckofer S, 2007, DIABETES EDUCATOR, V33, P680, DOI 10.1177/0145721707304079
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Revenson T. A., 1994, ANN BEHAVIORAL MED, V16, P122
   RUBIN RR, 1991, DIABETES CARE, V14, P335, DOI 10.2337/diacare.14.4.335
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Stephens MAP, 2010, FAM SYST HEALTH, V28, P199, DOI 10.1037/a0020513
   Talbot F, 1999, HEALTH PSYCHOL, V18, P537
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Travis T, 1997, DIABETES EDUCATOR, V23, P152, DOI 10.1177/014572179702300205
   Trief P., 2003, FAMILIES SYSTEMS HLT, V21, P57, DOI [DOI 10.1037/H0089502, 10.1037/h0089502]
   Vijan S, 2005, DIABETIC MED, V22, P32, DOI 10.1111/j.1464-5491.2004.01342.x
   White P, 2007, DIABETIC MED, V24, P796, DOI 10.1111/j.1464-5491.2007.02271.x
   Williams K. E., 2002, PSYCHOL HEALTH MED, V7, P127, DOI [10.1080/13548500120116076, DOI 10.1080/13548500120116076]
   Yancik R, 2007, J GERONTOL A-BIOL, V62, P275, DOI 10.1093/gerona/62.3.275
NR 38
TC 10
Z9 10
U1 1
U2 12
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND
SN 1360-7863
J9 AGING MENT HEALTH
JI Aging Ment. Health
PY 2012
VL 16
IS 7
BP 902
EP 910
DI 10.1080/13607863.2012.674486
PG 9
WC Geriatrics & Gerontology; Gerontology; Psychiatry
SC Geriatrics & Gerontology; Psychiatry
GA 987TI
UT WOS:000307440200012
PM 22533446
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Vingilis, E
   Wilk, P
AF Vingilis, Evelyn
   Wilk, Piotr
TI Medical Conditions, Medication Use, and Their Relationship With
   Subsequent Motor Vehicle Injuries: Examination of the Canadian National
   Population Health Survey
SO TRAFFIC INJURY PREVENTION
LA English
DT Article
DE Motor vehicle injuries; Medical conditions; Medication use; Canada
ID OLDER DRIVERS; PSYCHOLOGICAL DISTRESS; RISK-FACTORS; COLLISION INJURIES;
   BENZODIAZEPINE USE; SCREENING SCALES; TRAFFIC CRASHES; MENTAL-HEALTH;
   INVOLVEMENT; DEPRESSION
AB Purpose: To examine the effects of various medical conditions and medications on subsequent motor vehicle injuries (MVIs).
   Method: The National Population Health Survey, a large, nationally representative, longitudinal study of Canadians, included self-reported medical conditions of asthma, arthritis/rheumatism, back problems excluding arthritis, high blood pressure, migraine headaches, diabetes, heart disease and distress, and medication use during the past month for asthma, high blood pressure, diabetes, heart, codeine/pethidine (Demerol)/morphine, other pain relievers, antidepressants, tranquilizers, and sleeping medication. Path analyses were used to examine the odds of subsequent MVI for different medical conditions and medication use reported prior to the MVI (in the previous wave of the survey) while controlling for age and sex.
   Results: Increased odds of subsequent MVIs were found for asthma (odds ratio [OR]: 1.864, 95% confidence interval [CI]: 1.281, 2.713), arthritis/rheumatism (OR: 1.659, 95% CI: 1.163, 2.365), back problems (OR: 2.169, 95% CI: 1.624, 2.895), and migraines (OR: 1.631, 95% CI: 1.125, 2.364) but not for high blood pressure (OR: 1.435, 95% CI: 0.944, 2.181), diabetes (OR: 1.479, 95% CI: 0.743, 2.944), heart disease (OR: 2.627, 95% CI: 0.941, 7.334) or distress (OR: 1.153, 95% CI: 0.840, 1.581). Except for migraine with codeine/pethidine/morphine, this effect persisted regardless of whether medication was used to treat the condition. Respondents who reported using certain medications, namely, codeine/pethidine/morphine (OR: 2.215, 95% CI: 1.274, 3.850), other pain medication (OR: 1.630, 95% CI: 1.242, 2.139), antidepressants (OR: 2.664. 95% CI: 1.602, 4.429), and sleeping medication (OR: 2.059, 95% CI: 1.161, 3.651), had increased odds of subsequent MVI, independent of related medical condition, whereas tranquillizers showed no increased odds of subsequent MVIs.
   Conclusions: This study suggests that the relationship between medical conditions, medications, and MVIs is complex but consistent with other studies.
C1 [Vingilis, Evelyn] Univ Western Ontario, Dept Family Med, Populat & Community Hlth Unit, Schulich Sch Med & Dent, London, ON N6A 5C1, Canada.
   [Vingilis, Evelyn; Wilk, Piotr] Univ Western Ontario, Dept Epidemiol & Biostat, Schulich Sch Med & Dent, London, ON N6A 5C1, Canada.
   [Wilk, Piotr] Univ Western Ontario, Dept Paediat, Schulich Sch Med & Dent, London, ON N6A 5C1, Canada.
RP Vingilis, E (reprint author), Univ Western Ontario, Dept Family Med, Populat & Community Hlth Unit, Schulich Sch Med & Dent, Room 2710, London, ON N6A 5C1, Canada.
EM evingili@uwo.ca
CR Andrews G, 2001, AUST NZ J PUBL HEAL, V25, P494, DOI 10.1111/j.1467-842X.2001.tb00310.x
   Begg DJ, 1999, ACCIDENT ANAL PREV, V31, P1, DOI 10.1016/S0001-4575(98)00039-6
   Berger JT, 2000, J GEN INTERN MED, V15, P667, DOI 10.1046/j.1525-1497.2000.04309.x
   Charlton J, 2004, 213 MON U ACC RES CT
   Charlton J., 2010, 300 MON U ACC RES CT
   CHIPMAN ML, 1995, ACCIDENT ANAL PREV, V27, P699, DOI 10.1016/0001-4575(95)00013-P
   Cross JM, 2009, BRIT J OPHTHALMOL, V93, P400, DOI 10.1136/bjo.2008.144584
   de Gier Johan J., 2009, P121
   Dobbs B. M., 2005, 809690 DOT HS NAT HI
   Dubois S, 2008, TRAFFIC INJ PREV, V9, P404, DOI 10.1080/15389580802161943
   FOLEY DJ, 1995, J AM GERIATR SOC, V43, P776, DOI 10.1111/j.1532-5415.1995.tb07049.x
   Furukawa TA, 2003, PSYCHOL MED, V33, P357, DOI 10.1017/S0033291702006700
   GRATTAN E, 1968, BMJ-BRIT MED J, V1, P75, DOI 10.1136/bmj.1.5584.75
   Harsch IA, 2009, DRUGS DRIVING TRAFFI, P393
   Hours M, 2008, ACCIDENT ANAL PREV, V40, P1789, DOI 10.1016/j.aap.2008.06.017
   Hu PS, 1998, ACCIDENT ANAL PREV, V30, P569, DOI 10.1016/S0001-4575(98)00019-0
   Jenkins P, 2002, AM J IND MED, V41, P98, DOI 10.1002/ajim.10035
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   KOEPSEL TD, 1994, J AM GERIATR SOC, V42, P695, DOI 10.1111/j.1532-5415.1994.tb06526.x
   Laflamme L, 2000, Inj Prev, V6, P293, DOI 10.1136/ip.6.4.293
   Lerman Y, 1995, J TRAUMA, V39, P1058, DOI 10.1097/00005373-199512000-00007
   LEVEILLE SG, 1994, EPIDEMIOLOGY, V5, P591, DOI 10.1097/00001648-199411000-00006
   Lindsay VL, 2008, P 2008 AUSTR ROAD SA, P610
   Lococo KH, 2006, 810681 NAT HIGHW TRA
   Marshall CS, 2008, TRAFFIC INJ PREV, V9, P291
   MCCLOSKEY LW, 1994, AGE AGEING, V23, P267, DOI 10.1093/ageing/23.4.267
   McGwin G, 2000, AM J EPIDEMIOL, V152, P424, DOI 10.1093/aje/152.5.424
   Mock C, 1999, INT J EPIDEMIOL, V28, P750, DOI 10.1093/ije/28.4.750
   Muthen L. K., 2010, MPLUS USERS GUIDE
   Orriols L., 2010, PLOS MED, V7, P1
   PEDEN M, 2002, INJURY LEADING CAUSE
   Rapoport MJ, 2009, J CLIN PSYCHIAT, V70, P663, DOI 10.4088/JCP.08m04325
   Rhodes A, 2006, SOC SCI MED, V62, P828, DOI 10.1016/j.socscimed.2005.06.039
   Roberts S. E., 2007, ACCIDENT ANAL PREV, V40, P559
   ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069
   Sagberg F, 2006, ACCIDENT ANAL PREV, V38, P28, DOI 10.1016/j.aap.2005.06.018
   Schwarz N, 2001, AM J EVAL, V22, P127, DOI 10.1177/109821400102200202
   Sims RV, 2000, J GERONTOL A-BIOL, V55, pM22
   Statistics Canada, 1996, NAT POP HLTH SURV GE
   Statistics Canada, 2004, NAT POP HLTH SURV HO
   Statistics Canada, 2005, INF NAT POP HLTH SUR
   Statistics Canada, 2010, NAT POP HLTH SURV HO
   Sudman S, 1983, ASKING QUESTIONS PRA
   Thomas RE, 1998, CAN FAM PHYSICIAN, V44, P799
   Transport Canada, 2011, CAN MOT VEH TRAFF CO
   Vaa T., 2003, IMPAIRMENTS DIS AGE
   Vernon DD, 2002, ACCIDENT ANAL PREV, V34, P237, DOI 10.1016/S0001-4575(01)00019-7
   Verster J. C., 2009, DRUGS DRIVING TRAFFI
   Verster JC, 2009, INT J ENV RES PUB HE, V6, P1041, DOI 10.3390/ijerph6031041
   Vingilis E, 2002, TRAFFIC INJ PREV, V3, P1
   Vingilis Evelyn, 2007, Traffic Inj Prev, V8, P411, DOI 10.1080/15389580701626202
   Wade TJ, 1997, CAN J PUBLIC HEALTH, V88, P297
   Walsh J Michael, 2004, Traffic Inj Prev, V5, P241
   Wothke W, 2000, MODELING LONGITUDINAL AND MULTILEVEL DATA, P219
   Zhang J, 2000, ACCIDENT ANAL PREV, V32, P117, DOI 10.1016/S0001-4575(99)00039-1
NR 55
TC 13
Z9 13
U1 0
U2 4
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 1538-9588
J9 TRAFFIC INJ PREV
JI Traffic Inj. Prev.
PY 2012
VL 13
IS 3
BP 327
EP 336
DI 10.1080/15389588.2012.654411
PG 10
WC Public, Environmental & Occupational Health; Transportation
SC Public, Environmental & Occupational Health; Transportation
GA 945MF
UT WOS:000304277200014
PM 22607256
DA 2019-01-08
ER

PT J
AU Petrofsky, J
   Berk, L
   Al-Nakhli, H
AF Petrofsky, Jerrold
   Berk, Lee
   Al-Nakhli, Hani
TI The Influence of Autonomic Dysfunction Associated with Aging and Type 2
   Diabetes on Daily Life Activities
SO EXPERIMENTAL DIABETES RESEARCH
LA English
DT Review
ID SKIN BLOOD-FLOW; RESPIRATORY-DISTRESS-SYNDROME; SUBCUTANEOUS FAT
   THICKNESS; VEIN ENDOTHELIAL-CELLS; HEART-RATE-VARIABILITY; PPAR-ALPHA
   ACTIVATION; SWEAT GLAND DENSITY; NITRIC-OXIDE; ISOMETRIC-EXERCISE;
   OXIDATIVE STRESS
AB Type 2 diabetes (T2D) and ageing have well documented effects on every organ in the body. In T2D the autonomic nervous system is impaired due to damage to neurons, sensory receptors, synapses and the blood vessels. This paper will concentrate on how autonomic impairment alters normal daily activities. Impairments include the response of the blood vessels to heat, sweating, heat transfer, whole body heating, orthostatic intolerance, balance, and gait. Because diabetes is more prevalent in older individuals, the effects of ageing will be examined. Beginning with endothelial dysfunction, blood vessels have impairment in their ability to vasodilate. With this and synaptic damage, the autonomic nervous system cannot compensate for effectors such as pressure on and heating of the skin. This and reduced ability of the heart to respond to stress, reduces autonomic orthostatic compensation. Diminished sweating causes the skin and core temperature to be high during whole body heating. Impaired orthostatic tolerance, impaired vision and vestibular sensing, causes poor balance and impaired gait. Overall, people with T2D must be made aware and counseled relative to the potential consequence of these impairments.
C1 [Petrofsky, Jerrold; Berk, Lee; Al-Nakhli, Hani] Loma Linda Univ, Sch Allied Hlth Profess, Dept Phys Therapy, Loma Linda, CA 92350 USA.
RP Petrofsky, J (reprint author), Loma Linda Univ, Sch Allied Hlth Profess, Dept Phys Therapy, Loma Linda, CA 92350 USA.
EM jpetrofsky@llu.edu
CR Al-Janabi AAHS, 2011, J GLOB INFECT DIS, V3, P133, DOI 10.4103/0974-777X.81689
   Alemzadeh Ramin, 2005, Diabetes Technol Ther, V7, P587, DOI 10.1089/dia.2005.7.587
   Anburajan M, 2011, IEEE ENG MED BIO, P6254, DOI 10.1109/IEMBS.2011.6091544
   ANDERSON RK, 1987, J APPL PHYSIOL, V63, P1089
   Azad N, 1999, J DIABETES COMPLICAT, V13, P307, DOI 10.1016/S1056-8727(99)00062-8
   Baylie RL, 2011, ACTA PHYSIOL, V203, P99, DOI 10.1111/j.1748-1716.2010.02217.x
   Bharara Manish, 2010, J Diabetes Sci Technol, V4, P773
   Brunton S, 2006, CLIN THER, V28, P118, DOI 10.1016/j.clinthera.2006.01.011
   Bulhak A, 2006, BASIC RES CARDIOL, V101, P244, DOI 10.1007/s00395-005-0580-1
   Bulhak AA, 2009, AM J PHYSIOL-HEART C, V296, pH719, DOI 10.1152/ajpheart.00394.2008
   Buse JB, 2007, CIRCULATION, V115, P114, DOI 10.1161/CIRCULATIONAHA.106.179294
   Cameron FJ, 2010, CURR DIABETES REV, V6, P17, DOI 10.2174/157339910790442592
   Campanucci V, 2010, NEURON, V66, P827, DOI 10.1016/j.neuron.2010.06.010
   CAPUTI M, 1994, NUCLEIC ACIDS RES, V22, P1018, DOI 10.1093/nar/22.6.1018
   Carroll SL, 2004, J NEUROPATH EXP NEUR, V63, P1144, DOI 10.1093/jnen/63.11.1144
   Cui J, 2011, CLIN AUTON RES, V21, P381, DOI 10.1007/s10286-011-0126-6
   da Rosa EM, 2011, ARQ BRAS CARDIOL, V97, P541, DOI 10.1590/S0066-782X2011001500014
   Damon DH, 2011, AM J PHYSIOL-HEART C, V300, pH1386, DOI 10.1152/ajpheart.00300.2010
   Dandona P, 1996, LANCET, V347, P444, DOI 10.1016/S0140-6736(96)90013-6
   de Jongh R, 2007, NEUROUROL URODYNAM, V26, P302, DOI 10.1002/nau.20298
   de Wit C, 2008, CELL COMMUN ADHES, V15, P231, DOI 10.1080/15419060802440260
   DiBona GF, 2003, ACTA PHYSIOL SCAND, V177, P285, DOI 10.1046/j.1365-201X.2003.01074.x
   Farage M., 2010, INFLUENCE RACE GENDE
   FARAGE M. A., 2010, TXB AGING SKIN
   Fedorowski A, 2010, EUR HEART J, V31, P85, DOI 10.1093/eurheartj/ehp329
   Ferrari Alberto U, 2002, Am J Geriatr Cardiol, V11, P30
   Fredriksson I, 2010, DIABETES, V59, P1578, DOI 10.2337/db10-0080
   GATTINONI L, 1994, JAMA-J AM MED ASSOC, V271, P1772, DOI 10.1001/jama.271.22.1772
   Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545
   Gogg S, 2009, DIABETES, V58, P2238, DOI 10.2337/db08-0961
   Grubb BP, 1997, PACE, V20, P781, DOI 10.1111/j.1540-8159.1997.tb03904.x
   Grundy SM, 2006, DIABETES CARE, V29, P457, DOI 10.2337/diacare.29.02.06.dc05-1904
   Gupta PK, 2008, EUR J PHARMACOL, V591, P171, DOI 10.1016/j.ejphar.2008.06.031
   Harris RA, 2011, AM J HYPERTENS, V24, P557, DOI 10.1038/ajh.2011.12
   Hirai DM, 2011, J APPL PHYSIOL, V111, P989, DOI 10.1152/japplphysiol.00490.2011
   Hoeldtke RD, 2011, CLIN AUTON RES, V21, P19, DOI 10.1007/s10286-010-0084-4
   Horowitz SH, 2006, CURR OPIN ANESTHESIO, V19, P573, DOI 10.1097/01.aco.0000245287.37905.c5
   Infusino F, 2010, EUR REV MED PHARMACO, V14, P203
   Inoue Y, 1996, EUR J APPL PHYSIOL O, V74, P72, DOI 10.1007/BF00376497
   Jan YK, 2008, ARCH PHYS MED REHAB, V89, P137, DOI 10.1016/j.apmr.2007.07.046
   Jose RM, 2005, BRIT J GEN PRACT, V55, P222
   Katsilambros NL, 2011, EXP DIABETES RES, DOI 10.1155/2011/607309
   Keller DM, 2011, J APPL PHYSIOL, V110, P1592, DOI 10.1152/japplphysiol.00233.2010
   Kellogg DL, 1999, J APPL PHYSIOL, V86, P1185
   Kellogg DL, 1998, J APPL PHYSIOL, V85, P824
   KENNEY WL, 1988, MED SCI SPORT EXER, V20, P155
   Kostolanska J, 2011, Vnitr Lek, V57, P533
   Lawson D, 2007, MED SCI MONITOR, V13, pCR258
   Lee JH, 2009, AM J PHYSIOL-CELL PH, V296, pC327, DOI 10.1152/ajpcell.00254.2008
   Lin Zhong-qiu, 2011, Zhonghua Xin Xue Guan Bing Za Zhi, V39, P457
   Madden KM, 2011, J CARDIOVASC PHARM, V57, P666, DOI 10.1097/FJC.0b013e31821533cc
   Makrantonaki E, 2010, HAUTARZT, V61, P505, DOI 10.1007/s00105-009-1889-8
   Makrantonaki E, 2010, EXP GERONTOL, V45, P801, DOI 10.1016/j.exger.2010.08.005
   Maloney-Hinds C, 2009, DIABETES TECHNOL THE, V11, P39, DOI 10.1089/dia.2008.0011
   Maser RE, 2003, DIABETES CARE, V26, P1895, DOI 10.2337/diacare.26.6.1895
   Mayaudon H, 2010, DIABETES METAB, V36, P450, DOI 10.1016/j.diabet.2010.05.004
   McLellan K, 2009, DIABETES TECHNOL THE, V11, P791, DOI 10.1089/dia.2009.0097
   McLellan K, 2009, DIABETES TECHNOL THE, V11, P73, DOI 10.1089/dia.2008.0026
   McLellan K, 2009, MED ENG PHYS, V31, P165, DOI 10.1016/j.medengphy.2008.08.004
   MENARD S, 1994, BRIT J CANCER, V69, P1126, DOI 10.1038/bjc.1994.221
   Minson CT, 2001, J APPL PHYSIOL, V91, P1619
   MORELLI D, 1994, SCAND J IMMUNOL, V39, P453, DOI 10.1111/j.1365-3083.1994.tb03400.x
   Murrell C, 2009, J PHYSIOL-LONDON, V587, P5959, DOI 10.1113/jphysiol.2009.179549
   Nakagami G, 2010, ANN PLAS SURG, V64, P351, DOI 10.1097/SAP.0b013e3181a73078
   Namer B, 2004, AUTON NEUROSCI-BASIC, V114, P72, DOI 10.1016/j.autneu.2004.06.007
   Noble M, 2003, J REHABIL RES DEV, V40, P283
   Nunan D, 2010, PACE, V33, P1407, DOI 10.1111/j.1540-8159.2010.02841.x
   Nunan D, 2010, CLIN AUTON RES, V20, P213, DOI 10.1007/s10286-010-0073-7
   Obrosova IG, 2009, NEUROTHERAPEUTICS, V6, P638, DOI 10.1016/j.nurt.2009.07.004
   Oudit GY, 2006, J MOL MED, V84, P349, DOI 10.1007/s00109-005-0029-x
   Oudit Gavin Y., 2007, Cardiovascular & Hematological Disorders - Drug Targets, V7, P295, DOI 10.2174/187152907782793545
   PENNES HH, 1948, J APPL PHYSIOL, V1, P93
   Petrofsky J, 2005, MED SCI MONITOR, V11, pCR562
   Petrofsky J, 2005, MED SCI MONITOR, V11, pCR247
   Petrofsky J. S., 2002, J NEUROLOGICAL ORTHO, V22, P16
   Petrofsky J.S., 2005, BMC ENDOCR DISORD, V5, P4
   Petrofsky J, 2007, DIABETES TECHNOL THE, V9, P377, DOI 10.1089/dia.2006.0028
   Petrofsky J, 2006, MED SCI MONITOR, V12, pCR290
   Petrofsky Jerrold, 2011, Journal of Medical Engineering & Technology, V35, P330, DOI 10.3109/03091902.2011.592237
   Petrofsky Jerrold, 2011, Journal of Medical Engineering & Technology, V35, P262, DOI 10.3109/03091902.2011.580039
   Petrofsky J, 2011, DIABETES TECHNOL THE, V13, P365, DOI 10.1089/dia.2010.0161
   Petrofsky J, 2011, MED SCI MONITOR, V17, pCR1, DOI 10.12659/MSM.881315
   Petrofsky J, 2010, DIABETES TECHNOL THE, V12, P1003, DOI 10.1089/dia.2010.0152
   Petrofsky J, 2011, MED ENG PHYS, V33, P325, DOI 10.1016/j.medengphy.2010.10.018
   Petrofsky Jerrold, 2010, Physiotherapy Theory and Practice, V26, P107, DOI 10.3109/09593980802640059
   Petrofsky J, 2009, DIABETES TECHNOL THE, V11, P361, DOI 10.1089/dia.2008.0094
   Petrofsky Jerrold, 2007, Physiotherapy Theory and Practice, V23, P189, DOI 10.1080/09593980701209295
   Petrofsky JS, 2008, MED SCI MONITOR, V14, pCR399
   Petrofsky JS, 2010, DIABETES TECHNOL THE, V12, P153, DOI 10.1089/dia.2009.0123
   Petrofsky JS, 2009, MED SCI MONITOR, V15, pCR325
   Petrofsky JS, 2008, DIABETES TECHNOL THE, V10, P487, DOI 10.1089/dia.2008.0009
   Petrofsky JS, 2006, MED SCI MONITOR, V12, pCR273
   Petrofsky Jerrold Scott, 2011, J Diabetes Sci Technol, V5, P657
   Petrofsky JS, 2010, J DIABETES, V2, P41, DOI 10.1111/j.1753-0407.2009.00058.x
   Petrofsky JS, 2010, DIABETES TECHNOL THE, V12, P475, DOI 10.1089/dia.2009.0125
   Petrofsky JS, 2006, MED SCI MONITOR, V12, pCR21
   Petrofsky JS, 2005, MED SCI MONITOR, V11, pCR515
   Petrofsky JS, 2005, MED SCI MONITOR, V11, pCR470
   Petrofsky JS, 2005, MED SCI MONITOR, V11, pPI43
   Petrofsky JS, 2005, MED SCI MONITOR, V11, pCR153
   Petrofsky JS, 2002, EUR J APPL PHYSIOL, V86, P479
   PETROFSKY JS, 1975, J APPL PHYSIOL, V38, P863
   PETROFSKY JS, 1992, EUR J APPL PHYSIOL O, V64, P503, DOI 10.1007/BF00843758
   Philips JC, 2011, DIABETES METAB, V37, P489, DOI 10.1016/j.diabet.2011.09.004
   Philips JC, 2009, DIABETES-METAB RES, V25, P442, DOI 10.1002/dmrr.969
   Philips JC, 2011, AUTON NEUROSCI-BASIC, V162, P3, DOI 10.1016/j.autneu.2011.03.001
   Pop-Busui R, 2009, J PERIPHER NERV SYST, V14, P1, DOI 10.1111/j.1529-8027.2009.00200.x
   Potenza MA, 2009, CURR MED CHEM, V16, P94, DOI 10.2174/092986709787002853
   Quagliaro L, 2005, ATHEROSCLEROSIS, V183, P259, DOI 10.1016/j.atherosclerosis.2005.03.015
   Risso A, 2001, AM J PHYSIOL-ENDOC M, V281, pE924
   Rizzo AM, 2010, ADV EXP MED BIOL, V698, P52, DOI 10.1007/978-1-4419-7347-4_5
   ROWELL LB, 1977, J INVEST DERMATOL, V69, P154, DOI 10.1111/1523-1747.ep12497938
   ROWELL LB, 1983, CIRC RES, V52, P367, DOI 10.1161/01.RES.52.4.367
   ROWELL LB, 1992, INT J SPORTS MED, V13, pS25, DOI 10.1055/s-2007-1024583
   Samborski P, 2011, POL ARCH MED WEWN, V121, P67
   Santos-Garcia D, 2011, CEREBROVASC DIS, V32, P155, DOI 10.1159/000328651
   Sato T, 2002, DIABETES, V51, P1565, DOI 10.2337/diabetes.51.5.1565
   Sauerstein K, 2000, J PHYSIOL-LONDON, V529, P803, DOI 10.1111/j.1469-7793.2000.00803.x
   SAVIO ML, 1994, J CLIN MICROBIOL, V32, P935
   Schmidt RE, 2003, AM J PATHOL, V163, P21, DOI 10.1016/S0002-9440(10)63626-7
   Singh DK, 2011, NAT REV ENDOCRINOL, V7, P176, DOI 10.1038/nrendo.2010.212
   Song CH, 2011, DIABETES TECHNOL THE, V13, P803, DOI 10.1089/dia.2011.0036
   Sridhar B, 2010, TOHOKU J EXP MED, V220, P107, DOI 10.1620/tjem.220.107
   TAGLIABUE A, 1994, INT J OBESITY, V18, P537
   Tagliabue John, 1994, N Y Times Web, pA8
   TAGLIABUE M, 1994, ACTA RADIOL, V35, P230
   TANKERSLEY CG, 1991, J APPL PHYSIOL, V71, P236
   Triggle Chris R., 2003, Journal of Smooth Muscle Research, V39, P249, DOI 10.1540/jsmr.39.249
   Trott DW, 2011, J APPL PHYSIOL, V110, P1171, DOI 10.1152/japplphysiol.01037.2010
   Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009
   Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001
   Van Nassauw L, 2001, CELL TISSUE RES, V303, P329, DOI 10.1007/s004410000338
   Vincent AM, 2004, ENDOCR REV, V25, P612, DOI 10.1210/er.2003-0019
   Vinik AI, 2003, SEMIN NEUROL, V23, P365
   Vinik AI, 2003, DIABETES CARE, V26, P1553, DOI 10.2337/diacare.26.5.1553
   Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200
   Wong BJ, 2003, J APPL PHYSIOL, V95, P504, DOI 10.1152/japplphysiol.00254.2003
   Woodman RJ, 2006, DIABETES RES CLIN PR, V71, P59, DOI 10.1016/j.diabres.2005.05.008
   Ye Xi-yun, 2010, Zhonghua Xin Xue Guan Bing Za Zhi, V38, P264
NR 139
TC 13
Z9 13
U1 0
U2 7
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1687-5214
EI 1687-5303
J9 EXP DIABETES RES
JI Exp. Diabetes Res.
PY 2012
AR 657103
DI 10.1155/2012/657103
PG 12
WC Endocrinology & Metabolism; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Research & Experimental Medicine
GA 938JI
UT WOS:000303729400001
PM 22566994
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Robertson, SM
   Stanley, MA
   Cully, JA
   Naik, AD
AF Robertson, Suzanne M.
   Stanley, Melinda A.
   Cully, Jeffrey A.
   Naik, Aanand D.
TI Positive Emotional Health and Diabetes Care: Concepts, Measurement, and
   Clinical Implications
SO PSYCHOSOMATICS
LA English
DT Review
ID QUALITY-OF-LIFE; TREATMENT SATISFACTION; GLYCEMIC CONTROL; PSYCHOLOGICAL
   ADJUSTMENT; CONTROLLED TRIAL; SELF-MANAGEMENT; NEGATIVE AFFECT; MOOD;
   RESILIENCE; PEOPLE
AB Background: Numerous studies describe the effect of emotional problems, including diabetes-related distress and depression, on diabetes outcomes. Little attention has been devoted to positive emotional health and its potential role in facilitating patients' self-management and improved outcomes. Objective: This review describes the conceptualization and measurement of three empirically-tested aspects of positive emotional health (well-being, positive affect, resilience) in the diabetes literature and their relationship to diabetes outcomes. Method: A literature review was conducted using PubMed and the Cochrane Library databases from 1970 to January 2011 to identify studies focused on well-being, positive affect, and resilience in diabetes patients. Results: Twenty-two studies were identified based on our inclusion criteria. Well-being studies were least. likely to include conceptualizations and relied on two primary measurement instruments compared to more heterogeneous presentations found in positive affect and resilience studies. All three aspects of positive emotional health were linked to health-related outcomes and self-management. Conclusion: Positive emotional health may facilitate chronic care self-management and improved health outcomes. We present a model to guide future research and intervention development efforts designed to enhance positive emotional health. (Psychosomatics 2012; 53:1-12)
C1 [Robertson, Suzanne M.; Stanley, Melinda A.; Cully, Jeffrey A.; Naik, Aanand D.] Houston Hlth Serv Res & Dev Ctr Excellence, Michael E DeBakey Vet Affairs Med Ctr, Houston, TX USA.
   [Stanley, Melinda A.; Cully, Jeffrey A.; Naik, Aanand D.] Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA.
   [Stanley, Melinda A.; Cully, Jeffrey A.; Naik, Aanand D.] VA S Cent Mental Illness Res Educ & Clin Ctr, Houston, TX USA.
RP Robertson, SM (reprint author), Houston VA Hlth Serv Res & Dev Ctr Excellence, Michael E DeBakey VA Med Ctr, 2002 Holcombe Blvd,MEDVAMC 152, Houston, TX 77030 USA.
EM smr1@bcm.tmc.edu
FU Houston VA Health Services Research and Development Center of Excellence
   [HFP90-020]; VA Office of Academic Affiliations; National Institute of
   Aging [5K23AG027144]; Doris Duke Charitable Foundation
FX This review is supported with resources and the use of facilities at the
   Houston VA Health Services Research and Development Center of Excellence
   (HFP90-020) at the Michael E. DeBakey VA Medical Center, Houston, TX
   Suzanne M. Robertson is a VA HSR post-doctoral fellow supported by VA
   Office of Academic Affiliations. Aanand D. Naik receives support from a
   National Institute of Aging Career Development Award (5K23AG027144) and
   a Doris Duke Charitable Foundation Clinical Scientist Development Award.
   The views expressed reflect those of the authors and not necessarily
   those of the Department of Veterans Affairs or Baylor College of
   Medicine.
CR Anderson RM, 2010, PATIENT EDUC COUNS, V79, P277, DOI 10.1016/j.pec.2009.07.025
   Bech P, 2003, INT J METH PSYCH RES, V12, P85, DOI 10.1002/mpr.145
   BRADLEY C, 1990, DIABETIC MED, V7, P445, DOI 10.1111/j.1464-5491.1990.tb01421.x
   Bradshaw BG, 2007, DIABETES EDUCATOR, V33, P650, DOI 10.1177/0145721707303809
   Chan R, 2009, CLIN J AM SOC NEPHRO, V4, P160, DOI 10.2215/CJN.01520308
   Chesney MA, 2005, INT J BEHAV MED, V12, P50, DOI 10.1207/s15327558ijbm1202_2
   Ciechanowski P, 2011, CLIN DIABETES, V29, P43, DOI DOI 10.2337/DIACLIN.29.2.43
   Comellas M, 2010, DIABETES EDUCATOR, V36, P141, DOI 10.1177/0145721709354606
   de Ridder D, 2008, LANCET, V372, P246, DOI 10.1016/S0140-6736(08)61078-8
   Denollet J, 2006, J AFFECT DISORDERS, V91, P171, DOI 10.1016/j.jad.2005.12.044
   Douek IF, 2005, DIABETIC MED, V22, P634, DOI 10.1111/j.1464-5491.2005.01475.x
   Folkman S, 2000, AM PSYCHOL, V55, P647, DOI 10.1037/0003-066X.55.6.647
   Forlani G, 2006, J ENDOCRINOL INVEST, V29, P405, DOI 10.1007/BF03344123
   Gallant MP, 2003, HEALTH EDUC BEHAV, V30, P170, DOI 10.1177/1090198102251030
   Glasgow RE, 2001, DIABETES SPECTRUM, V14, P33, DOI DOI 10.2337/DIASPECT.14.1.33
   Heisler M, 2010, ANN INTERN MED, V153, P507, DOI 10.7326/0003-4819-153-8-201010190-00007
   Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955
   Keogh KM, 2011, AM J MANAG CARE, V17, P105
   Ligtenberg PC, 1998, DIABETES CARE, V21, P2196, DOI 10.2337/diacare.21.12.2196
   Logtenberg SJ, 2010, DIABETES CARE, V33, P1169, DOI 10.2337/dc09-1758
   Lorig KR, 2003, ANN BEHAV MED, V26, P1, DOI 10.1207/S15324796ABM2601_01
   Marra Giampiero, 2004, Acta Biomed, V75, P164
   Moskowitz JT, 2008, HEALTH PSYCHOL, V27, pS73, DOI 10.1037/0278-6133.27.1.S73
   Naik AD, 2011, ARCH INTERN MED, V171, P453, DOI 10.1001/archinternmed.2011.70
   Ong AD, 2006, J PERS SOC PSYCHOL, V91, P730, DOI 10.1037/0022-3514.91.4.730
   Ozer E, 2003, PATIENT EDUC COUNS, V51, P39, DOI 10.1016/S0738-3991(02)00246-X
   Papanas N, 2010, EXP CLIN ENDOCR DIAB, V118, P364, DOI 10.1055/s-0029-1243623
   Pelle AJ, 2011, QUAL LIFE RES, V20, P643, DOI 10.1007/s11136-010-9792-4
   Pelle AJ, 2009, QUAL LIFE RES, V18, P689, DOI 10.1007/s11136-009-9485-z
   Petterson T, 1998, DIABETES CARE, V21, P930, DOI 10.2337/diacare.21.6.930
   Piette JD, 2004, AM J MANAG CARE, V10, P152
   Pouwer F, 2001, DIABETES CARE, V24, P1929, DOI 10.2337/diacare.24.11.1929
   RYFF CD, 1995, J PERS SOC PSYCHOL, V69, P719, DOI 10.1037//0022-3514.69.4.719
   Saatci E, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-67
   Seligman M. E. P, 2011, FLOURISH VISIONARY N
   SJOBERG L, 1979, SCAND J PSYCHOL, V20, P1, DOI 10.1111/j.1467-9450.1979.tb00677.x
   Skaff MM, 2009, HEALTH PSYCHOL, V28, P265, DOI 10.1037/a0014429
   Spangler J G, 1993, Arch Fam Med, V2, P149, DOI 10.1001/archfami.2.2.149
   Steinhardt MA, 2009, DIABETES EDUCATOR, V35, P274, DOI 10.1177/0145721708329698
   Stenstrom U, 2003, DIABETES RES CLIN PR, V60, P147, DOI 10.1016/S0168-8227(03)00018-4
   Stuckey HL, 2010, QUAL HEALTH RES, V20, P42, DOI 10.1177/1049732309355286
   Tugade MM, 2004, J PERS, V72, P1161, DOI 10.1111/j.1467-6494.2004.00294.x
   Van der Does FEE, 1998, DIABETES CARE, V21, P2085, DOI 10.2337/diacare.21.12.2085
   WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063
   Wilson M, 2004, DIABETES RES CLIN PR, V66, P263, DOI 10.1016/j.diabres.2004.04.010
   Yi JP, 2008, BRIT J HEALTH PSYCH, V13, P311, DOI 10.1348/135910707X186994
   Yi-Frazier JP, 2010, STRESS HEALTH, V26, P51, DOI 10.1002/smi.1258
NR 47
TC 15
Z9 15
U1 0
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0033-3182
J9 PSYCHOSOMATICS
JI Psychosomatics
PD JAN-FEB
PY 2012
VL 53
IS 1
BP 1
EP 12
PG 12
WC Psychiatry; Psychology
SC Psychiatry; Psychology
GA 882TB
UT WOS:000299585700001
PM 22221716
DA 2019-01-08
ER

PT J
AU Primozic, S
   Tavcar, R
   Avbelj, M
   Dernovsek, MZ
   Oblak, MR
AF Primozic, Simona
   Tavcar, Rok
   Avbelj, Magdalena
   Dernovsek, Mojca Zvezdana
   Oblak, Maja Ravnik
TI Specific cognitive abilities are associated with diabetes
   self-management behavior among patients with type 2 diabetes
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Diabetes-self management; Cognitive functions; Executive functions;
   Depression
ID BLOOD-GLUCOSE CONTROL; GLYCEMIC CONTROL; MEDICATION ADHERENCE; MAJOR
   DEPRESSION; CARE; MELLITUS; DYSFUNCTION; ADULTS; DISTRESS; SYMPTOMS
AB Aim: Patients with diabetes differ in compliance to diabetes self-management which influences their long-term health. Psychological factors, namely depression and cognitive abilities, are associated with diabetes self-management behavior. The aim of the study was to identify independent association of particular cognitive functions with diabetes self-management.
   Methods: In a cross sectional study 98 adults with type 2 diabetes attending Diabetes Outpatient Clinic were examined using the measures of diabetes self-management (Summary of Diabetes Self-Care Activities (SDSCA) measure), depression (Hamilton Depression Inventory (HDI)), diabetes distress (Problem Areas In Diabetes scale (PAID)), and the neuropsychological battery of tests for assessment of cognitive functions. Sociodemographic and diabetes-related data were collected. Univariate and multivariate regression analyses were used to identify and evaluate the predictors of diabetes self-management.
   Results: Specific cognitive functions, namely immediate memory, visuospatial/constructional abilities, attention, and specific executive functions (planning and problem solving) were significantly associated with diabetes self-management. Among cognitive factors, planning and problem solving abilities were strongest predictors; furthermore, in a multivariate regression their association was independent from depression.
   Conclusions: Specific cognitive abilities, particularly planning and problem solving, play an independent role in diabetes self-management behaviors. Assessing patients' cognitive abilities may be of value for adjusting self-management education and treatment regimen. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
C1 [Primozic, Simona; Avbelj, Magdalena] Univ Childrens Hosp, Univ Med Ctr Ljubljana, Dept Paediat Endocrinol Diabet & Metab, Ljubljana 1525, Slovenia.
   [Tavcar, Rok; Dernovsek, Mojca Zvezdana] Univ Psychiat Hosp Ljubljana, Ljubljana, Slovenia.
   [Oblak, Maja Ravnik] Univ Med Ctr Ljubljana, Dept Endocrinol Diabet & Metab Dis, Ljubljana, Slovenia.
RP Primozic, S (reprint author), Univ Childrens Hosp, Univ Med Ctr Ljubljana, Dept Paediat Endocrinol Diabet & Metab, Bohoriceva 20, Ljubljana 1525, Slovenia.
EM simona.primozic@kclj.si
OI Avbelj Stefanija, Magdalena/0000-0002-0836-5114
FU Slovenian Research Agency [L3-6359, 1000-07-310249]; Slovene National
   Research Agency [P3-0343]
FX The study was supported by the Slovenian Research Agency (grant number
   L3-6359). SP was a recipient of a young researcher stipend (grant number
   1000-07-310249) awarded by the Slovenian Research Agency. MA is
   supported in part by the Slovene National Research Agency (grant number
   P3-0343).
CR Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x
   Awad N, 2004, J CLIN EXP NEUROPSYC, V26, P1044, DOI 10.1080/13803390490514875
   Brands AMA, 2007, J INT NEUROPSYCH SOC, V13, P288, DOI 10.1017/S1355617707070312
   Culbertson W. C., 2005, TOWER LONDON DREXEL
   Elderkin-Thompson V, 2003, ARCH CLIN NEUROPSYCH, V18, P529, DOI 10.1016/S0887-6177(03)00022-2
   Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Glasgow RE, 2007, DIABETES CARE, V30, P33, DOI 10.2337/dc06-1390
   Golden C. J., 2002, STROOP COLOR WORD TE
   Gonzalez JS, 2008, DIABETIC MED, V25, P1102, DOI 10.1111/j.1464-5491.2008.02535.x
   Gonzalez JS, 2008, DIABETOLOGIA, V51, P1822, DOI 10.1007/s00125-008-1113-x
   Gonzalez JS, 2007, DIABETES CARE, V30, P2222, DOI 10.2337/dc07-0158
   Gunstad J, 2007, COMPR PSYCHIAT, V48, P57, DOI 10.1016/j.comppsych.2006.05.001
   Hebert JR, 1997, AM J EPIDEMIOL, V146, P1046
   Kodl CT, 2008, ENDOCR REV, V29, P494, DOI 10.1210/er.2007-0034
   Landro NI, 2001, NEUROPSY NEUROPSY BE, V14, P233
   Legato Marianne J, 2006, Gend Med, V3, P131, DOI 10.1016/S1550-8579(06)80202-0
   Lin EHB, 2004, DIABETES CARE, V27, P2154, DOI 10.2337/diacare.27.9.2154
   Manschot SM, 2006, DIABETES, V55, P1106, DOI 10.2337/diabetes.55.04.06.db05-1323
   McCollum Marianne, 2005, Gend Med, V2, P246, DOI 10.1016/S1550-8579(05)80054-3
   McNally K, 2010, DIABETES CARE, V33, P1159, DOI 10.2337/dc09-2116
   Nguyen HT, 2010, J AM GERIATR SOC, V58, P1123, DOI 10.1111/j.1532-5415.2010.02857.x
   Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987
   Randolph C., 1998, RBANS REPEATABLE BAT
   Reynolds WM, 1995, HDI HAMILTON DEPRESS
   Schmitt DP, 2008, J PERS SOC PSYCHOL, V94, P168, DOI 10.1037/0022-3514.94.1.168
   Sinclair AJ, 2000, DIABETES RES CLIN PR, V50, P203, DOI 10.1016/S0168-8227(00)00195-9
   SPSS: An IBM Company, 2009, PASW STAT 18 0 0
   Thabit H, 2009, DIABETES RES CLIN PR, V86, P208, DOI 10.1016/j.diabres.2009.09.004
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Turner RC, 1998, LANCET, V352, P837
   van den Berg E, 2010, DIABETOLOGIA, V53, P58, DOI 10.1007/s00125-009-1571-9
   van Harten B, 2007, AGE AGEING, V36, P164, DOI 10.1093/ageing/afl180
   Weinger K, 2005, DIABETES CARE, V28, P1346, DOI 10.2337/diacare.28.6.1346
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
NR 35
TC 30
Z9 33
U1 0
U2 26
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD JAN
PY 2012
VL 95
IS 1
BP 48
EP 54
DI 10.1016/j.diabres.2011.09.004
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 866ST
UT WOS:000298403900016
PM 21963107
DA 2019-01-08
ER

PT J
AU Whisman, MA
   Uebelacker, LA
AF Whisman, Mark A.
   Uebelacker, Lisa A.
TI A Longitudinal Investigation of Marital Adjustment as a Risk Factor for
   Metabolic Syndrome
SO HEALTH PSYCHOLOGY
LA English
DT Article
DE satisfaction; distress; discord; biomarker; metabolic syndrome
ID DEPRESSIVE SYMPTOMS; OLDER-ADULTS; WOMEN; QUALITY; ASSOCIATIONS;
   METAANALYSIS; SATISFACTION; CONFLICT; DISTRESS; BEHAVIOR
AB Objective: Metabolic syndrome (MetS) is a constellation of features-central obesity, dyslipidemia, elevated blood pressure, and dysglycemia-that are associated with increased risk for cardiovascular disease, diabetes, stroke, and mortality. This longitudinal study was conducted to evaluate whether marital adjustment, which has been shown to predict a variety of health outcomes, increases risk for incidence of MetS. Methods: A population-based English sample of couples (N = 216 couples) completed a self-report measure of marital adjustment at baseline and nurse visits that included collection of blood pressure, blood samples, and anthropometric measures at baseline and 4-year follow-up. Multilevel modeling was used to evaluate the association between both partners' report of baseline marital adjustment and incidence of MetS, controlling for other baseline risk factors (demographics, current and previous smoking status, alcohol use, activity level, depressive symptoms, number of MetS criteria). Results: Gender moderated the association between marital adjustment and incidence of MetS. Follow-up analyses indicated that husbands' report of marital adjustment at baseline was significantly associated with incident MetS for wives at follow-up, controlling for baseline risk factors. Marital adjustment was not significantly associated with incident MetS for men. Conclusions: Findings suggest that MetS may be one mechanism by which poor marital adjustment increases risk for poor health outcomes in women. Improving marital adjustment may help prevent the incidence of MetS and improve health, particularly for women.
C1 [Whisman, Mark A.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA.
   [Uebelacker, Lisa A.] Brown Univ, Warren Alpert Med Sch, Dept Psychiat & Human Behav, Providence, RI 02912 USA.
   [Uebelacker, Lisa A.] Butler Hosp, Dept Psychosocial Res, Providence, RI 02906 USA.
RP Whisman, MA (reprint author), Univ Colorado, Dept Psychol & Neurosci, 345 UCB, Boulder, CO 80309 USA.
EM mark.whisman@colorado.edu
FU National Institute of Aging in the United States; consortium of U.K.
   government departments
FX The data were made available through the U.K. Data Archive. The English
   Longitudinal Study of Ageing (ELSA) was developed by a team of
   researchers based at the National Centre for Social Research, University
   College London, and the Institute for Fiscal Studies. The data were
   collected by the National Centre for Social Research. The funding is
   provided by the National Institute of Aging in the United States and a
   consortium of U.K. government departments coordinated by the Office for
   National Statistics. The developers and funders of ELSA and the U.K.
   Data Archive do not bear any responsibility for the analyses or
   interpretations presented here.
CR ACTIVITY & HEALTH RESEARCH, 1992, ALL DUNB NAT FITN SU
   Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644
   Baker B, 2003, J PSYCHOSOM RES, V55, P229, DOI 10.1016/S0022-3999(02)00551-2
   Beach SRH, 2003, J SOC PERS RELAT, V20, P355, DOI 10.1177/0265407503020003005
   Brien SE, 2006, APPL PHYSIOL NUTR ME, V31, P40, DOI 10.1139/H05-024
   Cornier MA, 2008, ENDOCR REV, V29, P777, DOI 10.1210/er.2008-0024
   Coyne JC, 2001, AM J CARDIOL, V88, P526, DOI 10.1016/S0002-9149(01)01731-3
   Cross SE, 1997, PSYCHOL BULL, V122, P5, DOI 10.1037//0033-2909.122.1.5
   Ford ES, 2008, DIABETES CARE, V31, P1898, DOI 10.2337/dc08-0423
   Forthofer MS, 1996, J MARRIAGE FAM, V58, P597, DOI 10.2307/353720
   Galassi A, 2006, AM J MED, V119, P812, DOI 10.1016/j.amjmed.2006.02.031
   Gallo LC, 2003, PSYCHOSOM MED, V65, P952, DOI 10.1097/01.PSY.0000097350.95305.FE
   Gallo LC, 2003, HEALTH PSYCHOL, V22, P453, DOI 10.1037/0278-6133.22.5.453
   Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032
   Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404
   HUSTON TL, 1991, J PERS SOC PSYCHOL, V61, P721, DOI 10.1037/0022-3514.61.5.721
   Kelley H. H., 1978, INTERPERSONAL RELATI
   Kenny D. A., 2006, DYADIC DATA ANAL
   Kiecolt-Glaser JK, 2001, PSYCHOL BULL, V127, P472, DOI 10.1037//0033-2909.127.4.472
   KIECOLTGLASER JK, 1993, PSYCHOSOM MED, V55, P395, DOI 10.1097/00006842-199309000-00001
   KiecoltGlaser JK, 1997, PSYCHOSOM MED, V59, P339, DOI 10.1097/00006842-199707000-00001
   Li W, 2008, CEREBROVASC DIS, V25, P539, DOI 10.1159/000131672
   Marmot M., 2010, ENGLISH LONGITUDINAL
   McMahon JM, 2006, COMPUT STAT DATA AN, V50, P3663, DOI 10.1016/j.csda.2005.08.008
   Orth-Gomer K, 2000, JAMA-J AM MED ASSOC, V284, P3008, DOI 10.1001/jama.284.23.3008
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Raikkonen K, 2002, METABOLISM, V51, P1573, DOI 10.1053/meta.2002.36301
   SAS Institute, 2008, SAS 9 13 WIND
   Steffick D. E, 2000, DR005 HRS SURV RES C
   Troxel WM, 2005, ARCH INTERN MED, V165, P1022, DOI 10.1001/archinte.165.9.1022
   Walen HR, 2000, J SOC PERS RELAT, V17, P5, DOI 10.1177/0265407500171001
   Whisman MA, 2005, J FAM PSYCHOL, V19, P111, DOI 10.1037/0893-3200-19.1.111
   Whisman MA, 2010, J FAM PSYCHOL, V24, P367, DOI 10.1037/a0019547
   Whisman MA, 2009, PSYCHOL AGING, V24, P184, DOI 10.1037/a0014759
   World Health Organization, 2008, GLOB BURD DIS 2004 U
NR 35
TC 28
Z9 28
U1 0
U2 12
PU AMER PSYCHOLOGICAL ASSOC
PI WASHINGTON
PA 750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA
SN 0278-6133
J9 HEALTH PSYCHOL
JI Health Psychol.
PD JAN
PY 2012
VL 31
IS 1
BP 80
EP 86
DI 10.1037/a0025671
PG 7
WC Psychology, Clinical; Psychology
SC Psychology
GA 878MM
UT WOS:000299261200012
PM 22004463
DA 2019-01-08
ER

PT J
AU Ogbera, A
   Adeyemi-Doro, A
AF Ogbera, Anthonia
   Adeyemi-Doro, Adekunle
TI Emotional distress is associated with poor self care in type 2 diabetes
   mellitus
SO JOURNAL OF DIABETES
LA English
DT Article
DE emotional distress; glycemic control; self-care
ID PSYCHOSOCIAL FACTORS; GLYCEMIC CONTROL; PREVALENCE; ADULTS
AB Background: The aim of the present study was to evaluate possible clinical and psychosocial variables that influence diabetes self-care management in patients with type 2 diabetes mellitus (T2DM).
   Methods: A total of 150 individuals with T2DM who had had diabetes for at least 6 months were recruited to this cross-sectional study. Levels of self-care and psychosocial status were determined using the Self-Care Inventory (SCI) and Problem Areas in Diabetes (PAID) scale. The PAID scores were calculated using a five-point Likert scale with options ranging from 0 (not a problem) to 4 (serious problem). Data were evaluated using non-parametric and parametric tests as appropriate.
   Results: The mean age of the study participants was 69.97 perpendicular to 8.68 years. Cronbach's alpha for SCI and PAID scores was 0.85 and 0.98, respectively. People with poor glycemic control had significantly higher mean (+/- SD) total PAID scores than individuals with good glycemic control (29.5 +/- 30.9 vs 16.7 +/- 26.9, respectively; P = 0.012). There was a significant relationship between PAID scores and glycemic control (r = 0.2; P = 0.012).
   Conclusions: The present study demonstrates that psychosocial factors directly influence glycemic control and diabetes self-care habits. In addition, diabetes-specific distress in study population was unrelated to the duration of diabetes, the age of the patients and anthropometric indices.
C1 [Ogbera, Anthonia; Adeyemi-Doro, Adekunle] Lagos State Univ Teaching Hosp, Dept Med, Ikeja, Lagos, Nigeria.
RP Ogbera, A (reprint author), Structured Healthcare Initiat, POB 579, Ikeja, Lagos State, Nigeria.
EM oogbera@yahoo.co.uk
CR Aikens JE, 2009, DIABETES CARE, V32, P1177, DOI 10.2337/dc09-0071
   Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x
   Delahanty LM, 2007, DIABETIC MED, V24, P48, DOI 10.1111/j.1464-5491.2007.02028.x
   Farmer AJ, 2003, DIABETIC MED, V20, P996, DOI 10.1046/j.1464-5491.2003.01042.x
   Greco P., 1990, DIABETES S1, V40, pA165
   Lerman I, 2004, BIOMED PHARMACOTHER, V58, P566, DOI 10.1016/j.biopha.2004.09.003
   Miller S. T., 2008, BMC PUBLIC HEALTH, V8, P70
   Mooy JM, 2000, DIABETES CARE, V23, P197, DOI 10.2337/diacare.23.2.197
   Nakahara R, 2006, PSYCHOSOMATICS, V47, P240, DOI 10.1176/appi.psy.47.3.240
   Ogbera A O, 2010, West Afr J Med, V29, P158
   Papelbaum M, 2010, DIABETES RES CLIN PR, V89, P227, DOI 10.1016/j.diabres.2010.05.024
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Spencer MS, 2006, J HEALTH CARE POOR U, V17, P88, DOI 10.1353/hpu.2006.0095
   Thoolen BJ, 2006, DIABETES CARE, V29, P2257, DOI 10.2337/dc06-0617
   Weinger K, 2005, DIABETES CARE, V28, P1346, DOI 10.2337/diacare.28.6.1346
NR 16
TC 26
Z9 27
U1 1
U2 7
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1753-0393
J9 J DIABETES
JI J. Diabetes
PD DEC
PY 2011
VL 3
IS 4
BP 348
EP 352
DI 10.1111/j.1753-0407.2011.00156.x
PG 5
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 982SJ
UT WOS:000307065400014
PM 21883978
DA 2019-01-08
ER

PT J
AU Wang, RH
   Wu, LC
   Hsu, HY
AF Wang, Ruey-Hsia
   Wu, Li-Chu
   Hsu, Hsiu-Yueh
TI A path model of health-related quality of life in Type 2 diabetic
   patients: a cross-sectional study in Taiwan
SO JOURNAL OF ADVANCED NURSING
LA English
DT Article
DE health-related quality of life; nursing; path model; structural equation
   modelling; Type 2 diabetes
ID METABOLIC-CONTROL; SELF-CARE; EMPOWERMENT; DEPRESSION; DISTRESS; ADULTS;
   OUTCOMES; POPULATION; PROGRAM; VERSION
AB Aims. To construct a path model about relationships of perceptions of empowerment, diabetes distress, self-care behaviour and glycemic control to health-related quality of life in Taiwanese Type 2 diabetic patients, suffering from diabetes for 10 years or less. Background. Health-related quality of life is the primary end point for people with diabetes. Understanding the path model of health-related quality of life in Type 2 diabetic patients is useful for nurses to design early intervention programmes. Methods. This was a cross-sectional study. An anonymous questionnaire was used to collect data from 2007 to 2008. Glycosylated haemoglobin (HbA1c) was also collected. Data from 428 Type 2 diabetic patients were analysed with structural equation modelling to test the fit of the hypothesized path model to the data. Results. A model was produced in which self-care behaviour had a statistically significantly direct influence on satisfaction, impact and worry aspects of health-related quality of life. Glycosylated haemoglobin had a statistically significantly negative influence on satisfaction, and impact aspects of health-related quality of life. Perceptions of empowerment had a statistically significantly direct influence on satisfaction aspect of health-related quality of life. Diabetes distress had a statistically significantly direct influence on satisfaction, impact and worry aspects of health-related quality of life. Conclusions. Nurses should develop new approaches to improve various aspects of health-related quality of life. Nurses could empower patients to improve satisfaction aspect of health-related quality of life. To improve the impact and worry aspects of health-related quality of life, nurses should reduce diabetes distress felt by patients.
C1 [Wang, Ruey-Hsia] Kaohsiung Med Univ, Coll Nursing, Kaohsiung, Taiwan.
   [Wu, Li-Chu] Kaohsiung Vet Gen Hosp, Kaohsiung, Taiwan.
   [Hsu, Hsiu-Yueh] Meiho Inst Technol, Dept Nursing, Pingtung, Taiwan.
RP Wang, RH (reprint author), Kaohsiung Med Univ, Coll Nursing, Kaohsiung, Taiwan.
EM wrhsia@kmu.edu.tw
FU National Science Council, Taiwan [NSC 96-2314-B-037-075-MY2]
FX Thanks to the National Science Council, Taiwan for funding this study
   (NSC 96-2314-B-037-075-MY2).
CR American Diabetes Association, 2010, DIAB BAS DIAB STAT
   Anderson RJ, 2000, DIABETES, V49, pA64
   ANDERSON RM, 1995, DIABETES CARE, V18, P943, DOI 10.2337/diacare.18.7.943
   Anderson RM, 2010, PATIENT EDUC COUNS, V79, P277, DOI 10.1016/j.pec.2009.07.025
   Bennett WL, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-110
   Black SA, 2003, DIABETES CARE, V26, P2822, DOI 10.2337/diacare.26.10.2822
   Brown G.C., 2004, J DIABETES COMPLICAT, V14, P18
   Bureau of Health Promotion, 2009, AD ELD HLTH
   El Achhab Y, 2008, DIABETES RES CLIN PR, V80, P171, DOI 10.1016/j.diabres.2007.12.020
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Forlani G, 2006, J ENDOCRINOL INVEST, V29, P405, DOI 10.1007/BF03344123
   Funnell Martha Mitchell, 2009, Nursing, V39, P34, DOI 10.1097/01.NURSE.0000347073.76891.2a
   Gross CC, 2007, DIABETES RES CLIN PR, V76, P455, DOI 10.1016/j.diabres.2006.09.022
   Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118
   Huang IC, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-87
   Huang MF, 2010, INT J NURS STUD, V47, P542, DOI 10.1016/j.ijnurstu.2009.10.012
   Jermendy G, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-88
   Karlsen B, 2004, PATIENT EDUC COUNS, V53, P299, DOI 10.1016/j.pec.2003.10.008
   Li CY, 2007, DIABETES CARE, V30, P1770, DOI 10.2337/dc06-2571
   Lin C. C, 2005, THESIS STATE U MICHI
   Lustman PJ, 2005, J DIABETES COMPLICAT, V19, P113, DOI 10.1016/j.jdiacomp.2004.01.002
   Maddigan SL, 2005, QUAL LIFE RES, V14, P1489, DOI 10.1007/s11136-005-0586-z
   Nuttall F Q, 1998, J Fam Pract, V47, pS45
   Papadopoulos AA, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-186
   Pibernik-Okanovic M, 2004, PATIENT EDUC COUNS, V52, P193, DOI 10.1016/S0738-3991(03)00038-7
   Polit DF, 2004, NURSING RES PRINCIPL
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Rodwell CM, 1996, J ADV NURS, V23, P305, DOI 10.1111/j.1365-2648.1996.tb02672.x
   Saito I, 2006, DIABETES RES CLIN PR, V73, P51, DOI 10.1016/j.diabres.2005.11.015
   Samuel-Hodge CD, 2008, DIABETES EDUCATOR, V34, P501, DOI 10.1177/0145721708316946
   Schumacker R. E., 1996, BEGINNERS GUIDE STRU
   Sigurthardottir AK, 2005, J CLIN NURS, V14, P301, DOI 10.1111/j.1365-2702.2004.01043.x
   Tengland Per-Anders, 2007, Med Health Care Philos, V10, P197, DOI 10.1007/s11019-006-9027-1
   Wang JX, 1998, J NURSING, V45, P60
   Watkins KW, 2000, DIABETES CARE, V23, P1511, DOI 10.2337/diacare.23.10.1511
   *WHO, 2008, DIAB
NR 37
TC 18
Z9 18
U1 2
U2 16
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0309-2402
EI 1365-2648
J9 J ADV NURS
JI J. Adv. Nurs.
PD DEC
PY 2011
VL 67
IS 12
BP 2658
EP 2667
DI 10.1111/j.1365-2648.2011.05701.x
PG 10
WC Nursing
SC Nursing
GA 858XX
UT WOS:000297837700016
PM 21615464
DA 2019-01-08
ER

PT J
AU Franc, S
   Daoudi, A
   Mounier, S
   Boucherie, B
   Laroye, H
   Peschard, C
   Dardari, D
   Juy, O
   Requeda, E
   Canipel, L
   Charpentier, G
AF Franc, S.
   Daoudi, A.
   Mounier, S.
   Boucherie, B.
   Laroye, H.
   Peschard, C.
   Dardari, D.
   Juy, O.
   Requeda, E.
   Canipel, L.
   Charpentier, G.
TI Telemedicine: What more is needed for its integration in everyday life?
SO DIABETES & METABOLISM
LA English
DT Article
DE Telemedicine; Type 1 and type 2 diabetes; Medical device; Smart-phone;
   Education; Organization of healthcare; Review
ID RANDOMIZED CONTROLLED-TRIAL; GLUCOSE MONITORING-SYSTEM;
   DIABETIC-PATIENTS; GLYCEMIC CONTROL; INTERNET; SUPPORT; PHONE; CARE
AB The Health Authorities have huge expectations of telemedicine (TM): improved patient access to healthcare, a solution to the shortage of doctors in the face of an exponentially expanding disease, and reduced healthcare costs with improved quality.
   There are a host of applications for TM in the area of diabetes. TM has been validated and has been widely used to screen for diabetic retinopathy, and a number of studies are currently underway for the follow-up of diabetic foot ulcers. However, the main indication of TM remains the follow-up and control of blood glucose. In this area, many studies have been conducted to improve glycaemic control. While most of these studies have failed to show any benefits vs. conventional care, a small number have demonstrated great efficacy of this approach with regard to glycaemia. Using these studies, we attempt to define the key qualities of a successful TM system.
   How can we extend the results of these experiments beyond the framework of clinical studies and integrate them in daily practice so as to improve diabetes management?
   This is the key challenge for TM, implementation of which will require reorganization of healthcare, given the evolution of medical demographics.
   This reorganization will involve healthcare providers specialized in diabetes that may intervene in assigning physicians for especially distressed patients. However, such reorganization will require medico-economic evaluation before it can be implemented on a larger scale. (C) 2011 Elsevier Masson SAS. All rights reserved.
C1 [Franc, S.; Daoudi, A.; Mounier, S.; Boucherie, B.; Laroye, H.; Peschard, C.; Dardari, D.; Juy, O.; Canipel, L.; Charpentier, G.] CERITD, Corbeil Essonnes, France.
   [Franc, S.; Requeda, E.; Charpentier, G.] Sud Francilien Hosp, Dept Diabet, Corbeil Essonnes, France.
RP Franc, S (reprint author), CERITD, Corbeil Essonnes, France.
EM sylvia.franc@free.fr
RI laroye, heloise/I-8082-2017
CR [Anonymous], NCT00937703
   [Anonymous], NCT01192711 INS ADM
   Benhamou PY, 2007, DIABETES METAB, V33, P220, DOI 10.1016/j.diabet.2007.01.002
   Chabouis A, 2009, DIABETES METAB, V35, P228, DOI 10.1016/j.diabet.2008.12.001
   Charpentier G, 2011, DIABETES CARE, V34, P533, DOI 10.2337/dc10-1259
   Cho JH, 2006, DIABETES CARE, V29, P2625, DOI 10.2337/dc05-2371
   Dardari D.FrancS.BoucherieB, 2006, DIABETES METAB S, V32, p1S73
   Farmer AJ, 2005, DIABETES CARE, V28, P269
   Franc S, 2009, DIABETES METAB, V35, P463, DOI 10.1016/j.diabet.2009.05.006
   Franc S, 2011, DIABETES METAB  0831
   Franc S, 2010, DIABETES CARE, V33, P1913, DOI 10.2337/dc10-0115
   Kwon HS, 2004, DIABETES CARE, V27, P478, DOI 10.2337/diacare.27.2.478
   Legmann M, TELEMEDECINE PRECONI
   Lim S, 2011, DIABETES CARE, V34, P308, DOI 10.2337/dc10-1447
   Massin P, 2008, DIABETES METAB, V34, P227, DOI 10.1016/j.diabet.2007.12.006
   Petrovski G, 2011, INTERNET VISITS IMPR
   Piette JD, 2000, AM J MED, V108, P20, DOI 10.1016/S0002-9343(99)00298-3
   Quinn CC, 2008, DIABETES TECHNOL THE, V10, P160, DOI 10.1089/dia.2008.0283
   Quinn CC, 2011, DIABETES CARE, V34, P1934, DOI 10.2337/dc11-0366
   Rigla Mercedes, 2007, J Diabetes Sci Technol, V1, P505
   Rossi MCE, 2010, DIABETES CARE, V33, P109, DOI 10.2337/dc09-1327
   Rossi MCE, 2009, DIABETES TECHNOL THE, V11, P19, DOI 10.1089/dia.2008.0020
   Rossi MCE, 2010, EUROPEAN ENDOCRINOLO, V6, P39
   SHAMOON H, 1993, NEW ENGL J MED, V329, P977
   Simon P, PLACE TELEMEDICINE O
   Thompson DM, 1999, CAN MED ASSOC J, V161, P959
   Verhoeven Fenne, 2010, J Diabetes Sci Technol, V4, P666
   Young RJ, 2005, DIABETES CARE, V28, P278, DOI 10.2337/diacare.28.2.278
NR 28
TC 6
Z9 6
U1 2
U2 21
PU MASSON EDITEUR
PI MOULINEAUX CEDEX 9
PA 21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE
SN 1262-3636
J9 DIABETES METAB
JI Diabetes Metab.
PD DEC
PY 2011
VL 37
SI 4
BP S71
EP S77
DI 10.1016/S1262-3636(11)70969-7
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 872UH
UT WOS:000298834700007
PM 22208714
DA 2019-01-08
ER

PT J
AU Rzeszut, JR
AF Rzeszut, Jennifer R.
TI Children With Diabetes: The Impact of Fear of Needles
SO JOURNAL OF PEDIATRIC NURSING-NURSING CARE OF CHILDREN & FAMILIES
LA English
DT Article
ID DISTRESS
C1 Univ Penn, Philadelphia, PA 19104 USA.
RP Rzeszut, JR (reprint author), Univ Penn, Philadelphia, PA 19104 USA.
EM jeni.rzeszut@gmail.com
CR Dahlquist Lynnda M, 2002, J Pediatr Oncol Nurs, V19, P22, DOI 10.1053/jpon.2002.30009
   Deacon B, 2006, J ANXIETY DISORD, V20, P946, DOI 10.1016/j.janxdis.2006.01.004
   FASSLER D, 1985, AM J ORTHOPSYCHIAT, V55, P371, DOI 10.1111/j.1939-0025.1985.tb03452.x
   Hanas R, 1997, PRACTICAL DIABETES, V14, P95, DOI DOI 10.1002/PDI.1960140404
   Howe CJ, 2010, AM J MATERN CHILD NU, V36, P25
   HUMPHREY GB, 1992, PEDIATRICS, V90, P87
   MOORE KE, 1995, CLIN PEDIATR, V34, P530, DOI 10.1177/000992289503401004
   RAINWATER N, 1988, CHILD FAM BEHAV THER, V10, P19
   Simmons JH, 2007, DIABETES CARE, V30, P987, DOI 10.2337/dc06-1553
   Sparks L, 2001, MCN Am J Matern Child Nurs, V26, P72, DOI 10.1097/00005721-200103000-00005
   Walco Gary A, 2008, Pediatrics, V122 Suppl 3, pS125, DOI 10.1542/peds.2008-1055d
NR 11
TC 6
Z9 6
U1 0
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0882-5963
J9 J PEDIATR NURS
JI J. Pediatr. Nurs.
PD DEC
PY 2011
VL 26
IS 6
BP 589
EP 592
DI 10.1016/j.pedn.2011.09.003
PG 4
WC Nursing; Pediatrics
SC Nursing; Pediatrics
GA 045OI
UT WOS:000311705800011
PM 21925589
DA 2019-01-08
ER

PT J
AU Jaser, SS
AF Jaser, Sarah S.
TI Family Interaction in Pediatric Diabetes
SO CURRENT DIABETES REPORTS
LA English
DT Article
DE Family relations; Type 1 diabetes mellitus; Adaptation; Psychological
ID QUALITY-OF-LIFE; METABOLIC-CONTROL; GLYCEMIC CONTROL; MATERNAL
   INVOLVEMENT; DEPRESSIVE SYMPTOMS; SYSTEMS THERAPY; YOUNG-CHILDREN;
   RISK-FACTORS; TYPE-1; ADHERENCE
AB Adaptation to type 1 diabetes is optimized in the presence of ongoing family support and supervision. Therefore, it is particularly important to understand how family interactions influence adaptation to the illness. The purpose of this paper is to review the current literature on family interaction in youth with type 1 diabetes. Recent advancements in the literature include greater specificity of types of parental involvement, attention to the role of fathers, acknowledgment of the impact of parental distress, increased use of observational methods, and awareness of the impact of culture. Continued parental involvement-particularly monitoring-in the management of diabetes care is important as children transition into adolescence, and the best outcomes are evident when this involvement occurs in a warm, collaborative manner. Parents need support in managing their own distress to maintain this type of involvement.
C1 Yale Univ, Sch Nursing, New Haven, CT 06536 USA.
RP Jaser, SS (reprint author), Yale Univ, Sch Nursing, 100 Church St S,POB 9740, New Haven, CT 06536 USA.
EM sarah.jaser@yale.edu
FU National Institute of Diabetes and Digestive and Kidney Diseases [K23
   NK088454]; National Center for Research Resources [UL1 RR024139]
FX This work was supported by awards from the National Institute of
   Diabetes and Digestive and Kidney Diseases (K23 NK088454) and the
   National Center for Research Resources (UL1 RR024139). The contents of
   this manuscript are solely the responsibility of the author and do not
   necessarily represent the official view of the US National Institutes of
   Health.
CR American Diabetes Association (ADA), 2011, DIABETES CARE S1, V34, pS11, DOI DOI 10.2337/DC11-S011
   Anderson BJ, 2007, DIS MANAG HEALTH OUT, V15, P101, DOI 10.2165/00115677-200715020-00005
   Anderson BJ, 2002, DIABETIC MED, V19, P635, DOI 10.1046/j.1464-5491.2002.00752.x
   Anderson BJ, 1999, DIABETES CARE, V22, P713, DOI 10.2337/diacare.22.5.713
   Berg CA, 2008, DIABETES CARE, V31, P678, DOI 10.2337/dc07-1678
   Cameron FJ, 2008, DIABETIC MED, V25, P463, DOI 10.1111/j.1464-5491.2008.02399.x
   Cameron FJ, 2007, DIABETES CARE, V30, P2716, DOI 10.2337/dc07-0603
   Cameron LD, 2007, J PEDIATR PSYCHOL, V32, P733, DOI 10.1093/jpepsy/jslo53
   Cohen DM, 2004, J PEDIATR PSYCHOL, V29, P171, DOI 10.1093/jpepsy/jsh019
   Delamater AM, 1999, DIABETES CARE, V22, P700, DOI 10.2337/diacare.22.5.700
   Drotar D, 1997, J PEDIATR PSYCHOL, V22, P149
   Ellis DA, 2008, J ADOLESCENT HEALTH, V42, P146, DOI 10.1016/j.jadohealth.2007.08.012
   Ellis DA, 2007, J PEDIATR PSYCHOL, V32, P907, DOI 10.1093/jpepsy/jsm009
   Faulkner Melissa Spezia, 2007, J Pediatr Nurs, V22, P59, DOI 10.1016/j.pedn.2006.02.008
   Gale EAM, 2002, DIABETES, V51, P3353, DOI 10.2337/diabetes.51.12.3353
   Gallegos-Macias Angela R, 2003, Pediatr Diabetes, V4, P19, DOI 10.1034/j.1399-5448.2003.00020.x
   Grey M, 2000, J PEDIATR-US, V137, P107, DOI 10.1067/mpd.2000.106568
   Grey M, 1998, DIABETES CARE, V21, P909, DOI 10.2337/diacare.21.6.909
   Grey M, 2009, RES NURS HEALTH, V32, P405, DOI 10.1002/nur.20336
   HEGELSON VS, 2009, J PEDIATR PSYCHOL, V34, P254
   Hood KK, 2006, DIABETES CARE, V29, P1389, DOI 10.2337/dc06-0087
   Horton D, 2009, J PEDIATR PSYCHOL, V34, P1008, DOI 10.1093/jpepsy/jsp022
   Hsin O, 2010, J PEDIATR PSYCHOL, V35, P156, DOI 10.1093/jpepsy/jsp045
   JACOBSON AM, 1994, PSYCHOSOM MED, V56, P401, DOI 10.1097/00006842-199409000-00004
   Jaser SS, 2008, J PEDIATR PSYCHOL, V33, P509, DOI 10.1093/jpepsy/jsm104
   Jaser SS, 2010, J PEDIATR PSYCHOL, V35, P738, DOI 10.1093/jpepsy/jsp098
   Kokkonen J, 1997, NORD J PSYCHIAT, V51, P165, DOI 10.3109/08039489709109091
   Kovacs M, 1997, DIABETES CARE, V20, P36, DOI 10.2337/diacare.20.1.36
   Laffel LMB, 2003, DIABETES CARE, V26, P3067, DOI 10.2337/diacare.26.11.3067
   Lewin AB, 2006, J PEDIATR PSYCHOL, V31, P174, DOI 10.1093/jpepsy/jsj004
   Martin MT, 1998, J FAM PSYCHOL, V12, P102, DOI 10.1037/0893-3200.12.1.102
   Palmer DL, 2004, J PEDIATR PSYCHOL, V29, P35, DOI 10.1093/jpepsy/jsh005
   Patton SR, 2008, J CLIN PSYCHOL MED S, V15, P252, DOI 10.1007/s10880-008-9123-x
   Patton SR, 2008, J PEDIATR PSYCHOL, V33, P885, DOI 10.1093/jpepsy/jsn026
   Piazza-Waggoner C, 2008, J DEV BEHAV PEDIATR, V29, P101, DOI 10.1097/DBP.0b013e31815f24ce
   SIEFFGEKRENKE I, 2002, J PEDIATR PSYCHOL, V27, P439
   SILVERSTEIN J, 2005, DIABETES CARE, V28, P2005
   Streisand R, 2005, J PEDIATR PSYCHOL, V30, P513, DOI 10.1093/jpepsy/jsi076
   Swift EE, 2006, ANN BEHAV MED, V32, P39, DOI 10.1207/s15324796abm3201_5
   Weinger K, 2001, J ADOLESCENT HEALTH, V29, P330, DOI 10.1016/S1054-139X(01)00270-1
   Weissberg-Benchell J, 2009, J PEDIATR PSYCHOL, V34, P977, DOI 10.1093/jpepsy/jsp003
   Whittemore R, 2003, DIABETES EDUCATOR, V29, P847, DOI 10.1177/014572170302900514
   Whittemore R, 2004, EVIDENCE BASED PRACT
   Wiebe DJ, 2005, J PEDIATR PSYCHOL, V30, P167, DOI 10.1093/jpepsy/jsi004
   Williams LB, 2009, DIABETIC MED, V26, P908, DOI 10.1111/j.1464-5491.2009.02794.x
   Wysocki T, 2006, J PEDIATR PSYCHOL, V31, P501, DOI 10.1093/jpepsy/jsj042
   Wysocki T, 2008, BEHAV THER, V39, P33, DOI 10.1016/j.beth.2007.04.001
   Wysocki T, 2007, DIABETES CARE, V30, P555, DOI 10.2337/dc06-1613
NR 48
TC 14
Z9 15
U1 0
U2 23
PU CURRENT MEDICINE GROUP
PI PHILADELPHIA
PA 400 MARKET STREET, STE 700, PHILADELPHIA, PA 19106 USA
SN 1534-4827
J9 CURR DIABETES REP
JI Curr. Diabetes Rep.
PD DEC
PY 2011
VL 11
IS 6
BP 480
EP 485
DI 10.1007/s11892-011-0222-y
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 841LA
UT WOS:000296512600005
PM 21853415
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Amparo, P
   Farr, SL
   Dietz, PM
AF Amparo, Pamela
   Farr, Sherry L.
   Dietz, Patricia M.
TI Chronic Disease Risk Factors Among American Indian/Alaska Native Women
   of Reproductive Age
SO PREVENTING CHRONIC DISEASE
LA English
DT Article
ID MATERNAL OBESITY; DIABETES-MELLITUS; HEALTH BEHAVIORS; PREGNANCY;
   METAANALYSIS; ADULTS
AB Introduction
   The magnitude of chronic conditions and risk factors among American Indian/Alaska Native women of reproductive age is unknown. The objective of our study was to estimate this magnitude.
   Methods
   We analyzed data for 2,821 American Indian/Alaska Native women and 105,664 non-Hispanic white women aged 18 to 44 years from the 2005 and 2007 Behavioral Risk Factor Surveillance System. We examined prevalence of high cholesterol, high blood pressure, diabetes, body mass index (kg/m(2)) >= 25.0, physical inactivity, smoking, excessive alcohol consumption, and frequent mental distress, and the cumulative number of these chronic conditions and risk factors (>= 3, 2, 1, or 0). In a multivariable, multinomial logistic regression model, we examined whether American Indian/Alaska Native race was associated with the cumulative number of chronic conditions and risk factors.
   Results
   American Indian/Alaska Native women, compared with white women, had significantly higher rates of high blood pressure, diabetes, obesity, smoking, and frequent mental distress. Of American Indian/Alaska Native women, 41% had 3 or more chronic conditions or risk factors compared with 27% of white women (chi(2), P < .001). After adjustment for income, education, and other demographic variables, American Indian/Alaska Native race was not associated with having either 1, 2, or 3 or more chronic conditions or risk factors.
   Conclusion
   Three out of every 5 American Indian/Alaska Native women aged 18 to 44 years have 3 or more chronic conditions or risk factors. Improving economic status and education for AI/AN women could help eliminate disparities in health status.
C1 [Dietz, Patricia M.] Ctr Dis Control & Prevent, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA.
RP Dietz, PM (reprint author), Ctr Dis Control & Prevent, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, MS K-22,4770 Buford Hwy NE, Atlanta, GA 30341 USA.
EM PDietz@cdc.gov
CR Arendas K, 2008, J OBSTET GYNAECOL CA, V30, P477, DOI 10.1016/S1701-2163(16)32863-8
   Balsells M, 2009, J CLIN ENDOCR METAB, V94, P4284, DOI 10.1210/jc.2009-1231
   Barnes PJ, 2010, PROG RESPIR RES, V39, P1
   Blumberg SJ, 2009, AM J PUBLIC HEALTH, V99, P1806, DOI 10.2105/AJPH.2008.152835
   Castro LC, 2002, CURR OPIN OBSTET GYN, V14, P601, DOI 10.1097/01.gco.0000045486.15021.c9
   Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P1148
   Centers for Disease Control and Prevention (CDC), 2004, MMWR-MORBID MORTAL W, V53, P121
   Centers for Disease Control and Prevention (CDC), 2003, MMWR-MORBID MORTAL W, V52, P702
   Chu SY, 2007, DIABETES CARE, V30, P2070, DOI 10.2337/dc06-2559a
   Doshi SR, 2006, J WOMENS HEALTH, V15, P919, DOI 10.1089/jwh.2006.15.919
   Fahimi M, 2008, PREV CHRONIC DIS, V5
   Frost JJ, 2008, AM J PUBLIC HEALTH, V98, P1814, DOI 10.2105/AJPH.2007.124719
   Giuliano A, 1998, ANN EPIDEMIOL, V8, P160, DOI 10.1016/S1047-2797(97)00200-7
   Gold RB, 2009, NEXT STEPS AM FAMILY, P14
   Haskell WL, 2007, CIRCULATION, V116, P1081, DOI 10.1161/CIRCULATIONAHA.107.185649
   Indian Health Service, 2011, IHS FACT SHEETS IND
   Jernigan VBB, 2010, AM J PUBLIC HEALTH, V100, P677, DOI 10.2105/AJPH.2009.164285
   Little J, 2004, B WORLD HEALTH ORGAN, V82, P213
   Livingston J C, 2003, Minerva Ginecol, V55, P1
   Lykke JA, 2009, HYPERTENSION, V53, P944, DOI 10.1161/HYPERTENSIONAHA.109.130765
   NCEP Executive, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI DOI 10.1001/JAMA.285.19.2486
   Nelson DE, 2003, AM J PUBLIC HEALTH, V93, P1335, DOI 10.2105/AJPH.93.8.1335
   Newschaffer CJ, 1998, VALIDATION BEHAV RIS
   Oken E, 2009, OBSTET GYN CLIN N AM, V36, P361, DOI 10.1016/j.ogc.2009.03.007
   Rasmussen SA, 2008, AM J OBSTET GYNECOL, V198, P611, DOI 10.1016/j.ajog.2008.04.021
   Taylor R, 2007, BMJ-BRIT MED J, V334, P742, DOI 10.1136/bmj.39154.700417.BE
   US Department of Health and Human Services, 2004, HLTH CONS SMOK REP S
   Zuckerman S, 2004, AM J PUBLIC HEALTH, V94, P53, DOI 10.2105/AJPH.94.1.53
NR 28
TC 17
Z9 17
U1 0
U2 2
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1545-1151
J9 PREV CHRONIC DIS
JI Prev. Chronic Dis.
PD NOV
PY 2011
VL 8
IS 6
AR A118
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 896JZ
UT WOS:000300563000001
PM 22005611
DA 2019-01-08
ER

PT J
AU Hessler, DM
   Fisher, L
   Mullan, JT
   Glasgow, RE
   Masharani, U
AF Hessler, Danielle M.
   Fisher, Lawrence
   Mullan, Joseph T.
   Glasgow, Russell E.
   Masharani, Umesh
TI Patient age: A neglected factor when considering disease management in
   adults with type 2 diabetes
SO PATIENT EDUCATION AND COUNSELING
LA English
DT Article
DE Age; Type 2 diabetes; HbA1c; Psychosocial stressors
ID MELLITUS; SCALE; CARE
AB Objective: The average age at diagnosis for type 2 diabetes is decreasing. However, because age is most often controlled for in clinical research, little is known regarding how adult age is associated with diabetes disease-related variables.
   Methods: In a community based study with type 2 diabetes patients (N = 506), after adjusting for potentially confounding variables, we examined associations between patients' age and: stress, depression, diabetes-related distress, self-efficacy, diet, exercise, and glycemic control. We then explored to what extent age interacts with these variables in their association with glycemic control.
   Results: Younger age was independently associated with: greater chronic stress and negative life events, higher levels of diabetes-related distress, higher depressed affect, eating healthier foods and exercising less frequently, lower diabetes self-efficacy, and higher HbA1c. Interactions showed that younger patients with high stress and/or low self-efficacy were more likely to have higher HbA1c levels than older patients.
   Conclusions: Results suggest younger adult patients with type 2 diabetes represent a unique patient subgroup with specific needs and health risks based on their developmental stage and life context.
   Practice implications: Treatment programs need to target younger adult patients and may need to utilize different Media or modalities (e.g., social media) to reach this group. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
C1 [Hessler, Danielle M.; Fisher, Lawrence] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA.
   [Mullan, Joseph T.] Univ Calif San Francisco, Dept Social & Behav Sci, Sch Nursing, San Francisco, CA 94143 USA.
   [Glasgow, Russell E.] Kaiser Permanente, Inst Hlth Res, Denver, CO USA.
   [Masharani, Umesh] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.
RP Hessler, DM (reprint author), Univ Calif San Francisco, Dept Family & Community Med, Box 0900, San Francisco, CA 94143 USA.
EM hesslerd@fcm.ucsf.edu
FU National Institute of Diabetes, Digestive and Kidney Disease [DK062732,
   DK061937]
FX This research was supported by Grants DK062732 and DK061937 from the
   National Institute of Diabetes, Digestive and Kidney Disease. The
   following medical groups and diabetes education centers collaborated in
   this research: Alta Bates Diabetes Education Center, Brown and Toland
   Medical Group, California Pacific Diabetes Education Center, Hill
   Physicians Medical Group, Mann IPA, St. Luke's Diabetes Education
   Center, St. Mary's Medical Center, University of California, San
   Francisco Hospital and Clinics. Declaration of Competing Interests:
   Nothing to declare.
CR Aiken L. S, 1991, MULTIPLE REGRESSION
   Campbell JL, 2001, QUAL HEALTH CARE, V10, P90, DOI 10.1136/qhc.10.2.90
   Centers for Disease Control and Prevention, 2008, DAT NAT HLTH INT SUR
   CENTERS FOR DISEASE CONTROL AND PREVENTION, 2008, NAT DIAB FACT SHEET
   Fisher L, 2000, DIABETES CARE, V23, P267, DOI 10.2337/diacare.23.3.267
   Gilliland SS, 2002, DIABETES CARE, V25, P2178, DOI 10.2337/diacare.25.12.2178
   Koopman RJ, 2005, ANN FAM MED, V3, P60, DOI 10.1370/afm.214
   Li JKY, 2006, DIABETES-METAB RES, V22, P46, DOI 10.1002/dmrr.577
   PALINKAS LA, 1991, DIABETIC MED, V8, P532, DOI 10.1111/j.1464-5491.1991.tb01646.x
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Scott KM, 2008, PSYCHOL MED, V38, P1659, DOI 10.1017/S0033291708003413
   Sherbourne C D, 1992, Qual Life Res, V1, P235, DOI 10.1007/BF00435632
   Sidell NL, 1997, HEALTH SOC WORK, V22, P5, DOI 10.1093/hsw/22.1.5
   SKAFF MM, 2007, ANN M GER SOC AM SAN
   SOUSA VD, 2006, ONLINE BRAZILIAN J N, P5
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   TURNER RJ, 1995, AM SOCIOL REV, V60, P104, DOI 10.2307/2096348
   Zhao W, 2006, PUBLIC HEALTH, V120, P696, DOI 10.1016/j.puhe.2006.04.012
NR 19
TC 32
Z9 32
U1 0
U2 9
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0738-3991
J9 PATIENT EDUC COUNS
JI Patient Educ. Couns.
PD NOV
PY 2011
VL 85
IS 2
BP 154
EP 159
DI 10.1016/j.pec.2010.10.030
PG 6
WC Public, Environmental & Occupational Health; Social Sciences,
   Interdisciplinary
SC Public, Environmental & Occupational Health; Social Sciences - Other
   Topics
GA 850WX
UT WOS:000297231400006
PM 21112720
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Hajos, TRS
   Polonsky, WH
   Twisk, JWR
   Dain, MP
   Snoek, FJ
AF Hajos, Tibor R. S.
   Polonsky, William H.
   Twisk, Jos W. R.
   Dain, Marie-Paule
   Snoek, Frank J.
TI Do physicians understand Type 2 diabetes patients' perceptions of
   seriousness; the emotional impact and needs for care improvement? A
   cross-national survey
SO PATIENT EDUCATION AND COUNSELING
LA English
DT Article
DE Type 2 diabetes; Patient-provider interaction; Perceptions;
   Collaborative care; Concordance
ID PROVIDER PERCEPTIONS; SELF-MANAGEMENT; SATISFACTION; ATTITUDES;
   DISTRESS; BARRIERS; QUALITY; DISEASE; DAWN
AB Objective: To explore across countries the extent to which physicians understand Type 2 diabetes patients' perceptions of seriousness, worries about complications, emotional distress, and needs for care improvement.
   Methods: Cross-sectional data were collected in a multinational survey (SHARED). Type 2 diabetes patients (n=1609), general practitioners (n=818) and diabetes specialists (n=697) from eight countries were included. Data were gathered online and via telephone interviews. Responses from patients and professionals were compared using descriptive statistics and multilevel analyses.
   Results: Patients generally perceived diabetes as a serious condition and reported moderate distress. Physicians tended to underestimate patients' perceived seriousness, while overestimating their level of distress. Physicians had difficulty estimating which diabetes complications concerned patients most, and what they needed to feel more confident about their diabetes. Patients did not wish for more consultation time, but rather active involvement, information and easy access to their physician.
   Conclusion: Results of this large survey highlight the importance of patient involvement and shared decision making.
   Practice implications: Further improvement of patient-provider communication as a basis for shared responsibilities and achieving optimal treatment outcomes is needed. With the growing numbers of diabetes patients worldwide, task delegation should be considered, in the framework of a multidisciplinary diabetes care model. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
C1 [Hajos, Tibor R. S.; Twisk, Jos W. R.; Snoek, Frank J.] Vrije Univ Amsterdam Med Ctr, EMGO Inst, NL-1081 BT Amsterdam, Netherlands.
   [Hajos, Tibor R. S.; Snoek, Frank J.] Vrije Univ Amsterdam Med Ctr, Dept Med Psychol, NL-1081 BT Amsterdam, Netherlands.
   [Polonsky, William H.] Univ Calif San Diego, Behav Diabet Inst, San Diego, CA 92103 USA.
   [Polonsky, William H.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA.
   [Twisk, Jos W. R.] Vrije Univ Amsterdam Med Ctr, Dept Clin Epidemiol & Biostat, NL-1081 BT Amsterdam, Netherlands.
   [Dain, Marie-Paule] Sanofi Aventis, Paris, France.
RP Hajos, TRS (reprint author), Vrije Univ Amsterdam Med Ctr, EMGO Inst, Van der Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.
EM t.hajos@vumc.nl
FU sanofi-aventis; Eli Lilly; Roche Diagnostics; Novo Nordisk; Amylin
FX Declaration of competing interests: Tibor Hajos has no conflict of
   interest. William H. Polonsky has received fees for lectures, consulting
   and advisory board memberships from sanofi-aventis, Eli Lilly, Roche
   Diagnostics, Novo Nordisk and Amylin and unrestricted research grant;
   from Roche Diagnostics. Jos Twisk has no conflict of interest.
   Marie-Paule Dain is an employee of sanofi-aventis. Frank J. Snoek has
   received fees for lectures and advisory board membership from
   sanofi-aventis, Eli Lilly, Roche Diagnostics and Novo Nordisk, and
   unrestricted research grants from sanofi-aventis and Novo Nordisk.
CR ANDERSON RM, 1993, PATIENT EDUC COUNS, V21, P41, DOI 10.1016/0738-3991(93)90058-5
   BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191
   Davies M, 2006, DIABETIC MED, V23, P917, DOI 10.1111/j.1464-5491.2006.01892.x
   Deutskens E, 2004, MARKET LETT, V15, P21, DOI 10.1023/B:MARK.0000021968.86465.00
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fitzgerald JT, 2008, PATIENT EDUC COUNS, V70, P118, DOI 10.1016/j.pec.2007.09.005
   Fitzgerald JT, 2003, DIABETES EDUCATOR, V29, P480, DOI 10.1177/014572170302900312
   Holman H, 2004, PUBLIC HEALTH REP, V119, P239, DOI 10.1016/j.phr.2004.04.002
   Joosten EAG, 2008, PSYCHOTHER PSYCHOSOM, V77, P219, DOI 10.1159/000126073
   Loewe R, 2000, CULT MED PSYCHIAT, V24, P379, DOI 10.1023/A:1005611207687
   Mead N, 2002, SOC SCI MED, V55, P283, DOI 10.1016/S0277-9536(01)00171-X
   Nabi RL, 2008, HEALTH COMMUN, V23, P191, DOI 10.1080/10410230701808327
   Nicholson TRJ, 2009, DIABETIC MED, V26, P447, DOI 10.1111/j.1464-5491.2009.02701.x
   Peyrot M, 2006, DIABETOLOGIA, V49, P279, DOI 10.1007/s00125-005-0048-8
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   Shoor S, 2002, MED CARE, V40, P40
   Snoek FJ, 2002, INT J CLIN PRACT, P80
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Snoek FI, 2007, BMJ-BRIT MED J, V335, P458, DOI 10.1136/bmj.39315.443160.BE
   Solli O, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-18
   Tamblyn R, 2010, ARCH INTERN MED, V170, P1064, DOI 10.1001/archinternmed.2010.167
   Wagner E H, 1996, Manag Care Q, V4, P12
NR 22
TC 11
Z9 11
U1 1
U2 6
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0738-3991
J9 PATIENT EDUC COUNS
JI Patient Educ. Couns.
PD NOV
PY 2011
VL 85
IS 2
BP 258
EP 263
DI 10.1016/j.pec.2010.08.019
PG 6
WC Public, Environmental & Occupational Health; Social Sciences,
   Interdisciplinary
SC Public, Environmental & Occupational Health; Social Sciences - Other
   Topics
GA 850WX
UT WOS:000297231400022
PM 20932702
DA 2019-01-08
ER

PT J
AU Park, SW
   Lee, CS
   Lee, CK
   Kwak, YG
   Moon, C
   Kim, BN
   Kim, ES
   Kang, JM
   Oh, MD
AF Park, Sang-Won
   Lee, Chang-Seop
   Lee, Chi Kug
   Kwak, Yee Gyung
   Moon, Chisook
   Kim, Baek-Nam
   Kim, Eu Suk
   Kang, Jae Myung
   Oh, Myoung-don
TI Severity Predictors in Eschar-Positive Scrub Typhus and Role of Serum
   Osteopontin
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID ORIENTIA TSUTSUGAMUSHI INFECTION; RESPIRATORY-DISTRESS-SYNDROME;
   RICKETTSIA-TSUTSUGAMUSHI; NATURAL-RESISTANCE; DISEASE-ACTIVITY; HOST
   DEFENSES; SOUTH-KOREA; GENE; MICE; CLASSIFICATION
AB We prospectively evaluated severity predictors in terms of host, microorganism, and treatment factors in 153 eschar-positive scrub typhus patients. Severity was assessed with the Acute Physiology and Chronic Health Evaluation (APACHE) II score (< 10 versus >= 10) and predefined criteria of severe complications. Genotypes of Orientia tsutsugamushi were determined. Independent risk factors for severity (APACHE II score >= 10) were old age, diabetes mellitus, serum osteopontin > 100 ng/mL, and a group of underlying diseases (congestive heart failure, cerebrovascular disease, chronic liver disease, bronchial asthma, and chronic obstructive lung diseases). Anemia (<= 10 g/dL) and C-reactive protein > 10 mg/dL were indicators of current severity. Neither the delay in antibiotics administration nor strain types (Boryong, Taguchi, or Kanda/Kawasaki) contributed to the severity. The risk factors for severe complications were similar. Serum osteopontin > 100 ng/mL had a negative predictive value of 96% for severe complications. This marker can be used to rule out severe disease status.
C1 [Moon, Chisook] Inje Univ, Coll Med, Dept Internal Med, Pusan 614735, South Korea.
   Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea.
   Boramae Med Ctr, Seoul, South Korea.
   Chonbuk Natl Univ, Sch Med, Dept Internal Med, Jeonju, South Korea.
   Namwon Med Ctr, Dept Internal Med, Namwon, South Korea.
   Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam, South Korea.
   Handong Global Univ, Sunlin Hosp, Dept Internal Med, Pohang, South Korea.
RP Moon, C (reprint author), Inje Univ, Coll Med, Dept Internal Med, 633-165 Gaegeum Dong, Pusan 614735, South Korea.
EM duomon@hanmail.net
RI Park, Sang Won/J-5485-2012
OI Park, Sang Won/0000-0002-0550-1897; Kim, Baek-Nam/0000-0001-5551-2132;
   Kwak, Yee Gyung/0000-0002-4713-8045; Oh, Myoung-don/0000-0002-2344-7695
FU Seoul National University Hospital (SNUH) [04-2009-610]
FX This study was supported by grant 04-2009-610 from the Seoul National
   University Hospital (SNUH) Research Fund.
CR Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860
   Chang Woo-Hyun, 1995, Journal of Korean Medical Science, V10, P227
   Chanta Chulapong, 2007, Journal of the Medical Association of Thailand, V90, P2366
   Cho NH, 2001, INFECT IMMUN, V69, P1265, DOI 10.1128/IAI.69.3.1265-1272.2001
   Chrispal A, 2010, TROP DOCT, V40, P129, DOI 10.1258/td.2010.090452
   Chung DR, 2008, J INFECTION, V56, P44, DOI 10.1016/j.jinf.2007.09.009
   Ewig S, 1998, AM J RESP CRIT CARE, V158, P1102, DOI 10.1164/ajrccm.158.4.9803114
   GROVES MG, 1978, INFECT IMMUN, V19, P583
   GROVES MG, 1980, J IMMUNOL, V125, P1395
   HANSON B, 1991, INFECT IMMUN, V59, P4134
   Inomata S, 2005, CYTOKINE, V30, P203, DOI 10.1016/j.cyto.2005.01.014
   Iwasaki H, 1997, J CLIN MICROBIOL, V35, P3320
   IWASAKI H, 1994, LANCET, V343, P1236
   Iwasaki H, 2010, INT J INFECT DIS, V14, pE328, DOI 10.1016/j.ijid.2009.06.002
   Kelly DJ, 2009, CLIN INFECT DIS, V48, pS203, DOI 10.1086/596576
   KELLY DJ, 1990, ANN NY ACAD SCI, V590, P564, DOI 10.1111/j.1749-6632.1990.tb42267.x
   Kim DM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-108
   Kim IH, 2010, CLIN MICROBIOL INFEC, V16, P419, DOI 10.1111/j.1469-0691.2009.02825.x
   Kim YS, 2004, CLIN INFECT DIS, V39, P1329, DOI 10.1086/425008
   KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009
   Kweon SS, 2009, EMERG INFECT DIS, V15, P1127, DOI 10.3201/eid1507.080399
   Lee CS, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-216
   Liu YX, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-82
   Maeno Y, 2006, ACTA TROP, V98, P305, DOI 10.1016/j.actatropica.2006.05.001
   Moron CG, 2001, MODERN PATHOL, V14, P752, DOI 10.1038/modpathol.3880385
   Nau GJ, 1999, INFECT IMMUN, V67, P4223
   Park JS, 2000, J KOREAN MED SCI, V15, P343, DOI 10.3346/jkms.2000.15.3.343
   Park SW, 2010, AM J TROP MED HYG, V83, P930, DOI 10.4269/ajtmh.2010.09-0791
   PATARCA R, 1989, J EXP MED, V170, P145, DOI 10.1084/jem.170.1.145
   Raoult D, 2010, PRINCIPLES PRACTICE, P2529
   Rollo EE, 1996, J LEUKOCYTE BIOL, V60, P397
   Seong SY, 2001, MICROBES INFECT, V3, P11, DOI 10.1016/S1286-4579(00)01352-6
   Shiga K, 1997, Kansenshogaku Zasshi, V71, P299
   Sonthayanon P, 2009, J CLIN MICROBIOL, V47, P430, DOI 10.1128/JCM.01927-08
   Takahashi F, 2004, LUNG, V182, P173
   TAMURA A, 1995, INT J SYST BACTERIOL, V45, P589, DOI 10.1099/00207713-45-3-589
   Tamura A, 2001, MICROBIOL IMMUNOL, V45, P439, DOI 10.1111/j.1348-0421.2001.tb02643.x
   Thap Lon Chan, 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P780
   Varghese GM, 2006, J INFECTION, V52, P56, DOI 10.1016/j.jinf.2005.02.001
   WATT G, 1994, CLIN INFECT DIS, V18, P624, DOI 10.1093/clinids/18.4.624
   Wong CK, 2005, RHEUMATOLOGY, V44, P602, DOI 10.1093/rheumatology/keh558
   Yasunaga H, 2011, INTERNAL MED, V50, P37, DOI 10.2169/internalmedicine.50.4220
NR 42
TC 11
Z9 13
U1 0
U2 5
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2011
VL 85
IS 5
BP 924
EP 930
DI 10.4269/ajtmh.2011.11-0134
PG 7
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 843HC
UT WOS:000296661900025
PM 22049051
OA Green Published, Bronze
DA 2019-01-08
ER

PT J
AU Gois, C
   Barbosa, A
   Ferro, A
   Santos, AL
   Sousa, F
   Akiskal, H
   Akiskal, K
   Figueira, ML
AF Gois, Carlos
   Barbosa, Antonio
   Ferro, Ana
   Santos, Ana Luisa
   Sousa, Filomena
   Akiskal, Hagop
   Akiskal, Kareen
   Luisa Figueira, M.
TI The role of affective temperaments in metabolic control in patients with
   type 2 diabetes
SO JOURNAL OF AFFECTIVE DISORDERS
LA English
DT Article
DE Affective temperaments; TEMPS-A; Type 2 diabetes; Diabetes psychological
   adjustment; Metabolic control; Depression
ID MAJOR DEPRESSIVE DISORDER; TEMPS-A; GLYCEMIC CONTROL; ANXIETY DISORDERS;
   INTERNAL CONSISTENCY; PERSONALITY; DISTRESS; VALIDATION; QUESTIONNAIRE;
   ASSOCIATION
AB Background: In non-diabetic populations, anxious and depressive affective temperaments are associated with stress and distress disorders (anxious and depressive). In type 2 diabetes, distress with diabetes and distress disorders have been associated with metabolic control. There are few studies undertaken on temperament and metabolic control in patients with type 2 diabetes. The aim of our study was to examine the independent association between affective temperaments and metabolic control in patients with type 2 diabetes.
   Methods: The sample included 90 patients with type 2 diabetes from two outpatient clinics aged 53.54 (SD +/- 8.05) years and with 66.7% female gender. Depression was evaluated by using the MADRS observer rating scale (mean value: 16.38 +/- 11).
   Results: Patients with excessive depressive and anxious temperaments had more depressive symptoms, worse psychological adjustment to diabetes and worse metabolic control. In logistic regression (crude model), only depressive temperament was independently associated with metabolic control.
   Conclusions: Affective temperaments are associated with psychological adjustment to diabetes and metabolic control in patients with type 2 diabetes. Patients above threshold on depressive temperament should be considered for greater scrutiny and psycho-education by the diabetes clinic staff. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Gois, Carlos; Barbosa, Antonio; Ferro, Ana; Santos, Ana Luisa; Sousa, Filomena; Luisa Figueira, M.] Univ Lisbon, Hosp Santa Maria, Dept Psychiat, Fac Med, P-1600 Lisbon, Portugal.
   [Akiskal, Hagop; Akiskal, Kareen] Univ Calif San Diego, San Diego, CA 92103 USA.
   [Akiskal, Hagop; Akiskal, Kareen] Int Mood Ctr, La Jolla, CA USA.
RP Gois, C (reprint author), Univ Lisbon, Hosp Santa Maria, Dept Psychiat, Fac Med, Av Prof Egas Moniz, P-1600 Lisbon, Portugal.
EM cargois@gmail.com
OI Gois, Carlos/0000-0003-4346-4844
CR Adriaanse MC, 2008, DIABETES CARE, V31, P2268, DOI 10.2337/dc08-1074
   Aikens JE, 2009, DIABETES CARE, V32, P1177, DOI 10.2337/dc09-0071
   Akiskal H. S., 1995, DEPRESSION MANIA NEU, P99
   Akiskal HS, 1998, J AFFECT DISORDERS, V51, P7, DOI 10.1016/S0165-0327(98)00152-9
   Akiskal HS, 2005, J AFFECT DISORDERS, V85, P3, DOI 10.1016/j.jad.2004.12.001
   Akiskal HS, 2005, J AFFECT DISORDERS, V85, P29, DOI 10.1016/j.jad.2003.12.009
   AKISKAL HS, 1983, ARCH GEN PSYCHIAT, V40, P801
   AKSIKAL HS, 2005, J AFFECT DISORDERS, V85, P45
   Bloink R, 2005, J AFFECT DISORDERS, V85, P77, DOI 10.1016/S0165-0327(03)00101-0
   Bryan CJ, 2008, J AFFECT DISORDERS, V108, P113, DOI 10.1016/j.jad.2007.10.003
   CLARK LA, 1994, J ABNORM PSYCHOL, V103, P103, DOI 10.1037/0021-843X.103.1.103
   Collins MM, 2009, DIABETIC MED, V26, P153, DOI 10.1111/j.1464-5491.2008.02648.x
   COYNE JC, 1994, PSYCHOL BULL, V116, P29, DOI 10.1037/0033-2909.116.1.29
   Delahanty LM, 2007, DIABETIC MED, V24, P48, DOI 10.1111/j.1464-5491.2007.02028.x
   DUNN SM, 1986, DIABETES CARE, V9, P480, DOI 10.2337/diacare.9.5.480
   Egede LE, 2003, DIABETES CARE, V26, P104, DOI 10.2337/diacare.26.1.104
   Egede LE, 2010, DIABETES RES CLIN PR, V87, P302, DOI 10.1016/j.diabres.2010.01.024
   Erfurth A, 2005, J AFFECT DISORDERS, V85, P53, DOI 10.1016/S0165-0327(03)00102-2
   Figueira ML, 2008, J AFFECT DISORDERS, V111, P193, DOI 10.1016/j.jad.2008.03.001
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2009, DIABETIC MED, V26, P622, DOI 10.1111/j.1464-5491.2009.02730.x
   Fisher L, 2001, DIABETES CARE, V24, P1751, DOI 10.2337/diacare.24.10.1751
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Gois C., 2006, PSIQUIATRIA CLIN, V27, P71
   Grigsby AB, 2002, J PSYCHOSOM RES, V53, P1053, DOI 10.1016/S0022-3999(02)00417-8
   Hall PA, 2009, J PSYCHOSOM RES, V67, P297, DOI 10.1016/j.jpsychores.2009.05.015
   Hosmer D.W., 2000, APPL LOGISTIC REGRES
   International Diabetes Federation, 2005, GLOB GUID TYP 2 DIAB
   Ismail K, 2007, DIABETES CARE, V30, P1473, DOI 10.2337/dc06-2313
   Katon W, 2004, DIABETES CARE, V27, P914, DOI 10.2337/diacare.27.4.914
   Katon W, 2010, DEPRESSION DIABETES, P81
   KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P853
   Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095
   Lane JD, 2000, DIABETES CARE, V23, P1321, DOI 10.2337/diacare.23.9.1321
   Lloyd Cathy E., 2010, DEPRESSION DIABETES, P1
   Lustman PJ, 1997, GEN HOSP PSYCHIAT, V19, P138, DOI 10.1016/S0163-8343(96)00170-3
   LUSTMAN PJ, 1992, PSYCHOSOM MED, V54, P602, DOI 10.1097/00006842-199209000-00007
   LUSTMAN PJ, 1991, PSYCHOSOM MED, V53, P305, DOI 10.1097/00006842-199105000-00004
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Maremmani I, 2005, J AFFECT DISORDERS, V85, P17, DOI 10.1016/S0165-0327(03)00099-5
   Montgomery P., 1979, BRIT J PSYCHIAT, V134, P382
   Muller MJ, 2000, J AFFECT DISORDERS, V60, P137, DOI 10.1016/S0165-0327(99)00162-7
   Nakahara R, 2006, PSYCHOSOMATICS, V47, P240, DOI 10.1176/appi.psy.47.3.240
   Ormel J, 2004, ARCH GEN PSYCHIAT, V61, P990, DOI 10.1001/archpsyc.61.10.990
   Placidi GF, 1998, J AFFECT DISORDERS, V47, P1, DOI 10.1016/S0165-0327(97)00122-5
   Pouwer F, 2009, NAT REV ENDOCRINOL, V5, P665, DOI 10.1038/nrendo.2009.214
   Richardson LK, 2008, GEN HOSP PSYCHIAT, V30, P509, DOI 10.1016/j.genhosppsych.2008.07.001
   Rihmer A, 2009, J AFFECT DISORDERS, V116, P18, DOI 10.1016/j.jad.2008.10.024
   Rihmer Z, 2010, CURR OPIN PSYCHIATR, V23, P12, DOI 10.1097/YCO.0b013e32833299d4
   Rozsa S, 2008, J AFFECT DISORDERS, V106, P45, DOI 10.1016/j.jad.2007.03.016
   Stratton IM, 2000, BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405
   Tomassini A, 2009, INT J PSYCHIAT CLIN, V13, P31, DOI 10.1080/13651500802369482
   Tyrer P, 2001, BRIT J PSYCHIAT, V179, P191, DOI 10.1192/bjp.179.3.191
   Watson D, 2005, J RES PERS, V39, P46, DOI 10.1016/j.jrp.2004.09.006
   Welch G. W., 1996, HDB PSYCHOL DIABETES, P223
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
NR 57
TC 22
Z9 24
U1 2
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-0327
J9 J AFFECT DISORDERS
JI J. Affect. Disord.
PD NOV
PY 2011
VL 134
IS 1-3
BP 52
EP 58
DI 10.1016/j.jad.2011.05.021
PG 7
WC Clinical Neurology; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 831TG
UT WOS:000295753400007
PM 21641045
DA 2019-01-08
ER

PT J
AU Shles, A
   Fainmesser, P
   Eliakim, A
   Nemet, D
AF Shles, Ayelet
   Fainmesser, Pinchas
   Eliakim, Alon
   Nemet, Dan
TI Child abuse suspicion masquerading new onset insulin dependent diabetes
   mellitus
SO JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM
LA English
DT Article
DE child maltreatment; diabetic ketoacidosis
ID NONACCIDENTAL-INJURY; MUNCHAUSEN-SYNDROME; MISTAKEN DIAGNOSIS;
   PHYSICIANS; EXPERIENCE; PROXY
AB The identification and diagnosis of child abuse is a challenging task to the pediatrician. The increased awareness among both the public and medical personnel, while improving attentiveness to this important subject, can sometimes result in misdiagnosing medical conditions, thus causing distress and delay in required treatment. Numerous reports have described conditions mimicking non-accidental injuries; most of these include dermatological findings related to skin diseases, medical conditions causing pathological fractures, and rare diseases with unusual physical findings. We present a case of a 9.5-year-old child in which the workup for a suspected abusive event led to a delay in the diagnosis of insulin dependent diabetes mellitus later presented as diabetic ketoacidosis.
C1 [Eliakim, Alon; Nemet, Dan] Tel Aviv Univ, Sackler Sch Med, Endocrine Clin, Dept Pediat,Meir Med Ctr, IL-44281 Kefar Sava, Israel.
   [Shles, Ayelet; Fainmesser, Pinchas] Tel Aviv Univ, Sackler Sch Med, Pediat Emergency Care Unit, Dept Pediat,Meir Med Ctr, IL-44281 Kefar Sava, Israel.
RP Nemet, D (reprint author), Tel Aviv Univ, Sackler Sch Med, Endocrine Clin, Dept Pediat,Meir Med Ctr, IL-44281 Kefar Sava, Israel.
EM dan.nemet@clalit.org.il
CR AlJasser M, 2008, EUR J PEDIATR, V167, P1221, DOI 10.1007/s00431-008-0792-0
   ANH NT, 1976, JAMA-J AM MED ASSOC, V236, P2288, DOI 10.1001/jama.1976.03270210020012
   BALDWIN K, 2010, CLIN ORTHOP RELAT RE
   COPELAND AR, 1988, J FORENSIC SCI, V33, P1493
   Flaherty EG, 2008, PEDIATRICS, V122, P611, DOI 10.1542/peds.2007-2311
   HORAN PF, 1986, DIABETES CARE, V9, P302, DOI 10.2337/diacare.9.3.302
   Jones R, 2008, PEDIATRICS, V122, P259, DOI 10.1542/peds.2007-2312
   Karavanaki K, 2008, J ENDOCRINOL INVEST, V31, P406, DOI 10.1007/BF03346384
   KIRSCHNER RH, 1985, AM J DIS CHILD, V139, P873, DOI 10.1001/archpedi.1985.02140110027022
   KOVACS CS, 1993, DIABETES CARE, V16, P1294, DOI 10.2337/diacare.16.9.1294
   Laskey AL, 2007, CHILD ABUSE NEGLECT, V31, P329, DOI 10.1016/j.chiabu.2006.02.017
   Lindberg DM, 2008, PEDIATRICS, V121, pE945, DOI 10.1542/peds.2007-2485
   MCSWEENEY JJ, 1991, DIABETES CARE, V14, P928, DOI 10.2337/diacare.14.10.928
   Merrick J, 1999, Public Health Rev, V27, P279
   Mimasaka S, 1998, J Clin Forensic Med, V5, P72, DOI 10.1016/S1353-1131(98)90057-8
   MORRIS JL, 1985, AM J DIS CHILD, V139, P194, DOI 10.1001/archpedi.1985.02140040096037
   Paterson CR, 2009, ACTA PAEDIATR, V98, P2008, DOI 10.1111/j.1651-2227.2009.01407.x
   SAULSBURY FT, 1986, SOUTHERN MED J, V79, P585, DOI 10.1097/00007611-198605000-00016
   Senniappan S, 2008, ACTA PAEDIATR, V97, P992
   Senniappan S, 2008, ACTA PAEDIATR, V97, P836, DOI 10.1111/j.1651-2227.2008.00790.x
   *US ADM CHILDR YOU, 2005, CHILD MAN 2003
   Walsh J, 2008, ARCH DIS CHILD, V93, P65, DOI 10.1136/adc.2007.125443
   WARDINSKY TD, 1995, MIL MED, V160, P15
   WHEELER DM, 1988, BRIT MED J, V296, P1233, DOI 10.1136/bmj.296.6631.1233
NR 24
TC 0
Z9 0
U1 0
U2 1
PU WALTER DE GRUYTER & CO
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0334-018X
J9 J PEDIATR ENDOCR MET
JI J. Pediatr. Endocrinol. Metab.
PD OCT
PY 2011
VL 24
IS 9-10
BP 823
EP 825
DI 10.1515/JPEM.2011.284
PG 3
WC Endocrinology & Metabolism; Pediatrics
SC Endocrinology & Metabolism; Pediatrics
GA 854BQ
UT WOS:000297470000041
PM 22145485
DA 2019-01-08
ER

PT J
AU Allen, NA
   Melkus, GD
   Chyun, DA
AF Allen, Nancy A.
   Melkus, Gail D.
   Chyun, Deborah A.
TI Physiological and Behavioral Factors Related to Physical Activity in
   Black Women With Type 2 Diabetes Mellitus
SO JOURNAL OF TRANSCULTURAL NURSING
LA English
DT Article
DE women's health; methods/designs; type 2 diabetes mellitus; physical
   activity; exercise; psychosocial factors; behavioral factors; Black;
   African American; women
ID QUALITY-OF-LIFE; CARDIOVASCULAR-DISEASE; AFRICAN-AMERICAN; US ADULTS;
   HEALTH; RISK; ASSOCIATION; DEPRESSION; EXERCISE; ANXIETY
AB Purpose: To describe relationships among physical activity (PA), physiological factors, and psychological factors in Black women with type 2 diabetes mellitus (T2DM). Methods: A cross-sectional design was used (N = 109). Data were collected on PA (activity/inactivity, TV hours, bed confinement), physiology (blood pressure, lipids, hemoglobin A1c), psychology (anxiety, emotional distress, physical functioning, bodily pain, vitality), and health care provider (HCP) support. Results: Walking was the preferred PA; TV viewing averaged 3.7 hours/day, and 24% reported confinement to bed >1 week in the last year. Inactive women had greater physiological and psychological problems than active women. Women watching TV >2 hours/day had more physiological problems than women watching TV <2 hours/day. Women reporting >1 week of confinement to bed in the last year had more physiological and psychological problems than those confined to bed <1 week. Conclusions: PA interventions in Black women with T2DM should promote walking, address TV viewing time, incorporate HCP's role of PA counseling/support, and address several psychological factors.
C1 [Allen, Nancy A.] Boston Coll, Connell Sch Nursing, Chestnut Hill, MA 02467 USA.
   [Melkus, Gail D.; Chyun, Deborah A.] NYU, New York, NY USA.
RP Allen, NA (reprint author), Boston Coll, Connell Sch Nursing, 140 Commonwealth Ave, Chestnut Hill, MA 02467 USA.
EM Nancy.a.allen@bc.edu
FU National Institute of Health [R01NR05341, T32 NR 008346-06]
FX National Institute of Health Grant R01NR05341 and T32 NR 008346-06.
CR Adams-Campbell LL, 2000, PREV MED, V30, P43, DOI 10.1006/pmed.1999.0604
   Allan JL, 2007, J PSYCHOSOM RES, V63, P501, DOI 10.1016/j.jpsychores.2007.08.001
   [Anonymous], AM TIM US SURV
   Bennett GG, 2006, AM J PUBLIC HEALTH, V96, P1681, DOI 10.2105/AJPH.2005.080580
   Blanc S, 2000, J CLIN ENDOCR METAB, V85, P2223, DOI 10.1210/jc.85.6.2223
   Bonnet F, 2005, ATHEROSCLEROSIS, V178, P339, DOI 10.1016/j.atgersclerosis.2004.08.035
   BURGESS PM, 1987, BRIT J MED PSYCHOL, V60, P61
   *CDCP, 2007, CDCS DIAB PROGR DAT
   *CDCP, 2007, DIAB DAT TRENDS 2007
   *CDCP, 2004, MMWR-MORBID MORTAL W, V53, P82
   CROWN S, 1966, BRIT J PSYCHIAT, V112, P917, DOI 10.1192/bjp.112.490.917
   De Moor MHM, 2008, ARCH GEN PSYCHIAT, V65, P897, DOI 10.1001/archpsyc.65.8.897
   Duvigneaud N, 2008, J SPORT MED PHYS FIT, V48, P201
   Jakes RW, 2003, EUR J CLIN NUTR, V57, P1089, DOI 10.1038/sj.ejcn.1601648
   Kleefstra N, 2005, NETH J MED, V63, P215
   KRISKA AM, 1990, DIABETES CARE, V13, P401, DOI 10.2337/diacare.13.4.401
   Kumanyika SK, 2002, ETHNICITY DIS S3, V12, P62
   Li C, 2008, DIABETIC MED, V25, P878, DOI 10.1111/j.1464-5491.2008.02477.x
   Maddigan SL, 2005, QUAL LIFE RES, V14, P1489, DOI 10.1007/s11136-005-0586-z
   Miller ST, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-70
   Morrato EH, 2007, DIABETES CARE, V30, P203, DOI 10.2337/dc06-1128
   Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858
   Nelson KM, 2002, DIABETES CARE, V25, P1722, DOI 10.2337/diacare.25.10.1722
   Panagiotakos DB, 2008, ANN EPIDEMIOL, V18, P387, DOI 10.1016/j.annepidem.2007.11.002
   Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Rejeski WJ, 2006, OBESITY, V14, P870, DOI 10.1038/oby.2006.101
   Sharpe PA, 2008, AM J HEALTH BEHAV, V32, P701, DOI 10.5555/ajhb.2008.32.6.701
   Smits JAJ, 2006, DEPRESS ANXIETY, V23, P102, DOI 10.1002/da.20146
   Spencer MS, 2006, J HEALTH CARE POOR U, V17, P88, DOI 10.1353/hpu.2006.0095
   Stenholm S, 2007, AGING CLIN EXP RES, V19, P277
   Volpato S, 2002, DIABETES CARE, V25, P678, DOI 10.2337/diacare.25.4.678
   WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002
   Ware JE, 1997, SF 36 HLTH SURVEY MA
   Wexler DJ, 2006, DIABETOLOGIA, V49, P1489, DOI 10.1007/s00125-006-0249-9
   Whittemore R, 2005, J CLIN NURS, V14, P195, DOI 10.1111/j.1365-2702.2004.00937.x
   WILLIAMS GC, 1998, HEALTH PSYCHOL, V17, P169
NR 37
TC 1
Z9 1
U1 0
U2 12
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1043-6596
J9 J TRANSCULT NURS
JI J. Transcult. Nurs.
PD OCT
PY 2011
VL 22
IS 4
BP 376
EP 385
DI 10.1177/1043659611414143
PG 10
WC Nursing
SC Nursing
GA 848TB
UT WOS:000297076700007
PM 21807961
DA 2019-01-08
ER

PT J
AU Mulvaney, SA
   Hood, KK
   Schlundt, DG
   Osborn, CY
   Johnson, KB
   Rothman, RL
   Wallston, KA
AF Mulvaney, Shelagh A.
   Hood, Korey K.
   Schlundt, David G.
   Osborn, Chandra Y.
   Johnson, Kevin B.
   Rothman, Russell L.
   Wallston, Kenneth A.
TI Development and initial validation of the barriers to diabetes adherence
   measure for adolescents
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Adherence; Adolescents; Type 1 diabetes; Barriers; Assessment
ID METABOLIC-CONTROL; SELF-MANAGEMENT; SITUATIONAL OBSTACLES; REGIMEN
   ADHERENCE; STRESS; CARE; MELLITUS; PERCEPTIONS; DISTRESS; SUPPORT
AB Aims: The purpose of this study was to develop a measure of psychosocial barriers to adherence in adolescents with type 1 diabetes (T1D) and examine relationships to patient characteristics, adherence, and hemoglobin A1C (A1C).
   Methods: Barriers to diabetes adherence (BDA) items were generated by researchers, clinicians, and patients. Adolescents aged 12-17 with T1D completed the BDA and an adherence measure. Hemoglobin A1C was obtained through medical chart review.
   Results: Factor analysis from 123 adolescents resulted in a 21-item, five-component solution that accounted for 64.5% of the variance. The components were stress and burnout, time pressure and planning, social support, parental autonomy support, and stigma. The BDA total and subscales were internally consistent. The BDA total and some components were associated with adherence and A1C. The BDA was the only predictor of A1C compared to demographic, clinical, and adherence variables (F 6.17, p < .05). Subjects with higher A1C (>8.5) showed a higher level of barriers (F 15.20, p < .001) and a differential profile of barriers (F 5.75, p < .05).
   Conclusions: The BDA may be useful in research and clinical settings as a compliment to adherence measures and to tailor educational programs. Additional research is necessary to establish test-retest reliability and discriminant validity. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
C1 [Mulvaney, Shelagh A.; Wallston, Kenneth A.] Vanderbilt Univ, Med Ctr, Sch Nursing, Nashville, TN 37240 USA.
   [Mulvaney, Shelagh A.; Johnson, Kevin B.] Vanderbilt Univ, Med Ctr, Dept Biomed Informat, Nashville, TN 37240 USA.
   [Mulvaney, Shelagh A.; Johnson, Kevin B.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37240 USA.
   [Hood, Korey K.] Cincinnati Childrens Hosp Med Ctr, Div Behav Med & Clin Psychol, Cincinnati, OH USA.
   [Schlundt, David G.] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA.
   [Osborn, Chandra Y.; Rothman, Russell L.] Vanderbilt Univ, Med Ctr, Ctr Hlth Serv Res, Nashville, TN 37240 USA.
RP Mulvaney, SA (reprint author), Vanderbilt Univ, Med Ctr, Sch Nursing, 461 21st Ave S, Nashville, TN 37240 USA.
EM shelagh.mulvaney@vanderbilt.edu
RI Hanghoj, Signe/E-2440-2012
OI Osborn, Chandra/0000-0002-7668-028X
FU Vanderbilt Diabetes Research and Training Center [P60DK020593];
   Vanderbilt Institute for Clinical and Translational Research, NCRR/NIH
   [1 UL1 RR024975]
FX The authors wish to thank Mr. Eric Pittel and Ms. Kathleen Smith for
   assistance with data collection. This research was supported by a Pilot
   and Feasibility grant to Dr. Mulvaney from the Vanderbilt Diabetes
   Research and Training Center (P60DK020593) and by the Vanderbilt
   Institute for Clinical and Translational Research (1 UL1 RR024975 from
   NCRR/NIH).
CR Admi H, 2007, QUAL HEALTH RES, V17, P1178, DOI 10.1177/1049732307307548
   Auslander WF, 2010, DIABETES EDUCATOR, V36, P613, DOI 10.1177/0145721710369706
   Baars R., 2005, HEALTH QUAL LIFE OUT, V3, P1
   Burroughs TE, 1997, DIABETES EDUCATOR, V23, P438, DOI 10.1177/014572179702300409
   Casillas J, 2010, PSYCHO-ONCOLOGY, V19, P982, DOI 10.1002/pon.1650
   Delamater AM, 2000, PROMOTING ADHERENCE TO MEDICAL TREATMENT IN CHRONIC CHILDHOOD ILLNESS: CONCEPTS, METHODS, AND INTERVENTIONS, P173
   DELAMATER AM, 1987, J DEV BEHAV PEDIATR, V8, P136
   Delamater AM, 2006, CLIN DIABETES, V24, P71, DOI [10.2337/diaclin.24.2.71, DOI 10.2337/DIACLIN.24.2.71]
   DeVellis RF, 2003, SCALE DEV THEORY APP
   Di Battista AM, 2009, DIABETES EDUCATOR, V35, P465, DOI 10.1177/0145721709333492
   Ellis DA, 2005, PEDIATRICS, V116, pE826, DOI 10.1542/peds.2005-0638
   Farrell SP, 2004, J ADOLESCENT HEALTH, V34, P461, DOI 10.1016/S1054-139X(03)00215-5
   Fisher EB, 2007, DIABETES EDUCATOR, V33, P1080, DOI 10.1177/0145721707309808
   GLASGOW RE, 1986, J BEHAV MED, V9, P65, DOI 10.1007/BF00844645
   GLASGOW RE, 1992, PATIENT EDUC COUNS, V19, P61, DOI 10.1016/0738-3991(92)90102-O
   Glasgow RE, 2001, DIABETES SPECTRUM, V14, P33, DOI DOI 10.2337/DIASPECT.14.1.33
   Greening L, 2007, J PEDIATR PSYCHOL, V32, P437, DOI 10.1093/jpepsy/jsl029
   Grey M, 2000, J PEDIATR-US, V137, P107, DOI 10.1067/mpd.2000.106568
   Hains AA, 2006, DIABETES CARE, V29, P818, DOI 10.2337/diacare.29.04.06.dc05-1828
   Hains AA, 2000, DIABETES EDUCATOR, V26, P417, DOI 10.1177/014572170002600309
   Hanna K M, 2000, Issues Compr Pediatr Nurs, V23, P165
   Hanson CL, 1992, STRESS COPING CHILD, P213
   Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010
   Hayes RA, 2002, PSYCHOL REP, V90, P1161, DOI 10.2466/PR0.90.4.1161-1173
   Holmes CS, 2006, J PEDIATR PSYCHOL, V31, P770, DOI 10.1093/jpepsy/jsj083
   Hood KK, 2009, PEDIATRICS, V124, pE1171, DOI 10.1542/peds.2009-0207
   Iannotti RJ, 2006, DIABETES CARE, V29, P2263, DOI 10.2337/dc06-0685
   Lancaster BM, 2010, DIABETES RES CLIN PR, V90, P243, DOI 10.1016/j.diabres.2010.07.003
   Larkin ME, 2008, DIABETES EDUCATOR, V34, P511, DOI 10.1177/0145721708317869
   Lenhart A., 2007, TEENS PRIVACY ONLINE, P1
   Logan D, 2003, J PEDIATR PSYCHOL, V28, P383, DOI 10.1093/jpepsy/jsg028
   Mulvaney SA, PATIENT ED IN PRESS
   Mulvaney SA, 2008, DIABETES EDUCATOR, V34, P674, DOI 10.1177/0145721708320902
   Mulvaney SA, 2010, DIABETES CARE, V33, P602, DOI 10.2337/dc09-1881
   Paulhus DL, 1991, MEASURES PERSONALITY, P17, DOI DOI 10.1016/B978-0-12-590241-0.50006-X
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Riekert KA, 2000, PROMOTING ADHERENCE TO MEDICAL TREATMENT IN CHRONIC CHILDHOOD ILLNESS: CONCEPTS, METHODS, AND INTERVENTIONS, P3
   Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68
   Schlundt DG, 1996, J ADOLESCENT HEALTH, V19, P282, DOI 10.1016/1054-139X(95)00197-Z
   SCHLUNDT DG, 1994, DIABETES EDUCATOR, V20, P207, DOI 10.1177/014572179402000305
   Siminerio LM, 2008, DIABETES EDUCATOR, V34, p18S, DOI 10.1177/0145721707313938
   Simons LE, 2007, J PEDIATR PSYCHOL, V32, P831, DOI 10.1093/jpepsy/jsm030
   Skinner T., 1998, J PEDIATR PSYCHOL, V25, P257
   Soo H, 2009, J HEALTH PSYCHOL, V14, P933, DOI 10.1177/1359105309341146
   Tabachnick B. G., 2007, USING MULTIVARIATE S
   Travis T, 1997, DIABETES EDUCATOR, V23, P152, DOI 10.1177/014572179702300205
   Weissberg-Benchell J, 2011, PEDIATR DIABETES, V12, P341, DOI 10.1111/j.1399-5448.2010.00720.x
   Williams GC, 1998, DIABETES CARE, V21, P1644, DOI 10.2337/diacare.21.10.1644
   Williams GC, 2009, ANN BEHAV MED, V37, P315, DOI 10.1007/s12160-009-9090-y
   Wysocki Tim, 2006, Curr Diab Rep, V6, P117, DOI 10.1007/s11892-006-0022-y
NR 50
TC 30
Z9 30
U1 0
U2 25
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD OCT
PY 2011
VL 94
IS 1
BP 77
EP 83
DI 10.1016/j.diabres.2011.06.010
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 841RA
UT WOS:000296529100019
PM 21737172
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Siegelaar, SE
   Hoekstra, JBL
   DeVries, JH
AF Siegelaar, Sarah E.
   Hoekstra, Joost B. L.
   DeVries, J. Hans
TI Special considerations for the diabetic patient in the ICU; targets for
   treatment and risks of hypoglycaemia
SO BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
LA English
DT Article
DE diabetes mellitus; intensive care unit; hyperglycaemia; hypoglycaemia;
   glucose variability; morbidity; mortality; intensive insulin therapy
ID CRITICALLY-ILL PATIENTS; INTENSIVE-CARE-UNIT;
   RESPIRATORY-DISTRESS-SYNDROME; BLOOD-GLUCOSE CONCENTRATION; INSULIN
   THERAPY; GLYCEMIC CONTROL; STRESS HYPERGLYCEMIA; INCREASED MORTALITY;
   HOSPITAL MORTALITY; RANDOMIZED-TRIAL
AB Due to the diabetes pandemic the number of diabetic patients admitted to the intensive care unit (ICU) increases. Diabetic patients admitted to the ICU are more vulnerable for developing complications as compared to non-diabetic patients, but this does not directly translate into higher mortality rates. However, mortality might differ per admission diagnosis. Hyperglycaemia is common in diabetic as well as non-diabetic critically ill patients, but probably chronic hyperglycaemia is pathophysiologically different from acute hyperglycaemia. As opposed to non-diabetic patients, there is discussion about the association between hyperglycaemia and mortality in diabetic patients. They do not seem to benefit from strict glycaemic control and also glucose variability appears less harmful, although clinical trials in diabetic populations have not been performed yet. Diabetes is a risk factor for hypoglycaemia and evidence suggests that even near-normal glucose levels are associated with worse outcome. Taking this together, it is suggested to strive for moderate targets when treating hyperglycaemia in critically ill diabetic patients. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Siegelaar, Sarah E.; Hoekstra, Joost B. L.; DeVries, J. Hans] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands.
RP Siegelaar, SE (reprint author), Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Meibergdreef 9,Room F4-257, NL-1105 AZ Amsterdam, Netherlands.
EM s.e.siegelaar@amc.uva.nl; j.b.hoekstra@amc.uva.nl;
   j.h.devries@amc.uva.nl
OI DeVries, J. Hans/0000-0001-9196-9906
CR Ahmad R, 2007, ARCH SURG-CHICAGO, V142, P613, DOI 10.1001/archsurg.142.7.613
   Al-Dorzi HM, 2010, ANAESTH INTENS CARE, V38, P695
   ALEXIEWICZ JM, 1995, ANN INTERN MED, V123, P919, DOI 10.7326/0003-4819-123-12-199512150-00004
   Alvarez-Lerma F, 2003, INTENS CARE MED, V29, P1069, DOI 10.1007/s00134-003-1807-y
   Arabi YM, 2008, CRIT CARE MED, V36, P3190, DOI 10.1097/CCM.0b013e31818f21aa
   Bochicchio GV, 2006, WORLD J SURG, V30, P114, DOI 10.1007/s00268-005-0203-x
   Braithwaite SS, 2010, CRIT CARE MED, V38, P717, DOI 10.1097/CCM.0b013e3181cc8c6a
   Brown JR, 2006, SEMIN THORAC CARDIOV, V18, P281, DOI 10.1053/j.semtcvs.2006.04.004
   Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a
   Brunkhorst FM, 2008, NEW ENGL J MED, V358, P125, DOI 10.1056/NEJMoa070716
   BRUNNER R, 2011, CRITICAL CARE MED
   Bucerius J, 2003, THORAC CARDIOV SURG, V51, P11, DOI 10.1055/s-2003-37280
   De la Rosa GD, 2008, CRIT CARE, V12, DOI 10.1186/cc7017
   Dossett LA, 2008, AM SURGEON, V74, P679
   Douglas SL, 2007, AM J CRIT CARE, V16, P447
   Douglas SL, 2009, J CRIT CARE, V24, P302, DOI 10.1016/j.jcrc.2008.02.004
   Dungan KM, 2009, LANCET, V373, P1798, DOI 10.1016/S0140-6736(09)60553-5
   Durao MS, 2010, ANAESTH INTENS CARE, V38, P467
   Egi M, 2011, CRITICAL CARE MED, V39, P1
   Egi M, 2008, CRIT CARE MED, V36, P2249, DOI [10.1097/CCM.0b013e318181039a, 10.1097/CCM.0b013e31818039a]
   Egi M, 2006, ANESTHESIOLOGY, V105, P244, DOI 10.1097/00000542-200608000-00006
   Falciglia M, 2009, CRIT CARE MED, V37, P3001, DOI 10.1097/CCM.0b013e3181b083f7
   Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625
   Finney SJ, 2003, JAMA-J AM MED ASSOC, V290, P2041, DOI 10.1001/jama.290.15.2041
   Furnary Anthony P, 2006, Endocr Pract, V12 Suppl 3, P22
   Furnary AP, 2003, J THORAC CARDIOV SUR, V125, P1007, DOI 10.1067/mtc.2003.181
   Gandhi GY, 2007, ANN INTERN MED, V146, P233, DOI 10.7326/0003-4819-146-4-200702200-00002
   Gong MN, 2005, CRIT CARE MED, V33, P1191, DOI 10.1097/01.CCM.0000165566.82925.14
   Graham BB, 2010, CRIT CARE MED, V38, P16, DOI 10.1097/CCM.0b013e3181b9eaa5
   Guvener M, 2002, ENDOCR J, V49, P531, DOI 10.1507/endocrj.49.531
   Hermanides J, 2010, CRIT CARE MED, V38, P1430, DOI 10.1097/CCM.0b013e3181de562c
   Hermanides J, 2010, CRIT CARE MED, V38, P838, DOI 10.1097/CCM.0b013e3181cc4be9
   HEUSER MD, 1992, ARCH INTERN MED, V152, P1683, DOI 10.1001/archinte.152.8.1683
   Hirshberg E, 2008, PEDIATR CRIT CARE ME, V9, P361, DOI 10.1097/PCC.0b013e318172d401
   Holzinger U, 2010, DIABETES CARE, V33, P467, DOI 10.2337/dc09-1352
   Kee Cheryl A, 2006, Can J Cardiovasc Nurs, V16, P20
   Krinsley JS, 2008, CRIT CARE MED, V36, P3008, DOI 10.1097/CCM.0b013e31818b38d2
   Krinsley JS, 2007, CRIT CARE MED, V35, P2262, DOI 10.1097/01.CCM.0000282073.98414.4B
   Krinsley JS, 2006, SEMIN THORAC CARDIOV, V18, P317, DOI 10.1053/j.semtcvs.2006.12.003
   Krinsley James Stephen, 2009, J Diabetes Sci Technol, V3, P1292
   Krinsley JS, 2003, MAYO CLIN PROC, V78, P1471, DOI 10.4065/78.12.1471
   Laupland KB, 2004, CRIT CARE MED, V32, P992, DOI 10.1097/01.CCM.0000119424.31648.1E
   Lazar HL, 2004, CIRCULATION, V109, P1497, DOI 10.1161/01.CIR.0000121747.71054.79
   Leavitt BJ, 2004, CIRCULATION, V110, pII41, DOI 10.1161/10.CIR.0000138197.07051.e7
   Lemkes BA, 2010, J THROMB HAEMOST, V8, P1663, DOI 10.1111/j.1538-7836.2010.03910.x
   Ligtenberg JJM, 2006, INTENS CARE MED, V32, P435, DOI 10.1007/s00134-005-0052-y
   Logtenberg SJ, 2009, DIABETES TECHNOL THE, V11, P31, DOI 10.1089/dia.2008.0028
   MARHOFFER W, 1992, DIABETES CARE, V15, P256, DOI 10.2337/diacare.15.2.256
   MASLA M, 2010, J CARDIOTHORACIC VAS
   Michalia M, 2009, INTENS CARE MED, V35, P448, DOI 10.1007/s00134-008-1288-0
   Moghissi ES, 2009, DIABETES CARE, V32, P1119, DOI 10.2337/dc09-9029
   Moss M, 2000, CRIT CARE MED, V28, P2187, DOI 10.1097/00003246-200007000-00001
   Rabiee Atoosa, 2009, J Diabetes Sci Technol, V3, P951
   Rady MY, 2005, MAYO CLIN PROC, V80, P1558, DOI 10.4065/80.12.1558
   Reyes Maryrose, 2008, Dynamics, V19, P18
   Ryan T, 1997, CRIT CARE MED, V25, P2009, DOI 10.1097/00003246-199712000-00018
   Siegelaar SE, 2011, DIABETES CARE, V34, P855, DOI [10.2337/dc10-1684, 10.2337/dc10-1882]
   Siegelaar SE, 2010, CRIT CARE, V14, DOI 10.1186/cc9369
   Siegelaar SE, 2010, ENDOCR REV, V31, P171, DOI 10.1210/er.2009-0021
   Skjaervold NK, 2011, ANESTHESIOLOGY, V114, P120, DOI 10.1097/ALN.0b013e3181ff4187
   Slynkova K, 2006, CRIT CARE, V10, DOI 10.1186/cc5051
   Stegenga ME, 2010, CRIT CARE MED, V38, P539, DOI 10.1097/CCM.0b013e3181c02726
   Tissot E, 2001, EUR J CLIN MICROBIOL, V20, P260, DOI 10.1007/s10096-001-8097-5
   Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521
   Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300
   Van den Berghe G, 2006, DIABETES, V55, P3151, DOI 10.2337/db06-0855
   Vardakas KZ, 2007, DIABETIC MED, V24, P1168, DOI 10.1111/j.1464-5491.2007.02234.x
   Vincent JL, 2010, CRIT CARE, V14, DOI 10.1186/cc8866
   Vriesendorp TM, 2006, CRIT CARE MED, V34, P96, DOI 10.1097/01.CCM.0000194536.89694.06
   Whitcomb BW, 2005, CRIT CARE MED, V33, P2772, DOI 10.1097/01.CCM.0000189741.44071.25
NR 70
TC 6
Z9 6
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1521-690X
EI 1532-1908
J9 BEST PRACT RES CL EN
JI Best Pract. Res. Clin. Endoc. Metab.
PD OCT
PY 2011
VL 25
IS 5
BP 825
EP 834
DI 10.1016/j.beem.2011.03.004
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 833CQ
UT WOS:000295859800011
PM 21925081
DA 2019-01-08
ER

PT J
AU Quinn, CC
   Shardell, MD
   Terrin, ML
   Barr, EA
   Ballew, SH
   Gruber-Baldini, AL
AF Quinn, Charlene C.
   Shardell, Michelle D.
   Terrin, Michael L.
   Barr, Erik A.
   Ballew, Shoshana H.
   Gruber-Baldini, Ann L.
TI Cluster-Randomized Trial of a Mobile Phone Personalized Behavioral
   Intervention for Blood Glucose Control
SO DIABETES CARE
LA English
DT Article
ID DIABETES MANAGEMENT; CARE; OUTCOMES; POPULATION; DISTRESS; SIZE; US
AB OBJECTIVE-To test whether adding mobile application coaching and patient/provider web portals to community primary care compared with standard diabetes management would reduce glycated hemoglobin levels in patients with type 2 diabetes.
   RESEARCH DESIGN AND METHODS-A cluster-randomized clinical trial, the Mobile Diabetes Intervention Study, randomly assigned 26 primary care practices to one of three stepped treatment groups or a control group (usual care). A total of 163 patients were enrolled and included in analysis. The primary outcome was change in glycated hemoglobin levels over a 1-year treatment period. Secondary outcomes were changes in patient-reported diabetes symptoms, diabetes distress, depression, and other clinical (blood pressure) and laboratory (lipid) values. Maximal treatment was a mobile- and web-based self-management patient coaching system and provider decision support. Patients received automated, real-time educational and behavioral messaging in response to individually analyzed blood glucose values, diabetes medications, and lifestyle behaviors communicated by mobile phone. Providers received quarterly reports summarizing patient's glycemic control, diabetes medication management, lifestyle behaviors, and evidence-based treatment options.
   RESULTS-The mean declines in glycated hemoglobin were 1.9% in the maximal treatment group and 0.7% in the usual care group, a difference of 1.2% (P < 0.001) over 12 months. Appreciable differences were not observed between groups for patient-reported diabetes distress, depression, diabetes symptoms, or blood pressure and lipid levels (all P > 0.05).
   CONCLUSIONS-The combination of behavioral mobile coaching with blood glucose data, lifestyle behaviors, and patient self-management data individually analyzed and presented with evidence-based guidelines to providers substantially reduced glycated hemoglobin levels over 1 year.
C1 [Quinn, Charlene C.; Shardell, Michelle D.; Terrin, Michael L.; Barr, Erik A.; Ballew, Shoshana H.; Gruber-Baldini, Ann L.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA.
RP Quinn, CC (reprint author), Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA.
EM cquinn@epi.umaryland.edu
RI Emchi, Karma/Q-1952-2016
FU University of Maryland Baltimore; WellDoc; University of Maryland
FX This research project is funded through a contract between the
   University of Maryland Baltimore and WellDoc in addition to
   contributions by WellDoc, CareFirst Blue Cross/Blue Shield of Maryland,
   LifeScan, and Sprint. Additional funding was provided by the Maryland
   Industrial Partnerships program through the University of Maryland, an
   initiative of the A. James Clark School of Engineering's Maryland
   Technology Enterprise Institute. No other potential conflicts of
   interest relevant to this article were reported.
CR Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS12, DOI 10.2337/dc08-S012
   Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS13, DOI 10.2337/dc09-S013
   Cleland JGF, 2010, JAMA-J AM MED ASSOC, V304, P1383, DOI 10.1001/jama.2010.1387
   Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296
   Duke SAS, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005268.pub2
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Gaede Peter Haulund, 2003, Ugeskr Laeger, V165, P2658
   Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743
   GRIFFIN S, 2000, COCHRANE DB SYST REV
   Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319
   Huang ES, 2009, DIABETES CARE, V32, P2225, DOI 10.2337/dc09-0459
   Knowler WC, 2002, NEW ENGL J MED, V346, P393
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   MCCOLL E, 1995, SOC SCI MED, V41, P1339, DOI 10.1016/0277-9536(95)00120-V
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Quinn CC, 2008, DIABETES TECHNOL THE, V10, P160, DOI 10.1089/dia.2008.0283
   Quinn CC, 2009, CONTEMP CLIN TRIALS, V30, P334, DOI 10.1016/j.cct.2009.02.004
   Renders CM, 2001, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD001481
   ROBINS JM, 1995, J AM STAT ASSOC, V90, P122, DOI 10.2307/2291135
   Saaddine JB, 2006, ANN INTERN MED, V144, P465, DOI 10.7326/0003-4819-144-7-200604040-00005
   Shea S, 2006, J AM MED INFORM ASSN, V13, P40, DOI 10.1197/jamia.M1917
   Solomon CG, 2003, NEW ENGL J MED, V348, P457, DOI 10.1056/NEJMe020172
   VERBEKE G, 2007, REPEATED MEASUREMENT
   Whitty P, 1997, QUAL LIFE RES, V6, P407, DOI 10.1023/A:1018443628933
NR 25
TC 202
Z9 208
U1 1
U2 48
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
EI 1935-5548
J9 DIABETES CARE
JI Diabetes Care
PD SEP
PY 2011
VL 34
IS 9
BP 1934
EP 1942
DI 10.2337/dc11-0366
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 824IH
UT WOS:000295195100009
PM 21788632
OA Green Published, Other Gold
HC Y
HP N
DA 2019-01-08
ER

PT J
AU Welch, G
   Allen, NA
   Zagarins, SE
   Stamp, KD
   Bursell, SE
   Kedziora, RJ
AF Welch, Garry
   Allen, Nancy A.
   Zagarins, Sofija E.
   Stamp, Kelly D.
   Bursell, Sven-Erik
   Kedziora, Richard J.
TI Comprehensive Diabetes Management Program for Poorly Controlled Hispanic
   Type 2 Patients at a Community Health Center
SO DIABETES EDUCATOR
LA English
DT Article
ID ETHNIC-DIFFERENCES; PROBLEM AREAS; CARE; RETINOPATHY; BARRIERS;
   QUESTIONNAIRE; IMPROVEMENT; PREDICTORS
AB Technology and improved care coordination models can help diabetes educators and providers meet national care standards and provide culturally sensitive diabetes education that may improve diabetes outcomes. The purpose of the study was to evaluate the clinical usefulness of a nurse-led diabetes care program (Comprehensive Diabetes Management Program, CDMP) for poorly controlled Hispanic type 2 diabetes (T2DM) patients in an urban community health center setting. Patients were randomized to the intervention condition (IC; n = 21) or an attention control condition (AC; n = 18). IC and AC conditions were compared on rates of adherence to national clinical practice guidelines (blood glucose, blood pressure, foot exam, eye exam), and levels of diabetes distress, depression, and treatment satisfaction. IC patients had a significant improvement in A1C from baseline to 12-month follow-up compared with AC (-1.6% +/- 1.4% versus -0.6% +/- 1.1%; P = .01). The proportion of IC patients meeting clinical goals at follow-up tended to be higher than AC for A1c (IC = 45%; AC = 28%), systolic blood pressure (IC = 55%; AC = 28%), eye screening (IC = 91%; AC = 78%), and foot screening, (IC = 86%; AC = 72%). Diabetes distress and treatment satisfaction also showed greater improvement for IC than AC (P = .05 and P = .06, respectively), with no differences for depression. The CDMP intervention was more effective than an attention control condition in helping patients meet evidence-based guidelines for diabetes care.
C1 [Welch, Garry] Baystate Hlth Syst, Behav Med Res, Dept Behav Med Res, Springfield, MA 01105 USA.
   [Allen, Nancy A.; Stamp, Kelly D.] Boston Coll, William F Connell Sch Nursing, Chestnut Hill, MA 02167 USA.
   [Bursell, Sven-Erik] Univ Hawaii Manoa, Telehealth Res Inst, John A Burns Sch Med, Honolulu, HI 96822 USA.
   [Kedziora, Richard J.] Estenda Solut Inc, Conshohocken, PA USA.
RP Welch, G (reprint author), Baystate Hlth Syst, Behav Med Res, Dept Behav Med Res, 140 High St,Room 2104, Springfield, MA 01105 USA.
EM garry.welch@baystatehealth.org
FU Baystate Medical Center [AA-BMC P99]
FX This study was funded by Baystate Medical Center Academic Affairs
   Internal Research Grant #AA-BMC P99.
CR Abu-Qamar M, 2007, INT J EVID-BASED HEA, V5, P254, DOI 10.1111/j.1479-6988.2007.00066.x
   *AM ASS DIAB ED, 2002, DIABETES ED, V28, P735
   American Psychiatric Association, 2000, DIAGN STAT MAN MENT
   BEASER RS, 2001, JOSLINS DIABETES DES
   Bradley C, 1999, DIABETES CARE, V22, P530, DOI 10.2337/diacare.22.3.530
   Bursell SE, 2001, OPHTHALMOLOGY, V108, P572, DOI 10.1016/S0161-6420(00)00604-7
   Caban A, 2006, DIABETES EDUCATOR, V32, P584, DOI 10.1177/0145721706290435
   Cavallerano JD, 2005, AM J OPHTHALMOL, V140, P667, DOI 10.1016/j.ajo.2005.03.075
   Centers for Disease Control and Prevention, 2007, NAT DIAB FACT SHEET
   Chin MH, 2001, DIABETES CARE, V24, P268, DOI 10.2337/diacare.24.2.268
   Conlin PR, 2006, J REHABIL RES DEV, V43, P733, DOI 10.1682/JRRD.2005.07.0117
   Dall TM, 2010, HEALTH AFFAIR, V29, DOI 10.1377/hlthaff.2009.0155
   Fanning EL, 2004, DIABETES CARE, V27, P1638, DOI 10.2337/diacare.27.7.1638
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Fonda SJ, 2008, DIABETES TECHNOL THE, V10, P16, DOI 10.1089/dia.2007.0252
   Goderis G, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-41
   Hjelm-Karlsson K, 1991, West J Nurs Res, V13, P284, DOI 10.1177/019394599101300211
   Khattab M, 2010, J DIABETES COMPLICAT, V24, P84, DOI 10.1016/j.jdiacomp.2008.12.008
   Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06
   Lanting LC, 2005, DIABETES CARE, V28, P2280, DOI 10.2337/diacare.28.9.2280
   Latham CL, 2009, WESTERN J NURS RES, V31, P364, DOI 10.1177/0193945908328263
   Lee PW, 2007, J AM BOARD FAM MED, V20, P427, DOI 10.3122/jabfm.2007.05.070045
   Mensing Carole, 2007, Diabetes Care, V30 Suppl 1, pS96, DOI 10.2337/dc07-S096
   Nagelkerk J, 2006, J ADV NURS, V54, P151, DOI 10.1111/j.1365-2648.2006.03799.x
   *NAT ASS COMM HLTH, ON YEAR LAT HLTH CTR
   Nuovo J, 2007, CURR DIABETES REV, V3, P226, DOI 10.2174/157339907782330030
   Philis-Tsimikas A, 2004, DIABETES CARE, V27, P110, DOI 10.2337/diacare.27.1.110
   Pleis John R, 2009, Vital Health Stat 10, P1
   RUBIN R, 2000, PSYCHOL DIABETES CAR
   Saaddine JB, 2006, ANN INTERN MED, V144, P465, DOI 10.7326/0003-4819-144-7-200604040-00005
   Schram MT, 2009, CURR DIABETES REV, V5, P112, DOI 10.2174/157339909788166828
   Spenceley SM, 2006, CAN J NURS RES, V38, P124
   *US CENS BUR, 2009, AM COMM SURV B03001
   *US DEP HHS, STAT APPR DIAB QUAL
   Weinick RM, 2000, MED CARE RES REV, V57, P36, DOI 10.1177/107755800773743592
   Welch G, 2005, DIABETES, V54, pA470
   Welch G, 2003, DIABETIC MED, V20, P69, DOI 10.1046/j.1464-5491.2003.00832.x
   WELCH G, 2009, J DIAB NURSING, V13, P319
   Welch G, 2010, DIABETES RES CLIN PR, V88, P1, DOI 10.1016/j.diabres.2009.12.026
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   Whited JD, 2005, TELEMED J E-HEALTH, V11, P641, DOI 10.1089/tmj.2005.11.641
   Whittemore R, 2007, J TRANSCULT NURS, V18, P157, DOI 10.1177/1043659606298615
   ZAGARINS SE, 2011, J BEHAV MED
   2009, DIABETES CARE S1, V32, pS6
NR 44
TC 24
Z9 25
U1 1
U2 15
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0145-7217
J9 DIABETES EDUCATOR
JI Diabetes Educ.
PD SEP-OCT
PY 2011
VL 37
IS 5
BP 680
EP 688
DI 10.1177/0145721711416257
PG 9
WC Endocrinology & Metabolism; Public, Environmental & Occupational Health
SC Endocrinology & Metabolism; Public, Environmental & Occupational Health
GA 819PY
UT WOS:000294841600007
PM 21918206
DA 2019-01-08
ER

PT J
AU Trief, PM
   Sandberg, J
   Fisher, L
   Dimmock, JA
   Scales, K
   Hessler, DM
   Weinstock, RS
AF Trief, Paula M.
   Sandberg, Jonathan
   Fisher, Lawrence
   Dimmock, Jacqueline A.
   Scales, Kasandra
   Hessler, Danielle M.
   Weinstock, Ruth S.
TI Challenges and lessons learned in the development and implementation of
   a couples-focused telephone intervention for adults with type 2
   diabetes: the Diabetes Support Project
SO TRANSLATIONAL BEHAVIORAL MEDICINE
LA English
DT Article
DE Type 2 diabetes; Glycemic control; Marital interaction; Social support;
   Telephone intervention
AB Type 2 diabetes (T2DM) studies report that marital/family support relates to glycemic control, adherence, and quality of life. Yet, there are few reports on couples-focused interventions. This study aims to describe the challenges faced and lessons learned in the implementation of a theoretically based, couples intervention. Three hundred fifty couples (one partner has T2DM in poor glycemic control) are randomized to a couples intervention, individual intervention, or enhanced usual care. All contacts are by telephone to increase reach. The medical (e.g., glycemic control), psychosocial (e.g., diabetes distress), and behavioral (e.g., regimen adherence) outcomes were measured. Challenges in recruitment, assessment, and intervention with couples are described, with suggestions about how to address them. Findings concerning the efficacy and cost-effectiveness of the couples intervention, its effect on partners, and possible mechanisms of demonstrated changes, are anticipated in 2013. Interventionists need specific skills to work with couples to promote communal coping and increase the likelihood of an efficacious couples intervention.
C1 [Trief, Paula M.; Dimmock, Jacqueline A.; Scales, Kasandra; Weinstock, Ruth S.] SUNY Upstate Med Univ, Syracuse, NY 13210 USA.
   [Sandberg, Jonathan] Brigham Young Univ, Provo, UT 84602 USA.
   [Fisher, Lawrence; Hessler, Danielle M.] Univ Calif San Francisco, San Francisco, CA 94143 USA.
RP Trief, PM (reprint author), SUNY Upstate Med Univ, 750 E Adams St, Syracuse, NY 13210 USA.
EM triefp@upstate.edu
OI Trief, Paula/0000-0002-2827-5722
FU National Institute of Diabetes, Digestive, and Kidney Diseases of the
   National Institutes of Health [1R18DK080867-01A2]
FX This study is being funded by the National Institute of Diabetes,
   Digestive, and Kidney Diseases of the National Institutes of Health
   (grant no. 1R18DK080867-01A2 Clinicaltrials.gov no. NCT0107523).
CR Bandura A., 1963, SOCIAL LEARNING PERS
   BLACK DR, 1990, HEALTH PSYCHOL, V9, P330, DOI 10.1037//0278-6133.9.3.330
   Campbell TA, 2002, EFFECTIVENESS RES MA, P311
   CARDENAS L, 1987, AM J MED SCI, V293, P28, DOI 10.1097/00000441-198701000-00007
   Delamater AM, 2001, DIABETES CARE, V24, P1286, DOI 10.2337/diacare.24.7.1286
   DEVOOGD JN, 1993, J MUSCULOSKELET PAIN, V1, P273
   DUNKELSCHETTER C, 1984, J SOC ISSUES, V40, P77, DOI 10.1111/j.1540-4560.1984.tb01108.x
   Fisher L, 2000, J FAM PRACTICE, V49, P561
   Fukunishi I, 1998, DIABETES RES CLIN PR, V41, P207, DOI 10.1016/S0168-8227(98)00083-7
   GARAYSEVILA ME, 1995, J DIABETES COMPLICAT, V9, P81, DOI 10.1016/1056-8727(94)00021-F
   GILDEN JL, 1989, J AM GERIATR SOC, V37, P1023, DOI 10.1111/j.1532-5415.1989.tb06915.x
   Glasgow RE, 2006, AM J PREV MED, V30, P67, DOI 10.1016/j.amepre.2005.08.037
   HERBERT TB, 1993, PSYCHOL BULL, V113, P472, DOI 10.1037//0033-2909.113.3.472
   Kelley H. H., 1978, INTERPERSONAL RELATI
   Kiecolt-Glaser JK, 2001, PSYCHOL BULL, V127, P472, DOI 10.1037//0033-2909.127.4.472
   Lewis MA, 2006, SOC SCI MED, V62, P1369, DOI 10.1016/j.socscimed.2005.08.006
   Manne S, 2007, HEALTH PSYCHOL, V26, P735, DOI 10.1037/0278-6133.26.6.735
   Martire LM, 2010, ANN BEHAV MED, V40, P325, DOI 10.1007/s12160-010-9216-2
   McBride CM, 2004, AM J PREV MED, V27, P232, DOI 10.1016/j.amepre.2004.06.005
   Palmer C. A., 2000, PSYCHOL COUPLES ILLN, P311
   PEYROT M, 1988, J MARRIAGE FAM, V50, P363, DOI 10.2307/352003
   Pieper B A, 1990, Diabetes Educ, V16, P108, DOI 10.1177/014572179001600206
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   PRIMOMO J, 1990, RES NURS HEALTH, V13, P153, DOI 10.1002/nur.4770130304
   Rissman R., 1987, FAMILY SYSTEM MED, V5, P61
   Robles TF, 2003, PHYSIOL BEHAV, V79, P409, DOI 10.1016/S0031-9384(03)00160-4
   Rusbult CE, 2003, ANNU REV PSYCHOL, V54, P351, DOI 10.1146/annurev.psych.54.101601.145059
   SCHMALING K, 2000, PSYCHOL COUPLES ILLN
   SHUMAKER SA, 1998, HDB HLTH BEHAV CHANG
   Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339
   Trief PM, 1998, DIABETES CARE, V21, P241, DOI 10.2337/diacare.21.2.241
   Trief PM, 2004, ANN BEHAV MED, V27, P148, DOI 10.1207/s15324796abm2703_2
   Trief PM, 2001, DIABETES CARE, V24, P1384, DOI 10.2337/diacare.24.8.1384
   WING RR, 1991, J CONSULT CLIN PSYCH, V59, P156, DOI 10.1037/0022-006X.59.1.156
NR 34
TC 12
Z9 12
U1 0
U2 4
PU SPRINGER INTERNATIONAL PUBLISHING AG
PI CHAM
PA GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND
SN 1869-6716
EI 1613-9860
J9 TRANSL BEHAV MED
JI Transl. Behav. Med.
PD SEP
PY 2011
VL 1
IS 3
BP 461
EP 467
DI 10.1007/s13142-011-0057-8
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA V39LI
UT WOS:000209412100016
PM 22003374
OA Green Accepted, Green Published
DA 2019-01-08
ER

PT J
AU Hajos, TRS
   Pouwer, F
   de Grooth, R
   Holleman, F
   Twisk, JWR
   Diamant, M
   Snoek, FJ
AF Hajos, T. R. S.
   Pouwer, F.
   de Grooth, R.
   Holleman, F.
   Twisk, J. W. R.
   Diamant, M.
   Snoek, F. J.
TI Initiation of insulin glargine in patients with Type 2 diabetes in
   suboptimal glycaemic control positively impacts health-related quality
   of life. A prospective cohort study in primary care
SO DIABETIC MEDICINE
LA English
DT Article
DE emotional well-being; insulin glargine; insulin initiation; quality of
   life
ID OF-LIFE; THERAPY; SYMPTOMS; TRIAL; HYPOGLYCEMIA; SATISFACTION;
   VALIDATION; MELLITUS; ANALOGS; SCALE
AB Aims To study prospectively the impact of initiating insulin glargine in suboptimally controlled insulin-naive patients with Type 2 diabetes on health-related quality of life in relation to glycaemic control.
   Methods Insulin-naive Dutch patients with Type 2 diabetes in suboptimal glycaemic control (HbA(1c) > 53 mmol/mol; 7%) on maximum dose of oral glucose-lowering medications were included from 363 primary care practices (n = 911). Patients started insulin glargine and were followed up for 6 months. At baseline (start insulin therapy), 3 and 6 months, HbA(1c) was measured and patients completed self-report health-related quality of life measures, including emotional well-being (World Health Organization-5 well-being index), fear of hypoglycaemia (Hypoglycaemia Fear Survey) and diabetes symptom distress (Diabetes Symptom Checklist-revised). Data were analysed using generalized estimating equations analysis.
   Results HbA(1c) (mmol/mol; %) decreased from 69 +/- 16; 8.5 +/- 1.7 to 60 +/- 11; 7.6 +/- 1.0 and 57 +/- 11; 7.3 +/- 1.0 at 3 and 6 months, respectively (P < 0.001). Pre-insulin BMI (kg/m(2)) was 30 +/- 5.7, which remained stable at 3 months (30 +/- 5.8) and increased to 31 +/- 5.9 at 6 months (P = 0.004); no significant changes in self-reported symptomatic and severe hypoglycaemia were observed, while nocturnal hypoglycaemia slightly decreased. The Hypoglycaemia Fear Survey score decreased from 14.6 +/- 16.2 to 12.1 +/- 15.2 and 10.8 +/- 14.4 at 3 and 6 months, respectively (P < 0.001). The Diabetes Symptom Checklist-revised score decreased from 15 +/- 14 to 10 +/- 12 and 10 +/- 13 (P < 0.001), with most pronounced reductions in hyperglycaemic symptoms and fatigue. The World Health Organization-5 score increased from 57 +/- 25.3 to 65 +/- 21.6 at 3-month follow-up and 67 +/- 21.8 at 6-month follow-up (P < 0.001).
   Conclusions Results of this observational study demonstrate combined glycaemic and health-related quality of life benefits of initiating insulin glargine in patients with Type 2 diabetes in routine primary care.
C1 [Hajos, T. R. S.] Vrije Univ Amsterdam Med Ctr, EMGO Inst, Dept Med Psychol, NL-1081 BT Amsterdam, Netherlands.
   [Hajos, T. R. S.; Twisk, J. W. R.; Diamant, M.; Snoek, F. J.] EMGO Res Inst, Amsterdam, Netherlands.
   [Pouwer, F.] Tilburg Univ, Ctr Res Psychol Somat Dis CoRPS, NL-5000 LE Tilburg, Netherlands.
   [de Grooth, R.] Sanofi Aventis, Gouda, Netherlands.
   [Holleman, F.] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands.
   [Twisk, J. W. R.] Vrije Univ Amsterdam Med Ctr, Dept Clin Epidemiol & Biostat, NL-1081 BT Amsterdam, Netherlands.
   Vrije Univ Amsterdam Med Ctr, Ctr Diabet, Dept Internal Med, NL-1081 BT Amsterdam, Netherlands.
RP Hajos, TRS (reprint author), Vrije Univ Amsterdam Med Ctr, EMGO Inst, Dept Med Psychol, Van der Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.
EM t.hajos@vumc.nl
FU sanofi-aventis; Amylin Pharmaceuticals Inc.; Eli Lilly and Company; Novo
   Nordisk; Merck; Sharp and Dohme; Novartis; Takeda; VU Medical Centre
   from sanofi-aventis
FX RdeG is an employee of sanofi-aventis. FH has acquired funds for his
   activities as a principal investigator and steering committee member for
   a multinational trial sponsored by sanofi-aventis. MD is a consultant
   and speaker for Eli Lilly and Company, Novo Nordisk and Merck, Sharp and
   Dohme, and a consultant for sanofi-aventis. Through MD, the VU
   University Medical Center in Amsterdam has received research grants from
   Amylin Pharmaceuticals Inc., Eli Lilly and Company, Novo Nordisk, Merck,
   Sharp and Dohme, Novartis and Takeda. FJS has received a research grant
   via the VU Medical Centre from sanofi-aventis for two observational
   studies related to psychological outcomes of insulin glargine therapy;
   he has consulted for sanofi-aventis on the topic of quality-of-life
   measurement and received speakers fee from sanofi-aventis for lectures
   delivered in the context of continuous medical education. There are no
   other potential conflicts of interest relevant to this article.
CR Amiel SA, 2008, DIABETIC MED, V25, P245, DOI 10.1111/j.1464-5491.2007.02341.x
   Bech P, 2003, INT J METH PSYCH RES, V12, P85, DOI 10.1002/mpr.145
   Bouma M, 2006, Ned Tijdschr Geneeskd, V150, P2251
   Boye KS, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-80
   Bradley C, 2008, DIABETES OBES METAB, V10, P50, DOI 10.1111/j.1463-1326.2008.00871.x
   COX DJ, 1987, DIABETES CARE, V10, P617, DOI 10.2337/diacare.10.5.617
   Dale J, 2010, PRIM CARE DIABETES, V4, P85, DOI 10.1016/j.pcd.2010.03.001
   de Sonnaville JJJ, 1998, DIABETES CARE, V21, P919, DOI 10.2337/diacare.21.6.919
   DeVries JH, 2003, DIABETES-METAB RES, V19, P357, DOI 10.1002/dmrr.405
   Dluhy RG, 2008, NEW ENGL J MED, V358, P2630, DOI 10.1056/NEJMe0804182
   Hartman I, 2008, CLIN MED RES, V6, P54, DOI 10.3121/cmr.2008.793
   Heinemann L, 2000, DIABETES CARE, V23, P644, DOI 10.2337/diacare.23.5.644
   Hirsch IB, 2005, NEW ENGL J MED, V352, P174, DOI 10.1056/NEJMra040832
   Horvath K, 2007, COCHRANE DB SYST REV
   Kunt T, 2009, INT J CLIN PRACT, V63, P6, DOI 10.1111/j.1742-1241.2009.02176.x
   Lowe B, 2004, J AFFECT DISORDERS, V78, P131, DOI 10.1016/S0165-0327(02)00237-9
   Nathan DM, 2006, DIABETES CARE, V29, P1963, DOI 10.2337/dc06-9912
   Polonsky WH, 2005, DIABETES CARE, V28, P2543, DOI 10.2337/diacare.28.10.2543
   Pouwer F, 2009, DIABETES-METAB RES, V25, pS4, DOI 10.1002/dmrr.981
   Rubin DB, 1987, MULTIPLE IMPUTATION
   Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147
   Schreiber SA, 2008, DIABETES TECHNOL THE, V10, P121, DOI 10.1089/dia.2007.0265
   Snoek FJ, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-69
   Swinnen SG, 2010, DIABETES CARE, V33, P1176, DOI 10.2337/dc09-2294
   Testa MA, 1998, JAMA-J AM MED ASSOC, V280, P1490, DOI 10.1001/jama.280.17.1490
   VanderDoes FEE, 1996, DIABETES CARE, V19, P204, DOI 10.2337/diacare.19.3.204
   Vinik AI, 2007, DIABETES CARE, V30, P795, DOI 10.2337/dc06-1712
NR 27
TC 19
Z9 19
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD SEP
PY 2011
VL 28
IS 9
BP 1096
EP 1102
DI 10.1111/j.1464-5491.2011.03329.x
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 807NG
UT WOS:000293905000015
PM 21843305
DA 2019-01-08
ER

PT J
AU Castillo, O
   Roig, B
   Sanz, I
   Herrero, R
   Garay, T
   Fuentes, ME
   Barreales, L
   Egido, JA
AF Castillo, Olga
   Roig, Beatriz
   Sanz, Isabel
   Herrero, Rosa
   Garay, Teresa
   Fuentes, Manuel E.
   Barreales, Laura
   Egido, Jose A.
TI Agreement between information provided by stroke patients and their
   relatives on psychophysical and vascular risk factors
SO INTERNATIONAL JOURNAL OF NURSING STUDIES
LA English
DT Article
DE Agreement; Psychophysical stress; Risk factors; Stroke
ID MIDDLE-AGED MEN; PROXY RESPONDENTS; PSYCHOLOGICAL STRESS;
   CARDIOVASCULAR-DISEASE; ISCHEMIC-STROKE; VALIDITY; MORTALITY; DISTRESS;
   VERSION; CANCER
AB Background: In studies examining vascular risk factors and the effects of stress in stroke patients, information sometimes has to be provided by a close relative.
   Objectives: The present study was designed to assess agreement between the information provided by a stroke patient and his/her next-of-kin or other close relative on prior vascular risk factors and situations of psychophysical stress based on a standardized interview within 72 h after stroke.
   Design: Case-control observational study.
   Participants and settings: All patients with incident stroke aged 18-65 years admitted to our centre were enrolled as cases, and their coinhabiting relatives as controls. The study was conducted from January to June 2008.
   Methods: A structured questionnaire about vascular risk factors and psychophysical stress factors were obtained from the participants within 72 h after stroke. Subjects were required to grade themselves or their relatives using validated Spanish versions of the Life Events Stress Scale of Holmes and Rahe, Goldberg's General Health Questionnaire GHQ-28 and the SF-12 Health Survey, as well as the Spanish Type A Behaviour Scale. The questionnaires were self-administered. Cases and controls completed the same questionnaires and which were administered with a time difference of no longer than 24 h between the two groups of subjects. Risk factors were analyzed by determining kappa statistics and interclass correlation coefficients (ICC). Bland-Altman plots were used to examine the scores obtained in graded scales.
   Results: 25 patients and 25 relatives were recruited. Agreement between cases and controls was good for reported atrial fibrillation, diabetes, alcohol consumption and smoking (range 0.83-1.0). ICC were low for the questionnaires Holmes-Rahe Life Events (0.26; 95%CI: 0.08-0.57), General Health GHQ-28 (0.39; 95%CI: 0.03-0.67) and SF12 Health Survey (0.52; 95%CI: 0.16-0.76 and 0.35; 95%CI: 0.06-0.66), and good for the Type A Behaviour Scale ERCTA (0.62; 95%CI: 0.32-0.81).
   Conclusions: The information obtained from family members on patient risk factors could be considered reliable, while that related to psychophysical aspects was not sufficiently reliable for research purposes. Agreement assessments could be useful to avoid misclassification biases. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Castillo, Olga; Roig, Beatriz; Sanz, Isabel; Herrero, Rosa; Garay, Teresa; Fuentes, Manuel E.; Barreales, Laura; Egido, Jose A.] Hosp Clin San Carlos, Stroke Unit, Madrid 28040, Spain.
RP Roig, B (reprint author), Hosp Clin San Carlos, Stroke Unit, C Prof Martin Lagos S-N, Madrid 28040, Spain.
EM beatrizroig@hotmail.com
RI Egido, Jose/E-3837-2015; Fuentes Ferrer, Manuel Enrique/L-1086-2017
OI Egido, Jose/0000-0003-1698-9127; Fuentes Ferrer, Manuel
   Enrique/0000-0002-5177-1441
FU Ministry of Health and Social Policy (FIS); Fondo de Investigaciones
   Sanitarias del Ministerio de Sanidad y Politica Social (FIS) [PI7/0124]
FX Funding. Health Research Fund of the Ministry of Health and Social
   Policy (FIS).; The source of public funding of this research was "Fondo
   de Investigaciones Sanitarias del Ministerio de Sanidad y Politica
   Social (FIS) PI7/0124". To Dr. Fernandez and Dr.Garcia, for their help
   in the manuscript elaboration.
CR ALLEN MT, 1995, BIOL PSYCHOL, V41, P1, DOI 10.1016/0301-0511(95)05123-R
   ALONSO J, 1995, MED CLIN-BARCELONA, V104, P771
   Boden-Albala B, 2000, Curr Atheroscler Rep, V2, P160, DOI 10.1007/s11883-000-0111-3
   Carod-Artal FJ, 2006, REV NEUROLOGIA, V42, P169
   DeVries AC, 2001, P NATL ACAD SCI USA, V98, P11824, DOI 10.1073/pnas.201215298
   Dimsdale JE, 2008, J AM COLL CARDIOL, V51, P1237, DOI 10.1016/j.jacc.2007.12.024
   Farrow D C, 1990, Epidemiology, V1, P370, DOI 10.1097/00001648-199009000-00006
   Gainotti G, 1997, STROKE, V28, P2145, DOI 10.1161/01.STR.28.11.2145
   Gavalda L, 1995, Gac Sanit, V9, P334
   Gonzalez de Rivera J, 1984, PSIQUIS, V4, P121
   Hamer M, 2008, J AM COLL CARDIOL, V52, P2156, DOI 10.1016/j.jacc.2008.08.057
   Hankey GJ, 2006, STROKE, V37, P2181, DOI 10.1161/01.STR.0000229883.72010.e4
   KOLONEL LN, 1977, AM J EPIDEMIOL, V106, P476, DOI 10.1093/oxfordjournals.aje.a112494
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   LOBO A, 1986, PSYCHOL MED, V16, P135, DOI 10.1017/S0033291700002579
   LYON JL, 1992, EPIDEMIOLOGY, V3, P223, DOI 10.1097/00001648-199205000-00007
   May M, 2002, STROKE, V33, P7, DOI 10.1161/hs0102.100529
   *NAT I STAT, 2010, INT CLASS DIS CAUS D
   NELSON LM, 1994, EPIDEMIOLOGY, V5, P204, DOI 10.1097/00001648-199403000-00011
   NELSON LM, 1990, EPIDEMIOL REV, V12, P71, DOI 10.1093/oxfordjournals.epirev.a036063
   Ohlin B, 2004, EUR HEART J, V25, P867, DOI 10.1016/j.ehj.2004.03.003
   ROCCA WA, 1986, J CHRON DIS, V39, P907, DOI 10.1016/0021-9681(86)90039-1
   ROGOT E, 1975, INT J EPIDEMIOL, V4, P51, DOI 10.1093/ije/4.1.51
   ROSENGREN A, 1991, AM J CARDIOL, V68, P1171, DOI 10.1016/0002-9149(91)90189-R
   SACCO RL, 2001, NEUROLOGY, V57, P31
   Schneck MJ, 1997, NEUROEPIDEMIOLOGY, V16, P174, DOI 10.1159/000109684
   Sharkey SW, 2005, CIRCULATION, V111, P472, DOI 10.1161/01.CIR.0000153801.51470.EB
   SUTIL RC, 1997, CLIN SALUD, V8, P347
   SZKLO M, 2003, LACK VALIDITY BIAS I
   Tang ST, 2006, CANCER NURS, V29, P49, DOI 10.1097/00002820-200601000-00009
   TEPPER A, 1993, J CLIN EPIDEMIOL, V46, P1243, DOI 10.1016/0895-4356(93)90088-I
   Truelsen T, 2003, STROKE, V34, P856, DOI 10.1161/01.STR.0000062345.80774.40
   Villanueva V, 2006, J ALZHEIMERS DIS, V10, P409
   WEISS A, 1966, J CLIN EPIDEMIOL, V49, P1187
   World Health Organization, 1998, GUID CONTR MON TOB E
NR 35
TC 1
Z9 1
U1 0
U2 9
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0020-7489
J9 INT J NURS STUD
JI Int. J. Nurs. Stud.
PD AUG
PY 2011
VL 48
IS 8
BP 952
EP 958
DI 10.1016/j.ijnurstu.2011.01.003
PG 7
WC Nursing
SC Nursing
GA 826JQ
UT WOS:000295350800006
PM 21295779
DA 2019-01-08
ER

PT J
AU Swartz, JA
AF Swartz, James A.
TI Chronic Medical Conditions among Jail Detainees in Residential
   Psychiatric Treatment: A Latent Class Analysis
SO JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE
LA English
DT Article
DE Co-occurring disorders; Medical complexity; Chronic medical conditions;
   Serious mental illness; Jail detainees; Latent class analysis
ID COMORBIDITY SURVEY REPLICATION; DIAGNOSTIC INTERVIEW CIDI;
   MINI-MENTAL-STATE; DSM-IV DISORDERS; PSYCHOLOGICAL DISTRESS;
   SUBSTANCE-ABUSE; PREVALENCE; PRISON; CARE; POPULATION
AB Studies of incarcerates with serious mental illnesses have found elevated rates of chronic medical conditions such as asthma and diabetes, and of infectious diseases such as tuberculosis compared with general population rates. This study explored the pattern of chronic medical conditions in a sample of adult detainees in psychiatric treatment in a large urban jail to develop a clinical profile encompassing the full range of medical conditions. A total of 431 male and female detainees were sampled with certainty from admissions to a residential psychiatric treatment program (overall recruitment rate = 67%). Interviews used the World Mental Health version of the Composite International Diagnostic Interview to assess psychiatric and substance use disorders per DSM-IV criteria and chronic medical conditions. Latent class analysis was conducted using 17 medical conditions as class indicators, yielding a 3-class model composed of: a latent class with a high to intermediate probability of multiple medical conditions (HMC; 12.5% of the sample); an intermediate class with a lower probability of having a smaller number of medical conditions (MMC; 43.2%); and a class with a low probability of any medical condition (44.3%). Those in the HMC class were more likely to report respiratory problems, severe headaches, musculoskeletal pain, hypertension, and arthritis, have greater functional impairment, and have a higher number of co-occurring psychiatric disorders. Being older (50+ years) and female were associated with higher odds of being in the HMC or MMC classes. The policy implications for providing medical care to incarcerates with complex mixtures of medical conditions and psychiatric disorders are considered.
C1 Univ Illinois, Jane Addams Coll Social Work, Chicago, IL 60680 USA.
RP Swartz, JA (reprint author), Univ Illinois, Jane Addams Coll Social Work, Chicago, IL 60680 USA.
EM jaswartz@uic.edu
RI Swartz, James/G-3931-2017
OI Swartz, James/0000-0003-2206-7962
FU Bureau of Justice Assistance, Office of Justice Programs, US Department
   of Justice [04-DB-BX-0043]; National Institute on Drug Abuse
   [5-R01-DA013943-05]
FX This study was supported by grant no. 04-DB-BX-0043 awarded to the
   Illinois Criminal Justice Information Authority by the Bureau of Justice
   Assistance, Office of Justice Programs, US Department of Justice and by
   grant no. 5-R01-DA013943-05 from the National Institute on Drug Abuse.
   Points of view or opinions contained within this document are those of
   the author and do not necessarily represent the official position or
   policies of the US Department of Justice, the Illinois Criminal Justice
   Information Authority, or the National Institute on Drug Abuse.
CR Andrews G, 2001, AUST NZ J PUBL HEAL, V25, P494, DOI 10.1111/j.1467-842X.2001.tb00310.x
   APA (American Psychiatric Association), 2002, DIAGN STAT MAN MENT
   Babudieri S, 2005, J MED VIROL, V76, P311, DOI 10.1002/jmv.20375
   Baillargeon J, 2004, PREV MED, V38, P607, DOI 10.1016/j.ypmed.2003.11.020
   Baillargeon JG, 2008, AIDS CARE, V20, P124, DOI 10.1080/09540120701426532
   Biemer Paul P., 2008, SAMPLING POPULATIONS, P489
   Binswanger IA, 2009, J EPIDEMIOL COMMUN H, V63, P912, DOI 10.1136/jech.2009.090662
   Binswanger IA, 2007, NEW ENGL J MED, V356, P157, DOI 10.1056/NEJMsa064115
   Binswanger IA, 2010, AM J PUBLIC HEALTH, V100, P476, DOI 10.2105/AJPH.2008.149591
   Callahan CM, 2002, MED CARE, V40, P771, DOI 10.1097/01.MLR.0000024610.33213.C8
   Cuddeback GS, 2010, PSYCHIAT SERV, V61, P45, DOI 10.1176/appi.ps.61.1.45
   Draine J, 2007, PSYCHIAT SERV, V58, P1577, DOI 10.1176/appi.ps.58.12.1577
   Druss BG, 2006, GEN HOSP PSYCHIAT, V28, P145, DOI 10.1016/j.genhosppsych.2005.10.006
   Fagiolini A, 2009, J CLIN PSYCHIAT, V70, P22, DOI 10.4088/JCP.7075su1c.04
   Fazel S, 2006, ADDICTION, V101, P181, DOI 10.1111/j.1360-0443.2006.01316.x
   Fazel S, 2002, LANCET, V359, P545, DOI 10.1016/S0140-6736(02)07740-1
   FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6
   GUNTER TD, 2008, J AM ACAD PSYCHIAT L, V36, P35
   Hennessey KA, 2009, J URBAN HEALTH, V86, P93, DOI 10.1007/s11524-008-9305-8
   Kessler RC, 2005, BIOL PSYCHIAT, V58, P668, DOI 10.1016/j.biopsych.2005.04.034
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168
   Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617
   Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593
   MARUSCHAK LM, 2006, US DOJ PUBLICATION N
   MARUSCHAK LM, 2009, US DOJ PUBLICATION N
   MURMOLA CJ, 2006, US DOJ PUBLICATION N
   MUTHEN LK, 2008, MPLUS COMP PROGR VER
   *NAT COMM CORR HLT, 2002, HLTH STAT SOON TO BE, V1
   Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396
   Restum ZG, 2005, AM J PUBLIC HEALTH, V95, P1689, DOI 10.2105/AJPH.2004.055053
   Roberts CA, 2006, AM J PREV MED, V30, P125, DOI 10.1016/j.amepre.2005.10.018
   Saitz R, 2005, ADDICTION, V100, P70, DOI 10.1111/j.1360-0443.2004.00916.x
   Sheehan DV, 1996, INT CLIN PSYCHOPHARM, V11, P89, DOI 10.1097/00004850-199606003-00015
   Smith KL, 2006, DRUG ALCOHOL DEPEN, V82, P231, DOI 10.1016/j.drugalcdep.2005.09.012
   SOBELL LC, 1992, MEASURING ALCOHOL CONSUMPTION, P41
   *SPSS INC, 2007, SPSS MAC COMP PROGR
   *STAT CORP, 2009, STAT MAC COMP PROGR
   Swartz J. A., 2010, STUDY COOCCURRING HL
   Teplin LA, 2005, ARCH GEN PSYCHIAT, V62, P911, DOI 10.1001/archpsyc.62.8.911
   Vogeli C, 2007, J GEN INTERN MED, V22, P391, DOI 10.1007/s11606-007-0322-1
   *WHO, 1990, INT CLASS DIS 10 CLA
   WITTCHEN HU, 1994, J PSYCHIAT RES, V28, P57, DOI 10.1016/0022-3956(94)90036-1
   2009, STAT ANAL SYSTEMS CO
NR 44
TC 8
Z9 8
U1 0
U2 12
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1099-3460
J9 J URBAN HEALTH
JI J. Urban Health
PD AUG
PY 2011
VL 88
IS 4
BP 700
EP 717
DI 10.1007/s11524-011-9554-9
PG 18
WC Public, Environmental & Occupational Health; Medicine, General &
   Internal
SC Public, Environmental & Occupational Health; General & Internal Medicine
GA 808XD
UT WOS:000294014400009
PM 21394659
OA Green Published
DA 2019-01-08
ER

PT J
AU Maslow, GR
   Haydon, A
   Mcree, AL
   Ford, CA
   Halpern, CT
AF Maslow, Gary R.
   Haydon, Abigail
   Mcree, Annie-Laurie
   Ford, Carol A.
   Halpern, Carolyn T.
TI Growing Up With a Chronic Illness: Social Success,
   Educational/Vocational Distress
SO JOURNAL OF ADOLESCENT HEALTH
LA English
DT Article
DE Young adult; Chronic illness; Transition to adulthood; Social outcomes;
   Educational outcomes; Vocational outcomes
ID CHILDHOOD-CANCER SURVIVOR; CHRONIC PHYSICAL ILLNESS;
   SICKLE-CELL-DISEASE; LONG-TERM SURVIVORS; ADULT SURVIVORS; FOLLOW-UP;
   LIFE; HEALTH; COHORT; TRANSITION
AB Objectives: We compared adult educational, vocational, and social outcomes among young adults with and without childhood-onset chronic illness in a nationally representative U. S. sample.
   Methods: We used data from Wave IV (2008) of the National Longitudinal Study of Adolescent Health. We compared respondents who reported childhood-onset cancer, heart disease, diabetes, or epilepsy with young adults without these chronic illnesses in terms of marriage, having children, living with parents, romantic relationship quality, educational attainment, income, and employment. Multivariate models controlled for sociodemographic factors and adult-onset chronic illness.
   Results: As compared with those without childhood chronic illness, respondents with childhood chronic illness had similar odds of marriage (odds ratios [OR] = .89, 95% CI: .65-1.24), having children (OR = .99, 95% CI: .70-1.42), and living with parents (OR = 1.49, 95% CI .94-2.33), and similar reports of romantic relationship quality. However, the chronic illness group had lower odds of graduating college (OR = .49, 95% CI: .31-.78) and being employed (OR = .56, 95% CI: .39-.80), and higher odds of receiving public assistance (OR = 2.13, 95% CI: 1.39-3.25), and lower mean income.
   Conclusions: Young adults growing up with chronic illness succeed socially, but are at increased risk of poorer educational and vocational outcomes. (C) 2011 Society for Adolescent Health and Medicine. All rights reserved.
C1 [Maslow, Gary R.] Univ N Carolina, Cecil B Sheps Ctr Hlth Serv Res, Div Hlth Affairs, Chapel Hill, NC 27599 USA.
   [Maslow, Gary R.] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA.
   [Haydon, Abigail; Mcree, Annie-Laurie; Ford, Carol A.; Halpern, Carolyn T.] UNC Gillings Sch Global Hlth, Dept Maternal & Child Hlth, Chapel Hill, NC USA.
   [Haydon, Abigail; Halpern, Carolyn T.] Univ N Carolina, Div Hlth Affairs, Carolina Populat Ctr, Chapel Hill, NC 27599 USA.
   [Ford, Carol A.] UNC Sch Med, Dept Pediat, Chapel Hill, NC USA.
RP Maslow, GR (reprint author), Univ N Carolina, Cecil B Sheps Ctr Hlth Serv Res, Div Hlth Affairs, 725 Martin Luther King Jr Blvd,CB 7590, Chapel Hill, NC 27599 USA.
EM gmaslow@unc.edu
RI McRee, Annie/J-3077-2013
FU Eunice Kennedy Shriver National Institute of Child Health and Human
   Development [P01-HD31921, R01-HD57046]
FX This research used data from Add Health, a program project directed by
   Kathleen Mullan Harris and designed by J. Richard Udry, Peter S.
   Bearman, and Kathleen Mullan Harris at the University of North Carolina
   at Chapel Hill, and funded by grant P01-HD31921 from the Eunice Kennedy
   Shriver National Institute of Child Health and Human Development, with
   cooperative funding from 23 other federal agencies and foundations.
   Special acknowledgment is due to Ronald R. Rindfuss and Barbara Entwisle
   for assistance in the original design. Information on how to obtain the
   Add Health data files is available on the Add Health Web site
   (http://www.cpc.unc.edu/addhealth). No direct support was received from
   grant P01-HD31921 for this analysis.; Training support for Gary Maslow,
   M. D. provided by T32HP14001 from the Health Resources and Services
   Administration for University of North Carolina's National Research
   Service Administration Primary Care Research Fellowship. Effort by A.
   Haydon and C. T. Halpern was supported by Eunice Kennedy Shriver
   National Institute of Child Health and Human Development grant
   R01-HD57046; C. T. Halpern, Principal Investigator. Thanks to the
   National Research Service Administration Primary Care Research Fellows
   for careful review of this manuscript.
CR Boman KK, 2010, CANCER-AM CANCER SOC, V116, P1385, DOI 10.1002/cncr.24840
   Bussing R, 1996, ARCH PEDIAT ADOL MED, V150, P181, DOI 10.1001/archpedi.1996.02170270063009
   Camfield CS, 2007, EPILEPSIA, V48, P3, DOI 10.1111/j.1528-1167.2007.01390.x
   Canadian Paediatric Society, 2006, PAEDIAT CHILD HLTH, V11, P43
   Ellenberg L, 2009, NEUROPSYCHOLOGY, V23, P705, DOI 10.1037/a0016674
   Gerhardt CA, 2007, J ADOLESC HLTH, V40
   Gledhill J, 2000, ARCH DIS CHILD, V83, P104, DOI 10.1136/adc.83.2.104
   GORTMAKER SL, 1984, PEDIATR CLIN N AM, V31, P3
   GORTMAKER SL, 1993, J RES ADOLESCENCE, V0003
   Gurney JG, 2009, J CLIN ONCOL, V27, P2390, DOI 10.1200/JCO.2008.21.1458
   Harris K. M., 2009, NATL LONGITUDINAL ST
   Hartung PJ, 2005, J VOCAT BEHAV, V66, P385, DOI 10.1016/j.jvb.2004.05.006
   Huurre TM, 2002, EUR CHILD ADOLES PSY, V11, P85, DOI 10.1007/s007870200015
   Jacobson AM, 1997, DIABETIC MED, V14, P73, DOI 10.1002/(SICI)1096-9136(199701)14:1<73::AID-DIA294>3.0.CO;2-Q
   KOKKONEN J, 1995, EUR J PEDIATR, V154, P676, DOI 10.1007/BF02079077
   La Greca AM, 2002, J DEV BEHAV PEDIATR, V23, DOI 10.1097/00004703-200208000-00013
   Lancashire ER, 2010, J NATL CANCER I, V102, P254, DOI 10.1093/jnci/djp498
   Lipkin PH, 2007, PEDIATRICS, V119, P1218, DOI 10.1542/peds.2007-0885
   Madan-Swain A, 2004, HANDBOOK OF PEDIATRIC PSYCHOLOGY IN SCHOOL SETTINGS, P637
   McDonald S, 2007, SOC SCI RES, V36, P1328, DOI 10.1016/j.ssresearch.2007.01.008
   Miauton L, 2003, EUR J PEDIATR, V162, P682, DOI 10.1007/s00431-003-1179-x
   Mitby PA, 2003, CANCER, V97, P1115, DOI 10.1002/cncr.11117
   Noll RB, 2010, PEDIATRICS, V125, pE1453, DOI 10.1542/peds.2009-2996
   Pang JWY, 2008, PEDIATR BLOOD CANCER, V50, P104, DOI 10.1002/pbc.21226
   PERRIN EC, 1993, PEDIATRICS, V91, P787
   PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303
   PLESS IB, 1989, DEV MED CHILD NEUROL, V31, P746
   PLESS IB, 1971, PEDIATRICS, V47, P405
   Quinn CT, 2004, BLOOD, V103, P4023, DOI 10.1182/blood-2003-11-3758
   Reiss J, 2002, PEDIATRICS, V110, P1307
   Roberts M. C., 2009, HDB PEDIAT PSYCHOL, P689
   Shandra CL, 2008, J VOCAT REHABIL, V29, P117
   Stam H, 2006, J ADOLESCENT HEALTH, V39, P4, DOI 10.1016/j.jadohealth.2005.03.011
   STEIN REK, 1982, PUBLIC HEALTH REP, V97, P354
   Thompson AL, 2009, PSYCHO-ONCOL, V18, P767, DOI 10.1002/pon.1471
   Wakamoto H, 2000, BRAIN DEV-JPN, V22, P246, DOI 10.1016/S0387-7604(00)00121-2
   Wittenburg D. C., 2002, J VOCATIONAL REHABIL, V17, P195
   1990, PEDIATRICS, V86, P636
NR 38
TC 79
Z9 79
U1 0
U2 25
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1054-139X
J9 J ADOLESCENT HEALTH
JI J. Adolesc. Health
PD AUG
PY 2011
VL 49
IS 2
BP 206
EP 212
DI 10.1016/j.jadohealth.2010.12.001
PG 7
WC Psychology, Developmental; Public, Environmental & Occupational Health;
   Pediatrics
SC Psychology; Public, Environmental & Occupational Health; Pediatrics
GA 795TB
UT WOS:000292997600016
PM 21783055
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Wu, FL
   Juang, JH
   Yeh, MC
AF Wu, Fei-Ling
   Juang, Jyuhn-Huarng
   Yeh, Mei Chang
TI The dilemma of diabetic patients living with hypoglycaemia
SO JOURNAL OF CLINICAL NURSING
LA English
DT Article
DE diabetes mellitus; hypoglycaemia; nurses; nursing; psychosocial factors;
   self-management
ID COMPLICATIONS; EXPERIENCES; ADOLESCENT; MELLITUS; WOMEN
AB Aims. To examine the impact of the threat of hypoglycaemic episodes on people with diabetes in Taiwan.
   Background. Intensive diabetes treatment in people with diabetes helps them to achieve better glycaemic control. However, it also causes more frequent hypoglycaemic episodes and has an impact on their overall quality of life. Hypoglycaemia is accompanied by various distressing symptoms which may cause excessive fear, affecting decision making in hypoglycaemic management.
   Design. Purposive sampling and in-depth, face-to-face interviews were used to collect data.
   Methods. Semi-structured interviews were conducted from July 2008-January 2009 with 17 individuals treated with insulin who had previous hypoglycaemic episodes. Data were analysed using qualitative content analysis.
   Results. Four themes were generated from the analysis, 'inability to control fluctuations in health', challenges to interpersonal relationships', 'facing the disease alone' and 'finding a balance between competing symptoms'.
   Conclusions. Hypoglycaemia is a major health issue for many people with diabetes. Understanding individuals' experiences with hypoglycaemic episodes should help practitioners become more fully involved in promoting self-management. We identified key areas that health care providers should address, including concerns about patient education and professional support for people with diabetes experiencing hypoglycaemia, to enhance problem solving skills for them and their families.
   Relevance to clinical practice. We recommend that health care providers make proper use of support groups for family caregivers or other important individuals in the lives of people with diabetes to provide education, clarification, support and guidance. In addition, health care providers also need to provide clients with hypoglycaemia-related emotional support, while enhancing diabetes self-management and problem-solving skills.
C1 [Wu, Fei-Ling] Natl Taiwan Univ, Dept Nursing, Coll Med, Taipei 100, Taiwan.
   [Wu, Fei-Ling] Chang Gung Inst Technol, Dept Nursing, Tao Yuan, Taiwan.
   [Juang, Jyuhn-Huarng] Chang Gung Univ, Tao Yuan, Taiwan.
   [Juang, Jyuhn-Huarng] Chang Gung Mem Hosp, Tao Yuan, Taiwan.
   [Yeh, Mei Chang] Natl Taiwan Univ Hosp, Dept Nursing, Taipei, Taiwan.
RP Yeh, MC (reprint author), Natl Taiwan Univ, Dept Nursing, Coll Med, 1 Jen Ai Rd,Sec 1, Taipei 100, Taiwan.
EM mchang@ntu.edu.tw
OI CHANG, MEI/0000-0002-4166-3498
CR Aalto AM, 2000, EUR J PUBLIC HEALTH, V10, P68, DOI 10.1093/eurpub/10.1.68
   CHAN JCN, 1996, HONG KONG PRACTITION, V18, P270
   *CHIN TAIW DIAB AS, 2006, 2006 TYP 2 DIAB CAR
   Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278
   COX DJ, 1992, J CONSULT CLIN PSYCH, V60, P628, DOI 10.1037//0022-006X.60.4.628
   *DEP HLTH EX YUAN, 2003, INTR TAIW TEL PIL PR
   *DIAB CONTR COMPL, 1993, NEW ENGL J MED, V329, P977, DOI DOI 10.1056/NEJM199309303291401
   Dickinson JK, 2004, DIABETES EDUCATOR, V30, P99, DOI 10.1177/014572170403000117
   Dovey-Pearce G, 2007, BRIT J HEALTH PSYCH, V12, P75, DOI 10.1348/135910706X98317
   Freidson E., 1970, PROFESSION MED
   GONDERFREDERICK LA, 2003, PRACTICAL PSYCHOL DI, P113
   Kay C, 2009, J HEALTH PSYCHOL, V14, P242, DOI 10.1177/1359105308100208
   Lincoln Y. S., 1985, NATURALISTIC ENQUIRY
   Luttik Marie Louise, 2005, J Cardiovasc Nurs, V20, P162
   MacLean LM, 2004, QUAL HEALTH RES, V14, P113, DOI 10.1177/1049732303259804
   Miles M., 1994, QUALITATIVE DATA ANA
   Penckofer S, 2007, DIABETES EDUCATOR, V33, P680, DOI 10.1177/0145721707304079
   POLONSKY W, 2006, DIABETES FORECAST, V59, P9
   Pouwer F, 2006, PATIENT EDUC COUNS, V60, P235, DOI 10.1016/j.pec.2005.01.009
   Richmond J, 1996, Br J Nurs, V5, P1054
   Ritholz MD, 1998, J GEN INTERN MED, V13, P799, DOI 10.1046/j.1525-1497.1998.00243.x
   Samuel-Hodge CD, 2000, DIABETES CARE, V23, P928, DOI 10.2337/diacare.23.7.928
   Shiu ATY, 2002, J ADV NURS, V39, P155
   UKPDS Study Group, 1998, LANCET, V352, P837, DOI DOI 10.1016/S0140-6736(98)07019-6
   Weber RP, 1990, BASIC CONTENT ANAL
   Wen LK, 2004, DIABETES EDUCATOR, V30, P980, DOI 10.1177/014572170403000619
   Zoffmann V, 2006, PATIENT EDUC COUNS, V64, P78, DOI 10.1016/j.pec.2005.11.017
NR 27
TC 8
Z9 8
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0962-1067
EI 1365-2702
J9 J CLIN NURS
JI J. Clin. Nurs.
PD AUG
PY 2011
VL 20
IS 15-16
BP 2277
EP 2285
DI 10.1111/j.1365-2702.2011.03725.x
PG 9
WC Nursing
SC Nursing
GA 792LB
UT WOS:000292744900018
PM 21627701
DA 2019-01-08
ER

PT J
AU Collins, RE
   Lopez, LM
   Marteau, TM
AF Collins, Ruth E.
   Lopez, Laureen M.
   Marteau, Theresa M.
TI Emotional impact of screening: a systematic review and meta-analysis
SO BMC PUBLIC HEALTH
LA English
DT Article
ID RANDOMIZED CONTROLLED-TRIAL; QUALITY-OF-LIFE; SMOKING-CESSATION
   TREATMENT; ABDOMINAL AORTIC-ANEURYSM; CERVICAL SMEAR TEST; PSYCHOLOGICAL
   IMPACT; BREAST-CANCER; GENETIC SUSCEPTIBILITY; GENERAL-PRACTICE;
   FOLLOW-UP
AB Background: There is a widely held expectation that screening for disease has adverse emotional impacts. The aim of the current review is to estimate the short (< 4 weeks) and longer term (> 4 weeks) emotional impact of such screening.
   Methods: Studies selected for inclusion were (a) randomised controlled trials in which (b) participants in one arm underwent screening and received test results, and those in a control arm did not, and (c) emotional outcomes were assessed in both arms. MEDLINE via PubMed (1950 to present), EMBASE (1980 to present), PsycINFO (1985 to present) using OVID SP, and CINAHL (1982 to present) via EBSCO were searched, using strategies developed with keywords and medical subject headings. Data were extracted on emotional outcomes, type of screening test and test results.
   Results: Of the 12 studies that met the inclusion criteria, six involved screening for cancer, two for diabetes, and one each for abdominal aortic aneurysms, peptic ulcer, coronary heart disease and osteoporosis. Five studies reported data on anxiety, four on depression, two on general distress and eight on quality of life assessed between one week and 13 years after screening (median = 1.3 years). Meta-analyses revealed no significant impact of screening on longer term anxiety (pooled SMD 0.01, 95% CI -0.10, 0.11), depression (pooled SMD -0.04, 95% CI -12, 0.20), or quality of life subscales (mental and self-assessed health pooled SMDs, respectively: 0.03; -0.01, 95% CI -02, 0.04; 0.00, 95% CI -04, 0.03).
   Conclusion: Screening does not appear to have adverse emotional impacts in the longer term (> 4 weeks). Too few studies assessed outcomes before four weeks to comment on the shorter term emotional impact of screening.
C1 [Collins, Ruth E.; Marteau, Theresa M.] Kings Coll London, Hlth Psychol Sect, Dept Psychol Guys, London SE1 9RT, England.
   [Lopez, Laureen M.] Clin Sci FHI, Res Triangle Pk, NC 27709 USA.
RP Marteau, TM (reprint author), Kings Coll London, Hlth Psychol Sect, Dept Psychol Guys, 5th Floor Bermondsey Wing,Guys Campus, London SE1 9RT, England.
EM theresa.marteau@kcl.ac.uk
RI Collins, Ruth/A-2276-2013
OI Marteau, Theresa/0000-0003-3025-1129
FU NHS; Medical Research Council [G0500274]
FX This review was conducted as part of a grant from the NHS Heath
   Technology Assessment Program (03/38 Investigations following abnormal
   liver function tests). We would like to express our gratitude to
   Professors McBride, Whynes and Christensen who kindly supplied data for
   the analysis in this review and to those who also searched but were
   unable to find raw data sets often from many years ago. We are also
   grateful both to Professor Roger Jones, Dr Alison Wright and Dr Rachel
   Crockett who commented on earlier drafts of the manuscript.
CR Andersen MR, 2007, PSYCHO-ONCOLOGY, V16, P814, DOI 10.1002/pon.1151
   Antoni MH, 2001, HEALTH PSYCHOL, V20, P20, DOI 10.1037//0278-6133.20.1.20
   Ashton HA, 2002, LANCET, V360, P1531, DOI 10.1016/S0140-6736(02)11522-4
   Audrain J, 1997, ADDICT BEHAV, V22, P741, DOI 10.1016/S0306-4603(97)00060-9
   Brett J, 2005, PSYCHO-ONCOLOGY, V14, P917, DOI 10.1002/pon.904
   Broadstock M, 2000, EUR J HUM GENET, V8, P731, DOI 10.1038/sj.ejhg.5200532
   Butow PN, 2003, MED J AUSTRALIA, V178, P77
   Carver C. S, 1999, SELF SOCIAL PSYCHOL, P299
   Christensen B, 2004, EUR J CARDIOV PREV R, V11, P239, DOI 10.1097/01.hjr.0000129739.30593.23
   Cockburn J, 1994, J Med Screen, V1, P7
   Eborall HC, 2007, BRIT MED J, V335, P486, DOI 10.1136/bmj.39303.723449.55
   Eich E, 2000, COGNITION EMOTION CO
   FALLOWFIELD LJ, 1990, J ROY SOC MED, V83, P547
   French DP, 2006, PSYCHO-ONCOL, V15, P498, DOI 10.1002/pon.980
   Goldberg D., 1978, MANUAL GEN HLTH QUES
   Hansen JM, 2008, AM J GASTROENTEROL, V103, P1106, DOI 10.1111/j.1572-0241.2007.01770.x
   HAYNES RB, 1978, NEW ENGL J MED, V299, P741, DOI 10.1056/NEJM197810052991403
   Heshka JT, 2008, GENET MED, V10, P19, DOI 10.1097/GIM.0b013e31815f524f
   Higgins J, 2008, COCHRANE HDB SYSTEMA
   Holland WW, 1990, SCREENING HLTH CARE
   HUNT SM, 1981, SOC SCI MED-MED SOC, V15, P221, DOI 10.1016/0271-7123(81)90005-5
   Johnson James N, 2008, BMJ, V336, P863, DOI 10.1136/bmj.39514.494167.AD
   Kane RA, 2009, NEW ENGL J MED, V361, P298, DOI 10.1056/NEJMe0903449
   KASH KM, 1992, J NATL CANCER I, V84, P24, DOI 10.1093/jnci/84.1.24
   Lerman C, 1997, HEALTH PSYCHOL, V16, P87, DOI 10.1037//0278-6133.16.1.87
   LERMAN C, 1993, BREAST CANCER RES TR, V28, P145, DOI 10.1007/BF00666427
   Lindholt JS, 2000, EUR J VASC ENDOVASC, V20, P79, DOI 10.1053/ejvs.1999.1087
   McBride CM, 2002, CANCER EPIDEM BIOMAR, V11, P521
   Meiser B, 2005, PSYCHO-ONCOL, V14, P1060, DOI 10.1002/pon.933
   Michie S, 1996, BRIT J HEALTH PSYCH, V1, P3, DOI 10.1111/j.2044-8287.1996.tb00487.x
   Park P, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-350
   PARKER MA, 2002, J MED SCREEN, P7
   PERRY S, 1991, ARCH GEN PSYCHIAT, V48, P143
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Rogstad KE, 2002, BJOG-INT J OBSTET GY, V109, P364, DOI 10.1111/j.1471-0528.2002.99023.x
   RUDD P, 1987, HYPERTENSION, V10, P425, DOI 10.1161/01.HYP.10.4.425
   Sanderson SC, 2008, J HEALTH PSYCHOL, V13, P481, DOI 10.1177/1359105308088519
   Shaw C, 1999, SOC SCI MED, V49, P1571, DOI 10.1016/S0277-9536(99)00244-0
   Spielberger C. D., 1970, STAI MANUAL STATE TR
   STEWART DE, 1993, OBSTET GYNECOL, V81, P280
   Taylor KL, 2004, JNCI-J NATL CANCER I, V96, P1083, DOI 10.1093/jnci/djh194
   Tercyak KP, 2001, HEALTH PSYCHOL, V20, P217, DOI 10.1037/0278-6133.20.3.217
   Timman R, 2004, HEALTH PSYCHOL, V23, P189, DOI 10.1037/0278-6133.23.2.189
   Torgerson DJ, 1997, ARCH INTERN MED, V157, P2121, DOI 10.1001/archinte.157.18.2121
   Wardle J, 1999, BRIT MED J, V319, P1037, DOI 10.1136/bmj.319.7216.1037
   WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002
   WHYNES DK, 1994, QUAL LIFE RES, V3, P191, DOI 10.1007/BF00435384
   WILKINSON C, 1990, BRIT MED J, V300, P440, DOI 10.1136/bmj.300.6722.440
   WILSON JMG, 1971, P ROY SOC MED, V64, P1255
   Yerkes RM, 1908, J COMP NEUROL PSYCHO, V18, P459, DOI 10.1002/cne.920180503
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
NR 51
TC 19
Z9 20
U1 0
U2 13
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD JUL 28
PY 2011
VL 11
AR 603
DI 10.1186/1471-2458-11-603
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 826TT
UT WOS:000295378400001
PM 21798046
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Sabourin, BC
   Vallis, TM
   Currie, S
AF Sabourin, Brigitte C.
   Vallis, T. Michael
   Currie, Shannon
TI Development and Pilot-Testing of a Brief Psychosocial Group Intervention
   Protocol for Type 2 Diabetes Self-Management
SO CANADIAN JOURNAL OF DIABETES
LA English
DT Article
DE brief intervention; group intervention; knowledge translation;
   psychosocial; self-management; type 2 diabetes
ID QUALITY-OF-LIFE; DISTRESS; MELLITUS; ADULTS; SCALE; DEPRESSION;
   AGREEMENT; SCIENCE; CALL; CARE
AB OBJECTIVES: To develop a brief psychosocial intervention protocol for type 2 diabetes self-management and pilot-test its implementation.
   METHODS: A 6-session evidence-based psychosocial intervention protocol was developed focusing on the role of behaviour modification, maintenance of motivation and emotion management in type 2 diabetes self-management. The intervention was pilot-tested with 15 individuals with type 2 diabetes recruited from participants in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) study.
   RESULTS: Repeated-measures analyses of variance of validated psychosocial and behavioural outcome measures revealed that following the intervention, diabetes-related distress and intake of high-fat foods decreased and exercise participation increased. Furthermore, all participants found the intervention to be helpful for diabetes management. The most helpful aspect of the group sessions, derived from inductive classical content analysis of open-ended feedback questionnaires, was the development of friendship and trust in openly sharing experiences with group members.
   CONCLUSION: This promising intervention should be further tested using a randomized, controlled trial. The protocol could then be developed as a training manual so that other university-educated professionals could deliver the intervention to people with diabetes, helping to fulfill 1 of the Canadian Diabetes Association's clinical guidelines: providing psychosocial interventions as part of diabetes care.
C1 [Sabourin, Brigitte C.] Dalhousie Univ, Dept Psychol, Halifax, NS B3H 4J1, Canada.
   [Vallis, T. Michael] Dalhousie Univ, QEII Diabet Management Ctr, Halifax, NS B3H 4J1, Canada.
   [Currie, Shannon] Schneider & Associates Psychol Serv, Hamilton, ON, Canada.
   [Currie, Shannon] Burlington Psychol & Counselling Serv, Burlington, ON, Canada.
RP Sabourin, BC (reprint author), Dalhousie Univ, Dept Psychol, 1355 Oxford St, Halifax, NS B3H 4J1, Canada.
EM brigitte.sabourin@dal.ca
OI Sabourin, Brigitte/0000-0001-7600-9974
FU Canadian Institutes of Health Research; Nova Scotia Health Research
   Foundation
FX BS is supported by a doctoral fellowship from the Canadian Institutes of
   Health Research and was supported through a doctoral-level scholarship
   from the Nova Scotia Health Research Foundation for part of the study.
CR ACCORD STUD GRO, 2007, AM J CARDIOL, V99, P21
   Beck J. S., 1995, COGNITIVE THERAPY BA
   Canadian Diabetes Association Clinical Practice Guidelines Committee: Canadian, 2008, CAN J DIABETES S1, V32, pS1, DOI DOI 10.1503/CMAJ.080554
   COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104
   CRAIG TJ, 1978, AM J PSYCHIAT, V135, P1036
   Deakin T, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003417.pub2
   DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13
   El Achhab Y, 2008, DIABETES RES CLIN PR, V80, P171, DOI 10.1016/j.diabres.2007.12.020
   Elliott TR, 2001, J CLIN PSYCHOL MED S, V8, P283, DOI 10.1023/A:1011920914079
   Field A., 2009, DISCOVERING STAT USI
   Fisher L, 2007, DIABETES CARE, V30, P2746, DOI 10.2337/dc07-1166
   Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743
   Glasgow RE, 1999, DIABETES CARE, V22, P832, DOI 10.2337/diacare.22.5.832
   Glasgow RE, 2006, CHRONIC ILLN, V2, P27, DOI 10.1179/174592006X93851
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Leech NL, 2007, SCHOOL PSYCHOL QUART, V22, P557, DOI 10.1037/1045-3830.22.4.557
   LUSTMAN PJ, 1992, DIABETES CARE, V15, P1631, DOI 10.2337/diacare.15.11.1631
   Marcus BH, 2000, HEALTH PSYCHOL, V19, P32, DOI 10.1037/0278-6133.19.Suppl1.32
   Marlatt G. A., 2005, RELAPSE PREVENTION M
   Miller W. R., 2002, MOTIVATIONAL INTERVI
   Nelson KM, 2002, DIABETES CARE, V25, P1722, DOI 10.2337/diacare.25.10.1722
   Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561
   PAVOT W, 1993, PSYCHOL ASSESSMENT, V5, P164, DOI DOI 10.1037/1040-3590.5.2.164
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Prochaska J. O., 2008, HLTH BEHAV HLTH ED T, V4, P97
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Rickheim PL, 2002, DIABETES CARE, V25, P269, DOI 10.2337/diacare.25.2.269
   Ruggiero LP, 1993, DIABETES SPECTRUM, V6, P22
   Sultan S, 2001, J HEALTH PSYCHOL, V6, P731, DOI 10.1177/135910530100600616
   SURWIT RS, 1992, DIABETES CARE, V15, P1413, DOI 10.2337/diacare.15.10.1413
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Vallis TM, 2001, CAN J DIABETES, V25, P31
   WIETKIEWITZ K, 2007, THERAPISTS GUIDE EVI, P3
   Zhang XP, 2007, MED CARE, V45, P820, DOI 10.1097/MLR.0b013e3180618b55
NR 35
TC 3
Z9 4
U1 0
U2 7
PU CANADIAN DIABETES ASSOC
PI TORONTO
PA 1400-522 UNIVERSITY AVE, TORONTO, ONTARIO M5G 2R5, CANADA
SN 1499-2671
J9 CAN J DIABETES
JI Can. J. Diabetes
PD JUL
PY 2011
VL 35
IS 3
BP 287
EP 294
DI 10.1016/S1499-2671(11)53013-8
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 836AX
UT WOS:000296079800012
DA 2019-01-08
ER

PT J
AU Paradise, MB
   Glozier, NS
   Naismith, SL
   Davenport, TA
   Hickie, IB
AF Paradise, Matt B.
   Glozier, Nick S.
   Naismith, Sharon L.
   Davenport, Tracey A.
   Hickie, Ian B.
TI Subjective memory complaints, vascular risk factors and psychological
   distress in the middle-aged: a cross-sectional study
SO BMC PSYCHIATRY
LA English
DT Article
ID MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; SUBCORTICAL
   HYPERINTENSITIES; SEVERE DEPRESSION; APOE GENOTYPE; OLDER-PEOPLE;
   DEMENTIA; POPULATION; DISABILITY; DISORDERS
AB Background: Subjective memory complaints (SMC) are common but their significance is still unclear. It has been suggested they are a precursor of mild cognitive impairment (MCI) or dementia and an early indicator of cognitive decline. Vascular risk factors have an important role in the development of dementia and possibly MCI. We therefore aimed to test the hypothesis that vascular risk factors were associated with SMC, independent of psychological distress, in a middle-aged community-dwelling population.
   Methods: A cross-sectional analysis of baseline data from the 45 and Up Study was performed. This is a cohort study of people living in New South Wales (Australia), and we explored the sample of 45, 532 participants aged between 45 and 64 years. SMC were defined as 'fair' or 'poor' on a self-reported five-point Likert scale of memory function. Vascular risk factors of obesity, diabetes, hypertension, hypercholesterolemia and smoking were identified by self- report. Psychological distress was measured by the Kessler Psychological Distress Scale. We tested the model generated from a randomly selected exploratory sample (n = 22, 766) with a confirmatory sample of equal size.
   Results: 5, 479/45, 532 (12%) of respondents reported SMC. Using multivariate logistic regression, only two vascular risk factors: smoking (OR 1.18; 95% CI = 1.03 - 1.35) and hypercholesterolaemia (OR 1.19; 95% CI = 1.04 - 1.36) showed a small independent association with SMC. In contrast psychological distress was strongly associated with SMC. Those with the highest levels of psychological distress were 7.00 (95% CI = 5.41 - 9.07) times more likely to have SMC than the non-distressed. The confirmatory sample also demonstrated the strong association of SMC with psychological distress rather than vascular risk factors.
   Conclusions: In a large sample of middle-aged people without any history of major affective illness or stroke, psychological distress was strongly, and vascular risk factors only weakly, associated with SMC, although we cannot discount psychological distress acting as a mediator in any association between vascular risk factors and SMC. Given this, clinicians should be vigilant regarding the presence of an affective illness when assessing middle-aged patients presenting with memory problems.
C1 [Paradise, Matt B.; Glozier, Nick S.; Naismith, Sharon L.; Hickie, Ian B.] Univ Sydney, Brain & Mind Res Inst, Camperdown, NSW 2050, Australia.
   [Davenport, Tracey A.] Acad Res & Stat Consulting, W Ryde, NSW 2114, Australia.
RP Paradise, MB (reprint author), Univ Sydney, Brain & Mind Res Inst, Bldg F,94 Mallet St, Camperdown, NSW 2050, Australia.
EM matthew.paradise@sydney.edu.au
OI Glozier, Nick/0000-0002-0476-9146; Naismith, Sharon/0000-0001-9076-2778;
   Paradise, Matthew/0000-0003-4002-9599
FU NHMRC Australia
FX Dr Paradise, A/Prof Naismith and Prof Hickie and are funded by an NHMRC
   Australia Fellowship awarded to Prof Hickie.
CR *ABS HLTH SURV, 2001, 4817055001 ABS HLTH
   Alexopoulos GS, 1997, ARCH GEN PSYCHIAT, V54, P915
   Andrews G, 2001, AUST NZ J PUBL HEAL, V25, P494, DOI 10.1111/j.1467-842X.2001.tb00310.x
   Banks E, 2008, INT J EPIDEMIOL, V37, P941, DOI 10.1093/ije/dym184
   CHAO LL, 2008, NEUROBIOL AGING, V31, P368
   Minett TSC, 2008, INT J GERIATR PSYCH, V23, P49, DOI 10.1002/gps.1836
   de la Torre JC, 2004, LANCET NEUROL, V3, P184, DOI 10.1016/S1474-4422(04)00683-0
   Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013
   Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0
   Ganguli M, 2004, NEUROLOGY, V63, P115, DOI 10.1212/01.WNL.0000132523.27540.81
   Geerlings MI, 1999, AM J PSYCHIAT, V156, P531
   Gorelick PB, 2004, STROKE, V35, P2620, DOI 10.1161/01.STR.000143318.70292.47
   HANNINEN T, 1994, J AM GERIATR SOC, V42, P1
   Hickie I, 1998, PSYCHOL MED, V28, P1007, DOI 10.1017/S0033291797006090
   Hickie I, 2005, BRIT J PSYCHIAT, V186, P197, DOI 10.1192/bjp.186.3.197
   Hickie I, 1997, BIOL PSYCHIAT, V42, P367, DOI 10.1016/S0006-3223(96)00363-0
   HICKIE I, 1995, BIOL PSYCHIAT, V37, P151, DOI 10.1016/0006-3223(94)00174-2
   Hickie I.B., 2001, MED J AUSTRALIA, V175, P16
   JESSEN F, ARCH GEN PSYCHIAT, V67, P414
   Jonker C, 2000, INT J GERIATR PSYCH, V15, P983, DOI 10.1002/1099-1166(200011)15:11<983::AID-GPS238>3.0.CO;2-5
   Jorm AF, 2004, PSYCHOL MED, V34, P1495, DOI 10.1017/S0033291704003162
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Kivipelto M, 2001, NEUROLOGY, V56, P1683, DOI 10.1212/WNL.56.12.1683
   Larrabee G J, 1994, Int Psychogeriatr, V6, P95, DOI 10.1017/S1041610294001663
   Luchsinger JA, 2005, NEUROLOGY, V65, P545, DOI 10.1212/01.wnl.0000172914.08967.dc
   Mariani E, 2007, DEMENT GERIATR COGN, V24, P448, DOI 10.1159/000110653
   MEALING NM, BMC MED RES METHODOL, V10, P26
   Minett TSC, 2005, AM J GERIAT PSYCHIAT, V13, P665, DOI 10.1176/appi.ajgp.13.8.665
   Modrego PJ, 2004, ARCH NEUROL-CHICAGO, V61, P1290, DOI 10.1001/archneur.61.8.1290
   Naismith SL, 2009, EARLY INTERV PSYCHIA, V3, P19, DOI 10.1111/j.1751-7893.2008.00102.x
   Naismith SL, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-32
   Naismith SL, 2003, J CLIN EXP NEUROPSYC, V25, P866, DOI 10.1076/jcen.25.6.866.16472
   NAISMITH SL, 2001, MED J AUSTRALIA, V175, P16
   Ownby RL, 2006, ARCH GEN PSYCHIAT, V63, P530, DOI 10.1001/archpsyc.63.5.530
   Purser JL, 2006, J AM GERIATR SOC, V54, P335, DOI 10.1111/j.1532-5415.2005.00589.x
   Ravaglia G, 2006, DEMENT GERIATR COGN, V21, P51, DOI 10.1159/000089515
   Reid LM, 2006, DEMENT GERIATR COGN, V22, P471, DOI 10.1159/000096295
   Reisberg B, 2008, ALZHEIMERS DEMENT, V4, pS98, DOI 10.1016/j.jalz.2007.11.017
   Saykin AJ, 2006, NEUROLOGY, V67, P834, DOI 10.1212/01.wnl.0000234032.77541.a2
   Solfrizzi V, 2004, NEUROLOGY, V63, P1882, DOI 10.1212/01.WNL.0000144281.38555.E3
   Stewart R, 2001, PSYCHOL MED, V31, P431
   TOBIANSKY R, 1995, PSYCHOL MED, V25, P779, DOI 10.1017/S0033291700035029
   World Health Organization, 2000, TECHN REP SER WHO
NR 43
TC 46
Z9 48
U1 5
U2 16
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-244X
J9 BMC PSYCHIATRY
JI BMC Psychiatry
PD JUL 1
PY 2011
VL 11
AR 108
DI 10.1186/1471-244X-11-108
PG 7
WC Psychiatry
SC Psychiatry
GA 803OI
UT WOS:000293590200001
PM 21722382
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Pengpid, S
   Peltzer, K
   Van der Heever, H
AF Pengpid, Supa
   Peltzer, Karl
   Van der Heever, Hendry
TI Prevalence of Alcohol Use and Associated Factors in Urban Hospital
   Outpatients in South Africa
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE alcohol misuse; tobacco use; associated factors; hospital out-patients;
   South Africa
ID IDENTIFICATION TEST AUDIT; PRIMARY-CARE; USE DISORDERS; ANXIETY
   DISORDERS; PROBLEM DRINKING; PSYCHOLOGICAL DISTRESS; COLLABORATIVE
   PROJECT; BRIEF INTERVENTION; SUBSTANCE USE; CONSUMPTION
AB The aim of this study was to assess the prevalence of alcohol use and associated factors among outpatients in an urban hospital in South Africa. The sample included 1,532 (56.4% men and women 43.6%) consecutively selected patients from different hospital outpatient departments. Results indicate that 41.2% of men and 18.3% of women were found to be hazardous drinkers, and 3.6% of men and 1.4% of women meet criteria for probable alcohol dependence or harmful drinking as defined by the Alcohol Use Disorder Identification Test (AUDIT). Two in five patients (40.5%) were hazardous or harmful drinkers and/or had anxiety or depression. Logistic multiple regression found that for men tobacco use and not having been diagnosed with diabetes and for women tobacco use and having been diagnosed with migraine headache was associated with hazardous and harmful drinking. Although the study is cross-sectional, it does identify groups that may be at high risk of alcohol misuse and for whom intervention is urgent. Because prevalence of hazardous and harmful alcohol use is high in this population, routine screening should be introduced in hospital out-patient settings.
C1 [Pengpid, Supa; Van der Heever, Hendry] Univ Limpopo, Dept Hlth Syst Management & Policy, ZA-0204 Pretoria, South Africa.
   [Peltzer, Karl] Human Sci Res Council, HIV AIDS SIT & TB HAST, ZA-0002 Pretoria, South Africa.
   [Peltzer, Karl] Univ Limpopo, Dept Psychol, ZA-0727 Sovenga, Limpopo, South Africa.
RP Pengpid, S (reprint author), Univ Limpopo, Dept Hlth Syst Management & Policy, Ga Rankuwa Campus, ZA-0204 Pretoria, South Africa.
EM Supa_Pengpid@embanet.com; Kpeltzer@hsrc.ac.za; Hendry_Heever@embanet.com
OI van der Heever, Hendry/0000-0002-2217-6504
FU University of Limpopo; FLIR-UOS
FX We thank FLIR-UOS under program collaboration with the University of
   Limpopo (Project 7) for funding the study.
CR Abiodun OA, 1996, ACTA PSYCHIAT SCAND, V93, P235, DOI 10.1111/j.1600-0447.1996.tb10640.x
   Allen JP, 1997, ALCOHOL CLIN EXP RES, V21, P613, DOI 10.1111/j.1530-0277.1997.tb03811.x
   Andrews G, 2001, AUST NZ J PUBL HEAL, V25, P494, DOI 10.1111/j.1467-842X.2001.tb00310.x
   Arch JJ, 2006, GEN HOSP PSYCHIAT, V28, P37, DOI 10.1016/j.genhosppsych.2005.08.007
   Babor TF, 2001, BRIEF INTERVENTION H
   Babor TF, 2001, AUDIT ALCOHOL USE DI
   Bekker D., 2003, S AFRICAN FAMILY PRA, V45, P10
   Brooks RT, 2006, PSYCHOL ASSESSMENT, V18, P62, DOI 10.1037/1040-3590.18.1.62
   CHINYADZA E, 1993, CENT AFR J MED, V39, P26
   Emmen MJ, 2005, NETH J MED, V63, P421
   Emmen MJ, 2006, PATIENT EDUC COUNS, V60, P32, DOI 10.1016/j.pec.2004.11.011
   Emmen MJ, 2004, BMJ-BRIT MED J, V328, P318, DOI 10.1136/bmj.37956.562130.EE
   Flisher AJ, 2001, S AFR MED J, V91, P243
   Freeborn DK, 2000, J BEHAV HEALTH SER R, V27, P446, DOI 10.1007/BF02287826
   Goldberger BA, 2007, J ADDICT DIS, V26, P113, DOI 10.1300/J069v26S01_02
   GUREJE O, 1992, DRUG ALCOHOL DEPEN, V30, P163, DOI 10.1016/0376-8716(92)90021-4
   Jane-Llopis E, 2006, DRUG ALCOHOL REV, V25, P515, DOI 10.1080/09595230600944461
   Johnson T, 2005, ANN EPIDEMIOL, V15, P381, DOI 10.1016/j.annepidem.2004.09.004
   Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Kushner MG, 2000, CLIN PSYCHOL REV, V20, P149, DOI 10.1016/S0272-7358(99)00027-6
   Liu C, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-713
   MPHI M, 1994, ADDICTION, V89, P945, DOI 10.1111/j.1360-0443.1994.tb03350.x
   Newcombe DAL, 2005, DRUG ALCOHOL REV, V24, P217, DOI 10.1080/0959230500170266
   Nordstrom A, 2008, NORD J PSYCHIAT, V62, P249, DOI 10.1080/08039480802141129
   Panconesi A, 2008, J HEADACHE PAIN, V9, P19, DOI 10.1007/s10194-008-0006-1
   Peltzer K, 2011, AFR J PSYCHIATRY, V14, P30
   Peltzer K, 2006, PSYCHOL REP, V99, P176, DOI 10.2466/PR0.99.1.176-178
   Reid MC, 1999, ARCH INTERN MED, V159, P1681, DOI 10.1001/archinte.159.15.1681
   SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x
   Spies G, 2009, AIDS CARE, V21, P1163, DOI 10.1080/09540120902729965
   Spies G, 2009, ARCH WOMEN MENT HLTH, V12, P69, DOI 10.1007/s00737-009-0050-0
   STREBEL A, 1999, ARCH WOMEN MENT HLTH, V2, P75
   Swendsen JD, 2000, CLIN PSYCHOL REV, V20, P173, DOI 10.1016/S0272-7358(99)00026-4
   Tsai YF, 2009, ALCOHOL CLIN EXP RES, V33, P95, DOI 10.1111/j.1530-0277.2008.00815.x
   Ward CL, 2008, SUBST USE MISUSE, V43, P1395, DOI 10.1080/10826080801922744
NR 36
TC 16
Z9 16
U1 0
U2 7
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD JUL
PY 2011
VL 8
IS 7
BP 2629
EP 2639
DI 10.3390/ijerph8072629
PG 11
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA 796QS
UT WOS:000293067300004
PM 21845149
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU van Bastelaar, K
   Cuijpers, P
   Pouwer, F
   Riper, H
   Snoek, FJ
AF van Bastelaar, Kim
   Cuijpers, Pim
   Pouwer, Francois
   Riper, Heleen
   Snoek, Frank J.
TI Development and reach of a web-based cognitive behavioural therapy
   programme to reduce symptoms of depression and diabetes-specific
   distress
SO PATIENT EDUCATION AND COUNSELING
LA English
DT Article
DE Depression; Diabetes; Intervention development
ID GROUP TRAINING CBGT; QUALITY-OF-LIFE; GLYCEMIC CONTROL; PSYCHOSOCIAL
   ADAPTATION; COMORBID DEPRESSION; INTERNET; ADULTS; VALIDITY; ANXIETY;
   METAANALYSIS
AB Objectives: There is an urgent need for more effective and efficient depression treatments in diabetes. We developed a diabetes-specific version of the Dutch web-based 'Coping with Depression' (CWD) course. Here, we report on the development, reach, patients' reasons for choosing our intervention and their characteristics.
   Methods: The CWD programme was amended for use in diabetes patients with co-morbid depression. Data were collected using a telephone interview, self-report questionnaires, and medical records.
   Results: Adding diabetes-specific topics to an effective web-based depression programme resulted in an 8-lesson intervention ("www.diabetergestemd.nl"), with minimal guidance by coaches. In the framework of a randomised trial, the intervention attracted serious interest of 540 patients. After screening, 255 depressed diabetes patients were enrolled. Less than half had a history of depression treatment; 80% reported the diabetes-specific approach to be an important reason for signing up.
   Conclusion: We successfully developed a diabetes-specific version of the web-based CWD course, which attracted a large group of patients. Our results affirm the importance of addressing diabetes-specific issues in the context of depression treatment.
   Practice implications: Our intervention could be implemented on a large scale at low costs, and may serve as a model on how to develop other illness-specific online self-help interventions. Crown Copyright (C) 2010 Published by Elsevier Ireland Ltd. All rights reserved.
C1 [van Bastelaar, Kim] Vrije Univ Amsterdam Med Ctr, Dept Med Psychol, Diabet Psychol Res Grp, NL-1081 BT Amsterdam, Netherlands.
   [van Bastelaar, Kim; Cuijpers, Pim; Snoek, Frank J.] EMGO Inst Hlth & Care Res, Amsterdam, Netherlands.
   [Cuijpers, Pim] Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands.
   [Pouwer, Francois] Tilburg Univ, CoRPS Ctr Res Psychol Somat Dis, Dept Med Psychol & Neuropsychol, NL-5000 LE Tilburg, Netherlands.
   [Riper, Heleen] Netherlands Inst Mental Hlth & Addict Trimbos, Utrecht, Netherlands.
RP van Bastelaar, K (reprint author), Vrije Univ Amsterdam Med Ctr, Dept Med Psychol, Diabet Psychol Res Grp, Van der Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.
EM k.vanbastelaar@vumc.nl
RI Cuijpers, Pim/G-1703-2013
OI Cuijpers, Pim/0000-0001-5497-2743
FU Dutch Diabetes Research Foundation
FX This study was funded by the Dutch Diabetes Research Foundation.
CR Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS13, DOI 10.2337/dc09-S013
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   ANDERSSON G, 2009, COGN BEHAV THER, V1
   Andersson G, 2008, BRIT J PSYCHIAT, V193, P270, DOI 10.1192/bjp.bp.108.054080
   Baan Caroline A, 2009, Ned Tijdschr Geneeskd, V153, pA580
   BARAK A, 2009, ANN BEHAV MED
   Beekman ATF, 1997, PSYCHOL MED, V27, P231, DOI 10.1017/S0033291796003510
   Clarke G, 2005, J MED INTERNET RES, V7, DOI 10.2196/jmir.7.2.e16
   Cuijpers P, 1998, PSYCHOL REP, V82, P735, DOI 10.2466/PR0.82.3.735-738
   Cuijpers P, 2009, EVID-BASED MENT HEAL, V12, P76, DOI 10.1136/ebmh.12.3.76
   Cuijpers P, 2009, CLIN PSYCHOL REV, V29, P449, DOI 10.1016/j.cpr.2009.04.005
   Cuijpers P, 2008, J CLIN PSYCHIAT, V69, P1675, DOI 10.4088/JCP.v69n1102
   Cuijpers P, 2008, J CONSULT CLIN PSYCH, V76, P909, DOI 10.1037/a0013075
   de Graaf LE, 2009, BRIT J PSYCHIAT, V195, P73, DOI 10.1192/bjp.bp.108.054429
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   GEORGIADES A, 2007, CHANGES DEPRESSIVE S
   Griffiths F, 2006, J MED INTERNET RES, V8, DOI 10.2196/jmir.8.2.e10
   IDF, 2006, DIABETIC MED, V23, P579
   Katon WJ, 2005, DIABETES CARE, V28, P2668, DOI 10.2337/diacare.28.11.2668
   Kazantzis N, 2000, CLIN PSYCHOL-SCI PR, V7, P189, DOI 10.1093/clipsy/7.2.189
   Lin YR, 2008, J CLIN NURS, V17, P2875, DOI 10.1111/j.1365-2702.2008.02343.x
   Mosaku K, 2008, J NATL MED ASSOC, V100, P73, DOI 10.1016/S0027-9684(15)31178-0
   Petrak F, 2009, CURR OPIN PSYCHIATR, V22, P211, DOI 10.1097/YCO.0b013e3283207b45
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   Piette JD, 2004, AM J MANAG CARE, V10, P152
   Pouwer F, 2006, PATIENT EDUC COUNS, V60, P235, DOI 10.1016/j.pec.2005.01.009
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Rohde P, 1997, AM J PSYCHIAT, V154, P1593, DOI 10.1176/ajp.154.11.1593
   Rubin Richard R, 2004, Curr Diab Rep, V4, P119, DOI 10.1007/s11892-004-0067-8
   Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O
   Samson A, 2008, PATIENT EDUC COUNS, V70, P426, DOI 10.1016/j.pec.2007.10.018
   Snoek FJ, 2008, DIABETIC MED, V25, P1337, DOI 10.1111/j.1464-5491.2008.02595.x
   Snoek FJ, 2001, PATIENT EDUC COUNS, V45, P143, DOI 10.1016/S0738-3991(01)00113-6
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   SNOEK FJ, 2008, PRACT DIABET INT, V23, P241
   SPEK V, 2008, PSYCHOL MED, P1
   Spek V, 2007, PSYCHOL MED, V37, P319, DOI 10.1017/S0033291706008944
   Strecher V, 2007, ANNU REV CLIN PSYCHO, V3, P53, DOI 10.1146/annurev.clinpsy.3.022806.091428
   Surwit RS, 2002, DIABETES CARE, V25, P30, DOI 10.2337/diacare.25.1.30
   TATE DF, 2009, ANN BEHAV MED
   TEN HM, 2001, SOC PSYCH PSYCH EPID, V36, P141
   Trief PM, 1998, DIABETES CARE, V21, P241, DOI 10.2337/diacare.21.2.241
   Trief PM, 2001, DIABETES CARE, V24, P1384, DOI 10.2337/diacare.24.8.1384
   van Bastelaar KM, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-9
   van der Ven NCW, 2005, PATIENT EDUC COUNS, V56, P313, DOI 10.1016/j.pec.2004.03.005
   VANMEETERENSCHR.MT, 2007, 2608010032007 RIVM
   Warmerdam L, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.1094
   WITTCHEN HU, 1994, J PSYCHIAT RES, V28, P57, DOI 10.1016/0022-3956(94)90036-1
NR 48
TC 17
Z9 18
U1 0
U2 24
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0738-3991
J9 PATIENT EDUC COUNS
JI Patient Educ. Couns.
PD JUL
PY 2011
VL 84
IS 1
BP 49
EP 55
DI 10.1016/j.pec.2010.06.013
PG 7
WC Public, Environmental & Occupational Health; Social Sciences,
   Interdisciplinary
SC Public, Environmental & Occupational Health; Social Sciences - Other
   Topics
GA 791OH
UT WOS:000292674000009
PM 20619577
DA 2019-01-08
ER

PT J
AU Capuron, L
   Poitou, C
   Machaux-Tholliez, D
   Frochot, V
   Bouillot, JL
   Basdevant, A
   Laye, S
   Clement, K
AF Capuron, L.
   Poitou, C.
   Machaux-Tholliez, D.
   Frochot, V.
   Bouillot, J. -L.
   Basdevant, A.
   Laye, S.
   Clement, K.
TI Relationship between adiposity, emotional status and eating behaviour in
   obese women: role of inflammation
SO PSYCHOLOGICAL MEDICINE
LA English
DT Article
DE Eating behaviour; inflammation; neuroticism; obesity; psychological
   characteristics; weight loss
ID GENERALIZED ANXIETY DISORDER; GASTRIC BYPASS-SURGERY; LOW-GRADE
   INFLAMMATION; C-REACTIVE PROTEIN; WEIGHT-LOSS; INTERFERON-ALPHA; MAJOR
   DEPRESSION; MACROPHAGE INFILTRATION; INSULIN-RESISTANCE; TISSUE
AB Background. Obesity is characterized by chronic low-grade inflammation that may lead to emotional distress and behavioural symptoms. This study assessed the relationship between adiposity, low-grade inflammation, eating behaviour and emotional status in obese women awaiting gastric surgery and investigated the effects of surgery-induced weight loss on this relationship.
   Method. A total of 101 women with severe or morbid obesity awaiting gastric surgery were recruited. Assessments were performed before and at 1 year post-surgery and included the measurement of neuroticism and extraversion using the revised Neuroticism-Extraversion-Openness personality inventory (NEO-PI-R) and eating behaviour using the Three-Factor Eating Questionnaire (TFEQ). Blood samples were collected for the measurement of serum inflammatory markers [interleukin-6 (IL-6), high-sensitive C-reactive protein (hsCRP)] and adipokines (leptin, adiponectin).
   Results. At baseline, body mass index (BMI) was positively correlated with inflammatory markers and adipokines. Regression analyses adjusting for age and diabetes revealed that baseline concentrations of IL-6 and hsCRP were associated with the depression and anxiety facets of neuroticism, with higher inflammation predicting higher anxiety and depression. This association remained significant after adjusting for BMI. Gastric surgery induced significant weight loss, which correlated with reduced inflammation. After controlling for BMI variations, decreases in inflammatory markers, notably hsCRP, were associated with reduced anxiety and TFEQ-cognitive restraint scores.
   Conclusions. These findings indicate strong associations between adiposity, inflammation and affectivity in obese subjects and show that surgery-induced weight loss is associated concomitantly with reduced inflammation and adipokines and with significant improvement in emotional status and eating behaviour. Inflammatory status appears to represent an important mediator of emotional distress and psychological characteristics of obese individuals.
C1 [Capuron, L.; Laye, S.] Univ Bordeaux 2, Lab Psychoneuroimmunol Nutr & Genet PSYNUGEN, INRA 1286, CNRS 5226, F-33076 Bordeaux, France.
   [Poitou, C.; Machaux-Tholliez, D.; Basdevant, A.; Clement, K.] Hop La Pitie Salpetriere, AP HP, Nutr & Endocrinol Dept, CRNH Ile France, F-75013 Paris, France.
   [Poitou, C.; Basdevant, A.; Clement, K.] INSERM, U872, Nutri Team 7, F-75006 Paris, France.
   [Poitou, C.; Basdevant, A.; Clement, K.] Univ Paris 06, Ctr Rech Cordeliers, UMR S 872, F-75006 Paris, France.
   [Poitou, C.; Basdevant, A.; Clement, K.] Univ Paris 05, UMR S 872, F-75006 Paris, France.
   [Frochot, V.] Hop La Pitie Salpetriere, AP HP, Endocrinol & Oncol Biochem Dept, F-75013 Paris, France.
   [Bouillot, J. -L.] Hop Hotel Dieu, AP HP, Dept Surg, F-75013 Paris, France.
RP Capuron, L (reprint author), Univ Bordeaux 2, Lab Psychoneuroimmunol Nutr & Genet PSYNUGEN, INRA 1286, CNRS 5226, 146 Rue Leo Saignat, F-33076 Bordeaux, France.
EM lucile.capuron@bordeaux.inra.fr
RI Clement, karine/R-1120-2017
OI Capuron, Lucile/0000-0002-2060-5918
FU Assistance Publique Hopitaux de Paris/Direction de la Recherche Clinique
   [CRC P050318]; PHRC [0207]
FX This work was supported by Assistance Publique Hopitaux de
   Paris/Direction de la Recherche Clinique (CRC P050318) and PHRC (0207).
   We thank Dr Florence Marchelli, Madame Christine Baudoin and Madame
   Patricia Ancel for their involvement in patient recruitment, data
   collection and sampling at the Centre of Research on Human Nutrition
   (CRNH), Ile de France.
CR Bankier B, 2008, EUR HEART J, V29, P2212, DOI 10.1093/eurheartj/ehn326
   BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037//0022-3514.51.6.1173
   Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4
   Bastard JP, 1999, CIRCULATION, V99, P2221
   Bastard JP, 2000, J CLIN ENDOCR METAB, V85, P3338, DOI 10.1210/jc.85.9.3338
   Bean MK, 2008, J CLIN PSYCHOL MED S, V15, P214, DOI 10.1007/s10880-008-9124-9
   Bellisle F, 2004, OBES RES, V12, P2023, DOI 10.1038/oby.2004.253
   Branca F, 2007, CHALLENGE OBESITY WH
   Cancello R, 2006, BJOG-INT J OBSTET GY, V113, P1141, DOI 10.1111/j.1471-0528.2006.01004.x
   Cancello R, 2005, DIABETES, V54, P2277, DOI 10.2337/diabetes.54.8.2277
   Canetti L, 2009, INT J EAT DISORDER, V42, P109, DOI 10.1002/eat.20592
   Capuron L, 2005, BIOL PSYCHIAT, V58, P190, DOI 10.1016/j.biopsych.2005.03.033
   Capuron L, 2004, BIOL PSYCHIAT, V56, P819, DOI 10.1016/j.biopsych.2004.02.009
   Capuron L, 2002, NEUROPSYCHOPHARMACOL, V26, P643, DOI 10.1016/S0893-133X(01)00407-9
   Capuron L, 2001, AM J PSYCHIAT, V158, P1163, DOI 10.1176/appi.ajp.158.7.1163
   Capuron L, 2008, BIOL PSYCHIAT, V64, P896, DOI 10.1016/j.biopsych.2008.05.019
   CHARLES SC, 1987, GASTROENTEROL CLIN N, V16, P415
   Clement K, 2004, FASEB J, V18, P1657, DOI 10.1096/fj.04-2204com
   Costa Jr P. T., 1985, NEO PERSONALITY INVE
   Costa P. T., 1998, NEO PI R INVENTAIRE
   DANTZER R, 1999, CYTOKINES STRESS DEP
   de Zwaan M, 2003, COMPR PSYCHIAT, V44, P428, DOI 10.1016/S0010-440X(03)00092-0
   Dixon JB, 2003, ARCH INTERN MED, V163, P2058, DOI 10.1001/archinte.163.17.2058
   Evans DL, 2005, BIOL PSYCHIAT, V58, P175, DOI 10.1016/j.biopsych.2005.05.001
   Faith MS, 2001, OBES RES, V9, P647, DOI 10.1038/oby.2001.86
   Forsythe LKS, 2008, NUTR RES REV, V21, P117, DOI 10.1017/S0954422408138732
   Gibson EL, 2006, PHYSIOL BEHAV, V89, P53, DOI 10.1016/j.physbeh.2006.01.024
   Herva A, 2006, INT J OBESITY, V30, P520, DOI 10.1038/sj.ijo.0803174
   Hsu LKG, 2002, INT J OBESITY, V26, P1398, DOI 10.1038/sj.ijo.0802081
   Jylha P, 2006, DEPRESS ANXIETY, V23, P281, DOI 10.1002/da.20167
   Karlsson J, 2000, INT J OBESITY, V24, P1715, DOI 10.1038/sj.ijo.0801442
   Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402
   Kendler KS, 2007, PSYCHOL MED, V37, P453, DOI 10.1017/S0033291706009135
   Kendler KS, 2006, ARCH GEN PSYCHIAT, V63, P1113, DOI 10.1001/archpsyc.63.10.1113
   Konsman JP, 2002, TRENDS NEUROSCI, V25, P154, DOI 10.1016/S0166-2236(00)02088-9
   Lluch A, 1995, THESIS U H POINCARE
   Lykouras L, 2008, DIGEST DIS, V26, P36, DOI 10.1159/000109384
   Musselman DL, 2001, NEW ENGL J MED, V344, P961, DOI 10.1056/NEJM200103293441303
   O'Rourke RW, 2009, SURGERY, V145, P255, DOI 10.1016/j.surg.2008.08.038
   Plotkin SR, 1996, J NEUROIMMUNOL, V67, P41
   Poitou C, 2006, OBESITY, V14, P309, DOI 10.1038/oby.2006.40
   Poitou C, 2009, J CLIN ENDOCR METAB, V94, P1810, DOI 10.1210/jc.2008-2040
   Provencher Veronique, 2008, Eat Behav, V9, P294, DOI 10.1016/j.eatbeh.2007.10.004
   Rabe K, 2008, MOL MED, V14, P741, DOI 10.2119/2008-00058.Rabe
   Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006
   Rivest S, 2000, P SOC EXP BIOL MED, V223, P22, DOI 10.1046/j.1525-1373.2000.22304.x
   Roberts SB, 1999, PSYCHOL MED, V29, P1101, DOI 10.1017/S0033291799008739
   ROLLAND JP, 1998, REV FRANCAISE PSYCHI, V18, P139
   WATKINS LR, 1995, NEUROSCI LETT, V183, P27, DOI 10.1016/0304-3940(94)11105-R
   Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI200320514
   Wilberg T, 2009, J NERV MENT DIS, V197, P187, DOI 10.1097/NMD.0b013e3181923fa0
   Wolfe BL, 2006, OBES SURG, V16, P1622, DOI 10.1381/096089206779319473
NR 52
TC 46
Z9 48
U1 0
U2 19
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0033-2917
J9 PSYCHOL MED
JI Psychol. Med.
PD JUL
PY 2011
VL 41
IS 7
BP 1517
EP 1528
DI 10.1017/S0033291710001984
PG 12
WC Psychology, Clinical; Psychiatry; Psychology
SC Psychology; Psychiatry
GA 780KL
UT WOS:000291854700019
PM 20961476
DA 2019-01-08
ER

PT J
AU Raja-Khan, N
   Stener-Victorin, E
   Wu, XK
   Legro, RS
AF Raja-Khan, Nazia
   Stener-Victorin, Elisabet
   Wu, XiaoKe
   Legro, Richard S.
TI The physiological basis of complementary and alternative medicines for
   polycystic ovary syndrome
SO AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
LA English
DT Review
DE acupuncture; mindfulness meditation; herbs; dietary supplements;
   traditional Chinese medicine
ID RANDOMIZED CONTROLLED-TRIAL; TYPE-2 DIABETES-MELLITUS; LOW-FREQUENCY
   ELECTROACUPUNCTURE; SYMPATHETIC-NERVE ACTIVITY; STRESS REDUCTION MBSR;
   BLOOD-FLOW RESPONSES; QUALITY-OF-LIFE; TAI-CHI-CHUAN;
   INSULIN-RESISTANCE; GREEN TEA
AB Raja-Khan N, Stener-Victorin E, Wu X, Legro RS. The physiological basis of complementary and alternative medicines for polycystic ovary syndrome. Am J Physiol Endocrinol Metab 301: E1-E10, 2011. First published April 12, 2011; doi: 10.1152/ajpendo.00667.2010.-Polycystic ovary syndrome (PCOS) is a common endocrine disorder that is characterized by chronic hyperandrogenic anovulation leading to symptoms of hirsutism, acne, irregular menses, and infertility. Multiple metabolic and cardiovascular risk factors are associated with PCOS, including insulin resistance, obesity, type 2 diabetes, hypertension, inflammation, and subclinical atherosclerosis. However, current treatments for PCOS are only moderately effective at controlling symptoms and preventing complications. This article describes how the physiological effects of major complementary and alternative medicine (CAM) treatments could reduce the severity of PCOS and its complications. Acupuncture reduces hyperandrogenism and improves menstrual frequency in PCOS. Acupuncture's clinical effects are mediated via activation of somatic afferent nerves innervating the skin and muscle, which, via modulation of the activity in the somatic and autonomic nervous system, may modulate endocrine and metabolic functions in PCOS. Chinese herbal medicines and dietary supplements may also exert beneficial physiological effects in PCOS, but there is minimal evidence that these CAM treatments are safe and effective. Mindfulness has not been investigated in PCOS, but it has been shown to reduce psychological distress and exert positive effects on the central and autonomic nervous systems, hypothalamic-pituitary-adrenal axis, and immune system, leading to reductions in blood pressure, glucose, and inflammation. In conclusion, CAM treatments may have beneficial endocrine, cardiometabolic, and reproductive effects in PCOS. However, most studies of CAM treatments for PCOS are small, nonrandomized, or uncontrolled. Future well-designed studies are needed to further evaluate the safety, effectiveness, and mechanisms of CAM treatments for PCOS.
C1 [Raja-Khan, Nazia] Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Div Endocrinol Diabet & Metab, Hershey, PA 17033 USA.
   [Stener-Victorin, Elisabet] Univ Gothenburg, Sahlgrenska Acad, Dept Physiol, Inst Neurosci & Physiol, Gothenburg, Sweden.
   [Stener-Victorin, Elisabet; Wu, XiaoKe] Heilongjiang Univ Chinese Med, Natl Key Discipline & Clin Base, Dept Obstet & Gynecol, Harbin, Peoples R China.
   [Legro, Richard S.] Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Dept Obstet & Gynecol, Hershey, PA 17033 USA.
RP Raja-Khan, N (reprint author), Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Div Endocrinol Diabet & Metab, 500 Univ Dr,H044, Hershey, PA 17033 USA.
EM nrajakhan@psu.edu
RI Stener-Victorin, Elisabet/W-6322-2018
OI Stener-Victorin, Elisabet/0000-0002-3424-1502; Legro,
   Richard/0000-0001-9927-7584; Raja-Khan, Nazia/0000-0002-2751-9609
FU NICHD NIH HHS [K12 HD055882]
CR Ahmed MI, 2008, HUM REPROD, V23, P2564, DOI 10.1093/humrep/den273
   Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009
   Anderson RA, 2004, J AGR FOOD CHEM, V52, P65, DOI 10.1021/jf034916b
   Barber TM, 2006, CLIN ENDOCRINOL, V65, P137, DOI 10.1111/j.1365-2265.2006.02587.x
   Barnard L, 2007, HUM REPROD, V22, P2279, DOI 10.1093/humrep/dem108
   Bian Zhao-Xiang, 2006, Zhong Xi Yi Jie He Xue Bao, V4, P233
   Blank SK, 2007, SEMIN REPROD MED, V25, P352, DOI 10.1055/s-2007-984741
   Broadhurst CL, 2000, J AGR FOOD CHEM, V48, P849, DOI 10.1021/jf9904517
   Carlson LE, 2007, BRAIN BEHAV IMMUN, V21, P1038, DOI 10.1016/j.bbi.2007.04.002
   Chan CCW, 2006, J SOC GYNECOL INVEST, V13, P63, DOI 10.1016/j.jsgi.2005.10.006
   Chantre P, 2002, PHYTOMEDICINE, V9, P3, DOI 10.1078/0944-7113-00078
   Chen ZH, 2008, AM J CHINESE MED, V36, P939, DOI 10.1142/S0192415X08006363
   Chiesa A, 2010, PSYCHOL MED, V40, P1239, DOI 10.1017/S0033291709991747
   Ciampelli M, 1998, HORM RES, V49, P263, DOI 10.1159/000023185
   Cussons AJ, 2009, J CLIN ENDOCR METAB, V94, P3842, DOI 10.1210/jc.2009-0870
   Dasgupta A, 2006, ANN CLIN BIOCHEM, V43, P223, DOI 10.1258/000456306776865214
   Davidson RJ, 2003, PSYCHOSOM MED, V65, P564, DOI 10.1097/01.PSY.0000077505.67574.E3
   Deeks AA, 2010, FERTIL STERIL, V93, P2421, DOI 10.1016/j.fertnstert.2009.09.018
   Dissen GA, 2009, ENDOCRINOLOGY, V150, P2906, DOI 10.1210/en.2008-1575
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Dvorak Z, 2011, FERTIL STERIL, V95, pE7, DOI 10.1016/j.fertnstert.2010.11.014
   EISENBERG DM, 1993, NEW ENGL J MED, V328, P246, DOI 10.1056/NEJM199301283280406
   Eyvazzadeh AD, 2009, FERTIL STERIL, V92, P1, DOI 10.1016/j.fertnstert.2009.05.012
   Feng Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006638
   Figueiroa MS, 2009, ASIAN J ANDROL, V11, P362, DOI 10.1038/aja.2009.2
   Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2
   Fruzzetti F, 2002, FERTIL STERIL, V77, P936, DOI 10.1016/S0015-0282(02)02955-2
   GERHARD I, 1992, GYNECOL ENDOCRINOL, V6, P171
   GillingSmith C, 1997, CLIN ENDOCRINOL, V47, P93, DOI 10.1046/j.1365-2265.1997.2321049.x
   Goldin PR, 2010, EMOTION, V10, P83, DOI 10.1037/a0018441
   Gonzalez F, 2009, METABOLISM, V58, P954, DOI 10.1016/j.metabol.2009.02.022
   Grant P, 2010, PHYTOTHER RES, V24, P186, DOI 10.1002/ptr.2900
   Grant SJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006690.pub2
   Hahn S, 2006, EXP CLIN ENDOCR DIAB, V114, P577, DOI 10.1055/s-2006-948308
   Han JS, 2003, TRENDS NEUROSCI, V26, P17, DOI 10.1016/S0166-2236(02)00006-1
   Heider U, 2001, FERTIL STERIL, V75, P1141, DOI 10.1016/S0015-0282(01)01805-2
   Higashimura Y, 2009, AUTON NEUROSCI-BASIC, V150, P100, DOI 10.1016/j.autneu.2009.06.003
   Holzel BK, 2008, SOC COGN AFFECT NEUR, V3, P55, DOI 10.1093/scan/nsm038
   Holmang A, 2002, J APPL PHYSIOL, V92, P982, DOI 10.1152/japplphysiol.01194.2000
   Hung JW, 2009, J REHABIL MED, V41, P924, DOI 10.2340/16501977-0445
   JANSEN G, 1989, NEUROSCI LETT, V97, P305, DOI 10.1016/0304-3940(89)90615-0
   Jarvill-Taylor KJ, 2001, J AM COLL NUTR, V20, P327, DOI 10.1080/07315724.2001.10719053
   Jedel E, 2010, HUM REPROD, V25, P450, DOI 10.1093/humrep/dep384
   Jedel E, 2011, AM J PHYSIOL-ENDOC M, V300, pE37, DOI 10.1152/ajpendo.00495.2010
   JENKINS PJ, 1993, HUM REPROD, V8, P154, DOI 10.1093/humrep/8.suppl_2.154
   Johansson J, 2010, AM J PHYSIOL-ENDOC M, V299, pE551, DOI 10.1152/ajpendo.00323.2010
   Jonsdottir IH, 2000, IMMUNOL CELL BIOL, V78, P562, DOI 10.1046/j.1440-1711.2000.00961.x
   Kagitani F, 2005, JPN J PHYSIOL, V55, P149, DOI 10.2170/jjphysiol.R2120
   Kao YH, 2000, ENDOCRINOLOGY, V141, P980, DOI 10.1210/en.141.3.980
   Kaptchuk TJ, 2008, BMJ-BRIT MED J, V336, P999, DOI 10.1136/bmj.39524.439618.25
   Kaptchuk TJ, 2000, J CLIN EPIDEMIOL, V53, P786, DOI 10.1016/S0895-4356(00)00206-7
   Kaptchuk TJ, 2002, ANN INTERN MED, V136, P817, DOI 10.7326/0003-4819-136-11-200206040-00011
   Kasim-Karakas SE, 2004, J CLIN ENDOCR METAB, V89, P615, DOI 10.1210/jc.2003-030666
   Kaya C, 2009, REPROD BIOMED ONLINE, V19, P721, DOI 10.1016/j.rbmo.2009.06.005
   Kotsa K, 2009, FERTIL STERIL, V92, P1053, DOI 10.1016/j.fertnstert.2008.07.1757
   Kubota Y, 2001, COGNITIVE BRAIN RES, V11, P281, DOI 10.1016/S0926-6410(00)00086-0
   LARA HE, 1993, ENDOCRINOLOGY, V133, P2690, DOI 10.1210/en.133.6.2690
   Lau CH, 2008, PHYTOTHER RES, V22, P1384, DOI 10.1002/ptr.2513
   Lazar SW, 2005, NEUROREPORT, V16, P1893, DOI 10.1097/01.wnr.0000186598.66243.19
   Lee MJ, 2010, J ENZYM INHIB MED CH, V25, P702, DOI 10.3109/14756360903524312
   Legro RS, 1999, J CLIN ENDOCR METAB, V84, P165, DOI 10.1210/jc.84.1.165
   Legro RS, 2001, AM J MED, V111, P607, DOI 10.1016/S0002-9343(01)00948-2
   Liang F, 2011, EVID-BASED COMPL ALT
   Lin RT, 2009, BMC COMPLEM ALTERN M, V9, DOI 10.1186/1472-6882-9-26
   Lin SH, 2002, LANCET, V360, P224, DOI 10.1016/S0140-6736(02)09460-6
   Linde K, 2010, FORSCH KOMPLEMENTMED, V17, P259, DOI 10.1159/000320374
   Liu J. P., 2004, COCHRANE DB SYST REV
   Liu X, 2010, BRIT J SPORT MED, V44, P704, DOI 10.1136/bjsm.2008.051144
   LOBO RA, 1983, AM J OBSTET GYNECOL, V145, P496, DOI 10.1016/0002-9378(83)90324-1
   Ludwig DS, 2008, JAMA-J AM MED ASSOC, V300, P1350, DOI 10.1001/jama.300.11.1350
   Lund Irene, 2006, Acupunct Med, V24, P13
   MacPherson H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000261
   Manneras L, 2008, ENDOCRINOLOGY, V149, P3559, DOI 10.1210/en.2008-0053
   Manneras L, 2009, AM J PHYSIOL-REG I, V296, pR1124, DOI 10.1152/ajpregu.90947.2008
   Manni L, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1177-7827-3-21
   Matchim Y, 2010, W J NURS RES    1018
   McKay DL, 2002, J AM COLL NUTR, V21, P1
   Mo X, 1993, J Tradit Chin Med, V13, P115
   Moffet Howard H, 2006, BMC Complement Altern Med, V6, P25, DOI 10.1186/1472-6882-6-25
   Moffet HH, 2009, J ALTERN COMPLEM MED, V15, P213, DOI 10.1089/acm.2008.0356
   Nagai M, 2010, J AM SOC HYPERTENS, V4, P174, DOI 10.1016/j.jash.2010.05.001
   Ng EHY, 2008, SEMIN REPROD MED, V26, P14, DOI 10.1055/s-2007-992920
   Ni HY, 2007, LIAONING J TRADITION, V34, P123
   Norman RJ, 2007, LANCET, V370, P685, DOI 10.1016/S0140-6736(07)61345-2
   Palomba S, 2010, DIABETES CARE, V33, P246, DOI 10.2337/dc09-1516
   Qin BL, 2003, DIABETES RES CLIN PR, V62, P139, DOI 10.1016/S0168-8227(03)00173-6
   Raja-Khan N, 2005, J CLIN OUTCOMES MANA, V12, P218
   Raja-Khan N, 2011, EUR J OBSTET GYN R B, V155, P49, DOI 10.1016/j.ejogrb.2010.10.027
   Rashidi B, 2009, TAIWAN J OBSTET GYNE, V48, P142, DOI 10.1016/S1028-4559(09)60275-8
   Rosenzweig S, 2007, ALTERN THER HEALTH M, V13, P36
   SATO A, 1992, NEUROSCI RES, V14, P242, DOI 10.1016/0168-0102(92)90071-J
   Schuering Andreas N., 2008, Gynaekologisch-Geburtshilfliche Rundschau, V48, P9, DOI 10.1159/000111465
   Selimoglu H, 2010, J ENDOCRINOL INVEST, V33, P234, DOI 10.3275/6560
   Shapiro SL, 2009, J CLIN PSYCHOL, V65, P555, DOI 10.1002/jclp.20602
   Sherman KJ, 2010, SPINE, V35, P1471, DOI 10.1097/BRS.0b013e3181c2a8d3
   Sills ES, 2001, BMC WOMENS HEALTH, V1, P3, DOI DOI 10.1186/1472-6874-1-1
   Stener-Victorin E, 2000, BIOL REPROD, V63, P1497, DOI 10.1095/biolreprod63.5.1497
   Stener-Victorin E, 2006, J APPL PHYSIOL, V101, P84, DOI 10.1152/jappalphysiol.01593.2005
   Stener-Victorin E, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-44
   Stener-Victorin E, 2003, AUTON NEUROSCI-BASIC, V108, P50, DOI 10.1016/j.autneu.2003.08.006
   Stener-Victorin E, 2000, ACTA OBSTET GYN SCAN, V79, P180, DOI 10.1034/j.1600-0412.2000.079003180.x
   Stener-Victorin E, 2009, AM J PHYSIOL-REG I, V297, pR387, DOI 10.1152/ajpregu.00197.2009
   Streitberger K, 1998, LANCET, V352, P364, DOI 10.1016/S0140-6736(97)10471-8
   Sun F, 2000, P SOC EXP BIOL MED, V223, P295, DOI 10.1046/j.1525-1373.2000.22342.x
   Sun Guan-Cheng, 2010, Diabetes Care, V33, pe8, DOI 10.2337/dc09-1543
   Sverrisdottir YB, 2008, AM J PHYSIOL-ENDOC M, V294, pE576, DOI 10.1152/ajpendo.00725.2007
   Takahashi T, 2005, INT J PSYCHOPHYSIOL, V55, P199, DOI 10.1016/j.ijpsycho.2004.07.004
   Teede H, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-41
   Tsai JC, 2003, J ALTERN COMPLEM MED, V9, P747, DOI 10.1089/107555303322524599
   Tsujiuchi T, 2002, DIABETES CARE, V25, P241, DOI 10.2337/diacare.25.1.241
   Wang BQ, 2008, SHANDONG J TRADITION, V27, P138
   Wang JG, 2007, FERTIL STERIL, V88, P240, DOI 10.1016/j.fertnstert.2006.11.082
   Wang Jing Hao, 2008, V52, P230, DOI 10.1159/000134303
   Wehr E, 2009, EUR J ENDOCRINOL, V161, P575, DOI 10.1530/EJE-09-0432
   White A, 2008, ACUPUNCT MED, V26, P111, DOI 10.1136/aim.26.2.111
   Witek-Janusek L, 2008, BRAIN BEHAV IMMUN, V22, P969, DOI 10.1016/j.bbi.2008.01.012
   Xia W, 2011, PHYTOMEDICINE, V18, P516, DOI 10.1016/j.phymed.2010.09.007
   Yang X. B., 2002, XHONGGUO SHI YIAN FA, V18, P336
   Yang XM, 2011, AM J PHYSIOL-REG I, V300, pR869, DOI 10.1152/ajpregu.00334.2010
   YAO T, 1982, BRAIN RES, V240, P77, DOI 10.1016/0006-8993(82)90645-X
   YING CB, 1991, ACUPUNCTURE ELECTRO, V16, P1
   Zhang Hongwei, 2010, Chin Med, V5, P1, DOI 10.1186/1749-8546-5-1
   Zhang J, 2010, COCHRANE DB SYST REV, V9
   Zhang ZJ, 2010, J AFFECT DISORDERS, V124, P9, DOI 10.1016/j.jad.2009.07.005
   Zhao L, 2011, FERTIL STERIL, V95, P461, DOI 10.1016/j.fertnstert.2010.07.1090
NR 125
TC 33
Z9 35
U1 15
U2 81
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0193-1849
EI 1522-1555
J9 AM J PHYSIOL-ENDOC M
JI Am. J. Physiol.-Endocrinol. Metab.
PD JUL
PY 2011
VL 301
IS 1
BP E1
EP E10
DI 10.1152/ajpendo.00667.2010
PG 10
WC Endocrinology & Metabolism; Physiology
SC Endocrinology & Metabolism; Physiology
GA 783MA
UT WOS:000292085900001
PM 21487075
OA Green Published
DA 2019-01-08
ER

PT J
AU Minet, LKR
   Wagner, L
   Lonvig, EM
   Hjelmborg, J
   Henriksen, JE
AF Minet, L. K. Rosenbek
   Wagner, L.
   Lonvig, E. M.
   Hjelmborg, J.
   Henriksen, J. E.
TI The effect of motivational interviewing on glycaemic control and
   perceived competence of diabetes self-management in patients with type 1
   and type 2 diabetes mellitus after attending a group education
   programme: a randomised controlled trial
SO DIABETOLOGIA
LA English
DT Article
DE Clinical trial; Diabetes mellitus; Motivation; Patient education; Self
   care
ID PROBLEM AREAS; METAANALYSIS; INTERVENTION; CARE; ADOLESCENTS; ATTITUDES;
   DISTRESS; BEHAVIOR; SKILLS; WOMEN
AB The aim of this study was to measure the efficacy of motivational interviewing (MI) compared with usual care on changes in glycaemic control and competence of diabetes self-management in patients with diabetes mellitus.
   Patients were eligible if they had type 1 or 2 diabetes mellitus, were over 18 years of age and had participated in a 4 day group education programme offered at a diabetes clinic at a university hospital in Denmark. Exclusion criteria included pregnancy, severe debilitating disease and cognitive deficit. Out of 469 patients who attended the group education programme, 349 patients were randomised to either a usual care control group or an intervention group, which received up to five individual counselling sessions in 1 year based on MI, in addition to usual care. A randomised parallel design was used and open-label allocation was done by random permuted blocks, with allocation concealment by sequentially numbered, sealed, opaque envelopes. The primary outcome was glycated haemoglobin (HbA(1c)). Analysis regarding measurements of glycated haemoglobin (HbA(1c)) and competence of self-management (using the Problem Areas in Diabetes Scale [PAID] and Perceived Competence for Diabetes Scale [PCDS]) was based on 298 participants followed for a 24 month period. Data were collected at the Department of Endocrinology at Odense University Hospital. Our hypotheses were that MI could: (1) reduce HbA(1c) levels; (2) increase self-efficacy; and (3) increase diabetes self-care, compared with usual care.
   Out of the 176 included in the control group and 173 in the intervention group, 153 and 145 were analysed in the groups, respectively. When using the baseline value as covariate there were no significant differences in change score between the two study groups with regard to mean level of HbA(1c) (0.131, p = 0.221), PAID scores (-1.793, p = 0.191) or PCDS scores (0.017, p = 0.903) at the 24 month follow-up, using a mixed effects regression model. The patients in the intervention group showed significantly higher levels of perceived competence in dealing with diabetes compared with the control group (mean change score = -0.387, p = 0.002) following 1 year of intervention.
   We were unable to demonstrate any benefit, over or above usual care, of MI in patients with diabetes who have just completed a diabetes education programme, and who have well-regulated diabetes.
   Clinical Trials NCT00555854.
   The National Board of Health, Funen County, Danish Association of Diabetes, Odense University Hospital, University of Southern Denmark and TRYG Fonden.
C1 [Minet, L. K. Rosenbek; Henriksen, J. E.] Odense Univ Hosp, Dept Endocrinol M, DK-5000 Odense, Denmark.
   [Wagner, L.] Univ So Denmark, Inst Clin Res, Fac Hlth Sci, Res Unit Nursing, DK-5000 Odense C, Denmark.
   [Lonvig, E. M.] Odense Univ Hosp, Dept Qual, DK-5000 Odense, Denmark.
   [Minet, L. K. Rosenbek] Odense Univ Hosp, Dept Rehabil, DK-5000 Odense C, Denmark.
   [Hjelmborg, J.] Univ So Denmark, Dept Biostat, DK-5000 Odense C, Denmark.
RP Minet, LKR (reprint author), Odense Univ Hosp, Dept Endocrinol M, DK-5000 Odense, Denmark.
EM lisbeth.minet@ouh.regionsyddanmark.dk
OI Rosenbek Minet, Lisbeth/0000-0001-6179-5183; Hjelmborg,
   Jacob/0000-0001-9630-9149; Henriksen, Jan Erik/0000-0002-1908-7017
FU National Board of Health; Funen County; Danish Association of Diabetes;
   Odense University Hospital; University of Southern Denmark; TRYG Fonden
FX The authors thank the study patients for their participation in the
   study. Thanks to the team members at the Diabetes Clinic Department of
   Endocrinology L. Sjoberg, I. Kamp, E. Romanczuk, I. Eggertsen, T.
   Flemming Larsen, G. Kramer and B. Nielsen for their invaluable
   contributions to the study. Thanks also to other staff at the Diabetes
   Clinic Department of Endocrinology for co-operation and assistance
   throughout the trial. Thanks also to L. Stark at the Research Unit of
   General Practice for language editing of the manuscript. This study was
   financially supported by the National Board of Health, Funen County,
   Danish Association of Diabetes, Odense University Hospital, University
   of Southern Denmark and TRYG Fonden.
CR Adolfsson ET, 2004, PATIENT EDUC COUNS, V53, P319, DOI 10.1016/j.pec.2003.07.009
   Bandura A., 1997, SELF EFFICACY EXERCI
   Brug J, 2007, J NUTR EDUC BEHAV, V39, P8, DOI 10.1016/j.jneb.2006.08.010
   Channon S, 2003, ARCH DIS CHILD, V88, P680, DOI 10.1136/adc.88.8.680
   Channon SJ, 2007, DIABETES CARE, V30, P1390, DOI 10.2337/dc06-2260
   Clark M, 2001, PATIENT EDUC COUNS, V42, P247, DOI 10.1016/S0738-3991(00)00128-2
   Colagiuri R, 2009, DIABETIC MED, V26, P442, DOI 10.1111/j.1464-5491.2009.02700.x
   Deakin T, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003417.pub2
   *DIAB CONTR COMPL, 1993, NEW ENGL J MED, V329, P977, DOI DOI 10.1056/NEJM199309303291401
   Duke SAS, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005268.pub2
   Fain JA, 1999, DIABETES EDUCATOR, V25, P7, DOI 10.1177/014572179902500618
   FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
   Funnell MM, 2004, CLIN DIABETES, V22, P123, DOI DOI 10.2337/DIACLIN.22.3.123
   Gary TL, 2003, DIABETES EDUCATOR, V29, P488, DOI 10.1177/014572170302900313
   Ismail K, 2004, LANCET, V363, P1589, DOI 10.1016/S0140-6736(04)16202-8
   Ismail K, 2008, ANN INTERN MED, V149, P708, DOI 10.7326/0003-4819-149-10-200811180-00005
   Knight KM, 2006, BRIT J HEALTH PSYCH, V11, P319, DOI 10.1348/135910705X52516
   Knight KM, 2003, PSYCHOL HEALTH MED, V8, P149, DOI DOI 10.1080/1354850031000087528
   Loveman E, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003286
   Martins RK, 2009, CLIN PSYCHOL REV, V29, P283, DOI 10.1016/j.cpr.2009.02.001
   Miller W. R., 2002, MOTIVATIONAL INTERVI
   Miller WR, 2009, BEHAV COGN PSYCHOTH, V37, P129, DOI 10.1017/S1352465809005128
   Minet L, 2010, PATIENT EDUC COUNS, V80, P29, DOI 10.1016/j.pec.2009.09.033
   Norris SL, 2002, DIABETES CARE, V25, P1159, DOI 10.2337/diacare.25.7.1159
   Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   Pill R, 1999, J ADV NURS, V29, P1492, DOI 10.1046/j.1365-2648.1999.01037.x
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Rollnick S., 2008, MOTIVATIONAL INTERVI
   Rubak S, 2005, BRIT J GEN PRACT, V55, P305
   Shojania KG, 2006, JAMA-J AM MED ASSOC, V296, P427, DOI 10.1001/jama.296.4.427
   Smith DE, 1997, DIABETES CARE, V20, P52, DOI 10.2337/diacare.20.1.52
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   *SWED COUNC TECHN, 2009, PAT ED DIAB SYST REV
   UKPDS Study Group, 1998, LANCET, V352, P837, DOI DOI 10.1016/S0140-6736(98)07019-6
   Viner RM, 2003, DIABETIC MED, V20, P739, DOI 10.1046/j.1464-5491.2003.00995.x
   Welch G, 2003, DIABETIC MED, V20, P69, DOI 10.1046/j.1464-5491.2003.00832.x
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   West DS, 2007, DIABETES CARE, V30, P1081, DOI 10.2337/dc06-1966
   Williams GC, 1998, DIABETES CARE, V21, P1644, DOI 10.2337/diacare.21.10.1644
   Woodcock AJ, 1999, PATIENT EDUC COUNS, V37, P65, DOI 10.1016/S0738-3991(98)00104-9
   ZOFFMANN V, 2004, THESIS U AARHUS AARH
   Zoffmann V, 2006, PATIENT EDUC COUNS, V64, P78, DOI 10.1016/j.pec.2005.11.017
NR 43
TC 27
Z9 27
U1 2
U2 36
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0012-186X
EI 1432-0428
J9 DIABETOLOGIA
JI Diabetologia
PD JUL
PY 2011
VL 54
IS 7
BP 1620
EP 1629
DI 10.1007/s00125-011-2120-x
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 774MZ
UT WOS:000291392000006
PM 21455729
OA Bronze
DA 2019-01-08
ER

PT J
AU O'Sullivan, EP
   Avalos, G
   O'Reilly, M
   Dennedy, MC
   Gaffney, G
   Dunne, F
AF O'Sullivan, E. P.
   Avalos, G.
   O'Reilly, M.
   Dennedy, M. C.
   Gaffney, G.
   Dunne, F.
CA Atlantic DIP Collaborators
TI Atlantic Diabetes in Pregnancy (DIP): the prevalence and outcomes of
   gestational diabetes mellitus using new diagnostic criteria
SO DIABETOLOGIA
LA English
DT Article
DE Atlantic DIP; Gestational diabetes mellitus; Maternal and neonatal
   outcomes; Pregnancy
ID INTERNATIONAL ASSOCIATION; GLUCOSE; HYPERGLYCEMIA; WOMEN
AB New diagnostic criteria for gestational diabetes mellitus (GDM) have recently been published. We wished to evaluate what impact these new criteria would have on GDM prevalence and outcomes in a predominantly European population.
   The Atlantic Diabetes In Pregnancy (DIP) programme performed screening for GDM in 5,500 women with an oral glucose tolerance test at 24-28 weeks. GDM was defined according to the new International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria and compared with previous WHO criteria; maternal and neonatal adverse outcomes were prospectively recorded.
   Of the participants, 12.4% and 9.4% were diagnosed with GDM using IADPSG and WHO criteria, respectively. IADPSG GDM pregnancies were associated with a statistically significant increased incidence of adverse maternal outcomes (gestational hypertension, polyhydramnios and Caesarean section) and neonatal outcomes (prematurity, large for gestational age, neonatal unit admission, neonatal hypoglycaemia and respiratory distress). The odds ratio for the development of these adverse outcomes remained significant after adjustment for maternal age, body mass index and non-European ethnicity. Those women who were classified as having normal glucose tolerance by WHO criteria but as having GDM by IADPSG criteria also had significant adverse pregnancy outcomes.
   GDM prevalence is higher when using newer IADPSG, compared with WHO, criteria, and these women and their offspring experience significant adverse pregnancy outcomes. Higher rates of GDM pose a challenge to healthcare systems, but improved screening provides an opportunity to attempt to reduce the associated morbidity for mother and child.
C1 [Dunne, F.] Natl Univ Ireland, Inst Clin Sci, Sch Med, Galway, Ireland.
   [O'Sullivan, E. P.; Avalos, G.; O'Reilly, M.; Dennedy, M. C.; Dunne, F.] Galway Univ Hosp, Dept Diabet, Galway, Ireland.
   [Gaffney, G.] Natl Univ Ireland, Dept Obstet & Gynaecol, Galway, Ireland.
RP Dunne, F (reprint author), Natl Univ Ireland, Inst Clin Sci, Sch Med, Galway, Ireland.
EM fidelma.dunne@nuigalway.ie
OI O'Reilly, Michael/0000-0002-9108-9105; Dennedy,
   Michael/0000-0001-9325-6520
FU Health Research Board of Ireland
FX Funding for the study was provided by the Health Research Board of
   Ireland.
CR Agarwal MM, 2010, DIABETES CARE, V33, P2018, DOI 10.2337/dc10-0572
   *AM DIAB ASS, 2010, DIABETES CARE S1, V34, pS15
   Central Statistics Office, 2009, POP MIGR EST APR 200
   Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973
   Dunne FP, 2009, DIABETES CARE, V32, P1205, DOI [10.2337/dc09-1118, 10.2337/dc09-0118]
   Griffin ME, 2000, DIABETIC MED, V17, P26, DOI 10.1046/j.1464-5491.2000.00214.x
   Harrington J., 2008, SLAN 2007 SURVEY LIF
   HOD M, 1991, DIABETES S2, V40, pS74
   Jovanovic L, 2001, JAMA-J AM MED ASSOC, V286, P2516, DOI 10.1001/jama.286.20.2516
   Landon MB, 2009, NEW ENGL J MED, V361, P1339, DOI 10.1056/NEJMoa0902430
   Langer O, 2000, CLIN OBSTET GYNECOL, V43, P283, DOI 10.1097/00003081-200006000-00006
   Lee PA, 2003, PEDIATRICS, V111, P1253, DOI 10.1542/peds.111.6.1253
   Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943
   Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848
   Ostlund I, 2003, DIABETES CARE, V26, P2107, DOI 10.2337/diacare.26.7.2107
   Owens LA, 2010, DIABETES CARE, V33, P577, DOI 10.2337/dc09-0911
   Rosenn B M, 2000, J Matern Fetal Med, V9, P29, DOI 10.3109/14767050009020509
   Stella CL, 2008, AM J PERINAT, V25, P325, DOI 10.1055/s-2008-1078758
   World Health Organization, 2006, DEF DIAGN DIAB MILL
NR 19
TC 137
Z9 140
U1 1
U2 13
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0012-186X
EI 1432-0428
J9 DIABETOLOGIA
JI Diabetologia
PD JUL
PY 2011
VL 54
IS 7
BP 1670
EP 1675
DI 10.1007/s00125-011-2150-4
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 774MZ
UT WOS:000291392000012
PM 21494772
OA Bronze
DA 2019-01-08
ER

PT J
AU Leyva, B
   Zagarins, SE
   Allen, NA
   Welch, G
AF Leyva, Bryan
   Zagarins, Sofija E.
   Allen, Nancy A.
   Welch, Garry
TI THE RELATIVE IMPACT OF DIABETES DISTRESS VS DEPRESSION ON GLYCEMIC
   CONTROL IN HISPANIC PATIENTS FOLLOWING A DIABETES SELF-MANAGEMENT
   EDUCATION INTERVENTION
SO ETHNICITY & DISEASE
LA English
DT Article
DE Diabetes Distress; Depression; Depressive Symptoms; Glycemic Control;
   Type 2 Diabetes; Intervention; Hispanic; Latino
ID EMOTIONAL DISTRESS; UNITED-STATES; PROBLEM AREAS; ADULTS; CARE;
   MELLITUS; GLUCOSE; ASSOCIATION; SYMPTOMS; UTILITY
AB Objectives: Studies in non-Hispanic populations have shown that depression and diabetes distress are associated with glycemic control. Although rates of depression and diabetes distress are high among Hispanics with diabetes, there is little research investigating the relationship between these factors and glycemic control in this population. The purpose of the current analysis was to examine the relative impact of change in diabetes distress and change in depressive symptoms on change in glycemic control in Hispanic patients following a diabetes self-management education (DSME) intervention.
   Design: We conducted a diabetes self-management education intervention in 23 Hispanic (predominantly Puerto Rican) and 168 non-Hispanic type 2 diabetes patients and measured glycemic control (HbA1c), depressive symptoms (CES-D), and diabetes distress (PAID) at baseline and 6 months.
   Results: In multiple linear regression, change in diabetes distress from baseline to six-month follow-up was significantly associated with change in HbA1c among Hispanic patients, such that a 10-point reduction on the PAID scale of diabetes distress was associated with a clinically significant reduction in HbA1c of .55 +/- .06% (P=.03). Change in depression was not associated with change in HbA1c (P=.59). Findings in non-Hispanic patients were similar.
   Conclusions: Change in diabetes distress, but not change in depressive symptoms, was associated with change in HbA1c in both Hispanic and non-Hispanic patients. This analysis supports the utility of DSME in reducing diabetes distress and improving glycemic control among Hispanic patients. (Ethn Dis. 2011;21(3):322-327)
C1 [Zagarins, Sofija E.; Welch, Garry] Baystate Med Ctr, Dept Behav Med Res, Springfield, MA 01105 USA.
   [Leyva, Bryan; Allen, Nancy A.] Boston Coll, William F Connell Sch Nursing, Chestnut Hill, MA 02167 USA.
RP Zagarins, SE (reprint author), Baystate Med Ctr, Dept Behav Med Res, 140 High St,Room 298, Springfield, MA 01105 USA.
EM Sofija.Zagarins@baystatehealth.org
OI Leyva, Bryan/0000-0003-1929-4910
FU National Institutes of Health [1R01DK-060076]
FX This research was supported by National Institutes of Health grant
   #1R01DK-060076.
CR Adriaanse MC, 2008, DIABETES CARE, V31, P2268, DOI 10.2337/dc08-1074
   AIKENS JE, 1994, J BEHAV MED, V17, P535, DOI 10.1007/BF01857596
   Albright TL, 2001, FAM MED, V33, P354
   Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x
   Carter JS, 1996, ANN INTERN MED, V125, P221, DOI 10.7326/0003-4819-125-3-199608010-00011
   *CDCP, 2004, MMWR-MORBID MORTAL W, V53, P941
   Centers for Disease Control and Prevention, 2007, NAT DIAB FACT SHEET
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2009, DIABETIC MED, V26, P622, DOI 10.1111/j.1464-5491.2009.02730.x
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Glassy CM, 2010, PSYCHOL HEALTH MED, V15, P117, DOI 10.1080/13548501003615274
   KAPLAN MS, 1990, SOC SCI MED, V31, P1313, DOI 10.1016/0277-9536(90)90070-9
   Katon WJ, 2004, ARCH GEN PSYCHIAT, V61, P1042, DOI 10.1001/archpsyc.61.10.1042
   Lewis-Fernandez R, 2005, J AM BOARD FAM PRACT, V18, P282, DOI 10.3122/jabfm.18.4.282
   Lin EHB, 2006, ANN FAM MED, V4, P46, DOI 10.1370/afm.423
   Narayan KMV, 2003, JAMA-J AM MED ASSOC, V290, P1884, DOI 10.1001/jama.290.14.1884
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Shao WA, 1997, J FAM PRACTICE, V44, P161
   Skaff MM, 2009, HEALTH PSYCHOL, V28, P265, DOI 10.1037/a0014429
   Spencer MS, 2006, J HEALTH CARE POOR U, V17, P88, DOI 10.1353/hpu.2006.0095
   Thomas JL, 2001, INT J PSYCHIAT MED, V31, P25, DOI 10.2190/FUFR-PK9F-6U10-JXRK
   van Bastelaar KMP, 2010, DIABETIC MED, V27, P798, DOI 10.1111/j.1464-5491.2010.03025.x
   WAUGH N, 2010, HLTH TECHNOL ASSESS, V14, P1
   Weinger K, 2005, DIABETES CARE, V28, P1346, DOI 10.2337/diacare.28.6.1346
   Welch G, 2003, DIABETIC MED, V20, P69, DOI 10.1046/j.1464-5491.2003.00832.x
   Welch G, 2007, ETHNIC DIS, V17, P541
   Welch G, 2011, DIABETES RES CLIN PR, V91, P54, DOI 10.1016/j.diabres.2010.09.036
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   Welch GW, 2007, TXB TYPE 2 DIABETES
NR 32
TC 13
Z9 14
U1 0
U2 12
PU INT SOC HYPERTENSION BLACKS-ISHIB
PI ATLANTA
PA 100 AUBURN AVE NE STE 401, ATLANTA, GA 30303-2527 USA
SN 1049-510X
J9 ETHNIC DIS
JI Ethn. Dis.
PD SUM
PY 2011
VL 21
IS 3
BP 322
EP 327
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 820UB
UT WOS:000294930500010
PM 21942165
DA 2019-01-08
ER

PT J
AU Weissberg-Benchell, J
   Antisdel-Lomaglio, J
AF Weissberg-Benchell, Jill
   Antisdel-Lomaglio, Jeanne
TI Diabetes-specific emotional distress among adolescents: feasibility,
   reliability, and validity of the problem areas in diabetes-teen version
SO PEDIATRIC DIABETES
LA English
DT Article
DE adolescents; emotional distress; measure development
ID GLYCEMIC CONTROL; TYPE-1; ASSOCIATION; SYMPTOMS; CHILDREN; ANXIETY
AB Weissberg-Benchell J, Antisdel-Lomaglio J. Diabetes-specific emotional distress among adolescents: feasibility, reliability, and validity of the problem areas in diabetes-teen version.
C1 [Weissberg-Benchell, Jill; Antisdel-Lomaglio, Jeanne] Northwestern Univ, Childrens Mem Hosp, Feinberg Sch Med, Chicago, IL 60614 USA.
RP Weissberg-Benchell, J (reprint author), Northwestern Univ, Childrens Mem Hosp, Feinberg Sch Med, 2300 Childrens Plaza,POB 10, Chicago, IL 60614 USA.
EM JWBenchell@childrensmemorial.org
CR Anderson BJ, 2002, DIABETIC MED, V19, P635, DOI 10.1046/j.1464-5491.2002.00752.x
   ANDERSON BJ, 1990, J PEDIATR PSYCHOL, V15, P477, DOI 10.1093/jpepsy/15.4.477
   Beck AT, 1996, BECK DEPRESSION INVE
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Grey M, 1997, NURS RES, V46, P312, DOI 10.1097/00006199-199711000-00003
   HANSON CL, 1987, J CONSULT CLIN PSYCH, V55, P529, DOI 10.1037/0022-006X.55.4.529
   Herzer M, 2010, J PEDIATR PSYCHOL, V35, P415, DOI 10.1093/jpepsy/jsp063
   Hood KK, 2006, DIABETES CARE, V29, P1389, DOI 10.2337/dc06-0087
   Hood KK, 2009, PEDIATRICS, V124, pE1171, DOI 10.1542/peds.2009-0207
   Ingersoll G M, 1991, Diabetes Educ, V17, P114, DOI 10.1177/014572179101700219
   KOVACS M, 1985, PSYCHOPHARMACOL BULL, V21, P995
   McKelvey J, 1993, Diabetes Educ, V19, P125, DOI 10.1177/014572179301900206
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 1996, DIABETES SPECTRUM, V9, P8
   Reynolds CR, 1997, J ABNORM CHILD PSYCH, V25, P15, DOI 10.1023/A:1025751206600
   SPEILBERGER C, 1973, MANUAL STATE TRAIT I
   Varni JW, 2003, DIABETES CARE, V26, P631, DOI 10.2337/diacare.26.3.631
   WEISSBERGBENCHELL J, 1995, DIABETES CARE, V18, P77, DOI 10.2337/diacare.18.1.77
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   Wysocki T, 2008, J PEDIATR PSYCHOL, V33, P875, DOI 10.1093/jpepsy/jsn024
NR 20
TC 37
Z9 38
U1 0
U2 13
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1399-543X
J9 PEDIATR DIABETES
JI Pediatr. Diabetes
PD JUN
PY 2011
VL 12
IS 4
BP 341
EP 344
DI 10.1111/j.1399-5448.2010.00720.x
PN 1
PG 4
WC Endocrinology & Metabolism; Pediatrics
SC Endocrinology & Metabolism; Pediatrics
GA 768UJ
UT WOS:000290963600009
PM 21443583
DA 2019-01-08
ER

PT J
AU Aida, J
   Kuriyama, S
   Ohmori-Matsuda, K
   Hozawa, A
   Osaka, K
   Tsuji, I
AF Aida, J.
   Kuriyama, S.
   Ohmori-Matsuda, K.
   Hozawa, A.
   Osaka, K.
   Tsuji, I.
TI The association between neighborhood social capital and self-reported
   dentate status in elderly Japanese - The Ohsaki Cohort 2006 Study
SO COMMUNITY DENTISTRY AND ORAL EPIDEMIOLOGY
LA English
DT Article
DE dental status; multilevel analysis; remaining teeth; social capital;
   social epidemiology
ID PSYCHOLOGICAL DISTRESS; ORAL-HEALTH; MULTILEVEL ANALYSIS; SCREENING
   SCALES; INEQUALITIES; ADOLESCENTS; VALIDATION; MORTALITY; CARIES
AB Objectives: Little is known about the influence of social capital on dental health. The aim of the present cross-sectional study was to determine the association between neighborhood social capital, individual social networks and social support and the number of remaining teeth in elderly Japanese.
   Methods: In December 2006, self-administered questionnaires were sent to 31 237 eligible community-dwelling individuals (response rate: 73.9%). Included in the analysis were 21 736 participants. Five neighborhood social capital variables were calculated from individual civic networks, sports and hobby networks, volunteer networks, friendship networks and social support variables. We used multilevel logistic regression models to estimate the odds ratio (OR) of having 20 or more teeth according to neighborhood social capital variables with adjustment for sex, age, individual social networks and social support, educational attainment, neighborhood educational level, dental health behavior, smoking status, history of diabetes and self-rated health.
   Results: The average age of the participants was 74.9 (standard deviation; 6.6) years, and 28.5% of them had 20 or more teeth. In the univariate multilevel model, there were statistically significant associations between neighborhood sports and hobby networks, friendship networks and self-reported dentate status. In the multivariable multilevel model, compared with participants living in lowest friendship network neighborhoods, those living in highest friendship network neighborhoods had an OR 1.17 (95% confidence interval, 1.04-1.30) times higher for having 20 or more teeth.
   Conclusions: There is a significant association between one network aspect of neighborhood social capital and individual dentate status regardless of individual social networks and social support.
C1 [Aida, J.] Tohoku Univ, Grad Sch Dent, Dept Int & Community Oral Hlth, Aoba Ku, Sendai, Miyagi 9808575, Japan.
   [Kuriyama, S.; Ohmori-Matsuda, K.; Hozawa, A.; Tsuji, I.] Tohoku Univ, Grad Sch Dent, Dept Publ Hlth & Forens Med, Div Epidemiol, Sendai, Miyagi 9808575, Japan.
RP Aida, J (reprint author), Tohoku Univ, Grad Sch Dent, Dept Int & Community Oral Hlth, Aoba Ku, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.
EM j-aida@umin.ac.jp
OI Aida, Jun/0000-0002-8405-9872
FU Ministry of Health, Labour and Welfare, Japan [H20-Junkanki
   (Seishuu)-Ippan-013, H21-Choju-Ippan-001]; Japan Society for the
   Promotion of Science [21390200]
FX This study was supported by Health and Labour Sciences Research Grants
   (H20-Junkanki (Seishuu)-Ippan-013, H21-Choju-Ippan-001) from the
   Ministry of Health, Labour and Welfare, Japan, and a Grant-in-Aid for
   Scientific Research (B) (21390200) from the Japan Society for the
   Promotion of Science. The authors thank Ms Yoshiko Nakata, Ms Mika
   Wagatsuma, Ms Naoko Sato, Ms Yuki Takeda and Dr Toru Tsuboya for their
   technical assistance.
CR Aida J, 2008, COMMUNITY DENT ORAL, V36, P149, DOI 10.1111/j.1600-0528.2007.00380.x
   Aida J, 2009, SOC SCI MED, V69, P512, DOI 10.1016/j.socscimed.2009.06.003
   Blakely T., 2006, METHODS SOCIAL EPIDE, P316
   Boyapati L, 2007, PERIODONTOL 2000, V44, P195, DOI 10.1111/j.1600-0757.2007.00211.x
   Carpiano RM, 2006, SOC SCI MED, V62, P165, DOI 10.1016/j.socscimed.2005.05.020
   *FED DENT INT, 1982, INT DENT J, V32, P74
   Furukawa TA, 2003, PSYCHOL MED, V33, P357, DOI 10.1017/S0033291702006700
   Harpham T., 2008, SOCIAL CAPITAL HLTH, P51, DOI DOI 10.1007/978-0-387-71311-3_3
   Hox J., 2002, MULTILEVEL ANAL TECH
   Kawachi I, 1997, AM J PUBLIC HEALTH, V87, P1491, DOI 10.2105/AJPH.87.9.1491
   Kawachi I, 2008, SOCIAL CAPITAL HLTH, V10, P1, DOI DOI 10.1007/978-0-387-71311-3_1
   Kawachi Ichiro, 2000, SOCIAL EPIDEMIOLOGY, P174
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Kuriyama S, 2010, J EPIDEMIOL, V20, P253, DOI 10.2188/jea.JE20090093
   LANDRINE H, 1994, J BEHAV MED, V17, P331, DOI 10.1007/BF01857956
   LEYLAND AH, 2001, MULTILEVEL MODELLING
   Macintyre S, 2002, SOC SCI MED, V55, P125, DOI 10.1016/S0277-9536(01)00214-3
   Marmot M., 1999, SOCIAL DETERMINANTS
   Muraoka Y, 1996, RONEN SEISHIN IGAKU, V7, P397
   Ogawa K, 2003, PUBLIC HEALTH NUTR, V6, P147, DOI 10.1079/PHN2002411
   Pattussi MP, 2006, COMMUNITY DENT ORAL, V34, P344, DOI 10.1111/j.1600-0528.2006.00283.x
   Pattussi MP, 2006, AM J PUBLIC HEALTH, V96, P1462, DOI 10.2105/AJPH.2005.066159
   Persson GR, 2003, J CLIN PERIODONTOL, V30, P691, DOI 10.1034/j.1600-051X.2003.00360.x
   Phongsavan P, 2006, SOC SCI MED, V63, P2546, DOI 10.1016/j.socscimed.2006.06.021
   Pitiphat W, 2002, J PUBLIC HEALTH DENT, V62, P122, DOI 10.1111/j.1752-7325.2002.tb03432.x
   Putnam Robert, 1993, MAKING DEMOCRACY WOR, P167
   Rasbash J., 2009, USERS GUIDE MLWIN VE
   Scheffler RM, 2008, SOC SCI MED, V66, P1603, DOI 10.1016/j.socscimed.2007.12.007
   Shimizu Hiroyuki, 2002, J Epidemiol, V12, P54
   Sisson KL, 2007, COMMUNITY DENT ORAL, V35, P81, DOI 10.1111/j.1600-0528.2007.00354.x
   Suzuki I, 1998, J Epidemiol, V8, P152
   Suzuki Naoko, 2007, Nihon Ronen Igakkai Zasshi, V44, P619, DOI 10.3143/geriatrics.44.619
   Watt RG, 2007, COMMUNITY DENT ORAL, V35, P1, DOI 10.1111/j.1600-0528.2007.00348.x
   Wilkinson RG, 1998, SOCIOL HEALTH ILL, V20, P578, DOI 10.1111/1467-9566.00120
NR 34
TC 22
Z9 24
U1 0
U2 16
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0301-5661
J9 COMMUNITY DENT ORAL
JI Community Dentist. Oral Epidemiol.
PD JUN
PY 2011
VL 39
IS 3
BP 239
EP 249
DI 10.1111/j.1600-0528.2010.00590.x
PG 11
WC Dentistry, Oral Surgery & Medicine; Public, Environmental & Occupational
   Health
SC Dentistry, Oral Surgery & Medicine; Public, Environmental & Occupational
   Health
GA 764JS
UT WOS:000290626400006
PM 21091754
DA 2019-01-08
ER

PT J
AU Wiltink, J
   Beutel, ME
   Till, Y
   Ojeda, FM
   Wild, PS
   Munzel, T
   Blankenberg, S
   Michal, M
AF Wiltink, Joerg
   Beutel, Manfred E.
   Till, Yvonne
   Ojeda, Francisco M.
   Wild, Philipp S.
   Muenzel, Thomas
   Blankenberg, Stefan
   Michal, Matthias
TI Prevalence of distress, comorbid conditions and well being in the
   general population
SO JOURNAL OF AFFECTIVE DISORDERS
LA English
DT Article
DE Anxiety; Community; Depression; Somatic comorbidity; Type D; Well being
ID CORONARY-HEART-DISEASE; PATIENT HEALTH QUESTIONNAIRE; MENTAL-DISORDERS;
   D PERSONALITY; MAJOR DEPRESSION; SEX-DIFFERENCES; PANIC DISORDER;
   CARDIAC EVENTS; PSYCHIATRIC-DISORDERS; METABOLIC SYNDROME
AB Background: The purposes of this paper are to determine the prevalence of distress in the community, to identify its determinants and to assess its relationship to somatic conditions and subjective well being.
   Methods: Distress and associated factors were investigated in a random sample of 5000 participants (35-74 years) of a community-based, prospective, observational cohort study in western Mid-Germany ("Gutenberg Heart Study") between 04/2007 and 10/2008. The sample was stratified 1:1 for gender and residence and in equal strata for decades of age. Data were assessed by self-report instruments, interviews and medical examination.
   Results: We found a prevalence rate for depression of 7.2% (6.5-8.0%), social anxiety 7.0% (6.3-7.7%), panic 4.6% (4.0-5.2%), generalized anxiety 3.4% (2.9-3.9%), and Type D personality 22.1% (21.0-23.2%). Mental conditions declined by age. Depression was related to diabetes (OR = 1.99, 95% Cl = 1.26-3.15), dyslipidemia (OR = 1.35, 95% Cl = 1.02-1.79), coronary heart disease (CHD; OR = 1.88, 95% Cl = 1.04-3.39), and the history of stroke (OR = 2.43, 95% Cl = 1.02-5.76). Panic was related to the history of myocardial infarction (OR = 2.46, 95% CI = 1.15-5.25), and generalized anxiety to obesity (OR = 1.65, 95% CI = 1.11-2.44). Mental distress was unrelated to hypertension, atrial fibrillation and cancer. In ordinal logistic regression subjective physical and mental well being were associated with anxiety, depression and Type D personality.
   Conclusions: While mental conditions' are highly prevalent, especially depression is associated with several somatic conditions. Mental and physical well being are strongly related to mental conditions. Future work should take into account comorbid conditions when identifying the impact of depression on CHD. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Wiltink, Joerg; Beutel, Manfred E.; Till, Yvonne; Michal, Matthias] Johannes Gutenberg Univ Mainz, Clin Psychosomat Med & Psychotherapy, Univ Med Ctr, D-55131 Mainz, Germany.
   [Till, Yvonne; Ojeda, Francisco M.; Wild, Philipp S.; Muenzel, Thomas; Blankenberg, Stefan] Johannes Gutenberg Univ Mainz, Clin Cardiol, Univ Med Ctr, D-55131 Mainz, Germany.
RP Wiltink, J (reprint author), Johannes Gutenberg Univ Mainz, Clin Psychosomat Med & Psychotherapy, Univ Med Ctr, Untere Zahlbacher Str 8, D-55131 Mainz, Germany.
EM joerg.wiltink@unimedizin-mainz.de
CR Akbaraly TN, 2009, DIABETES CARE, V32, P499, DOI 10.2337/dc08-1358
   Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P38
   ALONSO J, 2000, J CLIN PSYCHIAT S2, V68, P3
   Appelros P, 2009, STROKE, V40, P1082, DOI 10.1161/STROKEAHA.108.540781
   Baumeister H, 2007, INT J OBESITY, V31, P1155, DOI 10.1038/sj.ijo.0803556
   Becker ES, 2001, INT J OBESITY, V25, pS5, DOI 10.1038/sj.ijo.0801688
   BEEKMAN ATF, 1995, SOC PSYCH PSYCH EPID, V30, P32, DOI 10.1007/BF00784432
   Beutel ME, 2002, EUR UROL, V41, P85, DOI 10.1016/S0302-2838(01)00003-3
   Birmaher B, 1996, J AM ACAD CHILD PSY, V35, P1427, DOI 10.1097/00004583-199611000-00011
   Carpenter KM, 2000, AM J PUBLIC HEALTH, V90, P251, DOI 10.2105/AJPH.90.2.251
   Chen YH, 2009, PSYCHOSOM MED, V71, P798, DOI 10.1097/PSY.0b013e3181ad55e3
   Connor KM, 2001, DEPRESS ANXIETY, V14, P137, DOI 10.1002/da.1055
   Denollet J, 2006, AM J CARDIOL, V97, P970, DOI 10.1016/j.amjcard.2005.10.035
   Denollet J, 2005, PSYCHOSOM MED, V67, P89, DOI 10.1097/01.psy.0000149256.81953.49
   Fehm L, 2008, SOC PSYCH PSYCH EPID, V43, P257, DOI 10.1007/s00127-007-0299-4
   Fleet R, 2000, J PSYCHOSOM RES, V48, P347, DOI 10.1016/S0022-3999(99)00101-4
   Frasure-Smith N, 2008, ARCH GEN PSYCHIAT, V65, P62, DOI 10.1001/archgenpsychiatry.2007.4
   Frasure-Smith N, 2010, POSTGRAD MED J, V86, P193, DOI 10.1136/hrt.2009.186957
   Gilbody S, 2007, J GEN INTERN MED, V22, P1596, DOI 10.1007/s11606-007-0333-y
   Goldbacher EM, 2007, ANN BEHAV MED, V34, P240, DOI 10.1007/BF02874549
   Goldbacher EM, 2009, PSYCHOSOM MED, V71, P266, DOI 10.1097/PSY.0b013e318197a4d5
   Grande G, 2004, PSYCHOTHER PSYCH MED, V54, P413, DOI 10.1088/s-2004-828376
   Hach I, 2007, EUR J PUBLIC HEALTH, V17, P297, DOI 10.1093/eurpub/ckl227
   Heo M, 2006, INT J OBESITY, V30, P513, DOI 10.1038/sj.ijo.0803122
   Herva A, 2006, INT J OBESITY, V30, P520, DOI 10.1038/sj.ijo.0803174
   Jacobi F, 2004, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V47, P736
   Jacobi F, 2004, PSYCHOL MED, V34, P597, DOI 10.1017/S0033291703001399
   John U, 2005, OBES RES, V13, P101, DOI 10.1038/oby.2005.13
   Katon W, 2007, GEN HOSP PSYCHIAT, V29, P147, DOI 10.1016/j.genhosppsych.2006.11.005
   Katon WJ, 2003, ARCH GEN PSYCHIAT, V60, P897, DOI 10.1001/archpsyc.60.9.897
   Kessler RC, 2003, J OCCUP ENVIRON MED, V45, P1257, DOI 10.1097/01.jom.0000100000.70011.bb
   Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617
   KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8
   KNAUPER B, 1994, J PSYCHIATR RES, V28, P147, DOI 10.1016/0022-3956(94)90026-4
   Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004
   Kuehner C, 2003, ACTA PSYCHIAT SCAND, V108, P163, DOI 10.1034/j.1600-0447.2003.00204.x
   Ladwig KH, 2008, PSYCHIAT RES, V161, P248, DOI 10.1016/j.psychres.2008.03.011
   Lamertz CM, 2002, OBES RES, V10, P1152, DOI 10.1038/oby.2002.156
   Lichtman JH, 2008, CIRCULATION, V118, P1768, DOI 10.1161/CIRCULATIONAHA.108.190769
   Lowe B, 2004, PSYCHOTHER PSYCHOSOM, V73, P386, DOI 10.1159/000080393
   Lowe B, 2003, J PSYCHOSOM RES, V55, P515, DOI 10.1016/S0022-3999(03)00072-2
   McElroy SL, 2004, J CLIN PSYCHIAT, V65, P634
   McManus D, 2005, AM J CARDIOL, V96, P1076, DOI 10.1016/j.amjcard.2005.06.037
   Miettola J, 2008, SCAND J PRIM HEALTH, V26, P203, DOI 10.1080/02813430802117624
   Onyike CU, 2003, AM J EPIDEMIOL, V158, P1139, DOI 10.1093/aje/kwg275
   Pedersen SS, 2003, EUR J CARDIOV PREV R, V10, P241, DOI 10.1097/01.hjr.0000085246.65733.06
   Pedersen SS, 2006, CURR CARDIOL REV, V2, P205, DOI 10.2174/157340306778019441
   PETERSON B, 1990, APPL STAT-J ROY ST C, V39, P205
   Poynter B, 2009, PSYCHOSOMATICS, V50, P563, DOI 10.1176/appi.psy.50.6.563
   Roberts RE, 2000, AM J EPIDEMIOL, V152, P163, DOI 10.1093/aje/152.2.163
   Seeley-Wait Elizabeth, 2009, Prim Care Companion J Clin Psychiatry, V11, P231, DOI 10.4088/PCC.07m00576
   Spindler H, 2009, INT J BEHAV MED, V16, P98, DOI 10.1007/s12529-009-9037-5
   Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737
   Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092
   Stokes ME, 2000, CATEGORICAL DATA ANA
   Walters K, 2008, EUR HEART J, V29, P2981, DOI 10.1093/eurheartj/ehn477
   Weissman MM, 1996, JAMA-J AM MED ASSOC, V276, P293, DOI 10.1001/jama.276.4.293
   Williams L, 2008, J PSYCHOSOM RES, V64, P63, DOI 10.1016/j.jpsychores.2007.06.008
   Wittchen H U, 2001, BUNDESGESUNDHEITSBLA, V44, P993, DOI DOI 10.1007/S001030100269
   Wittchen HU, 1998, PSYCHOL MED, V28, P109, DOI 10.1017/S0033291797005928
   Wittchen HU, 2005, EUR NEUROPSYCHOPHARM, V15, P357, DOI 10.1016/j.euroneuro.2005.04.012
NR 61
TC 40
Z9 41
U1 1
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-0327
EI 1573-2517
J9 J AFFECT DISORDERS
JI J. Affect. Disord.
PD MAY
PY 2011
VL 130
IS 3
BP 429
EP 437
DI 10.1016/j.jad.2010.10.041
PG 9
WC Clinical Neurology; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 771WT
UT WOS:000291192100009
PM 21106250
DA 2019-01-08
ER

PT J
AU Donald, M
   Ware, RS
   Ozolins, IZ
   Begum, N
   Crowther, R
   Bain, C
AF Donald, Maria
   Ware, Robert S.
   Ozolins, Ieva Z.
   Begum, Nelufa
   Crowther, Ruth
   Bain, Christopher
TI The role of patient activation in frequent attendance at primary care: A
   population-based study of people with chronic disease
SO PATIENT EDUCATION AND COUNSELING
LA English
DT Article
DE Patient activation; Health service utilisation; Frequent attenders;
   Chronic illness
ID SELF-MANAGEMENT; GENERAL-PRACTICE; HEALTH; ATTENDERS; PROGRAM; COPD; ILL
AB Objective: This study explores a range of relevant socio-demographic, physical and psychological factors in a unique examination of the risk factors for frequent attendance at primary care. The impact of patient activation for self-management on health service utilisation is of particular interest.
   Methods: A population-based sample of people with chronic disease from Queensland, Australia, was interviewed using computer assisted telephone surveying. Data were collected from a random sample of 1470 people with either diabetes or a cardiovascular condition.
   Results: As participants became more activated they were less likely to frequently attend their main health care provider for assistance with their chronic condition. For both conditions the association was graduated and for participants with a cardiovascular condition this association remained statistically significant even after controlling for other potentially influential factors such as disease severity, length of time since diagnosis, and psychological distress.
   Conclusion: Characteristics of the individual, including patient activation and psychological functioning, as well as disease factors contribute to primary care consulting patterns among people with chronic illness.
   Practical implications: Efforts to improve patient activation for self-management should remain a central element of chronic care. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
C1 [Donald, Maria; Ware, Robert S.; Ozolins, Ieva Z.; Begum, Nelufa; Crowther, Ruth; Bain, Christopher] Univ Queensland, Sch Populat Hlth, Herston, Qld 4006, Australia.
RP Donald, M (reprint author), Univ Queensland, Sch Populat Hlth, Herston, Qld 4006, Australia.
EM m.donald@sph.uq.edu.au
RI Donald, Maria/G-2532-2010; Ware, Robert/B-2024-2014; Crowther,
   Ruth/K-8461-2014
OI Ware, Robert/0000-0002-6129-6736; Crowther, Ruth/0000-0002-7628-5618;
   Donald, Maria/0000-0002-4962-7627
FU Queensland Health
FX This research was funded by Queensland Health through the Queensland
   Strategy for Chronic Disease 2005-2015.
CR Battersby MW, 2005, BRIT MED J, V330, P662, DOI 10.1136/bmj.330.7492.662
   Bourbeau J, 2006, CHEST, V130, P1704, DOI 10.1378/chest.130.6.1704
   Carney TA, 2001, BRIT J GEN PRACT, V51, P567
   deBoer AGEM, 1997, HEALTH POLICY, V42, P101, DOI 10.1016/S0168-8510(97)00062-6
   *DIAB AUSTR ROYAL, 2009, DIAB MAN GEN PRACT G
   Dowrick C, 2006, MED J AUSTRALIA, V185, P61
   Elzen H, 2008, J EVAL CLIN PRACT, V14, P159, DOI 10.1111/j.1365-2753.2007.00791.x
   Field KS, 2001, HEALTH SOC CARE COMM, V9, P294, DOI 10.1046/j.0966-0410.2001.00303.x
   Foster A, 2006, FAM PRACT, V23, P444, DOI 10.1093/fampra/cml019
   Foster G, 2007, COCHRANE DATABASE SY
   Furukawa TA, 2003, PSYCHOL MED, V33, P357, DOI 10.1017/S0033291702006700
   Hansell A, 2003, EUR RESPIR J, V21, P279, DOI 10.1183/09031936.03.00006102
   Heywood PL, 1998, FAM PRACT, V15, P198, DOI 10.1093/fampra/15.3.198
   Hibbard JH, 2005, HEALTH SERV RES, V40, P1918, DOI 10.1111/j.1475-6773.2005.00438.x
   Hibbard JH, 2004, HEALTH SERV RES, V39, P1005, DOI 10.1111/j.1475-6773.2004.00269.x
   Kennedy A, 2007, J EPIDEMIOL COMMUN H, V61, P254, DOI 10.1136/jech.2006.053538
   Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184
   Lorig KR, 2001, MED CARE, V39, P1217, DOI 10.1097/00005650-200111000-00008
   Naessens JA, 2005, ANN FAM MED, V3, P324, DOI 10.1370/afm.352
   Nolte E.E., 2008, EUROPEAN OBSERVATORY
   Queensland Health, 2005, QUEENSL STRAT CHRON
   SCHRIRE S, 1986, FAM PRACT, V3, P272, DOI 10.1093/fampra/3.4.272
   Vedsted P, 2005, PUBLIC HEALTH, V119, P118, DOI 10.1016/j.puhe.2004.03.007
   Wagner E H, 1998, Eff Clin Pract, V1, P2
   Wetzels R, 2005, J AM GERIATR SOC, V53, P918, DOI 10.1111/j.1532-5415.2005.53278_8.x
NR 25
TC 20
Z9 20
U1 0
U2 14
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0738-3991
J9 PATIENT EDUC COUNS
JI Patient Educ. Couns.
PD MAY
PY 2011
VL 83
IS 2
BP 217
EP 221
DI 10.1016/j.pec.2010.05.031
PG 5
WC Public, Environmental & Occupational Health; Social Sciences,
   Interdisciplinary
SC Public, Environmental & Occupational Health; Social Sciences - Other
   Topics
GA 768JC
UT WOS:000290929200014
PM 20598825
DA 2019-01-08
ER

PT J
AU Ting, RZW
   Nan, H
   Yu, MWM
   Kong, APS
   Ma, RCW
   Wong, RYM
   Loo, K
   So, WY
   Chow, CC
   Ko, GTC
   Wing, YK
   Chan, JCN
AF Ting, Rose Z. W.
   Nan, Hairong
   Yu, Mandy W. M.
   Kong, Alice P. S.
   Ma, Ronald C. W.
   Wong, Rebecca Y. M.
   Loo, Kitman
   So, Wing-Yee
   Chow, Chun-Chung
   Ko, Gary T. C.
   Wing, Yun-Kwok
   Chan, Juliana C. N.
TI Diabetes-Related Distress and Physical and Psychological Health in
   Chinese Type 2 Diabetic Patients
SO DIABETES CARE
LA English
DT Article
ID QUALITY-OF-LIFE; SCALE; OBESITY
AB OBJECTIVE-To validate a Chinese version of the Diabetes Distress Scale (CDDS).
   RESEARCH DESIGN AND METHODS-The CDDS was derived using forward-backward translation and administered in 189 Chinese type 2 diabetic patients with evaluation of its psychometric properties.
   RESULTS-On the basis of principal-component analysis, three factors of the 15-item version of the CDDS (CDDS-15) accounted for 63% of the variance. The correlation coefficient between the original 17-item and 15-item scales was 0.99. The Cronbach alpha for internal consistency was 0.90, and the test-retest reliability coefficient was 0.74. The CDDS-15 score was significantly associated with glycemic control, obesity, depressive symptoms, and quality of life.
   CONCLUSIONS-The CDDS-15 is a valid and reliable instrument to assess diabetes-related distress.
C1 [Ting, Rose Z. W.; Kong, Alice P. S.; Ma, Ronald C. W.; Wong, Rebecca Y. M.; Loo, Kitman; So, Wing-Yee; Chow, Chun-Chung; Ko, Gary T. C.; Chan, Juliana C. N.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China.
   [Nan, Hairong; So, Wing-Yee; Ko, Gary T. C.; Chan, Juliana C. N.] Chinese Univ Hong Kong, Prince Wales Hosp, Hong Kong Inst Diabet & Obes, Hong Kong, Hong Kong, Peoples R China.
   [Yu, Mandy W. M.; Wing, Yun-Kwok] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China.
RP Chan, JCN (reprint author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China.
EM jchan@cuhk.edu.hk
RI Chan, Juliana/B-7918-2016; Ma, Ronald/C-2788-2009; Kong,
   Alice/P-3703-2015
OI Chan, Juliana/0000-0003-1325-1194; Ma, Ronald/0000-0002-1227-803X; Wing,
   Yun kwok/0000-0002-5745-5474
CR Cheung CK, 1998, J PSYCHOL, V132, P169, DOI 10.1080/00223989809599157
   Fisher L, 2009, DIABETIC MED, V26, P622, DOI 10.1111/j.1464-5491.2009.02730.x
   Hlatky MA, 2010, AM HEART J, V159, DOI 10.1016/j.ahj.2009.11.004
   Katz DA, 2000, J GEN INTERN MED, V15, P789, DOI 10.1046/j.1525-1497.2000.90906.x
   Kong APS, 2006, CURR DIABETES REV, V2, P397, DOI 10.2174/1573399810602040397
   Mullan JT, 2006, DIABETES, V55, pA426
   Phillips MR, 2009, LANCET, V373, P2041, DOI 10.1016/S0140-6736(09)60660-7
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Yang XL, 2008, CAN MED ASSOC J, V179, P427, DOI 10.1503/cmaj.071474
   Yeung A, 2008, COMPR PSYCHIAT, V49, P211, DOI 10.1016/j.comppsych.2006.06.002
NR 12
TC 31
Z9 34
U1 0
U2 8
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
J9 DIABETES CARE
JI Diabetes Care
PD MAY
PY 2011
VL 34
IS 5
BP 1094
EP 1096
DI 10.2337/dc10-1612
PG 3
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 761RV
UT WOS:000290419200007
PM 21398526
OA Green Published, Other Gold
DA 2019-01-08
ER

PT J
AU Gonder-Frederick, LA
   Schmidt, KM
   Vajda, KA
   Greear, ML
   Singh, H
   Shepard, JA
   Cox, DJ
AF Gonder-Frederick, Linda A.
   Schmidt, Karen M.
   Vajda, Karen A.
   Greear, Megan L.
   Singh, Harsimran
   Shepard, Jaclyn A.
   Cox, Daniel J.
TI Psychometric Properties of the Hypoglycemia Fear Survey-II for Adults
   With Type 1 Diabetes
SO DIABETES CARE
LA English
DT Article
ID FIT INDEXES; RELIABILITY; INVENTORY; VALIDITY; EPISODES; VERSION
AB OBJECTIVE-To perform the first comprehensive psychometric evaluation of the Hypoglycemia Fear Survey-II (HFS-II), a measure of the behavioral and affective dimensions of fear of hypoglycemia, using modern test-theory methods, including item-response theory (IRT).
   RESEARCH DESIGN AND METHODS-Surveys completed in four previous studies by 777 adults with type 1 diabetes were aggregated for analysis, with 289 subjects completing both subscales of the HFS-II and 488 subjects completing only the Worry subscale. The aggregated sample (53.3% female, 44.4% using insulin pumps) had a mean age of 41.9 years, diabetes duration of 23.8 years, HbA(1c) value of 7.7%, and 1.4 severe hypoglycemic episodes in the past year. Data analysis included exploratory factor analysis using polychoric correlations and IRT. Factors were analyzed for fit, trait-level locations, point-measure correlations, and separation values.
   RESULTS-Internal and test-retest reliability was good, as well as convergent validity, as demonstrated by significant correlations with other measures of psychological distress. Scores were significantly higher in subjects who had experienced severe hypoglycemia in the past year. Factor analyses validated the two subscales of the HFS-II. Item analyses showed that 12 of 15 items on the Behavior subscale, and all of the items on the Worry subscale had good-fit statistics.
   CONCLUSIONS-The HFS-II is a reliable and valid measure of the fear of hypoglycemia in adults with type 1 diabetes, and actor analyses and IRT support the two separate subscales of the survey. Diabetes Care 34:801-806, 2011
C1 [Gonder-Frederick, Linda A.; Vajda, Karen A.; Greear, Megan L.; Singh, Harsimran; Shepard, Jaclyn A.; Cox, Daniel J.] Univ Virginia, Hlth Sci Ctr, Charlottesville, VA 22903 USA.
   [Schmidt, Karen M.] Univ Virginia, Dept Psychol, Charlottesville, VA 22903 USA.
RP Gonder-Frederick, LA (reprint author), Univ Virginia, Hlth Sci Ctr, Charlottesville, VA 22903 USA.
EM lag3g@virginia.edu
FU National Institutes of Health, National Institute of Diabetes and
   Digestive and Kidney Diseases [R21-DK-080896, R01-DK-028288,
   R01-DK-051562]; LifeScan (Milpitas, CA)
FX This research was supported in part by National Institutes of Health,
   National Institute of Diabetes and Digestive and Kidney Diseases Grants
   R21-DK-080896, R01-DK-028288, and R01-DK-051562 and a grant from
   LifeScan (Milpitas, CA). No other potential conflicts of interest
   relevant to this article were reported.
CR Anderbro T, 2008, PATIENT EDUC COUNS, V73, P127, DOI 10.1016/j.pec.2008.03.022
   BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893
   BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561
   BENDER PM, 1980, PSYCHOL BULL, V88, P588, DOI DOI 10.1037/0033-2909.88.3.588
   BROWNE MW, 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005
   Clarke WL, 1998, J PEDIATR ENDOCR MET, V11, P189
   COX D, 1995, DIABETES CARE, V18, P523, DOI 10.2337/diacare.18.4.523
   Cox DJ, 2009, DIABETES CARE, V32, P2177, DOI 10.2337/dc08-1510
   COX DJ, 1987, DIABETES CARE, V10, P617, DOI 10.2337/diacare.10.5.617
   COX DJ, 1990, DIABETES CARE, V13, P458, DOI 10.2337/diacare.13.4.458
   Embretson S. W., 1999, NEW RULES MEASUREMEN
   Gilbert RE, 2008, CAN J DIABETES, V32, P101, DOI 10.1016/S1499-2671(08)90000-9
   Gonder-Frederick LA, 2006, PEDIATR DIABETES, V7, P215, DOI 10.1111/j.1399-5448.2006.00182.x
   GonderFrederick L, 1997, DIABETES CARE, V20, P1543, DOI 10.2337/diacare.20.10.1543
   Hu LT, 1998, PSYCHOL METHODS, V3, P424, DOI 10.1037//1082-989X.3.4.424
   Irvin A, 1994, HDB PSYCHOL DIABETES, P133
   Kovatchev Boris P, 2003, Diabetes Technol Ther, V5, P817, DOI 10.1089/152091503322527021
   Linacre JM, WINSTEPS RASCH MODEL
   Marsh HW, 2004, STRUCT EQU MODELING, V11, P320, DOI 10.1207/s15328007sem1103_2
   Muthen L. K., 1998, MPLUS USERS GUIDE VE
   Shiu ATY, 2004, PUBLIC HEALTH NURS, V21, P257, DOI 10.1111/j.0737-1209.2004.21308.x
   SPIELBERGER C, 1979, STATE TRAIT PERSONAL
   Stargardt T, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-91
   Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003
NR 24
TC 72
Z9 75
U1 1
U2 8
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
J9 DIABETES CARE
JI Diabetes Care
PD APR
PY 2011
VL 34
IS 4
BP 801
EP 806
DI 10.2337/dc10-1343
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 746DE
UT WOS:000289221800003
PM 21346182
OA Other Gold, Green Published
DA 2019-01-08
ER

PT J
AU Anderson, RT
   Narayan, KMV
   Feeney, P
   Goff, D
   Ali, MK
   Simmons, DL
   Sperl-Hillen, JA
   Bigger, T
   Cuddihy, R
   O'Conner, PJ
   Sood, A
   Zhang, P
   Sullivan, MD
AF Anderson, Roger T.
   Narayan, K. M. Venkat
   Feeney, Patricia
   Goff, David, Jr.
   Ali, Mohammed K.
   Simmons, Debra L.
   Sperl-Hillen, Jo-Ann
   Bigger, Thomas
   Cuddihy, Robert
   O'Conner, Patrick J.
   Sood, Ajay
   Zhang, Ping
   Sullivan, Mark D.
CA Action Control Cardiovasc Risk
TI Effect of Intensive Glycemic Lowering on Health-Related Quality of Life
   in Type 2 Diabetes ACCORD trial
SO DIABETES CARE
LA English
DT Article
ID CONTROL CARDIOVASCULAR RISK; MELLITUS; DEPRESSION; SATISFACTION;
   SEVERITY; UTILITY; DESIGN; ADULTS; CARE
AB OBJECTIVE-To compare the effect of intensive versus standard glycemic control strategies on health-related quality of life (HRQL) in a substudy of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.
   RESEARCH DESIGN AND METHODS-A randomly selected subsample of 2,053 ACCORD participants enrolled fit the HRQL substudy was assessed at baseline and 12-, 36-, and 48-month visits. HRQL assessment included general health status (the 36-Item Short Form Health Survey [SF-36]), diabetes symptoms (the Diabetes Symptom Distress Checklist), depression (Patient Health Questionnaire [PHQ]-9), and treatment satisfaction (Diabetes Treatment Satisfaction Questionnaire [DTSQ]). Repeated-measures ANOVA models were used to estimate change in HRQL outcomes by treatment group over 48 months adjusting for model covariates. The effects of early discontinuation of the ACCORD intensive glycemic control arm on study results were explored.
   RESULTS-A total of 1,956 (95%) completed the self-report HRQL instrument (s) at baseline. The intensive arm had a larger decrease in SF-36 physical health component score than the standard arm (-1.6 vs. -1.1, P = 0.0345). Treatment satisfaction (DTSQ) showed larger improvement with intensive than standard (P = 0.0004). There were no differences in mean scores of the Diabetes Symptom Checklist and PHQ-9. Effects of participant transition following discontinuation of the intensive arm on HRQL were not significant.
   CONCLUSIONS-The ACCORD trial strategy of intensive glycemic control did not lead to benefits in HRQL and was associated with modest improvement in diabetes treatment satisfaction. Thus patient acceptability was apparently not compromised with intensive and complex interventions such as those used in ACCORD. Diabetes Care 34:807-812, 2011
C1 [Anderson, Roger T.] Penn State Univ, Coll Med, Dept Publ Hlth Sci, Hershey, PA USA.
   [Narayan, K. M. Venkat; Ali, Mohammed K.] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.
   [Narayan, K. M. Venkat] Emory Univ, Sch Med, Atlanta, GA USA.
   [Feeney, Patricia] Wake Forest Univ Hlth Sci, Winston Salem, NC USA.
   [Goff, David, Jr.] Wake Forest Univ, Dept Epidemiol, Sch Med, Winston Salem, NC 27109 USA.
   [Goff, David, Jr.] Wake Forest Univ, Dept Internal Med, Sch Med, Winston Salem, NC 27109 USA.
   [Goff, David, Jr.] Wake Forest Univ, Dept Social Sci & Hlth Policy, Winston Salem, NC 27109 USA.
   [Simmons, Debra L.] Cent Arkansas Vet Healthcare Syst, Little Rock, AR USA.
   [Simmons, Debra L.] Univ Arkansas Med Sci, Little Rock, AR 72205 USA.
   [Sperl-Hillen, Jo-Ann; O'Conner, Patrick J.] HealthPartners Res Fdn, Minneapolis, MN USA.
   [Bigger, Thomas] Columbia Univ, Coll Phys & Surg, New York, NY USA.
   [Sood, Ajay] Case Western Reserve Univ, Cleveland, OH 44106 USA.
   [Zhang, Ping] Ctr Dis Control & Prevent, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA.
   [Sullivan, Mark D.] Univ Washington, Sch Med, Seattle, WA USA.
RP Anderson, RT (reprint author), Penn State Univ, Coll Med, Dept Publ Hlth Sci, Hershey, PA USA.
EM rtanders@psu.edu
RI Narayan, K.M. Venkat/J-9819-2012
OI Narayan, K.M. Venkat/0000-0001-8621-5405
FU National Heart, Lung, and Blood Institute [N01-HC-95178, N01-HC-95179,
   N01-HC-95180, N01-HC-95181, N01-HC-95182, N01-HC-95183, N01-HC-95184,
   IAA-Y1-HC-9035, IAA-Y1-HC-1010]; National Institutes of Health; National
   Institute of Diabetes and Digestive and Kidney Diseases; National
   Institute on Aging; National Eye Institute; Centers for Disease Control
   and Prevention; General Clinical Research Centers; Merck; GSK; Lilly;
   Abbott Laboratories through HealthPartners Research Foundation; Amylin;
   Abbott; Bayer; Daiichi Sankyo; Dexcom; Edwards Life-sciences; Eli Lilly;
   Hygeia; Intarcia; Johnson and Johnson/LifeScan; MannKind; Medtronic;
   Novo Nordisk; Quotient Diagnostics; ResMed; Roche; sanofi-aventis;
   Schering-Plough; Takeda; Valeritas
FX The ACCORD study was supported by grants (N01-HC-95178, N01-HC-95179,
   N01-HC-95180, N01-HC-95181, N01-HC-95182, N01-HC-95183, N01-HC-95184,
   IAA-Y1-HC-9035, and IAA-Y1-HC-1010) from the National Heart, Lung, and
   Blood Institute; by other components of the National Institutes of
   Health, including the National Institute of Diabetes and Digestive and
   Kidney Diseases, the National Institute on Aging, and the National Eye
   Institute; by the Centers for Disease Control and Prevention; and by
   General Clinical Research Centers.; The following companies provided
   study medications, equipment, or supplies: Abbott Laboratories, Amylin
   Pharmaceutical, AstraZeneca, Bayer Health Care, Closer Healthcare,
   GlaxoSmithKline, King Pharmaceuticals, Merck, Novartis, Novo Nordisk,
   Omron Healthcare, sanofi-aventis, and Schering-Plough. R.T.A. is a
   consultant for Abbott Laboratories, Inc. D.G. is a consultant for Merck
   Inc. and serves as a DSMB member for Takeda Inc. J.-A.S.-H. is an
   investigator of clinical trials sponsored by Merck, GSK, Lilly and
   Abbott Laboratories through HealthPartners Research Foundation. R.C.
   serves as an investigator on clinical trials sponsored by Amylin,
   Abbott, Bayer, Daiichi Sankyo, Dexcom, Edwards Life-sciences, Eli Lilly,
   Hygeia, Intarcia, Johnson and Johnson/LifeScan, MannKind, Medtronic,
   Merck, Novo Nordisk, Quotient Diagnostics, ResMed, Roche,
   sanofi-aventis, Schering-Plough, Takeda, Valeritas; and serves as an
   Advisory Board Member for Abbott, Bayer, CeQur, Eli Lilly, Novo Nordisk,
   and Roche. No other potential conflicts of interest relevant to this
   article were reported.
CR Anderson RT, 2009, DIABETES CARE, V32, P51, DOI 10.2337/dc08-0856
   Bradley C., 1994, HDB PSYCHOL DIABETES, P111
   Buse JB, 2007, AM J CARDIOL, V99, p21I, DOI 10.1016/j.amjcard.2007.03.003
   Ciechanowski PS, 2003, GEN HOSP PSYCHIAT, V25, P246, DOI 10.1016/S0163-8343(03)00055-0
   Currie CJ, 2006, DIABETOLOGIA, V49, P2272, DOI 10.1007/s00125-006-0380-7
   Eaton WW, 1996, DIABETES CARE, V19, P1097, DOI 10.2337/diacare.19.10.1097
   Egede LE, 2004, DIABETES CARE, V27, P421, DOI 10.2337/diacare.27.2.421
   Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743
   Gerstein HC, 2007, AM J CARDIOL, V99, p34I, DOI 10.1016/j.amjcard.2007.03.004
   Goddijn PPM, 1999, DIABETIC MED, V16, P23, DOI 10.1046/j.1464-5491.1999.00002.x
   Gulliford MC, 1999, J CLIN EPIDEMIOL, V52, P773, DOI 10.1016/S0895-4356(99)00053-0
   KOVACS M, 1990, J PEDIATR PSYCHOL, V15, P619, DOI 10.1093/jpepsy/15.5.619
   Peyrot M, 1997, DIABETES CARE, V20, P585, DOI 10.2337/diacare.20.4.585
   PEYROT M, 1994, DIABETES CARE, V17, P994, DOI 10.2337/diacare.17.9.994
   Peyrot M, 2009, DIABETES CARE, V32, P1411, DOI 10.2337/dc08-2256
   Riddle MC, 2010, DIABETES CARE, V33, P983, DOI 10.2337/dc09-1278
   Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O
   SONGER T, 1995, NIH PUBL
   Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737
   Sullivan MD, 2007, AM J CARDIOL, V99, p90I, DOI 10.1016/j.amjcard.2007.03.027
   Testa MA, 1998, JAMA-J AM MED ASSOC, V280, P1490, DOI 10.1001/jama.280.17.1490
   UK Prospective Diabetes Study Group, 1999, DIABETES CARE, V22, P1125, DOI DOI 10.2337/DIACARE.22.7.1125
   Ware JE, 2000, SCORE VERSION 2 SF 3
   Wikblad K, 1996, QUAL LIFE RES, V5, P123, DOI 10.1007/BF00435977
   Zhang XP, 2007, MED CARE, V45, P820, DOI 10.1097/MLR.0b013e3180618b55
NR 25
TC 26
Z9 28
U1 0
U2 8
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
J9 DIABETES CARE
JI Diabetes Care
PD APR
PY 2011
VL 34
IS 4
BP 807
EP 812
DI 10.2337/dc10-1926
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 746DE
UT WOS:000289221800004
PM 21346183
OA Green Published, Other Gold
DA 2019-01-08
ER

PT J
AU Wilfley, D
   Berkowitz, R
   Goebel-Fabbri, A
   Hirst, K
   Ievers-Landis, C
   Lipman, TH
   Marcus, M
   Ng, D
   Pham, T
   Saletsky, R
   Schanuel, J
   Van Buren, D
AF Wilfley, Denise
   Berkowitz, R.
   Goebel-Fabbri, A.
   Hirst, K.
   Ievers-Landis, C.
   Lipman, T. H.
   Marcus, M.
   Ng, D.
   Pham, T.
   Saletsky, R.
   Schanuel, J.
   Van Buren, D.
CA TODAY Study Grp
TI Binge Eating, Mood, and Quality of Life in Youth With Type 2 Diabetes
   Baseline data from the TODAY study
SO DIABETES CARE
LA English
DT Article
ID OVERWEIGHT YOUTH; ADOLESCENTS; ATTITUDES; BEHAVIOR; OBESITY; FAMILY;
   GIRLS
AB OBJECTIVE-The current study examines the prevalence of binge eating and its association with adiposity and psychosocial functioning in a large, diverse sample of youth with type 2 diabetes.
   RESEARCH DESIGN AND METHODS-In the TODAY study, 678 (mean age 14.0 years; 64.9% girls) of the 704 youth randomized to the study completed a self-report measure of eating disorder symptoms and were categorized as nonovereaters, overeaters, subclinical binge eaters, or clinical binge eaters.
   RESULTS-Youth with clinical (6%) and subclinical (20%) levels of binge eating had significantly higher levels and rates of extreme obesity, global eating disorder and depressive symptoms, and impaired quality of life.
   CONCLUSIONS-These findings highlight the importance of evaluating youth with type 2 diabetes for the presence of binge eating. Future research is needed to determine the cumulative effects of disordered eating, obesity, and psychosocial distress on adherence to lifestyle change recommendations and longitudinal response to treatment. Diabetes Care 34:858-860, 2011
C1 [Wilfley, Denise; Van Buren, D.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA.
   [Lipman, T. H.] Univ Penn, Sch Nursing, Philadelphia, PA 19104 USA.
   [Goebel-Fabbri, A.] Harvard Univ, Sch Med, Boston, MA USA.
   [Hirst, K.; Pham, T.] George Washington Univ, Ctr Biostat, Rockville, MD USA.
   [Ievers-Landis, C.] Rainbow Babies & Childrens Hosp, Div Behav Pediat & Psychol, Cleveland, OH USA.
   [Ievers-Landis, C.] Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA.
   [Marcus, M.] Western Psychiat Inst & Clin, Pittsburgh, PA USA.
   [Ng, D.] Columbia Univ, Naomi Berry Diabet Ctr, New York, NY USA.
   [Saletsky, R.] SUNY Upstate Med Univ, Syracuse, NY USA.
   [Schanuel, J.] Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Oklahoma City, OK USA.
RP Wilfley, D (reprint author), Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA.
EM wilfley@psychiatry.wustl.edu
OI Zeitler, Philip/0000-0001-5756-7858
FU NIDDK/NIH [U01-DK-61212, U01-DK-61230, U01-DK-61239, U01-DK-61242,
   U01-DK-61254]; National Institute of Mental Health [1K24-MH-070446-01];
   National Center for Research Resources (Washington University School of
   Medicine) [M01-RR-00036]; Children's Hospital Los Angeles
   [M01-RR-00043-45]; University of Colorado Denver [M01-RR-00069];
   Children's Hospital of Pittsburgh [M01-RR-00084, UL1-RR-024153];
   Massachusetts General Hospital [M01-RR-01066, UL1-RR-025758]; Yale
   University [M01-RR-00125, UL1-RR-024139]; University of Oklahoma Health
   Sciences Center [M01-RR-14467]; National Center for Research Resources
   Clinical and Translational Science (Children's Hospital of Philadelphia)
   [UL1-RR-024134]; Washington University [UL1-RR-024992]
FX This work was completed with funding from NIDDK/NIH grant numbers
   U01-DK-61212, U01-DK-61230, U01-DK-61239, U01-DK-61242, and
   U01-DK-61254; from National Institute of Mental Health Grant
   1K24-MH-070446-01 (to D.W.); from the National Center for Research
   Resources General Clinical Research Centers Program Grants M01-RR-00036
   (Washington University School of Medicine), M01-RR-00043-45 (Children's
   Hospital Los Angeles), M01-RR-00069 (University of Colorado Denver),
   M01-RR-00084 (Children's Hospital of Pittsburgh), M01-RR-01066
   (Massachusetts General Hospital), M01-RR-00125 (Yale University), and
   M01-RR-14467 (University of Oklahoma Health Sciences Center); and from
   the National Center for Research Resources Clinical and Translational
   Science Awards Grants UL1-RR-024134 (Children's Hospital of
   Philadelphia), UL1-RR-024139 (Yale University), UL1-RR-024153
   (Children's Hospital of Pittsburgh), UL1-RR-024989 (Case Western Reserve
   University), UL1-RR-024992 (Washington University), UL1-RR-025758
   (Massachusetts General Hospital), and UL1-RR-025780 (University of
   Colorado Denver).
CR *AM DIAB ASS, 2010, DIABETES CARE S1, V33, pS11, DOI DOI 10.2337/DC10-S011
   BACK AT, 1996, BECK DEPRESSION INVE
   Colton P, 2004, DIABETES CARE, V27, P1654, DOI 10.2337/diacare.27.7.1654
   Goldschmidt AB, 2008, OBESITY, V16, P257, DOI 10.1038/oby.2007.48
   Goldschmidt AB, 2007, INT J EAT DISORDER, V40, P460, DOI 10.1002/eat.20387
   Goran MI, 2003, J CLIN ENDOCR METAB, V88, P1417, DOI 10.1210/jc.2002-021442
   Howe Carol J, 2008, J Am Psychiatr Nurses Assoc, V13, P376, DOI 10.1177/1078390307310154
   Kovacs M., 1992, CHILDRENS DEPRESSION
   Olmsted MP, 2008, DIABETES CARE, V31, P1978, DOI 10.2337/dc08-0333
   Peveler RC, 2005, DIABETES CARE, V28, P84, DOI 10.2337/diacare.28.1.84
   Pinhas-Hamiel O, 1999, ARCH PEDIAT ADOL MED, V153, P1063, DOI 10.1001/archpedi.153.10.1063
   Tanofsky-Kraff M, 2007, OBESITY, V15, P1345, DOI 10.1038/oby.2007.162
   Varni JW, 2003, DIABETES CARE, V26, P631, DOI 10.2337/diacare.26.3.631
   Wildes JE, 2010, INT J OBESITY, V34, P1143, DOI 10.1038/ijo.2010.35
   ZEITLER P, 2007, PEDIAT DIABETES, V8, P74
NR 15
TC 45
Z9 45
U1 0
U2 7
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
EI 1935-5548
J9 DIABETES CARE
JI Diabetes Care
PD APR
PY 2011
VL 34
IS 4
BP 858
EP 860
DI 10.2337/dc10-1704
PG 3
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 746DE
UT WOS:000289221800013
PM 21357794
OA Green Published, Other Gold
DA 2019-01-08
ER

PT J
AU Lamers, F
   Jonkers, CCM
   Bosma, H
   Knottnerus, JA
   van Eijk, JTM
AF Lamers, Femke
   Jonkers, Catharina C. M.
   Bosma, Hans
   Knottnerus, J. Andre
   van Eijk, Jacques Th M.
TI Treating depression in diabetes patients: does a nurse-administered
   minimal psychological intervention affect diabetes-specific quality of
   life and glycaemic control? A randomized controlled trial
SO JOURNAL OF ADVANCED NURSING
LA English
DT Article
DE depression; diabetes; nursing; primary care; psychological intervention;
   quality of life; randomized controlled trial
ID PLACEBO-CONTROLLED TRIAL; PROBLEM AREAS; SYMPTOM CHECKLIST; ELDERLY
   PERSONS; PRIMARY-CARE; DOUBLE-BLIND; TYPE-2; METAANALYSIS; OUTCOMES;
   SCALE
AB P>Aims.
   The aim of this study was to examine whether a nurse-administered minimal psychological intervention for depressive symptoms improves diabetes-specific quality of life and glycaemic control in older persons with diabetes.
   Background.
   Depression is common among persons with diabetes and may have a negative impact on diabetes. Interventions aimed at reducing depressive symptoms may positively influence diabetes-specific quality of life as well.
   Methods.
   A pragmatic, randomized controlled trial was carried out comparing the intervention with usual care among 208 Dutch primary care patients of >= 60 years with type 2 diabetes and co-occurring minor to moderate depression. Data on symptom distress and emotional distress were collected during 2003-2006, and haemoglobin A1c levels were obtained from general practices. Data were analysed using mixed model, repeated measures ancovas. Hba1c was collected retrospectively from general practices between December 2006-February 2007. In July 2007 we retrieved some additional HbA1c data from the medical records of the university hospital.
   Results.
   Only in higher-educated persons did the intervention have statistically significant effect on both emotional distress and symptom distress (DSC-R total score at 9 months P = 0 center dot 001; PAID, 9 months P = 0 center dot 03). Furthermore, we found an effect on symptom distress in men (9 months P = 0 center dot 01), and on emotional distress in persons with a shorter diabetes duration (< 7 years) (9 months P = 0 center dot 04). A significant trend over time for haemoglobin A1c was found in favour of the intervention, with a statistically significant difference between groups after 9 months (P = 0 center dot 02).
   Conclusion.
   The nurse-administered intervention had limited effects on diabetes-specific quality of life. As only certain subgroups benefited, ways of increasing effectiveness in other groups should be explored. The potentially beneficial effect on glycaemic control is encouraging and needs further research because of small numbers in the analysis.
C1 [Lamers, Femke; Jonkers, Catharina C. M.; Bosma, Hans; van Eijk, Jacques Th M.] Maastricht Univ, Sch Publ Hlth & Primary Care CAPHRI, Dept Social Med, Maastricht, Netherlands.
   [Knottnerus, J. Andre] Maastricht Univ, Sch Publ Hlth & Primary Care CAPHRI, Dept Gen Practice, Maastricht, Netherlands.
RP Lamers, F (reprint author), Maastricht Univ, Sch Publ Hlth & Primary Care CAPHRI, Dept Social Med, Maastricht, Netherlands.
EM lamersf@mail.nih.gov
RI Knottnerus, Johannes/A-3829-2009; Lamers, Femke/G-5161-2012; Albertin,
   Paloma/X-1093-2018; Lamers, F/M-9742-2018; Bosma, Hans/A-6184-2013;
   Knottnerus, Andre/F-4866-2013
OI Lamers, Femke/0000-0003-4344-5766
FU Netherlands Organisation for Health Research and Development (ZonMw)
   [945-03-047]
FX This study was funded by the Netherlands Organisation for Health
   Research and Development (ZonMw) programme on Health Care Efficiency
   Research (grant number 945-03-047).
CR Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x
   Arbuckle RA, 2009, VALUE HEALTH, V12, P1168, DOI 10.1111/j.1524-4733.2009.00571.x
   Arean PA, 2007, PSYCHIAT SERV, V58, P1057, DOI 10.1176/appi.ps.58.8.1057
   Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278
   Cole MG, 1999, AM J PSYCHIAT, V156, P1182
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   de Rekeneire N, 2003, DIABETES CARE, V26, P1986, DOI 10.2337/diacare.26.7.1986
   Eigenmann CA, 2009, DIABETIC MED, V26, P425, DOI 10.1111/j.1464-5491.2009.02697.x
   Gonzalez JS, 2007, DIABETES CARE, V30, P2222, DOI 10.2337/dc07-0158
   GROOTENHUIS PA, 1994, DIABETIC MED, V11, P253, DOI 10.1111/j.1464-5491.1994.tb00268.x
   HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56
   Jonkers C, 2007, PATIENT EDUC COUNS, V68, P252, DOI 10.1016/j.pec.2007.06.010
   Katon W, 2007, GEN HOSP PSYCHIAT, V29, P147, DOI 10.1016/j.genhosppsych.2006.11.005
   Koro CE, 2004, DIABETES CARE, V27, P17, DOI 10.2337/diacare.27.1.17
   Lamers F, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-161
   Lamers F, 2010, PSYCHOTHER PSYCHOSOM, V79, P217, DOI 10.1159/000313690
   Larranaga I, 2005, DIABETIC MED, V22, P1047, DOI 10.1111/j.1464-5491.2005.01598.x
   Lustman PJ, 1997, PSYCHOSOM MED, V59, P241, DOI 10.1097/00006842-199705000-00007
   Lustman PJ, 2005, J DIABETES COMPLICAT, V19, P113, DOI 10.1016/j.jdiacomp.2004.01.002
   Lustman PJ, 2000, DIABETES CARE, V23, P618, DOI 10.2337/diacare.23.5.618
   Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442
   Paile-Hyvarinen M, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-34
   Richardson LK, 2008, GEN HOSP PSYCHIAT, V30, P509, DOI 10.1016/j.genhosppsych.2008.07.001
   RUTTEN GEH, 2006, HUISARTS WET, V49, P137
   Sheehan DV, 1997, EUR PSYCHIAT, V12, P232, DOI 10.1016/S0924-9338(97)83297-X
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737
   van Eijk JTM, 2004, PATIENT EDUC COUNS, V54, P87, DOI 10.1016/s0738-3991(03)00201-5
   Wang MY, 2008, J CLIN NURS, V17, P2524, DOI 10.1111/j.1365-2702.2008.02301.x
   Ware JE, 1993, SF 36 HLTH SURVEY MA
   Welch G, 2003, DIABETIC MED, V20, P69, DOI 10.1046/j.1464-5491.2003.00832.x
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   Williams JW, 2004, ANN INTERN MED, V140, P1015, DOI 10.7326/0003-4819-140-12-200406150-00012
NR 33
TC 25
Z9 25
U1 0
U2 10
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0309-2402
J9 J ADV NURS
JI J. Adv. Nurs.
PD APR
PY 2011
VL 67
IS 4
BP 788
EP 799
DI 10.1111/j.1365-2648.2010.05540.x
PG 12
WC Nursing
SC Nursing
GA 736OA
UT WOS:000288502800011
PM 21226754
DA 2019-01-08
ER

PT J
AU Pouwer, F
   Tack, CJ
   Geelhoed-Duijvestijn, PHLM
   Bazelmans, E
   Beekman, AT
   Heine, RJ
   Snoek, FJ
AF Pouwer, F.
   Tack, C. J.
   Geelhoed-Duijvestijn, P. H. L. M.
   Bazelmans, E.
   Beekman, A. T.
   Heine, R. J.
   Snoek, F. J.
TI Limited effect of screening for depression with written feedback in
   outpatients with diabetes mellitus: a randomised controlled trial
SO DIABETOLOGIA
LA English
DT Article
DE Depression; Diabetes; Randomised controlled trial; Screening
ID CO-MORBID DEPRESSION; INTERNATIONAL DIAGNOSTIC INTERVIEW;
   CORONARY-HEART-DISEASE; PRIMARY-CARE; EMOTIONAL DISTRESS; GLYCEMIC
   CONTROL; PROBLEM AREAS; METAANALYSIS; PREVALENCE; VALIDITY
AB The aim of this study was to test the effectiveness of a screening procedure for depression (SCR) vs care as usual (CAU) in outpatients with diabetes. The primary outcome measured was depression score and the secondary outcomes were mental healthcare consumption, diabetes-distress and HbA(1c).
   In a multicentre parallel randomised controlled trial, 223 outpatients with diabetes, who had an elevated depression score, were randomly assigned to SCR (n = 116) or CAU (n = 107), using computer generated numbers. SCR-patients were invited for a Composite International Diagnostic Interview (CIDI) to diagnose depression and/or anxiety (interviewers were not blinded for group assignment). As part of the intervention, patients and their physicians were informed of the outcome of the CIDI in a letter and provided with treatment advice. At baseline and 6 month follow-up, depression and diabetes-distress were measured using the Centre for Epidemiologic Studies Depression Scale (CES-D) and the Problem Areas in Diabetes survey (PAID). HbA(1c) levels were obtained from medical charts.
   Mean CES-D depression scores decreased from baseline to 6 months in both groups (24 +/- 8 to 21 +/- 8 [CAU] and 26 +/- 7 to 22 +/- 10 [SCR] respectively [p < 0.001]), with no significant differences between groups. Neither diabetes-distress nor HbA(1c) changed significantly within and between groups. The percentage of patients receiving mental healthcare increased in the SCR group from 20% to 28%, compared with 15% to 18% in the CAU group.
   Depression screening with written feedback to patient and physician does not improve depression scores and has a limited impact on mental healthcare utilisation, compared with CAU. It appears that more intensive depression management is required to improve depression outcomes in patients with diabetes.
C1 [Pouwer, F.] Tilburg Univ, Dept Med Psychol & Neuropsychol, Ctr Res Psychol Somat Dis CoRPS, NL-5000 LE Tilburg, Netherlands.
   [Pouwer, F.; Snoek, F. J.] Vrije Univ Amsterdam Med Ctr, EMGO Inst, Dept Med Psychol, Diabet Psychol Res Grp, Amsterdam, Netherlands.
   [Tack, C. J.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands.
   [Geelhoed-Duijvestijn, P. H. L. M.] Haaglanden Med Ctr, Dept Internal Med, The Hague, Netherlands.
   [Bazelmans, E.] Radboud Univ Nijmegen, Med Ctr, Dept Med Psychol, NL-6525 ED Nijmegen, Netherlands.
   [Beekman, A. T.] Vrije Univ Amsterdam Med Ctr, EMGO Inst, Dept Psychiat, Amsterdam, Netherlands.
   [Heine, R. J.] Vrije Univ Amsterdam Med Ctr, Ctr Diabet, Dept Endocrinol, Amsterdam, Netherlands.
RP Pouwer, F (reprint author), Tilburg Univ, Dept Med Psychol & Neuropsychol, Ctr Res Psychol Somat Dis CoRPS, POB 90153, NL-5000 LE Tilburg, Netherlands.
EM f.pouwer@uvt.nl
RI Tack, Cees/A-2368-2014
FU Dutch Diabetes Research Foundation (Diabetesfonds) [2000.00.018]
FX Dutch Diabetes Research Foundation (Diabetesfonds), 2000.00.018.
CR Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x
   *AM DIAB ASS, 2009, DIABETES CARE S1, V32, pS13, DOI DOI 10.2337/DC09-S013
   American Psychiatric Association, 1994, DIAGN STAT MAN MENT
   Andrews G, 1998, SOC PSYCH PSYCH EPID, V33, P80, DOI 10.1007/s001270050026
   BAKKER K, 2004, PRACT DIAB INT, V21, P88
   Barnard KD, 2006, DIABETIC MED, V23, P445, DOI 10.1111/j.1464-5491.2006.01814.x
   Beekman ATF, 1997, PSYCHOL MED, V27, P231, DOI 10.1017/S0033291796003510
   Bot M, 2010, DIABETIC MED, V27, P1295, DOI 10.1111/j.1464-5491.2010.03119.x
   Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   DOWRICK C, 1995, BMJ-BRIT MED J, V311, P1274, DOI 10.1136/bmj.311.7015.1274
   Egede LE, 2005, DIABETES CARE, V28, P1339, DOI 10.2337/diacare.28.6.1339
   Gilbody S, 2008, CAN MED ASSOC J, V178, P997, DOI 10.1503/cmaj.070281
   International Diabetes Federation, 2005, GLOB GUID TYP 2 DIAB
   Ismail K, 2007, DIABETES CARE, V30, P1473, DOI 10.2337/dc06-2313
   Katon W, 2010, CONTEMP CLIN TRIALS, V31, P312, DOI 10.1016/j.cct.2010.03.009
   Katon WJ, 2004, ARCH GEN PSYCHIAT, V61, P1042, DOI 10.1001/archpsyc.61.10.1042
   Lewis G, 1996, FAM PRACT, V13, P120, DOI 10.1093/fampra/13.2.120
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Nicholson TRJ, 2009, DIABETIC MED, V26, P447, DOI 10.1111/j.1464-5491.2009.02701.x
   Nouwen A, 2010, DIABETOLOGIA, V53, P2480, DOI 10.1007/s00125-010-1874-x
   Penninx BWJH, 2007, AM J GERIAT PSYCHIAT, V15, P522, DOI 10.1097/JGP.0b013e318033ed80
   Petrak F, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-21
   Peyrot M, 2006, DIABETES CARE, V29, P1256, DOI 10.2337/dc05-2444
   Pickup JC, 2004, DIABETES CARE, V27, P813, DOI 10.2337/diacare.27.3.813
   Pouwer F, 2003, DIABETOLOGIA, V46, P892, DOI 10.1007/s00125-003-1124-6
   Pouwer F, 2006, PATIENT EDUC COUNS, V60, P235, DOI 10.1016/j.pec.2005.01.009
   Pouwer F, 2010, DIABETIC MED, V27, P217, DOI 10.1111/j.1464-5491.2009.02903.x
   Pouwer F, 2001, DIABETES CARE, V24, P1929, DOI 10.2337/diacare.24.11.1929
   Pouwer F, 2009, NAT REV ENDOCRINOL, V5, P665, DOI 10.1038/nrendo.2009.214
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Schram MT, 2009, CURR DIABETES REV, V5, P112, DOI 10.2174/157339909788166828
   Simon GE, 2007, ARCH GEN PSYCHIAT, V64, P65, DOI 10.1001/archpsyc.64.1.65
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Thombs BD, 2008, JAMA-J AM MED ASSOC, V300, P2161, DOI 10.1001/jama.2008.667
   Tylee A, 2007, J CLIN PSYCHIAT, V68, P27
   van Bastelaar KMP, 2010, DIABETIC MED, V27, P798, DOI 10.1111/j.1464-5491.2010.03025.x
   van Bastelaar KM, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-9
   Van der Feltz-Cornelis CM, 2010, GEN HOSP PSYCHIAT, V32, P380, DOI 10.1016/j.genhosppsych.2010.03.011
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   Whooley MA, 2000, J GEN INTERN MED, V15, P293, DOI 10.1046/j.1525-1497.2000.04319.x
   WITTCHEN HU, 1994, J PSYCHIAT RES, V28, P57, DOI 10.1016/0022-3956(94)90036-1
NR 42
TC 29
Z9 29
U1 0
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0012-186X
J9 DIABETOLOGIA
JI Diabetologia
PD APR
PY 2011
VL 54
IS 4
BP 741
EP 748
DI 10.1007/s00125-010-2033-0
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 732VG
UT WOS:000288217200005
PM 21221528
OA Green Published, Other Gold
DA 2019-01-08
ER

PT J
AU Stankovic, Z
   Jasovic-Gasic, M
   Zamaklar, M
AF Stankovic, Zana
   Jasovic-Gasic, Miroslava
   Zamaklar, Miroslava
TI PSYCHO-SOCIAL AND CLINICAL VARIABLES ASSOCIATED WITH DEPRESSION IN
   PATIENTS WITH TYPE 2 DIABETES
SO PSYCHIATRIA DANUBINA
LA English
DT Article
DE depression; type 2 diabetes; comorbidity; risk factors; neuropathy;
   diabetes related distress
ID QUALITY-OF-LIFE; GLYCEMIC CONTROL; METABOLIC SYNDROME; EUROPEAN
   DEPRESSION; COMORBID DEPRESSION; RESEARCH CONSORTIUM; RISK-FACTOR;
   SYMPTOMS; PREVALENCE; DISORDERS
AB Background: Type 2 diabetes (T2DM,) doubles the odds of comorbid depression. Depression is a strong predictor of developing T2DM The aim of the study was to compare depressed patients with T2DM to non-depressed ones with respect to demographic, psycho-social, clinical, anthropometric and metabolic characteristics; to examine the relationship between glycemic control and depression severity in depressed patients; to estimate the risk factors of depression.
   Subjects and Methods: A group of depressed diabetic patients comprising those with a Major depressive episode, first or repeated (ICD-10; 1992) and endocrinologist-diagnosed T2DM, duration >= 5 years on oral, insulin therapy or both (N=46) and non-depressed ones (N=44) (90 in total) of both genders (< 65 years) were included in this cross-sectional study. Laboratory and non-laboratory measures were performed.. The patient Health Questionnaire (PHQ-9) and a structured interview (MINI) were used to establish diagnosis, while the Beck Depression Inventory (BDI; cut off >= 16) was used to assess the severity of depression. Scaling of Life Events (SLE) for self-assessment of life events and Problem in Areas in Diabetes (PAID) for self-assessment of diabetes distress were also performed.
   Results: Statistically significant higher rates of psychiatric heredity, neuropathy, higher level of diabetes related distress and a greater number of life events in depressed patients compared to non-depressed ones were found There was a statistically significant positive correlation between BDI somatic subscore and the HbAlc level (r=0.343; p=0.020). The level of diabetes related distress (OR=1.084; p=0.000), total number of life events (OR=4.528; p=0.001) and neuropathy (OR=8.699; p=0.039) were statistically significant predictors of depression using logistic regression.
   Conclusions: The results obtained showed that depression in diabetic patients was predicted by both psychological (diabetes related distress, life events) and disease-specific variables (neuropathy). The severity of self-reported somatic depressive symptoms significantly correlated with the HbAlc level in depressed diabetic patients.
C1 [Stankovic, Zana; Jasovic-Gasic, Miroslava] Univ Belgrade, Psychiat Clin, Clin Ctr Serbia, Belgrade 11000, Serbia.
   [Zamaklar, Miroslava] Univ Belgrade, Inst Endocrinol Diabet & Dis Metab, Belgrade 11000, Serbia.
   [Jasovic-Gasic, Miroslava; Zamaklar, Miroslava] Univ Belgrade, Sch Med, Belgrade 11000, Serbia.
RP Stankovic, Z (reprint author), Univ Belgrade, Psychiat Clin, Clin Ctr Serbia, Pasterova 2, Belgrade 11000, Serbia.
EM stankovic.zana@gmail.com
CR Abrahamian H, 2009, NEUROPSYCH DIS TREAT, V5, P261
   Agbir TM, 2010, ANN AFR MED, V9, P5, DOI 10.4103/1596-3519.62617
   Aikens JE, 2008, DIABETIC MED, V25, P1324, DOI 10.1111/j.1464-5491.2008.02590.x
   Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x
   Almawi W, 2008, J ENDOCRINOL INVEST, V31, P1020, DOI 10.1007/BF03345642
   ALONSO J, 2004, ACTA PSYCHIAT SCAN S, V420, P21
   *AM DIAB ASS, 2003, DIABETES CARE, V1, P94
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   [Anonymous], 1992, INT STAT CLASS DIS R
   BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561
   BHALLA RN, 2010, DEPRESSION
   Boulton AJM, 2004, DIABETES CARE, V27, P1458, DOI 10.2337/diacare.27.6.1458
   Brown LC, 2005, DIABETES CARE, V28, P1063, DOI 10.2337/diacare.28.5.1063
   BROWN LC, 2006, CMAJ, V175
   Collins MM, 2009, DIABETIC MED, V26, P153, DOI 10.1111/j.1464-5491.2008.02648.x
   Cosgrove MP, 2008, OCCUP MED-OXFORD, V58, P7, DOI 10.1093/occmed/kqm105
   Daly JM, 2009, J AM BOARD FAM MED, V22, P280, DOI 10.3122/jabfm.2009.03.080114
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   Despres JP, 2008, ARTERIOSCL THROM VAS, V28, P1039, DOI 10.1161/ATVBAHA.107.159228
   Egede LE, 2005, PSYCHOSOM MED, V67, P46, DOI 10.1097/01.psy.0000149260.82006.fb
   Egede LE, 2010, DIABETES TECHNOL THE, V12, P257, DOI 10.1089/dia.2009.0143
   *EXP COMM DIAGN CL, 2003, DIABETES CARE, V26, P5, DOI DOI 10.2337/DIACARE.26.2007.S5
   Filipcic I, 2010, PSYCHIAT DANUB, V22, P231
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2001, DIABETES CARE, V24, P1751, DOI 10.2337/diacare.24.10.1751
   Fisher L, 2009, DIABETES CARE, V33, P23
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6
   Georgiades A, 2007, PSYCHOSOM MED, V69, P235, DOI 10.1097/PSY.0b013e318042588d
   Golden SH, 2008, JAMA-J AM MED ASSOC, V299, P2751, DOI 10.1001/jama.299.23.2751
   Gonzalez JS, 2008, DIABETOLOGIA, V51, P1822, DOI 10.1007/s00125-008-1113-x
   Halbreich U, 2007, J AFFECT DISORDERS, V102, P159, DOI 10.1016/j.jad.2006.09.033
   Heckbert SR, 2010, J GEN INTERN MED, V25, P524, DOI 10.1007/s11606-010-1272-6
   INGRAM RE, 1984, COGNITIVE THER RES, V8, P443, DOI 10.1007/BF01173284
   Jakovjevic M, 2007, PSYCHIAT DANUB, V19, P76
   Katon WJ, 2004, J GEN INTERN MED, V19, P1192, DOI 10.1111/j.1525-1497.2004.30405.x
   Kawakami N, 1999, DIABETES CARE, V22, P1071, DOI 10.2337/diacare.22.7.1071
   Knol MJ, 2006, DIABETOLOGIA, V49, P837, DOI 10.1007/s00125-006-0159-x
   Kokoszka A, 2009, EUR PSYCHIAT, V24, P425, DOI 10.1016/j.eurpsy.2009.04.002
   Koponen H, 2008, J CLIN PSYCHIAT, V69, P178, DOI 10.4088/JCP.v69n0202
   Lecrubier Y, 1997, EUR PSYCHIAT, V12, P224, DOI 10.1016/S0924-9338(97)83296-8
   Lee HJ, 2009, J AM ACAD NURSE PRAC, V21, P214, DOI 10.1111/j.1745-7599.2009.00396.x
   Lin EHB, 2010, DIABETES CARE, V33, P264, DOI 10.2337/dc09-1068
   Lustman PJ, 2007, DIABETES CARE, V30, P459, DOI 10.2337/dc06-1769
   Lustman PJ, 1997, PSYCHOSOM MED, V59, P241, DOI 10.1097/00006842-199705000-00007
   Lustman PJ, 2005, J DIABETES COMPLICAT, V19, P113, DOI 10.1016/j.jdiacomp.2004.01.002
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   LUSTMAN PJ, 2004, DIABETES SPECTRUM, V17, P160, DOI DOI 10.2337/DIASPECT.17.3.160
   MCINTYRE SR, 2006, EXPERT OPINION DRUG, V5, P157
   Mezuk B, 2008, AM J PUBLIC HEALTH, V98, P1480, DOI 10.2105/AJPH.2007.126441
   Miyaoka Y, 1997, PSYCHIAT CLIN NEUROS, V51, P203, DOI 10.1111/j.1440-1819.1997.tb02583.x
   Moreira RO, 2007, BRAZ J MED BIOL RES, V40, P269, DOI 10.1590/S0100-879X2006005000051
   Musselman DL, 2003, BIOL PSYCHIAT, V54, P317, DOI 10.1016/S0006-3223(03)00569-9
   *NIH, 2001, NIH PUBL
   Norhammar A, 2004, J AM COLL CARDIOL, V43, P585, DOI 10.1016/j.jacc.2003.08.050
   Paola LD, 2006, CURR DIABETES REV, V2, P431, DOI 10.2174/1573399810602040431
   PAYKEL SE, 1971, ARCH GEN PSICHIATRY, V25, P340
   Pibernik-Okanovic M, 2008, J DIABETES COMPLICAT, V22, P246, DOI 10.1016/j.jdiacomp.2007.03.002
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Pouwer F, 2005, DIABETES RES CLIN PR, V70, P166, DOI 10.1016/j.diabres.2005.03.031
   Pouwer F, 2001, DIABETIC MED, V18, P595, DOI 10.1046/j.1464-5491.2001.00499.x
   Raikkonen K, 2007, DIABETES CARE, V30, P872, DOI 10.2337/dc06-1857
   Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737
   Ustun TB, 2004, BRIT J PSYCHIAT, V184, P386, DOI 10.1192/bjp.184.5.386
   van Bastelaar KMP, 2010, DIABETIC MED, V27, P798, DOI 10.1111/j.1464-5491.2010.03025.x
   Van Tilburg MAL, 2001, PSYCHOSOM MED, V63, P551, DOI 10.1097/00006842-200107000-00005
   Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047
   World Health Organization, 2001, WORLD HLTH REP 2001
   Yoshida S, 2008, PSYCHIAT CLIN NEUROS, V63, P65
   ZIMMERMAN M, 1986, J HUMAN STRESS, V4, P13
NR 70
TC 8
Z9 8
U1 1
U2 8
PU MEDICINSKA NAKLADA
PI ZAGREB
PA VLASKA 69, HR-10000 ZAGREB, CROATIA
SN 0353-5053
J9 PSYCHIAT DANUB
JI Psychiatr. Danub.
PD MAR
PY 2011
VL 23
IS 1
BP 34
EP 44
PG 11
WC Psychiatry
SC Psychiatry
GA 752OT
UT WOS:000289702700005
PM 21448095
DA 2019-01-08
ER

PT J
AU Grahovac, T
   Ruzic, K
   Dadic-Hero, E
   Sepic-Grahovac, D
   Sabljic, V
AF Grahovac, Tanja
   Ruzic, Klementina
   Dadic-Hero, Elizabeta
   Sepic-Grahovac, Dubravka
   Sabljic, Vladimir
TI WEIGHT GAIN - AS POSSIBLE PREDICTOR OF METABOLIC SYNDROME
SO PSYCHIATRIA DANUBINA
LA English
DT Article
DE metabolic syndrome; quetiapine; weight gain
ID QUETIAPINE; SCHIZOPHRENIA; DISORDER; MANIA
AB Rapid weight gain among patients with mental disorders can further compound psychological distress and negatively influence compliance. Weight gain associated with treatment with atypical ant:psychotic medication has been widely recognized as a risk factor for the development of diabetes type II and cardiovascular diseases.
   This paper describes a 33-year old female patient treated for schizoaffective disorder. Within two months after introducing quetiapine the patient experienced considerable weight gain amounting to 19 kg. The replacement of antipsychotic during inpatient psychiatric care resulted in weight loss.
C1 [Grahovac, Tanja; Ruzic, Klementina; Sabljic, Vladimir] Univ Psychiat Clin Rijeka, Clin Hosp Ctr Rijeka, Rijeka 51000, Croatia.
   [Dadic-Hero, Elizabeta] Sch Med, Dept Social Med & Epidemiol, Rijeka, Croatia.
   [Sepic-Grahovac, Dubravka] Policlin Neurol & Psychiat Interneuron, Rijeka, Croatia.
RP Grahovac, T (reprint author), Univ Psychiat Clin Rijeka, Clin Hosp Ctr Rijeka, Cambierieva 17-7, Rijeka 51000, Croatia.
EM tanja.grahovac@ri.t-com.hr
OI Grahovac Juretic, Tanja/0000-0002-8508-6688
CR Anderson IM, 2009, J AFFECT DISORDERS, V117, P116, DOI 10.1016/j.jad.2008.12.016
   Brecher M, 2007, J CLIN PSYCHIAT, V68, P597, DOI 10.4088/JCP.v68n0416
   Bushe C, 2010, J PSYCHOPHARMACOL, V24, P1001, DOI 10.1177/0269881108101783
   Cates ME, 2009, COMMUNITY MENT HLT J, V45, P251, DOI 10.1007/s10597-009-9200-0
   Correll CU, 2007, SCHIZOPHR RES, V89, P91, DOI 10.1016/j.schres.2006.08.017
   Dadic-Hero E, 2010, PSYCHIAT DANUB, V22, P381
   FILAKOVIC P, 2003, PSYCHIAT DANUBINA S1, V15, pS104
   FOLNEGOVICSMALC V, 2009, MEDIX, V80, P212
   Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6
   HOTUJAC LJ, 2002, MEDICUS, V11, P207
   Kozumplik O, 2010, PSYCHIAT DANUB, V22, P69
   Meyer JM, 2001, J CLIN PSYCHOPHARM, V21, P369, DOI 10.1097/00004714-200108000-00003
   Newcomer JW, 2007, AM J MANAG CARE, V13, pS170
   Sajatovic M, 2008, BIPOLAR DISORD, V10, P662, DOI 10.1111/j.1399-5618.2008.00614.x
   Stahl SM, 2008, ESSENTIAL PSYCHOPHAR
   UZUN S, 2005, NUSPOJAVE PSIHOFARMA, P19
   Vieta E, 2005, CURR MED RES OPIN, V21, P923, DOI 10.1185/030079905X46340
NR 17
TC 2
Z9 2
U1 0
U2 1
PU MEDICINSKA NAKLADA
PI ZAGREB
PA VLASKA 69, HR-10000 ZAGREB, CROATIA
SN 0353-5053
J9 PSYCHIAT DANUB
JI Psychiatr. Danub.
PD MAR
PY 2011
VL 23
IS 1
BP 105
EP 107
PG 3
WC Psychiatry
SC Psychiatry
GA 752OT
UT WOS:000289702700020
PM 21448110
DA 2019-01-08
ER

PT J
AU Hilliard, ME
   Monaghan, M
   Cogen, FR
   Streisand, R
AF Hilliard, M. E.
   Monaghan, M.
   Cogen, F. R.
   Streisand, R.
TI Parent stress and child behaviour among young children with type 1
   diabetes
SO CHILD CARE HEALTH AND DEVELOPMENT
LA English
DT Article
DE behaviour; diabetes; parenting stress
ID PEDIATRIC PSYCHOLOGY; MATERNAL PERCEPTIONS; ADJUSTMENT; MOTHERS;
   PRESCHOOLERS; DISCIPLINE; INVENTORY; DISTRESS; MELLITUS; YOUTH
AB Background
   Parents of young children with type 1 diabetes (T1D) are responsible for executing a complex daily management regimen and are at risk for elevated levels of stress. Normative misbehaviour during the preschool years can complicate T1D management, and interpretation of behavioural concerns may vary because of child health status and parent stress. Within a paediatric transactional model framework, child characteristics (e.g. behaviour problems, metabolic control) and parent functioning (e.g. parenting stress, anxiety) likely impact one another.
   Methods
   Parents of 2- to 6-year-old children with T1D completed self-report measures, including the Pediatric Inventory for Parents (PIP), State-Trait Anxiety Inventory (STAI), Eyberg Child Behavior Inventory (ECBI), and 24-h Recall Interviews. Medical data were obtained by parent report and medical record review. It was hypothesized that greater parent stress and child blood glucose variability would be significantly associated with greater parent-reported child behaviour concerns.
   Results
   Moderate levels of parent stress and child behaviour problems were endorsed; however, parents perceived children's misbehaviour as problematic, particularly with relation to tasks relevant to diabetes management (e.g. bedtimes and mealtimes). Structural equation modelling indicated that greater general anxiety and paediatric parenting stress was associated with parent report of more problematic child behaviour. Blood glucose variability did not significantly contribute to this relationship.
   Conclusions
   The stress experienced by parents of young children with chronic illness appears to relate to their perception of their children's behaviour problems. Parents' experiences with developmentally normative misbehaviour may interfere with disease management and exacerbate parents' stress and the subsequent impact on well-being. Implications for supporting parents and children with T1D are discussed.
C1 [Hilliard, M. E.; Monaghan, M.; Streisand, R.] Childrens Natl Med Ctr, Dept Psychol, Washington, DC 20010 USA.
   [Cogen, F. R.] Childrens Natl Med Ctr, Dept Endocrinol & Diabet, Washington, DC 20010 USA.
   [Cogen, F. R.] George Washington Univ, Sch Med & Hlth Sci, Dept Pediat, Washington, DC 20052 USA.
   [Streisand, R.] George Washington Univ, Sch Med & Hlth Sci, Dept Psychiat & Pediat, Washington, DC 20052 USA.
RP Streisand, R (reprint author), Childrens Natl Med Ctr, Dept Psychol, 111 Michigan Ave NW, Washington, DC 20010 USA.
EM rstreis@cnmc.org
OI Hilliard, Marisa/0000-0002-8813-629X
CR Abdul-Rasoul M, 2006, PEDIATR DIABETES, V7, P101, DOI 10.1111/j.1399-543X.2006.00155.x
   Alderfer MA, 2008, J PEDIATR PSYCHOL, V33, P1046, DOI 10.1093/jpepsy/jsm083
   Barry TD, 2009, CHILD FAM BEHAV THER, V31, P1, DOI 10.1080/07317100802701186
   Barry TD, 2005, J AM ACAD CHILD PSY, V44, P265, DOI 10.1097/00004583-200503000-00011
   Centers for Disease Control and Prevention, 2005, NAT DIAB FACT SHEET
   Colvin A., 1999, RESTANDARDIZATION EY
   Dabelea D, 2007, JAMA-J AM MED ASSOC, V297, P2716
   EURODIAB ACE Study Group, 2000, LANCET, V355, P873
   FIESE BH, 1989, J PEDIATR PSYCHOL, V14, P293, DOI 10.1093/jpepsy/14.2.293
   FREUND A, 1991, RELATIONSHIP ADHEREN
   Holmes CS, 2006, J PEDIATR PSYCHOL, V31, P770, DOI 10.1093/jpepsy/jsj083
   Jaser SS, 2009, CHILD HEALTH CARE, V38, P91, DOI 10.1080/02739610902813229
   Kline R. B., 2005, PRINCIPLES PRACTICE
   KRECH KH, 1992, J CLIN CHILD PSYCHOL, V21, P115, DOI 10.1207/s15374424jccp2102_3
   Lewin A. B., 2005, FAMILIES SYSTEMS HLT, V23, P56, DOI DOI 10.1037/1091-7527.23.1.56
   LORENZI M, 1985, DIABETOLOGIA, V28, P734
   MacCallum RC, 2000, ANNU REV PSYCHOL, V51, P201, DOI 10.1146/annurev.psych.51.1.201
   MACCOBY EE, 1983, SOCIALIZATION CONTEX, V4
   McDonnell CM, 2007, DIABETES CARE, V30, P2211, DOI 10.2337/dc07-0328
   MIDDLEBROOK JL, 1985, BEHAV THER, V16, P494, DOI 10.1016/S0005-7894(85)80027-7
   Mitchell SJ, 2009, FAM SYST HEALTH, V27, P314, DOI 10.1037/a0018191
   Monaghan MC, 2009, FAM SYST HEALTH, V27, P28, DOI 10.1037/a0014770
   Muthen B. O., 1998, MPLUS VERSION 6
   MUTHEN LK, 2006, MPLUS VERSION 4
   Patton SR, 2004, PEDIATR DIABETES, V5, P190, DOI 10.1111/j.1399-543X.2004.00058.x
   Powers SW, 2002, DIABETES CARE, V25, P313, DOI 10.2337/diacare.25.2.313
   Quittner AL, 2008, J PEDIATR PSYCHOL, V33, P916, DOI 10.1093/jpepsy/jsm064
   Renk K, 2007, CHILD FAM BEHAV THER, V29, P37, DOI 10.1300/J019v29n01_03
   ROBINSON EA, 1980, J CLIN CHILD PSYCHOL, V9, P22, DOI 10.1080/15374418009532938
   SHAW DS, 1993, J ABNORMAL CHILD PSY, V21, P35
   Silverstein J, 2005, DIABETES CARE, V28, P186, DOI 10.2337/diacare.28.1.186
   SOKOL DK, 1996, BRAIN INJURY, V10, P493
   Spielberger C. D., 1983, MANUAL STATE TRAIT A
   *SPSS INC, 2007, SPSS COMP PROGR VERS
   Stallwood Lynda, 2005, J Pediatr Health Care, V19, P293, DOI 10.1016/j.pedhc.2005.04.003
   Streisand R, 2005, J PEDIATR PSYCHOL, V30, P513, DOI 10.1093/jpepsy/jsi076
   Streisand R, 2001, J PEDIATR PSYCHOL, V26, P155, DOI 10.1093/jpepsy/26.3.155
   Sullivan-Bolyai S, 2003, J Pediatr Nurs, V18, P21, DOI 10.1053/jpdn.2003.4
   THOMPSON KL, 1987, J PEDIATR PSYCHOL, V12, P241, DOI 10.1093/jpepsy/12.2.241
   Visconti KJ, 2002, J DEV BEHAV PEDIATR, V23, P314, DOI 10.1097/00004703-200210000-00003
   WACHTEL J, 1994, J PEDIATR PSYCHOL, V19, P723, DOI 10.1093/jpepsy/19.6.723
   Walker LO, 2007, J SPEC PEDIATR NURS, V12, P93, DOI 10.1111/j.1744-6155.2005.00098.x
   WEBSTERSTRATTON C, 1982, J CLIN CHILD PSYCHOL, V11, P123, DOI 10.1207/s15374424jccp1102_5
   WILCOX RR, 1987, ANNU REV PSYCHOL, V38, P29, DOI 10.1146/annurev.psych.38.1.29
   Wilson AC, 2009, J CLIN PSYCHOL MED S, V16, P216, DOI 10.1007/s10880-009-9163-x
   WYSOCKI T, 1989, DIABETES CARE, V12, P524, DOI 10.2337/diacare.12.8.524
NR 46
TC 46
Z9 46
U1 2
U2 29
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0305-1862
J9 CHILD CARE HLTH DEV
JI Child Care Health Dev.
PD MAR
PY 2011
VL 37
IS 2
BP 224
EP 232
DI 10.1111/j.1365-2214.2010.01162.x
PG 9
WC Psychology, Developmental; Pediatrics
SC Psychology; Pediatrics
GA 720XT
UT WOS:000287316700009
PM 21083686
DA 2019-01-08
ER

PT J
AU Engel, L
   Cummins, R
AF Engel, L.
   Cummins, R.
TI Impact of dose adjustment for normal eating in Australia (OzDAFNE) on
   subjective wellbeing, coping resources and negative affects in adults
   with type 1 diabetes: A prospective comparison study
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Type 1 diabetes; Structured patient education; Subjective wellbeing;
   Coping; Therapeutic alliance
ID QUALITY-OF-LIFE; DEPRESSION; ANXIETY; HEALTH; MODEL
AB Aim: This prospective study examined the impact of a structured education program (OzDAFNE) on subjective wellbeing, coping resources, and negative affects in adults with type 1 diabetes. Participants completing the OzDAFNE program were compared to those using continuous subcutaneous insulin (CSII) and multiple daily injections (MDI) over the same time period.
   Methods: Participants in the OzDAFNE group (N = 144) were recruited from diabetes centres throughout Australia. The comparison groups were recruited from Diabetes Australia-Victoria's membership database and comprised 383 people using MDI and 64 people using CSII. All participants completed self-report questionnaires at baseline and 12-months later. Additional assessments for OzDAFNE participants were conducted at the end of the education program and at three and six-months following the training.
   Results: The results demonstrated that participants completing the OzDAFNE program experienced improved subjective wellbeing (p < .01), a greater sense of mastery and control in managing their diabetes (p < .001), and reduced diabetes-related distress (p < .001) compared to the CSII and MDI groups. However, the CSII group recorded a significant drop in self-esteem (p < .001) over the duration of the study.
   Conclusions/Interpretations: The OzDAFNE program provides a powerful mastery experience for participants, positively influencing subjective wellbeing and diabetes-related distress. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
C1 [Engel, L.] Hlth Psychologist MOTS Consulting, Melbourne, Vic, Australia.
   [Cummins, R.] Deakin Univ, Fac Hlth Med Nursing & Behav Sci, Sch Psychol, Melbourne, Vic, Australia.
RP Engel, L (reprint author), 54 Fernhill Rd, Sandringham, Vic 3191, Australia.
EM lisaengel@netspace.net.au
FU Australian Diabetes Educators Association
FX Lisa Engel received a post-graduate grant from the Australian Diabetes
   Educators Association.
CR Amiel S, 2002, BRIT MED J, V325, P746
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Byrne B. M., 1996, MEASURING SELF CONCE
   Cummins R. A., 2002, UNIVERSALITY SUBJECT, P7, DOI DOI 10.1007/978-94-010-0271-4_3
   Cummins RA, 2000, SOC INDIC RES, V52, P55, DOI 10.1023/A:1007027822521
   Cummins RA, 2003, SOC INDIC RES, V64, P225, DOI 10.1023/A:1024712527648
   Cummins RA, 2003, SOC INDIC RES, V64, P159, DOI 10.1023/A:1024704320683
   Cummins RA, 2010, J HAPPINESS STUD, V11, P1, DOI 10.1007/s10902-009-9167-0
   Engel L., 2009, PSYCHOL IMPACT DAFNE
   HARVEY D, 2008, AUSTR DIAB SOC AUSTR
   HORVATH AO, 1989, J COUNS PSYCHOL, V36, P223, DOI 10.1037/0022-0167.36.2.223
   Lazarus R. S, 1984, STRESS APPRAISAL COP
   Leventhal H, 2008, ANNU REV PSYCHOL, V59, P477, DOI 10.1146/annurev.psych.59.103006.093643
   MCINTYRE D, 2008, AUSTR DIAB SOC AUSTR
   Muhlhauser I, 2002, DIABETOLOGIA, V45, P1723, DOI 10.1007/s00125-002-0987-2
   Nistico H., 2002, J HAPPINESS STUD, V3, P37, DOI DOI 10.1023/A:1015678915305
   Peyrot M, 1997, DIABETES CARE, V20, P585, DOI 10.2337/diacare.20.4.585
   Rosenberg M., 1979, CONCEIVING SELF
   SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063
   SEEMAN M, 1995, SOC SCI MED, V41, P517, DOI 10.1016/0277-9536(94)00362-W
   Sheldon K. M., 2006, J HAPPINESS STUD, V7, P55, DOI DOI 10.1007/S10902-005-0868-8
   SNAITH P, HOSP ANXIETY DEPRESS
   Speight J, 2007, DIABETIC MED, V24, P693, DOI 10.1111/j.1464-5491.2007.02201.x
   Taylor SE, 2007, ANNU REV CLIN PSYCHO, V3, P377, DOI 10.1146/annurev.clinpsy.3.022806.091520
   TROCHIM W, 2006, STAT ANAL NONEQUIVAL
   Welch G, 2003, DIABETIC MED, V20, P69, DOI 10.1046/j.1464-5491.2003.00832.x
NR 26
TC 7
Z9 8
U1 0
U2 5
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD MAR
PY 2011
VL 91
IS 3
BP 271
EP 279
DI 10.1016/j.diabres.2010.11.023
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 732EW
UT WOS:000288168800008
PM 21146889
DA 2019-01-08
ER

PT J
AU Yang, Y
   Salam, ZHA
   Ong, BC
   Yang, KS
AF Yang, Yong
   Salam, Zakir-Hussain Abdul
   Ong, Biauw Chi
   Yang, Kok Soong
TI RESPIRATORY DYSFUNCTION IN PATIENTS WITH SEPSIS: PROTECTIVE EFFECT OF
   DIABETES MELLITUS
SO AMERICAN JOURNAL OF CRITICAL CARE
LA English
DT Article
ID ACUTE LUNG INJURY; DISTRESS-SYNDROME; POLYMORPHONUCLEAR LEUKOCYTES;
   UNITED-STATES; SEPTIC SHOCK; RISK-FACTORS; EPIDEMIOLOGY; NEUTROPHILS;
   METABOLISM; INSULIN
AB Background Sepsis is a common complication in patients with diabetes mellitus. In a Western population, risk of respiratory dysfunction was lower in diabetic patients with sepsis.
   Objective To compare organ dysfunction, particularly respiratory dysfunction, between sepsis patients with and without diabetes mellitus in an Asian population.
   Method Hospital discharge data were collected for the period 2004 through 2008. Patients with sepsis, diabetes mellitus, and organ dysfunction were identified by using the International Statistical Classification of Diseases and Related Health Problems, 9th Revision, Australian Modification codes.
   Results Of the 383 238 patients hospitalized during the 5 years, 2943 of the 9221 who had sepsis also had diabetes (31.9%). The most common organ dysfunctions in patients with sepsis were renal (31.5%), cardiovascular (19.2%), and respiratory (10.9%). Among patients with sepsis, respiratory dysfunction was less likely in patients with diabetes (9.4%) than in those without (11.6%; P = .002), but renal dysfunction was more likely in patients with diabetes (46.5%) than in those without (24.4%; P <.001). However, only 27.6% of patients with diabetes had a respiratory source of sepsis compared with 33.4% in patients without diabetes (P <.001). Among patients with sepsis, diabetes mellitus was a significant and independent predictor of respiratory dysfunction (odds ratio, 0.80; 95% confidence interval, 0.66-0.98) after adjustments for age, sex, ethnicity, admission to intensive care, number of comorbid conditions, and other infection sources.
   Conclusion Among an Asian population, respiratory dysfunction in patients with sepsis is less likely to develop in those with diabetes than in those without diabetes. (American Journal of Critical Care. 2011;20:e41-e47)
C1 [Yang, Yong; Ong, Biauw Chi; Yang, Kok Soong] Singapore Gen Hosp, Dept Epidemiol, Singapore 169608, Singapore.
   [Salam, Zakir-Hussain Abdul] Natl Univ Singapore, Singapore, Singapore.
RP Yang, Y (reprint author), Singapore Gen Hosp, Dept Epidemiol, Outram Rd, Singapore 169608, Singapore.
EM yang.yong@sgh.com.sg
CR Alba-Loureiro TC, 2007, BRAZ J MED BIOL RES, V40, P1037, DOI 10.1590/S0100-879X2006005000143
   Alba-Loureiro TC, 2006, J ENDOCRINOL, V188, P295, DOI 10.1677/joe.1.06438
   Alberti C, 2005, AM J RESP CRIT CARE, V171, P461, DOI 10.1164/rccm.200403-324OC
   ALEXIEWICZ JM, 1995, ANN INTERN MED, V123, P919, DOI 10.7326/0003-4819-123-12-199512150-00004
   ANDERSEN B, 1988, J LAB CLIN MED, V111, P275
   Angus DC, 2001, CRIT CARE MED, V29, P1303, DOI 10.1097/00003246-200107000-00002
   Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726
   Chowdhury TA, 2008, LANCET, V371, P1728, DOI 10.1016/S0140-6736(08)60738-2
   Delamaire M, 1997, DIABETIC MED, V14, P29, DOI 10.1002/(SICI)1096-9136(199701)14:1<29::AID-DIA300>3.0.CO;2-V
   DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8
   Eaton S, 2002, AM J RESP CRIT CARE, V165, pA471
   Ernst FR, 2006, AM J HEALTH-SYST PH, V63, P575, DOI 10.2146/ajhp050214
   Esper AM, 2006, CRIT CARE MED, V34, P2576, DOI 10.1097/01.CCM.0000239114.50519.0E
   Esper AM, 2009, CRIT CARE, V13, DOI 10.1186/cc7704
   Esper AM, 2009, CRIT CARE, V13, DOI 10.1186/cc7717
   Frank JA, 2000, CRIT CARE MED, V28, P2645, DOI 10.1097/00003246-200007000-00079
   Gedeborg R, 2007, J CLIN EPIDEMIOL, V60, P155, DOI 10.1016/j.jclinepi.2006.05.013
   Gong MN, 2005, CRIT CARE MED, V33, P1191, DOI 10.1097/01.CCM.0000165566.82925.14
   Honiden S, 2009, CRIT CARE MED, V37, P2455, DOI 10.1097/CCM.0b013e3181a0fea5
   Iscimen R, 2008, CRIT CARE MED, V36, P1518, DOI 10.1097/CCM.0b013e31816fc2c0
   JUBIZ W, 1984, PROSTA LEUKOTR MED, V14, P305, DOI 10.1016/0262-1746(84)90114-8
   Kornum JB, 2008, DIABETES CARE, V31, P1541, DOI 10.2337/dc08-0138
   Kornum JB, 2007, DIABETES CARE, V30, P2251, DOI 10.2337/dc06-2417
   Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139
   Moss M, 2000, CRIT CARE MED, V28, P2187, DOI 10.1097/00003246-200007000-00001
   Perner A, 2003, INTENS CARE MED, V29, P642, DOI 10.1007/s00134-002-1628-4
   REPINE JE, 1980, J INFECT DIS, V142, P869, DOI 10.1093/infdis/142.6.869
   Schoenman Julie. A, 2005, VALUE HOSP DISCHARGE
   Statistics Singapore, 2012, TIM SER POP MID EST
   Vanhorebeek I, 2005, LANCET, V365, P53, DOI 10.1016/S0140-6736(04)17665-4
   Yang Y, 2010, J CRIT CARE, V25, P398, DOI 10.1016/j.jcrc.2009.09.001
   Yilmaz M, 2007, CRIT CARE MED, V35, P1660, DOI 10.1097/01.CCM.0000269037.66955.F0
   Zgibor JC, 2007, DIABETES RES CLIN PR, V75, P313, DOI 10.1016/j.diabres.2006.07.007
NR 33
TC 11
Z9 14
U1 0
U2 2
PU AMER ASSOC CRITICAL CARE NURSES
PI ALISO VIEJO
PA 101 COLUMBIA, ALISO VIEJO, CA 92656 USA
SN 1062-3264
J9 AM J CRIT CARE
JI Am. J. Crit. Care
PD MAR 1
PY 2011
VL 20
IS 2
BP E41
EP E47
DI 10.4037/ajcc2011391
PG 7
WC Critical Care Medicine; Nursing
SC General & Internal Medicine; Nursing
GA 728AO
UT WOS:000287846100002
PM 21362712
OA Bronze
DA 2019-01-08
ER

PT J
AU Storz, SM
   Wylenzek, SAM
   Matheis, N
   Weber, MM
   Kahaly, GJ
AF Storz, S. M.
   Wylenzek, S. A. M.
   Matheis, N.
   Weber, M. M.
   Kahaly, G. J.
TI Impaired psychometric testing in polyglandular autoimmunity
SO CLINICAL ENDOCRINOLOGY
LA English
DT Article
ID SUBJECTIVE HEALTH-STATUS; ADRENAL INSUFFICIENCY; HOSPITAL ANXIETY; LARGE
   POPULATION; DEPRESSION SCALE; DISORDERS; REPLACEMENT; PREVALENCE;
   TYPE-1; LIFE
AB P>Objective
   Patients with the autoimmune polyglandular syndrome (APS) could be exposed to many limitations in daily life owing to their illness. To quantify the degree of physical and emotional distress, the psychometric profile of these patients was evaluated prospectively.
   Design, patients and measurements
   After a complete endocrine investigation, three international validated self-assessment questionnaires were applied in 75 patients with APS: the health-related quality of life Short-Form 36 (SF-36), the Giessen Complaint List (GBB-24) and the Hospital Anxiety and Depression Scale (HADS).
   Results
   Average duration of APS was 7 center dot 7 years. The most frequent disease combination was type 1 diabetes and autoimmune thyroid disease (n = 47, 62 center dot 6%). Every scale of the SF-36, GBB-24, and the HADS anxiety score demonstrated markedly impaired physical and emotional well-being, foremost in female subjects (P < 0 center dot 001). Compared to a German reference cohort, all subscales of the SF-36 were decreased (P < 0 center dot 001). Sex- and age-matched z-scores were significantly lower for physical functioning (-1 center dot 1; reference population z = 0), physical role limitations (-0 center dot 8), bodily pain (-0 center dot 7), general health perception (-1 center dot 2), vitality (-0 center dot 8), social functioning (-0 center dot 8), emotional role limitations (-1 center dot 1) and mental health (-0 center dot 5). Also, the global score of discomfort was increased in comparison with the reference population (27 center dot 27 vs 13 center dot 93, P < 0 center dot 001). Generalized anxiety (25%, P < 0 center dot 001) and depression episode (18 center dot 1%, P < 0 center dot 001) were prevalent in APS. Neither time interval between two endocrine diseases, duration of APS, age, nor autoantibody positivity influenced psychometric testing results.
   Conclusion
   Patients with APS have a severely impaired psychometric profile. Treatment modalities that would improve their well-being are warranted.
C1 [Storz, S. M.; Wylenzek, S. A. M.; Matheis, N.; Weber, M. M.; Kahaly, G. J.] Johannes Gutenberg Univ Mainz, Med Ctr, Dept Med 1, Endocrine Unit, D-55101 Mainz, Germany.
RP Kahaly, GJ (reprint author), Johannes Gutenberg Univ Mainz, Med Ctr, Dept Med 1, Endocrine Unit, D-55101 Mainz, Germany.
EM kahaly@ukmainz.de
CR Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P28
   Bekker MHJ, 2007, GENDER MED, V4, pS178, DOI 10.1016/S1550-8579(07)80057-X
   Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395
   Betterle C, 2004, CLIN EXP IMMUNOL, V137, P225, DOI 10.1111/j.1365-2249.2004.02561.x
   Bianchi GP, 2004, QUAL LIFE RES, V13, P45, DOI 10.1023/B:QURE.0000015315.35184.66
   Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3
   Bleicken B, 2008, EUR J ENDOCRINOL, V159, P811, DOI 10.1530/EJE-08-0578
   Brahler E, 2000, PSYCHOTHER PSYCH MED, V50, P14, DOI 10.1055/s-2000-13233
   Brahler E., 2008, GBB 24 GIESSENER BES
   Bullinger M, 1996, Rehabilitation (Stuttg), V35, pXVII
   BULLINGER M, 1995, SOC SCI MED, V41, P1359, DOI 10.1016/0277-9536(95)00115-N
   Bullinger M, 1996, REHABILITATION STUTT, V35, pXXVII
   Bullinger M, 1998, SF 36 FRAGEBOGEN ZUM
   Dekkers JC, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-69
   EISENBARTH GS, 2004, J MED, V350, P2068
   Eley T C, 1999, Clin Child Fam Psychol Rev, V2, P21, DOI 10.1023/A:1021863324202
   Engum A, 2005, J PSYCHOSOM RES, V59, P263, DOI 10.1016/j.jpychores.2005.04.002
   Engum A, 2005, DIABETES CARE, V28, P1904, DOI 10.2337/diacare.28.8.1904
   Engum A, 2002, ACTA PSYCHIAT SCAND, V106, P27, DOI 10.1034/j.1600-0447.2002.01250.x
   Erichsen MM, 2009, J CLIN ENDOCR METAB, V94, P4882, DOI 10.1210/jc.2009-1368
   Grigoriadis Sophie, 2007, Ann Clin Psychiatry, V19, P247, DOI 10.1080/10401230701653294
   Gurnell EM, 2008, J CLIN ENDOCR METAB, V93, P400, DOI 10.1210/jc.2007-1134
   Hahner S, 2007, J CLIN ENDOCR METAB, V92, P3912, DOI 10.1210/jc.2007-0685
   Hermann-Lingen C, 2005, HADS D HOSP ANXIETY
   Kahaly GJ, 2009, EUR J ENDOCRINOL, V161, P11, DOI 10.1530/EJE-09-0044
   Kahaly GJ, 2005, CLIN ENDOCRINOL, V63, P395, DOI 10.1111/j.1365-2265.2005.02352.x
   Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617
   Lovas K, 2002, CLIN ENDOCRINOL, V56, P581, DOI 10.1046/j.1365-2265.2002.01466.x
   Mykletun A, 2001, BRIT J PSYCHIAT, V179, P540, DOI 10.1192/bjp.179.6.540
   NEUFELD M, 1980, PEDIATR ANN, V9, P43, DOI 10.3928/0090-4481-19800401-07
   Obermayer-Straub P, 2000, CLIN REV ALLERG IMMU, V18, P167, DOI 10.1385/CRIAI:18:2:167
   Owen CJ, 2009, ENDOCRIN METAB CLIN, V38, P419, DOI 10.1016/j.ecl.2009.01.007
   Pigott TA, 2003, PSYCHIAT CLIN N AM, V26, P621, DOI 10.1016/S0193-953X(03)00040-6
   Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008
   Wilhelm KA, 2009, AUST FAM PHYSICIAN, V38, P102
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
NR 36
TC 5
Z9 5
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0300-0664
EI 1365-2265
J9 CLIN ENDOCRINOL
JI Clin. Endocrinol.
PD MAR
PY 2011
VL 74
IS 3
BP 394
EP 403
DI 10.1111/j.1365-2265.2010.03952.x
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 718AY
UT WOS:000287093200018
PM 21128996
DA 2019-01-08
ER

PT J
AU Goebel-Fabbri, AE
   Anderson, BJ
   Fikkan, J
   Franko, DL
   Pearson, K
   Weinger, K
AF Goebel-Fabbri, Ann E.
   Anderson, Barbara J.
   Fikkan, Janna
   Franko, Debra L.
   Pearson, Kimberly
   Weinger, Katie
TI Improvement and Emergence of Insulin Restriction in Women With Type 1
   Diabetes
SO DIABETES CARE
LA English
DT Article
ID CLINICAL EATING-DISORDERS; MICROVASCULAR COMPLICATIONS; MELLITUS;
   BEHAVIOR; INVENTORY; OMISSION; FEMALES; ADULTS; GIRLS; IDDM
AB OBJECTIVE To determine the distinguishing characteristics of women who report stopping insulin restriction at 11 years of follow-up from those continuing to endorse insulin restriction as well as those characteristics differing in patients who continue to Use insulin appropriately from new insulin restrictors.
   RESEARCH DESIGN AND METHODS This is an 11-year follow-up study of 207 women with type 1 diabetes. Insulin restriction, diabetes self-care behaviors, diabetes-specific distress, and psychiatric and eating disorder symptoms were assessed using self-report surveys.
   RESULTS Of the original sample, 57% participated in the follow-up study. Mean age was 44 +/- 12 years, diabetes duration was 28 +/- 11 years, and A1C was 7.9 +/- 1.3%. At follow-up, 20 of 60 baseline insulin restrictors had stopped restriction. Women who stopped reported improved diabetes self-care and distress, fewer problems with diabetes self-management, and lower levels of psychologic distress and eating disorder symptoms. Logistic regression indicated that lower levels of fear of weight gain with improved blood glucose and fewer problems with diabetes self-management predicted stopping restriction. At follow-up, 34 women (23%) reported new restriction, and a larger proportion of new insulin restrictors, relative to nonrestrictors, endorsed fear of weight gain with improved blood glucose.
   CONCLUSIONS Findings indicate that fear of weight gain associated with improved blood glucose and problems with diabetes self-care are core issues related to both the emergence and resolution of insulin restriction. Greater attention to these concerns may help treatment teams to better meet the unique treatment needs of women struggling with insulin restriction. Diabetes Care 34:545-550, 2011
C1 [Goebel-Fabbri, Ann E.; Weinger, Katie] Joslin Diabet Ctr, Boston, MA 02215 USA.
   [Goebel-Fabbri, Ann E.; Pearson, Kimberly; Weinger, Katie] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA.
   [Anderson, Barbara J.] Texas Childrens Hosp, Dept Pediat, Houston, TX 77030 USA.
   [Fikkan, Janna] Duke Univ, Med Ctr, Durham, NC USA.
   [Franko, Debra L.] Northeastern Univ, Dept Counseling & Appl Educ Psychol, Boston, MA 02115 USA.
   [Pearson, Kimberly] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA.
RP Weinger, K (reprint author), Joslin Diabet Ctr, Boston, MA 02215 USA.
EM katie.weinger@joslin.harvard.edu
FU Center of Excellence in Women's Health; Harvard Medical School; National
   Institute of Diabetes and Digestive and Kidney Diseases [R01-DK-060115,
   P30-DK-36836]; National Institutes of Health; Herbert Graetz Fund
FX This project was funded by a grant from the Center of Excellence in
   Women's Health, Harvard Medical School and the National Institute of
   Diabetes and Digestive and Kidney Diseases (R01-DK-060115 and
   P30-DK-36836). The original work was supported by grants from the
   National Institutes of Health-supported Diabetes and Endocrinology
   Research Center at Joslin Diabetes Center and the Herbert Graetz Fund.
CR Affenito SG, 1997, DIABETES CARE, V20, P182, DOI 10.2337/diacare.20.2.182
   Bryden KS, 1999, DIABETES CARE, V22, P1956, DOI 10.2337/diacare.22.12.1956
   Colton PA, 2007, DIABETES CARE, V30, P2861, DOI 10.2337/dc07-1057
   COX DJ, 1987, DIABETES CARE, V10, P617, DOI 10.2337/diacare.10.5.617
   DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017
   Goebel-Fabbri AE, 2008, DIABETES CARE, V31, P415, DOI 10.2337/dc07-2026
   Greco P., 1990, DIABETES S1, V39, p165A
   Jones JM, 2000, BMJ-BRIT MED J, V320, P1563, DOI 10.1136/bmj.320.7249.1563
   KROLEWSKI AS, 1995, NEW ENGL J MED, V332, P1251, DOI 10.1056/NEJM199505113321902
   Olmsted MP, 2008, DIABETES CARE, V31, P1978, DOI 10.2337/dc08-0333
   PEVELER RC, 1990, INT J EAT DISORDER, V11, P45
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   POLONSKY WH, 1994, DIABETES CARE, V17, P1178, DOI 10.2337/diacare.17.10.1178
   Rydall AC, 1997, NEW ENGL J MED, V336, P1849, DOI 10.1056/NEJM199706263362601
   SHAMOON H, 1993, NEW ENGL J MED, V329, P977
   Takii M, 2008, INT J EAT DISORDER, V41, P259, DOI 10.1002/eat.20498
   THELEN MH, 1991, PSYCHOL ASSESSMENT J, V3, P119, DOI DOI 10.1037/1040-3590.3.1.119
   Weinger K, 2005, DIABETES CARE, V28, P1346, DOI 10.2337/diacare.28.6.1346
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
NR 19
TC 12
Z9 12
U1 2
U2 14
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
EI 1935-5548
J9 DIABETES CARE
JI Diabetes Care
PD MAR
PY 2011
VL 34
IS 3
BP 545
EP 550
DI 10.2337/dc10-1547
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 731YA
UT WOS:000288145400003
PM 21266653
OA Green Published, Other Gold
DA 2019-01-08
ER

PT J
AU Sorkin, DH
   Quyen, NM
   Billimek, J
   August, KJ
   Greenfield, S
   Kaplan, SH
AF Sorkin, Dara H.
   Quyen Ngo-Metzger
   Billimek, John
   August, Kristin J.
   Greenfield, Sheldon
   Kaplan, Sherrie H.
TI Underdiagnosed and Undertreated Depression Among Racially/Ethnically
   Diverse Patients With Type 2 Diabetes
SO DIABETES CARE
LA English
DT Article
ID PRIMARY-CARE PATIENTS; GLYCEMIC CONTROL; CES-D; LATINO; SERVICES;
   SYMPTOMS; DISTRESS
AB OBJECTIVE-To examine racial/ethnic differences in the prevalence of depressive symptoms and in provider recognition of depression among Latino, Asian, and non-Hispanic white patients with type 2 diabetes.
   RESEARCH DESIGN AND METHODS-Patients (n = 1,209) with type 2 diabetes were recruited from five university-affiliated primary care clinics for an observational study.
   RESULTS-Vietnamese American (133, 59.4%) and Mexican American (351, 50.2%) patients were more likely to report symptoms consistent with clinical depression (Center for Epidemiological Studies Depression [CES-D] scale score >= 22) than non-Hispanic whites (119, 41.6%; F [2, 1206] = 8.05, P < 0.001). Despite comparable diabetes care, Vietnamese and Mexican patients with high depressive symptoms were less likely to be diagnosed and treated than non-Hispanic whites (all P values < 0.001). Minority patients who reported low levels of trust in their provider were less likely to have been diagnosed or treated for depression (adjusted odds ratio 0.65, 95% CI 0.44-0.98, P < 0.05).
   CONCLUSIONS-Innovative strategies are needed to improve recognition of depressive symptoms in minority patients.
C1 [Sorkin, Dara H.] Univ Calif Irvine, Div Gen Internal Med, Irvine, CA 92717 USA.
   Univ Calif Irvine, Primary Care & Hlth Policy Res Inst, Irvine, CA USA.
RP Sorkin, DH (reprint author), Univ Calif Irvine, Div Gen Internal Med, Irvine, CA 92717 USA.
EM dsorkin@uci.edu
OI Greenfield, Sheldon/0000-0003-4628-1998
FU Robert Wood Johnson Foundation [1051084, 59758]; Novo Nordisk
   Foundation; National Institute of Diabetes and Digestive and Kidney
   Diseases [R18DK69846, K01DK078939]
FX This work was supported by the Robert Wood Johnson Foundation (grants
   1051084 and 59758), the Novo Nordisk Foundation, and the National
   Institute of Diabetes and Digestive and Kidney Diseases (R18DK69846 and
   K01DK078939).
CR CHENG SH, 2010, HLTH POLICY PLA 0810
   Chung H, 2003, COMMUNITY MENT HLT J, V39, P33, DOI 10.1023/A:1021221806912
   Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278
   Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175
   Leng JCF, 2010, J IMMIGR MINOR HEALT, V12, P234, DOI 10.1007/s10903-009-9254-7
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   *NAT DIAB QUAL IMP, 2009, PERF MEAS SET AD DIA
   Pignone MP, 2002, ANN INTERN MED, V136, P765, DOI 10.7326/0003-4819-136-10-200205210-00013
   *REG U CA, 2009, RED RAC DISP DIAB CO
   Santor DA, 1997, PSYCHOL ASSESSMENT, V9, P233, DOI 10.1037/1040-3590.9.3.233
   SIMON GE, 1995, MEDICINE, V4, P99
   Ta VM, 2010, AM J PUBLIC HEALTH, V100, P115, DOI 10.2105/AJPH.2009.160762
   Thom DH, 1999, ACAD MED, V74, P195, DOI 10.1097/00001888-199902000-00019
   *US CENS BUR, 2000, AM FACT FIND QT P17
   ZICH JM, 1990, INT J PSYCHIAT MED, V20, P259, DOI 10.2190/LYKR-7VHP-YJEM-MKM2
NR 15
TC 19
Z9 19
U1 0
U2 6
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
J9 DIABETES CARE
JI Diabetes Care
PD MAR
PY 2011
VL 34
IS 3
BP 598
EP 600
DI 10.2337/dc10-1825
PG 3
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 731YA
UT WOS:000288145400013
PM 21273497
OA Green Published, Other Gold
DA 2019-01-08
ER

PT J
AU Snoek, FJ
   Kersch, NYA
   Eldrup, E
   Harman-Boehm, I
   Hermanns, N
   Kokoszka, A
   Matthews, DR
   McGuire, BE
   Pibernik-Okanovic, M
   Singer, J
   de Wit, M
   Skovlund, SE
AF Snoek, Frank J.
   Kersch, Nancy Y. A.
   Eldrup, Ebbe
   Harman-Boehm, Ilana
   Hermanns, Norbert
   Kokoszka, Andrzej
   Matthews, David R.
   McGuire, Brian E.
   Pibernik-Okanovic, Mirjana
   Singer, Joelle
   de Wit, Maartje
   Skovlund, Soren E.
TI Monitoring of Individual Needs in Diabetes (MIND): Baseline Data From
   the Cross-National Diabetes Attitudes, Wishes, and Needs (DAWN) MIND
   Study
SO DIABETES CARE
LA English
DT Article
ID RANDOMIZED CONTROLLED-TRIAL; CO-MORBID DEPRESSION; VALIDITY; ADULTS;
   CARE; PREVALENCE; DISTRESS; QUALITY; PEOPLE
AB OBJECTIVE-To test the feasibility and impact of implementing the computer-assisted Monitoring of Individual Needs in Diabetes (MIND) procedure, which is aimed at improving recognition and management of the psychological needs of diabetic patients in routine care.
   RESEARCH DESIGN AND METHODS-The MIND study was implemented in diabetes clinics across eight countries as part of the annual review. The computerized assessment covered emotional well-being (World Health Organization 5 Well-Being Index), diabetes-related distress (Problem Areas in Diabetes), life events, and the patient's agenda. Medical data were retrieved from the charts, and agreed-upon actions were recorded.
   RESULTS-Of 1,567 patients monitored using the MIND, 24.9% had either likely depression or high diabetes-related distress; 5.4% had both. Over 80% of these patients were newly identified cases, and 41% of patients with depression were referred to a mental health professional.
   CONCLUSIONS-Monitoring of well-being and diabetes-related distress as part of routine diabetes care is feasible and helps to identify and discuss unmet psychosocial needs.
C1 [Snoek, Frank J.; Kersch, Nancy Y. A.; de Wit, Maartje] Vrije Univ Amsterdam, Med Ctr, Dept Med Psychol, Amsterdam, Netherlands.
   [Eldrup, Ebbe] Steno Diabet Ctr, Copenhagen, Denmark.
   [Harman-Boehm, Ilana] Soroka Univ Med Ctr, Beer Sheva, Israel.
   [Hermanns, Norbert] Mergentheim Diabet Zentrum, Mergentheim, Germany.
   [Kokoszka, Andrzej] Med Univ Warsaw & Poradnia Diabetologiczna, Dept Psychiat 2, Warsaw, Poland.
   [Matthews, David R.] Oxford Ctr Diabet Endocrinol & Metab, Oxford, England.
   [McGuire, Brian E.] Univ Coll Hosp, Ctr Diabet, Galway, Ireland.
   [McGuire, Brian E.] Natl Univ Ireland, Sch Psychol, Galway, Ireland.
   [Pibernik-Okanovic, Mirjana] Vuk Vrhovac Univ Clin, Zagreb, Croatia.
   [Singer, Joelle] Rabin Med Ctr, Petah Tiqwa, Israel.
   [Skovlund, Soren E.] Novo Nordisk AS, Diabet Attitudes Wishes & Needs Program, DK-2880 Bagsvaerd, Denmark.
RP Snoek, FJ (reprint author), Vrije Univ Amsterdam, Med Ctr, Dept Med Psychol, Amsterdam, Netherlands.
EM fj.snoek@vumc.nl
RI Kokoszka, Andrzej/O-7454-2018
OI Kokoszka, Andrzej/0000-0003-4518-5494
FU Novo Nordisk; National Institute for Health Research [NF-SI-0508-10272]
FX This study was supported by an unrestricted research grant from Novo
   Nordisk. No other potential conflicts of interest relevant to this
   article were reported.
CR Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x
   American Diabetes Association, 2006, DIABETES CARE S1, V29, pS4
   Awata S, 2007, PSYCHIAT CLIN NEUROS, V61, P112, DOI 10.1111/j.1440-1819.2007.01619.x
   Barnard KD, 2006, DIABETIC MED, V23, P445, DOI 10.1111/j.1464-5491.2006.01814.x
   Davies M, 2006, DIABETIC MED, V23, P917, DOI 10.1111/j.1464-5491.2006.01892.x
   De Wit M, 2008, DIABETES CARE, V31, P1521, DOI 10.2337/dc08-0394
   Home P, 2006, DIABETIC MED, V23, P579
   Li CY, 2010, DIABETES CARE, V33, P1061, DOI 10.2337/dc09-1515
   Lowe B, 2004, J AFFECT DISORDERS, V78, P131, DOI 10.1016/S0165-0327(02)00237-9
   McGuire BE, 2010, DIABETOLOGIA, V53, P66, DOI 10.1007/s00125-009-1559-5
   Peyrot M, 2006, DIABETES CARE, V29, P1256, DOI 10.2337/dc05-2444
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   Pouwer F, 2001, DIABETES CARE, V24, P1929, DOI 10.2337/diacare.24.11.1929
   Simon GE, 2007, ARCH GEN PSYCHIAT, V64, P65, DOI 10.1001/archpsyc.64.1.65
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
NR 15
TC 57
Z9 60
U1 0
U2 14
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
J9 DIABETES CARE
JI Diabetes Care
PD MAR
PY 2011
VL 34
IS 3
BP 601
EP 603
DI 10.2337/dc10-1552
PG 3
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 731YA
UT WOS:000288145400014
PM 21266654
OA Green Published, Other Gold
DA 2019-01-08
ER

PT J
AU Oakley, LD
   Aekwarangkoon, S
   Ward, EC
AF Oakley, Linda Denise
   Aekwarangkoon, Saifon
   Ward, Earlise C.
TI Successful Holistic Management of Type 2 Diabetes With Depression A Very
   Personal Story
SO HOLISTIC NURSING PRACTICE
LA English
DT Article
DE depression; diabetes; holistic management; illness story; narrative
ID HEALTH-CARE; STRESS; DISTRESS; RISK; STRATEGIES; DIAGNOSIS; RECOVERY;
   SYMPTOMS; MELLITUS; WOMEN
AB We used illness narrative methods to evaluate the retrospective illness story of a bereaved woman who has recovered from type 2 diabetes and depression with comorbid hypertension, hyperlipidemia, vertigo, and obesity. Her spoken illness story was obtained with a single interview question: What happened? Our findings show that the patient searched for and found personal meaning in her illness. The finding of meaning in her illness appears to have supported her efforts to adopt more positive health beliefs and health behaviors. Although she received excellent health care throughout her illness, she attributes her return to good health to spiritual growth. We discuss the practice implications of this patient's illness story for clinicians who seek new insights into patients who have complex illness stories.
C1 [Oakley, Linda Denise; Ward, Earlise C.] Univ Wisconsin, Madison, WI 53792 USA.
   [Aekwarangkoon, Saifon] Walailak Univ, Nakhon Si Thammarat, Thailand.
RP Oakley, LD (reprint author), Univ Wisconsin, Clin Sci Ctr Room K6-356,600 Highland Ave, Madison, WI 53792 USA.
EM ldoakley@wisc.edu
CR Aekwarangkoon S., 2006, THAI J NURSING RES, V10, P288
   Anderson DHC, 2007, DIABETES SPECTRUM, V20, P10
   Baldacchino D, 2001, J ADV NURS, V34, P833, DOI 10.1046/j.1365-2648.2001.01814.x
   Boulos Maged N Kamel, 2003, Int J Health Geogr, V2, P2, DOI 10.1186/1476-072X-2-2
   Buck Harleah G, 2006, Holist Nurs Pract, V20, P288
   Clarke D, 2009, PERS INDIV DIFFER, V46, P460, DOI 10.1016/j.paid.2008.11.014
   Coe CL, 2010, HDB HLTH PSYCHOL BEH, P182
   Csordas TJ, 2008, J NERV MENT DIS, V196, P585, DOI [10.1097/NMD.0b013e3181812c68, 10.1097/NMD.0b013c3181812c68]
   Egede LE, 2009, GEN HOSP PSYCHIAT, V31, P422, DOI 10.1016/j.genhosppsych.2009.06.007
   Eriksson AK, 2008, DIABETIC MED, V25, P834, DOI 10.1111/j.1464-5491.2008.02463.x
   Fisher EB, 2005, AM J PUBLIC HEALTH, V95, P1523, DOI 10.2105/AJPH.2005.066084
   Gaynor SI, 2008, BEHAV MODIF, V32, P372, DOI 10.1177/0145445507309028
   Golden SH, 2008, JAMA-J AM MED ASSOC, V299, P2751, DOI 10.1001/jama.299.23.2751
   Guidone C, 2006, DIABETES, V55, P2025, DOI 10.2337/db06-0068
   Guzman Susan, 2004, Diabetes Forecast, V57, P52
   Kaslow NJ, 2007, PROF PSYCHOL-RES PR, V38, P278, DOI 10.1037/0735-7028.38.3.278
   Katon W, 2004, DIABETES CARE, V27, P914, DOI 10.2337/diacare.27.4.914
   Kearney MH, 2001, RES NURS HEALTH, V24, P145, DOI 10.1002/nur.1017
   Kirkpatrick H, 2008, ARCH PSYCHIAT NURS, V22, P61, DOI 10.1016/j.apnu.2002.12.002
   Lustman PJ, 2005, J DIABETES COMPLICAT, V19, P113, DOI 10.1016/j.jdiacomp.2004.01.002
   Matthews SC, 2005, PSYCHOSOM MED, V67, P509, DOI 10.1097/01.psy.0000160467.78373.d8
   McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006
   McEwen BS, 2004, ANN NY ACAD SCI, V1032, P1, DOI 10.1193/annals.1314.001
   McFarlane SI, 2001, DIABETIC MED, V18, P10, DOI 10.1046/j.1464-5491.2001.00395.x
   Meyer Bonnie L, 2008, Holist Nurs Pract, V22, P81, DOI 10.1097/01.HNP.0000312656.68147.7f
   Mezuk B, 2008, AM J PUBLIC HEALTH, V98, P1480, DOI 10.2105/AJPH.2007.126441
   Pan A, 2011, ARCH GEN PSYCHIAT, V68, P42, DOI 10.1001/archgenpsychiatry.2010.176
   Praissman S, 2008, J AM ACAD NURSE PRAC, V20, P212, DOI 10.1111/j.1745-7599.2008.00306.x
   Reifsnider E, 2005, J PROF NURS, V21, P216, DOI 10.1016/j.profnurs.2005.05.006
   Riley A. A., 2009, JNP-J NURSE PRACT, V5, P523, DOI DOI 10.1016/J.NURPRA.2009.03.020
   Riley T, 2005, HEALTH EDUC RES, V20, P226, DOI 10.1093/her/cyg122
   Rudell K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-207
   Saha S, 2008, J NATL MED ASSOC, V100, P1275, DOI 10.1016/S0027-9684(15)31505-4
   Vickers AJ, 2008, ANN INTERN MED, V149, P200, DOI 10.7326/0003-4819-149-3-200808050-00010
   Whittemore Robin, 2004, J Community Health Nurs, V21, P87, DOI 10.1207/s15327655jchn2102_03
   Whittemore Robin, 2004, Issues Ment Health Nurs, V25, P243, DOI 10.1080/01612840490274750
   *WHO, DEPR
NR 37
TC 1
Z9 1
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0887-9311
J9 HOLIST NURS PRACT
JI Holist. Nurs. Pract.
PD MAR-APR
PY 2011
VL 25
IS 2
BP 88
EP 96
DI 10.1097/HNP.0b013e31820de840
PG 9
WC Integrative & Complementary Medicine; Nursing
SC Integrative & Complementary Medicine; Nursing
GA 785BX
UT WOS:000292203500006
PM 21325909
DA 2019-01-08
ER

PT J
AU Haugstvedt, A
   Wentzel-Larsen, T
   Rokne, B
   Graue, M
AF Haugstvedt, Anne
   Wentzel-Larsen, Tore
   Rokne, Berit
   Graue, Marit
TI Perceived family burden and emotional distress: similarities and
   differences between mothers and fathers of children with type 1 diabetes
   in a population-based study
SO PEDIATRIC DIABETES
LA English
DT Article
DE childhood diabetes; family burden; gender differences; parental
   emotional distress
ID QUALITY-OF-LIFE; PATERNAL INVOLVEMENT; CHRONIC ILLNESS; MATERNAL SLEEP;
   CHRONIC SORROW; PARENTS; MANAGEMENT; ASSOCIATIONS; ADOLESCENTS;
   DEPRESSION
AB Background: Parenting children with diabetes entail an extra burden for the families. More information is needed about associations between perceived family burden and emotional distress in both mothers and fathers.
   Objective: To analyze (i) perceived burden and emotional distress in mothers and fathers of children with type 1 diabetes and (ii) associations between parental burden and distress and factors related to the child.
   Methods: Mothers (n = 103) and fathers (n = 97) of 115 children (1-15 yr) with type 1 diabetes participated in this population-based survey. The parents completed the Hopkins Symptom Checklist-25 items (HSCL-25), measuring emotional distress, and the Family Burden Scale, which includes five questions measuring perceived family burden related to the child's diabetes.
   Results: Both mothers and fathers reported that the greatest burden was related to long-term health concerns. The mothers reported a significantly greater burden related to medical treatment and significantly more emotional distress than the fathers. The mothers' perceived burden was significantly correlated with emotional distress. Nighttime blood glucose measurements were significantly associated with perceived parental burden, and experienced nocturnal hypoglycemia was significantly associated with parental emotional distress.
   Conclusions: The higher perceived burden related to medical treatment, the more emotional distress, and the correlations between burdens and emotional distress in mothers vs. fathers emphasize the importance of discussing both parents' roles and responsibilities in relation to the child's diabetes in follow-up. In the consultations, emphasizing nighttime caregiving and nocturnal hypoglycemia might also be important to prevent emotional distress.
C1 [Haugstvedt, Anne; Graue, Marit] Bergen Univ Coll, Fac Hlth & Social Sci, N-5020 Bergen, Norway.
   [Haugstvedt, Anne; Rokne, Berit] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, N-5020 Bergen, Norway.
   [Haugstvedt, Anne; Graue, Marit] Haukeland Hosp, Dept Pediat, N-5021 Bergen, Norway.
   [Wentzel-Larsen, Tore] Haukeland Hosp, Clin Res Ctr, N-5021 Bergen, Norway.
RP Haugstvedt, A (reprint author), Bergen Univ Coll, Fac Hlth & Social Sci, Postbox 7030, N-5020 Bergen, Norway.
EM ahau@hib.no
FU Diabetes Research Foundation of Western Norway; Norwegian Diabetes
   Association; Norwegian Nurses' Association; Western Norway Regional
   Health Authority; University of Bergen; Bergen University College
FX We thank all the parents and children who participated in this study.
   The study was supported by the Diabetes Research Foundation of Western
   Norway, the Norwegian Diabetes Association, the Norwegian Nurses'
   Association, the Western Norway Regional Health Authority, the
   University of Bergen, and Bergen University College.
CR Bowes S, 2009, J ADV NURS, V65, P992, DOI 10.1111/j.1365-2648.2009.04963.x
   Carpentier MY, 2006, CHILD HEALTH CARE, V35, P141, DOI 10.1207/s15326888chc3502_3
   Cottrell L, 2005, CLIN PEDIATR, V44, P613, DOI 10.1177/000992280504400709
   Dashiff Carol, 2008, J Pediatr Nurs, V23, P101, DOI 10.1016/j.pedn.2007.08.007
   Davis C. S., 2002, STAT METHODS ANAL RE
   DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102
   Gavin L, 2006, J PEDIATR PSYCHOL, V31, P481, DOI 10.1093/jpepsy/jsj043
   Haugstvedt A, 2010, DIABETIC MED, V27, P72, DOI 10.1111/j.1464-5491.2009.02867.x
   Hoey H, 2001, DIABETES CARE, V24, P1923, DOI 10.2337/diacare.24.11.1923
   Hoey H, 2006, QUAL LIFE RES, V15, P1033, DOI 10.1007/s11136-006-0042-8
   Landolt MA, 2005, J AM ACAD CHILD PSY, V44, P682, DOI 10.1097/01-chi.0000161645.98022.35
   Lowes L, 2000, J ADV NURS, V32, P41, DOI 10.1046/j.1365-2648.2000.01418.x
   Meltzer LJ, 2006, ARCH INTERN MED, V166, P1749, DOI 10.1001/archinte.166.16.1749
   Monaghan MC, 2009, FAM SYST HEALTH, V27, P28, DOI 10.1037/a0014770
   Naerde A, 2000, J AFFECT DISORDERS, V58, P181, DOI 10.1016/S0165-0327(99)00119-6
   Pelchat Diane, 2007, J Child Health Care, V11, P112, DOI 10.1177/1367493507076064
   Pelchat Diane, 2003, J Child Health Care, V7, P231, DOI 10.1177/13674935030074001
   Polit DF, 2008, NURSING RES GENERATI
   Sandanger I, 1998, SOC PSYCH PSYCH EPID, V33, P345, DOI 10.1007/s001270050064
   Streisand R, 2005, J PEDIATR PSYCHOL, V30, P513, DOI 10.1093/jpepsy/jsi076
   Streisand R, 2008, PATIENT EDUC COUNS, V73, P333, DOI 10.1016/j.pec.2008.06.014
   Sullivan-Bolyai S, 2006, MCN-AM J MATERN-CHIL, V31, P24, DOI 10.1097/00005721-200601000-00007
   Sullivan-Bolyai S, 2003, J Pediatr Nurs, V18, P21, DOI 10.1053/jpdn.2003.4
   Taanila A, 1996, DEV MED CHILD NEUROL, V38, P567
   WINOKUR A, 1984, BRIT J PSYCHIAT, V144, P395, DOI 10.1192/bjp.144.4.395
   Wysocki T, 2006, J PEDIATR PSYCHOL, V31, P501, DOI 10.1093/jpepsy/jsj042
NR 26
TC 37
Z9 38
U1 0
U2 24
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1399-543X
J9 PEDIATR DIABETES
JI Pediatr. Diabetes
PD MAR
PY 2011
VL 12
IS 2
BP 107
EP 114
DI 10.1111/j.1399-5448.2010.00661.x
PG 8
WC Endocrinology & Metabolism; Pediatrics
SC Endocrinology & Metabolism; Pediatrics
GA 726DZ
UT WOS:000287700300007
PM 20522171
DA 2019-01-08
ER

PT J
AU van Son, J
   Nyklicek, I
   Pop, VJM
   Pouwer, F
AF van Son, Jenny
   Nyklicek, Ivan
   Pop, Victor J. M.
   Pouwer, Francois
TI Testing the effectiveness of a mindfulness-based intervention to reduce
   emotional distress in outpatients with diabetes (DiaMind): design of a
   randomized controlled trial
SO BMC PUBLIC HEALTH
LA English
DT Article
ID AMBULATORY BLOOD-PRESSURE; QUALITY-OF-LIFE; STRESS REDUCTION; D
   PERSONALITY; SOCIAL INHIBITION; DEPRESSION SCALE; HOSPITAL ANXIETY;
   GLYCEMIC CONTROL; PSYCHOMETRIC PROPERTIES; CARDIOVASCULAR-DISEASE
AB Background: Approximately 20-40% of outpatients with diabetes experience elevated levels of emotional distress, varying from disease-specific distress to general symptoms of anxiety and depression. The patient's emotional wellbeing is related to other unfavorable outcomes, like reduced quality of life, sub-optimal self-care, impaired glycemic control, higher risk of complications, and increased mortality rates. The purpose of this study is to test the effectiveness of a new diabetes-specific, mindfulness-based psychological intervention. First, with regard to reducing emotional distress; second, with respect to improving quality of life, dispositional mindfulness, and selfesteem of patients with diabetes; third, with regard to self-care and clinical outcomes; finally, a potential effect modification by clinical and personality characteristics will be explored.
   Methods/Design: The Diabetes and Mindfulness study (DiaMind) is a randomized controlled trial. Patients with diabetes with low levels of emotional well-being will be recruited from outpatient diabetes clinics. Eligible patients will be randomized to an intervention group or a wait-list control group. The intervention group will receive the mindfulness program immediately, while the control group will receive the program eight months later. The primary outcome is emotional distress (anxiety, stress, depressive symptoms), for which data will be collected at baseline, four weeks, post intervention, and after six months follow-up. In addition, self-report data will be collected on quality of life, dispositional mindfulness, self-esteem, self-care, and personality, while complications and glycemic control will be assessed from medical files and blood pressure will be measured. Group differences will be analyzed with repeated measures analysis of covariance. The study is supported by grants from the Dutch Diabetes Research Foundation and Tilburg University and has been approved by a medical ethics committee.
   Discussion: It is hypothesized that emotional well-being, quality of life, dispositional mindfulness, self-esteem, self-care, and blood pressure will improve significantly more in the mindfulness group compared to the control group. Results of this study can contribute to a better care for patients with diabetes with lowered levels of emotional well-being. It is expected that the first results will become available in 2012.
C1 [van Son, Jenny; Nyklicek, Ivan; Pop, Victor J. M.; Pouwer, Francois] Tilburg Univ, Ctr Res Psychol Somat Dis CoRPS, Dept Med Psychol & Neuropsychol, NL-5000 LE Tilburg, Netherlands.
RP Nyklicek, I (reprint author), Tilburg Univ, Ctr Res Psychol Somat Dis CoRPS, Dept Med Psychol & Neuropsychol, NL-5000 LE Tilburg, Netherlands.
EM I.Nyklicek@uvt.nl
FU Dutch Diabetes Research Foundation [2008.13.005]; Tilburg University
FX The study is supported by grants from the Dutch Diabetes Research
   Foundation or 'Diabetesfonds' (project number 2008.13.005, awarded to Dr
   I. Nyklicek) and Tilburg University. The authors wish to acknowledge and
   express their special thanks to internal medicine physician Dr Marion
   Blonk, for her efforts in recruiting patients at the Catharina Hospital
   Eindhoven. In addition, we want to thank the internal medicine
   physicians Dr Bravenboer, Dr Erdtsieck, Dr Lieverse, and Dr Spooren,
   their secretaries, and the diabetes nurses of the participating
   hospitals, for their continuing assistance in the recruitment of
   patients for this study. Moreover, we want to thank the general
   practitioners and nurse practitioners of the Health Centre Plus
   Eindhoven and Vlaslant Valkenswaard, and their patients for their
   participation in the pilot study.
CR Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x
   American Diabetes Association, 2011, Diabetes Care, V34 Suppl 1, pS11, DOI 10.2337/dc11-S011
   Baer RA, 2006, ASSESSMENT, V13, P27, DOI 10.1177/1073191105283504
   BAER RA, 2009, COGN BEHAV THER, P1
   Baer RA, 2008, ASSESSMENT, V15, P329, DOI 10.1177/1073191107313003
   Barnes VA, 2004, PSYCHOSOM MED, V66, P909, DOI 10.1097/01.psy.0000145902.91749.35
   Bishop SR, 2004, CLIN PSYCHOL-SCI PR, V11, P230, DOI 10.1093/clipsy/bph077
   Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3
   Bogner HR, 2007, DIABETES CARE, V30, P3005, DOI 10.2337/dc07-0974
   Branstrom R, 2010, ANN BEHAV MED, V39, P151, DOI 10.1007/s12160-010-9168-6
   COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404
   COHEN S, 1988, CLAR SYMP, P31
   de Jonge P, 2007, J PSYCHOSOM RES, V63, P477, DOI 10.1016/j.jpsychores.2007.06.002
   de Wit M, 2007, DIABETES CARE, V30, P2003, DOI 10.2337/dc07-0447
   Denollet J, 2006, EUR HEART J, V27, P171, DOI 10.1093/eurheartj/ehi616
   Denollet J, 2005, PSYCHOSOM MED, V67, P89, DOI 10.1097/01.psy.0000149256.81953.49
   Egede LE, 2005, CURR DIABETES REV, V1, P235, DOI 10.2174/157339905774574356
   Emons WHM, 2007, J PSYCHOSOM RES, V63, P27, DOI 10.1016/j.jphyschores.2007.03.010
   Evers A, 2009, COTAN DOCUMENTATIE
   Franck E, 2008, PSYCHOL BELG, V48, P25, DOI 10.5334/pb-48-1-25
   Gregg JA, 2007, J CONSULT CLIN PSYCH, V75, P336, DOI 10.1037/0022-006X.75.2.336
   Grigsby AB, 2002, J PSYCHOSOM RES, V53, P1053, DOI 10.1016/S0022-3999(02)00417-8
   Grossman P, 2004, J PSYCHOSOM RES, V57, P35, DOI 10.1016/S0022-3999(03)00573-7
   Heine RJ, 2004, HDB DIABETES MELLITU
   Henry JL, 1997, PSYCHOL HEALTH MED, V2, P109
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   Hofmann SG, 2010, J CONSULT CLIN PSYCH, V78, P169, DOI 10.1037/a0018555
   *INT DIAB FED, EP MORB
   International Diabetes Federation, 2005, GLOB GUID TYP 2 DIAB
   Jenkinson C, 1997, J PUBLIC HEALTH MED, V19, P179, DOI 10.1093/oxfordjournals.pubmed.a024606
   Jonas BS, 2000, PSYCHOSOM MED, V62, P188, DOI 10.1097/00006842-200003000-00006
   Kabat-Zinn J., 1990, FULL CATASTROPHE LIV
   Lustman PJ, 2005, J DIABETES COMPLICAT, V19, P113, DOI 10.1016/j.jdiacomp.2004.01.002
   Makine C, 2009, DIABETIC MED, V26, P28, DOI 10.1111/j.1464-5491.2008.02606.x
   Martens EJ, 2007, J PSYCHOSOM RES, V63, P545, DOI 10.1016/j.jpsychores.2007.06.005
   Morone NE, 2008, PAIN, V134, P310, DOI 10.1016/j.pain.2007.04.038
   Nouwen A, 2010, DIABETOLOGIA, V53, P2480, DOI 10.1007/s00125-010-1874-x
   Nyklicek I, 2008, ANN BEHAV MED, V35, P331, DOI 10.1007/s12160-008-9030-2
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Pouwer F, 2006, PATIENT EDUC COUNS, V60, P235, DOI 10.1016/j.pec.2005.01.009
   Rosenzweig S, 2007, ALTERN THER HEALTH M, V13, P36
   SANDERMAN R, 1995, METEN PERSOONLIJKHEI
   Segal Z., 2002, MINDFULNESS BASED CO
   Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Sowers JR, 2001, HYPERTENSION, V37, P1053, DOI 10.1161/01.HYP.37.4.1053
   Speca M, 2000, PSYCHOSOM MED, V62, P613, DOI 10.1097/00006842-200009000-00004
   Spinhoven P, 1997, PSYCHOL MED, V27, P363, DOI 10.1017/S0033291796004382
   Steed L, 2003, PATIENT EDUC COUNS, V51, P5, DOI 10.1016/S0738-3991(02)00213-6
   Teasdale JD, 2000, J CONSULT CLIN PSYCH, V68, P615, DOI 10.1037/0022-006X.68.4.615
   van Bastelaar KM, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-9
   Van der Feltz-Cornelis CM, 2010, GEN HOSP PSYCHIAT, V32, P380, DOI 10.1016/j.genhosppsych.2010.03.011
   van der Ven NCW, 2005, DIABETIC MED, V22, P1619
   VANBASTELAAR KM, 2011, DIABETES CARE
   Wald F., 1990, NED T PSYCHOL, V45, P86
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   Westhoff TH, 2005, BLOOD PRESS MONIT, V10, P239, DOI 10.1097/01.mbp.0000172711.82287.7f
   WICHERTS JM, 2003, NEDERLANDS TIJDSCHRI, V59, P12
   World Health Organization, WHO 5 WELL BEING IND
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
   NEEMT AANTAL MENSEN
   HOE VAAK KOMT DIABET
NR 62
TC 16
Z9 16
U1 3
U2 33
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD FEB 24
PY 2011
VL 11
AR 131
DI 10.1186/1471-2458-11-131
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 732XF
UT WOS:000288222300001
PM 21349184
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Ireland, SE
   Arthur, HM
   Gunn, EA
   Oczkowski, W
AF Ireland, Sandra E.
   Arthur, Heather M.
   Gunn, Elizabeth A.
   Oczkowski, Wieslaw
TI Stroke prevention care delivery: Predictors of risk factor management
   outcomes
SO INTERNATIONAL JOURNAL OF NURSING STUDIES
LA English
DT Article
DE Stroke; Prevention; Hypertension; Diabetes; Adherence
ID MINI-MENTAL-STATE; TRANSIENT ISCHEMIC ATTACK; BLOOD-PRESSURE;
   SELF-EFFICACY; PSYCHOLOGICAL DISTRESS; COGNITIVE IMPAIRMENT;
   PATIENT-ADHERENCE; MEDICAL-TREATMENT; HEALTH BEHAVIOR; SOCIAL SUPPORT
AB Background: Internationally, the development and implementation of stroke care guidelines have resulted in the evolution of stroke prevention outpatient clinics designed to accelerate patient access to treatment and behavioral risk reduction following transient ischemic attack or stroke.
   Objectives: To examine the extent to which selected demographic, social-psychological, physiological, and adherence characteristics predicted achievement of blood pressure and glucose targets in a group of patients referred to a Canadian stroke prevention clinic with confirmed transient ischemic attack (TIA) or stroke and hypertension and/or diabetes.
   Participants: A total of 313, English speaking, adult patients who were referred from family or emergency department physicians to a stroke prevention clinic provided demographic data and received social-psychological screening testing at intake. Of these, 93 participants who met criteria of confirmed TIA or stroke plus hypertension and/or diabetes were identified as the study group. Seventy-seven of study group participants completed a 6-month follow-up.
   Methods: Admission screening tests included the Modified and Mini-Mental State Examinations, Trail Making Test, Clock Drawing Test, a medication self-efficacy scale, the Lubben Social Network Scale and the Geriatric Depression Scale. Family physician follow-up was ascertained 4-8 weeks after intake. At approximately 6 months after the initial screening measures, 77 study group participants completed additional measures of adherence, blood pressure and/or glycated hemoglobin.
   Results: Transient ischemic attack was confirmed in 58% and stroke in 42% of the study group. Mean age was 69 years (SD = 11); 53% were male; 97% had hypertension; and 25% were diabetic; some had both. Twenty-three percent were not followed-up by family practitioners. At 6-month follow-up, 97% reported >= 80% adherence to medication; only 57% met treatment targets. A logistic regression analysis identified three independent predictors of achieving blood pressure and/or glucose targets: self-efficacy expectations (OR, 1.61; 95% Cl, 1.03-2.54; p = 0.04), Mini-Mental State (OR, 1.28; 95% Cl, 1.06-1.54; p = 0.009); and self-reported adherence (OR, 1.14; 95% Cl, 1.01-1.29; p = 0.03).
   Conclusions: Three simple screening measures identified patients at increased risk of not achieving clinical risk factor management targets. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Ireland, Sandra E.] McMaster Univ, Hamilton Gen Hosp, Hamilton Hlth Sci, Hamilton, ON L8K 2X2, Canada.
   [Arthur, Heather M.] McMaster Univ, Sch Nursing, Heart & Stroke Fdn Ontario, Michael G DeGroote Endowed Chair Cardiovasc Nursi, Hamilton, ON L8N 3Z5, Canada.
   [Gunn, Elizabeth A.] McMaster Univ, Hamilton Gen Hosp, Cardiac Hlth & Rehabil Ctr, Hamilton, ON L8K 2X2, Canada.
   [Oczkowski, Wieslaw] McMaster Univ, Hamilton Gen Hosp, Hamilton Hlth Sci Reg Stroke Program, Hamilton, ON L8L 2X2, Canada.
RP Ireland, SE (reprint author), McMaster Univ, Hamilton Gen Hosp, Hamilton Hlth Sci, Room 722,7 North,237 Barton St E, Hamilton, ON L8K 2X2, Canada.
EM irelasan@hhsc.ca
FU Hamilton Health Sciences; Heart and Stroke Foundation of Canada;
   Canadian Stroke Network
FX The study was funded by a grant from the Hamilton Health Sciences New
   Investigator Fund. The funding source had no involvement in the study
   design, in the collection, analysis and interpretation of the data.;
   Sandra Ireland was sponsored by a Nursing Research Fellowship from the
   Heart and Stroke Foundation of Canada and the Canadian Stroke Network.
CR *AM HEART ASS, 2002, MULT COMPL CHALL
   [Anonymous], 1994, CMAJ, V150, P899
   Appelros P, 2006, EUR J NEUROL, V13, P491, DOI 10.1111/j.1468-1331.2006.01299.x
   Ballard C, 2003, DEMENT GERIATR COGN, V16, P52, DOI 10.1159/000069994
   Bandura A, 1998, PSYCHOL HEALTH, V13, P623, DOI 10.1080/08870449808407422
   BANDURA A, 1982, AM PSYCHOL, V37, P22
   Barba R, 2002, STROKE, V33, P1993, DOI 10.1161/01.STR.0000017285.73172.91
   Berlowitz DR, 1998, NEW ENGL J MED, V339, P1957, DOI 10.1056/NEJM199812313392701
   Black MEA, 2001, HEALTH EDUC BEHAV, V28, P200, DOI 10.1177/109019810102800206
   *CAN DIAB ASS, 2006, BEST PRACT GUID
   *CAN HYP ED PROGR, 2006, PERSPECTIVES CARDIOL, P28
   *CAN STROK STRAT, 2008, CAN BEST PRACT REC S
   Carney RA, 2002, STROKE, V33, P5, DOI 10.1161/str.33.1.5
   Censori B, 1996, STROKE, V27, P1205, DOI 10.1161/01.STR.27.7.1205
   Clark NM, 1999, HEALTH EDUC BEHAV, V26, P72, DOI 10.1177/109019819902600107
   COLANTONIO A, 1993, J GERONTOL, V48, pS261, DOI 10.1093/geronj/48.5.S261
   CRAIG HM, 1985, RES NURS HEALTH, V8, P61, DOI 10.1002/nur.4770080112
   DEBUSK RF, 1994, ANN INTERN MED, V120, P721, DOI 10.7326/0003-4819-120-9-199405010-00001
   DICK JPR, 1984, J NEUROL NEUROSUR PS, V47, P496, DOI 10.1136/jnnp.47.5.496
   DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101
   DiMatteo MR, 2004, HEALTH PSYCHOL, V23, P207, DOI 10.1037/0278-6133.23.2.207
   DiMatteo MR, 2004, MED CARE, V42, P200, DOI 10.1097/01.mlr.0000114908.90348.f9
   Elias MF, 2004, STROKE, V35, P404, DOI 10.1161/01.STR.0000103141.82869.77
   Elkins JS, 2004, NEUROLOGY, V63, P793, DOI 10.1212/01.WNL.0000137014.36689.7F
   FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6
   Fure B, 2006, ACTA NEUROL SCAND, V114, P17, DOI 10.1111/j.1600-0404.2006.00603.x
   Gladstone DJ, 2004, CAN MED ASSOC J, V170, P1099, DOI 10.1503/cmaj.1031349
   Gordis L., 1979, COMPLIANCE HLTH CARE, P23
   Green L. W., 1999, HLTH PROMOTION PLANN
   GREMBOWSKI D, 1993, J HEALTH SOC BEHAV, V34, P89, DOI 10.2307/2137237
   HAYNES RB, 2005, COCHRANE DATABASE SY, V4
   HAYNES RB, 2003, COCHRANE LIB, V4
   *HEART STROK FDN C, 2008, CANADIAN MED ASS J, V179, pE4
   Hosemer D., 2000, APPL LOGISTIC REGRES
   Jonas BS, 2000, PSYCHOSOM MED, V62, P463, DOI 10.1097/00006842-200007000-00001
   Joseph LN, 1999, STROKE, V30, P16, DOI 10.1161/01.STR.30.1.16
   Kernan WN, 2000, STROKE, V31, P415, DOI 10.1161/01.STR.31.2.415
   Keys BA, 2000, J INT NEUROPSYCH SOC, V6, P76
   Libon DJ, 1994, NEUROPSYCHOLOGY, V8, P38, DOI 10.1037/0894-4105.8.1.38
   Lubben J. E., 1988, FAM COMMUNITY HEALTH, V11, P42, DOI DOI 10.1097/00003727-198811000-00008
   May M, 2002, STROKE, V33, P7, DOI 10.1161/hs0102.100529
   Mead GE, 2000, STROKE, V31, P714, DOI 10.1161/01.STR.31.3.714
   Miller N H, 1996, J Cardiovasc Nurs, V11, P76
   *MIN HLTH LONG TER, 2000, INT STROK STRAT ONT
   Moses James A Jr, 2004, Arch Clin Neuropsychol, V19, P703, DOI 10.1016/j.acn.2004.02.004
   Mouradian MS, 2002, STROKE, V33, P1656, DOI 10.1161/01.STR.0000017877.62543.14
   Nelson MR, 2006, MED J AUSTRALIA, V185, P487
   Norman G. R., 1994, BIOSTATISTICS BARE E
   Pender NJ, 2002, HLTH PROMOTION NURSI
   Reitan R. M, 1993, HALSTEAD REITAN NEUR
   REITAN RM, 2004, COMPREHENSIVE HDB PS, V1, P385
   Sacco RL, 2006, STROKE, V37, P577, DOI 10.1161/01.STR.0000199147.30016.74
   SACKETT DL, 1979, COMPLIANCE HLTH CARE, P286
   Samsa GP, 2000, ARCH INTERN MED, V160, P967, DOI 10.1001/archinte.160.7.967
   SEEMAN TE, 1987, PSYCHOSOM MED, V49, P341, DOI 10.1097/00006842-198707000-00003
   SHULMAN K, 2003, QUICK COGNITIVE SCRE
   Spalletta G, 2002, J NEUROL, V249, P1541, DOI 10.1007/s00415-002-0885-z
   Srikanth V, 2006, INT PSYCHOGERIATR, V18, P295, DOI 10.1017/S1041610205002711
   STEPHENSON BJ, 1993, JAMA-J AM MED ASSOC, V269, P2779, DOI 10.1001/jama.269.21.2779
   STRECHER VJ, 1986, HEALTH EDUC QUART, V13, P73, DOI 10.1177/109019818601300108
   Suhr JA, 1999, ARCH PHYS MED REHAB, V80, P773, DOI 10.1016/S0003-9993(99)90226-5
   TATEMICHI TK, 1994, J NEUROL NEUROSUR PS, V57, P202, DOI 10.1136/jnnp.57.2.202
   TENG EL, 1987, J CLIN PSYCHIAT, V48, P314
   TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x
   Tombaugh TN, 1996, PSYCHOL ASSESSMENT, V8, P48, DOI 10.1037/1040-3590.8.1.48
   Uchino BN, 1996, PSYCHOL BULL, V119, P488, DOI 10.1037/0033-2909.119.3.488
   VANLATUM JD, 1995, STROKE, V26, P331
   WADE DT, 1987, BRIT J PSYCHIAT, V151, P200, DOI 10.1192/bjp.151.2.200
   WATSON YI, 1993, J AM GERIATR SOC, V41, P1235, DOI 10.1111/j.1532-5415.1993.tb07308.x
   WHO, 2005, WHO STEPWISE APPR ST
   *WORLD HEART FED, 2006, COUNTR SHOULD FORM G
   *WORLD MED ASS, 1965, DECL HELS
   YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4
NR 73
TC 1
Z9 1
U1 2
U2 9
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0020-7489
J9 INT J NURS STUD
JI Int. J. Nurs. Stud.
PD FEB
PY 2011
VL 48
IS 2
BP 156
EP 164
DI 10.1016/j.ijnurstu.2010.07.003
PG 9
WC Nursing
SC Nursing
GA 725GB
UT WOS:000287632100003
PM 20673897
DA 2019-01-08
ER

PT J
AU van Bastelaar, KMP
   Pouwer, F
   Cuijpers, P
   Riper, H
   Snoek, FJ
AF van Bastelaar, Kim M. P.
   Pouwer, Francois
   Cuijpers, Pim
   Riper, Heleen
   Snoek, Frank J.
TI Web-Based Depression Treatment for Type 1 and Type 2 Diabetic Patients A
   randomized, controlled trial
SO DIABETES CARE
LA English
DT Article
ID COGNITIVE-BEHAVIOR THERAPY; INTERNET-BASED TREATMENT; EMOTIONAL
   DISTRESS; SYMPTOMS; ANXIETY; PSYCHOTHERAPY; METAANALYSIS; DISORDERS;
   DROPOUT; ADULTS
AB OBJECTIVE-Comorbid depression is common in patients with type 1 and type 2 diabetes, adversely affecting quality of life, diabetes outcomes, and mortality. Depression can be effectively treated with cognitive behavior therapy (CBT). The Internet is a new and attractive method for delivering CBT intervention on a large scale at relatively low costs. This study evaluated the effectiveness of Web-based CBT for depression treatment in adults with type 1 or type 2 diabetes, with minimal guidance.
   RESEARCH DESIGN AND METHODS-A randomized controlled trial was conducted in the Netherlands in 255 adult diabetic patients with elevated depressive symptoms. Primary outcomes were depressive symptoms. Secondary outcomes were diabetes-specific emotional distress and glycemic control. Assessments were at baseline, after treatment, and at the 1-month follow-up.
   RESULTS-The Web-based CBT was effective in reducing depressive symptoms by intention-to-treat analyses (P = 0.04, d = 0.29; clinical improvement 41% vs. 24% P < 0.001) and by per-protocol analyses (P < 0.001, d = 0.70; clinical improvement, 56% vs. 24% P < 0.001). The intervention reduced diabetes-specific emotional distress (P = 0.03) but had no beneficial effect on glycemic control (P > 0.05).
   CONCLUSIONS-Web-based CBT depression treatment is effective in reducing depressive symptoms in adults with type 1 and type 2 diabetes. In addition, the intervention reduces diabetes-specific emotional distress in depressed patients.
C1 [van Bastelaar, Kim M. P.; Snoek, Frank J.] Vrije Univ Amsterdam Med Ctr, Dept Med Psychol, Amsterdam, Netherlands.
   [van Bastelaar, Kim M. P.; Cuijpers, Pim; Snoek, Frank J.] Vrije Univ Amsterdam Med Ctr, EMGO Inst, Inst Hlth & Care Res, Amsterdam, Netherlands.
   [Pouwer, Francois] Tilburg Univ, Ctr Res Psychol Somat Dis CoRPS, Dept Med Psychol & Neuropsychol, NL-5000 LE Tilburg, Netherlands.
   [Cuijpers, Pim] Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands.
   [Riper, Heleen] Netherlands Inst Mental Hlth & Addict Trimbos, Utrecht, Netherlands.
RP van Bastelaar, KMP (reprint author), Vrije Univ Amsterdam Med Ctr, Dept Med Psychol, Amsterdam, Netherlands.
EM k.vanbastelaar@vumc.nl
RI Cuijpers, Pim/G-1703-2013
OI Cuijpers, Pim/0000-0001-5497-2743
FU Dutch Diabetes Research Foundation [2005.00.009]
FX This study was financed by the Dutch Diabetes Research Foundation (grant
   number 2005.00.009).
CR *AM DIAB ASS, 2010, DIABETES CARE S1, V33, pS11, DOI DOI 10.2337/DC10-S011
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Christensen H, 2004, BRIT MED J, V328, P265, DOI 10.1136/bmj.37945.566632.EE
   Cohen J., 1988, STAT POWER ANAL BEHA, Vxxi
   Cuijpers P, 2009, CLIN PSYCHOL REV, V29, P449, DOI 10.1016/j.cpr.2009.04.005
   de Graaf LE, 2009, BRIT J PSYCHIAT, V195, P73, DOI 10.1192/bjp.bp.108.054429
   Egede LE, 2010, DIABETES RES CLIN PR, V87, P302, DOI 10.1016/j.diabres.2010.01.024
   Eysenbach G, 2005, J MED INTERNET RES, V7, DOI 10.2196/jmir.7.1.e11
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037//0022-006X.59.1.12
   Kaltenthaler E, 2006, HEALTH TECHNOL ASSES, V10, P1, DOI 10.3310/hta10330
   Li XM, 2006, STAT MED, V25, P2107, DOI 10.1002/sim.2343
   Melville KM, 2010, BRIT J CLIN PSYCHOL, V49, P455, DOI 10.1348/014466509X472138
   Peters L, 1998, PSYCHOL MED, V28, P893, DOI 10.1017/S0033291798006655
   Radloff L. S., 1977, APPL PSYCHOL MEAS, V1
   Simon GE, 2010, PSYCHIAT SERV, V61, P684, DOI 10.1176/ps.2010.61.7.684
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Spek V, 2007, PSYCHOL MED, V37, P319, DOI 10.1017/S0033291706008944
   *US BUR CENS, 2010, INT WORLD STAT
   van Bastelaar KMP, 2010, DIABETIC MED, V27, P798, DOI 10.1111/j.1464-5491.2010.03025.x
   van Bastelaar KM, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-9
   Van der Feltz-Cornelis CM, 2010, GEN HOSP PSYCHIAT, V32, P380, DOI 10.1016/j.genhosppsych.2010.03.011
   VANBASTELAAR KMP, 2010, PATIENT ED COUN 0707
   Warmerdam L, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.1094
NR 25
TC 85
Z9 85
U1 0
U2 32
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
J9 DIABETES CARE
JI Diabetes Care
PD FEB
PY 2011
VL 34
IS 2
BP 320
EP 325
DI 10.2337/dc10-1248
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 722LO
UT WOS:000287433900013
PM 21216855
OA Green Published, Other Gold
DA 2019-01-08
ER

PT J
AU Andreadou, E
   Anagnostouli, M
   Vasdekis, V
   Kararizou, E
   Rentzos, M
   Kontaxis, T
   Evdokimidis, I
AF Andreadou, Elisabeth
   Anagnostouli, Maria
   Vasdekis, Vassilis
   Kararizou, Evangelia
   Rentzos, Michael
   Kontaxis, Theodoros
   Evdokimidis, Ioannis
TI The impact of comorbidity and other clinical and sociodemographic
   factors on health-related quality of life in Greek patients with
   Parkinson's disease
SO AGING & MENTAL HEALTH
LA English
DT Article
DE comorbidity; depression; disability; sleep problems; gastrointestinal
   disturbances
ID NONMOTOR SYMPTOMS; QUESTIONNAIRE; DISABILITY; DETERMINANTS; VALIDATION;
   DEPRESSION; MORTALITY; DIAGNOSIS; ACCURACY; ONSET
AB Objectives: This study was designed to evaluate the impact of other common self-reported comorbid disorders (hypertension, dyslipidemia, ischemic heart disease, diabetes mellitus, minor stroke, arthritis, low back pain or osteoporosis and depression) on health-related Quality of Life (HRQoL) of Parkinson's disease (PD) patients and to explore the association of their HRQoL with various sociodemographic and clinical factors.
   Methods: Data about age, gender, education, occupation, income, marital and residential status, social relations, disease duration, functional status, treatment and concomitant diseases were collected of 139 Greek patients (68 men and 71 women) with PD. Patients were consecutively recruited from the outpatient clinic of the first Neurology Department of Athens National University at Aeginition Hospital. Disease severity was assessed using the unified Parkinson's disease rating scale including Hoehn and Yahr and Schwab and England (S&E) scales. HRQoL was measured by the specific Parkinson's disease questionnaire (PDQ-39). A multivariate multiple regression model with normal errors was used for the statistical analysis.
   Results: The main determinants of HRQoL were low degree of independence measured by the S&E scale (F = 35.942, p < 0.001), social isolation (F = 20.508, p < 0.001), disease duration (F = 14.983, p < 0.001), sleep (F = 6.507, p = 0.013) and gastrointestinal disturbances (F = 4.643, p = 0.035) and the presence of depression (F = 6.022, p = 0.017).
   Conclusion: Among the other chronic comorbidities only depression was associated with a poor HRQoL in PD patients. Functional dependence and social isolation contributed most to worse HRQoL. Our findings suggest that adequate social support and management of depression, sleep and gastrointestinal disturbances could reduce the distress and improve HRQoL in patients with PD.
C1 [Andreadou, Elisabeth; Anagnostouli, Maria; Kararizou, Evangelia; Rentzos, Michael; Kontaxis, Theodoros; Evdokimidis, Ioannis] Univ Athens, Aeginit Hosp, Sch Med, Dept Neurol 1, Athens 11528, Greece.
   [Vasdekis, Vassilis] Athens Univ Econ & Business, Dept Stat, Athens, Greece.
RP Andreadou, E (reprint author), Univ Athens, Aeginit Hosp, Sch Med, Dept Neurol 1, Athens 11528, Greece.
EM eandread@med.uoa.gr
OI Andreadou, Elisabeth/0000-0002-9634-9631
CR Alonso J, 2004, QUAL LIFE RES, V13, P283, DOI 10.1023/B:QURE.0000018472.46236.05
   Aydemir O, 2005, ARCH MED RES, V36, P136, DOI 10.1016/j.arcmed.2004.12.009
   Barone P, 2009, MOVEMENT DISORD, V24, P1641, DOI 10.1002/mds.22643
   Caap-Ahlgren M, 2001, ARCH GERONTOL GERIAT, V32, P23, DOI 10.1016/S0167-4943(00)00087-X
   Carod-Artal FJ, 2007, MOVEMENT DISORD, V22, P1408, DOI 10.1002/mds.21408
   Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8
   Findley L, 2002, MOVEMENT DISORD, V17, P60
   Forsaa EB, 2008, MOVEMENT DISORD, V23, P1420, DOI 10.1002/mds.22121
   Fulop T, 2006, PATHOL BIOL, V54, P375, DOI 10.1016/j.patbio.2006.07.002
   Gage H, 2003, J NEUROL NEUROSUR PS, V74, P163, DOI 10.1136/jnnp.74.2.163
   Goetz CG, 2003, MOVEMENT DISORD, V18, P738, DOI 10.1002/mds.10473
   Gulati A, 2004, MOVEMENT DISORD, V19, pS406
   HARLOW SD, 1989, AM J EPIDEMIOL, V129, P233, DOI 10.1093/oxfordjournals.aje.a115129
   HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427
   HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181
   Karlsen KH, 2000, J NEUROL NEUROSUR PS, V69, P584, DOI 10.1136/jnnp.69.5.584
   Karlsen KH, 1999, J NEUROL NEUROSUR PS, V66, P431, DOI 10.1136/jnnp.66.4.431
   Katsarou Z, 2004, MOVEMENT DISORD, V19, P308, DOI 10.1002/mds.10678
   Katsarou Z, 2001, QUAL LIFE RES, V10, P159, DOI 10.1023/A:1016720400862
   Lyons K E, 1997, Parkinsonism Relat Disord, V3, P207, DOI 10.1016/S1353-8020(97)00021-7
   Martinez-Martin P, 1998, J NEUROL, V245, pS2, DOI 10.1007/PL00007733
   Martinez-Martin P, 2007, MOVEMENT DISORD, V22, P1623, DOI 10.1002/mds.21586
   Menza M, 2009, MOVEMENT DISORD, V24, P1325, DOI 10.1002/mds.22586
   Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2
   Muslimovic D, 2008, NEUROLOGY, V70, P2241, DOI 10.1212/01.wnl.0000313835.33830.80
   PETO V, 1995, QUAL LIFE RES, V4, P241, DOI 10.1007/BF02260863
   Rahman S, 2008, MOVEMENT DISORD, V23, P1428, DOI 10.1002/mds.21667
   Reuther M, 2007, PARKINSONISM RELAT D, V13, P108, DOI 10.1016/j.parkreldis.2006.07.009
   Riedinger MS, 2002, AM J CRIT CARE, V11, P211
   Schrag A, 2003, MOVEMENT DISORD, V18, P1250, DOI 10.1002/mds.10527
   Schrag A, 2006, J NEUROL SCI, V248, P151, DOI 10.1016/j.jns.2006.05.030
   SCHWAB RS, 1969, 3 S PARK DIS, P152
   Sprangers MAG, 1999, SOC SCI MED, V48, P1507, DOI 10.1016/S0277-9536(99)00045-3
   Tandberg E, 1998, MOVEMENT DISORD, V13, P895, DOI 10.1002/mds.870130606
   Wee Hwee-Lin, 2005, Health Qual Life Outcomes, V3, P2, DOI 10.1186/1477-7525-3-2
   Welsh M, 2004, NEUROL CLIN, V22, pS141, DOI 10.1016/j.ncl.2004.05.003
   Winter Y, 2010, PARKINSONISM RELAT D, V16, P243, DOI 10.1016/j.parkreldis.2009.11.012
   Zach M, 2004, MOVEMENT DISORD, V19, P667, DOI 10.1002/mds.10698
NR 38
TC 14
Z9 14
U1 0
U2 11
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND
SN 1360-7863
J9 AGING MENT HEALTH
JI Aging Ment. Health
PY 2011
VL 15
IS 7
BP 913
EP 921
DI 10.1080/13607863.2011.569477
PG 9
WC Geriatrics & Gerontology; Gerontology; Psychiatry
SC Geriatrics & Gerontology; Psychiatry
GA 881KI
UT WOS:000299482500013
PM 21547746
DA 2019-01-08
ER

PT J
AU Rosal, MC
   Borg, A
   Bodenlos, JS
   Tellez, T
   Ockene, IS
AF Rosal, Milagros C.
   Borg, Amy
   Bodenlos, Jamie S.
   Tellez, Trinidad
   Ockene, Ira S.
TI Awareness of Diabetes Risk Factors and Prevention Strategies Among a
   Sample of Low-Income Latinos With No Known Diagnosis of Diabetes
SO DIABETES EDUCATOR
LA English
DT Article
ID BREAST-CANCER RISK; SOCIOECONOMIC-STATUS; MEXICAN-AMERICANS;
   CARDIOVASCULAR HEALTH; PSYCHOSOCIAL FACTORS; ETHNIC-DIFFERENCES;
   PHYSICAL-ACTIVITY; PERCEIVED RISK; CARE PROVIDERS; US POPULATION
AB Purpose
   This study assessed awareness of type 2 diabetes risk and severity, perceived risk factors, knowledge of diabetes prevention strategies, and challenges of and opportunities for prevention among low-income Latinos in Lawrence, Massachusetts.
   Methods
   Qualitative research design. Latinos with no known diagnosis of diabetes participated in 4 focus groups, conducted in Spanish, which were recorded and transcribed for systematic analysis.
   Results
   The sample, (N = 41) was largely female (85%) with a wide age range (22-76 years), most (71%) had an educational level of high school or less, and less than half (46%) were employed. Participants had basic knowledge of diabetes, but gaps were apparent. Many perceived family history of diabetes, poor diet, emotional distress, and stress associated with the United States as risk factors for diabetes. There was little or no awareness of risk associated with Latino ethnicity, gestational diabetes, hypertension, lipid abnormalities, or obesity. Few cited physical activity or weight loss as diabetes prevention strategies. More than half the participants perceived themselves at low risk for diabetes.
   Conclusions
   This Latino sample had limited knowledge of diabetes risk factors and lifestyle changes that can prevent or delay diabetes onset. Insights for intervening for diabetes prevention are offered.
C1 [Rosal, Milagros C.] Univ Massachusetts, Sch Med, Dept Med, Div Prevent & Behav Med, Worcester, MA 01655 USA.
   [Bodenlos, Jamie S.] Hobart & William Smith Coll, Dept Psychol, Geneva, NY 14456 USA.
   [Tellez, Trinidad] New Hampshire Dept Hlth & Human Serv, Concord, NH 03301 USA.
   [Tellez, Trinidad] Greater Lawrence Family Hlth Ctr, Lawrence, MA USA.
RP Rosal, MC (reprint author), Univ Massachusetts, Sch Med, Dept Med, Div Prevent & Behav Med, 55 Lake Ave N, Worcester, MA 01655 USA.
EM Milagros.Rosal@umassmed.edu
FU National Institute of Diabetes and Digestive and Kidney diseases (NIDDK)
   [R18 DK067549]
FX This project described was made possible by Grant Number R18 DK067549
   from the National Institute of Diabetes and Digestive and Kidney
   diseases (NIDDK). Its contents are solely the responsibility of the
   authors and do not necessarily represent the official views of the
   NIDDK. We thank our community partners-the Lawrence Council on Aging,
   the YWCA of Greater Lawrence, and the Greater Lawrence Family Health
   Center-for their contributions to the implementation of the research. We
   also thank Philip Merriam, MPH, for his assistance coordinating the
   recruitment of participants, and Karin Valentine Goins, MPH, for her
   editorial assistance.
CR Ball K, 2006, WOMEN HEALTH, V43, P93, DOI 10.1300/J013v43n01_06
   Boltri JM, 2006, DIABETES EDUCATOR, V32, P901, DOI 10.1177/0145721706295010
   Brewer NT, 2004, ANN BEHAV MED, V27, P125, DOI 10.1207/s15324796abm2702_7
   Byrd TL, 2004, PREV MED, V38, P192, DOI 10.1016/j.ypmed.2003.09.017
   Carbone ET, 2007, PATIENT EDUC COUNS, V66, P202, DOI 10.1016/j.pec.2006.12.003
   Castro FG, 2009, J BEHAV MED, V32, P89, DOI 10.1007/s10865-008-9194-z
   *CDCP, 2004, MMWR-MORBID MORTAL W, V53, P935
   Cohen S, 2006, PSYCHOSOM MED, V68, P414, DOI 10.1097/01.psy.0000221236.37158.b9
   Coronado GD, 2004, J HEALTH CARE POOR U, V15, P576, DOI 10.1353/hpu.2004.0057
   Cowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062
   Cramer JS, 2007, DIABETES EDUCATOR, V33, P503, DOI 10.1177/0145721707301680
   Dalle Grave R, 2005, OBES RES, V13, P1961, DOI DOI 10.1038/OBY.2005.241
   Davidson Jaime A, 2007, Endocr Pract, V13, P77
   Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8
   Dutton GR, 2005, DIABETES CARE, V28, P1209, DOI 10.2337/diacare.28.5.1209
   Engum A, 2007, J PSYCHOSOM RES, V62, P31, DOI 10.1016/j.jpsychores.2006.07.009
   Falcon LM, 2000, J GERONTOL B-PSYCHOL, V55, pS108, DOI 10.1093/geronb/55.2.S108
   Ferrara A, 2002, DIABETES CARE, V25, P1625, DOI 10.2337/diacare.25.9.1625
   FRANKLIN GM, 1990, AM J EPIDEMIOL, V131, P633, DOI 10.1093/oxfordjournals.aje.a115547
   Gallo LC, 2003, PSYCHOL BULL, V129, P10, DOI 10.1037//0033-2909.129.1.10
   George GC, 2005, J AM DIET ASSOC, V105, P916, DOI 10.1016/j.jada.2005.03.009
   Getaneh A, 2008, ETHNIC DIS, V18, P342
   Hannan EL, 1999, MED CARE, V37, P68, DOI 10.1097/00005650-199901000-00010
   Harris MI, 1998, DIABETES CARE, V21, P1230, DOI 10.2337/diacare.21.8.1230
   Helitzer DL, 2007, AM J HEALTH PROMOT, V21, P517, DOI 10.4278/0890-1171-21.6.517
   Ho LS, 2008, HEALTH EDUC BEHAV, V35, P561, DOI 10.1177/1090198108315367
   Hussain A, 2007, DIABETES RES CLIN PR, V76, P317, DOI 10.1016/j.diabres.2006.09.020
   Jenkins JH, 2005, INT J SOC PSYCHIATR, V51, P211, DOI 10.1177/0020764005056986
   Jezewski MA, 2002, WESTERN J NURS RES, V24, P840, DOI 10.1177/019394502237695
   Jotkowitz AB, 2006, AM J MED, V119, P665, DOI 10.1016/j.amjmed.2006.02.010
   Katapodi MC, 2004, PREV MED, V38, P388, DOI 10.1016/j.ypmed.2003.11.012
   Knowler WC, 2002, NEW ENGL J MED, V346, P393
   Kurian AK, 2007, ETHNIC DIS, V17, P143
   La Pelle N, 2004, FIELD METHOD, V18, P85, DOI [10.1177/1525822x03259227, DOI 10.1177/1525822X03259227]
   Lanting LC, 2005, DIABETES CARE, V28, P2280, DOI 10.2337/diacare.28.9.2280
   Lantz PM, 2005, J HEALTH SOC BEHAV, V46, P274, DOI 10.1177/002214650504600305
   Lee AJ, 2007, DIABETES CARE, V30, P878, DOI 10.2337/dc06-1816
   MAINOUS AG, 2007, DIABETOLOGIA, V50, P934
   Markosyan KM, 2007, AIDS BEHAV, V11, P325, DOI 10.1007/s10461-006-9147-x
   Martin R, 1998, HEALTH PSYCHOL, V17, P346, DOI 10.1037//0278-6133.17.4.346
   McCaul KD, 1996, HEALTH PSYCHOL, V15, P423, DOI 10.1037/0278-6133.15.6.423
   Mensah GA, 2005, CIRCULATION, V111, P1233, DOI 10.1161/01.CIR.0000158136.76824.04
   Mier Nelda, 2007, Prev Chronic Dis, V4, pA24
   Mosca L, 2006, CIRCULATION, V113, P525, DOI 10.1161/CIRCULATIONAHA.105.588103
   Mosca L, 2005, CIRCULATION, V111, P499, DOI 10.1161/01.CIR.0000154568.43333.82
   NHLBI obesity Education Initiative Expert Panel, 1998, CLIN GUID ID EV TREA
   Pope C., 2006, QUALITATIVE RES HLTH
   Prata N, 2006, INT FAM PLAN PERSPEC, V32, P192, DOI 10.1363/3219206
   Rice P, 2001, QUALITATIVE RES METH
   Robb KA, 2004, CANCER EPIDEM BIOMAR, V13, P366
   Rosal MC, 2004, HEALTH EDUC BEHAV, V31, P388, DOI 10.1177/1090198104263360
   Rosecrans AM, 2008, HEALTH EDUC RES, V23, P272, DOI 10.1093/her/cym031
   Seidel MC, 2008, DIABETES CARE, V31, P684, DOI 10.2337/dc07-1869
   Taveras EM, 2006, AMBUL PEDIATR, V6, P342, DOI 10.1016/j.ambp.2006.07.004
   U.S. Department of Health and Human Services Centers for Disease Control and Prevention, EARL REL SEL EST BAS
   *UD DEP HHS, 2006, NAT HEALTHC DISP REP
   *US BUR CENS, 2006, ANN EST POP SEX RAC
   van Ryn M, 2000, SOC SCI MED, V50, P813, DOI 10.1016/S0277-9536(99)00338-X
   Weinstein Neil D., 1999, Journal of the National Cancer Institute Monographs, P15
   Wing RR, 1999, J CONSULT CLIN PSYCH, V67, P132, DOI 10.1037//0022-006X.67.1.132
NR 60
TC 15
Z9 15
U1 1
U2 13
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0145-7217
J9 DIABETES EDUCATOR
JI Diabetes Educ.
PD JAN-FEB
PY 2011
VL 37
IS 1
BP 47
EP 55
DI 10.1177/0145721710392247
PG 9
WC Endocrinology & Metabolism; Public, Environmental & Occupational Health
SC Endocrinology & Metabolism; Public, Environmental & Occupational Health
GA 715LC
UT WOS:000286885000003
PM 21220363
DA 2019-01-08
ER

PT J
AU Welch, G
   Zagarins, SE
   Feinberg, RG
   Garb, JL
AF Welch, Garry
   Zagarins, Sofija E.
   Feinberg, Rebecca G.
   Garb, Jane L.
TI Motivational interviewing delivered by diabetes educators: Does it
   improve blood glucose control among poorly controlled type 2 diabetes
   patients?
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Type 2 diabetes; Diabetes self management education (DSME); Motivational
   interviewing; Blood glucose control; HbA1c
ID SELF-MANAGEMENT; PROGRAM; WOMEN
AB Aim: To determine whether glycemic control is improved when motivational interviewing (MI), a patient-centered behavior change strategy, is used with diabetes self management education (DSME) as compared to DSME alone.
   Methods: Poorly controlled type 2 diabetes (T2DM) patients (n = 234) were randomized into 4 groups: MI + DSME or DSME alone, with or without use of a computerized summary of patient self management barriers. We compared HbA1c changes between groups at 6 months and investigated mediators of HbA1c change.
   Results: Study patients attended the majority of the four intervention visits (mean 3.4), but drop-out rate was high at follow-up research visits (35%). Multiple regression showed that groups receiving MI had a mean change in HbA1c that was significantly lower (less improved) than those not receiving MI (t = 2.10; p = 0.037). Mediators of HbA1c change for the total group were diabetes self-care behaviors and diabetes distress; no between-group differences were found.
   Conclusions: DSME improved blood glucose control, underlining its benefit for T2DM management. However, MI + DSME was less effective than DSME alone. Overall, weak support was found for the clinical utility of MI in the management of T2DM delivered by diabetes educators. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
C1 [Welch, Garry; Zagarins, Sofija E.; Feinberg, Rebecca G.] Baystate Med Ctr, Dept Behav Med Res, Springfield, MA 01105 USA.
   [Garb, Jane L.] Baystate Med Ctr, Dept Acad Affairs, Springfield, MA 01104 USA.
RP Welch, G (reprint author), Baystate Med Ctr, Dept Behav Med Res, 140 High St,Room 2104, Springfield, MA 01105 USA.
EM Garry.Welch@baystatehealth.org
RI Albertin, Paloma/X-1093-2018
FU National Institutes of Health [1R01DK060076]
FX This research was supported by National Institutes of Health grant
   #1R01DK060076.
CR *AM ASS DIAB ED, 2009, DIABETES ED
   *AM DIAB ASS, 1998, DIABETES CARE, V21, P2180
   American Association of Diabetes Educators, 2008, DIABETES ED, V34, P445, DOI DOI 10.1177/0145721708316625
   American Diabetes Association, 2008, DIABETES CARE S1, V31, pS12, DOI DOI 10.2337/DC08-S012
   Barnard KD, 2007, PRACT INT DIABETES, V24, P36
   Bradley C, 1999, DIABETES CARE, V22, P530, DOI 10.2337/diacare.22.3.530
   Centers for Disease Control and Prevention, 2001, TEAM CAR COMPR LIF M
   Funnell MM, 2005, DIABETES EDUCATOR, V31, P53, DOI 10.1177/0145721704273166
   MACKINNON DP, 1993, EVALUATION REV, V17, P144, DOI 10.1177/0193841X9301700202
   MACKINNON DP, 1995, MULTIVAR BEHAV RES, V30, pR2
   Miller W. R., 2002, MOTIVATIONAL INTERVI
   *MOT INT, 2010, MOT INT RES CLIN RES
   Peyrot M, 2007, DIABETES CARE, V30, P2433, DOI 10.2337/dc07-1222
   Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   RUBAK S, 2005, THESIS U AARHUS DENM
   Smith DE, 1997, DIABETES CARE, V20, P52, DOI 10.2337/diacare.20.1.52
   Weinger K, 2005, DIABETES CARE, V28, P1346, DOI 10.2337/diacare.28.6.1346
   WELCH G, 2002, DIABETES SPECTRUM, V15, P203
   WELCH G, 2007, DIABETES
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   Welch GW, 2007, TXB TYPE 2 DIABETES
   West DS, 2007, DIABETES CARE, V30, P1081, DOI 10.2337/dc06-1966
   Williams GC, 2005, PATIENT EDUC COUNS, V56, P28, DOI 10.1016/j.pec.2003.11.008
NR 24
TC 36
Z9 38
U1 0
U2 18
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD JAN
PY 2011
VL 91
IS 1
BP 54
EP 60
DI 10.1016/j.diabres.2010.09.036
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 698XS
UT WOS:000285629100017
PM 21074887
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Gasquoine, PG
AF Gasquoine, Philip G.
TI Cognitive impairment in common, noncentral nervous system medical
   conditions of adults and the elderly
SO JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY
LA English
DT Article
DE Cognitive impairment; Neuropsychological testing; Frontal-subcortical
   brain injury; Hypoxic-ischemic encephalopathy; Cytokines
ID OBSTRUCTIVE SLEEP-APNEA; RESPIRATORY-DISTRESS-SYNDROME; BREAST-CANCER;
   NEUROPSYCHOLOGICAL SEQUELAE; ADJUVANT CHEMOTHERAPY; OLDER-ADULTS;
   HYPERTENSION; DISEASE; PERFORMANCE; COMPLAINTS
AB Common, noncentral nervous system medical conditions linked with cognitive impairment in adults and the elderly include: acute respiratory distress syndrome; cancer; chronic kidney disease; chronic obstructive pulmonary disease; coronary heart disease; hypertension; obesity (bariatric surgical candidates); obstructive sleep apnea; and type 2 diabetes. Cross-condition comparison of the nature and frequency of cognitive impairment is difficult as these conditions often coexist, and there exists no consensus as to the definition of cognitive impairment, nor the optimal number and type of neuropsychological tests required for evaluation. There is as yet no clear evidence for condition-specific profiles of cognitive impairment. Rather, a generalized profile consisting of subclinical levels of impairment in attention, processing speed, executive, and memory functions from bilateral frontal-subcortical ischemia fits across all conditions. This profile: occurs only in subgroups of patients; is inconsistently related to measures of illness severity; is unrelated to patient self-report or level of functional independence; is exacerbated by very high levels of emotional distress; and is reversible in some cases but can also progress to frank neurological disease (dementia) in others, especially the elderly, when multiple conditions coexist, and/or when medical condition severity progresses.
C1 Univ Texas Pan Amer, Dept Psychol & Anthropol, Edinburg, TX 78541 USA.
RP Gasquoine, PG (reprint author), Univ Texas Pan Amer, Dept Psychol & Anthropol, 1201 W Univ Dr, Edinburg, TX 78541 USA.
EM drgdrg13@yahoo.com
FU College of Social and Behavioral Sciences, University of Texas-Pan
   American
FX This work was supported in part by a 2010 Summer Writing Institute Grant
   from the College of Social and Behavioral Sciences, University of
   Texas-Pan American.
CR AH DV, 2009, CLIN NEUROPSYCHOL, V23, P661
   Aloia MS, 2004, J INT NEUROPSYCH SOC, V10, P772, DOI 10.1017/S1355617704105134
   Amenta F, 2002, J NEUROL SCI, V203, P147, DOI 10.1016/S0022-510X(02)00281-2
   American Psychiatric Association, 1994, DIAGN STAT MAN MENT
   Anderson-Hanley C, 2003, J INT NEUROPSYCH SOC, V9, P967, DOI 10.1017/S1355617703970019
   Antonelli-Incalzi R, 2008, J CLIN EXP NEUROPSYC, V30, P141, DOI 10.1080/13803390701287390
   Awad N, 2004, J CLIN EXP NEUROPSYC, V26, P1044, DOI 10.1080/13803390490514875
   Binder LM, 2004, J CLIN EXP NEUROPSYC, V26, P369, DOI 10.1080/13803390490510095
   Boeka AG, 2008, ARCH CLIN NEUROPSYCH, V23, P467, DOI 10.1016/j.acn.2008.03.003
   Bossema ER, 2006, J CLIN EXP NEUROPSYC, V28, P357, DOI 10.1080/13803390590935318
   Brady CB, 2005, NEUROPSYCHOLOGY, V19, P770, DOI 10.1037/0894-4105.19.6.770
   Brands AMA, 2007, J INT NEUROPSYCH SOC, V13, P288, DOI 10.1017/S1355617707070312
   Brandt J, 2007, CLIN NEUROPSYCHOL, V21, P553, DOI 10.1080/13854040600770800
   Castellon SA, 2004, J CLIN EXP NEUROPSYC, V26, P955, DOI 10.1080/13803390490510905
   Catania A, 2009, BRAIN BEHAV IMMUN, V23, P877, DOI 10.1016/j.bbi.2009.04.006
   *CDCP, A Z IND
   CHELUNE GJ, 1986, INT J EAT DISORDER, V5, P701, DOI 10.1002/1098-108X(198605)5:4<701::AID-EAT2260050409>3.0.CO;2-7
   Cohen RA, 2009, J CLIN EXP NEUROPSYC, V31, P96, DOI 10.1080/13803390802014594
   Daurat A, 2008, J CLIN EXP NEUROPSYC, V30, P91, DOI 10.1080/13803390701236116
   Delis D. C., 2000, CALIFORNIA VERBAL LE
   DeLuca J, 2004, J INT NEUROPSYCH SOC, V10, P101
   Denes A, 2010, BRAIN BEHAV IMMUN, V24, P708, DOI 10.1016/j.bbi.2009.09.010
   Dijkstra JB, 2002, NEUROPSYCHOL REV, V12, P1, DOI 10.1023/A:1015404122161
   EHRENGAFT J, 1961, J THORAC CARDIOV SUR, V42, P514
   Finkelstein EA, 2005, AM J MANAG CARE, V11, P630
   Gale SD, 2004, J INT NEUROPSYCH SOC, V10, P60
   Gasquoine PG, 1997, NEUROPSYCHOL REV, V7, P77, DOI 10.1023/B:NERV.0000005945.58251.c0
   Hopkins RO, 2004, J INT NEUROPSYCH SOC, V10, P1005, DOI 10.1017/S135561770410711X
   Incalzi RA, 2003, J CLIN EXP NEUROPSYC, V25, P14, DOI 10.1076/jcen.25.1.14.13635
   Jackson JC, 2009, SOUTH MED J, V102, P1150, DOI 10.1097/SMJ.0b013e3181b6a592
   Kesler SR, 2009, CLIN CANCER RES, V15, P6665, DOI 10.1158/1078-0432.CCR-09-1227
   Koushik NS, 2010, NEUROPSYCHOL REV, V20, P33, DOI 10.1007/s11065-009-9110-5
   Larson MJ, 2007, J INT NEUROPSYCH SOC, V13, P595, DOI 10.1017/S1355617707070749
   Liao DP, 1996, STROKE, V27, P2262, DOI 10.1161/01.STR.27.12.2262
   Lu FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004144
   Miles WR, 1922, ARCH INTERN MED, V30, P767, DOI 10.1001/archinte.1922.00110120086003
   Moss M, 2005, J CLIN EXP NEUROPSYC, V27, P139, DOI 10.1080/13803390490515450
   Naismith S, 2004, J CLIN EXP NEUROPSYC, V26, P43, DOI 10.1076/jcen.26.1.43.23929
   Obler W, 1911, CAN MED ASSOC J, V40, P919
   Ortapamuk H, 2006, ANN NUCL MED, V20, P99, DOI 10.1007/BF02985621
   Ouimet LA, 2009, J CLIN EXP NEUROPSYC, V31, P73, DOI 10.1080/13803390801992725
   Pedersen AD, 2009, J INT NEUROPSYCH SOC, V15, P296, DOI 10.1017/S1355617709090316
   Perry VH, 2004, BRAIN BEHAV IMMUN, V18, P407, DOI 10.1016/j.bbi.2004.01.004
   Prohl J, 2009, J INT NEUROPSYCH SOC, V15, P344, DOI 10.1017/S1355617709090493
   Reid LM, 2006, DEMENT GERIATR COGN, V22, P471, DOI 10.1159/000096295
   Rourke SB, 1999, J CLIN EXP NEUROPSYC, V21, P737, DOI 10.1076/jcen.21.6.737.863
   Sanchez AI, 2004, CLIN NEUROPSYCHOL, V18, P277, DOI 10.1080/13854040490501547
   Schretlen DJ, 2008, J INT NEUROPSYCH SOC, V14, P436, DOI 10.1017/S1355617708080387
   Selnes OA, 2010, J INT NEUROPSYCH SOC, V16, P221, DOI 10.1017/S1355617709991196
   Shilling V, 2006, BREAST CANCER RES TR, V95, P125, DOI 10.1007/s10549-005-9055-1
   Stewart A, 2006, CLIN NEUROPSYCHOL, V20, P76, DOI 10.1080/138540491005875
   Thornton WL, 2007, J INT NEUROPSYCH SOC, V13, P344, DOI 10.1017/S1355617707070361
   Verhaeghen P, 1997, PSYCHOL BULL, V122, P231, DOI 10.1037//0033-2909.122.3.231
   WALDSTEIN SR, 1991, PSYCHOL BULL, V110, P451, DOI 10.1037//0033-2909.110.3.451
   Waldstein SR, 2005, ANN BEHAV MED, V29, P174, DOI 10.1207/s15324796abm2903_3
   Watari K, 2006, ARCH CLIN NEUROPSYCH, V21, P787, DOI 10.1016/j.acn.2006.06.014
   Wefel JS, 2008, NEUROPSYCHOL REV, V18, P121, DOI 10.1007/s11065-008-9058-x
   Wefel JS, 2004, CANCER, V101, P466, DOI 10.1002/cncr.20393
   Yeung SE, 2009, NEUROPSYCHOLOGY, V23, P1, DOI 10.1037/a0013849
NR 59
TC 14
Z9 14
U1 0
U2 13
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1380-3395
EI 1744-411X
J9 J CLIN EXP NEUROPSYC
JI J. Clin. Exp. Neuropsychol.
PY 2011
VL 33
IS 4
BP 486
EP 496
AR PII 931971666
DI 10.1080/13803395.2010.536759
PG 11
WC Psychology, Clinical; Clinical Neurology; Psychology
SC Psychology; Neurosciences & Neurology
GA 746SC
UT WOS:000289266300009
PM 21218318
DA 2019-01-08
ER

PT J
AU Hatfield, L
   Schwoebel, A
   Lynyak, C
AF Hatfield, Linda
   Schwoebel, Ann
   Lynyak, Corinne
TI Caring for the Infant of a Diabetic Mother
SO MCN-THE AMERICAN JOURNAL OF MATERNAL-CHILD NURSING
LA English
DT Article
DE Gestational diabetes; Infant; Newborn; Pregnancy in diabetics/metabolism
ID GLUCOSE-METABOLISM; PREGNANCY; FETAL; MELLITUS; OUTCOMES; NEWBORN
AB In the United States, approximately 100,000 infants are born to diabetic mothers each year. If diabetes in pregnancy is uncontrolled, the diversity of resulting health problems can have a profound effect on the embryo, the fetus, and the neonate. These infants are at risk for a multitude of physiologic, metabolic, and congenital complications such as macrosomia, asphyxia, respiratory distress, hypoglycemia, hypocalcemia, hyperbilirubinemia, polycythemia and hyperviscosity, cardiomegaly, and central nervous system disruption. Preconception control of glucose metabolism throughout the trajectory of a woman's pregnancy is a significant factor in decreasing the adverse impact of diabetes on the fetus and newborn. Meticulous attention to neonatal glucose levels, thorough physical examination, and precise diagnosis are prerequisites to appropriate care for the neonate.
C1 [Hatfield, Linda] Univ Penn, Sch Nursing, Neonatal Nurse Practitioner Program, Philadelphia, PA 19104 USA.
   [Hatfield, Linda; Schwoebel, Ann; Lynyak, Corinne] Penn Hosp, Philadelphia, PA 19107 USA.
RP Hatfield, L (reprint author), Univ Penn, Sch Nursing, Neonatal Nurse Practitioner Program, Philadelphia, PA 19104 USA.
EM linda.hatfield@nursing.upenn.edu
CR [Anonymous], 2005, DIABETES CARE, V28, pS4
   Armentrout Debra C, 2003, MCN Am J Matern Child Nurs, V28, P234
   Barnes-Powell LL, 2007, NEONATAL NETW, V26, P283, DOI 10.1891/0730-0832.26.5.283
   Bromiker R, 2006, J PEDIATR-US, V149, P640, DOI 10.1016/j.jpeds.2006.07.034
   Chu SY, 2007, DIABETES CARE, V30, P2070, DOI 10.2337/dc06-2559a
   Cornblath M, 2000, SEMIN PERINATOL, V24, P136, DOI 10.1053/sp.2000.6364
   COWETT RM, 2002, NEOREVIEWS, V3, pE173, DOI DOI 10.1542/NEO.3-9-E173
   Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973
   Eidelman AI, 2002, SEMIN PERINATOL, V26, P232, DOI 10.1053/sper.2002.34215
   Garg M, 2006, CLIN PERINATOL, V33, P853, DOI 10.1016/j.clp.2006.10.001
   Jain A, 2008, INDIAN J PEDIATR, V75, P165, DOI 10.1007/s12098-008-0067-9
   Kamanu CI, 2009, ARCH GYNECOL OBSTET, V279, P857, DOI 10.1007/s00404-008-0780-7
   Meur S, 2007, PAEDIAT CHILD HLTH, V17, P217, DOI DOI 10.1016/J.PAED.2007.03.004
   Mitanchez D, 2007, HORM RES, V68, P265, DOI 10.1159/000104174
   NAFDAY SM, 2008, AAP TXB PEDIAT CARE, P2935
   Parretti E, 2001, DIABETES CARE, V24, P1319, DOI 10.2337/diacare.24.8.1319
   Persson B, 2009, SEMIN FETAL NEONAT M, V14, P106, DOI 10.1016/j.siny.2009.01.003
   ROHATGI PK, 2001, PRINCIPLES PRACTICE, P1848
   Sasidharan P, 2004, PEDIATR CLIN N AM, V51, P999, DOI 10.1016/j.pcl.2004.03.010
   Waters TP, 2009, OBSTET GYNECOL, V114, P45, DOI 10.1097/AOG.0b013e3181a9454b
   Yang J, 2006, OBSTET GYNECOL, V108, P644, DOI 10.1097/01.AOG.0000231688.08263.47
NR 21
TC 6
Z9 6
U1 0
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0361-929X
EI 1539-0683
J9 MCN-AM J MATERN-CHIL
JI MCN-Am. J. Matern.-Child Nurs.
PD JAN-FEB
PY 2011
VL 36
IS 1
BP 10
EP 16
DI 10.1097/NMC.0b013e3181fb0b4c
PG 7
WC Nursing
SC Nursing
GA 695YA
UT WOS:000285407600004
PM 21164312
DA 2019-01-08
ER

PT J
AU Howe, CJ
   Ratcliffe, SJ
   Tuttle, A
   Dougherty, S
   Lipman, TH
AF Howe, Carol J.
   Ratcliffe, Sarah J.
   Tuttle, Alan
   Dougherty, Shayne
   Lipman, Terri H.
TI Needle Anxiety in Children With Type 1 Diabetes and Their Mothers
SO MCN-THE AMERICAN JOURNAL OF MATERNAL-CHILD NURSING
LA English
DT Article
DE Blood injury phobia; Children; Diabetes; Mothers; Needle anxiety; Needle
   phobia
ID INJURY PHOBIA; PAIN; FEAR; DISTRESS; BLOOD; VENIPUNCTURE; CHILDHOOD;
   CANCER
AB Purpose: To report the prevalence of fear, distress, pain, and level of cooperation with insulin injections and blood glucose fingersticks in children with newly diagnosed diabetes and their mothers, and the association with diabetes control.
   Study Design and Methods: Forty-six subjects (23 children and mother pairs) completed the Perceptions of Insulin Shots and Fingersticks Survey at diagnosis and 6 to 9 months later. Standard descriptive statistics, Fisher's exact tests, and Spearman correlation coefficients were used to analyze the data. Scores were analyzed for associations with age and hemoglobin A1c as a marker of diabetes control.
   Results: More young children as compared to older subjects reported fear and pain with injections and fingersticks. A high percentage of mothers reported high fear and distress with needles at diagnosis. Although most improve, 13.6% of mothers continued to report high fear and distress 6 to 9 months later. Mothers' continued report of high distress correlated with the poor cooperation of children, which correlated with poorer diabetes control.
   Clinical Implications: Nurses should incorporate assessment and intervention for needle anxiety in children and parents at diagnosis of diabetes through informal interview or formal survey. Nurses can effectively incorporate coping strategies into their teaching of parents and children to administer injections and fingersticks.
C1 [Howe, Carol J.; Dougherty, Shayne] Childrens Hosp Philadelphia, Div Endocrinol, Diabet Ctr Children, Philadelphia, PA 19104 USA.
   [Ratcliffe, Sarah J.] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA.
   [Tuttle, Alan] Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA.
   [Lipman, Terri H.] Childrens Hosp Philadelphia, Div Endocrinol & Diabet, Philadelphia, PA 19104 USA.
RP Howe, CJ (reprint author), Childrens Hosp Philadelphia, Div Endocrinol, Diabet Ctr Children, Philadelphia, PA 19104 USA.
EM howe@email.chop.edu
OI Ratcliffe, Sarah/0000-0002-6644-8284
CR ABUSAAD H, 1984, PAIN, V19, P163, DOI 10.1016/0304-3959(84)90836-4
   Berlin I, 1997, DIABETES CARE, V20, P176, DOI 10.2337/diacare.20.2.176
   Bienvenu OJ, 1998, PSYCHOL MED, V28, P1129, DOI 10.1017/S0033291798007144
   Boman KK, 2004, J PEDIATR-US, V145, P373, DOI 10.1016/j.jpeds.2004.05.043
   Broome M E, 1990, Oncol Nurs Forum, V17, P361
   Chambers CT, 2009, CLIN THER, V31, pS77, DOI 10.1016/j.clinthera.2009.07.023
   Chapman HR, 2002, BRIT DENT J, V193, P447, DOI 10.1038/sj.bdj.4801593
   Cline RJW, 2006, SOC SCI MED, V63, P883, DOI 10.1016/j.socscimed.2006.03.007
   DAHQUIST LM, 2002, J PEDIATR ONCOL NURS, V19, P22, DOI DOI 10.1053/JPON.2002.30009
   Deacon B, 2006, J ANXIETY DISORD, V20, P946, DOI 10.1016/j.janxdis.2006.01.004
   Frank RG, 1998, ARTHRIT CARE RES, V11, P166, DOI 10.1002/art.1790110304
   Goodenough B, 1999, PAIN, V80, P179, DOI 10.1016/S0304-3959(98)00201-2
   Hagglof B, 1994, Arctic Med Res, V53 Suppl 1, P20
   HANAS R, 2001, THESIS FACULTY HLTH
   Hanas R, 1997, PRACTICAL DIABETES, V14, P95, DOI DOI 10.1002/PDI.1960140404
   Keck J F, 1996, J Pediatr Nurs, V11, P368, DOI 10.1016/S0882-5963(96)80081-9
   MARKS I, 1988, AM J PSYCHIAT, V145, P1207
   McGrath P. A., 1985, ADV PAIN RES THER, V9, P387
   Simmons JH, 2007, DIABETES CARE, V30, P987, DOI 10.2337/dc06-1553
   Spagrud LJ, 2008, J PAIN SYMPTOM MANAG, V36, P173, DOI 10.1016/j.jpainsymman.2007.10.009
   SPARKS L, 2001, AM J MATERNAL CHILD, V26, P72, DOI DOI 10.1097/00005721/200103000-00005
   ULMAN LS, 2009, COCHRANE COLLABORATI, V3, P1
   Walco Gary A, 2008, Pediatrics, V122 Suppl 3, pS125, DOI 10.1542/peds.2008-1055d
   WONG D, 1991, NURSING CARE INFANTS
   Wright S, 2009, AUST FAM PHYSICIAN, V38, P172
   Zambanini A, 1999, DIABETES RES CLIN PR, V46, P239, DOI 10.1016/S0168-8227(99)00099-6
NR 26
TC 18
Z9 18
U1 0
U2 17
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0361-929X
J9 MCN-AM J MATERN-CHIL
JI MCN-Am. J. Matern.-Child Nurs.
PD JAN-FEB
PY 2011
VL 36
IS 1
BP 25
EP 31
DI 10.1097/NMC.0b013e3181fc6093
PG 7
WC Nursing
SC Nursing
GA 695YA
UT WOS:000285407600006
PM 21164314
DA 2019-01-08
ER

PT J
AU Min, LC
   Reuben, DB
   Keeler, E
   Ganz, DA
   Fung, CH
   Shekelle, P
   Roth, CP
   Wenger, NS
AF Min, Lillian C.
   Reuben, David B.
   Keeler, Emmett
   Ganz, David A.
   Fung, Constance H.
   Shekelle, Paul
   Roth, Carol P.
   Wenger, Neil S.
TI Is Patient-Perceived Severity of a Geriatric Condition Related to Better
   Quality of Care?
SO MEDICAL CARE
LA English
DT Article
DE quality of care; urinary incontinence; falls
ID CORONARY-ARTERY-DISEASE; URINARY-INCONTINENCE; ELDERLY-PATIENTS;
   SEX-DIFFERENCES; BLOOD-PRESSURE; OLDER PATIENTS; DIABETES CARE; MANAGED
   CARE; MEDICAL-CARE; FOLLOW-UP
AB Background: Care for falls and urinary incontinence (UI) among older patients is inadequate. One possible explanation is that physicians provide less recommended care to patients who are not as concerned about their falls and UI.
   Objective: To test whether patient-reported severity for 2 geriatric conditions, falls, and UI, is associated with quality of care.
   Research Design: Prospective cohort study of elders with falls and/or fear of falling (n = 384) and UI (n = 163).
   Subjects: Participants in the Assessing Care of Vulnerable Elders-2 Study (2002-2003), which evaluated an intervention to improve the care for falls and UI among older (age, >= 75) ambulatory care patients with falls/fear of falling or UI. Measures: Falls Efficacy Scale (FES) and the Incontinence Quality of Life surveys measured at baseline, quality of care measured by a 13-month medical record abstraction.
   Results: There was a small difference in falls quality scores across the range of FES, with greater patient-perceived falls severity associated with better odds of passing falls quality indicators (OR: 1.11 [95% CI: 1.02-1.21] per 10-point increment in FES). Greater patient-perceived UI severity (Incontinence Quality of Life score) was not associated with better quality of UI care.
   Conclusions: Although older persons with greater patient-perceived falls severity receive modestly better quality of care, those with more distressing incontinence do not. For both conditions, however, even the most symptomatic patients received less than half of recommended care. Low patient-perceived severity of condition is not the basis of poor care for falls and UI.
C1 [Min, Lillian C.] Univ Michigan, Sch Med, Div Geriatr, Dept Med, Ann Arbor, MI 48109 USA.
   [Reuben, David B.; Fung, Constance H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Geriatr, Los Angeles, CA 90095 USA.
   [Keeler, Emmett; Ganz, David A.; Shekelle, Paul; Wenger, Neil S.] Univ Calif Los Angeles, David Geffen Sch Med, Gen Internal Med & Hlth Serv Res, Los Angeles, CA 90095 USA.
   [Shekelle, Paul; Roth, Carol P.; Wenger, Neil S.] RAND Hlth, Santa Monica, CA USA.
   [Ganz, David A.; Shekelle, Paul] Greater Los Angeles Vet Affairs Healthcare Syst, Los Angeles, CA USA.
RP Min, LC (reprint author), Univ Michigan, Sch Med, Div Geriatr, Dept Med, 300 N Ingalls Bldg,Wing E,Room 966, Ann Arbor, MI 48109 USA.
EM lmin@med.umich.edu
FU AHRQ [R21 HS017621]; NIA-UCLA [K12 AG001004]; U.S. Department of
   Veterans Affairs, Veterans Health Administration; VA Health Services
   Research & Development (HSR&D) Service through the VA Greater Los
   Angeles HSR& D Center of Excellence [VA CD2 08-012-1]; National
   Institute of Aging [AG028748]
FX Dr. Min is supported by the AHRQ (R21 HS017621). Dr. Min was on the UCLA
   faculty during the writing of this manuscript, supported by NIA-UCLA
   (K12 AG001004). Dr. Ganz is funded by the U.S. Department of Veterans
   Affairs, Veterans Health Administration, VA Health Services Research &
   Development (HSR&D) Service through the VA Greater Los Angeles HSR& D
   Center of Excellence (Project # VA CD2 08-012-1). This research was also
   supported by the UCLA Claude Pepper Older Americans Independence Center
   funded by the National Institute of Aging (AG028748).
CR [Anonymous], 2001, ANN INTERN MED, V135, P653, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00004
   Asch SM, 2004, INT J QUAL HEALTH C, V16, P41, DOI 10.1093/intqhc/mzh004
   AYANIAN JZ, 1994, NEW ENGL J MED, V331, P1136, DOI 10.1056/NEJM199410273311707
   Backer V, 2006, ANN ALLERG ASTHMA IM, V97, P490, DOI 10.1016/S1081-1206(10)60940-4
   Borowsky SJ, 2000, J GEN INTERN MED, V15, P381, DOI 10.1046/j.1525-1497.2000.12088.x
   Burack RC, 1998, J GEN INTERN MED, V13, P366, DOI 10.1046/j.1525-1497.1998.00116.x
   Cheng EM, 2007, MOVEMENT DISORD, V22, P515, DOI 10.1002/mds.21311
   Chodosh J, 2004, J AM GERIATR SOC, V52, pS189
   Choudhry NK, 2005, ANN INTERN MED, V142, P260, DOI 10.7326/0003-4819-142-4-200502150-00008
   Cumming RG, 2000, J GERONTOL A-BIOL, V55, pM299, DOI 10.1093/gerona/55.5.M299
   Cwikel JG, 1998, DISABIL REHABIL, V20, P161, DOI 10.3109/09638289809166077
   Dedier J, 2001, ARCH INTERN MED, V161, P2099, DOI 10.1001/archinte.161.17.2099
   Diette GB, 2001, PEDIATRICS, V108, P432, DOI 10.1542/peds.108.2.432
   Diokno AC, 2004, AM J MANAG CARE, V10, P69
   Etzioni DA, 2006, DIS COLON RECTUM, V49, P1002, DOI 10.1007/s10350-006-0533-2
   Fagard RH, 2003, J HUM HYPERTENS, V17, P681, DOI 10.1038/sj.jhh.1001598
   Fairchild DG, 2001, J GEN INTERN MED, V16, P663, DOI 10.1111/j.1525-1497.2001.01111.x
   Fine JM, 2002, ARCH INTERN MED, V162, P827, DOI 10.1001/archinte.162.7.827
   Gallagher TH, 2004, AM J MANAG CARE, V10, P61
   Higashi Takahiro, 2005, Health Qual Life Outcomes, V3, P75, DOI 10.1186/1477-7525-3-75
   Higashi T, 2007, NEW ENGL J MED, V356, P2496, DOI 10.1056/NEJMsa066253
   Humphries KH, 2001, CIRCULATION, V103, P2365
   Kerr EA, 2008, ANN INTERN MED, V148, P717, DOI 10.7326/0003-4819-148-10-200805200-00004
   Kinchen KS, 2003, J WOMENS HEALTH, V12, P687, DOI 10.1089/154099903322404339
   Kressig RW, 2001, J AM GERIATR SOC, V49, P1456, DOI 10.1046/j.1532-5415.2001.4911237.x
   Landon BE, 2004, JAMA-J AM MED ASSOC, V291, P1744, DOI 10.1001/jama.291.14.1744
   LEWIS CE, 1991, ANN INTERN MED, V114, P54, DOI 10.7326/0003-4819-114-1-54
   McCall DT, 2004, DIABETES CARE, V27, P1060, DOI 10.2337/diacare.27.5.1060
   Mehrotra A, 2006, ANN INTERN MED, V145, P826, DOI 10.7326/0003-4819-145-11-200612050-00007
   Miller M, 2000, ARCH INTERN MED, V160, P343, DOI 10.1001/archinte.160.3.343
   Min LC, 2005, J AM GERIATR SOC, V53, P1705, DOI 10.1111/j.1532-5415.2005.53520.x
   Min LC, 2007, MED CARE, V45, P480, DOI 10.1097/MLR.0b013e318030fff9
   Patrick DL, 1999, QUALITY LIFE INSTRUM
   Peters TJ, 2004, HEALTH SOC CARE COMM, V12, P53, DOI 10.1111/j.1365-2524.2004.00468.x
   Pham HH, 2005, JAMA-J AM MED ASSOC, V294, P473, DOI 10.1001/jama.294.4.473
   Piette JD, 2006, DIABETES CARE, V29, P725, DOI 10.2337/diacare.29.03.06.dc05-2078
   POWELL LE, 1995, J GERONTOL A-BIOL, V50, pM28, DOI 10.1093/gerona/50A.1.M28
   Rathore SS, 2003, JAMA-J AM MED ASSOC, V289, P2517, DOI 10.1001/jama.289.19.2517
   Reuben DB, 2003, J AM GERIATR SOC, V51, P1787, DOI 10.1046/j.1532-5415.2003.51565.x
   ROYSTON P, 2005, STATA J, V5, P527
   Smetana GW, 2007, ARCH INTERN MED, V167, P10, DOI 10.1001/archinte.167.1.10
   Solomon DH, 2003, J AM GERIATR SOC, V51, P902, DOI 10.1046/j.1365-2389.2003.513331.x
   STEINGART RM, 1991, NEW ENGL J MED, V325, P226, DOI 10.1056/NEJM199107253250402
   TINETTI ME, 1990, J GERONTOL, V45, pP239, DOI 10.1093/geronj/45.6.P239
   Turner BJ, 2008, ANN INTERN MED, V148, P578, DOI 10.7326/0003-4819-148-8-200804150-00002
   Wagner TH, 1996, UROLOGY, V47, P67, DOI 10.1016/S0090-4295(99)80384-7
   Walsh JME, 1999, AM J PREV MED, V16, P307, DOI 10.1016/S0749-3797(99)00021-5
   Wenger NS, 2009, J AM GERIATR SOC, V57, P547, DOI 10.1111/j.1532-5415.2008.02128.x
   Wenger NS, 2003, ANN INTERN MED, V139, P740, DOI 10.7326/0003-4819-139-9-200311040-00008
   Wu AW, 2001, ARCH INTERN MED, V161, P2554, DOI 10.1001/archinte.161.21.2554
NR 50
TC 2
Z9 2
U1 0
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0025-7079
J9 MED CARE
JI Med. Care
PD JAN
PY 2011
VL 49
IS 1
BP 101
EP 107
DI 10.1097/MLR.0b013e3181f53523
PG 7
WC Health Care Sciences & Services; Health Policy & Services; Public,
   Environmental & Occupational Health
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA 695XW
UT WOS:000285407100014
PM 21079526
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Chen, HY
   Baumgardner, DJ
   Rice, JP
AF Chen, Han-Yang
   Baumgardner, Dennis J.
   Rice, Jessica P.
TI Health-Related Quality of Life Among Adults With Multiple Chronic
   Conditions in the United States, Behavioral Risk Factor Surveillance
   System, 2007
SO PREVENTING CHRONIC DISEASE
LA English
DT Article
AB Introduction
   Little is known about health-related quality of life (HRQOL) among people with multiple chronic conditions. We examined the association between the number of chronic conditions and self-reported HRQOL outcomes among adults in the United States.
   Methods
   We used data from the Behavioral Risk Factor Surveillance System (BRFSS) in 2007 (n = 430,912) to compare 4 HRQOL measures for people with any of 8 chronic conditions. We also assessed the frequency of self-reported physical and mental distress and the number of days activity was limited because of chronic conditions. We estimated prevalence and adjusted odds ratios (AORs) and 95% confidence intervals (CIs) by using survey logistic regression analyses.
   Results
   People with 3 or more chronic conditions had the highest risk of reporting fair or poor health compared with respondents with no chronic conditions (AOR, 8.7; 95% CI, 8.0-9.4). People with cardiovascular conditions or diabetes had higher risk of reporting poor HRQOL outcomes than those with other chronic conditions. The odds ratios for frequent physical distress were consistently higher than those for frequent mental distress and frequent activity limitations for all conditions.
   Conclusion
   Strategies that help clinicians to manage their patients' chronic conditions may contribute to improved HRQOL among adults. Our findings may help to inform these strategies.
C1 [Baumgardner, Dennis J.; Rice, Jessica P.] Univ Wisconsin, Sch Med & Publ Hlth, Ctr Urban Populat Hlth, Milwaukee, WI 53233 USA.
   [Baumgardner, Dennis J.] Aurora UW Med Grp, Milwaukee, WI USA.
RP Chen, HY (reprint author), Univ Wisconsin, Sch Med & Publ Hlth, Ctr Urban Populat Hlth, 1020 N 12th St,Suite 4180, Milwaukee, WI 53233 USA.
EM chen25@wisc.edu
CR Andresen EM, 1999, ARCH PHYS MED REHAB, V80, P877, DOI 10.1016/S0003-9993(99)90077-1
   Andresen EM, 2003, J EPIDEMIOL COMMUN H, V57, P339, DOI 10.1136/jech.57.5.339
   Bethell C., 2001, PORTRAIT CHRONICALLY
   Bombard JM, 2005, AM J PREV MED, V28, P251, DOI 10.1016/j.amepre.2004.12.004
   BROWNSON RC, 1994, EPIDEMIOLOGY, V5, P545
   Centers for Disease Control and Prevention, CHRON DIS POW PREV C
   Centers for Disease Control and Prevention, 2000, MEAS HLTH DAYS POP A
   Centers for Disease Control and Prevention, 2007, BEH RISK FACT SURV S
   de Visser CL, 2002, QUAL LIFE RES, V11, P249, DOI 10.1023/A:1015287825660
   Dominick Kelli L, 2004, Health Qual Life Outcomes, V2, P5
   Engelgau MM, 2004, ANN INTERN MED, V140, P945, DOI 10.7326/0003-4819-140-11-200406010-00035
   Ford ES, 2003, CHEST, V123, P119, DOI 10.1378/chest.123.1.119
   Greenlund KJ, 2002, STROKE, V33, P565, DOI 10.1161/hs0202.102882
   HENNESSY CH, 1994, PUBLIC HEALTH REP, V109, P665
   Heo M, 2003, OBES RES, V11, P209, DOI 10.1038/oby.2003.33
   Jiang YW, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-14
   JUNIPER EF, 1992, THORAX, V47, P76, DOI 10.1136/thx.47.2.76
   Miller W. R., 2002, MOTIVATIONAL INTERVI
   Moriarty DG, 2005, PREV CHRONIC DIS, V2
   Mowad L, 2004, WESTERN J NURS RES, V26, P293, DOI 10.1177/0193945903261556
   Newschaffer CJ, 1998, VALIDATION BEHAV RIS
   Pew Research Center for the People and the Press, 2006, CELL PHON CHALL SURV
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Robert SA, 2009, J GERONTOL B-PSYCHOL, V64, P378, DOI 10.1093/geronb/gbp012
   Schecter S, 1999, COGNITION AGING SELF
   SNOEK F., 2000, DIABETES SPECTRUM, V13, P24
   Strine TW, 2005, AM J PREV MED, V28, P182, DOI 10.1016/j.ampre.2004.10.002
   Thompson DR, 2002, QUAL LIFE RES, V11, P535, DOI 10.1023/A:1016354516168
   Thorpe KE, 2006, HEALTH AFFAIR, V25, pW378, DOI 10.1377/hlthaff.25.w378
   U. S. Department of Health and Human Services, 2000, HLTH PEOPL 2010
   Valdmanis V, 2001, AM J PUBLIC HEALTH, V91, P129
   Verbrugge LM, 1999, DISABIL REHABIL, V21, P295
   Vogeli C, 2007, J GEN INTERN MED, V22, P391, DOI 10.1007/s11606-007-0322-1
   Walker AE, 2007, CHRONIC ILLN, V3, P202, DOI 10.1177/1742395307081504
   Williams LS, 1999, STROKE, V30, P1362, DOI 10.1161/01.STR.30.7.1362
NR 35
TC 30
Z9 30
U1 0
U2 5
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1545-1151
J9 PREV CHRONIC DIS
JI Prev. Chronic Dis.
PD JAN
PY 2011
VL 8
IS 1
AR UNSP A09
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA V29DW
UT WOS:000208730100009
PM 21159221
DA 2019-01-08
ER

PT J
AU Manzoni, GM
   Villa, V
   Compare, A
   Castelnuovo, G
   Nibbio, F
   Titon, AM
   Molinari, E
   Gondoni, LA
AF Manzoni, Gian Mauro
   Villa, Valentina
   Compare, Angelo
   Castelnuovo, Gianluca
   Nibbio, Ferruccio
   Titon, Anna Maria
   Molinari, Enrico
   Gondoni, Luca Alessandro
TI Short-term effects of a multi-disciplinary cardiac rehabilitation
   programme on psychological well-being, exercise capacity and weight in a
   sample of obese in-patients with coronary heart disease: A
   practice-level study
SO PSYCHOLOGY HEALTH & MEDICINE
LA English
DT Article
DE cardiac rehabilitation; psychological well-being; exercise capacity;
   obesity; weight loss
ID QUALITY-OF-LIFE; BODY-MASS INDEX; ECHOCARDIOGRAPHIC MEASUREMENTS;
   CARDIOVASCULAR-DISEASE; RISK; OVERWEIGHT; DEPRESSION; PROFILES;
   OUTCOMES; PARADOX
AB Given that many patients referred to cardiac rehabilitation (CR) are obese, diet therapy, exercise training, nutritional and psychological counselling for both obesity and psychological distress should be included as important components in all CR programmes. In this practice-level, observational study we evaluated the short-term within-group effects of a four-week multi-factorial inpatient CR programme specifically addressed to weight loss, fitness improvement and psychological health increase on 176 obese in-patients with coronary heart disease (CHD). Outcome measures were exercise capacity measured with estimated metabolic equivalents (METs), body mass index (BMI) and psychological well-being (PGWBI). Results show statistically significant improvements in all the PGWBI sub-scales and total score, except in general health (p=0.393). No moderation effects were found for BMI class, age, diabetes and ejection fraction (EF). METs significantly increased by 30.3% (p0.001) and BMI decreased by 1.37 points (p0.001). Significant correlations were found between BMI and weight reductions with PGWBI anxiety and total score improvements. This multi-disciplinary CR programme including diet therapy, exercise training and psychological counselling provides indication for short-term within-group effectiveness on functional exercise capacity, BMI and PGWBI in a sample of obese in-patients with CHD. However, controlled studies are needed to corroborate the results we found.
C1 [Manzoni, Gian Mauro; Villa, Valentina; Compare, Angelo; Castelnuovo, Gianluca; Molinari, Enrico] Osped San Giuseppe, Psychol Res Lab, Ist Auxol Italiano IRCCS, Verbania, Italy.
   [Manzoni, Gian Mauro; Compare, Angelo] Univ Bergamo, Dept Psychol, Bergamo, Italy.
   [Castelnuovo, Gianluca; Molinari, Enrico] Catholic Univ, Dept Psychol, Milan, Italy.
   [Nibbio, Ferruccio; Titon, Anna Maria; Gondoni, Luca Alessandro] Osped San Giuseppe, Unit Cardiac Rehabil, Ist Auxol Italiano IRCCS, Verbania, Italy.
RP Manzoni, GM (reprint author), Osped San Giuseppe, Psychol Res Lab, Ist Auxol Italiano IRCCS, Verbania, Italy.
EM gm.manzoni@auxologico.it
OI Castelnuovo, Gianluca/0000-0003-2633-9822; Villa,
   Valentina/0000-0002-9972-1064; Manzoni, Gian Mauro/0000-0003-3384-0359;
   Gondoni, Luca/0000-0002-7139-0726; Molinari, Enrico/0000-0001-8132-694X;
   Compare, Angelo/0000-0002-3336-7920
CR Ades PA, 2009, CIRCULATION, V119, P2671, DOI 10.1161/CIRCULATIONAHA.108.834184
   Ashley EA, 2000, LANCET, V356, P1592, DOI 10.1016/S0140-6736(00)03138-X
   Bader D S, 2001, J Cardiopulm Rehabil, V21, P210, DOI 10.1097/00008483-200107000-00003
   Barth J, 2009, J WOMENS HEALTH, V18, P2033, DOI 10.1089/jwh.2008.1058
   Benzer W, 2007, EUR J CARDIOV PREV R, V14, P441, DOI 10.1097/HJR.0b013e32802bf7ae
   Bjarnason-Wehrens B, 2007, CLIN RES CARDIOL, V96, P77, DOI 10.1007/s00392-007-0461-0
   Boesch C., 2005, J CARDIOPULM REHABIL, V25, P22, DOI [10.1097/ 00008483- 200501000- 00004, DOI 10.1097/00008483-200501000-00004]
   Boesch Claudia, 2005, J Cardiopulm Rehabil, V25, P14, DOI 10.1097/00008483-200501000-00004
   Brochu M, 2000, J Cardiopulm Rehabil, V20, P96, DOI 10.1097/00008483-200003000-00003
   Cohen J, 1988, STAT POWER ANAL BEHA
   Cooper Z, 2001, BEHAV RES THER, V39, P499, DOI 10.1016/S0005-7967(00)00065-6
   Davin SA, 2009, PSYCHOL HEALTH MED, V14, P716, DOI 10.1080/13548500903431501
   Dela Cruz CS, 2009, CLIN CHEST MED, V30, P509, DOI 10.1016/j.ccm.2009.06.001
   Dupuy HJ., 1984, ASSESSMENT QUALITY L, P170
   Fabricatore AN, 2004, CLIN DERMATOL, V22, P332, DOI 10.1016/j.clindermatol.2004.01.006
   Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861
   Gondoni LA, 2008, ACTA CARDIOL, V63, P153, DOI 10.2143/AC.63.2.2029521
   GRAHAM I, 2007, EUR J CARDIOVASC S2, V14, P1
   GROSSI E, 2002, QUESTIONARIO PSYCHOL
   Gunstad John, 2007, Prev Cardiol, V10, P64, DOI 10.1111/j.1520-037X.2007.05860.x
   Harvey-Berino J, 1998, CORONARY ARTERY DIS, V9, P795, DOI 10.1097/00019501-199809120-00003
   Herlitz J, 2003, CORONARY ARTERY DIS, V14, P509, DOI 10.1097/00019501-200311000-00006
   Jobin Jean, 2005, J Cardiopulm Rehabil, V25, P103, DOI 10.1097/00008483-200503000-00010
   Kinge JM, 2010, SOC SCI MED, V71, P1864, DOI 10.1016/j.socscimed.2010.09.001
   Kushner RF, 2000, NUTRITION, V16, P947, DOI 10.1016/S0899-9007(00)00404-4
   Lavie Carl J, 2008, J Cardiometab Syndr, V3, P136, DOI 10.1111/j.1559-4572.2008.00002.x
   Lavie CJ, 2007, AM J MED, V120, P825, DOI 10.1016/j.amjmed.2007.06.023
   Lavie CJ, 2006, ARCH INTERN MED, V166, P1878, DOI 10.1001/archinte.166.17.1878
   Lavie CJ, 2009, AM J MED, V122, P1106, DOI 10.1016/j.amjmed.2009.06.006
   Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068
   Lavie CJ, 1997, AM J CARDIOL, V79, P397, DOI 10.1016/S0002-9149(97)89239-9
   Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2
   Michie S, 2005, PSYCHOL HEALTH MED, V10, P88, DOI DOI 10.1080/13548500512331315398
   Milani RV, 1996, AM HEART J, V132, P726, DOI 10.1016/S0002-8703(96)90304-X
   NIH, 1998, OBES RES S2, V6, pS1
   Otterstad JE, 1997, EUR HEART J, V18, P507
   Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891
   Rozanski A, 1999, CIRCULATION, V99, P2192, DOI 10.1161/01.CIR.99.16.2192
   SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072
   Savage Patrick D, 2002, J Cardiopulm Rehabil, V22, P154, DOI 10.1097/00008483-200205000-00005
   Savage PD, 2006, CORONARY ARTERY DIS, V17, P227, DOI 10.1097/00019501-200605000-00004
   Sierra-Johnson J, 2005, AM J CARDIOL, V96, P211, DOI 10.1016/j.ajmcard.2005.03.046
   Sommaruga Marinella, 2003, Monaldi Arch Chest Dis, V60, P40
   Vanhecke TE, 2009, CLIN CARDIOL, V32, P121, DOI 10.1002/clc.20458
   Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4
   *WHO, 2006, OBES OV FACT SHEET 3
   Yu CM, 2003, AM J CARDIOL, V91, P321, DOI 10.1016/S0002-9149(02)03159-4
NR 47
TC 26
Z9 26
U1 1
U2 7
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND
SN 1354-8506
J9 PSYCHOL HEALTH MED
JI Psychol. Health Med.
PY 2011
VL 16
IS 2
BP 178
EP 189
AR PII 933307214
DI 10.1080/13548506.2010.542167
PG 12
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 720WX
UT WOS:000287314500005
PM 21328146
DA 2019-01-08
ER

PT J
AU Chun, KM
   Chesla, CA
   Kwan, CML
AF Chun, Kevin M.
   Chesla, Catherine A.
   Kwan, Christine M. L.
TI "So We Adapt Step by Step": Acculturation experiences affecting diabetes
   management and perceived health for Chinese American immigrants
SO SOCIAL SCIENCE & MEDICINE
LA English
DT Article
DE Acculturation; Diabetes management; Chinese American immigrant health;
   USA
ID DISEASE MANAGEMENT; ASIAN-AMERICANS; RISK-FACTORS; PREVALENCE;
   POPULATIONS; OBESITY; CARE
AB This study examines how acculturation affects type 2 diabetes management and perceived health for Chinese American immigrants in the U.S. Acculturation experiences or cultural adaptation experiences affecting diabetes management and health were solicited from an informant group of immigrant patients and their spouses (N = 40) during group, couple and individual interviews conducted from 2005 to 2008. A separate respondent group of immigrant patients and their spouses (N = 19) meeting inclusion criteria reviewed and confirmed themes generated by the informant group. Using interpretive phenomenology, three key themes in patients' and spouses' acculturation experiences were identified: a) utilizing health care, b) maintaining family relations and roles, and c) establishing community ties and groundedness in the U.S. Acculturation experiences reflecting these themes were broad in scope and not fully captured by current self-report and proxy acculturation measures. In the current study, shifting family roles and evaluations of diabetes care and physical environment in the U.S. significantly affected diabetes management and health, yet are overlooked in acculturation and health investigations. Furthermore, the salience and impact of specific acculturation experiences respective to diabetes management and perceived health varied across participants due to individual, family, developmental, and environmental factors. In regards to salience, maintaining filial and interdependent family relations in the U.S. was of particular concern for older participants and coping with inadequate health insurance in the U.S. was especially distressing for self-described lower-middle to middle-class participants. In terms of impact, family separation and relocating to ethnically similar neighborhoods in the U.S. differentially affected diabetes management and health due to participants' varied family relations and pre-migration family support levels and diverse cultural and linguistic backgrounds, respectively. Implications for expanding current conceptualizations and measures of acculturation to better comprehend its dynamic and multidimensional properties and complex effects on health are discussed. Additionally, implications for developing culturally-appropriate diabetes management recommendations for Chinese immigrants and their families are outlined. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Chun, Kevin M.] Univ San Francisco, Dept Psychol, San Francisco, CA 94117 USA.
   [Chesla, Catherine A.; Kwan, Christine M. L.] Univ Calif San Francisco, Dept Family Hlth Care Nursing, San Francisco, CA 94143 USA.
RP Chun, KM (reprint author), Univ San Francisco, Dept Psychol, 2130 Fulton St, San Francisco, CA 94117 USA.
EM chunk@usfca.edu
FU National Institute of Nursing [R01-NR009111]
FX This work was supported by the National Institute of Nursing Research
   Grant R01-NR009111 (Principal Investigator: Catherine A. Chesla). We
   thank the following organizations and individuals: the California
   Pacific Medical Center; the Chinese Community Health Resource Center;
   Donaldina Cameron House; North East Medical Services; University of
   California San Francisco (UCSF) Diabetes Teaching Center; UCSF Lakeshore
   Family Practice; Peggy Huang; Kenneth Chang; Y.H. Cheng: Eunice Lew;
   Phiona Tan; Barbara Jung, and Ivan Wu.
CR Abate N, 2003, J DIABETES COMPLICAT, V17, P39, DOI 10.1016/S1056-8727(02)00190-3
   Abe-Kim J, 2001, Cultur Divers Ethnic Minor Psychol, V7, P232, DOI 10.1037/1099-9809.7.3.232
   Benner P, 1994, INTERPRETATIVE PHENO
   Candib LM, 2007, ANN FAM MED, V5, P547, DOI 10.1370/afm.754
   Chesla CA, 2005, QUAL HEALTH RES, V15, P240, DOI 10.1177/1049732304272050
   Chesla CA, 2009, DIABETES CARE, V32, P1812, DOI 10.2337/dc09-0278
   Chun K. M., 2007, HDB ASIAN AM PSYCHOL, P47
   Chun K. M., 2009, HDB MENTAL HLTH ACCU, P99
   Chun KM, 2004, PSYCHOL HEALTH, V19, P767, DOI 10.1080/08870440410001722958
   Chun KM, 2003, ACCULTURATION ADV TH
   CHUN KM, 2006, ACCULTURATION PARENT, P63
   Cohen MZ, 2000, HERMENEUTIC PHENOMEN
   Fisher L, 2004, J FAM PSYCHOL, V18, P302, DOI 10.1037/0893-3200.18.2.302
   Gomez SL, 2004, AM J PUBLIC HEALTH, V94, P1977, DOI 10.2105/AJPH.94.11.1977
   Green AR, 2005, J GEN INTERN MED, V20, P1050, DOI 10.1111/j.1525-1497.2005.0223.x
   Hosler AS, 2003, AM J PUBLIC HEALTH, V93, P1279, DOI 10.2105/AJPH.93.8.1279
   Huang BJ, 1996, AM J EPIDEMIOL, V144, P674
   Jayne RL, 2001, J NURS SCHOLARSHIP, V33, P53, DOI 10.1111/j.1547-5069.2001.00053.x
   Kandula NR, 2008, DIABETES CARE, V31, P1621, DOI 10.2337/dc07-2182
   LU N, 2004, J AM DIET ASSOC, V104, P771
   Marin G., 2003, HDB RACIAL ETHNIC MI, P208
   McDonald JT, 2005, SOC SCI MED, V61, P2469, DOI 10.1016/j.socscimed.2005.05.004
   McNeely MJ, 2004, DIABETES CARE, V27, P66, DOI 10.2337/diacare.27.1.66
   Miltiades HB, 2008, SOC SCI MED, V66, P704, DOI 10.1016/j.socscimed.2007.10.016
   Myers H. F., 2003, ACCULTURATION ADV TH, P163, DOI DOI 10.1037/10472-011
   Ngo-Metzger Q, 2003, J GEN INTERN MED, V18, P44, DOI 10.1046/j.1525-1497.2003.20205.x
   PEREZESCAMILLA IT, 2007, J NUTR, V137, P860
   Salant T, 2003, SOC SCI MED, V57, P71, DOI 10.1016/S0277-9536(02)00300-3
   Satia JA, 2001, J AM DIET ASSOC, V101, P548, DOI 10.1016/S0002-8223(01)00137-7
   Shinagawa LH, 2008, PORTRAIT CHINESE AM
   Sue S., 2003, ACCULTURATION ADV TH, pxvii
   SUINN RM, 1992, EDUC PSYCHOL MEAS, V52, P1041, DOI 10.1177/0013164492052004028
   Trimble J. E., 2003, ACCULTURATION ADV TH
   Unger JB, 2004, J COMMUN HEALTH, V29, P467, DOI 10.1007/s10900-004-3395-3
   Ying YW, 1995, AM J COMMUN PSYCHOL, V23, P893, DOI 10.1007/BF02507020
   ZANE N, 2003, ACCULTURATION ADV TH, P39, DOI DOI 10.1037/10472-005
NR 36
TC 34
Z9 34
U1 0
U2 18
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0277-9536
J9 SOC SCI MED
JI Soc. Sci. Med.
PD JAN
PY 2011
VL 72
IS 2
BP 256
EP 264
DI 10.1016/j.socscimed.2010.11.010
PG 9
WC Public, Environmental & Occupational Health; Social Sciences, Biomedical
SC Public, Environmental & Occupational Health; Biomedical Social Sciences
GA 755EZ
UT WOS:000289911300018
PM 21147509
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Osborn, CY
   Mayberry, LS
   Mulvaney, SA
   Hess, R
AF Osborn, Chandra Y.
   Mayberry, Lindsay Satterwhite
   Mulvaney, Shelagh A.
   Hess, Rachel
TI Patient Web Portals to Improve Diabetes Outcomes: A Systematic Review
SO CURRENT DIABETES REPORTS
LA English
DT Review
DE Patient web portal; Systematic review; Diabetes; Evaluation; Usability;
   Electronic health record; Personal health record; Glycemic control;
   Satisfaction; Type 1; Type 2; Providers; Caregivers; Self-care;
   Behaviors; Quality of life; Diabetes distress; Management; Communication
ID RANDOMIZED CONTROLLED-TRIAL; ELECTRONIC HEALTH RECORDS;
   DECISION-SUPPORT; SELF-MANAGEMENT; CARE; INTERVENTION; IMPLEMENTATION;
   INFORMATION; TECHNOLOGY; PHYSICIANS
AB Patient web portals (PWPs), defined as the integration of electronic medical records and patient health records, have been related to enhanced patient outcomes. A literature review was conducted to characterize the design and evaluation of PWPs to improve health care processes and outcomes in diabetes. A summary of 26 articles revealed the positive impact PWPs have on patient outcomes, patient-provider communication, disease management, and access to and patient satisfaction with health care. Innovative and useful approaches included the evaluation of specific components of the PWPs, assessing the impact of PWPs on mediators of health behaviors, such as patient distress, identification of barriers to use, and patient willingness to pay for access. Future research should focus on relevant processes that mediate patient and provider use, impact on health care utilization, and a patient-centered approach to the design and integration of educational opportunities afforded through PWPs.
C1 [Osborn, Chandra Y.] Vanderbilt Univ, Med Ctr, Div Gen Internal Med & Publ Hlth, Ctr Hlth Serv Res, Nashville, TN 37232 USA.
   [Mayberry, Lindsay Satterwhite] Vanderbilt Univ, Peabody Coll, Nashville, TN 37232 USA.
   [Mulvaney, Shelagh A.] Vanderbilt Univ, Sch Nursing, Med Ctr, Nashville, TN 37232 USA.
   [Hess, Rachel] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA.
   [Hess, Rachel] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA.
RP Osborn, CY (reprint author), Vanderbilt Univ, Med Ctr, Div Gen Internal Med & Publ Hlth, Ctr Hlth Serv Res, 1215 21st Ave S,Suite 6000,MCE N Tower, Nashville, TN 37232 USA.
EM chandra.osborn@vanderbilt.edu
OI Osborn, Chandra/0000-0002-7668-028X
FU NIDDK [P60 DK020593, DK 070026]; AHRQ [R18 HS018168]; Department of
   Defense
FX Dr. Chandra Y. Osborn is supported by a Diversity Supplement Award
   (NIDDK P60 DK020593). Dr. Shelagh A. Mulvaney is supported by NIDDK P60
   DK020593, DK 070026, and AHRQ R18 HS018168. Dr. Rachel Hess is supported
   by a grant from the Department of Defense for development, evaluation,
   and adaptation of a PWP.
CR Beaudoin Denise E, 2005, AMIA Annu Symp Proc, P892
   Bellazzi Riccardo, 2004, Diabetes Technol Ther, V6, P567, DOI 10.1089/dia.2004.6.567
   Britto MT, 2009, J AM MED INFORM ASSN, V16, P660, DOI 10.1197/jamia.M3154
   Bryce CL, 2008, TELEMED J E-HEALTH, V14, P1035, DOI 10.1089/tmj.2008.0005
   Burrington-Brown Jill, 2005, J AHIMA, V76, P24
   Businger Alexandra, 2007, AMIA Annu Symp Proc, P887
   Crosson JC, 2007, ANN FAM MED, V5, P209, DOI 10.1370/afm.696
   DesRoches CM, 2008, NEW ENGL J MED, V359, P50, DOI 10.1056/NEJMsa0802005
   Detmer D, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-45
   Dorr D, 2007, J AM MED INFORM ASSN, V14, P156, DOI 10.1197/jamia.M2255
   *EXP COMM DIAGN CL, 2002, DIABETES CARE S1, V25, pS1
   Faridi Z, 2008, J EVAL CLIN PRACT, V14, P465, DOI 10.1111/j.1365-2753.2007.00881.x
   Fonda SJ, 2008, DIABETES TECHNOL THE, V10, P16, DOI 10.1089/dia.2007.0252
   Fonda Stephanie J, 2009, J Diabetes Sci Technol, V3, P117
   Hess R, 2007, TELEMED J E-HEALTH, V13, P509, DOI 10.1089/tmj.2006.0089
   Holbrook A, 2009, CAN MED ASSOC J, V181, P37, DOI 10.1503/cmaj.081272
   Hsu J, 2005, J AM MED INFORM ASSN, V12, P164, DOI 10.1197/jamia.M1672
   Institute of Medicine, 2001, CROSS QUAL CHASM NEW
   Jha AK, 2009, NEW ENGL J MED, V360, P1628, DOI 10.1056/NEJMsa0900592
   Kaufman DR, 2006, HOME HLTH CARE MAN P, V18, P223, DOI 10.1177/1084822305281949
   Kim EH, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1256
   Kim HS, 2006, J NURS CARE QUAL, V21, P266, DOI 10.1097/00001786-200607000-00012
   Kittler Anne F, 2004, Inform Prim Care, V12, P129
   Knecht LAD, 2006, J HOSP MED, V1, P151, DOI 10.1002/jhm.94
   Kobb R, 2003, TELEMED J E-HEALTH, V9, P189, DOI 10.1089/153056203766437525
   Kollmann A, 2007, J MED INTERNET RES, V9, DOI 10.2196/jmir.9.5.e36
   Koonce TY, 2007, J MED LIBR ASSOC, V95, P77
   Krishna Santosh, 2008, J Diabetes Sci Technol, V2, P509
   Kushniruk AW, 2009, STUD HEALTH TECHNOL, V150, P883, DOI 10.3233/978-1-60750-044-5-883
   Leveille SG, 2008, J GEN INTERN MED, V23, P472, DOI 10.1007/s11606-007-0443-6
   Lin CT, 2005, J MED INTERNET RES, V7, P13, DOI 10.2196/jmir.7.4.e47
   Lobach David F, 2006, AMIA Annu Symp Proc, P509
   Ma CL, 2006, INT J MED INFORM, V75, P577, DOI 10.1016/j.ijmedinf.2005.09.001
   McMahon GT, 2005, DIABETES CARE, V28, P1624, DOI 10.2337/diacare.28.7.1624
   Noel HC, 2004, TELEMED J E-HEALTH, V10, P170, DOI 10.1089/1530562041641291
   NORDFELDT S, J MED INTERNET RES, V12, pE17
   Nordqvist C, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1152
   Olshansky E, 2008, DIABETES EDUCATOR, V34, P1004, DOI 10.1177/0145721708327304
   Quinn CC, 2008, DIABETES TECHNOL THE, V10, P160, DOI 10.1089/dia.2008.0283
   Quinn CC, 2009, CONTEMP CLIN TRIALS, V30, P334, DOI 10.1016/j.cct.2009.02.004
   Ralston James D, 2006, AMIA Annu Symp Proc, P1070
   Ralston JD, 2009, J GEN INTERN MED, V24, P349, DOI 10.1007/s11606-008-0899-z
   Ross Stephen E, 2007, AMIA Annu Symp Proc, P1097
   Ross Stephen E, 2006, AMIA Annu Symp Proc, P1080
   Smith Karen E, 2004, Diabetes Technol Ther, V6, P828, DOI 10.1089/dia.2004.6.828
   STEAD WW, 2009, COMPUTATIONAL TECHNO
   Stratton IM, 2000, BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405
   Tang Chien Hui, 2003, AMIA Annu Symp Proc, P1026
   Tang PC, 2006, J AM MED INFORM ASSN, V13, P121, DOI 10.1197/jamia.M2025
   Varonen H, 2008, FAM PRACT, V25, P162, DOI 10.1093/fampra/cmn020
   VERHOEVEN F, J DIABETES SCI TECHN, V4, P666
   WALD JS, 2009, AMIA ANN S P, P678
   Weingart SN, 2006, J AM MED INFORM ASSN, V13, P91, DOI 10.1197/jamia.M1833
   Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047
   Yach D, 2006, NAT MED, V12, P62, DOI 10.1038/nm0106-62
   Zickmund SL, 2008, J GEN INTERN MED, V23, P20, DOI 10.1007/s11606-007-0273-6
NR 56
TC 75
Z9 75
U1 2
U2 35
PU CURRENT MEDICINE GROUP
PI PHILADELPHIA
PA 400 MARKET STREET, STE 700, PHILADELPHIA, PA 19106 USA
SN 1534-4827
J9 CURR DIABETES REP
JI Curr. Diabetes Rep.
PD DEC
PY 2010
VL 10
IS 6
BP 422
EP 435
DI 10.1007/s11892-010-0151-1
PG 14
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 736LC
UT WOS:000288495200004
PM 20890688
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Mitanchez, D
AF Mitanchez, D.
TI Foetal and neonatal complications in gestational diabetes: perinatal
   mortality, congenital malformations, macrosomia, shoulder dystocia,
   birth injuries, neonatal complications
SO DIABETES & METABOLISM
LA English
DT Article
DE malformations; macrosomia; excessive foetal growth; hypoglycaemia;
   perinatal asphyxia; birth injuries; gestational diabetes mellitus;
   complications; review
ID ADVERSE PREGNANCY OUTCOMES; METABOLIC-CONTROL; GLUCOSE-LEVELS; PLASMA
   ERYTHROPOIETIN; CESAREAN DELIVERY; MOTHERS; INFANTS; MELLITUS; INSULIN;
   WEIGHT
AB Objective : To evaluate the risks of perinatal complications in infants born to mothers with treated or untreated gestational diabetes mellitus (GDM).
   Methods :A search of the PubMed database was performed and recommendations from NICE and the French National Authority for Health were consulted.
   Results : Untreated moderate or severe GDM increases the risk of foetal and neonatal complications (EL1). The risk of malformations slightly increases in newborns of mothers with GDM compared to the general population (EL2). This risk is probably associated with the presence of undiagnosed type 2 diabetes among patients with GDM (EL2). There is a linear relationship between maternal blood glucose levels and an increased birth weight (EL2). Treatment for GDM reduces the incidence of macrosomia (EL1). Although the risk of cardiomyopathy in cases of GDM cannot be accurately estimated based on the available data, severe clinical forms are rare. The risks of neonatal asphyxia and perinatal mortality are no higher in infants born to women with GDM (EL2). Birth injuries and brachial plexus injuries are rare, and no more likely to occur in cases of untreated GDM: It is difficult to assess the risk of respiratory distress, regardless of its cause. It is not possible to establish a link between GDM and neonatal respiratory problems due to insufficient data. Although the risk of neonatal hypoglycaemia is difficult to determine due to the variable definitions reported in the literature, the incidence of hypoglycaemia requiring intravenous therapy is low (EL1). The risks of hypocalcaemia (EL4) and hyperbilirubinemia (EL1) are similar to the general population.
   Conclusion : Serious perinatal complications specifically associated with GDM are rare. Macrosomia has been demonstrated to be the predominant adverse outcome in cases of GDM. It is the main factor linked to reported cases of complications in GDM. Maternal obesity is an additional risk factor for complications, regardless of diabetes status. (C) 2010 Elsevier Masson SAS. All rights reserved.
C1 Univ Paris 06, Hop Armand Trousseau, AP HP, Fac Med,Serv Neonatol, F-75571 Paris 12, France.
RP Mitanchez, D (reprint author), Univ Paris 06, Hop Armand Trousseau, AP HP, Fac Med,Serv Neonatol, F-75571 Paris 12, France.
EM delphine.mitanchez@trs.aphp.fr
CR Aberg A, 2001, EARLY HUM DEV, V61, P85, DOI 10.1016/S0378-3782(00)00125-0
   Allen VM, 2007, J OBSTET GYNAECOL CA, V29, P927, DOI 10.1016/S1701-2163(16)32653-6
   Balsells M, 2000, DIABETES NUTR METAB, V13, P257
   Cheng YW, 2008, OBSTET GYNECOL, V112, P1015, DOI 10.1097/AOG.0b013e31818b5dd9
   Chu SY, 2007, AM J OBSTET GYNECOL, V197, P223, DOI 10.1016/j.ajog.2007.03.027
   Cnattingius S, 1998, NEW ENGL J MED, V338, P147, DOI 10.1056/NEJM199801153380302
   Cordero L, 1998, ARCH PEDIAT ADOL MED, V152, P249
   Correa A, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.028
   Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973
   Cundy T, 2000, DIABETIC MED, V17, P33, DOI 10.1046/j.1464-5491.2000.00215.x
   Das S, 2009, ARCH DIS CHILD-FETAL, V94, pF419, DOI 10.1136/adc.2008.156026
   Daskalakis G, 2008, ACTA OBSTET GYN SCAN, V87, P403, DOI 10.1080/00016340801908783
   De Luca R, 2009, PEDIATRICS, V123, pE1064, DOI 10.1542/peds.2008-2407
   DEMARINI S, 1994, OBSTET GYNECOL, V83, P918, DOI 10.1097/00006250-199406000-00003
   Dudley DJ, 2007, OBSTET GYN CLIN N AM, V34, P293, DOI 10.1016/j.ogc.2007.03.001
   Ehrenberg HM, 2004, AM J OBSTET GYNECOL, V191, P964, DOI 10.1016/j.ajog.2004.05.052
   Esakoff TF, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.02.035
   Garcia-Patterson A, 2004, DIABETOLOGIA, V47, P509, DOI 10.1007/s00125-004-1337-3
   Gherman RB, 2006, AM J OBSTET GYNECOL, V195, P657, DOI 10.1016/j.ajog.2005.09.007
   Hedderson MM, 2003, OBSTET GYNECOL, V102, P850, DOI 10.1016/S0029-7844(03)00661-6
   Hollander MH, 2007, OBSTET GYNECOL SURV, V62, P125, DOI 10.1097/01.ogx.0000253303.92229.59
   Horvath K, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1395
   Ilves P, 2000, ACTA PAEDIATR, V89, P680, DOI 10.1080/080352500750043990
   Janssen PA, 1996, PAEDIATR PERINAT EP, V10, P52, DOI 10.1111/j.1365-3016.1996.tb00026.x
   Jolly MC, 2003, EUR J OBSTET GYN R B, V111, P9, DOI 10.1016/S0301-2115(03)00154-4
   Landon MB, 2009, NEW ENGL J MED, V361, P1339, DOI 10.1056/NEJMoa0902430
   Langer O, 2005, AM J OBSTET GYNECOL, V192, P989, DOI 10.1016/j.ajog.2004.11.039
   Langer O, 2000, CLIN OBSTET GYNECOL, V43, P283, DOI 10.1097/00003081-200006000-00006
   Metzger BE, 2010, BJOG-INT J OBSTET GY, V117, P575, DOI 10.1111/j.1471-0528.2009.02486.x
   Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943
   Metzger BE, 2009, DIABETES, V58, P453, DOI 10.2337/db08-1112
   MILLEY JR, 1984, AM J OBSTET GYNECOL, V149, P673, DOI 10.1016/0002-9378(84)90257-6
   MIMOUNI F, 1990, AM J PERINAT, V7, P203, DOI 10.1055/s-2007-999481
   MIMOUNI F, 1988, J PEDIATR-US, V113, P345, DOI 10.1016/S0022-3476(88)80282-8
   Moore TR, 2002, AM J OBSTET GYNECOL, V186, P641, DOI 10.1067/mob.2002.122851
   National Collaborating Centre for Women's and Children's Health,, 2008, DIAB PREGN MAN DIAB
   Naylor CD, 1996, JAMA-J AM MED ASSOC, V275, P1165, DOI 10.1001/jama.275.15.1165
   Oberhoffer R, 1997, EUR J PEDIATR, V156, P262, DOI 10.1007/s004310050596
   Ong KK, 2008, DIABETES CARE, V31, P2193, DOI 10.2337/dc08-1111
   Ostlund I, 2003, DIABETES CARE, V26, P2107, DOI 10.2337/diacare.26.7.2107
   OSULLIVA.JB, 1973, AM J OBSTET GYNECOL, V116, P901
   OSULLIVAN JB, 1966, OBSTET GYNECOL, V27, P683
   OSULLIVAN JB, 1966, DIABETES, V15, P466, DOI 10.2337/diab.15.7.466
   PEDERSEN J, 1954, ACTA ENDOCRINOL-COP, V16, P330, DOI 10.1530/acta.0.0160330
   Piper J M, 1998, J Matern Fetal Med, V7, P148, DOI 10.1002/(SICI)1520-6661(199805/06)7:3<148::AID-MFM9>3.0.CO;2-K
   Raatikainen K, 2006, OBESITY, V14, P165, DOI 10.1038/oby.2006.20
   Russell NE, 2008, PEDIATR DEVEL PATHOL, V11, P10, DOI 10.2350/07-05-0277.1
   SALVESEN DR, 1993, AM J OBSTET GYNECOL, V168, P88, DOI 10.1016/S0002-9378(12)90891-1
   Sarkar S, 2008, SEMIN FETAL NEONAT M, V13, P248, DOI 10.1016/j.siny.2008.02.003
   Schaefer-Graf UM, 2000, AM J OBSTET GYNECOL, V182, P313, DOI 10.1016/S0002-9378(00)70217-1
   Schwartz R, 2000, SEMIN PERINATOL, V24, P120, DOI 10.1053/sp.2000.6363
   Sheffield JS, 2002, OBSTET GYNECOL, V100, P925, DOI 10.1016/S0029-7844(02)02242-1
   Silver RM, 2007, AM J OBSTET GYNECOL, V196, P433, DOI 10.1016/j.ajog.2006.11.041
   SOSENKO IR, 1979, NEW ENGL J MED, V301, P859, DOI 10.1056/NEJM197910183011603
   Taricco E, 2009, BJOG-INT J OBSTET GY, V116, P1729, DOI 10.1111/j.1471-0528.2009.02341.x
   TERAMO K, 1983, OBSTET GYNECOL, V61, P559
   TERAMO KA, 1987, OBSTET GYNECOL, V69, P710
   Ullmo S, 2007, EUR HEART J, V28, P1319, DOI 10.1093/eurheartj/ehl416
   VEILLE JC, 1992, OBSTET GYNECOL, V79, P51
   WIDNESS JA, 1981, J CLIN INVEST, V67, P637, DOI 10.1172/JCI110078
   WIDNESS JA, 1990, DIABETOLOGIA, V33, P378, DOI 10.1007/BF00404643
   Yogev Yariv, 2007, Archives of Gynecology and Obstetrics, V276, P361, DOI 10.1007/s00404-007-0359-8
   Zhang J, 2008, AM J OBSTET GYNECOL, V199, pS51, DOI 10.1016/j.ajog.2008.09.161
NR 63
TC 57
Z9 60
U1 1
U2 19
PU MASSON EDITEUR
PI MOULINEAUX CEDEX 9
PA 21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE
SN 1262-3636
EI 1878-1780
J9 DIABETES METAB
JI Diabetes Metab.
PD DEC
PY 2010
VL 36
IS 6
BP 617
EP 627
DI 10.1016/j.diabet.2010.11.013
PN 2
PG 11
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 704IK
UT WOS:000286044600011
PM 21163425
DA 2019-01-08
ER

PT J
AU Thiebaugeorges, O
   Guyard-Boileau, B
AF Thiebaugeorges, O.
   Guyard-Boileau, B.
TI Obstetrical care in gestational diabetes and management of preterm
   labour
SO DIABETES & METABOLISM
LA English
DT Article
DE gestational diabetes; obstetrical monitoring; ultrasound; threat of
   preterm labour; corticosteroids; asymmetric septal hypertrophy; review
ID ARTERY DOPPLER VELOCIMETRY; UMBILICAL ARTERY; FETAL WEIGHT; HIGH-RISK;
   17-ALPHA-HYDROXYPROGESTERONE CAPROATE; ULTRASOUND ESTIMATION;
   RESPIRATORY-DISTRESS; METABOLIC THERAPY; MACROSOMIC FETUS;
   RANDOMIZED-TRIAL
AB Aim : To investigate data enabling the development of guidelines for obstetrical monitoring and management of the threat of preterm labour in gestational diabetes.
   Methodology : Systematic literature review.
   Results : With gestational diabetes and the absence of other disorders or associated risk factors, there is no argument justifying a systematic clinical monitoring schedule different from other pregnancies. The relevance of ultrasound weight estimations is limited. No formula has emerged as being superior to the others or to the simple measurement of abdominal circumference for the prediction of macrosomia (EL3). The usefulness of testing for asymmetric septal hypertrophy has not been demonstrated (EL4). The routine performance of umbilical artery Doppler has no demonstrated utility in the absence of growth restriction or associated hypertension (EL4). Monthly ultrasound monitoring can be proposed for poorly-controlled diabetes or that requiring insulin. With gestational diabetes that is well-controlled with diet, foetal heart rate recording has no demonstrated use. The recording is debateable for poorly-controlled diabetes or that requiring insulin, while taking associated risk factors into consideration. Weekly recording of the foetal heart rate is often advised for type 2 diabetes diagnosed during pregnancy.
   If there is a threat of preterm labour, calcium channel blockers and oxytocin receptor antagonists may be used without special precautions. The risk-benefit ratio does not appear favourable for the beta(2)-adrenergic agonists. Lung maturation with corticosteroids may be done in parallel with glycaemic testing and insulin therapy if necessary. Diabetic screening tests should be done several days after the last injection of corticosteroid. (C) 2010 Elsevier Masson SAS. All rights reserved.
C1 [Thiebaugeorges, O.] Maternite Reg Univ Nancy, Serv Obstet, F-54000 Nancy, France.
   [Guyard-Boileau, B.] Hop Paule de Viguier, Serv Obstet, TSA 70034, F-31059 Toulouse 9, France.
RP Thiebaugeorges, O (reprint author), Maternite Reg Univ Nancy, Serv Obstet, 10 Rue Dr Heydenreich, F-54000 Nancy, France.
EM o.thiebaugeorges@maternite.chu-nancy.fr;
   guyard-boileau.b@chu-toulouse.fr
CR Allen VM, 2007, J OBSTET GYNAECOL CA, V29, P927, DOI 10.1016/S1701-2163(16)32653-6
   [Anonymous], 2001, OBSTET GYNECOL, V98, P525
   [Anonymous], 2005, RAPP COM NAT TECHN E
   BALLARD PL, 1975, J CLIN INVEST, V56, P1548, DOI 10.1172/JCI108236
   BENACERRAF BR, 1988, AM J OBSTET GYNECOL, V159, P1118, DOI 10.1016/0002-9378(88)90425-5
   BENAMI M, 1995, AM J PERINAT, V12, P437, DOI 10.1055/s-2007-994515
   BOCHNER CJ, 1987, AM J OBSTET GYNECOL, V157, P703, DOI 10.1016/S0002-9378(87)80033-9
   Bonomo M, 2004, DIABETES METAB, V30, P237, DOI 10.1016/S1262-3636(07)70114-3
   Bracero LA, 1996, J ULTRAS MED, V15, P301
   BUCHANAN TA, 1994, DIABETES CARE, V17, P275, DOI 10.2337/diacare.17.4.275
   Chauhan SP, 1998, OBSTET GYNECOL, V91, P72, DOI 10.1016/S0029-7844(97)00590-5
   Chauhan SP, 2000, OBSTET GYNECOL, V95, P639, DOI 10.1016/S0029-7844(99)00606-7
   Colman Atalie, 2006, N Z Med J, V119, pU2146
   Combs C A, 2000, J Matern Fetal Med, V9, P55, DOI 10.3109/14767050009020514
   Conway DL, 2007, DIABETES CARE, V30, pS175, DOI [10.2337/dc07-s212, 10.2337/dcN/-s212]
   Coomarasamy A, 2005, BJOG-INT J OBSTET GY, V112, P1461, DOI 10.1111/j.1471-0528.2005.00702.x
   COOPER MJ, 1992, AM J DIS CHILD, V146, P226, DOI 10.1001/archpedi.1992.02160140092027
   Dudley DJ, 2007, OBSTET GYN CLIN N AM, V34, P293, DOI 10.1016/j.ogc.2007.03.001
   Dudley NJ, 2005, ULTRASOUND OBST GYN, V25, P80, DOI 10.1002/uog.1751
   Engstrom J L, 1992, J Obstet Gynecol Neonatal Nurs, V21, P486, DOI 10.1111/j.1552-6909.1992.tb01769.x
   FIELD NT, 1995, OBSTET GYNECOL, V86, P102, DOI 10.1016/0029-7844(95)00096-A
   Fisher JE, 1997, OBSTET GYNECOL, V90, P880, DOI 10.1016/S0029-7844(97)00544-9
   Gmehlin U, 1994, Zentralbl Gynakol, V116, P706
   Guideline Development Group, 2008, BMJ-BRIT MED J, V336, P714, DOI 10.1136/bmj.39505.641273.AD
   GUTGESELL HP, 1976, J PEDIATR-US, V89, P120, DOI 10.1016/S0022-3476(76)80945-6
   Gyamfi C, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.036
   HADLOCK FP, 1985, AM J OBSTET GYNECOL, V151, P333, DOI 10.1016/0002-9378(85)90298-4
   HADLOCK FP, 1985, RADIOLOGY, V154, P503, DOI 10.1148/radiology.154.2.3880915
   Haute Autorite de Sante ( HAS), 2007, SUIV OR FEMM ENC FON
   JOHNSTONE FD, 1992, BRIT J OBSTET GYNAEC, V99, P135, DOI 10.1111/j.1471-0528.1992.tb14472.x
   Kaushal K, 2003, DIABETIC MED, V20, P73, DOI 10.1046/j.1464-5491.2003.00853.x
   Kehl R J, 1996, J Matern Fetal Med, V5, P273
   Kernaghan D, 2007, EUR J OBSTET GYN R B, V132, P189, DOI 10.1016/j.ejogrb.2006.07.012
   Kjos SL, 2007, DIABETES CARE, V30, pS200, DOI 10.2337/dc07-s216
   KJOS SL, 1995, AM J OBSTET GYNECOL, V173, P1532, DOI 10.1016/0002-9378(95)90645-2
   Kjos SL, 2001, DIABETES CARE, V24, P1904, DOI 10.2337/diacare.24.11.1904
   KOFINAS AD, 1991, AM J PERINAT, V8, P273, DOI 10.1055/s-2007-999395
   Leticee NS, 2007, C MED FOET CANN
   Leung WC, 2004, ULTRASOUND OBST GYN, V24, P534, DOI 10.1002/uog.1730
   Mathiesen ER, 2002, ACTA OBSTET GYN SCAN, V81, P835, DOI 10.1034/j.1600-0412.2002.810906.x
   Mehdizadeh A, 2000, AM J PERINAT, V17, P233, DOI 10.1055/s-2000-10003
   Metzger BE, 2007, DIABETES CARE, V30, pS251, DOI 10.2337/dc07-s225
   Mulholland C, 2007, J WOMENS HEALTH, V16, P790, DOI 10.1089/jwh.2007.CDC7
   NEILSON JP, 2000, COCHRANE DB SYST REV
   Rebarber A, 2007, DIABETES CARE, V30, P2277, DOI 10.2337/dc07-0564
   REECE EA, 1994, J ULTRAS MED, V13, P73, DOI 10.7863/jum.1994.13.2.73
   RIZZO G, 1992, ULTRASOUND OBST GYN, V2, P434, DOI 10.1046/j.1469-0705.1992.02060434.x
   ROSSI G, 2000, ACTA OBSTET GYN SCAN, V79, P649
   Sacks DA, 2007, CLIN OBSTET GYNECOL, V50, P980, DOI 10.1097/GRF.0b013e31815a6242
   SALVESEN KA, 1993, BRIT MED J, V307, P1064, DOI 10.1136/bmj.307.6911.1064-b
   Schaefer-Graf UM, 2004, DIABETES CARE, V27, P297, DOI 10.2337/diacare.27.2.297
   Schumacher A, 2006, Z Geburtshilfe Neonatol, V210, P184, DOI 10.1055/s-2006-951743
   Serlin DC, 2009, AM FAM PHYSICIAN, V80, P57
   Sherman DJ, 1998, OBSTET GYNECOL, V91, P212, DOI 10.1016/S0029-7844(97)00654-6
   Sotiriadis A, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006614.pub2
   Stutchfield P, 2005, BMJ-BRIT MED J, V331, P662, DOI 10.1136/bmj.38547.416493.06
   Turok DK, 2003, AM FAM PHYSICIAN, V68, P1767
   Vidaeff AC, 2003, OBSTET GYNECOL SURV, V58, P759, DOI 10.1097/01.OGX.0000093782.25261.AC
   Waters TP, 2009, OBSTET GYNECOL, V114, P45, DOI 10.1097/AOG.0b013e3181a9454b
   Westergaard HB, 2001, ULTRASOUND OBST GYN, V17, P466, DOI 10.1046/j.1469-0705.2001.00415.x
   WESTIN B, 1977, ACTA OBSTET GYN SCAN, V56, P273, DOI 10.3109/00016347709154978
   WIKSTROM I, 1993, GYNECOL OBSTET INVES, V35, P27, DOI 10.1159/000292658
   Williams KP, 2003, AM J OBSTET GYNECOL, V188, P1366, DOI 10.1067/mob.2003.305
   Wong SF, 2003, AUST NZ J OBSTET GYN, V43, P302, DOI 10.1046/j.0004-8666.2003.00094.x
   ZIMMERMANN P, 1992, EUR J OBSTET GYN R B, V47, P85, DOI 10.1016/0028-2243(92)90036-X
NR 65
TC 3
Z9 4
U1 0
U2 5
PU MASSON EDITEUR
PI MOULINEAUX CEDEX 9
PA 21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE
SN 1262-3636
EI 1878-1780
J9 DIABETES METAB
JI Diabetes Metab.
PD DEC
PY 2010
VL 36
IS 6
BP 672
EP 681
DI 10.1016/j.diabet.2010.11.017
PN 2
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 704IK
UT WOS:000286044600015
PM 21163429
DA 2019-01-08
ER

PT J
AU Yukawa, K
   Yamazaki, Y
   Yonekura, Y
   Togari, T
   Abbott, FK
   Homma, M
   Park, M
   Kagawa, Y
AF Yukawa, Keiko
   Yamazaki, Yoshihiko
   Yonekura, Yuki
   Togari, Taisuke
   Abbott, Fusae K.
   Homma, Mieko
   Park, Minjeong
   Kagawa, Yumi
TI Effectiveness of Chronic Disease Self-management Program in Japan:
   Preliminary report of a longitudinal study
SO NURSING & HEALTH SCIENCES
LA English
DT Article
DE chronic disease; diabetes; Japan; rheumatic disease; self-efficacy;
   self-management
ID RANDOMIZED CONTROLLED-TRIAL; EDUCATION-PROGRAMS; COST-EFFECTIVENESS;
   CHRONIC ILLNESS; HEALTH-STATUS; CARE; PEOPLE
AB This is the preliminary report of a study to evaluate the effectiveness of the Chronic Disease Self-management Program in Japan by comparing changes in health outcomes at the baseline and 3-month and 6-month follow-ups. The program is a patient-centered educational program for the self-management of chronic conditions. The study's participants were recruited from among the attendees of the program workshops. During the study period (August 2006 to May 2007), 18 workshops were held and 128 attendees agreed to participate in the study. The health outcomes that were measured included health status, self-management behaviors, utilization of health services, self-efficacy, satisfaction with daily living, and clinical indicators. These indicators were further analyzed by disease type: diabetes, rheumatic disease, and cardiovascular disease/dyslipidemia. The findings indicated statistically significant positive changes in health distress, coping with symptoms, stretching exercises, communication with the physician, and satisfaction with daily living. The positive changes were especially remarkable among the groups with diabetes and rheumatic disease. These findings suggest that the Chronic Disease Self-management Program can be effective for Japanese people with chronic conditions.
C1 [Yukawa, Keiko] Univ Tokyo, Grad Sch Med, Dept Hlth Sociol, Bunkyo Ku, Tokyo 1130033, Japan.
   [Togari, Taisuke] Yamaguchi Univ, Grad Sch Med, Dept Hyg, Div Syst Control Med, Ube, Yamaguchi 755, Japan.
   [Abbott, Fusae K.] Samuel Merritt Univ, Sch Nursing, Oakland, CA USA.
RP Yukawa, K (reprint author), Univ Tokyo, Grad Sch Med, Dept Hlth Sociol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.
EM tkykeiko-tky@umin.ac.jp
FU Japanese Ministry of Health, Education and Labor
FX This study was funded by Japanese Ministry of Health, Education and
   Labor research grants during the 2006 and 2007 fiscal years. The authors
   appreciate all the participants in this study and the workshop leaders,
   as well as everyone at the JCDSMA, the Stanford University Patient
   Education Research Center, California, USA, and the Department of Health
   Sociology at the University of Tokyo, Japan.
CR Bagiella E, 2000, PSYCHOPHYSIOLOGY, V37, P13, DOI 10.1017/S0048577200980648
   Barlow J, 2002, PATIENT EDUC COUNS, V48, P177, DOI 10.1016/S0738-3991(02)00032-0
   Bisschop MI, 2004, SOC SCI MED, V59, P721, DOI 10.1016/j.socscimed.2003.11.038
   DONGBO F, 2003, B WORLD HEALTH ORGAN, V81, P174
   Griffiths C, 2005, BRIT J GEN PRACT, V55, P831
   Griffiths C, 2007, BRIT MED J, V334, P1254, DOI 10.1136/bmj.39227.698785.47
   Higashi A, 1996, Nihon Shokakibyo Gakkai Zasshi, V93, P884
   Kennedy A, 2007, J EPIDEMIOL COMMUN H, V61, P254, DOI 10.1136/jech.2006.053538
   KONDO F, 2009, JPN J CLIN DIALYSIS, V25, P1513
   KONDO F, 2001, LIVING HLTH LIFE CHR
   KONDO F, 2005, CHRONIC DIS SELF MAN
   KUSUNAGA T, 2002, JPN J HLTH MED SOCIO, V14, P1
   Lorig K, 1996, OUTCOME MEASURES HLT
   Lorig K, 2008, DIABETES CARE, V31, P408, DOI 10.2337/dc07-1313
   Lorig KR, 1999, MED CARE, V37, P5, DOI 10.1097/00005650-199901000-00003
   Lorig KR, 2003, ANN BEHAV MED, V26, P1, DOI 10.1207/S15324796ABM2601_01
   Lorig KR, 2001, MED CARE, V39, P1217, DOI 10.1097/00005650-200111000-00008
   Mann RJ, 2006, CHARGING AHEAD: THE GROWTH AND REGULATION OF PAYMENT CARD MARKETS, P45, DOI 10.1017/CBO9780511754227.006
   MCGOWAN P, 2010, IMPLEMENTATION EVALU
   *MHLW, OV PAT SURV JAP
   *MHLW, OV NAT HLTH NUTR EX
   Newman S, 2004, LANCET, V364, P1523, DOI 10.1016/S0140-6736(04)17277-2
   Osborne RH, 2007, J RHEUMATOL, V34, P1112
   Reeves D, 2008, BRIT J GEN PRACT, V58, P198, DOI 10.3399/bjgp08X277320
   Richardson G, 2008, J EPIDEMIOL COMMUN H, V62, P361, DOI 10.1136/jech.2006.057430
   Siu AMH, 2007, PATIENT EDUC COUNS, V65, P42, DOI 10.1016/j.pec.2006.04.013
   *STANF PAT ED RES, 2010, ORG LIC OFF CHRON DI
   Wagner EH, 2001, HEALTH AFFAIR, V20, P64, DOI 10.1377/hlthaff.20.6.64
   Warsi A, 2004, ARCH INTERN MED, V164, P1641, DOI 10.1001/archinte.164.15.1641
   Williams TR, 2008, SEMIN RADIAT ONCOL, V18, P175, DOI 10.1016/j.semradonc.2008.01.005
NR 30
TC 10
Z9 11
U1 1
U2 8
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1441-0745
J9 NURS HEALTH SCI
JI Nurs. Health Sci.
PD DEC
PY 2010
VL 12
IS 4
BP 456
EP 463
DI 10.1111/j.1442-2018.2010.00559.x
PG 8
WC Nursing
SC Nursing
GA 703SI
UT WOS:000286001200012
PM 21210924
DA 2019-01-08
ER

PT J
AU Mommersteeg, PMC
   Kupper, N
   Denollet, J
AF Mommersteeg, Paula M. C.
   Kupper, Nina
   Denollet, Johan
TI Type D personality is associated with increased metabolic syndrome
   prevalence and an unhealthy lifestyle in a cross-sectional Dutch
   community sample
SO BMC PUBLIC HEALTH
LA English
DT Article
ID CHRONIC HEART-FAILURE; D SCALE DS14; CARDIOVASCULAR-DISEASE; NEGATIVE
   AFFECTIVITY; SOCIAL INHIBITION; CLINICAL-PRACTICE; PHYSICAL-ACTIVITY;
   YOUNG-ADULTS; RISK-FACTORS; DEPRESSION
AB Background: People with Type D-Distressed-personality have a general tendency towards increased negative affectivity (NA), while at the same time inhibiting these emotions in social situations (SI). Type D personality is associated with an increased risk of adverse outcomes in patients with cardiovascular disease. Whether Type D personality is a cardiovascular risk factor in healthy populations remains to be investigated. In the present study, the relations between Type D personality and classical cardiovascular risk factors, i.e. metabolic syndrome and lifestyle were investigated in a Dutch community sample.
   Methods: In a cross-sectional study 1592 participants were included, aged 20-80 years. Metabolic syndrome was defined by self-report, following the International Diabetes Federation-IDF-guidelines including an increased waist circumference, dyslipidemia, hypertension, and diabetes. In addition lifestyle factors smoking, alcohol use, exercise and dietary habits were examined. Metabolic syndrome prevalence was stratified by Type D personality (a high score on both NA and SI), lifestyle and confounders age, gender, having a partner, higher education level, cardiac history, family history of cardiovascular disease.
   Results: Metabolic syndrome was more prevalent in persons with a Type D personality (13% vs. 6%). Persons with Type D personality made poorer lifestyle choices, adhered less to the physical activity norm (OR = 1.5, 95% CI = 1.1-2.0, p = .02), had a less varied diet (OR = 0.50, 95% CI = 0.40-0.70, p < .0005), and were less likely to restrict their fat intake (OR = 0.70, 95% CI = 0.50-0.90, p = .01). Type D personality was related to a twofold increased risk of metabolic syndrome (OR = 2.2, 95% CI = 1.2-4.0, p = .011), independent of lifestyle factors and confounders.
   Conclusions: Type D personality is related to an increased prevalence of metabolic syndrome and unhealthy lifestyle, which suggests both behavioral and biological vulnerability for development of cardiovascular disorders
C1 [Mommersteeg, Paula M. C.; Kupper, Nina; Denollet, Johan] Tilburg Univ, Dept Med Psychol, CoRPS Ctr Res Psychol Somat Dis, Tilburg, Netherlands.
RP Mommersteeg, PMC (reprint author), Tilburg Univ, Dept Med Psychol, CoRPS Ctr Res Psychol Somat Dis, Tilburg, Netherlands.
EM P.M.C.Mommersteeg@uvt.nl
RI Kupper, Nina/B-6337-2011; Kupper, Nina/B-7045-2011
OI Kupper, Nina/0000-0001-8721-5239; 
FU Netherlands Organization for Scientific Research (NWO, The Hague, The
   Netherlands) [453-04-004]
FX We gratefully acknowledge our research assistants for their efforts in
   data collection and data entering. This research was partly funded by a
   VICI grant (#453-04-004) from the Netherlands Organization for
   Scientific Research (NWO, The Hague, The Netherlands) awarded to Dr.
   Johan Denollet. All authors declare that there is no conflict of
   interest.
CR Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009
   Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644
   Aquarius AE, 2009, ARCH SURG-CHICAGO, V144, P728, DOI 10.1001/archsurg.2009.75
   ARSENAULT BJ, 2009, INT J OBESITY
   Bigaard J, 2005, J NUTR, V135, P2263
   Bindraban NR, 2008, EUR J EPIDEMIOL, V23, P37, DOI 10.1007/s10654-007-9200-8
   BORKOLES E, 2009, BODY IMAGE
   Cho ER, 2009, ANN EPIDEMIOL, V19, P784, DOI 10.1016/j.annepidem.2009.06.010
   COHEN BE, 2009, PSYCHIAT RES
   Denollet J, 2005, PSYCHOSOM MED, V67, P89, DOI 10.1097/01.psy.0000149256.81953.49
   Deshmukh-Taskar PR, 2009, PUBLIC HEALTH NUTR, V12, P2493, DOI 10.1017/S1368980009991261
   Djousse L, 2009, JAMA-J AM MED ASSOC, V302, P394, DOI 10.1001/jama.2009.1062
   Doolan Daniel M, 2008, Prog Cardiovasc Nurs, V23, P119, DOI 10.1111/j.1751-7117.2008.00001.x
   Dunbar JA, 2008, DIABETES CARE, V31, P2368, DOI 10.2337/dc08-0175
   EINVIK G, 2010, EUROPEAN J CARDIOVAS
   FINUCANE FM, 2010, DIABETOLOGIA
   Fleming P, 2008, CAN FAM PHYSICIAN, V54, P1706
   Ford ES, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-35
   Goldbacher EM, 2007, ANN BEHAV MED, V34, P240, DOI 10.1007/BF02874549
   Graham I, 2007, EUR J CARDIOV PREV R, V14, pE1, DOI 10.1097/01.hjr.0000277984.31558.c4
   Grande G, 2004, PSYCHOTHER PSYCH MED, V54, P413, DOI 10.1088/s-2004-828376
   Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882
   Hausteiner C, 2010, PSYCHOSOM MED, V72, P163, DOI 10.1097/PSY.0b013e3181cb8bae
   Herva A, 2006, PSYCHOSOM MED, V68, P213, DOI 10.1097/01.psy.0000203172.02305.ea
   Karlsson MR, 2007, J BEHAV MED, V30, P253, DOI 10.1007/s10865-007-9096-5
   Kemper HGC, 2000, TIJDSCHRIFT SOCIALE, V78, P180
   Kupper N, 2007, J PERS ASSESS, V89, P265, DOI 10.1080/00223890701629797
   Kupper N, 2007, PSYCHOSOM MED, V69, P675, DOI 10.1097/PSY.0b013e318149f4a7
   Lichtenstein AH, 2006, CIRCULATION, V114, P82, DOI 10.1161/CIRCULATIONAHA.106.176158
   Manolio T, 2003, NEW ENGL J MED, V349, P1587, DOI 10.1056/NEJMp038136
   Martens EJ, 2007, J PSYCHOSOM RES, V63, P545, DOI 10.1016/j.jpsychores.2007.06.005
   Molenaar EA, 2009, DIABETES CARE, V32, P505, DOI 10.2337/dc08-1382
   Molloy GJ, 2008, PSYCHOSOM MED, V70, P863, DOI 10.1097/PSY.0b013e3181842e0c
   Ocke MC, 1997, INT J EPIDEMIOL, V26, pS37, DOI 10.1093/ije/26.suppl_1.S37
   Pedersen SS, 2003, EUR J CARDIOV PREV R, V10, P241, DOI 10.1097/01.hjr.0000085246.65733.06
   Pedersen SS, 2007, EUR J CARDIOV PREV R, V14, P135, DOI 10.1097/HJR.0b013e328045c282
   Pedersen SS, 2006, CURR CARDIOL REV, V2, P205, DOI 10.2174/157340306778019441
   Pedersen SS, 2009, INT J BEHAV MED, V16, P108, DOI 10.1007/s12529-008-9022-4
   PELLE AJ, 2009, INT J CARDIOLOGY
   Pelle AJ, 2009, J AFFECT DISORDERS, V113, P150, DOI 10.1016/j.jad.2008.05.017
   SCHIFFER AA, 2009, INT J CARDIOLOGY
   Schiffer AA, 2008, EUR J HEART FAIL, V10, P802, DOI 10.1016/j.ejheart.2008.06.012
   Spencer EA, 2004, PUBLIC HEALTH NUTR, V7, P723, DOI 10.1079/PHN2004600
   Spindler H, 2009, INT J BEHAV MED, V16, P98, DOI 10.1007/s12529-009-9037-5
   Vaccarino V, 2008, PSYCHOSOM MED, V70, P40, DOI 10.1097/PSY.0b013e31815c1b85
   van Dam RM, 2003, AM J CLIN NUTR, V77, P1156
   van den Broek KC, 2009, J AM COLL CARDIOL, V54, P531, DOI 10.1016/j.jacc.2009.04.043
   VANDENDONK M, 2009, PREVENTIVE MED
   Vogelzangs N, 2009, AM J GERIAT PSYCHIAT, V17, P716, DOI 10.1097/JGP.0b013e3181aad5d7
   Wendel-Vos GCW, 2009, AM J PREV MED, V37, P50, DOI 10.1016/j.amepre.2009.03.015
   Williams L, 2008, J PSYCHOSOM RES, V64, P63, DOI 10.1016/j.jpsychores.2007.06.008
   Yu XN, 2008, J PSYCHOSOM RES, V65, P595, DOI 10.1016/j.jpsychores.2008.06.009
NR 52
TC 53
Z9 54
U1 2
U2 16
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD NOV 19
PY 2010
VL 10
AR 714
DI 10.1186/1471-2458-10-714
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 695EC
UT WOS:000285352400001
PM 21092104
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Hamer, M
   Stamatakis, E
   Kivimaki, M
   Kengne, AP
   Batty, GD
AF Hamer, Mark
   Stamatakis, Emmanuel
   Kivimaeki, Mika
   Kengne, Andre Pascal
   Batty, G. David
TI Psychological Distress, Glycated Hemoglobin, and Mortality in Adults
   With and Without Diabetes
SO PSYCHOSOMATIC MEDICINE
LA English
DT Article
DE epidemiology; mortality; glycated hemoglobin; psychological stress;
   diabetes
ID DEPRESSIVE SYMPTOMS; GLUCOSE-METABOLISM; GLYCEMIC CONTROL; MELLITUS;
   ASSOCIATION; HEALTH; COMORBIDITY; COHORT; HOORN
AB Objective: To examine associations between psychological distress, glucose metabolism, and death. There is limited information about the long-term prognosis of diabetic patients with psychological distress. Methods: In a representative cohort of 11,546 adults (6.2% with high-risk/undiagnosed diabetes and 4.8% with physician-diagnosed diabetes), we measured glycated hemoglobin A I C as an indicator of glucose metabolism and psychological distress with the 12-item General Health Questionnaire (GHQ-12). Results: During the mean follow-up of 4.7 years, there were 682 deaths (93 among diabetic, 88 in high-risk/undiagnosed diabetic [A I C >= 6.0% without physician-diagnosed diabetes], and 501 in nondiabetic participants). Psychological distress was apparent in 18.9%, 16.5%, and 13.4% of diabetic, high-risk/undiagnosed diabetic, and nondiabetic participants, respectively. In participants with diabetes, a unit increase in GHQ-12 score was associated with higher risk of death at follow-up (multivariate adjusted hazard ratio, 1.16; 95% confidence interval, 1.09-1.24). Levels of A1C were also higher in diabetic participants with distress (GHQ-12 score of >3) compared with those without (7.86% versus 7.40%; p = .008), although adjustment for A1C did alter the association between distress and mortality. In the whole sample, the coexistence of diabetes and distress was associated with an elevated risk of death, beyond that due to having either diabetes or distress alone (multivariate adjusted hazard ratio, 3.64; 95% confidence interval, 2.21-5.98). Conclusions: Psychological distress is an independent risk factor for death in diabetic patients, although impaired glucose metabolism did not explain the excess risk.
C1 [Hamer, Mark; Stamatakis, Emmanuel; Kivimaeki, Mika; Batty, G. David] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England.
   [Kengne, Andre Pascal] Univ Sydney, George Inst Int Hlth, Sydney, NSW 2006, Australia.
   [Batty, G. David] MRC, Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland.
   [Batty, G. David] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland.
RP Hamer, M (reprint author), UCL, Dept Epidemiol & Publ Hlth, 1-19 Torrington Pl, London WC1E 6BT, England.
EM m.hamer@ucl.ac.uk
RI Stamatakis, Emmanuel/C-4958-2009; Batty, George/Y-4401-2018; Kivimaki,
   Mika/B-3607-2012; Hamer, Mark/C-1602-2008
OI Stamatakis, Emmanuel/0000-0001-7323-3225; Hamer,
   Mark/0000-0002-8726-7992; Kivimaki, Mika/0000-0002-4699-5627
FU Scottish Executive; British Heart Foundation [RG 05/006]; Wellcome
   Trust; National Heart, Lung, and Blood Institute [R01 HL036310];
   National Institute on Aging, National Institutes of Health [R01
   AG034454]; Bupa Foundation; Academy of Finland; U.K. MRC; Chief
   Scientist Office at the Scottish Government Health Directorates; Medical
   Research Council [MC_U130059821]
FX The Scottish Health Survey is funded, in part, by the Scottish
   Executive. M.H. is supported by the British Heart Foundation (RG
   05/006); E.S. is a National Institute for Health Research Fellow; G.D.B.
   is a Wellcome Trust Career Development Fellow (WBS
   U.1300.00.006.00012.01); M.K. is supported by Grant R01 HL036310 from
   the National Heart, Lung, and Blood Institute and Grant R01 AG034454
   from the National Institute on Aging, National Institutes of Health, the
   Bupa Foundation, and the Academy of Finland. The Medical Research
   Council (MRC) Social and Public Health Sciences Unit receives funding
   from the U.K. MRC and the Chief Scientist Office at the Scottish
   Government Health Directorates.
CR Adriaanse MC, 2008, DIABETIC MED, V25, P843, DOI 10.1111/j.1464-5491.2008.02464.x
   Adriaanse MC, 2008, DIABETES CARE, V31, P2268, DOI 10.2337/dc08-1074
   Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x
   Aujla N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007755
   Batty GD, 2009, J EPIDEMIOL COMMUN H, V63, P952, DOI 10.1136/jech.2008.086892
   Brotman DJ, 2007, LANCET, V370, P1089, DOI 10.1016/S0140-6736(07)61305-1
   Bruce DG, 2005, DIABETOLOGIA, V48, P2532, DOI 10.1007/s00125-005-0024-3
   Egede LE, 2005, DIABETES CARE, V28, P1339, DOI 10.2337/diacare.28.6.1339
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Gale CR, 2010, BIOL PSYCHIAT, V67, P189, DOI 10.1016/j.biopsych.2009.09.019
   Georgiades A, 2007, PSYCHOSOM MED, V69, P235, DOI 10.1097/PSY.0b013e318042588d
   Gillett Melissa J, 2009, Clin Biochem Rev, V30, P197
   Gillett MJ, 2009, DIABETES CARE, V32, P1327
   Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242
   Golden SH, 2008, JAMA-J AM MED ASSOC, V299, P2751, DOI 10.1001/jama.299.23.2751
   Hankins Matthew, 2008, Clin Pract Epidemiol Ment Health, V4, P10, DOI 10.1186/1745-0179-4-10
   Holt RIG, 2009, DIABETIC MED, V26, P641, DOI 10.1111/j.1464-5491.2009.02742.x
   Icks A, 2008, DIABETIC MED, V25, P1330, DOI 10.1111/j.1464-5491.2008.02585.x
   Katon WJ, 2008, AM J MED, V121, P8, DOI 10.1016/j.amjmed.2008.09.008
   Katon WJ, 2005, DIABETES CARE, V28, P2668, DOI 10.2337/diacare.28.11.2668
   Knol MJ, 2007, PSYCHOSOM MED, V69, P300, DOI 10.1097/PSY.0b013e31805f48b9
   Ludman EJ, 2010, J GERONTOL A-BIOL, V65, P93, DOI 10.1093/gerona/glp151
   Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0
   Rhee MK, 2008, DIABETIC MED, V25, P1361, DOI 10.1111/j.1464-5491.2008.02543.x
   Richardson DB, 2009, AM J EPIDEMIOL, V169, P756, DOI 10.1093/aje/kwn411
   *SCOTT GOV STAT, SCOTT HLTH SURV PUBL
   Testa MA, 1998, JAMA-J AM MED ASSOC, V280, P1490, DOI 10.1001/jama.280.17.1490
NR 27
TC 20
Z9 20
U1 0
U2 10
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0033-3174
J9 PSYCHOSOM MED
JI Psychosom. Med.
PD NOV-DEC
PY 2010
VL 72
IS 9
BP 882
EP 886
DI 10.1097/PSY.0b013e3181f6696e
PG 5
WC Psychiatry; Psychology; Psychology, Multidisciplinary
SC Psychiatry; Psychology
GA 685ZA
UT WOS:000284665400007
PM 20884891
DA 2019-01-08
ER

PT J
AU Yokokawa, H
   Goto, A
   Khue, NT
   Nam, TQ
   Trung, TT
   Khoa, VT
   Nguyen, TBN
   Minh, PN
   Vinh, NQ
   Okayama, A
   Yasumura, S
AF Yokokawa, Hirohide
   Goto, Aya
   Nguyen Thy Khue
   Tran Quang Nam
   Tran The Trung
   Vo Tuan Khoa
   Nguyen Thi Boi Ngoc
   Pham Nghiem Minh
   Nguyen Quang Vinh
   Okayama, Akira
   Yasumura, Seiji
TI Characteristics of metabolic syndrome and its clinical components among
   diabetic Vietnamese patients: A survry at two institutions in Ho Chi
   Minh City
SO OBESITY RESEARCH & CLINICAL PRACTICE
LA English
DT Article
DE Metabolic syndrome; Diabetes mellitus; Disease management; Chronic
   disease; Primary care
ID CHOLESTEROL EDUCATION-PROGRAM; CORONARY-HEART-DISEASE; TREATMENT PANEL
   III; CARDIOVASCULAR MORTALITY; ALL-CAUSE; PREVALENCE; FEDERATION;
   MELLITUS; ADULTS; AGE
AB Objective: The purpose of this study was to estimate the prevalence of metabolic syndrome among Vietnamese diabetic patients and to investigate their characteristics.
   Methods: This cross-sectional study was conducted among 652 outpatients who were recruited from one public general hospital (People Hospital 115) and one private clinic (Medic Center) in Ho Chi Minh City, Vietnam. We obtained informed consent from participants, collected clinical information from medical files, and conducted patient interviews. We evaluated the collected information descriptively and diagnosed metabolic syndrome according to the International Diabetes Federation (IDF) Worldwide Definition of the Metabolic Syndrome.
   Results: A total of 517 eligible patients (175 men and 342 women) were analyzed. Mean age was 54.6 years for men and 60.7 years for women. Metabolic syndrome was observed in 39.4% of men and 70.5% of women. Central obesity was more prevalent among women (72.5%) compared to men (39.4%). Participants with metabolic syndrome were less likely to endorse a sense of general well-being, and women with metabolic syndrome were likely to have less diabetes-related distress.
   Conclusions: this study revealed a high prevalence of metabolic syndrome in diabetic Vietnamese patients, especially among women, and revealed central obesity as a key feature. A prospective study should be conducted in this population in order to assess impacts of metabolic syndrome on disease outcome. (C) 2010 Asian Oceanian Association for the Study of Obesity. Published by Elsevier Ltd. All rights reserved.
C1 [Yokokawa, Hirohide] Juntendo Univ, Sch Med, Dept Gen Med, Bunkyo Ku, Tokyo 1138421, Japan.
   [Yokokawa, Hirohide; Goto, Aya; Yasumura, Seiji] Fukushima Med Univ, Sch Med, Dept Publ Hlth, Fukushima, Japan.
   [Nguyen Thy Khue; Tran Quang Nam; Tran The Trung] Univ Med & Pharm, Dept Endocrinol, Ho Chi Minh City, Vietnam.
   [Vo Tuan Khoa; Nguyen Thi Boi Ngoc] Peoples Hosp 115, Dept Endocrinol, Ho Chi Minh City, Vietnam.
   [Pham Nghiem Minh] Tu Du Obstet & Gynecol Hosp, Anapathol Cytol Genet Dept, Ho Chi Minh City, Vietnam.
   [Nguyen Quang Vinh] Hanh Phuc Women & Children Hosp Project, Ho Chi Minh City, Vietnam.
   [Okayama, Akira] Japan AntiTB Assoc, Inst Hlth Promot & Hlth Care 1, Tokyo, Japan.
RP Yokokawa, H (reprint author), Juntendo Univ, Sch Med, Dept Gen Med, Bunkyo Ku, Hongo 2-1-1, Tokyo 1138421, Japan.
EM yokokawa@pa3.so-net.ne.jp
OI Goto, Aya/0000-0002-7927-7648
FU Health Promotion Foundation; Health Promotion Foundation, Azusawa,
   Itabashi, Tokyo, Japan
FX We thank the Health Promotion Foundation for grant support, as well as
   Drs. Tran Viet Thang and Do Hoang Oanh for their excellent help in data
   collection.; This study was funded by a grant from the Health Promotion
   Foundation, 2-8-22, Azusawa, Itabashi, Tokyo, 174-0051, Japan.
CR Alexander CM, 2003, DIABETES, V52, P1210, DOI 10.2337/diabetes.52.5.1210
   [Anonymous], 2003, DIABETES ATLAS
   Bruno G, 2004, DIABETES CARE, V27, P2689, DOI 10.2337/diacare.27.11.2689
   Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486
   Ford ES, 2005, DIABETES CARE, V28, P2745, DOI 10.2337/diacare.28.11.2745
   FRIEDLANDER Y, 1982, ISRAEL J MED SCI, V18, P1242
   Hunt KJ, 2004, CIRCULATION, V110, P1251, DOI 10.1161/01.CIR.0000140762.04598.F9
   International Diabetes Federation, WORLDW DEF MET SYNDR
   Kuk JL, 2005, AM J CLIN NUTR, V81, P1330
   Le DSNT, 2006, J ATHEROSCLER THROMB, V13, P16
   Lear SA, 2007, AM J CLIN NUTR, V86, P353
   Levetan CS, 2002, DIABETES CARE, V25, P2, DOI 10.2337/diacare.25.1.2
   Ministry of Health, NAT HLTH NUTR SURV 2
   Mohsin Abdul, 2007, J Pak Med Assoc, V57, P235
   Rubin RR, 2006, DIABETES CARE, V29, P1249, DOI 10.2337/dc05-2494
   Son LNTD, 2005, DIABETES RES CLIN PR, V67, P243, DOI 10.1016/j.diabres.2004.07.014
   Song SH, 2008, QJM-INT J MED, V101, P875, DOI 10.1093/qjmed/hcn109
   Tong PC, 2007, DIABETES CARE, V30, P1206, DOI 10.2337/dc06-1484
   WHO (Five), 5 WELL BEING IND 199
   Yokokawa H, 2010, J HLTH ED, V13, P1
NR 20
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1871-403X
EI 1878-0318
J9 OBES RES CLIN PRACT
JI Obes. Res. Clin. Pract.
PD OCT-DEC
PY 2010
VL 4
IS 4
BP E293
EP E299
DI 10.1016/j.orcp.2010.08.006
PG 7
WC Endocrinology & Metabolism; Nutrition & Dietetics
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA V24JX
UT WOS:000208407800007
PM 24345695
DA 2019-01-08
ER

PT J
AU Polonsky, WH
   Fisher, L
   Guzman, S
   Sieber, WJ
   Philis-Tsimikas, A
   Edelman, SV
AF Polonsky, William H.
   Fisher, Lawrence
   Guzman, Susan
   Sieber, William J.
   Philis-Tsimikas, Athena
   Edelman, Steven V.
TI Are Patients' Initial Experiences at the Diagnosis of Type 2 Diabetes
   Associated With Attitudes and Self-management Over Time?
SO DIABETES EDUCATOR
LA English
DT Article
ID PERCEPTIONS; SCALE
AB Objective
   The purpose of this study was to investigate patients' experiences when diagnosed with type 2 diabetes and diabetes-related distress and self-management years later.
   Method
   One hundred seventy-nine adults with type 2 diabetes, 1 to 5 years after diagnosis, completed a questionnaire assessing what they were told and what was recommended at diagnosis as well as current diet, physical activity, and diabetes distress.
   Results
   Most patients (60%) expressed confidence in their health care provider (HCP) at diagnosis, but 30% reported that a clear action plan was not communicated. Current diabetes distress was significantly lower among those who reported being reassured at diagnosis that diabetes could be managed successfully and had developed a clearer action plan with their HCP. Patients' current dietary behaviors were significantly better among those receiving a clearer action plan at diagnosis.
   Conclusion
   Patients' retrospective reports of reassuring HCP messages when diagnosed, along with the presentation of a clear action plan, are associated with less diabetes distress and better self-management at 1 to 5 years after diagnosis.
   Practical implications
   Findings suggest a long-lasting impact on patients' attitudes and behaviors when the diagnosis of type 2 diabetes is delivered clearly, a sense of hope is provided, and a specific care plan is put forward.
C1 [Polonsky, William H.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA.
   [Fisher, Lawrence] Univ Calif San Diego, Dept Family & Community Med, San Diego, CA 92103 USA.
   [Polonsky, William H.; Guzman, Susan] Behav Diabet Inst, San Diego, CA USA.
   [Sieber, William J.] Univ Calif San Diego, Dept Family & Prevent Med, San Diego, CA 92103 USA.
   [Sieber, William J.] Inner Solut Success LLC, San Diego, CA USA.
   [Philis-Tsimikas, Athena] Scripps Whittier Diabet Inst, La Jolla, CA USA.
   [Edelman, Steven V.] Univ Calif San Diego, Div Endocrinol & Metab, San Diego, CA 92103 USA.
   [Edelman, Steven V.] Vet Affairs Med Ctr, San Diego, CA 92161 USA.
RP Polonsky, WH (reprint author), POB 2148, Del Mar, CA 92014 USA.
EM whp@behavioraldiabetes.org
FU Roche Diagnostics
FX This research was funded by an unrestricted educational grant from Roche
   Diagnostics. There are no conflicts of interest for any author.
CR Adriaanse MC, 2002, DIABETIC MED, V19, P406
   Beeney LJ, 1996, PATIENT EDUC COUNS, V29, P109, DOI 10.1016/0738-3991(96)00939-1
   Lawson VL, 2008, DIABETIC MED, V25, P482, DOI 10.1111/j.1464-5491.2008.02394.x
   Parry O, 2004, FAM PRACT, V21, P131, DOI 10.1093/fampra/cmh203
   Peel E, 2004, PATIENT EDUC COUNS, V53, P269, DOI 10.1016/j.pec.2003.07.010
   PibernikOkanovic M, 1996, DIABETES RES CLIN PR, V34, P99, DOI 10.1016/S0168-8227(96)01342-3
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Thoolen BJ, 2006, DIABETES CARE, V29, P2257, DOI 10.2337/dc06-0617
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
NR 9
TC 10
Z9 10
U1 0
U2 6
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0145-7217
J9 DIABETES EDUCATOR
JI Diabetes Educ.
PD SEP-OCT
PY 2010
VL 36
IS 5
BP 828
EP 834
DI 10.1177/0145721710378539
PG 7
WC Endocrinology & Metabolism; Public, Environmental & Occupational Health
SC Endocrinology & Metabolism; Public, Environmental & Occupational Health
GA 682TU
UT WOS:000284426700014
PM 20729511
DA 2019-01-08
ER

PT J
AU Pena, MMEY
   Barrera, VH
   Cordero, XF
   de Miguel, AG
   Perez, MR
   Andres, AL
   Jimenez-Garcia, R
AF Esteban y Pena, M. M.
   Hernandez Barrera, V.
   Fernandez Cordero, X.
   Gil de Miguel, A.
   Rodriguez Perez, M.
   Lopez-de Andres, A.
   Jimenez-Garcia, R.
TI Self-perception of health status, mental health and quality of life
   among adults with diabetes residing in a metropolitan area
SO DIABETES & METABOLISM
LA English
DT Article
DE Quality of life; Diabetes; GHQ-12; Chronic diseases; Depression
ID IQOLA PROJECT; DEPRESSION; POPULATION; DISEASE; IMPACT; SF-36;
   COMORBIDITY; DISABILITY; COUNTRIES; MELLITUS
AB Aim. - The study aimed to compare the self-perception of health, physiological distress and health-related quality of life (HRQL) in subjects with and without diabetes residing in a large metropolitan area (the city of Madrid), and to identify the variables associated with the poorest HRQL among diabetes patients.
   Methods. - In this case-control epidemiological study, we selected 358 patients with diabetes from the Madrid City Health Survey. For every patient, two controls without diabetes were randomly selected from the same database and matched for age, gender and health district. The resultant study population comprised 1074 subjects, who were analyzed according to their self-rated health status, with mental health assessed by the 12-item General Health Questionnaire (GHQ-12) and HRQL by the COOP/WONCA questionnaire. Independent variables included sociodemographic characteristics, lifestyle variables, associated chronic diseases and consumption of medications. Multivariate analyses were conducted using ANCOVA tests.
   Results. - The prevalence of health perceived as fair or poor was 64.12% in those with diabetes vs 38.57% in those without diabetes (P<0.05). The GHQ-12 results showed that mental health was also significantly worse among diabetes sufferers, and the COOP/WONCA questionnaire results indicated significantly poorer HRQL in those with diabetes. The variables that determined a poorer perception of HRQL among diabetes sufferers were female gender, older age, obesity, lack of physical exercise, coexistence of depression, use of sleeping pills, and Alzheimer's and cerebrovascular diseases.
   Conclusion. - Self-rated health and psychological well-being, and HRQL, are all considerably poorer among patients with diabetes vs those without diabetes. The poorest quality of life among those with diabetes associated with female gender, depression, lack of exercise and obesity. (C) 2010 Elsevier Masson SAS. All rights reserved.
C1 [Hernandez Barrera, V.; Gil de Miguel, A.; Lopez-de Andres, A.; Jimenez-Garcia, R.] Rey Juan Carlos Univ, Prevent Med & Publ Hlth Teaching & Res Unit, Fac Hlth Sci, Madrid 28922, Spain.
   [Esteban y Pena, M. M.; Fernandez Cordero, X.] Madrid City Council, Inst Publ Hlth, Madrid 28007, Spain.
   [Rodriguez Perez, M.] Madrid City Council, Dept Evaluat & Qual, Madrid 28007, Spain.
RP Jimenez-Garcia, R (reprint author), Rey Juan Carlos Univ, Prevent Med & Publ Hlth Teaching & Res Unit, Fac Hlth Sci, Av Atenas Alcorcon, Madrid 28922, Spain.
EM rodrigo.jimenez@urjc.es
FU ISCIII [ETES: PI09/90515]
FX The authors are grateful to the Public Health Institute of the Madrid
   City Council (Instituto de Salud Publica - Ayuntamiento de Madrid) for
   providing access to the 2005 Madrid City Health Survey database. The
   present study was supported by a grant from the ISCIII (ETES:
   PI09/90515). The authors also thank Patricia Santa-Olalla for
   translating the abstract and title into French.
CR Aaronson N K, 1992, Qual Life Res, V1, P349, DOI 10.1007/BF00434949
   Alonso J, 2004, QUAL LIFE RES, V13, P283, DOI 10.1023/B:QURE.0000018472.46236.05
   Aydin IO, 2001, GEN HOSP PSYCHIAT, V23, P77
   Carnes D, 2007, RHEUMATOLOGY, V46, P1168, DOI 10.1093/rheumatology/kem118
   Casado J, 2001, Aten Primaria, V28, P167
   de Jonge P, 2006, DIABETOLOGIA, V49, P2627, DOI 10.1007/s00125-006-0442-x
   Donmez L, 2005, ARCH GERONTOL GERIAT, V40, P213, DOI 10.1016/j.archger.2004.08.006
   FERNANDEZMAYORA.G, 2003, REV MULT GERONTOL, V3, P43
   Glasgow RE, 1997, DIABETES CARE, V20, P562, DOI 10.2337/diacare.20.4.562
   JACOBSON AM, 1994, DIABETES CARE, V17, P267, DOI 10.2337/diacare.17.4.267
   Jenkinson C, 1997, AGE AGEING, V26, P7, DOI 10.1093/ageing/26.1.7
   Jimenez-Garcia R, 2008, DIABETES CARE, V31, P90, DOI 10.2337/dc07-1382
   Katon WJ, 2008, AM J MED, V121, P8, DOI 10.1016/j.amjmed.2008.09.008
   Kempen GIJM, 1997, AM J PUBLIC HEALTH, V87, P38, DOI 10.2105/AJPH.87.1.38
   Lam C. L. K., 1995, Hong Kong Medical Journal, V1, P225
   Lam CLK, 2000, FAM PRACT, V17, P159, DOI 10.1093/fampra/17.2.159
   Lizan Tudela L, 2000, Med Clin (Barc), V114 Suppl 3, P76
   Lizan Tudela L, 1999, Aten Primaria, V24, P75
   *MADR SAL, 2005, ENC SAL CIUD MADR 20
   Madrid Salud, EST SAL CIUD MADR 20
   Mata M, 2003, ATEN PRIM, V31, P493
   Mena Martin F J, 2006, An Med Interna, V23, P357
   *MIN SAN CONS INE, HLTH SPAN POP 2006
   MUNOZ PE, 1979, ARCH NEUROBIOL, V42, P139
   Papadopoulos AA, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-186
   PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402
   Pena F, 2010, HIPPOCAMPUS, V20, P78, DOI 10.1002/hipo.20592
   Peyrot M, 2007, DIABETES CARE, V30, P2433, DOI 10.2337/dc07-1222
   Regidor E, 2001, Rev Esp Salud Publica, V75, P13
   Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O
   Saito I, 2006, DIABETES RES CLIN PR, V73, P51, DOI 10.1016/j.diabres.2005.11.015
   Sanchez-Lopez MP, 2008, PSICOTHEMA, V20, P839
   Sanchez-Lopez MP, 2008, WOMEN HEALTH, V48, P445, DOI 10.1080/03630240802575096
   SCHELLEVIS FG, 1994, BRIT J GEN PRACT, V44, P259
   Schlenk EA, 1998, QUAL LIFE RES, V7, P57
   Shao WA, 1997, J FAM PRACTICE, V44, P161
   SNEEUW KC, 1992, J CLIN EPIDEMIOL, V45, P743
   Tapp RJ, 2006, DIABETES RES CLIN PR, V74, P154, DOI 10.1016/j.diabres.2006.03.012
   TOMAS C, 1999, GAC SANIT, V13, P90
   Van Weel C, 1993, Disabil Rehabil, V15, P96
   Wagner AK, 1998, J CLIN EPIDEMIOL, V51, P925, DOI 10.1016/S0895-4356(98)00083-3
   *WHO, 1983, BAS DOC
   *WONCA ERGHO, 1995, MEAS FUNCT HLTH STAT
NR 43
TC 18
Z9 18
U1 0
U2 7
PU MASSON EDITEUR
PI MOULINEAUX CEDEX 9
PA 21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE
SN 1262-3636
J9 DIABETES METAB
JI Diabetes Metab.
PD SEP
PY 2010
VL 36
IS 4
BP 305
EP 311
DI 10.1016/j.diabet.2010.02.003
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 671BN
UT WOS:000283474800009
PM 20483647
DA 2019-01-08
ER

PT J
AU Papelbaum, M
   Lemos, HM
   Duchesne, M
   Kupfer, R
   Moreira, RO
   Coutinho, WF
AF Papelbaum, M.
   Lemos, H. M.
   Duchesne, M.
   Kupfer, R.
   Moreira, R. O.
   Coutinho, W. F.
TI The association between quality of life, depressive symptoms and
   glycemic control in a group of type 2 diabetes patients
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Type 2 diabetes mellitus; Quality of life; Metabolic control; Depression
ID PROBLEM AREAS; INVENTORY; DISTRESS; SCALE
AB Aims: Several studies have demonstrated worse perception of quality of life (QoL) among patients with type 2 diabetes mellitus (T2DM). The purpose of our study was to assess QoL in a clinical sample of patients with T2DM and its association with depressive symptoms and glycemic control.
   Methods: One hundred outpatients from a sequential sample underwent clinical and psychiatric evaluation. The Problem Areas of Diabetes scale (PAID) and the Beck Depression Inventory (BDI) were used to assess, respectively, QoL and the presence of overall psychopathology. The levels of glycated hemoglobin (HbA1c) were used as the main parameter of glycemic control.
   Results: The perception degree of the QoL related with diabetes was associated with the severity of depressive symptoms (r = 0.503; p <0.001), but not with HbA1c levels (p = 0.117). However, the severity of general psychopathology, evaluated through the BDI scores, predicted the metabolic control, measured by HbA1c levels, among the patients in our sample (r = 0.233; p = 0.019).
   Conclusions: In our study, PAID was a valuable tool for the evaluation of QoL in T2DM and the screening of depressive symptoms. However, no correlation observed between PAID scores and HbA1c levels. Self-perception evaluation of T2DM patient can help to identify susceptible subjects to current depression. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
C1 [Papelbaum, M.; Duchesne, M.] Univ Fed Rio de Janeiro, Inst Psychiat, BR-22440033 Rio De Janeiro, Brazil.
   [Papelbaum, M.; Lemos, H. M.; Duchesne, M.; Kupfer, R.; Moreira, R. O.; Coutinho, W. F.] State Inst Diabet & Endocrinol Rio de Janeiro, Rio De Janeiro, Brazil.
RP Papelbaum, M (reprint author), Univ Fed Rio de Janeiro, Inst Psychiat, Ave Ataulfo Paiva 204,707, BR-22440033 Rio De Janeiro, Brazil.
EM marcelo@papelbaum.com
CR Bonow RO, 2004, AM J MED, V116, P2, DOI 10.1016/j.amjmed.2003.10.014
   CRRER CJ, 2008, ARQ BRAS ENDOCRINOL, V52, P515
   Edelman D, 2002, DIABETES CARE, V25, P1022, DOI 10.2337/diacare.25.6.1022
   Fryers T, 2003, SOC PSYCH PSYCH EPID, V38, P229, DOI 10.1007/s00127-003-0627-2
   GODNEY RD, 2004, DIABETES CARE, V27, P1066
   Gorenstein C, 1996, BRAZ J MED BIOL RES, V29, P453
   Gregg E. W., 2009, Morbidity and Mortality Weekly Report, V58, P1259
   Gross CC, 2007, DIABETES RES CLIN PR, V76, P455, DOI 10.1016/j.diabres.2006.09.022
   Gusmao Ricardo M, 2005, Acta Med Port, V18, P129
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   Kokoszka A, 2009, EUR PSYCHIAT, V24, P425, DOI 10.1016/j.eurpsy.2009.04.002
   Lin EHB, 2004, DIABETES CARE, V27, P2154, DOI 10.2337/diacare.27.9.2154
   Lloyd A, 2001, Value Health, V4, P392, DOI 10.1046/j.1524-4733.2001.45029.x
   Lohr KN, 1996, CLIN THER, V18, P979, DOI 10.1016/S0149-2918(96)80054-3
   Lustman PJ, 1997, PSYCHOSOM MED, V59, P24, DOI 10.1097/00006842-199701000-00004
   LUTSMAN PJ, 1997, PSYCHOSOM MED, V59, P24
   LUTSMANN PJ, 2000, DIABETES CARE, V23, P934
   Miller ST, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-70
   Peyrot M, 2010, DIABETES CARE, V33, P240, DOI 10.2337/dc09-1348
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   Wilder RP, 2003, DIABETES CARE, V26, P1650, DOI 10.2337/diacare.26.5.1650
NR 23
TC 30
Z9 30
U1 0
U2 6
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD SEP
PY 2010
VL 89
IS 3
BP 227
EP 230
DI 10.1016/j.diabres.2010.05.024
PG 4
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 643AB
UT WOS:000281263000005
PM 20696361
DA 2019-01-08
ER

PT J
AU Barker, L
   Crespo, R
   Gerzoff, RB
   Denham, S
   Shrewsberry, M
   Cornelius-Averhart, D
AF Barker, Lawrence
   Crespo, Richard
   Gerzoff, Robert B.
   Denham, Sharon
   Shrewsberry, Molly
   Cornelius-Averhart, Darrlyn
TI Residence in a Distressed County in Appalachia as a Risk Factor for
   Diabetes, Behavioral Risk Factor Surveillance System, 2006-2007
SO PREVENTING CHRONIC DISEASE
LA English
DT Article
AB Introduction
   We compared the risk of diabetes for residents of Appalachian counties to that of residents of non-Appalachian counties after controlling for selected risk factors in states containing at least 1 Appalachian county.
   Methods
   We combined Behavioral Risk Factor Surveillance System data from 2006 and 2007 and conducted a logistic regression analysis, with self-reported diabetes as the dependent variable. We considered county of residence (5 classifications for Appalachian counties, based on economic development, and 1 for non-Appalachian counties), age, sex, race/ethnicity, education, household income, smoking status, physical activity level, and obesity to be independent variables. The classification "distressed" refers to counties in the worst 10%, compared with the nation as a whole, in terms of 3-year unemployment rate, per capita income, and poverty.
   Results
   Controlling for covariates, residents in distressed Appalachian counties had 33% higher odds (95% confidence interval, 1.10-1.60) of reporting diabetes than residents of non-Appalachian counties. We found no significant differences between other classifications of Appalachian counties and non-Appalachian counties.
   Conclusions
   Residents of distressed Appalachian counties are at higher risk of diabetes than are residents of other counties. States with distressed Appalachian counties should implement culturally sensitive programs to prevent diabetes.
C1 [Barker, Lawrence] Ctr Dis Control & Prevent, Div Diabet Translat, Atlanta, GA 30341 USA.
   [Crespo, Richard; Shrewsberry, Molly] Marshall Univ, Huntington, WV USA.
   [Denham, Sharon] Ohio Univ, Athens, OH 45701 USA.
RP Barker, L (reprint author), Ctr Dis Control & Prevent, Div Diabet Translat, 2877 Brandywine Rd,Mail Stop K-10, Atlanta, GA 30341 USA.
EM LBarker1@cdc.gov
CR [Anonymous], 1994, APP LEAD IN CANC SOW
   Appalachian Regional Commission, 2016, APP REG
   Birdsall S, 2008, OUTLINE AM GEOGRAPHY
   Blakeney AB, 2005, ED CULTURALLY SENSIT, P161
   Bovell-Benjamin AC, 2009, HEALTH PLACE, V15, P429, DOI 10.1016/j.healthplace.2008.08.001
   *CDCP, 2007 NAT DIAB FACT S
   Centers for Disease Control and Prevention, BEH RISK FACT SURV S
   Coyne CA, 2006, PREV CHRONIC DIS, V3
   Crespo R, HLTH PROMOT IN PRESS
   Denham SA, 2004, FAM COMMUNITY HEALTH, V27, P170, DOI 10.1097/00003727-200404000-00010
   Denham SA, 2009, DIABETES FAMILY MATT
   Dinour LM, 2007, J AM DIET ASSOC, V107, P1952, DOI 10.1016/j.jada.2007.08.006
   Holben DH, 2006, PREV CHRONIC DIS, V3
   Holtzman D., 2003, COMMUNITY BASED HLTH, P115
   Hortz B, 2009, J RURAL HEALTH, V25, P58, DOI 10.1111/j.1748-0361.2009.00199.x
   Lantz PM, 1998, JAMA-J AM MED ASSOC, V279, P1703, DOI 10.1001/jama.279.21.1703
   Martin KS, 2007, J NUTR EDUC BEHAV, V39, P31, DOI 10.1016/j.jneb.2006.08.021
   Murasko JE, 2009, ECON HUM BIOL, V7, P376, DOI 10.1016/j.ehb.2009.04.004
   Pollard Kelvin M., 2004, NEW DIVERSITY RACE E
   Rizvi AA, 2007, AM J MED SCI, V333, P35, DOI 10.1097/00000441-200701000-00005
   Robbins JM, 2001, AM J PUBLIC HEALTH, V91, P76
   Roussos ST, 2000, ANNU REV PUBL HEALTH, V21, P369, DOI 10.1146/annurev.publhealth.21.1.369
   Tessaro I, 2005, PREV CHRONIC DIS, V2
   Townsend MS, 2001, J NUTR, V131, P1738
   US Department of Health and Human Services Health Resources and Service Administration, FIND SHORT AR HPSA S
   Wewers ME, 2000, J COMMUN HEALTH, V25, P377, DOI 10.1023/A:1005127917122
   Wewers ME, 2006, PREV CHRONIC DIS, V3
   Wilde PE, 2006, J NUTR, V136, P1395
   Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654
   Williams KJ, 2008, RURAL REMOTE HEALTH, V8
NR 30
TC 14
Z9 14
U1 0
U2 4
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1545-1151
J9 PREV CHRONIC DIS
JI Prev. Chronic Dis.
PD SEP
PY 2010
VL 7
IS 5
AR A104
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA V20SD
UT WOS:000208158800014
PM 20712931
DA 2019-01-08
ER

PT J
AU Ivanova, A
   Nitka, D
   Schmitz, N
AF Ivanova, Anna
   Nitka, Danit
   Schmitz, Norbert
TI Epidemiology of antidepressant medication use in the Canadian diabetes
   population
SO SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY
LA English
DT Article
DE Diabetes; Depression; Antidepressant medication; Survey
ID DIAGNOSTIC INTERVIEW CIDI; PLACEBO-CONTROLLED TRIAL; PSYCHOLOGICAL
   DISTRESS; MENTAL-HEALTH; DEPRESSION SYMPTOMS; GENERAL-POPULATION;
   PREVENTION PROGRAM; SCREENING SCALES; DOUBLE-BLIND; MEDICINE USE
AB Depression has been shown to be a common co-morbidity in diabetes. From a public health point of view, there is a lack of population-based studies regarding the use of antidepressant medication in non-clinical samples of people with diabetes. The objective of the present study was to provide demographic and clinical information about the use of antidepressant medication in a representative community sample of people with diabetes.
   The Canadian Community Health Survey 1.2 (CCHS 1.2) is a cross-sectional survey that collects information related to health status, health-care utilization and health determinants of the Canadian general population. Diabetes presence was ascertained by self-report of physician diagnosis. Depression and anxiety were assessed using a modified version of the World Mental Health Composite International Diagnostic Interview. Antidepressant use was determined through self-report.
   The population prevalence of self-reported antidepressant use in the past 12 months was 8.4% (SE = 0.95) among people with diabetes (n = 1,662). People who took antidepressants had higher average body mass index (M = 32.6, SD = 6.5) than those not taking antidepressants (M = 29.2, SD = 5.7). The use of antidepressants was associated with poorer health status and higher number of co-morbid chronic conditions. Half of diabetes subjects who used antidepressant medication in the last year did not have a lifetime history of major depression.
   In a community sample of people with diabetes, the prevalence of antidepressant use exceeded the prevalence of major depression. Anxiety disorders and other somatic chronic conditions were associated with the prescription of antidepressant medication in people with diabetes, but without a history of major depression.
C1 [Ivanova, Anna; Nitka, Danit; Schmitz, Norbert] McGill Univ, Douglas Mental Hlth Univ Inst, Montreal, PQ H4H 1R3, Canada.
   [Schmitz, Norbert] McGill Univ, Dept Psychiat, Montreal, PQ H4H 1R3, Canada.
RP Schmitz, N (reprint author), McGill Univ, Douglas Mental Hlth Univ Inst, 6875 LaSalle Blvd, Montreal, PQ H4H 1R3, Canada.
EM norbert.schmitz@mcgill.ca
RI Schmitz, Norbert/A-5177-2010
OI Schmitz, Norbert/0000-0001-7777-6323
FU Canadian Institutes for Health Research (CIHR) [MOP-79464]; FRSQ
   Chercheur-Boursier
FX This analysis is based on Statistics Canada's Canadian Community Health
   Survey, Cycle 1.2 (2005), public use microdata file which contains
   anonymized collected data. All computations on these microdata were
   prepared by Anna Ivanova, Danit Nitka, and Norbert Schmitz, and the
   responsibility for the use and interpretation of these data is entirely
   that of the authors. All authors had full access to all of the data in
   the study and take responsibility for the integrity of the data and the
   accuracy of the data analysis. This research was funded by the Canadian
   Institutes for Health Research (CIHR Grant MOP-79464) and a FRSQ
   Chercheur-Boursier fellowship to Dr Schmitz.
CR Andrews G, 2001, AUST NZ J PUBL HEAL, V25, P494, DOI 10.1111/j.1467-842X.2001.tb00310.x
   Beck CA, 2005, SOC PSYCH PSYCH EPID, V40, P799, DOI 10.1007/s00127-005-0968-0
   Cairney J, 2007, CAN J PSYCHIAT, V52, P111, DOI 10.1177/070674370705200209
   Demyttenaere K, 2008, J PSYCHOPHARMACOL, V22, P792, DOI 10.1177/0269881107083798
   Deshmukh R, 2003, CLEV CLIN J MED, V70, P614, DOI 10.3949/ccjm.70.7.614
   Furukawa TA, 2003, PSYCHOL MED, V33, P357, DOI 10.1017/S0033291702006700
   Ghaemi SN, 2001, J CLIN PSYCHIAT, V62, P565, DOI 10.4088/JCP.v62n07a12
   Gonzalez JS, 2007, DIABETES CARE, V30, P2222, DOI 10.2337/dc07-0158
   Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341
   Goodnick P J, 2001, Ann Clin Psychiatry, V13, P31, DOI 10.3109/10401230109147127
   Hirschfield RMA, 1997, JAMA-J AM MED ASSOC, V277, P333, DOI 10.1001/jama.277.4.333
   Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359
   Katon W, 2007, GEN HOSP PSYCHIAT, V29, P147, DOI 10.1016/j.genhosppsych.2006.11.005
   Katon WJ, 2005, DIABETES CARE, V28, P2668, DOI 10.2337/diacare.28.11.2668
   Katon WJ, 2004, ARCH GEN PSYCHIAT, V61, P1042, DOI 10.1001/archpsyc.61.10.1042
   Keller MB, 2000, NEW ENGL J MED, V342, P1462, DOI 10.1056/NEJM200005183422001
   Kennedy SH, 2006, EUR NEUROPSYCHOPHARM, V16, pS619, DOI 10.1016/S0924-977X(06)70007-4
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168
   Lin EHB, 2008, J PSYCHOSOM RES, V65, P571, DOI 10.1016/j.jpsychores.2008.06.007
   Lustman PJ, 1997, PSYCHOSOM MED, V59, P241, DOI 10.1097/00006842-199705000-00007
   Lustman PJ, 2000, DIABETES CARE, V23, P618, DOI 10.2337/diacare.23.5.618
   Lustman PJ, 1998, ANN INTERN MED, V129, P613, DOI 10.7326/0003-4819-129-8-199810150-00005
   McCollum M, 2007, AM J MANAG CARE, V13, P65
   McIntyre RS, 2006, EXPERT OPIN DRUG SAF, V5, P157, DOI 10.1517/14740338.5.1.157
   McIntyre RS, 2006, EXPERT OPIN DRUG SAF, V5, P523, DOI 10.1517/14740338.5.4.523
   Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76
   *NIH, 1998, OBES RES S2, V6, P51
   Ohayon MM, 1998, J CLIN EPIDEMIOL, V51, P273, DOI 10.1016/S0895-4356(97)00238-2
   Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Rubin RR, 2008, DIABETES CARE, V31, P420, DOI 10.2337/dc07-182T
   Rubin RR, 2005, DIABETES CARE, V28, P830
   *STAT CAN, 2002, PROF DIS CAN CAN RES
   Tunks ER, 2008, CAN J PSYCHIAT, V53, P235
   Williams JW, 2004, ANN INTERN MED, V140, P1015, DOI 10.7326/0003-4819-140-12-200406150-00012
   WITTCHEN HU, 1994, J PSYCHIAT RES, V28, P57, DOI 10.1016/0022-3956(94)90036-1
NR 37
TC 3
Z9 4
U1 0
U2 5
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0933-7954
J9 SOC PSYCH PSYCH EPID
JI Soc. Psychiatry Psychiatr. Epidemiol.
PD SEP
PY 2010
VL 45
IS 9
BP 911
EP 919
DI 10.1007/s00127-009-0129-y
PG 9
WC Psychiatry
SC Psychiatry
GA 637VJ
UT WOS:000280846500007
PM 19730761
DA 2019-01-08
ER

PT J
AU Cusi, K
AF Cusi, Kenneth
TI The Role of Adipose Tissue and Lipotoxicity in the Pathogenesis of Type
   2 Diabetes
SO CURRENT DIABETES REPORTS
LA English
DT Article
DE Adipose tissue; Lipotoxicity; NAFLD; Type 2 diabetes mellitus; Insulin
   resistance
ID FREE FATTY-ACIDS; ENCODED MITOCHONDRIAL GENES; IMPAIRS
   INSULIN-SECRETION; BETA-CELL DYSFUNCTION; HUMAN SKELETAL-MUSCLE;
   BODY-MASS INDEX; NONALCOHOLIC STEATOHEPATITIS; HEPATIC STEATOSIS;
   FAMILY-HISTORY; METABOLIC DISEASES
AB The widespread epidemics of obesity and type 2 diabetes mellitus (T2DM) suggest that both conditions are closely linked. An increasing body of evidence has shifted our view of adipose tissue from a passive energy depot to a dynamic "endocrine organ" that tightly regulates nutritional balance by means of a complex crosstalk of adipocytes with their microenvironment. Dysfunctional adipose tissue, particularly as observed in obesity, is characterized by adipocyte hypertrophy, macrophage infiltration, impaired insulin signaling, and insulin resistance. The result is the release of a host of inflammatory adipokines and excessive amounts of free fatty acids that promote ectopic fat deposition and lipotoxicity in muscle, liver, and pancreatic beta cells. This review focuses on recent work on how glucose homeostasis is profoundly altered by distressed adipose tissue. A better understanding of this relationship offers the best chance for early intervention strategies aimed at preventing the burden of T2DM.
C1 Univ Texas Hlth Sci Ctr San Antonio, Diabet Div, San Antonio, TX 78284 USA.
RP Cusi, K (reprint author), Univ Texas Hlth Sci Ctr San Antonio, Diabet Div, Room 3-380S,7703 Floyd Curl Dr, San Antonio, TX 78284 USA.
EM cusi@uthscsa.edu
FU American Diabetes Association; Burroughs Wellcome Fund; Veterans Affairs
   Medical Research Fund; National Center for Research Resources [UL
   1RR025767]
FX Dr. Kenneth Cusi is supported by the American Diabetes Association, the
   Burroughs Wellcome Fund, the Veterans Affairs Medical Research Fund, and
   by Award Number UL 1RR025767 from the National Center for Research
   Resources. The content is solely the responsibility of the authors and
   does not necessarily represent the official views of the National Center
   for Research Resources of the National Institutes of Health.
CR Abdul-Ghani MA, 2008, CURR DIABETES REP, V8, P173, DOI 10.1007/s11892-008-0030-1
   Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515
   Belfort R, 2005, DIABETES, V54, P1640, DOI 10.2337/diabetes.54.6.1640
   Belfort R, 2006, NEW ENGL J MED, V355, P2297, DOI 10.1056/NEJMoa060326
   Boden G, 2002, AM J PHYSIOL-ENDOC M, V283, pE12, DOI 10.1152/ajpendo.00429.2001
   Bogacka I, 2004, DIABETES CARE, V27, P1660, DOI 10.2337/diacare.27.7.1660
   Brassard P, 2008, J CLIN ENDOCR METAB, V93, P837, DOI 10.1210/jc.2007-1670
   Buchanan TA, 2007, DIABETES, V56, P1502, DOI 10.2337/db07-0140
   Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102
   CHAN DC, 2010, THROMB VASC BIOL, V30, P1043
   Chavez AO, 2010, J CLIN ENDOCR METAB, V95, P422, DOI 10.1210/jc.2009-1387
   Choi CS, 2008, P NATL ACAD SCI USA, V105, P19926, DOI 10.1073/pnas.0810339105
   Choi SS, 2008, CURR OPIN LIPIDOL, V19, P295, DOI 10.1097/MOL.0b013e3282ff5e55
   Civitarese AE, 2004, DIABETOLOGIA, V47, P816, DOI 10.1007/s00125-004-1359-x
   Cusi K, 2000, J CLIN INVEST, V105, P311, DOI 10.1172/JCI7535
   Cusi K, 2007, AM J PHYSIOL-ENDOC M, V292, pE1775, DOI 10.1152/ajpendo.00624.2006
   Cusi K, 2009, CLIN LIVER DIS, V13, P545, DOI 10.1016/j.cld.2009.07.009
   Cusi K, 2009, CONTEMP DIABETES, P3, DOI 10.1007/978-1-59745-260-1_1
   Cusi K, 2009, CURR OPIN ENDOCRINOL, V16, P141, DOI 10.1097/MED.0b013e3283293015
   Cusi K, 2009, CURR DIABETES REP, V9, P200, DOI 10.1007/s11892-009-0033-6
   De Filippis E, 2008, AM J PHYSIOL-ENDOC M, V294, pE607, DOI 10.1152/ajpendo.00729.2007
   DeFronzo RA, 2010, DIABETOLOGIA, V53, P435, DOI 10.1007/s00125-009-1614-2
   Delghingaro-Augusto V, 2009, DIABETOLOGIA, V52, P1122, DOI 10.1007/s00125-009-1317-8
   Estall JL, 2009, P NATL ACAD SCI USA, V106, P22510, DOI 10.1073/pnas.0912533106
   Federici M, 2001, DIABETES, V50, P1290, DOI 10.2337/diabetes.50.6.1290
   Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014
   Franks PW, 2010, NEW ENGL J MED, V362, P485, DOI 10.1056/NEJMoa0904130
   Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589
   Gastaldelli A, 2004, DIABETOLOGIA, V47, P31, DOI 10.1007/s00125-003-1263-9
   Gastaldelli A, 2009, HEPATOLOGY, V50, P1087, DOI 10.1002/hep.23116
   Greenfield V, 2008, CURR OPIN GASTROEN, V24, P320, DOI 10.1097/MOG.0b013e3282fbccf2
   Gregor MF, 2009, DIABETES, V58, P693, DOI 10.2337/db08-1220
   GULLI G, 1992, DIABETES, V41, P1575, DOI 10.2337/diabetes.41.12.1575
   Han CY, 2010, DIABETES, V59, P386, DOI 10.2337/db09-0925
   Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206
   Hojlund K, 2008, ENDOCRIN METAB CLIN, V37, P713, DOI 10.1016/j.ecl.2008.06.006
   Holloszy JO, 2009, AM J CLIN NUTR, V89, p463S, DOI 10.3945/ajcn.2008.26717C
   Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449
   Huang W, 2010, DIABETES, V59, P347, DOI 10.2337/db09-0016
   Isganaitis E, 2009, DIABETES, V58, P1192, DOI 10.2337/db08-1266
   Kashyap S, 2003, DIABETES, V52, P2461, DOI 10.2337/diabetes.52.10.2461
   Kashyap Sangeeta R, 2008, J Cardiometab Syndr, V3, P141, DOI 10.1111/j.1559-4572.2008.00013.x
   Kashyap SR, 2004, AM J PHYSIOL-ENDOC M, V287, pE537, DOI 10.1152/ajpendo.00541.2003
   Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08
   Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021
   Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005
   Li ZZ, 2009, J BIOL CHEM, V284, P5637, DOI 10.1074/jbc.M807616200
   Liang H, 2009, AM J PHYSIOL-ENDOC M, V296, pE945, DOI 10.1152/ajpendo.90292.2008
   Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100
   Liu L, 2009, J BIOL CHEM, V284, P36312, DOI 10.1074/jbc.M109.049817
   Liu L, 2009, DIABETES, V58, P2516, DOI 10.2337/db08-1096
   MATHEW M, 2010, CARDIOVASC DIABETOL, V9, P1
   Mathew M, 2007, DIABETES, V56, pA674
   MCGARRY JD, 1992, SCIENCE, V258, P766, DOI 10.1126/science.1439783
   Minehira K, 2008, J LIPID RES, V49, P2038, DOI 10.1194/jlr.M800248-JLR200
   Muhlhausler B, 2009, TRENDS ENDOCRIN MET, V20, P51, DOI 10.1016/j.tem.2008.10.006
   Muniyappa R, 2008, ENDOCRIN METAB CLIN, V37, P685, DOI 10.1016/j.ecl.2008.06.001
   Ogden CL, 2010, JAMA-J AM MED ASSOC, V303, P242, DOI 10.1001/jama.2009.2012
   ORTIZLOPEZ C, 2010, DIABETES S, V1, P59
   Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100
   Perseghin G, 1997, DIABETES, V46, P1001, DOI 10.2337/diabetes.46.6.1001
   Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314
   Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023
   Pratipanawatr W, 2001, DIABETES, V50, P2572, DOI 10.2337/diabetes.50.11.2572
   Reyna SM, 2008, DIABETES, V57, P2595, DOI 10.2337/db08-0038
   Richardson DK, 2005, J BIOL CHEM, V280, P10290, DOI 10.1074/jbc.M408985200
   Roden M, 2000, DIABETES, V49, P701, DOI 10.2337/diabetes.49.5.701
   Rutkowski JM, 2009, FEBS J, V276, P5738, DOI 10.1111/j.1742-4658.2009.07303.x
   Semple RK, 2009, J CLIN INVEST, V119, P315, DOI 10.1172/JCI37432
   Shaw JE, 2009, DIABETES RES CLIN PR, V87, P4
   Szendroedi J, 2009, CURR OPIN LIPIDOL, V20, P50, DOI 10.1097/MOL.0b013e328321b3a8
   UNGER RH, 2001, DIABETES S1, V50, P118
   Vaag A, 2007, CURR OPIN CLIN NUTR, V10, P591, DOI 10.1097/MCO.0b013e3282ab9ea6
   Virkamaki A, 2001, DIABETES, V50, P2337, DOI 10.2337/diabetes.50.10.2337
   Wouters K, 2008, HEPATOLOGY, V48, P474, DOI 10.1002/hep.22363
   Wueest S, 2010, J CLIN INVEST, V120, P191, DOI 10.1172/JCI38388
   Yang XL, 2004, BIOCHEM BIOPH RES CO, V317, P1045, DOI 10.1016/j.bbrc.2004.03.152
   Ye J, 2009, INT J OBESITY, V33, P54, DOI 10.1038/ijo.2008.229
NR 78
TC 144
Z9 157
U1 1
U2 23
PU CURRENT MEDICINE GROUP
PI PHILADELPHIA
PA 400 MARKET STREET, STE 700, PHILADELPHIA, PA 19106 USA
SN 1534-4827
J9 CURR DIABETES REP
JI Curr. Diabetes Rep.
PD AUG
PY 2010
VL 10
IS 4
BP 306
EP 315
DI 10.1007/s11892-010-0122-6
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 615IT
UT WOS:000279128900008
PM 20556549
DA 2019-01-08
ER

PT J
AU Skinner, TC
   Carey, ME
   Cradock, S
   Dallosso, HM
   Daly, H
   Davies, MJ
   Doherty, Y
   Heller, S
   Khunti, K
   Oliver, L
AF Skinner, T. C.
   Carey, M. E.
   Cradock, S.
   Dallosso, H. M.
   Daly, H.
   Davies, M. J.
   Doherty, Y.
   Heller, S.
   Khunti, K.
   Oliver, L.
CA Desmond Collaborative
TI Depressive symptoms in the first year from diagnosis of Type 2 diabetes:
   results from the DESMOND trial
SO DIABETIC MEDICINE
LA English
DT Article
DE depression; type 2 diabetes
ID RANDOMIZED CONTROLLED-TRIAL; HOSPITAL ANXIETY; METAANALYSIS; PREVALENCE;
   PEOPLE; ADULTS; SCALE
AB P>Aims
   To describe the course of depressive symptoms during the first year after diagnosis of Type 2 diabetes.
   Methods
   Post hoc analysis of data from a randomized controlled trial of self-management education for 824 individuals newly diagnosed with Type 2 diabetes. Participants completed the Depression scale of the Hospital Anxiety and Depression Scale after diagnosis and at 4, 8 and 12 months follow-up. Participants also completed the Problem Areas in Diabetes scale at 8 and 12 months follow-up. We present descriptive statistics on prevalence and persistence of depressive symptoms. Logistic regression is used to predict possible depression cases, and multiple regression to predict depressive symptomatology.
   Results
   The prevalence of depressive symptoms in individuals recently diagnosed with diabetes (18-22% over the year) was not significantly different from normative data for the general population (12%) in the UK. Over 20% of participants indicated some degrees of depressive symptoms over the first year of living with Type 2 diabetes; these were mostly transient episodes, with 5% (1% severe) reporting having depressive symptoms throughout the year. At 12 months post diagnosis, after controlling for baseline depressive symptoms, diabetes-specific emotional distress was predictive of depressive symptomatology.
   Conclusions
   The increased prevalence of depressive symptoms in diabetes is not manifest until at least 1 year post diagnosis in this cohort. However, there are a significant number of people with persistent depressive symptoms in the early stages of diabetes, and diabetes-specific distress may be contributing to subsequent development of depressive symptoms in people with Type 2 diabetes.
C1 [Skinner, T. C.] Univ Western Australia, Combined Univ Ctr Rural Hlth, Geraldton, WA 6531, Australia.
   [Carey, M. E.; Dallosso, H. M.; Daly, H.] Univ Hosp Leicester NHS Trust, Diabet Res Team, Leicester, Leics, England.
   [Cradock, S.] Portsmouth Diabet Ctr & Portsmouth City Primary C, Portsmouth, Hants, England.
   [Davies, M. J.] Univ Leicester, Dept Cardiovasc Serv, Leicester, Leics, England.
   [Heller, S.] Univ Sheffield, Sch Med, Dept Res & Dev, Sheffield, S Yorkshire, England.
   [Heller, S.] Univ Sheffield, Sch Med, Acad Unit Diabet Endocrinol & Metab, Sheffield, S Yorkshire, England.
   [Khunti, K.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England.
RP Skinner, TC (reprint author), Univ Western Australia, Combined Univ Ctr Rural Hlth, POB 109, Geraldton, WA 6531, Australia.
EM timskinner@cucrh.uwa.edu.au
RI Skinner, Timothy/G-2865-2010
OI Khunti, Kamlesh/0000-0003-2343-7099; Davies,
   Michael/0000-0002-5196-6919; Heller, Simon/0000-0002-2425-9565; Davies,
   Melanie/0000-0002-9987-9371; Skinner, Timothy/0000-0002-0018-6963
CR Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3
   Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278
   Crawford JR, 2001, BRIT J CLIN PSYCHOL, V40, P429, DOI 10.1348/014466501163904
   Davies MJ, 2008, BRIT MED J, V336, P491, DOI 10.1136/bmj.39474.922025.BE
   Khunti K, 2008, DIABETIC MED, V25, P1454, DOI 10.1111/j.1464-5491.2008.02620.x
   Knol MJ, 2006, DIABETOLOGIA, V49, P837, DOI 10.1007/s00125-006-0159-x
   Lustman Patrick J, 2008, Curr Psychiatry Rep, V10, P495
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Pouwer F, 2005, DIABETES RES CLIN PR, V70, P166, DOI 10.1016/j.diabres.2005.03.031
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
NR 12
TC 15
Z9 16
U1 0
U2 7
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0742-3071
J9 DIABETIC MED
JI Diabetic Med.
PD AUG
PY 2010
VL 27
IS 8
BP 965
EP 967
DI 10.1111/j.1464-5491.2010.03028.x
PG 3
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 626RN
UT WOS:000279984700019
PM 20653757
DA 2019-01-08
ER

PT J
AU Ogihara, T
   Mirmira, RG
AF Ogihara, Takeshi
   Mirmira, Raghavendra G.
TI An islet in distress: beta cell failure in type 2 diabetes
SO JOURNAL OF DIABETES INVESTIGATION
LA English
DT Review
DE Islet; Diabetes; Insulin resistance
ID ENDOPLASMIC-RETICULUM STRESS; INSULIN GENE-TRANSCRIPTION;
   UNFOLDED-PROTEIN RESPONSE; HUMAN PANCREATIC-ISLETS;
   TUMOR-NECROSIS-FACTOR; FREE FATTY-ACIDS; THIOREDOXIN-INTERACTING
   PROTEIN; NUCLEAR FACTOR-4-ALPHA GENE; RECEPTOR-GAMMA ACTIVATION; CHRONIC
   OXIDATIVE STRESS
AB Over 200 million people worldwide suffer from diabetes, a disorder of glucose homeostasis. The majority of these individuals are diagnosed with type 2 diabetes. It has traditionally been thought that tissue resistance to the action of insulin is the primary defect in type 2 diabetes. However, recent longitudinal and genome-wide association studies have shown that insulin resistance is more likely to be a precondition, and that the failure of the pancreatic beta cell to meet the increased insulin requirements is the triggering factor in the development of type 2 diabetes. A major emphasis in diabetes research has therefore shifted to understanding the causes of beta cell failure. Collectively, these studies have implicated a complex network of triggers, which activate intersecting execution pathways leading to beta cell dysfunction and death. In the present review, we discuss these triggers (glucotoxicity, lipotoxicity, amyloid and cytokines) with respect to the pathways they activate (oxidative stress, inflammation and endoplasmic reticulum stress) and propose a model for understanding beta cell failure in type 2 diabetes. (J Diabetes Invest, doi: 10.1111/j.2040-1124.2010.00021.x, 2010)
C1 [Ogihara, Takeshi; Mirmira, Raghavendra G.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA.
   [Ogihara, Takeshi; Mirmira, Raghavendra G.] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN USA.
   [Mirmira, Raghavendra G.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN USA.
   [Mirmira, Raghavendra G.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN USA.
RP Mirmira, RG (reprint author), Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA.
EM rmirmira@iupui.edu
FU National Institutes of Health [R01 DK60581]; Ball Brothers Foundation
FX The authors were supported by grant R01 DK60581 from the National
   Institutes of Health, an ADA-Takeda Mentor-based Postdoctoral
   Fellowship, and a gift from the Ball Brothers Foundation (all to RGM).
CR Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9
   Alquier T, 2009, DIABETES, V58, P2607, DOI 10.2337/db09-0362
   Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS81, DOI [10.2337/dc14-S081, 10.2337/dc10-s062, 10.2337/dc11-S062, 10.2337/dc10-S062]
   Anello M, 2005, DIABETOLOGIA, V48, P282, DOI 10.1007/s00125-004-1627-9
   Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143-4160(023)00182-3
   Bertolotti A, 2000, NAT CELL BIOL, V2, P326
   BLEICH D, 1995, ENDOCRINOLOGY, V136, P5736, DOI 10.1210/en.136.12.5736
   BODEN G, 1995, DIABETES, V44, P1239, DOI 10.2337/diabetes.44.10.1239
   Bouzakri K, 2009, J BIOL CHEM, V284, P27892, DOI 10.1074/jbc.M109.048058
   Briaud I, 2001, DIABETES, V50, P315, DOI 10.2337/diabetes.50.2.315
   Brunham LR, 2007, NAT MED, V13, P340, DOI 10.1038/nm1546
   Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911
   Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102
   Butler AE, 2004, DIABETES, V53, P1509, DOI 10.2337/diabetes.53.6.1509
   BUTLER PC, 1990, DIABETES, V39, P752, DOI 10.2337/diabetes.39.6.752
   Casas S, 2007, DIABETES, V56, P2284, DOI 10.2337/db07-0178
   Cha-Molstad H, 2009, J BIOL CHEM, V284, P16898, DOI 10.1074/jbc.M109.010504
   Chen J, 2008, DIABETES, V57, P938, DOI 10.2337/db07-0715
   Chen M, 2005, DIABETOLOGIA, V48, P486, DOI 10.1007/s00125-005-1673-y
   Chen M, 2002, ENDOCRINOLOGY, V143, P2341, DOI 10.1210/en.143.6.2341
   CLARK A, 1995, DIABETES RES CLIN PR, V28, pS39, DOI 10.1016/0168-8227(95)01075-O
   Cnop M, 2002, DIABETES, V51, P1005, DOI 10.2337/diabetes.51.4.1005
   Cnop M, 2002, ENDOCRINOLOGY, V143, P3449, DOI 10.1210/en.2002-220273
   Cnop M, 2003, DIABETOLOGIA, V46, P459, DOI 10.1007/s00125-003-1074-z
   Deeney JT, 2000, J BIOL CHEM, V275, P9363, DOI 10.1074/jbc.275.13.9363
   DeFronzo RA, 2010, DIABETOLOGIA, V53, P435, DOI 10.1007/s00125-009-1614-2
   Dickson LM, 2004, AM J PHYSIOL-ENDOC M, V287, pE192, DOI 10.1152/ajpendo.00031.2004
   EHRLICH JC, 1961, AM J PATHOL, V38, P49
   Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650
   Eitel K, 2003, DIABETES, V52, P991, DOI 10.2337/diabetes.52.4.991
   Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015
   Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021
   El-Assaad W, 2003, ENDOCRINOLOGY, V144, P4154, DOI 10.1210/en.2003-0410
   Elouil H, 2007, DIABETOLOGIA, V50, P1442, DOI 10.1007/s00125-007-0674-4
   Emilsson V, 1997, DIABETES, V46, P313, DOI 10.2337/diabetes.46.2.313
   Evans-Molina C, 2009, MOL CELL BIOL, V29, P2053, DOI 10.1128/MCB.01179-08
   Festa A, 2006, DIABETES, V55, P1114, DOI 10.2337/diabetes.55.04.06.db05-1100
   GRANKVIST K, 1981, BIOCHEM J, V199, P393, DOI 10.1042/bj1990393
   Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732
   Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027
   Hagman DK, 2008, DIABETES, V57, P424, DOI 10.2337/db07-1285
   Hagman DK, 2005, J BIOL CHEM, V280, P32413, DOI 10.1074/jbc.M506000200
   Han X, 2002, MOL ENDOCRINOL, V16, P2145, DOI 10.1210/me.2001-0300
   Harmon JS, 2009, ENDOCRINOLOGY, V150, P4855, DOI 10.1210/en.2009-0708
   Henquin JC, 2004, DIABETES, V53, pS48, DOI 10.2337/diabetes.53.suppl_3.S48
   HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936
   Huang CJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE1656, DOI 10.1152/ajpendo.00318.2007
   Huang CJ, 2007, DIABETES, V56, P2016, DOI 10.2337/db07-0197
   Hundal RS, 2002, J CLIN INVEST, V109, P1321, DOI 10.1172/JCI200214955
   Ihara Y, 1999, DIABETES, V48, P927, DOI 10.2337/diabetes.48.4.927
   Ishida H, 2004, METABOLISM, V53, P488, DOI 10.1016/j.metabol.2003.11.021
   Jacqueminet S, 2000, METABOLISM, V49, P532, DOI 10.1016/S0026-0495(00)80021-9
   Janson J, 1996, P NATL ACAD SCI USA, V93, P7283, DOI 10.1073/pnas.93.14.7283
   Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCD.24.3.1365-1377.2004
   Jonas JC, 2009, DIABETES OBES METAB, V11, P65, DOI 10.1111/j.1463-1326.2009.01112.x
   Jonas JC, 1999, J BIOL CHEM, V274, P14112, DOI 10.1074/jbc.274.20.14112
   Joseph JW, 2004, J BIOL CHEM, V279, P51049, DOI 10.1074/jbc.M409189200
   Joseph JW, 2002, DIABETES, V51, P3211, DOI 10.2337/diabetes.51.11.3211
   KAHN SE, 1990, DIABETES, V39, P634, DOI 10.2337/diabetes.39.5.634
   Kajimoto Y, 2004, ANN NY ACAD SCI, V1011, P168, DOI 10.1196/annals.1293.017
   Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JC126498
   Kawasaki F, 2005, AM J PHYSIOL-ENDOC M, V288, pE510, DOI 10.1152/ajpendo.00128.2004
   Kelpe CL, 2003, J BIOL CHEM, V278, P30015, DOI 10.1074/jbc.M302548200
   Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745
   Kieffer TJ, 1997, DIABETES, V46, P1087, DOI 10.2337/diabetes.46.6.1087
   Kjorholt C, 2005, DIABETES, V54, P2755, DOI 10.2337/diabetes.54.9.2755
   Koshkin V, 2003, J BIOL CHEM, V278, P19709, DOI 10.1074/jbc.M209709200
   Kulkarni RN, 1997, J CLIN INVEST, V100, P2729, DOI 10.1172/JCI119818
   KULKARNI RN, 2001, MOL BASIS PANCREAS D, P299
   Kwon G, 1999, J BIOL CHEM, V274, P18702, DOI 10.1074/jbc.274.26.18702
   Lameloise N, 2001, DIABETES, V50, P803, DOI 10.2337/diabetes.50.4.803
   Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213
   Larsen CM, 2009, DIABETES CARE, V32, P1663, DOI 10.2337/dc09-0533
   Laybutt DR, 2007, DIABETOLOGIA, V50, P2117, DOI 10.1007/s00125-007-0749-2
   Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z
   Lee JW, 2009, CELL SIGNAL, V21, P69, DOI 10.1016/j.cellsig.2008.09.015
   LEFFERT JD, 1989, P NATL ACAD SCI USA, V86, P3127, DOI 10.1073/pnas.86.9.3127
   Liu M, 2007, P NATL ACAD SCI USA, V104, P15841, DOI 10.1073/pnas.0702697104
   Liu SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007983
   Love-Gregory LD, 2004, DIABETES, V53, P1134, DOI 10.2337/diabetes.53.4.1134
   Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437
   Ma K, 2010, J CLIN ENDOCR METAB, V95, P887, DOI 10.1210/jc.2009-1102
   Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6
   Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587
   Maedler K, 2003, DIABETES, V52, P726, DOI 10.2337/diabetes.52.3.726
   Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318
   Maedler K, 2002, P NATL ACAD SCI USA, V99, P8236, DOI 10.1073/pnas.122686299
   Maedler K, 2001, DIABETES, V50, P69, DOI 10.2337/diabetes.50.1.69
   MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155
   Meier JJ, 2006, AM J PHYSIOL-ENDOC M, V291, pE1317, DOI 10.1152/ajpendo.00082.2006
   Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196
   Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76
   Molina AJA, 2009, DIABETES, V58, P2303, DOI 10.2337/db07-1781
   Morioka T, 2007, J CLIN INVEST, V117, P2860, DOI 10.1172/JCI30910
   Nolan CJ, 2008, TRENDS ENDOCRIN MET, V19, P285, DOI 10.1016/i.tem.2008.07.006
   Nolan CJ, 2006, DIABETES, V55, pS16, DOI 10.2337/db06-S003
   NOVIALS A, 1993, DIABETES, V42, P1514, DOI 10.2337/diabetes.42.10.1514
   Nunemaker CS, 2008, AM J PHYSIOL-ENDOC M, V295, pE1065, DOI 10.1152/ajpendo.90371.2008
   Ogihara T, 2010, J BIOL CHEM, V285, P5392, DOI 10.1074/jbc.M109.064659
   Ogilvie RF, 1933, J PATHOL BACTERIOL, V37, P473, DOI 10.1002/path.1700370314
   OLSON LK, 1993, J CLIN INVEST, V92, P514, DOI 10.1172/JCI116596
   Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JC1200214550
   Paz K, 1997, J BIOL CHEM, V272, P29911, DOI 10.1074/jbc.272.47.29911
   Petersen KF, 2006, AM J MED, V119, p10S, DOI 10.1016/j.amjmed.2006.01.009
   Pinney SE, 2010, TRENDS ENDOCRIN MET, V21, P223, DOI 10.1016/j.tem.2009.10.002
   Piro S, 2002, METABOLISM, V51, P1340, DOI 10.1053/meta.2002.35200
   Pirot P, 2007, DIABETES, V56, P1069, DOI 10.2337/db06-1253
   Poitout V, 1996, J CLIN INVEST, V97, P1041, DOI 10.1172/JCI118496
   Poitout V, 2010, BBA-MOL CELL BIOL L, V1801, P289, DOI 10.1016/j.bbalip.2009.08.006
   PRENTKI M, 1992, J BIOL CHEM, V267, P5802
   Richardson SJ, 2009, DIABETOLOGIA, V52, P1143, DOI 10.1007/s00125-009-1276-0
   Robertson RP, 2007, CELL BIOCHEM BIOPHYS, V48, P139, DOI 10.1007/s12013-07-0026-5
   Robertson RP, 2004, J BIOL CHEM, V279, P42351, DOI 10.1074/jbc.R400019200
   ROCKEN C, 1992, VIRCHOWS ARCH A, V421, P339, DOI 10.1007/BF01660981
   SAKO Y, 1990, ENDOCRINOLOGY, V127, P1580, DOI 10.1210/endo-127-4-1580
   Sakuraba H, 2002, DIABETOLOGIA, V45, P85, DOI 10.1007/s125-002-8248-z
   SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746
   Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039
   SHARMA A, 1995, MOL ENDOCRINOL, V9, P1127, DOI 10.1210/me.9.9.1127
   Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4
   Shimabukuro M, 1998, J BIOL CHEM, V273, P32487, DOI 10.1074/jbc.273.49.32487
   Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498
   Sigal RJ, 2004, DIABETES CARE, V27, P2518, DOI 10.2337/diacare.27.10.2518
   Silander K, 2004, DIABETES, V53, P1141, DOI 10.2337/diabetes.53.4.1141
   Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616
   Solinas G, 2006, P NATL ACAD SCI USA, V103, P16454, DOI 10.1073/pnas.0607626103
   Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587
   Stein DT, 1996, J CLIN INVEST, V97, P2728, DOI 10.1172/JCI118727
   Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000
   Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X
   Tabak AG, 2009, LANCET, V373, P2215, DOI 10.1016/S0140-6736(09)60619-X
   Tan CP, 2008, DIABETES, V57, P2211, DOI 10.2337/db08-0130
   Tanaka Y, 1999, P NATL ACAD SCI USA, V96, P10857, DOI 10.1073/pnas.96.19.10857
   Tanaka Y, 2002, P NATL ACAD SCI USA, V99, P12363, DOI 10.1073/pnas.192445199
   Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733
   Tomita T, 2006, DIABETOLOGIA, V49, P962, DOI 10.1007/s00125-006-0193-8
   *UK PROSP DIAB STU, 1995, DIABETES, V44, P1249
   Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431
   Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16
   Welsh N, 2005, DIABETES, V54, P3238, DOI 10.2337/diabetes.54.11.3238
   WESTERMARK P, 1989, DIABETES RES CLIN PR, V7, P219, DOI 10.1016/0168-8227(89)90008-9
   Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231
   Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930
   Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047
   Xiang AH, 2006, DIABETES, V55, P517, DOI 10.2337/diabetes.55.02.06.db05-1066
   Zhang SP, 2008, DIABETES, V57, P348, DOI 10.2337/db07-0849
   ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0
   Zhao AZ, 1998, J CLIN INVEST, V102, P869, DOI 10.1172/JCI3920
   Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831
   ZHOU YP, 1994, J CLIN INVEST, V93, P870, DOI 10.1172/JCI117042
   Zraika S, 2009, DIABETOLOGIA, V52, P626, DOI 10.1007/s00125-008-1255-x
NR 151
TC 17
Z9 17
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2040-1124
J9 J DIABETES INVEST
JI J. Diabetes Investig.
PD AUG
PY 2010
VL 1
IS 4
BP 123
EP 133
DI 10.1111/j.2040-1124.2010.00021.x
PG 11
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 755DI
UT WOS:000289906500002
PM 24843420
OA Green Published, Bronze
DA 2019-01-08
ER

PT J
AU Phillips, AC
   Carroll, D
   Thomas, GN
   Gale, CR
   Deary, I
   Batty, GD
AF Phillips, Anna C.
   Carroll, Douglas
   Thomas, G. Neil
   Gale, Catharine R.
   Deary, Ian
   Batty, G. David
TI The influence of multiple indices of socioeconomic disadvantage across
   the adult life course on the metabolic syndrome: the Vietnam Experience
   Study
SO METABOLISM-CLINICAL AND EXPERIMENTAL
LA English
DT Article
ID RISK-FACTORS; SOCIAL INEQUALITIES; WHITEHALL-II; COURSE ORIGINS;
   ALL-CAUSE; MORTALITY; HEALTH; PREVALENCE; POSITION; POPULATION
AB Few studies have explored the relationship between individual and combined multiple indicators of socioeconomic status across the life course and the metabolic syndrome, or attempted to understand the mechanisms underlying any associations. The present study examined the associations between 4 indicators of socioeconomic status, individually and in combination, and metabolic syndrome risk in a study of male US veterans and examined the influence of health behaviors, intelligence, and psychologic distress on these associations. Participants (N = 4253) were drawn from the Vietnam Experience Study. From military service files, telephone interviews, and a medical examination, occupational, sociodemographic, health behavior, intelligence, psychologic, and health data were collected. The 4 indices of socioeconomic status were as follows: education achieved, early adulthood income, household income in midlife, and occupational prestige in midlife. Metabolic syndrome was diagnosed from the following: body mass index, fasting blood glucose or a diagnosis of diabetes, blood pressure a diagnosis of hypertension or taking antihypertensives, high-density lipoprotein cholesterol, and triglyceride levels. In models that adjusted for age, men in the lower 2 groups on the combined measure of socioeconomic status experienced a higher risk of metabolic syndrome. This association was accounted for mainly by education achieved, household income in midlife, and occupational prestige in midlife. Intelligence appeared to explain much of this association. Combined socioeconomic status measures across the life course were related to metabolic syndrome but in a threshold rather than dose-response manner. Intelligence appeared to mediate this relationship. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Phillips, Anna C.; Carroll, Douglas] Univ Birmingham, Sch Sport & Exercise Sci, Birmingham B15 2TT, W Midlands, England.
   [Thomas, G. Neil] Univ Birmingham, Sch Med & Dent Sci, Birmingham B15 2TT, W Midlands, England.
   [Gale, Catharine R.] Univ Southampton, MRC Epidemiol Resource Ctr, Southampton SO9 5NH, Hants, England.
   [Deary, Ian; Batty, G. David] Univ Edinburgh, Dept Psychol, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh EH8 9YL, Midlothian, Scotland.
   [Batty, G. David] Univ Glasgow, MRC Social & Publ Hlth Sci Unit, Glasgow G12 8QQ, Lanark, Scotland.
   [Batty, G. David] George Inst Int Hlth, Sydney, NSW, Australia.
RP Phillips, AC (reprint author), Univ Birmingham, Sch Sport & Exercise Sci, Birmingham B15 2TT, W Midlands, England.
EM a.c.phillips@bham.ac.uk
RI Batty, George/Y-4401-2018; Deary, Ian/C-6297-2009; Gale,
   Catharine/B-1653-2012; Phillips, Anna/A-3577-2013; Thomas, G.
   Neil/A-1879-2013
OI Deary, Ian/0000-0002-1733-263X; Phillips, Anna/0000-0002-5461-0598;
   Thomas, G. Neil/0000-0002-2777-1847
FU UK Medical Research Council; Chief Scientist Office at the Scottish
   Government Health Directorates; Biotechnology and Biological Sciences
   Research Council; Engineering and Physical Sciences Research Council;
   Economic and Social Research Council; Medical Research Council;
   University of Edinburgh as part of the cross-council Lifelong Health and
   Wellbeing initiative; Wellcome Trust [WBS U.1300.00.006.00012.01];
   Medical Research Council [MC_U130059821, MC_UP_A620_1015, G0700704,
   U1475000002]
FX The Medical Research Council Social and Public Health Sciences Unit
   receives funding from the UK Medical Research Council and the Chief
   Scientist Office at the Scottish Government Health Directorates. The
   Centre for Cognitive Ageing and Cognitive Epidemiology is supported by
   the Biotechnology and Biological Sciences Research Council, the
   Engineering and Physical Sciences Research Council, the Economic and
   Social Research Council, the Medical Research Council, and the
   University of Edinburgh as part of the cross-council Lifelong Health and
   Wellbeing initiative. David Batty is a Wellcome Trust Career Development
   Fellow (WBS U.1300.00.006.00012.01).
CR American Psychiatric Association, 1980, DIAGN STAT MAN MENT
   Batty GD, 2008, J EPIDEMIOL COMMUN H, V62, P522, DOI 10.1136/jech.2007.064881
   Batty GD, 2008, DIABETOLOGIA, V51, P436, DOI 10.1007/s00125-007-0908-5
   Batty GD, 2006, BRIT MED J, V332, P580, DOI 10.1136/bmj.38723.660637.AE
   Blane D, 2007, REV EPIDEMIOL SANTE, V55, P31, DOI 10.1016/j.respe.2006.12.004
   Blane D, 1996, BMJ-BRIT MED J, V313, P1434, DOI 10.1136/bmj.313.7070.1434
   Brunner EJ, 1997, DIABETOLOGIA, V40, P1341, DOI 10.1007/s001250050830
   CARROLL D, 1993, PSYCHOL HEALTH, V8, P295, DOI 10.1080/08870449308401924
   Carroll D, 2009, BIOL PSYCHIAT, V66, P91, DOI 10.1016/j.biopsych.2009.02.020
   Dallongeville J, 2005, DIABETES CARE, V28, P409, DOI 10.2337/diacare.28.2.409
   Davey Smith G, 1994, EUROPEAN J PUBLIC HL, V4, P131
   DESTEFANO F, 1988, JAMA-J AM MED ASSOC, V259, P2708
   Hart CL, 1998, AM J PUBLIC HEALTH, V88, P471, DOI 10.2105/AJPH.88.3.471
   Kaplan GA, 1996, BRIT MED J, V312, P999
   Langenberg C, 2006, AM J PUBLIC HEALTH, V96, P2216, DOI 10.2105/AJPH.2004.049429
   Lawlor DA, 2002, BRIT MED J, V325, P805, DOI 10.1136/bmj.325.7368.805
   Loucks EB, 2007, ANN EPIDEMIOL, V17, P782, DOI 10.1016/j.annepidem.2007.05.003
   Loucks EB, 2007, ANN EPIDEMIOL, V17, P19, DOI 10.1016/j.annepidem.2006.07.002
   Paek KW, 2006, ANN EPIDEMIOL, V16, P756, DOI 10.1016/j.annepidem.2006.04.012
   Park MJ, 2007, ANN EPIDEMIOL, V17, P320, DOI 10.1016/j.annepidem.2006.10.007
   Perel P, 2006, DIABETES CARE, V29, P2694, DOI 10.2337/dc06-0022
   Ramsay SE, 2008, DIABETES CARE, V31, P2380, DOI 10.2337/dc08-1158
   Razzouk L, 2009, CURR HYPERTENS REP, V11, P127, DOI 10.1007/s11906-009-0023-8
   Reppert A, 2008, AM J HEALTH PROMOT, V23, P130, DOI 10.4278/ajhp.071009105
   ROBINS LN, 1987, DIAGNOSTIC INTERVIEW
   Sanchez-Chaparro MA, 2008, DIABETES CARE, V31, P1884, DOI 10.2337/dc08-0431
   Schooling CM, 2008, AM J EPIDEMIOL, V167, P419, DOI 10.1093/aje/kwm329
   Smith GD, 2000, PUBLIC HEALTH, V114, P308, DOI 10.1016/S0033-3506(00)00353-X
   Stansfeld SA, 2003, J EPIDEMIOL COMMUN H, V57, P361, DOI 10.1136/jech.57.5.361
   STEVENS G, 1985, SOC SCI RES, V14, P142, DOI 10.1016/0049-089X(85)90008-0
   Thomas GN, 2007, CLIN ENDOCRINOL, V66, P666, DOI 10.1111/j.1365-2265.2007.02798.x
   Wamala SP, 1999, DIABETES CARE, V22, P1999, DOI 10.2337/diacare.22.12.1999
   Welin L, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-403
   WILKINSON RG, 1996, UNHEALTHY SOC INEQUA
   Wilkinson RG, 2003, SOCIAL DETERMINANTS
NR 35
TC 5
Z9 6
U1 0
U2 2
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0026-0495
J9 METABOLISM
JI Metab.-Clin. Exp.
PD AUG
PY 2010
VL 59
IS 8
BP 1164
EP 1171
DI 10.1016/j.metabol.2009.11.009
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 635PZ
UT WOS:000280669900012
PM 20045139
DA 2019-01-08
ER

PT J
AU Melkus, GD
   Chyun, D
   Vorderstrasse, A
   Newlin, K
   Jefferson, V
   Langerman, S
AF Melkus, Gail D'Eramo
   Chyun, Deborah
   Vorderstrasse, Allison
   Newlin, Kelley
   Jefferson, Vanessa
   Langerman, Susan
TI The Effect of a Diabetes Education, Coping Skills Training, and Care
   Intervention on Physiological and Psychosocial Outcomes in Black Women
   With Type 2 Diabetes
SO BIOLOGICAL RESEARCH FOR NURSING
LA English
DT Article
DE diabetes; self-management; outcomes; Blacks; intervention; primary care
ID AFRICAN-AMERICAN WOMEN; SELF-MANAGEMENT EDUCATION; METABOLIC-CONTROL;
   GLYCEMIC CONTROL; HEALTH OUTCOMES; RISK-FACTORS; ADULTS; MELLITUS;
   EFFICACY; DISEASE
AB An 11-week culturally relevant group diabetes self-management training (DSMT), coping skills training (CST), and diabetes care intervention was compared to a 10-week usual diabetes education and diabetes care intervention on physiological and psychosocial outcomes in 109 Black women (aged 48 +/- 10 years) with type 2 diabetes in primary care (PC). Strong time effects for hemoglobin Alc improvement were seen in both groups from baseline to 3 months and remained similar at 12 and 24 months (p < .0001). Systolic blood pressure (p = .01) and low-density lipoprotein cholesterol levels (p = .05) improved in both groups from baseline to 24 months. Baseline quality of life ([QOL]; Medical Outcome Study Short Form-36) was low. Social function, role-emotional, and mental health domains increased initially in both groups then declined slightly, with less decline for the experimental group at 12 months. At 24 months, experimental group scores increased. General health (p = .002), vitality (p = .01), role-physical, and bodily pain (p = .02) domains increased in both groups over time. Perceived provider support for diet (p = .0001) and exercise (p = .0001) increased in both groups over time. Diabetes-related emotional distress decreased in the experimental compared to the control group (group x time, p = .01). Findings suggest that both methods of diabetes education combined with care can improve metabolic control, QOL, and perceptions of provider care. CST may further assist in long-term improvements in health outcomes. Behavioral interventions are needed in addition to routine diabetes care, particularly in PC.
C1 [Melkus, Gail D'Eramo; Chyun, Deborah; Newlin, Kelley] New York Univ, Coll Nursing, New York, NY 10003 USA.
   [Vorderstrasse, Allison] Duke Univ, Sch Nursing, Durham, NC USA.
   [Jefferson, Vanessa] Yale Univ, Sch Nursing, New Haven, CT 06536 USA.
   [Langerman, Susan] Yale Univ Hlth Plan, New Haven, CT USA.
RP Melkus, GD (reprint author), New York Univ, Coll Nursing, 726 Broadway 1083, New York, NY 10003 USA.
EM Gail.Melkus@nyu.edu
FU NIH NINR [ROI NR 05341-01A1]
FX Research was supported by NIH NINR Funding ROI NR 05341-01A1.
CR *AM DIAB ASS, 2009, DIABETES CARE S1, V32, pS13, DOI DOI 10.2337/DC09-S013
   American Association of Diabetes Educators, 2008, DIABETES ED, V34, P445, DOI DOI 10.1177/0145721708316625
   Anderson-Loftin W, 2000, DIABETES EDUCATOR, V26, P821, DOI 10.1177/014572170002600511
   Balukonis J, 2008, ETHNIC DIS, V18, P141
   BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191
   BECKLES G, 2001, DIABETES WOMEN LIFE
   Brown Sharon A, 2002, Curr Diab Rep, V2, P166, DOI 10.1007/s11892-002-0077-3
   Carter-Edwards L, 2004, DIABETES EDUCATOR, V30, P493, DOI 10.1177/014572170403000321
   *CDCP, 2002, MMWR-MORBID MORTAL W, V51, P159
   Centers for Disease Control and Prevention, 2007, NAT DIAB FACT SHEET
   Centers for Disease Control and Prevention (CDC), 2002, MMWR-MORBID MORTAL W, V51, P147
   CRISP AH, 1984, LANCET, V1, P616
   CROWN S, 1966, BRIT J PSYCHIAT, V112, P917, DOI 10.1192/bjp.112.490.917
   DERAMOMELKUS GA, 1992, DIABETES CARE, V15, P864, DOI 10.2337/diacare.15.7.864
   Eakin EG, 2002, DIABETES-METAB RES, V18, P26, DOI 10.1002/dmrr.266
   Eigenmann CA, 2009, DIABETIC MED, V26, P425, DOI 10.1111/j.1464-5491.2009.02697.x
   Fisher EB, 2005, AM J PUBLIC HEALTH, V95, P1523, DOI 10.2105/AJPH.2005.066084
   Fisher EB, 2007, DIABETES EDUCATOR, V33, p216S, DOI 10.1177/0145721707304124
   Fitzgerald JT, 1996, EVAL HEALTH PROF, V19, P208, DOI 10.1177/016327879601900205
   Fitzgerald JT, 1998, EVAL HEALTH PROF, V21, P52, DOI 10.1177/016327879802100103
   Funnell Martha M, 2003, Curr Diab Rep, V3, P127, DOI 10.1007/s11892-003-0036-7
   Garfield SA, 2003, DIABETES CARE, V26, P2670, DOI 10.2337/diacare.26.9.2670
   Glasgow RE, 2006, CHRONIC ILLN, V2, P27, DOI 10.1179/174592006X93851
   Glasgow RE, 2007, J MED INTERNET RES, V9, DOI 10.2196/jmir.9.2.e11
   Grey M, 1998, DIABETES CARE, V21, P902, DOI 10.2337/diacare.21.6.902
   Grey M, 2000, J PEDIATR-US, V137, P107, DOI 10.1067/mpd.2000.106568
   HEIGHT DI, 1994, BLACK FAMILY DINNER
   HERON M, 2009, NATL VITAL STAT REPO, V57
   Hill-Briggs F, 2007, DIABETES EDUCATOR, V33, P1032, DOI 10.1177/0145721707308412
   *HLTH PROM COUNC S, 1999, PUT FAT BACK
   Howard BV, 1998, DIABETES CARE, V21, P1258, DOI 10.2337/diacare.21.8.1258
   *IS INC, 1992, GLYC AFF GHB AFF ACC
   KANNEL WB, 1995, MED CLIN N AM, V79, P951, DOI 10.1016/S0025-7125(16)30016-5
   KAWACHI I, 1994, CIRCULATION, V89, P1992, DOI 10.1161/01.CIR.89.5.1992
   Leeman J, 2008, DIABETES EDUCATOR, V34, P310, DOI 10.1177/0145721708316623
   Liebman J, 2007, DIABETES EDUCATOR, V33, p132S, DOI 10.1177/0145721707304075
   Maciejewski PK, 2000, BRIT J PSYCHIAT, V176, P373, DOI 10.1192/bjp.176.4.373
   MCCAUL KD, 1987, MED CARE, V25, P868, DOI 10.1097/00005650-198709000-00005
   MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006
   Melkus G, 2001, DIABETES S, V50, P811
   Melkus GD, 2004, APPL NURS RES, V17, P10, DOI 10.1016/j.apnr.2003.10.009
   Miller CK, 2002, J AM DIET ASSOC, V102, P1069, DOI 10.1016/S0002-8223(02)90242-7
   Moser DK, 2000, NURS RES, V49, P109, DOI 10.1097/00006199-200003000-00008
   *NAT I DIAB DIG KI, 2007, NAT DIAB STAT 2007
   Nelson KM, 2002, DIABETES CARE, V25, P1722, DOI 10.2337/diacare.25.10.1722
   Newlin K, 2003, ETHNIC DIS, V13, P61
   Newlin K, 2006, ETHNIC DIS, V16, P956
   Norris SL, 2004, AM J MED, V117, P762, DOI 10.1016/j.amjmed.2004.05.024
   Norris SL, 2002, DIABETES CARE, V25, P1159, DOI 10.2337/diacare.25.7.1159
   Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   Peyrot M, 2009, DIABETES EDUCATOR, V35, P246, DOI 10.1177/0145721708329546
   Pickering TG, 2005, CIRCULATION, V111, P697, DOI [10.1161/01.CIR.0000154900.76284.F6, 10.1161/01.HYP.0000150859.47929.8e]
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Prochaska J O, 1984, Prog Clin Biol Res, V156, P131
   PROCHASKA JO, 1992, AM PSYCHOL, V47, P1102, DOI 10.1037//0003-066X.47.9.1102
   Rayman Kathleen, 2004, Health Care Women Int, V25, P900, DOI 10.1080/07399330490508604
   Ruggiero L, 1998, Med Health R I, V81, P355
   SHAMOON H, 1993, NEW ENGL J MED, V329, P977
   SKELLY AH, 1995, DIABETES EDUCATOR, V21, P38, DOI 10.1177/014572179502100107
   Smith SC, 2005, CIRCULATION, V111, P134
   *STATEHEALTHFACTS, 2006, NUMB DIAB DEATHS PER
   Surgenor LJ, 2000, J PSYCHOSOM RES, V49, P267, DOI 10.1016/S0022-3999(00)00181-1
   Surwit RS, 2002, DIABETES CARE, V25, P30, DOI 10.2337/diacare.25.1.30
   Utz SW, 2008, DIABETES EDUCATOR, V34, P854, DOI 10.1177/0145721708323642
   van der Ven N., 2003, DIABETES SPECTRUM, V16, P88, DOI [DOI 10.2337/DIASPECT.16.2.88, 10.2337/diaspect.16.2.88]
   WARE J, 1992, MED CARE, V30, P43
   Whittemore R, 2005, J CLIN NURS, V14, P195, DOI 10.1111/j.1365-2702.2004.00937.x
   Whittemore R, 2007, J TRANSCULT NURS, V18, P157, DOI 10.1177/1043659606298615
   Williams GC, 1996, DIABETES, V45, p13A
NR 70
TC 19
Z9 19
U1 2
U2 10
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1099-8004
J9 BIOL RES NURS
JI Biol. Res. Nurs.
PD JUL
PY 2010
VL 12
IS 1
BP 7
EP 19
DI 10.1177/1099800410369825
PG 13
WC Nursing
SC Nursing
GA 617IE
UT WOS:000279273400002
PM 20484058
DA 2019-01-08
ER

PT J
AU Nefs, G
   Pouwer, F
   Denollet, J
   Pop, VJM
AF Nefs, Giesje
   Pouwer, Francois
   Denollet, Johan
   Pop, Victor J. M.
TI Psychological risk factors of micro- and macrovascular outcomes in
   primary care patients with type 2 diabetes: rationale and design of the
   DiaDDZoB Study
SO BMC PUBLIC HEALTH
LA English
DT Article
ID POSTNATAL DEPRESSION SCALE; CORONARY-HEART-DISEASE; D PERSONALITY;
   CARDIOVASCULAR EVENTS; EMOTIONAL-PROBLEMS; MAJOR DEPRESSION; GLYCEMIC
   CONTROL; ARTERY-DISEASE; SYMPTOMS; COMPLICATIONS
AB Background: Depression is a common psychiatric complication of diabetes, but little is known about the natural course and the consequences of depressive symptoms in primary care patients with type 2 diabetes. While depression has been related to poor glycemic control and increased risk for macrovascular disease, its association with microvascular complications remains understudied. The predictive role of other psychological risk factors such as Type D (distressed) personality and the mechanisms that possibly link depression and Type D personality with poor vascular outcomes are also still unclear.
   Methods/Design: This prospective cohort study will examine: (1) the course of depressive symptoms in primary care patients with type 2 diabetes; (2) whether depressive symptoms and Type D personality are associated with the development of microvascular and/or macrovascular complications and with the risk of all-cause or vascular mortality; and (3) the behavioral and physiological mechanisms that may mediate these associations. The DiaDDZoB Study is embedded within the larger DIAZOB Primary Care Diabetes study, which covers a comprehensive cohort of type 2 diabetes patients treated by over 200 primary care physicians in South-East Brabant, The Netherlands. These patients will be followed during their lifetime and are assessed annually for demographic, clinical, lifestyle and psychosocial factors. Measurements include an interviewer-administered and self-report questionnaire, regular care laboratory tests and physical examinations, and pharmacy medication records. The DiaDDZoB Study uses data that have been collected during the original baseline assessment in 2005 (M-0; N = 2,460) and the 2007 (M-1; N = 2,225) and 2008 (M-2; N = 2,032) follow-up assessments.
   Discussion: The DiaDDZoB Study is expected to contribute to the current understanding of the course of depression in primary care patients with type 2 diabetes and will also test whether depressed patients or those with Type D personality are at increased risk for (further) development of micro- andand cardiovascular disease. More knowledge about the mechanisms behind this association is needed to guide new intervention studies.
C1 [Nefs, Giesje; Pouwer, Francois; Denollet, Johan; Pop, Victor J. M.] Tilburg Univ, Dept Med Psychol & Neuropsychol, CoRPS Ctr Res Psychol Somat Dis, NL-5000 LE Tilburg, Netherlands.
RP Pouwer, F (reprint author), Tilburg Univ, Dept Med Psychol & Neuropsychol, CoRPS Ctr Res Psychol Somat Dis, NL-5000 LE Tilburg, Netherlands.
EM f.pouwer@uvt.nl
RI Nefs, Giesje/C-9992-2018
FU Netherlands Organisation for Health Research and Development [5881];
   Netherlands Organisation for Scientific Research (The Hague, The
   Netherlands) [453-04.004]
FX This study was supported by a ZonMW grant (call for diabetes health care
   groups, application number 5881) from the Netherlands Organisation for
   Health Research and Development to Victor Pop, and by Vici grant #
   453-04.004 from the Netherlands Organisation for Scientific Research
   (The Hague, The Netherlands) to Johan Denollet.
CR Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x
   American Diabetes Association, 2008, DIABETES CARE, V31, P12
   [Anonymous], 1996, BRIT MED J, V313, P1448
   Becht MC, 2001, J AFFECT DISORDERS, V63, P209, DOI 10.1016/S0165-0327(99)00189-5
   Beekman ATF, 2002, ARCH GEN PSYCHIAT, V59, P605, DOI 10.1001/archpsyc.59.7.605
   Black SA, 2003, DIABETES CARE, V26, P2822, DOI 10.2337/diacare.26.10.2822
   Bruce DG, 2005, DIABETOLOGIA, V48, P2532, DOI 10.1007/s00125-005-0024-3
   Clouse RE, 2003, PSYCHOSOM MED, V65, P376, DOI 10.1097/01.PSY.0000041624.96580.1F
   COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782
   Cox JL, 1996, J AFFECT DISORDERS, V39, P185, DOI 10.1016/0165-0327(96)00008-0
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   Denollet J, 2005, PSYCHOSOM MED, V67, P89, DOI 10.1097/01.psy.0000149256.81953.49
   Egede LE, 2005, DIABETES CARE, V28, P1339, DOI 10.2337/diacare.28.6.1339
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   HERMANNS N, 2004, 40 EASD M MUN GERM
   HINTZE J, 2008, PASS 2008
   Katon WJ, 2005, DIABETES CARE, V28, P2668, DOI 10.2337/diacare.28.11.2668
   Katon WJ, 2004, J GEN INTERN MED, V19, P1192, DOI 10.1111/j.1525-1497.2004.30405.x
   Khunti K, 2000, J ROY SOC MED, V93, P183, DOI 10.1177/014107680009300407
   Knol MJ, 2008, PHARMACOEPIDEM DR S, V17, P577, DOI 10.1002/pds.1608
   Knol MJ, 2006, DIABETOLOGIA, V49, P837, DOI 10.1007/s00125-006-0159-x
   Koopmans B, 2009, DIABETOLOGIA, V52, P2056, DOI 10.1007/s00125-009-1460-2
   Koopmans B, 2009, FAM PRACT, V26, P171, DOI 10.1093/fampra/cmp016
   Kop WJ, 1997, J PSYCHOSOM RES, V43, P167, DOI 10.1016/S0022-3999(97)80002-5
   Kupper N, 2007, J PERS ASSESS, V89, P265, DOI 10.1080/00223890701629797
   Lett HS, 2004, PSYCHOSOM MED, V66, P305, DOI 10.1097/01.psy.0000126207.43307.c0
   Lin EHB, 2010, DIABETES CARE, V33, P264, DOI 10.2337/dc09-1068
   Lustman PJ, 1997, GEN HOSP PSYCHIAT, V19, P138, DOI 10.1016/S0163-8343(96)00170-3
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542
   Marshall SM, 2006, BRIT MED J, V333, P475, DOI 10.1136/bmj.38922.650521.80
   Martens EJ, 2007, J PSYCHOSOM RES, V63, P545, DOI 10.1016/j.jpsychores.2007.06.005
   Matthey S, 2006, ARCH WOMEN MENT HLTH, V9, P309, DOI 10.1007/s00737-006-0152-x
   Matthey S, 2001, J AFFECT DISORDERS, V64, P175, DOI 10.1016/S0165-0327(00)00236-6
   McIntyre RS, 2006, EXPERT OPIN DRUG SAF, V5, P157, DOI 10.1517/14740338.5.1.157
   Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985
   NOUWEN A, 2009, DIABETES CARE, V32, P57
   Nouwen Arie, 2009, Diabetes Care, V32, pe57, DOI 10.2337/dc09-0027
   Nyklicek I, 2004, PSYCHIAT RES, V128, P111, DOI 10.1016/j.psychres.2004.05.017
   OHARA MW, 1986, ARCH GEN PSYCHIAT, V43, P569
   Pedersen SS, 2003, EUR J CARDIOV PREV R, V10, P241, DOI 10.1097/01.hjr.0000085246.65733.06
   Pelle AJ, 2009, J AFFECT DISORDERS, V113, P150, DOI 10.1016/j.jad.2008.05.017
   Peyrot M, 1999, DIABETES CARE, V22, P448, DOI 10.2337/diacare.22.3.448
   Pibernik-Okanovic M, 2008, J DIABETES COMPLICAT, V22, P246, DOI 10.1016/j.jdiacomp.2007.03.002
   Poortvliet MC, 2007, DIABETES NEDERLAND O
   POP VJ, 1992, J AFFECT DISORDERS, V26, P105, DOI 10.1016/0165-0327(92)90041-4
   Pouwer F, 2006, PATIENT EDUC COUNS, V60, P235, DOI 10.1016/j.pec.2005.01.009
   Pouwer F, 2009, NAT REV ENDOCRINOL, V5, P665, DOI 10.1038/nrendo.2009.214
   Rozanski A, 1999, CIRCULATION, V99, P2192, DOI 10.1161/01.CIR.99.16.2192
   RUTTEN GEH, 2006, HUISARTS WET, V49, P137
   Schiffer AA, 2007, HEART, V93, P814, DOI 10.1136/hrt.2006.102822
   Sheeran T, 2002, PSYCHIAT RES, V109, P51, DOI 10.1016/S0165-1781(01)00364-X
   Ubink-Vetmaat LJ, 2005, NETH J MED, V63, P103
   UK Prospective Diabetes Study Grp, 1999, DIABETES CARE, V22, P1125
   Van der Kooy K, 2007, INT J GERIATR PSYCH, V22, P613, DOI 10.1002/gps.1723
   van Melle JP, 2004, PSYCHOSOM MED, V66, P814, DOI 10.1097/01.psy.0000146294.82810.9c
   VANWEEL C, 2005, ANN FAM MED S1, V3, P46
   Vrijhoef HJM, 2002, INT J NURS STUD, V39, P441, DOI 10.1016/S0020-7489(01)00046-3
   Vuorilehto MS, 2009, PSYCHOL MED, V39, P1697, DOI 10.1017/S0033291709005182
   Whooley MA, 2008, JAMA-J AM MED ASSOC, V300, P2379, DOI 10.1001/jama.2008.711
   Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047
   Williams R, 2002, DIABETOLOGIA, V45, pS13, DOI 10.1007/s00125-002-0859-9
   Zhang XP, 2005, AM J EPIDEMIOL, V161, P652, DOI 10.1093/aje/kwi089
   Zimmet P, 2009, DIABETES RES CLIN PR, V84, P107, DOI 10.1016/j.diabres.2009.01.016
NR 65
TC 9
Z9 9
U1 0
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD JUL 1
PY 2010
VL 10
AR 388
DI 10.1186/1471-2458-10-388
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 650OA
UT WOS:000281857700002
PM 20594337
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU van Bastelaar, KMP
   Pouwer, F
   Geelhoed-Duijvestijn, PHLM
   Tack, CJ
   Bazelmans, E
   Beekman, AT
   Heine, RJ
   Snoek, FJ
AF van Bastelaar, K. M. P.
   Pouwer, F.
   Geelhoed-Duijvestijn, P. H. L. M.
   Tack, C. J.
   Bazelmans, E.
   Beekman, A. T.
   Heine, R. J.
   Snoek, F. J.
TI Diabetes-specific emotional distress mediates the association between
   depressive symptoms and glycaemic control in Type 1 and Type 2 diabetes
SO DIABETIC MEDICINE
LA English
DT Article
DE depression; diabetes-specific emotional distress; glycaemic control;
   type 1 diabetes; type 2 diabetes
ID RANDOMIZED CONTROLLED-TRIAL; COMORBID DEPRESSION; METAANALYSIS;
   NETHERLANDS; PREVALENCE; STANDARD; VALIDITY; ADULTS; SCALE; CARE
AB P>Objectives
   To investigate whether diabetes-specific emotional distress mediates the relationship between depression and glycaemic control in patients with Type 1 and Type 2 diabetes.
   Research design and methods
   Data were derived from the baseline assessment of a depression in diabetes screening study carried out in three tertiary diabetes clinics in the Netherlands. Most recent glycated haemoglobin (HbA(1c)) measurement was obtained from medical records. The Centre for Epidemiologic Studies Depression Scale (CES-D) and Problem Areas in Diabetes scale (PAID) were used to measure depression and diabetes-specific emotional distress respectively. Linear regression was performed to examine the mediating effect of diabetes-distress.
   Results
   Complete data were available for 627 outpatients with Type 1 (n = 280) and Type 2 (n = 347) diabetes. Analyses showed that diabetes-distress mediated the relation between depression and glycaemic control and not differently for both disease types. Post-hoc analyses revealed that patients depressed and distressed by their diabetes were in significantly poorer glycaemic control relative to those not depressed nor distressed (HbA(1c) 8.7 +/- 1.7 vs. 7.6 +/- 1.2% in those without depressive symptoms, 7.6 +/- 1.1% in depressed only and 7.7 +/- 1.1% in the distressed only, P < 0.001). Depressed patients without elevated diabetes-distress did not show a significantly increased risk of elevated HbA(1c).
   Conclusions
   In explaining the association between depression and glycaemic control, diabetes-specific emotional distress appears to be an important mediator. Addressing diabetes-specific emotional problems as part of depression treatment in diabetes patients may help improve glycaemic outcomes.
C1 [van Bastelaar, K. M. P.] Vrije Univ Amsterdam, Med Ctr, Dept Med Psychol, Diabet Psychol Res Grp,EMGO Inst Hlth & Care Res, NL-1081 BT Amsterdam, Netherlands.
   [Pouwer, F.] Tilburg Univ, Dept Med Psychol & Neuropsychol, CoRPS Ctr Res Psychol Somat Dis, NL-5000 LE Tilburg, Netherlands.
   [Geelhoed-Duijvestijn, P. H. L. M.] Haaglanden Med Ctr, Dept Internal Med, The Hague, Netherlands.
   [Tack, C. J.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands.
   [Bazelmans, E.] Radboud Univ Nijmegen, Med Ctr, Dept Med Psychol, NL-6525 ED Nijmegen, Netherlands.
   [Beekman, A. T.] Vrije Univ Amsterdam, Med Ctr, Dept Psychiat, NL-1081 BT Amsterdam, Netherlands.
   [Heine, R. J.] Vrije Univ Amsterdam, Med Ctr, Dept Endocrinol, NL-1081 BT Amsterdam, Netherlands.
   [Heine, R. J.] Eli Lilly & Co, Indianapolis, IN 46285 USA.
RP van Bastelaar, KMP (reprint author), Vrije Univ Amsterdam, Med Ctr, Dept Med Psychol, Diabet Psychol Res Grp,EMGO Inst Hlth & Care Res, Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.
EM k.vanbastelaar@vumc.nl
RI Tack, Cees/A-2368-2014
FU Lundbeck; Eli Lilly
FX AB has received funding from Lundbeck and Eli Lilly for speaking and for
   research. RJH is affiliated with Eli Lilly and Company. All other
   authors declare no competing interests.
CR *ADA, 2009, DIABETES CARE S1, V32, pS13
   Amsberg S, 2009, PATIENT EDUC COUNS, V77, P72, DOI 10.1016/j.pec.2009.01.015
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037//0022-3514.51.6.1173
   Beekman ATF, 1997, PSYCHOL MED, V27, P231, DOI 10.1017/S0033291796003510
   Bijl RV, 1998, SOC PSYCH PSYCH EPID, V33, P587, DOI 10.1007/s001270050098
   BOUMA J, 1995, MEASURING DEPRESSION
   BRYAN CJ, 2007, J AFFECT DISORDERS, P113
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   DeVries JH, 2004, DIABETIC MED, V21, P1263, DOI 10.1111/j.1464-5491.2004.01386.x
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2009, DIABETES CARE, V33, P23
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341
   Henkel V, 2004, GEN HOSP PSYCHIAT, V26, P190, DOI 10.1016/j.genhosppsych.2004.02.003
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   Home P, 2006, DIABETIC MED, V23, P579
   Katon WJ, 2005, DIABETES CARE, V28, P2668, DOI 10.2337/diacare.28.11.2668
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   McGuire BE, 2010, DIABETOLOGIA, V53, P66, DOI 10.1007/s00125-009-1559-5
   McHale M, 2008, PSYCHOSOM MED, V70, P869, DOI 10.1097/PSY.0b013e318186dea9
   Petrak F, 2009, CURR OPIN PSYCHIATR, V22, P211, DOI 10.1097/YCO.0b013e3283207b45
   Pibernik-Okanovic M, 2008, DIABETIC MED, V25, P1252, DOI 10.1111/j.1464-5491.2008.02553.x
   Piette JD, 2004, AM J MANAG CARE, V10, P152
   Pouwer F, 2010, DIABETIC MED, V27, P217, DOI 10.1111/j.1464-5491.2009.02903.x
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Schram MT, 2009, CURR DIABETES REV, V5, P112, DOI 10.2174/157339909788166828
   Snoek FJ, 2008, DIABETIC MED, V25, P1337, DOI 10.1111/j.1464-5491.2008.02595.x
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   van Bastelaar KM, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-9
NR 30
TC 73
Z9 73
U1 1
U2 29
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0742-3071
J9 DIABETIC MED
JI Diabetic Med.
PD JUL
PY 2010
VL 27
IS 7
BP 798
EP 803
DI 10.1111/j.1464-5491.2010.03025.x
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 619OX
UT WOS:000279440600012
PM 20636961
DA 2019-01-08
ER

PT J
AU Fritschi, C
   Quinn, L
AF Fritschi, Cynthia
   Quinn, Laurie
TI Fatigue in patients with diabetes: A review
SO JOURNAL OF PSYCHOSOMATIC RESEARCH
LA English
DT Review
DE Diabetes; Fatigue; Review
ID AFRICAN-AMERICAN WOMEN; PHYSICAL-ACTIVITY; DEPRESSIVE SYMPTOMS;
   CARDIOVASCULAR-DISEASE; OXIDATIVE STRESS; SOMATIC SYMPTOMS;
   SELF-MANAGEMENT; PRIMARY-CARE; TYPE-2; EXERCISE
AB Objective: Fatigue is a common and distressing complaint among people with diabetes and likely to hinder the ability to perform daily diabetes self-management tasks. A review of the literature about diabetes-related fatigue was conducted with an eye toward creating a framework for beginning to conduct more focused studies on this subject. Methods: A literature search containing the terms diabetes, fatigue, tiredness, and symptoms was conducted to search for literature that addressed diabetes-related fatigue. Results: Diabetes presents many potential pathways for fatigue, but focused studies on this symptom are rare. Furthermore, research on diabetes-related fatigue is limited by fatigue's nonspecific symptoms and because fatigue researchers have yet to agree on standardized definition, measurement, or diagnostic criteria. Additionally, few diabetes randomized clinical trials included measurement of patient-reported outcomes, such as symptoms or health-related quality of life in their study designs, although one that did provided some meaningful finding that symptom-focused education improved self-management practices, Hb(A1c) levels, quality of life, and symptom distress. Conclusion: There is a need to standardize the definition, measurement, and diagnostic criteria of fatigue in diabetes. We present a model that can guide focused studies on fatigue in diabetes. The model capitalizes on the multidimensional phenomena (physiological, psychological, and lifestyle) associated with fatigue in diabetes. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Fritschi, Cynthia; Quinn, Laurie] Univ Illinois, Coll Nursing, Dept Biobehav Hlth Sci, Chicago, IL 60612 USA.
RP Fritschi, C (reprint author), Univ Illinois, Coll Nursing MC 802, 845 S Damen Ave, Chicago, IL 60612 USA.
EM fritschi@uic.edu
OI Fritschi, Cynthia/0000-0001-5447-8315
FU National Institutes of Health/National Institute for Nursing Research
   [F31 NR009751]
FX This research was funded in part by the National Institutes of
   Health/National Institute for Nursing Research F31 NR009751.
CR Aaronson L S, 1999, Image J Nurs Sch, V31, P45
   Aistars J, 1987, Oncol Nurs Forum, V14, P25
   Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS55, DOI 10.2337/dc08-S055
   American Diabetes Association, DIAB STAT
   American Psychiatric Association, 1994, DIAGN STAT MAN MENT
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Avlund K, 2008, DAN MED BULL, V55, P147
   BARTLEY SH, 1976, PSYCHOL ASPECTS PHYS, P409
   Bonora E, 2001, DIABETES CARE, V24, P2023, DOI 10.2337/diacare.24.12.2023
   Bonora E, 2001, DIABETOLOGIA, V44, P2107, DOI 10.1007/s001250100020
   Bulpitt CJ, 1998, DIABETES CARE, V21, P111, DOI 10.2337/diacare.21.1.111
   Casalenuovo GA, 2002, FATIGUE DIABETES MEL
   Chasens Eileen R, 2008, Issues Ment Health Nurs, V29, P1134, DOI 10.1080/01612840802319878
   Chaudhuri A, 2000, J NEUROL SCI, V179, P34, DOI 10.1016/S0022-510X(00)00411-1
   Cuellar NG, 2008, J CLIN SLEEP MED, V4, P50
   de Jonge P, 2006, DIABETOLOGIA, V49, P2627, DOI 10.1007/s00125-006-0442-x
   de Sonnaville JJJ, 1998, DIABETES CARE, V21, P919, DOI 10.2337/diacare.21.6.919
   Deray G, 2004, AM J NEPHROL, V24, P522, DOI 10.1159/000081058
   Drayer RA, 2005, INT J GERIATR PSYCH, V20, P973, DOI 10.1002/gps.1389
   DRIVSHOLM T, 2005, DIABETOLOGIA
   FORD ES, 1995, DIABETES CARE, V18, P27, DOI 10.2337/diacare.18.1.27
   Gandhi GY, 2008, JAMA-J AM MED ASSOC, V299, P2543, DOI 10.1001/jama.299.21.2543
   Glass JM, 2004, J PSYCHOSOM RES, V57, P391, DOI 10.1016/j.jpsychores.2004.04.002
   Golden SH, 2004, DIABETES CARE, V27, P429, DOI 10.2337/diacare.27.2.429
   Golden SH, 2008, JAMA-J AM MED ASSOC, V299, P2751, DOI 10.1001/jama.299.23.2751
   GROOTENHUIS PA, 1994, DIABETIC MED, V11, P253, DOI 10.1111/j.1464-5491.1994.tb00268.x
   HART LK, 1982, CONCEPT CLARIFICATIO
   Hays LM, 1999, DIABETES CARE, V22, P706, DOI 10.2337/diacare.22.5.706
   Hill-Briggs F, 2003, DIABETES EDUCATOR, V29, P1018
   *INT DIAB FED, DIAB ATL
   Kant IJ, 2003, OCCUP ENVIRON MED, V60, P32
   Kennedy G, 2005, FREE RADICAL BIO MED, V39, P584, DOI 10.1016/j.freeradbiomed.2005-04.020
   King P, 1998, DIABETES CARE, V21, P341, DOI 10.2337/diacare.21.3.341
   Koch T, 1999, J CLIN NURS, V8, P712, DOI 10.1046/j.1365-2702.1999.00320.x
   Kovatchev Boris P, 2002, Diabetes Technol Ther, V4, P295, DOI 10.1089/152091502760098438
   KROENKE K, 1993, ARCH INTERN MED, V153, P2474, DOI 10.1001/archinte.153.21.2474
   Lavidor M, 2002, BRIT J HEALTH PSYCH, V7, P67, DOI 10.1348/135910702169367
   LeMone P, 1996, DIABETES EDUCATOR, V22, P361, DOI 10.1177/014572179602200409
   LEWIS G, 1992, J EPIDEMIOL COMMUN H, V46, P92, DOI 10.1136/jech.46.2.92
   Lim K, 2005, PREV MED, V40, P33, DOI 10.1016/j.ypmed.2004.04.046
   Lim WJ, 2005, ARCH INTERN MED, V165, P910, DOI 10.1001/archinte.165.8.910
   Magnusson K, 1999, EUR J CANCER CARE, V8, P224
   Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397
   Mcardle W. D., 2001, EXERCISE PHYSL
   McNair D M, 2003, PROFILE MOOD STATES
   Miller MA, 2007, CURR VASC PHARMACOL, V5, P93, DOI 10.2174/157016107780368280
   MOCK V, 2004, PSYCHOONCOLOGY
   Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681, DOI 10.1001/jama.295.14.1681
   Morrato EH, 2007, DIABETES CARE, V30, P203, DOI 10.2337/dc06-1128
   Morsch CM, 2006, J CLIN NURS, V15, P498, DOI 10.1111/j.1365-2702.2006.01349.x
   MOSSO A, 2004, FATIGUE
   *NANDA, 2001, NURS DIAGN DEF CLASS
   Neuberger GB, 1997, RES NURS HEALTH, V20, P195, DOI 10.1002/(SICI)1098-240X(199706)20:3<195::AID-NUR3>3.0.CO;2-D
   Nijrolder I, 2008, ANN FAM MED, V6, P519, DOI 10.1370/afm.908
   O'Connor PJ, 2005, MED SCI SPORT EXER, V37, P299, DOI 10.1249/01.MMS.0000152802.89770.CF
   Palinkas LA, 2004, DIABETIC MED, V21, P1185, DOI 10.1111/j.1464-5491.2004.01315.x
   Petersen M, 2008, DIABETES CARE, V31, P596, DOI 10.2337/dc08-9017
   Pickup JC, 2004, DIABETES CARE, V27, P813, DOI 10.2337/diacare.27.3.813
   Polonsky W. H., 1999, DIABETES BURNOUT WHA
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Polonsky William H, 2002, Curr Diab Rep, V2, P153, DOI 10.1007/s11892-002-0075-5
   Praet SFE, 2006, CLIN SCI, V111, P119, DOI 10.1042/CS20060041
   Puetz TW, 2006, EUR J CARDIOV PREV R, V13, P886, DOI 10.1097/01.hjr.0000230102.55653.0b
   Puetz TW, 2006, PSYCHOL BULL, V132, P866, DOI 10.1037/0033-2909.132.6.866
   Puetz TW, 2006, SPORTS MED, V36, P767, DOI 10.2165/00007256-200636090-00004
   Ream E, 1997, INT J NURS STUD, V34, P44, DOI 10.1016/S0020-7489(96)00032-6
   Ream E, 1996, INT J NURS STUD, V33, P519, DOI 10.1016/0020-7489(96)00004-1
   Resnick HE, 2006, J CLIN SLEEP MED, V2, P163
   Rijken PM, 1998, DISABIL REHABIL, V20, P330, DOI 10.3109/09638289809166090
   Rose L, 1998, J ADV NURS, V28, P295, DOI 10.1046/j.1365-2648.1998.00789.x
   RUBIN RR, DEAL DIAB OV
   Samuel-Hodge CD, 2000, DIABETES CARE, V23, P928, DOI 10.2337/diacare.23.7.928
   Samuel-Hodge CD, 2005, ETHNIC DIS, V15, P436
   Skelly AH, 2005, APPL NURS RES, V18, P213, DOI 10.1016/j.apnr.2004.08.008
   Sommerfield AJ, 2004, DIABETES CARE, V27, P2335, DOI 10.2337/diacare.27.10.2335
   STEWART AL, 1994, J CLIN EPIDEMIOL, V47, P719, DOI 10.1016/0895-4356(94)90169-4
   Stewart ST, 2008, MED CARE, V46, P954, DOI 10.1097/MLR.0b013e318179199f
   Stover JC, 2001, APPL NURS RES, V14, P72, DOI 10.1053/apnr.2001.22372
   Sugahara H, 2004, PSYCHIAT RES, V128, P303, DOI 10.1016/j.psychres.2004.06.014
   Theorell-Haglow J, 2006, SLEEP, V29, P751, DOI 10.1093/sleep/29.6.751
   Thomas MC, 2003, DIABETES CARE, V26, P1164, DOI 10.2337/diacare.26.4.1164
   Trendall J, 2000, J ADV NURS, V32, P1126, DOI 10.1046/j.1365-2648.2000.01583.x
   VACCARINO AL, 2008, J AFFECT DISORD
   VanderDoes FEE, 1996, DIABETES CARE, V19, P204, DOI 10.2337/diacare.19.3.204
   VARNI JW, 2008, PEDIAT DIABETES
   Vgontzas AN, 2006, ANN NY ACAD SCI, V1083, P329, DOI 10.1196/annals.1367.023
   Von Korff M, 2005, DIABETES CARE, V28, P1326, DOI 10.2337/diacare.28.6.1326
   Warren RE, 2003, DIABETES-METAB RES, V19, P408, DOI 10.1002/dmrr.396
   Weijman I, 2004, J OCCUP ENVIRON MED, V46, P828, DOI 10.1097/01.jom.0000135605.62330.ca
   Weijman I, 2003, OCCUP ENVIRON MED, V60, P93
   Wenzel J, 2005, DIABETES EDUCATOR, V31, P98, DOI 10.1177/0145721704273242
   Wessely S, 1998, Epidemiol Psichiatr Soc, V7, P10
   Wijeratne C, 2007, J PSYCHOSOM RES, V62, P153, DOI 10.1016/j.jpsychores.2006.09.011
   Winningham M L, 1994, Oncol Nurs Forum, V21, P23
   Wood FG, 2004, J ADV NURS, V45, P190, DOI 10.1046/j.1365-2648.2003.02880.x
   Zimmerman M, 2006, J NERV MENT DIS, V194, P313, DOI 10.1097/01.nmd.0000217806.16329.ff
NR 97
TC 80
Z9 81
U1 2
U2 22
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0022-3999
EI 1879-1360
J9 J PSYCHOSOM RES
JI J. Psychosomat. Res.
PD JUL
PY 2010
VL 69
IS 1
BP 33
EP 41
DI 10.1016/j.jpsychores.2010.01.021
PG 9
WC Psychiatry
SC Psychiatry
GA 618NR
UT WOS:000279363100005
PM 20630261
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Kerr, WC
   Ye, Y
AF Kerr, William C.
   Ye, Yu
TI Relationship of Life-Course Drinking Patterns to Diabetes, Heart
   Problems, and Hypertension Among Those 40 and Older in the 2005 US
   National Alcohol Survey
SO JOURNAL OF STUDIES ON ALCOHOL AND DRUGS
LA English
DT Article
ID PROPENSITY-SCORE; METABOLIC SYNDROME; UNITED-STATES; RISK; MORTALITY;
   CONSUMPTION; DISEASE; ADULTS; METAANALYSIS; PREVALENCE
AB Objective: The goal of this study was to estimate relationships between life-course drinking patterns and the risks of self-reported diabetes, heart problems, and hypertension. Method: Respondents to the 2005 National Alcohol Survey, age 40 and older, reported ever having a doctor or health professional diagnose each of the health-problem outcomes. Retrospective earlier-life drinking patterns were characterized by lifetime abstention and the frequency of 5+ drinking days (i.e., days on which five or more drinks were consumed) in the respondent's teens, 20s, and 30s. Past-year drinking patterns were measured through intake volume and 5+ days. Potential confounders in the domains of demographics, socioeconomic resources, and other health-risk variables that is, depression, distress, sense of coherence, body mass index, tobacco use, marijuana use, childhood abuse, and family history of alcohol problems were controlled through propensity-score matching. Results: After matching, lifetime abstainers were found to be at increased risk of diabetes compared with both lifetime and current moderate drinkers. Exdrinkers were found to be at increased risk of diabetes, heart problems, and hypertension. Higher volume drinkers without monthly 5+ days were found to be at reduced risk of diabetes relative to moderate-volume current drinkers. Heavy-occasion drinkers were found to be at increased risk of hypertension. Conclusions: Regular lower quantity alcohol intake may be protective against adult onset of diabetes, but no evidence of protection from heart problems or hypertension was found. Both life course defined and past year defined drinking groups exhibit substantial clustering of confounding risk variables, indicating the need for modeling strategies like propensity-score matching. Increased risks among exdrinkers suggest a substantial "sick-quitter" effect. (J. Stud. Alcohol Drugs, 71, 515-525, 2010)
C1 [Kerr, William C.; Ye, Yu] Alcohol Res Grp, Emeryville, CA 94608 USA.
RP Kerr, WC (reprint author), Alcohol Res Grp, 6475 Christie Ave,Suite 400, Emeryville, CA 94608 USA.
EM wkerr@arg.org
FU National Institute on Alcohol Abuse and Alcoholism; National Alcohol
   Research Center [P30-AA05595]
FX This research was supported by National Institute on Alcohol Abuse and
   Alcoholism, National Alcohol Research Center grant P30-AA05595 awarded
   to Thomas K. Greenfield (principal investigator), Alcohol Research
   Group, Public Health Institute, Emeryville, CA.
CR American Association for Public Opinion Research, 2000, STAND DEF FIN DISP C
   Austin PC, 2008, STAT MED, V27, P2037, DOI 10.1002/sim.3150
   BRESLOW RA, 2008, ALCOHOLISM CLIN EXPT, V32, P1
   Brookhart MA, 2006, AM J EPIDEMIOL, V163, P1149, DOI 10.1093/aje/kwj149
   BURR ML, 1986, BRIT J NUTR, V56, P81, DOI 10.1079/BJN19860087
   Caldwell TM, 2006, ALCOHOL ALCOHOLISM, V41, P650, DOI 10.1093/alcalc/agl088
   Chen L, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050052
   Corrao G, 2004, PREV MED, V38, P613, DOI 10.1016/j.ypmed.2003.11.027
   Cutler JA, 2008, HYPERTENSION, V52, P818, DOI 10.1161/HYPERTENSIONAHA.108.113357
   D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B
   Dawson DA, 2000, ALCOHOL CLIN EXP RES, V24, P1820, DOI 10.1097/00000374-200012000-00011
   Djousse L, 2004, OBES RES, V12, P1375, DOI 10.1038/oby.2004.174
   Dong MX, 2004, CIRCULATION, V110, P1761, DOI 10.1161/01.CIR.0000143074.54995.7F
   Dorn JM, 2007, ADDICTION, V102, P730, DOI 10.1111/j.1360-0443.2007.01765.x
   Dufour MC, 2001, J NUTR, V131, p552S, DOI 10.1093/jn/131.2.552S
   Emberson JR, 2005, AM J EPIDEMIOL, V161, P856, DOI 10.1093/aje/kwi111
   Fan AZ, 2006, EUR J EPIDEMIOL, V21, P129, DOI 10.1007/s10654-005-5457-y
   Fillmore KM, 2006, ADDICT RES THEORY, V14, P101, DOI 10.1080/16066350500497983
   Gmel G, 2003, EUR J EPIDEMIOL, V18, P631, DOI 10.1023/A:1024805021504
   Greenfield TK, 2000, J SUBST ABUSE, V12, P33, DOI 10.1016/S0899-3289(00)00039-0
   Hodge AM, 2006, DIABETIC MED, V23, P690, DOI 10.1111/j.1464-5491.2006.01864.x
   Howard AA, 2004, ANN INTERN MED, V140, P211, DOI 10.7326/0003-4819-140-6-200403160-00011
   Hudson JI, 2005, EPIDEMIOLOGY, V16, P355, DOI 10.1097/01.ede.0000158224.50593.e3
   Imamura F, 2009, AM J EPIDEMIOL, V170, P37, DOI 10.1093/aje/kwp096
   Kerr WC, 2005, ALCOHOL CLIN EXP RES, V29, P2015, DOI 10.1097/01.alc.0000187596.92804.bd
   Kerr WC, 2002, J STUD ALCOHOL, V63, P325, DOI 10.15288/jsa.2002.63.325
   Kerr WC, 2008, ALCOHOL CLIN EXP RES, V32, P1623, DOI 10.1111/j.1530-0277.2008.00741.x
   Kerr WC, 2009, ADDICTION, V104, P1503, DOI 10.1111/j.1360-0443.2009.02579.x
   Kuper H, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4265
   Lemmens PH, 1997, CONTEMP DRUG PROBL, V24, P581
   LEUVEN E, 2003, S432001 BOST COLL DE
   MIDANIK LT, 2009, SUBST USE MISUSE, V44, P357
   Naimi TS, 2005, AM J PREV MED, V28, P369, DOI 10.1016/j.amepre.2005.01.011
   Norris SL, 2008, ANN INTERN MED, V148, P855, DOI 10.7326/0003-4819-148-11-200806030-00008
   Rehm J, 2008, AM J EPIDEMIOL, V168, P866, DOI 10.1093/aje/kwn093
   Rehm J, 2006, CONTEMP DRUG PROBL, V33, P205, DOI DOI 10.1177/009145090603300203
   RHEM J, 2003, J CARDIOVASCULAR RIS, V10, P15
   ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41
   ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903
   RUBIN DB, 1973, BIOMETRICS, V29, P185, DOI 10.2307/2529685
   Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064
   Russell M, 1997, AM J EPIDEMIOL, V146, P975
   SHAPER AG, 1990, BRIT J ADDICT, V85, P837
   SHAPER AG, 1988, LANCET, V2, P1267
   Stewart SH, 2008, ADDICTION, V103, P1622, DOI 10.1111/j.1360-0443.2008.02317.x
   Stranges S, 2004, HYPERTENSION, V44, P813, DOI 10.1161/01.HYP.0000146537.03103.f2
   Valmadrid CT, 1999, JAMA-J AM MED ASSOC, V282, P239, DOI 10.1001/jama.282.3.239
   Wainwright NWJ, 2008, J EPIDEMIOL COMMUN H, V62, P829, DOI 10.1136/jech.2007.066464
NR 48
TC 25
Z9 26
U1 1
U2 8
PU ALCOHOL RES DOCUMENTATION INC CENT ALCOHOL STUD RUTGERS UNIV
PI PISCATAWAY
PA C/O DEIRDRE ENGLISH, 607 ALLISON RD, PISCATAWAY, NJ 08854-8001 USA
SN 1937-1888
EI 1938-4114
J9 J STUD ALCOHOL DRUGS
JI J. Stud. Alcohol Drugs
PD JUL
PY 2010
VL 71
IS 4
BP 515
EP 525
DI 10.15288/jsad.2010.71.515
PG 11
WC Substance Abuse; Psychology
SC Substance Abuse; Psychology
GA 619EA
UT WOS:000279410800006
PM 20553659
OA Green Published
DA 2019-01-08
ER

PT J
AU McEwen, MM
   Pasvogel, A
   Gallegos, G
   Barrera, L
AF McEwen, Marylyn Morris
   Pasvogel, Alice
   Gallegos, Gwen
   Barrera, Lourdes
TI Type 2 Diabetes Self-Management Social Support Intervention at the
   US-Mexico Border
SO PUBLIC HEALTH NURSING
LA English
DT Article
DE culturally sensitive intervention; diabetes self-management; Mexican
   Americans; promotoras
ID CULTURALLY APPROPRIATE; EDUCATION; AMERICANS; CARE; QUESTIONNAIRE;
   COMMUNITY; PROGRAM; RELIABILITY; DISTRESS; MELLITUS
AB Objectives
   To pilot test the efficacy of a culturally tailored diabetes self-management social support intervention for Mexican American adults with Type 2 diabetes (T2DM) living in the U.S.-Mexico border region and to test the feasibility of recruiting and training promotoras to participate in intervention delivery.
   Design and Sample
   This study used a single-group pretest and posttest design. The convenience sample consisted of 21 Mexican American adults with T2DM. The setting for the study was a community in the Arizona-Sonora, Mexico border region.
   Interventions
   A bilingual, bicultural certified diabetes educator (CDE) and a nurse researcher developed the intervention to improve T2DM self-management activities for Mexican Americans. Data were collected using self-report questionnaires, glycosolated hemoglobin (HbA(1c)), and anthropometric measures.
   Results
   Intervention efficacy was demonstrated by an increase in participants' diabetes self-management activities and diabetes knowledge and a decrease in diabetes-related distress and sedentary behaviors. There were no significant changes in physiologic outcomes. Feasibility of recruitment and training of 2 promotoras who participated in intervention delivery was established.
   Conclusions
   Promotoras, in collaboration with a CDE, successfully delivered a culturally tailored diabetes self-management social support intervention for Mexican American adults with T2DM. This intervention positively affected diabetes self-management behaviors.
C1 [McEwen, Marylyn Morris; Pasvogel, Alice; Barrera, Lourdes] Univ Arizona, Tucson, AZ USA.
   [Gallegos, Gwen] Carondelet Hlth Network, Tucson, AZ USA.
RP McEwen, MM (reprint author), 1305 N Martin, Tucson, AZ 85721 USA.
EM mmcewen@nursing.arizona.edu
FU NIH Center on Minority Health and Health Disparities [5P60 MD000155-04]
FX The authors wish to thank the promotoras, Josefina Meranza and Rose
   Urias, and The University of Arizona College of Nursing Writer's Group.
   This research was supported by the NIH Center on Minority Health and
   Health Disparities 5P60 MD000155-04. PI: Cecilia Rosales, M.D., M.P.H.,
   Associate Professor, MEZCOPH, University of Arizona.
CR *ADA, 2009, DIABETES CARE S1, V32, pS13
   Albright TL, 2001, FAM MED, V33, P354
   American Association of Diabetes Educators, 2003, DIABETES ED, V29, P818
   *AZ DEP HLTH SERV, 2008, ARIZ DIAB STRAT PLAN
   Brown SA, 2005, DIABETES CARE, V28, P527, DOI 10.2337/diacare.28.3.527
   Brown SA, 2002, DIABETES CARE, V25, P259, DOI 10.2337/diacare.25.2.259
   Campanini M, 2007, MULTIDISCIP RESP MED, V2, P100
   Carranza SN, 2004, FAM MED, V36, P539
   Centers for Disease Control and Prevention, 2007, BMI AD
   Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB
   *DIRECNET STUD GRO, 2005, COMP FING HEM A1C LE
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Garcia AA, 2001, DIABETES CARE, V24, P16, DOI 10.2337/diacare.24.1.16
   Gleeson-Kreig J, 2002, PUBLIC HEALTH NURS, V19, P215, DOI 10.1046/j.0737-1209.2002.19310.x
   Hertzog MA, 2008, RES NURS HEALTH, V31, P180, DOI 10.1002/nur.20247
   Ingram M. G., 2005, PREV CHRONIC DIS, V2, P1
   Ingram M, 2007, DIABETES EDUCATOR, V33, p172S, DOI 10.1177/0145721707304170
   ISRAEL BA, 1982, PATIENT COUNS HEALTH, V4, P65, DOI 10.1016/S0190-2040(82)80002-5
   Jones PS, 2001, NURS RES, V50, P300, DOI 10.1097/00006199-200109000-00008
   Little RR, 2003, CLIN CHEM LAB MED, V41, P1191, DOI 10.1515/CCLM.2003.183
   Lujan J, 2007, DIABETES EDUCATOR, V33, P660, DOI 10.1177/0145721707304080
   Mauldon M, 2006, DIABETES EDUCATOR, V32, P751, DOI 10.1177/0145721706291999
   Mensing Carole, 2007, Diabetes Care, V30 Suppl 1, pS96, DOI 10.2337/dc07-S096
   McEwen MM, 2007, FAM COMMUNITY HEALTH, V30, P201, DOI 10.1097/01.FCH.0000277763.70031.0d
   *NAT CTR CHRON DIS, 2005, COMM HLTH WORK PROM
   *NIDDK, 2008, NAT DIAB STAT 2007 F
   Norris SL, 2006, DIABETIC MED, V23, P544, DOI 10.1111/j.1464-5491.2006.01845.x
   Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561
   *PAN AM HLTH ORG, 2008, PAN AM HLTH ORG US M
   Philis-Tsimikas A, 2004, DIABETES CARE, V27, P110, DOI 10.2337/diacare.27.1.110
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Sixta CS, 2008, DIABETES EDUCATOR, V34, P285, DOI 10.1177/0145721708314486
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Van de Waterbeemd Han, 2005, Expert Opin Drug Metab Toxicol, V1, P1, DOI 10.1517/17425255.1.1.1
   Vincent D, 2008, NURS RES, V57, P101, DOI 10.1097/01.NNR.0000313484.18670.ab
NR 35
TC 32
Z9 34
U1 0
U2 11
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0737-1209
J9 PUBLIC HEALTH NURS
JI Public Health Nurs.
PD JUL-AUG
PY 2010
VL 27
IS 4
BP 310
EP 319
DI 10.1111/j.1525-1446.2010.00860.x
PG 10
WC Public, Environmental & Occupational Health; Nursing
SC Public, Environmental & Occupational Health; Nursing
GA 621UR
UT WOS:000279610900005
PM 20626831
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Lorig, K
   Ritter, PL
   Laurent, DD
   Plant, K
   Green, M
   Jernigan, VBB
   Case, S
AF Lorig, Kate
   Ritter, Philip L.
   Laurent, Diana D.
   Plant, Kathryn
   Green, Maurice
   Jernigan, Valarie Blue Bird
   Case, Siobhan
TI Online Diabetes Self-Management Program A randomized study
SO DIABETES CARE
LA English
DT Article
ID CARE; EFFICACY; TRIAL
AB OBJECTIVE - We hypothesized that people with type 2 diabetes in an online diabetes self-management program, compared with usual-care control subjects, would 1) demonstrate reduced A1C at 6 and 18 months, 2) have fewer symptoms, 3) demonstrate increased exercise, and 4) have improved self-efficacy and patient activation. In addition, participants randomized to listserve reinforcement would have better 18-month outcomes than participants receiving no reinforcement.
   RESEARCH DESIGN AND METHODS - A total of 761 participants were randomized to 1) the program, 2) the program with e-mail reinforcement, or 3) were usual-care control subjects (no treatment). This sample included 110 American Indians/Alaska Natives (Al/ANs). Analyses of covariance models were used at the 6- and 18-month follow-up to compare groups.
   RESULTS - At 6 months, A1C, patient activation, and self-efficacy were improved for program participants compared with usual care control subjects (P < 0.05). There were no changes in other health or behavioral indicators. The Al/AN program participants demonstrated improvements in health distress and activity limitation compared with usual-care control subjects. The subgroup with initial A1C >7% demonstrated stronger improvement in A1C (P = 0.01). At 18 months, self-efficacy and patient activation were improved for program participants. A1C was not measured. Reinforcement showed no improvement.
   CONCLUSIONS - An online diabetes self-management program is acceptable for people with type 2 diabetes. Although the results were mixed they suggest 1) that the program may have beneficial effects in reducing A1C, 2) Al/AN populations can be engaged in and benefit from online interventions, and 3) our follow-up reinforcement appeared to have no value.
C1 [Lorig, Kate; Ritter, Philip L.; Laurent, Diana D.; Plant, Kathryn; Green, Maurice] Stanford Univ, Sch Med, Stanford Patient Educ Res Ctr, Palo Alto, CA 94304 USA.
   [Jernigan, Valarie Blue Bird] Stanford Univ, Stanford Prevent Res Ctr, Palo Alto, CA 94304 USA.
   [Case, Siobhan] Yale Univ, Sch Med, New Haven, CT USA.
RP Ritter, PL (reprint author), Stanford Univ, Sch Med, Stanford Patient Educ Res Ctr, Palo Alto, CA 94304 USA.
EM philr@stanford.edu
FU National Institutes of Health [1R18DK065729]; Robert Wood Johnson
   Foundation [096223]
FX The study was supported by National Institutes of Health Grant
   1R18DK065729 and Robert Wood Johnson Foundation Grant 096223.
CR BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191
   Case S, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1153
   Deakin T, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003417.pub2
   Gerber BS, 2007, DIABETES TECHNOL THE, V9, P60, DOI 10.1089/dia.2006.0058
   Glasgow RE, 2004, J GEN INTERN MED, V19, P1167, DOI 10.1111/j.1525-1497.2004.30425.x
   Glasgow RE, 2003, PREV MED, V36, P410, DOI 10.1016/S0091-7435(02)00056-7
   GLASGOW RE, CHRONIC ILLN, V2, P27
   Hibbard JH, 2005, HEALTH SERV RES, V40, P1918, DOI 10.1111/j.1475-6773.2005.00438.x
   Jackson CL, 2006, J GEN INTERN MED, V21, P105, DOI 10.1111/j.1525-1497.2005.00310.x
   JERNIGAN VBB, HLTH PROMOT IN PRESS
   JERRIGAN VJ, THESIS U CALIFORNIA
   Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06
   Lorig K, 1996, OUTCOME MEASURES HLT
   Lorig K, 2008, DIABETES CARE, V31, P408, DOI 10.2337/dc07-1313
   Lorig K, 2009, DIABETES EDUCATOR, V35, P641, DOI 10.1177/0145721709335006
   Lorig KR, 2006, LIVING HLTH LIFE CHR
   Miedema K, 2005, SCAND J CLIN LAB INV, V65, P61, DOI 10.1080/00365510500236143
   *NAT I DIAB DIG KI, 2005, NIH PUBL
   Ritter PL, 2001, J CLIN EPIDEMIOL, V54, P136, DOI 10.1016/S0895-4356(00)00261-4
   Stewart A., 1992, MEASURING FUNCTIONIN
   TYRRELL SP, 2006, BIOSAFE LAB B, V4018
   Wangberg SC, 2008, HEALTH EDUC RES, V23, P170, DOI 10.1093/her/cym014
NR 22
TC 161
Z9 165
U1 1
U2 40
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
EI 1935-5548
J9 DIABETES CARE
JI Diabetes Care
PD JUN
PY 2010
VL 33
IS 6
BP 1275
EP 1281
DI 10.2337/dc09-2153
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 617TI
UT WOS:000279304300024
PM 20299481
OA Other Gold, Green Published
DA 2019-01-08
ER

PT J
AU Wagner, JA
   Tennen, H
   Osborn, CY
AF Wagner, J. A.
   Tennen, H.
   Osborn, C. Y.
TI Lifetime depression and diabetes self-management in women with Type 2
   diabetes: a case-control study
SO DIABETIC MEDICINE
LA English
DT Article
DE diabetes; depression; distress; health behaviour; women
ID POSTMENOPAUSAL WOMEN; RECURRENT DEPRESSION; MAJOR DEPRESSION; HISTORY;
   DISTRESS; CARE; METAANALYSIS; SYMPTOMS; EFFICACY; DISORDER
AB Aims Little is known about the association between lifetime history of major depressive disorder (L-MDD) and diabetes self-management, particularly when depression is remitted. We examined the association between L-MDD and diabetes self-management in women with Type 2 diabetes who were not depressed at the time of assessment.
   Methods L-MDD was assessed with structured psychiatric interview. Participants completed paper-and-pencil measures of demographics, diabetes-related distress, self-care behaviours, healthcare utilization and diabetes self-efficacy.
   Results One-hundred and fifty-three women participated; 41% had L-MDD. Compared with their never-depressed counterparts, women with L-MDD had more diabetes distress, reported lower overall rates of self-monitoring of blood glucose (SMBG) and greater tendency to skip SMBG, had lower diet adherence and were less likely to have seen a primary care provider in the past year. Diabetes self-efficacy mediated the relationship between L-MDD and self-management.
   Conclusions Interventions to promote self-management for patients with L-MDD may be warranted.
C1 [Wagner, J. A.] Univ Connecticut, Ctr Hlth, Dept Behav Sci & Community Hlth, Farmington, CT 06410 USA.
   [Tennen, H.] Univ Connecticut, Ctr Hlth, Dept Community Med, Farmington, CT 06410 USA.
   [Osborn, C. Y.] Vanderbilt Univ, Eskind Diabet Ctr, Ctr Hlth Serv Res, Div Gen Internal Med & Publ Hlth,Med Ctr, Nashville, TN USA.
RP Wagner, JA (reprint author), Univ Connecticut, Ctr Hlth, Dept Behav Sci & Community Hlth, MC3910,263 Farmington Ave, Farmington, CT 06410 USA.
EM juwagner@uchc.edu
FU American Diabetes Association [7-05-CR-31]; American Heart Association
   [0535301N]; National Institute of Diatest and Digestive and Kidney
   Diseases (NIDDK) [1 R21 DK074468, 3P60 DK020593]; NIH [M01RR06192]
FX This research was supported by grants to JAW from the American Diabetes
   Association (7-05-CR-31), the American Heart Association (0535301N) and
   National Institute of Diatest and Digestive and Kidney Diseases (NIDDK)
   (1 R21 DK074468). The research was supported in part by the General
   Clinical Research Center grant from NIH (M01RR06192) awarded to the
   University of Connecticut Health Center, Farmington, CT, USA. Dr CYO is
   supported by a Diversity Supplement Award (NIDDK 3P60 DK020593).
CR Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037//0022-3514.51.6.1173
   Cherrington A, 2010, J BEHAV MED, V33, P81, DOI 10.1007/s10865-009-9233-4
   Costa P. T., 1992, NEO PI R PROFESSIONA
   First MB, 1998, STRUCTURED CLIN INTE
   Fisher L, 2009, DIABETIC MED, V26, P622, DOI 10.1111/j.1464-5491.2009.02730.x
   Gillen R, 2001, ARCH PHYS MED REHAB, V82, P1645, DOI 10.1053/apmr.2001.26249
   Gonzalez JS, 2008, DIABETOLOGIA, V51, P1822, DOI 10.1007/s00125-008-1113-x
   Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341
   HOLAHAN CK, 1987, J GERONTOL, V42, P65, DOI 10.1093/geronj/42.1.65
   Katon W, 2009, PSYCHOSOMATICS, V50, P570, DOI 10.1176/appi.psy.50.6.570
   Lin EHB, 2006, ANN FAM MED, V4, P46, DOI 10.1370/afm.423
   Lustman PJ, 2007, DIABETES CARE, V30, P459, DOI 10.2337/dc06-1769
   Lustman PJ, 2005, PSYCHOSOM MED, V67, P195, DOI 10.1097/01.psy.0000155670.88919.ad
   Lustman PJ, 1997, GEN HOSP PSYCHIAT, V19, P138, DOI 10.1016/S0163-8343(96)00170-3
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Rapley Pat, 2003, Nurs Health Sci, V5, P289, DOI 10.1046/j.1442-2018.2003.00162.x
   Sarkar U, 2006, DIABETES CARE, V29, P823, DOI 10.2337/diacare.29.04.06.dc05-1615
   SOBEL ME, 1982, SOCIOL METHODOL, P290, DOI [rg/10.2307/270723, DOI 10.2307/270723]
   Tennen H, 2006, HEALTH PSYCHOL, V25, P370, DOI 10.1037/0278-6133.25.3.370
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   USAF SO, 1990, J COGNITIVE PSYCHOTH, V4, P51
   Wagner JA, 2007, DIABETIC MED, V24, P211, DOI 10.1111/j.1464-5491.2007.02044.x
   Wagner Julie, 2005, Diabetes Technol Ther, V7, P612, DOI 10.1089/dia.2005.7.612
   Wagner J, 2009, J DIABETES COMPLICAT, V23, P18, DOI 10.1016/j.jdiacomp.2007.11.007
   Zautra AJ, 2008, J CONSULT CLIN PSYCH, V76, P408, DOI 10.1037/0022-006X.76.3.408
NR 28
TC 18
Z9 19
U1 0
U2 6
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0742-3071
J9 DIABETIC MED
JI Diabetic Med.
PD JUN
PY 2010
VL 27
IS 6
BP 713
EP 717
DI 10.1111/j.1464-5491.2010.02996.x
PG 5
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 600GO
UT WOS:000277973600018
PM 20546294
OA Bronze, Green Accepted
DA 2019-01-08
ER

PT J
AU Fisher, L
   Glasgow, RE
   Strycker, LA
AF Fisher, Lawrence
   Glasgow, Russell E.
   Strycker, Lisa A.
TI The Relationship Between Diabetes Distress and Clinical Depression With
   Glycemic Control Among Patients With Type 2 Diabetes
SO DIABETES CARE
LA English
DT Article
ID OLDER-ADULTS; CHAMPS
AB OBJECTIVE -To clarify previous findings that diabetes distress is related to glycemic control and self-management whereas measures of depression are not, using both binary and continuous measures of depression.
   RESEARCH DESIGN AND METHODS - Four hundred and sixty-three type 2 patients completed measures of diabetes distress (Diabetes Distress Scale [DDS]) and clinical depression (Patient Health Questionnaire 8 [PHQ8]). PHQ8 was employed as either a binary (10) or continuous variable. Dependent variables were A1C, diet, physical activity (PA), and medication adherence (MA).
   RESULTS - The inclusion of a binary or continuous PHQ8 score yielded no differences in any equation. DDS was significantly associated with A1C and PA, whereas PHQ8 was not; both DDS and PHQ8 were significantly and independently associated with diet and MA.
   CONCLUSIONS - The lack of association between depression and glycemic control is not due to the use of a binary measure of depression. Findings further clarify the significant association between distress and MC.
C1 [Fisher, Lawrence] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA.
   [Glasgow, Russell E.] Kaiser Permanente, Denver, CO USA.
   [Strycker, Lisa A.] Oregon Res Inst, Eugene, OR 97403 USA.
RP Fisher, L (reprint author), Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA.
EM fisherl@fcm.ucsf.edu
FU National Institute of Diabetes and Digestive and Kidney Diseases [R01
   DK-35524]
FX This report was supported by Grant R01 DK-35524 from the National
   Institute of Diabetes and Digestive and Kidney Diseases.
CR Adriaanse MC, 2008, DIABETES CARE, V31, P2268, DOI 10.2337/dc08-1074
   COYNE JC, 1994, PSYCHOL BULL, V116, P29, DOI 10.1037/0033-2909.116.1.29
   FERNALD DH, 2008, TRANSFORMING PRIMARY
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238
   Kraemer HC, 2001, AM J PSYCHIAT, V158, P848, DOI 10.1176/appi.ajp.158.987.848
   Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737
   Stewart AL, 1997, ANN BEHAV MED, V19, P353, DOI 10.1007/BF02895154
   Stewart AL, 2001, MED SCI SPORT EXER, V33, P1126
   WITTCHEN HU, 1994, J PSYCHIAT RES, V28, P57, DOI 10.1016/0022-3956(94)90036-1
   Wittkampf K, 2009, GEN HOSP PSYCHIAT, V31, P451, DOI 10.1016/j.genhosppsych.2009.06.001
NR 14
TC 130
Z9 131
U1 1
U2 27
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
J9 DIABETES CARE
JI Diabetes Care
PD MAY
PY 2010
VL 33
IS 5
BP 1034
EP 1036
DI 10.2337/dc09-2175
PG 3
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 595RV
UT WOS:000277631200017
PM 20150291
OA Green Published, Other Gold
DA 2019-01-08
ER

PT J
AU Osborn, CY
   Trott, HW
   Buchowski, MS
   Patel, KA
   Kirby, LD
   Hargreaves, MK
   Blot, WJ
   Cohen, SS
   Schlundt, DG
AF Osborn, Chandra Y.
   Trott, Hollister W.
   Buchowski, Maciej S.
   Patel, Kushal A.
   Kirby, Leslie D.
   Hargreaves, Margaret K.
   Blot, William J.
   Cohen, Sarah S.
   Schlundt, David G.
TI Racial Disparities in the Treatment of Depression in Low-Income Persons
   With Diabetes
SO DIABETES CARE
LA English
DT Article
ID PLACEBO-CONTROLLED TRIAL; PRIMARY-CARE PATIENTS; CES-D;
   AFRICAN-AMERICANS; SOCIOECONOMIC-STATUS; DOUBLE-BLIND; ADULTS;
   PREVALENCE; SYMPTOMS; WHITES
AB OBJECTIVE - Individuals with diabetes are at higher risk for depression than the general population. Although depression can be treated with antidepressant medications, patients with diabetes and comorbid depression often go untreated. The goal of this study was to examine racial disparities in the treatment of depression with antidepressant medication in the southeastern U.S.
   RESEARCH DESIGN AND METHODS - Cross-sectional data were collected at baseline from 69,068 participants (71% African American, 60% female, and 82% with incomes <$25,000) recruited from community health centers and enrolled in the Southern Cohort Community Study (SCCS). The SCCS is a prospective epidemiological cohort study designed to explore causes of health disparities in adults aged 40-79 years. Binary logistic regression was used to identify factors associated with antidepressant use among those with diabetes (n = 14,279).
   RESULTS - Individuals with diagnosed diabetes (14,279) were classified with no depressive symptoms (54.7%), or with mild (24.2%), moderate (12.8%), or severe depressive symptoms (8.3%). After controlling for sex, age, insurance, income, education, BMI, smoking status, alcohol consumption, and level of depression, African Americans with diabetes were much less likely to report taking antidepressant medication than whites (adjusted odds ratio 0.32 [95% CI 0.29-0.35], P < 0.0001).
   CONCLUSIONS - Antidepressant use is much less common among African Americans than among whites with diabetes. Reasons for racial disparities in treatment of depressive symptoms are unclear but may include a combination of differential diagnosis and treatment by health professionals as well as cultural differences in seeking help for emotional distress.
C1 [Osborn, Chandra Y.; Buchowski, Maciej S.; Blot, William J.; Cohen, Sarah S.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37203 USA.
   [Osborn, Chandra Y.; Buchowski, Maciej S.; Hargreaves, Margaret K.; Schlundt, David G.] Vanderbilt Univ, Med Ctr, Diabet Res & Training Ctr, Vanderbilt Eskind Diabet Ctr, Nashville, TN USA.
   [Trott, Hollister W.; Kirby, Leslie D.; Schlundt, David G.] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA.
   [Patel, Kushal A.; Hargreaves, Margaret K.] Meharry Med Coll, Dept Internal Med, Nashville, TN 37208 USA.
   [Blot, William J.] Int Epidemiol Inst, Rockville, MD USA.
   [Cohen, Sarah S.] Univ N Carolina Chapel Hill, Dept Epidemiol, Chapel Hill, NC USA.
RP Osborn, CY (reprint author), Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37203 USA.
EM chandra.osborn@vanderbilt.edu
RI Buchowski, Maciej/A-2683-2008
OI Buchowski, Maciej/0000-0002-0566-1743
FU National Institutes of Health [R01-CA-92447, HL-67715, P01-DK-20593];
   Diversity Supplement Award; National Institute of Diabetes and Digestive
   and Kidney Diseases [P60-DK-020593]
FX This research was funded with support by the National Institutes of
   Health (Grants R01-CA-92447, HL-67715, and P01-DK-20593). C.Y.O. is
   supported by a Diversity Supplement Award, National Institute of
   Diabetes and Digestive and Kidney Diseases (P60-DK-020593).
CR Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   ANDRESEN EM, 1994, AM J PREV MED, V10, P77
   Dwight-Johnson M, 2000, J GEN INTERN MED, V15, P527, DOI 10.1046/j.1525-1497.2000.08035.x
   Egede LE, 2005, DIABETES CARE, V28, P1339, DOI 10.2337/diacare.28.6.1339
   Egede LE, 2005, CURR DIABETES REV, V1, P235, DOI 10.2174/157339905774574356
   Egede LE, 2008, DIABETES TECHNOL THE, V10, P213, DOI 10.1089/dia.2007.0278
   Ghods BK, 2008, J GEN INTERN MED, V23, P600, DOI 10.1007/s11606-008-0539-7
   Huizinga M, 2009, P 69 ANN M AM DIAB A, pA279
   Katon W, 2008, J GEN INTERN MED, V23, P1571, DOI 10.1007/s11606-008-0731-9
   Katon WJ, 2008, DIABETES CARE, V31, P1155, DOI 10.2337/dc08-0032
   Katon WJ, 2004, MED CARE, V42, P1222, DOI 10.1097/00005650-200412000-00009
   Lustman PJ, 2002, J PSYCHOSOM RES, V53, P917, DOI 10.1016/S0022-3999(02)00416-6
   Lustman PJ, 2006, ARCH GEN PSYCHIAT, V63, P521, DOI 10.1001/archpsyc.63.5.521
   Lustman PJ, 2005, J DIABETES COMPLICAT, V19, P113, DOI 10.1016/j.jdiacomp.2004.01.002
   Lustman PJ, 2000, DIABETES CARE, V23, P618, DOI 10.2337/diacare.23.5.618
   Miranda J, 2004, J GEN INTERN MED, V19, P120, DOI 10.1111/j.1525-1497.2004.30272.x
   Nguyen HT, 2004, PSYCHIAT RES, V126, P177, DOI 10.1016/j.psychres.2004.02.004
   Perreira KM, 2005, SOC FORCES, V83, P1567, DOI 10.1353/sof.2005.0077
   Rubin Richard R, 2004, Curr Diab Rep, V4, P119, DOI 10.1007/s11892-004-0067-8
   Sambamoorthi U, 2006, J HEALTH CARE POOR U, V17, P141
   Signorello LB, 2005, J NATL MED ASSOC, V97, P972
   Signorello LB, 2007, AM J PUBLIC HEALTH, V97, P2260, DOI 10.2105/AJPH.2006.094482
   Stahl D, 2008, DIABETES CARE, V31, P1118, DOI 10.2337/dc07-2019
   Thomas JL, 2001, INT J PSYCHIAT MED, V31, P25, DOI 10.2190/FUFR-PK9F-6U10-JXRK
   Wagner J, 2007, DIABETES RES CLIN PR, V75, P119, DOI 10.1016/j.diabres.2006.05.004
NR 25
TC 19
Z9 20
U1 0
U2 5
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
J9 DIABETES CARE
JI Diabetes Care
PD MAY
PY 2010
VL 33
IS 5
BP 1050
EP 1054
DI 10.2337/dc09-1929
PG 5
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 595RV
UT WOS:000277631200020
PM 20185741
OA Other Gold, Green Published
DA 2019-01-08
ER

PT J
AU Li, CY
   Ford, ES
   Zhao, GX
   Balluz, LS
   Berry, JT
   Mokdad, AH
AF Li, Chaoyang
   Ford, Earl S.
   Zhao, Guixiang
   Balluz, Lina S.
   Berry, Joyce T.
   Mokdad, Ali H.
TI Undertreatment of Mental Health Problems in Adults With Diagnosed
   Diabetes and Serious Psychological Distress The Behavioral Risk Factor
   Surveillance System, 2007
SO DIABETES CARE
LA English
DT Article
ID PREVALENCE
AB OBJECTIVE - To assess the prevalence and correlates of undertreatment for mental health problems among adults with diabetes and serious psychological distress (SPD).
   RESEARCH DESIGN AND METHODS - We analyzed data of adults aged >= 8 years from the 2007 Behavioral Risk Factor Surveillance System. SPD was assessed with the Kessler-6 scale.
   RESULTS - The prevalence of untreated SPD was estimated to be 2.1 +/- 0.1% (mean +/- SE), 3.4 +/- 0.3%, and 2.0 +/- 0.1% in the total population, diabetic population, and nondiabetic population, respectively. Among people with SPD, those with diagnosed diabetes had a lower rate of undertreatment for mental health problems (45.0%) than those without diabetes (54.9%) (P = 0.002). Nonwhite race/ethnicity, advanced age, lack of health insurance, and currently being employed were associated with increased likelihood of undertreatmera for mental health problems (P < 0.05).
   CONCLUSIONS - People with diagnosed diabetes may be screened for SPD and treated for specific mental health problems in routine health care.
C1 [Li, Chaoyang; Ford, Earl S.; Zhao, Guixiang; Balluz, Lina S.] Ctr Dis Control & Prevent, Div Adult & Community Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
   [Berry, Joyce T.] Subst Abuse & Mental Hlth Serv Adm, Washington, DC USA.
   [Mokdad, Ali H.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA.
RP Li, CY (reprint author), Ctr Dis Control & Prevent, Div Adult & Community Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
EM cli@cdc.gov
CR Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x
   Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21
   Centers for Disease Control and Prevention, 2006, BEH RISK FACT SURV S
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Kessler RC, 2005, NEW ENGL J MED, V352, P2515, DOI 10.1056/NEJMsa043266
   Kessler RC, 2001, HEALTH SERV RES, V36, P987
   Li C, 2008, DIABETIC MED, V25, P878, DOI 10.1111/j.1464-5491.2008.02477.x
   LI C, 2009, INT J PUBLIC HEALTH, V54, pS43
   Li CY, 2009, DIABETES RES CLIN PR, V83, P268, DOI 10.1016/j.diabres.2008.11.006
   Mokdad AH, 2009, ANNU REV PUBL HEALTH, V30, P43, DOI 10.1146/annurev.publhealth.031308.100226
NR 10
TC 25
Z9 27
U1 0
U2 4
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
J9 DIABETES CARE
JI Diabetes Care
PD MAY
PY 2010
VL 33
IS 5
BP 1061
EP 1064
DI 10.2337/dc09-1515
PG 4
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 595RV
UT WOS:000277631200022
PM 20185747
OA Other Gold, Green Published
DA 2019-01-08
ER

PT J
AU Sarwat, S
   Ilag, LL
   Carey, MA
   Shrom, DS
   Heine, RJ
AF Sarwat, S.
   Ilag, L. L.
   Carey, M. A.
   Shrom, D. S.
   Heine, R. J.
TI The relationship between self-monitored blood glucose values and
   glycated haemoglobin in insulin-treated patients with Type 2 diabetes
SO DIABETIC MEDICINE
LA English
DT Article
DE glargine; glycated haemoglobin; insulin lispro mixtures; self-monitoring
   of blood glucose; type 2 diabetes
ID PLASMA-GLUCOSE; GLYCEMIC CONTROL; PLUS METFORMIN; OPEN-LABEL; THERAPY;
   COMPLICATIONS; MIXTURE; DISTRESS; GLARGINE; LISPRO
AB P>Aims
   Self-monitoring of blood glucose (SMBG) is an important self-management tool for insulin-treated patients with Type 2 diabetes mellitus (T2DM). Its value in estimating glycaemic control in insulin-treated T2DM patients remains unclear. The relationship between glycated haemoglobin (HbA(1c)) and SMBG measures in T2DM patients treated with premixed insulin lispro mixtures or basal insulin glargine was examined.
   Methods
   HbA(1c) and plasma equivalent glucose (PGe) data derived from SMBG profiles were pooled from five randomized clinical trials of patients with T2DM on one or more oral glucose-lowering medication +/- 0-2 insulin injections per day switching to insulin lispro mixtures (N = 317) or glargine (N = 306). Patients generated seven-point SMBG profiles three times in a 2-week period prior to each HbA(1c) measurement. Pearson's correlation coefficients (r) were calculated for PGe values and HbA(1c). Receiver-operating characteristic (ROC) curves determined the ability of sets of PGe to estimate HbA(1c) (< or > 7.0%).
   Results
   Mean +/- standard deviation age was 57.5 +/- 9.5 years, body mass index 31.3 +/- 5.6 kg/m2, 52.5% were male and HbA(1c) overall was 7.4 +/- 1.0% at end-point. Among individual SMBG measures, r for HbA(1c) ranged from 0.34 to 0.49. For means of two or more PGe measures, r for HbA(1c) ranged from 0.51 to 0.59. Correlations were similar for either regimen. ROC curves were consistent with the correlation data.
   Conclusions
   These data provide patients and clinicians information on the relationship between HbA(1c) and SMBG measurements in patients with T2DM, and support the value of frequent blood glucose measurements for assessing overall glycaemic control.
C1 [Ilag, L. L.] Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA.
   [Carey, M. A.] i3 Statprobe, Cary, NC USA.
RP Ilag, LL (reprint author), Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA.
EM ilagll@lilly.com
CR Bonora E, 2001, DIABETES CARE, V24, P2023, DOI 10.2337/diacare.24.12.2023
   Bouma M, 1999, DIABETES CARE, V22, P904, DOI 10.2337/diacare.22.6.904
   Delahanty LM, 2007, DIABETIC MED, V24, P48, DOI 10.1111/j.1464-5491.2007.02028.x
   Jacober SJ, 2006, DIABETES OBES METAB, V8, P448, DOI 10.1111/j.1463-1326.2006.00605.x
   Kazda C, 2006, J DIABETES COMPLICAT, V20, P145, DOI 10.1016/j.jdiacomp.2005.09.004
   Malone JK, 2005, DIABETIC MED, V22, P374, DOI 10.1111/j.1464-5491.2005.01511.x
   Malone JK, 2004, CLIN THER, V26, P2034, DOI 10.1016/j.clinthera.2004.12.015
   Nathan DM, 2008, DIABETES CARE, V31, P1473, DOI 10.2337/dc08-0545
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Robbins DC, 2007, CLIN THER, V29, P2349, DOI 10.1016/j.clinthera.2007.11.016
   Rohlfing CL, 2002, DIABETES CARE, V25, P275, DOI 10.2337/diacare.25.2.275
   SHAMOON H, 1993, NEW ENGL J MED, V329, P977
   Shimizu H, 2008, ENDOCR J, V55, P753, DOI 10.1507/endocrj.K07E-142
   Turner RC, 1998, LANCET, V352, P837
NR 14
TC 3
Z9 4
U1 1
U2 4
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0742-3071
J9 DIABETIC MED
JI Diabetic Med.
PD MAY
PY 2010
VL 27
IS 5
BP 589
EP 592
DI 10.1111/j.1464-5491.2010.02955.x
PG 4
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 586XM
UT WOS:000276948600014
PM 20536957
DA 2019-01-08
ER

PT J
AU van den Donk, M
   Gorter, KJ
   Rutten, GE
AF van den Donk, Maureen
   Gorter, Kees J.
   Rutten, Guy E.
TI No negative effects of a multi-factorial, intensified treatment on
   self-reported health status, treatment satisfaction, and
   diabetes-related distress in screen-detected type 2 diabetes patients.
   The ADDITION-Netherlands study
SO QUALITY OF LIFE RESEARCH
LA English
DT Article
DE Randomised controlled trial; Diabetes mellitus, type 2; Intensified
   treatment; Primary health care; Health status; Treatment satisfaction
ID QUALITY-OF-LIFE; DISEASE; DUTCH; SF-36; RISK
AB To examine the effects of a multi-factorial, intensified treatment on self-reported health status, treatment satisfaction, and diabetes-related distress in screen-detected type 2 diabetes patients.
   Cluster-randomised controlled trial; A total of 498 screen-detected type 2 diabetes patients from 79 general practices were assigned to intensified (n = 255) or routine treatment according to Dutch guidelines (n = 243). At baseline and after 3 years, patients completed the Short Form-36 and the European Quality of Life-5 Dimensions questionnaires. After 4.5 years, patients completed the Diabetes Treatment Satisfaction Questionnaire and the Problem Areas In Diabetes scale. We analysed the effects of intensified treatment on self-rated health status, treatment satisfaction, and diabetes-related distress, using random effects models to account for clustering at practice level.
   Three to 5 years after type 2 diabetes was detected by screening, there were no differences between intensified and routine treatment in self-reported health status, treatment satisfaction, and diabetes-related distress.
   Multi-factorial, intensified treatment did not influence self-rated health status, treatment satisfaction, and distress in screen-detected type 2 diabetes patients. Therefore, health care professionals do not have to fear negative effects of an intensified treatment on these psychological outcomes.
C1 [van den Donk, Maureen; Gorter, Kees J.; Rutten, Guy E.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands.
RP van den Donk, M (reprint author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Str 6-131,POB 85500, NL-3508 GA Utrecht, Netherlands.
EM m.vandendonk@umcutrecht.nl
FU Novo Nordisk; Glaxo Smith Kline; Dutch Diabetes Research Foundation
   [2007.13.001]
FX The ADDITION-Netherlands study is made possible by unrestricted grants
   from Novo Nordisk and Glaxo Smith Kline. For the current analyses, we
   received a grant from the Dutch Diabetes Research Foundation (grant
   number 2007.13.001).
CR Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3
   ALBERTI K, 1999, DEFINITION DIAGNOSIS
   Bradley C, 1994, HDB PSYCHOL DIABETES, P65
   Bradley C., 1994, HDB PSYCHOL DIABETES, P111
   Brommels M, 2001, ANN MED, V33, P319, DOI 10.3109/07853890109002084
   Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778
   Janssen PGH, 2007, FAM PRACT, V24, P555, DOI 10.1093/fampra/cmm052
   Janssen PGH, 2009, BRIT J GEN PRACT, V59, P43, DOI 10.3399/bjgp09X394851
   Lauritzen T., 2000, INT J OBESITY, V24, P6
   Menard J, 2007, DIABETES METAB, V33, P54, DOI 10.1016/j.diabet.2006.09.001
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Redekop WK, 2002, DIABETES CARE, V25, P458, DOI 10.2337/diacare.25.3.458
   Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O
   RUTTEN GEH, 2006, HUISARTS WET, V49, P137
   Sandbaek A, 2008, DIABETOLOGIA, V51, P1127, DOI 10.1007/s00125-008-1013-0
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   The EuroQol Group, 1990, HLTH POLICY, V16, P199, DOI DOI 10.1016/0168-8510(90)90421-9
   Thoolen BJ, 2006, DIABETES CARE, V29, P2257, DOI 10.2337/dc06-0617
   UKPDS UK, 1999, DIABETES CARE, V22, P1125, DOI DOI 10.2337/DIACARE.22.7.1125
   VANDENBRINK CL, 2005, 260854009 RIVM
   WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002
NR 22
TC 5
Z9 5
U1 0
U2 2
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0962-9343
J9 QUAL LIFE RES
JI Qual. Life Res.
PD MAY
PY 2010
VL 19
IS 4
BP 509
EP 513
DI 10.1007/s11136-010-9604-x
PG 5
WC Health Care Sciences & Services; Health Policy & Services; Public,
   Environmental & Occupational Health
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA 581HN
UT WOS:000276512700009
PM 20155327
OA Green Published, Other Gold
DA 2019-01-08
ER

PT J
AU Fadl, HE
   Ostlund, IKM
   Magnuson, AFK
   Hanson, USB
AF Fadl, H. E.
   Ostlund, I. K. M.
   Magnuson, A. F. K.
   Hanson, U. S. B.
TI Maternal and neonatal outcomes and time trends of gestational diabetes
   mellitus in Sweden from 1991 to 2003
SO DIABETIC MEDICINE
LA English
DT Article
DE gestational diabetes mellitus; maternal outcome; neonatal outcome
ID GLUCOSE-TOLERANCE TEST; CHRONIC HYPERTENSION; PERINATAL OUTCOMES;
   PREGNANCY OUTCOMES; DANISH WOMEN; RISK; PREVALENCE; POPULATION; COHORT;
   AGE
AB P>Aims
   To determine maternal and neonatal outcomes for women with gestational diabetes mellitus (GDM) in Sweden during 1991-2003, and to compare the outcomes in the two time periods.
   Methods
   This is a population-based cohort study using the Swedish Medical Birth Register data for the period 1991-2003. There were 1 260 297 women with singleton pregnancies registered during this time, of whom 10 525 were diagnosed with GDM, based on a 75 g oral glucose tolerance test. The main diagnostic criteria were fasting capillary whole blood glucose >= 6.1 mmol/l and 2 h blood glucose >= 9.0 mmol/l.
   Results
   Maternal characteristics differed significantly between the GDM and non-GDM group. Adjusted odds ratios (OR) were as follows: for pre-eclampsia, 1.81 (95% confidence interval (CI) 1.64-2.00); for shoulder dystocia, 2.74 (2.04-3.68); and for Caesarean section, 1.46 (1.38-1.54). No difference was seen in perinatal mortality, stillbirth rates, Apgar scores, fetal distress or transient tachypnoea. There was a markedly higher risk of large for gestational age, OR 3.43 (3.21-3.67), and Erb's palsy, OR 2.56 (1.96-3.32), in the GDM group, and statistically significant differences in prematurity < 37 weeks, birth weight > 4.5 kg, and major malformation, OR 1.19-1.71. No statistically significant improvement in outcomes was seen between the two study periods.
   Conclusions
   Women with GDM have higher risks of pre-eclampsia, shoulder dystocia and Caesarean section. Their infants are often large for gestational age and have higher risks of prematurity, Erb's palsy and major malformations. These outcomes did not improve over time.
C1 [Fadl, H. E.; Ostlund, I. K. M.; Hanson, U. S. B.] Orebro Univ Hosp, Dept Obstet & Gynaecol, SE-70185 Orebro, Sweden.
   [Magnuson, A. F. K.] Orebro Univ Hosp, Stat & Epidemiol Unit, SE-70185 Orebro, Sweden.
   [Hanson, U. S. B.] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden.
RP Fadl, HE (reprint author), Orebro Univ Hosp, Dept Obstet & Gynaecol, SE-70185 Orebro, Sweden.
EM helena.fadl@orebroll.se
FU Orebro County Council
FX The study was supported by grants from the research Committee of Orebro
   County Council.
CR Anderberg E, 2007, ACTA OBSTET GYN SCAN, V86, P1432, DOI 10.1080/00016340701532444
   [Anonymous], 2003, SWEDISH MED BIRTH RE
   Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973
   Eliasson M, 2002, DIABETIC MED, V19, P874, DOI 10.1046/j.1464-5491.2002.00789.x
   HJALMARSON O, 1981, ACTA PAEDIATR SCAND, V70, P773, DOI 10.1111/j.1651-2227.1981.tb06228.x
   Jansson SPO, 2007, DIABETOLOGIA, V50, P703, DOI 10.1007/s00125-007-0593-4
   Jensen DM, 2000, DIABETIC MED, V17, P281, DOI 10.1046/j.1464-5491.2000.00268.x
   Jensen DM, 2003, DIABETIC MED, V20, P51, DOI 10.1046/j.1464-5491.2003.00857.x
   Jensen DM, 2008, ACTA OBSTET GYN SCAN, V87, P59, DOI 10.1080/00016340701823975
   Kim C, 2002, DIABETES CARE, V25, P1862, DOI 10.2337/diacare.25.10.1862
   Lawrence JM, 2008, DIABETES CARE, V31, P899, DOI 10.2337/dc07-2345
   LINDER DH, 1991, IEEE T COMPUT, V40, P2, DOI 10.1109/12.67315
   Martinez-Frias ML, 2005, DIABETIC MED, V22, P775, DOI 10.1111/j.1464-5491.2005.01492.x
   Metzger BE, 1998, DIABETES CARE, V21, pB161
   Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943
   Ostlund I, 2004, ACTA OBSTET GYN SCAN, V83, P46, DOI 10.1111/j.1600-0412.2004.00267.x
   Ostlund I, 2003, DIABETES CARE, V26, P2107, DOI 10.2337/diacare.26.7.2107
   Patel RR, 2005, INT J EPIDEMIOL, V34, P353, DOI 10.1093/ije/dyh401
   Persson B, 1998, DIABETES CARE, V21, pB79
   Russell MA, 2007, CLIN OBSTET GYNECOL, V50, P949, DOI 10.1097/GRF.0b013e31815a5510
   Teramo KA, 2009, NEONATOLOGY, V95, P105, DOI 10.1159/000153094
   Yu CKH, 2006, BJOG-INT J OBSTET GY, V113, P1117, DOI 10.1111/j.1471-0528.2006.00991.x
   Zetterstrom K, 2005, ACTA OBSTET GYN SCAN, V84, P419, DOI 10.1111/j.0001-6349.2005.00508.x
   Zetterstrom K, 2006, ACTA OBSTET GYN SCAN, V85, P1046, DOI 10.1080/00016340500442654
   1990, DIABET MED, V7, P360
NR 25
TC 84
Z9 89
U1 0
U2 3
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0742-3071
J9 DIABETIC MED
JI Diabetic Med.
PD APR
PY 2010
VL 27
IS 4
BP 436
EP 441
DI 10.1111/j.1464-5491.2010.02978.x
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 580RH
UT WOS:000276466600011
PM 20536516
DA 2019-01-08
ER

PT J
AU Siegel, B
   Chan, C
   Willies-Jacobo, L
   Stein, MT
AF Siegel, Benjamin
   Chan, Christina
   Willies-Jacobo, Lindia
   Stein, Martin T.
TI Culture Clash: A Missed Opportunity
SO JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS
LA English
DT Article
AB CASE: Erasto is a term infant born by vaginal delivery to a gravida 7 para 7 Somalia woman with full prenatal care in the United States. His mother had gestational diabetes. The delivery was complicated by respiratory distress and an urgent admission to the neonatal intensive care unit for further evaluation for possible pulmonary disease and a congenital heart condition.
   A female pediatric intern was assigned to update Erasto's mother on the baby's status and to obtain consent for an intravascular line placement. When she entered the room to talk to the mother, multiple family members spanning at 3 generations were with the baby's mother. They were all women with the exception of Erasto's father who was apprised of the baby's clinical status by the male neonatal physician several minutes earlier. Through a telephone translator, the intern explained to Erasto's mother that her baby may have heart and lung problems that may be related to her gestational diabetes.
   At this point, many family members spoke simultaneously and excitedly. Some accused the intern of keeping the baby in the neonatal intensive care unit "to make more money," and others said they would sue her " if anything happened to Erasto. "The mother denied that she had gestational diabetes, and claimed that because she " believed in God. nothing is wrong with my baby." The intern was not prepared for this response and asked herself, " What went wrong?"
C1 [Siegel, Benjamin] Boston Univ, Sch Med, Boston Med Ctr Pediat, Dept Pediat & Psychiat, Boston, MA 02118 USA.
   [Willies-Jacobo, Lindia; Stein, Martin T.] Univ Calif San Diego, Sch Med, Rady Childrens Hosp San Diego, Dept Pediat, San Diego, CA 92103 USA.
RP Siegel, B (reprint author), Boston Univ, Sch Med, Boston Med Ctr Pediat, Dept Pediat & Psychiat, Boston, MA 02118 USA.
OI Siegel, Benjamin/0000-0003-3572-2575
CR Anderson MR, 2004, PEDIATRICS, V114, P1677, DOI 10.1542/peds.2004-2091
   BARNES L, BOSTON HEALING LANDS, P24311
   Carroll J, 2007, PATIENT EDUC COUNS, V66, P337, DOI 10.1016/j.pec.2007.01.008
   Carroll Jennifer, 2007, Health Care Women Int, V28, P360, DOI 10.1080/07399330601179935
   Epstein RM, 1999, JAMA-J AM MED ASSOC, V282, P833, DOI 10.1001/jama.282.9.833
   *GEORG U NAT CTR C, GUID FAM CTR CAR CUL, P24311
   Goode TD, 2006, EVIDENCE BASE CULTUR
   KLINEMAN A, 1978, ANN INTERN MED, V88, P251
   Levetown M, 2008, PEDIATRICS, V121, pE1441, DOI 10.1542/peds.2008-0565
   Lewis Toby, 1996, SOMALI CULTURAL PROF
   Mohamed M, 1997, MENDING RIPS SKY OPT, P145
   Plack MM, 2005, PEDIATRICS, V116, P1546, DOI 10.1542/peds.2005-0209
   Scuglik Deborah L, 2007, Transcult Psychiatry, V44, P581, DOI 10.1177/1363461507083899
   Stein MT, 2003, J DEV BEHAV PEDIATR, V24, P434
   TAYLOR L, 2006, ENCOUNTERS CHILDREN, P44
NR 15
TC 0
Z9 0
U1 1
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0196-206X
J9 J DEV BEHAV PEDIATR
JI J. Dev. Behav. Pediatr.
PD APR
PY 2010
VL 31
IS 3
SU S
BP S96
EP S99
DI 10.1097/DBP.0b013e3181d82f49
PG 4
WC Behavioral Sciences; Psychology, Developmental; Pediatrics
SC Behavioral Sciences; Psychology; Pediatrics
GA 589WS
UT WOS:000277185500026
PM 20414088
DA 2019-01-08
ER

PT J
AU Denham, SA
   Remsberg, K
   Wood, L
AF Denham, S. A.
   Remsberg, K.
   Wood, L.
TI Diabetes education in the Appalachian region: providers' views
SO RURAL AND REMOTE HEALTH
LA English
DT Article
DE Appalachia; diabetes; diabetes educators; diabetes self-management;
   education; rural health; type 2 diabetes; USA
ID HEALTH-CARE UTILIZATION; FAMILY SUPPORT; UNITED-STATES; RURAL REGION;
   PERSPECTIVES; BARRIERS; ASSOCIATION; MANAGEMENT; LITERACY; MELLITUS
AB Introduction: The aim of this study was to examine provider perceptions concerning the provision and accessibility of diabetes education, according to levels of economic distress and rurality throughout the US Appalachian region.
   Methods: A questionnaire regarding diabetes education resources was developed and mailed to all Federally Qualified Health Centers (FQHC), health departments, and known certified diabetes educators (CDEs) in the Appalachian region. Diabetes education was examined according to historical economic distress, distressed/at risk (DAR) versus not DAR (NDAR).
   Results: Diabetes education classes were offered equally across DAR and NDAR locations and most patients with diabetes had attended. The CDEs and physicians were less common in DAR compared with NDAR sites (adjusted odds ratios [aOR]=0.33 [0.13, 0.85] and 59.1 vs 166.9 per 100 000; p<0.001). The DAR sites were more likely than NDAR sites to report transportation (aORs 2.19-4.94) as a problem for patients and insufficient staff (aOR=2.50 [1.20, 5.18]) as a problem for diabetes education programs.
   Conclusions: Although DAR areas functioned with fewer health professionals than NDAR areas, many of the barriers to providing education affected patients and health professionals in both DAR and NDAR areas.
C1 [Denham, S. A.; Remsberg, K.; Wood, L.] Ohio Univ, Athens, OH 45701 USA.
RP Denham, SA (reprint author), Ohio Univ, Athens, OH 45701 USA.
CR *AM ASS CLIN END, STAT DIAB AM
   Anderson RM, 2005, PATIENT EDUC COUNS, V57, P153, DOI 10.1016/j.pec.2004.05.008
   Arcury TA, 2005, J RURAL HEALTH, V21, P31, DOI 10.1111/j.1748-0361.2005.tb00059.x
   Arcury TA, 2005, HEALTH SERV RES, V40, P135, DOI 10.1111/j.1475-6773.2005.00346.x
   BARTLETT EE, 1986, PATIENT EDUC COUNS, V8, P135, DOI 10.1016/0738-3991(86)90085-6
   Behringer Bruce, 2006, Prev Chronic Dis, V3, pA113
   Bell RA, 2001, AM J PREV MED, V21, P124, DOI 10.1016/S0749-3797(01)00328-2
   Brown AF, 2004, EPIDEMIOL REV, V26, P63, DOI 10.1093/epirev/mxh002
   Carbone ET, 2007, PATIENT EDUC COUNS, V66, P202, DOI 10.1016/j.pec.2006.12.003
   Carter-Edwards L, 2004, DIABETES EDUCATOR, V30, P493, DOI 10.1177/014572170403000321
   *CDCP, 2000, MMWR-MORBID MORTAL W, V49, P954
   Centers for Disease Control and Prevention, 2005, NAT DIAB FACT SHEET
   Chin MH, 2000, MED CARE, V38, P131, DOI 10.1097/00005650-200002000-00003
   Chin MH, 2001, DIABETES CARE, V24, P268, DOI 10.2337/diacare.24.2.268
   Coyne Cathy A, 2006, Prev Chronic Dis, V3, pA124
   Denham SA, 2010, RURAL REMOTE HEALTH, V10
   DENHAM SA, 2006, FAM SYST HLTH, V25, P36
   *EC RES SERV, 2004, BRIEF ROOMS MEAS RUR
   El-Deirawi K M, 2001, J Vasc Nurs, V19, P95, DOI 10.1067/mvn.2001.118311
   Epple C, 2003, DIABETES CARE, V26, P2829, DOI 10.2337/diacare.26.10.2829
   Funnell M M, 1992, Diabetes Educ, V18, P139, DOI 10.1177/014572179201800207
   Funnell MM, 2006, DIABETES EDUCATOR, V32, P359, DOI 10.1177/0145721706288041
   FUNNELL MM, 2006, DIABETES ED, V32, P368
   FUNNELL MM, 2006, DIABETES ED, V32, P364
   Halverson JA, 2004, ANAL DISPARITIES HLT
   Hayes PA, 2006, QUAL HEALTH RES, V16, P282, DOI 10.1177/1049732305275629
   *HLTH FDN GREAT CI, 2005, 2005 GREAT CINC COMM
   Irvine A A, 1992, Diabetes Educ, V18, P29, DOI 10.1177/014572179201800105
   Johnson Janelle L, 2004, J Cardiopulm Rehabil, V24, P121, DOI 10.1097/00008483-200403000-00010
   Liu J, 2007, J HEALTH CARE POOR U, V18, P590, DOI 10.1353/hpu.2007.0062
   Lohri-Posey B, 2006, FAM COMMUNITY HEALTH, V29, P214, DOI 10.1097/00003727-200607000-00008
   *NAT DIAB INF CLEA, 2004, DIAB DAT MOST PEOPL
   Nelson KM, 2005, HEALTH SERV RES, V40, P361, DOI 10.1111/j.1475-6773.2005.0d362.x
   O'Brien T, 2008, DIABETES EDUCATOR, V34, P334, DOI 10.1177/0145721708316318
   Pan LP, 2007, DIABETES, V56, pA257
   Rothman R, 2004, DIABETES EDUCATOR, V30, P263, DOI 10.1177/014572170403000219
   Schillinger D, 2002, JAMA-J AM MED ASSOC, V288, P475, DOI 10.1001/jama.288.4.475
   Siminerio LM, 2007, DIABETES EDUCATOR, V33, P152, DOI 10.1177/0145721706298194
   Sprague MA, 1999, DIABETES EDUCATOR, V25, P907, DOI 10.1177/014572179902500608
   Tessaro Irene, 2005, Prev Chronic Dis, V2, pA13
   *US CENS BUR, 2000, US CENS 2000
   Visser A, 2004, PATIENT EDUC COUNS, V53, P251, DOI 10.1016/j.pec.2004.05.003
   Voeks JH, 2008, STROKE, V39, P1675, DOI 10.1161/STROKEAHA.107.507053
   Wen LK, 2004, DIABETES EDUCATOR, V30, P980, DOI 10.1177/014572170403000619
   Whiteis DG, 1998, SOC SCI MED, V47, P795, DOI 10.1016/S0277-9536(98)00137-3
   *WHO MED CTR, 2009, DIAB
NR 46
TC 5
Z9 5
U1 0
U2 8
PU AUSTRALIAN RURAL HEALTH EDUC NETWORK
PI DEAKIN WEST
PA PO BOX 242, DEAKIN WEST, ACT 2600, AUSTRALIA
SN 1445-6354
J9 RURAL REMOTE HEALTH
JI Rural Remote Health
PD APR-JUN
PY 2010
VL 10
IS 2
AR 1321
PG 13
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 708DT
UT WOS:000286342500010
PM 20560683
DA 2019-01-08
ER

PT J
AU Denham, SA
   Wood, LE
   Remsberg, K
AF Denham, S. A.
   Wood, L. E.
   Remsberg, K.
TI Diabetes care: provider disparities in the US Appalachian region
SO RURAL AND REMOTE HEALTH
LA English
DT Article
DE Appalachia; diabetes; health disparities; rural health care; rural
   poverty
ID SOCIOECONOMIC-STATUS; NATIONAL-HEALTH; PREVALENCE; AMERICAN; RATES;
   AREAS
AB Introduction: Diabetes is a devastating and growing problem in the USA and throughout the world. Parts of Appalachia, especially the most rural and economically 'distressed' areas of the region, have disproportionately high levels of diabetes incidence and have had long-standing problems in healthcare access. Purpose: Little is known about the status of public health infrastructures and expertise available to address the diabetes epidemic, whether in Appalachia or elsewhere. This research examines the availability of professional diabetes care in Appalachia, including the economically distressed areas of the region.
   Methods: A 2006 cross-sectional survey of healthcare providers in the Appalachian Region identified diabetes service needs and availability in Appalachian healthcare facilities. Survey data and socioeconomic data were combined as a means to assess intra-regional variation in service availability.
   Results: Participants perceived that diabetes prevalence was growing in Appalachia and that they were seeing increasing numbers of persons with diabetes. Healthcare facilities in the region rarely employed specialized health professional providers and the expertise concerning diabetes in some clinicians may be limited.
   Conclusions: The current and growing diabetes problem in Appalachia underscores the need for appropriate diabetes services and health professionals acquainted with current standards in diabetes care. Such problems in Appalachia have long been identified and linked with insufficient healthcare resources. The identification of ways to assure that local clinicians have current knowledge of diabetes standards of care is warranted.
C1 [Denham, S. A.; Wood, L. E.; Remsberg, K.] Ohio Univ, Athens, OH 45701 USA.
RP Denham, SA (reprint author), Ohio Univ, Athens, OH 45701 USA.
FU Centers for Disease Control and Prevention National Diabetes; Ohio
   Department of Health Diabetes Prevention and Control; Ohio University's
   Diabetes Research Institute; Appalachian Rural Health Institute;
   Diabetes Center; College of Health and Human Services; School of Nursing
FX This project was supported in part by the Centers for Disease Control
   and Prevention National Diabetes Education Program, the Ohio Department
   of Health Diabetes Prevention and Control Program, Ohio University's
   Diabetes Research Institute, the Appalachian Rural Health Institute, the
   Diabetes Center, the College of Health and Human Services, and the
   School of Nursing. Graduate assistants who assisted with this project
   were Tara O'Brien, Cara Butcher, Stacey Hartman, Tammy Collier, Eimi
   Lev, and Patricia Harris.
CR *AM DIAB ASS, 2007, TOT PREV DIAB PRED
   Anderson Roger T, 2003, N C Med J, V64, P58
   [Anonymous], 1964, APP REP PRES APP REG
   *APP REG COMM, 1970, 1 YEARS APP HLTH PRO
   *APP REG COMM, 2004, APP REG COMM ANN REP
   *APP RUR HLTH I, 2006, DIAB
   Appalachian Regional Commission, 2006, COUNT EC STAT DES AP
   Appalachian Rural Health Institute, 2004, PREV DIAB
   Bell RA, 2005, J RURAL HEALTH, V21, P198, DOI 10.1111/j.1748-0361.2005.tb00083.x
   Bell RA, 2001, AM J PREV MED, V21, P124, DOI 10.1016/S0749-3797(01)00328-2
   Billings D. B., 1993, FORGOTTEN PLACES UNE, P7
   Centers for Disease Control and Prevention, 2005, NAT DIAB FACT SHEET
   Connolly V, 2000, J EPIDEMIOL COMMUN H, V54, P173, DOI 10.1136/jech.54.3.173
   Coyne Cathy A, 2006, Prev Chronic Dis, V3, pA124
   DENHAM SA, 1995, J APPALACHIAN STUDIE, V2, P299
   Duncan C. M., 1999, WORLDS APART WHY POV
   FULLENBAUM R, 1995, SURVEY COMP DISTRESS
   Halverson JA, 2004, ANAL DISPARITIES HLT
   Huttlinger K., 2004, ONLINE J RURAL NURSI, V4, P22
   Ismail AA, 1999, QJM-MON J ASSOC PHYS, V92, P707, DOI 10.1093/qjmed/92.12.707
   Jack Leonard Jr, 2007, Prev Chronic Dis, V4, pA71
   Kaplan GA, 2007, INT J EPIDEMIOL, V36, P542, DOI 10.1093/ije/dym008
   LICHTER DT, 2006, CHANGING SPATIAL CON
   Mainous AG, 2004, ANN FAM MED, V2, P563, DOI 10.1370/afm.119
   O'Brien T, 2008, DIABETES EDUCATOR, V34, P334, DOI 10.1177/0145721708316318
   Pathman DE, 2005, J RURAL HEALTH, V21, P214, DOI 10.1111/j.1748-0361.2005.tb00085.x
   Robbins JM, 2001, AM J PUBLIC HEALTH, V91, P76
   Weingarten JP, 2006, J RURAL HEALTH, V22, P351, DOI 10.1111/j.1748-0361.2006.00057.x
   Wood L. J., 2000, PROGR CHALLENGES RED
   Wood LE, 2005, TRENDS NATL REGIONAL
   Zoorob RJ, 1996, J COMMUN HEALTH, V21, P175, DOI 10.1007/BF01557997
NR 31
TC 10
Z9 10
U1 0
U2 6
PU AUSTRALIAN RURAL HEALTH EDUC NETWORK
PI DEAKIN WEST
PA PO BOX 242, DEAKIN WEST, ACT 2600, AUSTRALIA
SN 1445-6354
J9 RURAL REMOTE HEALTH
JI Rural Remote Health
PD APR-JUN
PY 2010
VL 10
IS 2
AR 1320
PG 13
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 708DT
UT WOS:000286342500009
PM 20509722
DA 2019-01-08
ER

PT J
AU Plack, K
   Herpertz, S
   Petrak, F
AF Plack, Kristin
   Herpertz, Stephan
   Petrak, Frank
TI Behavioral medicine interventions in diabetes
SO CURRENT OPINION IN PSYCHIATRY
LA English
DT Article
DE behavioral medicine; diabetes; randomized controlled trials; treatment
ID RANDOMIZED CONTROLLED-TRIAL; QUALITY-OF-LIFE; POOR GLYCEMIC CONTROL;
   CORONARY-HEART-DISEASE; SCHOOL-AGE-CHILDREN; SELF-MANAGEMENT;
   MICROVASCULAR COMPLICATIONS; PSYCHOLOGICAL INTERVENTIONS; HYPOGLYCEMIA
   UNAWARENESS; CONSENSUS STATEMENT
AB Purpose of review
   Poor glycemic control is prevalent in the majority of patients with diabetes and has a strong impact on medical as well as psychological outcomes. Psychological and behavioral variables are of particular interest, as the patients themselves are the most determining factor of treatment success. Consequently, a wide range of behavioral medicine interventions are aimed at improvement in diabetes self-management, coping strategies, blood glucose awareness, and stress reduction. This review provides an overview of randomized controlled trials (RCTs) published in the past 18 months (from March 2008 to September 2009) that evaluated behavioral medicine interventions in patients with diabetes. The review summarizes the interventions' effects on metabolic control and other medical variables, as well as diabetes self-management and psychological outcomes.
   Recent findings
   Behavioral medicine interventions in the diabetes field encompass a number of different approaches with the goal of improving medical outcomes such as glycemic control as well as psychological outcomes. There is evidence for beneficial effects of recent behavioral medicine treatments in terms of improvement of metabolic control as indicated by decreased glycated hemoglobin (HbA1c). Furthermore, positive effects were observed regarding diabetes-related self-efficacy, self-management, proactive coping, and the reduction of psychological burdens and symptoms.
   Summary
   Behavioral medicine interventions are effective in diabetes treatment, especially in patients with a high level of diabetes-related distress, difficulty in coping, or insufficient blood glucose awareness.
C1 [Plack, Kristin] Johannes Gutenberg Univ Mainz, Dept Clin Psychol & Psychotherapy, D-55122 Mainz, Germany.
   [Herpertz, Stephan; Petrak, Frank] Ruhr Univ Bochum, Dept Psychosomat Med, Dortmund, Germany.
   [Herpertz, Stephan; Petrak, Frank] Ruhr Univ Bochum, Dept Psychotherapy, LWL Clin Dortmund, Dortmund, Germany.
RP Plack, K (reprint author), Johannes Gutenberg Univ Mainz, Dept Clin Psychol & Psychotherapy, Wallstr 3, D-55122 Mainz, Germany.
EM kplack@uni-mainz.de
CR Allen NA, 2008, DIABETES RES CLIN PR, V80, P371, DOI 10.1016/j.diabres.2008.01.006
   Ambrosino JM, 2008, PEDIATR DIABETES, V9, P74, DOI 10.1111/j.1399-5448.2007.00356.x
   Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS13, DOI 10.2337/dc09-S013
   Amsberg S, 2009, PATIENT EDUC COUNS, V77, P72, DOI 10.1016/j.pec.2009.01.015
   Anderson RJ, 2002, INT J PSYCHIAT MED, V32, P235, DOI 10.2190/KLGD-4H8D-4RYL-TWQ8
   Avogaro A, 2007, DIABETES CARE, V30, P1241, DOI 10.2337/dc06-2558
   Bremer JP, 2009, DIABETES CARE, V32, P1513, DOI 10.2337/dc09-0114
   Cheung N, 2007, DIABETES CARE, V30, P1742, DOI 10.2337/dc07-0264
   Ciechanowski P, 2004, PSYCHOSOM MED, V66, P720, DOI 10.1097/01.psy.0000138125.59122.23
   Cochran J, 2008, DIABETES EDUCATOR, V34, P815, DOI 10.1177/0145721708323640
   Conn VS, 2007, DIABETOLOGIA, V50, P913, DOI 10.1007/s00125-007-0625-0
   Conn VS, 2008, AM J HEALTH BEHAV, V32, P315
   Cox D, 2008, DIABETES CARE, V31, P1527, DOI 10.2337/dc07-1956
   Cox DJ, 2001, DIABETES CARE, V24, P637, DOI 10.2337/diacare.24.4.637
   Cox DJ, 2006, DIABETES SPECTRUM, V19, P43, DOI DOI 10.2337/DIASPECT.19.1.43
   Davies MJ, 2008, BRIT MED J, V336, P491, DOI 10.1136/bmj.39474.922025.BE
   Delahanty LM, 2007, DIABETIC MED, V24, P48, DOI 10.1111/j.1464-5491.2007.02028.x
   DeVries JH, 2004, DIABETIC MED, V21, P1263, DOI 10.1111/j.1464-5491.2004.01386.x
   Dueck AC, 2007, VALUE HEALTH, V10, pS64, DOI 10.1111/j.1524-4733.2007.00268.x
   Ellis D, 2008, DIABETES CARE, V31, P1746, DOI 10.2337/dc07-2094
   Engstrom I, 1999, ACTA PAEDIATR, V88, P175, DOI 10.1080/08035259950170358
   Farmer AJ, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13150
   Farmer AJ, 2009, HEALTH TECHNOL ASSES, V13, pix
   Fisher EB, 2007, DIABETES EDUCATOR, V33, P1080, DOI 10.1177/0145721707309808
   Garber AJ, 2006, DIABETES CARE, V29, P1955, DOI 10.2337/dc06-9913
   Gary TL, 2003, DIABETES EDUCATOR, V29, P488, DOI 10.1177/014572170302900313
   Geddes J, 2008, DIABETIC MED, V25, P501, DOI 10.1111/j.1464-5491.2008.02413.x
   Geddes J, 2006, DIABETIC MED, V23, P1155, DOI 10.1111/j.1464-5491.2006.01933.x
   Grey M, 2009, RES NURS HEALTH, V32, P405, DOI 10.1002/nur.20336
   Hesketh KD, 2004, DIABETES CARE, V27, P415, DOI 10.2337/diacare.27.2.415
   Ismail K, 2004, LANCET, V363, P1589, DOI 10.1016/S0140-6736(04)16202-8
   Ismail K, 2008, ANN INTERN MED, V149, P708, DOI 10.7326/0003-4819-149-10-200811180-00005
   Jones JM, 2000, BMJ-BRIT MED J, V320, P1563, DOI 10.1136/bmj.320.7249.1563
   Kilpatrick ES, 2008, CURR MED RES OPIN, V24, P2651, DOI 10.1185/03007990802347209 
   Kilpatrick ES, 2008, DIABETES CARE, V31, P2198, DOI 10.2337/dc08-0864
   Li CY, 2009, INT J PUBLIC HEALTH, V54, P43, DOI 10.1007/s00038-009-0006-1
   Lloyd CE, 1999, DIABETES CARE, V22, P1278, DOI 10.2337/diacare.22.8.1278
   Lorig K, 2008, DIABETES CARE, V31, P408, DOI 10.2337/dc07-1313
   Lorig K, 2009, DIABETES EDUCATOR, V35, P641, DOI 10.1177/0145721709335006
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Ly TT, 2009, DIABETES CARE, V32, P1802, DOI 10.2337/dc09-0541
   Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025
   Norris SL, 2004, AM J MED, V117, P762, DOI 10.1016/j.amjmed.2004.05.024
   Norris Susan L, 2005, Curr Diab Rep, V5, P124, DOI 10.1007/s11892-005-0039-7
   Pereira MG, 2008, INT J BEHAV MED, V15, P187, DOI 10.1080/10705500802222436
   Petersen M, 2008, DIABETES CARE, V31, P596, DOI 10.2337/dc08-9017
   Sacco WP, 2009, J BEHAV MED, V32, P349, DOI 10.1007/s10865-009-9209-4
   Samuel-Hodge CD, 2009, DIABETES EDUCATOR, V35, P439, DOI 10.1177/0145721709333270
   Schillinger D, 2009, DIABETES CARE, V32, P559, DOI 10.2337/dc08-0787
   Smith CB, 2009, DIABETES CARE, V32, P1196, DOI 10.2337/dc08-2259
   Snoek FJ, 2008, DIABETIC MED, V25, P1337, DOI 10.1111/j.1464-5491.2008.02595.x
   Soo H, 2009, J HEALTH PSYCHOL, V14, P933, DOI 10.1177/1359105309341146
   Surwit RS, 2002, DIABETES CARE, V25, P30, DOI 10.2337/diacare.25.1.30
   van der Ven N., 2003, DIABETES SPECTRUM, V16, P88, DOI [DOI 10.2337/DIASPECT.16.2.88, 10.2337/diaspect.16.2.88]
   Wens J, 2008, DIABETES RES CLIN PR, V79, P377, DOI 10.1016/j.diabres.2007.06.006
   Wexler DJ, 2007, DIABETES CARE, V30, P367, DOI 10.2337/dc06-1715
   Wheeler ML, 2001, DIABETES CARE, V24, P421, DOI 10.2337/diacare.24.3.421
   Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047
   Winkley K, 2006, BRIT MED J, V333, P65, DOI 10.1136/bmj.38874.652569.55
   Winterstein AG, 2002, AM J HEALTH-SYST PH, V59, P1742
   Young MJ, 2008, DIABETES CARE, V31, P2143, DOI 10.2337/dc08-1242
   Zhang XP, 2007, MED CARE, V45, P820, DOI 10.1097/MLR.0b013e3180618b55
   Ziegler D, 2008, DIABETES CARE, V31, P464, DOI 10.2337/dc07-1796
NR 63
TC 15
Z9 16
U1 0
U2 15
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0951-7367
EI 1473-6578
J9 CURR OPIN PSYCHIATR
JI Curr. Opin. Psychiatr.
PD MAR
PY 2010
VL 23
IS 2
BP 131
EP 138
DI 10.1097/YCO.0b013e3283366555
PG 8
WC Psychiatry
SC Psychiatry
GA 559DC
UT WOS:000274799900009
PM 20057315
DA 2019-01-08
ER

PT J
AU Chawla, A
   Saha, C
   Marrero, DG
AF Chawla, Apoorva
   Saha, Chandan
   Marrero, David G.
TI A Novel Application of the Problem Areas in Diabetes (PAID) Instrument
   to Improve Glycemic Control and Patient Satisfaction
SO DIABETES EDUCATOR
LA English
DT Article
ID DISTRESS; SCALE; US
AB Purpose
   The purpose of this study was to use the Problem Areas in Diabetes (PAID) instrument in a novel manner and assess whether providing primary care physicians the results of the questionnaire completed by their patients immediately prior to a clinical encounter would result in improvement in a patient's glycemic control and/or post-encounter satisfaction score.
   Methods
   A 6-month longitudinal pilot study, involving 4 general internal medicine physicians and 61 patients in 4 separate offices, was designed. The patient sample was 54% male and 46% female with ages from 41 to 91. The sample included newly diagnosed diabetic patients and those with longstanding disease; as such, the patient population had a range of diabetes-related complications from none to end-stage renal disease. At baseline, 3-month, and 6-month clinic visits, patients completed the PAID questionnaire, and results were provided to the physician prior to the clinical encounter. Satisfaction was measured postencounter. A1C was checked at all 3 visits with the first visit serving as baseline.
   Results
   Patients in all 3 groups had improved hemoglobin A1C, reduced perceived problem areas, and increased satisfaction with the quality of care received. These effects were most pronounced after the first visit and for patients with poorer quality of glycemic control at baseline.
   Conclusions
   The PAID instrument facilitates a therapeutic dialogue between patient and physician, has the most effect at the initial encounter, and makes the most impact on at-risk patients presenting with poor glycemic control.
C1 [Marrero, David G.] Indiana Univ, Sch Med, Div Endocrinol & Metab, Indianapolis, IN 46202 USA.
   [Chawla, Apoorva] Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46202 USA.
   [Saha, Chandan] Indiana Univ, Sch Med, Div Biostat, Indianapolis, IN 46202 USA.
RP Marrero, DG (reprint author), Indiana Univ, Sch Med, Div Endocrinol & Metab, 410 W 10th St,Suite 1140, Indianapolis, IN 46202 USA.
EM dgmarrer@iupui.edu
CR Cowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   *NAT CTR CHRON DIS, 2007 NAT DIAB FACT S
   Petersen M, 2008, DIABETES CARE, V31, P596, DOI 10.2337/dc08-9017
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Welch G, 2003, DIABETIC MED, V20, P69, DOI 10.1046/j.1464-5491.2003.00832.x
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
NR 9
TC 5
Z9 5
U1 0
U2 4
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0145-7217
EI 1554-6063
J9 DIABETES EDUCATOR
JI Diabetes Educ.
PD MAR-APR
PY 2010
VL 36
IS 2
BP 337
EP 344
DI 10.1177/0145721709354607
PG 8
WC Endocrinology & Metabolism; Public, Environmental & Occupational Health
SC Endocrinology & Metabolism; Public, Environmental & Occupational Health
GA 577ZG
UT WOS:000276262000015
PM 19959745
DA 2019-01-08
ER

PT J
AU Hahner, S
   Loeffler, M
   Bleicken, B
   Drechsler, C
   Milovanovic, D
   Fassnacht, M
   Ventz, M
   Quinkler, M
   Allolio, B
AF Hahner, Stefanie
   Loeffler, Melanie
   Bleicken, Benjamin
   Drechsler, Christiane
   Milovanovic, Danijela
   Fassnacht, Martin
   Ventz, Manfred
   Quinkler, Marcus
   Allolio, Bruno
TI Epidemiology of adrenal crisis in chronic adrenal insufficiency: the
   need for new prevention strategies
SO EUROPEAN JOURNAL OF ENDOCRINOLOGY
LA English
DT Article
ID SUBJECTIVE HEALTH-STATUS; ADDISONS-DISEASE; CUSHINGS-DISEASE; THERAPY;
   THYROXINE; HYDROCORTISONE; MORTALITY; QUALITY; DEATH; STILL
AB Objective: Adrenal crisis (AC) is a life-threatening complication of adrenal insufficiency (AI). Here, we evaluated frequency, causes and risk factors of AC in patients with chronic AI.
   Methods: In a cross-sectional study, 883 patients with AI were contacted by mail. Five-hundred and twenty-six patients agreed to participate and received a disease-specific questionnaire.
   Results: Four-hundred and forty-four datasets were available for analysis (primary AI (PAI), n=254; secondary AI (SAI), n=190). Forty-two percent (PAI 47% and SAI 35%) reported at least one crisis. Three hundred and eighty-four AC in 6092 patient years were documented (frequency of 6.3 crises/100 patient years). Precipitating causes were mainly gastrointestinal infection and fever (45%) but also other stressful events (e. g. major pain, surgery, psychic distress, heat and pregnancy). Sudden onset of apparently unexplained AC was also reported (PAI 6.6% and SAI 12.7%). Patients with PAI reported more frequent emergency glucocorticoid administration (42.5 vs 28.4%, P=0.003). Crisis incidence was not influenced by educational status, body mass index, glucocorticoid dose, DHEA treatment, age at diagnosis, hypogonadism, hypothyroidism or GH deficiency. In PAI, patients with concomitant non-endocrine disease were at higher risk of crisis (odds ratio (OR)=2.02, 95% confidence interval (CI) 1.05-3.89, P=0.036). In SAI, female sex (OR=2.18, 95% CI 1.06-4.5, P=0.035) and diabetes insipidus (OR=2.71, 95% CI 1.22-5.99, P=0.014) were associated with higher crisis incidence.
   Conclusion: AC occurs in a substantial proportion of patients with chronic AI, mainly triggered by infectious disease. Only a limited number of risk factors suitable for targeting prevention of AC were identified. These findings indicate the need for new concepts of crisis prevention in patients with AI.
C1 [Hahner, Stefanie; Loeffler, Melanie; Milovanovic, Danijela; Fassnacht, Martin; Allolio, Bruno] Univ Wurzburg, Endocrinol & Diabet Unit, Dept Med 1, D-97080 Wurzburg, Germany.
   [Drechsler, Christiane] Univ Wurzburg, Dept Nephrol, Dept Med 1, D-97080 Wurzburg, Germany.
   [Bleicken, Benjamin; Ventz, Manfred; Quinkler, Marcus] Charite, Dept Med Gastroenterol Hepatol & Endocrinol, D-10117 Berlin, Germany.
RP Allolio, B (reprint author), Univ Wurzburg, Endocrinol & Diabet Unit, Dept Med 1, Oberdurrbacher Str 6, D-97080 Wurzburg, Germany.
EM allolio_b@medizin.uni-wuerzburg.de
OI Hahner, Stefanie/0000-0003-1616-8986
FU Wilhelm-Sander-Stiftung [2003.175.1, 2003.175.2]
FX This work was supported by the Wilhelm-Sander-Stiftung (project grants
   2003.175.1 and 2003.175.2 to B Allolio and S Hahner).
CR Arlt W, 2003, LANCET, V361, P1881, DOI 10.1016/S0140-6736(03)13492-7
   Bergthorsdottir R, 2006, J CLIN ENDOCR METAB, V91, P4849, DOI 10.1210/jc.2006-0076
   Bleicken B, 2010, CLIN ENDOCRINOL, V72, P297, DOI 10.1111/j.1365-2265.2009.03596.x
   Bleicken B, 2008, EUR J ENDOCRINOL, V159, P811, DOI 10.1530/EJE-08-0578
   BRAATVEDT GD, 1990, BRIT MED J, V301, P1312, DOI 10.1136/bmj.301.6764.1312
   DAVIS J, 1986, BRIT MED J, V292, P1595, DOI 10.1136/bmj.292.6535.1595
   Erichsen MM, 2009, EUR J ENDOCRINOL, V160, P233, DOI 10.1530/EJE-08-0550
   Flemming TG, 1999, J INTERN MED, V246, P497, DOI 10.1046/j.1365-2796.1999.00538.x
   FONSECA V, 1986, BRIT MED J, V292, P1185, DOI 10.1136/bmj.292.6529.1185
   Graves L, 2003, SOUTH MED J, V96, P824, DOI 10.1097/01.SMJ.0000056647.58668.CD
   Hahner S, 2007, J CLIN ENDOCR METAB, V92, P3912, DOI 10.1210/jc.2007-0685
   KHOSLA S, 1989, ARCH INTERN MED, V149, P802, DOI 10.1001/archinte.149.4.802
   Lundy Jonathan B, 2007, J Intensive Care Med, V22, P111, DOI 10.1177/0885066606298140
   Nagesser SK, 2000, WORLD J SURG, V24, P108, DOI 10.1007/s002689910020
   Omori K, 2003, ENDOCR J, V50, P745, DOI 10.1507/endocrj.50.745
   SAAG KG, 1994, AM J MED, V96, P115, DOI 10.1016/0002-9343(94)90131-7
   Sarver RG, 1997, UROLOGY, V49, P781, DOI 10.1016/S0090-4295(96)00630-9
   Shalitin S, 2008, DIABETES CARE, V31, pS121, DOI 10.2337/dc08-s228
   Shulman DI, 2007, PEDIATRICS, V119, pE484, DOI 10.1542/peds.2006-1612
   Swinnen S, 2009, DIABETOLOGIA, V52, P38, DOI 10.1007/s00125-008-1147-0
   Thompson SK, 2007, ANN SURG, V245, P790, DOI 10.1097/01.sla.0000251578.03883.2f
   WHITE K, 2009, EUROPEAN J ENDOCRINO, V162, P115
NR 22
TC 136
Z9 138
U1 0
U2 10
PU BIOSCIENTIFICA LTD
PI BRISTOL
PA EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4JT,
   ENGLAND
SN 0804-4643
EI 1479-683X
J9 EUR J ENDOCRINOL
JI Eur. J. Endocrinol.
PD MAR
PY 2010
VL 162
IS 3
BP 597
EP 602
DI 10.1530/EJE-09-0884
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 582QF
UT WOS:000276612100019
PM 19955259
OA Bronze
DA 2019-01-08
ER

PT J
AU Kvamme, JM
   Wilsgaard, T
   Florholmen, J
   Jacobsen, BK
AF Kvamme, Jan-Magnus
   Wilsgaard, Tom
   Florholmen, Jon
   Jacobsen, Bjarne K.
TI Body mass index and disease burden in elderly men and women: The Tromso
   Study
SO EUROPEAN JOURNAL OF EPIDEMIOLOGY
LA English
DT Article
DE Body mass index; Elderly; Chronic disease; Life style; Socioeconomic
   factors; Hand strength
ID RESTING ENERGY-EXPENDITURE; AGED 50 YEARS; HIP FRACTURE; RISK-FACTORS;
   NUTRITIONAL-STATUS; UNITED-STATES; OVERWEIGHT; OBESITY; HEALTH; OLDER
AB Chronic health problems may be related to body mass index (BMI, kg/m(2)), but this has been best documented in overweight and obese adults. The primary objective of this study was to identify factors associated with different categories of BMI in elderly men and women from the general population, also including the lower categories of BMI. In a cross-sectional population survey from the municipality of Tromso, Norway we analyzed associations between BMI and a wide range of chronic disease conditions, lifestyle and socioeconomic factors. BMI was categorized into six groups (< 20, 20.0-22.4, 22.5-24.9, 25.0-27.4, 27.5-29.9, a parts per thousand yen30.0 kg/m(2)). The study included 4,259 men and women aged 65 years and older from the general population. We found low relative weight (BMI < 20 kg/m(2)) to be associated with increasing prevalence of mental distress, hip fracture, smoking and low handgrip strength. A U-shaped relation to BMI was found for asthma and chronic bronchitis, poor current health and low physical activity. The higher categories of BMI were associated with low education level, a difficult economical situation, diabetes mellitus and ischemic heart disease. These results demonstrate that both low and high BMI are associated with a wide range of prevalent conditions and diseases in elderly men and women. For the clinician the findings emphasize the importance of nutritional assessment as part of the medical evaluation of elderly patients.
C1 [Kvamme, Jan-Magnus; Wilsgaard, Tom; Jacobsen, Bjarne K.] Univ Tromso, Fac Hlth Sci, Dept Community Med, N-9037 Tromso, Norway.
   [Kvamme, Jan-Magnus; Florholmen, Jon] Univ Hosp N Norway, Dept Gastroenterol, Tromso, Norway.
   [Florholmen, Jon] Univ Tromso, Inst Clin Med, Lab Gastroenterol & Nutr, N-9037 Tromso, Norway.
RP Kvamme, JM (reprint author), Univ Tromso, Fac Hlth Sci, Dept Community Med, N-9037 Tromso, Norway.
EM jan-magnus.kvamme@uit.no
OI Kvamme, Jan-Magnus/0000-0002-5029-1606
FU Northern Norway Regional health Authority
FX This study was supported by a grant from the Centre for research in the
   elderly, the Northern Norway Regional health Authority. The National
   Health Screening Service helped organize and carry out the Tromso 4
   survey. J. - M. K. and B. K. J. were responsible for the design of the
   study. J. - M. K. did the analysis and wrote the first draft of the
   paper. B. K. J. contributed to the analysis, interpretation of the
   results and the review of the drafts. J. F. contributed to the study
   design, the interpretation of the results and reviewed the final draft.
   T. W. contributed to the statistical analysis, interpretation of the
   data and reviewed the final draft. All the authors approved the final
   version.
CR ALBANES D, 1987, AM J PUBLIC HEALTH, V77, P439, DOI 10.2105/AJPH.77.4.439
   Andreyeva T, 2007, PUBLIC HEALTH, V121, P497, DOI 10.1016/j.puhe.2006.11.016
   Baarends EM, 1997, THORAX, V52, P780, DOI 10.1136/thx.52.9.780
   Bachrach-Lindstrom M, 2000, AGING CLIN EXP RES, V12, P366, DOI 10.1007/BF03339862
   Bechtold Matthew, 2006, Curr Diab Rep, V6, P64, DOI 10.1007/s11892-006-0054-3
   Bruera E, 1997, BRIT MED J, V315, P1219, DOI 10.1136/bmj.315.7117.1219
   CALZA S, 2008, BMC PUBLIC HEALTH, V28, P140
   Campillo B, 2004, CLIN NUTR, V23, P551, DOI 10.1016/j.clnu.2003.10.003
   Chen Y, 2000, J CLIN EPIDEMIOL, V53, P755, DOI 10.1016/S0895-4356(99)00211-5
   Choi BCK, 2001, DIABETOLOGIA, V44, P1221, DOI 10.1007/s001250100648
   Collins LC, 1996, METABOLISM, V45, P923, DOI 10.1016/S0026-0495(96)90256-5
   Davalos A, 1996, STROKE, V27, P1028, DOI 10.1161/01.STR.27.6.1028
   de Groot CPGM, 2002, CLIN GERIATR MED, V18, P699, DOI 10.1016/S0749-0690(02)00043-5
   De Laet C, 2005, OSTEOPOROSIS INT, V16, P1330, DOI 10.1007/s00198-005-1863-y
   DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102
   Feldblum I, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-37
   GALANOS AN, 1994, J AM GERIATR SOC, V42, P368, DOI 10.1111/j.1532-5415.1994.tb07483.x
   German L, 2008, J NUTR HEALTH AGING, V12, P313, DOI 10.1007/BF02982661
   GOLDBERG DP, 1970, BMJ-BRIT MED J, V2, P439, DOI 10.1136/bmj.2.5707.439
   Grundy EMD, 2003, BROCKLEHURSTS TXB GE, P3
   Guerra S, 2002, CHEST, V122, P1256, DOI 10.1378/chest.122.4.1256
   Jenkins KR, 2004, GERONTOLOGIST, V44, P206, DOI 10.1093/geront/44.2.206
   KATON W, 1991, J ABNORM PSYCHOL, V100, P337, DOI 10.1037//0021-843X.100.3.337
   Kondrup J, 2003, CLIN NUTR, V22, P415, DOI 10.1016/S0261-5614(03)00098-0
   LAUNER LJ, 1994, JAMA-J AM MED ASSOC, V271, P1093, DOI 10.1001/jama.271.14.1093
   LINN BS, 1980, SOC SCI MED-MED SOC, V14, P311, DOI 10.1016/0160-7979(80)90112-5
   Lumbers M, 2001, BRIT J NUTR, V85, P733, DOI 10.1079/BJN2001350
   Manari AP, 2003, ADDICT BIOL, V8, P201, DOI 10.1080/1355621031000117437
   Marsh SE, 2008, THORAX, V63, P761, DOI 10.1136/thx.2007.089193
   Medbo A, 2007, RESP MED, V101, P1097, DOI [10.1016/j.rmed.2006.11.019, 10.1016/j.rmed.2007.07.018]
   MEYER HE, 1993, AM J EPIDEMIOL, V137, P1203, DOI 10.1093/oxfordjournals.aje.a116622
   Michaelsson K, 1996, OSTEOPOROSIS INT, V6, P120, DOI 10.1007/BF01623934
   Morabia A, 1999, BRIT J NUTR, V82, P49, DOI 10.1017/S0007114599001117
   Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523
   Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549
   Patterson RE, 2004, AM J PREV MED, V27, P385, DOI 10.1016/j.amepre.2004.08.001
   Perissinotto E, 2002, BRIT J NUTR, V87, P177, DOI 10.1079/BJN2001487
   Petry NM, 2008, PSYCHOSOM MED, V70, P288, DOI 10.1097/PSY.0b013e3181651651
   Peytremann-Bridevaux I, 2008, SWISS MED WKLY, V138, P261, DOI 2008/17/smw-12067
   Rantanen T, 2003, SCAND J MED SCI SPOR, V13, P3, DOI 10.1034/j.1600-0838.2003.00298.x
   RIMM EB, 1995, AM J EPIDEMIOL, V141, P1117, DOI 10.1093/oxfordjournals.aje.a117385
   Roskam AJR, 2008, PUBLIC HEALTH NUTR, V11, P1256, DOI 10.1017/S1368980008002747
   Santolaria F, 2000, DRUG ALCOHOL DEPEN, V59, P295, DOI 10.1016/S0376-8716(99)00129-5
   Schols Annemie M W J, 2009, Curr Opin Support Palliat Care, V3, P282, DOI 10.1097/SPC.0b013e328331e91c
   Sergi G, 2005, J GERONTOL A-BIOL, V60, P866, DOI 10.1093/gerona/60.7.866
   SLEMENDA C, 1997, AM J MED, V103, P65
   SOGAARD AJ, 2003, NOR EPIDEMIOL, V13, P279
   Sternfeld B, 2002, AM J EPIDEMIOL, V156, P110, DOI 10.1093/aje/kwf023
   STRATTON RJ, 2003, DIS RELATED MALNUTRI, P93
   *UN, 2007, WORLD POP PROSP 2006
   Vennemann MM, 2008, J NEUROL, V255, P1121, DOI 10.1007/s00415-008-0807-9
   Wolinsky FD, 1997, AM J PUBLIC HEALTH, V87, P398, DOI 10.2105/AJPH.87.3.398
   World Health Organization, 1995, PHYS STAT US INT ANT
   Yoo SH, 2008, ARCH NEUROL-CHICAGO, V65, P39, DOI 10.1001/archneurol.2007.12
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
NR 55
TC 20
Z9 22
U1 0
U2 4
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0393-2990
EI 1573-7284
J9 EUR J EPIDEMIOL
JI Eur. J. Epidemiol.
PD MAR
PY 2010
VL 25
IS 3
BP 183
EP 193
DI 10.1007/s10654-009-9422-z
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 567OK
UT WOS:000275456300005
PM 20087630
DA 2019-01-08
ER

PT J
AU Helgeson, VS
   Escobar, O
   Siminerio, L
   Becker, D
AF Helgeson, Vicki S.
   Escobar, Oscar
   Siminerio, Linda
   Becker, Dorothy
TI Relation of Stressful Life Events to Metabolic Control Among Adolescents
   With Diabetes: 5-Year Longitudinal Study
SO HEALTH PSYCHOLOGY
LA English
DT Article
DE Type 1 diabetes; metabolic control; adolescence; stressful life events
ID CHILDRENS DEPRESSION; PERCEIVED STRESS; MELLITUS; ADJUSTMENT;
   MANAGEMENT; BEHAVIORS; INVENTORY; ADHERENCE; YOUTHS; FAMILY
AB Objective: To determine the relation of stressful life events to metabolic control. Design: We interviewed adolescents with Type I diabetes (n = 132; average age at enrollment = 12 years) annually for 5 years. Measures: Each year we administered measures of stressful life events, psychological distress, and self-care behavior. We downloaded data from blood glucose meters, and obtained measures of metabolic control (hemoglobin Ale) from medical records. Results: Using longitudinal growth curve modeling, stressful life events predicted greater psychological distress, poorer self-care behavior, and worse metabolic control in both cross-sectional and longitudinal (lagged) analyses. Cross-sectionally, many of these relations were stronger among older than younger adolescents. Self-care behavior partly mediated this association. Conclusion: Stressful life events are related to poor metabolic control especially for older adolescents. A primary mechanism appears to be a lack of good self care.
C1 [Helgeson, Vicki S.] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA.
   [Escobar, Oscar; Becker, Dorothy] Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA USA.
   [Siminerio, Linda] Univ Pittsburgh, Med Ctr, Dept Med, Pittsburgh, PA 15260 USA.
RP Helgeson, VS (reprint author), Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA.
EM vh2e@andrew.cmu.edu
FU National Institutes of Health [R01 DK60586, 5M01 RR00084]
FX Portions of this article were presented at the 2008 Meeting of the
   Society of Behavioral Medicine. The authors acknowledge the support of
   Grant R01 DK60586 from the National Institutes of Health to conduct this
   work and the support of the Pediatric Clinical and Translational
   Research Center at Children's Hospital (GCRC Grant, 5M01 RR00084). The
   authors extend their appreciation to Pamela Snyder for her management of
   the day-to-day aspects of the project as well as for the statistical
   analyses. The authors are grateful to Laura Kiley, Abigail Kunz Vaughn,
   Michelle Merriman, Elizabeth Muia. and Laura Viccaro for conducting the
   majority of the adolescent interviews. We also acknowledge the support
   of the clinic staff of Children's Hospital of Pittsburgh.
CR Allison KR, 1999, CAN J PUBLIC HEALTH, V90, P85
   American Diabetes Association, 2008, DIABETES CARE S1, V31, pS12, DOI DOI 10.2337/DC08-S012
   BALFOUR L, 1993, HEALTH PSYCHOL, V12, P33, DOI 10.1037/0278-6133.12.1.33
   Bauer DJ, 2006, PSYCHOL METHODS, V11, P142, DOI 10.1037/1082-989X.11.2.142
   BROOKSGUNN J, 1991, SO INST S, P131
   Byrne DG, 2007, J ADOLESCENCE, V30, P393, DOI 10.1016/j.adolescence.2006.04.004
   Byrne DG, 2003, J PSYCHOSOM RES, V54, P313, DOI 10.1016/S0022-3999(02)00411-7
   Delamater A, 1998, DIABETES, V47, pA326
   DELAMATER AM, 1988, J PEDIATR PSYCHOL, V13, P69, DOI 10.1093/jpepsy/13.1.69
   DELAMATER AM, 1992, STRESS COPING CHILD, P191
   GE XJ, 1994, DEV PSYCHOL, V30, P467, DOI 10.1037/0012-1649.30.4.467
   Goetsch VL, 1995, HDB HLTH REHABILITAT, P513
   GOLDSTON DB, 1995, HEALTH PSYCHOL, V14, P409, DOI 10.1037/0278-6133.14.5.409
   Graber J. A., 2004, HDB ADOLESCENT PSYCH
   Greening L, 2007, J PEDIATR PSYCHOL, V32, P437, DOI 10.1093/jpepsy/jsl029
   HANSON CL, 1987, J CONSULT CLIN PSYCH, V55, P529, DOI 10.1037/0022-006X.55.4.529
   HANSON SL, 1986, HEALTH PSYCHOL, V5, P439, DOI 10.1037//0278-6133.5.5.439
   Helgeson VS, 2009, HEALTH PSYCHOL, V28, P273, DOI 10.1037/a0013784
   HELGESON VS, 1996, WOMENS HLTH RES GEND, V2, P163
   Hollingshead A. A., 1975, 4 FACTOR INDEX UNPUB
   Holmbeck G. N., 2006, BEHAV EMOTIONAL DISO, P21
   IZARD CE, 1993, J PERS SOC PSYCHOL, V64, P847, DOI 10.1037/0022-3514.64.5.847
   Johnson JG, 2002, ARCH GEN PSYCHIAT, V59, P741, DOI 10.1001/archpsyc.59.8.741
   KAGER VA, 1992, J PEDIATR PSYCHOL, V17, P491, DOI 10.1093/jpepsy/17.4.491
   Kiviniemi MT, 2007, HEALTH PSYCHOL, V26, P152, DOI 10.1037/0278-6133.26.2.152
   Korbel CD, 2007, CHILD HEALTH CARE, V36, P83, DOI 10.1080/02739610701316936
   KOVACS M, 1985, PSYCHOPHARMACOL BULL, V21, P995
   Kovacs M, 2001, CHILDRENS DEPRESSION
   Kramer JR, 2000, ANN BEHAV MED, V22, P17, DOI 10.1007/BF02895164
   La Greca A. M., 1990, CHILDRENS HLTH CARE, V19, P132, DOI DOI 10.1207/S15326888CHC1903_
   LAGRECA AM, 1988, 9 ANN CONV SOC BEH M
   LARSON R, 1993, DEV PSYCHOL, V29, P130, DOI 10.1037//0012-1649.29.1.130
   Leonard BJ, 2005, J FAM NURS, V11, P102, DOI 10.1177/1074840705275152
   NEWCOMB MD, 1981, J HEALTH SOC BEHAV, V22, P400, DOI 10.2307/2136681
   Raudenbush S. W., 2004, HLM 6 HIERARCHICAL L
   Shih JH, 2006, J CLIN CHILD ADOLESC, V35, P103, DOI 10.1207/s15374424jccp3501_9
   Singer J. D., 2003, APPL LONGITUDINAL DA
   SMITH MS, 1991, ADOLESCENCE, V26, P31
   Stark KD, 2001, J CLIN CHILD PSYCHOL, V30, P552, DOI 10.1207/S15374424JCCP3004_11
   Stevens Sally J, 2003, Child Maltreat, V8, P46, DOI 10.1177/1077559502239611
   WEISSBERGBENCHELL J, 1995, DIABETES CARE, V18, P77, DOI 10.2337/diacare.18.1.77
   YEAWORTH RC, 1980, ADOLESCENCE, V15, P91
NR 42
TC 27
Z9 27
U1 0
U2 13
PU AMER PSYCHOLOGICAL ASSOC
PI WASHINGTON
PA 750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA
SN 0278-6133
J9 HEALTH PSYCHOL
JI Health Psychol.
PD MAR
PY 2010
VL 29
IS 2
BP 153
EP 159
DI 10.1037/a0018163
PG 7
WC Psychology, Clinical; Psychology
SC Psychology
GA 576HT
UT WOS:000276135800008
PM 20230088
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Kop, WJ
   Kuhl, EA
   Barasch, E
   Jenny, NS
   Gottlieb, SS
   Gottdiener, JS
AF Kop, Willem J.
   Kuhl, Emily A.
   Barasch, Eddy
   Jenny, Nancy S.
   Gottlieb, Stephen S.
   Gottdiener, John S.
TI Association between depressive symptoms and fibrosis markers: The
   Cardiovascular Health Study
SO BRAIN BEHAVIOR AND IMMUNITY
LA English
DT Article
DE Fibrosis; Inflammation; Depression; Heart failure; Risk factors;
   Cardiovascular disease; Collagen deposition; Extra-cellular matrix
   formation; Psychological distress
ID CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; COLLAGEN TYPE-I; DILATED
   CARDIOMYOPATHY; MYOCARDIAL FIBROSIS; OLDER-ADULTS; III PROCOLLAGEN;
   YOUNG-ADULTS; FAILURE; INFLAMMATION
AB Objective: Fibrosis plays an important role in heart failure (HF) and other diseases that occur more frequently with increasing age. Depression is associated with an increased risk of heart failure and other age-related diseases. This study examined the association between depressive symptoms and fibrosis markers in adults aged 65 years and above.
   Methods: Fibrosis markers and depressive symptoms were assessed in 870 participants (age = 80.9 +/- 5.9 yrs, 49% women) using a case-control design based on heart failure status (307 HF patients and 563 age- and sex-matched controls, of whom 284 with CVD risk factors (hypertension, diabetes mellitus, or hypercholesterolemia) and 279 controls without these CVD risk factors). Fibrosis markers were procollagen type I (PIP), type I collagen (CITP), and procollagen type III (PIIINP). Inflammation markers included C-reactive protein, white blood cell counts and fibrinogen. Depression was assessed using the Center for Epidemiological Studies-Depression (CES-D) scale using a previously validated cut-off point for depression (CES-D >= 8). Covariates included demographic and clinical variables.
   Results: Depression was associated with higher levels of PIP (median = 411.0, inter-quartile range (IQR) = 324.4-472.7 ng/mL vs. 387.6, IQR = 342.0-512.5 ng/mL, p = 0.006) and CITP (4.99, IQR = 3.53-6.85 vs. 4.53, IQR = 3.26-6.22 mu g/L, p = 0.024), but not PIIIINP (4.07, IQR = 2.75-5.54 mu g/L vs. 3.58, IQR = 2.71-5.01 mu g/L, p, = 0.29) compared to individuals without depression. Inflammation markers were also elevated in depressed participants (CRP, p = 0.014; WBC, p = 0.075; fibrinogen, p = 0.074), but these inflammation markers did not account for the relationship between depression and fibrosis markers.
   Conclusions: Depression is associated with elevated fibrosis markers and may therefore adversely affect heart failure and other age-related diseases in which extra-cellular matrix formation plays a pathophysiological role. (C) 2009 Elsevier Inc. All rights reserved.
C1 [Kop, Willem J.; Kuhl, Emily A.; Gottlieb, Stephen S.; Gottdiener, John S.] Univ Maryland, Dept Med, Baltimore, MD 21201 USA.
   [Barasch, Eddy] SUNY Stony Brook, St Francis Hosp, Roslyn, NY USA.
   [Jenny, Nancy S.] Univ Vermont, Coll Med, Dept Pathol & Biochem, Burlington, VT USA.
RP Kop, WJ (reprint author), Univ Maryland, Dept Med, 22 S Greene St,Ste 3B08, Baltimore, MD 21201 USA.
EM wkop@medicine.umaryland.edu
FU National Heart, Lung, and Blood Institute [N01-HC-85079, N01-HC-85086,
   N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133,
   U01 HL080295, R0-1 HL079376]
FX Funding sources: The research reported in this article was supported by
   contract numbers N01-HC-85079 through N01-HC-85086, N01-HC-35129. N01
   HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, Grant No. U01
   HL080295 and also by R0-1 HL079376 from the National Heart, Lung, and
   Blood Institute, with additional contribution from the National
   Institute of Neurological Disorders and Stroke. A full list of principal
   CHS investigators and institutions can be found at
   http://www.chs-nhlbi.org/pi.htm.
CR ANDRESEN EM, 1994, AM J PREV MED, V10, P77
   Arbelaez JJ, 2007, J AM GERIATR SOC, V55, P1825, DOI 10.1111/j.1532-5415.2007.01393.x
   BARASH E, 2009, CIRC HEART FAIL
   Bovill EG, 1996, AM J EPIDEMIOL, V143, P1107
   Cavallari Larisa H, 2007, Congest Heart Fail, V13, P275, DOI 10.1111/j.1527-5299.2007.07217.x
   Cicoira M, 2004, J CARD FAIL, V10, P403, DOI 10.1016/j.cardfail.2004.01.010
   CUSHMAN M, 1995, CLIN CHEM, V41, P264
   Cuspidi C, 2006, NEPHROL DIAL TRANSPL, V21, P20, DOI 10.1093/ndt/gfi237
   Danner M, 2003, PSYCHOSOM MED, V65, P347, DOI 10.1097/01.PSY.0000041542.29808.01
   Davidson K, 2000, ARCH INTERN MED, V160, P1495, DOI 10.1001/archinte.160.10.1495
   de Souza RR, 2002, BIOGERONTOLOGY, V3, P325, DOI 10.1023/A:1021312027486
   Fried Linda P., 1991, Annals of Epidemiology, V1, P263
   GOLD PW, 1988, NEW ENGL J MED, V319, P348, DOI 10.1056/NEJM198808113190606
   GONZALEZ A, 2008, CARDIOVASC RES
   Gottdiener JS, 2000, J AM COLL CARDIOL, V35, P1628, DOI 10.1016/S0735-1097(00)00582-9
   Izawa H, 2005, CIRCULATION, V112, P2940, DOI 10.1161/CIRCULATIONAHA.105.571653
   KLAPPACHER G, 1995, AM J CARDIOL, V75, P913, DOI 10.1016/S0002-9149(99)80686-9
   Kop WJ, 2007, PSYCHONEUROIMMUNOLOGY, VOLS I AND II, 4TH EDITION, P921
   Kop WJ, 2002, AM J CARDIOL, V89, P419, DOI 10.1016/S0002-9149(01)02264-0
   KOP WJ, 2005, PSYCHOSOM MED, V67, P537
   Laviades C, 1998, CIRCULATION, V98, P535, DOI 10.1161/01.CIR.98.6.535
   Lesperance F, 2000, J PSYCHOSOM RES, V48, P379, DOI 10.1016/S0022-3999(99)00102-6
   Lewis MR, 2001, THROMB HAEMOSTASIS, V86, P1495
   Lombardi R, 2003, CIRCULATION, V108, P1455, DOI 10.1161/01.CIR.0000090687.97972.10
   Lopez B, 2007, J AM COLL CARDIOL, V50, P859, DOI 10.1016/j.jacc.2007.04.080
   Macy EM, 1997, CLIN CHEM, V43, P52
   MAES M, 1995, PROG NEURO-PSYCHOPH, V19, P11, DOI 10.1016/0278-5846(94)00101-M
   Meyer CM, 2004, J AFFECT DISORDERS, V83, P127, DOI 10.1016/j.jad.2004.06.004
   Nicholson A, 2006, EUR HEART J, V27, P2763, DOI 10.1093/eurheartj/ehl338
   O'Brien SM, 2007, J PSYCHIAT RES, V41, P326, DOI 10.1016/j.jpsychires.2006.05.013
   Panagiotakos DB, 2004, EUR HEART J, V25, P492, DOI 10.1016/j.ehj.2004.01.018
   Querejeta R, 2004, CIRCULATION, V110, P1263, DOI 10.1161/01.CIR.0000140973.60992.9A
   Radloff L. S., 1977, APPL PSYCHOL MEAS, V1
   Ressler KJ, 1999, BIOL PSYCHIAT, V46, P1219, DOI 10.1016/S0006-3223(99)00127-4
   RISTELI J, 1988, CLIN CHEM, V34, P715
   Rozanski A, 2005, J AM COLL CARDIOL, V45, P637, DOI 10.1016/j.jac.2004.12.005
   Ruiz-Ruiz FJ, 2007, EUR J INTERN MED, V18, P129, DOI 10.1016/j.ejim.2006.09.014
   Rutledge T, 2006, J AM COLL CARDIOL, V48, P1527, DOI 10.1016/j.jacc.2006.06.055
   Scalco Andréia Zavaloni, 2005, Clinics, V60, P241, DOI 10.1590/S1807-59322005000300010
   Schulz R, 2000, ARCH INTERN MED, V160, P1761, DOI 10.1001/archinte.160.12.1761
   Schwartzkopff B, 2002, EUR J HEART FAIL, V4, P439, DOI 10.1016/S1388-9842(02)00092-2
   Segerstrom SC, 2004, PSYCHOL BULL, V130, P601, DOI 10.1037/0033-2909.130.4.601
   Suzuki Y, 2003, INT J BIOCHEM CELL B, V35, P881, DOI 10.1016/S1357-2725(02)00271-6
   Timonen P, 2008, INT J CARDIOL, V124, P293, DOI 10.1016/j.ijcard.2007.02.004
   TRACY RP, 1995, ARTERIOSCL THROM VAS, V15, P1269, DOI 10.1161/01.ATV.15.9.1269
   Wang TJ, 2007, AM HEART J, V154, P291, DOI 10.1016/j.ahj.2007.04.006
   Weber KT, 1997, CIRCULATION, V96, P2488
   Weber KT, 2004, HYPERTENSION, V43, P716, DOI 10.1161/01.HYP.0000118586.38323.5b
   Whooley MA, 2008, JAMA-J AM MED ASSOC, V300, P2379, DOI 10.1001/jama.2008.711
   Williams SA, 2002, PSYCHOSOM MED, V64, P6, DOI 10.1097/00006842-200201000-00002
   Wulsin LR, 2003, PSYCHOSOM MED, V65, P201, DOI 10.1097/01.PSY.0000058371.50240.E3
   Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277
   Yan LJL, 2003, JAMA-J AM MED ASSOC, V290, P2138, DOI 10.1001/jama.290.16.2138
NR 53
TC 16
Z9 16
U1 0
U2 2
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0889-1591
J9 BRAIN BEHAV IMMUN
JI Brain Behav. Immun.
PD FEB
PY 2010
VL 24
IS 2
BP 229
EP 235
DI 10.1016/j.bbi.2009.09.017
PG 7
WC Immunology; Neurosciences; Psychiatry
SC Immunology; Neurosciences & Neurology; Psychiatry
GA 542PN
UT WOS:000273507000011
PM 19800964
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Lloyd, CE
   Pambianco, G
   Orchard, TJ
AF Lloyd, C. E.
   Pambianco, G.
   Orchard, T. J.
TI Does diabetes-related distress explain the presence of depressive
   symptoms and/or poor self-care in individuals with Type 1 diabetes?
SO DIABETIC MEDICINE
LA English
DT Article
DE depression; emotions; self-management; Type 1 diabetes
ID PITTSBURGH EPIDEMIOLOGY; PSYCHOSOCIAL FACTORS; EUROPEAN DEPRESSION;
   RESEARCH CONSORTIUM; EMOTIONAL-PROBLEMS; PROBLEM AREAS; COMPLICATIONS;
   PREVALENCE; IDDM; ADULTS
AB P>Aims
   To examine the relationship between depressive symptomatology, diabetes-related distress and aspects of diabetes self-care in a cohort of individuals with Type 1 diabetes.
   Methods
   Individuals with Type 1 diabetes taking part in the Pittsburgh Epidemiology of Diabetes Complications Study completed the Beck Depression Inventory (BDI), the Center for Epidemiologic Studies Depression (CES-D) Scale and the Problem Areas in Diabetes (PAID) scale. Self-care was measured by physical activity in the past week and over the previous year, frequency of blood glucose/urine testing, smoking status and alcohol intake.
   Results
   Clinically significant levels of depressive symptomatology (i.e. scores >= 16) were reported by 14% of the study population on the BDI and by 18% on the CES-D. There were strong correlations between depressive symptoms and diabetes-related distress (PAID scores) and physical activity. Multivariate analyses indicated that depression was independently associated with diabetes-related distress scores and with physical activity, but not with frequency of blood glucose testing.
   Conclusions
   These findings have implications for clinical practice and treatment of both psychological morbidity and diabetes. There may be significant effects of depression on aspects of diabetes self-care. Further prospective studies are required to confirm these findings.
C1 [Lloyd, C. E.] Open Univ, Fac Hlth & Social Care, Milton Keynes MK7 6AA, Bucks, England.
   [Pambianco, G.; Orchard, T. J.] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA.
RP Lloyd, CE (reprint author), Open Univ, Fac Hlth & Social Care, Walton Hall, Milton Keynes MK7 6AA, Bucks, England.
EM c.e.lloyd@open.ac.uk
OI orchard, trevor/0000-0001-9552-3215
FU National Institutes of Health [DK034818]
FX This research was supported by National Institutes of Health grant
   number DK034818.
CR Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Barnard KD, 2006, DIABETIC MED, V23, P445, DOI 10.1111/j.1464-5491.2006.01814.x
   BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   *EARL TREATM DIAB, 1980, MAN OP
   Gendelman N, 2009, DIABETES CARE, V32, P575, DOI 10.2337/dc08-1835
   Goldney RD, 2004, DIABETES CARE, V27, P1066, DOI 10.2337/diacare.27.5.1066
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   Katon W, 2004, DIABETES CARE, V27, P914, DOI 10.2337/diacare.27.4.914
   Kinder LS, 2002, HEALTH PSYCHOL, V21, P542, DOI 10.1037//0278-6133.21.6.542
   Lin EHB, 2004, DIABETES CARE, V27, P2154, DOI 10.2337/diacare.27.9.2154
   Lloyd CE, 1996, ARTERIOSCL THROM VAS, V16, P720, DOI 10.1161/01.ATV.16.6.720
   LLOYD CE, 1992, DIABETES CARE, V15, P166, DOI 10.2337/diacare.15.2.166
   Lloyd CE, 2003, DIABETES-METAB RES, V19, P401, DOI 10.1002/dmrr.394
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   ORCHARD TJ, 1990, DIABETES, V39, P1116, DOI 10.2337/diabetes.39.9.1116
   ORCHARD TJ, 1990, DIABETES CARE, V13, P741, DOI 10.2337/diacare.13.7.741
   Pibernik-Okanovic M, 2008, J DIABETES COMPLICAT, V22, P246, DOI 10.1016/j.jdiacomp.2007.03.002
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Pouwer F, 2005, DIABETES RES CLIN PR, V70, P166, DOI 10.1016/j.diabres.2005.03.031
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
NR 23
TC 42
Z9 42
U1 0
U2 14
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0742-3071
J9 DIABETIC MED
JI Diabetic Med.
PD FEB
PY 2010
VL 27
IS 2
BP 234
EP 237
DI 10.1111/j.1464-5491.2009.02896.x
PG 4
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 552RL
UT WOS:000274311000018
PM 20546270
OA Green Accepted, Bronze
DA 2019-01-08
ER

PT J
AU Bansil, P
   Kuklina, EV
   Meikle, SF
   Posner, SF
   Kourtis, AP
   Ellington, SR
   Jamieson, DJ
AF Bansil, Pooja
   Kuklina, Elena V.
   Meikle, Susan F.
   Posner, Samuel F.
   Kourtis, Athena P.
   Ellington, Sascha R.
   Jamieson, Denise J.
TI Maternal and Fetal Outcomes Among Women with Depression
SO JOURNAL OF WOMENS HEALTH
LA English
DT Article
ID SEROTONIN-REUPTAKE INHIBITORS; SUBSTANCE USE DISORDERS;
   LOW-BIRTH-WEIGHT; POSTPARTUM DEPRESSION; PREGNANCY; RISK; SYMPTOMS;
   PREVALENCE; DIAGNOSES; DELIVERY
AB Objective: To compare maternal and fetal outcomes among women with and without diagnosed depression at the time of delivery.
   Methods: Hospital discharge data from the 1998-2005 Nationwide Inpatient Sample (NIS) were used to examine delivery-related hospitalizations for select maternal and fetal outcomes by depression diagnosis.
   Results: The rate of depression per 1000 deliveries increased significantly from 2.73 in 1998 to 14.1 in 2005 (p<0.001). Women diagnosed with depression were significantly more likely to have cesarean delivery, preterm labor, anemia, diabetes, and preeclampsia or hypertension compared with women without depression. Fetal outcomes significantly associated with maternal depression were fetal growth restriction, fetal abnormalities, fetal distress, and fetal death.
   Conclusions: These findings suggest that depression is associated with adverse maternal and fetal outcomes. Our results provide additional impetus to screen for depression among women of reproductive age, especially those who plan to become pregnant.
C1 [Bansil, Pooja] CONRAD, Atlanta, GA 30341 USA.
   [Kuklina, Elena V.] Quantell Inc, Mchenry, MD USA.
   [Meikle, Susan F.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bethesda, MD USA.
   [Posner, Samuel F.; Kourtis, Athena P.; Jamieson, Denise J.] Ctr Dis Control & Prevent, Div Reprod Hlth, Atlanta, GA USA.
   [Ellington, Sascha R.] Sci Applicat Int Corp, Atlanta, GA USA.
RP Bansil, P (reprint author), CONRAD, 4770 Buford Highway NE,MS-K34, Atlanta, GA 30341 USA.
EM pbansil@cdc.gov
OI Posner, Samuel/0000-0003-1574-585X; Kourtis, Athena/0000-0003-1585-1310
CR Alder J, 2007, J MATERN-FETAL NEO M, V20, P189, DOI 10.1080/14767050701209560
   Alwan S, 2007, NEW ENGL J MED, V356, P2684, DOI 10.1056/NEJMoa066584
   American College of Obstetricians, 2006, OBSTET GYNECOL, V108, P469, DOI DOI 10.1097/00006250-200608000-00046
   Bennett HA, 2004, OBSTET GYNECOL, V103, P698, DOI 10.1097/01.AOG.0000116689.75396.5f
   Compton WM, 2006, AM J PSYCHIAT, V163, P2141, DOI 10.1176/appi.ajp.163.12.2141
   Dietz PM, 2007, AM J PSYCHIAT, V164, P1515, DOI 10.1176/appi.ajp.2007.06111893
   Gaynes BN, 2005, AHRQ PUBLICATION, V05-E006-2
   Hansen D, 2000, LANCET, V356, P875, DOI 10.1016/S0140-6736(00)02676-3
   *HLTH CAR FIN ADM, 1994, DHHS PUBL
   Hoffman S, 2000, HEALTH PSYCHOL, V19, P535, DOI 10.1037/0278-6133.19.6.535
   Houchens R, 2005, HCUP METHODS SERIES
   Kalantaridou SN, 2004, J REPROD IMMUNOL, V62, P61, DOI 10.1016/j.jri.2003.09.004
   Kelly RH, 2002, OBSTET GYNECOL, V100, P297, DOI 10.1016/S0029-7844(02)02014-8
   Kelly RH, 1999, PSYCHIATR SERV, V50, P1584, DOI 10.1176/ps.50.12.1584
   Kuklina EV, 2008, MATERN CHILD HLTH J, V12, P469, DOI 10.1007/s10995-007-0256-6
   LaRocco-Cockburn A, 2003, OBSTET GYNECOL, V101, P892, DOI 10.1016/S0029-7844(03)00171-6
   Lesch KP, 2004, J PSYCHIATR NEUROSCI, V29, P174
   Louik C, 2007, NEW ENGL J MED, V356, P2675, DOI 10.1056/NEJMoa067407
   Marcus SM, 2003, J WOMEN HEALTH GEN-B, V12, P373, DOI 10.1089/154099903765448880
   Miller LJ, 2002, JAMA-J AM MED ASSOC, V287, P762, DOI 10.1001/jama.287.6.762
   O'Hara MW, 2000, ARCH GEN PSYCHIAT, V57, P1039, DOI 10.1001/archpsyc.57.11.1039
   O'Keane V, 2007, BRIT MED J, V334, P1003, DOI 10.1136/bmj.39189.662581.55E
   Oberlander TF, 2008, BRIT J PSYCHIAT, V192, P338, DOI 10.1192/bjp.bp.107.037101
   ORR ST, 1995, EPIDEMIOL REV, V17, P165, DOI 10.1093/oxfordjournals.epirev.a036172
   Orr ST, 2002, AM J EPIDEMIOL, V156, P797, DOI 10.1093/aje/kwf131
   Paarlberg KM, 1999, BRIT J OBSTET GYNAEC, V106, P834, DOI 10.1111/j.1471-0528.1999.tb08406.x
   PERKIN MR, 1993, BRIT J OBSTET GYNAEC, V100, P629, DOI 10.1111/j.1471-0528.1993.tb14228.x
   STEER RA, 1992, J CLIN EPIDEMIOL, V45, P1093, DOI 10.1016/0895-4356(92)90149-H
   Suri R, 2007, AM J PSYCHIAT, V164, P1206, DOI 10.1176/appi.ajp.2007.06071172
   United States Department of Labor Bureau of Labor Statistics, CONS PRIC IND
   Wu J, 2002, AM J OBSTET GYNECOL, V187, P864, DOI 10.1067/mob.2002.127126
   Yasmeen S, 2006, AM J OBSTET GYNECOL, V194, P992, DOI 10.1016/j.ajog.2005.08.058
   ZUCKERMAN B, 1989, AM J OBSTET GYNECOL, V160, P1107, DOI 10.1016/0002-9378(89)90170-1
NR 33
TC 49
Z9 50
U1 0
U2 11
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1540-9996
J9 J WOMENS HEALTH
JI J. Womens Health
PD FEB
PY 2010
VL 19
IS 2
BP 329
EP 334
DI 10.1089/jwh.2009.1387
PG 6
WC Public, Environmental & Occupational Health; Medicine, General &
   Internal; Obstetrics & Gynecology; Women's Studies
SC Public, Environmental & Occupational Health; General & Internal
   Medicine; Obstetrics & Gynecology; Women's Studies
GA 557JF
UT WOS:000274664700020
PM 20095906
DA 2019-01-08
ER

PT J
AU Wetherell, JL
   Ayers, CR
   Nuevo, R
   Stein, MB
   Ramsdell, J
   Patterson, TL
AF Wetherell, Julie Loebach
   Ayers, Catherine R.
   Nuevo, Roberto
   Stein, Murray B.
   Ramsdell, Joe
   Patterson, Thomas L.
TI Medical conditions and depressive, anxiety, and somatic symptoms in
   older adults with and without generalized anxiety disorder
SO AGING & MENTAL HEALTH
LA English
DT Article
DE elderly; somatization; depression
ID QUALITY-OF-LIFE; ELDERLY-PATIENTS; RISK-FACTORS; HEALTH; EPIDEMIOLOGY;
   DISABILITY; DISEASE
AB Objective: The objective of this study was to examine medical illness and anxiety, depressive, and somatic symptoms in older medical patients with generalized anxiety disorder (GAD). Method: A case-control study was designed and conducted in the University of California, San Diego (UCSD) Geriatrics Clinics. A total of fifty-four older medical patients with GAD and 54 matched controls participated. Measurements: The measurements used for this study include: Brief Symptom Inventory-18, Mini International Neuropsychiatric Interview, and the Anxiety Disorders Interview Schedule. Results: Older medical patients with GAD reported higher levels of somatic symptoms, anxiety, and depression than other older adults, as well as higher rates of diabetes and gastrointestinal conditions. In a multivariate model that included somatic symptoms, medical conditions, and depressive and anxiety symptoms, anxiety symptoms were the only significant predictors of GAD. Conclusion: These results suggest first, that older medical patients with GAD do not primarily express distress as somatic symptoms; second, that anxiety symptoms in geriatric patients should not be discounted as a byproduct of medical illness or depression; and third, that older adults with diabetes and gastrointestinal conditions may benefit from screening for anxiety.
C1 [Wetherell, Julie Loebach; Ayers, Catherine R.; Stein, Murray B.; Patterson, Thomas L.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA.
   [Wetherell, Julie Loebach; Ayers, Catherine R.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA.
   [Nuevo, Roberto] CIBERSAM, Inst Salud Carlos III, Ctr Invest Red Salud Mental, Barcelona, Spain.
   [Ramsdell, Joe] Univ Calif San Diego, Div Geriatr, Dept Internal Med, San Diego, CA 92103 USA.
RP Wetherell, JL (reprint author), Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA.
EM jwetherell@ucsd.edu
OI Nuevo, Roberto/0000-0003-3385-2747
FU NIMH [K23 MH067643]
FX The authors thank Dilip V. Jeste, MD for his contributions to this
   research. This study was supported by NIMH K23 MH067643. Portions of
   this article were presented at the annual meetings of the Anxiety
   Disorders Association of America, March 2007, and the Gerontological
   Society of America, November 2007.
CR *AM PSYCH ASS, 2000, DIAGN STAT MAN
   Barger SD, 2005, J AFFECT DISORDERS, V88, P87, DOI 10.1016/j.jad.2005.05.012
   Beekman ATF, 1998, INT J GERIATR PSYCH, V13, P717, DOI 10.1002/(SICI)1099-1166(1998100)13:10<717::AID-GPS857>3.0.CO;2-M
   BRESLOW N, 1982, BIOMETRICS, V38, P661, DOI 10.2307/2530047
   Cully JA, 2006, PSYCHOSOMATICS, V47, P312, DOI 10.1176/appi.psy.47.4.312
   de Beurs E, 1999, PSYCHOL MED, V29, P583, DOI 10.1017/S0033291799008351
   Derogatis L. R., 2001, BSI 18 BRIEF SYMPTOM
   Di Nardo P. A., 1994, ANXIETY DISORDERS IN
   Drayer RA, 2005, INT J GERIATR PSYCH, V20, P973, DOI 10.1002/gps.1389
   Flint AJ, 2005, DRUG AGING, V22, P101, DOI 10.2165/00002512-200522020-00002
   Greenland S, 2000, AM J EPIDEMIOL, V151, P531
   Grigsby AB, 2002, J PSYCHOSOM RES, V53, P1053, DOI 10.1016/S0022-3999(02)00417-8
   Gum Amber M, 2009, Am J Geriatr Psychiatry, V17, P769, DOI 10.1097/JGP.0b013e3181ad4f5a
   Hanel G, 2009, J PSYCHOSOM RES, V67, P189, DOI 10.1016/j.jpsychores.2009.04.013
   Harter MC, 2003, EUR ARCH PSY CLIN N, V253, P313, DOI 10.1007/s00406-003-0449-y
   HOSHMER DW, 1989, APPL LOGISTIC REGRES
   Lenze EJ, 2005, J GERIATR PSYCH NEUR, V18, P89, DOI 10.1177/0891988705276251
   Lieb R, 2007, PSYCHOSOM MED, V69, P860, DOI 10.1097/PSY.0b013e31815b0103
   Ludbrook J, 1998, CLIN EXP PHARMACOL P, V25, P1032, DOI 10.1111/j.1440-1681.1998.tb02179.x
   Porensky EK, 2009, AM J GERIAT PSYCHIAT, V17, P473, DOI 10.1097/JGP.0b013e31819b87b2
   Riedel-Heller SG, 2006, ACTA PSYCHIAT SCAND, V113, P388, DOI 10.1111/j.1600-0447.2005.00632.x
   Roy-Byrne PP, 2004, J CLIN PSYCHIAT, V65, P20
   Rubio G, 2007, ACTA PSYCHIAT SCAND, V115, P372, DOI 10.1111/j.1600-0447.2006.00896.x
   Seung Kim HF, 2001, J CLIN GEROPSYCHOLOG, V7, P117, DOI DOI 10.1023/A:1009585605902
   Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi
   Sihvo S, 2006, J AFFECT DISORDERS, V96, P31, DOI 10.1016/j.jad.2006.05.009
   *STATACORP, 2007, STAT STAT OFTW REL 1
   Van Hout HPJ, 2004, BRIT J PSYCHIAT, V185, P399, DOI 10.1192/bjp.185.5.399
   Vink D, 2008, J AFFECT DISORDERS, V106, P29, DOI 10.1016/j.jad.2007.06.005
   Wetherell JL, 2005, J PSYCHOPATHOL BEHAV, V27, P17, DOI 10.1007/s10862-005-3261-3
   Wetherell JL, 2004, J PSYCHIAT RES, V38, P305, DOI 10.1016/j.jpsychires.2003.09.003
NR 31
TC 18
Z9 18
U1 2
U2 11
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND
SN 1360-7863
J9 AGING MENT HEALTH
JI Aging Ment. Health
PY 2010
VL 14
IS 6
BP 764
EP 768
AR PII 924376300
DI 10.1080/13607861003713240
PG 5
WC Geriatrics & Gerontology; Gerontology; Psychiatry
SC Geriatrics & Gerontology; Psychiatry
GA 635DH
UT WOS:000280635300015
PM 20635235
OA Green Accepted, Green Published
DA 2019-01-08
ER

PT J
AU Zihl, J
   Schaaf, L
   Zillmer, EA
AF Zihl, Josef
   Schaaf, Ludwig
   Zillmer, Eric A.
TI The Relationship Between Adult Neuropsychological Profiles and Diabetic
   Patients' Glycemic Control
SO APPLIED NEUROPSYCHOLOGY
LA English
DT Article
DE anxiety; cognition; depression; Type 1 diabetes; Type 2 diabetes
ID CO-MORBID DEPRESSION; COGNITIVE FUNCTION; ACUTE HYPOGLYCEMIA;
   PSYCHOLOGICAL DISTRESS; MEMORY IMPAIRMENTS; METABOLIC SYNDROME; TYPE-1;
   PREVALENCE; ANXIETY; COMPLICATIONS
AB The purpose of this study was to assess, in relation to metabolic control, the cognitive, depressive, and anxiety symptoms among 40 adult patients (age: 18-60 years) with either type 1 (n=28) or type 2 (n=12) diabetes mellitus (DM1, DM2). Nineteen healthy subjects matched for age, gender, and education served as the control group. For most cognitive domains, no significant performance differences were found between subjects from the diabetic groups and control subjects. However, diabetes patients demonstrated reduced information processing accuracy along with impaired visual and verbal working memory performance. In addition, psychopathology scores were significantly elevated but did not reach the clinical criteria for depression or anxiety. Overall, there were no significant differences between diabetic subgroups, and no significant correlation was found between cognitive performance, psychopathology scores, and HbA1c values for either subgroup. Thus, patients with DM1 or DM2 may show mild-to-moderate cognitive impairment as well as subtle psychopathological symptoms. While cognitive impairments may be understood in terms of diabetes-associated cognitive dysfunction, psychopathological symptoms may also result from unsuccessful coping with high task demands in everyday life activities. The outcome of the current study underscores the importance of early clinical neuropsychological standardized assessment as well as the diagnosis of cognitive and psychopathological symptoms in adult patients with diabetes.
C1 [Zihl, Josef; Schaaf, Ludwig] Max Planck Inst Psychiat, D-80404 Munich, Germany.
   [Zihl, Josef] Univ Munich, Dept Psychol, Munich, Germany.
   [Zillmer, Eric A.] Drexel Univ, Dept Athlet, Philadelphia, PA 19104 USA.
RP Zihl, J (reprint author), Max Planck Inst Psychiat, Kraepelinstr 10, D-80404 Munich, Germany.
EM zihl@mpipsykl.mpg.de
OI Josef, Zihl/0000-0002-0838-0103
CR Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x
   Allen KV, 2004, EUR J PHARMACOL, V490, P169, DOI 10.1016/j.ejphar.2004.02.054
   Aschenbrenner S, 2000, REGENSBURGER WORTFLU
   Aster M., 2006, WECHSLER INTELLIGENZ
   Barnard KD, 2006, DIABETIC MED, V23, P445, DOI 10.1111/j.1464-5491.2006.01814.x
   Brands AMA, 2007, J INT NEUROPSYCH SOC, V13, P288, DOI 10.1017/S1355617707070312
   Brands AMA, 2007, DEMENT GERIATR COGN, V23, P343, DOI 10.1159/000100980
   Brickenkamp R., 2002, TEST D2 AUFMERKSAMKE
   Brickenkamp R., 1998, D2 TEST ATTENTION
   Bruehl H, 2007, J CLIN ENDOCR METAB, V92, P2439, DOI 10.1210/jc.2006-2540
   Cosway R, 2001, DIABETIC MED, V18, P803, DOI 10.1046/j.1464-5491.2001.00577.x
   Cox D, 2002, INT J CLIN PRACT, P20
   Dik MG, 2007, DIABETES CARE, V30, P2655, DOI 10.2337/dc06-1190
   Egeland J, 2005, ACTA PSYCHIAT SCAND, V112, P434, DOI 10.1111/j.1600-0447.2005.00599.x
   Gatto NM, 2008, AGING NEUROPSYCHOL C, V15, P627, DOI 10.1080/13825580802036936
   Geddes J, 2008, DIABETIC MED, V25, P501, DOI 10.1111/j.1464-5491.2008.02413.x
   Genuth S, 2007, NEW ENGL J MED, V356, P1842
   Gold SM, 2007, DIABETOLOGIA, V50, P711, DOI 10.1007/s00125-007-0602-7
   Grodstein F, 2001, DIABETES CARE, V24, P1060, DOI 10.2337/diacare.24.6.1060
   Heller SR, 1996, DIABETIC MED, V13, P607, DOI 10.1002/(SICI)1096-9136(199607)13:7<607::AID-DIA159>3.0.CO;2-I
   Hermanns N, 2007, DIABETOLOGIA, V50, P930, DOI 10.1007/s00125-007-0643-y
   Hermanns N, 2005, DIABETIC MED, V22, P293, DOI 10.1111/j.1464-5491.2005.01414.x
   Herrmann CH, 1995, HOSP ANXIETY DEPRESS
   Hislop AL, 2008, DIABETIC MED, V25, P91, DOI 10.1111/j.1464-5491.2007.02310.x
   Karlson B, 1997, DIABETIC MED, V14, P1066, DOI 10.1002/(SICI)1096-9136(199712)14:12<1066::AID-DIA462>3.0.CO;2-M
   Kivimaki M, 2007, DIABETIC MED, V24, P1043, DOI 10.1111/j.1464-5491.2007.02216.x
   Kumari M, 2005, NEUROLOGY, V65, P1597, DOI 10.1212/01.wnl.0000184521.80820.e4
   Lloyd CE, 2000, DIABETIC MED, V17, P198, DOI 10.1046/j.1464-5491.2000.00260.x
   LOBNIG BM, 2006, DIABETIC MED, V23, P2
   Luchsinger JA, 2007, ARCH NEUROL-CHICAGO, V64, P570, DOI 10.1001/archneur.64.4.570
   McAulay V, 2006, DIABETIC MED, V23, P26, DOI 10.1111/j.1464-5491.2005.01795.x
   Mijnhout GS, 2006, DIABETOLOGIA, V49, P1447, DOI 10.1007/s00125-006-0221-8
   Mort DJ, 2003, CURR OPIN NEUROL, V16, P51, DOI 10.1097/01.wco.0000053590.70044.c5
   Musen G, 2008, J CLIN ENDOCR METAB, V93, P1450, DOI 10.1210/jc.2007-2007
   Mussell M, 2004, DIABETIC MED, V21, P1253, DOI 10.1111/j.1464-5491.2004.01322.x
   Pais I, 2007, EXP CLIN ENDOCR DIAB, V115, P42, DOI 10.1055/s-2007-957348
   RAVEN JC, 1988, STANDARD PROGR MATRI
   Shaban MC, 2006, DIABETIC MED, V23, P1381, DOI 10.1111/j.1464-5491.2006.02012.x
   *SPSS INC, 2005, STAT PACK SOC SCI SP
   Warren RE, 2007, DIABETOLOGIA, V50, P178, DOI 10.1007/s00125-006-0535-6
   Watari K, 2006, ARCH CLIN NEUROPSYCH, V21, P787, DOI 10.1016/j.acn.2006.06.014
   WECHSLER D, 2000, WECHSLERGEDACHTNISTE
   Wessels AM, 2007, DIABETOLOGIA, V50, P1763, DOI 10.1007/s00125-007-0714-0
   Wessels AM, 2007, DIABETIC MED, V24, P735, DOI 10.1111/j.1464-5491.2007.02153.x
   Zimmermann P, 1993, TESTBATTERIE AUFMERK
NR 45
TC 9
Z9 11
U1 0
U2 11
PU PSYCHOLOGY PRESS
PI HOVE
PA 27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND
SN 0908-4282
J9 APPL NEUROPSYCHOL
JI Appl. Neuropsychol.
PY 2010
VL 17
IS 1
BP 44
EP 51
AR PII 919153746
DI 10.1080/09084280903526133
PG 8
WC Clinical Neurology; Psychology
SC Neurosciences & Neurology; Psychology
GA 554JY
UT WOS:000274432500006
PM 20146121
DA 2019-01-08
ER

PT J
AU Fisher, L
   Mullan, JT
   Arean, P
   Glasgow, RE
   Hessler, D
   Masharani, U
AF Fisher, Lawrence
   Mullan, Joseph T.
   Arean, Patricia
   Glasgow, Russell E.
   Hessler, Danielle
   Masharani, Umesh
TI Diabetes Distress but Not Clinical Depression or Depressive Symptoms Is
   Associated With Glycemic Control in Both Cross-Sectional and
   Longitudinal Analyses
SO DIABETES CARE
LA English
DT Article
ID SELF-REPORTED DISTRESS; METAANALYSIS; SCALE; DISORDERS; MELLITUS;
   ILLNESS; STRESS; TYPE-1; CARE
AB OBJECTIVE - To deter-mine the concurrent, prospective, and time-concordant relationships among major depressive disorder (MDD), depressive symptoms, and diabetes distress With glycemic control.
   RESEARCH DESIGN AND METHODS - In a noninterventional Study, we assessed 506 type 2 diabetic patients for MDD (Composite International Diagnostic interview), for depressive symptoms (Center for Epidemiological Studies-Depression), and for diabetes distress (Diabetes Distress Scale), along With self-management, stress, demographics, and diabetes status, at baseline and 9 and 18 months later. Using multilevel modeling (MLM), we explored the cross-sectional relationships of the three affective variables with A1C, the prospective relationships of baseline variables with change in A1C over time, and the time-concordant relationships with A1C.
   RESULTS - All three affective variables were moderately intercorrelated, although the relationship between depressive symptoms and diabetes distress was greater than the relationship of either with MDD. In the cross-sectional MLM, only diabetes distress but not MDD or depressive symptoms was significantly associated with A1C. None of the three affective variables were linked with A1C in prospective analyses. Only diabetes distress displayed significant time-concordant relationships with A1C.
   CONCLUSIONS - We found no concurrent or longitudinal association between MDD or depressive symptoms With A1C, whereas both concurrent and time-concordant relationships were found between diabetes distress and A1C. What has been called "depression" among type 2 diabetic patients may really be two conditions, MDD and diabetes distress, With only the latter displaying significant associations With A1C. Ongoing evaluation of both diabetes distress and MDD may be helpful in clinical settings.
C1 [Fisher, Lawrence; Hessler, Danielle] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA.
   [Mullan, Joseph T.] Univ Calif San Francisco, Sch Nursing, Dept Social & Behav Sci, San Francisco, CA 94143 USA.
   [Arean, Patricia] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.
   [Glasgow, Russell E.] Kaiser Permanente, Denver, CO USA.
   [Masharani, Umesh] Univ Calif San Francisco, Dept Med, San Francisco, CA USA.
RP Fisher, L (reprint author), Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA.
EM fisherl@fcm.ucsf.edu
FU National Institute of Diabetes and Digestive and Kidney Diseases
   [DK062732, DK061937]
FX This research was supported by grants DK062732 and DK061937 from the
   National Institute of Diabetes and Digestive and Kidney Diseases.; No
   potential conflicts of interest relevant to this article were reported.
CR AIKENS JE, 1994, J BEHAV MED, V17, P535, DOI 10.1007/BF01857596
   Albright TL, 2001, FAM MED, V33, P354
   Beck A. T., 1960, ARCH GEN PSYCHIAT, V4, P53, DOI DOI 10.1001/ARCHPSYC.1961.01710120031004
   COYNE JC, 1994, PSYCHOL BULL, V116, P29, DOI 10.1037/0033-2909.116.1.29
   Das-Munshi J, 2007, PSYCHOSOM MED, V69, P543, DOI 10.1097/PSY.0b013e3180cc3062
   De Groot M, 2000, DIABETES, V49, pA63
   FECHNERBATES S, 1994, J CONSULT CLIN PSYCH, V62, P550, DOI 10.1037//0022-006X.62.3.550
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Freeman M. F., 1950, APPL LONGITUDINAL AN, V21, P607
   Georgiades A, 2007, PSYCHOSOM MED, V69, P235, DOI 10.1097/PSY.0b013e318042588d
   Golden SH, 2008, JAMA-J AM MED ASSOC, V299, P2751, DOI 10.1001/jama.299.23.2751
   Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341
   Jerant A, 2008, MED CARE, V46, P523, DOI 10.1097/MLR.0b013e31815f53a4
   KALON WJ, 2004, ARCH GEN PSYCHIAT, V61, P1042
   Katon WJ, 2005, DIABETES CARE, V28, P2668, DOI 10.2337/diacare.28.11.2668
   Lin EHB, 2006, ANN FAM MED, V4, P46, DOI 10.1370/afm.423
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985
   O'Connor PJ, 2009, ANN FAM MED, V7, P328, DOI 10.1370/afm.964
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Stein MB, 2006, PSYCHOL MED, V36, P587, DOI 10.1017/S0033291706007239
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Trief PM, 2006, DIABETES CARE, V29, P830, DOI 10.2337/diacare.29.04.06.dc05-1769
   TURNER RJ, 1995, AM SOCIOL REV, V60, P104, DOI 10.2307/2096348
   van der Ven NCW, 2005, DIABETIC MED, V22, P1619
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   WITTCHEN HU, 1994, J PSYCHIAT RES, V28, P57, DOI 10.1016/0022-3956(94)90036-1
NR 28
TC 255
Z9 260
U1 3
U2 32
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
J9 DIABETES CARE
JI Diabetes Care
PD JAN
PY 2010
VL 33
IS 1
BP 23
EP 28
DI 10.2337/dc09-1238
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 544AA
UT WOS:000273622200005
PM 19837786
OA Green Published, Other Gold
HC Y
HP N
DA 2019-01-08
ER

PT J
AU Huang, MF
   Courtney, M
   Edwards, H
   McDowell, J
AF Huang, Min-Feng
   Courtney, Mary
   Edwards, Helen
   McDowell, Jan
TI Validation of the Chinese Version of the Problem Areas in Diabetes
   (PAID-C) Scale
SO DIABETES CARE
LA English
DT Article
ID RELIABILITY; DISTRESS; VALIDITY
AB OBJECTIVE - To examine the psychometric properties of a Chinese version of the Problem Areas In Diabetes (PAID-C) scale.
   RESEARCH DESIGN AND METHODS - The reliability and validity of the PAID-C were evaluated in a convenience sample of 205 outpatients with type 2 diabetes. Confirmatory factor analysis, Bland-Altman analysis, and Spearman's correlations facilitated the psychometric evaluation.
   RESULTS - Confirmatory factor analysis confirmed a one-factor Structure Of the PAID-C (chi(2)/df ratio = 1.894, goodness-of-fit index = 0.901, comparative fit index = 0.905, root mean square error of approximation = 0.066). The PAID-C was associated with A1C (r(s) = 0.15; P < 0.05) and diabetes self-care behaviors in general diet (r(s) = -0.17; P < 0.05) and exercise (r(s) = -0.17; P < 0.05). The 4-week test-retest reliability demonstrated satisfactory stability (r(s) = 0.83; P < 0.01).
   CONCLUSIONS - The PAID-C is a reliable and valid measure to determine diabetes-related emotional distress in Chinese people with type 2 diabetes.
C1 [Huang, Min-Feng] Yuanpei Univ, Dept Nursing, Hsinchu, Taiwan.
   [Huang, Min-Feng; Courtney, Mary; Edwards, Helen; McDowell, Jan] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Sch Nursing & Midwifery, Brisbane, Qld 4001, Australia.
RP Huang, MF (reprint author), Yuanpei Univ, Dept Nursing, Hsinchu, Taiwan.
EM minfeng@mail.ypu.edu.tw
RI Edwards, Helen/I-9554-2012
OI Edwards, Helen/0000-0002-4451-0577
CR BLAND JM, 1986, LANCET, V1, P307
   Brislin R, 1986, FIELD METHODS CROSS, V8, P137, DOI DOI 10.1016/J.IJINTREL.2011.08.001
   Hair J. F., 2006, MULTIVARIATE DATA AN
   Jones PS, 2001, NURS RES, V50, P300, DOI 10.1097/00006199-200109000-00008
   Pett M., 2003, MAKING SENSE FACTOR
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Rousson V, 2002, STAT MED, V21, P3431, DOI 10.1002/sim.1253
   Sigurdardottir AK, 2008, INT J NURS STUD, V45, P526, DOI 10.1016/j.ijnurstu.2006.10.008
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Welch G, 2003, DIABETIC MED, V20, P69, DOI 10.1046/j.1464-5491.2003.00832.x
NR 11
TC 15
Z9 20
U1 0
U2 5
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
J9 DIABETES CARE
JI Diabetes Care
PD JAN
PY 2010
VL 33
IS 1
BP 38
EP 40
DI 10.2337/dc09-0768
PG 3
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 544AA
UT WOS:000273622200008
PM 19808922
OA Other Gold, Green Published
DA 2019-01-08
ER

PT J
AU Haugstvedt, A
   Wentzel-Larsen, T
   Graue, M
   Sovik, O
   Rokne, B
AF Haugstvedt, A.
   Wentzel-Larsen, T.
   Graue, M.
   Sovik, O.
   Rokne, B.
TI Fear of hypoglycaemia in mothers and fathers of children with Type 1
   diabetes is associated with poor glycaemic control and parental
   emotional distress: a population-based study
SO DIABETIC MEDICINE
LA English
DT Article
DE fear; hypoglycaemia; Hypoglycaemia Fear Survey-Parent version; parental
   emotional distress; Type 1 diabetes
ID YOUNG-CHILDREN; ADOLESCENTS
AB Aims To analyse, in a population-based study, the association between parental fear of hypoglycaemia and (i) the prevalence of hypoglycaemia and diabetes treatment factors in children with Type 1 diabetes and (ii) emotional distress in mothers and fathers.
   Methods Mothers (n = 103) and fathers (n = 97) of 115 children with Type 1 diabetes (1-15 years old) participated in the study. In addition to demographic and disease-specific data, the participants completed the Hypoglycaemia Fear Survey-Parent version (HFS-P) (worry and behaviour subscales) and the Hopkins Symptom Checklist-25 items (HSCL-25) to measure emotional distress.
   Results A higher HFS-P worry score was associated with higher glycated haemoglobin (HbA(1c)), a higher frequency (7) of what parents experienced as problematic hypoglycaemic events during the past year and co-morbid disease in the child. A higher HFS-P behaviour score was associated with children receiving insulin injections compared with using an insulin pump and a higher frequency (7 per day) of blood glucose measurements. The mothers had higher scores than the fathers in both the worry and behaviour subscales. The mothers' and the fathers' HFS-P worry scores correlated significantly with their HSCL-25 scores.
   Conclusions The association between a higher level of hypoglycaemic-related fear and parental emotional distress and poorer glycaemic control in the child emphasizes the need for programmes to support and guide parents. The results suggest that future interventions should target both the parents' fear and appropriate ways to prevent hypoglycaemia in children with Type 1 diabetes.
C1 [Haugstvedt, A.; Graue, M.] Bergen Univ Coll, Fac Hlth & Social Sci, N-5020 Bergen, Norway.
   [Haugstvedt, A.; Rokne, B.] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Bergen, Norway.
   [Haugstvedt, A.; Graue, M.; Sovik, O.] Haukeland Hosp, Dept Paediat, N-5021 Bergen, Norway.
   [Wentzel-Larsen, T.] Haukeland Hosp, Clin Res Ctr, N-5021 Bergen, Norway.
RP Haugstvedt, A (reprint author), Bergen Univ Coll, Fac Hlth & Social Sci, Post Box 7030, N-5020 Bergen, Norway.
EM anne.haugstvedt@hib.no
FU Diabetes Research Foundation of Western Norway; Norwegian Diabetes
   Association; Norwegian Nurses' Association; Western Norway Regional
   Health Authority; University of Bergen; Bergen University College
FX The authors thank all the parents and children who participated in this
   study. The study was supported by the Diabetes Research Foundation of
   Western Norway, the Norwegian Diabetes Association, the Norwegian
   Nurses' Association, the Western Norway Regional Health Authority, the
   University of Bergen and Bergen University College.
CR Bangstad HJ, 2007, PEDIATR DIABETES, V8, P88, DOI 10.1111/j.1399-5448.2007.00233.x
   Bulsara MK, 2004, DIABETES CARE, V27, P2293, DOI 10.2337/diacare.27.10.2293
   CLARKE WL, 1998, J PEDIAT ENDOCRINOL, V11, pS189
   Dashiff Carol, 2008, J Pediatr Nurs, V23, P101, DOI 10.1016/j.pedn.2007.08.007
   Davis C. S., 2002, STAT METHODS ANAL RE
   DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102
   Efron B, 1993, INTRO BOOTSTRAP
   Fayers P., 2007, QUALITY LIFE ASSESSM
   Gonder-Frederick LA, 2006, PEDIATR DIABETES, V7, P215, DOI 10.1111/j.1399-5448.2006.00182.x
   IRVINE A, 1994, HDB PSYCHOL DIABETES, V2, P133
   Lewin AB, 2006, J PEDIATR PSYCHOL, V31, P174, DOI 10.1093/jpepsy/jsj004
   Marrero DG, 1997, DIABETES EDUCATOR, V23, P281, DOI 10.1177/014572179702300306
   Naerde A, 2002, ACTA PSYCHIAT SCAND, V105, P301, DOI 10.1034/j.1600-0447.2002.1010.x
   Patton SR, 2007, PEDIATR DIABETES, V8, P362, DOI 10.1111/j.1399-5448.2007.00242.x
   Pelchat Diane, 2007, J Child Health Care, V11, P112, DOI 10.1177/1367493507076064
   Rewers M, 2007, PEDIATR DIABETES, V8, P408, DOI 10.1111/j.1399-5448.2007.00352.x
   SANDANGER I, 1998, SOC PSYCH PSYCH EPID, V33, P245
   Streisand R., 2005, J PEDIATR PSYCHOL, V30, P287
   Sullivan-Bolyai S, 2006, MCN-AM J MATERN-CHIL, V31, P24, DOI 10.1097/00005721-200601000-00007
   Tamborlane WV, 2006, REV ENDOCR METAB DIS, V7, P205, DOI 10.1007/s11154-006-9018-9
   The DCCT Research Group, 1997, DIABETES, V46, P271, DOI 10.2337/diabetes. 46.2.271
   Wagner Verena M, 2005, Eur J Pediatr, V164, P73, DOI 10.1007/s00431-004-1560-4
   Wild D, 2007, PATIENT EDUC COUNS, V68, P10, DOI 10.1016/j.pec.2007.05.003
   WINOKUR A, 1984, BRIT J PSYCHIAT, V144, P395, DOI 10.1192/bjp.144.4.395
NR 24
TC 54
Z9 57
U1 0
U2 12
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0742-3071
J9 DIABETIC MED
JI Diabetic Med.
PD JAN
PY 2010
VL 27
IS 1
BP 72
EP 78
DI 10.1111/j.1464-5491.2009.02867.x
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 541WM
UT WOS:000273451900011
PM 20121892
DA 2019-01-08
ER

PT J
AU McGuire, BE
   Morrison, TG
   Hermanns, N
   Skovlund, S
   Eldrup, E
   Gagliardino, J
   Kokoszka, A
   Matthews, D
   Pibernik-Okanovic, M
   Rodriguez-Saldana, J
   de Wit, M
   Snoek, FJ
AF McGuire, B. E.
   Morrison, T. G.
   Hermanns, N.
   Skovlund, S.
   Eldrup, E.
   Gagliardino, J.
   Kokoszka, A.
   Matthews, D.
   Pibernik-Okanovic, M.
   Rodriguez-Saldana, J.
   de Wit, M.
   Snoek, F. J.
TI Short-form measures of diabetes-related emotional distress: the Problem
   Areas in Diabetes Scale (PAID)-5 and PAID-1
SO DIABETOLOGIA
LA English
DT Article
DE Diabetes; Distress; Emotional; Measurement; Problem areas in diabetes
   scale
ID DEPRESSION
AB We wanted to identify a five-item short form of the Problem Areas in Diabetes Scale and a single-item measure for rapid screening of diabetes-related emotional distress.
   Using an existing database of 1,153 patients with diabetes, we conducted a principal-components analysis to identify a set of five items and then conducted a reliability analysis and validity checks. From those five items, we identified the item with the strongest psychometric properties as a one-item screening tool.
   We identified a reliable and valid short version of the Problem Areas in Diabetes Scale (PAID) comprising five of the emotional-distress questions of the full PAID items (PAID-5, with items 3, 6, 12, 16, 19). The PAID-5 has satisfactory sensitivity (94%) and specificity (89%) for recognition of diabetes-related emotional distress. We also identified a one-item screening tool, the PAID-1 (Question 12: Worrying about the future and the possibility of serious complications), which has concurrent sensitivity and specificity of about 80% for the recognition of diabetes-related emotional distress.
   The PAID-5 and PAID-1 appear to be psychometrically robust short-form measures of diabetes-related emotional distress.
C1 [McGuire, B. E.] Natl Univ Ireland, Sch Psychol, Clin Psychol Programme, Galway, Ireland.
   [Morrison, T. G.] Univ Saskatchewan, Dept Psychol, Saskatoon, SK S7N 0W0, Canada.
   [Hermanns, N.] Diabet Klin, Bad Mergentheim, Germany.
   [Skovlund, S.] Novo Nordisk AS, Copenhagen, Denmark.
   [Eldrup, E.] STENO Diabet Ctr, Copenhagen, Denmark.
   [Gagliardino, J.] Natl Univ La Plata, Ctr Expt & Appl Endocrinol, RA-1900 La Plata, Argentina.
   [Kokoszka, A.] Med Univ Warsaw, Dept Psychiat 2, Warsaw, Poland.
   [Pibernik-Okanovic, M.] VUK Vrhovac Univ Clin, Zagreb, Croatia.
   [Rodriguez-Saldana, J.] Diabet Program, Hidalgo, Mexico.
   [de Wit, M.; Snoek, F. J.] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands.
   [Matthews, D.] NIHR Oxford Biomed Res, Oxford, England.
RP McGuire, BE (reprint author), Natl Univ Ireland, Sch Psychol, Clin Psychol Programme, Galway, Ireland.
EM brian.mcguire@nuigalway.ie
RI Kokoszka, Andrzej/O-7454-2018
OI Kokoszka, Andrzej/0000-0003-4518-5494
FU DAWN MIND; National Institute for Health Research [NF-SI-0508-10272]
FX We are grateful to N. Zandbelt and W. Cleijne for their assistance in
   data management and to Novo Nordisk for an unrestricted research grant
   to conduct the DAWN MIND study.
CR *AM DIAB ASS, 2009, DIABETES CARE S1, V32, pS13, DOI DOI 10.2337/DC09-S013
   Arroll B, 2003, BMJ-BRIT MED J, V327, P1144, DOI 10.1136/bmj.327.7424.1144
   Centres for Disease Control and Prevention, 2004, MMWR-MORBID MORTAL W, V53, P1089
   El Achhab Y, 2008, DIABETES RES CLIN PR, V80, P171, DOI 10.1016/j.diabres.2007.12.020
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   *INT DIAB FED CLIN, 2005, GLOB GUID TYP 2 DIAB
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   ZANDBELT N, 2008, DIABETES S1, V57, pP1906
NR 10
TC 96
Z9 99
U1 1
U2 20
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0012-186X
J9 DIABETOLOGIA
JI Diabetologia
PD JAN
PY 2010
VL 53
IS 1
BP 66
EP 69
DI 10.1007/s00125-009-1559-5
PG 4
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 529PV
UT WOS:000272530600010
PM 19841892
OA Bronze
DA 2019-01-08
ER

PT J
AU Williams, SL
   Haskard-Zolnierek, KB
   Banta, JE
   Haviland, MG
   Dimatteo, MR
   Anderson, DL
   Werner, LS
AF Williams, Summer L.
   Haskard-Zolnierek, Kelly B.
   Banta, Jim E.
   Haviland, Mark G.
   Dimatteo, M. Robin
   Anderson, Donald L.
   Werner, Leonard S.
TI SERIOUS PSYCHOLOGICAL DISTRESS AND DIABETES CARE AMONG CALIFORNIA ADULTS
SO INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE
LA English
DT Article
DE Type 2 diabetes; serious psychological distress; quality of care
ID MENTAL-ILLNESS; PREVENTIVE CARE; UNITED-STATES; HEALTH-CARE; QUALITY;
   POPULATION; DEPRESSION; DISORDERS; MEDICAID; MANAGEMENT
AB Objective To evaluate three aspects of diabetes care (foot checks eye examinations, and hemoglobin A1C checks by a physician) among California adults with Type 2 diabetes and serious psychological distress (SPD) Method Data were from the population-based 2005 California Health Interview Survey Estimates were that in 2005, 1,516 171 Californians (5 75% of all adults) had a physician given diabetes diagnosis, and of those, 108,621 (7 16%) had co-morbid SPD Results Among Californians with Type 2 diabetes, SPD was associated with fewer physician foot checks (odds ratio = 0 56, 95% Confidence Interval = 0 32 to 0 97) but not with fewer eye examinations or hemoglobin A1C checks Conclusions The findings highlight a specific area-foot complication evaluation and prevention-for improving the quality of diabetes care among adult Californians with Type 2 diabetes and SPD (Int l J Psychiatry in Medicine 2010 40 233 245)
C1 [Williams, Summer L.] Westfield State Coll, Dept Psychol, Westfield, MA 01086 USA.
   [Haskard-Zolnierek, Kelly B.] Texas State Univ, San Marcos, TX USA.
   [Banta, Jim E.] Loma Linda Univ, Sch Publ Hlth, Loma Linda, CA 92350 USA.
   [Haviland, Mark G.; Anderson, Donald L.; Werner, Leonard S.] Loma Linda Univ, Sch Med, Loma Linda, CA 92350 USA.
   [Dimatteo, M. Robin] Univ Calif Riverside, Riverside, CA 92521 USA.
RP Williams, SL (reprint author), Westfield State Coll, Dept Psychol, 577 Western Ave, Westfield, MA 01086 USA.
RI Banta, Jim/B-7312-2008
OI Banta, Jim/0000-0002-9717-7683
FU Forest Laboratories, Inc
FX This research was supported in part by a grant from Forest Laboratories,
   Inc to the Department of Psychiatry, Loma Linda University School of
   Medicine (Dr Haviland) Portions of these findings were presented at the
   2008 meeting of the American Public Health Association San Diego
   California
CR Banta JE, 2009, J GEN INTERN MED, V24, P802, DOI 10.1007/s11606-009-0994-9
   *CA HLTH INT SURV, 2007, CHIS 2005 AD SURV
   California Health Interview Survey, 2007, CHIS 2005 METH SER
   California Health Interview Survey, 2007, CHIS 2005 AD PUBL US
   Clark RE, 2009, MED CARE, V47, P545, DOI 10.1097/MLR.0b013e318190db45
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   Desai MM, 2002, AM J PSYCHIAT, V159, P1584, DOI 10.1176/appi.ajp.159.9.1584
   Frayne SM, 2005, ARCH INTERN MED, V165, P2631, DOI 10.1001/archinte.165.22.2631
   Glied S, 1998, HEALTH SERV RES, V33, P891
   Goldberg RW, 2007, PSYCHIAT SERV, V58, P536, DOI 10.1176/appi.ps.58.4.536
   Hall JA, 1996, MED CARE, V34, P1205, DOI 10.1097/00005650-199612000-00006
   Himelhoch S, 2009, GEN HOSP PSYCHIAT, V31, P30, DOI 10.1016/j.genhosppsych.2008.07.007
   JOHNSON L, 2009, DIABETICS SKIMP LIFE
   Katon WJ, 2004, MED CARE, V42, P1222, DOI 10.1097/00005650-200412000-00009
   Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Kessler RC, 2005, NEW ENGL J MED, V352, P2515, DOI 10.1056/NEJMsa043266
   Krein SL, 2006, PSYCHIAT SERV, V57, P1016, DOI 10.1176/appi.ps.57.7.1016
   Li CY, 2009, INT J PUBLIC HEALTH, V54, P43, DOI 10.1007/s00038-009-0006-1
   Lin EHB, 2004, DIABETES CARE, V27, P2154, DOI 10.2337/diacare.27.9.2154
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615
   Morden NE, 2009, J AM BOARD FAM MED, V22, P187, DOI 10.3122/jabfm.2009.02.080059
   MORIATO EH, 2008, J CLIN PSYCHIAT, V69, P316
   *NAT I DIAB DIG KI, 2008, NAT DAIB STAT 2007 F
   Ponce NA, 2004, PUBLIC HEALTH REP, V119, P388, DOI 10.1016/j.phr.2004.05.002
   Pratt Laura A, 2007, Adv Data, P1
   Rittenhouse DR, 2006, MED CARE, V44, P47, DOI 10.1097/01.mlr.0000188992.48592.cd
   Stahl SM, 2009, ACTA PSYCHIAT SCAND, V119, P171, DOI 10.1111/j.1600-0447.2008.01334.x
   Strine TW, 2007, DIGEST DIS SCI, V52, P70, DOI 10.1007/s10620-006-9466-9
   Wang PS, 2002, AM J PUBLIC HEALTH, V92, P92, DOI 10.2105/AJPH.92.1.92
   2007, DIABETES CARE S1, V30, pS4
NR 32
TC 3
Z9 3
U1 1
U2 4
PU BAYWOOD PUBL CO INC
PI AMITYVILLE
PA 26 AUSTIN AVE, PO BOX 337, AMITYVILLE, NY 11701 USA
SN 0091-2174
J9 INT J PSYCHIAT MED
JI Int. J. Psychiatr. Med.
PY 2010
VL 40
IS 3
BP 233
EP 245
DI 10.2190/PM.40.3.a
PG 13
WC Psychiatry
SC Psychiatry
GA 681RT
UT WOS:000284335200001
PM 21166335
DA 2019-01-08
ER

PT J
AU Newlin, K
   Melkus, GD
   Peyrot, M
   Koenig, HG
   Allard, E
   Chyun, D
AF Newlin, Kelley
   Melkus, Gail D.
   Peyrot, Mark
   Koenig, Harold G.
   Allard, Emily
   Chyun, Deborah
TI COPING AS A MEDIATOR IN THE RELATIONSHIPS OF SPIRITUAL WELL-BEING TO
   MENTAL HEALTH IN BLACK WOMEN WITH TYPE 2 DIABETES
SO INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE
LA English
DT Article
DE type 2 diabetes; religion; spirituality; mental health
ID QUALITY-OF-LIFE; AFRICAN-AMERICANS; SELF-MANAGEMENT; GLYCEMIC CONTROL;
   METABOLIC-CONTROL; DEPRESSIVE SYMPTOMS; THE-LITERATURE; FOCUS GROUPS;
   MELLITUS; STRESS
AB Objective: Examine coping as a mediator in the relationships of spiritual well-being to mental health in Black women with type 2 diabetes (T2DM). Methods: Using a cross-sectional design, data were collected from a convenience sample of 45 Black women with T2DM. Measures of coping strategies, spiritual well-being (religious and existential well-being), and mental health, as measured by diabetes-specific distress (DSED), were collected. Bivariate findings informed mediational, trivariate model development. Results: Religious well-being was significantly related to cognitive reframing (CR) coping strategies (p = 0.026) but not DSED (p = 0.751). Existential well-being was significantly related to CR (beta = 0.575, p < 0.001), direct assistance (DA) coping (beta = 0.368, p = 0.006) and DSED (beta = -0.338, p = 0.023). Although CR (beta = -0.305, p = 0.021) and DA (beta = -0.262, p = 0.041) had significant bivariate associations with DSED, the relationships were not significant when existential well-being was controlled. However, the relationship of existential well-being to DSED was mediated by specific CR and DA strategies that were associated with DSED to varying degrees -"I came up with a couple different solutions to the problem" (beta = 0.301, p = 0.049); "I came out of the experience better than I went in" (beta = 0.308, p=0.061); and "I talked to someone who could do something concrete about the problem" (beta = 0.272, p = 0.078). Conclusion: Findings indicate that diabetes care address spiritual well-being, both its religious and existential components, in Black women with T2DM. (Int'l. J. Psychiatry in Medicine 2010;40:439-459)
C1 [Newlin, Kelley; Melkus, Gail D.; Chyun, Deborah] NYU, Coll Nursing, New York, NY 10003 USA.
   [Peyrot, Mark] Loyola Coll Maryland, Baltimore, MD USA.
   [Koenig, Harold G.] Duke Univ, Med Ctr, Durham, NC USA.
   [Allard, Emily] Florida Atlantic Univ, Coll Nursing, Boca Raton, FL 33431 USA.
RP Newlin, K (reprint author), NYU, Coll Nursing, 726 Broadway,10th Floor, New York, NY 10003 USA.
EM kelley.newlin@nyu.edu
RI Koenig, Harold/F-7379-2011
FU National Institute of Nursing Research [F31 NR008190, F32 NR010043,
   R01NR05341]
FX This study was supported by the National Institute of Nursing Research
   (Grant F31 NR008190, F32 NR010043, and R01NR05341).
CR Anderson RM, 1996, DIABETES EDUCATOR, V22, P28, DOI 10.1177/014572179602200104
   BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037//0022-3514.51.6.1173
   Bekelman DB, 2007, J GEN INTERN MED, V22, P470, DOI 10.1007/s11606-006-0044-9
   *CDCP, DAT TRENDS
   Centers for Disease Control and Prevention, NAT DIAB FACT SHEET
   Centers for Disease Control and Prevention, DIAB COMPL
   DeCoster VA, 2004, SOC WORK HEALTH CARE, V40, P37, DOI 10.1300/J010v40n02_03
   Degazon CE, 2007, RES NURS HEALTH, V30, P151, DOI 10.1002/nur.20192
   *DIAB CONTR COMPL, 1993, NEW ENGL J MED, V329, P977, DOI DOI 10.1056/NEJM199309303291401
   Didjurgeit U, 2002, DIABETIC MED, V19, P814, DOI 10.1046/j.1464-5491.2002.00811.x
   Duangdao KM, 2008, J BEHAV MED, V31, P291, DOI 10.1007/s10865-008-9155-6
   Egede LE, 2003, DIABETES EDUCATOR, V29, P105, DOI 10.1177/014572170302900115
   Ellison CG, 2001, SOC FORCES, V80, P215, DOI 10.1353/sof.2001.0063
   ELLISON CW, 1983, J PSYCHOL THEOL, V11, P330
   Enzlin P, 2002, PATIENT EDUC COUNS, V48, P139, DOI 10.1016/S0738-3991(02)00009-5
   Fitchett G., 2003, ANN BEHAV MED, V25, pS173
   Folkman S., 1988, WAYS COPING MANUAL
   Gary TL, 2000, DIABETES CARE, V23, P23, DOI 10.2337/diacare.23.1.23
   Glasgow RE, 2007, DIABETES CARE, V30, P33, DOI 10.2337/dc06-1390
   GOETSCH VL, 1994, BEHAV RES THER, V32, P503, DOI 10.1016/0005-7967(94)90137-6
   Grey M, 2000, J PEDIATR-US, V137, P107, DOI 10.1067/mpd.2000.106568
   Harvey IS, 2007, J CROSS-CULT GERONTO, V22, P205, DOI 10.1007/s10823-007-9038-2
   Hill-Briggs F, 2006, J BEHAV MED, V29, P69, DOI 10.1007/s10865-005-9037-0
   Hill-Briggs F, 2007, DIABETES EDUCATOR, V33, P1032, DOI 10.1177/0145721707308412
   JAMES LR, 1984, J APPL PSYCHOL, V69, P307, DOI 10.1037//0021-9010.69.2.307
   Kenny DA, 2003, PSYCHOL METHODS, V8, P115, DOI 10.1037/1082-989X.8.2.115
   Koenig H. G., 2001, HDB RELIG HLTH
   Krupski TL, 2006, PSYCHO-ONCOLOGY, V15, P121, DOI 10.1002/pon.929
   Landis B J, 1996, Issues Ment Health Nurs, V17, P217, DOI 10.3109/01612849609049916
   Lazarus R. S, 1984, STRESS APPRAISAL COP
   Levin J, 2005, J NATL MED ASSOC, V97, P237
   LUNDMAN B, 1993, DIABETES ED, V19, P198
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Maillet NA, 1996, DIABETES EDUCATOR, V22, P39, DOI 10.1177/014572179602200106
   Mayfield JA, 2004, DIABETES ED, V27, pS63, DOI DOI 10.1177/0145721708316625
   Melkus GD, 2004, APPL NURS RES, V17, P10, DOI 10.1016/j.apnr.2003.10.009
   MELKUS GD, 2007, DIABETES S1, V56, P2521
   Meraviglia MG, 2004, ONCOL NURS FORUM, V31, P89
   Newlin K, 2003, ETHNIC DIS, V13, P61
   NEWLIN K, DHHS 2004 MIN WOM HL
   Newlin K, 2008, NURS RES, V57, P331, DOI 10.1097/01.NNR.0000313497.10154.66
   Newlin K, 2008, DIABETES, V57, pA244
   Norris SL, 2002, DIABETES CARE, V25, P1159, DOI 10.2337/diacare.25.7.1159
   Olphen J, 2003, J GEN INTERN MED, V18, P549, DOI 10.1046/j.1525-1497.2003.21031.x
   Peyrot M, 1996, J PEDIATR PSYCHOL, V21, P3, DOI 10.1093/jpepsy/21.1.3
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polzer RL, 2007, RES NURS HEALTH, V30, P164, DOI 10.1002/nur.20179
   Polzer RL, 2007, QUAL HEALTH RES, V17, P176, DOI 10.1177/1049732306297750
   Rippentrop AE, 2005, PAIN, V116, P311, DOI 10.1016/j.pain.2005.05.008
   Rose M, 2002, DIABETES CARE, V25, P35, DOI 10.2337/diacare.25.1.35
   Samuel-Hodge CD, 2008, DIABETES EDUCATOR, V34, P501, DOI 10.1177/0145721708316946
   Samuel-Hodge CD, 2000, DIABETES CARE, V23, P928, DOI 10.2337/diacare.23.7.928
   Searle A, 2007, BRIT J HEALTH PSYCH, V12, P621, DOI 10.1348/135910706X164935
   Shrout PE, 2002, PSYCHOL METHODS, V7, P422, DOI 10.1037//1082-989X.7.4.422
   THOITS PA, 1995, J HEALTH SOC BEHAV, V35, P53, DOI 10.2307/2626957
   UK Prospective Diabetes Study Group, 1998, BMJ-BRIT MED J, V317, P703, DOI DOI 10.1136/BMJ.317.7160.703
   Upton LR, 1998, J VISUAL IMPAIR BLIN, V92, P656
   Walker EA, 1997, J DIABETES COMPLICAT, V11, P298, DOI 10.1016/S1056-8727(96)00121-3
   Willoughby DF, 2000, J ADV NURS, V32, P1422, DOI 10.1046/j.1365-2648.2000.01620.x
   WINEMAN NM, 1994, NURS RES, V43, P268
   Yi MS, 2006, J GEN INTERN MED, V21, pS21, DOI 10.1111/j.1525-1497.2006.00643.x
NR 61
TC 3
Z9 3
U1 1
U2 8
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0091-2174
EI 1541-3527
J9 INT J PSYCHIAT MED
JI Int. J. Psychiatr. Med.
PY 2010
VL 40
IS 4
BP 439
EP 459
DI 10.2190/PM.40.4.g
PG 21
WC Psychiatry
SC Psychiatry
GA 725DT
UT WOS:000287626100007
PM 21391414
DA 2019-01-08
ER

PT J
AU Gucciardi, E
   Vogt, JA
   DeMelo, M
   Stewart, DE
AF Gucciardi, Enza
   Vogt, Janet A.
   DeMelo, Margaret
   Stewart, Donna E.
TI Exploration of the Relationship Between Household Food Insecurity and
   Diabetes in Canada
SO DIABETES CARE
LA English
DT Article
ID POOR GLYCEMIC CONTROL; SOCIAL-CLASS; ADULTS; HEALTH; INSUFFICIENCY;
   DEPRESSION; PREVALENCE; ANXIETY
AB OBJECTIVE - To determine the household food insecurity (HFI) prevalence in Canadians with diabetes and its relationship With diabetes management, self-care practices, and health status.
   RESEARCH DESIGN AND METHODS - We analyzed data from Canadians with diabetes aged >= 12 years (n = 6,237) from cycle 3.1 of the Canadian Community Health Survey, a population-based cross-sectional survey conducted in 2005. The HFI prevalence in Canadians with diabetes was compared with that in those without diabetes. The relationships between HFI and management services, self-care practices, and health status were examined for Ontarians with diabetes (n = 2,523).
   RESULTS - HFI was more prevalent among individuals with diabetes (9.3% [8.2-10.4]) than among those without diabetes (6.8% [6.5-7.0]) and was not associated With diabetes management services but was associated with physical inactivity (odds ratio 1.54 [95% Cl 1.10-2.17]), lower fruit and vegetable consumption (0.52 [0.33-0.81]), current smoking (1.71 [1.09-2.69]), unmet health care needs (2.71 [1.74-4.23]), having been an overnight patient (2.08 [1.43-3.04]), having a mood disorder (2.18 [1.54-3.08]), having effects from a Stroke (2.39 [1.32-4.32]), lower satisfaction with life (0.28 [0.18-0.43]), self-rated general (0.37 [0.21-0.66]) and mental (0.17 [0.10-0.29]) health, and higher self-perceived Stress (2.04 [1.30-3.20]). The odds of HFI were higher for an individual in whom diabetes was diagnosed at age <40 years (3.08 [1.96-4.84]).
   CONCLUSIONS - HFI prevalence is higher among Canadians with diabetes and is associated with an increased likelihood of unhealthy behaviors, psychological distress, and poorer physical health.
C1 [Gucciardi, Enza] Ryerson Univ, Toronto, ON, Canada.
   [Gucciardi, Enza] Univ Hlth Network Womans Hlth Program, Toronto, ON, Canada.
   [Vogt, Janet A.; DeMelo, Margaret] Univ Hlth Network Diabet Educ Ctr, Toronto, ON, Canada.
   [Stewart, Donna E.] Univ Toronto, Fac Med, Toronto, ON, Canada.
RP Gucciardi, E (reprint author), Ryerson Univ, Toronto, ON, Canada.
EM egucciar@ryerson.ca
RI Stewart, Donna Eileen/J-2844-2016
OI Stewart, Donna Eileen/0000-0002-8157-7746
FU Banting and Best Diabetes Centre, Faculty of Medicine, University of
   Toronto
FX We acknowledge Dr. Valerie Tarasuk's review of the manuscript before
   submission and our reviewers for their constructive feedback.
CR Agriculture and Agri-Food Canada, 1998, CAN ACT PLAN FOOD SE, P1
   Anderson RJ, 2002, INT J PSYCHIAT MED, V32, P235, DOI 10.2190/KLGD-4H8D-4RYL-TWQ8
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   [Anonymous], 2003, DIAB ONT ICES PRACT
   [Anonymous], 2007, POP DWELL COUNTS CAN
   Bickel G, 2000, GUIDE MEASURING HOUS
   Chen Jiajian, 2002, Health Rep, V13, P23
   Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245
   Grigsby AB, 2002, J PSYCHOSOM RES, V53, P1053, DOI 10.1016/S0022-3999(02)00417-8
   *HLTH CAN, 2007, PUBL OFF NUTR POL PR, V4694
   Hollingshead AB, 2007, AM J PUBLIC HEALTH, V97, P1756
   Kirkpatrick SI, 2008, J NUTR, V138, P604
   Kraut A, 2001, DIABETES CARE, V24, P64, DOI 10.2337/diacare.24.1.64
   Ledrou Ingird, 2005, Health Rep, V16, P47
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Morris E, 2005, CAN J PUBLIC HEALTH, V96, P201
   Nathan DM, 2005, NEW ENGL J MED, V353, P2643
   Nelson K, 2001, J GEN INTERN MED, V16, P404, DOI 10.1046/j.1525-1497.2001.016006404.x
   OHINMAA A, 2004, CAN J DIABETES, V28, P116
   Ricciuto L, 2006, EUR J CLIN NUTR, V60, P778, DOI 10.1038/sj.ejcn.1602382
   Seligman HK, 2007, J GEN INTERN MED, V22, P1018, DOI 10.1007/s11606-007-0192-6
   Shields Margot, 2005, Health Rep, V16, P19
   Tuerk PW, 2008, DIABETES CARE, V31, P869, DOI 10.2337/dc07-1662
   Vozoris NT, 2003, J NUTR, V133, P120
   WENDER PH, 1973, ARCH GEN PSYCHIAT, V28, P318
NR 25
TC 68
Z9 69
U1 0
U2 11
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
J9 DIABETES CARE
JI Diabetes Care
PD DEC
PY 2009
VL 32
IS 12
BP 2218
EP 2224
DI 10.2337/dc09-0823
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 532YH
UT WOS:000272786600015
PM 19720843
OA Green Published, Other Gold
DA 2019-01-08
ER

PT J
AU Pouwer, F
AF Pouwer, Francois
TI Should we screen for emotional distress in type 2 diabetes mellitus?
SO NATURE REVIEWS ENDOCRINOLOGY
LA English
DT Review
ID RANDOMIZED CONTROLLED-TRIAL; EDID RESEARCH CONSORTIUM;
   PLACEBO-CONTROLLED TRIAL; POOR GLYCEMIC CONTROL; PRIMARY-CARE PATIENTS;
   CO-MORBID DEPRESSION; EUROPEAN DEPRESSION; MENTAL-DISORDERS;
   DOUBLE-BLIND; ADULTS
AB Emotional problems such as depression, anxiety and diabetes-specific distress are common in patients with type 2 diabetes mellitus (T2DM) but often remain unrecognized and thus untreated. The present Review focuses on the extent of this problem and discusses whether we should screen for depression, anxiety and diabetes-specific distress in patients with this condition. Depression has received by far the greatest attention from researchers. Strong evidence exists that depression affects 10-20% of patients with T2DM, but it is often unrecognized. Several guidelines have therefore recommended periodic assessments of emotional well-being in patients with T2DM. However, this recommendation is not based on strong evidence, as the effects of screening (case-finding) on psychological outcomes and diabetes outcomes have not been tested in a randomized controlled study. Results from studies in patients without T2DM have shown that screening for depression does not improve outcomes. On the other hand, collaborative care approaches for depression in patients with type 1 diabetes mellitus (T1DM) or T2DM seem to be effective. Intervention studies for anxiety or diabetes-specific emotional distress are currently lacking, and further research that can help to optimize antidepressant treatment is also urgently needed.
C1 Tilburg Univ, Ctr Res Psychol Somat Dis, Dept Med Psychol, Fac Social Sci, NL-5000 LE Tilburg, Netherlands.
RP Pouwer, F (reprint author), Tilburg Univ, Ctr Res Psychol Somat Dis, Dept Med Psychol, Fac Social Sci, POB 90153, NL-5000 LE Tilburg, Netherlands.
EM f.pouwer@uvt.nl
CR Adriaanse MC, 2008, DIABETIC MED, V25, P843, DOI 10.1111/j.1464-5491.2008.02464.x
   Adriaanse MC, 2006, DIABETES-METAB RES, V22, P20, DOI 10.1002/dmrr.590
   Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x
   *AM DIAB ASS, 2009, DIABETES CARE S1, V32, pS13, DOI DOI 10.2337/DC09-S013
   Anderson RJ, 2002, INT J PSYCHIAT MED, V32, P235, DOI 10.2190/KLGD-4H8D-4RYL-TWQ8
   Black SA, 2003, DIABETES CARE, V26, P2822, DOI 10.2337/diacare.26.10.2822
   Bogner HR, 2007, DIABETES CARE, V30, P3005, DOI 10.2337/dc07-0974
   Bruce DG, 2005, DIABETOLOGIA, V48, P2532, DOI 10.1007/s00125-005-0024-3
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   Delahanty LM, 2007, DIABETIC MED, V24, P48, DOI 10.1111/j.1464-5491.2007.02028.x
   DOWRICK C, 1995, BMJ-BRIT MED J, V311, P1274, DOI 10.1136/bmj.311.7015.1274
   Egede LE, 2005, DIABETES CARE, V28, P1339, DOI 10.2337/diacare.28.6.1339
   Egede LE, 2005, CURR DIABETES REV, V1, P235, DOI 10.2174/157339905774574356
   Farmer AJ, 2003, DIABETIC MED, V20, P996, DOI 10.1046/j.1464-5491.2003.01042.x
   Gilbody S, 2008, CAN MED ASSOC J, V178, P997, DOI 10.1503/cmaj.070281
   Gonzalez JS, 2008, DIABETOLOGIA, V51, P1822, DOI 10.1007/s00125-008-1113-x
   Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341
   Grigsby AB, 2002, J PSYCHOSOM RES, V53, P1053, DOI 10.1016/S0022-3999(02)00417-8
   International Diabetes Federation, 2005, GLOB GUID TYP 2 DIAB
   Katon WJ, 2005, DIABETES CARE, V28, P2668, DOI 10.2337/diacare.28.11.2668
   Katon WJ, 2004, ARCH GEN PSYCHIAT, V61, P1042, DOI 10.1001/archpsyc.61.10.1042
   KOOPMANS B, DIABETOLOGIA
   Koopmans B, 2009, FAM PRACT, V26, P171, DOI 10.1093/fampra/cmp016
   Kruse J, 2003, DIABETES CARE, V26, P1841, DOI 10.2337/diacare.26.6.1841
   Lewis G, 1996, FAM PRACT, V13, P120, DOI 10.1093/fampra/13.2.120
   Lustman Patrick J, 2008, Curr Psychiatry Rep, V10, P495
   Lustman PJ, 1997, PSYCHOSOM MED, V59, P241, DOI 10.1097/00006842-199705000-00007
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Lustman PJ, 2000, DIABETES CARE, V23, P618, DOI 10.2337/diacare.23.5.618
   Lustman PJ, 1998, ANN INTERN MED, V129, P613, DOI 10.7326/0003-4819-129-8-199810150-00005
   Makine C, 2009, DIABETIC MED, V26, P28, DOI 10.1111/j.1464-5491.2008.02606.x
   Marwick TH, 2009, CIRCULATION, V119, P3244, DOI 10.1161/CIRCULATIONAHA.109.192521
   Michaud CM, 2001, JAMA-J AM MED ASSOC, V285, P535, DOI 10.1001/jama.285.5.535
   *NAT I HLTH CLIN E, 2004, DEPR MAN DEPR PRIM C
   Peyrot M, 2007, DIABETES CARE, V30, P2433, DOI 10.2337/dc07-1222
   Pouwer F, 2003, DIABETOLOGIA, V46, P892, DOI 10.1007/s00125-003-1124-6
   Pouwer F, 2006, PATIENT EDUC COUNS, V60, P235, DOI 10.1016/j.pec.2005.01.009
   Pouwer F, 2005, DIABETES RES CLIN PR, V70, P166, DOI 10.1016/j.diabres.2005.03.031
   Pouwer F, 2001, DIABETES CARE, V24, P1929, DOI 10.2337/diacare.24.11.1929
   Rubin Richard R, 2004, Curr Diab Rep, V4, P119, DOI 10.1007/s11892-004-0067-8
   Schram MT, 2009, CURR DIABETES REV, V5, P112, DOI 10.2174/157339909788166828
   Simon GE, 2007, ARCH GEN PSYCHIAT, V64, P65, DOI 10.1001/archpsyc.64.1.65
   Skinner TC, 2005, DIABETIC MED, V22, P1497, DOI 10.1111/j.1464-5491.2005.01680.x
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Talbot F, 2000, DIABETES CARE, V23, P1556, DOI 10.2337/diacare.23.10.1556
   Thomas J, 2003, DIABETES CARE, V26, P2311, DOI 10.2337/diacare.26.8.2311
   Thombs BD, 2008, JAMA-J AM MED ASSOC, V300, P2161, DOI 10.1001/jama.2008.667
   Thompson C, 2000, LANCET, V355, P185, DOI 10.1016/S0140-6736(99)03171-2
   THOOLEN BJ, 2005, DIABETES CARE, V29, P2257
   Timonen M, 2008, BRIT MED J, V336, P435, DOI 10.1136/bmj.39478.609097.BE
   Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779
   Whooley MA, 2000, J GEN INTERN MED, V15, P293, DOI 10.1046/j.1525-1497.2000.04319.x
NR 52
TC 80
Z9 85
U1 0
U2 21
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1759-5029
J9 NAT REV ENDOCRINOL
JI Nat. Rev. Endocrinol.
PD DEC
PY 2009
VL 5
IS 12
BP 665
EP 671
DI 10.1038/nrendo.2009.214
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 521MB
UT WOS:000271924400008
PM 19884900
DA 2019-01-08
ER

PT J
AU Swinnen, SGHA
   Snoek, FJ
   Dain, MP
   DeVries, JH
   Hoekstra, JBL
   Holleman, F
AF Swinnen, Sanne G. H. A.
   Snoek, Frank J.
   Dain, Marie-Paule
   DeVries, J. Hans
   Hoekstra, Joost B. L.
   Holleman, Frits
TI Rationale, Design, and Baseline Data of the Insulin Glargine (Lantus)
   Versus Insulin Detemir (Levemir) Treat-To-Target (L2T3) Study: A
   Multinational, Randomized Noninferiority Trial of Basal Insulin
   Initiation in Type 2 Diabetes
SO DIABETES TECHNOLOGY & THERAPEUTICS
LA English
DT Article
ID QUALITY-OF-LIFE; ORAL-THERAPY; GLUCOSE CONTROL; NPH INSULIN; MELLITUS;
   COMPLICATIONS; VALIDATION; MANAGEMENT; DISORDERS; VALIDITY
AB Objective: To discuss the design and baseline data of the Lantus (R) (sanofi-aventis, Paris, France) versus Levemir (R) (Novo Nordisk A/S, Bagsvaerd, Denmark) Treat-To-Target (L2T3) study, a multinational, randomized comparison between the basal insulin analogs insulin glargine and insulin detemir.
   Methods: Insulin-naive subjects with type 2 diabetes suboptimally controlled on oral glucose-lowering drugs (OGLDs) (including at least metformin) were randomized to 24-week treatment with either insulin glargine once-daily or insulin detemir twice-daily, titrated to obtain fasting plasma glucose <100 mg/dL. The primary outcome was the percentage of subjects reaching hemoglobin A1c (HbA1c) <7% without symptomatic confirmed hypoglycemia. Important secondary outcomes were quality of life and treatment satisfaction, which were repeatedly assessed using validated questionnaires. Also, biomedical and psychological determinants of failure to reach HbA1c <7% were explored.
   Results: Recruitment was completed in November 2007. The majority of the randomized population (n = 973) was white (77.8%) and used one other OGLD beside metformin (70.7%). Concerning patient-reported outcomes, similar to 20% of subjects reported no physical symptoms of fatigue or hyperglycemia before insulin initiation, and similar to 10% were maximally satisfied with their previous treatment. One-third of patients (29.9%) reported suboptimal well-being, and 9.3% had a score indicating depression. Better emotional well-being was significantly associated with lower diabetes symptom distress and higher treatment satisfaction (respectively, r = -0.56 and 0.41; P<0.001).
   Conclusions: The L2T3 study will extend the evidence on both the efficacy and the effects on quality of life and treatment satisfaction of the long-acting insulin analogs glargine and detemir. Additionally, it will increase our understanding of the factors important to the (self-) management of type 2 diabetes patients starting insulin.
C1 [Snoek, Frank J.] Vrije Univ Amsterdam, Med Ctr, Dept Med Psychol, Amsterdam, Netherlands.
   [Swinnen, Sanne G. H. A.; DeVries, J. Hans; Hoekstra, Joost B. L.; Holleman, Frits] Vrije Univ Amsterdam, Med Ctr, Acad Med Ctr, Dept Internal Med, Amsterdam, Netherlands.
   [Dain, Marie-Paule] Sanofi Aventis, Global Metab, Paris, France.
RP Swinnen, SGHA (reprint author), Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Meibergdreef 9,Room F4-257, NL-1105 AZ Amsterdam, Netherlands.
EM s.g.swinnen@amc.uva.nl
OI Holleman, Frits/0000-0001-5858-5089; DeVries, J.
   Hans/0000-0001-9196-9906
FU sanofi-aventis (Paris, France); Novo Nordisk
FX S. G. H. A. S. is employed by the Department of Internal Medicine of the
   Academic Medical Center, partly through funding from Novo Nordisk and
   sanofi-aventis for the conduct of clinical trials. F.J.S. has received
   unrestricted educational grants and honoraria for consultancy work from
   Novo Nordisk and sanofi-aventis. M.-P. D. is employed as Diabetes
   Medical Director at sanofi-aventis. J.H.D. has received honoraria for
   consultancy work as well as research funding from Novo Nordisk and
   sanofi-aventis. J.B.L.H. has received honoraria for consultancy work
   from Novartis and sanofi-aventis. F. H. is the principal investigator of
   this study and has served on advisory boards for sanofi-aventis and
   received a study grant from Novo Nordisk.
CR Awata S, 2007, PSYCHIAT CLIN NEUROS, V61, P112, DOI 10.1111/j.1440-1819.2007.01619.x
   Bonsignore M, 2001, EUR ARCH PSY CLIN N, V251, P27
   Boye KS, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-80
   Bradley C., 1994, HDB PSYCHOL DIABETES, P111
   Brown JB, 2004, DIABETES CARE, V27, P1535, DOI 10.2337/diacare.27.7.1535
   COX DJ, 1987, DIABETES CARE, V10, P617, DOI 10.2337/diacare.10.5.617
   de Wit M, 2007, DIABETES CARE, V30, P2003, DOI 10.2337/dc07-0447
   *EMEA, LEV EUR PUBL ASS REP
   GROOTENHUIS PA, 1994, DIABETIC MED, V11, P253, DOI 10.1111/j.1464-5491.1994.tb00268.x
   Hermansen K, 2007, DIABETES CARE, V30, P1035
   Holleman F, 2007, DIABETOLOGIA, V50, P1783, DOI 10.1007/s00125-007-0763-4
   Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470
   Holman RR, 2007, NEW ENGL J MED, V357, P1716, DOI 10.1056/NEJMoa075392
   Horvath K, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005613.pub3
   Houlden R, 2007, DIABETES RES CLIN PR, V78, P254, DOI 10.1016/j.diabres.2007.03.021
   Jacobson AM, 1997, QUAL LIFE RES, V6, P11
   Lowe B, 2004, J AFFECT DISORDERS, V78, P131, DOI 10.1016/S0165-0327(02)00237-9
   Nakar S, 2007, J DIABETES COMPLICAT, V21, P220, DOI 10.1016/j.jdiacomp.2006.02.004
   Nathan DM, 2002, NEW ENGL J MED, V347, P1342, DOI 10.1056/NEJMcp021106
   OHKUBO Y, 1995, DIABETES RES CLIN PR, V28, P103, DOI 10.1016/0168-8227(95)01064-K
   Philis-Tsimikas A, 2006, CLIN THER, V28, P1569, DOI 10.1016/j.clinthera.2006.10.020
   Riddle MC, 2003, DIABETES CARE, V26, P3080, DOI 10.2337/diacare.26.11.3080
   Rosenstock J, 2008, DIABETOLOGIA, V51, P408, DOI 10.1007/s00125-007-0911-x
   Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O
   Turner RC, 1998, LANCET, V352, P837
   Vinik AI, 2007, DIABETES CARE, V30, P795, DOI 10.2337/dc06-1712
   Wexler DJ, 2006, DIABETOLOGIA, V49, P1489, DOI 10.1007/s00125-006-0249-9
NR 27
TC 11
Z9 12
U1 0
U2 5
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1520-9156
J9 DIABETES TECHNOL THE
JI Diabetes Technol. Ther.
PD NOV
PY 2009
VL 11
IS 11
BP 739
EP 743
DI 10.1089/dia.2009.0044
PG 5
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 519ED
UT WOS:000271746900008
PM 19905891
DA 2019-01-08
ER

PT J
AU Kuriyama, S
   Nakaya, N
   Ohmori-Matsuda, K
   Shimazu, T
   Kikuchi, N
   Kakizaki, M
   Sone, T
   Sato, F
   Nagai, M
   Sugawara, Y
   Akhter, M
   Higashiguchi, M
   Fukuchi, N
   Takahashi, H
   Hozawa, A
   Tsuji, I
AF Kuriyama, Shinichi
   Nakaya, Naoki
   Ohmori-Matsuda, Kaori
   Shimazu, Taichi
   Kikuchi, Nobutaka
   Kakizaki, Masako
   Sone, Toshimasa
   Sato, Fumi
   Nagai, Masato
   Sugawara, Yumi
   Akhter, Munira
   Higashiguchi, Mizuka
   Fukuchi, Naru
   Takahashi, Hideko
   Hozawa, Atsushi
   Tsuji, Ichiro
TI Factors Associated With Psychological Distress in a Community-Dwelling
   Japanese Population: The Ohsaki Cohort 2006 Study
SO JOURNAL OF EPIDEMIOLOGY
LA English
DT Article
DE cross-sectional; K6; population-based; psychological distress
ID INTERNATIONAL DIAGNOSTIC INTERVIEW; MENTAL-HEALTH; GENDER-DIFFERENCES;
   SCREENING SCALES; NATIONAL-SURVEY; DEPRESSION; PERFORMANCE; ILLNESS;
   VERSION; TRENDS
AB Background: In Asia, there has been no population-based epidemiological study using the K6, a 6-item instrument that assesses nonspecific psychological distress.
   Methods: Using cross-sectional data from 2006, we studied 43 716 (20 168 men and 23 548 women) community-dwelling people aged 40 years or older living in Japan. We examined the association between psychological distress and demographic, medical, lifestyle, and social factors by using the K6, with psychological distress defined as 13 or more points out of a total of 24 points.
   Results: The following variables were significantly associated with psychological distress among the population: female sex, young and old age, a history of serious disease (hypertension, diabetes mellitus, stroke, myocardial infarction, or cancer), current smoking, former alcohol drinking, low body mass index, shorter daily walking time, lack of social support (4 of 5 components), and lack of participation in community activities (4 of 5 components). Among men aged 40 to 64 years, only "lack of social support for consultation when in trouble" and a history of diabetes mellitus remained significant on multivariate analysis. Among men aged 65 years or older, age was not significantly associated with psychological distress, and the significant association with current smoking disappeared on multivariate analysis. Among women aged 40 to 64 years, a history of stroke was not associated with psychological distress. Among women aged 65 years or older, the significant association with current smoking disappeared on multivariate analysis.
   Conclusions: A number of factors were significantly associated with psychological distress, as assessed by the K6. These factors differed between men and women, and also between middle-aged and elderly people.
C1 [Kuriyama, Shinichi] Tohoku Univ, Grad Sch Med, Dept Publ Hlth & Forens Med, Div Epidemiol,Aoba Ku, Sendai, Miyagi 9808575, Japan.
   [Shimazu, Taichi; Akhter, Munira] Natl Canc Ctr, Epidemiol & Prevent Div, Res Ctr Canc Prevent & Screening, Tokyo 104, Japan.
RP Kuriyama, S (reprint author), Tohoku Univ, Grad Sch Med, Dept Publ Hlth & Forens Med, Div Epidemiol,Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.
EM s-kuri@mail.tains.tohoku.ac.jp
RI Shimazu, Taichi/A-4470-2015
OI Shimazu, Taichi/0000-0001-6000-9830; Nagai, Masato/0000-0003-0818-3158;
   Kakizaki, Masako/0000-0001-6030-8953
FU Ministry of Health, Labour and Welfare, Japan [H19-Seisaku-Ippan-026,
   H18-Choju-Ippan-014]; Japan Society for the Promotion of Science
   [18390191]
FX This study was supported by Health Sciences Research Grants
   (H19-Seisaku-Ippan-026, H18-Choju-Ippan-014) from the Ministry of
   Health, Labour and Welfare, Japan, and a Grant-in-Aid for Scientific
   Research (B) (18390191) from the Japan Society for the Promotion of
   Science.
CR Afifi M., 2007, SMJ Singapore Medical Journal, V48, P385
   Brink T., 1982, CLIN GERONTOLOGIST, V1, P37, DOI DOI 10.1300/J018V01N01_06
   Dafer RM, 2008, TOP STROKE REHABIL, V15, P13, DOI 10.1310/tsr1501-13
   Furukawa TA, 2003, PSYCHOL MED, V33, P357, DOI 10.1017/S0033291702006700
   Furukawa TA, 2008, INT J METH PSYCH RES, V17, P152, DOI 10.1002/mpr.257
   Hagman BT, 2008, ADDICT BEHAV, V33, P582, DOI 10.1016/j.addbeh.2007.11.007
   Kessler RC, 2008, MOL PSYCHIATR, V13, P374, DOI 10.1038/sj.mp.4002119
   Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168
   Koizumi Y, 2005, PSYCHIAT CLIN NEUROS, V59, P563, DOI 10.1111/j.1440-1819.2005.01415.x
   Koizumi Yayoi, 2004, Nihon Ronen Igakkai Zasshi, V41, P426
   Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442
   Muraoka Y, 1996, RONEN SEISHIN IGAKU, V7, P397
   Ogawa K, 2003, PUBLIC HEALTH NUTR, V6, P147, DOI 10.1079/PHN2002411
   Piccinelli M, 2000, BRIT J PSYCHIAT, V177, P486, DOI 10.1192/bjp.177.6.486
   Pratt Laura A, 2007, Adv Data, P1
   Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0
   ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069
   ROBINS LN, 1981, ARCH GEN PSYCHIAT, V38, P381
   Seeman MV, 1997, AM J PSYCHIAT, V154, P1641, DOI 10.1176/ajp.154.12.1641
   Shimizu Hiroyuki, 2002, J Epidemiol, V12, P54
   Suzuki I, 1998, J Epidemiol, V8, P152
   Suzuki Naoko, 2007, Nihon Ronen Igakkai Zasshi, V44, P619, DOI 10.3143/geriatrics.44.619
   Yamada A, 2007, PSYCHIAT CLIN NEUROS, V61, P651, DOI 10.1111/j.1440-1819.2007.01736.x
NR 25
TC 35
Z9 36
U1 0
U2 12
PU JAPAN EPIDEMIOLOGICAL ASSOC
PI TOCHIGI
PA JICHI MEDICAL SCHOOL, DEPT PUBLIC HEALTH, 3311-1 YAKUSHIJI,
   MINAMIKAWACH, TOCHIGI, 329-0498, JAPAN
SN 0917-5040
J9 J EPIDEMIOL
JI J. Epidemiol.
PD NOV
PY 2009
VL 19
IS 6
BP 294
EP 302
DI 10.2188/jea.JE20080076
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 521VZ
UT WOS:000271955300003
PM 19749498
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Skelly, AH
   Carlson, J
   Leeman, J
   Soward, A
   Burns, D
AF Skelly, Anne H.
   Carlson, John
   Leeman, Jennifer
   Soward, April
   Burns, Dorothy
TI Controlled Trial of Nursing Interventions to Improve Health Outcomes of
   Older African American Women With Type 2 Diabetes
SO NURSING RESEARCH
LA English
DT Article
DE African American; diabetes; symptoms
ID SYMPTOM MANAGEMENT INTERVENTION; SELF-CARE; PHYSICAL-ACTIVITY; ADULTS;
   DISTRESS; PROGRAM; SCALE
AB Background: Type 2 diabetes affects one in five African American women older than 60 years. These women face distinct challenges in managing diabetes self-care. Therefore, tailored self-care interventions for this population need to be developed and tested.
   Objectives: The effectiveness of a tailored, four-visit, in-home symptom-focused diabetes intervention with and without booster telephone calls was compared with an attentional control focused on skills training for weight management and diet.
   Methods: African American women (n = 180; >55 years old, Type 2 diabetes mellitus >1 year, HbA1c >7%) were randomly assigned to the intervention or attentional control condition. Half the intervention participants were assigned to also receive a telephone-delivered booster intervention. Participants pants were evaluated at baseline and 3, 6, and 9 months.
   Results: Baseline HbA1 was 8.3 in the intervention group (n = 60), 8.29 in the intervention with booster group (n = 55), and 8.44 in the attentional control condition (n = 59). HbA1c declined significantly in the whole sample (0.57%) with no differences between study arms. Participants in the booster arm decreased HbA1c by 0.76%. Symptom distress, perceived quality of life, impact of diabetes, and self-care activities also improved significantly for the whole sample with no significant differences between study arms.
   Discussion: Parsimonious interventions of four in-person visits yielded clinically significant decreases in HbA1c. Although the weight and diet program was intended as an attentional control, the positive effects suggest it met a need in this population. Because the contents of both the intervention and the attentional control were effective despite different approaches, a revised symptom-focused intervention that incorporates weight and diet skills training may offer even better results.
C1 [Skelly, Anne H.; Carlson, John; Leeman, Jennifer; Soward, April] Univ N Carolina, Sch Nursing, Chapel Hill, NC 27599 USA.
   [Burns, Dorothy] Hampton Univ, Sch Nursing, Hampton, VA 23668 USA.
RP Skelly, AH (reprint author), Univ N Carolina, Sch Nursing, Carrington Hall, Chapel Hill, NC 27599 USA.
EM askelly@email.unc.edu
OI Leeman, Jennifer/0000-0003-3130-8297
FU National Institute of Nursing Research to the School of Nursing [R01
   NR008S82]; University of North Carolina at Chapel Hill
FX This study was funded through grant no. R01 NR008S82 from the National
   Institute of Nursing Research to the School of Nursing, University of
   North Carolina at Chapel Hill.
CR AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705
   *AM DIAB ASS, 2005, DIAB 4 1 1 FACTS FIG
   *AM DIAB ASS, 2008, DIABETES CARE, V31, pS1
   Anderson RM, 2005, ETHNIC DIS, V15, P671
   Becker H, 2003, WESTERN J NURS RES, V25, P746, DOI 10.1177/S0193945903253002
   COWARD RT, 1998, AGING RURAL SETTINGS, P16
   Dilworth-Anderson P, 2004, J GERONTOL B-PSYCHOL, V59, pS138, DOI 10.1093/geronb/59.3.S138
   Dodd M J, 2001, Oncol Nurs Forum, V28, P465
   Elasy TA, 2000, DIABETES CARE, V23, P325, DOI 10.2337/diacare.23.3.325
   Feathers JT, 2007, DIABETES EDUCATOR, V33, P509, DOI 10.1177/0145721707301371
   FUNNELL MM, 1993, NURS CLIN N AM, V28, P45
   Funnell MM, 1998, DIABETES EDUCATOR, V24, P163, DOI 10.1177/014572179802400205
   Given C, 2004, PSYCHO-ONCOL, V13, P818, DOI 10.1002/pon.807
   GLASGOW RE, 1992, PATIENT EDUC COUNS, V19, P61, DOI 10.1016/0738-3991(92)90102-O
   Keyserling TC, 2002, DIABETES CARE, V25, P1576, DOI 10.2337/diacare.25.9.1576
   Larson P. J., 1994, IMAGE J NURSING SCHO, V26, P272, DOI DOI 10.1111/JNU.1994.26.ISSUE-4
   LEBOVITZ H, 1998, THERAPY DIABETES REL
   Leeman J, 2008, DIABETES EDUCATOR, V34, P310, DOI 10.1177/0145721708316623
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Samuel-Hodge CD, 2000, DIABETES CARE, V23, P928, DOI 10.2337/diacare.23.7.928
   Sarkisian CA, 2003, DIABETES EDUCATOR, V29, P467, DOI 10.1177/014572170302900311
   Saydah S, 2007, ETHNIC DIS, V17, P529
   SKELLY AH, 1995, DIABETES EDUCATOR, V21, P38, DOI 10.1177/014572179502100107
   Skelly AH, 2005, APPL NURS RES, V18, P213, DOI 10.1016/j.apnr.2004.08.008
   Skelly AH, 2008, J NURS SCHOLARSHIP, V40, P261, DOI 10.1111/j.1547-5069.2008.00236.x
   Stoodt G, 1993, N C Med J, V54, P532
   Stover JC, 2001, APPL NURS RES, V14, P72, DOI 10.1053/apnr.2001.22372
   Teel C S, 1997, Image J Nurs Sch, V29, P175
   *UK PROSP DIAB STU, 1998, ISS TYP 2 DIAB, V2
   Wassem Rebecca, 2003, Clin Nurs Res, V12, P102, DOI 10.1177/1054773803238743
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   Zimmerman L, 2007, J CARDIOVASC NURS, V22, P493, DOI 10.1097/01.JCN.0000297379.06379.b6
NR 33
TC 25
Z9 27
U1 0
U2 8
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-6562
EI 1538-9847
J9 NURS RES
JI Nurs. Res.
PD NOV-DEC
PY 2009
VL 58
IS 6
BP 410
EP 418
DI 10.1097/NNR.0b013e3181bee597
PG 9
WC Nursing
SC Nursing
GA 529LA
UT WOS:000272516900005
PM 19851122
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Anstey, KJ
   Burns, R
   Butterworth, P
   Windsor, TD
   Christensen, H
   Sachdev, P
AF Anstey, Kaarin J.
   Burns, Richard
   Butterworth, Peter
   Windsor, Tim D.
   Christensen, Helen
   Sachdev, Perminder
TI Cardiovascular Risk Factors and Life Events as Antecedents of Depressive
   Symptoms in Middle and Early-Old Age: Path Through Life Study
SO PSYCHOSOMATIC MEDICINE
LA English
DT Article
DE depression; epidemiology; longitudinal study; diabetes; BMI; life
   events; cardiovascular risk factors
ID ACUTE CORONARY SYNDROMES; COMMUNITY SAMPLE; PSYCHOLOGICAL DISTRESS;
   ALCOHOL-CONSUMPTION; DIABETES-MELLITUS; MEDICAL SETTINGS; CARDIAC
   EVENTS; YOUNG-ADULTS; ANXIETY; ASSOCIATION
AB Objective: To evaluate cardiovascular risk factors (CVRF) and life events (LE) as predictors of depressive symptoms in a mid-life and an early late-life cohort to determine whether they had independent or interacting effects, and whether there were age differences in the effects. Methods: Cohorts aged 40 to 44 years (n = 2530) and 60 to 64 years (n = 2551) at baseline (Wave 1) were followed up after 4 years (Wave 2) as part of the PATH Through Life Study based in Canberra and Queanbeyan, Australia. Cross-sectional analyses evaluated rates of CVRF and LE in depressed compared with nondepressed participants. Hierarchical generalized linear models were used to evaluate demographic variables, CVRF (diabetes, smoking, alcohol, body mass index, cholesterol medication, hypertension), LE, and Wave 1 depressive symptoms as predictors of depressive symptoms at Wave 2. Results: At baseline, those with high levels of depressive symptoms were more likely to report smoking, using cholesterol-lowering medications, hypertension, diabetes, past stroke, and higher body mass index. Predictors of depressive symptoms at Wave 2 in the cohort of 40- to 44-year-old persons included Wave 1 depressive symptoms, diabetes, and LE at Wave 2. In the cohort of 60- to 64-year-old individuals, Wave 1 depression, stroke, smoking, low education, and Wave 2 LE predicted depressive symptoms. There was no evidence of interactions between CVRF and LE. Conclusions: LE and CVRF are independent sets of risk factors for depressive symptoms with different effects in the 40- to 44-year-old and 60- to 64-year-old cohorts. These findings have implications for preventative strategies for depression.
C1 [Anstey, Kaarin J.; Burns, Richard; Butterworth, Peter; Windsor, Tim D.; Christensen, Helen] Australian Natl Univ, Mental Hlth Res Ctr, Canberra, ACT 0200, Australia.
   [Sachdev, Perminder] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia.
   Prince Wales Hosp, Inst Neuropsychiat, Sydney, NSW, Australia.
RP Anstey, KJ (reprint author), Australian Natl Univ, Mental Hlth Res Ctr, GPO Box 4, Canberra, ACT 0200, Australia.
EM kaarin.anstey@anu.edu.au
RI Burns, Richard/C-4231-2011; Christensen, Helen/F-5053-2012; Anstey,
   Kaarin/A-3852-2008
OI Burns, Richard/0000-0002-7750-4341; Sachdev,
   Perminder/0000-0002-9595-3220; Butterworth, Peter/0000-0002-1531-3881;
   Anstey, Kaarin/0000-0002-9706-9316; Christensen,
   Helen/0000-0003-0435-2065
FU National Health and Medical Research Council (NHMRC) [157125, 366756,
   366781, 316970]
FX This study was supported, in part, by Program Grant 179805 and Project
   Grant 157125 from the National Health and Medical Research Council
   (NHMRC). The sponsors had no role in the design, conduct or reporting of
   the research. Drs. Ansley, Butterworth, and Christensen are funded by
   NHMRC Fellowships #366756, #366781 and #316970, respectively.
CR Alexopoulos GS, 1997, ARCH GEN PSYCHIAT, V54, P915
   Anstey KJ, 2002, PSYCHOSOM MED, V64, P880, DOI 10.1097/01.PSY.0000028827.64279.60
   Bremmer MA, 2006, AM J GERIAT PSYCHIAT, V14, P523, DOI 10.1097/01.JGP.0000216172.31735.d5
   BRUGHA TS, 1990, ACTA PSYCHIAT SCAND, V82, P77, DOI 10.1111/j.1600-0447.1990.tb01360.x
   Caldwell TM, 2002, ADDICTION, V97, P583, DOI 10.1046/j.1360-0443.2002.00092.x
   Carney RM, 2002, J PSYCHOSOM RES, V53, P897, DOI 10.1016/S0022-3999(02)00311-2
   Chen PS, 2006, INT PSYCHOGERIATR, V18, P445, DOI 10.1017/S1041610205002796
   Dafer RM, 2008, TOP STROKE REHABIL, V15, P13, DOI 10.1310/tsr1501-13
   Duman RS, 1997, ARCH GEN PSYCHIAT, V54, P597
   Fairweather AK, 2006, PSYCHOL MED, V36, P1235, DOI 10.1017/S0033291706007823
   Gilbody S, 2007, J GEN INTERN MED, V22, P1596, DOI 10.1007/s11606-007-0333-y
   Gillespie KM, 2004, LANCET, V364, P1699, DOI 10.1016/S0140-6736(04)17357-1
   GOLDBERG D, 1988, BRIT MED J, V297, P897, DOI 10.1136/bmj.297.6653.897
   Golden SH, 2004, DIABETES CARE, V27, P429, DOI 10.2337/diacare.27.2.429
   Golden SH, 2007, CURR DIABETES REV, V3, P252, DOI 10.2174/157339907782330021
   Golden SH, 2008, JAMA-J AM MED ASSOC, V299, P2751, DOI 10.1001/jama.299.23.2751
   Golden SH, 2007, PSYCHOSOM MED, V69, P529, DOI 10.1097/PSY.0b013e3180f61c5c
   Hislop AL, 2008, DIABETIC MED, V25, P91, DOI 10.1111/j.1464-5491.2007.02310.x
   Holley C, 2006, AM J GERIAT PSYCHIAT, V14, P84, DOI 10.1097/01.JGP.0000192504.48810.cb
   Holley CK, 2007, AM J GERIAT PSYCHIAT, V15, P690, DOI 10.1097/JGP.0b013e3180311209
   Iosifescu DV, 2005, PSYCHOSOM MED, V67, P703, DOI 10.1097/01.psy.0000170338.75346.d0
   Jacobs N, 2006, ARCH GEN PSYCHIAT, V63, P989, DOI 10.1001/archpsyc.63.9.989
   Jorm AF, 2005, PSYCHOL MED, V35, P1253, DOI 10.1017/S0033291705004976
   Jorm AF, 2005, AM J PSYCHIAT, V162, P699, DOI 10.1176/appi.ajp.162.4.699
   Keller MC, 2007, AM J PSYCHIAT, V164, P1521, DOI 10.1176/appi.ajp.2007.06091564
   Klungsoyr O, 2006, AM J EPIDEMIOL, V163, P421, DOI 10.1093/aje/kwj058
   Koloski NA, 2008, AGE AGEING, V37, P464, DOI 10.1093/ageing/afn091
   Leach LS, 2008, J NERV MENT DIS, V196, P128, DOI 10.1097/NMD.0b013e318162aa63
   MACKINNON A, 1994, PSYCHOL MED, V24, P977, DOI 10.1017/S0033291700029068
   Maraldi C, 2007, ARCH INTERN MED, V167, P1137, DOI 10.1001/archinte.167.11.1137
   MAXWELL SE, 1993, PSYCHOL BULL, V113, P181, DOI 10.1037/0033-2909.113.1.181
   Miller GE, 2005, AM J CARDIOL, V95, P317, DOI 10.1016/j.amjcard.2004.09.026
   Nakatani D, 2005, AM HEART J, V150, P652, DOI 10.1016/j.ahj.2005.03.062
   National Health and Medical Research Council, 2001, AUSTR ALC GUID HLTH
   NEWMAN SC, 1994, COMPR PSYCHIAT, V35, P76, DOI 10.1016/0010-440X(94)90173-2
   Otte C, 2007, AM J PSYCHIAT, V164, P1379, DOI 10.1176/appi.apj.2007.06.06101617
   Panagiotakos DB, 2004, EUR HEART J, V25, P492, DOI 10.1016/j.ehj.2004.01.018
   Panagiotakos DB, 2001, ACTA CARDIOL, V56, P357, DOI 10.2143/AC.56.6.2005699
   Panagiotakos DB, 2008, J CLIN NURS, V17, P688, DOI 10.1111/j.1365-2702.2007.02056.x
   SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x
   Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737
   Strandberg TE, 2006, ARCH INTERN MED, V166, P2266, DOI 10.1001/archinte.166.20.2266
   Tupler LA, 2002, J PSYCHOSOM RES, V53, P665, DOI 10.1016/S0022-3999(02)00425-7
NR 43
TC 8
Z9 9
U1 0
U2 10
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0033-3174
J9 PSYCHOSOM MED
JI Psychosom. Med.
PD NOV-DEC
PY 2009
VL 71
IS 9
BP 937
EP 943
DI 10.1097/PSY.0b013e3181beab60
PG 7
WC Psychiatry; Psychology; Psychology, Multidisciplinary
SC Psychiatry; Psychology
GA 522UP
UT WOS:000272024800006
PM 19834045
DA 2019-01-08
ER

PT J
AU Schlotz, W
   Phillips, DIW
AF Schlotz, Wolff
   Phillips, David I. W.
TI Fetal origins of mental health: Evidence and mechanisms
SO BRAIN BEHAVIOR AND IMMUNITY
LA English
DT Review
DE Fetal programming; Fetal origins; Birth weight; Fetal growth; Cognitive
   function; Schizophrenia; Mood disorders; Behavioural problems;
   Temperament; Stress reactivity; Distress
ID LOW-BIRTH-WEIGHT; FOR-GESTATIONAL-AGE; DEFICIT HYPERACTIVITY DISORDER;
   PRENATAL ALCOHOL EXPOSURE; ANTENATAL MATERNAL ANXIETY;
   ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; INTRAUTERINE
   GROWTH-RETARDATION; CHRONIC PLACENTAL INSUFFICIENCY; GENE-ENVIRONMENT
   INTERACTION; RANDOMIZED CONTROLLED-TRIAL
AB The concept of fetal programming states that changes in the fetal environment during sensitive periods of organ development may cause long-lasting changes in the structure and functioning of these organs later in life and influence the risk for chronic diseases such as coronary heart disease and type 2 diabetes. Fetal growth is a summary marker of the fetal environment and is reflected by relatively easy-to-obtain measures of size at birth such as birth weight. In the last two decades, a body of evidence emerged linking fetal growth with behavioural and mental health outcomes later in life. Cognitive functioning and behavioural problems in childhood, in particular inattention/hyperactivity, have been shown to be inversely related to fetal growth. Although results are mixed, risk for personality disorders and schizophrenia seems to be linked with fetal growth and adversity, while the evidence for mood disorders is weak. Vulnerability for psychopathology may also be influenced by prenatal adversity. There is evidence for associations of fetal growth with temperament in childhood as well as stress reactivity and distress. The associations of fetal growth with mental health later in life are potentially caused by specific prenatal factors such as maternal smoking, alcohol, toxins/drugs, nutrition, psychosocial stress and infection during pregnancy. The mechanisms likely involve changes in neurodevelopment and in the set point of neuroendocrine systems, and there is evidence that prenatal adversity interacts with genetic and postnatal environmental factors. Future studies should examine the effects of specific prenatal factors and attempt to disentangle genetic and prenatal environmental effects. (C) 2009 Elsevier Inc. All rights reserved.
C1 [Schlotz, Wolff] Univ Southampton, Sch Psychol, Southampton SO17 1BJ, Hants, England.
   [Phillips, David I. W.] Southampton Gen Hosp, MRC, Epidemiol Resource Ctr, Southampton SO16 6YD, Hants, England.
RP Schlotz, W (reprint author), Univ Southampton, Sch Psychol, Highfield Campus, Southampton SO17 1BJ, Hants, England.
EM ws@southampton.ac.uk; diwp@mrc.soton.ac.uk
OI Schlotz, Wolff/0000-0003-2356-7766
CR Alati R, 2007, AM J EPIDEMIOL, V165, P575, DOI 10.1093/aje/kwk036
   Altink ME, 2008, J CHILD PSYCHOL PSYC, V49, P1053, DOI 10.1111/j.1469-7610.2008.01998.x
   American Psychiatric Association, 2000, DIAGN STAT MAN MENT
   Andersen SL, 2003, NEUROSCI BIOBEHAV R, V27, P3, DOI 10.1016/S0149-7634(03)00005-8
   Andreasyan K, 2007, EUR J CLIN NUTR, V61, P498, DOI 10.1038/sj.ejcn.1602552
   Ashford J, 2008, J AM ACAD CHILD PSY, V47, P779, DOI 10.1097/CHI.0b013e318172eefb
   Bada HS, 2007, PEDIATRICS, V119, pE348, DOI 10.1542/peds.2006-1404
   BARKER DJ, 1994, P ROY SOC LOND B BIO, V262, P37
   BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095
   Barker DJP, 2004, PHILOS T ROY SOC B, V359, P1359, DOI 10.1098/rstb.2004.1518
   BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171
   BARKER DJP, 1995, BRIT MED J, V311, P1203, DOI 10.1136/bmj.311.7014.1203
   Barros VG, 2006, J NEUROSCI RES, V83, P787, DOI 10.1002/jnr.20758
   Bartholomeusz HH, 2002, NEUROPEDIATRICS, V33, P239, DOI 10.1055/s-2002-36735
   Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725
   Batty GD, 2006, PEDIATRICS, V118, P943, DOI 10.1542/peds.2006-0168
   Bennett DS, 2008, DEV PSYCHOL, V44, P919, DOI 10.1037/0012-1649.44.4.919
   Bergman K, 2008, J CHILD PSYCHOL PSYC, V49, P1089, DOI 10.1111/j.1469-7610.2008.01987.x
   Bergman K, 2007, J AM ACAD CHILD PSY, V46, P1454, DOI 10.1097/chi.0b013e31814a62f6
   Bergvall N, 2006, PEDIATRICS, V117, P714, DOI 10.1542/peds.2005-0735
   Beversdorf DQ, 2005, J AUTISM DEV DISORD, V35, P471, DOI 10.1007/s10803-005-5037-8
   Bohnert KM, 2008, ARCH GEN PSYCHIAT, V65, P1080, DOI 10.1001/archpsyc.65.9.1080
   BOLGER N, 1991, J PERS, V59, P355, DOI 10.1111/j.1467-6494.1991.tb00253.x
   BOYCE WT, 1995, PSYCHOSOM MED, V57, P411, DOI 10.1097/00006842-199509000-00001
   Braun JM, 2006, ENVIRON HEALTH PERSP, V114, P1904, DOI 10.1289/ehp.9478
   BRESLAU N, 1995, EPIDEMIOL REV, V17, P96, DOI 10.1093/oxfordjournals.epirev.a036191
   Breslau N, 1996, J ABNORM CHILD PSYCH, V24, P385, DOI 10.1007/BF01441637
   BROOKS AA, 1995, EARLY HUM DEV, V42, P29, DOI 10.1016/0378-3782(95)01637-I
   Brown AS, 2006, SCHIZOPHRENIA BULL, V32, P200, DOI 10.1093/schbul/sbj052
   Brown AS, 2000, SCHIZOPHRENIA BULL, V26, P287, DOI 10.1093/oxfordjournals.schbul.a033453
   Brown AS, 2000, AM J PSYCHIAT, V157, P438, DOI 10.1176/appi.ajp.157.3.438
   Brown AS, 2004, ARCH GEN PSYCHIAT, V61, P774, DOI 10.1001/archpsyc.61.8.774
   BROWN AS, 1995, BRIT J PSYCHIAT, V166, P601, DOI 10.1192/bjp.166.5.601
   Brown AS, 2000, AM J PSYCHIAT, V157, P190, DOI 10.1176/appi.ajp.157.2.190
   Cannon M, 2002, AM J PSYCHIAT, V159, P1080, DOI 10.1176/appi.ajp.159.7.1080
   Caspi A., 2008, RUTTERS CHILD ADOLES, P182, DOI DOI 10.1002/9781444300895
   Chen YW, 1996, BIOL PSYCHIAT, V39, P896, DOI 10.1016/0006-3223(95)00295-2
   Cheung YB, 2002, SOC SCI MED, V55, P937, DOI 10.1016/S0277-9536(01)00225-8
   Cheung YB, 2002, BRIT MED J, V325, P749, DOI 10.1136/bmj.325.7367.749
   Clark L. A., 1999, HDB PERSONALITY THEO, V2, P399
   CLONINGER CR, 1987, ARCH GEN PSYCHIAT, V44, P573
   Coe CL, 2003, BIOL PSYCHIAT, V54, P1025, DOI 10.1016/S0006-3223(03)00698-X
   Cohen S, 2003, BRAIN BEHAV IMMUN, V17, P407, DOI 10.1016/S0889-1591(03)00110-7
   Colombo J, 2004, CHILD DEV, V75, P1254, DOI 10.1111/j.1467-8624.2004.00737.x
   Costello EJ, 2007, ARCH GEN PSYCHIAT, V64, P338, DOI 10.1001/archpsyc.64.3.338
   Dabelea D, 2008, DIABETES CARE, V31, P1422, DOI 10.2337/dc07-2417
   de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683
   DEMINIERE JM, 1992, BRAIN RES, V586, P135, DOI 10.1016/0006-8993(92)91383-P
   Diego MA, 2006, PSYCHOSOM MED, V68, P747, DOI 10.1097/01.psy.0000238212.21598.7b
   Duncan JR, 2004, J NEUROPATH EXP NEUR, V63, P1131, DOI 10.1093/jnen/63.11.1131
   Dunger DB, 1998, NAT GENET, V19, P98, DOI 10.1038/ng0598-98
   Fan AP, 2001, BR J PSYCHIAT SUPPL, V40, P578
   Fergusson DM, 1998, ARCH GEN PSYCHIAT, V55, P721, DOI 10.1001/archpsyc.55.8.721
   FERREIRA AJ, 1965, J NERV MENT DIS, V141, P108, DOI 10.1097/00005053-196507000-00011
   Fryer SL, 2007, PEDIATRICS, V119, pE733, DOI 10.1542/peds.2006-1606
   Fujioka A, 2006, NEUROSCIENCE, V141, P907, DOI 10.1016/j.neuroscience.2006.04.046
   Gale CR, 2004, BRIT J PSYCHIAT, V184, P28, DOI 10.1192/bjp.184.1.28
   GALE CR, 2008, J CHILD PSYCHOL PSYC, V40, P1061
   Georgieff MK, 2007, AM J CLIN NUTR, V85, p614S
   Geva R, 2006, PEDIATRICS, V118, P91, DOI 10.1542/peds.2005-2343
   Gillman MW, 2005, NEW ENGL J MED, V353, P1848, DOI 10.1056/NEJMe058187
   Gillman MW, 2002, INT J EPIDEMIOL, V31, P294, DOI 10.1093/ije/31.2.294
   Gluckman P., 2005, FETAL MATRIX EVOLUTI
   Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292
   Glynn LM, 2001, AM J OBSTET GYNECOL, V184, P637, DOI 10.1067/mob.2001.111066
   Godfrey K, 1996, BRIT MED J, V312, P410
   Goldenberg RL, 1998, EUR J CLIN NUTR, V52, pS54
   Goldschmidt L, 2008, J AM ACAD CHILD PSY, V47, P254, DOI [10.1097/CHI.0b013e318160b3f0, 10.1097/chi.0b013e318160b3f0]
   Gorman KS, 2001, J DEV BEHAV PEDIATR, V22, P366, DOI 10.1097/00004703-200112000-00004
   Gunnar M, 2007, ANNU REV PSYCHOL, V58, P145, DOI 10.1146/annurev.psych.58.110405.085605
   Gunnell D, 2005, SCHIZOPHR RES, V79, P315, DOI 10.1016/j.schres.2005.07.022
   Gunnell D, 2003, AM J EPIDEMIOL, V158, P291, DOI 10.1093/aje/kwg118
   Gunthert KC, 2007, PSYCHOSOM MED, V69, P762, DOI 10.1097/PSY.0b013e318157ad42
   Gutteling BM, 2006, J ABNORM CHILD PSYCH, V34, P789, DOI 10.1007/s10802-006-9054-7
   Gutteling BM, 2005, EUR CHILD ADOLES PSY, V14, P41, DOI 10.1007/s00787-005-0435-1
   Haley DW, 2006, ALCOHOL CLIN EXP RES, V30, P2055, DOI 10.1111/j.1530-0277.2006.00251.x
   Hammen C, 2005, ANNU REV CLIN PSYCHO, V1, P293, DOI 10.1146/annurev.clinpsy.1.102803.143938
   Herva A, 2008, PSYCHIAT RES, V160, P263, DOI 10.1016/j.psychres.2007.07.020
   Hibbeln JR, 2007, LANCET, V369, P578, DOI 10.1016/S0140-6736(07)60277-3
   Hoek HW, 1996, AM J PSYCHIAT, V153, P1637
   Hollo O, 2002, ARCH PEDIAT ADOL MED, V156, P179, DOI 10.1001/archpedi.156.2.179
   Holmes MC, 2006, J NEUROSCI, V26, P3840, DOI 10.1523/JNEUROSCI.4464-05.2006
   Huijbregts SCJ, 2007, J ABNORM CHILD PSYCH, V35, P203, DOI 10.1007/s10802-006-9073-4
   Huizink AC, 2006, NEUROSCI BIOBEHAV R, V30, P24, DOI 10.1016/j.neubiorev.2005.04.005
   Hultman CM, 2007, J AM ACAD CHILD PSY, V46, P370, DOI 10.1097/01.chi.0000246059.62706.22
   Indredavik MS, 2007, ACTA PAEDIATR, V96, P377, DOI 10.1111/j.1651-2227.2006.00148.x
   Indredavik MS, 2005, EUR CHILD ADOLES PSY, V14, P226, DOI 10.1007/s00787-005-0459-6
   Indredavik MS, 2004, ARCH DIS CHILD, V89, pF445, DOI 10.1136/adc.2003.038943
   Jefferis BJMH, 2002, BRIT MED J, V325, P305, DOI 10.1136/bmj.325.7359.305
   Jensen PS, 1997, J AM ACAD CHILD PSY, V36, P1672, DOI 10.1097/00004583-199712000-00015
   Jones A, 2006, J CLIN ENDOCR METAB, V91, P1868, DOI 10.1210/jc.2005-2077
   Jones A, 2007, HYPERTENSION, V49, P548, DOI 10.1161/01.HYP.0000257196.13485.9b
   JONES P, 1994, LANCET, V344, P1398, DOI 10.1016/S0140-6736(94)90569-X
   Kagan J., 2004, LONG SHADOW TEMPERAM
   Kaku K, 2007, ACTA PAEDIATR, V96, P363, DOI 10.1111/j.1651-2227.2006.00120.x
   Kapoor A, 2005, J PHYSIOL-LONDON, V566, P967, DOI 10.1113/jphysiol.2005.090191
   Kelly YJ, 2001, INT J EPIDEMIOL, V30, P88, DOI 10.1093/ije/30.1.88
   Kelmanson IA, 2002, KLIN PADIATR, V214, P359, DOI 10.1055/s-2002-35369
   Keltikangas-Jarvinen L, 2007, PEDIATRICS, V120, P756, DOI 10.1542/peds.2007-0073
   Kendler KS, 2006, AM J PSYCHIAT, V163, P109, DOI 10.1176/appi.ajp.163.1.109
   Khashan AS, 2008, PSYCHOSOM MED, V70, P688, DOI 10.1097/PSY.0b013e318177940d
   Khashan AS, 2008, ARCH GEN PSYCHIAT, V65, P146, DOI 10.1001/archgenpsychiatry.2007.20
   Kinney DK, 2008, J AUTISM DEV DISORD, V38, P481, DOI 10.1007/s10803-007-0414-0
   Knopik VS, 2006, PSYCHOL MED, V36, P1461, DOI 10.1017/S0033291706007884
   KOVELMAN JA, 1986, ACTA NEUROL SCAND, V73, P1
   Lahti J, 2006, J CHILD PSYCHOL PSYC, V47, P1167, DOI 10.1111/j.1469-7610.2006.01661.x
   Lahti J, 2008, PSYCHIAT RES, V160, P167, DOI 10.1016/j.psychres.2007.07.016
   Langley K, 2008, AM J MED GENET B, V147B, P49, DOI 10.1002/ajmg.b.30571
   Leitner Y, 2007, J CHILD NEUROL, V22, P580, DOI 10.1177/0883073807302605
   Leonard H, 2008, AM J EPIDEMIOL, V167, P103, DOI 10.1093/aje/kwm245
   Levitt P, 2003, J PEDIATR-US, V143, pS35, DOI 10.1067/S0022-3476(03)00400-1
   Linnet KM, 2006, ARCH DIS CHILD, V91, P655, DOI 10.1136/adc.2005.088872
   Linnet KM, 2005, PEDIATRICS, V116, P462, DOI 10.1542/peds.2004-2054
   Linnet KM, 2003, AM J PSYCHIAT, V160, P1028, DOI 10.1176/appi.ajp.160.6.1028
   Lobel M, 2008, HEALTH PSYCHOL, V27, P604, DOI 10.1037/a0013242
   Lou HC, 1996, ACTA PAEDIATR, V85, P1266, DOI 10.1111/j.1651-2227.1996.tb13909.x
   LOU HC, 1994, DEV MED CHILD NEUROL, V36, P826
   Lunde A, 2007, AM J EPIDEMIOL, V165, P734, DOI 10.1093/aje/kwk107
   Lundgren EM, 2003, HORM RES, V59, P139, DOI 10.1159/000067850
   Lundgren EM, 2001, PEDIATR RES, V50, P91, DOI 10.1203/00006450-200107000-00017
   Mallard C, 2000, NEUROSCIENCE, V100, P327, DOI 10.1016/S0306-4522(00)00271-2
   Manjarrez G, 2005, J PEDIATR-US, V147, P592, DOI 10.1016/j.jpeds.2005.06.025
   Martinussen M, 2005, BRAIN, V128, P2588, DOI 10.1093/brain/awh610
   Matte TD, 2001, BRIT MED J, V323, P310, DOI 10.1136/bmj.323.7308.310
   Matthews SG, 2002, TRENDS ENDOCRIN MET, V13, P373, DOI 10.1016/S1043-2760(02)00690-2
   MATTHEWS SG, 2006, PERINATAL PROGRAMMIN, P61
   Maughan B, 2004, ARCH GEN PSYCHIAT, V61, P836, DOI 10.1001/archpsyc.61.8.836
   McCann D, 2007, LANCET, V370, P1560, DOI 10.1016/S0140-6736(07)61306-3
   McCormick MC, 1996, PEDIATRICS, V97, P18
   McEwen BS, 2003, MENT RETARD DEV D R, V9, P149, DOI 10.1002/mrdd.10074
   McLoyd VC, 1998, AM PSYCHOL, V53, P185, DOI 10.1037//0003-066X.53.2.185
   MEDNICK SA, 1988, ARCH GEN PSYCHIAT, V45, P189
   Mick E, 2002, J DEV BEHAV PEDIATR, V23, P16, DOI 10.1097/00004703-200202000-00004
   Mittendorfer-Rutz E, 2004, LANCET, V364, P1135, DOI 10.1016/S0140-6736(04)17099-2
   Mortensen EL, 2005, PAEDIATR PERINAT EP, V19, P4, DOI 10.1111/j.1365-3016.2004.00622.x
   Mueser KT, 2004, LANCET, V363, P2063, DOI 10.1016/S0140-6736(04)16458-1
   Myin-Germeys I, 2003, ACTA PSYCHIAT SCAND, V107, P124, DOI 10.1034/j.1600-0447.2003.02025.x
   Myin-Germeys I, 2007, CLIN PSYCHOL REV, V27, P409, DOI 10.1016/j.cpr.2006.09.005
   Neugebauer R, 1999, JAMA-J AM MED ASSOC, V282, P455, DOI 10.1001/jama.282.5.455
   Neuman RJ, 2007, BIOL PSYCHIAT, V61, P1320, DOI 10.1016/j.biopsych.2006.08.049
   Nigg JT, 2006, J CHILD PSYCHOL PSYC, V47, P395, DOI 10.1111/j.1469-7610.2006.01612.x
   Nilsson E, 2005, TWIN RES HUM GENET, V8, P402, DOI 10.1375/1832427054936727
   Nilsson PM, 2004, J EPIDEMIOL COMMUN H, V58, P571, DOI 10.1136/jech.2003.015495
   Nilsson PM, 2001, INT J EPIDEMIOL, V30, P75, DOI 10.1093/ije/30.1.75
   Nomura Y, 2008, J CHILD PSYCHOL PSYC, V49, P1108, DOI 10.1111/j.1469-7610.2008.01939.x
   O'Connor TG, 2002, BRIT J PSYCHIAT, V180, P502, DOI 10.1192/bjp.180.6.502
   O'Keeffe MJ, 2003, PEDIATRICS, V112, P301, DOI 10.1542/peds.112.2.301
   Ogendahl BK, 2006, PSYCHOL MED, V36, P1219, DOI 10.1017/S0033291706008269
   OLDS DL, 1994, PEDIATRICS, V93, P221
   Ong KK, 2004, DIABETES, V53, P1128, DOI 10.2337/diabetes.53.4.1128
   Osler M, 2005, BRIT J PSYCHIAT, V186, P400, DOI 10.1192/bjp.186.5.400
   Owen D, 2005, NEUROSCI BIOBEHAV R, V29, P209, DOI 10.1016/j.neubiorev.2004.10.004
   Parsons AG, 2008, BRIT J NUTR, V99, P1133, DOI 10.1017/S0007114507853359
   Pesonen AK, 2006, DEV PSYCHOBIOL, V48, P633, DOI 10.1002/dev.20153
   Phillips DIW, 2007, J INTERN MED, V261, P453, DOI 10.1111/j.1365-2796.2007.01801.x
   Phillips DIW, 2002, TRENDS ENDOCRIN MET, V13, P363, DOI 10.1016/S1043-2760(02)00696-3
   Pickett KE, 2008, J EPIDEMIOL COMMUN H, V62, P318, DOI 10.1136/jech.2006.058768
   POL HEH, 2000, AM J PSYCHIAT, V157, P1170
   PRYOR J, 1995, J PAEDIATR CHILD H, V31, P403, DOI 10.1111/j.1440-1754.1995.tb00847.x
   Raikkonen K, 2008, PSYCHOSOM MED, V70, P306, DOI 10.1097/PSY.0b013e3181651638
   Rees S, 2004, NEUROSCI LETT, V361, P111, DOI 10.1016/j.neulet.2004.02.002
   Rehn AE, 2004, NEUROSCIENCE, V129, P381, DOI 10.1016/j.neuroscience.2004.04.047
   Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.1289/ehp.00108s3511
   Rice F, 2007, ACTA PSYCHIAT SCAND, V115, P171, DOI 10.1111/j.1600-0447.2006.00895.x
   Richards M, 2001, BRIT MED J, V322, P199, DOI 10.1136/bmj.322.7280.199
   Robinson M, 2008, J CHILD PSYCHOL PSYC, V49, P1118, DOI 10.1111/j.1469-7610.2008.01955.x
   Robinson S, 2007, BRIT J NUTR, V98, P1029, DOI 10.1017/S0007114507750936
   Rodriguez A, 2005, J CHILD PSYCHOL PSYC, V46, P246, DOI 10.1111/j.1469-7610.2004.00359.x
   Rondo PHC, 2003, EUR J CLIN NUTR, V57, P266, DOI 10.1038/sj.ejcn.1601526
   Rose RJ, 2005, NEUROSCI BIOBEHAV R, V29, P321, DOI 10.1016/j.neubiorev.2004.12.001
   Rothbart M. K., 2006, HDB CHILD PSYCHOL, V6, P99, DOI DOI 10.1002/9780470147658.CHPSY0303
   Roza SJ, 2008, J AM ACAD CHILD PSY, V47, P264, DOI 10.1097/chi.0b013e318160b3df
   Rutter M, 2005, J AM ACAD CHILD PSY, V44, P3, DOI 10.1097/01.chi.0000145374.45992.c9
   Rutter M, 2004, DEV PSYCHOL, V40, P81, DOI 10.1037/0012-1649.40.1.81
   Rutter M., 1977, ECOLOGICAL FACTORS H, P173
   Salm AK, 2004, DEV BRAIN RES, V148, P159, DOI 10.1016/j.devbrainres.2003.11.005
   Sarkar P, 2008, J NEUROENDOCRINOL, V20, P489, DOI 10.1111/j.1365-2826.2008.01659.x
   Sayal K, 2007, PEDIATRICS, V119, pE426, DOI 10.1542/peds.2006-1840
   Schempf A, 2009, SOC SCI MED, V68, P100, DOI 10.1016/j.socscimed.2008.10.006
   SCHLOTZ W, 2007, LOWER MATERNAL UNPUB
   Schlotz W, 2008, J CHILD PSYCHOL PSYC, V49, P1228, DOI 10.1111/j.1469-7610.2008.01946.x
   Schlotz W, 2008, PSYCHOSOM MED, V70, P787, DOI 10.1097/PSY.0b013e3181810658
   Schlotz W, 2007, PEDIATRICS, V120, pE1237, DOI 10.1542/peds.2006-3277
   Schmitz M, 2006, J AM ACAD CHILD PSY, V45, P1338, DOI 10.1097/01.chi.0000235076.25038.81
   Schulz P, 2005, DIAGNOSTICA, V51, P124, DOI 10.1026/0012-1924.51.3.124
   Selten JP, 1999, SCHIZOPHR RES, V35, P243, DOI 10.1016/S0920-9964(98)00143-1
   Sengupta SM, 2006, J AM ACAD CHILD PSY, V45, P1363, DOI 10.1097/01.chi.0000235074.86919.dc
   Shenkin SD, 2001, ARCH DIS CHILD, V85, P189, DOI 10.1136/adc.85.3.189
   Shenkin SD, 2004, PSYCHOL BULL, V130, P989, DOI 10.1037/0033-2909.130.6.989
   Singer LT, 2004, JAMA-J AM MED ASSOC, V291, P2448, DOI 10.1001/jama.291.20.2448
   Sommerfelt K, 2001, EARLY HUM DEV, V65, P107, DOI 10.1016/S0378-3782(01)00200-6
   Sood B, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.2.e34
   Sorensen HT, 1997, BRIT MED J, V315, P401, DOI 10.1136/bmj.315.7105.401
   St Clair D, 2005, JAMA-J AM MED ASSOC, V294, P557, DOI 10.1001/jama.294.5.557
   STREISSGUTH AP, 1990, ALCOHOL CLIN EXP RES, V14, P662, DOI 10.1111/j.1530-0277.1990.tb01224.x
   STREISSGUTH AP, 1991, JAMA-J AM MED ASSOC, V265, P1961, DOI 10.1001/jama.265.15.1961
   Susser E, 1996, ARCH GEN PSYCHIAT, V53, P25
   SUSSER ES, 1992, ARCH GEN PSYCHIAT, V49, P983
   Suvisaari J, 1999, AM J PSYCHIAT, V156, P1100
   Talge NM, 2007, J CHILD PSYCHOL PSYC, V48, P245, DOI 10.1111/j.1469-7610.2007.01714.x
   Thapar A, 2005, ARCH GEN PSYCHIAT, V62, P1275, DOI 10.1001/archpsyc.62.11.1275
   Thapar A, 2003, AM J PSYCHIAT, V160, P1985, DOI 10.1176/appi.ajp.160.11.1985
   Thapar A, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-25
   Thompson C, 2001, BRIT J PSYCHIAT, V179, P450, DOI 10.1192/bjp.179.5.450
   Tully LA, 2004, J CONSULT CLIN PSYCH, V72, P218, DOI 10.1037/0022-006X.72.2.218
   Vallee M, 1997, J NEUROSCI, V17, P2626
   Van Den Bergh BRH, 2006, PEDIATR RES, V59, P78, DOI 10.1203/01.pdr.0000191143.75673.52
   Van den Bergh BRH, 2005, NEUROSCI BIOBEHAV R, V29, P259, DOI 10.1016/j.neubiorev.2004.10.010
   Van den Bergh BRH, 2005, NEUROSCI BIOBEHAV R, V29, P237, DOI 10.1016/j.neubiorev.2004.10.007
   Van den Bergh BRH, 2004, CHILD DEV, V75, P1085, DOI 10.1111/j.1467-8624.2004.00727.x
   Van Den Hove DLA, 2006, NEUROSCIENCE, V137, P145, DOI 10.1016/j.neuroscience.2005.08.060
   van Os J, 1998, BRIT J PSYCHIAT, V172, P324, DOI 10.1192/bjp.172.4.324
   van Os J, 2001, BIOL PSYCHIAT, V50, P593, DOI 10.1016/S0006-3223(01)01085-X
   Wadhwa PD, 2005, PSYCHONEUROENDOCRINO, V30, P724, DOI 10.1016/j.psyneuen.2005.02.004
   Wahlbeck K, 2001, ARCH GEN PSYCHIAT, V58, P48, DOI 10.1001/archpsyc.58.1.48
   Wakschlag LS, 2006, J AM ACAD CHILD PSY, V45, P461, DOI 10.1097/01.chi.0000198597.53572.3e
   Ward AMV, 2004, J HYPERTENS, V22, P2295, DOI 10.1097/00004872-200412000-00011
   WATSON D, 1984, PSYCHOL BULL, V96, P465, DOI 10.1037/0033-2909.96.3.465
   Watson JB, 1999, DEV PSYCHOPATHOL, V11, P457, DOI 10.1017/S0954579499002151
   Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276
   Weinstock M, 2005, BRAIN BEHAV IMMUN, V19, P296, DOI 10.1016/j.bbi.2004.09.006
   Weissman MM, 1999, J AM ACAD CHILD PSY, V38, P892, DOI 10.1097/00004583-199907000-00020
   Westendorp RGJ, 1998, NATURE, V396, P743, DOI 10.1038/25519
   Wichers MC, 2002, PSYCHOL MED, V32, P1165, DOI 10.1017/S0033291702006372
   Wiles NJ, 2009, EUR J CLIN NUTR, V63, P491, DOI 10.1038/sj.ejcn.1602967
   Wiles NJ, 2006, AM J EPIDEMIOL, V163, P829, DOI 10.1093/aje/kwj108
   Wiles NJ, 2005, BRIT J PSYCHIAT, V187, P21, DOI 10.1192/bjp.187.1.21
   Worthman CM, 2005, AM J HUM BIOL, V17, P95, DOI 10.1002/ajhb.20096
   Wust S, 2005, PSYCHONEUROENDOCRINO, V30, P591, DOI 10.1016/j.psyneuen.2005.01.008
   Zhou SJ, 2006, AM J CLIN NUTR, V83, P1112
   Zubrick SR, 2000, DEV MED CHILD NEUROL, V42, P14, DOI 10.1017/S0012162200000049
NR 231
TC 197
Z9 199
U1 3
U2 64
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0889-1591
J9 BRAIN BEHAV IMMUN
JI Brain Behav. Immun.
PD OCT
PY 2009
VL 23
IS 7
BP 905
EP 916
DI 10.1016/j.bbi.2009.02.001
PG 12
WC Immunology; Neurosciences; Psychiatry
SC Immunology; Neurosciences & Neurology; Psychiatry
GA 540PV
UT WOS:000273348600005
PM 19217937
DA 2019-01-08
ER

PT J
AU Coffey, L
   Gallagher, P
   Horgan, O
   Desmond, D
   MacLachlan, M
AF Coffey, L.
   Gallagher, P.
   Horgan, O.
   Desmond, D.
   MacLachlan, M.
TI Psychosocial adjustment to diabetes-related lower limb amputation
SO DIABETIC MEDICINE
LA English
DT Article
DE amputation; body image; diabetes; psychosocial adjustment
ID DEPRESSION SCALE; ANXIETY; PEOPLE; DISABILITY; ILLNESS
AB Aim
   To examine psychosocial adjustment in persons with lower limb amputations related to diabetes.
   Methods
   Thirty-eight participants with diabetes-related lower limb amputations, recruited from two limb-fitting centres, completed three psychological self-report assessments: the Trinity Amputation and Prosthesis Experience Scales (TAPES); the Hospital Anxiety and Depression Scale (HADS); and the Amputation Body Image Scale-Revised (ABIS-R).
   Results
   Over 18% of participants scored above the normal range (> 8) for depression on the HADS and 18.5% scored above the normal range for anxiety. Both depression (rho = 0.75, P < 0.01) and anxiety (rho = 0.62, P < 0.01) scores were significantly associated with body image disturbance, as measured using the ABIS-R. Significant relationships were also observed between body image disturbance and three TAPES subscales measuring psychosocial adjustment [general adjustment (rho = -0.48, P < 0.01), social adjustment (rho = -0.51, P < 0.01), adjustment to limitations (rho = -0.45, P < 0.05)].
   Conclusions
   Individuals with diabetes-related amputations may be at elevated risk for psychological distress as a result of their co-morbid medical condition. Regular screening for anxiety and depression and the provision of appropriate follow-up care may therefore be advisable in this population.
C1 [Coffey, L.; Gallagher, P.] Dublin City Univ, Sch Nursing, Fac Sci & Hlth, Dublin 9, Ireland.
   [Coffey, L.; Gallagher, P.; Horgan, O.; Desmond, D.; MacLachlan, M.] Dublin Psychoprosthet Grp, Dublin, Ireland.
   [Horgan, O.] Deeside Community Hosp, Community Mental Hlth Team, Deeside, Flint, Wales.
   [Desmond, D.] Natl Univ Ireland Maynooth, Dept Psychol, Maynooth, Kildare, Ireland.
   [MacLachlan, M.] Univ Dublin, Trinity Coll, Sch Psychol, Dublin, Ireland.
RP Gallagher, P (reprint author), Dublin City Univ, Sch Nursing, Fac Sci & Hlth, Dublin 9, Ireland.
EM pamela.gallagher@dcu.ie
RI Coffey, Laura/N-1783-2015; Desmond, Deirdre/P-5625-2015
OI Coffey, Laura/0000-0001-5946-377X; Desmond, Deirdre/0000-0002-6746-7006
CR Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001
   Canavan RJ, 2008, DIABETES CARE, V31, P459, DOI 10.2337/dc07-1159
   Carrington AL, 1996, DIABETES RES CLIN PR, V32, P19, DOI 10.1016/0168-8227(96)01198-9
   Crawford JR, 2001, BRIT J CLIN PSYCHOL, V40, P429, DOI 10.1348/014466501163904
   DEROGATIS LR, 1986, J PSYCHOSOM RES, V30, P77, DOI 10.1016/0022-3999(86)90069-3
   Fisher K, 1998, BRIT MED J, V316, P903, DOI 10.1136/bmj.316.7135.903
   Fletcher DD, 2001, ARCH PHYS MED REHAB, V82, P776, DOI 10.1053/apmr.2001.21856
   Fosse S, 2009, DIABETIC MED, V26, P391, DOI 10.1111/j.1464-5491.2009.02698.x
   Gallagher P, 2000, REHABIL PSYCHOL, V45, P130, DOI 10.1037//0090-5550.45.2.130
   Gallagher P, 2007, AM J PHYS MED REHAB, V86, P205, DOI 10.1097/PHM.0b013e3180321439
   Horgan O, 2004, DISABIL REHABIL, V26, P837, DOI 10.1080/09638280410001708869
   Li C, 2008, DIABETIC MED, V25, P878
   Peters EJG, 2001, DIABETES CARE, V24, P1799, DOI 10.2337/diacare.24.10.1799
   Singh R, 2007, CLIN REHABIL, V21, P754, DOI 10.1177/0269215507077361
   Singh Rajiv, 2008, Diabetes Res Clin Pract, V80, pe14, DOI 10.1016/j.diabres.2008.02.015
   Turner RC, 1998, LANCET, V352, P837
   Van Damme Hendrik, 2007, Clin Podiatr Med Surg, V24, P569, DOI 10.1016/j.cpm.2007.03.007
   Williamson GM, 1998, REHABIL PSYCHOL, V43, P327
   WILLIAMSON GM, 1994, J SOC BEHAV PERS, V9, P249
   Williamson GM, 1995, J CLIN GEROPSYCHOLOG, V1, P229
   Willrich A, 2005, FOOT ANKLE INT, V26, P128, DOI 10.1177/107110070502600203
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
   ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63
NR 24
TC 34
Z9 34
U1 0
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD OCT
PY 2009
VL 26
IS 10
BP 1063
EP 1067
DI 10.1111/j.1464-5491.2009.02802.x
PG 5
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 498ZQ
UT WOS:000270186100016
PM 19900240
DA 2019-01-08
ER

PT J
AU Kokoszka, A
   Pouwer, F
   Jodko, A
   Radzio, R
   Mucko, P
   Bienkowska, J
   Kuligowska, E
   Smoczynska, O
   Sklodowska, Z
AF Kokoszka, A.
   Pouwer, F.
   Jodko, A.
   Radzio, R.
   Mucko, P.
   Bienkowska, J.
   Kuligowska, E.
   Smoczynska, O.
   Sklodowska, Z.
TI Serious diabetes-specific emotional problems in patients with type 2
   diabetes who have different levels of comorbid depression: A Polish
   study from the European Depression in Diabetes (EDID) Research
   Consortium
SO EUROPEAN PSYCHIATRY
LA English
DT Article
DE Type 2 diabetes; Depression; Emotional distress; Anxiety; Glycaemic
   control
ID GLYCEMIC CONTROL; FOOT ULCER; DISTRESS; MOOD; METAANALYSIS; OUTPATIENTS;
   DISORDERS; SYMPTOMS; MELLITUS; VALIDITY
AB Objective: Depression is a common psychiatric problem in patients with type 2 diabetes (DM2). A common view is that the burden of having DM2 contributes to the development of depression in DM2. Aim of the present study was to compare the levels of diabetes-specific emotional problems of DM2 patients with diagnosed depression with those with a subclinical form of depression and those without depression.
   Methods: A cross-sectional study was conducted in 101 DM2 patients (51 men and 50 women, mean age = 63,17; SD = 10,74) who completed a standardized, structured psychiatric diagnostic interview (MINI), the Beck Depression Inventory, the Hamilton Depression Rating Scale as well as the Problem Areas in Diabetes (PAID) scale (a 20-item measure, with an overall scale measuring diabetes-related emotional distress and four subscales [negative emotions, treatment-related problems, food-related problems, lack of social Support]).
   Results: A depression diagnosis was made in 35% (n = 35) of the participants, 24% (n = 24) had a subclinical form of depression, 42% (n = 42) were not diagnosed with any kind of depressive disorder. Diabetes-specific emotional problems were most common in DM2 patients with a depressive disorder (significantly highest PAID score: 39) compared to patients with subclinical depression or no depression. In the group of non-depressed patients, only 14% agreed to have four or more (somewhat) serious diabetes-specific problems. In those with subclinical depression, this percentage was 42% and in those with a depressive disorder 49% (P < 0.001).
   Conclusions: Diabetes-related emotional problems are particularly common among DM2 patients with comorbid clinical depression and to a lesser extent in patients with subclinical depression, compared to non-depressed DM2 patients. Male diabetes patients with a depressive disorder are particularly vulnerable to develop high levels of diabetes-specific emotional distress. Major differences between the three groups mainly concern the diabetes-specific problems connected with the illness. (C) 2009 Elsevier Masson SAS. All rights reserved.
C1 [Kokoszka, A.; Pouwer, F.] Med Univ Warsaw, Dept Psychiat 2, PL-03242 Warsaw, Poland.
   [Pouwer, F.; Bienkowska, J.; Kuligowska, E.; Smoczynska, O.] Tilburg Univ, Ctr Res Psychol Somatic Dis CoRPS, NL-5000 LE Tilburg, Netherlands.
   [Jodko, A.] Warsaw Sch Social Psychol, Warsaw, Poland.
   [Radzio, R.] Nowowiejski Hosp, Psychotherapy Ctr, Warsaw, Poland.
   [Mucko, P.] Med Univ Warsaw, Dept Med Psychol, PL-03242 Warsaw, Poland.
   [Sklodowska, Z.] Diabet Outpatients Clin, Warsaw, Poland.
RP Kokoszka, A (reprint author), Med Univ Warsaw, Dept Psychiat 2, Ul Kondratowicza 8, PL-03242 Warsaw, Poland.
EM Andrzej.Kokoszka@wum.edu.pl
RI Kokoszka, Andrzej/O-7454-2018
OI Kokoszka, Andrzej/0000-0003-4518-5494
CR Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x
   BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561
   Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278
   Cuijpers P, 2004, ACTA PSYCHIAT SCAND, V109, P325, DOI 10.1111/j.1600-0447.2004.00301.x
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   HAMILTON M, 1967, BRIT J SOC CLIN PSYC, V6, P278
   HAMILTON M., 1960, J NEUROL NEUROSUR PS, V23, P53
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   Ismail K, 2007, DIABETES CARE, V30, P1473, DOI 10.2337/dc06-2313
   Jacobson AM, 1997, QUAL LIFE RES, V6, P11
   Lustman PJ, 2005, J DIABETES COMPLICAT, V19, P113, DOI 10.1016/j.jdiacomp.2004.01.002
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Masiak M, 2002, INT NEUROPSYCHIATRIC
   Parnowski T, 1977, Psychiatr Pol, V11, P417
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Pouwer F, 2006, PATIENT EDUC COUNS, V60, P235, DOI 10.1016/j.pec.2005.01.009
   Pouwer F, 2005, DIABETES RES CLIN PR, V70, P166, DOI 10.1016/j.diabres.2005.03.031
   Pouwer F, 2001, DIABETES CARE, V24, P1929, DOI 10.2337/diacare.24.11.1929
   PUZYNSKI S, 2002, PSYCHIATRIA, V1, P435
   Sheehan DV, 1997, EUR PSYCHIAT, V12, P232, DOI 10.1016/S0924-9338(97)83297-X
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Tylee A, 2007, J CLIN PSYCHIAT, V68, P27
   Winkley K, 2007, J DIABETES COMPLICAT, V21, P341, DOI 10.1016/j.jdiacomp.2007.09.004
NR 24
TC 29
Z9 29
U1 0
U2 11
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 0924-9338
J9 EUR PSYCHIAT
JI Eur. Psychiat.
PD OCT
PY 2009
VL 24
IS 7
BP 425
EP 430
DI 10.1016/j.eurpsy.2009.04.002
PG 6
WC Psychiatry
SC Psychiatry
GA 513CV
UT WOS:000271300800001
PM 19541457
DA 2019-01-08
ER

PT J
AU Sigurdardottir, AK
   Benediktsson, R
   Jonsdottir, H
AF Sigurdardottir, Arun K.
   Benediktsson, Rafn
   Jonsdottir, Helga
TI Instruments to tailor care of people with type 2 diabetes
SO JOURNAL OF ADVANCED NURSING
LA English
DT Article
DE empowerment randomized controlled trial; nursing; tailored diabetes
   care; type 2 diabetes; use of instruments
ID SELF-MANAGEMENT EDUCATION; RANDOMIZED CONTROLLED-TRIAL; NURSE FOLLOW-UP;
   GLYCEMIC CONTROL; ADULTS; EMPOWERMENT; RELIABILITY; KNOWLEDGE; VALIDITY;
   SCALE
AB P>Title.
   Instruments to tailor care of people with type 2 diabetes.
   Aim.
   This paper is a report of a study conducted to assess the effectiveness of an educational intervention for people with type 2 diabetes based on self-completed instruments to identify particular areas of self-care needs.
   Background.
   Diabetes is a demanding disease which requires self-care. Instruments that identify self-care needs or factors affecting self-care can be helpful to detect level of self-care, distress or knowledge among individuals with diabetes.
   Methods.
   Participants were randomized into intervention (n = 28) or control groups (n = 25). Both groups answered five validated instruments three times, at baseline and after 3 and 6 months, and biological measurements were conducted simultaneously. The intervention was based on an empowerment approach. The study started in November 2005 and lasted until March 2007.
   Findings.
   There was no statistically significant difference between groups in level of glycated haemoglobin postintervention as it reduced statistically significantly in both groups between baseline and 3 months but increased again after 6 months. There was no statistically significant difference between groups in body mass index reduction; the intervention group achieved a statistically significant body mass index reduction but this was unchanged in the control group. No statistically significant differences between groups were found in scores for empowerment, well-being and distress. There was a statistically significant difference between groups in knowledge postintervention.
   Conclusion.
   Use of instruments to identify self-care needs can enable patient-tailored care as it allows direct focusing on issues that are challenging and of relevance for each individual. It seems to be feasible to use the telephone to conduct an empowering educational intervention after one meeting.
C1 [Sigurdardottir, Arun K.] Univ Akureyri, Fac Hlth Sci, Akureyri, Iceland.
   [Benediktsson, Rafn] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland.
   [Jonsdottir, Helga] Univ Iceland, Fac Nursing, IS-101 Reykjavik, Iceland.
RP Sigurdardottir, AK (reprint author), Univ Akureyri, Fac Hlth Sci, Akureyri, Iceland.
EM arun@uank.is
RI Albertin, Paloma/X-1093-2018
OI Benediktsson, Rafn/0000-0002-2954-9801
FU University of Akureyri, Iceland; Icelandic Nursing Association
FX Research funds from the University of Akureyri, Iceland and from the
   Icelandic Nursing Association are acknowledged (no grant number
   provided).
CR ANDERSON R, 2000, ART EMPOWERMENT STOR, P1539
   ANDERSON RM, 1995, DIABETES CARE, V18, P943, DOI 10.2337/diacare.18.7.943
   Anderson RM, 2000, DIABETES CARE, V23, P739, DOI 10.2337/diacare.23.6.739
   BANDURA A, 1986, SOCIAL FDN THOUGHTS
   Bowling A., 2005, HDB HLTH RES METHODS, P394
   Bradshaw JS, 2000, SUPRAMOL CHEM, V12, P23, DOI 10.1080/10610270008029802
   Brown SA, 2005, DIABETES CARE, V28, P527, DOI 10.2337/diacare.28.3.527
   Bruttomesso D, 2003, PATIENT EDUC COUNS, V51, P29, DOI 10.1016/S0738-3991(02)00226-4
   Chodosh J, 2005, ANN INTERN MED, V143, P427, DOI 10.7326/0003-4819-143-6-200509200-00007
   COATES VE, 1999, ED PATIENT CLIENT
   Deakin TA, 2006, DIABETIC MED, V23, P944, DOI 10.1111/j.1464-5491.2006.01906.x
   Despres JP, 2001, BMJ-BRIT MED J, V322, P716, DOI 10.1136/bmj.322.7288.716
   Eckel RH, 1998, CIRCULATION, V97, P2099, DOI 10.1161/01.CIR.97.21.2099
   Fitzgerald JT, 1998, DIABETES CARE, V21, P706, DOI 10.2337/diacare.21.5.706
   Funnell MM, 2008, DIABETES CARE, V31, pS97, DOI 10.2337/dc08-S097
   Goudswaard AN, 2004, DIABETIC MED, V21, P491, DOI 10.1111/j.1464-5491.2004.01153.x
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   Home P, 2006, DIABETIC MED, V23, P579
   Hu G, 2005, DIABETES CARE, V28, P799, DOI 10.2337/diacare.28.4.799
   Knight KM, 2006, DIABETIC MED, V23, P485, DOI 10.1111/j.1464-5491.2005.01802.x
   KULZER B, 2007, DIABETIC MED, V24, P424
   Lauver DR, 2002, RES NURS HEALTH, V25, P246, DOI 10.1002/nur.10044
   Lipsey M.W., 1990, DESIGN SENSITIVITY
   Murata GH, 2003, DIABETOLOGIA, V46, P1170, DOI 10.1007/s00125-003-1161-1
   Nagelkerk J, 2006, J ADV NURS, V54, P151, DOI 10.1111/j.1365-2648.2006.03799.x
   Nathan DM, 1998, LANCET, V352, P832, DOI 10.1016/S0140-6736(98)22937-0
   Norris SL, 2002, DIABETES CARE, V25, P1159, DOI 10.2337/diacare.25.7.1159
   Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561
   Piette JD, 2000, AM J MED, V108, P20, DOI 10.1016/S0002-9343(99)00298-3
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Pouwer F, 1999, DIABETES CARE, V22, P2004, DOI 10.2337/diacare.22.12.2004
   Pouwer F, 2001, DIABETES CARE, V24, P1929, DOI 10.2337/diacare.24.11.1929
   Sarkar U, 2006, DIABETES CARE, V29, P823, DOI 10.2337/diacare.29.04.06.dc05-1615
   SHAW K, 2007, COCHRANE DATABASE SY, V2
   Siebolds M, 2006, PATIENT EDUC COUNS, V62, P104, DOI 10.1016/j.pec.2005.06.013
   Sigurdardottir AK, 2008, INT J NURS STUD, V45, P526, DOI 10.1016/j.ijnurstu.2006.10.008
   Sigurdardottir AK, 2008, SCAND J CARING SCI, V22, P284, DOI 10.1111/j.1471-6712.2007.00506.x
   Sigurdardottir AK, 2007, PATIENT EDUC COUNS, V67, P21, DOI 10.1016/j.pec.2007.03.007
   Thompson D., 2007, COCHRANE LIB, P1
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Trento M, 2002, DIABETOLOGIA, V45, P1231, DOI 10.1007/s00125-002-0904-8
   Weinger K, 2005, DIABETES CARE, V28, P1346, DOI 10.2337/diacare.28.6.1346
   Welch G, 2003, DIABETIC MED, V20, P69, DOI 10.1046/j.1464-5491.2003.00832.x
   Wong FKY, 2005, J ADV NURS, V50, P391, DOI 10.1111/j.1365-2648.2005.03404.x
NR 44
TC 13
Z9 14
U1 0
U2 6
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0309-2402
J9 J ADV NURS
JI J. Adv. Nurs.
PD OCT
PY 2009
VL 65
IS 10
BP 2118
EP 2130
DI 10.1111/j.1365-2648.2009.05040.x
PG 13
WC Nursing
SC Nursing
GA 493NG
UT WOS:000269743200013
PM 19674176
DA 2019-01-08
ER

PT J
AU Kogan, SA
   Brody, GH
   Chen, YF
AF Kogan, Steven A.
   Brody, Gene H.
   Chen, Yi-fu
TI Depressive symptomatology mediates the effect of socioeconomic
   disadvantage on HbA(1c) among rural African Americans with type 2
   diabetes
SO JOURNAL OF PSYCHOSOMATIC RESEARCH
LA English
DT Article
DE African Americans; Depression; Diabetes mellitus type 2; Glycemic
   control; Poverty areas; Rural environments
ID NUTRITION EXAMINATION SURVEY; CARDIOVASCULAR-DISEASE RISK; GLYCEMIC
   CONTROL; SELF-CARE; NEIGHBORHOOD DEPRIVATION; EDUCATIONAL STATUS;
   PHYSICAL-ACTIVITY; NATIONAL-HEALTH; WOMEN; ADULTS
AB Objective: Rural African Americans with diabetes mellitus type 2 (T2D) represent a disadvantaged and understudied group who experience difficulties with maintaining glycemic control. Although mounting evidence has linked socioeconomic disadvantage to chronic disease morbidity, few studies have examined the mediating mechanisms that account for this effect. We hypothesized that rural African Americans' financial distress, community disadvantage, and educational attainment would predict glycemic control, indirectly, via effects on depressive symptoms. Methods: Predictions were tested using data from 192 rural African American adults with T2D and data from community support persons the participants nominated. Participants completed an in-home interview and provided a blood sample at a local laboratory. Levels of glycosylated hemoglobin (HbA(1c)) constituted the criterion variable. Results: Structural equation modeling analyses confirmed our hypotheses: financial distress, community disadvantage, and educational attainment demonstrated significant indirect effects on HbA(1c) via their influence on depressive symptoms. Conclusions: The findings underscore the importance of targeting mental health in interventions to support glycemic control as well as tailoring interventions for individuals in difficult socioeconomic circumstances. (C) 2009 Elsevier Inc. All tights reserved.
C1 [Kogan, Steven A.; Brody, Gene H.; Chen, Yi-fu] Univ Georgia, Athens, GA 30602 USA.
RP Kogan, SA (reprint author), 1095 Coll Stn Rd, Athens, GA 30602 USA.
EM smkogan@uga.edu
FU Centers for Disease Control and Prevention
FX This research was supported by a grant from the Centers for Disease
   Control and Prevention. We want to acknowledge Ms. Eileen Neubaum-Carlan
   for her assistance and helpful comments during the preparation of the
   manuscript.
CR Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Arbuckle J. L., 2003, AMOS 5 0 UPDATE AMOS
   BENTLER PM, 1985, THEORY IMPLEMENTATIO
   Booth GL, 2003, ARCH INTERN MED, V163, P101, DOI 10.1001/archinte.163.1.101
   Borrell LN, 2006, AM J PUBLIC HEALTH, V96, P1637, DOI 10.2105/AJPH.2005.072884
   Brody GH, 1997, DEV PSYCHOL, V33, P1000, DOI 10.1037//0012-1649.33.6.1000
   BRODY GH, 2001, DIABETES ED, V27, P17
   Ciechanowski PS, 2003, GEN HOSP PSYCHIAT, V25, P246, DOI 10.1016/S0163-8343(03)00055-0
   Cohen DA, 2003, AM J PUBLIC HEALTH, V93, P467, DOI 10.2105/AJPH.93.3.467
   Cowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062
   Cubbin C, 2006, SCAND J PUBLIC HEALT, V34, P228, DOI 10.1080/14034940500327935
   Cubbin Catherine, 2001, Ethnicity and Disease, V11, P687
   Cutrona CE, 2006, CURR DIR PSYCHOL SCI, V15, P188, DOI 10.1111/j.1467-8721.2006.00433.x
   Cutrona CE, 2000, J PERS SOC PSYCHOL, V79, P1088, DOI 10.1037//0022-3514.79.6.1088
   de Groot M, 2003, ANN BEHAV MED, V25, P172, DOI 10.1207/S15324796ABM2503_03
   Deshpande AD, 2005, DIABETES CARE, V28, P1012, DOI 10.2337/diacare.28.5.1012
   Fisher EB, 2005, AM J PUBLIC HEALTH, V95, P1523, DOI 10.2105/AJPH.2005.066084
   Fryers T, 2003, SOC PSYCH PSYCH EPID, V38, P229, DOI 10.1007/s00127-003-0627-2
   Goldstein DE, 2004, DIABETES CARE, V27, P1761, DOI 10.2337/diacare.27.7.1761
   Hargreaves MK, 2002, ETHNIC HEALTH, V7, P133, DOI 10.1080/1355785022000041980
   Harris MI, 1999, DIABETES CARE, V22, P403, DOI 10.2337/diacare.22.3.403
   Hartley D, 2004, AM J PUBLIC HEALTH, V94, P1675, DOI 10.2105/AJPH.94.10.1675
   Heisler M, 2007, ARCH INTERN MED, V167, P1853, DOI 10.1001/archinte.167.17.1853
   Hendrickx H, 2005, NEUROBIOL AGING, V26, pS1, DOI 10.1016/j.neurobiolaging.2005.10.005
   Hill-Briggs F, 2002, J GEN INTERN MED, V17, P412, DOI 10.1046/j.1525-1497.2002.11002.x
   Holben David H, 2006, Prev Chronic Dis, V3, pA82
   Jackson JE, 2005, J RURAL HEALTH, V21, P140, DOI 10.1111/j.1748-0361.2005.tb00074.x
   Kogan SM, 2007, ETHNIC DIS, V17, P106
   Konen J C, 1999, Ethn Health, V4, P39
   Little RR, 2003, CLIN CHEM LAB MED, V41, P1191, DOI 10.1515/CCLM.2003.183
   *LOW MS DELT NUTR, 2004, J HEALTH CARE POOR U, V15, P645
   Lustman PJ, 2005, J DIABETES COMPLICAT, V19, P113, DOI 10.1016/j.jdiacomp.2004.01.002
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   MacKinnon DP, 2002, PSYCHOL METHODS, V7, P83, DOI 10.1037//1082-989X.7.1.83
   Mainous AG, 2004, ANN FAM MED, V2, P563, DOI 10.1370/afm.119
   McKellar JD, 2004, DIABETES EDUCATOR, V30, P485, DOI 10.1177/014572170403000320
   MCLAUGHLIN DK, 1988, RURAL SOCIOL, V53, P287
   Mobley LR, 2006, AM J PREV MED, V30, P327, DOI 10.1016/j.amepre.2005.12.001
   Murry VM, 2004, J MARITAL FAM THER, V30, P271, DOI 10.1111/j.1752-0606.2004.tb01240.x
   Musselman DL, 2003, BIOL PSYCHIAT, V54, P317, DOI 10.1016/S0006-3223(03)00569-9
   Nilsson PM, 1998, DIABETIC MED, V15, P213, DOI 10.1002/(SICI)1096-9136(199803)15:3<213::AID-DIA569>3.3.CO;2-R
   Norris SL, 2002, DIABETES CARE, V25, P1159, DOI 10.2337/diacare.25.7.1159
   PROBST JC, 2002, MINORITIES RURAL AM
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Ramsey PW, 2002, SOUTH MED J, V95, P666, DOI 10.1097/00007611-200295070-00002
   Rhee MK, 2005, J HEALTH CARE POOR U, V16, P734
   Robbins JM, 2001, AM J PUBLIC HEALTH, V91, P76
   Ross CE, 2000, J HEALTH SOC BEHAV, V41, P177, DOI 10.2307/2676304
   Rothman RL, 2004, JAMA-J AM MED ASSOC, V292, P1711, DOI 10.1001/jama.292.14.1711
   Rubin Richard R, 2004, Curr Diab Rep, V4, P119, DOI 10.1007/s11892-004-0067-8
   Schootman M, 2006, AM J EPIDEMIOL, V163, P450, DOI 10.1093/aje/kwj054
   Shavers-Hornaday V L, 1997, Ethn Health, V2, P31
   Shaw BA, 2006, J COMMUN HEALTH, V31, P393, DOI 10.1007/s10900-006-9018-4
   Simmons LA, 2008, J RURAL HEALTH, V24, P292, DOI 10.1111/j.1748-0361.2008.00171.x
   Simons RL, 2002, J MARRIAGE FAM, V64, P331, DOI 10.1111/j.1741-3737.2002.00331.x
   Stafford M, 2003, INT J EPIDEMIOL, V32, P357, DOI 10.1093/ije/dyg084
   Steenland K, 2002, AM J EPIDEMIOL, V156, P11, DOI 10.1093/aje/kwf001
   Turrell G, 2002, J HUM NUTR DIET, V15, P355, DOI 10.1046/j.1365-277X.2002.00384.x
   Wachtel MS, 2005, J NATL MED ASSOC, V97, P334
   Wilder RP, 2003, DIABETES CARE, V26, P1650, DOI 10.2337/diacare.26.5.1650
   Williams DR, 2001, PUBLIC HEALTH REP, V116, P404, DOI 10.1093/phr/116.5.404
   Williams LK, 2007, J ALLERGY CLIN IMMUN, V119, P168, DOI 10.1016/j.jaci.2006.09.029
   Wilson DK, 2004, ANN BEHAV MED, V28, P20, DOI 10.1207/s15324796abm2801_4
NR 63
TC 10
Z9 10
U1 0
U2 10
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0022-3999
EI 1879-1360
J9 J PSYCHOSOM RES
JI J. Psychosomat. Res.
PD OCT
PY 2009
VL 67
IS 4
BP 289
EP 296
DI 10.1016/j.jpsychores.2009.01.016
PG 8
WC Psychiatry
SC Psychiatry
GA 503VA
UT WOS:000270567700003
PM 19773021
DA 2019-01-08
ER

PT J
AU Amsberg, S
   Anderbro, T
   Wredling, R
   Lisspers, J
   Lins, PE
   Adamson, U
   Johansson, UB
AF Amsberg, Susanne
   Anderbro, Therese
   Wredling, Regina
   Lisspers, Jan
   Lins, Per-Eric
   Adamson, Ulf
   Johansson, Unn-Britt
TI A cognitive behavior therapy-based intervention among poorly controlled
   adult type 1 diabetes patients-A randomized controlled trial
SO PATIENT EDUCATION AND COUNSELING
LA English
DT Article
DE Type 1 diabetes; Behavior modification; Cognitive behavior therapy;
   Continuous glucose monitoring system
ID GROUP TRAINING CBGT; GLYCEMIC CONTROL; SELF-CARE; METABOLIC-CONTROL;
   MANAGEMENT; EDUCATION; HYPOGLYCEMIA; DEPRESSION; SCALE; COMPLICATIONS
AB Objective: To examine the impact of a Cognitive Behavior Therapy (CBT)-based intervention on Hba(1c), self-care behaviors and psychosocial factors among poorly controlled adult type 1 diabetes patients.
   Methods: Ninety-four type 1 diabetes patients were randomly assigned to either an intervention group or a control group. The intervention was based on CBT and was mainly delivered in group format, but individual sessions were also included. All subjects were provided with a continuous glucose monitoring system (CGMS) during two 3-day periods. HbA(1c), self-care behaviors and psychosocial factors were measured up to 48 weeks.
   Results: Significant differences were observed with respect to HbA(1c), (P < 0.05), well-being (P < 0.05), diabetes-related distress (P < 0.01), frequency of blood glucose testing (P < 0.05), avoidance of hypoglycemia (P < 0.01), perceived stress (P < 0.05), anxiety (P < 0.05) and depression (P < 0.05), all of which showed greater improvement in the intervention group compared with the control group. A significant difference (P < 0.05) was registered with respect to non-severe hypoglycemia, which yielded a higher score in the intervention group.
   Conclusion: This CBT-based intervention appears to be a promising approach to diabetes self-management.
   Practice implications: Diabetes care may benefit from applying tools commonly used in CBT. For further scientific evaluation in clinical practice, there is a need for specially educated diabetes care teams, trained in the current approach, as well as cooperation between diabetes care teams and psychologists trained in CBT. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
C1 [Amsberg, Susanne; Anderbro, Therese; Wredling, Regina; Lins, Per-Eric; Adamson, Ulf; Johansson, Unn-Britt] Karolinska Inst, Dept Clin Sci, Danderyd Hosp, Div Med, SE-18288 Stockholm, Sweden.
   [Amsberg, Susanne; Johansson, Unn-Britt] Sophiahemmet Univ, Coll Stockholm, Stockholm, Sweden.
   [Wredling, Regina] Karolinska Inst, Dept Neurobiol Caring Sci & Soc, Div Nursing, SE-18288 Stockholm, Sweden.
   [Lisspers, Jan] Mid Sweden Univ Campus Ostersund, Dept Social Sci, Ostersund, Sweden.
RP Amsberg, S (reprint author), Karolinska Inst, Dept Clin Sci, Danderyd Hosp, Div Med, House 17,4th Floor, SE-18288 Stockholm, Sweden.
EM susanne.amsberg@ki.se
OI Johansson, Unn-Britt/0000-0003-3309-136X
FU Health Care Sciences Postgraduate School, Karolinska Institutet;
   Sophiahemmet University College, the Foundation for Medical Research at
   Sophiahemmet; Bert von Kantzow Foundation; Swedish Diabetes Federation
FX This project was supported by grants from: the Health Care Sciences
   Postgraduate School, Karolinska Institutet; Sophiahemmet University
   College, the Foundation for Medical Research at Sophiahemmet; the Bert
   von Kantzow Foundation; and the Swedish Diabetes Federation. The authors
   wish to express their gratitude to Lena Landstedt-Hallin, Nils Adner and
   Anna-Lena Wedfelt for assistance with the study, and Marcus Thuresson
   for statistical support. We are also grateful to all patients who have
   taken part in this study.
CR Amsberg S, 2008, INT J NURS STUD, V45, P1319, DOI 10.1016/j.ijnurstu.2007.09.010
   ANDERSON RM, 1995, DIABETES CARE, V18, P943, DOI 10.2337/diacare.18.7.943
   Baranowski T, 1998, AM J PREV MED, V15, P266, DOI 10.1016/S0749-3797(98)00080-4
   Barnard KD, 2006, DIABETIC MED, V23, P445, DOI 10.1111/j.1464-5491.2006.01814.x
   Bradley G, 2000, DIABETES CARE, V23, P875
   Bragd J, 2003, DIABETIC MED, V20, P216, DOI 10.1046/j.1464-5491.2003.00902.x
   Burell G, 2002, INT J BEHAV MED, V9, P228, DOI 10.1207/S15327558IJBM0903_05
   Clark D., 1997, SCI PRACTICE COGNITI
   COX DJ, 1987, DIABETES CARE, V10, P617, DOI 10.2337/diacare.10.5.617
   *DCCT RES GROUP, 1995, DIABETES, V44, P968, DOI DOI 10.2337/DIABETES.44.8.968
   DeVries JH, 2004, DIABETIC MED, V21, P1263, DOI 10.1111/j.1464-5491.2004.01386.x
   DEWEERDT I, 1990, SOC SCI MED, V30, P605, DOI 10.1016/0277-9536(90)90159-P
   Eskin M, 1996, INTRO SWEDISH VERSIO
   Fisher E. B., 2007, DIABETES ED, V33, P1104
   Fisher EB, 2007, DIABETES EDUCATOR, V33, P1080, DOI 10.1177/0145721707309808
   Foreyt J P, 1998, Obes Res, V6 Suppl 1, p18S
   Foster GD, 2005, AM J CLIN NUTR, V82, p230S, DOI 10.1093/ajcn/82.1.230S
   Hampson S E, 2001, Health Technol Assess, V5, P1
   Hetherington MM, 2001, PSYCHIAT CLIN N AM, V24, P235, DOI 10.1016/S0193-953X(05)70220-3
   Hobbis ICA, 2005, J HEALTH PSYCHOL, V10, P37, DOI 10.1177/1359105305048555
   Hobbis ICA, 2005, J HEALTH PSYCHOL, V10, P7, DOI 10.1177/1359105305048549
   Hundley V, 2004, MIDWIFERY, V20, P27, DOI 10.1016/S0266-6138(03)00050-0
   Jeppsson JO, 1996, DIABETES CARE, V19, P142, DOI 10.2337/diacare.19.2.142
   Karlsen B, 2004, PATIENT EDUC COUNS, V53, P299, DOI 10.1016/j.pec.2003.10.008
   Kazdin A. E., 2003, RES DESIGN CLIN PSYC
   Knight KM, 2006, DIABETIC MED, V23, P485, DOI 10.1111/j.1464-5491.2005.01802.x
   Lisspers J, 2005, HEALTH PSYCHOL, V24, P41, DOI 10.1037/0278-6133.24.1.41
   Lisspers J, 1999, J PSYCHOSOM RES, V46, P143, DOI 10.1016/S0022-3999(98)00074-9
   Lisspers J, 1997, ACTA PSYCHIAT SCAND, V96, P281, DOI 10.1111/j.1600-0447.1997.tb10164.x
   LISSPERS J, 2003, APPL TENSION RELEASE
   Lorenz RA, 1996, DIABETES CARE, V19, P648, DOI 10.2337/diacare.19.6.648
   Norris SL, 2002, DIABETES CARE, V25, P1159, DOI 10.2337/diacare.25.7.1159
   OSTELO RW, 2005, COCHRANE DB SYST REV, V25
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   Peyrot M, 2007, DIABETES CARE, V30, P2433, DOI 10.2337/dc07-1222
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Ramnero J., 2008, ABCS HUMAN BEHAV BEH
   Ruggiero LP, 1993, DIABETES SPECTRUM, V6, P22
   Schutt M, 2006, EXP CLIN ENDOCR DIAB, V114, P384, DOI 10.1055/s-2006-924152
   Schwartz M., 2003, BIOFEEDBACK PRACTITI
   Shaban MC, 2006, DIABETIC MED, V23, P1381, DOI 10.1111/j.1464-5491.2006.02012.x
   SHAMOON H, 1993, NEW ENGL J MED, V329, P977
   Sigurthardottir AK, 2005, J CLIN NURS, V14, P301, DOI 10.1111/j.1365-2702.2004.01043.x
   Snoek FJ, 2002, DIABETIC MED, V19, P265, DOI 10.1046/j.1464-5491.2002.00678.x
   Snoek FJ, 2001, PATIENT EDUC COUNS, V45, P143, DOI 10.1016/S0738-3991(01)00113-6
   SNOEK FJ, 2002, MEDICINE, V30, P14
   Spenceley SM, 2006, CAN J NURS RES, V38, P124
   SUNDEL M, 1999, BEHAV CHANGE HUMAN S
   Adolfsson ET, 2007, DIABETES RES CLIN PR, V76, P341, DOI 10.1016/j.diabres.2006.09.018
   Toljamo M, 2001, J CLIN NURS, V10, P618, DOI 10.1046/j.1365-2702.2001.00520.x
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   van der Ven NCW, 2005, DIABETIC MED, V22, P1619
   Wild D, 2007, PATIENT EDUC COUNS, V68, P10, DOI 10.1016/j.pec.2007.05.003
   Winkley K, 2006, BRIT MED J, V333, P65, DOI 10.1136/bmj.38874.652569.55
   Wredling R, 1995, QUAL LIFE RES, V4, P515, DOI 10.1007/BF00634746
NR 55
TC 45
Z9 48
U1 2
U2 27
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0738-3991
J9 PATIENT EDUC COUNS
JI Patient Educ. Couns.
PD OCT
PY 2009
VL 77
IS 1
BP 72
EP 80
DI 10.1016/j.pec.2009.01.015
PG 9
WC Public, Environmental & Occupational Health; Social Sciences,
   Interdisciplinary
SC Public, Environmental & Occupational Health; Social Sciences - Other
   Topics
GA 500UW
UT WOS:000270332000014
PM 19297117
DA 2019-01-08
ER

PT J
AU White, P
   Smith, SM
   Hevey, D
   O'Dowd, T
AF White, Patricia
   Smith, Susan M.
   Hevey, David
   O'Dowd, Thomas
TI Understanding Type 2 Diabetes Including the Family Member's Perspective
SO DIABETES EDUCATOR
LA English
DT Article
ID ILLNESS PERCEPTION QUESTIONNAIRE; WELL-BEING QUESTIONNAIRE; SOCIAL
   SUPPORT; REPRESENTATIONS; DISSIMILARITY; ADHERENCE; PATIENT;
   EXPLORATION; ADOLESCENT; MANAGEMENT
AB Purpose
   The purpose of this study was to examine the relationship between psychological and social factors and diabetes outcomes in people with type 2 diabetes and their family members.
   Methods
   A total of 153 patients with type 2 diabetes were assessed at a diabetes outpatient clinic and postal questionnaires were sent to nominated family members. The measures examined were diabetes knowledge, social support, wellbeing, and illness perceptions.
   Results
   When compared with those with diabetes, family members reported lower positive well-being and lower levels of satisfaction with support. They also perceived diabetes as a more cyclical illness, which was controlled more by treatment than by the individual. Family members also reported that the person with diabetes was more emotionally distressed and knew more about diabetes than the patient had actually reported himself or herself. There were no differences between the family members of those in good or poor glycaemic control.
   Conclusions
   This study reinforces the importance of understanding social context and illness beliefs in diabetes management. It also highlights the potential for including family members in discussions and education about diabetes management.
C1 [White, Patricia] Natl Childrens Hosp, Dept Publ Hlth & Primary Care, Trinity Coll, Ctr Hlth Sci,Adelaide & Meath Hosp Incorporating, Dublin 24, Ireland.
   [Hevey, David] Trinity Coll Dublin, Sch Psychol, Dublin, Ireland.
RP White, P (reprint author), Natl Childrens Hosp, Dept Publ Hlth & Primary Care, Trinity Coll, Ctr Hlth Sci,Adelaide & Meath Hosp Incorporating, Dublin 24, Ireland.
EM pwhite@tcd.ie
RI Smith, Susan/D-1872-2012
OI Smith, Susan/0000-0001-6027-2727; Hevey, David/0000-0003-2844-0449
FU Health Research Board, Ireland
FX This study was funded by a fellowship from the Health Research Board,
   Ireland.
CR ANDERSON BJ, 2006, SYSTEMS HLTH, V24, P332
   BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191
   Barrowclough C, 2001, BRIT J CLIN PSYCHOL, V40, P371, DOI 10.1348/014466501163869
   Belgrave F Z, 1994, J Health Soc Policy, V5, P55, DOI 10.1300/J045v05n03_05
   BENYAMINI Y, 2008, PSYCHOL HEALTH, V22, P765
   Bradley G, 2000, DIABETES CARE, V23, P875
   DiMatteo MR, 2004, HEALTH PSYCHOL, V23, P207, DOI 10.1037/0278-6133.23.2.207
   Edwards P, 2002, BRIT MED J, V324, P1183, DOI 10.1136/bmj.324.7347.1183
   Figueiras MJ, 2003, PSYCHOL HEALTH, V18, P201, DOI 10.1080/0887044021000057266
   Fisher L, 1998, DIABETES EDUCATOR, V24, P599, DOI 10.1177/014572179802400504
   FRENCH DP, 2007, PSYCHOL HEALTH, V23, P5
   GARAYSEVILA ME, 1995, J DIABETES COMPLICAT, V9, P81, DOI 10.1016/1056-8727(94)00021-F
   Garcia AA, 2001, DIABETES CARE, V24, P16, DOI 10.2337/diacare.24.1.16
   Heijmans M, 1999, PSYCHOL HEALTH, V14, P451, DOI 10.1080/08870449908407340
   Jones RA, 2008, DIABETES EDUCATOR, V34, P318, DOI 10.1177/0145721708314485
   KEOGH KM, 2007, COCHRANE DB SYST REV, P1
   Law GU, 2002, CHILD CARE HLTH DEV, V28, P369, DOI 10.1046/j.1365-2214.2002.00286.x
   Leventhal H, 1998, PSYCHOL HEALTH, V13, P717, DOI 10.1080/08870449808407425
   Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494
   Olsen B, 2008, PSYCHOL HEALTH, V23, P113, DOI 10.1080/08870440701437343
   PATTERSON JM, 1994, FAM PROCESS, V33, P287, DOI 10.1111/j.1545-5300.1994.00287.x
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   Pouwer F, 1999, DIABETES CARE, V22, P2004, DOI 10.2337/diacare.22.12.2004
   *SAINT VINC DECL I, 1999, INT DIAB FED M IST T
   SARASON IG, 1987, J SOC PERS RELAT, V4, P497, DOI 10.1177/0265407587044007
   SCHLUNDT DG, 1994, J AM DIET ASSOC, V94, P874, DOI 10.1016/0002-8223(94)92367-1
   Searle A, 2007, J PSYCHOSOM RES, V63, P175, DOI 10.1016/j.jpyschores.2007.02.006
   THOMPSON SC, 1992, STRESS ANXIETY, V6
   TRIEF PM, 2006, SYSTEMS HLTH, V24, P318
   Wade DT, 2004, BRIT MED J, V329, P1398, DOI 10.1136/bmj.329.7479.1398
   Wen LK, 2004, DIABETES EDUCATOR, V30, P980, DOI 10.1177/014572170403000619
   White P, 2007, DIABETIC MED, V24, P796, DOI 10.1111/j.1464-5491.2007.02271.x
   World Health Organization (WHO), 2002, INN CAR CHRON COND B
NR 33
TC 15
Z9 15
U1 0
U2 6
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0145-7217
J9 DIABETES EDUCATOR
JI Diabetes Educ.
PD SEP
PY 2009
VL 35
IS 5
BP 810
EP 817
DI 10.1177/0145721709340930
PG 8
WC Endocrinology & Metabolism; Public, Environmental & Occupational Health
SC Endocrinology & Metabolism; Public, Environmental & Occupational Health
GA 498UT
UT WOS:000270170300011
PM 19783768
DA 2019-01-08
ER

PT J
AU Shaban, C
   Fosbury, JA
   Cavan, DA
   Kerr, D
   Skinner, TC
AF Shaban, C.
   Fosbury, J. A.
   Cavan, D. A.
   Kerr, D.
   Skinner, T. C.
TI The relationship between generic and diabetes specific psychological
   factors and glycaemic control in adults with type 1 diabetes
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Depression; Anxiety; HbA1c; Diabetes distress; Type 1 diabetes
AB 259 adults with type 1 diabetes completed measure of anxiety, depression and diabetes specific distress, HbA1c from medical records. Anxiety not depression predicted HbA1c, this association was mediated by illness specific cognitions. Targeting illness specific cognitions may be more productive than treatment of general dysphoria in type 1 diabetes. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
C1 [Shaban, C.; Cavan, D. A.; Kerr, D.] Royal Bournemouth Hosp, Bournemouth Diabet & Endocrine Ctr, Bournemouth, Dorset, England.
   [Fosbury, J. A.] Guys & St Thomas NHS Fdn Trust, St Thomas Hosp, Diabet & Endocrine Ctr, London, England.
   [Skinner, T. C.] Univ Western Australia, Combined Univ Ctr Rural Hlth, Geraldton, WA 6531, Australia.
RP Skinner, TC (reprint author), Univ Western Australia, Combined Univ Ctr Rural Hlth, POB 109, Geraldton, WA 6531, Australia.
EM timskinner@cucrh.uwa.edu.au
RI Geraldton, WACRH/O-3695-2018
OI Skinner, Timothy/0000-0002-0018-6963
FU British Diabetic Association [BDA:R99/00201666]
FX This research was supported by British Diabetic Association Grant No.
   BDA:R99/00201666.
CR Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Barnard KD, 2006, DIABETIC MED, V23, P445, DOI 10.1111/j.1464-5491.2006.01814.x
   BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037//0022-3514.51.6.1173
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Lustman PJ, 1998, GEN HOSP PSYCHIAT, V20, P302, DOI 10.1016/S0163-8343(98)00039-5
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Meadows K, 1996, QUAL LIFE RES, V5, P242, DOI 10.1007/BF00434746
   Pouwer F, 2005, DIABETES RES CLIN PR, V70, P166, DOI 10.1016/j.diabres.2005.03.031
   Winkley K, 2006, BRIT MED J, V333, P65, DOI 10.1136/bmj.38874.652569.55
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
NR 10
TC 7
Z9 7
U1 1
U2 7
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
EI 1872-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD SEP
PY 2009
VL 85
IS 3
BP E26
EP E29
DI 10.1016/j.diabres.2009.05.006
PG 4
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA V33CR
UT WOS:000208997400001
PM 19500869
DA 2019-01-08
ER

PT J
AU Williams, LB
   Laffel, LMB
   Hood, KK
AF Williams, L. B.
   Laffel, L. M. B.
   Hood, K. K.
TI Diabetes-specific family conflict and psychological distress in
   paediatric Type 1 diabetes
SO DIABETIC MEDICINE
LA English
DT Article
DE anxiety; depression; distress; family management; Type 1 diabetes
ID QUALITY-OF-LIFE; METABOLIC-CONTROL; DEPRESSIVE SYMPTOMS; GLYCEMIC
   CONTROL; ADOLESCENTS; CHILDREN; MELLITUS; ADHERENCE; ASSOCIATION;
   BEHAVIOR
AB Aims
   Diabetes-specific family conflict is associated with suboptimal adherence and glycaemic control. Little is known about the individual and family factors associated with diabetes-specific family conflict. The purpose of this study was to examine whether background factors (e.g. age, gender), diabetes variables (e.g. duration of diabetes, adherence, glycaemic control) and psychological distress (i.e. depression and anxiety) in parents and children and adolescents were associated with diabetes-specific family conflict.
   Methods
   Participants were 187 children and adolescents with Type 1 diabetes and their parents. Study measures assessed diabetes-specific family conflict, youth depression and parent depression and anxiety. Demographic and disease-specific data (adherence, glycaemic control) were also collected.
   Results
   Findings suggested a close link between psychological distress in parents and children and adolescents and reports of increased diabetes-specific family conflict. In the presence of suboptimal glycaemic control, children and adolescents and parents reported more family conflict. Adherence was not significantly associated with family conflict.
   Conclusions
   This study highlights the importance of considering the impact of individual psychological functioning on family conflict and also suggests a bidirectional relationship between conflict and glycaemic control.
C1 [Williams, L. B.; Hood, K. K.] Cincinnati Childrens Hosp, Med Ctr, Div Behav Med & Clin Psychol, Ctr Treatment Adherence, Cincinnati, OH 45229 USA.
   [Laffel, L. M. B.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Pediat Adolescent & Young Adult Sect,Genet & Epid, Boston, MA 02115 USA.
   [Hood, K. K.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA.
RP Hood, KK (reprint author), Cincinnati Childrens Hosp, Med Ctr, Div Behav Med, 3333 Burnet Ave,MLC 7039, Cincinnati, OH 45229 USA.
EM Korey.hood@cchmc.org
RI Smith, Laura/J-4480-2016
OI Smith, Laura/0000-0002-3722-7490
FU NIH [K23 DK 073340]
FX Funding for this study comes from NIH (K23 DK 073340; PI - Hood).
CR Anderson B, 1997, J PEDIATR-US, V130, P257, DOI 10.1016/S0022-3476(97)70352-4
   Anderson BJ, 2002, DIABETIC MED, V19, P635, DOI 10.1046/j.1464-5491.2002.00752.x
   ANDERSON BJ, 1990, J PEDIATR PSYCHOL, V15, P477, DOI 10.1093/jpepsy/15.4.477
   Cicchetti D, 1998, DEV PSYCHOPATHOL, V10, P283, DOI 10.1017/S0954579498001618
   Grey M, 2002, J PSYCHOSOM RES, V53, P907, DOI 10.1016/S0022-3999(02)00312-4
   Grey M, 1998, DIABETES CARE, V21, P909, DOI 10.2337/diacare.21.6.909
   HANSON CL, 1989, HEALTH PSYCHOL, V8, P239, DOI 10.1037/0278-6133.8.2.239
   Hassan K, 2006, J PEDIATR-US, V149, P526, DOI 10.1016/j.jpeds.2006.05.039
   HAUSER ST, 1990, J PEDIATR PSYCHOL, V15, P527, DOI 10.1093/jpepsy/15.4.527
   Hood KK, 2006, DIABETES CARE, V29, P1389, DOI 10.2337/dc06-0087
   Hood KK, 2007, DIABETES CARE, V30, P1764, DOI 10.2337/dc06-2358
   Horwitz SM, 2007, J WOMENS HEALTH, V16, P678, DOI 10.1089/jwh.2006.0185
   JACOBSON AM, 1994, PSYCHOSOM MED, V56, P401, DOI 10.1097/00006842-199409000-00004
   Jaser SS, 2008, J PEDIATR PSYCHOL, V33, P509, DOI 10.1093/jpepsy/jsm104
   Kokkonen J, 1997, NORD J PSYCHIAT, V51, P165, DOI 10.3109/08039489709109091
   Kovacs M, 1997, DIABETES CARE, V20, P36, DOI 10.2337/diacare.20.1.36
   Kovacs M, 2003, CHILDRENS DEPRESSION
   LAGRECA AM, 1995, J PEDIATR PSYCHOL, V20, P449, DOI 10.1093/jpepsy/20.4.449
   Lewin AB, 2006, J PEDIATR PSYCHOL, V31, P174, DOI 10.1093/jpepsy/jsj004
   McKelvey J, 1993, Diabetes Educ, V19, P125, DOI 10.1177/014572179301900206
   ORVASCHEL H, 1980, J AFFECT DISORDERS, V2, P1, DOI 10.1016/0165-0327(80)90017-8
   RADKEYARROW M, 1994, CHILD DEV, V65, P1405, DOI 10.2307/1131507
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Rubin R. R., 1989, DIABETES S2, V38, p28A
   Silverstein J, 2005, DIABETES CARE, V28, P186, DOI 10.2337/diacare.28.1.186
   Spielberger C, 1983, STATE TRAIT ANXIETY
   Stewart SM, 2005, PEDIATRICS, V115, P1315, DOI 10.1542/peds.2004-1717
   Whittemore R, 2003, DIABETES EDUCATOR, V29, P847, DOI 10.1177/014572170302900514
   Wysocki T, 2006, J PEDIATR PSYCHOL, V31, P928, DOI 10.1093/jpepsy/jsj098
NR 29
TC 42
Z9 43
U1 0
U2 21
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD SEP
PY 2009
VL 26
IS 9
BP 908
EP 914
DI 10.1111/j.1464-5491.2009.02794.x
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 488RC
UT WOS:000269366400010
PM 19719712
OA Green Accepted, Bronze
DA 2019-01-08
ER

PT J
AU Sim, LA
   Homme, JH
   Lteif, AN
   Voort, JLV
   Schak, KM
   Ellingson, J
AF Sim, Leslie A.
   Homme, Jason H.
   Lteif, Aida N.
   Voort, Jennifer L. Vande
   Schak, Kathryn M.
   Ellingson, Jarrod
TI Family Functioning and Maternal Distress in Adolescent Girls with
   Anorexia Nervosa
SO INTERNATIONAL JOURNAL OF EATING DISORDERS
LA English
DT Article
DE anorexia nervosa; family functioning; adolescence
ID BECK DEPRESSION INVENTORY; STATE WORRY QUESTIONNAIRE; SELF-REPORT
   QUESTIONNAIRE; EATING-DISORDERS; SHORT FORM; VALIDITY; ILLNESS;
   RELIABILITY; ENVIRONMENT; SATISFACTION
AB Objective: To determine the nature of family distress in families of girls with anorexia nervosa (AN), this study compared aspects of family functioning in adolescent girls with AN to girls with a chronic illness and girls without a condition.
   Method: Participants consisted of 25 adolescent girls with a primary DSM-IV diagnosis of AN, 20 girls with an ICD-10 diagnosis of insulin dependent diabetes mellitus (IDDM), and 20 girls from the community. Mothers and daughters completed questionnaires of family functioning and psychological symptoms.
   Results: When compared with mothers of daughters with IDDM, families of girls with AN experienced greater family conflict, reduced parental alliance, and increased feelings of depression. However, once the emotional impact of the illness on the mothers was statistically controlled, group differences were no longer significant.
   Discussion: Family distress and dysfunction may reflect an accommodation process that occurs in families living with a child with AN. (C) 2009 by Wiley Periodicals, Inc.
C1 [Sim, Leslie A.; Voort, Jennifer L. Vande; Schak, Kathryn M.] Mayo Clin, Dept Psychiat & Psychol, Coll Med, Rochester, MN 55905 USA.
   [Homme, Jason H.; Lteif, Aida N.] Mayo Clin, Dept Pediat, Coll Med, Rochester, MN 55905 USA.
   [Ellingson, Jarrod] San Diego State Univ, Dept Psychol, San Diego, CA 92182 USA.
RP Sim, LA (reprint author), Mayo Clin, Dept Psychiat & Psychol, Coll Med, 200 1st St SW, Rochester, MN 55905 USA.
EM Sim.Leslie@mayo.edu
CR ABIDIN RR, 1995, J CLIN CHILD PSYCHOL, V24, P31, DOI 10.1207/s15374424jccp2401_4
   Anderson A., 1983, MED ASPECTS HUMAN SE, V17, P57
   BECK AT, 1972, POSTGRAD MED, V52, P81, DOI 10.1080/00325481.1972.11713319
   Beck AT, 1996, MANUAL BECK DEPRESSI
   BLOOMQUIST ML, 1984, J CLIN PSYCHOL, V40, P1209, DOI 10.1002/1097-4679(198409)40:5<1209::AID-JCLP2270400515>3.0.CO;2-S
   Bogels SM, 2006, CLIN PSYCHOL REV, V26, P834, DOI 10.1016/j.cpr.2005.08.001
   BROWN TA, 1992, BEHAV RES THER, V30, P33, DOI 10.1016/0005-7967(92)90093-V
   Castro J, 2000, PSYCHOL MED, V30, P61, DOI 10.1017/S0033291799001385
   Cook-Darzens S, 2005, EUR EAT DISORD REV, V13, P223, DOI 10.1002/erv.628
   de la Rie Simone M, 2005, Eat Disord, V13, P345, DOI 10.1080/10640260591005236
   Emanuelli F, 2004, Eat Weight Disord, V9, P1
   Espina A, 2003, J PSYCHOSOM RES, V55, P553, DOI 10.1016/S0022-3999(03)00016-3
   Evans S, 1996, J AFFECT DISORDERS, V38, P73, DOI 10.1016/0165-0327(95)00045-3
   FAIRBURN CG, 1994, INT J EAT DISORDER, V16, P363
   FELKER KR, 1994, ADOLESCENCE, V29, P821
   Ferguson TJ, 1999, DEV PSYCHOL, V35, P347, DOI 10.1037/0012-1649.35.2.347
   Furlanetto LM, 2005, J AFFECT DISORDERS, V86, P87, DOI 10.1016/j.jad.2004.12.011
   Gilbert A A, 2000, Eat Disord, V8, P331, DOI 10.1080/10640260008251240
   Gull W. W., 1874, T CLIN SOC LONDON, V7, P22
   Holliday J, 2005, INT J EAT DISORDER, V37, P50, DOI 10.1002/eat.20056
   HUMPHREY LL, 1989, J CONSULT CLIN PSYCH, V57, P206, DOI 10.1037//0022-006X.57.2.206
   Irving LM, 2002, PREV MED, V34, P299, DOI 10.1006/pmed.2001.0997
   JOHNSTON C, 1989, J CLIN CHILD PSYCHOL, V18, P167, DOI 10.1207/s15374424jccp1802_8
   KASHANI JH, 1990, J AM ACAD CHILD PSY, V29, P278, DOI 10.1097/00004583-199003000-00018
   Kyriacou O, 2008, INT J EAT DISORDER, V41, P233, DOI 10.1002/eat.20488
   LEAHY JM, 1992, J CLIN PSYCHOL, V48, P64, DOI 10.1002/1097-4679(199201)48:1<64::AID-JCLP2270480109>3.0.CO;2-9
   LEGRANGE D, 1992, INT J EAT DISORDER, V12, P347, DOI 10.1002/1098-108X(199212)12:4<347::AID-EAT2260120402>3.0.CO;2-W
   Luce KH, 1999, INT J EAT DISORDER, V25, P349, DOI 10.1002/(SICI)1098-108X(199904)25:3<349::AID-EAT15>3.0.CO;2-M
   MARCHI M, 1990, J AM ACAD CHILD PSY, V29, P112, DOI 10.1097/00004583-199001000-00017
   Martin AR, 2004, EUR J CLIN NUTR, V58, P846, DOI 10.1038/sj.ejcn.1601884
   MEYER TJ, 1990, BEHAV RES THER, V28, P487, DOI 10.1016/0005-7967(90)90135-6
   Minuchin S., 1978, PSYCHOSOMATIC FAMILI
   Moos R. H., 1986, FAMILY ENV SCALE MAN
   Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494
   NORTH C, 1995, BRIT J PSYCHIAT, V167, P673, DOI 10.1192/bjp.167.5.673
   Northam E, 1996, J PEDIATR PSYCHOL, V21, P699, DOI 10.1093/jpepsy/21.5.699
   Perkins S, 2004, INT J EAT DISORDER, V36, P256, DOI 10.1002/eat.20067
   Quittner AL, 1998, HEALTH PSYCHOL, V17, P112, DOI 10.1037/0278-6133.17.2.112
   RATNASURIYA RH, 1991, BRIT J PSYCHIAT, V158, P495, DOI 10.1192/bjp.158.4.495
   Richter P, 1998, PSYCHOPATHOLOGY, V31, P160, DOI 10.1159/000066239
   Ruuska J, 2007, NORD J PSYCHIAT, V61, P452, DOI 10.1080/08039480701773253
   Santonastaso P, 1997, Eat Weight Disord, V2, P44
   Selvini-Palazzoli M., 1978, SELF STARVATION INDI
   Sepulveda AR, 2008, INT J EAT DISORDER, V41, P318, DOI 10.1002/eat.20502
   Shoebridge P, 2000, BRIT J PSYCHIAT, V176, P132, DOI 10.1192/bjp.176.2.132
   STERN SL, 1989, INT J EAT DISORDER, V8, P25, DOI 10.1002/1098-108X(198901)8:1<25::AID-EAT2260080104>3.0.CO;2-S
   Stewart MC, 2006, INT J EAT DISORDER, V39, P320, DOI 10.1002/eat.20262
   Strober M, 1997, INT J EAT DISORDER, V22, P339
   Treasure J, 2001, SOC PSYCH PSYCH EPID, V36, P343, DOI 10.1007/s001270170039
   Treasure J, 2003, EUR EAT DISORD REV, V11, P25, DOI 10.1002/erv.485
   Wandersman L. P., 1978, 86 ANN CONV AM PSYCH
   Weinman J, 2000, BRIT J HEALTH PSYCH, V5, P263, DOI 10.1348/135910700168900
   Whitney J, 2007, BRIT J CLIN PSYCHOL, V46, P413, DOI 10.1348/014466507X173781
NR 53
TC 29
Z9 30
U1 1
U2 20
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0276-3478
EI 1098-108X
J9 INT J EAT DISORDER
JI Int. J. Eating Disord.
PD SEP
PY 2009
VL 42
IS 6
BP 531
EP 539
DI 10.1002/eat.20654
PG 9
WC Psychology, Clinical; Nutrition & Dietetics; Psychiatry; Psychology
SC Psychology; Nutrition & Dietetics; Psychiatry
GA 486UE
UT WOS:000269224000007
PM 19189407
OA Bronze
DA 2019-01-08
ER

PT J
AU Peltzer, K
   Shisana, O
   Zuma, K
   Van Wyk, B
   Zungu-Dirwayi, N
AF Peltzer, Karl
   Shisana, Olive
   Zuma, Khangelani
   Van Wyk, Brian
   Zungu-Dirwayi, Nompumelelo
TI Job stress, job satisfaction and stress-related illnesses among South
   African educators
SO STRESS AND HEALTH
LA English
DT Article
DE job stress; job satisfaction; risk behaviours; stress-related illnesses;
   public educators; South Africa
ID CORONARY-HEART-DISEASE; BLOOD-PRESSURE; RISK-FACTORS; STRAIN;
   HYPERTENSION; RELIABILITY; ASSOCIATION; POPULATION; DIMENSIONS; TEACHERS
AB The aim of this study was to explore the relationship between self-reported job stress and job satisfaction, and the prevalence of stress-related illnesses and risk factors among educators. A cross-sectional survey was conducted in a representative sample of 21,307 educators from public schools in South Africa. Results indicate that the prevalence of stress-related illnesses were 15.6 per cent for hypertension, 9.1 per cent stomach ulcer, 4.5 per cent diabetes, 3.3 per cent minor mental distress, 3.1 per cent major mental distress and 3.5 per cent asthma. The study found considerably high stress levels among educators. job stress and lack of job satisfaction were associated with most stress-related illnesses (hypertension, heart disease, stomach ulcer, asthma, mental distress, tobacco and alcohol misuse). From three components of the demand-control model, two, namely work stress from teaching methods and low peer support, were related to hypertension but not to heart disease. The components of the effort-reward model of low socioeconomic status and lack of career advancement were both not related to heart disease, and only lack of career advancement was inversely related to hypertension. Most components assessed here of the demand-control model (including stress with teaching methods and educational system and low peer support) and effort-reward model (including job insecurity and lack of career advancement) were related to stomach ulcer and mental distress. Copyright (C) 2008 John Wiley & Sons, Ltd.
C1 [Peltzer, Karl; Shisana, Olive; Zuma, Khangelani; Zungu-Dirwayi, Nompumelelo] Human Sci Res Council, ZA-0001 Pretoria, South Africa.
   [Peltzer, Karl] Univ Free State, Pretoria, South Africa.
   [Peltzer, Karl] Human Sci Res Council, Bloemfontein, South Africa.
   [Peltzer, Karl] Univ Free State, Bloemfontein, South Africa.
   [Van Wyk, Brian] Univ Western Cape, Cape Town, South Africa.
RP Peltzer, K (reprint author), Human Sci Res Council, Private Bag X41, ZA-0001 Pretoria, South Africa.
EM KPeltzer@hsrc.ac.za
OI Peltzer, Karl/0000-0002-5980-0876
FU The Education Labour Relations Council
FX The Education Labour Relations Council is thanked for commissioning,
   supporting and funding this study.
CR Andresen EM, 2003, J EPIDEMIOL COMMUN H, V57, P339, DOI 10.1136/jech.57.5.339
   Babor TF, 2001, AUDIT ALCOHOL USE DI
   BEARD PN, 1990, S AFRICAN J ED, V10, P109
   BOYLE GJ, 1995, BRIT J EDUC PSYCHOL, V65, P49, DOI 10.1111/j.2044-8279.1995.tb01130.x
   BROWN A, 2001, WORK, V16, P219
   BUWALDA RA, 1991, S AFRICAN J ED, V11, P118
   Cesana G, 2003, PSYCHOSOM MED, V65, P558, DOI 10.1097/01.PSY.0000041473.03828.67
   COOMBE C, 2000, MANAGING IMPACT HIV
   COOPER CL, 1993, BRIT J EDUC PSYCHOL, V63, P130, DOI 10.1111/j.2044-8279.1993.tb01046.x
   COX T, 1988, WORK STRESS, V2, P353, DOI 10.1080/02678378808257497
   CROUCH L, 2003, CHANGING PATTERNS ED, P45
   Dawson DA, 2005, ALCOHOL ALCOHOLISM, V40, P453, DOI 10.1093/alcalc/agh176
   *DEP ED, 2004, ANN REP
   Department of Education, 2001, 6 DEP ED
   Ducher M, 2006, AM J HYPERTENS, V19, P694, DOI 10.1016/j.amjhyper.2005.12.016
   Guimont C, 2006, AM J PUBLIC HEALTH, V96, P1436, DOI 10.2105/AJPH.2004.057679
   HALL E, 2005, POTENTIAL ATTRITION
   Israel B A, 1996, J Occup Health Psychol, V1, P261, DOI 10.1037//1076-8998.1.3.261
   JORDAN J, 2003, BEACONS EXCELLENCE S
   Kang MG, 2005, PREV MED, V40, P583, DOI 10.1016/j.ypmed.2004.07.018
   Karasek R, 1990, HLTH WORK STRESS PRO
   Kawakami N, 1999, IND HEALTH, V37, P174, DOI 10.2486/indhealth.37.174
   Kuper H, 2003, J EPIDEMIOL COMMUN H, V57, P147, DOI 10.1136/jech.57.2.147
   LESTER PE, 1987, EDUC PSYCHOL MEAS, V47, P223, DOI 10.1177/0013164487471031
   MARAIS JL, 1992, S AFRICAN J ED, V12, P305
   MUNTANER C, 1993, SOC SCI MED, V36, P1509, DOI 10.1016/0277-9536(93)90393-I
   *NAT I OCC SAF HLT, 1998, NIOSH PUBL
   Ngidi DP, 2002, S AFR J PSYCHOL, V32, P7, DOI 10.1177/008124630203200302
   Oliver M. A. J., 2003, S AFRICAN J ED, V23, P186
   Peter R, 2002, INT CONGR SER, V1241, P165, DOI 10.1016/S0531-5131(02)00637-4
   Pickering T, 1997, ACTA PHYSIOL SCAND, V161, P125
   REHLE T, 2005, HIV POSITIVE ED S AF
   Rehle Thomas M, 2005, SAHARA J, V2, P304
   SCHNALL PL, 1994, ANNU REV PUBL HEALTH, V15, P381, DOI 10.1146/annurev.pu.15.050194.002121
   Shigemi J, 1999, J Epidemiol, V9, P320
   SHISANA O, 2005, HLTH OUR ED FOCUS HI
   SHISANA O, 2006, MRC CDC S AFR WORKSH
   Siegrist J, 1996, J Occup Health Psychol, V1, P27, DOI 10.1037/1076-8998.1.1.27
   SPIELBERGER CD, 1994, INT J STRESS MANAGE, V1, P19
   SPIELBERGER CD, 1994, PROFESSIONAL MANUAL
   SQUELCH J, 1994, 8 WAYS EFFECTIVE SCH
   Tsutsumi A, 2001, OCCUP ENVIRON MED, V58, P367, DOI 10.1136/oem.58.6.367
   van Saane N, 2003, OCCUP MED-OXFORD, V53, P191, DOI 10.1093/occmed/kqg038
   VANWYK J, 1998, STRESBELEWING ONDERW
   VANZYL E, 1999, S AFRICAN J PSYCHOL, V19, P74
   Wamala SP, 2000, SOC SCI MED, V51, P481, DOI 10.1016/S0277-9536(00)00006-X
   Yao San-qiao, 2003, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V21, P20
NR 47
TC 28
Z9 29
U1 0
U2 26
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1532-3005
EI 1532-2998
J9 STRESS HEALTH
JI Stress Health
PD AUG
PY 2009
VL 25
IS 3
BP 247
EP 257
DI 10.1002/smi.1244
PG 11
WC Psychology, Applied; Psychiatry; Psychology
SC Psychology; Psychiatry
GA 484ZU
UT WOS:000269090700006
DA 2019-01-08
ER

PT J
AU Mosnier-Pudar, H
   Hochberg, G
   Eschwege, E
   Virally, ML
   Halimi, S
   Guillausseau, PJ
   Peixoto, O
   Touboul, C
   Dubois, C
   Dejager, S
AF Mosnier-Pudar, H.
   Hochberg, G.
   Eschwege, E.
   Virally, M. -L.
   Halimi, S.
   Guillausseau, P. J.
   Peixoto, O.
   Touboul, C.
   Dubois, C.
   Dejager, S.
TI How do patients with type 2 diabetes perceive their disease? Insights
   from the French DIABASIS survey
SO DIABETES & METABOLISM
LA English
DT Article
DE Type 2 diabetes; Self-questionnaires; Patient perceptions;
   Self-management; Family support
ID PATIENTS PERSPECTIVES; HEALTH-CARE; NEEDS DAWN; FRANCE; PREVALENCE;
   EDUCATION; PERCEPTIONS; MANAGEMENT; ATTITUDES; OUTCOMES
AB Aim. - The main purpose of this survey was to describe type 2 diabetes (T2DM) from the patient's standpoint in a representative French panel in 2008.
   Methods. - Fourteen thousand two hundred and one individuals from the general population aged 45 or older completed a self-questionnaire exploring knowledge about diabetes; 1092 replies were from patients with T2DM.
   Results. - The prevalence of T2DM in this population was 7.7%, with demographics as follows: 60% men; mean age: 66 years; mean age at diagnosis: 55 years; mean BMI: 29 kg/m(2). Eighty-five percent of T2DM patients reported that they wanted more information about at least one aspect of the disease at diagnosis; they reported feeling anxious (30%), frightened (13%), angry (4%) or that the disease was unfair (12%). Half of the patients had modified their dietary habits but 71% found it difficult to engage in regular physical activity. Most patients (90%) were treated with drugs: 81% with oral antidiabetic drugs (OAD) (44% in monotherapy) while 19% received insulin (alone or in combination with OAD). Twenty-three percent complained of weight gain since start of current therapy (average gain of 7.3 kg). Insulin initiation represented a turning point for patients who became more aware of the disease severity, more willing to follow advice and to take greater control over their disease management. The mean time from diagnosis to insulin initiation was 13.8 years. Half of the patients perceived their disease as severe especially women, patients who initially reacted with anxiety, insulin-treated patients and those actively involved in their disease management. Some gender differences emerged: women took the disease more seriously, were more engaged in self-management, and reported a higher impact on daily life.
   Conclusions. - DIABASIS provides important information for diabetes care by highlighting patients' views of the disease, such as distress at diagnosis, lack of adequate information to cope with this distress and the important supportive role played by the family. A deeper understanding of patients' perception of the disease would help optimize customized care. (C) 2009 Elsevier Masson SAS. All rights reserved.
C1 [Dejager, S.] Novartis Pharma SAS, F-92506 Rueil Malmaison, France.
   [Mosnier-Pudar, H.] AP HP, Cochin Port Royal Diabet & Endocrine Ctr, Paris, France.
   [Hochberg, G.] Hop Sud Francilien, DELF, Corbeil Essonnes, France.
   [Eschwege, E.] INSERM, Epidemiol & Stat Res Unit, U780, Villejuif, France.
   [Virally, M. -L.; Guillausseau, P. J.] Lariboisiere Hosp, AP HP, Serv Internal Med B, Paris, France.
   [Halimi, S.; Peixoto, O.] CHU Grenoble, Serv Endocrinol Diabetol Nutr, Grenoble, France.
   [Touboul, C.] TNS Healthcare, F-92120 Montrouge, France.
   [Dubois, C.] Hop Ambroise Pare, AP HP, Boulogne, France.
RP Dejager, S (reprint author), Novartis Pharma SAS, Rue Lionel Terray,BP 308, F-92506 Rueil Malmaison, France.
EM sylvie.dejager@novartis.com
FU Novartis Pharmaceuticals Corporation
FX The authors gratefully acknowledge the patients and their families, the
   operational support from TNS HealthCare France, and helpful discussion
   with Felicity Neilson. This study was funded by Novartis Pharmaceuticals
   Corporation.
CR Charles MA, 2008, OBESITY, V16, P2180, DOI [10.1038/oby.2008.285, 10.1038/oby.2008.286]
   Cooper HC, 2003, HEALTH EDUC RES, V18, P191, DOI 10.1093/her/18.2.191
   Debussche X, 2006, DIABETES METAB, V32, P50, DOI 10.1016/S1262-3636(07)70246-X
   Detournay B, 2008, DIABETOLOGIA, V51, pS421
   Detournay B, 2000, DIABETES METAB, V26, P363
   Eschwege E, 2007, DIABETES METAB, V33, pS74
   Fagot-Campagna Anne, 2007, Rev Prat, V57, P2209
   Girerd X, 2001, ARCH MAL COEUR VAISS, V94, P839
   Gucciardi E, 2008, CAN FAM PHYSICIAN, V54, P219
   Hillier Teresa A, 2006, J Cardiometab Syndr, V1, P318, DOI 10.1111/j.1559-4564.2006.05737.x
   Kusnik-Joinville O, 2008, DIABETES METAB, V34, P266, DOI 10.1016/j.diabet.2008.01.005
   Peel E, 2007, BRIT MED J, V335, P493, DOI 10.1136/bmj.39302.444572.DE
   Peyrot M, 2006, DIABETOLOGIA, V49, P279, DOI 10.1007/s00125-005-0048-8
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   Romon I, 2008, DIABETES METAB, V34, P140, DOI 10.1016/j.diabet.2007.11.002
   Rubin RR, 2006, DIABETES CARE, V29, P1249, DOI 10.2337/dc05-2494
   Sarkadi A, 2005, PATIENT EDUC COUNS, V58, P137, DOI 10.1016/j.pec.2004.08.002
   VARROUDVIAL M, 2008, DIABETOLOGIA, V70, pS70
   Veg A, 2007, DIABETIC MED, V24, P408, DOI 10.1111/j.1464-5491.2006.02064.x
   1999, PRISE CHARGE DIABETI
NR 20
TC 23
Z9 23
U1 1
U2 9
PU MASSON EDITEUR
PI MOULINEAUX CEDEX 9
PA 21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE
SN 1262-3636
EI 1878-1780
J9 DIABETES METAB
JI Diabetes Metab.
PD JUN
PY 2009
VL 35
IS 3
BP 220
EP 227
DI 10.1016/j.diabet.2009.02.001
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 466IV
UT WOS:000267655700009
PM 19303338
DA 2019-01-08
ER

PT J
AU Fisher, L
   Mullan, JT
   Skaff, MM
   Glasgow, RE
   Arean, P
   Hessler, D
AF Fisher, L.
   Mullan, J. T.
   Skaff, M. M.
   Glasgow, R. E.
   Arean, P.
   Hessler, D.
TI Predicting diabetes distress in patients with Type 2 diabetes: a
   longitudinal study
SO DIABETIC MEDICINE
LA English
DT Article
DE diabetes; distress; type 2
ID BLOOD-GLUCOSE; STRESS; ADULTS; SCALE; ANXIETY
AB Diabetes distress (DD) is a condition distinct from depression that is related to diabetes outcomes. In those without distress initially, little is known about what indicators place patients at risk for subsequent distress over time.
   From a community-based, three-wave, 18-month study of Type 2 diabetic patients (n = 506), we identified patients with no DD at T1 who displayed DD at T2, T3 or both (n = 57). Using logistic regression with full and trimmed models, we compared them with patients with no DD at all three time points (n = 275) on three blocks of variables: patient characteristics (demographics, depression, extra-disease stress), biological (HbA(1c), body mass index, comorbidities, complications, blood pressure, non-high-density lipoprotein-cholesterol), and behavioural variables (diet, exercise). Selected interactions with stress and major depressive disorder (MDD) were explored.
   The odds of becoming distressed over time were higher for being female, previously having had MDD, experiencing more negative events or more chronic stress, having more complications, and having poor diet and low exercise. Negative life events increased the negative effects of both high HbA(1c) and high complications on the emergence of distress over time.
   We identified a list of significant, independent direct and interactive predictors of high DD that can be used for patient screening to identify this high-risk patient cohort. Given the impact of high DD on diabetes behavioural and biological indicators, the findings suggest the usefulness of regularly appraising both current life and disease-related stressors in clinical care.
C1 [Fisher, L.; Skaff, M. M.; Hessler, D.] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA.
   [Glasgow, R. E.] Kaiser Permanente Colorado, Clin Res Unit, Denver, CO USA.
   [Arean, P.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.
   [Mullan, J. T.] Univ Calif San Francisco, Sch Nursing, Dept Social & Behav Sci, San Francisco, CA 94143 USA.
RP Fisher, L (reprint author), Univ Calif San Francisco, Dept Family & Community Med, POB 0900, San Francisco, CA 94143 USA.
EM fisherl@fcm.ucsf.edu
FU National Institute of Diabetes, Digestive and Kidney Disease [DK062732,
   DK061937]
FX This research was supported by grants DK062732 and DK061937 from the
   National Institute of Diabetes, Digestive and Kidney Disease. The
   following medical groups and diabetes education centres collaborated in
   this research: Alta Bates Diabetes Education Center, Brown and Toland
   Medical Group, California Pacific Diabetes Education Center, Hill
   Physicians Medical Group, Marin IPA, St Luke's Diabetes Education
   Center, St Mary's Medical Center, University of California, San
   Francisco Hospital and Clinics.
CR AIKENS JE, 1994, J BEHAV MED, V17, P535, DOI 10.1007/BF01857596
   Albright TL, 2001, FAM MED, V33, P354
   Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   GOETSCH VL, 1994, BEHAV RES THER, V32, P503, DOI 10.1016/0005-7967(94)90137-6
   Grigsby AB, 2002, J PSYCHOSOM RES, V53, P1053, DOI 10.1016/S0022-3999(02)00417-8
   Hosmer D.W., 2000, APPL LOGISTIC REGRES
   Mullan JT, 2006, DIABETES, V55, pA426
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   SKAFF MM, 2009, HLTH PSYCHO IN PRESS
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   TURNER RJ, 1995, AM SOCIOL REV, V60, P104, DOI 10.2307/2096348
   WITTCHEN HU, 1994, J PSYCHIAT RES, V28, P57, DOI 10.1016/0022-3956(94)90036-1
NR 14
TC 71
Z9 72
U1 1
U2 11
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0742-3071
J9 DIABETIC MED
JI Diabetic Med.
PD JUN
PY 2009
VL 26
IS 6
BP 622
EP 627
DI 10.1111/j.1464-5491.2009.02730.x
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 453FV
UT WOS:000266596600009
PM 19538238
OA Bronze, Green Accepted
DA 2019-01-08
ER

PT J
AU Li, CY
   Ford, ES
   Zhao, GX
   Strine, TW
   Dhingra, S
   Barker, L
   Berry, JT
   Mokdad, AH
AF Li, Chaoyang
   Ford, Earl S.
   Zhao, Guixiang
   Strine, Tara W.
   Dhingra, Satvinder
   Barker, Lawrence
   Berry, Joyce T.
   Mokdad, Ali H.
TI Association between diagnosed diabetes and serious psychological
   distress among US adults: the Behavioral Risk Factor Surveillance
   System, 2007
SO INTERNATIONAL JOURNAL OF PUBLIC HEALTH
LA English
DT Article
DE Serious psychological distress; Diagnosed diabetes; Cardiovascular
   comorbidity; Diabetes-related complication
ID CARDIOVASCULAR-DISEASE RISK; MAJOR DEPRESSIVE DISORDER; SCREENING
   SCALES; MELLITUS; METAANALYSIS; POPULATION; PREVALENCE; ANXIETY; HEALTH;
   INDIVIDUALS
AB To estimate the prevalence of serious psychological distress (SPD) according to diabetes status and to assess the association of diabetes-related risks and conditions with SPD among U.S. adults.
   We analyzed data from the Behavioral Risk Factor Surveillance System, 2007. SPD was determined by a score of a parts per thousand yen 13 on the Kessler-6 scale. We used log-binomial regression analysis to estimate prevalence ratios (PRs) and 95 % confidence intervals (CIs).
   We estimated the prevalence of SPD to be 7.6 % and 3.6 % among U.S. adults with and without diagnosed diabetes (unadjusted PR: 2.09; 95 % CI: 1.87, 2.34). The association of diagnosed diabetes with SPD was attenuated after adjustments for potential confounding effects of cardiovascular risk factors and cardiovascular comorbid conditions (adjusted PR, 1.12; 95 % CI: 0.99, 1.27). Significant correlates of SPD among persons with diagnosed diabetes were young age, low education levels, low household income, obesity, current smoking, no leisure-time physical activity, presence of one or more micro- or macro-vascular complications, and disability.
   The crude prevalence of SPD among adults with diagnosed diabetes was twice as high as that among those without diabetes. The increased prevalence of SPD may be accounted for by the excessive rates of cardiovascular risks and comorbid conditions among people with diagnosed diabetes.
C1 [Li, Chaoyang; Ford, Earl S.; Zhao, Guixiang; Strine, Tara W.; Dhingra, Satvinder] Ctr Dis Control & Prevent, Div Adult & Community Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA.
   [Barker, Lawrence] Ctr Dis Control & Prevent, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA.
   [Berry, Joyce T.] Subst Abuse & Mental Hlth Serv Adm, Washington, DC USA.
   [Mokdad, Ali H.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA.
RP Li, CY (reprint author), 4770 Buford Highway,MS K66, Atlanta, GA 30341 USA.
EM cli@cdc.gov
CR Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   [Anonymous], 2003, MMWR MORB MORTAL WKL, V53, P1089
   Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21
   BOWLIN SJ, 1993, J CLIN EPIDEMIOL, V46, P561, DOI 10.1016/0895-4356(93)90129-O
   BRUCE ML, 1994, SOC PSYCH PSYCH EPID, V29, P165
   *CDCP, EARL REL SEL EST BAS
   Centers for Disease Control and Prevention, 2006, BEH RISK FACT SURV S
   CENTERS FOR DISEASE CONTROL AND PREVENTION, 2008, NAT DIAB FACT SHEET
   Centers for Disease Control and Prevention, BEH RISK FACT SURV S
   Egede LE, 2004, DIABETES CARE, V27, P421, DOI 10.2337/diacare.27.2.421
   Egede LE, 2003, DIABETES CARE, V26, P104, DOI 10.2337/diacare.26.1.104
   Engum A, 2005, DIABETES CARE, V28, P1904, DOI 10.2337/diacare.28.8.1904
   Fan AZ, 2008, PREV MED, V46, P445, DOI 10.1016/j.ypmed.2008.02.016
   Furukawa TA, 2003, PSYCHOL MED, V33, P357, DOI 10.1017/S0033291702006700
   Hanninen JA, 1999, DIABETES CARE, V22, P997, DOI 10.2337/diacare.22.6.997
   Katon W, 2004, DIABETES CARE, V27, P914, DOI 10.2337/diacare.27.4.914
   Kessler RC, 2008, PSYCHOL MED, V38, P365, DOI 10.1017/S0033291707002012
   Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617
   Knol MJ, 2007, PSYCHOSOM MED, V69, P300, DOI 10.1097/PSY.0b013e31805f48b9
   Knol MJ, 2006, DIABETOLOGIA, V49, P837, DOI 10.1007/s00125-006-0159-x
   Li C, 2008, DIABETIC MED, V25, P878, DOI 10.1111/j.1464-5491.2008.02477.x
   LI C, 2008, CLUSTERING CARDIOVAS
   Mazzone T, 2008, LANCET, V371, P1800, DOI 10.1016/S0140-6736(08)60768-0
   MOKDAD AH, 2003, MMWR-MORBID MORTAL W, V52, pRR9
   Nelson DE, 2003, AM J PUBLIC HEALTH, V93, P1335, DOI 10.2105/AJPH.93.8.1335
   Nelson DE, 2001, SOZ PRAVENTIV MED, V46, pS3
   Penninx BWJH, 1998, JAMA-J AM MED ASSOC, V279, P1720, DOI 10.1001/jama.279.21.1720
   SHIH M, QUAL LIFE R IN PRESS
   Smith SC, 2007, AM J MED, V120, pS3, DOI 10.1016/j.amjmed.2007.01.002
   Tellez-Zenteno JF, 2002, ARCH MED RES, V33, P53, DOI 10.1016/S0188-4409(01)00349-6
   *WHO STUD GROUP, 1994, PREV DIAB
NR 34
TC 29
Z9 29
U1 2
U2 9
PU BIRKHAUSER VERLAG AG
PI BASEL
PA VIADUKSTRASSE 40-44, PO BOX 133, CH-4010 BASEL, SWITZERLAND
SN 1661-8556
J9 INT J PUBLIC HEALTH
JI Int. J. Public Health
PD JUN
PY 2009
VL 54
BP 43
EP 51
DI 10.1007/s00038-009-0006-1
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 462GW
UT WOS:000267340100009
PM 19396581
DA 2019-01-08
ER

PT J
AU McKnight-Eily, LR
   Elam-Evans, LD
   Strine, TW
   Zack, MM
   Perry, GS
   Presley-Cantrell, L
   Edwards, VJ
   Croft, JB
AF McKnight-Eily, Lela R.
   Elam-Evans, Laurie D.
   Strine, Tara W.
   Zack, Matthew M.
   Perry, Geraldine S.
   Presley-Cantrell, Letitia
   Edwards, Valerie J.
   Croft, Janet B.
TI Activity limitation, chronic disease, and comorbid serious psychological
   distress in US adults - BRFSS 2007
SO INTERNATIONAL JOURNAL OF PUBLIC HEALTH
LA English
DT Article
DE Activity limitation; Role disability; Serious psychological distress
ID MENTAL-HEALTH SURVEYS; PHYSICAL CONDITIONS; GENERAL-POPULATION;
   DEPRESSION; DISORDERS; ILLNESS; COMMUNITY
AB This study examines the prevalence of self-reported activity limitation from poor physical or mental health in the past 30 days among a sample of noninstitutionalized U.S. adults. The associations between frequent activity limitation, chronic diseases, and comorbid serious psychological distress (SPD) were also examined.
   2007 Behavioral Risk Factor Surveillance System (BRFSS) data were used to generate prevalence estimates of days of self-reported activity limitation in the past 30 days (i. e., 0 days, 1-13 days, 14-29 days, 30 days, and 14 or more days) by selected sociodemographic characteristics, chronic disease conditions (i. e., lifetime diagnosis of diabetes, hypertension, coronary heart disease, stroke, asthma), and comorbid serious psychological distress. Multivariate logistic regression analysis was used to generate adjusted odds ratios of frequent activity limitation (14-30 days in the past 30 days) among persons with selected chronic disease conditions and among those with comorbid serious psychological distress.
   A total of 21 % of adults reported activity limitation for at least 1 day in the past 30 days; 6.6 % reported 14 or more days, and 3.4 % reported all 30 days. Comorbid serious psychological distress was significantly associated with reported frequent activity limitation among persons who also reported a lifetime diagnosis of selected chronic diseases. Furthermore, in multivariate models adjusted for sociodemographic variables and the presence of the other chronic conditions, adults with comorbid lifetime diagnosis of a selected chronic disease and serious psychological distress were significantly more likely to report 14 or more days of activity limitation than those with only a lifetime diagnosis of a chronic condition.
   Physicians should proactively screen and effectively treat co-occurring mental conditions in patients with chronic diseases who report frequent days of activity limitation because serious psychological distress may contribute to their level of impairment.
C1 [McKnight-Eily, Lela R.; Elam-Evans, Laurie D.; Strine, Tara W.; Zack, Matthew M.; Perry, Geraldine S.; Presley-Cantrell, Letitia; Edwards, Valerie J.; Croft, Janet B.] Ctr Dis Control & Prevent, Div Adult & Community Hlth, Atlanta, GA 30341 USA.
RP McKnight-Eily, LR (reprint author), Ctr Dis Control & Prevent, Div Adult & Community Hlth, 4770 Buford Hwy NE MS K-67, Atlanta, GA 30341 USA.
EM LMcKnightEily@cdc.gov
CR Bisschop MI, 2004, J CLIN EPIDEMIOL, V57, P187, DOI 10.1016/j.jclinepi.2003.01.001
   Cairney J, 2007, CAN J PSYCHIAT, V52, P111, DOI 10.1177/070674370705200209
   DeVol R, 2007, UNHEALTHY AM EC BURD
   Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184
   Kessler RC, 2003, J OCCUP ENVIRON MED, V45, P1257, DOI 10.1097/01.jom.0000100000.70011.bb
   Kessler RC, 2008, AM J PSYCHIAT, V165, P703, DOI 10.1176/appi.ajp.2008.08010126
   Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9
   Merikangas KR, 2007, ARCH GEN PSYCHIAT, V64, P1180, DOI 10.1001/archpsyc.64.10.1180
   PALINKAS LA, 1990, J CLIN EPIDEMIOL, V43, P1131, DOI 10.1016/0895-4356(90)90014-G
   Roy-Byrne PP, 2008, GEN HOSP PSYCHIAT, V30, P208, DOI 10.1016/j.genhosppsych.2007.12.006
   SCOTT K, 2008, PSYCHOL MED, P1
   Scott KM, 2007, J AFFECT DISORDERS, V103, P113, DOI 10.1016/j.jad.2007.01.015
   Shih M, 2008, QUAL LIFE RES, V17, P521, DOI 10.1007/s11136-008-9330-9
   TUNSTALLPEDOE H, 2005, PREVENTING CHRONIC D
   *US DEP HHS, 1998, BEH RISK FACT SURV S
   Veldhuizen S, 2007, CAN J PSYCHIAT, V52, P256, DOI 10.1177/070674370705200408
   World Health Organization, 2001, WORLD HLTH REP 2001
   Zahran Hatice S., 2005, Morbidity and Mortality Weekly Report, V54, P1
NR 18
TC 16
Z9 17
U1 0
U2 4
PU BIRKHAUSER VERLAG AG
PI BASEL
PA VIADUKSTRASSE 40-44, PO BOX 133, CH-4010 BASEL, SWITZERLAND
SN 1661-8556
J9 INT J PUBLIC HEALTH
JI Int. J. Public Health
PD JUN
PY 2009
VL 54
BP 111
EP 119
DI 10.1007/s00038-009-0015-0
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 462GW
UT WOS:000267340100018
PM 19421709
DA 2019-01-08
ER

PT J
AU Wallace, AS
   Seligman, HK
   Davis, TC
   Schillinger, D
   Arnold, CL
   Bryant-Shilliday, B
   Freburger, JK
   DeWalt, DA
AF Wallace, Andrea S.
   Seligman, Hilary K.
   Davis, Terry C.
   Schillinger, Dean
   Arnold, Connie L.
   Bryant-Shilliday, Betsy
   Freburger, Janet K.
   DeWalt, Darren A.
TI Literacy-appropriate educational materials and brief counseling improve
   diabetes self-management
SO PATIENT EDUCATION AND COUNSELING
LA English
DT Article
DE Patient education; Literacy; Diabetes; Self-care; Health promotion
ID FUNCTIONAL HEALTH LITERACY; PATIENT ACTIVATION MEASURE; CHRONIC ILLNESS
   CARE; PHYSICAL-ACTIVITY; GLYCEMIC CONTROL; BEHAVIOR-CHANGE; EFFICACY;
   PROGRAM; DISEASE; DIETARY
AB Objective: In this pilot study, we evaluated the impact of providing patients with a literacy-appropriate diabetes education guide accompanied by brief counseling designed for use in primary care.
   Methods: We provided the Living with Diabetes guide and brief behavior change counseling to 250 English and Spanish speaking patients with type 2 diabetes. Counseling sessions using collaborative goal setting occurred at baseline and by telephone at 2 and 4 weeks. We measured patients' activation, self-efficacy, diabetes distress, knowledge, and self-care at baseline and 3-month follow-up.
   Results: Statistically significant (p <= 0.001) and clinically important (effect sizes = 0.29-0.42) improvements were observed in participants' activation, self-efficacy, diabetes-related distress, self-reported behaviors, and knowledge. Improvements were similar across literacy levels. Spanish speakers experienced both greater improvement in diabetes-related distress and less improvement in self-efficacy levels than English speakers.
   Conclusion: A diabetes self-management support package combining literacy-appropriate patient education materials with brief counseling suitable for use in primary care resulted in important short-term health-related psychological and behavioral changes across literacy levels.
   Practice implications: Coupling literacy-appropriate education materials with brief counseling in primary care settings may be an effective and efficient strategy for imparting skills necessary for diabetes self-management. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
C1 [DeWalt, Darren A.] Univ N Carolina, Sch Med, Div Gen Internal Med, Chapel Hill, NC 27599 USA.
   [Wallace, Andrea S.] Univ New Mexico, Coll Nursing, Albuquerque, NM 87131 USA.
   [Seligman, Hilary K.; Schillinger, Dean] Univ Calif San Francisco, Sch Med, San Francisco, CA USA.
   [Davis, Terry C.; Arnold, Connie L.] Louisiana State Univ, Hlth Sci Ctr, Shreveport, LA 71105 USA.
   [Freburger, Janet K.; DeWalt, Darren A.] Univ N Carolina, Cecil G Sheps Ctr Hlth Serv Res, Chapel Hill, NC 27599 USA.
RP DeWalt, DA (reprint author), Univ N Carolina, Sch Med, Div Gen Internal Med, 5039 Old Clin Bldg,CB 7110, Chapel Hill, NC 27599 USA.
EM darren_dewalt@med.unc.edu
OI DeWalt, Darren/0000-0003-2270-751X
FU American College of Physicians Foundation; NIH [T32 NR08856]
FX The materials development and feasibility study described in this paper
   were supported by the American College of Physicians Foundation.
   Additional support for ASW's time was supplied by NIH T32 NR08856.
   Neither funding source participated in study design; in the collection,
   analysis, and interpretation of data; in the writing of the report; nor
   in the decision to submit the paper for publication.
CR Ammerman AS, 2002, PREV MED, V35, P25, DOI 10.1006/pmed.2002.1028
   Baker DW, 1999, PATIENT EDUC COUNS, V38, P33, DOI 10.1016/S0738-3991(98)00116-5
   Bandura A., 1997, SELF EFFICACY EXERCI
   Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P2469, DOI 10.1001/jama.288.19.2469
   Bodenheimer T, 2007, CLIN DIABETES, V25, P66
   Bradshaw BG, 2007, DIABETES EDUCATOR, V33, P650, DOI 10.1177/0145721707303809
   Davis T C, 1993, Fam Med, V25, P391
   Davis T. C., 2004, UNDERSTANDING HLTH L, P157
   Davis TC, 1998, PATIENT EDUC COUNS, V33, P25, DOI 10.1016/S0738-3991(97)00053-0
   Deakin TA, 2006, DIABETIC MED, V23, P944, DOI 10.1111/j.1464-5491.2006.01906.x
   DeWalt DA, 2004, PATIENT EDUC COUNS, V55, P78, DOI 10.1016/j.pec.2003.06.002
   Gerber BS, 2005, DIABETES CARE, V28, P1574, DOI 10.2337/diacare.28.7.1574
   Glasgow RE, 2001, AM J PREV MED, V21, P189, DOI 10.1016/S0749-3797(01)00350-6
   Glasgow RE, 2005, DIABETES CARE, V28, P2655, DOI 10.2337/diacare.28.11.2655
   GLASGOW RE, 2002, ANN BEHAV MED, V24, P880
   Handley M, 2006, J AM BOARD FAM MED, V19, P224, DOI 10.3122/jabfm.19.3.224
   Heisler M, 2003, DIABETES CARE, V26, P738, DOI 10.2337/diacare.26.3.738
   Heisler M, 2007, ARCH INTERN MED, V167, P1853, DOI 10.1001/archinte.167.17.1853
   Hibbard JH, 2005, HEALTH SERV RES, V40, P1918, DOI 10.1111/j.1475-6773.2005.00438.x
   Hibbard JH, 2004, HEALTH SERV RES, V39, P1005, DOI 10.1111/j.1475-6773.2004.00269.x
   Hibbard JH, 2007, HEALTH SERV RES, V42, P1443, DOI 10.1111/j.1475-6773.2006.00669.x
   Lorig K, 2006, J AM BOARD FAM MED, V19, P324, DOI 10.3122/jabfm.19.3.324
   Ma J, 2004, PREV MED, V39, P815, DOI 10.1016/j.ypmed.2004.03.006
   Marks P, 2005, ATHEROSCLEROSIS SUPP, V6, P148, DOI 10.1016/S1567-5688(05)80579-3
   Mosen DM, 2007, J AMBUL CARE MANAG, V30, P21
   PARKER RM, 1995, J GEN INTERN MED, V10, P537, DOI 10.1007/BF02640361
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Rothman RL, 2004, JAMA-J AM MED ASSOC, V292, P1711, DOI 10.1001/jama.292.14.1711
   Sarkar U, 2006, DIABETES CARE, V29, P823, DOI 10.2337/diacare.29.04.06.dc05-1615
   Schillinger D, 2006, PUBLIC HEALTH REP, V121, P245, DOI 10.1177/003335490612100305
   Schillinger D, 2003, ARCH INTERN MED, V163, P83, DOI 10.1001/archinte.163.1.83
   Seligman HK, 2007, AM J HEALTH BEHAV, V31, pS69
   Shilts MK, 2004, AM J HEALTH PROMOT, V19, P81, DOI 10.4278/0890-1171-19.2.81
   Siminerio LM, 2005, DIABETES EDUCATOR, V31, P225, DOI 10.1177/0145721705275325
   Wagner EH, 2005, J ALTERN COMPLEM MED, V11, pS7, DOI 10.1089/acm.2005.11.s-7
NR 35
TC 59
Z9 60
U1 1
U2 22
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0738-3991
J9 PATIENT EDUC COUNS
JI Patient Educ. Couns.
PD JUN
PY 2009
VL 75
IS 3
SI SI
BP 328
EP 333
DI 10.1016/j.pec.2008.12.017
PG 6
WC Public, Environmental & Occupational Health; Social Sciences,
   Interdisciplinary
SC Public, Environmental & Occupational Health; Social Sciences - Other
   Topics
GA 464ST
UT WOS:000267527700007
PM 19167857
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Benson, S
   Arck, PC
   Tan, S
   Hahn, S
   Mann, K
   Rifaie, N
   Janssen, OE
   Schedlowski, M
   Elsenbruch, S
AF Benson, S.
   Arck, P. C.
   Tan, S.
   Hahn, S.
   Mann, K.
   Rifaie, N.
   Janssen, O. E.
   Schedlowski, M.
   Elsenbruch, S.
TI Disturbed stress responses in women with polycystic ovary syndrome
SO PSYCHONEUROENDOCRINOLOGY
LA English
DT Article
DE Polycystic ovary syndrome; Psychological stress; Cardiovascular system;
   Immune system; Obesity
ID LOW-GRADE INFLAMMATION; METABOLIC SYNDROME; INSULIN-RESISTANCE;
   YOUNG-WOMEN; NEUROENDOCRINE RESPONSES; PSYCHOSOCIAL STRESS; MAJOR
   DEPRESSION; BLOOD-PRESSURE; FOLLOW-UP; CORTISOL
AB Background: We analyzed the neuroendocrine and immune cell responses to psychosocial stress in PCOS patients compared to BMI-matched healthy controls.
   Methods: Responses to public speaking stress were analyzed in 32 PCOS patients and 32 BMI-matched healthy controls. At baseline, during, and 10- and 45-min after stress, state anxiety, cardiovascular responses, cortisol, ACTH, as welt as circulating leukocyte subpopulations were analyzed, together with hsCRP and serum IL-6 concentrations.
   Results: In response to public speaking stress, both groups showed significant but comparable increases in state anxiety, and blood pressure (all p < 0.001; time effects). The ACTH and cortisol stress responses were significantly enhanced in PCOS (both p < 0.05; interaction effect). In addition, heart rate was significantly higher in PCOS (p < 0.05; group effect). PCOS patients displayed a reduced upregulation of IL-6 levels in response to stress (p < 0.05; interaction effect). Baseline levels of circulating leukocyte subpoputations, IL-6 and hsCRP concentrations did not differ between BMI-matched controls and PCOS patients. PCOS patients were characterized by markedly increased psychological distress.
   Conclusions: PCOS patients showed enhanced HPA-axis and heart rate reactivity as well as a reduced upregulation of IL-6 in response to stress. The altered stress reactivity in PCOS patients may constitute a link between depression, overweight, and the cardiovascular and diabetes risks associated with the diagnosis. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Benson, S.; Schedlowski, M.; Elsenbruch, S.] Univ Duisburg Essen, Dept Med Psychol & Behav Immunobiol, Univ Hosp Essen, D-45122 Essen, Germany.
   [Arck, P. C.] Charite Univ Med Berlin, Ctr Internal Med & Dermatol, Clin Internal Med & Psychosomat, D-13353 Berlin, Germany.
   [Tan, S.] Univ Duisburg Essen, Dep Endocrinol, Univ Hosp Essen, D-45122 Essen, Germany.
   [Tan, S.] Univ Duisburg Essen, Div Lab Res, Univ Hosp Essen, D-45122 Essen, Germany.
   [Hahn, S.] Ctr Endocrine & Metab Dis, Wuppertal, Germany.
   [Mann, K.; Janssen, O. E.] Ctr Endocrine & Metab Dis, Hamburg, Germany.
RP Elsenbruch, S (reprint author), Univ Duisburg Essen, Dept Med Psychol & Behav Immunobiol, Univ Hosp Essen, Hufelandstr 55, D-45122 Essen, Germany.
EM sigrid.elsenbruch@uk-essen.de
RI Arck, Petra/D-7094-2013; Benson, Sven/I-1981-2014
OI Benson, Sven/0000-0002-4487-4258
FU Lienert-Stiftung
FX The authors would like to express their gratitude to Katia Brassmann,
   Petra Busse, Evetin Hagen, Andrea Jaeger, and Natalie Riemenschneider
   for excellent technical support.; Sven Benson was supported by a stipend
   from the Lienert-Stiftung.
CR Alevizaki M, 2007, METABOLISM, V56, P222, DOI 10.1016/j.metabol.2006.09.017
   Apridonidze T, 2005, J CLIN ENDOCR METAB, V90, P1929, DOI 10.1210/jc.2004-1045
   Benson S, 2008, BRAIN BEHAV IMMUN, V22, P177, DOI 10.1016/j.bbi.2007.07.003
   BENSON S, 2008, PSYCHONEURO IN PRESS
   Black PH, 2003, BRAIN BEHAV IMMUN, V17, P350, DOI 10.1016/S0889-1591(03)00048-5
   Bullinger M, 1998, SF 36 FRAGEBOGEN ZUM
   Chen MJ, 2007, HYPERTENSION, V49, P1442, DOI 10.1161/HYPERTENSIONAHA.106.083972
   DEROGATIS LR, 1976, BRIT J PSYCHIAT, V128, P280, DOI 10.1192/bjp.128.3.280
   Diamanti-Kandarakis E, 2006, HUM REPROD, V21, P1426, DOI 10.1093/humrep/de1003
   Diamanti-Kandarakis E, 2006, ANN NY ACAD SCI, V1092, P175, DOI 10.1196/annals.1365.015
   Diamanti-Kandarakis E, 2006, ANN NY ACAD SCI, V1083, P54, DOI 10.1196/annals.1367.006
   Duncko R, 2006, PROG NEURO-PSYCHOPH, V30, P1058, DOI 10.1016/j.pnpbp.2006.04.002
   Ehrmann DA, 2006, J CLIN ENDOCR METAB, V91, P48, DOI 10.1210/jc.2005-1329
   Elsenbruch S, 2003, J CLIN ENDOCR METAB, V88, P5801, DOI 10.1210/jc.2003-030562
   Elsenbruch S, 2006, HUM REPROD, V21, P1092, DOI 10.1093/humrep/dei409
   Elsenbruch S, 2006, AM J GASTROENTEROL, V101, P2300, DOI 10.1111/j.1572-0241.2006.00837.x
   Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098
   Gallinelli A, 2000, FERTIL STERIL, V73, P812, DOI 10.1016/S0015-0282(99)00601-9
   Hautzinger M, 1995, BECK DEPRESSIONS INV
   Invitti C, 1998, METABOLISM, V47, P143, DOI 10.1016/S0026-0495(98)90210-4
   Janssen OE, 2008, SEMIN REPROD MED, V26, P45, DOI 10.1055/s-2007-992924
   Kajantie E, 2006, PSYCHONEUROENDOCRINO, V31, P151, DOI 10.1016/j.psyneuen.2005.07.002
   Koertge J, 2002, PSYCHONEUROENDOCRINO, V27, P893, DOI 10.1016/S0306-4530(02)00002-1
   Langhorst J, 2007, PSYCHONEUROENDOCRINO, V32, P1086, DOI 10.1016/j.psyneuen.2007.09.003
   LANZONE A, 1995, FERTIL STERIL, V63, P1195, DOI 10.1016/S0015-0282(16)57596-7
   Legro RS, 2003, ENDOCR REV, V24, P302, DOI 10.1210/er.2003-0004
   Lord JM, 2003, BRIT MED J, V327, P951, DOI 10.1136/bmj.327.7421.951
   Mansson M, 2008, PSYCHONEUROENDOCRINO, V33, P1132, DOI 10.1016/j.psyneuen.2008.06.003
   Matthews SC, 2005, PSYCHOSOM MED, V67, P509, DOI 10.1097/01.psy.0000160467.78373.d8
   Mohlig M, 2004, EUR J ENDOCRINOL, V150, P525, DOI 10.1530/eje.0.1500525
   Norman RJ, 2004, MED J AUSTRALIA, V180, P132
   Orio F, 2004, J CLIN ENDOCR METAB, V89, P4588, DOI 10.1210/jc.2003-031867
   Orio F, 2004, J CLIN ENDOCR METAB, V89, P3696, DOI 10.1210/jc.2003-032049
   Orio F, 2007, EUR J ENDOCRINOL, V157, P69, DOI 10.1530/EJE-07-0133
   Pace TWW, 2006, AM J PSYCHIAT, V163, P1630, DOI 10.1176/appi.ajp.163.9.1630
   Pasquali R, 2006, ANN NY ACAD SCI, V1083, P111, DOI 10.1196/annals.1367.009
   Pasquali R, 2006, EUR J ENDOCRINOL, V154, P763, DOI 10.1530/eje.1.02156
   Pickup JC, 2004, DIABETES CARE, V27, P813, DOI 10.2337/diacare.27.3.813
   Player MS, 2007, ANN FAM MED, V5, P403, DOI 10.1370/afm.738
   Pratt LA, 1996, CIRCULATION, V94, P3123, DOI 10.1161/01.CIR.94.12.3123
   Puder JJ, 2005, J CLIN ENDOCR METAB, V90, P6014, DOI 10.1210/jc.2005-1002
   Rosmond R, 2005, PSYCHONEUROENDOCRINO, V30, P1, DOI 10.1016/j.psyneuen.2004.05.007
   Shaw LJ, 2008, J CLIN ENDOCR METAB, V93, P1276, DOI 10.1210/jc.2007-0425
   Sher L, 2004, MED HYPOTHESES, V62, P198, DOI 10.1016/S0306-9877(03)00320-7
   Simeon D, 2007, BIOL PSYCHIAT, V61, P966, DOI 10.1016/j.biopsych.2006.07.030
   Spielberger CD, 1970, MANUAL STATE TRAIT A
   Steptoe A, 2005, J HYPERTENS, V23, P529, DOI 10.1097/01.hjh.0000160208.66405.a8
   Steptoe A, 2007, BRAIN BEHAV IMMUN, V21, P901, DOI 10.1016/j.bbi.2007.03.011
   Tarkun I, 2004, J CLIN ENDOCR METAB, V89, P5592, DOI 10.1210/jc.2004-0751
   Tichomirowa MA, 2005, J ENDOCRINOL INVEST, V28, P89, DOI 10.1007/BF03345535
   Vgontzas AN, 2006, METABOLISM, V55, P1076, DOI 10.1016/j.metabol.2006.04.002
   Weber-Hamann B, 2006, PSYCHONEUROENDOCRINO, V31, P347, DOI 10.1016/j.psyneuen.2005.08.014
   WOLF JM, 2008, BRAIN BEHAV IMMU SEP
NR 53
TC 59
Z9 61
U1 0
U2 11
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0306-4530
J9 PSYCHONEUROENDOCRINO
JI Psychoneuroendocrinology
PD JUN
PY 2009
VL 34
IS 5
BP 727
EP 735
DI 10.1016/j.psyneuen.2008.12.001
PG 9
WC Endocrinology & Metabolism; Neurosciences; Psychiatry
SC Endocrinology & Metabolism; Neurosciences & Neurology; Psychiatry
GA 444BC
UT WOS:000265953900010
PM 19150179
DA 2019-01-08
ER

PT J
AU Hermanns, N
   Kulzer, B
   Gulde, C
   Eberle, H
   Pradler, E
   Patzelt-Bath, A
   Haak, T
AF Hermanns, N.
   Kulzer, B.
   Gulde, C.
   Eberle, H.
   Pradler, E.
   Patzelt-Bath, A.
   Haak, T.
TI Short-Term Effects on Patient Satisfaction of Continuous Glucose
   Monitoring with the GlucoDay with Real-Time and Retrospective Access to
   Glucose Values: A Crossover Study
SO DIABETES TECHNOLOGY & THERAPEUTICS
LA English
DT Article
ID DIABETIC-PATIENTS; GLYCEMIC CONTROL; MANAGEMENT; SENSORS
AB Background: This randomized crossover trial examines the effect of continuous glucose monitoring (CGM) with real-time access (RTA) to glucose data versus CGM with a retrospective analysis (RA) of glucose data regarding satisfaction with CGM and other patient-reported outcomes.
   Methods: Participants used the CGM device (GlucoDay (R), Menarini Diagnostics, Florence, Italy) twice. In one study phase, patients were allowed RTA to, and in the other phase RA of, current glucose values. The order of these two conditions was randomized. At baseline and after the first and second trials, subjects completed questionnaires (Continuous Glucose Monitoring Satisfaction Scale) about perceived satisfaction with CGM. They also completed the Problem Areas in Diabetes Questionnaire, a state anxiety scale (State-Trait Anxiety Inventory), and a depression scale (Center of Epidemiological Studies-Depression Scale).
   Results: Fifty patients with type 1 diabetes (41.7 +/- 12.3 years old, diabetes duration of 14.75 +/- 11.9 years, 48% female, hemoglobin A1c 8.1 +/- 1.5%, years of education 10.3 +/- 2.1 years) participated in this study. At baseline patients perceived CGM as rather advantageous, but after RA and RTA the perceived benefits were reduced (baseline, 101.0 +/- 16.0; RA, 95.7 +/- 20.2; RTA, 93.6 +/- 22.8; P < 0.01). However, there was no significant difference between RA and RTA. Also, there was no significant effect on diabetes-related distress or state anxiety, but a positive effect on depression scores.
   Conclusions: There was no specific, significant, negative or positive effect of RA versus RTA on satisfaction with CGM. Exposing patients with type 1 diabetes to their current glucose values does not seem to have a specific negative impact on the appraisal of CGM or more generic patient-reported outcomes.
C1 [Hermanns, N.; Kulzer, B.; Gulde, C.; Eberle, H.; Haak, T.] Diabet Acad Mergentheim, Res Inst, Bad Mergentheim, Germany.
   [Pradler, E.; Patzelt-Bath, A.] A Menarini Diagnost, Berlin, Germany.
RP Hermanns, N (reprint author), Diabet Res Inst, Theodor Klotzbuecher Str 12, D-97980 Bad Mergentheim, Germany.
EM hermanns@diabetes-zentrum.de
FU Menarini Diagnostics
FX This study was funded by an unrestricted grant of Menarini Diagnostics.
CR Cohen J, 1977, STAT POWER ANAL BEHA
   Cryer PE, 2002, DIABETOLOGIA, V45, P937, DOI 10.1007/s00125-002-0822-9
   *DIRECNET STUD GRO, 2006, PEDIAT DIABETES, V7, P32
   Garg S, 2006, DIABETES CARE, V29, P44, DOI 10.2337/diacare.29.01.06.dc05-1686
   Garg SK, 2007, DIABETES CARE, V30, P3023, DOI 10.2337/dc07-1436
   Kaufman FR, 2001, DIABETES CARE, V24, P2030, DOI 10.2337/diacare.24.12.2030
   Koschinsky T, 2001, DIABETES-METAB RES, V17, P113, DOI 10.1002/dmrr.188
   Kubiak T, 2006, DIABETES TECHNOL THE, V8, P570, DOI 10.1089/dia.2006.8.570
   Laux L, 1981, STATE TRAIT ANGSTINV
   Maran A, 2002, DIABETES CARE, V25, P347, DOI 10.2337/diacare.25.2.347
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   SHAMOON H, 1993, NEW ENGL J MED, V329, P977
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   Wentholt IM, 2005, DIABETES CARE, V28, P2871, DOI 10.2337/diacare.28.12.2871
   Wysocki T, 2005, DIABETES CARE, V28, P1929
NR 15
TC 5
Z9 5
U1 0
U2 4
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1520-9156
J9 DIABETES TECHNOL THE
JI Diabetes Technol. Ther.
PD MAY
PY 2009
VL 11
IS 5
BP 275
EP 281
DI 10.1089/dia.2008.0078
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 444DD
UT WOS:000265959700002
PM 19425875
DA 2019-01-08
ER

PT J
AU Pratikaki, M
   Platsouka, E
   Sotiropoulou, C
   Vassilakopoulos, T
   Paniara, O
   Roussos, C
   Routsi, C
AF Pratikaki, M.
   Platsouka, E.
   Sotiropoulou, C.
   Vassilakopoulos, T.
   Paniara, O.
   Roussos, C.
   Routsi, C.
TI Risk factors for and influence of bloodstream infections on mortality: a
   1-year prospective study in a Greek intensive-care unit
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
DE Bloodstream infection; ICU; mortality; risk factors
ID CRITICALLY-ILL PATIENTS; GRAM-NEGATIVE BACILLI; NOSOCOMIAL INFECTIONS;
   ANTIMICROBIAL RESISTANCE; ACINETOBACTER-BAUMANNII;
   HOSPITALIZED-PATIENTS; ACQUIRED BACTEREMIA; IMPACT; TRENDS; EPIDEMIOLOGY
AB To determine the incidence, risk factors for, and the influence of bloodstream infections (BSIs) on mortality of patients in intensive-care units (ICUs), prospectively collected data from all patients with a stay in an ICU >48 h, during a I-year period, were analysed. Of 572 patients, 148 developed a total of 232 BSI episodes (incidence 16.3 episodes/1000 patient-days). Gram-negative organisms with high level of resistance to antibiotics were the most frequently isolated pathogens (157 strains, 67.8%). The severity of illness on admission, as estimated by APACHE II score (OR 1.07, 95% CI 1.04-1.1, P<0.001), the presence of acute respiratory distress syndrome (OR 3.57, 95% CI 1.92-6.64, P<0.001), and a history of diabetes mellitus (OR 2.37, 95% CI 1.36-4.11, P = 0.002) were risk factors for the occurrence of BSI whereas the development of an ICU-acquired BSI was an independent risk factor for death (OR 1.76, 95% CI 1.11-2.78, P = 0.015). Finally, the severity of organ dysfunction on the day of the first BSI episode, as estimated by SOFA score, and the level of serum albumin, independently affected the outcome (OR 1.44, 95% CI 1.22-1.7, P < 0.001 and OR 0.47, 95% CI 0.23-0.97, P = 0.04 respectively).
C1 [Pratikaki, M.; Sotiropoulou, C.; Vassilakopoulos, T.; Roussos, C.; Routsi, C.] Univ Athens, Evangelismos Hosp, Sch Med, Dept Intens Care,Dept Clin Microbiol, Athens 10676, Greece.
   [Pratikaki, M.; Platsouka, E.; Paniara, O.] Evangelismos Med Ctr, Dept Clin Microbiol, Athens, Greece.
RP Routsi, C (reprint author), Univ Athens, Evangelismos Hosp, Sch Med, Dept Intens Care,Dept Clin Microbiol, 45-47 Ipsilantou Str, Athens 10676, Greece.
EM croutsi@hotmail.com
FU Thorax Foundation; University of Athens
FX This study was supported in part by the Thorax Foundation and by the
   Special Account for Research Grants of the University of Athens.
CR American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee, 1992, CRIT CARE MED, V20, P864, DOI [10.1097/00003246-199206000-00025, DOI 10.1097/00003246-199206000-00025]
   Blot S, 2003, INTENS CARE MED, V29, P471, DOI 10.1007/s00134-003-1648-8
   Borg MA, 2003, J HOSP INFECT, V54, P316, DOI 10.1016/S0195-6701(03)00153-1
   BrunBuisson C, 1996, AM J RESP CRIT CARE, V154, P617, DOI 10.1164/ajrccm.154.3.8810595
   BUENOCAVANILLAS A, 1994, CRIT CARE MED, V22, P55, DOI 10.1097/00003246-199401000-00013
   Correa L, 2000, J HOSP INFECT, V46, P89, DOI 10.1053/jhin.2000.0803
   Falagas ME, 2007, CLIN MICROBIOL INFEC, V13, P816, DOI 10.1111/j.1469-0691.2007.01761.x
   FEIN AM, 1983, CHEST, V83, P40, DOI 10.1378/chest.83.1.40
   Flournoy DJ, 2000, AM J INFECT CONTROL, V28, P244, DOI 10.1067/mic.2000.103836
   GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3
   Gaynes R, 2005, CLIN INFECT DIS, V41, P848, DOI 10.1086/432803
   Gerberding J, 1999, AM J INFECT CONTROL, V27, P520
   Harbarth S, 2002, ARCH SURG-CHICAGO, V137, P1353, DOI 10.1001/archsurg.137.12.1353
   Harbarth S, 1999, SCAND J INFECT DIS, V31, P163
   Jerassy Z, 2006, J HOSP INFECT, V62, P230, DOI 10.1016/j.jhin.2005.07.007
   Jones RN, 1996, DIAGN MICR INFEC DIS, V25, P153, DOI 10.1016/S0732-8893(96)00099-5
   JONES RN, 2001, CHEST S2, V119, P397
   KAJDACSYBALLA A, 2005, INTENS CARE MED, V31, P243
   Kang CI, 2005, ANTIMICROB AGENTS CH, V49, P760, DOI 10.1128/AAC.49.2.760-766.2005
   KAPLAN RL, 1979, ARCH INTERN MED, V139, P867, DOI 10.1001/archinte.139.8.867
   KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009
   Kohlenberg A, 2008, CLIN MICROBIOL INFEC, V14, P93, DOI 10.1111/j.1469-0691.2007.01879.x
   Kraniotaki E, 2006, INT J ANTIMICROB AG, V28, P193, DOI 10.1016/j.ijantimicag.2006.04.016
   Laupland KB, 2004, J HOSP INFECT, V58, P137, DOI 10.1016/j.jhin.2004.06.007
   *NAT COMM CLIN LAB, 2000, M2A7 NCCLS
   Pittet D, 1997, CLIN INFECT DIS, V24, P1068, DOI 10.1086/513640
   PITTET D, 1995, ARCH INTERN MED, V155, P1177, DOI 10.1001/archinte.155.11.1177
   PITTET D, 1994, JAMA-J AM MED ASSOC, V271, P1598, DOI 10.1001/jama.271.20.1598
   PITTET D, 2006, CLIN CRITICAL CARE M, P71
   Raymond DP, 2003, CRIT CARE MED, V31, P1035, DOI 10.1097/01.CCM.0000060015.77443.31
   Rello J, 2000, AM J RESP CRIT CARE, V162, P1027, DOI 10.1164/ajrccm.162.3.9911093
   RELLO J, 1994, INTENS CARE MED, V20, P94, DOI 10.1007/BF01707661
   Routsi C, 2007, INFECTION, V35, P240, DOI 10.1007/s15010-007-6217-6
   Sreeramoju PV, 2008, INFECT CONT HOSP EP, V29, P51, DOI 10.1086/524334
   Tsai CL, 2007, J INFECTION, V55, P27, DOI 10.1016/j.jinf.2007.01.004
   Valles J, 1997, CLIN INFECT DIS, V24, P387, DOI 10.1093/clinids/24.3.387
   Waterer GW, 2001, CRIT CARE MED, V29, pN75, DOI 10.1097/00003246-200104001-00004
   Wenzel RP, 2001, EMERG INFECT DIS, V7, P174, DOI 10.3201/eid0702.010203
   *WHONET GREEC, GREEK SYST SURV ANT
   Wu Chi-Jung, 2006, Journal of Microbiology Immunology and Infection, V39, P135
NR 40
TC 13
Z9 15
U1 0
U2 1
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PD MAY
PY 2009
VL 137
IS 5
BP 727
EP 735
DI 10.1017/S0950268808001271
PG 9
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA 435UU
UT WOS:000265369600014
PM 18796170
DA 2019-01-08
ER

PT J
AU Skaff, MM
   Mullan, JT
   Almeida, DM
   Hoffman, L
   Masharani, U
   Mohr, D
   Fisher, L
AF Skaff, Marilyn M.
   Mullan, Joseph T.
   Almeida, David M.
   Hoffman, Lesa
   Masharani, Umesh
   Mohr, David
   Fisher, Lawrence
TI Daily Negative Mood Affects Fasting Glucose in Type 2 Diabetes
SO HEALTH PSYCHOLOGY
LA English
DT Article
DE negative affect; positive affect; diabetes; mood; glucose
ID DEPRESSIVE SYMPTOMS; GLYCEMIC CONTROL; DAILY EXPERIENCE; IMMUNE
   FUNCTION; ASSOCIATION; HEALTH; RISK; METAANALYSIS; RUMINATION; DISTRESS
AB Objective: To examine the relationship between mood and blood glucose in a 21-day daily diary study. Design: During a home visit, information was gathered from 206 persons with Type 2 diabetes regarding demographics, disease characteristics and treatment, and depressive symptoms. They had blood drawn at a laboratory, yielding HbA1C. The participants were then telephoned each evening for 21 days and were asked about their positive and negative mood during the past 24 hours. They also tested their blood glucose upon rising in the morning. Main Outcome Measures: The main outcomes measures were positive and negative affect and fasting glucose. Results: Multilevel analyses revealed a relationship between negative affect on one day and morning glucose on the next day. There was no such relationship between positive affect and glucose, nor was there a comparable effect of glucose on one day and either positive or negative affect on the next day. Conclusion: The observed relationship between mood and blood glucose appears to be because of negative affect, not positive, with no evidence of a lagged effect of glucose on mood.
C1 [Skaff, Marilyn M.; Fisher, Lawrence] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA.
   [Skaff, Marilyn M.] Univ Calif San Francisco, Dept Family & Med, San Francisco, CA 94143 USA.
   [Mullan, Joseph T.] Univ Calif San Francisco, Dept Social & Behav Sci, San Francisco, CA 94143 USA.
   [Almeida, David M.] Penn State Univ, Dept Human Dev & Family Studies, University Pk, PA 16802 USA.
   [Hoffman, Lesa] Univ Nebraska, Dept Psychol, Lincoln, NE 68583 USA.
   [Masharani, Umesh] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.
   [Mohr, David] Northwestern Univ, Dept Prevent Med, Evanston, IL 60208 USA.
RP Skaff, MM (reprint author), Univ Calif San Francisco, Dept Family & Community Med, Box 0900, San Francisco, CA 94143 USA.
EM marilyn.skaff@ucsf.edu
OI Mohr, David/0000-0002-5443-7596
FU National Institute of Diabetes, Digestive, and Kidney Disease [DK062732,
   DK061937]
FX This research was supported by grants DK062732 and DK061937 from the
   National Institute of Diabetes, Digestive, and Kidney Disease. The
   following medical groups and diabetes education centers collaborated in
   this research: Alta Bates Diabetes Education Center. Brown and Toland
   Medical Group, CA Pacific Diabetes Education Center, Hill Physicians
   Medical Group, Marin IPA, St. Luke's Diabetes Education Center, St.
   Mary's Medical Center, University of California, San Francisco Hospital
   and Clinics. We thank Roche diagnostics for providing glucose monitors
   and strips.
CR Almeida DM, 2005, CURR DIR PSYCHOL SCI, V14, P64, DOI 10.1111/j.0963-7214.2005.00336.x
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Arroyo C, 2004, DIABETES CARE, V27, P129, DOI 10.2337/diacare.27.1.129
   Bode BW, 2005, DIABETES CARE, V28, P2361, DOI 10.2337/diacare.28.10.2361
   CAMETHON MR, 2003, AM J EPIDEMIOL, V158, P416
   Charles ST, 2006, PSYCHOL HEALTH, V21, P1, DOI 10.1080/14768320500129239
   Chepenik LG, 2006, AM J GERIAT PSYCHIAT, V14, P270, DOI 10.1097/01.JGP.0000194644.63245.42
   Cohen S., 1995, MEASURING STRESS GUI, P3
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   Denollet J, 2006, J AFFECT DISORDERS, V91, P171, DOI 10.1016/j.jad.2005.12.044
   Eaton WW, 2002, J PSYCHOSOM RES, V53, P903, DOI 10.1016/S0022-3999(02)00302-1
   Everson-Rose SA, 2004, DIABETES CARE, V27, P2856, DOI 10.2337/diacare.27.12.2856
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Freeman M. F., 1950, APPL LONGITUDINAL AN, V21, P607
   GONDERFREDERICK LA, 1989, HEALTH PSYCHOL, V8, P45, DOI 10.1037//0278-6133.8.1.45
   Hoffman L, 2007, MULTIVAR BEHAV RES, V42, P609, DOI 10.1080/00273170701710072
   Kamarck TW, 2005, J PERS, V73, P1749, DOI 10.1111/j.1467-6494.2005.00365.x
   Kiecolt-Glaser JK, 2002, J PSYCHOSOM RES, V53, P873, DOI 10.1016/S0022-3999(02)00309-4
   Kiecolt-Glaser JK, 2002, J CONSULT CLIN PSYCH, V70, P537, DOI 10.1037//0022-006X.70.3.537
   Littell R. C., 1996, SAS SYSTEM MIXED MOD
   Lustman PJ, 2005, J DIABETES COMPLICAT, V19, P113, DOI 10.1016/j.jdiacomp.2004.01.002
   MCCULLOUGH ME, 2002, HEALTH PSYCHOL, V26, P126
   MCEWEN BS, 1998, SEMINARS MED BETH IS, V338, P171
   MUTHEN BO, 1998, MPLUS USER GUIDE
   Nolen-Hoeksema S, 2001, PSYCHOL WOMEN QUART, V25, P37, DOI 10.1111/1471-6402.00005
   Oltmanns KM, 2006, EUR J ENDOCRINOL, V154, P325, DOI 10.1530/eje.1.02074
   Palinkas LA, 2004, DIABETIC MED, V21, P1185, DOI 10.1111/j.1464-5491.2004.01315.x
   Pressman SD, 2005, PSYCHOL BULL, V131, P925, DOI 10.1037/0033-2909.131.6.925
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Ryff CD, 2006, PSYCHOTHER PSYCHOSOM, V75, P85, DOI 10.1159/000090892
   Spitzer C, 2008, DIABETIC MED, V25, P349, DOI 10.1111/j.1464-5491.2007.02369.x
   Steptoe A, 2005, NEUROBIOL AGING, V26, pS108, DOI 10.1016/j.neurobiolaging.2005.08.016
   Taylor SE, 1997, ANNU REV PSYCHOL, V48, P411, DOI 10.1146/annurev.psych.48.1.411
   Tennen H, 2005, J PERS, V73, P1465, DOI 10.1111/j.1467-6494.2005.00355.x
   Trief PM, 2001, DIABETES CARE, V24, P1384, DOI 10.2337/diacare.24.8.1384
   Valdimarsdottir HB, 1997, PSYCHOL HEALTH, V12, P319, DOI 10.1080/08870449708406710
   WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063
   Watson D, 1999, J PERS SOC PSYCHOL, V76, P820, DOI 10.1037//0022-3514.76.5.820
   WITTCHEN HU, 1994, J PSYCHIAT RES, V28, P57, DOI 10.1016/0022-3956(94)90036-1
   Yancura LA, 2006, J GERONTOL B-PSYCHOL, V61, pP295, DOI 10.1093/geronb/61.5.P295
NR 40
TC 33
Z9 33
U1 0
U2 12
PU AMER PSYCHOLOGICAL ASSOC
PI WASHINGTON
PA 750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA
SN 0278-6133
EI 1930-7810
J9 HEALTH PSYCHOL
JI Health Psychol.
PD MAY
PY 2009
VL 28
IS 3
BP 265
EP 272
DI 10.1037/a0014429
PG 8
WC Psychology, Clinical; Psychology
SC Psychology
GA 445XM
UT WOS:000266084800001
PM 19450031
OA Green Published, Green Accepted
DA 2019-01-08
ER

PT J
AU Cameron, LD
   Sherman, KA
   Marteau, TM
   Brown, PM
AF Cameron, Linda D.
   Sherman, Kerry A.
   Marteau, Theresa M.
   Brown, Paul M.
TI Impact of Genetic Risk Information and Type of Disease on Perceived
   Risk, Anticipated Affect, and Expected Consequences of Genetic Tests
SO HEALTH PSYCHOLOGY
LA English
DT Article
DE genetic testing; risk perception; affect; attitudes; communication
ID BREAST-CANCER SUSCEPTIBILITY; PSYCHOLOGICAL IMPACT; PERCEPTIONS;
   POPULATION; WORRY; DISCRIMINATION; PROBABILITY; MOTIVATIONS; INSURANCE;
   DECISIONS
AB Objective: Genetic tests vary in their prediction of disease occurrence, with some mutations conferring relatively low risk and others indicating near certainty. The authors assessed how increments in absolute risk of disease influence risk perceptions, interest, and expected consequences of genetic tests for diseases of varying severity. Design: Adults (N = 752), recruited from New Zealand, Australia, and the United Kingdom for an online analogue study, were randomly assigned to receive information about a test of genetic risk for diabetes, heart disease, colon cancer, or lung cancer. The lifetime risk varied across conditions by 10% increments, from 20% to 100%. Main Outcome Measures: Participants completed measures of perceived likelihood of disease for individuals with mutations, risk-related affect, interest, and testing consequences. Results: Analyses revealed two increment clusters yielding differences in likelihood perceptions: A "moderate-risk" cluster (20%-70%), and a "high-risk" cluster (80%-100%). Risk increment influenced anticipated worry, feelings of risk, testing-induced distress, and family obligations, with nonlinear patterns including disproportionately high responses for the 50% increment. Risk increment did not alter testing interest or perceived benefits. These patterns of effects held across the four diseases. Conclusion: Magnitude of risk from genetic testing has a nonlinear influence on risk-related appraisals and affect but is unrelated to test interest.
C1 [Cameron, Linda D.] Univ Auckland, Dept Psychol, Auckland Mail Ctr, Auckland, New Zealand.
   [Sherman, Kerry A.] Macquarie Univ, Sydney, NSW 2109, Australia.
   [Sherman, Kerry A.] NSW Breast Canc Inst, Sydney, NSW, Australia.
   [Marteau, Theresa M.] Kings Coll London, London, England.
RP Cameron, LD (reprint author), Univ Auckland, Dept Psychol, Auckland Mail Ctr, Tamaki Campus,Private Bag 92019, Auckland, New Zealand.
EM l.cameron@auckland.ac.nz
OI Marteau, Theresa/0000-0003-3025-1129; Sherman, Kerry/0000-0001-7780-6668
CR Aiken L S, 1995, Womens Health, V1, P27
   Audrain J, 1997, ADDICT BEHAV, V22, P741, DOI 10.1016/S0306-4603(97)00060-9
   Axworthy D, 1996, LANCET, V347, P1443
   Brewer NT, 2004, ANN BEHAV MED, V27, P125, DOI 10.1207/s15324796abm2702_7
   BROWN PM, 2007, J HEALTHCARE TECHNOL, V8, P522
   Cameron LD, 2006, PSYCHOL HEALTH, V21, P211, DOI 10.1080/14768320500230318
   Cameron LD, 2001, J HEALTH PSYCHOL, V6, P47, DOI 10.1177/135910530100600104
   Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626
   Connolly T, 2005, HEALTH PSYCHOL, V24, pS29, DOI 10.1037/0278-6133.24.4.S29
   de Bruin WB, 2000, ORGAN BEHAV HUM DEC, V81, P115, DOI 10.1006/obhd.1999.2868
   Esplen MJ, 2001, AM J MED GENET, V103, P9, DOI 10.1002/ajmg.1493
   ETCHEGARY H, 2004, ANAL SOC ISS PUB POL, V4, P13
   French DP, 2007, CAMBRIDGE HANDBOOK OF PSYCHOLOGY, HEALTH AND MEDICINE, 2ND EDITION, P431
   Gollust SE, 2002, JAMA-J AM MED ASSOC, V288, P1762, DOI 10.1001/jama.288.14.1762
   Hallowell N, 1999, SOCIOL HEALTH ILL, V21, P597, DOI 10.1111/1467-9566.00175
   Harris PR, 2005, PSYCHOL HEALTH, V20, P319, DOI 10.1080/08870440512331317689
   Hay JL, 2006, PREV MED, V42, P401, DOI 10.1016/j.ypmed.2006.03.002
   Helmes AW, 2002, PREV MED, V35, P453, DOI 10.1006/pmed.2002.1110
   HERNANDEZ LM, 2005, IMPLICATIONS GENOMIC
   JEMMOTT JB, 1986, J PERS SOC PSYCHOL, V50, P899, DOI 10.1037/0022-3514.50.5.899
   Klein WM, 1997, J PERS SOC PSYCHOL, V72, P763, DOI 10.1037//0022-3514.72.4.763
   Lerman C, 1997, J CONSULT CLIN PSYCH, V65, P414, DOI 10.1037//0022-006X.65.3.414
   Lerman C, 2002, J CONSULT CLIN PSYCH, V70, P784, DOI 10.1037//0022-006X.70.3.784
   Lerman C, 2000, PREV MED, V31, P75, DOI 10.1006/pmed.2000.0684
   Leventhal HLBI, 2003, SELF REGULATION HLTH, P42
   Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267
   Low L, 1998, BRIT MED J, V317, P1632, DOI 10.1136/bmj.317.7173.1632
   Marteau T, 2004, AM J MED GENET A, V128A, P285, DOI 10.1002/ajmg.a.30102
   Marteau TM, 2001, BRIT MED J, V322, P1056, DOI 10.1136/bmj.322.7293.1056
   McBride CM, 2002, CANCER EPIDEM BIOMAR, V11, P521
   Peterson EA, 2002, CANCER EPIDEM BIOMAR, V11, P79
   Reyna V. F., 1991, Journal of Behavioral Decision Making, V4, P249, DOI 10.1002/bdm.3960040403
   Senior V, 1999, PSYCHOL HEALTH, V14, P1077, DOI 10.1080/08870440008407368
   SHILOH S, 1989, AM J MED GENET, V33, P130, DOI 10.1002/ajmg.1320330121
   Shiloh S, 1998, PSYCHOL HEALTH, V13, P1071, DOI 10.1080/08870449808407451
   Slovic P, 1980, SOCIETAL RISK ASSESS
   Slovic Paul, 2002, HEURISTICS BIASES PS, P397, DOI DOI 10.1017/CBO9780511808098.025
   Turner RD, 1999, DIS MARKERS, V15, P175, DOI 10.1155/1999/753674
   WAGNER CJ, 2003, AM J MED GENET C, V119, P11
   Weinstein ND, 2000, HEALTH PSYCHOL, V19, P65, DOI 10.1037//0278-6133.19.1.65
   WEINSTEIN ND, 2002, HEURISTICS BIASES PS, P313
   Weinstein ND, 2007, HEALTH PSYCHOL, V26, P146, DOI 10.1037/0278-6133.26.2.146
NR 42
TC 63
Z9 63
U1 0
U2 20
PU AMER PSYCHOLOGICAL ASSOC
PI WASHINGTON
PA 750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA
SN 0278-6133
J9 HEALTH PSYCHOL
JI Health Psychol.
PD MAY
PY 2009
VL 28
IS 3
BP 307
EP 316
DI 10.1037/a0013947
PG 10
WC Psychology, Clinical; Psychology
SC Psychology
GA 445XM
UT WOS:000266084800006
PM 19450036
DA 2019-01-08
ER

PT J
AU Wiltink, J
   Tschan, R
   Michal, M
   Subic-Wrana, C
   Eckhardt-Henn, A
   Dieterich, M
   Beutel, ME
AF Wiltink, Joerg
   Tschan, Regine
   Michal, Matthias
   Subic-Wrana, Claudia
   Eckhardt-Henn, Annegret
   Dieterich, Marianne
   Beutel, Manfred E.
TI Dizziness: Anxiety, health care utilization and health behavior -
   Results from a representative German community survey
SO JOURNAL OF PSYCHOSOMATIC RESEARCH
LA English
DT Article
DE Epidemiology; Dizziness; Vertigo; Anxiety; Comorbidities; Migraine
ID PERIPHERAL VESTIBULAR DISORDER; PANIC DISORDER; VERTIGO; PREVALENCE;
   SYMPTOMS; REHABILITATION; DIAGNOSIS; IMPACT; COMORBIDITY; DEPRESSION
AB Background: Due to the lack of epidemiological data on the relation of dizziness and anxiety, we investigated the prevalence of dizziness and anxiety in a representative sample of the German population. We explored the consequences of comorbid anxiety for emotional distress, functional impairment, health care utilization, and health behavior in dizziness. Methods: By the end of 2006, we surveyed a total of 1287 persons between 14 and 90 years of age in their homes by trained interviewers with standardized self-rating questionnaires on anxiety (Patient Health Questionnaire, Generalized Anxiety Disorder Scale, Mini-Social Phobia Inventory) and dizziness (Vertigo Symptom Scale). The sample was representative for the German population in terms of age, sex, and education. Results: Symptoms of dizziness were reported by 15.8% of the participants. Of the participants with dizziness, 28.3% reported symptoms of at least one anxiety disorder (generalized anxiety, social phobia, panic). Persons with dizziness reported more somatic problems such as hypertension, migraine, diabetes, etc. Comorbid anxiety was associated with increased health care use and impairment. Conclusion: Dizziness is a highly prevalent symptom in the general population. A subgroup with comorbid anxiety is characterized by an increased subjective impairment and health care utilization due to their dizziness. Because treatment options for distinct neurotologic disorders are also known to reduce psychological symptoms, and in order to avoid unnecessary medical treatment, early neurologic and psychiatric/psychotherapeutic referral may be indicated. (C) 2009 Elsevier Inc. All fights reserved.
C1 [Wiltink, Joerg; Tschan, Regine; Michal, Matthias; Subic-Wrana, Claudia; Beutel, Manfred E.] Johannes Gutenberg Univ Mainz, Clin Psychosomat Med & Psychotherapy, Mainz, Germany.
   [Dieterich, Marianne] Johannes Gutenberg Univ Mainz, Dept Neurol, Mainz, Germany.
   [Eckhardt-Henn, Annegret] Hosp Stuttgart, Dept Psychosomat Med, Stuttgart, Germany.
   [Dieterich, Marianne] Univ Munich, Dept Neurol, D-8000 Munich, Germany.
RP Tschan, R (reprint author), Johannes Gutenberg Univ Mainz, Clin Psychosomat Med & Psychotherapy, Mainz, Germany.
EM tschan@psychosomatik.klinik.uni-mainz.de
CR Andersson G, 2006, BEHAV RES THER, V44, P1265, DOI 10.1016/j.brat.2005.09.008
   Ardic FN, 2006, OTOL NEUROTOL, V27, P676
   Asmundson GJG, 1998, J PSYCHOSOM RES, V44, P107, DOI 10.1016/S0022-3999(97)00132-3
   Balaban CD, 2001, J ANXIETY DISORD, V15, P53, DOI 10.1016/S0887-6185(00)00042-6
   Best C, 2006, J NEUROL NEUROSUR PS, V77, P658, DOI 10.1136/jnnp.2005.072934
   Beutel ME, 2002, EUR UROL, V41, P85, DOI 10.1016/S0302-2838(01)00003-3
   CLARK MR, 1994, J PSYCHOSOM RES, V38, P461, DOI 10.1016/0022-3999(94)90107-4
   Connor KM, 2001, DEPRESS ANXIETY, V14, P137, DOI 10.1002/da.1055
   Davis A, 2003, TXB AUDIOLOGICAL MED, P89
   EAGGER S, 1992, J NEUROL NEUROSUR PS, V55, P383, DOI 10.1136/jnnp.55.5.383
   Eckhardt-Henn A, 2005, NEUROL CLIN, V23, P731, DOI 10.1016/j.ncl.2005.01.008
   Eckhardt-Henn A, 2003, J ANXIETY DISORD, V17, P369, DOI 10.1016/S0887-6185(02)00226-8
   Eckhardt-Henn A, 2008, J NEUROL, V255, P420, DOI 10.1007/s00415-008-0697-x
   Furman JM, 2005, J NEUROL NEUROSUR PS, V76, P1, DOI 10.1136/jnnp.2004.048926
   Godemann F, 2005, J PSYCHIATR RES, V39, P529, DOI 10.1016/j.jpsychires.2004.12.006
   Godemann F, 2004, PSYCHOSOM MED, V66, P783, DOI 10.1097/01.psy.0000140004.06247.c9
   Hannaford PC, 2005, FAM PRACT, V22, P227, DOI 10.1093/fampra/cmi004
   Jacob RG, 2001, CURR OPIN NEUROL, V14, P41, DOI 10.1097/00019052-200102000-00007
   JACOB RG, 1996, AM J PSYCHIAT, V8, P530
   Kroenke K, 2000, SOUTH MED J, V93, P160
   Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004
   Lowe B, 2003, J PSYCHOSOM RES, V55, P515, DOI 10.1016/S0022-3999(03)00072-2
   Lowe B, 2002, PHQ D GESUNDHEITSFRA
   Luxon LM, 2004, J NEUROL NEUROSUR PS, V75, P45, DOI 10.1136/jnnp.2004.055285
   Meli A, 2007, J PSYCHOSOM RES, V63, P185, DOI 10.1016/j.jpsychores.2007.02.007
   Mendel B, 1999, CLIN OTOLARYNGOL, V24, P286, DOI 10.1046/j.1365-2273.1999.00261.x
   Mussell M, 2008, J PSYCHOSOM RES, V64, P605, DOI 10.1016/j.jpsychores.2008.02.019
   Neuhauser HK, 2006, NEUROLOGY, V67, P1028, DOI 10.1212/01.wnl.0000237539.09942.06
   Neuhauser HK, 2007, CURR OPIN NEUROL, V20, P40, DOI 10.1097/WCO.0b013e328013f432
   Pollak L, 2003, OTOLARYNG HEAD NECK, V128, P829, DOI 10.1016/S0194-5998(03)00454-6
   Radtke A, 2000, LANCET, V356, P736, DOI 10.1016/S0140-6736(00)02635-0
   Riedl A, 2008, J PSYCHOSOM RES, V64, P573, DOI 10.1016/j.jpsychores.2008.02.021
   Sloane PD, 2001, ANN INTERN MED, V134, P823, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00005
   Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092
   Staab JP, 2007, ARCH OTOLARYNGOL, V133, P170, DOI 10.1001/archotol.133.2.170
   Staab JP, 2005, ARCH OTOLARYNGOL, V131, P675, DOI 10.1001/archotol.131.8.675
   Staab JP, 2003, LARYNGOSCOPE, V113, P1714, DOI 10.1097/00005537-200310000-00010
   Staab JP, 2006, CURR OPIN NEUROL, V19, P41, DOI 10.1097/01.wco.0000198102.95294.1f
   TSCHAN R, 2008, J NEUROL, V8, P1168
   Yardley L, 1998, BRIT J GEN PRACT, V48, P1131
   YARDLEY L, 1992, J PSYCHOSOM RES, V36, P731, DOI 10.1016/0022-3999(92)90131-K
   Yardley L, 2004, ANN INTERN MED, V141, P598, DOI 10.7326/0003-4819-141-8-200410190-00007
   Yardley L, 2001, J NERV MENT DIS, V189, P321, DOI 10.1097/00005053-200105000-00009
NR 43
TC 59
Z9 65
U1 1
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0022-3999
EI 1879-1360
J9 J PSYCHOSOM RES
JI J. Psychosomat. Res.
PD MAY
PY 2009
VL 66
IS 5
BP 417
EP 424
DI 10.1016/j.jpsychores.2008.09.012
PG 8
WC Psychiatry
SC Psychiatry
GA 439WF
UT WOS:000265657600008
PM 19379958
DA 2019-01-08
ER

PT J
AU Johnson, SB
   Baughcum, AE
   Rafkin-Mervis, LE
   Schatz, DA
AF Johnson, Suzanne Bennett
   Baughcum, Amy E.
   Rafkin-Mervis, Lisa E.
   Schatz, Desmond A.
CA DPT 1 Study Grp
TI Participant and parent experiences in the oral insulin study of the
   Diabetes Prevention Trial for Type 1 Diabetes
SO PEDIATRIC DIABETES
LA English
DT Article
DE primary prevention; protocol compliance; randomized controlled trials;
   research subjects; type 1 diabetes mellitus
ID CHILDREN
AB Johnson SB, Baughcum AE, Rafkin-Mervis LE, Schatz DA, for the DPT-1 Study Group. Participant and parent experiences in the oral insulin study of the Diabetes Prevention Trial for Type 1 Diabetes.Pediatric Diabetes 2009: 10: 177-183.
   To assess the experiences of participants and parents of children in the oral insulin study of the Diabetes Prevention Trial - Type 1.
   Before trial results were publicized, surveys were completed by 124 participants and 219 parents of children in the oral trial.
   Although most of those surveyed were positive about the trial, survey results suggest that participant perspective (adult, child, parent, and gender), study procedures, and beliefs about placebo vs. active drug assignment have important implications for planning future clinical trials. Parents and children reported greater distress, worry, and difficulty making the decision to join the trial compared with adult participants. Mothers and female participants were particularly interested in additional psychosocial support during the study. Random assignment was viewed negatively by both parents and children, and close observation for diabetes onset was viewed as the most favorable aspect of the study. Adherence to study procedures declined over time and behaviors outside the study protocol to prevent/delay diabetes onset were common, particularly among those who believed the participant was taking a placebo. Children and respondents who believed that the participant was taking the active drug expressed confidence in oral insulin's ability to delay or prevent type 1 diabetes.
   Although most participants were positive about the trial and many expressed optimism about the intervention's potential for success, future trials need to address negative reactions to random assignment, the unique concerns of children and their parents, declining adherence, and behaviors - external to the trial - designed to delay or prevent diabetes.
C1 [Johnson, Suzanne Bennett] Florida State Univ, Coll Med, Dept Med Humanities & Social Sci, Tallahassee, FL 32306 USA.
   [Baughcum, Amy E.] Nationwide Childrens Hosp, Dept Psychol, Columbus, OH USA.
   [Rafkin-Mervis, Lisa E.] Univ Miami, Sch Med, Dept Med, Res Inst, Miami, FL USA.
   [Schatz, Desmond A.] Univ Florida, Dept Pediat, Coll Med, Gainesville, FL USA.
RP Johnson, SB (reprint author), Florida State Univ, Coll Med, Dept Med Humanities & Social Sci, 1115 W Call St, Tallahassee, FL 32306 USA.
EM suzanne.johnson@med.fsu.edu
FU National Institutes of Health; National Center for Research Resources;
   American Diabetes Association; Juvenile Diabetes Research Foundation
FX The DPT-1 was supported by the National Institutes of Health, National
   Center for Research Resources, American Diabetes Association, and
   Juvenile Diabetes Research Foundation.
CR Baughcum AE, 2005, DIABETES CARE, V28, P916, DOI 10.2337/diacare.28.4.916
   JOHNSON SB, 1995, DIABETES CARE, V18, P1370, DOI 10.2337/diacare.18.10.1370
   Johnson SB, 2007, DIABETES CARE, V30, P2193, DOI 10.2337/dc06-2422
   LUCIDARME N, 1998, DIABETES METAB, V23, P550
   Skyler JS, 2002, NEW ENGL J MED, V346, P1685
   The Diabetes Prevention Trial-Type 1 Study Group, 2005, DIABETES CARE, V28, P1068
NR 6
TC 6
Z9 6
U1 0
U2 4
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1399-543X
J9 PEDIATR DIABETES
JI Pediatr. Diabetes
PD MAY
PY 2009
VL 10
IS 3
BP 177
EP 183
DI 10.1111/j.1399-5448.2008.00463.x
PG 7
WC Endocrinology & Metabolism; Pediatrics
SC Endocrinology & Metabolism; Pediatrics
GA 434CI
UT WOS:000265252400004
PM 18823410
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Linscott, RJ
   Cross, FV
AF Linscott, Richard J.
   Cross, Fraser V.
TI The burden of awareness of psychometric risk for schizophrenia
SO PSYCHIATRY RESEARCH
LA English
DT Article
DE Disclosure; Ethics; Schizophrenia risk; Schizotypy; Screening; Stigma
ID MENTAL-ILLNESS; TRAITS QUESTIONNAIRE; PUBLIC-ATTITUDES; SCHIZOTYPY;
   STIGMA; PEOPLE; REPLICATION; ADOLESCENTS; DISORDERS; ANXIETY
AB Participants in studies of psychometric risk for schizophrenia are rarely informed of their risk status. Nondisclosure may be justifiable if the harmful effects of disclosure outweigh its benefits. We examined whether disclosure may adversely affect wellbeing and, if so, factors that predict the degree of adverse effect. Undergraduates (n=114) rated the anticipated impact-on felt distress, coping, optimism, helplessness, future lifestyle choices, and survival-of discovering they were at risk for schizophrenia and six other diseases. They also completed measures of potential predictors of this impact, including knowledge about schizophrenia, vicarious experience of schizophrenia, their potential to suffer stigmatization because of schizophrenia, and schizotypy. Participants judged schizophrenia risk more negatively than risk for heart disease, arthritis, depression, and diabetes, and less negatively than risk for cancer and Alzheimer's disease. Higher disorder-nonspecific impact, greater stigma, and lower psychometric risk for schizophrenia together provided the best linear prediction of schizophrenia-specific impact. Awareness of schizophrenia risk creates a significant adverse impact,
C1 [Linscott, Richard J.; Cross, Fraser V.] Univ Otago, Dept Psychol, Dunedin 9054, New Zealand.
RP Linscott, RJ (reprint author), Univ Otago, Dept Psychol, POB 56, Dunedin 9054, New Zealand.
EM linscott@psy.otago.ac.nz
CR Ajzen I, 2001, ANNU REV PSYCHOL, V52, P27, DOI 10.1146/annurev.psych.52.1.27
   Angermeyer MC, 2003, CAN J PSYCHIAT, V48, P663, DOI 10.1177/070674370304801004
   Angermeyer MC, 2003, ACTA PSYCHIAT SCAND, V108, P304, DOI 10.1034/j.1600-0447.2003.00150.x
   Braunstein-Bercovitz H, 2000, SCHIZOPHR RES, V46, P255, DOI 10.1016/S0920-9964(00)00021-9
   CHAPMAN JP, 1989, NORMS PSYCHOSI UNPUB
   CHAPMAN LJ, 1994, J ABNORM PSYCHOL, V103, P171, DOI 10.1037//0021-843X.103.2.171
   CLARIDGE G, 1984, PERS INDIV DIFFER, V5, P633, DOI 10.1016/0191-8869(84)90111-9
   Claridge G., 1997, SCHIZOTYPY IMPLICATI, P3, DOI DOI 10.1093/MED:PSYCH/9780198523536.003.0001
   Corcoran C, 2005, SCHIZOPHR RES, V73, P173, DOI 10.1016/j.schres.2004.05.021
   Corrigan PW, 2001, SCHIZOPHRENIA BULL, V27, P187, DOI 10.1093/oxfordjournals.schbul.a006865
   Cyhlarova E, 2005, SCHIZOPHR RES, V80, P253, DOI 10.1016/j.schres.2005.07.037
   Ertugrul A, 2004, SOC PSYCH PSYCH EPID, V39, P73, DOI 10.1007/s00127-004-0697-9
   Freedman Robert, 2005, Dialogues Clin Neurosci, V7, P17
   Gaebel W, 2002, EUR ARCH PSY CLIN N, V252, P278, DOI 10.1007/s00406-002-0393-2
   GOLDEN RR, 1979, J ABNORM PSYCHOL, V88, P217, DOI 10.1037/0021-843X.88.3.217
   HOLM S, 1979, SCAND J STAT, V6, P65
   Kolodziej ME, 1996, J CONSULT CLIN PSYCH, V64, P1387, DOI 10.1037/0022-006X.64.6.1387
   KORFINE L, 1995, J ABNORM PSYCHOL, V104, P26, DOI 10.1037/0021-843X.104.1.26
   Kwapil TR, 1997, J ABNORM PSYCHOL, V106, P491, DOI 10.1037/0021-843X.106.3.491
   Link BG, 1997, J HEALTH SOC BEHAV, V38, P177, DOI 10.2307/2955424
   LINK BG, 1989, AM SOCIOL REV, V54, P400, DOI 10.2307/2095613
   Linscott RJ, 2007, J PERS DISORD, V21, P225, DOI 10.1521/pedi.2007.21.3.225
   Linscott RJ, 2006, SCHIZOPHR RES, V84, P289, DOI 10.1016/j.schres.2006.02.006
   Linscott RJ, 2004, PERS INDIV DIFFER, V37, P1503, DOI 10.1016/j.paid.2004.02.007
   Meehl P. E., 1990, J PERSONALITY DISORD, V4, P1, DOI [10.1521/pedi.1990.4.1.1, DOI 10.1521/PEDI.1990.4.1.1]
   Meehl PE, 1964, MANUAL USE CHECKLIST
   Miller E. N., 1982, J CONSULT CLIN PSYCH, V85, P374
   NIELSEN TC, 1976, SCAND J PSYCHOL, V17, P73, DOI 10.1111/j.1467-9450.1976.tb00214.x
   Penn DL, 1999, SCHIZOPHRENIA BULL, V25, P437, DOI 10.1093/oxfordjournals.schbul.a033391
   Pinel EC, 1999, J PERS SOC PSYCHOL, V76, P114, DOI 10.1037//0022-3514.76.1.114
   Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9101.88.5.879
   Poulton R, 2000, ARCH GEN PSYCHIAT, V57, P1053, DOI 10.1001/archpsyc.57.11.1053
   RAINE A, 1991, SCHIZOPHRENIA BULL, V17, P555, DOI 10.1093/schbul/17.4.555
   RAWLINGS D, 1994, PERS INDIV DIFFER, V17, P489, DOI 10.1016/0191-8869(94)90086-8
   Stuart H, 2001, CAN J PSYCHIAT, V46, P245, DOI 10.1177/070674370104600304
   van Os J, 2000, SCHIZOPHR RES, V45, P11, DOI 10.1016/S0920-9964(99)00224-8
   van Os J., 1999, CAPE COMMUNITY ASSES
   Van Os Jim, 2005, Dialogues Clin Neurosci, V7, P53
   VENABLES PH, 1990, PERS INDIV DIFFER, V11, P481, DOI 10.1016/0191-8869(90)90061-U
   WILLIAMS LJ, 1989, J APPL PSYCHOL, V74, P462, DOI 10.1037//0021-9010.74.3.462
   *WORLD MED ASS, 2004, DECL HELS ETH PRINC
NR 41
TC 4
Z9 5
U1 0
U2 3
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0165-1781
J9 PSYCHIAT RES
JI Psychiatry Res.
PD APR 30
PY 2009
VL 166
IS 2-3
BP 184
EP 191
DI 10.1016/j.psychres.2008.03.007
PG 8
WC Psychiatry
SC Psychiatry
GA 435LD
UT WOS:000265344500011
PM 19285732
DA 2019-01-08
ER

PT J
AU Frey, RS
   Ushio-Fukai, M
   Malik, AB
AF Frey, Randall S.
   Ushio-Fukai, Masuko
   Malik, Asrar B.
TI NADPH Oxidase-Dependent Signaling in Endothelial Cells: Role in
   Physiology and Pathophysiology
SO ANTIOXIDANTS & REDOX SIGNALING
LA English
DT Review
ID NF-KAPPA-B; VASCULAR SMOOTH-MUSCLE; PROTEIN-KINASE-C; CHRONIC
   GRANULOMATOUS-DISEASE; NECROSIS-FACTOR-ALPHA; TOLL-LIKE RECEPTOR-4;
   HYPOXIA-INDUCIBLE FACTOR; LOW-DENSITY-LIPOPROTEIN;
   EXTRACELLULAR-SUPEROXIDE DISMUTASE; LUNG NEUTROPHIL SEQUESTRATION
AB Reactive oxygen species (ROS) including superoxide (O-2.(-)) and hydrogen peroxide (H2O2) are produced endogenously in response to cytokines, growth factors; G-protein coupled receptors, and shear stress in endothelial cells (ECs). ROS function as signaling molecules to mediate various biological responses such as gene expression, cell proliferation, migration, angiogenesis, apoptosis, and senescence in ECs. Signal transduction activated by ROS, "oxidant signaling," has received intense investigation. Excess amount of ROS contribute to various pathophysiologies, including endothelial dysfunction, atherosclerosis, hypertension, diabetes, and acute respiratory distress syndrome ( ARDS). The major source of ROS in EC is a NADPH oxidase. The prototype phagaocytic NADPH oxidase is composed of membrane-bound gp91phox and p22hox, as well as cytosolic sub-units such as p47(phox), p67(phox) and small GTPase Rac. In ECs, in addition to all the components of phagocytic NADPH oxidases, homologues of gp91(phox) (Nox2) including Nox1, Nox4, and Nox5 are expressed. The aim of this review is to provide an overview of the emerging area of ROS derived from NADPH oxidase and oxidant signaling in ECs linked to physiological and pathophysiological functions. Understanding these mechanisms may provide insight into the NADPH oxidase and oxidant signaling components as potential therapeutic targets. Antioxid. Redox Signal. 11, 791-810.
C1 [Frey, Randall S.] Univ Illinois, Dept Pharmacol, Coll Med, Chicago, IL 60612 USA.
   Univ Illinois, Ctr Lung & Vasc Biol, Coll Med, Chicago, IL 60612 USA.
RP Frey, RS (reprint author), Univ Illinois, Dept Pharmacol, Coll Med, M-C 868,835 S Wolcott Ave, Chicago, IL 60612 USA.
EM RFrey@uic.edu
FU NHLBI NIH HHS [R01 HL077524-01A2, R01 HL077524]
CR Abid MR, 2007, J BIOL CHEM, V282, P35373, DOI 10.1074/jbc.M702175200
   Adler V, 1999, EMBO J, V18, P1321, DOI 10.1093/emboj/18.5.1321
   Al-Mehdi AB, 1998, CIRC RES, V83, P730, DOI 10.1161/01.RES.83.7.730
   Allingham MJ, 2007, J IMMUNOL, V179, P4053, DOI 10.4049/jimmunol.179.6.4053
   Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200
   Andonegui G, 2003, J CLIN INVEST, V111, P1011, DOI 10.1172/JCI200316510
   Anrather J, 2006, J BIOL CHEM, V281, P5657, DOI 10.1074/jbc.M506172200
   Aviram M, 1996, METABOLISM, V45, P1069, DOI 10.1016/S0026-0495(96)90005-0
   Azoulay E, 2002, CRIT CARE MED, V30, P2115, DOI 10.1097/01.CCM.0000025216.93075.66
   Babior BM, 2000, IUBMB LIFE, V50, P267, DOI 10.1080/15216540051080976
   Ballinger SW, 2002, CIRCULATION, V106, P544, DOI 10.1161/01.CIR.0000023921.93743.89
   Bao W, 2007, J CARDIOVASC PHARM, V49, P362, DOI 10.1097/FJC.0b013e318046f34a
   Barry-Lane PA, 2001, J CLIN INVEST, V108, P1513, DOI 10.1172/JCI11927
   Baynes JW, 1999, DIABETES, V48, P1, DOI 10.2337/diabetes.48.1.1
   Bayraktutan U, 2005, FREE RADICAL BIO MED, V39, P1342, DOI 10.1016/j.freeradbiomed.2005.06.016
   BelAiba RS, 2007, FREE RADICAL BIO MED, V42, P446, DOI 10.1016/j.freeradbiomed.2006.10.054
   Bellacosa A, 2004, CANCER BIOL THER, V3, P268, DOI 10.4161/cbt.3.3.703
   Bladier C, 1997, CELL GROWTH DIFFER, V8, P589
   Blouin CC, 2004, BLOOD, V103, P1124, DOI 10.1182/blood-2003-07-2427
   Bonello S, 2007, ARTERIOSCL THROM VAS, V27, P755, DOI 10.1161/01.ATV.0000258979.92828.bc
   BOSSALLER C, 1987, J CLIN INVEST, V79, P170, DOI 10.1172/JCI112779
   Breitschopf K, 2001, FEBS LETT, V493, P21, DOI 10.1016/S0014-5793(01)02272-4
   Brookes S, 2002, EMBO J, V21, P2936, DOI 10.1093/emboj/cdf289
   Brumelll JH, 1996, J BIOL CHEM, V271, P1455, DOI 10.1074/jbc.271.3.1455
   BURDON RH, 1995, FREE RADICAL BIO MED, V18, P775, DOI 10.1016/0891-5849(94)00198-S
   Cadwallader KA, 2002, J IMMUNOL, V169, P3336, DOI 10.4049/jimmunol.169.6.3336
   Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840
   Cave AC, 2006, ANTIOXID REDOX SIGN, V8, P691, DOI 10.1089/ars.2006.8.691
   Chavakis E, 2007, CIRC RES, V100, P204, DOI 10.1161/01.RES.0000257774.55970.f4
   Chaves FJ, 2007, AM J HYPERTENS, V20, P62, DOI 10.1016/j.amjhyper.2006.06.006
   Chen JH, 2005, NAT MED, V11, P1188, DOI 10.1038/nm1307
   Chen JX, 2007, AM J PHYSIOL-HEART C, V292, pH1664, DOI 10.1152/ajpheart.01138.2006
   Chen JX, 2006, AM J PHYSIOL-HEART C, V291, pH1563, DOI 10.1152/ajpheart.01081.2005
   CHEN KS, 1994, BBA-GENE STRUCT EXPR, V1219, P26, DOI 10.1016/0167-4781(94)90242-9
   CHEN Q, 1994, P NATL ACAD SCI USA, V91, P4130, DOI 10.1073/pnas.91.10.4130
   Chen QD, 2003, J IMMUNOL, V170, P5302, DOI 10.4049/jimmunol.170.10.5302
   Chowdhury AK, 2005, J BIOL CHEM, V280, P20700, DOI 10.1074/jbc.M411722200
   Chu FF, 2004, FREE RADICAL BIO MED, V36, P1481, DOI 10.1016/j.freeradbiomed.2004.04.010
   Chu Y, 2003, CIRC RES, V92, P461, DOI 10.1161/01.RES.0000057755.02845.F9
   Clement MV, 1996, EMBO J, V15, P216, DOI 10.1002/j.1460-2075.1996.tb00352.x
   Colavitti R, 2005, IUBMB LIFE, V57, P277, DOI 10.1080/15216540500091890
   Cosentino F, 1997, CIRCULATION, V96, P25
   Crapo JD, 2003, AM J RESP CRIT CARE, V168, P1027, DOI 10.1164/rccm.2309001
   Crawford LE, 1996, J BIOL CHEM, V271, P26863, DOI 10.1074/jbc.271.43.26863
   Cross JV, 2004, BIOCHEM J, V381, P675, DOI 10.1042/BJ20040591
   Dandapat A, 2007, ARTERIOSCL THROM VAS, V27, P2435, DOI 10.1161/ATVBAHA.107.152272
   Datla SR, 2007, ARTERIOSCL THROM VAS, V27, P2319, DOI 10.1161/ATVBAHA.107.149450
   Deem TL, 2007, J IMMUNOL, V178, P3865, DOI 10.4049/jimmunol.178.6.3865
   DEJANA E, 1995, FASEB J, V9, P910
   DeLeo FR, 1998, J CLIN INVEST, V101, P455, DOI 10.1172/JCI949
   DEMLING RH, 1995, ANNU REV MED, V46, P193
   Deng QD, 2004, J BIOL CHEM, V279, P1050, DOI 10.1074/jbc.M308644200
   Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t
   Deshpande SS, 2000, FASEB J, V14, P1705, DOI 10.1096/fj.99-0910com
   Dhar SK, 2006, J BIOL CHEM, V281, P21698, DOI 10.1074/jbc.M601083200
   Dikalova A, 2005, CIRCULATION, V112, P2668, DOI 10.1161/CIRCULATIONAHA.105.538934
   Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224
   Djordjevic T, 2005, FREE RADICAL BIO MED, V38, P616, DOI 10.1016/j.freeradbiomed.2004.09.036
   Donato AJ, 2007, CIRC RES, V100, P1659, DOI 10.1161/01.RES.0000269183.13937.e8
   Downes CP, 2007, BIOCHEM SOC T, V35, P188, DOI 10.1042/BST0350188
   Dumitrescu C, 2007, P NATL ACAD SCI USA, V104, P15081, DOI 10.1073/pnas.0702986104
   Ebrahimian TG, 2006, AM J PATHOL, V169, P719, DOI 10.2353/ajpath.2006.060042
   El-Remessy AB, 2007, FASEB J, V21, P2528, DOI 10.1096/fj.06-7854com
   Ellson CD, 2001, NAT CELL BIOL, V3, P679, DOI 10.1038/35083076
   Eskurza I, 2006, J PHYSIOL-LONDON, V571, P661, DOI 10.1113/jphysiol.2005.102566
   Eskurza I, 2004, J PHYSIOL-LONDON, V556, P315, DOI 10.1113/jphysiol.2003.057042
   Fan J, 2002, J BIOL CHEM, V277, P3404, DOI 10.1074/jbc.M110054200
   Fan J, 2003, J CLIN INVEST, V112, P1234, DOI 10.1172/JCI200318696
   Fan J, 2003, NAT MED, V9, P315, DOI 10.1038/nm832
   Faure E, 2001, J IMMUNOL, V166, P2018, DOI 10.4049/jimmunol.166.3.2018
   Frey RS, 2006, J BIOL CHEM, V281, P16128, DOI 10.1074/jbc.M508810200
   Frey RS, 2002, CIRC RES, V90, P1012, DOI 10.1161/01.RES.0000017631.28815.8E
   FRIDOVICH I, 1978, SCIENCE, V201, P875, DOI 10.1126/science.210504
   FU MX, 1994, DIABETES, V43, P676, DOI 10.2337/diabetes.43.5.676
   Fu XY, 2006, J BIOL CHEM, V281, P20368, DOI 10.1074/jbc.M603353200
   Fukui T, 1997, CIRC RES, V80, P45, DOI 10.1161/01.RES.80.1.45
   Furst R, 2005, CIRC RES, V96, P43, DOI 10.1161/01.RES.0000151983.01148.06
   Gal A, 1997, CANCER RES, V57, P1823
   Gao XP, 2002, J IMMUNOL, V168, P3974, DOI 10.4049/jimmunol.168.8.3974
   Gao XP, 2001, J IMMUNOL, V167, P2895, DOI 10.4049/jimmunol.167.5.2895
   GARG UC, 1989, J CLIN INVEST, V83, P1774, DOI 10.1172/JCI114081
   Gates PE, 2007, J APPL PHYSIOL, V102, P63, DOI 10.1152/japplphysiol.00660.2006
   Geiszt M, 2000, P NATL ACAD SCI USA, V97, P8010, DOI 10.1073/pnas.130135897
   Go YM, 1998, AM J PHYSIOL-HEART C, V275, pH1898, DOI 10.1152/ajpheart.1998.275.5.H1898
   Gorlach A, 2001, CIRC RES, V89, P47, DOI 10.1161/hh1301.092678
   Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494
   Grishko V, 2003, AM J PHYSIOL-HEART C, V285, pH2364, DOI 10.1152/ajpheart.00408.2003
   GRYGLEWSKI RJ, 1986, NATURE, V320, P454, DOI 10.1038/320454a0
   Guzik TJ, 2000, CIRC RES, V86, pE85, DOI 10.1161/01.RES.86.9.e85
   HA HJ, 1994, KIDNEY INT, V46, P1620, DOI 10.1038/ki.1994.461
   Haddad JJ, 2001, FEBS LETT, V505, P269, DOI 10.1016/S0014-5793(01)02833-2
   Haendeler J, 2005, J BIOL CHEM, V280, P42945, DOI 10.1074/jbc.M506985200
   Haendeler J, 2004, FEBS LETT, V577, P427, DOI 10.1016/j.febslet.2004.10.041
   Hamanishi T, 2004, DIABETES, V53, P2455, DOI 10.2337/diabetes.53.9.2455
   Hampton MB, 1998, ANN NY ACAD SCI, V854, P328, DOI 10.1111/j.1749-6632.1998.tb09913.x
   Hannigan M, 2002, P NATL ACAD SCI USA, V99, P3603, DOI 10.1073/pnas.052010699
   Hannken T, 1998, KIDNEY INT, V54, P1923, DOI 10.1046/j.1523-1755.1998.00212.x
   Harfouche R, 2005, FASEB J, V19, P1728, DOI 10.1096/fj.04-3621fje
   Hayaishi-Okano Rieko, 2002, J Atheroscler Thromb, V9, P200
   Hecquet CM, 2008, CIRC RES, V102, P347, DOI 10.1161/CIRCRESAHA.107.160176
   Hink U, 2001, CIRC RES, V88, pE14
   Hirota K, 1997, P NATL ACAD SCI USA, V94, P3633, DOI 10.1073/pnas.94.8.3633
   Ho YS, 1997, J BIOL CHEM, V272, P16644, DOI 10.1074/jbc.272.26.16644
   Hoffmann J, 2001, CIRC RES, V89, P709, DOI 10.1161/hh2001.097796
   HORGAN MJ, 1991, AM J PHYSIOL, V261, pH1578
   Hoyal CR, 2003, P NATL ACAD SCI USA, V100, P5130, DOI 10.1073/pnas.1031526100
   Ikeda S, 2005, ARTERIOSCL THROM VAS, V25, P2295, DOI 10.1161/01.ATV.0000187472.55437.af
   Irani K, 2000, CIRC RES, V87, P179, DOI 10.1161/01.RES.87.3.179
   Ishii H, 1998, J MOL MED, V76, P21, DOI 10.1007/s109-1998-8101-y
   Issekutz AC, 1999, J LEUKOCYTE BIOL, V65, P117
   JACKSON SH, 1995, J EXP MED, V182, P751, DOI 10.1084/jem.182.3.751
   Jaffer ZM, 2002, INT J BIOCHEM CELL B, V34, P713, DOI 10.1016/S1357-2725(01)00158-3
   Jakobi R, 2001, J BIOL CHEM, V276, P16624, DOI 10.1074/jbc.M007753200
   Jones SA, 1996, AM J PHYSIOL-HEART C, V271, pH1626
   Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041
   Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297
   Kassim SY, 2005, J BIOL CHEM, V280, P30201, DOI 10.1074/jbc.M503292200
   Khan BV, 1996, P NATL ACAD SCI USA, V93, P9114, DOI 10.1073/pnas.93.17.9114
   Kim HW, 2007, CIRC RES, V101, P409, DOI 10.1161/CIRCRESAHA.107.153791
   King J, 2004, MICROVASC RES, V67, P139, DOI 10.1016/j.mvr.2003.11.006
   Klatt P, 1999, FASEB J, V13, P1481
   Knaus UG, 1998, J BIOL CHEM, V273, P21512, DOI 10.1074/jbc.273.34.21512
   KNAUS UG, 1995, SCIENCE, V269, P221, DOI 10.1126/science.7618083
   Kruger AL, 2005, CIRCULATION, V111, P3126, DOI 10.1161/CIRCULATIONAHA.104.517102
   Krystal G, 2000, SEMIN IMMUNOL, V12, P397, DOI 10.1006/smim.2000.0222
   Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516
   Lahiri S, 2006, PROG BIOPHYS MOL BIO, V91, P249, DOI 10.1016/j.pbiomolbio.2005.07.001
   Lakatta EG, 2003, CIRCULATION, V107, P346, DOI 10.1161/01.CIR.0000048893.62841.F7
   Lakkakorpi PT, 1999, J BIOL CHEM, V274, P4900, DOI 10.1074/jbc.274.8.4900
   Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P332, DOI 10.1016/j.freeradbiomed.2007.03.027
   Landmesser U, 2002, HYPERTENSION, V40, P511, DOI 10.1161/01.HYP.0000032100.23772.98
   Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200
   Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366
   Lewis P, 2007, CIRCULATION, V115, P2178, DOI 10.1161/CIRCULATIONAHA.106.664250
   Li JM, 2007, FREE RADICAL BIO MED, V43, P976, DOI 10.1016/j.freeradbiomed.2007.06.001
   Li JM, 2004, AM J PHYSIOL-REG I, V287, pR1014, DOI 10.1152/ajpregu.00124.2004
   Li PF, 1997, CIRCULATION, V96, P3602
   Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046
   Liao F, 2000, CANCER RES, V60, P6805
   Liu H, 2000, MOL CELL BIOL, V20, P2198, DOI 10.1128/MCB.20.6.2198-2208.2000
   LO SK, 1992, J CLIN INVEST, V89, P981, DOI 10.1172/JCI115681
   Martyn KD, 2005, BLOOD, V106, P3962, DOI 10.1182/blood-2005-03-0859
   Matheny HE, 2000, J IMMUNOL, V164, P6550, DOI 10.4049/jimmunol.164.12.6550
   Matoba T, 2002, BIOCHEM BIOPH RES CO, V290, P909, DOI 10.1006/bbrc.2001.6278
   Matoba T, 2000, J CLIN INVEST, V106, P1521, DOI 10.1172/JCI10506
   Matsuno K, 2005, CIRCULATION, V112, P2677, DOI 10.1161/CIRCULATIONAHA.105.573709
   Matsushita H, 2001, CIRC RES, V89, P793, DOI 10.1161/hh2101.098443
   MATTHEWS JR, 1992, NUCLEIC ACIDS RES, V20, P3821, DOI 10.1093/nar/20.15.3821
   Maulik N, 2002, J CELL MOL MED, V6, P13, DOI 10.1111/j.1582-4934.2002.tb00308.x
   Maxwell PH, 2005, EXP PHYSIOL, V90, P791, DOI 10.1113/expphysiol.2005.030924
   Mehdi MZ, 2005, ANTIOXID REDOX SIGN, V7, P1014, DOI 10.1089/ars.2005.7.1014
   Menshikov M, 2006, ARTERIOSCL THROM VAS, V26, P801, DOI 10.1161/01.ATV.0000207277.27432.15
   Mochizuki T, 2006, ONCOGENE, V25, P3699, DOI 10.1038/sj.onc.1209406
   Modlinger PS, 2004, SEMIN NEPHROL, V24, P354, DOI 10.1016/j.semnephrol.2004.04.007
   Moldovan L, 2000, CIRC RES, V86, P549, DOI 10.1161/01.RES.86.5.549
   Moreno MU, 2006, J HYPERTENS, V24, P1299, DOI 10.1097/01.hjh.0000234110.54110.56
   Morgenstern DE, 1997, J EXP MED, V185, P207, DOI 10.1084/jem.185.2.207
   Napoli C, 2003, P NATL ACAD SCI USA, V100, P2112, DOI 10.1073/pnas.0336359100
   NEEPER M, 1992, J BIOL CHEM, V267, P14998
   Ni W, 2007, CIRC RES, V101, P985, DOI 10.1161/CIRCRESAHA.107.152439
   O'Donnell RW, 2003, ENDOTHELIUM-J ENDOTH, V10, P291, DOI 10.1080/10623320390272280
   OKUNO H, 1993, ONCOGENE, V8, P695
   Outinen PA, 1999, BLOOD, V94, P959
   Ozolins TRS, 1997, J PHARMACOL EXP THER, V280, P1085
   Parinandi NL, 2003, AM J PHYSIOL-LUNG C, V284, pL26, DOI 10.1152/ajplung.00123.2002
   Parinandi NL, 2001, ARCH BIOCHEM BIOPHYS, V396, P231, DOI 10.1006/abbi.2001.2609
   Parman T, 1999, NAT MED, V5, P582
   Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024
   Petry A, 2006, ANTIOXID REDOX SIGN, V8, P1473, DOI 10.1089/ars.2006.8.1473
   Pineda-Molina E, 2001, BIOCHEMISTRY-US, V40, P14134, DOI 10.1021/bi011459o
   POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202
   Ponting CP, 1996, PROTEIN SCI, V5, P2353, DOI 10.1002/pro.5560051122
   Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925
   Potter MD, 2005, J BIOL CHEM, V280, P31906, DOI 10.1074/jbc.M505568200
   Ptasznik A, 1996, J BIOL CHEM, V271, P25204, DOI 10.1074/jbc.271.41.25204
   Puri KD, 2005, BLOOD, V106, P150, DOI 10.1182/blood-2005-01-0023
   Rahman A, 2000, AM J PHYSIOL-CELL PH, V279, pC906
   RAINWATER R, 1995, MOL CELL BIOL, V15, P3892
   Rajagopalan S, 1996, J CLIN INVEST, V97, P1916, DOI 10.1172/JCI118623
   Rajagopalan S, 1996, J CLIN INVEST, V98, P2572, DOI 10.1172/JCI119076
   RAO GN, 1993, ONCOGENE, V8, P2759
   RAO GN, 1993, NUCLEIC ACIDS RES, V21, P1259, DOI 10.1093/nar/21.5.1259
   Redon J, 2003, HYPERTENSION, V41, P1096, DOI 10.1161/01.HYP.0000068370.21009.38
   Rocic P, 2001, AM J PHYSIOL-CELL PH, V280, pC90
   Rocic P, 2007, AM J PHYSIOL-HEART C, V292, pH2729, DOI 10.1152/ajpheart.01330.2006
   RODMAN DM, 1990, AM J PHYSIOL, V258, pL207
   ROEBUCK KA, 1995, J BIOL CHEM, V270, P18966, DOI 10.1074/jbc.270.32.18966
   Roy S, 2003, CIRC RES, V92, P264, DOI 10.1161/01.RES.0000056770.30922.E6
   Ruas JL, 2005, SEMIN CELL DEV BIOL, V16, P514, DOI 10.1016/j.semcdb.2005.04.001
   Rueckschloss U, 2001, CIRCULATION, V104, P1767, DOI 10.1161/hc4001.097056
   Saez GT, 2004, AM J HYPERTENS, V17, P809, DOI 10.1016/j.amjhyper.2004.05.022
   Salmeen A, 2005, ANTIOXID REDOX SIGN, V7, P560, DOI 10.1089/ars.2005.7.560
   Sanlioglu S, 2001, J BIOL CHEM, V276, P30188, DOI 10.1074/jbc.M102061200
   Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI14002
   Schoonbroodt S, 2000, J IMMUNOL, V164, P4292, DOI 10.4049/jimmunol.164.8.4292
   SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x
   Schroeder P, 2007, ARTERIOSCL THROM VAS, V27, P2325, DOI 10.1161/ATVBAHA.107.149419
   Schumacker PT, 2003, ADV EXP MED BIOL, V543, P57
   Segal BH, 2000, INFECT IMMUN, V68, P2374, DOI 10.1128/IAI.68.4.2374-2378.2000
   Semenza GL, 2000, J APPL PHYSIOL, V88, P1474
   Seshiah PN, 2002, CIRC RES, V91, P406, DOI 10.1161/01.RES.0000033523.08033.16
   Shackelford RE, 2000, FREE RADICAL BIO MED, V28, P1387, DOI 10.1016/S0891-5849(00)00224-0
   Shiose A, 2001, J BIOL CHEM, V276, P1417, DOI 10.1074/jbc.M007597200
   SHWEIKI D, 1992, NATURE, V359, P845
   Sieck GC, 2004, J APPL PHYSIOL, V96, P1, DOI 10.1152/japplphysiol.01033.2003
   SIFLINGERBIRNBOIM A, 1992, LAB INVEST, V67, P24
   SOLODUSHKO V, 2007, AM J RESP CELL MOL B, V38, P491
   Sorescu D, 2002, CIRCULATION, V105, P1429, DOI 10.1161/01.CIR.0000012917.74432.66
   Stephens LR, 1997, CELL, V89, P105, DOI 10.1016/S0092-8674(00)80187-7
   Stevens T, 2000, AM J PHYSIOL-LUNG C, V279, pL419
   Stojanovic A, 2006, J BIOL CHEM, V281, P16333, DOI 10.1074/jbc.M512378200
   Sturrock A, 2006, AM J PHYSIOL-LUNG C, V290, pL661, DOI 10.1152/ajplung.00269.2005
   Suh YA, 1999, NATURE, V401, P79
   Suire S, 2005, CURR BIOL, V15, P566, DOI 10.1016/j.cub.2005.02.020
   't Hoen PAC, 2003, CIRC RES, V93, P262, DOI 10.1161/01.RES.0000082978.92494.B1
   TAHER MM, 1993, ARCH BIOCHEM BIOPHYS, V303, P260, DOI 10.1006/abbi.1993.1281
   Tai LK, 2002, ARTERIOSCL THROM VAS, V22, P1790, DOI 10.1161/01.ATV.0000034475.40227.40
   Takada Y, 2003, J BIOL CHEM, V278, P24233, DOI 10.1074/jbc.M212389200
   Takeya R, 2003, J BIOL CHEM, V278, P25234, DOI 10.1074/jbc.M212856200
   Thomas DD, 2006, J BIOL CHEM, V281, P25984, DOI 10.1074/jbc.M602242200
   Tojo T, 2005, CIRCULATION, V111, P2347, DOI 10.1161/01.CIR.0000164261.62586.14
   Touyz RM, 2004, J HYPERTENS, V22, P1141, DOI 10.1097/01.hjh.0000125391
   Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714
   True AL, 2000, AM J PHYSIOL-LUNG C, V279, pL302
   Turkseven S, 2007, J CELL BIOCHEM, V100, P815, DOI 10.1002/jcb.21138
   Usatyuk PV, 2007, J BIOL CHEM, V282, P23284, DOI 10.1074/jbc.M700535200
   Ushio-Fukai M, 2002, CIRC RES, V91, P1160, DOI 10.1161/01.RES.0000046227.65158.F8
   USHIOFUKAI M, 2006, SCI STKE, pRE8, DOI DOI 10.1126/STKE.3492006RE8
   van der Loo B, 2000, J EXP MED, V192, P1731, DOI 10.1084/jem.192.12.1731
   van Wetering S, 2003, AM J PHYSIOL-CELL PH, V285, pC343, DOI 10.1152/ajpcell.00048.2003
   van Wetering S, 2002, J CELL SCI, V115, P1837
   Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535
   WANG GL, 1995, BIOCHEM BIOPH RES CO, V216, P669, DOI 10.1006/bbrc.1995.2674
   Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806
   Wei SJ, 2000, CANCER RES, V60, P6688
   Widder J, 2004, CARDIOVASC RES, V63, P161, DOI 10.1016/j.cardiores.2004.03.008
   Wilson LA, 2005, FASEB J, V19, P2085, DOI 10.1096/fj.05-4401fje
   Wojciak-Stothard B, 2005, AM J PHYSIOL-LUNG C, V288, pL749, DOI 10.1152/ajplung.00361.2004
   Wu RF, 2005, J CELL BIOL, V171, P893, DOI 10.1083/jcb.200507004
   Wu RF, 2007, J BIOL CHEM, V282, P37412, DOI 10.1074/jbc.M704481200
   XANTHOUDAKIS S, 1992, EMBO J, V11, P3323, DOI 10.1002/j.1460-2075.1992.tb05411.x
   Xie ZL, 2001, J CELL PHYSIOL, V188, P132, DOI 10.1002/jcp.1104
   Xu XH, 2001, CIRCULATION, V104, P3103, DOI 10.1161/hc5001.100631
   Yamaguchi T, 2007, CELL SIGNAL, V19, P2088, DOI 10.1016/j.cellsig.2007.06.002
   Yamamori T, 2004, BIOCHEM BIOPH RES CO, V316, P720, DOI 10.1016/j.bbrc.2004.02.018
   Yang H, 2004, CIRC RES, V95, P1075, DOI 10.1161/01.RES.0000149564.49410.0d
   Yasuda Masako, 1999, Life Sciences, V64, P249
   Yet SF, 2001, CIRC RES, V89, P168, DOI 10.1161/hh1401.093314
   Zhang J, 2007, CELL SIGNAL, V19, P2194, DOI 10.1016/j.cellsig.2007.06.022
   ZHANG Q, 2007, ANTIOXID REDOX SIGN, V10, P679
NR 250
TC 231
Z9 238
U1 2
U2 21
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1523-0864
EI 1557-7716
J9 ANTIOXID REDOX SIGN
JI Antioxid. Redox Signal.
PD APR
PY 2009
VL 11
IS 4
BP 791
EP 810
DI 10.1089/ars.2008.2220
PG 20
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 411TH
UT WOS:000263673000008
PM 18783313
OA Green Published, Green Accepted
DA 2019-01-08
ER

PT J
AU Amsberg, S
   Anderbro, T
   Wredling, R
   Lisspers, J
   Lins, PE
   Adamson, U
   Johansson, UB
AF Amsberg, Susanne
   Anderbro, Therese
   Wredling, Regina
   Lisspers, Jan
   Lins, Per-Eric
   Adamson, Ulf
   Johansson, Unn-Britt
TI Experience from a behavioural medicine intervention among poorly
   controlled adult type 1 diabetes patients
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE Type 1 diabetes; Behavioural medicine; Cognitive behaviour therapy;
   Predictor; Glycaemic control
ID GLYCEMIC CONTROL; SELF-CARE; METABOLIC-CONTROL; PROBLEM AREAS; SCALE;
   DEPRESSION; PREDICTORS; MANAGEMENT; EDUCATION; OUTCOMES
AB Aim: To describe experience from a behavioural medicine intervention among poorly controlled adult type 1 diabetes patients, in terms of feasibility, predictors and associations of improved glycaemic control.
   Methods: Data were collected on 94 poorly controlled adult type 1 diabetes patients who were randomised to a study evaluating the effects of a behavioural medicine intervention. Statistics covered descriptive and comparison analysis. Backward stepwise regression models were used for predictive and agreement analyses involving socio-demographic and medical factors, as well as measures of diabetes self-efficacy (DES), diabetes locus of control (DLOC), self-care activities (SDSCA), diabetes-related distress (Swe-PAID-20), fear of hypoglycaemia (HFS), well-being (WBQ), depression (HAD) and perceived stress (PSS).
   Results: The participation rate in the study was 41% and attrition was 24%. Of those patients actually participating in the behavioural medicine intervention, 13% withdrew. From the regression models no predictors or associations of improvement in HbA(1c) were found.
   Conclusions: The programme proved to be feasible in terms of design and methods. However, no clear pattern was found regarding predictors or associations of improved metabolic control as the response to the intervention. Further research in this area is called for. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
C1 [Amsberg, Susanne; Anderbro, Therese; Wredling, Regina; Lins, Per-Eric; Adamson, Ulf; Johansson, Unn-Britt] Danderyd Hosp, Div Med, Karolinska Inst, Dept Clin Sci, SE-18288 Stockholm, Sweden.
   [Amsberg, Susanne; Johansson, Unn-Britt] Sophiahemmet Univ Coll, Stockholm, Sweden.
   [Wredling, Regina] Karolinska Inst, Div Nursing, Dept Neurobiol Caring Sci & Soc, Stockholm, Sweden.
   [Lisspers, Jan] Mid Sweden Univ, Dept Social Sci, Ostersund, Sweden.
RP Amsberg, S (reprint author), Danderyd Hosp, Div Med, Karolinska Inst, Dept Clin Sci, House 17,4th Floor, SE-18288 Stockholm, Sweden.
EM susanne.amsberg@ki.se
OI Johansson, Unn-Britt/0000-0003-3309-136X
FU Health Care Sciences Postgraduate School, Karolinska Institutet;
   Sophiahemmet University College; Foundation for Medical Research at
   Sophiahemmet; Bert von Kantzow Foundation; Swedish Diabetes Federation
FX This project was supported by grants from: the Health Care Sciences
   Postgraduate School, Karolinska Institutet; Sophiahemmet University
   College, the Foundation for Medical Research at Sophiahemmet; the Bert
   von Kantzow Foundation; and the Swedish Diabetes Federation. The authors
   wish to express their gratitude to Lena Landstedt-Hallin, Nils Adner and
   Anna-Lena Wedfelt for assistance with the study, and Marcus Thuresson
   for statistical support.
CR AMSBERG S, 2008, AM DIAB ASS 68 SCI S
   Amsberg S, 2008, INT J NURS STUD, V45, P1319, DOI 10.1016/j.ijnurstu.2007.09.010
   Anderson RM, 2000, DIABETES CARE, V23, P739, DOI 10.2337/diacare.23.6.739
   ANTONOVSKY A, 1993, SOC SCI MED, V36, P725, DOI 10.1016/0277-9536(93)90033-Z
   ANTONOWSKY A, 1988, UNRAVELLING MYSTERY
   Barnard KD, 2006, DIABETIC MED, V23, P445, DOI 10.1111/j.1464-5491.2006.01814.x
   BOTT U, 1994, DIABETIC MED, V11, P362, DOI 10.1111/j.1464-5491.1994.tb00287.x
   COX DJ, 1987, DIABETES CARE, V10, P617, DOI 10.2337/diacare.10.5.617
   DeVries JH, 2004, DIABETIC MED, V21, P1263, DOI 10.1111/j.1464-5491.2004.01386.x
   Eskin M, 1996, INTRO SWEDISH VERSIO
   Gage H, 2004, PATIENT EDUC COUNS, V53, P333, DOI 10.1016/j.pec.2003.06.003
   Glasgow RE, 2001, PATIENT EDUC COUNS, V44, P119, DOI 10.1016/S0738-3991(00)00186-5
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   Hundley V, 2004, MIDWIFERY, V20, P27, DOI 10.1016/S0266-6138(03)00050-0
   Jeppsson JO, 1996, DIABETES CARE, V19, P142, DOI 10.2337/diacare.19.2.142
   Karlsen B, 2004, PATIENT EDUC COUNS, V53, P299, DOI 10.1016/j.pec.2003.10.008
   Kazdin A. E., 2003, RES DESIGN CLIN PSYC
   Knight KM, 2006, DIABETIC MED, V23, P485, DOI 10.1111/j.1464-5491.2005.01802.x
   Levine BS, 2001, J PEDIATR-US, V139, P197, DOI 10.1067/mpd.2001.116283
   Lisspers J, 2005, HEALTH PSYCHOL, V24, P41, DOI 10.1037/0278-6133.24.1.41
   Lisspers J, 1997, ACTA PSYCHIAT SCAND, V96, P281, DOI 10.1111/j.1600-0447.1997.tb10164.x
   Loveman E, 2003, HEALTH TECHNOL ASSES, V7, P1, DOI DOI 10.3310/HTA7220
   Norris SL, 2002, DIABETES CARE, V25, P1159, DOI 10.2337/diacare.25.7.1159
   O'Connor P J, 1992, J Am Board Fam Pract, V5, P381
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   Peyrot M, 2007, DIABETES CARE, V30, P2433, DOI 10.2337/dc07-1222
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Sarkadi A, 2001, PATIENT EDUC COUNS, V44, P129, DOI 10.1016/S0738-3991(00)00170-1
   Shaban MC, 2006, DIABETIC MED, V23, P1381, DOI 10.1111/j.1464-5491.2006.02012.x
   SHOJANIA KG, 2006, JAMA-J AM MED ASSOC, V269, P427
   Sigurdardottir AK, 2007, PATIENT EDUC COUNS, V67, P21, DOI 10.1016/j.pec.2007.03.007
   Sigurthardottir AK, 2005, J CLIN NURS, V14, P301, DOI 10.1111/j.1365-2702.2004.01043.x
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Stenstrom U, 1998, BRIT J HEALTH PSYCH, V3, P15, DOI 10.1111/j.2044-8287.1998.tb00552.x
   Toljamo M, 2001, J CLIN NURS, V10, P618, DOI 10.1046/j.1365-2702.2001.00520.x
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   van der Ven NCW, 2005, PATIENT EDUC COUNS, V56, P313, DOI 10.1016/j.pec.2004.03.005
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   Wild D, 2007, PATIENT EDUC COUNS, V68, P10, DOI 10.1016/j.pec.2007.05.003
   Winkley K, 2006, BRIT MED J, V333, P65, DOI 10.1136/bmj.38874.652569.55
   Wredling R, 1995, QUAL LIFE RES, V4, P515, DOI 10.1007/BF00634746
   ZEIDNER M, 1995, WILEY SERIES PERSONA
NR 42
TC 5
Z9 5
U1 0
U2 7
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
EI 1872-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD APR
PY 2009
VL 84
IS 1
BP 76
EP 83
DI 10.1016/j.diabres.2008.12.011
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 435FM
UT WOS:000265329300012
PM 19181414
DA 2019-01-08
ER

PT J
AU Eigenmann, CA
   Colagiuri, R
   Skinner, TC
   Trevena, L
AF Eigenmann, C. A.
   Colagiuri, R.
   Skinner, T. C.
   Trevena, L.
TI Are current psychometric tools suitable for measuring outcomes of
   diabetes education?
SO DIABETIC MEDICINE
LA English
DT Article
DE diabetes education; indicators; measurement tools; outcomes
ID PROBLEM AREAS; GLYCEMIC CONTROL; SCALE; DISTRESS; VALIDITY
AB To critically appraise the suitability, validity, reliability, feasibility and sensitivity to change of available psychometric tools for measuring the education outcomes identified in the (Australian) National Consensus on Outcomes and Indicators for Diabetes Patient Education.
   Potentially suitable psychometric measurement tools were identified through a two-step process. Step 1: a structured semi-systematic literature review and consultation with experts; step 2: development of inclusion criteria and a formal, purpose-designed, systematically derived Appraisal Checklist-from the literature and with expert psychometric advice-to critically appraise the identified tools for relevance, validity, reliability, responsiveness to change, burden, feasibility and acceptability.
   Searching medline, PubMed, PsycINFO and cinhal yielded 37 diabetes-specific and generic measurement tools. Eleven of these did not address the research questions, leaving 26 tools. Of these, 11 assessed indicators of psychological adjustment; seven assessed various domains of self-determination; five measured self-management behaviours, for example, foot care, blood glucose testing and lifestyle domains; and three measured diabetes knowledge und understanding, respectively. When the Appraisal Checklist was applied, only three tools met all criteria, namely the Problem Areas in Diabetes (PAID) scale, the Summary of Diabetes Self-Care Activities (SDSCA) scale and the Appraisal of Diabetes Scale (ADS). However, a number of other suitable tools [i.e. the Diabetes Integration Scale (ATT19), the Diabetes Health Profile (DHP-1/18), the Self-Care Inventory-Revised (SCI-R), the Diabetes Management Self Efficacy Scale Australian/English version (DMSES-A/E), the Diabetes Empowerment Scale-Short Form (DES-SF)] met all except one criteria, that is, either no formal test-retest or no responsiveness to change data.
   Although numerous tools were identified, few met rigorous psychometric appraisal criteria. Issues of suitability, adequate psychometric testing for the intended purpose, burden and feasibility need to be considered before adopting tools for measuring diabetes education outcomes.
C1 [Eigenmann, C. A.; Colagiuri, R.; Trevena, L.] Univ Sydney, Diabet Unit, Menzies Ctr Hlth Policy, Sydney, NSW 2006, Australia.
   [Skinner, T. C.] Univ Western Australia, Combined Univ Ctr Rural Hlth, Geraldton, WA, Australia.
RP Colagiuri, R (reprint author), Univ Sydney, Diabet Unit, Menzies Ctr Hlth Policy, Victor Coppleson DO2, Sydney, NSW 2006, Australia.
EM cecile.e@bigpond.net.au
RI Geraldton, WACRH/O-3695-2018
OI Skinner, Timothy/0000-0002-0018-6963; Trevena,
   Lyndal/0000-0003-1419-1832
FU Australian Diabetes Society-Servier National Action Plan Grant
FX This project was supported by an Australian Diabetes Society-Servier
   National Action Plan Grant.
CR Aaronson N, 2002, QUAL LIFE RES, V11, P193
   Aikens JE, 2005, DIABETES EDUCATOR, V31, P681, DOI 10.1177/0145721705280829
   Bradley C., 1994, HDB PSYCHOL DIABETES
   CAREY MP, 1991, J BEHAV MED, V14, P43, DOI 10.1007/BF00844767
   Colagiuri R., 2004, INFORM ED PEOPLE DIA
   Colagiuri R, 2007, OUTCOMES INDICATORS
   Deakin TA, 2006, DIABETIC MED, V23, P944, DOI 10.1111/j.1464-5491.2006.01906.x
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Fitzpatrick R, 1998, Health Technol Assess, V2, pi
   Garratt AM, 2002, DIABETIC MED, V19, P1, DOI 10.1046/j.1464-5491.2002.00650.x
   Izquierdo RE, 2003, DIABETES CARE, V26, P1002, DOI 10.2337/diacare.26.4.1002
   Majumdar SJ, 2005, CAN J DIABETES, V29, P220
   Mokkink L B, 2006, BMC Med Res Methodol, V6, P2, DOI 10.1186/1471-2288-6-2
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 2000, DIABETES SPECTRUM, V13, P36
   Skovlund Soren E, 2005, Curr Diab Rep, V5, P115, DOI 10.1007/s11892-005-0038-8
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Trief PM, 1999, DIABETES CARE, V22, P569, DOI 10.2337/diacare.22.4.569
   Welch G, 2003, DIABETIC MED, V20, P69, DOI 10.1046/j.1464-5491.2003.00832.x
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   Williams GC, 2004, HEALTH PSYCHOL, V23, P58, DOI 10.1037/0278-6133.23.1.58
NR 22
TC 48
Z9 50
U1 0
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD APR
PY 2009
VL 26
IS 4
BP 425
EP 436
DI 10.1111/j.1464-5491.2009.02697.x
PG 12
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 429YH
UT WOS:000264955500016
PM 19388974
DA 2019-01-08
ER

PT J
AU Binder, G
   Weber, S
   Ehrismann, M
   Zaiser, N
   Meisner, C
   Ranke, MB
   Maier, L
   Wudy, SA
   Hartmann, MF
   Heinrich, U
   Bettendorf, M
   Doerr, HG
   Pfaeffle, RW
   Keller, E
AF Binder, G.
   Weber, S.
   Ehrismann, M.
   Zaiser, N.
   Meisner, C.
   Ranke, M. B.
   Maier, L.
   Wudy, S. A.
   Hartmann, M. F.
   Heinrich, U.
   Bettendorf, M.
   Doerr, H. G.
   Pfaeffle, R. W.
   Keller, E.
CA S German Working Grp Pediat
TI Effects of Dehydroepiandrosterone Therapy on Pubic Hair Growth and
   Psychological Well-Being in Adolescent Girls and Young Women with
   Central Adrenal Insufficiency: A Double-Blind, Randomized,
   Placebo-Controlled Phase III Trial
SO JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
LA English
DT Article
ID SUBJECTIVE HEALTH-STATUS; ADDISONS-DISEASE; SERUM-LEVELS; REPLACEMENT;
   SULFATE; ESTROGENS; ANDROGENS; HORMONE; LIFE; DHEA
AB Context and Objective: The efficacy of oral dehydroepiandrosterone (DHEA) in the treatment of atrichia pubis and psychological distress in young females with central adrenal insufficiency is unknown. Our study aimed to evaluate this therapy.
   Design and Patients: A total of 23 young females (mean age 18 yr, range 13-25) was enrolled in a double-blind randomized placebo-controlled trial. Inclusion criteria were ACTH deficiency plus two or more additional pituitary deficiencies, serum DHEA less than 400 ng/ml, and pubertal stage more than B2. Exclusion criteria were cerebral radiation with more than 30 Gy, tumor remission less than 1 yr, amaurosis, hypothalamic obesity, psychiatric disorders, and unstable hormone medication.
   Intervention: Patients were randomized to placebo (n = 12) or 25 mg HPLC-purified DHEA/d (n = 11) orally for 12 months after stratification into a nontumor (n = 7) and a tumor group (n = 16).
   Main Outcome Measures: Clinical scoring of pubic hair stage was performed at 0, 6, and 12 months (primary endpoint), and psychometrical evaluation (Symptom Check-List-90-R and the Centre for Epidemiological Studies-Depression Scale) at 0 and 12 months (secondary endpoint). Androgen levels and safety parameters were measured at 0, 6, and 12 months; 24-h androgen urinary excretion rates were calculated at 0 and 12 months.
   Results: In the placebo group, four patients dropped out because of recurrence of craniopharyngioma, manifestation of type 1 diabetes, and change of residence (n = 2); in the DHEA group, one patient dropped out because of recurrent anxiety attacks. DHEA substitution resulted in normalization of DHEA sulfate and androstanediol glucuronide morning serum levels 2h after drug intake (P < 0.006), and of its 24 h urinary metabolite levels (P < 0.0001), placebo had no effect. Morning serum levels of androstenedione increased in the DHEA group (P < 0.02) but did not normalize. The DHEA group exhibited significant progress in pubic hair growth from Tanner stage I-III to II-V (mean: + 1.5 stages), whereas the placebo group did not (relative risk 0.138; 95% confidence interval 0.021-0.914; P = 0.0046). Importantly, eight of the 10 Symptom Check-List-90-R scores, including those for depression, anxiety, and interpersonal sensitivity, and the global severity index improved in the DHEA group in comparison to the placebo group (P < 0.048). DHEA was well tolerated.
   Conclusions: In adolescent girls with central adrenal insufficiency, daily replacement with 25 mg DHEA orally is beneficial: atrichia pubis vanishes, and psychological well-being improves significantly. (J Clin Endocrinol Metab 94: 1182-1190, 2009)
C1 [Binder, G.; Weber, S.; Ehrismann, M.; Ranke, M. B.] Univ Childrens Hosp, D-72076 Tubingen, Germany.
   [Zaiser, N.] Univ Tubingen, Ctr Coordinat Clin Studies, D-72076 Tubingen, Germany.
   [Meisner, C.] Univ Tubingen, Dept Med Biometry, D-72076 Tubingen, Germany.
   [Maier, L.] Univ Ulm, D-89081 Ulm, Germany.
   [Wudy, S. A.; Hartmann, M. F.] Univ Giessen, Steroid Res & Mass Spectrometry Unit, Ctr Child & Adolescent Med, D-35392 Giessen, Germany.
   [Heinrich, U.; Bettendorf, M.] Univ Childrens Hosp, D-69120 Heidelberg, Germany.
   [Doerr, H. G.] Univ Childrens Hosp, D-91054 Erlangen, Germany.
   [Pfaeffle, R. W.; Keller, E.] Univ Childrens Hosp, D-04317 Leipzig, Germany.
RP Binder, G (reprint author), Univ Childrens Hosp, Hoppe Seyler Str 1, D-72076 Tubingen, Germany.
EM gerhard.binder@med.uni-tuebingen.de
FU Applied Clinical Research
FX Disclosure Summary: The authors have nothing to declare.
CR ABRAHAM GE, 1994, J CLIN ENDOCR METAB, V39, P340
   Achermann JC, 2001, LANCET, V357, P1381, DOI 10.1016/S0140-6736(00)04617-1
   Ankarberg C, 1999, J CLIN ENDOCR METAB, V84, P975, DOI 10.1210/jc.84.3.975
   Arlt W, 1998, J CLIN ENDOCR METAB, V83, P1928, DOI 10.1210/jc.83.6.1928
   Arlt W, 1999, NEW ENGL J MED, V341, P1013, DOI 10.1056/NEJM199909303411401
   CRAEN M, 1982, PEDIATR RES, V16, P888
   Emlinger MW, 2002, CLIN CHEM LAB MED, V40, P1151
   ESSAU CA, 2001, Z DIFFERENTIELLE DIA, V22, P139
   FERRIMAN D, 1961, J CLIN ENDOCR METAB, V21, P1440, DOI 10.1210/jcem-21-11-1440
   GE XJ, 1994, DEV PSYCHOL, V30, P467, DOI 10.1037/0012-1649.30.4.467
   Gurnell EM, 2008, J CLIN ENDOCR METAB, V93, P400, DOI 10.1210/jc.2007-1134
   Hunt PJ, 2000, J CLIN ENDOCR METAB, V85, P4650, DOI 10.1210/jc.85.12.4650
   Ibanez L, 2000, ENDOCR REV, V21, P671, DOI 10.1210/er.21.6.671
   Johannsson G, 2002, J CLIN ENDOCR METAB, V87, P2046, DOI 10.1210/jc.87.5.2046
   Kleinbaum DG, 1982, EPIDEMIOLOGIC RES PR
   Labrie F, 2005, J ENDOCRINOL, V187, P169, DOI 10.1677/joe.1.06264
   Labrie F, 1997, J CLIN ENDOCR METAB, V82, P2403, DOI 10.1210/jc.82.8.2403
   Lovas K, 2003, J CLIN ENDOCR METAB, V88, P1112, DOI 10.1210/jc.2002-020769
   Lovas K, 2002, CLIN ENDOCRINOL, V56, P581, DOI 10.1046/j.1365-2265.2002.01466.x
   MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Remer T, 2005, J CLIN ENDOCR METAB, V90, P2015, DOI 10.1210/jc.2004-1571
   RITTMASTER RS, 1993, ENDOCR REV, V14, P121, DOI 10.1210/er.14.1.121
   RITTSCHOF D, 1997, RECENT ADV MARINE BI, V3, P245
   Steinhausen HC, 2000, PRAX KINDERPSYCHOL K, V49, P419
   Sulcova J, 1997, J ENDOCRINOL, V154, P57, DOI 10.1677/joe.0.1540057
   van Thiel SW, 2005, J CLIN ENDOCR METAB, V90, P3295, DOI 10.1210/jc.2004-1802
   Wit JM, 2001, HORM RES, V56, P134, DOI 10.1159/000048106
   Young J, 1997, J CLIN ENDOCR METAB, V82, P2578, DOI 10.1210/jc.82.8.2578
NR 29
TC 19
Z9 19
U1 0
U2 3
PU ENDOCRINE SOC
PI CHEVY CHASE
PA 8401 CONNECTICUT AVE, SUITE 900, CHEVY CHASE, MD 20815-5817 USA
SN 0021-972X
J9 J CLIN ENDOCR METAB
JI J. Clin. Endocrinol. Metab.
PD APR
PY 2009
VL 94
IS 4
BP 1182
EP 1190
DI 10.1210/jc.2008-1982
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 432PB
UT WOS:000265145100023
PM 19126625
OA Bronze
DA 2019-01-08
ER

PT J
AU Siegel, B
   Chan, C
   Willies-Jacobo, L
   Stein, MT
AF Siegel, Benjamin
   Chan, Christina
   Willies-Jacobo, Lindia
   Stein, Martin T.
TI Culture Clash: A Missed Opportunity
SO JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS
LA English
DT Article
AB CASE: Erasto is a term infant born by vaginal delivery to a gravida 7 para 7 Somalia woman with full prenatal care in the United States. His mother had gestational diabetes. The delivery was complicated by respiratory distress and an urgent admission to the neonatal intensive care unit for further evaluation for possible pulmonary disease and a congenital heart condition.
   A female pediatric intern was assigned to update Erasto's mother on the baby's status and to obtain consent for an intravascular line placement. When she entered the room to talk to the mother, multiple family members spanning at 3 generations were with the baby's mother. They were all women with the exception of Erasto's father who was apprised of the baby's clinical status by the male neonatal physician several minutes earlier. Through a telephone translator, the intern explained to Erasto's mother that her baby may have heart and lung problems that may be related to her gestational diabetes.
   At this point, many family members spoke simultaneously and excitedly. Some accused the intern of keeping the baby in the neonatal intensive care unit "to make more money," and others said they would sue her "if anything happened to Erasto." The mother denied that she had gestational diabetes, and claimed that because she "believed in God... nothing is wrong with my baby." The intern was not prepared for this response and asked herself, "What went wrong?"
C1 [Siegel, Benjamin] Boston Univ, Sch Med, Boston Med Ctr Pediat, Dept Pediat & Psychiat, Boston, MA 02118 USA.
   [Willies-Jacobo, Lindia; Stein, Martin T.] Univ Calif San Diego, Sch Med, Rady Childrens Hosp San Diego, Dept Pediat, San Diego, CA 92103 USA.
RP Siegel, B (reprint author), Boston Univ, Sch Med, Boston Med Ctr Pediat, Dept Pediat & Psychiat, Boston, MA 02118 USA.
OI Siegel, Benjamin/0000-0003-3572-2575
CR Carroll J, 2007, PATIENT EDUC COUNS, V66, P337, DOI 10.1016/j.pec.2007.01.008
   Carroll Jennifer, 2007, Health Care Women Int, V28, P360, DOI 10.1080/07399330601179935
   Epstein RM, 1999, JAMA-J AM MED ASSOC, V282, P833, DOI 10.1001/jama.282.9.833
   Goode TD, 2006, EVIDENCE BASE CULTUR
   KLINEMAN A, 1978, ANN INTERN MED, V88, P251
   Lewis Toby, 1996, SOMALI CULTURAL PROF
   Mohamed M, 1997, MENDING RIPS SKY OPT, P145
   Scuglik Deborah L, 2007, Transcult Psychiatry, V44, P581, DOI 10.1177/1363461507083899
   Stein MT, 2003, J DEV BEHAV PEDIATR, V24, P434
   TAYLOR L, 2006, ENCOUNTERS CHILDREN, P44
NR 10
TC 1
Z9 1
U1 1
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0196-206X
J9 J DEV BEHAV PEDIATR
JI J. Dev. Behav. Pediatr.
PD APR
PY 2009
VL 30
IS 2
BP 154
EP 157
DI 10.1097/DBP.0b013e3181a00765
PG 4
WC Behavioral Sciences; Psychology, Developmental; Pediatrics
SC Behavioral Sciences; Psychology; Pediatrics
GA 434BD
UT WOS:000265249300008
PM 19363368
DA 2019-01-08
ER

PT J
AU Dale, J
   Caramlau, I
   Sturt, J
   Friede, T
   Walker, R
AF Dale, Jeremy
   Caramlau, Isabela
   Sturt, Jackie
   Friede, Tim
   Walker, Rosemary
TI Telephone peer-delivered intervention for diabetes motivation and
   support: The telecare exploratory RCT
SO PATIENT EDUCATION AND COUNSELING
LA English
DT Article
DE Peer support; Telecare; Motivational interviewing; Diabetes; Exploratory
   RCT; Patient empowerment; Patient satisfaction
ID RANDOMIZED CONTROLLED-TRIAL; SELF-MANAGEMENT PROGRAM; PRIMARY-CARE;
   VOLUNTEERS; EXPERIENCES; IMPROVEMENT; DEPRESSION; ADHERENCE; EDUCATION;
   DISTRESS
AB Objective: To test trial design issues related to measuring the effectiveness of a peer telephone intervention to enhance self-efficacy in type 2 diabetes; evaluate the impact on self-efficacy and clinical Outcome; and describe patient and peer experience.
   Methods: Eligible patients had raised HbA1c (initial threshold >8%, reduced to >7.4% mid-way through trial). Patients were recruited from 40 general practices and randomised (40:40:20 ratio) to receive routine care alone or, in addition, motivational telephone support from a peer supporter or a diabetes specialist nurse (9 peers and 12 DSNs) for a period of up to 6 months. The primary outcome measure was self-efficacy score, and secondary outcome measures included HbA1c. Patient and telecare supporter satisfaction and experience were evaluated.
   Results: In all, 231 patients participated. At 6 months there were no statistically significant differences in self-efficacy scores (p = 0.68), HbA1c (p = 0.87) or other secondary outcome measures. There was evidence of a high level of acceptability, but peer telecare support was less highly valued than that from a DSN. Some patients stated that they would have valued more information and advice.
   Conclusions: Further consideration needs to be given to the targeting of the telecare peer support, its intensity, the training and ongoing supervision of peer supporters, and the extent to which information and advice should be incorporated.
   Practice implications: While some patients with poorly controlled type 2 diabetes value peer telephone support, this approach appears not to suit all patients. Further intervention development and evaluation is required before widespread adoption can be recommended. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
C1 [Dale, Jeremy; Caramlau, Isabela; Sturt, Jackie; Friede, Tim; Walker, Rosemary] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England.
RP Dale, J (reprint author), Univ Warwick, Warwick Med Sch, Gibbet Hill Campus, Coventry CV4 7AL, W Midlands, England.
EM jeremy.dale@warwick.ac.uk
OI Dale, Jeremy/0000-0001-9256-3553; Friede, Tim/0000-0001-5347-7441
FU BUPA Foundation
FX We-are grateful to the BUPA Foundation for its funding of this study; to
   the Warwick Diabetes User Group for their advice about study design:,to
   the telecare supporters who participated; and the general practitioners
   and practice nurses, and patients who provided data. In addition we
   thank Fiona Rae, Oana Mitrofan, Malena Digiuni for providing clerical
   support for the trial, and we are particularly grateful to Rachel Potter
   and Rachel Adams for supporting practice recruitment and data
   collection.
CR Andersen MR, 2000, AM J PREV MED, V18, P199, DOI 10.1016/S0749-3797(99)00161-0
   ANDERSON B, 2000, ART EMPOWERMENT
   Arnstein Paul, 2002, Pain Manag Nurs, V3, P94, DOI 10.1053/jpmn.2002.126069
   Barlow JH, 2005, HEALTH EDUC RES, V20, P128, DOI 10.1093/her/cyg112
   Barlow JH, 2000, HEALTH EDUC RES, V15, P665, DOI 10.1093/her/15.6.665
   BARLOW JH, 2001, PATIENT EDUC COUNS, V48, P177
   Bodenheimer T, 2003, BRIT MED J, V326, P796, DOI 10.1136/bmj.326.7393.796
   Currell R, 2000, COCHRANE DATABASE SY
   DALE J, 2007, TRIALS, V8
   Dennis CL, 2003, CAN J PSYCHIAT, V48, P115
   Dennis CL, 2002, CAN MED ASSOC J, V166, P21
   Department of Health, 2001, EXP PAT NEW APPR CHR
   Docherty A, 2004, PATIENT EXPERIENCE C
   Donnan PT, 2002, DIABETIC MED, V19, P279, DOI 10.1046/j.1464-5491.2002.00689.x
   Duan NH, 2000, AM J PUBLIC HEALTH, V90, P1468, DOI 10.2105/AJPH.90.9.1468
   EDELMAN R, 2000, PSYCHOL ASPECTS HLTH
   GIBSON PG, 2002, SELF MANAGEMENT ED R
   Glasgow RE, 2000, MED CARE, V38, P1062, DOI 10.1097/00005650-200011000-00002
   Glasgow RE, 1999, DIABETES CARE, V22, P832, DOI 10.2337/diacare.22.5.832
   Hainsworth J, 2001, ARTHRIT RHEUM-ARTHR, V45, P378, DOI 10.1002/1529-0131(200108)45:4<378::AID-ART351>3.0.CO;2-T
   HEARNSHAW H, 2007, DIABETIC MED
   Heckman TG, 2004, HEALTH PSYCHOL, V23, P94, DOI 10.1037/0278-6133.23.1.94
   Hunkeler EM, 2000, ARCH FAM MED, V9, P700, DOI 10.1001/archfami.9.8.700
   Long AF, 2005, DIABETES CARE, V28, P283, DOI 10.2337/diacare.28.2.283
   Lorig K, 1998, ARTHRIT CARE RES, V11, P448, DOI 10.1002/art.1790110604
   LUKS A, 1998, PSYCHOL TODAY    OCT, P39
   Mallinckrodt Craig H, 2003, J Biopharm Stat, V13, P179, DOI 10.1081/BIP-120019265
   *MED RES COUNC, 2000, MED RES COUNC FRAM D
   MOEN P, 1989, AM SOCIOL REV, V54, P635, DOI 10.2307/2095884
   Mowbray CT, 1996, COMMUNITY MENT HLT J, V32, P47, DOI 10.1007/BF02249367
   NHS Centre for reviews and dissemination, 2000, EFFECTIVE HLTH CARE, V6, P1
   Ogden J., 1996, HLTH PSYCHOL
   OMOTO AM, 2000, J GERONTOL B-PSYCHOL, V54, pS173
   Philis-Tsimikas A, 2004, DIABETES CARE, V27, P110, DOI 10.2337/diacare.27.1.110
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   POTTER R, 2008, J RES NURS, V13
   Ritchie J, 1994, ANAL QUALITATIVE DAT
   RODGERS J, 1999, J DIABET NURS, V3, P55
   ROLLNICK S, 2005, HLTH BEHAV CHANGE
   SAVISHINSKY JS, 1992, SOC SCI MED, V34, P1325, DOI 10.1016/0277-9536(92)90141-C
   Schwartz CE, 1999, SOC SCI MED, V48, P1563, DOI 10.1016/S0277-9536(99)00049-0
   Shumaker SA, 1998, HDB HLTH BEHAV CHANG, P435
   Sturt J., 2003, DIABETIC MED S2, V20, P78
   Uitewaal P, 2004, PATIENT EDUC COUNS, V53, P359, DOI 10.1016/j.pec.2003.07.011
   Wagner EH, 2001, DIABETES CARE, V24, P695, DOI 10.2337/diacare.24.4.695
   WALKER R, 2004, DIABETES PRACTICAL G
   Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047
   YIP MP, 2000, J TELEMED TELECARE, V6, P263
   Young RJ, 2005, DIABETES CARE, V28, P278, DOI 10.2337/diacare.28.2.278
   QUALITY OUTCOMES FRA
NR 50
TC 61
Z9 65
U1 2
U2 33
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0738-3991
J9 PATIENT EDUC COUNS
JI Patient Educ. Couns.
PD APR
PY 2009
VL 75
IS 1
BP 91
EP 98
DI 10.1016/j.pec.2008.09.014
PG 8
WC Public, Environmental & Occupational Health; Social Sciences,
   Interdisciplinary
SC Public, Environmental & Occupational Health; Social Sciences - Other
   Topics
GA 426WC
UT WOS:000264738000012
PM 19013741
DA 2019-01-08
ER

PT J
AU Pirkola, S
   Saarni, S
   Suvisaari, J
   Elovainio, M
   Partonen, T
   Aalto, AM
   Honkonen, T
   Perala, J
   Lonnqvist, J
AF Pirkola, Sami
   Saarni, Samull
   Suvisaari, Jaana
   Elovainio, Marko
   Partonen, Timo
   Aalto, Anna-Mari
   Honkonen, Teija
   Perala, Jonna
   Lonnqvist, Jouko
TI General health and quality-of-life measures in active, recent, and
   comorbid mental disorders: a population-based health 2000 study
SO COMPREHENSIVE PSYCHIATRY
LA English
DT Article
ID BECK DEPRESSION INVENTORY; CATCHMENT-AREA ECA; DIABETES-MELLITUS;
   ANXIETY DISORDER; PANIC DISORDER; MIXED ANXIETY; PREVALENCE; ALCOHOL;
   AGE; EPIDEMIOLOGY
AB Aims: We studied the impact of comorbidity and recency in psychiatric disorders on psychological well-being, perceived health, and quality of life and compared their effect with the effect of a chronic medical condition, type 2 diabetes mellitus.
   Methods: Established instruments for psychological distress (12-item General Health Questionnaire [GHQ-12]), self-rated general health, and health-related quality of life (EQ-5D and 15D) were administered for the participants of the nationwide Finnish Health 2000 survey. The diagnoses of depressive, anxiety, and alcohol use disorders and their unique comorbid combinations were based on the Munich version of the Composite International Diagnostic Interview (M-CIDI).
   Results: People with comorbid anxiety and depressive disorders had the highest distress and lowest health and quality-of-life ratings on all scales. The effects of mental disorders on health-related quality of life and self-rated health were comparable to the effects of diabetes. Type 2 diabetes mellitus and alcohol use disorder were associated with minimal, although statistically significant, increase of psychological distress. Symptom recovery from an active depressive disorder associated with improved well-being on all measures, but residual ill-being was also remarkably common among the partly or fully recovered in all disorder categories.
   Conclusions: Even in comparison with a chronic physical illness such as diabetes, comorbid psychiatric disorders have a high impact on psychological well-being, perceived health, and quality of life, when evaluated by simple, useful, and feasible self-rating scales. The scales used may be useful in monitoring the severity and course of psychiatric conditions. Recognizing and treating psychiatric comorbidity is important in improving the quality of life of psychiatric patients. (c) 2009 Elsevier Inc. All rights reserved.
C1 [Pirkola, Sami] Univ Helsinki, Cent Hosp, Dept Psychiat, FIN-00029 Helsinki, Finland.
   [Pirkola, Sami; Saarni, Samull; Suvisaari, Jaana; Partonen, Timo; Perala, Jonna; Lonnqvist, Jouko] Natl Publ Hlth Inst, Dept Mental Hlth & Alcohol Res, FIN-00300 Helsinki, Finland.
   [Elovainio, Marko; Aalto, Anna-Mari] STAKES Natl Res & Dev Ctr Welf & Hlth, Hlth & Social Serv Div, FIN-00530 Helsinki, Finland.
   [Lonnqvist, Jouko] Univ Helsinki, Dept Psychiat, FIN-00260 Helsinki, Finland.
   [Honkonen, Teija] Finnish Inst Occupat Hlth, FIN-00250 Helsinki, Finland.
RP Pirkola, S (reprint author), Univ Helsinki, Cent Hosp, Dept Psychiat, POB 590, FIN-00029 Helsinki, Finland.
RI Partonen, Timo/G-1105-2012
OI Partonen, Timo/0000-0003-1951-2455; Elovainio,
   Marko/0000-0002-1401-1910; Suvisaari, Jaana/0000-0001-7167-0990
CR Aromaa A, 2004, HLTH FUNCTIONAL CAPA
   BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5
   Bradley C, 2002, DIABETES METAB RES, V18, pS64, DOI 10.1002/dmrr.279
   Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6
   Bruce SE, 2005, AM J PSYCHIAT, V162, P1179, DOI 10.1176/appi.ajp.162.6.1179
   Carpiniello B, 2002, EUR PSYCHIAT, V17, P394, DOI 10.1016/S0924-9338(02)00701-0
   CONG R, 2000, MARGINAL EFFECTS TOB
   Dolan P, 1996, HEALTH ECON, V5, P141, DOI 10.1002/(SICI)1099-1050(199603)5:2<141::AID-HEC189>3.0.CO;2-N
   Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242
   GOLDBERG DP, 1976, BRIT J PSYCHIAT, V129, P61, DOI 10.1192/bjp.129.1.61
   Kessler RC, 1996, AM J ORTHOPSYCHIAT, V66, P17, DOI 10.1037/h0080151
   Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593
   KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8
   Krueger RF, 1999, ARCH GEN PSYCHIAT, V56, P921, DOI 10.1001/archpsyc.56.10.921
   Lowe B, 2004, MED CARE, V42, P1194
   Malyszczak K, 2006, PSYCHIAT CLIN NEUROS, V60, P168, DOI 10.1111/j.1440-1819.2006.01482.x
   Moffitt TE, 2007, ARCH GEN PSYCHIAT, V64, P651, DOI 10.1001/archpsyc.64.6.651
   Mojtabai R, 2002, ARCH GEN PSYCHIAT, V59, P77, DOI 10.1001/archpsyc.59.1.77
   Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9
   Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2
   Ormel J, 2004, ARCH GEN PSYCHIAT, V61, P387, DOI 10.1001/archpsyc.61.4.387
   Pirkola S, 2005, SOC PSYCH PSYCH EPID, V40, P769, DOI 10.1007/s00127-005-0950-x
   Pirkola SP, 2006, ALCOHOL ALCOHOLISM, V41, P315, DOI 10.1093/alcalc/agh240
   Pirkola SP, 2005, SOC PSYCH PSYCH EPID, V40, P1, DOI 10.1007/s00127-005-0848-7
   Puavilai G, 1999, DIABETES RES CLIN PR, V44, P21, DOI 10.1016/S0168-8227(99)00008-X
   Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087
   REGIER D A, 1990, Journal of the American Medical Association, V264, P2511, DOI 10.1001/jama.264.19.2511
   REGIER DA, 1990, J PSYCHIAT RES, V24, P3, DOI 10.1016/0022-3956(90)90031-K
   Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O
   Saarni SI, 2007, J CLIN EPIDEMIOL, V60, P1288, DOI 10.1016/j.jclinepi.2007.03.004
   Saarni SI, 2006, QUAL LIFE RES, V15, P1403, DOI 10.1007/s11136-006-0020-1
   SAARNI SI, 2007, BRIT J PSYCHIAT, P190
   Sintonen H, 2001, ANN MED, V33, P328, DOI 10.3109/07853890109002086
   SINTONEN H, 1995, 42 MON U CTR HLTH PR
   SINTONEN H, 1994, 41 MON U CTR HLTH PR
   STEER RA, 1986, J CLIN PSYCHOL, V42, P475, DOI 10.1002/1097-4679(198605)42:3<475::AID-JCLP2270420311>3.0.CO;2-D
   Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X
   Tengs TO, 2000, MED CARE, V38, P583, DOI 10.1097/00005650-200006000-00004
   The EuroQol Group, 1990, HLTH POLICY, V16, P199, DOI DOI 10.1016/0168-8510(90)90421-9
   TOBIN J, 1958, ECONOMETRICA, V26, P24, DOI 10.2307/1907382
   Wandell PE, 2005, SCAND J PRIM HEALTH, V23, P68, DOI 10.1080/02813430510015296
   Weiss RD, 2005, J CLIN PSYCHIAT, V66, P730, DOI 10.4088/JCP.v66n0609
   WEISS RD, 2005, J CLIN PSYCHIAT, V66, P808
   *WHO EXP COMM, 1999, DEF DIAGN CLASS DIAB
   Wittchen HU, 2001, HUM PSYCHOPHARM CLIN, V16, pS21, DOI 10.1002/hup.267
   Wittchen HU, 1999, ARCH GEN PSYCHIAT, V56, P929, DOI 10.1001/archpsyc.56.10.929
   Zimmerman M, 2005, AM J PSYCHIAT, V162, P1911, DOI 10.1176/appi.ajp.162.10.1911
   Zimmerman M, 2006, CNS SPECTRUMS, V11, P1
NR 48
TC 25
Z9 27
U1 0
U2 7
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0010-440X
EI 1532-8384
J9 COMPR PSYCHIAT
JI Compr. Psychiat.
PD MAR-APR
PY 2009
VL 50
IS 2
BP 108
EP 114
DI 10.1016/j.comppsych.2008.06.003
PG 7
WC Psychiatry
SC Psychiatry
GA 414HA
UT WOS:000263853300003
PM 19216886
DA 2019-01-08
ER

PT J
AU Melkus, GD
   Whittemore, R
   Mitchell, J
AF Melkus, Gail D'Eramo
   Whittemore, Robin
   Mitchell, Jessica
TI Type 2 Diabetes in Urban Black and Rural White Women
SO DIABETES EDUCATOR
LA English
DT Article
ID AFRICAN-AMERICAN WOMEN; SELF-MANAGEMENT; DEPRESSIVE SYMPTOMS; HEALTH
   DISPARITIES; GLYCEMIC CONTROL; FOCUS GROUPS; CARE; EDUCATION; BARRIERS;
   MELLITUS
AB Purpose The purpose of this secondary analysis was to describe and compare physiological, psychosocial, and self-management characteristics of urban black and rural white women with type 2 diabetes (T2D) in the northeast United States.
   Methods A descriptive, cross-sectional secondary analysis was conducted with baseline data from 2 independent study samples: rural white women and urban black women.
   Results Results revealed the sample were on average educated, working, low-income, mid-life women with poor glycemic and blood pressure control, despite having a usual source of primary care. When compared, black women were younger, had lower income levels, worked more, and were often single and/or divorced. They had worse glycemic control, significantly higher levels of diabetes-related emotional distress, and less support than white women.
   Conclusion Despite differences in geography and study findings, both groups had suboptimal physiological and psychosocial levels that impede self-management. These findings serve to aid in the understanding of health disparities, emphasizing the importance of developing and evaluating effective interventions of diabetes care for women with T2D.
C1 [Melkus, Gail D'Eramo; Whittemore, Robin; Mitchell, Jessica] Yale Univ, Sch Nursing, New Haven, CT 06536 USA.
RP Melkus, GD (reprint author), NYU, Coll Nursing, 246 Greene St, New York, NY 10003 USA.
EM gdm3@nyu.edu
FU NIH/NINR [5F32NR07823-02]
FX This study was completed with partial support from the NIH/NINR grant
   5F32NR07823-02 NIH/NINR, AADE Roche Diagnostics Diabetes Education
   Research Award, and Patrick and Catherine Weldon Donaghue Foundation.
CR AHIJEVYCH K, 1994, NURS RES, V43, P86
   ANDERSON R, 2001, DIABETES ED, V24, P1060
   Anderson RM, 1996, DIABETES EDUCATOR, V22, P28, DOI 10.1177/014572179602200104
   Balukonis J., 2005, DIABETES S1, V54, pA2823
   BECKLES G, 2001, DIABETES WOMEN LIFE
   Carter-Edwards L, 2004, DIABETES EDUCATOR, V30, P493, DOI 10.1177/014572170403000321
   Chesla CA, 2004, DIABETES CARE, V27, P2850, DOI 10.2337/diacare.27.12.2850
   Cooper LA, 2003, MED CARE, V41, P479, DOI 10.1097/00005650-200304000-00004
   DUELBERG SI, 1992, SOC SCI MED, V34, P191, DOI 10.1016/0277-9536(92)90096-9
   Egede LE, 2002, DIABETES EDUCATOR, V28, P258, DOI 10.1177/014572170202800211
   ERIKSSON BS, 1993, WOMEN HEALTH, V20, P59, DOI 10.1300/J013v20n04_04
   FITZGERALD J, 1994, DIABETES ED, V21, P523
   Fitzgerald JT, 1996, EVAL HEALTH PROF, V19, P208, DOI 10.1177/016327879601900205
   Flaskerud JH, 2002, NURS RES, V51, P74, DOI 10.1097/00006199-200203000-00003
   Galasso P, 2005, DIABETES EDUCATOR, V31, P719, DOI 10.1177/0145721705280941
   Gary TL, 2000, DIABETES CARE, V23, P23, DOI 10.2337/diacare.23.1.23
   HANDRON DS, 1994, DIABETES EDUCATOR, V20, P515, DOI 10.1177/014572179402000609
   HARRIS M, 1999, DIABETES CARE, V20, P403
   *IS INC, 1992, GLYC AFF GHB AFF ACC
   Jefferson VW, 2000, DIABETES EDUCATOR, V26, P295, DOI 10.1177/014572170002600210
   Jerant AF, 2005, PATIENT EDUC COUNS, V57, P300, DOI 10.1016/j.pec.2004.08.004
   Karter AJ, 2002, JAMA-J AM MED ASSOC, V287, P2519, DOI 10.1001/jama.287.19.2519
   LUSTMAN PJ, 1992, DIABETES CARE, V15, P1631, DOI 10.2337/diacare.15.11.1631
   Maciejewski PK, 2000, BRIT J PSYCHIAT, V176, P373, DOI 10.1192/bjp.176.4.373
   Maillet NA, 1996, DIABETES EDUCATOR, V22, P39, DOI 10.1177/014572179602200106
   Melkus GD, 2004, APPL NURS RES, V17, P10, DOI 10.1016/j.apnr.2003.10.009
   Mulcahy K, 2000, DIABETES EDUCATOR, V26, P957, DOI 10.1177/014572170002600608
   Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561
   O'Neill ES, 2001, J ADV NURS, V33, P257, DOI 10.1046/j.1365-2648.2001.01653.x
   Peek ME, 2007, MED CARE RES REV, V64, p101S, DOI 10.1177/1077558707305409
   Peyrot M, 1997, DIABETES CARE, V20, P585, DOI 10.2337/diacare.20.4.585
   QUACKENBUSH P, 2000, DIABETES ED, V22, P231
   Rayman Kathleen, 2004, Health Care Women Int, V25, P900, DOI 10.1080/07399330490508604
   Samuel-Hodge CD, 2000, DIABETES CARE, V23, P928, DOI 10.2337/diacare.23.7.928
   Samuel-Hodge CD, 2005, ETHNIC DIS, V15, P436
   Sarkadi Anna, 2002, Health Care Women Int, V23, P600, DOI 10.1080/07399330290107368
   TOOBERT K, 1994, HDB PSYCHOL DIABETES
   WEATHERSPOON LJ, 1994, DIABETES CARE, V17, P1148, DOI 10.2337/diacare.17.10.1148
   Welch G, 2003, DIABETIC MED, V20, P69, DOI 10.1046/j.1464-5491.2003.00832.x
   White KE, 2004, J EXPO ANAL ENV EPID, V14, P195, DOI 10.1038/sj.jea.7500312
NR 40
TC 5
Z9 5
U1 2
U2 8
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0145-7217
J9 DIABETES EDUCATOR
JI Diabetes Educ.
PD MAR
PY 2009
VL 35
IS 2
BP 293
EP 301
DI 10.1177/0145721708327532
PG 9
WC Endocrinology & Metabolism; Public, Environmental & Occupational Health
SC Endocrinology & Metabolism; Public, Environmental & Occupational Health
GA 425LC
UT WOS:000264637000011
PM 19204103
DA 2019-01-08
ER

PT J
AU Iversen, MM
   Midthjell, K
   Tell, GS
   Moum, T
   Ostbye, T
   Nortvedt, MW
   Uhlving, S
   Hanestad, BR
AF Iversen, Marjolein M.
   Midthjell, Kristian
   Tell, Grethe S.
   Moum, Torbjorn
   Ostbye, Truls
   Nortvedt, Monica W.
   Uhlving, Sverre
   Hanestad, Berit R.
TI The association between history of diabetic foot ulcer, perceived health
   and psychological distress: the Nord-Trondelag Health Study
SO BMC ENDOCRINE DISORDERS
LA English
DT Article
ID QUALITY-OF-LIFE; DEPRESSIVE SYMPTOMS; HOSPITAL ANXIETY; RISK-FACTOR;
   MORTALITY; ADULTS; CARE; METAANALYSIS; POPULATION; PREVALENCE
AB Background: While the adverse impact of a history of a foot ulcer on physical health among persons with diabetes is well known, little is known about the association between foot ulcer, perceived health and psychological distress. Results from various studies are difficult to compare as different study designs, samples and/or different questionnaires have been used. The aim of this study was to compare levels of anxiety and depression, psychological well-being and perceived health between persons with diabetes, with or without a history of foot ulcer, and persons without diabetes in a large study of community-dwelling individuals.
   Methods: This study included 65,126 persons, of whom 63,632 did not have diabetes, 1,339 had diabetes without a history of foot ulcer and 155 had diabetes and a history of foot ulcer. Levels of anxiety and depression were assessed by the Hospital Anxiety and Depression Scale (HADS). Psychological well-being was measured on a four-item scale, and perceived health was measured with a one-item question. We investigated whether levels of anxiety, depression, psychological well-being and perceived health were different in the three study groups using multiple regression models controlling for demographic factors, body mass index, smoking and cardiovascular conditions. Separate multivariate analyses comparing the two diabetes samples were additionally adjusted for diabetes-specific variables.
   Results: A history of foot ulcer was significantly associated with more depressive symptoms, poorer psychological wellbeing and poorer perceived health compared to participants without diabetes. In multivariate analyses, perceived health and psychological well-being were significantly poorer among those with a history of foot ulcer compared to those without diabetes. Among persons with diabetes, perceived health was significantly worse among those with a history of foot ulcer. After multivariate adjustment, levels of anxiety and depression and psychological well-being did not differ between the two diabetes groups.
   Conclusion: Perceived health and psychological well-being were significantly poorer among participants with diabetes and a history of foot ulcer compared to those without diabetes. Among people with diabetes, a history of foot ulcer had significant negative impact on perceived health but did not independently contribute to psychological distress.
C1 [Iversen, Marjolein M.; Nortvedt, Monica W.] Bergen Univ Coll, Fac Hlth & Social Sci, N-5020 Bergen, Norway.
   [Iversen, Marjolein M.; Tell, Grethe S.; Hanestad, Berit R.] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, N-5020 Bergen, Norway.
   [Midthjell, Kristian] Norwegian Univ Sci & Technol, HUNT Res Ctr, N-7650 Verdal, Norway.
   [Moum, Torbjorn] Univ Oslo, Dept Behav Sci Med, N-0317 Oslo, Norway.
   [Ostbye, Truls] Duke Univ, Med Ctr, Dept Community & Family Med, Durham, NC 27710 USA.
   [Uhlving, Sverre] Stavanger Univ Hosp, Dept Internal Med, N-4068 Stavanger, Norway.
RP Iversen, MM (reprint author), Bergen Univ Coll, Fac Hlth & Social Sci, POB 7030, N-5020 Bergen, Norway.
EM miv@hib.no; kristian.midthjell@ntnu.no; grethe.tell@isf.uib.no;
   torbjorn.moum@medisin.uio.no; ostby001@mc.duke.edu; mwn@hib.no;
   uhsv@sus.no; berit.rokne@rektor.uib.no
RI Tell, Grethe/G-5639-2015
OI Tell, Grethe/0000-0003-1386-1638; Nortvedt, Monica
   Wammen/0000-0002-1859-6071
FU Norwegian Diabetes Association; GlaxoSmithKline Norway; Bergen
   University College
FX The Nord-Trondelag Health Study (the HUNT2 study) is a collaboration
   between the HUNT Research Centre, Faculty of Medicine, Norwegian
   University of Science and Technology (NTNU), Verdal, Norwegian Institute
   of Public Health, Oslo and the Nord-Trondelag County Council. The
   present study was supported by the Bergen University College. The
   diabetes part of HUNT2 has gained support from the Norwegian Diabetes
   Association and GlaxoSmithKline Norway.
CR ABETZ L, 2002, PRACT DIAB INT, V19, P167, DOI DOI 10.1002/PDI.356
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Apelqvist J, 2000, DIABETES-METAB RES, V16, pS75, DOI 10.1002/1520-7560(200009/10)16:1+<::AID-DMRR139>3.0.CO;2-8
   Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3
   Brod M, 1998, QUAL LIFE RES, V7, P365
   Carrington AL, 1996, DIABETES RES CLIN PR, V32, P19, DOI 10.1016/0168-8227(96)01198-9
   De Berardis G, 2005, J DIABETES COMPLICAT, V19, P319, DOI 10.1016/j.jdiacomp.2005.02.005
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   Diener E, 1999, PSYCHOL BULL, V125, P276, DOI 10.1037//0033-2909.125.2.276
   Goodridge D, 2006, FOOT ANKLE INT, V27, P274, DOI 10.1177/107110070602700408
   Holmen J, 2003, NORSK EPIDEMIOLOGI, V13, P19
   Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359
   Ismail K, 2007, DIABETES CARE, V30, P1473, DOI 10.2337/dc06-2313
   Iversen MM, 2008, RES NURS HEALTH, V31, P226, DOI 10.1002/nur.20255
   Iversen MM, 2008, SCAND J PUBLIC HEALT, V36, P62, DOI 10.1177/1403494807085314
   Kaplan GA, 1996, INT J EPIDEMIOL, V25, P259, DOI 10.1093/ije/25.2.259
   Katon W, 2004, DIABETES CARE, V27, P914, DOI 10.2337/diacare.27.4.914
   Li CY, 2008, DIABETES CARE, V31, P105, DOI 10.2337/dc07-1154
   Meijer JWG, 2001, DISABIL REHABIL, V23, P336
   Monami M, 2008, J AM PODIAT MED ASSN, V98, P130, DOI 10.7547/0980130
   MOUM T, 1990, PSYCHOL MED, V20, P635, DOI 10.1017/S0033291700017153
   Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9
   Mykletun A, 2001, BRIT J PSYCHIAT, V179, P540, DOI 10.1192/bjp.179.6.540
   Nabuurs-Franssen MH, 2005, DIABETOLOGIA, V48, P1906, DOI 10.1007/s00125-005-1856-6
   NAESS S, 1995, SCAND J SOC MED, V23, P179
   Ribu L, 2007, QUAL LIFE RES, V16, P179, DOI 10.1007/s11136-006-0031-y
   Roysamb E, 2002, PERS INDIV DIFFER, V32, P211, DOI 10.1016/S0191-8869(01)00019-8
   Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O
   Singh N, 2005, JAMA-J AM MED ASSOC, V293, P217, DOI 10.1001/jama.293.2.217
   Snaith RP, 1994, HOSP ANXIETY DEPRESS
   Tennvall GR, 2000, J DIABETES COMPLICAT, V14, P235
   Vileikyte L, 2005, DIABETES CARE, V28, P2378, DOI 10.2337/diacare.28.10.2378
   Vileikyte L, 2003, DIABETES CARE, V26, P2549, DOI 10.2337/diacare.26.9.2549
   Vileikyte L, 2009, DIABETOLOGIA, V52, P1265, DOI 10.1007/s00125-009-1363-2
NR 34
TC 13
Z9 13
U1 0
U2 6
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1472-6823
J9 BMC ENDOCR DISORD
JI BMC Endocr. Disord.
PY 2009
VL 9
AR 18
DI 10.1186/1472-6823-9-18
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA V20CX
UT WOS:000208119200018
PM 19706152
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Giel, KE
   Enck, P
   Zipfel, S
   Schrauth, M
   Bury, A
   Graf, M
   Kummerle, S
   Guthoff, M
   Stefan, N
   Haring, HU
   Fritsche, A
AF Giel, Katrin E.
   Enck, Paul
   Zipfel, Stephan
   Schrauth, Markus
   Bury, Anna
   Graf, Marjo
   Kuemmerle, Sabine
   Guthoff, Martina
   Stefan, Norbert
   Haering, Hans-Ulrich
   Fritsche, Andreas
TI Psychological effects of prevention: do participants of a type 2
   diabetes prevention program experience increased mental distress?
SO DIABETES-METABOLISM RESEARCH AND REVIEWS
LA English
DT Article
DE type 2 diabetes; lifestyle intervention; prevention; mental distress;
   depression; SCL-90-R
ID IMPAIRED GLUCOSE-TOLERANCE; LIFE-STYLE; IMPACT; HYPOCHONDRIASIS;
   INTERVENTION; MELLITUS; TRIAL
AB Objective To evaluate the mental health outcome of a lifestyle intervention for the prevention of type 2 diabetes and to exclude possible harmful psychological effects.
   Background There is little empirical data on potential harmful effects of prevention programs. However, information, education, diagnostic procedures, phenotyping and risk assessment may cause or intensify psychological distress such as anxiety, depression or somatization in vulnerable individuals.
   Methods The Tuebingen Lifestyle Intervention Program (TULIP) for the prevention of type 2 diabetes has assessed mental health outcome in the participants after 9 months of program participation using the Symptom Checklist-90-R (SCL-90-R). The 24-months lifestyle intervention TULIP comprises regular exercise and changes in nutrition and assesses both, a broad range of somatic parameters as well as psychometric variables. For an interim analysis of psychological outcome, complete data sets of the SCL-90-R assessed at baseline and after 9 months of intervention were available for 195 participants (125 females, 70 males; age: 46.1 +/- 10.6 years). Data on somatization, anxiety, depression and overall psychological distress were compared to baseline levels.
   Results SCL-90-R scores of the TULIP-participants did not significantly differ from the German healthy reference population. Compared to baseline, a significant decrease in SCL-90-R scores was found for anxiety, depression and overall psychological distress at re-assessment after 9 months.
   Conclusion The interim analysis on mental health outcome of a type 2 diabetes prevention program comprising extensive phenotyping and risk assessment rules out adverse psychological effects, suggesting rather beneficial changes concerning symptoms of anxiety, depression and overall psychological distress. Copyright (C) 2009 John Wiley & Sons, Ltd.
C1 [Giel, Katrin E.; Enck, Paul; Zipfel, Stephan; Schrauth, Markus] Univ Tubingen Hosp, Dept Internal Med Psychosoam Med & Psychotherapy, Tubingen, Germany.
   [Bury, Anna; Graf, Marjo; Kuemmerle, Sabine; Guthoff, Martina; Stefan, Norbert; Haering, Hans-Ulrich; Fritsche, Andreas] Univ Tubingen Hosp, Dept Internal Med Endocrinol Diabet Vasc Med 4, Tubingen, Germany.
RP Giel, KE (reprint author), Univ Tubingen Hosp, Dept Internal Med Psychosoam Med & Psychotherapy, Osianderstr 5, Tubingen, Germany.
EM katrin.giel@med.uni-tuebingen.de
RI Guthoff, Martina/D-3960-2018
OI Stefan, Norbert/0000-0002-2186-9595
FU Deutsche Forschungsgerneinschaft [KFO 114]
FX We thank all research volunteers for their participation in the study.
   TULIP was supported by a grant from the Deutsche Forschungsgerneinschaft
   (KFO 114).
CR Adriaanse MC, 2006, DIABETES-METAB RES, V22, P20, DOI 10.1002/dmrr.590
   Aikens JE, 1998, INT J PSYCHIAT MED, V28, P265, DOI 10.2190/RJ82-3JKB-YKEM-BNU0
   Braithwaite D, 2004, J NATL CANCER I, V96, P122, DOI 10.1093/jnci/djh017
   Brands AMA, 2007, J INT NEUROPSYCH SOC, V13, P288, DOI 10.1017/S1355617707070312
   Brett J, 2005, PSYCHO-ONCOLOGY, V14, P917, DOI 10.1002/pon.904
   DEROGATIS LR, 1983, SCL90R ADM SCORING P
   Eborall HC, 2007, BRIT MED J, V335, P486, DOI 10.1136/bmj.39303.723449.55
   Fisher L, 2001, DIABETES CARE, V24, P1751, DOI 10.2337/diacare.24.10.1751
   French DP, 2006, PSYCHO-ONCOL, V15, P498, DOI 10.1002/pon.980
   GILLON R, 1990, J MED ETHICS, V16, P171, DOI 10.1136/jme.16.4.171
   Kinmonth AL, 2008, LANCET, V371, P41, DOI 10.1016/S0140-6736(08)60070-7
   Knol MJ, 2007, PSYCHOSOM MED, V69, P300, DOI 10.1097/PSY.0b013e31805f48b9
   Marcus DK, 2007, CLIN PSYCHOL REV, V27, P127, DOI 10.1016/j.cpr.2006.09.003
   Marshall KG, 1996, CAN MED ASSOC J, V155, P169
   PANZER M, 2008, HEALTH PSYCHOL, V23, P617
   Petrak F, 2005, CURR DIABETES REV, V1, P255, DOI 10.2174/157339905774574329
   Rief W, 1998, J ABNORM PSYCHOL, V107, P587, DOI 10.1037/0021-843X.107.4.587
   Schafer S, 2007, EUR J CLIN INVEST, V37, P535, DOI 10.1111/j.1365-2362.2007.01820.x
   SCHIAVI RC, 1995, J PSYCHOSOM RES, V39, P305, DOI 10.1016/0022-3999(94)00092-J
   Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801
   Weber B, 1997, ANN MED, V29, P461, DOI 10.3109/07853899708999377
NR 21
TC 8
Z9 8
U1 0
U2 9
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 1520-7552
J9 DIABETES-METAB RES
JI Diabetes-Metab. Res. Rev.
PD JAN
PY 2009
VL 25
IS 1
BP 83
EP 88
DI 10.1002/dmrr.917
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 402KU
UT WOS:000263013400010
PM 19145589
DA 2019-01-08
ER

PT J
AU Makine, C
   Karsidag, C
   Kadioglu, P
   Ilkova, H
   Karsidag, K
   Skovlund, SE
   Snoek, FJ
   Pouwer, F
AF Makine, C.
   Karsidag, C.
   Kadioglu, P.
   Ilkova, H.
   Karsidag, K.
   Skovlund, S. E.
   Snoek, F. J.
   Pouwer, F.
TI Symptoms of depression and diabetes-specific emotional distress are
   associated with a negative appraisal of insulin therapy in insulin-naive
   patients with Type 2 diabetes mellitus. A study from the European
   Depression in Diabetes [EDID] Research Consortium
SO DIABETIC MEDICINE
LA English
DT Article
DE diabetes mellitus; depression; insulin
ID GLYCEMIC CONTROL; SCALE; PREVALENCE; MIGRANTS; TURKISH; RISK
AB A meta-analysis concluded that depression is associated with poor glycaemic control in Type 2 diabetes (DM2). In DM2 patients with deteriorating glycaemic control, the initiation of insulin therapy is often postponed. The aim of the present study was to determine whether symptoms of depression and diabetes-specific emotional distress are associated with a more negative appraisal of insulin therapy.
   We collected cross-sectional data in two outpatient university clinics in Istanbul, Turkey. The study sample consisted of 154 insulin-naive patients with DM2. A self-report questionnaire was used to obtain demographic and clinical data. Main instruments were the Centre for Epidemiologic Studies Depression Scale, (CES-D), the Problem Areas In Diabetes scale (PAID) and the Insulin Treatment Appraisal Scale (ITAS).
   Analysis of variance revealed that patients with a higher depression score rated insulin therapy significantly more negative then patients with lower depression scores. Moreover, 47% of patients with a high depression score had a negative appraisal of insulin therapy on 7 or more of the 20 ITAS-items, compared to 25 to 29% of those with low-moderate depression scores. Multiple regression analyses showed that a negative appraisal of insulin therapy was significantly associated with higher depression and diabetes-distress scores and low education, but not with sex, age or duration of diabetes.
   Our results suggest that in insulin-naive Type 2 diabetes patients, higher levels of depression and diabetes-distress tend to be associated with more negative beliefs about insulin. Whether these negative attitudes translate into postponing initiation of insulin therapy needs to be tested in longitudinal research.
   Diabet. Med. 26, 28-33 (2009).
C1 [Pouwer, F.] Tilburg Univ, Dept Med Psychol & Neuropsychol, Ctr Res Psychol Somat Dis, NL-5000 LE Tilburg, Netherlands.
   [Makine, C.; Snoek, F. J.] Vrije Univ Amsterdam Med Ctr, EMGO Inst, Dept Med Psychol, Amsterdam, Netherlands.
   [Karsidag, C.] Bakirkoy Mental & Neurol Dis Hosp, Istanbul, Turkey.
   [Kadioglu, P.; Ilkova, H.] Istanbul Univ, Cerrahpasa Med Fac, Istanbul, Turkey.
   [Karsidag, K.] Istanbul Univ, Istanbul Fac Med, Istanbul, Turkey.
   [Skovlund, S. E.] Novo Nordisk AS, DK-2880 Bagsvaerd, Denmark.
RP Pouwer, F (reprint author), Tilburg Univ, Dept Med Psychol & Neuropsychol, Ctr Res Psychol Somat Dis, POB 90153, NL-5000 LE Tilburg, Netherlands.
EM f.pouwer@vumc.nl
FU Novo Nordisk Turkey; Novo Nordisk Denmark
FX This study was supported by an unrestricted grant from Novo Nordisk
   Turkey and Novo Nordisk Denmark. The authors wish to express their
   gratitude to the patients who participated in the present study.
CR American Psychiatric Association APA, 2000, DIAGN STAT MAN MENT
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   DOBSON KS, 1995, COGNITIVE THER RES, V19, P179, DOI 10.1007/BF02229693
   Kara M, 2004, J NURS SCHOLARSHIP, V36, P331, DOI 10.1111/j.1547-5069.2004.04060.x
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Meece J, 2006, DIABETES EDUCATOR, V32, p9S, DOI 10.1177/014572170585638
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   Pinar Rukiye, 2003, Pediatr Diabetes, V4, P168, DOI 10.1111/j.1399-543X.2003.00028.x
   Polonsky WH, 2005, DIABETES CARE, V28, P2543, DOI 10.2337/diacare.28.10.2543
   Pouwer F, 2001, DIABETIC MED, V18, P595, DOI 10.1046/j.1464-5491.2001.00499.x
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Snoek FJ, 2002, INT J CLIN PRACT, P80
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Snoek FJ, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-69
   Spijker J, 2004, INT J GERIATR PSYCH, V19, P538, DOI 10.1002/gps.1122
   UKPDS Study Group, 1998, LANCET, V352, P837, DOI DOI 10.1016/S0140-6736(98)07019-6
   van der Wurff FB, 2004, J AFFECT DISORDERS, V83, P33, DOI 10.1016/j.jad.2004.04.009
NR 17
TC 45
Z9 52
U1 2
U2 17
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD JAN
PY 2009
VL 26
IS 1
BP 28
EP 33
DI 10.1111/j.1464-5491.2008.02606.x
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 391HF
UT WOS:000262223700005
PM 19125757
OA Green Published, Bronze
DA 2019-01-08
ER

PT J
AU Lerman, I
   Diaz, JPM
   Ibarguengoitia, MER
   Perez, FJG
   Villa, AR
   Velasco, ML
   Cruz, RG
   Rodrigo, JAR
AF Lerman, Israel
   Moreira Diaz, Juan Pablo
   Romero Ibarguengoitia, Ma Elena
   Gomez Perez, Francisco Javier
   Villa, Antonio R.
   Luisa Velasco, Maria
   Gomez Cruz, Roberto
   Rull Rodrigo, Juan Antonio
TI NONADHERENCE TO INSULIN THERAPY IN LOW-INCOME, TYPE 2 DIABETIC PATIENTS
SO ENDOCRINE PRACTICE
LA English
DT Article
ID STARTING INSULIN; SUBCUTANEOUS INSULIN; GLYCEMIC CONTROL; NEEDS DAWN;
   ATTITUDES; BARRIERS; POPULATION; RESISTANCE; PROVIDERS; MELLITUS
AB Objective: To evaluate the psychosocial barriers to insulin use in low-income, type 2 diabetic patients; the clinical characteristics of these patients; and the possible causes of nonadherence to insulin regimens months after prescription.
   Methods: We studied a prospective cohort of low-income patients with type 2 diabetes mellitus, aged 45 to 75 years, attending a tertiary health care center in Mexico City, Mexico. Patients were eligible if their diabetes was not controlled with oral agents, and they were excluded if they had type 1 diabetes mellitus, a secondary cause of diabetes, had been admitted to the hospital within the month before study commencement, had been previously treated with insulin, had severe diabetic complications, or had a chronic or disabling medical illness. All patients were prescribed 6 to 10 units of neutral protamine Hagedorn insulin before bedtime and received a referral to visit with a diabetes nurse educator. The main outcome was adherence or nonadherence to insulin therapy, and it was correlated with several variables including attitudes toward insulin, diabetes self-management, diabetes-related knowledge, depression, and diabetes-related distress. Brief medical history, complete battery of questionnaires, and laboratory workup were obtained at baseline and 1 to 3 months after insulin prescription.
   Results: Twenty-nine consecutive patients were included. Mean age (standard deviation) was 59 8 years, 18 (62%) were women, mean diabetes duration was 14 9 years, and mean hemoglobin A(1c) level was 10.8 +/- 1.4%. Negative attitudes toward insulin were very common, particularly in patients with less education and poorer diabetes-related knowledge (odds ratio, 6.2; 95% confidence interval, 1.04-47.3; P = .02). Even when they received precise recommendations, 12 patients (41%) did not adhere to insulin treatment. Patients who did not adhere to therapy were most commonly women and were depressed (P = .05). Improved adherence was significantly associated with the additional support of a diabetes nurse educator (odds ratio, 6.6; 95% confidence interval, 1.0-55.7; P = .02).
   Conclusions: Improving patient perception and acceptance of insulin with the help of diabetes educators can facilitate earlier and more aggressive intervention and thus optimize glycemic control. (Endocr Pract. 2009;15:41-46)
C1 [Lerman, Israel; Moreira Diaz, Juan Pablo; Romero Ibarguengoitia, Ma Elena; Gomez Perez, Francisco Javier; Luisa Velasco, Maria; Rull Rodrigo, Juan Antonio] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Endocrinol & Metab, Mexico City 14000, DF, Mexico.
   [Villa, Antonio R.] Natl Inst Med Sci & Nutr Salvador Zubirin, Clin Epidemiol Unit, Mexico City, DF, Mexico.
RP Lerman, I (reprint author), Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Endocrinol & Metab, Vasco Quiroga 15, Mexico City 14000, DF, Mexico.
EM israellerman@gmail.com
CR *AM DIAB ASS, 2005, DIABETES CARE S1, V28, pS4, DOI DOI 10.2337/DIACARE
   *AM DIAB ASS, 2005, DIABETES CARE, V28, P990
   Barquera S, 2003, ARCH MED RES, V34, P407, DOI 10.1016/S0188-4409(03)00075-4
   Bautista-Martinez S, 1999, DIABETES EDUCATOR, V25, P374, DOI 10.1177/014572179902500308
   Cefalu WT, 2008, DIABETES TECHNOL THE, V10, P25, DOI 10.1089/dia.2008.0249
   CLEMENT S, 1995, DIABETES CARE, V18, P1204, DOI 10.2337/diacare.18.8.1204
   Gavin JR, 1997, DIABETES CARE, V20, P1183
   GRECO P, 1990, DIABETES, V1, P64
   Hayward RA, 1997, JAMA-J AM MED ASSOC, V278, P1663, DOI 10.1001/jama.278.20.1663
   Koro CE, 2004, DIABETES CARE, V27, P17, DOI 10.2337/diacare.27.1.17
   Korytkowski M, 2002, INT J OBESITY, V26, pS18, DOI 10.1038/sj.ijo.0802173
   Kurtz S M, 1990, Diabetes Educ, V16, P50, DOI 10.1177/014572179001600112
   Larme AC, 1998, DIABETES CARE, V21, P1391, DOI 10.2337/diacare.21.9.1391
   Lerman-Garber I, 2001, ISRAEL MED ASSOC J, V3, P369
   Okazaki K, 1999, DIABETES, V48, pA319
   Peyrot M, 2005, DIABETES CARE, V28, P2673, DOI 10.2337/diacare.28.11.2673
   Polonsky WH, 2005, DIABETES CARE, V28, P2543, DOI 10.2337/diacare.28.10.2543
   Riddle MC, 2002, DIABETES METAB RES, V18, pS42, DOI 10.1002/dmrr.277
   Rubin RR, 2006, DIABETES CARE, V29, P1249, DOI 10.2337/dc05-2494
   Rubino A, 2007, DIABETIC MED, V24, P1412, DOI 10.1111/j.1464-5491.2007.02279.x
   Skovlund S. E., 2005, DIABETES SPECTRUM, V18, P136, DOI DOI 10.2337/DIASPECT.18.3.136
   TURNER RC, 1995, DIABETES, V44, P1249
   *UK PROSP DIAB STU, 1996, DIABETES, V45, P1655
   Wallace TM, 2000, QJM-MON J ASSOC PHYS, V93, P369, DOI 10.1093/qjmed/93.6.369
   Whooley MA, 1997, J GEN INTERN MED, V12, P439, DOI 10.1046/j.1525-1497.1997.00076.x
NR 25
TC 22
Z9 22
U1 2
U2 4
PU AMER ASSOC CLIN ENDOCRINOL
PI JACKSONVILLE
PA 1000 RIVERSIDE AVE, STE 205, JACKSONVILLE, FL 32204 USA
SN 1530-891X
J9 ENDOCR PRACT
JI Endocr. Pract.
PD JAN-FEB
PY 2009
VL 15
IS 1
BP 41
EP 46
DI 10.4158/EP.15.1.41
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 437NO
UT WOS:000265494400007
PM 19211396
DA 2019-01-08
ER

PT J
AU Ricart, W
   Lopez, J
   Mozas, J
   Pericot, A
   Sancho, MA
   Gonzalez, N
   Balsells, M
   Luna, R
   Cortazar, A
   Navarro, P
   Ramirez, O
   Flandez, B
   Pallardo, LF
   Hernandez, A
   Ampudia, J
   Fernandez-Real, JM
   Hernandez-Aguado, I
   Corcoy, R
AF Ricart, W.
   Lopez, J.
   Mozas, J.
   Pericot, A.
   Sancho, M. A.
   Gonzalez, N.
   Balsells, M.
   Luna, R.
   Cortazar, A.
   Navarro, P.
   Ramirez, O.
   Flandez, B.
   Pallardo, L. F.
   Hernandez, A.
   Ampudia, J.
   Fernandez-Real, J. M.
   Hernandez-Aguado, I.
   Corcoy, R.
CA Spanish Grp Study Impact Carpenter
TI Maternal glucose tolerance status influences the risk of macrosomia in
   male but not in female fetuses
SO JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH
LA English
DT Article
ID GESTATIONAL DIABETES-MELLITUS; RESPIRATORY-DISTRESS SYNDROME; FACTOR
   BINDING PROTEIN-1; GROWTH-FACTOR-I; FETAL SEX; IGF-I;
   INSULIN-RESISTANCE; BODY-COMPOSITION; PRETERM BIRTH; PLACENTAL GH
AB Objective: To elucidate whether the risk of macrosomia, large for gestational age (LGA) and small for gestational age (SGA) is influenced by maternal body mass index and glucose tolerance differently in male and female fetuses.
   Methods: A population study was conducted in 16 general hospitals from the Spanish National Health Service that included 9270 consecutive women with singleton pregnancies and without a former diagnosis of diabetes mellitus who delivered 4793 male and 4477 female newborns. Logistic regression analyses were performed to predict the effect of body mass index (BMI) category and glucose tolerance on macrosomia, large for gestational age newborns (LGA) and small for gestational age newborns (SGA) Separate analyses according to foetal sex were carried out for each outcome. The results were adjusted for maternal age, gestational age and pregnancy-induced hypertension.
   Results: There were significant differences between males and females in the percentage of infants who had macrosomia, LGA or SGA. Maternal BMI category was positively associated with the risk of macrosomia and LGA in both male and female newborns. In addition, there was a negative association between maternal BMI and SGA that only reached significance in males. In contrast, gestational diabetes was only a predictor of macrosomia exclusively in male fetuses (OR 1.67, 95% CI 1.12 to 2.49)
   Conclusions: There is sexual dimorphism in the risk of abnormal birth weight attributed to maternal glucose tolerance status. A closer surveillance of foetal growth might be warranted in pregnant women with abnormal glucose tolerance carrying a male fetus.
C1 [Ricart, W.; Fernandez-Real, J. M.] Hosp Univ Girona Dr Josep Trueta, Unit Diabet Endocrinol & Nutr, Girona 17007, Spain.
   [Sancho, M. A.] Hosp Clin Univ Lozano Blesa, Zaragoza, Spain.
   [Gonzalez, N.] Hosp Univ Canarias, Tenerife, Spain.
   [Balsells, M.] Hosp Mutua Terrassa, Terrassa, Spain.
   [Luna, R.] Complejo Hosp Univ Xeral Cies Vigo, Vigo, Spain.
   [Pericot, A.] Hosp Clin Univ Barcelona, Barcelona, Spain.
   [Mozas, J.] Hosp Univ Virgen Nieves, Granada, Spain.
   [Lopez, J.] Hosp Virgen Salud, Toledo, Spain.
   [Cortazar, A.] Hosp Cruces, Baracaldo, Spain.
   [Navarro, P.] Hosp Gen Univ, Alicante, Spain.
   [Ramirez, O.] Hosp Univ Maternoinfantil Canarias, Las Palmas Gran Canaria, Spain.
   [Flandez, B.] Hosp Univ Getafe, Getafe, Spain.
   [Pallardo, L. F.] Hosp La Paz, Madrid, Spain.
   [Hernandez, A.] Hosp Univ Dr Peset, Valencia, Spain.
   [Ampudia, J.] Hosp Clin Valencia, Valencia, Spain.
   [Hernandez-Aguado, I.] Hosp Univ Alicante, CIBER Epidemiol & Salud Publ, Alicante, Spain.
   [Corcoy, R.] Hosp Santa Creu & Sant Pau, Barcelona, Spain.
RP Ricart, W (reprint author), Hosp Univ Girona Dr Josep Trueta, Unit Diabet Endocrinol & Nutr, Avgda Franca SN, Girona 17007, Spain.
EM uden.wricart@htrueta.scs.es
RI Hernandez-Aguado, Ildefonso/I-2634-2015
OI Hernandez-Aguado, Ildefonso/0000-0003-1911-5759; Ampudia Blasco,
   Francisco Javier/0000-0003-0221-0901; Ricart,
   Wifredo/0000-0002-3452-9098; Navarro, Pino/0000-0002-2852-3976;
   Fernandez-Real, Jose Manuel/0000-0002-7442-9323
FU CIBER (Instituto de Salud Carlos III, Spain)
FX CIBER (Instituto de Salud Carlos III, Spain).
CR [Anonymous], 1995, WHO TECHN REP SER, P854
   Bekedam DJ, 2002, AM J OBSTET GYNECOL, V187, P1605, DOI 10.1067/mob.2002.127379
   Boyne MS, 2003, J CLIN ENDOCR METAB, V88, P1687, DOI 10.1210/jc.2002-020633
   Bracero LA, 1996, GYNECOL OBSTET INVES, V41, P10, DOI 10.1159/000292026
   Cagnacci A, 2005, FERTIL STERIL, V84, P246, DOI 10.1016/j.fertnstert.2004.12.054
   CATALANO PM, 1995, AM J OBSTET GYNECOL, V172, P1464, DOI 10.1016/0002-9378(95)90479-4
   Catalano PM, 1998, DIABETES CARE, V21, pB85
   CATALANO PM, 2003, J NUTR, V133, P1674
   Catalano R, 2006, P NATL ACAD SCI USA, V103, P1639, DOI 10.1073/pnas.0510567103
   Chellakooty M, 2002, J CLIN ENDOCR METAB, V87, P2734, DOI 10.1210/jc.87.6.2734
   Cooperstock M, 1996, OBSTET GYNECOL, V88, P189, DOI 10.1016/0029-7844(96)00106-8
   Cui W, 2005, BIRTH DEFECTS RES A, V73, P876, DOI 10.1002/bdra.20196
   Dahlgren J, 2001, AM J PHYSIOL-ENDOC M, V281, pE326
   Divon MY, 2002, AM J OBSTET GYNECOL, V187, P1081, DOI 10.1067/mob.2002.126645
   Ehrenberg HM, 2004, AM J OBSTET GYNECOL, V191, P964, DOI 10.1016/j.ajog.2004.05.052
   Engstrom E, 2005, PEDIATR RES, V57, P605, DOI 10.1203/01.PDR.0000155950.67503.BC
   Eogan MA, 2003, BRIT MED J, V326, P137, DOI 10.1136/bmj.326.7381.137
   Feinstein U, 2002, INT J GYNECOL OBSTET, V77, P7, DOI 10.1016/S0020-7292(02)00007-3
   Fernandez-Real JM, 2003, ENDOCR REV, V24, P278, DOI 10.1210/er.2002-0010
   Geary MPP, 2003, J CLIN ENDOCR METAB, V88, P3708, DOI 10.1210/jc.2002-022006
   Gibson MA, 2003, P ROY SOC B-BIOL SCI, V270, pS108, DOI 10.1098/rsbl.2003.0031
   HARRIS M, 1979, DIABETES, V28, P1039
   Hershkovitz R, 2001, EUR J OBSTET GYN R B, V98, P36, DOI 10.1016/S0301-2115(01)00312-8
   Juntunen KST, 1997, HUM REPROD, V12, P2321, DOI 10.1093/humrep/12.10.2321
   KHOURY MJ, 1985, AM J OBSTET GYNECOL, V151, P777, DOI 10.1016/0002-9378(85)90518-6
   Kim YM, 2005, AM J OBSTET GYNECOL, V193, P921, DOI 10.1016/j.ajog.2005.06.053
   LANGER O, 1989, AM J OBSTET GYNECOL, V161, P646, DOI 10.1016/0002-9378(89)90371-2
   Lieberman E, 1997, AM J OBSTET GYNECOL, V176, P667, DOI 10.1016/S0002-9378(97)70567-2
   Lozano R Santamaria, 1998, TABLAS ESPANOLAS PES
   Nicolich MJ, 2000, FERTIL STERIL, V73, P487, DOI 10.1016/S0015-0282(99)00576-2
   Ong K, 2000, J CLIN ENDOCR METAB, V85, P4266, DOI 10.1210/jc.85.11.4266
   Ong KK, 2004, EUR J ENDOCRINOL, V151, pU131, DOI 10.1530/eje.0.151U131
   PERELMAN RH, 1986, PEDIATRICS, V78, P238
   Quinones JN, 2005, AM J OBSTET GYNECOL, V193, P1233, DOI 10.1016/j.ajog.2005.05.053
   Ricart W, 2005, DIABETOLOGIA, V48, P1736, DOI 10.1007/s00125-005-1877-1
   Ricart W, 2005, DIABETOLOGIA, V48, P1135, DOI 10.1007/s00125-005-1756-9
   Sheiner E, 2004, FETAL DIAGN THER, V19, P366, DOI 10.1159/000077967
   Sheiner E, 2002, ACTA OBSTET GYN SCAN, V81, P222, DOI 10.1034/j.1600-0412.2002.810306.x
   Tan HZ, 2004, OBSTET GYNECOL, V103, P327, DOI 10.1097/01.AOG.0000109427.85586.71
   Verhaeghe J, 1996, AM J OBSTET GYNECOL, V175, P1180, DOI 10.1016/S0002-9378(96)70025-X
   Verhaeghe J, 2003, AM J OBSTET GYNECOL, V188, P485, DOI 10.1067/mob.2003.26
   Verhaeghe J, 2002, J CLIN ENDOCR METAB, V87, P2875, DOI 10.1210/jc.87.6.2875
   Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a
NR 43
TC 26
Z9 28
U1 0
U2 5
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0143-005X
J9 J EPIDEMIOL COMMUN H
JI J. Epidemiol. Community Health
PD JAN
PY 2009
VL 63
IS 1
BP 64
EP 68
DI 10.1136/jech.2008.074542
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 384RE
UT WOS:000261761100012
PM 18718980
DA 2019-01-08
ER

PT J
AU Chiu, YN
   Gau, SSF
   Tsai, WC
   Soong, WT
   Shang, CY
AF Chiu, Yen-Nan
   Gau, Susan Shur-Fen
   Tsai, Wen-Che
   Soong, Wei-Tsuen
   Shang, Chi-Yung
TI Demographic and perinatal factors for behavioral problems among children
   aged 4-9 in Taiwan
SO PSYCHIATRY AND CLINICAL NEUROSCIENCES
LA English
DT Article
DE childhood emotional/behavioral problems; comorbid patterns; maternal
   psychological distress; prenatal/perinatal factors
ID LOW-BIRTH-WEIGHT; DEFICIT HYPERACTIVITY DISORDER; MATERNAL DEPRESSION;
   EMOTIONAL-PROBLEMS; MENTAL-DISORDERS; SLEEP PROBLEMS; ADOLESCENTS;
   CHILDHOOD; RISK; ASSOCIATION
AB Aim: To investigate the effects of age, gender, prenatal/perinatal factors, and maternal psychological distress on childhood emotional/behavioral problems, and the gender difference in the patterns of comorbid emotional/behavioral problems.
   Methods: The sample included 1391 children aged 4-9 in Taipei using a multi-stage sampling method. Their mothers completed questionnaires including demographics, prenatal/perinatal variables, the Child Behavior Checklist, and the Chinese Health Questionnaire. The linear and non-linear mixed model was used for data analysis.
   Results: Boys scored higher on externalizing problems, and girls scored higher on internalizing problems. Gender also modified the comorbid patterns of emotional/behavioral problems. Aggressive behaviors decreased, but attention and thought problems increased with age. Prenatal/perinatal exposure to alcohol and coffee, vaginal bleeding, and gestational diabetes, low birthweight, and postnatal incubation and resuscitation, and maternal psychological distress predicted the risk for several childhood emotional/behavioral problems.
   Conclusion: Prenatal/perinatal and maternal care, and gender-specific measures are important for prevention of childhood emotional/behavioral problems.
C1 [Chiu, Yen-Nan; Gau, Susan Shur-Fen; Tsai, Wen-Che; Soong, Wei-Tsuen; Shang, Chi-Yung] Natl Taiwan Univ Hosp, Dept Psychiat, Taipei 10002, Taiwan.
   [Gau, Susan Shur-Fen; Soong, Wei-Tsuen; Shang, Chi-Yung] Natl Taiwan Univ, Coll Med, Dept Psychiat, Yunlin, Taiwan.
   [Soong, Wei-Tsuen] St Josephs Hosp, Yunlin, Taiwan.
RP Shang, CY (reprint author), Natl Taiwan Univ Hosp, Dept Psychiat, 7 Chung Shan S Rd, Taipei 10002, Taiwan.
EM cyshang@ntu.edu.tw
RI Gau, Susan Shur-Fen/P-4726-2017
OI Gau, Susan Shur-Fen/0000-0002-2718-8221; Tsai,
   Wen-Che/0000-0002-9437-5131; SHANG, CHI-YUNG/0000-0001-6658-7359
FU National Taiwan University Hospital [NTUH-S861517-A33]; National Health
   Research Institute [NHRIEX959407PC]
FX This work was supported by grants from the National Taiwan University
   Hospital (NTUH-S861517-A33) and the National Health Research Institute
   (NHRIEX959407PC), Taiwan.
CR Achenbach T. M., 1991, MANUAL CHILD BEHAV C
   Bohlin G, 2004, EUR CHILD ADOLES PSY, V13, P14, DOI 10.1007/s00787-004-3003-1
   Briggs-Gowan MJ, 2001, J AM ACAD CHILD PSY, V40, P811, DOI 10.1097/00004583-200107000-00016
   Burt KB, 2005, J CHILD PSYCHOL PSYC, V46, P490, DOI 10.1111/j.1469-7610.2004.00367.x
   Chatterji P, 2001, J HEALTH ECON, V20, P703, DOI 10.1016/S0167-6296(01)00090-X
   CHENG TA, 1986, PSYCHOL MED, V16, P415, DOI 10.1017/S0033291700009247
   Crijnen AAM, 1999, AM J PSYCHIAT, V156, P569
   Crijnen AAM, 1997, J AM ACAD CHILD PSY, V36, P1269, DOI 10.1097/00004583-199709000-00020
   Engle PL, 1999, EARLY HUM DEV, V53, P251, DOI 10.1016/S0378-3782(98)00080-2
   Gau SSF, 2005, AM J PSYCHIAT, V162, P1344, DOI 10.1176/appi.ajp.162.7.1344
   Gau SSF, 2007, J BIOL RHYTHM, V22, P268, DOI 10.1177/0748730406298447
   Gau Susan Shur-Fen, 2006, J Atten Disord, V9, P648, DOI 10.1177/1087054705284241
   Gray RF, 2004, PEDIATRICS, V114, P736, DOI 10.1542/peds.2003-1150-L
   Gregory AM, 2002, J AM ACAD CHILD PSY, V41, DOI 10.1097/00004583-200208000-00015
   Knopik VS, 2005, PSYCHOL MED, V35, P625, DOI 10.1017/S0033291704004155
   Leung TY, 2001, GYNECOL OBSTET INVES, V52, P227, DOI 10.1159/000052980
   Linnet KM, 2003, AM J PSYCHIAT, V160, P1028, DOI 10.1176/appi.ajp.160.6.1028
   Liu XC, 1999, J AM ACAD CHILD PSY, V38, P708, DOI 10.1097/00004583-199906000-00018
   Liu XC, 2001, J AM ACAD CHILD PSY, V40, P828, DOI 10.1097/00004583-200107000-00018
   Masi G, 2004, J AFFECT DISORDERS, V78, P175, DOI 10.1016/S0165-0327(03)00107-1
   MCCONAUGHY SH, 1994, J CHILD PSYCHOL PSYC, V35, P1141, DOI 10.1111/j.1469-7610.1994.tb01814.x
   Mick E, 2002, J DEV BEHAV PEDIATR, V23, P16, DOI 10.1097/00004703-200202000-00004
   O'Connor MJ, 2006, J PEDIATR PSYCHOL, V31, P50, DOI 10.1093/jpepsy/jsj0021
   Shang CY, 2006, J SLEEP RES, V15, P63, DOI 10.1111/j.1365-2869.2006.00492.x
   Somersalo H, 1999, EUR CHILD ADOLES PSY, V8, P89
   Sourander A, 2006, J AM ACAD CHILD PSY, V45, P578, DOI 10.1097/01.chi.0000205699.58626.b5
   SPIKER D, 1992, CHILD DEV, V63, P1481, DOI 10.1111/j.1467-8624.1992.tb01709.x
   Weissman MM, 2006, JAMA-J AM MED ASSOC, V296, P1234
   Weissman MM, 2006, JAMA-J AM MED ASSOC, V295, P1389, DOI 10.1001/jama.295.12.1389
   Yang HJ, 2001, J AM ACAD CHILD PSY, V40, P1045, DOI 10.1097/00004583-200109000-00013
   Zukauskiene R, 2003, EUR CHILD ADOLES PSY, V12, P136, DOI 10.1007/s00787-003-0321-7
NR 31
TC 7
Z9 7
U1 1
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1323-1316
EI 1440-1819
J9 PSYCHIAT CLIN NEUROS
JI Psychiatry Clin. Neurosci.
PY 2009
VL 63
IS 4
BP 569
EP 576
DI 10.1111/j.1440-1819.2009.01979.x
PG 8
WC Clinical Neurology; Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 472AM
UT WOS:000268101000020
PM 19497002
OA Bronze
DA 2019-01-08
ER

PT J
AU Adriaanse, MC
   Pouwer, F
   Dekker, JM
   Nijpels, G
   Stehouwer, CD
   Heine, RJ
   Snoek, FJ
AF Adriaanse, Marcel C.
   Pouwer, Frans
   Dekker, Jacqueline M.
   Nijpels, Giel
   Stehouwer, Coen D.
   Heine, Robert J.
   Snoek, Frank J.
TI Diabetes-Related Symptom Distress in Association With Glucose Metabolism
   and Comorbidity The Hoorn Study
SO DIABETES CARE
LA English
DT Article
ID QUALITY-OF-LIFE; DEPRESSIVE SYMPTOMS; MELLITUS
AB OBJECTIVE - The purpose of this study was to determine the associations between diabetes-related symptom distress, glucose metabolism status, and comorbidities of type 2 diabetes.
   RESEARCH DESIGN AND METHODS - This was a cross-sectional sample of 281 individuals with normal glucose metabolism (NGM), 181 individuals with impaired glucose metabolism (IGM), and 107 subjects with type 2 diabetes. We used the revised type 2 Diabetes Symptom Checklist (DSC-R) to assess diabetes-related symptom distress.
   RESULTS - The total symptom distress score (range 0-100) was relatively low for diabetic subjects (mean +/- SD 8.4 +/- 9.4), although it was significantly different from that for subjects with IGM (6.5 +/- 7.1) and NGM (6.1 +/- 7.9) (F = 3.1, 2 d.f., P = 0.046). Ischemic heart disease was associated with elevated DSC-R scores on three subscales, whereas depression showed higher symptom distress levels across all DSC-R domains.
   CONCLUSIONS - Worsening glucose metabolism is associated with increasing diabetes-related symptom distress. This relationship is attenuated by ischemic heart disease and particularly by depression.
C1 [Adriaanse, Marcel C.] Vrije Univ Amsterdam, Fac Earth & Life Sci, Inst Hlth Sci, Amsterdam, Netherlands.
   [Pouwer, Frans; Dekker, Jacqueline M.; Nijpels, Giel; Heine, Robert J.; Snoek, Frank J.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst, Amsterdam, Netherlands.
   [Pouwer, Frans; Snoek, Frank J.] Vrije Univ Amsterdam, Med Ctr, Dept Med Psychol, Amsterdam, Netherlands.
   [Nijpels, Giel] Vrije Univ Amsterdam, Med Ctr, Dept Gen Practice, Amsterdam, Netherlands.
   [Stehouwer, Coen D.] Univ Limburg, Acad Hosp Maastricht, Dept Internal Med, Maastricht, Netherlands.
   [Heine, Robert J.] Vrije Univ Amsterdam, Med Ctr, Dept Endocrinol, Amsterdam, Netherlands.
RP Adriaanse, MC (reprint author), Vrije Univ Amsterdam, Fac Earth & Life Sci, Inst Hlth Sci, Amsterdam, Netherlands.
EM marcel.adriaanse@falw.vu.nl
CR Adriaanse MC, 2005, QUAL LIFE RES, V14, P1501, DOI 10.1007/s11136-004-0028-3
   Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
   Ciechanowski PS, 2003, GEN HOSP PSYCHIAT, V25, P246, DOI 10.1016/S0163-8343(03)00055-0
   Dueck AC, 2007, VALUE HEALTH, V10, pS64, DOI 10.1111/j.1524-4733.2007.00268.x
   Golden SH, 2008, JAMA-J AM MED ASSOC, V299, P2751, DOI 10.1001/jama.299.23.2751
   GROOTENHUIS PA, 1994, DIABETIC MED, V11, P253, DOI 10.1111/j.1464-5491.1994.tb00268.x
   Jager A, 1998, DIABETOLOGIA, V41, P694, DOI 10.1007/s001250050970
   KLEIN R, 1986, OPHTHALMOLOGY, V93, P1183
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   ROSE G, 1977, BRIT J PREV SOC MED, V31, P42
   Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O
   Snijder MB, 2004, DIABETES CARE, V27, P372, DOI 10.2337/diacare.27.2.372
   Testa MA, 1998, JAMA-J AM MED ASSOC, V280, P1490, DOI 10.1001/jama.280.17.1490
NR 13
TC 29
Z9 29
U1 0
U2 4
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
J9 DIABETES CARE
JI Diabetes Care
PD DEC
PY 2008
VL 31
IS 12
BP 2268
EP 2270
DI 10.2337/dc08-1074
PG 3
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 381RB
UT WOS:000261552500007
PM 18728236
OA Other Gold, Green Published
DA 2019-01-08
ER

PT J
AU Dunbar, JA
   Reddy, P
   Davis-Lameloise, N
   Philpot, B
   Laatikainen, T
   Kilkkinen, A
   Bunker, SJ
   Best, JD
   Vartiainen, E
   Lo, SK
   Janus, ED
AF Dunbar, James A.
   Reddy, Prasuna
   Davis-Lameloise, Nathalie
   Philpot, Benjamin
   Laatikainen, Tiina
   Kilkkinen, Annamari
   Bunker, Stephen J.
   Best, James D.
   Vartiainen, Erkki
   Lo, Sing Kai
   Janus, Edward D.
TI Depression: An Important Comorbidity With Metabolic Syndrome in a
   General Population
SO DIABETES CARE
LA English
DT Article
ID INSULIN-RESISTANCE; YOUNG-ADULTS; INFLAMMATORY MARKERS; OBESITY;
   DISEASE; SYMPTOMS; ANXIETY; HEALTH; WOMEN; HEART
AB OBJECTIVE - There is a recognized association among depression, diabetes, and cardiovascular disease. The aim of this study was to examine in a sample representative of the general population whether depression, anxiety, and psychological distress are associated with metabolic syndrome and its components.
   RESEARCH DESIGN AND METHODS - Three cross-sectional surveys including clinical health measures were completed in rural regions of Australia during 2004-2006. A stratified random sample (n = 1,690, response rate 48%) of men and women aged 25-84 years was selected from the electoral roll. Metabolic syndrome was defined by the Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, Adult Treatment Panel III (NCEP ATP III), and International Diabetes Federation (IDF) criteria. Anxiety and depression were assessed by the Hospital Anxiety and Depression Scale and psychological distress by the Kessler 10 measure.
   RESULTS - Metabolic syndrome was associated with depression but not psychological stress or anxiety. Participants with the metabolic syndrome had higher scores for depression (n = 409, mean score 3.41, 95% CI 3.12-3.70) than individuals without the metabolic syndrome (n = 936, mean 2.95, 95% CI 2.76-3.13). This association was also present in 338 participants with the metabolic syndrome and without diabetes (mean score 3.37, 95% CI 3.06-3.68). Large waist circumference and low HDL cholesterol showed significant and independent associations with depression.
   CONCLUSIONS - Our results show an association between metabolic syndrome and depression in a heterogeneous sample. The presence of depression in individuals with the metabolic syndrome has implications for clinical management.
C1 [Dunbar, James A.; Reddy, Prasuna; Davis-Lameloise, Nathalie; Philpot, Benjamin; Laatikainen, Tiina; Kilkkinen, Annamari; Bunker, Stephen J.; Janus, Edward D.] Flinders Univ S Australia, Dept Rural Hlth, Greater Green Triangle Univ, Warrnambool, Vic, Australia.
   [Dunbar, James A.; Reddy, Prasuna; Davis-Lameloise, Nathalie; Philpot, Benjamin; Laatikainen, Tiina; Kilkkinen, Annamari; Bunker, Stephen J.; Janus, Edward D.] Deakin Univ, Warrnambool, Vic, Australia.
   [Laatikainen, Tiina; Kilkkinen, Annamari; Vartiainen, Erkki] Natl Publ Hlth Inst, Helsinki, Finland.
   [Janus, Edward D.] Univ Melbourne, Dept Med, Melbourne, Vic, Australia.
   [Best, James D.] Univ Melbourne, Dept Med, St Vincent Hosp, Melbourne, Vic, Australia.
   [Lo, Sing Kai] Deakin Univ, Fac Hlth Med Nursing & Behav Sci, Melbourne, Vic, Australia.
RP Dunbar, JA (reprint author), Flinders Univ S Australia, Dept Rural Hlth, Greater Green Triangle Univ, Warrnambool, Vic, Australia.
EM director@greaterhealth.org
RI Dunbar, James/G-3034-2012
OI Laatikainen, Tiina/0000-0002-6614-4782; Reddy,
   Prasuna/0000-0002-0709-9352; Bunker, Stephen/0000-0003-0780-4784
FU Australian Government Department of Health and Aging; Royal Australian
   College of General Practitioners; Sanofi-Aventis; Pfizer; Roche
   Diagnostics Australia; Servier Laboratories
FX We thank Professor Kerin O'Dea, Anna Chapman, Anna Kao-Philpot, Dr.
   Andrew Baird, the nurses carrying out the survey, and regional hospitals
   providing facilities for the study.
CR Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x
   Andrews G, 2001, AUST NZ J PUBL HEAL, V25, P494, DOI 10.1111/j.1467-842X.2001.tb00310.x
   BJORNTORP P, 1991, J INTERN MED, V230, P195
   Bjorntorp P, 2000, BRIT J NUTR, V83, pS49, DOI 10.1017/S0007114500000957
   CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008
   Ford ES, 2004, DIABETES CARE, V27, P2444, DOI 10.2337/diacare.27.10.2444
   HEISTARO S, 2006, GREATER GREEN TRIANG
   Herva A, 2006, PSYCHOSOM MED, V68, P213, DOI 10.1097/01.psy.0000203172.02305.ea
   HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183
   Janus ED, 2007, MED J AUSTRALIA, V187, P147
   Kinder LS, 2004, PSYCHOSOM MED, V66, P316, DOI 10.1097/01.psy.0000124755.91880.f4
   Lustman PJ, 2005, J DIABETES COMPLICAT, V19, P113, DOI 10.1016/j.jdiacomp.2004.01.002
   Maes M, 1997, ACTA PSYCHIAT SCAND, V95, P212, DOI 10.1111/j.1600-0447.1997.tb09622.x
   McCaffery JM, 2003, PSYCHOSOM MED, V65, P490, DOI 10.1097/01.PSY.0000041545.52924.82
   Miller GE, 2003, BRAIN BEHAV IMMUN, V17, P276, DOI 10.1016/S0889-1591(03)00057-6
   *NCEP EXP PAN DET, 2002, CIRCULATION, V106, P3143
   Raikkonen K, 2002, METABOLISM, V51, P1573, DOI 10.1053/meta.2002.36301
   Raikkonen K, 2007, DIABETES CARE, V30, P872, DOI 10.2337/dc06-1857
   REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595
   Skilton MR, 2007, BIOL PSYCHIAT, V62, P1251, DOI 10.1016/j.biopsych.2007.01.012
   Snaith RP, 1994, HOSP ANXIETY DEPRESS
   Vogelzangs N, 2007, PSYCHONEUROENDOCRINO, V32, P151, DOI 10.1016/j.psyneuen.2006.11.009
   Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451
   Yirmiya R, 2000, ANN NY ACAD SCI, V917, P478
   Yudkin JS, 2000, ATHEROSCLEROSIS, V148, P209, DOI 10.1016/S0021-9150(99)00463-3
NR 25
TC 111
Z9 115
U1 1
U2 7
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
J9 DIABETES CARE
JI Diabetes Care
PD DEC
PY 2008
VL 31
IS 12
BP 2368
EP 2373
DI 10.2337/dc08-0175
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 381RB
UT WOS:000261552500028
PM 18835951
OA Green Published, Other Gold
DA 2019-01-08
ER

PT J
AU Peyrot, M
   Rubin, RR
   Polonsky, WH
AF Peyrot, Mark
   Rubin, Richard R.
   Polonsky, William H.
TI Diabetes Distress and Its Association with Clinical Outcomes in Patients
   with Type 2 Diabetes Treated with Pramlintide as an Adjunct to Insulin
   Therapy
SO DIABETES TECHNOLOGY & THERAPEUTICS
LA English
DT Article
ID RANDOMIZED CONTROLLED-TRIAL; TREATMENT SATISFACTION; WEIGHT CONTROL;
   SCALE; 1-YEAR
AB Objective: This study was designed to assess diabetes-related distress and its association with clinical outcomes in patients with type 2 diabetes using basal insulin who were treated with pramlintide.
   Methods: In a 16-week, double-blind, placebo-controlled study 211 patients using insulin glargine with or without oral antidiabetes agents were randomized to addition of pramlintide or placebo. Clinical outcomes (change in A1C, postprandial glucose, daily basal insulin dose, and weight) and during-trial hypoglycemia were assessed, along with the Diabetes Distress Scale (DDS). The DDS assesses overall diabetes distress and four sub-domains: regimen distress (RD), emotional burden (EB), interpersonal distress (ID), and physician-related distress (PD). Hierarchical, stepwise multiple regression was used to assess the association of clinical outcomes and during-trial hypoglycemia with DDS score changes during the study.
   Results: Pramlintide use was associated with a significant reduction in total DDS and RD, but only among those above the median of distress at baseline. Across treatment groups, reduction in basal insulin dose was linked to a drop in total DDS, RD, EB, and ID, reduction in postprandial glucose was associated with reduced total DDS and ID, and reduction in A1C was associated with reduced EB and RD. PD was not associated with hypoglycemia or any clinical outcome. Reduction in weight and incidence of hypoglycemia were not associated with any DDS measure.
   Conclusions: Pramlintide use reduced diabetes-related distress among those with high levels of distress at baseline, and better clinical outcomes were associated with improvements in several domains of diabetes-related distress. Efforts should be made to enhance these potential benefits of treatment.
C1 [Peyrot, Mark] Loyola Coll, Dept Sociol, Baltimore, MD 21210 USA.
   [Peyrot, Mark; Rubin, Richard R.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.
   [Rubin, Richard R.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA.
   [Polonsky, William H.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA.
RP Peyrot, M (reprint author), Loyola Coll, Dept Sociol, 4501 N Charles St, Baltimore, MD 21210 USA.
EM mpeyrot@loyola.edu
FU Amylin Pharmaceuticals
FX Preparation of this manuscript was funded by Amylin Pharmaceuticals. The
   authors were responsible for all analyses and all aspects of manuscript
   preparation, including interpretation of results. No medical writers
   assisted in the preparation of this manuscript.
CR *AM PHARM, 2005, SYMLIN PACK INS
   Chapman I, 2005, DIABETOLOGIA, V48, P838, DOI 10.1007/s00125-005-1732-4
   Cohen J., 1969, STAT POWER ANAL BEHA
   Edelman S, 2006, DIABETES CARE, V29, P2189, DOI 10.2337/dc06-0042
   Fineman MS, 2002, METABOLISM, V51, P636, DOI 10.1053/meta.2002.32022
   Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Food and Drug Administration Department of Health and Human Services, GUID IND PAT REP OUT
   Glasgow RE, 2007, DIABETES CARE, V30, P33, DOI 10.2337/dc06-1390
   Hollander PA, 2003, DIABETES CARE, V26, P784, DOI 10.2337/diacare.26.3.784
   Kong MF, 1998, DIABETOLOGIA, V41, P577, DOI 10.1007/s001250050949
   Marra Giampiero, 2004, Acta Biomed, V75, P164
   Marrero DG, 2007, DIABETES CARE, V30, P210, DOI 10.2337/dc06-1026
   Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004
   Peyrot M, 1996, J PEDIATR PSYCHOL, V21, P3, DOI 10.1093/jpepsy/21.1.3
   Peyrot M, 2007, DIABETES CARE, V30, P2433, DOI 10.2337/dc07-1222
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 2005, DIABETES CARE, V28, P2543, DOI 10.2337/diacare.28.10.2543
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Ratner RE, 2004, DIABETIC MED, V21, P1204, DOI 10.1111/j.1464-5491.2004.01319.x
   Riddle M, 2007, DIABETES CARE, V30, P2794, DOI 10.2337/dc07-0589
   Rubin RR, 2007, CURR MED RES OPIN, V23, P1919, DOI 10.1185/030079907X210804
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Snoek FJ, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-69
   Whitehouse F, 2002, DIABETES CARE, V25, P724, DOI 10.2337/diacare.25.4.724
NR 25
TC 14
Z9 15
U1 0
U2 3
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1520-9156
J9 DIABETES TECHNOL THE
JI Diabetes Technol. Ther.
PD DEC
PY 2008
VL 10
IS 6
BP 461
EP 466
DI 10.1089/dia.2008.0031
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 382HR
UT WOS:000261597300005
PM 19049375
DA 2019-01-08
ER

PT J
AU Snoek, FJ
   van der Ven, NCW
   Twisk, JWR
   Hogenelst, MHE
   Tromp-Wever, AME
   van der Ploeg, HM
   Heine, RJ
AF Snoek, F. J.
   van der Ven, N. C. W.
   Twisk, J. W. R.
   Hogenelst, M. H. E.
   Tromp-Wever, A. M. E.
   van der Ploeg, H. M.
   Heine, R. J.
TI Cognitive behavioural therapy (CBT) compared with blood glucose
   awareness training (BGAT) in poorly controlled Type 1 diabetic patients:
   long-term effects on HbA(1c) moderated by depression. A randomized
   controlled trial
SO DIABETIC MEDICINE
LA English
DT Article
DE cognitive behavioural therapy; glycaemic control; Type 1 diabetes
ID GLYCEMIC CONTROL; CBGT; DISTRESS; SCALE; DUTCH
AB Objective To test the effectiveness at 6 and 12 months' follow-up of group cognitive behavioural therapy (CBT) compared with blood glucose awareness training (BGAT) in poorly controlled Type 1 diabetic patients and to explore the moderating effect of baseline depression.
   Research design and methods Adults with Type 1 diabetes (n=86) with glycated haemoglobin (HbA(1c))>= 8% were randomized to CBT or BGAT. Primary outcome was HbA(1c) control. Secondary outcomes were: self-care, diabetes-related distress (Problem Areas in Diabetes scale; PAID), diabetes self-efficacy (Confidence in Diabetes Self-care scale; CIDS) and depressive symptoms (Centre for Epidemiological Studies-Depression scale; CES-D). Measurements were scheduled before CBT and BGAT, and at 3, 6 and 12 months after. Differential effects were analysed for the subgroup of patients reporting low vs. high baseline levels of depression.
   Results Neither CBT nor BGAT had a significant impact on HbA1c at 6 and 12 months' follow-up. Both interventions resulted in lower depressive symptoms (CES-D 15.7-13.3, P = 0.01) up to 12 months, but only CBT was effective in lowering HbA1c in patients with high baseline depression scores (HbA(1c) 9.5-8.8%) up to 1 year of follow-up ( P = 0.03).
   Conclusions Our findings suggest that group CBT can effectively help Type 1 diabetic patients with co-morbid depression achieve and maintain better glycaemic outcomes.
C1 [Snoek, F. J.; van der Ven, N. C. W.; Hogenelst, M. H. E.; Tromp-Wever, A. M. E.; van der Ploeg, H. M.] Vrije Univ Amsterdam, Med Ctr, Dept Med Psychol, NL-1081 BT Amsterdam, Netherlands.
   [Snoek, F. J.; Twisk, J. W. R.; Heine, R. J.] Vrije Univ Amsterdam, Med Ctr, Inst Res Extramural Med EMGO, NL-1081 BT Amsterdam, Netherlands.
   [Twisk, J. W. R.] Vrije Univ Amsterdam, Med Ctr, Dept Clin Epidemiol & Biostat, NL-1081 BT Amsterdam, Netherlands.
   [Heine, R. J.] Vrije Univ Amsterdam, Med Ctr, Dept Endocrinol, NL-1081 BT Amsterdam, Netherlands.
RP Snoek, FJ (reprint author), Vrije Univ Amsterdam, Med Ctr, Dept Med Psychol, Van der Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.
EM fj.snoek@vumc.nl
FU Dutch Diabetes Research Foundation [99.005]
FX We gratefully acknowledge the financial support of the Dutch Diabetes
   Research Foundation (grant no. 99.005) and the dedicated assistance of
   A. van Iperen, C. Lubach and A. Vriend (DNS).
CR Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   BECK AT, 1979, COGNITIVE THERAPY DE
   Bond F. W., 2002, HDB BRIEF COGNITIVE
   Cox DJ, 2001, DIABETES CARE, V24, P637, DOI 10.2337/diacare.24.4.637
   Cox DJ, 2006, DIABETES SPECTRUM, V19, P43, DOI DOI 10.2337/DIASPECT.19.1.43
   DeVries JH, 2004, DIABETIC MED, V21, P1263, DOI 10.1111/j.1464-5491.2004.01386.x
   DeVries JH, 2003, DIABETES-METAB RES, V19, P357, DOI 10.1002/dmrr.405
   DeVries JH, 2002, DIABETES CARE, V25, P2074, DOI 10.2337/diacare.25.11.2074
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Free ML, 1999, COGNITIVE THERAPY GR
   Genuth S, 2002, JAMA-J AM MED ASSOC, V287, P2563
   Lustman Patrick J, 2007, Curr Diab Rep, V7, P114, DOI 10.1007/s11892-007-0020-8
   Radloff L., 1977, APPL PSYCH MEAS, V1, P185
   Rubin RR, 2001, J CLIN PSYCHOL, V57, P457, DOI 10.1002/jclp.1041
   Simson U, 2008, DIABETIC MED, V25, P206, DOI 10.1111/j.1464-5491.2007.02370.x
   Snoek FJ, 2002, DIABETIC MED, V19, P265, DOI 10.1046/j.1464-5491.2002.00678.x
   Snoek FJ, 2001, PATIENT EDUC COUNS, V45, P143, DOI 10.1016/S0738-3991(01)00113-6
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   *SPSS INC, 2001, SPSS 11 01 STAT AN P
   *STATA CORP, 2001, STATA 7 STAT AN PROG
   van Bastelaar KM, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-9
   Van der Ven N., 2000, PSYCHOL DIABETES CAR, P207
   van der Ven NCW, 2005, DIABETIC MED, V22, P1619
   van der Ven NCW, 2005, PATIENT EDUC COUNS, V56, P313, DOI 10.1016/j.pec.2004.03.005
   van der Ven NCW, 2003, DIABETES CARE, V26, P713, DOI 10.2337/diacare.26.3.713
   Winkley K., 2006, BRIT MED J, V333, P55
NR 26
TC 38
Z9 39
U1 0
U2 14
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0742-3071
J9 DIABETIC MED
JI Diabetic Med.
PD NOV
PY 2008
VL 25
IS 11
BP 1337
EP 1342
DI 10.1111/j.1464-5491.2008.02595.x
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 367BT
UT WOS:000260528200012
PM 19046225
DA 2019-01-08
ER

PT J
AU Gonzalez, JS
   Delahanty, LM
   Safren, SA
   Meigs, JB
   Grant, RW
AF Gonzalez, J. S.
   Delahanty, L. M.
   Safren, S. A.
   Meigs, J. B.
   Grant, R. W.
TI Differentiating symptoms of depression from diabetes-specific distress:
   relationships with self-care in type 2 diabetes
SO DIABETOLOGIA
LA English
DT Article
DE adherence; depression; diabetes-specific distress; self-care;
   self-management; type 2 diabetes
AB Aims/hypothesis The aim of this study was to examine the relationship between depressive symptoms and diabetes-specific distress and the independent relationships of each of these factors with diabetes self-care. We expected that symptoms of depression would be associated with poorer diabetes self-care, independent of diabetes-specific distress.
   Methods We surveyed 848 primary care patients with type 2 diabetes using the Harvard Department of Psychiatry/National Depression Screening Day Scale (HANDS), Problem Areas in Diabetes scale (PAID), Summary of Diabetes Self-Care Activities, and self-reported medication adherence.
   Results The PAID and HANDS scores were positively correlated in the overall sample (r=0.54, p < 0.0001), among those who did not meet diagnostic criteria for major depressive disorder (MDD) based on the HANDS screening result (n=685; r=0.36, p < 0.001) and in patients who did meet the screening criteria for MDD (n=163; r=0.36, p < 0.001). Higher PAID scores significantly predicted lower levels of diet, exercise and medication adherence (all p values < 0.05). However, once depression symptom scores were entered into these models, most relationships were reduced to non-significance, while the HANDS score retained significant relationships with most indices of diabetes self-care. The same pattern of results was found in the subset of patients who did not screen positive for MDD.
   Conclusions/interpretation These results suggest that specific symptoms of depression have a greater negative relationship with diabetes self-care than diabetes-specific distress, even among those patients who do not meet screening criteria for MDD. Interventions that focus on improving the management of specific symptoms of depression may be more effective in improving self-care than those that focus on reducing distress.
C1 [Gonzalez, J. S.; Safren, S. A.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA.
   [Gonzalez, J. S.; Delahanty, L. M.; Safren, S. A.; Meigs, J. B.; Grant, R. W.] Harvard Univ, Sch Med, Boston, MA 02114 USA.
   [Delahanty, L. M.] Massachusetts Gen Hosp, Ctr Diabet, Boston, MA 02114 USA.
   [Meigs, J. B.; Grant, R. W.] Massachusetts Gen Hosp, Dept Med, Div Gen Med, Boston, MA 02114 USA.
RP Gonzalez, JS (reprint author), Massachusetts Gen Hosp, Dept Psychiat, One Bowdoin Sq,7th Floor, Boston, MA 02114 USA.
EM jsgonzalez@partners.org
OI Grant, Richard/0000-0002-6164-8025
FU National Institute of Mental Health [1R01MH078571]; American Diabetes
   Association Career Development Award; National Institute of Diabetes and
   Digestive and Kidney Diseases (NIDDK) [K24 DK080140, K23 DK067452];
   GlaxoSmithKline
FX J. S. Gonzalez's and S. A. Safren's efforts on this manuscript were
   supported by a grant from the National Institute of Mental Health (no.
   1R01MH078571). J. B. Meigs was supported by an American Diabetes
   Association Career Development Award and by National Institute of
   Diabetes and Digestive and Kidney Diseases (NIDDK) grant no. K24
   DK080140. J. B. Meigs currently has research grants from GlaxoSmithKline
   and sanofi-aventis, and consults for GlaxoSmithKline, sanofi-aventis,
   Interleukin Genetics, Kalypsis and Outcomes Science. R. W. Grant is
   supported by a Career Development Award (no. K23 DK067452) from the
   NIDDK.
CR Baer L, 2000, PSYCHOTHER PSYCHOSOM, V69, P35, DOI 10.1159/000012364
   Delahanty LM, 2007, DIABETIC MED, V24, P48, DOI 10.1111/j.1464-5491.2007.02028.x
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Gonzalez JS, 2007, DIABETES CARE, V30, P2222, DOI 10.2337/dc07-0158
   GONZALEZ JS, DIABETIC MED
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Vileikyte L, 2005, DIABETES CARE, V28, P2378, DOI 10.2337/diacare.28.10.2378
NR 9
TC 49
Z9 53
U1 1
U2 11
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0012-186X
J9 DIABETOLOGIA
JI Diabetologia
PD OCT
PY 2008
VL 51
IS 10
BP 1822
EP 1825
DI 10.1007/s00125-008-1113-x
PG 4
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 344WQ
UT WOS:000258958400011
PM 18690422
OA Green Accepted, Bronze
DA 2019-01-08
ER

PT J
AU Fisher, L
   Skaff, MM
   Mullan, JT
   Arean, P
   Glasgow, R
   Masharani, U
AF Fisher, L.
   Skaff, M. M.
   Mullan, J. T.
   Arean, P.
   Glasgow, R.
   Masharani, U.
TI A longitudinal study of affective and anxiety disorders, depressive
   affect and diabetes distress in adults with Type 2 diabetes
SO DIABETIC MEDICINE
LA English
DT Article
DE affective and anxiety disorder; depressive affect; distress; prevalence
ID COMORBIDITY SURVEY REPLICATION; MENTAL-DISORDERS; PRIMARY-CARE; AGE;
   PREVALENCE; SYMPTOMS; INDIVIDUALS; ASSOCIATION; DISABILITY; INTERVIEW
AB Aims To report the prevalence and correlates of affective and anxiety disorders, depressive affect and diabetes distress over time.
   Methods In a non-interventional study, 506 patients with Type 2 diabetes were assessed three times over 18 months (9-month intervals) for: major-depressive disorder (MDD), general anxiety disorder (GAD), panic disorder (PANIC), dysthymia (DYS) (Composite International Diagnostic Interview); depressive affect [Center for Epidemiological Studies-Depression (CES-D)]; Diabetes Distress Scale (DDS); HbA(1c); and demographic data.
   Results Diabetic patients displayed high rates of affective and anxiety disorders over time, relative to community adults: 60%, higher for MDD, 123% for GAD, 85% for PANIC, 7% for DYS. The prevalence of depressive affect and distress was 60-737%, higher than of affective and anxiety disorders. The prevalence of individual patients with an affective and anxiety disorder over 18 months was double the rate assessed at any single wave. The increase for CES-D and DDS was about 60%). Persistence of CES-D and DDS disorders over time was significantly greater than persistence of affective and anxiety disorders, which tended to be episodic. Younger age, female gender and high comorbidities were related to persistence of all conditions over time. HbA(1c) was positively related to CES-D and DDS, but not to affective and anxiety disorders over time.
   Conclusions The high prevalence of comorbid disorders and the persistence of depressive affect and diabetes distress over time highlight the need for both repeated mental health and diabetes distress screening at each patient contact, not just periodically, particularly for younger adults, women and those with complications/comorbidities.
C1 [Fisher, L.; Skaff, M. M.] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA.
   [Mullan, J. T.] Univ Calif San Francisco, Dept Social & Behav Sci, Sch Nursing, San Francisco, CA 94143 USA.
   [Arean, P.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.
   [Masharani, U.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.
   [Glasgow, R.] Kaiser Permanente, Inst Hlth Res, Denver, CO USA.
RP Fisher, L (reprint author), Univ Calif San Francisco, Dept Family & Community Med, Box 0900, San Francisco, CA 94143 USA.
EM fisherl@fcm.ucsf.edu
FU NIDDK NIH HHS [R01 DK061937-05A1, R01 DK061937, R01 DK062732, DK062732,
   DK061937]
CR Anderson RJ, 2002, INT J PSYCHIAT MED, V32, P235, DOI 10.2190/KLGD-4H8D-4RYL-TWQ8
   CALLAHAN CM, 1992, J GEN INTERN MED, V7, P26, DOI 10.1007/BF02599097
   Charles ST, 2001, J PERS SOC PSYCHOL, V80, P136, DOI 10.1037//0022-3514.80.1.136
   Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278
   Das-Munshi J, 2007, PSYCHOSOM MED, V69, P543, DOI 10.1097/PSY.0b013e3180cc3062
   Dombrovski AY, 2006, AM J GERIAT PSYCHIAT, V14, P550, DOI 10.1097/01.JGP.0000218325.76196.d1
   Egede LE, 2004, DIABETES CARE, V27, P1751, DOI 10.2337/diacare.27.7.1751
   Egede LE, 2002, DIABETES CARE, V25, P464, DOI 10.2337/diacare.25.3.464
   Fisher L, 2001, DIABETES CARE, V24, P1751, DOI 10.2337/diacare.24.10.1751
   Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614
   Grigsby AB, 2002, J PSYCHOSOM RES, V53, P1053, DOI 10.1016/S0022-3999(02)00417-8
   Hegel MT, 2005, AM J GERIAT PSYCHIAT, V13, P48, DOI 10.1176/appi.ajgp.13.1.48
   Hermanns N, 2005, DIABETIC MED, V22, P293, DOI 10.1111/j.1464-5491.2005.01414.x
   Jones LE, 2007, DIABETES CARE, V30, P2216, DOI 10.2337/dc07-0350
   Katon WJ, 2005, DIABETES CARE, V28, P2668, DOI 10.2337/diacare.28.11.2668
   Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617
   Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095
   Kruse J, 2003, DIABETES CARE, V26, P1841, DOI 10.2337/diacare.26.6.1841
   Mirowsky J, 2000, SOCIOL METHOD RES, V28, P476, DOI 10.1177/0049124100028004004
   Peyrot M, 1997, DIABETES CARE, V20, P585, DOI 10.2337/diacare.20.4.585
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   Schieman S, 2002, J AGING HEALTH, V14, P260, DOI 10.1177/089826430201400205
   Scott KM, 2007, J AFFECT DISORDERS, V103, P113, DOI 10.1016/j.jad.2007.01.015
   Shao WA, 1997, J FAM PRACTICE, V44, P161
   WITTCHEN HU, 1994, J PSYCHIAT RES, V28, P57, DOI 10.1016/0022-3956(94)90036-1
NR 26
TC 205
Z9 210
U1 1
U2 24
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0742-3071
J9 DIABETIC MED
JI Diabetic Med.
PD SEP
PY 2008
VL 25
IS 9
BP 1096
EP 1101
DI 10.1111/j.1464-5491.2008.02533.x
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 353BW
UT WOS:000259542100015
PM 19183314
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Amsberg, S
   Wredling, R
   Lins, PE
   Adamson, U
   Johansson, UB
AF Amsberg, Susanne
   Wredling, Regina
   Lins, Per-Eric
   Adamson, Ulf
   Johansson, Unn-Britt
TI The psychometric properties of the Swedish version of the Problem Areas
   in Diabetes Scale (Swe-PAID-20): Scale development
SO INTERNATIONAL JOURNAL OF NURSING STUDIES
LA English
DT Article
DE measurement; PAID; psychological distress; psychometrics; diabetes
   mellitus; type 1
ID GLYCEMIC CONTROL; DEPRESSION; DISTRESS; VALIDITY; ADULTS
AB Background: Considering the importance of psychological aspects in the management of diabetes, there is a need of validated measurements in this area. Such tools make it possible to screen patients for specific conditions as well as they serve Lis reliable measures when evaluating medical, psychological and educational interventions.
   Objectives: The current study was conducted to adapt the Problem Areas in Diabetes Scale for use among Swedish-speaking patients with type I diabetes and to evaluate the psychometric properties.
   Design: Methodological research design was used in this study.
   Setting and participants: A convenience sample of 325 type I diabetes patients was systematically selected from the local diabetes registry of a university hospital in Stockholm, Sweden.
   Methods: Following the linguistic adaptation using the forward-backward translation method, the 20-item PAID was answered by the selected patients. Statistics covered exploratory factor analysis, Cronbach's alpha, convergent validity and content validity.
   Results: In the factor analysis a three-factor solution was found to be reasonable with the sub-dimensions diabetes-related emotional problems (15 items), treatment-related problems (2 items) and support-related problems (3 items). Cronbach's alpha coefficient for the total score was 0.94 and varied between 0.61 and 0.94 in the three subscales. The findings also gave support for the convergent and content validity.
   Conclusions: The Swedish version of the Problem Areas in Diabetes Scale (Swe-PAID-20) seems to be a reliable and valid outcome for measuring diabetes-related emotional distress in type I diabetes patients. (C) 2007 Elsevier Ltd. All rights reserved.
C1 [Amsberg, Susanne; Wredling, Regina; Lins, Per-Eric; Adamson, Ulf; Johansson, Unn-Britt] Danderyd Hosp, Karolinska Inst, Dept Clin Sci, Div Med, S-18288 Stockholm, Sweden.
   [Wredling, Regina] Karolinska Inst, Dept Neurobiol Caring Sci & Soc, Div Nursing, Stockholm, Sweden.
   [Johansson, Unn-Britt] Sophiahemmet Univ Coll, Stockholm, Sweden.
RP Amsberg, S (reprint author), Danderyd Hosp, Karolinska Inst, Dept Clin Sci, Div Med, House 17,4th floor, S-18288 Stockholm, Sweden.
EM susanne.amsberg@ki.se
OI Johansson, Unn-Britt/0000-0003-3309-136X
FU Health Care Sciences Postgraduate School, Karolinska Institutet,
   Sophiahemmet University College; Foundation for Medical Research at
   Sophiahemmet; Bert von Kantzow Foundation; Swedish Diabetes Federation
FX This study was supported by grants from the Health Care Sciences
   Postgraduate School, Karolinska Institutet, Sophiahemmet University
   College, the Foundation for Medical Research at Sophiahemmet, the Bert
   von Kantzow Foundation, and the Swedish Diabetes Federation. We also
   wish to thank Lena Landstedt-Hallin and Anna-Lena Wedfelt for assistance
   with the study and Eva Lagercrantz and Jenny Larson for statistical
   support. We also appreciate the assistance provided by diabetes
   specialist nurses as well as patients taking part in this study.
CR Barnard KD, 2006, DIABETIC MED, V23, P445, DOI 10.1111/j.1464-5491.2006.01814.x
   COX DJ, 1987, DIABETES CARE, V10, P617, DOI 10.2337/diacare.10.5.617
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   LAWSHE CH, 1975, PERS PSYCHOL, V28, P563, DOI 10.1111/j.1744-6570.1975.tb01393.x
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Meadows K, 1996, QUAL LIFE RES, V5, P242, DOI 10.1007/BF00434746
   Nichols GA, 2000, DIABETES CARE, V23, P273, DOI 10.2337/diacare.23.3.273
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   Polit DF, 2004, NURSING RES PRINCIPL
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Shiu ATY, 2004, PUBLIC HEALTH NURS, V21, P257, DOI 10.1111/j.0737-1209.2004.21308.x
   SIGURDARDOTTIR A, 2006, INT J NURSI IN PRESS, DOI DOI 10.1016/J.IJNURSTU.2006.10.008
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Spector PE, 1992, SUMMATED RATING SCAL
   Streiner DL, 2003, HLTH MEASUREMENT SCA
   Weinger K, 2001, J ADOLESCENT HEALTH, V29, P330, DOI 10.1016/S1054-139X(01)00270-1
   Welch G, 2003, DIABETIC MED, V20, P69, DOI 10.1046/j.1464-5491.2003.00832.x
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
NR 19
TC 29
Z9 30
U1 0
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0020-7489
J9 INT J NURS STUD
JI Int. J. Nurs. Stud.
PD SEP
PY 2008
VL 45
IS 9
BP 1319
EP 1328
DI 10.1016/j.ijnurstu.2007.09.010
PG 10
WC Nursing
SC Nursing
GA 354FX
UT WOS:000259625400007
PM 17983618
DA 2019-01-08
ER

PT J
AU Newlin, K
   Melkus, GD
   Tappen, R
   Chyun, D
   Koenig, HG
AF Newlin, Kelley
   Melkus, Gail D.
   Tappen, Ruth
   Chyun, Deborah
   Koenig, Harold G.
TI Relationships of religion and spirituality to glycemic control in Black
   women with type 2 diabetes
SO NURSING RESEARCH
LA English
DT Article
DE glycemic control; religion; spirituality; type 2 diabetes
ID SOCIAL SUPPORT; AFRICAN-AMERICANS; SELF-MANAGEMENT; DEPRESSIVE SYMPTOMS;
   PHYSICAL HEALTH; BLOOD-PRESSURE; CARE PROFILE; STRESS; INVOLVEMENT;
   ADULTS
AB Background: Although religion and spirituality are prominent in the lives of Black women with type 2 diabetes (T2DM), there is little research on the relationships of religion and spirituality to glycemic control (GC) in this population.
   Objective: To examine the relations of religion and spirituality to GC.
   Methods: Using a cross-sectional, descriptive, correlational design, a convenience sample of 109 Black women with T2DM was recruited. Measures of demographic (age, income, and education), clinical (body mass index and use of diabetes medications), psychosocial (emotional distress and social support), religion and spirituality (religious and existential wellbeing), and GC (hemoglobin A1c) factors were collected. A theoretical model, based on the work of Koenig, McCullough, and Larson (2001), informed linear regression analyses to examine the relations of religion and spirituality to GC, with psychosocial factors as putative mediators.
   Results: With age (beta = -.133, SE = .020, p = .145), income (beta = .020, SE = .139, p = .853), education (beta = -.221, SE = .204, p = .040), body mass index (beta = .237, SE = .031, p = .011), and diabetes medications (beta = .338, SE = .216, p < .001) held constant, religion and spirituality demonstrated significant relations with GC (beta = .289, SE = .032, p = .028 and beta = -.358, SE = .030, p = .006, respectively). Evidence of emotional distress and social support as mediators in the relationships of religion and spirituality to GC was lacking.
   Discussion: Religion and spirituality were related to GC, with 4 evidence of psychosocial mediation lacking, thereby forcing revision of the model for the study population. Research is warranted to validate the findings, with further examination of theoretical mediators linking religion and spirituality to GC. Findings suggest that religion and spirituality be addressed in diabetes care to improve GC in Black women with T2DM.
C1 [Newlin, Kelley] Florida Atlantic Univ, Christine E Lynn Coll Nursing, Natl Inst Nursing Res Postdoctoral Fellow, Boca Raton, FL 33431 USA.
   [Melkus, Gail D.] Yale Univ, Sch Nursing, New Haven, CT 06536 USA.
   [Chyun, Deborah] Yale Univ, Coll Nursing, New Haven, CT 06536 USA.
   [Koenig, Harold G.] Duke Univ, Med Ctr, Durham, NC USA.
RP Newlin, K (reprint author), Florida Atlantic Univ, Christine E Lynn Coll Nursing, Natl Inst Nursing Res Postdoctoral Fellow, 777 Glades Rd, Boca Raton, FL 33431 USA.
EM knewlin@fau.edu
RI Albertin, Paloma/X-1093-2018; Koenig, Harold/F-7379-2011
FU National Institute of Nursing Research [F31 NR008190, F32 NR010043,
   R01NR05341]
FX This study was supported by the National Institute of Nursing Research
   (Grant F31 NR008190, F32 NR010043, and R01NR05341).
CR Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS12, DOI 10.2337/dc08-S012
   BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037//0022-3514.51.6.1173
   *CDC, 2008, HLTH PEOPL 2010 DAT
   *CDC, 2008, DAT TRENDS
   CHATTERS LM, 1992, J GERONTOL, V47, pS269, DOI 10.1093/geronj/47.6.S269
   *DIAB CONTR COMPL, 1993, NEW ENGL J MED, V329, P977, DOI DOI 10.1056/NEJM199309303291401
   Drayton-Brooks Shirlee, 2004, ABNF J, V15, P84
   Ellison CG, 2001, SOC FORCES, V80, P215, DOI 10.1353/sof.2001.0063
   ELLISON CG, 1994, J SCI STUD RELIG, V33, P46, DOI 10.2307/1386636
   ELLISON CW, 1983, J PSYCHOL THEOL, V11, P330
   Fetzer Institute & National Institute on Aging Working Group, 1999, MULT MEAS REL SPIR U
   Figueroa Lydia R, 2006, ABNF J, V17, P82
   Fitchett G., 2003, ANN BEHAV MED, V25, pS173
   Fitzgerald JT, 1996, EVAL HEALTH PROF, V19, P208, DOI 10.1177/016327879601900205
   Fitzgerald JT, 1998, EVAL HEALTH PROF, V21, P52, DOI 10.1177/016327879802100103
   Funnell MM, 2008, DIABETES CARE, V31, pS97, DOI 10.2337/dc08-S097
   Gary TL, 2000, DIABETES CARE, V23, P23, DOI 10.2337/diacare.23.1.23
   GRIFFITH LS, 1990, INT J PSYCHIAT MED, V20, P365, DOI 10.2190/APH4-YMBG-NVRL-VLWD
   Ilias I, 2001, PSYCHOL REP, V88, P929, DOI 10.2466/pr0.2001.88.3.929
   Kawakami N, 2000, OCCUP ENVIRON MED, V57, P805, DOI 10.1136/oem.57.12.805
   Koenig H. G., 2001, HDB RELIG HLTH
   Koenig HG, 1997, AM J GERIAT PSYCHIAT, V5, P131
   Koenig HG, 1998, INT J PSYCHIAT MED, V28, P189, DOI 10.2190/75JM-J234-5JKN-4DQD
   Lawler KA, 2002, J RELIG HEALTH, V41, P347, DOI 10.1023/A:1021126510680
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Mattis J. J., 2000, J BLACK PSYCHOL, V26, P101, DOI [10.1177/0095798400026001006, DOI 10.1177/0095798400026001006]
   McNabb WL, 1997, DIABETES CARE, V20, P215, DOI 10.2337/diacare.20.2.215
   MELKUS GD, 2007, DIABETES S1, V56, P2521
   Nakahara R, 2006, PSYCHOSOMATICS, V47, P240, DOI 10.1176/appi.psy.47.3.240
   Newlin K, 2003, ETHNIC DIS, V13, P61
   NEWLIN K, 2004, 2004 MIN WOM HLTH SU
   NHLBI Obesity Education Initiative Expert Panel on the Identification Evaluation and Treatment of Overweight and Obesity in Adults (US), 1998, CLIN GUID ID EV TREA
   *NIH, 2008, MAK SYST CHANG BETT
   Olphen J, 2003, J GEN INTERN MED, V18, P549, DOI 10.1046/j.1525-1497.2003.21031.x
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polzer RL, 2007, RES NURS HEALTH, V30, P164, DOI 10.1002/nur.20179
   Puchalski C, 2000, J Palliat Med, V3, P129, DOI 10.1089/jpm.2000.3.129
   Samuel-Hodge CD, 2000, DIABETES CARE, V23, P928, DOI 10.2337/diacare.23.7.928
   Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55
   Shahabi L, 2002, ANN BEHAV MED, V24, P59, DOI 10.1207/S15324796ABM2401_07
   UK Prospective Diabetes Study Group, 1998, BMJ-BRIT MED J, V317, P703, DOI DOI 10.1136/BMJ.317.7160.703
NR 41
TC 34
Z9 34
U1 0
U2 11
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-6562
EI 1538-9847
J9 NURS RES
JI Nurs. Res.
PD SEP-OCT
PY 2008
VL 57
IS 5
BP 331
EP 339
DI 10.1097/01.NNR.0000313497.10154.66
PG 9
WC Nursing
SC Nursing
GA 352CG
UT WOS:000259472200005
PM 18794717
DA 2019-01-08
ER

PT J
AU Suarez, EC
AF Suarez, Edward C.
TI Self-reported symptoms of sleep disturbance and inflammation,
   coagulation, insulin resistance and psychosocial distress: Evidence for
   gender disparity
SO BRAIN BEHAVIOR AND IMMUNITY
LA English
DT Article
DE sleep disturbance; inflammation; coagulation; adiposity; psychosocial
   distress; gender differences; insulin
ID CORONARY-ARTERY-DISEASE; HOMEOSTASIS MODEL ASSESSMENT; C-REACTIVE
   PROTEIN; RISK-FACTORS; HEALTHY-SUBJECTS; CARDIOVASCULAR-DISEASE;
   TRYPTOPHAN DEPLETION; DAYTIME SLEEPINESS; GLUCOSE-TOLERANCE; PRIMARY
   INSOMNIA
AB Self-reported ratings of sleep quality and symptoms of poor sleep have been linked to increased risk of coronary heart disease (CHD), Type 2 diabetes and hypertension with recent evidence suggesting stronger associations in women. At this time, the mechanisms of action that underlie these gender-specific associations are incompletely defined. The current study examined whether gender moderates the relation of subjective sleep and sleep-related symptoms to indices of inflammation, coagulation, insulin resistance (IR) and psychosocial distress, factors associated with increased risk of cardiovascular and metabolic disorders. Subjects were 210 healthy men and women without a history of sleep disorders. The Pittsburgh Sleep Quality Index (PSQI) was used to assess sleep quality and frequency of sleep symptoms. In multivariate-adjusted models, overall poor sleep quality, more frequent problems falling asleep (>2 night/week) and longer periods to fall asleep (>30 min) were associated with greater psychosocial distress, higher fasting insulin, fibrinogen and inflammatory biomarkers, but only for women. The data suggest that subjective ratings of poor sleep, greater frequency of sleep-related symptoms, and longer period of time to fall asleep are associated with a mosaic of biobehavioral mechanisms in women and that these gender-specific associations have direct implications to recent observations suggesting gender differences in the association between symptoms of poor sleep and cardiovascular disease. (c) 2008 Elsevier Inc. All rights reserved.
C1 Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA.
RP Suarez, EC (reprint author), Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, POB 3328, Durham, NC 27710 USA.
EM suare001@mc.duke.edu
FU NHLBI NIH HHS [R01 HL067459, HL67459]
CR Akerstedt T, 2002, J PSYCHOSOM RES, V53, P741, DOI 10.1016/S0022-3999(02)00333-1
   Arad Y, 2001, ARTERIOSCL THROM VAS, V21, P2051, DOI 10.1161/hq1201.100257
   Barbier O, 2002, ARTERIOSCL THROM VAS, V22, P717, DOI 10.1161/01/ATV.0000015598.86369.04
   Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506
   Bassetti CL, 2006, STROKE, V37, P967, DOI 10.1161/01.STR.0000208215.49243.c3
   BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5
   Booij L, 2002, NEUROPSYCHOPHARMACOL, V27, P852, DOI 10.1016/S0893-133X(02)00361-5
   BOYLE SH, 2007, PSYCHOSOM MED, V68, P844
   Brummett BH, 2006, HEALTH PSYCHOL, V25, P220, DOI 10.1037/0278-6133.25.2.220
   Burgos I, 2006, BRAIN BEHAV IMMUN, V20, P246, DOI 10.1016/j.bbi.2005.06.007
   BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037//0022-3514.63.3.452
   BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4
   CAPPUCCIO FP, 2007, HYPERTENSION
   Capuron L, 2004, BIOL PSYCHIAT, V56, P819, DOI 10.1016/j.biopsych.2004.02.009
   Casabiell X, 1998, J CLIN ENDOCR METAB, V83, P2149, DOI 10.1210/jc.83.6.2149
   Clegg DJ, 2003, DIABETES, V52, P682, DOI 10.2337/diabetes.52.3.682
   Cohen S, 1985, SOCIAL SUPPORT THEOR, P73, DOI DOI 10.1007/978-94-009-5115-0_5
   Cook WW, 1954, J APPL PSYCHOL, V38, P414, DOI 10.1037/h0060667
   Dale GL, 2002, NATURE, V415, P175, DOI 10.1038/415175a
   Dandona P, 2003, J CLIN ENDOCR METAB, V88, P2422, DOI 10.1210/jc.2003-030178
   Daynes RA, 2002, NAT REV IMMUNOL, V2, P748, DOI 10.1038/nri912
   DELGADO PL, 1989, LIFE SCI, V45, P2323, DOI 10.1016/0024-3205(89)90114-8
   Dunn SE, 2007, J EXP MED, V204, P321, DOI 10.1084/jem.20061839
   Festa A, 2003, CIRCULATION, V108, P1822, DOI 10.1161/01.CIR.0000091339.70120.53
   Ford DE, 2001, DEPRESS ANXIETY, V14, P3, DOI 10.1002/da.1041
   Friedman EM, 2005, P NATL ACAD SCI USA, V102, P18757, DOI 10.1073/pnas.0509281102
   Gangwisch JE, 2005, SLEEP, V28, P1289, DOI 10.1093/sleep/28.10.1289
   Hall M, 2000, PSYCHOSOM MED, V62, P227, DOI 10.1097/00006842-200003000-00014
   Hong S, 2005, BRAIN BEHAV IMMUN, V19, P165, DOI 10.1016/j.bbi.2004.07.008
   JANS LAW, 2006, MOL PSYCHIATR, P1
   Kaptoge S, 2007, AM J EPIDEMIOL, V166, P867, DOI 10.1093/aje/kwm191
   Krantz DS, 2002, ANNU REV PSYCHOL, V53, P341, DOI 10.1146/annurev.psych.53.100901.135208
   Kubera M, 2005, PSYCHIAT RES, V134, P251, DOI 10.1016/j.psychres.2004.01.014
   Libby P, 2006, J AM COLL CARDIOL, V48, pA33, DOI 10.1016/j.jacc.2006.08.011
   Licinio J, 1998, J CLIN ENDOCR METAB, V83, P4140, DOI 10.1210/jc.83.11.4140
   LIVERMAN CT, 2004, TESTOSTERONE AGING C
   Macy EM, 1997, CLIN CHEM, V43, P52
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   McDade TW, 2006, PSYCHOSOM MED, V68, P376, DOI 10.1097/01.psy.0000221371.43607.64
   Mooe T, 2001, AM J RESP CRIT CARE, V164, P1910, DOI 10.1164/ajrccm.164.10.2101072
   Nakai Y, 2002, DIABETIC MED, V19, P346, DOI 10.1046/j.1464-5491.2002.00712_3.x
   Neckelmann D, 2007, SLEEP, V30, P873, DOI 10.1093/sleep/30.7.873
   Newman AB, 2000, J AM GERIATR SOC, V48, P115, DOI 10.1111/j.1532-5415.2000.tb03901.x
   OPP MR, 1992, P SOC EXP BIOL MED, V201, P16
   Parati G, 2007, AM J PHYSIOL-REG I, V293, pR1671, DOI 10.1152/ajpregu.00400.2007
   Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901
   Pilcher JJ, 1997, J PSYCHOSOM RES, V42, P583, DOI 10.1016/S0022-3999(97)00004-4
   Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327
   Reichmuth KJ, 2005, AM J RESP CRIT CARE, V172, P1590, DOI 10.1164/rccm.200504-6370C
   Ridker Paul M., 2003, Cardiology Clinics, V21, P315, DOI 10.1016/S0733-8651(03)00079-1
   Rozanski A, 2005, J AM COLL CARDIOL, V45, P637, DOI 10.1016/j.jac.2004.12.005
   ROZANSKI A, 1999, CIRCULATION, V99, P2129
   Schieman S, 2007, J AGING HEALTH, V19, P286, DOI 10.1177/0898264307299300
   Sloan DME, 2003, PSYCHIAT CLIN N AM, V26, P581, DOI 10.1016/S0193-953X(03)00044-3
   Spiegel K, 2005, J APPL PHYSIOL, V99, P2008, DOI 10.1152/japplphysiol.00660.2005
   Suarez EC, 2000, PSYCHOSOM MED, V62, P150
   Suarez EC, 2006, ANN BEHAV MED, V31, P254, DOI 10.1207/s15324796abm3103_7
   Temelkova-Kurktschiev T, 2002, METABOLISM, V51, P743, DOI 10.1053/meta.2002.32804
   Trenell MI, 2007, CLIN EXP PHARMACOL P, V34, P1, DOI 10.1111/j.1440-1681.2007.04541.x
   Tworoger SS, 2005, J PSYCHOSOM RES, V59, P11, DOI 10.1016/j.jpsychores.2005.03.008
   Vgontzas AN, 2005, SLEEP MED REV, V9, P211, DOI 10.1016/j.smrv.2005.01.006
   Vgontzas AN, 2000, J CLIN ENDOCR METAB, V85, P1151, DOI 10.1210/jc.85.3.1151
   VIRKKUNEN M, 1987, NEUROPSYCHOBIOLOGY, V17, P19, DOI 10.1159/000118335
   Voderholzer U, 1998, NEUROPSYCHOPHARMACOL, V18, P112, DOI 10.1016/S0893-133X(97)00094-8
   von Kanel R, 2006, J AM GERIATR SOC, V54, P431, DOI 10.1111/j.1532-5415.2005.00642.x
   WALDBILLIG RJ, 1981, J COMP PHYSIOL PSYCH, V95, P391, DOI 10.1037/h0077790
   Yaggi HK, 2006, DIABETES CARE, V29, P657, DOI 10.2337/diacare.29.03.06.dc05-0879
   Yanase M, 2004, CIRC J, V68, P47, DOI 10.1253/circj.68.47
   Zambon A, 2006, ARTERIOSCL THROM VAS, V26, P977, DOI 10.1161/01.ATV.0000204327.96431.9a
NR 69
TC 126
Z9 127
U1 1
U2 17
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0889-1591
J9 BRAIN BEHAV IMMUN
JI Brain Behav. Immun.
PD AUG
PY 2008
VL 22
IS 6
BP 960
EP 968
DI 10.1016/j.bbi.2008.01.011
PG 9
WC Immunology; Neurosciences; Psychiatry
SC Immunology; Neurosciences & Neurology; Psychiatry
GA 325RL
UT WOS:000257605900019
PM 18328671
OA Green Accepted
DA 2019-01-08
ER

PT J
AU Janicke, DM
   Harman, JS
   Kelleher, KJ
   Zhang, JY
AF Janicke, David M.
   Harman, Jeffrey S.
   Kelleher, Kelly J.
   Zhang, Jianyi
TI Psychiatric diagnosis in children and adolescents with obesity-related
   health conditions
SO JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS
LA English
DT Article
DE children; obesity; psychiatric diagnosis; chronic illness
ID PSYCHOLOGICAL ADJUSTMENT; PSYCHOSOCIAL ADJUSTMENT; GLUCOSE-METABOLISM;
   DIABETES-MELLITUS; PHYSICAL-ACTIVITY; WEIGHT STATUS; YOUNG-ADULTS;
   RISK-FACTORS; CARE USE; OVERWEIGHT
AB Objective: Childhood obesity is linked with a number of problematic health conditions. While data suggest that children who are obese are at increased risk of psychosocial distress relative to nonobese peers, there are limited data outlining the rates of psychiatric diagnoses in children with obesity-related health conditions such as type 2 diabetes and the metabolic syndrome. Methods: This study used Medicaid claims data from the State of Florida to compare the rates of psychiatric diagnoses for children with obesity-related health conditions, aged 5 to 18 years, to those of children with comparison chronic health conditions. Results: Overall, 35% of children with an obesity-related diagnosis had a psychiatric diagnosis. While controlling for age, gender, and race, youths with type 2 diabetes, the metabolic syndrome, and dyslipidemia had higher rates of International Classification of Disease, Ninth Revision (ICD-9) psychiatric diagnoses than children with cystic fibrosis, sickle cell disease, and juvenile rheumatoid arthritis (p < .001), but similar to those of children with asthma. Non-Hispanic white children with an obesity-related health condition had greater odds of receiving a psychiatric diagnosis than African American (odds ratio [OR] = 0.54, p < .001) or Hispanic (OR = 0.41, p < .001) children. Males and females differed in rates of externalizing and internalizing diagnoses. Conclusions:The data suggest that children with an obesity-related health condition have higher rates of internalizing and externalizing mental health conditions relative to children with other chronic health conditions. Prospective, longitudinal research is needed to further confirm these findings and examine factors that affect this association and potential impacts on the health care system.
C1 [Janicke, David M.] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL 32610 USA.
   [Harman, Jeffrey S.] Univ Florida, Dept Hlth Serv Res Management & Policy, Gainesville, FL 32610 USA.
   [Kelleher, Kelly J.] Childrens Hosp, Dept Pediat & Publ Hlth, Columbus, OH 43205 USA.
   [Zhang, Jianyi] Univ Florida, Ctr Medicaid & Uninsured, Gainesville, FL 32610 USA.
RP Janicke, DM (reprint author), Univ Florida, Dept Clin & Hlth Psychol, POB 100165, Gainesville, FL 32610 USA.
EM djanicke@phhp.ufl.edu
RI Kelleher, Kelly/E-3361-2011
CR BROWNBRIDGE G, 1994, PEDIATR NEPHROL, V8, P744, DOI 10.1007/BF00869109
   Cooper-Patrick L, 1999, JAMA-J AM MED ASSOC, V282, P583, DOI 10.1001/jama.282.6.583
   Correll CU, 2008, J AM ACAD CHILD PSY, V47, P9, DOI 10.1097/chi.0b013e31815b5cb1
   Dilley KJ, 2007, PEDIATRICS, V119, pE148, DOI 10.1542/peds.2005-2867
   DORSEY KB, 2007, ARCH PEDIAT ADOLESC, V159, P632
   Duncan GE, 2004, DIABETES CARE, V27, P2438, DOI 10.2337/diacare.27.10.2438
   Fagot-Campagna A, 2000, J PEDIATR-US, V136, P664, DOI 10.1067/mpd.2000.105141
   Falkner NH, 2001, OBES RES, V9, P32, DOI 10.1038/oby.2001.5
   Field AE, 2005, OBES RES, V13, P163, DOI 10.1038/oby.2005.21
   Freedman DS, 1999, PEDIATRICS, V103, P1175, DOI 10.1542/peds.103.6.1175
   GUO JH, 1994, ACTA PETROL SIN, V11, P1
   Hampl SE, 2007, ARCH PEDIAT ADOL MED, V161, P11, DOI 10.1001/archpedi.161.1.11
   Henderson DC, 2005, ARCH GEN PSYCHIAT, V62, P19, DOI 10.1001/archpsyc.62.1.19
   Janicke DM, 2001, MED CARE, V39, P990, DOI 10.1097/00005650-200109000-00009
   Janssen I, 2004, PEDIATRICS, V113, P1187, DOI 10.1542/peds.113.5.1187
   Johnson RL, 2004, AM J PUBLIC HEALTH, V94, P2084, DOI 10.2105/AJPH.94.12.2084
   Kelly DL, 1998, J CHILD ADOL PSYCHOP, V8, P151, DOI 10.1089/cap.1998.8.151
   KOVACS M, 1992, J AM ACAD CHILD PSY, V31, P1112, DOI 10.1097/00004583-199211000-00020
   LAVIGNE JV, 1992, J PEDIATR PSYCHOL, V17, P133, DOI 10.1093/jpepsy/17.2.133
   Lavigne JV, 1998, J AM ACAD CHILD PSY, V37, P262, DOI 10.1097/00004583-199803000-00010
   McQuaid EL, 2001, J DEV BEHAV PEDIATR, V22, P430, DOI 10.1097/00004703-200112000-00011
   O'Brien SH, 2004, PEDIATRICS, V114, P154, DOI 10.1542/peds.114.2.e154
   Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549
   Rapoff MA, 2003, HDB PEDIAT PSYCHOL, P392
   Rhodes ET, 2007, DIABETES CARE, V30, P141, DOI 10.2337/dc06-1142
   Sallis JF, 2000, MED SCI SPORT EXER, V32, P963
   SATCHER S, 1999, 92 ANN NAACP CONV NE
   Scheen AJ, 2007, DIABETES METAB, V33, P169, DOI 10.1016/j.diabet.2007.01.003
   Schwimmer JB, 2003, JAMA-J AM MED ASSOC, V289, P1813, DOI 10.1001/jama.289.14.1813
   Sjoberg RL, 2005, PEDIATRICS, V116, pE389, DOI 10.1542/peds.2005-0170
   SMOAK CG, 1987, AM J EPIDEMIOL, V125, P364, DOI 10.1093/oxfordjournals.aje.a114543
   Storch EA, 2007, J PEDIATR PSYCHOL, V32, P80, DOI 10.1093/jpepsy/jsj113
   Thompson RJ, 1998, J CLIN PSYCHOL, V54, P121, DOI 10.1002/(SICI)1097-4679(199801)54:1<121::AID-JCLP14>3.3.CO;2-G
   Wei JN, 2003, JAMA-J AM MED ASSOC, V290, P1345, DOI 10.1001/jama.290.10.1345
   Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049
   Welch C, 2004, J AM DIET ASSOC, V104, P1080, DOI 10.1016/j.jada.2004.04.019
   White MA, 2005, INT J EAT DISORDER, V38, P78, DOI 10.1002/eat.20142
   Woolford SJ, 2007, OBESITY, V15, P1895, DOI 10.1038/oby.2007.224
   Zito JM, 1998, J CHILD ADOL PSYCHOP, V8, P99, DOI 10.1089/cap.1998.8.99
NR 39
TC 28
Z9 29
U1 0
U2 6
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0196-206X
EI 1536-7312
J9 J DEV BEHAV PEDIATR
JI J. Dev. Behav. Pediatr.
PD AUG
PY 2008
VL 29
IS 4
BP 276
EP 284
DI 10.1097/DBP.0b013e31817102f8
PG 9
WC Behavioral Sciences; Psychology, Developmental; Pediatrics
SC Behavioral Sciences; Psychology; Pediatrics
GA 337CA
UT WOS:000258411900008
PM 18562982
DA 2019-01-08
ER

PT J
AU Schmitz, N
   Wang, J
   Lesage, A
   Malla, A
   Strychar, I
AF Schmitz, Norbert
   Wang, JianLi
   Lesage, Alain
   Malla, Ashok
   Strychar, Irene
TI Psychological distress and short-term disability in people with
   diabetes: Results from the Canadian Community Health Survey
SO JOURNAL OF PSYCHOSOMATIC RESEARCH
LA English
DT Article
DE diabetes; psychological distress; disability; epidemiology
ID MAJOR DEPRESSION; SCREENING SCALES; ADULTS; POPULATION; INDIVIDUALS;
   COMORBIDITY; PREVALENCE; ANXIETY; K10
AB Objectives: Psychological distress may have different effects on short-term disability depending on individual disease severity, which can affect daily life activities. The objective of this study was to evaluate the interaction between psychological distress and activity limitations in daily life, in relation to self-reported disability days in a community sample of people with diabetes. Methods: The responses of 3082 adults with self-reported diabetes to the Canadian Community Health Survey Cycle 3.1 were analyzed. Results: Prevalence of disability days was higher in diabetic subjects with coexisting psychological distress and activity limitations (67%) than in individuals with either activity limitations in daily life (38%) or psychological distress (30%) alone. With no psychological distress and no activity limitations as reference and after adjusting for relevant covariates, the odds ratio of disability was 2.63 [95% confidence interval (95% Cl)=1.60-4.33] for psychological distress, 5.57 (95% CI=3.86-8.05) for activity limitations, and 19.4 (95% CI=11.7-31.9) for activity limitations and comorbid psychological distress. Conclusions: The results suggest that there is a joint effect of psychological distress and activity limitations on short-term disability. Detecting and managing psychological distress might be particularly beneficial for persons with diabetes. (C) 2008 Elsevier Inc. All rights reserved.
C1 [Schmitz, Norbert; Malla, Ashok] McGill Univ, Douglas Hosp, Res Ctr, Dept Psychiat, Verdun, PQ H4H 1R3, Canada.
   [Wang, JianLi] Univ Calgary, Fac Med, Dept Psychiat, Calgary, AB, Canada.
   [Wang, JianLi] Univ Calgary, Fac Med, Dept Community Hlth Sci, Calgary, AB, Canada.
   [Lesage, Alain] Univ Montreal, Hop Louis H Lafontaine, Ctr Rech Fernand Seguin, Montreal, PQ, Canada.
   [Strychar, Irene] Univ Montreal, Fac Med, Dept Nutr, Montreal, PQ H3C 3J7, Canada.
RP Schmitz, N (reprint author), McGill Univ, Douglas Hosp, Res Ctr, Dept Psychiat, 6875 LaSalle Blvd, Verdun, PQ H4H 1R3, Canada.
EM norbert.schmitz@mcgill.ca
RI Schmitz, Norbert/A-5177-2010
OI Schmitz, Norbert/0000-0001-7777-6323
CR Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Andrews G, 2001, AUST NZ J PUBL HEAL, V25, P494, DOI 10.1111/j.1467-842X.2001.tb00310.x
   Breiman L, 1984, CLASSIFICATION REGRE
   Cairney J, 2007, CAN J PSYCHIAT, V52, P111, DOI 10.1177/070674370705200209
   DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101
   Egede LE, 2004, DIABETES CARE, V27, P1751, DOI 10.2337/diacare.27.7.1751
   Egede LE, 2004, DIABETES CARE, V27, P421, DOI 10.2337/diacare.27.2.421
   Ferrie JE, 2005, OCCUP ENVIRON MED, V62, P74, DOI 10.1136/oem.2004.013896
   Fougeyrollas P, 1998, INT J REHABIL RES, V21, P127, DOI 10.1097/00004356-199806000-00002
   Furukawa TA, 2003, PSYCHOL MED, V33, P357, DOI 10.1017/S0033291702006700
   Glasgow RE, 1999, DIABETES CARE, V22, P832, DOI 10.2337/diacare.22.5.832
   Grigsby AB, 2002, J PSYCHOSOM RES, V53, P1053, DOI 10.1016/S0022-3999(02)00417-8
   Kadam UT, 2005, J CLIN EPIDEMIOL, V58, P909, DOI 10.1016/j.jclinepi.2005.02.007
   Katon WJ, 2004, ARCH GEN PSYCHIAT, V61, P1042, DOI 10.1001/archpsyc.61.10.1042
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Lustman PJ, 1997, GEN HOSP PSYCHIAT, V19, P138, DOI 10.1016/S0163-8343(96)00170-3
   MCVEIGH K, 2005, JAMA-J AM MED ASSOC, V53, P1053
   NATHAN DM, 1993, NEW ENGL J MED, V328, P1676, DOI 10.1056/NEJM199306103282306
   Penninx BWJH, 1998, JAMA-J AM MED ASSOC, V279, P1720, DOI 10.1001/jama.279.21.1720
   Polonsky WH, 2000, DIABETES SPECTRUM, V13, P36
   REVICKI DA, 1994, MED CARE, V32, P401, DOI 10.1097/00005650-199404000-00008
   Ryerson B, 2003, DIABETES CARE, V26, P206, DOI 10.2337/diacare.26.1.206
   Schmitz N, 2003, COMPR PSYCHIAT, V44, P169, DOI 10.1053/comp.2003.50033
   SONGER TJ, 1995, DIABETES AM, P259
   *STAT CAN, 2005, PART ACT LIM SURV PA
   Statistics Canada, 2005, CAN COMM HLTH SURV C
   Steinberg D., 1995, CART TREE STRUCTURED
   Von Korff M, 2005, DIABETES CARE, V28, P1326, DOI 10.2337/diacare.28.6.1326
   Ware JE, 1993, SF 36 HLTH SURVEY MA
   WELLS KB, 1989, JAMA-J AM MED ASSOC, V262, P914, DOI 10.1001/jama.262.7.914
   World Health Organization (WHO), 2001, INT CLASS FUNCT DIS
NR 31
TC 7
Z9 7
U1 0
U2 7
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0022-3999
J9 J PSYCHOSOM RES
JI J. Psychosomat. Res.
PD AUG
PY 2008
VL 65
IS 2
BP 165
EP 172
DI 10.1016/j.jpsychores.2008.03.004
PG 8
WC Psychiatry
SC Psychiatry
GA 335ER
UT WOS:000258274100010
PM 18655862
DA 2019-01-08
ER

PT J
AU Jackson, C
   Richer, J
   Edge, JA
AF Jackson, Clare
   Richer, John
   Edge, Julie A.
TI Sibling psychological adjustment to type 1 diabetes mellitus
SO PEDIATRIC DIABETES
LA English
DT Article
DE adjustment; children; family; siblings; T1DM
ID CHRONIC ILLNESS
AB Objective: Type 1 diabetes mellitus (T1DM) is a chronic condition whose management affects the whole family, and siblings of children with chronic conditions have been shown to be at higher risk of emotional and behavioural problems. The aims of this study were to investigate sibling adjustment to T1DM using a cross-sectional questionnaire survey design.
   Methods: Forty-one families (48% of those eligible) were recruited from a children's diabetes clinic. From each family, one parent and one sibling of the child with T1DM participated. Parents completed questionnaires measuring sibling adjustment and measures of major life events, social support and parenting stress. Demographic and disease information was obtained from medical records. Siblings completed questionnaires assessing cognitive appraisals and coping strategies. A semi-structured interview was also administered to siblings.
   Results: Siblings were found to be better adjusted than normative data (p < 0.01). Factors associated with poorer sibling adjustment were higher sibling age at diagnosis, higher levels of parenting stress, more difficult sibling temperament, poorer adjustment of the child with T1DM, higher levels of parental distress and more negative sibling perceptions of diabetes and its impact on the family. Results suggest that sibling perceptions of diabetes and parental distress are important predictors of sibling adjustment to T1DM.
   Conclusions: The findings from this study emphasize the relationships between the adjustment of the sibling and that of the child with T1DM and their parents. Many parents worry about how the siblings may cope with the diabetes, but the results of this study are generally reassuring.
C1 [Edge, Julie A.] John Radcliffe Hosp, Dept Paediat, Oxford OX3 9DU, England.
   [Jackson, Clare] Warneford Hosp, Oxford Doctoral Course Clin Psychol, Isis Educ Ctr, Oxford OX3 7JX, England.
   [Richer, John] John Radcliffe Hosp, Dept Paediat Psychol, Oxford OX3 9DU, England.
RP Edge, JA (reprint author), John Radcliffe Hosp, Dept Paediat, Oxford OX3 9DU, England.
EM julie.edge@paediatrics.ox.ac.uk
CR Abidin R. R., 1995, PARENTING STRESS IND
   CARPENTER PJ, 1991, ADVANCES IN CHILD HEALTH PSYCHOLOGY, P193
   Chess S, 1986, TEMPERAMENT CLIN PRA
   Dunst C. J., 1984, J INDIVIDUAL FAMILY, V1, P45
   Elander J, 1997, PSYCHOLOGIST, V10, P211
   FERRARI M, 1984, J CHILD PSYCHOL PSYC, V25, P459, DOI 10.1111/j.1469-7610.1984.tb00164.x
   Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x
   MELTZER H, 2000, SDQ NORMATIVE SDQ DA
   Pidgeon N., 1996, HDB QUALITATIVE RES, P86
   SPIRITO A, 1988, J PEDIATR PSYCHOL, V13, P555, DOI 10.1093/jpepsy/13.4.555
   Tamborlane WV, 1997, PEDIATR CLIN N AM, V44, P285, DOI 10.1016/S0031-3955(05)70477-6
   Taylor V, 2001, J CHILD PSYCHOL PSYC, V42, P953, DOI 10.1111/1469-7610.00791
   Wallander JL, 1992, STRESS COPING CHILD, P279
   Williams PD, 1997, INT J NURS STUD, V34, P312, DOI 10.1016/S0020-7489(97)00019-9
NR 14
TC 16
Z9 16
U1 0
U2 6
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1399-543X
J9 PEDIATR DIABETES
JI Pediatr. Diabetes
PD AUG
PY 2008
VL 9
IS 4
BP 308
EP 311
DI 10.1111/j.1399-5448.2008.00385.x
PN 1
PG 4
WC Endocrinology & Metabolism; Pediatrics
SC Endocrinology & Metabolism; Pediatrics
GA 331CU
UT WOS:000257991100009
PM 18466212
DA 2019-01-08
ER

PT J
AU Eriksson, AK
   Ekbom, A
   Granath, F
   Hilding, A
   Efendic, S
   Ostenson, CG
AF Eriksson, A. -K.
   Ekbom, A.
   Granath, F.
   Hilding, A.
   Efendic, S.
   Ostenson, C. -G.
TI Psychological distress and risk of pre-diabetes and Type 2 diabetes in a
   prospective study of Swedish middle-aged men and women
SO DIABETIC MEDICINE
LA English
DT Article
DE epidemiology; lifestyle; longitudinal study; psychological distress;
   Type 2 diabetes
ID CORONARY-HEART-DISEASE; DEPRESSIVE SYMPTOMS; INSULIN-RESISTANCE;
   WHITEHALL II; FOLLOW-UP; MELLITUS; HEALTH; MORBIDITY; MIDLIFE
AB Aims To determine the role of psychological distress as a predictor of pre-diabetes and Type 2 diabetes.
   Methods This cohort study comprised 2127 Swedish middle-aged men and 3100 women with baseline normal glucose tolerance measured by oral glucose tolerance test. At follow-up 8-10 years later, 245 men and 177 women had pre-diabetes [impaired fasting glucose (IFG), impaired glucose tolerance (IGT) and IFG + IGT] and Type 2 diabetes was detected in 103 men and 57 women. Baseline psychological distress was measured by an index of five questions concerning anxiety, apathy, depression, fatigue and insomnia. Odds ratios (ORs) were estimated for pre-diabetes and Type 2 diabetes in association with total psychological distress. In addition, ORs of the single-item questions were calculated.
   Results In men, adjusted ORs (95% confidence interval) in the highest index group of psychological distress compared with the lowest group were 1.9 (1.2-2.8) and 2.2 (1.2-4.1) for pre-diabetes and Type 2 diabetes, respectively. Corresponding estimates in women were 1.2 (0.7-2.1) and 0.5 (0.2-1.2). In the middle symptoms groups, adjusted ORs in men were 1.1 (0.8-1.4) for pre-diabetes and 1.2 (0.7-2.0) for Type 2 diabetes and in women 1.8 (1.1-3.0) and 0.7 (0.3-1.4). When analysed separately, the associations with each of the five single factors were similar.
   Conclusions The results indicate that psychological distress, including symptoms of anxiety, apathy, depression, fatigue and insomnia, increases the risk of pre-diabetes and Type 2 diabetes in Swedish middle-aged men. Increased risks were not present in women, except for pre-diabetes in the middle index group.
C1 [Eriksson, A. -K.; Ekbom, A.; Granath, F.] Karolinska Inst, Dept Med, Clin Epidemiol Unit, Stockholm, Sweden.
   [Hilding, A.; Efendic, S.; Ostenson, C. -G.] Karolinska Inst, Dept Mol Med & Surg, Endocrine & Diabet Unit, Stockholm, Sweden.
RP Eriksson, AK (reprint author), Karolinska Univ Hosp, Diabet Prevent Unit, SE-17176 Stockholm, Sweden.
EM eriksson@karolinska.se
CR Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
   Andersson CM, 2002, HEALTH PROMOT INT, V17, P317, DOI 10.1093/heapro/17.4.317
   ANSON O, 1993, SOC SCI MED, V36, P419, DOI 10.1016/0277-9536(93)90404-R
   Arroyo C, 2004, DIABETES CARE, V27, P129, DOI 10.2337/diacare.27.1.129
   Bjorkelund C, 2005, DIABETES CARE, V28, P2739, DOI 10.2337/diacare.28.11.2739
   Bjorntorp P, 2001, SCAND CARDIOVASC J, V35, P172, DOI 10.1080/140174301750305045
   BOSTROM G, 2006, SCAND J PUBLIC HEALT, V34, pS69
   Carnethon MR, 2003, AM J EPIDEMIOL, V158, P416, DOI 10.1093/aje/kwg172
   ELIASSON M, 2003, SCAND J PUBLIC HEALT, V31, pS70
   Everson-Rose SA, 2004, DIABETES CARE, V27, P2856, DOI 10.2337/diacare.27.12.2856
   Golden SH, 2004, DIABETES CARE, V27, P429, DOI 10.2337/diacare.27.2.429
   Gonzalez JS, 2007, DIABETES CARE, V30, P2222, DOI 10.2337/dc07-0158
   HAMMAN RF, 1992, DIABETES METAB REV, V8, P287, DOI 10.1002/dmr.5610080402
   Hemingway H, 1999, BMJ-BRIT MED J, V318, P1460, DOI 10.1136/bmj.318.7196.1460
   Hippisley-Cox J, 1998, BMJ-BRIT MED J, V316, P1714, DOI 10.1136/bmj.316.7146.1714
   JUEL K, 2008, J PUBLIC HLTH, V1, P111
   Knol MJ, 2006, DIABETOLOGIA, V49, P837, DOI 10.1007/s00125-006-0159-x
   Kumari M, 2004, ARCH INTERN MED, V164, P1873, DOI 10.1001/archinte.164.17.1873
   Macintyre S, 1999, SOC SCI MED, V48, P89, DOI 10.1016/S0277-9536(98)00292-5
   Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9
   NOLENHOEKSEMA S, 1987, PSYCHOL BULL, V101, P259, DOI 10.1037//0033-2909.101.2.259
   Palinkas LA, 2004, DIABETIC MED, V21, P1185, DOI 10.1111/j.1464-5491.2004.01315.x
   Rosmond Roland, 2003, Med Sci Monit, V9, pRA35
   Spiegel K, 2005, J APPL PHYSIOL, V99, P2008, DOI 10.1152/japplphysiol.00660.2005
   Stansfeld SA, 2002, INT J EPIDEMIOL, V31, P248, DOI 10.1093/ije/31.1.248
   *STAT SWED, 1989, SWED SOC CLASS
   *STAT SWED, 2006, HLTH MED CAR 1980 20
   STEFANSSON CG, 2006, SCAND J PUBLIC HEALT, V34, pS87
   Weitoft GR, 2005, J EPIDEMIOL COMMUN H, V59, P794, DOI 10.1136/jech.2005.033076
   Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047
NR 30
TC 113
Z9 115
U1 0
U2 22
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0742-3071
J9 DIABETIC MED
JI Diabetic Med.
PD JUL
PY 2008
VL 25
IS 7
BP 834
EP 842
DI 10.1111/j.1464-5491.2008.02463.x
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 327GB
UT WOS:000257716500012
PM 18513304
DA 2019-01-08
ER

PT J
AU Franks, S
AF Franks, S.
TI Polycystic ovary syndrome in adolescents
SO INTERNATIONAL JOURNAL OF OBESITY
LA English
DT Review
DE anovulation; intrauterine environment; insulin resistance; androgens;
   candidate genes
ID IMPAIRED GLUCOSE-TOLERANCE; PRENATAL ANDROGEN EXCESS; GRANULOSA-LUTEIN
   CELLS; FEMALE RHESUS-MONKEYS; INSULIN-RESISTANCE; ROTTERDAM CRITERIA;
   ANOVULATORY WOMEN; CHROMOSOME 19P13.2; MEDICAL PROGRESS; GENETIC-BASIS
AB Background: Polycystic ovary syndrome (PCOS) is the commonest endocrine disorder in women and typically presents during adolescence. The clinical and biochemical presentation is heterogeneous, but elevated serum concentrations of androgens are the most consistent biochemical abnormality and may be considered to be the hallmark of the syndrome. Many women with PCOS also have insulin resistance and hyperinsulinaemia, which may contribute to the clinical and endocrine abnormalities. The aetiology of PCOS is not clear but studies in the Rhesus monkey suggest that exposure to excess androgen during intrauterine life results in many of the features of human PCOS, including ovarian dysfunction, abnormal LH secretion and insulin resistance.
   Objective: To review the studies from the literature, including those of the author, regarding aetiology, presentation and management of PCOS in adolescents.
   Results and conclusions: We have proposed that PCOS in adolescents arises as a result of a genetically determined disorder of ovarian function that results in hyper-secretion of androgens, possibly during fetal life and also during physiological activation of the hypothalamic-pituitary-ovarian in infancy and at the onset of puberty. There is plentiful evidence for a genetic basis for PCOS (it appears to be a complex endocrine disorder resulting from the effects of a several genes), but environmental factors, notably nutrition, influence the clinical and biochemical phenotype. Obesity unmasks or amplifies symptoms, endocrine and metabolic abnormalities. The increasing incidence of childhood obesity has resulted in an alarming Increase not only in distressing symptoms but also impaired glucose tolerance and even diabetes among adolescent girls with PCOS. The search for PCOS genes in this condition, that is not only heterogeneous but also presents only in women of reproductive age, is not straightforward and has produced few convincing candidates so far. In due course, however, identification of the major susceptibility loci is likely to provide key insight into the aetiology of the syndrome and improve diagnosis and management.
C1 Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Inst Reprod & Dev Biol, London W12 0NN, England.
RP Franks, S (reprint author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Inst Reprod & Dev Biol, Du Cane Rd, London W12 0NN, England.
EM s.franks@imperial.ac.uk
CR Abbott DH, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740001
   ADAMS J, 1986, BRIT MED J, V293, P355, DOI 10.1136/bmj.293.6543.355
   Allen HF, 2005, J PEDIATR ENDOCR MET, V18, P761
   Anderson R, 2006, INT J ANDROL, V29, P286, DOI 10.1111/j.1365-2605.2005.00680.x
   Azziz R, 2006, J CLIN ENDOCR METAB, V91, P781, DOI 10.1210/jc.2005-2153
   Barber TM, 2007, CLIN ENDOCRINOL, V66, P513, DOI 10.1111/j.1365-2265.2007.02764.x
   BARNES RB, 1994, J CLIN ENDOCR METAB, V79, P1328, DOI 10.1210/jc.79.5.1328
   BERGH C, 1991, ANN NY ACAD SCI, V626, P169, DOI 10.1111/j.1749-6632.1991.tb37911.x
   BRIDGES NA, 1993, FERTIL STERIL, V60, P456
   Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543
   CAREY AH, 1993, CLIN ENDOCRINOL, V38, P653, DOI 10.1111/j.1365-2265.1993.tb02150.x
   Clark AM, 1998, HUM REPROD, V13, P1502, DOI 10.1093/humrep/13.6.1502
   CLARK AM, 1995, HUM REPROD, V10, P2705, DOI 10.1093/oxfordjournals.humrep.a135772
   Cole B, 2006, J CLIN ENDOCR METAB, V91, P3654, DOI 10.1210/jc.2006-0641
   CONWAY GS, 1989, CLIN ENDOCRINOL, V30, P459, DOI 10.1111/j.1365-2265.1989.tb00446.x
   CONWAY GS, 1993, CLIN ENDOCRINOL, V39, P623, DOI 10.1111/j.1365-2265.1993.tb02419.x
   Cresswell JL, 1997, LANCET, V350, P1131, DOI 10.1016/S0140-6736(97)06062-5
   Dewailly D, 2006, J CLIN ENDOCR METAB, V91, P3922, DOI 10.1210/jc.2006-1054
   Dumesic DA, 1998, FERTIL STERIL, V70, P94, DOI 10.1016/S0015-0282(98)00098-3
   Dunaif A, 1997, ENDOCR REV, V18, P774, DOI 10.1210/er.18.6.774
   Eagleson CA, 2000, J CLIN ENDOCR METAB, V85, P4047, DOI 10.1210/jc.85.11.4047
   Ehrmann DA, 2005, NEW ENGL J MED, V352, P1223, DOI 10.1056/NEJMra041536
   Ehrmann DA, 1999, DIABETES CARE, V22, P141, DOI 10.2337/diacare.22.1.141
   Eisner JR, 2002, FERTIL STERIL, V77, P167, DOI 10.1016/S0015-0282(01)02947-8
   Eisner JR, 2000, J CLIN ENDOCR METAB, V85, P1206, DOI 10.1210/jc.85.3.1206
   Fedorcsak P, 2000, GYNECOL ENDOCRINOL, V14, P327, DOI 10.3109/09513590009167701
   FERRIMAN D, 1979, CLIN ENDOCRINOL, V11, P291, DOI 10.1111/j.1365-2265.1979.tb03077.x
   Franks S, 2006, J CLIN ENDOCR METAB, V91, P786, DOI 10.1210/jc.2005-2501
   Franks S, 1997, HUM REPROD, V12, P2641, DOI 10.1093/humrep/12.12.2641
   Franks S, 2004, REV ENDOCR METAB DIS, V5, P69, DOI 10.1023/B:REMD.0000016125.05878.96
   Franks S, 2002, BEST PRACT RES CL EN, V16, P263, DOI 10.1053/beem.2002.0203
   FRANKS S, 1995, NEW ENGL J MED, V333, P853, DOI 10.1056/NEJM199509283331307
   FRANKS S, 1989, CLIN ENDOCRINOL, V31, P87, DOI 10.1111/j.1365-2265.1989.tb00457.x
   Franks S, 2000, MOL CELL ENDOCRINOL, V163, P49, DOI 10.1016/S0303-7207(99)00239-7
   FRANKS S, 1978, INT J ANDROL, V29, P286
   Franks S, 2006, REPROD BIOMED ONLINE, V12, P526, DOI 10.1016/S1472-6483(10)61177-7
   Freemark M, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.4.e55
   Gaasenbeek M, 2004, J CLIN ENDOCR METAB, V89, P2408, DOI 10.1210/jc.2003-031640
   Gharani N, 1997, HUM MOL GENET, V6, P397, DOI 10.1093/hmg/6.3.397
   GILLINGSMITH C, 1994, J CLIN ENDOCR METAB, V79, P1158, DOI 10.1210/jc.79.4.1158
   HAGUE WM, 1988, CLIN ENDOCRINOL, V29, P593, DOI 10.1111/j.1365-2265.1988.tb03707.x
   Hannon TS, 2006, PEDIATR RES, V60, P759, DOI 10.1203/01.pdr.0000246097.73031.27
   HOLTE J, 1994, CLIN ENDOCRINOL, V41, P463, DOI 10.1111/j.1365-2265.1994.tb02577.x
   Huber-Buchholz MM, 1999, J CLIN ENDOCR METAB, V84, P1470, DOI 10.1210/jc.84.4.1470
   Ibanez L, 2006, HUM REPROD UPDATE, V12, P243, DOI 10.1093/humupd/dmi054
   Ibanez L, 1998, J CLIN ENDOCR METAB, V83, P3558, DOI 10.1210/jc.83.10.3558
   Ibanez L, 2003, HUM REPROD, V18, P57, DOI 10.1093/humrep/deg056
   KIDDY DS, 1992, CLIN ENDOCRINOL, V36, P105, DOI 10.1111/j.1365-2265.1992.tb02909.x
   KIDDY DS, 1990, CLIN ENDOCRINOL, V32, P213, DOI 10.1111/j.1365-2265.1990.tb00857.x
   Knowler WC, 2002, NEW ENGL J MED, V346, P393
   Koulouri O, 2008, CLIN ENDOCRINOL, V68, P800, DOI 10.1111/j.1365-2265.2007.03105.x
   Laitinen J, 2003, INT J OBESITY, V27, P710, DOI 10.1038/sj.ijo.0802301
   Legro Richard S, 2006, Nat Clin Pract Endocrinol Metab, V2, P188, DOI 10.1038/ncpendmet0115
   Legro RS, 1998, P NATL ACAD SCI USA, V95, P14956, DOI 10.1073/pnas.95.25.14956
   Legro RS, 1999, J CLIN ENDOCR METAB, V84, P165, DOI 10.1210/jc.84.1.165
   Legro RS, 2002, J CLIN ENDOCR METAB, V87, P2128, DOI 10.1210/jc.87.5.2128
   Lin Y, 1997, HUM REPROD, V12, P2469, DOI 10.1093/humrep/12.11.2469
   Luttikhuis HO, 2009, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD001872
   Maciel GAR, 2004, J CLIN ENDOCR METAB, V89, P5321, DOI 10.1210/jc.2004-0643
   Matzuk MM, 2000, MOL CELL ENDOCRINOL, V163, P61, DOI 10.1016/S0303-7207(99)00241-5
   MCCLAMROCK HD, 1992, FERTIL STERIL, V57, P257
   Menke MN, 2007, CLIN OBSTET GYNECOL, V50, P188
   Moran L, 2004, BEST PRACT RES CL OB, V18, P719, DOI 10.1016/j.bpopgyn.2004.05.003
   NAHUM R, 1995, HUM REPROD, V10, P75, DOI 10.1093/humrep/10.1.75
   Nelson VL, 2001, J CLIN ENDOCR METAB, V86, P5925, DOI 10.1210/jc.86.12.5925
   Palmert MR, 2002, J CLIN ENDOCR METAB, V87, P1017, DOI 10.1210/jc.87.3.1017
   Rice S, 2005, HUM REPROD, V20, P373, DOI 10.1093/humrep/deh609
   Rosenfield RL, 2007, J CLIN ENDOCR METAB, V92, P787, DOI 10.1210/jc.2006-2012
   ROTTERDAM, 2003, HUM REPROD, V19, P41
   Simpson J., 1992, POLYCYSTIC OVARY SYN, P59
   SINGH A, 1990, J ENDOCRINOL, V124, pR1, DOI 10.1677/joe.0.124R001
   Stewart DR, 2006, J CLIN ENDOCR METAB, V91, P4112, DOI 10.1210/jc.2006-0951
   Tucci S, 2001, J CLIN ENDOCR METAB, V86, P446, DOI 10.1210/jc.86.1.446
   Urbanek M, 2005, J CLIN ENDOCR METAB, V90, P6623, DOI 10.1210/jc.2005-0622
   Urbanek M, 1999, P NATL ACAD SCI USA, V96, P8573, DOI 10.1073/pnas.96.15.8573
   Vink JM, 2006, J CLIN ENDOCR METAB, V91, P2100, DOI 10.1210/jc.2005-1494
   Webber LJ, 2007, J CLIN ENDOCR METAB, V92, P1975, DOI 10.1210/jc.2006-1422
   Webber LJ, 2003, LANCET, V362, P1017, DOI 10.1016/S0140-6736(03)14410-8
   Welt CK, 2006, J CLIN ENDOCR METAB, V91, P4842, DOI 10.1210/jc.2006-1327
   Willis D, 1996, J CLIN ENDOCR METAB, V81, P302, DOI 10.1210/jc.81.1.302
   WILLIS D, 1995, J CLIN ENDOCR METAB, V80, P3788, DOI 10.1210/jc.80.12.3788
   Willis DS, 1998, J CLIN ENDOCR METAB, V83, P3984, DOI 10.1210/jc.83.11.3984
   ZAWADZKI JK, 1992, POLYCYSTIC OVARY SYN, P377
   Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364
   1999, NAT GENET, V22, P1
NR 85
TC 91
Z9 95
U1 0
U2 8
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0307-0565
EI 1476-5497
J9 INT J OBESITY
JI Int. J. Obes.
PD JUL
PY 2008
VL 32
IS 7
BP 1035
EP 1041
DI 10.1038/ijo.2008.61
PG 7
WC Endocrinology & Metabolism; Nutrition & Dietetics
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 325SA
UT WOS:000257607400001
PM 18458678
OA Bronze
DA 2019-01-08
ER

PT J
AU Pibernik-Okanovic, M
   Begic, D
   Peros, K
   Szabo, S
   Metelko, Z
AF Pibernik-Okanovic, Mirjana
   Begic, Drazen
   Peros, Kristijan
   Szabo, Silvija
   Metelko, Zeljko
TI Psychosocial factors contributing to persistent depressive symptoms in
   type 2 diabetic patients: a Croatian survey from the European Depression
   in Diabetes Research Consortium
SO JOURNAL OF DIABETES AND ITS COMPLICATIONS
LA English
DT Article
DE depressive symptoms; type 2 diabetes; diabetes-related distress; quality
   of life; persistence of depression
ID ADULTS; METAANALYSIS; PREVALENCE; MELLITUS; ANXIETY
AB Objective: The study was aimed at exploring a 1-year course of depression in persons with type 2 diabetes and analysing demographic, disease-related, and psychological variables that may predict persistent depressive symptoms. Patients and methods: One hundred patients from a randomly selected sample of 470 outpatients were found to be suffering from severe depressive symptoms. They were followed and re-examined for depression after I year. Baseline depression was assessed by the Center for Epidemiologic Studies-Depression scale (CES-D) and a face-to-face diagnostic interview relying on the DSM-IV. Nonparametric tests for between-group differences were used to compare patients who recovered from depression with those who still suffered from severe depressive symptoms. Multiple logistic regression was used to determine predictors of depression persistence. Results: Seventy-nine of 100 patients with baseline depression scores indicative of severe depression were reached at I-year follow-up. Among them, 53% were shown to have improved depressive symptoms to CES-D <16, while 47% continued to suffer from severe depressive disturbances (CES-D >= 16). Logistic regression analysis indicated that psychosocial variables predicted persistently elevated depressive symptoms better than demographic and diabetes-related ones. Clinical depression at baseline (OR=3.8, CI 1.31-10.98, P=.01), diabetes-related distress (OR=3.3, CI 1.01-10.98, P=.05), and social and physical quality-of-life aspects (OR=0.92, CI 0.88-0.97, P=.0005 and OR=0.94, CI 0.90-0.98, P=.002, respectively) were shown to be independent predictors of 1-year depression outcomes. Conclusions: Severity of baseline depression, a degree to which depression disrupted the patients' quality of life, and concomitant emotional problems related to diabetes were shown to be associated with persistently elevated depressive symptoms. (C) 2008 Elsevier Inc. All rights reserved.
C1 [Pibernik-Okanovic, Mirjana; Peros, Kristijan; Szabo, Silvija; Metelko, Zeljko] Vuk Vrhovac Inst, Zagreb 10000, Croatia.
   [Begic, Drazen] Rebro Univ Hosp, Psychiat Clin, Zagreb, Croatia.
RP Pibernik-Okanovic, M (reprint author), Vuk Vrhovac Inst, Dugi Dol 4A, Zagreb 10000, Croatia.
EM pibernik@idb.hr
CR Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   Egede LE, 2003, DIABETES CARE, V26, P104, DOI 10.2337/diacare.26.1.104
   FIRST MB, 2000, STRUKURIRANI KLIN IN
   Fisher L, 2001, DIABETES CARE, V24, P1751, DOI 10.2337/diacare.24.10.1751
   GREENBERG PE, 1993, J CLIN PSYCHIAT, V54, P405
   HERMANNS N, 2004, DIABETES S1, V52, pA16
   Keller MB, 2004, J CLIN PSYCHIAT, V65, P53
   Knol MJ, 2006, DIABETOLOGIA, V49, P837, DOI 10.1007/s00125-006-0159-x
   Kohen D, 1998, QUAL LIFE RES, V7, P197, DOI 10.1023/A:1008817812520
   Lustman PJ, 1998, GEN HOSP PSYCHIAT, V20, P302, DOI 10.1016/S0163-8343(98)00039-5
   LUSTMAN PJ, 1988, DIABETES CARE, V11, P605, DOI 10.2337/diacare.11.8.605
   Lustman PJ, 1997, GEN HOSP PSYCHIAT, V19, P138, DOI 10.1016/S0163-8343(96)00170-3
   LUSTMAN PJ, 1992, DIABETES CARE, V15, P1631, DOI 10.2337/diacare.15.11.1631
   Penninx BWJH, 1998, JAMA-J AM MED ASSOC, V279, P1720, DOI 10.1001/jama.279.21.1720
   Peyrot M, 1999, DIABETES CARE, V22, P448, DOI 10.2337/diacare.22.3.448
   Peyrot M, 1997, DIABETES CARE, V20, P585, DOI 10.2337/diacare.20.4.585
   Pibernik-Okanovic M, 2005, DIABETIC MED, V22, P942, DOI 10.1111/j.1464-5491.2005.01528.x
   POUWER F, 2005, DIABETES RES CLIN PR, V70, P160
   Radloff LS, 1986, COMMUNITY SURVEYS PS, V4, P177
   Rubin Richard R, 2004, Curr Diab Rep, V4, P119, DOI 10.1007/s11892-004-0067-8
   Talbot F, 1999, HEALTH PSYCHOL, V18, P537
   Talbot F, 2000, DIABETES CARE, V23, P1556, DOI 10.2337/diacare.23.10.1556
   Vucic M., 1999, Clinical Chemistry and Laboratory Medicine, V37, pS199
   Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
NR 27
TC 16
Z9 18
U1 1
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1056-8727
J9 J DIABETES COMPLICAT
JI J. Diabetes Complications
PD JUL-AUG
PY 2008
VL 22
IS 4
BP 246
EP 253
DI 10.1016/j.jdiacomp.2007.03.002
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 329LD
UT WOS:000257868200004
PM 18413168
DA 2019-01-08
ER

PT J
AU Bertalan, R
   Patocs, A
   Vasarhelyi, B
   Treszl, A
   Varga, I
   Szabo, E
   Tamas, J
   Toke, J
   Boyle, B
   Nobilis, A
   Rigo, J
   Racz, K
AF Bertalan, Rita
   Patocs, Attila
   Vasarhelyi, Barna
   Treszl, Andras
   Varga, Ibolya
   Szabo, Eva
   Tamas, Judit
   Toke, Judit
   Boyle, Belema
   Nobilis, Andras
   Rigo, Janos, Jr.
   Racz, Karoly
TI Association between birth weight in preterm neonates and the BclI
   polymorphism of the glucocorticoid receptor gene
SO JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
LA English
DT Article
DE glucocorticoid receptor gene; BclI polymorphism; birth weight; preterm
   neonates; perinatal morbidity; maternal dexamethasone treatment
ID FRAGMENT-LENGTH-POLYMORPHISM; N363S VARIANT; ANTENATAL CORTICOSTEROIDS;
   DIABETES-MELLITUS; IN-VIVO; OBESITY; INFANTS; GROWTH; SENSITIVITY;
   DISEASE
AB Endogenous and exogenous glucocorticoids influence fetal growth and development, and maternal administration of synthetic glucocorticoids may decrease the risk of perinatal morbidity including lung disease in preterm neonates. Because polymorphisms of the glucocorticoid receptor gene are known to influence the sensitivity to glucocorticoids, in the present study we examined whether any associations could exist among the BclI, N363S and ER22/23EK polymorphisms of the glucocorticoid receptor gene and gestational age, birth weight and/or perinatal morbidity of 125 preterm neonates born at 28-35 weeks' gestation with (n = 57) or without maternal dexamethasone treatment (n = 68). The prevalence of the three polymorphisms in the whole group of preterm infants was similar to that reported in healthy adult Hungarian population. However, we found that the BclI polymorphism significantly associated with higher birth weight adjusted for the gestational age (p = 0.004, ANOVA analysis). None of the three polymorphisms showed an association with perinatal morbidities, including necrotizing enterocolitis, intraventricular hemorrhagia, patent ductus arteriosus, respiratory distress syndrome, bronchopulmonary dysplasia and sepsis in the two groups of preterm neonates with and without maternal dexamethasone treatment. These results suggest that the BclI polymorphism of the glucocorticoid receptor gene may have an impact on gestational age-adjusted birth weight, but it does not influence perinatal morbidities of preterm neonates. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Bertalan, Rita; Toke, Judit; Boyle, Belema; Racz, Karoly] Semmelweis Univ, Fac Med, Dept Med 2, H-1088 Budapest, Hungary.
   [Patocs, Attila; Varga, Ibolya] Hungarian Acad Sci, Mol Med Res Grp, Budapest, Hungary.
   [Vasarhelyi, Barna; Treszl, Andras] Hungarian Acad Sci, Res Lab Pediat & Nephrol, H-1083 Budapest, Hungary.
   [Szabo, Eva; Tamas, Judit] Csolnoky F Cty Hosp, H-8200 Veszprem, Hungary.
   [Nobilis, Andras] Semmelweis Univ, Dept Obstet & Gynecol 2, H-1082 Budapest, Hungary.
   [Rigo, Janos, Jr.] Semmelweis Univ, Fac Med, Dept Obstet & Gynecol 1, H-1088 Budapest, Hungary.
RP Bertalan, R (reprint author), Semmelweis Univ, Fac Med, Dept Med 2, Szentkiralyi 46, H-1088 Budapest, Hungary.
EM ritabertalan@gmail.com
FU OTKA [T046086]; GVOP [3.1.12004/300]
FX This study was supported by OTKA T046086 and GVOP 3.1.12004/300 grants.
CR Bloom SL, 2001, OBSTET GYNECOL, V97, P485, DOI 10.1016/S0029-7844(00)01206-0
   Bolt RJ, 2002, J CLIN ENDOCR METAB, V87, P1194, DOI 10.1210/jc.87.3.1194
   Buemann B, 1997, OBES RES, V5, P186, DOI 10.1002/j.1550-8528.1997.tb00292.x
   Challis JRG, 2001, MOL CELL ENDOCRINOL, V185, P135, DOI 10.1016/S0303-7207(01)00624-4
   Challis JRG, 2002, REPRODUCTION, V124, P1
   Derzbach L, 2006, ACTA PAEDIATR, V95, P1213, DOI 10.1080/08035250600575404
   Dobson MG, 2001, J CLIN ENDOCR METAB, V86, P2270, DOI 10.1210/jc.86.5.2270
   Elimian A, 2003, OBSTET GYNECOL, V102, P352, DOI 10.1016/S0029-7844(03)00485-X
   Gergics P, 2006, J STEROID BIOCHEM, V100, P161, DOI 10.1016/j.jsbmb.2006.04.004
   Howie RN, 1982, LUNG DEV BIOL CLIN P, P255
   Huizenga NATM, 1998, J CLIN ENDOCR METAB, V83, P144, DOI 10.1210/jc.83.1.144
   Ikegami M, 1997, AM J RESP CRIT CARE, V156, P178, DOI 10.1164/ajrccm.156.1.9612036
   Kajantie E, 2002, CLIN ENDOCRINOL, V57, P635, DOI 10.1046/j.1365-2265.2002.01659.x
   Lawrence C, 1989, Acta Paediatr Scand Suppl, V350, P55
   LIGGINS GC, 1972, PEDIATRICS, V50, P515
   Liko I, 2004, CURR MED CHEM, V11, P3229, DOI 10.2174/0929867043363749
   Lin RCY, 2003, OBES RES, V11, P802, DOI 10.1038/oby.2003.111
   Lin RCY, 2003, HYPERTENSION, V41, P404, DOI 10.1161/01.HYP.0000055342.40301.DC
   Luczay A, 2006, EUR J ENDOCRINOL, V154, P859, DOI 10.1530/eje.1.02162
   Lye SJ, 1998, FETAL MATERNAL MED R, V10, P121, DOI DOI 10.1017/S096553959800031X)
   Majnik J, 2004, J STEROID BIOCHEM, V92, P465, DOI 10.1016/j.jsbmb.2004.08.005
   Nobilis A, 2006, ACTA PAEDIATR, V95, P747, DOI 10.1080/08035250600453256
   Panarelli M, 1998, J CLIN ENDOCR METAB, V83, P1846, DOI 10.1210/jc.83.6.1846
   Rautanen A, 2006, J CLIN ENDOCR METAB, V91, P4544, DOI 10.1210/jc.2006-1065
   Rosmond R, 2000, OBES RES, V8, P211, DOI 10.1038/oby.2000.24
   Rosmond R, 2003, OBES RES, V11, P1606, DOI 10.1038/oby.2003.213
   Rosmond R, 2002, OBES RES, V10, P1078, DOI 10.1038/oby.2002.146
   Roussel R, 2003, CLIN ENDOCRINOL, V59, P237, DOI 10.1046/j.1365-2265.2003.01831.x
   Russcher H, 2005, J CLIN ENDOCR METAB, V90, P5804, DOI 10.1210/jc.2005-0646
   Smith GCS, 1998, NEW ENGL J MED, V339, P1817, DOI 10.1056/NEJM199812173392504
   SZALAI A, 1996, EUR J PEDIATR, V155, P256
   TABOR BL, 1991, AM J OBSTET GYNECOL, V164, P675, DOI 10.1016/S0002-9378(11)80045-1
   Treszl A, 2001, ACTA PAEDIATR, V90, P1182, DOI 10.1080/080352501317061611
   van Rossum EFC, 2002, DIABETES, V51, P3128, DOI 10.2337/diabetes.51.10.3128
   van Rossum EFC, 2005, TRENDS ENDOCRIN MET, V16, P445, DOI 10.1016/j.tem.2005.10.009
   van Rossum EFC, 2004, RECENT PROG HORM RES, V59, P333, DOI 10.1210/rp.59.1.333
   WATTERBERG KL, 1995, PEDIATRICS, V95, P120
   Watterberg Kristi L, 2004, Semin Neonatol, V9, P13, DOI 10.1016/j.siny.2003.08.003
   WEAVER JU, 1992, J MOL ENDOCRINOL, V9, P295, DOI 10.1677/jme.0.0090295
   Wickelgren I, 2004, SCIENCE, V304, P666, DOI 10.1126/science.304.5671.666
   WU FF, 1993, FETAL DIAGN THER, V8, P89, DOI 10.1159/000263754
NR 41
TC 12
Z9 13
U1 0
U2 9
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-0760
J9 J STEROID BIOCHEM
JI J. Steroid Biochem. Mol. Biol.
PD JUL
PY 2008
VL 111
IS 1-2
BP 91
EP 94
DI 10.1016/j.jsbmb.2008.05.002
PG 4
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 342NM
UT WOS:000258790800015
PM 18595687
DA 2019-01-08
ER

PT J
AU Akca, AT
   Cinar, S
AF Akca, Asli Talaz
   Cinar, Sezgi
TI Comparison of psychosocial adjustment in people with diabetes with and
   without diabetic foot ulceration
SO AUSTRALIAN JOURNAL OF ADVANCED NURSING
LA English
DT Article
DE Type 1 diabetes mellitus; type 2 diabetes mellitus; diabetic foot
   ulceration; psychosocial adjustment to illness; metabolic control
ID QUALITY-OF-LIFE; SELF-MANAGEMENT; METABOLIC-CONTROL; GLYCEMIC CONTROL;
   RISK; ADAPTATION; THERAPY; COMPLICATIONS; DEPRESSION; MELLITUS
AB Objective
   To determine whether psychosocial adjustment to illness differs in people with diabetes between those who have or do not have diabetic foot ulceration.
   Design
   The study employed as a cross-sectional sample survey design.
   Setting
   The setting for the study was a training hospital, a marine and undersea medicine outpatient clinic and an endocrinology outpatient clinic.
   Subjects
   Two hundred participants with a diagnosis, according to World Health Organization criteria, of type 1 or type 2 diabetes for at least one year were enrolled in the study. 100 participants receiving hyperbaric oxygen therapy had diabetic foot ulceration (DFU) and 100 participants had diabetes without DFU.
   Outcome measures
   Data were collected using a demographic data sheet and analysed using the Psychosocial Adjustment to Illness Scale-Self Report (PAIS-SR).
   Results
   Advanced age, low education levels, long diabetes duration, poor metabolic control and not exercising may be risk factors for DFU. Total PAIS-SR score was 61.01 +/- 21.42 (poor adjustment) in participants with DFU, and 43 +/- 17.13 (moderate adjustment) in participants without DFU. Participants without DFU had fewer problems in the domain of health care orientation, vocational environment, sexual relationships, social environment and psychological distress than participants with DFU. In participants with DFU; poorer psychosocial adjustment was associated with poorer metabolic control, lower education status, not exercising and retirement. In participants without DFU, women had better psychosocial adjustment than men. Also, participants exercising had better psychosocial adjustment than participants not exercising.
   Conclusion
   The participants without DFU had adjusted better to their illness than participants with DFU. The nurse should evaluate and support the patient for psychosocial adjustment to diabetes to prevent chronic complication such as DFU.
C1 [Akca, Asli Talaz] Haydarpasa Training Hosp, Marine & Undersea Dept, Gulhane Mil Med Fac, Istanbul, Turkey.
   [Cinar, Sezgi] Marmara Univ, Collage Nursing, Istanbul, Turkey.
RP Akca, AT (reprint author), Haydarpasa Training Hosp, Marine & Undersea Dept, Gulhane Mil Med Fac, Istanbul, Turkey.
EM sezcinar@hotmail.com
CR ADAYLAR M, 1995, THESIS ISTANBUL U I
   ANDERSON RM, 1995, DIABETES CARE, V18, P943, DOI 10.2337/diacare.18.7.943
   Boyko EJ, 1999, DIABETES CARE, V22, P1036, DOI 10.2337/diacare.22.7.1036
   CLEMENT S, 1995, DIABETES CARE, V18, P1204, DOI 10.2337/diacare.18.8.1204
   Courts N F, 2000, Clin Nurs Res, V9, P177
   DEROGATIS L, 1990, PAIS SR PAIS SR ADM
   *DIAB CONTR COMPL, 1993, NEW ENGL J MED, V329, P977, DOI DOI 10.1056/NEJM199309303291401
   Drory Y, 1999, ARCH PHYS MED REHAB, V80, P811, DOI 10.1016/S0003-9993(99)90232-0
   Duncan GE, 2003, DIABETES CARE, V26, P557, DOI 10.2337/diacare.26.3.557
   Dunning T, 2005, AUST J ADV NURS, V23, P7
   International Diabetes Federation, 2007, DIAB PREV
   Inzucchi SE, 2002, JAMA-J AM MED ASSOC, V287, P360, DOI 10.1001/jama.287.3.360
   Lange C, 2003, ORTHOPADE, V32, P241, DOI 10.1007/s00132-003-0451-0
   Lernmark B, 1999, DIABETIC MED, V16, P14, DOI 10.1046/j.1464-5491.1999.00008.x
   Leymarie F, 2005, DIABETES METAB, V31, P603, DOI 10.1016/S1262-3636(07)70238-0
   LUTMAN P, 1999, ANN BEHAV MED, V21, P158
   LUTMAN P, 1998, ANN INTERN MED, V129, P613
   MALIK R, 2005, VASCULAR COMPLICATIO
   Michael S R, 1996, J Holist Nurs, V14, P251, DOI 10.1177/089801019601400307
   MILLER KL, 1994, DIABETES CARE, V17, P1495, DOI 10.2337/diacare.17.12.1495
   Peyrot M, 1999, J HEALTH SOC BEHAV, V40, P141, DOI 10.2307/2676370
   Pollock S E, 1993, Nurs Sci Q, V6, P86, DOI 10.1177/089431849300600208
   POLLOCK SE, 1990, NURS RES, V39, P218
   Rapley P, 1990, Aust J Adv Nurs, V8, P41
   Satman I, 2002, DIABETES CARE, V25, P1551, DOI 10.2337/diacare.25.9.1551
   SCOTT A, 2005, VASCULAR COMPLICATIO
   Steed DL, 1998, AM J SURG, V176, p20S, DOI 10.1016/S0002-9610(98)00178-0
   Swain SM, 1996, J CLIN ONCOL, V14, P1565, DOI 10.1200/JCO.1996.14.5.1565
   Tanyi Ruth A, 2003, Clin Nurs Res, V12, P229, DOI 10.1177/1054773803253163
   Trief PM, 2001, DIABETES CARE, V24, P1384, DOI 10.2337/diacare.24.8.1384
   Turner RC, 1998, LANCET, V352, P837
   Whittemore R, 2005, J CLIN NURS, V14, P195, DOI 10.1111/j.1365-2702.2004.00937.x
   Willoughby DF, 2000, J ADV NURS, V32, P1422, DOI 10.1046/j.1365-2648.2000.01620.x
   WULSIN LR, 1993, DIABETES CARE, V16, P1061, DOI 10.2337/diacare.16.8.1061
   Zimmermann PR, 2001, CLIN NEPHROL, V56, P387
NR 35
TC 4
Z9 4
U1 0
U2 7
PU AUSTRALIAN NURSING FEDERATION
PI KINGSTON
PA PO BOX 4239, KINGSTON, ACT 2604, AUSTRALIA
SN 0813-0531
EI 1447-4328
J9 AUST J ADV NURS
JI Aust. J. Adv. Nurs.
PD JUN-AUG
PY 2008
VL 25
IS 4
BP 87
EP 96
PG 10
WC Nursing
SC Nursing
GA 453QG
UT WOS:000266625400012
DA 2019-01-08
ER

PT J
AU Sturt, JA
   Whitlock, S
   Fox, C
   Hearnshaw, H
   Farmer, AJ
   Wakelin, M
   Eldridge, S
   Griffiths, F
   Dale, J
AF Sturt, J. A.
   Whitlock, S.
   Fox, C.
   Hearnshaw, H.
   Farmer, A. J.
   Wakelin, M.
   Eldridge, S.
   Griffiths, F.
   Dale, J.
TI Effects of the Diabetes Manual 1 : 1 structured education in primary
   care
SO DIABETIC MEDICINE
LA English
DT Article
DE complex intervention; diabetes; patient education; primary care
ID RANDOMIZED CONTROLLED-TRIAL; PHYSICAL-ACTIVITY; PROBLEM AREAS;
   REHABILITATION; INTERVENTION; ADJUSTMENT; MANAGEMENT; DISTRESS;
   EFFICACY; PROGRAM
AB Aims To determine the effects of the Diabetes Manual on glycaemic control, diabetes-related distress and confidence to self-care of patients with Type 2 diabetes.
   Methods A cluster randomized, controlled trial of an intervention group vs. a 6-month delayed-intervention control group with a nested qualitative study. Participants were 48 urban general practices in the West Midlands, UK, with high population deprivation levels and 245 adults with Type 2 diabetes with a mean age of 62 years recruited pre-randomization. The Diabetes Manual is 1:1 structured education designed for delivery by practice nurses. Measured outcomes were HbA(1c), cardiovascular risk factors, diabetes-related distress measured by the Problem Areas in Diabetes Scale and confidence to self-care measured by the Diabetes Management Self-Efficacy Scale. Outcomes were assessed at baseline and 26 weeks.
   Results There was no significant difference in HbA(1c) between the intervention group and the control group [difference -0.08%, 95% confidence interval (CI) -0.28, 0.11]. Diabetes-related distress scores were lower in the intervention group compared with the control group (difference -4.5, 95% CI -8.1, -1.0). Confidence to self-care Scores were 11.2 points higher (95% CI 4.4, 18.0) in the intervention group compared with the control group. The patient response rate was 18.5%.
   Conclusions In this population, the Diabetes Manual achieved a small improvement in patient diabetes-related distress and confidence to self-care over 26 weeks, without a change in glycaemic control. Further study is needed to optimize the intervention and characterize those for whom it is more clinically and psychologically effective to support its use in primary care.
C1 [Sturt, J. A.; Whitlock, S.; Hearnshaw, H.; Eldridge, S.; Griffiths, F.; Dale, J.] Warwick Med Sch, Warwick, England.
   [Fox, C.] Newman Univ Coll, Birmingham, W Midlands, England.
   [Farmer, A. J.] Univ Oxford, Oxford, England.
   [Wakelin, M.] Queen Mary Univ London, London, England.
RP Sturt, JA (reprint author), Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England.
EM jackie.sturt@warwick.ac.uk
OI Dale, Jeremy/0000-0001-9256-3553
FU Department of Health; National Institute for Health Research [CSA03/003]
CR Altman DG, 2005, BRIT MED J, V330, P843, DOI 10.1136/bmj.330.7495.843
   BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191
   BARKER D, 2005, NATL DATABASE PRIMAR
   COHEN J, 1985, STAT ANAL BEHAV SCI
   DAFNE Study Group, 2002, BMJ-BRIT MED J, V325, DOI DOI 10.1136/BMJ.325.7367.746
   Dalal HM, 2003, BRIT MED J, V326, P481, DOI 10.1136/bmj.326.7387.481
   Deakin TA, 2006, DIABETIC MED, V23, P944, DOI 10.1111/j.1464-5491.2006.01906.x
   Department of Health, 2001, EXP PAT NEW APPR CHR
   Department of Health Diabetes UK, 2005, STRUCT PAT ED DIAB R
   Di Loreto C, 2003, DIABETES CARE, V26, P404, DOI 10.2337/diacare.26.2.404
   GILLIS AJ, 1993, J ADV NURS, V18, P345, DOI 10.1046/j.1365-2648.1993.18030345.x
   Hardeman W, 2008, PSYCHOL HEALTH, V23, P11, DOI 10.1080/08870440701615948
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   LEWIN B, 1992, LANCET, V339, P1036, DOI 10.1016/0140-6736(92)90547-G
   *MED RES COUNC, 2000, MED RES COUNC FRAM D
   *NAT I CLIN EXC, 2003, GUID US PAT ED MOD D
   *NHS, NHS HLTH SOC CAR INF
   Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Sturt J., 2003, DIABETIC MED S2, V20, P78
   STURT J, 2005, J DIABETES NURSING, V9, P145
   STURT J, 2006, INT J BEHAV MED, V13, P135
   Sturt J, 2005, PRIM HEALTH CARE RES, V6, P291
   Sturt Jackie, 2006, BMC Fam Pract, V7, P45, DOI 10.1186/1471-2296-7-45
   Sturt Jackie, 2006, BMC Fam Pract, V7, P70, DOI 10.1186/1471-2296-7-70
   van der Bijl J, 1999, J ADV NURS, V30, P352, DOI 10.1046/j.1365-2648.1999.01077.x
   Welch G, 2003, DIABETIC MED, V20, P69, DOI 10.1046/j.1464-5491.2003.00832.x
   Williams K, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2548-4-48
NR 29
TC 36
Z9 39
U1 1
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD JUN
PY 2008
VL 25
IS 6
BP 722
EP 731
DI 10.1111/j.1464-5491.2008.02451.x
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 308GN
UT WOS:000256376400013
PM 18435777
DA 2019-01-08
ER

PT J
AU El Achhab, Y
   Nejjari, C
   Chikri, M
   Lyoussi, B
AF El Achhab, Youness
   Nejjari, Chakib
   Chikri, Mohamed
   Lyoussi, Badiaa
TI Disease-specific health-related quality of life instruments among adults
   diabetic: A systematic review
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Review
DE health-related quality of life; diabetes mellitus; review
ID IMPACT MEASUREMENT SCALES; PSYCHOMETRIC EVALUATION; TREATMENT
   SATISFACTION; PROBLEM AREAS; OUTCOME MEASURES; GLYCEMIC CONTROL;
   SELF-EFFICACY; QUESTIONNAIRE; VALIDATION; VALIDITY
AB This paper provides a systematic review on health-related quality of life (HRQoL) measures in diabetic patients. For each included study, a description of the measure and its psychometric findings is provided. To evaluate these measures, a databases search (Medline, Scopus and Proqolid) was undertaken to identify relevant publications. Instruments were assessed according to predefined inclusion and exclusion criteria.
   Sixteen instruments met the inclusion criteria among 1049 references produced: appraisal of diabetes scale (ADS), audit of diabetes-dependent quality of life (ADDQoL), diabetes-39 (D-39), diabetes care profile (DCP), diabetes distress scale (DDS), diabetes health profile (DHP1, DHP-18), diabetes impact measurement scales (DIMS), diabetes quality of life measure (DQOL), diabetes quality of life clinical trial questionnaire-revised (DQLCTQ-R), diabetes-specific quality of life scale (DSQOLS), elderly diabetes burden scale (EDBS), insulin delivery system rating questionnaire (IDSRQ), quality of life with diabetes questionnaire (LQD), problem areas in diabetes scale (PAID), questionnaire on stress in diabetic patients-revised (QSD-R) and well-being enquiry for diabetics (WED). All those instruments have been developed in northern countries. The shortest instrument (ADS) has seven items and the longest (IDSRQ) has 67 items. ADDQoL was widely translated followed by DHP and PAID. Only authors of ADS and DIMS have not involved patients in the construction of instruments. The authors of instruments: ADS, ADDQoL, DHP, D-39, and PAID reported the item-total correlation which is ranged from 0.28 to 0.84. The ADS, DQOL, EDBS, IDSRQ, LQD, PAID, QSD-R, and WED have been assessed for test-retest reliability which varies between 0.27 and 0.99. The DQLCTQ-R, DQOL and IDSRQ were not subjected to factor analysis. Responsiveness was assessed in PAID with effect sizes and ranged from 0.32 to 0.65 for interventions. Four domains were responsive to clinical change in metabolic control in DQLCTQ-R. The other instruments were not been formally assessed for responsiveness.
   This review found evidence that the instruments: ADDQoL, D-39, DDS, DHP1/18, DSQOLS, EDBS and QSD-R had adequate psychometric properties. For future research, responsiveness should be a priority and further study is also required to examine the effect of ethnicity and to determine the validity of these scales in developing countries. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
C1 [El Achhab, Youness; Nejjari, Chakib] Fac Med & Pharm Fez, Lab Epidemiol Clin Res & Community Hlth, Fes 30000, Morocco.
   [El Achhab, Youness; Chikri, Mohamed] Fac Med & Pharm Fez, Biochem & Mol Biol Lab, Fes 30000, Morocco.
   [El Achhab, Youness; Lyoussi, Badiaa] Fac Sci Dhar El Mahraz, UFR Physiopathol & Pharmacol, Fes, Morocco.
RP El Achhab, Y (reprint author), Fac Med & Pharm Fez, Lab Epidemiol Clin Res & Community Hlth, BP 1893,Km 2-2 Route Sidi Harazem, Fes 30000, Morocco.
EM youness_elachhab@yahoo.fr
CR Aaronson N, 2002, QUAL LIFE RES, V11, P193
   Anderson RM, 1998, DIABETES CARE, V21, P1403, DOI 10.2337/diacare.21.9.1403
   Anderson RM, 2000, DIABETES CARE, V23, P739, DOI 10.2337/diacare.23.6.739
   Anderson RT, 2004, CLIN THER, V26, P565, DOI 10.1016/S0149-2918(04)90059-8
   Araki A, 1995, Nihon Ronen Igakkai Zasshi, V32, P786
   Araki A, 2003, GERIATR GERONTOL INT, V3, P212
   Barr J T, 1995, J Allied Health, V24, P13
   Bott U, 2003, DIABETIC MED, V20, P626, DOI 10.1046/j.1464-5491.2003.01010.x
   Bott U, 1998, DIABETES CARE, V21, P757, DOI 10.2337/diacare.21.5.757
   Boyer JG, 1997, MED CARE, V35, P440, DOI 10.1097/00005650-199705000-00003
   BRADLEY C, 1990, DIABETIC MED, V7, P445, DOI 10.1111/j.1464-5491.1990.tb01421.x
   Bradley C, 2002, DIABETES METAB RES, V18, pS64, DOI 10.1002/dmrr.279
   Bradley C, 1999, QUAL LIFE RES, V8, P79, DOI 10.1023/A:1026485130100
   CAREY MP, 1991, J BEHAV MED, V14, P43, DOI 10.1007/BF00844767
   Cheng AY, 1999, DIABETES RES CLIN PR, V46, P259, DOI 10.1016/S0168-8227(99)00091-1
   Cook DA, 2006, AM J MED, V119, p166e7
   Costa Filipa Alves, 2006, Pharm Pract (Granada), V4, P123
   COX DJ, 1987, DIABETES CARE, V10, P617, DOI 10.2337/diacare.10.5.617
   Cunningham V, 2005, EVAL HEALTH PROF, V28, P447, DOI 10.1177/0163278705281077
   DAFNE Study Group, 2002, BMJ-BRIT MED J, V325, DOI DOI 10.1136/BMJ.325.7367.746
   DCCT Res Grp, 1988, DIABETES CARE, V11, P725
   DUNN SM, 1986, DIABETES CARE, V9, P480, DOI 10.2337/diacare.9.5.480
   DURAN G, 1995, PSYCHOL REP, V76, P515, DOI 10.2466/pr0.1995.76.2.515
   Fitzgerald JT, 1996, EVAL HEALTH PROF, V19, P208, DOI 10.1177/016327879601900205
   Fitzgerald JT, 2000, DIABETES CARE, V23, P313, DOI 10.2337/diacare.23.3.313
   Fitzpatrick R, 1998, Health Technol Assess, V2, P1
   Garratt AM, 2002, DIABETIC MED, V19, P1, DOI 10.1046/j.1464-5491.2002.00650.x
   GILDEN JL, 1992, J AM GERIATR SOC, V40, P147, DOI 10.1111/j.1532-5415.1992.tb01935.x
   GROOTENHUIS PA, 1994, DIABETIC MED, V11, P253, DOI 10.1111/j.1464-5491.1994.tb00268.x
   GUYATT GH, 1993, ANN INTERN MED, V118, P622, DOI 10.7326/0003-4819-118-8-199304150-00009
   HAMMOND GS, 1992, DIABETES CARE, V15, P469, DOI 10.2337/diacare.15.4.469
   HENDERSON MJ, 1990, PRACT DIABETES, V7, P206
   Herschbach P, 1997, HEALTH PSYCHOL, V16, P171, DOI 10.1037/0278-6133.16.2.171
   Hirsch A, 2000, QUAL LIFE RES, V9, P207, DOI 10.1023/A:1008959810698
   JACOBSON AM, 1994, DIABETES CARE, V17, P267, DOI 10.2337/diacare.17.4.267
   JACOBSON AM, 1997, SEMIN CLIN NEUROPSYC, V2, P82
   Kotsanos JG, 1997, DIABETES CARE, V20, P948, DOI 10.2337/diacare.20.6.948
   Li TC, 2006, QUAL LIFE RES, V15, P1613, DOI 10.1007/s11136-006-0024-x
   Mannucci E, 1996, DIABETES NUTR METAB, V9, P89
   *MAP RES I, INSTR PATH DIS
   MCCOLL E, 1995, SOC SCI MED, V41, P1339, DOI 10.1016/0277-9536(95)00120-V
   *MDRTC, DIAB HIST
   Meadows K, 1996, QUAL LIFE RES, V5, P242, DOI 10.1007/BF00434746
   Meadows KA, 2000, DIABETIC MED, V17, P572, DOI 10.1046/j.1464-5491.2000.00322.x
   Mollema ED, 2000, DIABETES CARE, V23, P765, DOI 10.2337/diacare.23.6.765
   Norris Susan L, 2005, Curr Diab Rep, V5, P124, DOI 10.1007/s11892-005-0039-7
   Peyrot M, 2005, DIABETES CARE, V28, P53, DOI 10.2337/diacare.28.1.53
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   RUBIN RR, 1999, DIABETES METAB REV, V5, P205
   Shen W, 1999, MED CARE, V37, pAS45, DOI 10.1097/00005650-199904001-00008
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Streiner DL, 1995, HLTH MEASUREMENT SCA
   Talbot F, 1997, J BEHAV MED, V20, P291, DOI 10.1023/A:1025508928696
   Taylor EP, 2005, DIABETES-METAB RES, V21, P264, DOI 10.1002/dmrr.524
   Trief PM, 1998, DIABETES CARE, V21, P241, DOI 10.2337/diacare.21.2.241
   Trief PM, 1999, DIABETES CARE, V22, P569, DOI 10.2337/diacare.22.4.569
   van der Ven NCW, 2003, DIABETES CARE, V26, P713, DOI 10.2337/diacare.26.3.713
   Watkins K, 2004, PHARMACOECONOMICS, V22, P1109, DOI 10.2165/00019053-200422170-00002
   Wee HL, 2006, PHARMACOECONOMICS, V24, P673, DOI 10.2165/00019053-200624070-00006
   Welch G, 2003, DIABETIC MED, V20, P69, DOI 10.1046/j.1464-5491.2003.00832.x
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   WIERENGA ME, 1994, PATIENT EDUC COUNS, V23, P33
   Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047
   2000, MED CARE, V38, P7
NR 65
TC 85
Z9 85
U1 0
U2 15
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
EI 1872-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD MAY
PY 2008
VL 80
IS 2
BP 171
EP 184
DI 10.1016/j.diabres.2007.12.020
PG 14
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 300RQ
UT WOS:000255843300002
PM 18279993
DA 2019-01-08
ER

PT J
AU Savona-Ventura, C
   Chircop, M
AF Savona-Ventura, Charles
   Chircop, Marcel
TI Significant thresholds for the 75-g oral glucose tolerance test in
   pregnancy
SO JOURNAL OF DIABETES AND ITS COMPLICATIONS
LA English
DT Article
DE diabetes mellitus; pregnancy; diagnosis; complications
AB The significant threshold values for the 75-g oral glucose tolerance test (oGTT) during pregnancy have yet to be conclusively determined. This study aimed to identify the risk significance of various set thresholds for the oGTT result. Women undergoing a 75-g oGTT during the third trimester of pregnancy were classified into three groups: mild gestational impaired glucose tolerance (GIGT, 2-h postload glucose, 8.0-8.5 mmol/l; n=75), moderate-severe GIGT (8.6-10.9 mmol/l; n=167), and GDM (>= 11.0 mmol/l; n=76). Outcome indicators of these three groups of women were compared to the parameters of the women with a presumed normal carbohydrate metabolism (n=12,185). The results show that with increasing oGTT thresholds, there was an increasing risk of maternal morbidity in the form of hypertensive disorders complicating pregnancy, as well as obstetric intervention such as induction of labor, cesarean delivery, and preterm delivery. The infant was also at increasing risk with increasing oGTT thresholds from respiratory distress, macrosomia, and associated shoulder dystocia. It would appear, therefore, that abnormal glucose tolerance in pregnancy, even as defined by the World Health Organization criteria, has proportionate risks to both mother and child. (c) 2008 Elsevier Inc. All rights reserved.
C1 [Savona-Ventura, Charles; Chircop, Marcel] St Lukes Teaching Hosp, Dept Obstet Gynecol, Diabet Pregnancy Joint Clin, Guardamangia, Malta.
EM charles.savona-ventura@um.edu.mt
OI Savona-Ventura, Charles/0000-0001-9143-4311
CR *AM DIAB ASS, 2002, DIABETES CARE S1, V25, pS94
   Contreras M, 2002, INT J GYNECOL OBSTET, V78, P69
   HOD M, 2002, EUROPEAN ASS PERINAT, P1
   MOSES RG, 1995, DIABETES CARE, V18, P1527, DOI 10.2337/diacare.18.12.1527
   SAVONAVENTURA C, 2003, INT J DIABETES METAB, V11, P7
   Schranz AG, 2002, EXP CLIN ENDOCR DIAB, V110, P219, DOI 10.1055/s-2002-33070
   *WHO, 1994, TECH REP SER, V844
NR 7
TC 2
Z9 2
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1056-8727
J9 J DIABETES COMPLICAT
JI J. Diabetes Complications
PD MAY-JUN
PY 2008
VL 22
IS 3
BP 178
EP 180
DI 10.1016/j.jdiacomp.2006.10.001
PG 3
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 295WO
UT WOS:000255505100004
PM 18413221
DA 2019-01-08
ER

PT J
AU Shih, M
   Simon, PA
AF Shih, Margaret
   Simon, Paul A.
TI Health-related quality of life among adults with serious psychological
   distress and chronic medical conditions
SO QUALITY OF LIFE RESEARCH
LA English
DT Article
DE chronic disease; health-related quality of life; mental health;
   psychological distress
ID NATIONAL-COMORBIDITY-SURVEY; UNITED-STATES; OLDER-ADULTS; RISK-FACTOR;
   PSYCHIATRIC-DISORDERS; DEPRESSIVE SYMPTOMS; COST-EFFECTIVENESS;
   SCREENING SCALES; MENTAL-HEALTH; GLOBAL BURDEN
AB Objective Determine the prevalence of serious psychological distress (SPD) among adults with and without chronic medical conditions and examine the association between SPD and health-related quality of life (HRQOL).
   Methods Cross-sectional data from the 2005 Los Angeles County Health Survey were used to estimate prevalence of SPD. The association between SPD and HRQOL was evaluated using logistic regression and analysis of covariance, adjusting for sociodemographic variables and number of chronic conditions.
   Results SPD was significantly associated with younger age, lower income, being unemployed or disabled, being unmarried, fair or poor health, and having one or more chronic conditions. Adults with three or more chronic conditions were six times as likely to have SPD as those with no conditions. Adults with SPD reported significantly more unhealthy days (mental and physical) and activity limitation days than adults without SPD. The adjusted mean number of unhealthy days was highest among adults with SPD (23.3), followed by adults with depression (14.1), and diabetes (10.6).
   Conclusions SPD is associated with decreased HRQOL and presence of chronic medical conditions. Mental health should be routinely assessed when addressing health needs of individuals and communities. Persons with chronic diseases may benefit from targeted mental health screening and programs that employ treatment approaches that jointly manage physical and mental health and provide improved links and access to services.
C1 [Shih, Margaret] Los Angeles Cty Dept Publ Hlth, Off Hlth Assessment & Epidemiol, Los Angeles, CA 90012 USA.
   [Simon, Paul A.] Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90024 USA.
   [Simon, Paul A.] Los Angeles Cty Dept Publ Hlth, Div Chron Dis & Injury Prevent, Los Angeles, CA 90010 USA.
RP Shih, M (reprint author), Los Angeles Cty Dept Publ Hlth, Off Hlth Assessment & Epidemiol, 313 N Figueroa St,Rm 127, Los Angeles, CA 90012 USA.
EM mshih@ph.lacounty.gov
CR American Psychiatric Association, 1994, DIAGN STAT MENT DIS
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Bijl RV, 2003, HEALTH AFFAIR, V22, P122, DOI 10.1377/hlthaff.22.3.122
   Chapman Daniel P, 2005, Prev Chronic Dis, V2, pA14
   Coulehan JL, 1997, ARCH INTERN MED, V157, P1113, DOI 10.1001/archinte.157.10.1113
   DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101
   DOHRENWEND BP, 1992, SCIENCE, V255, P946, DOI 10.1126/science.1546291
   Dominick KL, 2002, AGING CLIN EXP RES, V14, P499, DOI 10.1007/BF03327351
   EATON WW, 1992, AM J EPIDEMIOL, V135, P1051, DOI 10.1093/oxfordjournals.aje.a116399
   Engum A, 2007, J PSYCHOSOM RES, V62, P31, DOI 10.1016/j.jpsychores.2006.07.009
   Evans DL, 2005, BIOL PSYCHIAT, V58, P175, DOI 10.1016/j.biopsych.2005.05.001
   Furukawa TA, 2003, PSYCHOL MED, V33, P357, DOI 10.1017/S0033291702006700
   Golden SH, 2004, DIABETES CARE, V27, P429, DOI 10.2337/diacare.27.2.429
   Hunkeler EM, 2006, BRIT MED J, V332, P259, DOI 10.1136/bmj.38683.710255.BE
   Jonas BS, 2000, PSYCHOSOM MED, V62, P188, DOI 10.1097/00006842-200003000-00006
   Katon W, 2006, DIABETES CARE, V29, P265, DOI 10.2337/diacare.29.02.06.dc05-1572
   Katon WJ, 2005, DIABETES CARE, V28, P2668, DOI 10.2337/diacare.28.11.2668
   Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617
   KESSLER RC, 1995, EPIDEMIOL REV, V17, P192, DOI 10.1093/oxfordjournals.epirev.a036176
   KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8
   Lett HS, 2004, PSYCHOSOM MED, V66, P305, DOI 10.1097/01.psy.0000126207.43307.c0
   Lin EHB, 2003, JAMA-J AM MED ASSOC, V290, P2428, DOI 10.1001/jama.290.18.2428
   Lowe B, 2004, PSYCHOSOM MED, V66, P395, DOI 10.1097/01.psy.0000126203.89941.a3
   Markovitz J H, 2001, Curr Hypertens Rep, V3, P25
   McKenna MT, 2005, AM J PREV MED, V28, P415, DOI 10.1016/j.amepre.2005.02.009
   McVeigh K. H., 2004, Morbidity and Mortality Weekly Report, V53, P1089
   Meyer CM, 2004, J AFFECT DISORDERS, V83, P127, DOI 10.1016/j.jad.2004.06.004
   Moriarty David G, 2005, Prev Chronic Dis, V2, pA16
   MOSSEY JM, 1982, AM J PUBLIC HEALTH, V72, P800, DOI 10.2105/AJPH.72.8.800
   MOSSEY JM, 1989, AM J PUBLIC HEALTH, V79, P279, DOI 10.2105/AJPH.79.3.279
   Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9
   Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8
   Mykletun A, 2007, PSYCHOSOM MED, V69, P323, DOI 10.1097/PSY.0b013e31803cb862
   Sherbourne CD, 1999, J GEN INTERN MED, V14, P357, DOI 10.1046/j.1525-1497.1999.00354.x
   Shih M, 2006, J GEN INTERN MED, V21, P1160, DOI 10.1111/j.1525-1497.2006.00573.x
   Simon GE, 2007, ARCH GEN PSYCHIAT, V64, P65, DOI 10.1001/archpsyc.64.1.65
   Simon PA, 2001, AM J PUBLIC HEALTH, V91, P1950, DOI 10.2105/AJPH.91.12.1950
   Smith A, 2006, CHEST, V130, P1034, DOI 10.1378/chest.130.4.1034
   Strine TW, 2004, AM J PREV MED, V26, P213, DOI 10.1016/j.amepre.2003.11.002
   Thorpe JM, 2006, MED CARE, V44, P187, DOI 10.1097/01.mlr.0000196965.54871.d5
   Ustun TB, 2004, BRIT J PSYCHIAT, V184, P386, DOI 10.1192/bjp.184.5.386
   Verbrugge LM, 1999, DISABIL REHABIL, V21, P295
   Wang PS, 2007, LANCET, V370, P841, DOI 10.1016/S0140-6736(07)61414-7
   Wang PS, 2006, ARCH GEN PSYCHIAT, V63, P1345, DOI 10.1001/archpsyc.63.12.1345
NR 46
TC 40
Z9 40
U1 0
U2 5
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0962-9343
EI 1573-2649
J9 QUAL LIFE RES
JI Qual. Life Res.
PD MAY
PY 2008
VL 17
IS 4
BP 521
EP 528
DI 10.1007/s11136-008-9330-9
PG 8
WC Health Care Sciences & Services; Health Policy & Services; Public,
   Environmental & Occupational Health
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA 303EZ
UT WOS:000256025100003
PM 18365766
DA 2019-01-08
ER

PT J
AU Sigurdardottir, AK
   Benediktsson, R
AF Sigurdardottir, A. K.
   Benediktsson, R.
TI Reliability and validity of the Icelandic version of the problem area in
   diabetes (PAID) scale
SO INTERNATIONAL JOURNAL OF NURSING STUDIES
LA English
DT Article
DE insulin-dependent diabetes mellitus; paid scale; reliability; validity
ID EMPOWERMENT SCALE; GLYCEMIC CONTROL; DISTRESS; QUESTIONNAIRE;
   TRANSLATION; DEPRESSION; KNOWLEDGE
AB Background: Diabetes is a burdensome disease that increases distress among people with diabetes.
   Objectives: To test the validity and reliability of an Icelandic version of the problem area in diabetes scale (PAID) and to assess the hitherto unknown distress level of Icelandic people with insulin requiring diabetes.
   Design: Methodological research design.
   Setting: Diabetes clinics.
   Participants: People with insulin-dependent diabetes, between 18 and 61 years.
   Methods: All instruments were translated using a back-translation technique. Participants answered three consecutive questionnaires in succession, the PAID scale, the diabetes empowerment scale (DES) and the diabetes knowledge test (DKT). Principical component analysis with varimax rotation was conducted on the PAID scale to identify latent factors.
   Results: Factor analysis revealed two factors: (a) distress in relation to life with diabetes, with Cronbach alpha coefficient of 0.93 and (b) distress in relation to management of diabetes, with Cronbach alpha coefficient of 0.88, for PAID overall Cronbach alpha coefficient was 0.94. PAID showed neither floor nor ceilings effects. Propositions set to indicate validity were generally met. However, PAID's factor structure and predictive validity needs to be tested further.
   Conclusions: The Icelandic version of PAID is sufficiently psychometrically robust. PAID is simple to administer and by using the scale clinicians can identify people at risk for developing diabetes-related distress. The results are comparable to results from studies in other countries using the PAID scale. (c) 2006 Elsevier Ltd. All rights reserved.
C1 [Sigurdardottir, A. K.] Univ Akureyri, Fac Hlth, IS-600 Solborg, Akureyri, Iceland.
   [Benediktsson, R.] Univ Hosp, Dept Endocrinol & Metab, IS-108 Reykjavik, Iceland.
   [Benediktsson, R.] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland.
   [Benediktsson, R.] Iceland Heart Assoc, IS-201 Kopavogur, Iceland.
RP Sigurdardottir, AK (reprint author), Univ Akureyri, Fac Hlth, IS-600 Solborg, Akureyri, Iceland.
EM arun@unak.is
OI Benediktsson, Rafn/0000-0002-2954-9801
CR Aalto AM, 2000, EUR J PUBLIC HEALTH, V10, P68, DOI 10.1093/eurpub/10.1.68
   ANDERSON RM, 1995, DIABETES CARE, V18, P943, DOI 10.2337/diacare.18.7.943
   Anderson RM, 2003, DIABETES CARE, V26, P1641, DOI 10.2337/diacare.26.5.1641-a
   Anderson RM, 2000, DIABETES CARE, V23, P739, DOI 10.2337/diacare.23.6.739
   BRISLIN RW, 1970, J CROSS CULT PSYCHOL, V1, P185, DOI 10.1177/135910457000100301
   CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016
   Carlson ED, 2000, PUBLIC HEALTH NURS, V17, P61, DOI 10.1046/j.1525-1446.2000.00061.x
   Fayers P. M., 2000, QUALITY LIFE ASSESSM
   Fitzgerald JT, 1998, DIABETES CARE, V21, P706, DOI 10.2337/diacare.21.5.706
   Gonder-Frederick LA, 2002, J CONSULT CLIN PSYCH, V70, P611, DOI 10.1037//0022-006X.70.3.611
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   Herschbach P, 1997, HEALTH PSYCHOL, V16, P171, DOI 10.1037/0278-6133.16.2.171
   Hyrkas K, 2003, INT J NURS STUD, V40, P619, DOI 10.1016/S0020-7489(03)00036-1
   *IDF, 2006, DIAB PREV
   Ishii H. W. G., 1999, DIABETES S1, V48, pA139
   Kim J., 1978, FACTOR ANAL STAT MET
   Lewis-Beck M. S., 1980, APPL REGRESSION INTR
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   MARQUIS P, 2004, ASSESSING QUALITY LI, P78
   Murata GH, 2003, DIABETOLOGIA, V46, P1170, DOI 10.1007/s00125-003-1161-1
   Onkamo P, 1999, DIABETOLOGIA, V42, P1395, DOI 10.1007/s001250051309
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Rubin R. R., 1993, DIABETES ED, V19, P210, DOI [DOI 10.1177/014572179301900308, 10.1177/014572179301900308]
   SHIN AT, 2003, DIABETES CARE, V26, P2817
   SNOCK FJ, 2000, DIABETES CARE, V23, P1305
   Spencer MS, 2006, J HEALTH CARE POOR U, V17, P88, DOI 10.1353/hpu.2006.0095
   Tacq Jacques, 1997, MULTIVARIATE ANAL TE
   Tanzer NK, 1999, EUR J PSYCHOL ASSESS, V15, P258, DOI 10.1027//1015-5759.15.3.258
   Weinger K, 2001, PATIENT EDUC COUNS, V42, P123, DOI 10.1016/S0738-3991(00)00098-7
   Welch G, 2003, DIABETIC MED, V20, P69, DOI 10.1046/j.1464-5491.2003.00832.x
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
NR 31
TC 19
Z9 21
U1 0
U2 14
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0020-7489
J9 INT J NURS STUD
JI Int. J. Nurs. Stud.
PD APR
PY 2008
VL 45
IS 4
BP 526
EP 533
DI 10.1016/j.ijnurstu.2006.10.008
PG 8
WC Nursing
SC Nursing
GA 292KW
UT WOS:000255265900006
PM 17161401
DA 2019-01-08
ER

PT J
AU Lorig, K
   Ritter, PL
   Villa, F
   Piette, JD
AF Lorig, Kate
   Ritter, Philip L.
   Villa, Frank
   Piette, John D.
TI Spanish diabetes self-management with and without automated telephone
   reinforcement - Two randomized trials
SO DIABETES CARE
LA English
DT Article
ID NON-HISPANIC WHITES; HEALTH-CARE COSTS; MEXICAN-AMERICANS; GLYCEMIC
   CONTROL; STARR COUNTY; EDUCATION; MORTALITY; CALLS
AB OBJECTIVE - To determine 1) whether participants in the Spanish Diabetes Self-Management Program (SDSMP), when compared at 6 months to randomized control subjects, would demonstrate improvements in health status, health behaviors, and self-efficacy; and 2) whether SDSMP participants receiving monthly automated telephone reinforcement would maintain improvements at 18 months better than those not receiving reinforcement.
   RESEARCH DESIGN AND METHODS - A total of 567 Spanish-speaking adults with type 2 diabetes were randomized to a usual-care control group or 6-week community-based, peer-led SDSMP. SDSMP participants were re-randomized to receive 15 months of automated telephone messages or no reinforcement. A1C was measured at baseline and 6 and 18 months. All other data were collected by self-administered questionnaires.
   RESULTS - At 6 months SDSMP participants compared with control subjects demonstrated improvements in A1C (-0.4%), health distress, symptoms of hypo- and hyperglycemia, and self-efficacy (P < 0.05). At 18 months all improvements persisted (P < 0.05). SDSMP participants also demonstrated improvements in self-rated health and communication with physicians, had fewer emergency room visits (-0.18 visits in 6 months, P < 0.05), and trended toward fewer visits to physicians. At 18 months the only difference between reinforced and nonreinforced participants was increased glucose monitoring for the reinforcement group.
   CONCLUSIONS- The SDSMP demonstrated effectiveness in lowering A1C and improving health status. Reinforcement did not add to its effectiveness. Given the high needs of the Spanish-speaking population, the SDSMP deserves consideration for implementation.
C1 [Lorig, Kate; Ritter, Philip L.; Villa, Frank] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA.
   [Piette, John D.] Univ Michigan, Div Gen Med, Ann Arbor, MI 48109 USA.
   [Piette, John D.] Ctr Practice Management & Outcomes Res, VA Hlth Serv Res & Dev Serv Ctr Excellence, Ann Arbor, MI 48109 USA.
RP Ritter, PL (reprint author), Stanford Univ, Sch Med, 2000 Welch Rd,Ste 204, Palo Alto, CA 94304 USA.
EM philr@stanford.edu
FU NINR NIH HHS [NR053250]
CR Adams PF, 2006, VITAL HLTH STAT, V10, P230
   BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191
   BROWN S, 1995, DIABETES ED, V21, P230
   Brown S A, 1992, Diabetes Educ, V18, P47, DOI 10.1177/014572179201800108
   Brown SA, 2005, DIABETES CARE, V28, P527, DOI 10.2337/diacare.28.3.527
   Brown SA, 1999, DIABETES EDUCATOR, V25, P226, DOI 10.1177/014572179902500208
   DOMENECH MI, 1995, ACTA DIABETOL, V32, P143, DOI 10.1007/BF00838482
   ESPINO DV, 1994, J AM GERIATR SOC, V42, P604, DOI 10.1111/j.1532-5415.1994.tb06857.x
   Gerber BS, 2005, DIABETES CARE, V28, P1574, DOI 10.2337/diacare.28.7.1574
   Gilmer TP, 2005, DIABETES CARE, V28, P59, DOI 10.2337/diacare.28.1.59
   GONZALEZ RG, 1997, REV PANAM SALUD PUBL, V2, P32
   GONZALEZ VM, 1995, ARTHRITIS RHEUM-US, V38, P1429, DOI 10.1002/art.1780381010
   HAFFNER SM, 1988, DIABETES, V37, P878, DOI 10.2337/diabetes.37.7.878
   HARRIS MI, 1991, DIABETES CARE, V14, P639, DOI 10.2337/diacare.14.7.639
   HE G, 2007, DIABETES CALIFORNIA
   IDLER EL, 1990, AM J PUBLIC HEALTH, V80, P446, DOI 10.2105/AJPH.80.4.446
   LOLINSKY FD, 1992, J GERONTOL, V47, P304
   Lorig K, 1996, OUTCOME MEASURES HLT
   LORIG K, 2000, DIABETES SPECTRUM, V13, P234
   MARIN M, 2001, MANUAL INSTRUCTORES
   Miedema K, 2005, SCAND J CLIN LAB INV, V65, P61, DOI 10.1080/00365510500236143
   *NATL I DIAB DIG K, 2005, NATL DIAB STAT FACT
   Piette JD, 1999, AM J PREV MED, V17, P138, DOI 10.1016/S0749-3797(99)00061-6
   Piette JD, 2000, AM J MED, V108, P20, DOI 10.1016/S0002-9343(99)00298-3
   PIETTE JD, 2000, MED CARE, V38, P2
   PUGH JA, 1988, AM J EPIDEMIOL, V127, P135, DOI 10.1093/oxfordjournals.aje.a114773
   Ritter PL, 2006, J RHEUMATOL, V33, P574
   Ritter PL, 2001, J CLIN EPIDEMIOL, V54, P136, DOI 10.1016/S0895-4356(00)00261-4
   Rosal MC, 2005, ANN BEHAV MED, V29, P225, DOI 10.1207/s15324796abm2903_9
   Stewart A., 1992, MEASURING FUNCTIONIN
   TYRRELL SP, HEMOGLOBIN A1C DETEC, V4018
   Wagner EH, 2001, JAMA-J AM MED ASSOC, V285, P182, DOI 10.1001/jama.285.2.182
   Yoon J, 2004, J AM BOARD FAM PRACT, V17, P165, DOI 10.3122/jabfm.17.3.165
NR 33
TC 128
Z9 131
U1 0
U2 6
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
J9 DIABETES CARE
JI Diabetes Care
PD MAR
PY 2008
VL 31
IS 3
BP 408
EP 414
DI 10.2337/dc07-1313
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 271PL
UT WOS:000253801100006
PM 18096810
OA Bronze
DA 2019-01-08
ER

PT J
AU Goebel-Fabbri, AE
   Fikkan, J
   Franko, DL
   Pearson, K
   Anderson, BJ
   Weinger, K
AF Goebel-Fabbri, Ann E.
   Fikkan, Janna
   Franko, Debra L.
   Pearson, Kimberly
   Anderson, Barbara J.
   Weinger, Katie
TI Insulin restriction and associated morbidity and mortality in women with
   type 1 diabetes
SO DIABETES CARE
LA English
DT Article
ID EATING-DISORDERS; ANOREXIA-NERVOSA; COMPLICATIONS; VALIDATION;
   INVENTORY; ATTITUDES; MELLITUS; OUTCOMES; FEMALES; IDDM
AB OBJECTIVE - To determine whether insulin restriction increases morbidity and mortality in women with type 1 diabetes.
   RESEARCH DESIGN AND METHODS - This is an 11-year follow-up study of women with type 1 diabetes. A total of 234 women (60% of the original cohort) participated in the follow-up. Mean age was 45 years and mean diabetes duration was 28 years at follow-up. Mean BMI was 25 kg/m(2) and mean A1C was 7.9%. Measures of diabetes self-care behaviors, diabetes-specific distress, fear of hypoglycemia, psychological distress, and eating disorder symptoms were administered at baseline. At follow-up, mortality data were collected through state and national databases. Follow-up data regarding diabetes complications were gathered by self-report.
   RESULTS - Seventy-one women (30%) reported insulin restriction at baseline. Twenty-six women died during follow-up. Based on multivariate Cox regression analysis, insulin restriction conveyed a threefold increased risk of mortality after controlling for baseline age, BMI, and A1C. Mean age of death was younger for insulin restrictors (45 vs. 58 years, P < 0.01). insulin restrictors reported higher rates of nephropathy and foot problems at follow-up. Deceased women had reported more frequent insulin restriction (P < 0.05) and reported more eating disorder symptoms (P < 0.05) at baseline than their living counterparts.
   CONCLUSIONS - Our data demonstrate that insulin restriction is associated with increased rates of diabetes complications and increased mortality risk. Mortality associated with insulin restriction appeared to occur in the context of eating disorder symptoms, rather than other psychological distress. We propose a screening question appropriate for routine diabetes care to improve detection of this problem.
C1 [Goebel-Fabbri, Ann E.; Fikkan, Janna; Weinger, Katie] Joslin Diabet Ctr, Boston, MA 02215 USA.
   [Goebel-Fabbri, Ann E.; Pearson, Kimberly; Weinger, Katie] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA.
   [Franko, Debra L.] Northeastern Univ, Dept Counseling & Appl Educ Psychol, Boston, MA 02115 USA.
   [Pearson, Kimberly] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA.
   [Anderson, Barbara J.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.
RP Weinger, K (reprint author), Joslin Diabet Ctr, Suite 350,1 Joslin Pl, Boston, MA 02215 USA.
EM katie.weinger@joslin.harvard.edu
FU NIDDK NIH HHS [P30DK36836]
CR Affenito SG, 1997, DIABETES CARE, V20, P182, DOI 10.2337/diacare.20.2.182
   American Psychiatric Association, 1994, DIAGN STAT MAN MENT
   COX DJ, 1987, DIABETES CARE, V10, P617, DOI 10.2337/diacare.10.5.617
   Daneman D, 1998, HORM RES, V50, P79, DOI 10.1159/000053110
   DCCT Res Grp, 1988, DIABETES CARE, V11, P567
   DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017
   GARNER DM, 1983, INT J EAT DISORDER, V2, P15, DOI 10.1002/1098-108X(198321)2:2<15::AID-EAT2260020203>3.0.CO;2-6
   Greco P., 1990, DIABETES S1, V39, p165A
   JACQUEMINET S, 2005, DIABETES METAB, V31
   Jones JM, 2000, BMJ-BRIT MED J, V320, P1563, DOI 10.1136/bmj.320.7249.1563
   Keel PK, 2003, ARCH GEN PSYCHIAT, V60, P179, DOI 10.1001/archpsyc.60.2.179
   KROLEWSKI AS, 1995, NEW ENGL J MED, V332, P1251, DOI 10.1056/NEJM199505113321902
   Nielsen S, 2002, DIABETES CARE, V25, P309, DOI 10.2337/diacare.25.2.309
   Pambianco G, 2006, DIABETES, V55, P1463, DOI 10.2337/db05-1423
   Peveler RC, 2005, DIABETES CARE, V28, P84, DOI 10.2337/diacare.28.1.84
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   POLONSKY WH, 1994, DIABETES CARE, V17, P1178, DOI 10.2337/diacare.17.10.1178
   Resnick HE, 2006, DIABETES CARE, V29, P531, DOI 10.2337/diacare.29.03.06.dc05-1254
   Saaddine JB, 2006, ANN INTERN MED, V144, P465, DOI 10.7326/0003-4819-144-7-200604040-00005
   SHAMOON H, 1993, NEW ENGL J MED, V329, P977
   STEEL JM, 1989, BRIT J PSYCHIAT, V155, P515, DOI 10.1192/bjp.155.4.515
   THELEN MH, 1991, PSYCHOL ASSESSMENT J, V3, P119, DOI DOI 10.1037/1040-3590.3.1.119
   Walker JD, 2002, DIABETES CARE, V25, P1664, DOI 10.2337/diacare.25.9.1664-a
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
NR 24
TC 108
Z9 109
U1 2
U2 10
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
J9 DIABETES CARE
JI Diabetes Care
PD MAR
PY 2008
VL 31
IS 3
BP 415
EP 419
DI 10.2337/dc07-2026
PG 5
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 271PL
UT WOS:000253801100007
PM 18070998
OA Bronze
DA 2019-01-08
ER

PT J
AU Balukonis, J
   Mellcus, GD
   Chyun, D
AF Balukonis, Jennifer
   Mellcus, Gail D'Erarno
   Chyun, Deborah
TI Grandparenthood status and health outcomes in midlife African American
   women with type 2 diabetes
SO ETHNICITY & DISEASE
LA English
DT Article; Proceedings Paper
CT 65th Annual Meeting of the American-Diabetes-Association
CY JUN 10-14, 2005
CL San Diego, CA
SP Amer Diabet Assoc
DE grandparenthood; African American women; type 2 diabetes; psychosocial
   factors; caregiver role
ID RAISING GRANDCHILDREN; GLYCEMIC CONTROL; GRANDMOTHERS; PREVALENCE;
   PROFILE; RISK; COMPLICATIONS; DEPRESSION; CHILDREN; ADULTS
AB Objective: To describe grandparenthood status and determine the relationship between grandparenthood status, metabolic control, and psychosocial factors in African American women with type 2 diabetes.
   Methods: A secondary, descriptive, exploratory analysis was conducted to examine the relationship between grandparenting status, physiologic indices related to metabolic control (body mass index, hemoglobin A1c, systolic blood pressure, low-density lipoprotein cholesterol) and psychosocial factors (emotional distress and quality of life) in a sample of 109 urban midlife African American women with type 2 diabetes.
   Results: Grandmothers made up 60% of the sample and were stratified into three groups on the basis of caretaking status. Grandmothers who cared for but did not live with grandchildren had the highest body mass index, hemoglobin A1c, low-density lipoprotein cholesterol, and systolic blood pressure. Caregiving grandmothers also had higher diabetes-related emotional distress scores but had better quality of life scores than did the non-caretaking grandmothers. Non-grand mothers had the lowest quality of life scores.
   Conclusions: These findings suggest relationships between grandmother caretaking status and metabolic and psychosocial factors. Research is needed to further examine these relationships and implications on practice and policy decisions.
C1 [Balukonis, Jennifer; Mellcus, Gail D'Erarno; Chyun, Deborah] Yale Univ, Sch Nursing, New Haven, CT 06536 USA.
RP Mellcus, GD (reprint author), Yale Univ, Sch Nursing, 100 Church St S,POB 9740, New Haven, CT 06536 USA.
EM Gail.Melkus@Yale.edu
FU NINR NIH HHS [1R01NR05341-01A1]
CR *AM DIAB ASS, DIAB STAT AFR AM
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   BRYSON K, 1999, P23198 US CENS BUR
   BUDER FR, 2005, J GERONTOL NURS, V31, P43
   CASPER LM, 1998, 26 POP DIV US CENS B
   Cox CB, 2002, SOC WORK, V47, P45, DOI 10.1093/sw/47.1.45
   de Rekeneire N, 2003, DIABETES CARE, V26, P1986, DOI 10.2337/diacare.26.7.1986
   DOWDELL EB, 1995, AM J MATERNALLCHILD, V29, P299
   Emick MA, 1999, INT J AGING HUM DEV, V48, P35, DOI 10.2190/1FH2-AHWT-1Q3J-PC1K
   Fuller-Thomson E, 2000, HEALTH SOC WORK, V25, P109, DOI 10.1093/hsw/25.2.109
   Fuller-Thomson E, 2001, GERONTOLOGIST, V41, P201, DOI 10.1093/geront/41.2.201
   FullerThomson E, 1997, GERONTOLOGIST, V37, P406, DOI 10.1093/geront/37.3.406
   Gary TL, 2000, DIABETES CARE, V23, P23, DOI 10.2337/diacare.23.1.23
   Giarrusso R., 1996, INT J SOCIOLOGY SOCI, V16, P124, DOI DOI 10.1108/EB013288
   Gibbons C, 2003, J FAMILY SOCIAL WORK, V7, P1
   Harris MI, 1999, DIABETES CARE, V22, P403, DOI 10.2337/diacare.22.3.403
   HARRIS TL, 1995, LIT DICT VOCABULARY
   Hayslip B, 2002, J APPL GERONTOL, V21, P139, DOI 10.1177/07364802021002001
   JENDREK MP, 1994, GERONTOLOGIST, V34, P200
   Kelley S J, 1993, Image J Nurs Sch, V25, P331, DOI 10.1111/j.1547-5069.1993.tb00268.x
   Lee S, 2003, AM J PUBLIC HEALTH, V93, P1939, DOI 10.2105/AJPH.93.11.1939
   Minkler M, 2001, J Am Med Womens Assoc (1972), V56, P199
   Minkler M, 1999, AM J PUBLIC HEALTH, V89, P1384, DOI 10.2105/AJPH.89.9.1384
   Musil C M, 1998, Health Care Women Int, V19, P441
   Musil CM, 2006, J GERONTOL B-PSYCHOL, V61, pS89, DOI 10.1093/geronb/61.2.S89
   Musil CM, 2002, J AGING HEALTH, V14, P96, DOI 10.1177/089826430201400106
   Musil CM, 2000, J WOMEN AGING, V12, P129, DOI 10.1300/J074v12n01_09
   *NAT WOM HLTH INF, STEP HLTH WOM DIAB
   Nichols GA, 2003, DIABETES CARE, V26, P744, DOI 10.2337/diacare.26.3.744
   Pruchno R, 1999, GERONTOLOGIST, V39, P209, DOI 10.1093/geront/39.2.209
   Roe KM, 1996, MED CARE, V34, P1072, DOI 10.1097/00005650-199611000-00002
   Samuel-Hodge CD, 2005, ETHNIC DIS, V15, P436
   SHAMOON H, 1993, NEW ENGL J MED, V329, P977
   SIMMONS T, 2003, C2BKR31 US CENS BUR
   Stearne MR, 1998, BRIT MED J, V317, P703
   U. S. Department of Health and Human Services, 2000, HLTH PEOPL 2010
   WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   Whitley DM, 2001, HEALTH SOC WORK, V26, P105, DOI 10.1093/hsw/26.2.105
NR 39
TC 11
Z9 12
U1 1
U2 12
PU INT SOC HYPERTENSION BLACKS-ISHIB
PI ATLANTA
PA 100 AUBURN AVE NE STE 401, ATLANTA, GA 30303-2527 USA
SN 1049-510X
J9 ETHNIC DIS
JI Ethn. Dis.
PD SPR
PY 2008
VL 18
IS 2
BP 141
EP 146
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 286YH
UT WOS:000254882200003
PM 18507264
DA 2019-01-08
ER

PT J
AU Miller, ST
   Elasy, TA
AF Miller, Stephania T.
   Elasy, Tom A.
TI Psychometric evaluation of the Problem Areas in Diabetes (PAID) survey
   in Southern, rural African American women with Type 2 diabetes
SO BMC PUBLIC HEALTH
LA English
DT Article
ID SELF-CARE; EMOTIONAL DISTRESS; SCALE; EFFICACY; ADULTS
AB Background: The Problem Areas in Diabetes (PAID) survey is a measure of diabetes-related stress for which reported use has been in largely Caucasian populations. Our purpose was to assess the psychometric properties of the PAID in Southern rural African American women with Type 2 diabetes.
   Methods: A convenience sample of African American women (N = 131) ranging from 21-50 years of age and diagnosed with Type 2 diabetes were recruited for a survey study from two rural Southern community health centers. Participants completed the PAID, Center for Epidemiological Studies-Depression Scale (CES-D), and the Summary of Diabetes Self-Care Activities Scale (SDSCA). Factor analysis, Cronbach's coefficient alpha, and construct validation facilitated psychometric evaluation.
   Results: A principle component factor analysis of the PAID yielded two factors, 1) a lack of confidence subscale, and 2) a negative emotional consequences subscale. The Lack of Confidence and Negative Emotional Consequences subscales, but not the overall PAID scale, were associated with glycemic control and body mass index, respectively. Relationships with measures of depression and diabetes self-care supported construct validity of both subscales. Both subscales had acceptable (alpha = 0.85 and 0.94) internal consistency measures.
   Conclusion: A psychometrically sound two-factor solution to the PAID survey is identified in Southern, rural African American women with Type 2 diabetes. Lack of confidence in and negative emotional consequences of diabetes self-care implementation provide a better understanding of determinants of glycemic control and weight than an aggregate of the two scales.
C1 [Miller, Stephania T.] Meharry Med Coll, Ctr Womens Hlth Res, Dept Surg, Nashville, TN 37208 USA.
   [Elasy, Tom A.] Vanderbilt Univ, Med Ctr, Vanderbilt Eskind Diabet Clin, Nashville, TN USA.
   [Elasy, Tom A.] Vanderbilt Univ, Med Ctr, Ctr Hlth Serv Res, Nashville, TN USA.
RP Miller, ST (reprint author), Meharry Med Coll, Ctr Womens Hlth Res, Dept Surg, Nashville, TN 37208 USA.
EM smiller@mmc.edu; tom.elasy@vanderbilt.edu
FU NCRR NIH HHS [1 R25 RR017577-01, R25 RR017577]; NIMHD NIH HHS [P20
   MD000516, 5 P20 MD000516-03]; NIDDK NIH HHS [3 P60 DK020593-2651, P60
   DK020593]
CR Aljasem LI, 2001, DIABETES EDUCATOR, V27, P393, DOI 10.1177/014572170102700309
   Chadiha LA, 2004, J AGING HEALTH, V16, p18S, DOI 10.1177/0898264304268147
   Ciechanowski PS, 2003, GEN HOSP PSYCHIAT, V25, P246, DOI 10.1016/S0163-8343(03)00055-0
   DEVELLIS RF, 2003, SCALE DEV THEORY APP, V26, P170
   *DIAB CONTR COMPL, 1993, NEW ENGL J MED, V329, P977, DOI DOI 10.1056/NEJM199309303291401
   Gooden Kyna M, 2005, Ethn Dis, V15, P68
   Harris MI, 1999, DIABETES CARE, V22, P403, DOI 10.2337/diacare.22.3.403
   Lloyd Cathy E, 2002, Curr Womens Health Rep, V2, P188
   Melkus GD, 2004, APPL NURS RES, V17, P10, DOI 10.1016/j.apnr.2003.10.009
   National Heart Lung and Blood Institute., 1998, AM J CLIN NUTR, V68, P899
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   RESNICOW K, 2002, MOTIVATIONAL INTERVI, P265
   SKELLY AH, 1995, DIABETES EDUCATOR, V21, P38, DOI 10.1177/014572179502100107
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Spencer MS, 2006, J HEALTH CARE POOR U, V17, P88, DOI 10.1353/hpu.2006.0095
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
NR 18
TC 12
Z9 13
U1 0
U2 8
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD FEB 22
PY 2008
VL 8
AR 70
DI 10.1186/1471-2458-8-70
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 276NJ
UT WOS:000254148800001
PM 18294380
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU van Bastelaar, KM
   Pouwer, F
   Cuijpers, P
   Twisk, JW
   Snoek, FJ
AF van Bastelaar, Kim M. P.
   Pouwer, Frans
   Cuijpers, Pim
   Twisk, Jos W. R.
   Snoek, Frank J.
TI Web-based cognitive behavioural therapy (W-CBT) for diabetes patients
   with co-morbid depression: Design of a randomised controlled trial
SO BMC PSYCHIATRY
LA English
DT Article
ID GROUP TRAINING CBGT; POOR GLYCEMIC CONTROL; COMORBID DEPRESSION;
   PRIMARY-CARE; METAANALYSIS; INTERNET; ANXIETY; INDIVIDUALS; SYMPTOMS;
   MELLITUS
AB Background: Depression is common among people with diabetes, negatively affecting quality of life, treatment adherence and diabetes outcomes. In routine clinical care, diabetes patients have limited access to mental health services and depression therefore often remains untreated. Web-based therapy could potentially be an effective way to improve the reach of psychological care for diabetes patients, at relatively low costs. This study seeks to test the effectiveness of a web-based self-help depression programme for people with diabetes and co-morbid depression.
   Methods/Design: The effectiveness of a web-based self-help course for adults with diabetes with comorbid depression will be tested in a randomised trial, using a wait-list controlled design. The intervention consists of an 8-week, moderated self-help course that is tailored to the needs of persons living with diabetes and is offered on an individual basis. Participants receive feedback on their homework assignments by e-mail from their coach. We aim to include 286 patients (143/143), as power analyses showed that this number is needed to detect an effect size of 0.35, with measurements at baseline, directly after completing the web-based intervention and at 1, 3, 4 and 6 months follow-up. Patients in the control condition are placed on a waiting list, and follow the course 12 weeks after randomisation.
   Primary outcomes are depressive symptoms and diabetes-specific emotional distress. Secondary outcomes are satisfaction with the course, perceived health status, self-care behaviours, glycaemic control, and days in bed/absence from work. Questionnaires are administered via the Internet.
   Discussion: The intervention being trialled is expected to help improve mood and reduce diabetes-specific emotional distress in diabetes patients with depression, with subsequent beneficial effects on diabetes self-care and glycaemic outcomes. When proven efficacious, the intervention could be disseminated to reach large groups of patients with diabetes and concurrent depressive symptoms.
   Trial registration: Current Controlled Trials ISRCTN24874457.
C1 [van Bastelaar, Kim M. P.; Pouwer, Frans; Snoek, Frank J.] Vrije Univ Amsterdam Med Ctr, Dept Med Psychol, Amsterdam, Netherlands.
   [van Bastelaar, Kim M. P.; Pouwer, Frans; Cuijpers, Pim; Twisk, Jos W. R.; Snoek, Frank J.] Vrije Univ Amsterdam Med Ctr, EMGO Inst, Amsterdam, Netherlands.
   [Cuijpers, Pim] Vrije Univ Amsterdam Med Ctr, Dept Clin Psychol, Amsterdam, Netherlands.
   [Twisk, Jos W. R.] Vrije Univ Amsterdam Med Ctr, Dept Clin Epidemiol & Biostat, Amsterdam, Netherlands.
   [van Bastelaar, Kim M. P.] Vrije Univ Amsterdam Med Ctr, Diabet Psychol Res Grp, Dept Med Psychol, Amsterdam, Netherlands.
RP van Bastelaar, KM (reprint author), Vrije Univ Amsterdam Med Ctr, Dept Med Psychol, Amsterdam, Netherlands.
EM k.vanbastelaar@vumc.nl; f.pouwer@vumc.nl; p.cuijpers@psy.vu.nl;
   jwr.twisk@vumc.nl; fj.snoek@vumc.nl
RI Cuijpers, Pim/G-1703-2013
OI Cuijpers, Pim/0000-0001-5497-2743
CR Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Buchanan Tom, 2003, Cognitive Behaviour Therapy, V32, P100, DOI 10.1080/16506070310000957
   Cavanagh K, 2004, J CLIN PSYCHOL, V60, P239, DOI 10.1002/jclp.10261
   Christensen H, 2004, BRIT MED J, V328, P265, DOI 10.1136/bmj.37945.566632.EE
   Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278
   Cohen J, 1988, STAT POWER ANAL BEHA
   Cuijpers P, 1998, BEHAV THER, V29, P521, DOI 10.1016/S0005-7894(98)80047-6
   Egede LE, 2002, DIABETES CARE, V25, P464, DOI 10.2337/diacare.25.3.464
   Glasgow RE, 2004, AM J PREV MED, V27, P80, DOI 10.1016/j.amepre.2004.04.026
   Hervas A, 2007, AN SIST SANIT NAVAR, V30, P45, DOI 10.4321/s1137-66272007000100005
   Houston TK, 2002, AM J PSYCHIAT, V159, P2062, DOI 10.1176/appi.ajp.159.12.2062
   Kaltenthaler E, 2002, Health Technol Assess, V6, P1
   Katon WJ, 2004, ARCH GEN PSYCHIAT, V61, P1042, DOI 10.1001/archpsyc.61.10.1042
   LEWINSOHN PM, 1995, PUT UIT PUT ZELF DEP
   LINDSAY WR, 1993, BRIT J MED PSYCHOL, V66, P135, DOI 10.1111/j.2044-8341.1993.tb01736.x
   Lustman PJ, 2002, J PSYCHOSOM RES, V53, P917, DOI 10.1016/S0022-3999(02)00416-6
   Lustman PJ, 2000, DIABETES CARE, V23, P618, DOI 10.2337/diacare.23.5.618
   Lustman PJ, 1998, ANN INTERN MED, V129, P613, DOI 10.7326/0003-4819-129-8-199810150-00005
   McCrone P, 2004, BRIT J PSYCHIAT, V185, P55, DOI 10.1192/bjp.185.1.55
   Piette JD, 2004, AM J MANAG CARE, V10, P152
   Pouwer F, 2005, DIABETES RES CLIN PR, V70, P166, DOI 10.1016/j.diabres.2005.03.031
   Pouwer F, 1998, QUAL LIFE RES, V7, P33
   Proudfoot J, 2003, PSYCHOL MED, V33, P217, DOI 10.1017/S0033291702007225
   Rubin Richard R, 2004, Curr Diab Rep, V4, P119, DOI 10.1007/s11892-004-0067-8
   Schroevers MJ, 2000, QUAL LIFE RES, V9, P1015, DOI 10.1023/A:1016673003237
   Snoek FJ, 2001, PATIENT EDUC COUNS, V45, P143, DOI 10.1016/S0738-3991(01)00113-6
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Spek V, 2007, PSYCHOL MED, V37, P1797, DOI 10.1017/S0033291707000542
   Spek V, 2007, PSYCHOL MED, V37, P319, DOI 10.1017/S0033291706008944
   Twisk JWR, 2004, EUR J EPIDEMIOL, V19, P769
   van der Ven NCW, 2005, DIABETIC MED, V22, P1619
   van der Ven NCW, 2005, PATIENT EDUC COUNS, V56, P313, DOI 10.1016/j.pec.2004.03.005
NR 32
TC 27
Z9 27
U1 0
U2 21
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-244X
J9 BMC PSYCHIATRY
JI BMC Psychiatry
PD FEB 19
PY 2008
VL 8
AR 9
DI 10.1186/1471-244X-8-9
PG 7
WC Psychiatry
SC Psychiatry
GA 282FL
UT WOS:000254552900001
PM 18284670
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Kouvonen, AM
   Vaananen, A
   Woods, SA
   Heponiemi, T
   Koskinen, A
   Toppinen-Tanner, S
AF Kouvonen, Anne M.
   Vaananen, Ari
   Woods, Stephen A.
   Heponiemi, Tarja
   Koskinen, Aki
   Toppinen-Tanner, Salla
TI Sense of coherence and diabetes: A prospective occupational cohort study
SO BMC PUBLIC HEALTH
LA English
DT Article
ID CORONARY-HEART-DISEASE; FOLLOW-UP; GLUCOSE REGULATION;
   PHYSICAL-ACTIVITY; HEALTH; MORTALITY; MEN; WOMEN; PERSONALITY;
   PREVALENCE
AB Background: Sense of coherence (SOC) is an individual characteristic related to a positive life orientation leading to effective coping. A weak SOC has been associated with indicators of general morbidity and mortality. However, the relationship between SOC and diabetes has not been studied in prospective design. The present study prospectively examined the relationship between a weak SOC and the incidence of diabetes.
   Methods: The relationship between a weak SOC and the incidence of diabetes was investigated among 5827 Finnish male employees aged 18-65 at baseline (1986). SOC was measured by questionnaire survey at baseline. Data on prescription diabetes drugs from 1987 to 2004 were obtained from the Drug Imbursement Register held by the Social Insurance Institution.
   Results: During the follow-up, 313 cases of diabetes were recorded. A weak SOC was associated with a 46% higher risk of diabetes in participants who had been =<50 years of age on entry into the study. This association was independent of age, education, marital status, psychological distress, self-rated health, smoking status, binge drinking and physical activity. No similar association was observed in older employees.
   Conclusion: The results suggest that besides focusing on well-known risk factors for diabetes, strengthening SOC in employees of =<50 years of age can also play a role in attempts to tackle increasing rates of diabetes.
C1 [Vaananen, Ari; Toppinen-Tanner, Salla] Finnish Inst Occupat Hlth, FIN-00250 Helsinki, Finland.
   [Kouvonen, Anne M.; Woods, Stephen A.] Univ Nottingham, Inst Work Hlth & Org, Nottingham NG7 2RQ, England.
   [Heponiemi, Tarja] Natl Res & Dev Ctr Welf & Hlth STAKES, FIN-00531 Helsinki, Finland.
   [Koskinen, Aki] Univ Helsinki, Dept Psychol, FIN-00014 Helsinki, Finland.
RP Kouvonen, AM (reprint author), Univ Nottingham, Inst Work Hlth & Org, 8 William Lee Bldg,Nottingham Sci & Technol Pk,Un, Nottingham NG7 2RQ, England.
EM anne.kouvonen@nottingham.ac.uk; ari.vaananen@ttl.fi;
   s.a.woods@aston.ac.uk; tarja.heponiemi@stakes.fi;
   aki.koskinen@helsinki.fi; salla.toppinen-tanner@ttl.fi
OI Heponiemi, Tarja/0000-0001-8540-049X; Kouvonen, Anne/0000-0001-6997-8312
CR Agardh EE, 2003, DIABETES CARE, V26, P719, DOI 10.2337/diacare.26.3.719
   Amelang M, 1997, EUR J PERSONALITY, V11, P319, DOI 10.1002/(SICI)1099-0984(199712)11:5<319::AID-PER304>3.0.CO;2-D
   Antonovsky A., 1987, UNRAVELING MYSTERY H
   Bjorntorp P, 1999, DIABETIC MED, V16, P373, DOI 10.1046/j.1464-5491.1999.00067.x
   Brummett BH, 2006, J RES PERS, V40, P222, DOI 10.1016/j.jrp.2004.12.002
   CACIOPPO JT, 1994, PSYCHOPHYSIOLOGY, V31, P113, DOI 10.1111/j.1469-8986.1994.tb01032.x
   Central Statistical Office of Finland, 1989, HLTH 1989
   Delaunay F, 1997, J CLIN INVEST, V100, P2094, DOI 10.1172/JCI119743
   Elo A-L, 1992, OCCUPATIONAL STRESS
   Eng PM, 2002, AM J EPIDEMIOL, V155, P700, DOI 10.1093/aje/155.8.700
   Eriksson M, 2006, J EPIDEMIOL COMMUN H, V60, P376, DOI 10.1136/j.jech.2005.041616
   Feldt T, 2005, EUR PSYCHOL, V10, P298, DOI 10.1027/1016-9040.10.4.298
   Feldt T, 2000, J ORGAN BEHAV, V21, P461, DOI 10.1002/(SICI)1099-1379(200006)21:4<461::AID-JOB11>3.0.CO;2-T
   Feldt T, 2004, J OCCUP ORGAN PSYCH, V77, P323, DOI 10.1348/0963179041752655
   Feldt T, 2000, PERS INDIV DIFFER, V28, P239, DOI 10.1016/S0191-8869(99)00094-X
   Feldt T, 2007, QUAL LIFE RES, V16, P483, DOI 10.1007/s11136-006-9130-z
   Gibson LM, 1996, PSYCHOL REP, V79, P343, DOI 10.2466/pr0.1996.79.1.343
   Goldberg D., 1988, USERS GUIDE GEN HLTH
   Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518
   HELMIO T, 2004, AIKUISTEN DIABETESLA
   Hilding A, 2006, DIABETOLOGIA, V49, P2589, DOI 10.1007/s00125-006-0402-5
   Hoge T, 2004, J OCCUP HEALTH PSYCH, V9, P195, DOI 10.1037/1076-8998.9-3-195
   IDLER EL, 1990, AM J PUBLIC HEALTH, V80, P446, DOI 10.2105/AJPH.80.4.446
   Institute of Medicine, 1990, BROAD BAS TREATM ALC
   Kalimo R, 1999, PREVENTING STRESS IM, P52
   Kivimaki M, 2000, SOC SCI MED, V50, P583, DOI 10.1016/S0277-9536(99)00326-3
   Kuuppelomaki M, 2003, INT J NURS STUD, V40, P383, DOI 10.1016/S0020-7489(02)00103-7
   Landsbergis P., 2003, HDB OCCUPATIONAL HLT, P265
   Langeland E, 2006, PATIENT EDUC COUNS, V62, P212, DOI 10.1016/j.pec.2005.07.004
   Lindmark U, 2005, NUTR J, V28, P9
   Nelson D.L., 2003, HDB OCCUPATIONAL HLT, V2, P97, DOI DOI 10.1037/10474-005
   Neuner B, 2006, DRUG ALCOHOL DEPEN, V82, P143, DOI 10.1016/j.drugalcdep.2005.09.001
   Niaura R, 2000, PSYCHOSOM MED, V62, P7, DOI 10.1097/00006842-200001000-00002
   Niemi Marja, 2005, DIABETES SUOMESSA ES
   Okada K, 2000, DIABETIC MED, V17, P53, DOI 10.1046/j.1464-5491.2000.00229.x
   Ozer DJ, 2006, ANNU REV PSYCHOL, V57, P401, DOI 10.1146/annurev.psych.57.102904.190127
   Poppius E, 1999, SOC SCI MED, V49, P109, DOI 10.1016/S0277-9536(99)00105-7
   Richardson CG, 2005, J EPIDEMIOL COMMUN H, V59, P979, DOI 10.1136/jech.2005.036756
   Sundquist K, 2004, AM J PREV MED, V27, P22, DOI 10.1016/j.amepre.2004.03.011
   Suominen S, 2005, J EPIDEMIOL COMMUN H, V59, P455, DOI 10.1136/jech.2003.019414
   Suominen S, 2001, J PSYCHOSOM RES, V50, P77, DOI 10.1016/S0022-3999(00)00216-6
   Surtees P, 2003, AM J EPIDEMIOL, V158, P1202, DOI 10.1093/aje/kwg272
   Surtees PG, 2006, HEALTH PSYCHOL, V25, P102, DOI 10.1037/0278-6133.25.1.102
   Toppinen-Tanner S, 2003, PSYCHOL REP, V92, P667
   Tuomilehto J, 2003, DIABETES CARE, V26, P61
   Volanen SM, 2004, EUR J PUBLIC HEALTH, V14, P322, DOI 10.1093/eurpub/14.3.322
   *WHO COLL CTR DRUG, 2004, GUID ATC CLASS DDD A
   Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047
   ZEMMET P, 2001, NATURE, V414, P782
NR 49
TC 38
Z9 38
U1 0
U2 6
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD FEB 6
PY 2008
VL 8
AR 46
DI 10.1186/1471-2458-8-46
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 276NB
UT WOS:000254147900001
PM 18254945
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Hislop, AL
   Fegan, PG
   Schlaeppi, MJ
   Duck, M
   Yeap, BB
AF Hislop, A. L.
   Fegan, P. G.
   Schlaeppi, M. J.
   Duck, M.
   Yeap, B. B.
TI Prevalence and associations of psychological distress in young adults
   with Type 1 diabetes
SO DIABETIC MEDICINE
LA English
DT Article
DE depression; psychological distress; Type 1 diabetes
ID SUBCUTANEOUS INSULIN INFUSION; QUALITY-OF-LIFE; GLYCEMIC CONTROL;
   DEPRESSIVE SYMPTOMS; PSYCHIATRIC MORBIDITY; SEVERE HYPOGLYCEMIA;
   EMOTIONAL-PROBLEMS; METABOLIC-CONTROL; MELLITUS; IDDM
AB Aims To determine the prevalence of psychological distress in young adults with Type 1 diabetes and to explore associated factors.
   Methods Ninety-two participants with Type 1 diabetes (46 male, 46 female) attending a young adult clinic completed two psychological self-report assessments; the Centre for Epidemiological Studies-Depression Scale (CES-D) and Adult Self-Report Scale (ASR). The mean age was 21.6 +/- 2.8 years (SD) and mean duration of diabetes was 9.3 +/- 5.4 years. A questionnaire identified the method of insulin delivery, the frequency of blood glucose monitoring and hypoglycaemia requiring third-party assistance. HbA(1c) was measured.
   Results Of the participants, 35.2% reported depressive symptoms (CES-D >= 16), 23.1% indicating severe depressive symptoms (CES-D >= 24), and 32.2, 40.4 and 35.5% of participants reported significant distress (ASR >= 60) on the ASR total problem scales, ASR internalizing and ASR externalizing scores, respectively. Mean HbA(1c) levels were higher in participants with depressive symptoms compared with those with normal scores (CES-D >= 16, HbA(1c)= 9.4% vs. CES-D < 16, HbA(1c)= 8.4%, P = 0.01). Factors associated with psychological distress included use of continuous subcutaneous insulin infusion (CSII) (P = 0.02) and increased frequency of hypoglycaemic episodes (P = 0.03). CSII users had higher CES-D (21.3 vs. 11.9, P = 0.001) and ASR-Total (59.7 vs. 53.0, P = 0.02) scores than non-CSII users.
   Conclusions Approximately one-third of young adults with Type 1 diabetes experience psychological distress, which is associated with poorer glycaemic control. Psychological distress was related to frequency of hypoglycaemic episodes and method of insulin administration, with significantly greater distress being observed in those using CSII. These findings support inclusion of a psychologist in the diabetes team.
C1 [Hislop, A. L.; Schlaeppi, M. J.; Duck, M.] Fremantle Hosp, Diabet Educ Unit, Fremantle, WA 6160, Australia.
   [Fegan, P. G.; Yeap, B. B.] Fremantle Hosp, Dept Endocrinol & Diabet, Fremantle, WA 6160, Australia.
   [Yeap, B. B.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia.
RP Yeap, BB (reprint author), Fremantle Hosp, Sch Med & Pharmacol, Level 2,T Block,Alma St, Fremantle, WA 6160, Australia.
EM byeap@cyllene.uwa.edu.au
CR Achenbach T. M., 2003, MANUAL ASEBA ADULT F
   Achenbach TM, 2005, J PERS ASSESS, V84, P49, DOI 10.1207/s15327752jpa8401_10
   Achenbach TM, 2003, J CLIN CHILD ADOLESC, V32, P328, DOI 10.1207/S15374424JCCP3203_02
   American Diabetes Association, 2007, DIABETES CARE S1, V30, pS4, DOI DOI 10.2337/DC07-S004
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Barnard KD, 2006, DIABETIC MED, V23, P445, DOI 10.1111/j.1464-5491.2006.01814.x
   Beck-Nielsen H, 1985, Diabetes Res, V2, P37
   BLANZ BJ, 1993, DIABETES CARE, V16, P1579, DOI 10.2337/diacare.16.12.1579
   Boland EA, 1999, DIABETES CARE, V22, P1779, DOI 10.2337/diacare.22.11.1779
   Bruttomesso D, 2002, DIABETIC MED, V19, P628, DOI 10.1046/j.1464-5491.2002.00750.x
   Bryden KS, 2001, DIABETES CARE, V24, P1536, DOI 10.2337/diacare.24.9.1536
   Dantzer C, 2003, CLIN PSYCHOL REV, V23, P787, DOI 10.1016/S0272-7358(03)00069-2
   DAVISS WB, 1995, J AM ACAD CHILD PSY, V34, P1629, DOI 10.1097/00004583-199512000-00013
   de Groot M, 1999, J PSYCHOSOM RES, V46, P425, DOI 10.1016/S0022-3999(99)00014-8
   Doyle EA, 2004, DIABETES CARE, V27, P1554, DOI 10.2337/diacare.27.7.1554
   Edge JA, 2005, ARCH DIS CHILD, V90, P1005, DOI 10.1136/adc.2005.071613
   GOLD AE, 1994, DIABETIC MED, V11, P499, DOI 10.1111/j.1464-5491.1994.tb00314.x
   Gold AE, 1997, DIABETIC MED, V14, P111, DOI 10.1002/(SICI)1096-9136(199702)14:2<111::AID-DIA309>3.0.CO;2-S
   Grey M, 1998, DIABETES CARE, V21, P909, DOI 10.2337/diacare.21.6.909
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   Hoogma RPLM, 2006, DIABETIC MED, V23, P141, DOI 10.1111/j.1464-5491.2005.01738.x
   Jacobson AM, 2002, INT REV NEUROBIOL, V51, P455, DOI 10.1016/S0074-7742(02)51013-8
   Jacobson AM, 1997, DIABETES CARE, V20, P811, DOI 10.2337/diacare.20.5.811
   Kovacs M, 1997, DIABETES CARE, V20, P36, DOI 10.2337/diacare.20.1.36
   Kovacs M, 1997, DIABETES CARE, V20, P45, DOI 10.2337/diacare.20.1.45
   Lawrence JM, 2006, PEDIATRICS, V117, P1348, DOI 10.1542/peds.2005-1398
   Linkeschova R, 2002, DIABETIC MED, V19, P746, DOI 10.1046/j.1464-5491.2002.00713.x
   Lloyd CE, 2003, DIABETES-METAB RES, V19, P401, DOI 10.1002/dmrr.394
   Lustman PJ, 2005, PSYCHOSOM MED, V67, P195, DOI 10.1097/01.psy.0000155670.88919.ad
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   MAYOU R, 1991, PSYCHOL MED, V21, P639, DOI 10.1017/S0033291700022273
   Northam EA, 2005, DIABETIC MED, V22, P152, DOI 10.1111/j.1464-5491.2004.01370.x
   Northam EA, 2004, J PEDIATR ENDOCR MET, V17, P5
   Peyrot M, 1997, DIABETES CARE, V20, P585, DOI 10.2337/diacare.20.4.585
   POLONSKY WH, 1992, HEALTH PSYCHOL, V11, P199, DOI 10.1037/0278-6133.11.3.199
   Pouwer F, 2005, DIABETES RES CLIN PR, V70, P166, DOI 10.1016/j.diabres.2005.03.031
   RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306
   RADLOFF LS, 1991, J YOUTH ADOLESCENCE, V20, P149, DOI 10.1007/BF01537606
   Ritholz MD, 2007, DIABETES CARE, V30, P549, DOI 10.2337/dc06-1755
   Rushton JL, 2002, J AM ACAD CHILD PSY, V41, P199, DOI 10.1097/00004583-200202000-00014
   Shaban MC, 2006, DIABETIC MED, V23, P1381, DOI 10.1111/j.1464-5491.2006.02012.x
   SHAMOON H, 1993, NEW ENGL J MED, V329, P977
   Stewart SM, 2005, PEDIATRICS, V115, P1315, DOI 10.1542/peds.2004-1717
   Talbot F, 2000, DIABETES CARE, V23, P1556, DOI 10.2337/diacare.23.10.1556
   Van Tilburg MAL, 2001, PSYCHOSOM MED, V63, P551, DOI 10.1097/00006842-200107000-00005
   Weissberg-Benchell J, 2003, DIABETES CARE, V26, P1079, DOI 10.2337/diacare.26.4.1079
   Whittemore Robin, 2002, Pediatr Diabetes, V3, P135, DOI 10.1034/j.1399-5448.2002.30303.x
   Winkley K, 2006, BRIT MED J, V333, P65, DOI 10.1136/bmj.38874.652569.55
   Wolpert HA, 2001, DIABETES CARE, V24, P1513, DOI 10.2337/diacare.24.9.1513
   Zhang XP, 2005, AM J EPIDEMIOL, V161, P652, DOI 10.1093/aje/kwi089
NR 50
TC 59
Z9 61
U1 0
U2 10
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0742-3071
J9 DIABETIC MED
JI Diabetic Med.
PD JAN
PY 2008
VL 25
IS 1
BP 91
EP 96
DI 10.1111/j.1464-5491.2007.02310.x
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 250SI
UT WOS:000252320400013
PM 18199136
DA 2019-01-08
ER

PT J
AU Kanczkowski, W
   Ziegler, CG
   Zacharowski, K
   Bornstein, SR
AF Kanczkowski, W.
   Ziegler, C. G.
   Zacharowski, K.
   Bornstein, S. R.
TI Toll-like receptors in endocrine disease and diabetes
SO NEUROIMMUNOMODULATION
LA English
DT Article
DE stress; hypothalamic-pituitary-adrenal axis; proinflammatory cytokines;
   insulin resistance; obesity; pattern recognition receptors
ID INTERLEUKIN-6 PRODUCTION; AUTOIMMUNE-THYROIDITIS; NONTHYROIDAL ILLNESS;
   INSULIN-RESISTANCE; IMMUNE; CELLS; LIPOPOLYSACCHARIDE; EXPRESSION;
   INFLAMMATION; PATHWAYS
AB The body's ability to keep a steady homeostatic state is crucial to health and life. This involves providing an adequate response to a variety of challenges both physical and mental, such as microbial invasion and emotional distress. Interplay between the neuroendocrine and immune systems is essential in either case. Studies have demonstrated that toll-like receptors, or TLRs, play a regulatory role in both systems, and have been proposed as a possible link between the immune, hormonal and metabolic systems. As part of the innate immune system, these receptors control the identification by the body of microbial invaders and its immediate reaction in immune and inflammatory response. What are referred to as pattern recognition receptors are mostly expressed by cells involved in hematopoietic linkage, but an increasing number of studies have demonstrated their expression in other cell types such as neurons and endocrine cells on the hypothalamic-pituitary-adrenal (HPA) axis, thyrocytes, adipocytes and islets of Langerhans. Together with endocrine and metabolic dysregulation, immune system overreaction is often associated with infection and autoimmunity, clearly indicating TLR involvement at organ level which affects organ function. Several diseases such as autoimmune thyroid and pancreatic diseases, septic dysregulation of the HPA axis, diabetes and the metabolic syndrome have been linked to TLR activation and polymorphism. To gain insight into stress response and adaptation, we need to know more about TLRs and the specific physiological role they play in the endocrine and metabolic system and its processes. Copyright (C) 2008 S. Karger AG, Basel.
C1 [Zacharowski, K.] Bristol Royal Infirm & Gen Hosp, Mol Cardioprotect & Inflammat Grp, Bristol, England.
   Carl Gustav Carus Univ Hosp, Dept Med 3, Dresden, Germany.
RP Bornstein, SR (reprint author), Tech Univ Dresden, Carl Gustav Carus Med Sch, Dept Med 3, Fetscherstr 74, DE-01307 Dresden, Germany.
EM Stefan.Bornstein@uniklinikum-dresden.de
CR Akasaka S, 2006, BRAIN RES, V1089, P1, DOI 10.1016/j.brainres.2006.02.112
   Besedovsky HO, 1996, ENDOCR REV, V17, P64, DOI 10.1210/er.17.1.64
   Bornstein SR, 2006, ANN NY ACAD SCI, V1088, P307, DOI 10.1196/annals.1366.027
   Bornstein SR, 2004, P NATL ACAD SCI USA, V101, P16695, DOI 10.1073/pnas.04707550101
   Bornstein SR, 2004, HORM METAB RES, V36, P470, DOI 10.1055/s-2004-825750
   Breuel KF, 2004, NEUROIMMUNOMODULAT, V11, P1, DOI 10.1159/000072963
   CHANG CK, 1993, CIRC SHOCK, V41, P35
   Cho K, 2004, PATHOBIOLOGY, V71, P302, DOI 10.1159/000081725
   CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008
   Chung S, 2006, ENDOCRINOLOGY, V147, P5340, DOI 10.1210/en.2006-0536
   Dayan CM, 1996, NEW ENGL J MED, V335, P99, DOI 10.1056/NEJM199607113350206
   De Groot LJ, 2006, CRIT CARE CLIN, V22, P57, DOI 10.1016/j.ccc.2005.10.001
   de Salamanca AE, 2003, J STEROID BIOCHEM, V85, P81, DOI 10.1016/S0960-0760(03)00134-1
   Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991
   Girling JE, 2007, IMMUNOL CELL BIOL, V85, P481, DOI 10.1038/sj.icb.7100086
   Gloddek J, 2001, EXP CLIN ENDOCR DIAB, V109, P410, DOI 10.1055/s-2001-18995
   Goldberg A, 2007, FASEB J, V21, P2840, DOI 10.1096/fj.06-7910com
   Harii N, 2005, MOL ENDOCRINOL, V19, P1231, DOI 10.1210/me.2004-0100
   Kanczkowski W, 2007, HORM METAB RES, V39, P457, DOI 10.1055/s-2007-980189
   Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118
   Lee JY, 2003, J LIPID RES, V44, P479, DOI 10.1194/jlr.M200361-JLR200
   Lohrer P, 2000, ENDOCRINOLOGY, V141, P4457, DOI 10.1210/en.141.12.4457
   Makola D, 2007, J CLIN GASTROENTEROL, V41, P548, DOI 10.1097/MCG.0b013e318030e3c3
   Marx C, 1998, HORM METAB RES, V30, P416, DOI 10.1055/s-2007-978907
   Maxime V, 2007, CRIT CARE MED, V35, pS596, DOI 10.1097/01.CCM.0000279097.67263.52
   McCall KD, 2007, ENDOCRINOLOGY, V148, P4226, DOI 10.1210/en.2007-0459
   Moynagh PN, 2003, J ENDOCRINOL, V179, P139, DOI 10.1677/joe.0.1790139
   Oeff MK, 2006, DERMATOLOGY, V213, P266, DOI 10.1159/000095056
   Prigent H, 2004, CRIT CARE, V8, P243, DOI 10.1186/cc2878
   Rocchi R, 2007, P NATL ACAD SCI USA, V104, P6019, DOI 10.1073/pnas.0701319104
   SCHNEIDER DS, 1994, DEVELOPMENT, V120, P1243
   Schroder NW, 2005, LANCET INFECT DIS, V5, P156, DOI 10.1016/S1473-3099(05)70023-2
   Schteingart DE, 2001, J CLIN ENDOCR METAB, V86, P3968, DOI 10.1210/jc.86.8.3968
   Takeda K, 2005, J ENDOTOXIN RES, V11, P51, DOI 10.1179/096805105225006687
   Tichomirowa M, 2005, J NEUROENDOCRINOL, V17, P152, DOI 10.1111/j.1365-2826.2005.01286.x
   Tran N, 2007, J CLIN ENDOCR METAB, V92, P2773, DOI 10.1210/jc.2006-2697
   Tsan MF, 2004, J LEUKOCYTE BIOL, V76, P514, DOI 10.1189/jlb.0304127
   Tschop M, 2006, NAT MED, V12, P1359, DOI 10.1038/nm1206-1359
   Turrin NP, 2004, EXP BIOL MED, V229, P996
   Vakharia K, 2005, ENDOCRINOLOGY, V146, P1398, DOI 10.1210/en.2004-0882
   VIRKAMAKI A, 1992, J CLIN ENDOCR METAB, V74, P673, DOI 10.1210/jc.74.3.673
   Vives-Pi M, 2003, CLIN EXP IMMUNOL, V133, P208, DOI 10.1046/j.1365-2249.2003.02211.x
   Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102
   Wen L, 2004, J IMMUNOL, V172, P3173, DOI 10.4049/jimmunol.172.5.3173
   Yamazaki K, 2007, ENDOCRINOLOGY, V148, P3226, DOI 10.1210/en.2006-1638
   Zacharowski K, 2006, P NATL ACAD SCI USA, V103, P6392, DOI 10.1073/pnas.0601527103
   Zouboulis CC, 2007, HORM METAB RES, V39, P69, DOI 10.1055/s-2007-967095
NR 47
TC 19
Z9 23
U1 0
U2 2
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1021-7401
J9 NEUROIMMUNOMODULAT
JI Neuroimmunomodulation
PY 2008
VL 15
IS 1
BP 54
EP 60
DI 10.1159/000135624
PG 7
WC Endocrinology & Metabolism; Immunology; Neurosciences
SC Endocrinology & Metabolism; Immunology; Neurosciences & Neurology
GA 334ME
UT WOS:000258225100007
PM 18667800
DA 2019-01-08
ER

PT J
AU Ridner, SH
   Dietrich, MS
AF Ridner, Sheila H.
   Dietrich, Mary S.
TI Self-reported comorbid conditions and medication usage in breast cancer
   survivors with and without lymphedema
SO ONCOLOGY NURSING FORUM
LA English
DT Article
ID PSYCHOLOGICAL DISTRESS; UNPLEASANT SYMPTOMS; RATED HEALTH; NODE BIOPSY;
   ARM; COMPLICATIONS; SECONDARY
AB Purpose/Objectives: To compare the self-reported comorbid conditions and medication usage between breast cancer survivors with and without breast cancer treatment-related lymphedema.
   Design: Descriptive, cross-sectional.
   Setting: A community-based study conducted in a major metropolitan area and surrounding rural counties in the southeastern United States.
   Sample: A convenience sample of 64 breast cancer survivors with lymphedema and 64 breast cancer survivors without lymphedema who were age matched within three years and recruited for a parent study. Twenty-one additional nonage-matched breast cancer survivors with or without lymphedema also were included.
   Methods: Self-reported survey instruments and height and weight measurement.
   Main Research Variables: Lymphedema, demographic information, self-reported comorbid diseases or medical issues, and medication usage.
   Findings: Breast cancer survivors with lymphedema experienced more comorbid conditions. Statistically significant group differences were found in body mass index, orthopedic issues, cardiac medications, hormone blockers, and osteoporosis medication or calcium supplement usage. Co-occurrence of diabetes and carpal tunnel syndrome approached statistical significance. Breast cancer survivors with lymphedema were older and had lower incomes.
   Conclusions: Comorbid conditions may influence the development of breast cancer treatment-related lymphedema. Further research, particularly a longitudinal study, is indicated.
   Implications for Nursing: Healthcare professionals who care for breast cancer survivors need to routinely assess them for the presence of comorbid conditions and the development of lymphedema. Obese breast cancer survivors may benefit from weight reduction interventions to possibly decrease their risk of developing lymphedema and improve their overall health status. Patients with arthritis and orthopedic and cardiac issues such as hypertension may warrant careful monitoring.
C1 [Ridner, Sheila H.; Dietrich, Mary S.] Vanderbilt Univ, Sch Nursing, Nashville, TN 37240 USA.
RP Ridner, SH (reprint author), Vanderbilt Univ, Sch Nursing, Nashville, TN 37240 USA.
FU NINR NIH HHS [1F31NR07854-02]
CR Armer J, 2001, LYMPH LINK, V13, P1
   Armer JM, 2004, LYMPHOLOGY, V37, P73
   Armer JM, 2003, NURS RES, V52, P370, DOI 10.1097/00006199-200311000-00004
   Bosompra Kwadwo, 2002, Breast J, V8, P338, DOI 10.1046/j.1524-4741.2002.08603.x
   Carpenter J S, 1999, Oncol Nurs Forum, V26, P1311
   Carpenter Janet S, 2002, Oncol Nurs Forum, V29, pE16, DOI 10.1188/02.ONF.E16-E25
   Centers for Disease Control and Prevention (CDC), 2007, BMI BOD MASS IND BMI
   Deutsch M, 2001, AM J CLIN ONCOL-CANC, V24, P172, DOI 10.1097/00000421-200104000-00015
   Dodd M J, 2001, Oncol Nurs Forum, V28, P465
   El Saghir NS, 2005, BREAST, V14, P347, DOI 10.1016/j.breast.2005.02.011
   Foldi M, 2003, TXB LYMPHOLOGY PHYS
   Franks P, 2003, SOC SCI MED, V56, P2505, DOI 10.1016/S0277-9536(02)00281-2
   Gold M, 1996, MED CARE, V34, P163, DOI 10.1097/00005650-199602000-00008
   Handley WS, 1908, LANCET, V1, P783
   Hinrichs CS, 2004, ANN SURG ONCOL, V11, P573, DOI 10.1245/ASO.2004.04.017
   *IMPEDIMED, 2007, IMPEDIMED US DISTR L
   Johansson K, 2002, LYMPHOLOGY, V35, P59
   Langer I, 2005, BREAST CANCER RES TR, V90, P85, DOI 10.1007/s10549-004-3268-6
   LENZ ER, 1995, ADV NURS SCI, V17, P1
   Lenz ER, 1997, ADV NURS SCI, V19, P14, DOI 10.1097/00012272-199703000-00003
   LEWISSON EF, 1955, BREAST CANC DIAGNOSI
   LOBB A W, 1949, West J Surg Obstet Gynecol, V57, P550
   Masmoudi A, 2005, Dermatol Online J, V11, P12
   Matas R., 1913, AM J TROP DIS, VI, P60
   McWayne J, 2005, CANCER, V104, P457, DOI 10.1002/cncr.21195
   *NAT CANC I, 2007, CANC BREAST
   Newman ML, 1996, J PAIN SYMPTOM MANAG, V12, P376, DOI 10.1016/S0885-3924(96)00187-X
   Parshall MB, 2001, HEART LUNG, V30, P47
   Passik SD, 1995, PSYCHO-ONCOL, V4, P255, DOI 10.1002/pon.2960040402
   Petrek JA, 2000, CA-CANCER J CLIN, V50, P292, DOI 10.3322/canjclin.50.5.292
   Pugh L C, 1999, J Obstet Gynecol Neonatal Nurs, V28, P74, DOI 10.1111/j.1552-6909.1999.tb01967.x
   Ridner SH, 2007, LYMPHOLOGY, V40, P35
   Ridner SH, 2006, PATIENT EDUC COUNS, V61, P72, DOI 10.1016/j.pec.2005.02.009
   Ridner SH, 2005, SUPPORT CARE CANCER, V13, P904, DOI 10.1007/s00520-005-0810-y
   RIDNER SH, 2004, DISS ABSTR INT, V64, DOI UNSP AA3113289
   Rockson SG, 2001, AM J MED, V110, P288, DOI 10.1016/S0002-9343(00)00727-0
   SAY CC, 1974, SURG GYNECOL OBSTET, V138, P370
   Tabibiazar R, 2006, PLOS MED, V3, P1114, DOI 10.1371/journal.pmed.0030254
   U.S. Department of Health and Human Services, 2006, 2006 HHS POV GUID
   Wilke LG, 2006, ANN SURG ONCOL, V13, P491, DOI 10.1245/ASO.2006.05.013
NR 40
TC 22
Z9 24
U1 0
U2 8
PU ONCOLOGY NURSING SOC
PI PITTSBURGH
PA 125 ENTERPRISE DR, PITTSBURGH, PA 15275 USA
SN 0190-535X
J9 ONCOL NURS FORUM
JI Oncol. Nurs. Forum
PD JAN
PY 2008
VL 35
IS 1
BP 57
EP 63
DI 10.1188/08.ONF.57-63
PG 7
WC Oncology; Nursing
SC Oncology; Nursing
GA 253ZH
UT WOS:000252555600008
PM 18192153
OA Bronze
DA 2019-01-08
ER

PT S
AU Derogatis, LR
AF Derogatis, Leonard R.
BE Balon, R
TI Clinical and research evaluations of sexual dysfunctions
SO SEXUAL DYSFUNCTION: THE BRAIN-BODY CONNECTION
SE Advances in Psychosomatic Medicine
LA English
DT Article; Book Chapter
ID ERECTILE FUNCTION IIEF; FEMALE SIDI-F; DESIRE DISORDER; INTERNATIONAL
   INDEX; VALIDATION; SCALE; WOMEN; QUESTIONNAIRE; DISTRESS; PROFILE
AB Evaluations of the nature of an individual's sexual functioning are done with relative frequency in today's clinical healthcare environment, often prompted by sequelae of a medical disorder (e.g. diabetes, breast cancer), surgical procedure (e.g. bilateral oophorectomy), or prescribed medications (SSRI antidepressant, antihypertensive). In addition, an increasingly large number of evaluations of sexual functioning are done in association with clinical trials research in the rapidly emerging field of sexual medicine, Although clinical and research assessments of sexual functioning share many similarities, they can also be quite different, with distinct perspectives and goals regarding the assessment process. Research evaluations tend to be narrowly focused on an index condition, with highly defined patient characteristics, and long lists of inclusion/exclusion criteria. Treatment regimens are defined by research protocol a priori, and assigned through randomization, with few options for alternatives. The process results in a rigorously defined sample of patients, but one that may be hard to generalize from to real world clinical reality. Clinical sexual evaluations, on the other hand, tend to arise in a much broader health context. There are no exclusionary patient characteristics; medical, psychological, and relationship complexities all form the context in which the patient's sexual functioning occurs, and must be factored in to the clinical evaluation and treatment recommendations. Regardless of which context gives rise to the evaluation, there are three basic sources of data that we draw from: psychometric assessment, clinical interview and laboratory assays. The clinician doing a sexual evaluation must assimilate and integrate the data from these three sources in an iterative process and arrive at a cogent diagnosis and treatment plan. Copyright (C) 2008 S. Karger AG, Basel.
C1 [Derogatis, Leonard R.] Johns Hopkins Univ, Sch Med, Ctr Sexual Med Sheppard Pratt, Baltimore, MD 21285 USA.
   [Derogatis, Leonard R.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21285 USA.
RP Derogatis, LR (reprint author), Johns Hopkins Univ, Sch Med, Ctr Sexual Med Sheppard Pratt, 6501 N Charles St, Baltimore, MD 21285 USA.
EM Lderogatis@sheppardpratt.org
CR Althof S, 2006, J SEX MED, V3, P465, DOI 10.1111/j.1743-6109.2006.00239.x
   Bonierbale M, 2003, CURR MED RES OPIN, V19, P114, DOI 10.1185/030079902125001461
   Clayton AH, 2006, J SEX MARITAL THER, V32, P115, DOI 10.1080/00926230500442300
   Clayton AH, 2002, J CLIN PSYCHIAT, V63, P357, DOI 10.4088/JCP.v63n0414
   Derogatis L, 2004, J SEX MARITAL THER, V30, P25, DOI 10.1080/00926230490247183
   DeRogatis LR, 2008, J SEX MED, V5, P289, DOI 10.1111/j.1743-6109.2007.00668.x
   Derogatis LR, 1997, J SEX MARITAL THER, V23, P291
   Derogatis LR, 2002, J SEX MARITAL THER, V28, P317, DOI 10.1080/00926230290001448
   DEROGATIS LR, 2008, INT J IMPOT IN PRESS
   MCHORNEY CA, 2004, MENOPAUSE, V11, P1
   Nunnally J. C., 1978, PSYCHOMETRIC THEORY
   Quirk FH, 2002, J WOMEN HEALTH GEN-B, V11, P277, DOI 10.1089/152460902753668475
   Rosen R, 2000, J SEX MARITAL THER, V26, P191, DOI 10.1080/009262300278597
   Rosen RC, 1997, UROLOGY, V49, P822, DOI 10.1016/S0090-4295(97)00238-0
   Rosen RC, 2002, INT J IMPOT RES, V14, P226, DOI 10.1038/sj.ijir.3900857
   Rust J, 2007, GYNECOL ENDOCRINOL, V23, P638, DOI 10.1080/09513590701592306
   Sills T, 2005, J SEX MED, V2, P801, DOI 10.1111/j.1743-6109.2005.00146.x
   *US DEP HHS, 2000, GUID IND FEM SEX DYS
NR 18
TC 8
Z9 9
U1 0
U2 4
PU KARGER
PI BASEL
PA POSTFACH, CH-4009 BASEL, SWITZERLAND
SN 0065-3268
BN 978-3-8055-8357-2
J9 ADV PSYCHOSOM MED
JI Adv.Psychosom.Med.
PY 2008
VL 29
BP 7
EP 22
DI 10.1159/000126621
PG 16
WC Clinical Neurology; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA BHZ89
UT WOS:000257855200002
PM 18391554
DA 2019-01-08
ER

PT J
AU Hu, J
AF Hu, Jie
TI Health-related quality of life in low-income older African Americans
SO JOURNAL OF COMMUNITY HEALTH NURSING
LA English
DT Article
ID DIABETES-MELLITUS; SURVEY SF-36; DEPRESSIVE SYMPTOMS; FUNCTIONAL STATUS;
   CHRONIC DISEASES; HEART-FAILURE; ADULTS; COMORBIDITY; OUTCOMES; MODEL
AB This study examined the relationships among comorbid conditions, symptom stress, depression, functional status and health-related quality of life (HRQOL) in low-income older African Americans with chronic diseases. A convenience sample of 83 older African American adults living in subsidized housing for elders participated in the study. Data were collected in face-to-face interviews. Participants reported lower scores on HRQOL than the SF-36 norms for age 60 or older in the general U.S. population. Comorbid conditions, symptom distress, depression, and functional status significantly predicted both the physical (F = 38.92, p < .001) and mental (F = 23.21, p < .001) health components of HRQOL, accounting for 63% of variance in the SF-36 physical health score and 55% of the variance in the SF-36 mental health score. The findings suggested that developing interventions to assist older African Americans to better manage their symptoms and depression are of prime importance for improving HRQOL.
C1 Univ N Carolina, Sch Nursing, Greensboro Sch Nursing, Chapel Hill, NC 27515 USA.
RP Hu, J (reprint author), POB 26170, Greensboro, NC 27402 USA.
EM jie_hu@uncg.edu
CR Angel RJ, 2002, MULTICULTURAL MEASUREMENT IN OLDER POPULATIONS, P129
   Ashing-Giwa KT, 2005, QUAL LIFE RES, V14, P297, DOI 10.1007/s11136-004-0729-7
   Blaum CS, 2003, J AM GERIATR SOC, V51, P745, DOI 10.1046/j.1365-2389.2003.51256.x
   Brown DW, 2004, DIABETES RES CLIN PR, V65, P105, DOI 10.1016/j.diabres.2003.11.014
   Camacho F, 2002, QUAL LIFE RES, V11, P783, DOI 10.1023/A:1020858102483
   *CDCP, 2006, HLTH AG PREV DIS IMP
   *CDCP, 2005, HLTH PEOPL 2010
   *CDCP, 2006, EL RAC ETHN HLTH DIS
   *CDCP, 2006, HLTH REL QUAL LIF
   *CDCP, 2005, STAT AG HLTH AM 2004
   *DEP HLTH HUM SERV, 2004, BURD CHRON DIS THEIR
   Dominick KL, 2004, ARTHRIT RHEUM-ARTHR, V51, P326, DOI 10.1002/art.20390
   ERICKCON SR, 2004, J HUMAN HYPERTENSION, V15, P539
   Ferrucci L, 2000, J AM GERIATR SOC, V48, P1490, DOI 10.1111/jgs.2000.48.11.1490
   Franks P, 2006, SOC SCI MED, V62, P2469, DOI 10.1016/j.socscimed.2005.10.035
   Gaynes BN, 2002, J NERV MENT DIS, V190, P799, DOI 10.1097/00005053-200212000-00001
   Gijsen R, 2001, J CLIN EPIDEMIOL, V54, P661, DOI 10.1016/S0895-4356(00)00363-2
   Gulliford MC, 1999, J CLIN EPIDEMIOL, V52, P773, DOI 10.1016/S0895-4356(99)00053-0
   HILL CV, 2003, AFRICAN AM RES PERSP, V9, P10
   HUSAINI AB, 2004, HLTH SOCIAL WORK, V15, P258
   Ibrahim SA, 2002, J CLIN EPIDEMIOL, V55, P512, DOI 10.1016/S0895-4356(01)00501-7
   Jang Y, 2005, J GERONTOL B-PSYCHOL, V60, pP313, DOI 10.1093/geronb/60.6.P313
   JANG Y, 2003, J GERONTOL B-PSYCHOL, V53, pS221
   Juenger J, 2002, HEART, V87, P235, DOI 10.1136/heart.87.3.235
   Kovac SH, 2006, QUAL LIFE RES, V15, P451, DOI 10.1007/s11136-005-3213-0
   Kriegsman DMW, 2004, J CLIN EPIDEMIOL, V57, P55, DOI 10.1016/S0895-4356(03)00258-0
   LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179
   LEVI J, 2001, GOD FAITH HLTH EXPLO
   Maddigan SL, 2005, QUAL LIFE RES, V14, P1311, DOI 10.1007/s11136-004-6640-4
   Maille AR, 1996, QUAL LIFE RES, V5, P287, DOI 10.1007/BF00434751
   MCCORKLE R, 1983, SOC SCI MED, V17, P431, DOI 10.1016/0277-9536(83)90348-9
   McCorkle R, 1978, Cancer Nurs, V1, P373
   MCCORKLE R, 2000, USERS MANUAL SYMPTOM
   MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006
   MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004
   McKellar JD, 2004, DIABETES EDUCATOR, V30, P485, DOI 10.1177/014572170403000320
   MITCHELL GJ, 1997, MED CARE, V35, pNS1
   OTSEY SO, 2002, CULTURAL DIVERSITY E, V8, P224
   Parkerson GR, 2000, HEALTH CARE FINANC R, V21, P171
   Ruo B, 2003, JAMA-J AM MED ASSOC, V290, P215, DOI 10.1001/jama.290.2.215
   Schlenk EA, 1998, QUAL LIFE RES, V7, P57
   SHEIKH J I, 1986, Clinical Gerontologist, V5, P165
   Skarupski KA, 2007, QUAL LIFE RES, V16, P287, DOI 10.1007/s11136-006-9115-y
   Sousa KH, 2003, J ADV NURS, V42, P571, DOI 10.1046/j.1365-2648.2003.02660.x
   SPECTOR WD, 2006, QUALITY LIFE PHARM C
   Spiro L, 2003, J AM GERIATR SOC, V51, P1511, DOI 10.1046/j.1532-5415.2003.514848.x
   STILES PG, 1998, J CLIN GEROPSYCHOL, V4, P89
   Stover JC, 2001, APPL NURS RES, V14, P72, DOI 10.1053/apnr.2001.22372
   Upchurch S, 2005, INT J AGING HUM DEV, V60, P77, DOI 10.2190/X05G-XGRL-778R-UHBW
   WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002
   Ware JE, 1994, SF 36 PHYS MENTAL HL
   Wensing M, 2001, QUAL LIFE RES, V10, P141, DOI 10.1023/A:1016705615207
   Westlake C, 2002, HEART LUNG, V31, P85, DOI 10.1067/mhl.2002.122839
   Wijnhoven HAH, 2003, RESP MED, V97, P468, DOI 10.1053/rmed.2002.1463
   WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59
   Wolinsky FD, 2004, J GERONTOL B-PSYCHOL, V59, pS118, DOI 10.1093/geronb/59.2.S118
   Wolinsky FD, 1996, MED CARE, V34, P537, DOI 10.1097/00005650-199606000-00004
NR 57
TC 12
Z9 12
U1 0
U2 4
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0737-0016
EI 1532-7655
J9 J COMMUN HEALTH NURS
JI J. Community Health Nurs.
PD WIN
PY 2007
VL 24
IS 4
BP 253
EP 265
DI 10.1080/07370010701645901
PG 13
WC Nursing
SC Nursing
GA 235VG
UT WOS:000251261800004
PM 18092917
DA 2019-01-08
ER

PT J
AU Lecube, A
   Fort, JM
   Baena, JA
   Armengol, M
   Simo, R
   Mesa, J
AF Lecube, Albert
   Manuel Fort, Jose
   Baena, Juan Antonio
   Armengol, Manuel
   Simo, Rafael
   Mesa, Jordi
TI Initial experience with 150 consecutive gastric bypass: an approach to
   the learning curve of bariatric procedures
SO OBESITY AND METABOLISM-MILAN
LA English
DT Article
DE bypass; complications; experience; mortality; surgery
ID MULTIVARIATE-ANALYSIS; HOSPITAL VOLUME; RISK-FACTORS; SURGERY; OBESITY;
   MORTALITY; OUTCOMES; RHABDOMYOLYSIS; PREVALENCE; OVERWEIGHT
AB Background and aims: The gastric bypass surgery for the treatment of obesity has increased its popularity in the last years. Although a steep learning curve and severe life-threatening complications are associated with bariatric procedures, large series have acceptable levels of morbidity and mortality. The aim of this study was to report the characteristics and outcomes of the first 150 Roux-en-Y gastric bypass performed in our institution from May 2001 to September 2006. Methods: Data were reviewed prospectively from a maintained database. Out of 150, the last 23 procedures were performed laparoscopically. Results The mean age of the patients was 43 years and 78.7% were female. The mean preoperative body mass index was 48.24 kg/m(2). Data at one year after surgery were available in 105 (70.0%) patients. Seventy-three percent were discharged within 4 days. The incidence of early major and minor complications was 12.00% and 10.66%, respectively. Major complications include 10 anastomotic leaks, 2 intestinal occlusions, 2 gastrointestinal bleedings, 2 respiratory failures, and 2 pulmonary embolisms. Thirteen patients required reoperation. Four male patients died: causes were multiorgan failure due to anastomotic leak and sepsis, rhabdomyolysis, adult respiratory distress syndrome after bronchoaspiration, and massive thromboembolism. Weight loss at one year was 74.45% of excess body weight. Notably, 89.18% of patients with type 2 diabetes and 71.85% of patients with hypertension no longer required medications. Conclusions: Bariatric surgery is an effective long-term treatment for severe obesity. However, the strengths of this study include the importance for teams that are just at the beginning of their experience to select appropriate candidates for surgery.
C1 [Lecube, Albert; Simo, Rafael; Mesa, Jordi] Univ Autonoma Barcelona, Hosp Univ Vall Hebron, Div Endocrinol, Planta Ctr 8A,Inst Recerca Vall Hebron,Obes Unit, Barcelona 08035, Spain.
   [Manuel Fort, Jose; Baena, Juan Antonio; Armengol, Manuel] Univ Autonoma Barcelona, Hosp Univ Vall Hebron, Inst Recerca Vall Hebron, Endocrinol Surg Unit, Barcelona 08035, Spain.
RP Lecube, A (reprint author), Univ Autonoma Barcelona, Hosp Univ Vall Hebron, Div Endocrinol, Planta Ctr 8A,Inst Recerca Vall Hebron,Obes Unit, Pg Vall Hebron 119-129, Barcelona 08035, Spain.
EM alecube@vhebron.net
RI Baena Fustegueras, Juan Antonio/E-2912-2012
OI Baena Fustegueras, Juan Antonio/0000-0001-8543-6863
CR Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643
   [Anonymous], 2006, LANCET, V367, P1549
   [Anonymous], 1992, AM J CLIN NUTR, V55, p615S, DOI DOI 10.1093/AJCN/55.2.615S
   Aranceta-Bartrina J, 2005, MED CLIN-BARCELONA, V125, P460, DOI 10.1157/13079612
   Benotti PN, 2006, SURGERY, V139, P340, DOI 10.1016/j.surg.2005.08.017
   Biertho L, 2003, J AM COLL SURGEONS, V197, P536, DOI 10.1016/S1072-7515(03)00730-0
   Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205
   BUCHWALD H, 2004, JAMA-J AM MED ASSOC, V92, P1724, DOI DOI 10.1001/JAMA.292.14.1724
   Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423
   Courcoulas A, 2003, SURGERY, V134, P613, DOI 10.1016/S0039-6060(03)00306-4
   Fernandez AZ, 2004, ANN SURG, V239, P698, DOI 10.1097/01.sla.0000124295.41578.ab
   Fernandez AZ, 2004, SURG ENDOSC, V18, P193, DOI 10.1007/s00464-003-8926-y
   Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723
   Flum DR, 2005, JAMA-J AM MED ASSOC, V294, P1903, DOI 10.1001/jama.294.15.1903
   Flum DR, 2004, J AM COLL SURGEONS, V199, P543, DOI 10.1016/j.jamcollsurg.2004.06.014
   Jamal MK, 2005, SURG OBES RELAT DIS, V1, P73
   James PT, 2001, OBES RES, V9, p228S, DOI 10.1038/oby.2001.123
   Khurana RN, 2004, ARCH SURG-CHICAGO, V139, P73, DOI 10.1001/archsurg.139.1.73
   Liu JH, 2003, AM SURGEON, V69, P823
   Livingston EH, 2004, AM J SURG, V188, P105, DOI 10.1016/j.amjsurg.2004.03.001
   Livingston EH, 2002, ANN SURG, V236, P576, DOI 10.1097/01.SLA.0000033321.22614.D6
   Maggard MA, 2005, ANN INTERN MED, V142, P547, DOI 10.7326/0003-4819-142-7-200504050-00013
   Melinek J, 2002, ARCH PATHOL LAB MED, V126, P1091
   Mognol P, 2004, OBES SURG, V14, P91, DOI 10.1381/096089204772787356
   Mokdad AH, 2001, JAMA-J AM MED ASSOC, V289, P76, DOI DOI 10.1001/JAMA.289.1.76
   Neira M, 2006, BRIT J NUTR, V96, pS8, DOI 10.1079/BJN20061690
   Nguyen NT, 2004, ANN SURG, V240, P586, DOI 10.1097/01.sla.0000140752.74893.24
   Nguyen NT, 2001, ANN SURG, V234, P279, DOI 10.1097/00000658-200109000-00002
   Oria HE, 1998, OBES SURG, V8, P487, DOI 10.1381/096089298765554043
   Pope GD, 2002, J GASTROINTEST SURG, V6, P855, DOI 10.1016/S1091-255X(02)00085-9
   Sugerman HJ, 2001, ANN SURG, V234, P41, DOI 10.1097/00000658-200107000-00007
   Wittgrove AC, 2000, OBES SURG, V10, P233, DOI 10.1381/096089200321643511
NR 32
TC 2
Z9 2
U1 0
U2 0
PU EDITRICE KURTIS S R L
PI MILAN
PA VIA LUIGI ZOJA 30, 20153 MILAN, ITALY
SN 1825-3865
EI 1826-7572
J9 OBES METAB-MILAN
JI Obes. Metab.-Milan
PD DEC
PY 2007
VL 3
IS 4
BP 175
EP 182
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 339HM
UT WOS:000258568700004
DA 2019-01-08
ER

PT J
AU Williams, GC
   Lynch, M
   Glasgow, RE
AF Williams, Geoffrey C.
   Lynch, Martin
   Glasgow, Russell E.
TI Computer-assisted intervention improves patient-centered diabetes care
   by increasing autonomy support
SO HEALTH PSYCHOLOGY
LA English
DT Article
DE patient-centered diabetes care; autonomy support; diabetes quality of
   care; computer-assisted intervention; perceived competence
ID SELF-DETERMINATION THEORY; CHRONIC ILLNESS; GLYCEMIC CONTROL;
   HEALTH-CARE; TRIAL; PREVENTION; COMPETENCE; MANAGEMENT; MODEL
AB Objective: To determine if a patient-centered, computer-assisted diabetes care intervention increased perceived autonomy support, perceived competence (from self-determination theory), and if these constructs mediated the effect of the intervention on ADA/NCQA recommended diabetes care outcomes. Design: A randomized controlled trial of 866 adult type 2 diabetes patients in heterogeneous primary care settings in Colorado. Main Outcome Measures: Perceived autonomy support, perceived competence, patient satisfaction, glycemic control (HbA1c), ratio of total to HDL cholesterol, diabetes distress, and depressive symptoms. Results: The computer-assisted intervention increased patient perception of autonomy support relative to a computer-based control condition (p < .05). Change in perceived competence partially mediated the effects of increased autonomy support on the change in lipids, diabetes distress, and depressive symptoms. The construct of autonomy support was found to be separate from that of patient satisfaction. Conclusions: A patient-centered, computer-assisted intervention was effective in improving diabetes self-management outcomes, in part, because it increased patients' perception that their autonomy was supported which changed perceived competence. These findings support the self-determination model for health behavior change and the chronic care model and support the further study of the use of these technologies to motivate patients to improve their health outcomes.
C1 Univ Rochester, Dept Clin & Social Sci Psychol, Rochester, NY 14627 USA.
   Univ Rochester, Dept Med, Rochester, NY 14627 USA.
   Univ Rochester, Dept Psychiat, Rochester, NY 14627 USA.
   Univ S Florida, Dept Psychol, Tampa, FL 33620 USA.
   Kaiser Permanente, Clin Res Unit, Denver, CO USA.
RP Williams, GC (reprint author), Univ Rochester, Dept Clin & Social Sci Psychol, 601 Elmwood Ave, Rochester, NY 14627 USA.
EM Geoffrey_Williams@urmc.rochester.edu
CR Bandura A., 1997, SELF EFFICACY EXERCI
   Baranowski T, 2000, HEALTH EDUC BEHAV, V27, P157, DOI 10.1177/109019810002700202
   Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775
   Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1909, DOI 10.1001/jama.288.15.1909
   Byrne BM, 2001, STRUCTURAL EQUATION
   Coffield AB, 2001, AM J PREV MED, V21, P1, DOI 10.1016/S0749-3797(01)00308-7
   Deci E. L, 2002, HDB SELF DETERMINATI
   Deci EL, 1985, INTRINSIC MOTIVATION
   Glasgow RE, 2002, ANN BEHAV MED, V24, P80, DOI 10.1207/S15324796ABM2402_04
   Glasgow RE, 2005, DIABETES CARE, V28, P33, DOI 10.2337/diacare.28.1.33
   Glasgow RE, 2004, J GEN INTERN MED, V19, P1167, DOI 10.1111/j.1525-1497.2004.30425.x
   Glasgow RE, 2004, AM J PREV MED, V27, P80, DOI 10.1016/j.amepre.2004.04.026
   Glasgow RE, 2003, DIABETES CARE, V26, P2451, DOI 10.2337/diacare.26.8.2451
   Holman H, 2000, BRIT MED J, V320, P526, DOI 10.1136/bmj.320.7234.526
   Joyner L, 1997, HMO Pract, V11, P168
   King D. K., 2004, DIABETES SPECTRUM, V17, P234
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   MACKINNON DP, 1993, EVALUATION REV, V17, P144, DOI 10.1177/0193841X9301700202
   McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615
   *NAT COMM QUAL ASS, 2003, DIAB PHYS REC PROGR
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68
   Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012
   WAGNER EH, 1998, NEW WAYS CARE OLDER, P39
   Williams GC, 2006, HEALTH PSYCHOL, V25, P91, DOI 10.1037/0278-6133.25.1.91
   Williams GC, 1996, J PERS SOC PSYCHOL, V70, P115, DOI 10.1037/0022-3514.70.1.115
   Williams GC, 2005, PATIENT EDUC COUNS, V57, P39, DOI 10.1016/j.pec.2004.04.001
   Williams GC, 2004, HEALTH PSYCHOL, V23, P58, DOI 10.1037/0278-6133.23.1.58
   Williams GC, 1998, DIABETES CARE, V21, P1644, DOI 10.2337/diacare.21.10.1644
   Yarnall KSH, 2003, AM J PUBLIC HEALTH, V93, P635, DOI 10.2105/AJPH.93.4.635
NR 30
TC 91
Z9 91
U1 1
U2 13
PU AMER PSYCHOLOGICAL ASSOC/EDUCATIONAL PUBLISHING FOUNDATION
PI WASHINGTON
PA 750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA
SN 0278-6133
J9 HEALTH PSYCHOL
JI Health Psychol.
PD NOV
PY 2007
VL 26
IS 6
BP 728
EP 734
DI 10.1037/0278-6133.26.6.728
PG 7
WC Psychology, Clinical; Psychology
SC Psychology
GA 230FN
UT WOS:000250861700012
PM 18020845
DA 2019-01-08
ER

PT J
AU Prakash, O
   Gupta, LN
   Singh, VB
   Singhal, AK
   Verma, KK
AF Prakash, Om
   Gupta, L. N.
   Singh, V. B.
   Singhal, A. K.
   Verma, K. K.
TI Profile of psychiatric disorders and life events in medically ill
   elderly: experiences from geriatric clinic in Northern India
SO INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
LA English
DT Article
DE physical illness; elderly; mental disorders; life events
ID MENTAL-HEALTH; CONSENSUS STATEMENT; PRIMARY-CARE; DEPRESSION;
   PREVALENCE; DISABILITY; ANXIETY; STRESS
AB Background Morbidity among elderly people has an important influence on their psychological well-being. Evaluation of the morbidity profile and its determinants, which have implications for management of medical problems of elderly people, are scarce in developing countries. Even the physicians' detection rate of mental distress in elderly populations is low in medical outpatient clinics. This could be due to the large caseloads and also, importantly, underestimation of psychological concerns of the elderly. The objective of this study was to study the psychiatric co-morbidity and life events among elderly medical outpatients.
   Methods One hundred medically ill elderly (>60 years) patients attending the Geriatric Clinic at Bikaner (North India) constituted the study population. The physical diagnosis was made by a physician based on reported illness, clinical examination and medical records. Psychiatric diagnosis was made by detailed clinical psychiatric interview using ICD-10 guidelines. Life events were assessed by the Indian adaptation of Presumptive Stressful Life Events Scale.
   Results Hypertension was the most commonly reported physical diagnosis (50%), other specific medical illnesses were osteoarthritis (15%), diabetes (13%) and constipation (8%). The study found 18% subjects had depression and 11% had other mental disorders. Patients with mental disorders had suffered more recent stressful life events. Among life events, conflicts in family (16%); unemployment of self or children (9%) was reported by elderly psychiatric patients. Other reported life events in psychiatric diagnosed elderly were conflict in family (7%), illness of self (6%) or family members (5%) and death of family mernbers (5%) or close relatives (4%).
   Conclusion Mental disorders are common among medically ill elderly patients, but they are poorly recognized and treated. Assessment of the psychiatric morbidity will help in strengthening psycho-geriatric services and thus, improve the quality of life of the elderly. Copyright (c) 2007 John Wiley & Sons, Ltd.
C1 Natl Inst Mental Hlth & Neurosci, Geriatr Clin & Serv, Dept Psychiat, Bangalore 560029, Karnataka, India.
   SP Med Coll, Dept Psychiat, Bikaner, India.
   SP Med Coll, Geriatr Clin, Dept Internal Med, Bikaner, India.
RP Prakash, O (reprint author), Natl Inst Mental Hlth & Neurosci, Geriatr Clin & Serv, Dept Psychiat, Bangalore 560029, Karnataka, India.
EM op@nimhans.kar.nic.in
RI Prakash, Om/A-4846-2009
OI Prakash, Om/0000-0003-4846-9871
CR Bartels SJ, 2003, PSYCHIAT CLIN N AM, V26, P971, DOI 10.1016/S0193-953X(03)00072-8
   BLAZER D, 1980, HDB GERIATRIC PSYCHI
   Charney DS, 2003, ARCH GEN PSYCHIAT, V60, P664, DOI 10.1001/archpsyc.60.7.664
   GATZ M, 1992, AM PSYCHOL, V47, P741, DOI 10.1037/0003-066X.47.6.741
   Harris MF, 1996, MED J AUSTRALIA, V164, P526
   Jeste DV, 1999, ARCH GEN PSYCHIAT, V56, P848, DOI 10.1001/archpsyc.56.9.848
   Joshi K, 2003, INT J EPIDEMIOL, V32, P978, DOI 10.1093/ije/dyg204
   KAHANA E, 1995, RES AGING, V17, P459, DOI 10.1177/0164027595174005
   KANNER A D, 1981, Journal of Behavioral Medicine, V4, P1, DOI 10.1007/BF00844845
   Kishore S, 1997, Indian J Public Health, V41, P43
   KITCHELL MA, 1982, J AM GERIATR SOC, V30, P174, DOI 10.1111/j.1532-5415.1982.tb01300.x
   KOENIG HG, 1988, ARCH INTERN MED, V148, P1929, DOI 10.1001/archinte.148.9.1929
   KOENIG HG, 1991, J AM GERIATR SOC, V39, P887
   Patel V, 2001, PSYCHOL MED, V31, P29, DOI 10.1017/S0033291799003098
   RAJAN SI, 1999, LIVING CONDITIONS EL, P211
   Singh G, 1980, MENTAL HLTH RES MONO, V1
   Solomon R, 1996, GERIATRICS, V51, P46
   Stanley MA, 1999, J PSYCHOPATHOL BEHAV, V21, P157, DOI 10.1023/A:1022160522908
   Sunder L, 1999, HLTH MILLIONS, V25, P18
   Weiller E, 1998, BRIT J PSYCHIAT, V173, P18, DOI 10.1192/S0007125000293471
   WHO, 1992, INT CLASS DIS REL HL
   WILLIAMS JW, 1995, J GEN INTERN MED, V10, P7, DOI 10.1007/BF02599568
NR 22
TC 13
Z9 13
U1 0
U2 4
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 0885-6230
J9 INT J GERIATR PSYCH
JI Int. J. Geriatr. Psychiatr.
PD NOV
PY 2007
VL 22
IS 11
BP 1101
EP 1105
DI 10.1002/gps.1793
PG 5
WC Geriatrics & Gerontology; Gerontology; Psychiatry
SC Geriatrics & Gerontology; Psychiatry
GA 232CJ
UT WOS:000250995500004
PM 17357180
DA 2019-01-08
ER

PT J
AU Wallin, AM
   Lofvander, M
   Ahlstrom, G
AF Wallin, Anne-Marie
   Lofvander, Monica
   Ahlstrom, Gerd
TI Diabetes: a cross-cultural interview study of immigrants from Somalia
SO JOURNAL OF CLINICAL NURSING
LA English
DT Article
DE cross-cultural interview study; diabetes; ethnic minorities; everyday
   life; interpreter latent content analysis
ID AFRICAN-AMERICANS; NURSING-RESEARCH; MELLITUS; RAMADAN; HEALTH; WOMEN;
   CARE; INTERPRETERS; EPIDEMIOLOGY; MANAGEMENT
AB Aim. To describe how diabetic immigrants from Somalia experience everyday life in Sweden and how they manage diabetes- related problems, with inclusion of a gender perspective.
   Background. To treat and care for minority populations successfully, healthcare staff in Sweden must thoroughly understand the illness experiences of different ethnic groups. However, no studies have so far been reported that focus on immigrants from Somalia with diabetes.
   Design. Descriptive, qualitative interview study with 19 diabetic adults born in Somalia and now living in Sweden.
   Method. Cross- cultural interviews with the aid of an interpreter. The transcribed interviews were subjected to qualitative latent content analysis, resulting in sub- themes and themes.
   Results. Four themes emerged: experience of distress in everyday life; everyday life continues as before; comprehensibility gives a feeling of control; and being compliant. A major finding was the variation in how the participants managed the fasting month of Ramadan. Several participants fasted and did not see the diabetes as an obstacle, others did see it as an obstacle or indicated that fasting was not compulsory for a sick person.
   Conclusions. This study provides healthcare staff with information about how a minority group experience and manage diabetes. The results indicate the importance of considering cultural background, as well as religious traditions such as Ramadan, in diabetes care. They also indicate that men and women differ in their reaction to diabetes and that care should be adapted to this.
   Relevance for clinical practice. It is important to develop evidence- based guidelines for diabetes care in ethnic groups that are fasting during Ramadan to prevent complications and promote relevant self- care. Further, the prescribed dietary advice must be culturally appropriate.
C1 Jonkoping Univ, Dept Nursing Sci, Sch Hlth Sci, SE-55111 Jonkoping, Sweden.
   Dept Community Med & Publ Hlth, Orebro, Sweden.
   Karolinska Inst, Dept Neurobiol Caring Sci & Soc, Ctr Family Med, Stockholm, Sweden.
   Rinkeby Hlth Ctr, Stockholm, Sweden.
RP Wallin, AM (reprint author), Jonkoping Univ, Dept Nursing Sci, Sch Hlth Sci, POB 1026, SE-55111 Jonkoping, Sweden.
EM anne-marie.wallin@hhj.hj.se
OI Ahlstrom, Gerd/0000-0001-6230-7583
CR Aadil N, 2004, BRIT MED J, V329, P778, DOI 10.1136/bmj.329.7469.778
   ARMSTRONG N, 1987, NURS CLIN N AM, V22, P559
   ASLAM M, 1986, J CLIN HOSP PHARM, V11, P321, DOI 10.1111/j.1365-2710.1986.tb00859.x
   Baker P, 1991, INTERPRETERS PUBLIC
   Barber SG, 1979, BRIT MED J JULY, V7, P46
   Benaji B, 2006, DIABETES RES CLIN PR, V73, P117, DOI 10.1016/j.diabres.2005.10.028
   Downe-Wamboldt B, 1992, Health Care Women Int, V13, P313
   Edwards R., 1998, J ETHN MIGR STUD, V24, P197, DOI DOI 10.1080/1369183X.1998.9976626
   ElKebbi IM, 1996, DIABETES EDUCATOR, V22, P488, DOI 10.1177/014572179602200508
   Esposito N, 2001, QUAL HEALTH RES, V11, P568, DOI 10.1177/104973201129119217
   FITZGERALD JT, 1995, DIABETES EDUCATOR, V21, P523, DOI 10.1177/014572179502100605
   FREED AO, 1988, SOCIAL WORK      JUL, P315
   Gillibrand W, 2001, J ADV NURS, V34, P501, DOI 10.1046/j.1365-2648.2001.01779.x
   Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001
   Green Veronica, 2004, Br J Nurs, V13, P658
   Hawthorne K, 1999, DIABETIC MED, V16, P591, DOI 10.1046/j.1464-5491.1999.00102.x
   Hill Jillian, 2006, Nurs Stand, V20, P57
   Hjelm K, 2003, J ADV NURS, V41, P424, DOI 10.1046/j.1365-2648.2003.02548.x
   Hjelm K, 1999, J ADV NURS, V30, P1147, DOI 10.1046/j.1365-2648.1999.01167.x
   HJELM K, 1998, THESIS LUND U
   Hjelm KG, 2005, J ADV NURS, V50, P47, DOI 10.1111/j.1365-2648.2004.03348.x
   Im EO, 2004, INT J NURS STUD, V41, P891, DOI 10.1016/j.ijnurstu.2004.04.003
   Jentsch B, 1998, J EUR SOC POLICY, V8, P275, DOI 10.1177/095892879800800401
   Jonsson IM, 2002, ETHNIC HEALTH, V7, P149, DOI 10.1080/1355785022000041999
   Jonsson IM, 2002, INT J CONSUM STUD, V26, P328, DOI DOI 10.1046/J.1470-6431.2002.00247.X
   KING H, 1993, DIABETES CARE, V16, P157, DOI 10.2337/diacare.16.1.157
   Koch T, 2000, J CLIN NURS, V9, P247, DOI 10.1046/j.1365-2702.2000.00341.x
   Koch T, 1999, J CLIN NURS, V8, P712, DOI 10.1046/j.1365-2702.1999.00320.x
   Lipson J G, 1989, Med Anthropol, V12, P103
   LOFVANDER M, 1997, ILLNESS DIS SICKNESS
   LUNDMAN BM, 1990, J INTERN MED, V227, P101, DOI 10.1111/j.1365-2796.1990.tb00126.x
   McCord E C, 1995, Fam Med, V27, P267
   Murray C. D., 2001, COMMUNITY WORK FAMIL, V4, P151, DOI DOI 10.1080/713658930
   Nthangeni G, 2002, PUBLIC HEALTH NUTR, V5, P329, DOI 10.1079/PHN2001256
   Nyhlin K T, 1987, Scand J Caring Sci, V1, P59
   Qureshi B, 2002, J ROY SOC MED, V95, P489, DOI 10.1258/jrsm.95.10.489
   Salti I, 2004, DIABETES CARE, V27, P2306, DOI 10.2337/diacare.27.10.2306
   Samarasinghe K, 2002, SCAND J CARING SCI, V16, P292, DOI 10.1046/j.1471-6712.2002.00089.x
   Samuel-Hodge CD, 2000, DIABETES CARE, V23, P928, DOI 10.2337/diacare.23.7.928
   STATTIN NS, 2001, THESIS UPPSALA U SWE
   SULMANI RA, 1988, DIABETIC MED, V5, P589
   Sutton M, 2000, PRACTICAL DIABETES I, V17, P147, DOI DOI 10.1002/1528-252X(200007/08)17:5<147::AID-PDI57>3.0.CO;2-8
   TSAI JHC, 2004, INT J QUALITATIVE ME, V3
   Wallin AM, 2006, J ADV NURS, V55, P723, DOI 10.1111/j.1365-2648.2006.03963.x
   Wenzel J, 2005, DIABETES EDUCATOR, V31, P98, DOI 10.1177/0145721704273242
   *WHO, 2002, DEF DIAGN CLASS DI 1
   Zimmet P, 2000, J INTERN MED, V247, P301, DOI 10.1046/j.1365-2796.2000.00625.x
   Zimmet PZ, 1997, J DIABETES COMPLICAT, V11, P60, DOI 10.1016/S1056-8727(96)00090-6
NR 48
TC 16
Z9 16
U1 0
U2 9
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0962-1067
J9 J CLIN NURS
JI J. Clin. Nurs.
PD NOV
PY 2007
VL 16
IS 11C
BP 305
EP 314
DI 10.1111/j.1365-2702.2007.02099.x
PG 10
WC Nursing
SC Nursing
GA 221ZE
UT WOS:000250265100008
PM 17931324
DA 2019-01-08
ER

PT J
AU Laatikainen, T
   Dunbar, JA
   Chapman, A
   Kilkkinen, A
   Vartiainen, E
   Heistaro, S
   Philpot, B
   Absetz, P
   Bunker, S
   O'Neil, A
   Reddy, P
   Best, JD
   Janus, ED
AF Laatikainen, Tiina
   Dunbar, James A.
   Chapman, Anna
   Kilkkinen, Annamari
   Vartiainen, Erkki
   Heistaro, Sami
   Philpot, Ben
   Absetz, Pilvikki
   Bunker, Stephen
   O'Neil, Adrienne
   Reddy, Prasuna
   Best, James D.
   Janus, Edward D.
TI Prevention of type 2 diabetes by lifestyle intervention in an Australian
   primary health care setting: Greater green triangle (GGT) diabetes
   prevention project
SO BMC PUBLIC HEALTH
LA English
DT Article
ID IMPAIRED GLUCOSE-TOLERANCE; RANDOMIZED CONTROLLED-TRIAL; REDUCTION;
   FRAMEWORK; RISK
AB Background: Randomised controlled trials demonstrate a 60% reduction in type 2 diabetes incidence through lifestyle modification programmes. The aim of this study is to determine whether such programmes are feasible in primary health care.
   Methods: An intervention study including 237 individuals 40-75 years of age with moderate or high risk of developing type 2 diabetes. A structured group programme with six 90 minute sessions delivered during an eight month period by trained nurses in Australian primary health care in 2004-2006. Main outcome measures taken at baseline, three, and 12 months included weight, height, waist circumference, fasting plasma glucose and lipids, plasma glucose two hours after oral glucose challenge, blood pressure, measures of psychological distress and general health outcomes. To test differences between baseline and follow-up, paired t-tests and Wilcoxon rank sum tests were performed.
   Results: At twelve months participants' mean weight reduced by 2.52 kg (95% confidence interval 1.85 to 3.19) and waist circumference by 4.17 cm (3.48 to 4.87). Mean fasting glucose reduced by 0.14 mmol/l (0.07 to 0.20), plasma glucose two hours after oral glucose challenge by 0.58 mmol/l (0.36 to 0.79), total cholesterol by 0.29 mmol/l (0.18 to 0.40), low density lipoprotein cholesterol by 0.25 mmol/l (0.16 to 0.34), triglycerides by 0.15 mmol/l (0.05 to 0.24) and diastolic blood pressure by 2.14 mmHg (0.94 to 3.33). Significant improvements were also found in most psychological measures.
   Conclusion: This study provides evidence that a type 2 diabetes prevention programme using lifestyle intervention is feasible in primary health care settings, with reductions in risk factors approaching those observed in clinical trials.
C1 Flinders Univ S Australia, Greater Green Triangle Univ, Dept Rural Hlth, Warrnambool, Vic 3280, Australia.
   Natl Publ Hlth Inst, FI-00300 Helsinki, Finland.
   Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia.
   Univ Melbourne, Western Hosp, Dept Med, Footscray, Vic 3011, Australia.
   Deakin Univ, Greater Green Triangle Univ, Dept Rural Hlth, Warrnambool, Vic 3280, Australia.
RP Kilkkinen, A (reprint author), Flinders Univ S Australia, Greater Green Triangle Univ, Dept Rural Hlth, POB 423, Warrnambool, Vic 3280, Australia.
EM tiina.laatikainen@ktl.fi; Director@greaterhealth.org;
   anna.chapman@greaterhealth.org; annamari.kilkkinen@greaterhealth.org;
   erkki.vartiainen@ktl.fi; sami.heistaro@ktl.fi;
   ben.philpot@greaterhealth.org; pilvikki.absetz@ktl.fi;
   Stephen.Bunker@med.monash.edu.au; adrienne.oneil@greaterhealth.org;
   HSR@greaterhealth.org; jdbest@medstv.unimelb.edu.au;
   edwarddj@unimelb.edu.au
RI Dunbar, James/G-3034-2012
OI Bunker, Stephen/0000-0003-0780-4784; Chapman, Anna/0000-0001-7965-4098;
   Laatikainen, Tiina/0000-0002-6614-4782; Reddy,
   Prasuna/0000-0002-0709-9352
CR ABSETZ P, 2007, DIABETES CARE
   *AUSTR GOV NHMRC, 2003, DIET GUID AUSTR AD G
   Australian Government Department of Health and Aged Care, 1999, NAT PHYS ACT GUID AD
   Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694
   *DIAB PREV PROGR R, 2005, DIABETES, V54, P1150
   Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9
   Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8
   Glasgow RE, 2003, AM J PUBLIC HEALTH, V93, P1261, DOI 10.2105/AJPH.93.8.1261
   KAZIS LE, 1989, MED CARE S, V27, P178
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   Kilkkinen A, 2007, DIABETES RES CLIN PR, V76, P460, DOI 10.1016/j.diabres.2006.09.027
   Knowler WC, 2002, NEW ENGL J MED, V346, P393
   Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725
   Lindstrom J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8
   Marshall SM, 2006, BRIT MED J, V333, P475, DOI 10.1136/bmj.38922.650521.80
   Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537
   Shaw JE, 2003, MED J AUSTRALIA, V179, P379
   Tolonen H, 2002, RECOMMENDATION INDIC
   Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801
   Unwin N, 2002, DIABETIC MED, V19, P708
   Uutela A, 2004, J HEALTH PSYCHOL, V9, P73, DOI 10.1177/1359105304036103
   Wang YF, 2005, AM J CLIN NUTR, V81, P555
   WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002
   Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047
   YOSHIDA S, 2006, PARTICIPANT MOTIVATI
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
NR 26
TC 141
Z9 141
U1 1
U2 12
PU BIOMED CENTRAL LTD
PI LONDON
PA MIDDLESEX HOUSE, 34-42 CLEVELAND ST, LONDON W1T 4LB, ENGLAND
SN 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD SEP 19
PY 2007
VL 7
AR 249
DI 10.1186/1471-2458-7-249
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 225FT
UT WOS:000250503200001
PM 17877832
OA DOAJ Gold, Green Published
DA 2019-01-08
ER

PT J
AU Nomura, Y
   Wickramaratne, PJ
   Pilowsky, DJ
   Newcorn, JH
   Bruder-Costello, B
   Davey, C
   Fifer, WP
   Brooks-Gunn, J
   Weissman, MM
AF Nomura, Yoko
   Wickramaratne, Priya J.
   Pilowsky, Daniel J.
   Newcorn, Jeffrey H.
   Bruder-Costello, Beth
   Davey, Charles
   Fifer, William P.
   Brooks-Gunn, Jeanne
   Weissman, Myrna M.
TI Low birth weight and risk of affective disorders and selected medical
   illness in offspring at high and low risk for depression
SO COMPREHENSIVE PSYCHIATRY
LA English
DT Article
ID GLOBAL ASSESSMENT SCALE; ANXIETY DISORDERS; PSYCHOLOGICAL DISTRESS;
   PSYCHIATRIC-DIAGNOSIS; PSYCHOPATHOLOGY; CHILDREN; COHORT; PREGNANCY;
   PARENTS; BORN
AB Numerous studies have demonstrated that low birth weight (LBW) is associated with the development of medical conditions, such as hypertension and diabetes, and psychiatric disorders, such as depression. One possible mechanism through which LBW might increase risk for both medical and psychiatric disorders is by altering the biologic systems (such as the hypothalamic-pituitary-adrenal [HPA] axis function) that govern emotion regulation and physical reactivity. In this study, we conducted secondary data analyses in a longitudinal study originally designed to understand the intergenerational transmission of major depressive disorder (MDD). We examined the risk for both medical and psychiatric illnesses known to be influenced by HPA axis dysregulation in the context of parental depression. The study had 2 primary objectives: (1) to examine whether LBW increases the risk of selected adult illness that may be influenced by the HPA axis and (2) to examine whether the increased risk of illness varies by parental depression status. We conducted longitudinal assessments of 244 offspring of depressed and nondepressed parents for more than 20 years. Psychopathology and medical illness were assessed by direct interview conducted by clinicians blind to risk status and previous diagnosis. We examined the effect of BW in 3 categories: less than 2.5 kg (LBW), 2.5-3.5 kg, and more than 3.5 kg (reference group). Offspring with LBW had a significantly increased risk of MDD, anxiety disorders, phobia, suicidal ideation, impaired functioning, allergies, and hypertension compared to those with BW exceeding 3.5 kg. The association between LBW and depression was stronger among children of depressed parents than among children of nondepressed parents, with an interaction term (BW and parental depression status) significant for MDD (P =.05), suggesting that parental depression may augment the impact of LBW on offspring depression: (C) 2007 Elsevier Inc. All rights reserved.
C1 CUNY Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA.
   New York State Psychiat Inst & Hosp, New York, NY 10032 USA.
   Columbia Univ, Sch Publ Hlth, Dept Epidemiol, New York, NY 10032 USA.
   Columbia Univ, Sch Publ Hlth, Dept Biostat, New York, NY 10032 USA.
   Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA.
   Columbia Univ, Coll Phys & Surg, Dept Pediat, New York, NY 10032 USA.
   Columbia Univ Teachers Coll, New York, NY 10027 USA.
   Columbia Univ, New York, NY 10025 USA.
RP Nomura, Y (reprint author), CUNY Mt Sinai Sch Med, Dept Psychiat, 1 Gustave L Levy Pl Box 1230, New York, NY 10029 USA.
EM yoko.nomura@mssm.edu
OI Weissman, Myrna/0000-0003-3490-3075; Fifer, William
   P./0000-0002-6936-9303; Newcorn, Jeffrey/0000-0001-8993-9337
FU NIMH NIH HHS [R03 MH067761, R01 MH036197, R03 MH067761-01A2, R03
   MH067761-02]
CR Arborelius L, 1999, J ENDOCRINOL, V160, P1, DOI 10.1677/joe.0.1600001
   Barker DJP, 2004, ACTA PAEDIATR, V93, P26, DOI 10.1080/08035320410022730
   Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728
   BINDER DA, 1992, BIOMETRIKA, V79, P139, DOI 10.1093/biomet/79.1.139
   Cheung YB, 2004, ACTA PAEDIATR, V93, P965, DOI 10.1080/08035250410026824
   Cox DR, 1972, J ROYAL STAT SOC B, V34, P87
   ENDICOTT J, 1976, ARCH GEN PSYCHIAT, V33, P766
   Gale CR, 2004, BRIT J PSYCHIAT, V184, P28, DOI 10.1192/bjp.184.1.28
   GRAY RF, 2004, PEDIATRICS, V114, P932
   Heim C, 2001, BIOL PSYCHIAT, V49, P1023, DOI 10.1016/S0006-3223(01)01157-X
   Hollingshead AB, 1958, SOCIAL CLASS MENTAL
   Indredavik MS, 2004, ARCH DIS CHILD, V89, pF445, DOI 10.1136/adc.2003.038943
   Koeppen-Schomerus G, 2000, J PEDIATR-US, V137, P527, DOI 10.1067/mpd.2000.108445
   LECKMAN JF, 1982, ARCH GEN PSYCHIAT, V39, P879
   Leon DA, 1998, BMJ-BRIT MED J, V317, P241, DOI 10.1136/bmj.317.7153.241
   LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085
   Lithell HO, 1996, BMJ-BRIT MED J, V312, P406
   MANNUZZA S, 1986, J PSYCHIAT RES, V20, P317, DOI 10.1016/0022-3956(86)90034-8
   McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307
   Nomura Y, 2002, J AM ACAD CHILD PSY, V41, P402, DOI 10.1097/00004583-200204000-00012
   NOMURA Y, IN PRESS PSYCHOL MED
   Olson JE, 1997, AM J EPIDEMIOL, V145, P58
   ORVASCHEL H, 1982, J AM ACAD CHILD PSY, V21, P392, DOI 10.1016/S0002-7138(09)60944-4
   Osler M, 2005, BRIT J PSYCHIAT, V186, P400, DOI 10.1192/bjp.186.5.400
   Rickards AL, 2001, J DEV BEHAV PEDIATR, V22, P11, DOI 10.1097/00004703-200102000-00002
   Saigal S, 2003, PEDIATRICS, V111, P969, DOI 10.1542/peds.111.5.969
   SHAFFER D, 1983, ARCH GEN PSYCHIAT, V40, P1228
   SHAH B, 1997, SUDAAN USERS MANUAL
   Thompson C, 2001, BRIT J PSYCHIAT, V179, P450, DOI 10.1192/bjp.179.5.450
   VAN OJ, 2001, BIOL PSYCHIAT, V50, P593
   Wadhwa PD, 2005, PSYCHONEUROENDOCRINO, V30, P724, DOI 10.1016/j.psyneuen.2005.02.004
   Wals M, 2003, J AM ACAD CHILD PSY, V42, P1116, DOI 10.1097/01.CHI.0000070242.24125.78
   Weissman MM, 1999, J AM ACAD CHILD PSY, V38, P892, DOI 10.1097/00004583-199907000-00020
   Weissman MM, 1997, ARCH GEN PSYCHIAT, V54, P932
   WEISSMAN MM, 1992, J AM ACAD CHILD PSY, V31, P640, DOI 10.1097/00004583-199207000-00010
   WEISSMAN MM, 1987, ARCH GEN PSYCHIAT, V44, P847
   WEISSMAN MM, 1990, J AM ACAD CHILD PSY, V29, P789, DOI 10.1097/00004583-199009000-00019
   WEISSMAN MM, 2005, ARCH GEN PSYCHIAT, V62, P9
   Wichers MC, 2002, PSYCHOL MED, V32, P1165, DOI 10.1017/S0033291702006372
   Wiles NJ, 2005, BRIT J PSYCHIAT, V187, P21, DOI 10.1192/bjp.187.1.21
NR 40
TC 47
Z9 50
U1 1
U2 7
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0010-440X
J9 COMPR PSYCHIAT
JI Compr. Psychiat.
PD SEP-OCT
PY 2007
VL 48
IS 5
BP 470
EP 478
DI 10.1016/j.comppsych.2007.04.005
PG 9
WC Psychiatry
SC Psychiatry
GA 206OS
UT WOS:000249193400013
PM 17707257
OA Green Accepted
DA 2019-01-08
ER

PT J
AU van der Velden, PG
   Kleber, RJ
   Fournier, M
   Grievink, L
   Drogendijk, A
   Gersons, BPR
AF van der Velden, Peter G.
   Kleber, Rolf J.
   Fournier, Marijda
   Grievink, Linda
   Drogendijk, Annelieke
   Gersons, Berthold P. R.
TI The association between dispositional optimism and mental health
   problems among disaster victims and a comparison group: A prospective
   study
SO JOURNAL OF AFFECTIVE DISORDERS
LA English
DT Article
DE anxiety; depression; disaster; dispositional optimism; prospective
ID POSTTRAUMATIC-STRESS-DISORDER; LIFE ORIENTATION TEST; COPING
   SELF-EFFICACY; MULTIPLE-SCLEROSIS; CHRONIC DISEASE; PSYCHOLOGICAL
   DISTRESS; RHEUMATOID-ARTHRITIS; TERRORIST ATTACKS; DIABETES-MELLITUS;
   PHYSICAL SYMPTOMS
AB Background: It is unclear whether the associations between the level of dispositional optimism on the one hand, and depression symptoms and other health problems on the other hand among disaster victims differ from the associations among non-affected residents.
   Methods: To assess the associations between the level of dispositional optimism and health problems among disaster victims and non-affected residents, data of the longitudinal Enschede Fireworks Disaster Study was analyzed. Participants in the present study consisted of adult native Dutch victims of the disaster (N = 662) and a non-affected comparison group (N=526). Both groups participated 18 months (T1) and almost four years post-disaster (T2). Multivariate logistic regression analyses were applied to examine the association between optimism and health problems among both groups.
   Results: Results showed that pessimistic victims were more at risk for severe depression symptoms and obsessive-compulsive symptoms than optimistic victims when controlling for demographic characteristics, life events, smoking, and existing health problems at T1. However, pessimistic participants in the comparison group were also more at risk for severe anxiety symptoms, sleeping problems, somatic problems, and problems in social functioning than optimistic control participants.
   Limitations: We had no information on dispositional optimism before 18 months post-disaster.
   Conclusions: Pessimists at baseline are more at risk for health problems after 27 months than optimists. However, among non-affected residents pessimism is a stronger independent risk factor than among victims. Results suggest that professional helpers such as general practitioners, psychologists and psychiatrists should not rely too much on optimistic views of disaster victims. (c) 2006 Elsevier B.V. All rights reserved.
C1 Inst Psychotrauma, NL-5300 AG Zaltbommel, Netherlands.
   Univ Utrecht, Dept Clin & Hlth Psychol, Utrecht, Netherlands.
   Vrije Univ Amsterdam Med Ctr, GGZ Buitenamstel, Amsterdam, Netherlands.
   Natl Inst Publ Hlth & Environm RIVM, Ctr Environm Hlth Sci, Bilthoven, Netherlands.
   Univ Amsterdam, Acad Med Ctr De Maren, Dept Psychiat, Amsterdam, Netherlands.
RP van der Velden, PG (reprint author), Inst Psychotrauma, POB 266, NL-5300 AG Zaltbommel, Netherlands.
EM peter.vdvelden@ivp.nl
CR Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3
   Ai AL, 2006, J INTERPERS VIOLENCE, V21, P689, DOI 10.1177/0886260506287245
   Andersson G, 1996, PERS INDIV DIFFER, V21, P719, DOI 10.1016/0191-8869(96)00118-3
   ARRINDELL WA, 1986, MANUAL MUTLIDMENSION
   Aspinwall LG, 1996, PERS SOC PSYCHOL B, V22, P993, DOI 10.1177/01461672962210002
   ASPINWALL LG, 2001, OPTIMISM PESSIMISM I, P217, DOI DOI 10.1037/10385-010
   Basoglu M, 2005, J TRAUMA STRESS, V18, P1, DOI 10.1002/jts.20011
   Benight CC, 1999, ANXIETY STRESS COPIN, V12, P107, DOI 10.1080/10615809908248325
   Benight CC, 2004, BEHAV RES THER, V42, P1129, DOI 10.1016/j.brat.2003.08.008
   Benight CC, 2002, J TRAUMA STRESS, V15, P177, DOI 10.1023/A:1015295025950
   BENIGHT CC, 2000, J APPL SOC PSYCHOL, V30, P1131
   Brenner G F, 1994, J Clin Psychol Med Settings, V1, P115, DOI 10.1007/BF01999741
   BREWIN C, 2006, OVERVIEW BASELINE SU
   Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748
   CARVER CS, 1994, CANCER, V73, P1213, DOI 10.1002/1097-0142(19940215)73:4<1213::AID-CNCR2820730415>3.0.CO;2-Q
   DEROGATIS LR, 1983, CLIN PSYCHIMETRIC RE
   Dijkema MBA, 2005, EUR J EPIDEMIOL, V20, P839, DOI 10.1007/s10654-005-2149-6
   Dirkzwager AJE, 2006, BRIT J PSYCHIAT, V189, P144, DOI 10.1192/bjp.bp.105.017855
   Dougall AL, 2001, J APPL SOC PSYCHOL, V31, P223, DOI 10.1111/j.1559-1816.2001.tb00195.x
   Fournier M, 2003, PSYCHOL HEALTH, V18, P277, DOI 10.1080/0887044031000062197
   Fournier M, 2002, BRIT J HEALTH PSYCH, V7, P409, DOI 10.1348/135910702320645390
   Fournier M, 1999, J BEHAV MED, V22, P303, DOI 10.1023/A:1018776618323
   Galea S, 2005, EPIDEMIOL REV, V27, P78, DOI 10.1093/epirev/mxi003
   GGD Nederland (Health Authority Netherlands), 2003, STAND VRAAGST ROK
   Giltay EJ, 2006, J AFFECT DISORDERS, V91, P45, DOI 10.1016/j.jad.2005.12.027
   Grievink L, 2006, ANN EPIDEMIOL, V16, P782, DOI 10.1016/j.annepidem.2006.04.008
   IRVING LM, 1997, INT SCO TRAUMA STRES, P465
   Kangas M, 2002, CLIN PSYCHOL REV, V22, P499, DOI 10.1016/S0272-7358(01)00118-0
   KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012
   KOENEN KC, 2005, ARCH GEN PSYCHIAT, V62, P258
   Lauterbach D, 2001, J TRAUMA STRESS, V14, P29
   LUTGENDORF SK, 1995, PSYCHOSOM MED, V57, P310, DOI 10.1097/00006842-199507000-00002
   MOOREN TTM, 2001, STUDIES PSYCHOL CONS
   NES SL, 2006, PERS SOC PSYCHOL REV, V10, P235
   Norris FH, 2006, J TRAUMA STRESS, V19, P173, DOI 10.1002/jts.20109
   Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173
   NORRIS FH, 2005, RANGE MAGNITUDE DURA
   Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52
   SCHEIER MF, 1985, HEALTH PSYCHOL, V4, P219, DOI 10.1037//0278-6133.4.3.219
   SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063
   SCHEIER MF, 1992, COGNITIVE THER RES, V16, P201, DOI 10.1007/BF01173489
   SCHOU I, 2005, J PERS ASSESS, V84, P149
   Smith BW, 2000, J TRAUMA STRESS, V13, P349, DOI 10.1023/A:1007745920466
   Sumer N, 2005, J TRAUMA STRESS, V18, P331, DOI 10.1002/jts.20032
   van der Velden PG, 2006, J TRAUMA STRESS, V19, P493, DOI 10.1002/jts.20140
   Van der Velden PG, 2006, ADM POLICY MENT HLTH, V33, P279, DOI 10.1007/s10488-005-0027-x
   VANDENBERG B, 2005, ARCH INTERN MED, V65, P2402
   VANDERZEE K, 1993, HET METEN ALGEMENE G
   VANKAMP I, 2005, EUR J PUBLIC HEALTH, V16, P253
   Vlahov D, 2002, AM J EPIDEMIOL, V155, P988, DOI 10.1093/aje/155.11.988
   Waysman M, 2001, J TRAUMA STRESS, V14, P531, DOI 10.1023/A:1011112723704
   ZEIDNER M, 1992, J PERS, V60, P709, DOI 10.1111/j.1467-6494.1992.tb00271.x
NR 52
TC 14
Z9 14
U1 1
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-0327
J9 J AFFECT DISORDERS
JI J. Affect. Disord.
PD SEP
PY 2007
VL 102
IS 1-3
BP 35
EP 45
DI 10.1016/j.jad.2006.12.004
PG 11
WC Clinical Neurology; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 201HY
UT WOS:000248823300005
PM 17239959
DA 2019-01-08
ER

PT J
AU Graham, J
   Zhang, L
   Schwalberg, R
AF Graham, Juanita
   Zhang, Lei
   Schwalberg, Renee
TI Association of maternal chronic disease and negative birth outcomes in a
   non-Hispanic black-white Mississippi birth cohort
SO PUBLIC HEALTH NURSING
LA English
DT Article
DE chronic disease; infant mortality; low birth weight; prematurity
ID INFANT-MORTALITY; HEART-DISEASE; HYPERTENSIVE DISORDERS;
   DIABETES-MELLITUS; PREGNANCY; WEIGHT; WOMEN; ASTHMA; DISTRESS; FETAL
AB Objective: To investigate the impact of selected maternal chronic medical conditions, race, and age on preterm birth (PTB), low birth weight (LBW), and infant mortality among Mississippi mothers from 1999 to 2003. Design :A retrospective cohort analysis of linked birth and death certificates. Sample: The 1999-2003 Mississippi birth cohort comprising 202,931 singleton infants born to African American and White women. Measurements: The relationship between maternal chronic conditions and the dependent variables of PTB, LBW, and infant mortality were investigated using logistic regression analysis. Results: PTB, LBW, and infant mortality were more prevalent among African American women, very young women (<= 15 years), and women with certain chronic medical conditions. Among White mothers, maternal chronic hypertension was significantly associated with PTB and LBW, and maternal diabetes with PTB and infant mortality. Among African American mothers, maternal cardiac disease was significantly associated with PTB and LBW; maternal chronic hypertension was significantly associated with LBW and infant mortality; and maternal diabetes with PTB. Conclusions:Maternal chronic hypertension and diabetes were significantly associated with negative birth outcomes regardless of maternal race. Maternal cardiac disease was only significantly associated with PTB and LBW among African Americans.
C1 Mississippi Dept Hlth, Bur Hlth Data, Jackson, MS 39215 USA.
   Maternal & Child Hlth Informat Resource Ctr, Washington, DC USA.
RP Graham, J (reprint author), Mississippi Dept Hlth, Bur Hlth Data, 570 E Woodrow Wilson,POB 1700, Jackson, MS 39215 USA.
EM Juanita.Graham@msdh.state.ms.us
CR Cundy T, 2002, DIABETIC MED, V19, P482, DOI 10.1046/j.1464-5491.2002.00729.x
   Curhan GC, 1996, CIRCULATION, V94, P3246, DOI 10.1161/01.CIR.94.12.3246
   Curran CA, 2006, J PERINAT NEONAT NUR, V20, P147, DOI 10.1097/00005237-200604000-00008
   Dewyea VA, 2005, ALLERGY ASTHMA PROC, V26, P323
   Dombrowski MP, 2006, OBSTET GYNECOL, V108, P667, DOI 10.1097/01.AOG.0000235059.84188.9c
   HACK M, 1995, FUTURE CHILD, V5, P176, DOI 10.2307/1602514
   Hameed A, 2001, J AM COLL CARDIOL, V37, P893, DOI 10.1016/S0735-1097(00)01198-0
   Hanania Nicola A, 2005, Crit Care Med, V33, pS319, DOI 10.1097/01.CCM.0000182789.14710.A1
   Kajantie E, 2005, INT J EPIDEMIOL, V34, P655, DOI 10.1093/ije/dyi048
   Khairy P, 2006, CIRCULATION, V113, P517, DOI 10.1161/CIRCULATIONAHA.105.589655
   KLEINMAN JC, 1988, AM J EPIDEMIOL, V127, P274, DOI 10.1093/oxfordjournals.aje.a114803
   KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663
   Lau TK, 2005, ACTA OBSTET GYN SCAN, V84, P875, DOI 10.1111/j.0001-6349.2005.00740.x
   LUKE B, 1992, J REPROD MED, V37, P661
   MacMullen NJ, 2006, MCN-AM J MATERN-CHIL, V31, P263
   MARTIN JA, 2006, NATL VITAL STAT REPO, V55, P79
   MCCORMICK MC, 1985, NEW ENGL J MED, V312, P82, DOI 10.1056/NEJM198501103120204
   National Center for Health Statistics, 2006, HLTH US 2006 CHARTB
   Ramadhani MK, 2006, ATHEROSCLEROSIS, V184, P21, DOI 10.1016/j.atherosclerosis.2005.03.022
   Ray JG, 2001, EARLY HUM DEV, V64, P129, DOI 10.1016/S0378-3782(01)00181-5
   ROSENBERG TJ, 2005, AM J PUBLIC HEALTH, V95, P1548
   Sibai BM, 2000, AM J OBSTET GYNECOL, V182, P364, DOI 10.1016/S0002-9378(00)70225-0
   Siu SC, 1997, CIRCULATION, V96, P2789
   Stoll BJ, 1996, J PEDIATR-US, V129, P63, DOI 10.1016/S0022-3476(96)70191-9
   van Wassenaer Aleid, 2005, Pediatr Endocrinol Rev, V2, P372
   Wiles NJ, 2005, BRIT J PSYCHIAT, V187, P21, DOI 10.1192/bjp.187.1.21
NR 26
TC 13
Z9 13
U1 0
U2 2
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0737-1209
J9 PUBLIC HEALTH NURS
JI Public Health Nurs.
PD JUL-AUG
PY 2007
VL 24
IS 4
BP 311
EP 317
DI 10.1111/j.1525-1446.2007.00639.x
PG 7
WC Public, Environmental & Occupational Health; Nursing
SC Public, Environmental & Occupational Health; Nursing
GA 177SY
UT WOS:000247174000003
PM 17553020
DA 2019-01-08
ER

PT J
AU Hussain, A
   Claussen, B
   Ramachandran, A
   Williams, R
AF Hussain, A.
   Claussen, B.
   Ramachandran, A.
   Williams, R.
TI Prevention of type 2 diabetes: A review
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Review
DE prevention; type 2 diabetes; review
ID IMPAIRED GLUCOSE-TOLERANCE; LOW-BIRTH-WEIGHT; INTRAUTERINE ENVIRONMENT;
   LIFE-STYLE; INSULIN-RESISTANCE; THRIFTY GENOTYPE; BODY-COMPOSITION;
   CONTROLLED-TRIAL; PIMA-INDIANS; FETAL GROWTH
AB One of the major public health challenges of the 21st century is type 2 diabetes. WHO estimates that by 2025 as many as 200300 million people worldwide will have developed the disease. A distressing increase in children is perhaps the most alarming sign of something going wrong. Roughly half of the risk of type 2 diabetes can be attributed to environmental exposure and the other half to genetics. Central themes for prevention are the risk factors overweight, sedentary lifestyle, certain dietary components and perinatal factors. Overweight is the most critical risk factor, and should be targeted for prevention of type 2 diabetes especially among children and youths. Ethnicity and perinatal factors are also worth considering. Today we know that prevention helps. In the US Diabetes Prevention Programme for high risk individuals, there was a 58% relative reduction in the progression to diabetes in the lifestyle group compared with the controls. Within the lifestyle group, 50% achieved the goal of more than 7% weight reduction, and 74% maintained at least 150 min of moderately intense activity each week. This review discusses different forms of prevention, and proposes first of all to target people with Impaired Glucose Tolerance with increasing activity and altering dietary factors. And secondly, population-based measures to encourage increased physical activity and decreased consumption of energy-dense foods are important, and may target school children and young people, certain ethnic groups and women with gestational diabetes. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
C1 Univ Oslo, Dept Gen Practice & Community Med, N-0318 Oslo, Norway.
   WHO, Collaborating Ctr Res Educ & Training Diabet, Diabet Res Ctr, Madras 600013, Tamil Nadu, India.
   WHO, Collaborating Ctr Res Educ & Training Diabet, MV Hosp Diabet, Madras 600013, Tamil Nadu, India.
   Univ Coll Swansea, Sch Med, Swansea SA2 8PP, W Glam, Wales.
RP Hussain, A (reprint author), Univ Oslo, Dept Gen Practice & Community Med, Post Box 1130 Blindern, N-0318 Oslo, Norway.
EM akhtar.hussain@medisin.uio.no
CR Abate N, 2001, J DIABETES COMPLICAT, V15, P320, DOI 10.1016/S1056-8727(01)00161-1
   Ananth CV, 2002, SEMIN PERINATOL, V26, P260, DOI 10.1053/sper.2002.34772
   Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255
   Azen SP, 1998, CONTROL CLIN TRIALS, V19, P217, DOI 10.1016/S0197-2456(97)00151-7
   BLAIR SN, 1999, MED SCI SPORT EXER S, V31, P646
   Bray GA, 2000, DIABETES CARE, V23, P1619
   Chiasson J, 2002, DIABETOLOGIA, V45, P104
   Chiasson JL, 1998, DIABETES CARE, V21, P1720, DOI 10.2337/diacare.21.10.1720
   Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5
   CHIASSON JL, 2002, LANCET, V359, P2
   Dabelea D, 1999, DIABETES CARE, V22, P944, DOI 10.2337/diacare.22.6.944
   Davies MJ, 2004, DIABETIC MED, V21, P403, DOI 10.1111/j.1464-5491.2004.01176.x
   Dyck RF, 2001, CAN J PUBLIC HEALTH, V92, P340
   Dyson PA, 1997, METABOLISM, V46, P50, DOI 10.1016/S0026-0495(97)90318-8
   Eriksson J, 2001, BRIT MED BULL, V60, P183, DOI 10.1093/bmb/60.1.183
   ERIKSSON KF, 1991, DIABETOLOGIA, V34, P891, DOI 10.1007/BF00400196
   Franz Marion J, 2003, Diabetes Care, V26 Suppl 1, pS51
   Gutin B, 2002, AM J CLIN NUTR, V75, P818
   Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5
   Hanefeld M, 2002, DIABETOLOGIA, V45, P104
   HANEFELD M, 2002, DIABETOLOGIA, V45, pS104
   Herman WH, 2003, DIABETES CARE, V26, P36
   HOLMAN RR, 2000, DIABETIC MED, V17, pS1
   Holman RR, 2003, DIABETIC MED, V20, P15
   Holman RR, 2000, DIABETIC MED, V17, P17
   Innes KE, 2002, JAMA-J AM MED ASSOC, V287, P2534, DOI 10.1001/jama.287.19.2534
   *INT DIAB FED, 2002, CONS AET TYP 2 DIAB
   Jovanovic L, 2000, DIABETES CARE, V23, P1219, DOI 10.2337/diacare.23.9.1219
   KING H, 1991, B WORLD HEALTH ORGAN, V69, P643
   King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414
   KING RJB, 1990, ENDOCRINE THERAPY BR, V4, P3
   Knowler WC, 2002, NEW ENGL J MED, V346, P393
   Kramer MS, 2002, J PEDIATR-US, V141, P538, DOI 10.1067/mpg.2002.128029
   Li CY, 2001, DIABETES CARE, V24, P2035, DOI 10.2337/diacare.24.12.2035
   LINDSAY RS, 2000, DIABETES CARE, V23, P249
   Lluch A, 2000, INT J OBESITY, V24, P1493, DOI 10.1038/sj.ijo.0801425
   Lu GC, 2001, AM J OBSTET GYNECOL, V185, P845, DOI 10.1067/mob.2001.117351
   Ludwig DS, 2001, JAMA-J AM MED ASSOC, V286, P1427, DOI 10.1001/jama.286.12.1427
   McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7
   MCKINLAY JA, 1975, BEHAV ASPECTS PREVEN
   NEEL JV, 1962, AM J HUM GENET, V14, P353
   Nemet D, 2003, PEDIATR RES, V53, P148, DOI 10.1203/01.PDR.0000039766.53698.3D
   Pettitt DJ, 1997, LANCET, V350, P166, DOI 10.1016/S0140-6736(96)12103-6
   Pettitt DJ, 1998, DIABETES CARE, V21, pB138
   Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z
   Reaven G M, 2000, Curr Atheroscler Rep, V2, P503, DOI 10.1007/s11883-000-0050-z
   RITCHIE L, 2001, PEDIAT OVERWEIGHT RE
   Ritchie Lorrene D, 2003, Pediatr Diabetes, V4, P174, DOI 10.1111/j.1399-543X.2003.00030.x
   ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32
   Rosenbloom A L, 2000, Pediatr Diabetes, V1, P150, DOI 10.1034/j.1399-5448.2000.010306.x
   SARTOR G, 1980, DIABETES, V29, P41, DOI 10.2337/diabetes.29.1.41
   Sherwood NE, 2000, INT J OBESITY, V24, P395, DOI 10.1038/sj.ijo.0801169
   Silverman BL, 1998, DIABETES CARE, V21, pB142
   SJOSTROM L, 2002, 9 INT C OB SAO PAUL
   STERN MP, 1991, DIABETES CARE, V14, P399, DOI 10.2337/diacare.14.5.399
   Strauss RS, 1997, BRIT MED BULL, V53, P81
   Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801
   Van Assche FA, 2001, BRIT MED BULL, V60, P173, DOI 10.1093/bmb/60.1.173
   Veening MA, 2002, J CLIN ENDOCR METAB, V87, P4657, DOI 10.1210/jc.2001-011940
   VUORI I, 1909, DIABETES, V44, P1010
   VUORI I, 1995, DIABETES, V44, P1010
   Wei JN, 2003, DIABETES CARE, V26, P343, DOI 10.2337/diacare.26.2.343
   Whitaker RC, 1998, J PEDIATR-US, V132, P768, DOI 10.1016/S0022-3476(98)70302-6
   Young TK, 2002, ARCH PEDIAT ADOL MED, V156, P651, DOI 10.1001/archpedi.156.7.651
   Zimmet P, 2000, J INTERN MED, V247, P301, DOI 10.1046/j.1365-2796.2000.00625.x
NR 65
TC 112
Z9 117
U1 1
U2 28
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD JUN
PY 2007
VL 76
IS 3
BP 317
EP 326
DI 10.1016/j.diabres.2006.09.020
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 164NP
UT WOS:000246241100001
PM 17069920
DA 2019-01-08
ER

PT J
AU Gross, CC
   Scain, SF
   Scheffel, R
   Gross, JL
   Hutz, CS
AF Gross, Carolina Campos
   Scain, Suzana Fiore
   Scheffel, Rafael
   Gross, Jorge Luiz
   Hutz, Cldudio Simon
TI Brazilian version of the Problem Areas in Diabetes Scale (B-PAID):
   Validation and identification of individuals at high risk for emotional
   distress
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE type 2 diabetes; emotional distress; health-related quality of life;
   questionnaires reliability; validity
ID QUALITY
AB The purpose of this study was to validate the Brazilian version of the Problem Areas in Diabetes Scale (B-PAID) in a sample of outpatients with type 2 diabetes (DM2) and to identify the characteristics of individuals at high risk for emotional distress.
   A cross-sectional study was conducted in a sample of 146 patients randomly selected among those attending outpatient clinics at a University Hospital in Porto Alegre, Brazil. Information was collected regarding age, gender, known duration of diabetes, type of treatment and level of schooling, and a blood sample was taken to measure HbA1c. B-PAID was compared with the already validated Brazilian versions of Satisfaction with Life (SWL) and WHO Quality of Life-Brief (WHOQOL) Scales.
   One-hundred forty-six DM2 patients (48% males, 59.7 +/- 9 years, BMI: 29.7 +/- 5.2 kg/m(2), mean duration: 8.63 +/- 8 years, HbA(1c): 7.2 +/- 1.7%) were included. There were significant correlations between B-PAID and SWL (r(p) = 0.55, p < 0.001) and WHOQOL (r(p) = -0.33, p < 0.05) Scales. In a multiple regression analysis the B-PAID Scale was associated with younger age (p = 0.006) and lower education level (p = 0.05).
   In conclusion, B-PAID is a reliable, valid outcome measure for Brazilian DM2 patients and identifies patients at increased risk for emotional distress who should be prioritized in psychosocial intervention. (c) 2006 Published by Elsevier Ireland Ltd.
C1 Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Endocrine Div, BR-90003590 Porto Alegre, RS, Brazil.
   Univ Fed Rio Grande do Sul, Dept Dev Psychol, BR-90046900 Porto Alegre, RS, Brazil.
   Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Publ Hlth Unit, BR-90046900 Porto Alegre, RS, Brazil.
RP Gross, JL (reprint author), Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Endocrine Div, Predio 12-4,Rua Ramiro Barcelos 2350, BR-90003590 Porto Alegre, RS, Brazil.
EM jorgegross@terra.com.br
RI Gross, Jorge/G-9138-2012; Hutz, Claudio/L-7499-2013
OI Hutz, Claudio/0000-0002-3252-7339
CR ANDERSON BJ, 2002, PRACTICAL PSYCHOL DI, P209
   BRADLEY C, 1994, HDB PSYCHOL DIABETES, P4
   COHEN J, 1985, STAT POWER ANAL BEHA
   DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13
   Fleck MPA, 2000, REV SAUDE PUBL, V34, P178, DOI 10.1590/S0034-89102000000200012
   Floyd FJ, 1995, PSYCHOL ASSESSMENT, V7, P286, DOI 10.1037/1040-3590.7.3.286
   GIACOMONI C. H., 1997, 26 INT PSYCHOL C SIP, P313
   Herschbach P, 1997, HEALTH PSYCHOL, V16, P171, DOI 10.1037/0278-6133.16.2.171
   Ishii H. W. G., 1999, DIABETES S1, V48, pA139
   PAVOT W, 1991, J PERS ASSESS, V57, P149, DOI 10.1207/s15327752jpa5701_17
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   RUBIN RR, 1992, DIABETES CARE, V15, P1640, DOI 10.2337/diacare.15.11.1640
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Spilker B, 1996, QUALITY LIFE PHARMAC
   Ware JE, 1998, J CLIN EPIDEMIOL, V51, P945, DOI 10.1016/S0895-4356(98)00085-7
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
NR 16
TC 27
Z9 27
U1 0
U2 4
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
EI 1872-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD JUN
PY 2007
VL 76
IS 3
BP 455
EP 459
DI 10.1016/j.diabres.2006.09.022
PG 5
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 164NP
UT WOS:000246241100019
PM 17081645
DA 2019-01-08
ER

PT J
AU Welch, G
   Schwartz, CE
   Santiago-Kelly, P
   Garb, J
   Shayne, R
   Bode, R
AF Welch, Garry
   Schwartz, Carolyn E.
   Santiago-Kelly, Paula
   Garb, Jane
   Shayne, Rebecca
   Bode, Rita
TI Disease-related emotional distress of Hispanic and non-Hispanic type 2
   diabetes patients
SO ETHNICITY & DISEASE
LA English
DT Article
DE type 2 diabetes; emotional distress; Hispanic; psychometric
ID OF-LIFE; INTERVENTION; RELIABILITY; DEPRESSION; EXPERIENCE; EDUCATION;
   VALIDITY; SAMPLE; ADULTS; SCALES
AB Background: Diabetes is a serious chronic illness that disproportionately affects prevalence and comorbidity rates among Hispanic populations. Little comparative research has been conducted on the emotional distress experienced by Hispanic patients living with type 2 diabetes.
   Purpose: To conduct a psychometric examination of an established measure of emotional distress specific to diabetes and to use this tool to examine levels and predictors of distress in a comparative study of Hispanic and non-Hispanic type 2 diabetes patients.
   Method: Psychometric analyses were conducted (skewness, kurtosis, differential item function (DIF), confirmatory factor analysis (CFA), internal consistency reliability) to examine the equivalence of US English and US Spanish language versions of a measure of diabetes-related distress Problem Areas in Diabetes (PAID). Regression modeling was used to evaluate differences in distress by ethnic group, after adjusting for blood glucose control, sex, age, education, physical functioning, mental health functioning, and spirituality. Psychometric results showed that PAID had high reliability (alpha = 0.96). Skewness, kurtosis, and DIF were not present. CFA identified a large general factor, supporting use of the total PAID score. Univariate analyses found a significantly higher mean PAID score for Hispanic patients compared to non-Hispanic (45.9 +/- 28.5 vs 35.9 +/- 26.4). A final regression model based on age, physical functioning, and mental functioning accounted for approximately 50% of PAID variance.
   Conclusion: Our findings supported the reliability and unidimensionality of the US Spanish and US English PAID versions for comparative research. Compared to non-Hispanic patients, Hispanic patients reported higher distress, which was substantially predicted from age and physical and mental functioning.
C1 Baystate Med Ctr, High St Adult Med Clin, Springfield, MA 01199 USA.
   Baystate Med Ctr, Dept Surg, Springfield, MA 01199 USA.
   DeltaQuest Fdn, Concord, MA USA.
   Social Sectors Dev Strategies, Boston, MA USA.
   Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA.
   Northwestern Univ, Dept Phys Med & Rehabil, Feinberg Sch Med, Chicago, IL 60611 USA.
RP Welch, G (reprint author), Baystate Med Ctr, High St Adult Med Clin, 140 High St,Room 2104, Springfield, MA 01199 USA.
EM garry.welch@bhs.org
CR BARNHART DK, 1997, HISPANIC AM SO MANY
   Brodie M., 2002, NATL SURVEY LATINOS
   Consedine Nathan S, 2002, J Cross Cult Gerontol, V17, P71, DOI 10.1023/A:1014838920556
   Gonder-Frederick LA, 2002, J CONSULT CLIN PSYCH, V70, P611, DOI 10.1037//0022-006X.70.3.611
   Gordon C, 1997, NURS PRACT FORUM, V8, P5
   GORSUCH RL, 1972, J SCI STUD RELIG, V11, P53, DOI 10.2307/1384298
   GUADAGNOLI E, 1988, PSYCHOL BULL, V103, P265, DOI 10.1037/0033-2909.103.2.265
   Haire-Joshu Debra, 2006, Curr Diab Rep, V6, P123, DOI 10.1007/s11892-006-0023-x
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   Hernandez A, 2006, PSYCHOSOM MED, V68, P121, DOI 10.1097/01.psy.0000197673.29650.8e
   Lerman-Garber I, 2003, SALUD PUBLICA MEXICO, V45, P13, DOI 10.1590/s0036-36342003000100002
   LUSTMAN PJ, 2002, PYSCHIAT TIMES, V19
   MARIN H, 2003, PSYCHAIT TIMES, V20
   Melkus GD, 2004, APPL NURS RES, V17, P10, DOI 10.1016/j.apnr.2003.10.009
   Miller W. R., 1999, INTEGRATING SPIRITUA
   MUTHEN B, 2004, MPLU STAT SOFTWARE P
   Nichols GA, 2000, DIABETES CARE, V23, P273, DOI 10.2337/diacare.23.3.273
   NUNNALLY UC, 1994, PSYCHOMETRIC THEORY
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   POLONSKY WH, 2000, DIABETES BURNOUT
   Rosal MC, 2004, HEALTH EDUC BEHAV, V31, P388, DOI 10.1177/1090198104263360
   RUBIN RR, 2002, PSYCHOL DIABETES CAR
   Schwartz Carolyn E, 2004, J Palliat Med, V7, P233, DOI 10.1089/109662104773709350
   Schwartz Carolyn E, 2003, J Palliat Med, V6, P575, DOI 10.1089/109662103768253687
   Schwartz CE, 2002, ARCH INTERN MED, V162, P1611, DOI 10.1001/archinte.162.14.1611
   SHAFRANSKE EP, 1984, J TRANSPERSONAL PSY, V16, P231
   Skinner Chas T., 2000, PSYCHOL DIABETES CAR
   Snedecor GW, 1980, STAT METHODS
   Soto JA, 2005, EMOTION, V5, P154, DOI 10.1037/1528-3542.5.2.154
   Underwood LG, 2002, ANN BEHAV MED, V24, P22, DOI 10.1207/S15324796ABM2401_04
   *US CENS BUR, POP PROJ US AG SEX R
   Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003
   WEINGER K, 2002, PRINCIPLES DIABETES
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   WELCH GW, 1997, DIABETES, V46
   WELCH GW, 2003, TXB TYPE 2 DIABETES
   WELCH GW, 1999, DIABETES S1, V48
   ZUMBO BD, 1999, METHODS DIFFERENTIAL
   1999, STAT PACKAGE SOCIAL
NR 39
TC 12
Z9 12
U1 0
U2 8
PU INT SOC HYPERTENSION BLACKS-ISHIB
PI ATLANTA
PA 100 AUBURN AVE NE STE 401, ATLANTA, GA 30303-2527 USA
SN 1049-510X
J9 ETHNIC DIS
JI Ethn. Dis.
PD SUM
PY 2007
VL 17
IS 3
BP 541
EP 547
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 204TI
UT WOS:000249066500020
PM 17985511
DA 2019-01-08
ER

PT J
AU Yildirim, A
   Akinci, F
   Gozu, H
   Sargin, H
   Orbay, E
   Sargin, M
AF Yildirim, Aysegul
   Akinci, Fevzi
   Gozu, Hulya
   Sargin, Haluk
   Orbay, Ekrem
   Sargin, Mehmet
TI Translation, cultural adaptation, cross-validation of the Turkish
   diabetes quality-of-life (DQOL) measure
SO QUALITY OF LIFE RESEARCH
LA English
DT Article
DE diabetes; quality of life; diabetes quality of life; validation
ID MELLITUS; TRANSPLANTATION; COMPLICATIONS; EPIDEMIOLOGY; MANAGEMENT;
   SYMPTOMS; VERSION; PEOPLE
AB Objective The aim of this study was to test the validity and reliability of the Turkish version of the diabetes quality of life (DQOL) questionnaire for use with patients with diabetes.
   Methods Turkish version of the generic quality of life (QoL) scale 15D and DQOL, socio-demographics and clinical parameter characteristics were administered to 150 patients with type 2 diabetes. Study participants were randomly sampled from the Endocrinology and Diabetes Outpatient Department of Dr. Lutfi Kirdar Kartal Education and Research Hospital in Istanbul, Turkey.
   Results The Cronbach alpha coefficient of the overall DQOL scale was 0.89; the Cronbach alpha coefficient ranged from 0.80 to 0.94 for subscales. Distress, discomfort and its symptoms, depression, mobility, usual activities, and vitality on the 15 D scale had statistically significant correlations with social/vocational worry and diabetes-related worry on the DQOL scale indicating good convergent validity. Factor analysis identified four subscales: satisfaction", impact", "diabetes-related worry", and "social/vocational worry".
   Conclusion Statistical analyses showed that the Turkish version of the DQOL is a valid and reliable instrument to measure disease related QoL in patients with diabetes. It is a simple and quick screening tool with about 15 +/- 5.8 min administration time for measuring QoL in this population.
C1 Washington State Univ, Spokane, WA 98225 USA.
   Dr Lutfi Kirdar Kartal Educ & Res Hosp, Istanbul, Turkey.
RP Akinci, F (reprint author), Washington State Univ, Spokane, WA 98225 USA.
EM akinci@wsu.edu
CR Akinci F, 2005, EVAL HEALTH PROF, V28, P53, DOI 10.1177/0163278704273078
   BRISLIN RW, 1970, J CROSS CULT PSYCHOL, V1, P185, DOI 10.1177/135910457000100301
   Brown DW, 2004, DIABETES RES CLIN PR, V65, P105, DOI 10.1016/j.diabres.2003.11.014
   Cheng AY, 1999, DIABETES CARE, V22, P1216, DOI 10.2337/diacare.22.7.1216
   DCCT Res Grp, 1988, DIABETES CARE, V11, P725
   Hahl J, 2002, QUAL LIFE RES, V11, P427, DOI 10.1023/A:1015684100227
   Hirsch A, 2000, QUAL LIFE RES, V9, P207, DOI 10.1023/A:1008959810698
   Hoyle R. H., 2002, RES METHODS SOCIAL R
   Jacobson AM, 1997, QUAL LIFE RES, V6, P11
   JACOBSON AM, 1994, DIABETES CARE, V17, P267, DOI 10.2337/diacare.17.4.267
   Kohen D, 1998, QUAL LIFE RES, V7, P197, DOI 10.1023/A:1008817812520
   Kutlay S, 2003, RHEUMATOL INT, V23, P21, DOI 10.1007/s00296-002-0247-2
   LLOYD CE, 1992, DIABETES CARE, V15, P166, DOI 10.2337/diacare.15.2.166
   Mensing C, 2000, DIABETES CARE, V23, P682, DOI 10.2337/diacare.23.5.682
   NAKACHE R, 1994, TRANSPL P, V26, P510
   NATHAN DM, 1991, TRANSPLANTATION, V52, P85, DOI 10.1097/00007890-199107000-00018
   Redekop WK, 2002, DIABETES CARE, V25, P458, DOI 10.2337/diacare.25.3.458
   Roman SH, 1997, ENDOCRIN METAB CLIN, V26, P443, DOI 10.1016/S0889-8529(05)70260-7
   Satman I, 2002, DIABETES CARE, V25, P1551, DOI 10.2337/diacare.25.9.1551
   SELAM JL, 1992, DIABETES CARE, V15, P877, DOI 10.2337/diacare.15.7.877
   SINTONEN H, 1993, QUALITY OF LIFE ASSESSMENT : KEY ISSUES IN THE 1990S, P185
   SINTONEN H, 1994, WORKING PAPER NATL C, V42
   Wiebe S, 2003, J CLIN EPIDEMIOL, V56, P52, DOI 10.1016/S0895-4356(02)00537-1
   Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047
   Wu SY, 1998, DIABETES CARE, V21, P725, DOI 10.2337/diacare.21.5.725
   YFANTOPOULOS J, 2001, ARCH HELL MED, V18, P279
NR 26
TC 17
Z9 19
U1 0
U2 12
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0962-9343
EI 1573-2649
J9 QUAL LIFE RES
JI Qual. Life Res.
PD JUN
PY 2007
VL 16
IS 5
BP 873
EP 879
DI 10.1007/s11136-007-9172-x
PG 7
WC Health Care Sciences & Services; Health Policy & Services; Public,
   Environmental & Occupational Health
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA 159TD
UT WOS:000245888600016
PM 17286193
DA 2019-01-08
ER

PT J
AU Chodosh, J
   Kado, DM
   Seeman, TE
   Karlamangla, AS
AF Chodosh, Joshua
   Kado, Deborah M.
   Seeman, Teresa E.
   Karlamangla, Arun S.
TI Depressive symptoms as a predictor of cognitive decline: MacArthur
   studies of successful aging
SO AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
LA English
DT Article
DE depression; dementia; distress; cognitive decline
ID MENTAL STATUS QUESTIONNAIRE; ALZHEIMERS-DISEASE; OLDER PERSONS;
   INFLAMMATORY MARKERS; RISK-FACTOR; FOLLOW-UP; COMMUNITY; DEMENTIA;
   IMPAIRMENT; ASSOCIATION
AB Objective: The prevalence of dementia continues to rise, and yet, there are few known modifiable risk factors. Depression, as a treatable condition, may be important in the development of dementia. Our objective was to examine the association between depressive symptoms and longitudinal cognitive changes in older adults who were high-functioning at baseline. Methods: The authors analyzed data from a community-based cohort (aged 70-79 at baseline), who, at study entry, scored 7 or more (out of 9) on the Short Portable Mental Status Questionnaire (SPMSQ). Depressive symptoms were assessed at baseline using the depression subscale of the Hopkins Symptom Check List. Cognitive performance was measured at baseline and at seven-year follow up by the SPMSQ and by summary scores from standard tests of naming, construction, spatial recognition, abstraction, and delayed recall. Results: After adjusting for potential confounders, including age, education, and chronic health conditions such as diabetes, heart attack, stroke, and hypertension, a higher number of baseline depressive symptoms were strongly associated with greater seven-year decline in cognitive performance and with higher odds of incident cognitive impairment, i.e., decline in SPMSQ score to <= 6 (adjusted odds ratio per quartile of depressive symptoms score: 1.34, 95% confidence interval: 1.10-1.68). Conclusions: Depressive symptomatology independently predicts cognitive decline and incident cognitive impairment in previously high-functioning older persons.
C1 VA Greater Los Angeles Hlth Syst, HSR&D COE, Los Angeles, CA 90073 USA.
   VA Greater Los Angeles Hlth Syst, GRECC, Los Angeles, CA 90073 USA.
   Univ Calif Los Angeles, Sch Med, Dept Med, Div Geriatr, Los Angeles, CA 90024 USA.
RP Chodosh, J (reprint author), VA Greater Los Angeles Hlth Syst, HSR&D COE, 11G,11301 Wilshire Blvd, Los Angeles, CA 90073 USA.
EM jchodosh@mednet.ucla.edu
OI Chodosh, Joshua/0000-0001-7784-4306
FU NIA NIH HHS [AG-17265, AG-17056, 1K12AG01004]
CR American Psychiatric Association, 1994, DIAGN STAT MAN MENT
   Austin MP, 2001, BRIT J PSYCHIAT, V178, P200, DOI 10.1192/bjp.178.3.200
   Berger AK, 1999, NEUROLOGY, V53, P1998, DOI 10.1212/WNL.53.9.1998
   BERKMAN LF, 1993, J CLIN EPIDEMIOL, V46, P1129, DOI 10.1016/0895-4356(93)90112-E
   Chen PJ, 1999, ARCH GEN PSYCHIAT, V56, P261, DOI 10.1001/archpsyc.56.3.261
   Chodosh J, 2004, AM J GERIAT PSYCHIAT, V12, P75, DOI 10.1176/appi.ajgp.12.1.75
   Chodosh J, 2002, J AM GERIATR SOC, V50, P1051, DOI 10.1046/j.1532-5415.2002.50260.x
   Comijs HC, 2001, INT J GERIATR PSYCH, V16, P361, DOI 10.1002/gps.343
   Danner M, 2003, PSYCHOSOM MED, V65, P347, DOI 10.1097/01.PSY.0000041542.29808.01
   DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102
   Efron B, 1994, INTRO BOOTSTRAP
   ERKINJUNTTI T, 1987, J AM GERIATR SOC, V35, P412, DOI 10.1111/j.1532-5415.1987.tb04662.x
   FILLENBAUM G, 1990, J CLIN EPIDEMIOL, V43, P651, DOI 10.1016/0895-4356(90)90035-N
   Fuhrer R, 2003, J AM GERIATR SOC, V51, P1055, DOI 10.1046/j.1532-5415.2003.51352.x
   Gold PW, 1999, P ASSOC AM PHYSICIAN, V111, P22, DOI 10.1046/j.1525-1381.1999.09423.x
   GOLD PW, 1988, NEW ENGL J MED, V319, P413, DOI 10.1056/NEJM198808183190706
   Green RC, 2003, ARCH NEUROL-CHICAGO, V60, P753, DOI 10.1001/archneur.60.5.753
   Holroyd S, 1997, INT J GERIATR PSYCH, V12, P1100, DOI 10.1002/(SICI)1099-1166(199711)12:11<1100::AID-GPS691>3.0.CO;2-5
   Inouye S. K., 1993, J GERONTOL A-BIOL, V48, P146, DOI 10.1093/geronj/48.4.M146
   Jost BC, 1996, J AM GERIATR SOC, V44, P1078, DOI 10.1111/j.1532-5415.1996.tb02942.x
   Kaplan E, 1983, BOSTON NAMING TEST
   KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016
   LUPIEN S, 1994, J NEUROSCI, V14, P2893
   MADDEN JJ, 1952, JAMA-J AM MED ASSOC, V150, P1567, DOI 10.1001/jama.1952.03680160017004
   Maes M, 1997, CYTOKINE, V9, P853, DOI 10.1006/cyto.1997.0238
   MARTIGNONI E, 1992, PSYCHONEUROENDOCRINO, V17, P343, DOI 10.1016/0306-4530(92)90040-E
   McEwen BS, 1997, MOL PSYCHIATR, V2, P255, DOI 10.1038/sj.mp.4000254
   McGeer EG, 2003, PROG NEURO-PSYCHOPH, V27, P741, DOI 10.1016/S0278-5846(03)00124-6
   McNeil JK, 1999, CLIN NEUROPSYCHOL, V13, P136
   MOSS MB, 1986, ARCH NEUROL-CHICAGO, V43, P239, DOI 10.1001/archneur.1986.00520030031008
   NAGI SZ, 1976, MILBANK MEM FUND Q, V6, P493
   PARMELEE PA, 1991, PSYCHOL AGING, V6, P504, DOI 10.1037//0882-7974.6.4.504
   Penninx BWJH, 2003, BIOL PSYCHIAT, V54, P566, DOI 10.1016/S0006-3223(03)01811-5
   PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x
   RADLOFF L S, 1986, Clinical Gerontologist, V5, P119
   RADLOFF LS, 1977, J APPL PSYCHOL MEASU, V1, P385, DOI DOI 10.1177/014662167700100306
   Rasmuson S, 2002, DEMENT GERIATR COGN, V13, P74, DOI 10.1159/000048637
   ROSEN WG, 1984, AM J PSYCHIAT, V141, P1356
   ROSOW I, 1966, J GERONTOL, V21, P556, DOI 10.1093/geronj/21.4.556
   SAPOLSKY RM, 1986, ENDOCR REV, V7, P284, DOI 10.1210/edrv-7-3-284
   Schmidt R, 2002, ANN NEUROL, V52, P168, DOI 10.1002/ana.10265
   SEIDEL A, 1995, SCAND J IMMUNOL, V41, P534, DOI 10.1111/j.1365-3083.1995.tb03604.x
   SPECK CE, 1995, EPIDEMIOLOGY, V6, P366, DOI 10.1097/00001648-199507000-00006
   Suarez EC, 2003, PSYCHOSOM MED, V65, P362, DOI 10.1097/01.PSY.0000035719.79068.2B
   Tiemeier H, 2002, AM J PSYCHIAT, V159, P2099, DOI 10.1176/appi.ajp.159.12.2099
   Weaver JD, 2002, NEUROLOGY, V59, P371, DOI 10.1212/WNL.59.3.371
   Wechsler D, 1981, ADULT INTELLIGENCE S
   Wilson CJ, 2002, J AM GERIATR SOC, V50, P2041, DOI 10.1046/j.1532-5415.2002.50619.x
   Wilson RS, 2005, NEUROLOGY, V64, P380, DOI 10.1212/01.WNL.0000149525.53525.E7
   Wilson RS, 2004, J NEUROL NEUROSUR PS, V75, P191
   Yaffe K, 2003, NEUROLOGY, V61, P76, DOI 10.1212/01.WNL.0000073620.42047.D7
NR 51
TC 78
Z9 79
U1 0
U2 20
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1064-7481
J9 AM J GERIAT PSYCHIAT
JI Am. J. Geriatr. Psychiatr.
PD MAY
PY 2007
VL 15
IS 5
BP 406
EP 415
DI 10.1097/01.JGP.0b013e31802c0c63
PG 10
WC Geriatrics & Gerontology; Gerontology; Psychiatry
SC Geriatrics & Gerontology; Psychiatry
GA 165IZ
UT WOS:000246299600006
PM 17353297
DA 2019-01-08
ER

PT J
AU O'Halloran, PD
AF O'Halloran, Paul D.
TI Mood changes in weeks 2 and 6 of a graduated group walking program in
   previously sedentary people with type 2 diabetes
SO AUSTRALIAN JOURNAL OF PRIMARY HEALTH
LA English
DT Article
DE mood; walking; type 2 diabetes
ID IMPAIRED GLUCOSE-TOLERANCE; PHYSICAL-ACTIVITY; ACUTE EXERCISE; AEROBIC
   EXERCISE; LIFE-STYLE; INTENSITY; MELLITUS; INTERVENTION; EXPERIENCES;
   ADHERENCE
AB Exercise-induced mood improvements are well documented in relatively young and active populations. However, it is not clear if older sedentary people with chronic illnesses such as type 2 diabetes also experience these benefits. This is particularly important given that people with type 2 diabetes are not sufficiently active and mood improvement is a potentially important motivator to exercise. The aim of the present study was to examine the effects of group walking on mood change in a sample of previously sedentary people with type 2 diabetes who were undertaking a six-week walking program. A multidimensional mood scale was utilised to assess the mood of 24 people aged 40-65 prior to and following sessions of supervised group walking on two occasions: across a 20-minute walk during week 2 of the program; and across a 40-minute walk during week 6 of the program. Results revealed improvements in positive well-being after both sessions of walking, no change in psychological distress, and increases in fatigue after the 40-minute walk. These findings could be useful to people who develop group-walking programs designed to facilitate regular exercise in people with type 2 diabetes.
C1 La Trobe Univ, Sch Publ Hlth, Bundoora, Vic 3086, Australia.
RP O'Halloran, PD (reprint author), La Trobe Univ, Sch Publ Hlth, Bundoora, Vic 3086, Australia.
EM P.O'Halloran@latrobe.edu.au
CR Annesi JJ, 2002, PERCEPT MOTOR SKILL, V94, P425, DOI 10.2466/PMS.94.2.425-439
   *AUSTR I HLTH WELF, 2005, DIAB AUSTR FACTS 200
   Berger BG, 2000, J APPL SPORT PSYCHOL, V12, P69, DOI 10.1080/10413200008404214
   Biddle S. J. H., 2000, PHYS ACTIVITY PSYCHO, P154
   Blanchard CM, 2001, J SCI MED SPORT, V4, P30, DOI 10.1016/S1440-2440(01)80005-0
   Borg G, 1985, INTRO BORGS RPE SCAL
   Boule NG, 2001, JAMA-J AM MED ASSOC, V286, P1218, DOI 10.1001/jama.286.10.1218
   COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037//0033-2909.112.1.155
   Colberg SR, 2003, DIABETES CARE, V26, P986, DOI 10.2337/diacare.26.4.986
   Daley AJ, 2004, J SPORT SCI, V22, P621, DOI 10.1080/02640410310001655778
   Daley AJ, 2003, J HEALTH PSYCHOL, V8, P685, DOI 10.1177/13591053030086003
   Di Loreto C, 2005, DIABETES CARE, V28, P1295, DOI 10.2337/diacare.28.6.1295
   Dunstan DW, 2002, DIABETES CARE, V25, P829, DOI 10.2337/diacare.25.5.829
   Ekkekakis P, 2000, J BEHAV MED, V23, P245, DOI 10.1023/A:1005558025163
   Ekkekakis P, 1999, SPORTS MED, V28, P337, DOI 10.2165/00007256-199928050-00005
   Kirk A, 2003, DIABETES CARE, V26, P1186, DOI 10.2337/diacare.26.4.1186
   MCAULEY E, 1994, J SPORT EXERCISE PSY, V16, P163
   Murphy M, 2002, MED SCI SPORT EXER, V34, P1468, DOI 10.1249/01.MSS.0000027686.50344.77
   Osei-Tutu KB, 2005, PREV MED, V40, P92, DOI 10.1016/j.ypmed.2004.05.005
   Robertson RJ, 2001, INT J SPORT PSYCHOL, V32, P177
   Sigal RJ, 2004, DIABETES CARE, V27, P2518, DOI 10.2337/diacare.27.10.2518
   SWARTZ AM, 2003, PREV MED, V28, P356
   Tate AK, 1995, J SPORT MED PHYS FIT, V35, P295
   Tudor-Locke CE, 2001, RES Q EXERCISE SPORT, V72, P1
   Uusitupa MIJ, 1996, ANN MED, V28, P445, DOI 10.3109/07853899608999106
   VANNINEN E, 1992, DIABETOLOGIA, V35, P340, DOI 10.1007/BF00401201
   WANKEL LM, 1993, INT J SPORT PSYCHOL, V24, P151
NR 27
TC 2
Z9 2
U1 0
U2 5
PU CSIRO PUBLISHING
PI CLAYTON
PA UNIPARK, BLDG 1, LEVEL 1, 195 WELLINGTON RD, LOCKED BAG 10, CLAYTON, VIC
   3168, AUSTRALIA
SN 1448-7527
EI 1836-7399
J9 AUST J PRIM HEALTH
JI Aust. J. Prim. Health.
PD APR
PY 2007
VL 13
IS 1
BP 68
EP 73
PG 6
WC Health Care Sciences & Services; Health Policy & Services; Primary
   Health Care; Public, Environmental & Occupational Health
SC Health Care Sciences & Services; General & Internal Medicine; Public,
   Environmental & Occupational Health
GA 270MX
UT WOS:000253726000009
DA 2019-01-08
ER

PT J
AU Vinik, AI
   Zhang, QW
AF Vinik, Aaron I.
   Zhang, Quanwu
TI Adding insulin glargine versus rosiglitazone - Health-related
   quality-of-life impact in type 2 diabetes
SO DIABETES CARE
LA English
DT Article
ID GLYCEMIC CONTROL; TRIPLE THERAPY; ORAL-AGENTS; MELLITUS; SULFONYLUREA;
   COMPLICATIONS; METFORMIN
AB OBJECTIVE - We sought to assess health-related quality of life (HRQOL) in patients with type 2 diabetes treated with insulin glargine or rosiglitazone as add-on therapy to sulfonylurea plus metlormin.
   RESEARCH DESIGN AND METHODS - HRQOL was evaluated in 217 subjects uncontrolled With sulfonylurea plus metformin, enrolled in a 24-week, multicenter, randomized, open-label, parallel-group trial of add-on insulin glargine versus rosightazone. A 40-item, selfadministered questionnaire at baseline and at weeks 2, 6, 12, 18, and 24 was given, including the 34-iLem Diabetes Symptom CheckliSL-Revised (DSC-R), a 5-item mental health scale from the 36-item Short-Forin Health Survey (SF-36), and a single-item health rating from the SF-36. These assessments do not specify route of therapy.
   RESULTS - Both treatment groups showed similar improvements in glycemic control from baseline to week 24 (change in AlC: -1.66% in the insulin glargine group, -1.51% in the rosiglitazone group, P = 0. 1446). Both groups also showed improvement in HRQOL, although subjects treated with insulin glargine experienced significantly greater improvements compared with rosightazone in the DSC-R total symptom score (P = 0.005), total symptom distress score (P = 0.03), individual domain scores for mood symptoms (P = 0.007), oplithalmologic symptoms (P = 0.007), oplithalmologic distress (P = 0.013), fatigue distress (P = 0.033), and SF-36 perception of general health (P = 0.047).
   CONCLUSIONS - Although addition of insulin glargine and rosightazone achieved comparable improvements in glycemic control, insulin glargine was associated with greater improvements in HRQOL, indicating that other factors (e.g., safety profile and nonglycemic actions) may further enhance HRQOL in patients with type 2 diabetes.
C1 Eastern Virginia Med Sch, Strelitz Diabet Res Inst, Norfolk, VA 23510 USA.
   Sanofi Aventis US, Dept Hlth Outcomes, Bridgewater, MA USA.
RP Vinik, AI (reprint author), Eastern Virginia Med Sch, Strelitz Diabet Res Inst, 855 W Brambleton Ave, Norfolk, VA 23510 USA.
EM vinikai@evms.edu
CR Davis TME, 2001, DIABETES RES CLIN PR, V52, P63, DOI 10.1016/S0168-8227(00)00245-X
   de Sonnaville JJJ, 1998, DIABETES CARE, V21, P919, DOI 10.2337/diacare.21.6.919
   Fischer JS, 2004, CURR MED RES OPIN, V20, P1703, DOI 10.1185/030079904X5526
   Goddijn PPM, 1999, DIABETIC MED, V16, P23, DOI 10.1046/j.1464-5491.1999.00002.x
   GROOTENHUIS PA, 1994, DIABETIC MED, V11, P253, DOI 10.1111/j.1464-5491.1994.tb00268.x
   Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118
   Hunt LM, 1997, DIABETES CARE, V20, P292, DOI 10.2337/diacare.20.3.292
   Korytkowski M, 2002, INT J OBESITY, V26, pS18, DOI 10.1038/sj.ijo.0802173
   LeRoith D, 2005, DIABETES-METAB RES, V21, P85, DOI 10.1002/dmrr.530
   Pibernik-Okanovic M, 1998, PHARMACOECONOMICS, V14, P201, DOI 10.2165/00019053-199814020-00008
   Rosenstock J, 2006, DIABETES CARE, V29, P554, DOI 10.2337/diacare.29.03.06.dc05-0695
   SHAMOON H, 1993, NEW ENGL J MED, V329, P977
   Strowig SM, 2004, DIABETES CARE, V27, P1577, DOI 10.2337/diacare.27.7.1577
   Turner RC, 1999, JAMA-J AM MED ASSOC, V281, P2005, DOI 10.1001/jama.281.21.2005
   Turner RC, 1998, LANCET, V352, P837
   UK Prospective Diabetes Study Group, 1999, DIABETES CARE, V22, P1125, DOI DOI 10.2337/DIACARE.22.7.1125
   Vinik Etta J, 2005, Diabetes Technol Ther, V7, P497, DOI 10.1089/dia.2005.7.497
   WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002
   Wright A, 2002, DIABETES CARE, V25, P330, DOI 10.2337/diacare.25.2.330
NR 19
TC 38
Z9 38
U1 0
U2 4
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
J9 DIABETES CARE
JI Diabetes Care
PD APR
PY 2007
VL 30
IS 4
BP 795
EP 800
DI 10.2337/dc06-1712
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 157DA
UT WOS:000245697600005
PM 17259481
OA Bronze
DA 2019-01-08
ER

PT J
AU Degazon, CE
   Parker, VG
AF Degazon, Cynthia E.
   Parker, Veronica G.
TI Coping and psychosocial adaptation to type 2 diabetes in older blacks
   born in the Southern US and the Caribbean
SO RESEARCH IN NURSING & HEALTH
LA English
DT Article
DE coping; psychosocial adaptation; birth origin; type 2 diabetes; Blacks
   born in the Southern US and the Caribbean
ID AFRICAN-AMERICAN WOMEN; GLYCEMIC CONTROL; ETHNIC-DIFFERENCES;
   RACIAL-DIFFERENCES; HEALTH-CARE; ADULTS; POPULATION; PREVALENCE; CANCER;
   ADJUSTMENT
AB Older Black men and women (n=212) with Type 2 diabetes completed questionnaires. Spearman's rho correlation indicated that canfrontive coping strategies supported effective psychosocial adaptation for persons originally from Haiti and Jamaica, while emotive coping strategies were related to ineffective psychosocial adaptation for persons originally from Barbados and to increased psychological distress for all participants. Women used more palliative coping; no gender differences were observed for psychosocial adaptation. Health care orientation, extended family relationships, and psychological distress domains distinguished Blacks born in Haiti from Blacks born in Barbados and Jamaica, the Southern US and Jamaica, and the Southern US, Barbados, and Jamaica. Findings from this study may aid in the development of interventions focused on improving diabetes self-management for older Blacks. (c) 2007 Wiley Periodicals,
C1 CUNY Hunter Coll, Hunter Bellevue Sch Nursing, New York, NY 10021 USA.
   Clemson Univ, Sch Nursing, Clemson, SC USA.
RP Degazon, CE (reprint author), 29 Homewood Dr, Morristown, NJ 07960 USA.
RI Parker, Veronica/I-5160-2013
OI Parker, Veronica/0000-0002-5217-4569
CR *AM DIAB ASS, 2005, DIAB STAT AFR AM
   *AM DIAB ASS, 2001, DIAB 2001 VIT STAT
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   [Anonymous], 2005, NAT DIAB FACT SHEET
   Baptiste DA, 1997, CONTEMP FAM THER, V19, P337
   Barcelo A, 2001, Rev Panam Salud Publica, V10, P300, DOI 10.1590/S1020-49892001001100002
   BELL RA, 1995, BEHAV MED, V21, P69, DOI 10.1080/08964289.1995.9933745
   Boyle JP, 2001, DIABETES CARE, V24, P1936, DOI 10.2337/diacare.24.11.1936
   Brice-Baker JR, 2005, ETHNICITY FAMILY THE, P117
   Byrd W. M., 2003, UNEQUAL TREATMENT CO, P455
   Chin MH, 2000, DIABETES EDUCATOR, V26, P439, DOI 10.1177/014572170002600311
   COSGRAY RE, 2004, TRANSCULTURAL NURSIN, P517
   de Groot M, 2003, ETHNIC DIS, V13, P6
   de Rekeneire N, 2003, DIABETES CARE, V26, P1986, DOI 10.2337/diacare.26.7.1986
   Degazon CE, 1995, NURS OUTLOOK, V43, P254, DOI 10.1016/S0029-6554(95)80090-5
   DEROGATIS LR, 1990, PSYCHOSOCIAL ADJUSTM
   Elasy TA, 2000, DIABETES CARE, V23, P325, DOI 10.2337/diacare.23.3.325
   Glasgow RE, 2001, DIABETES SPECTRUM, V14, P33, DOI DOI 10.2337/DIASPECT.14.1.33
   GREY M, 1991, NURS RES, V40, P144
   HANDRON DS, 1994, DIABETES EDUCATOR, V20, P515, DOI 10.1177/014572179402000609
   Harris MI, 1999, DIABETES CARE, V22, P403, DOI 10.2337/diacare.22.3.403
   Harris MI, 2001, DIABETES CARE, V24, P454, DOI 10.2337/diacare.24.3.454
   Hennis AJM, 2004, DIABETES CARE, V27, P2636, DOI 10.2337/diacare.27.11.2636
   HOLCOMB LO, 1996, HAITIAN AM IMPLICATI, V13, P249
   HUSAINI BA, 1991, J GERONTOL, V46, pP236, DOI 10.1093/geronj/46.5.P236
   JALOWIEC A, 1984, NURS RES, V33, P157
   Jalowiec A., 1988, MEASUREMENT NURSING, P287
   Jenkins R, 2004, J SEX MARITAL THER, V30, P79, DOI 10.1080/00926230490258884
   *KAIS COMM MED UN, 2004, HLTH INS COV AM
   Karter AJ, 2000, DIABETES CARE, V23, P477, DOI 10.2337/diacare.23.4.477
   Keppel G., 1991, DESIGN ANAL RES HDB
   Lazarus R. S, 1984, STRESS APPRAISAL COP
   Macrodimitris SD, 2001, HEALTH PSYCHOL, V20, P208, DOI 10.1037//0278-6133.20.3.208
   MELEIS AI, 1992, NURS RES, V41, P98
   Melkus GD, 2004, APPL NURS RES, V17, P10, DOI 10.1016/j.apnr.2003.10.009
   Montague Mamie C, 2002, ABNF J, V13, P103
   Nichols GA, 2000, DIABETES CARE, V23, P273, DOI 10.2337/diacare.23.3.273
   Nichols GA, 2003, DIABETES CARE, V26, P744, DOI 10.2337/diacare.26.3.744
   *NYC DEP CIT PLANN, 2004, NEW NEW YORK 2000 IM
   POWE BD, 1995, J RELIG HEALTH, V34, P119, DOI 10.1007/BF02248767
   POWE BD, 1995, CANCER NURS, V18, P385
   *RAND HOUS, 1999, RAND HOUS WEBST COLL
   Riste L, 2001, DIABETES CARE, V24, P1377, DOI 10.2337/diacare.24.8.1377
   Schorling JB, 2000, DIABETES CARE, V23, P330, DOI 10.2337/diacare.23.3.330
   Sedgwick JEC, 2003, ETHNIC HEALTH, V8, P121, DOI 10.1080/1355785032000123177
   Stewart R, 2003, J AM GERIATR SOC, V51, P1547, DOI 10.1046/j.1532-5415.2003.51504.x
   Stover JC, 2001, APPL NURS RES, V14, P72, DOI 10.1053/apnr.2001.22372
   SUMMERSON JH, 1992, SOUTHERN MED J, V85, P953, DOI 10.1097/00007611-199210000-00005
   Turner DC, 1996, AM BEHAV SCI, V39, P717, DOI 10.1177/0002764296039006008
   Umpierrez GE, 1997, ARCH INTERN MED, V157, P669, DOI 10.1001/archinte.157.6.669
   US Department of Health and Human Services, 2000, HLTH PEOPL 2010 UND
   Wenzel J, 2005, DIABETES EDUCATOR, V31, P98, DOI 10.1177/0145721704273242
   White N E, 1992, West J Nurs Res, V14, P211, DOI 10.1177/019394599201400208
   Willoughby DF, 2000, DIABETES EDUCATOR, V26, P105, DOI 10.1177/014572170002600111
NR 54
TC 4
Z9 7
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0160-6891
EI 1098-240X
J9 RES NURS HEALTH
JI Res. Nurs. Health
PD APR
PY 2007
VL 30
IS 2
BP 151
EP 163
DI 10.1002/nur.20192
PG 13
WC Nursing
SC Nursing
GA 153SM
UT WOS:000245455500004
PM 17380516
DA 2019-01-08
ER

PT J
AU Fekete, EM
   Antoni, MH
   Schneiderman, N
AF Fekete, Erin M.
   Antoni, Michael H.
   Schneiderman, Neil
TI Psychosocial and behavioral interventions for chronic medical conditions
SO CURRENT OPINION IN PSYCHIATRY
LA English
DT Article
DE behavioral interventions; chronic illness; psychosocial interventions
ID RANDOMIZED CONTROLLED-TRIAL; LIFE-STYLE INTERVENTION; EARLY-STAGE
   BREAST; QUALITY-OF-LIFE; STRESS-MANAGEMENT INTERVENTION;
   HUMAN-IMMUNODEFICIENCY-VIRUS; FINNISH-DIABETES-PREVENTION; IMPAIRED
   GLUCOSE-TOLERANCE; CORONARY-HEART-DISEASE; CLINICAL-TRIAL
AB Purpose of review
   This paper critically reviews recent studies that have used behavioral or psychosocial interventions aimed at preventing type 2 diabetes mellitus, cardiovascular disease and HIV/AIDS as well as the psychosocial management of cardiovascular disease. HIV and cancer.
   Recent findings
   Behavioural (lifestyle) interventions can decrease risk of type 2 diabetes mellitus and cardiovascular disease. Psychosocial interventions have proven efficacy for cardiovascular disease and HIV/AIDS. These interventions may also help to prevent HIV infection, and improve medication adherence in HIV/AIDS.
   Summary
   Behavioural and psychosocial interventions are useful in preventing some chronic diseases and for alleviating distress in patients who have been medically treated for diseases such as cancer, cardiovascular disease and HIV/AIDS. Findings regarding the effects of psychosocial interventions on disease processes, morbidity and mortality are not well established and require appropriate clinical trials.
C1 Univ Miami, Dept Psychol, Coral Gables, FL 33124 USA.
   Univ Miami, Behav Med Res Ctr, Coral Gables, FL 33124 USA.
RP Schneiderman, N (reprint author), Univ Miami, Dept Psychol, POB 248185, Coral Gables, FL 33124 USA.
EM nschneid@miami.edu
CR Andersen BL, 2004, J CLIN ONCOL, V22, P3570, DOI 10.1200/JCO.2004.06.030
   Antoni MH, 2006, PSYCHOSOM MED, V68, P143, DOI 10.1097/01.psy.0000195749.60049.63
   Antoni MH, 2005, J PSYCHOSOM RES, V58, P3, DOI 10.1016/j.jpsychores.2004.05.010
   Antoni MH, 2006, NAT REV CANCER, V6, P240, DOI 10.1038/nrc1820
   Antoni MH, 2001, HEALTH PSYCHOL, V20, P20, DOI 10.1037//0278-6133.20.1.20
   ANTONI MH, 2006, AM J  PSYCHIAT, V163, P7
   ANTONI MH, 2006, IN PRESS J CONSULT C, V74
   Appels A, 2005, PSYCHOSOM MED, V67, P217, DOI 10.1097/01.psy.0000151485.38411.36
   Appels A, 2006, J PSYCHOSOM RES, V61, P1, DOI 10.1016/j.jpsychores.2005.12.008
   Barrera M, 2006, J HEALTH PSYCHOL, V11, P483, DOI 10.1177/1359105306063321
   BERKMAN LF, 2003, JAMA-J AM MED ASSOC, V289, P3171
   Boesen EH, 2005, J CLIN ONCOL, V23, P1270, DOI 10.1200/JCO.2005.05.193
   Carey MP, 2004, J CONSULT CLIN PSYCH, V72, P252, DOI 10.1037/0022-006X.72.2.252
   Carrico AW, 2005, CHRONIC ILLN, V1, P207, DOI 10.1179/174239505X55996
   Clark M, 2004, BRIT J HEALTH PSYCH, V9, P365, DOI 10.1348/1359107041557066
   DELEON CFM, 1991, PSYCHOSOM MED, V53, P407, DOI 10.1097/00006842-199107000-00006
   Doorenbos A, 2005, PSYCHO-ONCOL, V14, P574, DOI 10.1002/pon.874
   Fisher JD, 2006, JAIDS-J ACQ IMM DEF, V41, P44, DOI 10.1097/01.qai.0000192000.15777.5c
   FRIEDMAN M, 1986, AM HEART J, V112, P653, DOI 10.1016/0002-8703(86)90458-8
   Given C, 2004, PSYCHO-ONCOL, V13, P818, DOI 10.1002/pon.807
   Hamalainen H, 2005, DIABETOLOGIA, V48, P2248, DOI 10.1007/s00125-005-1938-5
   Hamman RF, 2006, DIABETES CARE, V29, P2102, DOI 10.2337/dc06-0560
   Helgeson VS, 2006, HEALTH PSYCHOL, V25, P348, DOI 10.1037/0278-6133.25.3.348
   Hernandez-Reif M, 2004, J PSYCHOSOM RES, V57, P45, DOI 10.1016/S0022-3999(03)00500-2
   Ironson G, 2005, PSYCHOSOM MED, V67, P1013, DOI 10.1097/01.psy.0000188569.58998.c8
   Kiene SM, 2006, J ADOLESCENT HEALTH, V39, P404, DOI 10.1016/j.jadohealth.2005.12.029
   King DK, 2006, ANN BEHAV MED, V31, P128, DOI 10.1207/s15324796abm3102_4
   Kitabchi AE, 2005, DIABETES, V54, P2404
   Knowler WC, 2002, NEW ENGL J MED, V346, P393
   Koblin B, 2004, LANCET, V364, P41, DOI 10.1016/S0140-6736(04)16588-4
   Laaksonen DE, 2005, DIABETES, V54, P158, DOI 10.2337/diabetes.54.1.158
   Manne SL, 2005, J CONSULT CLIN PSYCH, V73, P634, DOI 10.1037/0022-006X.73.4.634
   Mayer-Davis EJ, 2004, AM J PUBLIC HEALTH, V94, P1736, DOI 10.2105/AJPH.94.10.1736
   McGregor BA, 2004, J PSYCHOSOM RES, V56, P1, DOI 10.1016/S0022-3999(03)00036-9
   Milam J, 2005, JAIDS-J ACQ IMM DEF, V40, P356, DOI 10.1097/01.qai.0000159710.98960.81
   Monti DA, 2006, PSYCHO-ONCOL, V15, P363, DOI 10.1002/pon.988
   Northouse L, 2005, PSYCHO-ONCOLOGY, V14, P478, DOI 10.1002/pon.871
   Ornish D, 2005, J UROLOGY, V174, P1065, DOI 10.1097/01.ju.0000169487.49018.73
   Paul-Labrador M, 2006, ARCH INTERN MED, V166, P1218, DOI 10.1001/archinte.166.11.1218
   Penedo FJ, 2006, ANN BEHAV MED, V31, P261, DOI 10.1207/s15324796abm3103_8
   Penedo FJ, 2004, CANCER, V100, P192, DOI 10.1002/cncr.11894
   PENEDO FJ, 2006, IN PRESS INT J BEHAV
   Remien RH, 2005, AIDS, V19, P807, DOI 10.1097/01.aids.0000168975.44219.45
   Richardson JL, 2004, AIDS, V18, P1179, DOI 10.1097/01.aids.0000125965.01259.5f
   Scheier MF, 2005, J CLIN ONCOL, V23, P4298, DOI 10.1200/JCO.2005.05.362
   Schneider RH, 2005, AM J CARDIOL, V95, P1060, DOI 10.1016/j.amjcard.2004.12.058
   Schneiderman N, 2004, PSYCHOSOM MED, V66, P475, DOI 10.1097/01.psy.0000133217.96180.e8
   Scott JL, 2004, J CONSULT CLIN PSYCH, V72, P1122, DOI 10.1037/0022-006X.72.6.1122
   Seligman MEP, 2000, AM PSYCHOL, V55, P5, DOI 10.1037//0003-066X.55.1.5
   Sikkema KJ, 2006, HEALTH PSYCHOL, V25, P563, DOI 10.1037/0278-6133.25.5.563
   Sikkema KJ, 2004, DEATH STUD, V28, P187, DOI 10.1080/07481180490276544
   TAYLOR CB, 2005, ARCH GEN PSYCHIAT, V62, P711
   Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801
   Williams ML, 2006, AIDS EDUC PREV, V18, P204, DOI 10.1521/aeap.2006.18.3.204
NR 54
TC 28
Z9 29
U1 0
U2 9
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0951-7367
J9 CURR OPIN PSYCHIATR
JI Curr. Opin. Psychiatr.
PD MAR
PY 2007
VL 20
IS 2
BP 152
EP 157
DI 10.1097/YCO.0b013e3280147724
PG 6
WC Psychiatry
SC Psychiatry
GA 142EW
UT WOS:000244633200010
PM 17278914
DA 2019-01-08
ER

PT J
AU Fisher, L
   Skaff, MM
   Mullan, JT
   Arean, P
   Mohr, D
   Masharani, U
   Glasgow, R
   Laurencin, G
AF Fisher, Lawrence
   Skaff, Marilyn M.
   Mullan, Joseph T.
   Arean, Patricia
   Mohr, David
   Masharani, Umesh
   Glasgow, Russell
   Laurencin, Grace
TI Clinical depression versus distress among patients with type 2 diabetes
   - Not just a question of semantics
SO DIABETES CARE
LA English
DT Article
ID COMORBIDITY SURVEY REPLICATION; SELF-REPORTED DISTRESS; PRIMARY-CARE;
   INDIVIDUALS; PREVALENCE; DISORDERS; VALIDITY; OUTCOMES; IMPACT; SCALE
AB OBJECTIVE - We sought to determine differences between structured interviews, symptom questionnaires, and distress measures for assessment of depression in patients with diabetes.
   RESEARCH DESIGN AND METHODS - We assessed 506 diabetic patients for major depressive disorder (MDD) by a structured interview (Composite International Diagnostic Interview [CIDI]), a questionnaire for depressive symptoms (Center for Epidemiological Studies Depression Scale [CESD]), and on the Diabetes Distress Scale. Demographic characteristics, two biological variables (A1C and non-HDL cholesterol), and four behavioral management measures (kilocalories, calories of saturated fat, number of fruit and vegetable servings, and minutes of physical activity) were assessed. Comparisons were made between those with and without depression on the CIDI and the CESD.
   RESULTS - Findings showed that 22% of patients reached CESD 16, and 9.9% met a CIDI diagnosis of MDD. Of those above CESD cut points, 70% were not clinically depressed, and 34% o t ose who were clinically depressed did not reach CESD scores ! 16. Those scoring - 16, compared with those < 16 on the CESD, had higher A1C, kilocalories, and calories of saturated fat and lower physical activity. No differences were found using the CIDI. Diabetes distress as minimally related to MDD but substantively linked to CESD scores and to outcomes.
   CONCLUSIONS - Most patients with diabetes and high levels of depressive symptoms are not clinically depressed. The CESD may be more reflective of general emotional and diabetes-specific distress than clinical depression. Most treatment of distress, however, is based on the depression literature, which suggests the need to consider different interventions for distressed but not clinically depressed diabetic patients.
C1 Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA.
   Univ Calif San Francisco, Sch Nursing, Dept Social & Behav Sci, San Francisco, CA 94143 USA.
   Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.
   Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.
   Kaiser Permanente, Denver, CO USA.
RP Fisher, L (reprint author), Univ Calif San Francisco, Dept Family & Community Med, Box 0900, San Francisco, CA 94143 USA.
EM fisherl@fcm.ucsf.edu
OI Mohr, David/0000-0002-5443-7596
FU NIDDK NIH HHS [DK061937, DK062732]
CR AINSWORTH BE, 2000, MED SCI SPORTS EXERC, V32, P498, DOI DOI 10.1097/00005768-200009001-00009
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561
   Black SA, 2003, DIABETES CARE, V26, P2822, DOI 10.2337/diacare.26.10.2822
   Block G, 1990, Epidemiology, V1, P58, DOI 10.1097/00001648-199001000-00013
   Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278
   Coyne JC, 2001, PSYCHOL ASSESSMENT, V13, P163, DOI 10.1037//1040-3590.13.2.163
   COYNE JC, 1994, PSYCHOL BULL, V116, P29, DOI 10.1037/0033-2909.116.1.29
   Egede LE, 2004, DIABETES CARE, V27, P1751, DOI 10.2337/diacare.27.7.1751
   Egede LE, 2002, DIABETES CARE, V25, P464, DOI 10.2337/diacare.25.3.464
   FECHNERBATES S, 1994, J CONSULT CLIN PSYCH, V62, P550, DOI 10.1037//0022-006X.62.3.550
   First MB, 1995, J PERSONALITY DISORD, V9, P2
   Fisher L, 2001, DIABETES CARE, V24, P1751, DOI 10.2337/diacare.24.10.1751
   Fisher L., 2004, DIABETES SPECTRUM, V17, P215, DOI [10.2337/diaspect.17.4.215, DOI 10.2337/DIASPECT.17.4.215]
   Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2
   Katon WJ, 2005, DIABETES CARE, V28, P2668, DOI 10.2337/diacare.28.11.2668
   Katon WJ, 2004, ARCH GEN PSYCHIAT, V61, P1042, DOI 10.1001/archpsyc.61.10.1042
   Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617
   Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095
   Kubzansky LD, 2005, PSYCHOSOM MED, V67, pS10, DOI 10.1097/01.psy.0000164012.88829.41
   Lin EHB, 2006, ANN FAM MED, V4, P46, DOI 10.1370/afm.423
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Mullan JT, 2006, DIABETES, V55, pA426
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   Pouwer F, 2003, DIABETOLOGIA, V46, P892, DOI 10.1007/s00125-003-1124-6
   RADLOFF LS, 1977, APPL PSYCH MEAS, V3, P385
   REID MC, 1995, JAMA-J AM MED ASSOC, V274, P645, DOI 10.1001/jama.274.8.645
   SHEEHAN DV, 1998, J CLIN PSYCHIAT S20, V59, P20
   Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737
   Williams JW, 2004, ANN INTERN MED, V140, P1015, DOI 10.7326/0003-4819-140-12-200406150-00012
   WITTCHEN HU, 1994, J PSYCHIAT RES, V28, P57, DOI 10.1016/0022-3956(94)90036-1
   ZICH JM, 1990, INT J PSYCHIAT MED, V20, P259, DOI 10.2190/LYKR-7VHP-YJEM-MKM2
NR 32
TC 240
Z9 249
U1 0
U2 25
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
J9 DIABETES CARE
JI Diabetes Care
PD MAR
PY 2007
VL 30
IS 3
BP 542
EP 548
DI 10.2337/dc06-1614
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 146NM
UT WOS:000244941200014
PM 17327318
OA Bronze
DA 2019-01-08
ER

PT J
AU Brands, AMA
   Van den Berg, E
   Manschot, SM
   Biessels, GJ
   Kappelle, LJ
   De Haan, EHF
   Kessels, RPC
AF Brands, Augustina M. A.
   Van den Berg, Esther
   Manschot, Sanne M.
   Biessels, Geert Jan
   Kappelle, L. Jaap
   De Haan, Edward H. F.
   Kessels, Roy P. C.
TI A detailed profile of cognitive dysfunction and its relation to
   psychological distress in patients with type 2 diabetes mellitus
SO JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY
LA English
DT Article
DE insulin; depression; aging; brain MRI; neuropsychological; assessment
ID GERIATRIC DEPRESSION; LEARNING TEST; BRAIN; ADULTS; MRI;
   HYPERINTENSITIES; METAANALYSIS; IMPAIRMENT; VALIDATION; ATTENTION
AB Type 2 diabetes mellitus (DM2) is a common metabolic disorder. DM2 is associated with cognitive impairments, and with depressive symptoms, which occur in about one third of patients. In the current study we compared the cognitive profile and psychological well-being of 119 patients with DM2 (mean age: 66 +/- 6; mean duration: 9 +/- 6 years) with 55 age and education matched-control participants. Groups were compared on cognitive performance in five major cognitive domains, psychological wellbeing [assessed by Symptom Checklist (SCL)-90-R and the Beck Depression Inventory (BDI-II)]. and abnormalities on brain MRI. We hypothesized an interrelationship between cognition, MRI abnormalities, and psychological well-being. DM2 patients performed significantly worse than controls on cognitive tasks, especially on tasks that required more mental efficiency, although the differences were modest (effect sizes Cohen d <.6). We speculate that DM2 patients have a diminished ability to efficiently process unstructured information. Patients with DM2 had significantly higher scores on the SCL-90-R (p <.001) and on the BDI-II (p <.001) and worse MRI ratings than controls, but psychological distress did not correlate with cognition, MRI ratings or biomedical characteristics. Contrary to our hypothesis, cognitive disturbances and psychological distress thus seem independent symptoms of the same disease.
C1 Zuwe Hofpoort Reg Psychiat Ctr, NL-3447 AC Woerden, Netherlands.
   Univ Med Ctr, Rudolf Magnus Inst Neurosci, Dept Neurol, Utrecht, Netherlands.
   Univ Utrecht, Dept Expt Psychol, Inst Helminthol, Utrecht, Netherlands.
   Radboud Univ Nijmegen Med Ctr, Dept Psychol Med, Nijmegen, Netherlands.
   Radboud Univ Nijmegen Med Ctr, Dept Geriatr, Nijmegen, Netherlands.
   Radboud Univ Nijmegen, NICI, Nijmegen, Netherlands.
RP Brands, AMA (reprint author), Zuwe Hofpoort Reg Psychiat Ctr, Blekerijlaan 3, NL-3447 AC Woerden, Netherlands.
EM I.Brands@altrecht.nl
RI Kessels, Roy/D-1902-2010
OI Kessels, Roy/0000-0001-9500-9793; van den Berg,
   Esther/0000-0002-8120-7366
CR ALEXOPOULOS GS, 1993, AM J PSYCHIAT, V150, P1693
   Alexopoulos GS, 1997, ARCH GEN PSYCHIAT, V54, P915
   *AM DIAB ASS, 2002, DIABETES CARE, V25, P213
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   ARAKI Y, 1994, NEURORADIOLOGY, V36, P101, DOI 10.1007/BF00588069
   Arrindell WA, 2003, SCL 90 HANDLEIDING B
   Awad N, 2004, J CLIN EXP NEUROPSYC, V26, P1044, DOI 10.1080/13803390490514875
   Baldwin RC, 2006, INT J GERIATR PSYCH, V21, P57, DOI 10.1002/gps.1424
   BECK AT, 2002, BDI II NL HANDLEIDIN
   Beck AT, 1996, BECK DEPRESSION INVE
   Berch DB, 1998, BRAIN COGNITION, V38, P317, DOI 10.1006/brcg.1998.1039
   Bril V, 2002, DIABETES CARE, V25, P2048, DOI 10.2337/diacare.25.11.2048
   BUCKS RS, 2000, LOCATION LEARNING TE
   Burgess P., 1997, HAYLING BRIXTON TEST
   COHEN G, 1996, HDB CLIN PSYCHOL AGE
   Cohen J, 1988, STAT POWER ANAL BEHA
   CORRIGAN JD, 1987, J CLIN PSYCHOL, V43, P402, DOI 10.1002/1097-4679(198707)43:4<402::AID-JCLP2270430411>3.0.CO;2-E
   Deelman BG, 1981, SAN TEST AFASIE TEST
   DEROGATIS LR, 1976, BRIT J PSYCHIAT, V128, P280, DOI 10.1192/bjp.128.3.280
   Elderkin-Thompson V, 2003, ARCH CLIN NEUROPSYCH, V18, P529, DOI 10.1016/S0887-6177(03)00022-2
   ESTES WK, 1974, AM PSYCHOL, V29, P740, DOI 10.1037/h0037458
   GARDE E, 2006, J NEUROL NEUROSUR PS, V76, P1289
   Gispen WH, 2000, TRENDS NEUROSCI, V23, P542, DOI 10.1016/S0166-2236(00)01656-8
   GOMORI JM, 1984, NEURORADIOLOGY, V26, P21, DOI 10.1007/BF00328197
   Goudswaard AN, 2004, EUR J EPIDEMIOL, V19, P541
   Gregg EW, 2000, ARCH INTERN MED, V160, P174, DOI 10.1001/archinte.160.2.174
   Gunning-Dixon FM, 2000, NEUROPSYCHOLOGY, V14, P224, DOI 10.1037//0894-4105.14.2.224
   JOKINEN H, 2005, J NEUROL NEUROSUR PS, V76, P1185
   Jorm AF, 2005, AM J PSYCHIAT, V162, P699, DOI 10.1176/appi.ajp.162.4.699
   Kessels R P, 2000, Appl Neuropsychol, V7, P252, DOI 10.1207/S15324826AN0704_8
   Kessels RPC, 2006, ARCH CLIN NEUROPSYCH, V21, P841, DOI 10.1016/j.acn.2006.06.015
   Kessels RPC, 1998, ACTA NEUROL SCAND, V97, P188
   KLEIN R, 1986, OPHTHALMOLOGY, V93, P1183
   LEEDOM L, 1991, PSYCHOSOMATICS, V32, P280, DOI 10.1016/S0033-3182(91)72066-5
   LEZAK MD, 2004, NEUROPSYCHOLOGICAL
   Lockwood KA, 2002, AM J PSYCHIAT, V159, P1119, DOI 10.1176/appi.ajp.159.7.1119
   LOWE LP, 1994, DIABETES CARE, V17, P891, DOI 10.2337/diacare.17.8.891
   Lustman PJ, 1997, PSYCHOSOM MED, V59, P24, DOI 10.1097/00006842-199701000-00004
   Manschot SM, 2006, DIABETES, V55, P1106, DOI 10.2337/diabetes.55.04.06.db05-1323
   PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865
   RABBITT PMA, 1998, BROCKLEHURSS TXB GER
   RAVEN J, 1993, MANUAL RAVENS PROGR
   Rey A., 1964, EXAMEN CLIN PSYCHOL
   Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286
   ROBERTSONTCHABO EA, 1986, EXP GERONTOL, V21, P459, DOI 10.1016/0531-5565(86)90051-3
   Ryan CM, 2000, DIABETES METAB RES, V16, P308, DOI 10.1002/1520-7560(2000)9999:9999<::AID-DMRR141>3.0.CO;2-X
   SCHELTENS P, 1993, J NEUROL SCI, V114, P7, DOI 10.1016/0022-510X(93)90041-V
   Schmand B, 1992, NEDERLANDSE LEESTEST
   Stewart R, 1999, DIABETIC MED, V16, P93, DOI 10.1046/j.1464-5491.1999.00027.x
   Strachan MWJ, 1997, DIABETES CARE, V20, P438, DOI 10.2337/diacare.20.3.438
   Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/0096-3445.121.1.15
   Tisserand DJ, 2003, CORTEX, V39, P1107, DOI 10.1016/S0010-9452(08)70880-3
   Troyer AK, 1997, NEUROPSYCHOLOGY, V11, P138, DOI 10.1037//0894-4105.11.1.138
   Van der Elst W, 2005, J INT NEUROPSYCH SOC, V11, P290, DOI 10.1017/S1355617705050344
   Verhaeghen P, 1997, PSYCHOL BULL, V122, P231, DOI 10.1037//0033-2909.122.3.231
   Vermeer SE, 2003, STROKE, V34, P392, DOI 10.1161/01.STR.0000052631.98405.15
   Videbech P, 1997, ACTA PSYCHIAT SCAND, V96, P157, DOI 10.1111/j.1600-0447.1997.tb10146.x
   Wechsler D., 1997, WECHSLER ADULT INTEL
   YLIKOSKI R, 1993, ARCH NEUROL-CHICAGO, V50, P818, DOI 10.1001/archneur.1993.00540080029009
NR 59
TC 62
Z9 63
U1 0
U2 6
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1355-6177
J9 J INT NEUROPSYCH SOC
JI J. Int. Neuropsychol. Soc.
PD MAR
PY 2007
VL 13
IS 2
BP 288
EP 297
DI 10.1017/S1355617707070312
PG 10
WC Clinical Neurology; Neurosciences; Psychiatry; Psychology
SC Neurosciences & Neurology; Psychiatry; Psychology
GA 144XD
UT WOS:000244828800012
PM 17286886
DA 2019-01-08
ER

PT J
AU Hidalgo, JLT
   Gras, CB
   Garcia, YD
   Lapeira, JT
   del Campo, JMD
   Verdejo, MAL
AF Lopez-Torres Hidalgo, Jesus
   Boix Gras, Clotilde
   David Garcia, Yolanda
   Tellez Lapeira, Juan
   del Campo del Campo, Jose Maria
   Lopez Verdejo, Maria Angeles
TI Functional status in the elderly with insomnia
SO QUALITY OF LIFE RESEARCH
LA English
DT Article
DE aged; insomnia; disability evaluation
ID QUALITY-OF-LIFE; ORGANIC SLEEP DISORDERS; SUBJECTIVE QUALITY;
   POPULATION; PREVALENCE
AB Background: Insomnia causes psychological distress in the elderly. Besides primary insomnia (PI), illness, medications and psychosocial factors contribute to development of sleep disorders. Although elderly insomniacs usually complain of poorer daytime functioning, it is unknown whether the disorder affects capacity to carry out activities. Objective: To assess the relationship in the elderly between PI, level of physical functioning, depression and anxiety symptoms, state of psychological well-being and consumption of psychopharmaceuticals. Design: Cross-sectional, observational study. Setting Populational. Subjects: About 424 non-institutionalized elderly patients. Methods Subjects were interviewed at public Health Centres or at home. They were considered to have PI if DSM-IV criteria were met. The remaining variables measured were: depression and anxiety symptoms (The Goldberg's Depression and Anxiety Scale), cognitive state (Short Portable Mental Status Questionnaire), physical functioning (The Katz Index and the Instrumental Activities of Daily Living Scale), life satisfaction (The Philadelphia Geriatric Center Morale Scale), health problems, consumption of pharmaceuticals and sociodemographic variables. Results: About 34.2% of the elderly admitted to having problems with sleep, but only 20.3% (CI: 95%: 16.5-24.1) fulfilled the criteria for PI. The existence of an anxiety disorder, a score below the 50th percentile on The Philadelphia Geriatric Center Morale Scale (lower life satisfaction) and consumption of psychopharmaceuticals were variables associated with insomnia. Amongst the most common illnesses reported, only diabetes appeared with significantly higher frequency in the elderly with insomnia (24.4% vs. 14.7%) (p < 0.05). No statistically significant association was found between insomnia and level of dependence in carrying out basic or instrumental activities. Conclusions: Approximately one fifth of the non-institutionalized elderly meet the criteria for PI. Those affected present a poorer state of psychological and social well-being, although level of autonomy for conducting basic and instrumental activities does not appear to be modified by the disorder. The existence of an anxiety disorder, low life satisfaction and consumption of psychopharmaceuticals constitute variables associated with PI in the population we studied.
C1 Univ Castilla La Mancha, Primary Care Head Off, Albacete 02001, Spain.
   Univ Castilla La Mancha, Fac Med, Albacete 02001, Spain.
   Primary Care Head Off, Albacete 02001, Spain.
   Primary Care Ctr Zona VII, Albacete 02005, Spain.
   Primary Care Ctr Zona VB, Albacete 02005, Spain.
   Primary Care Ctr Ossa Montiel, Albacete 02611, Spain.
   Univ Castilla La Mancha, Gen Hosp Albacete, Albacete 02006, Spain.
   Univ Castilla La Mancha, Fac Med, Albacete 02006, Spain.
RP Hidalgo, JLT (reprint author), Univ Castilla La Mancha, Primary Care Head Off, C Marques Villores 6, Albacete 02001, Spain.
EM jesusl@sescam.org; cboix@sescam.org
RI Lopez-Torres Hidalgo, Jesus/Q-8234-2017
OI Lopez-Torres Hidalgo, Jesus/0000-0001-7249-3623
CR American Psychiatric Association, 1994, DIAGN STAT MAN MENT
   Ancoli-Israel S, 2005, J AM GERIATR SOC, V53, P264
   ASHTON H, 1994, DRUGS, V48, P25, DOI 10.2165/00003495-199448010-00004
   Avidan AY, 2005, PRIMARY CARE, V32, P563, DOI 10.1016/j.pop.2005.03.001
   BIXLER EO, 1979, AM J PSYCHIAT, V136, P1257
   Byles JE, 2003, AGE AGEING, V32, P154, DOI 10.1093/ageing/32.2.154
   Chokroverty S, 1996, NEUROL CLIN, V14, P807, DOI 10.1016/S0733-8619(05)70286-3
   GOLDBERG D, 1988, BRIT MED J, V297, P897, DOI 10.1136/bmj.297.6653.897
   *ICHPPC, 1983, INT CLASS HLTH PROBL
   Jensen E, 1998, J SLEEP RES, V7, P183, DOI 10.1046/j.1365-2869.1998.00118.x
   KATZ S, 1970, GERONTOLOGIST, V10, P20, DOI 10.1093/geront/10.1_Part_1.20
   LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179
   LAWTON MP, 1975, RES PLANNING ACTION, P122
   LAWTON MP, 1975, PHILADELPHIA GERIATR, V30, P85
   Leger D, 2001, REV NEUROL-FRANCE, V157, P1270
   LEGER D, 2000, PUBL HLTH INSOMNIA E, V23, P69
   Lichstein KL, 2001, PSYCHOL AGING, V16, P264, DOI 10.1037//0882-7974.16.2.264
   LLAVONA CM, 1995, ATEN PRIMARIA, V15, P176
   Manocchia M, 2001, QUAL LIFE RES, V10, P331, DOI 10.1023/A:1012299519637
   MCCALL WV, 2005, J AM GERIATR SOC, V53, P272
   MELLINGER GD, 1985, ARCH GEN PSYCHIAT, V42, P225
   PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x
   Prause W, 2003, WIEN KLIN WOCHENSCHR, V115, P326, DOI 10.1007/BF03041484
   REDONDO MP, 2000, ATEN PRIMARIA, V25, P70
   ROSEKIND MR, 1992, J CLIN PSYCHIAT, V53, P4
   Roth Thomas, 2003, Clin Cornerstone, V5, P5, DOI 10.1016/S1098-3597(03)90031-7
   Saletu B, 2003, WIEN KLIN WOCHENSCHR, V115, P246, DOI 10.1007/BF03040323
   Schubert CR, 2002, SLEEP, V25, P889
   Seppala M, 1997, AGING-CLIN EXP RES, V9, P327, DOI 10.1007/BF03339611
   Vigg A, 2003, J Assoc Physicians India, V51, P479
   Walsh JK, 2004, J CLIN PSYCHIAT, V65, P13
NR 31
TC 23
Z9 24
U1 1
U2 7
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0962-9343
J9 QUAL LIFE RES
JI Qual. Life Res.
PD MAR
PY 2007
VL 16
IS 2
BP 279
EP 286
DI 10.1007/s11136-006-9125-9
PG 8
WC Health Care Sciences & Services; Health Policy & Services; Public,
   Environmental & Occupational Health
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA 124VR
UT WOS:000243399100010
PM 17033891
DA 2019-01-08
ER

PT J
AU Chou, KL
AF Chou, Kee-Lee
TI Psychological distress in migrants in Australia over 50 years old: A
   longitudinal investigation
SO JOURNAL OF AFFECTIVE DISORDERS
LA English
DT Article
DE psychological distress; older migrants; Australia
ID FORMER SOVIET-UNION; MENTAL-HEALTH; SOCIAL SUPPORT; MEXICAN-AMERICANS;
   ELDERLY CHINESE; UNITED-STATES; LIVING ARRANGEMENTS; DEPRESSIVE
   SYMPTOMS; LIFETIME PREVALENCE; IMMIGRANTS
AB Background: Although it is a well-known fact that migration is a risk factor contributing to psychopathology, little is known in migrants who migrated in their old age. The present Study examined whether origin of countries and visa types predicted psychological distress over a period of 1 year and whether their association changed after factors in health, social roles, cohort effect and social support were adjusted.
   Methods: A nationwide representative sample of 431 migrants who aged 50 and above were interviewed in 2000-2001 and 359 of them were re-interviewed 1 year after the baseline assessment. 12-item General Health Questionnaire (GHQ-12) was used measure psychological distress and a series of questions regarding socio-demographic characteristics (age, gender, living alone), days in Australia, origin Of Countries, visa types, health, social role, cohort effect, and social support were also included.
   Results: GHQ-12 scores did deteriorate over a period of 1 year among older migrants to Australia. In multiple regression analyses, origin of countries and visa types were significant predictors of future GHQ-12 scores. Baseline GHQ-12 scores, age, gender, living alone, days in Australia, poor self-rated health, the presence of heart disease, diabetes, and asthma, being a student or economically inactive, widowhood or divorce, as well as education were also significant predictors of GHQ-12 scores at 1-year follow-up.
   Conclusions: The Status of refugees predicts future psychological distress in older migrants even when other known correlates of psycliological distress are controlled. (c) 2006 Elsevier B.V. All rights reserved.
C1 Lingnan Univ, Dept Polit & Sociol, Tuen Mun, Hong Kong, Peoples R China.
RP Chou, KL (reprint author), Lingnan Univ, Dept Polit & Sociol, Tuen Mun, Hong Kong, Peoples R China.
EM klchou@hku.hk
RI Chou, Kee Lee/B-5434-2015
CR BARRERA M, 1986, AM J COMMUN PSYCHOL, V14, P413, DOI 10.1007/BF00922627
   Beiser M., 1990, TRIANGLE, V29, P83
   Bennett KM, 2005, INT J GERIATR PSYCH, V20, P280, DOI 10.1002/gps.1280
   Black SA, 1998, J GERONTOL B-PSYCHOL, V53, pS198, DOI 10.1093/geronb/53B.4.S198
   Cantor-Graae E, 2005, PSYCHOL MED, V35, P1155, DOI 10.1017/S0033291705004721
   Carr D, 2000, J GERONTOL B-PSYCHOL, V55, pS197, DOI 10.1093/geronb/55.4.S197
   Carstensen LL, 1998, MOTIVATION SELF REGU, P341, DOI DOI 10.1017/CB09780511527869.015
   Chou KL, 2006, INT J GERIATR PSYCH, V21, P594, DOI 10.1002/gps.1535
   Chou KL, 2004, INT J GERIATR PSYCH, V19, P825, DOI 10.1002/gps.1174
   CLARKE DM, 1993, INT J PSYCHIAT MED, V23, P323, DOI 10.2190/J5HD-QPTQ-E47G-VJ0X
   COHEN S, 1983, J APPL SOC PSYCHOL, V13, P99, DOI 10.1111/j.1559-1816.1983.tb02325.x
   *DEP IMM MULT AFF, 2002, SETTL EXP NEW MIGR C
   Donath S, 2001, AUST NZ J PSYCHIAT, V35, P231, DOI 10.1046/j.1440-1614.2001.00869.x
   Ennis NE, 2000, AM J COMMUN PSYCHOL, V28, P149, DOI 10.1023/A:1005183100610
   Fox P G, 2001, Int J Psychiatr Nurs Res, V7, P778
   GLASS TA, 1995, J GERONTOL B-PSYCHOL, V50, pS65, DOI 10.1093/geronb/50B.2.S65
   Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242
   Gonzalez HM, 2001, J AM GERIATR SOC, V49, P948, DOI 10.1046/j.1532-5415.2001.49186.x
   Grant BF, 2004, ARCH GEN PSYCHIAT, V61, P1226, DOI 10.1001/archpsyc.61.12.1226
   Hermansson AC, 2003, SCAND J CARING SCI, V17, P317, DOI 10.1046/j.0283-9318.2003.00241.x
   Hinton WL, 1997, J NERV MENT DIS, V185, P39, DOI 10.1097/00005053-199701000-00007
   Holman EA, 2000, ARCH FAM MED, V9, P802, DOI 10.1001/archfami.9.9.802
   HUSAIN MM, 1991, PSYCHIAT RES-NEUROIM, V40, P95, DOI 10.1016/0165-1781(91)90149-J
   Jorm AF, 2005, PSYCHOL MED, V35, P1253, DOI 10.1017/S0033291705004976
   Kendler KS, 2003, AM J PSYCHIAT, V160, P496, DOI 10.1176/appi.ajp.160.3.496
   KESSLER RC, 1993, J AFFECT DISORDERS, V29, P85, DOI 10.1016/0165-0327(93)90026-G
   Keyes E F, 2000, Issues Ment Health Nurs, V21, P397, DOI 10.1080/016128400248013
   Lee MS, 1996, INT J AGING HUM DEV, V42, P313, DOI 10.2190/2VHH-JLXY-EBVG-Y8JB
   Lee RM, 2001, J COUNS PSYCHOL, V48, P410, DOI 10.1037//0022-0167.48.4.410
   Lerner Y, 2005, PSYCHOL MED, V35, P1805, DOI 10.1017/S0033291705005726
   Lerner Y, 1996, PSYCHOL MED, V26, P503, DOI 10.1017/S0033291700035583
   Lynch TR, 1999, J AFFECT DISORDERS, V55, P159, DOI 10.1016/S0165-0327(99)00017-8
   Maddern Steve, 2004, Nurs Stand, V18, P36
   MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224
   MIROWSKY J, 1992, J HEALTH SOC BEHAV, V33, P187, DOI 10.2307/2137349
   Mollica RH, 2001, JAMA-J AM MED ASSOC, V286, P546, DOI 10.1001/jama.286.5.546
   Mui AC, 1996, SOC WORK, V41, P633
   Mui AC, 2003, INT PSYCHOGERIATR, V15, P253, DOI 10.1017/S1041610203009517
   NICASSIO PM, 1984, SOC PSYCHIATR, V19, P135, DOI 10.1007/BF00595153
   Picardi A, 2001, J EUR ACAD DERMATOL, V15, P410, DOI 10.1046/j.1468-3083.2001.00336.x
   Plant EA, 2004, J CONSULT CLIN PSYCH, V72, P41, DOI 10.1037/0022-006X.72.1.41
   Ponizovsky A, 1998, INT J SOC PSYCHIATR, V44, P35, DOI 10.1177/002076409804400104
   Pumariega AJ, 2005, COMMUNITY MENT HLT J, V41, P581, DOI 10.1007/s10597-005-6363-1
   Rothe E. M., 2002, ADOLESCENT PSYCHIAT, V26, P97
   Rothermund K, 2003, PSYCHOL AGING, V18, P80, DOI 10.1037/0882-7974.18.1.80
   RUSSELL DW, 1991, PSYCHOL AGING, V6, P190, DOI 10.1037//0882-7974.6.2.190
   Schieman S, 2001, J HEALTH SOC BEHAV, V42, P80, DOI 10.2307/3090228
   Shapiro J, 1999, J COMMUN HEALTH, V24, P95, DOI 10.1023/A:1018702323648
   Shevlin M., 2001, APPL REGRESSION CORR
   Silove D, 2002, COMPR PSYCHIAT, V43, P49, DOI 10.1053/comp.2002.29843
   Silveira ERT, 1998, INT J GERIATR PSYCH, V13, P801
   Spijker J, 2004, INT J GERIATR PSYCH, V19, P538, DOI 10.1002/gps.1122
   Steel Z, 2002, LANCET, V360, P1056, DOI 10.1016/S0140-6736(02)11142-1
   Steel Z, 2001, MED J AUSTRALIA, V175, P596
   Stokes SC, 2002, J GERONTOLOGICAL SOC, V36, P27, DOI DOI 10.1300/J083V36N01_
   Strawbridge WJ, 2001, ANN BEHAV MED, V23, P68, DOI 10.1207/S15324796ABM2301_10
   THOMAS T, 2003, MATTERS, V66, P40
   Tran TV, 2000, J GERONTOL SOC WORK, V33, P63, DOI 10.1300/J083v33n02_05
   TRAN TV, 1990, GERONTOLOGIST, V30, P94, DOI 10.1093/geront/30.1.94
   *UN HIGH COMM REF, 2000, WORLD REF STAT
   Wilmoth JM, 2003, J GERONTOL B-PSYCHOL, V58, pS305, DOI 10.1093/geronb/58.5.S305
   Zilber N, 2001, INT J GERIATR PSYCH, V16, P993, DOI 10.1002/gps.456
NR 62
TC 21
Z9 21
U1 0
U2 17
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-0327
EI 1573-2517
J9 J AFFECT DISORDERS
JI J. Affect. Disord.
PD FEB
PY 2007
VL 98
IS 1-2
BP 99
EP 108
DI 10.1016/j.jad.2006.07.002
PG 10
WC Clinical Neurology; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 134XC
UT WOS:000244116700010
PM 16890296
DA 2019-01-08
ER

PT J
AU Glasgow, RE
   Fisher, L
   Skaff, M
   Mullan, J
   Toobert, DJ
AF Glasgow, Russell E.
   Fisher, Lawrence
   Skaff, Marilyn
   Mullan, Joe
   Toobert, Deborah J.
TI Problem solving and diabetes self-management - Investigation in a large,
   multiracial sample
SO DIABETES CARE
LA English
DT Article
ID PRIMARY-CARE; MODEL; EDUCATION; DISTRESS
AB OBJECTIVE - Problem solving is a core aspect of effective diabetes and chronic illness self-management, yet there are relatively few objective evaluations of problem-solving skills, especially in large, multiracial samples.
   RESEARCH DESIGN AND METHODS - A multiracial sample of 506 adults who have type 2 diabetes were assessed on a variety of patient characteristics, self-management behaviors, and biological and psychosocial measures. They also completed the Diabetes Problem-Solving Inter-view (DPSI).
   RESULTS - DPSI scores revealed significant variability across patients in problem-solving skill and were related to a number of comorbid conditions and complications but not to several other demographic factors, including race/ethnicity. Problem solving was also related to selfmanagement behaviors (eating and exercise patterns), biological variables (A 1 C and lipids), and psychosocial measures (Diabetes Distress Scale) in multivariable analyses controlling for a variety of potential confounding factors.
   CONCLUSIONS - Diabetes problem solving, as measured by the DPSI, is an important patient skill related to several key diabetes management variables that appears applicable across racial and ethnic groups. Future research is needed to identify the generality versus specificity of diabetes problem solving and practical interventions to enhance problem-solving skills.
C1 Kaiser Permanente Colorado, Clin Res Unit, Denver, CO 80237 USA.
   Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA.
   Oregon Res Inst, Eugene, OR 97403 USA.
RP Glasgow, RE (reprint author), Kaiser Permanente Colorado, Clin Res Unit, POB 378066, Denver, CO 80237 USA.
EM russg@ris.net
FU NIDDK NIH HHS [DK061937, DK062732]
CR AINSWORTH BE, 2000, MED SCI SPORTS EXERC, V32, P498, DOI DOI 10.1097/00005768-200009001-00009
   Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P2469, DOI 10.1001/jama.288.19.2469
   Chang EC, 2004, SOCIAL PROBLEM SOLVI
   DZURILLA TJ, 1996, PROBLEM SOLVING THER
   Elliott TR, 2001, J CLIN PSYCHOL MED S, V8, P283, DOI 10.1023/A:1011920914079
   Glasgow RE, 2002, ANN BEHAV MED, V24, P80, DOI 10.1207/S15324796ABM2402_04
   Glasgow RE, 2004, J BEHAV MED, V27, P477, DOI 10.1023/B:JOBM.0000047611.81027.71
   GLASGOW RE, 1995, DIABETES CARE, V18, P117, DOI 10.2337/diacare.18.1.117
   Glasgow RE, 2005, EVIDENCE BASED ENDOC, P241
   Glasgow Russell E, 2003, Jt Comm J Qual Saf, V29, P563
   Hill-Briggs F, 2006, J BEHAV MED, V29, P69, DOI 10.1007/s10865-005-9037-0
   Hill-Briggs F, 2003, ANN BEHAV MED, V25, P182, DOI 10.1207/S15324796ABM2503_04
   Johnson MO, 2006, HEALTH PSYCHOL, V25, P355, DOI 10.1037/0278-6133.25.3.355
   Lorig K R, 2001, Eff Clin Pract, V4, P256
   Norris SL, 2002, AM J PREV MED, V22, P39, DOI 10.1016/S0749-3797(02)00424-5
   PERRI MG, 1988, J CONSULT CLIN PSYCH, V56, P529, DOI 10.1037/0022-006X.56.4.529
   Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626
   RADLOFF LS, 1977, APPL PSYCH MEAS, V3, P385
   TOOBERT DJ, 1991, J BEHAV MED, V14, P71, DOI 10.1007/BF00844769
   Whitlock EP, 2002, AM J PREV MED, V22, P267, DOI 10.1016/S0749-3797(02)00415-4
NR 20
TC 48
Z9 49
U1 0
U2 15
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
J9 DIABETES CARE
JI Diabetes Care
PD JAN
PY 2007
VL 30
IS 1
BP 33
EP 37
DI 10.2337/dc06-1390
PG 5
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 125UZ
UT WOS:000243469800006
PM 17192329
OA Bronze
DA 2019-01-08
ER

PT J
AU Delahanty, LM
   Grant, RW
   Wittenberg, E
   Bosch, JL
   Wexler, DJ
   Cagliero, E
   Meigs, JB
AF Delahanty, L. M.
   Grant, R. W.
   Wittenberg, E.
   Bosch, J. L.
   Wexler, D. J.
   Cagliero, E.
   Meigs, J. B.
TI Association of diabetes-related emotional distress with diabetes
   treatment in primary care patients with Type 2 diabetes
SO DIABETIC MEDICINE
LA English
DT Article
DE diabetes-related emotional distress; primary care; quality of life; Type
   2 diabetes
ID QUALITY-OF-LIFE; PROBLEM AREAS; CONTROLLED-TRIAL; OUTCOMES; SCALE;
   THERAPY; HEALTH; IMPACT; DUTCH
AB Aims To characterize the determinants of diabetes-related emotional distress by treatment modality (diet only, oral medication only, or insulin).
   Methods A total of 815 primary care patients with Type 2 diabetes completed the Problem Areas in Diabetes (PAID) Scale and other questions. We linked survey data to a diabetes clinical research database and used linear regression models to assess the associations of treatment with PAID score. Results PAID scores were significantly higher among insulin-treated (24.6) compared with oral-treated (17.8, P < 0.001) or diet-treated patients (14.7, P < 0.001), but not different between oral- vs. diet-treated patients (P = 0.2). Group scores remained similar, but the statistical significance of their differences was reduced and ultimately eliminated after sequential adjustment for diabetes severity, HbA(1c), body mass index, regimen adherence, and self-blood-glucose monitoring. Insulin-treated patients reported significantly higher distress than oral- or diet-treated patients on 16 of 20 PAID items. 'Worrying about the future' and 'guilt/anxiety when ... off track with diabetes' were the top two serious problems (PAID >= 5) in all treatment groups. Not accepting diabetes diagnosis was a top concern for oral- and diet-treated patients, and unclear management goals distressed diet-treated patients.
   Conclusions Primary care patients treated with insulin reported higher diabetes-related emotional distress compared with oral- or diet-treated patients. Greater distress was largely explained by greater disease severity and self-care burdens. To improve diabetes-specific quality of life, clinicians should address patients' sense of worry and guilt, uncertain acceptance of diabetes diagnosis, and unclear treatment goals.
C1 Massachusetts Gen Hosp, MGH Diabet Ctr, Dept Med, Boston, MA 02114 USA.
   Massachusetts Gen Hosp, Div Gen Med, Dept Med, Boston, MA 02114 USA.
   Harvard Univ, Sch Med, Boston, MA 02115 USA.
   Massachusetts Gen Hosp, Inst Technol Assessment, Boston, MA 02114 USA.
   Erasmus MC Univ, Med Ctr, Dept Epidemiol & Biostat, Rotterdam, Netherlands.
   Erasmus MC Univ, Med Ctr, Dept Radiol, Rotterdam, Netherlands.
RP Delahanty, LM (reprint author), Massachusetts Gen Hosp, MGH Diabet Ctr, Dept Med, 50 Staniford St,Suite 340, Boston, MA 02114 USA.
EM ldelahanty@partners.org
OI Grant, Richard/0000-0002-6164-8025
FU NIDDK NIH HHS [DK067452, K23 DK080228]
CR CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8
   Davis RE, 2005, CURR MED RES OPIN, V21, P1477, DOI 10.1185/030079905X61929
   Franciosi M, 2001, DIABETES CARE, V24, P1870, DOI 10.2337/diacare.24.11.1870
   Grant RW, 2004, DIABETES CARE, V27, P2299, DOI 10.2337/diacare.27.10.2299
   Hill-Briggs F, 2005, DIABETES CARE, V28, P443, DOI 10.2337/diacare.28.2.443
   Hippisley-Cox J, 2004, LANCET, V364, P423, DOI 10.1016/S0140-6736(04)16765-2
   Hunt LM, 1997, DIABETES CARE, V20, P292, DOI 10.2337/diacare.20.3.292
   Koopmanschap M, 2002, DIABETOLOGIA, V45, pS18, DOI 10.1007/s00125-002-0861-2
   KRAMER CY, 1956, BIOMETRICS, V12, P309
   Lemon CC, 2004, J AM DIET ASSOC, V104, P1805, DOI 10.1016/j.jada.2004.09.024
   Linekin Patricia Landi, 2002, Home Healthc Nurse, V20, P168, DOI 10.1097/00004045-200203000-00009
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 2005, DIABETES CARE, V28, P2543, DOI 10.2337/diacare.28.10.2543
   Redekop WK, 2002, DIABETES CARE, V25, P458, DOI 10.2337/diacare.25.3.458
   Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Tankova T, 2004, PATIENT EDUC COUNS, V53, P285, DOI 10.1016/j.pec.2003.09.013
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Trento M, 2004, DIABETES CARE, V27, P670, DOI 10.2337/diacare.27.3.670
   UK Prospective Diabetes Study Group, 1999, DIABETES CARE, V22, P1125, DOI DOI 10.2337/DIACARE.22.7.1125
   Vijan S, 2005, J GEN INTERN MED, V20, P479, DOI 10.1111/j.1525-1497.2005.0117.x
   Welch G, 2003, DIABETIC MED, V20, P69, DOI 10.1046/j.1464-5491.2003.00832.x
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
NR 23
TC 94
Z9 99
U1 0
U2 16
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0742-3071
J9 DIABETIC MED
JI Diabetic Med.
PD JAN
PY 2007
VL 24
IS 1
BP 48
EP 54
DI 10.1111/j.1464-5491.2007.02028.x
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 124WS
UT WOS:000243403200008
PM 17227324
DA 2019-01-08
ER

PT J
AU Hjelm, K
   Bard, K
   Nyberg, P
   Apelqvist, J
AF Hjelm, Katarina
   Bard, Karin
   Nyberg, Per
   Apelqvist, Jan
TI Management of gestational diabetes from the patient's perspective - a
   comparison of Swedish and Middle-Eastern born women
SO JOURNAL OF CLINICAL NURSING
LA English
DT Article
DE evaluation; gestational diabetes; migrants; nursing; patient-focused;
   patient-centred care
ID PSYCHOLOGICAL DISTRESS; CARE; PREGNANCY; HEALTH; SATISFACTION; BELIEFS;
   RISK; POPULATION; MELLITUS; BEHAVIOR
AB Aim. To explore patients' evaluation of a specialized diabetes clinic for management of women with gestational diabetes born in Sweden and the Middle East and its contribution to a decreased level of stress and improved coping capability to promote health in patients receiving care.
   Background. No studies comparing patients' perceptions of healthcare in women of different origin with gestational diabetes have been found. A perceived clinical problem in specialized diabetes care is of lower activity level in self-care in foreign-than Swedish-born women and the question is whether the healthcare organization is optimal in meeting different individuals' needs.
   Design. Explorative study.
   Method. Semi-structured individual interviews by external evaluators.
   Participants. Consecutive sample. Females with gestational diabetes, 13 born in Sweden and 14 born in the Middle East.
   Results. The healthcare model was perceived as functioning well. Swedish women were problem focused and information seeking. Frustration and stress were increased due to perceived delay in information concerning gestational diabetes, limited access to telephone service and lack of confidence in staff because they lacked the expected competence. Control of gestational diabetes and pregnancy by different persons led to perceived lack of holistic care. Women from the Middle East felt cared, had been given the necessary information and claimed to follow advice. Adequate information reduced respondents' anxiety and increased their control over the situation.
   Conclusions. The clinic needs to be further improved by adapting programmes to persons to become problem focused by giving adequate information immediately.
   Relevance to clinical practice. Cultural differences in coping strategies and attitudes to gestational diabetes need to be considered. Training of staff working with gestational diabetes patients is urgently needed.
C1 Univ Vaxjo, Dept Hlth Sci & Social Work, S-35195 Vaxjo, Sweden.
   Lund Univ, Dept Community Med, S-22100 Lund, Sweden.
   Lund Univ, Dept Caring Sci, S-22100 Lund, Sweden.
   Lund Univ, Malmo Univ Hosp, Dept Endocrinol, S-22100 Lund, Sweden.
RP Hjelm, K (reprint author), Univ Vaxjo, Dept Hlth Sci & Social Work, S-35195 Vaxjo, Sweden.
EM katarina.hjelm@vxu.se
CR ADA (American Diabetes Association), 2003, DIABETES CARE, V26, P103
   Agardh CD, 1996, J INTERN MED, V240, P303, DOI 10.1046/j.1365-2796.1996.52872000.x
   Biro MA, 2003, BIRTH-ISS PERINAT C, V30, P1, DOI 10.1046/j.1523-536X.2003.00211.x
   BONDAS T, 2000, THESIS ABO AKAD U PR
   Brown S, 1997, INT J QUAL HEALTH C, V9, P265, DOI 10.1093/intqhc/9.4.265
   Essen B, 2000, BRIT J OBSTET GYNAEC, V107, P1507, DOI 10.1111/j.1471-0528.2000.tb11676.x
   Flick U., 1998, INTRO QUALITATIVE RE
   FOLKMAN S, 1984, J PERS SOC PSYCHOL, V46, P839, DOI 10.1037/0022-3514.46.4.839
   Gabbe SG, 2003, OBSTET GYNECOL, V102, P857, DOI 10.1016/S0029-7844(03)00810-X
   GATRAD AR, 1994, ARCH DIS CHILD, V71, P170, DOI 10.1136/adc.71.2.170
   GERTEIS M, 1993, PATIENTS EYES
   Harrison MJ, 2003, BIRTH-ISS PERINAT C, V30, P109, DOI 10.1046/j.1523-536X.2003.00229.x
   HILDINGSSON I, 2003, BIRTH-ISS PERINAT C, V31, P11
   Hjelm K, 1999, J ADV NURS, V30, P1147, DOI 10.1046/j.1365-2648.1999.01167.x
   Hjelm K, 2003, INT J NURS STUD, V40, P627, DOI 10.1016/S0020-7489(03)00020-8
   Hjelm K, 1998, PRACTICAL DIABETES I, V15, P233
   Hjelm K., 2002, CLIN EFFECTIVENESS N, V6, P66
   Hjelm K., 2003, CLIN EFFECTIVENESS N, V7, P3
   HJELM K, 2004, MIDWIFERY, V21, P44
   JOHNSON JV, 1988, AM J PUBLIC HEALTH, V78, P1336, DOI 10.2105/AJPH.78.10.1336
   Karasek R, 1990, HEALTHY WORK STRESS
   Kemp C, 1996, AM J HEALTH BEHAV, V20, P83
   Ladfors L, 2001, ACTA OBSTET GYN SCAN, V80, P130, DOI 10.1034/j.1600-0412.2001.080002130.x
   LAFFREY SC, 1989, SOC SCI MED, V29, P877, DOI 10.1016/0277-9536(89)90087-7
   LANGER N, 1994, OBSTET GYNECOL, V16, P536
   LAWSON EJ, 1994, SOCIOL HEALTH ILL, V16, P536, DOI 10.1111/1467-9566.ep11347644
   Lazarus R. S, 1984, STRESS APPRAISAL COP
   Leydon GM, 2000, BMJ-BRIT MED J, V320, P909, DOI 10.1136/bmj.320.7239.909
   LUND C, 1994, FRAN ARBETSKRAFTSIMP
   Miles M., 1994, EXPANDED SOURCEBOOK
   Morgan M, 1998, QUAL HEALTH CARE, V7, P77, DOI 10.1136/qshc.7.2.77
   Persson B, 1998, DIABETES S2, V21, P79
   SACHS L, 1983, THESIS U STOCKHOLM S
   SCHWARTZ MD, 1995, HEALTH PSYCHOL, V14, P232, DOI 10.1037//0278-6133.14.3.232
   *SFS, 1982, SVENSK HALS SJUKV 19
   *SOS, 2002, BEF OFF STAT SWED PO
   Stuart L, 1997, DIABETIC MED, V14, P785, DOI 10.1002/(SICI)1096-9136(199709)14:9<785::AID-DIA466>3.0.CO;2-0
   TAYLOR SE, 1992, J PERS SOC PSYCHOL, V63, P460, DOI 10.1037/0022-3514.63.3.460
   Vileikyte L, 1999, DIABETES REV, V7, P387
   WENZEL L, 2002, HLTH BEHAV HLTH ED T, P210
   Williamson S, 1996, MIDWIFERY, V12, P198, DOI 10.1016/S0266-6138(96)80007-6
   Young WB, 1996, J NURS ADMIN, V26, P15, DOI 10.1097/00005110-199605000-00005
NR 42
TC 15
Z9 15
U1 1
U2 9
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0962-1067
J9 J CLIN NURS
JI J. Clin. Nurs.
PD JAN
PY 2007
VL 16
IS 1
BP 168
EP 178
DI 10.1111/j.1365-2702.2005.01422.x
PG 11
WC Nursing
SC Nursing
GA 118TQ
UT WOS:000242965000019
PM 17181679
DA 2019-01-08
ER

PT J
AU Ganguli, R
AF Ganguli, Rohan
TI Behavioral therapy for weight loss in patients with schizophrenia
SO JOURNAL OF CLINICAL PSYCHIATRY
LA English
DT Article; Proceedings Paper
CT Meeting on Strategies to Integrate Physical Health Care Into Mental
   Health
CY AUG 28, 2006
CL Philadelphia, PA
ID PLACEBO-CONTROLLED TRIAL; BODY-MASS INDEX; QUALITY-OF-LIFE;
   DOUBLE-BLIND; PSYCHIATRIC-PATIENTS; ANTIPSYCHOTIC MEDICATIONS;
   CARDIOVASCULAR-DISEASE; DIABETES-MELLITUS; CONTROL PROGRAM;
   MENTAL-HEALTH
AB Compared with the general population, individuals with schizophrenia demonstrate an increased prevalence of obesity. While most antipsychotics are associated with weight gain, certain second-generation antipsychotics (SGAs) appear to be especially problematic. Weight gain and obesity are highly distressing to these patients, can reduce treatment adherence, and may increase the relative risk of serious medical conditions and all-cause premature mortality. The selection of an antipsychotic on the basis of its effectiveness and relative side effect profile is recognized as an important initial consideration in the treatment of schizophrenia. However, less is known regarding the efficacy of dietary, pharmacologic, and behavioral therapy in reducing antipsychotic-related weight gain and obesity. Behavioral therapy, in particular, is understudied, and there are relatively few controlled trials of its effectiveness in reducing SGA-induced weight gain. Although weight loss resulting from behavioral therapy has been observed mostly as a result of effective short-term interventions, controlled behavioral studies do exist to suggest that weight can be controlled long term. In addition, a small pilot study in patients with schizophrenia or schizoaffective disorder recently demonstrated that behavioral therapy that utilizes stepped interventions, involving body weight self-monitoring, diet, and exercise, can prevent weight gain in patients initiating treatment with SGAs. Additional studies of behavioral therapy for long-term weight control in patients with schizophrenia and other forms of severe mental illness are warranted.
C1 Univ Pittsburgh, Western Psychiat Inst & Clin, Pittsburgh, PA 15213 USA.
   Univ Pittsburgh, Sch Med, Pittsburgh, PA 15260 USA.
   Univ Pittsburgh, Med Ctr, Serv & Res Recovery Serious Mental Illness, Pittsburgh, PA 15260 USA.
RP Ganguli, R (reprint author), Univ Pittsburgh, Western Psychiat Inst & Clin, 3811 Ohara St, Pittsburgh, PA 15213 USA.
EM gangulir@upmc.edu
CR Allison DB, 2003, PSYCHIAT SERV, V54, P565, DOI 10.1176/appi.ps.54.4.565
   Allison DB, 1999, J CLIN PSYCHIAT, V60, P215, DOI 10.4088/JCP.v60n0402
   Allison DB, 1999, AM J PSYCHIAT, V156, P1686
   American Psychiatric Association, 2004, PRACT GUID TREATM PA
   [Anonymous], 2004, J CLIN PSYCHIAT, V65, P267
   Aquila R, 2002, J CLIN PSYCHIAT, V63, P33
   AREHARTTREICHEL J, 2005, PSYCHIAT NEWS, V40, P32
   Awad AG, 1995, INT CLIN PSYCHOPHARM, V10, P123, DOI 10.1097/00004850-199509000-00016
   Ball MP, 2001, PSYCHIATR SERV, V52, P967, DOI 10.1176/appi.ps.52.7.967
   Bandura A, 1977, COGNITIVE THERAPY RE, V1, P177, DOI [DOI 10.1007/BF01186792, 10.1007/BF01186792]
   Baptista T, 2006, CAN J PSYCHIAT, V51, P192, DOI 10.1177/070674370605100310
   Baptista T, 2001, J CLIN PSYCHIAT, V62, P653, DOI 10.4088/JCP.v62n0813b
   BARNES RF, 1983, GEN HOSP PSYCHIAT, V5, P191, DOI 10.1016/0163-8343(83)90055-5
   Brar JS, 2005, J CLIN PSYCHIAT, V66, P205, DOI 10.4088/JCP.v66n0208
   *BRIT ASS PSYCH, 2005, J PSYCHOPHARMACOL S, V19, P118
   Brown S, 2000, BRIT J PSYCHIAT, V177, P212, DOI 10.1192/bjp.177.3.212
   BROWNELL KD, 1991, HEALTH PSYCHOL, V10, P303, DOI 10.1037/0278-6133.10.5.303
   BROWNELL KD, 1986, AM PSYCHOL, V41, P765, DOI 10.1037//0003-066X.41.7.765
   Cavazzoni P, 2003, EUR NEUROPSYCHOPHARM, V13, P81, DOI 10.1016/S0924-977X(02)00127-X
   Coodin S, 2001, CAN J PSYCHIAT, V46, P549, DOI 10.1177/070674370104600610
   DERCOLE A, 1991, HOSP COMMUNITY PSYCH, V42, P395
   *DIAB PREV PROGR R, 1999, DIABETES CARE, V22, P623
   Dickey B, 2002, PSYCHIATR SERV, V53, P861, DOI 10.1176/appi.ps.53.7.861
   Dixon L, 2000, SCHIZOPHRENIA BULL, V26, P903, DOI 10.1093/oxfordjournals.schbul.a033504
   Dixon L, 1999, J NERV MENT DIS, V187, P496, DOI 10.1097/00005053-199908000-00006
   DZURILLA TJ, 1971, J ABNORM PSYCHOL, V78, P107, DOI 10.1037/h0031360
   Evans S, 2005, AUST NZ J PSYCHIAT, V39, P479, DOI 10.1111/j.1440-1614.2005.01607.x
   Felker B, 1996, PSYCHIAT SERV, V47, P1356
   Ferster CB, 1996, OBES RES, V4, P401
   Gale SM, 2004, J NUTR, V134, P295
   Ganguli R, 2005, SCHIZOPHRENIA BULL, V31, P561
   Ganguli R, 1999, J CLIN PSYCHIAT, V60, P20
   GANGULI R, 2001, 53 I PSYCH SERV OCT
   GOPALASWAMY AK, 1985, ACTA PSYCHIAT SCAND, V72, P254, DOI 10.1111/j.1600-0447.1985.tb02603.x
   Gough ARS, 2005, POWER ENGINEER, V19, P47
   Graham KA, 2005, AM J PSYCHIAT, V162, P1744, DOI 10.1176/appi.ajp.162.9.1744
   HARMATZ MG, 1968, J CONSULT CLIN PSYCH, V32, P583, DOI 10.1037/h0026402
   Henderson DC, 2005, AM J PSYCHIAT, V162, P954, DOI 10.1176/appi.ajp.162.5.954
   HENDERSON DC, 2006, ACTA PSYCHIAT SCAND, V115, P101
   Hennekens CH, 2005, AM HEART J, V150, P1115, DOI 10.1016/j.ahj.2005.02.007
   Homel P, 2002, SCHIZOPHR RES, V55, P277, DOI 10.1016/S0920-9964(01)00256-0
   Jakicic JM, 2003, JAMA-J AM MED ASSOC, V290, P1323, DOI 10.1001/jama.290.10.1323
   Jakicic JM, 2002, J NUTR, V132, p3826S
   Jakicic JM, 2003, EXERC SPORT SCI REV, V31, P91, DOI 10.1097/00003677-200304000-00007
   Jaspers K., 1923, GEN PSYCHOPATHOLOGY
   Jeffery RW, 1999, AM J PUBLIC HEALTH, V89, P747, DOI 10.2105/AJPH.89.5.747
   KAZDIN AE, 1974, J CONSULT CLIN PSYCH, V42, P704, DOI 10.1037/h0037050
   Klem ML, 2000, INT J OBESITY, V24, P219, DOI 10.1038/sj.ijo.0801117
   KORAN LM, 1989, ARCH GEN PSYCHIAT, V46, P733
   Koro CE, 2002, ARCH GEN PSYCHIAT, V59, P1021, DOI 10.1001/archpsyc.59.11.1021
   Kraepelin E, 1971, DEMENTIA PRAECOX PAR
   Lambert Timothy J R, 2003, Med J Aust, V178 Suppl, pS67
   Larson-Meyer DE, 2006, OBESITY, V14, P73, DOI 10.1038/oby.2006.10
   Leslie DL, 2004, AM J PSYCHIAT, V161, P1709, DOI 10.1176/appi.ajp.161.9.1709
   Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688
   Littrell KH, 2003, J NURS SCHOLARSHIP, V35, P237, DOI 10.1111/j.1547-5069.2003.00237.x
   McEvoy JP, 2005, SCHIZOPHR RES, V80, P19, DOI 10.1016/j.schres.2005.07.014
   Menza M, 2004, J CLIN PSYCHIAT, V65, P471
   Morrison JA, 2002, AM J PSYCHIAT, V159, P655, DOI 10.1176/appi.ajp.159.4.655
   MORTENSEN PB, 1993, BRIT J PSYCHIAT, V163, P183, DOI 10.1192/bjp.163.2.183
   Muir-Cochrane E, 2006, J PSYCHIATR MENT HLT, V13, P447, DOI 10.1111/j.1365-2850.2006.01002.x
   *NAT SCHIZ FELL, 2000, QUEST CHOIC, P1
   National Semiconducter, 2000, DIG DIL INT PROP INF, P1
   NIH Publication, 1998, NIH PUBL
   Osborn DPJ, 2001, WESTERN J MED, V175, P329, DOI 10.1136/ewjm.175.5.329
   Osby U, 2000, SCHIZOPHR RES, V45, P21, DOI 10.1016/S0920-9964(99)00191-7
   Perri MG, 2001, J CONSULT CLIN PSYCH, V69, P722, DOI 10.1037//0022-006X.69.4.722
   PISUNYER FX, 1993, ANN INTERN MED, V119, P655, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00006
   Poirier P, 2006, ARTERIOSCL THROM VAS, V26, P968, DOI 10.1161/01.ATV.0000216787.85457.f3
   Poyurovsky M, 2004, EUR NEUROPSYCHOPHARM, V14, P332
   Poyurovsky M, 2003, AM J PSYCHIAT, V160, P297, DOI 10.1176/appi.ajp.160.2.297
   Reynolds GP, 2002, LANCET, V359, P2086, DOI 10.1016/S0140-6736(02)08913-4
   ROTATORI AF, 1980, PSYCHOL REP, V46, P483, DOI 10.2466/pr0.1980.46.2.483
   Sernyak MJ, 2002, AM J PSYCHIAT, V159, P561, DOI 10.1176/appi.ajp.159.4.561
   Strassnig M, 2005, SCHIZOPHR RES, V75, P425, DOI 10.1016/j.schres.2004.04.007
   Stuart RB, 1996, OBES RES, V4, P411, DOI 10.1002/j.1550-8528.1996.tb00249.x
   The Diabetes Prevention Program Research Group, 2002, DIABETES CARE, V25, P2165, DOI DOI 10.2337/DIACARE.25.12.2165
   TSUANG MT, 1980, ARCH GEN PSYCHIAT, V37, P979
   Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801
   Vreeland B, 2003, PSYCHIAT SERV, V54, P1155, DOI 10.1176/appi.ps.54.8.1155
   Vreeland B., 2004, J AM PSYCHIAT NUR S3, V10, pS17
   Wadden TA, 2004, OBES RES, V12, p151S, DOI 10.1038/oby.2004.282
   Wadden TA, 2003, ENDOCRIN METAB CLIN, V32, P981, DOI 10.1016/S0889-8529(03)00072-0
   Wadden TA, 2000, MED CLIN N AM, V84, P441, DOI 10.1016/S0025-7125(05)70230-3
   Weiden PJ, 2004, SCHIZOPHR RES, V66, P51, DOI 10.1016/S0920-9964(02)00498-X
   WING RR, 1989, DIABETES CARE, V12, P139, DOI 10.2337/diacare.12.2.139
   WING RR, 2004, HDB OBESITY
   Wirshing DA, 1999, J CLIN PSYCHIAT, V60, P358, DOI 10.4088/JCP.v60n0602
NR 88
TC 40
Z9 40
U1 0
U2 15
PU PHYSICIANS POSTGRADUATE PRESS
PI MEMPHIS
PA P O BOX 752870, MEMPHIS, TN 38175-2870 USA
SN 0160-6689
EI 1555-2101
J9 J CLIN PSYCHIAT
JI J. Clin. Psychiatry
PY 2007
VL 68
SU 4
BP 19
EP 25
PG 7
WC Psychology, Clinical; Psychiatry
SC Psychology; Psychiatry
GA 167PD
UT WOS:000246462700004
PM 17592901
DA 2019-01-08
ER

PT J
AU Lee, S
   Chiu, A
   Tsang, A
   Chow, CC
   Chan, WB
AF Lee, Sing
   Chiu, Alice
   Tsang, Adley
   Chow, Chun-Chung
   Chan, Wing-Bun
TI Treatment-related stresses and anxiety-depressive symptoms among Chinese
   outpatients with type 2 diabetes mellitus in Hong Kong
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE anxiety; depression; diabetes mellitus; stress; Chinese
ID POOR GLYCEMIC CONTROL; SOCIAL STIGMA; PEOPLE; COMPLICATIONS;
   ASSOCIATION; PREVALENCE; EXPERIENCE; ADULTS; FEARS
AB Based on focus group findings, a descriptive instrument was developed to examine the relationship among treatment-related stress, anxiety and depressive symptoms, distress, and impairment of 333 Chinese outpatients with type 2 diabetes mellitus (DM) in Hong Kong. It was found that the main stresses included fears of diabetes complications, work impairment, lifestyle adjustment, stigmatization, and discrimination. Over 1/4 of patients concealed their DM from family members in order not to make the latter worry. 28.3% felt that life was not worth living. 33.6% of patients exhibited four or more anxiety and depressive symptoms accompanied by significant distress and/or impairment. These patients were more likely to be female, of lower educational level, and unemployed. Diabetes complications, concealment of DM, and feeling of being a burden to the family predicted anxiousdepressed status. The study showed that treatment-related stresses and anxiety-depressive symptoms were common and associated among Chinese diabetes outpatients in Hong Kong. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
C1 Prince Wales Hosp, Hong Kong Mood Disorders Ctr, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China.
   Chinese Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China.
   Chinese Univ Hong Kong, Hong Kong Mood Disorders Ctr, Hong Kong, Hong Kong, Peoples R China.
RP Lee, S (reprint author), Prince Wales Hosp, Hong Kong Mood Disorders Ctr, Dept Med & Therapeut, 7A Block E,Staff Quarters, Shatin, Hong Kong, Peoples R China.
EM singlee@cuhk.edu.hk
RI Lee, Sing/O-2136-2015
CR Anderson RJ, 2002, INT J PSYCHIAT MED, V32, P235, DOI 10.2190/KLGD-4H8D-4RYL-TWQ8
   Chou KL, 2005, INT J GERIATR PSYCH, V20, P570, DOI 10.1002/gps.1328
   Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   Dinos S, 2004, BRIT J PSYCHIAT, V184, P176, DOI 10.1192/bjp.184.2.176
   FRIIS R, 1986, SOC SCI MED, V23, P471, DOI 10.1016/0277-9536(86)90006-7
   Green L, 2000, DIABETES METAB RES, V16, P287, DOI 10.1002/1520-7560(2000)9999:9999<::AID-DMRR123>3.3.CO;2-K
   Janus ED, 2000, DIABETIC MED, V17, P741, DOI 10.1046/j.1464-5491.2000.00376.x
   Lee S, 2005, BRIT J PSYCHIAT, V186, P153, DOI 10.1192/bjp.186.2.153
   Ludman EJ, 2004, GEN HOSP PSYCHIAT, V26, P430, DOI 10.1016/j.genhosppsych.2004.08.010
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Peyrot M, 1997, DIABETES CARE, V20, P585, DOI 10.2337/diacare.20.4.585
   SCHMITT GS, 1985, J APPL FAM CHILD STU, V34, P109
   SHEN YC, 2005, PSYCHOL MED, V36, P257
   Shiu ATY, 2003, J CLIN NURS, V12, P149, DOI 10.1046/j.1365-2702.2003.00735.x
   Shiu ATY, 2002, J ADV NURS, V39, P155
   Stake R. E., 1995, ART CASE STUDY RES
   Tossani E, 2005, SEMIN DIALYSIS, V18, P73, DOI 10.1111/j.1525-139X.2005.18217.x
   Triandis H. C., 1995, INDIVIDUALISM COLLEC
   Watkins KW, 2000, DIABETES CARE, V23, P1511, DOI 10.2337/diacare.23.10.1511
NR 20
TC 15
Z9 15
U1 0
U2 9
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD DEC
PY 2006
VL 74
IS 3
BP 282
EP 288
DI 10.1016/j.diabres.2006.03.026
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 106TV
UT WOS:000242125400011
PM 16701917
DA 2019-01-08
ER

PT J
AU Zoffmann, V
   Lauritzen, T
AF Zoffmann, Vibeke
   Lauritzen, Torsten
TI Guided self-determination improves life skills with Type 1 diabetes and
   AlC in randomized controlled trial
SO PATIENT EDUCATION AND COUNSELING
LA English
DT Article
DE life skills; empowerment; self-determination; group training; diabetes;
   glycaemic control
ID PATIENT EMPOWERMENT; PROBLEM AREAS; DISTRESS; MELLITUS; SCALE; MODEL
AB Objective: To report 1-year results of newly developed method, guided self-determination (GSD), applied in group training (GSD-GT) for Type I diabetes patients with persistent poor glycaemic control.
   Methods: GSD was designed on the basis of qualitative research to help patients develop life skills with diabetes using worksheets filled in at home and coached by nurses in mutual reflection. We randomized 18-49-year-old adults at a Danish university hospital to either 16 It GSD-GT in 2001 or to similar training I year later. Inclusion criteria: mean A IC > 8.0% for at least 2 years, disease onset < 40 years and insulin treatment from onset.
   Results: Thirty GSD-GT patients and 20 controls completed the study. GSD-GT patients did better than control patients in terms of (a) increased autonomy support perceived from health professionals (p < 0.01); (b) higher frequency of self-monitored blood glucoses (p < 0.001); (c) increased perceived competence in managing diabetes (p < 0.01); (d) fewer diabetes-related problems (p < 0.05); and (e) improved glycaemic control (p < 0.01).
   Conclusion: GSD was effective in improving life skills with diabetes, including AlC, over a period of I year.
   Practice implications: GSD is a worthy candidate for further research. We consider it adjustable to people with type 2 diabetes and other chronic conditions. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
C1 Univ Aarhus, Inst Publ Hlth, Dept Nursing Sci, DK-8000 Aarhus C, Denmark.
   Univ Aarhus, Inst Publ Hlth, Dept Gen Practice, DK-8000 Aarhus C, Denmark.
RP Zoffmann, V (reprint author), Univ Aarhus, Inst Publ Hlth, Dept Nursing Sci, Hoegh Guldbergsgade 6A, DK-8000 Aarhus C, Denmark.
EM vz@nursingscience.au.dk
OI Zoffmann, Vibeke/0000-0003-0571-5331
CR ANDERSON RM, 1995, DIABETES CARE, V18, P943, DOI 10.2337/diacare.18.7.943
   ANDERSON RM, 1995, DIABETES CARE, V18, P412, DOI 10.2337/diacare.18.3.412
   BOX AH, 2001, URTEILSBILDUNG GRUPP
   BROOKS DK, 1984, LIFE SKILLS TAXONOMY
   Deci EL, 1985, INTRINSIC MOTIVATION
   *DIAB CONTR COMPL, 1993, NEW ENGL J MED, V329, P977, DOI DOI 10.1056/NEJM199309303291401
   Grey M, 2000, J PEDIATR-US, V137, P107, DOI 10.1067/mpd.2000.106568
   Harwell TS, 2002, DIABETES EDUCATOR, V28, P99, DOI 10.1177/014572170202800111
   HERNANDEZ CA, 1995, DIABETES EDUCATOR, V21, P33, DOI 10.1177/014572179502100106
   KNUDSEN VZ, 1997, DIABETIKER DIABETEST
   Kvamme O J, 1998, Nord Med, V113, P363
   Mullen D., 1985, CONCEPTUAL FRAMEWORK
   Nutbeam D, 1996, CAN J PUBLIC HEALTH, V87, pS18
   Paterson B, 2001, J ADV NURS, V34, P574, DOI 10.1046/j.1365-2648.2001.01786.x
   Paterson B L, 1998, Image J Nurs Sch, V30, P57
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Prochaska J. O., 1994, CHANGING GOOD
   Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68
   Sando S H, 1994, Int J Qual Health Care, V6, P47
   Sheldon KM, 1999, J PERS SOC PSYCHOL, V76, P482, DOI 10.1037//0022-3514.76.3.482
   Snoek FJ, 2001, PATIENT EDUC COUNS, V45, P143, DOI 10.1016/S0738-3991(01)00113-6
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   Williams GC, 1998, DIABETES CARE, V21, P1644, DOI 10.2337/diacare.21.10.1644
   Williams GC, 2000, SELF DETERMINATION H, P1
   Yong A, 2002, J CLIN NURS, V11, P773, DOI 10.1046/j.1365-2702.2002.00661.x
   Zoffmann V., 2004, GUIDED SELF DETERMIN
NR 27
TC 55
Z9 56
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0738-3991
J9 PATIENT EDUC COUNS
JI Patient Educ. Couns.
PD DEC
PY 2006
VL 64
IS 1-3
BP 78
EP 86
DI 10.1016/j.pec.2005.11.017
PG 9
WC Public, Environmental & Occupational Health; Social Sciences,
   Interdisciplinary
SC Public, Environmental & Occupational Health; Social Sciences - Other
   Topics
GA 119LA
UT WOS:000243012600010
PM 16720089
DA 2019-01-08
ER

PT J
AU Lorig, KR
   Ritter, PL
   Laurent, DD
   Plant, K
AF Lorig, Kate R.
   Ritter, Philip L.
   Laurent, Diana D.
   Plant, Kathryn
TI Internet-based chronic disease self-management - A randomized trial
SO MEDICAL CARE
LA English
DT Article
DE self-management; chronic disease; self-efficacy; internet
ID VISUAL ANALOG SCALE; HEALTH-CARE COSTS; ARTHRITIS; PROGRAM; EDUCATION;
   OUTCOMES
AB Background: The small-group Chronic Disease Self-Management Program (CDSMP) has proven effective in changing health-related behaviors and improving health statuses. An Internet-based CDSMP was developed to reach additional chronic-disease patients.
   Objectives: We sought to determine the efficacy of the Internetbased CDSMP.
   Design: We compared randomized intervention participants with usual-care controls at 1 year. We compared intervention participants with the small-group CDSMP at 1 year.
   Subjects: Nine-hundred fifty-eight patients with chronic diseases (heart, lung, or type 2 diabetes) and Internet and e-mail access were randomized to intervention (457) or usual care control (501).
   Measures: Measures included 7 health status variables (pain, shortness of breath, fatigue, illness intrusiveness, health distress, disability, and self-reported global health), 4 health behaviors (aerobic exercise, stretching and strengthening exercise, practice of stress management, and communication with physicians), 3 utilization variables (physician visits, emergency room visits, and nights in hospital), and self-efficacy.
   Results: At 1 year, the intervention group had significant improvements in health statuses compared with usual care control patients. The intervention group had similar results to the small-group CDSMP participants. Change in self-efficacy at 6 months was found to be associated with better health status outcomes at 1 year.
   Conclusions: The Internet-based CDSMP proved effective in improving health statutes by I year and is a viable alternative to the small-group Chronic Disease Self Management Program.
C1 Stanford Univ, Sch Med, Palo Alto, CA 94306 USA.
RP Ritter, PL (reprint author), Stanford Univ, Sch Med, 1000 Welsch Rd,Suite 204, Palo Alto, CA 94306 USA.
EM philr@stanford.edu
CR Anderson G, 2001, HEALTH AFFAIR, V20, P146, DOI 10.1377/hlthaff.20.6.146
   Bandura A., 1997, SELF EFFICACY EXERCI
   Bodenheimer T, 2005, ANN INTERN MED, V142, P847, DOI 10.7326/0003-4819-142-10-200505170-00010
   DEVINS GM, 1990, HEALTH PSYCHOL, V9, P117, DOI 10.1037/0278-6133.9.2.117
   DEVINS GM, 1984, INT J PSYCHIAT MED, V13, P327, DOI 10.2190/5DCP-25BV-U1G9-9G7C
   DIXON JS, 1981, ANN RHEUM DIS, V40, P87, DOI 10.1136/ard.40.1.87
   DOWNIE WW, 1978, ANN RHEUM DIS, V37, P378, DOI 10.1136/ard.37.4.378
   DOWNIE WW, 1978, ANN RHEUM DIS, V37, P382, DOI 10.1136/ard.37.4.382
   FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202
   Fu DB, 2003, B WORLD HEALTH ORGAN, V81, P174
   IDLER EL, 1990, AM J PUBLIC HEALTH, V80, P446, DOI 10.2105/AJPH.80.4.446
   Kruger JMS, 1998, ARCH INTERN MED, V158, P1245, DOI 10.1001/archinte.158.11.1245
   Lorig K, 1999, MED CARE, V37, P957, DOI 10.1097/00005650-199909000-00011
   LORIG K, 1985, ARTHRITIS RHEUM, V28, P680, DOI 10.1002/art.1780280612
   Lorig K, 1996, OUTCOME MEASURES HLT
   LORIG K, 2000, LIVING HLTH LIFE CHR
   Lorig K R, 2001, Eff Clin Pract, V4, P256
   Lorig KR, 1999, MED CARE, V37, P5, DOI 10.1097/00005650-199901000-00003
   Lorig KR, 2005, DIABETES EDUCATOR, V31, P401, DOI 10.1177/0145721705276574
   Lorig KR, 2003, NURS RES, V52, P361, DOI 10.1097/00006199-200311000-00003
   LORIG KR, 1993, ARTHRITIS RHEUM, V36, P439, DOI 10.1002/art.1780360403
   Lorig KR, 2001, MED CARE, V39, P1217, DOI 10.1097/00005650-200111000-00008
   Nodhturft V, 2000, NURS CLIN N AM, V35, P507
   Ritter P, 1994, J CLIN EPIDEMIOL, V54, P136
   Ritter PL, 2006, J RHEUMATOL, V33, P574
   Stewart A., 1992, MEASURING FUNCTIONIN
   Wagner EH, 2001, HEALTH AFFAIR, V20, P64, DOI 10.1377/hlthaff.20.6.64
NR 27
TC 263
Z9 266
U1 3
U2 54
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0025-7079
EI 1537-1948
J9 MED CARE
JI Med. Care
PD NOV
PY 2006
VL 44
IS 11
BP 964
EP 971
DI 10.1097/01.mlr.0000233678.80203.c1
PG 8
WC Health Care Sciences & Services; Health Policy & Services; Public,
   Environmental & Occupational Health
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA 104KF
UT WOS:000241956600002
PM 17063127
DA 2019-01-08
ER

PT J
AU Thoolen, BJ
   de Ridder, DT
   Bensing, JM
   Gorter, KJ
   Rutten, GE
AF Thoolen, Bart J.
   de Ridder, Denise T.
   Bensing, Jozien M.
   Gorter, Kees J.
   Rutten, Guy E.
TI Psychological outcomes of patients with screen-detected type 2 diabetes
SO DIABETES CARE
LA English
DT Article
ID MULTIFACTORIAL INTERVENTION; HOSPITAL ANXIETY; DEPRESSION SCALE;
   ILLNESS; VALIDITY; BELIEFS; PEOPLE; IMPACT; DUTCH
AB OBJECTIVE - The objective of this study was to investigate how time since diagnosis and treatment intensity influence psychological outcomes in patients with screen-detected type 2 diabetes.
   RESEARCH DESIGN AND METHODS - A 2 X 2 factorial cross-sectional design was used to examine psychological outcomes in 196 patients with screen-detected diabetes diagnosed 3-33 months previously who were receiving usual care or intensive multifactorial pharmacological treatment. Outcomes included anxiety, depression, diabetes-related distress, perceived seriousness and vulnerability, self-efficacy, and self-care. Multivariate analysis was used to examine variations in outcomes based on time since diagnosis (< 1 vs. 2-3 years) and treatment intensity.
   RESULTS - Most patients reported little distress, low perceived seriousness and vulnerability, high self-efficacy, and low self-care, but outcomes varied considerably across conditions. Time effects were found for perceived vulnerability, which increases significantly with time since diagnosis. Time X treatment interactions were found for anxiety, diabetes-related distress, and self-efficacy; notably, intensively treated patients showed more distress and less self-efficacy in the 1st year, and usual-care patients reported more distress and less self-efficacy 2-3 years after diagnosis.
   CONCLUSIONS - Screen-detected patients generally do not experience much difficulty with their condition in the first few years, but early and intensive treatment can influence patients' psychological outcomes, leading to relatively more anxiety and less self-efficacy in the 1st year after diagnosis but not necessarily improving self-care. This suggests that intensive treatments confront patients with their diabetes earlier on whereas milder treatments may delay confrontation. This Ending should be taken into account in the development and timing of psychological interventions for patients with newly diagnosed diabetes.
C1 Univ Utrecht, Dept Clin & Hlth Psychol, NL-3508 TC Utrecht, Netherlands.
   NIVEL, Netherlands Inst Hlth Serv Res, Utrecht, Netherlands.
   Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.
RP Thoolen, BJ (reprint author), Univ Utrecht, Dept Clin & Hlth Psychol, POB 80-140, NL-3508 TC Utrecht, Netherlands.
EM b.j.thoolen@fss.uu.nl
CR Abraham C, 1998, PSYCHOL HEALTH, V13, P569, DOI 10.1080/08870449808407420
   Adriaanse MC, 2006, DIABETES-METAB RES, V22, P20, DOI 10.1002/dmrr.590
   ADRIAANSE MC, 2002, DIABETIC MED, V19, P1
   Borch-Johnsen K, 2003, DIABETIC MED, V20, P175, DOI 10.1046/j.1464-5491.2003.00842.x
   CASSILETH B R, 1984, New England Journal of Medicine, V311, P506
   DAS EHH, 2001, FEAR APPEALS WORK MO
   DOUST J, 2003, COCHRANE DB SYST REV, V2
   DUNNING T, 1998, J DIABETES NURS, V2, P315
   Engelgau MM, 2000, DIABETES CARE, V23, P1563, DOI 10.2337/diacare.23.10.1563
   Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778
   Gillibrand W, 2001, J ADV NURS, V34, P501, DOI 10.1046/j.1365-2648.2001.01779.x
   Kuijer RG, 2003, PSYCHOL HEALTH, V18, P313, DOI 10.1080/0887044031000146815
   Lauritzen T, 2000, INT J OBESITY, V24, pS6, DOI 10.1038/sj.ijo.0801420
   LEVENTHAL H, 2001, HDB HLTH PSYCHOL, P19
   Lorig K, 1996, OUTCOME MEASURES HLT
   Peel E, 2004, PATIENT EDUC COUNS, V53, P269, DOI 10.1016/j.pec.2003.07.010
   Shaw C, 1999, SOC SCI MED, V49, P1571, DOI 10.1016/S0277-9536(99)00244-0
   Shumaker SA, 1998, HDB HLTH BEHAV CHANG, P435
   Skinner TC, 2005, DIABETIC MED, V22, P1497, DOI 10.1111/j.1464-5491.2005.01680.x
   Skinner TC, 2003, DIABETIC MED, V20, P283, DOI 10.1046/j.1464-5491.2003.00923.x
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Spinhoven P, 1997, PSYCHOL MED, V27, P363, DOI 10.1017/S0033291796004382
   Stanton AL, 2001, HANDBOOK OF HEALTH PSYCHOLOGY, P387
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Wiebe D. J., 2003, SELF REGULATION HLTH, P184
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
NR 26
TC 39
Z9 39
U1 0
U2 8
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
EI 1935-5548
J9 DIABETES CARE
JI Diabetes Care
PD OCT
PY 2006
VL 29
IS 10
BP 2257
EP 2262
DI 10.2337/dc06-0617
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 091FZ
UT WOS:000241013600013
PM 17003303
OA Bronze, Green Published
DA 2019-01-08
ER

PT J
AU Robertson, N
   Burden, ML
   Burden, AC
AF Robertson, N.
   Burden, M. L.
   Burden, A. C.
TI Psychological morbidity and problems of daily living in people with
   visual loss and diabetes: do they differ from people without diabetes?
SO DIABETIC MEDICINE
LA English
DT Article
DE aids; anxiety; blind; coping; depression
ID HOSPITAL ANXIETY; DEPRESSION SCALE; RETINOPATHY; REPRESENTATIONS;
   ADJUSTMENT; ILLNESS; STRESS
AB Aims To examine psychological adjustment and changes in the activities of daily living in relation to visual loss in diabetes.
   Methods This was an incident cohort, longitudinal, observational study contrasting the adjustment of individuals with visual loss associated with diabetes and those whose visual loss arose from other conditions; in the year subsequent to registration for blindness and 12 months later, 124 individuals participated in the study (51 with diabetes and 73 without). Participants provided demographic and biomedical information, and completed the Brief COPE, Hospital Anxiety and Depression Scale, SF-36, Instrumental Activities of Daily Living scale and Social Avoidance and Distress Scale via interview. People with diabetes were compared with those without.
   Results Both diabetic and non-diabetic groups showed elevated and comparable levels of psychological morbidity, sustained over time. Significant differences in functional adjustment were found at initial interview: people with diabetes having more problems coping but these were no longer present 1 year later.
   Conclusions There was a significant and enduring elevation of anxiety and depression in those who were newly registered blind or visually handicapped. Taking these findings into account, psychological assessment should be developed for all those experiencing visual loss.
C1 Univ Leicester, Dept Psychol, Leicester LE1 7RH, Leics, England.
   Heart Birmingham tPCT, Birmingham, W Midlands, England.
   Univ Leicester, Dept Social & Med Educ, Leicester, Leics, England.
RP Burden, ML (reprint author), 273 Wake Green Rd, Birmingham B13 9XL, W Midlands, England.
EM marylb@btinternet.com
CR BERNBAUM M, 1988, DIABETES CARE, V11, P551, DOI 10.2337/diacare.11.7.551
   Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3
   BOWLING A, 1997, MEASURING HLTH REV Q, P25
   Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6
   CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267
   Cohen J, 1988, STAT POWER ANAL BEHA
   Cox DJ, 1998, DIABETES EDUCATOR, V24, P481, DOI 10.1177/014572179802400406
   CRAWFORD J, 2001, BR J CLIN PSYCHOL, V4, P429
   HAYWARD LM, 2002, DIABETIC MED, V1, P27
   HILL S, 1994, UK CLEARING HOUSE AS, V4, P26
   JACOBSON AM, 1985, PSYCHOSOM MED, V47, P372, DOI 10.1097/00006842-198507000-00007
   Kemp S, 1999, BRIT J CLIN PSYCHOL, V38, P43, DOI 10.1348/014466599162656
   Kosnik W., 1988, J GERONTOL, V43, P63
   LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179
   OEHLER JW, 1980, THESIS BOSTON U BOST
   OLLENDICK TH, 1985, BEHAV RES THER, V23, P375, DOI 10.1016/0005-7967(85)90017-8
   Orbell S, 1998, SOC SCI MED, V47, P93, DOI 10.1016/S0277-9536(97)10132-0
   Upton LR, 1998, J VISUAL IMPAIR BLIN, V92, P656
   WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002
   Watkins PJ, 2003, BRIT MED J, V326, P924, DOI 10.1136/bmj.326.7395.924
   WATSON D, 1969, J CONSULT CLIN PSYCH, V33, P448, DOI 10.1037/h0027806
   WULSIN LR, 1991, PSYCHOSOM MED, V53, P107
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
   2001, NATL STAT CENSUS
NR 24
TC 12
Z9 12
U1 0
U2 4
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0742-3071
J9 DIABETIC MED
JI Diabetic Med.
PD OCT
PY 2006
VL 23
IS 10
BP 1110
EP 1116
DI 10.1111/j.1464-5491.2006.01970.x
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 084IJ
UT WOS:000240526300011
PM 16978376
DA 2019-01-08
ER

PT J
AU Deaton, C
   Kimble, LP
   Veledar, E
   Hartigan, P
   Boden, WE
   O'Rourke, RA
   Weintraub, WS
AF Deaton, Christi
   Kimble, Laura P.
   Veledar, Emir
   Hartigan, Pamela
   Boden, William E.
   O'Rourke, Robert A.
   Weintraub, William S.
TI The synergistic effect of heart disease and diabetes on self-management,
   symptoms, and health status
SO HEART & LUNG
LA English
DT Article
ID CORONARY-ARTERY DISEASE; QUALITY-OF-LIFE; CARDIOVASCULAR-DISEASE;
   CLINICAL-OUTCOMES; FUNCTIONAL STATUS; ANGINA-PECTORIS; MELLITUS;
   REVASCULARIZATION; IMPACT; BYPASS
AB BACKGROUND: Coronary heart disease (CHD) and diabetes may have synergistic effects on symptoms, self-management, and general and cardiac-specific health status.
   PURPOSE: We compared symptom distress, self-management difficulties, and general and cardiac-specific health status in patients with CHD by the presence and severity of diabetes.
   METHODS: We performed a cross-sectional study of 1013 patients enrolled in the COURAGE trial, with the use of clinical data, the Symptom Distress Scale, the Self-Management Difficulties Scale, the Short-Form 36, and the Seattle Angina Questionnaire.
   RESULTS: Patients with diabetes and greater severity of diabetes had worse findings in symptom distress, self-management difficulties, and general and cardiac-specific health status than patients without diabetes.
   CONCLUSIONS: A robust effect of diabetes on symptom distress and self-management difficulties was found in patients with CHD. The results from the Seattle Angina Questionnaire illustrate difficulty in attributing physical limitations to specific symptoms or conditions, and show the experience of comorbid conditions to be synergistic. Clinicians' understanding of this synergy and integration of condition-specific care with general treatment and self-management practices are needed.
C1 Univ Manchester, Sch Nursing Midwifery & Social Work, Manchester M13 9PL, Lancs, England.
   Emory Univ, Atlanta, GA 30322 USA.
   VA Connecticut Healthcare Syst, West Haven, CT USA.
   Yale Univ, New Haven, CT USA.
   S Texas Vet Hlth Care Syst, San Antonio, TX USA.
   Univ Texas San Antonio, San Antonio, TX 78285 USA.
   Christiana Care Hlth Syst, Newark, DE USA.
RP Deaton, C (reprint author), Univ Manchester, Sch Nursing Midwifery & Social Work, Coupland 3,Coupland St, Manchester M13 9PL, Lancs, England.
RI Veledar, Emir/K-2808-2012; Deaton, Christi/F-6485-2010
OI Veledar, Emir/0000-0002-3831-5433; 
CR Bucerius J, 2003, THORAC CARDIOV SURG, V51, P11, DOI 10.1055/s-2003-37280
   CAMPEAU L, 1976, CIRCULATION, V54, P522, DOI 10.1161/circ.54.3.947585
   Chyun D, 2002, AM J CRIT CARE, V11, P504
   COLE JH, 2003, CIRCULATION S, V108, P751
   de Visser CL, 2002, QUAL LIFE RES, V11, P249, DOI 10.1023/A:1015287825660
   DeBusk RF, 1999, ARCH INTERN MED, V159, P2739, DOI 10.1001/archinte.159.22.2739
   Department of Health, 2001, EXP PAT NEW APPR CHR
   Dunbar SB, 2000, CIRCULATION, V102, P671
   Gregg EW, 2000, DIABETES CARE, V23, P1272, DOI 10.2337/diacare.23.9.1272
   Halon DA, 2000, AM J CARDIOL, V85, P1420, DOI 10.1016/S0002-9149(00)00788-8
   IRVINE AA, 1990, DIABETES CARE, V13, P705, DOI 10.2337/diacare.13.7.705
   LIAO YL, 1993, DIABETES CARE, V16, P708, DOI 10.2337/diacare.16.5.708
   Lorig KR, 2001, MED CARE, V39, P1217, DOI 10.1097/00005650-200111000-00008
   Loutfi M, 2003, CATHETER CARDIO INTE, V58, P451, DOI 10.1002/ccd.10455
   Magee MJ, 2001, ANN THORAC SURG, V72, P776, DOI 10.1016/S0003-4975(01)02840-5
   McGuire DK, 2000, EUR HEART J, V21, P1750, DOI 10.1053/euhj.2000.2317
   MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006
   Nichols GA, 2004, DIABETIC MED, V21, P793, DOI 10.1111/j.1464-5491.2004.01191.x
   Sobel BE, 2003, CIRCULATION, V107, P636, DOI 10.1161/01.CIR.0000048897.03553.E4
   SPERTUS JA, 1995, J AM COLL CARDIOL, V25, P333, DOI 10.1016/0735-1097(94)00397-9
   Thourani VH, 1999, ANN THORAC SURG, V67, P1045, DOI 10.1016/S0003-4975(99)00143-5
   Vaglio Joseph Jr, 2004, Health Qual Life Outcomes, V2, P24, DOI 10.1186/1477-7525-2-24
   Wandell PE, 2000, DIABETES METAB, V26, P465
   Ware JE, 1994, SF 36 PHYS MENTAL HL
   Weintraub WS, 2006, AM HEART J, V151, P1180, DOI 10.1016/j.ahj.2005.07.035
   Yun KL, 1999, ANN THORAC SURG, V68, P1314, DOI 10.1016/S0003-4975(99)00675-X
NR 26
TC 7
Z9 7
U1 0
U2 1
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0147-9563
EI 1527-3288
J9 HEART LUNG
JI Heart Lung
PD SEP-OCT
PY 2006
VL 35
IS 5
BP 315
EP 323
DI 10.1016/j.hrting.2006.05.005
PG 9
WC Cardiac & Cardiovascular Systems; Nursing; Respiratory System
SC Cardiovascular System & Cardiology; Nursing; Respiratory System
GA 085XO
UT WOS:000240637900003
PM 16963363
DA 2019-01-08
ER

PT J
AU Morse, SA
   Ciechanowski, PS
   Katon, WJ
   Hirsch, IB
AF Morse, Shereen A.
   Ciechanowski, Paul S.
   Katon, Wayne J.
   Hirsch, Irl B.
TI Isn't this just bedtime snacking? The potential adverse effects of
   night-eating symptoms on treatment adherence and outcomes in patients
   with diabetes
SO DIABETES CARE
LA English
DT Article
ID CONTROLLED-TRIAL; PRIMARY-CARE; SELF-CARE; DEPRESSION; DISORDERS; OBESE;
   MANAGEMENT; SERTRALINE; PATTERNS; FEMALES
AB OBJECTIVE - Night-eating syndrome is characterized by excessive eating in the evening and nocturnal awakening with ingestion of food. Psychosocial variables and emotional triggers may be associated with these behaviors. In patients with diabetes, such behaviors may lead to glucose dysregulation and contribute to obesity and complications.
   RESEARCH DESIGN AND METHODS - in 714 tertiary care patients with type I and 2 diabetes, we determined the proportion of patients reporting eating > 25% of their daily food intake after regular suppertime. We also screened patients for major depression, childhood maltreatment histories, nonsecure attachment styles, and emotional eating triggers. We examined whether patients reporting night-eating behaviors had greater psychosocial distress, higher HbA(1c) (A1C) levels, more obesity, and more diabetes complications. compared with patients without night-eating behaviors.
   RESULTS - Night-eating behaviors were reported in 9.7% of patients. Compared with patients without night-eating behaviors, those with these behaviors were less adherent with diet, exercise, and glucose monitoring and more likely to be depressed, to report childhood maltreatment histories, to have nonsecure attachment styles, and to report eating in response to anger, sadness, loneliness, worry, and being upset. Controlling for age, sex, race, and major depression, patients with night-eating behaviors, compared with patients without night-eating behaviors, were more likely to be obese (odds ratio 2.6 [95% CI 1.5-4.5]), to have A1C values > 7% (2.2 [1.1-4.11) and to have two or more diabetes complications (2.6 [1.5-45]).
   CONCLUSIONS - Night-eating behaviors are associated with adverse outcomes inpatients with diabetes. Use of clinical screening tools may help identify patients with night-eating behaviors.
C1 Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA.
   Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA.
RP Ciechanowski, PS (reprint author), Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Box 356560,1959 NE Pacific, Seattle, WA 98195 USA.
EM pavelcie@u.washington.edu
FU NIDDK NIH HHS [K23 DK60652-01]
CR Allison K, 2005, OBES RES, V13, pA83
   Allison KC, 2005, J CLIN ENDOCR METAB, V90, P6214, DOI 10.1210/jc.2005-1018
   *AM PHARM, 2005, SYML PRAML AC PACK I
   *AM PHARM, 2005, BYETT EX INJ PACK IN
   Aubert RE, 1998, ANN INTERN MED, V129, P605, DOI 10.7326/0003-4819-129-8-199810150-00004
   Bernstein D, 1998, CHILDHOOD TRAUMA QUE
   Birketvedt GS, 1999, JAMA-J AM MED ASSOC, V282, P657, DOI 10.1001/jama.282.7.657
   Colton P, 2004, DIABETES CARE, V27, P1654, DOI 10.2337/diacare.27.7.1654
   CROW S, 2000, INT J EAT DISORDER, V30, P222
   de Zwaan M., 2002, EUR EAT DISORD REV, V11, P7
   Devlin MJ, 2005, OBES RES, V13, P1077, DOI 10.1038/oby.2005.126
   Fisher EB, 2005, AM J PUBLIC HEALTH, V95, P1523, DOI 10.2105/AJPH.2005.066084
   Gluck ME, 2001, OBES RES, V9, P264, DOI 10.1038/oby.2001.31
   Griffin D. W., 1994, ADV PERSONAL RELATIO, P17
   Jacobson AM, 1997, QUAL LIFE RES, V6, P11
   Jones JM, 2000, BMJ-BRIT MED J, V320, P1563, DOI 10.1136/bmj.320.7249.1563
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   KULDAU JM, 1986, INT J EAT DISORDER, V5, P143, DOI 10.1002/1098-108X(198601)5:1<143::AID-EAT2260050114>3.0.CO;2-T
   Lin EHB, 2004, DIABETES CARE, V27, P2154, DOI 10.2337/diacare.27.9.2154
   O'Reardon JP, 2006, AM J PSYCHIAT, V163, P893, DOI 10.1176/appi.ajp.163.5.893
   O'Reardon JP, 2004, OBES RES, V12, P1789, DOI 10.1038/oby.2004.222
   O'Reardon JP, 2004, INT J EAT DISORDER, V35, P16, DOI 10.1002/eat.10224
   Pawlow LA, 2003, INT J OBESITY, V27, P970, DOI 10.1038/sj.ijo.0802320
   Peveler RC, 2005, DIABETES CARE, V28, P84, DOI 10.2337/diacare.28.1.84
   Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737
   STUNKARD AJ, 1955, AM J MED, V19, P78, DOI 10.1016/0002-9343(55)90276-X
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   Walker EA, 1999, AM J MED, V107, P332, DOI 10.1016/S0002-9343(99)00235-1
   Wells KB, 2000, JAMA-J AM MED ASSOC, V283, P212, DOI 10.1001/jama.283.2.212
   Whitty P, 1997, QUAL LIFE RES, V6, P407, DOI 10.1023/A:1018443628933
NR 30
TC 53
Z9 53
U1 1
U2 11
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
J9 DIABETES CARE
JI Diabetes Care
PD AUG
PY 2006
VL 29
IS 8
BP 1800
EP 1804
DI 10.2337/dc06-0315
PG 5
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 071HA
UT WOS:000239589000013
PM 16873783
OA Bronze
DA 2019-01-08
ER

PT J
AU Davies, M
   Dempster, M
   Malone, A
AF Davies, M.
   Dempster, M.
   Malone, A.
TI Do people with diabetes who need to talk want to talk?
SO DIABETIC MEDICINE
LA English
DT Article
DE anxiety; binge eating; depression; psychological support; service users
ID HOSPITAL ANXIETY; DEPRESSION SCALE; PREVALENCE; SYMPTOMS
AB Aim Our objective was to determine whether people with diabetes who ask for psychological support are those who are experiencing clinically significant levels of psychological distress.
   Method Three hundred people with diabetes were asked to complete psychometrically validated questionnaires that assessed subjective need and objective psychological distress.
   Results High levels of psychological distress were reported: 25% reported depressive symptomatology, 41% reported clinically significant levels of anxiety and 51% reported some binge eating behaviour. Participants also indicated a desire to talk to diabetes professionals about various problem areas in diabetes. Those reporting psychological distress, especially depression, were most likely to indicate a desire to talk to someone about living with diabetes.
   Conclusions Those who want to talk are those who need to talk. Future service development issues should acknowledge the needs and expressed wishes of service users.
C1 Belfast City Hosp, Dept Clin Psychol, Belfast BT9 7AE, Antrim, North Ireland.
   Queens Univ Belfast, Sch Psychol, Belfast, Antrim, North Ireland.
RP Davies, M (reprint author), Belfast City Hosp, Dept Clin Psychol, 95 Lisburn Rd, Belfast BT9 7AE, Antrim, North Ireland.
EM mark.davies@bch.n-i.nhs.uk
RI Dempster, Martin/D-7188-2013
OI Dempster, Martin/0000-0001-9499-3186
CR Anderson RJ, 2000, DIABETES, V49, pA64
   Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3
   Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278
   *CLIN RES EFF SUPP, 2003, BLUEPR DIAB CAR NO I
   Crow S, 2001, INT J EAT DISORDER, V30, P222, DOI 10.1002/eat.1077
   GORMALLY J, 1982, ADDICT BEHAV, V5, P219
   Grigsby AB, 2002, J PSYCHOSOM RES, V53, P1053, DOI 10.1016/S0022-3999(02)00417-8
   Lloyd CE, 2000, DIABETIC MED, V17, P198, DOI 10.1046/j.1464-5491.2000.00260.x
   Malone A, 2005, PRACT DIAB INT, V22, P244
   MARCUS MD, 1988, J CONSULT CLIN PSYCH, V56, P433, DOI 10.1037/0022-006X.56.3.433
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   WING RR, 1986, DIABETES CARE, V9, P162, DOI 10.2337/diacare.9.2.162
   WING RR, 1989, INT J EAT DISORDER, V8, P671, DOI 10.1002/1098-108X(198911)8:6<671::AID-EAT2260080608>3.0.CO;2-5
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
NR 14
TC 4
Z9 4
U1 0
U2 5
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0742-3071
J9 DIABETIC MED
JI Diabetic Med.
PD AUG
PY 2006
VL 23
IS 8
BP 917
EP 919
DI 10.1111/j.1464-5491.2006.01892.x
PG 3
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 067WF
UT WOS:000239332600016
PM 16911632
DA 2019-01-08
ER

PT J
AU Rubin, RR
   Peyrot, M
   Siminerio, LM
AF Rubin, RR
   Peyrot, M
   Siminerio, LM
CA Int DAWN Advisory Panel
TI Health care and patient-reported outcomes - Results of the
   cross-national Diabetes Attitudes, Wishes and Needs (DAWN) study
SO DIABETES CARE
LA English
DT Article
ID BLOOD-GLUCOSE CONTROL; QUALITY-OF-LIFE; GLYCEMIC CONTROL;
   SELF-MANAGEMENT; PROVIDER COMMUNICATION; COMORBID DEPRESSION;
   COMPLICATIONS; POPULATION; ADULTS; WELL
AB OBJECTIVE- The purpose of this study was to assess the relationship of patients' self-reported well-being, self-management, and diabetes control with factors related to the patient's health care. RESEARCH DESIGN AND
   METHODS- This was a cross-sectional survey of national samples of patients with diabetes (n = 5,104) from the multinational study of Diabetes Attitudes, Wishes and Needs (DAWN). Patients from 13 countries in Asia, Australia, Europe, and North America reported their level of well-being, self-management, and diabetes control. Hierarchical multiple regression analysis (blocs are countries, respondent characteristics, an ea care features) was used to examine predictors of diabetes-related distress and general well-being, adherence to lifestyle and medical treatment recommendations, and perceived diabetes control and hyperglycemic symptoms.
   RESULTS- Country, respondent demographic and disease characteristics, and health care features were all associated with patient-reported outcomes. Better patient-provider collaboration was associated with more favorable ratings on all outcomes, and better access to the provider and availability of team care were associated with some positive outcomes. Country differences were only partly accounted for by patient and health care factors. Relationships between health care factors and outcomes varied across countries.
   CONCLUSIONS- Patients' reports of well-being, self-management, and diabetes control were related to the countries in which they live, their demographic and disease characteristics, and features of their health care. Opportunities to enhance patient-provider collaboration, access to care, and availability of team care should be pursued.
C1 Johns Hopkins Univ, Dept Med, Baltimore, MD USA.
   Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21218 USA.
   Loyola Coll, Dept Sociol, Pittsburgh, PA USA.
   Univ Pittsburgh, Inst Diabet, Pittsburgh, PA USA.
RP Rubin, RR (reprint author), 946 E Piney Hill Rd, Monkton, MD 21111 USA.
EM rrubin443@aol.com
CR Aikens JE, 2005, DIABETES EDUCATOR, V31, P681, DOI 10.1177/0145721705280829
   Alberti G, 2002, PRACT DIABETES INT, V19, P22, DOI DOI 10.1002/PDI.305/PDF
   ANDERSON BA, 2002, PRACTICAL PSYCHOL DI
   Bech P, 2003, INT J METH PSYCH RES, V12, P85, DOI 10.1002/mpr.145
   BLACK SA, 2005, DIABETES CARE, V28, P288
   Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1909, DOI 10.1001/jama.288.15.1909
   Cegala DJ, 2000, ARCH FAM MED, V9, P57, DOI 10.1001/archfami.9.1.57
   Clark CM, 2000, JAMA-J AM MED ASSOC, V284, P363, DOI 10.1001/jama.284.3.363
   Dargis V, 1999, DIABETES CARE, V22, P1428, DOI 10.2337/diacare.22.9.1428
   Davidson MB, 2003, DIABETES CARE, V26, P2281, DOI 10.2337/diacare.26.8.2281
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   De Rekeneire N, 2003, DIABETES CARE, V26, P3257, DOI 10.2337/diacare.26.12.3257
   Eastman RC, 1997, DIABETES CARE, V20, P735, DOI 10.2337/diacare.20.5.735
   Egede LE, 2002, DIABETES CARE, V25, P464, DOI 10.2337/diacare.25.3.464
   Goldney RD, 2004, DIABETES CARE, V27, P1066, DOI 10.2337/diacare.27.5.1066
   Heisler M, 2003, DIABETES CARE, V26, P738, DOI 10.2337/diacare.26.3.738
   Heisler M, 2002, J GEN INTERN MED, V17, P243, DOI 10.1046/j.1525-1497.2002.10905.x
   Institute of Medicine ( US) Committee on Quality of Health Care in America, 2001, CROSS QUAL CHASM NEW
   Karter A, 2003, DIABETES CARE, V26, P2294, DOI 10.2337/diacare.26.8.2294
   Katon WJ, 2005, DIABETES CARE, V28, P2668, DOI 10.2337/diacare.28.11.2668
   Klein BEK, 1998, DIABETES CARE, V21, P236, DOI 10.2337/diacare.21.2.236
   McWilliams JM, 2003, JAMA-J AM MED ASSOC, V290, P757, DOI 10.1001/jama.290.6.757
   Nathan DM, 1996, JAMA-J AM MED ASSOC, V276, P1409
   PETERSON T, 1998, DIABETES CARE, V21, P930
   Peyrot M, 2005, DIABETES CARE, V28, P2673, DOI 10.2337/diacare.28.11.2673
   Peyrot M, 2005, DIABETIC MED, V22, P1379, DOI 10.1111/j.1464-5491.2005.01644.x
   Peyrot M, 1997, DIABETES CARE, V20, P585, DOI 10.2337/diacare.20.4.585
   PEYROT M, 2006, DIABETOLOGIA, V49, P276
   Philis-Tsimikas A, 2004, DIABETES CARE, V27, P110, DOI 10.2337/diacare.27.1.110
   Piette JD, 2003, J GEN INTERN MED, V18, P624, DOI 10.1046/j.1525-1497.2003.31968.x
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Rachmani R, 2005, DIABETIC MED, V22, P410, DOI 10.1111/j.1464-5491.2005.01428.x
   Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O
   Rubin RR, 1998, DIABETES SPECTRUM, V11, P81
   Sadur CN, 1999, DIABETES CARE, V22, P2011, DOI 10.2337/diacare.22.12.2011
   Selvin E, 2005, ARCH INTERN MED, V165, P1910, DOI 10.1001/archinte.165.16.1910
   SHAMOON H, 1993, NEW ENGL J MED, V329, P977
   Taylor CB, 2003, DIABETES CARE, V26, P1058, DOI 10.2337/diacare.26.4.1058
   Trief PM, 1998, DIABETES CARE, V21, P241, DOI 10.2337/diacare.21.2.241
   Tuncell K, 2000, ARCH INTERN MED, V160, P3278
   Turner RC, 1998, LANCET, V352, P854
   Turner RC, 1998, LANCET, V352, P837
   van Dam HA, 2003, PATIENT EDUC COUNS, V51, P17, DOI 10.1016/S0738-3991(02)00122-2
   WAGNER EH, 2001, DIABETES CARE, V25, P695
   Williams GC, 2005, PATIENT EDUC COUNS, V56, P28, DOI 10.1016/j.pec.2003.11.008
   Wredling R, 1995, QUAL LIFE RES, V4, P515, DOI 10.1007/BF00634746
   Zhang XP, 2005, AM J EPIDEMIOL, V161, P652, DOI 10.1093/aje/kwi089
NR 47
TC 79
Z9 80
U1 0
U2 7
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
J9 DIABETES CARE
JI Diabetes Care
PD JUN
PY 2006
VL 29
IS 6
BP 1249
EP 1255
DI 10.2337/dc05-2494
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 049YG
UT WOS:000238053200010
PM 16732004
OA Bronze
DA 2019-01-08
ER

PT J
AU Forlani, G
   Zannoni, C
   Tarrini, G
   Melchionda, N
   Marchesini, G
AF Forlani, G
   Zannoni, C
   Tarrini, G
   Melchionda, N
   Marchesini, G
TI An empowerment-based educational program improves psychological
   well-being and health-related quality of life in Type 1 diabetes
SO JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
LA English
DT Article
DE psychological general well-being; short-form 36; well-being enquiry for
   diabetics
ID RANDOMIZED CONTROLLED TRIAL; METABOLIC-CONTROL; SELF-REGULATION; ADULTS;
   MANAGEMENT; VARIABLES; MELLITUS; PEOPLE; ISSUES; SF-36
AB Educational programs are reported to improve metabolic control and well-being in Type 1 diabetes mellitus (DM), but the effects of newly-structured interventions, aimed at promoting empowerment in educated patients in active self-care, have received little attention. Ninety patients with Type 1 DIM in intensive insulin treatment were invited to an empowerment-based educational intervention. Changes in quality of life and psychological well-being in the 54 patients participating in the program (median age, 44 yr) were compared with those measured in patients who refused. The following questionnaires were administered at baseline and 12 months later: Psychological General Well-Being (PGWB), Medical Outcome Survey Short-Form 36 (SF-36), and Well-Being Enquiry for Diabetics (WED). Baseline values were indicative of moderate, but significant, psychological distress in the whole cohort. At follow-up, the experimental group had a better metabolic control {glycosylated hemoglobin, -0.4% [time x treatment analysis of variance (ANOVA), p = 0.005 vs controls]}, and a general improvement in comprehensive indices and most scales of PGWB and SF-36. Vitality (p = 0.042) and Social Functioning (p = 0.039) were no longer different from population norm. Similarly, the Symptoms (p = 0.005), Discomfort (p = 0.043) and Impact scales (p = 0.032) of WED, reflecting physical functioning, diabetes-related worries and familial relationships, role functioning and social network, improved significantly in treated patients. An educational empowerment-based intervention significantly improves the psychosocial aspects of diabetes and quality of life also in patients in active and effective self-care. Repeated educational interventions are the way towards a normal life with Type 1 DM.
C1 Univ Bologna, Policlin S Orsola, Unit Metab Dis, Dept Internal Med & Gastroenterol,Alma Mater Stud, I-40138 Bologna, Italy.
RP Marchesini, G (reprint author), Univ Bologna, Policlin S Orsola, Unit Metab Dis, Dept Internal Med & Gastroenterol,Alma Mater Stud, Via Massarenti 9, I-40138 Bologna, Italy.
EM giulio.marchesini@unibo.it
OI Zannoni, Claudio/0000-0002-7977-1005; Marchesini,
   Giulio/0000-0003-2407-9860
CR Aguilar M, 1999, DIABETIC MED, V16, P253
   Amiel S, 2002, BRIT MED J, V325, P746
   ANDERSON RM, 1995, DIABETES CARE, V18, P943, DOI 10.2337/diacare.18.7.943
   ANDERSON RM, 1991, DIABETES CARE, V14, P584, DOI 10.2337/diacare.14.7.584
   Anderson RM, 1996, PRACTICAL PSYCHOL DI, P163
   Apolone G, 1998, J CLIN EPIDEMIOL, V51, P1025, DOI 10.1016/S0895-4356(98)00094-8
   Apolone G, 2001, PHARMACOECONOMICS, V19, P187, DOI 10.2165/00019053-200119020-00005
   CLEMENT S, 1995, DIABETES CARE, V18, P1204, DOI 10.2337/diacare.18.8.1204
   Cohen J, 1977, STAT POWER ANAL BEHA
   DALY A, 1995, CARBOHYDRATE COUNTIN, P32
   DCCT Res Grp, 1988, DIABETES CARE, V11, P725
   Dupuy HJ., 1984, ASSESSMENT QUALITY L, P170
   FRANZ MJ, 2002, IMPLEMENTING GROUP I, P70
   Grey M, 2000, J PEDIATR-US, V137, P107, DOI 10.1067/mpd.2000.106568
   GROSSI E, 2002, QUESTIONARIO PSYCHOL
   HOLLER HJ, 1996, DIABETES MED NUTR TH, P290
   JACOBSON AM, 1994, DIABETES CARE, V17, P267, DOI 10.2337/diacare.17.4.267
   KAZIS LE, 1989, MED CARE, V27, pS178, DOI 10.1097/00005650-198903001-00015
   Mannucci E, 2005, ACTA DIABETOL, V42, P1, DOI 10.1007/s00592-005-0167-1
   Mannucci E, 1996, DIABETES NUTR METAB, V9, P89
   Marchesini G, 2001, GASTROENTEROLOGY, V120, P170, DOI 10.1053/gast.2001.21193
   MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006
   Peyrot M, 1999, DIABETES CARE, V22, P448, DOI 10.2337/diacare.22.3.448
   Peyrot M, 1997, DIABETES CARE, V20, P585, DOI 10.2337/diacare.20.4.585
   PIEBER TR, 1995, DIABETES CARE, V18, P625, DOI 10.2337/diacare.18.5.625
   POWERS MA, 1996, HDB DIABETES MED NUT, P711
   Rose M, 2002, DIABETES CARE, V25, P35, DOI 10.2337/diacare.25.1.35
   RUBIN RR, 1989, DIABETES CARE, V12, P673, DOI 10.2337/diacare.12.10.673
   Rubin RR, 2001, J CLIN PSYCHOL, V57, P457, DOI 10.1002/jclp.1041
   RUBIN RR, 1991, DIABETES CARE, V14, P335, DOI 10.2337/diacare.14.4.335
   SPITZER WO, 1987, J CHRON DIS, V40, P465, DOI 10.1016/0021-9681(87)90002-6
   Van Loon H, 2000, FAM PRACT, V17, P167, DOI 10.1093/fampra/17.2.167
   WARSHAW HS, 2001, COMPLETE GUIDE CARB, P210
   Watkins KW, 2000, DIABETES CARE, V23, P1511, DOI 10.2337/diacare.23.10.1511
   Williams GC, 1998, DIABETES CARE, V21, P1644, DOI 10.2337/diacare.21.10.1644
NR 35
TC 18
Z9 18
U1 0
U2 17
PU EDITRICE KURTIS S R L
PI MILAN
PA VIA LUIGI ZOJA 30, 20153 MILAN, ITALY
SN 0391-4097
J9 J ENDOCRINOL INVEST
JI J. Endocrinol. Invest.
PD MAY
PY 2006
VL 29
IS 5
BP 405
EP 412
DI 10.1007/BF03344123
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 058VF
UT WOS:000238692000006
PM 16794363
DA 2019-01-08
ER

PT J
AU Nakahara, R
   Yoshiuchi, K
   Kumano, H
   Hara, Y
   Suematsu, H
   Kuboki, T
AF Nakahara, R
   Yoshiuchi, K
   Kumano, H
   Hara, Y
   Suematsu, H
   Kuboki, T
TI Prospective study on influence of psychosocial factors on glycemic
   control in Japanese patients with Type 2 diabetes
SO PSYCHOSOMATICS
LA English
DT Article
ID STRESSFUL LIFE EVENTS; QUALITY-OF-LIFE; SOCIAL SUPPORT; SELF-CARE;
   MELLITUS; ADULTS; COMPLICATIONS; PREVALENCE; DEPRESSION; ADHERENCE
AB The authors prospectively assessed the causal relationship between psychosocial factors and glycemic control in 256 Japanese outpatients with Type 2 diabetes. Using structural-equation modeling, they first developed a causal model in which glycosylated hemoglobin (HbA(1c)) at 6 months after assessment was influenced by the baseline psychosocial factors. Then, the reliability of the causal model was investigated with measurement of HbA(1c) at 12 months after baseline. Self-efficacy directly reinforced adherence, and adherence had a direct association with future HbA(1c) Other psychosocial factors, including social support, diabetes-related distress, daily burden, and emotion-focused coping prospectively influenced HbA(1c) indirectly through self-efficacy.
C1 Univ Tokyo, Fac Med, Dept Psychosomat Med, Bunkyo Ku, Tokyo 1138655, Japan.
   Teikyo Univ, Dept Psychiat, Mizonokuchi Hosp, Kanagawa, Japan.
   Asahi Life Fdn, Inst Diabet Care & Res, Tokyo, Japan.
   Kawamura Gakuen Womans Uni, Chiba, Japan.
RP Nakahara, R (reprint author), Univ Tokyo, Fac Med, Dept Psychosomat Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.
EM nrika-tky@umin.ac.jp
CR Aikens JE, 1997, DIABETES CARE, V20, P1111, DOI 10.2337/diacare.20.7.1111
   Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
   BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191
   BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238
   Bollen K.A., 1989, STRUCTURAL EQUATIONS
   BRADLEY C, 1979, J PSYCHOSOM RES, V23, P159, DOI 10.1016/0022-3999(79)90021-7
   Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723
   Fukunishi I, 1998, DIABETES RES CLIN PR, V41, P207, DOI 10.1016/S0168-8227(98)00083-7
   GARAYSEVILA ME, 1995, J DIABETES COMPLICAT, V9, P81, DOI 10.1016/1056-8727(94)00021-F
   GAVARD JA, 1993, DIABETES CARE, V16, P1167, DOI 10.2337/diacare.16.8.1167
   Gavin JR, 1997, DIABETES CARE, V20, P1183
   GLASGOW RE, 1989, HEALTH PSYCHOL, V8, P285, DOI 10.1037/0278-6133.8.3.285
   Glasgow RE, 1997, DIABETES CARE, V20, P562, DOI 10.2337/diacare.20.4.562
   HOLMS TH, 1996, J PSYCHOSOM RES, V11, P213
   Ishii H., 2000, Journal of the Japan Diabetes Society, V43, P13
   KAVANAGH DJ, 1993, J BEHAV MED, V16, P509, DOI 10.1007/BF00844820
   Kuzuya Takeshi, 1999, Journal of the Japan Diabetes Society, V42, P385
   Lazarus R. S, 1984, STRESS APPRAISAL COP
   Lustman PJ, 2000, DIABETES CARE, V23, P618, DOI 10.2337/diacare.23.5.618
   MCMAIR DM, 1992, MANUAL PROFILE MOOD
   *MIN HLTH LAB WELF, 2001, NAT NUTR SURV
   Mooy JM, 2000, DIABETES CARE, V23, P197, DOI 10.2337/diacare.23.2.197
   NOMURA S, 1992, BEHAVIORAL MEDICINE : AN INTEGRATED BIOBEHAVIORAL APPROACH TO HEALTH AND ILLNESS, P195
   Okubo Y, 1995, DIABETES RES CLIN PR, V28, P103
   Peyrot M, 1997, DIABETES CARE, V20, P585, DOI 10.2337/diacare.20.4.585
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Rose M, 2002, DIABETES CARE, V25, P35, DOI 10.2337/diacare.25.1.35
   SHAMOON H, 1993, NEW ENGL J MED, V329, P977
   SKELLY AH, 1995, DIABETES EDUCATOR, V21, P38, DOI 10.1177/014572179502100107
   Soderstrom M, 2000, J BEHAV MED, V23, P311, DOI 10.1023/A:1005514310142
   Talbot F, 1997, J BEHAV MED, V20, P291, DOI 10.1023/A:1025508928696
   Tillotson LM, 1996, DIABETES EDUCATOR, V22, P133, DOI 10.1177/014572179602200206
   TOOBERT DJ, 1991, J BEHAV MED, V14, P71, DOI 10.1007/BF00844769
   TOOBERT DJ, 1994, HDB PSYCHOL DIABETES, P351
   Turner RC, 1998, LANCET, V352, P837
   UK Prospective Diabetes Study Group, 1999, DIABETES CARE, V22, P1125, DOI DOI 10.2337/DIACARE.22.7.1125
   VanderDoes FEE, 1996, DIABETES CARE, V19, P204, DOI 10.2337/diacare.19.3.204
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   YOKOYAMA K, 1990, JAPANESE J PUBLIC HL, V37, P913
   Yoshiuchi K, 1998, PSYCHOSOM MED, V60, P182, DOI 10.1097/00006842-199803000-00013
NR 40
TC 71
Z9 74
U1 0
U2 14
PU AMER PSYCHIATRIC PUBLISHING, INC
PI ARLINGTON
PA 1000 WILSON BOULEVARD, STE 1825, ARLINGTON, VA 22209-3901 USA
SN 0033-3182
J9 PSYCHOSOMATICS
JI Psychosomatics
PD MAY-JUN
PY 2006
VL 47
IS 3
BP 240
EP 246
DI 10.1176/appi.psy.47.3.240
PG 7
WC Psychiatry; Psychology
SC Psychiatry; Psychology
GA 038MO
UT WOS:000237226100007
PM 16684941
DA 2019-01-08
ER

PT J
AU Tanriover, MD
   Guven, GS
   Sen, D
   Unal, S
   Uzun, O
AF Tanriover, MD
   Guven, GS
   Sen, D
   Unal, S
   Uzun, O
TI Epidemiology and outcome of sepsis in a tertiary-care hospital in a
   developing country
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
ID SEPTIC SHOCK; ICU PATIENTS; BACTEREMIA; MORTALITY; UNITS; DEFINITIONS;
   INFECTION; THERAPY; TRIAL
AB Sepsis continues to have a substantial mortality and morbidity despite advances in the diagnosis and management of this condition. We retrospectively analysed hospital charts of patients diagnosed to have sepsis between January 2002 and June 2003. Demographic characteristics of patients, microbiological findings and predictors of survival were evaluated. Sixty-nine sepsis episodes that occurred in 63 patients were analysed. The most common underlying diseases were hypertension, malignancies and diabetes mellitus. Renal insufficiency, respiratory distress and disseminated intravascular coagulation developed in 52.2, 30.4 and 30.4% of the episodes respectively 47.7% of the blood cultures yielded an organism. Gram-negative bacteria were the predominant microorganisms (65.9%). Fifty-five patients (87.3%) died. Mechanical ventilation and underlying renal disease were significant determinants of mortality. In conclusion, Gram-negative bacteria remain the major pathogens in sepsis. The mortality remains very high, and a change in the clinical approach to the septic patient should be employed to improve the outcome.
C1 Hacettepe Univ, Sch Med, Dept Med, TR-06100 Ankara, Turkey.
RP Tanriover, MD (reprint author), Hacettepe Univ, Tip Fak, Ic Hastaliklari Anabilim Dali, TR-06100 Ankara, Turkey.
EM mdurusu@hacettepe.edu.tr
CR Alberti C, 2002, INTENS CARE MED, V28, P108, DOI 10.1007/s00134-001-1143-z
   ARPI M, 1995, SCAND J INFECT DIS, V27, P245, DOI 10.3109/00365549509019017
   Brun-Buisson C, 2004, INTENS CARE MED, V30, P580, DOI 10.1007/s00134-003-2121-4
   Brun-Buisson C, 2000, INTENS CARE MED, V26, P64
   Busund R, 2002, INTENS CARE MED, V28, P1434, DOI 10.1007/s00134-002-1410-7
   Clermont G, 2003, CRIT CARE MED, V31, P2627, DOI 10.1097/01.CCM.0000094233.35059.81
   Garnacho-Montero J, 2003, CRIT CARE MED, V31, P2742, DOI 10.1097/01.CCM.0000098031.24329.10
   GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3
   Gogos CA, 2003, J INFECTION, V47, P300, DOI 10.1016/S0163-4453(03)00101-4
   Harbarth S, 2003, AM J MED, V115, P529, DOI 10.1016/S0002-9343(03)00505-9
   Kubler A., 2004, MED SCI MONITOR, V10, P635
   Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B
   Lundberg JS, 1998, CRIT CARE MED, V26, P1020, DOI 10.1097/00003246-199806000-00019
   Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139
   MCCABE WR, 1962, ARCH INTERN MED, V110, P847, DOI 10.1001/archinte.1962.03620240029006
   Opal SM, 2003, SCAND J INFECT DIS, V35, P529, DOI 10.1080/00365540310015917
   Padkin A, 2003, CRIT CARE MED, V31, P2332, DOI 10.1097/01.CCM.0000085141.75513.2B
   Pittet D, 1996, AM J RESP CRIT CARE, V153, P684, DOI 10.1164/ajrccm.153.2.8564118
   Riedemann NC, 2003, J CLIN INVEST, V112, P460, DOI 10.1172/JCI200319523
   Sands KE, 1997, JAMA-J AM MED ASSOC, V278, P234
   Sundararajan V, 2005, CRIT CARE MED, V33, P71, DOI 10.1097/01.CCM.0000150027.98160.80
   Topeli A, 1997, EUR J CLIN MICROBIOL, V16, P411, DOI 10.1007/BF02471904
   UZUN O, 1992, CLIN INFECT DIS, V15, P866, DOI 10.1093/clind/15.5.866
   VAZQUEZ F, 1994, J HOSP INFECT, V26, P111, DOI 10.1016/0195-6701(94)90053-1
   Velasco E, 2004, CLIN MICROBIOL INFEC, V10, P542, DOI 10.1111/j.1469-0691.2004.00874.x
NR 25
TC 29
Z9 31
U1 0
U2 7
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 40 WEST 20TH ST, NEW YORK, NY 10011-4211 USA
SN 0950-2688
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PD APR
PY 2006
VL 134
IS 2
BP 315
EP 322
DI 10.1017/S0950268805004978
PG 8
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA 023PL
UT WOS:000236138600014
PM 16490136
DA 2019-01-08
ER

PT J
AU Hagedoorn, M
   Keers, JC
   Links, TP
   Bouma, J
   Ter Maaten, JC
   Sanderman, R
AF Hagedoorn, M
   Keers, JC
   Links, TP
   Bouma, J
   Ter Maaten, JC
   Sanderman, R
TI Improving self-management in insulin-treated adults participating in
   diabetes education. The role of overprotection by the partner
SO DIABETIC MEDICINE
LA English
DT Article
DE diabetes education; diabetes self-management; insulin-treated adults;
   overprotection; partners
ID QUALITY-OF-LIFE; EUROPEAN-AMERICAN PATIENTS; GLYCEMIC CONTROL; CHRONIC
   DISEASE; PSYCHOSOCIAL ADAPTATION; MARITAL RELATIONSHIP;
   GENDER-DIFFERENCES; INTIMATE PARTNERS; OLDER COUPLES; PROBLEM AREAS
AB Aims To examine the role of overprotection by the partner-i.e. excessive protection, unnecessary help, excessive praise for accomplishments, or attempts to restrict activities as a consequence of underestimating the patient's capabilities-in changes in patient self-management in the context of diabetes education.
   Methods Sixty-seven insulin-treated patients with a partner completed questionnaires on admission to a Multidisciplinary Intensive Education Programme (MIEP) and 3 months after completing the core module of MIEP. Factors assessed were overprotection by their partner and three aspects of diabetes self-management, namely internal locus of control, diabetes-related distress and HbA(1c). Regression analyses were used to test the independent associations of patient sex, baseline overprotection and the interaction between sex and overprotection with diabetes self-management at the follow-up stage, controlling for the baseline value of the dependent variable.
   Results The increase in internal locus of control and decrease in HbA(1c) were both significantly less for female patients who perceived their partner to be rather overprotective than for female patients who did not perceive their partner to be overprotective. The more patients, both male and female, perceived their partner to be overprotective, the less their diabetes-related distress decreased.
   Conclusions Overprotection by the partner showed a negative association with improvement in diabetes self-management, especially for female patients. Thus, an intervention programme with the aim of reducing overprotection by the partner, or the perception of this, may enhance self-management in patients participating in diabetes education.
C1 Univ Groningen, Dept Publ Hlth & Hlth Psychol, No Ctr Healthcare Res, NL-9700 AD Groningen, Netherlands.
   Univ Groningen, Med Ctr, Dept Endocrinol, Groningen, Netherlands.
   Acad Rehabil Ctr Beatrixoord, Haren, Netherlands.
   Univ Groningen, Med Ctr, Dept Internal Med, Groningen, Netherlands.
RP Hagedoorn, M (reprint author), Univ Groningen, Dept Publ Hlth & Hlth Psychol, No Ctr Healthcare Res, POB 196, NL-9700 AD Groningen, Netherlands.
EM m.hagedoorn@med.umcg.nl
RI Sanderman, Robbert/D-7234-2012; Hagedoorn, Mariet/B-5056-2010
OI Sanderman, Robbert/0000-0002-0823-1159; Hagedoorn,
   Mariet/0000-0003-3444-3662
CR ACITELLI LK, 1994, J PERS SOC PSYCHOL, V67, P688, DOI 10.1037//0022-3514.67.4.688
   ADA, 2005, DIABETES CARE, V28, ps4
   Aiken L. S, 1991, MULTIPLE REGRESSION
   BERKHUYSEN MA, 1998, J CARDIOPULM REHABIL, V19, P22
   CARDENAS L, 1987, AM J MED SCI, V293, P28, DOI 10.1097/00000441-198701000-00007
   Chesla CA, 2003, FAM PROCESS, V42, P375, DOI 10.1111/j.1545-5300.2003.00375.x
   Coates VE, 1998, J ADV NURS, V27, P528, DOI 10.1046/j.1365-2648.1998.00546.x
   Cohen J, 1988, STAT POWER ANAL BEHA
   Coyne J. C., 1990, SOCIAL SUPPORT INTER, P129
   Coyne JC, 1994, J FAMILY PSYCHOL, V8, P43, DOI DOI 10.1037/0893-3200.8.1.43
   Dalewitz J, 2000, AM J MED QUAL, V15, P16, DOI 10.1177/106286060001500104
   Fisher L, 2000, J FAM PRACTICE, V49, P561
   Fisher L, 1998, DIABETES EDUCATOR, V24, P599, DOI 10.1177/014572179802400504
   Fisher L, 2000, DIABETES CARE, V23, P267, DOI 10.2337/diacare.23.3.267
   Glasgow RE, 2001, DIABETES CARE, V24, P124, DOI 10.2337/diacare.24.1.124
   Gonder-Frederick LA, 2002, J CONSULT CLIN PSYCH, V70, P611, DOI 10.1037//0022-006X.70.3.611
   Hagedoorn M, 2000, HEALTH PSYCHOL, V19, P274, DOI 10.1037//0278-6133.19.3.274
   Hagedoorn M, 2001, J PSYCHOSOM RES, V51, P693, DOI 10.1016/S0022-3999(01)00279-3
   Hagedoorn M, 2000, PSYCHO-ONCOLOGY, V9, P232, DOI 10.1002/1099-1611(200005/06)9:3<232::AID-PON458>3.0.CO;2-J
   Jacobson AM, 1996, NEW ENGL J MED, V334, P1249, DOI 10.1056/NEJM199605093341907
   Keers JC, 2004, DIABETES RES CLIN PR, V66, P157, DOI 10.1016/j.diabres.2004.02.018
   Keers JC, 2004, PATIENT EDUC COUNS, V52, P151, DOI 10.1016/S0738-3991(03)00019-3
   KEERS JC, IN PRESS PATIENT ED
   Kiecolt-Glaser JK, 2001, PSYCHOL BULL, V127, P472, DOI 10.1037//0033-2909.127.4.472
   Kuijer RG, 2000, J SOC CLIN PSYCHOL, V19, P256, DOI 10.1521/jscp.2000.19.2.256
   MCCLELLAND GH, 1993, PSYCHOL BULL, V114, P376, DOI 10.1037//0033-2909.114.2.376
   MCRAE JA, 1989, SOC SCI RES, V18, P237, DOI 10.1016/0049-089X(89)90006-9
   Peyrot M, 1997, DIABETES CARE, V20, P585, DOI 10.2337/diacare.20.4.585
   QUIROUETTE C, 1992, INT J AGING HUM DEV, V34, P257, DOI 10.2190/35PY-3AXX-XT1V-71LR
   SCHWARTZ LS, 1991, GEN HOSP PSYCHIAT, V13, P19, DOI 10.1016/0163-8343(91)90005-H
   Snoek FJ, 2003, PATIENT EDUC COUNS, V51, P1, DOI 10.1016/S0738-3991(03)00204-0
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   THOMPSON SC, 1993, BASIC APPL SOC PSYCH, V14, P363, DOI 10.1207/s15324834basp1403_8
   Trief P., 2003, FAMILIES SYSTEMS HLT, V21, P57, DOI [DOI 10.1037/H0089502, 10.1037/h0089502]
   Trief PM, 1998, DIABETES CARE, V21, P241, DOI 10.2337/diacare.21.2.241
   Trief PM, 2004, ANN BEHAV MED, V27, P148, DOI 10.1207/s15324796abm2703_2
   Trief PM, 2002, DIABETES CARE, V25, P1154, DOI 10.2337/diacare.25.7.1154
   Trief PM, 2001, DIABETES CARE, V24, P1384, DOI 10.2337/diacare.24.8.1384
   WALLSTON KA, 1994, J PERS ASSESS, V63, P534, DOI 10.1207/s15327752jpa6303_10
   Watkins KW, 2000, DIABETES CARE, V23, P1511, DOI 10.2337/diacare.23.10.1511
   Wearden AJ, 2000, J PSYCHOSOM RES, V49, P125, DOI 10.1016/S0022-3999(00)00141-0
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
NR 42
TC 24
Z9 26
U1 2
U2 8
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0742-3071
J9 DIABETIC MED
JI Diabetic Med.
PD MAR
PY 2006
VL 23
IS 3
BP 271
EP 277
DI 10.1111/j.1464-5491.2006.01794.x
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 012WB
UT WOS:000235370500009
PM 16492210
OA Green Published
DA 2019-01-08
ER

PT J
AU Hughes, RCE
   Rowan, JA
AF Hughes, RCE
   Rowan, JA
TI Pregnancy in women with Type 2 diabetes: who takes metformin and what is
   the outcome?
SO DIABETIC MEDICINE
LA English
DT Article
DE pregnancy; Type 2 diabetes; metformin; preeclampsia; neonatal morbidity
ID POLYCYSTIC-OVARY-SYNDROME; ORAL HYPOGLYCEMIC AGENTS; IMPAIRED
   GLUCOSE-TOLERANCE; BODY-MASS INDEX; INSULIN-RESISTANCE; HYPERTENSIVE
   DISORDERS; 1ST TRIMESTER; PREECLAMPSIA; OBESITY; WEIGHT
AB Aims To review pregnancy outcomes in women with Type 2 diabetes (Type 2 DM), comparing women treated with those not treated with metformin.
   Methods Data were collected by case-note review for all pregnancies in women with Type 2 DM over a 6-year period (1998-2003) at the National Women's Hospital. Two hundred and fourteen pregnancies were included, metformin was taken in 93 pregnancies and continued until delivery in 32; the remaining 121 pregnancies comprised the control group. The principal outcome measures were preeclampsia, perinatal loss and neonatal morbidity.
   Results Baseline characteristics differed between groups: women in the metformin group had greater mean (SD) body mass index [35.5(7.6) vs. 33.5(6.6) kg/m(2), P < 0.05], more chronic hypertension (19% vs. 7%, P < 0.05) and higher mean (SD) first trimester glycated haemoglobin (HbA(1c)) levels [8.3(1.9)% vs. 7.5(1.7)%, P < 0.005]. There was no difference between metformin and control groups, respectively, in the rate of preeclampsia (13% vs. 14%, P = 0.84), perinatal loss (3% vs. 2%, P = 0.65) or neonatal morbidity, including rate of prematurity (23% vs. 22%, P = 0.7), admission to the neonatal unit (40% vs. 48%, P = 0.27), respiratory distress (9% vs. 18%, P = 0.07) and treatment with intravenous dextrose (20% vs. 31%, P = 0.08).
   Conclusions Pregnant women with Type 2 DM who were treated with metformin had more risk factors for adverse pregnancy outcomes, but no differences in outcomes were seen compared with women not taking metformin. We need randomized trials to address potential benefits of metformin treatment in this population that may be masked by current practice.
C1 Natl Womens Hosp, Auckland, New Zealand.
   Dept Med, Auckland, New Zealand.
RP Rowan, JA (reprint author), Natl Womens Hosp, Private Bag 92 189, Auckland, New Zealand.
EM jrowan@internet.co.nz
CR Beeby PJ, 1996, J PAEDIATR CHILD H, V32, P512, DOI 10.1111/j.1440-1754.1996.tb00965.x
   Brown MA, 2000, AUST NZ J OBSTET GYN, V40, P139, DOI 10.1111/j.1479-828X.2000.tb01137.x
   Caballero AE, 2004, J CLIN ENDOCR METAB, V89, P3943, DOI 10.1210/jc.2004-0019
   Caballero AE, 2003, OBES RES, V11, P1278, DOI 10.1038/oby.2003.174
   COETZEE EJ, 1979, DIABETOLOGIA, V16, P241, DOI 10.1007/BF01221950
   COETZEE EJ, 1980, S AFR MED J, V58, P795
   COETZEE EJ, 1984, S AFR MED J, V65, P635
   Coetzee EJ, 1985, DIABETES RES CLIN PR, V1, P281
   Cundy T, 2002, DIABETIC MED, V19, P482, DOI 10.1046/j.1464-5491.2002.00729.x
   Dabelea D, 2000, DIABETES, V49, P2208, DOI 10.2337/diabetes.49.12.2208
   de Vries MJ, 1998, EUR J OBSTET GYN R B, V76, P91, DOI 10.1016/S0301-2115(97)00164-4
   Dunne F, 2003, DIABETIC MED, V20, P734, DOI 10.1046/j.1464-5491.2003.01017.x
   ELLIOTT BD, 1994, AM J OBSTET GYNECOL, V171, P653, DOI 10.1016/0002-9378(94)90078-7
   Elliott BD, 1997, AM J OBSTET GYNECOL, V176, P527, DOI 10.1016/S0002-9378(97)70541-6
   Feig DS, 2002, LANCET, V359, P1690, DOI 10.1016/S0140-6736(02)08599-9
   Glueck CJ, 2002, FERTIL STERIL, V77, P520, DOI 10.1016/S0015-0282(01)03202-2
   Glueck CJ, 2004, HUM REPROD, V19, P1323, DOI 10.1093/humrep/deh263
   Glueck CJ, 2002, HUM REPROD, V17, P2858, DOI 10.1093/humrep/17.11.2858
   Glueck CJ, 2001, FERTIL STERIL, V75, P46, DOI 10.1016/S0015-0282(00)01666-6
   Glueck CJ, 2004, HUM REPROD, V19, P510, DOI 10.1093/humrep/deh109
   Glueck CJ, 2004, DIABETIC MED, V21, P829, DOI 10.1111/j.1464-5491.2004.01251.x
   Gutzin Sheryl J, 2003, Can J Clin Pharmacol, V10, P179
   Hague W, 2003, METFORMIN CROSSES PL
   Harborne L, 2003, LANCET, V361, P1894, DOI 10.1016/S0140-6736(03)13493-9
   Heard MJ, 2002, FERTIL STERIL, V77, P669, DOI 10.1016/S0015-0282(01)03266-6
   HELLMUTH E, 1994, DIABETIC MED, V11, P471, DOI 10.1111/j.1464-5491.1994.tb00308.x
   Hellmuth E, 2000, DIABETIC MED, V17, P507, DOI 10.1046/j.1464-5491.2000.00314.x
   Hundal RS, 2003, DRUGS, V63, P1879, DOI 10.2165/00003495-200363180-00001
   Jakubowicz DJ, 2002, J CLIN ENDOCR METAB, V87, P524, DOI 10.1210/jc.87.2.524
   Kirpichnikov D, 2002, ANN INTERN MED, V137, P25, DOI 10.7326/0003-4819-137-1-200207020-00009
   METZGER BE, 1990, ARCH DIS CHILD, V65, P1050, DOI 10.1136/adc.65.10_Spec_No.1050
   O'Brien TE, 2003, EPIDEMIOLOGY, V14, P368, DOI 10.1097/00001648-200305000-00020
   PIACQUADIO K, 1991, LANCET, V338, P866, DOI 10.1016/0140-6736(91)91512-S
   Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5
   SILVERMAN BL, 1995, DIABETES CARE, V18, P611, DOI 10.2337/diacare.18.5.611
   Thadhani R, 1999, OBSTET GYNECOL, V94, P543, DOI 10.1016/S0029-7844(99)00400-7
   Vanky E, 2004, HUM REPROD, V19, P1734, DOI 10.1093/humrep/deh347
   Weiss JL, 2004, AM J OBSTET GYNECOL, V190, P1091, DOI 10.1016/j.ajog.2003.09.058
   Wolf M, 2002, J CLIN ENDOCR METAB, V87, P1563, DOI 10.1210/jc.87.4.1563
   Yamashita H, 2000, CLIN OBSTET GYNECOL, V43, P87, DOI 10.1097/00003081-200003000-00009
NR 40
TC 49
Z9 54
U1 0
U2 3
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0742-3071
J9 DIABETIC MED
JI Diabetic Med.
PD MAR
PY 2006
VL 23
IS 3
BP 318
EP 322
DI 10.1111/j.1464-5491.2006.01750.x
PG 5
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 012WB
UT WOS:000235370500016
PM 16492217
DA 2019-01-08
ER

PT J
AU Hermanns, N
   Kulzer, B
   Krichbaum, M
   Kubiak, T
   Haak, T
AF Hermanns, N
   Kulzer, B
   Krichbaum, M
   Kubiak, T
   Haak, T
TI How to screen for depression and emotional problems in patients with
   diabetes: comparison of screening characteristics of depression
   questionnaires, measurement of diabetes-specific emotional problems and
   standard clinical assessment
SO DIABETOLOGIA
LA English
DT Article
DE depression; diabetes; Problem Areas In Diabetes (PAID) questionnaire;
   ROC analysis; screening
ID PLACEBO-CONTROLLED TRIAL; QUALITY-OF-LIFE; GLYCEMIC CONTROL; PROBLEM
   AREAS; COMORBID DEPRESSION; PRIMARY-CARE; DOUBLE-BLIND; CES-D;
   DISORDERS; ADULTS
AB Aims/hypothesis: We compared the screening performance of different measures of depression: the standard clinical assessment (SCA); the Beck Depression Inventory (BDI); the Center of Epidemiological Studies-Depression Scale (CES-D); and the Problem Areas in Diabetes (PAID) questionnaire, which assesses diabetes-specific distress. We also studied the ability of these measures to detect diabetes-related distress. Materials and methods: A total of 376 diabetic patients (37.2% type 1; 23.9% type 2 without insulin treatment, 38.8% type 2 with insulin) completed the BDI and CES-D; patients who screened positive participated in a diagnostic interview, the Composite International Diagnostic Interview (CIDI). Also, all patients completed the PAID questionnaire. Results of the SCA that related to depression diagnosis were reviewed to correct for false negative screening results. Results: The prevalence of clinical depression was 14.1%, with an additional 18.9% of patients receiving a diagnosis of subclinical depression. Sensitivity for clinical depression in SCA (56%) was moderate, whereas BDI, CES-D and the PAID questionnaire showed satisfactory sensitivity (87, 79 and 81%, respectively). For subclinical depression, the sensitivity of the PAID questionnaire (79%) was sufficient, whereas that of SCA (25%) was poor. All methods showed low sensitivity for the detection of diabetes-specific emotional problems (SCA 19%, CIDI 34%, BDI 60%, CES-D 49%). Conclusions/interpretation: The screening performance of SCA for clinical and subclinical depression was modest. Additional screening for depression using the PAID or another depression questionnaire seems reasonable. The ability of depression screening measures to identify diabetes-related distress is modest, suggesting that the PAID questionnaire could be useful when screening diabetic patients for both depression and emotional problems.
C1 FIDAM, D-97961 Bad Mergentheim, Germany.
   Univ Greifswald, Inst Psychol, Greifswald, Germany.
RP Hermanns, N (reprint author), FIDAM, Postfach 114, D-97961 Bad Mergentheim, Germany.
EM hermanns@diabetes-zentrum.de
RI Kubiak, Thomas/D-4655-2009
OI Kubiak, Thomas/0000-0003-0095-9265; Krichbaum,
   Michael/0000-0002-5937-1266
CR *AM DIAB ASS, 2005, DIABETES CARE S1, V28, pS4, DOI DOI 10.2337/DIACARE
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Andryschenko AV, 2003, ZH NEVROPATOL PSIKH, V103, P11
   Bensing JM, 2003, J GEN INTERN MED, V18, P335, DOI 10.1046/j.1525-1497.2003.10735.x
   Black SA, 2003, DIABETES CARE, V26, P2822, DOI 10.2337/diacare.26.10.2822
   Bland M., 2000, INTRO MED STAT
   Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   Egede LE, 2004, DIABETES CARE, V27, P421, DOI 10.2337/diacare.27.2.421
   Egede LE, 2002, DIABETES CARE, V25, P464, DOI 10.2337/diacare.25.3.464
   FISCHER L, 2001, DIABETES CARE, V24, P1751
   Furukawa TA, 1997, J AFFECT DISORDERS, V46, P1, DOI 10.1016/S0165-0327(97)00079-7
   GARRISON CZ, 1991, J AM ACAD CHILD PSY, V30, P636, DOI 10.1097/00004583-199107000-00017
   Hautzinger M., 1994, BECK DEPRESSIONS INV
   Hautzinger M, 1993, ALLGEMEINE DEPRESSIO
   Hermanns N, 2005, DIABETIC MED, V22, P293, DOI 10.1111/j.1464-5491.2005.01414.x
   Judd LL, 2002, PSYCHIAT CLIN N AM, V25, P685, DOI 10.1016/S0193-953X(02)00026-6
   Judd LL, 1997, J AFFECT DISORDERS, V45, P5, DOI 10.1016/S0165-0327(97)00055-4
   JUDD LL, 1994, J CLIN PSYCHIAT, V55, P18
   Judd LL, 1998, J AFFECT DISORDERS, V50, P97, DOI 10.1016/S0165-0327(98)00138-4
   Kruse J, 2003, DIABETES CARE, V26, P1841, DOI 10.2337/diacare.26.6.1841
   Kulzer B, 2002, DIABETES STOFFWECH H, V11, P144
   Lasa L, 2000, J AFFECT DISORDERS, V57, P261, DOI 10.1016/S0165-0327(99)00088-9
   Leentjens AFG, 2000, MOVEMENT DISORD, V15, P1221, DOI 10.1002/1531-8257(200011)15:6<1221::AID-MDS1024>3.0.CO;2-H
   Lustman PJ, 1997, PSYCHOSOM MED, V59, P24, DOI 10.1097/00006842-199701000-00004
   Lustman PJ, 1997, PSYCHOSOM MED, V59, P241, DOI 10.1097/00006842-199705000-00007
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Lustman PJ, 2000, DIABETES CARE, V23, P618, DOI 10.2337/diacare.23.5.618
   Lustman PJ, 1998, ANN INTERN MED, V129, P613, DOI 10.7326/0003-4819-129-8-199810150-00005
   PETRAK F, 2005, IN PRESS CURR DIAB R, V1
   Peyrot M, 2003, DIABETES CARE, V26, P2952, DOI 10.2337/diacare.26.10.2952
   Peyrot M, 1997, DIABETES CARE, V20, P585, DOI 10.2337/diacare.20.4.585
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Pouwer F, 2003, DIABETOLOGIA, V46, P892, DOI 10.1007/s00125-003-1124-6
   Pouwer F, 2005, DIABETES RES CLIN PR, V70, P166, DOI 10.1016/j.diabres.2005.03.031
   Pouwer F, 2001, DIABETES CARE, V24, P1929, DOI 10.2337/diacare.24.11.1929
   REID MC, 1995, JAMA-J AM MED ASSOC, V274, P645, DOI 10.1001/jama.274.8.645
   ROBERTS RE, 1991, J AM ACAD CHILD PSY, V30, P58, DOI 10.1097/00004583-199101000-00009
   Rubin R, 2000, DIABETES SPECTR, V13, P21
   Rubin Richard R, 2004, Curr Diab Rep, V4, P119, DOI 10.1007/s11892-004-0067-8
   Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Tahepold H, 2003, SCAND J PRIM HEALTH, V21, P167, DOI 10.1080/02813430310000708
   Talbot F, 2000, DIABETES CARE, V23, P1556, DOI 10.2337/diacare.23.10.1556
   Weinger K, 2001, PATIENT EDUC COUNS, V42, P123, DOI 10.1016/S0738-3991(00)00098-7
   Welch G, 2003, DIABETIC MED, V20, P69, DOI 10.1046/j.1464-5491.2003.00832.x
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   Williams JW, 2002, GEN HOSP PSYCHIAT, V24, P225, DOI 10.1016/S0163-8343(02)00195-0
   WITTCHEN HU, 1994, J PSYCHIAT RES, V28, P57, DOI 10.1016/0022-3956(94)90036-1
NR 49
TC 140
Z9 145
U1 0
U2 20
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0012-186X
J9 DIABETOLOGIA
JI Diabetologia
PD MAR
PY 2006
VL 49
IS 3
BP 469
EP 477
DI 10.1007/s00125-005-0094-2
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 014OB
UT WOS:000235488400006
PM 16432706
OA Bronze
DA 2019-01-08
ER

PT J
AU Lackner, JM
   Gudleski, GD
   Zack, MM
   Katz, LA
   Powell, C
   Krasner, S
   Holmes, E
   Dorscheimer, K
AF Lackner, JM
   Gudleski, GD
   Zack, MM
   Katz, LA
   Powell, C
   Krasner, S
   Holmes, E
   Dorscheimer, K
TI Measuring health-related quality of life in patients with irritable
   bowel syndrome: Can less be more?
SO PSYCHOSOMATIC MEDICINE
LA English
DT Article
DE generic health status; quality of life; irritable bowel syndrome;
   anxiety; somatization
ID FUNCTIONAL GASTROINTESTINAL DISORDERS; FACTOR SURVEILLANCE SYSTEM;
   OUTCOME MEASURES; OLDER-ADULTS; PAIN; IMPACT; POPULATION; ANXIETY; CARE;
   QUESTIONNAIRE
AB Objective: This study assessed the ability of a brief, well-validated generic health-related quality of life (HRQOL) measure to characterize the symptom burden of patients with irritable bowel syndrome (IBS) with reference to a large survey of U.S. community-living adults. Methods: One hundred four Rome II diagnosed patients with IBS completed measures of pain, psychological dysfunction (neuroticism, somatization, distress, abuse), and HRQOL (SF-36, IBS-QOL, CDC HRQOL-4) during baseline assessment of a National Institutes of Health-funded clinical trial. The four-item CDC HRQOL-4 assesses global health and the number of days in the past 30 days resulting from poor physical health, poor mental health, and activity limitation. Results: Patients with IBS averaged 15 of 30 days with poor physical or mental health. These average overall unhealthy days exceeded those of respondents with arthritis, diabetes, heart disease/stroke, cancer, and class III obesity (body mass index >= 40 kg/m(2)) from the U.S. survey. Fifteen percent of patients identified musculoskeletal disorders, not IBS symptoms, as the major cause of their activity limitation. Overall unhealthy days among patients with IBS varied directly with IBS symptom severity, abuse, pain, and psychological distress. Controlling for personality variables that influence perception and reporting HRQOL did not diminish the statistical significance of associations between the CDC HRQOL-4 and other study measures. Conclusions: The CDC HRQOL-4 is a psychometrically sound, rapid, and efficient instrument whose HRQOL profile reflects the symptom burden of moderate-to-severe IBS, is sensitive to treatment effects associated with cognitive behavior therapy, and is not a proxy for personality variables identified as potential confounders of HRQOL. HRQOL is related to but not redundant with psychological distress.
C1 SUNY Buffalo, Div Gastroenterol, Dept Med, Buffalo, NY 14260 USA.
   SUNY Buffalo, Dept Anesthesiol, Buffalo, NY 14260 USA.
   SUNY Buffalo, Sch Med & Biomed Sci, Buffalo, NY 14260 USA.
   Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Hlth Care & Aging Studies Branch, Div Adult & Community Hlth, Atlanta, GA 30333 USA.
RP Lackner, JM (reprint author), SUNY Buffalo, Sch Med, Dept Med, Behav Med Clin,ECMC, 462 Grider St, Buffalo, NY 14215 USA.
EM lackner@buffalo.edu
FU NIDDK NIH HHS [DK-67878, R03 DK067878, DK-54211]
CR *AM COLL GASTR FUN, 2002, AM J GASTROENTEROL S, V97, pS1
   American Psychiatric Association, 1994, DIAGN STAT MAN MENT
   Andresen EM, 1999, ARCH PHYS MED REHAB, V80, P877, DOI 10.1016/S0003-9993(99)90077-1
   Andresen EM, 2003, J EPIDEMIOL COMMUN H, V57, P339, DOI 10.1136/jech.57.5.339
   Barlow DH, 2000, AM PSYCHOL, V55, P1247, DOI 10.1037/0003-066X.55.11.1247
   BEATTY P, 1996, 51 ANN C AM STAT ASS, P956
   Biggs AM, 2004, GUT, V53, P180, DOI 10.1136/gut.2003.020974
   Bijkerk CJ, 2003, AM J GASTROENTEROL, V98, P122
   BRAZIER J, 1995, PHARMACOECONOMICS, V7, P403, DOI 10.2165/00019053-199507050-00005
   Brown DW, 2003, PREV MED, V37, P520, DOI 10.1016/S0091-7435(03)00179-8
   Centers for Disease Control and Prevention, 2000, MEAS HLTH DAYS
   Chang L, 2004, ALIMENT PHARM THERAP, V20, P31, DOI 10.1111/j.1365-2036.2004.02183.x
   Ciccone DS, 1996, PAIN, V68, P329, DOI 10.1016/S0304-3959(96)03216-2
   COHEN J, 1988, STAT POWR ANAL BEHAV
   Creed F, 2003, GASTROENTEROLOGY, V124, P303, DOI 10.1053/gast.2003.50055
   Currey SS, 2003, ARTHRIT RHEUM-ARTHR, V49, P658, DOI 10.1002/art.11381
   Derogatis L. R., 1993, BRIEF SYMPTOM INVENT
   Detmar SB, 2002, JAMA-J AM MED ASSOC, V288, P3027, DOI 10.1001/jama.288.23.3027
   DEYO RA, 1989, MED CARE S, V27, P254
   Dominick KL, 2004, ARTHRIT RHEUM-ARTHR, V51, P326, DOI 10.1002/art.20390
   Dominick KL, 2002, AGING CLIN EXP RES, V14, P499, DOI 10.1007/BF03327351
   Drossman DA, 2003, GASTROENTEROLOGY, V125, P19, DOI 10.1016/S0016-5085(03)00669-3
   Drossman DA, 2000, AM J GASTROENTEROL, V95, P999
   DROSSMAN DA, 2000, FUNCTIONAL GASTROINT
   EYSENCK MW, 1987, PSYCHOL RES-PSYCH FO, V49, P189, DOI 10.1007/BF00308686
   Frank L, 2002, CLIN THER, V24, P675, DOI 10.1016/S0149-2918(02)85143-8
   Frederick IO, 1997, QUALITY LIFE MEASURE
   Gralnek IM, 2000, GASTROENTEROLOGY, V119, P654, DOI 10.1053/gast.2000.16484
   Hagerty MR, 2001, SOC INDIC RES, V55, P1, DOI 10.1023/A:1010811312332
   Hahn BA, 1999, DIGESTION, V60, P77, DOI 10.1159/000007593
   Halder SLS, 2004, ALIMENT PHARM THERAP, V19, P233, DOI 10.1111/j.0269-2813.2004.01807.x
   HAYS RD, 1993, QUAL LIFE RES, V2, P441, DOI 10.1007/BF00422218
   JENSEN MP, 1986, PAIN, V27, P117, DOI 10.1016/0304-3959(86)90228-9
   Kempen GIJM, 1997, HEALTH PSYCHOL, V16, P539, DOI 10.1037/0278-6133.16.6.539
   Lackner JM, 2005, EUR J PAIN, V9, P207, DOI 10.1016/j.ejpain.2004.06.002
   Lackner JM, 2004, BEHAV RES THER, V42, P41, DOI 10.1016/S0005-7967(03)00069-X
   Leserman J, 1998, PSYCHOL MED, V28, P417, DOI 10.1017/S0033291797006508
   Levy RL, 2001, AM J GASTROENTEROL, V96, P3122
   Meissner JS, 1997, APPL PSYCHOPHYS BIOF, V22, P55, DOI 10.1023/A:1026289709751
   MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8
   Mili F, 2003, J RHEUMATOL, V30, P160
   Muldoon MF, 1998, BMJ-BRIT MED J, V316, P542, DOI 10.1136/bmj.316.7130.542
   Naliboff BD, 1997, GUT, V41, P505, DOI 10.1136/gut.41.4.505
   Newschaffer CJ, 1998, VALIDATION BEHAV RIS
   Patrick DL, 1998, DIGEST DIS SCI, V43, P400, DOI 10.1023/A:1018831127942
   PAYNE A, 1995, J CONSULT CLIN PSYCH, V63, P779, DOI 10.1037/0022-006X.63.5.779
   Raikkonen K, 1999, J PERS SOC PSYCHOL, V76, P104
   Rief W, 1998, J ABNORM PSYCHOL, V107, P587, DOI 10.1037/0021-843X.107.4.587
   SMITH TW, 1989, J PERS SOC PSYCHOL, V56, P640, DOI 10.1037/0022-3514.56.4.640
   SPEILBERGER CD, 1970, MANUAL STATE TRAIT A
   Spiegel BMR, 2004, ARCH INTERN MED, V164, P1773, DOI 10.1001/archinte.164.16.1773
   STEWART AL, 1989, JAMA-J AM MED ASSOC, V262, P907, DOI 10.1001/jama.262.7.907
   Tillisch K, 2005, AM J GASTROENTEROL, V100, P896, DOI 10.1111/j.1572-0241.2005.41211.x
   van der Zee KI, 1996, QUAL LIFE RES, V5, P165, DOI 10.1007/BF00435982
   Ware J. E, 2000, SF 36 HLTH SURVEY
   WELLS NE, 1987, ALIMENT PHARM THERAP, V11, P1019
   Whitehead WE, 2002, GASTROENTEROLOGY, V122, P1140, DOI 10.1053/gast.2002.32392
   World Health Organization, 1946, CONST
NR 58
TC 37
Z9 37
U1 0
U2 9
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0033-3174
J9 PSYCHOSOM MED
JI Psychosom. Med.
PD MAR-APR
PY 2006
VL 68
IS 2
BP 312
EP 320
DI 10.1097/01.psy.0000204897.25745.7c
PG 9
WC Psychiatry; Psychology; Psychology, Multidisciplinary
SC Psychiatry; Psychology
GA 029VB
UT WOS:000236591400020
PM 16554399
DA 2019-01-08
ER

PT J
AU Salonia, A
   Lanzi, R
   Scavini, M
   Pontillo, M
   Gatti, E
   Petrella, G
   Licata, G
   Nappi, RE
   Bosi, E
   Briganti, A
   Rigatti, P
   Montorsi, F
AF Salonia, A
   Lanzi, R
   Scavini, M
   Pontillo, M
   Gatti, E
   Petrella, G
   Licata, G
   Nappi, RE
   Bosi, E
   Briganti, A
   Rigatti, P
   Montorsi, F
TI Sexual function and endocrine profile in fertile women with type 1
   diabetes
SO DIABETES CARE
LA English
DT Article
ID ERECTILE DYSFUNCTION; FEMALE SEXUALITY; MEN; MELLITUS
AB OBJECTIVE - Aims of this study were 1) to assess sexual function and endocrine profile among fertile type 1 diabetic women during the follicular and luteal phases of the menstrual cycle, 2) to compare these results with those obtained among healthy fertile women who served as control subjects, and 3) to explore the correlations between sexual function and endocrine milieu among patients and control subjects during the follicular and luteal phases of the menstrual cycle.
   RESEARCH DESIGN AND METHODS - Fifty fertile women with type 1 diabetes and 47 healthy control subjects completed a semistructured medical interview and filled in self-administered validated instruments to evaluate sexual function, depression, and sexual distress. Venous blood samples were drawn to measure glycated hemoglobin and an endocrine profile during either the follicular or the luteal phase of the menstrual cycle.
   RESULTS - Type 1 diabetic women had decreased sexual function and increased sexual distress compared with control subjects during the luteal, but not the follicular, phase of the menstrual cycle. During the follicular phase, patients had lower estrogenic basal tone, lower "weak" androgen (namely Delta(4)-androstenedione and dehydroepiandrosterone sulfate) production, and lower free-triiodothyronine and free-thyroxine levels compared with control subjects. During the luteal phase, total testosterone levels were higher in patients than control subjects, while 17 beta-estradiol and progesterone levels were lower in patients than control subjects.
   CONCLUSIONS - Among type 1 diabetic women, sexual function and sexual distress vary according to the phase of the menstrual cycle. This finding may have implications on the clinical assessment of sexual function in type 1 diabetic women,
C1 Univ Vita San Raffaele, Dept Urol, Milan, Italy.
   Univ Vita San Raffaele, Dept Internal Med, Milan, Italy.
   Univ Vita San Raffaele, Dept Biochem Chem, Milan, Italy.
   Univ Pavia, Ist Ric & Cura Carattere Sci San Matteo, Dept Obstet & Gynecol, I-27100 Pavia, Italy.
RP Salonia, A (reprint author), Osped San Raffaele, UO Urol, Via Olgettina 60, I-20132 Milan, Italy.
EM salonia.andrea@hsr.it
OI Scavini, Marina/0000-0002-7983-6905
CR ARSHAG D, 1990, ARCH INTERN MED, V150, P1033
   Corona G, 2004, EUR UROL, V46, P222, DOI 10.1016/j.eururo.2004.03.010
   Derogatis LR, 2002, J SEX MARITAL THER, V28, P317, DOI 10.1080/00926230290001448
   Duby JJ, 2004, AM J HEALTH-SYST PH, V61, P160
   Enzlin P, 2003, DIABETES CARE, V26, P409, DOI 10.2337/diacare.26.2.409
   Enzlin P, 1998, DIABETIC MED, V15, P809, DOI 10.1002/(SICI)1096-9136(199810)15:10<809::AID-DIA689>3.0.CO;2-Z
   Enzlin P, 2002, DIABETES CARE, V25, P672, DOI 10.2337/diacare.25.4.672
   Erol B, 2003, INT J IMPOT RES, V15, P198, DOI 10.1038/sj.ijir.3900998
   Erol B, 2002, J SEX MARITAL THER, V28, P55, DOI 10.1080/00926230252851195
   Fedele D, 1998, DIABETES CARE, V21, P1973, DOI 10.2337/diacare.21.11.1973
   Guay AT, 2001, INT J IMPOT RES, V13, pS47, DOI 10.1038/sj.ijir.3900779
   Jackson G, 2004, INT J CLIN PRACT, V58, P358, DOI 10.1111/j.1368-5031.2004.00180.x
   JENSEN SB, 1981, ARCH SEX BEHAV, V10, P493, DOI 10.1007/BF01541585
   KOLODNY RC, 1971, DIABETES, V20, P557, DOI 10.2337/diab.20.8.557
   LEEDOM L, 1991, Journal of Diabetic Complications, V5, P38, DOI 10.1016/0891-6632(91)90009-E
   *NCCLS, 1995, C28A NCCLS, P59
   NEWMAN AS, 1986, J BEHAV MED, V9, P261, DOI 10.1007/BF00844773
   Penson DF, 2003, DIABETES CARE, V26, P1093, DOI 10.2337/diacare.26.4.1093
   Richter P, 1998, PSYCHOPATHOLOGY, V31, P160, DOI 10.1159/000066239
   Rosen R, 2000, J SEX MARITAL THER, V26, P191, DOI 10.1080/009262300278597
   SCHREINERENGEL P, 1987, J PSYCHOSOM RES, V31, P23, DOI 10.1016/0022-3999(87)90094-8
   Shifren JL, 2004, MAYO CLIN PROC, V79, pS19
   TYRER G, 1983, DIABETOLOGIA, V24, P166
   WIDOM B, 1992, DIABETES CARE, V15, P213, DOI 10.2337/diacare.15.2.213
NR 24
TC 77
Z9 82
U1 1
U2 3
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
J9 DIABETES CARE
JI Diabetes Care
PD FEB
PY 2006
VL 29
IS 2
BP 312
EP 316
DI 10.2337/diacare.29.02.06.dc05-1067
PG 5
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 011KJ
UT WOS:000235266700022
PM 16443879
OA Bronze
DA 2019-01-08
ER

PT J
AU Pouwer, F
   Beekman, ATF
   Lubach, C
   Snoek, FJ
AF Pouwer, F
   Beekman, ATF
   Lubach, C
   Snoek, FJ
TI Nurses' recognition and registration of depression, anxiety and
   diabetes-specific emotional problems in outpatients with diabetes
   mellitus
SO PATIENT EDUCATION AND COUNSELING
LA English
DT Article
DE diabetes; depression; anxiety; nurses; recognition
ID HOSPITAL ANXIETY; CONTROLLED-TRIAL; PRIMARY-CARE; PROBLEM AREAS; SCALE;
   PREVALENCE; DISTRESS; DISORDERS; QUALITY; UTILITY
AB Objective: The aim of this study was to investigate how often emotional problems were recognized and registered by diabetes nurses.
   Methods: We studied medical charts and questionnaire data of 112 diabetes patients. The hospital anxiety, depression scale and the problem areas in diabetes survey were used to measure anxiety, depression and diabetes-specific emotional distress.
   Results: In patients with moderate to severe levels of anxiety or depression, the presence of an emotional problem was recorded in the medical chart in 20-25% of the cases. The registration-rate of diabetes-specific emotional distress was also found to be low, ranging from 0% (treatment-related problems) to 29% (diabetes-related emotional problems).
   Conclusion: Registration-rates of emotional problems by diabetes nurses were found to be low, but quite similar to detection rates of physicians and nurses in studies with non-diabetic samples.
   Practice implications: These findings suggest that recognition-rates of emotional problems in diabetes patients need to be increased. Future studies should investigate whether recognition and subsequent treatment of emotional problems in diabetes patients can be facilitated by utilizing validated, standardized self-report questionnaires. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
C1 Vrije Univ Amsterdam, Med Ctr, Dept Psychol Med, Inst Res Extramural Med EMGO, NL-1081 BT Amsterdam, Netherlands.
   Vrije Univ Amsterdam, Med Ctr, Ctr Diabet, NL-1081 BT Amsterdam, Netherlands.
RP Pouwer, F (reprint author), Vrije Univ Amsterdam, Med Ctr, Dept Psychol Med, Inst Res Extramural Med EMGO, Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.
EM f.pouwer@vumc.nl
CR Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   BAKKER K, 2004, PRACT DIAB INT, V21, P88
   Chew-Graham CA, 2002, FAM PRACT, V19, P632, DOI 10.1093/fampra/19.6.632
   Dalton CC, 2003, J ADV NURS, V42, P108, DOI 10.1046/j.1365-2648.2003.02593.x
   Hansen MS, 2001, J PSYCHOSOM RES, V50, P199, DOI 10.1016/S0022-3999(00)00230-0
   Herrmann C, 1997, J PSYCHOSOM RES, V42, P17, DOI 10.1016/S0022-3999(96)00216-4
   Jacobson AM, 1997, QUAL LIFE RES, V6, P11
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   LUSTMAN PJ, 1987, COMPR PSYCHIAT, V28, P22, DOI 10.1016/0010-440X(87)90040-X
   Lustman PJ, 2000, DIABETES CARE, V23, P618, DOI 10.2337/diacare.23.5.618
   Lustman PJ, 1998, ANN INTERN MED, V129, P613, DOI 10.7326/0003-4819-129-8-199810150-00005
   McDonald M V, 1999, Oncol Nurs Forum, V26, P593
   Murata GH, 2003, DIABETOLOGIA, V46, P1170, DOI 10.1007/s00125-003-1161-1
   Plummer SE, 2000, PSYCHOL MED, V30, P1233, DOI 10.1017/S0033291799002597
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Pouwer F, 2003, DIABETOLOGIA, V46, P892, DOI 10.1007/s00125-003-1124-6
   Pouwer F, 1998, QUAL LIFE RES, V7, P33
   Pouwer F, 2001, DIABETES CARE, V24, P1929, DOI 10.2337/diacare.24.11.1929
   Rubin RR, 2001, J CLIN PSYCHOL, V57, P457, DOI 10.1002/jclp.1041
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Spinhoven P, 1997, PSYCHOL MED, V27, P363, DOI 10.1017/S0033291796004382
   Teresi J, 2001, SOC PSYCH PSYCH EPID, V36, P613, DOI 10.1007/s127-001-8202-7
   Thompson C, 2000, LANCET, V355, P185, DOI 10.1016/S0140-6736(99)03171-2
   Valenstein M, 2001, ANN INTERN MED, V134, P345, DOI 10.7326/0003-4819-134-5-200103060-00007
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
NR 26
TC 63
Z9 64
U1 0
U2 10
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0738-3991
J9 PATIENT EDUC COUNS
JI Patient Educ. Couns.
PD FEB
PY 2006
VL 60
IS 2
BP 235
EP 240
DI 10.1016/j.pec.2005.01.009
PG 6
WC Public, Environmental & Occupational Health; Social Sciences,
   Interdisciplinary
SC Public, Environmental & Occupational Health; Social Sciences - Other
   Topics
GA 012SG
UT WOS:000235359100020
PM 16442465
DA 2019-01-08
ER

PT J
AU Adriaanse, MC
   Snoek, FJ
AF Adriaanse, MC
   Snoek, FJ
TI The psychological impact of screening for type 2 diabetes
SO DIABETES-METABOLISM RESEARCH AND REVIEWS
LA English
DT Review
DE type 2 diabetes; screening; impact diagnosis; health-related quality of
   life
ID QUALITY-OF-LIFE; CARDIOVASCULAR RISK; GENERAL-PRACTICE; PERCEIVED RISK;
   DIAGNOSIS; SYMPTOMS; MELLITUS; PROGRAM; OPPORTUNITIES; CONSEQUENCES
AB Until recently, there was little empirical data regarding the psychological impact of screening for type 2 diabetes. There is now some progress in this area, as evidenced by emerging population based studies reporting on the effects of screening for type 2 diabetes on perceived health status and well-being.
   Recent studies from our own and other groups show that the diagnosis type 2 diabetes has no substantial adverse or positive effect on the participants' perceived health status and well-being after notification of the test result. Importantly, screening-detected type 2 diabetes patients beforehand perceive their risk for type 2 diabetes to be low, despite the presence of risk factors, such as obesity, hypertension and a family history, and overall report low levels of diabetes-related symptom distress. Yet, screening-detected type 2 diabetes patients were bothered more by symptoms of hyperglycaernia and fatigue in the first year following diagnosis type 2 diabetes than non-diabetics.
   On the basis of research to date, we conclude that screening for type 2 diabetes in the general population has no serious psychological side effects. Whether lack of emotional response to screening, is because of unawareness or indifference, needs further investigation. Future studies should be aiming towards a better understanding of how to raise the awareness and understanding of type 2 diabetes and its risk factors in high-risk individuals, while avoiding or minimizing negative effects, such as emotional distress and denial. The growing number of younger people developing type 2 diabetes warrants further research into labeling effects of an early diagnosis. Copyright (c) 2005 John Wiley & Sons, Ltd.
C1 Vrije Univ Amsterdam, Inst Hlth Sci, Fac Earth & Life Sci, NL-1081 HV Amsterdam, Netherlands.
   Vrije Univ Amsterdam, Med Ctr, EMGO Inst, NL-1081 HV Amsterdam, Netherlands.
   Vrije Univ Amsterdam, Med Ctr, Dept Psychol Med, NL-1081 HV Amsterdam, Netherlands.
RP Adriaanse, MC (reprint author), Vrije Univ Amsterdam, Inst Hlth Sci, Fac Earth & Life Sci, De Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands.
EM marcel.adriaanse@falw.vu.nl
CR Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3
   Adriaanse MC, 2005, QUAL LIFE RES, V14, P1501, DOI 10.1007/s11136-004-0028-3
   Adriaanse MC, 2004, DIABETIC MED, V21, P1075, DOI 10.1111/j.1464-5491.2004.01277.x
   Adriaanse MC, 2004, DIABETIC MED, V21, P992, DOI 10.1111/j.1464-5491.2004.01276.x
   Adriaanse MC, 2003, DIABETIC MED, V20, P210, DOI 10.1046/j.1464-5491.2003.00901.x
   Adriaanse MC, 2002, DIABETIC MED, V19, P406
   BASTIAN H, 1999, COCHRANE LIB, V2
   BERRY D, 2004, RISK COMMUNICATION H, P125
   Borch-Johnsen K, 2003, DIABETIC MED, V20, P175, DOI 10.1046/j.1464-5491.2003.00842.x
   Carey Marian, 2004, Prof Nurse, V20, P37
   Croyle RT, 1997, HEALTH PSYCHOL, V16, P63, DOI 10.1037//0278-6133.16.1.63
   Edelman D, 2002, DIABETES CARE, V25, P1022, DOI 10.2337/diacare.25.6.1022
   Fagot-Campagna A, 2000, J PEDIATR-US, V136, P664, DOI 10.1067/mpd.2000.105141
   Farmer AJ, 2003, DIABETIC MED, V20, P996, DOI 10.1046/j.1464-5491.2003.01042.x
   Farmer AJ, 1999, DIABETIC MED, V16, P233, DOI 10.1046/j.1464-5491.1999.00042.x
   Fisher EB, 2002, DIABETES CARE, V25, P599, DOI 10.2337/diacare.25.3.599
   Fox C, 2003, BRIT MED J, V327, P1120, DOI 10.1136/bmj.327.7424.1120
   Goyder EC, 2000, DIABETIC MED, V17, P469, DOI 10.1046/j.1464-5491.2000.00308.x
   Griffin SJ, 2000, DIABETES METAB RES, V16, P164, DOI 10.1002/1520-7560(200005/06)16:3<164::AID-DMRR103>3.0.CO;2-R
   HARRIS MI, 1993, DIABETES CARE, V16, P642, DOI 10.2337/diacare.16.4.642
   HAYNES RB, 1978, NEW ENGL J MED, V299, P741, DOI 10.1056/NEJM197810052991403
   JACKSON DMA, 1991, DIABETIC MED, V8, P971, DOI 10.1111/j.1464-5491.1991.tb01540.x
   JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101
   KNOWLER WC, 1994, DIABETES CARE, V17, P445, DOI 10.2337/diacare.17.5.445
   Leventhal H., 1997, PERCEPTIONS HLTH ILL, P19
   Lindholt JS, 2000, EUR J VASC ENDOVASC, V20, P79, DOI 10.1053/ejvs.1999.1087
   Marshall KG, 1999, CAN MED ASSOC J, V160, P1592
   Marteau TM, 2002, BRIT MED J, V325, P78, DOI 10.1136/bmj.325.7355.78
   Parry O, 2004, FAM PRACT, V21, P131, DOI 10.1093/fampra/cmh203
   Peel E, 2004, PATIENT EDUC COUNS, V53, P269, DOI 10.1016/j.pec.2003.07.010
   Pouwer F, 1999, DIABETES CARE, V22, P2004, DOI 10.2337/diacare.22.12.2004
   PUGH K, 1994, PSYCHOL MED, V24, P897, DOI 10.1017/S0033291700028981
   SKINNER TC, 2005, IN PRESS DIABET MED
   TIBBEN A, 1994, PSYCHOSOM MED, V56, P526, DOI 10.1097/00006842-199411000-00008
   TYMSTRA T, 1987, FAM PRACT, V4, P287, DOI 10.1093/fampra/4.4.287
   *UK PROSP DIAB STU, 1990, DIABETES RES, V13, P1
   van der Pligt J, 1998, BRIT J HEALTH PSYCH, V3, P1
   VanderDoes FEE, 1996, DIABETES CARE, V19, P204, DOI 10.2337/diacare.19.3.204
   Wiegand S, 2004, EUR J ENDOCRINOL, V151, P199, DOI 10.1530/eje.0.1510199
   Wilson J, 1968, PRINCIPLES PRACTICE
NR 40
TC 36
Z9 36
U1 1
U2 5
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 1520-7552
J9 DIABETES-METAB RES
JI Diabetes-Metab. Res. Rev.
PD JAN-FEB
PY 2006
VL 22
IS 1
BP 20
EP 25
DI 10.1002/dmrr.590
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 006KC
UT WOS:000234895400003
PM 16142814
DA 2019-01-08
ER

PT J
AU Gabbay, RA
   Lendel, I
   Saleem, TM
   Shaeffer, G
   Adelman, AM
   Mauger, DT
   Collins, M
   Polomano, RC
AF Gabbay, RA
   Lendel, I
   Saleem, TM
   Shaeffer, G
   Adelman, AM
   Mauger, DT
   Collins, M
   Polomano, RC
TI Nurse case management improves blood pressure, emotional distress and
   diabetes complication screening
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE hypertension; nurse case management; emotional distress; disease
   management
ID HEALTH MAINTENANCE ORGANIZATION; RANDOMIZED CONTROLLED-TRIAL;
   MICROVASCULAR COMPLICATIONS; DISEASE MANAGEMENT; COST-EFFECTIVENESS;
   GLYCEMIC CONTROL; PROBLEM AREAS; CARE; HYPERTENSION; OUTCOMES
AB We studied the impact of nurse case management (NCM) on blood pressure (BP), hemoglobin A1C, lipids, and diabetes complication screening.
   A I-year randomized-controlled trial was conducted in two primary care clinics of the Penn State Hershey Medical Center. Diabetes patients were randomized to control group (CG) (n = 182) who received usual care by their primary care provider and intervention group (IG) (n = 150) who received additional NCM care, including self-management education, and implementation of diabetes guidelines. Primary outcomes included BP, A1C, lipid, process measures, and secondary outcome was diabetes-related emotional distress as assessed by Problem Areas in Diabetes (PAID).
   BP significantly decreased from 137/77 to 129/72 in IG as compared to an increase from 136/77 to 138/79 in CG after I year. PAID scores improved significantly in IG (from 23 to 10) due to reduced emotional stress. A1C (7.4) and LDL (105) were unaffected. Complications screening significantly improved in IG compared to CG: opthalmologic exam 26 to 68%, foot exam 47 to 64%, and nephropathy screening 34 to 72%.
   NCM improved BP, diabetes-related emotional distress, and process measures in primary care. Unchanged A 1 C and lipids might be due to a threshold effect. Intervention based upon initial risk assessment may prove more cost-effective. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
C1 Penn State Univ, Penn State Diabet Ctr, Dept Endocrinol Diabet & Metab, Hershey, PA 17033 USA.
   Penn State Univ, Coll Med, Dept Endocrinol Diabet & Metab, Hershey, PA 17033 USA.
   Penn State Coll Med, Dept Family & Community Med, Hershey, PA 17033 USA.
   Penn State Univ, Coll Med, Dept Hlth Evaluat Sci, Hershey, PA 17033 USA.
   Univ Penn, Sch Nursing, Philadelphia, PA USA.
RP Gabbay, RA (reprint author), Penn State Univ, Penn State Diabet Ctr, Dept Endocrinol Diabet & Metab, 500 Univ Dr,H044, Hershey, PA 17033 USA.
EM rgabbay@psu.edu
CR Adler AI, 2000, BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412
   *AM DIAB ASS, 2003, DIABETES CARE, V6, P917
   *AM NURS ASS, 2001, NURS CAS MAN
   American Diabetes Association, 2004, DIABETES CARE S1, V27, pS15
   Aubert RE, 1998, ANN INTERN MED, V129, P605, DOI 10.7326/0003-4819-129-8-199810150-00004
   CHEN A, 2000, BEST PRACTICES COORD
   Clark CM, 2001, DIABETES CARE, V24, P1079, DOI 10.2337/diacare.24.6.1079
   Davidson MB, 2003, DIABETES CARE, V26, P2281, DOI 10.2337/diacare.26.8.2281
   Denver EA, 2003, DIABETES CARE, V26, P2256, DOI 10.2337/diacare.26.8.2256
   Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6
   Hoerger TJ, 2002, JAMA-J AM MED ASSOC, V287, P2542
   Ibrahim IA, 2002, SOUTHERN MED J, V95, P78
   *NCEP EXP PAN DET, 2002, CIRCULATION, V106, P3143
   New JP, 2003, DIABETES CARE, V26, P2250, DOI 10.2337/diacare.26.8.2250
   Norris SL, 2002, AM J PREV MED, V22, P15, DOI 10.1016/S0749-3797(02)00423-3
   Norris SL, 2002, AM J PREV MED, V22, P39, DOI 10.1016/S0749-3797(02)00424-5
   Peters AL, 1998, DIABETES CARE, V21, P1037, DOI 10.2337/diacare.21.7.1037
   RENDERS CM, 2003, COCHRANE LIBR, V3, P1
   Rubin RJ, 1998, J CLIN ENDOCR METAB, V83, P2635, DOI 10.1210/jc.83.8.2635
   Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O
   Saaddine JB, 2002, ANN INTERN MED, V136, P565, DOI 10.7326/0003-4819-136-8-200204160-00005
   Sadur CN, 1999, DIABETES CARE, V22, P2011, DOI 10.2337/diacare.22.12.2011
   Sidorov J, 2000, AM J MANAG CARE, V6, P1217
   Stratton IM, 2000, BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405
   Taylor CB, 2003, DIABETES CARE, V26, P1058, DOI 10.2337/diacare.26.4.1058
   Venning P, 2000, BMJ-BRIT MED J, V320, P1048, DOI 10.1136/bmj.320.7241.1048
   WAGNER EH, 2001, DIABETES CARE, V25, P695
   Welch G, 2003, DIABETIC MED, V20, P69, DOI 10.1046/j.1464-5491.2003.00832.x
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   Zander Karen, 2002, Nurs Adm Q, V26, P58
NR 30
TC 65
Z9 65
U1 0
U2 9
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD JAN
PY 2006
VL 71
IS 1
BP 28
EP 35
DI 10.1016/j.diabres.2005.05.002
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 005KW
UT WOS:000234822100004
PM 16019102
DA 2019-01-08
ER

PT J
AU Ford-Dunn, S
   Smith, A
   Quin, J
AF Ford-Dunn, S
   Smith, A
   Quin, J
TI Management of diabetes during the last days of life: attitudes of
   consultant diabetologists and consultant palliative care physicians in
   the UK
SO PALLIATIVE MEDICINE
LA English
DT Article
DE diabetes; dying; withdrawing treatment
ID ADVANCED CANCER
AB Diabetes is an increasingly common condition and hence, managing dying patients with diabetes as a co-morbidity will become a frequent challenge. It is uncertain whether there is net beneficence in preventing hyperglycaemia in diabetic patients during the terminal phase or whether the distress involved in administering therapy and blood glucose monitoring may outweigh this ordeal. Since there is no available evidence upon which to base clinical decisions, a semi-structured questionnaire based around three clinical vignettes was sent to consultants in diabetes and palliative care in the UK. There was consensus of opinion from both groups of consultants that treatment and monitoring should be stopped in patients with type 2 diabetes, once in the terminal phase. There was less consensus regarding management of type 1 diabetes. Practical issues were raised by both groups of consultants and clinical guidelines are suggested.
RP Ford-Dunn, S (reprint author), St Barnabas Hosp, Columbia Dr, Worthing, W Sussex, England.
EM suzanne_fd@hotmail.com
CR Boyd Kirsty, 1993, Palliative Medicine, V7, P163
   British Diabetes Association, 1999, GUID PRACT RES DIAB
   Edmonds P, 2003, CLIN MED, V3, P149, DOI 10.7861/clinmedicine.3-2-149
   Ford-Dunn S, 2004, PALLIATIVE MED, V18, P161
   Ford-Dunn S., 2004, DIABETIC MED, V21, P83
   *GEN MED COUNC, 2002, WITH WITHDR LIF PROL
   Lamont EB, 1999, ONCOLOGY-NY, V13, P1165
   McCoubrie R, 2005, EUR J CANCER CARE, V14, P244, DOI 10.1111/j.1365-2354.2005.00564.x
   Poulson J, 1997, J PAIN SYMPTOM MANAG, V13, P339, DOI 10.1016/S0885-3924(96)00326-0
   Turner HE, 2002, OXFORD HDB ENDOCRINO
   Warren RE, 2003, DIABETES-METAB RES, V19, P408, DOI 10.1002/dmrr.396
NR 11
TC 25
Z9 25
U1 0
U2 2
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0269-2163
EI 1477-030X
J9 PALLIATIVE MED
JI Palliat. Med.
PY 2006
VL 20
IS 3
BP 197
EP 203
DI 10.1191/0269216306pm1128oa
PG 7
WC Health Care Sciences & Services; Public, Environmental & Occupational
   Health; Medicine, General & Internal
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health; General & Internal Medicine
GA 038MD
UT WOS:000237224300006
PM 16764224
DA 2019-01-08
ER

PT S
AU Vgontzas, AN
   Bixler, EO
   Chrousos, GP
AF Vgontzas, Alexandros N.
   Bixler, Edward O.
   Chrousos, George P.
BE Chrousos, GP
   Tsigos, C
TI Obesity-related sleepiness and fatigue - The role of the stress system
   and cytokines
SO STRESS, OBESITY, AND METABOLIC SYNDROME
SE ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
LA English
DT Article; Proceedings Paper
CT Bjorntorp Symposium on Stress, Obesity, and Metabolic Syndrome
CY APR 09-10, 2005
CL Athens, GREECE
SP Roche Hellas, Abbott Hellas, Pfizer Hellas, Sanofi Aventis Hellas, GlaxoSmithKline Hellas
DE obesity; sleepiness; fatigue; stress; cytokines; cortisol
ID EXCESSIVE DAYTIME SLEEPINESS; PITUITARY-ADRENAL AXIS;
   POLYCYSTIC-OVARY-SYNDROME; PRADER-WILLI-SYNDROME; BODY-FAT DISTRIBUTION;
   YOUNG-ADULTS; INSULIN-RESISTANCE; CHRONIC INSOMNIA; BREATHING DISORDERS;
   GENERAL-POPULATION
AB Obesity has epidemic proportions in Western societies and, because of its significant association with morbidity and mortality, is a major public health issue. Excessive daytime sleepiness (EDS) and fatigue (tiredness without increased sleep propensity)-which have been associated with obesity-have a significant impact on individual wellbeing and public safety. In this article, we review data that challenge the belief that sleep apnea and sleep disruption per se are the primary determinants of obesity-related daytime sleepiness and fatigue. Specifically, it appears that obesity per se is associated with objective and subjective daytime sleepiness compared to normal-weight controls regardless of sleep apnea and sleep loss. Indeed, obese patients without sleep apnea are sleepier compared to nonobese controls whereas within the morbidly obese, those who have high sleep efficiency at night are sleepier than those who have low sleep efficiency. In addition, in recent studies based on large random samples of the general population, the primary determinants of subjective EDS were depression and metabolic disturbances, that is, obesity/diabetes, and not sleep apnea or objective sleep disruption. Furthermore, sleepiness and fatigue are very prevalent in conditions associated with insulin resistance, for instance, the polycystic ovary syndrome (PCOS), independently of sleep apnea or obesity, or in conditions of insufficient physical activity. On the basis of these data, we propose that obesity-related objective daytime sleepiness and fatigue are associated primarily with metabolic and psychological factors and less with sleep apnea and sleep disruption per se. Furthermore, we suggest that objective sleepiness is primarily related to metabolic factors, whereas fatigue appears to be related to psychological distress. Finally, based on data from studies in normal controls and patients with sleep disorders, we propose that the interaction of the hypothalamic-pituitary-adrenal (HPA) axis and proinflammatory cytokines determines the level of sleep/arousal within the 24-h cycle, that is, "hypercortisolemia" plus hypercytokinemia is associated with low sleep efficiency and fatigue, whereas "eucortisolemia" or "hypocortisolemia" plus hypercytokinemia is associated with high sleep efficiency and objective sleepiness.
C1 Penn State Univ, Coll Med, Dept Psychiat, Sleep Res & Treatment Ctr, Hershey, PA 17033 USA.
   NICHD, Reprod Biol & Med Branch, NIH, Bethesda, MD 20892 USA.
   Univ Athens, Sch Med, Dept Pediat 1, GR-11527 Athens, Greece.
   Univ Athens, Sch Med, Unit Endocrinol Metab & Diabet, GR-11527 Athens, Greece.
RP Vgontzas, AN (reprint author), Penn State Univ, Coll Med, Dept Psychiat, Sleep Res & Treatment Ctr, H073,500 Univ Dr, Hershey, PA 17033 USA.
EM avgontzas@psu.edu
CR Vgontzas AN, 2006, SLEEP, V29, pA314
   Bixler EO, 1998, AM J RESP CRIT CARE, V157, P144, DOI 10.1164/ajrccm.157.1.9706079
   Bixler EO, 2005, J CLIN ENDOCR METAB, V90, P4510, DOI 10.1210/jc.2005-0035
   BIXLER EO, 1979, AM J PSYCHIAT, V136, P1257
   Bixler EO, 2001, AM J RESP CRIT CARE, V163, P608, DOI 10.1164/ajrccm.163.3.9911064
   Bjorntorp P, 1997, LANCET, V350, P423, DOI 10.1016/S0140-6736(97)04503-0
   Breslau N, 1997, AM J PUBLIC HEALTH, V87, P1649, DOI 10.2105/AJPH.87.10.1649
   BUYSSE DJ, 2006, IN PRESS SLEEP
   Chrousos GP, 2000, INT J OBESITY, V24, pS50, DOI 10.1038/sj.ijo.0801278
   Chrousos GP, 1998, J CLIN ENDOCR METAB, V83, P1842, DOI 10.1210/jc.83.6.1842
   Chugh DK, 2002, SLEEP APNEA PATHOGEN, P265
   Dunaif A, 1997, ENDOCR REV, V18, P774, DOI 10.1210/er.18.6.774
   FEINBERG I, 1993, SLEEP, V16, P82
   Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723
   Flemons WW, 1999, SLEEP, V22, P667
   Fogel RB, 2001, J CLIN ENDOCR METAB, V86, P1175, DOI 10.1210/jc.86.3.1175
   FORD DE, 1989, JAMA-J AM MED ASSOC, V262, P1479, DOI 10.1001/jama.262.11.1479
   Goodman E, 2002, PEDIATRICS, V110, P497, DOI 10.1542/peds.110.3.497
   Gopal Mira, 2002, Sleep Med, V3, P401, DOI 10.1016/S1389-9457(02)00033-3
   Gottlieb DJ, 1999, AM J RESP CRIT CARE, V159, P502, DOI 10.1164/ajrccm.159.2.9804051
   GUILLEMINAULT C, 1993, CHEST, V104, P781, DOI 10.1378/chest.104.3.781
   Gupta NK, 2002, AM J HUM BIOL, V14, P762, DOI 10.1002/ajhb.10093
   Hasler G, 2005, MOL PSYCHIATR, V10, P842, DOI 10.1038/sj.mp.4001671
   Hasler G, 2005, J CLIN PSYCHIAT, V66, P521, DOI 10.4088/JCP.v66n0416
   Hasler G, 2004, SLEEP, V27, P661, DOI 10.1093/sleep/27.4.661
   Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847
   HOCH CC, 1992, NEUROBIOL AGING, V13, P353, DOI 10.1016/0197-4580(92)90049-4
   Jenkins JB, 2006, PHYSIOL BEHAV, V87, P255, DOI 10.1016/j.physbeh.2005.10.010
   MARIN P, 1992, METABOLISM, V41, P882, DOI 10.1016/0026-0495(92)90171-6
   MARTIKAINEN K, 1992, ACTA NEUROL SCAND, V86, P337, DOI 10.1111/j.1600-0404.1992.tb05097.x
   McElroy SL, 2004, J CLIN PSYCHIAT, V65, P634
   MONTSERRAT JP, 2001, AM J RESP CRIT CARE, V163, P344
   Mullington J, 2000, AM J PHYSIOL-REG I, V278, pR947
   *NAT SLEEP FDN, 2001, OMN SLEEP AM POLL
   Ohayon MM, 1997, ARCH INTERN MED, V157, P2645, DOI 10.1001/archinte.157.22.2645
   Pack AI, 2001, AM J RESP CRIT CARE, V164, P1675, DOI 10.1164/ajrccm.164.9.2103032
   PASQUALI R, 1993, J CLIN ENDOCR METAB, V77, P341, DOI 10.1210/jc.77.2.341
   Peppard PE, 2000, JAMA-J AM MED ASSOC, V284, P3015, DOI 10.1001/jama.284.23.3015
   Pine DS, 1997, AM J PUBLIC HEALTH, V87, P1303, DOI 10.2105/AJPH.87.8.1303
   Punjabi NM, 2003, SLEEP, V26, P678
   Punjabi NM, 1999, AM J RESP CRIT CARE, V159, P1703, DOI 10.1164/ajrccm.159.6.9808095
   Redline S, 1998, AM J RESP CRIT CARE, V157, P858, DOI 10.1164/ajrccm.157.3.9709042
   Resnick HE, 2006, J CLIN SLEEP MED, V2, P163
   Resta O, 2003, J INTERN MED, V253, P536, DOI 10.1046/j.1365-2796.2003.01133.x
   Resta O, 2001, INT J OBESITY, V25, P669, DOI 10.1038/sj.ijo.0801603
   REYNOLDS CF, 1991, J AM GERIATR SOC, V39, P957
   ROEHRS T, 2000, PRINCIPLES PRACTICE, P43
   Rosmond R, 1998, J CLIN ENDOCR METAB, V83, P1853, DOI 10.1210/jc.83.6.1853
   Sekine M, 2002, CHILD CARE HLTH DEV, V28, P163, DOI 10.1046/j.1365-2214.2002.00260.x
   Spath-Schwalbe E, 1998, J CLIN ENDOCR METAB, V83, P1573, DOI 10.1210/jc.83.5.1573
   Spiegel K, 2004, ANN INTERN MED, V141, P846, DOI 10.7326/0003-4819-141-11-200412070-00008
   Stunkard AJ, 2003, BIOL PSYCHIAT, V54, P330, DOI 10.1016/S0006-3223(03)00608-5
   Taheri S, 2004, PLOS MED, V1, P210, DOI 10.1371/journal.pmed.0010062
   Tasali E, 2006, J CLIN ENDOCR METAB, V91, P36, DOI 10.1210/jc.2005-1084
   Theorell-Haglow J, 2006, SLEEP, V29, P751, DOI 10.1093/sleep/29.6.751
   Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117
   VELABUENO A, 1984, ARCH NEUROL-CHICAGO, V41, P294, DOI 10.1001/archneur.1984.04050150072020
   Vgontzas AN, 2002, ENDOCRIN METAB CLIN, V31, P15, DOI 10.1016/S0889-8529(01)00005-6
   Vgontzas AN, 1996, AM J MED GENET, V67, P478
   Vgontzas AN, 1999, ANNU REV MED, V50, P387
   Vgontzas AN, 2003, J CLIN ENDOCR METAB, V88, P2087, DOI 10.1210/jc.2002-021176
   Vgontzas AN, 2004, J CLIN ENDOCR METAB, V89, P2119, DOI 10.1210/jc.2003-031562
   VGONTZAS AN, 1994, ARCH INTERN MED, V154, P1705, DOI 10.1001/archinte.154.15.1705
   Vgontzas AN, 1998, J PSYCHOSOM RES, V45, P21, DOI 10.1016/S0022-3999(97)00302-4
   Vgontzas AN, 2005, SLEEP, V28, pA202
   Vgontzas AN, 2005, NEUROIMMUNOMODULAT, V12, P131, DOI 10.1159/000084844
   Vgontzas AN, 1999, J CLIN ENDOCR METAB, V84, P2603, DOI 10.1210/jc.84.8.2603
   Vgontzas AN, 2001, J CLIN ENDOCR METAB, V86, P3787, DOI 10.1210/jc.86.8.3787
   Vgontzas AN, 1998, ARCH INTERN MED, V158, P1333, DOI 10.1001/archinte.158.12.1333
   VGONTZAS AN, 1995, ACTA PAEDIATR, V84, P813, DOI 10.1111/j.1651-2227.1995.tb13764.x
   Vgontzas AN, 1997, J CLIN ENDOCR METAB, V82, P1313, DOI 10.1210/jc.82.5.1313
   Vgontzas AN, 2002, METABOLISM, V51, P887, DOI 10.1053/meta.2002.33357
   Vgontzas AN, 2001, J CLIN ENDOCR METAB, V86, P517, DOI 10.1210/jc.86.2.517
   Vgontzas AN, 2000, PSYCHOSOM MED, V62, P220, DOI 10.1097/00006842-200003000-00013
   Vgontzas AN, 2000, J CLIN ENDOCR METAB, V85, P1151, DOI 10.1210/jc.85.3.1151
   VGONTZAS AN, 2005, 87 ANN M END SOC SAN
   Vicennati V, 2000, J CLIN ENDOCR METAB, V85, P4093, DOI 10.1210/jc.85.11.4093
   von Kries R, 2002, INT J OBESITY, V26, P710, DOI 10.1038/sj/ijo/0801980
   Vorona RD, 2005, ARCH INTERN MED, V165, P25, DOI 10.1001/archinte.165.1.25
   WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991
   Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080
   YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704
NR 82
TC 103
Z9 105
U1 0
U2 14
PU BLACKWELL SCIENCE PUBL
PI OXFORD
PA OSNEY MEAD, OXFORD OX2 0EL, ENGLAND
SN 0077-8923
BN 978-1-57331-625-5
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 2006
VL 1083
BP 329
EP 344
DI 10.1196/annals.1367.023
PG 16
WC Endocrinology & Metabolism; Multidisciplinary Sciences
SC Endocrinology & Metabolism; Science & Technology - Other Topics
GA BFR90
UT WOS:000244102900021
PM 17148748
DA 2019-01-08
ER

PT J
AU Skelly, AH
   Carlson, JR
   Leeman, J
   Holditch-Davis, D
   Soward, ACM
AF Skelly, AH
   Carlson, JR
   Leeman, J
   Holditch-Davis, D
   Soward, ACM
TI Symptom-focused management for African American women with type 2
   diabetes: a pilot study
SO APPLIED NURSING RESEARCH
LA English
DT Article
ID INTERVENTION; HEALTH
AB The purpose of this pilot study was to test the effectiveness of an in-home, nurse-delivered, symptom-focused teaching/counseling intervention with older rural African American women who have type 2 diabetes. Forty-one participants were randomly assigned to either the intervention or the comparison group. Participants in the intervention showed statistically significant improvement in their medication, diet, home glucose monitoring self-care practices, perceptions of quality of life, and distress from symptoms. Both groups evidenced improvement of HbA(1c) levels. The intervention group achieved greater improvement, but the difference was not statistically significant. Participant satisfaction was high. Further studies should look into the cost of the intervention, as compared with that of usual care, and its long-term effects. (c) 2005 Elsevier Inc. All rights reserved.
C1 Univ N Carolina, Sch Nursing, Chapel Hill, NC 27599 USA.
RP Skelly, AH (reprint author), Univ N Carolina, Sch Nursing, Chapel Hill, NC 27599 USA.
EM askelly@email.unc.edu
OI Leeman, Jennifer/0000-0003-3130-8297
CR Arshag D. M., 1999, DIABETES SPECTRUM, V12, P70
   BROWN SA, 1994, NURS RES, V43, P362
   Elasy TA, 2000, DIABETES CARE, V23, P325, DOI 10.2337/diacare.23.3.325
   Fitzgerald JT, 1998, DIABETES CARE, V21, P706, DOI 10.2337/diacare.21.5.706
   HALTER J, 2004, THERAPY DIABETES MEL, P259
   Keyserling TC, 2002, DIABETES CARE, V25, P1576, DOI 10.2337/diacare.25.9.1576
   Larson P. J., 1994, IMAGE J NURSING SCHO, V26, P272, DOI DOI 10.1111/JNU.1994.26.ISSUE-4
   LEBOVITZ H, 1998, THERAPY DIABETES REL
   Miles MS, 2003, NURS RES, V52, P350, DOI 10.1097/00006199-200311000-00002
   MITCHELL J, 2002, SERVING OLDER ADULTS, P36
   Samuel-Hodge CD, 2000, DIABETES CARE, V23, P928, DOI 10.2337/diacare.23.7.928
   SKELLY AH, 1995, DIABETES EDUCATOR, V21, P38, DOI 10.1177/014572179502100107
   Stearne MR, 1998, BRIT MED J, V317, P703
   Stover JC, 2001, APPL NURS RES, V14, P72, DOI 10.1053/apnr.2001.22372
   Teel C S, 1997, Image J Nurs Sch, V29, P175
   Williams RD, 1997, FAM COMMUNITY HEALTH, V20, P13, DOI 10.1097/00003727-199707000-00004
NR 16
TC 29
Z9 29
U1 0
U2 4
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0897-1897
EI 1532-8201
J9 APPL NURS RES
JI Appl. Nurs. Res.
PD NOV
PY 2005
VL 18
IS 4
BP 213
EP 220
DI 10.1016/j.apnr.2004.08.008
PG 8
WC Nursing
SC Nursing
GA 995BR
UT WOS:000234075400005
PM 16298697
DA 2019-01-08
ER

PT J
AU Peyrot, M
   Rubin, RR
   Lauritzen, T
   Skovlund, SE
   Snoek, FJ
   Matthews, DR
   Landgraf, RD
   Kleinebreil, L
AF Peyrot, M
   Rubin, RR
   Lauritzen, T
   Skovlund, SE
   Snoek, FJ
   Matthews, DR
   Landgraf, RD
   Kleinebreil, L
CA Int DAWN Advisory Panel
TI Resistance to insulin therapy among patients and providers - Results of
   the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study
SO DIABETES CARE
LA English
DT Article
ID PRIMARY-CARE PHYSICIANS; STARTING INSULIN; BARRIERS; SULFONYLUREAS;
   KNOWLEDGE; MELLITUS; FAILURE
AB OBJECTIVE - To examine the correlates of patient and provider attitudes toward insulin therapy.
   RESEARCH DESIGN AND METHODS - Data are from surveys of patients with type 2 diabetes not taking insulin (n = 2,061) and diabetes care providers (nurses = 1,109; physicians = 2,681) in 13 countries in Asia, Australia, Europe, and North America. Multiple regression analysis is used to identify correlates of attitudes toward insulin therapy among patients, physicians, and nurses.
   RESULTS - Patient and provider attitudes differ significantly across countries, controlling for individual characteristics. Patients rate the clinical efficacy of insulin as low and would blame themselves if they had to start insulin therapy. Self-blame is significantly lower among those who have better diet and exercise adherence and less diabetes-related distress. Patients who are not managing their diabetes well (poor perceived control, more complications, and diabetes-related distress) are significantly more likely to see insulin therapy as potentially beneficial. Most nurses and general practitioners (50 - 55%) delay insulin therapy until absolutely necessary, but specialists and opinion leaders are less likely to do so. Delay of insulin therapy is significantly less likely when physicians and nurses see their patients as more adherent to medication or appointment regimens, view insulin as more efficacious, and when they are less likely to delay oral diabetes medications.
   CONCLUSIONS - Patient and provider resistance to insulin therapy is substantial, and for providers it is part of a larger pattern of reluctance to prescribe blood glucose-lowering medication. Interventions to facilitate timely initiation of insulin therapy will need to address factors associated with this resistance.
C1 Loyola Coll, Dept Sociol, Baltimore, MD 21210 USA.
   Johns Hopkins Univ, Dept Med, Baltimore, MD USA.
   Aarhus Univ, Dept Med, Aarhus, Denmark.
   Stakeholder Relat, Bagsvaerd, Denmark.
   Vrije Univ Amsterdam, Dept Med Psychol, NL-1081 HV Amsterdam, Netherlands.
   Univ Oxford, Ctr Diabet Endocrinol & Metab, Oxford, England.
   Univ Munich, Dept Med, Munich, Germany.
   Jean Verdier Hosp, Dept Med, Bondy, France.
RP Peyrot, M (reprint author), Loyola Coll, Dept Sociol, 4501 N Charles St, Baltimore, MD 21210 USA.
EM mpeyrot@loyola.edu
CR Alberti G, 2002, PRACT DIABETES INT, V19, P22, DOI DOI 10.1002/PDI.305/PDF
   BASHOFF EC, 1995, POSTGRAD MED, V97, P86
   Brown JB, 2004, DIABETES CARE, V27, P1535, DOI 10.2337/diacare.27.7.1535
   BUCHSBAUM DG, 1990, TEACH LEARN MED, V2, P30
   CORMACK MA, 1992, FAM PRACT, V9, P466, DOI 10.1093/fampra/9.4.466
   Dailey GE, 2005, DIABETES CARE, V28, P220, DOI 10.2337/diacare.28.1.220
   Davidson MB, 2005, DIABETES CARE, V28, P222, DOI 10.2337/diacare.28.1.222
   DAVIS DA, 1995, JAMA-J AM MED ASSOC, V274, P700
   DeWitt DE, 2003, JAMA-J AM MED ASSOC, V289, P2254, DOI 10.1001/jama.289.17.2254
   FREMANTLE N, DIABETES CARE, V28, P427
   Funnell MM, 2004, DIABETES EDUCATOR, V30, P274, DOI 10.1177/014572170403000220
   GLICKMAN L, 1994, J AM GERIATR SOC, V42, P992, DOI 10.1111/j.1532-5415.1994.tb06594.x
   HADSALL RS, 1982, SOC SCI MED, V16, P1747, DOI 10.1016/0277-9536(82)90268-4
   Home PD, 2003, PRACTICAL DIABETES I, V20, P63
   Hunt LM, 1997, DIABETES CARE, V20, P292, DOI 10.2337/diacare.20.3.292
   Isacsson G, 1996, Ann Clin Psychiatry, V8, P153, DOI 10.3109/10401239609147752
   KOERBEL G, 2003, PRACTICAL DIABETOLOG, V22, P36
   Korytkowski M, 2002, INT J OBESITY, V26, pS18, DOI 10.1038/sj.ijo.0802173
   Larme AC, 1998, DIABETES CARE, V21, P1391, DOI 10.2337/diacare.21.9.1391
   LARUE F, 1995, CANCER, V76, P2375, DOI 10.1002/1097-0142(19951201)76:11<2375::AID-CNCR2820761129>3.0.CO;2-C
   LAURITZEN T, 2001, UEMO CLIN J, V1, P36
   LESLIE CA, 1994, DIABETES SPECTRUM, V7, P52
   LESLIE CA, 1995, J NEW DEV CLIN MED, V13, P21
   MIRELA BP, 2004, DIABETOLOGIA, V47, pA335
   MIRELA BP, 2004, PRACTICAL DIABETES I, V21, P247
   Mollema ED, 2000, DIABETES CARE, V23, P765, DOI 10.2337/diacare.23.6.765
   Nyman M A, 2000, Eff Clin Pract, V3, P205
   Okazaki K, 1999, DIABETES, V48, pA319
   Paredes P, 1996, SOC SCI MED, V42, P1141, DOI 10.1016/0277-9536(95)00387-8
   Peyrot M, 2003, DIABETOLOGIA, V46, pA89
   PEYROT M, IN PRESS DIABET MED
   Peyrot M., 2004, PRACT DIABETOL, V23, P6
   Polonsky WH, 2004, CLIN DIABETES, V22, P147
   PUSH MJV, 2003, MED CARE RES REV, V60, P178
   RATZMANN KP, 1991, DEUT MED WOCHENSCHR, V116, P87, DOI 10.1055/s-2008-1063586
   Rubin RR, 2001, J CLIN PSYCHOL, V57, P457, DOI 10.1002/jclp.1041
   SEGAL R, 1985, MED CARE, V23, P967, DOI 10.1097/00005650-198508000-00004
   Skovlund SE, 2003, DIABETOLOGIA, V46, pA89
   Turk DC, 1997, CLIN J PAIN, V13, P330, DOI 10.1097/00002508-199712000-00011
   Turner RC, 1998, LANCET, V352, P837
   VIRJI A, 1991, FAM PRACT, V8, P314, DOI 10.1093/fampra/8.4.314
   WOLFFENBUTTEL BHR, 1993, PATIENT EDUC COUNS, V22, P117, DOI 10.1016/0738-3991(93)90091-A
   Zambanini A, 1999, DIABETES RES CLIN PR, V46, P239, DOI 10.1016/S0168-8227(99)00099-6
NR 43
TC 472
Z9 486
U1 3
U2 21
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
J9 DIABETES CARE
JI Diabetes Care
PD NOV
PY 2005
VL 28
IS 11
BP 2673
EP 2679
DI 10.2337/diacare.28.11.2673
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 001PH
UT WOS:000234548300012
PM 16249538
OA Bronze
DA 2019-01-08
ER

PT J
AU Pouwer, F
   Skinner, IC
   Pibernik-Okanovic, M
   Beekman, ATF
   Cradock, S
   Szabo, S
   Metelko, Z
   Snoek, FJ
AF Pouwer, F
   Skinner, IC
   Pibernik-Okanovic, M
   Beekman, ATF
   Cradock, S
   Szabo, S
   Metelko, Z
   Snoek, FJ
TI Serious diabetes-specific emotional problems and depression in a
   Croatian-Dutch-English Survey from the European Depression in Diabetes
   [EDID] Research Consortium
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article
DE diabetes; depression; emotional distress; glycaemic control; diabetes
   mellitus; anxiety
ID WELL-BEING QUESTIONNAIRE; COGNITIVE-BEHAVIOR THERAPY; GLYCEMIC CONTROL;
   COMORBID DEPRESSION; PROBLEM AREAS; SYMPTOMS; VALIDITY; DISTRESS;
   MELLITUS; QUALITY
AB It has been hypothesized that coverage of diabetes-specific issues (e.g. coping with complications, incapacity, pain) during psychotherapy may optimize the likelihood of treatment success for depression in patients with diabetes. However, it is still unclear how often depression is confounded by diabetes-specific emotional problems. We aim to determine the levels of diabetes-specific emotional problems in diabetic individuals with high versus low levels of depression in a sample of 539 outpatients with diabetes (202 Dutch, 185 Croatian and 152 English). Subjects completed the Center for Epidemiological Studies Depression and the Problem Areas in Diabetes scales. Percentages of patients with high depression scores were: 39 and 34% (Croatian men and women), 19 and 21% (Dutch men and women), 19 and 39% (English men and women). Moreover, 79% (Croatian), 47% (Dutch) and 41% (English) of the patients with it severe depression score reported to have four or more serious diabetes-specific emotional problems. For patients with low depression scores, these percentages were: 29% (Croatian), 11% (Dutch) and 1% (English).
   Serious diabetes-specific emotional problems are particularly prevalent in depressed diabetes patients. Randomized controlled trials are warranted to test whether coverage of diabetes-specific issues during psychotherapy can further improve the treatment of depression in diabetes. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
C1 Vrije Univ Amsterdam, Med Ctr, Diabet Res Grp, EMGO, NL-1081 BT Amsterdam, Netherlands.
   Leicester Royal Infirm, Leicester, Leics, England.
   Vuk Vrhovac Univ Clin, Zagreb, Croatia.
   Queen Alexandra Hosp, Portsmouth, Hants, England.
RP Pouwer, F (reprint author), Vrije Univ Amsterdam, Med Ctr, Diabet Res Grp, EMGO, Van Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.
EM f.pouwer@vumc.nl
RI Skinner, Timothy/G-2865-2010
OI Skinner, Timothy/0000-0002-0018-6963
CR Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Barbui C, 2002, EUR J CLIN PHARMACOL, V58, P379, DOI 10.1007/s00228-002-0497-7
   Beekman A T, 1994, Tijdschr Gerontol Geriatr, V25, P95
   Beekman ATF, 1997, PSYCHOL MED, V27, P231, DOI 10.1017/S0033291796003510
   Beuke CJ, 2003, CLIN PSYCHOL REV, V23, P831, DOI 10.1016/S0272-7358(03)00074-6
   DeVries JH, 2002, DIABETIC MED, V19, P496, DOI 10.1046/j.1464-5491.2002.00727.x
   Egede LE, 2002, DIABETES CARE, V25, P464, DOI 10.2337/diacare.25.3.464
   Jacobson AM, 1997, QUAL LIFE RES, V6, P11
   Lustman PJ, 1998, GEN HOSP PSYCHIAT, V20, P302, DOI 10.1016/S0163-8343(98)00039-5
   Lustman PJ, 2002, J PSYCHOSOM RES, V53, P917, DOI 10.1016/S0022-3999(02)00416-6
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Lustman PJ, 1998, ANN INTERN MED, V129, P613, DOI 10.7326/0003-4819-129-8-199810150-00005
   Peyrot M, 1999, DIABETES CARE, V22, P448, DOI 10.2337/diacare.22.3.448
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Pouwer F, 2000, PSYCHOL MED, V30, P455, DOI 10.1017/S0033291700001719
   Pouwer F, 1999, DIABETES CARE, V22, P2004, DOI 10.2337/diacare.22.12.2004
   Pouwer F, 1998, QUAL LIFE RES, V7, P33
   Pouwer F, 2001, DIABETES CARE, V24, P1929, DOI 10.2337/diacare.24.11.1929
   Pouwer F, 2001, DIABETIC MED, V18, P595, DOI 10.1046/j.1464-5491.2001.00499.x
   RADLOFF LS, 1977, APPL PSYCH MEAS, V3, P385
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Welch G, 2003, DIABETIC MED, V20, P69, DOI 10.1046/j.1464-5491.2003.00832.x
NR 22
TC 50
Z9 51
U1 0
U2 8
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD NOV
PY 2005
VL 70
IS 2
BP 166
EP 173
DI 10.1016/j.diabres.2005.03.031
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 978BT
UT WOS:000232847900009
PM 15913827
DA 2019-01-08
ER

PT J
AU van der Ven, NCW
   Hogenelst, MHE
   Tromp-Wever, AME
   Twisk, JWR
   van der Ploeg, HM
   Heine, RJ
   Snoek, FJ
AF van der Ven, NCW
   Hogenelst, MHE
   Tromp-Wever, AME
   Twisk, JWR
   van der Ploeg, HM
   Heine, RJ
   Snoek, FJ
TI Short-term effects of cognitive behavioural group training (CBGT) in
   adult Type 1 diabetes patients in prolonged poor glycaemic control. A
   randomized controlled trial
SO DIABETIC MEDICINE
LA English
DT Article
DE Type 1 diabetes; psychosocial aspects; behavioural intervention
ID THERAPY; COMPLICATIONS; MELLITUS; INTERVENTION; SCALE; DUTCH
AB Aims To assess the effects of cognitive behavioural group training (CBGT) on glycaemic control, diabetes self-efficacy and well-being in Type 1 diabetes patients in persistent poor glycaemic control.
   Methods In a randomized controlled trial, a total of 107 patients with Type 1 diabetes in poor glycaemic control (HbA(1c)>= 8%) were assigned to a 6-week CBGT or blood glucose awareness training (BGAT) as control condition. The intervention was preceded by a 3-month run-in period. Glycaemic control (HbA(1c)), diabetes-specific self-efficacy (CIDS), diabetes-related distress (PAID) and depressive symptoms (CES-D), were assessed at baseline (T1), directly before (T2) and 3 months after (T3) the intervention.
   Results No significant changes in HbA(1c) were found after CBGT, whilst diabetes self-efficacy increased (mean CIDS score 71.6 +/- 14.0 to 74.3 +/- 12.2) and diabetes-related distress (mean PAID score 47.0 +/- 21.6 to 42.6 +/- 20.8) and depressive symptoms decreased (mean CES-D score 16.9 +/- 12.8 to 13.5 +/- 12.6). Changes in psychological outcomes were similar for both treatment groups. Diabetes self-care behaviours improved equally. Drop-out rate, which was higher among CBGT participants, was relatively low overall (total n = 15, 17.05%), and both interventions were well-appreciated by the participants.
   Conclusions CBGT was successful in improving self-efficacy, diabetes-related distress and mood at 3 months' follow-up, but not in improving glycaemic control.
C1 VU Univ Med Ctr, Dept Med Psychol, NL-1081 BT Amsterdam, Netherlands.
   VU Univ Med Ctr, IcaR, NL-1081 BT Amsterdam, Netherlands.
   VU Univ Med Ctr, EMGO, NL-1081 BT Amsterdam, Netherlands.
   VU Univ Med Ctr, Dept Endocrinol, NL-1081 BT Amsterdam, Netherlands.
RP van der Ven, NCW (reprint author), VU Univ Med Ctr, Dept Med Psychol, Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.
EM ncw.vanderven@vumc.nl
CR BECK A, 1980, COGNITIVE THERAPY DE
   Beck A. T., 1985, ANXIETY DISORDERS PH
   BOUMA J, 1995, METEN SYMPTOMEN DEPR
   COX DJ, 1995, BLOOD GLUCOSE AWAREN, V3
   DeVries JH, 2003, DIABETES-METAB RES, V19, P357, DOI 10.1002/dmrr.405
   Didjurgeit U, 2002, DIABETIC MED, V19, P814, DOI 10.1046/j.1464-5491.2002.00811.x
   EMMELKAMP PMG, 1993, PSYCHOTHER PSYCHOSOM, V59, P116, DOI 10.1159/000288656
   Enright SJ, 1997, BRIT MED J, V314, P1811, DOI 10.1136/bmj.314.7097.1811
   Fosbury JA, 1997, DIABETES CARE, V20, P959, DOI 10.2337/diacare.20.6.959
   Genuth S, 2002, JAMA-J AM MED ASSOC, V287, P2563
   Gonder-Frederick L, 2000, PSYCHOL DIABETES CAR, P169
   Jorde R, 2000, DIABETIC MED, V17, P451, DOI 10.1046/j.1464-5491.2000.00295.x
   Lustman PJ, 1998, ANN INTERN MED, V129, P613, DOI 10.7326/0003-4819-129-8-199810150-00005
   Radloff L., 1977, APPL PSYCH MEAS, V1, P185
   Snoek FJ, 2001, PATIENT EDUC COUNS, V45, P143, DOI 10.1016/S0738-3991(01)00113-6
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   *SPSS INC, 2001, SPSS WIND REL 11 01
   STEPHENSON J, 1994, DIABETOLOGIA, V37, P278, DOI 10.1007/BF00398055
   Street LL, 2002, ETHICS BEHAV, V12, P1, DOI 10.1207/S15327019EB1201_1
   Van der Ven N., 2000, PSYCHOL DIABETES CAR, P207
   van der Ven N., 2003, DIABETES SPECTRUM, V16, P88, DOI [DOI 10.2337/DIASPECT.16.2.88, 10.2337/diaspect.16.2.88]
   van der Ven NCW, 2005, PATIENT EDUC COUNS, V56, P313, DOI 10.1016/j.pec.2004.03.005
   van der Ven NCW, 2003, DIABETES CARE, V26, P713, DOI 10.2337/diacare.26.3.713
   VIINAMAKI H, 1991, PSYCHOTHER PSYCHOSOM, V56, P24, DOI 10.1159/000288526
   *WERKGR PSYCH DIAB, 1997, BEW JE BLOEDGL
NR 25
TC 29
Z9 30
U1 1
U2 10
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0742-3071
J9 DIABETIC MED
JI Diabetic Med.
PD NOV
PY 2005
VL 22
IS 11
BP 1619
EP 1623
PG 5
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 976ZL
UT WOS:000232772100026
PM 16241932
DA 2019-01-08
ER

PT J
AU Kahaly, GJ
   Petrak, F
   Hardt, J
   Pitz, S
   Egle, UT
AF Kahaly, GJ
   Petrak, F
   Hardt, J
   Pitz, S
   Egle, UT
TI Psychosocial morbidity of Graves' orbitopathy
SO CLINICAL ENDOCRINOLOGY
LA English
DT Article
ID QUALITY-OF-LIFE; MEDICAL OUTCOMES; HEALTH SURVEY; GO-QOL; FUNCTIONAL
   STATUS; DISEASE; OPHTHALMOPATHY; EVENTS; IMPACT; QUESTIONNAIRE
AB Objective Ocular diseases markedly impair daily function. In Graves' orbitopathy (GO), an associated psychosocial burden is present due to disfiguring proptosis and/or diplopia, signs with significant impact on functional status and well-being. We have therefore surveyed and assessed the psychosocial morbidity of GO.
   Design A prospective controlled study on subjects with GO using internationally validated, self-reporting questionnaires.
   Patients One hundred and two consecutive patients with varying degrees of severity and activity of GO.
   Measurements Emotional distress, coping styles and quality of life (QoL) were assessed by the Hospital Anxiety and Depression Scale, by a German adaptation of the Ways-of-Coping Checklist, and with the 36-item Short Form, respectively. Stressful events in the 6 months preceding diagnosis were registered with the Life Experience Survey. QoL findings were compared to German reference values, as well as to 102 age- and gender-matched patients, each with type 1 diabetes (insulin-dependent diabetes mellitus, IDDM) and inflammatory bowel disease (IBD), respectively.
   Results Compared to the German reference population, all QoL scales were at a lower rate and were especially decreased in subjects with active and/or severe GO, orbital pain, diplopia and stressful life events. Compared to diabetics, psychosocial scales were considerably reduced in GO (z = -1 vs. 0.1, P < 0.001) and higher scores for depressive coping (2.32 vs. 1.71, P < 0.001) and trivializing (2.37 vs. 1.97, P < 0.006) were noted. In GO, depressive coping and trivializing were negatively correlated with the mental (r = -0.603 and r =-0.411, both P < 0.001) and physical (r = -0.487 and r = -0.354, both P < 0.001) components of QoL. Depressive coping also positively correlated with anxiety (r = 0.636) and depression (r = 0.590), respectively, both P < 0.001. Emotional distress noted in 46 subjects, mostly with active and severe GO, was associated with poor QoL. Anxiety and depression were present in 41 and 24 GO patients, respectively. The number of stressful events positively correlated with the scores of anxiety (r = 0.3335) and depression (r = 0.3178), both P = 0.001. Foremost emotional distress, but also diplopia, stressful events and depressive coping had a major impact on QoL (proportion of variance explained = 13.1%, P < 0.001, multiple regression analysis). More than 75% of the psychosocial impairment in GO (R-2 = 0.76, P < 0.001) was associated with seven variables only (e.g. depression and anxiety). Six months prior to GO onset, 74 patients experienced a mean of 4 (range 0-13) stressful life events. Subjects with optic neuropathy had more stressful events than those without nerve involvement (5.1 vs. 2.7, P = 0.0425).
   Conclusions Psychosocial morbidity is present in severe and/or active GO, which negatively affects QoL. The patients are not only physically ill, they also exhibit emotional distress. Accompanying psychosomatic treatment is indicated among about half of all GO patients.
C1 Univ Mainz, Dept Med 1, D-6500 Mainz, Germany.
   Univ Mainz, Dept Psychosomat Med & Psychotherapy, D-6500 Mainz, Germany.
   Univ Mainz, Dept Ophthalmol, D-6500 Mainz, Germany.
   Ruhr Univ Bochum, Dept Psychosomat Med, D-4630 Bochum, Germany.
RP Kahaly, GJ (reprint author), Univ Hosp, Dept Med 1, D-55101 Mainz, Germany.
EM gkahaly@mail.uni-mainz.de
CR Bartalena L, 2000, ENDOCR REV, V21, P168, DOI 10.1210/er.21.2.168
   Bullinger M, 1995, Z GESUNDHEITSWISSENS, V3, P21, DOI [10.1007/BF02959944, DOI 10.1007/BF02959944]
   COX DR, 1992, J ROY STAT SOC A STA, V155, P353, DOI 10.2307/2982889
   Dickinson AJ, 2001, CLIN ENDOCRINOL, V55, P283, DOI 10.1046/j.1365-2265.2001.01349.x
   Dittmar M, 2003, METABOLISM, V52, P1551, DOI 10.1016/S0026-0495(03)00382-2
   Dow KH, 1997, THYROID, V7, P613, DOI 10.1089/thy.1997.7.613
   ELKINTON JR, 1966, ANN INTERN MED, V64, P710
   FITZPATRICK R, 1992, BRIT MED J, V305, P1074, DOI 10.1136/bmj.305.6861.1074
   Gerding MN, 1997, THYROID, V7, P885, DOI 10.1089/thy.1997.7.885
   GILL TM, 1994, JAMA-J AM MED ASSOC, V272, P619, DOI 10.1001/jama.272.8.619
   Guyatt GH, 1997, JAMA-J AM MED ASSOC, V277, P1232, DOI 10.1001/jama.277.15.1232
   GUYATT GH, 1993, ANN INTERN MED, V118, P622, DOI 10.7326/0003-4819-118-8-199304150-00009
   Hardt J, 2000, QUAL LIFE RES, V9, P1, DOI 10.1023/A:1008927809013
   HARRIS T, 1992, BRIT J PSYCHIAT, V161, P535, DOI 10.1192/bjp.161.4.535
   Herrmann C, 1995, HADS D HOSP ANXIETY
   Jenkinson C, 1997, MED CARE, V35, P410, DOI 10.1097/00005650-199704000-00010
   JOYCE CRB, 1995, PATIENT EDUC COUNS, V26, P319, DOI 10.1016/0738-3991(95)00734-H
   Kahaly GJ, 2005, CLIN EXP IMMUNOL, V140, P166, DOI 10.1111/j.1365-2249.2005.02750.x
   KUNG AWC, 1995, CLIN ENDOCRINOL, V42, P303, DOI 10.1111/j.1365-2265.1995.tb01879.x
   Lee PP, 1997, OPHTHALMOLOGY, V104, P390, DOI 10.1016/S0161-6420(97)30303-0
   Matos-Santos A, 2001, CLIN ENDOCRINOL, V55, P15, DOI 10.1046/j.1365-2265.2001.01332.x
   MUTHNY FA, 1989, FREIBURGER FRAGEBOGE
   Paunkovic N, 1998, THYROID, V8, P37, DOI 10.1089/thy.1998.8.37
   Petrak F, 2003, DIABETES-METAB RES, V19, P216, DOI 10.1002/dmrr.374
   Petrak F, 2001, SCAND J GASTROENTERO, V36, P375, DOI 10.1080/003655201300051171
   Prummel MF, 2003, EUR J ENDOCRINOL, V148, P491, DOI 10.1530/eje.0.1480491
   SARASON IG, 1978, J CONSULT CLIN PSYCH, V46, P932, DOI 10.1037/0022-006X.46.5.932
   SCOTT IU, 1994, ARCH OPHTHALMOL-CHIC, V112, P329, DOI 10.1001/archopht.1994.01090150059023
   Sonino N, 1998, CLIN ENDOCRINOL, V49, P1, DOI 10.1046/j.1365-2265.1998.00528.x
   SONINO N, 1993, ACTA ENDOCRINOL-COP, V128, P293, DOI 10.1530/acta.0.1280293
   STEWART AL, 1989, JAMA-J AM MED ASSOC, V262, P907, DOI 10.1001/jama.262.7.907
   Tehrani M, 2004, EUR J OPHTHALMOL, V14, P193, DOI 10.5301/EJO.2008.2576
   Terwee CB, 1999, J CLIN EPIDEMIOL, V52, P875, DOI 10.1016/S0895-4356(99)00069-4
   Terwee CB, 2001, CLIN ENDOCRINOL, V54, P391, DOI 10.1046/j.1365-2265.2001.01241.x
   Terwee CB, 1998, BRIT J OPHTHALMOL, V82, P773, DOI 10.1136/bjo.82.7.773
   TERWEE CB, 2001, GRAVES OPHTHALMOPATH
   Testa MA, 1996, NEW ENGL J MED, V334, P835, DOI 10.1056/NEJM199603283341306
   Ware JE, 1998, J CLIN EPIDEMIOL, V51, P1159, DOI 10.1016/S0895-4356(98)00107-3
   WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002
   WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59
   WINSA B, 1991, LANCET, V338, P1475, DOI 10.1016/0140-6736(91)92298-G
   Yoshiuchi K, 1998, PSYCHOSOM MED, V60, P592, DOI 10.1097/00006842-199809000-00014
   Yoshiuchi K, 1998, PSYCHOSOM MED, V60, P182, DOI 10.1097/00006842-199803000-00013
NR 43
TC 56
Z9 59
U1 0
U2 4
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0300-0664
J9 CLIN ENDOCRINOL
JI Clin. Endocrinol.
PD OCT
PY 2005
VL 63
IS 4
BP 395
EP 402
DI 10.1111/j.1365-2265.2005.02352.x
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 967OX
UT WOS:000232102200005
PM 16181231
DA 2019-01-08
ER

PT J
AU Kadam, UT
   Jordan, K
   Croft, PR
AF Kadam, UT
   Jordan, K
   Croft, PR
TI Clinical comorbidity was specific to disease pathology, psychologic
   distress, and somatic symptom amplification
SO JOURNAL OF CLINICAL EPIDEMIOLOGY
LA English
DT Article
DE anxiety disorders; case-control studies; comorbidity; diabetes mellitus;
   general practice; respiratory tract infections
ID GENERAL-PRACTICE; HEALTH-CARE; DIABETES-MELLITUS; MORBIDITY SURVEY;
   PREVALENCE; ANXIETY; COMMUNITY; EPIDEMIOLOGY; DEPRESSION; CLASSIFICATION
AB Objective: To test the hypothesis that disease pathology, psychologic distress, and somatic symptom amplification separately influence health care use by investigating the patterns of comorbidity in patients with diabetes, anxiety, and upper respiratory tract infection (URTI), respectively.
   Methods: Adult diabetes (n = 4,365), anxiety (13,42 1), and URTI (9,854) cases, and 15,000 randomly selected controls were identified from a 1-year national survey of general practice consultations. Comorbidity was based on a standard clinical morbidity classification used by general practitioners in actual consultations.
   Results: In case-control analyses of 122 morbidities, the number of significant comorbid associations (P < .01) for diabetes was 30, anxiety was 72, and URTI was 49. These associations showed significant heterogeneity in the odds ratios estimated using Cochran's Q and 12 statistic, both between case groups and within each case group. Diabetes associations were stronger with peripheral vascular disease (odds ratio 2.7), candidiasis (2.5), cataract(2.4), obesity(2.2), and hypertension (1.7); anxiety with depressive disorder (4.1), affective psychosis (4.0), adjustment reaction (3.2), functional gastrointestinal disorders (2.5) and general symptoms (2.5); and URTI with nonspecific blood findings (5.5), bronchitis (5.2), and injury (3.5).
   Conclusion: Our study shows patterns of clinical comorbidity specific to the case conditions that supports the hypothesis that different mechanisms (disease pathology, psychologic distress, and somatic symptom amplification) operate to influence consultation behavior and comorbidity. (c) 2005 Elsevier Inc. All rights reserved.
C1 Univ Keele, Primary Care Sci Res Ctr, Keele ST5 5BG, Staffs, England.
RP Kadam, UT (reprint author), Univ Keele, Primary Care Sci Res Ctr, Keele ST5 5BG, Staffs, England.
EM u.kadam@cphc.keele.ac.uk
OI Jordan, Kelvin/0000-0003-4748-5335
CR Barsky AJ, 1999, ANN INTERN MED, V130, P910, DOI 10.7326/0003-4819-130-11-199906010-00016
   BARSKY AJ, 1988, PSYCHOSOM MED, V50, P510, DOI 10.1097/00006842-198809000-00007
   Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570
   CarrHill RA, 1996, BRIT MED J, V312, P1008
   COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666
   ESCOBAR JI, 1987, ARCH GEN PSYCHIAT, V44, P713
   FEINSTEIN AR, 1970, J CHRON DIS, V23, P455, DOI 10.1016/0021-9681(70)90054-8
   FLEMING DM, 1991, J EPIDEMIOL COMMUN H, V45, P73, DOI 10.1136/jech.45.1.73
   Gill D, 1999, J PSYCHOSOM RES, V47, P115, DOI 10.1016/S0022-3999(98)00118-4
   GUCCIONE AA, 1994, AM J PUBLIC HEALTH, V84, P351, DOI 10.2105/AJPH.84.3.351
   Hansell A, 1999, THORAX, V54, P413, DOI 10.1136/thx.54.5.413
   Harding A, 1998, J AHIMA, V69, P34
   Hassey A, 2001, BRIT MED J, V322, P1401, DOI 10.1136/bmj.322.7299.1401
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Hochstrasser B, 1996, EUR ARCH PSY CLIN N, V246, P261, DOI 10.1007/BF02190278
   Hoffman C, 1996, JAMA-J AM MED ASSOC, V276, P1473, DOI 10.1001/jama.276.18.1473
   JICK H, 1991, BRIT MED J, V302, P766, DOI 10.1136/bmj.302.6779.766
   Jyvasjarvi S, 2001, J PSYCHOSOM RES, V50, P185, DOI 10.1016/S0022-3999(00)00217-8
   Kadam UT, 2004, ANN RHEUM DIS, V63, P408, DOI 10.1136/ard.2003.007526
   Kadam UT, 2001, J CLIN EPIDEMIOL, V54, P1112, DOI 10.1016/S0895-4356(01)00379-1
   KATON W, 1982, AM J MED, V72, P127, DOI 10.1016/0002-9343(82)90599-X
   Kessler D, 1999, BRIT MED J, V318, P436, DOI 10.1136/bmj.318.7181.436
   KLEINMAN A, 1987, BRIT J PSYCHIAT, V151, P447, DOI 10.1192/bjp.151.4.447
   KNOTTNERUS JA, 1992, FAM PRACT, V9, P15, DOI 10.1093/fampra/9.1.15
   KROENKE K, 1993, ARCH INTERN MED, V153, P2474, DOI 10.1001/archinte.153.21.2474
   Kvaerner KJ, 1996, INT J PEDIATR OTORHI, V35, P127, DOI 10.1016/0165-5876(95)01299-0
   MCCORMICK A, 1995, SERIES MB5, V3
   McNiece R, 1999, BRIT MED J, V319, P26, DOI 10.1136/bmj.319.7201.26
   Morris AD, 1997, BRIT MED J, V315, P524, DOI 10.1136/bmj.315.7107.524
   Muramatsu K, 2002, GEN HOSP PSYCHIAT, V24, P172, DOI 10.1016/S0163-8343(02)00177-9
   *OFF POP CENS SURV, 1991, STAND OCC CLASS, V3
   PRINGLE M, 1995, BRIT J GEN PRACT, V45, P537
   Rosenzweig JL, 2002, AM J MANAG CARE, V8, P950
   SCHELLEVIS FG, 1993, J CLIN EPIDEMIOL, V46, P469, DOI 10.1016/0895-4356(93)90024-U
   Sherbourne CD, 1996, ARCH GEN PSYCHIAT, V53, P889
   Sprangers MAG, 2000, J CLIN EPIDEMIOL, V53, P895, DOI 10.1016/S0895-4356(00)00204-3
   *SPSS INC, 2000, STAT PACK SOC SCI SP
   *STAT CORP, 2002, STATACORP STAT STAT
   van Balkom AJLM, 2000, ACTA PSYCHIAT SCAND, V101, P37, DOI 10.1034/j.1600-0447.2000.101001037.x
   van den Akker M, 1998, J CLIN EPIDEMIOL, V51, P367, DOI 10.1016/S0895-4356(97)00306-5
   VERBRUGGE LM, 1987, MED CARE, V25, P539, DOI 10.1097/00005650-198706000-00008
   Volpato S, 2002, DIABETES CARE, V25, P678, DOI 10.2337/diacare.25.4.678
   Wittchen HU, 1999, J CLIN PSYCHIAT, V60, P29
NR 43
TC 13
Z9 14
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0895-4356
J9 J CLIN EPIDEMIOL
JI J. Clin. Epidemiol.
PD SEP
PY 2005
VL 58
IS 9
BP 909
EP 917
DI 10.1016/j.jclinepi.2005.02.007
PG 9
WC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA 959TW
UT WOS:000231543200007
PM 16085194
DA 2019-01-08
ER

PT J
AU Poikolainen, K
   Vahtera, J
   Virtanen, M
   Linna, A
   Kivimaki, M
AF Poikolainen, K
   Vahtera, J
   Virtanen, M
   Linna, A
   Kivimaki, M
TI Alcohol and coronary heart disease risk - is there an unknown
   confounder?
SO ADDICTION
LA English
DT Article
DE alcohol drinking; confounding factors; coronary disease; psychosocial
   factors; risk factors
ID CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; SICKNESS ABSENCE;
   MORTALITY; DEPRESSION; COHORT; HEALTH; WOMEN; WORK; MEN
AB Aims To evaluate whether confounding by several known or suspected coronary heart disease risk factors are likely to explain the lower coronary heart disease risk among light alcohol drinkers compared with never-drinkers.
   Designs A population-based cross-sectional study.
   Methods Hypertension, body mass index (BMI), diabetes, depression, sleep disturbances, smoking, physical activity, life satisfaction, psychological distress, trait anxiety, independent and dependent life events, length of working hours, job control, job strain and effort-reward imbalance were compared between never-drinkers and light drinkers (< 70 g of alcohol per week). Data on 41099 participants (6222 men, 34877 women) were derived from two ongoing cohort studies, the '10-Town Study' and 'Finnish Hospital Personnel Study', in Finland in 2000-02.
   Results Of the 16 comparisons under study, seven showed significant differences between never-drinkers and light drinkers. Five of the differences favoured never-drinkers and two showed a disadvantage. The latter were low BMI and low leisure-time physical activity, both more common among never-drinkers than among light drinkers. In contrast, smoking, sleep disturbances, trait anxiety, effort-reward imbalance and dependent life events were less common among never-drinkers than among light drinkers.
   Conclusions None of the risk factors studied was a likely candidate for an unknown confounder.
C1 Finnish Fdn Alcohol Studies, FIN-00531 Helsinki, Finland.
   Finnish Inst Occupat Hlth, Turku Reg Inst, Turku, Finland.
   Finnish Inst Occupat Hlth, Dept Psychol, Helsinki, Finland.
   Univ Helsinki, Dept Psychol, SF-00100 Helsinki, Finland.
RP Poikolainen, K (reprint author), Finnish Fdn Alcohol Studies, POB 220, FIN-00531 Helsinki, Finland.
EM kari.poikolainen@stakes.fi
RI Kivimaki, Mika/B-3607-2012; Vahtera, Jussi/J-3271-2013
OI Kivimaki, Mika/0000-0002-4699-5627
CR *2 JOINT TASK FORC, 1998, EUR HEART J, V19, P1434
   Babor TF, 2003, ALCOHOL NO ORDINARY
   Corrao G, 2000, ADDICTION, V95, P1505, DOI 10.1046/j.1360-0443.2000.951015056.x
   Goldberg D., 1988, USERS GUIDE GEN HLTH
   Green CA, 2001, AM J PREV MED, V21, P298, DOI 10.1016/S0749-3797(01)00365-8
   JENKINS CD, 1988, J CLIN EPIDEMIOL, V41, P313, DOI 10.1016/0895-4356(88)90138-2
   Karasek R. A., 1985, JOB CONTENT QUESTION
   KENDLER KS, 1995, AM J PSYCHIAT, V152, P833
   Kivimaki M, 2003, OCCUP ENVIRON MED, V60, P779, DOI 10.1136/oem.60.10.779
   Kivimaki M, 2002, BRIT MED J, V325, P857, DOI 10.1136/bmj.325.7369.857
   Kivimaki M, 2002, PSYCHOSOM MED, V64, P817, DOI 10.1097/01.PSY.0000031576.42041.B1
   Koivumaa-Honkanen H, 2000, AM J EPIDEMIOL, V152, P983, DOI 10.1093/aje/152.10.983
   KOSKENVUO M, 1988, PSYCHOSOM MED, V50, P330, DOI 10.1097/00006842-198807000-00002
   Kujala UM, 1998, JAMA-J AM MED ASSOC, V279, P440, DOI 10.1001/jama.279.6.440
   McElduff P, 1997, BRIT MED J, V314, P1159, DOI 10.1136/bmj.314.7088.1159
   Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75
   ROBERTS R, 1995, SOC SCI MED, V41, P1513, DOI 10.1016/0277-9536(95)00056-D
   Rodgers B, 2000, ADDICTION, V95, P1833, DOI 10.1046/j.1360-0443.2000.9512183312.x
   Romelsjo A, 2003, ADDICTION, V98, P1453, DOI 10.1046/j.1360-0443.2003.00488.x
   Sokejima S, 1998, BRIT MED J, V317, P775, DOI 10.1136/bmj.317.7161.775
   SPIELBERGER CD, 1983, MANUAL STATE TRAIT A
   Taris TW, 2002, WORK STRESS, V16, P287, DOI 10.1080/0267837021000054500
   Vahtera J, 2002, AM J EPIDEMIOL, V156, P969, DOI 10.1093/aje/kwf138
NR 23
TC 6
Z9 8
U1 0
U2 2
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0965-2140
J9 ADDICTION
JI Addiction
PD AUG
PY 2005
VL 100
IS 8
BP 1150
EP 1157
DI 10.1111/j.1360-0443.2005.01126
PG 8
WC Substance Abuse; Psychiatry
SC Substance Abuse; Psychiatry
GA 949FC
UT WOS:000230769400023
PM 16042645
DA 2019-01-08
ER

PT J
AU Adriaanse, MC
   Dekker, JM
   Spijkerman, AMW
   Twisk, JWR
   Nijpels, G
   van der Ploeg, HM
   Heine, RJ
   Snoek, FJ
AF Adriaanse, MC
   Dekker, JM
   Spijkerman, AMW
   Twisk, JWR
   Nijpels, G
   van der Ploeg, HM
   Heine, RJ
   Snoek, FJ
TI Diabetes-related symptoms and negative mood in participants of a
   targeted population-screening program for type 2 diabetes: The Hoorn
   Screening study
SO QUALITY OF LIFE RESEARCH
LA English
DT Article
DE diabetes-related symptoms; negative mood; screening; type 2 diabetes
ID QUALITY-OF-LIFE; DEPRESSIVE SYMPTOMS; GLYCEMIC CONTROL; RISK; MELLITUS;
   AWARENESS; HEALTH; QUESTIONNAIRE; DIAGNOSIS; SEVERITY
AB Objective: To determine the level of diabetes-related symptom distress and its association with negative mood in subjects participating in a targeted population-screening program, comparing those identified as having type 2 diabetes vs. those who did not. Research design and methods: This study was conducted within the framework of a targeted screening project for type 2 diabetes in a general Dutch population (age 5075 years). The study sample consisted of 246 subjects, pre-selected on the basis of a high-risk profile; 116 of whom were subsequently identified as having type 2 diabetes, and 130 who were non-diabetic subjects. Diabetes-related symptom distress and negative mood was assessed similar to 2 weeks, 6 months, and 12 months after the diagnosis of type 2 diabetes, with the Type 2 Diabetes Symptom Checklist and the Negative wellbeing sub scale of the Well-being Questionnaire (W-BQ12), respectively. Results: Screening-detected diabetic patients reported significantly greater burden of hyperglycemic (F = 6.0, df = 1, p = 0.015) and of fatigue (F = 5.3, df = 1, p = 0.023) symptoms in the first year following diagnosis type 2 diabetes compared to non-diabetic subjects. These outcomes did not change over time. The total symptom distress (range 0-4) was relatively low for both screening-detected diabetic patients (median at similar to 2 weeks, 6 months, and 12 months; 0.24, 0.24, 0.29) and non-diabetic subjects (0.15, 0.15, 0.18), and not significantly different. No average difference and change over time in negative well-being was found between screening-detected diabetic patients and non-diabetic subjects. Negative well-being was significantly positive related with the total symptom distress score (regression coefficient beta = 2.86, 95% CI 2.15-3.58). Conclusions: The screening-detected diabetic patients were bothered more by symptoms of hyperglycemia and fatigue in the first year following diagnosis type 2 diabetes than non-diabetic subjects. More symptom distress is associated with increased negative mood in both screening-detected diabetic patients and non-diabetic subjects.
C1 VU Univ, Inst Res Extramural Med, EMGO Inst, Med Ctr, Amsterdam, Netherlands.
   VU Univ, Dept Med Psychol, Med Ctr, Amsterdam, Netherlands.
   VU Univ, Dept Endocrinol, Med Ctr, Amsterdam, Netherlands.
RP Adriaanse, MC (reprint author), Free Univ Amsterdam, Inst Hlth Sci, Fac Earth & Life Sci, De Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands.
EM marcel.adriaanse@falw.vu.nl
CR Adriaanse MC, 2003, DIABETIC MED, V20, P210, DOI 10.1046/j.1464-5491.2003.00901.x
   *AM DIAB ASS, 2002, DIABETES CARE S1, V25, pS21
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Arroyo C, 2004, DIABETES CARE, V27, P129, DOI 10.2337/diacare.27.1.129
   Borch-Johnsen K, 2003, DIABETIC MED, V20, P175, DOI 10.1046/j.1464-5491.2003.00842.x
   BRADLEY C, 1994, HDB PSYCHOL DIABETES, P89
   Carnethon MR, 2003, AM J EPIDEMIOL, V158, P416, DOI 10.1093/aje/kwg172
   Ciechanowski PS, 2003, GEN HOSP PSYCHIAT, V25, P246, DOI 10.1016/S0163-8343(03)00055-0
   *DG A COMP GROUPS, 1999, CONT DAT, P179
   Eaton WW, 1996, DIABETES CARE, V19, P1097, DOI 10.2337/diacare.19.10.1097
   Engelgau M M, 2001, Eff Clin Pract, V4, P281
   Golden SH, 2004, DIABETES CARE, V27, P429, DOI 10.2337/diacare.27.2.429
   Goyder E, 1998, BRIT MED J, V317, P1644, DOI 10.1136/bmj.317.7173.1644
   GROOTENHUIS PA, 1994, DIABETIC MED, V11, P253, DOI 10.1111/j.1464-5491.1994.tb00268.x
   Gulliford MC, 1999, J CLIN EPIDEMIOL, V52, P773, DOI 10.1016/S0895-4356(99)00053-0
   HARRIS MI, 1992, DIABETES CARE, V15, P815, DOI 10.2337/diacare.15.7.815
   Harris MI, 2000, DIABETES METAB RES, V16, P230, DOI 10.1002/1520-7560(2000)9999:9999<::AID-DMRR122>3.3.CO;2-N
   JACKSON DMA, 1991, DIABETIC MED, V8, P971, DOI 10.1111/j.1464-5491.1991.tb01540.x
   Kawakami N, 1999, DIABETES CARE, V22, P1071, DOI 10.2337/diacare.22.7.1071
   Ko GTC, 2000, DIABETES CARE, V23, P1290, DOI 10.2337/diacare.23.9.1290
   Kressin NR, 2000, MED CARE, V38, P858, DOI 10.1097/00005650-200008000-00009
   Lee D S, 2000, WMJ, V99, P39
   Lindahl B, 1999, DIABETES CARE, V22, P1988, DOI 10.2337/diacare.22.12.1988
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Muggeo M, 1998, DIABETIC MED, V15, pS60, DOI 10.1002/(SICI)1096-9136(1998120)15:4+<S60::AID-DIA736>3.3.CO;2-A
   PALINKAS LA, 1991, DIABETIC MED, V8, P532, DOI 10.1111/j.1464-5491.1991.tb01646.x
   Petrie KJ, 2003, J PSYCHOSOM RES, V54, P401, DOI 10.1016/S0022-3999(02)00461-0
   Polonsky William H, 2002, Curr Diab Rep, V2, P153, DOI 10.1007/s11892-002-0075-5
   Pouwer F, 2003, DIABETOLOGIA, V46, P892, DOI 10.1007/s00125-003-1124-6
   Pouwer F, 1999, DIABETES CARE, V22, P2004, DOI 10.2337/diacare.22.12.2004
   Roth J, 2000, DIABETES METAB RES, V16, P228
   Ruige JB, 1997, DIABETES CARE, V20, P491, DOI 10.2337/diacare.20.4.491
   Saydah SH, 2003, DIABETES-METAB RES, V19, P202, DOI 10.1002/dmrr.353
   Schrof J M, 1999, US News World Rep, V126, P50
   SINGH BM, 1994, BRIT MED J, V308, P632, DOI 10.1136/bmj.308.6929.632
   SINGH BM, 1992, BRIT MED J, V304, P1154, DOI 10.1136/bmj.304.6835.1154
   Spijkerman AMW, 2002, DIABETES CARE, V25, P1784, DOI 10.2337/diacare.25.10.1784
   Testa MA, 1998, JAMA-J AM MED ASSOC, V280, P1490, DOI 10.1001/jama.280.17.1490
   Thomas AJ, 2004, J AFFECT DISORDERS, V79, P81, DOI 10.1016/S0165-0327(02)00349-x
   VanderDoes FEE, 1996, DIABETES CARE, V19, P204, DOI 10.2337/diacare.19.3.204
   ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63
   ZUNG WWK, 1974, MEASUREMENT AFFECTS, P170
NR 42
TC 24
Z9 26
U1 0
U2 4
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0962-9343
J9 QUAL LIFE RES
JI Qual. Life Res.
PD AUG
PY 2005
VL 14
IS 6
BP 1501
EP 1509
DI 10.1007/s11136-004-0028-3
PG 9
WC Health Care Sciences & Services; Health Policy & Services; Public,
   Environmental & Occupational Health
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA 952ZV
UT WOS:000231046000006
PM 16110930
DA 2019-01-08
ER

PT J
AU Pibernik-Okanovic, M
   Peros, K
   Szabo, S
   Begic, D
   Metelko, Z
AF Pibernik-Okanovic, M
   Peros, K
   Szabo, S
   Begic, D
   Metelko, Z
TI Depression in Croatian type 2 diabetic patients: Prevalence and risk
   factors. A Croatian survey from the European Depression in Diabetes
   (EDID) Research Consortium
SO DIABETIC MEDICINE
LA English
DT Article
DE Type 2 diabetes; depression; cross-cultural comparisons
ID DISTRESS; SCALE
AB Aims To determine the prevalence rate of and risk factors for depression in Croatian Type 2 diabetic patients.
   Methods Depressive mood was examined in 384 randomly selected outpatients with Type 2 diabetes. Center for Epidemiological Studies Depression Scale (CES-D) and Structured Clinical Interview for DSM-IV Axis I Disorders (SCID) were used to identify depressive disturbances. The groups with CES-D >= 16 and < 16 were compared with respect to demographic, psychological and clinical characteristics. Regression analysis was used to determine risk factors for depression.
   Results Of the examined patients, 22% had CES-D scores >= 16, and in 33% of them clinical depression was confirmed by the psychiatric interview. Depressed patients compared with the non-depressed ones reported more diabetes-related problems and poorer well-being (t = 6.71, P < 0.001 and t = 11.98, P < 0.001, respectively). Multiple regression analysis indicated female gender, experienced support and the level of emotional well-being to predict depression (R = 0.74, F = 15.3, P < 0.001).
   Conclusions The obtained data indicate that the prevalence rate in Croatian Type 2 diabetic patients is comparable to findings from other cultural settings. Depressive symptoms can be predicted by psychological rather than disease-related variables. Psychological care for diabetic patients may be necessary to prevent depressive symptomatology.
C1 Rebro Univ Hosp, Vuk Vrhovac Univ Clin, Zagreb 10000, Croatia.
   Rebro Univ Hosp, Dept Psychiat, Zagreb 10000, Croatia.
RP Pibernik-Okanovic, M (reprint author), Rebro Univ Hosp, Vuk Vrhovac Univ Clin, Dugi Dol 4A, Zagreb 10000, Croatia.
EM pibernik@idb.hr
CR Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Bech P, 2003, INT J METH PSYCH RES, V12, P85, DOI 10.1002/mpr.145
   Black SA, 2003, DIABETES CARE, V26, P2822, DOI 10.2337/diacare.26.10.2822
   First M. B, 1997, STRUCTURED CLIN INTE
   Goldney RD, 2004, DIABETES CARE, V27, P1066, DOI 10.2337/diacare.27.5.1066
   Hermanns N, 2003, DIABETES, V52, pA415
   Pouwer F, 2003, DIABETOLOGIA, V46, P892, DOI 10.1007/s00125-003-1124-6
   Pouwer F, 2003, DIABETOLOGIA, V46, pA85
   Radloff LS, 1986, COMMUNITY SURVEYS PS, V4, P177
   Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
NR 11
TC 21
Z9 21
U1 0
U2 3
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DG, OXON, ENGLAND
SN 0742-3071
J9 DIABETIC MED
JI Diabetic Med.
PD JUL
PY 2005
VL 22
IS 7
BP 942
EP 945
DI 10.1111/j.1464-5491.2005.01528.x
PG 4
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 937GQ
UT WOS:000229913000019
PM 15975112
DA 2019-01-08
ER

PT J
AU Fox, LA
   Wysocki, T
   Buckloh, LM
   Mauras, N
   Smith, SD
AF Fox, LA
   Wysocki, T
   Buckloh, LM
   Mauras, N
   Smith, SD
TI A randomized controlled trial of insulin pump therapy in young children
   with type 1 diabetes
SO DIABETES CARE
LA English
DT Article; Proceedings Paper
CT Annual Meeting of the Pediatric-Academic-Societies
CY MAY 01-04, 2004
CL San Francisco, CA
SP Pediat Acad Soc
ID HYPOGLYCEMIA; MELLITUS; ADOLESCENTS; INFUSION
AB OBJECTIVE - This study assesses the effects of insulin pump therapy on diabetes control and family life in children 1-6 years old with type 1 diabetes.
   RESEARCH DESIGN AND METHODS - Twenty-six children with type 1 diabetes for >= 6 months were randomly assigned to current therapy (two or three shots per day using NPH insulin and rapid-acting analog) or continuous subcutaneous insulin infusion (CSII) for 6 months. After 6 months, current therapy subjects were offered CSII. Changes in HbA(Lc), mean blood glucose (MBG), hypoglycemia frequency, diabetes-related quality of life (QOL), and parental adjustment were recorded.
   RESULTS - Eleven subjects from each group completed the trial (age 46.3 +/- 3.2 months [means +/- SE]). At baseline, there were no differences between groups in HbA(1c), MBG, age, sex, diabetes duration, or parental QOL. Mean HbA(1c), MBG, and parental QOL were similar between groups at 6 months. Mean HbA(1c) and MBG did not change from baseline to 6 months in either group. The frequency of severe hypoglycemia, ketoacidosis, or hospitalization was similar between groups at any time period. Subjects on CSII had more fasting and predinner mild/moderate hypoglycemia at 1 and 6 months. Diabetes-related QOL improved in CSII fathers from baseline to 6 months. Psychological distress increased in current therapy mothers from baseline to 6 months. All subjects continued CSII after study completion.
   CONCLUSIONS - CSII is safe and well tolerated in young children with diabetes and may have positive effects on QOL. CSII did not improve diabetes control when compared with injections, despite more mild/moderate hypoglycemia. The benefits and realistic expectations of CSII should be thoroughly examined before starting this therapy in very young children.
C1 NE Florida Pediat Diabet Ctr, Nemours Childrens Clin, Div Endocrinol, Jacksonville, FL 32207 USA.
   Nemours Childrens Clin, Div Psychol & Psychiat, Jacksonville, FL 32207 USA.
RP Fox, LA (reprint author), NE Florida Pediat Diabet Ctr, Nemours Childrens Clin, Div Endocrinol, 807 Childrens Way, Jacksonville, FL 32207 USA.
EM lfox@lwpes.org
CR Abidin R. R., 1983, PARENTING STRESS IND
   AHERN JAH, 2002, PEDIAT DIABETES, V3, P10, DOI DOI 10.1034/J.1399-5448.2002.30103.X
   ANDERSON BJ, 1996, ELLENBERG RIFKINS DI, P811
   Cryer PE, 1999, DIABETES-METAB RES, V15, P42, DOI 10.1002/(SICI)1520-7560(199901/02)15:1<42::AID-DMRR1>3.0.CO;2-B
   DCCT Res Grp, 1994, J PEDIATR-US, V125, P177, DOI 10.1016/S0022-3476(94)70190-3
   DEROGATIS A, 1977, BRIEF SYMPTOM INVENT
   DiMeglio LA, 2004, J PEDIATR-US, V145, P380, DOI 10.1016/j.jpeds.2004.06.022
   Doyle EA, 2004, DIABETES CARE, V27, P1554, DOI 10.2337/diacare.27.7.1554
   Galloway T.A., 1986, DIABETES 1985, P877
   HILDEBRANDT P, 1984, ACTA MED SCAND, V215, P69
   Littom J, 2002, J PEDIATR-US, V141, P490, DOI 10.1067/mpd.2002.127500
   Maniatis AK, 2001, PEDIATRICS, V107, P351, DOI 10.1542/peds.107.2.351
   Marrero DG, 1997, DIABETES EDUCATOR, V23, P281, DOI 10.1177/014572179702300306
   ROVET JF, 1987, DIABETES CARE, V10, P510, DOI 10.2337/diacare.10.4.510
   SHAMOON H, 1993, NEW ENGL J MED, V329, P977
   SOLTESZ G, 1989, ARCH DIS CHILD, V64, P992, DOI 10.1136/adc.64.7.992
   STEIN REK, 1980, MED CARE, V18, P465, DOI 10.1097/00005650-198004000-00010
   Sulli N, 2003, J PEDIATR ENDOCR MET, V16, P393
   Wilson DM, 2005, DIABETES CARE, V28, P15, DOI 10.2337/diacare.28.1.15
   WYSOCKI T, 1997, HDB HLTH BEHAV RES, V2, P169
NR 20
TC 97
Z9 99
U1 0
U2 7
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
EI 1935-5548
J9 DIABETES CARE
JI Diabetes Care
PD JUN
PY 2005
VL 28
IS 6
BP 1277
EP 1281
DI 10.2337/diacare.28.6.1277
PG 5
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 931QM
UT WOS:000229500000001
PM 15920039
OA Other Gold
DA 2019-01-08
ER

PT J
AU Weinger, K
   Welch, GW
   Butler, HA
   La Greca, AM
AF Weinger, K
   Welch, GW
   Butler, HA
   La Greca, AM
TI Measuring diabetes self-care - A psychometric analysis of the self-care
   inventory-revised with adults
SO DIABETES CARE
LA English
DT Article
ID PROBLEM AREAS; REGIMEN ADHERENCE; GLYCEMIC CONTROL; SCALE;
   COMPLICATIONS; MANAGEMENT; DISTRESS; OUTCOMES; GENDER; WOMEN
AB OBJECTIVE - To examine psychometric properties of the Self-Care Inventory-revised (SCIR), a self-report measure of perceived adherence to diabetes self-care recommendations, among adults with diabetes.
   RESEARCH DESIGN AND METHODS - We used three data sets of adult type 1 and type 2 diabetic patients to examine psychometric properties of the SCI-R. Principal component and factor analyses examined whether a general factor or common factors were present. Associations with measures of theoretically related concepts were examined to assess SCI-R concurrent and convergent validity. Internal reliability coefficients were calculated. Responsiveness was assessed using paired t tests, effect size, and Guyatt's statistic for type 1 patients who completed psychoeducation.
   RESULTS - Principal component and factor analyses identified a general factor but no consistent common factors. Internal consistency of the SCI-R was a = 0.87. Correlation with a measure of frequency of diabetes self-care behaviors was r = 0.63, providing evidence for SCI-R concurrent validity. The SCI-R correlated with diabetes-related distress 0 (r = 0.25), self-efficacy (r = 0.47), depression (r = -0.22), anxiety (r = -0.24), and HbA(1c) (r = -0.37), supporting construct validity. Responsiveness analyses showed SCI-R scores improved with diabetes psychoeducation with a medium effect size of 0.62 and a Guyatt's statistic of 0.85.
   CONCLUSIONS - The SCI-R is a brief, psychometrically sound measure of perceptions of adherence to recommended diabetes self-care behaviors of adults with type 1 or type 2 diabetes.
C1 Joslin Diabet Ctr, Sect Behav & Mental Hlth Res, Boston, MA 02115 USA.
   Harvard Univ, Sch Med, Boston, MA USA.
   Bay State Med Ctr, Springfield, MA USA.
   Univ Miami, Dept Psychol, Coral Gables, FL USA.
RP Weinger, K (reprint author), Joslin Diabet Ctr, Sect Behav & Mental Hlth Res, 1 Joslin Pl, Boston, MA 02115 USA.
EM katie.weinger@joslin.harvard.edu; alagreca@miami.edu
FU NCRR NIH HHS [RR 01032]; NIDDK NIH HHS [DK 42315, DK 60115, R01
   DK042315, R01 DK060115, DK 07260-24, T32 DK007260]
CR Bradley C, 1984, Diabet Med, V1, P213
   COX DJ, 1992, J CONSULT CLIN PSYCH, V60, P628, DOI 10.1037//0022-006X.60.4.628
   Davis CL, 2001, J PEDIATR PSYCHOL, V26, P123, DOI 10.1093/jpepsy/26.2.123
   Derogatis L., 1994, SCL 90 R SYMPTOM CHE
   DEROGATIS LR, 1977, BRIT J SOC CLIN PSYC, V16, P347, DOI 10.1111/j.2044-8260.1977.tb00241.x
   DEYO RA, 1991, CONTROLLED CLIN TRIA, V12, P142
   Fisher E, 1991, DIABETES S1, V40, p538A
   Fisher EB, 1997, INT J BEHAV MED, V4, P131, DOI 10.1207/s15327558ijbm0402_3
   FREUND A, 1991, HEALTH PSYCHOL, V10, P200, DOI 10.1037//0278-6133.10.3.200
   GLASGOW RE, 1986, J BEHAV MED, V9, P65, DOI 10.1007/BF00844645
   Greco P., 1990, DIABETES S1, V40, pA165
   HARRIS MA, 1999, FAM SYST HEALTH, V17, P181, DOI DOI 10.1037/H0089881
   La Greca AM, 2004, MANUAL SELF CARE INV
   La Greca AM, 1988, 9 ANN SESS SOC BEH M, pA42
   LAGRECA A, 1990, DIABETES S1, V39, pA164
   LAGRECA AM, 1995, CHILD HEALTH CARE, V24, P61, DOI 10.1207/s15326888chc2401_6
   LAGRECA AM, 1987, DIABETES CARE, V10, P659
   LEWIS KS, 1994, HDB PSYCHOL DIABETES, P247
   McNabb WL, 1997, DIABETES CARE, V20, P215, DOI 10.2337/diacare.20.2.215
   Nunnally JC, 1994, PSYCHOMETRIC THEORY
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   POLONSKY WH, 1994, DIABETES CARE, V17, P1178, DOI 10.2337/diacare.17.10.1178
   Robinson J. P., 1991, MEASURES PERSONALITY
   ROSENBERG M, 1995, AM SOCIOL REV, V60, P141, DOI 10.2307/2096350
   Rosenberg M, 1965, SOC ADOLESCENT SELF
   SALLIS JF, 1985, AM J EPIDEMIOL, V121, P91, DOI 10.1093/oxfordjournals.aje.a113987
   SHAMOON H, 1993, NEW ENGL J MED, V329, P977
   Siminerio LM, 1999, DIABETES EDUCATOR, V25, P895, DOI 10.1177/014572179902500607
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   TOOBERT DJ, 1994, HDB PSYCHOL DIABETES, P351
   TRUST MO, 1993, SCORE SF 36 HLTH SUR
   Turner RC, 1998, LANCET, V352, P837
   van der Ven NCW, 2003, DIABETES CARE, V26, P713, DOI 10.2337/diacare.26.3.713
   Welch G, 2003, DIABETIC MED, V20, P69, DOI 10.1046/j.1464-5491.2003.00832.x
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   WELCH GW, 1991, AFFECT DISORD, V21, P101
   WICK P, 1991, DIABETES, V40, pA538
   WYLIE R, 1989, MEASURES SELF CONCEP
   Wysocki T, 1996, DIABETES CARE, V19, P119, DOI 10.2337/diacare.19.2.119
NR 40
TC 132
Z9 136
U1 1
U2 10
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
J9 DIABETES CARE
JI Diabetes Care
PD JUN
PY 2005
VL 28
IS 6
BP 1346
EP 1352
DI 10.2337/diacare.28.6.1346
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 931QM
UT WOS:000229500000012
PM 15920050
OA Green Published, Bronze, Green Accepted
DA 2019-01-08
ER

PT J
AU Lowes, L
   Gregory, JW
   Lyne, P
AF Lowes, L
   Gregory, JW
   Lyne, P
TI Newly diagnosed childhood diabetes: a psychosocial transition for
   parents?
SO JOURNAL OF ADVANCED NURSING
LA English
DT Article
DE childhood diabetes; parents; grief; adaptation; psychosocial transition;
   nursing
ID CHILDREN; MELLITUS
AB Aim. This paper reports a study to gain a new theoretical understanding of parental grief responses and the process of adaptation to a diagnosis of childhood diabetes.
   Background. A diagnosis of childhood (type 1) diabetes is an anxious and distressing event for the whole family. Little is known about the experience of parents of newly diagnosed children as they cope with and adapt to their new situation. Parkes' Theory of Psychosocial Transition proposes that life-change events, or 'psychosocial transitions', require people to undertake a major revision of their assumptions about the world. The relevance of this theory to adjusting to a diagnosis of childhood diabetes has not been explored.
   Method. Forty audio taped in-depth interviews were undertaken with 38 parents of 20 newly-diagnosed children. The data were subsequently examined using the framework of the Theory of Psychosocial Transition.
   Findings. Before diagnosis, most parents associated their child's symptoms with normal childhood illnesses. The unexpectedness and speed of the diagnosis left all parents ill-prepared to deal with the situation. Their world suddenly changed, leaving them insecure and uncertain about the future. Diabetes intruded emotionally and practically upon all of their lives. Parents successfully adjusted and adapted their lives and rebuilt a new model of the world to accommodate their child's diabetes. However, this dynamic process has no guaranteed endpoint for parents.
   Conclusions. A diagnosis of childhood diabetes leads to a psychosocial transition for parents. The concept of transition provides a logical explanation of parents' responses to loss, and allows increased understanding of the grieving and adaptation processes experienced by parents of children diagnosed with a chronic condition such as diabetes. This knowledge should help health care professionals to assist parents in the period of transition.
C1 Cardiff Univ, Wales Coll Med, Paediat Diabet Nursing Hlth & Social Care Res Ctr, Cardiff, S Glam, Wales.
   Cardiff Univ, Wales Coll Med, Dept Child Hlth, Cardiff, S Glam, Wales.
RP Lowes, L (reprint author), Univ Wales Hosp, Dept Child Hlth, Heath Pk, Cardiff CF14 4XW, S Glam, Wales.
EM lowes@cardiff.ac.uk
CR Brink S. J., 1995, P213
   BURDEN AC, 1989, DIABETIC MED, V6, P334
   BURNARD P, 1998, SOCIAL SCI HLTH, V4, P55
   CANAM C, 1993, J ADV NURS, V18, P46, DOI 10.1046/j.1365-2648.1993.18010046.x
   Dey I, 1996, QUALITATIVE DATA ANA
   *DIAB CONTR COMPL, 1993, NEW ENGL J MED, V329, P977, DOI DOI 10.1056/NEJM199309303291401
   Dorman J. S., 1995, P139
   Gardner SG, 1997, BRIT MED J, V315, P713, DOI 10.1136/bmj.315.7110.713
   Heidegger Martin, 1962, BEING TIME
   Karvonen M, 2000, DIABETES CARE, V23, P1516, DOI 10.2337/diacare.23.10.1516
   Koch T, 1996, J ADV NURS, V24, P174, DOI 10.1046/j.1365-2648.1996.17224.x
   Lazarus R. S, 1984, STRESS APPRAISAL COP
   LEONARD VW, 1989, ADV NURS SCI, V11, P40, DOI 10.1097/00012272-198907000-00008
   Lowes L, 1999, Br J Nurs, V8, P133
   Lowes L, 2000, J ADV NURS, V32, P41, DOI 10.1046/j.1365-2648.2000.01418.x
   Lowes L, 2004, DIABETIC MED, V21, P531, DOI 10.1111/j.1464-5491.2004.01193.x
   LOWES L, 2000, NEWLY DIAGNOSED CHIL
   MAY KA, 1991, QUALITATIVE NURSING, P188
   MCCUBBIN H., 1983, STRESS FAMILY, P5
   MCEVILLY A, 1996, CASCADE ACTION S DEC, P4
   Parkes C.M., 1996, BEREAVEMENT STUDIES
   PARKES CM, 1988, J SOC ISSUES, V44, P53, DOI 10.1111/j.1540-4560.1988.tb02076.x
   PARKES CM, 1971, SOC SCI MED, V5, P101
   PARKES CM, 1986, LOSS GRIEF 2
   Parkes Colin Murray, 1993, P91, DOI 10.1017/CBO9780511664076.007
   SANDELOWSKI M, 1986, ADV NURS SCI, V8, P27, DOI 10.1097/00012272-198604000-00005
   SCHRATZ M, 1995, RES SOCIAL CHANGE NE
   Svensson J, 2002, DIABETES CARE, V25, P2197, DOI 10.2337/diacare.25.12.2197
   WALTERS AJ, 1995, J ADV NURS, V22, P791, DOI 10.1046/j.1365-2648.1995.22040791.x
NR 29
TC 43
Z9 44
U1 1
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0309-2402
EI 1365-2648
J9 J ADV NURS
JI J. Adv. Nurs.
PD MAY
PY 2005
VL 50
IS 3
BP 253
EP 261
DI 10.1111/j.1365-2648.2005.03388.x
PG 9
WC Nursing
SC Nursing
GA 920DP
UT WOS:000228669900004
PM 15811104
DA 2019-01-08
ER

PT J
AU Polonsky, WH
   Fisher, L
   Earles, J
   Dudl, RJ
   Lees, J
   Mullan, J
   Jackson, RA
AF Polonsky, WH
   Fisher, L
   Earles, J
   Dudl, RJ
   Lees, J
   Mullan, J
   Jackson, RA
TI Assessing psychosocial distress in diabetes - Development of the
   Diabetes Distress Scale
SO DIABETES CARE
LA English
DT Article
ID QUALITY-OF-LIFE; PROBLEM AREAS; MARITAL RELATIONSHIP; INTENSIVE
   TREATMENT; GLYCEMIC CONTROL; QUESTIONNAIRE; INDIVIDUALS; VALIDITY
AB OBJECTIVE - The purpose of this Study was to describe the development of the Diabetes Distress Scale (DDS), a new instrument for the assessment of diabetes-related emotional distress, based on four independent patient samples.
   RESEARCH DESIGN AND METHODS - in consultation with patients and professionals from multiple disciplines, a preliminary scale of 28 items was developed, based a priori on four distress-related domains: emotional burden subscale, physician-related distress subscale, regimen-related distress subscale, and diabetes-related interpersonal distress. The new instrument was included in a larger battery of questionnaires used in diabetes studies at four diverse Sites: waiting room at a primary care clinic (n = 200), waiting room at a diabetes specialty clinic (n = 179), a diabetes management Study program (n = 167), and an ongoing diabetes management progam (n = 158).
   RESULTS - Exploratory factor analyses revealed four factors consistent across sites (involving 17 of the 28 items) that matched the critical content domains identified earlier. The correlation between the 28-item and 17-item scales was very high (r = 0.99). The mean correlation between the 17-item total score (DDS) and the four subscales was high (r = 0.82), but the pattern of interscale correlations suggested that the subscales, although not totally independent, tapped into relatively different areas of diabetes-related distress. Internal reliability of the DDS and the four subscales was adequate (alpha > 0.87), and validity coefficients yielded significant linkages with the Center for Epidemiological Studies Depression Scale, meal planning, exercise, and total cholesterol. Insulin users evidenced the highest mean DDS total scores, whereas diet-controlled subjects displayed the lowest scores (P < 0.001).
   CONCLUSIONS - The DDS has a consistent, generalizable factor structure and good internal reliability and validity across four different clinical sites. The new instrument may serve as a valuable measure of diabetes-related emotional distress for use in research and clinical practice.
C1 Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA.
   Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA.
   Tripler Army Med Ctr, Honolulu, HI 96859 USA.
   Kaiser Permanente, San Diego, CA USA.
   USN, Med Ctr, San Diego, CA 92152 USA.
   Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02115 USA.
RP Polonsky, WH (reprint author), CDE,POB 2148, Del Mar, CA 92014 USA.
EM whpolonsky@aol.com
CR DUNN SM, 1986, DIABETES CARE, V9, P480, DOI 10.2337/diacare.9.5.480
   Egede LE, 2003, DIABETES CARE, V26, P104, DOI 10.2337/diacare.26.1.104
   Herschbach P, 1997, HEALTH PSYCHOL, V16, P171, DOI 10.1037/0278-6133.16.2.171
   Ishii H, 1999, DIABETES, V48, pA319
   Lerman-Garber I, 2003, SALUD PUBLICA MEXICO, V45, P13, DOI 10.1590/s0036-36342003000100002
   Nichols GA, 2003, DIABETES CARE, V26, P744, DOI 10.2337/diacare.26.3.744
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 2003, DIABETES CARE, V26, P3048, DOI 10.2337/diacare.26.11.3048
   Polonsky WH, 2000, DIABETES SPECTRUM, V13, P36
   Polonsky William H, 2002, Curr Diab Rep, V2, P153, DOI 10.1007/s11892-002-0075-5
   RADLOFF LS, 1977, APPL PSYCH MEAS, V3, P385
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   TOOBERT DJ, 1994, HDB PSYCHOL DIABETES, P351
   Trief PM, 2002, DIABETES CARE, V25, P1154, DOI 10.2337/diacare.25.7.1154
   Trief PM, 2001, DIABETES CARE, V24, P1384, DOI 10.2337/diacare.24.8.1384
   Weinger K, 2001, PATIENT EDUC COUNS, V42, P123, DOI 10.1016/S0738-3991(00)00098-7
   Welch G, 2003, DIABETIC MED, V20, P69, DOI 10.1046/j.1464-5491.2003.00832.x
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
NR 19
TC 406
Z9 424
U1 2
U2 40
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
J9 DIABETES CARE
JI Diabetes Care
PD MAR
PY 2005
VL 28
IS 3
BP 626
EP 631
DI 10.2337/diacare.28.3.626
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 903ME
UT WOS:000227429200021
PM 15735199
OA Bronze
DA 2019-01-08
ER

PT J
AU Sigurthardottir, AK
AF Sigurthardottir, AK
TI Self-care in diabetes: model of factors affecting self-care
SO JOURNAL OF CLINICAL NURSING
LA English
DT Article
DE diabetes; emotional aspects; knowledge; physical skills; self-care;
   self-efficacy
ID RANDOMIZED CONTROLLED TRIAL; GLYCEMIC CONTROL; PROBLEM AREAS; EFFICACY;
   MANAGEMENT; ADHERENCE; PEOPLE; DISTRESS; MELLITUS; ADULTS
AB Aims and objectives. The aim of this paper is to explore self-care in diabetes and to present a model of factors that affect self-care according to reviewed literature.
   Background. Self-care in diabetes is crucial to keep the disease under control. Self-care consists at least four aspects: (i) self-monitoring of blood glucose, (ii) variation of nutrition to daily needs, (iii) insulin dose adjustments to actual needs and (iv) taking exercise regularly. It is known that diverse factors influence self-care such as knowledge, physical skills and emotional aspects and self-efficacy which have been listed as being of high importance.
   Methods. The searched databases were ProQuest, PsycINFO and Medline from 1995 to 2002. The search terms were 'self-care' or 'self-management' coexisting with diabetes and 'self-efficacy'. The search was limited to English and adults with type 1 diabetes.
   Results. The main components of the model clarify how knowledge, physical skills and emotional factors as well as self-efficacy influence self-care which again affects metabolic control. Flexible self-care indicates high level of self-care when patients are able to care for and manage the disease in a responsible and flexible way that does not affect their life extensively, resulting in adequate glycosylated haemoglobin value. Self-efficacy is a strong predictor of flexible self-care and affects metabolic control through increased perceived ability to conduct self-care.
   Conclusion. The review illuminated that benefits of self-care should be emphasized and knowledge of the Diabetes Complication and Control Trial results can contribute to better self-care. However, factors affecting flexible self-care still require better identification.
   Relevance to clinical practice.The review emphasizes and adds to the topic, that in daily practice health care practitioners must assess diabetes-related knowledge, physical skills and emotional factors in combination with self-efficacy and the four self-care areas. The effects of self-monitoring of blood glucose needs better clarifications as it is now regarded the cornerstone of flexible self-care.
C1 Univ Akureyri, Fac Hlth Sci, IS-602 Akureyri, Iceland.
RP Sigurthardottir, AK (reprint author), Univ Akureyri, Fac Hlth Sci, POB 224, IS-602 Akureyri, Iceland.
EM arun@unak.is
CR Aalto AM, 2000, EUR J PUBLIC HEALTH, V10, P68, DOI 10.1093/eurpub/10.1.68
   ADA, 2000, DIABETES CARE, V23, pS32 
   Amiel S, 2002, BRIT MED J, V325, P746
   ANDERSON RM, 1995, DIABETES CARE, V18, P943, DOI 10.2337/diacare.18.7.943
   BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191
   BANDURA A, 1986, SOCIAL FDN THOUGHT A
   Bandura A., 1997, SELF EFFICACY EXERCI
   Barlow J, 2002, PATIENT EDUC COUNS, V48, P177, DOI 10.1016/S0738-3991(02)00032-0
   Bernal H, 2000, DIABETES EDUCATOR, V26, P673, DOI 10.1177/014572170002600415
   BROOME M. E., 2000, CONCEPT DEV NURSING, P231
   BROWN SA, 1994, NURS RES, V43, P362
   COATES V, 1995, INT J NURS STUD, V12, P628
   Coates VE, 1998, J ADV NURS, V27, P528, DOI 10.1046/j.1365-2648.1998.00546.x
   Corbett C F, 1999, Home Healthc Nurse, V17, P587, DOI 10.1097/00004045-199909000-00010
   DEWEERDT I, 1990, SOC SCI MED, V30, P605, DOI 10.1016/0277-9536(90)90159-P
   Gilmer TP, 1997, DIABETES CARE, V20, P1847, DOI 10.2337/diacare.20.12.1847
   Hernandez CA, 1999, DIABETES EDUCATOR, V25, P576, DOI 10.1177/014572179902500410
   Herschbach P, 1997, HEALTH PSYCHOL, V16, P171, DOI 10.1037/0278-6133.16.2.171
   Hurley C, 1992, DIABETES ED, V18, P146
   JENSEN K, 1993, J ADV NURS, V18, P926, DOI 10.1046/j.1365-2648.1993.18060926.x
   Johnston-Brooks CH, 2002, PSYCHOSOM MED, V64, P43, DOI 10.1097/00006842-200201000-00007
   Lo R, 1999, J ADV NURS, V30, P418, DOI 10.1046/j.1365-2648.1999.01085.x
   Paterson B, 2000, RES NURS HEALTH, V23, P147, DOI 10.1002/(SICI)1098-240X(200004)23:2<147::AID-NUR7>3.0.CO;2-S
   Paterson B L, 1998, Image J Nurs Sch, V30, P57
   Peyrot M, 1999, J HEALTH SOC BEHAV, V40, P141, DOI 10.2307/2676370
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Rubin R. R., 1993, DIABETES ED, V19, P210, DOI [DOI 10.1177/014572179301900308, 10.1177/014572179301900308]
   Ruggiero L, 1997, DIABETES CARE, V20, P568, DOI 10.2337/diacare.20.4.568
   SCHWARZER R, 2001, PREDICTING BEHAV, P163
   Senecal C, 2000, HEALTH PSYCHOL, V19, P452, DOI 10.1037//0278-6133.19.5.452
   SHAMOON H, 1993, NEW ENGL J MED, V329, P977
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Toljamo M, 2001, J CLIN NURS, V10, P618, DOI 10.1046/j.1365-2702.2001.00520.x
   Toljamo M, 2001, J ADV NURS, V34, P780, DOI 10.1046/j.1365-2648.2001.01808.x
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
NR 35
TC 49
Z9 50
U1 2
U2 13
PU BLACKWELL PUBLISHING LTD
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DG, OXON, ENGLAND
SN 0962-1067
J9 J CLIN NURS
JI J. Clin. Nurs.
PD MAR
PY 2005
VL 14
IS 3
BP 301
EP 314
DI 10.1111/j.1365-2702.2004.01043.x
PG 14
WC Nursing
SC Nursing
GA 896WE
UT WOS:000226964100004
PM 15707440
DA 2019-01-08
ER

PT J
AU van der Ven, NCW
   Lubach, CHC
   Hogenelst, MHE
   van Iperen, A
   Tromp-Wever, AME
   Vriend, A
   van der Ploeg, HM
   Heine, RJ
   Snoek, FJ
AF van der Ven, NCW
   Lubach, CHC
   Hogenelst, MHE
   van Iperen, A
   Tromp-Wever, AME
   Vriend, A
   van der Ploeg, HM
   Heine, RJ
   Snoek, FJ
TI Cognitive behavioural group training (CBGT) for patients with type I
   diabetes in persistent poor glycaemic control: who do we reach?
SO PATIENT EDUCATION AND COUNSELING
LA English
DT Article
DE behavioural intervention; diabetes; reach
ID SELF-MANAGEMENT; PRIMARY-CARE; COMPLICATIONS; DEPRESSION; THERAPY;
   TRIAL; PREVALENCE; ADULTS; DUTCH; US
AB Approximately a quarter of adults with type 1 diabetes do not succeed in achieving satisfactory glycaemic control, partly due to problems with the demanding self-management regimen. To improve glycaemic control, interventions with a cognitive behavioural approach, aimed at modifying dysfunctional beliefs, reducing negative emotions and enhancing self-care practices are a potentially successful tool. Little is known about the reach of such an approach. This article describes characteristics of participants in a randomized, controlled trial of cognitive behavioural group training for patients with type I diabetes in poor glycaemic control. Results show that outpatients from seven hospitals in the area of Amsterdam, selected on long-standing high HbA1c and volunteering to participate, report high levels of psychological distress and depressive symptoms. Furthermore, self-care behaviours were perceived as important, but burdensome. Diabetes-specific self-efficacy was relatively low. It is concluded that this selected group of adults with type I diabetes would potentially benefit from a cognitive-behavioural intervention in order to reduce negative emotions, enhance diabetes self-efficacy, self-care behaviour and glycaemic outcomes. (c) 2004 Elsevier Ireland Ltd. All rights reserved.
C1 Vrije Univ Amsterdam, Med Ctr, Dept Med Psychol, Diabet Res Grp, NL-1081 BT Amsterdam, Netherlands.
   Vrije Univ Amsterdam, Med Ctr, ICaR, NL-1081 BT Amsterdam, Netherlands.
   Vrije Univ Amsterdam, Med Ctr, Dept Endocrinol, NL-1081 BT Amsterdam, Netherlands.
RP van der Ven, NCW (reprint author), Vrije Univ Amsterdam, Med Ctr, Dept Med Psychol, Diabet Res Grp, Vd Boechorstr 7, NL-1081 BT Amsterdam, Netherlands.
EM ncw.vanderven@vumc.nl
CR Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3
   *AM DIAB ASS, 2004, DIABETES CARE, V27, pS33
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Becker M. H., 1974, HLTH ED MONOGRAPHS, V2, P324, DOI DOI 10.1177/109019817400200401
   Bouma J, 1995, HET METEN SYMPTOMEN
   Coates VE, 1996, PATIENT EDUC COUNS, V29, P99, DOI 10.1016/0738-3991(96)00938-X
   COX DJ, 1994, BLOOD GLUCOSE AWAREN, V3
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   DeVries JH, 2002, DIABETES CARE, V25, P2074, DOI 10.2337/diacare.25.11.2074
   DEVRIES JH, 2002, DIAB METAB RES REV, V19, P357
   EMMELKAMP PMG, 1993, PSYCHOTHER PSYCHOSOM, V59, P116, DOI 10.1159/000288656
   Enright SJ, 1997, BRIT MED J, V314, P1811, DOI 10.1136/bmj.314.7097.1811
   Ettema J.H.M., 2003, SYMPTOM CHECKLIST SC
   Fosbury JA, 1997, DIABETES CARE, V20, P959, DOI 10.2337/diacare.20.6.959
   Genuth S, 2002, JAMA-J AM MED ASSOC, V287, P2563
   Glasgow RE, 2001, PATIENT EDUC COUNS, V44, P119, DOI 10.1016/S0738-3991(00)00186-5
   Harwell TS, 2002, DIABETES EDUCATOR, V28, P99, DOI 10.1177/014572170202800111
   Kessler D, 2002, BRIT MED J, V325, P1016, DOI 10.1136/bmj.325.7371.1016
   Kuijer RG, 2003, PSYCHOL HEALTH, V18, P313, DOI 10.1080/0887044031000146815
   LEVENTHAL H, HDB PSYCHOL HLTH, V4, P219
   Lorenz RA, 1996, DIABETES CARE, V19, P648, DOI 10.2337/diacare.19.6.648
   Penn JV, 1997, GEN HOSP PSYCHIAT, V19, P179, DOI 10.1016/S0163-8343(97)00005-4
   Peyrot M, 1997, DIABETES CARE, V20, P585, DOI 10.2337/diacare.20.4.585
   POLONSKY WH, 1999, DIABETES BURN WHAT D
   Pouwer F, 2001, DIABETES CARE, V24, P1929, DOI 10.2337/diacare.24.11.1929
   Radloff L., 1977, APPL PSYCH MEAS, V1, P185
   Ruggiero L, 1997, DIABETES CARE, V20, P568, DOI 10.2337/diacare.20.4.568
   SHAMOON H, 1993, NEW ENGL J MED, V329, P977
   Shapiro SL, 2002, J BEHAV MED, V25, P605, DOI 10.1023/A:1020693417427
   Snoek FJ, 2001, PATIENT EDUC COUNS, V45, P143, DOI 10.1016/S0738-3991(01)00113-6
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   SNOEK FJ, 2002, DIABETIC MED, V59, P265
   *SOC CULT PLANB, 1999, SOC SURV NETH 1999
   *SPSS INC, 2001, SPSS WIND
   Taylor MD, 2003, DIABETIC MED, V20, P135, DOI 10.1046/j.1464-5491.2003.00887.x
   Toeller M, 1999, HORM METAB RES, V31, P680, DOI 10.1055/s-2007-978820
   van der Ven NCW, 2003, DIABETES CARE, V26, P713, DOI 10.2337/diacare.26.3.713
   VIINAMAKI H, 1991, PSYCHOTHER PSYCHOSOM, V56, P24, DOI 10.1159/000288526
   Ware JE, 1993, SF 36 HLTH SURVEY MA
   Wittchen HU, 2002, HUM PSYCHOPHARM CLIN, V17, pS1, DOI 10.1002/hup.398
   *WRKGR PSYCH DIAB, 1996, DUTCH VERS BLOOD GLU
NR 41
TC 24
Z9 24
U1 1
U2 13
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0738-3991
J9 PATIENT EDUC COUNS
JI Patient Educ. Couns.
PD MAR
PY 2005
VL 56
IS 3
BP 313
EP 322
DI 10.1016/j.pec.2004.03.005
PG 10
WC Public, Environmental & Occupational Health; Social Sciences,
   Interdisciplinary
SC Public, Environmental & Occupational Health; Social Sciences - Other
   Topics
GA 905SO
UT WOS:000227590200009
PM 15721974
DA 2019-01-08
ER

PT J
AU Whittemore, R
   Melkus, GD
   Grey, M
AF Whittemore, R
   Melkus, GD
   Grey, M
TI Metabolic control, self-management and psychosocial adjustment in women
   with type 2 diabetes
SO JOURNAL OF CLINICAL NURSING
LA English
DT Article
DE metabolic control; psychosocial adjustment; self-management; type 2
   diabetes; women
ID AFRICAN-AMERICAN WOMEN; SOCIAL SUPPORT; PHYSICAL-ACTIVITY;
   CARDIOVASCULAR EVENTS; GLYCEMIC CONTROL; HEART-DISEASE; META-ANALYSIS;
   ADULTS; ADHERENCE; MELLITUS
AB Aims. To examine factors associated with metabolic control, self-management (diet and exercise behaviour), and psychosocial adjustment (diabetes-related distress) in women with type 2 diabetes.
   Design. Cross-sectional design using baseline data of women with type 2 diabetes enrolled to participate in a pilot study of a nurse coaching intervention (n = 53).
   Ethical issues. Appropriate ethical review and approval was completed. Informed consent from participants was obtained.
   Outcome measures. Physiological measures included body mass index and glycosylated haemoglobin (HbA1c). Self-management measures included the Dietary Subscale of the Summary of Diabetes Self-Care Activities Questionnaire and a modified Paffenbarger Physical Activity Questionnaire. Psychosocial measures included the Problem Areas in Diabetes Survey (diabetes-related distress), the Diabetes Questionnaire, the Diabetes Self-Management Assessment Tool Support and Confidence Subscale, and the Social Functioning Scale. Descriptive, bivariate, and multivariate analyses were completed.
   Results. The most consistent predictor of metabolic control, dietary self-management, and diabetes-related distress was support and confidence in living with diabetes. Additionally, women had difficulty meeting optimal goals for exercise, yet reported higher levels of other physical activity.
   Limitations. This study was an exploratory analysis with a homogeneous sample of women with type 2 diabetes enrolled in an intervention study and measurements included multiple self-report instruments.
   Conclusions. Interventions to increase women's perceived self-confidence and support may contribute to positive health outcomes in women with type 2 diabetes.
   Relevance to clinical practice. Assessment of social support and self-confidence in diabetes self-management in women with type 2 diabetes may assist in determining individualized goals and strategies. Enhanced social support and self-confidence in diabetes self-management may subsequently improve metabolic control, self-management and psychosocial adjustment to diabetes.
C1 Yale Univ, Sch Nursing, New Haven, CT 06536 USA.
RP Whittemore, R (reprint author), Yale Univ, Sch Nursing, 100 Church St S, New Haven, CT 06536 USA.
EM robin.whittemore@yale.edu
CR AINSWORTH BE, 1993, J CLIN EPIDEMIOL, V46, P1403, DOI 10.1016/0895-4356(93)90140-V
   *AM HEART ASS, 2003, STAT EX BEN REC PHYS
   ANDERSON RJ, 2001, DIABETES CARE, V24, P1067
   [Anonymous], 2002, DIET REF INT EN CARB
   BANDURA A, 1986, SOCIAL FDN THOUGHT A
   BARRETTCONNOR EL, 1991, JAMA-J AM MED ASSOC, V265, P627, DOI 10.1001/jama.265.5.627
   BECKLES G, 2001, DIABETES WOMENS HLTH
   BROWN SA, 1994, NURS RES, V43, P362
   CHRISTAKOS CN, 1995, J MUSCULOSKEL MED, V12, P16
   Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278
   Connell C M, 1991, Diabetes Educ, V17, P364, DOI 10.1177/014572179101700507
   CONNELL CM, 1994, HEALTH PSYCHOL, V13, P263, DOI 10.1037//0278-6133.13.3.263
   *DIAB UK, 2003, DIAB COSTS COMPL
   *DIAB UK, 2003, PHYS ACT DIAB
   Duncan GE, 2003, DIABETES CARE, V26, P557, DOI 10.2337/diacare.26.3.557
   Farmer IP, 1996, BEHAV MED, V22, P59, DOI 10.1080/08964289.1996.9933765
   FITZGERALD JT, 1995, DIABETES EDUCATOR, V21, P523, DOI 10.1177/014572179502100605
   Ford ME, 1998, J NATL MED ASSOC, V90, P361
   Gilmer TP, 1997, DIABETES CARE, V20, P1847, DOI 10.2337/diacare.20.12.1847
   GLASGOW RE, 1988, DIABETES CARE, V11, P377, DOI 10.2337/diacare.11.5.377
   Hernandez CA, 1995, CANADIAN J DIABETES, V19, P18
   Hu FB, 2001, ANN INTERN MED, V134, P96, DOI 10.7326/0003-4819-134-2-200101160-00009
   Hurley A C, 1992, Diabetes Educ, V18, P146, DOI 10.1177/014572179201800208
   Kaplan RM, 1990, SOCIAL SUPPORT INTER, P427
   KVAM SH, 1991, PSYCHOL REP, V68, P623, DOI 10.2466/PR0.68.2.623-632
   Lee IM, 2001, JAMA-J AM MED ASSOC, V285, P1447, DOI 10.1001/jama.285.11.1447
   Lenz ER, 2002, SELF EFFICACY NURSIN
   LITTLEFIELD CH, 1990, HEALTH PSYCHOL, V9, P737, DOI 10.1037//0278-6133.9.6.737
   LUDLOW AP, 1995, CANADIAN J DIABETES, V19, P10
   MacLean D, 1998, Aust J Adv Nurs, V15, P33
   Manson JE, 2002, NEW ENGL J MED, V347, P716, DOI 10.1056/NEJMoa021067
   Maxwell A E, 1992, Diabetes Educ, V18, P303, DOI 10.1177/014572179201800408
   MCCAUL KD, 1987, MED CARE, V25, P868, DOI 10.1097/00005650-198709000-00005
   MERCADO FJ, 1989, WOMEN HEALTH, V15, P111
   MONAGHAN MS, 1999, MONITORING CONTROL T
   Mulcahy K, 2000, DIABETES EDUCATOR, V26, P957, DOI 10.1177/014572170002600608
   *NAT DIAB INF CLEA, 1998, DIAB STAT
   Nelson KM, 2002, DIABETES CARE, V25, P1722, DOI 10.2337/diacare.25.10.1722
   PADGETT D, 1988, J CLIN EPIDEMIOL, V41, P1007, DOI 10.1016/0895-4356(88)90040-6
   PAFFENBARGER RS, 1978, AM J EPIDEMIOL, V108, P161, DOI 10.1093/oxfordjournals.aje.a112608
   Petersen M, 2003, DIABETES CARE, V26, P917
   Peyrot M, 1997, DIABETES CARE, V20, P585, DOI 10.2337/diacare.20.4.585
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 1996, DIABETES SPECTRUM, V9, P8
   Quackenbush PA, 1996, DIABETES EDUCATOR, V22, P231, DOI 10.1177/014572179602200306
   Rubin RR, 1998, DIABETES SPECTRUM, V11, P81
   Saaddine JB, 2002, ANN INTERN MED, V136, P565, DOI 10.7326/0003-4819-136-8-200204160-00005
   Samuel-Hodge CD, 2000, DIABETES CARE, V23, P928, DOI 10.2337/diacare.23.7.928
   SKELLY AH, 1995, DIABETES EDUCATOR, V21, P38, DOI 10.1177/014572179502100107
   Smith L, 2000, DIABETES EDUCATOR, V26, P645, DOI 10.1177/014572170002600412
   Toljamo M, 2001, J CLIN NURS, V10, P618, DOI 10.1046/j.1365-2702.2001.00520.x
   TOOBERT DJ, 1994, HDB PSYCHOL DIABETES, P351
   Trief PM, 2001, DIABETES CARE, V24, P1384, DOI 10.2337/diacare.24.8.1384
   Turner R, 1996, ANN INTERN MED, V124, P136, DOI 10.7326/0003-4819-124-1_Part_2-199601011-00011
   Turner RC, 1998, LANCET, V352, P837
   VANDENBERG DJE, 2002, SELF EFFICACY NURSIN, P53
   Wallberg-Henriksson H, 1992, Exerc Sport Sci Rev, V20, P339
   Ware JE, 1994, SF 36 PHYS MENTAL HL
   White N E, 1992, West J Nurs Res, V14, P211, DOI 10.1177/019394599201400208
   Willoughby DF, 2000, J ADV NURS, V32, P1422, DOI 10.1046/j.1365-2648.2000.01620.x
   Wood FG, 2002, WESTERN J NURS RES, V24, P502, DOI 10.1177/019394502400446388
NR 61
TC 81
Z9 83
U1 1
U2 21
PU BLACKWELL PUBLISHING LTD
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DG, OXON, ENGLAND
SN 0962-1067
J9 J CLIN NURS
JI J. Clin. Nurs.
PD FEB
PY 2005
VL 14
IS 2
BP 195
EP 203
DI 10.1111/j.1365-2702.2004.00937.x
PG 9
WC Nursing
SC Nursing
GA 890LJ
UT WOS:000226512400007
PM 15669928
DA 2019-01-08
ER

PT J
AU Rasul, F
   Stansfeld, SA
   Hart, CL
   Smith, GD
AF Rasul, F
   Stansfeld, SA
   Hart, CL
   Smith, GD
TI Psychological distress, physical illness, and risk of coronary heart
   disease
SO JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH
LA English
DT Article
ID CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; ARTERY-DISEASE;
   DEPRESSIVE SYMPTOMS; MAJOR DEPRESSION; PAISLEY MIDSPAN; MORTALITY; MEN;
   ADULTS; HOPELESSNESS
AB Study objective: The aims of this study are to confirm the association between psychological distress and coronary heart disease (CHD) using an epidemiological community study with hospital admissions data and to examine if any association is explained by existing illness.
   Design: Prospective cohort study modelling the association between psychological distress, measured using the 30 item general health questionnaire (GHQ), and hospital admissions data for CHD (ICD 410 414), using proportional hazards modelling adjusted for sociodemographic, CHD risk factors, and angina, bronchitis, diabetes, ischaemia, and stroke.
   Setting: Two suburbs of Glasgow, Renfrew and Paisley, in Scotland.
   Participants: 6575 men and women aged 45-64 years from Paisley.
   Main results: Five year CHD risk in distressed men compared with non-distressed men was 1.78 (95% confidence intervals (CI), 1.15 to 2.75) in age adjusted analysis, 1.78 (95% CI, 1.14 to 2.79) with sociodemographic and CHD risk factor adjustment, and 1.61 (95% CI 1.02 to 2.55) with additional adjustment for existing illness. Psychological distress was unrelated to five year CHD risk in women. In further analysis, compared with healthy, non-distressed men, distressed physically ill men had a greater risk of CHD than non-distressed physically ill men, a relative risk of 4.01 (95% CI 2.42 to 6.66) compared with 2.12 (95% CI 1.35 to 3.32).
   Conclusion: The association of psychological distress with an increased risk of five year CHD risk in men could be a function of baseline physical illness but an effect independent of physical illness cannot be ruled out. Its presence among physically ill men greatly increases CHD risk.
C1 Univ London, Barts & London Sch Med & Dent, Inst Community Hlth Sci, Dept Psychiat, London E1 4NS, England.
   Univ Glasgow, Div Community Based Sci, Glasgow, Lanark, Scotland.
   Univ Bristol, Dept Social Med, Bristol, Avon, England.
RP Rasul, F (reprint author), Univ London, Barts & London Sch Med & Dent, Inst Community Hlth Sci, Dept Psychiat, Mile End Rd, London E1 4NS, England.
EM F.R.Rasul@qmul.ac.uk
OI Venkatasubramanian, Siddharth/0000-0002-5860-0768; s,
   hema/0000-0002-3440-9475; Monsalve, Beatriz Elena/0000-0002-5994-866X;
   Davey Smith, George/0000-0002-1407-8314
CR ANDA R, 1993, EPIDEMIOLOGY, V4, P285, DOI 10.1097/00001648-199307000-00003
   ANDA RF, 1990, JAMA-J AM MED ASSOC, V264, P1541, DOI 10.1001/jama.264.12.1541
   Anfossi G, 1996, EUR J CLIN INVEST, V26, P353, DOI 10.1046/j.1365-2362.1996.150293.x
   Appels A, 1997, ACTA PHYSIOL SCAND, V161, P153
   Ariyo AA, 2000, CIRCULATION, V102, P1773
   Barefoot JC, 1996, CIRCULATION, V93, P1976, DOI 10.1161/01.CIR.93.11.1976
   Barrick CB, 1999, J AFFECT DISORDERS, V53, P193, DOI 10.1016/S0165-0327(98)00184-0
   BOOTHKEWLEY S, 1987, PSYCHOL BULL, V101, P343, DOI 10.1037//0033-2909.101.3.343
   Braunwald E, 1997, NEW ENGL J MED, V337, P1360, DOI 10.1056/NEJM199711063371906
   Carney RM, 2001, ARCH GEN PSYCHIAT, V58, P229, DOI 10.1001/archpsyc.58.3.229
   Everson SA, 1996, PSYCHOSOM MED, V58, P113, DOI 10.1097/00006842-199603000-00003
   Ferketich AK, 2000, ARCH INTERN MED, V160, P1261, DOI 10.1001/archinte.160.9.1261
   Ford DE, 1998, ARCH INTERN MED, V158, P1422, DOI 10.1001/archinte.158.13.1422
   GOLDBERG D, 1972, MAUDSLEY MONOGRAPH, V21
   GROOTHEEST DS, 1999, SOCIAL PSYCHIAT PSYC, V34, P391
   HAWTHORNE VM, 1995, SCOT MED J, V40, P102, DOI 10.1177/003693309504000402
   Hemingway H, 1999, BMJ-BRIT MED J, V318, P1460, DOI 10.1136/bmj.318.7196.1460
   Hippisley-Cox J, 1998, BMJ-BRIT MED J, V316, P1714, DOI 10.1136/bmj.316.7146.1714
   Ketterer MW, 2000, J PSYCHOSOM RES, V48, P357, DOI 10.1016/S0022-3999(00)00099-4
   Kop WJ, 1999, PSYCHOSOM MED, V61, P476, DOI 10.1097/00006842-199907000-00012
   Lesperance F, 1996, PSYCHOSOM MED, V58, P99, DOI 10.1097/00006842-199603000-00001
   Macleod J, 2002, BMJ-BRIT MED J, V324, P1247, DOI 10.1136/bmj.324.7348.1247
   MANN AH, 1984, PSYCHOL MED MONOGR S, V5
   Mendes De Leon Carlos F., 1998, Archives of Internal Medicine, V158, P2341, DOI 10.1001/archinte.158.21.2341
   MIYAWAKI E, 1991, Integrative Psychiatry, V7, P21
   Musselman DL, 1998, ARCH GEN PSYCHIAT, V55, P580, DOI 10.1001/archpsyc.55.7.580
   Penninx BWJH, 1998, AM J CARDIOL, V81, P988, DOI 10.1016/S0002-9149(98)00077-0
   Penninx BWJH, 2001, ARCH GEN PSYCHIAT, V58, P221, DOI 10.1001/archpsyc.58.3.221
   Rajagopalan S, 2001, AM J CARDIOL, V88, P196, DOI 10.1016/S0002-9149(01)01623-X
   Rasul F, 2001, J HEALTH PSYCHOL, V6, P149, DOI 10.1177/135910530100600205
   Roberts RE, 2000, AM J EPIDEMIOL, V152, P163, DOI 10.1093/aje/152.2.163
   Rozanski A, 1999, CIRCULATION, V99, P2192, DOI 10.1161/01.CIR.99.16.2192
   Sesso HD, 1998, AM J CARDIOL, V82, P851, DOI 10.1016/S0002-9149(98)00491-3
   SIMONSICK EM, 1995, PSYCHOSOM MED, V57, P427, DOI 10.1097/00006842-199509000-00003
   Stansfeld SA, 2002, INT J EPIDEMIOL, V31, P248, DOI 10.1093/ije/31.1.248
   Vaccarino V, 2000, DRUG TODAY, V36, P715, DOI 10.1358/dot.2000.36.10.599210
   VANDIEST R, 1991, J PSYCHOSOM RES, V35, P535, DOI 10.1016/0022-3999(91)90048-S
   WARDLE J, 1995, J PSYCHOSOM RES, V39, P549, DOI 10.1016/0022-3999(94)00169-3
   Wielgosz AT, 2000, J PSYCHOSOM RES, V48, P339, DOI 10.1016/S0022-3999(99)00093-8
   Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837
   Wulsin LR, 2003, PSYCHOSOM MED, V65, P201, DOI 10.1097/01.PSY.0000058371.50240.E3
NR 41
TC 36
Z9 39
U1 0
U2 8
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0143-005X
EI 1470-2738
J9 J EPIDEMIOL COMMUN H
JI J. Epidemiol. Community Health
PD FEB
PY 2005
VL 59
IS 2
BP 140
EP 145
DI 10.1136/jech.2004.019786
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 911NJ
UT WOS:000228010000011
PM 15650146
OA Green Published, Bronze
DA 2019-01-08
ER

PT J
AU Lange, LJ
   Piette, JD
AF Lange, LJ
   Piette, JD
TI Perceived health status and perceived diabetes control: psychological
   indicators and accuracy
SO JOURNAL OF PSYCHOSOMATIC RESEARCH
LA English
DT Article
DE diabetes mellitus; perceived health status; mental health; depression;
   accuracy; diabetes control
ID BLOOD-GLUCOSE; SYMPTOM PERCEPTION; NEGATIVE AFFECTIVITY; GLYCEMIC
   CONTROL; AWARENESS; CARE; DEPRESSION; LIFE; TERM; COMPLICATIONS
AB Objective: The aim of this study is to assess the association of psychological, as well as physical and sociodemographic, indicators with patients' ratings of personal health status and diabetes control and to investigate the association of mental health and depression with errors in the perception of diabetes control. Method: A sociodemographically diverse sample of 623 diabetes patients was recruited from the general medicine clinics of a county health care system and a Veterans Affairs health care system. We examined three types of determinants of patients' health perceptions: physical health indicators (symptoms, comorbid diagnoses, and glycosylated hemoglobin or HbA(1c), levels), psychological health indicators (general mental health and diabetes-related worry), and sociodemographic factors (age, race, gender, income, and education). Results: After controlling for patient' sociodemographic characteristics, perceived general health was associated with patients' symptom burden and emotional distress (but not with patients' HbA(1c), levels). Perceived diabetes control additionally was associated with HbA(1c) and diabetes-related worries. Further analyses showed that both mental health and diagnosed depression were associated with errors in personal appraisals of diabetes control, with depressed patients more often inaccurately assessing their glycemic control as poor (false-positive error) and nondepressed patients more often missing poor HbA(1c) levels (false-negative error). Conclusions: Findings indicate that patients use a comprehensive model for assessing their general health and that depression may lead to more accurate assessments of poor glucose control. &COPY; 2005 Elsevier Inc. All rights reserved.
C1 Univ N Florida, Dept Psychol, Jacksonville, FL 32224 USA.
   Univ Michigan, VA Anne Arbor Hlth Care Syst, Ctr Practice Management & Outcomes Res, Ann Arbor, MI 48109 USA.
   Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.
   Michigan Diabet Res & Training Ctr, Ann Arbor, MI USA.
RP Lange, LJ (reprint author), Univ N Florida, Dept Psychol, 4567 St Johns Bluff Rd, Jacksonville, FL 32224 USA.
EM llange@unf.edu
CR ALLOY LB, 1979, J EXP PSYCHOL GEN, V108, P441, DOI 10.1037/0096-3445.108.4.441
   *AM DIAB ASS, 1999, DIABETES CARE, V22, pS77
   *AM DIAB ASS, 1999, DIABETES CARE S1, V22, pS32
   Brink E, 2002, J HEALTH PSYCHOL, V7, P533, DOI 10.1177/1359105302007005673
   CAMERON L, 1995, PSYCHOSOM MED, V57, P37, DOI 10.1097/00006842-199501000-00006
   CIOFFI D, 1991, PSYCHOL BULL, V109, P25, DOI 10.1037//0033-2909.109.1.25
   COX D, 1995, DIABETES CARE, V18, P523, DOI 10.2337/diacare.18.4.523
   COX DJ, 1985, DIABETES CARE, V8, P529, DOI 10.2337/diacare.8.6.529
   COX DJ, 1991, PSYCHOSOM MED, V53, P453, DOI 10.1097/00006842-199107000-00010
   COX DJ, 1994, DIABETES CARE, V17, P1, DOI 10.2337/diacare.17.1.1
   DCCT Res Grp, 1988, DIABETES CARE, V11, P725
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   Di Landro D, 1998, NEPHROL DIAL TRANSPL, V13, P35, DOI 10.1093/ndt/13.suppl_8.35
   DIAMOND EL, 1989, HEALTH PSYCHOL, V8, P15, DOI 10.1037/0278-6133.8.1.15
   FARMER MM, 1997, J HEALTH SOC BEHAV, V39, P298
   Ferraro KF, 2000, AM J PUBLIC HEALTH, V90, P103, DOI 10.2105/AJPH.90.1.103
   GonderFrederick L, 1997, DIABETES CARE, V20, P661, DOI 10.2337/diacare.20.4.661
   Hampson S., 1997, PERCEPTIONS HLTH ILL, P323
   Howorka K, 2000, J PSYCHOSOM RES, V48, P37, DOI 10.1016/S0022-3999(99)00074-4
   INGHAM JG, 1976, J PSYCHOSOM RES, V20, P309, DOI 10.1016/0022-3999(76)90082-9
   JACOBSON AM, 1994, DIABETES CARE, V17, P267, DOI 10.2337/diacare.17.4.267
   Jorgensen LGM, 2002, SCAND J CLIN LAB INV, V62, P609, DOI 10.1080/003655102764654349
   Kapci EG, 1998, J PSYCHOL, V132, P659, DOI 10.1080/00223989809599297
   KAVANAGH DJ, 1993, J BEHAV MED, V16, P509, DOI 10.1007/BF00844820
   Lawrence James, 2003, Prev Cardiol, V6, P78, DOI 10.1111/j.1520-037X.2003.01662.x
   Leventhal H, 1980, CONTRIBUTIONS MED PS
   LEVENTHAL H, 2001, HDB HLTH PSYCHOL, P19
   LUSTMAN PJ, 1988, INT J PSYCHIAT MED, V18, P295
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Macrodimitris SD, 2001, HEALTH PSYCHOL, V20, P208, DOI 10.1037//0278-6133.20.3.208
   MECHANIC D, 1979, J HEALTH SOC BEHAV, V20, P387, DOI 10.2307/2955413
   MECHANIC D, 1972, NEW ENGL J MED, V286, P1132, DOI 10.1056/NEJM197205252862105
   MURPHY E, 1995, FAM PRACT, V12, P184, DOI 10.1093/fampra/12.2.184
   Peel E, 2004, BRIT J GEN PRACT, V54, P183
   PENNEBAKER JW, 1982, PSYCHOL PHYSICAL SYM
   Piette JD, 2000, J GEN INTERN MED, V15, P797, DOI 10.1046/j.1525-1497.2000.91107.x
   Piette JD, 2000, AM J MED, V108, P20, DOI 10.1016/S0002-9343(99)00298-3
   Piette JD, 1997, DIABETES EDUCATOR, V23, P672, DOI 10.1177/014572179702300607
   Rietveld S, 2001, CHILD HEALTH CARE, V30, P27, DOI 10.1207/S15326888CHC3001_3
   SALOVEY P, 1989, J PERS SOC PSYCHOL, V57, P539, DOI 10.1037/0022-3514.57.3.539
   SHAMOON H, 1993, NEW ENGL J MED, V329, P977
   TESSLER R, 1978, J HEALTH SOC BEHAV, V19, P254, DOI 10.2307/2136558
   van Wijk CMTG, 1999, SOC SCI MED, V49, P1061, DOI 10.1016/S0277-9536(99)00196-3
   vanWijk CMTG, 1996, PERS INDIV DIFFER, V20, P55
   Ware JE, 1997, SF 36 HLTH SURVEY MA
   WATSON D, 1989, PSYCHOL REV, V96, P234, DOI 10.1037//0033-295X.96.2.234
   WIEBE DJ, 1994, J CONSULT CLIN PSYCH, V62, P1204, DOI 10.1037/0022-006X.62.6.1204
NR 47
TC 24
Z9 24
U1 0
U2 7
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0022-3999
J9 J PSYCHOSOM RES
JI J. Psychosomat. Res.
PD FEB
PY 2005
VL 58
IS 2
BP 129
EP 137
DI 10.1016/j.jpsychores.2004.08.004
PG 9
WC Psychiatry
SC Psychiatry
GA 923CK
UT WOS:000228886300003
PM 15820840
DA 2019-01-08
ER

PT J
AU Lim, K
   Taylor, L
AF Lim, K
   Taylor, L
TI Factors associated with physical activity among older people - a
   population-based study
SO PREVENTIVE MEDICINE
LA English
DT Article
DE aged; aging; physical activity; older adults; mental health; health
   promotion
ID QUALITY-OF-LIFE; HEALTH; ADULTS; WOMEN; FALLS; PREVENTION; EXERCISE;
   FRAILTY; RISK
AB Background. Regular physical activity improves survival and functional ability, and can improve quality of life. Few studies have examined factors associated with physical activity in older adults at a population level. This study examines factors associated with physical activity in the New South Wales (NSW) older population.
   Methods. Data from a random survey of 8881 community-dwelling people aged 65+ years were examined. We used Cox's regression to analyze the influence of demographic, health, and social factors on physical activity. 'Adequate' physical activity was defined as at least 30 min of walking, moderate or vigorous activity on at least 5 days in the last week. Reported barriers to physical activity were also examined.
   Results. Adequate physical activity was independently associated with sex (male), younger age, ability to travel independently, better physical functioning, lower psychological distress, rural residence, not having diabetes, adequate fruit and vegetable intake, and speaking a language other than English at home. No independent associations were found for good long distance eyesight, being a caregiver, living alone, age left school, employment status, fear of falling, or perception of neighborhood safety. Health problems were frequently reported barriers to physical activity.
   Conclusions. About half of older adults report adequate physical activity. These results will inform strategies to promote physical activity among older people. Crown Copyright (C) 2004 Published by The Institute For Cancer Prevention and Elsevier Inc. All rights reserved.
C1 NSW Dept Hlth, Ctr Epidemiol & Res, Sydney, NSW 2059, Australia.
RP Taylor, L (reprint author), NSW Dept Hlth, Ctr Epidemiol & Res, Sydney, NSW 2059, Australia.
EM Itayl@doh.health.nsw.gov.au
CR ARMSTRONG T, 2000, J PHYS ACTIVITY PATT
   *AUSTR BUR STAT, 2002, 62850 ABS
   *AUSTR BUR STAT, 2002, 32010 ABS
   Bath PA, 1998, AGE AGEING, V27, P29, DOI 10.1093/ageing/27.suppl_3.29
   BAUMAN A, 2001, TRENDS POPULATION LE
   Blair SN, 2000, AM J HEALTH PROMOT, V15, P1
   Booth ML, 2000, PREV MED, V31, P15, DOI 10.1006/pmed.2000.0661
   Brown WJ, 2000, RES Q EXERCISE SPORT, V71, P206, DOI 10.1080/02701367.2000.10608901
   Davies HTO, 1998, BRIT MED J, V316, P989, DOI 10.1136/bmj.316.7136.989
   Day L, 2002, BRIT MED J, V325, P128, DOI 10.1136/bmj.325.7356.128
   Drewnowski A, 2001, J GERONTOL A-BIOL, V56, P89, DOI 10.1093/gerona/56.suppl_2.89
   FIATARONE MA, 1994, NEW ENGL J MED, V330, P1769, DOI 10.1056/NEJM199406233302501
   GIBSON D, 1999, 12 AIHW
   GILLESPIE LD, 2003, INTERVENTIONS PREVEN, V3
   Glass TA, 1999, BRIT MED J, V319, P478, DOI 10.1136/bmj.319.7208.478
   GREENLAND S, 1987, AM J EPIDEMIOL, V125, P761, DOI 10.1093/oxfordjournals.aje.a114593
   Gregg EW, 2000, J AM GERIATR SOC, V48, P883, DOI 10.1111/j.1532-5415.2000.tb06884.x
   Hirvensalo M, 2000, SCAND J MED SCI SPOR, V10, P37, DOI 10.1034/j.1600-0838.2000.010001037.x
   Kaplan MS, 2001, AM J PREV MED, V21, P306, DOI 10.1016/S0749-3797(01)00364-6
   Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074
   King AC, 2001, J GERONTOL A-BIOL, V56, P36, DOI 10.1093/gerona/56.suppl_2.36
   KORN EL, 1995, J ROY STAT SOC A STA, V158, P263, DOI 10.2307/2983292
   Levy P., 1999, SAMPLING POPULATIONS
   MATHERS C, 1999, 17 AIHW
   McTiernan A, 2003, JAMA-J AM MED ASSOC, V290, P1331, DOI 10.1001/jama.290.10.1331
   Munro J, 1997, J PUBLIC HEALTH MED, V19, P397, DOI 10.1093/oxfordjournals.pubmed.a024667
   *NSW DEP HLTH, 2000, ACT AUSTR INT YEAR O
   PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402
   *PUBL HLTH DIV, 2000, NSW PUBLIC HLTH B, V11, P8
   Rejeski WJ, 2001, J GERONTOL A-BIOL, V56, P23, DOI 10.1093/gerona/56.suppl_2.23
   SIMONSICK EM, 1993, AM J PUBLIC HEALTH, V83, P1443, DOI 10.2105/AJPH.83.10.1443
   *STAT CORP, 2001, STATA SOFTWARE
   STEPHENSON JB, 2000, COSTS ILLNESS ATTRIB
   STEVENSON S, 1996, INTERIM NORMS AUSTR
   TAYLOR A, 1998, PHYS ACTIVITY OLDER
   U. S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU
   WARE JEJ, 1993, SF36 HLTH SURVEY MAN
   Wolf SL, 1996, J AM GERIATR SOC, V44, P489, DOI 10.1111/j.1532-5415.1996.tb01432.x
NR 38
TC 156
Z9 157
U1 2
U2 35
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0091-7435
J9 PREV MED
JI Prev. Med.
PD JAN
PY 2005
VL 40
IS 1
BP 33
EP 40
DI 10.1016/j.ypmed.2004.04.046
PG 8
WC Public, Environmental & Occupational Health; Medicine, General &
   Internal
SC Public, Environmental & Occupational Health; General & Internal Medicine
GA 875XI
UT WOS:000225455400005
PM 15530578
DA 2019-01-08
ER

PT J
AU Moore, MC
   DiCostanzo, CA
   Dardevet, D
   Lautz, M
   Farmer, B
   Neal, DW
   Cherrington, AD
AF Moore, MC
   DiCostanzo, CA
   Dardevet, D
   Lautz, M
   Farmer, B
   Neal, DW
   Cherrington, AD
TI Portal infusion of a selective serotonin reuptake inhibitor enhances
   hepatic glucose disposal in conscious dogs
SO AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
LA English
DT Article
DE glycemia; liver; portal vein; hepatic glucose uptake; nonhepatic glucose
   uptake
ID PERFUSED RAT HINDLIMB; INSULIN-RESISTANCE; BODY-WEIGHT; METABOLISM;
   5-HYDROXYTRYPTAMINE; PLASMA; SIGNAL; LIVER; ANTIDEPRESSANTS;
   NOREPINEPHRINE
AB Intraportal delivery of serotonin enhanced net hepatic glucose uptake (NHGU) during a hyperinsulinemic hyperglycemic clamp, but serotonin elevated catecholamines and can cause gastrointestinal distress. We hypothesized that the selective serotonin reuptake inhibitor (SSRI) fluvoxamine would enhance NHGU without side effects. Arteriovenous difference and tracer ([3-H-3]glucose) techniques were used in conscious 42-h-fasted dogs. Experiments consisted of equilibration (-120 to -30 min), basal (-30 to 0 min), and experimental (EXP; 0-270 min) periods. During EXP, somatostatin, fourfold basal intraportal insulin, basal intraportal glucagon, and peripheral glucose ( to double the hepatic glucose load) were infused. Saline ( SAL) was infused intraportally during 0-90 min (P1), and fluvoxamine was infused intraportally at 0.5, 1, and 2 mug.kg(-1).min(-1) from 90 to 150 (P2), 150 to 210 (P3), and 210 to 270 (P4) min, respectively, in the FLUV group (n = 8). The SAL group (n = 9) received intraportal saline during 0-270 min. NHGU in SAL was 13.9 +/- 1.7 and 17.0 +/- 2.0 mumol.kg(-1).min(-1) in P3-P4, respectively, while NHGU in FLUV averaged 19.7 +/- 2.8 and 26.6 +/- 3.0 mumol.kg(-1).min(-1) (P < 0.05 vs. SAL). Net hepatic carbon retention was greater (P < 0.05) in FLUV than in SAL (17.6 +/- 2.6 vs. 13.9 +/- 2.7 and 23.8 +/- 3.0 vs. 14.4 +/- 3.3 mumol.kg(-1).min(-1) in P3-P4, respectively), and final hepatic glycogen concentrations were 50% greater in FLUV (P < 0.005). Nonhepatic glucose uptake was greater in SAL than in FLUV at 270 min (P < 0.05). Catecholamine concentrations remained basal, and the animals evidenced no distress. Thus fluvoxamine enhanced NHGU and hepatic carbon storage without raising circulating serotonin concentrations or causing stress, suggesting that hepatic-targeted SSRIs might be effective in reducing postprandial hyperglycemia in individuals with diabetes or impaired glucose tolerance.
C1 Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA.
   Vanderbilt Univ, Sch Med, Ctr Diabet Res & Training, Nashville, TN 37232 USA.
RP Moore, MC (reprint author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, 702 Light Hall, Nashville, TN 37232 USA.
EM genie.moore@vanderbilt.edu
FU CSAP SAMHSA HHS [SP60 AM 20593]; NICHD NIH HHS [P30 HD 15022]; NIDDK NIH
   HHS [DK 43706]
CR ADKINS BA, 1987, J CLIN INVEST, V79, P557, DOI 10.1172/JCI112847
   AHREN B, 1988, METABOLISM, V37, P68, DOI 10.1016/0026-0495(88)90031-5
   ANTHONY M, 1984, AUST NZ J MED, V14, P888, DOI 10.1111/j.1445-5994.1984.tb03802.x
   Bearcroft CP, 1998, GUT, V42, P42, DOI 10.1136/gut.42.1.42
   BLOMBERY PA, 1983, CIRC RES, V53, P688, DOI 10.1161/01.RES.53.5.688
   BONHAUS DW, 1995, BRIT J PHARMACOL, V115, P662
   Chu CA, 1997, J CLIN INVEST, V99, P1044, DOI 10.1172/JCI119232
   Clerk LH, 2003, AM J PHYSIOL-ENDOC M, V284, pE611, DOI 10.1152/ajpendo.00153.2002
   COWAN JS, 1971, METABOLISM, V20, P360, DOI 10.1016/0026-0495(71)90098-9
   ENDO Y, 1985, BRIT J PHARMACOL, V85, P591, DOI 10.1111/j.1476-5381.1985.tb10553.x
   Erenmemisoglu A, 1999, J PHARM PHARMACOL, V51, P741, DOI 10.1211/0022357991772899
   GEHO WB, 1986, Patent No. 4603044
   GOLDSTEIN RE, 1992, METABOLISM, V41, P1295, DOI 10.1016/0026-0495(92)90099-V
   Hajduch E, 1999, J BIOL CHEM, V274, P13563, DOI 10.1074/jbc.274.19.13563
   HENDRICK GK, 1990, AM J PHYSIOL, V258, pE841
   Hiemke C, 2000, PHARMACOL THERAPEUT, V85, P11, DOI 10.1016/S0163-7258(99)00048-0
   Hsieh PS, 1999, AM J PHYSIOL-ENDOC M, V276, pE930, DOI 10.1152/ajpendo.1999.276.5.E930
   Hsieh PS, 1998, AM J PHYSIOL-ENDOC M, V275, pE987, DOI 10.1152/ajpendo.1998.275.6.E987
   JACKSON RA, 1986, J CLIN ENDOCR METAB, V63, P541, DOI 10.1210/jcem-63-3-541
   JACKSON RA, 1987, METABOLISM, V36, P144, DOI 10.1016/0026-0495(87)90008-4
   Keppler D, 1974, METHOD ENZYMAT AN, P1127, DOI DOI 10.1242/JEB.037275
   Moore MC, 2004, DIABETES, V53, P14, DOI 10.2337/diabetes.53.1.14
   MYERS SR, 1991, J CLIN INVEST, V88, P158, DOI 10.1172/JCI115273
   NIIJIMA A, 1981, DIABETOLOGIA, V20, P325, DOI 10.1007/BF00254499
   NIIJIMA A, 1969, ANN NY ACAD SCI, V157, P690, DOI 10.1111/j.1749-6632.1969.tb12914.x
   Nishizawa M, 2003, AM J PHYSIOL-ENDOC M, V284, pE1027, DOI 10.1152/ajpendo.00503.2002
   Pagliassotti MJ, 1996, J CLIN INVEST, V97, P81, DOI 10.1172/JCI118410
   Park S, 2002, METABOLISM, V51, P38, DOI 10.1053/meta.2002.26712
   Pussard E, 1996, CLIN CHEM, V42, P1086
   RATTIGAN S, 1993, LIFE SCI, V53, P1545, DOI 10.1016/0024-3205(93)90563-I
   Satake S, 2002, DIABETES, V51, P1663, DOI 10.2337/diabetes.51.6.1663
   STEELE R, 1956, AM J PHYSIOL, V187, P15
   Sussman N, 2001, J CLIN PSYCHIAT, V62, P256, DOI 10.4088/JCP.v62n0407
   Tatsumi M, 1997, EUR J PHARMACOL, V340, P249, DOI 10.1016/S0014-2999(97)01393-9
   Turner RC, 1998, LANCET, V352, P837
   van Harten J, 1995, Clin Pharmacokinet, V29 Suppl 1, P1
   Wieczorek I, 2001, INT J OBESITY, V25, P1566, DOI 10.1038/sj.ijo.0801729
   YAMADA J, 1999, EUR J PHARMACOL, V382, P2111
NR 38
TC 17
Z9 18
U1 0
U2 1
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0193-1849
J9 AM J PHYSIOL-ENDOC M
JI Am. J. Physiol.-Endocrinol. Metab.
PD DEC
PY 2004
VL 287
IS 6
BP E1057
EP E1063
DI 10.1152/ajpendo.00313.2004
PG 7
WC Endocrinology & Metabolism; Physiology
SC Endocrinology & Metabolism; Physiology
GA 867WP
UT WOS:000224873800003
PM 15315909
DA 2019-01-08
ER

PT J
AU Cohen, M
   Kanter, Y
AF Cohen, M
   Kanter, Y
TI Relation between sense of coherence and glycemic control in type 1 and
   type 2 diabetes
SO BEHAVIORAL MEDICINE
LA English
DT Article
DE adherence; diabetes; glycemic control; psychological distress; sense of
   coherence
ID QUALITY-OF-LIFE; SELF-CARE BEHAVIORS; METABOLIC-CONTROL; DEPRESSIVE
   SYMPTOMS; PSYCHIATRIC-DISORDERS; MELLITUS; ADULTS; MANAGEMENT; STRESS;
   HEALTH
AB In this study, the authors examined the relation between glycemic control and sense of coherence (SOC) and the mediating role of psychological distress and of adherence to self-care behaviors in 67 people with type 1 and type 2 diabetes. In addition, 29 individuals without any chronic disease composed a control group. The authors determined glycemic control by glycosylated hemoglobin (HbA1c) measures. The participants answered a questionnaire that included questions about medical data, an adherence to self-care behaviors inventory, Derogatis' Brief Symptoms Inventory, and Antonovsky's SOC scale. People with diabetes showed higher levels of psychological distress than matched controls, but similar SOC scores. A path analysis revealed that SOC was indirectly related to glycemic control, through adherence to self-care behaviors and psychological distress. Adherence did not mediate the effect of psychological distress on glycemic control. In addition, the type of diabetes of the subject was directly related to glycemic control. The model explained 38% of the variance of glycemic control. The results suggest a possible role of SOC in the psychological and physical wellbeing of people with diabetes. SOC should constitute a focus of further research, particularly studies of possible psychological intervention to enhance SOC in people with diabetes.
C1 Univ Haifa, Fac Social Welf & Hlth Studies, IL-31905 Haifa, Israel.
   Rambam Med Ctr, Ctr Diabet, Haifa, Israel.
RP Cohen, M (reprint author), Univ Haifa, Fac Social Welf & Hlth Studies, IL-31905 Haifa, Israel.
EM cohenm@research.haifa.ac.il
CR Allgower A, 2001, HEALTH PSYCHOL, V20, P223, DOI 10.1037//0278-6133.20.3.223
   Anderson RJ, 2002, INT J PSYCHIAT MED, V32, P235, DOI 10.2190/KLGD-4H8D-4RYL-TWQ8
   ANTONOVSKY A, 1993, SOC SCI MED, V36, P725, DOI 10.1016/0277-9536(93)90033-Z
   ANTONOVSKY A, 1985, ISRAEL J PSYCHIAT, V22, P273
   Antonovsky A., 1987, UNRAVELING MYSTERY H
   Ben-Zur H, 2001, PSYCHOSOM MED, V63, P32, DOI 10.1097/00006842-200101000-00004
   BOWMAN B, 1996, J CLIN PSYCHOL, V52, P279
   Coates VE, 1998, J ADV NURS, V27, P528, DOI 10.1046/j.1365-2648.1998.00546.x
   COX DJ, 1991, STRESS COP, P119
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   Delbar V, 2001, J PSYCHOSOC ONCOL, V19, P57, DOI 10.1300/J077v19n02_04
   Derogatis L, 1982, BRIEF SYMPTOM INVENT
   Dutour A, 1996, PSYCHONEUROENDOCRINO, V21, P525, DOI 10.1016/S0306-4530(96)00014-5
   EATON WW, 1992, INT J PSYCHIAT MED, V22, P105, DOI 10.2190/DF4H-9HQW-NJEC-Q54E
   Eiser JR, 2001, PSYCHOL HEALTH, V16, P99, DOI 10.1080/08870440108405492
   FOLKMAN S, 1984, J PERS SOC PSYCHOL, V46, P839, DOI 10.1037/0022-3514.46.4.839
   FOLKMAN S, 1980, J HEALTH SOC BEHAV, V21, P219, DOI 10.2307/2136617
   Forsberg C, 1996, SCAND J CARING SCI, V10, P109, DOI 10.1111/j.1471-6712.1996.tb00320.x
   Freire MDM, 2001, COMMUNITY DENT ORAL, V29, P204
   Friedman S, 1998, EUR PSYCHIAT, V13, P295, DOI 10.1016/S0924-9338(98)80047-3
   Gana K, 2001, STRESS HEALTH, V17, P77, DOI 10.1002/smi.882
   GAVARD JA, 1993, DIABETES CARE, V16, P1167, DOI 10.2337/diacare.16.8.1167
   Germano D, 2001, J CLIN PSYCHOL MED S, V8, P253, DOI 10.1023/A:1011964729100
   Gilbar O, 2002, INT J STRESS MANAGE, V9, P1, DOI 10.1023/A:1013097816238
   GLASGOW RE, 1987, J CHRON DIS, V40, P399, DOI 10.1016/0021-9681(87)90173-1
   HANSON CL, 1996, J PEDIATR PSYCHOL, V21, P476
   Hassmen P, 2000, PREV MED, V30, P17, DOI 10.1006/pmed.1999.0597
   Jacobson AM, 1997, QUAL LIFE RES, V6, P11
   Jahnsen R, 2002, DISABIL REHABIL, V24, P511, DOI 10.1080/09638280110108805
   Johnston-Brooks CH, 2002, PSYCHOSOM MED, V64, P43, DOI 10.1097/00006842-200201000-00007
   Karlson B, 1997, DIABETIC MED, V14, P1066, DOI 10.1002/(SICI)1096-9136(199712)14:12<1066::AID-DIA462>3.0.CO;2-M
   KAVANAGH DJ, 1993, J BEHAV MED, V16, P509, DOI 10.1007/BF00844820
   LAGRECA AM, P 9 ANN CONV SOC BEH, pA42
   Lo R, 1999, J ADV NURS, V30, P418, DOI 10.1046/j.1365-2648.1999.01085.x
   LUNDMAN B, 1993, J ADV NURS, V18, P381, DOI 10.1046/j.1365-2648.1993.18030381.x
   Macrodimitris SD, 2001, HEALTH PSYCHOL, V20, P208, DOI 10.1037//0278-6133.20.3.208
   MAZZE R, 1984, DIABETES CARE, V7, P306
   Motzer SU, 1996, RES NURS HEALTH, V19, P287, DOI 10.1002/(SICI)1098-240X(199608)19:4<287::AID-NUR3>3.0.CO;2-E
   Mullen Paul M., 1993, Journal of Psychosocial Oncology, V11, P23
   Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561
   Pallant JF, 2002, PERS INDIV DIFFER, V33, P39, DOI 10.1016/S0191-8869(01)00134-9
   Peyrot M, 1999, DIABETES CARE, V22, P448, DOI 10.2337/diacare.22.3.448
   POPKIN MK, 1988, ARCH GEN PSYCHIAT, V45, P64
   POSTWHITE J, 1998, STRESS COPING HLTH F, P279
   REYNAERT C, 1995, DIABETES METAB, V21, P180
   Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O
   Sanden-Eriksson B, 2000, J ADV NURS, V31, P1393, DOI 10.1046/j.1365-2648.2000.01410.x
   SCHWARTZ LS, 1991, GEN HOSP PSYCHIAT, V13, P19, DOI 10.1016/0163-8343(91)90005-H
   SHAMOON H, 1993, NEW ENGL J MED, V329, P977
   Smari J, 1997, PERS INDIV DIFFER, V22, P151, DOI 10.1016/S0191-8869(96)00199-7
   Soderberg S, 1997, RES NURS HEALTH, V20, P495
   SPIESS K, 1994, J PSYCHOSOM RES, V38, P249, DOI 10.1016/0022-3999(94)90120-1
   Stenstrom U, 1998, BRIT J HEALTH PSYCH, V3, P15, DOI 10.1111/j.2044-8287.1998.tb00552.x
   Stewart SM, 2000, J PEDIATR PSYCHOL, V25, P393, DOI 10.1093/jpepsy/25.6.393
   Sultan S, 2001, J HEALTH PSYCHOL, V6, P731, DOI 10.1177/135910530100600616
   SURWIT RS, 1991, STRESS COP, P97
   SURWIT RS, 1984, BEHAV MED UPDATE, V6, P8
   Tsasis P, 2001, AIDS PATIENT CARE ST, V15, P109, DOI 10.1089/108729101750123544
   TUCKER D. C., 2002, PSYCHOL HEALTH MED, V7, P363, DOI DOI 10.1080/13548500220139449
   Van der Does FEE, 1998, DIABETES CARE, V21, P2085, DOI 10.2337/diacare.21.12.2085
   van Loon AJM, 2001, PERS INDIV DIFFER, V31, P541, DOI 10.1016/S0191-8869(00)00158-6
   Van Tilburg MAL, 2001, PSYCHOSOM MED, V63, P551, DOI 10.1097/00006842-200107000-00005
   Weissbecker I, 2002, J CLIN PSYCHOL MED S, V9, P297, DOI 10.1023/A:1020786917988
   WILSON W, 1986, DIABETES CARE, V9, P614, DOI 10.2337/diacare.9.6.614
   Wredling R, 1995, QUAL LIFE RES, V4, P515, DOI 10.1007/BF00634746
   Zhang JP, 2001, J BEHAV MED, V24, P33, DOI 10.1023/A:1005634420653
NR 66
TC 29
Z9 31
U1 0
U2 14
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND
SN 0896-4289
J9 BEHAV MED
JI Behav. Med.
PD WIN
PY 2004
VL 29
IS 4
BP 175
EP 183
DI 10.3200/BMED.29.4.175-185
PG 9
WC Behavioral Sciences; Psychiatry
SC Behavioral Sciences; Psychiatry
GA 848CK
UT WOS:000223444600004
PM 15369198
DA 2019-01-08
ER

PT J
AU Lepercq, J
   Coste, J
   Theau, A
   Dubois-Laforgue, D
   Timsit, J
AF Lepercq, J
   Coste, J
   Theau, A
   Dubois-Laforgue, D
   Timsit, J
TI Factors associated with preterm delivery in women with type 1 diabetes -
   A cohort study
SO DIABETES CARE
LA English
DT Article
ID GLYCEMIC CONTROL; PREGNANCY; COMPLICATIONS; NEPHROPATHY; MORTALITY;
   MELLITUS; OUTCOMES; SWEDEN; RISK
AB OBJECTIVE - The reported rate of preterm delivery in women With type 1 diabetes ranges from 22 to 45%, but the reasons are unclear. The purpose of this study was to identify factors associated with preterm delivery in these women.
   RESEARCH DESIGN AND METHODS - We studied the influence of maternal and diabetes-related factors on the occurrence of preterm delivery in 168 single pregnancies occurring in 127 women with type 1 diabetes. Women with spontaneous or indicated preterm delivery were compared with those who delivered after 37 weeks of gestation using polytomous logistic regression.
   RESULTS - The overall rate of preterm delivery was 24%, fivefold higher than the French prematurity rate in single pregnancy. Preterm delivery was spontaneous in 9% and indicated in 15%. HbA(1c) greater than or equal to7% at delivery was associated with spontaneous preterm delivery (odds ratio [OR] 5.3 [95% CI 1.1-26.8]). Nulliparity (12.0 [2.3-64.1]), progression of nephropathy (7.7 [1.3-46.9]), preeclampsia (12.0 [3.1-47.1]), and HbA(1c) greater than or equal to7% (7.5 [1.5-37.9]) at delivery were all associated with indicated preterm delivery. Preterm delivery was associated with significant neonatal morbidity as the risks for neonatal hypoglycemia and respiratory distress syndrome were increased by three- to sixfold compared with the reference group.
   CONCLUSIONS - The rate of preterm delivery remains high in women with type 1 diabetes. Different factors were associated with spontaneous and indicated preterm delivery, respectively. Because poor glycemic control was a risk factor for both outcomes, part of preterm delivery might be preventable.
C1 Hop Cochin, Dept Biostat, F-75674 Paris, France.
   Hop Cochin, Dept Diabetol, F-75674 Paris, France.
RP Lepercq, J (reprint author), Hop Cochin, Serv Gynecol Obstet, APHP, 82 Ave Denfert Rochereau, F-75674 Paris 14, France.
EM j.lepercq@svp.ap-hop-paris.fr
OI Dubois-Laforgue, Daniele/0000-0003-3287-6309
CR Boulot P, 2003, DIABETES CARE, V26, P2990
   Ceriello A, 2003, DIABETES CARE, V26, P1589, DOI 10.2337/diacare.26.5.1589
   CNATTINGIUS S, 1994, DIABETIC MED, V11, P696, DOI 10.1111/j.1464-5491.1994.tb00335.x
   Coomarasamy A, 2003, OBSTET GYNECOL, V101, P1319, DOI 10.1016/S0029-7844(03)00169-8
   Ekbom P, 2001, DIABETES CARE, V24, P1739, DOI 10.2337/diacare.24.10.1739
   Evers IN, 2004, BRIT MED J, V328, P915, DOI 10.1136/bmj.38043.583160.EE
   Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928
   Gordon M, 1996, OBSTET GYNECOL, V87, P401, DOI 10.1016/0029-7844(95)00420-3
   GREENE MF, 1989, AM J OBSTET GYNECOL, V161, P106, DOI 10.1016/0002-9378(89)90244-5
   HANSON U, 1993, AM J PERINAT, V10, P330, DOI 10.1055/s-2007-994754
   Hod M, 1995, NEPHROL DIAL TRANSPL, V10, P2328, DOI 10.1093/ndt/10.12.2328
   Kitzmiller JL, 1996, OBSTET GYN CLIN N AM, V23, P173, DOI 10.1016/S0889-8545(05)70251-5
   Kovilam O, 2002, J Matern Fetal Neonatal Med, V11, P245
   MAGANN EF, 1992, AM J OBSTET GYNECOL, V167, P1533, DOI 10.1016/0002-9378(92)91734-R
   Mamelle N., 1996, Journal de Gynecologie Obstetrique et Biologie de la Reproduction, V25, P71
   MIMOUNI F, 1988, OBSTET GYNECOL, V72, P175
   Penney GC, 2003, BJOG-INT J OBSTET GY, V110, P315, DOI 10.1016/S1470-0328(03)02967-7
   Sibai BM, 2000, AM J OBSTET GYNECOL, V183, P1520, DOI 10.1067/mob.2000.107621
   SLADEK SM, 1997, AM J PHYSIOL, V272, P441
   Temple R, 2002, BRIT MED J, V325, P1275, DOI 10.1136/bmj.325.7375.1275
   Wylie BR, 2002, AM J PERINAT, V19, P169, DOI 10.1055/s-2002-28499
NR 21
TC 42
Z9 42
U1 0
U2 1
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0149-5992
J9 DIABETES CARE
JI Diabetes Care
PD DEC
PY 2004
VL 27
IS 12
BP 2824
EP 2828
DI 10.2337/diacare.27.12.2824
PG 5
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 874DU
UT WOS:000225331900009
PM 15562192
OA Bronze
DA 2019-01-08
ER

PT J
AU DeVries, JH
   Snoek, FJ
   Heine, RJ
AF DeVries, JH
   Snoek, FJ
   Heine, RJ
TI Persistent poor glycaemic control in adult Type 1 diabetes. A closer
   look at the problem
SO DIABETIC MEDICINE
LA English
DT Article
DE insulin; Type 1 diabetes mellitus; glycaemic control; psychosocial
   factors; HbA(1c)
ID SUBCUTANEOUS INSULIN INFUSION; EURODIAB IDDM COMPLICATIONS; RANDOMIZED
   CONTROLLED TRIAL; MICROVASCULAR COMPLICATIONS; INTENSIVE THERAPY; MAJOR
   DEPRESSION; TEACHING PROGRAM; TREATED PATIENTS; MELLITUS; HEMOGLOBIN
AB Around 25% of the adult Type 1 diabetes population is in persistent poor glycaemic control and thus at increased risk of developing microvascular complications. We here discuss correlates of long-standing poor glycaemic control and review the efficacy of clinical strategies designed to overcome persistent poor control. Only a few studies have identified determinants and correlates of long-standing poor glycaemic control in Type 1 diabetes. There is some evidence implicating genetic factors, as well as lower economic status, and psychological factors, including lack of motivation, emotional distress, depression and eating disorders. Ways of improving glycaemic control include strategies to enable self-management, e.g. motivational strategies, coping-orientated education, psychosocial therapies, and/or intensifying insulin injection therapy plus continuous subcutaneous insulin infusion. Long-standing poor glycaemic control appears to be a heterogeneous and complex phenomenon, for which there is no simple, single solution. Comprehensive psycho-medical assessment in diabetes care may prove useful in tailoring interventions. Further research is warranted, to increase our understanding how psychosocial and biomedical factors, separately and in interaction, determine poor outcomes in Type 1 diabetes.
C1 Vrije Univ Amsterdam Med Ctr, Ctr Diabet, Dept Endocrinol, Amsterdam, Netherlands.
   Vrije Univ Amsterdam Med Ctr, Ctr Diabet, Dept Psychol Med, Amsterdam, Netherlands.
RP DeVries, JH (reprint author), Acad Med Ctr, Dept Internal Med, POB 22660, NL-1100 AD Amsterdam, Netherlands.
EM j.h.devries@amc.uva.nl
CR Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Beck A. T., COGNITIVE THERAPY DE
   Bisse E, 2003, CLIN CHEM, V49, P137, DOI 10.1373/49.1.137
   BOTT U, 1994, DIABETIC MED, V11, P362, DOI 10.1111/j.1464-5491.1994.tb00287.x
   Bott U, 2000, DIABETIC MED, V17, P635, DOI 10.1046/j.1464-5491.2000.00345.x
   BRADLEY C, HDB PSYCHOL DIABETES
   Bryden KS, 1999, DIABETES CARE, V22, P1956, DOI 10.2337/diacare.22.12.1956
   Chaturvedi N, 1996, DIABETES CARE, V19, P423, DOI 10.2337/diacare.19.5.423
   Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278
   Ciechanowski PS, 2002, DIABETES CARE, V25, P731, DOI 10.2337/diacare.25.4.731
   Danne T, 2001, DIABETES CARE, V24, P1342, DOI 10.2337/diacare.24.8.1342
   DCCT Res Grp, 1986, DIABETES, V35, P530
   de Groot M, 1999, J PSYCHOSOM RES, V46, P425, DOI 10.1016/S0022-3999(99)00014-8
   DELAHANTY LM, 1993, DIABETES CARE, V16, P1453, DOI 10.2337/diacare.16.11.1453
   DeVries JH, 2002, DIABETES CARE, V25, P2074, DOI 10.2337/diacare.25.11.2074
   DEWEERDT I, 1990, SOC SCI MED, V30, P605, DOI 10.1016/0277-9536(90)90159-P
   Didjurgeit U, 2002, DIABETIC MED, V19, P814, DOI 10.1046/j.1464-5491.2002.00811.x
   DUGDALE A, 1993, LANCET, V342, P1426, DOI 10.1016/0140-6736(93)92788-U
   Fosbury JA, 1997, DIABETES CARE, V20, P959, DOI 10.2337/diacare.20.6.959
   Genuth S, 2002, JAMA-J AM MED ASSOC, V287, P2563
   Glasgow RE, 1999, DIABETES CARE, V22, P832, DOI 10.2337/diacare.22.5.832
   GLASGOW RE, 1997, DIABETES SPECTRUM, V10, P12
   Goldstein D., 1991, DIABETES, V40, pA1923
   Hempe JM, 2002, J DIABETES COMPLICAT, V16, P313, DOI 10.1016/S1056-8727(01)00227-6
   HOME PD, 1982, DIABETES CARE, V5, P466, DOI 10.2337/diacare.5.5.466
   JACOBSON AM, 1990, DIABETES CARE, V13, P375, DOI 10.2337/diacare.13.4.375
   JACOBSON AM, 1991, DIABETES CARE, V14, P599, DOI 10.2337/diacare.14.7.599
   JACOBSON AM, 1996, PRACTICAL PSYCHOL DI, P105
   Jorde R, 2000, DIABETIC MED, V17, P451, DOI 10.1046/j.1464-5491.2000.00295.x
   KORHONEN T, 1983, DIABETES CARE, V6, P256, DOI 10.2337/diacare.6.3.256
   LANGDOWN JV, 1994, HEMOGLOBIN, V18, P333, DOI 10.3109/03630269408996199
   Lorenz RA, 1996, DIABETES CARE, V19, P648, DOI 10.2337/diacare.19.6.648
   Lustman PJ, 1997, GEN HOSP PSYCHIAT, V19, P138, DOI 10.1016/S0163-8343(96)00170-3
   LUSTMAN PJ, 1991, PSYCHOSOM MED, V53, P305, DOI 10.1097/00006842-199105000-00004
   Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934
   Lustman PJ, 2000, DIABETES CARE, V23, P618, DOI 10.2337/diacare.23.5.618
   MAZZE RS, 1984, DIABETES CARE, V7, P360, DOI 10.2337/diacare.7.4.360
   Mitchell C, 2000, DIABETIC MED, V17, P481, DOI 10.1046/j.1464-5491.2000.00310.x
   Mollema ED, 2001, J PSYCHOSOM RES, V51, P665, DOI 10.1016/S0022-3999(01)00229-X
   Morris AD, 1997, LANCET, V350, P1505, DOI 10.1016/S0140-6736(97)06234-X
   Nathan DM, 1996, JAMA-J AM MED ASSOC, V276, P1409
   OLMSTED M, 1997, DIABETES S1, V46, pA88
   Peyrot M, 1999, DIABETES CARE, V22, P448, DOI 10.2337/diacare.22.3.448
   POLONSKY WH, 1994, DIABETES CARE, V17, P1178, DOI 10.2337/diacare.17.10.1178
   Pouwer F, 2001, DIABETES CARE, V24, P1929, DOI 10.2337/diacare.24.11.1929
   REEVES ML, 1982, AM J MED, V72, P673, DOI 10.1016/0002-9343(82)90479-X
   RODIN GM, 1992, DIABETES CARE, V15, P1402, DOI 10.2337/diacare.15.10.1402
   Rollnick S, 1999, HLTH BEHAV CHANGE GU
   Rubin RR, 2000, PSYCHOL DIABETES CAR, P235
   Rydall AC, 1997, NEW ENGL J MED, V336, P1849, DOI 10.1056/NEJM199706263362601
   SAURBREY N, 1988, DIABETIC MED, V5, P150, DOI 10.1111/j.1464-5491.1988.tb00962.x
   SHAMOON H, 1993, NEW ENGL J MED, V329, P977
   Snieder H, 2001, DIABETES, V50, P2858, DOI 10.2337/diabetes.50.12.2858
   Snoek FJ, 2002, DIABETIC MED, V19, P265, DOI 10.1046/j.1464-5491.2002.00678.x
   STEPHENSON J, 1994, DIABETOLOGIA, V37, P278, DOI 10.1007/BF00398055
   Talbot F, 2000, DIABETES CARE, V23, P1556, DOI 10.2337/diacare.23.10.1556
   TATTERSALL R, 1997, J CLIN ENDOCR METAB, V6, P403
   Taylor MD, 2003, DIABETIC MED, V20, P135, DOI 10.1046/j.1464-5491.2003.00887.x
   TERENT A, 1985, ACTA MED SCAND, V217, P47
   Weinger K, 2002, DIABETES, V51, pA439
NR 60
TC 44
Z9 45
U1 0
U2 7
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3071
EI 1464-5491
J9 DIABETIC MED
JI Diabetic Med.
PD DEC
PY 2004
VL 21
IS 12
BP 1263
EP 1268
DI 10.1111/j.1464-5491.2004.01386.x
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 880DH
UT WOS:000225768700001
PM 15569126
DA 2019-01-08
ER

PT J
AU Keers, JC
   Links, TP
   Bouma, J
   Gans, ROB
   ter Maaten, JC
   Wolffenbuttel, BHR
   Sluiter, WJ
   Sanderman, R
AF Keers, JC
   Links, TP
   Bouma, J
   Gans, ROB
   ter Maaten, JC
   Wolffenbuttel, BHR
   Sluiter, WJ
   Sanderman, R
TI Do diabetologists recognise self-management problems in their patients?
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article; Proceedings Paper
CT 18th Congress of the International-Diabetes-Federation
CY AUG 24-29, 2003
CL PARIS, FRANCE
SP Int Diabetes Fed
DE diabetologists; distress; medical decision-making; referral
ID DIABETIC-PATIENTS; PROBLEM AREAS; PROGRAM; INTERVENTIONS; FRAMEWORK;
   EDUCATION; SCALE; CARE
AB Objective: The aim of this study was to determine whether diabetologists recognise patients' needs for additional intensive multidisciplinary care due to glycaemic and diabetes-related psychosocial difficulties. Research design and methods: We compared 114 participants in a diabetes intervention programme with 201 as yet non-referred outpatients, of whom 54 outpatients were considered eligible for the intervention by their diabetologists; thus, 147 outpatients were considered non-eligible. Results: Analysis revealed that the eligible patients had poorer glycaemic control but all other parameters were similar to non-eligible patients. Significantly, 22 (15%) of the 147 non-eligible patients clearly had diabetes distress and could potentially benefit from the intervention. Conclusion: The results suggest that in regular care, patients' needs with respect to glycaemic control are recognised by their diabetologists, but patients with high psychosocial diabetes-related distress are often overlooked, though they also may be in need of additional care. Integrated monitoring of diabetes-related distress in outpatients could improve this area of diabetes care. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
C1 No Ctr Healthcare Res, NL-9700 AD Groningen, Netherlands.
   Univ Groningen Hosp, Dept Endocrinol, Groningen, Netherlands.
   Univ Groningen Hosp, Dept Internal Med, Groningen, Netherlands.
   Univ Groningen Hosp, Acad Ctr Rehabil Beatrixoord, Haren, Netherlands.
RP Keers, JC (reprint author), No Ctr Healthcare Res, POB 196, NL-9700 AD Groningen, Netherlands.
EM j.c.keers@med.rug.nl
RI Sanderman, Robbert/D-7234-2012; Wolffenbuttel, Bruce/A-8419-2011
OI Sanderman, Robbert/0000-0002-0823-1159; Wolffenbuttel,
   Bruce/0000-0001-9262-6921
CR BRADLEY C, 1994, DIABETIC MED, V11, P510, DOI 10.1111/j.1464-5491.1994.tb00316.x
   Dalewitz J, 2000, AM J MED QUAL, V15, P16, DOI 10.1177/106286060001500104
   El Fakiri F, 2003, DIABETES RES CLIN PR, V61, P199, DOI 10.1016/S0168-8227(03)00116-5
   Funnell M M, 1991, Diabetes Educ, V17, P37, DOI 10.1177/014572179101700108
   Glasgow RE, 1999, DIABETES CARE, V22, P832, DOI 10.2337/diacare.22.5.832
   Glasgow RE, 1999, AM J PUBLIC HEALTH, V89, P1322, DOI 10.2105/AJPH.89.9.1322
   GLASGOW RE, 1995, DIABETES CARE, V18, P117, DOI 10.2337/diacare.18.1.117
   GLASGOW RE, 2000, PSYCHOL DIABETES CAR, P141
   Keers JC, 2004, PATIENT EDUC COUNS, V52, P151, DOI 10.1016/S0738-3991(03)00019-3
   Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561
   Pouwer F, 2001, DIABETES CARE, V24, P1929, DOI 10.2337/diacare.24.11.1929
   RUBIN RR, 1992, DIABETES CARE, V15, P1640, DOI 10.2337/diacare.15.11.1640
   Snoek FJ, 2002, DIABETIC MED, V19, P265, DOI 10.1046/j.1464-5491.2002.00678.x
   Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305
   Toobert DJ, 2002, PATIENT EDUC COUNS, V48, P99, DOI 10.1016/S0738-3991(02)00120-9
   van der Zee KI, 1996, INT J BEHAV MED, V3, P104, DOI 10.1207/s15327558ijbm0302_2
   WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
NR 18
TC 6
Z9 6
U1 0
U2 3
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0168-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD NOV
PY 2004
VL 66
IS 2
BP 157
EP 161
DI 10.1016/j.diabres.2004.02.018
PG 5
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 874CD
UT WOS:000225327600007
PM 15533583
OA Green Published
DA 2019-01-08
ER

PT J
AU Adriaanse, MC
   Dekker, JM
   Spijkerman, AMW
   Twisk, JWR
   Nijpels, G
   van der Ploeg, HM
   Heine, RJ
   Snoek, FJ
AF Adriaanse, MC
   Dekker, JM
   Spijkerman, AMW
   Twisk, JWR
   Nijpels, G
   van der Ploeg, HM
   Heine, RJ
   Snoek, FJ
TI Health-related quality of life in the first year following diagnosis of
   Type 2 diabetes: newly diagnosed patients in general practice compared
   with screening-detected patients. The Hoorn Screening Study
SO DIABETIC MEDICINE
LA English
DT Article
DE diagnosis; health-related quality of life; screening; Type 2 diabetes
ID RANDOMIZED TRIAL; GLYCEMIC CONTROL; PRIMARY-CARE; NIDDM; QUESTIONNAIRE;
   RETINOPATHY; SYMPTOMS; PEOPLE; SF-36; ONSET
AB Aims To determine health-related quality of life (HRQoL) in the first year following diagnosis of Type 2 diabetes among newly diagnosed patients in general practice compared with patients detected by targeted population screening.
   Methods The study population consisted of 49 newly diagnosed patients in general practice and 116 screening-detected patients. HRQoL was operationalized as symptom distress, perceived health status and emotional well-being, that were assessed prospectively similar to2 weeks, 6 months and 12 months after the diagnosis of Type 2 diabetes, with the Type 2 Diabetes Symptom Checklist (DSC-type 2), the Short Form 36 (SF-36) and the Well-Being Questionnaire (W-BQ12), respectively.
   Results The DSC-type 2 total score (range 0-4) improved significantly within newly diagnosed patients in general practice (median at similar to2 weeks, 6 months and 12 months; 0.56, 0.21, 0.26; P = 0.000) and not within screening-detected patients (0.24, 0.24, 0.29; P = 0.093). Descriptives showed that newly diagnosed patients in general practice compared with screening-detected patients had consistently worse mean scores on all SF-36 mental health subscales Social Functioning, Role Emotional, Mental Health, Vitality, and all W-BQ12 scales at each time point. The differences were statistically significant for Role Emotional, Mental Health, Vitality (SF-36), and General well-being (W-BQ12). The SF-36 General Health (F = 3.7, P = 0.028) and Vitality (F = 4.5, P = 0.012) scores of newly diagnosed patients in general practice improved significantly over time, compared with screening-detected patients.
   Conclusions Newly diagnosed patients in general practice compared with screening-detected patients reported more diabetes-related symptom distress shortly after the diagnosis, and a consistently worse mental health status at each time point. Improved Vitality scores in newly diagnosed patients in general practice in the first year following diagnosis of Type 2 diabetes suggest a positive effect of diabetes treatment on HRQoL.
C1 VU Univ, Med Ctr, Inst Res Extramural Med, EMGO Inst, Amsterdam, Netherlands.
   VU Univ, Med Ctr, Dept Med Psychol, Amsterdam, Netherlands.
   VU Univ, Med Ctr, Dept Endocrinol, Amsterdam, Netherlands.
RP Adriaanse, MC (reprint author), Free Univ Amsterdam, Dept Nutr & Hlth, Fac Earth & Life Sci, De Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands.
EM marcel.adriaanse@falis.vu.nl
CR Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3
   Adriaanse MC, 2002, DIABETIC MED, V19, P406
   BRADLEY C, 1994, HDB PSYCHOL DIABETES, P89
   Edelman D, 2002, DIABETES CARE, V25, P1022, DOI 10.2337/diacare.25.6.1022
   GROOTENHUIS PA, 1994, DIABETIC MED, V11, P253, DOI 10.1111/j.1464-5491.1994.tb00268.x
   HARRIS MI, 1992, DIABETES CARE, V15, P815, DOI 10.2337/diacare.15.7.815
   Jager A, 1998, DIABETOLOGIA, V41, P694, DOI 10.1007/s001250050970
   KLEIN R, 1986, OPHTHALMOLOGY, V93, P1183
   Marshall KG, 1999, CAN MED ASSOC J, V160, P1592
   Owen KR, 2002, DIABETIC MED, V19, P758, DOI 10.1046/j.1464-5491.2002.00766.x
   Polonsky William H, 2002, Curr Diab Rep, V2, P153, DOI 10.1007/s11892-002-0075-5
   Pouwer F, 1999, DIABETES CARE, V22, P2004, DOI 10.2337/diacare.22.12.2004
   Rajala U, 1998, DIABETES CARE, V21, P1664, DOI 10.2337/diacare.21.10.1664
   Ruige JB, 1997, DIABETES CARE, V20, P491, DOI 10.2337/diacare.20.4.491
   Spijkerman AMW, 2003, DIABETES CARE, V26, P2604, DOI 10.2337/diacare.26.9.2604
   Spijkerman AMW, 2002, DIABETES CARE, V25, P1784, DOI 10.2337/diacare.25.10.1784
   Testa MA, 1998, JAMA-J AM MED ASSOC, V280, P1490, DOI 10.1001/jama.280.17.1490
   Torgerson DJ, 1997, ARCH INTERN MED, V157, P2121, DOI 10.1001/archinte.157.18.2121
   VanderDoes FEE, 1996, DIABETES CARE, V19, P204, DOI 10.2337/diacare.19.3.204
   Verhoeven S, 1999, HUISARTS WET, V42, P67
   Wagner EH, 2001, DIABETES CARE, V24, P695, DOI 10.2337/diacare.24.4.695
   WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002
   Ware JE, 1993, SF 36 HLTH SURVEY MA
   Wareham NJ, 2001, BRIT MED J, V322, P986, DOI 10.1136/bmj.322.7292.986
   Wensing M, 2001, QUAL LIFE RES, V10, P141, DOI 10.1023/A:1016705615207
   WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59
NR 26
TC 28
Z9 28
U1 0
U2 1
PU BLACKWELL PUBLISHING LTD
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DG, OXON, ENGLAND
SN 0742-3071
J9 DIABETIC MED
JI Diabetic Med.
PD OCT
PY 2004
VL 21
IS 10
BP 1075
EP 1081
DI 10.1111/j.1464-5491.2004.01277.x
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 856FH
UT WOS:000224030600004
PM 15384953
DA 2019-01-08
ER

PT J
AU Whittemore, R
   Melkus, GD
   Sullivan, A
   Grey, M
AF Whittemore, Robin
   D'Eramo Melkus, Gail
   Sullivan, Amy
   Grey, Margaret
TI A nurse-coaching intervention for women with type 2 diabetes
SO DIABETES EDUCATOR
LA English
DT Article
AB PURPOSE
   the purpose of this pilot study was to determine the efficacy of a 6-month nurse-coaching intervention that was provided after diabetes education for women with type 2 diabetes.
   METHODS
   In this pilot study, 53 women were randomized to the nurse-coaching intervention or a standard care control condition. The nurse-coaching intervention consisted of 5 individualized sessions and 2 follow-up phone calls over 6 months. The nurse-coaching sessions included educational, behavioral, and affective strategies. Data were collected on physiologic adaptation ( hemoglobin A1c [A1C] and body mass index [BMI]), self-management ( dietary and exercise), psychosocial adaptation (diabetes-related distress and integration), and treatment satisfaction at baseline, 3 months, and 6 months.
   RESULTS
   Women in the treatment group demonstrated better diet self-management, less diabetes-related distress, better integration, and more satisfaction with care, and had trends of better exercise self-management and BMI. The A1C levels improved in both groups at 3 months, yet the difference between the groups was not significant. Attendance at nurse-coaching sessions was 96%.
   CONCLUSIONS
   This nurse-coaching intervention demonstrates promise as a means of improving self-management and psychosocial outcomes in women with type 2 diabetes.
C1 Yale Sch Nursing, New Haven, CT 06536 USA.
   Joslin Diabet Ctr, New London, CT USA.
RP Whittemore, R (reprint author), Diabet Educator, 367 W Chicago Ave, Chicago, IL 60610 USA.
EM robin.whittemore@yale.edu
FU NINR NIH HHS [F32NR07823]
CR AINSWORTH BE, 1993, J CLIN EPIDEMIOL, V46, P1403, DOI 10.1016/0895-4356(93)90140-V
   *AM DIAB ASS, 2003, DIABETES CARE S1, V25, pS1
   ANDERSON RM, 1995, DIABETES CARE, V18, P943, DOI 10.2337/diacare.18.7.943
   Bradley C., 1994, HDB PSYCHOL DIABETES, P111
   BROWN SA, 1988, NURS RES, V37, P223
   BROWN SA, 1990, PATIENT EDUC COUNS, V16, P189, DOI 10.1016/0738-3991(90)90070-2
   Brown SA, 1999, DIABETES EDUCATOR, V25, P52, DOI 10.1177/014572179902500623
   CARNEY RM, 1988, PSYCHOSOM MED, V50, P627, DOI 10.1097/00006842-198811000-00009
   Connell C M, 1991, Diabetes Educ, V17, P364, DOI 10.1177/014572179101700507
   DERAMOMELKUS GA, 1992, DIABETES CARE, V15, P864, DOI 10.2337/diacare.15.7.864
   FUNNELL MM, 1995, DIABETES CARE, V18, P100, DOI 10.2337/diacare.18.1.100
   GLASGOW RE, 1992, PATIENT EDUC COUNS, V19, P61, DOI 10.1016/0738-3991(92)90102-O
   Grey M, 2000, J PEDIATR-US, V137, P107, DOI 10.1067/mpd.2000.106568
   HAFFNER SM, 1992, DIABETES CARE, V15, P1277, DOI 10.2337/diacare.15.10.1277
   Hays LM, 1999, DIABETES CARE, V22, P706, DOI 10.2337/diacare.22.5.706
   HERNANDEZ CA, 1995, CANADIAN J NURSING R, V28, P37
   Howard BV, 1998, DIABETES CARE, V21, P1258, DOI 10.2337/diacare.21.8.1258
   Hunt LM, 1998, WESTERN J NURS RES, V20, P656, DOI 10.1177/019394599802000602
   KANNEL WB, 1979, CIRCULATION, V59, P8, DOI 10.1161/01.CIR.59.1.8
   Krug L M, 1991, Diabetes Educ, V17, P185, DOI 10.1177/014572179101700314
   Lee WL, 2000, DIABETES CARE, V23, P962, DOI 10.2337/diacare.23.7.962
   Lu WQ, 2003, DIABETES CARE, V26, P16, DOI 10.2337/diacare.26.1.16
   Lustman PJ, 2000, DIABETES CARE, V23, P618, DOI 10.2337/diacare.23.5.618
   Lustman PJ, 1998, ANN INTERN MED, V129, P613, DOI 10.7326/0003-4819-129-8-199810150-00005
   Maxwell A E, 1992, Diabetes Educ, V18, P303, DOI 10.1177/014572179201800408
   MAZURE CM, 2003, SUMM WOM DEPR P REC
   MAZZUCA SA, 1986, DIABETES CARE, V9, P1, DOI 10.2337/diacare.9.1.1
   MCNABB WL, 1993, J AM DIET ASSOC, V93, P75, DOI 10.1016/0002-8223(93)92138-N
   MONAGHAN MS, 1999, MONITORING CONTROL T
   Nelson KM, 2002, DIABETES CARE, V25, P1722, DOI 10.2337/diacare.25.10.1722
   PADGETT D, 1988, J CLIN EPIDEMIOL, V41, P1007, DOI 10.1016/0895-4356(88)90040-6
   PAFFENBARGER RS, 1978, AM J EPIDEMIOL, V108, P161, DOI 10.1093/oxfordjournals.aje.a112608
   Park S, 1996, DIABETES CARE, V19, P450, DOI 10.2337/diacare.19.5.450
   PERRI MG, 1993, DIABETES CARE, V16, P200, DOI 10.2337/diacare.16.1.200
   Pollock S E, 1993, Nurs Sci Q, V6, P86, DOI 10.1177/089431849300600208
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Polonsky WH, 1996, DIABETES SPECTRUM, V9, P8
   Pouwer F, 2001, DIABETES CARE, V24, P1929, DOI 10.2337/diacare.24.11.1929
   Prevention CfDCa, 2000, NAT DIAB FACT SHEET
   Quackenbush PA, 1996, DIABETES EDUCATOR, V22, P231, DOI 10.1177/014572179602200306
   Rexrode KM, 1998, JAMA-J AM MED ASSOC, V280, P1843, DOI 10.1001/jama.280.21.1843
   Rubin R. R., 1993, DIABETES ED, V19, P210, DOI [DOI 10.1177/014572179301900308, 10.1177/014572179301900308]
   Ruggiero L, 1997, DIABETES CARE, V20, P568, DOI 10.2337/diacare.20.4.568
   Schechter CB, 2002, DIABETES SPECTRUM, V15, P170
   SHERBOURNE CD, 1992, J BEHAV MED, V15, P447, DOI 10.1007/BF00844941
   SHUMAKER SS, 1998, HDB HLTH BEHV CHANGE
   Smith DE, 1997, DIABETES CARE, V20, P52, DOI 10.2337/diacare.20.1.52
   Smith L, 2000, DIABETES EDUCATOR, V26, P645, DOI 10.1177/014572170002600412
   SPRAFKA JM, 1993, DIABETIC MED, V10, P627, DOI 10.1111/j.1464-5491.1993.tb00135.x
   Sprague MA, 1999, DIABETES EDUCATOR, V25, P907, DOI 10.1177/014572179902500608
   Sullivan ED, 1998, DIABETES EDUCATOR, V24, P72, DOI 10.1177/014572179802400110
   Toobert D. J., 1994, HDB PSYCHOL DIABETES
   Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943
   *US DEP HHS, 2003, NAT AG PUBL HLTH ACT
   Whittemore R, 2002, NURS SCI QUART, V15, P311, DOI 10.1177/089431802236796
   Whittemore R, 2001, DIABETES EDUCATOR, V27, P887, DOI 10.1177/014572170102700614
   Whittemore Robin, 2004, Issues Ment Health Nurs, V25, P243, DOI 10.1080/01612840490274750
   WING RR, 1993, DIABETES CARE, V16, P193, DOI 10.2337/diacare.16.1.193
NR 58
TC 64
Z9 66
U1 0
U2 5
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0145-7217
J9 DIABETES EDUCATOR
JI Diabetes Educ.
PD SEP-OCT
PY 2004
VL 30
IS 5
BP 795
EP 804
DI 10.1177/014572170403000515
PG 10
WC Endocrinology & Metabolism; Public, Environmental & Occupational Health
SC Endocrinology & Metabolism; Public, Environmental & Occupational Health
GA V43QI
UT WOS:000202949200012
PM 15510531
DA 2019-01-08
ER

PT J
AU Weijman, I
   Kant, I
   Swaen, GM
   Ros, WJG
   Rutten, GEHM
   Schaufeli, WB
   Schabracq, MJ
   Winnubst, JAM
AF Weijman, I
   Kant, I
   Swaen, GM
   Ros, WJG
   Rutten, GEHM
   Schaufeli, WB
   Schabracq, MJ
   Winnubst, JAM
TI Diabetes, employment and fatigue-related complaints: A comparison
   between diabetic employees, "healthy" employees, and employees with
   other chronic diseases
SO JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
LA English
DT Article
ID MINOR PSYCHIATRIC-DISORDER; PSYCHOLOGICAL DISTRESS; WORKING POPULATION;
   PRIMARY-CARE; DEPRESSION; EPIDEMIOLOGY; ADULTS; PREVALENCE; COMMUNITY;
   COHORT
AB The work situation and fatigue-related complaints of employees with diabetes (N = 141) were compared with "healthy" employees (N = 8946) and employees with other chronic diseases (N = 1883). Baseline data from a Dutch Cohort Study on Fatigue at Work were used to test differences in background variables, work characteristics, lifestyle factors, and fatigue-related complaints. Odds ratios were calculated for prolonged fatigue, the need for recovery, burnout, and psychological distress. Results showed that employees with diabetes work more daytime hours and work less overtime than the other groups. If they have no comorbidity, they are no more likely to report fatigue-related complaints than "healthy" employees, except for a depressed mood. Comorbidity (the presence of one or more additional chronic diseases) is associated with increased fatigue-related complaints. Therefore, this group will need special attention from professionals.
C1 Univ Utrecht, Med Ctr, Julius Ctr Hlth Sci & Primary Care, Sect Med & Hlth Psychol, NL-3508 AB Utrecht, Netherlands.
   Maastricht Univ, Dept Epidemiol, Maastricht, Netherlands.
   Univ Utrecht, Med Ctr, Julius Ctr Hlth Sci & Primary Care, Sect Gen Practice, NL-3508 AB Utrecht, Netherlands.
   Univ Utrecht, Dept Social & Org Psychol, NL-3508 AB Utrecht, Netherlands.
   Univ Amsterdam, Dept Work & Org Psychol, NL-1012 WX Amsterdam, Netherlands.
RP Ros, WJG (reprint author), Univ Utrecht, Med Ctr, Julius Ctr Hlth Sci & Primary Care, Sect Med & Hlth Psychol, STR 3-130,POB 85060, NL-3508 AB Utrecht, Netherlands.
EM w.j.g.ros@med.uu.nl
RI Schaufeli, Wilmar/B-9645-2013
OI Schaufeli, Wilmar/0000-0002-6070-7150
CR Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3
   Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Bensing J, 1996, MED CONTACT, V51, P123
   BENSING JM, 2003, MED CONTACT, V14, P551
   BENSING JM, 1997, VERMOEIDHEID, P27
   BROERSEN JPJ, 1993, VEROUDERING WERK GEZ
   Bultmann U, 2002, J PSYCHOSOM RES, V52, P445, DOI 10.1016/S0022-3999(01)00228-8
   Bultmann U, 2000, J Occup Health Psychol, V5, P411, DOI 10.1037/1076-8998.5.4.411
   DERIJK A, 1999, THESIS UTRECHT U
   Eaton WW, 2002, J PSYCHOSOM RES, V53, P903, DOI 10.1016/S0022-3999(02)00302-1
   Franssen PML, 2003, J PSYCHOSOM RES, V54, P339, DOI 10.1016/S0022-3999(02)00395-1
   FUHRER R, 1995, PSYCHOL MED, V25, P895, DOI 10.1017/S0033291700037387
   GIJSEN R, 2003, VOLKSGEZONDHEID TOEK
   Glasgow RE, 1999, DIABETES CARE, V22, P2090, DOI 10.2337/diacare.22.12.2090
   GOLDBERG D, 1995, EPIDEMIOL REV, V17, P182, DOI 10.1093/oxfordjournals.epirev.a036174
   Gonder-Frederick L., 1991, MENTAL REPRESENTATIO, P220
   Hardy GE, 1997, J PSYCHOSOM RES, V43, P83, DOI 10.1016/S0022-3999(97)00019-6
   Houtman I, 1995, NIOSH APA C STRESS W
   Kant I. J., 2003, Occupational and Environmental Medicine, V60, pi32, DOI 10.1136/oem.60.suppl_1.i32
   Karasek R, 1990, HEALTHY WORK STRESS
   Karasek R. A., 1985, JOB CONTENT QUESTION
   KARASEK RA, 1979, ADMIN SCI QUART, V24, P285, DOI 10.2307/2392498
   Kelleher D, 1988, DIABETES
   Koeter M. W. J., 1991, GEN HLTH QUESTIONNAI
   LEWIS G, 1992, J EPIDEMIOL COMMUN H, V46, P92, DOI 10.1136/jech.46.2.92
   Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397
   Maslach C, 1986, MASLACH BURNOUT INVE
   MEIJMAN T, 1996, PSYCHOLOOG, V6, P236
   Meijman T.F., 1997, HANDLEIDING VBBA OND
   MEIJMAN TF, 1997, VERMOEIDHEID, P5
   Meijman TF., 1991, THESIS U AMSTERDAM
   Niedhammer I, 1998, SCAND J WORK ENV HEA, V24, P197, DOI 10.5271/sjweh.299
   PAWLIKOWSKA T, 1994, BRIT MED J, V308, P763, DOI 10.1136/bmj.308.6931.763
   PENNINGSVANDERE.LJ, 1990, BEHAV MED PSYCHOL BE, P247
   Polonsky WH, 2000, DIABETES SPECTRUM, V13, P36
   POOS MJJ, 2003, VOLKSGEZONDHEID TOEK
   Pouwer F, 2003, DIABETOLOGIA, V46, P892, DOI 10.1007/s00125-003-1124-6
   RIDSDALE L, 1993, BMJ-BRIT MED J, V307, P103, DOI 10.1136/bmj.307.6896.103
   Schaufeli W., 2000, UBOS UTRECHTSE BURNO
   Shumaker SA, 1998, HDB HLTH BEHAV CHANG, P435
   Sluiter JK, 1999, ERGONOMICS, V42, P573, DOI 10.1080/001401399185487
   Smets EMA, 1995, GEDRAG GEZONDHEID, V23, P79
   *SPSS INC, 1998, BAS 9 0 WIND US GUID
   Stevens JC, 1992, APPL MULTIVARIATE ST
   Talbot F, 2000, DIABETES CARE, V23, P1556, DOI 10.2337/diacare.23.10.1556
   van Veldhoven M, 2002, WORK STRESS, V16, P207, DOI 10.1080/02678370210166399
   VANOERS JAM, 2002, GEZONDHEID KOERS VOL
   VERCOULEN JHMM, 1994, J PSYCHOSOM RES, V38, P383, DOI 10.1016/0022-3999(94)90099-X
   Vercoulen JHMM, 1999, GEDRAGSTHERAPIE, V32, P131
   Wall TD, 1997, BRIT J PSYCHIAT, V171, P519, DOI 10.1192/bjp.171.6.519
   Watkins C, 2001, BRIT MED J, V323, P1159, DOI 10.1136/bmj.323.7322.1159
   Watkins KW, 2000, DIABETES CARE, V23, P1511, DOI 10.2337/diacare.23.10.1511
   WATSON M, 2003, COCHRANE LIB
   Weijman I., 2003, Occupational and Environmental Medicine, V60, pi93, DOI 10.1136/oem.60.suppl_1.i93
NR 54
TC 18
Z9 18
U1 1
U2 6
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1076-2752
J9 J OCCUP ENVIRON MED
JI J. Occup. Environ. Med.
PD AUG
PY 2004
VL 46
IS 8
BP 828
EP 836
DI 10.1097/01.jom.0000135605.62330.ca
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 845WU
UT WOS:000223276800011
PM 15300135
DA 2019-01-08
ER

PT J
AU Aversa, A
   Isidori, AM
   Gianfrilli, D
   Greco, EA
   Graziottin, A
   Zizzo, G
   Lenzi, A
   Fabbri, A
AF Aversa, A
   Isidori, AM
   Gianfrilli, D
   Greco, EA
   Graziottin, A
   Zizzo, G
   Lenzi, A
   Fabbri, A
TI Are subjects with erectile dysfunction aware of their condition? Results
   from a retrospective study based on an Italian free-call information
   service
SO JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
LA English
DT Article
DE impotence; epidemiology; erection; anxiety; sildenafil
ID RISK-FACTOR; IMPOTENCE; DETERMINANTS; EPIDEMIOLOGY; PREVALENCE
AB The aim of the study was to analyse the socio-demographic and epidemiological characteristics of the Italian male population affected by sexual disturbances. Men complaining of erectile dysfunction (ED) who called the Pfizer program "Man and Woman in Health" between April 18(th) 2001 and May 27(th) 2002 and asked for information about their medical condition, were interviewed by trained doctors using a computer-assisted questionnaire. 16007 out of 25018 calls were considered for statistical analysis. Mean age of callers was 48.8 +/- 14.2 yr, reporting ED in 83% of cases. In the majority of men ED was severe (58%) and lasting more than 3 yr (25%). Multivariate analysis revealed that diabetes, depression, prostate surgery, heart disease, neurological disorders, liver and renal diseases were all significant and independent contributors to the degree of erectile impairment adjusted for age (p<0.001). The principal concomitant medications were anti-hypertensive (23%), antidiabetic (9%) and cardiovascular agents (6%). Cigarette smoking was present in 24%. On directed questioning of the caller, anxiety and distress were perceived as the most frequent causes of ED (42%) across all age groups, followed by the presence of concomitant disease/s (26%) especially in aging men. Also, a large number of men (41%) with severe ED waited for more than 3 yr before looking for medical referral. Interestingly, only 19% had ever tried any specific medication for ED. These data indicate that 5 yr after worldwide approval and release of sildenafil, ED is still largely undiagnosed and under-treated, possibly because it is still perceived as a condition mainly due to distress or advancing age and therefore not deserving medical referral. Effective prevention of ED commences with better awareness of the pathological causes by the population and modification of risk factors by the doctors. (C) 2004, Editrice Kurtis.
C1 Univ Roma La Sapienza, Dipartimento Fisiopatol Med, Cattedra Med Interna, I-00161 Rome, Italy.
   Univ Roma La Sapienza, Chair Androl, Dept Med Pathophysiol, I-00161 Rome, Italy.
   Univ Roma La Sapienza, Dept Med Pathophysiol, Chair Clin Pathol 3, I-00161 Rome, Italy.
   Univ Roma Tor Vergata, Osped Fatebenefratelli Isola Tiberina, Dept Internal Med, Chair Endocrinol,AfaR,CRCCS,UO Endocrinol, Rome, Italy.
   San Raffaele Resnati Hosp, Ctr Gynaecol & Med Sexol, Milan, Italy.
RP Aversa, A (reprint author), Univ Roma La Sapienza, Dipartimento Fisiopatol Med, Cattedra Med Interna, Viale Policlin 155, I-00161 Rome, Italy.
EM antonio.aversa@uniromal.it
RI Lenzi, Andrea/I-7711-2015; Isidori, Andrea/F-3062-2010
OI Lenzi, Andrea/0000-0002-7711-0465; Isidori, Andrea/0000-0002-9037-5417;
   Greco, Emanuela/0000-0003-0603-4079; Aversa, Antonio/0000-0002-2989-2618
CR Araujo AB, 2000, AM J EPIDEMIOL, V152, P533, DOI 10.1093/aje/152.6.533
   Aversa A, 1996, INT J ANDROL, V19, P307, DOI 10.1111/j.1365-2605.1996.tb00481.x
   Aytac IA, 1999, BJU INT, V84, P50
   Braun M, 2000, INT J IMPOT RES, V12, P305, DOI 10.1038/sj.ijir.3900622
   BULPITT CJ, 1976, BRIT HEART J, V38, P121
   Chew KK, 2000, INT J IMPOT RES, V12, P41, DOI 10.1038/sj.ijir.3900457
   Fabbri A, 1999, J ENDOCRINOL INVEST, V22, P486, DOI 10.1007/BF03343595
   Fedele D, 1998, DIABETES CARE, V21, P1973, DOI 10.2337/diacare.21.11.1973
   FELDMAN HA, 1994, J UROLOGY, V151, P54, DOI 10.1016/S0022-5347(17)34871-1
   GIULIANO F, 2001, EUR J INTERN MED, V12, P240
   Jaffe A, 1996, HYPERTENSION, V28, P859, DOI 10.1161/01.HYP.28.5.859
   Kubin M, 2003, INT J IMPOT RES, V15, P63, DOI 10.1038/sj.ijir.3900949
   Mirone V, 2002, INT J IMPOT RES, V14, P256, DOI 10.1038/sj.ijir.3900879
   Mirone V, 2002, EUR UROL, V41, P294, DOI 10.1016/S0302-2838(02)00005-2
   MULLER SC, 1991, EUR UROL, V19, P29
   Parazzini F, 2000, EUR UROL, V37, P43, DOI 10.1159/000020098
   Ricci E, 2003, INT J IMPOT RES, V15, P221, DOI 10.1038/sj.ijir.3901008
   Schiel R, 1999, DIABETES RES CLIN PR, V44, P115, DOI 10.1016/S0168-8227(99)00012-1
   Shabsigh R, 2001, Curr Urol Rep, V2, P463, DOI 10.1007/s11934-001-0040-x
   SLAG MF, 1983, JAMA-J AM MED ASSOC, V249, P1736, DOI 10.1001/jama.249.13.1736
NR 20
TC 17
Z9 17
U1 0
U2 3
PU EDITRICE KURTIS S R L
PI MILAN
PA VIA LUIGI ZOJA 30, 20153 MILAN, ITALY
SN 0391-4097
J9 J ENDOCRINOL INVEST
JI J. Endocrinol. Invest.
PD JUN
PY 2004
VL 27
IS 6
BP 548
EP 556
DI 10.1007/BF03347477
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 852DB
UT WOS:000223734300007
PM 15717652
DA 2019-01-08
ER

PT J
AU Vileikyte, L
   Rubin, RR
   Leventhal, H
AF Vileikyte, L
   Rubin, RR
   Leventhal, H
TI Psychological aspects of diabetic neuropathic foot complications: an
   overview
SO DIABETES-METABOLISM RESEARCH AND REVIEWS
LA English
DT Article; Proceedings Paper
CT 4th International Symposium on the Diabetic Foot
CY MAY 22-24, 2003
CL Noordwijkerhout, NETHERLANDS
DE neuropathic foot complications; adherence; common-sense model; (CSM) of
   behaviour; negative affect; quality of life
ID QUALITY-OF-LIFE; ASSOCIATION; AMPUTATIONS; DEPRESSION; ILLNESS; PATIENT;
   MODEL
AB Despite recent advances in understanding and major efforts to control the biomedical risk factors for neuropathic foot complications, the rates of foot ulceration and amputation remain unacceptably high. As the current focus on physical factors alone has not led to a substantial decline in foot complications in persons with diabetes, we propose a more balanced approach with the consideration of potentially important psychological factors. Until recently, psychosocial research in diabetes has almost exclusively focused on self-care behaviours and the burdens associated with the management of glycaemia, almost to the total neglect of the effects of chronic complications including neuropathy. As the burdens associated with the complications of diabetes begin to overshadow those specific to the control of glycaemia, it is important to develop social and psychological concepts and measures that capture how patients perceive and respond to specific threats such as that of neuropathy. There is now some progress in this area as evidenced by emerging patient-centred, theory-based methods to identify psychological factors influencing adherence behaviours, emotional status and quality of life in diabetic patients at high risk of developing foot ulcers. The development of a conceptual model of patient's common-sense representations or beliefs about foot complications and the type and source of their emotional distress should allow clinicians and behavioural investigators to share ideas for the assessment of patient beliefs and behaviour, and the development of educational methods that should improve clinicians' ability to empower patients to manage their neuropathy more efficiently. Copyright (C) 2004 John Wiley Sons, Ltd.
C1 Univ Miami, Miami, FL 33152 USA.
   Univ Manchester, Manchester M13 9PL, Lancs, England.
   Johns Hopkins Univ, Baltimore, MD 21218 USA.
   Rutgers State Univ, New Brunswick, NJ 08903 USA.
RP Vileikyte, L (reprint author), Dept Med, Div Endocrinol Diabet & Metab, POB 016960,D-110, Miami, FL 33101 USA.
EM lvileikyte@med.miami.edu
CR ABETZ L, 2002, PRACT DIAB INT, V19, P167, DOI DOI 10.1002/PDI.356
   BOULTON AJM, 1995, PATIENT EDUC COUNS, V26, P183, DOI 10.1016/0738-3991(95)00746-M
   Bradley C, 2001, LANCET, V357, P7, DOI 10.1016/S0140-6736(00)03562-5
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   Diefenbach MA, 1999, HEALTH PSYCHOL, V18, P532, DOI 10.1037/0278-6133.18.5.532
   GILL TM, 1994, JAMA-J AM MED ASSOC, V272, P619, DOI 10.1001/jama.272.8.619
   GORDOIS A, 2003, DIABETES CARE, V26, P1796
   Kaptein A.A, 2003, SELF REGULATION HLTH, P97
   Kemeny ME, 2003, BRAIN BEHAV IMMUN, V17, pS62
   LARRSON J, 1995, DIABETIC MED, V12, P770
   LARRSON J, 1995, ACTA ORTHOP SCAND, V66, P181
   Leventhal H, 1997, PSYCHOL HEALTH, V12, P753, DOI 10.1080/08870449708406737
   Leventhal H, 1980, CONTRIBUTIONS MED PS, V2, P7
   LEVENTHAL H, 2003, SELF REGULATION HLTH, P97
   Mora PA, 2002, PSYCHOSOM MED, V64, P436, DOI 10.1097/00006842-200205000-00007
   RATHMAN W, 2003, TXB DIABETIC NEUROPA, P361
   Ray NF, 1998, DIABETES CARE, V21, P296
   Stiegler H, 1998, VASA-J VASCULAR DIS, V27, P10
   TESFAYE S, 2000, DIABETOLOGIA, V43, P957
   Trautner C, 2001, DIABETES CARE, V24, P855, DOI 10.2337/diacare.24.5.855
   Valk GD, 2002, ENDOCRIN METAB CLIN, V31, P633, DOI 10.1016/S0889-8529(02)00021-X
   Vileikyte L, 2003, DIABETES, V52, pA420
   Vileikyte L, 2003, DIABETES CARE, V26, P2549, DOI 10.2337/diacare.26.9.2549
   Vileikyte L, 2001, DIABETES METAB RES, V17, P246, DOI 10.1002/dmrr.216
   Vileikyte L, 1999, DIABETES REV, V7, P387
   VILEIKYTE L, 2002, DIABETES, V51, pA45
   VILEIKYTE L, 2001, DIABETES S2, V50, pA324
   Williamson GM, 1998, REHABIL PSYCHOL, V43, P327
NR 28
TC 70
Z9 73
U1 0
U2 12
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 1520-7552
J9 DIABETES-METAB RES
JI Diabetes-Metab. Res. Rev.
PD MAY-JUN
PY 2004
VL 20
SU 1
BP S13
EP S18
DI 10.1002/dmrr.437
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 826GD
UT WOS:000221816400005
PM 15150807
DA 2019-01-08
ER

PT J
AU Hassler-Hurst, J
   Wadham, C
   Rayman, G
AF Hassler-Hurst, J
   Wadham, C
   Rayman, G
TI A double-blind study comparing 0.5% and 1% tropicamide for annual
   retinal screening in diabetic adolescents
SO DIABETIC MEDICINE
LA English
DT Article
DE adolescent; mass screening; diabetes mellitus; ophthalmoscopy;
   tropicamide
ID RETINOPATHY; PUPIL; OPHTHALMOSCOPY; PHOTOGRAPHY; PREVENTION; MELLITUS;
   EYE
AB Aims To determine whether there is any difference between 0.5% and 1% tropicamide in ocular discomfort and mydriatic efficacy in adolescents with Type 1 diabetes.
   Methods In a double-blind study, one drop of 0.5% tropicamide was instilled in one eye and one drop of 1% instilled in the other eye of 30 subjects aged 12-18 years. Drop strengths were randomized. Pupil size was measured before instillation, at 10, 20 and 30 min. Discomfort was measured using a recognized pain scale.
   Results Irrespective of the concentration of tropicamide used, all pupils dilated to at least 6 mm at 30 min, sufficient for successful ophthalmoscopy. Pain was significantly less when the lower concentration of tropicamide was used; pain score for the 0.5% group [median (interquartile range)] 1.0 (0-2) and 2.0 (1-3) for the 1.0% group, P = 0.009 (Wilcoxon rank test).
   Conclusions This minor change in practice significantly reduces the distress associated with drop instillation without compromising the clinical examination, and may thus be important in encouraging compliance at the yearly diabetic review.
C1 Ipswich Hosp NHS Trust, Children & Young Adults Team, Ctr Diabet, Ipswich IP4 5PD, Suffolk, England.
RP Rayman, G (reprint author), Ipswich Hosp NHS Trust, Children & Young Adults Team, Ctr Diabet, Heath Rd, Ipswich IP4 5PD, Suffolk, England.
EM raymang@ipsh-tr.anglox.nhs.uk
CR Arun CS, 2003, DIABETIC MED, V20, P186, DOI 10.1046/j.1464-5491.2003.t01-1-00899.x
   Backlund LB, 1997, DIABETIC MED, V14, P732, DOI 10.1002/(SICI)1096-9136(199709)14:9<732::AID-DIA474>3.0.CO;2-J
   BARTLETT JD, 1993, J AM OPTOM ASSOC, V64, P637
   Benavides JO, 1997, OPTOMETRY VISION SCI, V74, P160, DOI 10.1097/00006324-199703000-00027
   BIERI D, 1990, PAIN, V41, P139, DOI 10.1016/0304-3959(90)90018-9
   Cahill M, 2001, BRIT J OPHTHALMOL, V85, P1225, DOI 10.1136/bjo.85.10.1225
   *DEP HLTH, 2002, EFF MISS OUTP APP
   *DIAB UK, 2002, WHAT CAR EXP YOUR CH
   FULLER G, 1993, NEUROLOGICAL EXAMINA
   HARDING SP, 1995, BMJ-BRIT MED J, V311, P1131, DOI 10.1136/bmj.311.7013.1131
   *HLTH TECHN BOARD, 2002, HLTH TECHN ASS ADV, V1
   HREIDARSSON AB, 1992, DAN MED BULL, V39, P400
   Hutchinson A, 2000, DIABETIC MED, V17, P495, DOI 10.1046/j.1464-5491.2000.00250.x
   JAVITT JC, 1989, OPHTHALMOLOGY, V96, P255
   KOHNER EM, 1984, DIABETOLOGIA, V26, P173
   MALLETT J, 2000, MANUAL CLIN NURSING, P376
   MORIARTY AP, 1993, PRACT DIAB, V10, P70
   MORROW LA, 1992, OXFORD TXB GERIATRIC, P136
   *NAT I CLIN EXC, 2002, MAN TYP 2 DIAB RET E
   Owens DR, 1998, DIABETIC MED, V15, P170, DOI 10.1002/(SICI)1096-9136(199802)15:2<170::AID-DIA518>3.0.CO;2-H
   Pandit RJ, 2000, DIABETIC MED, V17, P693, DOI 10.1046/j.1464-5491.2000.00368.x
   Pittasch D, 2002, DIABETES CARE, V25, P1545, DOI 10.2337/diacare.25.9.1545
   Porta M, 2002, DIABETOLOGIA, V45, P1617, DOI 10.1007/s00125-002-0990-7
   ROHAN TE, 1989, BMJ-BRIT MED J, V299, P1198, DOI 10.1136/bmj.299.6709.1198
   SHAMOON H, 1993, NEW ENGL J MED, V329, P977
   Siu S. C., 1998, Hong Kong Medical Journal, V4, P367
   Stevens RJ, 2002, J DIABETES COMPLICAT, V16, P371, DOI 10.1016/S1056-8727(02)00161-7
   *UK NAT SCREEN COM, 2000, MOD PHOT DIAB RET SC
   WILKIE DJ, 1990, PAIN, V41, P151, DOI 10.1016/0304-3959(90)90019-A
   WILLIAMS G, 1999, HDB DIABETES, P119
   WINN B, 1994, INVEST OPHTH VIS SCI, V35, P1132
   Wong D. L., 1996, HOME HLTH FOCUS, V2, P62
   WONG DL, 1997, WHALEY WONGS ESSENTI, P624
   ZHANG LY, 2001, DIABETES CARE, V24, P1279
NR 34
TC 7
Z9 8
U1 0
U2 2
PU BLACKWELL PUBLISHING LTD
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DG, OXON, ENGLAND
SN 0742-3071
J9 DIABETIC MED
JI Diabetic Med.
PD MAY
PY 2004
VL 21
IS 5
BP 434
EP 439
DI 10.1111/j.1464-5491.2004.01172.x
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 818KJ
UT WOS:000221243700005
PM 15089787
DA 2019-01-08
ER

PT J
AU Naess, S
   Eriksen, J
   Midthjell, K
   Tambs, K
AF Naess, S
   Eriksen, J
   Midthjell, K
   Tambs, K
TI Diabetes mellitus and psychological well-being. Change between 1984-1986
   and 1995-1997. Results of the Nord-Trondelag health study
SO JOURNAL OF DIABETES AND ITS COMPLICATIONS
LA English
DT Article
DE diabetes mellitus; psychological well-being; change over time
ID QUALITY-OF-LIFE; GENERAL-POPULATION; ADULTS; DEPRESSION; PREVALENCE;
   SYMPTOMS; SAMPLE; TYPE-1; EVENTS; CARE
AB Previous research has documented that people with diabetes report lower psychological well-being than do people with no reported disease. In recent years, new treatment regimens for diabetes have been introduced, including improved insulin and tablet treatment, easier blood sugar tests, and transfer of responsibility from doctor to patient. Have these improved methods for controlling diabetes resulted in enhanced psychological well-being for this group of patients? In this paper, we analyze changes in psychological well-being between 19841986 and 1995-1997 among diabetic patients. On these two occasions, the entire adult population of one county in Norway was invited to a health screening (the Nord-Trondelag Health Studies, HUNT 1 and HUNT 2). Participants reached 77,224 and 65,599 persons, respectively (90.7% in HUNT 1 and 71.0% in HUNT 2). The participants responded to questionnaires, including questions on several diseases and impairments, as well as self-assessed health and psychological well-being. People with diabetes reported significantly lower well-being than people with no reported diabetes in HUNT 1 as well as in HUNT 2. However, the relationship between diabetes and well-being was significantly weaker in HUNT 2 than in HUNT 1. Self-reported Subjective health, the feeling of being strong and fit (Vigor), the use of Tranquilizers, and Psychological distress had improved between the two surveys, for people with diabetes compared to people with no reported diabetes. Other outcome variables - Calmness, Cheerfulness, and Life satisfaction - were only weakly related to diabetes, and the relationship did not change significantly from HUNT I to HUNT 2. (C) 2004 Elsevier Inc. All rights reserved.
C1 NOVA, N-0208 Oslo, Norway.
   NTNU, HUNT Res Ctr, Fac Med, N-7650 Verdal, Norway.
   Natl Inst Publ Hlth, Epidemiol Sect, N-0403 Oslo, Norway.
RP Naess, S (reprint author), NOVA, PB 3223, N-0208 Oslo, Norway.
EM siri.nass@nova.no
CR Brown GC, 2000, J DIABETES COMPLICAT, V14, P18, DOI 10.1016/S1056-8727(00)00061-1
   COX DJ, 1992, J CONSULT CLIN PSYCH, V60, P628, DOI 10.1037//0022-006X.60.4.628
   Davis TME, 2001, DIABETES RES CLIN PR, V52, P63, DOI 10.1016/S0168-8227(00)00245-X
   de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015
   DIENER E, 1994, SOC INDIC RES, V31, P103, DOI 10.1007/BF01207052
   Eiser JR, 2001, PSYCHOL HEALTH, V16, P99, DOI 10.1080/08870440108405492
   ERIKSEN J, 1998, 1698 NOVA NORW SOC R
   GAVARD JA, 1993, DIABETES CARE, V16, P1167, DOI 10.2337/diacare.16.8.1167
   GERINGER FS, 1990, NEUROPSYCHOLOGICAL B, P239
   Glasgow RE, 1997, DIABETES CARE, V20, P562, DOI 10.2337/diacare.20.4.562
   HOLMEN J, 1990, 490 NAT I PUBL HLTH
   Hornquist J O, 1995, Pharmacoeconomics, V8 Suppl 1, P12
   HORNQUIST JO, 1995, DIABETES RES CLIN PR, V28, P63, DOI 10.1016/0168-8227(95)01054-H
   JACOBSON AM, 1995, QUALITY LIFE BEHAV M, P241
   Langhammer A, 2000, J EPIDEMIOL COMMUN H, V54, P917, DOI 10.1136/jech.54.12.917
   LUSTMAN PJ, 1997, SEMIN CLIN NEUROPSYC, V2, P15
   MAYOU R, 1990, J PSYCHOSOM RES, V34, P1, DOI 10.1016/0022-3999(90)90002-L
   MIDTHJELL K, 1992, J EPIDEMIOL COMMUN H, V46, P537, DOI 10.1136/jech.46.5.537
   Midthjell K, 1999, DIABETES CARE, V22, P1813, DOI 10.2337/diacare.22.11.1813
   MIDTHJELL K, 2001, THESIS HUNT RES CTR
   MOUM T, 1990, PSYCHOL MED, V20, P635, DOI 10.1017/S0033291700017153
   MOUM T, 1983, QUALITY LIFE PROBLEM, P112
   NAESS S, 1995, SCAND J SOC MED, V23, P179
   PALINKAS LA, 1991, DIABETIC MED, V8, P532, DOI 10.1111/j.1464-5491.1991.tb01646.x
   Peyrot M, 1997, DIABETES CARE, V20, P585, DOI 10.2337/diacare.20.4.585
   Rogers WH, 1993, STATA TECHNICAL B, V13, P19, DOI DOI 10.1016/J.IJFORECAST.2005.03.004
   SORENSEN T, 1987, INT J FAMILY PSYCHIA, V6, P189
   UK Prospective Diabetes Study Group, 1999, DIABETES CARE, V22, P1125, DOI DOI 10.2337/DIACARE.22.7.1125
   Wandell PE, 1998, QUAL LIFE RES, V7, P751, DOI 10.1023/A:1008893121086
   Wandell PE, 1999, DIABETES METAB, V25, P424
   WELLS KB, 1988, AM J PSYCHIAT, V145, P976
   Wikby A, 1998, DIABETES EDUCATOR, V24, P61, DOI 10.1177/014572179802400108
NR 32
TC 7
Z9 7
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1056-8727
J9 J DIABETES COMPLICAT
JI J. Diabetes Complications
PD MAY-JUN
PY 2004
VL 18
IS 3
BP 141
EP 147
DI 10.1016/S1056-8727(03)00036-9
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 824AK
UT WOS:000221655500001
PM 15145324
DA 2019-01-08
ER

PT J
AU Roth, E
   Manhart, N
   Wessner, B
AF Roth, E
   Manhart, N
   Wessner, B
TI Assessing the antioxidative status in critically ill patients
SO CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
LA English
DT Review
DE antioxidants; critically ill; reactive oxygen species
ID SYSTEMIC INFLAMMATORY RESPONSE; RESPIRATORY-DISTRESS-SYNDROME; KAPPA-B
   ACTIVATION; XANTHINE-OXIDASE ACTIVITY; INTENSIVE-CARE PATIENTS;
   FREE-RADICAL GENERATION; HUMAN SEPTIC SHOCK; OXIDATIVE STRESS;
   LIPID-PEROXIDATION; IN-VIVO
AB Purpose of review Oxidative stress is caused by a higher production of reactive oxygen and reactive nitrogen species or a decrease in endogenous protective antioxidative capacity. In all types of critical illness, such as sepsis, trauma, burn injury, acute pancreatitis, liver injury, severe diabetes, acute respiratory distress syndrome, AIDS and kidney failure, the occurrence of increased oxidative stress or a reduced antioxidative status is described. Whereas in the past, reactive oxygen and reactive nitrogen species were mainly known as harmful agents, recent investigations have given a new insight into the (patho) physiological importance of these substances as powerful messenger molecules involved in gene regulation, thereby enabling the synthesis of cytokines or adhesion molecules necessary for defending inflammatory processes. As shown in this review, there are numerous possibilities for the quantification of oxidative stress.
   Recent findings Several investigations showed a close association of single or multiple parameters, such as total antioxidative capacity, lipid peroxidation, vitamins C and E, the activation of nuclear factor kappa B, and respiratory burst, with the patient's outcome. However, no recommendation for a single parameter to be measured can be given because the assays described do not allow the definition of an overall 'antioxidative status' for patients.
   Summary The occurrence of oxidative stress in critically ill patients is associated with a poor prognosis. The measurement of a cluster of assays representative of the quantification of reactive species or of antioxidants may improve the usefulness of therapeutic intervention and increase knowledge of pathophysiological alterations.
C1 Univ Vienna, Gen Hosp, Surg Res Labs, A-1090 Vienna, Austria.
   Univ Vienna, Dept Surg, Res Labs, Vienna, Austria.
RP Roth, E (reprint author), Univ Vienna, Gen Hosp, Surg Res Labs, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
EM erich.roth@akh-wien.ac.at
RI Wessner, Barbara/J-8244-2012
OI Wessner, Barbara/0000-0002-9061-7914
CR Abu-Zidan FM, 2002, EUR J SURG, V168, P119, DOI 10.1080/11024150252884359
   ADAMS V, 2003, J CARDIOVASC RISK, V10, P273
   Berger MM, 1996, J TRAUMA, V40, P103, DOI 10.1097/00005373-199601000-00019
   Bertin-Maghit M, 2000, INTENS CARE MED, V26, P800, DOI 10.1007/s001340051250
   Cadenas S, 2002, TOXICOLOGY, V180, P45, DOI 10.1016/S0300-483X(02)00381-5
   Clermont G, 2000, CARDIOVASC RES, V47, P618, DOI 10.1016/S0008-6363(00)00117-6
   Clermont G, 2002, ANESTHESIOLOGY, V96, P80, DOI 10.1097/00000542-200201000-00019
   Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev
   Courderot-Masuyer C, 2000, CELL MOL BIOL, V46, P1397
   Cowley HC, 1996, CRIT CARE MED, V24, P1179, DOI 10.1097/00003246-199607000-00019
   Cracowski JL, 2002, TRENDS PHARMACOL SCI, V23, P360, DOI 10.1016/S0165-6147(02)02053-9
   Curran FJM, 2000, BRIT J SURG, V87, P301, DOI 10.1046/j.1365-2168.2000.01375.x
   Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5
   Davies MJ, 1999, FREE RADICAL BIO MED, V27, P1151, DOI 10.1016/S0891-5849(99)00206-3
   Davison GW, 2002, FREE RADICAL BIO MED, V33, P1543, DOI 10.1016/S0891-5849(02)01090-0
   de Vega JMA, 2000, CRIT CARE MED, V28, P1812, DOI 10.1097/00003246-200006000-00021
   de Vega JMA, 2002, CRIT CARE MED, V30, P1782, DOI 10.1097/00003246-200208000-00018
   Deplancke B, 2002, CURR OPIN CLIN NUTR, V5, P85, DOI 10.1097/00075197-200201000-00015
   Diaz-Araya G, 2002, CRIT CARE MED, V30, P417, DOI 10.1097/00003246-200202000-00025
   Exner R, 2000, WIEN KLIN WOCHENSCHR, V112, P610
   Fagan JM, 1999, INT J BIOCHEM CELL B, V31, P751, DOI 10.1016/S1357-2725(99)00034-5
   Flohe L, 1997, FREE RADICAL BIO MED, V22, P1115, DOI 10.1016/S0891-5849(96)00501-1
   Forceville X, 1998, CRIT CARE MED, V26, P1536, DOI 10.1097/00003246-199809000-00021
   Frass OM, 2001, CHEST, V120, P1599, DOI 10.1378/chest.120.5.1599
   Frey B, 2002, SHOCK, V18, P14, DOI 10.1097/00024382-200207000-00003
   Galley HF, 1996, CRIT CARE MED, V24, P1649, DOI 10.1097/00003246-199610000-00008
   Gerardi G, 2002, CLIN CHEM LAB MED, V40, P104, DOI 10.1515/CCLM.2002.019
   Ghiselli A, 2000, FREE RADICAL BIO MED, V29, P1106, DOI 10.1016/S0891-5849(00)00394-4
   GOODE HF, 1995, CRIT CARE MED, V23, P645
   Goodyear-Bruch C, 2002, AM J CRIT CARE, V11, P543
   Griffiths HR, 2002, MOL ASPECTS MED, V23, P101, DOI 10.1016/S0098-2997(02)00017-1
   Gutteridge JMC, 1999, BRIT MED BULL, V55, P49, DOI 10.1258/0007142991902295
   Hack V, 1998, BLOOD, V92, P59
   Hammarqvist F, 1997, CRIT CARE MED, V25, P78, DOI 10.1097/00003246-199701000-00016
   HAWKER FH, 1990, CRIT CARE MED, V18, P442, DOI 10.1097/00003246-199004000-00020
   Inoue T, 2002, CARDIOLOGY, V98, P13, DOI 10.1159/000064672
   IOANNIDIS I, 1995, TRANSPLANTATION, V59, P1293, DOI 10.1097/00007890-199505000-00012
   ISOWA N, 2002, N SURG J, V1, P1
   Kretzschmar M, 1998, EXP TOXICOL PATHOL, V50, P477, DOI 10.1016/S0940-2993(98)80037-7
   Lamb NJ, 1999, CRIT CARE MED, V27, P1738, DOI 10.1097/00003246-199909000-00007
   Lassnigg A, 2003, BRIT J ANAESTH, V90, P148, DOI 10.1093/bja/aeg042
   Luo JL, 1998, AM J PHYSIOL-ENDOC M, V275, pE359, DOI 10.1152/ajpendo.1998.275.2.E359
   Manhart N, 1998, WIEN KLIN WOCHENSCHR, V110, P796
   McNally JA, 1996, J BIOLUM CHEMILUM, V11, P99, DOI 10.1002/(SICI)1099-1271(199603)11:2<99::AID-BIO404>3.3.CO;2-V
   Metnitz PGH, 1999, INTENS CARE MED, V25, P180, DOI 10.1007/s001340050813
   Metnitz PGH, 2000, ACTA ANAESTH SCAND, V44, P236, DOI 10.1034/j.1399-6576.2000.440304.x
   Moine P, 2000, SHOCK, V13, P85, DOI 10.1097/00024382-200013020-00001
   Nakamori Y, 2003, J TRAUMA, V54, P253, DOI 10.1097/01.TA.0000037096.73714.E6
   NATHENS AB, 2002, ANN SURG, V6, P814
   Nemeth I, 2001, INTENS CARE MED, V27, P216, DOI 10.1007/s001340000791
   Nonaka-Sarukawa M, 2003, HEART, V89, P871, DOI 10.1136/heart.89.8.871
   Offord E, 2000, Free Radic Res, V33 Suppl, pS5
   Ohya M, 2002, SHOCK, V18, P116, DOI 10.1097/00024382-200208000-00004
   OISMULLER C, 1995, SHOCK, V4, P161, DOI 10.1097/00024382-199509000-00002
   Pascual C, 1998, CRIT CARE MED, V26, P705, DOI 10.1097/00003246-199804000-00019
   Paterson RL, 2000, CRIT CARE MED, V28, P1047, DOI 10.1097/00003246-200004000-00022
   Patteril MV, 2001, ANAESTH INTENS CARE, V29, P473
   Pintaudi AM, 2000, FREE RADICAL RES, V33, P139, DOI 10.1080/10715760000300691
   Prior RL, 1999, FREE RADICAL BIO MED, V27, P1173, DOI 10.1016/S0891-5849(99)00203-8
   Quasim T, 2003, CLIN NUTR, V22, P459, DOI 10.1016/S0261-5614(03)00044-X
   Quinlan GJ, 1997, AM J RESP CRIT CARE, V155, P479, DOI 10.1164/ajrccm.155.2.9032182
   Rahman I, 2003, J BIOCHEM MOL BIOL, V36, P95
   Reid M, 2001, CURR OPIN CLIN NUTR, V4, P65, DOI 10.1097/00075197-200101000-00012
   Rice-Evans CA, 2000, FREE RADICAL RES, V33, pS59
   ROBINSON JP, 1994, METHOD CELL BIOL, V41, P437
   Rossi R, 2002, CLIN CHEM, V48, P742
   Sakamoto H, 2002, EUR J ANAESTH, V19, P550, DOI 10.1017/S0265021502000893
   Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4
   Schoonbroodt S, 2000, BIOCHEM PHARMACOL, V60, P1075, DOI 10.1016/S0006-2952(00)00371-3
   Schorah CJ, 1996, AM J CLIN NUTR, V63, P760
   SIMMS HH, 1994, BLOOD, V83, P1388
   Story DA, 1999, CRIT CARE MED, V27, P220, DOI 10.1097/00003246-199901000-00057
   Strand OA, 2000, CRIT CARE MED, V28, P2779, DOI 10.1097/00003246-200008000-00017
   TENNENBERG SD, 1988, ARCH SURG-CHICAGO, V123, P171
   Therond P, 2000, Curr Opin Clin Nutr Metab Care, V3, P373, DOI 10.1097/00075197-200009000-00009
   Varma S, 2003, J NEUROTRAUM, V20, P781, DOI 10.1089/089771503767870005
   VESPASIANO MC, 1993, CRIT CARE MED, V21, P666, DOI 10.1097/00003246-199305000-00008
   Winterbourn CC, 2000, CRIT CARE MED, V28, P143, DOI 10.1097/00003246-200001000-00024
   Wu ZK, 2001, CARDIOVASC SURG, V9, P362, DOI 10.1016/S0967-2109(00)00146-0
   Yang KY, 2003, AM J RESP CRIT CARE, V167, P1567, DOI 10.1164/rccm.200207-664OC
NR 80
TC 79
Z9 83
U1 0
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1363-1950
J9 CURR OPIN CLIN NUTR
JI Curr. Opin. Clin. Nutr. Metab. Care
PD MAR
PY 2004
VL 7
IS 2
BP 161
EP 168
DI 10.1097/00075197-200403000-00010
PG 8
WC Endocrinology & Metabolism; Nutrition & Dietetics
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 804MT
UT WOS:000220303500009
PM 15075707
DA 2019-01-08
ER

PT J
AU Melkus, GD
   Spollett, G
   Jefferson, V
   Chyun, D
   Tuohy, B
   Robinson, T
   Kaisen, A
AF Melkus, GD
   Spollett, G
   Jefferson, V
   Chyun, D
   Tuohy, B
   Robinson, T
   Kaisen, A
TI A culturally competent intervention of education and care for black
   women with type 2 diabetes
SO APPLIED NURSING RESEARCH
LA English
DT Article; Proceedings Paper
CT 59th Scientific Session of the American-Diabetes-Association
CY JUN 18-22, 1999
CL SAN DIEGO, CA
SP Amer Diabet Assoc
ID AFRICAN-AMERICAN WOMEN; WEIGHT-LOSS PROGRAM; GLYCEMIC CONTROL;
   SELF-MANAGEMENT; ETHNIC-DIFFERENCES; HEALTH-STATUS; INNER-CITY;
   BEHAVIORS; OUTCOMES; WHITE
AB This article reports on the development and pilot feasibility testing of a culturally competent intervention of education and care for black women with type 2 diabetes mellitus (T2DM). Using a one group, pretest posttest quasi-experimental design, the intervention was tested with a convenience sample of 25 community black women with T2DM. The conceptual basis, process, and content of the intervention as well as the feasibility and acceptability of study materials and methods are described. Significant improvements from baseline to 3 months were observed in measures of glycemic control, weight, body mass index, and diabetes-related emotional distress. The findings suggest that a culturally sensitive intervention of nurse practitioner diabetes care and education is beneficial for black women with T2DM, resulting in program attendance, kept appointments, improved glycemic control and weight, and decreased diabetes-related emotional distress. (C) 2004 Elsevier Inc. All rights reserved.
C1 Yale Univ, Sch Nursing, New Haven, CT 06536 USA.
   Yale Univ, Sch Med, Dept Endocrinol, Ctr Diabet, New Haven, CT 06536 USA.
RP Melkus, GD (reprint author), Yale Univ, Sch Nursing, POB 9740, New Haven, CT 06536 USA.
EM Gail.Melkus@Yale.edu
CR ALLAN JD, 1993, RES NURS HEALTH, V16, P323, DOI 10.1002/nur.4770160503
   BLENDON RJ, 1995, JAMA-J AM MED ASSOC, V273, P341, DOI 10.1001/jama.273.4.341
   BROWN SA, 1992, RES NURS HEALTH, V15, P409, DOI 10.1002/nur.4770150603
   BROWN SA, 1990, PATIENT EDUC COUNS, V16, P189, DOI 10.1016/0738-3991(90)90070-2
   Chin MH, 2000, AM J PUBLIC HEALTH, V90, P431, DOI 10.2105/AJPH.90.3.431
   CLEMENT S, 1995, DIABETES CARE, V18, P1204, DOI 10.2337/diacare.18.8.1204
   DAWSON DA, 1988, AM J PUBLIC HEALTH, V78, P1326, DOI 10.2105/AJPH.78.10.1326
   DERAMOMELKUS GA, 1992, DIABETES CARE, V15, P864, DOI 10.2337/diacare.15.7.864
   *DIAB RES WORK GRO, 1999, CONQ DIAB STRAT PLAN
   Harris MI, 2000, DIABETES CARE, V23, P754, DOI 10.2337/diacare.23.6.754
   Harris MI, 1999, DIABETES CARE, V22, P403, DOI 10.2337/diacare.22.3.403
   Heckler MM, 1986, REPORT SECRETARYS TA
   HEIGHT DI, 1993, BLACK FAMILY DINNER
   ISOLAB I, 1992, GLYC AFFIN GHB AFFIN
   KANDERS BS, 1994, J AM DIET ASSOC, V94, P310, DOI 10.1016/0002-8223(94)90374-3
   KEYSERLING RC, 2002, DIABETES CARE, V25, P1576
   Keyserling TC, 2000, DIABETES EDUCATOR, V26, P796, DOI 10.1177/014572170002600508
   KUMANYIKA S, 1993, J AM DIET ASSOC, V93, P416, DOI 10.1016/0002-8223(93)92287-8
   KUMANYIKA S K, 1992, Ethnicity and Disease, V2, P166
   KUMANYIKA SK, 1992, PATIENT EDUC COUNS, V19, P19, DOI 10.1016/0738-3991(92)90099-5
   KUMANYIKA SK, 1990, DIABETES CARE S, V13, P1155
   Maillet NA, 1996, DIABETES EDUCATOR, V22, P39, DOI 10.1177/014572179602200106
   MCCAUL KD, 1987, MED CARE, V25, P868, DOI 10.1097/00005650-198709000-00005
   MCNABB WL, 1993, J AM DIET ASSOC, V93, P75, DOI 10.1016/0002-8223(93)92138-N
   Melkus Gail D'Eramo, 2002, J Am Acad Nurse Pract, V14, P43, DOI 10.1111/j.1745-7599.2002.tb00070.x
   MILLER KL, 1994, DIABETES CARE, V17, P1495, DOI 10.2337/diacare.17.12.1495
   NICKENS HW, 1995, HEALTH SERV RES, V30, P151
   *NIH, 1987, NIH PUBL
   Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561
   *OFF MIN HLTH, 2001, CLOS GAP
   PADGETT D, 1988, J CLIN EPIDEMIOL, V41, P1007, DOI 10.1016/0895-4356(88)90040-6
   Peyrot M, 1999, J HEALTH SOC BEHAV, V40, P141, DOI 10.2307/2676370
   Prochaska J. O., 1984, TRANSTHEORETICAL APP
   PROCHASKA JO, 1992, AM PSYCHOL, V47, P1102, DOI 10.1037//0003-066X.47.9.1102
   Quinn MT, 2001, DIABETES EDUCATOR, V27, P231, DOI 10.1177/014572170102700209
   Rimmer JH, 2002, DIABETES EDUCATOR, V28, P571, DOI 10.1177/014572170202800411
   Rubin R. R., 1993, DIABETES ED, V19, P210, DOI [DOI 10.1177/014572179301900308, 10.1177/014572179301900308]
   Ruggiero L, 1997, DIABETES CARE, V20, P568, DOI 10.2337/diacare.20.4.568
   SKELLY AH, 1995, DIABETES EDUCATOR, V21, P38, DOI 10.1177/014572179502100107
   *TASK FORC COMM DI, 1989, DIAB REL PROGR BLACK
   TRIPPREIMER T, 1999, CULTURAL INTERVENTIO
   Turner RC, 1998, LANCET, V352, P854
   *US DEP HHS, 1998, HLTH PEOPL 2010 OBJ
   WEATHERSPOON LJ, 1994, DIABETES CARE, V17, P1148, DOI 10.2337/diacare.17.10.1148
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
   WING RR, 1985, J CONSULT CLIN PSYCH, V53, P111, DOI 10.1037/0022-006X.53.1.111
   Wisdom K, 1997, DIABETES CARE, V20, P971, DOI 10.2337/diacare.20.6.971
   WOODSON J, 1993, DIABETES FORECAST, P35
NR 48
TC 39
Z9 39
U1 1
U2 6
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399 USA
SN 0897-1897
J9 APPL NURS RES
JI Appl. Nurs. Res.
PD FEB
PY 2004
VL 17
IS 1
BP 10
EP 20
DI 10.1016/j.apnr.2003.10.009
PG 11
WC Nursing
SC Nursing
GA 780KF
UT WOS:000189379300003
PM 14991551
DA 2019-01-08
ER

PT J
AU Keers, JC
   Blaauwwiekel, EE
   Hania, M
   Bouma, J
   Scholten-Jaegers, SMHJ
   Sanderman, R
   Links, TP
AF Keers, JC
   Blaauwwiekel, EE
   Hania, M
   Bouma, J
   Scholten-Jaegers, SMHJ
   Sanderman, R
   Links, TP
TI Diabetes rehabilitation: development and first results of a
   Multidisciplinary Intensive Education Program for patients with
   prolonged self-management difficulties
SO PATIENT EDUCATION AND COUNSELING
LA English
DT Article
DE diabetes mellitus; diabetes education; health-related quality of life;
   self-management
ID QUALITY-OF-LIFE; GLYCEMIC CONTROL; BLOOD-GLUCOSE; MELLITUS;
   COMPLICATIONS; KNOWLEDGE; CARE; OUTCOMES; THERAPY; PEOPLE
AB For a number of diabetes patients regular care may be insufficient. A Multidisciplinary Intensive Education Program (MIEP), based on the empowerment approach, has been developed to help patients obtain their treatment goals (adequate self-management, glycemic control and quality of life). The aim of this pilot study is to determine the effects of MIEP and it's mechanisms of influence. MIEP consisted of 12 days group-sessions and individual counseling. At baseline and 3-months follow-up, blood-glucose (HbA(1c)), quality of life, health locus of control, distress, and knowledge were obtained (N = 51). Paired T-tests and regression analyses were conducted. HbA(1c) and knowledge improved significantly, patients rated themselves healthier and were more internal and less powerful others oriented. Baseline scores explained effects in HbA(1c) and quality of life. Locus of control significantly contributed in effects on quality of life. MIEP benefited patients with prolonged self-management difficulties, and this form of care seems to complement regular care. (C) 2003 Elsevier Science Ireland Ltd. All rights reserved.
C1 Univ Groningen, NCH, NL-9700 AD Groningen, Netherlands.
   Univ Groningen Hosp, Dept Endocrinol, Groningen, Netherlands.
   Acad Rehabil Ctr Beatrixoord, Haren, Netherlands.
RP Keers, JC (reprint author), Univ Groningen, NCH, POB 196, NL-9700 AD Groningen, Netherlands.
EM j.c.keers@med.rug.nl
RI Sanderman, Robbert/D-7234-2012
OI Sanderman, Robbert/0000-0002-0823-1159
CR Aalto AM, 1997, PATIENT EDUC COUNS, V30, P215, DOI 10.1016/S0738-3991(96)00963-9
   *ADA, 2002, DIABETES CARE, V25, pS33
   Anderson R, 2002, PSYCHOL DIABETES CAR, DOI 10. 1002/0470846569. ch4
   Anderson RM, 1999, DIABETES EDUCATOR, V25, P43, DOI 10.1177/014572179902500622
   ANDERSON RM, 1995, DIABETES CARE, V18, P943, DOI 10.2337/diacare.18.7.943
   Berger M, 1999, JAMA-J AM MED ASSOC, V281, P1676, DOI 10.1001/jama.281.18.1676
   Coates VE, 1996, PATIENT EDUC COUNS, V29, P99, DOI 10.1016/0738-3991(96)00938-X
   Dalewitz J, 2000, AM J MED QUAL, V15, P16, DOI 10.1177/106286060001500104
   de Grauw WJC, 1999, FAM PRACT, V16, P133, DOI 10.1093/fampra/16.2.133
   de Sonnaville JJJ, 1998, DIABETES CARE, V21, P919, DOI 10.2337/diacare.21.6.919
   Diabet Control Complications Trial Res Grp, 1996, DIABETES CARE, V19, P195
   DUNN SM, 1984, DIABETES CARE, V7, P36, DOI 10.2337/diacare.7.1.36
   DUNN SM, 1990, SOC SCI MED, V31, P1135, DOI 10.1016/0277-9536(90)90235-K
   Funnell M M, 1991, Diabetes Educ, V17, P37, DOI 10.1177/014572179101700108
   GLASGOW RE, 1992, DIABETES CARE, V15, P1423, DOI 10.2337/diacare.15.10.1423
   Goddijn PPM, 1999, DIABETIC MED, V16, P23, DOI 10.1046/j.1464-5491.1999.00002.x
   GROOTENHUIS PA, 1994, DIABETIC MED, V11, P253, DOI 10.1111/j.1464-5491.1994.tb00268.x
   HALFENS, 1985, THESIS
   HANESTAD BR, 1993, DIABETES RES CLIN PR, V19, P139, DOI 10.1016/0168-8227(93)90107-G
   Jacobson AM, 1996, NEW ENGL J MED, V334, P1249, DOI 10.1056/NEJM199605093341907
   Mandrup-Poulsen T, 1998, BRIT MED J, V316, P1221, DOI 10.1136/bmj.316.7139.1221
   Meijer JWG, 2001, DISABIL REHABIL, V23, P336
   Muhlhauser I, 1998, DIABETOLOGIA, V41, P1139, DOI 10.1007/s001250051043
   Nathan DM, 1996, JAMA-J AM MED ASSOC, V276, P1409
   NERENZ DR, 1992, MED CARE, V30, pMS112, DOI 10.1097/00005650-199205001-00010
   Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561
   PEYROT M, 1994, DIABETES EDUCATOR, V20, P143, DOI 10.1177/014572179402000210
   Rose M, 2002, DIABETES CARE, V25, P35, DOI 10.2337/diacare.25.1.35
   RUBIN RR, 1992, DIABETES CARE, V15, P1640, DOI 10.2337/diacare.15.11.1640
   Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O
   SCHWARTZ LS, 1991, GEN HOSP PSYCHIAT, V13, P19, DOI 10.1016/0163-8343(91)90005-H
   SHAMOON H, 1993, NEW ENGL J MED, V329, P977
   Turner RC, 1998, LANCET, V352, P854
   UK Prospective Diabetes Study (UKPDS) Group, 1998, LANCET, V352, P837, DOI DOI 10.1016/S0140-6736(98)07019-6
   UKPDS UK, 1999, DIABETES CARE, V22, P1125, DOI DOI 10.2337/DIACARE.22.7.1125
   WALLSTON BS, 1978, HEALTH EDUC QUART, V6, P107, DOI 10.1177/109019817800600107
   WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002
   ZEE K, 1996, INT J BEHAV MED, V3, P104
NR 38
TC 19
Z9 20
U1 0
U2 4
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0738-3991
J9 PATIENT EDUC COUNS
JI Patient Educ. Couns.
PD FEB
PY 2004
VL 52
IS 2
BP 151
EP 157
DI 10.1016/S0738-3991(03)00019-3
PG 7
WC Public, Environmental & Occupational Health; Social Sciences,
   Interdisciplinary
SC Public, Environmental & Occupational Health; Social Sciences - Other
   Topics
GA 777HF
UT WOS:000189170000003
PM 15132519
DA 2019-01-08
ER

PT J
AU Fitchett, G
   Murphy, PE
   Kim, J
   Gibbons, JL
   Cameron, JR
   Davis, JA
AF Fitchett, G
   Murphy, PE
   Kim, J
   Gibbons, JL
   Cameron, JR
   Davis, JA
TI Religious struggle: Prevalence, correlates and mental health risks in
   diabetic, congestive heart failure, and oncology patients
SO INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE
LA English
DT Article; Proceedings Paper
CT Annual Meeting of the Society-for-the-Scientific-Study-of-Religion
CY OCT 18-21, 2001
CL Columbus, OH
SP Soc Sci Study Relig
DE religion; diabetes mellitus; congestive heart failure; cancer;
   depression
ID MEDICAL-PRACTICE; OF-LIFE; DEPRESSION; PHYSICIANS; CANCER; SPIRITUALITY;
   VALIDATION; STRESSORS; PREDICTOR; PATTERNS
AB Objectives: For some people, diagnosis with a serious illness or other adverse life events can precipitate a period of religious struggle. While evidence of the harmful effects of religious struggle is accumulating, less is known about its prevalence or correlates. The aim of this study was to examine the prevalence and correlates of religious struggle in three groups of medical patients. Methods: Study participants included diabetic outpatients (N = 71), congestive heart failure outpatients (N = 70), and oncology inpatients (N = 97). Participants completed questionnaires which included several measures of religion, including religious struggle, emotional distress or wellbeing, and demographic characteristics. Results: Half of the total sample (52%) reported no religious struggle, while 15% reported moderate or high levels. In a multi-variate analysis, younger patients (p < 0.001) and CHF patients (p < 0.05) had higher levels of religious struggle. Those with higher levels of positive religious coping also reported higher levels of religious struggle (p < 0.01), while those who attended worship most frequently had lower levels of religious struggle (p < 0.05). Religious struggle was associated with higher levels of depressive symptoms and emotional distress in all three patient groups. Conclusions: While further research is needed to help clarify the sources, additional correlates, and course of religious struggle, the findings in this study confirm the association between religious struggle and emotional distress in these three groups of medical patients. Clinicians should be attentive to signs of religious struggle. Where patient's responses indicate possible religious struggle, clinicians should consider referral to a trained, professional chaplain or pastoral counselor.
C1 Rush Univ, Med Ctr, Dept Relig Hlth & Human Values, Chicago, IL 60612 USA.
   Evanston NW Hlth Care, Evanston, IL USA.
   Advocate Hlth Care, Oak Brook, IL 60523 USA.
RP Fitchett, G (reprint author), Rush Univ, Med Ctr, Dept Relig Hlth & Human Values, 1653 W Congress Pkwy, Chicago, IL 60612 USA.
EM george_fitchett@rush.edu
FU NIA NIH HHS [K08 AG20145]
CR ALBRECHT P, 1989, APPL MATH COMPUT, V31, P1, DOI 10.1016/0096-3003(89)90108-2
   Anandarajah G, 2001, AM FAM PHYSICIAN, V63, P81
   Bennett S J, 1998, Health Care Women Int, V19, P217
   Berg G E, 1994, J Health Care Chaplain, V6, P11, DOI 10.1300/J080v06n01_03
   Berg G E, 1995, J Pastoral Care, V49, P359
   Bradshaw Anna, 2003, J Pastoral Care Counsel, V57, P179
   Carpenter JS, 1999, J ADV NURS, V29, P1402, DOI 10.1046/j.1365-2648.1999.01027.x
   CELLA DF, 1993, J CLIN ONCOL, V11, P570, DOI 10.1200/JCO.1993.11.3.570
   Daaleman TP, 1998, ARCH FAM MED, V7, P548, DOI 10.1001/archfami.7.6.548
   Ellis MR, 1999, J FAM PRACTICE, V48, P105
   Ellison CG, 1996, REV RELIG RES, V38, P111, DOI 10.2307/3512336
   Exline J J, 1999, J Health Psychol, V4, P365, DOI 10.1177/135910539900400306
   Exline JJ, 2000, J CLIN PSYCHOL, V56, P1481, DOI 10.1002/1097-4679(200012)56:12<1481::AID-1>3.0.CO;2-A
   Ferraro KF, 2000, J SCI STUD RELIG, V39, P220, DOI 10.1111/0021-8294.00017
   Fetzer Institute National Institute on Aging Working Group, 1999, MULT MEAS REL SPIR U
   Fitchett G, 1999, REHABIL PSYCHOL, V44, P333, DOI 10.1037//0090-5550.44.4.333
   FITCHETT G, 1998, PSYCHO-ONCOLOGY, P790
   Fitchett G., 2003, WALKING TOGETHER PHY, P23
   FITCHETT G, 1999, CHAPLAINCY TODAY, V15, P2, DOI DOI 10.1080/10999183.1999.10767102
   GORKIN L, 1993, AM J CARDIOL, V71, P1069, DOI 10.1016/0002-9149(93)90575-W
   Idler EL, 2003, RES AGING, V25, P327, DOI 10.1177/0164027503252749
   IDLER EL, 1987, SOC FORCES, V66, P226, DOI 10.2307/2578909
   IDLER EL, 1992, AM J SOCIOL, V97, P1052, DOI 10.1086/229861
   Ingersoll-Dayton B, 2002, INT J AGING HUM DEV, V55, P51, DOI 10.2190/297Q-MRMV-27TE-VLFK
   Kaldjian LC, 1998, AIDS, V12, P103, DOI 10.1097/00002030-199801000-00012
   Koenig HG, 1998, J NERV MENT DIS, V186, P513, DOI 10.1097/00005053-199809000-00001
   Kristeller JL, 1999, PSYCHO-ONCOLOGY, V8, P451, DOI 10.1002/(SICI)1099-1611(199909/10)8:5<451::AID-PON422>3.3.CO;2-V
   Lo B, 2002, JAMA-J AM MED ASSOC, V287, P749, DOI 10.1001/jama.287.6.749
   MAUGANS TA, 1991, J FAM PRACTICE, V32, P210
   MCKEE DD, 1992, J FAM PRACTICE, V35, P201
   McNair D. M., 1992, EDITS MANUAL PROFILE
   Mickley J R, 1998, Hosp J, V13, P1, DOI 10.1300/J011v13n04_01
   Murberg TA, 1998, INT J PSYCHIAT MED, V28, P273, DOI 10.2190/8TRC-PX8R-N498-7BTP
   Nyenhuis DL, 1998, J PERS ASSESS, V70, P386, DOI 10.1207/s15327752jpa7002_14
   OXMAN TE, 1995, PSYCHOSOM MED, V57, P5, DOI 10.1097/00006842-199501000-00002
   Pargament K. I., 1997, PSYCHOL RELIG COPING
   Pargament KI, 1998, J SCI STUD RELIG, V37, P710, DOI 10.2307/1388152
   Pargament KI, 2001, ARCH INTERN MED, V161, P1881, DOI 10.1001/archinte.161.15.1881
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Rector T, 1987, HEART FAILURE, V1, P198, DOI DOI 10.1177/1474515111435605
   Rector T. S., 1987, HEART FAILURE, V3, P192
   Rozanski A, 1999, CIRCULATION, V99, P2192, DOI 10.1161/01.CIR.99.16.2192
   Sloan RP, 2000, NEW ENGL J MED, V342, P1913, DOI 10.1056/NEJM200006223422513
   Smith TB, 2003, PSYCHOL BULL, V129, P614, DOI 10.1037/0033-2909.129.4.614
   Strawbridge WJ, 1998, J GERONTOL B-PSYCHOL, V53, pS118, DOI 10.1093/geronb/53B.3.S118
   Taylor EJ, 1999, PSYCHO-ONCOLOGY, V8, P386
   Trenholm P, 1998, J CLIN PSYCHOL, V54, P59, DOI 10.1002/(SICI)1097-4679(199801)54:1<59::AID-JCLP7>3.0.CO;2-P
   VandeCreek L., 2001, J PASTORAL CARE, V55, P81
   Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760
NR 49
TC 125
Z9 127
U1 1
U2 15
PU BAYWOOD PUBL CO INC
PI AMITYVILLE
PA 26 AUSTIN AVE, AMITYVILLE, NY 11701 USA
SN 0091-2174
J9 INT J PSYCHIAT MED
JI Int. J. Psychiatr. Med.
PY 2004
VL 34
IS 2
BP 179
EP 196
DI 10.2190/UCJ9-DP4M-9C0X-835M
PG 18
WC Psychiatry
SC Psychiatry
GA 850QB
UT WOS:000223626400007
PM 15387401
DA 2019-01-08
ER

PT J
AU Newlin, K
   Melkus, GD
   Chyun, D
   Jefferson, V
AF Newlin, K
   Melkus, GD
   Chyun, D
   Jefferson, V
TI The relationship of spirituality and health outcomes in black women with
   type 2 diabetes
SO ETHNICITY & DISEASE
LA English
DT Article
DE diabetes; black women; spirituality
ID AMBULATORY BLOOD-PRESSURE; PATIENT EDUCATION; GLYCEMIC CONTROL; CHRONIC
   ILLNESS; LIFE; AMERICANS; BELIEFS
AB The purpose of this pilot Study was to explore the relationships between spiritual well-being, emotional distress, HbA(1c) values, and blood pressure levels in a convenience sample of 22 Black women with type 2 diabetes. Results revealed significant inverse correlations between diastolic blood pressure (BP) and both total spiritual well-being (r=-.51, P=.02) and religious well-being (RWB) (r=-.55, P=.01). Women with higher RWB scores tended to have lower diastolic BP, as compared to their counterparts with lower RWB scores (z=2.78, P=.005). Emotional distress was positively related to systolic BP (r=.48, P=.03). These findings suggest that holistic care, addressing the spiritual and emotional dimensions, may foster improved BP levels among Black women with type 2 diabetes, thereby potentially reducing their high risk for secondary complications.
C1 Yale Univ, Sch Nursing, New Haven, CT 06520 USA.
RP Newlin, K (reprint author), Yale Univ, Sch Nursing, 100 Church St S, New Haven, CT 06520 USA.
EM newlin@yale.edu
CR American Diabetes Association, 2000, DIAB FACTS FIG
   American Diabetes Association, 2002, DIABETES CARE S1, V25, pS33, DOI DOI 10.2337/DIACARE.25.2007.S33
   BLOOMGARDEN ZT, 1987, DIABETES CARE, V10, P263, DOI 10.2337/diacare.10.3.263
   BROWN SA, 1992, RES NURS HEALTH, V15, P409, DOI 10.1002/nur.4770150603
   Carels RA, 2000, INT J PSYCHOPHYSIOL, V36, P25, DOI 10.1016/S0167-8760(99)00101-4
   Carson V B, 1992, J Prof Nurs, V8, P209, DOI 10.1016/8755-7223(92)90082-A
   *CDC, 2000, PUBL HLHT DIAB MELL
   Chatters L. M., 1992, J GERONTOL SOC SCI, V47, P269
   COLEMAN CL, 1996, EFFECTS RELIGIOUS AT
   *CTR DIS CONTR, 2000, PREV TREATM COMPL DI
   *CTR DIS CONTR, 1998, NATL DIAB FACT SHEET
   *DCA, 2001, BAY DIAGN BAY DIAGN
   DoRozario L, 1997, DISABIL REHABIL, V19, P427
   EDWARDS DL, 1989, PSYCHOL FACTORS AFFE
   ELLISON CG, 1993, SOC FORCES, V71, P1027, DOI 10.2307/2580129
   Ellison CG, 1996, REV RELIG RES, V38, P111, DOI 10.2307/3512336
   ELLISON CW, 1983, J PSYCHOL THEOL, V11, P330
   Fehring R J, 1997, Oncol Nurs Forum, V24, P663
   FERRARO K, 1994, J SCI STUD RELIG, V4, P362
   Gendolla GHE, 2001, INT J PSYCHOPHYSIOL, V41, P169, DOI 10.1016/S0167-8760(01)00130-1
   GURKLIS JA, 1988, NURS RES, V37, P236
   Hixson KA, 1998, PREV MED, V27, P545, DOI 10.1006/pmed.1998.0321
   Holland JC, 1999, PSYCHO-ONCOLOGY, V8, P14, DOI 10.1002/(SICI)1099-1611(199901/02)8:1<14::AID-PON321>3.3.CO;2-5
   Kaczorowski J M, 1989, Hosp J, V5, P105
   Koenig HG, 1998, INT J PSYCHIAT MED, V28, P189, DOI 10.2190/75JM-J234-5JKN-4DQD
   KRAUSE N, 1989, J GERONTOL, V44, P4
   Landis B J, 1996, Issues Ment Health Nurs, V17, P217, DOI 10.3109/01612849609049916
   LEVIN J, 1994, J GERONTOLOGY SOCIAL, V49, P137
   Levin J., 1995, J GERONTOL, V50B, P154
   Maillet NA, 1996, DIABETES EDUCATOR, V22, P39, DOI 10.1177/014572179602200106
   Melkus G, 2001, DIABETES S, V50, P811
   MELKUS GD, 1999, DIABETES, V48, P158
   Mickley J R, 1992, Image J Nurs Sch, V24, P267
   *NATL INT COAL, 1975, SPIR WELL BEING DEF
   Peyrot M, 1999, J HEALTH SOC BEHAV, V40, P141, DOI 10.2307/2676370
   POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754
   Potts RG, 1996, J PSYCHOSOC ONCOL, V14, P1, DOI 10.1300/J077v14n01_01
   REESMCGEE SA, 1991, CONTROL BELIEFS COPI
   Riley BB, 1998, ARCH PHYS MED REHAB, V79, P258, DOI 10.1016/S0003-9993(98)90004-1
   Rubin R. R., 1993, DIABETES ED, V19, P210, DOI [DOI 10.1177/014572179301900308, 10.1177/014572179301900308]
   RUBIN RR, 1989, DIABETES CARE, V12, P673, DOI 10.2337/diacare.12.10.673
   Samuel-Hodge CD, 2000, DIABETES CARE, V23, P928, DOI 10.2337/diacare.23.7.928
   Shapiro D, 2001, PSYCHOPHYSIOLOGY, V38, P197
   Sowell R L, 1997, Holist Nurs Pract, V11, P18
   Steffen PR, 2001, PSYCHOSOM MED, V63, P523, DOI 10.1097/00006842-200107000-00002
   *UKPDS GROUP, 1998, BMJ-BRIT MED J, V317, P703, DOI DOI 10.1136/BMJ.317.7160.703.PMID:9732337
   VanderDoes FEE, 1996, DIABETES CARE, V19, P204, DOI 10.2337/diacare.19.3.204
NR 47
TC 17
Z9 17
U1 0
U2 5
PU INT SOC HYPERTENSION BLACKS-ISHIB
PI ATLANTA
PA 100 AUBURN AVE NE STE 401, ATLANTA, GA 30303-2527 USA
SN 1049-510X
J9 ETHNIC DIS
JI Ethn. Dis.
PD WIN
PY 2003
VL 13
IS 1
BP 61
EP 68
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 802ML
UT WOS:000220167500010
PM 12723014
DA 2019-01-08
ER

PT J
AU Norrelund, H
   Djurhuus, C
   Jorgensen, JOL
   Nielsen, S
   Nair, KS
   Schmitz, O
   Christiansen, JS
   Moller, N
AF Norrelund, H
   Djurhuus, C
   Jorgensen, JOL
   Nielsen, S
   Nair, KS
   Schmitz, O
   Christiansen, JS
   Moller, N
TI Effects of GH on urea, glucose and lipid metabolism, and insulin
   sensitivity during fasting in GH-deficient patients
SO AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
LA English
DT Article
DE fasting; growth hormone; substrate metabolism
ID FREE FATTY-ACIDS; GROWTH-HORMONE; NORMAL MEN; FOREARM METABOLISM;
   DIABETES-MELLITUS; HUMAN-SERUM; AMINO-ACID; STIMULATION; RESISTANCE;
   SECRETION
AB Fasting-related states of distress pose major health problems, and growth hormone (GH) plays a key role in this context. The present study was designed to assess the effects of GH on substrate metabolism and insulin sensitivity during short-term fasting. Six GH-deficient adults underwent 42.5 h of fasting on two occasions, with and without concomitant GH replacement. Palmitate and urea fluxes were measured with the steady-state isotope dilution technique after infusion of [9,10-H-3] palmitate and [C-13] urea. During fasting with GH replacement, palmitate concentrations and fluxes increased by 50% [ palmitate: 378 +/- 42 (GH) vs. 244 +/- 12 mumol/l, P < 0.05; palmitate: 412 +/- 58 (GH) vs. 276 +/- 42 mu M, P = 0.05], and urea turnover and excretion decreased by 30 - 35% [ urea rate of appearance: 336 +/- 22 (GH) vs. 439 +/- 43 mu mol . kg(-1) . h(-1), P < 0.01; urea excretion: 445 +/- 43 (GH) vs. 602 +/- 74 mmol/24 h, P < 0.05]. Insulin sensitivity ( determined by a euglycemic hyperinsulinemic clamp) was significantly decreased [M value: 1.26 +/- 0.06 (GH) vs. 2.07 +/- 0.22 mg . kg(-1) . min(-1), P < 0.01] during fasting with GH replacement. In conclusion, continued GH replacement during fasting in GH-deficient adults decreases insulin sensitivity, increases lipid utilization, and conserves protein.
C1 Arhus Univ Hosp, Med Dept Endocrinol & Diabet M, DK-8000 Aarhus C, Denmark.
   Arhus Univ Hosp, Inst Expt Clin Res, DK-8000 Aarhus C, Denmark.
   Mayo Clin, Div Endocrinol, Rochester, MN 55905 USA.
RP Norrelund, H (reprint author), Arhus Kommune Hosp, Med Dept M, DK-8000 Aarhus C, Denmark.
EM helenenorrelund@dadlnet.dk
RI Moller, Niels/E-5091-2011
OI Moller, Niels/0000-0001-5627-7322
CR BAGDADE JD, 1970, NEW ENGL J MED, V282, P166
   BAK JF, 1991, AM J PHYSIOL, V260, pE736
   BODEN G, 1991, J CLIN INVEST, V88, P960, DOI 10.1172/JCI115399
   BOUGNERES PF, 1985, J CLIN ENDOCR METAB, V61, P1152, DOI 10.1210/jcem-61-6-1152
   BRATUSCHMARRAIN PR, 1982, J CLIN ENDOCR METAB, V55, P973, DOI 10.1210/jcem-55-5-973
   BUTLER P, 1991, AM J PHYSIOL, V260, pE513
   COPELAND KC, 1980, J CLIN ENDOCR METAB, V50, P690, DOI 10.1210/jcem-50-4-690
   ERIKSSON BM, 1982, J CHROMATOGR, V228, P143, DOI 10.1016/S0378-4347(00)80427-2
   FELIG P, 1969, J CLIN INVEST, V48, P584, DOI 10.1172/JCI106017
   FINEBERG SE, 1974, DIABETES, V23, P499, DOI 10.2337/diab.23.6.499
   FOWELIN J, 1991, DIABETOLOGIA, V34, P500, DOI 10.1007/BF00403286
   FRAYN KN, 1983, J APPL PHYSIOL, V55, P628
   FRYSTYK J, 1994, FEBS LETT, V348, P185, DOI 10.1016/0014-5793(94)00602-4
   Frystyk J, 1995, GROWTH REGULAT, V5, P169
   HAMADEH MJ, 1998, AM J PHYSIOL, V37, pE547
   HARRISON J, 1988, J CLIN CHEM CLIN BIO, V26, P141
   HARTMAN ML, 1992, J CLIN ENDOCR METAB, V74, P757, DOI 10.1210/jc.74.4.757
   HAYMOND MW, 1976, J CLIN ENDOCR METAB, V42, P846, DOI 10.1210/jcem-42-5-846
   HO KY, 1988, J CLIN INVEST, V81, P968, DOI 10.1172/JCI113450
   JAHOOR F, 1987, AM J PHYSIOL, V252, pE557
   JENSEN MD, 1988, AM J PHYSIOL, V254, pE562
   MILES JM, 1987, AM J PHYSIOL, V252, pE431
   MOLLER N, 1989, DIABETOLOGIA, V32, P105, DOI 10.1007/BF00505182
   MOLLER N, 1990, J CLIN ENDOCR METAB, V70, P1179, DOI 10.1210/jcem-70-4-1179
   MOLLER N, 1990, AM J PHYSIOL, V258, pE86
   Nielsen S, 2001, DIABETES, V50, P2301, DOI 10.2337/diabetes.50.10.2301
   Norrelund H, 2001, J CLIN ENDOCR METAB, V86, P3120, DOI 10.1210/jc.86.7.3120
   Norrelund H, 2001, DIABETES, V50, P96, DOI 10.2337/diabetes.50.1.96
   ORSKOV H, 1968, NATURE, V219, P193, DOI 10.1038/219193b0
   ORSKOV L, 1989, J CLIN ENDOCR METAB, V68, P276, DOI 10.1210/jcem-68-2-276
   Piatti PM, 1999, J CLIN ENDOCR METAB, V84, P1658, DOI 10.1210/jc.84.5.1658
   RANDLE PJ, 1963, LANCET, V1, P785
   RATHGEB I, 1970, DIABETES, V19, P487, DOI 10.2337/diab.19.7.487
   RIZZA RA, 1982, DIABETES, V31, P663, DOI 10.2337/diabetes.31.8.663
   Santomauro ATMG, 1999, DIABETES, V48, P1836, DOI 10.2337/diabetes.48.9.1836
   Segerlantz M, 2001, J CLIN ENDOCR METAB, V86, P5813, DOI 10.1210/jc.86.12.5813
   SHERWIN RS, 1975, J CLIN INVEST, V55, P1382, DOI 10.1172/JCI108057
   SHERWIN RS, 1983, DIABETOLOGIA, V24, P155
   SIREK A, 1979, AM J PHYSIOL, V237, pE107
   TAI TY, 1976, ENDOCRINOLOGY, V99, P669, DOI 10.1210/endo-99-3-669
   VAAG A, 1991, J CLIN INVEST, V88, P1282, DOI 10.1172/JCI115432
   YKIJARVINEN H, 1991, J CLIN ENDOCR METAB, V72, P1268, DOI 10.1210/jcem-72-6-1268
   ZIERLER KL, 1963, MEDICINE, V42, P385, DOI 10.1097/00005792-196311000-00002
NR 43
TC 27
Z9 28
U1 0
U2 1
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0193-1849
EI 1522-1555
J9 AM J PHYSIOL-ENDOC M
JI Am. J. Physiol.-Endocrinol. Metab.
PD OCT 1
PY 2003
VL 285
IS 4
BP E737
EP E743
DI 10.1152/ajpendo.00092.2003
PG 7
WC Endocrinology & Metabolism; Physiology
SC Endocrinology & Metabolism; Physiology
GA 718ZU
UT WOS:000185178200008
PM 12799313
DA 2019-01-08
ER

PT J
AU Matteucci, E
   Giampietro, O
AF Matteucci, E
   Giampietro, O
TI Closing the gap between literature and practice: Evaluation of a
   teaching programme (in the absence of a structured treatment) on both
   Type 1 and Type 2 diabetes
SO DIABETES NUTRITION & METABOLISM
LA English
DT Article
DE diabetes mellitus; metabolic control; education; anxiety; depression;
   general self-efficacy
ID RANDOMIZED CONTROLLED-TRIAL; QUALITY-OF-LIFE; EDUCATION-PROGRAM;
   GENERAL-PRACTICE; INSULIN THERAPY; MELLITUS; IMPACT; ADOLESCENTS;
   DEPRESSION; OUTCOMES
AB Athough education is considered an integral part of diabetes management, it remains low in the practical priorities of clinicians. We performed the first structured educational intervention in a diabetic outpatient department, where patients were controlled with no provider autonomy support available. We recruited 77 Type 1 (T1DM) and 154 Type 2 diabetic (T2DM) patients as well as 87 matched control subjects. Baseline evaluation included: medical interview; questionnaires concerning diabetes knowledge, diabetes quality of life, state-trait anxiety, depression and general perceived self-efficacy; biochemical examination (fasting blood glucose, HbA(1c) lipids, uric acid, urinary glucose and albumin excretion). Of the 231 diabetic patients, 154 agreed to attend an educational course, yet only 101 patients (37 T1DM and 64 T2DM) completed it (intervention group) due to organisational barriers. Intervention and reference (non-participant patients) groups received identical medical care, except that the educational group met with the educator during five teaching sessions. Three to six months after the completion of the course, they underwent a final assessment. Prospective results were: 1) in T1DM, a reduction in HbA(1c) levels and an increase in plasma HDL cholesterol with no change in drug treatment (the reference group showed no change in HbA(1c) values despite an increased insulin dose), improved technical skill, knowledge, quality of life and self-efficacy; 2) in T2DM, a reduction in fasting plasma glucose and an improvement in knowledge and quality of life. Analysis of the cross-sectional data at baseline evidenced: 3) the same levels of anxiety, depression and general self-efficacy in diabetic patients compared with healthy control subjects; 4) lower diabetes-specific quality of life associated with established insulin treatment in T2DM; 5) significant gender differences among healthy as well as diabetic subjects in degree of psychological distress. Education by itself is more than simply offering information to people (even in a troubled context) and its infrequent incorporation in practice really contradicts resource efficiency. (C) 2003, Editrice Kurtis.
C1 Univ Pisa, Med Clin 2, Dipartimento Med Interna, I-56100 Pisa, Italy.
RP Giampietro, O (reprint author), Univ Pisa, Med Clin 2, Dipartimento Med Interna, Via Roma 67, I-56100 Pisa, Italy.
EM ematteuc@int.med.unipi.it
CR Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069
   Berger M, 1999, JAMA-J AM MED ASSOC, V281, P1676, DOI 10.1001/jama.281.18.1676
   BRADSHAW C, 1999, PRACT DIAB INT, V16, P241
   Clark CM, 1999, ANN INTERN MED, V130, P324, DOI 10.7326/0003-4819-130-4-199902160-00020
   Davis TME, 2001, DIABETES RES CLIN PR, V52, P63, DOI 10.1016/S0168-8227(00)00245-X
   DAY JL, 1996, PRACT DIAB INT, V13, P125
   DCCT Res Grp, 1988, DIABETES CARE, V11, P725
   Gaede P, 2001, DIABETIC MED, V18, P104, DOI 10.1046/j.1464-5491.2001.00444.x
   GLASGOW RE, 1992, DIABETES CARE, V15, P1423, DOI 10.2337/diacare.15.10.1423
   Glasgow RE, 1999, DIABETES CARE, V22, P832, DOI 10.2337/diacare.22.5.832
   Grey M, 1998, DIABETES CARE, V21, P902, DOI 10.2337/diacare.21.6.902
   Grey M, 2001, J ADOLESCENT HEALTH, V28, P377, DOI 10.1016/S1054-139X(00)00211-1
   Kerse NM, 1999, BRIT MED J, V319, P683, DOI 10.1136/bmj.319.7211.683
   Kinmonth AL, 1998, BRIT MED J, V317, P1202, DOI 10.1136/bmj.317.7167.1202
   KRONSBEIN P, 1988, LANCET, V2, P1407
   MANNUCCI E, 1995, DIABETES CARE, V18, P237
   Matteucci E, 2000, DIABETES CARE, V23, P1182, DOI 10.2337/diacare.23.8.1182
   Paterson B, 2001, J ADV NURS, V34, P574, DOI 10.1046/j.1365-2648.2001.01786.x
   PEYROT M, 1991, P SAT S BEH ASP DIAB
   Renders CM, 2001, DIABETES CARE, V24, P1365, DOI 10.2337/diacare.24.8.1365
   Rose M, 1998, DIABETES CARE, V21, P1876, DOI 10.2337/diacare.21.11.1876
   Sarkadi A, 2001, PATIENT EDUC COUNS, V44, P129, DOI 10.1016/S0738-3991(00)00170-1
   Schwarzer R, 1995, MEASURES HLTH PSYCHO, P35, DOI DOI 10.1037/T00393-000
   Sidorov J, 2000, AM J MANAG CARE, V6, P1217
   SPIELBERGER CD, 1983, MANUAL STATE TRAIT A
   Surgenor LJ, 2000, J PSYCHOSOM RES, V49, P267, DOI 10.1016/S0022-3999(00)00181-1
   Williams GC, 1998, DIABETES CARE, V21, P1644, DOI 10.2337/diacare.21.10.1644
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
NR 28
TC 3
Z9 4
U1 1
U2 5
PU EDITRICE KURTIS S R L
PI MILAN
PA VIA LUIGI ZOJA 30, 20153 MILAN, ITALY
SN 0394-3402
J9 DIABETES NUTR METAB
JI Diabetes Nutr. Metab.
PD OCT-DEC
PY 2003
VL 16
IS 5-6
BP 298
EP 305
PG 8
WC Endocrinology & Metabolism; Nutrition & Dietetics
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 769QV
UT WOS:000188662000005
PM 15000441
DA 2019-01-08
ER

EF